<SEC-DOCUMENT>0001792044-22-000010.txt : 20220228
<SEC-HEADER>0001792044-22-000010.hdr.sgml : 20220228
<ACCEPTANCE-DATETIME>20220228161026
ACCESSION NUMBER:		0001792044-22-000010
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		150
CONFORMED PERIOD OF REPORT:	20211231
FILED AS OF DATE:		20220228
DATE AS OF CHANGE:		20220228

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Viatris Inc
		CENTRAL INDEX KEY:			0001792044
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				834364296
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39695
		FILM NUMBER:		22689559

	BUSINESS ADDRESS:	
		STREET 1:		1000 MYLAN BOULEVARD
		CITY:			CANONSBURG
		STATE:			PA
		ZIP:			15317
		BUSINESS PHONE:		(724) 514-1465

	MAIL ADDRESS:	
		STREET 1:		1000 MYLAN BOULEVARD
		CITY:			CANONSBURG
		STATE:			PA
		ZIP:			15317

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Upjohn Inc
		DATE OF NAME CHANGE:	20191023
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>vtrs-20211231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:7d588a56-150d-4ea9-a97c-5b39f92c59e0,g:83cb92d0-838c-40d0-a420-8487c2f4fc1b,d:e2fdfbf3ed474f27b20ef16155bfdf72--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:vtrs="http://www.viatris.com/20211231" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>vtrs-20211231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml83L2ZyYWc6MzNiOWUxYTlmOWZkNGJkYzk4YjJhYWFiNjA0OTQxNmIvdGFibGU6Mjk3ZTc4YzViODNmNDI3NWE2MzhjMzQwMjgwYzFiNzQvdGFibGVyYW5nZToyOTdlNzhjNWI4M2Y0Mjc1YTYzOGMzNDAyODBjMWI3NF8yLTEtMS0xLTMxNDIy_e66f2b19-5be2-411d-8461-223689120c55">0001792044</ix:nonNumeric><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml83L2ZyYWc6MzNiOWUxYTlmOWZkNGJkYzk4YjJhYWFiNjA0OTQxNmIvdGFibGU6Mjk3ZTc4YzViODNmNDI3NWE2MzhjMzQwMjgwYzFiNzQvdGFibGVyYW5nZToyOTdlNzhjNWI4M2Y0Mjc1YTYzOGMzNDAyODBjMWI3NF80LTMtMS0xLTMxNDIy_3b8314a4-63de-4401-b41f-7a99ecb33608">2021-12-31</ix:nonNumeric><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml83L2ZyYWc6MzNiOWUxYTlmOWZkNGJkYzk4YjJhYWFiNjA0OTQxNmIvdGFibGU6Mjk3ZTc4YzViODNmNDI3NWE2MzhjMzQwMjgwYzFiNzQvdGFibGVyYW5nZToyOTdlNzhjNWI4M2Y0Mjc1YTYzOGMzNDAyODBjMWI3NF81LTEtMS0xLTMxNDIy_febcfdeb-b0fb-408f-9b30-9859d8b2b3a7">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml83L2ZyYWc6MzNiOWUxYTlmOWZkNGJkYzk4YjJhYWFiNjA0OTQxNmIvdGFibGU6Mjk3ZTc4YzViODNmNDI3NWE2MzhjMzQwMjgwYzFiNzQvdGFibGVyYW5nZToyOTdlNzhjNWI4M2Y0Mjc1YTYzOGMzNDAyODBjMWI3NF82LTEtMS0xLTMxNDIy_1564e39a-a112-4b48-8dcd-238cf46f5777">2021</ix:nonNumeric><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml83L2ZyYWc6MzNiOWUxYTlmOWZkNGJkYzk4YjJhYWFiNjA0OTQxNmIvdGFibGU6Mjk3ZTc4YzViODNmNDI3NWE2MzhjMzQwMjgwYzFiNzQvdGFibGVyYW5nZToyOTdlNzhjNWI4M2Y0Mjc1YTYzOGMzNDAyODBjMWI3NF83LTEtMS0xLTMxNDIy_705edd04-80d7-4cd0-8da2-bcce1b17e920">FY</ix:nonNumeric><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml83L2ZyYWc6MzNiOWUxYTlmOWZkNGJkYzk4YjJhYWFiNjA0OTQxNmIvdGFibGU6Mjk3ZTc4YzViODNmNDI3NWE2MzhjMzQwMjgwYzFiNzQvdGFibGVyYW5nZToyOTdlNzhjNWI4M2Y0Mjc1YTYzOGMzNDAyODBjMWI3NF84LTEtMS0xLTMxNDIy_76605119-2725-450e-abb2-52211d9a70bd">December 31</ix:nonNumeric><ix:nonNumeric contextRef="i2d63a308e1b544aa993161c92d8cb125_D20201113-20201113" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzQ2NzE_7b74b1b4-9fe4-486d-b533-a57949c797fb">P5Y</ix:nonNumeric><ix:nonNumeric contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTMvZnJhZzo2ZWFmNDE2OTBmODU0ZGZlODEzNTY2MTVhNzRiNTI2ZC90YWJsZTo5ODM1Nzk3ZDRjY2I0ZTkyOGI2YzkyYWVhZTQ0MmJmNy90YWJsZXJhbmdlOjk4MzU3OTdkNGNjYjRlOTI4YjZjOTJhZWFlNDQyYmY3XzEtMC0xLTEtMzE0MjI_5d3710a9-3cc1-4033-a1c1-2c401012a753">http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTMvZnJhZzo2ZWFmNDE2OTBmODU0ZGZlODEzNTY2MTVhNzRiNTI2ZC90YWJsZTo5ODM1Nzk3ZDRjY2I0ZTkyOGI2YzkyYWVhZTQ0MmJmNy90YWJsZXJhbmdlOjk4MzU3OTdkNGNjYjRlOTI4YjZjOTJhZWFlNDQyYmY3XzEtMC0xLTEtMzE0MjI_d91afb44-c711-4a5d-bbbf-c4f2ea533df5">http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTMvZnJhZzo2ZWFmNDE2OTBmODU0ZGZlODEzNTY2MTVhNzRiNTI2ZC90YWJsZTo5ODM1Nzk3ZDRjY2I0ZTkyOGI2YzkyYWVhZTQ0MmJmNy90YWJsZXJhbmdlOjk4MzU3OTdkNGNjYjRlOTI4YjZjOTJhZWFlNDQyYmY3XzItMC0xLTEtMzE0MjI_055cf0e5-821f-4b2e-b5d4-feef52c31120">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTMvZnJhZzo2ZWFmNDE2OTBmODU0ZGZlODEzNTY2MTVhNzRiNTI2ZC90YWJsZTo5ODM1Nzk3ZDRjY2I0ZTkyOGI2YzkyYWVhZTQ0MmJmNy90YWJsZXJhbmdlOjk4MzU3OTdkNGNjYjRlOTI4YjZjOTJhZWFlNDQyYmY3XzItMC0xLTEtMzE0MjI_f0eb0100-3b43-4acb-a28a-b753e8c626a9">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTMvZnJhZzo2ZWFmNDE2OTBmODU0ZGZlODEzNTY2MTVhNzRiNTI2ZC90YWJsZTo5ODM1Nzk3ZDRjY2I0ZTkyOGI2YzkyYWVhZTQ0MmJmNy90YWJsZXJhbmdlOjk4MzU3OTdkNGNjYjRlOTI4YjZjOTJhZWFlNDQyYmY3XzMtMC0xLTEtMzE0MjI_126f3dd7-c76c-4f67-8736-69a850308556">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTMvZnJhZzo2ZWFmNDE2OTBmODU0ZGZlODEzNTY2MTVhNzRiNTI2ZC90YWJsZTo5ODM1Nzk3ZDRjY2I0ZTkyOGI2YzkyYWVhZTQ0MmJmNy90YWJsZXJhbmdlOjk4MzU3OTdkNGNjYjRlOTI4YjZjOTJhZWFlNDQyYmY3XzMtMC0xLTEtMzE0MjI_22a8adf1-c271-499b-bf41-e81a3d3d7e3a">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDUvZnJhZzozMDMwNmJhZmM1ZjA0ZjkyOTg0NWNjNTE2MjQzNDRkNy90YWJsZTpkOTQ5NDdkZjM2MGQ0NGFjOTkzNzhiOWYyM2FlOGFhZS90YWJsZXJhbmdlOmQ5NDk0N2RmMzYwZDQ0YWM5OTM3OGI5ZjIzYWU4YWFlXzAtMi0xLTEtMzE0MjI_8f8f2dca-8292-47ef-af0f-e53c2fdf5259">750.0</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="ib1bca36d1f664aa5be8e32facac152b9_I20201231" decimals="3" name="us-gaap:DerivativeAssetLiabilityNetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDUvZnJhZzozMDMwNmJhZmM1ZjA0ZjkyOTg0NWNjNTE2MjQzNDRkNy90YWJsZTpkOTQ5NDdkZjM2MGQ0NGFjOTkzNzhiOWYyM2FlOGFhZS90YWJsZXJhbmdlOmQ5NDk0N2RmMzYwZDQ0YWM5OTM3OGI5ZjIzYWU4YWFlXzEtMi0xLTEtMzE0MjI_02e76f85-d199-417f-8c9f-6c2eaa4efdae">2.1</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="iae67483ac8724d79b23607cbe3f99173_I20201231" decimals="3" name="us-gaap:DerivativeAssetLiabilityNetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDUvZnJhZzozMDMwNmJhZmM1ZjA0ZjkyOTg0NWNjNTE2MjQzNDRkNy90YWJsZTpkOTQ5NDdkZjM2MGQ0NGFjOTkzNzhiOWYyM2FlOGFhZS90YWJsZXJhbmdlOmQ5NDk0N2RmMzYwZDQ0YWM5OTM3OGI5ZjIzYWU4YWFlXzItMi0xLTEtMzE0MjI_abbab120-0d2c-4a1c-a210-90ed6df88342">10.5</ix:nonFraction><ix:nonNumeric contextRef="i9ac84504406d464583bea255d4678e35_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzE2Mjc_08ccde51-39fc-462c-a345-1572757200f2">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="ide9073c6a7c5441b8fcaffca6958c382_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzI2NDI_f3b767c1-16ad-4e4f-bd76-18f9bc8ce9a6">P3Y0M</ix:nonNumeric><ix:nonNumeric contextRef="ide9073c6a7c5441b8fcaffca6958c382_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzEyNjQ0MzgzNzI3MzQ5_f3b767c1-16ad-4e4f-bd76-18f9bc8ce9a6">P3Y0M</ix:nonNumeric><ix:nonNumeric contextRef="i9ac84504406d464583bea255d4678e35_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjMvZnJhZzphNGMyZDEyYTg1OTI0YTkyYmQwZDgzODM3YWMzNzdmMy90ZXh0cmVnaW9uOmE0YzJkMTJhODU5MjRhOTJiZDBkODM4MzdhYzM3N2YzXzIxOA_08ccde51-39fc-462c-a345-1572757200f2">three years</ix:nonNumeric><ix:nonNumeric contextRef="iff2871529dca49568da0067c4e5a5e0f_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjMvZnJhZzphNGMyZDEyYTg1OTI0YTkyYmQwZDgzODM3YWMzNzdmMy90ZXh0cmVnaW9uOmE0YzJkMTJhODU5MjRhOTJiZDBkODM4MzdhYzM3N2YzXzIyNA_03cba3f3-9320-42e2-9c6d-f9bd91619a00">four years</ix:nonNumeric><ix:nonNumeric contextRef="i2ee490046709489aa5f4269ad8f50ae8_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjMvZnJhZzphNGMyZDEyYTg1OTI0YTkyYmQwZDgzODM3YWMzNzdmMy90ZXh0cmVnaW9uOmE0YzJkMTJhODU5MjRhOTJiZDBkODM4MzdhYzM3N2YzXzI1Mg_c6be35ff-7474-4d0a-8808-913aaece6ea7">ten years</ix:nonNumeric><ix:nonNumeric contextRef="i2a6462103eda4e1aaf682901857ca256_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjMvZnJhZzphNGMyZDEyYTg1OTI0YTkyYmQwZDgzODM3YWMzNzdmMy90ZXh0cmVnaW9uOmE0YzJkMTJhODU5MjRhOTJiZDBkODM4MzdhYzM3N2YzXzMyMA_6cfb86d3-e4b8-496a-8391-ba38a4d15673">five years</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="vtrs-20211231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13f4973de7d347c1990aa06418f9a87d_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="idb49b3416a6648899c9dbb31e728c519_I20220222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-02-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i36d66b81144849148d1319e8bfed3c96_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d077e089f704543858c47bf4c5566bf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39d4f9fa88c04ae0856b7faa1bf73798_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic25b2c6a9a1244738c1de493abb87705_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f25078033394f518263d14867ea4eb6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iadb0452c57794c5498c4248d6691b32c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2b4674a5a824635bbb161ea5fe82fea_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie779f16aabc14a74b5468853e37f6dd2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id568b4f1929446b9942b42b58b8e069f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbe7edb935be4af4a3721e260440024e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b0e6896d0904a51b7f3d01a54c4ddc3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie99d2b10b5fa41a2b69de441e703d1be_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72a4e38013274704acf3fce567aec1b6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie12ac8dbb8e34d9bbb1bb903a175a2c8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57c4f10b75634ea68f1dca6a931ad8e6_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c63b953f9ab4ca380c2a6718f3499d2_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia50f87af01074210b75c18963d37110d_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0df3c349ea2b4fbfba28ebfb584419f0_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib23cdc694f6547709893256e80430c38_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibadea9a32ce84dc48523b37b0f0b23ce_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8ec92ba24d848d697ba737aeed13c05_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f90527bae0344d981ff43fd2126b229_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5143c6332d7249db9f3409e36def6483_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0cf1109448e4942a109317479a8de2d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic877d36b0d2e41a293e8217247ace76e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i759302137d4347189f09b28fddcb4d55_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i676ac4a93e7c42cf8130b6170dc1899a_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f069b3a590b4f41809c068d4484a771_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37a67212c0ef46a4ad4f6aa75d225fed_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00d14723d68d4566b474e37cf199d470_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia780b2ac8321464bae70f392c4b8e0ac_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd43c5aaf4d94827a901e78c27e732f7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib85f7a5cf6f64a0e84c35ebc74cd0576_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic39189fc54504b53be3c4281e5dd8f82_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac503b6d629d4bafb262ea6ec0b8a25e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc41db043d3e4f84b4c531fda801f18c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e5cd61854a54e59a6e1744de70eab75_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4251244738d4104aa6f320d2729ecf7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1aaa5a37c6f4415aaac4b207251f9e26_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i614ccdb2c5cd4297b966274861517991_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia12703913f6e4df58b4262b9bbb6ea77_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d45fba46a924824a984d4a911f8510f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba866be0d0f04d0cbdf171873fd7fd0b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14dba6c874d24fcfae05dbedf70952aa_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92e45e4918604661b681cd5b227d7bcc_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifcb976e09f3943ed918be4bf207b55e3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09fc106c667c4de189765013dc4a94ef_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7c969d8800446acace677aeab6fa885_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7428ecd34bd643bfb53dd62a4bce788c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if13be5161c804163b4305d5d326bef7e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a6cdd4c97954d22af41797509ecf7fb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87a0adf309ee48cab4e379bd487453b4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="molecule"><xbrli:measure>vtrs:molecule</xbrli:measure></xbrli:unit><xbrli:unit id="site"><xbrli:measure>vtrs:site</xbrli:measure></xbrli:unit><xbrli:context id="i8c96921a8e77407497a3fe28076245b9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i982f994b896949038225ee2127e449b8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17e28a6fde804fee9a50f41480db4409_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f9c5e0f0ba44c18819a8dd18e51076c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33eb2ebb7c134785bb1904a27dee8446_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ecc2d6f42a84a91b65e020dbcaad871_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84ab0bd68a334690be79969b61dd4796_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i500214b091fd4491a3e5f7c09d556da9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52196ab9082e4abaa0b8161e828c13e6_D20211216-20211216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-16</xbrli:startDate><xbrli:endDate>2021-12-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0914e4cffd32443cb84e261c6290c882_D20210616-20210616"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-16</xbrli:startDate><xbrli:endDate>2021-06-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49c23bc660594338939e7cd39689f85c_D20210916-20210916"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-16</xbrli:startDate><xbrli:endDate>2021-09-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85acd539c52b4ddd8dbb4b2c90aedaa6_D20220106-20220106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-06</xbrli:startDate><xbrli:endDate>2022-01-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1b5d3649e684795b5f4c627d6ba66fa_I20220316"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia473d9dc16fb4846abacc46ab07e5dd4_I20220228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90374f5d9f1b4c92a65a560a42412201_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iead6205586b04557a8ada1d7b914b227_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f125b5601ba485fa87e1359408bb169_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icdcd2c5e3dc049c9af2e2879fc06a18a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d43c5886aae45d78bf51b4acef73ab6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96fc2bf65c384f6d95e6f124e5de94a4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc09cb425c1a4b00bebeb7a3b1d088e4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i773e23ec8b4f40d2892b90d9c9b32095_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b2cacb9811a4855a05fcf61e040a1d7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbdc76c08f4f4be1a89d1b41630e9c46_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1cdfba9175504c2887d1d60461bee852_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i269ffde73a154b28805576347563a5cb_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic535a9058568425bb3eb5f0763a47e3d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie684c80cdcef4397b8798cbb98e6a796_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2a6d40b5f364731b5c17ef708876be7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ac0bcd2e1264e8b8347af73e216d016_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ed92dccf2314bd48c7373be7cf33d4e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ccdc9914af44b1bb1229e19c17326d8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02b3f133daa24190abd49dfdef6bb6ce_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2ddd71cee624b009233ae18ff01bcdb_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97c939970b2a44ec93ec3adde4f66f7a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1831edfa3a5a49a4bb77c12a7484690f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9abda492c204a6db32dc9d58d9d3283_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05eae9ce2c1146cda2761d09e8dfafec_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86d67a91f60c42daae98c579adcd3ce6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i835c7b50b49142419f07188c47c94df3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27e66858837c4e0e95198bd461c39df7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3131c3ac2a04122b50238e3e2e46c6e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4108be32c0e74b899efbefe5401e783f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i226439d9ee1a49f6b1bb3182d0a8d06d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i105959ab42be4a4484a43c24d4643610_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib26272e8a91e4d71b3b831cda82ccb89_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a9efc1a735d41babd68b5c507c58032_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe1b26c10c8d49dcb8d293449427f7d1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d668c3c2f2946a49634c6f0bfb9cdee_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec0737b261124d3f87ea9adcdb407b5a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e0c5048f8f84f26a1949d61f3285173_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d06b2c023334d92a7c83b2943f0232b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i281863eb67c44d0fbc00294dfaf0049c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icdd7bc10185c4685b4d14c9b6ac151b1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61ed8d945a654397b38ffd9a5155cc8a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a4ad71e069349d4bc77dedb205f5b6e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75185d8bca2c4c33b481ec3ed8ab4bc2_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9929171805eb41e3845525fcedeefdd7_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac08a240cf724732a33d7e4c11a51983_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic72949e3219d4b0db2547334d44e5760_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic570f6e38a0546fb9e89a31a80462c9b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f7590527ef14168a6dd4e6a2b81c5c7_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1614ddc606441f19d547ba1a785e380_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11d08a6a376f45179f8e6bb95bd31c27_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i309244cf155a4aba9fca199455319a32_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67d9cb8141084c58ac541cde4d576c50_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3166a2866ade49869d6aad191a5c8ef2_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iecf0266755484cffb55ddc7ba73da178_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff24ee1fc1974d94b68eb9cffe4e3dbf_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i864642c0e47a4b87a88be339d6673670_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4221a0900a14ced8a5c91eac2fcdf4f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94d3655a9cb44f37b3319f0d91bf87b1_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f91beda5d054492aed05bdaf3b7936e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84058a24993540f0abbe391aeff14baa_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:LipitorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac2df693fdec46b2a004f4136d918a15_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:NorvascMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02f7c66517fd42e99c981b2754110472_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:LyricaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2fb4efa6d51f4b0d81d894b26998702c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ViagraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5b45e5acb5a43d086ab1d31fe635f90_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:EpiPenAutoInjectorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32b74097924040a6a3b293c9de50757b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:CelebrexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29c8e33fbfc54cebb3298eb792f30230_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:CreonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b3ecbda1fdf4ee18c4b7043b1c74bd3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ZoloftMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45c0dc93080d496b936cfa154fdd5d2f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:EffexorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f3025b784d24010ab35acb02af8509d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:XalabrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b1907e0d66348049123902a21dcf855_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:InfluvacMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40e3530192d947059647f2b6af9576ce_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:AmitizaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bb2b10fff8b4b20b4933b549ff5105e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:XanaxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09fb6f5ceb234f24b3a2fd5497a71b54_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:YupelriMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c6990bf97834a12a1ac825a254bf046_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:DymistaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia30145a9cfd34adf9f91e6f9a1d897d6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="vtrs:VariableConsiderationCategoryAxis">vtrs:ChargebacksMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">vtrs:VariableConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81f43377851f4e9cbe28368c42243f3f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="vtrs:VariableConsiderationCategoryAxis">vtrs:ChargebacksMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">vtrs:VariableConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if864aa5c3fc0487aa3a78da7140b6dae_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="vtrs:VariableConsiderationCategoryAxis">vtrs:ChargebacksMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">vtrs:VariableConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59d64e28e4b04c0d99f30844bbc4e104_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="vtrs:VariableConsiderationCategoryAxis">vtrs:RebatesPromotionalProgramsandOtherSalesAllowancesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">vtrs:VariableConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67c331d11f9e4f3a92ca17c2d501cc83_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="vtrs:VariableConsiderationCategoryAxis">vtrs:RebatesPromotionalProgramsandOtherSalesAllowancesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">vtrs:VariableConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id58d328313c7408dbd05e2611ee1d266_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="vtrs:VariableConsiderationCategoryAxis">vtrs:RebatesPromotionalProgramsandOtherSalesAllowancesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">vtrs:VariableConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0a5fc9ab1014cc9828221ef14219272_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">vtrs:VariableConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="vtrs:VariableConsiderationCategoryAxis">vtrs:VariableConsiderationReturnsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62c2d36cecfc429d8366c26884930d60_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">vtrs:VariableConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="vtrs:VariableConsiderationCategoryAxis">vtrs:VariableConsiderationReturnsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3efb27c0d9ce4732970b87f4f7b6cadf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">vtrs:VariableConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="vtrs:VariableConsiderationCategoryAxis">vtrs:VariableConsiderationReturnsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab5c4046b8d2456db70b484a5adc2c29_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="vtrs:VariableConsiderationCategoryAxis">vtrs:GovernmentalRebateProgramsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">vtrs:VariableConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie03fd9221eda4da4a0b73570d90c8f67_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="vtrs:VariableConsiderationCategoryAxis">vtrs:GovernmentalRebateProgramsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">vtrs:VariableConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie35e86a55b3646a392f2363a1ff84e7f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="vtrs:VariableConsiderationCategoryAxis">vtrs:GovernmentalRebateProgramsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">vtrs:VariableConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8299fb24ad740a0bc5299022149cc89_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">vtrs:VariableConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25df0d0412f4491d87734041970219e9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">vtrs:VariableConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4f62d5c61184fe0a10c432fdf606fac_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">vtrs:VariableConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic23fe954f12a4fafb334644ca65a1579_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8aaae8d197ef43d0880965d47a937ced_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8023e485af7e4af6b209e877aaef3977_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">vtrs:ThreeCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i594757645c9e47d297a0b656a9168fb9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">vtrs:ThreeCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic831d526d86b425a838a3b514a51aa9b_I20190729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic08788a5b48c49cd8ad76565947aec25_I20190729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis">vtrs:PfizerInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1612a93b9c54c9ea53906da30119111_I20190729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35d0a01da1c741dc96caa2bc7d221b6f_D20190729-20190729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis">vtrs:PfizerInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-29</xbrli:startDate><xbrli:endDate>2019-07-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14c83873ae33424385c0f6babd91bbf8_I20201116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis">vtrs:PfizerInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73d9cbc916614385999dea1173262904_D20201113-20201113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-13</xbrli:startDate><xbrli:endDate>2020-11-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i383cdb78da1740a096ade479d7d4de29_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28f0f2ea42204c5aa8a8ebd404f312a7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6458ce2b0d942738f7ba444119cf196_I20190528"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-05-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i511ad858abed4134961216e0250f69b8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d755baaf2e14f4bab1de91a766aa0e6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b06121292274e728651da9462422d99_D20201231-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-31</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="market"><xbrli:measure>vtrs:market</xbrli:measure></xbrli:unit><xbrli:context id="i2d63a308e1b544aa993161c92d8cb125_D20201113-20201113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-13</xbrli:startDate><xbrli:endDate>2020-11-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06a1fb578d3742f48890eaae2166c53a_D20201113-20201113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-13</xbrli:startDate><xbrli:endDate>2020-11-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i796a35bd5773494f8cda6075e5980668_D20201113-20201113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-13</xbrli:startDate><xbrli:endDate>2020-11-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6b3029e4d7b457386fcdfda005379fc_I20201113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd8cc0a590a946f6ada83bcfa5b58725_D20201113-20201113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FiniteLivedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-13</xbrli:startDate><xbrli:endDate>2020-11-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54dfb4c408114c26bed39da8f1d171f2_D20201113-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-13</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4bd4b5ab32b4597b343305c1a782d79_D20201201-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis">vtrs:PfizerInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41666c68e32e49d291f852ff50719863_D20200901-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:AspenGlobalIncorporatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="i3210d91021fb432dbd047ea2f8487a57_I20210625"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">us-gaap:ScenarioPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:AspenGlobalIncorporatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3789042552e84c75b2b33ac579e33b2f_D20200901-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:AspenGlobalIncorporatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ccfb22de62b4dbfb381e7e2a79f34d0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97ba3f8ae46a4aaab4fc9b30066a831a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8bf94f5dfaca4ac4a4aee298a2a67610_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b4491a3703940ab85025237197bb24e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie99bf64200a74c20a3b7166e800c0872_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8ad288402464acb99bb2fd89ae7fe54_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ebc8189c1fd4f9aaed3d986d6412d72_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0bb3fb3a406f4ceab9b6b622c49f1572_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i500543a4ebe64602995d53387c0524dd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">vtrs:CleanEnergyPartnershipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i123b716b2a804024a0f1c41058fde09a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">vtrs:CleanEnergyPartnershipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c198dc35fb64539904dc17b63908f02_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i869e9de1ba0e414a8a1c0e4653ab950f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2de25d7ac8784fa18767316538f59631_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">vtrs:CleanEnergyPartnershipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43ea997ac5374cbbb9e8b44ce8488e9c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">vtrs:CleanEnergyPartnershipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8416dfbb7a5942b691bd8f0154ec826e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia89d28ed480a4556840f217684004588_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8227b4a3c2c48d0b659fec7ce3966a0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if35fa5c71ccb4d9cbe31d2dd6c8f7b48_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i284387cf86b54bd4adfef2f32bb9c670_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0853510f8095410c8cab4556a87f5fab_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:ConsolidatedEntityExcludingVieMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6259ebc7ed26431991c3b2aa187c0c91_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:ConsolidatedEntityExcludingVieMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0185425b6174d78bfd3fbdefaaaea64_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:ConsolidatedEntityExcludingVieMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae859ab23c9340b096f1af4c4f554c62_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:ConsolidatedEntityExcludingVieMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09587ab064ca42a8bec631ae169a3af9_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:ConsolidatedEntityExcludingVieMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i315c417d4b374c99bb802f2ca94fe20c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19b7b956b6644bcdb10d4dea546f710e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ca0195877e7427d95d7bf2d7026caa1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia340ab16326e432db33adc76e7d83306_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38a0011834694e8599d458b848606328_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25616a483e2e4a3da1bdb481fdcdc776_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93e12956332b44a59bb64bc33354f7ee_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec758a60e4bd425e896c1f35e907763b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibcede0739e844bf0be1dd96355937b5b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i257d82c8b1324095a90197f7a7cfb225_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i783790c3f4764f4f86bb8f68bcb4fff2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98548692221d4033bf9d5dc6b6466a25_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id71374cb5c304b1b8b38cd06a22b2e88_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ca13749baf74114b35b0784dde6edb1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i283b1cce431d414ab5f875e9a4bcbd90_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieade6f9a084b4f2eb5b23630a93f657d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia10b2e6ad58c4c4bb99c064d555b97da_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6bf87e450da84c279d1a95ba5e923d3e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55f2fb13e460418aa9bf86f68ca38852_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5caf17f0c9ca41c58ddd4ef0394bdc79_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id11e45101185446494c54622bb9b8177_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iade66ffae6e040cfa629525230c6273c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5450616961442a2b1ea8144698c669c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0395335aee314265a48396d57455b625_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd3f720b0b1c41c799a80daa8a9b8e4b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24495761b1564b3aaeeb420062790b06_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95eaf84899294b5cb1284e1df6d5d766_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31d60f66b7ca4f7b854b44502d7569c6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4832437dbcd3485cb386c3787124ef0c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83aed7ea547a47a2b816fee23196130f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fe4acec3d334f5c9bf8565f72ff2a83_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i955ba774e0a548c287a702e8c5749900_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaceccbde3b074329b263bcda37586891_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1479b6b2aacb40b29f35cd42b1e22f9f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifaa8db533b7d4f489edaa8a8c7c3b889_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c77a702a1dc4bd4b4d96321e085c678_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9674aa9104274c98b38914ca35d5f4c1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec67624464a845eeafd1548788c90737_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib511387dd7a949499aa59b3b5b4db16a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42391df0c964452ab8b60c6d0285b8cc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2edb03cf70c94cf8b258388ec10a11e8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia550848323274182a3d6c7ce2c204b4c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id180e5c47b5b4590aaabfb4d1aa9d1d3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic210cb32648544a095a3760cee270d5a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c23648696d148ada1075eba8138fa3b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaae8f6a141fc4440a2e80e908354b800_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf0dfbd7e212478fa3e85821b257efa9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ef03cc41bdf4f279229b376fbb43600_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53980f6dd1b44213ad5171bcab656699_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7318ad9d646d42ab8e2f84f2d4ed08e5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie81b4ce4914e4839924a78d8798397a9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9c761912e804561a14aa3acea5045c2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibbd726794242461a918bc026656e8819_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd0a85ff305c485ea29c4a037baa7ebf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa491650e0184ee0b2d04a336fcd9159_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa41c4de25dd421eb1ae018322f86643_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03aa196073ab4bffb46b9ece7f3ece15_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e7e1f56b7f54755a3741e3d317a47f4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1948994457e4a7d899f19777bc25f52_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8c6a1c4d0f5419a84aa95ca8cfce91e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i484f17d8c76443b28b80fc7cc73a4065_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2fcad26472544896b5f80c3807d319ee_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c1b06002c614ec0a7355c6ffde49cad_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d3ab4b3183547369e21bc16353ca096_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58799d0aadbb4faf8ae9cbb1ffa7e5c9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06896c6d773e4c648b6098ee68fc18cc_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8931abe1fc4c41e283d3f620f5185481_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i914407dcbd0742cea3b5fcdd61f4b1ed_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8894e39eabee436d9b912bcc70604238_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b0764905b0442fb808444acc20375f5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia93f6572cba64cc187e20095aeebe69b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2d0511984ae4ebb9a94c4f5aaa12d9d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb7025b0eca84850a521bee0487fc7b2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05e0f2d1f02d4ed3b1d3cd7d269a0f9f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97cf21063a7648e88dd9c911711f174d_I20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:NorthAmericaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6266e509f1d44dc9a60daacdb22a350_I20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieadb084d06104ed894bd8527a64a8317_I20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i784ed4be5e4640478be661b277b7af18_I20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f3c6cd031f7442181059f100dfd8aa7_I20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d71ef0b70eb4d1a88d365784c2806c2_D20210401-20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib215f03d4a004bb190d0b0c9e1810626_I20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EuropeSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputLongTermRevenueGrowthRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47d220da3337425183ad3fe98cff519f_I20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">vtrs:MeasurementInputTerminalYearRevenueGrowthRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e4d9eb373ac4cf5915b1ac7e264cb55_I20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">vtrs:MeasurementInputEstimatedTaxRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iedf8aaffd2f2406782984df0b60eedee_I20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputEbitdaMultipleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EuropeSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib890b7b1cb504759a309b083b68548ab_I20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputEbitdaMultipleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6d4f61859ba465d955863c12418c41b_I20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EuropeSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputControlPremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf56c4919fb14633bbf6386bb070262c_I20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">vtrs:MeasurementInputReductionInTerminalYearRevenueGrowthRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15608e6da3164b4dae3c3a578cacf736_I20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">vtrs:MeasurementInputIncreaseInDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ca2f0e0d1e2416f955e5ebad2fa3692_D20210401-20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0ea4341bffa478086acdce9a047ead6_I20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputLongTermRevenueGrowthRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b46955e83674aeab67ff94b9709968a_I20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">vtrs:MeasurementInputTerminalYearRevenueGrowthRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib16a3b6e8149409999a629fdf76b5e40_I20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e5e76e30a1e4232835b08cc5aa3dd1f_I20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">vtrs:MeasurementInputEstimatedTaxRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2faca452b6d7490fb6088b57bdba3eab_I20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputEbitdaMultipleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide52f85dc07b4fe0b82c8b1da6c36f02_I20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputControlPremiumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae70f297cb494e99b52ef9e2d4abc258_I20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">vtrs:MeasurementInputReductionInTerminalYearRevenueGrowthRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d259dda285943ceaa0938936cf8aa47_I20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">vtrs:MeasurementInputIncreaseInDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a9dac0334bc477ea0a456bbe46c3173_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6259c702de2f4a35b534481f8d19ba9a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib50d1f6af058476a9a20d36e4aeb1f1b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e35649af2d149e5a110744b54afb44e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2028EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65ebef80378f40ed961aba03c5a4b30c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2028SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c0d6145de9e46a7aee08ead29783fcb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2028SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea56cbd0617d400094855281cdd9e614_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2025EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd922556c9674ce280730c7b73219cfa_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2025EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9dbb1d37817941cfb609b9b9279f1790_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2025EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib435a6d77cd34f869cedbd596bf31419_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2022EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55b472eecaf147e68499e6e2321e7f65_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2022EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90dc4ad103024e6ea6ce10f50ae8d262_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2022EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17b748819db1409f90ab44c1656a6844_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotes1023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0df9f683c964ad68f7f6e10a639905c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotes1023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44be44738c944446a28c9e1a66f849ae_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotes1023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae4433500527462f9a53c262b4a193e2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15c58cf1262f420e80cbba022d020953_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i001cf1788fa14d23b2b35d333f8e42c9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if487c6ee083b40a88448340cd281fb87_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2032EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if483dc28a41d4a0fa6122644fd1ff629_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2032EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i738291780fb644b188734a680f12c170_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2032EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f150c27f3c842779f26851f4cf85e68_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2020FloatingRateEuroNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaea18053fed0452db5be6e9583326824_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2020FloatingRateEuroNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibef3bf81fb8c41a7a5b434d67be2e8f6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05cbcb5d225f4a1e8421221f4405ebae_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i203444b86c864e92be2fd1ad7307b680_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:YENTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="jpy"><xbrli:measure>iso4217:JPY</xbrli:measure></xbrli:unit><xbrli:context id="ifa97038cc597436695cbf1346cc9a0ab_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:YENTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie77d3b2d673e467fbbf3c091f8ded489_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:YENTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ab96945884b453e862399993bf9898b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4da71023bae940f99c4faea351670e06_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0ad6012a5fa43a49ad0a2980a19ddb3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf29789408364be881b52abb508e5de3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2274eaab76e54e488ce05bb95778a8cd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42eae6da7fc24ce694d83020bfe37e2b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf8418c5909549baad168bf445e46d9a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6a61ecb28ac40db9a5d31a3a4ad8e76_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f884def881b445f90dd9534fe3fb188_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7327d7b6283478083ef6d071f79ff32_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e4405916ad540b9a7f953c2af935d2a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i481467d95c4545e5bb497389f9859d4c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if732b369611b40bcad116753c69a9845_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25fbe74eb4264d7daff50e624f791260_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2629746dda6747b385fc80d8be9b7149_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e1bb69f19ec4a6298efcee5d069b518_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">vtrs:SeniorNotesTwoThousandTwentyThree3.125PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f9bb026157949c78212217fe9b44bb4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">vtrs:SeniorNotesTwoThousandTwentyThree3.125PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56846d199ffb4f219d37ebf51599c34f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">vtrs:SeniorNotesTwoThousandTwentyThree3.125PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8d0d63150a443a9a2d4e20b655c9e2f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6faa273322f64371a812153577418b44_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9654acb9de7d4ca493374d0d74ccd282_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80c54ac8020646d2ab7569f426de2da7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if06aa643a0dd4bd7a0bb9445a80b41e1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i237668ce34d742348fc490c31a89179a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5eac979dacba469ba19bc637404defc4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2fad0ea862684b18988c02daa98065dc_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8efba978bebc47919ee66621c13ee179_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3ebbb8721854743a8cb2b760433c11e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9ae6a7ac5cd4083b3bdd4eeba1b2668_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32ea16aa6d414c73a3f0814961d0178d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6ef68015996425387540c85e3abd584_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51898b0e23db4285b98783fe25f8e36f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46a7b47f4bfd48e38e1a40a09cc02687_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib281974ea08948ca9b385c9fbf70eb76_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61adc213c3bb41c1b79b08b95374ec05_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50e722bd905e484a9e5b58ca42df1a48_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie86e478f62084256bbe03e843d36bfd4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if871dc9d84a946f19d267f938caa03bb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac5b711af87d47b4909f4910be28f8fd_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd50cfa1e1e34150bb7e6bf364a6cf02_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f1f3ba4d1c44a5ea869a805433ebbbc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9dcaff92c9304ccca2976819941da18b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5387ecd95f1b4b21af4525dd7eb447b8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1fafcde031c3487c96b095c7e9b1a4b7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbc15c77f512432996fe6c2792f89851_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ef24702815341caa5d222e324cde377_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ee5436ebc91401299dbc66fb31d1ba1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93a9254901ed49de952eda7653f907ac_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21551c21cb5b4b48afb8bf862247798d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4fde47ed57994e7aa756ac70c39cbf8d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib97e2eb7978744c19ab31e5a8376b5a1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18a3ddb5107448a099979738cf774b3f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa7cf902531e404f8bad7f6968475c58_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8966d648d0f54ce1b447b567d34e2402_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5981a6477d5e43cd8437a6506268400c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32084c41b5404f8390dcf56f0215f989_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i858b714a7a1546fa86606e2c701719ee_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf0a8e4e52d64933bcd2cc97aa5788fe_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i329520eeb0a04b5bad45f6974d90de1a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if095f8bb1f1b41eab2ce30dfe31f5273_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie24e749ab05a4833892ad719d96c300b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd4f324d5afb475e82b0026903ef73a7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1ad37b49c494d5c8be906abfac6dc4c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if24b49e0068e4eb481af75b6062f9456_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vtrs:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i288c304410434dbe813214bf4eef76f1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vtrs:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42e5f527f22943e5b9d7a7a7685c1fba_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i997a640a9bd547beaed71dc4ba211d11_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c903b289b914375b5edd04b08ed0db1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb3ec9725b8947ae894c70cb9fb96fc0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibaee0ac5194a4c1491943ee3a6348a76_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice252435f6954b3dafd70d47c4bfa455_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fa346806c0a487197a11cf349c436db_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">vtrs:MarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic423a7424c864666be50a0a4f390acc3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">vtrs:MarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie58356c472ef49b48d4e2508fa52d3b6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3f56b439929457fba15cc320189f428_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb52f941e1874849b1e0f0c993cf6266_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa911871a605402e901504a7b4ac61d7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76e72c40fc9145b7a9caf8a61f156082_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35168e44d21d481481a247e34dfc73e0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57fa96c988344f0e818a196d4896959e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b458f3612f1402784b53aeac8a369dc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e3f3d362ea642ed9e7f8f139947c56d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i353b586581cf44dca4cb825b92b6aafd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8cae512912394bf5b5d2ebf918860db3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide391512e22947ccac25df3c07cb9228_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i561ba56147034042ab3232502e02546e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd529d4efdc24298b90ec1d3fc7c7068_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba340d0dfb4648819a3e1ddf13ac641e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1b09c1f40b047ff8dddca2986b053a3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7064536ad58d434ca55e232aa46556fb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7154adf94728411fa895c551c3a5e9c9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8da2ec9305974c688991d4d33e6a27db_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i666a97b1659e4674b1610db7c741b7b2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vtrs:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if75d03b186fe47ba9d810bcb281f1f3d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vtrs:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if70694466104422da2d7abde7dda9ee2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i898cd302e4b34c6896647b6396e46f83_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:RespiratorydeliveryplatformMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3052adbd4310483f8c87f27b0a935413_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">vtrs:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id01941d6bb0f45a4b724bf9f4a330e96_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">vtrs:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f4eb4a955334d9ba1854bafa06369c8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i400815bb3ce2404ea55584df1faffd10_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00babded181a4889991307d7e9be7b3e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56e83e9054ce46708f56540239a6c805_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd90ca69608a471ebdd2665fb68a10f0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9987758e9374f87a70ef8c4aca1fc6b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d7336def5e24f00b2fa9c82f8a246d0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04586f5a3ee649afbdb486e4d10a000a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1bca36d1f664aa5be8e32facac152b9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae67483ac8724d79b23607cbe3f99173_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6348c0871c354006bbb77663df6a8f55_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42c49c74e2aa485b82eb650616e9a5ed_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba8eb8ec1ddc4b67a8a39164a81b8561_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">vtrs:ReceivablesFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0333343531a84c508ec66fd2d2e00992_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">vtrs:ReceivablesFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83bd5820907e45cbbb4ea0f8abe30112_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">vtrs:NoteSecuritizationFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i761c7931f4534948be5b4250f7b81ef1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">vtrs:NoteSecuritizationFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1f6c291ccc34af59e5c6bbc708d16ed_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:OtherCurrentPortionofLongtermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie02ffa5a286a4854b0f6a8ae8fb7875b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:OtherCurrentPortionofLongtermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia14591b7ed4e4ed5b2119d20257b6803_I20170606"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:CommercialPaperProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-06-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied6eaf81eabd467eb19851b626292fa8_D20170606-20170606"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:CommercialPaperProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-06-06</xbrli:startDate><xbrli:endDate>2017-06-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58f2993346b2437da3921482cd53781f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">vtrs:ReceivablesFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3ae820bb2f84caeb01b1f76cfa70fc8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">vtrs:NoteSecuritizationFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ab05aad91f84733ae6b5e8d48936298_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotes2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44658e6f80d547aaa1d6f5eade2a3003_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2020FloatingRateEuroNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2463e684b0924c04a93cc915be90fe1b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2020FloatingRateEuroNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic818a0a0c1d2464bb6ef3218b78cc20e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2020EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1422ee4965c4486e9d857d1e0ef2b079_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2020EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i205f2aac79b04016b1da176b6a7fb1fa_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwenty3.75PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if007a084b1e34ea384fb202e6e9d6c38_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwenty3.75PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5cd223f958b74eae95243319a27d31f0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">vtrs:CurrentPortionofLongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8f7a9b488f94289a8d5b7710a4447af_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">vtrs:CurrentPortionofLongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab602c854a75461ab1e9ab8870796980_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2022EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i377027e221df4b5fbf54f4ccd718ed6e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotes2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia70edf5b85c1412c9e994cc32f0ac58b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotes2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10c40610432e48caaea6544a94cc0ff7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwentyThree3.125PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0c235dec46b409c9b237d080763da78_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwentyThree3.125PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa49209541544d93ba10801830d5f5a1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwentyThree4.2PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ca2c72c048b4966924c4641a6c8e4c3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwentyThree4.2PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78adee273e00402683245dff9ebb774d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9743aa24ff1b459f9b29bba570aa1521_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotes1023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib01fe9fec3ea48b998ccf8a7121177c3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotes1023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31ff8d2943a647b3927af7a7fc9ceb67_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2025EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1428d03b2da74d5a877a86979e4dd692_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2025SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad4fd165662b43738af77427b3894ed9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2025SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c630e4787804a5baafb37dfba1e9941_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwentySix3.95PrecentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if885e24274984b748d622171dad0e341_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwentySix3.95PrecentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd92e4609f2347c481397989d4d41bb5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02db2d48980748f2a8c4583ff56233ac_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic36c2f77ef1a4f429be7552a4ffdaf63_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec4db0b19b8f485ca0d0961ae936700c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic23232bd104348af9f1c272ee35c0c7c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18dc290bd62a46ed929e318042c29293_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2028EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d56a00686f94581be68c9eba8a25301_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2028SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0ded5c651e24a53b16c65e31f034e19_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2028SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia571e0c9398945dd93a699d5a8d8ca2f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2030SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e9d0561e01b4afb9c271809518e9c3a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2030SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01addae58bf447a1be4cf07b1417127c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2032EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04a235c228ea4cbe8dd8f7c77da0efca_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2040SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae33c84f581c444991bd3e6161e49454_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2040SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29c286b2a49347658e466f3c15ed9e36_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandFortyThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64f377462f4d49f9911bffc37608cd6d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandFortyThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c5902c6ea4c409c95333fd6263b9aa6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandFortySix5.25PrecentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6838f10691984228bc7b35ce8cf2c986_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandFortySix5.25PrecentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id459a294731e48d8a0be383eb2bd5a03_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2048SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5884d0b22a724fbea35305a07e9ec8d0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2048SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02e45f2fba7e4eaa8262e45ee8ba765e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2050SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i334d1da043744144986b7f8f561ca005_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2050SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74057de14b554e19bbd06da1ecb3f7f6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11a32a3e965842e590fc770eeb365fa6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic54954704318489dbfab83d2b541d300_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:OtherLongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3950381ba5bc4ae0902d2fcdc22dd1cc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:OtherLongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie66cc87b7d3e4499960b357a925f9705_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8fd6f22b8424a83b40aff917e8d37be_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:UnregisteredUpjohnUSDollarNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29d46e9d61754785892f1c72d3742cca_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:UpjohnEuroNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c0b7c74c50145a7a9f8bcb989137313_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74907a0e3a4245c29c61474d06752931_I20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-10-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide9302296aa644ea9e1bdea342face9a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2022SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86acbd5fe13c4222ac75586b553e6158_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2025SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic43055109f72489cb27f40c7c7d4de3c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2c9dbf2c41f4039ae995c0da9b29464_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2030SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i377de9a7ca4747a9bb0851b1789fcf71_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2040SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90b2414ad8e14d89af5f6b93c78866b8_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2050SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc91d97ca69b44cb8428d304cc80e7ff_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2022EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i012d654e3d7e4404bb0b696b2beb3cbb_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf2e4abfbda046d1983677a1e0f26357_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c5cbc4a7ad247e1816ce79abab0f406_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2032EuroSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i848b6b54a3a148dba6adff4fa331012e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3861691874974533b0f4beb0f744696d_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:USDTermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9e52c1741c94fa0880ca65abe054094_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2020RevolvingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4070295d773487892f0a0dafa6fb391_I20210731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:YENTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7883883a0a384706bef726bfa103f3b5_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:TwentyTwentyOneRevolvingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bb284525f0d40259f76a744fbd30263_I20210731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:TwentyTwentyOneLoanFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="rate"><xbrli:measure>utr:Rate</xbrli:measure></xbrli:unit><xbrli:context id="i20a65018b503434b88c9fd17e0c1dd18_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7f720468bec473f88d7a755ce8a5ae1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c4b4c0b310e423483a0fc1a47ab012a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i976d65e83c19475783582ea166af72a4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56fdbd1f3d9e4c75876f8cf6831038f3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c0da8410b1d4621bf16fd27e6c27d7f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1df50837d39f4ce5b1c56c576becf8f5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifdef52c121a44daba62d16f7a225ea09_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9752ebd80b74eb987fba8598e4bf4a2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45d796a115fe452291c016b2351113f4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieba8727d1a644f5981104c3b153e5919_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62110eec7c9843279ebc30fd8c8fa53f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43ffbc95ec5f4ed288d39bc9f96f6c51_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6ab091030ea4646909dc299bb408d0a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25e2d0bb39cd4c969048c3e9ffe0f1c7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c05a74c19dd474e9110514b3ceb45a0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e35c11727664c4ea9b3141cf19e2205_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1b8be0d1b2a44c1902af29f75363f53_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90f54d9de46f4354845f2d01a1f04798_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic989ea6602bd4856815f90f895e12304_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c1519bf270f496eacbc594c4a0b7a1c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3917c4bfc784a928c09f599e63910fb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0257efc303d94390b5707bbcdb863e52_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7ff2cf5a8154924b32963fb78602f3a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34f962bd787c40be86356d0feb3e5e5d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28fba30d8dfb4cd0851b24ff8fafab59_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id107db472b49491e9da06a69c94e6b07_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c5bfbeaa4b84f669ddcb52c7676aa3a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3048feb477df4b8aa1d56be7df44692f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b952231de244bb5b8417597c8764975_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7bd68519c5854bc58140fde2099d16e2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic20e72bb356c49d2a349292f49d443ab_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff87963fcab3463b90b3aec7f030e7e8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia95c695111874fdbb3c0f5b149b44326_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d41891210be43e2af666133ce0c96d7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ee696baa8c049df95516f082b5ca622_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32ef6703441a420db1866b7d7f4c494b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i321781565b4145808e327741d1625660_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5344c15e24b24e80990c2d8787392123_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6e565a95dd740df9577e0def6a5bfda_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7af73de9524c46c4b62467c275aebbd7_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41551e1e6fcd44d8adc77b1cfa48df2e_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0b0232bc9844e1fa3ea1d7b1ad31528_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb3ef4f6ed9f4ba49c083bede6eb5223_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4995b4611c2e4646adfd8b95ba3bf328_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d888ff098f442bcb4dc242559173835_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c03788583d749e2ab730831ee5d6f58_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09f02030d9994171b347d6d8fbc28c23_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe6488fc910b43d8b1655226467f1718_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i112fdb77391647eb924a8c3214c34e98_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb74362ce50848929419e79a2423af29_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd18a8e6cd32428db5246e85e1f56f15_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab6607a4159c4340888408df548e14fd_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i120ca88ef29b44beab20b026621f6293_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8483166a8454418b9ca018a1b3791f84_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0092b09635f64545a5710335f85fb20d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieab322d23a1c4d299859bb9ae133d4c8_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e27b51cd41a46a5a7deacf015486759_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib319269ea5d64fedbf03374a044144ba_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f40df9e1eb0444887127461f9ea3abe_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67d592a057184ff99b89d543e49e0118_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80866432756d4d8b99967ae5f95350a1_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31acc6e59ca047cbb296182a44e66784_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">vtrs:U.S.StateTaxAuthorityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f057c6cfa374421b697de391e7da037_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">vtrs:U.S.StateTaxAuthorityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icba6cc749c5c4336a2e5b99546806e1c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">vtrs:U.S.StateTaxAuthorityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd60fe8dbaf14660a60843e414c261cc_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">vtrs:NonU.S.statetaxauthorityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3fbb159e759f42c694ac12a036cae1b4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">vtrs:NonU.S.statetaxauthorityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0fabb51dcaa430e9611ab2f4e9a374e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">vtrs:NonU.S.statetaxauthorityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a8034bfa30e47bca846a18601de12b5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">vtrs:OtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b9f43ebce0a4eb1ba92976f05741fb0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">vtrs:OtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f5339a530fb4bbca97be48fbe5dff35_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">vtrs:OtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5705c46a88bf43f9b604c129b6396c1b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4373191f73a844d0aa8b62bcce8c341d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc53a28205ae4633a9527b98ec393f1e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i541721ab11fa46dba8a4f58aa82b8be6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:LU</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c017853d633417e84dadf12741d19be_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:LU</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i530b9bc93bc34ea6809e028e6321324d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:LU</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i690c125540df43569fe6e0ce50a677ab_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GI</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i854628b6099f4e6b8fede6d5c536249f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GI</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id11628fae2674f80be59cec699d8e459_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GI</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5823091b3fcd49398f313d160daadec4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i603a7cae6d9d4de3b979e27445a94107_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66146c05086e4529856e742dff83f191_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48d28293b4b04d2fb0191c06495228ce_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7fccea3458334b2ebd3c74f8a019e6de_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iffea22471c5c4e24861294dc6660f471_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26e9bb2c528b43d78cadc7fb8c8321fd_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:PR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9609b95c853486895e94e6a62b3157b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:PR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i543541ffe73f47e6872e055ae7bcffda_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:PR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf311f44a7fe473a9670fb0c3ff9a43c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa740ef330234878af7d2583fa1e040c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7234668fd9e1415280aed391af195c71_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d23542c1c7d4aa7afeff16b251e1769_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SG</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9e6322b8a51430198f1ea68537c7250_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SG</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89506361322145bba725864306af6680_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SG</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44835a71bdf64a59b0834e858746c694_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">vtrs:OtherforeignMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5804a0802eb7426eb85b8c6c303e8343_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">vtrs:OtherforeignMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i279ca6fa27f643e494543992d85cb2fc_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">vtrs:OtherforeignMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17563b55bf4c44c896a9a3066b542e39_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f870207d18e4404afdd0b0926003cbf_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc73a3ee0a3a41ee8832f3c122143ec1_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11b5aa7232f744ff861551a17b6a355f_D20250101-20251231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i205d721df41548169e4385e88938943b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">vtrs:U.S.FederalTaxAuthorityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icde9ccadb7ab473e9a5c2e38da57d5e0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">vtrs:U.S.StateTaxAuthorityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc7dfe40ed754a63957fa18d5cc47e7b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic92f6b9e1fe14acdbdc8bec1f348d9d6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">vtrs:IndefiniteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b804447ccbf4433b4fe613034758f52_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">vtrs:FutureyearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6ea526be10f4f0a866f5c6137509461_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:TaxYear2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i472d18e59f014ecfa0204966aa273da0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:AustralianTaxationOfficeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a20c8f3803144d58ca34d0fcee823ce_I20161231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf4cadf4931e4608b5a75d3c9e76220c_I20201116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide54256d4c4e4fd1bebbeda254f7381b_D20201116-20201116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-16</xbrli:startDate><xbrli:endDate>2020-11-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58936cbb4f69447d95f57e98537ab978_I20201116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ac84504406d464583bea255d4678e35_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff2871529dca49568da0067c4e5a5e0f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ee490046709489aa5f4269ad8f50ae8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i108f18c1c1f24f03914b8e2a90171783_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6030f8107f684fe8afa39a9cb5b4ce23_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59f89db7c1cf4fbbbb690f556ab2557f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1c2d553da14496cb03b6b87eb3cd0c0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="vtrs:VestingPeriodAxis">vtrs:VestratablyinfiveyearsorlessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i391ac2a5652949d58e918cbb11120117_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="vtrs:VestingPeriodAxis">vtrs:VestinthreeyearsorlessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="vtrs:SubjecttoMarketConditionsAxis">vtrs:NotSubjecttoMarketConditionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide9073c6a7c5441b8fcaffca6958c382_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="vtrs:SubjecttoMarketConditionsAxis">vtrs:SubjectToMarketConditionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="vtrs:VestingPeriodAxis">vtrs:VestinthreeyearsorlessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5c3b0237a83415cb42661ae906c1ba7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9267df240f8949458673188e0cc47584_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i149651f6a4da4798a97a769739151b62_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10a62822cebc4558b2338681f573875e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6da6a8af22304e098fe4c7c2f12e2ce6_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a6462103eda4e1aaf682901857ca256_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="vtrs:ProgramNameAxis">vtrs:A2014ProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">vtrs:StockappreciationrightsandperformancesharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9d424a72c6e4901a7dafb47ebf3c114_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ec108614a384362b6aac78bfa61c46c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec1504795a9c4c6693434e98197e0e95_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3db1d00ed7f642dcaf9157d146275821_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52ec07ca99e44636af66cf7c46bf1f5a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie04b72f184f64b9bb48662c33d2c6a24_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2229a1acd15a481eb03d17e8a82e053c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35e6c4cb2eb24b3083832b9f47b4f963_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica964033412a493d86144cd4f4685a99_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c56f90e02e14a18921a2b1fca1e4610_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i355af96d788e4eeaa662de6eabe91582_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2798085fac7a40bab607ca83a2fad67d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28361d88d14b44089d36a57c1d48a43d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0632cc54c5f54fbd8e82f58805b62de5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i194aa174ea9b4388bf2c16656d0150bf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iddab1d45dd6b4fdfaf6d0678d30eb8fc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if31a3af97d384ae08362cb4f324929b3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0be4e5a0f374fbea197c3659a4244d6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i113dbdd80d9d47d3a985b193d972938c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifaf8f068b6c14aafac4baf76995e06d1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice0b7aa6647047d0a7d2a82e05dd4199_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib712c6ec443747a98c9f948545566ae1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa37ab3dc9b74f588ce944ce366fad65_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea17365cc1064f1e8c0e3efbd1f7ccc0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30c18481b70448689ae9ec9f6c97ed57_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">vtrs:AssetsheldbyinsurancecompaniesandotherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia734afe5a0b94354a9267f684d7d593d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">vtrs:AssetsheldbyinsurancecompaniesandotherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1eef6ae4e1e4c43a6e2a37669db59f5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">vtrs:AssetsheldbyinsurancecompaniesandotherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89cce06582894866abc89dbadb2375fd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">vtrs:AssetsheldbyinsurancecompaniesandotherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1dd9e8a009f47628454dddf41a73509_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3676ae37352452a8c662f20b8fe3454_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f47061824334d3b9c233d127ac9201d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67df6863d3524e03bbe619803176d157_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b6e49e382c6413e8c432cb0c7d2a826_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie786a2024a274c5ebfea306dfddbac8f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if795583e146340668c945e4b814573bf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8945bf4fb0664758943f130a6664b9d9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8396afe5d3e94d92869781e35bbfc3bf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21a085c7f0f844d58b2d8d28f4fdebec_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b6ff9d1e6224b069f644c2dbd578b93_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia960324dc2a146a685f0dce110779fec_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic88bd3b21dd5437a90e5efdc21490b13_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">vtrs:AssetsheldbyinsurancecompaniesandotherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a800cd4602a4c15a8b533080cc7dd5f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">vtrs:AssetsheldbyinsurancecompaniesandotherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i644407156089438c9633f7019f15ae8f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">vtrs:AssetsheldbyinsurancecompaniesandotherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i525cf7cf63b54048a311ff3fde50c3d0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">vtrs:AssetsheldbyinsurancecompaniesandotherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0793dad309c04eeaab5ad95a6c7e0ace_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93fbd6aab228484480456d99cf697974_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8bb2b64c86464df1acb153f81b9bd1a2_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0beee820b7a44a2586a141b35bd7d70b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="vtrs:PeriodAxis">vtrs:FiscalYear2017Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98bb7963bee64ebb90779de770b2639f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis">vtrs:DeferredBaseSalaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e7e31d22fda4457bb400e7c5b5a9279_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis">us-gaap:DeferredBonusMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieeeb5a9479d24a7d8d17e6b3b937cfa1_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i920f0f119ac84408803bd50b9d0ab091_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22c52f21b85d4673a433d7b10508a1c0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib677e81a48d44a41987cce709676230a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd84b99acf144bc78660b64776c157a5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0acbb674a1248c0922f52ddee735cd9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d6ec2d7d94e40788a144ae7c9ec8647_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18815e8bb5a745709ff95e3d9c2c08e4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">vtrs:MckessonCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id731b23309e14cbdaad5c8a9b50a21be_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">vtrs:MckessonCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id209d8fb79664069a0121c7006665f1f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">vtrs:MckessonCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6dd5ebb08da94a34a07b74dd124ac3ee_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">vtrs:AmeriSourceBergenCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6901420439ef429ea919459425a5d402_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">vtrs:AmeriSourceBergenCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf1e59f7845645108df1bc93dddee7c7_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">vtrs:AmeriSourceBergenCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5e40498906e45c788a40df231de121f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">vtrs:CardinalHealthIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27fa8b92853d48fb94b00143112c4a79_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">vtrs:CardinalHealthIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76cdb8e6f69a4d70b0de5af0064a60da_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">vtrs:CardinalHealthIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i674ccad3b1334a35b429888309d5e766_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4bb4b6b6b5a4fe694af194311457a02_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94d6d4b3556e404b89c54e423c77d4f6_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a70f778cb3e42faa8640420190123d8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">vtrs:TransitionServiceAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis">vtrs:PfizerInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3bc8daf6f604468691d4e166c4089a06_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis">vtrs:PfizerInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie41a5079981b44deba916400b5db52f8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis">vtrs:PfizerInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6fb7985a0fed413082603dbe3300009f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis">vtrs:PfizerInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib89e351abdca4a2a8a91f6f3d20bc1e2_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">vtrs:A2020RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie59342892624442b9a277a53f425c7e3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">vtrs:A2020RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a2ed382584440da959bd00009045f49_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">vtrs:A2020RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18f47482de9e477aa4d85300745fbad3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">vtrs:A2020RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d1d75a5c8a447008aeaeea8bcbacd37_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">vtrs:A2020RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45a292f6066c4a5cae5e925da85f5c71_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">vtrs:A2020RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia07fba1fd0dd43ebabc004e6c0858d88_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">vtrs:A2020RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i681ce63aa00c4c9498e214af93461780_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">vtrs:A2020RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa3cdc4e3b274003ae2d838d289e9c7d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">vtrs:A2020RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieae368cfdd6248869144a96949edde48_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">vtrs:A2020RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b60006ae2c94bff820d1335a546ccba_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">vtrs:A2020RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i254bde0424ca475ebacf28a1bc15b3b1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0685a0412faf4f3b90366905bbeab604_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id51cb348481d4ec48766bf86b6cc391d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">vtrs:A2020RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6a9f98858454485bf0c770c4fd2c57c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">vtrs:A2020RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia84d707224a5471abcb6fb8f26708db5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">vtrs:A2020RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ad19c7802c7406b96da1212d434f4e3_D20160101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">vtrs:A2016RestructuringProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i266beeff762940c594ad7e6cb70ba95a_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a2f026c5d984a4baa08a46d2b7a633d_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie111b220c8104243b43abb19a557ed31_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied43c8ca68ed4621b226737a5d334eaf_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic88f207a9dad4e4d801b44cf3af9f10c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic46fb38f58024911a0b78897bd8338eb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74053317be7e49ca93f4eade0b20f377_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a14e7286e034496b3144a5acc8932d1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id700bedb414840799b353bf9084701c9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i864f1b9d64574c8c88114fc001040dd2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65836be0391145f5a3e61375cecd6594_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="vtrs:PeriodAxis">vtrs:FiscalYear2017Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26f84e3d52854c23bc765376727d547d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">vtrs:RevanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86776889abae4015b5e341878a1f94e0_I20160108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">vtrs:MomentaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-01-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="drugs"><xbrli:measure>vtrs:drugs</xbrli:measure></xbrli:unit><xbrli:context id="i20265a72ee5044e7aae84f97919d0147_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">vtrs:TheravanceBiopharmaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c6221856b4642fdaae580491808b3ca_D20150130-20150130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">vtrs:TheravanceBiopharmaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2015-01-30</xbrli:startDate><xbrli:endDate>2015-01-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c6036278a4b49a4901cdd582be7d9f0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">vtrs:TheravanceBiopharmaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13a8322297064621abf63668185d09b7_D20130211-20130212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SupplyCommitmentAxis">vtrs:GenericBiologicCompoundsCollaborationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-02-11</xbrli:startDate><xbrli:endDate>2013-02-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="product"><xbrli:measure>vtrs:Product</xbrli:measure></xbrli:unit><xbrli:context id="i9e5713b803ec4eaf933db1df619dac04_D20180920-20180920"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">vtrs:FKBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-20</xbrli:startDate><xbrli:endDate>2018-09-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1060ce14d7454734a57fb560f05c5dc2_D20190227-20190227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">vtrs:FKBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-02-27</xbrli:startDate><xbrli:endDate>2019-02-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf043a2e2c394069bf7b417157fabff5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:OtherCompaniesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc22e99190de4591a027585c2ec34f85_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:OtherCompaniesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d1a10fafb2f499895da7c0d46a48ae3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida50edb50e464fd8bfedb0e9bb7be1aa_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">vtrs:BiosimilarsBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07eb4f1ce070466a990b0cd1a54b7b81_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">vtrs:BiosimilarsBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d397ca7ee644114993a26171508834d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">vtrs:BiosimilarsBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b28bb833a94474bbc11b88b345af593_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:EpiPenAutoInjectorLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="agreement"><xbrli:measure>vtrs:agreement</xbrli:measure></xbrli:unit><xbrli:context id="i12d72077c53340de89fc310d8eef6974_D20220201-20220228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:EpiPenAutoInjectorLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-01</xbrli:startDate><xbrli:endDate>2022-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a9f5404bef24f4984a0f8f1a0ff008c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:EpiPenAutoInjectorLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i948e502442cc4e7ab6948ef233636a44_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:EpiPenAutoInjectorLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fb31abf3cd3486d8d73aaca15da3160_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:MultiDistrictLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="state"><xbrli:measure>vtrs:state</xbrli:measure></xbrli:unit><xbrli:context id="i1370ea34e27342908b81e9cd1ce42f04_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b8d7536128a476ab103cb2abe72db8f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:AnticompetitiveConductwithGenericDrugsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34298ab2efbf46afb7c78ba25e12f901_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:AmendedAnticompetitiveConductwithGenericDrugsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="case"><xbrli:measure>vtrs:case</xbrli:measure></xbrli:unit><xbrli:context id="i13c638ed56d343c18493f03648ee836f_D20140708-20140709"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:EUCommissionProceedingsPerindorprilMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">vtrs:AntitrustProceedingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-07-08</xbrli:startDate><xbrli:endDate>2014-07-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2fc086de1758443786ac3ba535a5b44a_D20141001-20141231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:EUCommissionProceedingsPerindorprilMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">vtrs:AntitrustProceedingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-10-01</xbrli:startDate><xbrli:endDate>2014-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27d7d7f87c3b47c29d865299535c55cc_D20130601-20130619"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:EUCommissionProceedingsCitalopramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-06-01</xbrli:startDate><xbrli:endDate>2013-06-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6585ef5edb5465980d61d05bc81776b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:EUCommissionProceedingsCitalopramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9abf215c0b25446ba1f1eee1bfce3634_D20160212-20160212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:U.K.CompetitionandMarketsAuthorityProceedingsParoxetineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-02-12</xbrli:startDate><xbrli:endDate>2016-02-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="gbp"><xbrli:measure>iso4217:GBP</xbrli:measure></xbrli:unit><xbrli:context id="if4052220c0bc4de89dc871350ec90cb2_D20160212-20160212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:U.K.CompetitionandMarketsAuthorityProceedingsParoxetineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-02-12</xbrli:startDate><xbrli:endDate>2016-02-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if54570ea2c7a42cc914556ebc926584c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:U.K.CompetitionandMarketsAuthorityProceedingsParoxetineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42721f7bfaa74a20b33b1b57026a7ec6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">vtrs:ProductLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ab3ba0c16f64666aae7af1ec4b0cb80_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="increase"><xbrli:measure>vtrs:increase</xbrli:measure></xbrli:unit><xbrli:context id="i2c861875a03848f989ff86d891f1a81c_D20171024-20171024"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:InsulinGlargineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-24</xbrli:startDate><xbrli:endDate>2017-10-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="patent"><xbrli:measure>vtrs:patent</xbrli:measure></xbrli:unit><xbrli:context id="i6531f624fba049f9a437e4af1aa3247a_I20171024"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:InsulinGlargineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-10-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c7914355ab94f1e9bb9a332a6d51ac5_I20190617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:InsulinGlargineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13e9207c6fef454e969d51bd9b9e9635_D20190617-20190617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:InsulinGlargineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-17</xbrli:startDate><xbrli:endDate>2019-06-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i368a17b2f56f4f73a262f1f28352eca3_D20180910-20180910"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:InsulinGlargineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-10</xbrli:startDate><xbrli:endDate>2018-09-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7341b8c6cd5240ccad4baad654635cb8_I20200402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:InsulinGlargineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9357aa4ee46c43e4a8bacdddc6635174_D20170630-20170630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:DimethylFumarateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-06-30</xbrli:startDate><xbrli:endDate>2017-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03c3c6915b9e41e286944ec9d4c597df_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">vtrs:OtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idaab369eeea042ca842eb8d98bec6dfb_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91018ff0be4748fdb394a71a73560ff1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i166cc270ce584702a76fe3b6fb475148_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic453dbe2bf5946b286bdd9f5cb841293_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia516f232fddf46f39a2dbdf6d82abbc9_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i450c01c12e2d40dcadab0111243d7980_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie71711028fa94d6fb804d5ada3c39b46_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i431eb8d7201c49618c010a346ae6a384_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c9701f467284632ac6d7745e16a0f7d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb67bdbafd2140308ea8ef185a517da0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebbc9cdf0d824f2db02b60856d24cfa2_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i816570cccc0745fcb3c38ba989d87af4_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzItNS0xLTEtMzE0MjI_30210044-a509-4191-8764-cb3e6b6447b6 id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzItMS0xLTEtMzE0MjI_ea7af4bd-9d7e-4e78-9fe9-e2f762f4be22 id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzItMy0xLTEtMzE0MjI_98df128a-434f-454a-b819-2258135f740c" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90ZXh0cmVnaW9uOjQ3ZDBjNDk5MjMxODRjNTJhY2JiYTAzZTJmN2NjNTU4XzM0Njc_53218c48-f2e9-4b86-9cac-d0d5943a00a2" order="1"></ix:relationship></ix:resources></ix:header></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_1"></div><div style="min-height:27pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.861%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM&#160;<ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGV4dHJlZ2lvbjo2YTQyZDk0ZTZjM2Q0ZDAyYjA5MjJiMGNkYWI0NDdmNV8yNzUw_86025e02-5ed5-4c63-b42f-d74c2ffb6835">10-K</ix:nonNumeric> </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGFibGU6MjU2YmRmMzNmNWU0NDMzMWFiMDllNDZkOWRlM2ZmMDAvdGFibGVyYW5nZToyNTZiZGYzM2Y1ZTQ0MzMxYWIwOWU0NmQ5ZGUzZmYwMF8wLTAtMS0xLTMxNDIy_1bbb98d9-22a1-4782-a783-a1d7c14fbd8a">&#9745;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Annual Report pursuant to Section&#160;13 or 15(d) of the Securities Exchange Act of 1934</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Fiscal Year Ended December 31, 2021</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGFibGU6MmMwNjQ0MmFmNzk2NGQ2MDk3NmQwN2ZhY2M3ZTdiYmEvdGFibGVyYW5nZToyYzA2NDQyYWY3OTY0ZDYwOTc2ZDA3ZmFjYzdlN2JiYV8wLTAtMS0xLTMxNDIy_1b581a9f-2b57-4770-8a3d-e837cb21a9f5">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Transition Report pursuant to Section&#160;13 or 15(d) of the Securities Exchange Act of 1934</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the transition period from &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; to &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Commission file number <ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGV4dHJlZ2lvbjo2YTQyZDk0ZTZjM2Q0ZDAyYjA5MjJiMGNkYWI0NDdmNV8yNzU0_e7bd9b99-3990-4e3b-8203-2ec7de68ba64">001-39695</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGV4dHJlZ2lvbjo2YTQyZDk0ZTZjM2Q0ZDAyYjA5MjJiMGNkYWI0NDdmNV8xMzI_afe7166e-096c-48d6-a162-ce5750c1aa2d">VIATRIS INC.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGFibGU6OWU0ODk1ZDM4ZjZkNDIwOWJkNGQ1MTJhZjZmNTVjZmQvdGFibGVyYW5nZTo5ZTQ4OTVkMzhmNmQ0MjA5YmQ0ZDUxMmFmNmY1NWNmZF8wLTAtMS0xLTMxNDIy_b2b9be07-919d-4903-9753-3de62cc644fb">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGFibGU6OWU0ODk1ZDM4ZjZkNDIwOWJkNGQ1MTJhZjZmNTVjZmQvdGFibGVyYW5nZTo5ZTQ4OTVkMzhmNmQ0MjA5YmQ0ZDUxMmFmNmY1NWNmZF8wLTItMS0xLTMxNDIy_f87e3fc4-3cdd-4e50-acfa-20fd7c5e1f62">83-4364296</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGV4dHJlZ2lvbjo2YTQyZDk0ZTZjM2Q0ZDAyYjA5MjJiMGNkYWI0NDdmNV8yNzUx_0b31bf0b-70ae-416c-ab0b-4a279013d448">1000 Mylan Boulevard</ix:nonNumeric>, <ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGV4dHJlZ2lvbjo2YTQyZDk0ZTZjM2Q0ZDAyYjA5MjJiMGNkYWI0NDdmNV8yNzQ1_729f476a-d6e8-4f09-9b1e-17ddd0b7af3f">Canonsburg</ix:nonNumeric>, <ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGV4dHJlZ2lvbjo2YTQyZDk0ZTZjM2Q0ZDAyYjA5MjJiMGNkYWI0NDdmNV8yNzQ2_3315759c-d79b-4146-9027-527e25a73657">Pennsylvania</ix:nonNumeric>, <ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGV4dHJlZ2lvbjo2YTQyZDk0ZTZjM2Q0ZDAyYjA5MjJiMGNkYWI0NDdmNV8yNzQ3_392b1a3e-a66a-4547-a12b-0c9fd947baf3">15317</ix:nonNumeric> </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(Address of principal executive offices)(Zip Code)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGV4dHJlZ2lvbjo2YTQyZDk0ZTZjM2Q0ZDAyYjA5MjJiMGNkYWI0NDdmNV8yNzUy_62c2a50d-1ff9-43b9-9f5b-2ae1803419da">(724)</ix:nonNumeric> <ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGV4dHJlZ2lvbjo2YTQyZDk0ZTZjM2Q0ZDAyYjA5MjJiMGNkYWI0NDdmNV8yNzQ0_e0af01a2-02e4-492f-ae21-901cb94943e3">514-1800</ix:nonNumeric> </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Securities registered pursuant to Section&#160;12(b) of the Act:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Title of Each Class:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name of Each Exchange on Which Registered:</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGFibGU6YmRlNmNjMDU3NmY1NGNlYTk3MTgxMmM3MzZhZGM1NjcvdGFibGVyYW5nZTpiZGU2Y2MwNTc2ZjU0Y2VhOTcxODEyYzczNmFkYzU2N18xLTAtMS0xLTMxNDIy_d5abccc6-1a6d-4e88-8fae-71603557f053">Common Stock, par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGFibGU6YmRlNmNjMDU3NmY1NGNlYTk3MTgxMmM3MzZhZGM1NjcvdGFibGVyYW5nZTpiZGU2Y2MwNTc2ZjU0Y2VhOTcxODEyYzczNmFkYzU2N18xLTItMS0xLTMxNDIy_2292b041-ca41-4f0d-ba53-14bced84b84f">VTRS</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGFibGU6YmRlNmNjMDU3NmY1NGNlYTk3MTgxMmM3MzZhZGM1NjcvdGFibGVyYW5nZTpiZGU2Y2MwNTc2ZjU0Y2VhOTcxODEyYzczNmFkYzU2N18xLTQtMS0xLTMxNDIy_414d9b9a-f49c-4598-b51b-1c76ab18cc6d">The NASDAQ Stock Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Securities registered pursuant to Section&#160;12(g) of the Act: None</span></div><div style="margin-bottom:2pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule&#160;405 of the Securities Act.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGV4dHJlZ2lvbjo2YTQyZDk0ZTZjM2Q0ZDAyYjA5MjJiMGNkYWI0NDdmNV8xNjQ5MjY3NDQ0NDU0_002de428-ab8c-427e-b23d-d7fe5e780532">Yes</ix:nonNumeric>&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;No&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:2pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or Section&#160;15(d) of the Act.&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGV4dHJlZ2lvbjo2YTQyZDk0ZTZjM2Q0ZDAyYjA5MjJiMGNkYWI0NDdmNV8yNzQx_28e90019-ded9-40ab-9c5b-12a7dd9ee227">No</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9745;</span></div><div style="margin-bottom:2pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGV4dHJlZ2lvbjo2YTQyZDk0ZTZjM2Q0ZDAyYjA5MjJiMGNkYWI0NDdmNV8yNzM5_f55e825a-5861-45f3-9aaa-bdc60e90cfb7">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:2pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation&#160;S-T (&#167;&#160;232.405 of this chapter) during the preceding 12&#160;months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGV4dHJlZ2lvbjo2YTQyZDk0ZTZjM2Q0ZDAyYjA5MjJiMGNkYWI0NDdmNV8yNzQ4_6f9eb3fa-62f6-4129-8e68-d998f0cf3932">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act.</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.161%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.872%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.442%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGFibGU6MTM4ZGI2MThiNTAyNDI3MmFkYzdhZWM2OTVhM2U2NDkvdGFibGVyYW5nZToxMzhkYjYxOGI1MDI0MjcyYWRjN2FlYzY5NWEzZTY0OV8wLTAtMS0xLTQwMTQw_59166f11-b7e7-4789-bfb0-84576f2a75b7">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9745;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGFibGU6MTM4ZGI2MThiNTAyNDI3MmFkYzdhZWM2OTVhM2U2NDkvdGFibGVyYW5nZToxMzhkYjYxOGI1MDI0MjcyYWRjN2FlYzY5NWEzZTY0OV8xLTYtMS0xLTMxNDIy_2820a2bf-9063-4afd-b629-5848dc3ff5b7">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGFibGU6MTM4ZGI2MThiNTAyNDI3MmFkYzdhZWM2OTVhM2U2NDkvdGFibGVyYW5nZToxMzhkYjYxOGI1MDI0MjcyYWRjN2FlYzY5NWEzZTY0OV8yLTYtMS0xLTMxNDIy_22f45d64-eaa6-41d9-8606-5330aa438472">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></div></td></tr></table></div><div style="margin-bottom:2pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="dei:IcfrAuditorAttestationFlag" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGV4dHJlZ2lvbjo2YTQyZDk0ZTZjM2Q0ZDAyYjA5MjJiMGNkYWI0NDdmNV8yNzQy_3fe43157-ad79-4aeb-a2d3-b7553cc2d17f">&#9745;</ix:nonNumeric></span></div><div style="margin-bottom:2pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Act).&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGV4dHJlZ2lvbjo2YTQyZDk0ZTZjM2Q0ZDAyYjA5MjJiMGNkYWI0NDdmNV8yNzQ5_d0d76082-0fff-441e-a228-387a9d9bdf11">&#9745;</ix:nonNumeric></span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant as of June&#160;30, 2021, the last business day of the registrant&#8217;s most recently completed second fiscal quarter, was approximately $<ix:nonFraction unitRef="usd" contextRef="i13f4973de7d347c1990aa06418f9a87d_I20210630" decimals="0" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGV4dHJlZ2lvbjo2YTQyZDk0ZTZjM2Q0ZDAyYjA5MjJiMGNkYWI0NDdmNV8xMDk5NTExNjMwNzAy_81cacd9a-6622-48b8-b947-b7da8c614dab">17,237,737,213</ix:nonFraction>. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The number of shares of common stock outstanding, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGV4dHJlZ2lvbjo2YTQyZDk0ZTZjM2Q0ZDAyYjA5MjJiMGNkYWI0NDdmNV8yNjU5_29580505-9394-4a84-b4a3-5b4c01d69e36">0.01</ix:nonFraction> per share, of the registrant as of February&#160;22, 2022 was <ix:nonFraction unitRef="shares" contextRef="idb49b3416a6648899c9dbb31e728c519_I20220222" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGV4dHJlZ2lvbjo2YTQyZDk0ZTZjM2Q0ZDAyYjA5MjJiMGNkYWI0NDdmNV8yNzA0_f30c1507-7c97-43bc-b1da-696eab48066d">1,209,576,280</ix:nonFraction>.</span></div><div style="margin-bottom:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INCORPORATED BY REFERENCE</span></div><div style="margin-top:5pt;text-align:center"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGV4dHJlZ2lvbjo2YTQyZDk0ZTZjM2Q0ZDAyYjA5MjJiMGNkYWI0NDdmNV8yNzQz_ffa72fba-22f2-4a5a-ba17-6e0b00b8a0e1" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.705%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.095%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Document</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Part&#160;of&#160;Form&#160;10-K into Which<br/>Document&#160;is Incorporated</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">An amendment to this Form 10-K will be filed no later than 120 days after the close of registrant&#8217;s fiscal year.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">III</span></td></tr></table></ix:nonNumeric></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.861%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_4"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO FORM&#160;10-K</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Year Ended December&#160;31, 2021 </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:77.492%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART&#160;I</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_13">Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_13">9</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM 1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_82">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_82">20</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM 1B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_85">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_85">52</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_88">Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_88">52</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_91">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_91">52</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_1099511630152">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_1099511630152">52</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART&#160;II</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM 5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_97">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_97">53</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM 6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_2199023257942">[Reserved]</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_2199023257942">54</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM 7.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_103">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_103">55</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM 7A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_139">Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_139">77</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM 8.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_142">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_142">78</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM 9.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_250">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_250">148</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM&#160;9A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_253">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_253">148</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM 9B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_256">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_256">148</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM 9C.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_1099511630180">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_1099511630180">148</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART&#160;III</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM 10.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_262">Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_262">149</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM 11.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_265">Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_265">149</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM 12.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_268">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_268">149</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM 13.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_271">Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_271">149</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM 14.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_274">Principal Accounting Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_274">149</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART&#160;IV</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ITEM&#160;15.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_280">Exhibits and Consolidated Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_280">150</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_283">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_283">159</a></span></div></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Glossary of Defined Terms</span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Unless the context requires otherwise, references to &#8220;Viatris,&#8221; &#8220;the Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221; in this 2021 Form 10-K (defined below) refer to Viatris Inc. and its subsidiaries. We also have used several other terms in this 2021 Form 10-K, most of which are explained or defined below. Some amounts in this Form 10-K may not add due to rounding.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2003 LTIP</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2003 Long-Term Incentive Plan</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Revolving Facility</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The revolving credit facility available pursuant to the revolving credit agreement, dated as of June 16, 2020, by and among Viatris, certain lenders and issuing banks from time to time party thereto and Bank of America, N.A., as administrative agent and repaid in full in July 2021</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Revolving Facility</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The $4.0 billion revolving facility dated as of July 1, 2021, by and among Viatris, certain lenders and issuing banks from time to time party thereto and Bank of America, N.A., as administrative agent</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AbbVie</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AbbVie Inc.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ACA</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Patient Protection and Affordable Care Act, as amended by the Health Care and Education and Reconciliation Act</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP financial measure that the Company believes is appropriate to provide information to investors - EBITDA (defined below) is further adjusted for share-based compensation expense, litigation settlements, and other contingencies, net, restructuring and other special items</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ANDA</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Abbreviated New Drug Application</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AOCE</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive earnings</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">API</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Active pharmaceutical ingredients</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ARV</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Antiretroviral medicines</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASC</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounting Standards Codification</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aspen</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aspen Global Incorporated</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASU</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounting Standards Update</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BEAT</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Base Erosion Anti-Abuse Tax</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biocon</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biocon Limited</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biocon Biologics</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biocon Biologics Limited, a majority owned subsidiary of Biocon</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biocon Biologics Transaction</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The pending transaction between Viatris and Biocon Biologics pursuant to which Viatris will contribute its biosimilar products and programs to Biocon Biologics in exchange for cash consideration and a convertible preferred equity interest in Biocon Biologics </span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biocon Agreement</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The agreement between Viatris and Biocon Biologics, dated   February 28, 2022, relating to the Biocon Biologics Transaction</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biogen</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biogen MA Inc. and Biogen International GmbH, collectively</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BPCIA</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biologics Price Competition and Innovation Act of 2009</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business Combination Agreement</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business Combination Agreement, dated as of July 29, 2019, as amended from time to time, among Viatris, Mylan, Pfizer and certain of their affiliates</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CARES Act</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Coronavirus Aid, Relief, and Economic Security Act</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">cGMP</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Good Manufacturing Practices</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CIA</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate Integrity Agreement, dated August 16, 2017, entered into between the OIG-HHA, Mylan Inc. and Mylan Specialty L.P. </span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CJEU</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">European Court of Justice</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">clean energy investments</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Used to define the three equity method investments the Company has in limited liability companies that own refined coal production plants whose activities qualify for income tax credits under Section 45 of the Code</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CMA</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Competition and Markets Authority</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CMS</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centers for Medicare &amp; Medicaid Services</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Code</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The U.S. Internal Revenue Code of 1986, as amended</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Combination</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Refers to Mylan combining with Pfizer's Upjohn Business in a Reverse Morris Trust transaction to form Viatris on November 16, 2020</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial Paper Program</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The $1.65 billion unsecured commercial paper program entered into as of November 16, 2020 by Viatris, as issuer, Mylan Inc., Utah Acquisition Sub Inc. and Mylan II B.V., as guarantors, and certain dealers from time to time</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">European Commission</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pfizer's contribution of the Upjohn Business to Viatris</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COPD</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chronic obstructive pulmonary disease </span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COSO</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Committee of Sponsoring Organizations of the Treadway Commission</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COVID-19</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Novel coronavirus disease of 2019</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CP Notes</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unsecured, short-term commercial paper notes issued pursuant to the Commercial Paper Program</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DEA</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Drug Enforcement Agency</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed Markets segment</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viatris&#8217; business segment that includes our operations primarily in the following markets: North America and Europe</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DGCL</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware General Corporation Law</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pfizer's distribution to Pfizer stockholders all the issued and outstanding shares of Upjohn Inc.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DOJ</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Department of Justice</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EBITDA</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP financial measure that the Company believes is appropriate to provide information to investors - U.S. GAAP net earnings (loss) adjusted for net contribution attributable to equity method investments, income tax provision (benefit), interest expense and depreciation and amortization</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EDPA</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. District Court for the Eastern District of Pennsylvania</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMA</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">European Medicines Agency </span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Markets segment</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viatris&#8217; business segment that includes, but is not limited to, our operations primarily in the following markets: Parts of Asia, the Middle East, South and Central America, Africa, and Eastern Europe</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPD Business</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Abbott Laboratories&#8217; non-U.S. developed markets specialty and branded generics business, prior to its acquisition by Mylan in February 2015</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ERP system</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Enterprise resource planning system</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EU</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">European Union</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EURIBOR </span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro Interbank Offered Rate </span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange Act </span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securities Exchange Act of 1934, as amended</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange Offer</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The offer to exchange the Unregistered Upjohn U.S. Dollar Notes for the Registered Upjohn Notes, which was conducted pursuant to a registration statement filed with the SEC in September 2021 by Viatris Inc., Mylan Inc., Mylan II B.V. and Utah Acquisition Sub Inc. and declared effective on September 28, 2021. The exchange offer expired on October 28, 2021 and settled on October 29, 2021.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FASB</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Accounting Standards Board</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FCA</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Financial Conduct Authority in the U.K.</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FDA</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Food and Drug Administration</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FKB</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fujifilm Kyowa Kirin Biologics Co. Ltd</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form 10-K</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This annual report on Form 10-K for the fiscal year ended December 31, 2021</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FTC </span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Federal Trade Commission</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GDPR</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The EU&#8217;s General Data Protection Regulation </span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GILTI</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Global intangible low-taxed income</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater China segment</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viatris&#8217; business segment that includes our operations primarily in the following markets: China, Taiwan and Hong Kong</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gx</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generic drugs</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hatch-Waxman Act </span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drug Price Competition and Patent Term Restoration Act of 1984</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HIPAA</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Insurance Portability and Accountability Act of 1996 and the Health Information Technology for Economic and Clinical Health Act</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HIV/AIDS</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Human immunodeficiency virus infection and acquired immune deficiency syndrome</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">INN</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International NonProprietary Name</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inter Partes review</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IRS</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Internal Revenue Service</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IRS Ruling</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The private letter ruling issued by the IRS to Pfizer with respect to the Combination, dated as of March 17, 2020</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IT</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Information technology</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JANZ segment</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viatris&#8217; business segment that includes our operations in the following markets: Japan, Australia and New Zealand</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LAMA</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-acting muscarinic antagonist </span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIBOR</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">London Interbank Offered Rate</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lilly</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eli Lilly and Company</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LOE</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss of exclusivity</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">maximum leverage ratio </span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The maximum consolidated leverage ratio financial covenant requiring maintenance of a maximum ratio of consolidated total indebtedness as of the end of any quarter to consolidated EBITDA for the trailing four quarters as defined in the related credit agreements from time to time</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MDL</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Multidistrict litigation</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Momenta</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Momenta Pharmaceuticals, Inc.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MPI</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mylan Pharmaceuticals Inc.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mylan</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mylan N.V. and its subsidiaries</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mylan II</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mylan II B.V., a company incorporated under the laws of the Netherlands and an indirect wholly owned subsidiary of Viatris, in which legacy Mylan merged with and into</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mylan Inc. Euro Notes</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The 2.125% Senior Notes due 2025 issued by Mylan Inc., which are fully and unconditionally guaranteed on a senior unsecured basis by Mylan II B.V., Viatris Inc. and Utah Acquisition Sub Inc.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mylan Inc. U.S. Dollar Notes</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The 4.200% Senior Notes due 2023, 3.125% Senior Notes due 2023, 4.550% Senior Notes due 2028, 5.400% Senior Notes due 2043 and 5.200% Senior Notes due 2048 issued by Mylan Inc., which are fully and unconditionally guaranteed on a senior unsecured basis by Mylan II B.V., Viatris Inc. and Utah Acquisition Sub Inc.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mylan Securitization</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mylan Securitization LLC</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NASDAQ</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The NASDAQ Stock Market</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NCDs</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">noncommunicable diseases</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NDA</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New drug application</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NHI </span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">National Health Insurance of Japan</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NHS</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">National Health Services</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NOLs</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Operating Losses</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Note Securitization Facility</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The note securitization facility entered into in July 2021 for borrowings up to $200 million and expiring in August 2022</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OIG-HHS</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office of Inspector General of the Department of Health and Human Services</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OTC</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Over-the-counter</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PBM</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy benefit managers</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PCAOB</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Public Company Accounting Oversight Board</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pfizer</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pfizer Inc.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pfizer Distribution Payments</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments made by Pfizer using the proceeds of the $12 billion cash distribution to (a) repurchase Pfizer common stock, (b) make pro rata special cash distributions to its stockholders and/or (c) repay or repurchase debt (including principal, interest and associated premiums and fees) held by third party lenders</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viatris Inc. 2020 Stock Incentive Plan</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PMS</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmascience Inc.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PPACA</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patient Protection and Affordable Care Act </span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Profit Sharing 401(k) Plan</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401(k) retirement plan with a profit sharing component for non-union represented employees</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSUs</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance awards</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PTAB</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Patent Trial and Appeal Board</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">QCE</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quality consistency evaluation</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">R&amp;D</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables Facility</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The $400 million accounts receivable entered into in August 2020 and expiring in April 2022</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Registered Upjohn Notes</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The 1.125% Senior Notes due 2022, 1.650% Senior Notes due 2025, 2.300% Senior Notes due 2027, 2.700% Senior Notes due 2030, 3.850% Senior Notes due 2040 and 4.000% Senior Notes due 2050 originally issued on October 29, 2021 registered with the SEC in exchange for the corresponding Unregistered Upjohn U.S. Dollar Notes in a similar aggregate principal amount and with terms substantially identical to the corresponding Unregistered Upjohn U.S. Dollar Notes and fully and unconditionally guaranteed by Mylan Inc., Mylan II and Utah Acquisition Sub Inc.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">respiratory delivery platform</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pfizer&#8217;s proprietary dry powder inhaler delivery platform</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restoration Plan</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Company&#8217;s 401(k) Restoration Plan </span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">restricted stock awards</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Company&#8217;s nonvested restricted stock and restricted stock unit awards, including PSUs</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revance</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revance Therapeutics, Inc. </span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RICO</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Racketeer Influenced and Corrupt Organizations Act</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU asset</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use asset</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Company's unvested restricted stock unit awards</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sanofi-Aventis U.S., LLC</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SARs</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock Appreciation Rights</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SDA </span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separation and Distribution Agreement between Viatris and Pfizer, dated as of July 29, 2019, as amended from time to time </span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SDNY</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. District Court for the Southern District of New York</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SEC</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Securities and Exchange Commission</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securities Act</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securities Act of 1933, as amended</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior U.S. Dollar Notes</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Registered Upjohn U.S. Dollar Notes, the Utah U.S. Dollar Notes and the Mylan Inc. U.S. Dollar Notes, collectively</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separation</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pfizer's transfer to Upjohn of substantially all the assets and liabilities comprising the Upjohn Business</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separation and Distribution Agreement</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separation and Distribution Agreement between Viatris and Pfizer, dated as of July 29, 2019, as amended from time to time</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SG&amp;A</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SOFR</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Secured overnight financial rate</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and SARs</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax Act</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2017 U.S. Tax Cuts and Jobs Act</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax Matters Agreement</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The agreement entered into by Pfizer and Viatris in connection with the Separation and the Distribution that governs the parties&#8217; respective rights, responsibilities and obligations with respect to taxes, including taxes arising in the ordinary course of business and taxes, if any, incurred as a result of any failure of the Distribution or certain related transactions to qualify as tax-free transactions</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax Opinion</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The tax opinion issued by Pfizer&#8217;s tax counsel, David Polk &amp; Wardwell LLP, with respect to the Combination</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Teva</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Teva Pharmaceutical Industries Ltd.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Theravance Biopharma</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Theravance Biopharma, Inc.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TSA</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transition service agreements</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.K.</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. GAAP</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounting principles generally accepted in the U.S.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unregistered Upjohn U.S. Dollar Notes</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The 1.125% Senior Notes due 2022, 1.650% Senior Notes due 2025, 2.300% Senior Notes due 2027, 2.700% Senior Notes due 2030, 3.850% Senior Notes due 2040 and 4.000% Senior Notes due 2050 originally issued on June 22, 2020 by Upjohn Inc. (now Viatris Inc.) in a private offering exempt from the registration requirements of the Securities Act and fully and unconditionally guaranteed by Mylan Inc., Mylan II and Utah Acquisition Sub Inc.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upjohn</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upjohn Inc., a wholly owned subsidiary of Pfizer prior to the Distribution, that combined with Mylan and was renamed Viatris Inc.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upjohn Business</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pfizer&#8217;s off-patent branded and generic established medicines business that, in connection with the Combination, was separated from Pfizer and combined with Mylan to form Viatris</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upjohn Euro Notes</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Senior unsecured notes denominated in euros and issued by Upjohn Finance B.V. pursuant to an indenture dated June 23, 2020</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upjohn Senior Notes</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Upjohn U.S. Dollar Notes together with the Upjohn Euro Notes</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upjohn U.S. Dollar Notes</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Senior unsecured notes denominated in U.S. dollars and issued by Upjohn Inc. pursuant to an indenture dated June 22, 2020</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">URP</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Universal reimbursement pricing</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD Term Loan Facility</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The $600 million delayed draw term loan credit agreement, dated as of June 16, 2020 by and among Viatris, Mizuho Bank, Ltd. and MUFG Bank, Ltd., as administrative agent, and repaid in full in July 2021</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utah Acquisition Sub</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utah Acquisition Sub Inc., a Delaware corporation and an indirect wholly owned subsidiary of Viatris</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utah Euro Notes</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The 2.250% Senior Notes due 2024 and 3.125% Senior Notes due 2028 issued by Utah Acquisition Sub Inc., which are fully and unconditionally guaranteed on a senior unsecured basis by Mylan Inc., Viatris Inc. and Mylan II B.V.</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utah U.S. Dollar Notes</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The 3.950% Senior Notes due 2026 and 5.250% Senior Notes due 2046 issued by Utah Acquisition Sub Inc., which are fully and unconditionally guaranteed on a senior unsecured basis by Mylan Inc., Viatris Inc. and Mylan II B.V.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VA</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Department of Veterans Affairs</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VBP</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volume-based procurement</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viatris</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viatris Inc., formerly known as Upjohn Inc. prior to the completion of the Combination</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viatris Board</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The board of directors of Viatris Inc.</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viatris Bylaws</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The amended and restated bylaws of Viatris Inc. </span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viatris Charter</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amended and restated certificate of incorporation of Viatris Inc.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">WHO</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">World Health Organization</span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">YEN Term Loan Facility</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The &#165;40 billion term loan agreement dated as of July 1, 2021, by and among Viatris, Mizuho Bank, Ltd. and MUFG Bank, Ltd., as administrative agent</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART&#160;I</span></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_13"></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:17.36pt">Business</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">About Viatris</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Viatris is a global healthcare company formed in November 2020 whose mission is to empower people worldwide to live healthier at every stage of life, regardless of geography or circumstance. Improving the ability of patients to gain access to sustainable and high-quality healthcare is our relentless pursuit. One that rests on visionary thinking, determination and best-in-class capabilities that were strategically built to remove barriers across the health spectrum and advance access globally.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Viatris&#8217; seasoned management team is focused on ensuring that the Company is optimally structured and efficiently resourced to deliver sustainable value to patients, shareholders, customers and other stakeholders. With a global workforce of approximately 37,000, the Company has industry leading commercial, R&amp;D, regulatory, manufacturing, legal and medical expertise complemented by a strong commitment to quality and unparalleled geographic footprint to deliver high-quality medicines to patients in more than 165 countries and territories. Viatris&#8217; portfolio comprises more than 1,400 approved molecules across a wide range of key therapeutic areas, including globally recognized iconic and key brands, generics, complex generics, and biosimilars. The Company operates approximately 40 manufacturing sites worldwide that produce oral solid doses, injectables, complex dosage forms and APIs. Viatris is headquartered in the U.S., with global centers in Pittsburgh, Pennsylvania, Shanghai, China and Hyderabad, India.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 16, 2020, Viatris, formerly known as Upjohn, Mylan and Pfizer consummated the combination of Mylan with the Upjohn Business through a Reverse Morris Trust transaction. In accordance with the terms and conditions of the BCA and SDA, (1) Pfizer contributed the Upjohn Business to Viatris (the &#8220;Contribution&#8221;), so that the Upjohn Business was separated from the remainder of Pfizer&#8217;s businesses (the &#8220;Separation&#8221;), (2) following the Separation, Pfizer distributed, on a pro rata basis (based on the number of shares of Pfizer common stock held by holders of Pfizer common stock as of the record date of November 13, 2020 (the &#8220;Record Date&#8221;)), all of the shares of Viatris common stock held by Pfizer to Pfizer stockholders as of the Record Date (the &#8220;Distribution&#8221;), and (3) immediately following the Distribution, Viatris and Mylan engaged in a strategic business combination transaction (the &#8220;Combination&#8221;). In addition, pursuant to the SDA and immediately prior to the Distribution, Viatris made a cash payment to Pfizer equal to $12 billion as partial consideration for the Contribution. As a result of the Combination, Viatris holds the combined Upjohn Business and Mylan business. Upon completion of the Distribution and the Combination, holders of Pfizer&#8217;s common stock as of the Record Date owned approximately 57% of the outstanding shares of Viatris common stock, and former Mylan shareholders owned approximately 43% of the outstanding shares of Viatris common stock, in each case on a fully diluted, as-converted and as-exercised basis. In connection with the Combination, on November 16, 2020, Mylan merged with and into Mylan II B.V., a company incorporated under the laws of the Netherlands and an indirect wholly owned subsidiary of Viatris, pursuant to and in accordance with the BCA. As a result of such merger, Mylan ceased to exist as a separate legal entity. In accordance with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC 805, Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Mylan is considered the accounting acquirer of the Upjohn Business and all historical financial information of the Company prior to November 16, 2020 represents Mylan&#8217;s historical results and the Company&#8217;s thereafter.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Separation, the legacy Upjohn Business historically received support services from Pfizer. In connection with the Separation and Combination, Viatris entered into several agreements with Pfizer or its subsidiaries, including among others, transition services and the manufacturing and supply agreements, which in general provide for the performance of certain services or obligations by each of Pfizer and Viatris for the benefit of each other for initial transitional periods following the Combination. The Company began the process of transitioning certain capabilities in 2021, but expects significant changes to occur in 2022 as a result of further transitioning of services and information and other systems. For additional information, see &#8220;Risk Factors &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Viatris could incur operational difficulties or losses if Pfizer is unable to perform under the agreements entered into as part of the Combination, if we are unable to obtain the same types and level of services and resources that historically have been provided to the legacy Upjohn Business by Pfizer, or if we are required to make payments to Pfizer pursuant to indemnities agreed to as part of the Combination.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise indicated, industry data included in this Item 1 are sourced from IQVIA Holdings Inc. and are for the twelve months ended November 2021. Viatris product and other company data included in this Item 1 are from internal sources and are as of November 30, 2021. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_16"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Organization</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upjohn was incorporated in Delaware on February 14, 2019 as a wholly-owned subsidiary of Pfizer to operate the Upjohn Business. Effective as of November 16, 2020, Upjohn changed its name to &#8220;Viatris Inc.&#8221; and became the parent entity of the combined Upjohn Business and Mylan business. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Upjohn Business was a global, primarily off-patent branded and generic established medicines business, which included 20 primarily off-patent solid oral dose legacy brands, such as Lyrica&#174;, Lipitor&#174;, Celebrex&#174; and Viagra&#174;. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mylan was founded in 1961 as a privately-owned company and grew over time into one of the largest manufacturers of generic drugs in the U.S. Mylan became a publicly traded company in 1973. Mylan&#8217;s strategy then led to many acquisitions which have played a significant role in the evolution of the company, including Matrix Laboratories Limited (2007); Merck KGaA&#8217;s generic and specialty pharmaceutical business (2007); the EPD Business (2015) and Meda AB (publ.) (2016). These acquisitions assisted in creating robust research, manufacturing, supply chain and commercial platforms on a global scale; substantially expanding its portfolio of medicines; diversifying by geography, product type and channel; maintaining its commitment to quality; and cultivating its global workforce.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the consummation of the Combination, the Viatris management team has been focused on ensuring that the Company is optimally structured and efficiently resourced to deliver sustainable value to patients, shareholders, customers and other stakeholders. This includes our previously disclosed significant global restructuring program, which is described further in Note 17 included in Part II. Item 8 of this Form 10-K.</span></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_19"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Model and Operations</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">At Viatris, we see healthcare not as it is, but as it should be. We act courageously and are uniquely positioned to be a source of stability in a world of evolving healthcare needs. Viatris empowers people worldwide to live healthier at every stage of life. We do so via</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Access</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Leadership</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Partnership</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</span></div><div style="margin-bottom:12pt"><img src="vtrs-20211231_g1.jpg" alt="vtrs-20211231_g1.jpg" style="height:63px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ACCESS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Viatris provides high-quality, trusted medicines, regardless of geography or circumstance.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We are committed to improving access to high-quality medicines while working to ensure a reliable supply so patients can get the treatments they need, when and where they need them. Our global portfolio, supported by our science, medical and manufacturing expertise, delivers global iconic and key brands, complex generics, biosimilars, generics - including complex and branded generics - and over-the-counter products. As a company, Viatris:</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Covers a broad range of therapeutic areas</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We produce medicines for patients across a broad range of major therapeutic areas. From cardiovascular health to oncology, Viatris offers quality treatment options across more than 10 major therapeutic areas covering a wide variety of noncommunicable and infectious diseases. We also offer support services such as diagnostic clinics, educational seminars and digital tools to help patients better manage their health. </span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Helps ease the burden of noncommunicable diseases.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> According to the WHO, NCDs, such as ischemic heart disease, stroke, diabetes, certain cancers and chronic obstructive pulmonary disease, were among the leading causes of death globally as of 2016. NCDs affect people of every age, gender and socioeconomic status in every corner of the world, and pose a heavy burden on individuals, families and communities. To overcome this global public health threat, patients worldwide need a partner they can trust &#8211; one that not only believes everyone deserves good health, but also has the portfolio, experience and expertise to make this belief a reality.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Helps hearts stay healthier. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">According to the WHO, coronary heart disease is the number one cause of death globally. Viatris collaborates with many organizations to help prevent, diagnose, and treat many cardiovascular illnesses. Our deep experience in emerging and developed markets affords a tried-and-true method of achieving high impact across the patient experience, from awareness to adherence. In close collaboration with governments, healthcare providers, technology partners and patients, we at Viatris work to nurture healthcare systems that can adapt and respond to patients&#8217; ever-changing needs. We continue to collaborate with medical associations, patient advocacy groups and academia to develop innovative, integrated solutions and programs to help strengthen both the delivery and quality of healthcare.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Fights infectious disease</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We are also a global leader in treating infectious diseases such as HIV/AIDS, hepatitis, and tuberculosis, and offer an extensive portfolio across these disease states. While many important strides have been made to treat these illnesses, there is still more to be done in countries where lack of access to therapeutics, preventative treatment and diagnostics often result in patients not receiving proper care, and those where HIV transmission continues thirty years into the epidemic. From manufacturing a pediatric-friendly antiretroviral used to treat HIV-positive infants to providing HIV self-tests in some low- and middle-income countries, we are innovating to help patients.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">An Increasingly Innovative and Differentiated Pipeline</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our confidence in the future delivery of our pipeline is rooted in our strong historic development programs and list of firsts, including the recent approval of the generic version of Allergan's Restasis&#174; and Semglee&#174; (insulin glargine-yfgn), the first interchangeable biosimilar ever approved in the U.S., and the launch of the first biosimilar to Humira&#174; (adalimumab) in Japan. In addition, we are working on many other programs, including the potential to be first to market for our BOTOX&#174; (onabotulinumtoxinA) and Eylea&#174; (aflibercept) biosimilars. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we will continue to diligently pursue important generics opportunities, we will increasingly focus on limited-competition complex and novel products targeting gaps in care, all with a first-to-market emphasis and serving our mission of patient access. Complex products categories are critical to patient health and are growing at a rapid pace. We believe that Viatris&#8217; early vision and continued commitment has given us one of the deepest complex product pipelines in the industry, and that we are well positioned to capitalize on these growth opportunities in the future. </span></div><div style="margin-bottom:12pt"><img src="vtrs-20211231_g2.jpg" alt="vtrs-20211231_g2.jpg" style="height:57px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LEADERSHIP</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Viatris is advancing sustainable operations and innovative solutions to improve patient health. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Viatris is committed to providing steady leadership in a world that is constantly evolving. We take that commitment seriously and know that advancing sustainable operations and innovative solutions to improve patient health requires strong global leadership. We know what it takes to reach more patients with more products, and believe that Viatris is uniquely positioned to make a difference through our:</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:14.5pt">Powerful global operating platform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, which combines what we believe to be best-in-class manufacturing and supply chain capabilities. Viatris operates approximately 40 manufacturing sites worldwide that produce oral solid doses, injectables, complex dosage forms and APIs on five different continents. Together with a global, flexible and diverse supply chain, our platform strives to mitigate risks of disruption and ensure supply reliability. Our efforts to build a responsive global network have helped us maintain a reliable supply of much needed medicines as the fight against the COVID-19 pandemic continues. We are committed to advancing responsible and sustainable operations and work diligently to minimize our environmental footprint across the Viatris network while safeguarding access to medicine. Our integrated, comprehensive approach focuses on water, air emissions, waste, climate change and energy.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Robust global technical resources</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, including thousands of scientists, regulatory experts and medical and product safety professionals working around the world on innovative therapies and solutions for patients everywhere.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Strong global commercial team</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, including sales team members and marketing professionals whose goal is to ensure that products are shipped to customers around the globe.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Diverse and differentiated global portfolio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> includes products in more than 10 major therapeutic areas, including both infectious diseases and NCDs and medicines that treat 9 out of 10 of the WHO&#8217;s leading causes of death. We are a leading supplier of medicines to the HIV/AIDS community around the world, with a legacy of providing access to high-quality and affordable ARVs in more than 100 countries. We also are a leading provider of biosimilars globally, with regulatory approvals for biosimilars in more than 85 countries in the areas of oncology, immunology, endocrinology, ophthalmology and dermatology.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that Viatris&#8217; global leadership in all of these areas uniquely positions us to efficiently and effectively serve patients regardless of geography or circumstance. Together, with our commitment to provide access to a sustainable, affordable, and diverse portfolio of high-quality medicines and our goal to be a Partner of Choice&#174; for companies big and small, Viatris works to improve access and meet evolving healthcare needs around the world.</span></div><div style="margin-bottom:12pt"><img src="vtrs-20211231_g3.jpg" alt="vtrs-20211231_g3.jpg" style="height:57px;margin-bottom:5pt;vertical-align:text-bottom;width:60px"/></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PARTNERSHIP</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leveraging our collective expertise to connect people to products and services. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a strong history of partnering with other pharmaceutical companies, nonprofit organizations, government agencies, policymakers, trade associations and alliances, industry researchers and patient advocacy groups. We engage with around 100 trade associations and not-for-profit organizations across more than 40 countries, as well as patient and industry groups and other partners. Our key collaborations focus on access to medicine; public awareness and disease screening; and healthcare provider education and support. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Global Healthcare Gateway&#174; Built to Fuel Growth and Partnerships</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Global Healthcare Gateway</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is open for business.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are actively engaging with potential partners to help them accelerate possibilities of using their own healthcare assets to reach more patients by leveraging our unique global platform &#8211; our R&amp;D, supply chain, manufacturing, regulatory, commercial and legal expertise. Although the global platforms and infrastructure supporting our innovative Global Healthcare Gateway are not entirely new, what is new is how we are enhancing our capital allocation approach to business development, and our organic and inorganic R&amp;D investments through a focused governance structure to ensure the highest level of strategic decision-making. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Licensing and Other Partner Agreements</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We periodically enter into commercial licensing and other partner agreements with other pharmaceutical companies for the development, manufacture, marketing and/or sale of pharmaceutical products. Doing so helps us share risks and costs, leverage strengths and scale up commercialization, but usually requires us to also share future profits. The result often is that medicines become available sooner and to a significantly larger group of patients.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our significant licensing and other partner agreements are primarily focused on the development, manufacturing, supply and commercialization of multiple, high-value generic biosimilar compounds, insulin analog products and respiratory products, among other complex products. Refer to Note 18 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Licensing and Other Partner Agreements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included in Part II. Item 8 of this Form 10-K for more information.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operations</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Viatris has developed an end-to-end experience across the total product life cycle, which includes global regulatory licensing, launch, growth and post-approval lifecycle management. Our research, development and medical platform seeks to maximize the impact of our existing portfolio by examining whether there is an opportunity for new indications, label extensions, formulations, and market registrations for our products. We also use our platform to determine whether there is an opportunity to integrate new products into our portfolio.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The manufacturing of APIs and finished dosage forms is performed by a combination of internal and external manufacturing operations. Internally, many of the products we produce are vertically integrated; meaning we manufacture both the APIs and finished dosage forms related to those products. Occasionally, however, resources we need are available from only a single supplier. As a result, we supplement our production footprint through arrangements with other manufacturers. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s significant manufacturing, warehousing and distribution activities are located primarily in the U.S., Puerto Rico, Singapore, India, Japan, China, and certain E.U. countries, including Ireland. In addition, we maintain administrative facilities around the world. While many of these key facilities are owned, Viatris also leases certain facilities from third parties.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe all our facilities are in good operating condition, the machinery and equipment are well-maintained, the facilities are suitable for their intended purposes and they have capacities adequate for the current operations.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Facilities and records related to our products are subject to periodic inspection by the FDA, the EMA and other regulatory authorities in jurisdictions where our products are marketed. In addition, authorities often conduct pre-approval plant inspections to determine whether our systems and processes comply with current GMP and other regulations, and clinical-trial reviews to evaluate regulatory compliance and data integrity. Our suppliers, contract manufacturers, clinical trial partners and other business partners are subject to similar regulations and periodic inspections. The Company remains committed to maintaining the highest quality manufacturing standards at its facilities around the world and to continuous assessment and improvement in a time of evolving industry dynamics and regulatory expectations.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are committed to advancing sustainable operations and innovative solutions to improve patient health. This means we focus on responsible conduct and have global policies and procedures to support our work. We work systematically and diligently to minimize our environmental footprint. Environmental and human health are interconnected, a relationship underscored by climate change and water stress. Our integrated, comprehensive approach focuses on water, air emissions, waste, climate change and energy. Looking ahead, to help ensure we identify and manage risks and opportunities appropriately, we are conducting a climate scenario analysis and intend to establish science-based greenhouse gas reduction targets and strategies, acknowledging the context of the Paris Agreement, as well as goals for water and waste. While it is impossible to predict accurately the future costs associated with environmental compliance and potential remediation activities, compliance with environmental laws is not expected to require significant capital expenditures and has not had, and is not expected to have, a material adverse effect on our operations or competitive position.</span></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_22"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Customers and Marketing</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our customers include retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions such as hospitals; among others. See &#8220;Channel Types&#8221; below for more information about our customers.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below displays the percentage of consolidated net sales to our largest customers during the years ended December&#160;31, 2021, 2020 and 2019.</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:65.615%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.503%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.503%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.507%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage of Consolidated Net Sales</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson Corporation</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AmerisourceBergen Corporation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health, Inc.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We serve our customers through a team of highly-skilled sales and marketing professionals, all of whom are focused on establishing Viatris as our customers&#8217; partner of choice. To best meet customers&#8217; needs, the Company manages its business on a geographic basis.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to being dynamic, the pharmaceutical industry is complex. How it functions, how it is regulated and how it provides patients access varies by location. Similarly, competition is affected by many factors. Examples of factors include innovation and development, timely approval of prescription drugs by health authorities, manufacturing capabilities, product quality, marketing effectiveness, portfolio size, customer service, consumer acceptance, product price, political stability and the availability of funding for healthcare.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain parts of our business also are affected by seasonality, e.g., due to the timing and severity of peak cough, cold and flu incidence, which can cause variability in sales trends for some of our products. While seasonality may affect quarterly comparisons within a fiscal year, it generally is not material to our annual consolidated results.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For these and other reasons, the Company&#8217;s sales and marketing efforts vary accordingly by product, market and channel type, each of which is described below. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Application of Critical Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section in Part II. Item 7 of this Form 10-K for more information related to customer arrangements.</span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Products</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From cardiovascular health to oncology, Viatris offers quality treatment options across more than 10 major therapeutic areas covering a wide variety of noncommunicable and infectious diseases. We also offer support services such as diagnostic clinics, educational seminars and digital tools to help patients better manage their health. We offer a broad and diverse range of treatment options across all our therapeutic areas, with many categories containing several products in a range of dosage forms, formulations and delivery systems that allow physicians to tailor care for optimal treatment.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Viatris markets prescription brand drugs, generic drugs, complex generic drugs, biosimilars and APIs.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Brand drugs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> typically are prescription</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">pharmaceuticals that are sufficiently novel as to be protected by patents or other forms of exclusivity. As such, these drugs, which bear trade names, may be produced and sold only by those owning the rights, subject to certain challenges that other companies may make. Developing new medicines can take years and significant investment. Only a few promising therapies ever enter clinical trials. Fewer still are approved for sale by health authorities, at which point marketing to healthcare providers and consumers begins. Because patents and exclusivities last many years, they serve as an incentive to developers. During the periods protected, developers often recoup their investments and earn a profit. In many high-income countries, the brand business often is characterized by higher margins on lower volumes - especially as compared with generic manufacturers. Viatris has numerous branded drugs, including iconic brands, as well as several global key brands to help patients manage their health. Brand drugs include branded generics which are off-patent products that are sold under an approved proprietary name for marketing purposes. Brand products often become branded generics once patent protections or other forms of exclusivity expire. Branded generic products are common in many countries outside the U.S., including emerging markets. Brand and branded generic products are more sensitive to promotion than are unbranded generic products. They therefore represent the primary focus of most of our sales representatives and product-level marketing activity. Our OTC products, which are sold directly to consumers without a prescription and without reimbursement, are generally sold under a brand name.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Generic drugs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are therapeutically equivalent versions of brand drugs. Generics generally become available once the patents and other exclusivities on their branded counterparts expire. The generics business is generally characterized by lower margins on higher volumes of a relatively large number of products. Our generic medicines work in the same way and provide the same clinical benefits as their as their brand-name counterparts and may cost less, providing patients and the healthcare system important savings and medicine options which we believe are essential to making healthcare accessible. The manufacturing of generic medicines is held to the same standards of GMP by health authorities as the manufacturing of branded medicines. National health authorities inspect our facilities around the world to ensure that generic manufacturing, packaging and testing sites pass the same quality standards as those of brand drugs. Gx products typically are sold under their INNs. INNs facilitate the identification of pharmaceutical substances or APIs. Each INN is unique and globally recognized. A nonproprietary name also is known as a generic name. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Complex generic drugs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are generic medicines that could have a complex active ingredient, complex formulation, complex route of delivery or complex drug device combinations. Viatris offers a number of these important medicines to patients, including our Wixela&#174; Inhub&#174;, the first generic of ADVAIR DISKUS&#174; and glatiramer acetate injection, a generic version of Copaxone&#174;, for example. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Biosimilars </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">are approved by regulatory authorities as highly similar to the originally approved biologic brand version with no clinically meaningful differences in safety or efficacy. Biosimilar versions are increasingly available as therapeutic alternatives for patients facing many serious diseases, including diabetes, autoimmune disorders and multiple cancers. We offer one of the industry&#8217;s largest and most diverse global biosimilars franchises with more than 300 marketing authorizations globally focused on the areas of oncology, immunology, endocrinology, ophthalmology and dermatology. These vital products can help increase access for current and future patients while supporting the sustainability of healthcare systems, and we continue to invest in bringing more to market, as we believe more than two-thirds of the products we will launch in the coming years will be either complex generics or biosimilars. Biosimilars often are marketed under a brand-name. Viatris offers one of the industry&#8217;s largest and most diverse global biosimilars franchises, including Fulphila&#174;, Ogivri&#174;, Hulio&#174;, and SEMGLEE&#174;.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">APIs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are responsible for the therapeutic effects of medicines. We are one of the world&#8217;s largest producers of APIs, providing them to customers in more than 100 countries. We are the leading producer of API used in generic ARVs, which treat HIV/AIDS. We also produce API for products in the following areas: antibacterial; central nervous system agents; antihistamines/antiasthmatics; cardiovascular, antivirals; antidiabetics; antifungals; and proton pump inhibitors. Our API is sold through a dedicated sales and marketing team primarily to pharmaceutical companies throughout the world.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Viatris invests significant sums in R&amp;D and in manufacturing capacity. We also often incur substantial litigation expense as a result of defending or challenging brand patents or exclusivities, which is described further in Note 19 included in Part II. Item 8 of this Form 10-K.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Market Types</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Viatris focuses its sales and marketing efforts on the people who make key decisions around pharmaceutical prescribing, dispensing or buying. Decision-makers vary by country or region, reflecting law and custom, giving rise to different types of pharmaceutical markets. Many countries feature a mix of or hybrids of various market types, though the Company may focus on just one type in a particular country.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">prescription</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> markets, physicians decide which medicines patients will take. Pharmacies then dispense the products as directed. Drug companies employ sales forces to educate doctors about the clinical benefits of their products. Representatives call on individual doctors or group practices; the process is known as detailing. Examples of countries served by Viatris that are mainly prescription markets are the U.S. brand business, Japan, China, Russia, Turkey, Poland and Mexico.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">substitution</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> markets, pharmacists generally are authorized (and in some cases required) by law to dispense an unbranded or branded generic, if available, in place of a brand-name medicine, or vice versa. Drug companies may use sales forces in these markets too, with representatives calling on and educating pharmacy personnel about their organization and products. Examples of countries served by Viatris that are mainly substitution markets are France, Italy, Spain, Portugal and Australia.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">tender</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> markets, payers, such as governments or insurance companies, negotiate the lowest price for a drug (or group of drugs) on behalf of their constituents or members. In exchange, the chosen supplier&#8217;s product is placed on the payer&#8217;s formulary, or list of covered prescriptions. Often, a supplier&#8217;s drug is the only one available in an entire class of drugs. Large sales forces are not needed to reach these decision-makers. Examples of generic markets served by Viatris that are mainly tender markets are New Zealand, Sweden, South Africa, as well as Germany.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">distribution</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> markets, retailers and wholesalers make drug-purchasing decisions. Large sales forces are not needed to reach the decision-makers representing these organizations. Note, however, that pharmacists operating in distribution markets also may be authorized to make substitution decisions when dispensing medicines. Examples of countries served by Viatris that are mainly distribution markets are the U.S. generics business, the U.K. and Norway.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The allocation of our sales and marketing resources reflects the characteristics of these different market types. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the case of OTC products, consumers are the decision-makers. OTC products are commonly sold via retail channels, such as pharmacies, drugstores and supermarkets. This makes their sale and marketing comparable to other retail businesses, with broad advertising and trade-channel promotion. Consumers often are loyal to well-known OTC brands. For this reason, suppliers of OTC products, Viatris included, must invest the time and resources needed to build strong OTC brand names. </span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Channel Types</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Viatris&#8217; products make their way to patients through a variety of intermediaries, or channels. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmaceutical</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">wholesalers/distributors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> purchase prescription medicines and other medical products directly from manufacturers for storage in warehouses and distribution centers. The distributors then fill orders placed by healthcare providers and other authorized buyers.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmaceutical</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">retailers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> purchase products directly from manufacturers or wholesalers/distributors. They then sell them to consumers in relatively small quantities for personal use.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Institutional pharmacies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> address the unique needs of hospitals, nursing homes and other such venues. Among the services provided are specialized packaging, including for injectables and unit-dose products, for controlled administration.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mail-order and e-commerce pharmacies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> receive prescriptions by mail, fax, phone or the internet at a central location; process them in large, mostly automated centers; and mail the drugs to the consumer.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Specialty pharmacies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> focus on managing the handling and service requirements associated with high-cost and more-complex drug therapies, such as those used to treat patients with rare or serious diseases.</span></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_25"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Segments</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Viatris has four reportable segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The Company reports segment information on the basis of markets and geography, which reflects its focus on bringing its broad and diversified portfolio of branded, complex generics and biosimilars, and generic products to people in markets everywhere. Our Developed Markets segment comprises our operations primarily in North America and Europe. Our Greater China segment includes our operations in China, Taiwan and Hong Kong. Our JANZ segment reflects our operations in Japan, Australia and New Zealand. Our Emerging Markets segment encompasses our presence in more than 125 countries with developing markets and emerging economies including in Asia, Africa, Eastern Europe, Latin America and the Middle East as well as the Company&#8217;s ARV franchise.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Developed Markets </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Developed Markets segment comprises our operations primarily in North America and Europe. The Company&#8217;s business in North America is driven mainly by our operations in the U.S., where we are one of the largest providers of prescription medicines. The U.S. pharmaceutical industry is very competitive, and the primary means of competition are innovation and development, timely FDA approval, manufacturing capabilities, product quality, marketing, portfolio size, customer service, reputation and price. We rely on cost-effective manufacturing processes to meet the rapidly changing needs of our customers around a reliable, high quality supply of generic pharmaceutical products. Europe, where many governments provide healthcare at a low direct cost to consumers and regulate pharmaceutical prices or patient reimbursement levels, continues to be a highly competitive market, especially in terms of pricing, quality standards, service levels and product portfolio. Our leadership position in a number of countries provides us a platform to fulfill the needs of patients, physicians, pharmacies, customers and payors.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant products sold by the Developed Markets segment include Lyrica&#174;, Lipitor&#174;, Creon&#174;, Influvac&#174;, Wixela&#174; Inhub&#174;, the EpiPen&#174; Auto-Injector, Hulio&#174;, Fraxiparine&#174;, and Yupelri&#174;.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">New product launches are an important growth driver. Important recent launches include SEMGLEE&#174;, Abiraterone, and Cyclosporine Ophthalmic Emulsion in early 2022.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While our U.S. customer base is extensive, it increasingly comprises a small number of very large firms as the pharmaceutical industry has undergone and continues to undergo tremendous change and consolidation. We believe Viatris is well positioned to serve such customers in the Developed Markets due to the scale we have built in terms of R&amp;D, API and finished-dosage-form manufacturing, and portfolio breadth.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Greater China</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Greater China segment includes our operations in mainland China, Taiwan and Hong Kong. Since the closing of the Combination, the Viatris Greater China portfolio is predominantly branded LOE products.  </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In China, the recent healthcare reform measures are aimed at controlling the overall healthcare costs, while providing better and broader care to the population. Healthcare spending is expected to increase in-line with GDP growth. The VBP policy for LOE molecules is now in its fourth year and includes more than 200 molecules. All major Viatris brands are included in the VBP molecule lists. We have re-balanced our business to expand our focus on the retail pharmacy and e-commerce channels while maintaining our presence in the hospital channel. Healthcare consumerism, increased spending power, and demand for premium medical products have generated strong growth in these new channels and partially absorbed the reductions seen in hospital channel due to VBP. Additional pricing and volume pressure for pharmaceutical products sold in the hospital channels is expected to continue during 2022 and could negatively impact our results of operations. For additional information, see &#8220;Risk Factors - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We have and may continue to experience pressure on the pricing of and reimbursements for certain of our products due to pricing controls, social or government pressure to lower the cost of drugs, and consolidation across the supply chain.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant products within the Greater China segment include Lipitor&#174;, Norvasc&#174;, and Viagra&#174;.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">JANZ</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The JANZ</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">segment consists of our operations in Japan, Australia and New Zealand. In Japan, the NHI regulates the pricing of pharmaceutical products to healthcare providers. The Company sells products in Japan primarily through a network of wholesalers who then sell the products to doctors, hospitals and pharmacies. In Australia, the healthcare system is a mix of public and private healthcare sectors, with Medicare, Australia&#8217;s public healthcare system, covering most of the country&#8217;s medical costs. The Department of Health oversees healthcare governance, law, and policy while the various state and territory governments administer the system. Most prescription pharmaceutical products are subsidized under the pharmaceutical benefits scheme by the federal government. Pricing of reimbursed pharmaceutical products is regulated by the government and funded via the Medicare levy and through company and patient contributions. The Company sells products primarily through the wholesale system, while promoting its products to both physicians and pharmacists.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant products within the JANZ segment include AMITIZA&#174;, Lipacreon&#174;, Lyrica&#174;, Norvasc&#174;, and Effexor&#174;.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New product launches are an important growth driver. Important recent launches include adalimumab biosimilar in Japan.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Emerging Markets</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Emerging Markets segment encompasses our presence in more than 125 countries with developing markets and emerging economies including in Asia, Africa, Eastern Europe, Latin America and the Middle East as well as the Company&#8217;s ARV franchise. With healthcare at various stages of development across these markets, we believe we are positioned to not only leverage our large geographical footprint to maximize the similarities between these markets, but also tailor solutions to meet local need. There is demand in this segment for better healthcare to serve a growing population and economic expansion. Many countries in this segment are brand-conscious with generic penetration rates lower than developed markets. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Among our products sold in the segment are Lipitor&#174;, Lyrica&#174;, Norvasc&#174;, Celebrex&#174;, and ARVs.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New product launches are an important growth driver. New products sold in the Emerging Markets segment in 2021 include Remdesivir and a number of biosimilars.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 15</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Segment Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included in Part II. Item 8 of this Form 10-K for more information about our segments.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Government Regulation</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regulation by governmental authorities is a significant factor in the R&amp;D, manufacture, marketing, sales and distribution of pharmaceuticals. Our products are subject to robust developmental studies which include analytical determinations of strength, quality, purity as well as rigorous safety and efficacy determinations using preclinical, pharmacokinetic studies and clinical evaluations to gather data to support regulatory review and approval. This body of work results in extensive data and scientific information that is incorporated into a given product&#8217;s regulatory dossier. Manufacturing is conducted under exacting conditions governed by extensive regulation including strict in-process and finished pharmaceutical products specifications and controls. Post-approval activities, such as advertising and promotion, pharmacovigilance, post-marketing regulatory commitments, and pharmacopeial monographs, are subject to extensive regulation and controls as well.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The lengthy process of developing products and obtaining required approvals and the continuing need for post-approval compliance with applicable statutes and regulations require the expenditure of substantial resources. Regulatory approval, if and when obtained, may be limited in scope. Further, approved drugs, as well as their manufacturers, are subject to ongoing post-marketing review and inspection, which can lead to the discovery of previously unknown problems with products or the manufacturing or quality control procedures used in their production, which may result in restrictions on their manufacture, sale or use or in their withdrawal from the market. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any failure or delay by us, our suppliers of manufactured drug product, collaborators or licensees, in obtaining and maintaining regulatory approvals could adversely affect the marketing of our products and our ability to receive product revenue, license revenue or profit-sharing payments.</span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Regulatory Requirements</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is subject to a wide range of various other federal, state, non-governmental, and local agency rules and regulations. They focus on fraud and corruption, pricing and reimbursement, data privacy, and the environment, among many other considerations. For more information about certain of these regulations and the associated risks we face, see Part I. Item 1A. &#8220;Risk Factors&#8221; of this Form 10-K.</span></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_31"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our R&amp;D organization, which includes researchers and regulatory and clinical experts, work collaboratively across our different R&amp;D centers around the world, which include technology-focused development sites and global R&amp;D centers. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our research, development and clinical platform, which includes regulatory activities, seeks to deliver new product opportunities across all of our categories and markets and to evaluate opportunities to expand the scope of our existing product portfolio. Our product pipeline includes a variety of dosage forms, including oral solid dosage forms, transdermals, injectables, inhalation, and other delivery systems. While committed to generics and specialty products, over the last several years, a greater portion of our investments has been focused on complex or difficult-to-formulate products, such as biosimilars and extended release injectables, rather than on commodity products, such as conventional oral solid dosage forms. For example, we are working on a number of programs including the potential to be first to market for our BOTOX&#174; (onabotulinumtoxinA) and Eylea&#174; (aflibercept) biosimilars.</span></div><div style="text-indent:36pt"><span><br/></span></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_34"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intellectual Property</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider the protection of our intellectual property rights to be extremely valuable, and we act to protect them from infringement by third parties.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have an extensive trademark portfolio and routinely apply to register key brand-name, generic, branded generic, biosimilar and trade names in numerous countries around the world. Our registered trademarks are renewable indefinitely, and these registrations are properly maintained in accordance with the laws of the countries in which they are registered.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have an extensive patent portfolio and actively file for patent protection in various countries to protect our brand-name, generic, branded generic, biosimilar and OTC products, including processes for making and using them. We have more than 3,400 patents filed globally. For additional information, see Part I. Item 1A &#8220;Risk Factors - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We rely on the effectiveness of our patents, confidentiality agreements and other measures to protect our intellectual property rights</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; of this Form 10-K.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, we have well-established safeguards in place to protect our proprietary know-how and trade secrets, both of which we consider extremely valuable to our intellectual property portfolio. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We look for intellectual property licensing opportunities to or from third parties, related not only to our existing products, but as a means for expanding our product portfolio.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on the aforementioned types of intellectual property, as well as our copyrights, trade dress, regulatory exclusivities and contractual protections, to establish a broad scope of intellectual property rights for our product portfolio. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Human Capital</span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our people, our culture</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our approximately 37,000 diverse colleagues are fueled by a shared passion, purpose, and genuine care for the patients we serve, and see healthcare not as it is, but as it should be.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To us, that means empowering patients worldwide to live healthier at every stage of life.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It also means empowering our colleagues to be the best they can be every day. This is our mindset as we build our performance-driven, highly engaging and inclusive culture: &#8220;The Viatris Way&#8221;. Since Day 1, we have had several accomplishments that lay the foundation for the kind of company we want to be, including:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Establishing four inaugural Employee Resource Groups (ERGs): Blacks, Women, LGBTQ+ and Working Parents. We believe that it is only through the diverse experiences and perspectives of all our colleagues that we can elicit the best ideas, drive innovation, and achieve business results; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Being recognized on the Forbes&#174; 2021 World&#8217;s Best Employers list.</span></div><div><span><br/></span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Talent, training and development</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The careers of our colleagues make a difference in the lives of patients around the world, and we want those careers to make a difference in their own lives as well. We provide tools and resources to help colleagues reach new heights. We are committed to cultivating and acquiring talent, developing capabilities and driving performance. We are systematically reviewing and developing structures, programs and processes to support colleagues&#8217; professional development and ensure that Viatris contains the appropriate competencies to support our mission. </span></div><div><span><br/></span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Diversity and inclusion </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diversity and inclusion, including understanding and embracing what makes individuals unique, are essential to Viatris&#8217; mission. The diversity we foster in all aspects of our business can be one of our greatest strengths in redefining healthcare not as it is, but as it should be.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Viatris strives to create a positive, productive work environment where integrity, dignity and mutual respect for all are valued. We are an equal opportunity employer and discrimination and harassment are strictly prohibited. Together, we are building a highly inclusive organization and our goal is to provide a safe, supportive community where employees feel they belong and can use their unique experiences, perspectives and skills to make a difference in the lives of others. </span></div><div><span><br/></span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Employee well-being and safety</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Viatris is committed to providing a safe and healthy workplace for our employees, contractors and visitors. In addressing the COVID-19 pandemic and helping meet urgent global health needs, tens of thousands of dedicated Viatris employees across the world have worked to help ensure a stable supply of much needed treatments. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because protecting the health and safety of our workforce remains paramount, we continue to align with government directives and the advice of relevant international, national and local health authorities at every Viatris facility around the world. Many of our colleagues are working in manufacturing facilities, where we have taken extra precautions to protect our site personnel and operations, including implementing social distancing measures, daily health assessments and split shifts where feasible. Others have traded their desks for kitchen tables and are juggling disrupted family schedules as well as work, like so many, during this time. We offer a wide range of benefits and programs that are locally customized to meet the unique needs of employees, and regularly offer advice and support to employees working from home.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Approach to restructuring</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Viatris is undertaking a global restructuring program intended to ensure that the organization is optimally structured and efficiently resourced to deliver sustainable value to patients, shareholders, customers, and other stakeholders. Any workforce actions taken as part of this restructuring program have been and will continue to be implemented in a way that is consistent with the company&#8217;s strong commitment to treating employees fairly and with respect. </span></div><div><span><br/></span></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_37"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exchange Act Reports</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Viatris maintains a website at Viatris.com where you can find certain reports and associated amendments that the Company files with the SEC in accordance with the Exchange Act. These filings will include our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and any amendments to those reports.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We make this information available on our website free of charge, as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC. The contents of our website are not incorporated by reference in this Annual Report on Form 10-K and shall not be deemed &#8220;filed&#8221; under the Exchange Act. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The SEC also maintains a website (www.sec.gov) that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC.</span></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_82"></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.14pt">Risk Factors</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We operate in a complex and rapidly changing environment that involves risks, many of which are beyond our control. Our business, financial condition, results of operations, cash flows, ability to pay dividends, and/or stock price could be materially affected by any of these risks, if they occur, or by other factors not currently known to us, or not currently considered to be material. These risk factors should be read in conjunction with the other information in this Form 10-K, as well as our other filings with the SEC. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our risk factors are organized into six categories: Combination, Strategic, Operational, Compliance, Finance and General.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Summary</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Below is a summary of some of the more significant risks and uncertainties we face. This summary is not exhaustive and is qualified by reference to the full set of risk factors set forth in Part I, Item 1A. </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Combination Risks</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">The integration of the Upjohn Business with Mylan following the Combination, as well as our global restructuring program, may present significant challenges.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Viatris may not realize the anticipated benefits from the Combination or its global restructuring program.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Viatris could incur operational difficulties or losses if Pfizer is unable to perform under the agreements entered into as part of the Combination, if we are unable to obtain the same types and level of services and resources that historically have been provided to the legacy Upjohn Business by Pfizer, or if we are required to make payments to Pfizer pursuant to indemnities agreed to as part of the Combination.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Strategic Risks</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.75pt">The risks and uncertainties associated with the pending transaction involving our biosimilars business.</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Our strategic initiatives, including our strategic alliances, may not achieve all intended benefits.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">We have and may continue to experience pressure on the pricing of and reimbursements for certain of our products due to pricing controls, social or government pressure to lower the cost of drugs, and consolidation across the supply chain.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">We have significant operations globally, which exposes us to the risks inherent in conducting our business internationally.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Charges to earnings resulting from acquisitions could have a material adverse effect on our business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Operational Risks</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Public health outbreaks, epidemics and pandemics, including the COVID-19 pandemic, have had and could continue to have a material adverse effect on our business, financial condition, results of operations, cash flows and/or stock price and may impact our ability to pay dividends.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Current and changing economic conditions may adversely affect our industry, business, partners and suppliers.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">The pharmaceutical industry is heavily regulated, and we face significant costs and uncertainties associated with our efforts to comply with applicable laws and regulations.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">The use of legal, regulatory, and legislative strategies by both brand and generic competitors, including but not limited to &#8220;authorized generics&#8221; and regulatory petitions, may increase costs associated with the introduction or marketing of our generic products, could delay or prevent such introduction, and could significantly reduce our revenue and profit.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">If we are unable to successfully introduce new products in a timely manner, our future revenue and profitability may be adversely affected.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">We expend a significant amount of resources on R&amp;D efforts that may not lead to successful product introductions.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Even if our products in development receive regulatory approval, such products may not achieve expected levels of market acceptance.</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Our business is highly dependent upon market perceptions of us, our products and brands, and the safety and quality of our products and brands, as well as the effectiveness of our sales and marketing activities, and we may be adversely impacted by negative publicity or findings.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">We have a limited number of manufacturing facilities and certain third-party suppliers produce a substantial portion of our API and products, some of which require a highly exacting and complex manufacturing process.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.75pt">Our future success is highly dependent on our ability to attract, motivate and retain key personnel.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Compliance Risks </span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.75pt">We are subject to the U.S. Foreign Corrupt Practices Act, the U.K. Bribery Act, Chinese anti-corruption laws and similar worldwide anti-corruption laws, which impose restrictions on certain conduct and may carry substantial fines and penalties.</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.46pt">Our competitors, including branded pharmaceutical companies, and/or other third parties, may allege that we or our suppliers are infringing upon their intellectual property, including in an &#8220;at risk launch&#8221; situation, which could result in substantial monetary damages, impact our ability to launch a product and/or our ability to continue marketing a product, and/or force us to expend substantial resources in resulting litigation, the outcome of which is uncertain.</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">We are involved in various legal proceedings and certain government inquiries and may experience unfavorable outcomes of such proceedings or inquiries. </span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">If we fail to comply with our corporate integrity agreement, we could be subject to substantial penalties and exclusion from participation in federal healthcare programs.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">We are increasingly dependent on IT and our systems and infrastructure face certain risks, including cybersecurity and data leakage risks.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Finance Risks </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.46pt">There can be no guarantee that we will continue to pay dividends or that we will implement a stock buyback program.</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">We may not be able to maintain competitive financial flexibility and our corporate tax rate which could adversely affect us and our shareholders </span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">We have significant indebtedness, which could lead to adverse consequences or adversely affect our financial position and prevent us from fulfilling our obligations under such indebtedness, and any refinancing of this debt could be at significantly higher interest rates.</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">There are inherent uncertainties involved in estimates, judgments and assumptions used in the preparation of financial statements in accordance with U.S. GAAP. Any future changes in estimates, judgments and assumptions used or necessary revisions to prior estimates, judgments or assumptions or changes in accounting standards could lead to a restatement or revision to previously issued financial statements.</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Viatris could suffer additional losses due to asset impairment charges.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Combination Risks</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">The integration of the Upjohn Business with Mylan following the Combination, as well as our global restructuring program, may present significant challenges. </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The combination of two independent businesses is a complex, costly and time-consuming process and there is a significant degree of difficulty inherent in the process of integrating the Upjohn Business and Mylan. These difficulties include:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">diversion of management&#8217;s attention from the ongoing operations of Viatris to integration and restructuring matters;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">the challenge of integrating the employees and business cultures of the Upjohn Business and Mylan;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">retaining existing customers and suppliers, or obtaining new customers and suppliers;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">risks associated with managing a larger and more complex company;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">the challenge and cost of integrating manufacturing, logistics, information technology, communications and other systems of the Upjohn Business and Mylan; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">the potential difficulty retaining key personnel and other employees of Mylan and the Upjohn Business; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">challenges in reducing reliance on certain transition services provided by Pfizer, including difficulty hiring employees or finding other suitable replacements and managing the amounts of related replacement costs, prior to the expiration of any period in which such services are provided; and</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">reducing costs associated with the transition services provided by Pfizer.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition to integration activities with respect to Mylan and the Upjohn Business, Viatris is also implementing a significant global restructuring program in order to achieve specified synergies and ensure the new company is optimally structured and efficiently resourced to deliver sustainable value to patients, shareholders, customers, and other stakeholders. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The process of integrating operations and implementing restructuring initiatives could cause an interruption of, or loss of momentum in, the activities of one or more of Viatris&#8217; businesses. These integration and restructuring processes are ongoing and members of Viatris&#8217; senior management are required to devote considerable amounts of time to these processes, which could decrease the time they have to manage and service Viatris&#8217; businesses, and develop new products or strategies. There is no assurance that Viatris will be able to manage this integration or restructuring in the manner or on the timelines currently anticipated. If our senior management is not able to timely and effectively manage these integration or restructuring processes, significant business activities are interrupted, or there is a delay or inability to achieve anticipated integration or restructuring goals, Viatris may not be able to achieve its synergy targets and there could be a material adverse effect on Viatris&#8217; business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Viatris may not realize the anticipated benefits from the Combination or its global restructuring program.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Viatris is expected to realize synergies, growth opportunities, and other financial and operating benefits as a result of the Combination. Viatris&#8217; success in realizing these benefits, and the timing of their realization, depends on the successful integration of the Upjohn Business with Mylan, as well as the success of our global restructuring program. See &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">The integration of the Upjohn Business with Mylan following the Combination, as well as our global restructuring program, may present significant challenges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221; above. Even if the integration and global restructuring program are successful, we may not achieve these synergies, growth opportunities and other financial and operating benefits within the timeline we anticipate, or at all. For example, the benefits from the Combination may be offset by significant costs incurred in connection with our global restructuring program and the Combination, including integration and post-closing costs, costs associated with our TSAs with Pfizer, and capital expenditures, which could be higher than currently estimated. The quantification of synergies expected to result from the Combination is based on significant estimates and assumptions that are subjective in nature and inherently uncertain. Realization of any benefits and synergies could be affected by a number of factors beyond our control, including, without limitation, general economic conditions, increased operating costs, regulatory developments, and the other risks described in these risk factors. In addition, our ability to achieve our synergy targets depends in large part on the successful implementation of the initiatives under our global restructuring program, which may not achieve their intended goals. The amount of synergies actually realized as a result of the Combination, if any, and the time periods in which any such synergies are realized, could differ materially from our current expectations and estimates, regardless of whether the two business operations are combined successfully. In addition, if key personnel and other employees depart because of issues relating to the uncertainty and difficulty of integration activities, Viatris&#8217; ability to realize the anticipated benefits of the Combination could be reduced. If the integration or our global restructuring program are unsuccessful, if the estimated costs are higher than anticipated, or if we are unable to realize the anticipated synergies and other benefits of the Combination, there could be a material adverse effect on Viatris&#8217; business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Viatris could incur operational difficulties or losses if Pfizer is unable to perform under the agreements entered into as part of the Combination, if we are unable to obtain the same types and level of services and resources that historically have been provided to the legacy Upjohn Business by Pfizer, or if we are required to make payments to Pfizer pursuant to indemnities agreed to as part of the Combination.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with the Combination, Viatris entered into several agreements with Pfizer or its subsidiaries, including among others, transition services and the manufacturing and supply agreements, which in general provide for the performance of certain services or obligations by each of Pfizer and Viatris for the benefit of each other for a transitional period following the Combination. If either party is unable to satisfy its obligations under such agreements in a timely manner or at all, or if the transitional agreements fail to provide for or cover certain essential services needed by Viatris during the applicable transitional period, we have limited recourse and could incur operational difficulties or losses or face liability.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In particular, the legacy Upjohn Business historically received benefits and services from Pfizer. Viatris no longer benefits from Pfizer&#8217;s services or business relationships to the extent not otherwise addressed in the definitive documents entered into in connection with the Combination. While Pfizer has agreed to provide certain transition services to Viatris for a transitional period following the Combination, such services may not provide benefits equivalent to the services provided when the Upjohn Business was operating as a part of Pfizer. Viatris may not be able to adequately replace resources formerly provided by Pfizer, or replace such services at the same or lower cost. Viatris may also need to make significant investments to replicate or outsource from other providers certain facilities, systems, infrastructure, and personnel to which it no longer has access and may incur significant costs to replace such services. In addition, we may experience operational disruptions associated with ending the transition services that Pfizer has agreed to provide Viatris under the transition agreements as Viatris transitions off of and attempts to replace these services. Further, because Viatris is reliant on Pfizer for such services during the transitional period, any interruption, disruption or breach of Pfizer&#8217;s systems relating to such services, including information technology and information security systems, could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with such transition services, Viatris and Pfizer agreed, among other things, that each of them will each bear 50% of the first $380 million of certain reasonable out-of-pocket costs incurred by Pfizer in connection with the services, with Viatris bearing all of such costs in excess of $380 million. As of December 31, 2021, the Company has incurred approximately $83.5 million of such expenses.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, in connection with the Combination, Viatris agreed to indemnify Pfizer for certain liabilities. Any payments pursuant to these indemnities could be significant and could have a material adverse effect on our business, financial condition, results of operations, cash flows, ability to pay dividends or stock price. See &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">We are involved in various legal proceedings and certain government inquiries and may experience unfavorable outcomes of such proceedings or inquiries</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221; below.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Viatris may be subject to significant U.S. tax liabilities, or be obligated to indemnify Pfizer for any such tax liability imposed on Pfizer and is subject to potentially significant restrictions that could limit its ability to undertake certain corporate actions (such as stock issuances or the undertaking of a merger or consolidation). </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with the Combination, Pfizer received the IRS Ruling and the Tax Opinion, each to the effect that, for U.S. federal income tax purposes, the Distribution, together with certain related transactions, will qualify as a tax-free &#8220;reorganization&#8221; within the meaning of Section 368(a)(1)(D) of the Code, the Distribution will qualify as a tax-free distribution within the meaning of Section 355 of the Code and the Pfizer Distribution Payments will qualify as money distributed to Pfizer creditors or stockholders in connection with the reorganization for purposes of Section 361(b) of the Code.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Although the IRS Ruling is generally binding on the IRS, the continuing validity of the IRS Ruling is subject to the accuracy of the factual representations made in the ruling request. An opinion of tax counsel neither binds the IRS nor precludes the IRS or the courts from adopting a contrary position. Accordingly, notwithstanding the IRS Ruling and Tax Opinion, there can be no assurance that the IRS will not assert a position contrary to one or more of the conclusions set forth herein and if the IRS prevails in such challenge, the U.S. federal income tax consequences of the Distribution, together with certain related transactions, to Pfizer, Viatris and the holders of Pfizer common stock could be materially different from, and worse than, the U.S. federal income tax consequences described below. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If the Distribution were determined not to have qualified for tax-free treatment under Section 355 of the Code, Pfizer would generally be subject to tax as if it sold the Viatris common stock in a transaction taxable to Pfizer, which could result in a material tax liability that, under certain circumstances, Viatris may be required to indemnify Pfizer against pursuant to the Tax Matters Agreement. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Even if the Distribution were otherwise to qualify as a tax-free transaction under Sections 368(a)(1)(D) and 355 of the Code, the Distribution would be taxable to Pfizer (but not to Pfizer&#8217;s stockholders) pursuant to Section 355(e) of the Internal Revenue Code if there were a 50 percent or greater change in ownership of either Pfizer or Viatris, directly or indirectly, as part of a plan or series of related transactions that included the Distribution. For this purpose, any acquisitions of Pfizer or Viatris common stock within the period beginning two years before the Distribution and ending two years after the Distribution (i.e., on November 16, 2022) are presumed to be part of such a plan, although Pfizer may be able to rebut that presumption. For purposes of this test, the Combination will be treated as part of a plan, but the Combination standing alone will not cause the Distribution to be taxable to Pfizer under Section 355(e) of the Code because holders immediately before the Distribution of Pfizer common stock directly owned more than 50 percent of Viatris common stock immediately following the Combination. Nevertheless, if the IRS were to determine that other acquisitions of Pfizer common stock or Viatris common stock, either before or after the Distribution, were part of a plan or series of related transactions that included the Distribution, such determination could result in the recognition of a material amount of taxable gain for U.S. federal income tax purposes by Pfizer under Section 355(e) of the Code. Under the Tax Matters Agreement, Viatris will be required to indemnify Pfizer against any taxes resulting from the Distribution or certain aspects of the Separation that arise as a result of Viatris&#8217; breach of certain representations or covenants in the Tax Matters Agreement or certain other acts or omissions by Viatris, including certain actions that could result in Section 355(e) of the Code applying to the Distribution. If Viatris was required to indemnify Pfizer for taxes resulting from the Distribution or certain aspects of the Separation, that indemnification obligation could be substantial and could have a material adverse effect on Viatris, including with respect to our business, financial condition and results of operations. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, the Tax Matters Agreement generally prohibits Viatris and its affiliates from taking certain actions that could cause the Distribution and certain related transactions to fail to qualify as tax-free transactions to Pfizer and its stockholders. Furthermore, unless an exception applies, for a two-year period following the date of the Distribution (i.e., until November 16, 2022), Viatris and its subsidiaries may not:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">engage in transactions in which Viatris&#8217; stock is acquired;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">engage in certain mergers or consolidations;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">discontinue the active conduct of the Upjohn Business;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">sell certain assets;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">redeem or repurchase any of Viatris&#8217; stock (other than share repurchases permitted by the IRS Ruling); or</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">amend the Viatris Charter or take any other action affecting the relative voting rights of any of its stock or stock rights.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If Viatris intends to take certain restricted actions before November 16, 2022, it must notify Pfizer of the proposal to take such action and either (a) obtain a ruling from the IRS or an unqualified opinion acceptable to Pfizer to the effect that such action will not affect the tax-free status of the Distribution and certain related transactions or (b) receive from Pfizer a waiver of such requirement. However, none of the receipt of an IRS ruling, an unqualified tax opinion or a waiver by Pfizer will relieve Viatris of any responsibility to indemnify Pfizer for tax-related losses resulting from such actions. As a result of these restrictions and indemnification obligations under the Tax Matters Agreement, Viatris may be limited in its ability to pursue strategic transactions, equity or convertible debt financings or other transactions that may otherwise be in our best interests.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Strategic Risks</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">There are risks and uncertainties associated with the pending transaction involving our biosimilars business, one or more of which</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">could have a material adverse effect on our business, financial condition, results of operations, cash flows, ability to pay dividends or stock price</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">There are a number of risks and uncertainties associated with the pending Biocon Biologics Transaction, including, among other things, the potential failure of a condition to closing, including the conditions related to obtaining required regulatory and other consents and approvals, which could give rise to the termination of Biocon Agreement and related agreements executed between us, Biocon and Biocon Biologics, as applicable. Either party has the right to terminate the Biocon Agreement if the closing has not occurred by March 31, 2023, subject to extension in certain circumstances. For example, a failure by Biocon Biologics to obtain necessary financing to consummate the transactions contemplated by the Biocon Agreement prior to such date could cause the Biocon Agreement to be terminated. To the extent that the current market price of our common stock reflects an assumption that the transactions contemplated by the Biocon Agreement and related agreements will be consummated in the timeframe and manner currently anticipated, and that a portion of the proceeds to us will be used to pay down debt and/or to fund other important company initiatives, any delay in closing or failure to close could result in a decline in the market price of our common stock. Similarly, any delay in closing or failure to close could result in damage to our relationships with customers, suppliers and employees, including our existing relationships with Biocon and Biocon Biologics, and have an adverse effect on our business. Pending the completion of the transactions contemplated by the Biocon Agreement, the attention of our management may be directed toward such transactions and related matters, and their focus may be diverted from the day-to-day business operations of our company, including from other opportunities that might otherwise be beneficial to us. We have agreed to indemnify Biocon Biologics and certain of its representatives against certain losses suffered as a result of certain breaches of our representations, warranties, covenants and agreements in the Biocon Agreement and related documents. Any event that results in a right for Biocon Biologics to seek indemnity from us could result in substantial liability to us and could adversely affect our financial position and results of operations. In addition, in connection with the closing of the pending transaction with Biocon Biologics, we will enter into a transition services agreement pursuant to which we will provide services to Biocon Biologics, including commercialization services substantially the same as we currently provide to our biosimilar business, generally for a period of up to two years. Once in effect, our obligations under the transition services agreement may result in additional expenses that are borne by us and may divert our focus and resources that would otherwise be invested into maintaining or growing our retained business. Furthermore, a significant portion of the consideration that we will receive in the pending transaction with Biocon will be in the form of equity in Biocon Biologics, which is a privately held Indian company. Although we have negotiated certain &#8220;downside&#8221; protection regarding the value of that equity in the Biocon Agreement and related documents, such protection does not guarantee any particular liquidity event or our ability to monetize our equity and, even if we are able to successfully liquidate our equity, the downside protection may be inadequate to guarantee a minimum return that we or investors expect. In addition, we believe the success of the Biocon biologics business over at least the first two years after closing, will be highly dependent upon the successful transition of the business to Biocon, including no major disruption in services provided under the transition services agreement, which will also have a significant impact on the value of the equity we will own in Biocon Biologics.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Whether the Biocon Biologics transaction is ultimately consummated or not, the pendency could have a number of negative effects on our current business, including potentially disrupting our regular operations, diverting the attention of our workforce and management team, and increasing workforce turnover. It could also disrupt existing business relationships, make it harder to develop new business relationships, or otherwise negatively impact the way that we operate the business, which could negatively impact Viatris&#8217; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">results of operations and cash flows</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> during the pendency of the transaction. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If we successfully complete the pending transaction involving our biosimilars business, our total revenues, results of operations and cash flows from operating activities are expected to be negatively impacted in the periods after close. We have expended significant time and resources, and expect to continue to expend significant time and resources, on the transaction involving our biosimilars business, including management time and focus, costs and expenses related to the separation of the biosimilars business from Viatris, the provision of the transition services and other transaction costs. Many of these expenses must be paid regardless of whether the transaction closes, and even if the expected benefits are not achieved. We may also face other challenges as a result of the announcement and completion of the transactions contemplated by the Biocon Agreement, including that we may not be able to realize the anticipated benefits from such transactions, such as deploying the proceeds to pay down our outstanding indebtedness and/or fund other important initiatives, and maintaining employee morale and retaining key management and other employees to provide the transition services and to operate our retained business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Any of the risks described above could have a material adverse effect on our business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Our strategic initiatives, including our strategic alliances, may not achieve all intended benefits.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In addition to the integration and restructuring activities and the Biocon Biologics Transaction, each of which is discussed above, we have entered into and continue to consider and evaluate various strategic transactions and business arrangements on an ongoing basis, including acquisitions, asset purchases, partnerships, collaborations, joint ventures, divestitures, product rationalization and investments. These transactions and arrangements may be material both from a strategic and financial perspective. We may miscalculate the risks associated with our strategic initiatives, including business development transactions, at the time they are made or not have the resources or ability to access all the relevant information to evaluate them properly, including with regard to the potential of R&amp;D pipelines, manufacturing issues, compliance issues, or the outcome of ongoing legal and other proceedings.  There can be no assurance that we will be able to fully realize the expected benefits of any such transactions or arrangements. Furthermore, divestitures, product rationalizations or asset sales could result in decreased total revenues, results of operations and cash flows from operating activities in future periods, reduce the size or scope of our business, our market share in particular markets or our opportunities and ability to compete with respect to certain markets, therapeutic areas or products. In addition, should we seek to divest other of our assets and business, we may be unable to dispose of such businesses and assets on satisfactory or commercially reasonable terms or within our anticipated timeline, in part because of competition from other companies in pursuing similar transactions in the pharmaceutical industry.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have also entered into strategic alliances with partners, including through our Global Healthcare Gateway&#174;, to develop, manufacture, market and/or distribute certain products, and/or certain components of our products, in various markets. We commit substantial effort, funds and other resources to these various collaborations, including with respect to the development of biosimilar products. There is a risk that the investments made by us in these collaborative arrangements will not generate financial returns. While we believe our relationships with our partners generally are successful, disputes or conflicting priorities and regulatory or legal intervention could be a source of delay or uncertainty as to the expected benefits of the collaboration. In addition, we enter into agreements with our collaboration partners that provide for certain services, as well as cross manufacturing, development and licensing arrangements. In addition, our Global Healthcare Gateway&#174; may not achieve all of its expected benefits. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The overall execution of a strategic initiative may result in material unanticipated problems, expenses, liabilities, competitive responses, operational inefficiencies, adverse tax consequences, loss of customer relationships, difficulty attracting and retaining qualified employees, and diversion of management&#8217;s and/or employee&#8217;s attention, among other potential adverse consequences. In addition, we may have to terminate a strategic alliance, or our collaboration partners may be unable to fulfill their collaboration obligations.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Any of the risks described above could have a material adverse effect on our business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We have and may continue to experience pressure on the pricing of and reimbursements for certain of our products due to pricing controls, social or government pressure to lower the cost of drugs, and consolidation across the supply chain. </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We operate in a challenging environment, with significant pressures on the pricing of our products and on our ability to obtain and maintain satisfactory rates of reimbursement for our products by governments, insurers and other payors. The growth of overall healthcare costs has led governments and payors to implement new measures to control healthcare spending. As a result, we face numerous cost-containment measures by governments and other payors, including certain government-imposed industry-wide price reductions, mandatory rebates or pricing, international reference pricing (i.e., the practice of a country linking its regulated medicine prices to those of other countries), volume-based procurement, tender systems, shifting of the payment burden to patients through higher co-payments, and requirements for increased transparency on pricing, all of which may have an adverse impact on the pricing of our products.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Many markets in which we operate have implemented or may implement tender systems for generic and biosimilar pharmaceuticals in an effort to lower prices. Under such tender systems, manufacturers submit bids which establish prices for generic pharmaceutical products. Upon winning the tender, the winning company will receive a preferential reimbursement for a period of time. If our bids do not win, we may not be able to participate in the given market or may lose out on market share. In addition, if customers to whom we supply API do not win their tender bids, the amount of API that we sell to them may be reduced. While criteria other than price can be included in tenders, tender systems often select the lowest bid, which often results in companies underbidding one another by proposing low pricing in order to win the tender. Other markets may also consider the implementation of a tender system, and even if a tender system or other price controls are ultimately not implemented, the anticipation of such could result in price reductions. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In the EU, U.K. and some other international markets, the government provides healthcare at low cost to consumers and regulates pharmaceutical prices, patient eligibility and/or reimbursement levels to control costs for the government-sponsored healthcare system. These systems of price regulations may lead to inconsistent and lower prices. Within the EU and in other countries, the availability of our products in some markets at lower prices undermines our sales in other markets with higher prices. Additionally, certain countries set prices by reference to the prices in other countries where our products are marketed. Thus, our inability to secure adequate prices in a particular country may also impair our ability to obtain acceptable prices in existing and potential new markets and may create the opportunity for third party cross-border trade. In addition to the impacts of these government-sponsored healthcare systems, in the EU, U.K. and other international markets, certain governmental agencies have or are considering enacting further measures to decrease the costs of providing healthcare, including government mandated price reductions and/or other forms of price controls, including retrospective &#8220;clawback&#8221; price reductions. as a result of the COVID-19 pandemic and the changing healthcare landscape in those markets.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In China, pricing pressures have increased in recent years, and the Chinese government has also increased its focus on patient access and reimbursement for pharmaceutical medicines. For example, in 2013, China began to implement a QCE process for post-LOE products to improve the quality of domestically manufactured generic drugs, primarily by requiring such drugs to pass a test to assess their bioequivalence to a qualified reference drug (typically the originator drug). In addition, VBP policy for post- LOE products is now in its fourth year and includes more than 200 molecules. In addition, the bidding process has resulted in significant price cuts for the molecules included with some bidders reducing the price of their products by as much as 96% as they attempt to secure volumes on the Chinese pharmaceutical market. We expect pricing pressures on our products included in the VBP program to continue to increase as a result of these programs. We have failed, and may continue to fail, to win bids due to various factors, including uncompetitive bidding prices. In addition, the URP policy will cap reimbursement of molecules at their VBP tender winning price. URP will create additional pricing and volume pressure for pharmaceutical products that are subject to the program and is expected to negatively impact our results of operations.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Demand for our products also depends in part on the extent to which reimbursements are available. In the U.S., third-party payors increasingly challenge the pricing of pharmaceutical products. These trends and other trends toward managed healthcare, the vertical consolidation among insurers, PBMs and pharmacies, and legislative healthcare reform create significant uncertainties regarding the future levels of reimbursement for pharmaceutical products. Further, any reimbursement may be reduced in the future to the point that market demand for our products and/or our profitability declines. Changes to Medicare and/or state Medicaid programs, or changes required in the way in which Medicare payment rates are set, the design of the Medicare Part D benefit, and/or the way Medicaid rebates are calculated, could adversely affect the payment we receive for our products. In order to control expenditures on pharmaceuticals, most member states in the EU regulate the pricing of products and, in some cases, limit the range of different forms of pharmaceuticals available for prescription by national health services. These controls can result in considerable price differences between member states.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">There has also been increasing U.S. federal and state legislative and enforcement interest with respect to drug pricing, as well as from international organizations like the United Nations, WHO and Organization for Economic Cooperation and Development, in addition to intense publicity and scrutiny regarding such matters, including publicity and pressure resulting from prices charged by competitors and peer companies for new products as well as price increases by competitors and peer companies on older products that some have deemed excessive. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, there have been executive orders, legislation, and legislative and regulatory proposals, including in connection with government programs such as Medicare, concerning drug prices and related issues, including the perceived need to bring more transparency to drug pricing, reviewing the relationship between pricing and manufacturer patient programs, and reforming government program reimbursement methodologies for drugs. Although we expect to see continued focus in regulating pricing, we cannot predict what, if any, additional legislative or regulatory developments may transpire at the state or country level, or what the ultimate impact may be.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the U.S., certain of these pressures are further compounded by increasing consolidation among wholesalers, retailer drug chains, PBMs, private insurers, managed care organizations and other private payors, which can increase their negotiating power, particularly with respect to our generic drugs. Please also refer to &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">A significant portion of our revenues is derived from sales to a limited number of customers.&#8221;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The numerous cost-containment measures by governments and other payors, failing to win tenders, the implementation of price control systems, adverse legislation and regulation, the consolidation of our customers, or continued social or government pressure to lower the cost of pharmaceutical products could have a material adverse impact on our business, reputation, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Healthcare reform legislation could have a material adverse effect on our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In recent years, there have been numerous initiatives on the federal and state levels for comprehensive reforms affecting the payment for, the availability of and reimbursement for, healthcare services in the U.S., and it is likely that Congress and state legislatures and health agencies will continue to focus on healthcare reform in the future. While the ACA increased the number of patients who have insurance coverage for our products, it also included provisions such as the assessment of a pharmaceutical manufacturer fee and an increase in the amount of rebates that manufacturers pay for coverage of their drugs by Medicaid programs. The ACA may be subject to revisions and modifications in the future. Further, Congress continues to consider drug pricing legislation that, if passed and signed into law, could impact companies&#8217; ability to increase prices for products beyond the rate of inflation, and could allow Medicare to negotiate prices on a subset of brand drugs. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are unable to predict the future course of federal or state healthcare legislation or reform, including temporary or permanent healthcare reform measures resulting from the COVID-19 pandemic or the outcome of challenges to such laws or reforms once passed. The ACA and further changes in the law or regulatory framework that reduce our revenues or increase our costs could have a material adverse effect on our business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price. Additionally, we encounter similar regulatory and legislative issues in most other countries. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant additional reforms to the U.S. healthcare system, or to the healthcare systems of other markets in which we operate, could have a material adverse effect on our business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We have significant operations globally, which exposes us to the risks inherent in conducting our business internationally.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our operations extend to numerous countries globally and therefore are subject to the risks inherent in this geographic scope. These risks include, but are not limited to:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">the impact of the COVID-19 pandemic; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">compliance with the national and local laws, regulations and customs of countries in which we do business, including, but not limited to, data privacy and protection, environmental and social regulations, import/export and enforcement of intellectual property protections;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">less established legal and regulatory regimes in certain jurisdictions, including China, where the interpretation and enforcement of laws, rules and regulations may involve uncertainties and can be inconsistent;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">that litigation, administrative and court proceedings may be protracted, expensive and unpredictable; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">that governments in certain jurisdictions may favor local businesses and make it more difficult for foreign businesses to operate on an equal footing;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">increased uncertainties related to the enforcement of contracts with certain parties;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">compliance with a variety of U.S. laws including, but not limited to, trade controls or sanctions, regulations put forth by the U.S. Treasury&#8217;s Office of Foreign Assets Control, the Iran Threat Reduction and Syria Human Rights Act of 2012 and rules relating to the use of certain &#8220;conflict minerals&#8221; under Section 1502 of the Dodd-Frank Wall Street Reform and the Consumer Protection Act;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">increased trade controls or sanctions as a result of the escalation of tensions between Russia and Ukraine that may affect our ability to market or sell pharmaceuticals in either country;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">changes in laws, regulations, and practices affecting the pharmaceutical industry and the healthcare system, including but not limited to imports, exports, manufacturing, quality, cost, pricing, reimbursement, approval, inspection, and delivery of healthcare;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">changes in policies designed to promote foreign investment, including significant tax incentives, liberalized import and export duties, and preferential rules on foreign investment and repatriation;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">increased EU and U.S. scrutiny of overseas pharmaceutical manufacturing, including executive orders and policy proposals related to increasing domestic production of pharmaceutical products and API;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">differing local product preferences and product requirements;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">adverse changes in the economies in which we or our partners and suppliers operate as a result of a slowdown in overall growth, a change in government or economic policies, or financial, political, or social change or instability in such countries that affects the markets in which we operate, particularly emerging markets;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">changes in employment or labor laws, or wage increases in the countries in which we or our partners and suppliers operate;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">local, regional and global restrictions on banking and commercial activities in certain markets, especially emerging markets; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">longer payment cycles and increased exposure to counterparty risk; </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">volatility in international financial markets and increased foreign currency risk;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">changes resulting from the formal withdrawal of the U.K. from the EU, commonly referred to as Brexit, including those related to additional trade agreements, tariffs and customs regulations and currency fluctuations, which could materially impact the way we conduct our operations in those markets;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">supply disruptions and increases in energy and transportation costs;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">increased tariffs on the import or export of our products or API, including on imports from China to the U.S. as a result of the escalation of trade tensions between the countries or otherwise;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">burdens to comply with multiple, changing and potentially conflicting laws, regulations and disclosure requirements, including those relating to  environmental, social and governance matters, carbon emissions, health and safety, labor and human rights;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">natural or man-made disasters, including droughts, floods, earthquakes, hurricanes and the impact of climate change in the countries in which we or our partners and suppliers operate; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">local disturbances, the outbreak of highly contagious diseases or other health epidemics (such as COVID-19), terrorist attacks, riots, social disruption, wars, or regional hostilities in the countries in which we or our partners and suppliers operate and that could affect the economy, our operations and employees by disrupting operations and communications, making travel and the conduct of our business more difficult, and/or causing our customers to be concerned about our ability to meet their needs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We also face the risk that some of our competitors have more experience with operations in such countries or with international operations generally and may be able to manage unexpected crises more easily. Moreover, the internal political stability of, or the relationship between, any country or countries where we conduct business operations may deteriorate. Changes in a country&#8217;s political stability or the state of relations between any such countries are difficult to predict and the political or social stability in and/or diplomatic relations between any countries in which we or our partners and suppliers do business could meaningfully deteriorate.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The occurrence of any one or more of the above risks could have a material adverse effect on our business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Charges to earnings resulting from acquisitions could have a material adverse effect on our business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Under U.S. GAAP provisions relating to business acquisition accounting standards, we recognize the identifiable assets acquired, the liabilities assumed, and any noncontrolling interests in acquired companies generally at their acquisition date fair values and, in each case, separately from goodwill. Goodwill as of the acquisition date is measured as the excess amount of consideration transferred, which is also generally measured at fair value, and the net of the acquisition date amounts of the identifiable assets acquired and the liabilities assumed. Our estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain. After we complete an acquisition, the following factors could result in material charges and adversely affect our operating results and may adversely affect our cash flows:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">costs incurred to combine the operations of companies we acquire, such as transitional employee expenses and employee retention, redeployment or relocation expenses;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">liabilities assumed in purchase accounting; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">impairment of goodwill or intangible assets, including acquired IPR&amp;D;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">amortization of intangible assets acquired;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">a reduction in the useful lives of intangible assets acquired;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">identification of or changes to assumed contingent liabilities, including, but not limited to, litigation reserves, contingent purchase price consideration including fair value adjustments, income tax contingencies and other non-income tax contingencies, after our final determination of the amounts for these contingencies or the conclusion of the measurement period (generally up to one year from the acquisition date), whichever comes first;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">charges to our operating results to eliminate certain duplicative pre-acquisition activities, including exiting TSAs with Pfizer;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">significant costs to restructure our operations and to reduce our cost structure, including cost related to severance payments, plant shutdowns and costs to achieve anticipated synergies; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">charges to our operating results resulting from expenses incurred to effect the acquisition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A significant portion of these adjustments could be accounted for as expenses that will decrease our net income and earnings per share for the periods in which those costs are incurred.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In particular, the amount of goodwill and identifiable intangible assets in our consolidated balance sheets is significant as a result of our acquisitions and other transactions, and may increase further following future potential acquisitions, and we may, from time to time, sell assets that we determine are not critical to our strategy or execution. Future events or decisions may also lead to asset impairments and/or related charges. Certain non-cash impairments may result from a change in our strategic goals, business direction or other factors relating to the overall business environment. Any such charges could cause a material adverse effect on our business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We applied purchase accounting to the Combination and determined that Mylan was the accounting acquirer in the Combination for purposes of applying purchase accounting to the acquired assets and assumed liabilities of the Upjohn Business in connection with the Combination.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">The illegal distribution and sale by third parties of counterfeit or IP-infringing versions of our products or of diverted or stolen products could have a negative impact on our reputation and our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The pharmaceutical drug supply has been increasingly challenged by the vulnerability of distribution channels to illegal counterfeiting and the presence of counterfeit or IP-infringing products in a growing number of markets and widespread over the internet.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Third parties may illegally distribute and sell counterfeit or IP-infringing versions of our products that do not meet our rigorous manufacturing and testing standards. Counterfeit products are frequently unsafe or ineffective and can be potentially life-threatening. Counterfeit medicines may contain harmful substances, the wrong API, an incorrect dose of API or no API at all, depriving patients of the therapeutic benefit of such medicines. However, to distributors and users, counterfeit products may be visually indistinguishable from the authentic version.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Reports of adverse reactions to counterfeit or IP-infringing drugs or increased levels of counterfeiting could materially affect patient confidence in the authentic product. It is possible that adverse events caused by unsafe counterfeit products will mistakenly be attributed to the authentic product. In addition, unauthorized diversions of products or thefts of inventory at warehouses, plants, or while in-transit could result in improper storage or compromise product integrity and therefore adversely impact patient safety, our reputation, and our business.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Loss of sales or revenues, as well as public loss of confidence in the integrity of pharmaceutical products as a result of counterfeiting, diversion, or theft could have a material adverse effect on our business, reputation, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We face vigorous competition that threatens the commercial acceptance and pricing of our products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The pharmaceutical industry is highly competitive. We face competition from other pharmaceutical manufacturers globally, some of whom are significantly larger than we are and have stronger, more well-established reputations than us. Our competitors may be able to develop products and processes competitive with or superior to our own for many reasons, including but not limited to the possibility that they may have:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">proprietary processes or delivery systems;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">larger or more productive R&amp;D and marketing staff;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">larger or more efficient production capabilities in a particular therapeutic area;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">more experience in preclinical testing and human clinical trials;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">more products;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">more experience in developing new drugs; or</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">greater financial resources.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We also face increasing competition from lower-cost generic products and other branded products, including our ARV products. Certain of our products are not protected by patent rights or have limited patent life and will soon lose patent protection. Loss of patent protection for a product typically is followed promptly with the launch of generic products. As a result, sales of many of these products may decline or stop growing over time, and may decline faster than has been projected. For example, Perforomist&#174; lost exclusivity and experienced generic competition in June 2021, and the compound patent for Celebrex in Japan expired in November 2019 with generics entering the market in June 2020. In June 2019, Lyrica&#8217;s pediatric exclusivity in the United States expired, and multi-source generic competition commenced in the United States in July 2019. Additionally, over the next several years, some products may lose market exclusivity upon entry of generic products prior to patent exclusivity. For example, several companies launched a generic to Lyrica in Japan in December 2020 despite pending patent infringement litigation. The litigation remains ongoing, we have received several unfavorable rulings, and the patents expire in July 2022. We may not be successful in managing competition from non-branded generics or other alternatives, or in generally managing revenues after loss of exclusivity, and our business may be materially adversely affected. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Generic competitors are also becoming more aggressive in terms of pricing in many of the regions in which Viatris operates. In China, for example, we face strong competition from certain generic manufacturers, which may result in price cuts and volume loss on some of Viatris&#8217; branded products. In many emerging markets, we face increased competition and contracting markets for certain of our ARV products, primarily related to competing therapies. We also face competition in the United States, the EU and other mature markets that have a robust generics market and favorable regulatory conditions for generics. In addition, legislative proposals emerge from time to time in various jurisdictions to further encourage the early and rapid approval of generic drugs. Any such proposal that is enacted into law could increase competition and worsen this negative effect on our branded sales.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, certain of our products also face potential competition from products that may be developed in the future that could render our products uncompetitive or obsolete. For example, companies may develop medicines that treat the same indications targeted by our products, and these medicines could be more effective than our products or patients and physicians could prefer these medicines over our medicines. The introduction of these new competing products could also have a negative impact on product sales.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Other related factors that could affect our business include: </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">Competitors&#8217; products may also be safer, more effective, more effectively marketed or sold, or have lower prices or better performance features than ours; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">PBMs and other pharmaceutical manufacturers may utilize contracting strategies that could decrease utilization of or otherwise negatively impact our products; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">Vertical integration of pharmacies and large purchasing organizations or consolidation among distribution outlets; and </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">Our sales may suffer as a result of changes in consumer demand for our products, including those related to fluctuations in consumer buying patterns tied to seasonality or COVID-19, willingness of customers to switch among products of different pharmaceutical manufacturers, importation by consumers or the introduction of new products by competitors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The occurrence of any of the above risks could have an adverse effect on our business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">A relatively small group of products may represent a significant portion of our revenues, net sales, gross profit, or net earnings from time to time.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Sales of a limited number of our products from time to time represent a significant portion of our revenues, net sales, gross profit, and net earnings. For the years ended December 31, 2021 and 2020, Viatris&#8217; top ten products in terms of sales, in the aggregate, represented approximately 33% and 23%, respectively, of the Company&#8217;s net sales. The increase in the concentration of our top product sales in 2021 was primarily driven by the impact of the Combination. If the volume or pricing of our largest selling products declines in the future, our business, financial condition, results of operations, cash flows, and/or share price could be materially adversely affected.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Operational Risks</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Public health outbreaks, epidemics and pandemics, including the COVID-19 pandemic, have had and could continue to have a material adverse effect on our business, financial condition, results of operations, cash flows and/or stock price and may impact our ability to pay dividends.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Public health outbreaks, epidemics and pandemics, including the COVID-19 pandemic, have had and could continue to have a material adverse effect on our business. We continue to closely monitor the impact of the COVID-19 pandemic on all aspects of our business, including its impact on our workforce, suppliers, vendors, business partners, distribution channels, customers and patients. As the pandemic continues to evolve and new COVID-19 variants are detected, the rate of infection remains high in many countries, including the U.S. Attempts continue to be made to reduce the spread of COVID-19, including quarantines, vaccination programs (including boosters), increased testing, government restrictions on movement, business closures and suspensions, canceled events and activities, self-isolation, and other voluntary and/or mandated changes in behavior. Both the outbreak, and continued spread of COVID-19 and actions to slow its spread have created and continue to create significant uncertainty, economic volatility and disruption, supply chain disruption, and increased unemployment, which have impacted and may continue to impact our business operations and workforce. In addition, recovery from the pandemic may not proceed as anticipated, and may have unpredictable impacts on demand for our products, our workforce and our business operations. All of these factors could have a material adverse impact on our workforce, business operations, financial condition, results of operations, cash flows and/or stock price and may impact our ability to pay dividends.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">While our business operations are currently considered essential based on current government guidelines throughout the world due to the important role pharmaceutical manufacturers play within the global healthcare system, many of our administrative offices have been operating under work from home protocols. In addition, certain programs or incentives implemented to ensure employee health and safety, such as subsidized testing, hazard pay, sick leave and bonus payments, have increased our operating costs. Extended changes in work conditions, including work from home protocols, could strain our business continuity plans, reduce productivity and morale, or introduce operational risk, including but not limited to increased cybersecurity risk. For example, remote working environments may be less secure and some may seek to exploit the COVID-19 pandemic to initiate hacking attacks, phishing and social engineering attempts and malware attacks. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Additionally, we have taken extra precautions at our manufacturing facilities to aid in the protection of on-site personnel and operations, including the implementation of social distancing guidelines, daily health assessments of on-site personnel, providing vaccinations on site, and split shifts where feasible. If we experience an increase in reported illnesses or quarantining at any of our facilities, including critical manufacturing sites, it is possible that such facilities may need to close for an extended period of time, which could negatively affect our ability to produce, ship, and supply products to our customers and would impact our business and financial results.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, some of our customer-facing field personnel continue to operate on a remote engagement model to ensure continued support for healthcare professionals, patient care and access to needed products. A remote engagement model may not be as successful as in-person meetings and could result in lower sales of products, particularly new products. We have also taken steps to protect the safety of study participants, employees and staff at clinical trial sites while continuing to ensure regulatory compliance and scientific integrity of trial data.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">COVID-19 and related responsive measures have also made, and may continue to make, it difficult for us, our partners or suppliers to source and manufacture products in, and to export our products from, certain affected areas. In addition, we have faced, and may continue to face, delays or difficulty sourcing certain products or raw materials, including APIs. Even if we are able to find alternate sources for such products or raw materials, they may cost more. In addition, we have experienced and may continue to experience increased shipping and freight costs, as well as delays in shipping. These factors have materially adversely affected and could continue to materially adversely affect our ability to produce, ship, and supply products, which could negatively impact our customer relationships, business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price, or result in negative publicity and reputational harm.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Lower retail pharmacy demand, as well as some patients, doctors and hospitals delaying or foregoing routine doctor and hospital visits and elective medical procedures, has led and could continue to lead to decreased demand for certain of our products, which has negatively impacted our sales, results of operations and financial results. At the same time, we have experienced, and could continue to experience, unpredictable increases in demand for certain of our products, which could exceed our capacity to meet such demand and negatively impact our customer relationships, business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Health regulatory agencies globally may also experience disruptions in their operations and greater regulatory uncertainty as a result of the COVID-19 pandemic. For instance, the FDA has announced its intention to temporarily postpone certain inspections of domestic and foreign manufacturing facilities. The FDA and comparable foreign regulatory agencies may have slower response times or reduced resources and, as a result, review of regulatory submissions, inspections, approval of </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">new products and other timelines important to our business may be materially impacted, which could delay our new product launches and have a material adverse effect on our business.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, our continued access to external sources of liquidity depends on multiple factors, including the condition of debt capital markets, our operating performance, and maintaining strong credit ratings. Also, the continuing impact of the COVID-19 pandemic could lead to our customers or suppliers having liquidity problems that could negatively impact our ability to collect cash on our receivables and/or negatively impact our ability to get inventory and materials. If the impacts of the pandemic create further disruptions or turmoil in the financial markets or customer or supplier liquidity issues, or if rating agencies lower our credit ratings, it could adversely affect our ability to access the debt markets, our cost of funds, and other terms for new debt, which could negatively impact our results of operations and financial position.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The extent to which the COVID-19 pandemic will continue to impact us depends on numerous evolving factors and future developments that we are not currently able to predict and may also exacerbate other risks discussed in these risk factors, any of which could have a material adverse effect on us, our business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Current and changing economic conditions may adversely affect our industry, business, partners and suppliers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The global economy continues to experience significant volatility, and the economic environment may become less favorable. Economic volatility, governmental financial restructuring efforts and evolving deficit and spending reduction programs could negatively impact the global economy and the pharmaceutical industry. This has led, or could lead, to reduced consumer and customer spending, reduced or eliminated governmental or third-party payor coverage or reimbursement or reduced spending on healthcare, including but not limited to pharmaceutical products. While generic drugs present an alternative to higher-priced branded products, our sales could be negatively impacted if patients forego obtaining healthcare, patients and customers reduce spending or purchases, or if governments or third-party payors reduce or eliminate coverage or reimbursement amounts for pharmaceuticals or impose price or other controls adversely impacting the price or availability of pharmaceuticals (whether for generics, branded products or both). In addition, reduced consumer and customer spending, reduced government or third-party payor coverage or reimbursement, or new government controls, may drive us and our competitors to decrease prices, may reduce the ability of customers to pay, or may result in reduced demand for our products. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In addition, accelerating rates of inflation are expected to continue in the near future and have resulted, and may continue to result, in increased costs of labor, raw materials, other supplies and freight and distribution costs, among others.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For the pharmaceutical industry and the healthcare systems in the markets in which we participate, the pricing dynamics of our products generally does not provide the opportunity to pass on such costs to customers. Inflation may also result in higher interest rates and increased costs of capital.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The occurrence of any of the above risks could have a material adverse effect on our industry, business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Failure to comply with applicable environmental and occupational health and safety laws and regulations worldwide could adversely impact our business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We are subject globally to various laws and regulations concerning, among other things, the environment, climate change, water, waste, chemicals and employee safety. These requirements include regulation of the handling, manufacture, transportation, storage, use and disposal of materials and wastes, including the discharge of regulated materials and emissions into the environment. We are also subject to related permitting, record-keeping, reporting and registration requirements. In the normal course of our business, we are exposed to risks relating to possible releases of hazardous substances into the environment, which could cause environmental or property damage or personal injuries, and which could result in (i) our noncompliance with such environmental and occupational health and safety laws, regulations and permits and (ii) regulatory enforcement actions or claims for personal injury and property damage against us. If environmental discharge occurs, or if we discover contamination caused by third parties, including by prior owners and operators of properties we acquire or lease, or by neighboring properties or other offsite sources, we could be liable for cleanup or remediation obligations, damages and fines or have relevant permits, authorizations or registrations modified or revoked, regardless of our responsibility for such contamination. In addition, any non-compliance with environmental and occupational health and safety laws and regulations and permits, or emissions into the environment, whether actual or perceived, may result in significant reputational damage. The substantial unexpected costs we may incur could have a material adverse effect on our business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price. Environmental and occupational health and safety laws and regulations are also complex and subject to change, and our related capital expenditures and costs for compliance may increase substantially in the future as a result of such changes, the development and manufacturing of a new product or increased development or manufacturing activities at any of our facilities. We may be required to expend significant funds and our </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">manufacturing activities could be delayed or suspended or we may lose the ability to purchase or use certain materials, or face restrictions on the amounts of materials we may use or purchase, which could have a material adverse effect on our business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">The pharmaceutical industry is heavily regulated, and we face significant costs and uncertainties associated with our efforts to comply with applicable laws and regulations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The pharmaceutical industry is subject to regulation by various governmental authorities in the jurisdictions in which we operate, including the U.S., EU, China and India. For instance, we must comply with applicable laws and requirements of the FDA and other regulatory agencies, including foreign authorities, with respect to the research, development, manufacture, quality, safety, effectiveness, approval, labeling, tracking, tracing, authentication, storage, record-keeping, reporting, pharmacovigilance, sale, distribution, import, export, marketing, advertising, and promotion of pharmaceutical products. We are committed to conducting our business, including the sale and marketing of our products, in compliance with all applicable laws and regulations. These laws and regulations, however, are numerous, complex and continue to evolve, and it is possible that a governmental authority may challenge our activities, or that an employee or agent could violate these laws and regulations without our knowledge. Failure to comply with these laws and regulations could result in a range of consequences, including, but not limited to, fines, penalties, disgorgement, exclusion from U.S. federal healthcare reimbursement programs, unanticipated compliance expenditures, suspension of review of applications or other submissions, rejection or delay in approval of applications, recall or seizure of products, total or partial suspension of production and/or distribution, our inability to sell products, the return by customers of our products, injunctions, and/or criminal prosecution. Under certain circumstances, a regulator may also have the authority to revoke or vary previously granted drug approvals.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The safety profile of any product will continue to be closely monitored by the FDA and comparable foreign regulatory authorities after approval. If such regulatory authorities become aware of new safety information about any of our marketed or investigational products, those authorities may require further inspections, enhancements to manufacturing controls, labeling changes, establishment of a risk evaluation and mitigation strategy or similar strategy, restrictions on a product&#8217;s indicated uses or marketing, or post-approval studies or post-market surveillance. In addition, we are subject to regulations in various jurisdictions, including the Federal Drug Supply Chain Security Act in the U.S., the Falsified Medicines Directive in the EU and several other such regulations in other countries that require us to develop electronic systems to serialize, track, trace and authenticate units of our products through the supply chain and distribution system. Compliance with these regulations has in the past and may in the future result in increased expenses for us or impose greater administrative burdens on our organization, and failure to meet these requirements could result in fines or other penalties.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In recent years, the regulatory framework in China regarding the pharmaceutical industry has undergone significant changes and Chinese authorities have become increasingly vigilant in enforcing laws in the pharmaceutical industry. We believe that Viatris&#8217; strategies regarding pharmaceutical research, development, manufacturing and commercialization in China are currently aligned with the Chinese government&#8217;s policies, but they may in the future diverge, requiring a change in such strategies. Any such change may result in increased compliance costs to us or cause delays in or prevent the successful research, development, manufacturing or commercialization of our products in China, result in the loss of required licenses and permits or the suspension or termination of Viatris&#8217; activities in China.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The FDA and comparable foreign regulatory authorities also regulate the facilities and operational procedures that we use to manufacture our products. We must register our facilities with the FDA and similar regulators in other countries. Products must be manufactured in our facilities in accordance with cGMP or similar standards in each territory in which we manufacture. Compliance with such regulations and with our own quality standards requires substantial expenditures of time, money, and effort in multiple areas, including training of personnel, record-keeping, production, and quality control and quality assurance. The FDA and other comparable regulatory authorities, including foreign authorities, periodically inspect our manufacturing facilities for compliance with cGMP or similar standards in the applicable territory. Regulatory approval to manufacture a drug is granted on a site-specific basis. Failure to comply with cGMP and other regulatory standards at one of our or our partners&#8217; or suppliers&#8217; manufacturing facilities could result in an adverse action brought by the FDA or other regulatory authorities, which could result in the receipt of an untitled or warning letter, fines, penalties, disgorgement, unanticipated compliance expenditures, rejection or delay in approval of applications, suspension of review of applications or other submissions, suspension of ongoing clinical trials, recall or seizure of products, total or partial suspension of production and/or distribution, our inability to sell products, the return by customers of our products, orders to suspend, vary, or withdraw marketing authorizations, injunctions, consent decrees, requirements to modify promotional materials or issue corrective information to healthcare practitioners, refusal to permit import or export, criminal prosecution and/or other adverse actions.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our business could be adversely affected if any regulatory body were to delay, withhold, or withdraw approval of an application; require a recall or other adverse product action; require one of our manufacturing facilities to cease or limit production; or suspend, vary, or withdraw related marketing authorization. Delay and cost in obtaining FDA or other regulatory approval to manufacture at a different facility also could have a material adverse effect on our business.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Although we have established internal quality and regulatory compliance programs and policies, there is no guarantee that these programs and policies, as currently designed, will meet regulatory agency standards in the future or will prevent instances of non-compliance with applicable laws and regulations. Additionally, despite our compliance efforts, from time to time we or our partners receive notices of manufacturing and quality-related observations following inspections by regulatory authorities around the world, as well as official agency correspondence regarding compliance. For example, the FDA has issued warning letters relating to valsartan API and nitrosamine impurities to our API manufacturers Mylan Laboratories Limited Unit 8 and Mylan Laboratories Limited Unit 7. We have provided thorough responses to the FDA regarding the issues identified and remediation is ongoing. We and our partners have in the past and may in the future receive similar observations and correspondence. If we are unable to resolve these observations and address regulatory concerns in a timely fashion, our business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price could be materially adversely affected.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We utilize controlled substances in certain of our current products and products in development, and therefore must meet the requirements of the Controlled Substances Act of 1970 and the related regulations administered by the DEA in the U.S., as well as those of similar laws in other countries where we operate. These laws relate to the manufacture, shipment, storage, sale, and use of controlled substances. The DEA and other regulatory agencies limit the availability of the controlled substances used in certain of our current products and products in development and, as a result, our procurement quota of these active ingredients may not be sufficient to meet commercial demand or complete clinical trials. We must annually apply to the DEA and similar regulatory agencies for procurement quotas in order to obtain these substances. Any delay or refusal by the DEA or such similar agencies in establishing our procurement quota for controlled substances could delay or stop our clinical trials or product launches, or could cause trade inventory disruptions for those products that have already been launched. In addition, some states have passed laws and regulations imposing assessments on the sale or distribution of certain controlled substances, and other states are considering and may implement similar laws and regulations in the future. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The occurrence of any of the above risks could have a material adverse effect on our business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">The use of legal, regulatory, and legislative strategies by both brand and generic competitors, including but not limited to &#8220;authorized generics&#8221; and regulatory petitions, may increase costs associated with the introduction or marketing of our generic products, could delay or prevent such introduction, and could significantly reduce our revenue and profit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our competitors, both branded and generic, often pursue strategies that could prevent or delay generic alternatives to branded products. These strategies include, but are not limited to:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">entering into agreements whereby other generic companies will begin to market an authorized generic, which is the approved brand-name drug without the brand-name on its label, at the same time or after generic competition initially enters the market;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">launching their own authorized generic product prior to or at the same time or after generic competition initially enters the market; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">pricing a branded product at a discount equivalent to generic pricing;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">filing frivolous petitions with the FDA or other regulatory bodies seeking to prevent or delay approvals, including timing the frivolous filings so as to thwart generic competition by causing delays of our product approvals;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">contracting strategies among pharmaceutical manufacturers and PBMs that could decrease generic or biosimilar utilization and negatively impact our product launches; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">seeking to establish regulatory and legal obstacles that would make it more difficult to demonstrate bioequivalence or to meet other requirements for approval, and/or to prevent regulatory agency review of applications;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">initiating legislative or other efforts to limit the substitution of generic versions of brand pharmaceuticals;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">filing suits for patent infringement and other claims that may delay or prevent regulatory approval, manufacture, and/or sale of generic products;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">introducing &#8220;next-generation&#8221; products prior to the expiration of market exclusivity for the reference product, which often materially reduces the demand for the generic or the reference product for which we seek regulatory approval;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">persuading regulatory bodies to withdraw the approval of brand-name drugs for which the patents are about to expire and converting the market to another product of the brand company on which longer patent protection exists;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">obtaining extensions of market exclusivity by conducting clinical trials of brand drugs in pediatric populations or by other methods; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">seeking to obtain new patents on drugs for which patent protection is about to expire.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the U.S., some companies have lobbied Congress for amendments to Hatch-Waxman Act that would give them additional advantages over generic competitors. For example, although the term of a company&#8217;s drug patent can be extended to reflect a portion of the time an NDA (which is filed in the U.S. with the FDA when approval is sought to market a newly developed branded product and, in certain instances, for a new dosage form, a new delivery system or a new indication for a previously approved drug) is under regulatory review, some companies have proposed extending the patent term by a full year for each year spent in clinical trials rather than the one-half year that is currently permitted.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If proposals like these in the U.S., EU, or in other countries where we or our partners and suppliers operate were to become effective, or if any other actions by our competitors and other third parties to prevent or delay activities necessary to the approval, manufacture, or distribution of our products are successful, our entry into the market and our ability to generate revenues associated with new products may be delayed, reduced, or eliminated, which could have a material adverse effect on our business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">If we are unable to successfully introduce new products in a timely manner, our future revenue and profitability may be adversely affected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our future revenues and profitability will depend, in part, upon our ability to successfully and timely develop, license, or otherwise acquire and commercialize new products. Product development is inherently risky, especially for new drugs for which safety and efficacy have not been established and/or the market is not yet fully developed as well as for complex generic drugs and biosimilars. Likewise, product licensing involves inherent risks, including, among others, uncertainties due to matters that may affect the achievement of milestones, as well as the possibility of contractual disagreements with regard to whether the supply of product meets certain specifications or terms such as license scope or termination rights. As Viatris focuses more on complex products, the development and commercialization process requires substantial time, effort and financial resources. We, or a partner, may not be successful in commercializing such products on a timely basis, or at all, which could adversely affect our business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Before any prescription drug product, including generic drug products, can be marketed, marketing authorization approval is required by the relevant regulatory authorities and/or national regulatory agencies (for example, the FDA in the U.S., the EMA in the EU and other regulatory authorities). The process of obtaining regulatory approval to manufacture and market new branded and generic pharmaceutical products is rigorous, time consuming, costly, and inherently unpredictable. In addition, these regulatory agencies may be delayed in reviewing and approving products as a result of lapsed or insufficient funding, insufficient staffing, travel or work restrictions (including as a result of the COVID-19 pandemic), or other factors beyond our control. Any delay in regulatory approval could impact the commercial or financial success of a product.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Outside the U.S., the approval process may be more or less rigorous, depending on the country, and the time required for approval may be longer or shorter than that required in the U.S. Bioequivalence, clinical, or other studies conducted in one country may not be accepted in other countries, the requirements for approval may differ among countries, and the approval of a pharmaceutical product in one country does not necessarily mean that the product will be approved in another country. We, or a partner or supplier, may be unable to obtain requisite approvals on a timely basis, or at all, for new products that we may develop, license or otherwise acquire. Moreover, if we obtain regulatory approval for a drug, it may be limited, for example, with respect to the indicated uses and delivery methods for which the drug may be marketed, or may include warnings, precautions or contraindications in the labeling, which could restrict our potential market for the drug. A regulatory approval may also include post-approval study or risk management requirements that may substantially increase the resources required to market the drug. Also, for products pending approval, we may obtain raw materials or produce batches of inventory to be used in efficacy and bioequivalence testing, as well as in anticipation of the product&#8217;s launch. In the event that regulatory approval is denied or delayed, we could be exposed to the risk of this inventory becoming obsolete.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The approval process for generic pharmaceutical products often results in the relevant regulatory agency granting final approval to a number of generic pharmaceutical products at the time a patent claim for a corresponding branded product or other market exclusivity expires. This often forces us to face immediate competition when we introduce a generic product into the market. Additionally, further generic approvals often continue to be granted for a given product subsequent to the initial launch of the generic product. These circumstances generally result in significantly lower prices, as well as reduced margins, for generic products compared to branded products. New generic market entrants generally cause continued price, margin, and sales erosion over the generic product life cycle.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the U.S., the Hatch-Waxman Act provides for a period of 180 days of generic marketing exclusivity for a &#8220;first applicant,&#8221; that is the first submitted ANDA (which is filed in the U.S. with the FDA when approval is sought to market a generic equivalent of a drug product previously approved under an NDA and listed in the FDA publication entitled Approved Drug Products with Therapeutic Equivalence Evaluations, popularly known as the &#8220;Orange Book&#8221; or for a new dosage strength for a drug previously approved under an ANDA) containing a certification of invalidity, non-infringement or unenforceability related to a patent listed with the ANDA&#8217;s reference drug product, commonly referred to as a Paragraph IV certification. During this exclusivity period, which under certain circumstances may be shared with other ANDAs filed on the same day, the FDA cannot grant final approval to later-submitted ANDAs for the same generic equivalent. If an ANDA is awarded 180-day exclusivity, the applicant generally enjoys higher market share, net revenues, and gross margin for that generic product. However, our ability to obtain 180 days of generic marketing exclusivity may be dependent upon our ability to obtain FDA approval or tentative approval within an applicable time period of the FDA&#8217;s acceptance of our ANDA. If we are unable to obtain approval or tentative approval within that time period, we may risk forfeiture of such marketing exclusivity. By contrast, if we are not a &#8220;first applicant&#8221; to challenge a listed patent for such a product, we may lose significant advantages to a competitor with 180-day exclusivity, even if we obtain FDA approval for our generic drug product. The same would be true in situations where we are required to share our exclusivity period with other ANDA sponsors with Paragraph IV certifications.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the EU and other countries and regions, there is no exclusivity period for the first generic product. The Commission or national regulatory agencies may grant marketing authorizations to any number of generics.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If we are unable to navigate our products through the approval process in a timely manner, there could be an adverse effect on our product introduction plans, business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We expend a significant amount of resources on R&amp;D efforts that may not lead to successful product introductions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Much of our development effort is focused on technically difficult-to-formulate products and/or products that require advanced manufacturing technology, including our biosimilars program and respiratory platform. We conduct R&amp;D primarily to enable us to gain approval for, manufacture, and market pharmaceuticals in accordance with applicable laws and regulations. We also partner with third parties to develop products. Typically, research expenses related to the development of innovative or complex compounds and the filing of marketing authorization applications for innovative and complex compounds (such as NDAs and biosimilar applications in the U.S.) are significantly greater than those expenses associated with the development of and filing of marketing authorization applications for most generic products (such as ANDAs in the U.S. and abridged applications in Europe). As we and our partners continue to develop new and/or complex products, our research expenses will likely increase. Because of the inherent risk associated with R&amp;D efforts in our industry, including the high cost and uncertainty of conducting clinical trials (where required) particularly with respect to new and/or complex drugs, our, or a partner&#8217;s, R&amp;D expenditures may not result in the successful introduction of new pharmaceutical products approved by the relevant regulatory bodies. Also, after we submit a marketing authorization application for a new compound or generic product, the relevant regulatory authority may change standards and/or request that we conduct additional studies or evaluations and, as a result, we may incur approval delays as well as R&amp;D costs in excess of what we anticipated.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Clinical testing is expensive and can take many years to complete, and its outcome is inherently uncertain. Failure can occur at any time during the clinical trial process. We or our partners may experience delays in our ongoing or future clinical trials, and we do not know whether planned clinical trials will begin or enroll subjects on time, need to be redesigned, or be completed on schedule, if at all.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Clinical trials may be delayed, suspended or prematurely terminated for a variety of reasons. If we experience delays in the completion of, or the termination of, any clinical trial of our product candidates, the commercial prospects of our product candidates will be harmed, and our ability to generate product revenues from any of these product candidates will be delayed. In addition, any delays in completing our clinical trials will increase our costs, slow down our product candidate development and approval process, and jeopardize our ability to commence product sales and generate revenues. Any of these occurrences may harm our business, financial condition and prospects significantly. In addition, many of the factors that cause, or lead to, a delay in the commencement or completion of clinical trials may also ultimately lead to the denial of regulatory approval of our product candidates.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Finally, we cannot be certain that any investment made in developing products will be recovered, even if we are successful in commercialization. To the extent that we expend significant resources on R&amp;D efforts and are not able, ultimately, to introduce successful new and/or complex products as a result of those efforts, there could be a material adverse effect on our business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Even if our products in development receive regulatory approval, such products may not achieve expected levels of market acceptance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Even if we are able to obtain regulatory approvals for our new products, the success of those products is dependent upon market acceptance. Levels of market acceptance for our products could be impacted by several factors, including but not limited to:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">the availability, perceived advantages, and relative safety and efficacy of alternative products from our competitors;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">the degree to which the approved labeling supports promotional initiatives for commercial success;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">the prices of our products relative to those of our competitors;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">the timing of our market entry;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">the effectiveness of our marketing, sales, and distribution strategy and operations; and </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">other competitor actions, including legal actions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Additionally, studies of the proper utilization, safety, and efficacy of pharmaceutical products are being conducted by the industry, government agencies, and others. Such studies, which increasingly employ sophisticated methods and techniques, can call into question the utilization, safety, and efficacy of previously marketed as well as future products. In some cases, such studies have resulted, and may in the future result, in the discontinuation or variation of product marketing authorizations or requirements for risk management programs, such as a patient registry. Any of these events could adversely affect our profitability, business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">The development, approval process, manufacture and commercialization of biosimilar products involve unique challenges and uncertainties, and our failure to successfully introduce biosimilar products could have a negative impact on our business and future operating results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We and our partners and suppliers are actively working to develop and commercialize biosimilar products. Although the BPCIA established a framework for the review and approval of biosimilar products and the FDA has begun to review and approve biosimilar product applications, there continues to be significant uncertainty regarding the regulatory pathway in the U.S., with the FDA continuing to issue and revise guidance related to its interpretation and implementation of the BPCIA. There is also uncertainty regarding the pathway to obtain approval for biosimilar products in other countries as well as uncertainty regarding the commercial pathway to successfully market and sell such products.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Moreover, biosimilar products generally involve extensive patent clearances and often involve patent infringement litigation related to multiple patents, which could delay or prevent the commercial launch of a biosimilar product for many years. If we are unable to obtain FDA or other non-U.S. regulatory authority approval for our products, we will be unable to market them. In addition, the development and manufacture of biosimilars pose unique challenges related to the supply of the materials needed to manufacture biosimilars. Access to and the supply of necessary biological materials may be limited, and government regulations restrict access to and regulate the transport and use of such materials.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Even if our biosimilar products are approved for marketing, the products may not be commercially successful, may require more time than expected to achieve market acceptance, and may not generate profits in amounts that are sufficient to offset the amount invested to obtain such approvals. Market success of biosimilar products will depend on demonstrating to regulators, patients, physicians and payors (such as insurance companies) that such products are safe and effective yet offer a more competitive price or other benefit over existing therapies. In addition, manufacturers of biologic products may try to dissuade physicians from prescribing or accepting biosimilar products. We may not be able to generate future sales of biosimilar products in certain jurisdictions and may not realize the anticipated benefits of our investments in the development, manufacture and sale of such products. If our development efforts do not result in the development and timely approval of biosimilar products or if such products, once developed and approved, are not commercially successful, or upon the occurrence of any of the above risks, our business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price could be materially adversely affected.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Our business is highly dependent upon market perceptions of us, our products and brands, and the safety and quality of our products and brands, as well as the effectiveness of our sales and marketing activities, and we may be adversely impacted by negative publicity or findings.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Market perceptions of us are very important to our business, especially market perceptions of our company, products, brands and the safety and quality of our products and brands. If we, our partners and suppliers, or our products or brands suffer from negative publicity, are subject to market withdrawal or recall or are proven to be, or are claimed to be, ineffective or harmful to consumers, then this could have a material adverse effect on our reputation and business. In addition, Viatris believes that maintaining and enhancing certain of its brands is important and often provides certain competitive advantages.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Viatris&#8217; sales and marketing efforts are anchored by promoting its products to physicians, pharmacists, clinics and hospitals. Therefore, Viatris&#8217; sales and marketing force, whether in-house sales representatives or third-party commercial partners, must possess a relatively high level of technical knowledge, up-to-date understanding of industry trends and expertise in the relevant therapeutic areas and products, as well as promotion and communication skills. Marketing, advertising and promotions may be expensive and may not achieve their intended benefits. If Viatris is unable to effectively train its in-house sales representatives and third-party commercial partners or monitor and evaluate their marketing performances, our sales and marketing may be less successful than desired. In addition, fewer in-person sales and marketing efforts as a result of restrictions put in place in order to contain the COVID-19 pandemic, or other similar limitations, may result in less successful sales and marketing activities.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Given our dependence on market perception and sales and marketing efforts, negative publicity associated with product or brand quality, patient illness, or other adverse effects resulting from, or perceived to be resulting from, our products or brands, or our partners&#8217; and suppliers&#8217; manufacturing facilities, or an inability to increase or maintain the effectiveness and efficiency of our sales and marketing activities could have a material adverse effect on our reputation, business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">A significant portion of our revenues is derived from sales to a limited number of customers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A significant portion of our revenues is derived from sales to a limited number of customers. If we were to experience a significant reduction in or loss of business with one or more such customers, or if one or more such customers were to experience difficulty in paying us on a timely basis, our business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price could be materially adversely affected.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, a significant amount of our sales are to a relatively small number of drug wholesalers and retail drug chains. These customers represent an essential part of the distribution chain of generic pharmaceutical products. Drug wholesalers and retail drug chains have undergone, and are continuing to undergo, significant consolidation. This consolidation has resulted in these groups gaining additional purchasing leverage and, consequently, increasing the product pricing pressures facing our business. We expect this trend of increased pricing pressures to continue. Additionally, the emergence of large buying groups representing independent retail pharmacies and the prevalence and influence of managed care organizations and similar institutions increases the negotiating power of these groups, enabling them to attempt to extract price discounts, rebates, and other restrictive pricing terms on our products. These factors could have a material adverse effect on our business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We have a limited number of manufacturing facilities and certain third-party suppliers produce a substantial portion of our API and products, some of which require a highly exacting and complex manufacturing process.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A substantial portion of our capacity, as well as our current production, is attributable to a limited number of manufacturing facilities and certain third-party suppliers. A significant disruption at any one of such facilities within our internal or third-party supply chain, even on a short-term basis, whether due to the failure of a third-party supplier to fulfill the terms of their agreement with us, labor disruption, adverse quality or compliance observation, other regulatory action, infringement of brand or other third-party intellectual property rights, natural disaster, civil or political unrest, export or import restrictions, or other events could impair our ability to produce and ship products to the market on a timely basis and could, among other consequences, subject us to exposure to claims from customers. Any of these events could have a material adverse effect on our reputation, business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price. The adverse effects of any of these events could be exacerbated as a result of our previously announced global restructuring program, which includes the closing, downsizing or divesting of a number of facilities globally. If we or our third-party suppliers&#8217; face significant manufacturing issues, this could lead to shutdowns, delays or product shortages, or to our being entirely unable to supply certain products to customers for an extended period of time. In addition, our facilities may be required to close for periods of time, be required to staff at reduced capacity, or suffer other manufacturing delays as the result of an outbreak of disease, epidemic or pandemic, such as the COVID-19 pandemic, in or near any of our facilities. Such shortages, delays or shutdowns have led and could continue to lead to significant losses of sales revenue, third-party litigation, or negative publicity. See also &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">The pharmaceutical industry is heavily regulated, and we face significant costs and uncertainties associated with our efforts to comply with applicable laws and regulations.&#8221;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We purchase certain API and other materials and supplies that we use in our manufacturing operations, as well as certain finished products, from many different foreign and domestic suppliers. The price of API and other materials and supplies is subject to volatility, including as a result of global supply chain disruptions due to COVID-19 or other events. In certain cases, we have listed only one supplier in our applications with regulatory agencies. There is no guarantee that we will always have timely, sufficient or affordable access to critical raw materials or finished product supplied by third parties, even when we have more than one supplier, which could lead to our or our partners&#8217; and suppliers&#8217; inability to supply sufficient quantities of our products to meet market demand. In addition, quality deficiencies in the products which we or our suppliers provide, or at our or their manufacturing facilities, have in the past and could in the future adversely impact our manufacturing and supply capabilities, cause supply interruptions, or lead to voluntary market withdrawals or product recalls. For example, the EU has implemented particularly stringent regulations with respect to manufacturing standards for API imported into Europe that place the certification requirement on the regulatory bodies of the exporting countries. An increase in the price, or an interruption in the supply, of a single-sourced or any other raw material, including the relevant API, or in the supply of finished product, could have a material adverse effect on our business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with the Combination, Viatris entered into certain manufacturing and supply agreements with Pfizer. Reliance on Pfizer under those agreements entails risks related to regulatory and quality assurance (including cGMP compliance), unforeseen disruption of the manufacture or supply or our products, the possible breach of the agreement by Pfizer, the possible misappropriation of our proprietary information or the possible termination of the agreements at a time that is costly or inconvenient to Viatris, any of which could have a material adverse effect on our business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price. See also &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Viatris could incur operational difficulties or losses if we are unable to obtain the same types and level of services and resources that historically had been provided to the legacy Upjohn Business by Pfizer, if Pfizer is unable to perform under the agreements entered into as part of the Combination or if we are required to make payments to Pfizer pursuant to indemnities agreed to as part of the Combination</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, the manufacture of some of our products is a highly exacting and complex process, due in part to strict regulatory requirements. Problems may arise during manufacturing at our or our third-party suppliers&#8217; facilities for a variety of reasons, including, among others, equipment malfunction, failure to follow specific protocols and procedures, problems with raw materials, natural disasters, power outages, labor disputes or other civil unrest, cybersecurity or compliance issues, and environmental, health and safety issues, laws, regulations and permits. If problems arise during the production of a batch of product, that batch of product may have to be discarded. This could, among other things, lead to increased costs, contractual penalties, lost revenue, damage to customer relations, time and expense spent investigating the cause, and, depending on the cause, similar losses with respect to other batches or products. If problems are not discovered before the product is released to the market, recall and product liability costs may also be incurred.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If we or one of our suppliers experience any of the problems described above, such problems could have a material adverse effect on our reputation, business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Our future success is highly dependent on our ability to attract, motivate and retain key personnel.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Given the size, complexity and global reach of our business, it is important that we attract, motivate and retain qualified management and other key employees in order to develop and commercialize new products, manage our business, and compete effectively. Our ability to do so also depends in part on how well we maintain a strong, diverse and inclusive workplace culture that is attractive to employees. Competition for qualified personnel in the pharmaceutical industry is intense. Current or prospective Viatris employees may have changing expectations around workplace flexibility, and a failure to meet these evolving expectations may result in reduced ability to attract and retain talent. In addition, current or prospective Viatris employees may experience uncertainty about their future roles at the Company as a result of the continued integration process with respect to the Combination, the end of certain TSA arrangements, our global restructuring program, or other strategic initiatives. As a result, we may lose key personnel or may be unable to attract, retain and motivate qualified individuals, or the associated costs may increase. If we fail to attract, develop, incentivize and retain key scientific, technical, commercial, regulatory, information security/privacy, or management personnel, this could lead to loss of customers, business disruption, and a decline in revenues, adversely affect the progress of pipeline products, or otherwise adversely affect our operations. Additionally, while we work to ensure that we have effective plans in place for management succession throughout the organization, any anticipated or unanticipated management transition could create uncertainty, which could disrupt or result in changes to our strategy and have a negative impact on our business. If we are unsuccessful in retaining our key employees or enforcing certain post-employment contractual provisions such as confidentiality or non-competition provisions, it may have a material adverse impact on our business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Compliance Risks</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We are subject to the U.S. Foreign Corrupt Practices Act, the U.K. Bribery Act, Chinese anti-corruption laws and similar worldwide anti-corruption laws, which impose restrictions on certain conduct and may carry substantial fines and penalties.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We are subject to the U.S. Foreign Corrupt Practices Act, the U.K. Bribery Act, Chinese anti-corruption laws and similar anti-corruption laws in other jurisdictions. These laws generally prohibit companies and their intermediaries from engaging in bribery or making other prohibited payments to government officials for the purpose of obtaining or retaining business, and some have record keeping requirements. The failure to comply with these laws could result in substantial criminal and/or monetary penalties. We operate in jurisdictions that have experienced corruption, bribery, pay-offs and other similar practices from time-to-time and, in certain circumstances, such practices may be local custom. We have implemented and trained relevant employees and third party agents regarding internal control policies and procedures that mandate compliance with these anti-corruption laws. However, we cannot be certain that these policies and procedures will protect us against liability. There can be no assurance that our employees or other agents will not engage in such conduct for which we might be held responsible. If our employees or agents are found to have engaged in such practices, we could suffer severe criminal or civil penalties, reputational harm and other consequences that could have a material adverse effect on our business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Our competitors, including branded pharmaceutical companies, and/or other third parties, may allege that we or our suppliers are infringing upon their intellectual property, including in an &#8220;at risk launch&#8221; situation, which could result in substantial monetary damages, impact our ability to launch a product and/or our ability to continue marketing a product, and/or force us to expend substantial resources in resulting litigation, the outcome of which is uncertain.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Companies that produce branded pharmaceutical products and other patent holders routinely bring litigation against entities selling or seeking regulatory approval to manufacture and market generic forms of their branded products, as well as other entities involved in the manufacture, supply, and other aspects relating to API and finished pharmaceutical products. These companies and other patent holders may allege patent infringement or other violations of intellectual property rights as the basis for filing suit against an applicant for a generic product as well as others who may be involved in some aspect of research, supply, production, distribution, testing, packaging or other processes. Litigation often involves significant expense and can delay or prevent introduction or sale of our generic products. If patents are held valid and infringed by our products in a particular jurisdiction, we and/or our supplier(s) or partner(s) may, unless we or the supplier(s) or partner(s) could obtain a license from the patent holder, need to cease manufacturing and other activities, including but not limited to selling in that jurisdiction. We may also need to pay damages, surrender or withdraw the product, or destroy existing stock in that jurisdiction.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">There also may be situations, such as the decision to launch our insulin glargine and dimethyl fumarate products, where we use our business judgment and decide to market and sell products directly or through third parties, notwithstanding the fact that allegations of patent infringement(s) and other third-party rights have not been finally resolved by the courts (i.e., an &#8220;at-risk launch&#8221;). The risk involved in doing so can be substantial because the remedies available to the owner of a patent for infringement may include, among other things, a reasonable royalty on sales, damages measured by the profits lost by the patent holder, or by profits earned by the infringer. If there is a finding by a court of willful infringement, the definition of which is subjective, such damages may be increased by up to three times. Moreover, because of the discount pricing typically involved with bioequivalent products, patented branded products generally realize a substantially higher profit margin than generic or biosimilar products. An adverse decision in a case such as this, or a judicial order preventing us or our suppliers and partners from manufacturing, marketing, selling, and/or other activities necessary to the manufacture and distribution of our products, could result in substantial penalties, and/or have a material adverse effect on our business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We rely on the effectiveness of our patents, trademarks, confidentiality agreements and other measures to protect our intellectual property rights.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our ability to commercialize any branded product successfully will largely depend upon our or any partner&#8217;s or supplier&#8217;s ability to obtain, maintain and enforce patents and trademarks of sufficient scope to lawfully prevent third parties from developing and/or marketing infringing products. In the absence of adequate intellectual property protections or other barriers to entry, competitors may adversely affect our branded products business by independently developing and/or marketing substantially equivalent products. It is also possible that we could incur substantial costs if we initiate litigation against others to protect or enforce our intellectual property rights.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We may submit patent filings covering the API, formulation, methods of making, and/or methods of using for our branded products and branded product candidates. We may not be issued patents based on patent applications already filed or that we file in the future. Further, due to other factors that affect patentability, and if patents are issued, they may be insufficient in scope to protect our branded products from generic competition, as generics may be able to design around our patents. Patents are national in scope and therefore the issuance of a patent in one country does not ensure the issuance of a patent in any other country. Furthermore, the patent position of companies in the pharmaceutical industry generally involves complex legal and factual questions and has been and remains the subject of significant litigation. Legal standards relating to scope and validity of patent claims are evolving and may differ in various countries. Any patents we have obtained, or obtain in the future, may be challenged, invalidated or circumvented. Moreover, the U.S. Patent and Trademark Office or any other governmental agency may commence or institute post-grant review, inter partes review, interference proceedings, or other challenges to our patents or patent applications. Although many of our products do not have patent protection, we continue to take steps to defend our patents for certain of our products. For example, many companies launched a generic to Lyrica in Japan in December 2020 despite pending patent litigation and the fact that these patents expire in July 2022. The patent litigation remains ongoing and we have received several unfavorable rulings. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, branded products often have market viability based upon the goodwill of the product name, which typically is the subject of a trademark registration or filing. Our branded products may therefore also be subject to risks related to the loss of a trademark or patent or to competition from generic or other branded products. Challenges can come from other businesses, individuals or governments, and governments could require compulsory licensing of our intellectual property. Any challenge to, or invalidation or circumvention of, our intellectual property (including patents or patent applications, copyrights and trademark protection) would be costly, would require significant time and attention of our management, and could cause a material adverse effect on our business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We also rely on trade secrets, unpatented proprietary know-how, trade dress, regulatory exclusivity and continuing technological innovation that we seek to protect, in part by confidentiality agreements with licensees, suppliers, employees and consultants. These measures may not provide adequate protection for our unpatented technology. If these agreements are breached, it is possible that we will not have adequate remedies. Disputes may arise concerning the ownership of intellectual property or the applicability of confidentiality agreements. Furthermore, our trade secrets and proprietary technology may otherwise become known or be independently developed by our competitors or we may not be able to maintain the confidentiality of information relating to such products.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our ability to enforce intellectual property rights also depends on the laws of individual countries, each country&#8217;s practices with respect to enforcement of intellectual property rights, and the extent to which certain countries may seek to engage in policies or practices that may weaken its intellectual property framework (e.g., a policy of routine compulsory licensing, or threat of compulsory licensing, of pharmaceutical intellectual property). If we are unable to adequately protect our technology, trade secrets or proprietary know-how, or enforce our intellectual property rights, this could cause a material adverse effect on our business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Our reporting and payment obligations related to our participation in U.S. federal healthcare programs, including Medicare, Medicaid and the VA, are complex and often involve subjective decisions that could change as a result of new business circumstances, new regulations or agency guidance, or advice of legal counsel. Any failure to comply with those obligations could subject us to investigation, penalties, and sanctions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">U.S. federal laws regarding reporting and payment obligations with respect to a pharmaceutical company&#8217;s participation in federal healthcare programs, including Medicare, Medicaid and the VA, are complex. Because our processes for calculating applicable government prices and the judgments involved in making these calculations involve subjective decisions and complex methodologies, these calculations are subject to risk of errors and differing interpretations. In addition, they are subject to review and challenge by the applicable governmental agencies, and it is possible that such reviews could result in changes that may have material adverse legal, regulatory, or economic consequences.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Any governmental agencies or authorities that have commenced, or may commence, an investigation of us relating to the sales, marketing, pricing, quality, or manufacturing of pharmaceutical products could seek to impose, based on a claim of violation of anti-fraud and false claims laws or otherwise, civil and/or criminal sanctions, including fines, penalties, and possible exclusion from federal healthcare programs, including Medicare, Medicaid and/or the VA. Some of the applicable laws may impose liability even in the absence of specific intent to defraud. Furthermore, should there be ambiguity with regard to how to properly calculate and report payments&#8212;and even in the absence of any such ambiguity&#8212;a governmental authority may take a position contrary to a position we have taken, and may impose or pursue civil and/or criminal sanctions. Governmental agencies may also make changes in program interpretations, requirements or conditions of participation, some of which may have implications for amounts previously estimated or paid. There can be no assurance that our submissions will not be found by CMS or the VA to be incomplete or incorrect. Any failure to comply with the above laws and regulations, and any such penalties or sanctions could have a material adverse effect on our business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We are involved in various legal proceedings and certain government inquiries and may experience unfavorable outcomes of such proceedings or inquiries. </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We are or may be involved in various legal proceedings and certain government inquiries or investigations, including, but not limited to, patent infringement, product liability, personal injury, securities fraud, claims with respect to the manufacture, sale marketing and distribution of opioid products, antitrust matters, breach of contract, and claims involving Medicare, Medicaid and/or VA reimbursements, or laws relating to sales, marketing, and pricing practices. These proceedings may involve claims for, or the possibility of, fines and penalties involving substantial amounts of money or other relief, including but not limited to civil or criminal fines and penalties and exclusion from participation in various government healthcare-related programs. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Viatris is subject to investigations and extensive regulation by government agencies in the United States, China and other developed markets and emerging markets in which we operate. Criminal charges, substantial fines and/or civil penalties, limitations on Viatris&#8217; ability to conduct business in applicable jurisdictions, as well as reputational harm and increased public interest in the matter could result from government investigations With respect to government enforcement of state and federal laws, including antitrust laws, as well as private plaintiff litigation of so-called &#8220;pay for delay&#8221; patent settlements, large verdicts, settlements or government fines are possible, especially in the U.S. and EU. Additionally, some state legislatures have and the U.S. federal government or additional state legislatures could, enact legislation to limit patent settlements between pharmaceutical companies and deem such patent agreements as anticompetitive. These changes could impact our ability to launch generic products prior to the originator&#8217;s patent expiry.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with the Combination, the Company has generally assumed liability for, and control of, pending and threatened legal matters relating to the Upjohn Business and has agreed to indemnify Pfizer for liabilities arising out of such assumed legal matters. Pfizer, however, has agreed to retain various matters &#8211; including certain specified competition law matters &#8211; to the extent they arise from conduct during the pre-Distribution period and has agreed to indemnify the Company for liabilities arising out of such matters.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If Pfizer were to dispute its retention of these matters, or if there is an adverse outcome in the matters that Pfizer has agreed to retain, this could have an adverse impact on Viatris. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, Viatris has agreed to pay Pfizer an amount equal to 57% of any losses actually incurred or suffered by Viatris, its predecessors or subsidiaries, since July 29, 2019, arising out of third-party actions relating to the manufacture, distribution, marketing, promotion or sale of opioids by or on behalf of Viatris, its predecessors or subsidiaries. If any of these legal proceedings or inquiries were to result in an adverse outcome, the impact could have a material adverse effect on our business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Emerging developments in the U.S. legal landscape relative to the liability of generic pharmaceutical manufacturers for certain product liabilities claims could increase our exposure to litigation costs and damages, including in connection with third party defense and indemnification demands. Although we maintain a combination of self-insurance and commercial insurance, no reasonable amount of insurance can fully protect against all risks because of the potential liability inherent in the business of producing pharmaceuticals for human consumption. To the extent that a loss occurs, depending on the nature of the loss and the level of insurance coverage maintained, it could have a material adverse effect on our business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, in limited circumstances, entities that we have acquired are party to litigation in matters under which we are, or may be, entitled to indemnification by the previous owners. Even in the case of indemnification, there are risks inherent in such indemnities and, accordingly, there can be no assurance that we will receive the full benefits of such indemnification, or that we will not experience an adverse result in a matter that is not indemnified, which could have a material adverse effect on our business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Refer to Note 19 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> included in Part II, Item 8 in this Form 10-K for further discussion of certain proceedings and litigation matters.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">If we fail to comply with our corporate integrity agreement, we could be subject to substantial penalties and exclusion from participation in federal healthcare programs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In August 2017, Mylan Inc. and Mylan Specialty L.P., then subsidiaries of Mylan and now subsidiaries of Viatris, entered into the CIA with the OIG-HHS. The CIA has a five-year term and requires, among other things, enhancements to our compliance program, fulfillment of reporting and monitoring obligations, management certifications and resolutions from Mylan Inc.&#8217;s board, as well as that an independent review organization annually review various matters relating to the Medicaid Drug Rebate Program, among other things. If we fail to comply with the CIA, the OIG-HHS may impose substantial monetary penalties or exclude us from federal healthcare programs, including Medicare, Medicaid or the VA, which could have a material adverse effect on our business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We are increasingly dependent on IT and our systems and infrastructure face certain risks, including cybersecurity and data leakage risks.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Significant disruptions to our IT systems or breaches of information security could adversely affect our business. We are increasingly dependent on sophisticated IT systems and infrastructure to operate our business. The number of new vulnerabilities identified to these systems combined with the increased number of systems that reach end of life each year creates an opportunity for successful malicious attacks. Such attacks are increasingly sophisticated and are made by groups and individuals with a wide range of motives and expertise, including state and quasi-state actors, criminal groups, &#8220;hackers&#8221; and others. Any security breach or other disruption to our or our vendors&#8217; IT infrastructure could also interfere with or disrupt our business operations, including our manufacturing, distribution, R&amp;D, sales and/or marketing activities.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We outsource significant elements of our operations to third parties, including as part of our TSAs with Pfizer. Some of these third parties are outside the U.S., including significant elements of our IT infrastructure, and as a result we are managing many independent vendor relationships with third parties who may or could have access to our confidential information. The overall increase in supply chain attacks on companies generally, such as SolarWinds, Kronos, and Accellion, and our interdependency on third party suppliers increases the potential for supply disruptions and service IT outages. In addition to our reliance upon third parties to provide IT and information security services, the market for such services continues to contract and converge, increasing both the challenges in identifying competent providers and the impact of a breach incident with any single vendor. In the ordinary course of business, we and our vendors collect, store and transmit large amounts of confidential information (including trade secrets or other intellectual property, proprietary business information and personal information), and it is critical that we do so in a secure manner to maintain the confidentiality and integrity of such confidential information. The size and complexity of our and our vendors&#8217; systems and the large amounts of confidential information that is present on them also makes them potentially vulnerable to security breaches from inadvertent or intentional actions by our employees, partners or vendors, or from attacks by malicious third parties. Maintaining the security, confidentiality and integrity of this confidential information (including trade secrets or other intellectual property, proprietary business information and personal information) is important to our competitive business position. However, such information can be difficult to protect. While we have taken steps to identify and protect such information, and to ensure that the third-party vendors&#8217; on which we rely have taken adequate steps to protect such information, there can be no assurance that our or our vendors&#8217; efforts will prevent service interruptions or security breaches in our systems or the unauthorized or inadvertent wrongful use or disclosure of confidential or material non-public information that could adversely affect our business operations or result in the loss, misappropriation, and/or unauthorized access, use or disclosure of, or the prevention of access to, confidential information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A breach of our or our vendors&#8217; security measures or the accidental loss, inadvertent disclosure, unapproved dissemination, misappropriation or misuse of trade secrets, proprietary information, or other confidential information, whether as a result of theft, hacking, fraud, trickery or other forms of deception, or for any other cause, could enable others to produce competing products, use our proprietary technology or information, and/or adversely affect our business position. Further, any such interruption, security breach, or loss, misappropriation, and/or unauthorized access, use or disclosure of confidential information, including personal information regarding our patients and employees, could result in financial, legal, business, and reputational harm to us and could have a material adverse effect on our business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Insurance may not be sufficient to cover the financial, legal, business or reputational losses that may result from a breakdown, breach, cyber-attack or other compromise of or interruption to our IT systems or confidential and other sensitive information. We also cannot ensure that any limitation of liability or indemnity provisions in our contracts, including with vendors and service providers, for a security lapse or breach or other security incident would be enforceable or adequate or would otherwise protect us from any liabilities or damages with respect to any particular claim.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We are subject to data privacy and security laws and regulations in many different jurisdictions and countries where we do business, and our or our vendors&#8217; inability to comply could result in fines, penalties, or reputational damage, and could impact the way we operate our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We are subject to federal, state and international data privacy and security laws and regulations governing the collection, use, disclosure, transmission and protection of personal information, including health-related information. As the legislative and regulatory landscape for data privacy and security continues to evolve around the world, there has been an increasing focus on data privacy and security matters that may affect our business.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the U.S., federal laws include HIPAA, which governs the use, disclosure, and security of protected health information by HIPAA covered entities and business associates. Several U.S. states, including California, Virginia, Colorado, Pennsylvania and Florida, have enacted or proposed broad data privacy laws and regulations governing the confidentiality, security, use and disclosure of personal information, which may impose greater restrictions than federal data privacy and security laws and regulations and provide transparency and privacy rights for their citizens. We may also be subject to other state data privacy and security breach notification laws, state health information privacy laws, and federal and state consumer protection laws such as the federal Controlling the Assault of Non-Solicited Pornography and Marketing (CAN-SPAM) Act, which impose requirements for the collection, use, disclosure, transmission and protection of personal information. Each of these laws are subject to varying interpretations by courts and regulatory or government agencies, creating complex compliance issues for us. If we, or the third-party vendors on which we rely, fail to comply with applicable laws and regulations we could be subject to fines, penalties or sanctions, including criminal penalties.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Outside of the U.S., the EU&#8217;s and U.K.&#8217;s GDPR and local implementing regulations impose significant compliance obligations on our organization. The GDPR contains data protection requirements in the EU and U.K. and imposes a framework of obligations and restrictions governing the collection, processing, and the transmission of personal information to jurisdictions outside of the EU and U.K.. The GDPR affords individuals with a series of privacy rights related to the collection, processing, and transmission of their personal information. The GDPR imposes significant compliance obligations, including required processes and policies governing our collection, transmission, processing and use of individuals personal information. In addition, the GDPR includes significant penalties for non-compliance, with fines up to the higher of &#8364;20 million or 4% of total annual worldwide revenue. In general, GDPR, and other data protection laws and regulations, could require adaptation of our technologies or practices to satisfy local country data protection requirements and standards.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Other countries in which we operate, such as Australia, Brazil, Canada, India, Japan, South Korea, Russia and South Africa, have, or are developing, laws and regulations governing the collection, use, securing and transmission of personal information as well that may affect our business or require us to adapt our technologies or practices. Recently, China enhanced its Cybersecurity Law and Data Security Law framework by enacting a significant and omnibus data privacy law, the Personal Information Protection Law (PIPL), which became effective in November 2021. The PIPL is China&#8217;s first comprehensive data protection law which aims to protect the rights and interests of individuals by introducing stringent requirements for companies doing business in China regarding the protection, control, and use of personal information.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">These and similar initiatives could increase the cost of developing, implementing or maintaining our IT systems, require us to allocate more resources to compliance initiatives or increase our costs. In addition, a failure by us, or our third-party vendors, to comply with applicable data privacy and security laws may lead to government enforcement actions and private litigation, which could result in financial, legal, business, and reputational harm to us and could have a material adverse effect on the way we operate our business, our financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Increasing scrutiny and evolving expectations from customers, regulators, investors, employees, and other stakeholders with respect to our environmental, social and governance practices may impose additional costs on us or expose us to new or additional risks.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Companies are facing increasing expectations and scrutiny from customers, regulators, investors, employees and other stakeholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">related to their environmental, social and governance practices and disclosure. Investor advocacy groups, investment funds and influential investors are also increasingly focused on these practices, especially as they relate to the environment, climate change, health and safety, supply chain management, diversity, labor conditions and human rights, both in our own operations and in our supply chain. Failure to adapt to or comply with regulatory requirements or investor or stakeholder expectations and standards could negatively impact our reputation, ability to do business with certain partners, access to investors and capital, and our stock price.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, a growing number of our customers, including certain government purchasers, have adopted, or may adopt, procurement policies that include social and environmental requirements, including, for example, requirements to monitor and conduct third party audits, or these customers may seek to include such provisions in their procurement contract terms and conditions. These social and environmental responsibility provisions and initiatives are subject to change, vary from jurisdiction to jurisdiction, and certain elements may be difficult and/or cost prohibitive for us to comply with given the inherent complexity of our external supply chain and the global scope of our operations. In certain circumstances, in order to meet the requirements or standards of our customers, we may be obligated to modify our sourcing practices or make other operational choices which may require additional investments and increase our costs or result in inefficiencies. Alternatively, we may be ineligible to participate in bids or tenders in certain markets, which may result in lost sales and revenues.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Any of the factors mentioned above, or the perception that we or our suppliers or contract manufacturers have not responded appropriately to the growing concern for such issues, regardless of whether we are legally required to do so, may damage our reputation and have a material adverse effect on our business, employees relations, access to investors and capital, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Our business and operations are subject to risks related to climate change.</span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The effects of global climate change present risks to our business. Extreme weather, natural disasters, power outages, or other conditions caused by climate change could adversely impact our supply chain and the availability and cost of raw materials, water supply, and other components required for the operation of our business, or result in the delay and/or disruption of our ability to deliver products. Such conditions could also result in physical damage to our or our partners&#8217; products, plants and distribution centers, as well as the infrastructure and facilities of hospitals, medical care facilities and other customers. Our programs to plan for and mitigate risk and build resilience to the impacts of climate change may not be successful. Current or future insurance arrangements may not provide protection for costs that may arise from such events, particularly if such events are catastrophic in nature or occur in combination. In addition, regulations intended to limit greenhouse gas emissions or water usage, such as carbon pricing, taxes on emissions, fuel and energy, or to mitigate the impacts of climate change may become more prevalent, which could increase our operating costs and the costs charged by suppliers. These events could have a material adverse effect on the way we operate our business, our financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Finance Risks</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">There can be no guarantee that we will continue to pay dividends or that we will implement repurchases under our stock buyback program.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Although Viatris currently intends to continue to pay quarterly dividends to its stockholders, there is no assurance that Viatris will declare and pay, or have the ability to declare and pay, any dividends on its common stock in the future. Whether dividends will be paid, and the amount and frequency of any such dividend payments, will depend upon a number of factors, including Viatris&#8217; results of operations, cash flows, financial position, competitive or commercial developments, contractual or statutory restrictions and any other factors considered relevant by the Viatris Board. Such payments, and the amount and frequency thereof, are also subject to the other risks set forth in these risk factors. In addition, although the Board of Directors has authorized a stock buyback program, there is no guarantee that we will implement repurchases under the program or, if we do, the timing or amount of any future share repurchases under such program. Even if implemented, we will not be obligated to repurchase shares under any such stock buyback program and, until November 2022, such a program may be impacted by certain conditions in our Tax Matters Agreement. Other factors, including changes in tax or securities laws, could also impact our stock buybacks. A stock buyback program could affect our stock price and increase volatility, and any announcement of a pause in, or termination of, a share buyback program may result in a decrease in our stock price. Payment of a cash dividend or share repurchases will reduce the amount of cash available to the Company for other activities, including repayment of debt, investment in the business or other capital expenditures.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">If the intercompany terms of cross border arrangements that we have among our subsidiaries are determined to be inappropriate or ineffective, our tax liability may increase.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have potential tax exposures resulting from the varying application of statutes, regulations, and interpretations which include exposures on intercompany terms of cross-border arrangements among our subsidiaries (including intercompany loans, sales, and services agreements) in relation to various aspects of our business, including manufacturing, marketing, sales, and delivery functions. Although we believe our cross-border arrangements among our subsidiaries are based upon internationally accepted standards and applicable law, tax authorities in various jurisdictions may disagree with and subsequently challenge the amount of profits taxed in their country, which may result in increased tax liability, including accrued interest and penalties, which would cause our tax expense to increase and could have a material adverse effect on our business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We may not be able to maintain competitive financial flexibility and our corporate tax rate which could adversely affect us and our shareholders.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We believe that our structure and operations give us the ability to achieve competitive financial flexibility and a competitive worldwide effective corporate tax rate. We must make material assumptions underlying our expected tax rates, including regarding the effect of certain internal reorganization transactions, including various intercompany transactions. We cannot give any assurance as to what our effective tax rate will be, however, because of, among other reasons, uncertainty regarding the tax policies of the jurisdictions where we operate, potential changes of laws and interpretations thereof, and the potential for tax audits or challenges. Our actual effective tax rate may vary from our expectation and that variance may be material. Furthermore, the tax laws of other jurisdictions could change in the future, and such changes could cause a material change in our effective tax rate. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Any of the factors discussed above could materially increase our overall effective income tax rate and income tax expense and could have a material adverse effect on our business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Unanticipated changes in our tax provisions or exposure to additional income tax liabilities and changes in income tax laws and tax rulings may have a significant adverse impact on our effective tax rate and income tax expense.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">We are subject to income taxes in many jurisdictions. Significant analysis and judgment are required in determining our worldwide provision for income taxes.</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">In the ordinary course of business, there are many transactions and calculations where the ultimate tax determination is uncertain. We are currently subject to tax audits and investigations in several jurisdictions, and may be subject to other audits and investigations in the future. The final determination of any tax audits or related litigation could be materially different from our income tax provisions and accruals.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Additionally, changes in the effective tax rate as a result of a change in the mix of earnings in countries with differing statutory tax rates, changes in our overall profitability, changes in the valuation of deferred tax assets and liabilities, changes in tax laws or in their application, the results of audits and the examination of previously filed tax returns and related challenges and assessments by taxing authorities, and continuing assessments of our tax exposures could impact our tax liabilities and affect our income tax expense, which could have a material adverse effect on our business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Currency fluctuations and changes in exchange rates could adversely affect our business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Although we report our financial results in U.S. Dollars, a significant portion of our revenues, indebtedness and other liabilities and our costs are denominated in non-U.S. currencies, including among others the Chinese Renminbi, Euro, Swedish Krona, Indian Rupee, Korean Won, Japanese Yen, Australian Dollar, Canadian Dollar, British Pound Sterling, South African Rand and Brazilian Real. Our results of operations and, in some cases, cash flows, have in the past been and may in the future be adversely affected by certain movements in currency exchange rates. Defaults or restructurings in other countries could have a similar adverse impact. In addition, there remains significant international pressure on the Chinese government to adopt a more flexible currency policy, including from the U.S. government, which designated China as a &#8220;currency manipulator&#8221; in August 2019 and subsequently removed such designation in January 2020, which could result in greater fluctuation of the Renminbi against the U.S. dollar. From time to time, we may implement currency hedges intended to reduce our exposure to changes in foreign currency exchange rates. However, our hedging strategies may not be successful, and any of our unhedged foreign exchange exposures will continue to be subject to market fluctuations. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, Viatris also faces risks arising from currency devaluations and the imposition of cash repatriation restrictions and exchange controls. Currency devaluations result in a diminished value of funds denominated in the currency of the country instituting the devaluation. Cash repatriation restrictions and exchange controls may limit our ability to convert foreign currencies into U.S. dollars or to remit dividends and other payments by its foreign subsidiaries or businesses located in or conducted within a country imposing restrictions or controls. For example, in China the conversion of currency in the &#8220;capital account&#8221; (e.g., capital items such as direct investments or loans) requires the approval of the State Administration for Foreign Exchange in China or its local branches which could materially and adversely affect the ability of our Chinese operating subsidiaries and affiliated companies to obtain foreign currencies through equity financing or for capital expenditures, therefore impeding our overall business operations. While we currently have no need, and do not intend, to repatriate or convert cash held in countries that have significant restrictions or controls in place, should we need to do so to fund our operations, we may be unable to repatriate or convert such cash, or be unable to do so without incurring substantial costs.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The occurrence of any of the above risks could cause a material adverse effect on our business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We have significant indebtedness, which could lead to adverse consequences or adversely affect our financial position and prevent us from fulfilling our obligations under such indebtedness, and any refinancing of this debt could be at significantly higher interest rates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our level of indebtedness could have important consequences, including but not limited to:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">increasing our vulnerability to general adverse economic and industry conditions;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">requiring us to dedicate a substantial portion of our cash flow from operations to make debt service payments, thereby reducing the availability of cash flow to fund working capital, capital expenditures, acquisitions and investments, dividend payments and other general corporate purposes;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">limiting our flexibility in planning for, or reacting to, challenges and opportunities, and changes in our businesses and the markets in which we operate;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">limiting our ability to obtain additional financing to fund our working capital, capital expenditures, acquisitions and debt service requirements and other financing needs;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">increasing our vulnerability to increases in interest rates in general related to any of our indebtedness that bears interest at floating rates; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">increasing our exposure to currency fluctuations, since a significant portion of our indebtedness is denominated in currencies other than the U.S. dollar, such as our Euro and Japanese yen denominated debt; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">placing us at a competitive disadvantage to our competitors that have less debt.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our ability to service our indebtedness will depend on our future operating performance and financial results, which will be subject, in part, to factors beyond our control, including interest rates, general economic, financial and business conditions and impacts of the COVID-19 pandemic. If we do not have sufficient cash flow to service our indebtedness, including the repayment of significant near-term indebtedness, we may need to refinance all or part of our existing indebtedness, borrow more money or sell securities or assets, some or all of which may not be available to us at acceptable terms or at all. In addition, we may need to incur additional indebtedness in the future in the ordinary course of business. Although the terms of our credit agreements and our bond indentures allow us to incur additional debt, this is subject to certain limitations which may preclude us from incurring the amount of indebtedness we otherwise desire.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Although Viatris expects to maintain an investment grade credit rating, a downgrade in the credit rating of Viatris or any indebtedness of Viatris or its subsidiaries could increase the cost of further borrowings or refinancings of such indebtedness, limit access to sources of financing in the future or lead to other adverse consequences.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If we incur additional debt, the risks described above could intensify. If global credit markets contract, future debt financing may not be available to us when required or may not be available on acceptable terms or at all, and as a result we may be unable to grow our business, take advantage of business opportunities, respond to competitive pressures or satisfy our obligations under our indebtedness. Any of the foregoing could have a material adverse effect on our business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">From time to time, we issue variable rate debt based on LIBOR or undertake interest rate swaps that contain a variable element based on LIBOR. On March 5, 2021, the FCA, the regulatory supervisor of LIBOR&#8217;s administrator, announced the </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">cessation or loss of representativeness of certain LIBOR benchmark settings by the end of 2021, including the </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">one-week and two-month U.S. dollar LIBOR settings, with publication of the overnight and one-, three-, six- and 12-month U.S. dollar LIBOR settings ceasing at the end of June 2023. U.S. federal banking agencies also issued a joint statement in November 2020 encouraging banks to stop using LIBOR for new contracts as soon as possible but in any event by the end of the year. As of December 31, 2021, we had no outstanding debt linked to LIBOR. Our credit facilities provide that, should LIBOR cease to exist, we may amend the credit facilities to replace LIBOR with (i) in the case of U.S. dollars, one or more rates based on SOFR or (ii) another alternate benchmark rate giving due consideration to any evolving or then existing convention for similarly syndicated credit facilities syndicated in the U.S. and denominated in the applicable currency for such alternative benchmarks and, in each case, including any mathematical or other adjustments to such benchmark giving due consideration to any evolving or then existing convention for similar syndicated credit facilities syndicated in the U.S. and denominated in the applicable currency for such benchmarks. SOFR or any other benchmark replacement may not be the economic equivalent of LIBOR or achieve market acceptance similar to LIBOR. As a result, our interest expense could increase. In addition, the overall financial market may be disrupted and there could be significant increases in benchmark rates or borrowing costs to borrowers as a result of the phase-out or replacement of LIBOR. Disruption in the financial market, significant increases in benchmark rates or borrowing costs or our inability to renegotiate agreements on favorable terms could have a material adverse effect on our business, financing activities, financial condition and operations.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our credit facilities, senior unsecured notes, commercial paper program, other outstanding indebtedness and any additional indebtedness we incur in the future impose, or may impose, significant operating and financial restrictions on us. These restrictions limit our ability to, among other things, incur additional indebtedness, make investments, pay certain dividends, prepay other indebtedness, sell assets, incur certain liens, enter into agreements with our affiliates or restricting our subsidiaries&#8217; ability to pay dividends, merge or consolidate. In addition, our credit facilities require us to maintain specified financial ratios. A breach of any of these covenants or our inability to maintain the required financial ratios could result in a default under the related indebtedness. If a default occurs, the relevant lenders could elect to declare our indebtedness, together with accrued interest and other fees, to be immediately due and payable. These factors could have a material adverse effect on our business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">There are inherent uncertainties involved in estimates, judgments and assumptions used in the preparation of financial statements in accordance with U.S. GAAP. Any future changes in estimates, judgments and assumptions used or necessary revisions to prior estimates, judgments or assumptions or changes in accounting standards could lead to a restatement or revision to previously issued financial statements.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The consolidated and condensed consolidated financial statements included in the periodic reports we file with the SEC are prepared in accordance with U.S. GAAP. The preparation of financial statements in accordance with U.S. GAAP involves making estimates, judgments and assumptions that affect reported amounts of assets, liabilities, revenues, expenses and income. Estimates, judgments and assumptions are inherently subject to change in the future and any necessary revisions to prior estimates, judgments or assumptions could lead to a restatement. Furthermore, although we have recorded reserves for certain critical accounting estimates, including litigation related contingencies based on estimates of probable future costs, actual costs in the future could be substantially in excess of those reserves. Also, any new or revised accounting standards may require adjustments to previously issued financial statements. Any such changes could result in corresponding changes to the amounts of liabilities, revenues, expenses and income and could have a material adverse effect on our business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We must maintain adequate internal controls and be able to provide an assertion as to the effectiveness of such controls on an annual basis.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Effective internal controls are necessary for us to provide reasonable assurance with respect to our financial reports. We spend a substantial amount of management and other employee time and resources to comply with laws, regulations and standards relating to corporate governance and public disclosure. In the U.S., such regulations include the Sarbanes-Oxley Act of 2002, SEC regulations and the NASDAQ listing standards. In particular, Section 404 of the Sarbanes-Oxley Act of 2002 requires management&#8217;s annual review and evaluation of our internal control over financial reporting and attestation as to the effectiveness of these controls by our independent registered public accounting firm. During the third quarter of 2021, we began to transition certain support services from Pfizer, as well as certain subsidiaries, to a new ERP system. We have modified and will continue to modify our internal controls relating to our business and financial processes throughout the transition period, which is expected through the end of calendar year 2022. While we believe that this new system and the related changes to internal controls will ultimately strengthen our internal control over financial reporting, there are inherent risks in implementing any new ERP system. If we fail to maintain the adequacy of our internal controls, we may not be able to ensure that we can conclude on an ongoing basis that we have effective internal control over financial reporting. Additionally, internal control over financial reporting may not prevent or detect misstatements because of its inherent limitations, including the possibility of human error, the circumvention or overriding of controls, or fraud. Therefore, even effective internal controls can provide only reasonable assurance with respect to the preparation and fair presentation of financial statements. In addition, projections of any evaluation of effectiveness of internal control over financial reporting to future periods are subject to the risk that the control may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. If we fail to maintain the adequacy of our internal controls, including any failure to implement required new or improved controls, this could have a material adverse effect on our business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Viatris could suffer additional losses due to asset impairment charges.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Viatris has significant amounts of goodwill and intangible assets on its balance sheet. Viatris tests goodwill for impairment during the second quarter of every fiscal year, and on an interim date should events or changes in circumstances indicate the carrying value of goodwill may not be recoverable in accordance with ASC 350 &#8220;Goodwill and Other Intangible Assets.&#8221; If the fair value of a reporting unit is revised downward due to declines in business performance or other factors, an impairment under ASC 350 could result and a non-cash charge could be required. Viatris tests intangible assets with indefinite lives for impairment on an annual basis and intangible assets with finite lives for impairment whenever events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. This assessment of the recoverability of intangible assets could result in an impairment and a non-cash charge could be required. Such impairments could materially affect Viatris&#8217; reported net earnings, business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Viatris may be adversely affected by disruptions in the credit markets, including disruptions that reduce customers&#8217; access to credit and increase the costs to customers of obtaining credit.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The credit markets have historically been volatile and therefore it is not possible to predict the ability of Viatris&#8217; customers to access short-term financing and other forms of capital. If a disruption in the credit markets were to occur, Viatris could be unable to refinance its outstanding indebtedness on reasonable terms or at all. Such a disruption could also pose a risk to Viatris&#8217; business if customers or suppliers are unable to obtain financing to meet their payment or delivery obligations. In addition, customers may decide to downsize, defer or cancel contracts which could negatively affect our revenue.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Further, Viatris had approximately $1.84 billion of floating rate debt as of December 31, 2021. A one percentage point increase in the average interest rate of this debt would increase the combined interest expense by approximately $18.4 million per year. Accordingly, a spike in interest rates would adversely affect our results of operations and cash flows.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">In connection with the Combination, Viatris assumed or retained certain material obligations relating to defined benefit pension and termination benefits and retiree medical and dental benefits associated with legacy employees of the Upjohn Business and/or sponsored by Upjohn entities. These liabilities and the related future funding obligations could restrict cash available for Viatris&#8217; operations, capital expenditures, dividend payments and other requirements, and may materially adversely affect Viatris&#8217; financial condition and liquidity.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with the Combination, Viatris assumed material pension obligations associated with the Upjohn Business. In particular, Viatris retained all liabilities relating to the Puerto Rico defined benefit pension plans and Pfizer Puerto Rico Retiree Medical and Dental Plan. In addition, with respect to non-U.S. defined benefit pension and termination benefit plans, Viatris generally established or designated plans similar to the Pfizer plans to assume assets and liabilities for the benefit of legacy employees of the Upjohn Business. Viatris also retained liabilities for legacy employees of the Upjohn Business who participate in the Japan defined benefit pension plan, to the extent such employees were employed by the Upjohn Business on the date of the Combination. Each of these liabilities and the related future payment obligations could restrict cash available for Viatris&#8217; operations, capital expenditures, dividend payments and other requirements, and may materially affect Viatris&#8217; financial condition and liquidity.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">General Risks</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">The market price of our common stock may be volatile, and the value of your investment could materially decline.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Investors who hold shares of Viatris common stock may not be able to sell their shares at or above the price at which they acquired them. The price of Viatris&#8217; common stock may fluctuate materially from time to time, including as a result of the other risks described herein, and we cannot predict the price of our common stock at any given time. In addition, the stock market in general, including the market for pharmaceutical companies, has experienced significant price and volume fluctuations which may materially harm the market price of our common stock, regardless of our operating performance. In addition, the price of our common stock may be affected by the valuations and recommendations of the analysts who cover us, and if our results do not meet the analysts&#8217; forecasts and expectations, the price of our common stock could decline as a result of analysts lowering their valuations and recommendations or otherwise. Following periods of volatility in the market and/or in the price of a company&#8217;s stock, securities class-action litigation actions have been instituted against companies (including Mylan and Viatris) and may be instituted against us in the future. Such litigation may result in substantial costs and diversion of management&#8217;s attention and resources, which could have a material adverse effect on our business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price. In addition, if we or our stockholders offer or sell shares of our common stock or securities convertible into or exchangeable or exercisable for shares of our common stock, this or the possibility thereof may depress the future trading price of our common stock and the voting power of our then existing stockholders may be diluted if such a transaction were to occur.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">The expansion of social media platforms presents new risks and challenges.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">To the extent that we seek to use social media tools as a means to communicate about our products and/or business, there are uncertainties as to the rules that apply to such communications, or as to the interpretations that authorities will apply to the rules that exist. As a result, despite our efforts to monitor evolving social media communication guidelines and comply with applicable rules, there is risk that our use of social media for such purposes may cause us to be found in violation of them. Our employees may knowingly or inadvertently make use of social media tools in ways that may not be aligned with our social media strategy, may give rise to liability, or could lead to the loss of material non-public information, trade secrets or other intellectual property, or public exposure of personal information (including sensitive personal information) of our employees, clinical trial patients, customers, and others. In addition, negative posts or comments about us on any social media website could damage our reputation. Any of the above risks could have a material adverse effect on our business, reputation, financial condition, results of operations, cash flows, and/or stock price.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Provisions in the Viatris Charter and Viatris Bylaws and of applicable law may prevent or delay an acquisition of Viatris, which could decrease the trading price of Viatris common stock.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Viatris Charter, Viatris Bylaws and Delaware law contain provisions that may have the effect of deterring takeovers by making such takeovers more expensive to the acquiror and by encouraging prospective acquirors to negotiate with the Viatris Board rather than to attempt a hostile takeover. These provisions include the division of the Viatris Board into three classes of directors until the 2023 annual meeting of Viatris stockholders, which could have the effect of making the replacement of incumbent directors more time-consuming and difficult, rules regarding how stockholders may present proposals or nominate directors for election at stockholder meetings and the right of the Viatris Board to issue preferred stock without stockholder approval. Delaware law also imposes some restrictions on mergers and other business combinations between Viatris and any holder of 15% or more of Viatris&#8217; outstanding common stock.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">These provisions are intended to protect Viatris&#8217; stockholders from coercive or otherwise unfair takeover tactics by requiring potential acquirors to negotiate with the Viatris Board and by providing the Viatris Board with more time to assess any acquisition proposal. These provisions are not intended to make Viatris immune from takeovers. However, these provisions apply even if the offer may be considered beneficial by some stockholders and could delay or prevent an acquisition that the Viatris Board determines is not in the best interests of Viatris and its stockholders. Accordingly, if the Viatris Board determines that a potential business combination transaction is not in the best interests of Viatris and its stockholders, but certain stockholders believe that such a transaction would be beneficial to Viatris and its stockholders, such stockholders may elect to sell their shares in Viatris and the trading price of Viatris common stock could decrease. These and other provisions of the Viatris Charter, the Viatris Bylaws and the DGCL could have the effect of delaying, deferring or preventing a proxy contest, tender offer, merger or other change in control, which may have a material adverse effect on Viatris&#8217; business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">The Viatris Charter designates the Court of Chancery of the State of Delaware, or, if such court lacks subject matter jurisdiction, another state court of the State of Delaware (or, if no state court located within the State of Delaware has jurisdiction, the federal district court for the District of Delaware), as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by Viatris&#8217; stockholders, which could discourage lawsuits against Viatris and its directors and officers.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Viatris Charter provides that unless Viatris, through approval of the Viatris Board, otherwise consents in writing, the Court of Chancery of the State of Delaware or, if and only if the Court of Chancery of the State of Delaware dismisses such action for lack of subject matter jurisdiction, another state court sitting in the State of Delaware (or, if no state court located within the State of Delaware has jurisdiction, the federal district court for the District of Delaware), will be the sole and exclusive forum for any derivative action or proceeding brought on behalf of Viatris, any action or proceeding asserting a claim of breach of a fiduciary duty owed by any director or officer or other employees of Viatris to Viatris or its stockholders, creditors or other constituents, any action asserting a claim against Viatris or any of its directors, officers or other employees arising pursuant to, or seeking to enforce any right, obligation or remedy under, any provision of the DGCL or the Viatris Charter or the Viatris Bylaws, as each may be amended from time to time, any action or proceeding asserting a claim against Viatris or any of its directors, officers or other employees governed by the internal affairs doctrine or any action or proceeding as to which the DGCL (as it may be amended from time to time) confers jurisdiction on the Court of Chancery of the State of Delaware.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">To the fullest extent permitted by law, this exclusive forum provision will apply to state and federal law claims, including claims under the federal securities laws, including the Securities Act and the Exchange Act. However, Viatris stockholders will not be deemed to have waived Viatris&#8217; compliance with the federal securities laws and the rules and regulations thereunder. The enforceability of similar choice of forum provisions in other companies&#8217; charters and bylaws has been challenged in legal proceedings, and it is possible that, in connection with claims arising under federal securities laws or otherwise, a court could find the exclusive forum provision contained in the Viatris Charter to be inapplicable or unenforceable.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">This exclusive forum provision may limit the ability of Viatris&#8217; stockholders to bring a claim in a judicial forum that such stockholders find favorable for disputes with Viatris or its directors or officers, which may discourage such lawsuits against Viatris or its directors or officers. Alternatively, if a court were to find this exclusive forum provision inapplicable to, or unenforceable in respect of, one or more of the specified types of actions or proceedings described above, Viatris may incur additional costs associated with resolving such matters in other jurisdictions or forums, which could materially and adversely affect Viatris&#8217; business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Our business and operations could be negatively affected by pressures from outside of the control of the company, including, but not limited to, shareholder actions, government regulations and disclosure requirements, and other market dynamics, which could cause us to incur significant expenses, hinder execution of our business strategy and negatively impact our share price.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In recent years, shareholder actions, government regulations and disclosure requirements, and other market dynamics, involving corporate governance, environmental and social matters, human capital, strategic direction and operations has become increasingly prevalent. In the event we become the subject of shareholder challenges or more extensive government regulation or intervention in these areas, this may create a significant distraction for our management and employees, negatively impact our ability to execute our business plans, require our management to expend significant time and resources, create uncertainties with respect to our financial position and operations, adversely affect our ability to attract and retain key employees or result in loss of potential business opportunities with our current and potential customers and business partners. In addition, such actions, regulation and intervention may cause significant fluctuations in our share price based on temporary or speculative market perceptions, uncertainties or other factors that do not necessarily reflect the underlying fundamentals and prospects of our business, which could cause the market value of our common stock to decline.</span></div><div><span><br/></span></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_85"></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1B.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.7pt">Unresolved Staff Comments</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_88"></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:17.36pt">Properties</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For information regarding properties, refer to Item 1 &#8220;Business&#8221; in Part I of this Form 10-K.</span></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_91"></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:17.36pt">Legal Proceedings</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For information regarding legal proceedings, refer to Note&#160;19 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included in Item 8 in Part II of this 10-K.</span></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_1099511630152"></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:17.36pt">Mine Safety Disclosures</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_94"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART&#160;II</span></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_97"></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:17.36pt">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock is traded on the NASDAQ Stock Market under the symbol &#8220;VTRS&#8221;. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of February&#160;22, 2021, there were approximately 113,007 holders of record of shares of Viatris common stock.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company paid quarterly cash dividends of $0.11 per share on the Company&#8217;s issued and outstanding common stock on June 16, 2021, September 16, 2021 and December 16, 2021. On January 4, 2022, the Company&#8217;s Board of Directors declared a quarterly cash dividend of $0.12 per share on the Company&#8217;s issued and outstanding common stock, which will be payable on March 16, 2022 to shareholders of record as of the close of business on February 24, 2022. The declaration and payment of future dividends to holders of the Company&#8217;s common stock will be at the discretion of the Board of Directors, and will depend upon factors, including but not limited to, the Company&#8217;s financial condition, earnings, capital requirements of its businesses, legal requirements, regulatory constraints, industry practice, and other factors that the Board of Directors deems relevant. The Company did not pay any dividends in 2020.</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNREGISTERED SALES OF DEBT SECURITIES</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the past three years, we have issued unregistered securities in connection with the following transactions:</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2020, Upjohn issued $7.45 billion aggregate principal amount of senior unsecured debt securities, comprised of 1.125% Senior Notes due 2022, 1.650% Senior Notes due 2025, 2.300% Senior Notes due 2027, 2.700% Senior Notes due 2030, 3.850% Senior Notes due 2040 and 4.000% Senior Notes due 2050 (collectively, the &#8220;Unregistered Upjohn U.S. Dollar Notes&#8221;). The Unregistered Upjohn U.S. Dollar Notes were issued in a private offering exempt from the registration requirements of the Securities Act, to qualified institutional buyers in accordance with Rule 144A under the Securities Act and to persons outside of the U.S. pursuant to Regulation S under the Securities Act. In September 2021, Viatris filed a registration statement with the SEC with respect to an offer to exchange up to $7.45 billion aggregate principal amount of Unregistered Upjohn U.S. Dollar Notes with Registered Upjohn Notes in the same aggregate principal amount and with terms substantially identical in all material respects, which was declared effective on September 28, 2021. The exchange offer expired on October 28, 2021 and settled on October 29, 2021. More than 99.9% of the aggregate principal amount of the Unregistered Upjohn U.S. Dollar Notes were exchanged for Registered Upjohn Notes.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In June 2020, Upjohn Finance B.V., a wholly owned financing subsidiary of Upjohn, issued &#8364;3.60 billion aggregate principal amount of senior unsecured debt securities, comprised of 0.816% Senior Notes due 2022, 1.023% Senior Notes due 2024, 1.362% Senior Notes due 2027 and 1.908% Senior Notes due 2032. These notes were issued in a private offering exempt from the registration requirements of the Securities Act, to persons outside of the U.S. pursuant to Regulation S under the Securities Act.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">STOCK PERFORMANCE GRAPH</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Viatris common stock has been listed on the NASDAQ under the symbol &#8220;VTRS&#8221; since November 17, 2020. Prior to that time, there was no public market for our common stock. Upon consummation of the Combination, Pfizer stockholders received approximately 0.124079 shares of Viatris common stock for every one share of Pfizer common stock held as of the close of business on the record date (which was November 13, 2020). Former Mylan ordinary shareholders received one share of Viatris common stock for every one share of Mylan ordinary share held. The graph below compares Viatris Inc.&#8217;s cumulative total shareholder return on common stock with the cumulative total returns of the S&amp;P 500 index and the Dow Jones US Pharmaceuticals index. The graph tracks the performance of a $100 investment in our common stock and in each index (with the reinvestment of all dividends) from November 16, 2020 to December 31, 2021.</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center;text-indent:36pt"><img src="vtrs-20211231_g4.jpg" alt="vtrs-20211231_g4.jpg" style="height:488px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:65.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.698%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.698%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.554%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">November 16,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viatris Inc.</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.32&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S&amp;P 500</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115.21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148.28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dow Jones U.S. Pharmaceuticals</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141.38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_2199023257942"></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:17.36pt">[Reserved]</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_103"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 7.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:17.36pt">Management&#8217;s Discussion and Analysis of Financial Condition And Results of Operations </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion and analysis addresses material changes in the financial condition and results of operations of Viatris Inc. and subsidiaries for the periods presented. Unless context requires otherwise, the &#8220;Company,&#8221; &#8220;Viatris,&#8221; &#8220;our&#8221; or &#8220;we&#8221; refer to Viatris Inc. and its subsidiaries. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This discussion and analysis should be read in conjunction with the consolidated financial statements and the related notes to consolidated financial statements included in Part II, Item 8 in this Form&#160;10-K, and our other SEC filings and public disclosures. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This Form 10-K contains &#8220;forward-looking statements&#8221;. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements may include, without limitation, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">statements about the Biocon Biologics Transaction;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> statements about the Combination, the benefits and synergies of the Combination or our global restructuring program, future opportunities for the Company and its products and any other statements regarding the Company&#8217;s future operations, financial or operating results, capital allocation, dividend policy and payments, debt ratio and covenants, anticipated business levels, future earnings, planned activities, anticipated growth, market opportunities, strategies, competitions, commitments, confidence in future results, efforts to create, enhance or otherwise unlock the value of our unique global platform, and other expectations and targets for future periods. Forward-looking statements may often be identified by the use of words such as &#8220;will&#8221;, &#8220;may&#8221;, &#8220;could&#8221;, &#8220;should&#8221;, &#8220;would&#8221;, &#8220;project&#8221;, &#8220;believe&#8221;, &#8220;anticipate&#8221;, &#8220;expect&#8221;, &#8220;plan&#8221;, &#8220;estimate&#8221;, &#8220;forecast&#8221;, &#8220;potential&#8221;, &#8220;pipeline&#8221;, &#8220;intend&#8221;, &#8220;continue&#8221;, &#8220;target&#8221;, &#8220;seek&#8221; and variations of these words or comparable words. Because forward-looking statements inherently involve risks and uncertainties, actual future results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">the integration of Mylan and the Upjohn Business or the implementation of the Company&#8217;s global restructuring program being more difficult, time consuming or costly than expected;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">the pending Biocon Biologics Transaction may not achieve its intended benefits; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">the possibility that the Company may be unable to achieve expected benefits, synergies and operating efficiencies in connection with the Combination or its global restructuring program within the expected timeframe or at all; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">the possibility that the Company may be unable to successfully integrate Mylan and the Upjohn Business or implement its global restructuring program;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">operational or financial difficulties or losses associated with the Company&#8217;s reliance on agreements with Pfizer in connection with the Combination, including with respect to transition services; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">the possibility that the Company may be unable to achieve all intended benefits of its strategic initiatives; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">the potential impact of public health outbreaks, epidemics and pandemics, including the ongoing challenges and uncertainties posed by the COVID-19 pandemic; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">the Company&#8217;s failure to achieve expected or targeted future financial and operating performance and results;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">actions and decisions of healthcare and pharmaceutical regulators;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">changes in relevant laws and regulations, including but not limited to changes in tax, healthcare and pharmaceutical laws and regulations globally (including the impact of potential tax reform in the U.S.);</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">the ability to attract and retain key personnel;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">the Company&#8217;s liquidity, capital resources and ability to obtain financing; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">any regulatory, legal or other impediments to the Company&#8217;s ability to bring new products to market, including but not limited to &#8220;at-risk launches&#8221;; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">success of clinical trials and the Company&#8217;s or its partners&#8217; ability to execute on new product opportunities and develop, manufacture and commercialize products; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">any changes in or difficulties with the Company&#8217;s manufacturing facilities, including with respect to inspections, remediation and restructuring activities, supply chain or inventory or the ability to meet anticipated demand; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">the scope, timing and outcome of any ongoing legal proceedings, including government inquiries or investigations, and the impact of any such proceedings on the Company; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">any significant breach of data security or data privacy or disruptions to our information technology systems;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">risks associated with having significant operations globally; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">the ability to protect intellectual property and preserve intellectual property rights;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">changes in third-party relationships; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">the effect of any changes in the Company&#8217;s or its partners&#8217; customer and supplier relationships and customer purchasing patterns, including customer loss and business disruption being greater than expected following the Combination; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">the impacts of competition, including decreases in sales or revenues as a result of the loss of market exclusivity for certain products; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">changes in the economic and financial conditions of the Company or its partners; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">uncertainties regarding future demand, pricing and reimbursement for the Company&#8217;s products;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">uncertainties and matters beyond the control of management, including but not limited to general political and economic conditions, inflation rates and global exchange rates; and</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">inherent uncertainties involved in the estimates and judgments used in the preparation of financial statements, and the providing of estimates of financial measures, in accordance with U.S. GAAP and related standards or on an adjusted basis.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">For more detailed information on the risks and uncertainties associated with Viatris, see the risks described in Part I, Item 1A in this Form 10-K, and our other filings with the SEC. You can access Viatris&#8217; filings with the SEC through the SEC website at www.sec.gov or through our website and Viatris strongly encourages you to do so. Viatris routinely posts information that may be important to investors on our website at investor.viatris.com, and we use this website address as a means of disclosing material information to the public in a broad, non-exclusionary manner for purposes of the SEC&#8217;s Regulation Fair Disclosure (Reg FD). The contents of our website are not incorporated by reference in this Form 10-K and shall not be deemed &#8220;filed&#8221; under the Securities Exchange Act of 1934, as amended. Viatris undertakes no obligation to update any statements herein for revisions or changes after the filing date of this Form 10-K other than as required by law.</span></div><div><span><br/></span></div><div><span><br/></span></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_106"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Explanatory Note</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC 805, Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Mylan is considered the accounting acquirer of the Upjohn Business and all historical financial information of the Company prior to November 16, 2020 represents Mylan&#8217;s historical results and the Company&#8217;s thereafter.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Company Overview</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Viatris is a global healthcare company formed in November 2020 whose mission is to empower people worldwide to live healthier at every stage of life, regardless of geography or circumstance. Improving the ability of patients to gain access to sustainable and high-quality healthcare is our relentless pursuit. One that rests on visionary thinking, determination and best-in-class capabilities that were strategically built to remove barriers across the health spectrum and advance access globally.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Viatris&#8217; seasoned management team is focused on ensuring that the Company is optimally structured and efficiently resourced to deliver sustainable value to patients, shareholders, customers and other stakeholders. With a global workforce of approximately 37,000, the Company has industry leading commercial, R&amp;D, regulatory, manufacturing, legal and medical expertise complemented by a strong commitment to quality and unparalleled geographic footprint to deliver high-quality medicines to patients in more than 165 countries and territories. Viatris&#8217; portfolio comprises more than 1,400 approved molecules across a wide range of key therapeutic areas, including globally recognized iconic and key brands, generics, complex generics, and biosimilars. The Company operates approximately 40 manufacturing sites worldwide that produce oral solid doses, injectables, complex dosage forms and APIs. Viatris is headquartered in the U.S., with global centers in Pittsburgh, Pennsylvania, Shanghai, China and Hyderabad, India.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Viatris has four reportable segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The Company reports segment information on the basis of markets and geography, which reflects its focus on bringing its broad and diversified portfolio of branded, complex generics and biosimilars, and generic products to people in markets everywhere. Our Developed Markets segment comprises our operations primarily in North America and Europe. Our Greater China segment includes our operations in China, Taiwan and Hong Kong. Our JANZ segment reflects our operations in Japan, Australia and New Zealand. Our Emerging Markets segment encompasses our presence in more than 125 countries with developing markets and emerging economies including in Asia, Africa, Eastern Europe, Latin America and the Middle East as well as the Company&#8217;s ARV franchise. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Certain Market and Industry Factors</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The global pharmaceutical industry is a highly competitive and highly regulated industry. As a result, we face a number of industry-specific factors and challenges, which can significantly impact our results.&#160;The following discussion highlights some of these key factors and market conditions.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generic products, particularly in the U.S., generally contribute most significantly to revenues and gross margins at the time of their launch, and even more so in periods of market exclusivity, or in periods of limited generic competition. As such, the timing of new product introductions can have a significant impact on the Company&#8217;s financial results. The entrance into the market of additional competition generally has a negative impact on the volume and pricing of the affected products. Additionally, pricing is often affected by factors outside of the Company&#8217;s control. Conversely, generic products generally experience less volatility over a longer period of time in Europe as compared to the U.S., primarily due to the role of government oversight of healthcare systems in the region.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For branded products, the majority of the product&#8217;s commercial value is usually realized during the period in which the product has market exclusivity. In the U.S.&#160;and some other countries, when market exclusivity expires and generic versions of a product are approved and marketed, there can often be very substantial and rapid declines in the branded product&#8217;s sales.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain markets in which we do business outside of the U.S. have undergone government-imposed price reductions, and further government-imposed price reductions are expected in the future. Such measures, along with the tender systems discussed below, are likely to have a negative impact on sales and gross profit in these markets. However, government initiatives in certain markets that appear to favor generic products could help to mitigate this unfavorable effect by increasing rates of generic substitution and penetration. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, a number of markets in which we operate outside of the U.S. have implemented, or may implement, tender systems for generic pharmaceuticals in an effort to lower prices. Generally speaking, tender systems can have an unfavorable impact on sales and profitability. Under such tender systems, manufacturers submit bids that establish prices for generic pharmaceutical products. Upon winning the tender, the winning company will receive priority placement for a period of time. The tender system often results in companies underbidding one another by proposing low pricing in order to win the tender. The loss of a tender by a third party to whom we supply API can also have a negative impact on our sales and profitability. Sales continue to be negatively affected by the impact of tender systems in certain countries.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Developments</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Biocon Biologics Agreement</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 28, 2022, the Company entered into an agreement to contribute its biosimilars business to Biocon Biologics. Under the terms of the Biocon Agreement, at closing Viatris will receive an up-front cash payment of $2.0 billion, $1.0 billion of convertible preferred equity and up to $335 million as additional cash payments that are expected to be paid in 2024. Viatris will own a stake of at least 12.9% of Biocon Biologics, on a fully-diluted basis, and will have certain priority rights with respect to certain liquidity events. The companies will also enter into a two-year transition services agreement, subject to extension in certain circumstances, during which time Viatris will provide certain commercial and administrative services for an applicable service fee. The transaction is expected to close in the second half of 2022 and is subject to customary closing conditions (including regulatory approvals).</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Share Repurchase Program</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 28, 2022, the Company announced that its Board of Directors had authorized a share repurchase program for the repurchase of up to $1.0 billion of the Company&#8217;s shares of common stock. The Company has not yet repurchased any shares of common stock under the share repurchase program and the share repurchase program does not obligate the Company to acquire any particular amount of common stock.  </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Cyclosporine Ophthalmic Emulsion</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 3, 2022, the Company announced that it had received approval from the FDA for its ANDA for Cyclosporine Ophthalmic Emulsion 0.05%, the first generic version of Allergan's Restasis&#174;. Cyclosporine Ophthalmic Emulsion is indicated to increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associated with keratoconjunctivitis sicca, also known as dry eye. The commercial launch of the product occurred in February 2022.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">SEMGLEE&#174;</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 11, 2020, the FDA approved the SEMGLEE&#174; vial and pen products, which the Company began selling on August 31, 2020. On July 28, 2021, Viatris and Biocon announced that the FDA had approved SEMGLEE&#174; (insulin glargine-yfgn) injection as the first interchangeable biosimilar product under the 351(k) regulatory pathway. The interchangeable SEMGLEE&#174; product, which allows substitution of SEMGLEE&#174; for the reference product, Lantus&#174;, at the pharmacy counter, was launched in the fourth quarter of 2021. The Company has exclusivity for 12 months from launch before the FDA can approve another biosimilar interchangeable to Lantus&#174;. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2020 Restructuring Program</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2020, Viatris announced a significant global restructuring program in order to achieve synergies and ensure that the organization is optimally structured and efficiently resourced to deliver sustainable value to patients, shareholders, customers, and other stakeholders. Viatris&#8217; restructuring initiative incorporates and expands on the restructuring program announced by Mylan N.V. earlier in 2020 as part of its business transformation efforts. As part of the restructuring, the Company is optimizing its commercial capabilities and enabling functions, and closing, downsizing or divesting certain manufacturing facilities globally that are deemed to be no longer viable either due to surplus capacity, challenging market dynamics or a shift in its product portfolio toward more complex products. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the committed restructuring actions, the Company expects to incur total pre-tax charges of up to approximately $1.4&#160;billion. Such charges are expected to include up to approximately $450&#160;million of non-cash charges mainly related to accelerated depreciation and asset impairment charges, including inventory write-offs. The remaining estimated cash costs of up to approximately $950&#160;million are expected to be primarily related to severance and employee benefits expense, as well as other costs, including those related to contract terminations and other plant disposal costs. In addition, management believes the potential annual savings related to these committed restructuring activities to be up to approximately $900&#160;million once fully implemented, with most of these savings expected to improve operating cash flow.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impact of the Coronavirus Pandemic</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a leading global pharmaceutical company, Viatris is committed to continue doing its part in support of public health needs amid the evolving COVID-19 pandemic. The Company&#8217;s priorities remain protecting the health and safety of our workforce, continuing to produce critically needed medicines, deploying resources and expertise in the fight against COVID-19 through potential prevention and treatment efforts, supporting the communities in which we operate and maintaining the health of our overall business. As a result, many Viatris administrative offices continue operating under work from home protocols and some of our customer facing field personnel continue on a remote engagement model to ensure continued support for healthcare professionals, patient care and access to needed products. Additionally, all of our manufacturing facilities, and those of our key global partners, are currently operational and, at this time, we are not experiencing any significant disruptions. Current inventory levels, both ours and those in our distribution channel, remain in-line with normal levels. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The global spread of COVID-19 has created and continues to create significant volatility, uncertainty and economic disruption affecting the markets we serve, including impacts on supply chain partners, third-party manufacturers, logistics providers and other vendors. The extent to which the COVID-19 pandemic will impact our business, operations and financial results in future periods will depend on numerous evolving factors that are beyond our control and that we may not be able to accurately predict, and could adversely impact our results of operations in future periods.  Due to the Company&#8217;s ability to generate significant cash flows from operations, combined with our access to borrowing facilities and capital markets, we believe that we currently have, and will maintain, the ability to meet foreseeable liquidity needs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Results of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Part II. Item 7.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_109"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Summary</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below is a summary of the Company&#8217;s financial results for the year ended December&#160;31, 2021 compared to the prior year period:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:53.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions, except per share amounts and %s)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,886.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,946.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,940.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,575.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,796.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,778.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(210.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">nm</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,269.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(669.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(599.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted loss per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.05)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A detailed discussion of the Company&#8217;s financial results can be found below in the section titled &#8220;Results of Operations.&#8221; As part of this discussion, we also report sales performance using the non-GAAP financial measures of &#8220;constant currency&#8221; net sales and total revenues. These measures provide information on the change in net sales and total revenues assuming that foreign currency exchange rates had not changed between the prior and current period. The comparisons presented at constant currency rates reflect comparative local currency sales at the prior year&#8217;s foreign exchange rates. We routinely evaluate our net sales and total revenues performance at constant currency so that sales results can be viewed without the impact of foreign currency exchange rates, thereby facilitating a period-to-period comparison of our operational activities, and believe that this presentation also provides useful information to investors for the same reason.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">More information about non-GAAP measures used by the Company as part of this discussion, including adjusted cost of sales, adjusted gross margins, adjusted net earnings, and adjusted EBITDA (all of which are defined below) are discussed further in this Part II. Item 7 under </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Results of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Results of Operations &#8212; Use of Non-GAAP Financial Measures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_112"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_115"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021 Compared to 2020</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:30.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.654%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 6.62pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions, except %s)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021 Currency Impact </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021 Constant Currency Revenues</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Constant Currency % Change </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed Markets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,428.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,510.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(185.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,243.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater China</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,212.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">nm</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,203.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">nm</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JANZ</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,027.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,195.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,024.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Markets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,144.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,853.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,135.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,813.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,819.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(206.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,607.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenues </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated total revenues </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,886.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,946.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(207.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,678.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Currency impact is shown as unfavorable (favorable).</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">The constant currency percentage change is derived by translating net sales or revenues for the current period at prior year comparative period exchange rates, and in doing so shows the percentage change from 2021 constant currency net sales or revenues to the corresponding amount in the prior year.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">For the year ended December&#160;31, 2021, other revenues in Developed Markets, JANZ, and Emerging Markets were approximately $51.0 million, $1.5 million, and $20.2 million, respectively.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Amounts exclude intersegment revenue which eliminates on a consolidated basis.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Total Revenues</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2021, the Company reported total revenues of $17.89 billion, compared to $11.95 billion for the comparable prior year period, representing an increase of $5.94 billion, or 50%. Total revenues include both net sales and other revenues from third parties. Net sales for the year ended December&#160;31, 2021 were $17.81 billion, compared to $11.82 billion for the comparable prior year period, representing an increase of $5.99 billion, or 51%. Other revenues for the year ended December&#160;31, 2021 were $72.7 million, compared to $126.1 million for the comparable prior year period, a decrease of $53.4 million.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in net sales was primarily driven by the incremental net sales from the Upjohn Business totaling $5.80 billion and the favorable impact of foreign currency translation, primarily reflecting changes in the U.S. Dollar as compared to the currencies of subsidiaries in countries within the EU, of approximately $206.4 million, or 2%. New product sales of $698.7 million were offset by a decrease in net sales from existing products as a result of lower pricing and volumes of $710.9 million. New product sales include new products launched in 2021 and the carryover impact of new products, including business development, launched within the last twelve months. We estimate that the COVID-19 pandemic positively impacted our 2021 net sales compared to the prior year by approximately 2%, primarily driven by a partial recovery of customer buying patterns in the current year.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, a limited number of our products may represent a significant portion of our net sales, gross profit and net earnings. Generally, this is due to the timing of new product introductions and the amount, if any, of additional competition in the market. Our top ten products in terms of net sales, in the aggregate, represented approximately 33% and 23% for the years ended December&#160;31, 2021 and 2020, respectively, with the year over year increase a result of the Combination. This percentage may fluctuate based upon the timing of new product launches, seasonality and the impact of competition. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales are derived from our four reporting segments: Developed Markets, Greater China, JANZ and Emerging Markets.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Developed Markets Segment</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales from Developed Markets increased by $1.92 billion or 23% during the year ended December 31, 2021 when compared to the prior year. Net sales within North America totaled approximately $4.59 billion and net sales within Europe totaled approximately $5.84 billion. This increase was primarily the result of the incremental net sales from the Upjohn Business in the current year of $1.83 billion and new product sales, including the portfolio of thrombosis products in Europe acquired from Aspen in the fourth quarter of 2020. This increase was partially offset by lower pricing and volumes on net sales of existing products, including Wixela&#174; Inhub&#174;, Perforomist&#174;, Xulane&#174;, and Miacalcin&#174; within the U.S., due to additional competition. Lower volumes were also due to the impact of product divestitures, including certain North American OTC products during the second quarter of 2021 and other products during 2020 as a result of the Combination. The favorable impact of foreign currency translation on current period net sales was approximately $185.1 million, or 2%. Constant currency net sales increased by approximately $1.73 billion, or 20% when compared to the prior year.</span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Greater China Segment</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales from Greater China increased by $1.95 billion for the year ended December 31, 2021 when compared to the prior year. This increase was primarily the result of the incremental net sales from the Upjohn Business of $1.93 billion. The favorable impact of foreign currency translation was approximately $9.3 million or 4%. Constant currency net sales increased by approximately $1.94 billion when compared to the prior year. </span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">JANZ Segment</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales from JANZ increased by $832.1 million or 70% for the year ended December 31, 2021 when compared to the prior year. This increase was primarily the result of the incremental net sales from the Upjohn Business of $666.6 million, and higher net sales of existing products driven by higher volumes primarily related to Amitiza&#174; and Creon&#174;, as well as the impact of the termination of the collaboration arrangement with Pfizer in the prior year in Japan. These increases were partially offset by lower pricing driven by government price reductions and product competition. Foreign currency translation had a favorable impact of approximately $2.7 million, or less than 1%. Constant currency net sales increased by approximately $829.4 million, or 69% when compared to the prior year. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Emerging Markets Segment</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales from Emerging Markets increased by $1.29 billion or 70% for the year ended December 31, 2021 when compared to the prior year. This increase was primarily the result of the incremental net sales from the Upjohn Business of $1.37 billion and COVID-19 related product sales in India, primarily remdesivir and ambisome. These increases were partially offset by lower volumes and, to a lesser extent, pricing as a result of customer purchasing patterns and competitive market conditions, including for ARV products. The increase in net sales was partially offset by the favorable impact of foreign currency translation of $9.3 million, or less than 1%. Constant currency net sales increased by approximately $1.28 billion, or 69%. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Sales and Gross Profit</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales increased from $8.15 billion for the year ended December&#160;31, 2020 to $12.31 billion for the year ended December 31, 2021. Cost of sales was primarily impacted by purchase accounting related amortization of acquired intangible assets and other special items, which are described further in the section titled </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Non-GAAP Financial Measures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Additional incremental cost of sales from the Upjohn Business, including the impact of amortization expense, was $3.57 billion for the year ended December 31, 2021. This includes incremental amortization expense of $2.01 billion primarily for purchase accounting related amortization of intangible assets and the fair value step-up of acquired inventory. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit from net sales of existing products was impacted by lower pricing and to a lesser extent, lower volumes. Gross margins were 31% and 32% for the years ended December&#160;31, 2021 and 2020, respectively. Adjusted gross margins were approximately 59% and 54% for the years ended December&#160;31, 2021 and 2020, respectively, with the year-over-year increase driven by the impact of the Combination.</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation between cost of sales, as reported under U.S. GAAP, and adjusted cost of sales and adjusted gross margin for the year ended December 31, 2021 compared to the year ended December&#160;31, 2020 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:76.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions, except %s)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. GAAP cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,310.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,149.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deduct:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase accounting amortization and other related items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,039.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,933.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition related items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and related costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(534.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(207.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other special items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(333.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(438.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted cost of sales</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,387.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,551.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted gross profit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,499.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,394.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted gross margin </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.8pt">Adjusted gross profit is calculated as total revenues less adjusted cost of sales. Adjusted gross margin is calculated as adjusted gross profit divided by total revenues.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research &amp; Development Expense</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D expense for the year ended December&#160;31, 2021 was $751.1 million, compared to $555.1 million for the prior year, an increase of $196.0 million. This&#160;increase&#160;was primarily due to additional incremental costs associated with the Upjohn Business of $81.7 million, higher expenses related to licensing arrangements for products in development, and increased costs for inventory validation batches for certain products under development.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, General &amp; Administrative Expense</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SG&amp;A expense for the year ended December&#160;31, 2021 was $4.53 billion, compared to $3.34 billion for the prior year, an increase of $1.18 billion. The&#160;increase&#160;was primarily due to additional incremental costs associated with the Upjohn Business of $1.21 billion and an increase of approximately $236.4 million in restructuring costs due to the implementation of the 2020 restructuring program. Partially offsetting these increases were lower selling and promotional expenses, including through our active management related to synergies and certain lower expenses as a result of COVID-19. In addition, the Company incurred lower acquisition related costs of approximately $386.9 million, as the prior year costs included approximately $200.9 million for advisory and consulting fees related to the closing of the Combination, $303.5 million related to the Company&#8217;s obligation to reimburse Pfizer for certain financing and transaction related costs under the BCA and SDA and approximately $69.3 million of employee related to change in control and retention amounts. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation Settlements and Other Contingencies, Net</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes the losses recognized in litigation settlements and other contingencies, net during the years ended December&#160;31, 2021 and 2020, respectively:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"><tr><td style="width:1.0%"></td><td style="width:76.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.849%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.696%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration adjustment (primarily related to respiratory delivery platform)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation settlements, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total litigation settlements and other contingencies, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Litigation settlements in 2021 include a $264.0 million charge for the EpiPen&#174; related settlement.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense for the year ended December&#160;31, 2021 totaled $636.2 million, compared to $497.8 million for the year ended December&#160;31, 2020, an increase of $138.4 million. The&#160;increase&#160;is primarily due to additional incremental interest expense related to the debt assumed in the Combination of approximately $247.6 million, partially offset by amortization of debt premium of $60.1 million and by the impact of debt repayments in 2021.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Expense, Net </span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense (income), net includes losses from equity affiliates, foreign exchange gains and losses, expense (income) related to post-employment benefit plans and interest and dividend income. Other expense (income), net was comprised of the following for the years ended December&#160;31, 2021 and 2020, respectively:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:76.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Losses from equity affiliates, primarily clean energy investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange losses, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other gains, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other expense, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Tax (Benefit) Provision </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2021, the Company recognized an income tax provision of $604.7 million, compared to an income tax benefit of $51.3 million for the comparable prior year, a change in the provision of $656.0 million. The income tax provision for the year ended December&#160;31, 2021 was negatively impacted by the tax rates applied to the reversal of intercompany profit in inventory reserve which was recorded on the opening balance sheet as part of the Combination. This reserve eliminates the profit in inventory related to intercompany transactions and changes to this reserve occur as products are sold to third parties. During the year ended December 31, 2020, the Company recognized a net charge as a result of adjustments to reserves for uncertain tax positions, partially offset by changes in the assessment of the realizability of deferred tax assets. Also impacting the current year income tax expense for both periods was the changing mix of income earned in jurisdictions with differing tax rates.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_1099511630199"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020 Compared to 2019</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discussions of 2019 items and year-to-year comparisons between 2020 and 2019 are not included in this Form 10-K, and can be found in &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in Part II, Item 7 of the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2020.</span></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_121"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Non-GAAP Financial Measures</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Whenever the Company uses non-GAAP financial measures, we provide a reconciliation of the non-GAAP financial measures to their most directly comparable U.S. GAAP financial measure. Investors and other readers are encouraged to review the related U.S. GAAP financial measures and the reconciliation of non-GAAP measures to their most directly comparable U.S. GAAP measure and should consider non-GAAP measures only as a supplement to, not as a substitute for or as a superior measure to, measures of financial performance prepared in accordance with U.S. GAAP. Additionally, since these are not measures determined in accordance with U.S. GAAP, non-GAAP financial measures have no standardized meaning across companies, or as prescribed by U.S. GAAP and, therefore, may not be comparable to the calculation of similar measures or measures with the same title used by other companies.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management uses these measures internally for forecasting, budgeting, measuring its operating performance, and incentive-based awards. Primarily due to acquisitions and other significant events which may impact comparability of our periodic operating results, we believe that an evaluation of our ongoing operations (and comparisons of our current operations with historical and future operations) would be difficult if the disclosure of our financial results was limited to financial measures prepared only in accordance with U.S. GAAP. We believe that non-GAAP financial measures are useful supplemental information for our investors and when considered together with our U.S. GAAP financial measures and the reconciliation to the most directly comparable U.S. GAAP financial measure, provide a more complete understanding of the factors and trends affecting our operations. The financial performance of the Company is measured by senior management, in part, using adjusted metrics as described below, along with other performance metrics. The Company&#8217;s use of such non-GAAP measures is governed by an adjusted reporting policy maintained by the Company and such non-GAAP measures are reviewed in detail with the Audit Committee of the Board of Directors.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Adjusted Cost of Sales and Adjusted Gross Margin</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the non-GAAP financial measure &#8220;adjusted cost of sales&#8221; and the corresponding non-GAAP financial measure &#8220;adjusted gross margin.&#8221; The principal items excluded from adjusted cost of sales include restructuring, acquisition related and other special items and purchase accounting related amortization, which are described in greater detail below.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Adjusted Net Earnings </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted net earnings is a non-GAAP financial measure and provides an alternative view of performance used by management. Management believes that, primarily due to acquisition activity and other significant events, an evaluation of the Company&#8217;s ongoing operations (and comparisons of its current operations with historical and future operations) would be difficult if the disclosure of its financial results were limited to financial measures prepared only in accordance with U.S. GAAP. Management believes that adjusted net earnings is an important internal financial metric related to the ongoing operating performance of the Company, and is therefore useful to investors and that their understanding of our performance is enhanced by this measure. Actual internal and forecasted operating results and annual budgets used by management include adjusted net earnings.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EBITDA and Adjusted EBITDA </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EBITDA and adjusted EBITDA are non-GAAP financial measures that the Company believes are appropriate to provide additional information to investors to demonstrate the Company&#8217;s ability to comply with financial debt covenants and assess the Company&#8217;s ability to incur additional indebtedness. The Company also believes that adjusted EBITDA better focuses management on the Company&#8217;s underlying operational results and true business performance and, is used, in part, for management&#8217;s incentive compensation. We calculate EBITDA as U.S. GAAP net earnings (loss) adjusted for net contribution attributable to equity method investments, income tax provision (benefit), interest expense and depreciation and amortization. EBITDA is further adjusted for share-based compensation expense, litigation settlements and other contingencies, net, and restructuring, acquisition related and other special items to determine adjusted EBITDA. These adjustments are generally permitted under our credit agreement in calculating adjusted EBITDA for determining compliance with our debt covenants.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant items excluded from adjusted cost of sales, adjusted net earnings, and adjusted EBITDA include:</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Purchase Accounting Amortization and Other Related Items</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ongoing impact of certain amounts recorded in connection with acquisitions of both businesses and assets is excluded from adjusted cost of sales, adjusted net earnings, and adjusted EBITDA. These amounts include the amortization of intangible assets, inventory step-up, property, plant and equipment step-up, and intangible asset impairment charges, including for in-process research and development. For the acquisition of businesses accounted for under the provisions of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC 805, Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, these purchase accounting impacts are excluded regardless of the financing method used for the acquisitions, including the use of cash, long-term debt, the issuance of common stock, contingent consideration or any combination thereof.</span></div><div style="margin-bottom:12pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Upfront and Milestone-Related R&amp;D Expenses</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These expenses and payments are excluded from adjusted net earnings and adjusted EBITDA because they generally occur at irregular intervals and are not indicative of the Company&#8217;s ongoing operations.</span></div><div style="margin-bottom:12pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accretion of Contingent Consideration Liability and Other Fair Value Adjustments</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact of changes to the fair value of contingent consideration and accretion expense are excluded from adjusted net earnings and adjusted EBITDA because they are not indicative of the Company&#8217;s ongoing operations due to the variability of the amounts and the lack of predictability as to the occurrence and/or timing and management believes their exclusion is helpful to understanding the underlying, ongoing operational performance of the business.</span></div><div style="margin-bottom:12pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-based Compensation Expense</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense is excluded from adjusted net earnings and adjusted EBITDA. Our share-based compensation programs have become increasingly weighted toward performance-based compensation, which leads to variability and to a lack of predictability as to the occurrence and/or timing of amounts incurred. As such, management believes the exclusion of such amounts on an ongoing basis is helpful to understanding the underlying operational performance of the business. </span></div><div style="margin-bottom:12pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restructuring, Acquisition Related and Other Special Items</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs related to restructuring, acquisition and integration activities and other actions are excluded from adjusted cost of sales, adjusted net earnings and adjusted EBITDA, as applicable. These amounts include items such as: </span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Costs related to formal restructuring programs and actions, including costs associated with facilities to be closed or divested, employee separation costs, impairment charges, accelerated depreciation, incremental manufacturing variances, equipment relocation costs, decommissioning and other restructuring related costs; </span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Certain acquisition related remediation and integration and planning costs, as well as other costs associated with acquisitions such as advisory and legal fees, certain financing related costs, certain reimbursements related to the Company&#8217;s obligation to reimburse Pfizer for certain financing and transaction related costs under the BCA and SDA, certain other TSA related exit costs, and other business transformation and/or optimization initiatives, which are not part of a formal restructuring program, including employee separation and post-employment costs; </span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The pre-tax loss of the Company&#8217;s clean energy investments, whose activities qualify for income tax credits under the Code; only included in adjusted net earnings is the net tax effect of the entity&#8217;s activities;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Other costs, incurred from time to time, related to certain special events or activities that lead to gains or losses, including, but not limited to, incremental manufacturing variances, asset write-downs, or liability adjustments;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Certain costs to further develop and optimize our global enterprise resource planning systems, operations and supply chain; and</span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of changes related to uncertain tax positions and certain impacts related to the Combination are excluded from adjusted net earnings. In addition, tax adjustments to adjusted earnings are recorded to present items on an after-tax basis consistent with the presentation of adjusted net earnings.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has undertaken restructurings and other optimization initiatives of differing types, scope and amount during the covered periods and, therefore, these charges should not be considered non-recurring; however, management excludes these amounts from adjusted net earnings and adjusted EBITDA because it believes it is helpful to understanding the underlying, ongoing operational performance of the business.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation Settlements, Net</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Charges and gains related to legal matters, such as those discussed in Note 19 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included in Part II. Item 8 of this Form 10-K are generally excluded from adjusted net earnings and adjusted EBITDA. Normal, ongoing defense costs of the Company made in the normal course of our business are not excluded.</span></div><div style="margin-bottom:3pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reconciliation of U.S. GAAP Net (Loss) Earnings to Adjusted Net Earnings</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation between net (loss) earnings as reported under U.S. GAAP, and adjusted net earnings for the periods shown follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:71.960%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.124%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.952%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.100%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. GAAP net (loss) earnings</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,269.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(669.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase accounting related amortization (primarily included in cost of sales) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,039.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,933.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,767.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation settlements and other contingencies, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense (primarily amortization of premiums and discounts on long term debt)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clean energy investments pre-tax loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition related costs (primarily included in SG&amp;A) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">613.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">899.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other special items included in:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(d)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">438.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (e)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effect of the above items and other income tax related items</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (f)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(343.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(589.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(380.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted net earnings</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,467.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,371.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,280.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant items for the year ended December&#160;31, 2021 include the following:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(a</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ncludes amortization of the purchase accounting inventory fair value adjustment related to the Combination totaling approximately $1.19 billion.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(b)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquisition related costs consist primarily of transaction costs including legal and consulting fees and integration activities.  </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(c)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2021, charges of approximately $534.7 million are included in cost of sales, approximately $13.3 million are included in R&amp;D, and approximately $351.5 million are included in SG&amp;A. Refer to Note 17 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included in Part II. Item 8 of this Form 10-K for additional information.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(d)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs incurred during the year ended December 31, 2021&#160;include incremental manufacturing variances and site remediation activities as a result of the activities at the Company&#8217;s Morgantown plant of approximately $123.4&#160;million, and at other plants in the 2020 restructuring program of approximately $143.3&#160;million. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(e)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjustments primarily relate to non-refundable payments related to development partner agreements.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(f)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted for changes for uncertain tax positions and for certain impacts of the Combination. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:3pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reconciliation of U.S. GAAP Net (Loss) Earnings to EBITDA and Adjusted EBITDA</span></div><div style="margin-bottom:3pt;text-indent:13.5pt"><span><br/></span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a reconciliation of U.S. GAAP net (loss) earnings to EBITDA and adjusted EBITDA for the year ended December&#160;31, 2021 compared to the prior year periods:</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.642%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. GAAP net (loss) earnings</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,269.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(669.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add / (deduct) adjustments:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net contribution attributable to equity method investments</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision (benefit)</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">636.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">517.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,506.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,216.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,019.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EBITDA</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,540.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,041.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,753.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add / (deduct) adjustments:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation settlements and other contingencies, net</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, acquisition related and other special items </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,445.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,426.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">751.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,426.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,654.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,539.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Includes amortization of premiums and discounts on long-term debt.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(b)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Includes purchase accounting related amortization.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(c)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See items detailed in the Reconciliation of U.S. GAAP Net (Loss) Earnings to Adjusted Net Earnings.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_124"></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary source of liquidity is net cash provided by operating activities, which was $3.02 billion for the year ended December&#160;31, 2021. We believe that net cash provided by operating activities and available liquidity will continue to allow us to meet our needs for working capital, capital expenditures, interest and principal payments on debt obligations, and dividend payments. Nevertheless, our ability to satisfy our working capital requirements and debt service obligations, fund planned capital expenditures, or dividend payments, will substantially depend upon our future operating performance (which will be affected by prevailing economic conditions), and financial, business and other factors, some of which are beyond our control.</span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Activities</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by operating activities increased by $1.79 billion to $3.02 billion for the year ended December&#160;31, 2021, as compared to net cash provided by operating activities of $1.23 billion for the year ended December&#160;31, 2020. Net cash provided by operating activities is derived from net (loss) earnings adjusted for non-cash operating items, gains and losses attributed to investing and financing activities and changes in operating assets and liabilities resulting from timing differences between the receipts and payments of cash, including changes in cash primarily reflecting the timing of cash collections from customers, payments to vendors and employees and tax payments in the ordinary course of business.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in net cash provided by operating activities was principally due to higher operating earnings after adjusting for non-cash operating items. Non-cash operating items increased significantly during the year reflecting the impacts of purchase accounting related to the Combination and non-cash charges related to the ongoing restructuring initiatives. In addition, net cash provided by operating activities was unfavorably impacted in 2021 by changes in operating assets and liabilities. </span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing Activities</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities was $117.8 million for the year ended December&#160;31, 2021, as compared to net cash used in investing activities of $301.1 million for the year ended December&#160;31, 2020, a decrease of $183.3 million. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">In 2021, significant items in investing activities included the following: </span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">cash received from acquisitions, net totaling approximately $277.0 million related to additional target cash balances received from Pfizer subsequent to the closing of the Combination;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">proceeds from the sale of assets of $96.7 million, primarily related to a group of OTC products in the U.S.; and</span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">capital expenditures, primarily for equipment and facilities, totaling approximately $457.2 million. While there can be no assurance that current expectations will be realized, capital expenditures for the 2022 calendar year are expected to be approximately $525 million to $675 million.</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">In 2020, significant items in investing activities included the following:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">cash received from acquisitions, net totaling approximately $415.8 million primarily related to the cash received as part of the Combination;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">payments for product rights and other, net totaling approximately $438.2 million, primarily related to the acquisition of Aspen&#8217;s thrombosis product portfolio in Europe along with other acquisitions of intellectual property rights and marketing authorizations; and</span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">capital expenditures, primarily for equipment and facilities, totaling approximately $243.0 million.</span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financing Activities</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in financing activities was $3.01 billion for the year ended December&#160;31, 2021, as compared to net cash used in financing activities of $605.7 million for the year ended December&#160;31, 2020, an increase of $2.41 billion. </span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">In 2021, significant items in financing activities included the following: </span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">long-term debt payments of approximately $4.20 billion, consisting of the redemption of $2.25 billion of the 3.150% Senior Notes due 2021, repayment of $1.35 billion of borrowings under the 2020 Revolving Facility and the 2021 Revolving Facility, and repayment of $600.0 million of the USD Term Loan;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">long-term borrowings of $1.71 billion, consisting of borrowings of $1.35 billion under the 2020 Revolving Facility and the 2021 Revolving Facility, and borrowings of $360.0 million under the YEN Term Loan; </span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">net short-term borrowings of $392.1 million;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">deferred non-contingent payments for product rights totaling approximately $456.0 million primarily related to the acquisition of Aspen&#8217;s thrombosis product portfolio in Europe; and</span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">cash dividends paid of $399.0 million.</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">In 2020, significant items in financing activities included the following:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">net short-term and long-term borrowings of $2.08 billion; </span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">long-term debt payments of approximately $2.48 billion, consisting primarily of repayment at maturity of &#8364;500.0 million principal amount of Floating Rate Euro Notes due May 2020, repayment at maturity of &#8364;750.0 million principal amount of Euro Senior Notes due November 2020, repayment of $983.0 million of borrowings under the 2020 Revolving Facility and repayment at maturity of $50.0 million principal amount of Senior Notes due 2020; and</span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">payments totaling approximately $48.5 million (of the $111.8 million) in profit share payments related to the respiratory delivery platform contingent consideration. The remaining payments related to the respiratory delivery platform contingent consideration are included as a component of other operating assets and liabilities, net within net cash from operating activities.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to the consolidated statements of cash flows in Part II. Item 8 of this Form 10-K for additional details on other significant sources and uses of cash during the years ended December&#160;31, 2021 and 2020.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Capital Resources </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash and cash equivalents totaled $701.2 million at December&#160;31, 2021, and the majority of these funds are held by our non-U.S. subsidiaries. The Company anticipates having sufficient liquidity, including existing borrowing capacity under the 2021 Revolving Facility, Commercial Paper Program and the Receivables Facility and the Note Securitization Facility combined with cash to be generated from operations, to fund foreseeable cash needs without requiring the repatriation of non-U.S. cash. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, Viatris filed a registration statement with the SEC with respect to an offer to exchange up to $7.45 billion aggregate principal amount of Unregistered Upjohn U.S Dollar Notes with Registered Upjohn Notes in the same aggregate principal amount and with terms substantially identical in all material respects, which was declared effective on September 28, 2021. The exchange offer expired on October 28, 2021 and settled on October 29, 2021. More than 99.9% of the aggregate principal amount of the Unregistered Upjohn U.S. Dollar Notes were exchanged for Registered Upjohn Notes.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, Viatris entered into (i) the YEN Term Loan Facility and (ii) the 2021 Revolving Facility with various syndicates of banks. The 2021 Revolving Facility amended and restated the 2020 Revolving Facility and proceeds from the 2021 Revolving Facility were used to repay outstanding obligations under the 2020 Revolving Facility and the 2020 Revolving Facility was terminated. Proceeds from the YEN Term Loan Facility and the 2021 Revolving Facility were also used to repay the USD Term Loan Facility in full and the USD Term Loan Facility was terminated. The 2021 Revolving Facility and the YEN Term Loan Facility have substantially identical terms to the 2020 Revolving Facility and USD Term Loan Facility, respectively, with the following exceptions: 1) the maturity of both the YEN Term Loan Facility and the 2021 Revolving Facility is July 2026, 2) the pricing was adjusted to reflect current market prices (which were generally more favorable) and 3) the maximum leverage ratio as of the end of any quarter was set at 4.25 to 1.00 for each quarter ending after June 30, 2021 through and including June 30, 2022, 4.0 to 1.00 for each quarter ending after June 30, 2022 through and including December 31, 2022 and 3.75 to 1.00 thereafter, except in circumstances as defined in the related credit agreement.  </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has access to $4.0 billion under the 2021 Revolving Facility which matures in July 2026. Up to $1.65 billion of the 2021 Revolving Facility may be used to support borrowings under our Commercial Paper Program. As of December&#160;31, 2021, the Company had $1.17 billion outstanding under the Commercial Paper Program and did not have any borrowings outstanding under the 2021 Revolving Facility. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the 2021 Revolving Facility, MPI, a wholly owned subsidiary of the Company, has access to $400 million under the Receivables Facility, which expires in April 2022. As of December&#160;31, 2021, the Company had $318.5 million outstanding under the Receivables Facility.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the Company entered into the Note Securitization Facility for borrowings up to $200 million, which was amended on July 1, 2021 to extend the term to August 2022. As of December 31, 2021, the Company did not have any borrowings outstanding under the Note Securitization Facility.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of each of the Receivables Facility and Note Securitization Facility, certain of our accounts receivable secure the amounts borrowed and cannot be used to pay our other debts or liabilities. The amount that we may borrow at a given point in time is determined based on the amount of qualifying accounts receivable that are present at such point in time. Borrowings outstanding under the Receivables Facility bear interest at a commercial paper rate plus 0.925% and under the Note Securitization Facility at a rate per annum quoted from time to time by MUFG Bank, Ltd. plus 0.85% and are included as a component of short-term borrowings, while the accounts receivable securing these obligations remain as a component of accounts receivable, net, in our consolidated balance sheets. In addition, the agreements governing the Receivables Facility and Note Securitization Facility contain various customary affirmative and negative covenants, and customary default and termination provisions.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into accounts receivable factoring agreements with financial institutions to sell certain of our non-U.S. accounts receivable. These transactions are accounted for as sales and result in a reduction in accounts receivable because the agreements transfer effective control over and risk related to the receivables to the buyers. Our factoring agreements do not allow for recourse in the event of uncollectibility, and we do not retain any interest in the underlying accounts receivable once sold. We derecognized $29.6 million and $153.0 million of accounts receivable as of December&#160;31, 2021 and 2020 under these factoring arrangements, respectively.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are continuously evaluating the potential acquisition of products, as well as companies, as a strategic part of our future growth. Consequently, we may utilize current cash reserves or incur additional indebtedness to finance any such acquisitions, which could impact future liquidity. Also, on an ongoing basis, we review our operations including the evaluation of potential divestitures of products and businesses as part of our future strategy. Any divestitures could impact future liquidity. In addition, we plan to continue to explore various other ways to create, enhance or otherwise unlock the value of the Company&#8217;s unique global platform in order to create shareholder value.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For information regarding our dividends paid and declared, refer to Note 2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Part II. Item 8 of this Form 10-K.</span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term Debt Maturity</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For information regarding our debt agreements and mandatory minimum repayments remaining on the outstanding notional amount of long-term debt at December&#160;31, 2021, refer to Note 10 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Part II. Item 8 of this Form 10-K.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The YEN Term Loan Facility and the 2021 Revolving Facility contain customary affirmative covenants for facilities of this type, including among others, covenants pertaining to the delivery of financial statements, notices of default and certain material events, maintenance of corporate existence and rights, property, and insurance and compliance with laws, as well as customary negative covenants for facilities of this type, including limitations on the incurrence of subsidiary indebtedness, liens, mergers and certain other fundamental changes, investments and loans, acquisitions, transactions with affiliates, payments of dividends and other restricted payments and changes in our lines of business.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is in compliance with its covenants at December&#160;31, 2021 and expects to remain in compliance for the next twelve months.</span></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Supplemental Guarantor Financial Information</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Viatris Inc. is the issuer of the Registered Upjohn Notes, which are fully and unconditionally guaranteed on a senior unsecured basis by Mylan Inc., Mylan II B.V. and Utah Acquisition Sub Inc. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the Combination, Utah Acquisition Sub Inc. is the issuer of the Utah U.S. Dollar Notes, which are fully and unconditionally guaranteed on a senior unsecured basis by Mylan Inc., Viatris Inc. and Mylan II B.V.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mylan Inc. is the issuer of the Mylan Inc. U.S. Dollar Notes, which are fully and unconditionally guaranteed on a senior unsecured basis by Mylan II B.V., Viatris Inc. and Utah Acquisition Sub Inc.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The respective obligations of Viatris Inc., Mylan Inc., Utah Acquisition Sub Inc., and Mylan II B.V. as guarantors of the applicable series of Senior U.S. Dollar Notes are senior unsecured obligations of the applicable guarantor and rank </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">pari passu</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in right of payment with all of such guarantor&#8217;s existing and future senior unsecured obligations that are not expressly subordinated to such guarantor&#8217;s guarantee of the applicable series of Senior U.S. Dollar Notes, rank senior in right of payment to any future obligations of such guarantor that are expressly subordinated to such guarantor&#8217;s guarantee of the applicable series of Senior U.S. Dollar Notes, and are effectively subordinated to such guarantor&#8217;s existing and future secured obligations to the extent of the value of the collateral securing such obligations. Such obligations are structurally subordinated to all of the existing and future liabilities, including trade payables, of the existing and future subsidiaries of such guarantor that do not guarantee the applicable series of Senior U.S. Dollar Notes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The guarantees by Mylan Inc., Mylan II B.V. and Utah Acquisition Sub Inc. under the applicable series of Senior U.S. Dollar Notes will terminate under certain customary circumstances, each as described in the applicable indenture, including: (1) a sale or disposition of the applicable guarantor in a transaction that complies with the applicable indenture such that such guarantor ceases to be a subsidiary of the issuer of the applicable series of Senior U.S. Dollar Notes; (2) legal defeasance or covenant defeasance or if the issuer&#8217;s obligations under the applicable indenture are discharged; (3) with respect to the Utah U.S. Dollar Notes, the earlier to occur of (i) with respect to the guarantee provided by Mylan Inc., (x) the release of Utah Acquisition Sub Inc.&#8217;s guarantee under all applicable Mylan Inc. Debt (as defined in the applicable indenture) and (y) Mylan Inc. no longer having any obligations in respect of any Mylan Inc. Debt and (ii) with respect to the guarantee provided by Mylan II B.V., (x) the release of Mylan II B.V.&#8217;s guarantee under all applicable Triggering Indebtedness (as defined in the applicable indenture) and (y) the issuer and/or borrower of the applicable Triggering Indebtedness no longer having any obligations with respect to such Triggering Indebtedness; (4) with respect to the guarantees provided by Utah Acquisition Sub Inc. and Mylan II B.V. of the Mylan Inc. U.S. Dollar Notes, subject to certain exceptions set forth in the applicable indenture, such guarantor ceasing to be a guarantor or obligor in respect of any Triggering Indebtedness; and (5) with respect to the Registered Upjohn Notes, (a) upon the applicable guarantor no longer being an issuer or guarantor in respect of (i) Mylan Notes (as defined in the indenture governing the Registered Upjohn Notes) that have an aggregate principal amount in excess of $500.0 million or (ii) any Triggering Indebtedness; in each case, other than in respect of indebtedness or guarantees, as applicable, that are being concurrently released; or (b) upon receipt of the consent of holders of a majority of the aggregate principal amount of the outstanding notes of such series in accordance with the indenture governing the Registered Upjohn Notes.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The guarantee obligations of Viatris Inc., Mylan Inc., Utah Acquisition Sub Inc., and Mylan II B.V. under the Senior U.S. Dollar Notes are subject to certain limitations and terms similar to those applicable to other guarantees of similar instruments, including that (i) the guarantees are subject to fraudulent transfer and conveyance laws and (ii) each guarantee is limited in amount to an amount not to exceed the maximum amount that can be guaranteed by the applicable guarantor without rendering the guarantee, as it relates to such guarantor, voidable under applicable fraudulent transfer and conveyance laws or similar laws affecting the rights of creditors generally. </span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents unaudited summarized financial information of Viatris Inc., Mylan Inc., Utah Acquisition Sub Inc., and Mylan II B.V. on a combined basis as of and for the year ended December&#160;31, 2021 and 2020. All intercompany balances have been eliminated in consolidation. This unaudited combined summarized financial information is presented utilizing the equity method of accounting.</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:67.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.341%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.342%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Combined Summarized Balance Sheet Information of Viatris Inc., Mylan Inc., Utah Acquisition Sub Inc. and Mylan II B.V. </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,298.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,272.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND EQUITY</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,619.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,951.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,465.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,844.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.253%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Combined Summarized Income Statement Information of Viatris Inc., Mylan Inc., Utah Acquisition Sub Inc. and Mylan II B.V. </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,023.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(929.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,269.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(669.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Commitments</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved in various disputes, governmental and/or regulatory inquiries, investigations and proceedings, tax proceedings and litigation matters, both in the U.S. and abroad, that arise from time to time, some of which could result in losses, including damages, fines and/or civil penalties, and/or criminal charges against the Company. These matters are often complex and have outcomes that are difficult to predict. We have approximately $609 million accrued for legal contingencies at December&#160;31, 2021.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company believes that it has meritorious defenses with respect to the claims asserted against it and the assumed legal matters referenced above, and intends to vigorously defend its position, the process of resolving these matters is inherently uncertain and may develop over a long period of time, and so it is not possible to predict the ultimate resolution of any such matter. It is possible that an unfavorable resolution of any of the ongoing matters could have a material effect on the Company&#8217;s business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the Combination, Viatris entered into a TSA with Pfizer pursuant to which each party will provide certain limited transition services to the other party generally for an initial period of 24 months from closing date of the Combination. In addition to the monthly service fees under the TSA, Viatris has agreed to reimburse Pfizer for fifty percent of the costs, up to the first $380&#160;million incurred, to establish and wind down the TSA services. Viatris will be required to fully reimburse Pfizer for total costs in excess of $380&#160;million. During the years ended December&#160;31, 2021 and 2020, the Company incurred $30.4&#160;million and $53.1&#160;million, respectively, related to this provision of the TSA, and approximately $83.5&#160;million during the period beginning on the closing date of the Combination and ended December 31, 2021.</span></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_127"></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021, our material cash requirements from known contractual and other obligations primarily relate to repayment of outstanding borrowings and interest, open purchase orders, post-employment benefit plans, unrecognized tax benefits, capital expenditures, dividends and leases. For additional information, refer to Notes 2, 6, 10, 12, 14, and 16 in Part II. Item 8 of this Form 10-K. We anticipate our cash requirements related to ordinary course purchases of goods and services will be consistent with our past levels. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, Viatris periodically enters into employment, legal settlement and other agreements which incorporate indemnification provisions. While the maximum amount to which Viatris may be exposed under such agreements cannot be reasonably estimated, the Company maintains insurance coverage, which management believes will effectively mitigate the Company&#8217;s obligations under these indemnification provisions. No amounts have been recorded in the consolidated financial statements with respect to the Company&#8217;s obligations under such agreements.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into employment and other agreements with certain executives and other employees that provide for compensation and certain other benefits. These agreements provide for severance payments under certain circumstances. </span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Licensing and Other Partner Agreements</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our licensing and other partner agreements, our potential maximum development milestones not accrued for at December&#160;31, 2021 totaled approximately $351 million. We estimate that the amounts that may be paid during the next twelve months to be approximately $18 million. Additionally, these agreements may also include potential sales-based milestones and call for us to pay a percentage of amounts earned from the sale of the product as a royalty or a profit share. Refer to Note 18 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Licensing and Other Partner Agreements </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">included in Part II. Item 8 of this Form&#160;10-K for additional information.</span></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_130"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Application of Critical Accounting Policies</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our significant accounting policies are described in Note&#160;2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">included in Part II. Item 8 of this Form 10-K and are in accordance with U.S. GAAP.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included within these policies are certain policies which contain critical accounting estimates and, therefore, have been deemed to be &#8220;critical accounting policies.&#8221; Critical accounting estimates are those which require management to make assumptions about matters that were uncertain at the time the estimate was made and for which the use of different estimates, which reasonably could have been used, or changes in the accounting estimates that are reasonably likely to occur from period to period could have a material impact on our financial condition or results of operations. We have identified the following to be our critical accounting policies: the determination of net revenue provisions, acquisitions, intangible assets, goodwill and contingent consideration, income taxes and the impact of existing legal matters.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenues in accordance with ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Under ASC 606, the Company recognizes net revenue for product sales when control of the promised goods or services is transferred to our customers in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. Revenues are recorded net of provisions for variable consideration, including discounts, rebates, governmental rebate programs, price adjustments, returns, chargebacks, promotional programs and other sales allowances. Accruals for these provisions are presented in the consolidated financial statements as reductions in determining net sales and as a contra asset in accounts receivable, net (if settled via credit) and other current liabilities (if paid in cash). Amounts recorded for revenue deductions can result from a complex series of judgements about future events and uncertainties and can rely heavily on estimates and assumptions. As such, they have been identified as critical accounting estimates. The following section briefly describes the nature of our provisions for variable consideration and how such provisions are estimated:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Chargebacks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: the Company has agreements with certain indirect customers, such as independent pharmacies, retail pharmacy chains, managed care organizations, hospitals, nursing homes, governmental agencies and pharmacy benefit managers, which establish contract prices for certain products. The indirect customers then independently select a wholesaler from which to purchase the products at these contracted prices. Alternatively, certain wholesalers may enter into agreements with indirect customers that establish contract pricing for certain products, which the wholesalers provide. Under either arrangement, Viatris will provide credit to the wholesaler for any difference between the contracted price with the indirect party and the wholesaler&#8217;s invoice price. Such credits are called chargebacks. The provision for chargebacks is based on expected sell-through levels by our wholesaler customers to indirect customers, as well as estimated wholesaler inventory levels. We continually monitor our provision for chargebacks and evaluate our reserve and estimates as additional information becomes available. A change of 5% would have an effect on our reserve balance of approximately $29.6 million.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Rebates, promotional programs and other sales allowances</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: this category includes rebate and other programs to assist in product sales. These programs generally provide that the customer receives credit directly related to the amount of purchases or credits upon the attainment of pre-established volumes. Also included in this category are prompt pay discounts, administrative fees and price adjustments to reflect decreases in the selling prices of products. A change of 5% would have an effect on our reserve balance of approximately $68.7 million.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Returns</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: consistent with industry practice, Viatris maintains a return policy that allows customers to return a product, which varies country by country in accordance with local practices, generally within a specified period prior (six months) and subsequent (twelve months) to the expiration date. The Company&#8217;s estimate of the provision for returns is generally based upon historical experience with actual returns. Generally, returned products are destroyed and customers are refunded the sales price in the form of a credit. A change of 5% would have an effect on our reserve balance of approximately $34.3 million.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Governmental rebate programs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: government reimbursement programs in the U.S. include Medicare, Medicaid, and State Pharmacy Assistance Programs established according to statute, regulations and policy. Manufacturers of pharmaceutical products that are covered by the Medicaid program are required to pay rebates to each state based on a statutory formula set forth in the Social Security Act. Medicare beneficiaries are eligible to obtain discounted prescription drug coverage from private sector providers. In addition, certain states have also implemented supplemental rebate programs that obligate manufacturers to pay rebates in excess of those required under federal law. Our estimate of these rebates is based on the historical trends of rebates paid as well as on changes in wholesaler inventory levels and increases or decreases in the level of sales. We estimate discounts on branded prescription drug sales to Medicare Part D participants in the Medicare &#8220;coverage gap&#8221; based on historical experience of prescriptions and utilization expected to result in the discount of the &#8220;coverage gap&#8221;.</span></div><div style="margin-bottom:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outside the U.S., the majority of our pharmaceutical sales are contractually or legislatively governed. In certain European countries, certain rebates are calculated on the governments total pharmaceutical spending or on specific product sale thresholds. We utilize historical data and obtain third party information to determine the adequacy of these accruals. Also, this provision includes price reductions that are mandated by law outside of the U.S. </span></div><div style="margin-bottom:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A change of 5% would have an effect on our reserve balance of approximately $20.0 million.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a rollforward of the categories of variable consideration during 2021:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:27.513%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.321%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.699%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.371%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.674%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current Provision Related to Sales Made in the Current Period </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Measurement Period Adjustments and Reclasses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Checks/ Credits Issued to Third Parties </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effects of Foreign Exchange</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chargebacks</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">585.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,530.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,585.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">591.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates, promotional programs and other sales allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,576.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,135.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,267.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,373.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Returns</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">539.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">384.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(499.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">686.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Governmental rebate programs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">689.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(705.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,014.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,739.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,056.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,050.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accruals for these provisions are presented in the consolidated financial statements as reductions in determining net revenues and in accounts receivable and other current liabilities. Accounts receivable are presented net of allowances relating to these provisions, which were comprised of the following at December&#160;31, 2021 and 2020, respectively:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:76.661%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.652%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,688.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,802.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,362.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,211.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,050.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,014.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have not made and do not anticipate making any significant changes to the methodologies that we use to measure provisions for variable consideration; however, the balances within these reserves can fluctuate significantly through the consistent application of our methodologies. Historically, we have not recorded in any current period any material amounts related to adjustments made to prior period reserves. </span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions, Intangible Assets, Goodwill and Contingent Consideration</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for acquired businesses using the acquisition method of accounting in accordance with the provisions of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC 805, Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which requires that the assets acquired and liabilities assumed be recorded at the date of acquisition at their respective estimated fair values. The cost to acquire businesses is allocated to the underlying net assets of the acquired business based on estimates of their respective fair values. Amounts allocated to acquired IPR&amp;D are capitalized at the date of acquisition and, at that time, such IPR&amp;D assets have indefinite lives. As products in development are approved for sale, amounts are allocated to product rights and licenses and will be amortized over their estimated useful lives. Finite-lived intangible assets are amortized over the expected life of the asset. Any excess of the purchase price over the estimated fair values of the net assets acquired is recorded as goodwill. Refer to Note 4 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Other Transactions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">included in Part II. Item 8 of this Form 10-K</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further additional information regarding the Company&#8217;s acquisitions, including the acquisition accounting related to the Combination.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchases of developed products and licenses that are accounted for as asset acquisitions are capitalized as intangible assets and amortized over an estimated useful life. IPR&amp;D assets acquired as part of an asset acquisition are expensed immediately if they have no alternative future uses.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The judgments made in determining the estimated fair value assigned to each class of assets acquired and liabilities assumed, as well as asset lives, can materially impact our results of operations. Fair values and useful lives are determined based on, among other factors, the expected future period of benefit of the asset, the various characteristics of the asset and projected cash flows. Because this process involves management making estimates with respect to future sales volumes, pricing, new product launches, government reform actions, anticipated cost environment and overall market conditions, and because these estimates form the basis for the determination of whether or not an impairment charge should be recorded, these estimates are considered to be critical accounting estimates.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records contingent consideration resulting from business acquisitions at its estimated fair value on the acquisition date. Each reporting period thereafter, the Company revalues these obligations and records increases or decreases in their fair value as adjustments to litigation settlements and other contingencies, net within the consolidated statements of operations. Changes in the fair value of the contingent consideration obligations can result from adjustments to the discount rates, payment periods and adjustments in the probability of achieving future development steps, regulatory approvals, market launches, sales targets and profitability. These fair value measurements represent Level 3 measurements as they are based on significant inputs not observable in the market.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant judgment is employed in determining the assumptions utilized as of the acquisition date and for each subsequent measurement period. Accordingly, changes in the assumptions described above could have a material impact on the Company&#8217;s consolidated financial condition and results of operations.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews goodwill for impairment at least annually or more frequently if events or changes in circumstances indicate that the carrying value of goodwill may not be recoverable based on management&#8217;s assessment of the fair value of the Company&#8217;s reporting units as compared to their related carrying value. Under the authoritative guidance issued by the FASB, we have the option to first assess the qualitative factors to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform a quantitative goodwill impairment test. If we choose to use qualitative factors and determine that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, then the goodwill impairment test would be required. The goodwill impairment test requires the Company to estimate the fair value of the reporting unit and to compare the fair value of the reporting unit with its carrying amount. If the carrying amount is less than its fair value, then no impairment is recognized. If the carrying amount recorded exceeds the fair value calculated, an impairment charge is recorded for the difference. The judgments made in determining the projected cash flows used to estimate the fair value can materially impact the Company&#8217;s financial condition and results of operations.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company performed its annual goodwill impairment test as of April 1, 2021 on a quantitative basis for its five reporting units, North America, Europe, Emerging Markets, JANZ, and Greater China. Additionally, the net assets acquired as part of the Combination were included in the respective reporting units and in the annual impairment test for the first time. In estimating each reporting unit&#8217;s fair value, the Company performed an extensive valuation analysis, utilizing both income and market-based approaches. The determination of the fair value of the reporting units requires the Company to make significant estimates and assumptions that affect the reporting unit&#8217;s expected future cash flows. These estimates and assumptions, utilizing Level 3 inputs, primarily include, but are not limited to, market multiples, control premiums, the discount rate, terminal growth rates, operating income before depreciation and amortization, and capital expenditures forecasts. The following describes the valuation methodologies used to derive the estimated fair value of the reporting units.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Approach</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:&#160;Under this approach, to determine fair value, we discounted the expected future cash flows of each reporting unit. We used a discount rate, which reflected the overall level of inherent risk and the rate of return an outside investor would have expected to earn. To estimate cash flows beyond the final year of our model, we used a terminal value approach. Under this approach, we used EBITDA in the final year of our model, adjusted to estimate a normalized cash flow, applied a perpetuity growth assumption, and discounted by a perpetuity discount factor to determine the terminal value. We incorporated the present value of the resulting terminal value into our estimate of fair value.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Market-Based Approach</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:&#160;The Company also utilizes a market-based approach to estimate fair value, principally utilizing the guideline company method which focuses on comparing our risk profile and growth prospects to a select group of publicly traded companies with reasonably similar guidelines.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April 1, 2021, the allocation of the Company&#8217;s total goodwill was as follows: North America $3.66 billion, Europe $5.15 billion, Emerging Markets $1.58 billion, JANZ $0.82 billion and Greater China $0.70 billion.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April 1, 2021, the Company determined that the fair value of the North America, Emerging Markets and Greater China reporting units was substantially in excess of the respective unit&#8217;s carrying value. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the Europe reporting unit, the estimated fair value exceeded its carrying value by approximately $0.91 billion or 5.8% for the annual goodwill impairment test. As it relates to the income approach for the Europe reporting unit at April 1, 2021, the Company forecasted cash flows for the next 10 years. During the forecast period, the revenue compound annual growth rate was approximately 3.0%. A terminal year value was calculated with a 0.9% revenue growth rate applied. The discount rate utilized was 10.5% and the estimated tax rate was 19.0%. Under the market-based approach, we utilized an estimated range of market multiples of 7.5 to 8.5 times EBITDA plus a control premium of 15.0%. If all other assumptions are held constant, a reduction in the terminal value growth rate by 2.9% or an increase in discount rate by 1.5% would result in an impairment charge for the Europe reporting unit.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the JANZ reporting unit, the estimated fair value exceeded its carrying value by approximately $0.23 billion or 7.0% for the annual goodwill impairment test. As it relates to the income approach for the JANZ reporting unit at April 1, 2021, the Company forecasted cash flows for the next 10 years. During the forecast period, the revenue compound annual growth rate was approximately negative 1.5%. A terminal year value was calculated with a 0.7% revenue growth rate applied. The discount rate utilized was 8.5% and the estimated tax rate was 30.5%. Under the market-based approach, we utilized an estimated market multiple of 6.0 times EBITDA plus a control premium of 15.0%. If all other assumptions are held constant, a reduction in the terminal value growth rate by 4.2% or an increase in discount rate by 2.0% would result in an impairment charge for the JANZ reporting unit.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the inherent uncertainty involved in making these estimates, actual results could differ from those estimates. In addition, changes in underlying assumptions, especially as they relate to the key assumptions detailed, could have a significant impact on the fair value of the reporting units.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values of long-lived assets, which include property, plant and equipment and intangible assets with finite lives, are evaluated periodically in relation to the expected future undiscounted cash flows of the underlying assets and monitored for other potential triggering events. We have assessed the recoverability of certain long-lived assets, principally finite-lived intangible assets, contained within the reporting units whenever certain impairment indicators are present. Any impairment of these assets must be considered prior to our impairment review of goodwill. The assessment for impairment is based on our ability to recover the carrying value of the long-lived assets or asset grouping by analyzing the expected future undiscounted pre-tax cash flows specific to the asset or asset grouping. If the carrying amount is greater than the undiscounted cash flows, the Company recognizes an impairment loss for the excess of the carrying amount over the estimated fair value based on discounted cash flows.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant management judgment is involved in estimating the recoverability of these assets and is dependent upon the accuracy of the assumptions used in making these estimates, as well as how the estimates compare to the eventual future operating performance of the specific asset or asset grouping. For the years ended December&#160;31, 2021, 2020 and 2019, the Company recorded $83.4 million (related to the sale of a group of OTC products in the U.S.), $45.0 million, and $42.3 million, respectively, of impairment charges for finite-lived intangible assets, which were recorded as a component of amortization expense. At December&#160;31, 2021 and 2020, the Company&#8217;s finite-lived intangible assets totaled $26.09 billion and $29.60 billion, respectively. Changes to any of the Company&#8217;s assumptions related to the estimated fair value based on the discounted cash flows, including discount rates or the competitive environment related to the assets, could lead to future material impairment charges. Any future long-lived assets impairment charges could have a material impact on the Company&#8217;s consolidated financial condition and results of operations.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s indefinite-lived intangible assets, principally IPR&amp;D, are tested at least annually for impairment or upon the occurrence of a triggering event. The impairment test for IPR&amp;D consists of a comparison of the asset&#8217;s fair value with its carrying value. Impairment is determined to exist when the fair value of IPR&amp;D assets, which is based upon updated forecasts and commercial development plans, is less than the carrying value of the assets being tested. For the years ended December&#160;31, 2021, 2020 and 2019, the Company recorded $19.4 million, $37.4 million, and $138.3 million, respectively, of impairment charges, which were recorded as a component of amortization expense. At December&#160;31, 2021 and 2020, the Company&#8217;s IPR&amp;D assets totaled $46.5 million and $80.7 million, respectively. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of both IPR&amp;D and finite-lived intangible assets was determined based upon detailed valuations employing the income approach which utilized Level 3 inputs, as defined in Note 9 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments and Risk Management </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">included in Part II. Item 8 of this Form 10-K. Changes to any of the Company&#8217;s assumptions including changes to or abandonment of development programs, regulatory timelines, discount rates or the competitive environment related to the assets could lead to future material impairment charges. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compute our income taxes based on the statutory tax rates and tax reliefs available to Viatris in the various jurisdictions in which we generate income. Significant judgment is required in determining our income taxes and in evaluating our tax positions. We establish reserves in accordance with Viatris&#8217; policy regarding accounting for uncertainty in income taxes. Our policy provides that the tax effects from an uncertain tax position be recognized in Viatris&#8217; financial statements, only if the position is more likely than not of being sustained upon audit, based on the technical merits of the position. We adjust these reserves in light of changing facts and circumstances, such as the settlement of a tax audit. Our provision for income taxes includes the impact of reserve provisions and changes to reserves. Favorable resolution would be recognized as a reduction to our provision for income taxes in the period of resolution or expiration of the underlying statutes of limitation. Based on this evaluation, as of December&#160;31, 2021, our reserve for unrecognized tax benefits totaled  $322.9 million, of which $264.0 million was recorded in connection with the Combination and is subject to Pfizer&#8217;s indemnification obligations to Viatris under the Tax Matters Agreement.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management assesses the available positive and negative evidence to estimate if sufficient future taxable income will be generated to utilize the existing deferred tax assets. A significant piece of objective negative evidence evaluated was the cumulative loss incurred in certain taxing jurisdictions over the three-year period ended December&#160;31, 2021. Such objective evidence limits the ability to consider other subjective evidence such as our projections for future growth.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on this evaluation and other factors, as of December&#160;31, 2021, a valuation allowance of $780.4 million has been recorded in order to measure only the portion of the deferred tax asset that more likely than not will be realized. The amount of the deferred tax asset considered realizable, however, could be adjusted if estimates of future taxable income during the carryforward period are reduced or if objective negative evidence in the form of cumulative losses is no longer present and additional weight may be given to subjective evidence such as projections for growth. When assessing the realizability of deferred tax assets, management considers all available evidence, including historical information, long-term forecasts of future taxable income and possible tax planning strategies. Amounts recorded for valuation allowances can result from a complex series of estimates, assumptions and judgments about future events. Due to the inherent uncertainty involved in making these estimates, assumptions and judgments, actual results could differ materially. Any future increases to the Company&#8217;s valuation allowances could materially impact the Company&#8217;s consolidated financial condition and results of operations. At December&#160;31, 2021 and 2020, the Company&#8217;s net deferred tax assets totaled $1.33 billion and $2.15 billion, respectively. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A variance of 5% between estimated reserves and valuation allowances and actual resolution and realization of these tax items would have an effect on our reserve balance and valuation allowance of approximately $55.1 million.</span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Matters</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Viatris is involved in various legal proceedings, some of which involve claims for substantial amounts. An estimate is made to accrue for a loss contingency relating to any of these legal proceedings if it is probable that a liability was incurred as of the date of the financial statements and the amount of loss can be reasonably estimated. Because of the subjective nature inherent in assessing the outcome of litigation and because of the potential that an adverse outcome in a legal proceeding could have a material adverse effect on our business, financial condition, results of operations, cash flows, and/or ordinary share price, such estimates are considered to be critical accounting estimates.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A variance of 5% between estimated and recorded litigation reserves and actual resolution of certain legal matters would have an effect on our litigation reserve balance of approximately $30.4 million. Refer to Note 19 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">included in Part II. Item 8 of this Form 10-K</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further discussion of litigation matters.</span></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_133"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impact of Currency Fluctuations and Inflation</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because our results are reported in U.S.&#160;Dollars, changes in the rate of exchange between the U.S.&#160;Dollar and the local currencies in the markets in which we operate, mainly the Euro, Indian Rupee, Chinese Renminbi, Japanese Yen, Australian Dollar, Canadian Dollar, Pound&#160;Sterling and South Korean Won affect our results as previously noted. We do not believe that inflation has had a material impact on our revenues or results of operations in any of the past three years. </span></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_136"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in Part II. Item 8 of this Form 10-K for recently adopted accounting pronouncements and recently issued accounting pronouncements not yet adopted.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_139"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 7A.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.14pt">Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Exchange Risk</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A significant portion of our revenues and earnings are exposed to changes in foreign currency exchange rates. We seek to manage this foreign exchange risk in part through operational means, including managing same currency revenues in relation to same currency costs and same currency assets in relation to same currency liabilities.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, foreign exchange risk is managed through the use of foreign currency forward-exchange contracts. These contracts are used to offset the potential earnings effects from mostly intercompany foreign currency assets and liabilities that arise from operations and from intercompany loans. Any unhedged foreign exchange exposures continue to be subject to market fluctuations.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial instrument holdings at year end were analyzed to determine their sensitivity to foreign exchange rate changes. The fair values of these instruments were determined as follows:</span></div><div style="margin-bottom:6pt;padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">foreign currency forward-exchange contracts&#160;&#8212; net present values</span></div><div style="margin-bottom:12pt;padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">foreign currency denominated receivables, payables, debt and loans&#160;&#8212; changes in exchange rates</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In this sensitivity analysis, we assumed that the change in one currency&#8217;s rate relative to the U.S.&#160;Dollar would not have an effect on other currencies&#8217; rates relative to the U.S.&#160;Dollar. All other factors were held constant.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If there were an adverse change in foreign currency exchange rates of 10%, the expected net effect on net income related to Viatris&#8217; foreign currency denominated financial instruments would not be material.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also exposed to translation risk on non-U.S. dollar-denominated net assets. Non-U.S. dollar borrowings, principally our Euro and Yen denominated long-term debt, are used to hedge the foreign currency exposures of our net investment in certain foreign affiliates and are designated as hedges of net investments. The foreign exchange gains or losses on these hedges is included in the foreign currency translation component of accumulated other comprehensive income (loss). If our net investment decreases below the equivalent value of the non-U.S. debt borrowings, the change in the remeasurement basis of the debt would be subject to recognition in net income as changes occur.</span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Rate and Long-Term Debt Risk</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Viatris&#8217; exposure to interest rate risk arises primarily from our U.S.&#160;Dollar and Euro borrowings and U.S. Dollar investments. We invest primarily on a variable-rate basis and we borrow on both a fixed and variable basis. In order to maintain a certain ratio of fixed to variable rate debt, from time to time, depending on market conditions, Viatris will use derivative financial instruments such as interest rate swaps to fix interest rates on variable-rate borrowings or to convert fixed-rate borrowings to variable interest rates.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, Viatris&#8217; outstanding fixed rate borrowings consist principally of $20.60 billion notional amount of senior U.S. dollar and Euro notes. Generally, the fair value of fixed interest rate debt will decrease as interest rates rise and increase as interest rates fall. As of December&#160;31, 2021, the fair value of our outstanding fixed rate senior U.S. dollar and Euro notes was approximately $22.01 billion. A 100 basis point change in interest rates on Viatris&#8217; variable rate debt, net of interest rate swaps, would result in a change in interest expense of approximately $18.4 million per year.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_142"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 8.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:17.36pt">Financial Statements And Supplementary Data</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Index to Consolidated Financial Statements and</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supplementary Financial Information</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:86.162%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_145">Management&#8217;s Report on Internal Control over Financial Reporting</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_145">79</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_148">Reports of Independent Registered Public Accounting Firm</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_148"> </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(PCAOB ID No. <ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="dei:AuditorFirmId" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNDIvZnJhZzpkOGM4MjZjNTEwYzQ0N2I3YTQ1NGMwYjZjOWRhYTdkZi90YWJsZTpmODYzYTA0ZDg0MzY0Zjk3YjE3NTIxZmRhMzg3NTVlZi90YWJsZXJhbmdlOmY4NjNhMDRkODQzNjRmOTdiMTc1MjFmZGEzODc1NWVmXzQtMC0xLTEtNTIwOTMvdGV4dHJlZ2lvbjoxOGE2YzNjYmI5NTk0MjM2OTdhYzZlY2ZmZGQwMTY1MF8xMDk5NTExNjI3ODU2_46fe6219-37b9-4484-bd07-30c2848c21b0">34</ix:nonNumeric>)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_148">80</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_154">Consolidated Balance Sheets as of December&#160;31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_154">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_154"> and 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_154">20</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_154">84</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_157">Consolidated Statements of Operations for the Years Ended December&#160;31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_157">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_157">, 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_157">20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_157">, and 201</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_157">9</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_157">85</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_160">Consolidated Statements of Comprehensive (Loss) Earnings for the Years Ended December 31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_160">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_160">, 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_160">2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_160">0</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_160"> and 201</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_160">9</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_160">86</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_163">Consolidated Statements of Equity for the Years Ended December 31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_163">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_163">, 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_163">20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_163"> and 201</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_163">9</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_163">87</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_166">Consolidated Statements of Cash Flows for the Years Ended December&#160;31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_166">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_166">, 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_166">20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_166"> and 201</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_166">9</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_166">88</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_169">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_169">89</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_145"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Report on Internal Control over Financial Reporting</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management of Viatris Inc. is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America. In order to evaluate the effectiveness of internal control over financial reporting, management has conducted an assessment, including testing, using the criteria in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Internal Control - Integrated Framework</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, issued by COSO. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of this assessment, management has concluded that the Company maintained effective internal control over financial reporting as of December&#160;31, 2021 based on the criteria in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Internal Control - Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> issued by COSO.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our independent registered public accounting firm, Deloitte&#160;&amp; Touche LLP (PCAOB ID No. <ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="dei:AuditorFirmId" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNDUvZnJhZzowYmRhMzgxMGEyMWM0MDI5OGNmNmEwMGE3YjJmNzc5ZS90ZXh0cmVnaW9uOjBiZGEzODEwYTIxYzQwMjk4Y2Y2YTAwYTdiMmY3NzllXzE2NDkyNjc0NDUyMTA_46fe6219-37b9-4484-bd07-30c2848c21b0">34</ix:nonNumeric>), has audited the effectiveness of the Company&#8217;s internal control over financial reporting. Deloitte&#160;&amp; Touche LLP&#8217;s opinion on the Company&#8217;s internal control over financial reporting appears on page 83 of this Annual Report on Form&#160;10-K.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_148"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the shareholders and the Board of Directors of Viatris Inc.:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Opinion on the Financial Statements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have audited the accompanying consolidated balance sheets of Viatris Inc. and subsidiaries (the "Company") as of December 31, 2021 and 2020, the related consolidated statements of operations, comprehensive (loss) earnings, equity, and cash flows, for each of the three years in the period ended December 31, 2021, and the related notes and the schedule listed in the Index at Item 15 (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2021, in conformity with accounting principles generally accepted in the United States of America.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December 31, 2021, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control &#8212; Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated February 28, 2022, expressed an unqualified opinion on the Company's internal control over financial reporting.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Basis for Opinion</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Critical Audit Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical audit matters communicated below are matters arising from the current-period audit of the financial statements that were communicated or required to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Goodwill &#8211; Viatris Inc. Europe and JANZ Reporting Units &#8211; Refer to Note 8 to the financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Critical Audit Matter Description</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company performed its annual goodwill impairment test as of April 1, 2021. As of April 1, 2021, the Company had $11.91 billion of consolidated goodwill, $5.15 billion and $0.82 billion of which was allocated to the Viatris Inc. Europe and JANZ reporting units, respectively. The Company&#8217;s evaluation of goodwill for impairment involves the comparison of the estimated fair value of each reporting unit to its carrying value. The Company performed its valuation analysis, using both income and market-based approaches, to determine the fair value of its Europe and JANZ reporting units. The determination of the fair value requires management to make significant estimates and assumptions that affect the reporting unit&#8217;s expected future cash flows. These estimates and assumptions, utilizing Level 3 valuation inputs, primarily include, but are not limited to, market multiples, control premiums, discount rates, terminal growth rates, operating income before depreciation and amortization, and capital expenditures forecasts. The fair values of the Europe and the JANZ reporting units exceeded their carrying values by approximately $0.91 billion, or 5.8%, and $0.23 billion, or 7.0%, respectively, as of April 1, 2021 and, therefore, no impairments were recognized. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Given that the Europe and JANZ reporting unit&#8217;s revenues are sensitive to changes in consumer demand, the approval of new product launches, the expansion of existing products into new jurisdictions (which have differentiated distribution and commercialization models throughout the regions), and the impact of business development activity, auditing management&#8217;s judgments regarding forecasts of future revenues, and the selection of the discount rates and terminal growth rates required a high degree of auditor judgment and an increased extent of effort, including the need to involve our fair value specialists.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">How the Critical Audit Matter Was Addressed in the Audit</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit procedures related to the forecasts of future revenues (&#8220;forecasts&#8221;), and the selection of the discount rates and terminal growth rates for the Europe and the JANZ reporting units included the following procedures, among others: </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.03pt">We tested the effectiveness of controls over the review of the goodwill impairment test, including those over the development of the business forecasts of future revenues and the selection of the discount rates and terminal growth rates. </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.03pt">We evaluated management&#8217;s ability to accurately forecast future revenues of the Europe and JANZ reporting units by comparing actual results to management&#8217;s historical forecasts.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.03pt">We evaluated the reasonableness of management&#8217;s revenue forecasts by comparing the projections to (1) historical results, (2) internal communications to management and the Board of Directors, and (3) forecasted information included in Company press releases. We also considered third party reports related to macroeconomic and industry trends and made inquiries of management, including various regional commercial and operations leaders to assess key inputs in the forecast assumptions.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.03pt">With the assistance of our fair value specialists, we evaluated the reasonableness of the valuation methodology, discount rates, and terminal growth rates, including (1) testing the source information underlying the determination of the discount rates and terminal growth rates and the mathematical accuracy of the calculations, (2) developing a range of independent estimates and comparing those to the discount rates selected by management, and (3) considering third party macroeconomic reports.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Net Revenue Provisions &#8211; Chargebacks Accrual at Mylan Pharmaceuticals Inc. (&#8220;MPI&#8221;) &#8211; Refer to Note 3 to the financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Critical Audit Matter Description </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has agreements with certain indirect customers, such as independent pharmacies, retail pharmacy chains, managed care organizations, hospitals, nursing homes, governmental agencies, and pharmacy benefit managers, which establish contract prices for certain products. The indirect customers then independently select a wholesaler from which to purchase the products at these contracted prices. Alternatively, certain wholesalers may enter into agreements with indirect customers that establish contract pricing for certain products, which the wholesalers provide. Under either arrangement, Viatris will provide credit to the wholesaler for any difference between the contracted price with the indirect party and the wholesaler&#8217;s invoice price. Such credits are called chargebacks. The provision for chargebacks is the most significant and complex provision in the context of the Company&#8217;s gross-to-net adjustments in the determination of net revenue. The chargeback accrual recorded at MPI represents the majority of the global chargeback reserve as of December 31, 2021. The Company's recorded estimate is based on expected sell-through levels by the Company&#8217;s wholesaler customers to indirect customers, as well as estimated wholesaler inventory levels. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Estimating the amounts to be accrued for chargebacks requires significant estimation as management&#8217;s model utilizes historical buying patterns, estimated end-user demand, estimated inventory levels in the distribution channel, contracted sales terms with customers, as well as other competitive factors. Given the volume of chargebacks and the level of estimation uncertainty involved, auditing management&#8217;s judgments required a high degree of auditor judgment and an increased extent of effort.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">How the Critical Audit Matter Was Addressed in the Audit</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit procedures related to the Net Revenue Provisions &#8211; Chargebacks accrual</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">included the following, among others: </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.03pt">We evaluated the Company&#8217;s methodology and assumptions in developing their chargeback accruals, including assessing the completeness and accuracy of the underlying data used by management in their estimates. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.03pt">We tested the effectiveness of controls over the calculation of the chargebacks reserves.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.03pt">We compared prior period chargebacks accruals to chargeback credits subsequently issued to evaluate management&#8217;s ability to accurately forecast chargeback activity. </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.03pt">We developed independent expectations of product-level chargeback accruals and chargeback accruals in the aggregate using the following: 1) customer contracts, 2) historical sales and chargeback activity, 3) third-party channel inventory for select wholesalers, and 4) credits subsequently issued to period end and compared those to the recorded amounts.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Net Revenue Provisions &#8211; Sales Returns Accrual at MPI &#8211; Refer to Note 3 to the financial statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Critical Audit Matter Description </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides customers with the ability to return product, which varies country by country in accordance with local practices, generally within a specified period prior (six months) and subsequent (twelve months) to the expiration date. The Company&#8217;s estimate of the provision for returns is generally based upon historical experience with actual returns. The returns reserve at MPI represents a significant component of the global sales returns reserve as of December 31, 2021. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimating the amounts to be accrued for returns requires significant estimation as management&#8217;s model utilizes historical experience with actual returns and considers levels of inventory in the distribution channel, product dating and expiration period, size and maturity of the market prior to a product launch, entrance into the market of additional competitors, and changes in the regulatory environment. Given the volume of sales returns and the level of estimation uncertainty involved, auditing management&#8217;s judgments required a high degree of auditor judgment and an increased extent of effort.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">How the Critical Audit Matter Was Addressed in the Audit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit procedures related to the Net Revenue Provisions &#8211; Sales Returns accrual included the following, among others: </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We evaluated the Company&#8217;s methodology and assumptions in developing their sales returns accrual model, including assessing the completeness and accuracy of the underlying data used by management in their estimates.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We tested the effectiveness of controls over the calculation of the sales returns reserve at MPI.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We compared prior period sales returns accruals to sales returns credits subsequently issued to evaluate management&#8217;s ability to accurately forecast sales returns activity.   </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We developed independent expectations of product-level sales returns accruals and sales returns accruals in the aggregate using the following: 1) historical sales and returns activity, 2) remaining shelf life information, 3) finished goods inventory on-hand at the end of the period, and 4) adjustments for known or anticipated sales return activity based on market dynamics (market prior to Viatris launch, impact of competition, and overall regulatory environment) and compared those to the recorded amounts.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-indent:5.05pt"><span><br/></span></div><div style="text-indent:5.05pt"><span><br/></span></div><div style="text-indent:5.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">/s/ DELOITTE &amp; TOUCHE LLP</span></div><div style="text-indent:5.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">Pittsburgh, Pennsylvania</span></div><div style="text-indent:5.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:300%">February 28, 2022</span></div><div style="text-indent:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:300%">We have served as the Company's auditor since 1976.</span></div><div style="margin-bottom:12pt"><span><br/></span></div><div style="margin-bottom:8pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_151"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">To the shareholders and the Board of Directors of Viatris Inc.: </span></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on Internal Control over Financial Reporting</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the internal control over financial reporting of Viatris, Inc. and subsidiaries (the &#8220;Company&#8221;) as of December 31, 2021, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control - Integrated Framework (2013) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2021, based on criteria established in Internal Control - Integrated Framework (2013) issued by COSO.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated financial statements as of and for the year ended December 31, 2021, of the Company and our report dated February 28, 2022, expressed an unqualified opinion on those financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Basis for Opinion</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management&#8217;s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Definition and Limitations of Internal Control over Financial Reporting</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. </span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">/s/ <ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="dei:AuditorName" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTEvZnJhZzpiOTMzYjFjOTY5NjE0MjIxYWRiMGI1ZTBlYmU0YmFjYy90ZXh0cmVnaW9uOmI5MzNiMWM5Njk2MTQyMjFhZGIwYjVlMGViZTRiYWNjXzEwOTk1MTE2MzI0MDQ_e3e1aa0d-3f81-4c2f-a3f1-4b63e4de6308">DELOITTE &amp; TOUCHE LLP</ix:nonNumeric></span></div><div style="text-indent:5.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="dei:AuditorLocation" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTEvZnJhZzpiOTMzYjFjOTY5NjE0MjIxYWRiMGI1ZTBlYmU0YmFjYy90ZXh0cmVnaW9uOmI5MzNiMWM5Njk2MTQyMjFhZGIwYjVlMGViZTRiYWNjXzEwOTk1MTE2MzI0MDU_d6ab792c-4b92-4a80-834d-05c56a78fd0a">Pittsburgh, Pennsylvania</ix:nonNumeric> </span></div><div style="text-indent:5.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">February 28, 2022</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_154"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Balance Sheets</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(In millions, except share and per share amounts)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:76.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzQtMS0xLTEtMzE0MjI_06e1e2e3-93cf-49d2-ae5c-00d175b8d2ad">701.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzQtMy0xLTEtMzE0MjI_57ad48e7-4078-4bdc-8dff-26197b10c6a3">844.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzUtMS0xLTEtMzE0MjI_a91113de-31d7-4520-8489-7647cf781bd2">4,266.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzUtMy0xLTEtMzE0MjI_817f9dc4-5e7d-4609-8621-1ce8bc2b9c9f">4,843.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzYtMS0xLTEtMzE0MjI_099fe197-b28e-4fbf-8ad2-50542d633d67">3,977.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzYtMy0xLTEtMzE0MjI_944346c4-e068-42e1-96ac-85ceed41694e">5,471.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzctMS0xLTEtMzE0MjI_de737564-7fa7-4719-aec1-594729581372">1,957.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzctMy0xLTEtMzE0MjI_2915e38f-6c9a-45db-b389-7c4ae23801ce">1,707.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzgtMS0xLTEtMzE0MjI_5ce03c51-5805-499d-8fce-a36f57c00959">10,902.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzgtMy0xLTEtMzE0MjI_5f5b6bb1-427f-41f9-a439-aaf0fd685eec">12,867.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzktMS0xLTEtMzE0MjI_07d376fc-fd6f-4cc0-8fb9-2262ee82b301">3,188.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzktMy0xLTEtMzE0MjI_7deef311-29a5-49dc-ba4e-95eb4b2a21b9">3,459.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzEwLTEtMS0xLTMxNDIy_e596d9c0-eb43-41e4-ae7b-7ce6238236c8">26,134.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzEwLTMtMS0xLTMxNDIy_2fc5b2ba-3f3d-41c9-b39e-40ffc392de75">29,683.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzExLTEtMS0xLTMxNDIy_e7eb6ff1-26b9-436e-bd2a-698abcf2d5f9">12,113.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzExLTMtMS0xLTMxNDIy_8c6484cf-2ef7-4c02-80e8-6081263b9931">12,347.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzEyLTEtMS0xLTMxNDIy_34aec302-f9e1-40ba-95fe-7097ed39f1ab">1,332.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzEyLTMtMS0xLTMxNDIy_c4f4cd97-b90b-4667-b54b-3e0ef01db98a">2,147.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzEzLTEtMS0xLTMxNDIy_5f30d052-bb9a-4051-9803-605d32a834ef">1,170.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzEzLTMtMS0xLTMxNDIy_50cec800-9969-401f-90ea-8287dd7085dc">1,047.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzE0LTEtMS0xLTMxNDIy_d8bae2c8-d9be-49f8-b87d-7a37f8adac36">54,842.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzE0LTMtMS0xLTMxNDIy_d3508224-3366-46d1-8892-c32ac0d5ada0">61,553.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND EQUITY</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:AccountsPayableTradeCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzE4LTEtMS0xLTMxNDIy_613ee762-1aec-40cb-a455-3cda6e4a1e53">1,657.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:AccountsPayableTradeCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzE4LTMtMS0xLTMxNDIy_83dbc6ba-8d63-4f1b-af3c-99e9095f73cf">1,904.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term borrowings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzE5LTEtMS0xLTMxNDIy_6072a6e0-5435-463d-a60c-8e2d50ab5fd9">1,493.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-3" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzE5LTMtMS0xLTMxNDIy_55b92a71-75cf-4adc-bf67-5f1da1b18f8b">1,100.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzIwLTEtMS0xLTMxNDIy_88bf8b4f-f62e-4197-b055-787dd2fba637">236.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzIwLTMtMS0xLTMxNDIy_18735572-ec82-47a1-8e71-46fcd0c7eb56">288.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt and other long-term obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzIxLTEtMS0xLTMxNDIy_d7bdd05e-3468-4623-8315-36a0fefe8268">1,877.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzIxLTMtMS0xLTMxNDIy_cb2d3f89-1d24-435b-a79f-9d10ab4d7222">2,308.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzIzLTEtMS0xLTMxNDIy_19c5bf17-b683-4657-a392-18ed73a211ef">4,619.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzIzLTMtMS0xLTMxNDIy_3e87b56b-c02c-4cad-abf8-beaad471c475">4,960.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzI0LTEtMS0xLTMxNDIy_57a67119-b215-4963-b909-a07e7df62a9d">9,884.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzI0LTMtMS0xLTMxNDIy_33049929-c5c0-463e-9e00-1f411c9e9c85">10,562.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzI1LTEtMS0xLTMxNDIy_28f60400-ed1f-44fc-871f-3bcb0490c10e">19,717.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzI1LTMtMS0xLTMxNDIy_942bc338-3e7e-43b4-9c54-b021093cd7bf">22,429.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzI2LTEtMS0xLTMxNDIy_b72ad144-d34f-4dce-a45a-bc795ab87d83">2,815.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzI2LTMtMS0xLTMxNDIy_f1897962-556e-44e9-80ee-677eb3329df1">3,123.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzI3LTEtMS0xLTMxNDIy_e52675df-777c-4c56-bc28-58ec291e222d">1,933.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzI3LTMtMS0xLTMxNDIy_114ce50f-e2bb-4cfb-9f49-e868652a7b28">2,483.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzI4LTEtMS0xLTMxNDIy_c168db01-d2bf-4c85-bc9e-b693262dc330">34,350.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzI4LTMtMS0xLTMxNDIy_a3cd52db-5ea3-4099-8b5a-2dc67478820e">38,598.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viatris Inc. shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock: $<ix:nonFraction unitRef="usdPerShare" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzM2LTAtMS0xLTMxNDIyL3RleHRyZWdpb246ZmQ2Y2YwMjNmNTM0NDFjYWI4YjAxZjE5NDcyMTdlMjNfMTA5OTUxMTYyNzk1NA_63235522-e64e-4195-b01a-758d4833ecdd">0.01</ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzM2LTAtMS0xLTMxNDIyL3RleHRyZWdpb246ZmQ2Y2YwMjNmNTM0NDFjYWI4YjAxZjE5NDcyMTdlMjNfMTA5OTUxMTYyNzk0Nw_db36512c-a4fd-43a4-8e27-46d7209f0a6c">3,000,000,000</ix:nonFraction> shares authorized; shares issued and outstanding: <ix:nonFraction unitRef="shares" contextRef="i3d077e089f704543858c47bf4c5566bf_I20211231" decimals="INF" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzM2LTAtMS0xLTMxNDIyL3RleHRyZWdpb246ZmQ2Y2YwMjNmNTM0NDFjYWI4YjAxZjE5NDcyMTdlMjNfMTk_c7a7818c-684f-4e99-87d7-c769d7e2f3f1">1,209,507,463</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i39d4f9fa88c04ae0856b7faa1bf73798_I20201231" decimals="INF" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzM2LTAtMS0xLTMxNDIyL3RleHRyZWdpb246ZmQ2Y2YwMjNmNTM0NDFjYWI4YjAxZjE5NDcyMTdlMjNfMjY_e111d640-a897-4a57-a009-9f1488a053c6">1,206,895,644</ix:nonFraction>, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzM2LTEtMS0xLTMxNDIy_7ec7d08d-7e17-42c3-be55-252d960e30ee">12.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzM2LTMtMS0xLTMxNDIy_fc1d733d-5cce-41bf-873d-5e418119f3f8">12.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzM3LTEtMS0xLTMxNDIy_b5e62ea0-8c9c-444a-86c7-cba27d32a18c">18,536.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzM3LTMtMS0xLTMxNDIy_27697876-8354-409d-8fd8-a5901187e28c">18,438.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzM4LTEtMS0xLTMxNDIy_7bd9b5fc-a0be-4bef-8169-795fece78b9c">3,688.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzM4LTMtMS0xLTMxNDIy_2a9cf1bd-f1d5-4b1d-a2f7-1878e8bc1495">5,361.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzM5LTEtMS0xLTMxNDIy_4b68c904-625b-4b96-a785-11fbf8721a83">1,744.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzM5LTMtMS0xLTMxNDIy_3f3457a0-383b-4529-98f1-eedbc4dc2028">858.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzQ0LTEtMS0xLTMxNDIy_93043268-219a-4acc-8a0e-a6a2d41a8452">20,492.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzQ0LTMtMS0xLTMxNDIy_884173b0-c3b6-42ef-9d2b-bb1e1d52873b">22,954.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzQ1LTEtMS0xLTMxNDIy_6011b164-b509-482b-8617-de7aeaea82c2">54,842.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzQ1LTMtMS0xLTMxNDIy_ba057d4a-37be-4584-87bd-f7a21774c29c">61,553.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:15pt;padding-left:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Notes to Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_157"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Operations</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(In millions, except per share amounts)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.006%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.712%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic25b2c6a9a1244738c1de493abb87705_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzMtMS0xLTEtMzE0MjI_7aa79eb2-d382-4529-8fc9-aa4d63f2ec2a">17,813.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f25078033394f518263d14867ea4eb6_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzMtMy0xLTEtMzE0MjI_54a369d6-0ccd-44fd-b9ac-55ef2df479e5">11,819.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadb0452c57794c5498c4248d6691b32c_D20190101-20191231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzMtNS0xLTEtMzE0MjI_39d62a6d-a618-4b98-90a3-4446d6b752b8">11,370.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2b4674a5a824635bbb161ea5fe82fea_D20210101-20211231" decimals="-5" name="us-gaap:RevenueNotFromContractWithCustomer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzQtMS0xLTEtMzE0MjI_2741cb1b-bb75-44d0-b57e-5bb2a6fb2e4c">72.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie779f16aabc14a74b5468853e37f6dd2_D20200101-20201231" decimals="-5" name="us-gaap:RevenueNotFromContractWithCustomer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzQtMy0xLTEtMzE0MjI_16453323-6658-495c-9d16-8028eb017734">126.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id568b4f1929446b9942b42b58b8e069f_D20190101-20191231" decimals="-5" name="us-gaap:RevenueNotFromContractWithCustomer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzQtNS0xLTEtMzE0MjI_4a9de4c1-fc37-4d51-a11c-b39dfad95c5f">130.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzUtMS0xLTEtMzE0MjI_b581e2e5-ccb0-4125-a906-67be94574159">17,886.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzUtMy0xLTEtMzE0MjI_2b5ac7e3-3fd5-4b3a-b160-56b667175750">11,946.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzUtNS0xLTEtMzE0MjI_4762ec1c-9af6-4af6-a461-eda678fa0594">11,500.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzYtMS0xLTEtMzE0MjI_c37bce58-a8b3-47f5-b891-6fe7bf789bec">12,310.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzYtMy0xLTEtMzE0MjI_7cae7a23-ce32-43cb-8b30-6ab4ecd39f50">8,149.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzYtNS0xLTEtMzE0MjI_95747363-24f5-451b-9619-520f6da13307">7,602.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzctMS0xLTEtMzE0MjI_27ac0d21-3c21-42a2-9998-ee0a432a2562">5,575.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzctMy0xLTEtMzE0MjI_11796364-3009-4b0e-8906-45c135e5fbf2">3,796.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzctNS0xLTEtMzE0MjI_01fd9098-f101-4948-9f39-33cba0ac42a6">3,897.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzktMS0xLTEtMzE0MjI_3c3f1df9-cb89-4045-9e3b-7e69158264db">751.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzktMy0xLTEtMzE0MjI_24315cf0-286e-414f-94d0-95c095153826">555.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzktNS0xLTEtMzE0MjI_98cf197b-9721-455f-a897-b92dc2e0f09a">639.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzEwLTEtMS0xLTMxNDIy_66c4d8a0-1add-4905-9bdf-9e728bedfea0">4,529.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzEwLTMtMS0xLTMxNDIy_e80db6f2-a7a6-4f01-834c-6f90a949856c">3,344.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzEwLTUtMS0xLTMxNDIy_be7490a7-dc26-4f47-abb8-8fab142fab4a">2,563.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation settlements and other contingencies, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzExLTEtMS0xLTMxNDIy_3b5a4d79-92e0-43a3-8d74-3bfefc76896f">329.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzExLTMtMS0xLTMxNDIy_c4e2d957-5ffe-4ccd-9f4b-65d8efced816">107.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzExLTUtMS0xLTMxNDIy_01054cdb-2a05-4165-b9d4-7cb5ea149e73">21.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzEyLTEtMS0xLTMxNDIy_bf6bbd58-1c74-41a0-8f6a-a69400953024">5,609.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzEyLTMtMS0xLTMxNDIy_b4750ebc-18fc-4246-85db-eece3f9888ed">4,007.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzEyLTUtMS0xLTMxNDIy_82516ebd-eb6b-4afb-880c-30578a16dc68">3,182.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) earnings from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzEzLTEtMS0xLTMxNDIy_661a6ba2-8993-4823-8ac6-4ad1bf37891c">34.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzEzLTMtMS0xLTMxNDIy_c715fac0-a2c1-40d7-868c-33109a351f64">210.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzEzLTUtMS0xLTMxNDIy_ed224eb0-3f51-4c57-823a-7e1b9af25823">715.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzE0LTEtMS0xLTMxNDIy_60675b64-43df-4f0b-a4a8-4fdfa3974582">636.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzE0LTMtMS0xLTMxNDIy_6ff4a43a-6d0c-4064-8559-942212b705f3">497.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzE0LTUtMS0xLTMxNDIy_27c2d51d-de50-4170-8ac0-ed3bf66ad413">517.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzE1LTEtMS0xLTMxNDIy_580953b6-00d6-4533-9656-b64c9cf18b5c">5.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzE1LTMtMS0xLTMxNDIy_1da376a0-7b48-4e2d-9ca6-48c27173f1ac">12.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzE1LTUtMS0xLTMxNDIy_7349a1b1-87dc-446d-979a-5ee0d82ba9af">43.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) earnings before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzE2LTEtMS0xLTMxNDIy_d31e412f-fa12-41d9-a277-b7475ab8b90e">664.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzE2LTMtMS0xLTMxNDIy_ebced4b1-8190-4aa2-a856-8765d8d1e1d2">721.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzE2LTUtMS0xLTMxNDIy_2cbfa2d8-bf1b-475d-90a8-78422e394e9e">154.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzE3LTEtMS0xLTMxNDIy_ab6219ab-4771-4540-bd66-9513921c2565">604.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzE3LTMtMS0xLTMxNDIy_5970843c-768c-447e-8c17-b588db3bf5b7">51.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzE3LTUtMS0xLTMxNDIy_53d4c8a0-f6f7-4462-8d42-fe5f88c1bb11">137.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) earnings</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzE4LTEtMS0xLTMxNDIy_ffa27d12-facd-4f39-ad7d-f29722788122">1,269.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzE4LTMtMS0xLTMxNDIy_d3964732-7a5a-4e5b-b453-0710d9cdb176">669.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzE4LTUtMS0xLTMxNDIy_1deb761f-119b-437b-91f1-d98bb88df93c">16.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) earnings per share attributable to Viatris Inc. shareholders</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzIyLTEtMS0xLTMxNDIy_83a56312-efc8-4c7c-8992-c89fc01be0f6">1.05</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzIyLTMtMS0xLTMxNDIy_c5ddd91b-63c8-4bc7-81fc-322dc5e7ac2b">1.11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzIyLTUtMS0xLTMxNDIy_a2850713-93e3-41e4-bb99-8401a21f7a65">0.03</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzIzLTEtMS0xLTMxNDIy_dc094c6e-593d-4700-8f8f-bf19abe72cba">1.05</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzIzLTMtMS0xLTMxNDIy_a9e78228-852b-4b03-974a-87f5df89e659">1.11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzIzLTUtMS0xLTMxNDIy_d9bd64aa-f57a-40db-bf31-bffd7d9f9166">0.03</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzI1LTEtMS0xLTMxNDIy_8ef8d9a4-49c3-4abd-a284-236ef377f112">1,208.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzI1LTMtMS0xLTMxNDIy_c5bdb6eb-0912-432b-adee-c98b880cf10f">601.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzI1LTUtMS0xLTMxNDIy_d286c930-1552-4da4-8348-235f7f5c1cba">515.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzI2LTEtMS0xLTMxNDIy_3178fee6-4548-4899-8968-113aa36003f6">1,208.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzI2LTMtMS0xLTMxNDIy_859e6723-314f-4b73-a244-f3df085c4e22">601.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzI2LTUtMS0xLTMxNDIy_9d746273-3e48-4f4d-b888-89d70754042d">516.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Notes to Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_160"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Comprehensive (Loss) Earnings </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(In millions)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.006%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.712%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) earnings</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzItMS0xLTEtMzE0MjI_ffa27d12-facd-4f39-ad7d-f29722788122">1,269.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzItMy0xLTEtMzE0MjI_d3964732-7a5a-4e5b-b453-0710d9cdb176">669.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzItNS0xLTEtMzE0MjI_1deb761f-119b-437b-91f1-d98bb88df93c">16.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) earnings, before tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzQtMS0xLTEtMzE0MjI_bacb7182-15bf-417b-8def-39853212ce52">1,340.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzQtMy0xLTEtMzE0MjI_8ca10a93-1da7-4ba5-9e1b-e6ae7034f5ac">1,213.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzQtNS0xLTEtMzE0MjI_64f62894-74ec-452b-a325-e28776dde071">415.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in unrecognized loss and prior service cost related to defined benefit plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzUtMS0xLTEtMzE0MjI_bbf2c8fc-440a-44ff-a82b-c94221b4d23a">73.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzUtMy0xLTEtMzE0MjI_3346e7b2-e4d3-4ca0-948c-59783a466401">14.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzUtNS0xLTEtMzE0MjI_64697ea8-2c71-4ecd-a87b-66a849a9f640">24.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrecognized gain on derivatives in cash flow hedging relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe7edb935be4af4a3721e260440024e_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzYtMS0xLTEtMzE0MjI_7a194794-1a41-4801-a832-fdda82331ff2">36.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b0e6896d0904a51b7f3d01a54c4ddc3_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzYtMy0xLTEtMzE0MjI_c22a7418-4827-44ac-83b7-6ef3e74592b3">18.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie99d2b10b5fa41a2b69de441e703d1be_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzYtNS0xLTEtMzE0MjI_13c3ad07-96f6-49b7-94db-3cb339922946">37.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrecognized gain (loss) on derivatives in net investment hedging relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72a4e38013274704acf3fce567aec1b6_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzctMS0xLTEtMzE0MjI_16ec1624-a1ed-4788-b152-45e5ba54667b">456.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie12ac8dbb8e34d9bbb1bb903a175a2c8_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzctMy0xLTEtMzE0MjI_f7fa54bb-04aa-476d-a45d-0c9890c38041">305.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57c4f10b75634ea68f1dca6a931ad8e6_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzctNS0xLTEtMzE0MjI_0a02ec3e-1b48-47ce-b2d6-89139c29e009">59.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized (loss) gain on marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzgtMS0xLTEtMzE0MjI_2a1e26b2-5f56-4f6d-b55e-bee04b1f9707">1.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzgtMy0xLTEtMzE0MjI_7b3568ce-12e0-4e70-843d-4b0cf9c57117">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzgtNS0xLTEtMzE0MjI_1a11cd4c-4d30-49f4-abe8-159725496566">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) earnings, before tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzktMS0xLTEtMzE0MjI_859f2352-946b-495a-b276-d28cc45ece97">775.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzktMy0xLTEtMzE0MjI_a4f13abe-022a-46ef-bc72-8e70084567e0">912.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzktNS0xLTEtMzE0MjI_27b13b0b-f739-46ea-821d-c52ffc90972f">343.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision (benefit) </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzEwLTEtMS0xLTMxNDIy_2d0bd743-f215-46f0-96da-32b28f815b74">111.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzEwLTMtMS0xLTMxNDIy_9c2e174d-73cd-43db-b8ac-eace1a297590">26.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzEwLTUtMS0xLTMxNDIy_319194bd-3d1e-49bf-8e61-c0fca121953f">9.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) earnings, net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzExLTEtMS0xLTMxNDIy_52cf9061-bad7-4eef-aeeb-ceeeb6de4c1e">886.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzExLTMtMS0xLTMxNDIy_342e671c-5202-4ce5-a274-d030defbcd82">939.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzExLTUtMS0xLTMxNDIy_796206db-97e7-413e-b847-931e71ea03dd">352.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive (loss) earnings</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzEyLTEtMS0xLTMxNDIy_8085f783-2ec2-434e-b9eb-dff1f5bb6ace">2,155.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzEyLTMtMS0xLTMxNDIy_5d7501f0-1764-435c-915f-597a2086f915">269.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzEyLTUtMS0xLTMxNDIy_a0d2fe9f-eb51-46c1-be5e-64b12e1a8b5b">335.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Notes to Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_163"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="text-align:center;text-indent:36pt"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Equity</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(In millions, except share amounts)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.645%"><tr><td style="width:1.0%"></td><td style="width:39.213%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.074%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.359%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.491%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.359%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.954%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.359%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.618%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.359%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.626%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.359%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.359%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.746%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.359%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:5.630%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-In Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Equity</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2018</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4c63b953f9ab4ca380c2a6718f3499d2_I20181231" decimals="INF" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzMtMS0xLTEtMzE0MjI_2abca13c-7d8f-4982-abd8-f3917f183f4a">539,289,665</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c63b953f9ab4ca380c2a6718f3499d2_I20181231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzMtMy0xLTEtMzE0MjI_f836f236-ace3-4ae8-b020-ed7a945448ed">6.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia50f87af01074210b75c18963d37110d_I20181231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzMtNS0xLTEtMzE0MjI_12b0bddf-4d35-45f5-8b4c-0a1026fb1eda">8,591.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0df3c349ea2b4fbfba28ebfb584419f0_I20181231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzMtNy0xLTEtMzE0MjI_bacc4c53-8500-4039-95ed-a6bd63d596c8">6,010.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib23cdc694f6547709893256e80430c38_I20181231" decimals="INF" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzMtOS0xLTEtMzE0MjI_36376471-b30f-4172-960f-dfeb7da7722f">23,490,867</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib23cdc694f6547709893256e80430c38_I20181231" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzMtMTEtMS0xLTMxNDIy_0fd7a420-9dcb-424b-84eb-f148c4e6cabb">999.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibadea9a32ce84dc48523b37b0f0b23ce_I20181231" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzMtMTMtMS0xLTMxNDIy_72126d1d-6a6c-46a5-8b77-972de12c7229">1,441.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8ec92ba24d848d697ba737aeed13c05_I20181231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzMtMTctMS0xLTMxNDIy_cb9e2f3f-f1cc-4fd5-9211-012370367e3d">12,167.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f90527bae0344d981ff43fd2126b229_D20190101-20191231" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzQtNy0xLTEtMzE0MjI_a9e0d3cf-5152-4f9a-bfa4-cab43ab20e7a">16.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzQtMTctMS0xLTMxNDIy_48eca2c2-acd9-40c8-aea2-b9bd2d09ecd4">16.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5143c6332d7249db9f3409e36def6483_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzUtMTMtMS0xLTMxNDIy_1d6ea2f7-82b5-4f0d-a2c6-f0533518e1b6">352.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzUtMTctMS0xLTMxNDIy_796206db-97e7-413e-b847-931e71ea03dd">352.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0cf1109448e4942a109317479a8de2d_D20190101-20191231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzctNS0xLTEtMzk3Mjg_1230ad6a-8c82-469a-aed2-af675645765f">56.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzctMTctMS0xLTM5NzI4_b27292aa-f0ee-49b6-99e5-12945360403e">56.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of restricted stock and stock options exercised, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic877d36b0d2e41a293e8217247ace76e_D20190101-20191231" decimals="INF" name="vtrs:StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzYtMS0xLTEtMzE0MjI_696a90f9-9e30-4ef5-aaa9-a4c3eb7d369c">1,457,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic877d36b0d2e41a293e8217247ace76e_D20190101-20191231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzYtMy0xLTEtMzE0MjI_c7f8f0ff-ddae-47d1-b62d-4a36db5d8828">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0cf1109448e4942a109317479a8de2d_D20190101-20191231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzYtNS0xLTEtMzE0MjI_4ef57e41-d6ed-4a31-a704-2713cf0f0663">8.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzYtMTctMS0xLTMxNDIy_55be6878-cf56-4d12-8a49-f6c302ab1d63">8.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxes related to the net share settlement of equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0cf1109448e4942a109317479a8de2d_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzctNS0xLTEtMzE0MjI_a41d90c7-c185-4974-9719-bd97bef3876a">12.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzctMTctMS0xLTMxNDIy_9278a9ad-40be-4877-a829-e140236732a7">12.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cancellation of restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i759302137d4347189f09b28fddcb4d55_D20190101-20191231" decimals="INF" name="us-gaap:TreasuryStockSharesRetired" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzktOS0xLTEtMzE0MjI_4de5c5e0-eb95-4349-ae35-6dceba4988b2">1,107,207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cumulative effect of the adoption of new accounting standards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i676ac4a93e7c42cf8130b6170dc1899a_I20181231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzEyLTctMS0xLTMxNDIy_1bcc778b-7c6d-44f4-8b37-00f000883a59">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f069b3a590b4f41809c068d4484a771_I20181231" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzEyLTEzLTEtMS0zMTQyMg_8bd7bfab-139f-488a-aa28-bb535bc94b08">3.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37a67212c0ef46a4ad4f6aa75d225fed_I20181231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzEyLTE3LTEtMS0zMTQyMg_7e8629a5-3cd7-4f30-93ba-48a7757d7353">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i00d14723d68d4566b474e37cf199d470_I20191231" decimals="INF" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzEzLTEtMS0xLTMxNDIy_cc02e5fe-a84b-4cb4-b0fe-2b12f391045e">540,746,871</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00d14723d68d4566b474e37cf199d470_I20191231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzEzLTMtMS0xLTMxNDIy_e2903fd3-0a0e-476d-aabc-02c6f9fa251e">6.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia780b2ac8321464bae70f392c4b8e0ac_I20191231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzEzLTUtMS0xLTMxNDIy_451e5808-f662-4fd1-9575-2d8cea25d8da">8,643.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd43c5aaf4d94827a901e78c27e732f7_I20191231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzEzLTctMS0xLTMxNDIy_2ecf38c6-d30e-4523-b096-11a8b48aa6ab">6,031.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib85f7a5cf6f64a0e84c35ebc74cd0576_I20191231" decimals="INF" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzEzLTktMS0xLTMxNDIy_e8b6eb5d-c145-4775-a483-315429c2939e">24,598,074</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib85f7a5cf6f64a0e84c35ebc74cd0576_I20191231" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzEzLTExLTEtMS0zMTQyMg_9bf3fc8e-4d77-495c-9acd-685dd98697c7">999.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic39189fc54504b53be3c4281e5dd8f82_I20191231" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzEzLTEzLTEtMS0zMTQyMg_8ca5ed1e-c6df-48db-a86c-02fc51b82f21">1,797.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac503b6d629d4bafb262ea6ec0b8a25e_I20191231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzEzLTE3LTEtMS0zMTQyMg_0cefecc0-273a-4825-9def-ec7b03d571da">11,883.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idc41db043d3e4f84b4c531fda801f18c_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzE0LTctMS0xLTMxNDIy_ccc00b2a-1344-4a84-ba86-c515c64b09c1">669.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzE0LTE3LTEtMS0zMTQyMg_d8d223bc-5b63-4c06-9c4a-93a99c719aa4">669.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive earnings, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e5cd61854a54e59a6e1744de70eab75_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzE1LTEzLTEtMS0zMTQyMg_0f7c4b0a-b01e-4303-ae52-9dcae1804d2d">939.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzE1LTE3LTEtMS0zMTQyMg_f00215e9-bc7c-41ae-b11e-cafdabda0451">939.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4251244738d4104aa6f320d2729ecf7_D20200101-20201231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzE3LTUtMS0xLTMxNDIy_a66978a5-c438-4b78-9227-9d1b6cf63d3f">79.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzE3LTE3LTEtMS0zMTQyMg_acf6631c-1a3a-46d2-afbe-d9589d0ae58e">79.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of restricted stock and stock options exercised, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1aaa5a37c6f4415aaac4b207251f9e26_D20200101-20201231" decimals="INF" name="vtrs:StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzE5LTEtMS0xLTM5ODAz_6346de63-da5d-4431-a7b3-78ac82a7a491">872,802</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4251244738d4104aa6f320d2729ecf7_D20200101-20201231" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzE5LTUtMS0xLTM5ODAz_986bfa29-79d9-4047-aa85-035c55481cea">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzE5LTE3LTEtMS0zOTgwMw_1b5bb865-01c7-48cf-bb3f-084cb1836d5f">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxes related to the net share settlement of equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4251244738d4104aa6f320d2729ecf7_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzIwLTUtMS0xLTM5Nzg0_8b809489-1d73-4ff4-9076-d4663d0e137c">6.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzIwLTE3LTEtMS0zOTc4NA_d18d9b19-b0bf-4514-95b4-89b824312231">6.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exchange of Mylan N.V. ordinary shares for Viatris Inc. common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i1aaa5a37c6f4415aaac4b207251f9e26_D20200101-20201231" decimals="INF" name="vtrs:StockExchangedDuringPeriodSharesExchanged" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzIxLTEtMS0xLTM5ODE4_d9fa79f7-ca00-46cc-8fba-e06cebc4fb2e">541,619,673</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1aaa5a37c6f4415aaac4b207251f9e26_D20200101-20201231" decimals="-5" name="vtrs:StockExchangedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzIxLTMtMS0xLTM5ODE4_78ad13e2-4906-4e3a-ba86-6a907b930d34">6.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4251244738d4104aa6f320d2729ecf7_D20200101-20201231" decimals="-5" sign="-" name="vtrs:StockExchangedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzIxLTUtMS0xLTM5ODE4_7dec9346-6b6e-4b6a-bee4-42478eae4dd5">6.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="vtrs:StockExchangedDuringPeriodValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzIxLTE3LTEtMS0zOTgxOA_ee6dc070-06ba-4428-9f42-ccd9538155f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock to Mylan N.V. shareholders</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1aaa5a37c6f4415aaac4b207251f9e26_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzE5LTEtMS0xLTMxNDIy_30e9a759-b6af-498f-9f8d-c402e59ce380">541,619,673</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1aaa5a37c6f4415aaac4b207251f9e26_D20200101-20201231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzE5LTMtMS0xLTMxNDIy_5e88d977-89bd-49f0-b581-2dc3771dcdc3">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4251244738d4104aa6f320d2729ecf7_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzE5LTUtMS0xLTMxNDIy_9a47b12c-8711-42f1-8edd-2de67890338c">5.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzE5LTE3LTEtMS0zMTQyMg_e9119b74-6dfa-4c7e-b094-e5b1532db63e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock for the Combination </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1aaa5a37c6f4415aaac4b207251f9e26_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzIwLTEtMS0xLTMxNDIy_39298a73-9abb-4399-aa1f-ba426b3379c0">689,874,045</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1aaa5a37c6f4415aaac4b207251f9e26_D20200101-20201231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzIwLTMtMS0xLTMxNDIy_169dcc8d-c355-476d-8160-77d8541dc092">6.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4251244738d4104aa6f320d2729ecf7_D20200101-20201231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzIwLTUtMS0xLTMxNDIy_ffcd5185-7fd5-498d-bf34-7366a30f8f5f">10,720.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzIwLTE3LTEtMS0zMTQyMg_24d1e204-a1b3-4d7e-b38c-ea8873ffbb9b">10,727.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Retirement of Mylan N.V. treasury stock, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i1aaa5a37c6f4415aaac4b207251f9e26_D20200101-20201231" decimals="INF" name="us-gaap:TreasuryStockSharesRetired" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzIxLTEtMS0xLTMxNDIy_cee31966-f48a-41bb-9dbe-e51e4927b8a0">24,598,074</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4251244738d4104aa6f320d2729ecf7_D20200101-20201231" decimals="-5" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzIxLTUtMS0xLTMxNDIy_190e85fc-e5bc-46ad-841c-9490b90f062c">999.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i614ccdb2c5cd4297b966274861517991_D20200101-20201231" decimals="INF" name="us-gaap:TreasuryStockSharesRetired" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzIxLTktMS0xLTMxNDIy_a675b144-6612-490b-bfbe-406da6741767">24,598,074</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i614ccdb2c5cd4297b966274861517991_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzIxLTExLTEtMS0zMTQyMg_724dcd4c-658d-4912-958d-a49bfd06ed79">999.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzIxLTE3LTEtMS0zMTQyMg_4c5845a4-f7e9-4d91-8a26-b6c7ccee8b14">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i39d4f9fa88c04ae0856b7faa1bf73798_I20201231" decimals="INF" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzIyLTEtMS0xLTMxNDIy_e111d640-a897-4a57-a009-9f1488a053c6">1,206,895,644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39d4f9fa88c04ae0856b7faa1bf73798_I20201231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzIyLTMtMS0xLTMxNDIy_bb90273f-858a-447a-adb3-4d55d4b44a47">12.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia12703913f6e4df58b4262b9bbb6ea77_I20201231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzIyLTUtMS0xLTMxNDIy_633454b2-d898-462f-97a0-5a3d28b7daaa">18,438.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d45fba46a924824a984d4a911f8510f_I20201231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzIyLTctMS0xLTMxNDIy_b1787e6b-2572-4bbb-b3d6-5f291bcb9052">5,361.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iba866be0d0f04d0cbdf171873fd7fd0b_I20201231" decimals="INF" name="us-gaap:SharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzIyLTktMS0xLTMxNDIy_61b1e3fb-5f24-4db9-8f96-03121c2e302d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba866be0d0f04d0cbdf171873fd7fd0b_I20201231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzIyLTExLTEtMS0zMTQyMg_85372474-d0b0-48b8-90b9-d4029ff099e7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzIyLTEzLTEtMS0zMTQyMg_3f3457a0-383b-4529-98f1-eedbc4dc2028">858.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzIyLTE3LTEtMS0zMTQyMg_884173b0-c3b6-42ef-9d2b-bb1e1d52873b">22,954.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i14dba6c874d24fcfae05dbedf70952aa_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzIzLTctMS0xLTMxNDIy_2de4079b-7e4b-412f-ae17-b4df2b272175">1,269.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzIzLTE3LTEtMS0zMTQyMg_2d7b90dc-c320-48e4-adb8-6d763708681f">1,269.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92e45e4918604661b681cd5b227d7bcc_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzI0LTEzLTEtMS0zMTQyMg_525ac6c1-0b51-4fb6-99c5-d86d94f94737">886.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzI0LTE3LTEtMS0zMTQyMg_01ddd282-ba16-4ac8-8114-101124980aac">886.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcb976e09f3943ed918be4bf207b55e3_D20210101-20211231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzI3LTUtMS0xLTMxNDIy_42c5e05c-3058-4a45-8227-71e9a473209e">111.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzI3LTE3LTEtMS0zMTQyMg_71f71290-055f-4c38-bf56-92667e78466c">111.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of restricted stock and stock options exercised, net </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i09fc106c667c4de189765013dc4a94ef_D20210101-20211231" decimals="INF" name="vtrs:StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzI4LTEtMS0xLTMxNDIy_0bb27dcd-73c4-4edd-bc4c-eac1aeea2e39">2,611,819</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxes related to the net share settlement of equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifcb976e09f3943ed918be4bf207b55e3_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzI5LTUtMS0xLTMxNDIy_83b77a84-7e97-4f99-a1a6-bcd735c161b1">13.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzI5LTE3LTEtMS0zMTQyMg_5a4d7bde-597e-45db-8f91-f27d4109d80e">13.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash dividends declared, $<ix:nonFraction unitRef="usdPerShare" contextRef="if7c969d8800446acace677aeab6fa885_D20210101-20211231" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzMwLTAtMS0xLTMxNDIyL3RleHRyZWdpb246NjIxNzgzZDZiZGRlNDBhZGFhM2M0YWZmYjcxNWFkYjBfMTA5OTUxMTYyNzgyMg_a61abc5a-e933-4b2a-a025-2a22f86c78cc">0.33</ix:nonFraction> per common share</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i14dba6c874d24fcfae05dbedf70952aa_D20210101-20211231" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzMwLTctMS0xLTMxNDIy_9d3eb719-8e17-4aad-b511-e3996f3df1ab">403.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i14dba6c874d24fcfae05dbedf70952aa_D20210101-20211231" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzMwLTE3LTEtMS0zMTQyMg_1d0a73ee-a95a-4549-9665-e21ece81ade9">403.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3d077e089f704543858c47bf4c5566bf_I20211231" decimals="INF" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzM1LTEtMS0xLTMxNDIy_c7a7818c-684f-4e99-87d7-c769d7e2f3f1">1,209,507,463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d077e089f704543858c47bf4c5566bf_I20211231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzM1LTMtMS0xLTMxNDIy_3bc40279-b5ea-49d9-bd54-82d04da7c927">12.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7428ecd34bd643bfb53dd62a4bce788c_I20211231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzM1LTUtMS0xLTMxNDIy_9cfcd4ca-1385-4946-bb93-7f13410eb3a4">18,536.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if13be5161c804163b4305d5d326bef7e_I20211231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzM1LTctMS0xLTMxNDIy_52ec3f9b-fdf3-4c13-97a4-b44918a38e49">3,688.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1a6cdd4c97954d22af41797509ecf7fb_I20211231" decimals="INF" name="us-gaap:SharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzM1LTktMS0xLTMxNDIy_ee7978f9-d6d6-4f72-bb38-3a596d2cf22e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a6cdd4c97954d22af41797509ecf7fb_I20211231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzM1LTExLTEtMS0zMTQyMg_ba0ac367-ce62-412d-855f-430ea247e588">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87a0adf309ee48cab4e379bd487453b4_I20211231" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzM1LTEzLTEtMS0zMTQyMg_c5ce1d88-266b-47e5-b0d9-67b52eed3a5e">1,744.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzM1LTE3LTEtMS0zMTQyMg_93043268-219a-4acc-8a0e-a6a2d41a8452">20,492.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.94pt;font-weight:400;line-height:120%;position:relative;top:-2.66pt;vertical-align:baseline">__________________</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> Ordinary Shares prior to November 16, 2020.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.6pt;font-weight:400;line-height:120%"> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Notes to Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_166"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Cash Flows</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(In millions)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.006%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.712%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (loss) earnings</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzMtMS0xLTEtMzE0MjI_0307ae27-48d6-4697-af7d-3819c150958e">1,269.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzMtMy0xLTEtMzE0MjI_d3964732-7a5a-4e5b-b453-0710d9cdb176">669.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzMtNS0xLTEtMzE0MjI_1deb761f-119b-437b-91f1-d98bb88df93c">16.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net earnings to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzUtMS0xLTEtMzE0MjI_60a789f9-5111-4d93-bf56-60eabc3a55a1">4,506.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzUtMy0xLTEtMzE0MjI_d49abcf5-6445-43c3-a452-cbe0ab5c78ce">2,216.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzUtNS0xLTEtMzE0MjI_d71b5145-8b9a-44cd-8eeb-1dfcce143ec9">2,019.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income tax expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzYtMS0xLTEtMzE0MjI_13c875be-a3d1-43d2-aab5-5836b8102005"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzYtMS0xLTEtMzE0MjI_b027852c-f2ea-4bac-a00e-24220a12184e">675.7</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzYtMy0xLTEtMzE0MjI_f19f7636-bf2b-450c-b7a4-1ebaff764cae">213.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzYtNS0xLTEtMzE0MjI_d6724e5c-88f5-4c87-b66b-29d72d774c62">192.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Litigation settlements and other contingencies, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" sign="-" name="vtrs:Changeinnoncashlitigationsettlementsnet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzctMS0xLTEtMzE0MjI_75d79249-663b-43dd-b21c-3354a699bf1c">323.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" sign="-" name="vtrs:Changeinnoncashlitigationsettlementsnet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzctMy0xLTEtMzE0MjI_60eb8703-2116-4eb0-9464-346a79621803">101.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="vtrs:Changeinnoncashlitigationsettlementsnet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzctNS0xLTEtMzE0MjI_eaa1be23-4350-4c5b-9d72-388f30deeb6c">11.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss from equity method investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzgtMS0xLTEtMzE0MjI_361d8db0-63e7-478a-8064-41b9a3a575a2">61.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzgtMy0xLTEtMzE0MjI_e2a03f1e-1c95-452d-a3ff-d46763affe0d">48.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzgtNS0xLTEtMzE0MjI_51bc5362-bc09-4535-a97a-9787be8a9167">62.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzktMS0xLTEtMzE0MjI_240d3df5-6bba-4ce1-9a15-333b7667a67e">111.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzktMy0xLTEtMzE0MjI_7186ad54-3c63-4b04-893d-fa36ac65bb56">79.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzktNS0xLTEtMzE0MjI_aac2e81f-cfb8-452d-991f-9e4d5730f769">56.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-cash items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzExLTEtMS0xLTMxNDIy_892af3d5-ccaa-4387-826e-6ff476365667"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzExLTEtMS0xLTMxNDIy_d2d84a33-3e36-47af-9895-fc83e10f7be5">411.8</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzExLTMtMS0xLTMxNDIy_c70bd4ab-26ef-4dbe-8792-e49a71a905e5">366.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzExLTUtMS0xLTMxNDIy_beadcd92-3527-4c38-81bb-3cd8c6fd45f5">360.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzEzLTEtMS0xLTMxNDIy_1f2457d2-1cd0-4604-8478-5e4804593345"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzEzLTEtMS0xLTMxNDIy_a5362394-fd2f-45f1-a9d6-d348c22e7428">59.3</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzEzLTMtMS0xLTMxNDIy_a532b3a0-bd56-44ba-b192-916d51f3eef0">78.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzEzLTUtMS0xLTMxNDIy_cd6b5019-7d75-4287-ad56-6f4efe04dfb2">20.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzE0LTEtMS0xLTMxNDIy_9be48501-5400-4949-8f0e-ccd5fa881688">427.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzE0LTMtMS0xLTMxNDIy_d608d5dd-d44b-46db-bbb8-c9521838763d">741.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzE0LTUtMS0xLTMxNDIy_8de00285-b32c-4b91-b058-20b12187771e">512.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzE1LTEtMS0xLTMxNDIy_ac63e4aa-de20-4545-9e11-b92174036e33"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzE1LTEtMS0xLTMxNDIy_e024cc6c-8718-4030-94a6-1fde56a2af6d">70.4</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzE1LTMtMS0xLTMxNDIy_8d655338-0f24-4d5e-a7eb-bc184a91fcc3">82.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzE1LTUtMS0xLTMxNDIy_ab6c896d-3f98-4514-86e8-0995d5526ec0">96.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzE2LTEtMS0xLTMxNDIy_4daa8eb0-8afb-4267-9d22-747e198b9162"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzE2LTEtMS0xLTMxNDIy_56024c4d-1219-4b1a-99a2-0a7a5ded0c5d">699.6</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzE2LTMtMS0xLTMxNDIy_1ec98692-7060-4e2f-a267-8c76307c9f7d">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzE2LTUtMS0xLTMxNDIy_4eb5916d-ad44-4745-97e9-a70098639a3a">57.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other operating assets and liabilities, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzE3LTEtMS0xLTMxNDIy_58316ab4-8196-4838-88ff-8bf5aa6b4381"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzE3LTEtMS0xLTMxNDIy_f3ab04e4-dd6a-4290-ae11-b7528cf4e95e">666.5</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzE3LTMtMS0xLTMxNDIy_11e9e3d8-de61-4c2a-a4cb-80aa220bbd58">46.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzE3LTUtMS0xLTMxNDIy_bb9e7b45-dbfc-4912-b534-3c7622a9dfe5">63.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzE4LTEtMS0xLTMxNDIy_880f1dbb-348c-4dcc-b5a1-1b666a84bc03"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzE4LTEtMS0xLTMxNDIy_f8cad04d-71fd-46bb-923e-4808391f9a87">3,016.9</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzE4LTMtMS0xLTMxNDIy_1a484cf2-0b19-465b-8348-ac580548f85e">1,231.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzE4LTUtMS0xLTMxNDIy_58825ec9-05e1-4e39-ab42-4c1b7a3827a8">1,803.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash received (paid) for acquisitions, net of cash acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzIwLTEtMS0xLTMxNDIy_8ba8fbea-d4b8-40c1-8667-58c6f6d0c456">277.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzIwLTMtMS0xLTMxNDIy_b045637c-39c2-41f9-884e-e2fa96e94cd5">415.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzIwLTUtMS0xLTMxNDIy_67a16517-591c-4985-b5e3-708e9225108f">148.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzIxLTEtMS0xLTMxNDIy_edf0f26e-2995-4e67-af9f-d1b26cbb2406">457.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzIxLTMtMS0xLTMxNDIy_03257c53-45da-4c0f-acb3-382c5c18f479">243.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzIxLTUtMS0xLTMxNDIy_0d316223-73a5-46e6-8360-c2e0f896a0bb">213.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments for product rights and other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzIyLTEtMS0xLTMxNDIy_3504a5d1-388f-4e95-92ee-5ae4d7834b20">52.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzIyLTMtMS0xLTMxNDIy_83b4ce69-79c9-48b1-b2bc-f052c60b886f">438.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzIyLTUtMS0xLTMxNDIy_0b5e7987-fa96-49ea-8b41-0393ff728ad1">192.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sale of property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzIzLTEtMS0xLTMxNDIy_2e50d6cd-b89b-447e-aadc-7869d5916a31">18.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzIzLTMtMS0xLTMxNDIy_4a0b6d1f-7c2e-40a6-b270-47334eb523ee">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzIzLTUtMS0xLTMxNDIy_0c901954-07d2-4ceb-894e-6411c927cfbc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sale of assets and subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzI0LTEtMS0xLTMxNDIy_78b05ad1-170e-48c9-826a-212cc2c2565e">96.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzI0LTMtMS0xLTMxNDIy_62eaa971-f2de-447f-b0a8-192dffde8242">20.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzI0LTUtMS0xLTMxNDIy_ca795139-a60c-44b0-9b52-3a55745fab34">28.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzI1LTEtMS0xLTMxNDIy_295c1256-5821-41df-ba3e-cfcfb0f42d77">30.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzI1LTMtMS0xLTMxNDIy_9a1c34b5-d7dc-4e47-8166-fd3c5b983b44">104.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzI1LTUtMS0xLTMxNDIy_b5e4cb88-8bae-42be-919c-eaca050a2f30">25.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from the sale of marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzI2LTEtMS0xLTMxNDIy_12a17127-24db-4262-8bee-a8ddd43655c5">29.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzI2LTMtMS0xLTMxNDIy_f2136368-e7b4-4fe8-b92f-2572f2c294cb">47.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzI2LTUtMS0xLTMxNDIy_11bec288-8921-4d2b-87af-c91c8c006c8b">27.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzI3LTEtMS0xLTMxNDIy_48273a2b-7ad5-4073-9e16-67cfaaba514c">117.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzI3LTMtMS0xLTMxNDIy_48d8d13f-9fbd-41f4-972b-0b342ffc0c31">301.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzI3LTUtMS0xLTMxNDIy_dcbdd751-694e-471a-baf5-a4210fb6de54">525.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from issuance of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzI5LTEtMS0xLTMxNDIy_af7999a2-106f-4990-bd4c-981451e07711">1,710.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzI5LTMtMS0xLTMxNDIy_03dfeb0a-c265-478c-8142-ff68e1559e17">983.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzI5LTUtMS0xLTMxNDIy_1b1cb8be-7883-4ef6-875a-e632e29e3100">7.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzMwLTEtMS0xLTMxNDIy_72caf5b4-2f50-4629-bcb6-a55124e8726d">4,201.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzMwLTMtMS0xLTMxNDIy_e74d062c-fecc-463e-8d3e-b2363fb832d1">2,484.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzMwLTUtMS0xLTMxNDIy_efbf646e-9c60-404b-b402-9df16572b644">1,108.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments of financing fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:PaymentsOfFinancingCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzMxLTEtMS0xLTMxNDIy_e48e9942-c740-4ee8-ada2-7f598be7aca5">7.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsOfFinancingCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzMxLTMtMS0xLTMxNDIy_5810dc31-df18-4e77-a176-8acfde919af3">2.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:PaymentsOfFinancingCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzMxLTUtMS0xLTMxNDIy_89118f96-f9d6-403a-955c-f39ac42c4cbb">3.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in short-term borrowings, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzMyLTEtMS0xLTMxNDIy_36d91701-8274-4e0d-b529-fd9f9e41d231">392.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzMyLTMtMS0xLTMxNDIy_957c9295-9c1c-4e8c-a94b-4eee2da7f25c">1,099.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzMyLTUtMS0xLTMxNDIy_5ff4b94e-99cc-46da-a107-d5ed1ff76585">1.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzM0LTEtMS0xLTMxNDIy_ee5cd4ef-607f-4e73-a806-f7f68b03a097">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzM0LTMtMS0xLTMxNDIy_662c558a-4b45-476f-8895-0b6baab92e98">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzM0LTUtMS0xLTMxNDIy_64601915-c9ae-415a-812c-97fc7e5ed9c4">8.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxes paid related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzM1LTEtMS0xLTMxNDIy_8fdc15a4-1787-4014-94db-e5ea75a881fc">17.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzM1LTMtMS0xLTMxNDIy_05ae8efa-929b-4a62-9b74-16bc142b7952">7.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzM1LTUtMS0xLTMxNDIy_e0c37a46-bc99-4e45-8d30-25e5b18d437d">8.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzM2LTEtMS0xLTMxNDIy_b3cd440f-a4b5-4f12-bdf4-9d8dd2df9b80">28.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzM2LTMtMS0xLTMxNDIy_1b1df502-8ee6-4be5-a6b1-5334681a9350">48.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzM2LTUtMS0xLTMxNDIy_056a3b47-f7b7-406b-98d4-30958fc7c613">60.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash dividends paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:PaymentsToMinorityShareholders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzM3LTEtMS0xLTMxNDIy_3af83d22-47be-48ca-8fea-7c2baf72bf58">399.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsToMinorityShareholders" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzM3LTMtMS0xLTMxNDIy_60d356de-e213-42f9-84fe-33b2dcbdfdc1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:PaymentsToMinorityShareholders" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzM3LTUtMS0xLTMxNDIy_e43d22fd-1be4-403f-83ee-76fa4697e062">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-contingent payments for product rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="vtrs:PaymentsForNonContingentConsiderationForProductRightsFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzM4LTEtMS0xLTMxNDIy_e8781326-5249-4cf2-92fd-fa42c2aacf2b">456.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="vtrs:PaymentsForNonContingentConsiderationForProductRightsFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzM4LTMtMS0xLTMxNDIy_4e16b08b-0ac2-40e2-b7f8-4b3bdc44155e">143.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="vtrs:PaymentsForNonContingentConsiderationForProductRightsFinancingActivities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzM4LTUtMS0xLTMxNDIy_dfc571c1-934c-481d-a1c4-0aa8f8df51f5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other items, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzM5LTEtMS0xLTMxNDIy_7e29b21a-dd75-444d-88b3-f45ba58e53cc">4.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzM5LTMtMS0xLTMxNDIy_4db02086-3918-4f43-85e7-287e0ca8d337">3.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzM5LTUtMS0xLTMxNDIy_3ef5abde-36dc-41fe-98c6-74c3ecaeb5d6">2.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzQwLTEtMS0xLTMxNDIy_4bf47bcf-a914-45a8-8a15-794238f0a8a9">3,012.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzQwLTMtMS0xLTMxNDIy_41a435ff-5ae3-440b-bc18-4d6140b06c84">605.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzQwLTUtMS0xLTMxNDIy_75ac939c-fed9-4a80-9b6c-441fe8af379b">1,169.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect on cash of changes in exchange rates</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzQxLTEtMS0xLTMxNDIy_2b266964-1635-4f35-a379-27ef70092895">30.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzQxLTMtMS0xLTMxNDIy_1ab1679b-5894-4075-bb2b-89e03ff16d56">33.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzQxLTUtMS0xLTMxNDIy_d681cc47-817d-495d-a308-e0830a5386e2">7.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (decrease) increase in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzQyLTEtMS0xLTMxNDIy_7b88a911-0b55-4434-b5ce-47810f9629b8">143.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzQyLTMtMS0xLTMxNDIy_ec553a6d-fa47-4948-b56c-520657711023">358.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzQyLTUtMS0xLTMxNDIy_f3968f21-0a05-417e-9730-34b86e6198c3">101.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash &#8212; beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzQzLTEtMS0xLTMxNDIy_59b59538-62d7-47ae-bc9f-5f77173edd00">850.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac503b6d629d4bafb262ea6ec0b8a25e_I20191231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzQzLTMtMS0xLTMxNDIy_e10049a2-3baf-4632-8ead-12c6a7ecdcbe">491.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8ec92ba24d848d697ba737aeed13c05_I20181231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzQzLTUtMS0xLTMxNDIy_634a0b0e-a6f2-4bf5-a620-d6cb28b870f4">389.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash &#8212; end of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzQ0LTEtMS0xLTMxNDIy_5e036a2b-d585-474f-bc5a-e0c597d6cc2a">706.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzQ0LTMtMS0xLTMxNDIy_59b59538-62d7-47ae-bc9f-5f77173edd00">850.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac503b6d629d4bafb262ea6ec0b8a25e_I20191231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzQ0LTUtMS0xLTMxNDIy_80c682de-cad0-43b4-abaf-576e56af9442">491.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supplemental disclosures of cash flow information &#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash transactions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issued for the Combination</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzQ3LTEtMS0xLTMxNDIy_5c6dc49a-ef91-4dd3-a6bb-ed5df03b581c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzQ3LTMtMS0xLTMxNDIy_75214f9d-4f96-45c1-98c4-ae9a03ff114f">10,727.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzQ3LTUtMS0xLTMxNDIy_80276eff-c6f6-424b-a00d-ef1313f1d0da">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid during the period for:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzUwLTEtMS0xLTMxNDIy_ffaa55ac-4738-4981-ad86-fd4e1e6ad8f3">641.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzUwLTMtMS0xLTMxNDIy_68e2e90c-de00-45ad-8c17-4543887421ba">324.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzUwLTUtMS0xLTMxNDIy_3c154236-5b9c-4997-946c-fc3d149b1473">278.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzUxLTEtMS0xLTMxNDIy_171a3671-799c-42aa-a82e-10975ca68726">684.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzUxLTMtMS0xLTMxNDIy_b8ef20e5-25ae-44a1-8399-db194d6831a3">555.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzUxLTUtMS0xLTMxNDIy_7cb47842-1715-4a03-b2c0-23042d940777">470.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Notes to Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_169"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Viatris Inc. and Subsidiaries</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_172"></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:NatureOfOperations" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzIvZnJhZzoxZGRmNDEyZTE3NDQ0Zjg5OTVhYWI5NThlM2JhZTgzZC90ZXh0cmVnaW9uOjFkZGY0MTJlMTc0NDRmODk5NWFhYjk1OGUzYmFlODNkXzI1NDA_3e0e07d9-46fe-40eb-aee8-d7e857d27174" continuedAt="i5d3b3a1066a445b7b51ef6f3db1400a1" escape="true">Nature of Operations</ix:nonNumeric></span></div><ix:continuation id="i5d3b3a1066a445b7b51ef6f3db1400a1"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Viatris is a global healthcare company formed in November 2020 whose mission is to empower people worldwide to live healthier at every stage of life, regardless of geography or circumstance. Improving the ability of patients to gain access to sustainable and high-quality healthcare is our relentless pursuit. One that rests on visionary thinking, determination and best-in-class capabilities that were strategically built to remove barriers across the health spectrum and advance access globally. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Viatris&#8217; portfolio comprises more than <ix:nonFraction unitRef="molecule" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="INF" name="vtrs:NumberOfMolecules" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzIvZnJhZzoxZGRmNDEyZTE3NDQ0Zjg5OTVhYWI5NThlM2JhZTgzZC90ZXh0cmVnaW9uOjFkZGY0MTJlMTc0NDRmODk5NWFhYjk1OGUzYmFlODNkXzgzMA_ed0d64a9-505d-4810-9829-3276c851fa31">1,400</ix:nonFraction> approved molecules across a wide range of key therapeutic areas, including globally recognized iconic and key brands, generics, complex generics, and biosimilars. The Company operates approximately <ix:nonFraction unitRef="site" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="INF" name="vtrs:NumberOfManufacturingSites" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzIvZnJhZzoxZGRmNDEyZTE3NDQ0Zjg5OTVhYWI5NThlM2JhZTgzZC90ZXh0cmVnaW9uOjFkZGY0MTJlMTc0NDRmODk5NWFhYjk1OGUzYmFlODNkXzEwMzM_1ec0279e-0f50-4cd5-ae52-e1e607e99e10">40</ix:nonFraction> manufacturing sites worldwide that produce oral solid doses, injectables, complex dosage forms and APIs. We conduct our business through four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. Viatris is headquartered in the U.S., with global centers in Pittsburgh, Pennsylvania, Shanghai, China and Hyderabad, India.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC 805, Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Mylan is considered the accounting acquirer of the Upjohn Business and all historical financial information of the Company prior to November 16, 2020 represents Mylan&#8217;s historical results and the Company&#8217;s thereafter.</span></div></ix:continuation><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_175"></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzMzNjMw_fc8156d3-ec94-4a62-a3a5-be81c07bea14" continuedAt="i1c7c51a368fe408aa9a581f66fc78d5a" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="i1c7c51a368fe408aa9a581f66fc78d5a" continuedAt="i6590dde793824c34b4db7007b00a2414"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzMzNTI2_02432d60-da06-4d99-a9a6-8ca675321074" continuedAt="i8877f635754f41b4ad2014df83e44444" escape="true">Principles of Consolidation.</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8877f635754f41b4ad2014df83e44444">&#160;The consolidated financial statements include the accounts of Viatris and those of its wholly owned and majority-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. Investments in equity method affiliates are recorded at cost and adjusted for the Company&#8217;s share of the affiliates&#8217; cumulative results of operations, capital contributions and distributions.</ix:continuation>  </span></div><div style="margin-bottom:12pt;text-indent:36pt"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzMzNjMx_179527ff-8119-4ca4-8f61-b6206563e867" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates in the Preparation of Financial Statements.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The preparation of financial statements, in conformity with U.S. GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Because of the uncertainty inherent in such estimates, actual results could differ from those estimates.</span></ix:nonNumeric></div><div style="margin-bottom:12pt;text-indent:36pt"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzMzNjM5_dd87a94f-e212-4c86-9c3e-c3727e2d299b" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currencies.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The consolidated financial statements are presented in U.S.&#160;Dollars, the reporting currency of Viatris. Statements of Operations and Cash Flows of all of the Company&#8217;s subsidiaries that have functional currencies other than U.S.&#160;Dollars are translated at a weighted average exchange rate for the period for inclusion in the consolidated statements of operations and cash flows, whereas assets and liabilities are translated at the end of the period exchange rates for inclusion in the consolidated balance sheets. Translation differences are recorded directly in shareholders&#8217; equity as foreign currency translation adjustments. Gains or losses on transactions denominated in a currency other than the subsidiaries&#8217; functional currency, which arise as a result of changes in foreign currency exchange rates, are recorded in the consolidated statements of operations.</span></ix:nonNumeric></div><div style="margin-bottom:12pt;text-indent:36pt"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzMzNTU4_ce486d88-2332-46a8-961c-332d8d4ab0bd" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Cash and cash equivalents are comprised of highly liquid investments with an original maturity of three months or less at the date of purchase.</span></ix:nonNumeric></div><div style="margin-bottom:12pt;text-indent:36pt"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:MarketableSecuritiesPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzMzNTk1_2260a856-aebc-47a0-b2c8-8146c1b2cf5c" continuedAt="iad6058e58f7142a9844bc577124dd9b5" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt and Equity Securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Debt securities classified as available-for-sale on the date of purchase are recorded at fair value, with net unrealized gains and losses, net of income taxes, reflected in accumulated other comprehensive loss as a component of shareholders&#8217; equity. Net realized gains and losses on sales of available-for-sale debt securities are computed on a specific security basis and are included in other expense, net, in the consolidated statements of operations. Debt securities classified as trading securities are valued using the quoted market price from broker or dealer quotations or transparent pricing sources at the reporting date, with gains and losses included in other expense, net, in the consolidated statements of operations. Fair value is determined based on observable market quotes or valuation models using assessments of counterparty credit worthiness, credit risk or underlying security and overall capital market liquidity. Debt securities are reviewed for impairment by assessing if the decline in market value of the investment below the carrying value is other than temporary.</span></ix:nonNumeric></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><ix:continuation id="i6590dde793824c34b4db7007b00a2414" continuedAt="ib4f82ef640af4b9e987ceb8fee173dd0"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iad6058e58f7142a9844bc577124dd9b5">Investments in equity securities with readily determinable fair values are recorded at fair value with changes in fair value recorded in other expense, net in the consolidated statements of operations. Investments in equity securities without readily determinable fair values are recorded at cost minus any impairment, plus or minus changes in their estimated fair value resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. Investments in entities are accounted for using the equity method of accounting when the ability to exercise significant influence over the operating and financial decisions of the investee is maintained. The share of net income or losses of equity method investments are included in other expense, net in the consolidated statements of operations. Investments in equity securities without readily determinable fair values and investments in equity accounted for using the equity method are assessed for potential impairment on a quarterly basis based on qualitative factors.</ix:continuation></span></div><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:ConcentrationRiskCreditRisk" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzMzNTIy_2aa85eda-eda9-448b-8815-d38724dca41b" escape="true"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Financial instruments that potentially subject the Company to credit risk consist principally of interest-bearing investments, derivatives and accounts receivable.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Viatris invests its excess cash in high-quality, liquid money market instruments, principally overnight deposits and highly rated money market funds. The Company maintains deposit balances at certain financial institutions in excess of federally insured amounts. Periodically, the Company reviews the creditworthiness of its counterparties to derivative transactions, and it does not expect to incur a loss from failure of any counterparties to perform under agreements it has with such counterparties.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzMzNjA2_70a32e7b-466c-43f8-8a05-38d542f62b84" continuedAt="ic70bc113f2134f8caef2ff4071207a3c" escape="true">Inventories.</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic70bc113f2134f8caef2ff4071207a3c">&#160;Inventories are stated at the lower of cost and net realizable value, with cost principally determined by the weighted average cost method. Provisions for potentially obsolete or slow-moving inventory, including pre-launch inventory, are made based on our analysis of product dating, inventory levels, historical obsolescence and future sales forecasts. Included as a component of cost of sales is expense related to the net realizable value of inventories.</ix:continuation> </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzMzNTQ1_0644f8e8-5b3c-430b-b203-937ef95ad966" continuedAt="i2c4d58b0fa824987bcb0f42c61cc4143" escape="true">Property, Plant and Equipment.</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2c4d58b0fa824987bcb0f42c61cc4143">&#160;Property, plant and equipment are stated at cost less accumulated depreciation. Depreciation is computed and recorded on a straight-line basis over the assets&#8217; estimated service lives (<ix:nonNumeric contextRef="i8c96921a8e77407497a3fe28076245b9_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzUzNzM_8d8b0d44-ab35-464f-9fbd-444c700ee548">3</ix:nonNumeric> to <ix:nonNumeric contextRef="i982f994b896949038225ee2127e449b8_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzUzNzk_3ee9d6ec-6c04-4cbf-a7de-07534d463857">18</ix:nonNumeric> years for machinery and equipment and other fixed assets and <ix:nonNumeric contextRef="i17e28a6fde804fee9a50f41480db4409_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzU0Mzc_45eb0383-d534-49e6-9f74-daf01b55df58">15</ix:nonNumeric> to <ix:nonNumeric contextRef="i2f9c5e0f0ba44c18819a8dd18e51076c_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzU0NDM_24a2600f-f2c0-4cb6-a100-4fe1e210fc09">39</ix:nonNumeric> years for buildings and improvements). Capitalized software is included in property, plant and equipment and is amortized over estimated useful lives ranging from <ix:nonNumeric contextRef="i33eb2ebb7c134785bb1904a27dee8446_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzU2MDM_c1a11fd0-7301-433c-ae3a-0bd973a7b94c">3</ix:nonNumeric> to <ix:nonNumeric contextRef="i0ecc2d6f42a84a91b65e020dbcaad871_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzU2MDk_7ff96b0b-0907-4699-af86-7ba78b8c343d">7</ix:nonNumeric> years.</ix:continuation> </span></div><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzMzNjcx_71428961-e430-47fc-a852-5858c33cba0d" continuedAt="i9d358a86014a42c4a07f2a0a7689f125" escape="true"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets and Goodwill.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Intangible assets are stated at cost less accumulated amortization. Amortization is generally recorded on a straight-line basis over estimated useful lives ranging from <ix:nonNumeric contextRef="i84ab0bd68a334690be79969b61dd4796_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzU4MTU_cebe7f78-c79c-4f53-9607-44e57ff0d59e">3</ix:nonNumeric> to <ix:nonNumeric contextRef="i500214b091fd4491a3e5f7c09d556da9_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzU4MjE_23b66a8d-8d56-4bb0-9107-73b8b7e54b7c">20</ix:nonNumeric> years. The Company periodically reviews the estimated useful lives of intangible assets and makes adjustments when events indicate that a shorter life is appropriate.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for acquired businesses using the acquisition method of accounting in accordance with the provisions of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC 805, Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which requires that the assets acquired and liabilities assumed be recorded at the date of acquisition at their respective estimated fair values. The cost to acquire businesses is allocated to the underlying net assets of the acquired business based on estimates of their respective fair values. Amounts allocated to acquired IPR&amp;D are capitalized at the date of acquisition and, at that time, such IPR&amp;D assets have indefinite lives. As products in development are approved for sale, amounts are allocated to product rights and licenses and will be amortized over their estimated useful lives. Finite-lived intangible assets are amortized over the expected life of the asset. Any excess of the purchase price over the estimated fair values of the net assets acquired is recorded as goodwill.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchases of developed products and licenses that are accounted for as asset acquisitions are capitalized as intangible assets and amortized over an estimated useful life. IPR&amp;D assets acquired as part of an asset acquisition are expensed immediately if they have no alternative future uses.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews goodwill for impairment at least annually or more frequently if events or changes in circumstances indicate that the carrying value of goodwill may not be recoverable based on management's assessment of the fair value of the Company's reporting units as compared to their related carrying value. Under the authoritative guidance issued by the FASB, we have the option to first assess the qualitative factors to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform a quantitative goodwill impairment test. If we choose to use qualitative factors and determine that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, then the goodwill impairment test would be required. The goodwill impairment test requires the Company to estimate the fair value of the reporting unit and to compare the fair value of the reporting unit with its carrying amount. If the carrying amount is less than its fair value, then no impairment is recognized. If the carrying amount recorded exceeds the fair value calculated, an impairment charge is recorded for the difference. The judgments made in determining the projected cash flows used to estimate the fair value can materially impact the Company&#8217;s financial condition and results of operations. </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><ix:continuation id="ib4f82ef640af4b9e987ceb8fee173dd0" continuedAt="ib6c83267d8da42ebbc20e31e175aaf77"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9d358a86014a42c4a07f2a0a7689f125">Indefinite-lived intangibles, principally IPR&amp;D, are tested at least annually for impairment or upon the occurrence of a triggering event. The impairment test for IPR&amp;D consists of a comparison of the asset&#8217;s fair value with its carrying value. Impairment is determined to exist when the fair value of IPR&amp;D assets, which is based upon updated forecasts and commercial development plans, is less than the carrying value of the assets being tested.</ix:continuation></span></div><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:BusinessCombinationsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzMzNTQ3_03d4fdd3-eb32-4e72-850d-c250010804e5" escape="true"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Consideration.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Viatris records contingent consideration resulting from business acquisitions at its estimated fair value on the acquisition date. Each reporting period thereafter, the Company revalues these obligations and records increases or decreases in their fair value as adjustments to litigation settlements and other contingencies, net within the consolidated statements of operations. Changes in the fair value of the contingent consideration obligations can result from adjustments to the discount rates, payment periods and adjustments in the probability of achieving future development steps, regulatory approvals, market launches, sales targets and profitability. These fair value measurements represent Level 3 measurements as they are based on significant inputs not observable in the market. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant judgment is employed in determining the assumptions utilized as of the acquisition date and for each subsequent measurement period. Accordingly, changes in the assumptions described above could have a material impact on the Company&#8217;s consolidated financial condition and results of operations.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzMzNTQy_1fd38058-d4bf-4e65-ab14-f4741d0fc6ff" escape="true"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment of Long-Lived Assets.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The carrying values of long-lived assets, which include property, plant and equipment and intangible assets with finite lives, are evaluated periodically in relation to the expected future undiscounted cash flows of the underlying assets and monitored for other potential triggering events. The assessment for impairment is based on our ability to recover the carrying value of the long-lived assets or asset grouping by analyzing the expected future undiscounted pre-tax cash flows specific to the asset or asset grouping. If the carrying amount is greater than the undiscounted cash flows, the Company recognizes an impairment loss for the excess of the carrying amount over the estimated fair value based on discounted cash flows.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant management judgment is involved in estimating the recoverability of these assets and is dependent upon the accuracy of the assumptions used in making these estimates, as well as how the estimates compare to the eventual future operating performance of the specific asset or asset grouping. Any future long-lived assets impairment charges could have a material impact on the Company&#8217;s consolidated financial condition and results of operations.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;text-indent:36pt"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:DebtPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzMzNjU3_52c788a9-d704-4584-9397-83b94652b84f" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-Term Borrowings.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The Company&#8217;s subsidiaries in India have working capital facilities with several banks which are secured by its current assets. The Company also has the CP Notes, Receivables Facility, which will expire in April 2022 and the Note Securitization Facility, which will expire in August 2022. Under the terms of each of the Receivables Facility and Note Securitization Facility, certain of our accounts receivable secure the amounts borrowed and cannot be used to pay our other debts or liabilities. As the accounts receivable do not transfer to the banks, any amounts outstanding under the facilities are recorded as borrowings and the underlying receivables continue to be included in accounts receivable, net, in the consolidated balance sheets.</span></ix:nonNumeric></div><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzMzNzA3_7827473b-ca13-4390-b4ba-1630190160d7" continuedAt="ie65f008396514b4d96534f8d1c169871" escape="true"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenues in accordance with ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Under ASC 606, the Company recognizes net revenue for product sales when control of the promised goods or services is transferred to our customers in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. Revenues are recorded net of provisions for variable consideration, including discounts, rebates, governmental rebate programs, price adjustments, returns, chargebacks, promotional programs and other sales allowances. Accruals for these provisions are presented in the consolidated financial statements as reductions in determining net sales and as a contra asset in accounts receivable, net (if settled via credit) and other current liabilities (if paid in cash). Amounts recorded for revenue deductions can result from a complex series of judgements about future events and uncertainties and can rely heavily on estimates and assumptions. The following section briefly describes the nature of our provisions for variable consideration and how such provisions are estimated:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Chargebacks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: the Company has agreements with certain indirect customers, such as independent pharmacies, retail pharmacy chains, managed care organizations, hospitals, nursing homes, governmental agencies and pharmacy benefit managers, which establish contract prices for certain products. The indirect customers then independently select a wholesaler from which to purchase the products at these contracted prices. Alternatively, certain wholesalers may enter into agreements with indirect customers that establish contract pricing for certain products, which the wholesalers provide. Under either arrangement, Viatris will provide credit to the wholesaler for any difference between the contracted price with the indirect party and the wholesaler&#8217;s invoice price. Such credits are called chargebacks. The provision for chargebacks is based on expected sell-through levels by our wholesaler customers to indirect customers, as well as estimated wholesaler inventory levels.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><ix:continuation id="ib6c83267d8da42ebbc20e31e175aaf77" continuedAt="i8237b538d2ee410eada810cd7784ab7a"><ix:continuation id="ie65f008396514b4d96534f8d1c169871" continuedAt="i0a9a457a0d384b259857a4c272b74c03"><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Rebates, promotional programs and other sales allowances</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: this category includes rebate and other programs to assist in product sales. These programs generally provide that the customer receives credit directly related to the amount of purchases or credits upon the attainment of pre-established volumes. Also included in this category are prompt pay discounts, administrative fees and price adjustments to reflect decreases in the selling prices of products. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Returns</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: consistent with industry practice, Viatris maintains a return policy that allows customers to return a product, which varies country by country in accordance with local practices, generally within a specified period prior (six months) and subsequent (twelve months) to the expiration date. The Company&#8217;s estimate of the provision for returns is generally based upon historical experience with actual returns. Generally, returned products are destroyed and customers are refunded the sales price in the form of a credit.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Governmental rebate programs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: government reimbursement programs in the U.S. include Medicare, Medicaid, and State Pharmacy Assistance Programs established according to statute, regulations and policy. Manufacturers of pharmaceutical products that are covered by the Medicaid program are required to pay rebates to each state based on a statutory formula set forth in the Social Security Act. Medicare beneficiaries are eligible to obtain discounted prescription drug coverage from private sector providers. In addition, certain states have also implemented supplemental rebate programs that obligate manufacturers to pay rebates in excess of those required under federal law. Our estimate of these rebates is based on the historical trends of rebates paid as well as on changes in wholesaler inventory levels and increases or decreases in the level of sales. We estimate discounts on branded prescription drug sales to Medicare Part D participants in the Medicare &#8220;coverage gap&#8221; based on historical experience of prescriptions and utilization expected to result in the discount of the &#8220;coverage gap&#8221;.</span></div><div style="margin-bottom:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outside the U.S., the majority of our pharmaceutical sales are contractually or legislatively governed. In certain European countries, certain rebates are calculated on the governments total pharmaceutical spending or on specific product sale thresholds. We utilize historical data and obtain third party information to determine the adequacy of these accruals. Also, this provision includes price reductions that are mandated by law outside of the U.S. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our net sales may be impacted by wholesaler and distributor inventory levels of our products, which can fluctuate throughout the year due to the seasonality of certain products, pricing, the timing of product demand, purchasing decisions and other factors. Such fluctuations may impact the comparability of our net sales between periods.</span></div></ix:continuation><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0a9a457a0d384b259857a4c272b74c03">Consideration received from licenses of intellectual property is recorded as other revenues. Royalty or profit share amounts, which are based on sales of licensed products or technology, are recorded when the customer&#8217;s subsequent sales or usages occur. Such consideration is included in other revenues in the consolidated statements of operations.</ix:continuation> </span></div><div style="margin-bottom:12pt;text-indent:36pt"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzMzNTI0_b3eb24b6-0ed2-4fcf-9843-690dd865de53" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;R&amp;D expenses are charged to operations as incurred.</span></ix:nonNumeric></div><div style="margin-bottom:12pt;text-indent:36pt"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzMzNjkz_c97371c6-fca7-46cf-a020-a3975f85b8a4" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Income taxes have been provided for using an asset and liability approach in which deferred income taxes reflect the tax consequences on future years of events that the Company has already recognized in the financial statements or tax returns. Changes in enacted tax rates or laws may result in adjustments to the recorded tax assets or liabilities in the period that the new tax law is enacted.</span></ix:nonNumeric></div><div style="margin-bottom:12pt;text-indent:36pt"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzMzNTUy_3c9eb375-a007-49e7-a4e8-a6590182fb7e" continuedAt="ie47911b916864572b76e08e32a057097" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Earnings per Share.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Basic earnings per share is computed by dividing net earnings attributable to holders of Viatris Inc. common stock by the weighted average number of shares outstanding during the period. Diluted earnings per share is computed by dividing net earnings attributable to holders of Viatris Inc. common stock by the weighted average number of shares outstanding during the period increased by the number of additional shares that would have been outstanding related to potentially dilutive securities or instruments, if the impact is dilutive.</span></ix:nonNumeric></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><ix:continuation id="i8237b538d2ee410eada810cd7784ab7a" continuedAt="i5de9569f59b541e08235b24eff29ef78"><ix:continuation id="ie47911b916864572b76e08e32a057097" continuedAt="i3259876c870847e48ef8f4a72c409624"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzMzNjEx_deefdf92-5ff3-4b90-9af9-dd70e78ab632" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted earnings per share attributable to Viatris Inc. are calculated as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.261%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions, except per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Basic (loss) earnings attributable to Viatris Inc. common shareholders (numerator):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) earnings attributable to Viatris Inc. common shareholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i14dba6c874d24fcfae05dbedf70952aa_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90YWJsZTo4M2E5YTM0ZTcyYzA0NzU2YjNkMGQ2OGQ2NmMzMDg1Zi90YWJsZXJhbmdlOjgzYTlhMzRlNzJjMDQ3NTZiM2QwZDY4ZDY2YzMwODVmXzMtMS0xLTEtMzE0MjI_2de4079b-7e4b-412f-ae17-b4df2b272175">1,269.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idc41db043d3e4f84b4c531fda801f18c_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90YWJsZTo4M2E5YTM0ZTcyYzA0NzU2YjNkMGQ2OGQ2NmMzMDg1Zi90YWJsZXJhbmdlOjgzYTlhMzRlNzJjMDQ3NTZiM2QwZDY4ZDY2YzMwODVmXzMtMy0xLTEtMzE0MjI_ccc00b2a-1344-4a84-ba86-c515c64b09c1">669.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f90527bae0344d981ff43fd2126b229_D20190101-20191231" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90YWJsZTo4M2E5YTM0ZTcyYzA0NzU2YjNkMGQ2OGQ2NmMzMDg1Zi90YWJsZXJhbmdlOjgzYTlhMzRlNzJjMDQ3NTZiM2QwZDY4ZDY2YzMwODVmXzMtNS0xLTEtMzE0MjI_a9e0d3cf-5152-4f9a-bfa4-cab43ab20e7a">16.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares (denominator):</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90YWJsZTo4M2E5YTM0ZTcyYzA0NzU2YjNkMGQ2OGQ2NmMzMDg1Zi90YWJsZXJhbmdlOjgzYTlhMzRlNzJjMDQ3NTZiM2QwZDY4ZDY2YzMwODVmXzUtMS0xLTEtMzE0MjI_8ef8d9a4-49c3-4abd-a284-236ef377f112">1,208.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90YWJsZTo4M2E5YTM0ZTcyYzA0NzU2YjNkMGQ2OGQ2NmMzMDg1Zi90YWJsZXJhbmdlOjgzYTlhMzRlNzJjMDQ3NTZiM2QwZDY4ZDY2YzMwODVmXzUtMy0xLTEtMzE0MjI_c5bdb6eb-0912-432b-adee-c98b880cf10f">601.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90YWJsZTo4M2E5YTM0ZTcyYzA0NzU2YjNkMGQ2OGQ2NmMzMDg1Zi90YWJsZXJhbmdlOjgzYTlhMzRlNzJjMDQ3NTZiM2QwZDY4ZDY2YzMwODVmXzUtNS0xLTEtMzE0MjI_d286c930-1552-4da4-8348-235f7f5c1cba">515.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic (loss) earnings per share attributable to Viatris Inc. shareholders</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90YWJsZTo4M2E5YTM0ZTcyYzA0NzU2YjNkMGQ2OGQ2NmMzMDg1Zi90YWJsZXJhbmdlOjgzYTlhMzRlNzJjMDQ3NTZiM2QwZDY4ZDY2YzMwODVmXzYtMS0xLTEtMzE0MjI_83a56312-efc8-4c7c-8992-c89fc01be0f6">1.05</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90YWJsZTo4M2E5YTM0ZTcyYzA0NzU2YjNkMGQ2OGQ2NmMzMDg1Zi90YWJsZXJhbmdlOjgzYTlhMzRlNzJjMDQ3NTZiM2QwZDY4ZDY2YzMwODVmXzYtMy0xLTEtMzE0MjI_c5ddd91b-63c8-4bc7-81fc-322dc5e7ac2b">1.11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90YWJsZTo4M2E5YTM0ZTcyYzA0NzU2YjNkMGQ2OGQ2NmMzMDg1Zi90YWJsZXJhbmdlOjgzYTlhMzRlNzJjMDQ3NTZiM2QwZDY4ZDY2YzMwODVmXzYtNS0xLTEtMzE0MjI_a2850713-93e3-41e4-bb99-8401a21f7a65">0.03</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Diluted (loss) earnings attributable to Viatris Inc. common shareholders (numerator):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) earnings attributable to Viatris Inc. common shareholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i14dba6c874d24fcfae05dbedf70952aa_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90YWJsZTo4M2E5YTM0ZTcyYzA0NzU2YjNkMGQ2OGQ2NmMzMDg1Zi90YWJsZXJhbmdlOjgzYTlhMzRlNzJjMDQ3NTZiM2QwZDY4ZDY2YzMwODVmXzktMS0xLTEtMzE0MjI_2de4079b-7e4b-412f-ae17-b4df2b272175">1,269.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idc41db043d3e4f84b4c531fda801f18c_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90YWJsZTo4M2E5YTM0ZTcyYzA0NzU2YjNkMGQ2OGQ2NmMzMDg1Zi90YWJsZXJhbmdlOjgzYTlhMzRlNzJjMDQ3NTZiM2QwZDY4ZDY2YzMwODVmXzktMy0xLTEtMzE0MjI_ccc00b2a-1344-4a84-ba86-c515c64b09c1">669.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f90527bae0344d981ff43fd2126b229_D20190101-20191231" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90YWJsZTo4M2E5YTM0ZTcyYzA0NzU2YjNkMGQ2OGQ2NmMzMDg1Zi90YWJsZXJhbmdlOjgzYTlhMzRlNzJjMDQ3NTZiM2QwZDY4ZDY2YzMwODVmXzktNS0xLTEtMzE0MjI_a9e0d3cf-5152-4f9a-bfa4-cab43ab20e7a">16.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares (denominator):</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90YWJsZTo4M2E5YTM0ZTcyYzA0NzU2YjNkMGQ2OGQ2NmMzMDg1Zi90YWJsZXJhbmdlOjgzYTlhMzRlNzJjMDQ3NTZiM2QwZDY4ZDY2YzMwODVmXzExLTEtMS0xLTMxNDIy_8ef8d9a4-49c3-4abd-a284-236ef377f112">1,208.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90YWJsZTo4M2E5YTM0ZTcyYzA0NzU2YjNkMGQ2OGQ2NmMzMDg1Zi90YWJsZXJhbmdlOjgzYTlhMzRlNzJjMDQ3NTZiM2QwZDY4ZDY2YzMwODVmXzExLTMtMS0xLTMxNDIy_c5bdb6eb-0912-432b-adee-c98b880cf10f">601.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90YWJsZTo4M2E5YTM0ZTcyYzA0NzU2YjNkMGQ2OGQ2NmMzMDg1Zi90YWJsZXJhbmdlOjgzYTlhMzRlNzJjMDQ3NTZiM2QwZDY4ZDY2YzMwODVmXzExLTUtMS0xLTMxNDIy_d286c930-1552-4da4-8348-235f7f5c1cba">515.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90YWJsZTo4M2E5YTM0ZTcyYzA0NzU2YjNkMGQ2OGQ2NmMzMDg1Zi90YWJsZXJhbmdlOjgzYTlhMzRlNzJjMDQ3NTZiM2QwZDY4ZDY2YzMwODVmXzEyLTEtMS0xLTMxNDIy_673e2cfa-aae9-4d47-8301-316fe053cc08">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90YWJsZTo4M2E5YTM0ZTcyYzA0NzU2YjNkMGQ2OGQ2NmMzMDg1Zi90YWJsZXJhbmdlOjgzYTlhMzRlNzJjMDQ3NTZiM2QwZDY4ZDY2YzMwODVmXzEyLTMtMS0xLTMxNDIy_708f9fc7-fcee-4343-8143-7ef82a8f88fa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90YWJsZTo4M2E5YTM0ZTcyYzA0NzU2YjNkMGQ2OGQ2NmMzMDg1Zi90YWJsZXJhbmdlOjgzYTlhMzRlNzJjMDQ3NTZiM2QwZDY4ZDY2YzMwODVmXzEyLTUtMS0xLTMxNDIy_ffa34af3-9e7c-48f5-b93a-a195037f3839">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total dilutive shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90YWJsZTo4M2E5YTM0ZTcyYzA0NzU2YjNkMGQ2OGQ2NmMzMDg1Zi90YWJsZXJhbmdlOjgzYTlhMzRlNzJjMDQ3NTZiM2QwZDY4ZDY2YzMwODVmXzEzLTEtMS0xLTMxNDIy_3178fee6-4548-4899-8968-113aa36003f6">1,208.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90YWJsZTo4M2E5YTM0ZTcyYzA0NzU2YjNkMGQ2OGQ2NmMzMDg1Zi90YWJsZXJhbmdlOjgzYTlhMzRlNzJjMDQ3NTZiM2QwZDY4ZDY2YzMwODVmXzEzLTMtMS0xLTMxNDIy_859e6723-314f-4b73-a244-f3df085c4e22">601.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90YWJsZTo4M2E5YTM0ZTcyYzA0NzU2YjNkMGQ2OGQ2NmMzMDg1Zi90YWJsZXJhbmdlOjgzYTlhMzRlNzJjMDQ3NTZiM2QwZDY4ZDY2YzMwODVmXzEzLTUtMS0xLTMxNDIy_9d746273-3e48-4f4d-b888-89d70754042d">516.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted (loss) earnings per share attributable to Viatris Inc. shareholders</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90YWJsZTo4M2E5YTM0ZTcyYzA0NzU2YjNkMGQ2OGQ2NmMzMDg1Zi90YWJsZXJhbmdlOjgzYTlhMzRlNzJjMDQ3NTZiM2QwZDY4ZDY2YzMwODVmXzE0LTEtMS0xLTMxNDIy_dc094c6e-593d-4700-8f8f-bf19abe72cba">1.05</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90YWJsZTo4M2E5YTM0ZTcyYzA0NzU2YjNkMGQ2OGQ2NmMzMDg1Zi90YWJsZXJhbmdlOjgzYTlhMzRlNzJjMDQ3NTZiM2QwZDY4ZDY2YzMwODVmXzE0LTMtMS0xLTMxNDIy_a9e78228-852b-4b03-974a-87f5df89e659">1.11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90YWJsZTo4M2E5YTM0ZTcyYzA0NzU2YjNkMGQ2OGQ2NmMzMDg1Zi90YWJsZXJhbmdlOjgzYTlhMzRlNzJjMDQ3NTZiM2QwZDY4ZDY2YzMwODVmXzE0LTUtMS0xLTMxNDIy_d9bd64aa-f57a-40db-bf31-bffd7d9f9166">0.03</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average shares outstanding used in the computation of earnings per share for the year ended December 31, 2020 includes the effect of the 689.9 million shares issued for the closing of the Combination.</span></div></ix:continuation><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3259876c870847e48ef8f4a72c409624">Additional stock awards and restricted ordinary shares were outstanding during the years ended December&#160;31, 2021, 2020 and 2019 but were not included in the computation of diluted earnings per share for each respective period because the effect would be anti-dilutive. Excluded shares also include certain share-based compensation awards and restricted shares whose performance conditions had not been fully met. Such excluded shares and anti-dilutive awards represented <ix:nonFraction unitRef="shares" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzE5NTky_b16fe42c-332c-4114-adad-b22088ad7b54">12.7</ix:nonFraction> million, <ix:nonFraction unitRef="shares" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzE5NTk2_bc1c807f-7a52-42db-a507-4426bed98c2b">10.3</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzE5NjAz_1f6b4246-d19d-4706-a853-520460d2897a">9.1</ix:nonFraction> million shares for the years ended December&#160;31, 2021, 2020 and 2019, respectively</ix:continuation>. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company paid quarterly cash dividends of $<ix:nonFraction unitRef="usdPerShare" contextRef="i52196ab9082e4abaa0b8161e828c13e6_D20211216-20211216" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzU0OTc1NTgyMDI2NDY_6b27730b-9e60-4dd8-b27a-cef3af68e83c"><ix:nonFraction unitRef="usdPerShare" contextRef="i0914e4cffd32443cb84e261c6290c882_D20210616-20210616" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzU0OTc1NTgyMDI2NDY_e369b560-9b2d-4220-b910-556d9921560f"><ix:nonFraction unitRef="usdPerShare" contextRef="i49c23bc660594338939e7cd39689f85c_D20210916-20210916" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzU0OTc1NTgyMDI2NDY_f4fc6cad-986a-4d43-aa14-5c0b178c0851">0.11</ix:nonFraction></ix:nonFraction></ix:nonFraction> per share on the Company&#8217;s issued and outstanding common stock on June 16, 2021, September 16, 2021, and December 16, 2021. On January 4, 2022, the Company&#8217;s Board of Directors declared a quarterly cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="i85acd539c52b4ddd8dbb4b2c90aedaa6_D20220106-20220106" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzU0OTc1NTgyMDI2NTM_4e733960-1317-41ca-bbc5-9acaf8e2f186"><ix:nonFraction unitRef="usdPerShare" contextRef="id1b5d3649e684795b5f4c627d6ba66fa_I20220316" decimals="2" name="us-gaap:DividendsPayableAmountPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzU0OTc1NTgyMDI2NTM_7540c336-b1f1-4c9d-bd75-22ee1a1e9c2d">0.12</ix:nonFraction></ix:nonFraction> per share on the Company&#8217;s issued and outstanding common stock, which will be payable on March 16, 2022 to shareholders of record as of the close of business on February 24, 2022. The declaration and payment of future dividends to holders of the Company&#8217;s common stock will be at the discretion of the Board of Directors, and will depend upon factors, including but not limited to, the Company&#8217;s financial condition, earnings, capital requirements of its businesses, legal requirements, regulatory constraints, industry practice, and other factors that the Board of Directors deems relevant.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 28, 2022, the Company announced that its Board of Directors had authorized a share repurchase program for the repurchase of up to $<ix:nonFraction unitRef="usd" contextRef="ia473d9dc16fb4846abacc46ab07e5dd4_I20220228" decimals="-9" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzE2NDkyNjc1MDcyMjM_c64d2072-4ba3-421b-a88f-76cf63e0e01a">1.0</ix:nonFraction> billion of the Company&#8217;s shares of common stock. The Company has not yet repurchased any shares of common stock under the share repurchase program and the share repurchase program does not obligate the Company to acquire any particular amount of common stock. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzMzNjkw_3e923945-d13f-4074-b699-e06de4d66608" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The fair value of share-based compensation is recognized as expense in the consolidated statements of operations over the vesting period.</span></ix:nonNumeric></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzMzNjU4_12067134-da9e-456a-b4d6-b6525f1c67ec" continuedAt="i9737bb34516c49bf90d6a148f29a412c" escape="true">Derivatives.</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9737bb34516c49bf90d6a148f29a412c">&#160;From time to time the Company may enter into derivative financial instruments (mainly foreign currency exchange forward contracts, interest rate swaps and purchased equity call options) designed to: 1) hedge the cash flows resulting from existing assets and liabilities and transactions expected to be entered into over the next 24 months in currencies other than the functional currency, 2) hedge the variability in interest expense on floating rate debt, 3) hedge the fair value of fixed-rate notes, 4) hedge against changes in interest rates that could impact future debt issuances, 5) hedge cash or share payments required on conversion of issued convertible notes, 6) hedge a net investment in a foreign operation, or 7) economically hedge the foreign currency exposure associated with the purchase price of non-U.S. acquisitions. Derivatives are recognized as assets or liabilities in the consolidated balance sheets at their fair value. When the derivative instrument qualifies as a cash flow hedge, changes in the fair value are deferred through other comprehensive earnings. If a derivative instrument qualifies as a fair value hedge, the changes in the fair value, as well as the offsetting changes in the fair value of the hedged items, are generally included in interest expense. When such instruments do not qualify for hedge accounting the changes in fair value are recorded in the consolidated statements of operations within other expense, net</ix:continuation>. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><ix:continuation id="i5de9569f59b541e08235b24eff29ef78"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzMzNjkx_0348997c-5f77-455e-8136-6923e30d2af6" continuedAt="i47793f87eb9d4267b6be83fc5aa03e83" escape="true"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instruments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The Company&#8217;s financial instruments consist primarily of short-term and long-term debt, interest rate swaps, forward contracts and option contracts. The Company&#8217;s financial instruments also include cash and cash equivalents as well as accounts and other receivables and accounts payable, the fair values of which approximate their carrying values. As a policy, the Company does not engage in speculative or leveraged transactions.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company carries derivative instruments in the consolidated balance sheets at fair value, determined by reference to market data such as forward rates for currencies, implied volatilities, and interest rate swap yield curves. The accounting for changes in the fair value of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and, if so, the reason for holding&#160;it. In addition, the Company has designated certain long-term debt instruments as net investment hedges.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzMzNTc2_ed5b99fd-4dc6-4665-991c-1700a27f8748" escape="true"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adoption of New Accounting Standards</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued Accounting Standards Update 2020-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Clarifying the Interactions Between Topic 321, Topic 323, and Topic 815 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2020-01&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which clarifies that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting for the purposes of applying the measurement alternative in accordance with Topic 321 immediately before applying or upon discontinuing the equity method. In addition, ASU 2020-01 states that for the purpose of applying paragraph 815-10-15-141(a) an entity should not consider whether, upon the settlement of the forward contract or exercise of the purchased option, individually or with existing investments, the underlying securities would be accounted for under the equity method in Topic 323 or the fair value option in accordance with the financial instruments guidance in Topic 825. The Company applied the provisions of ASU 2020-01 as of January 1, 2021. The adoption of this guidance did not have a material impact on the Company&#8217;s consolidated financial statements and disclosures. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued Accounting Standards Update 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which is intended to simplify the accounting for income taxes by eliminating certain exceptions and simplifying certain requirements under Topic 740. The Company applied the provisions of ASU 2019-12 on a prospective basis as of January 1, 2021. The adoption of this guidance did not have a material impact on the Company&#8217;s consolidated financial statements and disclosures.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting Standards Issued Not Yet Adopted&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued Accounting Standards Update 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform on Financial Reporting </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2020-04&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which provides optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. ASU 2020-04 applies only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. Entities can apply the provisions of ASU 2020-04 immediately, as applicable, and generally the provisions of the guidance are available through December 31, 2022 as entities transition away from reference rates that are expected to be discontinued. The Company is currently assessing the impact of the adoption of this guidance on its consolidated financial statements and disclosures. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued Accounting Standards Update 2021-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2021-08&#8221;), which requires entities (acquirers) to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with ASC Topic 606. ASU 2021-08 will be effective for fiscal years, including interim periods within those fiscal years, beginning after December 15, 2022 with early adoption permitted. The Company is currently assessing the impact of the adoption of this guidance on its consolidated financial statements and disclosures.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, the FASB issued Accounting Standards Update 2021-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2021-10&#8221;), which requires entities to provide annual disclosures about transactions with a government that are accounted for by applying a grant or contribution accounting model by analogy. ASU 2021-10 will be effective for fiscal years beginning after December 15, 2021 with early adoption permitted. The Company is currently assessing the impact of the adoption of this guidance on its disclosures.</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:12pt;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94</span></div></div></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_178"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90ZXh0cmVnaW9uOjkyYTgzOGNmNmU1NDRiMTZhOWU5YjgyZjAwNmQ2MjMwXzEyMzU_aa74d83d-3f9a-47b4-9f9f-026fc56a9b1d" continuedAt="ied929caeec0e479ab8f0613f3fd40052" escape="true">Revenue Recognition and Accounts Receivable</ix:nonNumeric></span></div><ix:continuation id="ied929caeec0e479ab8f0613f3fd40052" continuedAt="i134c466c65f54a8087c22861cc5c1bb1"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90ZXh0cmVnaW9uOjkyYTgzOGNmNmU1NDRiMTZhOWU5YjgyZjAwNmQ2MjMwXzEyMjk_8ed968bf-e9e0-47e0-9416-d3d29a88138f" continuedAt="icb7e60fb70d244e88a7fb600803c1f29" escape="true"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s net sales by product category for each of our reportable segments for the years ended December&#160;31, 2021, 2020, and 2019, respectively:</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:37.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.669%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021 Net Sales</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Product Category</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Developed Markets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Greater China</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">JANZ</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Emerging Markets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brands</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90374f5d9f1b4c92a65a560a42412201_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo0NzBmZDBjNTljMGY0MjM5YTZiNmRjMjhiNTk4MmNmYy90YWJsZXJhbmdlOjQ3MGZkMGM1OWMwZjQyMzlhNmI2ZGMyOGI1OTgyY2ZjXzItMS0xLTEtMzE0MjI_5b50823a-dcdb-4d6f-bf98-6224ce949128">5,759.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iead6205586b04557a8ada1d7b914b227_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo0NzBmZDBjNTljMGY0MjM5YTZiNmRjMjhiNTk4MmNmYy90YWJsZXJhbmdlOjQ3MGZkMGM1OWMwZjQyMzlhNmI2ZGMyOGI1OTgyY2ZjXzItMy0xLTEtMzE0MjI_91f4266e-46fd-4858-b221-ddd5569edc5e">2,207.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f125b5601ba485fa87e1359408bb169_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo0NzBmZDBjNTljMGY0MjM5YTZiNmRjMjhiNTk4MmNmYy90YWJsZXJhbmdlOjQ3MGZkMGM1OWMwZjQyMzlhNmI2ZGMyOGI1OTgyY2ZjXzItNS0xLTEtMzE0MjI_b49f17e4-fa18-4b8e-89ac-ff2559856f7d">1,197.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdcd2c5e3dc049c9af2e2879fc06a18a_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo0NzBmZDBjNTljMGY0MjM5YTZiNmRjMjhiNTk4MmNmYy90YWJsZXJhbmdlOjQ3MGZkMGM1OWMwZjQyMzlhNmI2ZGMyOGI1OTgyY2ZjXzItNy0xLTEtMzE0MjI_b90a524d-9998-432b-b0c5-c576212b41ef">1,677.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d43c5886aae45d78bf51b4acef73ab6_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo0NzBmZDBjNTljMGY0MjM5YTZiNmRjMjhiNTk4MmNmYy90YWJsZXJhbmdlOjQ3MGZkMGM1OWMwZjQyMzlhNmI2ZGMyOGI1OTgyY2ZjXzItOS0xLTEtMzE0MjI_ab4084f6-b6b8-419d-816d-274c9585e863">10,841.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Complex Gx and Biosimilars</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96fc2bf65c384f6d95e6f124e5de94a4_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo0NzBmZDBjNTljMGY0MjM5YTZiNmRjMjhiNTk4MmNmYy90YWJsZXJhbmdlOjQ3MGZkMGM1OWMwZjQyMzlhNmI2ZGMyOGI1OTgyY2ZjXzMtMS0xLTEtMzE0MjI_2c233bdb-60dd-4f93-bf30-b038d9e6c94e">1,241.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc09cb425c1a4b00bebeb7a3b1d088e4_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo0NzBmZDBjNTljMGY0MjM5YTZiNmRjMjhiNTk4MmNmYy90YWJsZXJhbmdlOjQ3MGZkMGM1OWMwZjQyMzlhNmI2ZGMyOGI1OTgyY2ZjXzMtMy0xLTEtMzE0MjI_73fc6fe4-3731-4ac3-9016-b27916ef04b7">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i773e23ec8b4f40d2892b90d9c9b32095_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo0NzBmZDBjNTljMGY0MjM5YTZiNmRjMjhiNTk4MmNmYy90YWJsZXJhbmdlOjQ3MGZkMGM1OWMwZjQyMzlhNmI2ZGMyOGI1OTgyY2ZjXzMtNS0xLTEtMzE0MjI_af259596-1b24-424f-a0d1-a92c762a714a">46.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b2cacb9811a4855a05fcf61e040a1d7_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo0NzBmZDBjNTljMGY0MjM5YTZiNmRjMjhiNTk4MmNmYy90YWJsZXJhbmdlOjQ3MGZkMGM1OWMwZjQyMzlhNmI2ZGMyOGI1OTgyY2ZjXzMtNy0xLTEtMzE0MjI_dcbb233e-0b37-4f3b-924c-f48d445a9482">53.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbdc76c08f4f4be1a89d1b41630e9c46_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo0NzBmZDBjNTljMGY0MjM5YTZiNmRjMjhiNTk4MmNmYy90YWJsZXJhbmdlOjQ3MGZkMGM1OWMwZjQyMzlhNmI2ZGMyOGI1OTgyY2ZjXzMtOS0xLTEtMzE0MjI_fdee210d-e227-470c-b497-61f1a6a53bd7">1,342.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cdfba9175504c2887d1d60461bee852_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo0NzBmZDBjNTljMGY0MjM5YTZiNmRjMjhiNTk4MmNmYy90YWJsZXJhbmdlOjQ3MGZkMGM1OWMwZjQyMzlhNmI2ZGMyOGI1OTgyY2ZjXzQtMS0xLTEtMzE0MjI_e7b8e4c0-9e63-43cd-932f-b6011a520b31">3,427.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i269ffde73a154b28805576347563a5cb_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo0NzBmZDBjNTljMGY0MjM5YTZiNmRjMjhiNTk4MmNmYy90YWJsZXJhbmdlOjQ3MGZkMGM1OWMwZjQyMzlhNmI2ZGMyOGI1OTgyY2ZjXzQtMy0xLTEtMzE0MjI_423bcd3c-6f72-4890-8a0a-ea45f2d9af60">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic535a9058568425bb3eb5f0763a47e3d_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo0NzBmZDBjNTljMGY0MjM5YTZiNmRjMjhiNTk4MmNmYy90YWJsZXJhbmdlOjQ3MGZkMGM1OWMwZjQyMzlhNmI2ZGMyOGI1OTgyY2ZjXzQtNS0xLTEtMzE0MjI_ba5be30c-6d4c-42f7-9811-008aa7421c71">783.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie684c80cdcef4397b8798cbb98e6a796_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo0NzBmZDBjNTljMGY0MjM5YTZiNmRjMjhiNTk4MmNmYy90YWJsZXJhbmdlOjQ3MGZkMGM1OWMwZjQyMzlhNmI2ZGMyOGI1OTgyY2ZjXzQtNy0xLTEtMzE0MjI_24aacefe-7aa4-4c1a-b5f6-01f4d519c4e9">1,413.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2a6d40b5f364731b5c17ef708876be7_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo0NzBmZDBjNTljMGY0MjM5YTZiNmRjMjhiNTk4MmNmYy90YWJsZXJhbmdlOjQ3MGZkMGM1OWMwZjQyMzlhNmI2ZGMyOGI1OTgyY2ZjXzQtOS0xLTEtMzE0MjI_9f431396-6b52-48ff-82c5-a9588a84f5c6">5,630.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Viatris</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ac0bcd2e1264e8b8347af73e216d016_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo0NzBmZDBjNTljMGY0MjM5YTZiNmRjMjhiNTk4MmNmYy90YWJsZXJhbmdlOjQ3MGZkMGM1OWMwZjQyMzlhNmI2ZGMyOGI1OTgyY2ZjXzUtMS0xLTEtMzE0MjI_46c03a2c-0102-4d26-ae91-2955f064ae86">10,428.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed92dccf2314bd48c7373be7cf33d4e_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo0NzBmZDBjNTljMGY0MjM5YTZiNmRjMjhiNTk4MmNmYy90YWJsZXJhbmdlOjQ3MGZkMGM1OWMwZjQyMzlhNmI2ZGMyOGI1OTgyY2ZjXzUtMy0xLTEtMzE0MjI_b5fddbfc-5bd6-474e-adb7-5954522cfcb5">2,212.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ccdc9914af44b1bb1229e19c17326d8_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo0NzBmZDBjNTljMGY0MjM5YTZiNmRjMjhiNTk4MmNmYy90YWJsZXJhbmdlOjQ3MGZkMGM1OWMwZjQyMzlhNmI2ZGMyOGI1OTgyY2ZjXzUtNS0xLTEtMzE0MjI_832e8028-33d7-4964-9d86-3be4b2e20f6a">2,027.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02b3f133daa24190abd49dfdef6bb6ce_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo0NzBmZDBjNTljMGY0MjM5YTZiNmRjMjhiNTk4MmNmYy90YWJsZXJhbmdlOjQ3MGZkMGM1OWMwZjQyMzlhNmI2ZGMyOGI1OTgyY2ZjXzUtNy0xLTEtMzE0MjI_e2aa8960-461c-48f3-adbe-1eb7d3f7cf8f">3,144.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2ddd71cee624b009233ae18ff01bcdb_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo0NzBmZDBjNTljMGY0MjM5YTZiNmRjMjhiNTk4MmNmYy90YWJsZXJhbmdlOjQ3MGZkMGM1OWMwZjQyMzlhNmI2ZGMyOGI1OTgyY2ZjXzUtOS0xLTEtMzE0MjI_99252933-6b88-4f07-abb6-fb664e180d7c">17,813.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:37.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.669%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020 Net Sales</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Product Category</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Developed Markets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Greater China</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">JANZ</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Emerging Markets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brands</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97c939970b2a44ec93ec3adde4f66f7a_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpiYjAwNmY2ZWYzNjE0NzBiYWRjZDQzZmQwMWZiMDY4ZC90YWJsZXJhbmdlOmJiMDA2ZjZlZjM2MTQ3MGJhZGNkNDNmZDAxZmIwNjhkXzItMS0xLTEtMzE0MjI_01a340f1-b75d-45a6-a849-75845525f7bb">3,920.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1831edfa3a5a49a4bb77c12a7484690f_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpiYjAwNmY2ZWYzNjE0NzBiYWRjZDQzZmQwMWZiMDY4ZC90YWJsZXJhbmdlOmJiMDA2ZjZlZjM2MTQ3MGJhZGNkNDNmZDAxZmIwNjhkXzItMy0xLTEtMzE0MjI_4971999a-d644-4f4d-a926-30e5ba0e587f">253.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9abda492c204a6db32dc9d58d9d3283_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpiYjAwNmY2ZWYzNjE0NzBiYWRjZDQzZmQwMWZiMDY4ZC90YWJsZXJhbmdlOmJiMDA2ZjZlZjM2MTQ3MGJhZGNkNDNmZDAxZmIwNjhkXzItNS0xLTEtMzE0MjI_3418fd6f-5513-48ab-962b-be7915d4279c">617.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05eae9ce2c1146cda2761d09e8dfafec_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpiYjAwNmY2ZWYzNjE0NzBiYWRjZDQzZmQwMWZiMDY4ZC90YWJsZXJhbmdlOmJiMDA2ZjZlZjM2MTQ3MGJhZGNkNDNmZDAxZmIwNjhkXzItNy0xLTEtMzE0MjI_7b18ba0d-7366-4b84-bc4c-64b9df32531b">443.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86d67a91f60c42daae98c579adcd3ce6_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpiYjAwNmY2ZWYzNjE0NzBiYWRjZDQzZmQwMWZiMDY4ZC90YWJsZXJhbmdlOmJiMDA2ZjZlZjM2MTQ3MGJhZGNkNDNmZDAxZmIwNjhkXzItOS0xLTEtMzE0MjI_a44d5faf-7b08-4df9-81a1-c2cf6a3194c7">5,234.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Complex Gx and Biosimilars</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i835c7b50b49142419f07188c47c94df3_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpiYjAwNmY2ZWYzNjE0NzBiYWRjZDQzZmQwMWZiMDY4ZC90YWJsZXJhbmdlOmJiMDA2ZjZlZjM2MTQ3MGJhZGNkNDNmZDAxZmIwNjhkXzMtMS0xLTEtMzE0MjI_e67d83b3-6781-4952-967e-a5fd72cd4934">1,202.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27e66858837c4e0e95198bd461c39df7_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpiYjAwNmY2ZWYzNjE0NzBiYWRjZDQzZmQwMWZiMDY4ZC90YWJsZXJhbmdlOmJiMDA2ZjZlZjM2MTQ3MGJhZGNkNDNmZDAxZmIwNjhkXzMtMy0xLTEtMzE0MjI_42cf2605-3521-4d14-9335-0a9bd1b35575">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3131c3ac2a04122b50238e3e2e46c6e_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpiYjAwNmY2ZWYzNjE0NzBiYWRjZDQzZmQwMWZiMDY4ZC90YWJsZXJhbmdlOmJiMDA2ZjZlZjM2MTQ3MGJhZGNkNDNmZDAxZmIwNjhkXzMtNS0xLTEtMzE0MjI_685c73cf-b918-4257-abb0-dbb9bafc11a0">42.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4108be32c0e74b899efbefe5401e783f_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpiYjAwNmY2ZWYzNjE0NzBiYWRjZDQzZmQwMWZiMDY4ZC90YWJsZXJhbmdlOmJiMDA2ZjZlZjM2MTQ3MGJhZGNkNDNmZDAxZmIwNjhkXzMtNy0xLTEtMzE0MjI_82f231dc-7b26-4408-bc2b-537e1774968b">49.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i226439d9ee1a49f6b1bb3182d0a8d06d_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpiYjAwNmY2ZWYzNjE0NzBiYWRjZDQzZmQwMWZiMDY4ZC90YWJsZXJhbmdlOmJiMDA2ZjZlZjM2MTQ3MGJhZGNkNDNmZDAxZmIwNjhkXzMtOS0xLTEtMzE0MjI_fd1c1ced-5cb9-4a17-9654-a4cfc6683870">1,295.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i105959ab42be4a4484a43c24d4643610_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpiYjAwNmY2ZWYzNjE0NzBiYWRjZDQzZmQwMWZiMDY4ZC90YWJsZXJhbmdlOmJiMDA2ZjZlZjM2MTQ3MGJhZGNkNDNmZDAxZmIwNjhkXzQtMS0xLTEtMzE0MjI_121c73ca-14b8-4e4b-a04b-08054bcc5e48">3,387.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib26272e8a91e4d71b3b831cda82ccb89_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpiYjAwNmY2ZWYzNjE0NzBiYWRjZDQzZmQwMWZiMDY4ZC90YWJsZXJhbmdlOmJiMDA2ZjZlZjM2MTQ3MGJhZGNkNDNmZDAxZmIwNjhkXzQtMy0xLTEtMzE0MjI_b0b4ea75-9ba5-4ac8-af1d-49beaa93a113">5.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a9efc1a735d41babd68b5c507c58032_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpiYjAwNmY2ZWYzNjE0NzBiYWRjZDQzZmQwMWZiMDY4ZC90YWJsZXJhbmdlOmJiMDA2ZjZlZjM2MTQ3MGJhZGNkNDNmZDAxZmIwNjhkXzQtNS0xLTEtMzE0MjI_a6986bb1-6c03-4c20-921a-6ea480e9a79c">535.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe1b26c10c8d49dcb8d293449427f7d1_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpiYjAwNmY2ZWYzNjE0NzBiYWRjZDQzZmQwMWZiMDY4ZC90YWJsZXJhbmdlOmJiMDA2ZjZlZjM2MTQ3MGJhZGNkNDNmZDAxZmIwNjhkXzQtNy0xLTEtMzE0MjI_2c382a9d-24ed-4ddb-a878-20b93188e43a">1,361.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d668c3c2f2946a49634c6f0bfb9cdee_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpiYjAwNmY2ZWYzNjE0NzBiYWRjZDQzZmQwMWZiMDY4ZC90YWJsZXJhbmdlOmJiMDA2ZjZlZjM2MTQ3MGJhZGNkNDNmZDAxZmIwNjhkXzQtOS0xLTEtMzE0MjI_dcf3bdfc-da7e-40e1-a3e8-bfbfef7666bb">5,289.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Viatris</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec0737b261124d3f87ea9adcdb407b5a_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpiYjAwNmY2ZWYzNjE0NzBiYWRjZDQzZmQwMWZiMDY4ZC90YWJsZXJhbmdlOmJiMDA2ZjZlZjM2MTQ3MGJhZGNkNDNmZDAxZmIwNjhkXzUtMS0xLTEtMzE0MjI_8855b6ca-b209-4e56-89d4-0f1788c0bc9e">8,510.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e0c5048f8f84f26a1949d61f3285173_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpiYjAwNmY2ZWYzNjE0NzBiYWRjZDQzZmQwMWZiMDY4ZC90YWJsZXJhbmdlOmJiMDA2ZjZlZjM2MTQ3MGJhZGNkNDNmZDAxZmIwNjhkXzUtMy0xLTEtMzE0MjI_c9a38177-8ba3-474f-b1cf-386cbeaaab0d">259.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d06b2c023334d92a7c83b2943f0232b_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpiYjAwNmY2ZWYzNjE0NzBiYWRjZDQzZmQwMWZiMDY4ZC90YWJsZXJhbmdlOmJiMDA2ZjZlZjM2MTQ3MGJhZGNkNDNmZDAxZmIwNjhkXzUtNS0xLTEtMzE0MjI_dcaecec0-9b96-49e1-bce2-bbd488dde2ec">1,195.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i281863eb67c44d0fbc00294dfaf0049c_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpiYjAwNmY2ZWYzNjE0NzBiYWRjZDQzZmQwMWZiMDY4ZC90YWJsZXJhbmdlOmJiMDA2ZjZlZjM2MTQ3MGJhZGNkNDNmZDAxZmIwNjhkXzUtNy0xLTEtMzE0MjI_d5698ea0-885c-4096-a21a-84095100a476">1,853.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdd7bc10185c4685b4d14c9b6ac151b1_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpiYjAwNmY2ZWYzNjE0NzBiYWRjZDQzZmQwMWZiMDY4ZC90YWJsZXJhbmdlOmJiMDA2ZjZlZjM2MTQ3MGJhZGNkNDNmZDAxZmIwNjhkXzUtOS0xLTEtMzE0MjI_1e9e31e6-814c-4ede-af82-58603d87ec1d">11,819.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:37.191%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.684%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019 Net Sales</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Product Category</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Developed Markets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Greater China</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">JANZ</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Emerging Markets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brands</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61ed8d945a654397b38ffd9a5155cc8a_D20190101-20191231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyOWRlZGNhZjNkYjg0NGJkYjMxYzJmYjU4ZTQwMjVhMy90YWJsZXJhbmdlOjI5ZGVkY2FmM2RiODQ0YmRiMzFjMmZiNThlNDAyNWEzXzItMS0xLTEtMzE0MjI_1e960b2b-3882-475c-8f54-314abd0e8cf8">4,199.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a4ad71e069349d4bc77dedb205f5b6e_D20190101-20191231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyOWRlZGNhZjNkYjg0NGJkYjMxYzJmYjU4ZTQwMjVhMy90YWJsZXJhbmdlOjI5ZGVkY2FmM2RiODQ0YmRiMzFjMmZiNThlNDAyNWEzXzItMy0xLTEtMzE0MjI_55520bab-ca18-47fd-8559-05c4f19169d7">207.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75185d8bca2c4c33b481ec3ed8ab4bc2_D20190101-20191231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyOWRlZGNhZjNkYjg0NGJkYjMxYzJmYjU4ZTQwMjVhMy90YWJsZXJhbmdlOjI5ZGVkY2FmM2RiODQ0YmRiMzFjMmZiNThlNDAyNWEzXzItNS0xLTEtMzE0MjI_bc8703e1-c579-44cb-8ca3-ac2dd3c64287">533.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9929171805eb41e3845525fcedeefdd7_D20190101-20191231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyOWRlZGNhZjNkYjg0NGJkYjMxYzJmYjU4ZTQwMjVhMy90YWJsZXJhbmdlOjI5ZGVkY2FmM2RiODQ0YmRiMzFjMmZiNThlNDAyNWEzXzItNy0xLTEtMzE0MjI_dd48baf9-285a-4eb4-b8e8-a4d874018244">422.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac08a240cf724732a33d7e4c11a51983_D20190101-20191231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyOWRlZGNhZjNkYjg0NGJkYjMxYzJmYjU4ZTQwMjVhMy90YWJsZXJhbmdlOjI5ZGVkY2FmM2RiODQ0YmRiMzFjMmZiNThlNDAyNWEzXzItOS0xLTEtMzE0MjI_9360b61a-4357-426a-a0d1-4618f1a7f01c">5,362.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Complex Gx and Biosimilars</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic72949e3219d4b0db2547334d44e5760_D20190101-20191231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyOWRlZGNhZjNkYjg0NGJkYjMxYzJmYjU4ZTQwMjVhMy90YWJsZXJhbmdlOjI5ZGVkY2FmM2RiODQ0YmRiMzFjMmZiNThlNDAyNWEzXzMtMS0xLTEtMzE0MjI_3f213c9e-3b06-4291-a501-041deb719e93">1,127.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic570f6e38a0546fb9e89a31a80462c9b_D20190101-20191231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyOWRlZGNhZjNkYjg0NGJkYjMxYzJmYjU4ZTQwMjVhMy90YWJsZXJhbmdlOjI5ZGVkY2FmM2RiODQ0YmRiMzFjMmZiNThlNDAyNWEzXzMtMy0xLTEtMzE0MjI_43a8f60a-8c61-4d15-ace8-2278ceeda697">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f7590527ef14168a6dd4e6a2b81c5c7_D20190101-20191231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyOWRlZGNhZjNkYjg0NGJkYjMxYzJmYjU4ZTQwMjVhMy90YWJsZXJhbmdlOjI5ZGVkY2FmM2RiODQ0YmRiMzFjMmZiNThlNDAyNWEzXzMtNS0xLTEtMzE0MjI_61563da3-4bce-4c4d-b138-2b571cabd463">23.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1614ddc606441f19d547ba1a785e380_D20190101-20191231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyOWRlZGNhZjNkYjg0NGJkYjMxYzJmYjU4ZTQwMjVhMy90YWJsZXJhbmdlOjI5ZGVkY2FmM2RiODQ0YmRiMzFjMmZiNThlNDAyNWEzXzMtNy0xLTEtMzE0MjI_2804ee8d-7e8b-4a6b-9135-3f3ae7c51867">59.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11d08a6a376f45179f8e6bb95bd31c27_D20190101-20191231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyOWRlZGNhZjNkYjg0NGJkYjMxYzJmYjU4ZTQwMjVhMy90YWJsZXJhbmdlOjI5ZGVkY2FmM2RiODQ0YmRiMzFjMmZiNThlNDAyNWEzXzMtOS0xLTEtMzE0MjI_97107ef3-731b-43aa-9b08-3873bd9d88ba">1,211.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i309244cf155a4aba9fca199455319a32_D20190101-20191231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyOWRlZGNhZjNkYjg0NGJkYjMxYzJmYjU4ZTQwMjVhMy90YWJsZXJhbmdlOjI5ZGVkY2FmM2RiODQ0YmRiMzFjMmZiNThlNDAyNWEzXzQtMS0xLTEtMzE0MjI_571f45bd-ccc1-4c8b-bab3-e0e324b54377">2,913.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67d9cb8141084c58ac541cde4d576c50_D20190101-20191231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyOWRlZGNhZjNkYjg0NGJkYjMxYzJmYjU4ZTQwMjVhMy90YWJsZXJhbmdlOjI5ZGVkY2FmM2RiODQ0YmRiMzFjMmZiNThlNDAyNWEzXzQtMy0xLTEtMzE0MjI_ee0d9726-fb5b-433b-aaf8-31ad023ea734">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3166a2866ade49869d6aad191a5c8ef2_D20190101-20191231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyOWRlZGNhZjNkYjg0NGJkYjMxYzJmYjU4ZTQwMjVhMy90YWJsZXJhbmdlOjI5ZGVkY2FmM2RiODQ0YmRiMzFjMmZiNThlNDAyNWEzXzQtNS0xLTEtMzE0MjI_e4a231f3-7a17-4f1e-ba1e-d2daae8711a6">635.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecf0266755484cffb55ddc7ba73da178_D20190101-20191231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyOWRlZGNhZjNkYjg0NGJkYjMxYzJmYjU4ZTQwMjVhMy90YWJsZXJhbmdlOjI5ZGVkY2FmM2RiODQ0YmRiMzFjMmZiNThlNDAyNWEzXzQtNy0xLTEtMzE0MjI_801ee8c3-1b7c-4791-a0aa-4b5cc0cec0c0">1,241.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff24ee1fc1974d94b68eb9cffe4e3dbf_D20190101-20191231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyOWRlZGNhZjNkYjg0NGJkYjMxYzJmYjU4ZTQwMjVhMy90YWJsZXJhbmdlOjI5ZGVkY2FmM2RiODQ0YmRiMzFjMmZiNThlNDAyNWEzXzQtOS0xLTEtMzE0MjI_1041a4e3-00d6-4c47-b1fc-bae507459b76">4,796.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Viatris</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i864642c0e47a4b87a88be339d6673670_D20190101-20191231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyOWRlZGNhZjNkYjg0NGJkYjMxYzJmYjU4ZTQwMjVhMy90YWJsZXJhbmdlOjI5ZGVkY2FmM2RiODQ0YmRiMzFjMmZiNThlNDAyNWEzXzUtMS0xLTEtMzE0MjI_b1f04a9b-386e-4402-8ff8-d794b4e8414e">8,240.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4221a0900a14ced8a5c91eac2fcdf4f_D20190101-20191231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyOWRlZGNhZjNkYjg0NGJkYjMxYzJmYjU4ZTQwMjVhMy90YWJsZXJhbmdlOjI5ZGVkY2FmM2RiODQ0YmRiMzFjMmZiNThlNDAyNWEzXzUtMy0xLTEtMzE0MjI_5410c4c5-e5fa-498f-a17b-2a06a0eb2360">214.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94d3655a9cb44f37b3319f0d91bf87b1_D20190101-20191231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyOWRlZGNhZjNkYjg0NGJkYjMxYzJmYjU4ZTQwMjVhMy90YWJsZXJhbmdlOjI5ZGVkY2FmM2RiODQ0YmRiMzFjMmZiNThlNDAyNWEzXzUtNS0xLTEtMzE0MjI_cfa3e91f-83bf-4d61-881d-6e8648e3664a">1,192.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f91beda5d054492aed05bdaf3b7936e_D20190101-20191231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyOWRlZGNhZjNkYjg0NGJkYjMxYzJmYjU4ZTQwMjVhMy90YWJsZXJhbmdlOjI5ZGVkY2FmM2RiODQ0YmRiMzFjMmZiNThlNDAyNWEzXzUtNy0xLTEtMzE0MjI_2b929035-1483-4f1b-879e-2be5db9f7fad">1,723.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadb0452c57794c5498c4248d6691b32c_D20190101-20191231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyOWRlZGNhZjNkYjg0NGJkYjMxYzJmYjU4ZTQwMjVhMy90YWJsZXJhbmdlOjI5ZGVkY2FmM2RiODQ0YmRiMzFjMmZiNThlNDAyNWEzXzUtOS0xLTEtMzE0MjI_39d62a6d-a618-4b98-90a3-4446d6b752b8">11,370.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents net sales on a consolidated basis for select key products for the year ended December&#160;31, 2021:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:83.110%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.106%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Select Key Global Products</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lipitor &#174;</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84058a24993540f0abbe391aeff14baa_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpmMGJhYTM2MTJkNzE0NGE3YjM5NjQ1MjQxYTYyZmFmNi90YWJsZXJhbmdlOmYwYmFhMzYxMmQ3MTQ0YTdiMzk2NDUyNDFhNjJmYWY2XzMtNC0xLTEtMzYyNTE_e756f3c2-a253-4cc9-a7dd-79362e5ef58c">1,663.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Norvasc &#174;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac2df693fdec46b2a004f4136d918a15_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpmMGJhYTM2MTJkNzE0NGE3YjM5NjQ1MjQxYTYyZmFmNi90YWJsZXJhbmdlOmYwYmFhMzYxMmQ3MTQ0YTdiMzk2NDUyNDFhNjJmYWY2XzQtNC0xLTEtMzYyNTE_ca272147-9618-419c-a8b5-7e3fcfd47b79">824.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lyrica &#174;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02f7c66517fd42e99c981b2754110472_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpmMGJhYTM2MTJkNzE0NGE3YjM5NjQ1MjQxYTYyZmFmNi90YWJsZXJhbmdlOmYwYmFhMzYxMmQ3MTQ0YTdiMzk2NDUyNDFhNjJmYWY2XzUtNC0xLTEtMzYyNTE_eda4851b-80ce-4e76-aa96-37b579bf732b">728.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viagra &#174;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fb4efa6d51f4b0d81d894b26998702c_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpmMGJhYTM2MTJkNzE0NGE3YjM5NjQ1MjQxYTYyZmFmNi90YWJsZXJhbmdlOmYwYmFhMzYxMmQ3MTQ0YTdiMzk2NDUyNDFhNjJmYWY2XzYtNC0xLTEtMzYyNTE_fc0f9eaa-6b9b-42b7-ba4f-6776a47c8b66">533.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EpiPen&#174; Auto-Injectors</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5b45e5acb5a43d086ab1d31fe635f90_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpmMGJhYTM2MTJkNzE0NGE3YjM5NjQ1MjQxYTYyZmFmNi90YWJsZXJhbmdlOmYwYmFhMzYxMmQ3MTQ0YTdiMzk2NDUyNDFhNjJmYWY2XzctNC0xLTEtMzYyNTE_672772d9-7e6c-4921-8ca9-4c7eb02b72d3">391.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Celebrex &#174;</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32b74097924040a6a3b293c9de50757b_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpmMGJhYTM2MTJkNzE0NGE3YjM5NjQ1MjQxYTYyZmFmNi90YWJsZXJhbmdlOmYwYmFhMzYxMmQ3MTQ0YTdiMzk2NDUyNDFhNjJmYWY2XzgtNC0xLTEtMzYyNTE_3de3970d-edb2-429f-b11f-c2f9c1106a30">344.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effexor &#174;</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29c8e33fbfc54cebb3298eb792f30230_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpmMGJhYTM2MTJkNzE0NGE3YjM5NjQ1MjQxYTYyZmFmNi90YWJsZXJhbmdlOmYwYmFhMzYxMmQ3MTQ0YTdiMzk2NDUyNDFhNjJmYWY2XzktNC0xLTEtMzYyNTE_0cb8b375-db1f-4b24-9c73-796202a3a9c6">316.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Creon &#174;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b3ecbda1fdf4ee18c4b7043b1c74bd3_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpmMGJhYTM2MTJkNzE0NGE3YjM5NjQ1MjQxYTYyZmFmNi90YWJsZXJhbmdlOmYwYmFhMzYxMmQ3MTQ0YTdiMzk2NDUyNDFhNjJmYWY2XzEwLTQtMS0xLTQ2MjY3_96b7d9d1-3929-4954-8f50-1459c2da222c">309.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zoloft &#174;</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45c0dc93080d496b936cfa154fdd5d2f_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpmMGJhYTM2MTJkNzE0NGE3YjM5NjQ1MjQxYTYyZmFmNi90YWJsZXJhbmdlOmYwYmFhMzYxMmQ3MTQ0YTdiMzk2NDUyNDFhNjJmYWY2XzEwLTQtMS0xLTM2MjUx_5ea1cbbb-5e2d-40c3-9553-9795f4906314">284.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Xalabrands</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f3025b784d24010ab35acb02af8509d_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpmMGJhYTM2MTJkNzE0NGE3YjM5NjQ1MjQxYTYyZmFmNi90YWJsZXJhbmdlOmYwYmFhMzYxMmQ3MTQ0YTdiMzk2NDUyNDFhNjJmYWY2XzEyLTQtMS0xLTM2MjUx_43c051c9-10a8-4e95-a1e0-3bf1fdbe844d">226.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Select Key Segment Products</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Influvac &#174;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1907e0d66348049123902a21dcf855_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpmMGJhYTM2MTJkNzE0NGE3YjM5NjQ1MjQxYTYyZmFmNi90YWJsZXJhbmdlOmYwYmFhMzYxMmQ3MTQ0YTdiMzk2NDUyNDFhNjJmYWY2XzE1LTQtMS0xLTM2MjU4_49bd2e26-d801-482e-811c-c621d6fe65d2">299.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amitiza &#174;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e3530192d947059647f2b6af9576ce_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpmMGJhYTM2MTJkNzE0NGE3YjM5NjQ1MjQxYTYyZmFmNi90YWJsZXJhbmdlOmYwYmFhMzYxMmQ3MTQ0YTdiMzk2NDUyNDFhNjJmYWY2XzE2LTQtMS0xLTM2MjU4_5db9e84d-d2a8-47ce-9fad-a405d4450507">201.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Xanax &#174;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bb2b10fff8b4b20b4933b549ff5105e_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpmMGJhYTM2MTJkNzE0NGE3YjM5NjQ1MjQxYTYyZmFmNi90YWJsZXJhbmdlOmYwYmFhMzYxMmQ3MTQ0YTdiMzk2NDUyNDFhNjJmYWY2XzE3LTQtMS0xLTM2MjU4_612e469b-e3b5-4a60-8875-215c96d3c3a8">185.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dymista &#174;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09fb6f5ceb234f24b3a2fd5497a71b54_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpmMGJhYTM2MTJkNzE0NGE3YjM5NjQ1MjQxYTYyZmFmNi90YWJsZXJhbmdlOmYwYmFhMzYxMmQ3MTQ0YTdiMzk2NDUyNDFhNjJmYWY2XzE4LTQtMS0xLTM2MjU4_d68f67fe-7bff-459f-a1a2-1a2cd3cd8444">168.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yupelri &#174;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c6990bf97834a12a1ac825a254bf046_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpmMGJhYTM2MTJkNzE0NGE3YjM5NjQ1MjQxYTYyZmFmNi90YWJsZXJhbmdlOmYwYmFhMzYxMmQ3MTQ0YTdiMzk2NDUyNDFhNjJmYWY2XzE5LTQtMS0xLTM2MjU4_de00ed2f-e95e-4a71-862b-9d411b6ef69c">161.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">____________</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.8pt">The Company does not disclose net sales for any products considered competitively sensitive.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><ix:continuation id="i134c466c65f54a8087c22861cc5c1bb1" continuedAt="i2cb7647ee3134efdbe1480ea14fe1742"><ix:continuation id="icb7e60fb70d244e88a7fb600803c1f29" continuedAt="ibb9a7e6a619e40b29114ec98d1756c9b"><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Products disclosed may change in future periods, including as a result of seasonality, competition or new product launches.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.8pt">Prior periods are not presented due to significance of products acquired as part of the Combination.</span></div></ix:continuation><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Variable Consideration and Accounts Receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a reconciliation of gross sales to net sales by each significant category of variable consideration during the years ended December&#160;31, 2021, 2020 and 2019, respectively:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:67.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.887%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross sales</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="vtrs:RevenuefromContractwithCustomerGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo4ZDg1ZDY0YjU4MTI0MjdkOWM3NWM2NTNiNmMzMTZiYS90YWJsZXJhbmdlOjhkODVkNjRiNTgxMjQyN2Q5Yzc1YzY1M2I2YzMxNmJhXzItMS0xLTEtMzE0MjI_e55d3349-145a-4cb7-9e1f-5aa470ebdad2">30,553.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="vtrs:RevenuefromContractwithCustomerGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo4ZDg1ZDY0YjU4MTI0MjdkOWM3NWM2NTNiNmMzMTZiYS90YWJsZXJhbmdlOjhkODVkNjRiNTgxMjQyN2Q5Yzc1YzY1M2I2YzMxNmJhXzItMy0xLTEtMzE0MjI_fd74876c-1279-4cbe-b129-aeefc77f6295">19,899.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="vtrs:RevenuefromContractwithCustomerGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo4ZDg1ZDY0YjU4MTI0MjdkOWM3NWM2NTNiNmMzMTZiYS90YWJsZXJhbmdlOjhkODVkNjRiNTgxMjQyN2Q5Yzc1YzY1M2I2YzMxNmJhXzItNS0xLTEtMzE0MjI_805a0984-efd6-41b0-b487-f8c0a5dbb48d">19,012.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross to net adjustments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chargebacks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="vtrs:Chargebacks" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo4ZDg1ZDY0YjU4MTI0MjdkOWM3NWM2NTNiNmMzMTZiYS90YWJsZXJhbmdlOjhkODVkNjRiNTgxMjQyN2Q5Yzc1YzY1M2I2YzMxNmJhXzQtMS0xLTEtMzE0MjI_e353e615-c572-4116-8e1d-f4b7073de5a0">5,530.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="vtrs:Chargebacks" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo4ZDg1ZDY0YjU4MTI0MjdkOWM3NWM2NTNiNmMzMTZiYS90YWJsZXJhbmdlOjhkODVkNjRiNTgxMjQyN2Q5Yzc1YzY1M2I2YzMxNmJhXzQtMy0xLTEtMzE0MjI_4b9524c3-b0f4-4334-bc89-1fa99c9a3e14">3,656.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="vtrs:Chargebacks" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo4ZDg1ZDY0YjU4MTI0MjdkOWM3NWM2NTNiNmMzMTZiYS90YWJsZXJhbmdlOjhkODVkNjRiNTgxMjQyN2Q5Yzc1YzY1M2I2YzMxNmJhXzQtNS0xLTEtMzE0MjI_43d3c54c-7f36-4ca3-bba8-9de9af97285e">3,309.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates, promotional programs and other sales allowances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="vtrs:AccruedSalesAllowances" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo4ZDg1ZDY0YjU4MTI0MjdkOWM3NWM2NTNiNmMzMTZiYS90YWJsZXJhbmdlOjhkODVkNjRiNTgxMjQyN2Q5Yzc1YzY1M2I2YzMxNmJhXzUtMS0xLTEtMzE0MjI_6cf91727-0122-4369-8383-0439b6cb35a7">6,135.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="vtrs:AccruedSalesAllowances" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo4ZDg1ZDY0YjU4MTI0MjdkOWM3NWM2NTNiNmMzMTZiYS90YWJsZXJhbmdlOjhkODVkNjRiNTgxMjQyN2Q5Yzc1YzY1M2I2YzMxNmJhXzUtMy0xLTEtMzE0MjI_3c987a3a-aa00-4e30-b396-401a9b1b50ea">3,765.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="vtrs:AccruedSalesAllowances" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo4ZDg1ZDY0YjU4MTI0MjdkOWM3NWM2NTNiNmMzMTZiYS90YWJsZXJhbmdlOjhkODVkNjRiNTgxMjQyN2Q5Yzc1YzY1M2I2YzMxNmJhXzUtNS0xLTEtMzE0MjI_c685cb4e-d40e-459e-85e1-443e5cab2b3d">3,629.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Returns</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="vtrs:RevenuefromContractwithCustomerReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo4ZDg1ZDY0YjU4MTI0MjdkOWM3NWM2NTNiNmMzMTZiYS90YWJsZXJhbmdlOjhkODVkNjRiNTgxMjQyN2Q5Yzc1YzY1M2I2YzMxNmJhXzYtMS0xLTEtMzE0MjI_508f86f4-28b3-4d6a-83d6-d156920fe613">384.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="vtrs:RevenuefromContractwithCustomerReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo4ZDg1ZDY0YjU4MTI0MjdkOWM3NWM2NTNiNmMzMTZiYS90YWJsZXJhbmdlOjhkODVkNjRiNTgxMjQyN2Q5Yzc1YzY1M2I2YzMxNmJhXzYtMy0xLTEtMzE0MjI_25a2d99e-e574-4e50-98ee-7aeb8c592d86">329.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="vtrs:RevenuefromContractwithCustomerReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo4ZDg1ZDY0YjU4MTI0MjdkOWM3NWM2NTNiNmMzMTZiYS90YWJsZXJhbmdlOjhkODVkNjRiNTgxMjQyN2Q5Yzc1YzY1M2I2YzMxNmJhXzYtNS0xLTEtMzE0MjI_709194db-c510-4e0a-91fd-cb56eafc3fc1">237.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Governmental rebate programs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="vtrs:Medicaidandothergovernmentalrebates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo4ZDg1ZDY0YjU4MTI0MjdkOWM3NWM2NTNiNmMzMTZiYS90YWJsZXJhbmdlOjhkODVkNjRiNTgxMjQyN2Q5Yzc1YzY1M2I2YzMxNmJhXzctMS0xLTEtMzE0MjI_98712ed5-cc3a-4704-b307-385f95268e81">689.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="vtrs:Medicaidandothergovernmentalrebates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo4ZDg1ZDY0YjU4MTI0MjdkOWM3NWM2NTNiNmMzMTZiYS90YWJsZXJhbmdlOjhkODVkNjRiNTgxMjQyN2Q5Yzc1YzY1M2I2YzMxNmJhXzctMy0xLTEtMzE0MjI_0840ce46-e2d9-4d14-8bc4-564d837cecea">327.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="vtrs:Medicaidandothergovernmentalrebates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo4ZDg1ZDY0YjU4MTI0MjdkOWM3NWM2NTNiNmMzMTZiYS90YWJsZXJhbmdlOjhkODVkNjRiNTgxMjQyN2Q5Yzc1YzY1M2I2YzMxNmJhXzctNS0xLTEtMzE0MjI_562b9738-7f07-4bd5-bb64-28ba962748c3">465.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total gross to net adjustments</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="vtrs:SalesRevenueGrosstonetadjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo4ZDg1ZDY0YjU4MTI0MjdkOWM3NWM2NTNiNmMzMTZiYS90YWJsZXJhbmdlOjhkODVkNjRiNTgxMjQyN2Q5Yzc1YzY1M2I2YzMxNmJhXzgtMS0xLTEtMzE0MjI_067940c2-5c9d-4dfc-b2d2-26129e53183f">12,739.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="vtrs:SalesRevenueGrosstonetadjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo4ZDg1ZDY0YjU4MTI0MjdkOWM3NWM2NTNiNmMzMTZiYS90YWJsZXJhbmdlOjhkODVkNjRiNTgxMjQyN2Q5Yzc1YzY1M2I2YzMxNmJhXzgtMy0xLTEtMzE0MjI_04d17d07-4ce1-4615-849f-aafec8243387">8,079.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="vtrs:SalesRevenueGrosstonetadjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo4ZDg1ZDY0YjU4MTI0MjdkOWM3NWM2NTNiNmMzMTZiYS90YWJsZXJhbmdlOjhkODVkNjRiNTgxMjQyN2Q5Yzc1YzY1M2I2YzMxNmJhXzgtNS0xLTEtMzE0MjI_2b3ebf9e-13d8-4bdd-9a0a-0a2cdc5b656f">7,641.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic25b2c6a9a1244738c1de493abb87705_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo4ZDg1ZDY0YjU4MTI0MjdkOWM3NWM2NTNiNmMzMTZiYS90YWJsZXJhbmdlOjhkODVkNjRiNTgxMjQyN2Q5Yzc1YzY1M2I2YzMxNmJhXzktMS0xLTEtMzE0MjI_7aa79eb2-d382-4529-8fc9-aa4d63f2ec2a">17,813.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f25078033394f518263d14867ea4eb6_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo4ZDg1ZDY0YjU4MTI0MjdkOWM3NWM2NTNiNmMzMTZiYS90YWJsZXJhbmdlOjhkODVkNjRiNTgxMjQyN2Q5Yzc1YzY1M2I2YzMxNmJhXzktMy0xLTEtMzE0MjI_54a369d6-0ccd-44fd-b9ac-55ef2df479e5">11,819.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadb0452c57794c5498c4248d6691b32c_D20190101-20191231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo4ZDg1ZDY0YjU4MTI0MjdkOWM3NWM2NTNiNmMzMTZiYS90YWJsZXJhbmdlOjhkODVkNjRiNTgxMjQyN2Q5Yzc1YzY1M2I2YzMxNmJhXzktNS0xLTEtMzE0MjI_39d62a6d-a618-4b98-90a3-4446d6b752b8">11,370.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><ix:continuation id="ibb9a7e6a619e40b29114ec98d1756c9b"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a rollforward of the categories of variable consideration during 2021:</span></div><div style="margin-bottom:7pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.433%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current Provision Related to Sales Made in the Current Period </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Measurement Period Adjustments and Reclasses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Checks/ Credits Issued to Third Parties </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effects of Foreign Exchange</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chargebacks</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia30145a9cfd34adf9f91e6f9a1d897d6_I20201231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzEtMS0xLTEtMzE0MjI_f820a324-a129-4071-9e34-7e1855a7e394">585.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81f43377851f4e9cbe28368c42243f3f_D20210101-20211231" decimals="-5" name="vtrs:AccountsReceivableSalesProvisionsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzEtMy0xLTEtMzE0MjI_3e8e2d28-4bc9-46af-89dd-e42e62b721b9">5,530.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81f43377851f4e9cbe28368c42243f3f_D20210101-20211231" decimals="-5" name="vtrs:AccountsReceivableIncreaseDueToAcquisitionCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzEtNS0xLTEtMzE0MjI_8f9074c8-57d6-43ff-b85a-afc07d9468e3">63.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81f43377851f4e9cbe28368c42243f3f_D20210101-20211231" decimals="-5" name="vtrs:AccountsReceivableCreditsIssuedtoThirdParties" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzEtNy0xLTEtMzE0MjI_1f73e02c-a785-4612-9e67-72cdeb0c791c">5,585.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81f43377851f4e9cbe28368c42243f3f_D20210101-20211231" decimals="-5" sign="-" name="vtrs:AccountsReceivableEffectsofForeignExchangeRates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzEtOS0xLTEtMzE0MjI_1896b889-ae27-4c42-b814-919336c7ce42">1.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864aa5c3fc0487aa3a78da7140b6dae_I20211231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzEtMTEtMS0xLTMxNDIy_f4a42e12-8943-4ca1-b6c5-8e20757de32a">591.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates, promotional programs and other sales allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59d64e28e4b04c0d99f30844bbc4e104_I20201231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzItMS0xLTEtMzE0MjI_8cb83522-a5e0-4945-9a2e-a9ded635c1e3">1,576.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67c331d11f9e4f3a92ca17c2d501cc83_D20210101-20211231" decimals="-5" name="vtrs:AccountsReceivableSalesProvisionsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzItMy0xLTEtMzE0MjI_10b4c23d-d9ca-476d-b070-f0195d92f6b4">6,135.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67c331d11f9e4f3a92ca17c2d501cc83_D20210101-20211231" decimals="-5" sign="-" name="vtrs:AccountsReceivableIncreaseDueToAcquisitionCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzItNS0xLTEtMzE0MjI_4c6323ab-0a1d-417e-8928-f24d8402ee6d">57.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67c331d11f9e4f3a92ca17c2d501cc83_D20210101-20211231" decimals="-5" name="vtrs:AccountsReceivableCreditsIssuedtoThirdParties" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzItNy0xLTEtMzE0MjI_4a424c7a-0542-4b3d-93c7-cfcbd5488876">6,267.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67c331d11f9e4f3a92ca17c2d501cc83_D20210101-20211231" decimals="-5" sign="-" name="vtrs:AccountsReceivableEffectsofForeignExchangeRates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzItOS0xLTEtMzE0MjI_e76c03eb-2157-41a4-8eea-1baa4db3ca67">14.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id58d328313c7408dbd05e2611ee1d266_I20211231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzItMTEtMS0xLTMxNDIy_eaa97f80-892d-440d-98e9-cdb99347cabf">1,373.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Returns</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0a5fc9ab1014cc9828221ef14219272_I20201231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzMtMS0xLTEtMzE0MjI_6c984e80-4b67-4233-b011-f3324ab8b6c6">539.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c2d36cecfc429d8366c26884930d60_D20210101-20211231" decimals="-5" name="vtrs:AccountsReceivableSalesProvisionsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzMtMy0xLTEtMzE0MjI_7c40a8a2-3b8a-4947-86e8-4f7e58615642">384.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c2d36cecfc429d8366c26884930d60_D20210101-20211231" decimals="-5" name="vtrs:AccountsReceivableIncreaseDueToAcquisitionCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzMtNS0xLTEtMzE0MjI_6d518113-3b95-4518-8c51-de91ec9b07c9">269.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62c2d36cecfc429d8366c26884930d60_D20210101-20211231" decimals="-5" name="vtrs:AccountsReceivableCreditsIssuedtoThirdParties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzMtNy0xLTEtMzE0MjI_c00a0f63-9f07-4e3c-99b2-cf9a8c2fe3f8">499.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62c2d36cecfc429d8366c26884930d60_D20210101-20211231" decimals="-5" sign="-" name="vtrs:AccountsReceivableEffectsofForeignExchangeRates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzMtOS0xLTEtMzE0MjI_72bc98d4-1925-49f2-a92f-5b93314172c0">7.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3efb27c0d9ce4732970b87f4f7b6cadf_I20211231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzMtMTEtMS0xLTMxNDIy_79c99bfb-9b1f-4d92-83d0-e85b2e854e62">686.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Governmental rebate programs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab5c4046b8d2456db70b484a5adc2c29_I20201231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzQtMS0xLTEtMzE0MjI_ec4bfa2c-a0ec-48cc-bb2f-3d61c2a40d9b">313.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie03fd9221eda4da4a0b73570d90c8f67_D20210101-20211231" decimals="-5" name="vtrs:AccountsReceivableSalesProvisionsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzQtMy0xLTEtMzE0MjI_e4be7394-3991-472d-880d-29289529ecf6">689.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie03fd9221eda4da4a0b73570d90c8f67_D20210101-20211231" decimals="-5" name="vtrs:AccountsReceivableIncreaseDueToAcquisitionCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzQtNS0xLTEtMzE0MjI_02bbd01e-0046-4fdc-b318-cc8ff742a50c">110.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie03fd9221eda4da4a0b73570d90c8f67_D20210101-20211231" decimals="-5" name="vtrs:AccountsReceivableCreditsIssuedtoThirdParties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzQtNy0xLTEtMzE0MjI_3b737542-c8b2-4263-8c71-b0e5f22c89b3">705.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie03fd9221eda4da4a0b73570d90c8f67_D20210101-20211231" decimals="-5" sign="-" name="vtrs:AccountsReceivableEffectsofForeignExchangeRates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzQtOS0xLTEtMzE0MjI_37e292c9-050b-44f0-9295-07190295ae2e">9.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie35e86a55b3646a392f2363a1ff84e7f_I20211231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzQtMTEtMS0xLTMxNDIy_ed1d3200-a8c9-4da2-9cac-04a80735f853">399.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8299fb24ad740a0bc5299022149cc89_I20201231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzUtMS0xLTEtMzE0MjI_de25a40c-cbe2-4531-9719-06e498a37551">3,014.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25df0d0412f4491d87734041970219e9_D20210101-20211231" decimals="-5" name="vtrs:AccountsReceivableSalesProvisionsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzUtMy0xLTEtMzE0MjI_c46af580-3320-45c0-9fe0-e3bf7ad73af6">12,739.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25df0d0412f4491d87734041970219e9_D20210101-20211231" decimals="-5" name="vtrs:AccountsReceivableIncreaseDueToAcquisitionCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzUtNS0xLTEtMzE0MjI_2df387f7-19d1-4714-bf2a-9583307180e2">385.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25df0d0412f4491d87734041970219e9_D20210101-20211231" decimals="-5" name="vtrs:AccountsReceivableCreditsIssuedtoThirdParties" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzUtNy0xLTEtMzE0MjI_c2c5dcec-aa69-45e8-803a-757faa8ecdb2">13,056.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25df0d0412f4491d87734041970219e9_D20210101-20211231" decimals="-5" sign="-" name="vtrs:AccountsReceivableEffectsofForeignExchangeRates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzUtOS0xLTEtMzE0MjI_dd22b4f4-6c15-48e3-988a-9b881115d84a">32.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f62d5c61184fe0a10c432fdf606fac_I20211231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzUtMTEtMS0xLTMxNDIy_56fd3fb7-bb54-4c4c-b66f-da98be3638e1">3,050.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accruals for these provisions are presented in the consolidated financial statements as reductions in determining net revenues and as a contra-asset in accounts receivable, net (if settled via credit) and other current liabilities (if paid in cash). <ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90ZXh0cmVnaW9uOjkyYTgzOGNmNmU1NDRiMTZhOWU5YjgyZjAwNmQ2MjMwXzEyMzM_342c378c-9927-49a1-8f6d-3aefe56861a3" continuedAt="i42e0712a530f4357b6eefc4194f520f3" escape="true">Accounts receivable are presented net of allowances relating to these provisions, which were comprised of the following at December&#160;31, 2021 and 2020, respectively:</ix:nonNumeric></span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><ix:continuation id="i42e0712a530f4357b6eefc4194f520f3"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:76.661%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.652%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f62d5c61184fe0a10c432fdf606fac_I20211231" decimals="-5" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyNWM5YTQ0OTUwYWE0ZDM1YjQxOWRhNmU4NzIyNzJlNi90YWJsZXJhbmdlOjI1YzlhNDQ5NTBhYTRkMzViNDE5ZGE2ZTg3MjI3MmU2XzEtMS0xLTEtMzE0MjI_b8de2bbb-bd17-46ce-8821-974746823788">1,688.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8299fb24ad740a0bc5299022149cc89_I20201231" decimals="-5" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyNWM5YTQ0OTUwYWE0ZDM1YjQxOWRhNmU4NzIyNzJlNi90YWJsZXJhbmdlOjI1YzlhNDQ5NTBhYTRkMzViNDE5ZGE2ZTg3MjI3MmU2XzEtMy0xLTEtMzE0MjI_a7eb53c4-c231-41c1-9581-2194a26bf78a">1,802.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f62d5c61184fe0a10c432fdf606fac_I20211231" decimals="-5" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyNWM5YTQ0OTUwYWE0ZDM1YjQxOWRhNmU4NzIyNzJlNi90YWJsZXJhbmdlOjI1YzlhNDQ5NTBhYTRkMzViNDE5ZGE2ZTg3MjI3MmU2XzItMS0xLTEtMzE0MjI_2fb5bb83-0d1e-4667-a0f7-13c28ad2d896">1,362.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8299fb24ad740a0bc5299022149cc89_I20201231" decimals="-5" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyNWM5YTQ0OTUwYWE0ZDM1YjQxOWRhNmU4NzIyNzJlNi90YWJsZXJhbmdlOjI1YzlhNDQ5NTBhYTRkMzViNDE5ZGE2ZTg3MjI3MmU2XzItMy0xLTEtMzE0MjI_89c69ddc-c38d-442b-9375-a8122ac327a8">1,211.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f62d5c61184fe0a10c432fdf606fac_I20211231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyNWM5YTQ0OTUwYWE0ZDM1YjQxOWRhNmU4NzIyNzJlNi90YWJsZXJhbmdlOjI1YzlhNDQ5NTBhYTRkMzViNDE5ZGE2ZTg3MjI3MmU2XzMtMS0xLTEtMzE0MjI_52d67ab4-6537-4a41-919b-da69b5e208be">3,050.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8299fb24ad740a0bc5299022149cc89_I20201231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyNWM5YTQ0OTUwYWE0ZDM1YjQxOWRhNmU4NzIyNzJlNi90YWJsZXJhbmdlOjI1YzlhNDQ5NTBhYTRkMzViNDE5ZGE2ZTg3MjI3MmU2XzMtMy0xLTEtMzE0MjI_0b263ba3-dbab-4bd1-838f-c33bac641033">3,014.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2cb7647ee3134efdbe1480ea14fe1742">We have not made and do not anticipate making any significant changes to the methodologies that we use to measure provisions for variable consideration; however, the balances within these reserves can fluctuate significantly through the consistent application of our methodologies. Historically, we have not recorded in any current period any material amounts related to adjustments made to prior period reserves.</ix:continuation> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable, net was comprised of the following at December 31, 2021 and December 31, 2020, respectively:</span></div><div style="margin-bottom:12pt;margin-top:5pt;padding-left:36pt;text-indent:-36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:76.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOTI5NmJhYzRkMDc0ZTQyYmFlN2Y2NWE5NGY3MzBmOS90YWJsZXJhbmdlOjA5Mjk2YmFjNGQwNzRlNDJiYWU3ZjY1YTk0ZjczMGY5XzEtMS0xLTEtMzg0NTI_00b80f2d-97e7-4407-93b6-eef61f303475">3,774.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOTI5NmJhYzRkMDc0ZTQyYmFlN2Y2NWE5NGY3MzBmOS90YWJsZXJhbmdlOjA5Mjk2YmFjNGQwNzRlNDJiYWU3ZjY1YTk0ZjczMGY5XzEtMy0xLTEtMzg0NTI_a3139904-b002-4b5d-89b0-a6db149d3946">3,891.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:OtherReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOTI5NmJhYzRkMDc0ZTQyYmFlN2Y2NWE5NGY3MzBmOS90YWJsZXJhbmdlOjA5Mjk2YmFjNGQwNzRlNDJiYWU3ZjY1YTk0ZjczMGY5XzItMS0xLTEtMzg0NTI_1a92e25c-c954-494d-94ce-75c49e9a119a">492.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:OtherReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOTI5NmJhYzRkMDc0ZTQyYmFlN2Y2NWE5NGY3MzBmOS90YWJsZXJhbmdlOjA5Mjk2YmFjNGQwNzRlNDJiYWU3ZjY1YTk0ZjczMGY5XzItMy0xLTEtMzg0NTI_cf2bde30-290b-4cea-8e29-1ea18fd6b87b">952.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accounts receivable, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOTI5NmJhYzRkMDc0ZTQyYmFlN2Y2NWE5NGY3MzBmOS90YWJsZXJhbmdlOjA5Mjk2YmFjNGQwNzRlNDJiYWU3ZjY1YTk0ZjczMGY5XzMtMS0xLTEtMzg0NTI_a91113de-31d7-4520-8489-7647cf781bd2">4,266.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOTI5NmJhYzRkMDc0ZTQyYmFlN2Y2NWE5NGY3MzBmOS90YWJsZXJhbmdlOjA5Mjk2YmFjNGQwNzRlNDJiYWU3ZjY1YTk0ZjczMGY5XzMtMy0xLTEtMzg0NTI_817f9dc4-5e7d-4609-8621-1ce8bc2b9c9f">4,843.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total allowances for doubtful accounts were $<ix:nonFraction unitRef="usd" contextRef="ic23fe954f12a4fafb334644ca65a1579_I20211231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90ZXh0cmVnaW9uOjkyYTgzOGNmNmU1NDRiMTZhOWU5YjgyZjAwNmQ2MjMwXzMyOTg1MzQ4ODY5MDY_a63546b3-9446-4928-a5b8-55ca953e804b">154.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i8aaae8d197ef43d0880965d47a937ced_I20201231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90ZXh0cmVnaW9uOjkyYTgzOGNmNmU1NDRiMTZhOWU5YjgyZjAwNmQ2MjMwXzMyOTg1MzQ4ODY5MTQ_3df7413c-f864-440d-a949-ad20423c8f45">159.9</ix:nonFraction> million at December&#160;31, 2021 and 2020, respectively. Viatris performs ongoing credit evaluations of its customers and generally does not require collateral. Approximately <ix:nonFraction unitRef="number" contextRef="i8023e485af7e4af6b209e877aaef3977_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90ZXh0cmVnaW9uOjkyYTgzOGNmNmU1NDRiMTZhOWU5YjgyZjAwNmQ2MjMwXzEwOTk1MTE2MzIwOTk_5696f291-4570-4648-9a4e-955d051e8945">18</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i594757645c9e47d297a0b656a9168fb9_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90ZXh0cmVnaW9uOjkyYTgzOGNmNmU1NDRiMTZhOWU5YjgyZjAwNmQ2MjMwXzE2NDkyNjc0NDU5Nzk_60fe109f-4148-4ccc-afb8-75c70744b20c">12</ix:nonFraction>% of the accounts receivable balances represent amounts due from three customers at December&#160;31, 2021 and 2020, respectively.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounts Receivable Factoring Arrangements</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into accounts receivable factoring agreements with financial institutions to sell certain of our non-U.S. accounts receivable. These transactions are accounted for as sales and result in a reduction in accounts receivable because the agreements transfer effective control over and risk related to the receivables to the buyers. Our factoring agreements do not allow for recourse in the event of uncollectibility, and we do not retain any interest in the underlying accounts receivable once sold. We derecognized $<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:ProceedsFromSaleAndCollectionOfReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90ZXh0cmVnaW9uOjkyYTgzOGNmNmU1NDRiMTZhOWU5YjgyZjAwNmQ2MjMwXzMyOTg1MzQ4ODcyMjg_363f040d-6d81-4759-a3dc-b3663529d04c">29.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:ProceedsFromSaleAndCollectionOfReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90ZXh0cmVnaW9uOjkyYTgzOGNmNmU1NDRiMTZhOWU5YjgyZjAwNmQ2MjMwXzMyOTg1MzQ4ODcyMzY_3f0f7215-4c5a-416c-80f5-aa145e122051">153.0</ix:nonFraction> million of accounts receivable as of December&#160;31, 2021 and 2020 under these factoring arrangements, respectively.</span></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_181"></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.</span><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzE3MjYz_3d1056c9-0563-439c-9c89-a56c1acdda63" continuedAt="i345534df8c4945bda2d1b6123d4c90a9" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">Acquisitions and Other Transactions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></ix:nonNumeric></div><ix:continuation id="i345534df8c4945bda2d1b6123d4c90a9" continuedAt="i26cef53e79ae4d7ea5892b4cf6f8c498"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Upjohn Business Combination Agreement</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 29, 2019, Mylan, Pfizer, Upjohn, a wholly-owned subsidiary of Pfizer, and certain other affiliated entities entered into a Business Combination Agreement pursuant to which Mylan would combine with the Upjohn Business in a Reverse Morris Trust transaction. The Upjohn Business was a global, primarily off-patent branded and generic established medicines business, which includes <ix:nonFraction unitRef="number" contextRef="ic831d526d86b425a838a3b514a51aa9b_I20190729" decimals="0" name="vtrs:NumberOfProducts" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzQ3OA_224dd55c-8d9f-4f4f-b416-8c64a0f8ba9c">20</ix:nonFraction> primarily off-patent solid oral dose legacy brands, such as Lyrica&#174;, Lipitor&#174;, Celebrex&#174; and Viagra&#174;. The Combination was completed on November 16, 2020. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Combination and pursuant to a Separation and Distribution Agreement, Pfizer had, among other things, transferred to Viatris substantially all of the assets and liabilities comprising the Upjohn Business (the Separation) and, thereafter, Pfizer had distributed to Pfizer stockholders all of the issued and outstanding shares of Viatris (the Distribution). When the Distribution and Combination were complete, Pfizer stockholders as of the record date of the Distribution owned <ix:nonFraction unitRef="number" contextRef="ic08788a5b48c49cd8ad76565947aec25_I20190729" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzExMjE_bda100b3-ed63-4af7-bb02-466a5b226a71">57</ix:nonFraction>% of the outstanding shares of Viatris common stock and Mylan shareholders as of immediately before the Combination owned <ix:nonFraction unitRef="number" contextRef="id1612a93b9c54c9ea53906da30119111_I20190729" decimals="2" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzEyNDQ_cd0aa444-5441-4356-aef0-69a014349218">43</ix:nonFraction>% of the outstanding shares of Viatris common stock, in each case on a fully diluted basis. Viatris also made a cash payment to Pfizer equal to $<ix:nonFraction unitRef="usd" contextRef="i35d0a01da1c741dc96caa2bc7d221b6f_D20190729-20190729" decimals="-6" name="vtrs:PaymentsforBusinessSeparation" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzEzODk_42976a89-449f-4034-9e75-357351f695fc">12</ix:nonFraction> billion, which was funded with the proceeds of debt incurred by Upjohn prior to the Combination.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction involved multiple legal entity restructuring transactions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and a reverse merger acquisition with Viatris representing the legal acquirer and Mylan representing the accounting acquirer of the Upjohn Business. In accordance with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC 805, Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Mylan is considered the accounting acquirer of the Upjohn Business and Viatris applied purchase accounting to the acquired assets and assumed liabilities of the Upjohn Business as of November 16, 2020. The debt incurred by Upjohn prior to the Combination was a liability assumed in purchase accounting. The fair value of the debt as of November 16, 2020 was $<ix:nonFraction unitRef="usd" contextRef="i14c83873ae33424385c0f6babd91bbf8_I20201116" decimals="-7" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzIxMTM_76470b6b-06f1-453a-9c01-e5893777495c">13.08</ix:nonFraction>&#160;billion.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purchase price consists of the issuance of approximately <ix:nonFraction unitRef="shares" contextRef="i73d9cbc916614385999dea1173262904_D20201113-20201113" decimals="-5" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzIxNzk_482cdbac-7604-4ed2-8e7f-0bb83402d44d">689.9</ix:nonFraction>&#160;million Viatris shares of common stock at a fair value of approximately $<ix:nonFraction unitRef="usd" contextRef="i73d9cbc916614385999dea1173262904_D20201113-20201113" decimals="-7" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzIyNDY_4788f2f7-240a-4882-a236-18d7c6ac872b">10.73</ix:nonFraction>&#160;billion based on the closing price of Mylan&#8217;s ordinary shares on November 13, 2020, as reported by the NASDAQ. In accordance with U.S. GAAP, the Company used the acquisition method of accounting to account for this transaction. Under the acquisition method of accounting, the assets acquired and liabilities assumed in the transaction have been recorded at their respective estimated fair values at the acquisition date. During the twelve months ended December&#160;31, 2021 and 2020, the Company incurred acquisition related costs of approximately $<ix:nonFraction unitRef="usd" contextRef="i383cdb78da1740a096ade479d7d4de29_D20210101-20211231" decimals="-5" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzMyOTg1MzQ5MDE3NzA_2c137aca-3eab-4bf0-8a89-ea69ccb3b520">234.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i28f0f2ea42204c5aa8a8ebd404f312a7_D20200101-20201231" decimals="-5" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzI3MDU_8fae2cca-d800-4d02-b4e4-a6a012059db7">602.9</ix:nonFraction>&#160;million, respectively. Acquisition related costs were recorded primarily in SG&amp;A in the consolidated statements of operations for such periods.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><ix:continuation id="i26cef53e79ae4d7ea5892b4cf6f8c498" continuedAt="i1cf6a43603d44b22aadd2e96754711ba"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzE3Mjgw_865f03f9-ebec-4cb4-956c-d42505aba670" escape="true"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2021, adjustments were made to the preliminary purchase price recorded at December 31, 2020, and are reflected as &#8220;Measurement Period and Other Adjustments&#8221; in the table below. The allocation of the $<ix:nonFraction unitRef="usd" contextRef="if6458ce2b0d942738f7ba444119cf196_I20190528" decimals="-7" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzI4OTE_9ec17a8c-3732-43c1-8473-6630d9450e62">10.73</ix:nonFraction>&#160;billion purchase price to the assets acquired and liabilities assumed under the Combination is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.046%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.981%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.131%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Preliminary Purchase Price Allocation as of December 31, 2020 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Measurement Period and Other Adjustments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Purchase Price Allocation as of December 31, 2021 (as adjusted)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets (excluding inventories and net of cash acquired)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i511ad858abed4134961216e0250f69b8_I20201231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzEtMS0xLTEtMzE0MjI_0f840c27-0a2c-4394-a14a-56eeb949ab5a">2,841.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i383cdb78da1740a096ade479d7d4de29_D20210101-20211231" decimals="-5" sign="-" name="vtrs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzEtMy0xLTEtMzY0MDY_c8791e6b-8962-4c4b-9888-1748e344aa87">38.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d755baaf2e14f4bab1de91a766aa0e6_I20211231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzEtNS0xLTEtMzY0MDY_6c7d3a34-8909-4284-afa8-611298035245">2,803.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i511ad858abed4134961216e0250f69b8_I20201231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzItMS0xLTEtMzE0MjI_ae2167d0-6225-4daa-9d57-7152897ddc9e">2,588.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i383cdb78da1740a096ade479d7d4de29_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzItMy0xLTEtMzYzOTI_b8356384-dbd8-437b-a3fa-49a0e35f065c">34.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d755baaf2e14f4bab1de91a766aa0e6_I20211231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzItNS0xLTEtMzY0MDY_f7b40055-200f-4f41-9902-958dce076ca5">2,554.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i511ad858abed4134961216e0250f69b8_I20201231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzMtMS0xLTEtMzE0MjI_a040c712-2727-48c2-b528-d1ae7160e712">1,394.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i383cdb78da1740a096ade479d7d4de29_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzMtMy0xLTEtMzYzOTM_098f2351-1175-463f-883a-6429242b7352">5.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d755baaf2e14f4bab1de91a766aa0e6_I20211231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzMtNS0xLTEtMzY0MDY_f6f881ce-ecca-4804-9963-610241a51fe0">1,389.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identified intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i511ad858abed4134961216e0250f69b8_I20201231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzQtMS0xLTEtMzE0MjI_15a26bad-76e3-4525-824a-2cd3a7ef0456">18,040.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d755baaf2e14f4bab1de91a766aa0e6_I20211231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzQtNS0xLTEtMzY0MDY_a13b514c-1adc-4993-963a-487dc41f10aa">18,040.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i511ad858abed4134961216e0250f69b8_I20201231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzUtMS0xLTEtMzE0MjI_a0c43976-6e1a-4969-a758-8647ccf6f47b">2,107.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i383cdb78da1740a096ade479d7d4de29_D20210101-20211231" decimals="-5" name="vtrs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzUtMy0xLTEtMzY0MDY_235a5a40-61ac-4100-80d4-0aa39ccddafb">295.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d755baaf2e14f4bab1de91a766aa0e6_I20211231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzUtNS0xLTEtMzY0MDY_9e1da8d0-af04-4535-9d07-d05dfb99e074">2,403.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i511ad858abed4134961216e0250f69b8_I20201231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzYtMS0xLTEtMzE0MjI_f6574049-7580-4156-a8e6-bf20b4299cf8">1,481.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i383cdb78da1740a096ade479d7d4de29_D20210101-20211231" decimals="-5" name="vtrs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzYtMy0xLTEtMzY0MDY_2a5958d3-a0ee-4ec1-bc76-6a9fc5ef7796">196.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d755baaf2e14f4bab1de91a766aa0e6_I20211231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzYtNS0xLTEtMzY0MDY_21063623-5516-4e61-adb1-87892664a17a">1,678.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i511ad858abed4134961216e0250f69b8_I20201231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzctMS0xLTEtMzE0MjI_b742a9d6-afbd-4a87-a93c-249883c06ebc">792.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" sign="-" name="vtrs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzctMy0xLTEtMzY0MDY_0e9689a7-f008-43d6-a476-80eb0abf39da">7.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d755baaf2e14f4bab1de91a766aa0e6_I20211231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzctNS0xLTEtMzY0MDY_b2aeb819-f852-4a9e-ab53-660df62c2b02">784.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i511ad858abed4134961216e0250f69b8_I20201231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzgtMS0xLTEtMzE0MjI_84a3bd7e-3194-4d6d-8a0a-3c4e66223bd0">29,246.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i383cdb78da1740a096ade479d7d4de29_D20210101-20211231" decimals="-5" name="vtrs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzgtMy0xLTEtMzY0MDY_1f5ed306-ada8-44c5-a010-94e958ba3823">406.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d755baaf2e14f4bab1de91a766aa0e6_I20211231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzgtNS0xLTEtMzY0MDY_348492f0-6239-4155-88e8-61b4263effa7">29,653.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i511ad858abed4134961216e0250f69b8_I20201231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzktMS0xLTEtMzE0MjI_a5165c26-316f-46c3-be1c-406c2e10a218">2,760.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i383cdb78da1740a096ade479d7d4de29_D20210101-20211231" decimals="-5" name="vtrs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzktMy0xLTEtMzY0MDY_ea5594ba-1a23-4e0f-8089-92a5fd279c06">419.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d755baaf2e14f4bab1de91a766aa0e6_I20211231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzktNS0xLTEtMzY0MDY_583321bd-29df-423b-ad3c-2c8db8875f87">3,179.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, including current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i511ad858abed4134961216e0250f69b8_I20201231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzEwLTEtMS0xLTMxNDIy_40294015-ff02-4547-9183-5d1caf05cfdd">13,076.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d755baaf2e14f4bab1de91a766aa0e6_I20211231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzEwLTUtMS0xLTM2NDA2_f2271df3-6b1b-4e7c-a249-afc4eed1788d">13,076.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i511ad858abed4134961216e0250f69b8_I20201231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzExLTEtMS0xLTMxNDIy_025dd0e5-bee8-4134-876d-b6284983e1ab">1,656.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="vtrs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzExLTMtMS0xLTM2NDA2_2cee92df-e250-4f67-bb18-49a2fc160934">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d755baaf2e14f4bab1de91a766aa0e6_I20211231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzExLTUtMS0xLTM2NDA2_3ce319b7-4069-4d1f-bff9-e4258e5c3cf8">1,657.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other noncurrent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i511ad858abed4134961216e0250f69b8_I20201231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzEyLTEtMS0xLTMxNDIy_f93b7fb8-c750-4717-adf2-51465deff9fb">1,441.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i383cdb78da1740a096ade479d7d4de29_D20210101-20211231" decimals="-5" sign="-" name="vtrs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzEyLTMtMS0xLTM2NDA2_532c1f13-b347-434d-a5fe-d463b5e68df1">14.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d755baaf2e14f4bab1de91a766aa0e6_I20211231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzEyLTUtMS0xLTM2NDA2_20294ebc-facc-41ca-ac60-c714ab4c8499">1,427.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired (net of $<ix:nonFraction unitRef="usd" contextRef="i5b06121292274e728651da9462422d99_D20201231-20201231" decimals="-5" name="us-gaap:CashAcquiredFromAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzEzLTAtMS0xLTU3NDQyL3RleHRyZWdpb246NjY2NWE1ZGE0Y2ZkNDczZWJjZDllNGE2NWJmNTgxZDBfMjE5OTAyMzI1NTYwMg_8a36ec8d-c659-461c-9127-6ed4feb49424">415.8</ix:nonFraction> of cash acquired)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i511ad858abed4134961216e0250f69b8_I20201231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzEzLTEtMS0xLTMxNDIy_b6d9c7a0-855f-421e-a55f-79ed70113241">10,311.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i383cdb78da1740a096ade479d7d4de29_D20210101-20211231" decimals="-5" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzEzLTMtMS0xLTM2NDA2_1689a0fe-1666-4747-b696-a132fed1f11a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d755baaf2e14f4bab1de91a766aa0e6_I20211231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzEzLTUtMS0xLTM2NDA2_d4972907-291e-4cba-ba2f-d4a48f0e30d0">10,311.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">____________</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.8pt">As previously reported in Viatris&#8217; Annual Report on Form 10-K for the fiscal year ended December 31, 2020.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">The measurement period adjustments are primarily for 1) certain working capital adjustments, an increase in litigation reserves to reflect facts and circumstances that existed as of the date of the Combination, and other adjustments and 2) the tax implications of these and other adjustments. These adjustments did not have a significant impact on the Company&#8217;s previously reported consolidated financial statements and accordingly, the Company has not retrospectively adjusted those consolidated financial statements.</span></div></ix:nonNumeric><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Combination enhanced each businesses&#8217; ability to serve patients&#8217; needs and expand their capabilities across more than <ix:nonFraction unitRef="market" contextRef="i0d755baaf2e14f4bab1de91a766aa0e6_I20211231" decimals="INF" name="vtrs:BusinessCombinationNumberOfMarketsServed" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzM2MjM_a67e218e-cef8-4219-904d-af3414dda819">165</ix:nonFraction> markets. Mylan brought a diverse portfolio across many geographies and key therapeutic areas, such as central nervous system and anesthesia, infectious disease and cardiovascular, as well as a robust pipeline, high-quality manufacturing and supply chain excellence. The Upjohn Business brought trusted, iconic brands, such as Lipitor&#174; (atorvastatin calcium), Celebrex&#174; (celecoxib) and Viagra&#174; (sildenafil), and proven commercialization capabilities, including leadership positions in China and other emerging markets. </span></div><div style="text-indent:39.6pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded a step-up in the fair value of inventory of approximately $<ix:nonFraction unitRef="usd" contextRef="i73d9cbc916614385999dea1173262904_D20201113-20201113" decimals="-7" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzQyNzI_a1bc93f4-a46b-416c-82e0-b233f6df9c3c">1.43</ix:nonFraction>&#160;billion at the acquisition date. During the twelve months ended December 31, 2021 and 2020, the Company recorded amortization of the inventory step-up of approximately $<ix:nonFraction unitRef="usd" contextRef="i383cdb78da1740a096ade479d7d4de29_D20210101-20211231" decimals="-7" name="vtrs:AmortizationOfInventoryStepUp" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzU0OTc1NTgxODQxMzY_8d9b1d4f-3989-47e3-955f-ade01fe98c9a">1.19</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="i28f0f2ea42204c5aa8a8ebd404f312a7_D20200101-20201231" decimals="-5" name="vtrs:AmortizationOfInventoryStepUp" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzQ0MDI_ec73d659-0922-4a55-91a6-f3be1bac3aa8">238.2</ix:nonFraction> million, respectively, which is included in cost of sales in the consolidated statements of operations. The inventory step-up was fully amortized during 2021. In addition, a step-up in the fair value of property, plant and equipment of approximately $<ix:nonFraction unitRef="usd" contextRef="i73d9cbc916614385999dea1173262904_D20201113-20201113" decimals="-6" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzQ1ODY_28dc8855-657d-4dda-98ea-3caf24c7d25e">385.0</ix:nonFraction>&#160;million was recognized. The related depreciation is being expensed over a service life of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzQ2NzE_7b74b1b4-9fe4-486d-b533-a57949c797fb">five</span> years for machinery and equipment and between <ix:nonNumeric contextRef="i06a1fb578d3742f48890eaae2166c53a_D20201113-20201113" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzQ3MjA_419bb957-6d04-4a36-9cbe-91a870bc3a65">10</ix:nonNumeric> and <ix:nonNumeric contextRef="i796a35bd5773494f8cda6075e5980668_D20201113-20201113" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzQ3Mjc_3d55c7c5-6c20-4ca2-8964-78eb9608853b">20</ix:nonNumeric> years for buildings.</span></div><div style="text-indent:39.6pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The identified intangible assets of $<ix:nonFraction unitRef="usd" contextRef="ib6b3029e4d7b457386fcdfda005379fc_I20201113" decimals="-7" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzQ3ODg_05f21d1f-90cb-4b29-9931-c48bf80c1b38">18.04</ix:nonFraction>&#160;billion are comprised of product rights and are being amortized over a weighted average useful life of <ix:nonNumeric contextRef="ibd8cc0a590a946f6ada83bcfa5b58725_D20201113-20201113" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzQ4ODY_b4bbf9c3-e35e-4f01-865d-71c85d00a7f9">15</ix:nonNumeric> years. Significant assumptions utilized in the valuation of identified intangible assets were based on company specific information and projections which are not observable in the market and are thus considered Level 3 measurements as defined by U.S. GAAP. The goodwill of $<ix:nonFraction unitRef="usd" contextRef="ib6b3029e4d7b457386fcdfda005379fc_I20201113" decimals="-7" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzUxNjI_0b2cd6b1-9bba-465f-983a-b0bc7c9afff6">2.40</ix:nonFraction>&#160;billion arising from the Combination consisted largely of the value of the employee workforce and products to be sold in new markets leveraging the combined entity. In addition, an allocation of the goodwill was assigned to the respective segments. None of the goodwill recognized in this transaction is expected to be deductible for income tax purposes.</span></div><div style="text-indent:39.6pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded a fair value adjustment of approximately $<ix:nonFraction unitRef="usd" contextRef="i73d9cbc916614385999dea1173262904_D20201113-20201113" decimals="-5" name="vtrs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzU3MDk_84ee124d-a35a-4a02-bd1f-77b1ff9878a6">759.4</ix:nonFraction>&#160;million related to the long-term debt assumed as part of the acquisition. The fair value of long-term debt as of the Combination date was determined by broker or dealer quotations, which is classified as Level 2 in the fair value hierarchy. The total fair value adjustment is being amortized as a reduction to interest expense over the maturity dates of the related debt instruments.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="text-indent:39.6pt"><span><br/></span></div><ix:continuation id="i1cf6a43603d44b22aadd2e96754711ba"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operating results of the Upjohn Business have been included in the Company&#8217;s consolidated statements of operations since the acquisition date. The total revenues of the Upjohn Business for the period from the acquisition date to December 31, 2020, were $<ix:nonFraction unitRef="usd" contextRef="i54dfb4c408114c26bed39da8f1d171f2_D20201113-20201231" decimals="-5" name="us-gaap:BusinessAcquisitionsProFormaRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzYzNDU_754eb99a-ba13-43a4-8b6c-fdd66d507fef">866.5</ix:nonFraction>&#160;million and net loss, net of tax, was approximately $<ix:nonFraction unitRef="usd" contextRef="i54dfb4c408114c26bed39da8f1d171f2_D20201113-20201231" decimals="-5" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzYzOTI_869c67fe-37f2-4e2b-89c3-85a9887895cc">360.9</ix:nonFraction>&#160;million. The net loss for the period includes the effect of the purchase accounting adjustments and acquisition related costs.</span></div><div style="text-indent:39.6pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Unaudited Pro Forma Financial Results</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents supplemental unaudited pro forma information for the Combination, as if it had occurred on January 1, 2019. The unaudited pro forma results reflect certain adjustments related to past operating performance and acquisition accounting adjustments, such as increased depreciation and amortization expense based on the fair value of assets acquired, the impact of transaction costs and the related income tax effects. The unaudited pro forma results do not include any anticipated synergies which may be achievable, or have been achieved, subsequent to the closing of the Combination. <ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:BusinessAcquisitionProFormaInformationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzE3Mjcw_2cf6918a-aeda-4514-90fe-d3dcb6fc767c" continuedAt="i824ea0f311b94e7a9ca5a57735f04c9f" escape="true">Accordingly, the unaudited pro forma results are not necessarily indicative of the results that actually would have occurred had the acquisitions been completed on the stated date above, nor are they indicative of the future operating results of Viatris and its subsidiaries.</ix:nonNumeric></span></div><div><ix:continuation id="i824ea0f311b94e7a9ca5a57735f04c9f"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.145%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(Unaudited, in millions, except per share amounts) </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i383cdb78da1740a096ade479d7d4de29_D20210101-20211231" decimals="-5" name="us-gaap:BusinessAcquisitionsProFormaRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZToxMTAxMDUxYmVkMDI0MjY1ODdiZTUyMjFhZTFjNTg5Ni90YWJsZXJhbmdlOjExMDEwNTFiZWQwMjQyNjU4N2JlNTIyMWFlMWM1ODk2XzItMS0xLTEtMzE0MjI_786435fd-2074-45d8-aa82-157a87f1b923">18,284.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f0f2ea42204c5aa8a8ebd404f312a7_D20200101-20201231" decimals="-5" name="us-gaap:BusinessAcquisitionsProFormaRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZToxMTAxMDUxYmVkMDI0MjY1ODdiZTUyMjFhZTFjNTg5Ni90YWJsZXJhbmdlOjExMDEwNTFiZWQwMjQyNjU4N2JlNTIyMWFlMWM1ODk2XzItMy0xLTEtMzE0MjI_bacbad88-98c6-474e-973b-661b0ab2a3d6">21,582.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i383cdb78da1740a096ade479d7d4de29_D20210101-20211231" decimals="-5" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZToxMTAxMDUxYmVkMDI0MjY1ODdiZTUyMjFhZTFjNTg5Ni90YWJsZXJhbmdlOjExMDEwNTFiZWQwMjQyNjU4N2JlNTIyMWFlMWM1ODk2XzMtMS0xLTEtMzE0MjI_c3d7405f-24c2-4fe1-9e54-6c85dc07a46c">1,483.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f0f2ea42204c5aa8a8ebd404f312a7_D20200101-20201231" decimals="-5" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZToxMTAxMDUxYmVkMDI0MjY1ODdiZTUyMjFhZTFjNTg5Ni90YWJsZXJhbmdlOjExMDEwNTFiZWQwMjQyNjU4N2JlNTIyMWFlMWM1ODk2XzMtMy0xLTEtMzE0MjI_a9061638-a289-4d73-9c61-06aee278a870">1,873.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i383cdb78da1740a096ade479d7d4de29_D20210101-20211231" decimals="2" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZToxMTAxMDUxYmVkMDI0MjY1ODdiZTUyMjFhZTFjNTg5Ni90YWJsZXJhbmdlOjExMDEwNTFiZWQwMjQyNjU4N2JlNTIyMWFlMWM1ODk2XzUtMS0xLTEtMzE0MjI_1550d59f-2d3f-4c66-8967-3eee5f21bded">1.23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i28f0f2ea42204c5aa8a8ebd404f312a7_D20200101-20201231" decimals="2" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZToxMTAxMDUxYmVkMDI0MjY1ODdiZTUyMjFhZTFjNTg5Ni90YWJsZXJhbmdlOjExMDEwNTFiZWQwMjQyNjU4N2JlNTIyMWFlMWM1ODk2XzUtMy0xLTEtMzE0MjI_b9cd0c81-76dc-4237-91a1-ada47aa241c2">1.55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i383cdb78da1740a096ade479d7d4de29_D20210101-20211231" decimals="2" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZToxMTAxMDUxYmVkMDI0MjY1ODdiZTUyMjFhZTFjNTg5Ni90YWJsZXJhbmdlOjExMDEwNTFiZWQwMjQyNjU4N2JlNTIyMWFlMWM1ODk2XzYtMS0xLTEtMzE0MjI_91639af3-9825-4108-92c0-7689cdb6e7cc">1.23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i28f0f2ea42204c5aa8a8ebd404f312a7_D20200101-20201231" decimals="2" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZToxMTAxMDUxYmVkMDI0MjY1ODdiZTUyMjFhZTFjNTg5Ni90YWJsZXJhbmdlOjExMDEwNTFiZWQwMjQyNjU4N2JlNTIyMWFlMWM1ODk2XzYtMy0xLTEtMzE0MjI_ef4bcf39-51fe-4b7b-8d29-fce2c544eba4">1.55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i383cdb78da1740a096ade479d7d4de29_D20210101-20211231" decimals="-5" name="us-gaap:WeightedAverageBasicSharesOutstandingProForma" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZToxMTAxMDUxYmVkMDI0MjY1ODdiZTUyMjFhZTFjNTg5Ni90YWJsZXJhbmdlOjExMDEwNTFiZWQwMjQyNjU4N2JlNTIyMWFlMWM1ODk2XzgtMS0xLTEtMzE0MjI_118cc9d8-7d90-40fb-a6d8-dcde1d086e55">1,206.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i28f0f2ea42204c5aa8a8ebd404f312a7_D20200101-20201231" decimals="-5" name="us-gaap:WeightedAverageBasicSharesOutstandingProForma" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZToxMTAxMDUxYmVkMDI0MjY1ODdiZTUyMjFhZTFjNTg5Ni90YWJsZXJhbmdlOjExMDEwNTFiZWQwMjQyNjU4N2JlNTIyMWFlMWM1ODk2XzgtMy0xLTEtMzE0MjI_18703827-709c-404f-a953-e849c759ffa4">1,205.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i383cdb78da1740a096ade479d7d4de29_D20210101-20211231" decimals="-5" name="us-gaap:ProFormaWeightedAverageSharesOutstandingDiluted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZToxMTAxMDUxYmVkMDI0MjY1ODdiZTUyMjFhZTFjNTg5Ni90YWJsZXJhbmdlOjExMDEwNTFiZWQwMjQyNjU4N2JlNTIyMWFlMWM1ODk2XzktMS0xLTEtMzE0MjI_574dc6bd-e106-4e32-9c9a-ac4d354b75d0">1,207.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i28f0f2ea42204c5aa8a8ebd404f312a7_D20200101-20201231" decimals="-5" name="us-gaap:ProFormaWeightedAverageSharesOutstandingDiluted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZToxMTAxMDUxYmVkMDI0MjY1ODdiZTUyMjFhZTFjNTg5Ni90YWJsZXJhbmdlOjExMDEwNTFiZWQwMjQyNjU4N2JlNTIyMWFlMWM1ODk2XzktMy0xLTEtMzE0MjI_9de831cc-7566-4f49-bbe3-7a91a94fdd06">1,206.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Transactions</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, Viatris and Pfizer terminated their strategic collaboration for generic drugs in Japan pursuant to an amendment and termination agreement. Under the prior collaboration agreement, both parties contributed products, which Pfizer distributed to third-parties in the Japan market. Under the terms of the amendment and termination agreement, Viatris purchased all collaboration related inventory held by Pfizer. As a result of the termination, and the repurchase of collaboration inventory, the Company reduced revenue by $<ix:nonFraction unitRef="usd" contextRef="if4bd4b5ab32b4597b343305c1a782d79_D20201201-20201231" decimals="-5" name="us-gaap:InventoryFirmPurchaseCommitmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzExMzc1_fb1a2187-16db-4b24-ab76-09cd632e6f52">86.5</ix:nonFraction>&#160;million during the year ended December 31, 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020, the Company entered into an agreement to acquire the related intellectual property and commercialization rights of Aspen&#8217;s thrombosis product portfolio in Europe for &#8364;<ix:nonFraction unitRef="eur" contextRef="i41666c68e32e49d291f852ff50719863_D20200901-20200930" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzExNTYz_ef75b6f0-dcea-4439-b23d-04953dba4966">641.9</ix:nonFraction>&#160;million. The portfolio consists of well-established injectable anticoagulants sold in Europe under the brand names, and variations of the brand names, Arixtra&#174;, Fraxiparine&#174;, Mono-Embolex&#174; and Orgaran&#174;. Upon closing of the transaction in November 2020, the Company made a payment of &#8364;<ix:nonFraction unitRef="eur" contextRef="i41666c68e32e49d291f852ff50719863_D20200901-20200930" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzExODM3_4737f124-6601-45bc-a24e-f180a85a715f">263.2</ix:nonFraction>&#160;million to Aspen and the remaining payment of &#8364;<ix:nonFraction unitRef="eur" contextRef="i3210d91021fb432dbd047ea2f8487a57_I20210625" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzExODc5_8889601e-6f93-43e8-bba8-65fe386f57cb">378.7</ix:nonFraction>&#160;million was made on June 25, 2021. The Company accounted for this transaction as an asset acquisition and recognized an intangible asset of &#8364;<ix:nonFraction unitRef="eur" contextRef="i41666c68e32e49d291f852ff50719863_D20200901-20200930" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzEyMDA5_ef75b6f0-dcea-4439-b23d-04953dba4966">641.9</ix:nonFraction>&#160;million for the product rights, which is being amortized over a useful life of <ix:nonNumeric contextRef="i3789042552e84c75b2b33ac579e33b2f_D20200901-20200930" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzEyMDgz_f10bb66f-7c2d-424b-aec4-58459b82c13c">8</ix:nonNumeric> years.</span></div></ix:continuation><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_184"></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt"> <ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90ZXh0cmVnaW9uOmNmNTk1OTZmZWI0ZjQwMThiZTUzZmY0NWEzOWNkN2ViXzIwNjE_7d52a78e-0b62-4677-b050-d6152b4d8dca" continuedAt="id99c997a2fd0470085937b38ebe7d470" escape="true">Balance Sheet Components</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id99c997a2fd0470085937b38ebe7d470" continuedAt="i282ae1619b83479f8ab4364c0110c6a6"> </ix:continuation></span></div><ix:continuation id="i282ae1619b83479f8ab4364c0110c6a6" continuedAt="i844c8d49f83042188fb86c5c8e373292"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selected balance sheet components consist of the following:</span></div><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="vtrs:ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90ZXh0cmVnaW9uOmNmNTk1OTZmZWI0ZjQwMThiZTUzZmY0NWEzOWNkN2ViXzIwNTg_ad6e74ce-ce68-407c-8ec0-a151ee66f57e" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and restricted cash</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.576%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTphMGUzMjQ3YTA0NGY0ZmI1ODAxMzUzMzc1NGFkN2M4Mi90YWJsZXJhbmdlOmEwZTMyNDdhMDQ0ZjRmYjU4MDEzNTMzNzU0YWQ3YzgyXzEtMS0xLTEtMzE0MjI_06e1e2e3-93cf-49d2-ae5c-00d175b8d2ad">701.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTphMGUzMjQ3YTA0NGY0ZmI1ODAxMzUzMzc1NGFkN2M4Mi90YWJsZXJhbmdlOmEwZTMyNDdhMDQ0ZjRmYjU4MDEzNTMzNzU0YWQ3YzgyXzEtMy0xLTEtMzE0MjI_57ad48e7-4078-4bdc-8dff-26197b10c6a3">844.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac503b6d629d4bafb262ea6ec0b8a25e_I20191231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTphMGUzMjQ3YTA0NGY0ZmI1ODAxMzUzMzc1NGFkN2M4Mi90YWJsZXJhbmdlOmEwZTMyNDdhMDQ0ZjRmYjU4MDEzNTMzNzU0YWQ3YzgyXzEtNS0xLTEtMzE0MjI_f144d637-7864-4487-8eeb-f24e7eff14f0">475.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash, included in other current and non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTphMGUzMjQ3YTA0NGY0ZmI1ODAxMzUzMzc1NGFkN2M4Mi90YWJsZXJhbmdlOmEwZTMyNDdhMDQ0ZjRmYjU4MDEzNTMzNzU0YWQ3YzgyXzItMS0xLTEtMzE0MjI_6620a1d8-4fb2-4548-b554-81e0d164bcf9">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTphMGUzMjQ3YTA0NGY0ZmI1ODAxMzUzMzc1NGFkN2M4Mi90YWJsZXJhbmdlOmEwZTMyNDdhMDQ0ZjRmYjU4MDEzNTMzNzU0YWQ3YzgyXzItMy0xLTEtMzE0MjI_9b132816-0ed1-43af-8065-e63ce9a99aee">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac503b6d629d4bafb262ea6ec0b8a25e_I20191231" decimals="-5" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTphMGUzMjQ3YTA0NGY0ZmI1ODAxMzUzMzc1NGFkN2M4Mi90YWJsZXJhbmdlOmEwZTMyNDdhMDQ0ZjRmYjU4MDEzNTMzNzU0YWQ3YzgyXzItNS0xLTEtMzE0MjI_bc0bfe37-32b5-4be6-ae73-cdb33686ea20">15.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTphMGUzMjQ3YTA0NGY0ZmI1ODAxMzUzMzc1NGFkN2M4Mi90YWJsZXJhbmdlOmEwZTMyNDdhMDQ0ZjRmYjU4MDEzNTMzNzU0YWQ3YzgyXzMtMS0xLTEtMzE0MjI_8a6c8a91-c440-4261-a29e-8f2ab14325b7">706.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTphMGUzMjQ3YTA0NGY0ZmI1ODAxMzUzMzc1NGFkN2M4Mi90YWJsZXJhbmdlOmEwZTMyNDdhMDQ0ZjRmYjU4MDEzNTMzNzU0YWQ3YzgyXzMtMy0xLTEtMzE0MjI_59b59538-62d7-47ae-bc9f-5f77173edd00">850.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac503b6d629d4bafb262ea6ec0b8a25e_I20191231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTphMGUzMjQ3YTA0NGY0ZmI1ODAxMzUzMzc1NGFkN2M4Mi90YWJsZXJhbmdlOmEwZTMyNDdhMDQ0ZjRmYjU4MDEzNTMzNzU0YWQ3YzgyXzMtNS0xLTEtMzE0MjI_af047b45-1fea-4bb4-b1a0-2d92570ce3bb">491.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><ix:continuation id="i844c8d49f83042188fb86c5c8e373292" continuedAt="i7d86681872224c7a8afc21533a14ff99"><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-bottom:12pt;margin-top:5pt"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90ZXh0cmVnaW9uOmNmNTk1OTZmZWI0ZjQwMThiZTUzZmY0NWEzOWNkN2ViXzIwNTk_83d91b0f-b20e-40b4-a1e6-65e480232ffc" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:76.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZToyMjJjYjBkNTVlN2E0ZDlhYWI4ZGQ3YWQ1ZDNiNjkyMy90YWJsZXJhbmdlOjIyMmNiMGQ1NWU3YTRkOWFhYjhkZDdhZDVkM2I2OTIzXzEtMS0xLTEtMzE0MjI_164501df-3f04-4331-82f2-5b50731da217">922.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZToyMjJjYjBkNTVlN2E0ZDlhYWI4ZGQ3YWQ1ZDNiNjkyMy90YWJsZXJhbmdlOjIyMmNiMGQ1NWU3YTRkOWFhYjhkZDdhZDVkM2I2OTIzXzEtMy0xLTEtMzE0MjI_1eec09d6-695a-443b-bfeb-4c1cc49dc693">958.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZToyMjJjYjBkNTVlN2E0ZDlhYWI4ZGQ3YWQ1ZDNiNjkyMy90YWJsZXJhbmdlOjIyMmNiMGQ1NWU3YTRkOWFhYjhkZDdhZDVkM2I2OTIzXzItMS0xLTEtMzE0MjI_a68e3105-f6fd-4a52-b878-34d07843f258">993.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZToyMjJjYjBkNTVlN2E0ZDlhYWI4ZGQ3YWQ1ZDNiNjkyMy90YWJsZXJhbmdlOjIyMmNiMGQ1NWU3YTRkOWFhYjhkZDdhZDVkM2I2OTIzXzItMy0xLTEtMzE0MjI_f281a8d7-118b-4ab2-8a62-a86a49a10ad4">1,438.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZToyMjJjYjBkNTVlN2E0ZDlhYWI4ZGQ3YWQ1ZDNiNjkyMy90YWJsZXJhbmdlOjIyMmNiMGQ1NWU3YTRkOWFhYjhkZDdhZDVkM2I2OTIzXzMtMS0xLTEtMzE0MjI_1a4c860e-c040-41f0-b91b-a7499da06ed7">2,062.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZToyMjJjYjBkNTVlN2E0ZDlhYWI4ZGQ3YWQ1ZDNiNjkyMy90YWJsZXJhbmdlOjIyMmNiMGQ1NWU3YTRkOWFhYjhkZDdhZDVkM2I2OTIzXzMtMy0xLTEtMzE0MjI_6304bf4c-650a-4ea7-bba0-7801c4d8e1e8">3,075.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZToyMjJjYjBkNTVlN2E0ZDlhYWI4ZGQ3YWQ1ZDNiNjkyMy90YWJsZXJhbmdlOjIyMmNiMGQ1NWU3YTRkOWFhYjhkZDdhZDVkM2I2OTIzXzQtMS0xLTEtMzE0MjI_099fe197-b28e-4fbf-8ad2-50542d633d67">3,977.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZToyMjJjYjBkNTVlN2E0ZDlhYWI4ZGQ3YWQ1ZDNiNjkyMy90YWJsZXJhbmdlOjIyMmNiMGQ1NWU3YTRkOWFhYjhkZDdhZDVkM2I2OTIzXzQtMy0xLTEtMzE0MjI_944346c4-e068-42e1-96ac-85ceed41694e">5,471.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory reserves totaled $<ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:InventoryValuationReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90ZXh0cmVnaW9uOmNmNTk1OTZmZWI0ZjQwMThiZTUzZmY0NWEzOWNkN2ViXzExODU_a3b4aea9-5fa3-473a-83b0-000124263a44">519.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:InventoryValuationReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90ZXh0cmVnaW9uOmNmNTk1OTZmZWI0ZjQwMThiZTUzZmY0NWEzOWNkN2ViXzExOTI_1799ad47-d60a-45b5-9b78-f75e89a97ebb">353.6</ix:nonFraction> million at December&#160;31, 2021 and 2020, respectively. Included as a component of cost of sales is expense related to the net realizable value of inventories of $<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="vtrs:Netrealizablevalueofinventoryrecognizedasexpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90ZXh0cmVnaW9uOmNmNTk1OTZmZWI0ZjQwMThiZTUzZmY0NWEzOWNkN2ViXzEzMjk_49aa6739-c2bc-4f7f-a711-2624b1a724b0">474.9</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="vtrs:Netrealizablevalueofinventoryrecognizedasexpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90ZXh0cmVnaW9uOmNmNTk1OTZmZWI0ZjQwMThiZTUzZmY0NWEzOWNkN2ViXzEzMzM_d7ee2916-1ce7-4891-acd9-cf6b646bbd5a">206.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="vtrs:Netrealizablevalueofinventoryrecognizedasexpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90ZXh0cmVnaW9uOmNmNTk1OTZmZWI0ZjQwMThiZTUzZmY0NWEzOWNkN2ViXzEzNDA_081785a3-66ac-407b-8147-2540f03d8b3e">399.2</ix:nonFraction> million for the years ended December&#160;31, 2021, 2020 and 2019, respectively.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90ZXh0cmVnaW9uOmNmNTk1OTZmZWI0ZjQwMThiZTUzZmY0NWEzOWNkN2ViXzIwNDI_b766b466-8c0f-409b-b112-4b02ae3479d7" escape="true"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prepaid expenses and other current assets</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:77.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.457%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.458%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:PrepaidExpenseCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTo5NTU3YWVjYTk1N2E0NWNhOGNmYTc4MDQ4NWQyZDBlMy90YWJsZXJhbmdlOjk1NTdhZWNhOTU3YTQ1Y2E4Y2ZhNzgwNDg1ZDJkMGUzXzEtMS0xLTEtMzE0MjI_98e24883-efcf-4f0f-b4d5-be9c6eacf190">256.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:PrepaidExpenseCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTo5NTU3YWVjYTk1N2E0NWNhOGNmYTc4MDQ4NWQyZDBlMy90YWJsZXJhbmdlOjk1NTdhZWNhOTU3YTQ1Y2E4Y2ZhNzgwNDg1ZDJkMGUzXzEtMy0xLTEtMzE0MjI_8f2edeef-0631-4edb-b146-20002d68299a">267.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale fixed income securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTo5NTU3YWVjYTk1N2E0NWNhOGNmYTc4MDQ4NWQyZDBlMy90YWJsZXJhbmdlOjk1NTdhZWNhOTU3YTQ1Y2E4Y2ZhNzgwNDg1ZDJkMGUzXzMtMS0xLTEtMzE0MjI_5687849e-00b2-4b45-90fc-fa52e8f66c8b">38.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTo5NTU3YWVjYTk1N2E0NWNhOGNmYTc4MDQ4NWQyZDBlMy90YWJsZXJhbmdlOjk1NTdhZWNhOTU3YTQ1Y2E4Y2ZhNzgwNDg1ZDJkMGUzXzMtMy0xLTEtMzE0MjI_cbf2168c-4b0f-4f69-90bc-d29127135af6">39.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of financial instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTo5NTU3YWVjYTk1N2E0NWNhOGNmYTc4MDQ4NWQyZDBlMy90YWJsZXJhbmdlOjk1NTdhZWNhOTU3YTQ1Y2E4Y2ZhNzgwNDg1ZDJkMGUzXzQtMS0xLTEtMzE0MjI_406b5836-de20-4cb3-8b3a-81ca4ece0767">144.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTo5NTU3YWVjYTk1N2E0NWNhOGNmYTc4MDQ4NWQyZDBlMy90YWJsZXJhbmdlOjk1NTdhZWNhOTU3YTQ1Y2E4Y2ZhNzgwNDg1ZDJkMGUzXzQtMy0xLTEtMzE0MjI_1f81a41f-a56d-4f95-94e9-cd131026bc5c">118.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTo5NTU3YWVjYTk1N2E0NWNhOGNmYTc4MDQ4NWQyZDBlMy90YWJsZXJhbmdlOjk1NTdhZWNhOTU3YTQ1Y2E4Y2ZhNzgwNDg1ZDJkMGUzXzUtMS0xLTEtMzE0MjI_bf938a30-8572-4bda-9a62-b718a9db7cf8">51.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTo5NTU3YWVjYTk1N2E0NWNhOGNmYTc4MDQ4NWQyZDBlMy90YWJsZXJhbmdlOjk1NTdhZWNhOTU3YTQ1Y2E4Y2ZhNzgwNDg1ZDJkMGUzXzUtMy0xLTEtMzE0MjI_ba46d00f-614b-419f-8b2b-9b979f6e1267">45.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTo5NTU3YWVjYTk1N2E0NWNhOGNmYTc4MDQ4NWQyZDBlMy90YWJsZXJhbmdlOjk1NTdhZWNhOTU3YTQ1Y2E4Y2ZhNzgwNDg1ZDJkMGUzXzYtMS0xLTEtMzE0MjI_4d06d3d2-bc67-4ea0-a530-ac263f9be484">1,467.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTo5NTU3YWVjYTk1N2E0NWNhOGNmYTc4MDQ4NWQyZDBlMy90YWJsZXJhbmdlOjk1NTdhZWNhOTU3YTQ1Y2E4Y2ZhNzgwNDg1ZDJkMGUzXzYtMy0xLTEtMzE0MjI_1d86aeed-b992-4ca1-9167-5fcb6b307db0">1,236.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTo5NTU3YWVjYTk1N2E0NWNhOGNmYTc4MDQ4NWQyZDBlMy90YWJsZXJhbmdlOjk1NTdhZWNhOTU3YTQ1Y2E4Y2ZhNzgwNDg1ZDJkMGUzXzctMS0xLTEtMzE0MjI_de737564-7fa7-4719-aec1-594729581372">1,957.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTo5NTU3YWVjYTk1N2E0NWNhOGNmYTc4MDQ4NWQyZDBlMy90YWJsZXJhbmdlOjk1NTdhZWNhOTU3YTQ1Y2E4Y2ZhNzgwNDg1ZDJkMGUzXzctMy0xLTEtMzE0MjI_2915e38f-6c9a-45db-b389-7c4ae23801ce">1,707.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses consist primarily of prepaid rent, insurance and other individually insignificant items.</span></div><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90ZXh0cmVnaW9uOmNmNTk1OTZmZWI0ZjQwMThiZTUzZmY0NWEzOWNkN2ViXzIwMzY_22b3e3a2-d983-4852-97a8-e55d58df8792" escape="true"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, plant and equipment, net</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:77.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.457%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.458%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ccfb22de62b4dbfb381e7e2a79f34d0_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplNmEzNGZlYTEyNWM0YzQ4OThkMDE5NjMwNjA3YWM4My90YWJsZXJhbmdlOmU2YTM0ZmVhMTI1YzRjNDg5OGQwMTk2MzA2MDdhYzgzXzEtMS0xLTEtMzE0MjI_9954e468-305e-4df0-a507-24aae2f5e272">3,054.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97ba3f8ae46a4aaab4fc9b30066a831a_I20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplNmEzNGZlYTEyNWM0YzQ4OThkMDE5NjMwNjA3YWM4My90YWJsZXJhbmdlOmU2YTM0ZmVhMTI1YzRjNDg5OGQwMTk2MzA2MDdhYzgzXzEtMy0xLTEtMzE0MjI_dee77fff-3c49-4032-b503-885219c2e2c6">3,235.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bf94f5dfaca4ac4a4aee298a2a67610_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplNmEzNGZlYTEyNWM0YzQ4OThkMDE5NjMwNjA3YWM4My90YWJsZXJhbmdlOmU2YTM0ZmVhMTI1YzRjNDg5OGQwMTk2MzA2MDdhYzgzXzItMS0xLTEtMzE0MjI_72254c5e-3d18-4c71-ba82-aa4fa0f9d450">1,808.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b4491a3703940ab85025237197bb24e_I20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplNmEzNGZlYTEyNWM0YzQ4OThkMDE5NjMwNjA3YWM4My90YWJsZXJhbmdlOmU2YTM0ZmVhMTI1YzRjNDg5OGQwMTk2MzA2MDdhYzgzXzItMy0xLTEtMzE0MjI_e27744b5-99a1-4b95-9be0-4e7764067c3f">1,954.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie99bf64200a74c20a3b7166e800c0872_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplNmEzNGZlYTEyNWM0YzQ4OThkMDE5NjMwNjA3YWM4My90YWJsZXJhbmdlOmU2YTM0ZmVhMTI1YzRjNDg5OGQwMTk2MzA2MDdhYzgzXzMtMS0xLTEtMzE0MjI_a525b8ee-fb25-4aed-a8d0-30d591423b73">588.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8ad288402464acb99bb2fd89ae7fe54_I20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplNmEzNGZlYTEyNWM0YzQ4OThkMDE5NjMwNjA3YWM4My90YWJsZXJhbmdlOmU2YTM0ZmVhMTI1YzRjNDg5OGQwMTk2MzA2MDdhYzgzXzMtMy0xLTEtMzE0MjI_1d5e4d83-58c5-411d-ab5a-70f5b4ca922a">376.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ebc8189c1fd4f9aaed3d986d6412d72_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplNmEzNGZlYTEyNWM0YzQ4OThkMDE5NjMwNjA3YWM4My90YWJsZXJhbmdlOmU2YTM0ZmVhMTI1YzRjNDg5OGQwMTk2MzA2MDdhYzgzXzQtMS0xLTEtMzE0MjI_00c7dc92-0136-461d-b145-87ae75a48724">137.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bb3fb3a406f4ceab9b6b622c49f1572_I20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplNmEzNGZlYTEyNWM0YzQ4OThkMDE5NjMwNjA3YWM4My90YWJsZXJhbmdlOmU2YTM0ZmVhMTI1YzRjNDg5OGQwMTk2MzA2MDdhYzgzXzQtMy0xLTEtMzE0MjI_d7b3b703-3149-4848-8bd8-2003bfb3408d">155.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplNmEzNGZlYTEyNWM0YzQ4OThkMDE5NjMwNjA3YWM4My90YWJsZXJhbmdlOmU2YTM0ZmVhMTI1YzRjNDg5OGQwMTk2MzA2MDdhYzgzXzUtMS0xLTEtMzE0MjI_1c10b1d5-a6dd-4642-bb3f-7d236041ac95">5,589.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplNmEzNGZlYTEyNWM0YzQ4OThkMDE5NjMwNjA3YWM4My90YWJsZXJhbmdlOmU2YTM0ZmVhMTI1YzRjNDg5OGQwMTk2MzA2MDdhYzgzXzUtMy0xLTEtMzE0MjI_c56b22fe-fc5b-4c14-b58b-d3a01602b662">5,721.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplNmEzNGZlYTEyNWM0YzQ4OThkMDE5NjMwNjA3YWM4My90YWJsZXJhbmdlOmU2YTM0ZmVhMTI1YzRjNDg5OGQwMTk2MzA2MDdhYzgzXzYtMS0xLTEtMzE0MjI_c8285580-e971-49f9-a4f3-9570d18f0aff">2,400.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplNmEzNGZlYTEyNWM0YzQ4OThkMDE5NjMwNjA3YWM4My90YWJsZXJhbmdlOmU2YTM0ZmVhMTI1YzRjNDg5OGQwMTk2MzA2MDdhYzgzXzYtMy0xLTEtMzE0MjI_11528869-5891-4a0e-877a-cadf6ec76ad2">2,262.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplNmEzNGZlYTEyNWM0YzQ4OThkMDE5NjMwNjA3YWM4My90YWJsZXJhbmdlOmU2YTM0ZmVhMTI1YzRjNDg5OGQwMTk2MzA2MDdhYzgzXzctMS0xLTEtMzE0MjI_07d376fc-fd6f-4cc0-8fb9-2262ee82b301">3,188.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplNmEzNGZlYTEyNWM0YzQ4OThkMDE5NjMwNjA3YWM4My90YWJsZXJhbmdlOmU2YTM0ZmVhMTI1YzRjNDg5OGQwMTk2MzA2MDdhYzgzXzctMy0xLTEtMzE0MjI_7deef311-29a5-49dc-ba4e-95eb4b2a21b9">3,459.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capitalized software costs included in our consolidated balance sheets were $<ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:CapitalizedComputerSoftwareNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90ZXh0cmVnaW9uOmNmNTk1OTZmZWI0ZjQwMThiZTUzZmY0NWEzOWNkN2ViXzE2MzE_9d9f1794-6cfe-4816-b028-29c2a278329d">62.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:CapitalizedComputerSoftwareNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90ZXh0cmVnaW9uOmNmNTk1OTZmZWI0ZjQwMThiZTUzZmY0NWEzOWNkN2ViXzE2Mzg_1b192a5b-a3e3-46a5-9761-f21ad286014a">70.9</ix:nonFraction> million, net of accumulated depreciation, at December&#160;31, 2021 and 2020, respectively. The Company periodically reviews the estimated useful lives of assets and makes adjustments when appropriate. Depreciation expense was approximately $<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90ZXh0cmVnaW9uOmNmNTk1OTZmZWI0ZjQwMThiZTUzZmY0NWEzOWNkN2ViXzE4NTI_aac1ce53-8bc8-454e-a937-5b7c6f4054fc">509.5</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90ZXh0cmVnaW9uOmNmNTk1OTZmZWI0ZjQwMThiZTUzZmY0NWEzOWNkN2ViXzE4NTY_ea28f140-997b-4de3-a4ee-3078db0cfb61">289.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90ZXh0cmVnaW9uOmNmNTk1OTZmZWI0ZjQwMThiZTUzZmY0NWEzOWNkN2ViXzE4NjM_e9602172-66f1-4e04-868b-2d6a6e8f7f07">256.1</ix:nonFraction> million for the years ended December&#160;31, 2021, 2020 and 2019, respectively.</span></div><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90ZXh0cmVnaW9uOmNmNTk1OTZmZWI0ZjQwMThiZTUzZmY0NWEzOWNkN2ViXzIwMjU_f505963a-9dac-4a5c-880b-a8ee0bb70a6a" escape="true"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other assets</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:76.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments, clean energy investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i500543a4ebe64602995d53387c0524dd_I20211231" decimals="-5" name="us-gaap:EquityMethodInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTo0MmJiNzk0N2M3YjU0NTNjYmNjODkwZWZhNWIwNDkzYi90YWJsZXJhbmdlOjQyYmI3OTQ3YzdiNTQ1M2NiY2M4OTBlZmE1YjA0OTNiXzEtMS0xLTEtMzE0MjI_a935307b-a38d-42fc-80c6-4cd97f2ec284">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i123b716b2a804024a0f1c41058fde09a_I20201231" decimals="-5" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTo0MmJiNzk0N2M3YjU0NTNjYmNjODkwZWZhNWIwNDkzYi90YWJsZXJhbmdlOjQyYmI3OTQ3YzdiNTQ1M2NiY2M4OTBlZmE1YjA0OTNiXzEtMy0xLTEtMzE0MjI_a806ec17-a434-4737-959e-054804cd794b">47.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTo0MmJiNzk0N2M3YjU0NTNjYmNjODkwZWZhNWIwNDkzYi90YWJsZXJhbmdlOjQyYmI3OTQ3YzdiNTQ1M2NiY2M4OTBlZmE1YjA0OTNiXzItMS0xLTEtMzE0MjI_e8c1d9f0-07c3-4ad8-a02a-5bc4be4288be">290.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTo0MmJiNzk0N2M3YjU0NTNjYmNjODkwZWZhNWIwNDkzYi90YWJsZXJhbmdlOjQyYmI3OTQ3YzdiNTQ1M2NiY2M4OTBlZmE1YjA0OTNiXzItMy0xLTEtMzE0MjI_ef063561-f27d-466f-88ba-7562048c0097">323.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="vtrs:Otherlongtermassets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTo0MmJiNzk0N2M3YjU0NTNjYmNjODkwZWZhNWIwNDkzYi90YWJsZXJhbmdlOjQyYmI3OTQ3YzdiNTQ1M2NiY2M4OTBlZmE1YjA0OTNiXzQtMS0xLTEtMzE0MjI_dfca15f2-fa75-448e-ad91-0a8a702da82d">879.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="vtrs:Otherlongtermassets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTo0MmJiNzk0N2M3YjU0NTNjYmNjODkwZWZhNWIwNDkzYi90YWJsZXJhbmdlOjQyYmI3OTQ3YzdiNTQ1M2NiY2M4OTBlZmE1YjA0OTNiXzQtMy0xLTEtMzE0MjI_0ad81a83-e178-47ad-86ec-c1f932560146">676.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTo0MmJiNzk0N2M3YjU0NTNjYmNjODkwZWZhNWIwNDkzYi90YWJsZXJhbmdlOjQyYmI3OTQ3YzdiNTQ1M2NiY2M4OTBlZmE1YjA0OTNiXzUtMS0xLTEtMzE0MjI_5f30d052-bb9a-4051-9803-605d32a834ef">1,170.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTo0MmJiNzk0N2M3YjU0NTNjYmNjODkwZWZhNWIwNDkzYi90YWJsZXJhbmdlOjQyYmI3OTQ3YzdiNTQ1M2NiY2M4OTBlZmE1YjA0OTNiXzUtMy0xLTEtMzE0MjI_50cec800-9969-401f-90ea-8287dd7085dc">1,047.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><ix:continuation id="i7d86681872224c7a8afc21533a14ff99"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90ZXh0cmVnaW9uOmNmNTk1OTZmZWI0ZjQwMThiZTUzZmY0NWEzOWNkN2ViXzIwNTA_e77138a0-c8c7-4f07-80f2-1c5c043d1663" escape="true"><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts payable</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:76.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:AccountsPayableTradeCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTpiZTY1OGRlMjgyZjQ0NzM4YThkM2Q4M2Y3ZTdkMzBkNS90YWJsZXJhbmdlOmJlNjU4ZGUyODJmNDQ3MzhhOGQzZDgzZjdlN2QzMGQ1XzEtMS0xLTEtMzE0MjI_4bf772db-075c-4963-a6a5-2311df0a1c90">1,056.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:AccountsPayableTradeCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTpiZTY1OGRlMjgyZjQ0NzM4YThkM2Q4M2Y3ZTdkMzBkNS90YWJsZXJhbmdlOmJlNjU4ZGUyODJmNDQ3MzhhOGQzZDgzZjdlN2QzMGQ1XzEtMy0xLTEtMzE0MjI_4d0b266a-3145-4b82-a512-af04e561289d">1,345.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other payables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:AccountsPayableOtherCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTpiZTY1OGRlMjgyZjQ0NzM4YThkM2Q4M2Y3ZTdkMzBkNS90YWJsZXJhbmdlOmJlNjU4ZGUyODJmNDQ3MzhhOGQzZDgzZjdlN2QzMGQ1XzItMS0xLTEtMzE0MjI_5abac1fb-6fec-485b-a64a-8f3fdcbbe22d">601.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:AccountsPayableOtherCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTpiZTY1OGRlMjgyZjQ0NzM4YThkM2Q4M2Y3ZTdkMzBkNS90YWJsZXJhbmdlOmJlNjU4ZGUyODJmNDQ3MzhhOGQzZDgzZjdlN2QzMGQ1XzItMy0xLTEtMzE0MjI_86ef32ab-f902-4d91-af2f-a57f41f2e069">558.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:AccountsPayableTradeCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTpiZTY1OGRlMjgyZjQ0NzM4YThkM2Q4M2Y3ZTdkMzBkNS90YWJsZXJhbmdlOmJlNjU4ZGUyODJmNDQ3MzhhOGQzZDgzZjdlN2QzMGQ1XzMtMS0xLTEtMzE0MjI_613ee762-1aec-40cb-a455-3cda6e4a1e53">1,657.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:AccountsPayableTradeCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTpiZTY1OGRlMjgyZjQ0NzM4YThkM2Q4M2Y3ZTdkMzBkNS90YWJsZXJhbmdlOmJlNjU4ZGUyODJmNDQ3MzhhOGQzZDgzZjdlN2QzMGQ1XzMtMy0xLTEtMzE0MjI_83dbc6ba-8d63-4f1b-af3c-99e9095f73cf">1,904.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90ZXh0cmVnaW9uOmNmNTk1OTZmZWI0ZjQwMThiZTUzZmY0NWEzOWNkN2ViXzIwNjA_3f01e7e8-4be4-421a-990d-e3f7a10a1077" escape="true"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other current liabilities</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:76.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued sales allowances</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f62d5c61184fe0a10c432fdf606fac_I20211231" decimals="-5" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplYTgzMjA1M2NiM2M0MGMzYjMwYTM5ODk3ZGVhOTcwMi90YWJsZXJhbmdlOmVhODMyMDUzY2IzYzQwYzNiMzBhMzk4OTdkZWE5NzAyXzEtMS0xLTEtMzE0MjI_2fb5bb83-0d1e-4667-a0f7-13c28ad2d896">1,362.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8299fb24ad740a0bc5299022149cc89_I20201231" decimals="-5" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplYTgzMjA1M2NiM2M0MGMzYjMwYTM5ODk3ZGVhOTcwMi90YWJsZXJhbmdlOmVhODMyMDUzY2IzYzQwYzNiMzBhMzk4OTdkZWE5NzAyXzEtMy0xLTEtMzE0MjI_89c69ddc-c38d-442b-9375-a8122ac327a8">1,211.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll and employee benefit liabilities </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplYTgzMjA1M2NiM2M0MGMzYjMwYTM5ODk3ZGVhOTcwMi90YWJsZXJhbmdlOmVhODMyMDUzY2IzYzQwYzNiMzBhMzk4OTdkZWE5NzAyXzItMS0xLTEtMzE0MjI_4e38103a-9989-4e0f-9b95-4a7ccf7c3f41">741.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplYTgzMjA1M2NiM2M0MGMzYjMwYTM5ODk3ZGVhOTcwMi90YWJsZXJhbmdlOmVhODMyMDUzY2IzYzQwYzNiMzBhMzk4OTdkZWE5NzAyXzItMy0xLTEtMzE0MjI_05acc20a-b359-4897-bb29-b3ed221e083b">828.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal and professional accruals, including litigation accruals</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:LitigationReserveCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplYTgzMjA1M2NiM2M0MGMzYjMwYTM5ODk3ZGVhOTcwMi90YWJsZXJhbmdlOmVhODMyMDUzY2IzYzQwYzNiMzBhMzk4OTdkZWE5NzAyXzMtMS0xLTEtMzE0MjI_44997036-2dd0-4040-a07b-7ad1eceaf594">715.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:LitigationReserveCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplYTgzMjA1M2NiM2M0MGMzYjMwYTM5ODk3ZGVhOTcwMi90YWJsZXJhbmdlOmVhODMyMDUzY2IzYzQwYzNiMzBhMzk4OTdkZWE5NzAyXzMtMy0xLTEtMzE0MjI_a7cf312d-b65e-4ba2-8578-99093880d778">362.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c198dc35fb64539904dc17b63908f02_I20211231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplYTgzMjA1M2NiM2M0MGMzYjMwYTM5ODk3ZGVhOTcwMi90YWJsZXJhbmdlOmVhODMyMDUzY2IzYzQwYzNiMzBhMzk4OTdkZWE5NzAyXzQtMS0xLTEtMzE0MjI_b79b03fd-7b34-41bc-ae50-18450b4d96d7">66.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i869e9de1ba0e414a8a1c0e4653ab950f_I20201231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplYTgzMjA1M2NiM2M0MGMzYjMwYTM5ODk3ZGVhOTcwMi90YWJsZXJhbmdlOmVhODMyMDUzY2IzYzQwYzNiMzBhMzk4OTdkZWE5NzAyXzQtMy0xLTEtMzE0MjI_748f2fce-85d5-4c7c-ab50-4e0ae6e3d255">100.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued restructuring</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:RestructuringReserveCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplYTgzMjA1M2NiM2M0MGMzYjMwYTM5ODk3ZGVhOTcwMi90YWJsZXJhbmdlOmVhODMyMDUzY2IzYzQwYzNiMzBhMzk4OTdkZWE5NzAyXzUtMS0xLTEtMzE0MjI_247071bf-67cc-4ecf-a7fd-43141d14d153">233.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:RestructuringReserveCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplYTgzMjA1M2NiM2M0MGMzYjMwYTM5ODk3ZGVhOTcwMi90YWJsZXJhbmdlOmVhODMyMDUzY2IzYzQwYzNiMzBhMzk4OTdkZWE5NzAyXzUtMy0xLTEtMzE0MjI_dda2ab1c-6dd9-4790-9bd7-0ad981b31780">149.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments, clean energy investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2de25d7ac8784fa18767316538f59631_I20211231" decimals="-5" name="us-gaap:OtherLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplYTgzMjA1M2NiM2M0MGMzYjMwYTM5ODk3ZGVhOTcwMi90YWJsZXJhbmdlOmVhODMyMDUzY2IzYzQwYzNiMzBhMzk4OTdkZWE5NzAyXzYtMS0xLTEtMzE0MjI_2ba28b6e-5410-4d42-99e8-361ab243d31f">10.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43ea997ac5374cbbb9e8b44ce8488e9c_I20201231" decimals="-5" name="us-gaap:OtherLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplYTgzMjA1M2NiM2M0MGMzYjMwYTM5ODk3ZGVhOTcwMi90YWJsZXJhbmdlOmVhODMyMDUzY2IzYzQwYzNiMzBhMzk4OTdkZWE5NzAyXzYtMy0xLTEtMzE0MjI_b2199be0-ec5a-4ee7-ae7f-83f52f00811f">47.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:InterestPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplYTgzMjA1M2NiM2M0MGMzYjMwYTM5ODk3ZGVhOTcwMi90YWJsZXJhbmdlOmVhODMyMDUzY2IzYzQwYzNiMzBhMzk4OTdkZWE5NzAyXzctMS0xLTEtMzE0MjI_833e35d6-90fc-4218-b687-0dec7619c5f7">86.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:InterestPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplYTgzMjA1M2NiM2M0MGMzYjMwYTM5ODk3ZGVhOTcwMi90YWJsZXJhbmdlOmVhODMyMDUzY2IzYzQwYzNiMzBhMzk4OTdkZWE5NzAyXzctMy0xLTEtMzE0MjI_aa398e40-2648-4459-8845-89cdeae2169d">90.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of financial instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplYTgzMjA1M2NiM2M0MGMzYjMwYTM5ODk3ZGVhOTcwMi90YWJsZXJhbmdlOmVhODMyMDUzY2IzYzQwYzNiMzBhMzk4OTdkZWE5NzAyXzgtMS0xLTEtMzE0MjI_310ee247-a63d-4420-857d-7de7a325a0fe">61.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplYTgzMjA1M2NiM2M0MGMzYjMwYTM5ODk3ZGVhOTcwMi90YWJsZXJhbmdlOmVhODMyMDUzY2IzYzQwYzNiMzBhMzk4OTdkZWE5NzAyXzgtMy0xLTEtMzE0MjI_5c7989cc-4a6a-45a6-a996-23cd7c0db23d">103.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplYTgzMjA1M2NiM2M0MGMzYjMwYTM5ODk3ZGVhOTcwMi90YWJsZXJhbmdlOmVhODMyMDUzY2IzYzQwYzNiMzBhMzk4OTdkZWE5NzAyXzktMS0xLTEtMzE0MjI_f580282d-ef39-456f-b999-d367b38d124d">86.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplYTgzMjA1M2NiM2M0MGMzYjMwYTM5ODk3ZGVhOTcwMi90YWJsZXJhbmdlOmVhODMyMDUzY2IzYzQwYzNiMzBhMzk4OTdkZWE5NzAyXzktMy0xLTEtMzE0MjI_7c2b75c1-e9fa-4f77-ae67-28a492a8850c">92.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplYTgzMjA1M2NiM2M0MGMzYjMwYTM5ODk3ZGVhOTcwMi90YWJsZXJhbmdlOmVhODMyMDUzY2IzYzQwYzNiMzBhMzk4OTdkZWE5NzAyXzEwLTEtMS0xLTMxNDIy_07e48323-3bd7-4c59-8182-b2102f321f4e">1,254.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplYTgzMjA1M2NiM2M0MGMzYjMwYTM5ODk3ZGVhOTcwMi90YWJsZXJhbmdlOmVhODMyMDUzY2IzYzQwYzNiMzBhMzk4OTdkZWE5NzAyXzEwLTMtMS0xLTMxNDIy_34233dd3-565c-4f91-9704-d18b9e8453d0">1,973.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplYTgzMjA1M2NiM2M0MGMzYjMwYTM5ODk3ZGVhOTcwMi90YWJsZXJhbmdlOmVhODMyMDUzY2IzYzQwYzNiMzBhMzk4OTdkZWE5NzAyXzExLTEtMS0xLTMxNDIy_19c5bf17-b683-4657-a392-18ed73a211ef">4,619.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplYTgzMjA1M2NiM2M0MGMzYjMwYTM5ODk3ZGVhOTcwMi90YWJsZXJhbmdlOmVhODMyMDUzY2IzYzQwYzNiMzBhMzk4OTdkZWE5NzAyXzExLTMtMS0xLTMxNDIy_3e87b56b-c02c-4cad-abf8-beaad471c475">4,960.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other long-term obligations</span></div><div style="margin-bottom:12pt;margin-top:5pt"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:OtherNoncurrentLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90ZXh0cmVnaW9uOmNmNTk1OTZmZWI0ZjQwMThiZTUzZmY0NWEzOWNkN2ViXzIwMjQ_11abcba6-81b5-4e6c-a627-18cd3282b2b5" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:76.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee benefit liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTpkOTYwM2FhNWI4MWU0YjY2YTE0ODQwOTJjYTRhMmFhMy90YWJsZXJhbmdlOmQ5NjAzYWE1YjgxZTRiNjZhMTQ4NDA5MmNhNGEyYWEzXzEtMS0xLTEtMzE0MjI_6670a58e-62db-4e60-b24e-d9a1608e39b3">876.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTpkOTYwM2FhNWI4MWU0YjY2YTE0ODQwOTJjYTRhMmFhMy90YWJsZXJhbmdlOmQ5NjAzYWE1YjgxZTRiNjZhMTQ4NDA5MmNhNGEyYWEzXzEtMy0xLTEtMzE0MjI_76786508-ef20-4d8d-a0fa-d63860c6beea">1,020.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8416dfbb7a5942b691bd8f0154ec826e_I20211231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTpkOTYwM2FhNWI4MWU0YjY2YTE0ODQwOTJjYTRhMmFhMy90YWJsZXJhbmdlOmQ5NjAzYWE1YjgxZTRiNjZhMTQ4NDA5MmNhNGEyYWEzXzMtMS0xLTEtMzE0MjI_cbe5954d-cb2f-406f-95c6-57b98acbe32c">133.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia89d28ed480a4556840f217684004588_I20201231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTpkOTYwM2FhNWI4MWU0YjY2YTE0ODQwOTJjYTRhMmFhMy90YWJsZXJhbmdlOmQ5NjAzYWE1YjgxZTRiNjZhMTQ4NDA5MmNhNGEyYWEzXzMtMy0xLTEtMzE0MjI_ac5db8ea-da89-4ca3-9320-9f8775d95749">123.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax related items, including contingencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:LiabilityForUncertainTaxPositionsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTpkOTYwM2FhNWI4MWU0YjY2YTE0ODQwOTJjYTRhMmFhMy90YWJsZXJhbmdlOmQ5NjAzYWE1YjgxZTRiNjZhMTQ4NDA5MmNhNGEyYWEzXzQtMS0xLTEtMzE0MjI_e84effd9-7a3c-40c3-ad60-2d390eb33cc0">426.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:LiabilityForUncertainTaxPositionsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTpkOTYwM2FhNWI4MWU0YjY2YTE0ODQwOTJjYTRhMmFhMy90YWJsZXJhbmdlOmQ5NjAzYWE1YjgxZTRiNjZhMTQ4NDA5MmNhNGEyYWEzXzQtMy0xLTEtMzE0MjI_49f18046-c801-4f21-b3ae-2bb6711c7a65">469.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTpkOTYwM2FhNWI4MWU0YjY2YTE0ODQwOTJjYTRhMmFhMy90YWJsZXJhbmdlOmQ5NjAzYWE1YjgxZTRiNjZhMTQ4NDA5MmNhNGEyYWEzXzUtMS0xLTEtMzE0MjI_8b5dc6bc-1206-4186-ac60-c34bcf6e1c19">200.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTpkOTYwM2FhNWI4MWU0YjY2YTE0ODQwOTJjYTRhMmFhMy90YWJsZXJhbmdlOmQ5NjAzYWE1YjgxZTRiNjZhMTQ4NDA5MmNhNGEyYWEzXzUtMy0xLTEtMzE0MjI_d808dea1-6d5b-40ed-8b22-8624ab151147">229.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued restructuring</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:RestructuringReserveNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTpkOTYwM2FhNWI4MWU0YjY2YTE0ODQwOTJjYTRhMmFhMy90YWJsZXJhbmdlOmQ5NjAzYWE1YjgxZTRiNjZhMTQ4NDA5MmNhNGEyYWEzXzYtMS0xLTEtMzE0MjI_d9b1a5b9-6688-4428-ae43-b69020bbf9d6">64.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:RestructuringReserveNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTpkOTYwM2FhNWI4MWU0YjY2YTE0ODQwOTJjYTRhMmFhMy90YWJsZXJhbmdlOmQ5NjAzYWE1YjgxZTRiNjZhMTQ4NDA5MmNhNGEyYWEzXzYtMy0xLTEtMzE0MjI_34ba86a9-0e99-47f2-8d0e-42db58da73e1">134.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTpkOTYwM2FhNWI4MWU0YjY2YTE0ODQwOTJjYTRhMmFhMy90YWJsZXJhbmdlOmQ5NjAzYWE1YjgxZTRiNjZhMTQ4NDA5MmNhNGEyYWEzXzctMS0xLTEtMzE0MjI_91c3c179-e90a-4605-aa35-3ca59ded5316">232.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTpkOTYwM2FhNWI4MWU0YjY2YTE0ODQwOTJjYTRhMmFhMy90YWJsZXJhbmdlOmQ5NjAzYWE1YjgxZTRiNjZhMTQ4NDA5MmNhNGEyYWEzXzctMy0xLTEtMzE0MjI_2c899f08-a4ff-4228-803b-8d8eaf3499ee">505.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other long-term obligations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTpkOTYwM2FhNWI4MWU0YjY2YTE0ODQwOTJjYTRhMmFhMy90YWJsZXJhbmdlOmQ5NjAzYWE1YjgxZTRiNjZhMTQ4NDA5MmNhNGEyYWEzXzgtMS0xLTEtMzE0MjI_e52675df-777c-4c56-bc28-58ec291e222d">1,933.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTpkOTYwM2FhNWI4MWU0YjY2YTE0ODQwOTJjYTRhMmFhMy90YWJsZXJhbmdlOmQ5NjAzYWE1YjgxZTRiNjZhMTQ4NDA5MmNhNGEyYWEzXzgtMy0xLTEtMzE0MjI_114ce50f-e2bb-4cfb-9f49-e868652a7b28">2,483.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_190"></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTAvZnJhZzozNjczMjc1N2I5MDE0MTgwODFjMDAyZDFiNDE2Y2IwYi90ZXh0cmVnaW9uOjM2NzMyNzU3YjkwMTQxODA4MWMwMDJkMWI0MTZjYjBiXzE3MzA_6a10e2c6-cbd0-4e3f-8380-8b9aeb0692b9" continuedAt="ia6fed395a9054b78bb63731ed0105b5c" escape="true">Leases</ix:nonNumeric></span></div><ix:continuation id="ia6fed395a9054b78bb63731ed0105b5c" continuedAt="ifbdc0a6ae60a4e19bea7e4bcc090b894"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has operating leases of real estate, consisting primarily of administrative offices, manufacturing and distribution facilities, and R&amp;D facilities. We also have operating leases of certain equipment, primarily automobiles, and certain limited supply arrangements.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We elected to apply the practical expedient to not separate lease and non-lease components for our leases except for those related to certain limited supply arrangements. We have also elected to apply the short-term lease recognition exemption which means we will not recognize ROU assets or lease liabilities for leases with an initial term of 12 months of less.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company recognized ROU assets of $<ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTAvZnJhZzozNjczMjc1N2I5MDE0MTgwODFjMDAyZDFiNDE2Y2IwYi90ZXh0cmVnaW9uOjM2NzMyNzU3YjkwMTQxODA4MWMwMDJkMWI0MTZjYjBiXzMzNw_e8c1d9f0-07c3-4ad8-a02a-5bc4be4288be">290.8</ix:nonFraction> million and total lease liabilities of $<ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTAvZnJhZzozNjczMjc1N2I5MDE0MTgwODFjMDAyZDFiNDE2Y2IwYi90ZXh0cmVnaW9uOjM2NzMyNzU3YjkwMTQxODA4MWMwMDJkMWI0MTZjYjBiXzM3MQ_83f9fbb6-461f-4154-b070-e9f94406db72">287.6</ix:nonFraction> million. The Company&#8217;s ROU assets are recorded in other assets. The related lease liability balances are recorded in other current liabilities and other long-term obligations in the consolidated balance sheets. Refer to Note 5 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Balance Sheet Components</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><ix:continuation id="ifbdc0a6ae60a4e19bea7e4bcc090b894"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ROU assets and liabilities are recognized at the present value of the future minimum lease payments over the lease term at commencement date. As most of our leases do not provide an implicit rate, we use an applicable incremental borrowing rate based on the information available at commencement date in determining the present value of future payments. Options to extend or terminate the ROU assets are reviewed at lease inception and these options are accounted for when they are reasonably certain of being exercised.</span></div><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTAvZnJhZzozNjczMjc1N2I5MDE0MTgwODFjMDAyZDFiNDE2Y2IwYi90ZXh0cmVnaW9uOjM2NzMyNzU3YjkwMTQxODA4MWMwMDJkMWI0MTZjYjBiXzE3MzE_53739172-5012-42a2-b40d-c9f7688044a2" escape="true"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other information related to leases was as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:82.648%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining lease terms</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id8227b4a3c2c48d0b659fec7ce3966a0_I20211231" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTAvZnJhZzozNjczMjc1N2I5MDE0MTgwODFjMDAyZDFiNDE2Y2IwYi90YWJsZTplMGNiZTEzNDJiMWE0ODcwYTFlNzNiZGVmYTdmOTdhNC90YWJsZXJhbmdlOmUwY2JlMTM0MmIxYTQ4NzBhMWU3M2JkZWZhN2Y5N2E0XzEtMS0xLTEtMzE0MjIvdGV4dHJlZ2lvbjozOGVkNTRlZDZhNDk0ZGZhOWQyZjMzYWUwYWFkZmI0YV80_6bcb0b71-e1c4-4ebb-9524-c8655ea3536e">1</ix:nonNumeric> year to <ix:nonNumeric contextRef="if35fa5c71ccb4d9cbe31d2dd6c8f7b48_I20211231" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTAvZnJhZzozNjczMjc1N2I5MDE0MTgwODFjMDAyZDFiNDE2Y2IwYi90YWJsZTplMGNiZTEzNDJiMWE0ODcwYTFlNzNiZGVmYTdmOTdhNC90YWJsZXJhbmdlOmUwY2JlMTM0MmIxYTQ4NzBhMWU3M2JkZWZhN2Y5N2E0XzEtMS0xLTEtMzE0MjIvdGV4dHJlZ2lvbjozOGVkNTRlZDZhNDk0ZGZhOWQyZjMzYWUwYWFkZmI0YV8xNQ_804cfa36-57d1-4193-9ac1-2a2be2ea69fe">23</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTAvZnJhZzozNjczMjc1N2I5MDE0MTgwODFjMDAyZDFiNDE2Y2IwYi90YWJsZTplMGNiZTEzNDJiMWE0ODcwYTFlNzNiZGVmYTdmOTdhNC90YWJsZXJhbmdlOmUwY2JlMTM0MmIxYTQ4NzBhMWU3M2JkZWZhN2Y5N2E0XzItMS0xLTEtMzE0MjI_4d135ebe-f440-4256-8866-ac55e6ef9d84">6</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTAvZnJhZzozNjczMjc1N2I5MDE0MTgwODFjMDAyZDFiNDE2Y2IwYi90YWJsZTplMGNiZTEzNDJiMWE0ODcwYTFlNzNiZGVmYTdmOTdhNC90YWJsZXJhbmdlOmUwY2JlMTM0MmIxYTQ4NzBhMWU3M2JkZWZhN2Y5N2E0XzMtMS0xLTEtMzE0MjI_8e8bdd37-4d63-4a0f-9643-b70e83fc9c92">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTAvZnJhZzozNjczMjc1N2I5MDE0MTgwODFjMDAyZDFiNDE2Y2IwYi90ZXh0cmVnaW9uOjM2NzMyNzU3YjkwMTQxODA4MWMwMDJkMWI0MTZjYjBiXzE3MzI_3d50f5af-6872-44d3-a390-17fc2b027e9c" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, maturities of lease liabilities were as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:89.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.753%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTAvZnJhZzozNjczMjc1N2I5MDE0MTgwODFjMDAyZDFiNDE2Y2IwYi90YWJsZTphMTk5OTcwMTFjMzA0NWFmODg3YTI3YTBmN2FhMTBhNS90YWJsZXJhbmdlOmExOTk5NzAxMWMzMDQ1YWY4ODdhMjdhMGY3YWExMGE1XzItMS0xLTEtMzE0MjI_bfb092d5-49a7-4e3d-b0a9-f1562d4cde39">82.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTAvZnJhZzozNjczMjc1N2I5MDE0MTgwODFjMDAyZDFiNDE2Y2IwYi90YWJsZTphMTk5OTcwMTFjMzA0NWFmODg3YTI3YTBmN2FhMTBhNS90YWJsZXJhbmdlOmExOTk5NzAxMWMzMDQ1YWY4ODdhMjdhMGY3YWExMGE1XzMtMS0xLTEtMzE0MjI_98f7ae1f-a8c8-4ee0-8a5e-f52cc8f832a1">65.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTAvZnJhZzozNjczMjc1N2I5MDE0MTgwODFjMDAyZDFiNDE2Y2IwYi90YWJsZTphMTk5OTcwMTFjMzA0NWFmODg3YTI3YTBmN2FhMTBhNS90YWJsZXJhbmdlOmExOTk5NzAxMWMzMDQ1YWY4ODdhMjdhMGY3YWExMGE1XzQtMS0xLTEtMzE0MjI_94c49255-6fde-4994-86d1-574972c0873d">42.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTAvZnJhZzozNjczMjc1N2I5MDE0MTgwODFjMDAyZDFiNDE2Y2IwYi90YWJsZTphMTk5OTcwMTFjMzA0NWFmODg3YTI3YTBmN2FhMTBhNS90YWJsZXJhbmdlOmExOTk5NzAxMWMzMDQ1YWY4ODdhMjdhMGY3YWExMGE1XzUtMS0xLTEtMzE0MjI_9f762e60-6c84-4ed9-86df-0293574014f2">28.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTAvZnJhZzozNjczMjc1N2I5MDE0MTgwODFjMDAyZDFiNDE2Y2IwYi90YWJsZTphMTk5OTcwMTFjMzA0NWFmODg3YTI3YTBmN2FhMTBhNS90YWJsZXJhbmdlOmExOTk5NzAxMWMzMDQ1YWY4ODdhMjdhMGY3YWExMGE1XzYtMS0xLTEtMzE0MjI_988a3be1-a967-4803-9ae7-434c04696b52">23.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTAvZnJhZzozNjczMjc1N2I5MDE0MTgwODFjMDAyZDFiNDE2Y2IwYi90YWJsZTphMTk5OTcwMTFjMzA0NWFmODg3YTI3YTBmN2FhMTBhNS90YWJsZXJhbmdlOmExOTk5NzAxMWMzMDQ1YWY4ODdhMjdhMGY3YWExMGE1XzctMS0xLTEtMzE0MjI_f229b62b-afb2-4014-8f5a-bf218dbf76ea">68.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTAvZnJhZzozNjczMjc1N2I5MDE0MTgwODFjMDAyZDFiNDE2Y2IwYi90YWJsZTphMTk5OTcwMTFjMzA0NWFmODg3YTI3YTBmN2FhMTBhNS90YWJsZXJhbmdlOmExOTk5NzAxMWMzMDQ1YWY4ODdhMjdhMGY3YWExMGE1XzgtMS0xLTEtMzE0MjI_2ec9a09a-c393-40ca-9f74-7b1224e9a646">310.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTAvZnJhZzozNjczMjc1N2I5MDE0MTgwODFjMDAyZDFiNDE2Y2IwYi90YWJsZTphMTk5OTcwMTFjMzA0NWFmODg3YTI3YTBmN2FhMTBhNS90YWJsZXJhbmdlOmExOTk5NzAxMWMzMDQ1YWY4ODdhMjdhMGY3YWExMGE1XzktMS0xLTEtNTQxNzU_60a62e52-bd87-4d9c-9259-bf933bf0368b">23.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liability</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTAvZnJhZzozNjczMjc1N2I5MDE0MTgwODFjMDAyZDFiNDE2Y2IwYi90YWJsZTphMTk5OTcwMTFjMzA0NWFmODg3YTI3YTBmN2FhMTBhNS90YWJsZXJhbmdlOmExOTk5NzAxMWMzMDQ1YWY4ODdhMjdhMGY3YWExMGE1XzEwLTEtMS0xLTU0MTg0_7ae53ced-25ce-47cb-9c41-3b83187da6f0">287.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, we have additional operating leases, primarily for administrative offices, that have not yet commenced totaling approximately $<ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="vtrs:LesseeOperatingLeaseLeaseNotyetCommencedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTAvZnJhZzozNjczMjc1N2I5MDE0MTgwODFjMDAyZDFiNDE2Y2IwYi90ZXh0cmVnaW9uOjM2NzMyNzU3YjkwMTQxODA4MWMwMDJkMWI0MTZjYjBiXzE0MTA_50de222b-6f17-4ac0-92e1-22b1939a1159">13.6</ix:nonFraction> million. These leases are expected to commence in 2022 and have lease terms of <ix:nonNumeric contextRef="id8227b4a3c2c48d0b659fec7ce3966a0_I20211231" name="us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTAvZnJhZzozNjczMjc1N2I5MDE0MTgwODFjMDAyZDFiNDE2Y2IwYi90ZXh0cmVnaW9uOjM2NzMyNzU3YjkwMTQxODA4MWMwMDJkMWI0MTZjYjBiXzE0ODQ_ae5cb41b-4582-4a79-9530-b80e62979c1c">5</ix:nonNumeric> to <ix:nonNumeric contextRef="if35fa5c71ccb4d9cbe31d2dd6c8f7b48_I20211231" name="us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTAvZnJhZzozNjczMjc1N2I5MDE0MTgwODFjMDAyZDFiNDE2Y2IwYi90ZXh0cmVnaW9uOjM2NzMyNzU3YjkwMTQxODA4MWMwMDJkMWI0MTZjYjBiXzE0OTA_5b2809d4-bb7a-4bba-bd85-8db8627067cd">9</ix:nonNumeric> years. For the years ended December&#160;31, 2021, 2020 and 2019, the Company had operating lease expense of approximately $<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:PaymentsForRent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTAvZnJhZzozNjczMjc1N2I5MDE0MTgwODFjMDAyZDFiNDE2Y2IwYi90ZXh0cmVnaW9uOjM2NzMyNzU3YjkwMTQxODA4MWMwMDJkMWI0MTZjYjBiXzE1ODY_0320d78b-a61a-44e5-b5ab-ba9a02066c16">97.6</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:PaymentsForRent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTAvZnJhZzozNjczMjc1N2I5MDE0MTgwODFjMDAyZDFiNDE2Y2IwYi90ZXh0cmVnaW9uOjM2NzMyNzU3YjkwMTQxODA4MWMwMDJkMWI0MTZjYjBiXzE1OTA_43f2dc23-887d-446d-b791-a552151b23a9">80.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i284387cf86b54bd4adfef2f32bb9c670_D20170101-20171231" decimals="-5" name="us-gaap:PaymentsForRent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTAvZnJhZzozNjczMjc1N2I5MDE0MTgwODFjMDAyZDFiNDE2Y2IwYi90ZXh0cmVnaW9uOjM2NzMyNzU3YjkwMTQxODA4MWMwMDJkMWI0MTZjYjBiXzE1OTc_ea10b532-7185-440f-8123-133fdd3d8b46">87.6</ix:nonFraction> million, respectively. Operating lease costs are classified primarily as selling, general and administrative expenses and cost of sales in the consolidated statements of operations.</span></div></ix:continuation><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_196"></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:EquityMethodInvestmentsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90ZXh0cmVnaW9uOjM5Y2Y1MjExZDNiNDQ3MzliZDkwN2U5NWZkYjk3ZTFiXzIyMjM_5159b627-d5b8-4403-ab70-6bd7dfd70ed2" continuedAt="ia3cead259c1f49bb82eb1c5e866a1252" escape="true">Equity Method Investments</ix:nonNumeric></span></div><ix:continuation id="ia3cead259c1f49bb82eb1c5e866a1252" continuedAt="if0553ffdcc3042b6b6b46e99c9eacc4a"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had <ix:nonFraction unitRef="number" contextRef="i2de25d7ac8784fa18767316538f59631_I20211231" decimals="INF" name="vtrs:Numberofequitymethodinvestments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90ZXh0cmVnaW9uOjM5Y2Y1MjExZDNiNDQ3MzliZDkwN2U5NWZkYjk3ZTFiXzU4_6097e572-4970-46b5-a6de-8dc4b12bfe34">three</ix:nonFraction> equity method investments in limited liability companies that owned refined coal production plants whose activities qualified for income tax credits under Section 45 of the Code. The Company did not consolidate these entities as we had determined that we were not the primary beneficiary of these entities and did not have the power to individually direct the activities of these entities. Accordingly, these investments were accounted for under the equity method of accounting. For each of the clean energy investments, the Company had entered into notes payable with the respective project sponsor, which in part were paid to the sponsor as certain production levels were met. The law that provides for IRC Section 45 tax credits expired during the year ended December 31, 2021 for all three clean energy investments and all of the clean energy investments have wound down operations.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December 31, 2021, 2020, and 2019, the Company reduced its long-term obligations for its three investments as a result of lower than anticipated production levels and lower expected future variable debt payments to the respective project sponsor. The Company recognized a net gain of approximately $<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="vtrs:EquityMethodInvestmentsNetGainLossFromImpairmentandReductionInObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90ZXh0cmVnaW9uOjM5Y2Y1MjExZDNiNDQ3MzliZDkwN2U5NWZkYjk3ZTFiXzEwOTk1MTE2MzA0ODY_b204a970-7121-43e0-a281-be20ba621b9a">5.7</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="vtrs:EquityMethodInvestmentsNetGainLossFromImpairmentandReductionInObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90ZXh0cmVnaW9uOjM5Y2Y1MjExZDNiNDQ3MzliZDkwN2U5NWZkYjk3ZTFiXzExNzY_d184b678-7dae-4b60-b7d4-96dca72d1d6b">21.4</ix:nonFraction>&#160;million and&#160;$<ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="vtrs:EquityMethodInvestmentsNetGainLossFromImpairmentandReductionInObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90ZXh0cmVnaW9uOjM5Y2Y1MjExZDNiNDQ3MzliZDkwN2U5NWZkYjk3ZTFiXzExODM_68173ce5-5198-4229-9d7f-1ed3575abfd9">7.0</ix:nonFraction> million, respectively, which was recognized as a component of the net loss of the equity method investments in the consolidated statements of operations.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><ix:continuation id="if0553ffdcc3042b6b6b46e99c9eacc4a"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:EquityMethodInvestmentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90ZXh0cmVnaW9uOjM5Y2Y1MjExZDNiNDQ3MzliZDkwN2U5NWZkYjk3ZTFiXzIyMjA_24c0e71f-52a2-4ff1-a58d-5a7703710530" escape="true"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values and respective balance sheet locations of the Company&#8217;s clean energy investments were as follows at December&#160;31, 2021 and 2020, respectively:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:76.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i500543a4ebe64602995d53387c0524dd_I20211231" decimals="-5" name="us-gaap:EquityMethodInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZTpiYjYwODg2ZWQ4NGQ0ODU4OTdhN2M1MGMxMzhiOTRhOC90YWJsZXJhbmdlOmJiNjA4ODZlZDg0ZDQ4NTg5N2E3YzUwYzEzOGI5NGE4XzEtMS0xLTEtMzE0MjI_eb6e51a0-9472-4f58-9582-305d94c39a0a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i123b716b2a804024a0f1c41058fde09a_I20201231" decimals="-5" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZTpiYjYwODg2ZWQ4NGQ0ODU4OTdhN2M1MGMxMzhiOTRhOC90YWJsZXJhbmdlOmJiNjA4ODZlZDg0ZDQ4NTg5N2E3YzUwYzEzOGI5NGE4XzEtMy0xLTEtMzE0MjI_35069db7-c74e-403a-a285-ecbe5b005d43">47.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2de25d7ac8784fa18767316538f59631_I20211231" decimals="-5" name="us-gaap:OtherLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZTpiYjYwODg2ZWQ4NGQ0ODU4OTdhN2M1MGMxMzhiOTRhOC90YWJsZXJhbmdlOmJiNjA4ODZlZDg0ZDQ4NTg5N2E3YzUwYzEzOGI5NGE4XzItMS0xLTEtMzE0MjI_2ba28b6e-5410-4d42-99e8-361ab243d31f">10.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43ea997ac5374cbbb9e8b44ce8488e9c_I20201231" decimals="-5" name="us-gaap:OtherLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZTpiYjYwODg2ZWQ4NGQ0ODU4OTdhN2M1MGMxMzhiOTRhOC90YWJsZXJhbmdlOmJiNjA4ODZlZDg0ZDQ4NTg5N2E3YzUwYzEzOGI5NGE4XzItMy0xLTEtMzE0MjI_b2199be0-ec5a-4ee7-ae7f-83f52f00811f">47.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Summarized financial information, in the aggregate, for the Company&#8217;s significant equity method investments on a 100% basis as of December&#160;31, 2021 and 2020 and for the years ended December&#160;31, 2021, 2020 and 2019 are as follows:</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:76.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0853510f8095410c8cab4556a87f5fab_I20211231" decimals="-5" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZTo3ZGQ1YWIyMzg1YjE0MmFkODVkMDAzM2M1ZmZlZTkyZC90YWJsZXJhbmdlOjdkZDVhYjIzODViMTQyYWQ4NWQwMDMzYzVmZmVlOTJkXzEtMS0xLTEtMzE0MjI_1f1ebec6-7d8c-4eab-b595-2bf46691baf6">4.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6259ebc7ed26431991c3b2aa187c0c91_I20201231" decimals="-5" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZTo3ZGQ1YWIyMzg1YjE0MmFkODVkMDAzM2M1ZmZlZTkyZC90YWJsZXJhbmdlOjdkZDVhYjIzODViMTQyYWQ4NWQwMDMzYzVmZmVlOTJkXzEtMy0xLTEtMzE0MjI_83512e2e-100a-48f7-ba9b-b9720d823a0b">38.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0853510f8095410c8cab4556a87f5fab_I20211231" decimals="-5" name="us-gaap:AssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZTo3ZGQ1YWIyMzg1YjE0MmFkODVkMDAzM2M1ZmZlZTkyZC90YWJsZXJhbmdlOjdkZDVhYjIzODViMTQyYWQ4NWQwMDMzYzVmZmVlOTJkXzItMS0xLTEtMzE0MjI_f421b472-68fb-4a94-843b-48e4f1cb07a8">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6259ebc7ed26431991c3b2aa187c0c91_I20201231" decimals="-5" name="us-gaap:AssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZTo3ZGQ1YWIyMzg1YjE0MmFkODVkMDAzM2M1ZmZlZTkyZC90YWJsZXJhbmdlOjdkZDVhYjIzODViMTQyYWQ4NWQwMDMzYzVmZmVlOTJkXzItMy0xLTEtMzE0MjI_e041851b-d258-44ef-9f9d-36269a552b57">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0853510f8095410c8cab4556a87f5fab_I20211231" decimals="-5" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZTo3ZGQ1YWIyMzg1YjE0MmFkODVkMDAzM2M1ZmZlZTkyZC90YWJsZXJhbmdlOjdkZDVhYjIzODViMTQyYWQ4NWQwMDMzYzVmZmVlOTJkXzMtMS0xLTEtMzE0MjI_afe0bf53-9cb2-4b23-80d9-c31685091799">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6259ebc7ed26431991c3b2aa187c0c91_I20201231" decimals="-5" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZTo3ZGQ1YWIyMzg1YjE0MmFkODVkMDAzM2M1ZmZlZTkyZC90YWJsZXJhbmdlOjdkZDVhYjIzODViMTQyYWQ4NWQwMDMzYzVmZmVlOTJkXzMtMy0xLTEtMzE0MjI_dfd6188d-533b-443f-95de-c09eddabee99">39.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0853510f8095410c8cab4556a87f5fab_I20211231" decimals="-5" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZTo3ZGQ1YWIyMzg1YjE0MmFkODVkMDAzM2M1ZmZlZTkyZC90YWJsZXJhbmdlOjdkZDVhYjIzODViMTQyYWQ4NWQwMDMzYzVmZmVlOTJkXzQtMS0xLTEtMzE0MjI_c71e30f4-73ec-4cee-8d2b-317438215b7d">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6259ebc7ed26431991c3b2aa187c0c91_I20201231" decimals="-5" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZTo3ZGQ1YWIyMzg1YjE0MmFkODVkMDAzM2M1ZmZlZTkyZC90YWJsZXJhbmdlOjdkZDVhYjIzODViMTQyYWQ4NWQwMDMzYzVmZmVlOTJkXzQtMy0xLTEtMzE0MjI_e4de5dcb-7ae9-47da-97d7-942f51005bd7">33.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0853510f8095410c8cab4556a87f5fab_I20211231" decimals="-5" name="us-gaap:LiabilitiesNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZTo3ZGQ1YWIyMzg1YjE0MmFkODVkMDAzM2M1ZmZlZTkyZC90YWJsZXJhbmdlOjdkZDVhYjIzODViMTQyYWQ4NWQwMDMzYzVmZmVlOTJkXzUtMS0xLTEtMzE0MjI_a332cc65-eeb0-4c82-9a76-f0e6c9788f2a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6259ebc7ed26431991c3b2aa187c0c91_I20201231" decimals="-5" name="us-gaap:LiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZTo3ZGQ1YWIyMzg1YjE0MmFkODVkMDAzM2M1ZmZlZTkyZC90YWJsZXJhbmdlOjdkZDVhYjIzODViMTQyYWQ4NWQwMDMzYzVmZmVlOTJkXzUtMy0xLTEtMzE0MjI_a9978e88-7c7d-4223-92f9-45e0cb3e1b00">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0853510f8095410c8cab4556a87f5fab_I20211231" decimals="-5" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZTo3ZGQ1YWIyMzg1YjE0MmFkODVkMDAzM2M1ZmZlZTkyZC90YWJsZXJhbmdlOjdkZDVhYjIzODViMTQyYWQ4NWQwMDMzYzVmZmVlOTJkXzYtMS0xLTEtMzE0MjI_d05e8a39-78e2-4433-8b9f-a82539efaf20">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6259ebc7ed26431991c3b2aa187c0c91_I20201231" decimals="-5" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZTo3ZGQ1YWIyMzg1YjE0MmFkODVkMDAzM2M1ZmZlZTkyZC90YWJsZXJhbmdlOjdkZDVhYjIzODViMTQyYWQ4NWQwMDMzYzVmZmVlOTJkXzYtMy0xLTEtMzE0MjI_8b3e3f3a-8ff5-473f-89c1-a675d71297aa">34.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0853510f8095410c8cab4556a87f5fab_I20211231" decimals="-5" name="vtrs:EquityMethodInvestmentSummarizedFinancialInformationNetAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZTo3ZGQ1YWIyMzg1YjE0MmFkODVkMDAzM2M1ZmZlZTkyZC90YWJsZXJhbmdlOjdkZDVhYjIzODViMTQyYWQ4NWQwMDMzYzVmZmVlOTJkXzctMS0xLTEtMzE0MjI_3fcfb1e3-7163-4d27-a688-141e38f6ee22">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6259ebc7ed26431991c3b2aa187c0c91_I20201231" decimals="-5" name="vtrs:EquityMethodInvestmentSummarizedFinancialInformationNetAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZTo3ZGQ1YWIyMzg1YjE0MmFkODVkMDAzM2M1ZmZlZTkyZC90YWJsZXJhbmdlOjdkZDVhYjIzODViMTQyYWQ4NWQwMDMzYzVmZmVlOTJkXzctMy0xLTEtMzE0MjI_216f0e70-78aa-4350-936f-379e8294c85b">5.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:65.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0185425b6174d78bfd3fbdefaaaea64_D20210101-20211231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZToxMTMxYWIxZDcxOTg0N2U2OTNkYmM5NmRkYjk1ZTMxOC90YWJsZXJhbmdlOjExMzFhYjFkNzE5ODQ3ZTY5M2RiYzk2ZGRiOTVlMzE4XzItMS0xLTEtMzE0MjI_b196df03-a0ec-4853-aa0a-c67199fb9b1b">326.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae859ab23c9340b096f1af4c4f554c62_D20200101-20201231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZToxMTMxYWIxZDcxOTg0N2U2OTNkYmM5NmRkYjk1ZTMxOC90YWJsZXJhbmdlOjExMzFhYjFkNzE5ODQ3ZTY5M2RiYzk2ZGRiOTVlMzE4XzItMy0xLTEtMzE0MjI_e0d44e81-cf4f-4616-8d47-10bcaa1b632a">374.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09587ab064ca42a8bec631ae169a3af9_D20190101-20191231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZToxMTMxYWIxZDcxOTg0N2U2OTNkYmM5NmRkYjk1ZTMxOC90YWJsZXJhbmdlOjExMzFhYjFkNzE5ODQ3ZTY5M2RiYzk2ZGRiOTVlMzE4XzItNS0xLTEtMzE0MjI_9d27c4e2-4cf6-478f-8af5-362613e354d1">385.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0185425b6174d78bfd3fbdefaaaea64_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZToxMTMxYWIxZDcxOTg0N2U2OTNkYmM5NmRkYjk1ZTMxOC90YWJsZXJhbmdlOjExMzFhYjFkNzE5ODQ3ZTY5M2RiYzk2ZGRiOTVlMzE4XzMtMS0xLTEtMzE0MjI_ea43110a-5570-4f19-865c-a04b3cee13b3">4.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae859ab23c9340b096f1af4c4f554c62_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZToxMTMxYWIxZDcxOTg0N2U2OTNkYmM5NmRkYjk1ZTMxOC90YWJsZXJhbmdlOjExMzFhYjFkNzE5ODQ3ZTY5M2RiYzk2ZGRiOTVlMzE4XzMtMy0xLTEtMzE0MjI_8ac19b35-ecec-4d95-8b5b-d3af07c2dd72">4.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09587ab064ca42a8bec631ae169a3af9_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZToxMTMxYWIxZDcxOTg0N2U2OTNkYmM5NmRkYjk1ZTMxOC90YWJsZXJhbmdlOjExMzFhYjFkNzE5ODQ3ZTY5M2RiYzk2ZGRiOTVlMzE4XzMtNS0xLTEtMzE0MjI_e2b50770-9f2f-4a37-826a-421d45758e94">4.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating and non-operating expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0185425b6174d78bfd3fbdefaaaea64_D20210101-20211231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZToxMTMxYWIxZDcxOTg0N2U2OTNkYmM5NmRkYjk1ZTMxOC90YWJsZXJhbmdlOjExMzFhYjFkNzE5ODQ3ZTY5M2RiYzk2ZGRiOTVlMzE4XzQtMS0xLTEtMzE0MjI_56cac91f-f912-4312-b451-6253d8171c5b">16.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae859ab23c9340b096f1af4c4f554c62_D20200101-20201231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZToxMTMxYWIxZDcxOTg0N2U2OTNkYmM5NmRkYjk1ZTMxOC90YWJsZXJhbmdlOjExMzFhYjFkNzE5ODQ3ZTY5M2RiYzk2ZGRiOTVlMzE4XzQtMy0xLTEtMzE0MjI_dac9429e-6ba1-4aca-8c73-15bf04d02779">19.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09587ab064ca42a8bec631ae169a3af9_D20190101-20191231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZToxMTMxYWIxZDcxOTg0N2U2OTNkYmM5NmRkYjk1ZTMxOC90YWJsZXJhbmdlOjExMzFhYjFkNzE5ODQ3ZTY5M2RiYzk2ZGRiOTVlMzE4XzQtNS0xLTEtMzE0MjI_369c9928-7638-4e5f-bb7e-e120b9a3a06d">20.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0185425b6174d78bfd3fbdefaaaea64_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZToxMTMxYWIxZDcxOTg0N2U2OTNkYmM5NmRkYjk1ZTMxOC90YWJsZXJhbmdlOjExMzFhYjFkNzE5ODQ3ZTY5M2RiYzk2ZGRiOTVlMzE4XzUtMS0xLTEtMzE0MjI_6dd3a4ef-d999-479b-aef1-7329f5c709f9">21.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae859ab23c9340b096f1af4c4f554c62_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZToxMTMxYWIxZDcxOTg0N2U2OTNkYmM5NmRkYjk1ZTMxOC90YWJsZXJhbmdlOjExMzFhYjFkNzE5ODQ3ZTY5M2RiYzk2ZGRiOTVlMzE4XzUtMy0xLTEtMzE0MjI_4aa6284d-cfd1-4a13-9232-dee8d78d937b">23.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09587ab064ca42a8bec631ae169a3af9_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZToxMTMxYWIxZDcxOTg0N2U2OTNkYmM5NmRkYjk1ZTMxOC90YWJsZXJhbmdlOjExMzFhYjFkNzE5ODQ3ZTY5M2RiYzk2ZGRiOTVlMzE4XzUtNS0xLTEtMzE0MjI_3131fd04-e83e-4c43-983a-0fdd115da05b">24.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s net losses from its equity method investments include amortization expense related to the excess of the cost basis of the Company&#8217;s investment over the underlying assets of each individual investee. For the years ended December&#160;31, 2021, 2020 and 2019, the Company recognized net losses from equity method investments of $<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90ZXh0cmVnaW9uOjM5Y2Y1MjExZDNiNDQ3MzliZDkwN2U5NWZkYjk3ZTFiXzE5ODU_361d8db0-63e7-478a-8064-41b9a3a575a2">61.9</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90ZXh0cmVnaW9uOjM5Y2Y1MjExZDNiNDQ3MzliZDkwN2U5NWZkYjk3ZTFiXzE5ODk_e2a03f1e-1c95-452d-a3ff-d46763affe0d">48.4</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90ZXh0cmVnaW9uOjM5Y2Y1MjExZDNiNDQ3MzliZDkwN2U5NWZkYjk3ZTFiXzE5OTc_51bc5362-bc09-4535-a97a-9787be8a9167">62.1</ix:nonFraction> million, respectively, which were recognized as a component of other expense, net in the consolidated statements of operations. The Company recognizes the income tax credits and benefits from the clean energy investments as part of its provision for income taxes.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103</span></div></div></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_199"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">Goodwill and Other Intangible Assets</span></div><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3Xzc1Njc_8e808bdb-345a-40d4-820a-9587ee3ac85f" escape="true"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill for the years ended December&#160;31, 2021 and 2020 are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.859%"><tr><td style="width:1.0%"></td><td style="width:38.931%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.277%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Developed Markets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Greater China</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">JANZ</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Emerging Markets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i315c417d4b374c99bb802f2ca94fe20c_I20191231" decimals="-5" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzItMS0xLTEtMzE0MjI_e5a5b60c-2917-4706-8c35-1946853f7dd1">8,258.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19b7b956b6644bcdb10d4dea546f710e_I20191231" decimals="-5" name="us-gaap:GoodwillGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzItMy0xLTEtMzE0MjI_da50ce8b-0f3c-4d00-aadb-8c1e4fb11fde">67.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ca0195877e7427d95d7bf2d7026caa1_I20191231" decimals="-5" name="us-gaap:GoodwillGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzItNS0xLTEtMzE0MjI_42d37bb2-eb0d-4950-9ba6-35b7a0bd8c02">584.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia340ab16326e432db33adc76e7d83306_I20191231" decimals="-5" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzItNy0xLTEtMzE0MjI_1206bce0-8579-4799-923b-46264daf1955">1,065.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac503b6d629d4bafb262ea6ec0b8a25e_I20191231" decimals="-5" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzItOS0xLTEtMzE0MjI_fcde58c2-4dab-49be-abe7-07084ea43689">9,975.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i315c417d4b374c99bb802f2ca94fe20c_I20191231" decimals="-5" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzMtMS0xLTEtMzE0MjI_07bfdb7a-356c-456d-8222-e0901cd4ab1c">385.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19b7b956b6644bcdb10d4dea546f710e_I20191231" decimals="-5" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzMtMy0xLTEtMzE0MjI_f8b4fdd2-eb7a-4a43-be9e-6b347c00cfbb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ca0195877e7427d95d7bf2d7026caa1_I20191231" decimals="-5" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzMtNS0xLTEtMzE0MjI_1637ebdf-3a65-4678-9e44-c381150dd320">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia340ab16326e432db33adc76e7d83306_I20191231" decimals="-5" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzMtNy0xLTEtMzE0MjI_75fb5420-a707-427a-a02d-134305b06983">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac503b6d629d4bafb262ea6ec0b8a25e_I20191231" decimals="-5" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzMtOS0xLTEtMzE0MjI_112d42c0-2365-445c-aa5d-b1cf94714986">385.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i315c417d4b374c99bb802f2ca94fe20c_I20191231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzQtMS0xLTEtMzE0MjI_dfed7b68-46cb-4a7c-81ee-c922d1b1efcf">7,873.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19b7b956b6644bcdb10d4dea546f710e_I20191231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzQtMy0xLTEtMzE0MjI_79142ee6-424d-45e2-888e-b9f44df99278">67.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ca0195877e7427d95d7bf2d7026caa1_I20191231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzQtNS0xLTEtMzE0MjI_dc0721ea-ded5-4e50-9f6f-9babf77d0215">584.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia340ab16326e432db33adc76e7d83306_I20191231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzQtNy0xLTEtMzE0MjI_c1210eb4-9f4c-47af-aa6d-0b09671be0c1">1,065.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac503b6d629d4bafb262ea6ec0b8a25e_I20191231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzQtOS0xLTEtMzE0MjI_10d31966-1347-4bd3-96c0-2e790e765a12">9,590.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38a0011834694e8599d458b848606328_D20190101-20191231" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzUtMS0xLTEtMzE0MjI_e14926a7-09b6-4c79-86a9-feac56c88fdd">704.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25616a483e2e4a3da1bdb481fdcdc776_D20190101-20191231" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzUtMy0xLTEtMzE0MjI_b3b0324e-4737-4955-a6f3-b10e6469d5dd">652.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93e12956332b44a59bb64bc33354f7ee_D20190101-20191231" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzUtNS0xLTEtMzE0MjI_80a91083-6529-4813-ad1c-4939c648d067">217.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec758a60e4bd425e896c1f35e907763b_D20190101-20191231" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzUtNy0xLTEtMzE0MjI_bf5213a0-a2ad-44c3-8777-b16bd8a76ccd">533.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzUtOS0xLTEtMzE0MjI_6f9fa972-4082-4d40-be89-27f714fcd2e9">2,107.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38a0011834694e8599d458b848606328_D20190101-20191231" decimals="-5" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzYtMS0xLTEtMzE0MjI_79d83919-f73e-4cfe-b42c-fdce136d5f9b">607.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25616a483e2e4a3da1bdb481fdcdc776_D20190101-20191231" decimals="-5" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzYtMy0xLTEtMzE0MjI_e4060b03-d7c4-4398-b79d-11862be89780">17.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93e12956332b44a59bb64bc33354f7ee_D20190101-20191231" decimals="-5" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzYtNS0xLTEtMzE0MjI_c7881019-c53e-409f-ad99-18774602caeb">61.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec758a60e4bd425e896c1f35e907763b_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzYtNy0xLTEtMzE0MjI_8ede23c2-18ab-4b2f-9cd1-f55b4964dbd2">37.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzYtOS0xLTEtMzE0MjI_36864574-e20f-46af-9dea-291890b59491">648.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcede0739e844bf0be1dd96355937b5b_I20201231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzctMS0xLTEtMzE0MjI_e839cc87-7912-438e-bbdb-cde705ff7f91">9,184.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257d82c8b1324095a90197f7a7cfb225_I20201231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzctMy0xLTEtMzE0MjI_8b93418d-9e9b-4b62-9e5b-a7846503201d">738.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i783790c3f4764f4f86bb8f68bcb4fff2_I20201231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzctNS0xLTEtMzE0MjI_63eecf35-db3b-4105-8fc3-cd8d75ec8bc7">864.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98548692221d4033bf9d5dc6b6466a25_I20201231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzctNy0xLTEtMzE0MjI_9238fb79-202f-4979-bad2-71bccb946d12">1,560.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzctOS0xLTEtMzE0MjI_8c6484cf-2ef7-4c02-80e8-6081263b9931">12,347.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcede0739e844bf0be1dd96355937b5b_I20201231" decimals="-5" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzktMS0xLTEtMzE0MjI_bf4213d5-88fb-465f-a255-69bce8bd518f">9,569.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257d82c8b1324095a90197f7a7cfb225_I20201231" decimals="-5" name="us-gaap:GoodwillGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzktMy0xLTEtMzE0MjI_3591960b-d037-4a85-bcbc-e1ac29e413f3">738.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i783790c3f4764f4f86bb8f68bcb4fff2_I20201231" decimals="-5" name="us-gaap:GoodwillGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzktNS0xLTEtMzE0MjI_df3f3f35-79c2-4e6b-8dae-f1765e50a4eb">864.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98548692221d4033bf9d5dc6b6466a25_I20201231" decimals="-5" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzktNy0xLTEtMzE0MjI_83e48b20-b94f-444f-aa9c-55833f50d326">1,560.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzktOS0xLTEtMzE0MjI_f8f7fedb-c50a-4459-8da9-f63911c6f482">12,732.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcede0739e844bf0be1dd96355937b5b_I20201231" decimals="-5" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzEwLTEtMS0xLTMxNDIy_6f2754e2-9715-4ad9-b02b-2a3ed4179034">385.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257d82c8b1324095a90197f7a7cfb225_I20201231" decimals="-5" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzEwLTMtMS0xLTMxNDIy_e092842d-3f6f-4ec1-a173-d4ebddb9c1ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i783790c3f4764f4f86bb8f68bcb4fff2_I20201231" decimals="-5" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzEwLTUtMS0xLTMxNDIy_3b9031ff-3473-4a5f-9ad5-11890c18c4eb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98548692221d4033bf9d5dc6b6466a25_I20201231" decimals="-5" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzEwLTctMS0xLTMxNDIy_f11f6fba-6380-497f-bfd4-3e3b50e83db4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzEwLTktMS0xLTMxNDIy_b2b5b076-aec1-421e-bfbc-a6c9ebd92203">385.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcede0739e844bf0be1dd96355937b5b_I20201231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzExLTEtMS0xLTMxNDIy_0b0117ee-e172-483d-af5f-51f90cff04ea">9,184.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i257d82c8b1324095a90197f7a7cfb225_I20201231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzExLTMtMS0xLTMxNDIy_d2e24d6d-a8cd-4a5e-9408-2f60a6e5ff29">738.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i783790c3f4764f4f86bb8f68bcb4fff2_I20201231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzExLTUtMS0xLTMxNDIy_0664935c-2b9e-45f4-bb51-475c1f016ef6">864.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98548692221d4033bf9d5dc6b6466a25_I20201231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzExLTctMS0xLTMxNDIy_ae9c9a01-b506-4feb-acbf-5e4b17a4173c">1,560.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzExLTktMS0xLTMxNDIy_8c6484cf-2ef7-4c02-80e8-6081263b9931">12,347.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement period and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id71374cb5c304b1b8b38cd06a22b2e88_D20200101-20201231" decimals="-5" name="vtrs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzEyLTEtMS0xLTMxNDIy_a916976b-c8dc-45f1-be80-417cbe2b982a">67.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ca13749baf74114b35b0784dde6edb1_D20200101-20201231" decimals="-5" name="vtrs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzEyLTMtMS0xLTMxNDIy_a82808ff-5da0-493c-9cfe-8a90494d6ccc">220.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i283b1cce431d414ab5f875e9a4bcbd90_D20200101-20201231" decimals="-5" sign="-" name="vtrs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzEyLTUtMS0xLTMxNDIy_1d0f1c5c-6f51-423f-961a-f23c6b6de898">30.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieade6f9a084b4f2eb5b23630a93f657d_D20200101-20201231" decimals="-5" name="vtrs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzEyLTctMS0xLTMxNDIy_2030d477-9e35-4234-b41a-30665e831224">38.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="vtrs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzEyLTktMS0xLTMxNDIy_fe1fbe0e-26fa-48be-80ec-1a8f6f3c98c9">295.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id71374cb5c304b1b8b38cd06a22b2e88_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzE0LTEtMS0xLTMxNDIy_92b89151-0682-4a3f-a36a-71807c63de0a">528.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ca13749baf74114b35b0784dde6edb1_D20200101-20201231" decimals="-5" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzE0LTMtMS0xLTMxNDIy_972e21a3-e2fd-41ab-a2fc-3415cc254fb6">10.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i283b1cce431d414ab5f875e9a4bcbd90_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzE0LTUtMS0xLTMxNDIy_71954a61-2f79-4e38-b2a1-6540eb0e5965">56.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieade6f9a084b4f2eb5b23630a93f657d_D20200101-20201231" decimals="-5" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzE0LTctMS0xLTMxNDIy_e60771b9-a077-494e-9ccd-2b95f75508a3">45.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzE0LTktMS0xLTMxNDIy_5b816640-ff68-4e1c-a0c1-a83a445c0b3e">528.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia10b2e6ad58c4c4bb99c064d555b97da_I20211231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzE1LTEtMS0xLTMxNDIy_1d41b109-ec3d-4178-828d-6af24efcbe8b">8,723.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bf87e450da84c279d1a95ba5e923d3e_I20211231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzE1LTMtMS0xLTMxNDIy_caf0250c-2e0e-4625-9c78-f206ab8d3289">969.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55f2fb13e460418aa9bf86f68ca38852_I20211231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzE1LTUtMS0xLTMxNDIy_ba9134f8-c63d-4122-955a-35ed7a71af55">776.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5caf17f0c9ca41c58ddd4ef0394bdc79_I20211231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzE1LTctMS0xLTMxNDIy_dfa0a540-e16a-4acd-9608-e3cf92db9ad0">1,644.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzE1LTktMS0xLTMxNDIy_e7eb6ff1-26b9-436e-bd2a-698abcf2d5f9">12,113.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia10b2e6ad58c4c4bb99c064d555b97da_I20211231" decimals="-5" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzE3LTEtMS0xLTMxNDIy_28dd8642-012c-45d2-a9c8-9c6ed5c3d015">9,108.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bf87e450da84c279d1a95ba5e923d3e_I20211231" decimals="-5" name="us-gaap:GoodwillGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzE3LTMtMS0xLTMxNDIy_c677f1c6-c55c-4131-9224-6138cf5db508">969.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55f2fb13e460418aa9bf86f68ca38852_I20211231" decimals="-5" name="us-gaap:GoodwillGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzE3LTUtMS0xLTMxNDIy_1418ee93-3b67-4143-bd91-0df3c0b60eb5">776.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5caf17f0c9ca41c58ddd4ef0394bdc79_I20211231" decimals="-5" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzE3LTctMS0xLTMxNDIy_c52238c0-bd28-46d4-a936-78f9549b9b62">1,644.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzE3LTktMS0xLTMxNDIy_de74846d-ad07-4b61-a42e-2ca10b581fb3">12,498.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia10b2e6ad58c4c4bb99c064d555b97da_I20211231" decimals="-5" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzE4LTEtMS0xLTMxNDIy_a62bc0c9-2fae-4e33-abf8-b6bd5f6a3d69">385.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bf87e450da84c279d1a95ba5e923d3e_I20211231" decimals="-5" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzE4LTMtMS0xLTMxNDIy_0196e262-6088-4f89-9faf-4d014391de00">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55f2fb13e460418aa9bf86f68ca38852_I20211231" decimals="-5" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzE4LTUtMS0xLTMxNDIy_bdfa7b0e-a92d-4ea4-a076-19da5d80a2f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5caf17f0c9ca41c58ddd4ef0394bdc79_I20211231" decimals="-5" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzE4LTctMS0xLTMxNDIy_74049b70-82f2-4121-a649-494d6f955934">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzE4LTktMS0xLTMxNDIy_5a751dbb-786b-493c-b59c-f0fd294bb7b9">385.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia10b2e6ad58c4c4bb99c064d555b97da_I20211231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzE5LTEtMS0xLTMxNDIy_d279bea0-13fc-4397-9c63-599b7a9c2b45">8,723.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bf87e450da84c279d1a95ba5e923d3e_I20211231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzE5LTMtMS0xLTMxNDIy_13028102-35e9-4bed-95e8-d2b0b4cf878e">969.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55f2fb13e460418aa9bf86f68ca38852_I20211231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzE5LTUtMS0xLTMxNDIy_ff911f9a-176f-4a62-a370-9368d3f143dd">776.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5caf17f0c9ca41c58ddd4ef0394bdc79_I20211231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzE5LTctMS0xLTMxNDIy_07e9aba7-5401-4346-be50-f024e4d43c41">1,644.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzE5LTktMS0xLTMxNDIy_e7eb6ff1-26b9-436e-bd2a-698abcf2d5f9">12,113.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3Xzc2MTY_1aec8ac8-0984-4924-bbe0-566a225219ed" escape="true"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consist of the following components at December&#160;31, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:53.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Life (Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Book Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product rights, licenses and other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTo5ZWExZmFmM2NkM2M0ZDc0YWFlMWFkYmQ0MTM1YzY4Ny90YWJsZXJhbmdlOjllYTFmYWYzY2QzYzRkNzRhYWUxYWRiZDQxMzVjNjg3XzItMS0xLTEtMzE0MjI_088fd8b2-b8d9-4459-a095-7e40de1270b6">15</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTo5ZWExZmFmM2NkM2M0ZDc0YWFlMWFkYmQ0MTM1YzY4Ny90YWJsZXJhbmdlOjllYTFmYWYzY2QzYzRkNzRhYWUxYWRiZDQxMzVjNjg3XzItMy0xLTEtMzE0MjI_802f137d-a551-4611-9d42-14408cbcd0ac">39,006.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTo5ZWExZmFmM2NkM2M0ZDc0YWFlMWFkYmQ0MTM1YzY4Ny90YWJsZXJhbmdlOjllYTFmYWYzY2QzYzRkNzRhYWUxYWRiZDQxMzVjNjg3XzItNS0xLTEtMzE0MjI_f2eeb6d3-e06b-4a6d-8792-65d93c54e4d7">12,918.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTo5ZWExZmFmM2NkM2M0ZDc0YWFlMWFkYmQ0MTM1YzY4Ny90YWJsZXJhbmdlOjllYTFmYWYzY2QzYzRkNzRhYWUxYWRiZDQxMzVjNjg3XzItNy0xLTEtMzE0MjI_2fe1ca60-5fcb-470a-90e0-f9f9b2ed6573">26,087.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTo5ZWExZmFmM2NkM2M0ZDc0YWFlMWFkYmQ0MTM1YzY4Ny90YWJsZXJhbmdlOjllYTFmYWYzY2QzYzRkNzRhYWUxYWRiZDQxMzVjNjg3XzMtMy0xLTEtMzE0MjI_929f1590-0a75-4d37-ae4e-70236ef99fe0">46.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTo5ZWExZmFmM2NkM2M0ZDc0YWFlMWFkYmQ0MTM1YzY4Ny90YWJsZXJhbmdlOjllYTFmYWYzY2QzYzRkNzRhYWUxYWRiZDQxMzVjNjg3XzMtNy0xLTEtMzE0MjI_d6874e5b-d675-4e66-a4e8-9935c8acf015">46.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTo5ZWExZmFmM2NkM2M0ZDc0YWFlMWFkYmQ0MTM1YzY4Ny90YWJsZXJhbmdlOjllYTFmYWYzY2QzYzRkNzRhYWUxYWRiZDQxMzVjNjg3XzQtMy0xLTEtMzE0MjI_4a07fac0-617d-49fb-8a63-37d634795988">39,052.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTo5ZWExZmFmM2NkM2M0ZDc0YWFlMWFkYmQ0MTM1YzY4Ny90YWJsZXJhbmdlOjllYTFmYWYzY2QzYzRkNzRhYWUxYWRiZDQxMzVjNjg3XzQtNS0xLTEtMzE0MjI_c05ee97e-5190-4a18-8f56-6fd69f96915d">12,918.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTo5ZWExZmFmM2NkM2M0ZDc0YWFlMWFkYmQ0MTM1YzY4Ny90YWJsZXJhbmdlOjllYTFmYWYzY2QzYzRkNzRhYWUxYWRiZDQxMzVjNjg3XzQtNy0xLTEtMzE0MjI_e596d9c0-eb43-41e4-ae7b-7ce6238236c8">26,134.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product rights, licenses and other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTo5ZWExZmFmM2NkM2M0ZDc0YWFlMWFkYmQ0MTM1YzY4Ny90YWJsZXJhbmdlOjllYTFmYWYzY2QzYzRkNzRhYWUxYWRiZDQxMzVjNjg3XzYtMS0xLTEtMzE0MjI_461c25b3-4c87-4c6e-81ef-9704ffa6ff6c">15</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTo5ZWExZmFmM2NkM2M0ZDc0YWFlMWFkYmQ0MTM1YzY4Ny90YWJsZXJhbmdlOjllYTFmYWYzY2QzYzRkNzRhYWUxYWRiZDQxMzVjNjg3XzYtMy0xLTEtMzE0MjI_5755a626-a2ac-489d-88a8-fd2931ed818b">40,404.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTo5ZWExZmFmM2NkM2M0ZDc0YWFlMWFkYmQ0MTM1YzY4Ny90YWJsZXJhbmdlOjllYTFmYWYzY2QzYzRkNzRhYWUxYWRiZDQxMzVjNjg3XzYtNS0xLTEtMzE0MjI_d886e0c1-558a-48e4-adac-08c12e6fe161">10,801.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTo5ZWExZmFmM2NkM2M0ZDc0YWFlMWFkYmQ0MTM1YzY4Ny90YWJsZXJhbmdlOjllYTFmYWYzY2QzYzRkNzRhYWUxYWRiZDQxMzVjNjg3XzYtNy0xLTEtMzE0MjI_96105f6d-0221-4e01-ada4-3e67fa660eec">29,602.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTo5ZWExZmFmM2NkM2M0ZDc0YWFlMWFkYmQ0MTM1YzY4Ny90YWJsZXJhbmdlOjllYTFmYWYzY2QzYzRkNzRhYWUxYWRiZDQxMzVjNjg3XzctMy0xLTEtMzE0MjI_0574b7e9-4202-40e2-9768-1958cf06d85f">80.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTo5ZWExZmFmM2NkM2M0ZDc0YWFlMWFkYmQ0MTM1YzY4Ny90YWJsZXJhbmdlOjllYTFmYWYzY2QzYzRkNzRhYWUxYWRiZDQxMzVjNjg3XzctNy0xLTEtMzE0MjI_50ad0966-0436-40cd-9e61-929e99166085">80.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTo5ZWExZmFmM2NkM2M0ZDc0YWFlMWFkYmQ0MTM1YzY4Ny90YWJsZXJhbmdlOjllYTFmYWYzY2QzYzRkNzRhYWUxYWRiZDQxMzVjNjg3XzgtMy0xLTEtMzE0MjI_c746cbb9-26a6-4395-b53c-905747c9c205">40,484.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTo5ZWExZmFmM2NkM2M0ZDc0YWFlMWFkYmQ0MTM1YzY4Ny90YWJsZXJhbmdlOjllYTFmYWYzY2QzYzRkNzRhYWUxYWRiZDQxMzVjNjg3XzgtNS0xLTEtMzE0MjI_156049cb-ad83-405f-a8ce-0edbed906f99">10,801.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTo5ZWExZmFmM2NkM2M0ZDc0YWFlMWFkYmQ0MTM1YzY4Ny90YWJsZXJhbmdlOjllYTFmYWYzY2QzYzRkNzRhYWUxYWRiZDQxMzVjNjg3XzgtNy0xLTEtMzE0MjI_2fc5b2ba-3f3d-41c9-b39e-40ffc392de75">29,683.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Represents amortizable intangible assets. Other intangibles consist principally of customer lists and contractual rights.</span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="vtrs:ProductRightsAndLicensesByTherapeuticCategoryTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3Xzc1NTg_a7fc46d2-1068-4d30-a83e-6a3675fe9302" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product rights and licenses are primarily comprised of the products marketed at the time of acquisition. These product rights and licenses relate to numerous individual products, the net book value of which, by product category, is as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Developed Markets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Greater China</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">JANZ</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Emerging Markets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brands</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id11e45101185446494c54622bb9b8177_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTphNjkwZTE3ZmJkYmE0ZDM1OTEwODUyMTkxYzU3NzdlNi90YWJsZXJhbmdlOmE2OTBlMTdmYmRiYTRkMzU5MTA4NTIxOTFjNTc3N2U2XzEtMS0xLTEtMzE0MjI_7320e575-d12b-40a6-921a-0534c193ce90">10,066.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iade66ffae6e040cfa629525230c6273c_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTphNjkwZTE3ZmJkYmE0ZDM1OTEwODUyMTkxYzU3NzdlNi90YWJsZXJhbmdlOmE2OTBlMTdmYmRiYTRkMzU5MTA4NTIxOTFjNTc3N2U2XzEtMy0xLTEtMzE0MjI_5778001f-a4c4-4773-998e-3e960127d755">6,102.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5450616961442a2b1ea8144698c669c_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTphNjkwZTE3ZmJkYmE0ZDM1OTEwODUyMTkxYzU3NzdlNi90YWJsZXJhbmdlOmE2OTBlMTdmYmRiYTRkMzU5MTA4NTIxOTFjNTc3N2U2XzEtNS0xLTEtMzE0MjI_039db44c-918b-4185-9f5a-d3aa6d7d21b2">1,174.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0395335aee314265a48396d57455b625_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTphNjkwZTE3ZmJkYmE0ZDM1OTEwODUyMTkxYzU3NzdlNi90YWJsZXJhbmdlOmE2OTBlMTdmYmRiYTRkMzU5MTA4NTIxOTFjNTc3N2U2XzEtNy0xLTEtMzE0MjI_f7d064e9-29a6-4a06-8a98-66c6f569ee30">3,801.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd3f720b0b1c41c799a80daa8a9b8e4b_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTphNjkwZTE3ZmJkYmE0ZDM1OTEwODUyMTkxYzU3NzdlNi90YWJsZXJhbmdlOmE2OTBlMTdmYmRiYTRkMzU5MTA4NTIxOTFjNTc3N2U2XzEtOS0xLTEtMzE0MjI_59b42569-4a90-41dc-90e7-517baee55068">21,146.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Complex Gx and Biosimilars</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24495761b1564b3aaeeb420062790b06_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTphNjkwZTE3ZmJkYmE0ZDM1OTEwODUyMTkxYzU3NzdlNi90YWJsZXJhbmdlOmE2OTBlMTdmYmRiYTRkMzU5MTA4NTIxOTFjNTc3N2U2XzItMS0xLTEtMzE0MjI_e3d3def7-fca3-442e-8f5f-8b698717aa67">226.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95eaf84899294b5cb1284e1df6d5d766_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTphNjkwZTE3ZmJkYmE0ZDM1OTEwODUyMTkxYzU3NzdlNi90YWJsZXJhbmdlOmE2OTBlMTdmYmRiYTRkMzU5MTA4NTIxOTFjNTc3N2U2XzItMy0xLTEtMzE0MjI_f3e02aef-e693-4a6d-beb1-9548673fc6b2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31d60f66b7ca4f7b854b44502d7569c6_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTphNjkwZTE3ZmJkYmE0ZDM1OTEwODUyMTkxYzU3NzdlNi90YWJsZXJhbmdlOmE2OTBlMTdmYmRiYTRkMzU5MTA4NTIxOTFjNTc3N2U2XzItNS0xLTEtMzE0MjI_a7ba675d-2fe7-45ba-89d9-dcce99c8633b">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4832437dbcd3485cb386c3787124ef0c_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTphNjkwZTE3ZmJkYmE0ZDM1OTEwODUyMTkxYzU3NzdlNi90YWJsZXJhbmdlOmE2OTBlMTdmYmRiYTRkMzU5MTA4NTIxOTFjNTc3N2U2XzItNy0xLTEtMzE0MjI_21ece253-c99d-4cb1-b276-94ce7f71b586">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83aed7ea547a47a2b816fee23196130f_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTphNjkwZTE3ZmJkYmE0ZDM1OTEwODUyMTkxYzU3NzdlNi90YWJsZXJhbmdlOmE2OTBlMTdmYmRiYTRkMzU5MTA4NTIxOTFjNTc3N2U2XzItOS0xLTEtMzE0MjI_23b4f52e-5024-4028-8b46-cb1dea006f88">228.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fe4acec3d334f5c9bf8565f72ff2a83_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTphNjkwZTE3ZmJkYmE0ZDM1OTEwODUyMTkxYzU3NzdlNi90YWJsZXJhbmdlOmE2OTBlMTdmYmRiYTRkMzU5MTA4NTIxOTFjNTc3N2U2XzMtMS0xLTEtMzE0MjI_2d8edd94-a1eb-48e6-b536-82c9771164c9">4,020.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i955ba774e0a548c287a702e8c5749900_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTphNjkwZTE3ZmJkYmE0ZDM1OTEwODUyMTkxYzU3NzdlNi90YWJsZXJhbmdlOmE2OTBlMTdmYmRiYTRkMzU5MTA4NTIxOTFjNTc3N2U2XzMtMy0xLTEtMzE0MjI_8a322fef-7806-4666-8331-5a3ccf3ec472">12.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaceccbde3b074329b263bcda37586891_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTphNjkwZTE3ZmJkYmE0ZDM1OTEwODUyMTkxYzU3NzdlNi90YWJsZXJhbmdlOmE2OTBlMTdmYmRiYTRkMzU5MTA4NTIxOTFjNTc3N2U2XzMtNS0xLTEtMzE0MjI_edfa3305-e52f-4ab8-bfe6-bc054988ae81">319.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1479b6b2aacb40b29f35cd42b1e22f9f_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTphNjkwZTE3ZmJkYmE0ZDM1OTEwODUyMTkxYzU3NzdlNi90YWJsZXJhbmdlOmE2OTBlMTdmYmRiYTRkMzU5MTA4NTIxOTFjNTc3N2U2XzMtNy0xLTEtMzE0MjI_a521eb3b-4a38-430f-a2b4-b4c935dfd93a">358.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaa8db533b7d4f489edaa8a8c7c3b889_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTphNjkwZTE3ZmJkYmE0ZDM1OTEwODUyMTkxYzU3NzdlNi90YWJsZXJhbmdlOmE2OTBlMTdmYmRiYTRkMzU5MTA4NTIxOTFjNTc3N2U2XzMtOS0xLTEtMzE0MjI_502358ed-ef58-40a4-9fd1-826310330bd0">4,710.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Product Rights and Licenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c77a702a1dc4bd4b4d96321e085c678_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTphNjkwZTE3ZmJkYmE0ZDM1OTEwODUyMTkxYzU3NzdlNi90YWJsZXJhbmdlOmE2OTBlMTdmYmRiYTRkMzU5MTA4NTIxOTFjNTc3N2U2XzQtMS0xLTEtMzE0MjI_1041d9e2-5752-4957-9779-6b164a7f7883">14,313.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9674aa9104274c98b38914ca35d5f4c1_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTphNjkwZTE3ZmJkYmE0ZDM1OTEwODUyMTkxYzU3NzdlNi90YWJsZXJhbmdlOmE2OTBlMTdmYmRiYTRkMzU5MTA4NTIxOTFjNTc3N2U2XzQtMy0xLTEtMzE0MjI_af24ca16-cdaa-4034-ae29-8db9b9a161ce">6,115.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec67624464a845eeafd1548788c90737_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTphNjkwZTE3ZmJkYmE0ZDM1OTEwODUyMTkxYzU3NzdlNi90YWJsZXJhbmdlOmE2OTBlMTdmYmRiYTRkMzU5MTA4NTIxOTFjNTc3N2U2XzQtNS0xLTEtMzE0MjI_b6b6b832-4eb1-4fc7-a4ba-929bcb171bb3">1,495.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib511387dd7a949499aa59b3b5b4db16a_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTphNjkwZTE3ZmJkYmE0ZDM1OTEwODUyMTkxYzU3NzdlNi90YWJsZXJhbmdlOmE2OTBlMTdmYmRiYTRkMzU5MTA4NTIxOTFjNTc3N2U2XzQtNy0xLTEtMzE0MjI_900d2624-87dd-4726-acec-436426648bae">4,160.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42391df0c964452ab8b60c6d0285b8cc_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTphNjkwZTE3ZmJkYmE0ZDM1OTEwODUyMTkxYzU3NzdlNi90YWJsZXJhbmdlOmE2OTBlMTdmYmRiYTRkMzU5MTA4NTIxOTFjNTc3N2U2XzQtOS0xLTEtMzE0MjI_6ac906d0-7da6-431b-825f-f4294e1ce45a">26,084.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Developed Markets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Greater China</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">JANZ</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Emerging Markets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brands</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2edb03cf70c94cf8b258388ec10a11e8_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpjNjBiNmUyM2Q0YzI0ZGIwODE2MmVmNjg1MTBjMWJhZC90YWJsZXJhbmdlOmM2MGI2ZTIzZDRjMjRkYjA4MTYyZWY2ODUxMGMxYmFkXzEtMS0xLTEtMzE0MjI_26c48fe6-cf3d-4521-a4b3-7e1d60c96dd0">10,988.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia550848323274182a3d6c7ce2c204b4c_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpjNjBiNmUyM2Q0YzI0ZGIwODE2MmVmNjg1MTBjMWJhZC90YWJsZXJhbmdlOmM2MGI2ZTIzZDRjMjRkYjA4MTYyZWY2ODUxMGMxYmFkXzEtMy0xLTEtMzE0MjI_3ac0c972-ea24-4ae4-8434-cb2cffa2304c">4,372.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id180e5c47b5b4590aaabfb4d1aa9d1d3_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpjNjBiNmUyM2Q0YzI0ZGIwODE2MmVmNjg1MTBjMWJhZC90YWJsZXJhbmdlOmM2MGI2ZTIzZDRjMjRkYjA4MTYyZWY2ODUxMGMxYmFkXzEtNS0xLTEtMzE0MjI_4d16dcdf-e227-407a-8545-10a917151dfd">2,377.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic210cb32648544a095a3760cee270d5a_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpjNjBiNmUyM2Q0YzI0ZGIwODE2MmVmNjg1MTBjMWJhZC90YWJsZXJhbmdlOmM2MGI2ZTIzZDRjMjRkYjA4MTYyZWY2ODUxMGMxYmFkXzEtNy0xLTEtMzE0MjI_2ce76fe2-1dc9-44d5-93a0-6d31d999eaae">4,478.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c23648696d148ada1075eba8138fa3b_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpjNjBiNmUyM2Q0YzI0ZGIwODE2MmVmNjg1MTBjMWJhZC90YWJsZXJhbmdlOmM2MGI2ZTIzZDRjMjRkYjA4MTYyZWY2ODUxMGMxYmFkXzEtOS0xLTEtMzE0MjI_9b4bd3d8-e7a4-4fbf-a2d6-737dcaa342e4">22,216.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Complex Gx and Biosimilars</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaae8f6a141fc4440a2e80e908354b800_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpjNjBiNmUyM2Q0YzI0ZGIwODE2MmVmNjg1MTBjMWJhZC90YWJsZXJhbmdlOmM2MGI2ZTIzZDRjMjRkYjA4MTYyZWY2ODUxMGMxYmFkXzItMS0xLTEtMzE0MjI_4905231c-d2e9-45f8-944e-d70f0926b51c">272.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf0dfbd7e212478fa3e85821b257efa9_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpjNjBiNmUyM2Q0YzI0ZGIwODE2MmVmNjg1MTBjMWJhZC90YWJsZXJhbmdlOmM2MGI2ZTIzZDRjMjRkYjA4MTYyZWY2ODUxMGMxYmFkXzItMy0xLTEtMzE0MjI_56b40c76-1130-40bc-acd0-f94bf37e942b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ef03cc41bdf4f279229b376fbb43600_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpjNjBiNmUyM2Q0YzI0ZGIwODE2MmVmNjg1MTBjMWJhZC90YWJsZXJhbmdlOmM2MGI2ZTIzZDRjMjRkYjA4MTYyZWY2ODUxMGMxYmFkXzItNS0xLTEtMzE0MjI_6f839167-8e86-4e96-b411-d68d6dc84ddd">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53980f6dd1b44213ad5171bcab656699_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpjNjBiNmUyM2Q0YzI0ZGIwODE2MmVmNjg1MTBjMWJhZC90YWJsZXJhbmdlOmM2MGI2ZTIzZDRjMjRkYjA4MTYyZWY2ODUxMGMxYmFkXzItNy0xLTEtMzE0MjI_2b10bd44-32c9-4389-bfa7-19ad867703dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7318ad9d646d42ab8e2f84f2d4ed08e5_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpjNjBiNmUyM2Q0YzI0ZGIwODE2MmVmNjg1MTBjMWJhZC90YWJsZXJhbmdlOmM2MGI2ZTIzZDRjMjRkYjA4MTYyZWY2ODUxMGMxYmFkXzItOS0xLTEtMzE0MjI_38f24bca-aa2f-408c-b05b-46ae1152ea46">274.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie81b4ce4914e4839924a78d8798397a9_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpjNjBiNmUyM2Q0YzI0ZGIwODE2MmVmNjg1MTBjMWJhZC90YWJsZXJhbmdlOmM2MGI2ZTIzZDRjMjRkYjA4MTYyZWY2ODUxMGMxYmFkXzMtMS0xLTEtMzE0MjI_71239a36-2644-4916-877b-c97f7916eba2">6,253.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9c761912e804561a14aa3acea5045c2_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpjNjBiNmUyM2Q0YzI0ZGIwODE2MmVmNjg1MTBjMWJhZC90YWJsZXJhbmdlOmM2MGI2ZTIzZDRjMjRkYjA4MTYyZWY2ODUxMGMxYmFkXzMtMy0xLTEtMzE0MjI_ba105d6c-d699-4f4a-9642-99ddda21e177">12.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbd726794242461a918bc026656e8819_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpjNjBiNmUyM2Q0YzI0ZGIwODE2MmVmNjg1MTBjMWJhZC90YWJsZXJhbmdlOmM2MGI2ZTIzZDRjMjRkYjA4MTYyZWY2ODUxMGMxYmFkXzMtNS0xLTEtMzE0MjI_433f4a58-1b10-41e6-8b7a-bf81b2fe0841">423.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd0a85ff305c485ea29c4a037baa7ebf_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpjNjBiNmUyM2Q0YzI0ZGIwODE2MmVmNjg1MTBjMWJhZC90YWJsZXJhbmdlOmM2MGI2ZTIzZDRjMjRkYjA4MTYyZWY2ODUxMGMxYmFkXzMtNy0xLTEtMzE0MjI_7a42aae0-0d81-42ad-8970-a876738701b1">417.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa491650e0184ee0b2d04a336fcd9159_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpjNjBiNmUyM2Q0YzI0ZGIwODE2MmVmNjg1MTBjMWJhZC90YWJsZXJhbmdlOmM2MGI2ZTIzZDRjMjRkYjA4MTYyZWY2ODUxMGMxYmFkXzMtOS0xLTEtMzE0MjI_04ac5b0d-ad3f-4424-84ab-ae3e82de6944">7,107.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Product Rights and Licenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa41c4de25dd421eb1ae018322f86643_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpjNjBiNmUyM2Q0YzI0ZGIwODE2MmVmNjg1MTBjMWJhZC90YWJsZXJhbmdlOmM2MGI2ZTIzZDRjMjRkYjA4MTYyZWY2ODUxMGMxYmFkXzQtMS0xLTEtMzE0MjI_f35e2120-9225-4aec-ba6b-dcb8d7ddca11">17,514.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03aa196073ab4bffb46b9ece7f3ece15_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpjNjBiNmUyM2Q0YzI0ZGIwODE2MmVmNjg1MTBjMWJhZC90YWJsZXJhbmdlOmM2MGI2ZTIzZDRjMjRkYjA4MTYyZWY2ODUxMGMxYmFkXzQtMy0xLTEtMzE0MjI_f15566a0-5ce6-40fe-8ca3-734c0c87f967">4,385.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e7e1f56b7f54755a3741e3d317a47f4_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpjNjBiNmUyM2Q0YzI0ZGIwODE2MmVmNjg1MTBjMWJhZC90YWJsZXJhbmdlOmM2MGI2ZTIzZDRjMjRkYjA4MTYyZWY2ODUxMGMxYmFkXzQtNS0xLTEtMzE0MjI_def687d9-623f-42c9-bc2d-b24b88fc988d">2,803.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1948994457e4a7d899f19777bc25f52_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpjNjBiNmUyM2Q0YzI0ZGIwODE2MmVmNjg1MTBjMWJhZC90YWJsZXJhbmdlOmM2MGI2ZTIzZDRjMjRkYjA4MTYyZWY2ODUxMGMxYmFkXzQtNy0xLTEtMzE0MjI_5959bccc-e23e-45db-b9bb-2781920f2264">4,896.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c6a1c4d0f5419a84aa95ca8cfce91e_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpjNjBiNmUyM2Q0YzI0ZGIwODE2MmVmNjg1MTBjMWJhZC90YWJsZXJhbmdlOmM2MGI2ZTIzZDRjMjRkYjA4MTYyZWY2ODUxMGMxYmFkXzQtOS0xLTEtMzE0MjI_8c72e97c-6cc3-4dfa-8739-c4510ead9419">29,598.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021 amounts include the finalization of the allocation of the intangible assets relating to the Combination.</span></div><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3Xzc1NTk_16419880-f29f-4181-beb1-6a9e30326460" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense and intangible asset impairment charges, which are included as a component of amortization expense, which is classified primarily within cost of sales in the consolidated statements of operations, for the years ended December&#160;31, 2021, 2020 and 2019 was as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:65.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset amortization expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZToyZmEzODQ1MWVhZDc0ZTQyYmI3MWZkOTQ0YTFmZWUyYi90YWJsZXJhbmdlOjJmYTM4NDUxZWFkNzRlNDJiYjcxZmQ5NDRhMWZlZTJiXzItMS0xLTEtMzE0MjI_356ba8ee-bb2e-4ee9-a0b7-552d58cff8dd">2,702.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZToyZmEzODQ1MWVhZDc0ZTQyYmI3MWZkOTQ0YTFmZWUyYi90YWJsZXJhbmdlOjJmYTM4NDUxZWFkNzRlNDJiYjcxZmQ5NDRhMWZlZTJiXzItMy0xLTEtMzE0MjI_dc14e039-d53c-4d86-bde1-5b84ef33c09a">1,605.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZToyZmEzODQ1MWVhZDc0ZTQyYmI3MWZkOTQ0YTFmZWUyYi90YWJsZXJhbmdlOjJmYTM4NDUxZWFkNzRlNDJiYjcxZmQ5NDRhMWZlZTJiXzItNS0xLTEtMzE0MjI_2e5f97b3-965e-4ac7-b575-6247c25fa1fd">1,582.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D intangible asset impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f17d8c76443b28b80fc7cc73a4065_D20210101-20211231" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZToyZmEzODQ1MWVhZDc0ZTQyYmI3MWZkOTQ0YTFmZWUyYi90YWJsZXJhbmdlOjJmYTM4NDUxZWFkNzRlNDJiYjcxZmQ5NDRhMWZlZTJiXzMtMS0xLTEtMzE0MjI_3624fd85-62aa-408e-bc18-14a11cb52557">19.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fcad26472544896b5f80c3807d319ee_D20200101-20201231" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZToyZmEzODQ1MWVhZDc0ZTQyYmI3MWZkOTQ0YTFmZWUyYi90YWJsZXJhbmdlOjJmYTM4NDUxZWFkNzRlNDJiYjcxZmQ5NDRhMWZlZTJiXzMtMy0xLTEtMzE0MjI_55fdb57d-1cb6-4a63-8362-fe7916a1628b">37.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c1b06002c614ec0a7355c6ffde49cad_D20190101-20191231" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZToyZmEzODQ1MWVhZDc0ZTQyYmI3MWZkOTQ0YTFmZWUyYi90YWJsZXJhbmdlOjJmYTM4NDUxZWFkNzRlNDJiYjcxZmQ5NDRhMWZlZTJiXzMtNS0xLTEtMzE0MjI_d13d414b-f3d1-4da8-a0aa-38ee1c0cd8ce">138.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finite-lived intangible asset impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d3ab4b3183547369e21bc16353ca096_D20210101-20211231" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZToyZmEzODQ1MWVhZDc0ZTQyYmI3MWZkOTQ0YTFmZWUyYi90YWJsZXJhbmdlOjJmYTM4NDUxZWFkNzRlNDJiYjcxZmQ5NDRhMWZlZTJiXzQtMS0xLTEtMzE0MjI_93cf9ab3-18b6-4dae-862d-2b17c0bbf9dd">83.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58799d0aadbb4faf8ae9cbb1ffa7e5c9_D20200101-20201231" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZToyZmEzODQ1MWVhZDc0ZTQyYmI3MWZkOTQ0YTFmZWUyYi90YWJsZXJhbmdlOjJmYTM4NDUxZWFkNzRlNDJiYjcxZmQ5NDRhMWZlZTJiXzQtMy0xLTEtMzE0MjI_d18fe9e3-0271-4355-91d1-069977af356f">45.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06896c6d773e4c648b6098ee68fc18cc_D20190101-20191231" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZToyZmEzODQ1MWVhZDc0ZTQyYmI3MWZkOTQ0YTFmZWUyYi90YWJsZXJhbmdlOjJmYTM4NDUxZWFkNzRlNDJiYjcxZmQ5NDRhMWZlZTJiXzQtNS0xLTEtMzE0MjI_2f205fe7-5af1-4fb6-9379-0682e1abd753">42.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible asset amortization expense (including impairment charges)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:AdjustmentForAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZToyZmEzODQ1MWVhZDc0ZTQyYmI3MWZkOTQ0YTFmZWUyYi90YWJsZXJhbmdlOjJmYTM4NDUxZWFkNzRlNDJiYjcxZmQ5NDRhMWZlZTJiXzUtMS0xLTEtMzE0MjI_ff4e5e22-f1df-4aa0-adbf-f45b606123a7">2,805.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:AdjustmentForAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZToyZmEzODQ1MWVhZDc0ZTQyYmI3MWZkOTQ0YTFmZWUyYi90YWJsZXJhbmdlOjJmYTM4NDUxZWFkNzRlNDJiYjcxZmQ5NDRhMWZlZTJiXzUtMy0xLTEtMzE0MjI_897fe2c3-8c34-40cb-ac2d-ac69f06b61d9">1,688.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:AdjustmentForAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZToyZmEzODQ1MWVhZDc0ZTQyYmI3MWZkOTQ0YTFmZWUyYi90YWJsZXJhbmdlOjJmYTM4NDUxZWFkNzRlNDJiYjcxZmQ5NDRhMWZlZTJiXzUtNS0xLTEtMzE0MjI_95d4ac60-0f4e-48d4-87b5-bf4914031134">1,763.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assessment for impairment of finite-lived intangibles is based on our ability to recover the carrying value of the long-lived assets or asset grouping by analyzing the expected future undiscounted pre-tax cash flows specific to the asset or asset grouping. If the carrying amount is greater than the undiscounted cash flows, the Company recognizes an impairment loss for the excess of the carrying amount over the estimated fair value based on discounted cash flows. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant management judgment is involved in estimating the recoverability of these assets and is dependent upon the accuracy of the assumptions used in making these estimates, as well as how the estimates compare to the eventual future operating performance of the specific asset or asset grouping. The fair value of finite-lived intangible assets was calculated as the present value of the estimated future net cash flows using a market rate of return. The assumptions inherent in the estimated future cash flows include, among other things, the impact of the current competitive environment and future market expectations. Discount rates ranging between <ix:nonFraction unitRef="usd" contextRef="i8931abe1fc4c41e283d3f620f5185481_I20211231" decimals="3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzIyODY_d5409acc-0a05-4b44-8c40-381bd08284b1">9.0</ix:nonFraction>% and <ix:nonFraction unitRef="usd" contextRef="i914407dcbd0742cea3b5fcdd61f4b1ed_I20211231" decimals="3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzIyOTM_3378250b-4ebb-41af-b22f-d168727d0d0c">11.0</ix:nonFraction>% were utilized in the valuations performed during the years ended December 31, 2021, 2020 and 2019. Any future long-lived assets impairment charges could have a material impact in the Company&#8217;s consolidated financial condition and results of operations.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 30, 2021, the Company completed an agreement to divest a group of OTC products in the U.S. As a result of this transaction, the Company recognized an intangible asset impairment charge of approximately $<ix:nonFraction unitRef="usd" contextRef="i9d3ab4b3183547369e21bc16353ca096_D20210101-20211231" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzEwOTk1MTE2NTA3Nzg_93cf9ab3-18b6-4dae-862d-2b17c0bbf9dd">83.4</ix:nonFraction> million during the year ended December 31, 2021.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s IPR&amp;D assets are tested at least annually for impairment or upon the occurrence of a triggering event. Impairment is determined to exist when the fair value of IPR&amp;D assets, which is based upon updated forecasts and commercial development plans, is less than the carrying value of the assets being tested. The fair value of IPR&amp;D was calculated as the present value of the estimated future net cash flows using a market rate of return. The assumptions inherent in the estimated future cash flows include, among other things, the impact of changes to the development programs, the projected development and regulatory time frames and the current competitive environment. Discount rates ranging between <ix:nonFraction unitRef="number" contextRef="i8894e39eabee436d9b912bcc70604238_I20211231" decimals="3" name="vtrs:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIndefiniteLivedIntangibleAssetsMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzMzNTE_0611e434-d97f-4f86-b48e-cccbfa761896">7.0</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i4b0764905b0442fb808444acc20375f5_I20211231" decimals="3" name="vtrs:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIndefiniteLivedIntangibleAssetsMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzMzNTg_2d2e08d0-47ed-4831-99de-a997bd8339dd">9.0</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="ia93f6572cba64cc187e20095aeebe69b_I20201231" decimals="3" name="vtrs:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIndefiniteLivedIntangibleAssetsMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzMzNjI_079ef4eb-cc00-4a78-84cc-e66508da64f2">9.0</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ie2d0511984ae4ebb9a94c4f5aaa12d9d_I20201231" decimals="3" name="vtrs:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIndefiniteLivedIntangibleAssetsMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzMzNjk_590a5898-eb5a-499c-b38c-e65ebae190ef">11.0</ix:nonFraction>%, and <ix:nonFraction unitRef="number" contextRef="ibb7025b0eca84850a521bee0487fc7b2_I20191231" decimals="3" name="vtrs:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIndefiniteLivedIntangibleAssetsMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzMzNzc_7d4c54a9-aa3e-4046-b895-0e70e07d628b">9.0</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i05e0f2d1f02d4ed3b1d3cd7d269a0f9f_I20191231" decimals="3" name="vtrs:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIndefiniteLivedIntangibleAssetsMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzMzODQ_396b76e5-e8dc-4213-a20c-fb33d90a0e0e">11.0</ix:nonFraction>% were utilized in the valuations performed during the years ended December 31, 2021, 2020 and 2019, respectively.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of both IPR&amp;D and finite-lived intangible assets was determined based upon detailed valuations employing the income approach which utilized Level 3 inputs, as defined in Note 9, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments and Risk Management</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Changes to any of the Company&#8217;s assumptions including changes to or abandonment of development programs, regulatory timelines, discount rates or the competitive environment related to the assets could lead to future material impairment charges.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company performed its annual goodwill impairment test as of April 1, 2021 on a quantitative basis for its five reporting units, North America, Europe, Emerging Markets, JANZ, and Greater China. See Note 15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further discussion. Additionally, the net assets acquired as part of the Combination were included in the respective reporting units and in the annual impairment test for the first time. In estimating each reporting unit&#8217;s fair value, the Company performed an extensive valuation analysis, utilizing both income and market-based approaches. The determination of the fair value of the reporting units requires the Company to make significant estimates and assumptions that affect the reporting unit&#8217;s expected future cash flows. These estimates and assumptions, utilizing Level 3 inputs, primarily include, but are not limited to, market multiples, control premiums, the discount rate, terminal growth rates, operating income before depreciation and amortization, and capital expenditures forecasts. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;1, 2021, the allocation of the Company&#8217;s total goodwill was as follows: North America $<ix:nonFraction unitRef="usd" contextRef="i97cf21063a7648e88dd9c911711f174d_I20210401" decimals="-7" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTU2ODQ_0fb8348a-3f3f-49a0-8ce9-603e8666d074">3.66</ix:nonFraction> billion, Europe $<ix:nonFraction unitRef="usd" contextRef="ie6266e509f1d44dc9a60daacdb22a350_I20210401" decimals="-7" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTU3MDI_2b4efd4d-ab6a-40dd-b421-45145e329957">5.15</ix:nonFraction> billion, Emerging Markets $<ix:nonFraction unitRef="usd" contextRef="ieadb084d06104ed894bd8527a64a8317_I20210401" decimals="-7" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTU3MTk_f5636b6d-b78a-4d86-b189-7df69787a1f9">1.58</ix:nonFraction> billion, JANZ $<ix:nonFraction unitRef="usd" contextRef="i784ed4be5e4640478be661b277b7af18_I20210401" decimals="-7" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTU3MzY_37e146bd-1ad4-4fa8-aa07-4570d024ea07">0.82</ix:nonFraction> billion and Greater China $<ix:nonFraction unitRef="usd" contextRef="i6f3c6cd031f7442181059f100dfd8aa7_I20210401" decimals="-7" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTU3NTM_2529d1ba-59ab-4422-8c3b-3952a6d9ae53">0.70</ix:nonFraction> billion. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April 1, 2021, the Company determined that the fair value of the North America, Emerging Markets and Greater China reporting units was substantially in excess of the respective unit&#8217;s carrying value. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the Europe reporting unit, the estimated fair value exceeded its carrying value by approximately $<ix:nonFraction unitRef="usd" contextRef="ie6266e509f1d44dc9a60daacdb22a350_I20210401" decimals="-7" name="us-gaap:ReportingUnitAmountOfFairValueInExcessOfCarryingAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTU5NDA_ed28f443-020b-4f7e-bb17-20b197c92f3a">0.91</ix:nonFraction> billion or <ix:nonFraction unitRef="number" contextRef="ie6266e509f1d44dc9a60daacdb22a350_I20210401" decimals="3" name="us-gaap:ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTU5NTA_e949af0c-12a1-46fe-af41-aea900f6ff97">5.8</ix:nonFraction>% for the annual goodwill impairment test. As it relates to the income approach for the Europe reporting unit at April&#160;1, 2021, the Company forecasted cash flows for the next <ix:nonNumeric contextRef="i4d71ef0b70eb4d1a88d365784c2806c2_D20210401-20210401" name="vtrs:GoodwillImpairmentMeasurementInputTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTU5NzM_1b89cff4-a6d3-49e9-bf37-16d62c8cbb6a">10</ix:nonNumeric> years. During the forecast period, the revenue compound annual growth rate was approximately <ix:nonFraction unitRef="number" contextRef="ib215f03d4a004bb190d0b0c9e1810626_I20210401" decimals="2" name="vtrs:GoodwillImpairmentMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTU5ODY_16ea2c29-7c04-4629-9fae-7d1f40098264">3.0</ix:nonFraction>%. A terminal year value was calculated with a <ix:nonFraction unitRef="number" contextRef="i47d220da3337425183ad3fe98cff519f_I20210401" decimals="3" name="vtrs:GoodwillImpairmentMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTU5OTM_63088ff8-a32d-4f6e-bec6-96b322eab46b">0.9</ix:nonFraction>% revenue growth rate applied. The discount rate utilized was 10.5% and the estimated tax rate was <ix:nonFraction unitRef="number" contextRef="i2e4d9eb373ac4cf5915b1ac7e264cb55_I20210401" decimals="3" name="vtrs:GoodwillImpairmentMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTYwMDk_910d14b1-a004-4723-97af-4bf2f867b6b7">19.0</ix:nonFraction>%. Under the market-based approach, we utilized an estimated range of market multiples of <ix:nonFraction unitRef="number" contextRef="iedf8aaffd2f2406782984df0b60eedee_I20210401" decimals="2" name="vtrs:GoodwillImpairmentMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTYwMTU_88c00026-3a8f-4a6c-803c-a3f21b203928">7.5</ix:nonFraction> to <ix:nonFraction unitRef="number" contextRef="ib890b7b1cb504759a309b083b68548ab_I20210401" decimals="2" name="vtrs:GoodwillImpairmentMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTYwMjE_562953e1-8733-44e5-934e-abb14bcbff03">8.5</ix:nonFraction> times EBITDA plus a control premium of <ix:nonFraction unitRef="number" contextRef="ia6d4f61859ba465d955863c12418c41b_I20210401" decimals="2" name="vtrs:GoodwillImpairmentMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTYwMjk_09245c79-37c9-4a26-b59e-6f1da76e95ce">15.0</ix:nonFraction>%. If all other assumptions are held constant, a reduction in the terminal value growth rate by <ix:nonFraction unitRef="number" contextRef="idf56c4919fb14633bbf6386bb070262c_I20210401" decimals="3" sign="-" name="vtrs:GoodwillImpairmentMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTYwMzY_8015d1fe-62cd-4eb9-b6a1-1df5a53df60c">2.9</ix:nonFraction>% or an increase in discount rate by <ix:nonFraction unitRef="number" contextRef="i15608e6da3164b4dae3c3a578cacf736_I20210401" decimals="3" name="vtrs:GoodwillImpairmentMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTYwNDM_b900a6f6-be8b-44de-b3b2-d9470d200788">1.5</ix:nonFraction>% would result in an impairment charge for the Europe reporting unit.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the JANZ reporting unit, the estimated fair value exceeded its carrying value by approximately $<ix:nonFraction unitRef="usd" contextRef="i784ed4be5e4640478be661b277b7af18_I20210401" decimals="-7" name="us-gaap:ReportingUnitAmountOfFairValueInExcessOfCarryingAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTYwNTk_211262a0-5c94-4bbe-aa5c-932d7e73d1a6">0.23</ix:nonFraction> billion or <ix:nonFraction unitRef="number" contextRef="i784ed4be5e4640478be661b277b7af18_I20210401" decimals="2" name="us-gaap:ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTYwNjg_4ab2f9b5-b10c-428d-805a-a7307b2915a3">7.0</ix:nonFraction>% for the annual goodwill impairment test. As it relates to the income approach for the JANZ reporting unit at April&#160;1, 2021, the Company forecasted cash flows for the next <ix:nonNumeric contextRef="i7ca2f0e0d1e2416f955e5ebad2fa3692_D20210401-20210401" name="vtrs:GoodwillImpairmentMeasurementInputTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTYzMTU_675fa4d8-ba49-4be1-b19b-fb071a9477ac">10</ix:nonNumeric> years. During the forecast period, the revenue compound annual growth rate was approximately negative <ix:nonFraction unitRef="number" contextRef="ic0ea4341bffa478086acdce9a047ead6_I20210401" decimals="3" name="vtrs:GoodwillImpairmentMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTYxMDU_e3ab75b6-0508-41d9-9cad-2960a1b5e06c">1.5</ix:nonFraction>%. A terminal year value was calculated with a <ix:nonFraction unitRef="number" contextRef="i0b46955e83674aeab67ff94b9709968a_I20210401" decimals="3" name="vtrs:GoodwillImpairmentMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTYxMTI_18d0f31a-5846-4214-9184-c7268c503d0e">0.7</ix:nonFraction>% revenue growth rate applied. The discount rate utilized was <ix:nonFraction unitRef="number" contextRef="ib16a3b6e8149409999a629fdf76b5e40_I20210401" decimals="3" name="vtrs:GoodwillImpairmentMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTYxMjc_a036c3fa-ad47-4b2b-b059-9b7fdc7b7a7e">8.5</ix:nonFraction>% and the estimated tax rate was <ix:nonFraction unitRef="number" contextRef="i3e5e76e30a1e4232835b08cc5aa3dd1f_I20210401" decimals="3" name="vtrs:GoodwillImpairmentMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTYxMzU_894031be-8d77-4cdf-93ad-c8a99c59d08c">30.5</ix:nonFraction>%. Under the market-based approach, we utilized an estimated market multiple of <ix:nonFraction unitRef="number" contextRef="i2faca452b6d7490fb6088b57bdba3eab_I20210401" decimals="2" name="vtrs:GoodwillImpairmentMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTYxNDE_53443ff3-ef26-42a7-9506-691dd6f78c15">6.0</ix:nonFraction> times EBITDA plus a control premium of <ix:nonFraction unitRef="number" contextRef="ide52f85dc07b4fe0b82c8b1da6c36f02_I20210401" decimals="2" name="vtrs:GoodwillImpairmentMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTYxNDk_9f470a54-b342-4af4-b0b4-fe4b63a2df92">15.0</ix:nonFraction>%. If all other assumptions are held constant, a reduction in the terminal value growth rate by <ix:nonFraction unitRef="number" contextRef="iae70f297cb494e99b52ef9e2d4abc258_I20210401" decimals="3" sign="-" name="vtrs:GoodwillImpairmentMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTYxNTY_d28df3e6-a60a-4843-accc-8ae517a67c5d">4.2</ix:nonFraction>% or an increase in discount rate by <ix:nonFraction unitRef="number" contextRef="i0d259dda285943ceaa0938936cf8aa47_I20210401" decimals="3" name="vtrs:GoodwillImpairmentMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTYxNjM_ded74d17-fd34-455b-b98b-e582d1b7a1c0">2.0</ix:nonFraction>% would result in an impairment charge for the JANZ reporting unit.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the inherent uncertainty involved in making these estimates, actual results could differ from those estimates. In addition, changes in underlying assumptions, especially as they relate to the key assumptions detailed, could have a significant impact on the fair value of the reporting units.</span></div><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3Xzc1NzQ_e06acd28-8796-4b0f-ab59-ff848518fb8b" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Intangible asset amortization expense for the years ending December&#160;31, 2022 through 2026 is estimated to be as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:88.782%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.018%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTozZmY0MWVjOWMxM2I0YTU5OWY2NjJjZWIyNTAzMWNmYS90YWJsZXJhbmdlOjNmZjQxZWM5YzEzYjRhNTk5ZjY2MmNlYjI1MDMxY2ZhXzEtMS0xLTEtMzE0MjI_312174c2-96db-40ba-9b76-60fa6a23ad85">2,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTozZmY0MWVjOWMxM2I0YTU5OWY2NjJjZWIyNTAzMWNmYS90YWJsZXJhbmdlOjNmZjQxZWM5YzEzYjRhNTk5ZjY2MmNlYjI1MDMxY2ZhXzItMS0xLTEtMzE0MjI_f5a920b6-0195-4b09-bb57-1c20cb6750a8">2,414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTozZmY0MWVjOWMxM2I0YTU5OWY2NjJjZWIyNTAzMWNmYS90YWJsZXJhbmdlOjNmZjQxZWM5YzEzYjRhNTk5ZjY2MmNlYjI1MDMxY2ZhXzMtMS0xLTEtMzE0MjI_87c50ef9-00cf-49b7-a7ad-66eb33e6297b">2,320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTozZmY0MWVjOWMxM2I0YTU5OWY2NjJjZWIyNTAzMWNmYS90YWJsZXJhbmdlOjNmZjQxZWM5YzEzYjRhNTk5ZjY2MmNlYjI1MDMxY2ZhXzQtMS0xLTEtMzE0MjI_7e807907-a0b2-46ca-907c-85202270dce7">2,222</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTozZmY0MWVjOWMxM2I0YTU5OWY2NjJjZWIyNTAzMWNmYS90YWJsZXJhbmdlOjNmZjQxZWM5YzEzYjRhNTk5ZjY2MmNlYjI1MDMxY2ZhXzUtMS0xLTEtMzE0MjI_c2c0d766-1b48-4dca-8c80-7bf91d8145f9">2,164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_202"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:FinancialInstrumentsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90ZXh0cmVnaW9uOmZmZGUwNDVjYjEzYjQ2YWQ5ZWE4Njk3OTNlZWQ1OTY3XzEyNTA3_06c93a23-319c-44ea-98dc-f9edf9c6a84f" continuedAt="iac303ad8ae7a4ec0b49bb5453a399623" escape="true">Financial Instruments and Risk Management</ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iac303ad8ae7a4ec0b49bb5453a399623" continuedAt="i231baecea45e44c88d73321a1246d86c">The Company is exposed to certain financial risks relating to its ongoing business operations. The primary financial risks that are managed by using derivative instruments are foreign currency risk and interest rate risk.</ix:continuation></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">106</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><ix:continuation id="i231baecea45e44c88d73321a1246d86c" continuedAt="idecb695bd5a44275a1e29f74b9413bf9"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Risk Management</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to manage certain foreign currency risks, the Company enters into foreign exchange forward contracts to mitigate risk associated with changes in spot exchange rates of mainly non-functional currency denominated assets or liabilities. The foreign exchange forward contracts are measured at fair value and reported as current assets or current liabilities in the consolidated balance sheets. Any gains or losses on the foreign exchange forward contracts are recognized in earnings in the period incurred in the consolidated statements of operations.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has also entered into forward contracts to hedge forecasted foreign currency denominated sales from certain international subsidiaries and a portion of forecasted intercompany inventory sales denominated in Euro, Japanese Yen and Chinese Renminbi for up to eighteen months. These contracts are designated as cash flow hedges to manage foreign currency transaction risk and are measured at fair value and reported as current assets or current liabilities in the consolidated balance sheets. Any changes in the fair value of designated cash flow hedges are deferred in AOCE and are reclassified into earnings when the hedged item impacts earnings.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Investment Hedges</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may hedge the foreign currency risk associated with certain net investment positions in foreign subsidiaries by either borrowing directly in foreign currencies and designating all or a portion of the foreign currency debt as a hedge of the applicable net investment position or entering into foreign currency swaps that are designated as hedges of net investments.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has designated certain Euro and Yen borrowings as a hedge of its investment in certain Euro-functional and Yen-functional currency subsidiaries in order to manage foreign currency translation risk. Borrowings designated as net investment hedges are marked-to-market using the current spot exchange rate as of the end of the period, with gains and losses included in the foreign currency translation component of AOCE until the sale or substantial liquidation of the underlying net investments. In addition, the Company manages the related foreign exchange risk of the Euro and Yen borrowings not designated as net investment hedges through certain Euro and Yen denominated financial assets and forward currency swaps. </span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the principal amounts of the Company&#8217;s outstanding Euro and Yen borrowings and the notional amounts of the Euro and Yen borrowings designated as net investment hedges:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:62.776%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.210%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount Designated as a Net Investment Hedge</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Principal Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Euro</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9a9dac0334bc477ea0a456bbe46c3173_I20211231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzMtMC0xLTEtMzY1NTYvdGV4dHJlZ2lvbjo1Y2MyMTg1NDA1NGU0ODFkYTE3ZjQ1NzdiMDQzZDhjNl80_8ae3d38a-f779-4705-8374-4082196e4a46">2.250</ix:nonFraction>% Euro Senior Notes due 2024</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8364;</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6259c702de2f4a35b534481f8d19ba9a_I20211231" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzMtMi0xLTEtMzY1NzA_9c07f22b-af27-4ddb-ac74-683f58857212">1,000.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8364;</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i6259c702de2f4a35b534481f8d19ba9a_I20211231" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzMtNC0xLTEtMzY1NzA_7b9ebd9b-e8d8-417f-9586-351b9c94d067">1,000.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8364;</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ib50d1f6af058476a9a20d36e4aeb1f1b_I20201231" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzMtNi0xLTEtMzY1NzA_80e26c9e-1f33-4ba6-8775-1a2c779d995b">1,000.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4e35649af2d149e5a110744b54afb44e_I20211231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzQtMC0xLTEtMzY1NTkvdGV4dHJlZ2lvbjowMzc3YjI4ZDMyYzI0ZmYxYjAyOWZlZTA1NDI0MWY3ZV80_b18df3d2-8e18-43ea-984b-c280040ebe15">3.125</ix:nonFraction>% Euro Senior Notes due 2028</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i65ebef80378f40ed961aba03c5a4b30c_I20211231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzQtMi0xLTEtMzY1NTk_218b2220-083d-4aa3-a7fe-7ae5ef00d4a1">750.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i65ebef80378f40ed961aba03c5a4b30c_I20211231" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzQtNC0xLTEtMzY1NTk_763087f2-e58e-40fc-a52a-33cad5f86b8f">750.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i8c0d6145de9e46a7aee08ead29783fcb_I20201231" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzQtNi0xLTEtMzY1NTk_ba298819-3221-4e72-b6b7-9a7e291814b5">750.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iea56cbd0617d400094855281cdd9e614_I20211231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzUtMC0xLTEtMzY1NjQvdGV4dHJlZ2lvbjo2ZDQ0NDliN2MyNWM0NjViYjYyODhmZDI1NDMwZGUwYV80_1ed194b5-5a8c-4532-9e57-dae164b8a336">2.125</ix:nonFraction>% Euro Senior Notes due 2025</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ifd922556c9674ce280730c7b73219cfa_I20211231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzUtMi0xLTEtMzY1NjQ_8bb6b46a-3ffd-4e88-92df-e6b15e64580b">500.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ifd922556c9674ce280730c7b73219cfa_I20211231" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzUtNC0xLTEtMzY1NjQ_66113583-6ebf-4fbc-b8ad-b71d39ec9d6a">500.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9dbb1d37817941cfb609b9b9279f1790_I20201231" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzUtNi0xLTEtMzY1NjQ_f4778459-7d58-421b-a317-104f3e6ed087">500.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib435a6d77cd34f869cedbd596bf31419_I20211231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzMtMC0xLTEtMzE0MjIvdGV4dHJlZ2lvbjphZjJkZjZkZjk3YzQ0YjZiYTY1YTU2MzE3YmY1ZTBmZl80_544f2cb7-4cd0-41c0-9e8b-e8b1173a3fb3">0.816</ix:nonFraction>% Euro Senior Notes due 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i55b472eecaf147e68499e6e2321e7f65_I20211231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzMtMi0xLTEtMzE0MjI_391839eb-2828-41a8-b704-be15386bd39f">750.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i55b472eecaf147e68499e6e2321e7f65_I20211231" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzMtNC0xLTEtMzE0MjI_eb09059d-fb88-4dc9-b075-d20b7d8e1e2d">750.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i90dc4ad103024e6ea6ce10f50ae8d262_I20201231" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzMtNi0xLTEtMzE0MjI_1ad80f16-ad9b-47cb-8a25-f7b024293f4f">750.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i17b748819db1409f90ab44c1656a6844_I20211231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzUtMC0xLTEtMzE0MjIvdGV4dHJlZ2lvbjowMzdlY2Q0YTA0ZGQ0MjdiYmM2NWE0MjAzOGQzNTM2OV80_1cf28c8b-38ba-46c5-9232-a7b529fdb96f">1.023</ix:nonFraction>% Euro Senior Notes due 2024</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie0df9f683c964ad68f7f6e10a639905c_I20211231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzUtMi0xLTEtMzE0MjI_d2842b8a-bbe8-4bb4-a5c5-436f54015f61">750.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie0df9f683c964ad68f7f6e10a639905c_I20211231" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzUtNC0xLTEtMzE0MjI_27732d94-9855-4feb-a67f-594e2fa36b13">750.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i44be44738c944446a28c9e1a66f849ae_I20201231" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzUtNi0xLTEtMzE0MjI_c4d6c161-6ad6-46c0-8852-b7d5bfe75b6a">750.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iae4433500527462f9a53c262b4a193e2_I20211231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzctMC0xLTEtMzE0MjIvdGV4dHJlZ2lvbjpiNWM5Mzk4NGVhZjU0ZjNmYjhiY2JmOTU1NmZjMjYxN180_b45e55fb-405e-4f27-95c6-c1c328550fcf">1.362</ix:nonFraction>% Euro Senior Notes due 2027</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i15c58cf1262f420e80cbba022d020953_I20211231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzctMi0xLTEtMzE0MjI_7cc03649-ab65-4fe2-af6e-034f51ba848a">850.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i15c58cf1262f420e80cbba022d020953_I20211231" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzctNC0xLTEtMzE0MjI_546b2511-ff12-47c8-b288-792d0b610651">850.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i001cf1788fa14d23b2b35d333f8e42c9_I20201231" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzctNi0xLTEtMzE0MjI_e29f482b-4d14-4f19-b09e-86ecdf1b2e7e">850.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if487c6ee083b40a88448340cd281fb87_I20211231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzktMC0xLTEtMzE0MjIvdGV4dHJlZ2lvbjphOTFlMWZiNzg0YzM0YjFmODhiNzkzZjIyN2Y5MTM1MF80_69afbe02-9255-4cac-90e3-62e5fd034b56">1.908</ix:nonFraction>% Euro Senior Notes due 2032</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if483dc28a41d4a0fa6122644fd1ff629_I20211231" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzktMi0xLTEtMzE0MjI_fc3b20a6-58e1-431d-b54d-32eb059ce7dc">1,250.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="if483dc28a41d4a0fa6122644fd1ff629_I20211231" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzktNC0xLTEtMzE0MjI_ccdf9f6c-0c85-495b-a643-05aef9aded6b">1,250.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i738291780fb644b188734a680f12c170_I20201231" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzktNi0xLTEtMzE0MjI_b4c14d6f-08b1-457a-b912-d5a66b155956">1,250.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3f150c27f3c842779f26851f4cf85e68_I20211231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzEwLTItMS0xLTMxNDIy_33493137-2749-4d3e-adb2-5d401ddcf125">105.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i3f150c27f3c842779f26851f4cf85e68_I20211231" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzEwLTQtMS0xLTMxNDIy_3a931f20-159f-4be7-ad84-f877f569d6d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="iaea18053fed0452db5be6e9583326824_I20201231" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzEwLTYtMS0xLTMxNDIy_a662a4f3-becf-476f-aa80-0edd6c7c0b9a">105.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8364;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibef3bf81fb8c41a7a5b434d67be2e8f6_I20211231" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzExLTItMS0xLTMxNDIy_b51d44cd-f690-4da2-a540-e181e17fac9c">5,955.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8364;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ibef3bf81fb8c41a7a5b434d67be2e8f6_I20211231" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzExLTQtMS0xLTMxNDIy_c5aabee6-c109-48a5-8d3c-446628cc9013">5,850.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8364;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i05cbcb5d225f4a1e8421221f4405ebae_I20201231" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzExLTYtMS0xLTMxNDIy_18fe0875-e19b-46c0-bf32-f1cb9847c714">5,955.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Yen</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">YEN Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#165;</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="jpy" contextRef="i203444b86c864e92be2fd1ad7307b680_I20211231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzE0LTItMS0xLTM2NjE4_e7a56e76-3d49-46db-8fc5-0cb5703770ac">40,000.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#165;</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="jpy" contextRef="i203444b86c864e92be2fd1ad7307b680_I20211231" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzE0LTQtMS0xLTM2NjI0_9e4e6449-ed74-4f74-9486-c5edc231d9ca">40,000.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#165;</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="jpy" contextRef="ifa97038cc597436695cbf1346cc9a0ab_I20201231" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzE0LTYtMS0xLTM2NjMw_075c89e1-9c1b-4896-9ab8-acdb124c48b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yen Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#165;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="jpy" contextRef="ibef3bf81fb8c41a7a5b434d67be2e8f6_I20211231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzE1LTItMS0xLTM2NjE4_82e72c60-5d1d-41df-a3bb-177e458f396f">40,000.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#165;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="jpy" contextRef="ibef3bf81fb8c41a7a5b434d67be2e8f6_I20211231" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzE1LTQtMS0xLTM2NjI0_f4555a98-58d4-42a4-aea4-a303fbb65c3a">40,000.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#165;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="jpy" contextRef="i05cbcb5d225f4a1e8421221f4405ebae_I20201231" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzE1LTYtMS0xLTM2NjMw_8fb7af8a-eb34-4d3d-8626-4b3017be7a46">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31,2021, the principal amount of the Company&#8217;s outstanding Yen borrowings and the notional amount of the Yen borrowings designated as net investment hedge was $<ix:nonFraction unitRef="usd" contextRef="ie77d3b2d673e467fbbf3c091f8ded489_I20211231" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90ZXh0cmVnaW9uOmZmZGUwNDVjYjEzYjQ2YWQ5ZWE4Njk3OTNlZWQ1OTY3XzEwOTk1MTE2NDI0MDk_804834a6-8681-4fd5-a3aa-2b62b309302b">347.6</ix:nonFraction>&#160;million.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><ix:continuation id="idecb695bd5a44275a1e29f74b9413bf9" continuedAt="i79059d5efa6842aeba105da16e445dd5"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk Management</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into interest rate swaps from time to time in order to manage interest rate risk associated with the Company&#8217;s fixed-rate and floating-rate debt. Interest rate swaps that meet specific accounting criteria are accounted for as fair value or cash flow hedges. All derivative instruments used to manage interest rate risk are measured at fair value and reported as current assets or current liabilities in the consolidated balance sheets. For fair value hedges, the changes in the fair value of both the hedging instrument and the underlying debt obligations are included in interest expense. For cash flow hedges, the change in fair value of the hedging instrument is deferred through AOCE and is reclassified into earnings when the hedged item impacts earnings.</span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flow Hedging Relationships</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s interest rate swaps designated as cash flow hedges fix the interest rate on a portion of the Company&#8217;s variable-rate debt or hedge part of the Company&#8217;s interest rate exposure associated with the variability in the future cash flows attributable to changes in interest rates. Any changes in fair value are included in earnings or deferred through AOCE, depending on the nature and effectiveness of the offset. Any ineffectiveness in a cash flow hedging relationship is recognized immediately in earnings in the consolidated statements of operations. </span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Hedging Relationships</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's interest rate swaps designated as fair value hedges convert the fixed rate on a portion of the Company's fixed-rate senior notes to a variable rate. Any changes in the fair value of these derivative instruments, as well as the offsetting change in fair value of the portion of the fixed-rate debt being hedged, is included in interest expense. The Company&#8217;s fair value hedge was terminated during 2020.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Risk Management</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company regularly reviews the creditworthiness of its financial counterparties and does not expect to incur a significant loss from the failure of any counterparties to perform under any agreements. The Company is not subject to any obligations to post collateral under derivative instrument contracts. Certain derivative instrument contracts entered into by the Company are governed by master agreements, which contain credit-risk-related contingent features that would allow the counterparties to terminate the contracts early and request immediate payment should the Company trigger an event of default on other specified borrowings. The Company records all derivative instruments on a gross basis in the consolidated balance sheets. Accordingly, there are no offsetting amounts that net assets against liabilities. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the classification and fair values of derivative instruments in our consolidated balance sheets:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.116%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset Derivatives </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability Derivatives</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021 Fair Value</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020 Fair Value</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021 Fair Value</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020 Fair Value</span></td></tr><tr style="height:15pt"><td colspan="24" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses &amp; other current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ab96945884b453e862399993bf9898b_I20211231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo5YTk5ZGM0MjE0MTg0YTc1OWZiZjQyOTFjODA0YWI2Yi90YWJsZXJhbmdlOjlhOTlkYzQyMTQxODRhNzU5ZmJmNDI5MWM4MDRhYjZiXzUtMi0xLTEtMzY3MDQ_cc134bb8-e881-492e-91a4-6e2cca7a03ae">62.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4da71023bae940f99c4faea351670e06_I20201231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo5YTk5ZGM0MjE0MTg0YTc1OWZiZjQyOTFjODA0YWI2Yi90YWJsZXJhbmdlOjlhOTlkYzQyMTQxODRhNzU5ZmJmNDI5MWM4MDRhYjZiXzUtMy0xLTEtMzY3MDQ_f097c370-bc64-4aae-a0e4-83f4f023f4b4">28.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ad6012a5fa43a49ad0a2980a19ddb3_I20211231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo5YTk5ZGM0MjE0MTg0YTc1OWZiZjQyOTFjODA0YWI2Yi90YWJsZXJhbmdlOjlhOTlkYzQyMTQxODRhNzU5ZmJmNDI5MWM4MDRhYjZiXzUtNi0xLTEtMzY3MDQ_a127e821-4b16-4f40-a9b1-7aa953d48743">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf29789408364be881b52abb508e5de3_I20201231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo5YTk5ZGM0MjE0MTg0YTc1OWZiZjQyOTFjODA0YWI2Yi90YWJsZXJhbmdlOjlhOTlkYzQyMTQxODRhNzU5ZmJmNDI5MWM4MDRhYjZiXzUtNy0xLTEtMzY3MDQ_c043f2f3-cb38-4100-bcf2-ade448b18093">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total derivatives designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2274eaab76e54e488ce05bb95778a8cd_I20211231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo5YTk5ZGM0MjE0MTg0YTc1OWZiZjQyOTFjODA0YWI2Yi90YWJsZXJhbmdlOjlhOTlkYzQyMTQxODRhNzU5ZmJmNDI5MWM4MDRhYjZiXzYtMi0xLTEtMzY3MDQ_687f2c04-7fb6-4331-a87e-bc7691f3bc84">62.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42eae6da7fc24ce694d83020bfe37e2b_I20201231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo5YTk5ZGM0MjE0MTg0YTc1OWZiZjQyOTFjODA0YWI2Yi90YWJsZXJhbmdlOjlhOTlkYzQyMTQxODRhNzU5ZmJmNDI5MWM4MDRhYjZiXzYtMy0xLTEtMzY3MDQ_35c5c3c5-fd19-43f5-9a44-0051c498a569">28.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives not designated as hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses &amp; other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf8418c5909549baad168bf445e46d9a_I20211231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo5YTk5ZGM0MjE0MTg0YTc1OWZiZjQyOTFjODA0YWI2Yi90YWJsZXJhbmdlOjlhOTlkYzQyMTQxODRhNzU5ZmJmNDI5MWM4MDRhYjZiXzgtMi0xLTEtMzY3MDQ_e1e25449-d414-45c5-87db-35d78c9a43b4">82.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6a61ecb28ac40db9a5d31a3a4ad8e76_I20201231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo5YTk5ZGM0MjE0MTg0YTc1OWZiZjQyOTFjODA0YWI2Yi90YWJsZXJhbmdlOjlhOTlkYzQyMTQxODRhNzU5ZmJmNDI5MWM4MDRhYjZiXzgtMy0xLTEtMzY3MDQ_002a3639-778e-4e5e-82b0-bd2ce8cb337a">90.3</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f884def881b445f90dd9534fe3fb188_I20211231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo5YTk5ZGM0MjE0MTg0YTc1OWZiZjQyOTFjODA0YWI2Yi90YWJsZXJhbmdlOjlhOTlkYzQyMTQxODRhNzU5ZmJmNDI5MWM4MDRhYjZiXzgtNi0xLTEtMzY3MDQ_bfcba6fb-d409-43a2-bbed-57f8c07c61a9">56.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7327d7b6283478083ef6d071f79ff32_I20201231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo5YTk5ZGM0MjE0MTg0YTc1OWZiZjQyOTFjODA0YWI2Yi90YWJsZXJhbmdlOjlhOTlkYzQyMTQxODRhNzU5ZmJmNDI5MWM4MDRhYjZiXzgtNy0xLTEtMzY3MDQ_5fb6b7d7-3b92-4651-990d-1cfdc3bbdd71">102.8</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total derivatives not designated as hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e4405916ad540b9a7f953c2af935d2a_I20211231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo5YTk5ZGM0MjE0MTg0YTc1OWZiZjQyOTFjODA0YWI2Yi90YWJsZXJhbmdlOjlhOTlkYzQyMTQxODRhNzU5ZmJmNDI5MWM4MDRhYjZiXzktMi0xLTEtMzY3MDQ_564466c6-dc31-4481-9668-625b30c93741">82.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i481467d95c4545e5bb497389f9859d4c_I20201231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo5YTk5ZGM0MjE0MTg0YTc1OWZiZjQyOTFjODA0YWI2Yi90YWJsZXJhbmdlOjlhOTlkYzQyMTQxODRhNzU5ZmJmNDI5MWM4MDRhYjZiXzktMy0xLTEtMzY3MDQ_5ba310b1-2709-49ea-80c9-30fbb1a1ed52">90.3</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e4405916ad540b9a7f953c2af935d2a_I20211231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo5YTk5ZGM0MjE0MTg0YTc1OWZiZjQyOTFjODA0YWI2Yi90YWJsZXJhbmdlOjlhOTlkYzQyMTQxODRhNzU5ZmJmNDI5MWM4MDRhYjZiXzktNi0xLTEtMzY3MDQ_06e3a398-9f36-46d7-8a3f-381ba0fd513f">56.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i481467d95c4545e5bb497389f9859d4c_I20201231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo5YTk5ZGM0MjE0MTg0YTc1OWZiZjQyOTFjODA0YWI2Yi90YWJsZXJhbmdlOjlhOTlkYzQyMTQxODRhNzU5ZmJmNDI5MWM4MDRhYjZiXzktNy0xLTEtMzY3MDQ_c465a4d2-b30a-470f-8667-5988c83b91ce">102.8</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total derivatives </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo5YTk5ZGM0MjE0MTg0YTc1OWZiZjQyOTFjODA0YWI2Yi90YWJsZXJhbmdlOjlhOTlkYzQyMTQxODRhNzU5ZmJmNDI5MWM4MDRhYjZiXzEwLTItMS0xLTM2NzA0_9ed51bef-4fcb-4651-8fb3-f5e058187158">144.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo5YTk5ZGM0MjE0MTg0YTc1OWZiZjQyOTFjODA0YWI2Yi90YWJsZXJhbmdlOjlhOTlkYzQyMTQxODRhNzU5ZmJmNDI5MWM4MDRhYjZiXzEwLTMtMS0xLTM2NzA0_87e171c0-946d-44b9-9483-bc4b1d89b20f">118.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo5YTk5ZGM0MjE0MTg0YTc1OWZiZjQyOTFjODA0YWI2Yi90YWJsZXJhbmdlOjlhOTlkYzQyMTQxODRhNzU5ZmJmNDI5MWM4MDRhYjZiXzEwLTYtMS0xLTM2NzA0_39460e51-645d-49a3-b4e9-57651642895d">61.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo5YTk5ZGM0MjE0MTg0YTc1OWZiZjQyOTFjODA0YWI2Yi90YWJsZXJhbmdlOjlhOTlkYzQyMTQxODRhNzU5ZmJmNDI5MWM4MDRhYjZiXzEwLTctMS0xLTM2NzA0_3d143e0c-2e91-48cb-a5d3-e4b082592b62">103.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">108</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="text-indent:36pt"><span><br/></span></div><ix:continuation id="i79059d5efa6842aeba105da16e445dd5" continuedAt="iebeb79298b0d48c59d3ef15cb19fca5c"><ix:nonNumeric contextRef="ibbe7edb935be4af4a3721e260440024e_D20210101-20211231" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90ZXh0cmVnaW9uOmZmZGUwNDVjYjEzYjQ2YWQ5ZWE4Njk3OTNlZWQ1OTY3XzEyNDM5_6024932f-c710-4b5c-aa6b-d37b0463d00a" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize information about the gains/(losses) incurred to hedge or offset operational foreign exchange or interest rate risk:</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.738%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.819%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.414%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.417%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gains/(Losses) Recognized in Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain Excluded from the Assessment of Hedge Effectiveness</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain/(Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivative Financial Instruments in Fair Value Hedge Relationships </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> :</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if732b369611b40bcad116753c69a9845_D20210101-20211231" decimals="-5" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzQtMi0xLTEtMzY3MDg_54cdd19b-2204-49f9-9593-03cdd32523c3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25fbe74eb4264d7daff50e624f791260_D20200101-20201231" decimals="-5" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzQtMy0xLTEtMzY3MDg_a7fa1c21-9cce-483b-bc00-9eb11cbc6759">22.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2629746dda6747b385fc80d8be9b7149_D20190101-20191231" decimals="-5" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzQtNS0xLTEtMzk5MzQ_9c38c3af-f52d-4d02-a4ac-8b2aa8c8dcb6">18.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 Senior Notes (3.125% coupon)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e1bb69f19ec4a6298efcee5d069b518_D20210101-20211231" decimals="-5" name="us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzUtMi0xLTEtMzY3MDg_db8ca472-1492-4762-9448-f71daade97ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f9bb026157949c78212217fe9b44bb4_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzUtMy0xLTEtMzY3MDg_17a15d59-82e0-4422-aa16-67d6ca53a0ff">22.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i56846d199ffb4f219d37ebf51599c34f_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzUtNS0xLTEtMzk5NDA_f559896e-4b2a-48a9-b350-1890e7f810fe">18.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivative Financial Instruments in Cash Flow Hedging Relationships</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8d0d63150a443a9a2d4e20b655c9e2f_D20210101-20211231" decimals="-5" name="us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzctNy0xLTEtNDAwMDc_7be552b9-8620-4698-a39b-98bf79053541">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6faa273322f64371a812153577418b44_D20200101-20201231" decimals="-5" name="us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzctOC0xLTEtNDAwMDk_5f7a7fe7-7d72-4d30-98d6-fd0310cf748b">7.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9654acb9de7d4ca493374d0d74ccd282_D20190101-20191231" decimals="-5" name="us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzctOS0xLTEtNDAwMTE_4533e585-17fd-4d70-a51a-b77d4e69b240">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivative Financial Instruments Not Designated as Hedging Instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option and forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80c54ac8020646d2ab7569f426de2da7_D20210101-20211231" decimals="-5" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzEyLTItMS0xLTM2NzA4_ca814d2d-970b-4fdf-8f9e-54abb0c73f4d">39.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if06aa643a0dd4bd7a0bb9445a80b41e1_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzEyLTMtMS0xLTM2NzA4_18e29964-c3c7-489f-9b5a-f7f1060651e8">10.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i237668ce34d742348fc490c31a89179a_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzktNS0xLTEtNDAwMjQ_fa550e1e-abb5-456b-aca2-07590436786d">17.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzEwLTMtMS0xLTQwMDMx_446cf192-20dd-4577-a5a1-2b72e3b489fa">39.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzEwLTQtMS0xLTQwMDMz_25c02b7a-695f-41bd-8b8d-289b02dae94a">10.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzEwLTUtMS0xLTQwMDM1_88269c7b-b890-4419-91ed-9d43d2846bda">17.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8d0d63150a443a9a2d4e20b655c9e2f_D20210101-20211231" decimals="-5" name="us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzEwLTctMS0xLTQwMDQz_ee3b5318-8eb6-4d35-9520-737a98022837">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6faa273322f64371a812153577418b44_D20200101-20201231" decimals="-5" name="us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzEwLTgtMS0xLTQwMDQz_75b47e3f-93cf-44ae-91d7-64dd9c2205ea">7.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9654acb9de7d4ca493374d0d74ccd282_D20190101-20191231" decimals="-5" name="us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzEwLTktMS0xLTQwMDQz_5c4bfad0-43ef-40b7-b56c-e2b09727431a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gains/(Losses) Recognized in AOCE (Net of Tax) on Derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gains/(Losses) Reclassified from AOCE into Earnings</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain/(Loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivative Financial Instruments in Cash Flow Hedging Relationships </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5eac979dacba469ba19bc637404defc4_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzE2LTMtMS0xLTM5OTcz_ecd39cbe-b8d6-44bc-a3af-55267c3c6149">45.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fad0ea862684b18988c02daa98065dc_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzE2LTQtMS0xLTM5OTc1_b6115cf1-047f-4201-b2b1-ad1cc909fa28">20.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8efba978bebc47919ee66621c13ee179_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzE2LTUtMS0xLTM5OTc3_d5d2f569-d5d3-43a0-88a9-1767f2aa0692">16.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3ebbb8721854743a8cb2b760433c11e_D20210101-20211231" decimals="-5" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzE2LTctMS0xLTM5OTg4_859f703b-2f3d-484f-ad2a-8d5d005a1559">30.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9ae6a7ac5cd4083b3bdd4eeba1b2668_D20200101-20201231" decimals="-5" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzE2LTgtMS0xLTM5OTkw_d809aeef-442d-4a87-ac46-875931e3130e">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i32ea16aa6d414c73a3f0814961d0178d_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzE2LTktMS0xLTM5OTky_7192f4f2-fd30-447d-8f97-b081f69cec7e">0.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6ef68015996425387540c85e3abd584_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzE3LTMtMS0xLTM5OTc5_ed85f839-da45-4b57-9d7b-041acf5ec25c">3.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51898b0e23db4285b98783fe25f8e36f_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzE3LTQtMS0xLTM5OTgx_d98ca3b1-0d23-4897-9562-ea5a6524b0bf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46a7b47f4bfd48e38e1a40a09cc02687_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzE3LTUtMS0xLTM5OTgz_85e97517-6730-4a3b-a0c5-491c792120fe">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib281974ea08948ca9b385c9fbf70eb76_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzE3LTctMS0xLTM5OTk5_ade0bdd3-0bb2-4771-8812-2f837d5f981a">4.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61adc213c3bb41c1b79b08b95374ec05_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzE3LTgtMS0xLTQwMDAx_aab7678b-61b6-4ebf-bc6c-e4b7dcacbfff">4.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i50e722bd905e484a9e5b58ca42df1a48_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzE3LTktMS0xLTUyMzY3_934be23f-f386-4e63-a27c-2205fce9aa59">7.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivative Financial Instruments in Net Investment Hedging Relationships:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency borrowings and forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie86e478f62084256bbe03e843d36bfd4_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzE5LTMtMS0xLTM5OTUx_861e0e30-d925-473d-8bb5-cf6082886b6b">436.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if871dc9d84a946f19d267f938caa03bb_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzE5LTQtMS0xLTM5OTUz_b19252ae-f992-4759-87fc-65a32517e360">346.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5b711af87d47b4909f4910be28f8fd_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzE5LTUtMS0xLTM5OTU1_25e69ec8-ee5e-4f92-a0f5-4e7b07d7fff1">56.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzIwLTMtMS0xLTQwMDM3_f4fe5eb1-cd26-499a-9554-303679a7c37f">479.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzIwLTQtMS0xLTQwMDM5_d0348726-ec1a-426b-a409-b9c551c74837">325.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzIwLTUtMS0xLTQwMDQx_2dfdfa43-cb23-4fad-a319-74651ed9ba68">76.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzIwLTctMS0xLTQwMDQ1_6f842bbf-83b4-44da-b583-d07c9ef8f4bb">26.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzIwLTgtMS0xLTQwMDQ3_1dc0c15e-7aa4-45e5-8745-0cba8ad8ab3e">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzIwLTktMS0xLTQwMDQ5_1fe6a4fc-d2a2-4b98-adc3-22405afa3d30">7.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">In the first quarter of 2020, the Company terminated interest rate swaps designated as a fair value hedge resulting in net proceeds of approximately $45 million. The amount included in the above tables represents the fair value adjustment recognized at the date the interest rate swaps were settled. </span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">At December&#160;31, 2021, the Company expects that approximately $<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-6" name="us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90ZXh0cmVnaW9uOmZmZGUwNDVjYjEzYjQ2YWQ5ZWE4Njk3OTNlZWQ1OTY3XzEwOTk1MTE2NDUyOTY_94fcf5bf-3e7c-4ba3-8fab-baadd2c7b558">21.0</ix:nonFraction> million of pre-tax net gains on cash flow hedges will be reclassified from AOCE into earnings during the next twelve months.</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Represents the location of the gain/(loss) recognized in earnings on derivatives.</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Represents the location of the gain/(loss) reclassified from AOCE into earnings.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Represents the location of the gain excluded from the assessment of hedge effectiveness.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement</span></div><ix:continuation id="i47793f87eb9d4267b6be83fc5aa03e83" continuedAt="ic11e20c3fb5b4f78a443880de484ce90"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is based on the price that would be received from the sale of an identical asset or paid to transfer an identical liability in an orderly transaction between market participants at the measurement date. In order to increase consistency and comparability in fair value measurements, a fair value hierarchy has been established that prioritizes observable and unobservable inputs used to measure fair value into three broad levels, which are described below:</span></div><div style="margin-bottom:6pt;padding-left:81pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level&#160;1:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities. The fair value hierarchy gives the highest priority to Level&#160;1 inputs.</span></div><div style="margin-bottom:6pt;padding-left:81pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level&#160;2:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Observable market-based inputs other than quoted prices in active markets for identical assets or liabilities.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">109</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><ix:continuation id="iebeb79298b0d48c59d3ef15cb19fca5c" continuedAt="ice0ac16770e34424b29ace2f67c1a264"><div style="margin-bottom:12pt;padding-left:81pt;text-indent:-45pt"><ix:continuation id="ic11e20c3fb5b4f78a443880de484ce90" continuedAt="i6fc6c531db5c4bfdb75c4c4d970e227d"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level&#160;3:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level&#160;3 inputs.</span></ix:continuation></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i6fc6c531db5c4bfdb75c4c4d970e227d">In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible, as well as considers counterparty credit risk in its assessment of fair value</ix:continuation>.</span></div><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90ZXh0cmVnaW9uOmZmZGUwNDVjYjEzYjQ2YWQ5ZWE4Njk3OTNlZWQ1OTY3XzEyNTMy_135b956c-491e-4e44-82f0-a7eb77738097" continuedAt="idd29e5f5182b4d4cb857ae28bb7847ad" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities carried at fair value are classified in the tables below in one of the three categories described above:</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:57.465%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.712%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Recurring fair value measurements</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="24" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd50cfa1e1e34150bb7e6bf364a6cf02_I20211231" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzUtMS0xLTEtMzE0MjI_17758c4c-cb9d-4d92-9ae8-e7f0df35237f">50.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f1f3ba4d1c44a5ea869a805433ebbbc_I20211231" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzUtNy0xLTEtMzE0MjI_d11939d1-9600-4897-966f-73e88fdb380a">50.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcaff92c9304ccca2976819941da18b_I20211231" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzYtMS0xLTEtMzE0MjI_e4d23585-957d-4291-bd99-f5ae9e5450d1">50.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzYtNy0xLTEtMzE0MjI_0c3dc327-1181-43d1-947d-08f6f85b531c">50.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange traded funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5387ecd95f1b4b21af4525dd7eb447b8_I20211231" decimals="-5" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzgtMS0xLTEtMzE0MjI_cc8abe94-7697-44fd-aac9-1d9a59ade9a7">50.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fafcde031c3487c96b095c7e9b1a4b7_I20211231" decimals="-5" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzgtNy0xLTEtMzE0MjI_116b3d2c-b046-4398-87ee-635944151c31">50.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbc15c77f512432996fe6c2792f89851_I20211231" decimals="-5" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzktMS0xLTEtMzE0MjI_64b5647c-464b-4d85-ab1a-91abb69b8563">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef24702815341caa5d222e324cde377_I20211231" decimals="-5" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzktNy0xLTEtMzE0MjI_6d92dcc3-8846-411a-bef6-87e7caa9a44f">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcaff92c9304ccca2976819941da18b_I20211231" decimals="-5" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzEwLTEtMS0xLTMxNDIy_449994c2-27d6-4f09-bc50-6f0d841115db">51.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzEwLTctMS0xLTMxNDIy_bf938a30-8572-4bda-9a62-b718a9db7cf8">51.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale fixed income investments:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ee5436ebc91401299dbc66fb31d1ba1_I20211231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzEyLTMtMS0xLTMxNDIy_d359bd63-27c0-4c30-b6e5-fcf581094c44">16.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93a9254901ed49de952eda7653f907ac_I20211231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzEyLTctMS0xLTMxNDIy_f02641eb-efb7-490e-be74-a5588439845f">16.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasuries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21551c21cb5b4b48afb8bf862247798d_I20211231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzEzLTMtMS0xLTMxNDIy_a128921a-701f-4ccd-88b3-39ee4e59dba4">14.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fde47ed57994e7aa756ac70c39cbf8d_I20211231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzEzLTctMS0xLTMxNDIy_1ece020b-1ca5-4711-8b52-1cc9c7a6e9c4">14.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib97e2eb7978744c19ab31e5a8376b5a1_I20211231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzE0LTMtMS0xLTMxNDIy_f7f30c56-27ee-4725-aad5-43a80706f4a1">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18a3ddb5107448a099979738cf774b3f_I20211231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzE0LTctMS0xLTMxNDIy_a2dbdea5-45f0-4a6a-8595-ec03d31c6d47">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa7cf902531e404f8bad7f6968475c58_I20211231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzE1LTMtMS0xLTMxNDIy_be86e9d9-996b-42e2-8ac5-c8e1137ee0f4">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8966d648d0f54ce1b447b567d34e2402_I20211231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzE1LTctMS0xLTMxNDIy_7b9781fd-335b-4426-9ef5-7443e702f1a9">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5981a6477d5e43cd8437a6506268400c_I20211231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzE2LTMtMS0xLTMxNDIy_07e8830d-afa1-43d9-ac70-1337398dd624">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32084c41b5404f8390dcf56f0215f989_I20211231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzE2LTctMS0xLTMxNDIy_863e3f98-021b-49bc-a70e-a45c8cd0dbd7">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale fixed income investments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i858b714a7a1546fa86606e2c701719ee_I20211231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzE3LTMtMS0xLTMxNDIy_3e184767-8bb9-4494-acf4-e32b540058ce">38.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf0a8e4e52d64933bcd2cc97aa5788fe_I20211231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzE3LTctMS0xLTMxNDIy_da040f9b-4b8f-431a-9c4f-c7eab1712115">38.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange derivative assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i329520eeb0a04b5bad45f6974d90de1a_I20211231" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzE4LTMtMS0xLTMxNDIy_6eb7db22-6a8a-460c-835b-058a1750e3ff">144.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if095f8bb1f1b41eab2ce30dfe31f5273_I20211231" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzE4LTctMS0xLTMxNDIy_450bf069-7b46-4e73-bebc-dba4b9b96e2b">144.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at recurring fair value measurement</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcaff92c9304ccca2976819941da18b_I20211231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzIwLTEtMS0xLTMxNDIy_2e8db5b9-b4ce-4dab-9786-aef983a2e987">101.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie24e749ab05a4833892ad719d96c300b_I20211231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzIwLTMtMS0xLTMxNDIy_b94a7e1b-1d2d-4b0e-ab55-3c9c1bfef857">182.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzIwLTctMS0xLTMxNDIy_3876375e-43c8-47d2-ae2d-b5140776b8ef">284.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="24" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange derivative liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd4f324d5afb475e82b0026903ef73a7_I20211231" decimals="-5" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzIyLTMtMS0xLTMxNDIy_6ba7cdf1-e5a1-477d-bdcd-f9419bc61def">61.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1ad37b49c494d5c8be906abfac6dc4c_I20211231" decimals="-5" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzIyLTctMS0xLTMxNDIy_3f3a97e1-4774-4357-b6f7-953363eded9a">61.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if24b49e0068e4eb481af75b6062f9456_I20211231" decimals="-5" name="us-gaap:OtherLiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzIzLTUtMS0xLTMxNDIy_14fae5f8-e648-495d-b743-1cad9da71be9">199.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i288c304410434dbe813214bf4eef76f1_I20211231" decimals="-5" name="us-gaap:OtherLiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzIzLTctMS0xLTMxNDIy_52d725aa-d2de-4367-be11-41846bbbe842">199.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities at recurring fair value measurement</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie24e749ab05a4833892ad719d96c300b_I20211231" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzI0LTMtMS0xLTMxNDIy_54ad51d4-c8b2-4ca6-890d-0a0142d44adb">61.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42e5f527f22943e5b9d7a7a7685c1fba_I20211231" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzI0LTUtMS0xLTMxNDIy_aaff1fbe-61ef-418a-8edb-4ffb2bac0893">199.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzI0LTctMS0xLTMxNDIy_2ba90504-8d65-4713-9a8c-1f486d2e9c6f">260.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">110</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><ix:continuation id="ice0ac16770e34424b29ace2f67c1a264" continuedAt="ib219abd59fdd47f0805312c4453200d6"><div style="margin-bottom:12pt"><ix:continuation id="idd29e5f5182b4d4cb857ae28bb7847ad"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:57.465%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.712%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Recurring fair value measurements</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="24" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i997a640a9bd547beaed71dc4ba211d11_I20201231" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzUtMS0xLTEtMzE0MjI_c585fcfc-923b-43ad-ac97-7c074a990ef8">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c903b289b914375b5edd04b08ed0db1_I20201231" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzUtNy0xLTEtMzE0MjI_af114d7d-a97b-4bb6-ac16-d279ffaf7684">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb3ec9725b8947ae894c70cb9fb96fc0_I20201231" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzYtMS0xLTEtMzE0MjI_e4ac8924-6beb-467c-8007-93faf8fc6e2a">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzYtNy0xLTEtMzE0MjI_48914118-7438-4d83-90a0-7e8f8e039320">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange traded funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaee0ac5194a4c1491943ee3a6348a76_I20201231" decimals="-5" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzgtMS0xLTEtMzE0MjI_d764aa50-0711-4c0a-916c-25610e595e9b">45.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice252435f6954b3dafd70d47c4bfa455_I20201231" decimals="-5" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzgtNy0xLTEtMzE0MjI_eb84fdfa-5e8e-4477-aa6f-b7e15b4671bc">45.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fa346806c0a487197a11cf349c436db_I20201231" decimals="-5" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzktMS0xLTEtMzE0MjI_729c386a-7407-48db-a831-7b110e48af30">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic423a7424c864666be50a0a4f390acc3_I20201231" decimals="-5" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzktNy0xLTEtMzE0MjI_58e67204-d5ee-4cac-9ba7-6f834983af14">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie58356c472ef49b48d4e2508fa52d3b6_I20201231" decimals="-5" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzEwLTEtMS0xLTMxNDIy_a752e0ef-4cd4-4254-b0bf-495e5b1c666f">45.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3f56b439929457fba15cc320189f428_I20201231" decimals="-5" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzEwLTctMS0xLTMxNDIy_98390d01-3ec5-42b9-aa1f-1d317db65c87">45.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale fixed income investments:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb52f941e1874849b1e0f0c993cf6266_I20201231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzEyLTMtMS0xLTMxNDIy_ddcaf334-cc78-464d-9734-ce902aaa8829">17.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa911871a605402e901504a7b4ac61d7_I20201231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzEyLTctMS0xLTMxNDIy_6a4286a7-a88c-451d-b80d-cbdf8db6d52e">17.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasuries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76e72c40fc9145b7a9caf8a61f156082_I20201231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzEzLTMtMS0xLTMxNDIy_edd3eba5-43ad-4323-bc5f-790c7d08f7b9">14.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35168e44d21d481481a247e34dfc73e0_I20201231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzEzLTctMS0xLTMxNDIy_92174277-0182-471c-bbb8-2b273ba50334">14.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57fa96c988344f0e818a196d4896959e_I20201231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzE0LTMtMS0xLTMxNDIy_58651571-a935-49fd-838a-b8e9a7ff0e56">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b458f3612f1402784b53aeac8a369dc_I20201231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzE0LTctMS0xLTMxNDIy_5ab0ab17-d2bf-4e26-b9f6-7b624ac0a7e0">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e3f3d362ea642ed9e7f8f139947c56d_I20201231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzE1LTMtMS0xLTMxNDIy_db0f44a5-86ce-4bcf-af1f-eb5a3d46c52c">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i353b586581cf44dca4cb825b92b6aafd_I20201231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzE1LTctMS0xLTMxNDIy_f0ad89ec-8dc0-4139-88ab-658a42df146c">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cae512912394bf5b5d2ebf918860db3_I20201231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzE2LTMtMS0xLTMxNDIy_b1c60ef6-e278-426f-858e-bfd5b1d038f1">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide391512e22947ccac25df3c07cb9228_I20201231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzE2LTctMS0xLTMxNDIy_7f518da0-ed80-4219-b495-65af6177b18a">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale fixed income investments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561ba56147034042ab3232502e02546e_I20201231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzE3LTMtMS0xLTMxNDIy_6587fbf8-c5a3-450f-9493-dcac3fbe9028">39.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd529d4efdc24298b90ec1d3fc7c7068_I20201231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzE3LTctMS0xLTMxNDIy_932a4e15-3610-4af6-aa0a-be1e4e5044fe">39.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange derivative assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba340d0dfb4648819a3e1ddf13ac641e_I20201231" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzE4LTMtMS0xLTMxNDIy_ddec82df-e318-4719-83fc-27d4a9fec1fc">118.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1b09c1f40b047ff8dddca2986b053a3_I20201231" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzE4LTctMS0xLTMxNDIy_cf5ac588-e011-4ec0-9563-7c90d59b63d6">118.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at recurring fair value measurement</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb3ec9725b8947ae894c70cb9fb96fc0_I20201231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzIwLTEtMS0xLTMxNDIy_0587943f-3849-4ea6-b74d-0c5bc93fdd21">46.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7064536ad58d434ca55e232aa46556fb_I20201231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzIwLTMtMS0xLTMxNDIy_8162ec59-08d2-44b8-98b3-877e969c58b0">157.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzIwLTctMS0xLTMxNDIy_4d136e74-99eb-44c1-af70-69a59a451fd9">204.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="24" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange derivative liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7154adf94728411fa895c551c3a5e9c9_I20201231" decimals="-5" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzIyLTMtMS0xLTMxNDIy_271e0da3-92d7-47d4-a6c5-f9ee4c9379e2">103.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8da2ec9305974c688991d4d33e6a27db_I20201231" decimals="-5" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzIyLTctMS0xLTMxNDIy_864a8fbc-5ddf-4673-b021-02c2ff3b756e">103.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i666a97b1659e4674b1610db7c741b7b2_I20201231" decimals="-5" name="us-gaap:OtherLiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzIzLTUtMS0xLTMxNDIy_99bb41d3-476b-4110-859e-721ccb78a518">223.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if75d03b186fe47ba9d810bcb281f1f3d_I20201231" decimals="-5" name="us-gaap:OtherLiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzIzLTctMS0xLTMxNDIy_01e0ac0b-c589-4070-959e-d59706009a61">223.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities at recurring fair value measurement</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7064536ad58d434ca55e232aa46556fb_I20201231" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzI0LTMtMS0xLTMxNDIy_4cca78dd-3a36-4330-911d-314a98c49aa9">103.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if70694466104422da2d7abde7dda9ee2_I20201231" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzI0LTUtMS0xLTMxNDIy_ca53de4a-97c7-43ae-a1fc-85e88c15c2f6">223.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzI0LTctMS0xLTMxNDIy_994a7633-0e25-460e-ad36-274172018ee2">327.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For financial assets and liabilities that utilize Level&#160;2 inputs, the Company utilizes both direct and indirect observable price quotes, including the LIBOR yield curve, foreign exchange forward prices, and bank price quotes. For the years ended December&#160;31, 2021 and 2020, there were no transfers between Level 1 and 2 of the fair value hierarchy. Below is a summary of valuation techniques for Level&#160;1 and Level&#160;2 financial assets and liabilities:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212;&#160;valued at observable net asset value prices.</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Equity securities, exchange traded funds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212;&#160;valued at the active quoted market prices from broker or dealer quotations or transparent pricing sources at the reporting date. Unrealized gains and losses attributable to changes in fair value are included in other expense, net, in the consolidated statements of operations.</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Equity securities, marketable securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">valued using quoted stock prices from public exchanges at the reporting date. Unrealized gains and losses attributable to changes in fair value are included in other expense, net, in the consolidated statements of operations.</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Available-for-sale fixed income investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212;&#160;valued at the quoted market prices from broker or dealer quotations or transparent pricing sources at the reporting date. Unrealized gains and losses attributable to changes in fair value, net of income taxes, are included in accumulated other comprehensive loss as a component of shareholders&#8217; equity.</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Interest rate swap derivative assets and liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212;&#160;valued using the LIBOR/EURIBOR yield curves at the reporting date. Counterparties to these contracts are highly rated financial institutions.</span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Foreign exchange derivative assets and liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212;&#160;valued using quoted forward foreign exchange prices and spot rates at the reporting date. Counterparties to these contracts are highly rated financial institutions.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">111</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><ix:continuation id="ib219abd59fdd47f0805312c4453200d6" continuedAt="i0269cd4256164863873e6792d3596b0d"><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent Consideration</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2011, the Company completed the acquisition of the exclusive worldwide rights to develop, manufacture and commercialize a generic equivalent to GlaxoSmithKline&#8217;s Advair&#174; Diskus incorporating Pfizer&#8217;s respiratory delivery platform. The Company accounted for this transaction as a purchase of a business and utilized the acquisition method of accounting. On January 30, 2019, the Company received FDA approval of Wixela&#174; Inhub&#174; (fluticasone propionate and salmeterol inhalation powder, USP), the first generic of GlaxoSmithKline&#8217;s Advair Diskus&#174;. The commercial launch of the Wixela&#174; Inhub&#174; occurred in February 2019. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company has a contingent consideration liability of $<ix:nonFraction unitRef="usd" contextRef="i898cd302e4b34c6896647b6396e46f83_I20211231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90ZXh0cmVnaW9uOmZmZGUwNDVjYjEzYjQ2YWQ5ZWE4Njk3OTNlZWQ1OTY3Xzk5MzE_545962c5-5792-4f03-a91c-0f14fee149b7">177.8</ix:nonFraction> million related to the respiratory delivery platform. The fair value measurement of contingent consideration is determined using Level 3 inputs. The Company&#8217;s contingent consideration represents a component of the total purchase consideration for Pfizer&#8217;s respiratory delivery platform and certain other acquisitions. The measurement is calculated using unobservable inputs based on the Company&#8217;s own assumptions primarily related to the probability and timing of future development and commercial milestones and future profit-sharing payments which are discounted using a market rate of return. At December&#160;31, 2021 and 2020, discount rates ranging from <ix:nonFraction unitRef="number" contextRef="i3052adbd4310483f8c87f27b0a935413_I20211231" decimals="3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90ZXh0cmVnaW9uOmZmZGUwNDVjYjEzYjQ2YWQ5ZWE4Njk3OTNlZWQ1OTY3XzEwNTY0_71bdc53c-34c9-4556-93e7-3e3542ef7c10">8.0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="id01941d6bb0f45a4b724bf9f4a330e96_I20211231" decimals="3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90ZXh0cmVnaW9uOmZmZGUwNDVjYjEzYjQ2YWQ5ZWE4Njk3OTNlZWQ1OTY3XzEwNTcw_f39fbf9f-5c0f-4a2e-9592-29bd3eee6ac1">10.5</ix:nonFraction>% were utilized in the valuations. Significant changes in unobservable inputs could result in material changes to the contingent consideration liability. </span></div><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90ZXh0cmVnaW9uOmZmZGUwNDVjYjEzYjQ2YWQ5ZWE4Njk3OTNlZWQ1OTY3XzEyNDYx_1f54c65c-0872-4c8c-8371-dbb25b590ade" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A rollforward of the activity in the Company&#8217;s fair value of contingent consideration from December&#160;31, 2019 to December&#160;31, 2021 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:65.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current Portion </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-Term Portion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Contingent Consideration</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f4eb4a955334d9ba1854bafa06369c8_I20191231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzEtMS0xLTEtMzE0MjI_2f8f30c0-4a92-4c2f-8370-a796f4707a09">120.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i400815bb3ce2404ea55584df1faffd10_I20191231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzEtMy0xLTEtMzE0MjI_b0511207-c1f4-44ee-86b6-6591a3e2c8cc">130.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac503b6d629d4bafb262ea6ec0b8a25e_I20191231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzEtNS0xLTEtMzE0MjI_629fbd7c-ad4a-40aa-84cf-af090e7a151f">250.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00babded181a4889991307d7e9be7b3e_D20200101-20201231" decimals="-5" sign="-" name="vtrs:BusinessCombinationContingentConsiderationLiabilityPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzMtMS0xLTEtMzE0MjI_8a5f14f4-100e-4099-8019-75c4c4a762d1">111.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56e83e9054ce46708f56540239a6c805_D20200101-20201231" decimals="-5" name="vtrs:BusinessCombinationContingentConsiderationLiabilityPayments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzMtMy0xLTEtMzE0MjI_53e6d3dc-6690-4cc4-a604-b745b6d4a710">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" sign="-" name="vtrs:BusinessCombinationContingentConsiderationLiabilityPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzMtNS0xLTEtMzE0MjI_4ecd75ae-857c-40fd-8e1f-0223446fea08">111.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassifications</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00babded181a4889991307d7e9be7b3e_D20200101-20201231" decimals="-5" name="vtrs:BusinessCombinationContingentConsiderationArrangementsReclassifications" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzQtMS0xLTEtMzE0MjI_d5a9324f-9ede-44e1-a8b2-1c88af7aad71">58.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i56e83e9054ce46708f56540239a6c805_D20200101-20201231" decimals="-5" sign="-" name="vtrs:BusinessCombinationContingentConsiderationArrangementsReclassifications" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzQtMy0xLTEtMzE0MjI_e8678bc4-2bf3-4d6f-b8fd-eb759511ac36">58.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="vtrs:BusinessCombinationContingentConsiderationArrangementsReclassifications" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzQtNS0xLTEtMzE0MjI_6e02fc15-68ee-4245-9c91-5d50eaee5863">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00babded181a4889991307d7e9be7b3e_D20200101-20201231" decimals="-5" name="us-gaap:AccretionExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzUtMS0xLTEtMzE0MjI_3e621ae1-93a5-4eb5-9419-635eb4a08da9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56e83e9054ce46708f56540239a6c805_D20200101-20201231" decimals="-5" name="us-gaap:AccretionExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzUtMy0xLTEtMzE0MjI_864a9294-645a-4101-bbc1-6f6ff16a16c5">11.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:AccretionExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzUtNS0xLTEtMzE0MjI_21326e08-acc6-413c-af94-e0ea0cae457a">11.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value loss </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00babded181a4889991307d7e9be7b3e_D20200101-20201231" decimals="-5" name="vtrs:BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzYtMS0xLTEtMzE0MjI_552e3403-0d87-4dca-bfaa-c79e0d083591">33.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56e83e9054ce46708f56540239a6c805_D20200101-20201231" decimals="-5" name="vtrs:BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzYtMy0xLTEtMzE0MjI_614d3858-c390-4ba3-bc90-e4d20aaa9313">39.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="vtrs:BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzYtNS0xLTEtMzE0MjI_8757fdee-9e90-437b-9e6b-6ceb61135dde">73.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i869e9de1ba0e414a8a1c0e4653ab950f_I20201231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzgtMS0xLTEtMzE0MjI_748f2fce-85d5-4c7c-ab50-4e0ae6e3d255">100.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia89d28ed480a4556840f217684004588_I20201231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzgtMy0xLTEtMzE0MjI_ac5db8ea-da89-4ca3-9320-9f8775d95749">123.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzgtNS0xLTEtMzE0MjI_386dee79-f0ff-4ef9-83f7-774511b2419e">223.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icd90ca69608a471ebdd2665fb68a10f0_D20210101-20211231" decimals="-5" sign="-" name="vtrs:BusinessCombinationContingentConsiderationLiabilityPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzktMS0xLTEtMzE0MjI_151da1f5-39e4-4d2a-8bc8-61d529d407ad">83.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9987758e9374f87a70ef8c4aca1fc6b_D20210101-20211231" decimals="-5" name="vtrs:BusinessCombinationContingentConsiderationLiabilityPayments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzktMy0xLTEtMzE0MjI_f06f5313-7028-42d1-866e-0d0ac4970bd4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" sign="-" name="vtrs:BusinessCombinationContingentConsiderationLiabilityPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzktNS0xLTEtMzE0MjI_a3362b91-83d2-4cae-be79-aa30a16c67c0">83.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd90ca69608a471ebdd2665fb68a10f0_D20210101-20211231" decimals="-5" name="vtrs:BusinessCombinationContingentConsiderationArrangementsReclassifications" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzEwLTEtMS0xLTMxNDIy_390056b7-d762-4376-8db6-41af040604d9">49.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9987758e9374f87a70ef8c4aca1fc6b_D20210101-20211231" decimals="-5" sign="-" name="vtrs:BusinessCombinationContingentConsiderationArrangementsReclassifications" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzEwLTMtMS0xLTMxNDIy_394510b9-4d40-4e97-b3b9-5bc0639816d9">49.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="vtrs:BusinessCombinationContingentConsiderationArrangementsReclassifications" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzEwLTUtMS0xLTMxNDIy_08cc351b-21f4-4f40-81e2-a13bf96d9bcb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd90ca69608a471ebdd2665fb68a10f0_D20210101-20211231" decimals="-5" name="us-gaap:AccretionExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzExLTEtMS0xLTMxNDIy_ae8d8af1-8fcf-4c85-9e77-333ba3f89e1f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9987758e9374f87a70ef8c4aca1fc6b_D20210101-20211231" decimals="-5" name="us-gaap:AccretionExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzExLTMtMS0xLTMxNDIy_c4fa9daf-56e6-4335-8b9c-98bfa0d6df55">9.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:AccretionExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzExLTUtMS0xLTMxNDIy_2eff890d-fdaf-452b-95eb-08e3cda6ede0">9.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value loss </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd90ca69608a471ebdd2665fb68a10f0_D20210101-20211231" decimals="-5" name="vtrs:BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzEyLTEtMS0xLTMxNDIy_776b3783-1e2d-456a-ab68-23a9de417158">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9987758e9374f87a70ef8c4aca1fc6b_D20210101-20211231" decimals="-5" name="vtrs:BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzEyLTMtMS0xLTMxNDIy_13bb45ae-403c-49a5-abde-5213a7a16372">50.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="vtrs:BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzEyLTUtMS0xLTMxNDIy_b66bd61f-ce69-4daf-9c18-9b290fedcb77">50.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c198dc35fb64539904dc17b63908f02_I20211231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzEzLTEtMS0xLTMxNDIy_b79b03fd-7b34-41bc-ae50-18450b4d96d7">66.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8416dfbb7a5942b691bd8f0154ec826e_I20211231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzEzLTMtMS0xLTMxNDIy_cbe5954d-cb2f-406f-95c6-57b98acbe32c">133.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzEzLTUtMS0xLTMxNDIy_c64401db-7c91-4967-9ec3-6e3ca5aa3ea7">199.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Included in other current liabilities in the consolidated balance sheets.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Included in other long-term obligations in the consolidated balance sheets.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Included in litigation settlements and other contingencies, net in the consolidated statements of operations.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expects to incur approximately $<ix:nonFraction unitRef="usd" contextRef="i84ab0bd68a334690be79969b61dd4796_D20210101-20211231" decimals="-6" name="us-gaap:AccretionExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90ZXh0cmVnaW9uOmZmZGUwNDVjYjEzYjQ2YWQ5ZWE4Njk3OTNlZWQ1OTY3XzEwOTk1MTE2NDY0ODU_e959f3b5-9e50-4d19-aadd-67837100649d">6</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="i500214b091fd4491a3e5f7c09d556da9_D20210101-20211231" decimals="-6" name="us-gaap:AccretionExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90ZXh0cmVnaW9uOmZmZGUwNDVjYjEzYjQ2YWQ5ZWE4Njk3OTNlZWQ1OTY3XzEwOTk1MTE2NDY0OTk_fccf2415-bb72-402f-bdd4-7f4bb11fced8">8</ix:nonFraction> million of non-cash accretion expense related to the increase in the net present value of the contingent consideration liabilities in 2022.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Company has not elected the fair value option for financial assets and liabilities, any future transacted financial asset or liability will be evaluated for the fair value election.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">112</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><ix:continuation id="i0269cd4256164863873e6792d3596b0d"><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Available-for-Sale Securities</span></div><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90ZXh0cmVnaW9uOmZmZGUwNDVjYjEzYjQ2YWQ5ZWE4Njk3OTNlZWQ1OTY3XzEyNTI2_b3efa5cc-6415-463c-a37f-706086aa3725" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost and estimated fair value of available-for-sale fixed income securities, included in prepaid expenses and other current assets, were as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:57.465%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.712%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d7336def5e24f00b2fa9c82f8a246d0_I20211231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTphZmMzYTQ1YThhMjQ0NmY1OGRiMWQ5M2ZjMjA4NTJkZC90YWJsZXJhbmdlOmFmYzNhNDVhOGEyNDQ2ZjU4ZGIxZDkzZmMyMDg1MmRkXzItMS0xLTEtMzE0MjI_dae01ffb-9e11-4bb1-b5b9-c00e810d8cfd">38.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d7336def5e24f00b2fa9c82f8a246d0_I20211231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTphZmMzYTQ1YThhMjQ0NmY1OGRiMWQ5M2ZjMjA4NTJkZC90YWJsZXJhbmdlOmFmYzNhNDVhOGEyNDQ2ZjU4ZGIxZDkzZmMyMDg1MmRkXzItMy0xLTEtMzE0MjI_7a88734e-943f-4707-9da3-3ec749a191ea">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d7336def5e24f00b2fa9c82f8a246d0_I20211231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTphZmMzYTQ1YThhMjQ0NmY1OGRiMWQ5M2ZjMjA4NTJkZC90YWJsZXJhbmdlOmFmYzNhNDVhOGEyNDQ2ZjU4ZGIxZDkzZmMyMDg1MmRkXzItNS0xLTEtMzE0MjI_a74e9ac7-8381-41f8-b3c4-4fcb311c3ce7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d7336def5e24f00b2fa9c82f8a246d0_I20211231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTphZmMzYTQ1YThhMjQ0NmY1OGRiMWQ5M2ZjMjA4NTJkZC90YWJsZXJhbmdlOmFmYzNhNDVhOGEyNDQ2ZjU4ZGIxZDkzZmMyMDg1MmRkXzItNy0xLTEtMzE0MjI_a9009fd5-7813-4e74-b88a-3e341d79422e">38.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTphZmMzYTQ1YThhMjQ0NmY1OGRiMWQ5M2ZjMjA4NTJkZC90YWJsZXJhbmdlOmFmYzNhNDVhOGEyNDQ2ZjU4ZGIxZDkzZmMyMDg1MmRkXzMtMS0xLTEtMzE0MjI_86fc51ad-d64d-411b-9682-b7d2774916d8">38.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTphZmMzYTQ1YThhMjQ0NmY1OGRiMWQ5M2ZjMjA4NTJkZC90YWJsZXJhbmdlOmFmYzNhNDVhOGEyNDQ2ZjU4ZGIxZDkzZmMyMDg1MmRkXzMtMy0xLTEtMzE0MjI_2ff2b152-1ee2-40f8-b20f-882107fa8b7e">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTphZmMzYTQ1YThhMjQ0NmY1OGRiMWQ5M2ZjMjA4NTJkZC90YWJsZXJhbmdlOmFmYzNhNDVhOGEyNDQ2ZjU4ZGIxZDkzZmMyMDg1MmRkXzMtNS0xLTEtMzE0MjI_93ea36f7-9da0-4cf1-8e0c-a9093aa879de">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTphZmMzYTQ1YThhMjQ0NmY1OGRiMWQ5M2ZjMjA4NTJkZC90YWJsZXJhbmdlOmFmYzNhNDVhOGEyNDQ2ZjU4ZGIxZDkzZmMyMDg1MmRkXzMtNy0xLTEtMzE0MjI_7f2c9f77-7447-418d-bb1f-18451fdb6c70">38.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04586f5a3ee649afbdb486e4d10a000a_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTphZmMzYTQ1YThhMjQ0NmY1OGRiMWQ5M2ZjMjA4NTJkZC90YWJsZXJhbmdlOmFmYzNhNDVhOGEyNDQ2ZjU4ZGIxZDkzZmMyMDg1MmRkXzUtMS0xLTEtMzE0MjI_2048b7ec-bca0-4c92-8c6b-52c629280103">37.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04586f5a3ee649afbdb486e4d10a000a_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTphZmMzYTQ1YThhMjQ0NmY1OGRiMWQ5M2ZjMjA4NTJkZC90YWJsZXJhbmdlOmFmYzNhNDVhOGEyNDQ2ZjU4ZGIxZDkzZmMyMDg1MmRkXzUtMy0xLTEtMzE0MjI_0edc086b-9e86-46cb-abaf-f41842a0ab56">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04586f5a3ee649afbdb486e4d10a000a_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTphZmMzYTQ1YThhMjQ0NmY1OGRiMWQ5M2ZjMjA4NTJkZC90YWJsZXJhbmdlOmFmYzNhNDVhOGEyNDQ2ZjU4ZGIxZDkzZmMyMDg1MmRkXzUtNS0xLTEtMzE0MjI_4b8cab02-466d-48f2-99bf-cd89a57ad482">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04586f5a3ee649afbdb486e4d10a000a_I20201231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTphZmMzYTQ1YThhMjQ0NmY1OGRiMWQ5M2ZjMjA4NTJkZC90YWJsZXJhbmdlOmFmYzNhNDVhOGEyNDQ2ZjU4ZGIxZDkzZmMyMDg1MmRkXzUtNy0xLTEtMzE0MjI_8006d031-afb6-46e2-96b0-e76added5c12">39.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTphZmMzYTQ1YThhMjQ0NmY1OGRiMWQ5M2ZjMjA4NTJkZC90YWJsZXJhbmdlOmFmYzNhNDVhOGEyNDQ2ZjU4ZGIxZDkzZmMyMDg1MmRkXzYtMS0xLTEtMzE0MjI_3333d9dc-2567-404b-8817-4a3bffdb9fbb">37.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTphZmMzYTQ1YThhMjQ0NmY1OGRiMWQ5M2ZjMjA4NTJkZC90YWJsZXJhbmdlOmFmYzNhNDVhOGEyNDQ2ZjU4ZGIxZDkzZmMyMDg1MmRkXzYtMy0xLTEtMzE0MjI_b98d394d-4ba7-4e23-9e2c-31f33832a6ad">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTphZmMzYTQ1YThhMjQ0NmY1OGRiMWQ5M2ZjMjA4NTJkZC90YWJsZXJhbmdlOmFmYzNhNDVhOGEyNDQ2ZjU4ZGIxZDkzZmMyMDg1MmRkXzYtNS0xLTEtMzE0MjI_96da0f4d-a9e2-4991-bf9b-ba6551e18a54">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTphZmMzYTQ1YThhMjQ0NmY1OGRiMWQ5M2ZjMjA4NTJkZC90YWJsZXJhbmdlOmFmYzNhNDVhOGEyNDQ2ZjU4ZGIxZDkzZmMyMDg1MmRkXzYtNy0xLTEtMzE0MjI_016b5436-b2fd-4429-9430-8ce061658fd6">39.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90ZXh0cmVnaW9uOmZmZGUwNDVjYjEzYjQ2YWQ5ZWE4Njk3OTNlZWQ1OTY3XzEyNDY1_09cd29a9-5eb5-4aa4-aa47-948b91f0e06d" escape="true"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of available-for-sale debt securities at fair value as of December&#160;31, 2021, were as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:89.090%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.710%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature within one year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0YmQxYTExNDNhMTc0NDcwYjczOTgzMjQwNDVjNzhmNC90YWJsZXJhbmdlOjRiZDFhMTE0M2ExNzQ0NzBiNzM5ODMyNDA0NWM3OGY0XzEtMS0xLTEtMzE0MjI_04a27d16-2cae-4297-8057-58986720de2f">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature in one to five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0YmQxYTExNDNhMTc0NDcwYjczOTgzMjQwNDVjNzhmNC90YWJsZXJhbmdlOjRiZDFhMTE0M2ExNzQ0NzBiNzM5ODMyNDA0NWM3OGY0XzItMS0xLTEtMzE0MjI_a632acc9-64df-49e3-892d-28f9366f0620">19.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature in five years and later</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="vtrs:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAndLaterFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0YmQxYTExNDNhMTc0NDcwYjczOTgzMjQwNDVjNzhmNC90YWJsZXJhbmdlOjRiZDFhMTE0M2ExNzQ0NzBiNzM5ODMyNDA0NWM3OGY0XzMtMS0xLTEtMzE0MjI_5ca175fe-b632-41ca-b91a-7f740cf1e7e4">17.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0YmQxYTExNDNhMTc0NDcwYjczOTgzMjQwNDVjNzhmNC90YWJsZXJhbmdlOjRiZDFhMTE0M2ExNzQ0NzBiNzM5ODMyNDA0NWM3OGY0XzQtMS0xLTEtMzE0MjI_8b8aad0e-eeef-4908-82f8-44084e09fb38">38.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_208"></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">Debt</span></div><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:ScheduleOfShortTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2Xzk2NDQ_e39a5440-e875-4394-8ed4-42e9e2290b99" continuedAt="ic1b5bd748ceb42cd8a8988cc4a10f6d8" escape="true"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-Term Borrowings</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had $<ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-7" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2XzQ5_9b496d51-d30a-4fc9-971e-a8df9bfad63e">1.49</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-7" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2XzEwOTk1MTE2NTM5MTA_dfa769e1-4fd2-46f7-aaa0-90218d9c998e">1.10</ix:nonFraction>&#160;billion of borrowings as of December&#160;31, 2021 and 2020, respectively.</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.575%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper notes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6348c0871c354006bbb77663df6a8f55_I20211231" decimals="-5" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTo3Zjc5YTFiYWEyMTY0OGI1OGU2M2JiOWY3MjYwYjIzMC90YWJsZXJhbmdlOjdmNzlhMWJhYTIxNjQ4YjU4ZTYzYmI5ZjcyNjBiMjMwXzEtMS0xLTEtMzE0MjI_80d9f41f-8769-491b-b7d5-eb2a2c75ab44">1,173.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42c49c74e2aa485b82eb650616e9a5ed_I20201231" decimals="-5" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTo3Zjc5YTFiYWEyMTY0OGI1OGU2M2JiOWY3MjYwYjIzMC90YWJsZXJhbmdlOjdmNzlhMWJhYTIxNjQ4YjU4ZTYzYmI5ZjcyNjBiMjMwXzEtMy0xLTEtMzE0MjI_e1df4e74-37fc-4217-b428-3ce806092779">651.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables Facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba8eb8ec1ddc4b67a8a39164a81b8561_I20211231" decimals="-5" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTo3Zjc5YTFiYWEyMTY0OGI1OGU2M2JiOWY3MjYwYjIzMC90YWJsZXJhbmdlOjdmNzlhMWJhYTIxNjQ4YjU4ZTYzYmI5ZjcyNjBiMjMwXzItMS0xLTEtMzE0MjI_13376767-89c3-4c4c-a384-a60ccab74ed8">318.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0333343531a84c508ec66fd2d2e00992_I20201231" decimals="-5" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTo3Zjc5YTFiYWEyMTY0OGI1OGU2M2JiOWY3MjYwYjIzMC90YWJsZXJhbmdlOjdmNzlhMWJhYTIxNjQ4YjU4ZTYzYmI5ZjcyNjBiMjMwXzItMy0xLTEtMzE0MjI_8c6d710d-c63f-4f78-8cb8-03850402c545">248.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Note Securitization Facility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83bd5820907e45cbbb4ea0f8abe30112_I20211231" decimals="-5" name="us-gaap:ShortTermBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTo3Zjc5YTFiYWEyMTY0OGI1OGU2M2JiOWY3MjYwYjIzMC90YWJsZXJhbmdlOjdmNzlhMWJhYTIxNjQ4YjU4ZTYzYmI5ZjcyNjBiMjMwXzMtMS0xLTEtMzE0MjI_8fc991de-e819-476b-a5ab-6715035eb668">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i761c7931f4534948be5b4250f7b81ef1_I20201231" decimals="-5" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTo3Zjc5YTFiYWEyMTY0OGI1OGU2M2JiOWY3MjYwYjIzMC90YWJsZXJhbmdlOjdmNzlhMWJhYTIxNjQ4YjU4ZTYzYmI5ZjcyNjBiMjMwXzMtMy0xLTEtMzE0MjI_103b23b1-3198-43f0-809c-8ed59309d99c">200.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1f6c291ccc34af59e5c6bbc708d16ed_I20211231" decimals="-5" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTo3Zjc5YTFiYWEyMTY0OGI1OGU2M2JiOWY3MjYwYjIzMC90YWJsZXJhbmdlOjdmNzlhMWJhYTIxNjQ4YjU4ZTYzYmI5ZjcyNjBiMjMwXzQtMS0xLTEtMzE0MjI_02376cab-50ef-4930-9d08-b3b1279bf936">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie02ffa5a286a4854b0f6a8ae8fb7875b_I20201231" decimals="-5" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTo3Zjc5YTFiYWEyMTY0OGI1OGU2M2JiOWY3MjYwYjIzMC90YWJsZXJhbmdlOjdmNzlhMWJhYTIxNjQ4YjU4ZTYzYmI5ZjcyNjBiMjMwXzQtMy0xLTEtMzE0MjI_bf486dc1-93cd-4132-bb55-b434ec65df5d">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term borrowings</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTo3Zjc5YTFiYWEyMTY0OGI1OGU2M2JiOWY3MjYwYjIzMC90YWJsZXJhbmdlOjdmNzlhMWJhYTIxNjQ4YjU4ZTYzYmI5ZjcyNjBiMjMwXzUtMS0xLTEtMzE0MjI_6072a6e0-5435-463d-a60c-8e2d50ab5fd9">1,493.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-3" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTo3Zjc5YTFiYWEyMTY0OGI1OGU2M2JiOWY3MjYwYjIzMC90YWJsZXJhbmdlOjdmNzlhMWJhYTIxNjQ4YjU4ZTYzYmI5ZjcyNjBiMjMwXzUtMy0xLTEtMzE0MjI_55b92a71-75cf-4adc-bf67-5f1da1b18f8b">1,100.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic1b5bd748ceb42cd8a8988cc4a10f6d8">The following provides an overview of the Company&#8217;s short-term credit facilities.</ix:continuation> </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commercial Paper Program</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 16, 2020, the Company established the Commercial Paper Program to support its working capital requirements and for general purposes. There was $<ix:nonFraction unitRef="usd" contextRef="i6348c0871c354006bbb77663df6a8f55_I20211231" decimals="-7" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2XzEwOTk1MTE2NTM5NDU_6696e5ad-f900-4162-bb97-6455095b8deb">1.17</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="i42c49c74e2aa485b82eb650616e9a5ed_I20201231" decimals="-5" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2XzMyOTg1MzQ4OTk4MTI_e1df4e74-37fc-4217-b428-3ce806092779">651.3</ix:nonFraction> million of CP Notes outstanding under this program as of December&#160;31, 2021 and 2020, respectively. Amounts available under the Commercial Paper Program may be borrowed, repaid and re-borrowed from time to time, with the aggregate principal amount of CP Notes outstanding at any time not to exceed $<ix:nonFraction unitRef="usd" contextRef="ia14591b7ed4e4ed5b2119d20257b6803_I20170606" decimals="-7" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2XzcyNA_80bad2c2-f9d4-4838-a558-57245448f228">1.65</ix:nonFraction> billion. The 2021 Revolving Facility will be available to pay the CP Notes, if necessary. The maturities of the CP Notes will vary but will not exceed <ix:nonNumeric contextRef="ied6eaf81eabd467eb19851b626292fa8_D20170606-20170606" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2Xzg2NQ_afb2bb08-dea7-4301-bccd-296da12df14c">364</ix:nonNumeric> days from the date of issue.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Receivables Facility and Note Securitization Facility </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a $<ix:nonFraction unitRef="usd" contextRef="iba8eb8ec1ddc4b67a8a39164a81b8561_I20211231" decimals="-6" name="vtrs:AccountsReceivableFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2Xzk3MQ_60446673-8cd2-410e-bf99-1d591040d907">400</ix:nonFraction> million Receivables Facility which expires in April 2022. Under the terms of the Receivables Facility, our subsidiary, MPI, sells certain accounts receivable to Mylan Securitization, a wholly-owned special purpose entity which in turn sells a percentage ownership interest in the receivables to financial institutions and commercial paper conduits sponsored by financial institutions. Mylan Securitization&#8217;s assets have been pledged to MUFG Bank, Ltd., as agent, in support of its obligations under the Receivables Facility. Any amounts outstanding under the facility are recorded as borrowings and the underlying receivables are included in accounts receivable, net, in the consolidated balance sheets.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">113</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the Company entered into the Note Securitization Facility for borrowings up to $<ix:nonFraction unitRef="usd" contextRef="i83bd5820907e45cbbb4ea0f8abe30112_I20211231" decimals="-6" name="vtrs:AccountsReceivableFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2XzE3NDA_2eafe133-af64-45d9-9977-8b7b249bc697">200</ix:nonFraction> million. In July 2021, the Note Securitization Facility was amended to extend its maturity to August 2022. Under the terms of each of the Receivables Facility and Note Securitization Facility, certain of our accounts receivable secure the amounts borrowed and cannot be used to pay our other debts or liabilities. The amount that we may borrow at a given point in time is determined based on the amount of qualifying accounts receivable that are present at such point in time. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings outstanding under the Receivables Facility bear interest at a commercial paper rate plus <ix:nonFraction unitRef="number" contextRef="i58f2993346b2437da3921482cd53781f_D20210101-20211231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2XzIyMTQ_39da2395-ed2e-40a3-b017-1c5aa1a7a9e4">0.925</ix:nonFraction>% and under the Note Securitization Facility at a rate per annum quoted from time to time by MUFG Bank, Ltd. plus <ix:nonFraction unitRef="number" contextRef="ie3ae820bb2f84caeb01b1f76cfa70fc8_D20210101-20211231" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2XzEwOTk1MTE2NDcxMjc_6b6b1b88-cdbd-4b01-bda9-018eb92eca9f">0.85</ix:nonFraction>% and are included as a component of short-term borrowings, while the accounts receivable securing these obligations remain as a component of accounts receivable, net, in our consolidated balance sheets. In addition, the agreements governing the Receivables Facility and Note Securitization Facility contain various customary affirmative and negative covenants, and customary default and termination provisions with which the Company was compliant as of December&#160;31, 2021. As of December&#160;31, 2021 and 2020, the Company had $<ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:AccountsReceivableFromSecuritization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2XzI4MTE_c9913687-7bab-4e99-8369-da4d061ad804">388.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:AccountsReceivableFromSecuritization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2XzI4MTg_5aacea87-b606-4183-98c2-5a767830f761">389.4</ix:nonFraction> million, respectively, of accounts receivable balances sold to Mylan Securitization. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">114</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Term Debt</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of long-term debt is as follows:</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:63.321%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.590%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">($ in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate as of December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current portion of long-term debt:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">**</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2ab05aad91f84733ae6b5e8d48936298_I20211231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzQtMS0xLTEtMzcyNjY_bb07866b-01b7-4578-a91c-ceeeed1ffb93">3.150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44658e6f80d547aaa1d6f5eade2a3003_I20211231" decimals="-5" name="us-gaap:DebtCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzQtMy0xLTEtMzE0MjI_17b9f218-c07c-42b2-bd37-9fe676188039">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2463e684b0924c04a93cc915be90fe1b_I20201231" decimals="-5" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzQtNS0xLTEtMzE0MjI_fa494967-ee6b-4b15-986f-ab1ccfa4e69a">2,249.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 Euro Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">****</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic818a0a0c1d2464bb6ef3218b78cc20e_I20211231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzUtMS0xLTEtMzE0MjI_a795c106-f8cf-40f5-96af-aff9718ac4fd">0.816</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic818a0a0c1d2464bb6ef3218b78cc20e_I20211231" decimals="-5" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzUtMy0xLTEtMzE0MjI_35bbd8fb-a1ee-4ff3-9008-e7d56da4e8fa">856.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1422ee4965c4486e9d857d1e0ef2b079_I20201231" decimals="-5" name="us-gaap:DebtCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzUtNS0xLTEtMzE0MjI_48820318-1273-49b5-84bb-0040b5a82a49">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">***</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i205f2aac79b04016b1da176b6a7fb1fa_I20211231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzYtMS0xLTEtMzE0MjI_a4bd0b2b-4061-45bf-aa10-2637ca15b373">1.125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i205f2aac79b04016b1da176b6a7fb1fa_I20211231" decimals="-5" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzYtMy0xLTEtMzE0MjI_0340e7fe-a8de-4815-bd43-0d6a3e7b678a">1,002.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if007a084b1e34ea384fb202e6e9d6c38_I20201231" decimals="-5" name="us-gaap:DebtCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzYtNS0xLTEtMzE0MjI_19aa181e-be33-42b7-8f10-52d6fdab51ab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1f6c291ccc34af59e5c6bbc708d16ed_I20211231" decimals="-5" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzgtMy0xLTEtMzE0MjI_0bc88246-8ac7-4944-8f96-35accef6be4e">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie02ffa5a286a4854b0f6a8ae8fb7875b_I20201231" decimals="-5" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzgtNS0xLTEtMzE0MjI_32b90399-6c85-4115-bd53-609cf02bf24f">8.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing fees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cd223f958b74eae95243319a27d31f0_I20211231" decimals="-5" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzktMy0xLTEtMzE0MjI_5da037fd-a344-4096-a1e3-9927857073af">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8f7a9b488f94289a8d5b7710a4447af_I20201231" decimals="-5" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzktNS0xLTEtMzE0MjI_601a1e1a-90a7-41f7-8804-69ecfa7ba76f">1.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzEwLTMtMS0xLTMxNDIy_cb8beec3-e88b-43fe-811d-3282e52d93b9">1,860.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzEwLTUtMS0xLTMxNDIy_edcd23f3-a96c-47fe-b6b0-6aa6e3fe4d9f">2,256.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-current portion of long-term debt:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 Euro Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">****</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib435a6d77cd34f869cedbd596bf31419_I20211231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzE3LTEtMS0xLTMxNDIy_544f2cb7-4cd0-41c0-9e8b-e8b1173a3fb3">0.816</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib435a6d77cd34f869cedbd596bf31419_I20211231" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzE3LTMtMS0xLTMxNDIy_4a1b28fe-a75b-47d8-ae3e-1c69fb0d7ee7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab602c854a75461ab1e9ab8870796980_I20201231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzE3LTUtMS0xLTMxNDIy_231aa2a0-41f0-4b09-980e-4dd19d35302f">928.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">***</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i377027e221df4b5fbf54f4ccd718ed6e_I20211231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzE4LTEtMS0xLTMxNDIy_03c06c86-d5d8-4e6f-8dfd-e0cc1397def2">1.125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i377027e221df4b5fbf54f4ccd718ed6e_I20211231" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzE4LTMtMS0xLTMxNDIy_d4890b8e-fa66-45e4-a09e-3f675784eb9b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia70edf5b85c1412c9e994cc32f0ac58b_I20201231" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzE4LTUtMS0xLTMxNDIy_662a0428-3dbf-4129-a8a1-50aaf0ec5791">1,008.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">*</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i10c40610432e48caaea6544a94cc0ff7_I20211231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzE5LTEtMS0xLTMxNDIy_f26043a9-19fa-45e9-82dd-26c3a95e8a91">3.125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c40610432e48caaea6544a94cc0ff7_I20211231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzE5LTMtMS0xLTMxNDIy_65f4899c-7bfe-4f2c-8cd6-e9914231670e">766.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0c235dec46b409c9b237d080763da78_I20201231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzE5LTUtMS0xLTMxNDIy_52267909-8bc1-4a3d-82ae-638f71cb35f9">781.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">*</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iaa49209541544d93ba10801830d5f5a1_I20211231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzIwLTEtMS0xLTMxNDIy_a04847d5-e603-43d2-acd8-06fc28a59185">4.200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa49209541544d93ba10801830d5f5a1_I20211231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzIwLTMtMS0xLTMxNDIy_9bcb1e95-00ec-4bd2-8887-03d3e807ae1d">499.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ca2c72c048b4966924c4641a6c8e4c3_I20201231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzIwLTUtMS0xLTMxNDIy_90a9dd01-5fb0-4d65-812a-1d16dc2b2e8f">499.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Euro Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">**</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9a9dac0334bc477ea0a456bbe46c3173_I20211231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzIxLTEtMS0xLTMxNDIy_8ae3d38a-f779-4705-8374-4082196e4a46">2.250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a9dac0334bc477ea0a456bbe46c3173_I20211231" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzIxLTMtMS0xLTMxNDIy_f5c5d939-8685-497c-b0ce-5a82a84c0537">1,135.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78adee273e00402683245dff9ebb774d_I20201231" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzIxLTUtMS0xLTMxNDIy_78ec8056-1dfa-4bc0-94ad-bbcfdec1cc60">1,219.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Euro Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">****</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i17b748819db1409f90ab44c1656a6844_I20211231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzIyLTEtMS0xLTMxNDIy_1cf28c8b-38ba-46c5-9232-a7b529fdb96f">1.023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9743aa24ff1b459f9b29bba570aa1521_I20211231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzIyLTMtMS0xLTMxNDIy_19bb56e4-8b2a-457c-93e5-eae8e4fc3da0">871.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib01fe9fec3ea48b998ccf8a7121177c3_I20201231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzIyLTUtMS0xLTMxNDIy_174e3bcd-1ff3-406d-abfa-5cdc2c89a240">944.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Euro Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">*</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iea56cbd0617d400094855281cdd9e614_I20211231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzIzLTEtMS0xLTMxNDIy_1ed194b5-5a8c-4532-9e57-dae164b8a336">2.125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea56cbd0617d400094855281cdd9e614_I20211231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzIzLTMtMS0xLTMxNDIy_d2db85aa-e6e5-4139-b4b7-48e35d3745d9">567.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31ff8d2943a647b3927af7a7fc9ceb67_I20201231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzIzLTUtMS0xLTMxNDIy_cc69a49c-3dc8-4d40-af96-3b7a01a9f853">609.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">***</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1428d03b2da74d5a877a86979e4dd692_I20211231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzI0LTEtMS0xLTMxNDIy_c3abef01-6ddb-4083-be0b-51213c85d5a8">1.650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1428d03b2da74d5a877a86979e4dd692_I20211231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzI0LTMtMS0xLTMxNDIy_62973969-b80b-4f5f-9e24-906ce252c497">763.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad4fd165662b43738af77427b3894ed9_I20201231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzI0LTUtMS0xLTMxNDIy_15032800-05fb-4512-8b40-b872f2f145e7">767.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">**</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2c630e4787804a5baafb37dfba1e9941_I20211231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzI1LTEtMS0xLTMxNDIy_ef5fa11a-1467-4315-a8e4-57b58d9d719b">3.950</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c630e4787804a5baafb37dfba1e9941_I20211231" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzI1LTMtMS0xLTMxNDIy_47a8f6f3-c0b2-4b55-91a6-2c55e339c684">2,241.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if885e24274984b748d622171dad0e341_I20201231" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzI1LTUtMS0xLTMxNDIy_9dfa5101-b895-43d8-84f3-d01322c9da2a">2,239.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Euro Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">****</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iae4433500527462f9a53c262b4a193e2_I20211231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzI2LTEtMS0xLTMxNDIy_b45e55fb-405e-4f27-95c6-c1c328550fcf">1.362</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd92e4609f2347c481397989d4d41bb5_I20211231" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzI2LTMtMS0xLTMxNDIy_23785553-c00a-403f-a298-caeb5d9670b7">1,013.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02db2d48980748f2a8c4583ff56233ac_I20201231" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzI2LTUtMS0xLTMxNDIy_9865f635-1923-42f9-997c-e904320a2474">1,097.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">***</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic36c2f77ef1a4f429be7552a4ffdaf63_I20211231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzI3LTEtMS0xLTMxNDIy_923d4142-8bd0-4bc3-946f-ff2169a07ad6">2.300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec4db0b19b8f485ca0d0961ae936700c_I20211231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzI3LTMtMS0xLTMxNDIy_48b48234-c70c-4883-9443-e1cbe0f00633">780.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic23232bd104348af9f1c272ee35c0c7c_I20201231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzI3LTUtMS0xLTMxNDIy_07dc4224-6108-407e-b086-04e4a4bfbf77">786.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Euro Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">**</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4e35649af2d149e5a110744b54afb44e_I20211231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzI4LTEtMS0xLTMxNDIy_b18df3d2-8e18-43ea-984b-c280040ebe15">3.125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e35649af2d149e5a110744b54afb44e_I20211231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzI4LTMtMS0xLTMxNDIy_fca5e5cb-1e8f-48c6-a267-4fdc11c57d37">847.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18dc290bd62a46ed929e318042c29293_I20201231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzI4LTUtMS0xLTMxNDIy_17c194d3-71bc-4afe-b263-985d3e344c7b">909.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">*</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9d56a00686f94581be68c9eba8a25301_I20211231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzI5LTEtMS0xLTM3NTE0_3bf5d9f1-91ed-41e6-aa1e-1460dbfcf01d">4.550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d56a00686f94581be68c9eba8a25301_I20211231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzI5LTMtMS0xLTM3NTE4_e43319cb-f46e-44fc-a6a4-7b778e1bceb9">748.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ded5c651e24a53b16c65e31f034e19_I20201231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzI5LTUtMS0xLTM3NTE4_4c5eaf81-742d-4a47-a093-eb61a988d335">748.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2030 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">***</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia571e0c9398945dd93a699d5a8d8ca2f_I20211231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzI5LTEtMS0xLTMxNDIy_efe92da1-53ed-4948-8497-c97b3db96d0d">2.700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia571e0c9398945dd93a699d5a8d8ca2f_I20211231" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzI5LTMtMS0xLTMxNDIy_d46c63a6-1c35-4fbe-a170-d6050686491b">1,520.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e9d0561e01b4afb9c271809518e9c3a_I20201231" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzI5LTUtMS0xLTMxNDIy_c4b525be-f502-4979-be3a-101f05ab5d5a">1,528.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2032 Euro Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">****</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if487c6ee083b40a88448340cd281fb87_I20211231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzMwLTEtMS0xLTMxNDIy_69afbe02-9255-4cac-90e3-62e5fd034b56">1.908</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if487c6ee083b40a88448340cd281fb87_I20211231" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzMwLTMtMS0xLTMxNDIy_35649ee0-92e8-42ab-b751-25b5d24661e6">1,546.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01addae58bf447a1be4cf07b1417127c_I20201231" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzMwLTUtMS0xLTMxNDIy_c387ee9d-ae4e-4a93-9d36-7905505af80b">1,672.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2040 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">***</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i04a235c228ea4cbe8dd8f7c77da0efca_I20211231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzMxLTEtMS0xLTMxNDIy_9ddec012-4237-4299-9de4-a282c9cc13cb">3.850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04a235c228ea4cbe8dd8f7c77da0efca_I20211231" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzMxLTMtMS0xLTMxNDIy_d255d722-b113-4744-a2be-3e3e8005323a">1,657.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae33c84f581c444991bd3e6161e49454_I20201231" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzMxLTUtMS0xLTMxNDIy_1f1c205a-dc87-42ab-985c-ccb4a46c117f">1,663.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2043 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">*</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i29c286b2a49347658e466f3c15ed9e36_I20211231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzMzLTEtMS0xLTMxNDIy_e33d9b1b-86e7-400a-861d-30df4d011c8d">5.400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29c286b2a49347658e466f3c15ed9e36_I20211231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzMzLTMtMS0xLTMxNDIy_69b3a3de-4151-41a8-92c8-da863bbb2f76">497.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64f377462f4d49f9911bffc37608cd6d_I20201231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzMzLTUtMS0xLTMxNDIy_6930bb85-2c3d-451a-b6fa-b6e0b4d1121c">497.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2046 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> **</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0c5902c6ea4c409c95333fd6263b9aa6_I20211231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzM0LTEtMS0xLTMxNDIy_b5583a97-0eb2-406d-9857-fb221a526811">5.250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c5902c6ea4c409c95333fd6263b9aa6_I20211231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzM0LTMtMS0xLTMxNDIy_81c70c1b-d96d-4dea-afc7-da6a06f1402f">999.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6838f10691984228bc7b35ce8cf2c986_I20201231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzM0LTUtMS0xLTMxNDIy_aed48c3b-a41a-443c-8503-a6dac948dcfe">999.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2048 Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> *</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id459a294731e48d8a0be383eb2bd5a03_I20211231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzM1LTEtMS0xLTMxNDIy_9abba238-d471-49fe-87d1-f0561399af3f">5.200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id459a294731e48d8a0be383eb2bd5a03_I20211231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzM1LTMtMS0xLTMxNDIy_a6929aaf-5cdd-455c-950f-425ff0477732">747.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5884d0b22a724fbea35305a07e9ec8d0_I20201231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzM1LTUtMS0xLTMxNDIy_980cc17e-71d1-4126-b139-8014d211542f">747.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2050 Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">***</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i02e45f2fba7e4eaa8262e45ee8ba765e_I20211231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzM2LTEtMS0xLTMxNDIy_1ded1ae7-c1b2-4dc9-9588-bedbacaff7fc">4.000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e45f2fba7e4eaa8262e45ee8ba765e_I20211231" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzM2LTMtMS0xLTMxNDIy_094368d5-767b-4f85-b35e-df49ae988fd1">2,205.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i334d1da043744144986b7f8f561ca005_I20201231" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzM2LTUtMS0xLTMxNDIy_4807e747-3779-4d52-a704-22f0f1cf5042">2,209.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD Term Loan Facility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74057de14b554e19bbd06da1ecb3f7f6_I20211231" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzM3LTMtMS0xLTMxNDIy_00ae4d2a-eedc-47d8-a31d-32296922f893">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11a32a3e965842e590fc770eeb365fa6_I20201231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzM3LTUtMS0xLTMxNDIy_1ee8d1fa-d5f1-4e31-8e17-9963ba2cd0d7">600.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">YEN Term Loan Facility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic54954704318489dbfab83d2b541d300_I20211231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzM4LTMtMS0xLTMxNDIy_a87a4ca1-e1c8-4463-bf29-9d96f53e953b">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3950381ba5bc4ae0902d2fcdc22dd1cc_I20201231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzM4LTUtMS0xLTMxNDIy_1f813a97-8a69-4d24-a39c-fa97bda3d617">17.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing fees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzM5LTMtMS0xLTMxNDIy_2995ba72-59f9-4829-a9a9-ccf7c91bd415">42.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzM5LTUtMS0xLTMxNDIy_77beb95e-78b4-473a-9655-286fbbe31123">47.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzQwLTMtMS0xLTMxNDIy_28f60400-ed1f-44fc-871f-3bcb0490c10e">19,717.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzQwLTUtMS0xLTMxNDIy_942bc338-3e7e-43b4-9c54-b021093cd7bf">22,429.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________&#160;&#160;&#160;&#160; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.8pt">The 2021 Senior Notes were repaid at maturity in the second quarter of 2021. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">In the first quarter of 2020, the Company terminated interest rate swaps designated as a fair value hedge resulting in net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="ie66cc87b7d3e4499960b357a925f9705_D20200101-20200331" decimals="-6" name="us-gaap:ProceedsFromSaleOfSecuritiesOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2XzEwOTk1MTE2MzgxNTg_0252d9f1-f9b3-422f-b50b-d28251eb5d18">45</ix:nonFraction>&#160;million. The fair value adjustment is being amortized to interest expense over the remaining term of the notes.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> &#160;&#160;&#160;&#160;Instrument was issued by Mylan Inc.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">** &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Instrument was originally issued by Mylan N.V.; now held by Utah Acquisition Sub Inc.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">*** &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Instrument was issued by Viatris Inc.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">115</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">**** &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Instrument was issued by Upjohn Finance B.V.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Notes</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Upjohn Senior Notes</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Combination, in June 2020, Viatris and Upjohn Finance B.V. completed privately placed debt offerings of $<ix:nonFraction unitRef="usd" contextRef="if8fd6f22b8424a83b40aff917e8d37be_I20210630" decimals="-7" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2XzM5MDQ_94d4c1e2-040f-44a2-b48d-606e3e37b8c5">7.45</ix:nonFraction>&#160;billion aggregate principal amount of the Unregistered Upjohn U.S. Dollar Notes and &#8364;<ix:nonFraction unitRef="eur" contextRef="i29d46e9d61754785892f1c72d3742cca_I20210630" decimals="-7" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2XzU0OTc1NTgxNzQwNDU_48741b15-9e8b-4908-a092-d97685857fc4">3.60</ix:nonFraction>&#160;billion aggregate principal amount of the Upjohn Euro Notes, respectively, and entered into other financing arrangements described below under &#8220;USD Term Loan Facility, 2020 Revolving Facility, YEN Term Loan Facility and 2021 Revolving Facility&#8221;. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Unregistered Upjohn U.S. Dollar Notes were issued pursuant to an indenture dated June 22, 2020. The Unregistered Upjohn U.S. Dollar Notes were issued in a private offering exempt from the registration requirements of the Securities Act to qualified institutional buyers in accordance with Rule 144A under the Securities Act and to persons outside of the U.S. pursuant to Regulation S under the Securities Act. Viatris entered into a registration rights agreement, dated as of June 22, 2020 pursuant to which Viatris was required to use commercially reasonable efforts to file a registration statement with respect to an offer to exchange each series of the Unregistered Upjohn U.S. Dollar Notes for new notes with the same aggregate principal amount and terms substantially identical in all material respects. In September 2021, Viatris filed a registration statement with the SEC with respect to an offer to exchange up to $<ix:nonFraction unitRef="usd" contextRef="i3c0b7c74c50145a7a9f8bcb989137313_I20210930" decimals="-7" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2XzEwOTk1MTE2NjI4NjA_b5297690-70e2-4c81-8bc8-6b262d4d1aa1">7.45</ix:nonFraction>&#160;billion aggregate principal amount of Unregistered Upjohn U.S. Dollar Notes with Registered Upjohn Notes in the same aggregate principal amount and with terms substantially identical in all material respects, which was declared effective on September 28, 2021. The exchange offer expired on October 28, 2021 and settled on October 29, 2021. More than <ix:nonFraction unitRef="number" contextRef="i74907a0e3a4245c29c61474d06752931_I20211029" decimals="3" name="vtrs:DebtInstrumentConversionOfUnregisteredNotesToRegisteredNotesAsAPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2XzEwOTk1MTE2NjI5MzM_11ee286a-06bd-42d6-9449-dd73c259d5ff">99.9</ix:nonFraction>% of the aggregate principal amount of the Unregistered Upjohn U.S. Dollar Notes were exchanged for Registered Upjohn Notes. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Upjohn Euro Notes were issued pursuant to an indenture dated June 23, 2020. The Upjohn Euro Notes were guaranteed upon issuance by Viatris and were issued in a private offering exempt from the registration requirements of the Securities Act, to persons outside of the U.S. pursuant to Regulation S under the Securities Act. Viatris and Upjohn Finance B.V. are U.S. dollar functional entities. </span></div><ix:nonNumeric contextRef="i383cdb78da1740a096ade479d7d4de29_D20210101-20211231" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2Xzk2NjE_98170b2e-f455-45f1-8b63-c361a6db0578" escape="true"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about the Upjohn Senior Notes issued in June 2020:</span></div><div style="margin-bottom:10pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Value</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 Senior Notes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide9302296aa644ea9e1bdea342face9a_I20210630" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTphODQ0NTFkYjg1NDM0MTc5OGM4ZGJlM2Q4NjE1NTQ4Ny90YWJsZXJhbmdlOmE4NDQ1MWRiODU0MzQxNzk4YzhkYmUzZDg2MTU1NDg3XzMtMS0xLTEtMzE0MjI_f5a91299-f4c4-4f6e-8704-2f68ad4855be">1,000.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86acbd5fe13c4222ac75586b553e6158_I20210630" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTphODQ0NTFkYjg1NDM0MTc5OGM4ZGJlM2Q4NjE1NTQ4Ny90YWJsZXJhbmdlOmE4NDQ1MWRiODU0MzQxNzk4YzhkYmUzZDg2MTU1NDg3XzQtMS0xLTEtMzE0MjI_6af95d5e-1293-4860-bc53-e80198e6efd1">750.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic43055109f72489cb27f40c7c7d4de3c_I20210630" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTphODQ0NTFkYjg1NDM0MTc5OGM4ZGJlM2Q4NjE1NTQ4Ny90YWJsZXJhbmdlOmE4NDQ1MWRiODU0MzQxNzk4YzhkYmUzZDg2MTU1NDg3XzUtMS0xLTEtMzE0MjI_865cc3b0-d825-4a59-b3d3-3c8e9f69093b">750.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2030 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c9dbf2c41f4039ae995c0da9b29464_I20210630" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTphODQ0NTFkYjg1NDM0MTc5OGM4ZGJlM2Q4NjE1NTQ4Ny90YWJsZXJhbmdlOmE4NDQ1MWRiODU0MzQxNzk4YzhkYmUzZDg2MTU1NDg3XzYtMS0xLTEtMzE0MjI_5819796a-4ed5-4bb7-a9aa-4982da82be85">1,450.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2040 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i377de9a7ca4747a9bb0851b1789fcf71_I20210630" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTphODQ0NTFkYjg1NDM0MTc5OGM4ZGJlM2Q4NjE1NTQ4Ny90YWJsZXJhbmdlOmE4NDQ1MWRiODU0MzQxNzk4YzhkYmUzZDg2MTU1NDg3XzctMS0xLTEtMzE0MjI_9098fc8c-df85-4d46-bdd1-aa70b8346177">1,500.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2050 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90b2414ad8e14d89af5f6b93c78866b8_I20210630" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTphODQ0NTFkYjg1NDM0MTc5OGM4ZGJlM2Q4NjE1NTQ4Ny90YWJsZXJhbmdlOmE4NDQ1MWRiODU0MzQxNzk4YzhkYmUzZDg2MTU1NDg3XzgtMS0xLTEtMzE0MjI_d7121a3d-4505-41d4-b9d8-993475e5ba35">2,000.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 Euro Senior Note</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc91d97ca69b44cb8428d304cc80e7ff_I20210630" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTphODQ0NTFkYjg1NDM0MTc5OGM4ZGJlM2Q4NjE1NTQ4Ny90YWJsZXJhbmdlOmE4NDQ1MWRiODU0MzQxNzk4YzhkYmUzZDg2MTU1NDg3XzktMS0xLTEtMzE0MjI_16f1fc36-3268-4c5c-a599-10ccf5b1a27e">916.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Euro Senior Note</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i012d654e3d7e4404bb0b696b2beb3cbb_I20210630" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTphODQ0NTFkYjg1NDM0MTc5OGM4ZGJlM2Q4NjE1NTQ4Ny90YWJsZXJhbmdlOmE4NDQ1MWRiODU0MzQxNzk4YzhkYmUzZDg2MTU1NDg3XzEwLTEtMS0xLTMxNDIy_747f1119-cf3a-41e0-b356-b2f18601ae2a">916.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Euro Senior Note</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf2e4abfbda046d1983677a1e0f26357_I20210630" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTphODQ0NTFkYjg1NDM0MTc5OGM4ZGJlM2Q4NjE1NTQ4Ny90YWJsZXJhbmdlOmE4NDQ1MWRiODU0MzQxNzk4YzhkYmUzZDg2MTU1NDg3XzExLTEtMS0xLTMxNDIy_3a442b8d-ba3f-4efe-a424-2368d294483f">1,038.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2032 Euro Senior Note</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c5cbc4a7ad247e1816ce79abab0f406_I20210630" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTphODQ0NTFkYjg1NDM0MTc5OGM4ZGJlM2Q4NjE1NTQ4Ny90YWJsZXJhbmdlOmE4NDQ1MWRiODU0MzQxNzk4YzhkYmUzZDg2MTU1NDg3XzEyLTEtMS0xLTMxNDIy_9fcaf68f-1ab1-4a24-accd-2568c5890659">1,527.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i848b6b54a3a148dba6adff4fa331012e_I20210630" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTphODQ0NTFkYjg1NDM0MTc5OGM4ZGJlM2Q4NjE1NTQ4Ny90YWJsZXJhbmdlOmE4NDQ1MWRiODU0MzQxNzk4YzhkYmUzZDg2MTU1NDg3XzEzLTEtMS0xLTMxNDIy_5bf3ecc0-721d-47f0-843e-37667ed3ebd1">11,847.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net proceeds from the offerings of the Upjohn Senior Notes, together with the proceeds from the $<ix:nonFraction unitRef="usd" contextRef="i3861691874974533b0f4beb0f744696d_I20200630" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2XzEwOTk1MTE2NjI4OTg_1b3542ba-865c-4d19-8812-ecaecb14aef3">600</ix:nonFraction>&#160;million USD Term Loan Facility, were utilized to fund the $<ix:nonFraction unitRef="usd" contextRef="i73d9cbc916614385999dea1173262904_D20201113-20201113" decimals="-9" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2XzU2Nzc_38230083-7c75-4f1f-b7a7-a53848c4419f">12</ix:nonFraction>&#160;billion cash payment by Viatris to Pfizer as partial consideration for Pfizer&#8217;s contribution of the Upjohn Business to Viatris and related transaction fees and expenses. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assumptions and Guarantees of Senior Unsecured Notes</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Viatris Inc. is the issuer of the Upjohn U.S. Dollar Notes, which are fully and unconditionally guaranteed on a senior unsecured basis by Mylan Inc., Mylan II B.V. and Utah Acquisition Sub Inc.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upjohn Finance B.V. is the issuer of the Upjohn Euro Notes, which are fully and unconditionally guaranteed on a senior unsecured basis by Viatris Inc., Mylan Inc., Mylan II B.V. and Utah Acquisition Sub Inc. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">116</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the Combination, Utah Acquisition Sub Inc. is the issuer of the Utah U.S. Dollar Notes and the Utah Euro Notes, which are each fully and unconditionally guaranteed on a senior unsecured basis by Mylan Inc., Viatris Inc. and Mylan II B.V.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mylan Inc. is the issuer of the Mylan Inc. U.S. Dollar Notes and the Mylan Inc. Euro Notes, which are each fully and unconditionally guaranteed on a senior unsecured basis by Mylan II B.V., Viatris Inc. and Utah Acquisition Sub Inc.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">USD Term Loan Facility, 2020 Revolving Facility, YEN Term Loan Facility and 2021 Revolving Facility</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2020, Viatris entered into (i) the $<ix:nonFraction unitRef="usd" contextRef="i3861691874974533b0f4beb0f744696d_I20200630" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2Xzc2OTM_a8a2f1d9-d034-40d7-9bdc-06fa172bdc35">600</ix:nonFraction>&#160;million USD Term Loan Facility and (ii) the $<ix:nonFraction unitRef="usd" contextRef="ia9e52c1741c94fa0880ca65abe054094_I20200630" decimals="-7" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2Xzc3Mjk_2a96c8f5-c13d-4619-ad67-28b09ff18f7c">4.0</ix:nonFraction>&#160;billion 2020 Revolving Facility with various syndicates of banks. The USD Term Loan Facility and the 2020 Revolving Facility were fully repaid and terminated in July 2021.  </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, Viatris entered into (i) the &#165;<ix:nonFraction unitRef="jpy" contextRef="id4070295d773487892f0a0dafa6fb391_I20210731" decimals="-9" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2XzEwOTk1MTE2NDI4ODE_cd3861b9-d723-4caa-8708-eb5a4b3ebf99">40</ix:nonFraction>&#160;billion YEN Term Loan Facility and (ii) the $<ix:nonFraction unitRef="usd" contextRef="i7883883a0a384706bef726bfa103f3b5_I20210630" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2XzEwOTk1MTE2NDI4OTQ_fd61fb45-8836-4cd5-b5ee-86370de1b539">4.0</ix:nonFraction>&#160;billion 2021 Revolving Facility with various syndicates of banks. The 2021 Revolving Facility amended and restated the 2020 Revolving Facility and proceeds from the 2021 Revolving Facility were used to repay outstanding obligations under the 2020 Revolving Facility and the 2020 Revolving Facility was terminated. Proceeds from the YEN Term Loan Facility and the 2021 Revolving Facility were also used to repay the USD Term Loan Facility in full and the USD Term Loan Facility was terminated. The 2021 Revolving Facility and the YEN Term Loan Facility have substantially identical terms to the 2020 Revolving Facility and USD Term Loan Facility, respectively, with the following exceptions: 1) the maturity of both the YEN Term Loan Facility and the 2021 Revolving Facility is July 2026, 2) the pricing was adjusted to reflect current market prices (which were generally more favorable) and 3) the maximum leverage ratio as of the end of any quarter was set at <ix:nonFraction unitRef="rate" contextRef="i5bb284525f0d40259f76a744fbd30263_I20210731" decimals="INF" name="vtrs:MaximumLeverageRatioPeriodOne" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2XzEwOTk1MTE2NDI5MDg_c745e7e4-4332-46cb-a43f-8c2bff6b034d">4.25</ix:nonFraction> to 1.00 for each quarter ending after June 30, 2021 through and including June 30, 2022, <ix:nonFraction unitRef="rate" contextRef="i5bb284525f0d40259f76a744fbd30263_I20210731" decimals="INF" name="vtrs:MaximumLeverageRatioPeriodTwo" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2XzEwOTk1MTE2NDI5MjA_a533a232-b015-4bcd-b554-1635ee84ea7f">4.0</ix:nonFraction> to 1.00 for each quarter ending after June 30, 2022 through and including December 31, 2022 and <ix:nonFraction unitRef="rate" contextRef="i5bb284525f0d40259f76a744fbd30263_I20210731" decimals="INF" name="vtrs:MaximumLeverageRatioPeriodThree" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2XzEwOTk1MTE2NDI5MzE_7d786d58-2865-4461-a121-cd3392d0b9e2">3.75</ix:nonFraction> to 1.00 thereafter, except in circumstances as defined in the related credit agreement. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The YEN Term Loan Facility and the 2021 Revolving Facility contain customary affirmative covenants for facilities of this type, covenants pertaining to the delivery of financial statements, notices of default and certain material events, maintenance of corporate existence and rights, property, and insurance and compliance with laws, as well as customary negative covenants for facilities of this type, including limitations on the incurrence of subsidiary indebtedness, liens, mergers and certain other fundamental changes, investments and loans, acquisitions, transactions with affiliates, payments of dividends and other restricted payments and changes in our lines of business.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021 and 2020, the aggregate fair value of the Company&#8217;s outstanding notes was approximately $<ix:nonFraction unitRef="usd" contextRef="i20a65018b503434b88c9fd17e0c1dd18_I20211231" decimals="-7" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2XzkyMzk_cdcea42b-5438-4bff-945e-1c3af3d8a351">22.01</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="ib7f720468bec473f88d7a755ce8a5ae1_I20201231" decimals="-7" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2XzkyNDY_a27a7eb6-b0ef-4740-aff6-a7b012ee5836">25.90</ix:nonFraction> billion, respectively. The fair values of the outstanding notes were valued at quoted market prices from broker or dealer quotations and were classified as Level 2 in the fair value hierarchy.</span></div><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2Xzk2Mjc_87c1e481-e232-45ca-b853-b66e87197dac" escape="true"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mandatory minimum repayments remaining on the notional amount of outstanding long-term debt at December&#160;31, 2021 were as follows for each of the periods ending December 31:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:89.090%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.710%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTpmNmM2NzUwNGY3Y2Q0NjA5YTZjYjg5ZjYwNDRmNWYxOC90YWJsZXJhbmdlOmY2YzY3NTA0ZjdjZDQ2MDlhNmNiODlmNjA0NGY1ZjE4XzEtMS0xLTEtMzE0MjI_9738490e-d026-4f36-8063-b54b6645840e">1,853</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTpmNmM2NzUwNGY3Y2Q0NjA5YTZjYjg5ZjYwNDRmNWYxOC90YWJsZXJhbmdlOmY2YzY3NTA0ZjdjZDQ2MDlhNmNiODlmNjA0NGY1ZjE4XzItMS0xLTEtMzE0MjI_1398c11c-0b70-402a-9ef1-d6f1b1ebf475">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTpmNmM2NzUwNGY3Y2Q0NjA5YTZjYjg5ZjYwNDRmNWYxOC90YWJsZXJhbmdlOmY2YzY3NTA0ZjdjZDQ2MDlhNmNiODlmNjA0NGY1ZjE4XzMtMS0xLTEtMzE0MjI_1c507ec2-a9d5-44c4-8bc2-8366af2bdbd0">1,990</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTpmNmM2NzUwNGY3Y2Q0NjA5YTZjYjg5ZjYwNDRmNWYxOC90YWJsZXJhbmdlOmY2YzY3NTA0ZjdjZDQ2MDlhNmNiODlmNjA0NGY1ZjE4XzQtMS0xLTEtMzE0MjI_916b529c-23a6-45e5-ba8a-76b694c2faff">1,318</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTpmNmM2NzUwNGY3Y2Q0NjA5YTZjYjg5ZjYwNDRmNWYxOC90YWJsZXJhbmdlOmY2YzY3NTA0ZjdjZDQ2MDlhNmNiODlmNjA0NGY1ZjE4XzUtMS0xLTEtMzE0MjI_0cad874e-4f40-4857-be11-632c5a0d61fc">2,598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTpmNmM2NzUwNGY3Y2Q0NjA5YTZjYjg5ZjYwNDRmNWYxOC90YWJsZXJhbmdlOmY2YzY3NTA0ZjdjZDQ2MDlhNmNiODlmNjA0NGY1ZjE4XzYtMS0xLTEtMzE0MjI_0dddd191-5d36-4785-818c-86fbc939698e">11,940</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTpmNmM2NzUwNGY3Y2Q0NjA5YTZjYjg5ZjYwNDRmNWYxOC90YWJsZXJhbmdlOmY2YzY3NTA0ZjdjZDQ2MDlhNmNiODlmNjA0NGY1ZjE4XzctMS0xLTEtMzE0MjI_19910e9b-454a-43ba-97e8-01039a7b410f">20,949</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">117</span></div></div></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_214"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90ZXh0cmVnaW9uOjI1NDU2MWI5YmE3MjQ0NzM4NDgxZDk3YzRkMGUxZWJjXzIxOA_af973097-23b3-4b28-bfde-2da1030a227c" continuedAt="id65181ea5f554e40ab4c1e2de0369ee9" escape="true">Comprehensive (Loss) Earnings</ix:nonNumeric></span></div><ix:continuation id="id65181ea5f554e40ab4c1e2de0369ee9" continuedAt="i19b77d5e036744e589c527828e6f8a4e"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90ZXh0cmVnaW9uOjI1NDU2MWI5YmE3MjQ0NzM4NDgxZDk3YzRkMGUxZWJjXzIyNA_1af628be-fb30-4ae2-a7bd-e35a5192ec6f" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated other comprehensive loss, as reflected in the consolidated balance sheets, is comprised of the following:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:76.661%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.652%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized gain on marketable securities, net of tax</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTo3ODk1MmMzOTFiMTE0NDEwYjllZTU4ZjU3ZjM1ODEwOS90YWJsZXJhbmdlOjc4OTUyYzM5MWIxMTQ0MTBiOWVlNThmNTdmMzU4MTA5XzItMS0xLTEtMzE0MjI_4795f6bd-d39b-4820-b089-0cc4a5d6d4db">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTo3ODk1MmMzOTFiMTE0NDEwYjllZTU4ZjU3ZjM1ODEwOS90YWJsZXJhbmdlOjc4OTUyYzM5MWIxMTQ0MTBiOWVlNThmNTdmMzU4MTA5XzItMy0xLTEtMzE0MjI_35fdf7ea-e8a8-46ab-87b9-eea34f208633">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrecognized (loss) gain and prior service cost related to defined benefit plans, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTo3ODk1MmMzOTFiMTE0NDEwYjllZTU4ZjU3ZjM1ODEwOS90YWJsZXJhbmdlOjc4OTUyYzM5MWIxMTQ0MTBiOWVlNThmNTdmMzU4MTA5XzMtMS0xLTEtMzE0MjI_6d92ef88-dfbb-4347-917d-56bd16d19e10">32.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTo3ODk1MmMzOTFiMTE0NDEwYjllZTU4ZjU3ZjM1ODEwOS90YWJsZXJhbmdlOjc4OTUyYzM5MWIxMTQ0MTBiOWVlNThmNTdmMzU4MTA5XzMtMy0xLTEtMzE0MjI_2de6e5c3-02d4-4b1c-a64f-8e31b0262df3">26.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrecognized loss on derivatives in cash flow hedging relationships, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c4b4c0b310e423483a0fc1a47ab012a_I20211231" decimals="-5" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTo3ODk1MmMzOTFiMTE0NDEwYjllZTU4ZjU3ZjM1ODEwOS90YWJsZXJhbmdlOjc4OTUyYzM5MWIxMTQ0MTBiOWVlNThmNTdmMzU4MTA5XzQtMS0xLTEtMzE0MjI_4799ff54-4531-4308-9fb7-cdf466fa10ef">9.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i976d65e83c19475783582ea166af72a4_I20201231" decimals="-5" sign="-" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTo3ODk1MmMzOTFiMTE0NDEwYjllZTU4ZjU3ZjM1ODEwOS90YWJsZXJhbmdlOjc4OTUyYzM5MWIxMTQ0MTBiOWVlNThmNTdmMzU4MTA5XzQtMy0xLTEtMzE0MjI_dc0fb32d-450d-4a1d-922d-c49f1799dcf4">18.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrecognized loss on derivatives in net investment hedging relationships, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56fdbd1f3d9e4c75876f8cf6831038f3_I20211231" decimals="-5" name="vtrs:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTo3ODk1MmMzOTFiMTE0NDEwYjllZTU4ZjU3ZjM1ODEwOS90YWJsZXJhbmdlOjc4OTUyYzM5MWIxMTQ0MTBiOWVlNThmNTdmMzU4MTA5XzUtMS0xLTEtMzE0MjI_6918df2b-298c-49cb-b35b-5af0ecf10d36">16.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c0da8410b1d4621bf16fd27e6c27d7f_I20201231" decimals="-5" sign="-" name="vtrs:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTo3ODk1MmMzOTFiMTE0NDEwYjllZTU4ZjU3ZjM1ODEwOS90YWJsZXJhbmdlOjc4OTUyYzM5MWIxMTQ0MTBiOWVlNThmNTdmMzU4MTA5XzUtMy0xLTEtMzE0MjI_bfcc8a24-b56a-443d-adb6-9c3924c44f92">353.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTo3ODk1MmMzOTFiMTE0NDEwYjllZTU4ZjU3ZjM1ODEwOS90YWJsZXJhbmdlOjc4OTUyYzM5MWIxMTQ0MTBiOWVlNThmNTdmMzU4MTA5XzYtMS0xLTEtMzE0MjI_a1ba6c7d-c9fa-46d7-964f-3f4856377b22">1,802.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTo3ODk1MmMzOTFiMTE0NDEwYjllZTU4ZjU3ZjM1ODEwOS90YWJsZXJhbmdlOjc4OTUyYzM5MWIxMTQ0MTBiOWVlNThmNTdmMzU4MTA5XzYtMy0xLTEtMzE0MjI_ad419db1-4da7-42a5-92c1-7bad3d02b67a">461.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87a0adf309ee48cab4e379bd487453b4_I20211231" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTo3ODk1MmMzOTFiMTE0NDEwYjllZTU4ZjU3ZjM1ODEwOS90YWJsZXJhbmdlOjc4OTUyYzM5MWIxMTQ0MTBiOWVlNThmNTdmMzU4MTA5XzctMS0xLTEtMzE0MjI_c5ce1d88-266b-47e5-b0d9-67b52eed3a5e">1,744.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTo3ODk1MmMzOTFiMTE0NDEwYjllZTU4ZjU3ZjM1ODEwOS90YWJsZXJhbmdlOjc4OTUyYzM5MWIxMTQ0MTBiOWVlNThmNTdmMzU4MTA5XzctMy0xLTEtMzE0MjI_3f3457a0-383b-4529-98f1-eedbc4dc2028">858.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90ZXh0cmVnaW9uOjI1NDU2MWI5YmE3MjQ0NzM4NDgxZDk3YzRkMGUxZWJjXzIyMA_b52c5df7-f229-49d9-9925-40d94d30c28e" continuedAt="i8c95327f23e64112828cb3a89151663f" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of accumulated other comprehensive (loss) earnings, before tax, consist of the following:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr style="height:36pt"><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Derivatives in Cash Flow Hedging Relationships</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Net Investment Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Marketable Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Defined Pension Plan Items</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Totals</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Forward Contracts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020, net of tax</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i976d65e83c19475783582ea166af72a4_I20201231" decimals="-5" sign="-" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzMtNS0xLTEtMzE0MjI_dc0fb32d-450d-4a1d-922d-c49f1799dcf4">18.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c0da8410b1d4621bf16fd27e6c27d7f_I20201231" decimals="-5" sign="-" name="vtrs:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzMtNy0xLTEtMzE0MjI_bfcc8a24-b56a-443d-adb6-9c3924c44f92">353.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzMtOS0xLTEtMzE0MjI_35fdf7ea-e8a8-46ab-87b9-eea34f208633">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzMtMTEtMS0xLTMxNDIy_2de6e5c3-02d4-4b1c-a64f-8e31b0262df3">26.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzMtMTMtMS0xLTMxNDIy_ad419db1-4da7-42a5-92c1-7bad3d02b67a">461.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzMtMTUtMS0xLTMxNDIy_3f3457a0-383b-4529-98f1-eedbc4dc2028">858.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (loss) before reclassifications, before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1df50837d39f4ce5b1c56c576becf8f5_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzQtNS0xLTEtMzE0MjI_8c983317-0a7a-4d52-be25-4833b0909a46">62.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72a4e38013274704acf3fce567aec1b6_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzQtNy0xLTEtMzE0MjI_7c1324e2-9927-4f3e-b515-faefcb2b6c25">456.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzQtOS0xLTEtMzE0MjI_93350b42-fefb-47ed-8cf0-6809007e048f">1.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdef52c121a44daba62d16f7a225ea09_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzQtMTEtMS0xLTMxNDIy_0130e98a-908e-4f4a-9607-fbefb3b5fac5">67.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9752ebd80b74eb987fba8598e4bf4a2_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzQtMTMtMS0xLTMxNDIy_591892e5-da9a-4612-b3ba-ed64aa87190f">1,340.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92e45e4918604661b681cd5b227d7bcc_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzQtMTUtMS0xLTMxNDIy_a4aa203a-5da7-42a6-8259-a95189778593">755.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive earnings (loss), before tax:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on foreign exchange forward contracts classified as cash flow hedges, included in net sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45d796a115fe452291c016b2351113f4_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzYtMS0xLTEtMzE0MjI_61302cd1-b923-4c76-a9f7-a86a254600e1">30.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieba8727d1a644f5981104c3b153e5919_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzYtNS0xLTEtMzE0MjI_fe844357-a245-4753-8558-94783e1ca039">30.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62110eec7c9843279ebc30fd8c8fa53f_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzYtMTUtMS0xLTMxNDIy_864e0edf-65f6-4643-91a7-1d950b3ef7f0">30.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on interest rate swaps classified as cash flow hedges, included in interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43ffbc95ec5f4ed288d39bc9f96f6c51_D20210101-20211231" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzctMy0xLTEtMzE0MjI_c3992ccb-d5d2-4a57-bfe5-4a556da06238">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6ab091030ea4646909dc299bb408d0a_D20210101-20211231" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzctNS0xLTEtMzE0MjI_4ef5e9b6-ea3f-4151-a24f-6e5a92f4f467">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25e2d0bb39cd4c969048c3e9ffe0f1c7_D20210101-20211231" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzctMTUtMS0xLTMxNDIy_0a2c1dbb-e4bb-4b4e-955c-9bc9ac1977e6">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service costs included in SG&amp;A </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c05a74c19dd474e9110514b3ceb45a0_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzgtMTEtMS0xLTMxNDIy_dc48c379-107f-48f3-82c3-422be6f74c77">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4e35c11727664c4ea9b3141cf19e2205_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzgtMTUtMS0xLTMxNDIy_56afc341-543f-460b-8d25-1887afa980ce">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial loss included in SG&amp;A </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c05a74c19dd474e9110514b3ceb45a0_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzktMTEtMS0xLTMxNDIy_78ed2627-020f-4196-bd50-842927829345">7.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e35c11727664c4ea9b3141cf19e2205_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzktMTUtMS0xLTMxNDIy_97d155de-64ca-4122-9df3-91ddc557517a">7.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive earnings (loss), before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1df50837d39f4ce5b1c56c576becf8f5_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzEwLTUtMS0xLTMxNDIy_284d95af-29c6-48cd-9251-2d46eb046e37">36.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72a4e38013274704acf3fce567aec1b6_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzEwLTctMS0xLTMxNDIy_16ec1624-a1ed-4788-b152-45e5ba54667b">456.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzEwLTktMS0xLTMxNDIy_2a1e26b2-5f56-4f6d-b55e-bee04b1f9707">1.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzEwLTExLTEtMS0zMTQyMg_bbf2c8fc-440a-44ff-a82b-c94221b4d23a">73.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9752ebd80b74eb987fba8598e4bf4a2_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzEwLTEzLTEtMS0zMTQyMg_40db388a-e86b-4f8d-87be-5813fa0a5b6e">1,340.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzEwLTE1LTEtMS0zMTQyMg_859f2352-946b-495a-b276-d28cc45ece97">775.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1df50837d39f4ce5b1c56c576becf8f5_D20210101-20211231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzExLTUtMS0xLTMxNDIy_2a0f829d-8334-4bbf-8b53-21007aeefc29">8.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72a4e38013274704acf3fce567aec1b6_D20210101-20211231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzExLTctMS0xLTMxNDIy_8cbb1902-7275-4f1d-8e8c-fa257deba2f3">86.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1b8be0d1b2a44c1902af29f75363f53_D20210101-20211231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzExLTktMS0xLTMxNDIy_45ff5fdd-e7a2-45b4-bf49-0730a142d22e">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c05a74c19dd474e9110514b3ceb45a0_D20210101-20211231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzExLTExLTEtMS0zMTQyMg_88d0fad1-3f8f-465f-968e-6ae75958092c">15.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90f54d9de46f4354845f2d01a1f04798_D20210101-20211231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzExLTEzLTEtMS0zMTQyMg_4f4ec447-4e21-472c-99fc-8c184029dc9e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e35c11727664c4ea9b3141cf19e2205_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzExLTE1LTEtMS0zMTQyMg_c02abd6a-85ec-452b-8f59-2177068870df">111.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c4b4c0b310e423483a0fc1a47ab012a_I20211231" decimals="-5" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzEzLTUtMS0xLTMxNDIy_4799ff54-4531-4308-9fb7-cdf466fa10ef">9.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56fdbd1f3d9e4c75876f8cf6831038f3_I20211231" decimals="-5" name="vtrs:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzEzLTctMS0xLTMxNDIy_6918df2b-298c-49cb-b35b-5af0ecf10d36">16.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzEzLTktMS0xLTMxNDIy_4795f6bd-d39b-4820-b089-0cc4a5d6d4db">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzEzLTExLTEtMS0zMTQyMg_6d92ef88-dfbb-4347-917d-56bd16d19e10">32.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzEzLTEzLTEtMS0zMTQyMg_a1ba6c7d-c9fa-46d7-964f-3f4856377b22">1,802.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87a0adf309ee48cab4e379bd487453b4_I20211231" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzEzLTE1LTEtMS0zMTQyMg_c5ce1d88-266b-47e5-b0d9-67b52eed3a5e">1,744.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:center"><ix:continuation id="i19b77d5e036744e589c527828e6f8a4e" continuedAt="if84f6f6ba9ee48bc8ddab8ecfc10b556"><ix:continuation id="i8c95327f23e64112828cb3a89151663f" continuedAt="i194738bc4d2f45a2bbfb5007d5fa7b28"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr style="height:36pt"><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Derivatives in Cash Flow Hedging Relationships</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Net Investment Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Marketable Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Defined Pension Plan Items</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Totals</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Forward Contracts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019, net of tax</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic989ea6602bd4856815f90f895e12304_I20191231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzMtNS0xLTEtMzE0MjI_a485cfde-133d-47ad-9ef4-533a968028f3">31.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c1519bf270f496eacbc594c4a0b7a1c_I20191231" decimals="-5" sign="-" name="vtrs:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzMtNy0xLTEtMzE0MjI_7d30cf76-b6e8-4592-96c5-6c1b61d93a0d">74.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3917c4bfc784a928c09f599e63910fb_I20191231" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzMtOS0xLTEtMzE0MjI_590d5334-9881-4bf7-aaaa-5106e7ced438">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0257efc303d94390b5707bbcdb863e52_I20191231" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzMtMTEtMS0xLTMxNDIy_1b3f47af-da3b-41be-9ffe-a198f3a55301">17.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7ff2cf5a8154924b32963fb78602f3a_I20191231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzMtMTMtMS0xLTMxNDIy_15d9e157-02e2-4c1d-a0c4-18c2b49bdd93">1,674.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic39189fc54504b53be3c4281e5dd8f82_I20191231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzMtMTUtMS0xLTMxNDIy_b539d8a8-cce3-40f9-bf3d-85329d789e9d">1,797.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) earnings before reclassifications, before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34f962bd787c40be86356d0feb3e5e5d_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzQtNS0xLTEtMzE0MjI_a387f50e-ddd8-4f1c-beea-c7280296acd8">18.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie12ac8dbb8e34d9bbb1bb903a175a2c8_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzQtNy0xLTEtMzE0MjI_d75ad2ec-8ace-45f7-b524-8dee31232d98">305.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28fba30d8dfb4cd0851b24ff8fafab59_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzQtOS0xLTEtMzE0MjI_94c72d41-8ad5-45d8-b705-aff19d21352f">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id107db472b49491e9da06a69c94e6b07_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzQtMTEtMS0xLTMxNDIy_a307e9d0-bbaf-4b8b-aaab-cfc0e27a3197">12.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c5bfbeaa4b84f669ddcb52c7676aa3a_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzQtMTMtMS0xLTMxNDIy_85494727-0484-4ef5-9de7-19fe02b0198f">1,213.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e5cd61854a54e59a6e1744de70eab75_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzQtMTUtMS0xLTMxNDIy_f0bfdef5-5177-499b-a676-aa09b956919a">914.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive (loss) earnings, before tax:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on foreign exchange forward contracts classified as cash flow hedges, included in net sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3048feb477df4b8aa1d56be7df44692f_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzYtMS0xLTEtMzE0MjI_807014ad-2399-4dfe-a926-e5e62fa93c41">4.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b952231de244bb5b8417597c8764975_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzYtNS0xLTEtMzE0MjI_4c8fca0b-ea57-4f7a-96cd-12623e558c3d">4.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7bd68519c5854bc58140fde2099d16e2_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzYtMTUtMS0xLTMxNDIy_9fcd4cc8-1fbc-4c63-bb99-aab149915478">4.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on interest rate swaps classified as cash flow hedges, included in interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic20e72bb356c49d2a349292f49d443ab_D20200101-20201231" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzctMy0xLTEtMzE0MjI_5de84633-f693-4605-b9f9-d8da8e09f478">4.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff87963fcab3463b90b3aec7f030e7e8_D20200101-20201231" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzctNS0xLTEtMzE0MjI_7252ff99-b144-4b75-b019-1bb306874982">4.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia95c695111874fdbb3c0f5b149b44326_D20200101-20201231" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzctMTUtMS0xLTMxNDIy_0a0d397e-93eb-4a4c-8387-3296e1474794">4.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service costs included in SG&amp;A </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d41891210be43e2af666133ce0c96d7_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzgtMTEtMS0xLTMxNDIy_73a7dc0f-59b2-4c60-9236-d5f3d28f6e2e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee696baa8c049df95516f082b5ca622_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzgtMTUtMS0xLTMxNDIy_70728d34-cdb4-4a42-a261-a64962e00d98">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial loss included in SG&amp;A </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d41891210be43e2af666133ce0c96d7_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzktMTEtMS0xLTMxNDIy_c318d5a2-4f10-4862-a4a8-d0e3a24904f1">1.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ee696baa8c049df95516f082b5ca622_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzktMTUtMS0xLTMxNDIy_ec842ee4-cb30-4c1d-875c-048737905133">1.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive (loss) earnings, before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b0e6896d0904a51b7f3d01a54c4ddc3_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzEwLTUtMS0xLTMxNDIy_c22a7418-4827-44ac-83b7-6ef3e74592b3">18.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie12ac8dbb8e34d9bbb1bb903a175a2c8_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzEwLTctMS0xLTMxNDIy_f7fa54bb-04aa-476d-a45d-0c9890c38041">305.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzEwLTktMS0xLTMxNDIy_7b3568ce-12e0-4e70-843d-4b0cf9c57117">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzEwLTExLTEtMS0zMTQyMg_3346e7b2-e4d3-4ca0-948c-59783a466401">14.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c5bfbeaa4b84f669ddcb52c7676aa3a_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzEwLTEzLTEtMS01NDUyNw_20676964-1fcf-453a-93f9-cdb9f88b2946">1,213.0</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e5cd61854a54e59a6e1744de70eab75_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzEwLTE1LTEtMS0zMTQyMg_86445e5a-64a5-4518-bad9-6747a92e2b84">912.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision (benefit)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32ef6703441a420db1866b7d7f4c494b_D20200101-20201231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzExLTUtMS0xLTMxNDIy_e6a4bf7e-099b-4690-ad51-192443dcfde9">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie12ac8dbb8e34d9bbb1bb903a175a2c8_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzExLTctMS0xLTMxNDIy_8189f02a-6a70-458f-ae07-116757fa68ca">25.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i321781565b4145808e327741d1625660_D20200101-20201231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzExLTktMS0xLTMxNDIy_dac3d3e8-f03b-49be-bd8d-928019a86f79">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d41891210be43e2af666133ce0c96d7_D20200101-20201231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzExLTExLTEtMS0zMTQyMg_0ff9124a-9a26-4d47-9484-c56551847495">5.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c5bfbeaa4b84f669ddcb52c7676aa3a_D20200101-20201231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzExLTEzLTEtMS0zMTQyMg_9a5d9f44-656a-4d5a-b32e-c798858a467e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ee696baa8c049df95516f082b5ca622_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzExLTE1LTEtMS0zMTQyMg_a72f462d-43db-4755-b034-6bf1668c3eaa">26.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i976d65e83c19475783582ea166af72a4_I20201231" decimals="-5" sign="-" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzEzLTUtMS0xLTMxNDIy_dc0fb32d-450d-4a1d-922d-c49f1799dcf4">18.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c0da8410b1d4621bf16fd27e6c27d7f_I20201231" decimals="-5" sign="-" name="vtrs:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzEzLTctMS0xLTMxNDIy_bfcc8a24-b56a-443d-adb6-9c3924c44f92">353.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzEzLTktMS0xLTMxNDIy_35fdf7ea-e8a8-46ab-87b9-eea34f208633">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzEzLTExLTEtMS0zMTQyMg_2de6e5c3-02d4-4b1c-a64f-8e31b0262df3">26.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzEzLTEzLTEtMS0zMTQyMg_ad419db1-4da7-42a5-92c1-7bad3d02b67a">461.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzEzLTE1LTEtMS0zMTQyMg_3f3457a0-383b-4529-98f1-eedbc4dc2028">858.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">119</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:7pt;text-align:center"><ix:continuation id="if84f6f6ba9ee48bc8ddab8ecfc10b556"><ix:continuation id="i194738bc4d2f45a2bbfb5007d5fa7b28"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Derivatives in Cash Flow Hedging Relationships</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Net Investment Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Marketable Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Defined Pension Plan Items</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Totals</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Forward Contracts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2018, net of tax</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5344c15e24b24e80990c2d8787392123_I20181231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzMtNS0xLTEtMzE0MjI_59be65a5-d3bc-4f6c-ab82-82f762cdf764">53.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6e565a95dd740df9577e0def6a5bfda_I20181231" decimals="-5" sign="-" name="vtrs:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzMtNy0xLTEtMzE0MjI_9a1693ac-acff-47b4-808d-fac71abd8c4e">130.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7af73de9524c46c4b62467c275aebbd7_I20181231" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzMtOS0xLTEtMzE0MjI_d68de815-0451-4118-b106-594b99ac2561">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41551e1e6fcd44d8adc77b1cfa48df2e_I20181231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzMtMTEtMS0xLTMxNDIy_60b73525-3306-4050-b0a7-761c37670ae7">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0b0232bc9844e1fa3ea1d7b1ad31528_I20181231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzMtMTMtMS0xLTMxNDIy_a419950c-3f28-4591-b041-4dfaffba696f">1,259.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibadea9a32ce84dc48523b37b0f0b23ce_I20181231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzMtMTUtMS0xLTMxNDIy_f4a2c7f6-46ac-4586-8bbb-7d7e1b368487">1,441.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (loss) before reclassifications, before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb3ef4f6ed9f4ba49c083bede6eb5223_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzQtNS0xLTEtMzE0MjI_92b42343-e35a-4b3f-81d6-74fcf9502c1f">29.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57c4f10b75634ea68f1dca6a931ad8e6_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzQtNy0xLTEtMzE0MjI_0f61dcfc-150c-4552-960b-a3654848ecce">59.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4995b4611c2e4646adfd8b95ba3bf328_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzQtOS0xLTEtMzE0MjI_e04d3692-4a78-4a1c-965e-6cd86b2864e4">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1d888ff098f442bcb4dc242559173835_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzQtMTEtMS0xLTMxNDIy_e4166998-407b-49ca-b408-8c767acada03">21.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c03788583d749e2ab730831ee5d6f58_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzQtMTMtMS0xLTMxNDIy_f48ae633-b37e-44d2-94a0-e3adb3cccf9b">415.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5143c6332d7249db9f3409e36def6483_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzQtMTUtMS0xLTMxNDIy_18770ef4-8298-4794-b24b-04a94a4d6914">347.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive (loss) earnings, before tax:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on foreign exchange forward contracts classified as cash flow hedges, included in net sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f02030d9994171b347d6d8fbc28c23_D20190101-20191231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzYtMS0xLTEtMzE0MjI_833f89de-5e48-448a-aa0e-2c2797c0b7ba">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe6488fc910b43d8b1655226467f1718_D20190101-20191231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzYtNS0xLTEtMzE0MjI_f4063bcd-ec37-4796-b1c5-a9ce098bee20">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112fdb77391647eb924a8c3214c34e98_D20190101-20191231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzYtMTUtMS0xLTMxNDIy_9a0f51f8-26ae-4a90-8000-f38b3ee6399e">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on interest rate swaps classified as cash flow hedges, included in interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb74362ce50848929419e79a2423af29_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzctMy0xLTEtMzE0MjI_cea47285-3c15-4b33-8638-ff6831fa83ce">7.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe6488fc910b43d8b1655226467f1718_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzctNS0xLTEtMzE0MjI_01c44977-8f63-4b9a-b93b-91bb602cf490">7.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd18a8e6cd32428db5246e85e1f56f15_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzctMTUtMS0xLTMxNDIy_90d832bb-4712-4b24-8e43-7c1ca7b72e93">7.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service costs included in SG&amp;A </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab6607a4159c4340888408df548e14fd_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzgtMTEtMS0xLTMxNDIy_e6242065-c7cd-4a8f-922b-fef4e48cb676">0.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i120ca88ef29b44beab20b026621f6293_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzgtMTUtMS0xLTMxNDIy_4826fe07-17e5-4303-bafc-06ae0ea88736">0.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial loss included in SG&amp;A </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab6607a4159c4340888408df548e14fd_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzktMTEtMS0xLTMxNDIy_733dc8b0-c77b-4aa5-ac37-ad861c23cc7d">2.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i120ca88ef29b44beab20b026621f6293_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzktMTUtMS0xLTMxNDIy_2be1e935-b7c9-4537-9d89-4d2da68278bc">2.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive earnings (loss), before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8483166a8454418b9ca018a1b3791f84_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzEwLTUtMS0xLTMxNDIy_b782820b-efbf-4f0b-bdaf-f1279d9e6ad4">37.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57c4f10b75634ea68f1dca6a931ad8e6_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzEwLTctMS0xLTMxNDIy_0a02ec3e-1b48-47ce-b2d6-89139c29e009">59.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4995b4611c2e4646adfd8b95ba3bf328_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzEwLTktMS0xLTMxNDIy_26cfedf9-4ca7-448b-abbb-9a0861e76824">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1d888ff098f442bcb4dc242559173835_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzEwLTExLTEtMS0zMTQyMg_a7e97bf5-fb0f-4f96-8cad-c364e944ccde">24.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c03788583d749e2ab730831ee5d6f58_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzEwLTEzLTEtMS0zMTQyMg_3ac31799-ef79-4264-afe9-17675c52f036">415.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5143c6332d7249db9f3409e36def6483_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzEwLTE1LTEtMS0zMTQyMg_0c81e82e-4b11-468e-a564-2e83162249e0">343.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision (benefit) </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe6488fc910b43d8b1655226467f1718_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzExLTUtMS0xLTMxNDIy_3f1cdda6-b949-4ede-b200-cd804ec377e8">12.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57c4f10b75634ea68f1dca6a931ad8e6_D20190101-20191231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzExLTctMS0xLTMxNDIy_49cb9c2f-2cfe-4168-affc-71d2939b6512">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0092b09635f64545a5710335f85fb20d_D20190101-20191231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzExLTktMS0xLTMxNDIy_5141acd3-89b4-4939-aac0-e75b5b92ea31">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab6607a4159c4340888408df548e14fd_D20190101-20191231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzExLTExLTEtMS0zMTQyMg_f912047a-d65e-4eb5-9725-244bfec0d5f3">5.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieab322d23a1c4d299859bb9ae133d4c8_D20190101-20191231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzExLTEzLTEtMS0zMTQyMg_b49582c6-c456-4720-b7a4-36b4b7a36661">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i120ca88ef29b44beab20b026621f6293_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzExLTE1LTEtMS0zMTQyMg_c003097c-f1a9-448c-9cd9-9d234beffcbf">9.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative effect of the adoption of new accounting standards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e27b51cd41a46a5a7deacf015486759_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeOtherNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzEyLTUtMS0xLTMxNDIy_929f06a2-0804-4098-9914-aaaf2b4c9ad2">3.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib319269ea5d64fedbf03374a044144ba_I20191231" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzEyLTExLTEtMS0zMTQyMg_77cbacdc-67af-4d61-8c6e-1c83e14328f0">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib319269ea5d64fedbf03374a044144ba_I20191231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzEyLTE1LTEtMS0zMTQyMg_8a3e60b2-64aa-4f89-ac4a-8f70e4b72298">3.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic989ea6602bd4856815f90f895e12304_I20191231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzEzLTUtMS0xLTMxNDIy_d85f5d6b-f814-46de-ad8e-c4c9cfd5d017">31.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c1519bf270f496eacbc594c4a0b7a1c_I20191231" decimals="-5" sign="-" name="vtrs:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzEzLTctMS0xLTMxNDIy_58c478db-dbae-488c-ae2f-01fd54be4c3e">74.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3917c4bfc784a928c09f599e63910fb_I20191231" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzEzLTktMS0xLTMxNDIy_ce3021a6-d6a1-47a2-83b9-eab56d6264b8">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0257efc303d94390b5707bbcdb863e52_I20191231" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzEzLTExLTEtMS0zMTQyMg_29f4e88e-a522-45b5-b261-29ac1c3110ab">17.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7ff2cf5a8154924b32963fb78602f3a_I20191231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzEzLTEzLTEtMS0zMTQyMg_439ff6ae-149f-438a-9938-30d830d8396f">1,674.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic39189fc54504b53be3c4281e5dd8f82_I20191231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzEzLTE1LTEtMS0zMTQyMg_32af4fac-405b-4f0d-96a0-8a01a5601c6a">1,797.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">120</span></div></div></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_217"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzEyMTgw_f97d3dde-43ec-4544-9eaa-a7f60066e0e2" continuedAt="i43dade0589a948249f0ede56a4d0bced" escape="true">Income Taxes </ix:nonNumeric></span></div><ix:continuation id="i43dade0589a948249f0ede56a4d0bced" continuedAt="i0d681feddf854ac2ad8e2b6f36c811b1"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzEyMTc0_06f28348-b8ec-4535-9b99-aa301020531a" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax provision (benefit) consisted of the following components:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:65.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Federal:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f40df9e1eb0444887127461f9ea3abe_D20210101-20211231" decimals="-5" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzMtMS0xLTEtMzE0MjI_fe0564c7-6d41-440c-bbea-c0f0133079ff">12.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67d592a057184ff99b89d543e49e0118_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzMtMy0xLTEtMzE0MjI_747f0bc0-e344-4af0-81e5-06df15df9727">6.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80866432756d4d8b99967ae5f95350a1_D20190101-20191231" decimals="-5" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzMtNS0xLTEtMzE0MjI_10cca476-2018-405c-a537-68cacacbce93">118.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f40df9e1eb0444887127461f9ea3abe_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzQtMS0xLTEtMzE0MjI_10f7270b-b51f-4352-85af-6ae10272c157">182.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67d592a057184ff99b89d543e49e0118_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzQtMy0xLTEtMzE0MjI_e4e021d4-3854-41e9-8a3a-c474801386e4">277.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80866432756d4d8b99967ae5f95350a1_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzQtNS0xLTEtMzE0MjI_69ed426f-4b02-4ff7-bfb4-eec2378f5fe2">165.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f40df9e1eb0444887127461f9ea3abe_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzUtMS0xLTEtMzE0MjI_2d94d0a6-a685-4e3a-9145-7fcf7c7aeb00">170.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67d592a057184ff99b89d543e49e0118_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzUtMy0xLTEtMzE0MjI_ad684808-b248-4781-b488-bc08fe5ee4b8">283.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80866432756d4d8b99967ae5f95350a1_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzUtNS0xLTEtMzE0MjI_419c1322-1851-40d7-b52b-28cee71cef0e">47.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. State:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31acc6e59ca047cbb296182a44e66784_D20210101-20211231" decimals="-5" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzctMS0xLTEtMzE0MjI_2ae14a31-0c21-4953-aefa-5d8d66fa759a">7.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f057c6cfa374421b697de391e7da037_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzctMy0xLTEtMzE0MjI_d505dd53-f3b5-47e3-aede-b672663c6dee">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icba6cc749c5c4336a2e5b99546806e1c_D20190101-20191231" decimals="-5" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzctNS0xLTEtMzE0MjI_bd3c02f2-7ef6-4afd-bace-1f240fe6e3a1">21.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31acc6e59ca047cbb296182a44e66784_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzgtMS0xLTEtMzE0MjI_9f5727e4-b330-4a15-87d0-a66b2dc4989d">10.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f057c6cfa374421b697de391e7da037_D20200101-20201231" decimals="-5" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzgtMy0xLTEtMzE0MjI_ad75edee-ab43-403f-9a9d-9b20aff413f2">7.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icba6cc749c5c4336a2e5b99546806e1c_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzgtNS0xLTEtMzE0MjI_b6103da5-d9e8-477d-a7bc-ced5d608c150">13.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31acc6e59ca047cbb296182a44e66784_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzktMS0xLTEtMzE0MjI_789f42b6-2f6c-44d0-b38e-cfb6e3ff0829">3.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f057c6cfa374421b697de391e7da037_D20200101-20201231" decimals="-5" name="us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzktMy0xLTEtMzE0MjI_dfa9630c-c093-4465-8bb4-35e2744f1a5b">7.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icba6cc749c5c4336a2e5b99546806e1c_D20190101-20191231" decimals="-5" name="us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzktNS0xLTEtMzE0MjI_8eb14238-c624-4cfb-bf7a-f024cf1f3723">7.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd60fe8dbaf14660a60843e414c261cc_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzExLTEtMS0xLTMxNDIy_59bcea60-f4f8-4e74-a9fc-2f4f34df8e3f">91.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fbb159e759f42c694ac12a036cae1b4_D20200101-20201231" decimals="-5" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzExLTMtMS0xLTMxNDIy_f34b6d62-dd02-4542-9961-f36390e6ff0f">168.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0fabb51dcaa430e9611ab2f4e9a374e_D20190101-20191231" decimals="-5" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzExLTUtMS0xLTMxNDIy_50530996-2287-4d0e-8cae-e6bfdc97682d">191.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd60fe8dbaf14660a60843e414c261cc_D20210101-20211231" decimals="-5" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzEyLTEtMS0xLTMxNDIy_591cf4f0-5e09-4466-9e6a-2aba1e8b2bc6">869.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fbb159e759f42c694ac12a036cae1b4_D20200101-20201231" decimals="-5" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzEyLTMtMS0xLTMxNDIy_fffa9083-a368-4111-b58f-7acc7e28689f">55.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0fabb51dcaa430e9611ab2f4e9a374e_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzEyLTUtMS0xLTMxNDIy_69d2b3f2-1a55-4857-a112-7d1ec7b12ad5">13.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd60fe8dbaf14660a60843e414c261cc_D20210101-20211231" decimals="-5" name="us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzEzLTEtMS0xLTMxNDIy_29d32769-fa11-4585-bdf7-054344fbeac8">777.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fbb159e759f42c694ac12a036cae1b4_D20200101-20201231" decimals="-5" name="us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzEzLTMtMS0xLTMxNDIy_c47c9254-95ea-4fa7-ab0f-af22528feebd">224.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0fabb51dcaa430e9611ab2f4e9a374e_D20190101-20191231" decimals="-5" name="us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzEzLTUtMS0xLTMxNDIy_55acc1fc-eaf0-4a2f-81d9-80a1c0118f39">177.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision (benefit)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzE0LTEtMS0xLTMxNDIy_ab6219ab-4771-4540-bd66-9513921c2565">604.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzE0LTMtMS0xLTMxNDIy_5970843c-768c-447e-8c17-b588db3bf5b7">51.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzE0LTUtMS0xLTMxNDIy_53d4c8a0-f6f7-4462-8d42-fe5f88c1bb11">137.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income taxes:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f40df9e1eb0444887127461f9ea3abe_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzE3LTEtMS0xLTMxNDIy_86bd1186-3aab-48af-a58b-027234ff8ed4">1,982.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67d592a057184ff99b89d543e49e0118_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzE3LTMtMS0xLTMxNDIy_7207fd1c-f855-4137-a6e9-fb5918164526">945.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80866432756d4d8b99967ae5f95350a1_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzE3LTUtMS0xLTMxNDIy_02a222c0-972a-4e4d-862c-3e0cb101e7e3">1,031.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign - Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a8034bfa30e47bca846a18601de12b5_D20210101-20211231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzE4LTEtMS0xLTMxNDIy_de610cd3-3cd0-4eb6-ab05-960479f3b91b">1,318.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b9f43ebce0a4eb1ba92976f05741fb0_D20200101-20201231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzE4LTMtMS0xLTMxNDIy_1bfe260b-f350-4521-8ffe-7a2b3501ee3a">224.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f5339a530fb4bbca97be48fbe5dff35_D20190101-20191231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzE4LTUtMS0xLTMxNDIy_968e74c2-e764-4ce9-90ce-13303b07fc0e">1,185.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total (loss) earnings before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzE5LTEtMS0xLTMxNDIy_d31e412f-fa12-41d9-a277-b7475ab8b90e">664.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzE5LTMtMS0xLTMxNDIy_ebced4b1-8190-4aa2-a856-8765d8d1e1d2">721.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzE5LTUtMS0xLTMxNDIy_2cbfa2d8-bf1b-475d-90a8-78422e394e9e">154.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For all periods presented, the allocation of earnings before income taxes between U.S. and non-U.S. operations includes intercompany interest allocations between certain domestic and foreign subsidiaries. These amounts are eliminated on a consolidated basis. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">121</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><ix:continuation id="i0d681feddf854ac2ad8e2b6f36c811b1" continuedAt="i0b464c26e16b4684a4f2f1ae0ef6c6ba"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzEyMTQ3_0ab0ef70-cc0b-4187-bff1-c70d25e118a8" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Temporary differences and carry-forwards that result in deferred tax assets and liabilities were as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:76.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee benefits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzItMS0xLTEtMzE0MjI_2613df6e-7834-48fd-a02f-da5b7cf5c58a">271.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzItMy0xLTEtMzE0MjI_eb22944a-e42c-4016-bcb1-e39450f52bea">273.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzMtMS0xLTEtMzE0MjI_748b6df6-6b5a-43cc-8ba7-4d9ca6f8305f">94.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzMtMy0xLTEtMzE0MjI_60aa7330-a1df-4fa1-9d63-27f6346b52d1">43.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzQtMS0xLTEtMzE0MjI_dcc55437-5e45-4c66-8d10-bdc90c6cbba9">425.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzQtMy0xLTEtMzE0MjI_631ac44a-223d-4d3e-a602-e201c6aa04dd">393.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzUtMS0xLTEtMzE0MjI_19d0b1ae-ff2a-4cc9-898d-bcff4607540b">187.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsInventory" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzUtMy0xLTEtMzE0MjI_077fd18a-ec25-40b4-a4af-8c2b1973d71f">1,187.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credit and loss carry-forwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzYtMS0xLTEtMzE0MjI_ec218a97-9a32-41f0-8f36-4a71d9a75fa3">1,256.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzYtMy0xLTEtMzE0MjI_3ef41e7e-dfd2-40d7-abb5-0c6767c6c3b8">1,080.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="vtrs:DeferredTaxAssetsOperatingLeaseRightofUseAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzctMS0xLTEtMzE0MjI_920d8638-b8f1-471c-9800-55eed34d8315">63.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="vtrs:DeferredTaxAssetsOperatingLeaseRightofUseAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzctMy0xLTEtMzE0MjI_146e6c52-d8f7-480a-bb74-19c97c7fb065">66.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="vtrs:DeferredTaxAssetsDeferredtaxexpenseinterestexpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzgtMS0xLTEtMzE0MjI_6fa88981-87a4-4e4c-ab9a-e3d330208684">111.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="vtrs:DeferredTaxAssetsDeferredtaxexpenseinterestexpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzgtMy0xLTEtMzE0MjI_6fe087e9-85b9-4531-972e-0b9773cd5b93">67.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="vtrs:DeferredTaxAssetsIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzktMS0xLTEtMzE0MjI_35a9063a-2cdf-4301-8058-793139b64d44">151.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="vtrs:DeferredTaxAssetsIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzktMy0xLTEtMzE0MjI_cf21b9bc-b8cf-4609-bd4a-1133c66900f5">156.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzEwLTEtMS0xLTMxNDIy_6e72181b-468c-4f8d-8169-e448a1dc2999">327.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzEwLTMtMS0xLTMxNDIy_60749d1c-4574-44f6-928f-1a5a9f4f9b20">396.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzExLTEtMS0xLTMxNDIy_debea257-3c27-44f1-8943-9ca19272942b">2,889.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzExLTMtMS0xLTMxNDIy_e0f902e6-681b-4e4a-a5c1-33b312376ad8">3,665.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzEyLTEtMS0xLTMxNDIy_e86532d6-feb9-4749-bf93-0cd68a2eab73">780.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzEyLTMtMS0xLTMxNDIy_c9f3468a-aedc-4ed5-a105-7e4a87d4d33b">443.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzEzLTEtMS0xLTMxNDIy_afbb6a12-82c7-4cfd-946c-d0be1b8916ee">2,109.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzEzLTMtMS0xLTMxNDIy_25584c3b-2be5-48e4-82d5-e5288238b129">3,221.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzE1LTEtMS0xLTMxNDIy_48a7ed35-53e9-4db8-95cf-d13aec75628b">19.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzE1LTMtMS0xLTMxNDIy_08e59464-a5a2-4b97-87ec-973f1a759c8b">50.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="vtrs:DeferredTaxLiabilitiesOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzE2LTEtMS0xLTMxNDIy_e1811e91-7b2f-4280-826e-1af44cde6441">63.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="vtrs:DeferredTaxLiabilitiesOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzE2LTMtMS0xLTMxNDIy_6036934a-64b0-45cf-944d-55e4331eb6a8">66.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets and goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzE3LTEtMS0xLTMxNDIy_7c62c6ed-ed10-47f6-b94e-d72a7bbbe784">3,468.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzE3LTMtMS0xLTMxNDIy_0f41e4a3-5cc2-4c3c-8c38-8f443fe05ed3">4,058.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzE4LTEtMS0xLTMxNDIy_1043fce0-651c-41bd-ac7c-af967b7204ea">39.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzE4LTMtMS0xLTMxNDIy_93c357b6-5a52-4e9a-bf80-07aca1aca984">22.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzE5LTEtMS0xLTMxNDIy_08399594-b22d-43b8-b004-9983afe09087">3,591.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzE5LTMtMS0xLTMxNDIy_9f18c8f4-86f0-4040-95ca-b8383ddadf18">4,197.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzIwLTEtMS0xLTMxNDIy_ab568d09-011a-489c-90e9-8f3afdd74fbb">1,482.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzIwLTMtMS0xLTMxNDIy_f49d54b7-c679-4304-ad9d-c6c3d90c238f">975.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For those foreign subsidiaries whose investments are permanent in duration, income and foreign withholding taxes have not been provided on the unremitted earnings of those subsidiaries. This amount may become taxable upon a repatriation of assets from the subsidiary or a sale or liquidation of the subsidiary. The amount of such unremitted earnings is approximately $<ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-8" name="us-gaap:DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzExODI_a0046801-5afd-485f-ae7d-2b5ccb96ffee">3.4</ix:nonFraction> billion at December&#160;31, 2021. Determination of the amount of any unrecognized deferred income tax liability on these unremitted earnings is not practicable as such determination involves material uncertainties about the potential extent and timing of any distributions, the availability and complexity of calculating foreign tax credits, and the potential indirect tax consequences of such distributions, including withholding taxes.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">122</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><ix:continuation id="i0b464c26e16b4684a4f2f1ae0ef6c6ba" continuedAt="i07d8014fbba641baa33453b7320857a5"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzEyMTg0_12d97067-a43e-4263-b830-f3fe7847ce69" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Combination, the applicable income tax rate to Mylan was the U.K. rate of 19%, and following the Combination, the statutory income tax rate applicable to Viatris Inc. is the U.S. rate of <ix:nonFraction unitRef="number" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzE4MDI_f0830b36-670f-487a-9a3c-de0981bdf198">21</ix:nonFraction>% for the years ended December 31, 2021 and 2020.  A reconciliation of the statutory tax rate to the effective tax rate is as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:65.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statutory tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzItMS0xLTEtMzE0MjI_f0830b36-670f-487a-9a3c-de0981bdf198">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzItMy0xLTEtMzE0MjI_149b6921-20b7-4fda-807f-d176e3fb2881">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzItNS0xLTEtMzE0MjI_b513ef8c-d848-412b-be18-2e34a5fa5bdc">19.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States Operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clean energy and research credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5705c46a88bf43f9b604c129b6396c1b_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzUtMS0xLTEtMzE0MjI_536ff4c9-b283-48c3-875f-022cf197b3b2">9.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4373191f73a844d0aa8b62bcce8c341d_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzUtMy0xLTEtMzE0MjI_2db1bb5e-20ce-48ad-a35a-5ddffb278c77">12.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="icc53a28205ae4633a9527b98ec393f1e_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzUtNS0xLTEtMzE0MjI_38a55f9b-7933-4be1-ac00-dcef903433c7">43.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. rate differentials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5705c46a88bf43f9b604c129b6396c1b_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzYtMS0xLTEtMzE0MjI_d6f44b43-6d1a-4bb7-9125-dd2ae873e147">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4373191f73a844d0aa8b62bcce8c341d_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzYtMy0xLTEtMzE0MjI_4a34ff11-8367-44ec-8ad3-e19bf58052f5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="icc53a28205ae4633a9527b98ec393f1e_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzYtNS0xLTEtMzE0MjI_7bfb9698-02ff-40c7-bc26-a06876e6f81d">3.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of changes in legislation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5705c46a88bf43f9b604c129b6396c1b_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzgtMS0xLTEtMzE0MjI_50e1d025-b670-4b60-9867-aea7bba8f5c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i4373191f73a844d0aa8b62bcce8c341d_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzgtMy0xLTEtMzE0MjI_838d64be-46e2-4660-9922-623e63f50f95">9.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icc53a28205ae4633a9527b98ec393f1e_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzgtNS0xLTEtMzE0MjI_9d067d83-9e1a-443a-8ac2-de69b6a32530">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes and credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i5705c46a88bf43f9b604c129b6396c1b_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzktMS0xLTEtMzE0MjI_80fbdbc8-1b90-4537-bc9b-76733fb4f3c8">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i4373191f73a844d0aa8b62bcce8c341d_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzktMy0xLTEtMzE0MjI_00026efa-5b73-425f-b28b-fe64b25c16f3">1.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="icc53a28205ae4633a9527b98ec393f1e_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzktNS0xLTEtMzE0MjI_ee2171a2-b3c2-4461-9eb9-e0277dbd19f8">4.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i5705c46a88bf43f9b604c129b6396c1b_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzEwLTEtMS0xLTMxNDIy_f6792abc-e755-4d63-970c-cfe31e2a5c64">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4373191f73a844d0aa8b62bcce8c341d_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzEwLTMtMS0xLTMxNDIy_10613831-dc46-4b3e-aea0-6634c2b9f57b">8.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="icc53a28205ae4633a9527b98ec393f1e_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzEwLTUtMS0xLTMxNDIy_6c6004a2-1437-4277-889f-76edef547db1">118.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax settlements and resolution of certain tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5705c46a88bf43f9b604c129b6396c1b_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlements" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzExLTEtMS0xLTMxNDIy_87ef4a08-f6ab-4aa1-83d9-cf57d9f03034">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4373191f73a844d0aa8b62bcce8c341d_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlements" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzExLTMtMS0xLTMxNDIy_769e6479-926e-4a56-b9d8-d35c02108d93">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icc53a28205ae4633a9527b98ec393f1e_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlements" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzExLTUtMS0xLTMxNDIy_9f310f08-cc9d-4401-936d-240ce7adf3a8">199.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incremental US Tax on Foreign Earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="3" sign="-" name="vtrs:EffectiveIncomeTaxRateReconciliationGILTIPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzEyLTEtMS0xLTMxNDIy_b75a23d6-49de-4ebe-a4e1-393e88e99cf8">36.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="3" sign="-" name="vtrs:EffectiveIncomeTaxRateReconciliationGILTIPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzEyLTMtMS0xLTMxNDIy_3c8e4054-6a2b-40f0-867c-98c2b70af85f">3.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="3" sign="-" name="vtrs:EffectiveIncomeTaxRateReconciliationGILTIPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzEyLTUtMS0xLTMxNDIy_31968f91-96d3-4934-883b-7ae79442125b">8.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Waived deductions under IRC &#167; 59A</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="3" name="vtrs:EffectiveIncomeTaxRateReconciliationWaivedDeductionsPercent" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzEzLTEtMS0xLTMxNDIy_61cd83bb-d17e-42de-b04a-2b9d17f453b3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="3" sign="-" name="vtrs:EffectiveIncomeTaxRateReconciliationWaivedDeductionsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzEzLTMtMS0xLTMxNDIy_c49c3709-c9d9-46ee-be1c-2bb9b41ff5a5">3.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="3" name="vtrs:EffectiveIncomeTaxRateReconciliationWaivedDeductionsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzEzLTUtMS0xLTMxNDIy_946e22d2-ba2d-4aa1-b258-d6a6b6076dfd">64.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of the Combination and Divestitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzE0LTEtMS0xLTMxNDIy_04c2f0c1-76e8-4efb-9005-42dc031bcf50">2.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzE0LTMtMS0xLTMxNDIy_cf6d66fa-7e99-4916-8691-6d1d439846b9">5.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzE0LTUtMS0xLTMxNDIy_34e921c7-8421-4591-8f19-937c5ef60e06">7.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other U.S. items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i5705c46a88bf43f9b604c129b6396c1b_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzE1LTEtMS0xLTMxNDIy_0f63f79e-2b9e-4d87-bf11-5c228ea1d4b2">6.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4373191f73a844d0aa8b62bcce8c341d_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzE1LTMtMS0xLTMxNDIy_8c3f245e-b1b3-4e12-a2db-991100030e55">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icc53a28205ae4633a9527b98ec393f1e_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzE1LTUtMS0xLTMxNDIy_2fb6c841-e4e2-4c0f-a926-64e9dec49b1c">6.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Foreign Operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Luxembourg</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i541721ab11fa46dba8a4f58aa82b8be6_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzE3LTEtMS0xLTMxNDIy_3e5c3b78-4115-476d-9e5b-4b475b384ae2">6.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i8c017853d633417e84dadf12741d19be_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzE3LTMtMS0xLTMxNDIy_b072f909-5870-42b7-9293-98c2b1aecc48">5.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i530b9bc93bc34ea6809e028e6321324d_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzE3LTUtMS0xLTMxNDIy_a10ef838-552a-4851-a17c-9d361ef8c6e4">14.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gibraltar</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i690c125540df43569fe6e0ce50a677ab_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzE4LTEtMS0xLTMxNDIy_f189d6d8-e8bf-4292-a2d2-635f8312bc0c">9.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i854628b6099f4e6b8fede6d5c536249f_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzE4LTMtMS0xLTMxNDIy_af2b926b-082f-4f67-b297-f7c8392f1c48">8.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="id11628fae2674f80be59cec699d8e459_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzE4LTUtMS0xLTMxNDIy_3e8447a0-e1ee-470d-a881-a6e2f3429deb">38.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5823091b3fcd49398f313d160daadec4_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzE5LTEtMS0xLTMxNDIy_c840ea3f-e37f-46c5-9195-b0e8933382da">5.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i603a7cae6d9d4de3b979e27445a94107_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzE5LTMtMS0xLTMxNDIy_443a8d4d-1b0a-404b-8886-a40fc1032992">8.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i66146c05086e4529856e742dff83f191_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzE5LTUtMS0xLTMxNDIy_684853b8-eb2a-420c-bada-8950bf727d12">13.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i48d28293b4b04d2fb0191c06495228ce_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzIwLTEtMS0xLTMxNDIy_d2dd88f5-6b2c-4b24-b3c1-6b1b0a3dce04">1.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i7fccea3458334b2ebd3c74f8a019e6de_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzIwLTMtMS0xLTMxNDIy_75ff422b-0770-4200-84b1-372ed18874e2">2.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iffea22471c5c4e24861294dc6660f471_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzIwLTUtMS0xLTMxNDIy_574e832c-f863-4bd1-9813-959ed00ed28d">15.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Puerto Rico</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i26e9bb2c528b43d78cadc7fb8c8321fd_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzIxLTEtMS0xLTMxNDIy_fa7d0ac0-c9c5-4321-a6a2-d83f322b7c82">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="id9609b95c853486895e94e6a62b3157b_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzIxLTMtMS0xLTMxNDIy_74143738-3646-44e2-a075-fe24543ced76">2.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i543541ffe73f47e6872e055ae7bcffda_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzIxLTUtMS0xLTMxNDIy_767911dd-f24c-469e-9f49-d502eec0e954">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Switzerland</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icf311f44a7fe473a9670fb0c3ff9a43c_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzIyLTEtMS0xLTMxNDIy_4574ba6f-8921-4752-ba76-2819e63f37fe">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iaa740ef330234878af7d2583fa1e040c_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzIyLTMtMS0xLTMxNDIy_5734196f-f30a-4c5c-8232-74e12ac77803">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7234668fd9e1415280aed391af195c71_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzIyLTUtMS0xLTMxNDIy_f39ba4a5-0575-48d2-b76b-09177e8ad0a4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Singapore</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0d23542c1c7d4aa7afeff16b251e1769_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzIyLTEtMS0xLTU2NTc3_239c2bb8-8d7e-4ed9-b1fe-d4072f1f9c6c">28.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie9e6322b8a51430198f1ea68537c7250_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzIyLTMtMS0xLTU2NTc3_a6422813-a09b-4194-af69-65f2c4bc8629">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i89506361322145bba725864306af6680_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzIyLTUtMS0xLTU2NTc3_b9af2a8f-d109-4027-bce6-e2ff666d2ec5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i44835a71bdf64a59b0834e858746c694_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzIzLTEtMS0xLTMxNDIy_ab4efc86-3114-4cbe-b760-812e1fc8290b">10.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i5804a0802eb7426eb85b8c6c303e8343_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzIzLTMtMS0xLTMxNDIy_517a347b-8623-4c5a-a926-71cd4982b5cf">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i279ca6fa27f643e494543992d85cb2fc_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzIzLTUtMS0xLTMxNDIy_cba9a378-f9b8-4055-8917-210b910eb371">12.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax impact of tax law changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i17563b55bf4c44c896a9a3066b542e39_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzI0LTEtMS0xLTMxNDIy_39e2df4e-560d-4818-9a28-977f80647f6c">7.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i0f870207d18e4404afdd0b0926003cbf_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzI0LTMtMS0xLTMxNDIy_1101e032-bf12-4b13-9b2b-4995c49b4531">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icc73a3ee0a3a41ee8832f3c122143ec1_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzI0LTUtMS0xLTMxNDIy_aad2e166-7bab-4053-be0d-d7aca1fbf800">36.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i17563b55bf4c44c896a9a3066b542e39_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzI1LTEtMS0xLTMxNDIy_f73b8c61-7fec-49ce-bab6-307b9742612c">8.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0f870207d18e4404afdd0b0926003cbf_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzI1LTMtMS0xLTMxNDIy_9de37ddc-5621-478b-b5fa-82ce802cef85">16.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="icc73a3ee0a3a41ee8832f3c122143ec1_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzI1LTUtMS0xLTMxNDIy_0b80bd14-c7b8-42df-b216-ee12a39c6769">9.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of the Combination and divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzI2LTEtMS0xLTMxNDIy_05041a29-dc51-477b-91cb-60bdb8b551b3">106.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzI2LTMtMS0xLTMxNDIy_8b611de7-5188-4b2e-86c3-0102997eb5dc">42.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzI2LTUtMS0xLTMxNDIy_80472668-f24d-466f-b7a4-4b5f37ab9cfe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Withholding taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i17563b55bf4c44c896a9a3066b542e39_D20210101-20211231" decimals="3" sign="-" name="vtrs:EffectiveIncomeTaxRateReconciliationWithholdingTaxesPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzI3LTEtMS0xLTMxNDIy_204af885-19a2-44bc-ad39-c6c153520f8e">1.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i0f870207d18e4404afdd0b0926003cbf_D20200101-20201231" decimals="3" sign="-" name="vtrs:EffectiveIncomeTaxRateReconciliationWithholdingTaxesPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzI3LTMtMS0xLTMxNDIy_184ea131-a591-47a9-bde6-cb9432acad50">1.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icc73a3ee0a3a41ee8832f3c122143ec1_D20190101-20191231" decimals="3" name="vtrs:EffectiveIncomeTaxRateReconciliationWithholdingTaxesPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzI3LTUtMS0xLTMxNDIy_e28339a2-4fe7-46a0-86ce-8d7c5bed3030">7.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax settlements and resolution of certain tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i17563b55bf4c44c896a9a3066b542e39_D20210101-20211231" decimals="3" name="vtrs:EffectiveIncomeTaxRateReconciliationIndiaAmagulation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzI4LTEtMS0xLTMxNDIy_7ffdf69b-ee30-4f35-868c-c8f7ad52d61c">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i0f870207d18e4404afdd0b0926003cbf_D20200101-20201231" decimals="3" sign="-" name="vtrs:EffectiveIncomeTaxRateReconciliationIndiaAmagulation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzI4LTMtMS0xLTMxNDIy_650da778-16c8-4aa7-8cc9-53ab7e5776fe">3.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="icc73a3ee0a3a41ee8832f3c122143ec1_D20190101-20191231" decimals="3" sign="-" name="vtrs:EffectiveIncomeTaxRateReconciliationIndiaAmagulation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzI4LTUtMS0xLTMxNDIy_c9a859f2-330c-4075-80e9-03ab7f405844">27.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other foreign items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i17563b55bf4c44c896a9a3066b542e39_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzI5LTEtMS0xLTMxNDIy_ed5e1daf-3426-4514-b277-afe6b209a069">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i0f870207d18e4404afdd0b0926003cbf_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzI5LTMtMS0xLTMxNDIy_14225b98-1af0-4ff7-aeb3-08ca1547ef85">1.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icc73a3ee0a3a41ee8832f3c122143ec1_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzI5LTUtMS0xLTMxNDIy_fbc6f1cf-7222-48e3-854b-2c9e065cdae2">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzMwLTEtMS0xLTMxNDIy_41edad47-dbfd-4047-afa0-cfdb080189e8">91.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzMwLTMtMS0xLTMxNDIy_b3b9b090-f3d3-4548-8221-6ae3e496e23d">7.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzMwLTUtMS0xLTMxNDIy_7d4ab1a5-ba06-474b-8340-08d4a83a87fb">89.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">123</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><ix:continuation id="i07d8014fbba641baa33453b7320857a5" continuedAt="i0667a12b0f764ce1a5ec8599b8c5c415"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In all years, our effective tax rate is impacted by the jurisdictional location of earnings and the corresponding tax rates in those jurisdictions. Subsequent to the Combination, the Company realizes benefits from lower tax rates in Singapore and Puerto Rico due to manufacturing and other incentives..</span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tax Act</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 22, 2017, the U.S. government enacted the Tax Act. The Tax Act makes broad and complex changes to the Code including, but not limited to, reducing the U.S. federal corporate income tax rate and requiring a one-time transition tax on certain unrepatriated earnings of non-U.S. corporate subsidiaries of large U.S. shareholders that may electively be paid over eight years. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Tax Act also puts in place new tax laws that impact our taxable income beginning in 2018, which include, but are not limited to (1) creating a BEAT, which is a new minimum tax, (2) generally eliminating U.S. federal income taxes on dividends from foreign subsidiaries, (3) a new provision designed to tax currently GILTI earned by non-U.S. corporate subsidiaries of large U.S. shareholders and a deduction generally equal to <ix:nonFraction unitRef="number" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="2" name="vtrs:DeductionlimitofGILTItax" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzMwODc_790834b7-8e5b-49b4-9849-070db856fbcc">50</ix:nonFraction> percent of GILTI (<ix:nonFraction unitRef="number" contextRef="i11b5aa7232f744ff861551a17b6a355f_D20250101-20251231" decimals="3" name="vtrs:DeductionlimitofGILTItax" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzMxMDA_79aa47ed-1fff-40f7-9b85-c9283a695513">37.5</ix:nonFraction> percent for tax years beginning after December 31, 2025) to offset the income tax liability, (4) a provision limiting the amount of deductible interest expense in the U.S., (5) limitations on the deductibility of certain executive compensation, and (6) limitations on the utilization of foreign tax credits to reduce the U.S. income tax liability. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, no U.S. deferred income taxes or foreign withholding taxes were recorded on earnings in the Company&#8217;s non-U.S. subsidiaries where there would be no U.S. or foreign tax upon repatriation or where the Company&#8217;s practice and intention was to reinvest the earnings outside of the U.S. The transition tax noted above resulted in the previously untaxed foreign earnings of U.S. subsidiaries being included in federal and state taxable income. We analyze on an ongoing basis our global working capital requirements and the potential tax liabilities that would be incurred if the non-U.S. subsidiaries repatriate cash, which include potential local country withholding taxes and U.S. state taxation.  The Company has elected to not record deferred taxes associated with the GILTI provision of the Tax Act.</span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Valuation Allowance</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A valuation allowance is provided when it is more likely than not that some portion or all of the deferred tax assets will not be realized. At December&#160;31, 2021, a valuation allowance has been applied to certain deferred tax assets in the amount of $<ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzQ2MjM_d7e34190-5a90-496f-8f1b-0d22ff9b671c">780.4</ix:nonFraction> million.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When assessing the realizability of deferred tax assets, management considers all available evidence, including historical information, long-term forecasts of future taxable income and possible tax planning strategies. Amounts recorded for valuation allowances can result from a complex series of estimates, assumptions and judgments about future events. Due to the inherent uncertainty involved in making these estimates, assumptions and judgments, actual results could differ materially. Any future increases to the Company&#8217;s valuation allowances could materially impact the Company&#8217;s consolidated financial condition and results of operations.</span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Operating Losses</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of December&#160;31, 2021, the Company had the following carryforwards and attributes: </span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. federal net operating loss carryforwards of  $<ix:nonFraction unitRef="usd" contextRef="i205d721df41548169e4385e88938943b_I20211231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzU0MTY_b815d091-0334-411f-b89a-931e64564f1a">7.9</ix:nonFraction> million.</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. state income tax loss carryforwards of approximately  $<ix:nonFraction unitRef="usd" contextRef="icde9ccadb7ab473e9a5c2e38da57d5e0_I20211231" decimals="-7" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzU0Nzk_6136a700-27bd-4427-9765-cf0cd72e919f">3.10</ix:nonFraction> billion, which are largely offset by a valuation allowance.</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Non-U.S. net operating loss carryforwards of approximately  $<ix:nonFraction unitRef="usd" contextRef="ifc7dfe40ed754a63957fa18d5cc47e7b_I20211231" decimals="-7" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzU1OTQ_30cd7733-ef81-4f40-aa3b-2c08783470a3">1.57</ix:nonFraction> billion, of which $<ix:nonFraction unitRef="usd" contextRef="ic92f6b9e1fe14acdbdc8bec1f348d9d6_I20211231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzU2MDc_7d6dcd1e-9f33-46ff-8510-307ef300e27a">748.4</ix:nonFraction> million can be carried forward indefinitely, with the remaining $<ix:nonFraction unitRef="usd" contextRef="i8b804447ccbf4433b4fe613034758f52_I20211231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzU2NjY_a866c12b-7dc4-4c0a-ac64-179b99fbc439">817.8</ix:nonFraction> million expiring in years 2022 through 2041.</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Foreign deductible attributes of $<ix:nonFraction unitRef="usd" contextRef="ifc7dfe40ed754a63957fa18d5cc47e7b_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzU3Mzk_d63da4d0-9c3c-4cd4-8e9a-ae73c0dd227d">39.6</ix:nonFraction> million that can be carried forward indefinitely, which are offset by a full valuation allowance.</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. and foreign credit carryovers of $<ix:nonFraction unitRef="usd" contextRef="ifc7dfe40ed754a63957fa18d5cc47e7b_I20211231" decimals="-5" name="us-gaap:TaxCreditCarryforwardAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzU4NzA_b327e12a-6f7e-4bb8-99bf-a2ce8c1d8790">329.2</ix:nonFraction> million, expiring in various amounts through 2041.</span></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Anticipatory foreign tax credits of $<ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzU5NTI_96fe470b-c8da-4726-a918-4e676e3ba6df">230.3</ix:nonFraction> million which will generate from the reversal of future taxable income in certain non-U.S. jurisdictions which are taxed both in their local jurisdictions and in the U.S.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">124</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><ix:continuation id="i0667a12b0f764ce1a5ec8599b8c5c415" continuedAt="id0263cfd7bf04b1f85cf034e21e0c684"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 16, 2020, the Company had a change in ownership pursuant to Section 382 of the Code. Under this provision of the Code, the utilization of any NOL or tax credit carryforwards incurred prior to the date of ownership change may be limited. Analyses of the limits for each ownership change indicates the annual limitation would not impair the Company's ability to utilize our U.S. federal credit carryovers.  While state loss carryforwards may be limited by Section 382 of the Code, the carryforwards are largely offset by a valuation allowance.</span></div><div style="margin-bottom:12pt;padding-left:18pt;padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CARES Act</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 27, 2020, the CARES Act was enacted and signed into law. The CARES Act includes several provisions, including increasing the amount of deductible interest, allowing companies to carryback certain NOLs, and increasing the amount of NOLs that corporations can use to offset income.During the year ended December 31, 2020, the CARES Act reduced the Company&#8217;s 2020 income tax expense by $<ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="vtrs:CARESActIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzU0OTc1NTgxNjA5MDQ_4aa0fec5-d174-445a-9579-ba623ddd6dfa">22.1</ix:nonFraction>&#160;million resulting from additional deductible interest. </span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tax Examinations</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to income taxes and tax audits in many jurisdictions. A certain degree of estimation is thus required in recording the assets and liabilities related to income taxes. Tax audits and examinations can involve complex issues, interpretations, and judgments and the resolution of matters that may span multiple years, particularly if subject to litigation or negotiation. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Although the Company believes that adequate provisions have been made for these uncertain tax positions, the Company&#8217;s assessment of uncertain tax positions, including those arising from legal entity restructuring transactions in connection with the Combination, is based on estimates and assumptions that the Company believes are reasonable but the estimates for unrecognized tax benefits and potential tax benefits may not be representative of actual outcomes, and variations from such estimates could materially affect the Company&#8217;s financial condition, results of operations or cash flows in the period of resolution, settlement or when the statutes of limitations expire. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to ongoing IRS examinations. The years 2015 through 2018 are open years under examination. The years 2012, 2013 and 2014 have one matter open, and a Tax Court petition was filed regarding the matter and a trial was held in December 2018 and is discussed further below. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2019, Mylan reached an agreement in principle with the IRS to resolve all issues relating to our positions on the February 27, 2015 acquisition by Mylan N.V. of Mylan Inc. and Abbott Laboratories&#8217; non-U.S. developed markets specialty and branded generics business. Under the agreement in principle, which was finalized as part of a closing agreement with the IRS on October 11, 2019, Mylan&#8217;s status as a non-U.S. corporation for U.S. Federal income tax purposes was confirmed, and we have adjusted the interest rates used for intercompany loans as necessary. During the year ended December 31, 2019, the Company recorded a reserve of approximately $<ix:nonFraction unitRef="usd" contextRef="ib6ea526be10f4f0a866f5c6137509461_I20191231" decimals="-5" name="vtrs:IncomeTaxExaminationReserveForUncertainTaxPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzkyOTU_875b0ea7-8d7f-4bd7-b4b8-95ed5b07ec7c">155.0</ix:nonFraction>&#160;million as part of its liability for uncertain tax positions, with a net impact to the income tax provision of approximately $<ix:nonFraction unitRef="usd" contextRef="ib6ea526be10f4f0a866f5c6137509461_I20191231" decimals="-5" name="vtrs:IncomeTaxExaminationReserveImpactOnIncomeTaxProvision" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzk0MTU_90b17f73-ea34-4701-8357-d1b9ce8a265a">144.9</ix:nonFraction>&#160;million related to this matter. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Several international audits are currently in progress. In some cases, the tax auditors have proposed adjustments </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or issued assessments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to our tax positions, including with respect to intercompany transactions, and we are in ongoing discussions with some of the auditors regarding the validity of their positions. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In instances where assessments have been issued, we disagree with these assessments and believe they are without merit and incorrect as a matter of law. As a result, we anticipate that certain of these matters may become the subject of litigation before tax courts where we intend to vigorously defend our position.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In Australia, the tax authorities have issued notices of assessments to the Company for the years ended December 2009 to December 2019, subject to additional interest and penalties, concerning our tax position with respect to certain intercompany transactions. The tax authorities denied our objections to the assessments and we have commenced litigation in the Australian Federal Court challenging that decision. During 2021, the Company made a partial payment of $<ix:nonFraction unitRef="usd" contextRef="i472d18e59f014ecfa0204966aa273da0_D20210101-20211231" decimals="-5" name="vtrs:IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzE2NDkyNjc0NjMxOTQ_78151ac2-212b-42bb-9d99-7c5167f4adbc">56.0</ix:nonFraction>&#160;million in order to stay potential interest and penalties resulting from this litigation.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In France, the tax authorities have issued notices of assessments to the Company for the years ended December 2013 to December 2016 concerning our tax position with respect to (i) certain intercompany transactions and (ii) whether income earned by a Company entity not domiciled in France should be subject to French tax. We have resolved our position concerning certain intercompany transactions with the tax authorities. Concerning the remaining issue, we have commenced litigation before the French tax courts where the tax authorities will seek unpaid taxes, penalties, and interest.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">125</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><ix:continuation id="id0263cfd7bf04b1f85cf034e21e0c684"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In India, the tax authorities have issued notices of assessments to the Company seeking unpaid taxes and interest for the financial years covering 2013 to 2018 concerning our tax position with respect to certain corporate tax deductions and certain intercompany transactions. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of these assessments remain in the audit phase where we are challenging them before the tax authorities while we are challenging some of the other assessments in the Indian tax courts.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has recorded a net reserve for uncertain tax positions of $<ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="vtrs:ReserveForUncertainTaxPositionsIncludingInterestAndPenalties" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzk3OTI_2912dc8a-11cb-45b3-b394-b63cc2905b16">315.6</ix:nonFraction>&#160;million, including interest and penalties, in connection with its international audits at December&#160;31, 2021. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reserve balance at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> reflects the impact of current year settlement payments. In connection with our international tax audits, it is possible that we will incur material losses above the amounts reserved.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s major U.S. state taxing jurisdictions remain open from fiscal year 2013 through 2020, with several state audits currently in progress. The Company&#8217;s major international taxing jurisdictions remain open from 2012 through 2020.</span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tax Court Proceedings </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's U.S. federal income tax returns for 2012 through 2014 had been subject to proceedings in U.S. Tax Court involving a dispute with the IRS regarding whether certain costs related to ANDAs were eligible to be expensed and deducted immediately or required to be amortized over longer periods. A trial was held in U.S. Tax Court in December 2018 and on April 27, 2021, the Court affirmed Mylan&#8217;s position and held that patent litigation expenses related to ANDAs are immediately deductible. The IRS has appealed this decision.</span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for Uncertainty in Income Taxes</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact of an uncertain tax position that is more likely than not of being sustained upon audit by the relevant taxing authority must be recognized at the largest amount that is more likely than not to be sustained. No portion of an uncertain tax position will be recognized if the position has less than a 50% likelihood of being sustained.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020, the Company&#8217;s consolidated balance sheets reflect net liabilities for unrecognized tax benefits of $<ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzExMzI1_16b3fb85-aa61-4feb-b09d-ef6efc6c7261">322.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzExMzMy_ad4e407e-7c9f-46f2-8998-aec6d990849a">391.1</ix:nonFraction> million, respectively, of which $<ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzExMzQ1_ac3308ed-4c07-44f7-b65b-0f573bf82e65">230.2</ix:nonFraction>&#160;million as of December 31, 2021 would affect the Company&#8217;s effective tax rate if recognized, with the remainder being offset by potential correlative adjustments. Related accrued interest and penalties included in the consolidated balance sheets were $<ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzExNDk2_7dd09f39-b4db-4e57-abcd-475a2f1e6979">96.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzExNTAz_8283abcb-14f0-4abc-a47f-7f97cd2a4734">86.7</ix:nonFraction> million as of December&#160;31, 2021 and 2020, respectively. For the years ended December&#160;31, 2021, 2020 and 2019, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:IncomeTaxExaminationInterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzExNTk0_70e47ed0-e7f6-4e69-b4f3-b4184244e1e3">18.5</ix:nonFraction> million of tax expense, $<ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:IncomeTaxExaminationInterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzExNTk4_982a3350-6fdf-45f5-bb11-a1803b0a674d">6.0</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i284387cf86b54bd4adfef2f32bb9c670_D20170101-20171231" decimals="-5" name="us-gaap:IncomeTaxExaminationInterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzExNjA2_454a0b32-404b-435e-8c27-b909179d6a44">35.2</ix:nonFraction> million of tax benefits, respectively, related to interest and penalties on uncertain tax positions. Interest and penalties related to income taxes are included in the tax provision.</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzEyMTYy_95731898-2234-4bf5-9d44-b37158699323" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the unrecognized tax benefits is as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.006%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.712%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefit&#160;&#8212; beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo4NTJjYzFhYjNkZjY0MGY4OTJjMzcxNjc2Y2U2Mzk0Ni90YWJsZXJhbmdlOjg1MmNjMWFiM2RmNjQwZjg5MmMzNzE2NzZjZTYzOTQ2XzItMS0xLTEtMzE0MjI_ddfa5cfd-877e-4640-aa11-5c0466cc381f">391.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac503b6d629d4bafb262ea6ec0b8a25e_I20191231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo4NTJjYzFhYjNkZjY0MGY4OTJjMzcxNjc2Y2U2Mzk0Ni90YWJsZXJhbmdlOjg1MmNjMWFiM2RmNjQwZjg5MmMzNzE2NzZjZTYzOTQ2XzItMy0xLTEtMzE0MjI_9a3393bd-11f3-4d52-b7b6-850efe772d34">92.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a20c8f3803144d58ca34d0fcee823ce_I20161231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo4NTJjYzFhYjNkZjY0MGY4OTJjMzcxNjc2Y2U2Mzk0Ni90YWJsZXJhbmdlOjg1MmNjMWFiM2RmNjQwZjg5MmMzNzE2NzZjZTYzOTQ2XzItNS0xLTEtMzE0MjI_b0acc27b-17f9-4a53-9943-d7087e33a3ff">96.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions for current year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo4NTJjYzFhYjNkZjY0MGY4OTJjMzcxNjc2Y2U2Mzk0Ni90YWJsZXJhbmdlOjg1MmNjMWFiM2RmNjQwZjg5MmMzNzE2NzZjZTYzOTQ2XzMtMS0xLTEtMzE0MjI_b92ad8dc-5a56-404b-9542-1e9e1f18ebf6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo4NTJjYzFhYjNkZjY0MGY4OTJjMzcxNjc2Y2U2Mzk0Ni90YWJsZXJhbmdlOjg1MmNjMWFiM2RmNjQwZjg5MmMzNzE2NzZjZTYzOTQ2XzMtMy0xLTEtMzE0MjI_94a08ce9-312e-4988-a169-3ef771ab62ae">13.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i284387cf86b54bd4adfef2f32bb9c670_D20170101-20171231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo4NTJjYzFhYjNkZjY0MGY4OTJjMzcxNjc2Y2U2Mzk0Ni90YWJsZXJhbmdlOjg1MmNjMWFiM2RmNjQwZjg5MmMzNzE2NzZjZTYzOTQ2XzMtNS0xLTEtMzE0MjI_041822a8-f72c-4bbf-8161-4649f3ec9865">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions for prior year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo4NTJjYzFhYjNkZjY0MGY4OTJjMzcxNjc2Y2U2Mzk0Ni90YWJsZXJhbmdlOjg1MmNjMWFiM2RmNjQwZjg5MmMzNzE2NzZjZTYzOTQ2XzQtMS0xLTEtMzE0MjI_776e66e0-51ce-413d-ae3d-c8e87a302176">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo4NTJjYzFhYjNkZjY0MGY4OTJjMzcxNjc2Y2U2Mzk0Ni90YWJsZXJhbmdlOjg1MmNjMWFiM2RmNjQwZjg5MmMzNzE2NzZjZTYzOTQ2XzQtMy0xLTEtMzE0MjI_49bcaab8-0f79-40e2-9357-c71eb13d7a60">35.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i284387cf86b54bd4adfef2f32bb9c670_D20170101-20171231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo4NTJjYzFhYjNkZjY0MGY4OTJjMzcxNjc2Y2U2Mzk0Ni90YWJsZXJhbmdlOjg1MmNjMWFiM2RmNjQwZjg5MmMzNzE2NzZjZTYzOTQ2XzQtNS0xLTEtMzE0MjI_552bc58e-447d-485b-a8f8-38b8c448b223">154.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions for prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo4NTJjYzFhYjNkZjY0MGY4OTJjMzcxNjc2Y2U2Mzk0Ni90YWJsZXJhbmdlOjg1MmNjMWFiM2RmNjQwZjg5MmMzNzE2NzZjZTYzOTQ2XzUtMS0xLTEtMzE0MjI_7c751f22-5d2a-46f6-8bac-2e3f8fe738a3">9.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo4NTJjYzFhYjNkZjY0MGY4OTJjMzcxNjc2Y2U2Mzk0Ni90YWJsZXJhbmdlOjg1MmNjMWFiM2RmNjQwZjg5MmMzNzE2NzZjZTYzOTQ2XzUtMy0xLTEtMzE0MjI_72d26224-ce86-4df1-a698-1b2745ecbc5f">5.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i284387cf86b54bd4adfef2f32bb9c670_D20170101-20171231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo4NTJjYzFhYjNkZjY0MGY4OTJjMzcxNjc2Y2U2Mzk0Ni90YWJsZXJhbmdlOjg1MmNjMWFiM2RmNjQwZjg5MmMzNzE2NzZjZTYzOTQ2XzUtNS0xLTEtMzE0MjI_eaab45e5-6e0b-492a-8489-b2b49a8ef91a">11.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo4NTJjYzFhYjNkZjY0MGY4OTJjMzcxNjc2Y2U2Mzk0Ni90YWJsZXJhbmdlOjg1MmNjMWFiM2RmNjQwZjg5MmMzNzE2NzZjZTYzOTQ2XzYtMS0xLTEtMzE0MjI_326f6ab0-089c-4e5f-ad6a-3fc1d2225a35">47.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo4NTJjYzFhYjNkZjY0MGY4OTJjMzcxNjc2Y2U2Mzk0Ni90YWJsZXJhbmdlOjg1MmNjMWFiM2RmNjQwZjg5MmMzNzE2NzZjZTYzOTQ2XzYtMy0xLTEtMzE0MjI_a257fb00-9cc7-454f-a212-f9bc0bf565f0">8.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i284387cf86b54bd4adfef2f32bb9c670_D20170101-20171231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo4NTJjYzFhYjNkZjY0MGY4OTJjMzcxNjc2Y2U2Mzk0Ni90YWJsZXJhbmdlOjg1MmNjMWFiM2RmNjQwZjg5MmMzNzE2NzZjZTYzOTQ2XzYtNS0xLTEtMzE0MjI_569b0ab9-c3ed-4022-8770-11d7ad7036c1">112.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions due to expirations of statute of limitations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo4NTJjYzFhYjNkZjY0MGY4OTJjMzcxNjc2Y2U2Mzk0Ni90YWJsZXJhbmdlOjg1MmNjMWFiM2RmNjQwZjg5MmMzNzE2NzZjZTYzOTQ2XzctMS0xLTEtMzE0MjI_9a8fd167-6d0e-4fa9-a76d-4958df9ced27">7.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo4NTJjYzFhYjNkZjY0MGY4OTJjMzcxNjc2Y2U2Mzk0Ni90YWJsZXJhbmdlOjg1MmNjMWFiM2RmNjQwZjg5MmMzNzE2NzZjZTYzOTQ2XzctMy0xLTEtMzE0MjI_d3ce5532-2f6a-4e25-bff1-d787a21ec792">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i284387cf86b54bd4adfef2f32bb9c670_D20170101-20171231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo4NTJjYzFhYjNkZjY0MGY4OTJjMzcxNjc2Y2U2Mzk0Ni90YWJsZXJhbmdlOjg1MmNjMWFiM2RmNjQwZjg5MmMzNzE2NzZjZTYzOTQ2XzctNS0xLTEtMzE0MjI_7dde27b0-b17e-4f17-8eee-722b097cc6c2">34.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Reduction) addition due to acquisition</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo4NTJjYzFhYjNkZjY0MGY4OTJjMzcxNjc2Y2U2Mzk0Ni90YWJsZXJhbmdlOjg1MmNjMWFiM2RmNjQwZjg5MmMzNzE2NzZjZTYzOTQ2XzgtMS0xLTEtMzE0MjI_8a9f16ad-85b2-4c46-a1d4-092a18e99f3f">4.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo4NTJjYzFhYjNkZjY0MGY4OTJjMzcxNjc2Y2U2Mzk0Ni90YWJsZXJhbmdlOjg1MmNjMWFiM2RmNjQwZjg5MmMzNzE2NzZjZTYzOTQ2XzgtMy0xLTEtMzE0MjI_e2181af1-2c66-4834-ad3f-41063e1261bf">264.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo4NTJjYzFhYjNkZjY0MGY4OTJjMzcxNjc2Y2U2Mzk0Ni90YWJsZXJhbmdlOjg1MmNjMWFiM2RmNjQwZjg5MmMzNzE2NzZjZTYzOTQ2XzgtNS0xLTEtMzE0MjI_bc8643aa-2b25-455b-b277-4d5dbf348da8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefit&#160;&#8212; end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo4NTJjYzFhYjNkZjY0MGY4OTJjMzcxNjc2Y2U2Mzk0Ni90YWJsZXJhbmdlOjg1MmNjMWFiM2RmNjQwZjg5MmMzNzE2NzZjZTYzOTQ2XzktMS0xLTEtMzE0MjI_be5e4ede-3d45-4967-917a-aa1aca17fd7e">322.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo4NTJjYzFhYjNkZjY0MGY4OTJjMzcxNjc2Y2U2Mzk0Ni90YWJsZXJhbmdlOjg1MmNjMWFiM2RmNjQwZjg5MmMzNzE2NzZjZTYzOTQ2XzktMy0xLTEtMzE0MjI_9ef90f48-72e8-4778-bb46-c0752e3b46f7">391.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac503b6d629d4bafb262ea6ec0b8a25e_I20191231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo4NTJjYzFhYjNkZjY0MGY4OTJjMzcxNjc2Y2U2Mzk0Ni90YWJsZXJhbmdlOjg1MmNjMWFiM2RmNjQwZjg5MmMzNzE2NzZjZTYzOTQ2XzktNS0xLTEtMzE0MjI_3b60809b-c2a6-4f87-9971-184e38a850ab">92.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that it is reasonably possible that the amount of unrecognized tax benefits will decrease in the next twelve months by approximately $<ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-6" name="us-gaap:IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzEyMDA2_30e9b933-91dc-4a20-a345-de8c8e6344e2">55.0</ix:nonFraction> million, involving international and state audits and settlements and expiring statutes of limitations. The Company does not anticipate significant increases to the reserve within the next twelve months.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">126</span></div></div></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_220"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzUwNzU_389edfea-cff4-422e-bbae-4d324387edd9" continuedAt="ib683728c93dd41ec96f3d28400053572" escape="true">Share-Based Incentive Plan</ix:nonNumeric></span></div><ix:continuation id="ib683728c93dd41ec96f3d28400053572" continuedAt="iaabbf1c6368b46f8a60c4187f18dbdc4"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Distribution, Viatris adopted and Pfizer, in the capacity as Viatris&#8217; sole stockholder at such time, approved the Plan (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Viatris Inc. 2020 Stock Incentive Plan) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which became effective as of the Distribution. In connection with the Combination, as of November 16, 2020, the Company assumed the 2003 LTIP (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mylan N.V. Amended and Restated 2003 Long-Term Incentive Plan)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which had previously been approved by Mylan shareholders. The Plan and 2003 LTIP include (i) <ix:nonFraction unitRef="shares" contextRef="icf4cadf4931e4608b5a75d3c9e76220c_I20201116" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzQ5OQ_1d72fe57-6add-42f3-9c7f-ce5f0ac04d7f">72,500,000</ix:nonFraction> shares of Common Stock authorized for grant pursuant to the Plan, which may include dividend payments payable in Common Stock on unvested shares granted under awards, (ii) <ix:nonFraction unitRef="shares" contextRef="ide54256d4c4e4fd1bebbeda254f7381b_D20201116-20201116" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzY3NA_6c014671-705f-4d8d-a49b-65ead44dd1e6">6,757,640</ix:nonFraction> shares of Common Stock to be issued pursuant to the exercise of outstanding stock options granted to participants under the 2003 LTIP and assumed by Viatris in connection with the Combination and (iii) <ix:nonFraction unitRef="shares" contextRef="i58936cbb4f69447d95f57e98537ab978_I20201116" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0Xzg3OQ_ecccdeb8-48ed-4d02-97b2-42e95dc2b0d3">13,535,627</ix:nonFraction> shares of Common Stock subject to outstanding equity-based awards, other than stock options, assumed by Viatris in connection with the Combination, or that otherwise remain available for issuance under the 2003 LTIP.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Plan and 2003 LTIP, shares are reserved for issuance to key employees, consultants, independent contractors and non-employee directors of the Company through a variety of incentive awards, including: stock options, SARs, restricted stock and units, PSUs, other stock-based awards and short-term cash awards. Stock option awards are granted with an exercise price equal to the fair market value of the shares underlying the stock options at the date of the grant, generally become exercisable over periods ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzE2Mjc_08ccde51-39fc-462c-a345-1572757200f2">three</span> to <ix:nonNumeric contextRef="iff2871529dca49568da0067c4e5a5e0f_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzE2MzM_03cba3f3-9320-42e2-9c6d-f9bd91619a00">four years</ix:nonNumeric>, and generally expire in <ix:nonNumeric contextRef="i2ee490046709489aa5f4269ad8f50ae8_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzE2NjE_c6be35ff-7474-4d0a-8808-913aaece6ea7">ten years</ix:nonNumeric>.</span></div><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzUwNzc_4409e516-062d-4688-9136-8e7b2a4c13b0" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock awards (stock options and SARs) activity under the Plan and 2003 LTIP:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:71.187%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.389%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.391%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of&#160;Shares<br/>Under Stock Awards</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise&#160;Price<br/>per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2018</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if8ec92ba24d848d697ba737aeed13c05_I20181231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzEtMS0xLTEtMzE0MjI_514e7357-6ce8-4d87-b105-94d31cd66a77">6,815,278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if8ec92ba24d848d697ba737aeed13c05_I20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzEtMy0xLTEtMzE0MjI_8c747a99-92b1-467d-a44c-49cc287dc2ac">36.61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzItMS0xLTEtMzE0MjI_553b6441-6710-462b-bcd1-45169c37680a">829,322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzItMy0xLTEtMzE0MjI_6d283387-b8ca-4c72-b6ec-b1443c7d15be">26.18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzMtMS0xLTEtMzE0MjI_62f931e7-52ad-4f49-abd9-5ef1d84b7622">580,950</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzMtMy0xLTEtMzE0MjI_93ef6cea-37e7-4953-85e7-8e19d862fc94">14.40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzQtMS0xLTEtMzE0MjI_16b3f36e-20ec-42cd-b6b2-b3efb7a836b9">715,941</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzQtMy0xLTEtMzE0MjI_d1b3474d-d5ea-4a8b-ac37-8011657845f0">39.40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iac503b6d629d4bafb262ea6ec0b8a25e_I20191231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzYtMS0xLTEtMzE0MjI_70cb5ee6-b3c4-4834-8818-60e85bdde82d">6,347,709</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iac503b6d629d4bafb262ea6ec0b8a25e_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzYtMy0xLTEtMzE0MjI_185cd2b0-0f33-4775-82fb-9cccacb5d84c">36.97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzctMS0xLTEtMzE0MjI_6c7f90df-e2fc-4ac4-9101-8265c1ac007f">814,351</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzctMy0xLTEtMzE0MjI_af536599-2d48-4b69-9b5e-a95f28322040">17.37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzgtMS0xLTEtMzE0MjI_f9841b9c-1ad6-4e2e-92ee-57df41ec3d64">27,615</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzgtMy0xLTEtMzE0MjI_eccb56d3-68b6-4c60-8c4f-8eb13c910798">21.13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzktMS0xLTEtMzE0MjI_9289f6e0-e429-4339-b956-b0f53b186fcd">422,714</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzktMy0xLTEtMzE0MjI_bc8eb9d8-ce64-45cf-b4aa-b4fd3b9a9e37">25.74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzEwLTEtMS0xLTMxNDIy_9fe1b400-6ec6-4f47-9a44-8f02d0e0a126">6,711,731</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzEwLTMtMS0xLTMxNDIy_0b35aaa3-abcd-4ea8-9517-572e57a068cc">35.36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzEzLTEtMS0xLTMxNDIy_f3f765ce-f1a1-4e58-b902-8c0121cd6143">1,135,241</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzEzLTMtMS0xLTMxNDIy_ff03460a-5326-4f5e-a859-9634b36c32ce">26.39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzE0LTEtMS0xLTMxNDIy_bd1ccd5f-0789-44bb-8b43-72287f0f906f">5,576,490</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzE0LTMtMS0xLTMxNDIy_dc4d66e4-b558-44e6-94f8-5d6717ddcef7">37.19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzE1LTEtMS0xLTMxNDIy_29c4c12b-c157-4a7f-b839-35e1b5f3b00e">5,487,788</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzE1LTMtMS0xLTMxNDIy_271ba711-4356-45ae-b6fb-4a824d4581bb">37.45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzE2LTEtMS0xLTMxNDIy_b969b6ba-e27f-47aa-b8f2-1fd09f96a818">4,969,602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzE2LTMtMS0xLTMxNDIy_c66cddbd-d85f-4dae-8c6c-0a0ff914a530">39.21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, stock awards outstanding, stock awards vested and expected to vest and stock awards exercisable had average remaining contractual terms of <ix:nonNumeric contextRef="i2ee490046709489aa5f4269ad8f50ae8_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzE5MzQ_e2911433-fa0b-4f60-b6ba-4108babfbf8a">4.6</ix:nonNumeric> years, <ix:nonNumeric contextRef="i2ee490046709489aa5f4269ad8f50ae8_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzE5Mzg_f35d1b12-3cf9-4726-a0e1-1a924f101269">4.6</ix:nonNumeric> years and <ix:nonNumeric contextRef="i2ee490046709489aa5f4269ad8f50ae8_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzE5NDU_61e71807-a8c7-4300-bba0-29f76a48a4f7">4.2</ix:nonNumeric> years, respectively. Also, at December&#160;31, 2021, stock awards outstanding, stock awards vested and expected to vest and stock awards exercisable had no aggregate intrinsic value.</span></div><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzUwNzM_76c22bae-ad76-4f51-b3b1-e5aa6ef447fd" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the status of the Company&#8217;s nonvested restricted stock awards (restricted stock and restricted stock unit awards, including PSUs), as of December&#160;31, 2020 and the changes during the year ended December&#160;31, 2021 are presented below:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:65.029%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.468%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.470%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of&#160;Restricted<br/>Stock Awards</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Grant-Date<br/>Fair&#160;Value&#160;Per&#160;Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i108f18c1c1f24f03914b8e2a90171783_I20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTpiZGMwNjAwNzRkMWU0OTVhOWE4MWZkYjIzYTFlODAwNi90YWJsZXJhbmdlOmJkYzA2MDA3NGQxZTQ5NWE5YTgxZmRiMjNhMWU4MDA2XzEtMS0xLTEtMzE0MjI_af774a38-63df-4491-9d71-c2028dbc5aec">12,073,790</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i108f18c1c1f24f03914b8e2a90171783_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTpiZGMwNjAwNzRkMWU0OTVhOWE4MWZkYjIzYTFlODAwNi90YWJsZXJhbmdlOmJkYzA2MDA3NGQxZTQ5NWE5YTgxZmRiMjNhMWU4MDA2XzEtMy0xLTEtMzE0MjI_f714c3af-56c6-4f74-956b-c9cfbfae00ce">18.34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6030f8107f684fe8afa39a9cb5b4ce23_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTpiZGMwNjAwNzRkMWU0OTVhOWE4MWZkYjIzYTFlODAwNi90YWJsZXJhbmdlOmJkYzA2MDA3NGQxZTQ5NWE5YTgxZmRiMjNhMWU4MDA2XzItMS0xLTEtMzE0MjI_ef526c62-c45f-41f4-b79d-a8b34d3fbfc3">9,850,443</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6030f8107f684fe8afa39a9cb5b4ce23_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTpiZGMwNjAwNzRkMWU0OTVhOWE4MWZkYjIzYTFlODAwNi90YWJsZXJhbmdlOmJkYzA2MDA3NGQxZTQ5NWE5YTgxZmRiMjNhMWU4MDA2XzItMy0xLTEtMzE0MjI_de1e96a8-b8c0-4276-ae42-3ff220454f25">14.46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Released</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i6030f8107f684fe8afa39a9cb5b4ce23_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTpiZGMwNjAwNzRkMWU0OTVhOWE4MWZkYjIzYTFlODAwNi90YWJsZXJhbmdlOmJkYzA2MDA3NGQxZTQ5NWE5YTgxZmRiMjNhMWU4MDA2XzMtMS0xLTEtMzE0MjI_ca9daa89-e242-4ba9-8bfd-c4390101426a">3,168,152</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6030f8107f684fe8afa39a9cb5b4ce23_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTpiZGMwNjAwNzRkMWU0OTVhOWE4MWZkYjIzYTFlODAwNi90YWJsZXJhbmdlOmJkYzA2MDA3NGQxZTQ5NWE5YTgxZmRiMjNhMWU4MDA2XzMtMy0xLTEtMzE0MjI_d67dd298-975e-4768-b0f7-3d51e1cc35e8">24.65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i6030f8107f684fe8afa39a9cb5b4ce23_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTpiZGMwNjAwNzRkMWU0OTVhOWE4MWZkYjIzYTFlODAwNi90YWJsZXJhbmdlOmJkYzA2MDA3NGQxZTQ5NWE5YTgxZmRiMjNhMWU4MDA2XzQtMS0xLTEtMzE0MjI_04821edf-ef88-42da-bc1a-1732714e7efa">1,897,953</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6030f8107f684fe8afa39a9cb5b4ce23_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTpiZGMwNjAwNzRkMWU0OTVhOWE4MWZkYjIzYTFlODAwNi90YWJsZXJhbmdlOmJkYzA2MDA3NGQxZTQ5NWE5YTgxZmRiMjNhMWU4MDA2XzQtMy0xLTEtMzE0MjI_d8449ac4-4c32-4c50-8014-f05eb23efa26">15.33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i59f89db7c1cf4fbbbb690f556ab2557f_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTpiZGMwNjAwNzRkMWU0OTVhOWE4MWZkYjIzYTFlODAwNi90YWJsZXJhbmdlOmJkYzA2MDA3NGQxZTQ5NWE5YTgxZmRiMjNhMWU4MDA2XzUtMS0xLTEtMzE0MjI_100998b0-2c96-4b34-b5df-9acbaa2d8dc5">16,858,128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i59f89db7c1cf4fbbbb690f556ab2557f_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTpiZGMwNjAwNzRkMWU0OTVhOWE4MWZkYjIzYTFlODAwNi90YWJsZXJhbmdlOmJkYzA2MDA3NGQxZTQ5NWE5YTgxZmRiMjNhMWU4MDA2XzUtMy0xLTEtMzE0MjI_aad1b102-cd1e-4016-ad88-5f7e45f1ddd8">15.12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">127</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><ix:continuation id="iaabbf1c6368b46f8a60c4187f18dbdc4"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Of the <ix:nonFraction unitRef="shares" contextRef="i6030f8107f684fe8afa39a9cb5b4ce23_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzIzNzU_ef526c62-c45f-41f4-b79d-a8b34d3fbfc3">9,850,443</ix:nonFraction> restricted stock awards granted during the year ended December&#160;31, 2021, <ix:nonFraction unitRef="shares" contextRef="ib1c2d553da14496cb03b6b87eb3cd0c0_D20210101-20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzI0MzY_eb416cae-d815-4f1e-a8eb-2264db343886">6,057,602</ix:nonFraction> vest ratably in <ix:nonNumeric contextRef="ib1c2d553da14496cb03b6b87eb3cd0c0_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzI0NTU_1371c118-7309-4002-8e8b-3e465d288a87">three years</ix:nonNumeric> or less and are not subject to market or performance conditions. Of the remaining restricted stock awards granted, <ix:nonFraction unitRef="shares" contextRef="i391ac2a5652949d58e918cbb11120117_D20210101-20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzI1NzM_8f7f2727-bfae-4f08-ac89-0a253ab25c10">587,025</ix:nonFraction> are not subject to market conditions and will cliff vest within a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzI2NDI_f3b767c1-16ad-4e4f-bd76-18f9bc8ce9a6">three</span>-year period, and <ix:nonFraction unitRef="shares" contextRef="ide9073c6a7c5441b8fcaffca6958c382_D20210101-20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzI2NjI_64210ff7-5631-4c86-89aa-0b51dd114cef">3,205,816</ix:nonFraction> are subject to market or performance conditions and will cliff vest in <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzEyNjQ0MzgzNzI3MzQ5_f3b767c1-16ad-4e4f-bd76-18f9bc8ce9a6">three</span> years or less.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company had $<ix:nonFraction unitRef="usd" contextRef="ie5c3b0237a83415cb42661ae906c1ba7_I20211231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzI3NzQ_4c43b82e-6c4f-40ce-a0c4-f83d12d50f6a">143.1</ix:nonFraction> million of total unrecognized compensation expense, net of estimated forfeitures, related to all of its stock-based awards, which we expect to recognize over the remaining weighted average vesting period of <ix:nonNumeric contextRef="i9267df240f8949458673188e0cc47584_D20210101-20211231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzI5NzY_1ea1e2db-8399-4891-b4b0-4f4103a77ae1">1.7</ix:nonNumeric> years. The total intrinsic value of stock awards exercised and restricted stock units released during the years ended December&#160;31, 2021 and 2020 was $<ix:nonFraction unitRef="usd" contextRef="i9267df240f8949458673188e0cc47584_D20210101-20211231" decimals="-5" name="vtrs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzMxMDU_45554ae9-3dfc-4fce-8212-091c9c2476aa">78.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i149651f6a4da4798a97a769739151b62_D20200101-20201231" decimals="-5" name="vtrs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzMxMTI_bfa6da10-cfcc-4262-a2a4-b97e5c51fb06">20.9</ix:nonFraction> million, respectively.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to options granted under the Plan and 2003 LTIP, the fair value of each option grant was estimated at the date of grant using the Black-Scholes option pricing model. Black-Scholes utilizes assumptions related to volatility, the risk-free interest rate, the dividend yield and employee exercise behavior. Expected volatilities utilized in the model are based mainly on the implied volatility of the Company&#8217;s stock price and other factors. The risk-free interest rate is derived from the U.S.&#160;Treasury yield curve in effect at the time of grant. The model incorporates exercise and post-vesting forfeiture assumptions based on an analysis of historical data. The expected lives of the grants are derived from historical and other factors.</span></div><ix:nonNumeric contextRef="i9267df240f8949458673188e0cc47584_D20210101-20211231" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzUwNDY_b6b9c8b5-957c-4fdc-b468-fd4834118ca2" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no options granted during the year ended December 31, 2021. The assumptions used for options granted under the Plan and 2003 LTIP during the years ended December 31, 2020 and 2019, respectively, are as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.578%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.697%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i10a62822cebc4558b2338681f573875e_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTo4ZTYyMDdiN2Y0N2E0ZGY2OWIyZTY2N2Q5NDFlYWU0OC90YWJsZXJhbmdlOjhlNjIwN2I3ZjQ3YTRkZjY5YjJlNjY3ZDk0MWVhZTQ4XzItMy0xLTEtMzE0MjI_402a912e-422d-482d-b7ca-9fe301144c15">46.7</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6da6a8af22304e098fe4c7c2f12e2ce6_D20190101-20191231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTo4ZTYyMDdiN2Y0N2E0ZGY2OWIyZTY2N2Q5NDFlYWU0OC90YWJsZXJhbmdlOjhlNjIwN2I3ZjQ3YTRkZjY5YjJlNjY3ZDk0MWVhZTQ4XzItNS0xLTEtMzE0MjI_7f4c3583-0a46-4d35-b0fa-7eb1a9fc5dad">38.1</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i10a62822cebc4558b2338681f573875e_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTo4ZTYyMDdiN2Y0N2E0ZGY2OWIyZTY2N2Q5NDFlYWU0OC90YWJsZXJhbmdlOjhlNjIwN2I3ZjQ3YTRkZjY5YjJlNjY3ZDk0MWVhZTQ4XzMtMy0xLTEtMzE0MjI_4fa6d7d5-e791-4fd6-a7d2-d71089e54f44">1.0</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6da6a8af22304e098fe4c7c2f12e2ce6_D20190101-20191231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTo4ZTYyMDdiN2Y0N2E0ZGY2OWIyZTY2N2Q5NDFlYWU0OC90YWJsZXJhbmdlOjhlNjIwN2I3ZjQ3YTRkZjY5YjJlNjY3ZDk0MWVhZTQ4XzMtNS0xLTEtMzE0MjI_e80e94a9-4201-4f52-8701-d2876349cb3f">2.5</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i10a62822cebc4558b2338681f573875e_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTo4ZTYyMDdiN2Y0N2E0ZGY2OWIyZTY2N2Q5NDFlYWU0OC90YWJsZXJhbmdlOjhlNjIwN2I3ZjQ3YTRkZjY5YjJlNjY3ZDk0MWVhZTQ4XzQtMy0xLTEtMzE0MjI_f3d3d464-ae46-48ee-8087-0a8d047fe264">6.5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6da6a8af22304e098fe4c7c2f12e2ce6_D20190101-20191231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTo4ZTYyMDdiN2Y0N2E0ZGY2OWIyZTY2N2Q5NDFlYWU0OC90YWJsZXJhbmdlOjhlNjIwN2I3ZjQ3YTRkZjY5YjJlNjY3ZDk0MWVhZTQ4XzQtNS0xLTEtMzE0MjI_2212ba0a-2c8a-4fd2-9314-97848cbdb3c3">6.5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeiture rate </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i10a62822cebc4558b2338681f573875e_D20200101-20201231" decimals="3" name="vtrs:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTo4ZTYyMDdiN2Y0N2E0ZGY2OWIyZTY2N2Q5NDFlYWU0OC90YWJsZXJhbmdlOjhlNjIwN2I3ZjQ3YTRkZjY5YjJlNjY3ZDk0MWVhZTQ4XzUtMy0xLTEtMzE0MjI_156c117f-624e-4075-85f5-0142c7eb6fde">5.5</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6da6a8af22304e098fe4c7c2f12e2ce6_D20190101-20191231" decimals="3" name="vtrs:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTo4ZTYyMDdiN2Y0N2E0ZGY2OWIyZTY2N2Q5NDFlYWU0OC90YWJsZXJhbmdlOjhlNjIwN2I3ZjQ3YTRkZjY5YjJlNjY3ZDk0MWVhZTQ4XzUtNS0xLTEtMzE0MjI_02b8e67e-5d21-47f3-b143-7d1ddb8b795f">5.5</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average grant date fair value per option</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i10a62822cebc4558b2338681f573875e_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTo4ZTYyMDdiN2Y0N2E0ZGY2OWIyZTY2N2Q5NDFlYWU0OC90YWJsZXJhbmdlOjhlNjIwN2I3ZjQ3YTRkZjY5YjJlNjY3ZDk0MWVhZTQ4XzYtMy0xLTEtMzE0MjI_b332bd9f-b2d8-4814-84d2-ffa2f612ca67">8.07</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i6da6a8af22304e098fe4c7c2f12e2ce6_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTo4ZTYyMDdiN2Y0N2E0ZGY2OWIyZTY2N2Q5NDFlYWU0OC90YWJsZXJhbmdlOjhlNjIwN2I3ZjQ3YTRkZjY5YjJlNjY3ZDk0MWVhZTQ4XzYtNS0xLTEtMzE0MjI_5be21b11-c42b-4e7e-b1c0-8659b7efc950">11.03</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_226"></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90ZXh0cmVnaW9uOjUyMmUwNGFkZTJlODQ4YjBiNjhhZWM3NTEzMzZhZTI0XzExODI5_e1cb6373-4c3d-4c11-a9ea-5743f60523c7" continuedAt="i948d83ebcf56449897d4af55e3bd8423" escape="true">Employee Benefit Plans</ix:nonNumeric></span></div><ix:continuation id="i948d83ebcf56449897d4af55e3bd8423" continuedAt="ic4aff221a8f645e7a8b77aceea987b03"><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Defined Benefit Plans</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sponsors various defined benefit pension plans in several countries. Benefits provided generally depend on length of service, pay grade and remuneration levels. Employees in the U.S., Puerto Rico and certain international locations are also provided retirement benefits through defined contribution plans.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also sponsors other postretirement benefit plans including plans that provide for postretirement supplemental medical coverage. Benefits from these plans are provided to employees and their spouses and dependents who meet various minimum age and service requirements. In addition, the Company sponsors other plans that provide for life insurance benefits and postretirement medical coverage for certain officers and management employees.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Combination, the Company assumed certain post retirement defined benefit pension plans sponsored by Upjohn. The most significant plans include those in Puerto Rico, Ireland and Japan. Upjohn is also the sponsor of one postretirement medical plan in Puerto Rico. As part of the acquisition accounting, the Company has recorded the fair value of these plans. Upon completion of the Combination, the excess of projected benefit obligation over the plan assets was recognized as a liability and any existing unrecognized actuarial gains or losses and unrecognized service costs or benefits were eliminated in purchase accounting.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for Defined Benefit Pension and Other Postretirement Plans</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes on its balance sheet an asset or liability equal to the over- or under-funded benefit obligation of each defined benefit pension and other postretirement plan. Actuarial gains or losses and prior service costs or credits that arise during the period are not recognized as components of net periodic benefit cost, but are recognized, net of tax, as a component of other comprehensive (loss) earnings.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">128</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><ix:continuation id="ic4aff221a8f645e7a8b77aceea987b03" continuedAt="i88b3f7a46b8846538ded0b378b9649a7"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90ZXh0cmVnaW9uOjUyMmUwNGFkZTJlODQ4YjBiNjhhZWM3NTEzMzZhZTI0XzExODA4_96308474-cd9a-42d9-a859-33f1234912dd" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in accumulated other comprehensive loss as of December&#160;31, 2021 and 2020 are:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:53.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Postretirement Benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized actuarial (gain) loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9d424a72c6e4901a7dafb47ebf3c114_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmNjE0ZmE5NTNkMDM0MDdiOTk5NGE0NmQ5ZDYyNjQxOC90YWJsZXJhbmdlOmY2MTRmYTk1M2QwMzQwN2I5OTk0YTQ2ZDlkNjI2NDE4XzMtMS0xLTEtMzE0MjI_0eff2c64-eac1-4a93-8f9e-e05b1307de7c">59.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ec108614a384362b6aac78bfa61c46c_I20201231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmNjE0ZmE5NTNkMDM0MDdiOTk5NGE0NmQ5ZDYyNjQxOC90YWJsZXJhbmdlOmY2MTRmYTk1M2QwMzQwN2I5OTk0YTQ2ZDlkNjI2NDE4XzMtMy0xLTEtMzE0MjI_dddbd1bc-7687-4324-9df2-567981895be4">33.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec1504795a9c4c6693434e98197e0e95_I20211231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmNjE0ZmE5NTNkMDM0MDdiOTk5NGE0NmQ5ZDYyNjQxOC90YWJsZXJhbmdlOmY2MTRmYTk1M2QwMzQwN2I5OTk0YTQ2ZDlkNjI2NDE4XzMtNS0xLTEtMzE0MjI_9863c7ed-ff30-4c04-be6c-5b5fab2d326d">21.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3db1d00ed7f642dcaf9157d146275821_I20201231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmNjE0ZmE5NTNkMDM0MDdiOTk5NGE0NmQ5ZDYyNjQxOC90YWJsZXJhbmdlOmY2MTRmYTk1M2QwMzQwN2I5OTk0YTQ2ZDlkNjI2NDE4XzMtNy0xLTEtMzE0MjI_49de61cd-da40-4b1b-8e93-a7d04f5abd8e">5.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized prior service cost (credit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9d424a72c6e4901a7dafb47ebf3c114_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmNjE0ZmE5NTNkMDM0MDdiOTk5NGE0NmQ5ZDYyNjQxOC90YWJsZXJhbmdlOmY2MTRmYTk1M2QwMzQwN2I5OTk0YTQ2ZDlkNjI2NDE4XzQtMS0xLTEtMzE0MjI_2d318dbf-b91a-4ee9-b373-f405b7cec9b5">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4ec108614a384362b6aac78bfa61c46c_I20201231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmNjE0ZmE5NTNkMDM0MDdiOTk5NGE0NmQ5ZDYyNjQxOC90YWJsZXJhbmdlOmY2MTRmYTk1M2QwMzQwN2I5OTk0YTQ2ZDlkNjI2NDE4XzQtMy0xLTEtMzE0MjI_091ae81f-b04f-4d8e-943b-59ba0edc6f0c">1.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec1504795a9c4c6693434e98197e0e95_I20211231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmNjE0ZmE5NTNkMDM0MDdiOTk5NGE0NmQ5ZDYyNjQxOC90YWJsZXJhbmdlOmY2MTRmYTk1M2QwMzQwN2I5OTk0YTQ2ZDlkNjI2NDE4XzQtNS0xLTEtMzE0MjI_36b14259-6a0a-43d2-8943-7a5894c46086">3.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3db1d00ed7f642dcaf9157d146275821_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmNjE0ZmE5NTNkMDM0MDdiOTk5NGE0NmQ5ZDYyNjQxOC90YWJsZXJhbmdlOmY2MTRmYTk1M2QwMzQwN2I5OTk0YTQ2ZDlkNjI2NDE4XzQtNy0xLTEtMzE0MjI_dd6e2c85-1dfb-4b1b-a6f5-027b1224b4c0">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9d424a72c6e4901a7dafb47ebf3c114_I20211231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmNjE0ZmE5NTNkMDM0MDdiOTk5NGE0NmQ5ZDYyNjQxOC90YWJsZXJhbmdlOmY2MTRmYTk1M2QwMzQwN2I5OTk0YTQ2ZDlkNjI2NDE4XzUtMS0xLTEtMzE0MjI_c0a54084-ee62-4197-991f-6a06beb35c93">53.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ec108614a384362b6aac78bfa61c46c_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmNjE0ZmE5NTNkMDM0MDdiOTk5NGE0NmQ5ZDYyNjQxOC90YWJsZXJhbmdlOmY2MTRmYTk1M2QwMzQwN2I5OTk0YTQ2ZDlkNjI2NDE4XzUtMy0xLTEtMzE0MjI_e71f8e7d-da98-4a8c-b304-06800113a18a">32.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec1504795a9c4c6693434e98197e0e95_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmNjE0ZmE5NTNkMDM0MDdiOTk5NGE0NmQ5ZDYyNjQxOC90YWJsZXJhbmdlOmY2MTRmYTk1M2QwMzQwN2I5OTk0YTQ2ZDlkNjI2NDE4XzUtNS0xLTEtMzE0MjI_4da641c4-60d8-4357-ae3c-4218ba0637c5">18.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3db1d00ed7f642dcaf9157d146275821_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmNjE0ZmE5NTNkMDM0MDdiOTk5NGE0NmQ5ZDYyNjQxOC90YWJsZXJhbmdlOmY2MTRmYTk1M2QwMzQwN2I5OTk0YTQ2ZDlkNjI2NDE4XzUtNy0xLTEtMzE0MjI_5f7c004e-5ad0-475e-ae69-12bbd5377484">6.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unrecognized net actuarial losses exceeded&#160;<ix:nonFraction unitRef="number" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="2" name="vtrs:AccumulatednetactuariallossesexceedhigherofmarketvalueofplanassetsorPBO" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90ZXh0cmVnaW9uOjUyMmUwNGFkZTJlODQ4YjBiNjhhZWM3NTEzMzZhZTI0XzIzNjQ_73d9a3f3-ccd1-4d63-8412-3af55d3a60b9">10</ix:nonFraction>%&#160;of the higher of the market value of plan assets or the projected benefit obligation at the beginning of the year for certain of the plans, therefore, amortization of such excess has been included in net periodic benefit costs for pension and other postretirement benefits in each of the last three years. The amortization period is the average remaining service period that active employees are expected to receive benefits, unless a plan is mostly inactive in which case the amortization period is the average remaining life expectancy of the plan participants. Unrecognized prior service cost is amortized over the future service periods of those employees who are active at the dates of the plan amendments and who are expected to receive benefits. If all or almost all of a plan's participants are inactive, unrecognized prior service cost is amortized over the remaining life expectancy of those participants. <ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90ZXh0cmVnaW9uOjUyMmUwNGFkZTJlODQ4YjBiNjhhZWM3NTEzMzZhZTI0XzExODEx_5e198da8-49ab-4f48-8817-48ab11315d2a" continuedAt="i4326bbf144b543be8bb406c9b37f6c93" escape="true">The increase in accumulated other comprehensive loss in 2021 relating to pension benefits and other postretirement benefits consists of:</ix:nonNumeric></span></div><div style="margin-bottom:12pt;margin-top:5pt"><ix:continuation id="i4326bbf144b543be8bb406c9b37f6c93"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:75.879%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.045%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Postretirement Benefits</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized actuarial (gain) loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo0MzY5YmFiZmUxOGE0OWQ4OWJjYTY1NDY5OGQwNWZhYy90YWJsZXJhbmdlOjQzNjliYWJmZTE4YTQ5ZDg5YmNhNjU0Njk4ZDA1ZmFjXzEtMS0xLTEtMzE0MjI_37cc5621-3955-4868-aac4-7d77eef9d624">102.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52ec07ca99e44636af66cf7c46bf1f5a_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo0MzY5YmFiZmUxOGE0OWQ4OWJjYTY1NDY5OGQwNWZhYy90YWJsZXJhbmdlOjQzNjliYWJmZTE4YTQ5ZDg5YmNhNjU0Njk4ZDA1ZmFjXzEtMy0xLTEtMzE0MjI_975e271c-1d03-45bc-8cd1-573bf27691c5">16.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial gain/(loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo0MzY5YmFiZmUxOGE0OWQ4OWJjYTY1NDY5OGQwNWZhYy90YWJsZXJhbmdlOjQzNjliYWJmZTE4YTQ5ZDg5YmNhNjU0Njk4ZDA1ZmFjXzItMS0xLTEtMzE0MjI_f6b1e7f6-3fd7-4e19-b420-5a7c1dd6e415">7.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52ec07ca99e44636af66cf7c46bf1f5a_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo0MzY5YmFiZmUxOGE0OWQ4OWJjYTY1NDY5OGQwNWZhYy90YWJsZXJhbmdlOjQzNjliYWJmZTE4YTQ5ZDg5YmNhNjU0Njk4ZDA1ZmFjXzItMy0xLTEtMzE0MjI_ea49b216-47b1-444a-850f-e21c10d00906">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized prior service credit (cost)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo0MzY5YmFiZmUxOGE0OWQ4OWJjYTY1NDY5OGQwNWZhYy90YWJsZXJhbmdlOjQzNjliYWJmZTE4YTQ5ZDg5YmNhNjU0Njk4ZDA1ZmFjXzMtMS0xLTEtMzE0MjI_e2922068-e011-4605-9fd2-fa04e3c7c4fd">8.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52ec07ca99e44636af66cf7c46bf1f5a_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo0MzY5YmFiZmUxOGE0OWQ4OWJjYTY1NDY5OGQwNWZhYy90YWJsZXJhbmdlOjQzNjliYWJmZTE4YTQ5ZDg5YmNhNjU0Njk4ZDA1ZmFjXzMtMy0xLTEtMzE0MjI_749aa797-7e56-48d9-9704-522035d51214">4.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo0MzY5YmFiZmUxOGE0OWQ4OWJjYTY1NDY5OGQwNWZhYy90YWJsZXJhbmdlOjQzNjliYWJmZTE4YTQ5ZDg5YmNhNjU0Njk4ZDA1ZmFjXzQtMS0xLTEtMzE0MjI_68752c83-e2bf-43dd-9738-6bd9108fcf84">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52ec07ca99e44636af66cf7c46bf1f5a_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo0MzY5YmFiZmUxOGE0OWQ4OWJjYTY1NDY5OGQwNWZhYy90YWJsZXJhbmdlOjQzNjliYWJmZTE4YTQ5ZDg5YmNhNjU0Njk4ZDA1ZmFjXzQtMy0xLTEtMzE0MjI_f8e5dc76-f9ab-4256-b1c2-16d86da2c2d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231" decimals="-5" sign="-" name="vtrs:OtherComprehensiveIncomeDefinedBenefitPlanForeignCurrencyTranslationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo0MzY5YmFiZmUxOGE0OWQ4OWJjYTY1NDY5OGQwNWZhYy90YWJsZXJhbmdlOjQzNjliYWJmZTE4YTQ5ZDg5YmNhNjU0Njk4ZDA1ZmFjXzUtMS0xLTEtMzE0MjI_6ca5787f-eecf-43aa-a900-669a2674eda3">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52ec07ca99e44636af66cf7c46bf1f5a_D20210101-20211231" decimals="-5" name="vtrs:OtherComprehensiveIncomeDefinedBenefitPlanForeignCurrencyTranslationBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo0MzY5YmFiZmUxOGE0OWQ4OWJjYTY1NDY5OGQwNWZhYy90YWJsZXJhbmdlOjQzNjliYWJmZTE4YTQ5ZDg5YmNhNjU0Njk4ZDA1ZmFjXzUtMy0xLTEtMzE0MjI_ce416a7f-62b9-4031-85e6-487abe73d2ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo0MzY5YmFiZmUxOGE0OWQ4OWJjYTY1NDY5OGQwNWZhYy90YWJsZXJhbmdlOjQzNjliYWJmZTE4YTQ5ZDg5YmNhNjU0Njk4ZDA1ZmFjXzYtMS0xLTEtMzE0MjI_072e1017-751f-4a6c-8564-db3ad2765b32">85.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52ec07ca99e44636af66cf7c46bf1f5a_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo0MzY5YmFiZmUxOGE0OWQ4OWJjYTY1NDY5OGQwNWZhYy90YWJsZXJhbmdlOjQzNjliYWJmZTE4YTQ5ZDg5YmNhNjU0Njk4ZDA1ZmFjXzYtMy0xLTEtMzE0MjI_2dd1b27a-c0c0-4a5e-b983-8ae9293d438b">11.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of net periodic benefit cost, change in projected benefit obligation, change in plan assets, funded status, fair value of plan assets, assumptions used to determine net periodic benefit cost, funding policy and estimated future benefit payments are summarized below for the Company&#8217;s pension plans and other postretirement plans.</span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Periodic Benefit Cost</span></div><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:ScheduleOfNetBenefitCostsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90ZXh0cmVnaW9uOjUyMmUwNGFkZTJlODQ4YjBiNjhhZWM3NTEzMzZhZTI0XzExODI2_ea8a9786-dd87-4a57-9d18-ef198d43e52e" escape="true"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of net periodic benefit cost for the years ended December&#160;31, 2021, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:30.858%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.503%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.655%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Postretirement Benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzMtMS0xLTEtMzE0MjI_2c2850e5-dc1e-4a70-82f5-e5ab600eb431">38.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie04b72f184f64b9bb48662c33d2c6a24_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzMtMy0xLTEtMzE0MjI_16c6f4df-d242-4998-81b5-ac6c5ecc70a5">23.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2229a1acd15a481eb03d17e8a82e053c_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzMtNS0xLTEtMzE0MjI_aefa12b3-c966-4962-a599-ce37c3dc963c">20.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35e6c4cb2eb24b3083832b9f47b4f963_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzMtNy0xLTEtMzE0MjI_ccadb99a-cd1d-42b7-bb11-989071eb0286">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica964033412a493d86144cd4f4685a99_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzMtOS0xLTEtMzE0MjI_7155f79a-c380-4199-a2ae-4a66a8972821">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzMtMTEtMS0xLTMxNDIy_9d7dbbcd-fc52-4c38-beb0-8badd5edd4f7">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzQtMS0xLTEtMzE0MjI_2c84cf87-7e82-4a26-b414-dced6a3dd0b1">31.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie04b72f184f64b9bb48662c33d2c6a24_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzQtMy0xLTEtMzE0MjI_7680c2c9-bfbb-4b38-af92-ed66e33bba07">13.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2229a1acd15a481eb03d17e8a82e053c_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzQtNS0xLTEtMzE0MjI_8ae6e468-df60-4c5b-bfe1-517ffc4cc97b">13.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35e6c4cb2eb24b3083832b9f47b4f963_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzQtNy0xLTEtMzE0MjI_386bb5d5-f14e-41ca-b598-a989a84307b9">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica964033412a493d86144cd4f4685a99_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzQtOS0xLTEtMzE0MjI_0dabb78c-9cde-4865-a922-1f470a7bad8b">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzQtMTEtMS0xLTMxNDIy_7f7eccb6-f4ba-4500-aa70-3fc80d57eb7d">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzUtMS0xLTEtMzE0MjI_7a5fbd1f-6248-4840-9ab1-9240d31e22b9">66.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie04b72f184f64b9bb48662c33d2c6a24_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzUtMy0xLTEtMzE0MjI_57cb6625-05fe-4c43-af49-45149a84a19d">19.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2229a1acd15a481eb03d17e8a82e053c_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzUtNS0xLTEtMzE0MjI_657e4d08-c96b-450f-9caf-dc875b9498df">12.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35e6c4cb2eb24b3083832b9f47b4f963_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzUtNy0xLTEtMzE0MjI_b6651c18-82ab-47ff-acf6-bce4344cfc57">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica964033412a493d86144cd4f4685a99_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzUtOS0xLTEtMzE0MjI_ae09547c-6e63-4ce5-bd42-d943997cb098">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzUtMTEtMS0xLTMxNDIy_6f8d3330-b9ab-4367-b9ac-a0c740725318">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan curtailment, settlement and termination</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanCurtailments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzYtMS0xLTEtMzE0MjI_2a458c74-a71f-4c1f-b8d7-486bc4f5410a">16.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie04b72f184f64b9bb48662c33d2c6a24_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanCurtailments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzYtMy0xLTEtMzE0MjI_9b10b8f0-fab5-4947-9214-4796aa2d85dd">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2229a1acd15a481eb03d17e8a82e053c_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanCurtailments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzYtNS0xLTEtMzE0MjI_eb25898b-40d1-4ab3-91ae-0dd518a42504">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35e6c4cb2eb24b3083832b9f47b4f963_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanCurtailments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzYtNy0xLTEtMzE0MjI_b6f8a01f-d0f8-4419-b1a7-dc896dc0afd3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica964033412a493d86144cd4f4685a99_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanCurtailments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzYtOS0xLTEtMzE0MjI_68c04281-a01c-4b8c-9655-9feffb06014e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanCurtailments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzYtMTEtMS0xLTMxNDIy_40c972d8-81c8-4250-929d-e6e370e24d53">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzctMS0xLTEtMzE0MjI_d165791f-57c2-4847-9a1d-a28c36ae1d9c">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie04b72f184f64b9bb48662c33d2c6a24_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzctMy0xLTEtMzE0MjI_e45e1f6f-9820-4872-8dbf-89386d0659eb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2229a1acd15a481eb03d17e8a82e053c_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzctNS0xLTEtMzE0MjI_5c0cee98-e3ba-4872-8449-6919f09956fe">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35e6c4cb2eb24b3083832b9f47b4f963_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzctNy0xLTEtMzE0MjI_953220e6-5783-4e65-87ea-bab71cc6deae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica964033412a493d86144cd4f4685a99_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzctOS0xLTEtMzE0MjI_340bb199-5f69-4269-9e67-1a65dfed08dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzctMTEtMS0xLTMxNDIy_f720f4a7-75af-4f84-a8dc-912d00e4a16f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized net actuarial losses (gains) </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzgtMS0xLTEtMzE0MjI_21b745d2-9115-46f0-8769-137f0b36212d">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie04b72f184f64b9bb48662c33d2c6a24_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzgtMy0xLTEtMzE0MjI_bf799f75-8988-4969-b48a-e4e608a79cc7">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2229a1acd15a481eb03d17e8a82e053c_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzgtNS0xLTEtMzE0MjI_a86f7778-823d-42f0-a057-fb37920904e1">0.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35e6c4cb2eb24b3083832b9f47b4f963_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzgtNy0xLTEtMzE0MjI_208a9ad4-9d69-4e14-8188-a605754e112d">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica964033412a493d86144cd4f4685a99_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzgtOS0xLTEtMzE0MjI_75213333-57ef-4260-915c-d86eb5be668f">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzgtMTEtMS0xLTMxNDIy_79acc11a-7ae1-42a6-a92c-31ef2d9bca22">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzktMS0xLTEtMzE0MjI_c71c4b02-1f94-4a9e-acd6-c56b25f2347e">10.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie04b72f184f64b9bb48662c33d2c6a24_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzktMy0xLTEtMzE0MjI_65a78b3d-6f39-43b3-b484-c8b37bc26805">18.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2229a1acd15a481eb03d17e8a82e053c_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzktNS0xLTEtMzE0MjI_6eb31735-fee2-41e0-9e1c-375737f9300c">22.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35e6c4cb2eb24b3083832b9f47b4f963_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzktNy0xLTEtMzE0MjI_85f89771-065a-4b90-8c95-9df0303d5416">6.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica964033412a493d86144cd4f4685a99_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzktOS0xLTEtMzE0MjI_5623f690-02be-4a62-9b9c-67e58e014382">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzktMTEtMS0xLTMxNDIy_d595acca-4f59-45ff-a51b-87a99a9b147e">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2021, the Company recognized a settlement gain as a result of cash payments from lump sum elections related to the U.S. and Puerto Rico pension plans.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">129</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><ix:continuation id="i88b3f7a46b8846538ded0b378b9649a7" continuedAt="if4a6344a71424ee49cacaf8aafd6c030"><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Change in Projected Benefit Obligation, Change in Plan Assets and Funded Status</span></div><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90ZXh0cmVnaW9uOjUyMmUwNGFkZTJlODQ4YjBiNjhhZWM3NTEzMzZhZTI0XzExODE0_544f83d3-6ec4-4b4a-b2b2-754c2dbc7434" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents components of the change in projected benefit obligation, change in plan assets and funded status at December&#160;31, 2021 and 2020.</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:53.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Postretirement Benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in Projected Benefit Obligation</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligation, beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ec108614a384362b6aac78bfa61c46c_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzMtMS0xLTEtMzE0MjI_24829cce-a116-433a-922a-d09b2662c001">2,145.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c56f90e02e14a18921a2b1fca1e4610_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzMtMy0xLTEtMzE0MjI_e9f3844c-5cbe-471f-9665-6327df9d2edd">674.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3db1d00ed7f642dcaf9157d146275821_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzMtNS0xLTEtMzE0MjI_b7e2fc26-7e97-41fd-9b00-129e300da277">188.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i355af96d788e4eeaa662de6eabe91582_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzMtNy0xLTEtMzE0MjI_57d4d526-d4ec-4d11-8a9c-d787aac39eda">33.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzQtMS0xLTEtMzE0MjI_1f39c77e-e524-460f-bafb-14c29991fb47">38.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie04b72f184f64b9bb48662c33d2c6a24_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzQtMy0xLTEtMzE0MjI_529138da-9bd2-4844-9605-3bedc4602c9a">23.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52ec07ca99e44636af66cf7c46bf1f5a_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzQtNS0xLTEtMzE0MjI_21e34b5b-e53b-4651-8846-6d22b4318d26">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2798085fac7a40bab607ca83a2fad67d_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzQtNy0xLTEtMzE0MjI_de5db699-2405-4556-a923-c4411c6581f2">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzUtMS0xLTEtMzE0MjI_54821cc2-94fa-4e22-90c7-77a1fe9d1c01">31.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie04b72f184f64b9bb48662c33d2c6a24_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzUtMy0xLTEtMzE0MjI_67cc1938-7ae7-4723-b258-5e5c0329ad72">13.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52ec07ca99e44636af66cf7c46bf1f5a_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzUtNS0xLTEtMzE0MjI_3c085c49-323b-426e-bd77-52f5ba08fca4">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2798085fac7a40bab607ca83a2fad67d_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzUtNy0xLTEtMzE0MjI_553711a9-309a-4dd9-bcc7-383329b1c559">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participant contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231" decimals="-5" name="vtrs:DefinedBenefitPlanContributionsByPlanParticipantsBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzYtMS0xLTEtMzE0MjI_7ab18398-3a46-40d3-ad26-7f7cf8f56f72">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie04b72f184f64b9bb48662c33d2c6a24_D20200101-20201231" decimals="-5" name="vtrs:DefinedBenefitPlanContributionsByPlanParticipantsBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzYtMy0xLTEtMzE0MjI_ca39845a-9c04-44a9-b459-6b62d7cb8fa4">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52ec07ca99e44636af66cf7c46bf1f5a_D20210101-20211231" decimals="-5" name="vtrs:DefinedBenefitPlanContributionsByPlanParticipantsBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzYtNS0xLTEtMzE0MjI_a9544a49-0388-4778-98e5-ecaaff1a0173">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2798085fac7a40bab607ca83a2fad67d_D20200101-20201231" decimals="-5" name="vtrs:DefinedBenefitPlanContributionsByPlanParticipantsBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzYtNy0xLTEtMzE0MjI_296e3aeb-d768-4bd1-835e-97066c78460f">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231" decimals="-5" name="vtrs:DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAssetsTransferredtofromPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzctMS0xLTEtMzE0MjI_edec2d20-df51-47c3-b4b6-494d0adb5647">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie04b72f184f64b9bb48662c33d2c6a24_D20200101-20201231" decimals="-5" name="vtrs:DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAssetsTransferredtofromPlan" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzctMy0xLTEtMzE0MjI_aba0f227-dd90-4b34-a3b8-f5c50d831752">1,389.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52ec07ca99e44636af66cf7c46bf1f5a_D20210101-20211231" decimals="-5" name="vtrs:DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAssetsTransferredtofromPlan" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzctNS0xLTEtMzE0MjI_3ef6f0ff-c2e0-49de-ac68-c0d99334e3c5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2798085fac7a40bab607ca83a2fad67d_D20200101-20201231" decimals="-5" name="vtrs:DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAssetsTransferredtofromPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzctNy0xLTEtMzE0MjI_2c11b494-9b43-4cd2-b363-246b43c062f8">153.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan settlements and terminations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanSettlementsBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzktMS0xLTEtMzE0MjI_88c7d47b-b991-4393-a46f-b09751426516">128.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie04b72f184f64b9bb48662c33d2c6a24_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanSettlementsBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzktMy0xLTEtMzE0MjI_e4a4754e-c732-44d2-a63a-15e0bb71ebfb">23.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52ec07ca99e44636af66cf7c46bf1f5a_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanSettlementsBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzktNS0xLTEtMzE0MjI_cae65265-eb72-4d52-90d3-09033e60d4e9">4.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2798085fac7a40bab607ca83a2fad67d_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanSettlementsBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzktNy0xLTEtMzE0MjI_18350fd1-a844-4b4f-b41a-7de00be99164">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial (gains) losses </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzEwLTEtMS0xLTMxNDIy_6721810a-f687-4e6b-af78-29b7099186ef">26.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie04b72f184f64b9bb48662c33d2c6a24_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzEwLTMtMS0xLTMxNDIy_8af1d519-ec21-42e6-81e1-40c7e2af54e7">37.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52ec07ca99e44636af66cf7c46bf1f5a_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzEwLTUtMS0xLTMxNDIy_1078eb83-adad-4230-94f1-b7f495414743">16.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2798085fac7a40bab607ca83a2fad67d_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzEwLTctMS0xLTMxNDIy_1b663fd0-e460-4a3f-8cd3-6447728dff37">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzExLTEtMS0xLTMxNDIy_e89400f9-274c-4acf-892f-951f533ec4f2">52.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie04b72f184f64b9bb48662c33d2c6a24_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzExLTMtMS0xLTMxNDIy_0b0c360a-f5a6-43f8-85a7-3405c88909c7">24.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52ec07ca99e44636af66cf7c46bf1f5a_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzExLTUtMS0xLTMxNDIy_4111a58b-e00f-460a-9afb-edea4a39a457">20.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2798085fac7a40bab607ca83a2fad67d_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzExLTctMS0xLTMxNDIy_f17fa885-d4cc-44ff-8f76-2f8ebcb17ebf">1.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzEyLTEtMS0xLTMxNDIy_204fb49f-4d3a-443b-b16d-08557c5fdd81">67.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie04b72f184f64b9bb48662c33d2c6a24_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzEyLTMtMS0xLTMxNDIy_93f88439-68ae-4023-aa24-75559f4cc8ac">53.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52ec07ca99e44636af66cf7c46bf1f5a_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzEyLTUtMS0xLTMxNDIy_520a59b8-3c95-4c0c-b0a8-28b3447416bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2798085fac7a40bab607ca83a2fad67d_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzEyLTctMS0xLTMxNDIy_b93a4828-3961-4f92-af2d-284922ded508">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligation, end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9d424a72c6e4901a7dafb47ebf3c114_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzEzLTEtMS0xLTMxNDIy_bc4d28ad-4a30-4cb5-a094-cfcc15f11cbd">1,946.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ec108614a384362b6aac78bfa61c46c_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzEzLTMtMS0xLTMxNDIy_9adda20a-3ff1-4746-9dd7-ad91b78e7c23">2,145.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec1504795a9c4c6693434e98197e0e95_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzEzLTUtMS0xLTMxNDIy_dc90d088-640a-4a3c-b140-1ecae0be2fcf">188.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3db1d00ed7f642dcaf9157d146275821_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzEzLTctMS0xLTMxNDIy_f59c6a99-c301-41da-b44d-b4931d36910c">188.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in Plan Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets, beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ec108614a384362b6aac78bfa61c46c_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzE2LTEtMS0xLTMxNDIy_ab5d4d9a-d0f9-4486-b764-469c6d934470">1,354.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c56f90e02e14a18921a2b1fca1e4610_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzE2LTMtMS0xLTMxNDIy_9591f7cf-a4a2-4954-81bc-d6a4c1cbb743">315.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3db1d00ed7f642dcaf9157d146275821_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzE2LTUtMS0xLTMxNDIy_76c57387-913c-48f5-b33a-9ad409446693">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i355af96d788e4eeaa662de6eabe91582_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzE2LTctMS0xLTMxNDIy_1df207d9-6fa7-4ec9-a0eb-c4184995b29e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzE3LTEtMS0xLTMxNDIy_46b4227e-c9c6-48af-8887-4878fe5308e4">141.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie04b72f184f64b9bb48662c33d2c6a24_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzE3LTMtMS0xLTMxNDIy_f09dc9aa-2740-421a-a020-5f3722c5c23e">46.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52ec07ca99e44636af66cf7c46bf1f5a_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzE3LTUtMS0xLTMxNDIy_053bfaf2-37a8-46e7-94ae-419b5e0865f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2798085fac7a40bab607ca83a2fad67d_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzE3LTctMS0xLTMxNDIy_88150081-65e9-435b-a698-fd9a52b6e0bf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Company contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzE4LTEtMS0xLTMxNDIy_1450f949-1b0b-4c28-ae49-7e262b89924b">97.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie04b72f184f64b9bb48662c33d2c6a24_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzE4LTMtMS0xLTMxNDIy_2377e723-ecc9-4cfc-9100-4b9117f2ce2e">58.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52ec07ca99e44636af66cf7c46bf1f5a_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzE4LTUtMS0xLTMxNDIy_6edd87c5-9ae9-4593-b93e-ee42b8299f55">18.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2798085fac7a40bab607ca83a2fad67d_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzE4LTctMS0xLTMxNDIy_aa51dcd5-20c0-4329-a656-6ac2ed2c6396">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participant contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzE5LTEtMS0xLTMxNDIy_7ab53686-1b5d-45c2-8d3f-372f7c4cd5c0">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie04b72f184f64b9bb48662c33d2c6a24_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzE5LTMtMS0xLTMxNDIy_17f19936-e6b7-43ae-a431-d175d2e2dbf1">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52ec07ca99e44636af66cf7c46bf1f5a_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzE5LTUtMS0xLTMxNDIy_2d84c52f-6a2a-4818-aeb4-f86eda8595c0">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2798085fac7a40bab607ca83a2fad67d_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzE5LTctMS0xLTMxNDIy_709f3eeb-a178-4221-9b99-5d71ecbaaf89">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAssetsTransferredToFromPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzIwLTEtMS0xLTMxNDIy_ba476e11-9f21-4156-8138-26b36d9d2e74">2.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie04b72f184f64b9bb48662c33d2c6a24_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzIwLTMtMS0xLTMxNDIy_bcf5af1b-2763-4c87-a3e3-8a044d6ad253">959.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52ec07ca99e44636af66cf7c46bf1f5a_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzIwLTUtMS0xLTMxNDIy_bd7686c8-a22f-48fe-9edb-629f21846cc6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2798085fac7a40bab607ca83a2fad67d_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzIwLTctMS0xLTMxNDIy_271be86d-fc75-4511-8d3f-eb1b3eb14845">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzIyLTEtMS0xLTMxNDIy_d81da785-869c-4b85-ac19-7c21238c9e3f">128.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie04b72f184f64b9bb48662c33d2c6a24_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzIyLTMtMS0xLTMxNDIy_237db314-45d6-4243-bf23-c38d2651d177">23.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52ec07ca99e44636af66cf7c46bf1f5a_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzIyLTUtMS0xLTMxNDIy_d8c941a6-4d79-457a-8d40-689202d1756c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2798085fac7a40bab607ca83a2fad67d_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzIyLTctMS0xLTMxNDIy_1bcf7f0c-edcb-45ce-b503-8da49c3377a4">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzIzLTEtMS0xLTMxNDIy_697548bc-98c9-42c8-98a1-48c7d48a85de">52.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie04b72f184f64b9bb48662c33d2c6a24_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzIzLTMtMS0xLTMxNDIy_79beb540-7054-4ddc-adad-64a68e82f25b">24.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52ec07ca99e44636af66cf7c46bf1f5a_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzIzLTUtMS0xLTMxNDIy_a52cbba5-8c12-4cd7-af20-a5eb4b7763a2">20.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2798085fac7a40bab607ca83a2fad67d_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzIzLTctMS0xLTMxNDIy_50520d72-738a-4813-ba63-e32dedf04b2b">1.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231" decimals="-5" sign="-" name="vtrs:DefinedBenefitPlanForeignCurrencyTranslationImpactonPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzI1LTEtMS0xLTMxNDIy_bb3c7af4-3347-4eca-a6d2-c6dcbe886701">45.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie04b72f184f64b9bb48662c33d2c6a24_D20200101-20201231" decimals="-5" name="vtrs:DefinedBenefitPlanForeignCurrencyTranslationImpactonPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzI1LTMtMS0xLTMxNDIy_1d3b559b-6537-49d8-b522-0eaf6f6529da">21.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52ec07ca99e44636af66cf7c46bf1f5a_D20210101-20211231" decimals="-5" name="vtrs:DefinedBenefitPlanForeignCurrencyTranslationImpactonPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzI1LTUtMS0xLTMxNDIy_4bdae649-6651-4723-aa7c-a4b9bc3685b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2798085fac7a40bab607ca83a2fad67d_D20200101-20201231" decimals="-5" name="vtrs:DefinedBenefitPlanForeignCurrencyTranslationImpactonPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzI1LTctMS0xLTMxNDIy_682a0b28-bdc5-42ec-bf51-00ab419af985">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets, end of year</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9d424a72c6e4901a7dafb47ebf3c114_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzI2LTEtMS0xLTMxNDIy_af6415fd-b79e-47fe-b397-28000083d333">1,366.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ec108614a384362b6aac78bfa61c46c_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzI2LTMtMS0xLTMxNDIy_9df22933-bbcd-4861-bc69-dfa5ebc2a7be">1,354.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec1504795a9c4c6693434e98197e0e95_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzI2LTUtMS0xLTMxNDIy_0a5a83d7-16c0-44f3-b163-40c363917245">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3db1d00ed7f642dcaf9157d146275821_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzI2LTctMS0xLTMxNDIy_d1dded2b-7824-411e-a43e-056519a1c47e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status of plans</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9d424a72c6e4901a7dafb47ebf3c114_I20211231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzI3LTEtMS0xLTMxNDIy_43d85e10-caba-4405-b214-f5bead87d826">580.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4ec108614a384362b6aac78bfa61c46c_I20201231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzI3LTMtMS0xLTMxNDIy_f0742f1f-3998-4552-9ed3-73e36f24808c">791.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec1504795a9c4c6693434e98197e0e95_I20211231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzI3LTUtMS0xLTMxNDIy_f2033184-a6bf-482e-be69-71bc927fa25b">188.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3db1d00ed7f642dcaf9157d146275821_I20201231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzI3LTctMS0xLTMxNDIy_a0db8c77-51cc-413f-8057-8746c298fba8">188.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90ZXh0cmVnaW9uOjUyMmUwNGFkZTJlODQ4YjBiNjhhZWM3NTEzMzZhZTI0XzExODE5_66d8af5e-032d-4d06-8b59-fedb29ef5605" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net accrued benefit costs for pension plans and other postretirement benefits are reported in the following components of the Company&#8217;s consolidated balance sheets at December&#160;31, 2021 and 2020:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:53.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Postretirement Benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9d424a72c6e4901a7dafb47ebf3c114_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo1MGM2OGQzOTA5MzA0M2M0OTUwYTNjOTk2ZDY3OTRmYi90YWJsZXJhbmdlOjUwYzY4ZDM5MDkzMDQzYzQ5NTBhM2M5OTZkNjc5NGZiXzMtMS0xLTEtMzE0MjI_1f333c55-cdcf-4aa9-a835-7004a4214154">117.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ec108614a384362b6aac78bfa61c46c_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo1MGM2OGQzOTA5MzA0M2M0OTUwYTNjOTk2ZDY3OTRmYi90YWJsZXJhbmdlOjUwYzY4ZDM5MDkzMDQzYzQ5NTBhM2M5OTZkNjc5NGZiXzMtMy0xLTEtMzE0MjI_04274f59-8580-4250-941e-cecbb09e5f7b">70.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec1504795a9c4c6693434e98197e0e95_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo1MGM2OGQzOTA5MzA0M2M0OTUwYTNjOTk2ZDY3OTRmYi90YWJsZXJhbmdlOjUwYzY4ZDM5MDkzMDQzYzQ5NTBhM2M5OTZkNjc5NGZiXzMtNS0xLTEtMzE0MjI_155e7c2e-a7b8-4500-85bb-4ce4efc44c7c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3db1d00ed7f642dcaf9157d146275821_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo1MGM2OGQzOTA5MzA0M2M0OTUwYTNjOTk2ZDY3OTRmYi90YWJsZXJhbmdlOjUwYzY4ZDM5MDkzMDQzYzQ5NTBhM2M5OTZkNjc5NGZiXzMtNy0xLTEtMzE0MjI_a432c224-38c9-4230-820f-5ec83ee5994c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9d424a72c6e4901a7dafb47ebf3c114_I20211231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo1MGM2OGQzOTA5MzA0M2M0OTUwYTNjOTk2ZDY3OTRmYi90YWJsZXJhbmdlOjUwYzY4ZDM5MDkzMDQzYzQ5NTBhM2M5OTZkNjc5NGZiXzQtMS0xLTEtMzE0MjI_c646674f-7de4-4892-84c7-ae24c00f0380">14.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4ec108614a384362b6aac78bfa61c46c_I20201231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo1MGM2OGQzOTA5MzA0M2M0OTUwYTNjOTk2ZDY3OTRmYi90YWJsZXJhbmdlOjUwYzY4ZDM5MDkzMDQzYzQ5NTBhM2M5OTZkNjc5NGZiXzQtMy0xLTEtMzE0MjI_7070f71e-24cb-487c-80dc-2db13345f9bb">15.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec1504795a9c4c6693434e98197e0e95_I20211231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo1MGM2OGQzOTA5MzA0M2M0OTUwYTNjOTk2ZDY3OTRmYi90YWJsZXJhbmdlOjUwYzY4ZDM5MDkzMDQzYzQ5NTBhM2M5OTZkNjc5NGZiXzQtNS0xLTEtMzE0MjI_d02a476a-00b4-411b-84f2-7541a12e5734">16.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3db1d00ed7f642dcaf9157d146275821_I20201231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo1MGM2OGQzOTA5MzA0M2M0OTUwYTNjOTk2ZDY3OTRmYi90YWJsZXJhbmdlOjUwYzY4ZDM5MDkzMDQzYzQ5NTBhM2M5OTZkNjc5NGZiXzQtNy0xLTEtMzE0MjI_5b8b8314-cb74-4a7b-aa6a-922de1fde511">16.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9d424a72c6e4901a7dafb47ebf3c114_I20211231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo1MGM2OGQzOTA5MzA0M2M0OTUwYTNjOTk2ZDY3OTRmYi90YWJsZXJhbmdlOjUwYzY4ZDM5MDkzMDQzYzQ5NTBhM2M5OTZkNjc5NGZiXzUtMS0xLTEtMzE0MjI_e5f9a292-ea92-4f4e-a23c-92fed19c0a55">682.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4ec108614a384362b6aac78bfa61c46c_I20201231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo1MGM2OGQzOTA5MzA0M2M0OTUwYTNjOTk2ZDY3OTRmYi90YWJsZXJhbmdlOjUwYzY4ZDM5MDkzMDQzYzQ5NTBhM2M5OTZkNjc5NGZiXzUtMy0xLTEtMzE0MjI_30f76f01-b06c-43e7-8ff1-bb9f6e5cd27f">846.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec1504795a9c4c6693434e98197e0e95_I20211231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo1MGM2OGQzOTA5MzA0M2M0OTUwYTNjOTk2ZDY3OTRmYi90YWJsZXJhbmdlOjUwYzY4ZDM5MDkzMDQzYzQ5NTBhM2M5OTZkNjc5NGZiXzUtNS0xLTEtMzE0MjI_cb595f3f-c19e-4905-9028-2b55bdda7286">172.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3db1d00ed7f642dcaf9157d146275821_I20201231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo1MGM2OGQzOTA5MzA0M2M0OTUwYTNjOTk2ZDY3OTRmYi90YWJsZXJhbmdlOjUwYzY4ZDM5MDkzMDQzYzQ5NTBhM2M5OTZkNjc5NGZiXzUtNy0xLTEtMzE0MjI_3ce1160b-f025-408a-8698-05187cfd3667">172.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net accrued benefit costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9d424a72c6e4901a7dafb47ebf3c114_I20211231" decimals="-5" name="vtrs:Netaccruedbenefitcosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo1MGM2OGQzOTA5MzA0M2M0OTUwYTNjOTk2ZDY3OTRmYi90YWJsZXJhbmdlOjUwYzY4ZDM5MDkzMDQzYzQ5NTBhM2M5OTZkNjc5NGZiXzYtMS0xLTEtMzE0MjI_dd06a41e-0425-48c9-8037-56c2665a3f60">580.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4ec108614a384362b6aac78bfa61c46c_I20201231" decimals="-5" name="vtrs:Netaccruedbenefitcosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo1MGM2OGQzOTA5MzA0M2M0OTUwYTNjOTk2ZDY3OTRmYi90YWJsZXJhbmdlOjUwYzY4ZDM5MDkzMDQzYzQ5NTBhM2M5OTZkNjc5NGZiXzYtMy0xLTEtMzE0MjI_7dde444a-29a1-4c6f-a148-029d68cda30e">791.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec1504795a9c4c6693434e98197e0e95_I20211231" decimals="-5" name="vtrs:Netaccruedbenefitcosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo1MGM2OGQzOTA5MzA0M2M0OTUwYTNjOTk2ZDY3OTRmYi90YWJsZXJhbmdlOjUwYzY4ZDM5MDkzMDQzYzQ5NTBhM2M5OTZkNjc5NGZiXzYtNS0xLTEtMzE0MjI_c61e9a18-8653-40cc-bbdd-d2b42f02821a">188.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3db1d00ed7f642dcaf9157d146275821_I20201231" decimals="-5" name="vtrs:Netaccruedbenefitcosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo1MGM2OGQzOTA5MzA0M2M0OTUwYTNjOTk2ZDY3OTRmYi90YWJsZXJhbmdlOjUwYzY4ZDM5MDkzMDQzYzQ5NTBhM2M5OTZkNjc5NGZiXzYtNy0xLTEtMzE0MjI_767c6a5c-a980-4be3-8004-24048b61215a">188.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The projected benefit obligation is the actuarial present value of benefits attributable to employee service rendered to date, including the effects of estimated future pay increases. The accumulated benefit obligation is the actuarial present value of benefits attributable to employee service rendered to date, but does not include the effects of estimated future pay increases.&#160;The accumulated benefit obligation for the Company&#8217;s pension plans was $<ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90ZXh0cmVnaW9uOjUyMmUwNGFkZTJlODQ4YjBiNjhhZWM3NTEzMzZhZTI0XzQ3MDY_747b814b-e8fe-4079-9fa0-031d43885686">1.86</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90ZXh0cmVnaW9uOjUyMmUwNGFkZTJlODQ4YjBiNjhhZWM3NTEzMzZhZTI0XzQ3MTM_6095b1e1-cec9-4584-b286-dc273d2a6347">2.04</ix:nonFraction> billion at December&#160;31, 2021 and 2020, respectively.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">130</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><ix:continuation id="if4a6344a71424ee49cacaf8aafd6c030" continuedAt="id480fedca12f41cab4b235f311ced29f"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90ZXh0cmVnaW9uOjUyMmUwNGFkZTJlODQ4YjBiNjhhZWM3NTEzMzZhZTI0XzExODMx_27849137-4e3a-4ad2-bd96-dfe1a1474f0a" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The projected benefit obligation, accumulated benefit obligation and fair value of plan assets for pension plans with an accumulated benefit obligation in excess of the fair value of plan assets at December&#160;31, 2021 and 2020 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:78.078%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.019%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Plans with accumulated benefit obligation in excess of plan assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9d424a72c6e4901a7dafb47ebf3c114_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphMzM5MDgwMWM2NTA0NWY0ODc2ZTRhZDZmMzNlMTc2OC90YWJsZXJhbmdlOmEzMzkwODAxYzY1MDQ1ZjQ4NzZlNGFkNmYzM2UxNzY4XzMtMS0xLTEtMzE0MjI_f9145670-2e93-4152-a062-f0a55070046d">1,591.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ec108614a384362b6aac78bfa61c46c_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphMzM5MDgwMWM2NTA0NWY0ODc2ZTRhZDZmMzNlMTc2OC90YWJsZXJhbmdlOmEzMzkwODAxYzY1MDQ1ZjQ4NzZlNGFkNmYzM2UxNzY4XzMtMy0xLTEtMzE0MjI_a6d2a59c-6885-46b3-b331-33d50921700c">1,747.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated benefit obligation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9d424a72c6e4901a7dafb47ebf3c114_I20211231" decimals="-5" name="vtrs:DefinedBenefitPensionPlanswithProjectedBenefitObligationInExcessofPlanAssetsAggregateProjectedBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphMzM5MDgwMWM2NTA0NWY0ODc2ZTRhZDZmMzNlMTc2OC90YWJsZXJhbmdlOmEzMzkwODAxYzY1MDQ1ZjQ4NzZlNGFkNmYzM2UxNzY4XzQtMS0xLTEtMzE0MjI_2e3aeb14-d9d0-4b0a-8491-156cc950f35f">1,546.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ec108614a384362b6aac78bfa61c46c_I20201231" decimals="-5" name="vtrs:DefinedBenefitPensionPlanswithProjectedBenefitObligationInExcessofPlanAssetsAggregateProjectedBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphMzM5MDgwMWM2NTA0NWY0ODc2ZTRhZDZmMzNlMTc2OC90YWJsZXJhbmdlOmEzMzkwODAxYzY1MDQ1ZjQ4NzZlNGFkNmYzM2UxNzY4XzQtMy0xLTEtMzE0MjI_c64f2f96-9f8f-4903-9241-f1591c4a5aa6">1,678.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9d424a72c6e4901a7dafb47ebf3c114_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphMzM5MDgwMWM2NTA0NWY0ODc2ZTRhZDZmMzNlMTc2OC90YWJsZXJhbmdlOmEzMzkwODAxYzY1MDQ1ZjQ4NzZlNGFkNmYzM2UxNzY4XzUtMS0xLTEtMzE0MjI_ab0aed0c-ef2f-4fce-91de-d3ca01a8eb52">904.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ec108614a384362b6aac78bfa61c46c_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphMzM5MDgwMWM2NTA0NWY0ODc2ZTRhZDZmMzNlMTc2OC90YWJsZXJhbmdlOmEzMzkwODAxYzY1MDQ1ZjQ4NzZlNGFkNmYzM2UxNzY4XzUtMy0xLTEtMzE0MjI_d75fc065-a5f7-4b6b-8a8e-b00769907a92">893.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value of Plan Assets</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures the fair value of plan assets based on the prices that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value measurements are based on a three-tier hierarchy described in Note 9 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments and Risk Management</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. <ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90ZXh0cmVnaW9uOjUyMmUwNGFkZTJlODQ4YjBiNjhhZWM3NTEzMzZhZTI0XzExODMz_e1d5ab7b-eeb1-4336-9419-d2ae23889d69" continuedAt="if51fbf4e841d4cd4b7481e36602330dc" escape="true">The table below presents total plan assets by investment category as of December&#160;31, 2021&#160;and&#160;2020&#160;and the classification of each investment category within the fair value hierarchy with respect to the inputs used to measure fair value:</ix:nonNumeric></span></div><ix:continuation id="if51fbf4e841d4cd4b7481e36602330dc"><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:53.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28361d88d14b44089d36a57c1d48a43d_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo3YzAwNTM4YjliMTk0M2MxOWY2NWY2OGQxYWZiNTE4ZC90YWJsZXJhbmdlOjdjMDA1MzhiOWIxOTQzYzE5ZjY1ZjY4ZDFhZmI1MThkXzItMS0xLTEtMzE0MjI_d0cffd26-e3a0-4039-8021-40eea67c9f7a">63.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0632cc54c5f54fbd8e82f58805b62de5_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo3YzAwNTM4YjliMTk0M2MxOWY2NWY2OGQxYWZiNTE4ZC90YWJsZXJhbmdlOjdjMDA1MzhiOWIxOTQzYzE5ZjY1ZjY4ZDFhZmI1MThkXzItMy0xLTEtMzE0MjI_fd608d38-6fd6-420d-a909-a9d28c49371d">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i194aa174ea9b4388bf2c16656d0150bf_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo3YzAwNTM4YjliMTk0M2MxOWY2NWY2OGQxYWZiNTE4ZC90YWJsZXJhbmdlOjdjMDA1MzhiOWIxOTQzYzE5ZjY1ZjY4ZDFhZmI1MThkXzItNS0xLTEtMzE0MjI_04165010-e669-4fee-b40d-84b894da26ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddab1d45dd6b4fdfaf6d0678d30eb8fc_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo3YzAwNTM4YjliMTk0M2MxOWY2NWY2OGQxYWZiNTE4ZC90YWJsZXJhbmdlOjdjMDA1MzhiOWIxOTQzYzE5ZjY1ZjY4ZDFhZmI1MThkXzItNy0xLTEtMzE0MjI_32276440-1b47-4b6e-9af9-65f791134ca3">65.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if31a3af97d384ae08362cb4f324929b3_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo3YzAwNTM4YjliMTk0M2MxOWY2NWY2OGQxYWZiNTE4ZC90YWJsZXJhbmdlOjdjMDA1MzhiOWIxOTQzYzE5ZjY1ZjY4ZDFhZmI1MThkXzMtMS0xLTEtMzE0MjI_951e3cb4-2c50-4665-8092-fb24ad700f2d">53.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0be4e5a0f374fbea197c3659a4244d6_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo3YzAwNTM4YjliMTk0M2MxOWY2NWY2OGQxYWZiNTE4ZC90YWJsZXJhbmdlOjdjMDA1MzhiOWIxOTQzYzE5ZjY1ZjY4ZDFhZmI1MThkXzMtMy0xLTEtMzE0MjI_002326d4-19be-4af2-8a14-76f6c52df832">497.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i113dbdd80d9d47d3a985b193d972938c_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo3YzAwNTM4YjliMTk0M2MxOWY2NWY2OGQxYWZiNTE4ZC90YWJsZXJhbmdlOjdjMDA1MzhiOWIxOTQzYzE5ZjY1ZjY4ZDFhZmI1MThkXzMtNS0xLTEtMzE0MjI_f0846ce0-eef2-416b-867d-191645388734">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaf8f068b6c14aafac4baf76995e06d1_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo3YzAwNTM4YjliMTk0M2MxOWY2NWY2OGQxYWZiNTE4ZC90YWJsZXJhbmdlOjdjMDA1MzhiOWIxOTQzYzE5ZjY1ZjY4ZDFhZmI1MThkXzMtNy0xLTEtMzE0MjI_9d14a2cb-cf20-4154-a9b9-23f17e9e05a6">551.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice0b7aa6647047d0a7d2a82e05dd4199_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo3YzAwNTM4YjliMTk0M2MxOWY2NWY2OGQxYWZiNTE4ZC90YWJsZXJhbmdlOjdjMDA1MzhiOWIxOTQzYzE5ZjY1ZjY4ZDFhZmI1MThkXzQtMS0xLTEtMzE0MjI_5b7af05c-c443-49e6-8822-93448c09f2e7">211.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib712c6ec443747a98c9f948545566ae1_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo3YzAwNTM4YjliMTk0M2MxOWY2NWY2OGQxYWZiNTE4ZC90YWJsZXJhbmdlOjdjMDA1MzhiOWIxOTQzYzE5ZjY1ZjY4ZDFhZmI1MThkXzQtMy0xLTEtMzE0MjI_18733bd1-f6c5-4105-9964-94ea6789bc1d">405.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa37ab3dc9b74f588ce944ce366fad65_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo3YzAwNTM4YjliMTk0M2MxOWY2NWY2OGQxYWZiNTE4ZC90YWJsZXJhbmdlOjdjMDA1MzhiOWIxOTQzYzE5ZjY1ZjY4ZDFhZmI1MThkXzQtNS0xLTEtMzE0MjI_08fca0fa-cc50-4272-bfeb-502b9307fbb7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea17365cc1064f1e8c0e3efbd1f7ccc0_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo3YzAwNTM4YjliMTk0M2MxOWY2NWY2OGQxYWZiNTE4ZC90YWJsZXJhbmdlOjdjMDA1MzhiOWIxOTQzYzE5ZjY1ZjY4ZDFhZmI1MThkXzQtNy0xLTEtMzE0MjI_55cef487-a89f-4a1f-9813-93b6033b3f47">616.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held by insurance companies and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30c18481b70448689ae9ec9f6c97ed57_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo3YzAwNTM4YjliMTk0M2MxOWY2NWY2OGQxYWZiNTE4ZC90YWJsZXJhbmdlOjdjMDA1MzhiOWIxOTQzYzE5ZjY1ZjY4ZDFhZmI1MThkXzUtMS0xLTEtMzE0MjI_c6ad6af5-2d98-4248-9507-a359ae3614e4">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia734afe5a0b94354a9267f684d7d593d_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo3YzAwNTM4YjliMTk0M2MxOWY2NWY2OGQxYWZiNTE4ZC90YWJsZXJhbmdlOjdjMDA1MzhiOWIxOTQzYzE5ZjY1ZjY4ZDFhZmI1MThkXzUtMy0xLTEtMzE0MjI_f26f9c24-715c-44f0-ae67-f511207c6e4f">41.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1eef6ae4e1e4c43a6e2a37669db59f5_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo3YzAwNTM4YjliMTk0M2MxOWY2NWY2OGQxYWZiNTE4ZC90YWJsZXJhbmdlOjdjMDA1MzhiOWIxOTQzYzE5ZjY1ZjY4ZDFhZmI1MThkXzUtNS0xLTEtMzE0MjI_022a5fd7-f1bb-4ef5-8893-6958d969df21">81.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89cce06582894866abc89dbadb2375fd_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo3YzAwNTM4YjliMTk0M2MxOWY2NWY2OGQxYWZiNTE4ZC90YWJsZXJhbmdlOjdjMDA1MzhiOWIxOTQzYzE5ZjY1ZjY4ZDFhZmI1MThkXzUtNy0xLTEtMzE0MjI_c52d780b-0b9c-4f39-ac17-105ba68afd9f">133.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcaff92c9304ccca2976819941da18b_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo3YzAwNTM4YjliMTk0M2MxOWY2NWY2OGQxYWZiNTE4ZC90YWJsZXJhbmdlOjdjMDA1MzhiOWIxOTQzYzE5ZjY1ZjY4ZDFhZmI1MThkXzYtMS0xLTEtMzE0MjI_f9c85159-be0d-4add-be17-a343394ea679">338.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie24e749ab05a4833892ad719d96c300b_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo3YzAwNTM4YjliMTk0M2MxOWY2NWY2OGQxYWZiNTE4ZC90YWJsZXJhbmdlOjdjMDA1MzhiOWIxOTQzYzE5ZjY1ZjY4ZDFhZmI1MThkXzYtMy0xLTEtMzE0MjI_598c33ca-c706-490d-ae42-745771ab3903">946.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42e5f527f22943e5b9d7a7a7685c1fba_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo3YzAwNTM4YjliMTk0M2MxOWY2NWY2OGQxYWZiNTE4ZC90YWJsZXJhbmdlOjdjMDA1MzhiOWIxOTQzYzE5ZjY1ZjY4ZDFhZmI1MThkXzYtNS0xLTEtMzE0MjI_c8099d5a-5497-4c45-804c-7c9e5184bf17">81.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo3YzAwNTM4YjliMTk0M2MxOWY2NWY2OGQxYWZiNTE4ZC90YWJsZXJhbmdlOjdjMDA1MzhiOWIxOTQzYzE5ZjY1ZjY4ZDFhZmI1MThkXzYtNy0xLTEtMzE0MjI_85f00556-4b80-4f79-bd0d-379c53e25191">1,366.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:53.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1dd9e8a009f47628454dddf41a73509_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmMGVjMGRjNzIxOGQ0ZDZiODk1ZjFiZTJmMjk5MmM0NS90YWJsZXJhbmdlOmYwZWMwZGM3MjE4ZDRkNmI4OTVmMWJlMmYyOTkyYzQ1XzItMS0xLTEtMzE0MjI_45c5ef62-0d58-4c94-a7bb-df7674504688">51.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3676ae37352452a8c662f20b8fe3454_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmMGVjMGRjNzIxOGQ0ZDZiODk1ZjFiZTJmMjk5MmM0NS90YWJsZXJhbmdlOmYwZWMwZGM3MjE4ZDRkNmI4OTVmMWJlMmYyOTkyYzQ1XzItMy0xLTEtMzE0MjI_ffdc9714-d9c8-46fa-b2cb-022bc608c9e7">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f47061824334d3b9c233d127ac9201d_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmMGVjMGRjNzIxOGQ0ZDZiODk1ZjFiZTJmMjk5MmM0NS90YWJsZXJhbmdlOmYwZWMwZGM3MjE4ZDRkNmI4OTVmMWJlMmYyOTkyYzQ1XzItNS0xLTEtMzE0MjI_e9a1b798-9812-44bc-a77d-a644865faa35">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67df6863d3524e03bbe619803176d157_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmMGVjMGRjNzIxOGQ0ZDZiODk1ZjFiZTJmMjk5MmM0NS90YWJsZXJhbmdlOmYwZWMwZGM3MjE4ZDRkNmI4OTVmMWJlMmYyOTkyYzQ1XzItNy0xLTEtMzE0MjI_e63c5b75-a01d-492b-bcb2-364598b65181">51.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b6e49e382c6413e8c432cb0c7d2a826_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmMGVjMGRjNzIxOGQ0ZDZiODk1ZjFiZTJmMjk5MmM0NS90YWJsZXJhbmdlOmYwZWMwZGM3MjE4ZDRkNmI4OTVmMWJlMmYyOTkyYzQ1XzMtMS0xLTEtMzE0MjI_0e452870-5b8c-43d0-8adc-d652e0c91a8d">145.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie786a2024a274c5ebfea306dfddbac8f_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmMGVjMGRjNzIxOGQ0ZDZiODk1ZjFiZTJmMjk5MmM0NS90YWJsZXJhbmdlOmYwZWMwZGM3MjE4ZDRkNmI4OTVmMWJlMmYyOTkyYzQ1XzMtMy0xLTEtMzE0MjI_183a9352-b55d-493f-8f4d-e61921b1c4f2">468.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if795583e146340668c945e4b814573bf_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmMGVjMGRjNzIxOGQ0ZDZiODk1ZjFiZTJmMjk5MmM0NS90YWJsZXJhbmdlOmYwZWMwZGM3MjE4ZDRkNmI4OTVmMWJlMmYyOTkyYzQ1XzMtNS0xLTEtMzE0MjI_8088ecfc-3ffd-40e7-8865-54ae38c5c151">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8945bf4fb0664758943f130a6664b9d9_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmMGVjMGRjNzIxOGQ0ZDZiODk1ZjFiZTJmMjk5MmM0NS90YWJsZXJhbmdlOmYwZWMwZGM3MjE4ZDRkNmI4OTVmMWJlMmYyOTkyYzQ1XzMtNy0xLTEtMzE0MjI_eed96305-e7ce-46d1-b429-fc81552ec747">613.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8396afe5d3e94d92869781e35bbfc3bf_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmMGVjMGRjNzIxOGQ0ZDZiODk1ZjFiZTJmMjk5MmM0NS90YWJsZXJhbmdlOmYwZWMwZGM3MjE4ZDRkNmI4OTVmMWJlMmYyOTkyYzQ1XzQtMS0xLTEtMzE0MjI_f32d4b35-aea5-431d-9775-f74665ac1ca0">292.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21a085c7f0f844d58b2d8d28f4fdebec_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmMGVjMGRjNzIxOGQ0ZDZiODk1ZjFiZTJmMjk5MmM0NS90YWJsZXJhbmdlOmYwZWMwZGM3MjE4ZDRkNmI4OTVmMWJlMmYyOTkyYzQ1XzQtMy0xLTEtMzE0MjI_7c2d704d-4581-44fb-9c8a-09bea74877af">299.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b6ff9d1e6224b069f644c2dbd578b93_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmMGVjMGRjNzIxOGQ0ZDZiODk1ZjFiZTJmMjk5MmM0NS90YWJsZXJhbmdlOmYwZWMwZGM3MjE4ZDRkNmI4OTVmMWJlMmYyOTkyYzQ1XzQtNS0xLTEtMzE0MjI_1818ae13-3785-4732-a576-d7d6b7d84bd9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia960324dc2a146a685f0dce110779fec_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmMGVjMGRjNzIxOGQ0ZDZiODk1ZjFiZTJmMjk5MmM0NS90YWJsZXJhbmdlOmYwZWMwZGM3MjE4ZDRkNmI4OTVmMWJlMmYyOTkyYzQ1XzQtNy0xLTEtMzE0MjI_c91a0bfa-2d3b-4197-822b-1d5a771ada0e">592.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held by insurance companies and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic88bd3b21dd5437a90e5efdc21490b13_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmMGVjMGRjNzIxOGQ0ZDZiODk1ZjFiZTJmMjk5MmM0NS90YWJsZXJhbmdlOmYwZWMwZGM3MjE4ZDRkNmI4OTVmMWJlMmYyOTkyYzQ1XzUtMS0xLTEtMzE0MjI_eaf3dcae-2e4a-45ca-b887-d05836214306">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a800cd4602a4c15a8b533080cc7dd5f_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmMGVjMGRjNzIxOGQ0ZDZiODk1ZjFiZTJmMjk5MmM0NS90YWJsZXJhbmdlOmYwZWMwZGM3MjE4ZDRkNmI4OTVmMWJlMmYyOTkyYzQ1XzUtMy0xLTEtMzE0MjI_69228700-e299-4f65-be38-b3877af89f0b">20.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i644407156089438c9633f7019f15ae8f_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmMGVjMGRjNzIxOGQ0ZDZiODk1ZjFiZTJmMjk5MmM0NS90YWJsZXJhbmdlOmYwZWMwZGM3MjE4ZDRkNmI4OTVmMWJlMmYyOTkyYzQ1XzUtNS0xLTEtMzE0MjI_62edd5ad-5568-452c-a5a2-4589bf73bb7f">73.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i525cf7cf63b54048a311ff3fde50c3d0_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmMGVjMGRjNzIxOGQ0ZDZiODk1ZjFiZTJmMjk5MmM0NS90YWJsZXJhbmdlOmYwZWMwZGM3MjE4ZDRkNmI4OTVmMWJlMmYyOTkyYzQ1XzUtNy0xLTEtMzE0MjI_330fabda-019a-4eb0-b908-145176372e43">97.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb3ec9725b8947ae894c70cb9fb96fc0_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmMGVjMGRjNzIxOGQ0ZDZiODk1ZjFiZTJmMjk5MmM0NS90YWJsZXJhbmdlOmYwZWMwZGM3MjE4ZDRkNmI4OTVmMWJlMmYyOTkyYzQ1XzYtMS0xLTEtMzE0MjI_3dc8b9b1-9429-4859-9fce-f530383d7ffb">493.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7064536ad58d434ca55e232aa46556fb_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmMGVjMGRjNzIxOGQ0ZDZiODk1ZjFiZTJmMjk5MmM0NS90YWJsZXJhbmdlOmYwZWMwZGM3MjE4ZDRkNmI4OTVmMWJlMmYyOTkyYzQ1XzYtMy0xLTEtMzE0MjI_a659c0c7-5196-43ef-bb6e-aa8a917b1e0a">788.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if70694466104422da2d7abde7dda9ee2_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmMGVjMGRjNzIxOGQ0ZDZiODk1ZjFiZTJmMjk5MmM0NS90YWJsZXJhbmdlOmYwZWMwZGM3MjE4ZDRkNmI4OTVmMWJlMmYyOTkyYzQ1XzYtNS0xLTEtMzE0MjI_d632b99a-ddf6-49c9-9ff0-223aa3a021e7">73.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmMGVjMGRjNzIxOGQ0ZDZiODk1ZjFiZTJmMjk5MmM0NS90YWJsZXJhbmdlOmYwZWMwZGM3MjE4ZDRkNmI4OTVmMWJlMmYyOTkyYzQ1XzYtNy0xLTEtMzE0MjI_e3cf802d-9755-4c04-b79e-77127acf5814">1,354.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk tolerance on invested pension plan assets is established through careful consideration of plan liabilities, plan funded status and corporate financial condition. Investment risk is measured and monitored on an ongoing basis through annual liability measures, periodic asset/liability studies and investment portfolio reviews. The Company&#8217;s investment strategy is to maintain, where possible, a diversified investment portfolio across several asset classes that, when combined with the Company&#8217;s contributions to the plans, will ensure that required benefit obligations are met.</span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assumptions</span></div><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:ScheduleOfAssumptionsUsedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90ZXh0cmVnaW9uOjUyMmUwNGFkZTJlODQ4YjBiNjhhZWM3NTEzMzZhZTI0XzExNzk0_4f0808f7-7608-45a2-8638-bc6693d01637" continuedAt="i38ed5290df1e473a8c964746f6eb7bea" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following weighted average assumptions were used to determine the benefit obligations for the Company&#8217;s defined benefit pension and other postretirement plans as of December&#160;31, 2021&#160;and&#160;2020:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:56.609%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.034%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Postretirement Benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia9d424a72c6e4901a7dafb47ebf3c114_I20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTowYjY2NzQ0OTQ2NTU0M2YzYTcxNjBlOWRhY2NkMGJlZC90YWJsZXJhbmdlOjBiNjY3NDQ5NDY1NTQzZjNhNzE2MGU5ZGFjY2QwYmVkXzItMS0xLTEtMzE0MjI_6233bd58-ccb9-4658-8e06-b50d56251719">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4ec108614a384362b6aac78bfa61c46c_I20201231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTowYjY2NzQ0OTQ2NTU0M2YzYTcxNjBlOWRhY2NkMGJlZC90YWJsZXJhbmdlOjBiNjY3NDQ5NDY1NTQzZjNhNzE2MGU5ZGFjY2QwYmVkXzItMy0xLTEtMzE0MjI_754b52b2-4387-4369-bb7a-0bbdbe0c0b36">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iec1504795a9c4c6693434e98197e0e95_I20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTowYjY2NzQ0OTQ2NTU0M2YzYTcxNjBlOWRhY2NkMGJlZC90YWJsZXJhbmdlOjBiNjY3NDQ5NDY1NTQzZjNhNzE2MGU5ZGFjY2QwYmVkXzItNS0xLTEtMzE0MjI_04619c5b-8918-49aa-81c9-f21e9ffb2f7c">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3db1d00ed7f642dcaf9157d146275821_I20201231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTowYjY2NzQ0OTQ2NTU0M2YzYTcxNjBlOWRhY2NkMGJlZC90YWJsZXJhbmdlOjBiNjY3NDQ5NDY1NTQzZjNhNzE2MGU5ZGFjY2QwYmVkXzItNy0xLTEtMzE0MjI_011045bd-40ac-4080-a365-fbb5e35eb3ee">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia9d424a72c6e4901a7dafb47ebf3c114_I20211231" decimals="3" name="vtrs:DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationExpectedLongtermReturnonAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTowYjY2NzQ0OTQ2NTU0M2YzYTcxNjBlOWRhY2NkMGJlZC90YWJsZXJhbmdlOjBiNjY3NDQ5NDY1NTQzZjNhNzE2MGU5ZGFjY2QwYmVkXzMtMS0xLTEtMzE0MjI_e4b60dfb-1430-4c0c-98fe-9236a80487c8">5.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4ec108614a384362b6aac78bfa61c46c_I20201231" decimals="3" name="vtrs:DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationExpectedLongtermReturnonAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTowYjY2NzQ0OTQ2NTU0M2YzYTcxNjBlOWRhY2NkMGJlZC90YWJsZXJhbmdlOjBiNjY3NDQ5NDY1NTQzZjNhNzE2MGU5ZGFjY2QwYmVkXzMtMy0xLTEtMzE0MjI_82b954cf-42ec-4300-a13e-fe332ac061e3">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iec1504795a9c4c6693434e98197e0e95_I20211231" decimals="3" name="vtrs:DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationExpectedLongtermReturnonAssets" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTowYjY2NzQ0OTQ2NTU0M2YzYTcxNjBlOWRhY2NkMGJlZC90YWJsZXJhbmdlOjBiNjY3NDQ5NDY1NTQzZjNhNzE2MGU5ZGFjY2QwYmVkXzMtNS0xLTEtMzE0MjI_c10f6ec3-4f99-437d-90f4-a7b424c77e2a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3db1d00ed7f642dcaf9157d146275821_I20201231" decimals="3" name="vtrs:DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationExpectedLongtermReturnonAssets" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTowYjY2NzQ0OTQ2NTU0M2YzYTcxNjBlOWRhY2NkMGJlZC90YWJsZXJhbmdlOjBiNjY3NDQ5NDY1NTQzZjNhNzE2MGU5ZGFjY2QwYmVkXzMtNy0xLTEtMzE0MjI_73c870eb-76a0-4311-867a-4a3d67d5ec38">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia9d424a72c6e4901a7dafb47ebf3c114_I20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTowYjY2NzQ0OTQ2NTU0M2YzYTcxNjBlOWRhY2NkMGJlZC90YWJsZXJhbmdlOjBiNjY3NDQ5NDY1NTQzZjNhNzE2MGU5ZGFjY2QwYmVkXzQtMS0xLTEtMzE0MjI_19f1f803-cc78-49c7-a50f-1ce40ad9b6fd">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4ec108614a384362b6aac78bfa61c46c_I20201231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTowYjY2NzQ0OTQ2NTU0M2YzYTcxNjBlOWRhY2NkMGJlZC90YWJsZXJhbmdlOjBiNjY3NDQ5NDY1NTQzZjNhNzE2MGU5ZGFjY2QwYmVkXzQtMy0xLTEtMzE0MjI_64096d13-757a-43bd-90b9-81ebc41f3872">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iec1504795a9c4c6693434e98197e0e95_I20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTowYjY2NzQ0OTQ2NTU0M2YzYTcxNjBlOWRhY2NkMGJlZC90YWJsZXJhbmdlOjBiNjY3NDQ5NDY1NTQzZjNhNzE2MGU5ZGFjY2QwYmVkXzQtNS0xLTEtMzE0MjI_a95a7a85-7d1e-4c12-856d-123ba925a53b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3db1d00ed7f642dcaf9157d146275821_I20201231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTowYjY2NzQ0OTQ2NTU0M2YzYTcxNjBlOWRhY2NkMGJlZC90YWJsZXJhbmdlOjBiNjY3NDQ5NDY1NTQzZjNhNzE2MGU5ZGFjY2QwYmVkXzQtNy0xLTEtMzE0MjI_94f377fb-2312-4d3f-8a94-db7f897d4405">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">131</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><ix:continuation id="id480fedca12f41cab4b235f311ced29f" continuedAt="i2836a8a4087c440a9c95136122199372"><ix:continuation id="i38ed5290df1e473a8c964746f6eb7bea"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following weighted average assumptions were used to determine the net periodic benefit cost for the Company&#8217;s defined benefit pension and other postretirement benefit plans for the three years in the period ended&#160;December&#160;31, 2021:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:35.170%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.035%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Postretirement Benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpkMzU1OTQ4MWZjMjE0N2ViOTZhMzMyY2RlZWM2Yjc4My90YWJsZXJhbmdlOmQzNTU5NDgxZmMyMTQ3ZWI5NmEzMzJjZGVlYzZiNzgzXzItMS0xLTEtMzE0MjI_c48727e8-6764-47c4-ab9a-c638a4d53278">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2229a1acd15a481eb03d17e8a82e053c_D20190101-20191231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpkMzU1OTQ4MWZjMjE0N2ViOTZhMzMyY2RlZWM2Yjc4My90YWJsZXJhbmdlOmQzNTU5NDgxZmMyMTQ3ZWI5NmEzMzJjZGVlYzZiNzgzXzItMy0xLTEtMzE0MjI_605a31c3-abd4-4bd8-9ea8-79420eb506c4">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0793dad309c04eeaab5ad95a6c7e0ace_D20170101-20171231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpkMzU1OTQ4MWZjMjE0N2ViOTZhMzMyY2RlZWM2Yjc4My90YWJsZXJhbmdlOmQzNTU5NDgxZmMyMTQ3ZWI5NmEzMzJjZGVlYzZiNzgzXzItNS0xLTEtMzE0MjI_f637b97c-7fa8-4347-b34a-b5fe71be62de">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i52ec07ca99e44636af66cf7c46bf1f5a_D20210101-20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpkMzU1OTQ4MWZjMjE0N2ViOTZhMzMyY2RlZWM2Yjc4My90YWJsZXJhbmdlOmQzNTU5NDgxZmMyMTQ3ZWI5NmEzMzJjZGVlYzZiNzgzXzItNy0xLTEtMzE0MjI_d33ad5b5-ae82-47f8-8442-f652179eb7ba">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i93fbd6aab228484480456d99cf697974_D20190101-20191231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpkMzU1OTQ4MWZjMjE0N2ViOTZhMzMyY2RlZWM2Yjc4My90YWJsZXJhbmdlOmQzNTU5NDgxZmMyMTQ3ZWI5NmEzMzJjZGVlYzZiNzgzXzItOS0xLTEtMzE0MjI_79e9eebb-78f9-4366-b0be-deb7054e83e0">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8bb2b64c86464df1acb153f81b9bd1a2_D20170101-20171231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpkMzU1OTQ4MWZjMjE0N2ViOTZhMzMyY2RlZWM2Yjc4My90YWJsZXJhbmdlOmQzNTU5NDgxZmMyMTQ3ZWI5NmEzMzJjZGVlYzZiNzgzXzItMTEtMS0xLTMxNDIy_f24e3454-57c6-4500-b2cd-cb91f21d66b0">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpkMzU1OTQ4MWZjMjE0N2ViOTZhMzMyY2RlZWM2Yjc4My90YWJsZXJhbmdlOmQzNTU5NDgxZmMyMTQ3ZWI5NmEzMzJjZGVlYzZiNzgzXzMtMS0xLTEtMzE0MjI_40d70af4-a8b9-483c-8637-b6f08e052d8b">5.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2229a1acd15a481eb03d17e8a82e053c_D20190101-20191231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpkMzU1OTQ4MWZjMjE0N2ViOTZhMzMyY2RlZWM2Yjc4My90YWJsZXJhbmdlOmQzNTU5NDgxZmMyMTQ3ZWI5NmEzMzJjZGVlYzZiNzgzXzMtMy0xLTEtMzE0MjI_f3ec7aa1-6c89-4ab4-b727-d1b4a033461d">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0793dad309c04eeaab5ad95a6c7e0ace_D20170101-20171231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpkMzU1OTQ4MWZjMjE0N2ViOTZhMzMyY2RlZWM2Yjc4My90YWJsZXJhbmdlOmQzNTU5NDgxZmMyMTQ3ZWI5NmEzMzJjZGVlYzZiNzgzXzMtNS0xLTEtMzE0MjI_74658b23-98d2-488f-905b-1b32e48da1bb">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i52ec07ca99e44636af66cf7c46bf1f5a_D20210101-20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpkMzU1OTQ4MWZjMjE0N2ViOTZhMzMyY2RlZWM2Yjc4My90YWJsZXJhbmdlOmQzNTU5NDgxZmMyMTQ3ZWI5NmEzMzJjZGVlYzZiNzgzXzMtNy0xLTEtMzE0MjI_255454a2-f614-4ddf-98f2-f75f694fb1f2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i93fbd6aab228484480456d99cf697974_D20190101-20191231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpkMzU1OTQ4MWZjMjE0N2ViOTZhMzMyY2RlZWM2Yjc4My90YWJsZXJhbmdlOmQzNTU5NDgxZmMyMTQ3ZWI5NmEzMzJjZGVlYzZiNzgzXzMtOS0xLTEtMzE0MjI_2b11cd41-8c65-49f0-8d68-3101d960ef56">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8bb2b64c86464df1acb153f81b9bd1a2_D20170101-20171231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpkMzU1OTQ4MWZjMjE0N2ViOTZhMzMyY2RlZWM2Yjc4My90YWJsZXJhbmdlOmQzNTU5NDgxZmMyMTQ3ZWI5NmEzMzJjZGVlYzZiNzgzXzMtMTEtMS0xLTMxNDIy_218f76df-1961-4541-9487-197f543944d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpkMzU1OTQ4MWZjMjE0N2ViOTZhMzMyY2RlZWM2Yjc4My90YWJsZXJhbmdlOmQzNTU5NDgxZmMyMTQ3ZWI5NmEzMzJjZGVlYzZiNzgzXzQtMS0xLTEtMzE0MjI_7876d4c5-46fd-4a61-874a-97915a9d3c05">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2229a1acd15a481eb03d17e8a82e053c_D20190101-20191231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpkMzU1OTQ4MWZjMjE0N2ViOTZhMzMyY2RlZWM2Yjc4My90YWJsZXJhbmdlOmQzNTU5NDgxZmMyMTQ3ZWI5NmEzMzJjZGVlYzZiNzgzXzQtMy0xLTEtMzE0MjI_00ceb66d-b2f8-4032-b216-179a1e891c38">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0793dad309c04eeaab5ad95a6c7e0ace_D20170101-20171231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpkMzU1OTQ4MWZjMjE0N2ViOTZhMzMyY2RlZWM2Yjc4My90YWJsZXJhbmdlOmQzNTU5NDgxZmMyMTQ3ZWI5NmEzMzJjZGVlYzZiNzgzXzQtNS0xLTEtMzE0MjI_bd22e6a1-07d4-4a4d-a766-7eb4c0609627">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i52ec07ca99e44636af66cf7c46bf1f5a_D20210101-20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpkMzU1OTQ4MWZjMjE0N2ViOTZhMzMyY2RlZWM2Yjc4My90YWJsZXJhbmdlOmQzNTU5NDgxZmMyMTQ3ZWI5NmEzMzJjZGVlYzZiNzgzXzQtNy0xLTEtMzE0MjI_14cf459e-d004-47a0-819a-fa108ec60b20">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i93fbd6aab228484480456d99cf697974_D20190101-20191231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpkMzU1OTQ4MWZjMjE0N2ViOTZhMzMyY2RlZWM2Yjc4My90YWJsZXJhbmdlOmQzNTU5NDgxZmMyMTQ3ZWI5NmEzMzJjZGVlYzZiNzgzXzQtOS0xLTEtMzE0MjI_fbb796ff-f968-480d-a75e-4c37ddfd002d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8bb2b64c86464df1acb153f81b9bd1a2_D20170101-20171231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpkMzU1OTQ4MWZjMjE0N2ViOTZhMzMyY2RlZWM2Yjc4My90YWJsZXJhbmdlOmQzNTU5NDgxZmMyMTQ3ZWI5NmEzMzJjZGVlYzZiNzgzXzQtMTEtMS0xLTMxNDIy_5470973f-2d88-40c9-b056-6b68f9439bcc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:continuation><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assumptions for each plan are reviewed on an annual basis. The discount rate reflects the current rate at which the pension and other benefit liabilities could be effectively settled at the measurement date. In setting the discount rates, we utilize comparable corporate bond indices as an indication of interest rate movements and levels. Corporate bond indices were selected based on individual plan census data and duration. The expected return on plan assets was determined using historical market returns and long-term historical relationships between equities and fixed income securities. The Company compares the expected return on plan assets assumption to actual historic returns to ensure reasonableness. Current market factors such as inflation and interest rates are also evaluated. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average healthcare cost trend rate used for&#160;2021&#160;was&#160;<ix:nonFraction unitRef="number" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="3" name="us-gaap:DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90ZXh0cmVnaW9uOjUyMmUwNGFkZTJlODQ4YjBiNjhhZWM3NTEzMzZhZTI0Xzc0MzI_6691b911-e6e2-4e51-8c51-45e34e388cc1">5.7</ix:nonFraction>%&#160;declining to a projected&#160;<ix:nonFraction unitRef="number" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="3" name="us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90ZXh0cmVnaW9uOjUyMmUwNGFkZTJlODQ4YjBiNjhhZWM3NTEzMzZhZTI0Xzc0NjA_0eb3d5cc-9124-477e-9fb2-04cc24b6e37b">4.5</ix:nonFraction>%&#160;in the year&#160;2037. For&#160;2022, the assumed weighted-average healthcare cost trend rate used will be&#160;<ix:nonFraction unitRef="number" contextRef="i0beee820b7a44a2586a141b35bd7d70b_I20211231" decimals="3" name="us-gaap:DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90ZXh0cmVnaW9uOjUyMmUwNGFkZTJlODQ4YjBiNjhhZWM3NTEzMzZhZTI0Xzc1NTY_e8e99fc4-7480-4288-9fd7-32f5dff22569">6.3</ix:nonFraction>%&#160;declining to a projected&#160;<ix:nonFraction unitRef="number" contextRef="i0beee820b7a44a2586a141b35bd7d70b_I20211231" decimals="3" name="us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90ZXh0cmVnaW9uOjUyMmUwNGFkZTJlODQ4YjBiNjhhZWM3NTEzMzZhZTI0Xzc1ODQ_9ef37fad-0ee0-4f34-b8d0-0c755b823f98">4.0</ix:nonFraction>%&#160;in the year&#160;2045. In selecting rates for current and long-term healthcare cost assumptions, the Company takes into consideration a number of factors including the Company&#8217;s actual healthcare cost increases, the design of the Company&#8217;s benefit programs, the demographics of the Company&#8217;s active and retiree populations and external expectations of future medical cost inflation rates.</span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Estimated Future Benefit Payments</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s funding policy for its funded pension plans is based upon&#160;local statutory requirements. The Company&#8217;s funding policy is subject to certain statutory regulations with respect to annual minimum and maximum company contributions. Plan benefits for the non-qualified plans are paid as they come due. </span></div><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90ZXh0cmVnaW9uOjUyMmUwNGFkZTJlODQ4YjBiNjhhZWM3NTEzMzZhZTI0XzExODE3_32355612-7187-4b55-98ae-3cae16ed7baa" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated benefit payments over the next ten years for the Company&#8217;s pension plans and retiree health plan are as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:75.879%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.045%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Postretirement Benefits</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9d424a72c6e4901a7dafb47ebf3c114_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZToxYTZkMTJmMDUyZDM0M2Y0YjA5NDYzZTYzMTY4ZGU1MS90YWJsZXJhbmdlOjFhNmQxMmYwNTJkMzQzZjRiMDk0NjNlNjMxNjhkZTUxXzEtMS0xLTEtMzE0MjI_740be2f1-cd25-431e-ac7e-37e83486f2a9">101.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec1504795a9c4c6693434e98197e0e95_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZToxYTZkMTJmMDUyZDM0M2Y0YjA5NDYzZTYzMTY4ZGU1MS90YWJsZXJhbmdlOjFhNmQxMmYwNTJkMzQzZjRiMDk0NjNlNjMxNjhkZTUxXzEtMy0xLTEtMzE0MjI_55d1b543-475d-452d-8976-61577fd43fb4">16.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9d424a72c6e4901a7dafb47ebf3c114_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZToxYTZkMTJmMDUyZDM0M2Y0YjA5NDYzZTYzMTY4ZGU1MS90YWJsZXJhbmdlOjFhNmQxMmYwNTJkMzQzZjRiMDk0NjNlNjMxNjhkZTUxXzItMS0xLTEtMzE0MjI_4404cef5-0d0e-47fd-bfd2-5b46b084d5c5">97.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec1504795a9c4c6693434e98197e0e95_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZToxYTZkMTJmMDUyZDM0M2Y0YjA5NDYzZTYzMTY4ZGU1MS90YWJsZXJhbmdlOjFhNmQxMmYwNTJkMzQzZjRiMDk0NjNlNjMxNjhkZTUxXzItMy0xLTEtMzE0MjI_5f699a64-5e1b-4de7-acd6-5a041fbe37e5">16.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9d424a72c6e4901a7dafb47ebf3c114_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZToxYTZkMTJmMDUyZDM0M2Y0YjA5NDYzZTYzMTY4ZGU1MS90YWJsZXJhbmdlOjFhNmQxMmYwNTJkMzQzZjRiMDk0NjNlNjMxNjhkZTUxXzMtMS0xLTEtMzE0MjI_93afe32e-ba6b-40c1-99d9-25825ff146e0">103.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec1504795a9c4c6693434e98197e0e95_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZToxYTZkMTJmMDUyZDM0M2Y0YjA5NDYzZTYzMTY4ZGU1MS90YWJsZXJhbmdlOjFhNmQxMmYwNTJkMzQzZjRiMDk0NjNlNjMxNjhkZTUxXzMtMy0xLTEtMzE0MjI_7cd1f61b-6cd8-4a77-a369-0c25cdaf07de">16.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9d424a72c6e4901a7dafb47ebf3c114_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZToxYTZkMTJmMDUyZDM0M2Y0YjA5NDYzZTYzMTY4ZGU1MS90YWJsZXJhbmdlOjFhNmQxMmYwNTJkMzQzZjRiMDk0NjNlNjMxNjhkZTUxXzQtMS0xLTEtMzE0MjI_120bf80e-1b8b-4f20-af15-1b2ec3d7f55c">100.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec1504795a9c4c6693434e98197e0e95_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZToxYTZkMTJmMDUyZDM0M2Y0YjA5NDYzZTYzMTY4ZGU1MS90YWJsZXJhbmdlOjFhNmQxMmYwNTJkMzQzZjRiMDk0NjNlNjMxNjhkZTUxXzQtMy0xLTEtMzE0MjI_03760944-5d94-434b-81e5-b849d540686d">16.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9d424a72c6e4901a7dafb47ebf3c114_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZToxYTZkMTJmMDUyZDM0M2Y0YjA5NDYzZTYzMTY4ZGU1MS90YWJsZXJhbmdlOjFhNmQxMmYwNTJkMzQzZjRiMDk0NjNlNjMxNjhkZTUxXzUtMS0xLTEtMzE0MjI_77002f08-de03-4a6d-bac4-5ed8088810dc">104.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec1504795a9c4c6693434e98197e0e95_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZToxYTZkMTJmMDUyZDM0M2Y0YjA5NDYzZTYzMTY4ZGU1MS90YWJsZXJhbmdlOjFhNmQxMmYwNTJkMzQzZjRiMDk0NjNlNjMxNjhkZTUxXzUtMy0xLTEtMzE0MjI_634ecbd5-54d5-4345-b29b-4b5a5335a009">16.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9d424a72c6e4901a7dafb47ebf3c114_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZToxYTZkMTJmMDUyZDM0M2Y0YjA5NDYzZTYzMTY4ZGU1MS90YWJsZXJhbmdlOjFhNmQxMmYwNTJkMzQzZjRiMDk0NjNlNjMxNjhkZTUxXzYtMS0xLTEtMzE0MjI_2972109a-567b-438b-a30e-9a7216a9e73b">528.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec1504795a9c4c6693434e98197e0e95_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZToxYTZkMTJmMDUyZDM0M2Y0YjA5NDYzZTYzMTY4ZGU1MS90YWJsZXJhbmdlOjFhNmQxMmYwNTJkMzQzZjRiMDk0NjNlNjMxNjhkZTUxXzYtMy0xLTEtMzE0MjI_b7976f8a-a7e2-4b88-b3a6-473bbabcfeb2">73.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9d424a72c6e4901a7dafb47ebf3c114_I20211231" decimals="-5" name="vtrs:ExpectedFutureBenefitPayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZToxYTZkMTJmMDUyZDM0M2Y0YjA5NDYzZTYzMTY4ZGU1MS90YWJsZXJhbmdlOjFhNmQxMmYwNTJkMzQzZjRiMDk0NjNlNjMxNjhkZTUxXzctMS0xLTEtMzE0MjI_23331a5e-dbbd-414a-b4a0-06260ccb29ee">1,035.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec1504795a9c4c6693434e98197e0e95_I20211231" decimals="-5" name="vtrs:ExpectedFutureBenefitPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZToxYTZkMTJmMDUyZDM0M2Y0YjA5NDYzZTYzMTY4ZGU1MS90YWJsZXJhbmdlOjFhNmQxMmYwNTJkMzQzZjRiMDk0NjNlNjMxNjhkZTUxXzctMy0xLTEtMzE0MjI_e019bb06-7269-474c-be5b-b3d7b164f283">155.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Defined Contribution Plans</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sponsors defined contribution plans covering its employees in the U.S. and Puerto Rico, as well as certain employees in a number of countries outside the U.S.&#160;The Company&#8217;s domestic defined contribution plans consist primarily of a Profit Sharing 401(k) Plan and a 401(k) retirement plan for union-represented employees. Profit sharing contributions are made at the discretion of the Board of Directors. The Company&#8217;s non-domestic plans vary in form depending on local legal requirements. The Company&#8217;s contributions are based upon employee contributions, service hours, or pre-determined amounts depending upon the plan. Obligations for contributions to defined contribution plans are recognized as expense in the consolidated statements of operations when they are earned.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">132</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><ix:continuation id="i2836a8a4087c440a9c95136122199372"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a 401(k) Restoration Plan, which permits employees who earn compensation in excess of the limits imposed by Section&#160;401(a)(17) of the Code to (i)&#160;defer a portion of base salary and bonus compensation, (ii)&#160;be credited with a Company matching contribution in respect of deferrals under the Restoration Plan, and (iii)&#160;be credited with Company non-elective contributions (to the extent so made by the Company), in each case, to the extent that participants otherwise would be able to defer or be credited with such amounts, as applicable, under the Profit Sharing 401(k) Plan if not for the limits on contributions and deferrals imposed by the Code.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains an Income Deferral Plan, which permits certain management or highly compensated employees who are designated by the plan administrator to participate in the Income Deferral Plan to elect to defer up to <ix:nonFraction unitRef="number" contextRef="i98bb7963bee64ebb90779de770b2639f_D20210101-20211231" decimals="2" name="us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90ZXh0cmVnaW9uOjUyMmUwNGFkZTJlODQ4YjBiNjhhZWM3NTEzMzZhZTI0XzEwMjI5_df342b80-deb8-4d88-b9e2-0f686d047160">50</ix:nonFraction>% of base salary and up to <ix:nonFraction unitRef="number" contextRef="i1e7e31d22fda4457bb400e7c5b5a9279_D20210101-20211231" decimals="2" name="us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90ZXh0cmVnaW9uOjUyMmUwNGFkZTJlODQ4YjBiNjhhZWM3NTEzMzZhZTI0XzEwMjU3_40aaa5f1-5752-4ae3-8255-5ea172d67dfd">100</ix:nonFraction>% of bonus compensation, in each case, in addition to any amounts that may be deferred by such participants under the Profit Sharing 401(k) Plan and the Restoration Plan. In addition, under the Income Deferral Plan, eligible participants may be granted employee deferral awards, which awards will be subject to the terms and conditions (including vesting) as determined by the plan administrator at the time such awards are granted.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total employer contributions to defined contribution plans were approximately $<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90ZXh0cmVnaW9uOjUyMmUwNGFkZTJlODQ4YjBiNjhhZWM3NTEzMzZhZTI0XzEwNzY5_4df9f3be-635f-4122-b07d-4866ef695571">107.4</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90ZXh0cmVnaW9uOjUyMmUwNGFkZTJlODQ4YjBiNjhhZWM3NTEzMzZhZTI0XzEwNzcz_55e91679-c533-45c4-a3e4-538fa3d4b0cf">115.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90ZXh0cmVnaW9uOjUyMmUwNGFkZTJlODQ4YjBiNjhhZWM3NTEzMzZhZTI0XzEwNzgw_20f999a9-7029-47af-a0ad-df6be11b9f2a">95.6</ix:nonFraction> million for the years ended December&#160;31, 2021, 2020 and 2019, respectively.</span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Benefit Arrangements</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company participated in a multi-employer pension plan under previous collective bargaining agreements. The PACE Industry Union-Management Pension Fund (the &#8220;PACE Plan&#8221;) provides defined benefits to certain retirees and certain production and maintenance employees at the Company&#8217;s manufacturing plant in Morgantown, West Virginia who were covered by the previous collective bargaining agreements. Pursuant to a collective bargaining agreement entered into on April 16, 2012, the Company withdrew from the PACE Plan effective May 10, 2012. In 2013, the PACE Plan trustee notified the Company that its withdrawal liability was approximately $<ix:nonFraction unitRef="usd" contextRef="i2a20c8f3803144d58ca34d0fcee823ce_I20161231" decimals="-5" name="us-gaap:MultiemployerPlansWithdrawalObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90ZXh0cmVnaW9uOjUyMmUwNGFkZTJlODQ4YjBiNjhhZWM3NTEzMzZhZTI0XzExNTAy_28ffe80c-46d7-4d07-b9b4-124e808cc04c">27.3</ix:nonFraction> million, which was accrued by the Company in 2013. The withdrawal liability is being paid over a period of approximately nine years; payments began in March 2014. The withdrawal liability was approximately $<ix:nonFraction unitRef="usd" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-5" name="us-gaap:MultiemployerPlansWithdrawalObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90ZXh0cmVnaW9uOjUyMmUwNGFkZTJlODQ4YjBiNjhhZWM3NTEzMzZhZTI0XzExNjgy_c7befdab-26c6-4d39-8f8b-ccfbea0d7cf3">5.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:MultiemployerPlansWithdrawalObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90ZXh0cmVnaW9uOjUyMmUwNGFkZTJlODQ4YjBiNjhhZWM3NTEzMzZhZTI0XzExNjg5_e1d901bb-69c1-4d13-915f-8aa115a4b394">8.9</ix:nonFraction> million at December&#160;31, 2021 and 2020, respectively. The Employer Identification Number for the PACE Plan is 11-6166763.</span></div></ix:continuation><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_229"></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">Seg<ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90ZXh0cmVnaW9uOjFhNWE5OTI3MTU4NDQ5ODQ4YTUxM2EyZWQ4ZWIxODU2XzQwOTc_58bb9d91-ac72-46a0-a783-12d156c2dddc" continuedAt="if294dd1c39b34c7787d907a20afc82de" escape="true">ment Information</ix:nonNumeric></span></div><ix:continuation id="if294dd1c39b34c7787d907a20afc82de" continuedAt="ie966ddd0baa743c4bc9c025160ed1e66"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Viatris has four reportable segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The Company reports segment information on the basis of markets and geography, which reflects its focus on bringing its broad and diversified portfolio of branded, complex generics and biosimilars, and generic products to people in markets everywhere. Our Developed Markets segment comprises our operations primarily in North America and Europe. Our Greater China segment includes our operations in China, Taiwan and Hong Kong. Our JANZ segment reflects our operations in Japan, Australia and New Zealand. Our Emerging Markets segment encompasses our presence in more than 125 countries with developing markets and emerging economies including in Asia, Africa, Eastern Europe, Latin America and the Middle East as well as the Company&#8217;s ARV franchise. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s chief operating decision maker is the Chief Executive Officer, who evaluates the performance of its segments based on total revenues and segment profitability.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain costs are not included in the measurement of segment profitability, such as costs, if any, associated with the following:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Intangible asset amortization expense and impairments of intangible assets;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">R&amp;D expense;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Net charges or net gains for litigation settlements and other contingencies;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Certain costs related to transactions and events such as (i) purchase accounting adjustments, where we incur expenses associated with the amortization of fair value adjustments to inventory and property, plant and equipment; (ii) acquisition-related costs, where we incur costs for executing the transaction, integrating the acquired operations and restructuring the combined company; and (iii) other significant items, which are substantive and/or unusual, and in some cases recurring, items (such as restructuring) that are evaluated on an individual basis by management and that either as a result of their nature or size, would not be expected to occur as part of our normal business on a regular basis. Such special items can include, but are not limited to, non-acquisition-related restructuring costs, as well as costs incurred for asset impairments and disposals of assets or businesses, including, as applicable, any associated transition activities. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">133</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><ix:continuation id="ie966ddd0baa743c4bc9c025160ed1e66" continuedAt="i606309653eff49419f5837a8227ea3dd"><div style="margin-bottom:12pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Corporate and other unallocated costs associated with platform functions (such as digital, facilities, legal, finance, human resources, insurance, public affairs and procurement), patient advocacy activities and certain compensation and other corporate costs (such as interest income and expense, and gains and losses on investments, as well as overhead expenses associated with our manufacturing, which include manufacturing variances associated with production) and operations that are not directly assessed to an operating segment as business unit (segment) management does not manage these costs.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not report depreciation expense, total assets and capital expenditures by segment, as such information is not used by the chief operating decision maker. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accounting policies of the segments are the same as those described in Note&#160;2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies.</span></div><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90ZXh0cmVnaW9uOjFhNWE5OTI3MTU4NDQ5ODQ4YTUxM2EyZWQ4ZWIxODU2XzQxMjE_536c4b23-bc73-425f-a01c-e0fef4c0c342" escape="true"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Presented in the table below is segment information for the periods identified and a reconciliation of segment information to total consolidated information.</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.702%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="15" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="15" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Segment Profitability</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31, </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31, </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reportable Segments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed Markets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ac0bcd2e1264e8b8347af73e216d016_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzUtMi0xLTEtMzE0MjI_42001303-821b-4966-a424-465a313c7e4f">10,428.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec0737b261124d3f87ea9adcdb407b5a_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzUtNC0xLTEtMzE0MjI_0375464e-a6d2-4be2-80b3-9092b4342daf">8,510.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i864642c0e47a4b87a88be339d6673670_D20190101-20191231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzUtNi0xLTEtMzE0MjI_edd3aea7-df04-4bf0-96fe-04481bb72c36">8,240.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ac0bcd2e1264e8b8347af73e216d016_D20210101-20211231" decimals="-5" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzUtOC0xLTEtMzE0MjI_dd14c8d4-7a0e-453d-9317-d285de7c8375">5,143.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec0737b261124d3f87ea9adcdb407b5a_D20200101-20201231" decimals="-5" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzUtMTAtMS0xLTMxNDIy_a26daeb1-9e9f-4b15-8971-1c53e18d7909">4,243.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i864642c0e47a4b87a88be339d6673670_D20190101-20191231" decimals="-5" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzUtMTItMS0xLTMxNDIy_b94bb940-816f-4e31-b757-76cfccb8974e">4,137.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater China</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed92dccf2314bd48c7373be7cf33d4e_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzYtMi0xLTEtMzE0MjI_83dd2772-7c5f-4491-8d0c-a12b43faa4b7">2,212.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e0c5048f8f84f26a1949d61f3285173_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzYtNC0xLTEtMzE0MjI_c122199e-c437-401d-a2e6-368231240a27">259.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4221a0900a14ced8a5c91eac2fcdf4f_D20190101-20191231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzYtNi0xLTEtMzE0MjI_2d16ae45-e48f-4aa4-b4df-f29062378c73">214.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed92dccf2314bd48c7373be7cf33d4e_D20210101-20211231" decimals="-5" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzYtOC0xLTEtMzE0MjI_37db9599-9561-40f3-a587-da85042ac2f4">1,397.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e0c5048f8f84f26a1949d61f3285173_D20200101-20201231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzYtMTAtMS0xLTMxNDIy_8cbd0e36-20d5-4468-883c-3182acf101e4">52.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4221a0900a14ced8a5c91eac2fcdf4f_D20190101-20191231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzYtMTItMS0xLTMxNDIy_a5e9e4e8-4b40-4d9d-b4f4-fd1bd029e2e1">89.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JANZ</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ccdc9914af44b1bb1229e19c17326d8_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzctMi0xLTEtMzE0MjI_ccdf6ff3-8bc2-4601-8141-c8e244557938">2,027.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d06b2c023334d92a7c83b2943f0232b_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzctNC0xLTEtMzE0MjI_f0161eb1-7cd1-4ddf-94e0-25f3be263cce">1,195.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94d3655a9cb44f37b3319f0d91bf87b1_D20190101-20191231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzctNi0xLTEtMzE0MjI_43e04259-b3f4-4a21-8864-baed98b2a668">1,192.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ccdc9914af44b1bb1229e19c17326d8_D20210101-20211231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzctOC0xLTEtMzE0MjI_57b42ece-9883-4cee-b96e-0d6fc96c5435">762.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d06b2c023334d92a7c83b2943f0232b_D20200101-20201231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzctMTAtMS0xLTMxNDIy_f28f222d-4670-4e66-a3f9-7e57f0b1e902">364.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94d3655a9cb44f37b3319f0d91bf87b1_D20190101-20191231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzctMTItMS0xLTMxNDIy_9b726652-7d79-411d-b4ac-0d0ecb42e899">323.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Markets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02b3f133daa24190abd49dfdef6bb6ce_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzgtMi0xLTEtMzE0MjI_1c5bda28-c0ff-4452-9112-d81bcc26f76f">3,144.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i281863eb67c44d0fbc00294dfaf0049c_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzgtNC0xLTEtMzE0MjI_8fb7b2bd-0c3e-47a8-8c0c-5d1df6145661">1,853.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f91beda5d054492aed05bdaf3b7936e_D20190101-20191231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzgtNi0xLTEtMzE0MjI_b79c0b10-f364-426d-a565-c21468aeab1c">1,723.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02b3f133daa24190abd49dfdef6bb6ce_D20210101-20211231" decimals="-5" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzgtOC0xLTEtMzE0MjI_fc6cc61b-cc6e-46eb-9a5f-2bfdc645a6cc">1,402.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i281863eb67c44d0fbc00294dfaf0049c_D20200101-20201231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzgtMTAtMS0xLTMxNDIy_5fb59a75-a3e9-498c-9d8a-552b6f9ae1dc">610.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f91beda5d054492aed05bdaf3b7936e_D20190101-20191231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzgtMTItMS0xLTMxNDIy_61b26167-69f0-489e-8aac-8074afb88830">561.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reportable segments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzktMi0xLTEtMzE0MjI_f7412cb4-7edf-4e51-be90-2f49cfee9afb">17,813.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzktNC0xLTEtMzE0MjI_3ac22bb5-b479-47dc-8c05-111ef82b7c76">11,819.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzktNi0xLTEtMzE0MjI_8623bc55-6250-4ca5-8729-4075887bfff0">11,370.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2ddd71cee624b009233ae18ff01bcdb_D20210101-20211231" decimals="-5" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzktOC0xLTEtMzE0MjI_c9796dc3-9082-41e4-a7f6-816dcd7a4340">8,705.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdd7bc10185c4685b4d14c9b6ac151b1_D20200101-20201231" decimals="-5" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzktMTAtMS0xLTMxNDIy_bbeabfcb-574d-4966-aac8-b77cb9166658">5,271.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieeeb5a9479d24a7d8d17e6b3b937cfa1_D20190101-20191231" decimals="-5" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzktMTItMS0xLTMxNDIy_e54efdbe-46fb-4280-ac40-af08e4182aa0">5,112.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reconciling items:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset amortization expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i920f0f119ac84408803bd50b9d0ab091_D20210101-20211231" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzEyLTgtMS0xLTMxNDIy_8d55403e-4a50-4b3a-b3e5-81dd668c1766">2,702.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22c52f21b85d4673a433d7b10508a1c0_D20200101-20201231" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzEyLTEwLTEtMS0zMTQyMg_c1932254-a123-4a32-9129-14dcd42bf09a">1,605.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib677e81a48d44a41987cce709676230a_D20190101-20191231" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzEyLTEyLTEtMS0zMTQyMg_f4e9cffd-4f56-47e8-badc-6c7ff8168034">1,582.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset impairment charges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i920f0f119ac84408803bd50b9d0ab091_D20210101-20211231" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzEzLTgtMS0xLTMxNDIy_561be6b2-96f2-4470-9f9d-d669f20224f1">102.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22c52f21b85d4673a433d7b10508a1c0_D20200101-20201231" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzEzLTEwLTEtMS0zMTQyMg_41fccdee-6cfe-4398-81a5-61733f0ba266">82.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib677e81a48d44a41987cce709676230a_D20190101-20191231" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzEzLTEyLTEtMS0zMTQyMg_958dc134-b555-4d8f-84b2-c9a76eb18506">180.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Globally managed research and development costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i920f0f119ac84408803bd50b9d0ab091_D20210101-20211231" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzE0LTgtMS0xLTMxNDIy_71b4ef81-98a5-4da0-abbc-d2607a9038d5">751.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22c52f21b85d4673a433d7b10508a1c0_D20200101-20201231" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzE0LTEwLTEtMS0zMTQyMg_2f48eac0-d6e6-481c-8bca-78d6278495fb">555.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib677e81a48d44a41987cce709676230a_D20190101-20191231" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzE0LTEyLTEtMS0zMTQyMg_2cc77912-7fd5-4dce-915c-775cf5841d17">639.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation settlements &amp; other contingencies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i920f0f119ac84408803bd50b9d0ab091_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzE1LTgtMS0xLTMxNDIy_90ee52b7-4ff4-42fe-a689-69baef36a163">329.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22c52f21b85d4673a433d7b10508a1c0_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzE1LTEwLTEtMS0zMTQyMg_8359e042-a7b5-48c1-a263-11416e97a062">107.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib677e81a48d44a41987cce709676230a_D20190101-20191231" decimals="-5" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzE1LTEyLTEtMS0zMTQyMg_76311206-f159-49e7-b90a-a98ead686ac0">21.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction related and other special items</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i920f0f119ac84408803bd50b9d0ab091_D20210101-20211231" decimals="-5" name="vtrs:OtherOneTimeNonoperatingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzE2LTgtMS0xLTMxNDIy_d236bb68-8c36-4e3f-8a3e-20556cc14397">2,832.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22c52f21b85d4673a433d7b10508a1c0_D20200101-20201231" decimals="-5" name="vtrs:OtherOneTimeNonoperatingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzE2LTEwLTEtMS0zMTQyMg_8c1bc13b-ba49-42be-bc83-d08736c654c1">1,739.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib677e81a48d44a41987cce709676230a_D20190101-20191231" decimals="-5" name="vtrs:OtherOneTimeNonoperatingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzE2LTEyLTEtMS0zMTQyMg_21c5b033-648d-497e-a0e4-4eafd8b36bd1">682.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and other unallocated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icd84b99acf144bc78660b64776c157a5_D20210101-20211231" decimals="-5" name="vtrs:Corporatecosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzE3LTgtMS0xLTMxNDIy_ad21794c-b3f4-4ce5-ab35-70772673b58d">2,021.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0acbb674a1248c0922f52ddee735cd9_D20200101-20201231" decimals="-5" name="vtrs:Corporatecosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzE3LTEwLTEtMS0zMTQyMg_deca1036-8cc2-4eb1-b226-008c05cf883a">1,391.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d6ec2d7d94e40788a144ae7c9ec8647_D20190101-20191231" decimals="-5" name="vtrs:Corporatecosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzE3LTEyLTEtMS0zMTQyMg_12e86a12-78bc-491e-a055-e3fe6e68cbcc">1,332.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) earnings from operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzE4LTgtMS0xLTMxNDIy_7f79be6c-13dc-42d4-af11-9f58d59a13ff">34.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzE4LTEwLTEtMS0zMTQyMg_bfdf181b-f0c1-4ca5-85ed-00da746719b8">210.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzE4LTEyLTEtMS0zMTQyMg_dc140237-1b5e-49c1-b205-2ff690eebea2">715.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90ZXh0cmVnaW9uOjFhNWE5OTI3MTU4NDQ5ODQ4YTUxM2EyZWQ4ZWIxODU2XzQwODA_a00f92bf-2345-4cef-96ca-a527d8a8b166" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the percentage of consolidated net sales to Viatris&#8217; major customers during the years ended December&#160;31, 2021, 2020, and 2019:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:65.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage of Consolidated Net Sales</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson Corporation</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i18815e8bb5a745709ff95e3d9c2c08e4_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo3NDdlOTk5ZWJlOWY0NjIxOThkMTMxZDc3YTQ2NzQ4YS90YWJsZXJhbmdlOjc0N2U5OTllYmU5ZjQ2MjE5OGQxMzFkNzdhNDY3NDhhXzItMS0xLTEtMzE0MjI_b1107ed6-20d5-45b5-96df-5903b26eea70">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id731b23309e14cbdaad5c8a9b50a21be_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo3NDdlOTk5ZWJlOWY0NjIxOThkMTMxZDc3YTQ2NzQ4YS90YWJsZXJhbmdlOjc0N2U5OTllYmU5ZjQ2MjE5OGQxMzFkNzdhNDY3NDhhXzItMy0xLTEtMzE0MjI_996c64cb-bedb-46cd-b300-319b7c1ca46f">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id209d8fb79664069a0121c7006665f1f_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo3NDdlOTk5ZWJlOWY0NjIxOThkMTMxZDc3YTQ2NzQ4YS90YWJsZXJhbmdlOjc0N2U5OTllYmU5ZjQ2MjE5OGQxMzFkNzdhNDY3NDhhXzItNS0xLTEtMzE0MjI_da6881da-a78e-4b9e-86ab-7acb3f4f52e4">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AmerisourceBergen Corporation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6dd5ebb08da94a34a07b74dd124ac3ee_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo3NDdlOTk5ZWJlOWY0NjIxOThkMTMxZDc3YTQ2NzQ4YS90YWJsZXJhbmdlOjc0N2U5OTllYmU5ZjQ2MjE5OGQxMzFkNzdhNDY3NDhhXzMtMS0xLTEtMzE0MjI_4a782fc7-b77f-4c6f-96c4-f6a12ad8f4e3">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6901420439ef429ea919459425a5d402_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo3NDdlOTk5ZWJlOWY0NjIxOThkMTMxZDc3YTQ2NzQ4YS90YWJsZXJhbmdlOjc0N2U5OTllYmU5ZjQ2MjE5OGQxMzFkNzdhNDY3NDhhXzMtMy0xLTEtMzE0MjI_68a10a16-03e2-4e21-a667-64cf13eec3ef">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idf1e59f7845645108df1bc93dddee7c7_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo3NDdlOTk5ZWJlOWY0NjIxOThkMTMxZDc3YTQ2NzQ4YS90YWJsZXJhbmdlOjc0N2U5OTllYmU5ZjQ2MjE5OGQxMzFkNzdhNDY3NDhhXzMtNS0xLTEtMzE0MjI_1cbb5582-54b7-4055-93b8-3554767d1e02">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health, Inc.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic5e40498906e45c788a40df231de121f_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo3NDdlOTk5ZWJlOWY0NjIxOThkMTMxZDc3YTQ2NzQ4YS90YWJsZXJhbmdlOjc0N2U5OTllYmU5ZjQ2MjE5OGQxMzFkNzdhNDY3NDhhXzQtMS0xLTEtMzE0MjI_e3b8f48d-2a9d-4026-b80d-cc782ebd4a46">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i27fa8b92853d48fb94b00143112c4a79_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo3NDdlOTk5ZWJlOWY0NjIxOThkMTMxZDc3YTQ2NzQ4YS90YWJsZXJhbmdlOjc0N2U5OTllYmU5ZjQ2MjE5OGQxMzFkNzdhNDY3NDhhXzQtMy0xLTEtMzE0MjI_8a316367-99ff-4d6c-86d9-15f6f3ae4764">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i76cdb8e6f69a4d70b0de5af0064a60da_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo3NDdlOTk5ZWJlOWY0NjIxOThkMTMxZDc3YTQ2NzQ4YS90YWJsZXJhbmdlOjc0N2U5OTllYmU5ZjQ2MjE5OGQxMzFkNzdhNDY3NDhhXzQtNS0xLTEtMzE0MjI_d7aa5d02-2879-48bf-8e63-ac0c880b4aea">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">134</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><ix:continuation id="i606309653eff49419f5837a8227ea3dd" continuedAt="i1b3e5428b8f84f67be34666691eb778f"><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sales by Country Information</span></div><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90ZXh0cmVnaW9uOjFhNWE5OTI3MTU4NDQ5ODQ4YTUxM2EyZWQ4ZWIxODU2XzQxMjA_0810fedf-6ad2-4604-a901-8a2648adf788" continuedAt="i865e933a0e0246f59fb0a1935255385b" escape="true"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales by country are presented on the basis of geographic location of our subsidiaries: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:65.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5705c46a88bf43f9b604c129b6396c1b_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTpkMGY2NTE3ZDliZjQ0OGI1ODE1MzVkNmVjNTRjNmIyZS90YWJsZXJhbmdlOmQwZjY1MTdkOWJmNDQ4YjU4MTUzNWQ2ZWM1NGM2YjJlXzItMS0xLTEtMzE0MjI_7fa596a0-9b7d-41bb-b83e-06642b8a8762">4,176.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4373191f73a844d0aa8b62bcce8c341d_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTpkMGY2NTE3ZDliZjQ0OGI1ODE1MzVkNmVjNTRjNmIyZS90YWJsZXJhbmdlOmQwZjY1MTdkOWJmNDQ4YjU4MTUzNWQ2ZWM1NGM2YjJlXzItMy0xLTEtMzE0MjI_6b12aead-84d2-4115-94ab-b873ade7039b">3,746.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc53a28205ae4633a9527b98ec393f1e_D20190101-20191231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTpkMGY2NTE3ZDliZjQ0OGI1ODE1MzVkNmVjNTRjNmIyZS90YWJsZXJhbmdlOmQwZjY1MTdkOWJmNDQ4YjU4MTUzNWQ2ZWM1NGM2YjJlXzItNS0xLTEtMzE0MjI_99cf8a5e-9a85-4476-8c72-32fe9a3ff0e8">3,965.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i674ccad3b1334a35b429888309d5e766_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTpkMGY2NTE3ZDliZjQ0OGI1ODE1MzVkNmVjNTRjNmIyZS90YWJsZXJhbmdlOmQwZjY1MTdkOWJmNDQ4YjU4MTUzNWQ2ZWM1NGM2YjJlXzMtMS0xLTEtMzg3NDI_4156ec12-f1b9-4fac-8425-b8a21ef2294a">1,981.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4bb4b6b6b5a4fe694af194311457a02_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTpkMGY2NTE3ZDliZjQ0OGI1ODE1MzVkNmVjNTRjNmIyZS90YWJsZXJhbmdlOmQwZjY1MTdkOWJmNDQ4YjU4MTUzNWQ2ZWM1NGM2YjJlXzMtMy0xLTEtMzg3NDI_5c1c7604-2762-446d-af99-75e6f0bda7b9">216.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94d6d4b3556e404b89c54e423c77d4f6_D20190101-20191231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTpkMGY2NTE3ZDliZjQ0OGI1ODE1MzVkNmVjNTRjNmIyZS90YWJsZXJhbmdlOmQwZjY1MTdkOWJmNDQ4YjU4MTUzNWQ2ZWM1NGM2YjJlXzMtNS0xLTEtMzg3NDI_b545c6d3-8bb5-42c3-bd43-b8b70892dbe0">171.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1b3e5428b8f84f67be34666691eb778f"><ix:continuation id="i865e933a0e0246f59fb0a1935255385b">No other country&#8217;s net sales represents more than 10% of consolidated net sales.</ix:continuation></ix:continuation> </span></div><div style="margin-bottom:3pt"><span><br/></span></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_232"></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">Commitments</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into employment and other agreements with certain executives and other employees that provide for compensation, retirement and certain other benefits. These agreements provide for severance payments under certain circumstances. Additionally, the Company has split-dollar life insurance agreements with certain retired executives.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the Combination, Viatris entered into a TSA with Pfizer pursuant to which each party will provide certain limited transition services to the other party generally for an initial period of <ix:nonNumeric contextRef="i9a70f778cb3e42faa8640420190123d8_D20210101-20211231" name="vtrs:BusinessCombinationLimitedTransitionServicesPaymentPeriod" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzIvZnJhZzphNzQ1MDE2ZGExZDg0YmZjOGI5Mzk2MGZiYWQ3ZTA1Ni90ZXh0cmVnaW9uOmE3NDUwMTZkYTFkODRiZmM4YjkzOTYwZmJhZDdlMDU2XzU4MA_062a51c9-79e7-4697-9176-cb488582c67e">24</ix:nonNumeric> months from closing date. In addition to the monthly service fees under the TSA, Viatris has agreed to reimburse Pfizer for fifty percent of the costs, up to the first $<ix:nonFraction unitRef="usd" contextRef="i3bc8daf6f604468691d4e166c4089a06_I20211231" decimals="-6" name="vtrs:BusinessCombinationContractualReimbursementAmountTrancheOne" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzIvZnJhZzphNzQ1MDE2ZGExZDg0YmZjOGI5Mzk2MGZiYWQ3ZTA1Ni90ZXh0cmVnaW9uOmE3NDUwMTZkYTFkODRiZmM4YjkzOTYwZmJhZDdlMDU2Xzc1MQ_276b7e78-5c18-4e34-9cf6-d1e1e60d086b">380</ix:nonFraction>&#160;million incurred, to establish and wind down the TSA services. Viatris will be required to fully reimburse Pfizer for total costs in excess of $<ix:nonFraction unitRef="usd" contextRef="i3bc8daf6f604468691d4e166c4089a06_I20211231" decimals="-5" name="vtrs:BusinessCombinationContractualReimbursementAmountTrancheOne" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzIvZnJhZzphNzQ1MDE2ZGExZDg0YmZjOGI5Mzk2MGZiYWQ3ZTA1Ni90ZXh0cmVnaW9uOmE3NDUwMTZkYTFkODRiZmM4YjkzOTYwZmJhZDdlMDU2Xzg4OQ_23781831-7d69-459c-8164-20e41dd86538">380</ix:nonFraction>&#160;million. During the years ended December 31, 2021 and 2020, the Company incurred $<ix:nonFraction unitRef="usd" contextRef="ie41a5079981b44deba916400b5db52f8_D20210101-20211231" decimals="-5" name="vtrs:BusinessCombinationContractualReimbursementAmountAmountsExpensed" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzIvZnJhZzphNzQ1MDE2ZGExZDg0YmZjOGI5Mzk2MGZiYWQ3ZTA1Ni90ZXh0cmVnaW9uOmE3NDUwMTZkYTFkODRiZmM4YjkzOTYwZmJhZDdlMDU2XzM4NDgyOTA2OTk5MTE_1ab342ea-4fab-45e3-8734-c0d5754bc1a0">30.4</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i6fb7985a0fed413082603dbe3300009f_D20200101-20201231" decimals="-5" name="vtrs:BusinessCombinationContractualReimbursementAmountAmountsExpensed" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzIvZnJhZzphNzQ1MDE2ZGExZDg0YmZjOGI5Mzk2MGZiYWQ3ZTA1Ni90ZXh0cmVnaW9uOmE3NDUwMTZkYTFkODRiZmM4YjkzOTYwZmJhZDdlMDU2Xzk2MA_ca863399-9378-4fbe-a5a9-844760bd306c">53.1</ix:nonFraction>&#160;million, respectively, related to this provision of the TSA. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In conjunction with the Combination, during the year ended December 31, 2020, the Company accrued approximately $<ix:nonFraction unitRef="usd" contextRef="i3bc8daf6f604468691d4e166c4089a06_I20211231" decimals="-5" name="vtrs:BusinessCombinationContractualReimbursementAmountAmountsAccrued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzIvZnJhZzphNzQ1MDE2ZGExZDg0YmZjOGI5Mzk2MGZiYWQ3ZTA1Ni90ZXh0cmVnaW9uOmE3NDUwMTZkYTFkODRiZmM4YjkzOTYwZmJhZDdlMDU2XzExMTk_9b176427-87cb-44e8-890a-f9bcb92de555">26.9</ix:nonFraction>&#160;million due to change in control clauses in employment arrangements for certain former Mylan employees, which was paid during 2021. In addition, the Company entered into retention agreements with certain key employees, whereby they agreed to continue to provide service to the Company for a period of time after the Combination. The Company is recording the expense for these agreements over the applicable service periods. </span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, Viatris periodically enters into employment, legal settlement and other agreements which incorporate indemnification provisions. While the maximum amount to which Viatris may be exposed under such agreements cannot be reasonably estimated, the Company maintains insurance coverage, which management believes will effectively mitigate the Company&#8217;s obligations under these indemnification provisions. No amounts have been recorded in the consolidated financial statements with respect to the Company&#8217;s obligations under such agreements.</span></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_238"></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90ZXh0cmVnaW9uOjQ3ZDBjNDk5MjMxODRjNTJhY2JiYTAzZTJmN2NjNTU4XzM0NjU_12ad0c27-ccc8-442e-8988-930f5f0e409e" continuedAt="i7119b918e258415abb66313979926e99" escape="true">Restructuring </ix:nonNumeric></span></div><ix:continuation id="i7119b918e258415abb66313979926e99" continuedAt="i8d8c3389a4a248a28ebfd12bd2abe4cb"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2020 Restructuring Program</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the fourth quarter of 2020, Viatris announced a significant global restructuring program in order to achieve synergies and ensure that the organization is optimally structured and efficiently resourced to deliver sustainable value to patients, shareholders, customers, and other stakeholders. Viatris&#8217; restructuring initiative incorporates and expands on the restructuring program announced by Mylan N.V. earlier in 2020 as part of its business transformation efforts. As part of the restructuring, the Company is optimizing its commercial capabilities and enabling functions, and closing, downsizing or divesting certain manufacturing facilities globally that are deemed to be no longer viable either due to surplus capacity, challenging market dynamics or a shift in its product portfolio toward more complex products. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the committed restructuring actions, the Company expects to incur total pre-tax charges of up to approximately $<ix:nonFraction unitRef="usd" contextRef="ib89e351abdca4a2a8a91f6f3d20bc1e2_D20211001-20211231" decimals="-8" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90ZXh0cmVnaW9uOjQ3ZDBjNDk5MjMxODRjNTJhY2JiYTAzZTJmN2NjNTU4XzExMTk_53d90023-523e-4163-8e40-f7808ffa7e7e">1.4</ix:nonFraction>&#160;billion. Such charges are expected to include up to approximately $<ix:nonFraction unitRef="usd" contextRef="ib89e351abdca4a2a8a91f6f3d20bc1e2_D20211001-20211231" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90ZXh0cmVnaW9uOjQ3ZDBjNDk5MjMxODRjNTJhY2JiYTAzZTJmN2NjNTU4XzExNzU_09186c32-0227-4596-bcd4-0c4506a94d81">450</ix:nonFraction>&#160;million of non-cash charges mainly related to accelerated depreciation and asset impairment charges, including inventory write-offs. The remaining estimated cash costs of up to approximately $<ix:nonFraction unitRef="usd" contextRef="ie59342892624442b9a277a53f425c7e3_I20211231" decimals="-6" name="us-gaap:RestructuringAndRelatedCostExpectedCostRemaining1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90ZXh0cmVnaW9uOjQ3ZDBjNDk5MjMxODRjNTJhY2JiYTAzZTJmN2NjNTU4XzEzNTY_cdeba9a7-998b-41e2-9c01-cfa957b0fcd9">950</ix:nonFraction>&#160;million are expected to be primarily related to severance and employee benefits expense, as well as other costs, including those related to contract terminations and other plant disposal costs. In addition, management believes the potential annual savings related to these committed restructuring activities to be up to approximately $<ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-6" name="us-gaap:EffectOnFutureCashFlowsAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90ZXh0cmVnaW9uOjQ3ZDBjNDk5MjMxODRjNTJhY2JiYTAzZTJmN2NjNTU4XzMyOTg1MzQ4OTAxOTk_8b7f6854-4709-4687-bf17-cffdd5cd155e">900</ix:nonFraction>&#160;million once fully implemented, with most of these savings expected to improve operating cash flow.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">135</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><ix:continuation id="i8d8c3389a4a248a28ebfd12bd2abe4cb" continuedAt="i00f96b58bf444dd99af6c84a565ec66c"><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90ZXh0cmVnaW9uOjQ3ZDBjNDk5MjMxODRjNTJhY2JiYTAzZTJmN2NjNTU4XzU0OTc1NTgxNDY4MDY_d8a2dec1-ae99-4f45-ad13-643f275b222b" continuedAt="i5b0a7efbba9148e19e88691270ba775c" escape="true"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the restructuring charges and the reserve activity for the 2020 restructuring program:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.006%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.712%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Related Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Exit Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a2ed382584440da959bd00009045f49_D20200101-20201231" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzEtMS0xLTEtMzE0MjI_a987bbc2-ce86-4d32-82e4-49762d87f65c">195.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18f47482de9e477aa4d85300745fbad3_D20200101-20201231" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzEtMy0xLTEtMzE0MjI_b29a3dbc-3c3a-4bf7-884b-6f9da7f85dee">75.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d1d75a5c8a447008aeaeea8bcbacd37_D20200101-20201231" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzEtNS0xLTEtMzE0MjI_fc4bfb5c-5748-4cc7-9208-251010e8084b">271.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired in the Combination</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a2ed382584440da959bd00009045f49_D20200101-20201231" decimals="-5" name="vtrs:RestructuringReserveAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzItMS0xLTEtMzE0MjI_c93dd8f3-6a88-4a0b-9aab-2398ca0412f1">91.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18f47482de9e477aa4d85300745fbad3_D20200101-20201231" decimals="-5" name="vtrs:RestructuringReserveAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzItMy0xLTEtMzE0MjI_c6e3cdeb-8cf7-424e-964d-a1f3fa50ff15">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d1d75a5c8a447008aeaeea8bcbacd37_D20200101-20201231" decimals="-5" name="vtrs:RestructuringReserveAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzItNS0xLTEtMzE0MjI_b36a5036-b335-4abf-baef-bf3e847623fb">92.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a2ed382584440da959bd00009045f49_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzMtMS0xLTEtMzE0MjI_b9bac704-8030-4a53-921b-e5c511534056">25.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i18f47482de9e477aa4d85300745fbad3_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzMtMy0xLTEtMzE0MjI_3859f7c4-c5e5-4bfc-bbdd-c0c66dda52f0">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d1d75a5c8a447008aeaeea8bcbacd37_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzMtNS0xLTEtMzE0MjI_53016664-1fd0-411a-b65f-2d334605dd2d">25.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utilization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a2ed382584440da959bd00009045f49_D20200101-20201231" decimals="-5" name="us-gaap:RestructuringAndRelatedCostIncurredCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzUtMS0xLTEtMzE0MjI_33f8567e-a676-4b0a-9316-25dec8c06ef1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i18f47482de9e477aa4d85300745fbad3_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzUtMy0xLTEtMzE0MjI_e0eeb98b-197f-4b7a-8ac9-9f7e235cfb54">70.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d1d75a5c8a447008aeaeea8bcbacd37_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzUtNS0xLTEtMzE0MjI_b8a5f6ca-1658-45f4-a5c7-c64e9ebbcf1c">70.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a2ed382584440da959bd00009045f49_D20200101-20201231" decimals="-5" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzYtMS0xLTEtMzE0MjI_51dd773b-c50b-49ff-8013-63edb33da142">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18f47482de9e477aa4d85300745fbad3_D20200101-20201231" decimals="-5" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzYtMy0xLTEtMzE0MjI_8d2a22ad-8b15-4ac7-8cd1-75b6d7f3cafc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d1d75a5c8a447008aeaeea8bcbacd37_D20200101-20201231" decimals="-5" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzYtNS0xLTEtMzE0MjI_f19d09ff-2147-41b7-9c40-d88341e7ea5e">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a292f6066c4a5cae5e925da85f5c71_I20201231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzctMS0xLTEtMzE0MjI_d150406d-ebab-4b9a-952d-75613f53ada6">262.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fba1fd0dd43ebabc004e6c0858d88_I20201231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzctMy0xLTEtMzE0MjI_d7d2f97f-1967-4e51-8360-d66ac7a325a5">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i681ce63aa00c4c9498e214af93461780_I20201231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzctNS0xLTEtMzE0MjI_43a6f9e5-c99c-4dc5-a473-221278455ba7">267.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa3cdc4e3b274003ae2d838d289e9c7d_D20210101-20211231" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzgtMS0xLTEtMzQxOTI_f920403a-0743-4f59-afc5-8b7beb01ccac">396.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieae368cfdd6248869144a96949edde48_D20210101-20211231" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzgtMy0xLTEtMzQyMDQ_0592590f-c39e-4ff8-b551-6f89e35b2c9b">496.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b60006ae2c94bff820d1335a546ccba_D20210101-20211231" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzgtNS0xLTEtMzM3ODI_556f97dc-abf7-4d12-8754-72f9fcc89374">892.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reimbursable restructuring charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i254bde0424ca475ebacf28a1bc15b3b1_D20210101-20211231" decimals="-5" name="vtrs:RestructuringReserveReimbursableRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzktMS0xLTEtMzM3NzQ_b2d9c6dd-b615-476b-ae46-9922e624ed86">26.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0685a0412faf4f3b90366905bbeab604_D20210101-20211231" decimals="-5" name="vtrs:RestructuringReserveReimbursableRestructuringCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzktMy0xLTEtMzM3OTg_8df9a865-5a8d-45ab-b3a5-84abe82a4f06">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" decimals="-5" name="vtrs:RestructuringReserveReimbursableRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzktNS0xLTEtMzM3ODI_e430420a-07a1-40ed-a9bb-71c43b0141a1">26.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa3cdc4e3b274003ae2d838d289e9c7d_D20210101-20211231" decimals="-5" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzEwLTEtMS0xLTM0MTky_31df610e-ce22-4fce-a500-5bf82403f74f">385.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieae368cfdd6248869144a96949edde48_D20210101-20211231" decimals="-5" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzEwLTMtMS0xLTM0MjA0_5e4064ac-3828-4ab4-abe4-139616b69e26">151.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b60006ae2c94bff820d1335a546ccba_D20210101-20211231" decimals="-5" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzEwLTUtMS0xLTMzNzgy_d2669f1a-6e4b-4503-9ec9-aa9e1f496bb9">537.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utilization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa3cdc4e3b274003ae2d838d289e9c7d_D20210101-20211231" decimals="-5" name="us-gaap:RestructuringAndRelatedCostIncurredCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzExLTEtMS0xLTMzODA5_bf03a001-3429-4769-9a6a-830d714fd0b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieae368cfdd6248869144a96949edde48_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzExLTMtMS0xLTM0MjA0_8129e816-4a37-492a-9012-931a1c20b26e">345.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b60006ae2c94bff820d1335a546ccba_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzExLTUtMS0xLTMzNzgy_1c5e5412-a003-4312-a253-32b298e6c273">345.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa3cdc4e3b274003ae2d838d289e9c7d_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzEyLTEtMS0xLTM0MTky_9e6ee2dc-76bf-45d1-8d3e-d76deaaae772">7.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieae368cfdd6248869144a96949edde48_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzEyLTMtMS0xLTM0MjA0_450c2ac8-81e2-4c7b-8ab6-7c521996b106">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b60006ae2c94bff820d1335a546ccba_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzEyLTUtMS0xLTMzNzgy_1f078e47-b0ab-47f5-af0c-d91099e0400c">7.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id51cb348481d4ec48766bf86b6cc391d_I20211231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzEzLTEtMS0xLTMzODIw_12c0ccb5-098f-4777-aa55-accc82872488">292.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6a9f98858454485bf0c770c4fd2c57c_I20211231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzEzLTMtMS0xLTMzODI5_c78a15bb-f7ad-4b9e-a0e3-f2785db8b70c">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia84d707224a5471abcb6fb8f26708db5_I20211231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzEzLTUtMS0xLTMzNzgy_49eb9c2b-1ef5-4353-9d4e-6432122c1837">296.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As part of the Combination, the Company acquired reserve balances related to restructuring activities initiated by the Upjohn Business prior to the Combination, primarily related to accrued severance. </span></div><div style="text-indent:24.5pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">2016 Restructuring Program</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mylan previously announced a restructuring program representing a series of actions in certain locations to further streamline its operations globally. We incurred total restructuring related costs of approximately $<ix:nonFraction unitRef="usd" contextRef="i9ad19c7802c7406b96da1212d434f4e3_D20160101-20201231" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90ZXh0cmVnaW9uOjQ3ZDBjNDk5MjMxODRjNTJhY2JiYTAzZTJmN2NjNTU4XzIxMzQ_d15a3a8b-0a77-49d1-af29-c708f084ae98">733.0</ix:nonFraction>&#160;million through December 31, 2020. The 2016 Restructuring Program was substantially completed at December 31, 2020. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2018, the FDA completed an inspection at Mylan&#8217;s plant in Morgantown, West Virginia and made observations through a Form 483. In the fourth quarter of 2018, Mylan received a warning letter related to the previously disclosed observations at the plant. The issues raised in the warning letter were addressed within the context of the Mylan&#8217;s comprehensive restructuring and remediation activities. On May 11, 2020, Mylan received the close-out of the warning letter. On December 11, 2020, the Company announced that it expects the Morgantown plant to be closed or divested as part of the 2020 Restructuring Program. The Morgantown plant was closed during the third quarter of 2021.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the restructuring charges and the reserve activity for the 2016 restructuring program from December 31, 2018 to December 31, 2020:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><ix:continuation id="i5b0a7efbba9148e19e88691270ba775c" continuedAt="i8d8cca491a354d529b8b8a3be0595d59"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.006%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.712%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Related Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Exit Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2018:</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i266beeff762940c594ad7e6cb70ba95a_I20181231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzEtMS0xLTEtNTEzNTA_0ed7662c-fcf5-4588-b5ee-a7979fcdf236">60.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a2f026c5d984a4baa08a46d2b7a633d_I20181231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzEtMy0xLTEtNTEzNTA_b4cf3a66-bbd6-45d5-9e7d-2ea8bfd91b7e">11.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8ec92ba24d848d697ba737aeed13c05_I20181231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzEtNS0xLTEtNTEzNTA_5d651e8e-825e-40c1-8f59-25ad81633186">72.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie111b220c8104243b43abb19a557ed31_D20190101-20191231" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzItMS0xLTEtNTEzNTA_4384931b-6ee7-4f00-be1d-8e8be54f69d3">16.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied43c8ca68ed4621b226737a5d334eaf_D20190101-20191231" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzItMy0xLTEtNTEzNTA_ed91caf8-bff4-44d1-89d6-0a0523c75e88">88.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzItNS0xLTEtNTEzNTA_0fa8b536-52ef-4dc5-8e47-1e794421f3e1">104.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie111b220c8104243b43abb19a557ed31_D20190101-20191231" decimals="-5" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzMtMS0xLTEtNTEzNTA_32cd0a89-0988-49c8-a027-79872851c09a">48.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied43c8ca68ed4621b226737a5d334eaf_D20190101-20191231" decimals="-5" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzMtMy0xLTEtNTEzNTA_752c7f98-a203-4d2b-930f-c14773a8dca1">10.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzMtNS0xLTEtNTEzNTA_db1dcee9-04c4-46d2-ab59-0b9169eb86e9">59.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie111b220c8104243b43abb19a557ed31_D20190101-20191231" decimals="-5" name="us-gaap:RestructuringReservePeriodIncreaseDecrease" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzQtMS0xLTEtNTEzNTU_1ee600f2-ffbc-4c09-b4c0-985d307ea748">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied43c8ca68ed4621b226737a5d334eaf_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:RestructuringReservePeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzQtMy0xLTEtNTEzNTc_69b0415c-6882-4f57-840d-ac6d7a5ea598">8.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:RestructuringReservePeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzQtNS0xLTEtNTEzNTk_6e1b8a30-8767-4237-ab13-c20c67d42ebf">8.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utilization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie111b220c8104243b43abb19a557ed31_D20190101-20191231" decimals="-5" name="us-gaap:RestructuringAndRelatedCostIncurredCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzUtMS0xLTEtNTEzNTM_5060df8e-78ee-411e-b2c4-8e2bb4dcf81b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied43c8ca68ed4621b226737a5d334eaf_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzUtMy0xLTEtNTEzNTM_708216da-1ad5-4ad9-b0a0-effdcf302eaa">78.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzUtNS0xLTEtNTEzNTM_930ed417-81b9-4fac-929e-c18e47c30482">78.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie111b220c8104243b43abb19a557ed31_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzYtMS0xLTEtNTEzNTM_d14c7b4b-5db3-4bad-9594-aa413e6e8735">2.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied43c8ca68ed4621b226737a5d334eaf_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzYtMy0xLTEtNTEzNTM_51b0cc52-c99a-497e-ae15-d6581bea0939">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzYtNS0xLTEtNTEzNTM_68274680-ecf0-45d1-80c7-57ef35d5e187">2.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019:</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic88f207a9dad4e4d801b44cf3af9f10c_I20191231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzEtMS0xLTEtMzE0MjI_68ef1dea-d455-41f3-bc47-ca75485e97e0">26.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic46fb38f58024911a0b78897bd8338eb_I20191231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzEtMy0xLTEtMzE0MjI_c44182d6-05d2-4c24-9328-d0b7f2b2e203">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac503b6d629d4bafb262ea6ec0b8a25e_I20191231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzEtNS0xLTEtMzE0MjI_155beb7f-7923-4a02-8bc3-ace959579499">29.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74053317be7e49ca93f4eade0b20f377_D20200101-20201231" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzItMS0xLTEtMzE0MjI_ea7af4bd-9d7e-4e78-9fe9-e2f762f4be22">9.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a14e7286e034496b3144a5acc8932d1_D20200101-20201231" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzItMy0xLTEtMzE0MjI_98df128a-434f-454a-b819-2258135f740c">40.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzItNS0xLTEtMzE0MjI_30210044-a509-4191-8764-cb3e6b6447b6">50.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74053317be7e49ca93f4eade0b20f377_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzMtMS0xLTEtMzE0MjI_0e89ccbe-d4cc-4c69-b7c3-36ad6ea4a63f">18.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a14e7286e034496b3144a5acc8932d1_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzMtMy0xLTEtMzE0MjI_fd1be981-03ec-446b-a4ff-21007714204d">7.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzMtNS0xLTEtMzE0MjI_14543499-75ea-41f5-aa4e-9956838538b6">25.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utilization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74053317be7e49ca93f4eade0b20f377_D20200101-20201231" decimals="-5" name="us-gaap:RestructuringAndRelatedCostIncurredCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzUtMS0xLTEtMzE0MjI_e7cbadd0-4404-4d7e-aa46-d5685fbe1ec3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a14e7286e034496b3144a5acc8932d1_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzUtMy0xLTEtMzE0MjI_49ffd6a5-681a-4184-afe9-62bf30deeb17">32.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzUtNS0xLTEtMzE0MjI_04540337-88ab-439b-b184-9bbe34d6d213">32.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74053317be7e49ca93f4eade0b20f377_D20200101-20201231" decimals="-5" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzYtMS0xLTEtMzE0MjI_a3e6ccd9-72d6-4b29-a3bd-b2fc205692b2">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a14e7286e034496b3144a5acc8932d1_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzYtMy0xLTEtMzE0MjI_d9a8b37c-8612-4143-95bf-ad40d651ed6a">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231" decimals="-5" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzYtNS0xLTEtMzE0MjI_4ceeab14-7805-4c38-a102-501174898195">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020:</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id700bedb414840799b353bf9084701c9_I20201231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzctMS0xLTEtMzE0MjI_fa0d9792-03c0-4320-a925-3e53164c95dd">20.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i864f1b9d64574c8c88114fc001040dd2_I20201231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzctMy0xLTEtMzE0MjI_b06dd484-0e62-42aa-b242-9c1676175132">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzctNS0xLTEtMzE0MjI_ec3cfc07-68d8-437f-b477-de2f8b037252">22.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">136</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><ix:continuation id="i00f96b58bf444dd99af6c84a565ec66c"><ix:continuation id="i8d8cca491a354d529b8b8a3be0595d59"><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;<ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90ZXh0cmVnaW9uOjQ3ZDBjNDk5MjMxODRjNTJhY2JiYTAzZTJmN2NjNTU4XzM0Njc_53218c48-f2e9-4b86-9cac-d0d5943a00a2" continuedAt="i857a0da4a20641cfb990fbf47ece6a12" footnoteRole="http://www.xbrl.org/2003/role/footnote">For the year ended December&#160;31, 2021, total restructuring charges for the 2020 Restructuring Program, in Developed Markets, Greater China, JANZ, Emerging Markets, and Corporate/Other were approximately $<ix:nonFraction unitRef="usd" contextRef="i1ac0bcd2e1264e8b8347af73e216d016_D20210101-20211231" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90ZXh0cmVnaW9uOjQ3ZDBjNDk5MjMxODRjNTJhY2JiYTAzZTJmN2NjNTU4XzMxNTU_de8c3256-7dd6-459d-9d53-9944f9a5b86b">623.8</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i7ed92dccf2314bd48c7373be7cf33d4e_D20210101-20211231" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90ZXh0cmVnaW9uOjQ3ZDBjNDk5MjMxODRjNTJhY2JiYTAzZTJmN2NjNTU4XzMxNTk_fb2fd14a-328d-4380-9161-f957b0fcf7f1">5.8</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i3ccdc9914af44b1bb1229e19c17326d8_D20210101-20211231" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90ZXh0cmVnaW9uOjQ3ZDBjNDk5MjMxODRjNTJhY2JiYTAzZTJmN2NjNTU4XzMxNjM_aa4c1cc7-14f6-423b-a6cd-613a93443b23">138.1</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i02b3f133daa24190abd49dfdef6bb6ce_D20210101-20211231" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90ZXh0cmVnaW9uOjQ3ZDBjNDk5MjMxODRjNTJhY2JiYTAzZTJmN2NjNTU4XzMxNzA_617e7b27-b4d4-4de7-8b17-7fd691ea02b3">94.1</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="icd84b99acf144bc78660b64776c157a5_D20210101-20211231" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90ZXh0cmVnaW9uOjQ3ZDBjNDk5MjMxODRjNTJhY2JiYTAzZTJmN2NjNTU4XzMyOTg1MzQ4ODcxNTI_1395ef22-c549-4c0d-b483-b10b588576a1">30.4</ix:nonFraction> million, respectively. </ix:footnote></span></div><ix:continuation id="i857a0da4a20641cfb990fbf47ece6a12"><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;For the year ended December&#160;31, 2020, total restructuring charges, for both programs, in Developed Markets, Greater China, JANZ, and Emerging Markets were approximately $<ix:nonFraction unitRef="usd" contextRef="iec0737b261124d3f87ea9adcdb407b5a_D20200101-20201231" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90ZXh0cmVnaW9uOjQ3ZDBjNDk5MjMxODRjNTJhY2JiYTAzZTJmN2NjNTU4XzMyOTg1MzQ4ODcwNjk_70642c01-101d-45f6-bf91-6a987262a2d0">292.1</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i4e0c5048f8f84f26a1949d61f3285173_D20200101-20201231" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90ZXh0cmVnaW9uOjQ3ZDBjNDk5MjMxODRjNTJhY2JiYTAzZTJmN2NjNTU4XzMyOTg1MzQ4ODcwNzg_6d9df001-ca1f-4659-9810-3e155bda008c">18.4</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i2d06b2c023334d92a7c83b2943f0232b_D20200101-20201231" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90ZXh0cmVnaW9uOjQ3ZDBjNDk5MjMxODRjNTJhY2JiYTAzZTJmN2NjNTU4XzMyOTg1MzQ4ODcwODM_824f206e-c7a6-4f1f-8c3a-e6e34bf722e8">2.9</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i281863eb67c44d0fbc00294dfaf0049c_D20200101-20201231" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90ZXh0cmVnaW9uOjQ3ZDBjNDk5MjMxODRjNTJhY2JiYTAzZTJmN2NjNTU4XzMyOTg1MzQ4ODcwOTQ_5149bc27-40ff-4eb3-b4eb-58c0f3fcef93">8.4</ix:nonFraction> million, respectively. </span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;For the year ended December 31, 2019, total restructuring charges for the 2016 Restructuring Program in Developed Markets and JANZ were approximately $<ix:nonFraction unitRef="usd" contextRef="i864642c0e47a4b87a88be339d6673670_D20190101-20191231" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90ZXh0cmVnaW9uOjQ3ZDBjNDk5MjMxODRjNTJhY2JiYTAzZTJmN2NjNTU4XzU0OTc1NTgxNDY3NDA_d72e1a06-78e2-42fd-a158-ce515686dc80">100.4</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i94d3655a9cb44f37b3319f0d91bf87b1_D20190101-20191231" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90ZXh0cmVnaW9uOjQ3ZDBjNDk5MjMxODRjNTJhY2JiYTAzZTJmN2NjNTU4XzU0OTc1NTgxNDY3NTY_5aaa1086-58fb-4132-9d9a-d221848fd0ef">4.2</ix:nonFraction>&#160;million, respectively.</span></div></ix:continuation></ix:continuation><div style="margin-bottom:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 2020, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">accrued liabilities for restructuring and other cost reduction programs were primarily included in other current liabilities and other long-term obligations in the consolidated balance sheets.</span></div></ix:continuation><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_241"></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">Licensing and Other Partner Agreements</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We periodically enter into licensing and other partner agreements with other pharmaceutical companies for the development, manufacture, marketing and/or sale of pharmaceutical products. Our significant licensing and other partner agreements are primarily focused on the development, manufacturing, supply and commercialization of multiple, high-value generic biologic compounds, insulin analog products and respiratory products, among other complex products. Under these agreements, we have future potential milestone payments and co-development expenses payable to third parties as part of our licensing, development and co-development programs. Payments under these agreements generally become due and are payable upon the satisfaction or achievement of certain developmental, regulatory or commercial milestones or as development expenses are incurred on defined projects. Milestone payment obligations are uncertain, including the prediction of timing and the occurrence of events triggering a future obligation and are not reflected as liabilities in the consolidated balance sheets, except for obligations reflected as acquisition related contingent consideration. Refer to Note 9 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments and Risk Management</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further discussion of contingent consideration. Our potential maximum development milestones not accrued for at December&#160;31, 2021 totaled approximately $<ix:nonFraction unitRef="usd" contextRef="i500214b091fd4491a3e5f7c09d556da9_D20210101-20211231" decimals="-6" name="vtrs:Developmentandsalesmilestonepayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDEvZnJhZzplM2FlYTcwNGZkOWY0OTZlOGIyOGRkODZhZDYxMDkwNi90ZXh0cmVnaW9uOmUzYWVhNzA0ZmQ5ZjQ5NmU4YjI4ZGQ4NmFkNjEwOTA2XzEzNzc_64be736d-6398-44a9-8936-815d2c2a5dfb">351</ix:nonFraction> million. We estimate that the amounts that may be paid during the next twelve months to be approximately $<ix:nonFraction unitRef="usd" contextRef="i65836be0391145f5a3e61375cecd6594_D20210101-20211231" decimals="-6" name="vtrs:Developmentandsalesmilestonepayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDEvZnJhZzplM2FlYTcwNGZkOWY0OTZlOGIyOGRkODZhZDYxMDkwNi90ZXh0cmVnaW9uOmUzYWVhNzA0ZmQ5ZjQ5NmU4YjI4ZGQ4NmFkNjEwOTA2XzE0Nzc_46dc0141-68a1-496a-8071-aaeaf43e395a">18</ix:nonFraction> million. These agreements may also include potential sales-based milestones and call for us to pay a percentage of amounts earned from the sale of the product as a royalty or a profit share. The amounts disclosed do not include sales-based milestones or royalty or profit share obligations on future sales of product as the timing and amount of future sales levels and costs to produce products subject to these obligations is not reasonably estimable. These sales-based milestones or royalty or profit share obligations may be significant depending upon the level of commercial sales for each product. </span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revance</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 28, 2018, the Company and Revance entered into an agreement with Revance pursuant to which the Company and Revance are collaborating exclusively, on a world-wide basis (excluding Japan), to develop, manufacture and commercialize a biosimilar to the branded biologic product (onabotulinumtoxinA) marketed as BOTOX&#174;.  Under the agreement, the Company is primarily responsible for (a) clinical development activities outside of North America (excluding Japan) (b) regulatory activities, and (c) commercialization for any approved product. Revance is primarily responsible for (a) non-clinical development activities, (b) clinical development activities in North America, and (c) manufacturing and supply of clinical drug substance and drug product; Revance is solely responsible for an initial portion of non-clinical development costs. The remaining portion of any non-clinical development costs and clinical development costs for obtaining approval in the U.S. and Europe is being shared equally between the parties, and the Company is responsible for all other clinical development costs and commercialization expenses. During the year ended December 31, 2020, the Company recorded $<ix:nonFraction unitRef="usd" contextRef="i26f84e3d52854c23bc765376727d547d_D20200101-20201231" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDEvZnJhZzplM2FlYTcwNGZkOWY0OTZlOGIyOGRkODZhZDYxMDkwNi90ZXh0cmVnaW9uOmUzYWVhNzA0ZmQ5ZjQ5NmU4YjI4ZGQ4NmFkNjEwOTA2XzcxNDY4MjU1OTkzNTA_f013c0dd-b299-4003-8bec-d641d44454fa">30</ix:nonFraction>&#160;million of R&amp;D expense for a milestone payment that was due upon the decision to continue the development program.</span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Momenta</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January&#160;8, 2016, the Company entered into an agreement with Momenta to develop, manufacture and commercialize up to <ix:nonFraction unitRef="drugs" contextRef="i86776889abae4015b5e341878a1f94e0_I20160108" decimals="0" name="vtrs:NumberOfDrugs" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDEvZnJhZzplM2FlYTcwNGZkOWY0OTZlOGIyOGRkODZhZDYxMDkwNi90ZXh0cmVnaW9uOmUzYWVhNzA0ZmQ5ZjQ5NmU4YjI4ZGQ4NmFkNjEwOTA2XzM1ODI_01deee21-173c-4f89-ac9e-b0449a6498a2">six</ix:nonFraction> of Momenta&#8217;s biosimilar candidates. Under the terms of the agreement, the Company and Momenta were jointly responsible for product development and equally shared in the costs and profits of the products with Viatris leading the worldwide commercialization efforts. In January 2019, the parties agreed to the termination of all collaboration activities, except for the continued development of M710, a proposed biosimilar to EYLEA&#174;. In October 2020, Momenta was acquired by Johnson &amp; Johnson. The parties continue to collaborate on the development of M710.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">137</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Theravance Biopharma</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January&#160;30, 2015, the Company entered into a development and commercialization collaboration with Theravance Biopharma, for revefenacin. On November 9, 2018, the Company announced that the FDA approved the NDA for YUPELRI&#174;&#160;(revefenacin) inhalation solution for the maintenance treatment of patients with COPD. YUPELRI&#174;, a LAMA, is the first and only once-daily, nebulized bronchodilator approved for the treatment of COPD in the U.S. Viatris  is responsible for commercial manufacturing and commercialization. Theravance Biopharma is co-promoting the product in the hospital channel under a profit-sharing arrangement.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In  2019, the Company acquired exclusive development and commercialization rights to nebulized revefenacin in&#160;China&#160;and adjacent territories, which include Hong Kong SAR, the Macau SAR and&#160;Taiwan. Theravance Biopharma received an upfront payment of&#160;$<ix:nonFraction unitRef="usd" contextRef="i20265a72ee5044e7aae84f97919d0147_D20210101-20211231" decimals="-5" name="vtrs:PaymentsToAcquireCollaborativeAgreement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDEvZnJhZzplM2FlYTcwNGZkOWY0OTZlOGIyOGRkODZhZDYxMDkwNi90ZXh0cmVnaW9uOmUzYWVhNzA0ZmQ5ZjQ5NmU4YjI4ZGQ4NmFkNjEwOTA2XzcxODk_29abf202-9df0-4a6b-9c9d-1920d8fb6444">18.5</ix:nonFraction> million&#160;and will be eligible to receive additional potential development and sales milestones&#160;together with tiered royalties on net sales of nebulized revefenacin, if approved. Viatris is responsible for all aspects of development and commercialization in the partnered regions, including pre- and post-launch activities and product registration and all associated costs. The upfront payment was recorded as R&amp;D expense during the year ended December 31, 2019. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the agreements, Theravance Biopharma is eligible to receive potential development and sales milestone payments totaling approximately&#160;$<ix:nonFraction unitRef="usd" contextRef="i8c6221856b4642fdaae580491808b3ca_D20150130-20150130" decimals="-6" name="vtrs:Developmentandsalesmilestonepayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDEvZnJhZzplM2FlYTcwNGZkOWY0OTZlOGIyOGRkODZhZDYxMDkwNi90ZXh0cmVnaW9uOmUzYWVhNzA0ZmQ5ZjQ5NmU4YjI4ZGQ4NmFkNjEwOTA2Xzc3Njk_52c2c157-70b3-46d2-ae26-f7ced786c56a">293</ix:nonFraction> million&#160;in the aggregate.&#160;As of December&#160;31, 2021, the Company has paid a total of $<ix:nonFraction unitRef="usd" contextRef="i1c6036278a4b49a4901cdd582be7d9f0_D20210101-20211231" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDEvZnJhZzplM2FlYTcwNGZkOWY0OTZlOGIyOGRkODZhZDYxMDkwNi90ZXh0cmVnaW9uOmUzYWVhNzA0ZmQ5ZjQ5NmU4YjI4ZGQ4NmFkNjEwOTA2Xzc4MjY_3842de4f-e6e6-460c-8a0e-61aa003213b5">50.0</ix:nonFraction>&#160;million in milestone payments to Theravance Biopharma. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Biocon</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into exclusive collaborations with Biocon on the development, manufacturing, supply and commercialization of multiple, high value biosimilar compounds and <ix:nonFraction unitRef="product" contextRef="i13a8322297064621abf63668185d09b7_D20130211-20130212" decimals="0" name="vtrs:InsulinAnalogProducts" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDEvZnJhZzplM2FlYTcwNGZkOWY0OTZlOGIyOGRkODZhZDYxMDkwNi90ZXh0cmVnaW9uOmUzYWVhNzA0ZmQ5ZjQ5NmU4YjI4ZGQ4NmFkNjEwOTA2XzgwNDU_ab6b0f19-2491-4046-a9d4-bef959b2afb2">three</ix:nonFraction> insulin analog products for the global marketplace. Under the agreements with Biocon, the Company has exclusive commercialization rights for the products under the collaborations in the U.S., Canada, Japan, Australia, New Zealand and in the EU and European Free Trade Association countries. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2017, the FDA approved  Ogivri</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (trastuzumab-dkst), a biosimilar to Herceptin&#174; (trastuzumab). Ogivri</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has been approved for all indications included in the label of the reference product, Herceptin, including for the treatment of HER2-overexpressing breast cancer and metastatic stomach cancer (gastric or gastroesophageal junction adenocarcinoma). On December 2, 2019, the Company and Biocon announced the U.S. launch of&#160;Ogivri</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#174;</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In June 2018, the Company and Biocon announced that the FDA approved Fulphila</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (pegfilgrastim-jmdb), a biosimilar to Neulasta</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#174;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(pegfilgrastim). Fulphila</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has been approved to reduce the duration of febrile neutropenia (fever or other signs of infection with a low count of neutrophils, a type of white blood cells) in patients treated with chemotherapy in certain types of cancer. The commercial launch of Fulphila</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> occurred in 2018. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August, 2020, the Company and Biocon announced the U.S. launch of SEMGLEE&#174; (insulin glargine injection) in vial and pre-filled pen presentations, approved to help control high blood sugar in adult and pediatric patients with type 1 diabetes and adults with type 2 diabetes.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On July 28, 2021, Viatris and Biocon announced that the FDA had approved SEMGLEE&#174; (insulin glargine-yfgn) injection as the first interchangeable biosimilar product under the 351(k) regulatory pathway. The interchangeable SEMGLEE&#174; product, which allows substitution of SEMGLEE&#174; for the reference product, Lantus&#174;. The commercial launch occurred in the fourth quarter of 2021. The Company has exclusivity for 12 months from launch before the FDA can approve another biosimilar interchangeable to Lantus&#174;. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to profit sharing payments to Biocon for the commercialized products, the Company continues to provide development funding related to this collaboration. As the timing of cash expenditures is dependent upon a number of factors, many of which are out of the Company&#8217;s control, it is difficult to forecast the amount of payments to be made over the next few years, which could be significant. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">138</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">FKB</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 22, 2018, the Company entered into a collaboration license and distribution agreement with FKB for the distribution of Hulio&#174;, a biosimilar to AbbVie's Humira&#174; (adalimumab). Under the agreement, the Company has exclusive commercialization rights for the product in the EU and the European Economic Area countries and FKB is responsible for development, manufacturing and supply of the product. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 20, 2018, the Company received final approval from the Commission to market Hulio&#174; for all adalimumab indications in all 28 EU member states and the European Economic Area.&#160;Under the agreement, FKB received an upfront payment of $<ix:nonFraction unitRef="usd" contextRef="i9e5713b803ec4eaf933db1df619dac04_D20180920-20180920" decimals="-5" name="vtrs:PaymentsToAcquireCollaborativeAgreement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDEvZnJhZzplM2FlYTcwNGZkOWY0OTZlOGIyOGRkODZhZDYxMDkwNi90ZXh0cmVnaW9uOmUzYWVhNzA0ZmQ5ZjQ5NmU4YjI4ZGQ4NmFkNjEwOTA2XzEwODk4_74bf2673-a2c3-4208-ae9c-53157530557c">25.0</ix:nonFraction> million, an approval milestone of $<ix:nonFraction unitRef="usd" contextRef="i9e5713b803ec4eaf933db1df619dac04_D20180920-20180920" decimals="-5" name="vtrs:Developmentandsalesmilestonepayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDEvZnJhZzplM2FlYTcwNGZkOWY0OTZlOGIyOGRkODZhZDYxMDkwNi90ZXh0cmVnaW9uOmUzYWVhNzA0ZmQ5ZjQ5NmU4YjI4ZGQ4NmFkNjEwOTA2XzEwOTI3_ded1d7e3-55eb-4f58-b23b-eaab59bf0636">10.0</ix:nonFraction> million and is eligible for a royalty based upon net sales.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 27, 2019, the Company amended its agreements with FKB for the commercialization of Hulio&#174;. Under the amended agreements, the Company received the exclusive global commercialization rights for Hulio&#174; and FKB received an additional upfront payment of $<ix:nonFraction unitRef="usd" contextRef="i1060ce14d7454734a57fb560f05c5dc2_D20190227-20190227" decimals="-5" name="vtrs:PaymentsToAcquireCollaborativeAgreement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDEvZnJhZzplM2FlYTcwNGZkOWY0OTZlOGIyOGRkODZhZDYxMDkwNi90ZXh0cmVnaW9uOmUzYWVhNzA0ZmQ5ZjQ5NmU4YjI4ZGQ4NmFkNjEwOTA2XzExMjM3_c46ac1e2-78b4-4a4e-8fb9-84908abe9b0f">33.0</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="i1060ce14d7454734a57fb560f05c5dc2_D20190227-20190227" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDEvZnJhZzplM2FlYTcwNGZkOWY0OTZlOGIyOGRkODZhZDYxMDkwNi90ZXh0cmVnaW9uOmUzYWVhNzA0ZmQ5ZjQ5NmU4YjI4ZGQ4NmFkNjEwOTA2XzEwOTk1MTE2NjQ5ODA_36a59fe3-f239-4121-9e22-071677fe20bb">23.3</ix:nonFraction>&#160;million was recorded as a component of R&amp;D expense during the year ended December 31, 2019. In addition, FKB is eligible to receive additional commercial milestones and royalty payments under the amended agreements.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 9, 2020, the Company announced that the FDA approved Hulio&#174; (adalimumab-fkjp), a biosimilar to AbbVie's Humira&#174; (adalimumab), for the treatment of rheumatoid arthritis, juvenile idiopathic arthritis (4 years and older), psoriatic arthritis, ankylosing spondylitis, adult Crohn's disease, ulcerative colitis and plaque psoriasis, in both prefilled syringe and auto-injector presentations. In accordance with its patent license agreement with AbbVie, the Company will be able to launch Hulio&#174; in the U.S. in July 2023.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Development Agreements</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 20, 2019, the Company entered into a Master Development Agreement with a privately owned research company to grant the Company rights with respect to acquiring certain pharmaceutical products. The Company expects to provide funding for select programs through upfront payments and development milestones and the Company will have the right and obligation to acquire the products at fair market value upon regulatory approval or other regulatory trigger dates.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company made an initial upfront payment of $<ix:nonFraction unitRef="usd" contextRef="idf043a2e2c394069bf7b417157fabff5_D20210101-20211231" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDEvZnJhZzplM2FlYTcwNGZkOWY0OTZlOGIyOGRkODZhZDYxMDkwNi90ZXh0cmVnaW9uOmUzYWVhNzA0ZmQ5ZjQ5NmU4YjI4ZGQ4NmFkNjEwOTA2XzEyNTMz_389cab51-e896-4700-800f-9c21dc8cb7ab">10.0</ix:nonFraction> million which was accounted for as R&amp;D expense during the year ended December 31, 2019. Additionally, under the terms of the agreement, the Company acquired $<ix:nonFraction unitRef="usd" contextRef="idc22e99190de4591a027585c2ec34f85_I20211231" decimals="-5" name="us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDEvZnJhZzplM2FlYTcwNGZkOWY0OTZlOGIyOGRkODZhZDYxMDkwNi90ZXh0cmVnaW9uOmUzYWVhNzA0ZmQ5ZjQ5NmU4YjI4ZGQ4NmFkNjEwOTA2XzEyNjky_250e911a-2280-4c72-89b6-ae5f0a2dc896">25.0</ix:nonFraction> million worth of equity shares in the privately owned research company during the year ended December 31, 2020. The investment is accounted for in accordance with ASC 321, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments - Equity Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. During the year ended December 31, 2021, the Company entered into an agreement with this entity for the future development of an ophthalmic product. The agreement included an upfront payment of $<ix:nonFraction unitRef="usd" contextRef="i6d1a10fafb2f499895da7c0d46a48ae3_D20210101-20211231" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDEvZnJhZzplM2FlYTcwNGZkOWY0OTZlOGIyOGRkODZhZDYxMDkwNi90ZXh0cmVnaW9uOmUzYWVhNzA0ZmQ5ZjQ5NmU4YjI4ZGQ4NmFkNjEwOTA2XzU0OTc1NTgxNjc1NTA_b1416de8-eff7-4046-bcc9-395e74000535">40.0</ix:nonFraction>&#160;million which was accounted for as R&amp;D expense.&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are actively pursuing, and are currently involved in, joint projects related to the development, distribution and marketing of both generic and branded products. Many of these arrangements provide for payments by us upon the attainment of specified milestones. While these arrangements help to reduce the financial risk for unsuccessful projects, fulfillment of specified milestones or the occurrence of other obligations may result in fluctuations in cash flows and R&amp;D expense.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Biocon Biologics Agreement</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 28, 2022, the Company entered into an agreement to contribute its biosimilars business to Biocon Biologics. Under the terms of the Biocon Agreement, at closing Viatris will receive an up-front cash payment of $<ix:nonFraction unitRef="usd" contextRef="ida50edb50e464fd8bfedb0e9bb7be1aa_D20221001-20221231" decimals="-8" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDEvZnJhZzplM2FlYTcwNGZkOWY0OTZlOGIyOGRkODZhZDYxMDkwNi90ZXh0cmVnaW9uOmUzYWVhNzA0ZmQ5ZjQ5NmU4YjI4ZGQ4NmFkNjEwOTA2XzEwOTk1MTE2NjU5NTE_4ef9e5d6-d7c3-488a-80ad-4b64cfff7099">2.0</ix:nonFraction>&#160;billion, $<ix:nonFraction unitRef="usd" contextRef="i07eb4f1ce070466a990b0cd1a54b7b81_D20221001-20221231" decimals="-8" name="us-gaap:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDEvZnJhZzplM2FlYTcwNGZkOWY0OTZlOGIyOGRkODZhZDYxMDkwNi90ZXh0cmVnaW9uOmUzYWVhNzA0ZmQ5ZjQ5NmU4YjI4ZGQ4NmFkNjEwOTA2XzEwOTk1MTE2NjU5NjU_dd4dfe16-7228-4ab3-aaee-5c755c5510e1">1.0</ix:nonFraction>&#160;billion of convertible preferred equity and up to $<ix:nonFraction unitRef="usd" contextRef="i6d397ca7ee644114993a26171508834d_D20220101-20221231" decimals="-6" name="vtrs:DivestitureOfBusinessDeferredCashConsideration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDEvZnJhZzplM2FlYTcwNGZkOWY0OTZlOGIyOGRkODZhZDYxMDkwNi90ZXh0cmVnaW9uOmUzYWVhNzA0ZmQ5ZjQ5NmU4YjI4ZGQ4NmFkNjEwOTA2XzEwOTk1MTE2NjU5Nzk_312d1a1f-4f96-49c2-8f6f-13d0851a2533">335</ix:nonFraction>&#160;million as additional cash payments that are expected to be paid in 2024. Viatris will own a stake of at least <ix:nonFraction unitRef="number" contextRef="ida50edb50e464fd8bfedb0e9bb7be1aa_D20221001-20221231" decimals="3" name="vtrs:DivestitureOfBusinessPercentageOwnershipInCombinedCompanyAfterTransaction" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDEvZnJhZzplM2FlYTcwNGZkOWY0OTZlOGIyOGRkODZhZDYxMDkwNi90ZXh0cmVnaW9uOmUzYWVhNzA0ZmQ5ZjQ5NmU4YjI4ZGQ4NmFkNjEwOTA2XzEwOTk1MTE2NjU5OTM_c336e598-264a-4ef7-b3dd-4da97370dfa7">12.9</ix:nonFraction>% of Biocon Biologics, on a fully-diluted basis, and will have certain priority rights with respect to certain liquidity events. The companies will also enter into a <ix:nonNumeric contextRef="i6d397ca7ee644114993a26171508834d_D20220101-20221231" name="vtrs:DivestitureOfBusinessTransitionServicesAgreementTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDEvZnJhZzplM2FlYTcwNGZkOWY0OTZlOGIyOGRkODZhZDYxMDkwNi90ZXh0cmVnaW9uOmUzYWVhNzA0ZmQ5ZjQ5NmU4YjI4ZGQ4NmFkNjEwOTA2XzEzMTk0MTM5NTcxNTUz_aef04005-3074-4a6e-8f9b-c1b3b8ee4cf6">two-year</ix:nonNumeric> transition services agreement, subject to extension in certain circumstances, during which time Viatris will provide certain commercial and administrative services for an applicable service fee. The transaction is expected to close in the second half of 2022 and is subject to customary closing conditions (including regulatory approvals).</span></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_244"></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">19.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">Litigation</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved in various disputes, governmental and/or regulatory inquiries, investigations and proceedings, tax proceedings and litigation matters, both in the U.S. and abroad, that arise from time to time, some of which could result in losses, including damages, fines and/or civil penalties, and/or criminal charges against the Company. These matters are often complex and have outcomes that are difficult to predict. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">139</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in connection with the Combination, the Company has generally assumed liability for, and control of, pending and threatened legal matters relating to the Upjohn Business &#8211; including certain matters initiated against Pfizer described below &#8211; and has agreed to indemnify Pfizer for liabilities arising out of such assumed legal matters. Pfizer, however, has agreed to retain various matters &#8211; including certain specified competition law matters &#8211; to the extent they arise from conduct during the pre-Distribution period and has agreed to indemnify the Company for liabilities arising out of such matters.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company believes that it has meritorious defenses with respect to the claims asserted against it and the assumed legal matters referenced above, and intends to vigorously defend its position, the process of resolving these matters is inherently uncertain and may develop over a long period of time, and so it is not possible to predict the ultimate resolution of any such matter. It is possible that an unfavorable resolution of any of the ongoing matters could have a material effect on the Company&#8217;s business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of these governmental inquiries, investigations, proceedings and litigation matters with which the Company is involved are described below, and unless otherwise disclosed, the Company is unable to predict the outcome of the matter or to provide an estimate of the range of reasonably possible material losses. The Company records accruals for loss contingencies to the extent we conclude it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. The Company is also involved in other pending proceedings for which, in the opinion of the Company based upon facts and circumstances known at the time, either the likelihood of loss is remote or any reasonably possible loss associated with the resolution of such proceedings is not expected to be material to the Company&#8217;s business, financial position, results of operations, cash flows, ability to pay dividends and/or stock price. If and when any reasonably possible losses associated with the resolution of such other pending proceedings, in the opinion of the Company, become material, the Company will disclose such matters.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legal costs are recorded as incurred and are classified in SG&amp;A in the Company&#8217;s consolidated statements of operations.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">EpiPen&#174; Auto-Injector Litigation</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and a former Mylan N.V. officer (collectively the &#8220;Mylan Defendants&#8221;) have been named as defendants in indirect purchaser class actions relating to the pricing and/or marketing of the EpiPen&#174; Auto-Injector. The plaintiffs in these cases asserted violations of various federal and state antitrust and consumer protection laws, RICO as well as common law claims. Plaintiffs&#8217; seek monetary damages, attorneys&#8217; fees and costs. These lawsuits were filed in various federal and state courts and have either been dismissed or transferred into a MDL in the U.S. District Court for the District of Kansas and have been consolidated or centralized. The District Court initially certified an antitrust class that applied to <ix:nonFraction unitRef="agreement" contextRef="i2b28bb833a94474bbc11b88b345af593_D20210101-20211231" decimals="INF" name="vtrs:LossContingencyNumberOfStates" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzM5MDY_c74828d3-8c9a-4c99-b73c-cd94a0517aff">17</ix:nonFraction> states and a RICO class. On June 23, 2021, the Court granted &#8211; in substantial part &#8211; the Mylan Defendants&#8217; motion for summary judgment by dismissing certain antitrust claims and the RICO claims, which included RICO claims asserted against the former Mylan N.V. officer.  Plaintiffs&#8217; motions for reconsideration and to certify an interlocutory appeal of the summary judgment decision with respect to the RICO claims were denied. On July 8, 2021, the Mylan Defendants filed a motion to decertify the class action with respect to the remaining antitrust theory, which concerns a patent settlement between Pfizer and Teva and other alleged actions regarding the launch of Teva&#8217;s generic epinephrine auto-injector. The motion to decertify was granted in part, decertifying portions of the class action asserting claims under the laws of certain states and dismissing one named plaintiff, and was denied in all other respects. The Mylan Defendants had filed a motion for reconsideration of this decision, which was pending. In February 2022, the parties reached an agreement to fully resolve this matter for $<ix:nonFraction unitRef="usd" contextRef="i12d72077c53340de89fc310d8eef6974_D20220201-20220228" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzU0OTc1NTgxODY2MzM_d985c537-1396-4975-ad3d-f7e6599c147d">264</ix:nonFraction>&#160;million. The settlement is subject to court approval and contains an express provision disclaiming and denying any wrongdoing or liability by the Mylan Defendants. During the year ended December&#160;31, 2021, the Company recognized an accrual of approximately $<ix:nonFraction unitRef="usd" contextRef="i6a9f5404bef24f4984a0f8f1a0ff008c_I20211231" decimals="-5" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzMyOTg1MzQ5Mjc5Mzk_64732030-d0e6-4d51-80ba-18e2344a8e08">264.0</ix:nonFraction> million related to this litigation. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 14, 2020, the Company, together with other non-Viatris affiliated companies, were named as defendants in a putative direct purchaser class action filed in the U.S. District Court for the District of Kansas relating to the pricing and/or marketing of the EpiPen&#174; Auto-Injector. On September 21, 2021, after Plaintiffs&#8217; then operative complaint was dismissed with an option to file a limited amended complaint, Plaintiffs filed an amended complaint asserting federal antitrust claims which are based on allegations that are similar to those in the putative indirect purchaser class actions discussed above. Plaintiffs&#8217; seek monetary damages, declaratory relief, attorneys&#8217; fees and costs. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">140</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in March 2020, the Company, together with other non-Viatris affiliated companies, were named as defendants in putative direct purchaser class actions filed in the U.S. District Court for the District of Minnesota relating to contracts with certain pharmacy benefit managers concerning EpiPen&#174; Auto-Injector. The plaintiffs claim that the alleged conduct resulted in the exclusion or restriction of competing products and the elimination of pricing constraints in violation of RICO and federal antitrust law. These actions have been consolidated. Plaintiffs&#8217; seek monetary damages, attorneys&#8217; fees and costs. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 24, 2017, Sanofi Aventis U.S., LLC (&#8220;Sanofi&#8221;) filed a lawsuit against the Company in the U.S. District Court for the District of New Jersey. This lawsuit has been transferred into the aforementioned MDL and alleges exclusive dealing and anti-competitive marketing practices in violation of the antitrust laws in connection with the sale and marketing of the EpiPen&#174; Auto-Injector. Sanofi seeks monetary damages, declaratory relief, attorneys&#8217; fees and costs. The Court granted the Company&#8217;s motion for summary judgment and dismissed Sanofi&#8217;s claims.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sanofi&#8217;s appeal is pending. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a total accrual of approximately $<ix:nonFraction unitRef="usd" contextRef="i948e502442cc4e7ab6948ef233636a44_I20211231" decimals="-5" name="us-gaap:LitigationReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzEwOTk1MTE2NzE0NjI_376acb54-2f03-4973-8ccf-5430746388c6">274.0</ix:nonFraction> million related to these matters at December&#160;31, 2021, which is included in other current liabilities in the consolidated balance sheets. Although it is reasonably possible that the Company may incur additional losses from these matters, any amount cannot be reasonably estimated at this time. In addition, the Company expects to incur additional legal and other professional service expenses associated with such matters in future periods and will recognize these expenses as services are received. The Company believes that the ultimate amount paid for these services and claims could have a material effect on the Company's business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price in future periods.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Drug Pricing Matters </span></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Department of Justice</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 3, 2015, the Company received a subpoena from the Antitrust Division of the DOJ seeking information relating to the marketing, pricing, and sale of certain of our generic products and any communications with competitors about such products. On September 8, 2016, the Company, as well as certain employees and a member of senior management, received subpoenas from the DOJ seeking similar information. Related search warrants also were executed.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 10, 2018, the Company received a civil investigative demand from the Civil Division of the DOJ seeking information relating to the pricing and sale of its generic drug products. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are fully cooperating with these investigations, which we believe are related to a broader industry-wide investigation of the generic pharmaceutical industry.</span></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Civil Litigation</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in 2016, the Company, along with other manufacturers, has been named as a defendant in lawsuits generally alleging anticompetitive conduct with respect to generic drugs. The lawsuits have been filed by plaintiffs, including putative classes of direct purchasers, indirect purchasers, and indirect resellers, as well as individual direct and indirect purchasers and certain cities and counties. They allege harm under federal and state laws, including federal and state antitrust laws, state consumer protection laws and unjust enrichment claims. Some of the lawsuits also name as defendants the Company&#8217;s President, including allegations against him with respect to a single drug product, and one of the Company&#8217;s sales employees, including allegations against him with respect to certain generic drugs. The vast majority of the lawsuits have been consolidated in an MDL proceeding in the Eastern District of Pennsylvania (&#8220;EDPA&#8221;). Plaintiffs generally seek monetary damages, restitution, declaratory and injunctive relief, attorneys&#8217; fees and costs. The Court has ordered certain plaintiffs&#8217; complaints regarding two single-drug product cases to proceed as bellwethers. The Company is named in those plaintiffs&#8217; complaints that regard one of the two individual drug products. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">141</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Attorneys General Litigation</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 21, 2015, the Company received a subpoena and interrogatories from the Connecticut Office of the Attorney General seeking information relating to the marketing, pricing and sale of certain of the Company&#8217;s generic products and communications with competitors about such products. On December 14, 2016, attorneys general of certain states originally filed a complaint in the United States District Court for the District of Connecticut against several generic pharmaceutical drug manufacturers, including the Company, alleging anticompetitive conduct with respect to, among other things, a single drug product. The complaint has subsequently been amended, including on June 18, 2018, to add attorneys general alleging violations of federal and state antitrust laws, as well as violations of various states&#8217; consumer protection laws. This lawsuit has been transferred to the aforementioned MDL proceeding in the EDPA. The operative complaint includes attorneys general of <ix:nonFraction unitRef="state" contextRef="i6fb31abf3cd3486d8d73aaca15da3160_I20211231" decimals="INF" name="vtrs:Numberofstates" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzk2NTE_af642830-36b7-4988-b9fd-780a1d7ba3e0">forty-seven</ix:nonFraction> states, the District of Columbia and the Commonwealth of Puerto Rico. The Company is alleged to have engaged in anticompetitive conduct with respect to four generic drug products. The amended complaint also includes claims asserted by attorneys general of <ix:nonFraction unitRef="state" contextRef="i1370ea34e27342908b81e9cd1ce42f04_I20211231" decimals="INF" name="vtrs:Numberofstates" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzk5MTA_01002c21-780c-4dcb-a181-2f3d458beade">thirty-seven</ix:nonFraction> states and the Commonwealth of Puerto Rico against certain individuals, including the Company&#8217;s President, with respect to a single drug product. The amended complaint seeks declaratory and injunctive relief, disgorgement, attorneys&#8217; fees and costs, and certain states seek monetary damages, civil penalties, and restitution.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 10, 2019, certain attorneys general filed a new complaint in the United States District Court for the District of Connecticut against various drug manufacturers and individuals, including the Company and one of its sales employees, alleging anticompetitive conduct with respect to additional generic drugs. On November 1, 2019, the complaint was amended, adding additional states as plaintiffs. The operative complaint is brought by attorneys general of <ix:nonFraction unitRef="state" contextRef="i9b8d7536128a476ab103cb2abe72db8f_I20211231" decimals="INF" name="vtrs:Numberofstates" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzEwNzAw_dc892f10-9a8d-4974-9c00-6d599211362b">forty-eight</ix:nonFraction> states, certain territories and the District of Columbia. The amended complaint also includes claims asserted by attorneys general of <ix:nonFraction unitRef="state" contextRef="i34298ab2efbf46afb7c78ba25e12f901_I20211231" decimals="INF" name="vtrs:Numberofstates" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzEwODM3_89c3191f-7b44-4393-8b19-2ff9622dfb69">forty-three</ix:nonFraction> states and certain territories against several individuals, including a Company sales employee. The amended complaint seeks declaratory and injunctive relief, disgorgement, attorneys&#8217; fees and costs, and certain states seek monetary damages, civil penalties, and restitution. This lawsuit has been transferred to the aforementioned MDL proceeding in the EDPA. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 10, 2020, certain attorneys general filed a new complaint in the United States District Court for the District of Connecticut against drug manufacturers, including the Company, and individual defendants (none from the Company), alleging anticompetitive conduct with respect to additional generic drugs. On September 9, 2021, the complaint was amended, adding an additional state as a plaintiff. The operative complaint is brought by attorneys general of <ix:nonFraction unitRef="state" contextRef="i6fb31abf3cd3486d8d73aaca15da3160_I20211231" decimals="INF" name="vtrs:Numberofstates" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzEwOTk1MTE2NzU1MjY_6be630ca-f5b1-43c1-96e2-7eaa04992506">forty-seven</ix:nonFraction> states, certain territories and the District of Columbia. The amended complaint seeks declaratory and injunctive relief, disgorgement, attorneys&#8217; fees and costs, and certain states seek monetary damages, civil penalties, and restitution. This lawsuit has been transferred to the aforementioned MDL proceeding in the EDPA and has been ordered to proceed as a bellwether.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Securities Related Litigation</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purported class action complaints were filed in October 2016 against Mylan N.V. and Mylan Inc. (collectively &#8220;Mylan&#8221;), certain of Mylan&#8217;s former directors and officers, and certain of the Company&#8217;s current directors and officers (collectively, for purposes of this paragraph, the &#8220;defendants&#8221;) in the United States District Court for the Southern District of New York (&#8220;SDNY&#8221;) on behalf of certain purchasers of securities of Mylan on the NASDAQ. The complaints alleged that defendants made false or misleading statements and omissions of purportedly material fact, in violation of federal securities laws, in connection with disclosures relating to the classification of their EpiPen&#174; Auto-Injector as a non-innovator drug for purposes of the Medicaid Drug Rebate Program.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 20, 2017, a consolidated amended complaint was filed alleging substantially similar claims, but adding allegations that defendants made false or misleading statements and omissions of purportedly material fact in connection with allegedly anticompetitive conduct with respect to EpiPen&#174; Auto-Injector and certain generic drugs.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operative complaint is the third amended consolidated complaint, which was filed on June 17, 2019, and contains the allegations as described above against Mylan, certain of Mylan&#8217;s former directors and officers, and certain of the Company&#8217;s current directors, officers, and employees (collectively, for purposes of this paragraph, the &#8220;defendants&#8221;).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A class has been certified covering all persons or entities that purchased Mylan common stock between February 21, 2012 and May 24, 2019 excluding defendants, certain of the Company&#8217;s current directors and officers, former directors and officers of Mylan, members of their immediate families and their legal representatives, heirs, successors or assigns, and any entity in which defendants have or had a controlling interest. Plaintiffs seek damages and costs and expenses, including attorneys&#8217; fees and expert costs. A decision on Defendants&#8217; motion for summary judgment seeking to dismiss the case in its entirety and Plaintiffs&#8217; cross-motion for partial summary judgment as to portions of certain claims is pending. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">142</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 30, 2017, a similar lawsuit was filed in the Tel Aviv District Court (Economic Division) in Israel, which has been stayed pending a decision in the SDNY class action litigation.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 14, 2020, the Abu Dhabi Investment Authority filed a complaint against Mylan in the SDNY asserting allegations pertaining to EpiPen&#174; Auto-Injector and certain generic drugs under the federal securities laws that overlap with those asserted in the third amended complaint identified above. The Abu Dhabi Investment Authority&#8217;s complaint seeks monetary damages as well as the plaintiff&#8217;s fees and costs. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 26, 2019, MYL Litigation Recovery I LLC (&#8220;MYL Plaintiff&#8221;) (an assignee of entities that purportedly purchased stock of Mylan N.V.) filed an additional complaint in the SDNY against Mylan, certain of Mylan&#8217;s former officers and directors, and an officer of the Company asserting allegations pertaining to EpiPen&#174; Auto-Injector under the federal securities laws that overlap in part with those asserted in the third amended complaint identified above. On May 6, 2020, MYL Plaintiff filed an amended complaint including additional allegations in connection with purportedly anticompetitive conduct with respect to EpiPen&#174; Auto-Injector.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">MYL Plaintiff subsequently filed a summons on October 30, 2020, naming Mylan, certain of Mylan&#8217;s former officers and directors, and certain of the Company&#8217;s current officers, directors, and employees in New York State Court, County of New York, claiming investment losses suffered as a result of purportedly false and misleading statements in connection with allegedly anticompetitive conduct concerning generic pharmaceuticals. The parties have resolved both matters filed by MYL Plaintiff and they have been dismissed with prejudice.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 26, 2020, a putative class action complaint was filed by the Public Employees Retirement System of Mississippi, which was subsequently amended on November 13, 2020, against Mylan N.V., certain of Mylan N.V.&#8217;s former directors and officers, and an officer and director of the Company (collectively for the purposes of this paragraph, the &#8220;defendants&#8221;) in the U.S. District Court for the Western District of Pennsylvania on behalf of certain purchasers of securities of Mylan N.V. The amended complaint alleges that defendants made false or misleading statements and omissions of purportedly material fact, in violation of federal securities laws, in connection with disclosures relating to the Morgantown manufacturing plant and inspections at the plant by the FDA. Plaintiff seeks certification of a class of purchasers of Mylan N.V. securities between February 16, 2016 and May 7, 2019. The complaint seeks monetary damages, as well as the plaintiff&#8217;s fees and costs.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 15, 2021, a complaint was filed by Skandia Mutual Life Ins. Co., Lansforsakringar AB, KBC Asset Management N.V., and GIC Private Limited, against the Company, certain of Mylan N.V.&#8217;s former directors and officers, a current director and officer of the Company, and current employees of the Company. The Complaint asserts claims which are based on allegations that are similar to those in the SDNY and the Western District of Pennsylvania complaints identified above.  Plaintiffs seek compensatory damages, costs and expenses and attorneys&#8217; fees.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 28, 2021, the Company and certain of its officers and directors were named as defendants in a putative class action lawsuit filed in the Court of Common Pleas of Allegheny County, Pennsylvania on behalf of former Mylan shareholders who received Company common stock in connection with the Combination.  A non-Viatris affiliated company and persons were also named as defendants.  The complaint alleges violations of Sections 11, 12(a)(2), and 15 of the Securities Act of 1933 for purportedly failing to disclose or misrepresenting material information in the registration statement and related prospectus issued in connection with the Combination.  Plaintiffs seek monetary damages, reasonable costs and expenses, and certain other equitable and injunctive relief. </span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Opioids</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company, along with other manufacturers, distributors, pharmacies, pharmacy benefit managers, and individual healthcare providers is a defendant in more than <ix:nonFraction unitRef="case" contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231" decimals="-3" name="vtrs:Numberofcases" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzE3MzA5_61f7a15f-2702-4bae-a1ae-899fb1869edc">1,000</ix:nonFraction> cases in the United States and Canada filed by various plaintiffs, including counties, cities and other local governmental entities, asserting civil claims related to sales, marketing and/or distribution practices with respect to prescription opioid products. In addition, lawsuits have been filed as putative class actions including on behalf of children with Neonatal Abstinence Syndrome due to alleged exposure to opioids.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The lawsuits generally seek equitable relief and monetary damages (including punitive and/or exemplary damages) based on a variety of legal theories, including various statutory and/or common law claims, such as negligence, public nuisance and unjust enrichment. The vast majority of these lawsuits have been consolidated in an MDL in the U.S. District Court for the Northern District Court of Ohio.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">143</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, the Company received a subpoena from the New York Department of Financial Services as part of an industry-wide inquiry into the effect of opioid prescriptions on New York health insurance premiums. The Company is fully cooperating with this subpoena request.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">European Commission Proceedings</span></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Perindopril</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 9, 2014, the Commission issued a decision finding that the Company as well as several other companies, had violated EU competition rules relating to the product Perindopril and fined the Company approximately &#8364;<ix:nonFraction unitRef="eur" contextRef="i13c638ed56d343c18493f03648ee836f_D20140708-20140709" decimals="-5" name="us-gaap:LossContingencyDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzEwOTk1MTE2NzE1NDQ_37b18e20-2b70-47a1-9dc9-9751c172255e">17.2</ix:nonFraction> million. The Company paid approximately $<ix:nonFraction unitRef="usd" contextRef="i2fc086de1758443786ac3ba535a5b44a_D20141001-20141231" decimals="-5" name="us-gaap:LossContingencyDamagesPaidValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzEwOTk1MTE2NzE1Nzg_9fa40fcc-a8a7-4baf-9565-2680e2b78f9b">21.7</ix:nonFraction> million related to this matter during the fourth quarter of 2014. The decision was affirmed on appeal by the General Court of the EU and is now on appeal to the CJEU. The Company has received a notice from an organization representing health insurers in the Netherlands stating an intention to commence follow-on litigation and asserting monetary damages.</span></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Citalopram</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On June 19, 2013, the Commission issued a decision finding that the Company as well as several other companies, had violated EU competition rules relating to the product Citalopram and fined the Company approximately &#8364;<ix:nonFraction unitRef="eur" contextRef="i27d7d7f87c3b47c29d865299535c55cc_D20130601-20130619" decimals="-5" name="us-gaap:LossContingencyDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzEwOTk1MTE2NzE2MTI_17d89e39-babd-487f-b257-ab1b1954d5da">7.8</ix:nonFraction> million, jointly and severally with Merck KGaA. The decision was affirmed on appeal by the General Court of the EU and the CJEU. The Commission&#8217;s matter as to the Company is now closed. The Company has received notices from European NHS and health insurers stating an intention to commence follow-on litigation and asserting monetary damages. The NHS England and Wales has instituted litigation against all parties to the Commission&#8217;s decision, including the Company. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sought indemnification from Merck KGaA with respect to the &#8364;<ix:nonFraction unitRef="eur" contextRef="i27d7d7f87c3b47c29d865299535c55cc_D20130601-20130619" decimals="-5" name="us-gaap:LossContingencyDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzEwOTk1MTE2NzE2NDQ_17d89e39-babd-487f-b257-ab1b1954d5da">7.8</ix:nonFraction> million portion of the fine for which Merck KGaA and the Company were held jointly and severally liable. Merck KGaA counterclaimed against the Company seeking the same indemnification. In June 2018, the Frankfurt Regional Court issued a judgment ordering the Company to indemnify Merck KGaA with respect to the amount for which the parties were held jointly and severally liable. The parties have resolved this matter.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has accrued approximately &#8364;<ix:nonFraction unitRef="usd" contextRef="ib6585ef5edb5465980d61d05bc81776b_I20211231" decimals="-5" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzEwOTk1MTE2NzE2NzQ_45dde0d0-d3aa-4055-8bd0-207ca3888316">11.4</ix:nonFraction> million as of December&#160;31, 2021 related to this matter. It is reasonably possible that we will incur additional losses above the amount accrued but we cannot estimate a range of such reasonably possible losses at this time. There are no assurances, however, that settlements reached and/or adverse judgments received, if any, will not exceed amounts accrued.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.K. Competition and Markets Authority</span></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Paroxetine</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 12, 2011, the Company received notice that the Office of Fair Trading (now the &#8220;CMA&#8221;) opened an investigation regarding possible infringement of the Competition Act 1998 and Articles 101 and 102 of the Treaty on the Functioning of the EU, with respect to alleged agreements related to Paroxetine. The CMA issued a decision on February 12, 2016, finding that the Company, Merck KGaA, and other companies were liable for infringing EU and U.K. competition rules. The CMA issued a penalty to Merck KGaA of approximately &#163;<ix:nonFraction unitRef="gbp" contextRef="i9abf215c0b25446ba1f1eee1bfce3634_D20160212-20160212" decimals="-5" name="us-gaap:LossContingencyDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzIxNDIw_a8253e87-34fe-418e-bb84-0b3efab4d05c">5.8</ix:nonFraction>&#160;million, for which the Company is jointly and severally liable for approximately &#163;<ix:nonFraction unitRef="gbp" contextRef="if4052220c0bc4de89dc871350ec90cb2_D20160212-20160212" decimals="-5" name="us-gaap:LossContingencyDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzIxNTU5_52a4e03d-aae2-4306-9e68-29a1b30654d3">2.7</ix:nonFraction>&#160;million. On appeal, the Competition Appeals Tribunal affirmed the CMA&#8217;s decision but reduced the penalty to Merck KGaA to approximately &#163;<ix:nonFraction unitRef="gbp" contextRef="i9abf215c0b25446ba1f1eee1bfce3634_D20160212-20160212" decimals="-5" name="vtrs:LossContingencyDamagesAwardedOnAppealValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzEwOTk1MTE2NzE3MjU_2237fb2d-3b38-4157-9cbe-5c312fbf81e9">3.9</ix:nonFraction>&#160;million, and reduced the amount for which the Company is jointly and severally liable to approximately &#163;<ix:nonFraction unitRef="gbp" contextRef="if4052220c0bc4de89dc871350ec90cb2_D20160212-20160212" decimals="-4" name="vtrs:LossContingencyDamagesAwardedOnAppealValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzEwOTk1MTE2NzE3Mzk_abe317e2-ecc5-4ff6-a05f-42abf9dce325">2.05</ix:nonFraction>&#160;million. The CMA&#8217;s matter as to the Company is now closed.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has also received a notice from the NHS England and Wales stating an intention to commence follow-on litigation and asserting monetary damages.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has accrued approximately &#163;<ix:nonFraction unitRef="gbp" contextRef="if54570ea2c7a42cc914556ebc926584c_I20211231" decimals="-5" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzEwOTk1MTE2NzE3ODA_4ff4b53f-3252-4824-8862-541b58e3e9d7">8.8</ix:nonFraction> million as of December&#160;31, 2021 related to this matter. It is reasonably possible that the Company will incur additional losses above the amount accrued but we cannot estimate a range of such reasonably possible losses at this time. There are no assurances, however, that settlements reached and/or adverse judgments received, if any, will not exceed amounts accrued.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">144</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Liability</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Like other pharmaceutical companies, the Company is involved in a number of product liability lawsuits related to alleged personal injuries arising out of certain products manufactured/or distributed by the Company, including but not limited to those discussed below. Plaintiffs in these cases generally seek damages and other relief on various grounds for alleged personal injury and economic loss.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has accrued approximately $<ix:nonFraction unitRef="usd" contextRef="i42721f7bfaa74a20b33b1b57026a7ec6_I20211231" decimals="-5" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzEwOTk1MTE2NzE4MzM_247b6ef9-f502-48f1-9975-7e5bbb857e5a">74.8</ix:nonFraction> million as of December&#160;31, 2021 for its product liability matters. It is reasonably possible that we will incur additional losses and fees above the amount accrued but we cannot estimate a range of such reasonably possible losses or legal fees related to these claims at this time. There are no assurances, however, that settlements reached and/or adverse judgments received, if any, will not exceed amounts accrued.</span></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nitrosamines</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company, along with numerous other manufacturers, retailers, and others, are parties to litigation relating to alleged trace amounts of nitrosamine impurities in certain products, including valsartan and ranitidine. The vast majority of these lawsuits in the United States are pending in two MDLs, namely an MDL pending in the United States District Court for the District of New Jersey concerning valsartan and an MDL pending in the United States District Court for the Southern District of Florida concerning ranitidine. The lawsuits against the Company in the MDLs include putative class actions seeking the refund of the purchase price and other economic and punitive damages allegedly sustained by consumers and end payors as well as individuals seeking compensatory and punitive damages for personal injuries allegedly caused by ingestion of the medications. Similar lawsuits pertaining to valsartan have been filed in other countries. The Company has also received claims and inquiries related to these products, as well as requests to indemnify purchasers of the Company&#8217;s API and/ or finished dose forms of these products. The original master complaints concerning ranitidine were dismissed on December 31, 2020. The Company was not named as a defendant in the amended master complaints, though it was still named in certain short form personal injury complaints. The end-payor plaintiffs and certain of the plaintiffs named in the short form personal injury complaints in the ranitidine matter have filed appeals to the U.S. Court of Appeals for the Eleventh Circuit. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lipitor</span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A number of individual and multi-plaintiff lawsuits have been filed against Pfizer in various federal and state courts alleging that the plaintiffs developed type 2 diabetes purportedly as a result of the ingestion of Lipitor. Plaintiffs seek compensatory and punitive damages. In February 2014, the federal actions were transferred for consolidated pre-trial proceedings to an MDL in the U.S. District Court for the District of South Carolina. Since 2016, certain cases in the MDL were remanded to certain state courts. In 2017, the District Court granted Pfizer&#8217;s motion for summary judgment, dismissing all of the cases pending in the MDL. In June 2018, this dismissal was affirmed by the U.S. Court of Appeals for the Fourth Circuit. The state court proceedings remain pending in various jurisdictions, including in California, Missouri, and New York. On January 27, 2021, the California Court granted Pfizer&#8217;s motion to exclude the opinions of plaintiffs&#8217; only general causation expert in connection with his opinions involving the three lowest doses of Lipitor (10, 20 and 40 mg). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s motion for summary judgment in connection with the 10, 20, and 40 mg plaintiffs was granted, resulting in their dismissal. On November 3, 2021, the Court granted the Company&#8217;s motion seeking the dismissal of the remaining cases involving the highest dose of Lipitor (80 mg).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Viagra</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since April 2016, an MDL has been pending in the U.S. District Court for the Northern District of California</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:line-through">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in which plaintiffs allege that they developed melanoma and/or the exacerbation of melanoma purportedly as a result of the ingestion of Viagra. Additional cases filed against Eli Lilly and Company (&#8220;Lilly&#8221;) with respect to Cialis have also been consolidated in the MDL. Plaintiffs seek compensatory and punitive damages. In January 2020, the District Court granted Pfizer&#8217;s and Lilly&#8217;s motion to exclude all of plaintiffs&#8217; general causation opinions. As a result, in April 2020, the District Court entered summary judgment in favor of defendants and dismissed all of plaintiffs&#8217; claims. In April 2020, plaintiffs filed a notice of appeal in the U.S. Court of Appeals for the Ninth Circuit. The parties have reached a settlement in principle.</span></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dilantin</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since 2018, a number of individual and multi-plaintiff lawsuits have been filed against Pfizer and related entities in various federal and state courts, alleging that the plaintiffs developed cerebellar atrophy as a result of the ingestion of Dilantin. Plaintiffs seek compensatory and punitive damages. The parties have resolved this matter.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">145</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intellectual Property</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved in a number of patent litigation lawsuits involving the validity and/or infringement of patents held by branded pharmaceutical manufacturers including but not limited to the matters described below.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses its business judgment to decide to market and sell certain products, in each case based on its belief that the applicable patents are invalid and/or that its products do not infringe, notwithstanding the fact that allegations of patent infringement(s) or other potential third party rights have not been finally resolved by the courts. The risk involved in doing so can be substantial because the remedies available to the owner of a patent for infringement may include, a reasonable royalty on sales or damages measured by the profits lost by the patent owner. If there is a finding of willful infringement, damages may be increased up to <ix:nonFraction unitRef="increase" contextRef="i3ab3ba0c16f64666aae7af1ec4b0cb80_D20210101-20211231" decimals="INF" name="vtrs:NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzI3OTk5_f178c4eb-f028-4eb7-8d5b-3f3726179f3d">three</ix:nonFraction> times. Moreover, because of the discount pricing typically involved with bioequivalent products, patented branded products generally realize a substantially higher profit margin than generic and biosimilar products. The Company also faces challenges to its patents, including suits in various jurisdictions pursuant to which generic drug manufacturers, payers, governments, or other parties are seeking damages for allegedly causing delay of generic entry. An adverse decision in any of these matters could have an adverse effect that is material to our business, financial condition, results of operations, cash flows, ability to pay dividends and/or stock price.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has accrued approximately $<ix:nonFraction unitRef="usd" contextRef="i3ab3ba0c16f64666aae7af1ec4b0cb80_D20210101-20211231" decimals="-5" name="us-gaap:LossContingencyDamagesPaidValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzEwOTk1MTE2NzE4ODc_e5086076-5d9c-4f0d-88fe-64c7097934e4">226.9</ix:nonFraction> million as of December&#160;31, 2021 for its intellectual property matters. It is reasonably possible that we will incur additional losses and fees above the amount accrued but we cannot estimate a range of such reasonably possible losses or legal fees related to these claims at this time. There are no assurances, however, that settlements reached and/or adverse judgments received, if any, will not exceed amounts accrued.</span></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Insulin Glargine</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 24, 2017, Sanofi and affiliated entities (collectively for the purposes of this section, &#8220;Sanofi&#8221;), sued Mylan GmbH and other Mylan entities in the U.S. District Court for the District of New Jersey asserting that Mylan GmbH&#8217;s new drug application for insulin glargine injection 100 Units/mL vials and prefilled injection pens (SEMGLEE</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">vial and pens) infringed <ix:nonFraction unitRef="patent" contextRef="i2c861875a03848f989ff86d891f1a81c_D20171024-20171024" decimals="INF" name="us-gaap:LossContingencyPatentsAllegedlyInfringedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzI5NTEw_62d5062d-2fc2-4aca-ad5c-70beec71ff72">18</ix:nonFraction> U.S. patents. 2 of the <ix:nonFraction unitRef="patent" contextRef="i2c861875a03848f989ff86d891f1a81c_D20171024-20171024" decimals="INF" name="us-gaap:LossContingencyPatentsAllegedlyInfringedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzI5NTM3_eb4fdd72-64dd-493d-b990-1f678aa460f5">18</ix:nonFraction> patents covered the insulin glargine formulation. Both of these patents have been held invalid and all appeals have concluded. These <ix:nonFraction unitRef="patent" contextRef="i6531f624fba049f9a437e4af1aa3247a_I20171024" decimals="INF" name="vtrs:LossContingencyRemainingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzI5Njcz_b6557489-8805-40e7-8278-671a51a92129">two</ix:nonFraction> patents were the only patents asserted against the SEMGLEE</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> vial product.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The <ix:nonFraction unitRef="patent" contextRef="i3c7914355ab94f1e9bb9a332a6d51ac5_I20190617" decimals="INF" name="vtrs:LossContingencyOtherAssertedPatentsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzI5NzU0_78914d15-9101-4435-bf2a-d4825ac0d391">16</ix:nonFraction> other asserted patents relate to a pen injection device (&#8220;device patents&#8221;) and were asserted only against the SEMGLEE</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">pen injection device. Prior to trial, Sanofi dismissed <ix:nonFraction unitRef="agreement" contextRef="i13e9207c6fef454e969d51bd9b9e9635_D20190617-20190617" decimals="INF" name="us-gaap:LossContingencyPatentsFoundNotInfringedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzI5OTMx_5ae73c31-4496-40fd-bb01-2fa634b6aefe">12</ix:nonFraction> of those device patents from the case and granted the Company a covenant not to sue with respect to them. On June 17, 2019, following the District Court&#8217;s claim construction order, the District Court entered judgment of non-infringement with respect to the asserted claims of <ix:nonFraction unitRef="patent" contextRef="i13e9207c6fef454e969d51bd9b9e9635_D20190617-20190617" decimals="INF" name="us-gaap:LossContingencyPatentsFoundNotInfringedNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzMwMjEw_80c14001-d184-48c2-b183-1c3ec7b9b648">three</ix:nonFraction> of the <ix:nonFraction unitRef="patent" contextRef="i3c7914355ab94f1e9bb9a332a6d51ac5_I20190617" decimals="INF" name="vtrs:LossContingencyRemainingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzMwMjIw_c232ffd2-61fa-4f35-a99b-49bb3717d76f">four</ix:nonFraction> remaining device patents (U.S. Patent Numbers 8,603,044, 8,679,069, 8,992,486).</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Only one device patent remained for trial (U.S. Patent Number 9,526,844). On March 9, 2020, the District Court issued an opinion after trial finding all asserted claims of the &#8216;844 patent not infringed and invalid for lack of written description. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 10, 2018, Mylan Pharmaceuticals Inc. (&#8220;MPI&#8221;) filed IPR petitions challenging <ix:nonFraction unitRef="patent" contextRef="i368a17b2f56f4f73a262f1f28352eca3_D20180910-20180910" decimals="INF" name="us-gaap:LossContingencyPatentsAllegedlyInfringedNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzMwNjY4_542b6657-14e6-4d70-afdb-514ae4af8068">five</ix:nonFraction> device patents (the &#8216;844, &#8216;044, &#8216;069, &#8216;486, and &#8216;008 patents). On April 2, 2020 and May 29, 2020, the PTAB issued final written decisions in the IPR proceedings finding all challenged claims unpatentable except for <ix:nonFraction unitRef="patent" contextRef="i7341b8c6cd5240ccad4baad654635cb8_I20200402" decimals="INF" name="vtrs:LossContingencyRemainingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzMwODg2_16aa4ae4-5b78-498f-bbb3-8d6da51a7cca">two</ix:nonFraction> claims of the &#8216;008 patent for which Sanofi granted the Company a covenant not to sue as described above. On appeal, the Federal Circuit affirmed the PTAB&#8217;s decisions finding the challenged patents unpatentable, including the &#8216;844 patent, and dismissed Sanofi&#8217;s appeal of the District Court decision as moot.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 26, 2021, the PTAB issued a final written decision in an IPR proceeding in which MPI challenged an additional Sanofi device patent (U.S. Patent Number RE47,614) and found all challenged claims unpatentable. Sanofi&#8217;s appeal is pending.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 11, 2020, the FDA approved the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SEMGLEE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> vial and pen products, which MPI began selling on August 31, 2020.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">146</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dimethyl Fumarate</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 30, 2017, Biogen MA Inc. and Biogen International GmbH (collectively, &#8220;Biogen&#8221;) sued MPI in the U.S. District Court for the Northern District of West Virginia asserting that MPI&#8217;s abbreviated new drug application for dimethyl fumarate delayed-release capsules containing 120 mg and 240 mg of dimethyl fumarate (generic for Tecfidera</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) infringed <ix:nonFraction unitRef="patent" contextRef="i9357aa4ee46c43e4a8bacdddc6635174_D20170630-20170630" decimals="INF" name="us-gaap:LossContingencyPatentsAllegedlyInfringedNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzMxNTI5_368121ff-f3a4-4290-9e69-b0064108bc93">six</ix:nonFraction> U.S. patents that Biogen had listed in the Orange Book: 6,509,376, 7,320,999, 7,619,001, 7,803,840, 8,759,393, and 8,399,514. All patents except for the &#8216;514 expired during the litigation and were dismissed from the case.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After a trial involving only the &#8217;514 patent on June 18, 2020, the District Court issued a judgment finding all claims of the &#8217;514 patent invalid for lack of adequate written description. On appeal, the Federal Circuit affirmed the District Court&#8217;s judgment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Biogen has filed a petition for rehearing.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 13, 2018, MPI filed an IPR petition challenging the &#8217;514 patent based only on obviousness. On February 5, 2020, the PTAB issued a final written decision finding the claims not obvious. MPI&#8217;s appeal was denied as moot in light of the above-described Federal Circuit decision affirming the District Court&#8217;s invalidity judgment.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 17, 2020, the FDA approved</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MPI&#8217;s dimethyl fumarate delayed-release capsules, which MPI began selling on August 18, 2020.</span></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lyrica - United Kingdom</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in 2014, Pfizer was involved in patent litigation in the English courts concerning the validity of its Lyrica pain use patent. In 2015, the High Court of Justice in London ordered that the NHS England issue guidance for prescribers and pharmacists directing the prescription and dispensing of Lyrica by brand when pregabalin was prescribed for the treatment of neuropathic pain and entered a preliminary injunction against certain Sandoz group companies preventing the sale of Sandoz&#8217;s full label pregabalin product.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pfizer undertook to compensate certain generic companies and NHS entities for losses caused by these orders, which remained in effect until patent expiration in July 2017. In November 2018, the U.K. Supreme Court ruled that all the relevant claims directed to neuropathic pain were invalid. </span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dr. Reddy&#8217;s Laboratories filed a claim for monetary damages, interest, and costs in May 2020, followed by the Scottish Ministers and fourteen Scottish Health Boards (together, NHS Scotland) in July 2020. In September 2020, Teva, Sandoz, Ranbaxy, Actavis, and the Secretary of State for Health and Social Care, together with 32 other NHS entities (together, NHS England, Wales, Scotland and Northern Ireland) filed their claims. T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he claims filed by Sandoz, Teva, Actavis, and Ranbaxy have been resolved. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lyrica - Canada </span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2014, Pharmascience Inc. (&#8220;PMS&#8221;) commenced an action against Pfizer Canada Inc., Warner-Lambert Company and Warner-Lambert Company LLC (the Pfizer Canada Defendants) seeking damages in connection with an earlier unsuccessful patent litigation brought by the Pfizer Canada Defendants involving pregabalin.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> PMS claimed lost profit damages from November 30, 2010, the date it received tentative regulatory approval for its pregabalin product, to February 13, 2013, the date Pfizer&#8217;s patent case against PMS was dismissed. The parties have resolved the matter.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Litigation</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved in various other legal proceedings including commercial, contractual, employment, or other similar matters that are considered normal to its business. The Company has approximately $<ix:nonFraction unitRef="usd" contextRef="i03c3c6915b9e41e286944ec9d4c597df_I20211231" decimals="-5" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzEwOTk1MTE2NzE5NDM_7fd94a95-6ba2-40b6-bea2-ab4b53a1c375">8.4</ix:nonFraction> million accrued related to these various other legal proceedings at December&#160;31, 2021.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">147</span></div></div></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_250"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:17.36pt">Changes in and Disagreements with Accountants on Accounting and Financial Disclosures</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_253"></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9A.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.14pt">Controls and Procedures</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An evaluation was performed under the supervision and with the participation of the Company&#8217;s management, including the Principal Executive Officer and the Principal Financial Officer, of the effectiveness of the design and operation of the Company&#8217;s disclosure controls and procedures as of December&#160;31, 2021. Based upon that evaluation, the Principal Executive Officer and the Principal Financial Officer concluded that the Company&#8217;s disclosure controls and procedures were effective. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the quarter ended December&#160;31, 2021, the Company continued to transition certain support services from Pfizer, as well as certain subsidiaries, to a new ERP system. The Company has modified and will continue to modify its internal controls relating to its business and financial processes throughout the transition period, which is expected through the end of calendar year 2022. While the Company believes that this new system and the related changes to internal controls will ultimately strengthen its internal control over financial reporting, there are inherent risks in implementing any new ERP system and the Company has evaluated and tested control changes in order to provide Management&#8217;s Report on Internal Control over Financial Reporting for the year ended December&#160;31, 2021.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s Report on Internal Control over Financial Reporting is on page&#160;79, which is incorporated herein by reference. The effectiveness of the Company&#8217;s internal control over financial reporting as of December&#160;31, 2021 has been audited by Deloitte&#160;&amp; Touche LLP (PCAOB ID No. 34), an independent registered public accounting firm, as stated in their report on page&#160;83, which is incorporated herein by reference.</span></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_256"></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9B.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.7pt">Other Information</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_1099511630180"></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9C.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.14pt">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">148</span></div></div></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_259"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART&#160;III</span></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_262"></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 10.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:12.36pt">Directors, Executive Officers and Corporate Governance</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain information required by this Item will be provided in an amendment to this Annual Report on Form 10-K in accordance with General Instruction G(3) to Form 10-K.</span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Code of Ethics</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Viatris board of directors has adopted a Code of Ethics for the Company&#8217;s Chief Executive Officer, Chief Financial Officer and Controller. The Viatris board of directors also has adopted a Code of Business Conduct and Ethics applicable to all directors, officers, and employees. The Code of Ethics for our Chief Executive Officer, Chief Financial Officer and Controller and the Code of Business Conduct and Ethics are posted on Viatris&#8217; website at http://www.viatris.com/en/About-Us/Corporate-Governance, and Viatris intends to post any amendments to and waivers from each of the Code of Ethics for the Company&#8217;s Chief Executive Officer, Chief Financial Officer and Controller and the Code of Business Conduct and Ethics that are required to be disclosed on that website.</span></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_265"></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 11.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:12.36pt">Executive Compensation</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item will be provided in an amendment to this Annual Report on Form 10-K in accordance with General Instruction G(3) to Form 10-K.</span></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_268"></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 12.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:12.36pt">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The additional information required by this Item will be provided in an amendment to this Form 10-K in accordance with General Instruction G(3) to Form 10-K.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity Compensation Plan Information</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows information about the securities authorized for issuance under Viatris&#8217; equity compensation plans as of December&#160;31, 2021:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:34.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.458%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.368%"></td><td style="width:0.1%"></td></tr><tr style="height:48pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of&#160;Securities&#160;to&#160;be<br/>Issued upon Exercise of<br/>Outstanding Options,<br/>Warrants and Rights<br/>(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Exercise<br/>Price of Outstanding<br/>Options, Warrants and<br/>Rights<br/>(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Securities<br/>Remaining Available for<br/>Future Issuance Under<br/>Equity Compensation Plans<br/>(excluding&#160;securities&#160;reflected<br/>in column (a))<br/>(c)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Plan Category</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation plans approved by security holders</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,434,618&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.60&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,591,643&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation plans not approved by security holders</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,434,618&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.60&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,591,643&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_271"></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 13.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:12.36pt">Certain Relationships and Related Transactions, and Director Independence</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item&#160;will be provided in an amendment to this Annual Report on Form 10-K in accordance with General Instruction G(3) to Form 10-K.</span></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_274"></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 14.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:12.36pt">Principal Accounting Fees and Services</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item&#160;will be provided in an amendment to this Annual Report on Form 10-K in accordance with General Instruction G(3) to Form 10-K.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">149</span></div></div></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_277"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART&#160;IV</span></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_280"></div><div style="-sec-extract:summary;margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 15.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:12.36pt">Exhibits, Consolidated Financial Statement Schedules </span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Consolidated Financial Statements</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Consolidated Financial Statements listed in the Index to Consolidated Financial Statements are filed as part of this Form.</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Consolidated Financial Statement Schedules</span></div><ix:nonNumeric contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231" name="srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90ZXh0cmVnaW9uOjJiNGM3N2UwNDk2ZjRkNzM5NDcwY2U4MDk1ZGQ5NzdkXzQ4OA_68ee70a4-f46e-42ae-9be3-c2a4387fea83" escape="true"><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE&#160;II&#160;&#8212; VALUATION AND QUALIFYING ACCOUNTS</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">(In millions)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.578%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Beginning<br/>Balance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additions Charged to Costs and Expenses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additions Charged to Other<br/>Accounts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deductions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ending<br/>Balance</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2021</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aaae8d197ef43d0880965d47a937ced_I20201231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzItMS0xLTEtMzE0MjI_8463cf5d-914d-4da5-93d4-eb2ba58003f0">159.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaab369eeea042ca842eb8d98bec6dfb_D20210101-20211231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzItMy0xLTEtMzE0MjI_e5e182fb-5e85-4c6b-a8ed-679bf8565036">16.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaab369eeea042ca842eb8d98bec6dfb_D20210101-20211231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzItNS0xLTEtMzE0MjI_5a90536c-1072-4da5-893d-ab7918200f14">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idaab369eeea042ca842eb8d98bec6dfb_D20210101-20211231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzItNy0xLTEtMzE0MjI_43a544cc-a1a5-43d0-9991-22b0e99c3302">21.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic23fe954f12a4fafb334644ca65a1579_I20211231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzItOS0xLTEtMzE0MjI_a63546b3-9446-4928-a5b8-55ca953e804b">154.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91018ff0be4748fdb394a71a73560ff1_I20191231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzMtMS0xLTEtMzE0MjI_a27fd80d-c9bb-49c1-986b-151470bb8159">72.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i166cc270ce584702a76fe3b6fb475148_D20200101-20201231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzMtMy0xLTEtMzE0MjI_7de01b11-d4c1-47f8-9142-b9c51628fbc7">16.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i166cc270ce584702a76fe3b6fb475148_D20200101-20201231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzMtNS0xLTEtMzE0MjI_4b862aa8-f579-4576-8091-21bae3642471">77.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i166cc270ce584702a76fe3b6fb475148_D20200101-20201231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzMtNy0xLTEtMzE0MjI_98bc0ff0-204c-42b7-890d-2d9c8e490c48">7.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aaae8d197ef43d0880965d47a937ced_I20201231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzMtOS0xLTEtMzE0MjI_3df7413c-f864-440d-a949-ad20423c8f45">159.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2019</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic453dbe2bf5946b286bdd9f5cb841293_I20181231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzQtMS0xLTEtMzE0MjI_e7718e94-379c-47fa-9ea8-96ee1f42f561">98.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia516f232fddf46f39a2dbdf6d82abbc9_D20190101-20191231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzQtMy0xLTEtMzE0MjI_35d21351-f337-468a-9dee-3f4f31307a8d">14.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia516f232fddf46f39a2dbdf6d82abbc9_D20190101-20191231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzQtNS0xLTEtMzE0MjI_43be7b7e-3886-463a-aa54-e9fa798513b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia516f232fddf46f39a2dbdf6d82abbc9_D20190101-20191231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzQtNy0xLTEtMzE0MjI_9d3cddbf-9ef5-4a64-a63e-92c9a92e0196">39.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91018ff0be4748fdb394a71a73560ff1_I20191231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzQtOS0xLTEtMzE0MjI_bbb45cd6-291a-4693-abd3-9d30a4eed3b4">72.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance for deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2021</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450c01c12e2d40dcadab0111243d7980_I20201231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzYtMS0xLTEtMzE0MjI_566dd4b5-512f-4ba7-a23a-d445076e4dbb">443.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie71711028fa94d6fb804d5ada3c39b46_D20210101-20211231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzYtMy0xLTEtMzE0MjI_d633ac8c-fd33-43c7-af48-9f6d66f1c791">82.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie71711028fa94d6fb804d5ada3c39b46_D20210101-20211231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzYtNS0xLTEtMzE0MjI_51011acb-9e0d-4496-bacf-e40d3a0b186d">260.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie71711028fa94d6fb804d5ada3c39b46_D20210101-20211231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzYtNy0xLTEtMzE0MjI_e928faa5-c674-4e71-9998-ba1914b3ee0b">6.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i431eb8d7201c49618c010a346ae6a384_I20211231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzYtOS0xLTEtMzE0MjI_9a34d336-3206-49b9-a69f-795ad7d2eabf">780.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c9701f467284632ac6d7745e16a0f7d_I20191231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzctMS0xLTEtMzE0MjI_8c6c2ffb-bbcc-437d-a931-7513608d10d7">603.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb67bdbafd2140308ea8ef185a517da0_D20200101-20201231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzctMy0xLTEtMzE0MjI_89783f8c-bde9-479b-8bfb-daac6973b23a">39.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb67bdbafd2140308ea8ef185a517da0_D20200101-20201231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzctNS0xLTEtMzE0MjI_c30486f8-de66-4096-a319-db5ae4383b5f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb67bdbafd2140308ea8ef185a517da0_D20200101-20201231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzctNy0xLTEtMzE0MjI_be782e63-4d28-490a-b798-cd22b2433295">198.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450c01c12e2d40dcadab0111243d7980_I20201231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzctOS0xLTEtMzE0MjI_566dd4b5-512f-4ba7-a23a-d445076e4dbb">443.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2019</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebbc9cdf0d824f2db02b60856d24cfa2_I20181231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzgtMS0xLTEtMzE0MjI_d044f6f5-0c9c-4ede-8f3f-a70ffb86c47b">806.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i816570cccc0745fcb3c38ba989d87af4_D20190101-20191231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzgtMy0xLTEtMzE0MjI_50b17804-3131-4ac0-ac7a-26eaad0ddc39">36.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i816570cccc0745fcb3c38ba989d87af4_D20190101-20191231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzgtNS0xLTEtMzE0MjI_f3dfec5c-f9cd-42de-a48f-95ec4ca2a17c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i816570cccc0745fcb3c38ba989d87af4_D20190101-20191231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzgtNy0xLTEtMzE0MjI_5ed02768-d130-4ebd-a9ad-0813fb03c2e1">239.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c9701f467284632ac6d7745e16a0f7d_I20191231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzgtOS0xLTEtMzE0MjI_3af063d9-47ce-4552-8c0d-8fb90578f81f">603.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________&#160;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">These amounts include opening balances of the Upjohn Business acquired in the Combination.</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Exhibits   </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"></td><td style="width:7.798%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.062%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000119312520212083/d159300dex991.htm#toc781435_29">2.1(a)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business Combination Agreement, dated as of July&#160;29, 2019, by and among Pfizer Inc., Upjohn Inc., Utah Acquisition Sub Inc.,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Mylan N.V., </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mylan I B.V. and Mylan II B.V., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">included as Annex A to the Information Statement included as Exhibit 99.1 to the Report on Form 8-K filed by Upjohn Inc. with the SEC on August 6, 2020, and incorporated herein by reference.</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#94;</span></div><div><span><br/></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000119312520157465/d904458dex21.htm">2.1(b)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Amendment No. 1, dated as of May 29, 2020, to the Business Combination Agreement, dated as of July 29, 2019, by and among Pfizer Inc., Upjohn Inc., Utah Acquisition Sub Inc., Mylan N.V., Mylan I B.V. and Mylan II B.V., included as Annex B to the Information Statement </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">included as Exhibit </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">99.1 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">to the Report on Form 8-K filed by Upjohn Inc. with the SEC on </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">August 6, 2020,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and incorporated herein by reference</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#94;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001623613/000119312519205031/d775236dex22.htm">2.2(a)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separation and Distribution Agreement, dated as of July 29, 2019, by and between Pfizer Inc. and Upjohn Inc., filed as Exhibit 2.2 to the Report on Form 8-K filed by Mylan N.V. with the SEC on July 29, 2019, and incorporated herein by reference.&#94;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001623613/000162361320000018/mylex2120200331-10q.htm">2.2(b)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Amendment No. 1, dated as of February 18, 2020, to the Separation and Distribution Agreement, dated as of July 29, 2019, by and between Pfizer Inc. and Upjohn Inc., </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">filed by Mylan N.V. as Exhibit 2.1 to the Form 10-Q </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">for the quarter ended March 31, 2020</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and incorporated herein by reference.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001623613/000119312520157416/d830428dex22.htm">2.2(c)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment No. 2, dated as of May 29, 2020, to the Separation and Distribution Agreement, dated as of July 29, 2019, by and between Pfizer Inc. and Upjohn Inc., filed as Exhibit 2.2 to the Report on Form 8-K filed by Mylan N.V. with the SEC on June 1, 2020, and incorporated herein by reference. &#94;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001792044/000119312520298226/d56774dex26.htm">2.2(d)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Amendment No. 3, dated as of September 18, 2020, to the Separation and Distribution Agreement, dated as of July 29, 2019, by and between Pfizer Inc. and Upjohn Inc., filed as Exhibit 2.6 to the Report on Form 8-K filed by Viatris Inc. with the SEC on November 19, 2020, and incorporated herein by reference. &#94;</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">150</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"></td><td style="width:7.798%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.062%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000119312520298226/d56774dex27.htm">2.2(e)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Amendment No. 4, dated as of November 15, 2020, to the Separation and Distribution Agreement, dated as of July 29, 2019, by and between Pfizer Inc. and Upjohn Inc., filed as Exhibit 2.7 to the Report on Form 8-K filed by Viatris Inc. with the SEC on November 19, 2020, and incorporated herein by reference. &#94; </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000119312520298226/d56774dex31.htm">3.1(a)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amended and Restated Certificate of Incorporation of Upjohn Inc., effective as of November 13, 2020, filed as Exhibit 3.1 to the Report on Form 8-K filed by Viatris Inc. with the SEC on November 19, 2020, and incorporated herein by reference.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000119312520298226/d56774dex33.htm">3.1(b)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Upjohn Inc., effective as of November 16, 2020, filed as Exhibit 3.3 to the Report on Form 8-K filed by Viatris Inc. with the SEC on November 19, 2020, and incorporated herein by reference. <br/></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000179204421000009/ex_32-vtrsx20201231x10k.htm">3.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Amended and Restated Bylaws of Viatris Inc., effective as of November 16, 2020, filed as Exhibit 3.2 to Form 10-K for the fiscal year ended December 31, 2020, and incorporated herein by reference.</span></div><div><span><br/></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/69499/000006949912000042/exhibit_41xindenture.htm">4.1(a)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indenture, dated December 21, 2012, between and among Mylan Inc., as issuer, the guarantors named therein, and The Bank of New York Mellon, as trustee, filed as Exhibit 4.1 to the Report on Form 8-K filed by Mylan Inc. with the SEC on December 24, 2012, and incorporated herein by reference.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1623613/000119312515068819/d882101dex44.htm">4.1(b)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Supplemental Indenture, dated February 27, 2015, between and among Mylan Inc., as issuer, Mylan N.V., as guarantor, and The Bank of New York Mellon, as trustee, to the Indenture, dated December 21, 2012, filed as Exhibit 4.4 to the Report on Form 8-K filed by Mylan N.V. with the SEC on February 27, 2015, and incorporated herein by reference.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1623613/000162361315000009/myl_ex43bx20150331-10q.htm">4.1(c)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second Supplemental Indenture, dated March 12, 2015, between and among Mylan Inc., as issuer, Mylan N.V., as parent, and The Bank of New York Mellon, as trustee, to the Indenture, dated December 21, 2012, filed by Mylan N.V. as Exhibit 4.3(b) to Form 10-Q for the quarter ended March 31, 2015, and incorporated herein by reference.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000119312520298236/d57281dex46.htm">4.1(d)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Third Supplemental Indenture dated November 16, 2020, by and among Mylan Inc., Viatris Inc., Utah Acquisition Sub Inc., Mylan II B.V. and the Bank of New York Mellon, as trustee, to the Indenture dated December 21, 2012, by and between Mylan Inc. and the Bank of New York Mellon, as trustee, filed as Exhibit 4.6 to the Report on Form 8-K/A filed by Viatris Inc. with the SEC on November 19, 2020, and incorporated herein by reference.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/69499/000110465913087739/a13-20314_5ex4d1.htm">4.2(a)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indenture, dated November 29, 2013, between Mylan Inc. and The Bank of New York Mellon, as trustee, filed as Exhibit 4.1 to the Report on Form 8-K filed by Mylan Inc. with the SEC on November 29, 2013, and incorporated herein by reference.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/69499/000110465913087739/a13-20314_5ex4d2.htm">4.2(b)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Supplemental Indenture, dated November 29, 2013, between Mylan Inc. and The Bank of New York Mellon, as trustee, filed as Exhibit 4.2 to the Report on Form 8-K filed by Mylan Inc. with the SEC on November 29, 2013, and incorporated herein by reference.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1623613/000119312515068819/d882101dex46.htm">4.2(c)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second Supplemental Indenture, dated February 27, 2015, among Mylan Inc., as issuer, Mylan N.V., as guarantor, and The Bank of New York Mellon, as trustee, to the Indenture, dated November 29, 2013, filed as Exhibit 4.6 to the Report on Form 8-K filed by Mylan N.V. with the SEC on February 27, 2015, and incorporated herein by reference. </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1623613/000162361315000009/myl_ex45bx20150331-10q.htm">4.2(d)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third Supplemental Indenture, dated March 12, 2015, between and among Mylan Inc., as issuer, Mylan N.V., as parent, and The Bank of New York Mellon, as trustee, to the Indenture, dated November 29, 2013, filed by Mylan N.V. as Exhibit 4.5(b) to Form 10-Q for the quarter ended March 31, 2015, and incorporated herein by reference.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000119312520298236/d57281dex47.htm">4.2(e)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Fourth Supplemental Indenture dated November 16, 2020, by and among Mylan Inc., Viatris Inc., Utah Acquisition Sub Inc., Mylan II B.V. and the Bank of New York Mellon, as trustee, to the Indenture dated November 29, 2013, by and between Mylan Inc. and the Bank of New York Mellon, as trustee, filed as Exhibit 4.7 to the Report on Form 8-K/A filed by Viatris Inc. with the SEC on November 19, 2020, and incorporated herein by reference. </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1623613/000119312515403822/d73153dex41.htm">4.3(a)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indenture, dated as of December 9, 2015, among Mylan N.V., as issuer, Mylan Inc., as guarantor, and The Bank of New York Mellon, as trustee, filed as Exhibit 4.1 to the Report on Form 8-K filed by Mylan N.V. with the SEC on December 15, 2015, and incorporated herein by reference.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000119312520298236/d57281dex43.htm">4.3(b)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">First Supplemental Indenture dated November 16, 2020, by and among Viatris Inc., Utah Acquisition Sub Inc., Mylan II B.V., Mylan Inc. and the Bank of New York Mellon, as trustee, to the Indenture dated December 9, 2015, by and among Mylan N.V., Mylan Inc. and the Bank of New York Mellon, as trustee, filed as Exhibit 4.3 to the Report on Form 8-K/A filed by Viatris Inc. with the SEC on November 19, 2020, and incorporated herein by reference.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1623613/000119312516622620/d207286dex41.htm">4.4(a)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indenture, dated as of June 9, 2016, among Mylan N.V., as issuer, Mylan Inc., as guarantor, and The Bank of New York Mellon, as trustee, filed as Exhibit 4.1 to the Report on Form 8-K filed by Mylan N.V. with the SEC on June 15, 2016, and incorporated herein by reference.</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">151</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"></td><td style="width:7.798%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.062%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000119312520298236/d57281dex44.htm">4.4(b)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">First Supplemental Indenture dated November 16, 2020, by and among Viatris Inc., Utah Acquisition Sub Inc., Mylan II B.V., Mylan Inc. and the Bank of New York Mellon, as trustee, to the Indenture dated June 9, 2016, by and among Mylan N.V., Mylan Inc. and the Bank of New York Mellon, as trustee, filed as Exhibit 4.4 to the Report on Form 8-K/A filed by Viatris Inc. with the SEC on November 19, 2020, and incorporated herein by reference.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1623613/000162361317000007/exhibit49.htm">4.5(a)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indenture, dated November 22, 2016, among Mylan N.V., as issuer, Mylan, Inc., as guarantor and Citibank, N.A., London Branch, as trustee, paying agent, transfer agent, registrar and calculation agent, filed by Mylan N.V. as Exhibit 4.9 to Form 10-K for the fiscal year ended December 31, 2016, and incorporated herein by reference.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000119312520298236/d57281dex45.htm">4.5(b)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Supplemental Indenture dated November 16, 2020, by and among Viatris Inc., Utah Acquisition Sub Inc., Mylan II B.V., Mylan Inc. and Citibank, N.A., London Branch, as trustee, paying agent, transfer agent, and registrar, to the Indenture dated November 22, 2016, by and among Mylan N.V., Mylan Inc. and Citibank, N.A., London Branch, as trustee, paying agent, transfer agent, registrar and calculation agent, filed as Exhibit 4.5 to the Report on Form 8-K/A filed by Viatris Inc. with the SEC on November 19, 2020, and incorporated herein by reference.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1623613/000119312518111603/d560332dex41.htm">4.6(a)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indenture, dated as of April 9, 2018, among Mylan Inc., as issuer, Mylan N.V., as guarantor, and the Bank of New York Mellon, as trustee, filed as Exhibit 4.1 to the Report on Form 8-K filed by Mylan N.V. with the SEC on April 9, 2018, and incorporated herein by reference.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000119312520298236/d57281dex48.htm">4.6(b)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">First Supplemental Indenture dated November 16, 2020, by and among Mylan Inc., Viatris Inc., Utah Acquisition Sub Inc., Mylan II B.V. and the Bank of New York Mellon, as trustee, to the Indenture dated April 9, 2018, by and among Mylan Inc., Mylan N.V. and the Bank of New York Mellon, as trustee, filed as Exhibit 4.8 to the Report on Form 8-K/A filed by Viatris Inc. with the SEC on November 19, 2020, and incorporated herein by reference. </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1623613/000119312518172116/d566535dex41.htm">4.7(a)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indenture, dated as of May 23, 2018, among Mylan Inc., as issuer, Mylan N.V., as guarantor, and Citibank, N.A., London Branch, as trustee, paying agent, transfer agent and registrar, filed as Exhibit 4.1 to the Report on Form 8-K filed by Mylan N.V. with the SEC on May 23, 2018, and incorporated herein by reference.<br/></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1792044/000119312520298236/d57281dex49.htm">4.7(b)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">First Supplemental Indenture dated November 16, 2020, by and among Mylan Inc., Viatris Inc., Utah Acquisition Sub Inc., Mylan II B.V. and Citibank, N.A., London Branch, as trustee, paying agent, transfer agent, and registrar, to the Indenture dated May 23, 2018, by and among Mylan Inc., Mylan N.V. and Citibank, N.A., London Branch, as trustee, paying agent, transfer agent, and registrar, filed as Exhibit 4.9 to the Report on Form 8-K/A filed by Viatris Inc. with the SEC on November 19, 2020, and incorporated herein by reference.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000119312520181088/d920857dex41.htm">4.8(a)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Indenture, dated as of June 22, 2020, between Upjohn Inc., as issuer, and The Bank of New York Mellon, as trustee, filed as Exhibit 4.1 to the Report on Form 8-K filed by Upjohn Inc. with the SEC on June 26, 2020, and incorporated herein by reference. </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000119312520298236/d57281dex41.htm">4.8(b)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">First Supplemental Indenture dated November 16, 2020, by and among Viatris Inc., Utah Acquisition Sub Inc., Mylan II B.V., Mylan Inc. and the Bank of New York Mellon, as trustee, to the Indenture dated June 22, 2020, by and among Viatris Inc. and the Bank of New York Mellon, as trustee, filed as Exhibit 4.1 to the Report on Form 8-K/A filed by Viatris Inc. with the SEC on November 19, 2020, and incorporated herein by reference. </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000119312520181088/d920857dex49.htm">4.9(a)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Indenture, dated as of June 23, 2020, among Upjohn Finance B.V., as issuer, Upjohn Inc., as guarantor, and Citibank, N.A., London Branch, as trustee, transfer agent, paying agent and registrar, filed as Exhibit 4.9 to the Report on Form 8-K filed by Upjohn Inc. with the SEC on June 26, 2020, and incorporated herein by reference.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000119312520298236/d57281dex42.htm">4.9(b)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">First Supplemental Indenture dated November 16, 2020, by and among Upjohn Finance B.V., Viatris Inc., Utah Acquisition Sub Inc., Mylan II B.V., Mylan Inc. and Citibank, N.A., London Branch, as trustee, paying agent, transfer agent, and registrar, to the Indenture dated June 23, 2020, by and among Upjohn Finance B.V., Viatris Inc. and Citibank, N.A., London Branch, as trustee, paying agent, transfer agent, and registrar, filed as Exhibit 4.2 to the Report on Form 8-K/A filed by Viatris Inc. with the SEC on November 19, 2020, and incorporated herein by reference. </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000179204421000009/ex_410-vtrsx20201231x10k.htm">4.10</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Description of Viatris Inc. Securities Registered Under Section 12 of the Exchange Act, filed as Exhibit 4.10 to Form 10-K for the fiscal year ended December 31, 2020, and incorporated herein by reference.</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">152</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"></td><td style="width:7.798%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.062%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000119312520167802/d781435dex101.htm">10.1(a)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Viatris Inc. 2020 Stock Incentive Plan, included as Exhibit 10.1 to Amendment No. 1 to Form 10 filed by Upjohn Inc. with the SEC on February 6, 2020, and incorporated herein by reference.*</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000179204421000009/ex_101b-vtrsx20201231x10xk.htm">10.1(b)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Form of Make-Whole Restricted Stock Unit Award Agreement under the Viatris 2020 Stock Incentive Plan, filed as Exhibit 10.1(b) to Form 10-K for the fiscal year ended December 31, 2020, and incorporated herein by reference.*</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000179204421000009/ex_101c-vtrsx20201231x10xk.htm">10.1(c)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Form of Retention Restricted Stock Unit Award Agreement under the Viatris 2020 Stock Incentive Plan, filed as Exhibit 10.1(c) to Form 10-K for the fiscal year ended December 31, 2020, and incorporated herein by reference.*</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000179204421000009/ex_101d-vtrsx20201231x10xk.htm">10.1(d)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Form of Restricted Stock Unit Award Agreement under the Viatris 2020 Stock Incentive Plan for Michael Goettler and Sanjeev Narula, filed as Exhibit 10.1(d) to Form 10-K for the fiscal year ended December 31, 2020, and incorporated herein by reference.*</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000179204421000009/ex_101e-vtrsx20201231x10xk.htm">10.1(e)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Value Creation Incentive Award Performance-Based Restricted Stock Unit Award Agreement for Robert J. Coury under the Viatris Inc. 2020 Stock Incentive Plan, effective as of November 23, 2020, filed as Exhibit 10.1(e) to Form 10-K for the fiscal year ended December 31, 2020, and incorporated herein by reference.*</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000179204421000018/ex_101xvtrsx20210331x10-q.htm">10.1(f)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Form of Restricted Stock Unit Award Agreement under the Viatris Inc. 2020 Stock Incentive Plan for awards granted on or after March 2, 2021, included as Exhibit 10.1 to Form 10-Q for the quarter ended March 31, 2021 and incorporated by reference herein.*</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000179204421000018/ex_102xvtrsx20210331x10-q.htm">10.1(g)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Form of Performance-Based Restricted Stock Unit Award Agreement under the Viatris Inc. 2020 Stock Incentive Plan for awards granted on or after March 2, 2021, included as Exhibit 10.2 to Form 10-Q for the quarter ended March </span><span style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1, 2021 and incorporated by reference herein.*</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000179204421000018/ex_103xvtrsx20210331x10-q.htm">10.1(h)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Form of Director Restricted Stock Unit Award Agreement under the Viatris Inc. 2020 Stock Incentive Plan for non-employee directors for awards granted on or after March 2, 2021, included as Exhibit 10.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> to Form 10-Q for the quarter ended March </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1, 2021 and incorporated by reference herein.*</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000179204421000009/ex_102-vtrsx20201231x10xk.htm">10.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Letter Agreement entered into on February 6, 2020 by and between Pfizer Inc. and Sanjeev Narula, filed as Exhibit 10.2 to Form 10-K for the fiscal year ended December 31, 2020, and incorporated herein by reference.*</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1792044/000179204421000009/ex_103-vtrsx20201231x10xk.htm">10.3</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Letter Agreement entered into on June 25, 2019 by and between Pfizer Inc. and Sanjeev Narula, filed as Exhibit 10.3 to Form 10-K for the fiscal year ended December 31, 2020, and incorporated herein by reference.*</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000179204421000009/ex_104-vtrsx20201231x10xk.htm">10.4</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Letter Agreement entered into on June 26, 2019 by and between Pfizer Inc. and Michael Goettler, filed as Exhibit 10.4 to Form 10-K for the fiscal year ended December 31, 2020, and incorporated herein by reference.*</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000179204421000009/ex_105-vtrsx20201231x10xk.htm">10.5</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Letter Agreement entered into on July 29, 2019 by and between Pfizer Inc. and Michael Goettler, filed as Exhibit 10.5 to Form 10-K for the fiscal year ended December 31, 2020, and incorporated herein by reference.*</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000179204421000009/ex_106-vtrsx20201231x10xk.htm">10.6</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Severance Agreement entered into on December 3, 2020 by and between Viatris Inc. and Michael Goettler, filed as Exhibit 10.6 to Form 10-K for the fiscal year ended December 31, 2020, and incorporated herein by reference.*</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000179204421000009/ex_107-vtrsx20201231x10xk.htm">10.7</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Retention Agreement entered into on December 3, 2020, by and between Viatris Inc. and Rajiv Malik, filed as Exhibit 10.7 to Form 10-K for the fiscal year ended December 31, 2020, and incorporated herein by reference.*</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000119312521145240/d113011dex101.htm">10.8</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Retention Agreement entered into on December 3, 2020, by and between Viatris Inc. and Anthony Mauro, filed as Exhibit 10.1 to Amendment No. 1 to Form 10-K for the fiscal year ended December 31, 2020, and incorporated herein by reference.*</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000179204421000009/ex_109-vtrsx20201231x10xk.htm">10.9</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Executive Employment Agreement, entered into on November 20, 2020, by and between Viatris Inc. and Robert J. Coury, filed as Exhibit 10.9 to Form 10-K for the fiscal year ended December 31, 2020, and incorporated herein by reference.*</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1623613/000119312516602386/d157810ddef14a.htm#toc157810_69">10.10(a)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mylan N.V. Amended and Restated 2003 Long-Term Incentive Plan, filed as Appendix B to Mylan N.V.&#8217;s Definitive Proxy Statement on Schedule 14A filed by Mylan N.V. with the SEC on May 25, 2016, and incorporated herein by reference.*</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">153</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"></td><td style="width:7.798%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.062%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1623613/000119312516602386/d157810ddef14a.htm#toc157810_69">10.10(b)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment to Mylan N.V. Amended and Restated 2003 Long-Term Incentive Plan, filed as Appendix B to Mylan N.V.&#8217;s Definitive Proxy Statement on Schedule 14A filed by Mylan N.V. on May 25, 2016, and incorporated herein by reference.*</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1623613/000162361317000014/exhibit101_20170331.htm">10.10(c)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment to the Mylan N.V. Amended and Restated 2003 Long-Term Incentive Plan, adopted as of February 23, 2017, filed by Mylan N.V. as Exhibit 10.1 to Form 10-Q for the quarter ended March 31, 2017, and incorporated herein by reference.*</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/69499/000006949913000044/myl_ex102x2013930-10q.htm">10.10(d)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amended and Restated Form of Stock Option Agreement under the Mylan N.V. 2003 Long-Term Incentive Plan for Robert J. Coury and Rajiv Malik, filed by Mylan Inc. as Exhibit 10.2 to Form 10-Q for the quarter ended September 30, 2013, and incorporated herein by reference.*</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/69499/000006949914000007/myl_ex104ix20131231-10k.htm">10.10(e)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amended and Restated Form of Stock Option Agreement under the Mylan N.V. 2003 Long-Term Incentive Plan for awards granted following fiscal year 2012, filed by Mylan Inc. as Exhibit 10.4(i) to Form 10-K for the fiscal year ended December 31, 2013, and incorporated herein by reference.*</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1623613/000162361316000046/myl_ex101ix20151231-10k.htm">10.10(f)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Stock Option Agreement under the Mylan N.V. 2003 Long-Term Incentive Plan for Robert J. Coury and Rajiv Malik for awards granted after February 27, 2015, filed by Mylan N.V. as Exhibit 10.1(i) to Form 10-K for the fiscal year ended December 31, 2015, and incorporated herein by reference.*</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1623613/000162361316000046/myl_ex101lx20151231-10k.htm">10.10(g)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Stock Option Agreement under the Mylan N.V. 2003 Long-Term Incentive Plan for awards granted after February 27, 2015, filed by Mylan N.V. as Exhibit 10.1(l) to Form 10-K for the fiscal year ended December 31, 2015, and incorporated herein by reference.*</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1623613/000162361318000019/myl_ex102x20180331-10q.htm">10.10(h)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Performance-Based Restricted Stock Unit Award Agreement under the Mylan N.V. 2003 Long-Term Incentive Plan for Rajiv Malik for awards granted on or after February 21, 2018, filed by Mylan N.V. as Exhibit 10.2 to Form 10-Q for the quarter ended March 31, 2018, and incorporated herein by reference.*</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1623613/000162361318000019/myl_ex103x20180331-10q.htm">10.10(i)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Performance-Based Restricted Stock Unit Award Agreement under the Mylan N.V. 2003 Long-Term Incentive Plan for awards granted on or after February 21, 2018, filed by Mylan N.V. as Exhibit 10.3 to Form 10-Q for the quarter ended March 31, 2018, and incorporated herein by reference.*<br/></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1623613/000162361319000016/myl_ex107x20190331-10xq.htm">10.10(j)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Stock Option Agreement under the Mylan N.V. 2003 Long-Term Incentive Plan for Rajiv Malik for awards granted on or after February 19, 2019, filed by Mylan N.V. as Exhibit 10.7 to Form 10-Q for the quarter ended March 31, 2019, and incorporated herein by reference.*<br/></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1623613/000162361319000016/myl_ex108x20190331-10q.htm">10.10(k)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Restricted Stock Unit Award Agreement under the Mylan N.V. 2003 Long-Term Incentive Plan for Rajiv Malik for awards granted on or after February 19, 2019, filed by Mylan N.V. as Exhibit 10.8 to Form 10-Q for the quarter ended March 31, 2019, and incorporated herein by reference.*<br/></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1623613/000162361319000016/myl_ex106x20190331-10q.htm">10.10(l)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Performance-Based Restricted Stock Unit Award Agreement under the Mylan N.V. 2003 Long-Term Incentive Plan for Rajiv Malik for awards granted on or after February 19, 2019, filed by Mylan N.V. as Exhibit 10.6 to Form 10-Q for the quarter ended March 31, 2019, and incorporated herein by reference.*<br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1623613/000162361320000018/mylex10120200331-10q.htm">10.10(m)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Form of Restricted Stock Unit Award Agreement under the Mylan N.V. 2003 Long-Term Incentive Plan for independent directors for awards granted on or after March 2, 2020, filed by Mylan N.V. as Exhibit 10.1 to Form 10-Q for the quarter ended March 31, 2020, and incorporated herein by reference.*</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1623613/000162361320000018/mylex10220200331-10q.htm">10.10(n)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Form of Stock Option Agreement under the Mylan N.V. 2003 Long-Term Incentive Plan for independent directors for awards granted on or after March 2, 2020, filed by Mylan N.V. as Exhibit 10.2 to Form 10-Q for the quarter ended March 31, 2020, and incorporated herein by reference.*</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1623613/000162361319000030/mylex10120190930-10xq.htm">10.11</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mylan N.V. Severance Plan and Global Guidelines</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, filed by Mylan N.V. as Exhibit 10.1 to Form 10-Q for the quarter ended September 30, 2019, and incorporated herein by reference.*</span></div><div><span><br/></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/69499/000095012309055689/l37693exv10w4.htm">10.12</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retirement Benefit Agreement, dated August 31, 2009, by and between Mylan Inc. and Rajiv Malik, filed by Mylan Inc. as Exhibit 10.4 to Form 10-Q for the quarter ended September 30, 2009, and incorporated herein by reference.*</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/69499/000095015208003868/l31450aexv10w5.htm">10.13(a)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transition and Succession Agreement, dated January 31, 2007, between Mylan Inc. and Rajiv Malik, filed by Mylan Inc. as Exhibit 10.5 to Form 10-Q for the quarter ended March 31, 2008, and incorporated herein by reference.*</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/69499/000095015209001668/l35088aexv10w28wb.htm">10.13(b)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment No. 1 to Transition and Succession Agreement, dated December 22, 2008, between Mylan Inc. and Rajiv Malik, filed by Mylan Inc. as Exhibit 10.28(b) to Form 10-K for the fiscal year ended December 31, 2008, and incorporated herein by reference.*</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">154</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"></td><td style="width:7.798%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.062%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/69499/000119312512187918/d327924dex105a.htm">10.14(a)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transition and Succession Agreement, dated February 25, 2008, by and between Mylan Inc. and Anthony Mauro, filed by Mylan Inc. as Exhibit 10.5(a) to Form 10-Q for the quarter ended March 31, 2012, and incorporated herein by reference.*</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/69499/000119312512187918/d327924dex105b.htm">10.14(b)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment No. 1 to Transition and Succession Agreement, dated December 15, 2008, by and between Mylan Inc. and Anthony Mauro, filed by Mylan Inc. as Exhibit 10.5(b) to Form 10-Q for the quarter ended March 31, 2012, and incorporated herein by reference.*</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/69499/000119312512187918/d327924dex105c.htm">10.14(c)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment No. 2 to Transition and Succession Agreement, dated October 15, 2009, by and between Mylan Inc. and Anthony Mauro, filed by Mylan Inc. as Exhibit 10.5(c) to Form 10-Q for the quarter ended March 31, 2012, and incorporated herein by reference.*</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/69499/000095012309070283/l38158exv10w1.htm">10.15(a)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mylan 401(k) Restoration Plan, dated January 1, 2010, filed by Mylan Inc. as Exhibit 10.1 to the Report on Form 8-K filed by Mylan Inc. with the SEC on December 14, 2009, and incorporated herein by reference.*</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/69499/000006949915000003/myl_ex1041bx20141231-10k.htm">10.15(b)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment to Mylan 401(k) Restoration Plan, dated November 4, 2014, filed by Mylan Inc. as Exhibit 10.41(b) to Form 10-K for the fiscal year ended December 31, 2014, and incorporated herein by reference.*</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/69499/000095012309070283/l38158exv10w2.htm">10.16(a)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mylan Executive Income Deferral Plan, filed by Mylan Inc. as Exhibit 10.2 to the Report on Form 8-K filed by Mylan Inc. with the SEC on December 14, 2009, and incorporated herein by reference.*</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/69499/000006949915000003/myl_ex1042bx20141231-10k.htm">10.16(b)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment to Mylan Executive Income Deferral Plan, dated November 4, 2014, filed by Mylan Inc. as Exhibit 10.42(b) to Form 10-K for the fiscal year ended December 31, 2014, and incorporated herein by reference.*</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/69499/000006949914000007/myl_ex1027bx20131232-10k.htm">10.17</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Executive Nonqualified Excess Plan Adoption Agreement, effective as of December 28, 2007, between Mylan International Holdings, Inc. and Rajiv Malik, filed by Mylan Inc. as Exhibit 10.27(b) to Form 10-K for the fiscal year ended December 31, 2013, and incorporated herein by reference.*</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/69499/000006949914000007/myl_ex1057x20131232-10k.htm">10.18</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Executive Nonqualified Excess Plan, effective as of December 28, 2007, between Mylan International Holdings, Inc. and Rajiv Malik, filed by Mylan Inc. as Exhibit 10.57 to Form 10-K for the fiscal year ended December 31, 2013, and incorporated herein by reference.*</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1623613/000162361320000018/mylex10320200331-10q.htm">10.19</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Executive Employment Agreement, entered into on April 15, 2020, by and between Mylan N.V., Mylan Inc. and Robert J. Coury, filed by Mylan N.V. as Exhibit 10.3 to Form 10-Q for the quarter ended March 31, 2020, and incorporated herein by reference.*</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1623613/000162361319000008/myl_ex1020cx20181231-10xk.htm">10.20</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third Amended and Restated Executive Employment Agreement, entered into on February 25, 2019, and effective as of April 1, 2019, by and between Mylan Inc. and Rajiv Malik, filed by Mylan N.V. as Exhibit 10.20(c) to Form 10-K for the fiscal year ended December 31, 2018, and incorporated herein by reference.*</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1623613/000162361319000008/myl_ex1021bx20181231-10xk.htm">10.21</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Employment Agreement, dated as of February 25, 2019, and effective as of April 1, 2019, by and between Mylan Inc. and Anthony Mauro, filed as Exhibit 10.21(b) to Form 10-K for the fiscal year ended December 31, 2018, and incorporated herein by reference.*<br/></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1623613/000162361316000065/myl_ex105x20160630-10q.htm">10.22</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Letter Agreement, dated June 3, 2016, among Mylan N.V., Mylan Inc., and Robert J. Coury, filed by Mylan N.V. as Exhibit 10.5 to Form 10-Q for the quarter ended June 30, 2016, and incorporated herein by reference.*</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1623613/000162361317000014/exhibit104_20170331.htm">10.23</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Waiver Letter with respect to Specified Award Agreements by and between Mylan N.V. and Rajiv Malik, February 23, 2017, filed by Mylan N.V. as Exhibit 10.4 to Form 10-Q for the quarter ended March 31, 2017, and incorporated herein by reference. *</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1623613/000162361320000011/mylex102920191231-10k.htm">10.24</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2007 Supplemental Health Insurance Plan for Certain Key Employees of Mylan Laboratories Inc., adopted as of January 29, 2007, filed by Mylan N.V. as Exhibit 10.29 to the Form 10-K for the fiscal year ended December 31, 2019 and incorporated herein by reference.*</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000179204421000009/ex_1025-vtrsx20201231x10xk.htm">10.25</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Form of Indemnification Agreement between Viatris Inc. and each of its directors and its executive officers, filed as Exhibit 10.25 to Form 10-K for the fiscal year ended December 31, 2020, and incorporated herein by reference.*</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/69499/000006949914000007/myl_ex1038x20131231-10k.htm">10.26</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amended and Restated Form of Indemnification Agreement between Mylan Inc. and each Director, filed by Mylan Inc. as Exhibit 10.38 to Form 10-K for the fiscal year ended December 31, 2013, and incorporated herein by reference.*</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">155</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"></td><td style="width:7.798%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.062%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1623613/000119312515068819/d882101dex101.htm">10.27</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Indemnification Agreement between Mylan N.V. and directors, filed as Exhibit 10.1 to the Report on Form 8-K filed by Mylan N.V. with the SEC on February 27, 2015, and incorporated herein by reference.*</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000119312520170586/d133688dex101.htm">10.28(a)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Revolving Credit Agreement, dated as of June 16, 2020, among Upjohn Inc., the guarantors from time to time party thereto, the lenders and issuing banks from time to time party thereto and Bank of America, N.A., as administrative agent, filed as Exhibit 10.1 to the Report on Form 8-K filed by Upjohn Inc. with the SEC on June 17, 2020, and incorporated herein by reference.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000119312521206477/d50384dex101.htm">10.28(b)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Amended and Restated Revolving Credit Agreement, dated as of July 1, 2021, among Viatris, the guarantors from time to time party thereto, the lenders and issuing banks from time to time party thereto and Bank of America, N.A., as administrative agent, filed as Exhibit 10.1 to the Report on Form 8-K filed by Viatris Inc. with the SEC on July 1, 2021, and incorporated herein by reference. &#94;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000119312520170586/d133688dex102.htm">10.29</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Delayed Draw Term Loan Credit Agreement, dated as of June 16, 2020, among Upjohn Inc., the guarantors from time to time party thereto, the lenders from time to time party thereto and MUFG Bank, Ltd., as administrative agent, filed as Exhibit 10.2 to the Report on Form 8-K filed by Upjohn Inc. with the SEC on June 17, 2020, and incorporated herein by reference.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000119312521206477/d50384dex102.htm">10.30</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Term Loan Credit Agreement, dated as of July 1, 2021, among Viatris, the guarantors from time to time party thereto, the lenders from time to time party thereto and Mizuho Bank, Ltd., as administrative agent, filed as Exhibit 10.2 to the Report on Form 8-K filed by Viatris Inc. with the SEC on July 1, 2021, and incorporated herein by reference. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#94;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000119312520298236/d57281dex101.htm">10.31</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Form of Dealer Agreement among Viatris Inc., Utah Acquisition Sub Inc., Mylan II B.V., Mylan Inc. and the dealer thereto, filed as Exhibit 10.1 to the Report on Form 8-K/A filed by Viatris Inc. with the SEC on November 19, 2020, and incorporated herein by reference. </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1623613/000119312517263762/d418144dex101.htm">10.32</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement Agreement with the U.S. Department of Justice and two relators finalizing the Medicaid drug rebate settlement, dated August 16, 2017, filed as Exhibit 10.1 to the Report on Form 8-K filed by Mylan N.V. with the SEC on August 21, 2017, and incorporated herein by reference.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1623613/000119312517263762/d418144dex102.htm">10.33</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate Integrity Agreement between the Office of Inspector General of the Department of Health and Human Services and Mylan Inc. and Mylan Specialty L.P., dated August 16, 2017, filed as Exhibit 10.2 to the Report on Form 8-K filed by Mylan N.V. with the SEC on August 21, 2017, and incorporated herein by reference.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000119312520181088/d920857dex48.htm">10.34</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Registration Rights Agreement, dated as of June 22, 2020, by and between Upjohn Inc. and Goldman Sachs &amp; Co. LLC, BofA Securities, Inc., Citigroup Global Markets Inc., Morgan Stanley and Co. LLC, and Mizuho Securities USA LLC, as representatives of the several initial purchasers of the U.S. Dollar Notes, filed as Exhibit 4.8 to the Report on Form 8-K filed by Upjohn Inc. with the SEC on June 26, 2020, and incorporated herein by reference.<br/></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1623613/000162361320000035/ex102myl10-q09302020.htm">10.35(a)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset Purchase Agreement, dated as of September 7, 2020, between Aspen Global Incorporated and Mylan Ireland Limited, filed by Mylan N.V. as Exhibit 10.2 to the Form 10-Q for the quarter ended September 30, 2020, and incorporated herein by reference.&#94;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000179204421000009/ex_1034b-vtrsx20201231x10xk.htm">10.35(b)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Amendment No. 1, dated as of November 5, 2020, to the Asset Purchase Agreement dated as of September 7, 2020, between Aspen Global Incorporated and Mylan Ireland Limited, filed as Exhibit 10.34(b) to Form 10-K for the fiscal year ended December 31, 2020, and incorporated herein by reference. &#94;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000119312520298226/d56774dex101.htm">10.36</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transition Services Agreement, dated as of November 16, 2020, by and between Pfizer Inc. (as Service Provider) and Upjohn Inc. (as Service Recipient), filed as Exhibit 10.1 to the Report on Form 8-K filed by Viatris Inc. with the SEC on November 19, 2020, and incorporated herein by reference. &#94;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000119312520298226/d56774dex102.htm">10.37</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transition Services Agreement, dated as of November 16, 2020, by and between Upjohn Inc. (as Service Provider) and Pfizer Inc. (as Service Recipient), filed as Exhibit 10.2 to the Report on Form 8-K filed by Viatris Inc. with the SEC on November 19, 2020, and incorporated herein by reference. &#94;</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">156</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"></td><td style="width:7.798%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.062%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000119312520298226/d56774dex103.htm">10.38</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax Matters Agreement, dated as of November 16, 2020, by and between Pfizer Inc. and Upjohn Inc., filed as Exhibit 10.3 to the Report on Form 8-K filed by Viatris Inc. with the SEC on November 19, 2020, and incorporated herein by reference. &#94;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000119312520298226/d56774dex104.htm">10.39</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee Matters Agreement, dated as of November 16, 2020, by and between Pfizer Inc. and Viatris Inc., filed as Exhibit 10.4 to the Report on Form 8-K filed by Viatris Inc. with the SEC on November 19, 2020, and incorporated herein by reference.&#94;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000119312520298226/d56774dex105.htm">10.40</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing and Supply Agreement, dated as of November 16, 2020, by and between Pfizer Inc. (as Manufacturer) and Viatris Inc. (as Customer), filed as Exhibit 10.5 to the Report on Form 8-K filed by Viatris Inc. with the SEC on November 19, 2020, and incorporated herein by reference.&#94;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000119312520298226/d56774dex106.htm">10.41</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing and Supply Agreement, dated as of November 16, 2020, by and between Viatris Inc. (as Manufacturer) and Pfizer Inc. (as Customer), filed as Exhibit 10.6 to the Report on Form 8-K filed by Viatris Inc. with the SEC on November 19, 2020, and incorporated herein by reference. &#94;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000119312520298226/d56774dex107.htm">10.42</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intellectual Property Matters Agreement, dated as of November 16, 2020, by and between Pfizer Inc. and Viatris Inc., filed as Exhibit 10.7 to the Report on Form 8-K filed by Viatris Inc. with the SEC on November 19, 2020, and incorporated herein by reference. &#94;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1792044/000119312520298226/d56774dex108.htm">10.43</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademark License Agreement, dated as of November 16, 2020, by and between Pfizer Inc. and Viatris Inc., filed as Exhibit 10.8 to the Report on Form 8-K filed by Viatris Inc. with the SEC on November 19, 2020, and incorporated herein by reference. &#94;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex_21xvtrsx20211231x10-k.htm">21</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subsidiaries of the registrant.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex_22xvtrsx20211231x10-k.htm">22</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">List of subsidiary guarantors and issuers of guaranteed securities.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex_23-vtrsx20211231x10xk.htm">23</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consent of Deloitte &amp; Touche LLP, Independent Registered Public Accounting Firm.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="vtrs_ex311x20211231-10k.htm">31.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="vtrs_ex312x20211231-10k.htm">31.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="vtrs_ex32x20211231-10k.htm">32</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Instance Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">157</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"></td><td style="width:7.798%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.062%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File - the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document (included in Exhibit 101).</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.024%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.776%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denotes management contract or compensatory plan or arrangement.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#94;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annexes, schedules and/or exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. Viatris agrees to furnish supplementally a copy of any omitted attachment to the SEC on a confidential basis upon request.</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">158</span></div></div></div><div id="ie2fdfbf3ed474f27b20ef16155bfdf72_283"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie2fdfbf3ed474f27b20ef16155bfdf72_4">Table of Contents</a></span></div><div style="text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of section&#160;13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Form to be signed on its behalf by the undersigned, thereunto duly authorized on February&#160;28, 2022.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:53.365%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.610%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.993%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viatris Inc.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">by&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ MICHAEL GOETTLER</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael Goettler</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</span></td></tr></table></div><div style="margin-top:1pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this Form has been signed below by the following persons on behalf of the registrant and in the capacities indicated as of February&#160;28, 2022.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.345%"><tr><td style="width:1.0%"></td><td style="width:45.485%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.425%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.790%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Signature</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;ROBERT J. COURY</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Chairman and Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Robert J. Coury</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/    MICHAEL GOETTLER</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer and Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael Goettler</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Executive Officer)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/    SANJEEV NARULA</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sanjeev Narula</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial Officer)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;PAUL B. CAMPBELL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Accounting Officer and Corporate Controller</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paul B. Campbell</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Accounting Officer)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;W. DON CORNWELL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">W. Don Cornwell</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;JOELLEN LYONS DILLON</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JoEllen Lyons Dillon</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;NEIL DIMICK</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neil Dimick</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;MELINA HIGGINS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Melina Higgins</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;JAMES M. KILTS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James M. Kilts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;HARRY A. KORMAN</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Harry A. Korman</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;RAJIV MALIK</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rajiv Malik</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;RICHARD A. MARK</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Richard A. Mark</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;MARK W. PARRISH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark W. Parrish</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;IAN READ</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ian Read</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;PAULINE VAN DER MEER MOHR</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pauline van der Meer Mohr</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">159</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21
<SEQUENCE>2
<FILENAME>ex_21xvtrsx20211231x10-k.htm
<DESCRIPTION>EX-21
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i21b5652f339746278a53640c3d0d857e_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Exhibit 21</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Subsidiaries as of December 31, 2021</font></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.684%"><tr><td style="width:1.0%"></td><td style="width:72.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.028%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%;text-decoration:underline">Name</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%;text-decoration:underline">State or Country of Organization</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Agila Australasia Pty Ltd</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Australia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Alphapharm Pty. Ltd.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Australia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Australia Holding Pty Ltd</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Australia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Australia Pty Limited</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Australia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Upjohn Australia Pty Ltd</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Australia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Viatris Pty. Ltd.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Australia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Arcana Arzneimittel GmbH</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Austria</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan &#214;sterreich GmbH</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Austria</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Viatris LLC</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Belarus</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Meda Pharma N.V.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Belgium</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan BV</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Belgium</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan EPD BVBA</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Belgium</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Pfizer Innovative Supply Point International BVBA</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Belgium</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Upjohn SRL</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Belgium</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Bermuda Ltd.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Bermuda</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Viatris BH, drustvo sa ogranicenom odgovornoscu za trgovinu i usluge</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Bosnia and Herzegovina</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Brasil Distribuidora de Medicamentos Ltda</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Brazil</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Laborat&#243;rios Ltda</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Brazil</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Upjohn Brasil Importadora e Distribuidora de Medicamentos Ltda</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Brazil</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan EOOD</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Bulgaria</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">BGP Pharma ULC</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Canada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Meda Pharmaceuticals Ltd</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Canada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Pharmaceuticals ULC</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Canada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Upjohn Canada ULC</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Canada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Medicine Meda Pharmaceutical Information Consultancy (Beijing) Co., Ltd.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">China</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Pharmaceutical Science and Technology (Shanghai) Co., Ltd.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">China</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Pfizer Pharmaceuticals Ltd.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">China</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Pfizer Upjohn Management Co., Ltd</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">China</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Viatris Pharmaceutical Co., Ltd.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">China</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Hrvatska d.o.o.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Croatia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Onco Laboratories Limited</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Cyprus</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">MEDA Pharma s.r.o.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Czech Republic</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">MYLAN HEALTHCARE CZ s.r.o.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Czech Republic</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Pharmaceuticals s.r.o.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Czech Republic</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Acton Pharmaceuticals, Inc.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Alaven Pharmaceutical LLC</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">ALVP Holdings, LLC</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delcor Asset Corporation</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.684%"><tr><td style="width:1.0%"></td><td style="width:72.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.028%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Denco Asset, LLC</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Deogun Manufacturing, LLC</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Dey, Inc.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Dey Limited Partner LLC</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">EMD, Inc.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Ezio Pharma, Inc.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Franklin Pharmaceutical LLC</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">G.D. Searle LLC</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Greenstone LLC</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Madaus Inc.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Marquis Industrial Company, LLC</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Meda Pharmaceuticals Inc.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan API Inc.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Consumer Healthcare, Inc.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan D.T. (U.S.) Holdings, Inc.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan D.T. DPT Partner Sub, LLC</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan D.T., Inc.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Holdings Inc.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Holdings I LLC</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Holdings II LLC</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Institutional LLC</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Investment Holdings 4 LLC</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Investment Holdings 5 LLC</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Investment Holdings 6 LLC</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Securitization LLC</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Special Investments LLC</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Special Investments II, LLC</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Special Investments III, LLC</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Special Investments IV, LLC</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Special Investments V, LLC</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Special Investments VI, LLC</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Specialty L.P.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Nimes Inc.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">PFE Wyeth Holdings LLC</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Pfizer Enterprises LLC</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Pfizer PFE US Holdings 4 LLC</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Pfizer PFE US Holdings 5 LLC</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Pfizer Pharmaceuticals LLC</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Powder Street, LLC</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Prestium Pharma, Inc.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Somerset Pharmaceuticals, Inc.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Upjohn US 2 LLC</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Upjohn US Employment Inc.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.684%"><tr><td style="width:1.0%"></td><td style="width:72.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.028%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Upjohn US Holdings Inc.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Upjohn Worldwide Holdings Inc.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Utah Acquisition Holdco Inc.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Utah Acquisition Sub Inc.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Viatris Specialty LLC</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Wallace Pharmaceuticals Inc.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan ApS</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Denmark</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Viatris ApS</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Denmark</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Pfizer Africa &#38; Middle East for Pharmaceuticals, Veterinarian Products &#38; Chemicals S.A.E.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Egypt</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Viatris Egypt S.A.E.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Egypt</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Viatris Health Care</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Egypt</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Agila Specialties Investments Limited</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">England &#38; Wales</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Generics (U.K.) Limited</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">England &#38; Wales</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Holdings Acquisition Limited</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">England &#38; Wales</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Holdings Acquisition 2 Limited</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">England &#38; Wales</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Holdings Ltd.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">England &#38; Wales</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Pharma UK Limited</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">England &#38; Wales</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Products Limited</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">England &#38; Wales</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Upjohn UK 2 Ltd.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">England &#38; Wales</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Upjohn UK Limited</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">England &#38; Wales</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Viatris UK Healthcare Limited</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">England &#38; Wales</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Meda Oy</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Finland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Viatris Oy</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Finland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Laboratoires Madaus S.A.S.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">France</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Meda Holding S.A.S.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">France</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Meda Manufacturing S.A.S.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">France</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Meda Pharma S.A.S.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">France</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Generics France Holding S.A.S.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">France</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Laboratories S.A.S.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">France</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Medical S.A.S.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">France</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Pfizer PFE France</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">France</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Rottapharm S.A.S.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">France</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Viatris Healthcare</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">France</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Viatris Sante</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">France</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Erste Madaus Beteiligungs GmbH</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Madaus GmbH</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">MEDA Germany Holding GmbH</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">MEDA Manufacturing GmbH</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">MEDA Pharma GmbH &#38; Co. KG</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">MWB Pharma GmbH</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan dura GmbH</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Germany GmbH</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Germany</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.684%"><tr><td style="width:1.0%"></td><td style="width:72.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.028%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Healthcare GmbH</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Pharmaceuticals GmbH</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Pharmazeutische Union GmbH</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">PharmLog Pharma Logistik GmbH</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Pfizer OFG Germany GmbH</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">ROTTAPHARM &#124;MADAUS GmbH</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">VIATRIS GmbH</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Zweite Madaus Beteiligungs GmbH</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan (Gibraltar) 4 Limited</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Gibraltar</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan (Gibraltar) 5 Limited</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Gibraltar</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan (Gibraltar) 6 Limited</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Gibraltar</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan (Gibraltar) 7 Limited</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Gibraltar</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan (Gibraltar) 8 Limited</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Gibraltar</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan (Gibraltar) 9 Limited</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Gibraltar</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">BGP Pharmaceutical Products Ltd.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Greece</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Generics Pharma Hellas Ltd.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Greece</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Meda Pharmaceuticals S.A.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Greece</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Upjohn Hellas Pharmaceutical Limited Liability Company</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Greece</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Pharmaceutical Hong Kong Limited</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Hong Kong</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Viatris Healthcare Hong Kong Limited</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Hong Kong</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Meda Pharma Hungary Kereskedelmi Kft.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Hungary</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan EPD Kft.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Hungary</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Hungary Kft.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Hungary</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Kft.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Hungary</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Institutional Inc.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Illinois</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Laboratories Limited</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">India</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Pharmaceuticals Private Limited</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">India</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">McDermott Laboratories Limited</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Meda Health Sales Ireland Limited</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Investments Limited</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan IRE Healthcare Limited</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Ireland Holdings Limited</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Ireland Investment Designated Activity Company</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Ireland Limited</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Pharma Acquisition Limited</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Pharma Group Limited</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Pharma Holdings Limited</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Pharmaceuticals Limited</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Teoranta</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Rottapharm Limited</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Upjohn Manufacturing Ireland Unlimited</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Viatris Healthcare Limited</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Viatris Limited</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Ireland</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.684%"><tr><td style="width:1.0%"></td><td style="width:72.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.028%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">DERMOGROUP S.r.l.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Italy</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Meda Pharma S.p.A.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Italy</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Italia S.r.l.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Italy</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan S.p.A.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Italy</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Viatris Pharma S.r.l.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Italy</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Rottapharm S.p.A.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Italy</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan EPD G.K.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Japan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Seiyaku Ltd.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Japan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Pfizer UPJ G.K.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Japan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Viatris Pharmaceuticals Japan Inc.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Japan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Viatris Limited Liability Partnership</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Kazakhstan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">SIA Meda Pharma</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Latvia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">SIA Mylan Healthcare</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Latvia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Healthcare UAB</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Lithuania</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">BGP Products S.&#224;.r.l.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Luxembourg</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Integral S.A.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Luxembourg</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Meda Pharma S.&#224; r.l.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Luxembourg</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Luxembourg 1 S.&#224; r.l.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Luxembourg</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Luxembourg 2 S.&#224; r.l.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Luxembourg</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Luxembourg 3 S.&#224; r.l.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Luxembourg</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Luxembourg 6 S.&#224; r.l.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Luxembourg</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Luxembourg 7 S.&#224; r.l.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Luxembourg</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Luxembourg S.&#224; r.l.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Luxembourg</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">SIM S.A.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Luxembourg</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Healthcare Sdn. Bhd.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Malaysia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Malaysia SDN. BHD.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Malaysia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Pfizer Parke Davis Sdn. Bhd.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Malaysia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Viatris Sdn Bhd.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Malaysia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">MP Laboratories (Mauritius) Ltd.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mauritius</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Meda Phama, S. de R.L. de C.V.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mexico</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Meda Pharma Servicios, S. de R.L. de C.V.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mexico</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Upjohn Pharma M&#233;xico, S. de R.L. de C.V.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mexico</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Viatris Pharmaceuticals S.A.S.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Morocco</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Viatris Pharmaceuticals Pty Ltd</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Nigeria</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Meda Pharma B.V.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan B.V.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Group B.V.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Healthcare B.V.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan II B.V.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">PF Asia Manufacturing B.V.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">PF OFG Ireland 1 B.V.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">PF OFG Mexico B.V.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">PF OFG Philippines B.V.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Netherlands</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.684%"><tr><td style="width:1.0%"></td><td style="width:72.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.028%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">PF OFG Spain B.V.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Pfizer Enterprise Holdings B.V.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Pfizer PFE Ireland Pharmaceuticals Holdings 1 B.V.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Pfizer PFE Turkey Holding 1 B.V.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Upjohn Belgium B.V.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Upjohn EESV</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Upjohn Europe Holdings B.V.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Upjohn Export B.V.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Upjohn Finance B.V.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Upjohn Global Holdings B.V.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Upjohn Group Holdings B.V.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Upjohn Intermediate Holdings B.V.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Upjohn International Holdings B.V.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Upjohn Vietnam Dutch B.V.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Viatris Netherlands B.V.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Agila Specialties Inc.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">New Jersey</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">BGP Products</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">New Zealand</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Upjohn New Zealand ULC</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">New Zealand</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Viatris Limited</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">New Zealand</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Health Management LLC</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">North Carolina</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Meda AS</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Norway</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Hospital AS</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Norway</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Viatris AS</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Norway</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">ZpearPoint AS</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Norway</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">MLRE LLC</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Pennsylvania</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Holdings Sub Inc.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Pennsylvania</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Inc.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Pennsylvania</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Synerx Pharma, LLC</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Pennsylvania</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Philippines Inc.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Philippines</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">PF OFG Philippines, Inc.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Philippines</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan EPD Sp. z o.o.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Poland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Healthcare S.p. z o.o.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Poland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">BGP Products, Unipessoal, LDA</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Portugal</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Laboratorios Anova - Produtos Farmaceuticos, LDA</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Portugal</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Laboratorios Delta, S.A.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Portugal</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan EPD Lda.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Portugal</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan, Lda</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Portugal</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">BGP Products S.r.l.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Romania</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Pharma LLC</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Russian Federation</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Viatris LLC</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Russian Federation</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Viatris Healthcare Drustvo SA Ogranicenom Odgovornoscu Beograd</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Serbia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Pharmaceuticals Pte. Ltd.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Singapore</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Pfizer Asia Pacific Pte Ltd.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Singapore</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.684%"><tr><td style="width:1.0%"></td><td style="width:72.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.028%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Pfizer PFE Private Limited</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Singapore</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Pfizer PFE Singapore Pte. Ltd.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Singapore</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">BGP Products s.r.o.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Slovakia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Meda Pharma spol. s.r.o.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Slovakia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan s.r.o.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Slovakia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Healthcare, farmacevtsko podjetje, d.o.o.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Slovenia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Meda Pharma South Africa (Pty) Limited</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">South Africa</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan (Proprietary) Limited</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">South Africa</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Pharmaceuticals (Pty) Ltd.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">South Africa</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">SCP Pharmaceuticals (Proprietary) Limited</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">South Africa</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Upjohn South Africa Proprietary Limited</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">South Africa</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Xixia Pharmaceuticals (Proprietary) Limited</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">South Africa</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Viatris Korea</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">South Korea</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Fundacion Viatris para la Salud</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Spain</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Laboratorios Parke Davis, S.L.U.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Spain</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Meda Pharma, S.L.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Spain</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">PEMB OFG Spain Holding, S.L.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Spain</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Pfizer PFE Spain Holding, S.L.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Spain</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Viatris Healthcare S.L.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Spain</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Viatris Pharmaceuticals S.L.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Spain</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Abbex AB</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Sweden</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">BGP Products AB</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Sweden</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Ipex AB</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Sweden</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Ipex Medical AB</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Sweden</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Meda AB</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Sweden</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Meda OTC AB</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Sweden</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan AB</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Sweden</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Sweden Holdings AB</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Sweden</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Recip AB</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Sweden</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Scandinavian Pharmaceuticals-Generics AB</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Sweden</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Viatris AB</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Sweden</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">BGP Products Operations GmbH</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Switzerland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">BGP Products Switzerland GmbH</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Switzerland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">MEDA Pharma GmbH</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Switzerland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">MEDA Pharmaceuticals Switzerland GmbH</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Switzerland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Holdings GmbH</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Switzerland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Pharma GmbH</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Switzerland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Pfizer PFE Switzerland GmbH</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Switzerland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan (Taiwan) Limited</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Taiwan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Viatris Pharmaceutical Company Limited</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Taiwan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">DPT Laboratories, Ltd.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Texas</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Bertek Pharmaceuticals Inc.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Texas</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Meda Pharma (Thailand) Co., Ltd.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Thailand</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.684%"><tr><td style="width:1.0%"></td><td style="width:72.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.028%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Pfizer Parke Davis (Thailand) Ltd.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Thailand</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Upjohn (Thailand) Limited</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Thailand</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Meda Pharma Ila&#231; Sanayi ve Ticaret Limited Sirketi</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Turkey</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Pfizer Ilaclari Limited Sirketi</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Turkey</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Meda Pharmaceuticals MEA FZ-LLC</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">United Arab Emirates</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan FZ-LLC</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">United Arab Emirates</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Upjohn Middle East FZ-LLC</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">United Arab Emirates</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">American Triumvirate Insurance Company</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Vermont</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan International Holdings, Inc.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Vermont</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Viatris Vietnam Limited Company</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Vietnam</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">MP AIR, Inc.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">West Virginia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Pharmaceuticals Inc.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">West Virginia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan Technologies, Inc.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">West Virginia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Mylan ASI LLC</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Wyoming</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-22
<SEQUENCE>3
<FILENAME>ex_22xvtrsx20211231x10-k.htm
<DESCRIPTION>EX-22
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ib562313c25b745a9853fb701d9ce01cf_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 22</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">List of Subsidiary Guarantors and Issuers of Guaranteed Securities</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">As of December 31, 2021, Viatris Inc., a Delaware corporation (&#8220;Viatris&#8221;), Mylan Inc., a Pennsylvania corporation (&#8220;Mylan Inc.&#8221;), and Mylan II B.V., a company incorporated under the laws of the Netherlands (&#8220;Mylan II&#8221;), were the guarantors of the 3.950% Senior Notes due 2026 and 5.250% Senior Notes due 2046 issued by Utah Acquisition Sub Inc., a Delaware corporation (&#8220;Utah&#8221;).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">As of December 31, 2021, Viatris, Utah and Mylan II were the guarantors of the 4.200% Senior Notes due 2023, 3.125% Senior Notes due 2023, 4.550% Senior Notes due 2028, 5.400% Senior Notes due 2043 and 5.200% Senior Notes due 2048 issued by Mylan Inc.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">As of December 31, 2021, Utah, Mylan Inc. and Mylan II were the guarantors of the 1.125% Senior Notes due 2022, 1.650% Senior Notes due 2025,</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.300% Senior Notes due 2027, 2.700% Senior Notes due 2030, 3.850% Senior Notes due 2040 and 4.000% Senior Notes due 2050 issued by Viatris.</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23
<SEQUENCE>4
<FILENAME>ex_23-vtrsx20211231x10xk.htm
<DESCRIPTION>EX-23
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i6ee79514b0e44fdfbaf147c0692b8f2e_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.75pt;padding-left:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exhibit 23</font></div><div style="margin-top:3.75pt;padding-left:5pt"><font><br></font></div><div style="margin-top:3.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">We consent to the incorporation by reference in Registration Statement No. 333-250845 on Form S-8 of our reports dated February 28, 2022, relating to the consolidated financial statements of Viatris Inc. and subsidiaries (the &#8220;Company&#8221;) and the effectiveness of the Company's internal control over financial reporting appearing in this Annual Report on Form 10-K for the year ended December 31, 2021.</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#47;s&#47; Deloitte &#38; Touche LLP</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pittsburgh, Pennsylvania</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">February 28, 2022</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>vtrs_ex311x20211231-10k.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ia0716ae38fa748ae9c1e7d1d99bdae59_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT&#160;31.1</font></div><div style="margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Principal Executive Officer Pursuant to</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section&#160;302 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Michael Goettler, certify that&#58;</font></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">I have reviewed this Form&#160;10-K of Viatris Inc.&#59;</font></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59;&#160;and</font></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59;&#160;and</font></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:63.760%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.040%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Michael Goettler</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael Goettler</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February&#160;28, 2022 </font></div><div style="margin-top:14pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>6
<FILENAME>vtrs_ex312x20211231-10k.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ife0ce2014a5e4799acb28b90bb5d6b73_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT&#160;31.2</font></div><div style="margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Principal Financial Officer Pursuant to</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section&#160;302 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Sanjeev Narula, certify that&#58;</font></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">I have reviewed this Form&#160;10-K of Viatris Inc.&#59;</font></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59;&#160;and</font></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59;&#160;and</font></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:63.760%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.040%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; SANJEEV NARULA</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sanjeev Narula</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial Officer)</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February&#160;28, 2022 </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>7
<FILENAME>vtrs_ex32x20211231-10k.htm
<DESCRIPTION>EX-32
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i357cd368a2ee44fe87286c387a95fbe9_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT&#160;32</font></div><div style="margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS OF PRINCIPAL EXECUTIVE OFFICER AND</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PRINCIPAL FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION&#160;906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Form&#160;10-K of Viatris Inc. (the &#8220;Company&#8221;) for the year ended December&#160;31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), each of the undersigned, in the capacities and on the date indicated below, hereby certifies pursuant to 18&#160;U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that to his knowledge&#58;</font></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Report fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934&#59;&#160;and</font></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February&#160;28, 2022 </font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:52.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.753%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; MICHAEL GOETTLER</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael Goettler</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Executive Officer)</font></div></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:52.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.753%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; SANJEEV NARULA</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sanjeev Narula</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial Officer)</font></div></td></tr></table></div><div style="margin-top:4pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section&#160;906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing certification is being furnished in accordance with Securities and Exchange Commission Release No.&#160;34-47551 and shall not be considered filed as part of the Form&#160;10-K.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>vtrs-20211231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:7d588a56-150d-4ea9-a97c-5b39f92c59e0,g:83cb92d0-838c-40d0-a420-8487c2f4fc1b-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:vtrs="http://www.viatris.com/20211231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.viatris.com/20211231">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vtrs-20211231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vtrs-20211231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vtrs-20211231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vtrs-20211231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.viatris.com/role/Cover">
        <link:definition>000010001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.viatris.com/role/ConsolidatedBalanceSheets">
        <link:definition>100010002 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.viatris.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>100020003 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofOperations" roleURI="http://www.viatris.com/role/ConsolidatedStatementsofOperations">
        <link:definition>100030004 - Statement - Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveEarnings" roleURI="http://www.viatris.com/role/ConsolidatedStatementsofComprehensiveEarnings">
        <link:definition>100040005 - Statement - Consolidated Statements of Comprehensive Earnings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofEquity" roleURI="http://www.viatris.com/role/ConsolidatedStatementsofEquity">
        <link:definition>100050006 - Statement - Consolidated Statements of Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofEquityParenthetical" roleURI="http://www.viatris.com/role/ConsolidatedStatementsofEquityParenthetical">
        <link:definition>140064001 - Statement - Consolidated Statements of Equity (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.viatris.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>100070007 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NatureofOperations" roleURI="http://www.viatris.com/role/NatureofOperations">
        <link:definition>210011001 - Disclosure - Nature of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NatureofOperationsNarrativeDetails" roleURI="http://www.viatris.com/role/NatureofOperationsNarrativeDetails">
        <link:definition>240024002 - Disclosure - Nature of Operations (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://www.viatris.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>210031002 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>220042001 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesTables" roleURI="http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesTables">
        <link:definition>230053001 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>240064003 - Disclosure - Summary of Significant Accounting Policies (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesBasicAndDilutedEarningsPerOrdinaryShareAttributableToMylanNVDetails" roleURI="http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesBasicAndDilutedEarningsPerOrdinaryShareAttributableToMylanNVDetails">
        <link:definition>240074004 - Disclosure - Summary of Significant Accounting Policies (Basic And Diluted Earnings Per Ordinary Share Attributable To Mylan N.V.) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandOtherTransactions" roleURI="http://www.viatris.com/role/AcquisitionsandOtherTransactions">
        <link:definition>210081003 - Disclosure - Acquisitions and Other Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandOtherTransactionsTables" roleURI="http://www.viatris.com/role/AcquisitionsandOtherTransactionsTables">
        <link:definition>230093002 - Disclosure - Acquisitions and Other Transactions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails" roleURI="http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails">
        <link:definition>240104005 - Disclosure - Acquisitions and Other Transactions (Other Transactions) (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails" roleURI="http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails">
        <link:definition>240114006 - Disclosure - Acquisitions and Other Transactions (Purchase Price Allocations) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails" roleURI="http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails">
        <link:definition>240124007 - Disclosure - Acquisitions and Other Transactions (Unaudited Pro Forma Financial Results) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionandAccountsReceivable" roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivable">
        <link:definition>210131004 - Disclosure - Revenue Recognition and Accounts Receivable</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionandAccountsReceivableTables" roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableTables">
        <link:definition>230143003 - Disclosure - Revenue Recognition and Accounts Receivable (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionandAccountsReceivableRevenueDisaggregationDetails" roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationDetails">
        <link:definition>240154008 - Disclosure - Revenue Recognition and Accounts Receivable Revenue Disaggregation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionandAccountsReceivableDisaggregationofRevenuebyKeyProductsDetails" roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableDisaggregationofRevenuebyKeyProductsDetails">
        <link:definition>240164009 - Disclosure - Revenue Recognition and Accounts Receivable - Disaggregation of Revenue by Key Products (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionandAccountsReceivableNarrativeDetails" roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableNarrativeDetails">
        <link:definition>240174010 - Disclosure - Revenue Recognition and Accounts Receivable (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionandAccountsReceivableVariableConsiderationDetails" roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails">
        <link:definition>240184011 - Disclosure - Revenue Recognition and Accounts Receivable Variable Consideration (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails" roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails">
        <link:definition>240194012 - Disclosure - Revenue Recognition and Accounts Receivable (Accounts Receivable, Net) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionandAccountsReceivableVariableConsiderationRollforwardDetails" roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationRollforwardDetails">
        <link:definition>240204013 - Disclosure - Revenue Recognition and Accounts Receivable Variable Consideration Rollforward (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponents" roleURI="http://www.viatris.com/role/BalanceSheetComponents">
        <link:definition>210211005 - Disclosure - Balance Sheet Components</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsTables" roleURI="http://www.viatris.com/role/BalanceSheetComponentsTables">
        <link:definition>230223004 - Disclosure - Balance Sheet Components (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsNarrativeDetails" roleURI="http://www.viatris.com/role/BalanceSheetComponentsNarrativeDetails">
        <link:definition>240234014 - Disclosure - Balance Sheet Components (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsBalanceSheetComponentsCashandCashEquivalentsDetails" roleURI="http://www.viatris.com/role/BalanceSheetComponentsBalanceSheetComponentsCashandCashEquivalentsDetails">
        <link:definition>240244015 - Disclosure - Balance Sheet Components Balance Sheet Components (Cash and Cash Equivalents) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsAccountsreceivablenetDetails" roleURI="http://www.viatris.com/role/BalanceSheetComponentsAccountsreceivablenetDetails">
        <link:definition>240254016 - Disclosure - Balance Sheet Components (Accounts receivable, net) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsInventoriesDetails" roleURI="http://www.viatris.com/role/BalanceSheetComponentsInventoriesDetails">
        <link:definition>240264017 - Disclosure - Balance Sheet Components (Inventories) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsPrepaidsandothercurrentassetsDetails" roleURI="http://www.viatris.com/role/BalanceSheetComponentsPrepaidsandothercurrentassetsDetails">
        <link:definition>240274018 - Disclosure - Balance Sheet Components (Prepaids and other current assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsPropertyPlantandEquipmentDetails" roleURI="http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails">
        <link:definition>240284019 - Disclosure - Balance Sheet Components (Property, Plant and Equipment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsOtherAssetsDetails" roleURI="http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails">
        <link:definition>240294020 - Disclosure - Balance Sheet Components (Other Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsTradeAccountsPayableDetails" roleURI="http://www.viatris.com/role/BalanceSheetComponentsTradeAccountsPayableDetails">
        <link:definition>240304021 - Disclosure - Balance Sheet Components (Trade Accounts Payable) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsOtherCurrentLiabilitiesDetails" roleURI="http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails">
        <link:definition>240314022 - Disclosure - Balance Sheet Components (Other Current Liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsOthernoncurrentliabilitiesDetails" roleURI="http://www.viatris.com/role/BalanceSheetComponentsOthernoncurrentliabilitiesDetails">
        <link:definition>240324023 - Disclosure - Balance Sheet Components (Other noncurrent liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.viatris.com/role/Leases">
        <link:definition>210331006 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.viatris.com/role/LeasesTables">
        <link:definition>230343005 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://www.viatris.com/role/LeasesNarrativeDetails">
        <link:definition>240354024 - Disclosure - Leases (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseInformationDetails" roleURI="http://www.viatris.com/role/LeasesLeaseInformationDetails">
        <link:definition>240364025 - Disclosure - Leases (Lease Information) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseMaturitiesDetails" roleURI="http://www.viatris.com/role/LeasesLeaseMaturitiesDetails">
        <link:definition>240374026 - Disclosure - Leases (Lease Maturities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseMaturitiesDetails_1" roleURI="http://www.viatris.com/role/LeasesLeaseMaturitiesDetails_1">
        <link:definition>240374026 - Disclosure - Leases (Lease Maturities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityMethodInvestments" roleURI="http://www.viatris.com/role/EquityMethodInvestments">
        <link:definition>210381007 - Disclosure - Equity Method Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityMethodInvestmentsTables" roleURI="http://www.viatris.com/role/EquityMethodInvestmentsTables">
        <link:definition>230393006 - Disclosure - Equity Method Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityMethodInvestmentsNarrativeDetails" roleURI="http://www.viatris.com/role/EquityMethodInvestmentsNarrativeDetails">
        <link:definition>240404027 - Disclosure - Equity Method Investments (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityMethodInvestmentsBalanceSheetDetails" roleURI="http://www.viatris.com/role/EquityMethodInvestmentsBalanceSheetDetails">
        <link:definition>240414028 - Disclosure - Equity Method Investments (Balance Sheet) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityMethodInvestmentsNetAssetsDetails" roleURI="http://www.viatris.com/role/EquityMethodInvestmentsNetAssetsDetails">
        <link:definition>240424029 - Disclosure - Equity Method Investments (Net Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityMethodInvestmentsIncomeStatementDetails" roleURI="http://www.viatris.com/role/EquityMethodInvestmentsIncomeStatementDetails">
        <link:definition>240434030 - Disclosure - Equity Method Investments (Income Statement) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssets" roleURI="http://www.viatris.com/role/GoodwillandOtherIntangibleAssets">
        <link:definition>210441008 - Disclosure - Goodwill and Other Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsTables" roleURI="http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsTables">
        <link:definition>230453007 - Disclosure - Goodwill and Other Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsNarrativeDetails" roleURI="http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails">
        <link:definition>240464031 - Disclosure - Goodwill and Other Intangible Assets (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsChangesinCarryingAmountOfGoodwillDetails" roleURI="http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountOfGoodwillDetails">
        <link:definition>240474032 - Disclosure - Goodwill and Other Intangible Assets (Changes in Carrying Amount Of Goodwill) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsComponentsofIntangibleAssetsDetails" roleURI="http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsComponentsofIntangibleAssetsDetails">
        <link:definition>240484033 - Disclosure - Goodwill and Other Intangible Assets (Components of Intangible Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsProductRightsandLicensebyTherapeuticCategoryDetails" roleURI="http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsProductRightsandLicensebyTherapeuticCategoryDetails">
        <link:definition>240494034 - Disclosure - Goodwill and Other Intangible Assets (Product Rights and License by Therapeutic Category) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails" roleURI="http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails">
        <link:definition>240504035 - Disclosure - Goodwill and Other Intangible Assets (Amortization Expense) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsGoodwillandOtherIntangibleAssetsFutureamortizationexpenseDetails" roleURI="http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsGoodwillandOtherIntangibleAssetsFutureamortizationexpenseDetails">
        <link:definition>240514036 - Disclosure - Goodwill and Other Intangible Assets Goodwill and Other Intangible Assets (Future amortization expense) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandRiskManagement" roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagement">
        <link:definition>210521009 - Disclosure - Financial Instruments and Risk Management</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandRiskManagementTables" roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables">
        <link:definition>230533008 - Disclosure - Financial Instruments and Risk Management (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandRiskManagementNarrativeDetails" roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails">
        <link:definition>240544037 - Disclosure - Financial Instruments and Risk Management (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandRiskManagementDerivativesDesignatedasHedgingInstrumentsFairValuesofDerivativeInstrumentsDetails" roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementDerivativesDesignatedasHedgingInstrumentsFairValuesofDerivativeInstrumentsDetails">
        <link:definition>240554038 - Disclosure - Financial Instruments and Risk Management (Derivatives Designated as Hedging Instruments Fair Values of Derivative Instruments) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandRiskManagementDerivativesNotDesignatedasHedgingInstrumentsFairValuesofDerivativeInstrumentsDetails" roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementDerivativesNotDesignatedasHedgingInstrumentsFairValuesofDerivativeInstrumentsDetails">
        <link:definition>240564039 - Disclosure - Financial Instruments and Risk Management (Derivatives Not Designated as Hedging Instruments Fair Values of Derivative Instruments) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails" roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails">
        <link:definition>240574040 - Disclosure - Financial Instruments and Risk Management (Effect of Derivative Instruments on the Consolidated Statements of Operations Derivatives in Fair Value Hedging Relationships) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofComprehensiveEarningsDerivativesinCashFlowHedgingRelationshipsDetails" roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofComprehensiveEarningsDerivativesinCashFlowHedgingRelationshipsDetails">
        <link:definition>240584041 - Disclosure - Financial Instruments and Risk Management (Effect of Derivative Instruments on the Consolidated Statements of Comprehensive Earnings Derivatives in Cash Flow Hedging Relationships) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinNetInvestmentHedgingRelationshipDetails" roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinNetInvestmentHedgingRelationshipDetails">
        <link:definition>240594042 - Disclosure - Financial Instruments and Risk Management (Effect of Derivative Instruments on the Condensed Consolidated Statements of Comprehensive Earnings Derivatives in Net Investment Hedging Relationship) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails" roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails">
        <link:definition>240604043 - Disclosure - Financial Instruments and Risk Management (Effect of Derivative Instruments on the Consolidated Statements of Operations Derivatives in Cash Flow Hedging Relationships) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesNotDesignatedasHedgingInstrumentsDetails" roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesNotDesignatedasHedgingInstrumentsDetails">
        <link:definition>240614044 - Disclosure - Financial Instruments and Risk Management (Effect of Derivative Instruments on the Consolidated Statements of Operations Derivatives Not Designated as Hedging Instruments) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails" roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails">
        <link:definition>240624045 - Disclosure - Financial Instruments and Risk Management (Financial Assets and Liabilities Carried at Fair Value) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails" roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails">
        <link:definition>240634046 - Disclosure - Financial Instruments and Risk Management (Rollforward of Contingent Consideration) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandRiskManagementScheduleofAvailableforsaleSecuritiesReconciliationDetails" roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementScheduleofAvailableforsaleSecuritiesReconciliationDetails">
        <link:definition>240644047 - Disclosure - Financial Instruments and Risk Management (Schedule of Available-for-sale Securities Reconciliation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandRiskManagementMaturitiesofAvailableforsaleDebtSecuritiesatFairValueDetails" roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementMaturitiesofAvailableforsaleDebtSecuritiesatFairValueDetails">
        <link:definition>240654048 - Disclosure - Financial Instruments and Risk Management (Maturities of Available-for-sale Debt Securities at Fair Value) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt" roleURI="http://www.viatris.com/role/Debt">
        <link:definition>210661010 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtTables" roleURI="http://www.viatris.com/role/DebtTables">
        <link:definition>230673009 - Disclosure - Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtShorttermborrowingsDetails" roleURI="http://www.viatris.com/role/DebtShorttermborrowingsDetails">
        <link:definition>240684049 - Disclosure - Debt (Short-term borrowings) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtDebtReceivablesFacilityandCommercialPaperProgramDetails" roleURI="http://www.viatris.com/role/DebtDebtReceivablesFacilityandCommercialPaperProgramDetails">
        <link:definition>240694050 - Disclosure - Debt Debt (Receivables Facility and Commercial Paper Program) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtSummaryofLongtermDebtDetails" roleURI="http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails">
        <link:definition>240704051 - Disclosure - Debt (Summary of Long-term Debt) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtRevolvingFacilitiesandTermFacilitiesDetails" roleURI="http://www.viatris.com/role/DebtRevolvingFacilitiesandTermFacilitiesDetails">
        <link:definition>240714052 - Disclosure - Debt (Revolving Facilities and Term Facilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtIssuanceof2018SeniorNotesDetails" roleURI="http://www.viatris.com/role/DebtIssuanceof2018SeniorNotesDetails">
        <link:definition>240724053 - Disclosure - Debt (Issuance of 2018 Senior Notes) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtSeniorNotesDetails" roleURI="http://www.viatris.com/role/DebtSeniorNotesDetails">
        <link:definition>240734054 - Disclosure - Debt (Senior Notes) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtFairValueNarrativeDetails" roleURI="http://www.viatris.com/role/DebtFairValueNarrativeDetails">
        <link:definition>240744055 - Disclosure - Debt (Fair Value) (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtUpjohnSeniorNotesDetails" roleURI="http://www.viatris.com/role/DebtUpjohnSeniorNotesDetails">
        <link:definition>240754056 - Disclosure - Debt (Upjohn Senior Notes) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtMinimumRepaymentsonOutstandingBorrowingsDetails" roleURI="http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails">
        <link:definition>240764057 - Disclosure - Debt (Minimum Repayments on Outstanding Borrowings) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ComprehensiveEarnings" roleURI="http://www.viatris.com/role/ComprehensiveEarnings">
        <link:definition>210771011 - Disclosure - Comprehensive Earnings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ComprehensiveEarningsTables" roleURI="http://www.viatris.com/role/ComprehensiveEarningsTables">
        <link:definition>230783010 - Disclosure - Comprehensive Earnings (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails" roleURI="http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails">
        <link:definition>240794058 - Disclosure - Comprehensive Earnings (Accumulated Other Comprehensive Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails" roleURI="http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails">
        <link:definition>240804059 - Disclosure - Comprehensive Earnings (Components of Other Comprehensive Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.viatris.com/role/IncomeTaxes">
        <link:definition>210811012 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.viatris.com/role/IncomeTaxesTables">
        <link:definition>230823011 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.viatris.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>240834060 - Disclosure - Income Taxes (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails" roleURI="http://www.viatris.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails">
        <link:definition>240844061 - Disclosure - Income Taxes (Schedule of Components of Income Tax Provision) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" roleURI="http://www.viatris.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails">
        <link:definition>240854062 - Disclosure - Income Taxes (Schedule of Deferred Tax Assets and Liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesStatutoryTaxRatetoEffectiveTaxRateReconciliationDetails" roleURI="http://www.viatris.com/role/IncomeTaxesStatutoryTaxRatetoEffectiveTaxRateReconciliationDetails">
        <link:definition>240864063 - Disclosure - Income Taxes (Statutory Tax Rate to Effective Tax Rate Reconciliation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails" roleURI="http://www.viatris.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails">
        <link:definition>240874064 - Disclosure - Income Taxes (Schedule of Unrecognized Tax Benefits) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedIncentivePlan" roleURI="http://www.viatris.com/role/ShareBasedIncentivePlan">
        <link:definition>210881013 - Disclosure - Share-Based Incentive Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedIncentivePlanTables" roleURI="http://www.viatris.com/role/ShareBasedIncentivePlanTables">
        <link:definition>230893012 - Disclosure - Share-Based Incentive Plan (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedIncentivePlanNarrativeDetails" roleURI="http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails">
        <link:definition>240904065 - Disclosure - Share-Based Incentive Plan (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedIncentivePlanStockAwardsDetails" roleURI="http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails">
        <link:definition>240914066 - Disclosure - Share-Based Incentive Plan (Stock Awards) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails" roleURI="http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails">
        <link:definition>240924067 - Disclosure - Share-Based Incentive Plan (Nonvested Restricted Stock, Restricted Stock Units and PSUs Activity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedIncentivePlanValuationAssumptionsDetails" roleURI="http://www.viatris.com/role/ShareBasedIncentivePlanValuationAssumptionsDetails">
        <link:definition>240934068 - Disclosure - Share-Based Incentive Plan (Valuation Assumptions) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlans" roleURI="http://www.viatris.com/role/EmployeeBenefitPlans">
        <link:definition>210941014 - Disclosure - Employee Benefit Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlansTables" roleURI="http://www.viatris.com/role/EmployeeBenefitPlansTables">
        <link:definition>230953013 - Disclosure - Employee Benefit Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlansNarrativeDetails" roleURI="http://www.viatris.com/role/EmployeeBenefitPlansNarrativeDetails">
        <link:definition>240964069 - Disclosure - Employee Benefit Plans (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlansAccumulatedOtherComprehensiveIncomeLossPretaxAmountsNotYetReclassifiedinNetPeriodicBenefitCostDetails" roleURI="http://www.viatris.com/role/EmployeeBenefitPlansAccumulatedOtherComprehensiveIncomeLossPretaxAmountsNotYetReclassifiedinNetPeriodicBenefitCostDetails">
        <link:definition>240974070 - Disclosure - Employee Benefit Plans (Accumulated Other Comprehensive Income (Loss) Pretax Amounts Not Yet Reclassified in Net Periodic Benefit Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlansChangeinAccumulatedIncomeLossRelatingtoDefinedBenefitPensionandOtherPostretirementBenefitsDetails" roleURI="http://www.viatris.com/role/EmployeeBenefitPlansChangeinAccumulatedIncomeLossRelatingtoDefinedBenefitPensionandOtherPostretirementBenefitsDetails">
        <link:definition>240984071 - Disclosure - Employee Benefit Plans (Change in Accumulated Income (Loss) Relating to Defined Benefit Pension and Other Postretirement Benefits) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlansNetPeriodicBenefitCostsDetails" roleURI="http://www.viatris.com/role/EmployeeBenefitPlansNetPeriodicBenefitCostsDetails">
        <link:definition>240994072 - Disclosure - Employee Benefit Plans (Net Periodic Benefit Costs) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlansChangesinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails" roleURI="http://www.viatris.com/role/EmployeeBenefitPlansChangesinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails">
        <link:definition>241004073 - Disclosure - Employee Benefit Plans (Changes in Projected Benefit Obligations, Plan Assets and Funded Status) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlansNetAccruedBenefitCostsClassificationonBalanceSheetDetails" roleURI="http://www.viatris.com/role/EmployeeBenefitPlansNetAccruedBenefitCostsClassificationonBalanceSheetDetails">
        <link:definition>241014074 - Disclosure - Employee Benefit Plans (Net Accrued Benefit Costs Classification on Balance Sheet) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlansPlanswithPBOinExcessofPlanAssetsDetails" roleURI="http://www.viatris.com/role/EmployeeBenefitPlansPlanswithPBOinExcessofPlanAssetsDetails">
        <link:definition>241024075 - Disclosure - Employee Benefit Plans (Plans with PBO in Excess of Plan Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlansFairValuesofPlanAssetsDetails" roleURI="http://www.viatris.com/role/EmployeeBenefitPlansFairValuesofPlanAssetsDetails">
        <link:definition>241034076 - Disclosure - Employee Benefit Plans (Fair Values of Plan Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlansWeightedAverageAssumptionsDetails" roleURI="http://www.viatris.com/role/EmployeeBenefitPlansWeightedAverageAssumptionsDetails">
        <link:definition>241044077 - Disclosure - Employee Benefit Plans (Weighted Average Assumptions) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlansEffectofOnePercentagePointIncreaseorDecreaseinHealthCareCostTrendRatesDetails" roleURI="http://www.viatris.com/role/EmployeeBenefitPlansEffectofOnePercentagePointIncreaseorDecreaseinHealthCareCostTrendRatesDetails">
        <link:definition>241054078 - Disclosure - Employee Benefit Plans (Effect of One Percentage Point Increase or Decrease in Health Care Cost Trend Rates) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlansEstimatedFutureBenefitPaymentsDetails" roleURI="http://www.viatris.com/role/EmployeeBenefitPlansEstimatedFutureBenefitPaymentsDetails">
        <link:definition>241064079 - Disclosure - Employee Benefit Plans (Estimated Future Benefit Payments) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformation" roleURI="http://www.viatris.com/role/SegmentInformation">
        <link:definition>211071015 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationTables" roleURI="http://www.viatris.com/role/SegmentInformationTables">
        <link:definition>231083014 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationReconciliationofSegmentInformationtoTotalConsolidatedInformationDetails" roleURI="http://www.viatris.com/role/SegmentInformationReconciliationofSegmentInformationtoTotalConsolidatedInformationDetails">
        <link:definition>241094080 - Disclosure - Segment Information (Reconciliation of Segment Information to Total Consolidated Information) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationThirdPartyNetSalesbyMajorCustomersDetails" roleURI="http://www.viatris.com/role/SegmentInformationThirdPartyNetSalesbyMajorCustomersDetails">
        <link:definition>241104081 - Disclosure - Segment Information (Third Party Net Sales by Major Customers) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationNetThirdPartySalesClassifiedBasedonGeographicLocationofEntityDetails" roleURI="http://www.viatris.com/role/SegmentInformationNetThirdPartySalesClassifiedBasedonGeographicLocationofEntityDetails">
        <link:definition>241114082 - Disclosure - Segment Information (Net Third Party Sales Classified Based on Geographic Location of Entity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Commitments" roleURI="http://www.viatris.com/role/Commitments">
        <link:definition>211121016 - Disclosure - Commitments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsDetails" roleURI="http://www.viatris.com/role/CommitmentsDetails">
        <link:definition>241134083 - Disclosure - Commitments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Restructuring" roleURI="http://www.viatris.com/role/Restructuring">
        <link:definition>211141017 - Disclosure - Restructuring</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringTables" roleURI="http://www.viatris.com/role/RestructuringTables">
        <link:definition>231153015 - Disclosure - Restructuring (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringNarrativeDetails" roleURI="http://www.viatris.com/role/RestructuringNarrativeDetails">
        <link:definition>241164084 - Disclosure - Restructuring (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Restructuring2020RestructuringPlanDetails" roleURI="http://www.viatris.com/role/Restructuring2020RestructuringPlanDetails">
        <link:definition>241174085 - Disclosure - Restructuring (2020 Restructuring Plan) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationandLicensingAgreements" roleURI="http://www.viatris.com/role/CollaborationandLicensingAgreements">
        <link:definition>211181018 - Disclosure - Collaboration and Licensing Agreements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationandLicensingAgreementsNarrativeDetails" roleURI="http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails">
        <link:definition>241194086 - Disclosure - Collaboration and Licensing Agreements (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Litigation" roleURI="http://www.viatris.com/role/Litigation">
        <link:definition>211201019 - Disclosure - Litigation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LitigationNarrativeDetails" roleURI="http://www.viatris.com/role/LitigationNarrativeDetails">
        <link:definition>241214087 - Disclosure - Litigation (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ValuationandQualifyingAccounts" roleURI="http://www.viatris.com/role/ValuationandQualifyingAccounts">
        <link:definition>211221020 - Disclosure - Valuation and Qualifying Accounts</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ValuationandQualifyingAccountsDetails" roleURI="http://www.viatris.com/role/ValuationandQualifyingAccountsDetails">
        <link:definition>241234088 - Disclosure - Valuation and Qualifying Accounts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://www.viatris.com/role/AuditInformation">
        <link:definition>000020008 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation_1" roleURI="http://www.viatris.com/role/AuditInformation_1">
        <link:definition>000030009 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="vtrs_BusinessCombinationContractualReimbursementAmountAmountsAccrued" abstract="false" name="BusinessCombinationContractualReimbursementAmountAmountsAccrued" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_MaximumLeverageRatioPeriodOne" abstract="false" name="MaximumLeverageRatioPeriodOne" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="vtrs_GoodwillImpairmentMeasurementInput" abstract="false" name="GoodwillImpairmentMeasurementInput" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:decimalItemType"/>
  <xs:element id="vtrs_A2050SeniorNotesMember" abstract="true" name="A2050SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIndefiniteLivedIntangibleAssetsMeasurementInput" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIndefiniteLivedIntangibleAssetsMeasurementInput" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:decimalItemType"/>
  <xs:element id="vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems" abstract="true" name="ScheduleofOtherNoncurrentLiabilitiesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="vtrs_A2025SeniorNotesMember" abstract="true" name="A2025SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_A2020RestructuringPlanMember" abstract="true" name="A2020RestructuringPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_SeniorNotes2021Member" abstract="true" name="SeniorNotes2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_DefinedBenefitPlanContributionsByPlanParticipantsBenefitObligation" abstract="false" name="DefinedBenefitPlanContributionsByPlanParticipantsBenefitObligation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_GoodwillImpairmentTestMeasurementInput" abstract="false" name="GoodwillImpairmentTestMeasurementInput" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:decimalItemType"/>
  <xs:element id="vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications" abstract="false" name="BusinessCombinationContingentConsiderationArrangementsReclassifications" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_Numberofstates" abstract="false" name="Numberofstates" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentLiabilities" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_ScheduleofActivityinContingentConsiderationRollForward" abstract="true" name="ScheduleofActivityinContingentConsiderationRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="vtrs_CardinalHealthIncMember" abstract="true" name="CardinalHealthIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_ProductRightsAndLicensesByTherapeuticCategoryTableTextBlock" abstract="false" name="ProductRightsAndLicensesByTherapeuticCategoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="vtrs_AssetsheldbyinsurancecompaniesandotherMember" abstract="true" name="AssetsheldbyinsurancecompaniesandotherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_GoodwillImpairedChangeinEstimatePeriod" abstract="false" name="GoodwillImpairedChangeinEstimatePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="vtrs_VoluntaryRecallofValsartanandCertainCombinationsValsartanMedicinesMember" abstract="true" name="VoluntaryRecallofValsartanandCertainCombinationsValsartanMedicinesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_AccountsReceivableIncreaseDueToAcquisitionCurrent" abstract="false" name="AccountsReceivableIncreaseDueToAcquisitionCurrent" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_CleanEnergyPartnershipsMember" abstract="true" name="CleanEnergyPartnershipsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_SeniorNotes2022Member" abstract="true" name="SeniorNotes2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_NorvascMember" abstract="true" name="NorvascMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_CARESActIncomeTaxExpenseBenefit" abstract="false" name="CARESActIncomeTaxExpenseBenefit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_GenericsMember" abstract="true" name="GenericsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_ReceivablesFacilityMember" abstract="true" name="ReceivablesFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember" abstract="true" name="SeniorNotesTwoThousandTwentySix3.95PrecentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_GoodwillImpairmentTestMeasurementInputIncrease" abstract="false" name="GoodwillImpairmentTestMeasurementInputIncrease" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:decimalItemType"/>
  <xs:element id="vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember" abstract="true" name="AmendedAnticompetitiveConductwithGenericDrugsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_IncreasedDiscountRateDomain" abstract="true" name="IncreasedDiscountRateDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_EquityMethodInvestmentsReductionInLongTermObligations" abstract="false" name="EquityMethodInvestmentsReductionInLongTermObligations" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_RestofWorldSegmentMember" abstract="true" name="RestofWorldSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_MaximumLeverageRatioPeriodTwo" abstract="false" name="MaximumLeverageRatioPeriodTwo" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="vtrs_NorthAmericaGenericsMember" abstract="true" name="NorthAmericaGenericsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_AccumulatednetactuariallossesexceedhigherofmarketvalueofplanassetsorPBO" abstract="false" name="AccumulatednetactuariallossesexceedhigherofmarketvalueofplanassetsorPBO" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="vtrs_PeriodDomain" abstract="true" name="PeriodDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_SalesMilestonePayments" abstract="false" name="SalesMilestonePayments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense" abstract="false" name="IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_SeniorNotesTwoThousandTwentyOne3.15PrecentMember" abstract="true" name="SeniorNotesTwoThousandTwentyOne3.15PrecentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_RestructuringAndRelatedCostExpectedNumberOfFacilitiesToBeEliminated" abstract="false" name="RestructuringAndRelatedCostExpectedNumberOfFacilitiesToBeEliminated" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="vtrs_StockappreciationrightsandperformancesharesMember" abstract="true" name="StockappreciationrightsandperformancesharesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_RebatesPromotionalProgramsandOtherSalesAllowancesMember" abstract="true" name="RebatesPromotionalProgramsandOtherSalesAllowancesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_ExpectedFutureBenefitPayments" abstract="false" name="ExpectedFutureBenefitPayments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember" abstract="true" name="SeniorNotesTwoThousandTwentyThree3.125PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_AccountsReceivableSalesProvisionsCurrent" abstract="false" name="AccountsReceivableSalesProvisionsCurrent" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_ProductLiabilityMember" abstract="true" name="ProductLiabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_AmeriSourceBergenCorporationMember" abstract="true" name="AmeriSourceBergenCorporationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties" abstract="false" name="ReserveForUncertainTaxPositionsIncludingInterestAndPenalties" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_A2027SeniorNotesMember" abstract="true" name="A2027SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_DevelopedMarketsSegmentMember" abstract="true" name="DevelopedMarketsSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_DeductionlimitofGILTItax" abstract="false" name="DeductionlimitofGILTItax" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="vtrs_AccruedSalesAllowances" abstract="false" name="AccruedSalesAllowances" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_LongTermIncentivePlan2003Member" abstract="true" name="LongTermIncentivePlan2003Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_XalabrandsMember" abstract="true" name="XalabrandsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_OtherLongTermDebtMember" abstract="true" name="OtherLongTermDebtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_OtherCompaniesMember" abstract="true" name="OtherCompaniesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_EffexorMember" abstract="true" name="EffexorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminatedPercent" abstract="false" name="RestructuringAndRelatedCostExpectedNumberOfPositionsEliminatedPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassLineItems" abstract="true" name="ScheduleOfProductRightsAndLicensesByTherapeuticClassLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="vtrs_RestructuringReserveAcquiredDuringPeriod" abstract="false" name="RestructuringReserveAcquiredDuringPeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity" abstract="false" name="AccountsReceivableFacilityMaximumBorrowingCapacity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_USDTermLoanFacilityMember" abstract="true" name="USDTermLoanFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_Changeinnoncashlitigationsettlementsnet" abstract="false" name="Changeinnoncashlitigationsettlementsnet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_A2020FloatingRateEuroNotesMember" abstract="true" name="A2020FloatingRateEuroNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_EmergingMarketsSegmentMember" abstract="true" name="EmergingMarketsSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_EffectiveIncomeTaxRateReconciliationWithholdingTaxesPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationWithholdingTaxesPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongTermDebt" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongTermDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_InsulinAnalogProducts" abstract="false" name="InsulinAnalogProducts" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="vtrs_YENTermLoanMember" abstract="true" name="YENTermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_ThreeFullFiscalQuartersFollowingQualifyingAcquisitionMember" abstract="true" name="ThreeFullFiscalQuartersFollowingQualifyingAcquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_VariableConsiderationMember" abstract="true" name="VariableConsiderationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_BusinessCombinationAbstract" abstract="true" name="BusinessCombinationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="vtrs_DeferredTaxAssetsDeferredtaxexpenseinterestexpense" abstract="false" name="DeferredTaxAssetsDeferredtaxexpenseinterestexpense" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_ImpairmentofEquityMethodInvestments" abstract="false" name="ImpairmentofEquityMethodInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_EuropeSegmentMember" abstract="true" name="EuropeSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_MultiDistrictLitigationMember" abstract="true" name="MultiDistrictLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_StockExchangedDuringPeriodSharesExchanged" abstract="false" name="StockExchangedDuringPeriodSharesExchanged" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="vtrs_ReductioninEquityMethodInvestmentLongTermObligation" abstract="false" name="ReductioninEquityMethodInvestmentLongTermObligation" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_Numberofcases" abstract="false" name="Numberofcases" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="vtrs_DeferredTaxAssetsOperatingLeaseRightofUseAssets" abstract="false" name="DeferredTaxAssetsOperatingLeaseRightofUseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_TOBIMember" abstract="true" name="TOBIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_FiscalYear2017Member" abstract="true" name="FiscalYear2017Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_OneTimeSpecialPerformanceBasedFiveYearRealizableValueIncentiveProgramMember" abstract="true" name="OneTimeSpecialPerformanceBasedFiveYearRealizableValueIncentiveProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_VestingPeriodDomain" abstract="true" name="VestingPeriodDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_VariableConsiderationReturnsMember" abstract="true" name="VariableConsiderationReturnsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_TwentyTwentyOneLoanFacilitiesMember" abstract="true" name="TwentyTwentyOneLoanFacilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_EURIBORMember" abstract="true" name="EURIBORMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_DeferredTaxLiabilitiesOperatingLeaseLiability" abstract="false" name="DeferredTaxLiabilitiesOperatingLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_AgilaSpecialtiesPrivateLimitedMember" abstract="true" name="AgilaSpecialtiesPrivateLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_PfizerInc.Member" abstract="true" name="PfizerInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_BusinessCombinationLimitedTransitionServicesPaymentPeriod" abstract="false" name="BusinessCombinationLimitedTransitionServicesPaymentPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="vtrs_NoteSecuritizationFacilityMember" abstract="true" name="NoteSecuritizationFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_OtherMember" abstract="true" name="OtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_LipitorMember" abstract="true" name="LipitorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_AccountsReceivableVariableConsiderationRollForward" abstract="true" name="AccountsReceivableVariableConsiderationRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="vtrs_Otherlongtermassets" abstract="false" name="Otherlongtermassets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_FKBMember" abstract="true" name="FKBMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_MeasurementInputReductionInTerminalYearRevenueGrowthRateMember" abstract="true" name="MeasurementInputReductionInTerminalYearRevenueGrowthRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember" abstract="true" name="A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_CreonMember" abstract="true" name="CreonMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_PaymentsforBusinessSeparation" abstract="false" name="PaymentsforBusinessSeparation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_ContingentConsiderationMember" abstract="true" name="ContingentConsiderationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_LyricaMember" abstract="true" name="LyricaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_Developmentandsalesmilestonepayments" abstract="false" name="Developmentandsalesmilestonepayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_RestructuringReserveReimbursableRestructuringCharges" abstract="false" name="RestructuringReserveReimbursableRestructuringCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_BusinessAcquisitionexpectedfuturepaymentyeartwo" abstract="false" name="BusinessAcquisitionexpectedfuturepaymentyeartwo" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_Netrealizablevalueofinventoryrecognizedasexpense" abstract="false" name="Netrealizablevalueofinventoryrecognizedasexpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_PaymentsForNonContingentConsiderationForProductRightsFinancingActivities" abstract="false" name="PaymentsForNonContingentConsiderationForProductRightsFinancingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_DivestitureOfBusinessTransitionServicesAgreementTerm" abstract="false" name="DivestitureOfBusinessTransitionServicesAgreementTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="vtrs_LossContingencyDamagesAwardedOnAppealValue" abstract="false" name="LossContingencyDamagesAwardedOnAppealValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_EUCommissionProceedingsPerindorprilMember" abstract="true" name="EUCommissionProceedingsPerindorprilMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_AspenGlobalIncorporatedMember" abstract="true" name="AspenGlobalIncorporatedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_LossContingencyRemainingClaimsNumber" abstract="false" name="LossContingencyRemainingClaimsNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="vtrs_BrandsMember" abstract="true" name="BrandsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_Chargebacks" abstract="false" name="Chargebacks" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_A2025EuroSeniorNotesMember" abstract="true" name="A2025EuroSeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_VestingPeriodAxis" abstract="true" name="VestingPeriodAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="vtrs_OtherOneTimeNonoperatingExpense" abstract="false" name="OtherOneTimeNonoperatingExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_NorthAmericaSpecialtyMember" abstract="true" name="NorthAmericaSpecialtyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_MomentaMember" abstract="true" name="MomentaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_BusinessCombinationContractualReimbursementAmountAmountsExpensed" abstract="false" name="BusinessCombinationContractualReimbursementAmountAmountsExpensed" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_DimethylFumarateMember" abstract="true" name="DimethylFumarateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_GoodwillImpairmentMeasurementInputTerm" abstract="false" name="GoodwillImpairmentMeasurementInputTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="vtrs_LossContingencyNumberOfStates" abstract="false" name="LossContingencyNumberOfStates" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="vtrs_BalanceSheetComponentsAbstract" abstract="true" name="BalanceSheetComponentsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="vtrs_A2040SeniorNotesMember" abstract="true" name="A2040SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_BusinessCombinationNumberOfMarketsServed" abstract="false" name="BusinessCombinationNumberOfMarketsServed" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="vtrs_SeniorNotesTwoThousandEighteen3.0PercentMember" abstract="true" name="SeniorNotesTwoThousandEighteen3.0PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_OtherforeignMember" abstract="true" name="OtherforeignMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_A2027EuroSeniorNotesMember" abstract="true" name="A2027EuroSeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_A2020RevolvingFacilityMember" abstract="true" name="A2020RevolvingFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_GoodwillImpairmentTestMeasurementInputReduction" abstract="false" name="GoodwillImpairmentTestMeasurementInputReduction" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:decimalItemType"/>
  <xs:element id="vtrs_MeasurementInputIncreaseInDiscountRateMember" abstract="true" name="MeasurementInputIncreaseInDiscountRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_IncomeTaxExaminationReserveImpactOnIncomeTaxProvision" abstract="false" name="IncomeTaxExaminationReserveImpactOnIncomeTaxProvision" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_U.S.FederalTaxAuthorityMember" abstract="true" name="U.S.FederalTaxAuthorityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_EUCommissionProceedingsCitalopramMember" abstract="true" name="EUCommissionProceedingsCitalopramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_GreaterChinaSegmentMember" abstract="true" name="GreaterChinaSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_TermLoanMember" abstract="true" name="TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_VestinthreeyearsorlessMember" abstract="true" name="VestinthreeyearsorlessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_VariableConsiderationCategoryDomain" abstract="true" name="VariableConsiderationCategoryDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_RevenuefromContractwithCustomerReturns" abstract="false" name="RevenuefromContractwithCustomerReturns" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_A2024EuroSeniorNotes1023Member" abstract="true" name="A2024EuroSeniorNotes1023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_EffectiveIncomeTaxRateReconciliationGILTIPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationGILTIPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="vtrs_UpjohnEuroNotesMember" abstract="true" name="UpjohnEuroNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_DivestitureOfBusinessDeferredCashConsideration" abstract="false" name="DivestitureOfBusinessDeferredCashConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_TwentyTwentyOneRevolvingFacilityMember" abstract="true" name="TwentyTwentyOneRevolvingFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_CurrentPortionofLongTermDebtMember" abstract="true" name="CurrentPortionofLongTermDebtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_EquityMethodInvestmentSummarizedFinancialInformationNetAssets" abstract="false" name="EquityMethodInvestmentSummarizedFinancialInformationNetAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_JapanAustraliaAndNewZealandSegmentMember" abstract="true" name="JapanAustraliaAndNewZealandSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_A2016TermLoansMember" abstract="true" name="A2016TermLoansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_AmortizationOfInventoryStepUp" abstract="false" name="AmortizationOfInventoryStepUp" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAndLaterFairValue" abstract="false" name="AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAndLaterFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_UnregisteredUpjohnUSDollarNotesMember" abstract="true" name="UnregisteredUpjohnUSDollarNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_SeniorNotesTwoThousandNineteenMember" abstract="true" name="SeniorNotesTwoThousandNineteenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_Netaccruedbenefitcosts" abstract="false" name="Netaccruedbenefitcosts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_InfluvacMember" abstract="true" name="InfluvacMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_JaiPharmaLimitedMember" abstract="true" name="JaiPharmaLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss" abstract="false" name="BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_DefinedBenefitPensionPlanswithProjectedBenefitObligationInExcessofPlanAssetsAggregateProjectedBenefitObligation" abstract="false" name="DefinedBenefitPensionPlanswithProjectedBenefitObligationInExcessofPlanAssetsAggregateProjectedBenefitObligation" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_InsulinGlargineMember" abstract="true" name="InsulinGlargineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_DevelopmentMilestonePayments" abstract="false" name="DevelopmentMilestonePayments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_XanaxMember" abstract="true" name="XanaxMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_A2016RestructuringProgramMember" abstract="true" name="A2016RestructuringProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_ProgramNameAxis" abstract="true" name="ProgramNameAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="vtrs_MckessonCorporationMember" abstract="true" name="MckessonCorporationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock" abstract="false" name="ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="vtrs_ProgramNameDomain" abstract="true" name="ProgramNameDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_IncomeTaxExaminationReserveForUncertainTaxPosition" abstract="false" name="IncomeTaxExaminationReserveForUncertainTaxPosition" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_OtherCurrentPortionofLongtermDebtMember" abstract="true" name="OtherCurrentPortionofLongtermDebtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_AspenPharmacareHoldingsLimitedMember" abstract="true" name="AspenPharmacareHoldingsLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsCurrent" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsCurrent" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_RevanceMember" abstract="true" name="RevanceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_April2018SeniorNotesMember" abstract="true" name="April2018SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_NumberOfProducts" abstract="false" name="NumberOfProducts" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="vtrs_StockExchangedDuringPeriodValue" abstract="false" name="StockExchangedDuringPeriodValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_FutureyearsMember" abstract="true" name="FutureyearsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_SeniorNotesTwoThousandTwenty3.75PercentMember" abstract="true" name="SeniorNotesTwoThousandTwenty3.75PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_AntitrustProceedingsMember" abstract="true" name="AntitrustProceedingsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_DeferredBaseSalaryMember" abstract="true" name="DeferredBaseSalaryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_EffectiveIncomeTaxRateReconciliationIndiaAmagulation" abstract="false" name="EffectiveIncomeTaxRateReconciliationIndiaAmagulation" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="vtrs_LossContingencyOtherAssertedPatentsNumber" abstract="false" name="LossContingencyOtherAssertedPatentsNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="vtrs_NonU.S.statetaxauthorityMember" abstract="true" name="NonU.S.statetaxauthorityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_BusinessCombinationContingentConsiderationLiabilityPayments" abstract="false" name="BusinessCombinationContingentConsiderationLiabilityPayments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_A2048SeniorNotesMember" abstract="true" name="A2048SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_A2024EuroSeniorNotesMember" abstract="true" name="A2024EuroSeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_AnticompetitiveConductwithGenericDrugsMember" abstract="true" name="AnticompetitiveConductwithGenericDrugsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_MarketableSecuritiesMember" abstract="true" name="MarketableSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_NorthAmericaSegmentMember" abstract="true" name="NorthAmericaSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_SalesRevenueGrosstonetadjustments" abstract="false" name="SalesRevenueGrosstonetadjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_NumberOfMolecules" abstract="false" name="NumberOfMolecules" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="vtrs_LesseeOperatingLeaseLeaseNotyetCommencedAmount" abstract="false" name="LesseeOperatingLeaseLeaseNotyetCommencedAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_SeniorNotesTwoThousandFortyThreeMember" abstract="true" name="SeniorNotesTwoThousandFortyThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_MeasurementInputEstimatedTaxRateMember" abstract="true" name="MeasurementInputEstimatedTaxRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax" abstract="false" name="AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember" abstract="true" name="SeniorNotesTwoThousandTwentyThree4.2PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesCurrent" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesCurrent" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_A2022EuroSeniorNotesMember" abstract="true" name="A2022EuroSeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentAssets" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_A2016SeniorRevolvingCreditFacilityMember" abstract="true" name="A2016SeniorRevolvingCreditFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_CelebrexMember" abstract="true" name="CelebrexMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_EffectiveIncomeTaxRateReconciliationWaivedDeductionsPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationWaivedDeductionsPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="vtrs_A2014ProgramMember" abstract="true" name="A2014ProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_MeasurementInputTerminalYearRevenueGrowthRateMember" abstract="true" name="MeasurementInputTerminalYearRevenueGrowthRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_TheravanceBiopharmaMember" abstract="true" name="TheravanceBiopharmaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_AnticompetitiveConductWithRespectToAdditionalGenericDrugsMember" abstract="true" name="AnticompetitiveConductWithRespectToAdditionalGenericDrugsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_SubjectToMarketConditionsMember" abstract="true" name="SubjectToMarketConditionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_U.S.StateTaxAuthorityMember" abstract="true" name="U.S.StateTaxAuthorityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_DeferredTaxAssetsIntangibleAssets" abstract="false" name="DeferredTaxAssetsIntangibleAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember" abstract="true" name="AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_EpiPenAutoInjectorLitigationMember" abstract="true" name="EpiPenAutoInjectorLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_A2018SeniorRevolvingCreditFacilityMember" abstract="true" name="A2018SeniorRevolvingCreditFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_EquityMethodInvestmentsNetGainLossFromImpairmentandReductionInObligations" abstract="false" name="EquityMethodInvestmentsNetGainLossFromImpairmentandReductionInObligations" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment" abstract="false" name="StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="vtrs_DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAssetsTransferredtofromPlan" abstract="false" name="DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAssetsTransferredtofromPlan" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_CollaborationsAbstract" abstract="true" name="CollaborationsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="vtrs_ScheduleofothercurrentliabilitiesTable" abstract="true" name="ScheduleofothercurrentliabilitiesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="vtrs_A2022SeniorNotesMember" abstract="true" name="A2022SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_A2028SeniorNotesMember" abstract="true" name="A2028SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_MaximumLeverageRatioPeriodThree" abstract="false" name="MaximumLeverageRatioPeriodThree" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="vtrs_SubjecttoMarketConditionsAxis" abstract="true" name="SubjecttoMarketConditionsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="vtrs_BusinessCombinationsNumberOfAgreements" abstract="false" name="BusinessCombinationsNumberOfAgreements" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="vtrs_NotSubjecttoMarketConditionsMember" abstract="true" name="NotSubjecttoMarketConditionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_DebtInstrumentConversionOfUnregisteredNotesToRegisteredNotesAsAPercentage" abstract="false" name="DebtInstrumentConversionOfUnregisteredNotesToRegisteredNotesAsAPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="vtrs_NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement" abstract="false" name="NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="vtrs_Numberofequitymethodinvestments" abstract="false" name="Numberofequitymethodinvestments" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="vtrs_A2020EuroSeniorNotesMember" abstract="true" name="A2020EuroSeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_ViagraMember" abstract="true" name="ViagraMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_ScheduleofOtherNoncurrentLiabilitiesTable" abstract="true" name="ScheduleofOtherNoncurrentLiabilitiesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="vtrs_ReductioninTerminalValueGrowthRateDomain" abstract="true" name="ReductioninTerminalValueGrowthRateDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_ScheduleofOtherAssetsLineItems" abstract="true" name="ScheduleofOtherAssetsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="vtrs_A2028EuroSeniorNotesMember" abstract="true" name="A2028EuroSeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationExpectedLongtermReturnonAssets" abstract="false" name="DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationExpectedLongtermReturnonAssets" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="vtrs_NumberOfDrugs" abstract="false" name="NumberOfDrugs" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="vtrs_YupelriMember" abstract="true" name="YupelriMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_TransitionServiceAgreementsMember" abstract="true" name="TransitionServiceAgreementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_BiosimilarsBusinessMember" abstract="true" name="BiosimilarsBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_DymistaMember" abstract="true" name="DymistaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_TrailingFourQuartersMember" abstract="true" name="TrailingFourQuartersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_SubjecttoMarketConditionsDomain" abstract="true" name="SubjecttoMarketConditionsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_U.K.CompetitionandMarketsAuthorityProceedingsParoxetineMember" abstract="true" name="U.K.CompetitionandMarketsAuthorityProceedingsParoxetineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_AccountsReceivableCreditsIssuedtoThirdParties" abstract="false" name="AccountsReceivableCreditsIssuedtoThirdParties" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="vtrs_AmitizaMember" abstract="true" name="AmitizaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_Concentrationrisknumberofmajorcustomers" abstract="false" name="Concentrationrisknumberofmajorcustomers" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="vtrs_ScheduleofOtherAssetsTable" abstract="true" name="ScheduleofOtherAssetsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="vtrs_VestratablyinfiveyearsorlessMember" abstract="true" name="VestratablyinfiveyearsorlessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassTable" abstract="true" name="ScheduleOfProductRightsAndLicensesByTherapeuticClassTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember" abstract="true" name="SeniorNotesTwoThousandFortySix5.25PrecentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_VariableConsiderationCategoryAxis" abstract="true" name="VariableConsiderationCategoryAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="vtrs_BusinessAcquisitionexpectedfuturepaymentsnexttwelvemonths" abstract="false" name="BusinessAcquisitionexpectedfuturepaymentsnexttwelvemonths" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_A2030SeniorNotesMember" abstract="true" name="A2030SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_RespiratorydeliveryplatformMember" abstract="true" name="RespiratorydeliveryplatformMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_ZoloftMember" abstract="true" name="ZoloftMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_ThreeCustomersMember" abstract="true" name="ThreeCustomersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_GovernmentalRebateProgramsMember" abstract="true" name="GovernmentalRebateProgramsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_OtherComprehensiveIncomeDefinedBenefitPlanForeignCurrencyTranslationBeforeTax" abstract="false" name="OtherComprehensiveIncomeDefinedBenefitPlanForeignCurrencyTranslationBeforeTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_A2032EuroSeniorNotesMember" abstract="true" name="A2032EuroSeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_DefinedBenefitPlanForeignCurrencyTranslationImpactonPlanAssets" abstract="false" name="DefinedBenefitPlanForeignCurrencyTranslationImpactonPlanAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_PeriodAxis" abstract="true" name="PeriodAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="vtrs_AccountsReceivableEffectsofForeignExchangeRates" abstract="false" name="AccountsReceivableEffectsofForeignExchangeRates" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_ReductioninSharebasedCompensationExpense" abstract="false" name="ReductioninSharebasedCompensationExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_AccretionExpenseToBeRecognizedWithinTheNextTwelveMonths" abstract="false" name="AccretionExpenseToBeRecognizedWithinTheNextTwelveMonths" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_CommercialPaperProgramMember" abstract="true" name="CommercialPaperProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_SeniorNotesTwoThousandEighteen2.6PercentMember" abstract="true" name="SeniorNotesTwoThousandEighteen2.6PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_UpjohnInc.Member" abstract="true" name="UpjohnInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_BusinessCombinationContractualReimbursementAmountTrancheOne" abstract="false" name="BusinessCombinationContractualReimbursementAmountTrancheOne" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_RevenuefromContractwithCustomerGross" abstract="false" name="RevenuefromContractwithCustomerGross" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_SeniorNotesTwoThousandNineteen2.50PrecentMember" abstract="true" name="SeniorNotesTwoThousandNineteen2.50PrecentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_EpiPenAutoInjectorsMember" abstract="true" name="EpiPenAutoInjectorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_DivestitureOfBusinessPercentageOwnershipInCombinedCompanyAfterTransaction" abstract="false" name="DivestitureOfBusinessPercentageOwnershipInCombinedCompanyAfterTransaction" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="vtrs_Corporatecosts" abstract="false" name="Corporatecosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_GenericBiologicCompoundsCollaborationMember" abstract="true" name="GenericBiologicCompoundsCollaborationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_IndefiniteMember" abstract="true" name="IndefiniteMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_ScheduleofothercurrentliabilitiesLineItems" abstract="true" name="ScheduleofothercurrentliabilitiesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="vtrs_ChargebacksMember" abstract="true" name="ChargebacksMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vtrs_FairValueInputsLongtermRevenueGrowthRateTerminalYear" abstract="false" name="FairValueInputsLongtermRevenueGrowthRateTerminalYear" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="vtrs_PaymentsToAcquireCollaborativeAgreement" abstract="false" name="PaymentsToAcquireCollaborativeAgreement" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_Medicaidandothergovernmentalrebates" abstract="false" name="Medicaidandothergovernmentalrebates" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vtrs_NumberOfManufacturingSites" abstract="false" name="NumberOfManufacturingSites" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="vtrs_ComplexGXAndBiosimilarsMember" abstract="true" name="ComplexGXAndBiosimilarsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>vtrs-20211231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:7d588a56-150d-4ea9-a97c-5b39f92c59e0,g:83cb92d0-838c-40d0-a420-8487c2f4fc1b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.viatris.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="vtrs-20211231.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5ab7520d-dcc8-4e60-a192-57f5efd9c7da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_73b05fa2-10b8-4fbc-8cef-8b937280ceb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5ab7520d-dcc8-4e60-a192-57f5efd9c7da" xlink:to="loc_us-gaap_AdditionalPaidInCapital_73b05fa2-10b8-4fbc-8cef-8b937280ceb2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_1209926d-2b43-4085-b82f-ff216b265b0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5ab7520d-dcc8-4e60-a192-57f5efd9c7da" xlink:to="loc_us-gaap_CommonStockValue_1209926d-2b43-4085-b82f-ff216b265b0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ff7c6e64-9807-4095-8ca1-197ad0016ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5ab7520d-dcc8-4e60-a192-57f5efd9c7da" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ff7c6e64-9807-4095-8ca1-197ad0016ca7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_79324935-7f69-42c1-99be-0ed3419a4652" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5ab7520d-dcc8-4e60-a192-57f5efd9c7da" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_79324935-7f69-42c1-99be-0ed3419a4652" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_166b6d95-3e72-4c2f-8fd0-892558383fc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2e76a3d1-6a10-4fe8-a84b-c9e366ada551" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_166b6d95-3e72-4c2f-8fd0-892558383fc0" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2e76a3d1-6a10-4fe8-a84b-c9e366ada551" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_e5f72572-465e-46f0-b37d-32f2a62a12b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_166b6d95-3e72-4c2f-8fd0-892558383fc0" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_e5f72572-465e-46f0-b37d-32f2a62a12b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_4644672f-b9f6-4d53-8e9c-e8f66d10fb18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_166b6d95-3e72-4c2f-8fd0-892558383fc0" xlink:to="loc_us-gaap_InventoryNet_4644672f-b9f6-4d53-8e9c-e8f66d10fb18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_7e135a37-d9f0-4be7-a6a0-eb34965b4268" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_166b6d95-3e72-4c2f-8fd0-892558383fc0" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_7e135a37-d9f0-4be7-a6a0-eb34965b4268" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_fe567d50-551d-430d-b86b-5e269499d527" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_26f57d65-4a98-4f44-b794-379c51a461e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_fe567d50-551d-430d-b86b-5e269499d527" xlink:to="loc_us-gaap_AssetsCurrent_26f57d65-4a98-4f44-b794-379c51a461e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_b646d8c3-62ae-416b-a861-eb50c321d44a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_fe567d50-551d-430d-b86b-5e269499d527" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_b646d8c3-62ae-416b-a861-eb50c321d44a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_4c2ef07a-dc36-4ce4-b016-86083b539350" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_fe567d50-551d-430d-b86b-5e269499d527" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_4c2ef07a-dc36-4ce4-b016-86083b539350" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_31d1a3b4-177f-48e7-a3c8-86a25ec6c488" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_fe567d50-551d-430d-b86b-5e269499d527" xlink:to="loc_us-gaap_Goodwill_31d1a3b4-177f-48e7-a3c8-86a25ec6c488" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_8816659d-0580-4b20-b1f0-105b07f77e95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_fe567d50-551d-430d-b86b-5e269499d527" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_8816659d-0580-4b20-b1f0-105b07f77e95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_25745a27-cd1e-450e-a88b-8f4b23f7ecb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_fe567d50-551d-430d-b86b-5e269499d527" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_25745a27-cd1e-450e-a88b-8f4b23f7ecb3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_36fbc956-8c87-412d-87ce-d8d5fe2642ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_829613c3-2a65-4a70-9788-2ff6d6b8faf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_36fbc956-8c87-412d-87ce-d8d5fe2642ab" xlink:to="loc_us-gaap_LiabilitiesCurrent_829613c3-2a65-4a70-9788-2ff6d6b8faf2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_a78e20f8-18c8-4ae1-ba91-22b6ff378e0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_36fbc956-8c87-412d-87ce-d8d5fe2642ab" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_a78e20f8-18c8-4ae1-ba91-22b6ff378e0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_8c7d68d6-04d9-48af-955d-89babdf86548" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_36fbc956-8c87-412d-87ce-d8d5fe2642ab" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_8c7d68d6-04d9-48af-955d-89babdf86548" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_d2015466-34a3-4d06-ac0f-399a5d77921b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_36fbc956-8c87-412d-87ce-d8d5fe2642ab" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_d2015466-34a3-4d06-ac0f-399a5d77921b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_e2d5c7b5-fecf-4cc8-87f2-88cc12a2fd93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_15ae4708-d031-497c-ba67-ac3b9b0f64f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e2d5c7b5-fecf-4cc8-87f2-88cc12a2fd93" xlink:to="loc_us-gaap_Liabilities_15ae4708-d031-497c-ba67-ac3b9b0f64f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8e9f749a-f577-45bb-8499-0c9da0aafe41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e2d5c7b5-fecf-4cc8-87f2-88cc12a2fd93" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8e9f749a-f577-45bb-8499-0c9da0aafe41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_f8e695f3-2383-4571-affb-c96180f23f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_1cd72e24-e6ba-4cf6-952d-2c7b85ba8fbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_f8e695f3-2383-4571-affb-c96180f23f5a" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_1cd72e24-e6ba-4cf6-952d-2c7b85ba8fbd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_62263d68-4ac9-4404-91aa-1795cf368a85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_f8e695f3-2383-4571-affb-c96180f23f5a" xlink:to="loc_us-gaap_ShortTermBorrowings_62263d68-4ac9-4404-91aa-1795cf368a85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_e7c04b7c-ef73-4bd6-8fae-869d9fa7f24f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_f8e695f3-2383-4571-affb-c96180f23f5a" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_e7c04b7c-ef73-4bd6-8fae-869d9fa7f24f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_7b4262d9-5c5f-419a-9e73-86767c487c8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_f8e695f3-2383-4571-affb-c96180f23f5a" xlink:to="loc_us-gaap_LongTermDebtCurrent_7b4262d9-5c5f-419a-9e73-86767c487c8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_2ed77e9c-46f1-4398-957c-bc5e70dcfc08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_f8e695f3-2383-4571-affb-c96180f23f5a" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_2ed77e9c-46f1-4398-957c-bc5e70dcfc08" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="vtrs-20211231.xsd#ConsolidatedStatementsofOperations"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3996dd8e-6f52-4d5a-ad5e-27f11d32b972" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_174dcc44-3034-4cec-abcb-e88b71d58dc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3996dd8e-6f52-4d5a-ad5e-27f11d32b972" xlink:to="loc_us-gaap_OperatingIncomeLoss_174dcc44-3034-4cec-abcb-e88b71d58dc8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_3ba61747-a7ff-42c0-a395-dfa22bf3d1e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3996dd8e-6f52-4d5a-ad5e-27f11d32b972" xlink:to="loc_us-gaap_InterestExpense_3ba61747-a7ff-42c0-a395-dfa22bf3d1e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_caf5425f-6312-4a9c-a0f9-11bfccfbf5ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3996dd8e-6f52-4d5a-ad5e-27f11d32b972" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_caf5425f-6312-4a9c-a0f9-11bfccfbf5ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_bedb0c93-47ab-487a-b0bc-7e4b40d0ce34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_45fb6e04-913b-4a75-907c-fcc2ccfebbd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_bedb0c93-47ab-487a-b0bc-7e4b40d0ce34" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_45fb6e04-913b-4a75-907c-fcc2ccfebbd4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_4fd9007d-fe23-4d77-93d4-9a00300a964b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_bedb0c93-47ab-487a-b0bc-7e4b40d0ce34" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_4fd9007d-fe23-4d77-93d4-9a00300a964b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_5e238301-e244-42e6-83dc-03ad92798a43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_34439413-96bb-4a0a-a46a-1fb935156f71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_5e238301-e244-42e6-83dc-03ad92798a43" xlink:to="loc_us-gaap_Revenues_34439413-96bb-4a0a-a46a-1fb935156f71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_f823c1bd-ffc9-4bea-a7df-4c9490989c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_5e238301-e244-42e6-83dc-03ad92798a43" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_f823c1bd-ffc9-4bea-a7df-4c9490989c6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_19e08480-ce92-4948-8ec1-6f2cd7e72d16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_5509c513-e182-4fcb-843a-0d5aefa435de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_19e08480-ce92-4948-8ec1-6f2cd7e72d16" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_5509c513-e182-4fcb-843a-0d5aefa435de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_31838d5f-1569-4e0c-84dd-a5567925c92c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_19e08480-ce92-4948-8ec1-6f2cd7e72d16" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_31838d5f-1569-4e0c-84dd-a5567925c92c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_60d84c00-6b2c-4090-a4de-29f6ac94d649" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_19e08480-ce92-4948-8ec1-6f2cd7e72d16" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_60d84c00-6b2c-4090-a4de-29f6ac94d649" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_c10bb364-124e-4481-8238-ad6991d30799" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer_56bc421b-963f-4775-9ebd-3fa5d3d09586" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_c10bb364-124e-4481-8238-ad6991d30799" xlink:to="loc_us-gaap_RevenueNotFromContractWithCustomer_56bc421b-963f-4775-9ebd-3fa5d3d09586" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b05358b7-3771-47c4-a4a7-4098e568cff7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_c10bb364-124e-4481-8238-ad6991d30799" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b05358b7-3771-47c4-a4a7-4098e568cff7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_d8a5cb31-31ae-46ef-877c-d944e0c5de98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_a6dfded3-159a-4dd5-9463-0bdc14eee908" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_d8a5cb31-31ae-46ef-877c-d944e0c5de98" xlink:to="loc_us-gaap_GrossProfit_a6dfded3-159a-4dd5-9463-0bdc14eee908" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_29a3230f-ae81-4d24-96a9-d31d34996af4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_d8a5cb31-31ae-46ef-877c-d944e0c5de98" xlink:to="loc_us-gaap_OperatingExpenses_29a3230f-ae81-4d24-96a9-d31d34996af4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ConsolidatedStatementsofComprehensiveEarnings" xlink:type="simple" xlink:href="vtrs-20211231.xsd#ConsolidatedStatementsofComprehensiveEarnings"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/ConsolidatedStatementsofComprehensiveEarnings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_61401122-e91a-40c9-812d-62dcfc14eb6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c1bfe8bd-f6b9-442a-8bc7-c2970790b86e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_61401122-e91a-40c9-812d-62dcfc14eb6a" xlink:to="loc_us-gaap_ProfitLoss_c1bfe8bd-f6b9-442a-8bc7-c2970790b86e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_592a26a9-3b31-4199-a6a5-b64ee75105de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_61401122-e91a-40c9-812d-62dcfc14eb6a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_592a26a9-3b31-4199-a6a5-b64ee75105de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_e5dcde2b-d08e-4f2e-a759-8783c5a56b55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_27f7f202-ea9e-48f7-8bc4-44a6629cd56d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_e5dcde2b-d08e-4f2e-a759-8783c5a56b55" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_27f7f202-ea9e-48f7-8bc4-44a6629cd56d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_8732e199-795e-486d-88c7-7a67539ffa8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_e5dcde2b-d08e-4f2e-a759-8783c5a56b55" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_8732e199-795e-486d-88c7-7a67539ffa8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_21e01d0b-f553-4e27-8251-6e06f8997b19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_e5dcde2b-d08e-4f2e-a759-8783c5a56b55" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_21e01d0b-f553-4e27-8251-6e06f8997b19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_2bd88faf-c440-419c-8b2a-51483b465705" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_e5dcde2b-d08e-4f2e-a759-8783c5a56b55" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_2bd88faf-c440-419c-8b2a-51483b465705" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_93fc03cb-fc96-4b6d-8a5f-7786bc1af821" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_2f7eff9f-8a7c-441a-b8cd-71f644e26259" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_93fc03cb-fc96-4b6d-8a5f-7786bc1af821" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_2f7eff9f-8a7c-441a-b8cd-71f644e26259" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_5485d630-1391-4a01-b5df-b71cf07662f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_93fc03cb-fc96-4b6d-8a5f-7786bc1af821" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_5485d630-1391-4a01-b5df-b71cf07662f4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="vtrs-20211231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_285077a9-2d02-46e5-9c49-58f4f710b81d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_0003d039-2848-4286-a21c-150d429b284c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_285077a9-2d02-46e5-9c49-58f4f710b81d" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_0003d039-2848-4286-a21c-150d429b284c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_fcc3dc01-e8c3-4cc3-a1ac-32f265157736" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_285077a9-2d02-46e5-9c49-58f4f710b81d" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_fcc3dc01-e8c3-4cc3-a1ac-32f265157736" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_28a5534b-a457-44a5-b1a7-a50d2e74c38d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_285077a9-2d02-46e5-9c49-58f4f710b81d" xlink:to="loc_us-gaap_PaymentsOfFinancingCosts_28a5534b-a457-44a5-b1a7-a50d2e74c38d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_db246158-678e-4275-83b0-886233da4335" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_285077a9-2d02-46e5-9c49-58f4f710b81d" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_db246158-678e-4275-83b0-886233da4335" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_f447bf42-e631-498e-bc18-402eff194f8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_285077a9-2d02-46e5-9c49-58f4f710b81d" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_f447bf42-e631-498e-bc18-402eff194f8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3a505a1b-0207-4022-bb60-7a283e11a07d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_285077a9-2d02-46e5-9c49-58f4f710b81d" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3a505a1b-0207-4022-bb60-7a283e11a07d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities_b09100e1-8a4e-467b-91e3-39bae5f4d6da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_285077a9-2d02-46e5-9c49-58f4f710b81d" xlink:to="loc_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities_b09100e1-8a4e-467b-91e3-39bae5f4d6da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_697e50ae-63c2-4b7d-a104-f7c8cc952a34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_285077a9-2d02-46e5-9c49-58f4f710b81d" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_697e50ae-63c2-4b7d-a104-f7c8cc952a34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_2d344076-5b88-4dde-9824-fc81463c2fbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_285077a9-2d02-46e5-9c49-58f4f710b81d" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_2d344076-5b88-4dde-9824-fc81463c2fbf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PaymentsForNonContingentConsiderationForProductRightsFinancingActivities_bdd26385-402b-4069-9e77-381a46a31e5b" xlink:href="vtrs-20211231.xsd#vtrs_PaymentsForNonContingentConsiderationForProductRightsFinancingActivities"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_285077a9-2d02-46e5-9c49-58f4f710b81d" xlink:to="loc_vtrs_PaymentsForNonContingentConsiderationForProductRightsFinancingActivities_bdd26385-402b-4069-9e77-381a46a31e5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_722ff9b1-9c72-42dc-b65b-4960f5fe63df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_71022310-ff7e-479e-89f0-641b4ae904cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_722ff9b1-9c72-42dc-b65b-4960f5fe63df" xlink:to="loc_us-gaap_ProfitLoss_71022310-ff7e-479e-89f0-641b4ae904cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_b464e74c-e353-4561-9a3b-deedfa086aa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_722ff9b1-9c72-42dc-b65b-4960f5fe63df" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_b464e74c-e353-4561-9a3b-deedfa086aa6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_2bc5c154-3bd1-4691-8e80-53d847e75784" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_722ff9b1-9c72-42dc-b65b-4960f5fe63df" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_2bc5c154-3bd1-4691-8e80-53d847e75784" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Changeinnoncashlitigationsettlementsnet_74170b9e-6e09-471a-a101-221cd7d32ac1" xlink:href="vtrs-20211231.xsd#vtrs_Changeinnoncashlitigationsettlementsnet"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_722ff9b1-9c72-42dc-b65b-4960f5fe63df" xlink:to="loc_vtrs_Changeinnoncashlitigationsettlementsnet_74170b9e-6e09-471a-a101-221cd7d32ac1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_92073d6b-4504-4979-a29d-3a83acab30ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_722ff9b1-9c72-42dc-b65b-4960f5fe63df" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_92073d6b-4504-4979-a29d-3a83acab30ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_25a15b97-4c92-4878-ab40-42ce4716c1fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_722ff9b1-9c72-42dc-b65b-4960f5fe63df" xlink:to="loc_us-gaap_ShareBasedCompensation_25a15b97-4c92-4878-ab40-42ce4716c1fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_093de3f3-d44b-4bc0-b462-bd5063a86d44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_722ff9b1-9c72-42dc-b65b-4960f5fe63df" xlink:to="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_093de3f3-d44b-4bc0-b462-bd5063a86d44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_48e16f0f-bd0b-4ce1-9fae-309c74df6d67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_722ff9b1-9c72-42dc-b65b-4960f5fe63df" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_48e16f0f-bd0b-4ce1-9fae-309c74df6d67" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_16231f2a-6678-4217-ad8f-f98d84eabdf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_722ff9b1-9c72-42dc-b65b-4960f5fe63df" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_16231f2a-6678-4217-ad8f-f98d84eabdf2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_b6afd314-d5f8-41b8-8ccc-b291425d9f7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_722ff9b1-9c72-42dc-b65b-4960f5fe63df" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_b6afd314-d5f8-41b8-8ccc-b291425d9f7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_5e459f39-e018-4e05-ac58-9069d70ec913" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_722ff9b1-9c72-42dc-b65b-4960f5fe63df" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_5e459f39-e018-4e05-ac58-9069d70ec913" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_f19c492b-e643-4d34-93b5-40ddc94a8c1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_722ff9b1-9c72-42dc-b65b-4960f5fe63df" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_f19c492b-e643-4d34-93b5-40ddc94a8c1c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_3be74902-9884-4af4-a8b9-dcbd7dd4d407" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_722ff9b1-9c72-42dc-b65b-4960f5fe63df" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_3be74902-9884-4af4-a8b9-dcbd7dd4d407" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_412f407e-047a-476c-a042-8200bd3cf4bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_527450f3-31d9-4546-ba44-62ddad5d05c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_412f407e-047a-476c-a042-8200bd3cf4bd" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_527450f3-31d9-4546-ba44-62ddad5d05c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_774476c4-f4d8-46bc-b4d3-d1121da2284a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_412f407e-047a-476c-a042-8200bd3cf4bd" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_774476c4-f4d8-46bc-b4d3-d1121da2284a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f5aafa48-f241-4c5d-96f5-f4759fbfd8e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_412f407e-047a-476c-a042-8200bd3cf4bd" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f5aafa48-f241-4c5d-96f5-f4759fbfd8e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8f8210e1-072c-4236-90b0-e035c51393ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_412f407e-047a-476c-a042-8200bd3cf4bd" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8f8210e1-072c-4236-90b0-e035c51393ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_289243b6-8fe0-498d-9932-65621499d8fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_612ff0df-4a3b-49d1-8f0b-a100fa7ed52b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_289243b6-8fe0-498d-9932-65621499d8fe" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_612ff0df-4a3b-49d1-8f0b-a100fa7ed52b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_a2ce8293-5021-4a3b-92ab-5c088a5b4936" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_289243b6-8fe0-498d-9932-65621499d8fe" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_a2ce8293-5021-4a3b-92ab-5c088a5b4936" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_335b0953-42fe-4acd-9cab-dbfd48cc933a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_289243b6-8fe0-498d-9932-65621499d8fe" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_335b0953-42fe-4acd-9cab-dbfd48cc933a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_c100be43-285b-4040-9f9a-4cf27e18fcf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_289243b6-8fe0-498d-9932-65621499d8fe" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_c100be43-285b-4040-9f9a-4cf27e18fcf8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_823a869d-439f-4481-b29f-fefa158078f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_289243b6-8fe0-498d-9932-65621499d8fe" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_823a869d-439f-4481-b29f-fefa158078f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_273af95a-66ab-4012-b09d-cd199023dfe6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_289243b6-8fe0-498d-9932-65621499d8fe" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_273af95a-66ab-4012-b09d-cd199023dfe6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_40456c81-518a-49cb-9ca8-4363c9bb83cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_289243b6-8fe0-498d-9932-65621499d8fe" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_40456c81-518a-49cb-9ca8-4363c9bb83cc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesBasicAndDilutedEarningsPerOrdinaryShareAttributableToMylanNVDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#SummaryofSignificantAccountingPoliciesBasicAndDilutedEarningsPerOrdinaryShareAttributableToMylanNVDetails"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesBasicAndDilutedEarningsPerOrdinaryShareAttributableToMylanNVDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ce6cffab-2d1d-4479-9b1e-b7e2748f19ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_de00f805-f183-4b5a-a9af-bf156ad747d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ce6cffab-2d1d-4479-9b1e-b7e2748f19ce" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_de00f805-f183-4b5a-a9af-bf156ad747d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_a85e2b75-ff6a-4709-9553-f16797177759" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ce6cffab-2d1d-4479-9b1e-b7e2748f19ce" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_a85e2b75-ff6a-4709-9553-f16797177759" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#RevenueRecognitionandAccountsReceivableVariableConsiderationDetails"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SalesRevenueGrosstonetadjustments_407b0905-9c2c-4af6-9d81-e22ea399f405" xlink:href="vtrs-20211231.xsd#vtrs_SalesRevenueGrosstonetadjustments"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Chargebacks_07d40cca-5318-4fd2-ab49-ddd7163d34ae" xlink:href="vtrs-20211231.xsd#vtrs_Chargebacks"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_vtrs_SalesRevenueGrosstonetadjustments_407b0905-9c2c-4af6-9d81-e22ea399f405" xlink:to="loc_vtrs_Chargebacks_07d40cca-5318-4fd2-ab49-ddd7163d34ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccruedSalesAllowances_fe177136-5d6b-4f99-8c26-bfa0eccea3e1" xlink:href="vtrs-20211231.xsd#vtrs_AccruedSalesAllowances"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_vtrs_SalesRevenueGrosstonetadjustments_407b0905-9c2c-4af6-9d81-e22ea399f405" xlink:to="loc_vtrs_AccruedSalesAllowances_fe177136-5d6b-4f99-8c26-bfa0eccea3e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RevenuefromContractwithCustomerReturns_6d12077e-7582-4806-88a1-3c22253ce942" xlink:href="vtrs-20211231.xsd#vtrs_RevenuefromContractwithCustomerReturns"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_vtrs_SalesRevenueGrosstonetadjustments_407b0905-9c2c-4af6-9d81-e22ea399f405" xlink:to="loc_vtrs_RevenuefromContractwithCustomerReturns_6d12077e-7582-4806-88a1-3c22253ce942" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Medicaidandothergovernmentalrebates_27d4be01-ee28-4916-b332-557499e496a7" xlink:href="vtrs-20211231.xsd#vtrs_Medicaidandothergovernmentalrebates"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_vtrs_SalesRevenueGrosstonetadjustments_407b0905-9c2c-4af6-9d81-e22ea399f405" xlink:to="loc_vtrs_Medicaidandothergovernmentalrebates_27d4be01-ee28-4916-b332-557499e496a7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_996ccd4e-693f-4ebc-900a-1694e9ef1075" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_cf8abae7-6c35-482c-b8dd-ffaeeefadbba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_996ccd4e-693f-4ebc-900a-1694e9ef1075" xlink:to="loc_us-gaap_ReceivablesNetCurrent_cf8abae7-6c35-482c-b8dd-ffaeeefadbba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_a4f4f519-1a37-4aad-9f87-31b6ae84996f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_996ccd4e-693f-4ebc-900a-1694e9ef1075" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_a4f4f519-1a37-4aad-9f87-31b6ae84996f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsBalanceSheetComponentsCashandCashEquivalentsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#BalanceSheetComponentsBalanceSheetComponentsCashandCashEquivalentsDetails"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsBalanceSheetComponentsCashandCashEquivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ecc01bc6-d4bd-4adc-b084-f7b8d3d60181" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f964250d-cfe3-4adf-beb0-3e5dcdd096fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ecc01bc6-d4bd-4adc-b084-f7b8d3d60181" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f964250d-cfe3-4adf-beb0-3e5dcdd096fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_a5c7f54b-4683-4dca-9400-92d1def18be2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ecc01bc6-d4bd-4adc-b084-f7b8d3d60181" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_a5c7f54b-4683-4dca-9400-92d1def18be2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsInventoriesDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#BalanceSheetComponentsInventoriesDetails"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_20a336f4-fded-46bb-aebb-f301c5387b7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_3f3c72ed-5a35-4910-b566-7e31d0dbb990" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_20a336f4-fded-46bb-aebb-f301c5387b7e" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_3f3c72ed-5a35-4910-b566-7e31d0dbb990" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_061d63a5-9bdc-4197-9df6-f54b204ba726" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_20a336f4-fded-46bb-aebb-f301c5387b7e" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_061d63a5-9bdc-4197-9df6-f54b204ba726" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_c776f767-3827-4584-9558-d6ea8a0ccea5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_20a336f4-fded-46bb-aebb-f301c5387b7e" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_c776f767-3827-4584-9558-d6ea8a0ccea5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsPrepaidsandothercurrentassetsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#BalanceSheetComponentsPrepaidsandothercurrentassetsDetails"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsPrepaidsandothercurrentassetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a8133664-cc87-44f6-9cd9-5d821f6af411" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_e680bc91-3a05-4c68-9bc4-c599f6b82bcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a8133664-cc87-44f6-9cd9-5d821f6af411" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_e680bc91-3a05-4c68-9bc4-c599f6b82bcd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_42a24b58-004e-4e1e-8532-fe6273cd90e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a8133664-cc87-44f6-9cd9-5d821f6af411" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_42a24b58-004e-4e1e-8532-fe6273cd90e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_a7831b95-6b63-4df1-ac6d-f1ddc84683b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a8133664-cc87-44f6-9cd9-5d821f6af411" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_a7831b95-6b63-4df1-ac6d-f1ddc84683b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_7ecaa646-02a3-41f2-8957-359a6ecbb92a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a8133664-cc87-44f6-9cd9-5d821f6af411" xlink:to="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_7ecaa646-02a3-41f2-8957-359a6ecbb92a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_12e739de-dd82-450c-b3d9-69ff2e0edb14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a8133664-cc87-44f6-9cd9-5d821f6af411" xlink:to="loc_us-gaap_OtherAssetsCurrent_12e739de-dd82-450c-b3d9-69ff2e0edb14" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#BalanceSheetComponentsPropertyPlantandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_6cf44ca6-ed10-46a3-a1c1-61a3a6ef0575" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_44c110d0-9f8a-4a1d-aa6e-d0f02c229ac2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_6cf44ca6-ed10-46a3-a1c1-61a3a6ef0575" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_44c110d0-9f8a-4a1d-aa6e-d0f02c229ac2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_a3986182-8e81-465f-9c85-cd0c16ffd0a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_6cf44ca6-ed10-46a3-a1c1-61a3a6ef0575" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_a3986182-8e81-465f-9c85-cd0c16ffd0a9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#BalanceSheetComponentsOtherAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_a5e762a0-5531-48ea-818c-d3975f12dc34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_0db410fd-5a25-465f-b826-c73020aaef96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_a5e762a0-5531-48ea-818c-d3975f12dc34" xlink:to="loc_us-gaap_EquityMethodInvestments_0db410fd-5a25-465f-b826-c73020aaef96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Otherlongtermassets_8dd53d88-3c28-40a7-a05c-edd1c63c3f39" xlink:href="vtrs-20211231.xsd#vtrs_Otherlongtermassets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_a5e762a0-5531-48ea-818c-d3975f12dc34" xlink:to="loc_vtrs_Otherlongtermassets_8dd53d88-3c28-40a7-a05c-edd1c63c3f39" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsTradeAccountsPayableDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#BalanceSheetComponentsTradeAccountsPayableDetails"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsTradeAccountsPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_558a4d03-2a24-49ca-b08d-cf9f50506b37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrentAndNoncurrent_46147e39-5b7b-4d0f-b3aa-bc4230d268dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrentAndNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableTradeCurrent_558a4d03-2a24-49ca-b08d-cf9f50506b37" xlink:to="loc_us-gaap_AccountsPayableTradeCurrentAndNoncurrent_46147e39-5b7b-4d0f-b3aa-bc4230d268dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableOtherCurrentAndNoncurrent_a612da9c-5ff0-4b6e-8904-66db8315ce2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableOtherCurrentAndNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableTradeCurrent_558a4d03-2a24-49ca-b08d-cf9f50506b37" xlink:to="loc_us-gaap_AccountsPayableOtherCurrentAndNoncurrent_a612da9c-5ff0-4b6e-8904-66db8315ce2c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LeasesLeaseMaturitiesDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#LeasesLeaseMaturitiesDetails"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/LeasesLeaseMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_20d87a99-dae8-45d6-a61c-2364f71a5229" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_6c4b7449-889c-42b2-a2dd-ba711d886bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_20d87a99-dae8-45d6-a61c-2364f71a5229" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_6c4b7449-889c-42b2-a2dd-ba711d886bf6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_7c71faf5-9d12-4e99-a9c2-e58d9558eb0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_20d87a99-dae8-45d6-a61c-2364f71a5229" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_7c71faf5-9d12-4e99-a9c2-e58d9558eb0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c4724679-15f1-4cf4-a16a-d629c51b3e12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_20d87a99-dae8-45d6-a61c-2364f71a5229" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c4724679-15f1-4cf4-a16a-d629c51b3e12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_7b370deb-fbb1-446a-b185-35e3e76c34ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_20d87a99-dae8-45d6-a61c-2364f71a5229" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_7b370deb-fbb1-446a-b185-35e3e76c34ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_686e6f53-b3a6-4095-a906-909be533049d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_20d87a99-dae8-45d6-a61c-2364f71a5229" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_686e6f53-b3a6-4095-a906-909be533049d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_ad1416d1-c066-496b-9ba7-48bd947289ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_20d87a99-dae8-45d6-a61c-2364f71a5229" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_ad1416d1-c066-496b-9ba7-48bd947289ad" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LeasesLeaseMaturitiesDetails_1" xlink:type="simple" xlink:href="vtrs-20211231.xsd#LeasesLeaseMaturitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/LeasesLeaseMaturitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8b819206-c0c1-44e4-8e0b-3694bcdb61b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_36e1b56a-cbd8-4c96-a2f5-2688acd87f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8b819206-c0c1-44e4-8e0b-3694bcdb61b4" xlink:to="loc_us-gaap_OperatingLeaseLiability_36e1b56a-cbd8-4c96-a2f5-2688acd87f1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_5902c380-ba13-414a-a5ca-d81f795b453f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8b819206-c0c1-44e4-8e0b-3694bcdb61b4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_5902c380-ba13-414a-a5ca-d81f795b453f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsComponentsofIntangibleAssetsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#GoodwillandOtherIntangibleAssetsComponentsofIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsComponentsofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_2debd07b-1d13-4675-825f-0dba8d2f0d41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_5ab8be3b-035c-492a-b2f9-2ed2472da2f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_2debd07b-1d13-4675-825f-0dba8d2f0d41" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_5ab8be3b-035c-492a-b2f9-2ed2472da2f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_df7ef48f-6f73-41b0-b236-bef9b44ffbdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_2debd07b-1d13-4675-825f-0dba8d2f0d41" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_df7ef48f-6f73-41b0-b236-bef9b44ffbdb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1d09a497-09a3-46d2-8a8a-b9758d5540ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_87db68a4-21b9-4ce6-a7a5-4fbc94744f71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1d09a497-09a3-46d2-8a8a-b9758d5540ec" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_87db68a4-21b9-4ce6-a7a5-4fbc94744f71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_909eaccb-4c06-488c-88ef-243af2ae9b55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1d09a497-09a3-46d2-8a8a-b9758d5540ec" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_909eaccb-4c06-488c-88ef-243af2ae9b55" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_37ab47e9-c77a-41bd-9fa1-3e53bfa6a810" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_b2dfed16-741f-4955-bee7-fe15ab5b4211" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_37ab47e9-c77a-41bd-9fa1-3e53bfa6a810" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_b2dfed16-741f-4955-bee7-fe15ab5b4211" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d27863ae-582d-401d-8e97-121b07cdc117" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_37ab47e9-c77a-41bd-9fa1-3e53bfa6a810" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d27863ae-582d-401d-8e97-121b07cdc117" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementScheduleofAvailableforsaleSecuritiesReconciliationDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#FinancialInstrumentsandRiskManagementScheduleofAvailableforsaleSecuritiesReconciliationDetails"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementScheduleofAvailableforsaleSecuritiesReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_90722c92-73ba-4167-afd5-60c3f970f7e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_7377fe22-3812-4a32-9756-7ef2b7185249" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_90722c92-73ba-4167-afd5-60c3f970f7e7" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_7377fe22-3812-4a32-9756-7ef2b7185249" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_1d7e8fe6-1e0d-437a-85cd-53aacf3d1484" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_90722c92-73ba-4167-afd5-60c3f970f7e7" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_1d7e8fe6-1e0d-437a-85cd-53aacf3d1484" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9b1630d6-5a33-4adc-b55c-b5e704734a09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_90722c92-73ba-4167-afd5-60c3f970f7e7" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9b1630d6-5a33-4adc-b55c-b5e704734a09" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementMaturitiesofAvailableforsaleDebtSecuritiesatFairValueDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#FinancialInstrumentsandRiskManagementMaturitiesofAvailableforsaleDebtSecuritiesatFairValueDetails"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementMaturitiesofAvailableforsaleDebtSecuritiesatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_eab1dc1c-f623-4cbf-ae82-f45aef501b42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAndLaterFairValue_e935e29a-044a-4a27-b749-716fba814fcb" xlink:href="vtrs-20211231.xsd#vtrs_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAndLaterFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_eab1dc1c-f623-4cbf-ae82-f45aef501b42" xlink:to="loc_vtrs_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAndLaterFairValue_e935e29a-044a-4a27-b749-716fba814fcb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_ed7253ed-8c87-4e04-a4b8-7c0ed66a8a5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_eab1dc1c-f623-4cbf-ae82-f45aef501b42" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_ed7253ed-8c87-4e04-a4b8-7c0ed66a8a5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_283816ba-c95e-43a7-ad05-123766eec28a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_eab1dc1c-f623-4cbf-ae82-f45aef501b42" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_283816ba-c95e-43a7-ad05-123766eec28a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#DebtMinimumRepaymentsonOutstandingBorrowingsDetails"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_490610e8-07df-4568-a7a7-75ede135f8c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_6f1c8826-cbf4-4531-b0d9-b363c8adcb1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_490610e8-07df-4568-a7a7-75ede135f8c1" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_6f1c8826-cbf4-4531-b0d9-b363c8adcb1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_65cfbf08-1257-4deb-a4d0-a57df624c679" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_490610e8-07df-4568-a7a7-75ede135f8c1" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_65cfbf08-1257-4deb-a4d0-a57df624c679" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_f812666c-bbda-4ace-aa83-f1acb00ea82a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_490610e8-07df-4568-a7a7-75ede135f8c1" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_f812666c-bbda-4ace-aa83-f1acb00ea82a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_b4714b30-5295-4754-8cf2-10ecba30ad90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_490610e8-07df-4568-a7a7-75ede135f8c1" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_b4714b30-5295-4754-8cf2-10ecba30ad90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_253cad9d-1c38-4eab-8afe-1e97587b6df8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_490610e8-07df-4568-a7a7-75ede135f8c1" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_253cad9d-1c38-4eab-8afe-1e97587b6df8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_30d9faf4-c865-4fe0-9950-413f3ef72ee5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_490610e8-07df-4568-a7a7-75ede135f8c1" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_30d9faf4-c865-4fe0-9950-413f3ef72ee5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_9676cf43-0646-46c3-b770-5d1aca4034d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_81126f2d-8b42-4aa7-a7ac-c27aaa350c6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_9676cf43-0646-46c3-b770-5d1aca4034d3" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_81126f2d-8b42-4aa7-a7ac-c27aaa350c6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_f8214438-f900-4209-af6a-103381c5226c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_9676cf43-0646-46c3-b770-5d1aca4034d3" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_f8214438-f900-4209-af6a-103381c5226c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_d8ae79fe-f46e-4763-bdf3-8dd796f309db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_33c3c0c4-5fd3-4aa8-a1d3-1cf13f3837c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_d8ae79fe-f46e-4763-bdf3-8dd796f309db" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_33c3c0c4-5fd3-4aa8-a1d3-1cf13f3837c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_35887a76-60a1-4a68-b998-d7061b236935" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_d8ae79fe-f46e-4763-bdf3-8dd796f309db" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_35887a76-60a1-4a68-b998-d7061b236935" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_19c7af75-8c6c-4022-bbcb-6fb21d4288f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_7bf2627c-3b56-4919-b63c-aae907a08308" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_19c7af75-8c6c-4022-bbcb-6fb21d4288f5" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_7bf2627c-3b56-4919-b63c-aae907a08308" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_7ee8634d-596c-43c0-bd2c-8a6402c76669" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_19c7af75-8c6c-4022-bbcb-6fb21d4288f5" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_7ee8634d-596c-43c0-bd2c-8a6402c76669" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_d2e49a45-d236-4e39-ba5b-3ed537743f02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_1abf8cf4-4e9a-406e-b24b-a4b04fdb0080" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d2e49a45-d236-4e39-ba5b-3ed537743f02" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_1abf8cf4-4e9a-406e-b24b-a4b04fdb0080" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DeferredTaxAssetsIntangibleAssets_271e6498-0edb-4c84-8090-25cdfb0d79ba" xlink:href="vtrs-20211231.xsd#vtrs_DeferredTaxAssetsIntangibleAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d2e49a45-d236-4e39-ba5b-3ed537743f02" xlink:to="loc_vtrs_DeferredTaxAssetsIntangibleAssets_271e6498-0edb-4c84-8090-25cdfb0d79ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits_2deade67-a83a-4b07-a2bd-251af3d5f4a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d2e49a45-d236-4e39-ba5b-3ed537743f02" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits_2deade67-a83a-4b07-a2bd-251af3d5f4a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_74aaabe5-cd44-4136-b0bb-d6a9de86720f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d2e49a45-d236-4e39-ba5b-3ed537743f02" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_74aaabe5-cd44-4136-b0bb-d6a9de86720f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_d387dcaa-94e0-4d80-8af3-b18e1585c017" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d2e49a45-d236-4e39-ba5b-3ed537743f02" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_d387dcaa-94e0-4d80-8af3-b18e1585c017" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies_d3708298-4cdc-4c73-8189-8268c75ee29e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d2e49a45-d236-4e39-ba5b-3ed537743f02" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies_d3708298-4cdc-4c73-8189-8268c75ee29e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_d2f0f805-9b7e-43be-897e-fab7853d8635" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d2e49a45-d236-4e39-ba5b-3ed537743f02" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_d2f0f805-9b7e-43be-897e-fab7853d8635" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DeferredTaxAssetsOperatingLeaseRightofUseAssets_cb82dc95-af1b-42f5-b43a-32b22c865873" xlink:href="vtrs-20211231.xsd#vtrs_DeferredTaxAssetsOperatingLeaseRightofUseAssets"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d2e49a45-d236-4e39-ba5b-3ed537743f02" xlink:to="loc_vtrs_DeferredTaxAssetsOperatingLeaseRightofUseAssets_cb82dc95-af1b-42f5-b43a-32b22c865873" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DeferredTaxAssetsDeferredtaxexpenseinterestexpense_ace0d2c0-b05d-44e4-9d66-6490b0742af9" xlink:href="vtrs-20211231.xsd#vtrs_DeferredTaxAssetsDeferredtaxexpenseinterestexpense"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d2e49a45-d236-4e39-ba5b-3ed537743f02" xlink:to="loc_vtrs_DeferredTaxAssetsDeferredtaxexpenseinterestexpense_ace0d2c0-b05d-44e4-9d66-6490b0742af9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_56654668-2f16-457a-a723-896fa8de28b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_c535710e-080d-424d-91e1-cfbc1f53c0aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_56654668-2f16-457a-a723-896fa8de28b9" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_c535710e-080d-424d-91e1-cfbc1f53c0aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_a86e882e-19ac-4294-b9fe-f790be9b5d76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_56654668-2f16-457a-a723-896fa8de28b9" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_a86e882e-19ac-4294-b9fe-f790be9b5d76" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_91cefe69-454d-474c-a9b6-8fa7cb587ace" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_883673a1-4498-4dbd-b844-49b2c85f8c16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_91cefe69-454d-474c-a9b6-8fa7cb587ace" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_883673a1-4498-4dbd-b844-49b2c85f8c16" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DeferredTaxLiabilitiesOperatingLeaseLiability_cca684c3-716e-4e8e-869e-043d72902c81" xlink:href="vtrs-20211231.xsd#vtrs_DeferredTaxLiabilitiesOperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_91cefe69-454d-474c-a9b6-8fa7cb587ace" xlink:to="loc_vtrs_DeferredTaxLiabilitiesOperatingLeaseLiability_cca684c3-716e-4e8e-869e-043d72902c81" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_5a1fcaf8-e148-4aee-9d6b-4e2ed1a6e7ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_91cefe69-454d-474c-a9b6-8fa7cb587ace" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_5a1fcaf8-e148-4aee-9d6b-4e2ed1a6e7ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_a12710c0-7344-42c0-9c87-51346e33b0c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_91cefe69-454d-474c-a9b6-8fa7cb587ace" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_a12710c0-7344-42c0-9c87-51346e33b0c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_1e843136-74f7-4f1f-aa36-2421edba8e4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_8249ebca-db14-4b95-9af4-fd10bb9c7762" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_1e843136-74f7-4f1f-aa36-2421edba8e4c" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_8249ebca-db14-4b95-9af4-fd10bb9c7762" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_34a47303-0519-4ee5-b4ae-ac4e6b8eabc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_1e843136-74f7-4f1f-aa36-2421edba8e4c" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_34a47303-0519-4ee5-b4ae-ac4e6b8eabc5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EmployeeBenefitPlansAccumulatedOtherComprehensiveIncomeLossPretaxAmountsNotYetReclassifiedinNetPeriodicBenefitCostDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#EmployeeBenefitPlansAccumulatedOtherComprehensiveIncomeLossPretaxAmountsNotYetReclassifiedinNetPeriodicBenefitCostDetails"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/EmployeeBenefitPlansAccumulatedOtherComprehensiveIncomeLossPretaxAmountsNotYetReclassifiedinNetPeriodicBenefitCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_6f8c45fe-2c28-4d14-a940-81973e94f145" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_aa872c75-c911-49fb-8c57-f07741376ec4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_6f8c45fe-2c28-4d14-a940-81973e94f145" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_aa872c75-c911-49fb-8c57-f07741376ec4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_593bceda-b18f-4fa4-ae5a-cd6e3fdf3c79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_6f8c45fe-2c28-4d14-a940-81973e94f145" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_593bceda-b18f-4fa4-ae5a-cd6e3fdf3c79" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EmployeeBenefitPlansChangeinAccumulatedIncomeLossRelatingtoDefinedBenefitPensionandOtherPostretirementBenefitsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#EmployeeBenefitPlansChangeinAccumulatedIncomeLossRelatingtoDefinedBenefitPensionandOtherPostretirementBenefitsDetails"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/EmployeeBenefitPlansChangeinAccumulatedIncomeLossRelatingtoDefinedBenefitPensionandOtherPostretirementBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_e45d5daf-7bf1-4a62-a42c-74edc1472032" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_6da068f8-9d68-4df3-a791-82eb12fb1386" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_e45d5daf-7bf1-4a62-a42c-74edc1472032" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_6da068f8-9d68-4df3-a791-82eb12fb1386" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_ae48ec73-c120-43b9-b9de-2c2c3e7140ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_e45d5daf-7bf1-4a62-a42c-74edc1472032" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_ae48ec73-c120-43b9-b9de-2c2c3e7140ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_e8f9d9da-b257-4cbc-af30-5ce6784cdf2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_e45d5daf-7bf1-4a62-a42c-74edc1472032" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_e8f9d9da-b257-4cbc-af30-5ce6784cdf2f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax_b7a517e5-d89e-44ad-aa13-cc5c430a4224" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_e45d5daf-7bf1-4a62-a42c-74edc1472032" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax_b7a517e5-d89e-44ad-aa13-cc5c430a4224" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherComprehensiveIncomeDefinedBenefitPlanForeignCurrencyTranslationBeforeTax_5a89cef1-50c1-4af1-b186-89f9740f06c0" xlink:href="vtrs-20211231.xsd#vtrs_OtherComprehensiveIncomeDefinedBenefitPlanForeignCurrencyTranslationBeforeTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_e45d5daf-7bf1-4a62-a42c-74edc1472032" xlink:to="loc_vtrs_OtherComprehensiveIncomeDefinedBenefitPlanForeignCurrencyTranslationBeforeTax_5a89cef1-50c1-4af1-b186-89f9740f06c0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EmployeeBenefitPlansNetPeriodicBenefitCostsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#EmployeeBenefitPlansNetPeriodicBenefitCostsDetails"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/EmployeeBenefitPlansNetPeriodicBenefitCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_55379aa1-cbda-4459-b355-b387808d1696" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_30309c53-775e-45f0-96d0-9233f3cea213" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_55379aa1-cbda-4459-b355-b387808d1696" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_30309c53-775e-45f0-96d0-9233f3cea213" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_3c1ef5cc-9d26-41c8-b2ca-8cafbc75b7c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_55379aa1-cbda-4459-b355-b387808d1696" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_3c1ef5cc-9d26-41c8-b2ca-8cafbc75b7c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_86b9b92b-dc23-4249-a879-f88780f2e93c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_55379aa1-cbda-4459-b355-b387808d1696" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_86b9b92b-dc23-4249-a879-f88780f2e93c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCurtailments_c325e686-51d6-49ab-b79d-988214878769" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanCurtailments"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_55379aa1-cbda-4459-b355-b387808d1696" xlink:to="loc_us-gaap_DefinedBenefitPlanCurtailments_c325e686-51d6-49ab-b79d-988214878769" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_ceac8b2a-7ad4-4f14-bb7f-0a9cad2c8a21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_55379aa1-cbda-4459-b355-b387808d1696" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_ceac8b2a-7ad4-4f14-bb7f-0a9cad2c8a21" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_b6f27fb6-5509-4ee3-ad8e-c5e06db9819f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_55379aa1-cbda-4459-b355-b387808d1696" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_b6f27fb6-5509-4ee3-ad8e-c5e06db9819f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EmployeeBenefitPlansNetAccruedBenefitCostsClassificationonBalanceSheetDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#EmployeeBenefitPlansNetAccruedBenefitCostsClassificationonBalanceSheetDetails"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/EmployeeBenefitPlansNetAccruedBenefitCostsClassificationonBalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Netaccruedbenefitcosts_d001f9d5-ea3c-4679-8fdc-eecfd31ed986" xlink:href="vtrs-20211231.xsd#vtrs_Netaccruedbenefitcosts"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_1b76d841-7936-4a2c-92bb-7d74ed169d04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_vtrs_Netaccruedbenefitcosts_d001f9d5-ea3c-4679-8fdc-eecfd31ed986" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_1b76d841-7936-4a2c-92bb-7d74ed169d04" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_ae1e9d78-5ce6-4aff-b027-6c475dc98e8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_vtrs_Netaccruedbenefitcosts_d001f9d5-ea3c-4679-8fdc-eecfd31ed986" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_ae1e9d78-5ce6-4aff-b027-6c475dc98e8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_2edabfd4-245a-4e1b-8a6c-a9df838c9b17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_vtrs_Netaccruedbenefitcosts_d001f9d5-ea3c-4679-8fdc-eecfd31ed986" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_2edabfd4-245a-4e1b-8a6c-a9df838c9b17" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EmployeeBenefitPlansEstimatedFutureBenefitPaymentsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#EmployeeBenefitPlansEstimatedFutureBenefitPaymentsDetails"/>
  <link:calculationLink xlink:role="http://www.viatris.com/role/EmployeeBenefitPlansEstimatedFutureBenefitPaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ExpectedFutureBenefitPayments_30ef42b5-c245-4278-bfbf-ce74784a6166" xlink:href="vtrs-20211231.xsd#vtrs_ExpectedFutureBenefitPayments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_0249e2f0-b0c3-4770-9206-9246f10dd177" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_vtrs_ExpectedFutureBenefitPayments_30ef42b5-c245-4278-bfbf-ce74784a6166" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_0249e2f0-b0c3-4770-9206-9246f10dd177" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_78ab1ebc-a5cb-45f5-9a57-ada80aa1462d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_vtrs_ExpectedFutureBenefitPayments_30ef42b5-c245-4278-bfbf-ce74784a6166" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_78ab1ebc-a5cb-45f5-9a57-ada80aa1462d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_9e667c8f-a516-4a56-a03a-905815178b9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_vtrs_ExpectedFutureBenefitPayments_30ef42b5-c245-4278-bfbf-ce74784a6166" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_9e667c8f-a516-4a56-a03a-905815178b9a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_00f2b5d5-6d81-4ace-be29-da4f6d1fe34f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_vtrs_ExpectedFutureBenefitPayments_30ef42b5-c245-4278-bfbf-ce74784a6166" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_00f2b5d5-6d81-4ace-be29-da4f6d1fe34f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_96bd8d58-e9d0-492d-b1e3-4ba3bf007950" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_vtrs_ExpectedFutureBenefitPayments_30ef42b5-c245-4278-bfbf-ce74784a6166" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_96bd8d58-e9d0-492d-b1e3-4ba3bf007950" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_617008a9-f46c-45db-a758-0904f170121f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_vtrs_ExpectedFutureBenefitPayments_30ef42b5-c245-4278-bfbf-ce74784a6166" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_617008a9-f46c-45db-a758-0904f170121f" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>vtrs-20211231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:7d588a56-150d-4ea9-a97c-5b39f92c59e0,g:83cb92d0-838c-40d0-a420-8487c2f4fc1b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.viatris.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="vtrs-20211231.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended" id="ie595cbbf87984bc8b68415f2a4600d66_ConsolidatedBalanceSheetsParenthetical">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_9185dde5-34fb-4d36-80f2-df4aee9fa43b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_f8267515-7d51-4842-a316-201348c6cbcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9185dde5-34fb-4d36-80f2-df4aee9fa43b" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_f8267515-7d51-4842-a316-201348c6cbcc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_baa7b8b8-9ffc-4690-8e3f-e903e82b612b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9185dde5-34fb-4d36-80f2-df4aee9fa43b" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_baa7b8b8-9ffc-4690-8e3f-e903e82b612b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_ff12bff8-b6b0-4a83-ba57-499ae1946a87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9185dde5-34fb-4d36-80f2-df4aee9fa43b" xlink:to="loc_us-gaap_SharesIssued_ff12bff8-b6b0-4a83-ba57-499ae1946a87" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f070a775-ead4-461d-8bb3-f48669e6e0f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_9185dde5-34fb-4d36-80f2-df4aee9fa43b" xlink:to="loc_us-gaap_StatementTable_f070a775-ead4-461d-8bb3-f48669e6e0f3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2593d148-6e5d-465c-9dbb-e399ee9adca4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_f070a775-ead4-461d-8bb3-f48669e6e0f3" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2593d148-6e5d-465c-9dbb-e399ee9adca4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2593d148-6e5d-465c-9dbb-e399ee9adca4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2593d148-6e5d-465c-9dbb-e399ee9adca4" xlink:to="loc_us-gaap_EquityComponentDomain_2593d148-6e5d-465c-9dbb-e399ee9adca4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2f212373-dff6-48ac-bec5-c3af454828c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2593d148-6e5d-465c-9dbb-e399ee9adca4" xlink:to="loc_us-gaap_EquityComponentDomain_2f212373-dff6-48ac-bec5-c3af454828c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_b73fcd55-3005-4b0a-96de-34affb6000e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2f212373-dff6-48ac-bec5-c3af454828c4" xlink:to="loc_us-gaap_CommonStockMember_b73fcd55-3005-4b0a-96de-34affb6000e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_c8fc063e-64fb-4ca2-b1ef-8e80a5262e9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2f212373-dff6-48ac-bec5-c3af454828c4" xlink:to="loc_us-gaap_TreasuryStockMember_c8fc063e-64fb-4ca2-b1ef-8e80a5262e9f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="vtrs-20211231.xsd#ConsolidatedStatementsofOperations"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/ConsolidatedStatementsofOperations" xlink:type="extended" id="i67392b7bcdd642f1acf6d02269da8231_ConsolidatedStatementsofOperations">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_adf9484d-8baf-4a63-adfe-25d1ec0594f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_9fc96218-ed98-4456-a0f5-d24eac9c99d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_adf9484d-8baf-4a63-adfe-25d1ec0594f2" xlink:to="loc_us-gaap_RevenuesAbstract_9fc96218-ed98-4456-a0f5-d24eac9c99d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_24407d64-090f-46a8-b24c-af395e0952a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_9fc96218-ed98-4456-a0f5-d24eac9c99d9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_24407d64-090f-46a8-b24c-af395e0952a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer_e69e6c87-665b-40dd-bb52-e30b3c73e963" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_9fc96218-ed98-4456-a0f5-d24eac9c99d9" xlink:to="loc_us-gaap_RevenueNotFromContractWithCustomer_e69e6c87-665b-40dd-bb52-e30b3c73e963" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_41e10ce1-731f-462f-8d0b-400bb88457d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_9fc96218-ed98-4456-a0f5-d24eac9c99d9" xlink:to="loc_us-gaap_Revenues_41e10ce1-731f-462f-8d0b-400bb88457d7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_376784aa-71e3-4b72-864a-124a7f3710d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_adf9484d-8baf-4a63-adfe-25d1ec0594f2" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_376784aa-71e3-4b72-864a-124a7f3710d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_c6b6d2d4-114b-4a86-9c25-6fb0bfa7d536" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_adf9484d-8baf-4a63-adfe-25d1ec0594f2" xlink:to="loc_us-gaap_GrossProfit_c6b6d2d4-114b-4a86-9c25-6fb0bfa7d536" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_3752b867-8f27-4362-b782-3c1bb84e5b81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_adf9484d-8baf-4a63-adfe-25d1ec0594f2" xlink:to="loc_us-gaap_OperatingExpensesAbstract_3752b867-8f27-4362-b782-3c1bb84e5b81" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_30b68773-4c46-4b42-b6d8-b2d8ee7022ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_3752b867-8f27-4362-b782-3c1bb84e5b81" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_30b68773-4c46-4b42-b6d8-b2d8ee7022ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_5f6abacd-12a8-4446-a6af-933d0cffe0d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_3752b867-8f27-4362-b782-3c1bb84e5b81" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_5f6abacd-12a8-4446-a6af-933d0cffe0d0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_ecf89a6f-8649-4eed-829a-2e92c359afc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_3752b867-8f27-4362-b782-3c1bb84e5b81" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_ecf89a6f-8649-4eed-829a-2e92c359afc3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_e9deb54f-09b8-472e-9f5a-b7f55bddf561" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_3752b867-8f27-4362-b782-3c1bb84e5b81" xlink:to="loc_us-gaap_OperatingExpenses_e9deb54f-09b8-472e-9f5a-b7f55bddf561" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_88666693-2f65-4d71-8564-9f0070f781ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_adf9484d-8baf-4a63-adfe-25d1ec0594f2" xlink:to="loc_us-gaap_OperatingIncomeLoss_88666693-2f65-4d71-8564-9f0070f781ac" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_24aec18d-f296-41b0-8860-19090e622d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_adf9484d-8baf-4a63-adfe-25d1ec0594f2" xlink:to="loc_us-gaap_InterestExpense_24aec18d-f296-41b0-8860-19090e622d2a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_1572d2e9-1e44-4e88-b61f-2b217a4b48f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_adf9484d-8baf-4a63-adfe-25d1ec0594f2" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_1572d2e9-1e44-4e88-b61f-2b217a4b48f5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e5448695-f9c5-46f2-8438-1d5298963e28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_adf9484d-8baf-4a63-adfe-25d1ec0594f2" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e5448695-f9c5-46f2-8438-1d5298963e28" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_734c541a-f2db-439f-a9af-e069b84ea224" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_adf9484d-8baf-4a63-adfe-25d1ec0594f2" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_734c541a-f2db-439f-a9af-e069b84ea224" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_70014ef6-d6d2-45a1-b7aa-ae3f47888ce0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_adf9484d-8baf-4a63-adfe-25d1ec0594f2" xlink:to="loc_us-gaap_ProfitLoss_70014ef6-d6d2-45a1-b7aa-ae3f47888ce0" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_2a547c5c-d254-4e14-ae19-e0c7e80dbea4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_adf9484d-8baf-4a63-adfe-25d1ec0594f2" xlink:to="loc_us-gaap_EarningsPerShareAbstract_2a547c5c-d254-4e14-ae19-e0c7e80dbea4" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_b5dfd9db-06b0-4d6c-9ae2-d7028c33cb01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2a547c5c-d254-4e14-ae19-e0c7e80dbea4" xlink:to="loc_us-gaap_EarningsPerShareBasic_b5dfd9db-06b0-4d6c-9ae2-d7028c33cb01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_71361ecc-b727-4ff1-9c42-634840d6e510" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2a547c5c-d254-4e14-ae19-e0c7e80dbea4" xlink:to="loc_us-gaap_EarningsPerShareDiluted_71361ecc-b727-4ff1-9c42-634840d6e510" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_f0c5af6d-c079-4ac9-9cf3-d41f43f89288" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_adf9484d-8baf-4a63-adfe-25d1ec0594f2" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_f0c5af6d-c079-4ac9-9cf3-d41f43f89288" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_390ea1fe-3324-495a-98ee-1f95857d7122" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_f0c5af6d-c079-4ac9-9cf3-d41f43f89288" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_390ea1fe-3324-495a-98ee-1f95857d7122" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_00e9b73a-cfc8-4293-bba4-3bf13f102e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_f0c5af6d-c079-4ac9-9cf3-d41f43f89288" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_00e9b73a-cfc8-4293-bba4-3bf13f102e5c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_59bada12-23b1-4a49-9081-6a4d65cf1787" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_adf9484d-8baf-4a63-adfe-25d1ec0594f2" xlink:to="loc_us-gaap_StatementTable_59bada12-23b1-4a49-9081-6a4d65cf1787" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_70a3419c-8f2e-457c-bc26-60a5d4ccffa8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_59bada12-23b1-4a49-9081-6a4d65cf1787" xlink:to="loc_srt_ProductOrServiceAxis_70a3419c-8f2e-457c-bc26-60a5d4ccffa8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_70a3419c-8f2e-457c-bc26-60a5d4ccffa8_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_70a3419c-8f2e-457c-bc26-60a5d4ccffa8" xlink:to="loc_srt_ProductsAndServicesDomain_70a3419c-8f2e-457c-bc26-60a5d4ccffa8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c4ed81e0-b696-447f-9817-890cdce5abe7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_70a3419c-8f2e-457c-bc26-60a5d4ccffa8" xlink:to="loc_srt_ProductsAndServicesDomain_c4ed81e0-b696-447f-9817-890cdce5abe7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_22d223a6-6b48-45b0-bedb-b39e3637ba4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c4ed81e0-b696-447f-9817-890cdce5abe7" xlink:to="loc_us-gaap_ProductMember_22d223a6-6b48-45b0-bedb-b39e3637ba4c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_f98316df-4677-45de-84f5-b067b0121bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c4ed81e0-b696-447f-9817-890cdce5abe7" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_f98316df-4677-45de-84f5-b067b0121bdd" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ConsolidatedStatementsofComprehensiveEarnings" xlink:type="simple" xlink:href="vtrs-20211231.xsd#ConsolidatedStatementsofComprehensiveEarnings"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/ConsolidatedStatementsofComprehensiveEarnings" xlink:type="extended" id="ie8a2421c6f8f45f7af37b2f5466d89e0_ConsolidatedStatementsofComprehensiveEarnings">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_79213795-71df-417f-ba5f-089951a68e67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_9062e93d-16a7-483e-884f-34f8e393b92e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_79213795-71df-417f-ba5f-089951a68e67" xlink:to="loc_us-gaap_ProfitLoss_9062e93d-16a7-483e-884f-34f8e393b92e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_24d4ef07-1bd6-4a37-b0c6-989f26a417c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_79213795-71df-417f-ba5f-089951a68e67" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_24d4ef07-1bd6-4a37-b0c6-989f26a417c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_148f2334-a588-4442-aca8-de95e71ec5c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_24d4ef07-1bd6-4a37-b0c6-989f26a417c1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_148f2334-a588-4442-aca8-de95e71ec5c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_2ae38a55-f80c-43a9-bf23-f9486396bad6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_24d4ef07-1bd6-4a37-b0c6-989f26a417c1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_2ae38a55-f80c-43a9-bf23-f9486396bad6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_35596636-9c82-4822-a999-9232fbfdb9a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_24d4ef07-1bd6-4a37-b0c6-989f26a417c1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_35596636-9c82-4822-a999-9232fbfdb9a2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_844d4014-bb26-4e2c-abd9-465586eac1a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_24d4ef07-1bd6-4a37-b0c6-989f26a417c1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_844d4014-bb26-4e2c-abd9-465586eac1a4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_e49035d2-0106-425a-b716-68ac913d0baf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_24d4ef07-1bd6-4a37-b0c6-989f26a417c1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_e49035d2-0106-425a-b716-68ac913d0baf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_e33bf1ba-0164-473d-8d65-8c79a5ee4e24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_79213795-71df-417f-ba5f-089951a68e67" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_e33bf1ba-0164-473d-8d65-8c79a5ee4e24" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_32f51770-13e3-446d-8469-2abd1ef1a549" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_79213795-71df-417f-ba5f-089951a68e67" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_32f51770-13e3-446d-8469-2abd1ef1a549" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_02448911-c95a-4d2e-b3ab-448a6bee643b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_79213795-71df-417f-ba5f-089951a68e67" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_02448911-c95a-4d2e-b3ab-448a6bee643b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e1186eaf-0e25-471f-a025-6e41163eda36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_79213795-71df-417f-ba5f-089951a68e67" xlink:to="loc_us-gaap_StatementTable_e1186eaf-0e25-471f-a025-6e41163eda36" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6efa85f0-71dc-4faf-9bae-39d09d0804b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_e1186eaf-0e25-471f-a025-6e41163eda36" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6efa85f0-71dc-4faf-9bae-39d09d0804b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_6efa85f0-71dc-4faf-9bae-39d09d0804b4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6efa85f0-71dc-4faf-9bae-39d09d0804b4" xlink:to="loc_us-gaap_HedgingRelationshipDomain_6efa85f0-71dc-4faf-9bae-39d09d0804b4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_ef664cae-bc80-4aff-9ca7-df69ae8b889e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6efa85f0-71dc-4faf-9bae-39d09d0804b4" xlink:to="loc_us-gaap_HedgingRelationshipDomain_ef664cae-bc80-4aff-9ca7-df69ae8b889e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_6804d967-fdcf-4e65-9c11-f545c6b3f956" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_ef664cae-bc80-4aff-9ca7-df69ae8b889e" xlink:to="loc_us-gaap_CashFlowHedgingMember_6804d967-fdcf-4e65-9c11-f545c6b3f956" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_6c67c92d-3f1e-41f0-9b00-344055cd1957" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_ef664cae-bc80-4aff-9ca7-df69ae8b889e" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_6c67c92d-3f1e-41f0-9b00-344055cd1957" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ConsolidatedStatementsofEquity" xlink:type="simple" xlink:href="vtrs-20211231.xsd#ConsolidatedStatementsofEquity"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/ConsolidatedStatementsofEquity" xlink:type="extended" id="ia50a983145c1437c81bbce87a99fc0ad_ConsolidatedStatementsofEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_8ee952ac-5d27-4747-a3f7-8a0d75767726" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9e714754-3a31-4e38-8c54-b009d9de834d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8ee952ac-5d27-4747-a3f7-8a0d75767726" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9e714754-3a31-4e38-8c54-b009d9de834d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_7188a5b3-9f0d-4172-8d6b-fdc8497b33cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8ee952ac-5d27-4747-a3f7-8a0d75767726" xlink:to="loc_us-gaap_SharesIssued_7188a5b3-9f0d-4172-8d6b-fdc8497b33cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_df25cc1c-6794-4dde-9aff-a189609987a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8ee952ac-5d27-4747-a3f7-8a0d75767726" xlink:to="loc_us-gaap_ProfitLoss_df25cc1c-6794-4dde-9aff-a189609987a5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3e0af63c-b4b0-41e0-a890-6d1ead3d43b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8ee952ac-5d27-4747-a3f7-8a0d75767726" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3e0af63c-b4b0-41e0-a890-6d1ead3d43b2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_7f0e72f0-94d2-460b-8629-a3a62564640a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8ee952ac-5d27-4747-a3f7-8a0d75767726" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_7f0e72f0-94d2-460b-8629-a3a62564640a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_28772b11-7f91-4f5d-aefb-c548e5428080" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8ee952ac-5d27-4747-a3f7-8a0d75767726" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_28772b11-7f91-4f5d-aefb-c548e5428080" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_9e9ee6cf-10ff-4980-9ca0-021ceddd3112" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8ee952ac-5d27-4747-a3f7-8a0d75767726" xlink:to="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_9e9ee6cf-10ff-4980-9ca0-021ceddd3112" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment_51f61bf8-57a5-4e1d-ac02-d3c6588a0811" xlink:href="vtrs-20211231.xsd#vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8ee952ac-5d27-4747-a3f7-8a0d75767726" xlink:to="loc_vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment_51f61bf8-57a5-4e1d-ac02-d3c6588a0811" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet_14c4b9f2-ea17-4e05-b16c-96a516bdbf19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8ee952ac-5d27-4747-a3f7-8a0d75767726" xlink:to="loc_us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet_14c4b9f2-ea17-4e05-b16c-96a516bdbf19" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired_f37833f6-f5c6-4896-9336-13e742905a6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8ee952ac-5d27-4747-a3f7-8a0d75767726" xlink:to="loc_us-gaap_TreasuryStockSharesRetired_f37833f6-f5c6-4896-9336-13e742905a6c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_StockExchangedDuringPeriodValue_29ba89b1-7417-4e2d-836d-6210afb76f42" xlink:href="vtrs-20211231.xsd#vtrs_StockExchangedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8ee952ac-5d27-4747-a3f7-8a0d75767726" xlink:to="loc_vtrs_StockExchangedDuringPeriodValue_29ba89b1-7417-4e2d-836d-6210afb76f42" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_StockExchangedDuringPeriodSharesExchanged_63d08af5-d34c-4c7b-b6d4-e06d42881a45" xlink:href="vtrs-20211231.xsd#vtrs_StockExchangedDuringPeriodSharesExchanged"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8ee952ac-5d27-4747-a3f7-8a0d75767726" xlink:to="loc_vtrs_StockExchangedDuringPeriodSharesExchanged_63d08af5-d34c-4c7b-b6d4-e06d42881a45" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_4292618d-02d1-4933-ac0b-be8e3644a061" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8ee952ac-5d27-4747-a3f7-8a0d75767726" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_4292618d-02d1-4933-ac0b-be8e3644a061" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_db16f538-5b54-4883-9dcd-c5a9cbb0feff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8ee952ac-5d27-4747-a3f7-8a0d75767726" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_db16f538-5b54-4883-9dcd-c5a9cbb0feff" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_2ebef1cb-fe9d-41ec-ba77-57158c3c7e27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8ee952ac-5d27-4747-a3f7-8a0d75767726" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_2ebef1cb-fe9d-41ec-ba77-57158c3c7e27" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_5e1fa22a-a965-4a02-82c1-939124a5117c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8ee952ac-5d27-4747-a3f7-8a0d75767726" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_5e1fa22a-a965-4a02-82c1-939124a5117c" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_aceb9cde-e8de-4b1b-ab24-ed3fdb4ccd1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockRetiredCostMethodAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8ee952ac-5d27-4747-a3f7-8a0d75767726" xlink:to="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_aceb9cde-e8de-4b1b-ab24-ed3fdb4ccd1e" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_e3155d7b-88d3-4fc1-a469-abc250a807b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8ee952ac-5d27-4747-a3f7-8a0d75767726" xlink:to="loc_us-gaap_DividendsCommonStockCash_e3155d7b-88d3-4fc1-a469-abc250a807b2" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1abadd5c-9272-4db0-b600-d630d2c44527" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_b5f87d16-acad-48a9-b276-f376c5eacb1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_82106073-07b8-4eed-88eb-f3a526f9d5b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_8ee952ac-5d27-4747-a3f7-8a0d75767726" xlink:to="loc_us-gaap_StatementTable_82106073-07b8-4eed-88eb-f3a526f9d5b0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_eb7d9bd4-f9a3-4708-9a3e-6b9636f55166" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_82106073-07b8-4eed-88eb-f3a526f9d5b0" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_eb7d9bd4-f9a3-4708-9a3e-6b9636f55166" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_eb7d9bd4-f9a3-4708-9a3e-6b9636f55166_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_eb7d9bd4-f9a3-4708-9a3e-6b9636f55166" xlink:to="loc_us-gaap_EquityComponentDomain_eb7d9bd4-f9a3-4708-9a3e-6b9636f55166_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b512308d-b1fc-4feb-866e-b3541ab7db20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_eb7d9bd4-f9a3-4708-9a3e-6b9636f55166" xlink:to="loc_us-gaap_EquityComponentDomain_b512308d-b1fc-4feb-866e-b3541ab7db20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_ed96a069-133d-4019-b7b0-ef57c20dc153" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b512308d-b1fc-4feb-866e-b3541ab7db20" xlink:to="loc_us-gaap_CommonStockMember_ed96a069-133d-4019-b7b0-ef57c20dc153" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_157a417e-932f-4a39-9f2b-348c6ca27bbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b512308d-b1fc-4feb-866e-b3541ab7db20" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_157a417e-932f-4a39-9f2b-348c6ca27bbe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_6a33b3a6-bb67-41c9-9989-b77996b1d69f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b512308d-b1fc-4feb-866e-b3541ab7db20" xlink:to="loc_us-gaap_RetainedEarningsMember_6a33b3a6-bb67-41c9-9989-b77996b1d69f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_7525e9db-b38e-40f9-b752-984c4f89a904" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b512308d-b1fc-4feb-866e-b3541ab7db20" xlink:to="loc_us-gaap_TreasuryStockMember_7525e9db-b38e-40f9-b752-984c4f89a904" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_135d8377-cc23-4113-9269-20be010ffef0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b512308d-b1fc-4feb-866e-b3541ab7db20" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_135d8377-cc23-4113-9269-20be010ffef0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f71b576e-34dc-479b-b6f3-356b5a4e1457" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_82106073-07b8-4eed-88eb-f3a526f9d5b0" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f71b576e-34dc-479b-b6f3-356b5a4e1457" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f71b576e-34dc-479b-b6f3-356b5a4e1457_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f71b576e-34dc-479b-b6f3-356b5a4e1457" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f71b576e-34dc-479b-b6f3-356b5a4e1457_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_4703e4f4-c318-443b-b853-e7c3ddde67e0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f71b576e-34dc-479b-b6f3-356b5a4e1457" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_4703e4f4-c318-443b-b853-e7c3ddde67e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_450b8d17-7e44-4c5a-b35b-0bb9fd20db72" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_4703e4f4-c318-443b-b853-e7c3ddde67e0" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_450b8d17-7e44-4c5a-b35b-0bb9fd20db72" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ConsolidatedStatementsofEquityParenthetical" xlink:type="simple" xlink:href="vtrs-20211231.xsd#ConsolidatedStatementsofEquityParenthetical"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/ConsolidatedStatementsofEquityParenthetical" xlink:type="extended" id="i3993c906d04044ad97fa096411212160_ConsolidatedStatementsofEquityParenthetical">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_110a0904-7a03-4c97-aff2-16b20ce046ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_d69bf914-3a81-4a0a-8be2-9a433c142746" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_110a0904-7a03-4c97-aff2-16b20ce046ca" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_d69bf914-3a81-4a0a-8be2-9a433c142746" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_81217e31-a7b7-4526-a31f-0f5215c97cfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_110a0904-7a03-4c97-aff2-16b20ce046ca" xlink:to="loc_us-gaap_StatementTable_81217e31-a7b7-4526-a31f-0f5215c97cfe" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_13c3c1c4-b31a-413c-939e-3415aee1dd15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_81217e31-a7b7-4526-a31f-0f5215c97cfe" xlink:to="loc_us-gaap_StatementClassOfStockAxis_13c3c1c4-b31a-413c-939e-3415aee1dd15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_13c3c1c4-b31a-413c-939e-3415aee1dd15_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_13c3c1c4-b31a-413c-939e-3415aee1dd15" xlink:to="loc_us-gaap_ClassOfStockDomain_13c3c1c4-b31a-413c-939e-3415aee1dd15_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_2a6146f1-00bc-4970-8f6f-8afab7e280df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_13c3c1c4-b31a-413c-939e-3415aee1dd15" xlink:to="loc_us-gaap_ClassOfStockDomain_2a6146f1-00bc-4970-8f6f-8afab7e280df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_ec16e220-c7e4-4bb1-ae99-18aa2bc9180b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_2a6146f1-00bc-4970-8f6f-8afab7e280df" xlink:to="loc_us-gaap_CommonStockMember_ec16e220-c7e4-4bb1-ae99-18aa2bc9180b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" id="i887edef79bd14d67a27940866942a7f2_SummaryofSignificantAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9cf909e5-767d-4a2a-b115-299d425c1bab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_e61a196d-c229-4b00-9b00-bf95aeb504d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9cf909e5-767d-4a2a-b115-299d425c1bab" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_e61a196d-c229-4b00-9b00-bf95aeb504d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_33ecf3cb-443c-4127-bcbd-8c382874e140" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9cf909e5-767d-4a2a-b115-299d425c1bab" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_33ecf3cb-443c-4127-bcbd-8c382874e140" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_db8ee26e-a133-479e-a874-ccc1fe36c007" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9cf909e5-767d-4a2a-b115-299d425c1bab" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_db8ee26e-a133-479e-a874-ccc1fe36c007" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_3804336f-22f0-4833-85a9-5bf344f99c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9cf909e5-767d-4a2a-b115-299d425c1bab" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_3804336f-22f0-4833-85a9-5bf344f99c8e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_60385321-3b1b-4c67-8ced-2fa519e9416e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9cf909e5-767d-4a2a-b115-299d425c1bab" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_60385321-3b1b-4c67-8ced-2fa519e9416e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableAmountPerShare_e28c91dd-eae3-4e0f-9616-9139fc49ab61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9cf909e5-767d-4a2a-b115-299d425c1bab" xlink:to="loc_us-gaap_DividendsPayableAmountPerShare_e28c91dd-eae3-4e0f-9616-9139fc49ab61" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_41c97b31-15a6-4deb-a935-1c25e6ec9759" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9cf909e5-767d-4a2a-b115-299d425c1bab" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_41c97b31-15a6-4deb-a935-1c25e6ec9759" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_c0b256c7-84f0-47a9-b810-8a00205d76cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9cf909e5-767d-4a2a-b115-299d425c1bab" xlink:to="loc_us-gaap_StatementTable_c0b256c7-84f0-47a9-b810-8a00205d76cd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d78a1962-dc3a-4d49-9540-372b4bdc685b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_c0b256c7-84f0-47a9-b810-8a00205d76cd" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d78a1962-dc3a-4d49-9540-372b4bdc685b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d78a1962-dc3a-4d49-9540-372b4bdc685b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d78a1962-dc3a-4d49-9540-372b4bdc685b" xlink:to="loc_us-gaap_EquityComponentDomain_d78a1962-dc3a-4d49-9540-372b4bdc685b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5a7fdf79-4d9f-4ef7-bcbf-ca990aafeada" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d78a1962-dc3a-4d49-9540-372b4bdc685b" xlink:to="loc_us-gaap_EquityComponentDomain_5a7fdf79-4d9f-4ef7-bcbf-ca990aafeada" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_5769b9f0-00c3-4b81-bebe-921b875adc50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_5a7fdf79-4d9f-4ef7-bcbf-ca990aafeada" xlink:to="loc_us-gaap_RetainedEarningsMember_5769b9f0-00c3-4b81-bebe-921b875adc50" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ceadb2ba-7d83-4f68-a998-34b6316ed7f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_c0b256c7-84f0-47a9-b810-8a00205d76cd" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ceadb2ba-7d83-4f68-a998-34b6316ed7f4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ceadb2ba-7d83-4f68-a998-34b6316ed7f4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ceadb2ba-7d83-4f68-a998-34b6316ed7f4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ceadb2ba-7d83-4f68-a998-34b6316ed7f4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_47210bb1-2061-4f90-af5a-98f948b8b1ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ceadb2ba-7d83-4f68-a998-34b6316ed7f4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_47210bb1-2061-4f90-af5a-98f948b8b1ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_2f81143e-e36b-4b66-99b9-d838d9b79610" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_47210bb1-2061-4f90-af5a-98f948b8b1ff" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_2f81143e-e36b-4b66-99b9-d838d9b79610" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_251b2cc7-6f1b-4c80-b40b-2b463f85659a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_47210bb1-2061-4f90-af5a-98f948b8b1ff" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_251b2cc7-6f1b-4c80-b40b-2b463f85659a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_6f67cee3-e9fd-4ea2-ba00-4670cff2f6a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_47210bb1-2061-4f90-af5a-98f948b8b1ff" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_6f67cee3-e9fd-4ea2-ba00-4670cff2f6a8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_38f00756-6fc6-44c0-af02-44b642918098" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_c0b256c7-84f0-47a9-b810-8a00205d76cd" xlink:to="loc_srt_RangeAxis_38f00756-6fc6-44c0-af02-44b642918098" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_38f00756-6fc6-44c0-af02-44b642918098_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_38f00756-6fc6-44c0-af02-44b642918098" xlink:to="loc_srt_RangeMember_38f00756-6fc6-44c0-af02-44b642918098_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e3721aef-33ad-4497-9a88-af84cb57ad49" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_38f00756-6fc6-44c0-af02-44b642918098" xlink:to="loc_srt_RangeMember_e3721aef-33ad-4497-9a88-af84cb57ad49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_14cdddfc-f5b1-48e0-a72f-1498d759abe3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e3721aef-33ad-4497-9a88-af84cb57ad49" xlink:to="loc_srt_MinimumMember_14cdddfc-f5b1-48e0-a72f-1498d759abe3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5389f13b-ef5f-414e-ba60-906baafa6718" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e3721aef-33ad-4497-9a88-af84cb57ad49" xlink:to="loc_srt_MaximumMember_5389f13b-ef5f-414e-ba60-906baafa6718" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_7d90ffdb-07ee-4be1-8fe6-ffe9022393a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_c0b256c7-84f0-47a9-b810-8a00205d76cd" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_7d90ffdb-07ee-4be1-8fe6-ffe9022393a8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_7d90ffdb-07ee-4be1-8fe6-ffe9022393a8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_7d90ffdb-07ee-4be1-8fe6-ffe9022393a8" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_7d90ffdb-07ee-4be1-8fe6-ffe9022393a8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_62209343-9c7f-4daf-b139-1e8c86f01341" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_7d90ffdb-07ee-4be1-8fe6-ffe9022393a8" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_62209343-9c7f-4daf-b139-1e8c86f01341" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_4e4a7d89-bdad-4609-9255-2d795a4b19ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_62209343-9c7f-4daf-b139-1e8c86f01341" xlink:to="loc_us-gaap_SubsequentEventMember_4e4a7d89-bdad-4609-9255-2d795a4b19ac" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesBasicAndDilutedEarningsPerOrdinaryShareAttributableToMylanNVDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#SummaryofSignificantAccountingPoliciesBasicAndDilutedEarningsPerOrdinaryShareAttributableToMylanNVDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesBasicAndDilutedEarningsPerOrdinaryShareAttributableToMylanNVDetails" xlink:type="extended" id="i1633db145d6844c39efc786a6a8f3e0a_SummaryofSignificantAccountingPoliciesBasicAndDilutedEarningsPerOrdinaryShareAttributableToMylanNVDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems_e8222ea4-9ac8-4f8a-a5b5-87f3b8f18389" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_091ddbad-753b-48be-b3cd-2d3b4cb0f01a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_e8222ea4-9ac8-4f8a-a5b5-87f3b8f18389" xlink:to="loc_us-gaap_ProfitLoss_091ddbad-753b-48be-b3cd-2d3b4cb0f01a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d6c9f398-34db-48c4-bfa9-bf8ad008c5a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_e8222ea4-9ac8-4f8a-a5b5-87f3b8f18389" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d6c9f398-34db-48c4-bfa9-bf8ad008c5a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_7b6caca0-624d-4272-8e45-d61e692db01f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_e8222ea4-9ac8-4f8a-a5b5-87f3b8f18389" xlink:to="loc_us-gaap_EarningsPerShareBasic_7b6caca0-624d-4272-8e45-d61e692db01f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_294b714c-1876-4f54-b50c-1b219b506787" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_e8222ea4-9ac8-4f8a-a5b5-87f3b8f18389" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_294b714c-1876-4f54-b50c-1b219b506787" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b6ff3917-617c-4cad-937f-d39d3fa8652e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_e8222ea4-9ac8-4f8a-a5b5-87f3b8f18389" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b6ff3917-617c-4cad-937f-d39d3fa8652e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_3bccc436-f6bc-4579-9dfb-162866223932" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_e8222ea4-9ac8-4f8a-a5b5-87f3b8f18389" xlink:to="loc_us-gaap_EarningsPerShareDiluted_3bccc436-f6bc-4579-9dfb-162866223932" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_cbf23a2b-8f97-4004-a5ea-3b06f2eef8d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_e8222ea4-9ac8-4f8a-a5b5-87f3b8f18389" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_cbf23a2b-8f97-4004-a5ea-3b06f2eef8d1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_f564f491-0390-4a80-b999-d517b18a235e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_cbf23a2b-8f97-4004-a5ea-3b06f2eef8d1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_f564f491-0390-4a80-b999-d517b18a235e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f564f491-0390-4a80-b999-d517b18a235e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f564f491-0390-4a80-b999-d517b18a235e" xlink:to="loc_us-gaap_EquityComponentDomain_f564f491-0390-4a80-b999-d517b18a235e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_21d99926-045b-4ed5-a39c-fddc44ef54e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f564f491-0390-4a80-b999-d517b18a235e" xlink:to="loc_us-gaap_EquityComponentDomain_21d99926-045b-4ed5-a39c-fddc44ef54e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_5a77a4bd-470b-4fb4-ac3c-b3ed17d5ed27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_21d99926-045b-4ed5-a39c-fddc44ef54e7" xlink:to="loc_us-gaap_RetainedEarningsMember_5a77a4bd-470b-4fb4-ac3c-b3ed17d5ed27" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails" xlink:type="extended" id="i67d2c29fb12447f8bd711c695e0c4078_AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NumberOfProducts_ca5e7251-d4a4-4c92-843d-7d3a274ab3f3" xlink:href="vtrs-20211231.xsd#vtrs_NumberOfProducts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_vtrs_NumberOfProducts_ca5e7251-d4a4-4c92-843d-7d3a274ab3f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_d2506653-0be1-482e-a5dc-346cc336b5f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_d2506653-0be1-482e-a5dc-346cc336b5f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_be679d05-c046-4066-b68c-b651db15acb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_be679d05-c046-4066-b68c-b651db15acb7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_0ef5a7b5-2ddd-42cc-a35b-c7780ab20b31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_0ef5a7b5-2ddd-42cc-a35b-c7780ab20b31" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_d68a6a87-d926-4f0c-b215-9ae7b7b0b051" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_d68a6a87-d926-4f0c-b215-9ae7b7b0b051" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PaymentsToAcquireCollaborativeAgreement_1ceb6911-1275-48a7-a8f0-697544b44a70" xlink:href="vtrs-20211231.xsd#vtrs_PaymentsToAcquireCollaborativeAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_vtrs_PaymentsToAcquireCollaborativeAgreement_1ceb6911-1275-48a7-a8f0-697544b44a70" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_79b8786a-afb1-4509-a907-02edaac24188" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_79b8786a-afb1-4509-a907-02edaac24188" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DevelopmentMilestonePayments_47e6dd9a-7b42-4048-8bed-22913ad10a6b" xlink:href="vtrs-20211231.xsd#vtrs_DevelopmentMilestonePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_vtrs_DevelopmentMilestonePayments_47e6dd9a-7b42-4048-8bed-22913ad10a6b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SalesMilestonePayments_23b90e52-fcde-4907-b642-293c631967dd" xlink:href="vtrs-20211231.xsd#vtrs_SalesMilestonePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_vtrs_SalesMilestonePayments_23b90e52-fcde-4907-b642-293c631967dd" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_02544d25-7dbf-43bd-8c0b-4c2b05c15b51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_02544d25-7dbf-43bd-8c0b-4c2b05c15b51" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_47868fca-2511-4c3e-8ac2-e72364a5b575" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_47868fca-2511-4c3e-8ac2-e72364a5b575" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_ec070cab-642c-40b2-83c6-6340913ab7b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_ec070cab-642c-40b2-83c6-6340913ab7b1" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_befbbf2c-b8c3-43eb-a712-e9aaefc5d140" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_befbbf2c-b8c3-43eb-a712-e9aaefc5d140" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PaymentsforBusinessSeparation_1ce04bdc-5fc8-4b3e-b178-35c8603744ac" xlink:href="vtrs-20211231.xsd#vtrs_PaymentsforBusinessSeparation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_vtrs_PaymentsforBusinessSeparation_1ce04bdc-5fc8-4b3e-b178-35c8603744ac" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessAcquisitionexpectedfuturepaymentsnexttwelvemonths_b243abe4-05d6-4b99-b13e-0aa5bad10c81" xlink:href="vtrs-20211231.xsd#vtrs_BusinessAcquisitionexpectedfuturepaymentsnexttwelvemonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_vtrs_BusinessAcquisitionexpectedfuturepaymentsnexttwelvemonths_b243abe4-05d6-4b99-b13e-0aa5bad10c81" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessAcquisitionexpectedfuturepaymentyeartwo_16e6f2cf-2ddc-452a-a60c-faedad01622d" xlink:href="vtrs-20211231.xsd#vtrs_BusinessAcquisitionexpectedfuturepaymentyeartwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_vtrs_BusinessAcquisitionexpectedfuturepaymentyeartwo_16e6f2cf-2ddc-452a-a60c-faedad01622d" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_cf8d287d-b0be-4c38-81d0-1d21aa957069" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_cf8d287d-b0be-4c38-81d0-1d21aa957069" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_eff49b5b-7b8d-41aa-bc45-9964a9b53beb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_eff49b5b-7b8d-41aa-bc45-9964a9b53beb" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFirmPurchaseCommitmentLoss_038365f8-aded-4fe1-a397-4f07f7b0b822" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFirmPurchaseCommitmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_us-gaap_InventoryFirmPurchaseCommitmentLoss_038365f8-aded-4fe1-a397-4f07f7b0b822" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_f304a7d9-0405-401b-8ad2-700e4bf61458" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_f304a7d9-0405-401b-8ad2-700e4bf61458" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_96b7b60b-3be6-43c2-bdae-f570e765f5f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_96b7b60b-3be6-43c2-bdae-f570e765f5f5" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_a50eb285-4788-4126-aee0-de80198f123d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_a50eb285-4788-4126-aee0-de80198f123d" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationsNumberOfAgreements_7e9338fc-1869-4549-bc8d-6d480adb8504" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationsNumberOfAgreements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_vtrs_BusinessCombinationsNumberOfAgreements_7e9338fc-1869-4549-bc8d-6d480adb8504" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_a37b2ec5-44ea-4bbb-949d-ad14c2e60452" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_a37b2ec5-44ea-4bbb-949d-ad14c2e60452" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_08ebfed9-e495-42b9-b759-d2e0226e260f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_08ebfed9-e495-42b9-b759-d2e0226e260f" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d435e6b3-02c8-4c9f-b88c-6a77494f2cb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_us-gaap_Goodwill_d435e6b3-02c8-4c9f-b88c-6a77494f2cb9" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_4f2caf90-5e3c-4861-9cf1-957331300fb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_4f2caf90-5e3c-4861-9cf1-957331300fb0" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_c5ae76e5-79fe-48d0-8f0c-3d3f735aa12f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_c5ae76e5-79fe-48d0-8f0c-3d3f735aa12f" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_4770eb8f-427a-4b97-9469-b78a3e2c0be6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_4770eb8f-427a-4b97-9469-b78a3e2c0be6" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongTermDebt_390aa094-fe6e-46b0-9202-c7ac7906c7a1" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongTermDebt_390aa094-fe6e-46b0-9202-c7ac7906c7a1" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AmortizationOfInventoryStepUp_a1c3bdec-dd89-44b4-850e-e3c1306667f9" xlink:href="vtrs-20211231.xsd#vtrs_AmortizationOfInventoryStepUp"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_vtrs_AmortizationOfInventoryStepUp_a1c3bdec-dd89-44b4-850e-e3c1306667f9" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationNumberOfMarketsServed_00176a07-4924-4626-a36f-8c5a34a53a22" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationNumberOfMarketsServed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_vtrs_BusinessCombinationNumberOfMarketsServed_00176a07-4924-4626-a36f-8c5a34a53a22" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_47ee6ab2-6da2-49f5-9495-813cf94d1ed2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_47ee6ab2-6da2-49f5-9495-813cf94d1ed2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_63077047-3a33-4d48-9278-7ea7ec82b828" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_47ee6ab2-6da2-49f5-9495-813cf94d1ed2" xlink:to="loc_srt_StatementScenarioAxis_63077047-3a33-4d48-9278-7ea7ec82b828" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_63077047-3a33-4d48-9278-7ea7ec82b828_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_63077047-3a33-4d48-9278-7ea7ec82b828" xlink:to="loc_srt_ScenarioUnspecifiedDomain_63077047-3a33-4d48-9278-7ea7ec82b828_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_895543a5-597b-428d-99d9-90ddf5ee5551" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_63077047-3a33-4d48-9278-7ea7ec82b828" xlink:to="loc_srt_ScenarioUnspecifiedDomain_895543a5-597b-428d-99d9-90ddf5ee5551" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScenarioPlanMember_5c98d0b3-1a2e-44f2-acb3-30ed6311684c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScenarioPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_895543a5-597b-428d-99d9-90ddf5ee5551" xlink:to="loc_us-gaap_ScenarioPlanMember_5c98d0b3-1a2e-44f2-acb3-30ed6311684c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_dddc3b97-7c9f-409c-bcbf-582cf732642d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_47ee6ab2-6da2-49f5-9495-813cf94d1ed2" xlink:to="loc_srt_CounterpartyNameAxis_dddc3b97-7c9f-409c-bcbf-582cf732642d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_dddc3b97-7c9f-409c-bcbf-582cf732642d_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_dddc3b97-7c9f-409c-bcbf-582cf732642d" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_dddc3b97-7c9f-409c-bcbf-582cf732642d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1d539995-cebd-427d-9716-b807e527b543" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_dddc3b97-7c9f-409c-bcbf-582cf732642d" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1d539995-cebd-427d-9716-b807e527b543" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_UpjohnInc.Member_0a00b55c-9e62-4129-bb55-2e4a6f1cfd67" xlink:href="vtrs-20211231.xsd#vtrs_UpjohnInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1d539995-cebd-427d-9716-b807e527b543" xlink:to="loc_vtrs_UpjohnInc.Member_0a00b55c-9e62-4129-bb55-2e4a6f1cfd67" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis_24205f22-df4e-440c-87e6-c67e777d5187" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_47ee6ab2-6da2-49f5-9495-813cf94d1ed2" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis_24205f22-df4e-440c-87e6-c67e777d5187" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalEntityTypeOfCounterpartyDomain_24205f22-df4e-440c-87e6-c67e777d5187_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LegalEntityTypeOfCounterpartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis_24205f22-df4e-440c-87e6-c67e777d5187" xlink:to="loc_us-gaap_LegalEntityTypeOfCounterpartyDomain_24205f22-df4e-440c-87e6-c67e777d5187_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalEntityTypeOfCounterpartyDomain_e0988aec-5ed8-4970-afe1-1e67c082a69f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LegalEntityTypeOfCounterpartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis_24205f22-df4e-440c-87e6-c67e777d5187" xlink:to="loc_us-gaap_LegalEntityTypeOfCounterpartyDomain_e0988aec-5ed8-4970-afe1-1e67c082a69f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PfizerInc.Member_999d9a27-007f-4eeb-8970-f1693f353556" xlink:href="vtrs-20211231.xsd#vtrs_PfizerInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LegalEntityTypeOfCounterpartyDomain_e0988aec-5ed8-4970-afe1-1e67c082a69f" xlink:to="loc_vtrs_PfizerInc.Member_999d9a27-007f-4eeb-8970-f1693f353556" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_908b5c1a-1178-4c9d-95e2-762f5730c308" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_47ee6ab2-6da2-49f5-9495-813cf94d1ed2" xlink:to="loc_srt_ProductOrServiceAxis_908b5c1a-1178-4c9d-95e2-762f5730c308" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_908b5c1a-1178-4c9d-95e2-762f5730c308_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_908b5c1a-1178-4c9d-95e2-762f5730c308" xlink:to="loc_srt_ProductsAndServicesDomain_908b5c1a-1178-4c9d-95e2-762f5730c308_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5de51408-ed8e-40f9-87b6-5a2fff5b0728" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_908b5c1a-1178-4c9d-95e2-762f5730c308" xlink:to="loc_srt_ProductsAndServicesDomain_5de51408-ed8e-40f9-87b6-5a2fff5b0728" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_732a4908-d6fd-49b9-857c-fdc3f50c92db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5de51408-ed8e-40f9-87b6-5a2fff5b0728" xlink:to="loc_us-gaap_ProductMember_732a4908-d6fd-49b9-857c-fdc3f50c92db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_f69ad8e2-5b10-4edc-b54c-34b40f8ae572" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_47ee6ab2-6da2-49f5-9495-813cf94d1ed2" xlink:to="loc_us-gaap_TypeOfArrangementAxis_f69ad8e2-5b10-4edc-b54c-34b40f8ae572" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f69ad8e2-5b10-4edc-b54c-34b40f8ae572_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_f69ad8e2-5b10-4edc-b54c-34b40f8ae572" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f69ad8e2-5b10-4edc-b54c-34b40f8ae572_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_166d5f47-a7d6-43a6-bca4-651ef9e4694a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_f69ad8e2-5b10-4edc-b54c-34b40f8ae572" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_166d5f47-a7d6-43a6-bca4-651ef9e4694a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RevanceMember_53d975d1-b7e8-4e39-92e7-75855faa7708" xlink:href="vtrs-20211231.xsd#vtrs_RevanceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_166d5f47-a7d6-43a6-bca4-651ef9e4694a" xlink:to="loc_vtrs_RevanceMember_53d975d1-b7e8-4e39-92e7-75855faa7708" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherCompaniesMember_7ddcb42b-740a-426e-90fb-d5671b91fd3f" xlink:href="vtrs-20211231.xsd#vtrs_OtherCompaniesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_166d5f47-a7d6-43a6-bca4-651ef9e4694a" xlink:to="loc_vtrs_OtherCompaniesMember_7ddcb42b-740a-426e-90fb-d5671b91fd3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_FKBMember_3aba836d-7cbd-440c-8c8b-ddf197456bc5" xlink:href="vtrs-20211231.xsd#vtrs_FKBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_166d5f47-a7d6-43a6-bca4-651ef9e4694a" xlink:to="loc_vtrs_FKBMember_3aba836d-7cbd-440c-8c8b-ddf197456bc5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0bcae202-8f07-40a7-8630-4a856f2d6063" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_47ee6ab2-6da2-49f5-9495-813cf94d1ed2" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0bcae202-8f07-40a7-8630-4a856f2d6063" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0bcae202-8f07-40a7-8630-4a856f2d6063_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0bcae202-8f07-40a7-8630-4a856f2d6063" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0bcae202-8f07-40a7-8630-4a856f2d6063_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_63905beb-d5aa-4d68-a332-15a3b5258f22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0bcae202-8f07-40a7-8630-4a856f2d6063" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_63905beb-d5aa-4d68-a332-15a3b5258f22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_UpjohnInc.Member_e7494069-e30a-4592-92d4-45315d1402b6" xlink:href="vtrs-20211231.xsd#vtrs_UpjohnInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_63905beb-d5aa-4d68-a332-15a3b5258f22" xlink:to="loc_vtrs_UpjohnInc.Member_e7494069-e30a-4592-92d4-45315d1402b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_c3f1f720-811c-4f93-a388-fe1ebc174643" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_63905beb-d5aa-4d68-a332-15a3b5258f22" xlink:to="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_c3f1f720-811c-4f93-a388-fe1ebc174643" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherCompaniesMember_eb61ea40-9a95-4452-8353-60fca3b39d4f" xlink:href="vtrs-20211231.xsd#vtrs_OtherCompaniesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_63905beb-d5aa-4d68-a332-15a3b5258f22" xlink:to="loc_vtrs_OtherCompaniesMember_eb61ea40-9a95-4452-8353-60fca3b39d4f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AspenGlobalIncorporatedMember_10cb760f-e10d-411d-80c0-99420763f7d3" xlink:href="vtrs-20211231.xsd#vtrs_AspenGlobalIncorporatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_63905beb-d5aa-4d68-a332-15a3b5258f22" xlink:to="loc_vtrs_AspenGlobalIncorporatedMember_10cb760f-e10d-411d-80c0-99420763f7d3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_TOBIMember_e141f471-5fdd-473d-8176-1eabb6870bf0" xlink:href="vtrs-20211231.xsd#vtrs_TOBIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_63905beb-d5aa-4d68-a332-15a3b5258f22" xlink:to="loc_vtrs_TOBIMember_e141f471-5fdd-473d-8176-1eabb6870bf0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AspenPharmacareHoldingsLimitedMember_6bc3d90c-1192-4466-8a15-bef3bda292ae" xlink:href="vtrs-20211231.xsd#vtrs_AspenPharmacareHoldingsLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_63905beb-d5aa-4d68-a332-15a3b5258f22" xlink:to="loc_vtrs_AspenPharmacareHoldingsLimitedMember_6bc3d90c-1192-4466-8a15-bef3bda292ae" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f72dfa9d-4156-40bd-8849-fce4fd3e1316" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_47ee6ab2-6da2-49f5-9495-813cf94d1ed2" xlink:to="loc_srt_RangeAxis_f72dfa9d-4156-40bd-8849-fce4fd3e1316" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f72dfa9d-4156-40bd-8849-fce4fd3e1316_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_f72dfa9d-4156-40bd-8849-fce4fd3e1316" xlink:to="loc_srt_RangeMember_f72dfa9d-4156-40bd-8849-fce4fd3e1316_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ad005993-fb5d-46cd-85da-6434dff8b8c3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_f72dfa9d-4156-40bd-8849-fce4fd3e1316" xlink:to="loc_srt_RangeMember_ad005993-fb5d-46cd-85da-6434dff8b8c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9b00ab70-7f03-4e13-878a-e0fbebf52175" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ad005993-fb5d-46cd-85da-6434dff8b8c3" xlink:to="loc_srt_MaximumMember_9b00ab70-7f03-4e13-878a-e0fbebf52175" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f02e0912-3a49-46ed-badb-23695a03c061" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ad005993-fb5d-46cd-85da-6434dff8b8c3" xlink:to="loc_srt_MinimumMember_f02e0912-3a49-46ed-badb-23695a03c061" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ec968c3f-3bdc-4cfd-9b72-d6ce2e636419" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_47ee6ab2-6da2-49f5-9495-813cf94d1ed2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ec968c3f-3bdc-4cfd-9b72-d6ce2e636419" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ec968c3f-3bdc-4cfd-9b72-d6ce2e636419_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ec968c3f-3bdc-4cfd-9b72-d6ce2e636419" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ec968c3f-3bdc-4cfd-9b72-d6ce2e636419_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fa8a2600-f798-4c46-9308-038d6e512509" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ec968c3f-3bdc-4cfd-9b72-d6ce2e636419" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fa8a2600-f798-4c46-9308-038d6e512509" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_edb509c0-8c9a-4b67-8a5c-36c8718b2801" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fa8a2600-f798-4c46-9308-038d6e512509" xlink:to="loc_us-gaap_LicensingAgreementsMember_edb509c0-8c9a-4b67-8a5c-36c8718b2801" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember_64b78316-926c-46bd-91f1-47e88bd2c372" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractualRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fa8a2600-f798-4c46-9308-038d6e512509" xlink:to="loc_us-gaap_ContractualRightsMember_64b78316-926c-46bd-91f1-47e88bd2c372" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_872b7464-7a5f-4952-abef-1f4906e52d22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_47ee6ab2-6da2-49f5-9495-813cf94d1ed2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_872b7464-7a5f-4952-abef-1f4906e52d22" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_872b7464-7a5f-4952-abef-1f4906e52d22_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_872b7464-7a5f-4952-abef-1f4906e52d22" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_872b7464-7a5f-4952-abef-1f4906e52d22_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_aba42942-db06-413d-8380-e5132889d494" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_872b7464-7a5f-4952-abef-1f4906e52d22" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_aba42942-db06-413d-8380-e5132889d494" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_818922f8-c6bf-4d80-9ad2-a02fbdf05fc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_aba42942-db06-413d-8380-e5132889d494" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_818922f8-c6bf-4d80-9ad2-a02fbdf05fc6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_22ff6d68-780d-42ea-a2e4-bfcd28f6e183" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_aba42942-db06-413d-8380-e5132889d494" xlink:to="loc_us-gaap_BuildingMember_22ff6d68-780d-42ea-a2e4-bfcd28f6e183" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMember_be294007-44ea-47ef-9718-00cd163c4f76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_aba42942-db06-413d-8380-e5132889d494" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMember_be294007-44ea-47ef-9718-00cd163c4f76" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_c61faa84-ed2f-42af-aa43-51a3f64d8aaf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_47ee6ab2-6da2-49f5-9495-813cf94d1ed2" xlink:to="loc_srt_OwnershipAxis_c61faa84-ed2f-42af-aa43-51a3f64d8aaf" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_c61faa84-ed2f-42af-aa43-51a3f64d8aaf_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_c61faa84-ed2f-42af-aa43-51a3f64d8aaf" xlink:to="loc_srt_OwnershipDomain_c61faa84-ed2f-42af-aa43-51a3f64d8aaf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_f554f4e9-5b22-442e-8fc3-b8452d0bacad" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_c61faa84-ed2f-42af-aa43-51a3f64d8aaf" xlink:to="loc_srt_OwnershipDomain_f554f4e9-5b22-442e-8fc3-b8452d0bacad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_UpjohnInc.Member_d44380cf-bd3c-474c-9459-23e8506b0710" xlink:href="vtrs-20211231.xsd#vtrs_UpjohnInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_f554f4e9-5b22-442e-8fc3-b8452d0bacad" xlink:to="loc_vtrs_UpjohnInc.Member_d44380cf-bd3c-474c-9459-23e8506b0710" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails" xlink:type="extended" id="i7899b83114e74be28e53ca642022de1a_AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_7a76fa56-e358-4576-b9a6-b6059de4c854" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_dbc7d7be-cc57-488c-a289-50e03b9017d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a76fa56-e358-4576-b9a6-b6059de4c854" xlink:to="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_dbc7d7be-cc57-488c-a289-50e03b9017d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_25579e39-b682-49c0-9c2b-d8cddc9057a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_dbc7d7be-cc57-488c-a289-50e03b9017d1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_25579e39-b682-49c0-9c2b-d8cddc9057a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_ae130c7f-5363-402e-97e1-b197273ff652" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_dbc7d7be-cc57-488c-a289-50e03b9017d1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_ae130c7f-5363-402e-97e1-b197273ff652" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_09407691-b48e-47e2-8a89-162a5c4f6b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_dbc7d7be-cc57-488c-a289-50e03b9017d1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_09407691-b48e-47e2-8a89-162a5c4f6b6e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_8ef303a7-3983-4407-bce2-45f65868ffbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_dbc7d7be-cc57-488c-a289-50e03b9017d1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_8ef303a7-3983-4407-bce2-45f65868ffbe" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_8ad4d515-850f-48f1-9d1c-44268528e0fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_dbc7d7be-cc57-488c-a289-50e03b9017d1" xlink:to="loc_us-gaap_Goodwill_8ad4d515-850f-48f1-9d1c-44268528e0fc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_7fd07af9-5108-40c4-b20c-5b900422484d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_dbc7d7be-cc57-488c-a289-50e03b9017d1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_7fd07af9-5108-40c4-b20c-5b900422484d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_08145a11-c678-449e-b80a-dfc5525e4960" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_dbc7d7be-cc57-488c-a289-50e03b9017d1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_08145a11-c678-449e-b80a-dfc5525e4960" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_aa7849fc-cac1-4e5d-b436-c69f0c0cb374" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_dbc7d7be-cc57-488c-a289-50e03b9017d1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_aa7849fc-cac1-4e5d-b436-c69f0c0cb374" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_5bbad8ec-388b-4de3-b4ea-3659504a43f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_dbc7d7be-cc57-488c-a289-50e03b9017d1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_5bbad8ec-388b-4de3-b4ea-3659504a43f6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_6a3ed7fd-50bb-4632-9971-30f82ac14c44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_dbc7d7be-cc57-488c-a289-50e03b9017d1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_6a3ed7fd-50bb-4632-9971-30f82ac14c44" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_01534497-23b8-4176-b805-744a30023e10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_dbc7d7be-cc57-488c-a289-50e03b9017d1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_01534497-23b8-4176-b805-744a30023e10" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_11254a44-1fea-4ead-805b-f1cf3a956b65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_dbc7d7be-cc57-488c-a289-50e03b9017d1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_11254a44-1fea-4ead-805b-f1cf3a956b65" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_54040386-e9a4-4dd3-829c-ef2ad6dd5da2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_dbc7d7be-cc57-488c-a289-50e03b9017d1" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_54040386-e9a4-4dd3-829c-ef2ad6dd5da2" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets_ee0c2900-116b-49f7-88e6-168f6f8b231b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_dbc7d7be-cc57-488c-a289-50e03b9017d1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets_ee0c2900-116b-49f7-88e6-168f6f8b231b" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7fcaff51-11eb-45c0-9e3c-94220f817f8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a76fa56-e358-4576-b9a6-b6059de4c854" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7fcaff51-11eb-45c0-9e3c-94220f817f8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsCurrent_3e15bad8-4bf1-4671-94b4-c3685b6d7218" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7fcaff51-11eb-45c0-9e3c-94220f817f8e" xlink:to="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsCurrent_3e15bad8-4bf1-4671-94b4-c3685b6d7218" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_f029147c-7da8-4a02-9a5d-dadbf3391614" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7fcaff51-11eb-45c0-9e3c-94220f817f8e" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_f029147c-7da8-4a02-9a5d-dadbf3391614" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_beb52430-4d5d-41b8-9803-03363f1231fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7fcaff51-11eb-45c0-9e3c-94220f817f8e" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_beb52430-4d5d-41b8-9803-03363f1231fa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_577e0bf6-6ef7-4e21-9673-9b445efe9f28" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7fcaff51-11eb-45c0-9e3c-94220f817f8e" xlink:to="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_577e0bf6-6ef7-4e21-9673-9b445efe9f28" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_1c47b310-e292-487a-a51f-ebd94f5b0227" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7fcaff51-11eb-45c0-9e3c-94220f817f8e" xlink:to="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_1c47b310-e292-487a-a51f-ebd94f5b0227" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentAssets_e2d18228-1e3f-4180-9b3a-f7f288a227e3" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7fcaff51-11eb-45c0-9e3c-94220f817f8e" xlink:to="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentAssets_e2d18228-1e3f-4180-9b3a-f7f288a227e3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_47c8aefa-07b0-4b26-bc95-834e56760fbe" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7fcaff51-11eb-45c0-9e3c-94220f817f8e" xlink:to="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_47c8aefa-07b0-4b26-bc95-834e56760fbe" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesCurrent_b8e67590-db22-4b33-a761-88b43fcaade4" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7fcaff51-11eb-45c0-9e3c-94220f817f8e" xlink:to="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesCurrent_b8e67590-db22-4b33-a761-88b43fcaade4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities_40430600-8055-45a0-bff8-3e034b029484" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7fcaff51-11eb-45c0-9e3c-94220f817f8e" xlink:to="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities_40430600-8055-45a0-bff8-3e034b029484" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentLiabilities_3717a0ae-8547-4890-b57f-13bb1bfbdc3d" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7fcaff51-11eb-45c0-9e3c-94220f817f8e" xlink:to="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentLiabilities_3717a0ae-8547-4890-b57f-13bb1bfbdc3d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_812f1488-05cb-4271-b576-6ab175ece288" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7fcaff51-11eb-45c0-9e3c-94220f817f8e" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_812f1488-05cb-4271-b576-6ab175ece288" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d1fa3c2c-48ee-477f-b96d-16394c09ebb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a76fa56-e358-4576-b9a6-b6059de4c854" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d1fa3c2c-48ee-477f-b96d-16394c09ebb3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_98c75f5d-552a-4865-9790-aea6d7cfd0de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d1fa3c2c-48ee-477f-b96d-16394c09ebb3" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_98c75f5d-552a-4865-9790-aea6d7cfd0de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_98c75f5d-552a-4865-9790-aea6d7cfd0de_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_98c75f5d-552a-4865-9790-aea6d7cfd0de" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_98c75f5d-552a-4865-9790-aea6d7cfd0de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_07359235-c5c0-4776-a677-718f83b11411" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_98c75f5d-552a-4865-9790-aea6d7cfd0de" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_07359235-c5c0-4776-a677-718f83b11411" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_UpjohnInc.Member_f8caac2a-800b-4f9d-aa13-558ec4907de6" xlink:href="vtrs-20211231.xsd#vtrs_UpjohnInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_07359235-c5c0-4776-a677-718f83b11411" xlink:to="loc_vtrs_UpjohnInc.Member_f8caac2a-800b-4f9d-aa13-558ec4907de6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_TOBIMember_1f2cbac3-ad5d-4cc0-9406-48f281b10ac0" xlink:href="vtrs-20211231.xsd#vtrs_TOBIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_07359235-c5c0-4776-a677-718f83b11411" xlink:to="loc_vtrs_TOBIMember_1f2cbac3-ad5d-4cc0-9406-48f281b10ac0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_a17ceb3a-74a5-4ff0-ad6e-7a7a44378b9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_07359235-c5c0-4776-a677-718f83b11411" xlink:to="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_a17ceb3a-74a5-4ff0-ad6e-7a7a44378b9c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AspenPharmacareHoldingsLimitedMember_290194d3-7151-4094-9241-a3652d2dfab1" xlink:href="vtrs-20211231.xsd#vtrs_AspenPharmacareHoldingsLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_07359235-c5c0-4776-a677-718f83b11411" xlink:to="loc_vtrs_AspenPharmacareHoldingsLimitedMember_290194d3-7151-4094-9241-a3652d2dfab1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_d38be229-21b2-4fd9-981f-db265bb0b6c3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d1fa3c2c-48ee-477f-b96d-16394c09ebb3" xlink:to="loc_srt_CounterpartyNameAxis_d38be229-21b2-4fd9-981f-db265bb0b6c3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d38be229-21b2-4fd9-981f-db265bb0b6c3_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_d38be229-21b2-4fd9-981f-db265bb0b6c3" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d38be229-21b2-4fd9-981f-db265bb0b6c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_aa1cc9d0-f023-4139-9f12-ada878f2c332" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_d38be229-21b2-4fd9-981f-db265bb0b6c3" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_aa1cc9d0-f023-4139-9f12-ada878f2c332" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_UpjohnInc.Member_bcb2400e-ffa4-4645-ab0d-3ce53979b70c" xlink:href="vtrs-20211231.xsd#vtrs_UpjohnInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_aa1cc9d0-f023-4139-9f12-ada878f2c332" xlink:to="loc_vtrs_UpjohnInc.Member_bcb2400e-ffa4-4645-ab0d-3ce53979b70c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis_5383c348-5637-4a6d-be9f-fbd00919e11d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d1fa3c2c-48ee-477f-b96d-16394c09ebb3" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis_5383c348-5637-4a6d-be9f-fbd00919e11d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalEntityTypeOfCounterpartyDomain_5383c348-5637-4a6d-be9f-fbd00919e11d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LegalEntityTypeOfCounterpartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis_5383c348-5637-4a6d-be9f-fbd00919e11d" xlink:to="loc_us-gaap_LegalEntityTypeOfCounterpartyDomain_5383c348-5637-4a6d-be9f-fbd00919e11d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalEntityTypeOfCounterpartyDomain_1ccf737b-3d6d-4937-833e-ab6952e75498" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LegalEntityTypeOfCounterpartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis_5383c348-5637-4a6d-be9f-fbd00919e11d" xlink:to="loc_us-gaap_LegalEntityTypeOfCounterpartyDomain_1ccf737b-3d6d-4937-833e-ab6952e75498" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PfizerInc.Member_ab5991f4-0e97-4293-abf3-c7468d692ce3" xlink:href="vtrs-20211231.xsd#vtrs_PfizerInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LegalEntityTypeOfCounterpartyDomain_1ccf737b-3d6d-4937-833e-ab6952e75498" xlink:to="loc_vtrs_PfizerInc.Member_ab5991f4-0e97-4293-abf3-c7468d692ce3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails" xlink:type="extended" id="i0cfb8976d4a440fdbe819655eddbc6e1_AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_3901288a-c5d1-4da1-956a-d48b1b5d0c8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_7125931d-2deb-49ff-8cc3-a0abcb7515f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3901288a-c5d1-4da1-956a-d48b1b5d0c8b" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_7125931d-2deb-49ff-8cc3-a0abcb7515f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_c9ab52b4-0484-40c9-b6f8-a97cb2448f83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3901288a-c5d1-4da1-956a-d48b1b5d0c8b" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_c9ab52b4-0484-40c9-b6f8-a97cb2448f83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_6884b3cb-8edf-4d18-bb6c-82adcd71a01b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3901288a-c5d1-4da1-956a-d48b1b5d0c8b" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_6884b3cb-8edf-4d18-bb6c-82adcd71a01b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_04aca583-d0d0-401b-a5db-f6bb2ab94559" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3901288a-c5d1-4da1-956a-d48b1b5d0c8b" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_04aca583-d0d0-401b-a5db-f6bb2ab94559" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageBasicSharesOutstandingProForma_cb2192fa-3a4d-429d-9997-60e7da13ca3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageBasicSharesOutstandingProForma"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3901288a-c5d1-4da1-956a-d48b1b5d0c8b" xlink:to="loc_us-gaap_WeightedAverageBasicSharesOutstandingProForma_cb2192fa-3a4d-429d-9997-60e7da13ca3a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted_8299eab7-6436-4656-9f43-0b6e04cdd85c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3901288a-c5d1-4da1-956a-d48b1b5d0c8b" xlink:to="loc_us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted_8299eab7-6436-4656-9f43-0b6e04cdd85c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3bf4c8ba-0714-453e-b009-18c0f739f180" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3901288a-c5d1-4da1-956a-d48b1b5d0c8b" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3bf4c8ba-0714-453e-b009-18c0f739f180" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_ff6511be-61a9-4c27-838b-12b84fd8885c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3bf4c8ba-0714-453e-b009-18c0f739f180" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_ff6511be-61a9-4c27-838b-12b84fd8885c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ff6511be-61a9-4c27-838b-12b84fd8885c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ff6511be-61a9-4c27-838b-12b84fd8885c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ff6511be-61a9-4c27-838b-12b84fd8885c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_769bb719-56d9-4bc6-aa79-5014166124f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ff6511be-61a9-4c27-838b-12b84fd8885c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_769bb719-56d9-4bc6-aa79-5014166124f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_UpjohnInc.Member_6ddb639f-dcbc-4164-b3c9-32ce776b95bf" xlink:href="vtrs-20211231.xsd#vtrs_UpjohnInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_769bb719-56d9-4bc6-aa79-5014166124f5" xlink:to="loc_vtrs_UpjohnInc.Member_6ddb639f-dcbc-4164-b3c9-32ce776b95bf" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#RevenueRecognitionandAccountsReceivableRevenueDisaggregationDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationDetails" xlink:type="extended" id="if6a40f480aae42ff8bc36adc81405b80_RevenueRecognitionandAccountsReceivableRevenueDisaggregationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_c1388fe4-de10-4f55-b31a-e2ba6039e3ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b767cfd2-207f-416b-82c9-f3e426cbbb28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c1388fe4-de10-4f55-b31a-e2ba6039e3ba" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b767cfd2-207f-416b-82c9-f3e426cbbb28" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_2313563c-f5fd-4e8a-9abb-6ec4d9d2f98e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c1388fe4-de10-4f55-b31a-e2ba6039e3ba" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_2313563c-f5fd-4e8a-9abb-6ec4d9d2f98e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_2a17b05c-4ded-4c3f-9f7f-0f4205ec9c01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2313563c-f5fd-4e8a-9abb-6ec4d9d2f98e" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_2a17b05c-4ded-4c3f-9f7f-0f4205ec9c01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2a17b05c-4ded-4c3f-9f7f-0f4205ec9c01_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2a17b05c-4ded-4c3f-9f7f-0f4205ec9c01" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2a17b05c-4ded-4c3f-9f7f-0f4205ec9c01_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7fd3350d-bba5-49d6-97e0-74fcafb84b8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2a17b05c-4ded-4c3f-9f7f-0f4205ec9c01" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7fd3350d-bba5-49d6-97e0-74fcafb84b8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember_05ef42c3-c540-4f7e-a5f3-d20246de2bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7fd3350d-bba5-49d6-97e0-74fcafb84b8d" xlink:to="loc_us-gaap_SalesMember_05ef42c3-c540-4f7e-a5f3-d20246de2bfe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_29d18d59-f3f6-490a-9992-fad065436eac" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2313563c-f5fd-4e8a-9abb-6ec4d9d2f98e" xlink:to="loc_srt_ConsolidationItemsAxis_29d18d59-f3f6-490a-9992-fad065436eac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_29d18d59-f3f6-490a-9992-fad065436eac_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_29d18d59-f3f6-490a-9992-fad065436eac" xlink:to="loc_srt_ConsolidationItemsDomain_29d18d59-f3f6-490a-9992-fad065436eac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_2d55efb2-de31-4124-9693-bd8088131b8d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_29d18d59-f3f6-490a-9992-fad065436eac" xlink:to="loc_srt_ConsolidationItemsDomain_2d55efb2-de31-4124-9693-bd8088131b8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_2e0f9f0e-c059-484d-88b8-4dc99b220797" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_2d55efb2-de31-4124-9693-bd8088131b8d" xlink:to="loc_us-gaap_OperatingSegmentsMember_2e0f9f0e-c059-484d-88b8-4dc99b220797" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_83f5c7a8-dd74-49aa-9b15-7938b00de4ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2313563c-f5fd-4e8a-9abb-6ec4d9d2f98e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_83f5c7a8-dd74-49aa-9b15-7938b00de4ae" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_83f5c7a8-dd74-49aa-9b15-7938b00de4ae_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_83f5c7a8-dd74-49aa-9b15-7938b00de4ae" xlink:to="loc_us-gaap_SegmentDomain_83f5c7a8-dd74-49aa-9b15-7938b00de4ae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1a35a772-a757-4f2e-9690-48713010a35b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_83f5c7a8-dd74-49aa-9b15-7938b00de4ae" xlink:to="loc_us-gaap_SegmentDomain_1a35a772-a757-4f2e-9690-48713010a35b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DevelopedMarketsSegmentMember_a96bec0c-ba44-4b19-9b25-b43069984f66" xlink:href="vtrs-20211231.xsd#vtrs_DevelopedMarketsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1a35a772-a757-4f2e-9690-48713010a35b" xlink:to="loc_vtrs_DevelopedMarketsSegmentMember_a96bec0c-ba44-4b19-9b25-b43069984f66" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GreaterChinaSegmentMember_11e3de9d-fc7e-4ac1-a6e8-38f24ad694c5" xlink:href="vtrs-20211231.xsd#vtrs_GreaterChinaSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1a35a772-a757-4f2e-9690-48713010a35b" xlink:to="loc_vtrs_GreaterChinaSegmentMember_11e3de9d-fc7e-4ac1-a6e8-38f24ad694c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_c7fa47b0-ce97-49e1-879c-fd79a5c16db1" xlink:href="vtrs-20211231.xsd#vtrs_JapanAustraliaAndNewZealandSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1a35a772-a757-4f2e-9690-48713010a35b" xlink:to="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_c7fa47b0-ce97-49e1-879c-fd79a5c16db1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EmergingMarketsSegmentMember_609cc239-9569-4b0c-a852-41652c4400bd" xlink:href="vtrs-20211231.xsd#vtrs_EmergingMarketsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1a35a772-a757-4f2e-9690-48713010a35b" xlink:to="loc_vtrs_EmergingMarketsSegmentMember_609cc239-9569-4b0c-a852-41652c4400bd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_86fc3dad-d71f-433a-bb6b-c747ce130764" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2313563c-f5fd-4e8a-9abb-6ec4d9d2f98e" xlink:to="loc_srt_ProductOrServiceAxis_86fc3dad-d71f-433a-bb6b-c747ce130764" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_86fc3dad-d71f-433a-bb6b-c747ce130764_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_86fc3dad-d71f-433a-bb6b-c747ce130764" xlink:to="loc_srt_ProductsAndServicesDomain_86fc3dad-d71f-433a-bb6b-c747ce130764_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_df666598-945a-4b88-9a75-51e4e6f7a701" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_86fc3dad-d71f-433a-bb6b-c747ce130764" xlink:to="loc_srt_ProductsAndServicesDomain_df666598-945a-4b88-9a75-51e4e6f7a701" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BrandsMember_3d5b43f8-e8f7-46dc-a8e9-5270fe08110b" xlink:href="vtrs-20211231.xsd#vtrs_BrandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_df666598-945a-4b88-9a75-51e4e6f7a701" xlink:to="loc_vtrs_BrandsMember_3d5b43f8-e8f7-46dc-a8e9-5270fe08110b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ComplexGXAndBiosimilarsMember_e35cfdba-a4fb-4f78-8a85-80c74e6bf719" xlink:href="vtrs-20211231.xsd#vtrs_ComplexGXAndBiosimilarsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_df666598-945a-4b88-9a75-51e4e6f7a701" xlink:to="loc_vtrs_ComplexGXAndBiosimilarsMember_e35cfdba-a4fb-4f78-8a85-80c74e6bf719" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GenericsMember_5016fa59-b321-4cee-b054-9bc43538544a" xlink:href="vtrs-20211231.xsd#vtrs_GenericsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_df666598-945a-4b88-9a75-51e4e6f7a701" xlink:to="loc_vtrs_GenericsMember_5016fa59-b321-4cee-b054-9bc43538544a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_401eef69-c8d1-4355-bc1d-038aec995ad5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_df666598-945a-4b88-9a75-51e4e6f7a701" xlink:to="loc_us-gaap_ProductMember_401eef69-c8d1-4355-bc1d-038aec995ad5" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableDisaggregationofRevenuebyKeyProductsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#RevenueRecognitionandAccountsReceivableDisaggregationofRevenuebyKeyProductsDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableDisaggregationofRevenuebyKeyProductsDetails" xlink:type="extended" id="iaaae29b4e4b343da91dcecfbe8ac9678_RevenueRecognitionandAccountsReceivableDisaggregationofRevenuebyKeyProductsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_7f51fb24-8811-4193-aae2-60c126302966" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_bdb79ed5-5dde-4d45-a214-c818e1bc366c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_7f51fb24-8811-4193-aae2-60c126302966" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_bdb79ed5-5dde-4d45-a214-c818e1bc366c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_576c9ac2-bb23-4826-8383-edd65d1f2030" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_7f51fb24-8811-4193-aae2-60c126302966" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_576c9ac2-bb23-4826-8383-edd65d1f2030" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_70fa9486-5d73-47d6-a165-945523a61b2f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_576c9ac2-bb23-4826-8383-edd65d1f2030" xlink:to="loc_srt_ProductOrServiceAxis_70fa9486-5d73-47d6-a165-945523a61b2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_70fa9486-5d73-47d6-a165-945523a61b2f_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_70fa9486-5d73-47d6-a165-945523a61b2f" xlink:to="loc_srt_ProductsAndServicesDomain_70fa9486-5d73-47d6-a165-945523a61b2f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_8005a9d2-a278-4c17-b725-ec46ddc8d9fd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_70fa9486-5d73-47d6-a165-945523a61b2f" xlink:to="loc_srt_ProductsAndServicesDomain_8005a9d2-a278-4c17-b725-ec46ddc8d9fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_LipitorMember_2a23068e-31ce-4f87-8e61-bb804ba71a64" xlink:href="vtrs-20211231.xsd#vtrs_LipitorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8005a9d2-a278-4c17-b725-ec46ddc8d9fd" xlink:to="loc_vtrs_LipitorMember_2a23068e-31ce-4f87-8e61-bb804ba71a64" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NorvascMember_0ab0e18a-979a-4415-b4da-cd1cfb78dd64" xlink:href="vtrs-20211231.xsd#vtrs_NorvascMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8005a9d2-a278-4c17-b725-ec46ddc8d9fd" xlink:to="loc_vtrs_NorvascMember_0ab0e18a-979a-4415-b4da-cd1cfb78dd64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_LyricaMember_7b1e52a6-e5b8-4160-881e-e3a298723a9c" xlink:href="vtrs-20211231.xsd#vtrs_LyricaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8005a9d2-a278-4c17-b725-ec46ddc8d9fd" xlink:to="loc_vtrs_LyricaMember_7b1e52a6-e5b8-4160-881e-e3a298723a9c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ViagraMember_3d4e632a-12cd-47fa-9414-12e1bec7670d" xlink:href="vtrs-20211231.xsd#vtrs_ViagraMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8005a9d2-a278-4c17-b725-ec46ddc8d9fd" xlink:to="loc_vtrs_ViagraMember_3d4e632a-12cd-47fa-9414-12e1bec7670d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EpiPenAutoInjectorsMember_76faa4ef-9e30-4c74-b828-89c9f3d7adf4" xlink:href="vtrs-20211231.xsd#vtrs_EpiPenAutoInjectorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8005a9d2-a278-4c17-b725-ec46ddc8d9fd" xlink:to="loc_vtrs_EpiPenAutoInjectorsMember_76faa4ef-9e30-4c74-b828-89c9f3d7adf4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CelebrexMember_93edf688-42de-4eee-8945-9e15d205284e" xlink:href="vtrs-20211231.xsd#vtrs_CelebrexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8005a9d2-a278-4c17-b725-ec46ddc8d9fd" xlink:to="loc_vtrs_CelebrexMember_93edf688-42de-4eee-8945-9e15d205284e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CreonMember_809b471c-b345-438d-ab60-80f31f6d1d03" xlink:href="vtrs-20211231.xsd#vtrs_CreonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8005a9d2-a278-4c17-b725-ec46ddc8d9fd" xlink:to="loc_vtrs_CreonMember_809b471c-b345-438d-ab60-80f31f6d1d03" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ZoloftMember_72882b72-72e9-4cc0-8ce3-dfad365bf6d5" xlink:href="vtrs-20211231.xsd#vtrs_ZoloftMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8005a9d2-a278-4c17-b725-ec46ddc8d9fd" xlink:to="loc_vtrs_ZoloftMember_72882b72-72e9-4cc0-8ce3-dfad365bf6d5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EffexorMember_a305f192-920d-4d68-b40d-8b364021461e" xlink:href="vtrs-20211231.xsd#vtrs_EffexorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8005a9d2-a278-4c17-b725-ec46ddc8d9fd" xlink:to="loc_vtrs_EffexorMember_a305f192-920d-4d68-b40d-8b364021461e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_XalabrandsMember_3d967ab1-14ee-4859-9f22-ff24969c6049" xlink:href="vtrs-20211231.xsd#vtrs_XalabrandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8005a9d2-a278-4c17-b725-ec46ddc8d9fd" xlink:to="loc_vtrs_XalabrandsMember_3d967ab1-14ee-4859-9f22-ff24969c6049" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_InfluvacMember_b89335bb-defc-4c2f-8344-735f32a1a1fe" xlink:href="vtrs-20211231.xsd#vtrs_InfluvacMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8005a9d2-a278-4c17-b725-ec46ddc8d9fd" xlink:to="loc_vtrs_InfluvacMember_b89335bb-defc-4c2f-8344-735f32a1a1fe" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AmitizaMember_8dc7f8be-c6d0-4789-98e1-adb487b2c13a" xlink:href="vtrs-20211231.xsd#vtrs_AmitizaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8005a9d2-a278-4c17-b725-ec46ddc8d9fd" xlink:to="loc_vtrs_AmitizaMember_8dc7f8be-c6d0-4789-98e1-adb487b2c13a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_XanaxMember_93e62939-1320-440e-a6a4-0ddb6b5d3bd9" xlink:href="vtrs-20211231.xsd#vtrs_XanaxMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8005a9d2-a278-4c17-b725-ec46ddc8d9fd" xlink:to="loc_vtrs_XanaxMember_93e62939-1320-440e-a6a4-0ddb6b5d3bd9" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_YupelriMember_4872cfa6-2d39-4ec8-8544-2c527fa3c022" xlink:href="vtrs-20211231.xsd#vtrs_YupelriMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8005a9d2-a278-4c17-b725-ec46ddc8d9fd" xlink:to="loc_vtrs_YupelriMember_4872cfa6-2d39-4ec8-8544-2c527fa3c022" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DymistaMember_2945aafc-f008-4a2a-95e9-a81f1e92aec0" xlink:href="vtrs-20211231.xsd#vtrs_DymistaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8005a9d2-a278-4c17-b725-ec46ddc8d9fd" xlink:to="loc_vtrs_DymistaMember_2945aafc-f008-4a2a-95e9-a81f1e92aec0" xlink:type="arc" order="14"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#RevenueRecognitionandAccountsReceivableNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableNarrativeDetails" xlink:type="extended" id="i695273efc93541c790ecd72cf79f3051_RevenueRecognitionandAccountsReceivableNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c7228adf-43d1-42d4-be5c-a1ffb0036200" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity_023e8d59-7c86-4ae7-8953-8e387dbe6939" xlink:href="vtrs-20211231.xsd#vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c7228adf-43d1-42d4-be5c-a1ffb0036200" xlink:to="loc_vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity_023e8d59-7c86-4ae7-8953-8e387dbe6939" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableFromSecuritization_0c197d7c-7895-46db-b5b1-81b239db5ce0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableFromSecuritization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c7228adf-43d1-42d4-be5c-a1ffb0036200" xlink:to="loc_us-gaap_AccountsReceivableFromSecuritization_0c197d7c-7895-46db-b5b1-81b239db5ce0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_8a0c83a1-5bec-4622-87b6-98a7d7782427" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c7228adf-43d1-42d4-be5c-a1ffb0036200" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_8a0c83a1-5bec-4622-87b6-98a7d7782427" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_7d5ec295-d6ac-4a4a-8c31-15b8499c1e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_8a0c83a1-5bec-4622-87b6-98a7d7782427" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_7d5ec295-d6ac-4a4a-8c31-15b8499c1e5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_7d5ec295-d6ac-4a4a-8c31-15b8499c1e5a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_7d5ec295-d6ac-4a4a-8c31-15b8499c1e5a" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_7d5ec295-d6ac-4a4a-8c31-15b8499c1e5a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_a163269f-cade-4de8-8e74-027ccfd414c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_7d5ec295-d6ac-4a4a-8c31-15b8499c1e5a" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_a163269f-cade-4de8-8e74-027ccfd414c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ReceivablesFacilityMember_13234c09-3829-4579-839b-a55cdb642974" xlink:href="vtrs-20211231.xsd#vtrs_ReceivablesFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_a163269f-cade-4de8-8e74-027ccfd414c0" xlink:to="loc_vtrs_ReceivablesFacilityMember_13234c09-3829-4579-839b-a55cdb642974" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#RevenueRecognitionandAccountsReceivableVariableConsiderationDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails" xlink:type="extended" id="i6ab661fd620f4bc2afc646c0207c7b2f_RevenueRecognitionandAccountsReceivableVariableConsiderationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_823eec14-f883-4b38-bf55-709b1ad7f6ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RevenuefromContractwithCustomerGross_0788cbb6-d59c-4849-a9a6-9736bed17fe9" xlink:href="vtrs-20211231.xsd#vtrs_RevenuefromContractwithCustomerGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_823eec14-f883-4b38-bf55-709b1ad7f6ec" xlink:to="loc_vtrs_RevenuefromContractwithCustomerGross_0788cbb6-d59c-4849-a9a6-9736bed17fe9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Chargebacks_3191e981-a17a-4c59-b88e-78b501ddc46d" xlink:href="vtrs-20211231.xsd#vtrs_Chargebacks"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_823eec14-f883-4b38-bf55-709b1ad7f6ec" xlink:to="loc_vtrs_Chargebacks_3191e981-a17a-4c59-b88e-78b501ddc46d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccruedSalesAllowances_1202d420-b73f-49c3-9343-b44f9193e302" xlink:href="vtrs-20211231.xsd#vtrs_AccruedSalesAllowances"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_823eec14-f883-4b38-bf55-709b1ad7f6ec" xlink:to="loc_vtrs_AccruedSalesAllowances_1202d420-b73f-49c3-9343-b44f9193e302" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RevenuefromContractwithCustomerReturns_16340c51-753f-4602-8103-0b4bec998e03" xlink:href="vtrs-20211231.xsd#vtrs_RevenuefromContractwithCustomerReturns"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_823eec14-f883-4b38-bf55-709b1ad7f6ec" xlink:to="loc_vtrs_RevenuefromContractwithCustomerReturns_16340c51-753f-4602-8103-0b4bec998e03" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Medicaidandothergovernmentalrebates_e6a2f54a-fe5f-467f-8796-e492894d92a3" xlink:href="vtrs-20211231.xsd#vtrs_Medicaidandothergovernmentalrebates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_823eec14-f883-4b38-bf55-709b1ad7f6ec" xlink:to="loc_vtrs_Medicaidandothergovernmentalrebates_e6a2f54a-fe5f-467f-8796-e492894d92a3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SalesRevenueGrosstonetadjustments_dd57b271-8626-41f1-81be-d0034685bf97" xlink:href="vtrs-20211231.xsd#vtrs_SalesRevenueGrosstonetadjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_823eec14-f883-4b38-bf55-709b1ad7f6ec" xlink:to="loc_vtrs_SalesRevenueGrosstonetadjustments_dd57b271-8626-41f1-81be-d0034685bf97" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_eeee9cda-853c-4162-96f7-47c23dff2f4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_823eec14-f883-4b38-bf55-709b1ad7f6ec" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_eeee9cda-853c-4162-96f7-47c23dff2f4c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_1bdaa4a4-a6c1-4d96-ae92-2c855c7e5b8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_823eec14-f883-4b38-bf55-709b1ad7f6ec" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_1bdaa4a4-a6c1-4d96-ae92-2c855c7e5b8f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_8a865ec2-177d-4b5e-98f2-13c1fda71867" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1bdaa4a4-a6c1-4d96-ae92-2c855c7e5b8f" xlink:to="loc_srt_ConsolidationItemsAxis_8a865ec2-177d-4b5e-98f2-13c1fda71867" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_8a865ec2-177d-4b5e-98f2-13c1fda71867_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_8a865ec2-177d-4b5e-98f2-13c1fda71867" xlink:to="loc_srt_ConsolidationItemsDomain_8a865ec2-177d-4b5e-98f2-13c1fda71867_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_e800fc60-541b-4f06-980a-f588a7ca0bda" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_8a865ec2-177d-4b5e-98f2-13c1fda71867" xlink:to="loc_srt_ConsolidationItemsDomain_e800fc60-541b-4f06-980a-f588a7ca0bda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_f5c554d9-acfe-41c0-9524-e841e2061b84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_e800fc60-541b-4f06-980a-f588a7ca0bda" xlink:to="loc_us-gaap_OperatingSegmentsMember_f5c554d9-acfe-41c0-9524-e841e2061b84" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c3cc8c4d-2ca7-4f1e-be00-1feeb0e4f60a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1bdaa4a4-a6c1-4d96-ae92-2c855c7e5b8f" xlink:to="loc_srt_ProductOrServiceAxis_c3cc8c4d-2ca7-4f1e-be00-1feeb0e4f60a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c3cc8c4d-2ca7-4f1e-be00-1feeb0e4f60a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_c3cc8c4d-2ca7-4f1e-be00-1feeb0e4f60a" xlink:to="loc_srt_ProductsAndServicesDomain_c3cc8c4d-2ca7-4f1e-be00-1feeb0e4f60a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4d8f34e1-083e-4fc3-a7af-2b044d7f8714" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_c3cc8c4d-2ca7-4f1e-be00-1feeb0e4f60a" xlink:to="loc_srt_ProductsAndServicesDomain_4d8f34e1-083e-4fc3-a7af-2b044d7f8714" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_627b566a-e859-40c3-b90e-5b3e9bdd4d86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_4d8f34e1-083e-4fc3-a7af-2b044d7f8714" xlink:to="loc_us-gaap_ProductMember_627b566a-e859-40c3-b90e-5b3e9bdd4d86" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails" xlink:type="extended" id="if7b21e7483e94c61962ed8992bc4167a_RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_4848da59-1fc5-44c9-be78-055e60f9c0e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_df4e5cf3-22f8-4354-8eb3-880acff3a8a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_4848da59-1fc5-44c9-be78-055e60f9c0e5" xlink:to="loc_us-gaap_ReceivablesNetCurrent_df4e5cf3-22f8-4354-8eb3-880acff3a8a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_5dfbc64d-17dd-4e7b-aa20-4938bfeb84b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_4848da59-1fc5-44c9-be78-055e60f9c0e5" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_5dfbc64d-17dd-4e7b-aa20-4938bfeb84b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_9f100e50-71ec-4beb-9962-d234ae508150" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_4848da59-1fc5-44c9-be78-055e60f9c0e5" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_9f100e50-71ec-4beb-9962-d234ae508150" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_451002f7-0600-487d-9efb-616ede046456" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_4848da59-1fc5-44c9-be78-055e60f9c0e5" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_451002f7-0600-487d-9efb-616ede046456" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_06983405-0c39-470c-9c71-9b97447c057f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_4848da59-1fc5-44c9-be78-055e60f9c0e5" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_06983405-0c39-470c-9c71-9b97447c057f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndCollectionOfReceivables_3f2c2561-50ec-41d9-b47b-7bb81b3669e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndCollectionOfReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_4848da59-1fc5-44c9-be78-055e60f9c0e5" xlink:to="loc_us-gaap_ProceedsFromSaleAndCollectionOfReceivables_3f2c2561-50ec-41d9-b47b-7bb81b3669e4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_17cf5ece-0538-4059-aa07-4ca9bc4629c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_4848da59-1fc5-44c9-be78-055e60f9c0e5" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_17cf5ece-0538-4059-aa07-4ca9bc4629c5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_17ea5730-33ec-4e2e-a279-99f50b762294" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_17cf5ece-0538-4059-aa07-4ca9bc4629c5" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_17ea5730-33ec-4e2e-a279-99f50b762294" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_17ea5730-33ec-4e2e-a279-99f50b762294_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_17ea5730-33ec-4e2e-a279-99f50b762294" xlink:to="loc_us-gaap_ReceivableTypeDomain_17ea5730-33ec-4e2e-a279-99f50b762294_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_4e0b29bc-eea8-44a8-a9f6-078885c02516" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_17ea5730-33ec-4e2e-a279-99f50b762294" xlink:to="loc_us-gaap_ReceivableTypeDomain_4e0b29bc-eea8-44a8-a9f6-078885c02516" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VariableConsiderationMember_0758abf8-9b84-4098-881e-28bfc40bf36c" xlink:href="vtrs-20211231.xsd#vtrs_VariableConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_4e0b29bc-eea8-44a8-a9f6-078885c02516" xlink:to="loc_vtrs_VariableConsiderationMember_0758abf8-9b84-4098-881e-28bfc40bf36c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_88a6d134-f050-418a-b5ba-fd60bcc0b073" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_17cf5ece-0538-4059-aa07-4ca9bc4629c5" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_88a6d134-f050-418a-b5ba-fd60bcc0b073" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_88a6d134-f050-418a-b5ba-fd60bcc0b073_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_88a6d134-f050-418a-b5ba-fd60bcc0b073" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_88a6d134-f050-418a-b5ba-fd60bcc0b073_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_5050bd39-87ec-4a29-b261-5b2e1b2041b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_88a6d134-f050-418a-b5ba-fd60bcc0b073" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_5050bd39-87ec-4a29-b261-5b2e1b2041b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditConcentrationRiskMember_ec83de08-e74a-45d6-9254-668df5b491f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_5050bd39-87ec-4a29-b261-5b2e1b2041b3" xlink:to="loc_us-gaap_CreditConcentrationRiskMember_ec83de08-e74a-45d6-9254-668df5b491f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c859ff32-63a8-449e-8615-b69114b86ace" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_17cf5ece-0538-4059-aa07-4ca9bc4629c5" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c859ff32-63a8-449e-8615-b69114b86ace" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c859ff32-63a8-449e-8615-b69114b86ace_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c859ff32-63a8-449e-8615-b69114b86ace" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c859ff32-63a8-449e-8615-b69114b86ace_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_9011abd0-6a79-47d1-a041-5078bcc66578" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c859ff32-63a8-449e-8615-b69114b86ace" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_9011abd0-6a79-47d1-a041-5078bcc66578" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_03892a32-05ed-4349-b1d6-bac4ad25eed8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_9011abd0-6a79-47d1-a041-5078bcc66578" xlink:to="loc_us-gaap_AccountsReceivableMember_03892a32-05ed-4349-b1d6-bac4ad25eed8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_453c24a3-d07f-434c-ac35-113df362990f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_17cf5ece-0538-4059-aa07-4ca9bc4629c5" xlink:to="loc_srt_MajorCustomersAxis_453c24a3-d07f-434c-ac35-113df362990f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_453c24a3-d07f-434c-ac35-113df362990f_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_453c24a3-d07f-434c-ac35-113df362990f" xlink:to="loc_srt_NameOfMajorCustomerDomain_453c24a3-d07f-434c-ac35-113df362990f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_8fdc4092-d808-4b06-a4d7-447c7d607214" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_453c24a3-d07f-434c-ac35-113df362990f" xlink:to="loc_srt_NameOfMajorCustomerDomain_8fdc4092-d808-4b06-a4d7-447c7d607214" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ThreeCustomersMember_3bc78d8c-dd63-4593-855f-836546a4a7b9" xlink:href="vtrs-20211231.xsd#vtrs_ThreeCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_8fdc4092-d808-4b06-a4d7-447c7d607214" xlink:to="loc_vtrs_ThreeCustomersMember_3bc78d8c-dd63-4593-855f-836546a4a7b9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_dff43c09-c7f8-41d0-8f32-02a77a341c85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_17cf5ece-0538-4059-aa07-4ca9bc4629c5" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_dff43c09-c7f8-41d0-8f32-02a77a341c85" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_dff43c09-c7f8-41d0-8f32-02a77a341c85_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_dff43c09-c7f8-41d0-8f32-02a77a341c85" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_dff43c09-c7f8-41d0-8f32-02a77a341c85_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_b784be68-b67d-42c8-9c01-298a1958aceb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_dff43c09-c7f8-41d0-8f32-02a77a341c85" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_b784be68-b67d-42c8-9c01-298a1958aceb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_e7968fe5-c04a-41f7-8697-cd79647dc3b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_b784be68-b67d-42c8-9c01-298a1958aceb" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_e7968fe5-c04a-41f7-8697-cd79647dc3b1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationRollforwardDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#RevenueRecognitionandAccountsReceivableVariableConsiderationRollforwardDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationRollforwardDetails" xlink:type="extended" id="i6c6f0768017743d1ad9592c5123c68bb_RevenueRecognitionandAccountsReceivableVariableConsiderationRollforwardDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_02217bed-c454-46e1-8615-a08351cf3cc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccountsReceivableVariableConsiderationRollForward_a43eba96-65e7-40c4-8d27-530b7b463c13" xlink:href="vtrs-20211231.xsd#vtrs_AccountsReceivableVariableConsiderationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_02217bed-c454-46e1-8615-a08351cf3cc8" xlink:to="loc_vtrs_AccountsReceivableVariableConsiderationRollForward_a43eba96-65e7-40c4-8d27-530b7b463c13" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_e2d81160-51c4-409e-ae8e-7bf8bf668779" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_AccountsReceivableVariableConsiderationRollForward_a43eba96-65e7-40c4-8d27-530b7b463c13" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_e2d81160-51c4-409e-ae8e-7bf8bf668779" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccountsReceivableSalesProvisionsCurrent_644e3c22-64c6-4d45-ae7c-6bf454a17a36" xlink:href="vtrs-20211231.xsd#vtrs_AccountsReceivableSalesProvisionsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_AccountsReceivableVariableConsiderationRollForward_a43eba96-65e7-40c4-8d27-530b7b463c13" xlink:to="loc_vtrs_AccountsReceivableSalesProvisionsCurrent_644e3c22-64c6-4d45-ae7c-6bf454a17a36" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccountsReceivableIncreaseDueToAcquisitionCurrent_85df3fe2-40d5-45fd-9f01-8b268651a35c" xlink:href="vtrs-20211231.xsd#vtrs_AccountsReceivableIncreaseDueToAcquisitionCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_AccountsReceivableVariableConsiderationRollForward_a43eba96-65e7-40c4-8d27-530b7b463c13" xlink:to="loc_vtrs_AccountsReceivableIncreaseDueToAcquisitionCurrent_85df3fe2-40d5-45fd-9f01-8b268651a35c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccountsReceivableCreditsIssuedtoThirdParties_58dd2dc4-eea5-4e3a-85d1-5ddb3f2d4f38" xlink:href="vtrs-20211231.xsd#vtrs_AccountsReceivableCreditsIssuedtoThirdParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_AccountsReceivableVariableConsiderationRollForward_a43eba96-65e7-40c4-8d27-530b7b463c13" xlink:to="loc_vtrs_AccountsReceivableCreditsIssuedtoThirdParties_58dd2dc4-eea5-4e3a-85d1-5ddb3f2d4f38" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccountsReceivableEffectsofForeignExchangeRates_6743a8a5-b429-4f8e-975e-b3b8781774ca" xlink:href="vtrs-20211231.xsd#vtrs_AccountsReceivableEffectsofForeignExchangeRates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_AccountsReceivableVariableConsiderationRollForward_a43eba96-65e7-40c4-8d27-530b7b463c13" xlink:to="loc_vtrs_AccountsReceivableEffectsofForeignExchangeRates_6743a8a5-b429-4f8e-975e-b3b8781774ca" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_236d0865-0346-48e8-a601-27e606bebca2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_8d2094f6-db0a-4259-b704-786b7da4c39a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_02217bed-c454-46e1-8615-a08351cf3cc8" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_8d2094f6-db0a-4259-b704-786b7da4c39a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_502d7f17-340d-488f-a12c-f4cbf8ac4d3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_8d2094f6-db0a-4259-b704-786b7da4c39a" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_502d7f17-340d-488f-a12c-f4cbf8ac4d3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_502d7f17-340d-488f-a12c-f4cbf8ac4d3e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_502d7f17-340d-488f-a12c-f4cbf8ac4d3e" xlink:to="loc_us-gaap_ReceivableTypeDomain_502d7f17-340d-488f-a12c-f4cbf8ac4d3e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_9ba1228f-c701-48c1-bfb9-68e6d40343d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_502d7f17-340d-488f-a12c-f4cbf8ac4d3e" xlink:to="loc_us-gaap_ReceivableTypeDomain_9ba1228f-c701-48c1-bfb9-68e6d40343d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VariableConsiderationMember_f940be40-2c3d-4aae-9eef-10694e5bd7e0" xlink:href="vtrs-20211231.xsd#vtrs_VariableConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_9ba1228f-c701-48c1-bfb9-68e6d40343d4" xlink:to="loc_vtrs_VariableConsiderationMember_f940be40-2c3d-4aae-9eef-10694e5bd7e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VariableConsiderationCategoryAxis_1e906490-3e93-4042-86b7-4e9aeebdaeba" xlink:href="vtrs-20211231.xsd#vtrs_VariableConsiderationCategoryAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_8d2094f6-db0a-4259-b704-786b7da4c39a" xlink:to="loc_vtrs_VariableConsiderationCategoryAxis_1e906490-3e93-4042-86b7-4e9aeebdaeba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VariableConsiderationCategoryDomain_1e906490-3e93-4042-86b7-4e9aeebdaeba_default" xlink:href="vtrs-20211231.xsd#vtrs_VariableConsiderationCategoryDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_vtrs_VariableConsiderationCategoryAxis_1e906490-3e93-4042-86b7-4e9aeebdaeba" xlink:to="loc_vtrs_VariableConsiderationCategoryDomain_1e906490-3e93-4042-86b7-4e9aeebdaeba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VariableConsiderationCategoryDomain_fc364d5c-5f9c-464a-b8a4-8fbad04b2147" xlink:href="vtrs-20211231.xsd#vtrs_VariableConsiderationCategoryDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_vtrs_VariableConsiderationCategoryAxis_1e906490-3e93-4042-86b7-4e9aeebdaeba" xlink:to="loc_vtrs_VariableConsiderationCategoryDomain_fc364d5c-5f9c-464a-b8a4-8fbad04b2147" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ChargebacksMember_563823cb-2d15-479e-b3bb-01877303f232" xlink:href="vtrs-20211231.xsd#vtrs_ChargebacksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_VariableConsiderationCategoryDomain_fc364d5c-5f9c-464a-b8a4-8fbad04b2147" xlink:to="loc_vtrs_ChargebacksMember_563823cb-2d15-479e-b3bb-01877303f232" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RebatesPromotionalProgramsandOtherSalesAllowancesMember_fabc71d9-dc89-455f-b771-bd10065d89fb" xlink:href="vtrs-20211231.xsd#vtrs_RebatesPromotionalProgramsandOtherSalesAllowancesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_VariableConsiderationCategoryDomain_fc364d5c-5f9c-464a-b8a4-8fbad04b2147" xlink:to="loc_vtrs_RebatesPromotionalProgramsandOtherSalesAllowancesMember_fabc71d9-dc89-455f-b771-bd10065d89fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VariableConsiderationReturnsMember_f7839a13-c391-4541-95c3-73c7b037777e" xlink:href="vtrs-20211231.xsd#vtrs_VariableConsiderationReturnsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_VariableConsiderationCategoryDomain_fc364d5c-5f9c-464a-b8a4-8fbad04b2147" xlink:to="loc_vtrs_VariableConsiderationReturnsMember_f7839a13-c391-4541-95c3-73c7b037777e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GovernmentalRebateProgramsMember_51688ae3-cb08-42b0-8d4f-85778f47ddcf" xlink:href="vtrs-20211231.xsd#vtrs_GovernmentalRebateProgramsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_VariableConsiderationCategoryDomain_fc364d5c-5f9c-464a-b8a4-8fbad04b2147" xlink:to="loc_vtrs_GovernmentalRebateProgramsMember_51688ae3-cb08-42b0-8d4f-85778f47ddcf" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#BalanceSheetComponentsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsNarrativeDetails" xlink:type="extended" id="i261760167a9b4889a6b18b7adade2a62_BalanceSheetComponentsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_03e0fe2e-2d0b-4b62-abe7-add5c804739e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_75b5d284-46d3-4da9-ae33-841a9ee5fa71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_03e0fe2e-2d0b-4b62-abe7-add5c804739e" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_75b5d284-46d3-4da9-ae33-841a9ee5fa71" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_4d2def4f-2257-4c94-bf32-ec04faddc453" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_03e0fe2e-2d0b-4b62-abe7-add5c804739e" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_4d2def4f-2257-4c94-bf32-ec04faddc453" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Concentrationrisknumberofmajorcustomers_6da3ef96-6a4e-4a60-8b93-1aa3f73372a8" xlink:href="vtrs-20211231.xsd#vtrs_Concentrationrisknumberofmajorcustomers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_03e0fe2e-2d0b-4b62-abe7-add5c804739e" xlink:to="loc_vtrs_Concentrationrisknumberofmajorcustomers_6da3ef96-6a4e-4a60-8b93-1aa3f73372a8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareNet_7dc5031f-fd04-4e55-95d6-2ad23de279bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_03e0fe2e-2d0b-4b62-abe7-add5c804739e" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareNet_7dc5031f-fd04-4e55-95d6-2ad23de279bf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Netrealizablevalueofinventoryrecognizedasexpense_b459b373-b5ad-4f65-adc9-38c6cde9b5b2" xlink:href="vtrs-20211231.xsd#vtrs_Netrealizablevalueofinventoryrecognizedasexpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_03e0fe2e-2d0b-4b62-abe7-add5c804739e" xlink:to="loc_vtrs_Netrealizablevalueofinventoryrecognizedasexpense_b459b373-b5ad-4f65-adc9-38c6cde9b5b2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_b275cfbd-e662-4c8c-9712-7c2fc7d7ac99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_03e0fe2e-2d0b-4b62-abe7-add5c804739e" xlink:to="loc_us-gaap_Depreciation_b275cfbd-e662-4c8c-9712-7c2fc7d7ac99" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_ab575b14-ed8e-401c-a70b-8da7eb5be1fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_03e0fe2e-2d0b-4b62-abe7-add5c804739e" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_ab575b14-ed8e-401c-a70b-8da7eb5be1fa" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_1e2b546c-e7e6-424b-a49d-2d8b3d57e8d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_03e0fe2e-2d0b-4b62-abe7-add5c804739e" xlink:to="loc_us-gaap_RestrictedCash_1e2b546c-e7e6-424b-a49d-2d8b3d57e8d5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_4fbba7b1-0809-480e-8c8c-84ab0c1dd531" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_03e0fe2e-2d0b-4b62-abe7-add5c804739e" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_4fbba7b1-0809-480e-8c8c-84ab0c1dd531" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_72da806d-ace4-4bcd-91b1-4475e322745f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_4fbba7b1-0809-480e-8c8c-84ab0c1dd531" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_72da806d-ace4-4bcd-91b1-4475e322745f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_72da806d-ace4-4bcd-91b1-4475e322745f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_72da806d-ace4-4bcd-91b1-4475e322745f" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_72da806d-ace4-4bcd-91b1-4475e322745f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_03353b90-2a71-471c-865b-37aacea62b31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_72da806d-ace4-4bcd-91b1-4475e322745f" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_03353b90-2a71-471c-865b-37aacea62b31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ContingentConsiderationMember_97a3c564-6b93-4cff-a81e-13261157fad1" xlink:href="vtrs-20211231.xsd#vtrs_ContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_03353b90-2a71-471c-865b-37aacea62b31" xlink:to="loc_vtrs_ContingentConsiderationMember_97a3c564-6b93-4cff-a81e-13261157fad1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_c8254bb5-8e45-48bf-8ced-5b4657250d43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_4fbba7b1-0809-480e-8c8c-84ab0c1dd531" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_c8254bb5-8e45-48bf-8ced-5b4657250d43" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_c8254bb5-8e45-48bf-8ced-5b4657250d43_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_c8254bb5-8e45-48bf-8ced-5b4657250d43" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_c8254bb5-8e45-48bf-8ced-5b4657250d43_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_fa612e44-575e-4944-bded-954afb5a8a1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_c8254bb5-8e45-48bf-8ced-5b4657250d43" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_fa612e44-575e-4944-bded-954afb5a8a1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_20cd50d0-fe8c-4e2c-8743-f36c101655c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_fa612e44-575e-4944-bded-954afb5a8a1c" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_20cd50d0-fe8c-4e2c-8743-f36c101655c9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_39afba33-2154-419b-ae17-e8f923d0527a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_4fbba7b1-0809-480e-8c8c-84ab0c1dd531" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_39afba33-2154-419b-ae17-e8f923d0527a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_39afba33-2154-419b-ae17-e8f923d0527a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_39afba33-2154-419b-ae17-e8f923d0527a" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_39afba33-2154-419b-ae17-e8f923d0527a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_0e1e75c6-c891-4464-9f48-230ddaebd7b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_39afba33-2154-419b-ae17-e8f923d0527a" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_0e1e75c6-c891-4464-9f48-230ddaebd7b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_85db7a36-ea44-4c1a-9e5e-dfe07dbcdb0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_0e1e75c6-c891-4464-9f48-230ddaebd7b1" xlink:to="loc_us-gaap_AccountsReceivableMember_85db7a36-ea44-4c1a-9e5e-dfe07dbcdb0b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_dbf55480-06b6-4d57-8add-f995ab12417e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_4fbba7b1-0809-480e-8c8c-84ab0c1dd531" xlink:to="loc_srt_StatementGeographicalAxis_dbf55480-06b6-4d57-8add-f995ab12417e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_dbf55480-06b6-4d57-8add-f995ab12417e_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_dbf55480-06b6-4d57-8add-f995ab12417e" xlink:to="loc_srt_SegmentGeographicalDomain_dbf55480-06b6-4d57-8add-f995ab12417e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_71ed88e6-1e4f-42cd-ab0c-44d856d30b10" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_dbf55480-06b6-4d57-8add-f995ab12417e" xlink:to="loc_srt_SegmentGeographicalDomain_71ed88e6-1e4f-42cd-ab0c-44d856d30b10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IN_abc2ccfb-3649-40eb-9634-efae59bf40c0" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IN"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_71ed88e6-1e4f-42cd-ab0c-44d856d30b10" xlink:to="loc_country_IN_abc2ccfb-3649-40eb-9634-efae59bf40c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_c32c4521-b6eb-456b-af23-483154399f2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_4fbba7b1-0809-480e-8c8c-84ab0c1dd531" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_c32c4521-b6eb-456b-af23-483154399f2e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_c32c4521-b6eb-456b-af23-483154399f2e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_c32c4521-b6eb-456b-af23-483154399f2e" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_c32c4521-b6eb-456b-af23-483154399f2e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_36d9297a-370f-4bc6-91f2-dc2cc5204824" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_c32c4521-b6eb-456b-af23-483154399f2e" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_36d9297a-370f-4bc6-91f2-dc2cc5204824" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VoluntaryRecallofValsartanandCertainCombinationsValsartanMedicinesMember_c924b02a-09a3-4e84-84d6-c7cc1551cb76" xlink:href="vtrs-20211231.xsd#vtrs_VoluntaryRecallofValsartanandCertainCombinationsValsartanMedicinesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_36d9297a-370f-4bc6-91f2-dc2cc5204824" xlink:to="loc_vtrs_VoluntaryRecallofValsartanandCertainCombinationsValsartanMedicinesMember_c924b02a-09a3-4e84-84d6-c7cc1551cb76" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsAccountsreceivablenetDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#BalanceSheetComponentsAccountsreceivablenetDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsAccountsreceivablenetDetails" xlink:type="extended" id="i176eebb3725f439398d4cbd5aec5e1e8_BalanceSheetComponentsAccountsreceivablenetDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_2ef125c7-27f8-4942-b364-b3e115b979b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Concentrationrisknumberofmajorcustomers_667c2129-7925-4a24-b17b-747683d1aa3f" xlink:href="vtrs-20211231.xsd#vtrs_Concentrationrisknumberofmajorcustomers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_2ef125c7-27f8-4942-b364-b3e115b979b9" xlink:to="loc_vtrs_Concentrationrisknumberofmajorcustomers_667c2129-7925-4a24-b17b-747683d1aa3f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndCollectionOfReceivables_3ce04cb2-d723-447f-a9cc-ed255abe9e47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndCollectionOfReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_2ef125c7-27f8-4942-b364-b3e115b979b9" xlink:to="loc_us-gaap_ProceedsFromSaleAndCollectionOfReceivables_3ce04cb2-d723-447f-a9cc-ed255abe9e47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_99554a13-a102-4a96-ad03-2f583fb05c20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_2ef125c7-27f8-4942-b364-b3e115b979b9" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_99554a13-a102-4a96-ad03-2f583fb05c20" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_a518312a-7bec-481e-9e64-2c61e2e2f428" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_99554a13-a102-4a96-ad03-2f583fb05c20" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_a518312a-7bec-481e-9e64-2c61e2e2f428" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a518312a-7bec-481e-9e64-2c61e2e2f428_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_a518312a-7bec-481e-9e64-2c61e2e2f428" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a518312a-7bec-481e-9e64-2c61e2e2f428_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e44379a1-3cf6-425a-9496-dda06ff0cf35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_a518312a-7bec-481e-9e64-2c61e2e2f428" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e44379a1-3cf6-425a-9496-dda06ff0cf35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_29cabf1f-eaa6-4f5f-b8a8-ef706719e1ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e44379a1-3cf6-425a-9496-dda06ff0cf35" xlink:to="loc_us-gaap_AccountsReceivableMember_29cabf1f-eaa6-4f5f-b8a8-ef706719e1ac" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#BalanceSheetComponentsPropertyPlantandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails" xlink:type="extended" id="ife6d4a3826ea48489588644b506d95ca_BalanceSheetComponentsPropertyPlantandEquipmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ccb54475-ec11-4048-94ea-0c819905755a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_ffe4554f-7723-4b16-b48f-bb843c4d4261" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ccb54475-ec11-4048-94ea-0c819905755a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_ffe4554f-7723-4b16-b48f-bb843c4d4261" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_258a5bcf-18f7-4b11-a778-f0ca4639bc29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ccb54475-ec11-4048-94ea-0c819905755a" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_258a5bcf-18f7-4b11-a778-f0ca4639bc29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_bda13f5e-e3b1-433a-a394-2b4c064e4215" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ccb54475-ec11-4048-94ea-0c819905755a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_bda13f5e-e3b1-433a-a394-2b4c064e4215" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_fb0e2ab4-3b18-42aa-b00b-59da0d55fef1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ccb54475-ec11-4048-94ea-0c819905755a" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_fb0e2ab4-3b18-42aa-b00b-59da0d55fef1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b11b774e-cc1d-4e3a-a2c9-426f5b1a4389" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_fb0e2ab4-3b18-42aa-b00b-59da0d55fef1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b11b774e-cc1d-4e3a-a2c9-426f5b1a4389" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b11b774e-cc1d-4e3a-a2c9-426f5b1a4389_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b11b774e-cc1d-4e3a-a2c9-426f5b1a4389" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b11b774e-cc1d-4e3a-a2c9-426f5b1a4389_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4ecc9d58-c8af-4827-ba2e-2ac5592406bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b11b774e-cc1d-4e3a-a2c9-426f5b1a4389" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4ecc9d58-c8af-4827-ba2e-2ac5592406bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAndLandImprovementsMember_c228c593-babc-437d-8933-127e7ebc5dfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandAndLandImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4ecc9d58-c8af-4827-ba2e-2ac5592406bb" xlink:to="loc_us-gaap_LandAndLandImprovementsMember_c228c593-babc-437d-8933-127e7ebc5dfd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_1f934906-7ef0-40dd-86da-a3a7edb1f049" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4ecc9d58-c8af-4827-ba2e-2ac5592406bb" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_1f934906-7ef0-40dd-86da-a3a7edb1f049" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_3e995934-e184-435a-9f1b-33cb39d9d33c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4ecc9d58-c8af-4827-ba2e-2ac5592406bb" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_3e995934-e184-435a-9f1b-33cb39d9d33c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_020c0475-6337-477b-9d65-ae9c0d26814c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4ecc9d58-c8af-4827-ba2e-2ac5592406bb" xlink:to="loc_us-gaap_ConstructionInProgressMember_020c0475-6337-477b-9d65-ae9c0d26814c" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#BalanceSheetComponentsOtherAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails" xlink:type="extended" id="i79e29ab592ec4b30972244ad38f13eaa_BalanceSheetComponentsOtherAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofOtherAssetsLineItems_c5346461-05c6-41b6-9cce-aef088d6fe30" xlink:href="vtrs-20211231.xsd#vtrs_ScheduleofOtherAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_bd1f4cd7-dbd5-4abf-a70f-903a4798c2fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofOtherAssetsLineItems_c5346461-05c6-41b6-9cce-aef088d6fe30" xlink:to="loc_us-gaap_EquityMethodInvestments_bd1f4cd7-dbd5-4abf-a70f-903a4798c2fb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_bcb93abe-e1ae-4c8b-a05f-fb212c8f06c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofOtherAssetsLineItems_c5346461-05c6-41b6-9cce-aef088d6fe30" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_bcb93abe-e1ae-4c8b-a05f-fb212c8f06c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Otherlongtermassets_847f0ac6-ee4e-42b0-b65c-302a4d6ff2c0" xlink:href="vtrs-20211231.xsd#vtrs_Otherlongtermassets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofOtherAssetsLineItems_c5346461-05c6-41b6-9cce-aef088d6fe30" xlink:to="loc_vtrs_Otherlongtermassets_847f0ac6-ee4e-42b0-b65c-302a4d6ff2c0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_e9ae8096-684e-4f21-bd23-e59e2347e8dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofOtherAssetsLineItems_c5346461-05c6-41b6-9cce-aef088d6fe30" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_e9ae8096-684e-4f21-bd23-e59e2347e8dd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofOtherAssetsTable_7df75294-c832-4078-8dc9-74df09c01377" xlink:href="vtrs-20211231.xsd#vtrs_ScheduleofOtherAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_vtrs_ScheduleofOtherAssetsLineItems_c5346461-05c6-41b6-9cce-aef088d6fe30" xlink:to="loc_vtrs_ScheduleofOtherAssetsTable_7df75294-c832-4078-8dc9-74df09c01377" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_536ebcc3-6d5a-471e-8781-f460a7edf4ac" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_vtrs_ScheduleofOtherAssetsTable_7df75294-c832-4078-8dc9-74df09c01377" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_536ebcc3-6d5a-471e-8781-f460a7edf4ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_536ebcc3-6d5a-471e-8781-f460a7edf4ac_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_536ebcc3-6d5a-471e-8781-f460a7edf4ac" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_536ebcc3-6d5a-471e-8781-f460a7edf4ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_4de456ca-0c33-4b64-9fcd-3778ac5a28aa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_536ebcc3-6d5a-471e-8781-f460a7edf4ac" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_4de456ca-0c33-4b64-9fcd-3778ac5a28aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CleanEnergyPartnershipsMember_b6d1b723-8ba0-497a-947e-532600d0a177" xlink:href="vtrs-20211231.xsd#vtrs_CleanEnergyPartnershipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4de456ca-0c33-4b64-9fcd-3778ac5a28aa" xlink:to="loc_vtrs_CleanEnergyPartnershipsMember_b6d1b723-8ba0-497a-947e-532600d0a177" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_de7a0ff5-1323-4f8c-a9ae-0ff3fe70438a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_vtrs_ScheduleofOtherAssetsTable_7df75294-c832-4078-8dc9-74df09c01377" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_de7a0ff5-1323-4f8c-a9ae-0ff3fe70438a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_de7a0ff5-1323-4f8c-a9ae-0ff3fe70438a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_de7a0ff5-1323-4f8c-a9ae-0ff3fe70438a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_de7a0ff5-1323-4f8c-a9ae-0ff3fe70438a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_01de1726-c153-4ea9-bd34-00c148df4d95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_de7a0ff5-1323-4f8c-a9ae-0ff3fe70438a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_01de1726-c153-4ea9-bd34-00c148df4d95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_7eb6d13e-12c4-4ee4-be0b-7680d0f816ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_01de1726-c153-4ea9-bd34-00c148df4d95" xlink:to="loc_us-gaap_OtherAssetsMember_7eb6d13e-12c4-4ee4-be0b-7680d0f816ee" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#BalanceSheetComponentsOtherCurrentLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails" xlink:type="extended" id="i87f30489ff304c0dbb836a5d526780e6_BalanceSheetComponentsOtherCurrentLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_0f3d9418-5bee-4c66-a9ef-31dd3989992e" xlink:href="vtrs-20211231.xsd#vtrs_ScheduleofothercurrentliabilitiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_0c7d48ed-6825-4621-97a6-8609488e5fea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_0f3d9418-5bee-4c66-a9ef-31dd3989992e" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_0c7d48ed-6825-4621-97a6-8609488e5fea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_cfb1dae7-01ae-4afe-a9df-45f1d2c73aab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_0f3d9418-5bee-4c66-a9ef-31dd3989992e" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_cfb1dae7-01ae-4afe-a9df-45f1d2c73aab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent_08553921-c9c1-489c-8674-57ff4769c00f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_0f3d9418-5bee-4c66-a9ef-31dd3989992e" xlink:to="loc_us-gaap_LitigationReserveCurrent_08553921-c9c1-489c-8674-57ff4769c00f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_4a4e35b1-2037-4b30-a7b7-eb368d7ff59f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_0f3d9418-5bee-4c66-a9ef-31dd3989992e" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_4a4e35b1-2037-4b30-a7b7-eb368d7ff59f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent_aa46f101-7bf7-4565-9557-cd7e96788c5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_0f3d9418-5bee-4c66-a9ef-31dd3989992e" xlink:to="loc_us-gaap_RestructuringReserveCurrent_aa46f101-7bf7-4565-9557-cd7e96788c5c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities_cc3e532a-5590-4f2d-a2aa-6d2a4de32e46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_0f3d9418-5bee-4c66-a9ef-31dd3989992e" xlink:to="loc_us-gaap_OtherLiabilities_cc3e532a-5590-4f2d-a2aa-6d2a4de32e46" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_1a6c7509-2460-4229-ad8f-12b70b3f333c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_0f3d9418-5bee-4c66-a9ef-31dd3989992e" xlink:to="loc_us-gaap_InterestPayableCurrent_1a6c7509-2460-4229-ad8f-12b70b3f333c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_c23d0f1d-6d92-4021-adb4-e58c771c9dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_0f3d9418-5bee-4c66-a9ef-31dd3989992e" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_c23d0f1d-6d92-4021-adb4-e58c771c9dcf" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_11fa7d07-c114-4b75-bd67-a83c8d15cdf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_0f3d9418-5bee-4c66-a9ef-31dd3989992e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_11fa7d07-c114-4b75-bd67-a83c8d15cdf2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_134ced5d-1d9b-43e4-b182-0cdd10821225" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_0f3d9418-5bee-4c66-a9ef-31dd3989992e" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_134ced5d-1d9b-43e4-b182-0cdd10821225" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_0a690dab-9add-4d4f-9421-8c1d3bf31e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_0f3d9418-5bee-4c66-a9ef-31dd3989992e" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_0a690dab-9add-4d4f-9421-8c1d3bf31e5a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRecallExpense_d174f368-a345-4bbe-8764-e3396e5c186b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRecallExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_0f3d9418-5bee-4c66-a9ef-31dd3989992e" xlink:to="loc_us-gaap_InventoryRecallExpense_d174f368-a345-4bbe-8764-e3396e5c186b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofothercurrentliabilitiesTable_b11a912c-3f76-4342-b1cb-c6f53031919c" xlink:href="vtrs-20211231.xsd#vtrs_ScheduleofothercurrentliabilitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_0f3d9418-5bee-4c66-a9ef-31dd3989992e" xlink:to="loc_vtrs_ScheduleofothercurrentliabilitiesTable_b11a912c-3f76-4342-b1cb-c6f53031919c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_e226e52e-d66a-4a15-a006-34ebf6141efb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesTable_b11a912c-3f76-4342-b1cb-c6f53031919c" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_e226e52e-d66a-4a15-a006-34ebf6141efb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_e226e52e-d66a-4a15-a006-34ebf6141efb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_e226e52e-d66a-4a15-a006-34ebf6141efb" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_e226e52e-d66a-4a15-a006-34ebf6141efb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_db27d359-80ad-44ac-9338-11dae2562747" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_e226e52e-d66a-4a15-a006-34ebf6141efb" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_db27d359-80ad-44ac-9338-11dae2562747" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VoluntaryRecallofValsartanandCertainCombinationsValsartanMedicinesMember_c0fc0a13-4a57-40f6-9725-b7f5c02d51a2" xlink:href="vtrs-20211231.xsd#vtrs_VoluntaryRecallofValsartanandCertainCombinationsValsartanMedicinesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_db27d359-80ad-44ac-9338-11dae2562747" xlink:to="loc_vtrs_VoluntaryRecallofValsartanandCertainCombinationsValsartanMedicinesMember_c0fc0a13-4a57-40f6-9725-b7f5c02d51a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_92bd6b8c-d143-4868-b0f1-481a7a751863" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesTable_b11a912c-3f76-4342-b1cb-c6f53031919c" xlink:to="loc_srt_StatementGeographicalAxis_92bd6b8c-d143-4868-b0f1-481a7a751863" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_92bd6b8c-d143-4868-b0f1-481a7a751863_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_92bd6b8c-d143-4868-b0f1-481a7a751863" xlink:to="loc_srt_SegmentGeographicalDomain_92bd6b8c-d143-4868-b0f1-481a7a751863_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_9f14421e-dfa4-4e08-9bbe-c675f3d1bf50" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_92bd6b8c-d143-4868-b0f1-481a7a751863" xlink:to="loc_srt_SegmentGeographicalDomain_9f14421e-dfa4-4e08-9bbe-c675f3d1bf50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IN_e974e5b5-58f0-4cca-a854-56768602fef8" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IN"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_9f14421e-dfa4-4e08-9bbe-c675f3d1bf50" xlink:to="loc_country_IN_e974e5b5-58f0-4cca-a854-56768602fef8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_b648df82-1c2b-4f22-a627-7745c8c861c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesTable_b11a912c-3f76-4342-b1cb-c6f53031919c" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_b648df82-1c2b-4f22-a627-7745c8c861c7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b648df82-1c2b-4f22-a627-7745c8c861c7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_b648df82-1c2b-4f22-a627-7745c8c861c7" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b648df82-1c2b-4f22-a627-7745c8c861c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_9b1418ea-5af0-4e7e-9a1d-f5aea960d6fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_b648df82-1c2b-4f22-a627-7745c8c861c7" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_9b1418ea-5af0-4e7e-9a1d-f5aea960d6fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_812620fb-ddf8-4238-a9ed-c01838637d91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9b1418ea-5af0-4e7e-9a1d-f5aea960d6fb" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_812620fb-ddf8-4238-a9ed-c01838637d91" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_17cc03ef-a6eb-4057-ac2f-0d9e4126d66e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesTable_b11a912c-3f76-4342-b1cb-c6f53031919c" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_17cc03ef-a6eb-4057-ac2f-0d9e4126d66e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_17cc03ef-a6eb-4057-ac2f-0d9e4126d66e_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_17cc03ef-a6eb-4057-ac2f-0d9e4126d66e" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_17cc03ef-a6eb-4057-ac2f-0d9e4126d66e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_28746429-259f-4a4d-8975-d8f8cec9e087" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_17cc03ef-a6eb-4057-ac2f-0d9e4126d66e" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_28746429-259f-4a4d-8975-d8f8cec9e087" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CleanEnergyPartnershipsMember_76c70c31-9324-497b-9bb5-8401e7ad000f" xlink:href="vtrs-20211231.xsd#vtrs_CleanEnergyPartnershipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_28746429-259f-4a4d-8975-d8f8cec9e087" xlink:to="loc_vtrs_CleanEnergyPartnershipsMember_76c70c31-9324-497b-9bb5-8401e7ad000f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_edae1434-c6b6-4652-8c18-988d49b97a83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesTable_b11a912c-3f76-4342-b1cb-c6f53031919c" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_edae1434-c6b6-4652-8c18-988d49b97a83" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_edae1434-c6b6-4652-8c18-988d49b97a83_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_edae1434-c6b6-4652-8c18-988d49b97a83" xlink:to="loc_us-gaap_ReceivableTypeDomain_edae1434-c6b6-4652-8c18-988d49b97a83_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_510cea0d-0ff6-491e-a508-4f1464c267b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_edae1434-c6b6-4652-8c18-988d49b97a83" xlink:to="loc_us-gaap_ReceivableTypeDomain_510cea0d-0ff6-491e-a508-4f1464c267b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VariableConsiderationMember_f8f4dc0c-3e74-4484-bd9b-30097d123df9" xlink:href="vtrs-20211231.xsd#vtrs_VariableConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_510cea0d-0ff6-491e-a508-4f1464c267b7" xlink:to="loc_vtrs_VariableConsiderationMember_f8f4dc0c-3e74-4484-bd9b-30097d123df9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsOthernoncurrentliabilitiesDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#BalanceSheetComponentsOthernoncurrentliabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsOthernoncurrentliabilitiesDetails" xlink:type="extended" id="i436fa86a59d9473294f6f42154cacbd0_BalanceSheetComponentsOthernoncurrentliabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_b5b921e4-eefd-4951-8e5b-3f1063d36f2a" xlink:href="vtrs-20211231.xsd#vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_6529b7af-bdcb-451d-9de1-9fc38d706ba8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_b5b921e4-eefd-4951-8e5b-3f1063d36f2a" xlink:to="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_6529b7af-bdcb-451d-9de1-9fc38d706ba8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_23b2812a-3dcf-4277-8f3f-ce0ad52366f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_b5b921e4-eefd-4951-8e5b-3f1063d36f2a" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_23b2812a-3dcf-4277-8f3f-ce0ad52366f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_f4dee7a0-32e2-4a1c-bd69-d22f2cb3c8e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_b5b921e4-eefd-4951-8e5b-3f1063d36f2a" xlink:to="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_f4dee7a0-32e2-4a1c-bd69-d22f2cb3c8e1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_dc607618-61df-419f-90b6-e6f5e06b6baa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_b5b921e4-eefd-4951-8e5b-3f1063d36f2a" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_dc607618-61df-419f-90b6-e6f5e06b6baa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveNoncurrent_35caa3fc-73f0-48c6-bcf3-c53929ffc87d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_b5b921e4-eefd-4951-8e5b-3f1063d36f2a" xlink:to="loc_us-gaap_RestructuringReserveNoncurrent_35caa3fc-73f0-48c6-bcf3-c53929ffc87d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_df7fefe3-adee-4917-9e1f-ef923e39ea75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_b5b921e4-eefd-4951-8e5b-3f1063d36f2a" xlink:to="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_df7fefe3-adee-4917-9e1f-ef923e39ea75" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_4c5c10ca-6521-4d58-ab0e-90f94e45c0ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_b5b921e4-eefd-4951-8e5b-3f1063d36f2a" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_4c5c10ca-6521-4d58-ab0e-90f94e45c0ee" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesTable_888899f6-93d0-4e96-9e0b-9fecb6fe603a" xlink:href="vtrs-20211231.xsd#vtrs_ScheduleofOtherNoncurrentLiabilitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_b5b921e4-eefd-4951-8e5b-3f1063d36f2a" xlink:to="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesTable_888899f6-93d0-4e96-9e0b-9fecb6fe603a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_aeeab195-4f2e-4788-843b-17950938ec9c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesTable_888899f6-93d0-4e96-9e0b-9fecb6fe603a" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_aeeab195-4f2e-4788-843b-17950938ec9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_aeeab195-4f2e-4788-843b-17950938ec9c_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_aeeab195-4f2e-4788-843b-17950938ec9c" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_aeeab195-4f2e-4788-843b-17950938ec9c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_a1248151-5b04-497a-9de9-64063d3062ac" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_aeeab195-4f2e-4788-843b-17950938ec9c" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_a1248151-5b04-497a-9de9-64063d3062ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CleanEnergyPartnershipsMember_7e7a1afe-9426-4440-9f04-7db9e83f49d1" xlink:href="vtrs-20211231.xsd#vtrs_CleanEnergyPartnershipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_a1248151-5b04-497a-9de9-64063d3062ac" xlink:to="loc_vtrs_CleanEnergyPartnershipsMember_7e7a1afe-9426-4440-9f04-7db9e83f49d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_35d15c1e-1743-49c8-b86f-abea20c04ddc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesTable_888899f6-93d0-4e96-9e0b-9fecb6fe603a" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_35d15c1e-1743-49c8-b86f-abea20c04ddc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_35d15c1e-1743-49c8-b86f-abea20c04ddc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_35d15c1e-1743-49c8-b86f-abea20c04ddc" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_35d15c1e-1743-49c8-b86f-abea20c04ddc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_5de47372-7cba-4887-ad95-fbfad7b66bc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_35d15c1e-1743-49c8-b86f-abea20c04ddc" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_5de47372-7cba-4887-ad95-fbfad7b66bc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_013ff9b4-3d92-4da7-bbbf-c0ff312aa773" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_5de47372-7cba-4887-ad95-fbfad7b66bc5" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_013ff9b4-3d92-4da7-bbbf-c0ff312aa773" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#LeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/LeasesNarrativeDetails" xlink:type="extended" id="id024c2a615644f418b0e74452766aab4_LeasesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_ed44299d-93f7-4f1d-b460-22ebeca7f2a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_461391fa-9ce7-4161-abe9-370f624e84c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ed44299d-93f7-4f1d-b460-22ebeca7f2a7" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_461391fa-9ce7-4161-abe9-370f624e84c8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_e8698e33-49be-413f-9e1b-e8a4693f9dc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ed44299d-93f7-4f1d-b460-22ebeca7f2a7" xlink:to="loc_us-gaap_OperatingLeaseLiability_e8698e33-49be-413f-9e1b-e8a4693f9dc8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_LesseeOperatingLeaseLeaseNotyetCommencedAmount_750b8e49-3c46-46ef-b6a0-f8f59920af63" xlink:href="vtrs-20211231.xsd#vtrs_LesseeOperatingLeaseLeaseNotyetCommencedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ed44299d-93f7-4f1d-b460-22ebeca7f2a7" xlink:to="loc_vtrs_LesseeOperatingLeaseLeaseNotyetCommencedAmount_750b8e49-3c46-46ef-b6a0-f8f59920af63" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_143bfefd-8b9a-4c9e-9bce-e7235db50d88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ed44299d-93f7-4f1d-b460-22ebeca7f2a7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_143bfefd-8b9a-4c9e-9bce-e7235db50d88" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseNet_8755e32b-70af-4145-b52f-d361d726d2d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ed44299d-93f7-4f1d-b460-22ebeca7f2a7" xlink:to="loc_us-gaap_OperatingLeasesRentExpenseNet_8755e32b-70af-4145-b52f-d361d726d2d7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_f3cf1bb8-891d-469b-8909-dfa4105c8182" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ed44299d-93f7-4f1d-b460-22ebeca7f2a7" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_f3cf1bb8-891d-469b-8909-dfa4105c8182" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_e75b80a1-cf5a-4292-adc4-6e84a186d073" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ed44299d-93f7-4f1d-b460-22ebeca7f2a7" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_e75b80a1-cf5a-4292-adc4-6e84a186d073" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_e61d8ae8-d09d-47f9-93a1-bf95597cc5db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ed44299d-93f7-4f1d-b460-22ebeca7f2a7" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_e61d8ae8-d09d-47f9-93a1-bf95597cc5db" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRent_373ee6d3-2e04-4a18-a2c3-55510ffdd621" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ed44299d-93f7-4f1d-b460-22ebeca7f2a7" xlink:to="loc_us-gaap_PaymentsForRent_373ee6d3-2e04-4a18-a2c3-55510ffdd621" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_6c960b63-c803-4120-894b-4f0562822e30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ed44299d-93f7-4f1d-b460-22ebeca7f2a7" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_6c960b63-c803-4120-894b-4f0562822e30" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c8329984-97ba-4fd9-b838-92e4df34ea7b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_6c960b63-c803-4120-894b-4f0562822e30" xlink:to="loc_srt_RangeAxis_c8329984-97ba-4fd9-b838-92e4df34ea7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c8329984-97ba-4fd9-b838-92e4df34ea7b_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_c8329984-97ba-4fd9-b838-92e4df34ea7b" xlink:to="loc_srt_RangeMember_c8329984-97ba-4fd9-b838-92e4df34ea7b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b48a13ff-501c-45bd-b0da-e142d714f541" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_c8329984-97ba-4fd9-b838-92e4df34ea7b" xlink:to="loc_srt_RangeMember_b48a13ff-501c-45bd-b0da-e142d714f541" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8f8510a4-13fd-45b4-9946-dd050e8e7894" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b48a13ff-501c-45bd-b0da-e142d714f541" xlink:to="loc_srt_MinimumMember_8f8510a4-13fd-45b4-9946-dd050e8e7894" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_cacf60dd-7c81-4100-a01d-09d1ff5d4a9d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b48a13ff-501c-45bd-b0da-e142d714f541" xlink:to="loc_srt_MaximumMember_cacf60dd-7c81-4100-a01d-09d1ff5d4a9d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LeasesLeaseInformationDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#LeasesLeaseInformationDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/LeasesLeaseInformationDetails" xlink:type="extended" id="i59072ec382ac41a5bd10e3e358cb6614_LeasesLeaseInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_69cf5866-f159-4d9d-b26a-699d2326586f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_a7fa7379-cc3d-4376-b385-a041a5c3a91e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_69cf5866-f159-4d9d-b26a-699d2326586f" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_a7fa7379-cc3d-4376-b385-a041a5c3a91e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_0157a1a6-73eb-4373-933b-351bab44b811" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_69cf5866-f159-4d9d-b26a-699d2326586f" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_0157a1a6-73eb-4373-933b-351bab44b811" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_4f6c9d21-d883-4210-9ccb-5cee73f34386" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_69cf5866-f159-4d9d-b26a-699d2326586f" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_4f6c9d21-d883-4210-9ccb-5cee73f34386" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_2894fbe3-b0d8-40d5-84f7-ae4528c5bf28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_69cf5866-f159-4d9d-b26a-699d2326586f" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_2894fbe3-b0d8-40d5-84f7-ae4528c5bf28" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4450fe7f-7a04-4ec5-9ea3-1856b8cb4266" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_2894fbe3-b0d8-40d5-84f7-ae4528c5bf28" xlink:to="loc_srt_RangeAxis_4450fe7f-7a04-4ec5-9ea3-1856b8cb4266" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4450fe7f-7a04-4ec5-9ea3-1856b8cb4266_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_4450fe7f-7a04-4ec5-9ea3-1856b8cb4266" xlink:to="loc_srt_RangeMember_4450fe7f-7a04-4ec5-9ea3-1856b8cb4266_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_526d3333-b7d9-4da3-a56e-18233901f998" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_4450fe7f-7a04-4ec5-9ea3-1856b8cb4266" xlink:to="loc_srt_RangeMember_526d3333-b7d9-4da3-a56e-18233901f998" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_3aa7b80b-4533-4536-98e9-39436928a8ff" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_526d3333-b7d9-4da3-a56e-18233901f998" xlink:to="loc_srt_MinimumMember_3aa7b80b-4533-4536-98e9-39436928a8ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_0d5fa82b-5ed8-44b9-b1d5-8f8271d45d35" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_526d3333-b7d9-4da3-a56e-18233901f998" xlink:to="loc_srt_MaximumMember_0d5fa82b-5ed8-44b9-b1d5-8f8271d45d35" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EquityMethodInvestmentsNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#EquityMethodInvestmentsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/EquityMethodInvestmentsNarrativeDetails" xlink:type="extended" id="i12b796100dc849ed9d946ea938f9d184_EquityMethodInvestmentsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_01ae6a44-f03b-48d5-ab15-caac5cb6a9b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EquityMethodInvestmentsReductionInLongTermObligations_aea83b84-ecf2-451d-bc34-8f63f9ab4e3c" xlink:href="vtrs-20211231.xsd#vtrs_EquityMethodInvestmentsReductionInLongTermObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_01ae6a44-f03b-48d5-ab15-caac5cb6a9b1" xlink:to="loc_vtrs_EquityMethodInvestmentsReductionInLongTermObligations_aea83b84-ecf2-451d-bc34-8f63f9ab4e3c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Numberofequitymethodinvestments_148e90d3-266f-49fe-901e-e2e583658495" xlink:href="vtrs-20211231.xsd#vtrs_Numberofequitymethodinvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_01ae6a44-f03b-48d5-ab15-caac5cb6a9b1" xlink:to="loc_vtrs_Numberofequitymethodinvestments_148e90d3-266f-49fe-901e-e2e583658495" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EquityMethodInvestmentsNetGainLossFromImpairmentandReductionInObligations_7807e8ff-b83b-439f-b6d7-bc9c40e88880" xlink:href="vtrs-20211231.xsd#vtrs_EquityMethodInvestmentsNetGainLossFromImpairmentandReductionInObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_01ae6a44-f03b-48d5-ab15-caac5cb6a9b1" xlink:to="loc_vtrs_EquityMethodInvestmentsNetGainLossFromImpairmentandReductionInObligations_7807e8ff-b83b-439f-b6d7-bc9c40e88880" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_7f80e05f-e7d2-4d03-a010-f648ffcec93f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_01ae6a44-f03b-48d5-ab15-caac5cb6a9b1" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_7f80e05f-e7d2-4d03-a010-f648ffcec93f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ImpairmentofEquityMethodInvestments_e83f904f-9026-484d-8293-5baf2dafe0a2" xlink:href="vtrs-20211231.xsd#vtrs_ImpairmentofEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_01ae6a44-f03b-48d5-ab15-caac5cb6a9b1" xlink:to="loc_vtrs_ImpairmentofEquityMethodInvestments_e83f904f-9026-484d-8293-5baf2dafe0a2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ReductioninEquityMethodInvestmentLongTermObligation_0c8d70a7-5b00-4d7f-ba1f-cfafdcca6dfb" xlink:href="vtrs-20211231.xsd#vtrs_ReductioninEquityMethodInvestmentLongTermObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_01ae6a44-f03b-48d5-ab15-caac5cb6a9b1" xlink:to="loc_vtrs_ReductioninEquityMethodInvestmentLongTermObligation_0c8d70a7-5b00-4d7f-ba1f-cfafdcca6dfb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_9eba9842-6e96-4924-8524-ccc216ebd711" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_01ae6a44-f03b-48d5-ab15-caac5cb6a9b1" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_9eba9842-6e96-4924-8524-ccc216ebd711" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_255bcba5-a932-4dfd-a52e-6fa7461ef716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_01ae6a44-f03b-48d5-ab15-caac5cb6a9b1" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_255bcba5-a932-4dfd-a52e-6fa7461ef716" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d0169132-256b-4d79-9216-fa876a9fe49e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_255bcba5-a932-4dfd-a52e-6fa7461ef716" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d0169132-256b-4d79-9216-fa876a9fe49e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_d0169132-256b-4d79-9216-fa876a9fe49e_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d0169132-256b-4d79-9216-fa876a9fe49e" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_d0169132-256b-4d79-9216-fa876a9fe49e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_e3e7d99e-0d6e-4da8-82b7-62155fbb6969" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d0169132-256b-4d79-9216-fa876a9fe49e" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_e3e7d99e-0d6e-4da8-82b7-62155fbb6969" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CleanEnergyPartnershipsMember_30ff2474-c767-4e9a-a7b6-6df0ef624494" xlink:href="vtrs-20211231.xsd#vtrs_CleanEnergyPartnershipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_e3e7d99e-0d6e-4da8-82b7-62155fbb6969" xlink:to="loc_vtrs_CleanEnergyPartnershipsMember_30ff2474-c767-4e9a-a7b6-6df0ef624494" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_33944dfe-57f2-4879-9bda-42914d472629" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_255bcba5-a932-4dfd-a52e-6fa7461ef716" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_33944dfe-57f2-4879-9bda-42914d472629" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_33944dfe-57f2-4879-9bda-42914d472629_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_33944dfe-57f2-4879-9bda-42914d472629" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_33944dfe-57f2-4879-9bda-42914d472629_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6c17f2a3-7b9e-4514-b3b0-7a78bc72e187" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_33944dfe-57f2-4879-9bda-42914d472629" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6c17f2a3-7b9e-4514-b3b0-7a78bc72e187" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_04fe97fd-1f80-4873-8325-432cbe0cadfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6c17f2a3-7b9e-4514-b3b0-7a78bc72e187" xlink:to="loc_us-gaap_OtherAssetsMember_04fe97fd-1f80-4873-8325-432cbe0cadfe" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EquityMethodInvestmentsBalanceSheetDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#EquityMethodInvestmentsBalanceSheetDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/EquityMethodInvestmentsBalanceSheetDetails" xlink:type="extended" id="i54b89788e8644ba69c7ba297cce137f7_EquityMethodInvestmentsBalanceSheetDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_1c26a877-df93-4d7f-8fb1-368a2fee96e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_37f572bb-1e36-4770-9894-1c0bd051e99e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_1c26a877-df93-4d7f-8fb1-368a2fee96e0" xlink:to="loc_us-gaap_EquityMethodInvestments_37f572bb-1e36-4770-9894-1c0bd051e99e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities_60a5eb0d-7852-447e-8846-ed4df96ac046" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_1c26a877-df93-4d7f-8fb1-368a2fee96e0" xlink:to="loc_us-gaap_OtherLiabilities_60a5eb0d-7852-447e-8846-ed4df96ac046" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_0f95ae72-def3-488d-8b44-25e74450fd92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_1c26a877-df93-4d7f-8fb1-368a2fee96e0" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_0f95ae72-def3-488d-8b44-25e74450fd92" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_908f32aa-27d8-41de-933f-ad50f821621d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_1c26a877-df93-4d7f-8fb1-368a2fee96e0" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_908f32aa-27d8-41de-933f-ad50f821621d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_95cd94ed-f7e3-467a-a99e-e9b48585b50f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_1c26a877-df93-4d7f-8fb1-368a2fee96e0" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_95cd94ed-f7e3-467a-a99e-e9b48585b50f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_261ecd9e-0383-4d22-9dee-b8a1f66b80d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_95cd94ed-f7e3-467a-a99e-e9b48585b50f" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_261ecd9e-0383-4d22-9dee-b8a1f66b80d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_261ecd9e-0383-4d22-9dee-b8a1f66b80d8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_261ecd9e-0383-4d22-9dee-b8a1f66b80d8" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_261ecd9e-0383-4d22-9dee-b8a1f66b80d8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_9c1390b9-0a0c-4ced-a0f2-c43cf868ee32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_261ecd9e-0383-4d22-9dee-b8a1f66b80d8" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_9c1390b9-0a0c-4ced-a0f2-c43cf868ee32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_9e6b4674-b6ef-49ef-8ce1-c187476e55a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9c1390b9-0a0c-4ced-a0f2-c43cf868ee32" xlink:to="loc_us-gaap_OtherAssetsMember_9e6b4674-b6ef-49ef-8ce1-c187476e55a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_c723a437-284b-48b1-a248-514f2475f4f3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_95cd94ed-f7e3-467a-a99e-e9b48585b50f" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_c723a437-284b-48b1-a248-514f2475f4f3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_c723a437-284b-48b1-a248-514f2475f4f3_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_c723a437-284b-48b1-a248-514f2475f4f3" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_c723a437-284b-48b1-a248-514f2475f4f3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_193930a9-32ec-425e-a62b-de1d1a997faa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_c723a437-284b-48b1-a248-514f2475f4f3" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_193930a9-32ec-425e-a62b-de1d1a997faa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CleanEnergyPartnershipsMember_454ce755-bcbc-482d-89c0-65ba576c6c44" xlink:href="vtrs-20211231.xsd#vtrs_CleanEnergyPartnershipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_193930a9-32ec-425e-a62b-de1d1a997faa" xlink:to="loc_vtrs_CleanEnergyPartnershipsMember_454ce755-bcbc-482d-89c0-65ba576c6c44" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EquityMethodInvestmentsNetAssetsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#EquityMethodInvestmentsNetAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/EquityMethodInvestmentsNetAssetsDetails" xlink:type="extended" id="i53ccf9c87e16403099a16ab14ae38a5b_EquityMethodInvestmentsNetAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e80bd09e-27cb-4041-b639-ffbd712e0ddc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_25416852-7f1e-4fa0-af5e-ab6f9645baa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e80bd09e-27cb-4041-b639-ffbd712e0ddc" xlink:to="loc_us-gaap_AssetsCurrent_25416852-7f1e-4fa0-af5e-ab6f9645baa6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_bb361248-88b5-4541-88fd-ff5bff2ac57e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e80bd09e-27cb-4041-b639-ffbd712e0ddc" xlink:to="loc_us-gaap_AssetsNoncurrent_bb361248-88b5-4541-88fd-ff5bff2ac57e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_d1511dc9-e46d-48eb-b945-a2dc671fcd63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e80bd09e-27cb-4041-b639-ffbd712e0ddc" xlink:to="loc_us-gaap_Assets_d1511dc9-e46d-48eb-b945-a2dc671fcd63" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_1de4fe0c-6dc2-4229-a5d9-5c5f9a7c1b83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e80bd09e-27cb-4041-b639-ffbd712e0ddc" xlink:to="loc_us-gaap_LiabilitiesCurrent_1de4fe0c-6dc2-4229-a5d9-5c5f9a7c1b83" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_a0e9c2b3-a224-490f-810a-69699baaf991" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e80bd09e-27cb-4041-b639-ffbd712e0ddc" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_a0e9c2b3-a224-490f-810a-69699baaf991" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_2300429a-5c70-41c5-984d-c3d5227a37b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e80bd09e-27cb-4041-b639-ffbd712e0ddc" xlink:to="loc_us-gaap_Liabilities_2300429a-5c70-41c5-984d-c3d5227a37b1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EquityMethodInvestmentSummarizedFinancialInformationNetAssets_2abc0b9f-ce1f-4397-8bf7-73eb79ab8774" xlink:href="vtrs-20211231.xsd#vtrs_EquityMethodInvestmentSummarizedFinancialInformationNetAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e80bd09e-27cb-4041-b639-ffbd712e0ddc" xlink:to="loc_vtrs_EquityMethodInvestmentSummarizedFinancialInformationNetAssets_2abc0b9f-ce1f-4397-8bf7-73eb79ab8774" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_6129ae1a-9cbf-4999-b93e-8ba5b2607e7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e80bd09e-27cb-4041-b639-ffbd712e0ddc" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_6129ae1a-9cbf-4999-b93e-8ba5b2607e7e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_577f395f-f841-4437-959e-85f09bf4cfff" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_6129ae1a-9cbf-4999-b93e-8ba5b2607e7e" xlink:to="loc_srt_ConsolidatedEntitiesAxis_577f395f-f841-4437-959e-85f09bf4cfff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_577f395f-f841-4437-959e-85f09bf4cfff_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_577f395f-f841-4437-959e-85f09bf4cfff" xlink:to="loc_srt_ConsolidatedEntitiesDomain_577f395f-f841-4437-959e-85f09bf4cfff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_9fb3ff40-7c01-4f52-b0d2-45702c4bccdd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_577f395f-f841-4437-959e-85f09bf4cfff" xlink:to="loc_srt_ConsolidatedEntitiesDomain_9fb3ff40-7c01-4f52-b0d2-45702c4bccdd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidatedEntityExcludingVieMember_55610c37-0fa8-4ff1-a84d-b289fd59c6c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidatedEntityExcludingVieMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_9fb3ff40-7c01-4f52-b0d2-45702c4bccdd" xlink:to="loc_us-gaap_ConsolidatedEntityExcludingVieMember_55610c37-0fa8-4ff1-a84d-b289fd59c6c8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EquityMethodInvestmentsIncomeStatementDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#EquityMethodInvestmentsIncomeStatementDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/EquityMethodInvestmentsIncomeStatementDetails" xlink:type="extended" id="i45290ecf9e764f7abad74c0f150c48b7_EquityMethodInvestmentsIncomeStatementDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3d3fb361-a82a-4e02-9343-6b77fd83508a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_dd75877c-5d0d-433f-b8ed-b2d10c89d788" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3d3fb361-a82a-4e02-9343-6b77fd83508a" xlink:to="loc_us-gaap_Revenues_dd75877c-5d0d-433f-b8ed-b2d10c89d788" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_f0290b2f-f3ad-4464-878a-d337f51d50bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3d3fb361-a82a-4e02-9343-6b77fd83508a" xlink:to="loc_us-gaap_GrossProfit_f0290b2f-f3ad-4464-878a-d337f51d50bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d8566528-a48c-463f-88b7-165b224bfeb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3d3fb361-a82a-4e02-9343-6b77fd83508a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d8566528-a48c-463f-88b7-165b224bfeb5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a978576c-a7cb-4843-b033-66eae6e57fe3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3d3fb361-a82a-4e02-9343-6b77fd83508a" xlink:to="loc_us-gaap_ProfitLoss_a978576c-a7cb-4843-b033-66eae6e57fe3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8fd7a1f9-0515-4d0b-bd24-d645dd8e6a29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3d3fb361-a82a-4e02-9343-6b77fd83508a" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8fd7a1f9-0515-4d0b-bd24-d645dd8e6a29" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_a893a46d-e8ad-4e29-85ae-3415c399b681" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8fd7a1f9-0515-4d0b-bd24-d645dd8e6a29" xlink:to="loc_srt_ConsolidatedEntitiesAxis_a893a46d-e8ad-4e29-85ae-3415c399b681" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_a893a46d-e8ad-4e29-85ae-3415c399b681_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_a893a46d-e8ad-4e29-85ae-3415c399b681" xlink:to="loc_srt_ConsolidatedEntitiesDomain_a893a46d-e8ad-4e29-85ae-3415c399b681_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_17cb840d-d598-41f8-a809-f79ad8aeb796" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_a893a46d-e8ad-4e29-85ae-3415c399b681" xlink:to="loc_srt_ConsolidatedEntitiesDomain_17cb840d-d598-41f8-a809-f79ad8aeb796" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidatedEntityExcludingVieMember_07555a73-3b85-4918-b123-5c1d623e3835" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidatedEntityExcludingVieMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_17cb840d-d598-41f8-a809-f79ad8aeb796" xlink:to="loc_us-gaap_ConsolidatedEntityExcludingVieMember_07555a73-3b85-4918-b123-5c1d623e3835" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#GoodwillandOtherIntangibleAssetsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails" xlink:type="extended" id="i5a19c38fea68408288c8b5d52c2f82fb_GoodwillandOtherIntangibleAssetsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_16ea2298-cb1e-459d-bf5e-0af352ad05d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_571108a9-89ce-4b49-acfc-d464fdb3d076" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_16ea2298-cb1e-459d-bf5e-0af352ad05d7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_571108a9-89ce-4b49-acfc-d464fdb3d076" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_2a9990d6-9b85-4c6c-9c42-dc1a0fd74768" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_16ea2298-cb1e-459d-bf5e-0af352ad05d7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_2a9990d6-9b85-4c6c-9c42-dc1a0fd74768" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_33db1cfc-b77e-47b6-a86a-866868872faa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_16ea2298-cb1e-459d-bf5e-0af352ad05d7" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_33db1cfc-b77e-47b6-a86a-866868872faa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_2b91ca81-05d4-4b30-a364-be95b27ee19d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_16ea2298-cb1e-459d-bf5e-0af352ad05d7" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_2b91ca81-05d4-4b30-a364-be95b27ee19d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_22fced06-b26c-464a-8830-cb3fce985c99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_16ea2298-cb1e-459d-bf5e-0af352ad05d7" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_22fced06-b26c-464a-8830-cb3fce985c99" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments_1b3657ba-e44c-42d8-9f7e-b426bff581d8" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationContingentConsiderationLiabilityPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_16ea2298-cb1e-459d-bf5e-0af352ad05d7" xlink:to="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments_1b3657ba-e44c-42d8-9f7e-b426bff581d8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIndefiniteLivedIntangibleAssetsMeasurementInput_b9cddf4a-3759-4027-b7c3-e3f23d9ccdaf" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIndefiniteLivedIntangibleAssetsMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_16ea2298-cb1e-459d-bf5e-0af352ad05d7" xlink:to="loc_vtrs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIndefiniteLivedIntangibleAssetsMeasurementInput_b9cddf4a-3759-4027-b7c3-e3f23d9ccdaf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_f8faa5ad-49b0-4d14-b90f-f4d93dc464cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_16ea2298-cb1e-459d-bf5e-0af352ad05d7" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_f8faa5ad-49b0-4d14-b90f-f4d93dc464cf" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_aff92477-aae1-4c0b-b9b5-9f7be4dc3b8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_16ea2298-cb1e-459d-bf5e-0af352ad05d7" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_aff92477-aae1-4c0b-b9b5-9f7be4dc3b8b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount_661fb92d-12cb-4780-aac3-ce0d4001175c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_16ea2298-cb1e-459d-bf5e-0af352ad05d7" xlink:to="loc_us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount_661fb92d-12cb-4780-aac3-ce0d4001175c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_2e46e26b-5267-47b3-9e7f-7a94408324f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_16ea2298-cb1e-459d-bf5e-0af352ad05d7" xlink:to="loc_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_2e46e26b-5267-47b3-9e7f-7a94408324f0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GoodwillImpairedChangeinEstimatePeriod_6297639c-1244-41a4-bafd-fcf0d945fd48" xlink:href="vtrs-20211231.xsd#vtrs_GoodwillImpairedChangeinEstimatePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_16ea2298-cb1e-459d-bf5e-0af352ad05d7" xlink:to="loc_vtrs_GoodwillImpairedChangeinEstimatePeriod_6297639c-1244-41a4-bafd-fcf0d945fd48" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GoodwillImpairmentTestMeasurementInput_604d16cc-1668-46a3-bff2-e7d650f80381" xlink:href="vtrs-20211231.xsd#vtrs_GoodwillImpairmentTestMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_16ea2298-cb1e-459d-bf5e-0af352ad05d7" xlink:to="loc_vtrs_GoodwillImpairmentTestMeasurementInput_604d16cc-1668-46a3-bff2-e7d650f80381" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_FairValueInputsLongtermRevenueGrowthRateTerminalYear_7923c996-8ee9-4b3c-a0b8-5bd5ef40f8e2" xlink:href="vtrs-20211231.xsd#vtrs_FairValueInputsLongtermRevenueGrowthRateTerminalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_16ea2298-cb1e-459d-bf5e-0af352ad05d7" xlink:to="loc_vtrs_FairValueInputsLongtermRevenueGrowthRateTerminalYear_7923c996-8ee9-4b3c-a0b8-5bd5ef40f8e2" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GoodwillImpairmentTestMeasurementInputReduction_3fdc5873-552c-4f0b-a324-c73cad67bf6a" xlink:href="vtrs-20211231.xsd#vtrs_GoodwillImpairmentTestMeasurementInputReduction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_16ea2298-cb1e-459d-bf5e-0af352ad05d7" xlink:to="loc_vtrs_GoodwillImpairmentTestMeasurementInputReduction_3fdc5873-552c-4f0b-a324-c73cad67bf6a" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GoodwillImpairmentTestMeasurementInputIncrease_750ef2bf-ed8c-42ec-a2f9-6b237c031075" xlink:href="vtrs-20211231.xsd#vtrs_GoodwillImpairmentTestMeasurementInputIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_16ea2298-cb1e-459d-bf5e-0af352ad05d7" xlink:to="loc_vtrs_GoodwillImpairmentTestMeasurementInputIncrease_750ef2bf-ed8c-42ec-a2f9-6b237c031075" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_fb9ac7bc-261c-4a8b-acaa-592df3781e37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_16ea2298-cb1e-459d-bf5e-0af352ad05d7" xlink:to="loc_us-gaap_Goodwill_fb9ac7bc-261c-4a8b-acaa-592df3781e37" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GoodwillImpairmentMeasurementInput_d6000a73-07ad-4399-88d5-6d10086e15bf" xlink:href="vtrs-20211231.xsd#vtrs_GoodwillImpairmentMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_16ea2298-cb1e-459d-bf5e-0af352ad05d7" xlink:to="loc_vtrs_GoodwillImpairmentMeasurementInput_d6000a73-07ad-4399-88d5-6d10086e15bf" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GoodwillImpairmentMeasurementInputTerm_7c87781a-a9d5-42f5-8179-dba8c768bd50" xlink:href="vtrs-20211231.xsd#vtrs_GoodwillImpairmentMeasurementInputTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_16ea2298-cb1e-459d-bf5e-0af352ad05d7" xlink:to="loc_vtrs_GoodwillImpairmentMeasurementInputTerm_7c87781a-a9d5-42f5-8179-dba8c768bd50" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d53c7bef-c101-465d-8b1c-445c8883925a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_16ea2298-cb1e-459d-bf5e-0af352ad05d7" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d53c7bef-c101-465d-8b1c-445c8883925a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_2e8786e2-6054-497a-ba31-30b6ea89e809" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d53c7bef-c101-465d-8b1c-445c8883925a" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_2e8786e2-6054-497a-ba31-30b6ea89e809" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_2e8786e2-6054-497a-ba31-30b6ea89e809_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_2e8786e2-6054-497a-ba31-30b6ea89e809" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_2e8786e2-6054-497a-ba31-30b6ea89e809_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b0192635-ba9b-423f-95ac-471f80b5a3fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_2e8786e2-6054-497a-ba31-30b6ea89e809" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b0192635-ba9b-423f-95ac-471f80b5a3fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_81bc9f13-99bb-4b7a-b37b-6a3494e9cb62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b0192635-ba9b-423f-95ac-471f80b5a3fe" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_81bc9f13-99bb-4b7a-b37b-6a3494e9cb62" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0d552c33-c839-4a9f-95d8-563fdb5cc182" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d53c7bef-c101-465d-8b1c-445c8883925a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0d552c33-c839-4a9f-95d8-563fdb5cc182" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0d552c33-c839-4a9f-95d8-563fdb5cc182_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0d552c33-c839-4a9f-95d8-563fdb5cc182" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0d552c33-c839-4a9f-95d8-563fdb5cc182_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a9231f24-99d5-4cb8-9394-4b8e6b86255a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0d552c33-c839-4a9f-95d8-563fdb5cc182" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a9231f24-99d5-4cb8-9394-4b8e6b86255a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RespiratorydeliveryplatformMember_0208cabb-75d4-4a0c-8442-8d9e98b65a50" xlink:href="vtrs-20211231.xsd#vtrs_RespiratorydeliveryplatformMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a9231f24-99d5-4cb8-9394-4b8e6b86255a" xlink:to="loc_vtrs_RespiratorydeliveryplatformMember_0208cabb-75d4-4a0c-8442-8d9e98b65a50" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_b6726176-2c5e-4d94-bde1-53efd70e2537" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d53c7bef-c101-465d-8b1c-445c8883925a" xlink:to="loc_srt_StatementScenarioAxis_b6726176-2c5e-4d94-bde1-53efd70e2537" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_b6726176-2c5e-4d94-bde1-53efd70e2537_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_b6726176-2c5e-4d94-bde1-53efd70e2537" xlink:to="loc_srt_ScenarioUnspecifiedDomain_b6726176-2c5e-4d94-bde1-53efd70e2537_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_57772b7f-a0f1-482e-b54f-c83ff40ddc8f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_b6726176-2c5e-4d94-bde1-53efd70e2537" xlink:to="loc_srt_ScenarioUnspecifiedDomain_57772b7f-a0f1-482e-b54f-c83ff40ddc8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_IncreasedDiscountRateDomain_d3c00963-307a-42eb-ae48-e12e86df27d5" xlink:href="vtrs-20211231.xsd#vtrs_IncreasedDiscountRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_57772b7f-a0f1-482e-b54f-c83ff40ddc8f" xlink:to="loc_vtrs_IncreasedDiscountRateDomain_d3c00963-307a-42eb-ae48-e12e86df27d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ReductioninTerminalValueGrowthRateDomain_eeb5c145-3d15-4aea-8af4-4707b7488f45" xlink:href="vtrs-20211231.xsd#vtrs_ReductioninTerminalValueGrowthRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_57772b7f-a0f1-482e-b54f-c83ff40ddc8f" xlink:to="loc_vtrs_ReductioninTerminalValueGrowthRateDomain_eeb5c145-3d15-4aea-8af4-4707b7488f45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_0c88c4a1-a994-48bd-8624-742635d370c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d53c7bef-c101-465d-8b1c-445c8883925a" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_0c88c4a1-a994-48bd-8624-742635d370c0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_0c88c4a1-a994-48bd-8624-742635d370c0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_0c88c4a1-a994-48bd-8624-742635d370c0" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_0c88c4a1-a994-48bd-8624-742635d370c0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_b88217e5-4233-4d5d-a7b0-8bf6ffd3e994" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_0c88c4a1-a994-48bd-8624-742635d370c0" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_b88217e5-4233-4d5d-a7b0-8bf6ffd3e994" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_083d2afd-cf6c-4dfe-86c8-28bfbd40d8d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_b88217e5-4233-4d5d-a7b0-8bf6ffd3e994" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_083d2afd-cf6c-4dfe-86c8-28bfbd40d8d7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_b90866c6-f4ed-453d-9abf-9166123795d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputLongTermRevenueGrowthRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_b88217e5-4233-4d5d-a7b0-8bf6ffd3e994" xlink:to="loc_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_b90866c6-f4ed-453d-9abf-9166123795d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_MeasurementInputEstimatedTaxRateMember_b56d1f86-fc31-4e6a-8b46-6e902d842488" xlink:href="vtrs-20211231.xsd#vtrs_MeasurementInputEstimatedTaxRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_b88217e5-4233-4d5d-a7b0-8bf6ffd3e994" xlink:to="loc_vtrs_MeasurementInputEstimatedTaxRateMember_b56d1f86-fc31-4e6a-8b46-6e902d842488" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputEbitdaMultipleMember_8f8679f8-71eb-425f-a200-0aa29d4b94c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputEbitdaMultipleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_b88217e5-4233-4d5d-a7b0-8bf6ffd3e994" xlink:to="loc_us-gaap_MeasurementInputEbitdaMultipleMember_8f8679f8-71eb-425f-a200-0aa29d4b94c0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputControlPremiumMember_6984cd22-b017-4b94-8aa2-286c43d5e9e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputControlPremiumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_b88217e5-4233-4d5d-a7b0-8bf6ffd3e994" xlink:to="loc_us-gaap_MeasurementInputControlPremiumMember_6984cd22-b017-4b94-8aa2-286c43d5e9e6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_MeasurementInputTerminalYearRevenueGrowthRateMember_f3f2e151-9914-45fe-92a1-45d380943f88" xlink:href="vtrs-20211231.xsd#vtrs_MeasurementInputTerminalYearRevenueGrowthRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_b88217e5-4233-4d5d-a7b0-8bf6ffd3e994" xlink:to="loc_vtrs_MeasurementInputTerminalYearRevenueGrowthRateMember_f3f2e151-9914-45fe-92a1-45d380943f88" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_MeasurementInputReductionInTerminalYearRevenueGrowthRateMember_1bbd36ad-a2bb-47fe-956b-df5a8462ee10" xlink:href="vtrs-20211231.xsd#vtrs_MeasurementInputReductionInTerminalYearRevenueGrowthRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_b88217e5-4233-4d5d-a7b0-8bf6ffd3e994" xlink:to="loc_vtrs_MeasurementInputReductionInTerminalYearRevenueGrowthRateMember_1bbd36ad-a2bb-47fe-956b-df5a8462ee10" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_MeasurementInputIncreaseInDiscountRateMember_558a83f3-ab23-48c6-9134-1ce6b93850b1" xlink:href="vtrs-20211231.xsd#vtrs_MeasurementInputIncreaseInDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_b88217e5-4233-4d5d-a7b0-8bf6ffd3e994" xlink:to="loc_vtrs_MeasurementInputIncreaseInDiscountRateMember_558a83f3-ab23-48c6-9134-1ce6b93850b1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_784c8e39-f456-4e2e-8a0e-2710e032aceb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d53c7bef-c101-465d-8b1c-445c8883925a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_784c8e39-f456-4e2e-8a0e-2710e032aceb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_784c8e39-f456-4e2e-8a0e-2710e032aceb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_784c8e39-f456-4e2e-8a0e-2710e032aceb" xlink:to="loc_us-gaap_SegmentDomain_784c8e39-f456-4e2e-8a0e-2710e032aceb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_413a75c2-ba26-407d-a6bf-55d6278c0c2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_784c8e39-f456-4e2e-8a0e-2710e032aceb" xlink:to="loc_us-gaap_SegmentDomain_413a75c2-ba26-407d-a6bf-55d6278c0c2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NorthAmericaGenericsMember_73c78344-8e52-4c87-b341-9fa6e4f02ec3" xlink:href="vtrs-20211231.xsd#vtrs_NorthAmericaGenericsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_413a75c2-ba26-407d-a6bf-55d6278c0c2e" xlink:to="loc_vtrs_NorthAmericaGenericsMember_73c78344-8e52-4c87-b341-9fa6e4f02ec3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NorthAmericaSpecialtyMember_600bf3be-12e1-4571-9c1f-1c588c515c14" xlink:href="vtrs-20211231.xsd#vtrs_NorthAmericaSpecialtyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_413a75c2-ba26-407d-a6bf-55d6278c0c2e" xlink:to="loc_vtrs_NorthAmericaSpecialtyMember_600bf3be-12e1-4571-9c1f-1c588c515c14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EuropeSegmentMember_0e812ca4-d288-41bb-acd8-d4941b762a71" xlink:href="vtrs-20211231.xsd#vtrs_EuropeSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_413a75c2-ba26-407d-a6bf-55d6278c0c2e" xlink:to="loc_vtrs_EuropeSegmentMember_0e812ca4-d288-41bb-acd8-d4941b762a71" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RestofWorldSegmentMember_23e66f34-225d-46e2-af76-cc2f6054128e" xlink:href="vtrs-20211231.xsd#vtrs_RestofWorldSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_413a75c2-ba26-407d-a6bf-55d6278c0c2e" xlink:to="loc_vtrs_RestofWorldSegmentMember_23e66f34-225d-46e2-af76-cc2f6054128e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NorthAmericaSegmentMember_2fb946c6-ed52-4d93-87d9-a8cd94d4d7d9" xlink:href="vtrs-20211231.xsd#vtrs_NorthAmericaSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_413a75c2-ba26-407d-a6bf-55d6278c0c2e" xlink:to="loc_vtrs_NorthAmericaSegmentMember_2fb946c6-ed52-4d93-87d9-a8cd94d4d7d9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_928d20d8-11bd-49f5-abdb-a05ec9386f47" xlink:href="vtrs-20211231.xsd#vtrs_JapanAustraliaAndNewZealandSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_413a75c2-ba26-407d-a6bf-55d6278c0c2e" xlink:to="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_928d20d8-11bd-49f5-abdb-a05ec9386f47" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d41d6f3d-0e0b-4db3-ba70-a5ec21837c58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d53c7bef-c101-465d-8b1c-445c8883925a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d41d6f3d-0e0b-4db3-ba70-a5ec21837c58" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d41d6f3d-0e0b-4db3-ba70-a5ec21837c58_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d41d6f3d-0e0b-4db3-ba70-a5ec21837c58" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d41d6f3d-0e0b-4db3-ba70-a5ec21837c58_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_441caf13-8664-4701-9078-1b7f30da38db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d41d6f3d-0e0b-4db3-ba70-a5ec21837c58" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_441caf13-8664-4701-9078-1b7f30da38db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_7b4fdf89-9b26-43a5-9eda-4ce91639c39b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_441caf13-8664-4701-9078-1b7f30da38db" xlink:to="loc_us-gaap_LicensingAgreementsMember_7b4fdf89-9b26-43a5-9eda-4ce91639c39b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_85498f66-6c48-47fc-8eeb-6428c75ee0ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d53c7bef-c101-465d-8b1c-445c8883925a" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_85498f66-6c48-47fc-8eeb-6428c75ee0ff" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_85498f66-6c48-47fc-8eeb-6428c75ee0ff_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_85498f66-6c48-47fc-8eeb-6428c75ee0ff" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_85498f66-6c48-47fc-8eeb-6428c75ee0ff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_601b6abb-cff9-41e2-805d-f8d3985813c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_85498f66-6c48-47fc-8eeb-6428c75ee0ff" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_601b6abb-cff9-41e2-805d-f8d3985813c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_72eb05bd-73f6-4f37-a38d-4d899326a1ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_601b6abb-cff9-41e2-805d-f8d3985813c9" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_72eb05bd-73f6-4f37-a38d-4d899326a1ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillMember_4b07c0d8-7dbf-4eb6-a6cf-c02148f8e5b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_601b6abb-cff9-41e2-805d-f8d3985813c9" xlink:to="loc_us-gaap_GoodwillMember_4b07c0d8-7dbf-4eb6-a6cf-c02148f8e5b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_94f6fb6d-117e-447d-80cc-cf72a8d7d1cc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d53c7bef-c101-465d-8b1c-445c8883925a" xlink:to="loc_srt_RangeAxis_94f6fb6d-117e-447d-80cc-cf72a8d7d1cc" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_94f6fb6d-117e-447d-80cc-cf72a8d7d1cc_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_94f6fb6d-117e-447d-80cc-cf72a8d7d1cc" xlink:to="loc_srt_RangeMember_94f6fb6d-117e-447d-80cc-cf72a8d7d1cc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_94ccf4a9-6958-410d-99b0-6c38343da882" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_94f6fb6d-117e-447d-80cc-cf72a8d7d1cc" xlink:to="loc_srt_RangeMember_94ccf4a9-6958-410d-99b0-6c38343da882" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_4b7e48bc-752d-4df7-ab87-a7c1a26526d4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_94ccf4a9-6958-410d-99b0-6c38343da882" xlink:to="loc_srt_MinimumMember_4b7e48bc-752d-4df7-ab87-a7c1a26526d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ff513ef5-d58d-4269-93dd-aad65b21120b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_94ccf4a9-6958-410d-99b0-6c38343da882" xlink:to="loc_srt_MaximumMember_ff513ef5-d58d-4269-93dd-aad65b21120b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_82fa90b7-1ef9-479c-8b22-17ff8b3f9ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d53c7bef-c101-465d-8b1c-445c8883925a" xlink:to="loc_us-gaap_ValuationTechniqueAxis_82fa90b7-1ef9-479c-8b22-17ff8b3f9ff1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_82fa90b7-1ef9-479c-8b22-17ff8b3f9ff1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationTechniqueAxis_82fa90b7-1ef9-479c-8b22-17ff8b3f9ff1" xlink:to="loc_us-gaap_ValuationTechniqueDomain_82fa90b7-1ef9-479c-8b22-17ff8b3f9ff1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_2539b670-e40c-450c-982d-5d76926f3c26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationTechniqueAxis_82fa90b7-1ef9-479c-8b22-17ff8b3f9ff1" xlink:to="loc_us-gaap_ValuationTechniqueDomain_2539b670-e40c-450c-982d-5d76926f3c26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_1cadd7bf-384e-4448-9e50-c053fd8eaa8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationTechniqueDomain_2539b670-e40c-450c-982d-5d76926f3c26" xlink:to="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_1cadd7bf-384e-4448-9e50-c053fd8eaa8c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountOfGoodwillDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#GoodwillandOtherIntangibleAssetsChangesinCarryingAmountOfGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountOfGoodwillDetails" xlink:type="extended" id="i49d5400a766c466e8233c3096f4472a8_GoodwillandOtherIntangibleAssetsChangesinCarryingAmountOfGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_d85abcc3-cfdf-41b5-8857-a70c2befd28a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_95820704-48e4-4e96-a8f0-7f44d34b3804" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_d85abcc3-cfdf-41b5-8857-a70c2befd28a" xlink:to="loc_us-gaap_GoodwillGross_95820704-48e4-4e96-a8f0-7f44d34b3804" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_fb03e9be-7d2b-4f81-b2ec-e54a8f7774cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_d85abcc3-cfdf-41b5-8857-a70c2befd28a" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_fb03e9be-7d2b-4f81-b2ec-e54a8f7774cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_747fc658-ed71-44d7-99bc-da277d6887a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_d85abcc3-cfdf-41b5-8857-a70c2befd28a" xlink:to="loc_us-gaap_Goodwill_747fc658-ed71-44d7-99bc-da277d6887a7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_38cf12e6-8db4-435f-bfd4-f3585d790c8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_d85abcc3-cfdf-41b5-8857-a70c2befd28a" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_38cf12e6-8db4-435f-bfd4-f3585d790c8d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_a428dcb7-a3de-4ade-a4b1-114415025d1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_d85abcc3-cfdf-41b5-8857-a70c2befd28a" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_a428dcb7-a3de-4ade-a4b1-114415025d1f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_8d7781ad-c457-4e18-b465-6c9a2a57d5d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTransfers_7408da90-f1a2-44bf-a8ab-151aceea47f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillTransfers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_d85abcc3-cfdf-41b5-8857-a70c2befd28a" xlink:to="loc_us-gaap_GoodwillTransfers_7408da90-f1a2-44bf-a8ab-151aceea47f1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_79b8f4ca-b9c8-4c02-95a2-b51da645aa88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_05fcfeb6-2e56-47ed-bd82-8e59f6fb1528" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_e2c78f07-11a9-468b-9151-c7c3de4d24ac" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_d85abcc3-cfdf-41b5-8857-a70c2befd28a" xlink:to="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_e2c78f07-11a9-468b-9151-c7c3de4d24ac" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_1f2a6398-4150-465b-ba09-badb0bccafc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_d85abcc3-cfdf-41b5-8857-a70c2befd28a" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_1f2a6398-4150-465b-ba09-badb0bccafc4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a396ef6f-8209-48e4-be9b-abf896823310" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_1f2a6398-4150-465b-ba09-badb0bccafc4" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a396ef6f-8209-48e4-be9b-abf896823310" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a396ef6f-8209-48e4-be9b-abf896823310_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a396ef6f-8209-48e4-be9b-abf896823310" xlink:to="loc_us-gaap_SegmentDomain_a396ef6f-8209-48e4-be9b-abf896823310_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c80dc357-757d-403e-afac-95c25f9589af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a396ef6f-8209-48e4-be9b-abf896823310" xlink:to="loc_us-gaap_SegmentDomain_c80dc357-757d-403e-afac-95c25f9589af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DevelopedMarketsSegmentMember_3d4b2a87-ff26-49b5-a0e4-5d4f5686bf92" xlink:href="vtrs-20211231.xsd#vtrs_DevelopedMarketsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c80dc357-757d-403e-afac-95c25f9589af" xlink:to="loc_vtrs_DevelopedMarketsSegmentMember_3d4b2a87-ff26-49b5-a0e4-5d4f5686bf92" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GreaterChinaSegmentMember_d4a86eff-c985-4efd-85fb-32c037927e6f" xlink:href="vtrs-20211231.xsd#vtrs_GreaterChinaSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c80dc357-757d-403e-afac-95c25f9589af" xlink:to="loc_vtrs_GreaterChinaSegmentMember_d4a86eff-c985-4efd-85fb-32c037927e6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_6699dc8b-3965-4f42-9409-a6e71503c0d8" xlink:href="vtrs-20211231.xsd#vtrs_JapanAustraliaAndNewZealandSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c80dc357-757d-403e-afac-95c25f9589af" xlink:to="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_6699dc8b-3965-4f42-9409-a6e71503c0d8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EmergingMarketsSegmentMember_2566474c-e0b2-494f-8d03-8e6ddaf59e6e" xlink:href="vtrs-20211231.xsd#vtrs_EmergingMarketsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c80dc357-757d-403e-afac-95c25f9589af" xlink:to="loc_vtrs_EmergingMarketsSegmentMember_2566474c-e0b2-494f-8d03-8e6ddaf59e6e" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsProductRightsandLicensebyTherapeuticCategoryDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#GoodwillandOtherIntangibleAssetsProductRightsandLicensebyTherapeuticCategoryDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsProductRightsandLicensebyTherapeuticCategoryDetails" xlink:type="extended" id="ifdd16299273c40af924e1f8816672036_GoodwillandOtherIntangibleAssetsProductRightsandLicensebyTherapeuticCategoryDetails">
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassLineItems_0371291a-712d-4840-ae92-60bdba2cb1ba" xlink:href="vtrs-20211231.xsd#vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f05f52cf-7b50-41ab-a484-8415ad0b9de9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassLineItems_0371291a-712d-4840-ae92-60bdba2cb1ba" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f05f52cf-7b50-41ab-a484-8415ad0b9de9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassTable_9c568fe3-a7c4-4ba0-b2c7-dc056af811d2" xlink:href="vtrs-20211231.xsd#vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassLineItems_0371291a-712d-4840-ae92-60bdba2cb1ba" xlink:to="loc_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassTable_9c568fe3-a7c4-4ba0-b2c7-dc056af811d2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3f67b2c1-21c3-44e4-ac87-a1380f7fed27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassTable_9c568fe3-a7c4-4ba0-b2c7-dc056af811d2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3f67b2c1-21c3-44e4-ac87-a1380f7fed27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3f67b2c1-21c3-44e4-ac87-a1380f7fed27_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3f67b2c1-21c3-44e4-ac87-a1380f7fed27" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3f67b2c1-21c3-44e4-ac87-a1380f7fed27_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_af993cff-ce56-4580-ba3d-7ee45edfcc2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3f67b2c1-21c3-44e4-ac87-a1380f7fed27" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_af993cff-ce56-4580-ba3d-7ee45edfcc2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_69ed9edf-eed8-48b3-bb3b-307e7a0fa5a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_af993cff-ce56-4580-ba3d-7ee45edfcc2b" xlink:to="loc_us-gaap_LicensingAgreementsMember_69ed9edf-eed8-48b3-bb3b-307e7a0fa5a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4c9ddb82-abf4-4bb4-a060-e03e9e5b890d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassTable_9c568fe3-a7c4-4ba0-b2c7-dc056af811d2" xlink:to="loc_srt_ProductOrServiceAxis_4c9ddb82-abf4-4bb4-a060-e03e9e5b890d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4c9ddb82-abf4-4bb4-a060-e03e9e5b890d_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_4c9ddb82-abf4-4bb4-a060-e03e9e5b890d" xlink:to="loc_srt_ProductsAndServicesDomain_4c9ddb82-abf4-4bb4-a060-e03e9e5b890d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_42e8ef8d-eab4-4e0e-9589-cdd7c63ca896" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_4c9ddb82-abf4-4bb4-a060-e03e9e5b890d" xlink:to="loc_srt_ProductsAndServicesDomain_42e8ef8d-eab4-4e0e-9589-cdd7c63ca896" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BrandsMember_195fe4dc-5c59-489c-8106-9b2df9065043" xlink:href="vtrs-20211231.xsd#vtrs_BrandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_42e8ef8d-eab4-4e0e-9589-cdd7c63ca896" xlink:to="loc_vtrs_BrandsMember_195fe4dc-5c59-489c-8106-9b2df9065043" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ComplexGXAndBiosimilarsMember_fb830ab8-02e1-4c6b-9de3-7348aa8b2e1e" xlink:href="vtrs-20211231.xsd#vtrs_ComplexGXAndBiosimilarsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_42e8ef8d-eab4-4e0e-9589-cdd7c63ca896" xlink:to="loc_vtrs_ComplexGXAndBiosimilarsMember_fb830ab8-02e1-4c6b-9de3-7348aa8b2e1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GenericsMember_f7d6297d-8f7a-41a3-8af5-7e4b28103859" xlink:href="vtrs-20211231.xsd#vtrs_GenericsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_42e8ef8d-eab4-4e0e-9589-cdd7c63ca896" xlink:to="loc_vtrs_GenericsMember_f7d6297d-8f7a-41a3-8af5-7e4b28103859" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a65311c3-4858-45f3-b261-177574f79e90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassTable_9c568fe3-a7c4-4ba0-b2c7-dc056af811d2" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a65311c3-4858-45f3-b261-177574f79e90" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a65311c3-4858-45f3-b261-177574f79e90_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a65311c3-4858-45f3-b261-177574f79e90" xlink:to="loc_us-gaap_SegmentDomain_a65311c3-4858-45f3-b261-177574f79e90_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_70195998-763d-4363-9f0d-ea05e46b593e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a65311c3-4858-45f3-b261-177574f79e90" xlink:to="loc_us-gaap_SegmentDomain_70195998-763d-4363-9f0d-ea05e46b593e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DevelopedMarketsSegmentMember_5d115df9-b3e1-4e87-ac3c-f3e418ba4892" xlink:href="vtrs-20211231.xsd#vtrs_DevelopedMarketsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_70195998-763d-4363-9f0d-ea05e46b593e" xlink:to="loc_vtrs_DevelopedMarketsSegmentMember_5d115df9-b3e1-4e87-ac3c-f3e418ba4892" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GreaterChinaSegmentMember_2385797a-5a77-42e0-b01a-ed3248225151" xlink:href="vtrs-20211231.xsd#vtrs_GreaterChinaSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_70195998-763d-4363-9f0d-ea05e46b593e" xlink:to="loc_vtrs_GreaterChinaSegmentMember_2385797a-5a77-42e0-b01a-ed3248225151" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_310e94c8-22c6-4255-ad28-13b9e9c82075" xlink:href="vtrs-20211231.xsd#vtrs_JapanAustraliaAndNewZealandSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_70195998-763d-4363-9f0d-ea05e46b593e" xlink:to="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_310e94c8-22c6-4255-ad28-13b9e9c82075" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EmergingMarketsSegmentMember_2fd410c0-eed9-4ef7-a4c7-3dbb2aaf5d0b" xlink:href="vtrs-20211231.xsd#vtrs_EmergingMarketsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_70195998-763d-4363-9f0d-ea05e46b593e" xlink:to="loc_vtrs_EmergingMarketsSegmentMember_2fd410c0-eed9-4ef7-a4c7-3dbb2aaf5d0b" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails" xlink:type="extended" id="i476599137e5f436e819f8c643dda392a_GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3d591e07-d278-4a27-84e7-eca218c22f34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_dcf7dcd4-c7d4-48f9-b726-86b4ef4e1fcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3d591e07-d278-4a27-84e7-eca218c22f34" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_dcf7dcd4-c7d4-48f9-b726-86b4ef4e1fcb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_1596650a-66d6-432e-9906-943e615a1ee8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3d591e07-d278-4a27-84e7-eca218c22f34" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_1596650a-66d6-432e-9906-943e615a1ee8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_e92a3cf7-43b9-4f72-8ad3-62be39377f98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3d591e07-d278-4a27-84e7-eca218c22f34" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_e92a3cf7-43b9-4f72-8ad3-62be39377f98" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_e985f0b5-55a3-4880-856d-4664c6e66a6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3d591e07-d278-4a27-84e7-eca218c22f34" xlink:to="loc_us-gaap_AdjustmentForAmortization_e985f0b5-55a3-4880-856d-4664c6e66a6c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b2649365-f4c0-4f23-a0f0-b57f7da6af55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3d591e07-d278-4a27-84e7-eca218c22f34" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b2649365-f4c0-4f23-a0f0-b57f7da6af55" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_78c80eb4-7441-47ed-a9e0-a854dfbda9ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b2649365-f4c0-4f23-a0f0-b57f7da6af55" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_78c80eb4-7441-47ed-a9e0-a854dfbda9ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_78c80eb4-7441-47ed-a9e0-a854dfbda9ce_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_78c80eb4-7441-47ed-a9e0-a854dfbda9ce" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_78c80eb4-7441-47ed-a9e0-a854dfbda9ce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f17364b3-47a1-45b4-bdea-e66e39db98ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_78c80eb4-7441-47ed-a9e0-a854dfbda9ce" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f17364b3-47a1-45b4-bdea-e66e39db98ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_c643a0c7-4001-4c9f-9853-81c1b7ab5590" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f17364b3-47a1-45b4-bdea-e66e39db98ac" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_c643a0c7-4001-4c9f-9853-81c1b7ab5590" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables" xlink:type="simple" xlink:href="vtrs-20211231.xsd#FinancialInstrumentsandRiskManagementTables"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables" xlink:type="extended" id="i3d3fb84596d14a6c82d694806987847c_FinancialInstrumentsandRiskManagementTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_bbebc39f-77c6-492a-b270-bb5b9388179b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_8f9120f0-730e-4223-88ed-7d1f6ecd0d58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_bbebc39f-77c6-492a-b270-bb5b9388179b" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_8f9120f0-730e-4223-88ed-7d1f6ecd0d58" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_e9edce87-97ad-4252-a6e9-7b719cc102c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_bbebc39f-77c6-492a-b270-bb5b9388179b" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_e9edce87-97ad-4252-a6e9-7b719cc102c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_079a5dbc-1c1d-4ffb-afc7-caebf310c476" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_bbebc39f-77c6-492a-b270-bb5b9388179b" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_079a5dbc-1c1d-4ffb-afc7-caebf310c476" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_8ab858d7-3ed7-4656-8cf0-931751fa85fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_bbebc39f-77c6-492a-b270-bb5b9388179b" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_8ab858d7-3ed7-4656-8cf0-931751fa85fe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_c989b74d-50c8-46ba-8694-e4efb51056e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_bbebc39f-77c6-492a-b270-bb5b9388179b" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_c989b74d-50c8-46ba-8694-e4efb51056e9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_84f3871c-a271-4f99-9006-127206734b49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_bbebc39f-77c6-492a-b270-bb5b9388179b" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_84f3871c-a271-4f99-9006-127206734b49" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_17f8118d-09a8-48c3-bcd2-3d8a27f9c712" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_bbebc39f-77c6-492a-b270-bb5b9388179b" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_17f8118d-09a8-48c3-bcd2-3d8a27f9c712" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_f2e81558-75c9-4a4c-90c6-fff74d0f684a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_17f8118d-09a8-48c3-bcd2-3d8a27f9c712" xlink:to="loc_us-gaap_HedgingDesignationAxis_f2e81558-75c9-4a4c-90c6-fff74d0f684a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_f2e81558-75c9-4a4c-90c6-fff74d0f684a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_f2e81558-75c9-4a4c-90c6-fff74d0f684a" xlink:to="loc_us-gaap_HedgingDesignationDomain_f2e81558-75c9-4a4c-90c6-fff74d0f684a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_d6cbba10-e71d-402e-9433-5af951e2a307" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_f2e81558-75c9-4a4c-90c6-fff74d0f684a" xlink:to="loc_us-gaap_HedgingDesignationDomain_d6cbba10-e71d-402e-9433-5af951e2a307" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_0c392336-b6b9-44b5-ae76-218f476918dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_d6cbba10-e71d-402e-9433-5af951e2a307" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_0c392336-b6b9-44b5-ae76-218f476918dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_b70466c1-189e-4768-b1ff-c2f904fdc838" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_d6cbba10-e71d-402e-9433-5af951e2a307" xlink:to="loc_us-gaap_NondesignatedMember_b70466c1-189e-4768-b1ff-c2f904fdc838" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_06517ca8-a2b2-49e3-9088-7d2b90e9ffc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_17f8118d-09a8-48c3-bcd2-3d8a27f9c712" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_06517ca8-a2b2-49e3-9088-7d2b90e9ffc8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_06517ca8-a2b2-49e3-9088-7d2b90e9ffc8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_06517ca8-a2b2-49e3-9088-7d2b90e9ffc8" xlink:to="loc_us-gaap_HedgingRelationshipDomain_06517ca8-a2b2-49e3-9088-7d2b90e9ffc8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_5205e463-4fa8-41a6-a5c5-d13eb9e0a379" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_06517ca8-a2b2-49e3-9088-7d2b90e9ffc8" xlink:to="loc_us-gaap_HedgingRelationshipDomain_5205e463-4fa8-41a6-a5c5-d13eb9e0a379" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_67ef2019-12c1-484d-932e-e1019a043bdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_5205e463-4fa8-41a6-a5c5-d13eb9e0a379" xlink:to="loc_us-gaap_FairValueHedgingMember_67ef2019-12c1-484d-932e-e1019a043bdf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_76d1cd0c-c38b-4937-bff2-b288c2562654" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_5205e463-4fa8-41a6-a5c5-d13eb9e0a379" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_76d1cd0c-c38b-4937-bff2-b288c2562654" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_b8383c20-24d8-4c46-972f-b6e831b0537a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_5205e463-4fa8-41a6-a5c5-d13eb9e0a379" xlink:to="loc_us-gaap_CashFlowHedgingMember_b8383c20-24d8-4c46-972f-b6e831b0537a" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#FinancialInstrumentsandRiskManagementNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails" xlink:type="extended" id="ia30ea8a9adf94b63975621118a3c988e_FinancialInstrumentsandRiskManagementNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_842cf934-b5c7-4b3e-b17b-83648ef416dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_7e09d24b-2f15-4d7f-aab8-a1f181625c82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_842cf934-b5c7-4b3e-b17b-83648ef416dd" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_7e09d24b-2f15-4d7f-aab8-a1f181625c82" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_2ea3c976-a3fb-466d-a018-56c4ff24da83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_842cf934-b5c7-4b3e-b17b-83648ef416dd" xlink:to="loc_us-gaap_LongTermDebt_2ea3c976-a3fb-466d-a018-56c4ff24da83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_5f758884-7e85-45d2-b836-9952c7a225ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_842cf934-b5c7-4b3e-b17b-83648ef416dd" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_5f758884-7e85-45d2-b836-9952c7a225ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_549b9be9-0fc1-40a6-8d33-682e3c6a23fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_842cf934-b5c7-4b3e-b17b-83648ef416dd" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_549b9be9-0fc1-40a6-8d33-682e3c6a23fe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_00ad76da-5eae-489a-879f-d57794f23c2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_842cf934-b5c7-4b3e-b17b-83648ef416dd" xlink:to="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_00ad76da-5eae-489a-879f-d57794f23c2b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_5131986c-e06e-4505-8645-9f7b740f8052" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_842cf934-b5c7-4b3e-b17b-83648ef416dd" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_5131986c-e06e-4505-8645-9f7b740f8052" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_92b7d042-1a42-433d-88a3-63bef606dceb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_842cf934-b5c7-4b3e-b17b-83648ef416dd" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_92b7d042-1a42-433d-88a3-63bef606dceb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_7015dce5-a6aa-4c1a-8f0f-ec72840f706e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_842cf934-b5c7-4b3e-b17b-83648ef416dd" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_7015dce5-a6aa-4c1a-8f0f-ec72840f706e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_f540bb76-0b23-45ef-a3e2-4a4b4c7ecf0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_842cf934-b5c7-4b3e-b17b-83648ef416dd" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_f540bb76-0b23-45ef-a3e2-4a4b4c7ecf0d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_36c131bf-6396-459c-a3da-edb9abfbc502" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_842cf934-b5c7-4b3e-b17b-83648ef416dd" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_36c131bf-6396-459c-a3da-edb9abfbc502" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications_70ae11d7-95a4-4bac-aa0e-7a3cf141e1c9" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_842cf934-b5c7-4b3e-b17b-83648ef416dd" xlink:to="loc_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications_70ae11d7-95a4-4bac-aa0e-7a3cf141e1c9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionExpense_c7da9dcc-6087-4a9b-929c-7653eda1c081" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_842cf934-b5c7-4b3e-b17b-83648ef416dd" xlink:to="loc_us-gaap_AccretionExpense_c7da9dcc-6087-4a9b-929c-7653eda1c081" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_7ba4fff5-25b7-4b6b-a54e-715247021869" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_842cf934-b5c7-4b3e-b17b-83648ef416dd" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_7ba4fff5-25b7-4b6b-a54e-715247021869" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments_c1593fe5-6855-4c33-93aa-0249e0dcca2d" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationContingentConsiderationLiabilityPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_842cf934-b5c7-4b3e-b17b-83648ef416dd" xlink:to="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments_c1593fe5-6855-4c33-93aa-0249e0dcca2d" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetLiabilityNetMeasurementInput_5e84ba3d-9280-492c-85d2-297d62e0b640" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetLiabilityNetMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_842cf934-b5c7-4b3e-b17b-83648ef416dd" xlink:to="loc_us-gaap_DerivativeAssetLiabilityNetMeasurementInput_5e84ba3d-9280-492c-85d2-297d62e0b640" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisGainLossIncludedInEarnings_acdc59d6-410e-424a-b1e6-a716ee27dead" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_842cf934-b5c7-4b3e-b17b-83648ef416dd" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisGainLossIncludedInEarnings_acdc59d6-410e-424a-b1e6-a716ee27dead" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccretionExpenseToBeRecognizedWithinTheNextTwelveMonths_681b4eef-5608-4159-9005-3fb9e56e2be4" xlink:href="vtrs-20211231.xsd#vtrs_AccretionExpenseToBeRecognizedWithinTheNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_842cf934-b5c7-4b3e-b17b-83648ef416dd" xlink:to="loc_vtrs_AccretionExpenseToBeRecognizedWithinTheNextTwelveMonths_681b4eef-5608-4159-9005-3fb9e56e2be4" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_fdaa4ec9-59a7-473b-bfac-67f9da29be23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_842cf934-b5c7-4b3e-b17b-83648ef416dd" xlink:to="loc_us-gaap_DerivativeTable_fdaa4ec9-59a7-473b-bfac-67f9da29be23" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_f06f79bc-f792-4507-addf-862e9532ff24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_fdaa4ec9-59a7-473b-bfac-67f9da29be23" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_f06f79bc-f792-4507-addf-862e9532ff24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_f06f79bc-f792-4507-addf-862e9532ff24_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_f06f79bc-f792-4507-addf-862e9532ff24" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_f06f79bc-f792-4507-addf-862e9532ff24_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_87a099f1-bbaa-4892-a94a-13b00b26818f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_f06f79bc-f792-4507-addf-862e9532ff24" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_87a099f1-bbaa-4892-a94a-13b00b26818f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_5591c01a-fe87-4c67-84ad-73bb10a9fb84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_87a099f1-bbaa-4892-a94a-13b00b26818f" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_5591c01a-fe87-4c67-84ad-73bb10a9fb84" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_761ebade-c5bd-429e-867f-ecd6c423447f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_fdaa4ec9-59a7-473b-bfac-67f9da29be23" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_761ebade-c5bd-429e-867f-ecd6c423447f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_761ebade-c5bd-429e-867f-ecd6c423447f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_761ebade-c5bd-429e-867f-ecd6c423447f" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_761ebade-c5bd-429e-867f-ecd6c423447f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_df3a11bc-895e-4c41-acda-630cd3ec5631" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_761ebade-c5bd-429e-867f-ecd6c423447f" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_df3a11bc-895e-4c41-acda-630cd3ec5631" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ContingentConsiderationMember_fc5dc7f4-5af1-411d-8b6d-cb32038cfce9" xlink:href="vtrs-20211231.xsd#vtrs_ContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_df3a11bc-895e-4c41-acda-630cd3ec5631" xlink:to="loc_vtrs_ContingentConsiderationMember_fc5dc7f4-5af1-411d-8b6d-cb32038cfce9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_48e97dd0-9bcb-4365-a647-5e36dd0da872" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_df3a11bc-895e-4c41-acda-630cd3ec5631" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_48e97dd0-9bcb-4365-a647-5e36dd0da872" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_01b98bf3-e0bf-493a-a285-dee92b9e8efb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_df3a11bc-895e-4c41-acda-630cd3ec5631" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_01b98bf3-e0bf-493a-a285-dee92b9e8efb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1dab26d7-f782-4372-8b0c-42f52ba0ebf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_fdaa4ec9-59a7-473b-bfac-67f9da29be23" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1dab26d7-f782-4372-8b0c-42f52ba0ebf7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1dab26d7-f782-4372-8b0c-42f52ba0ebf7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1dab26d7-f782-4372-8b0c-42f52ba0ebf7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1dab26d7-f782-4372-8b0c-42f52ba0ebf7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_851bf7cb-53aa-44fc-af65-a7d80c840b83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1dab26d7-f782-4372-8b0c-42f52ba0ebf7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_851bf7cb-53aa-44fc-af65-a7d80c840b83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenseMember_78091ff6-4e8d-4239-acbe-0d5bb2fa9436" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_851bf7cb-53aa-44fc-af65-a7d80c840b83" xlink:to="loc_us-gaap_OtherExpenseMember_78091ff6-4e8d-4239-acbe-0d5bb2fa9436" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8bae6584-be30-4437-8856-299dcb14a0f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_fdaa4ec9-59a7-473b-bfac-67f9da29be23" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8bae6584-be30-4437-8856-299dcb14a0f1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8bae6584-be30-4437-8856-299dcb14a0f1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8bae6584-be30-4437-8856-299dcb14a0f1" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8bae6584-be30-4437-8856-299dcb14a0f1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_2aecf1b6-fed7-411f-8ed5-9650f5c7e167" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8bae6584-be30-4437-8856-299dcb14a0f1" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_2aecf1b6-fed7-411f-8ed5-9650f5c7e167" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_8bfb981e-97af-4dbc-9cb2-24610834e28e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2aecf1b6-fed7-411f-8ed5-9650f5c7e167" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_8bfb981e-97af-4dbc-9cb2-24610834e28e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_05a79d74-c07b-493f-a4fe-abd78166fdf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2aecf1b6-fed7-411f-8ed5-9650f5c7e167" xlink:to="loc_us-gaap_InterestRateSwapMember_05a79d74-c07b-493f-a4fe-abd78166fdf8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_fa155591-233c-43c3-8d24-f441b4c10abe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_fdaa4ec9-59a7-473b-bfac-67f9da29be23" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_fa155591-233c-43c3-8d24-f441b4c10abe" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_fa155591-233c-43c3-8d24-f441b4c10abe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_fa155591-233c-43c3-8d24-f441b4c10abe" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_fa155591-233c-43c3-8d24-f441b4c10abe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_72a7d9c7-b008-472a-bf0b-f72c3b2b8447" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_fa155591-233c-43c3-8d24-f441b4c10abe" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_72a7d9c7-b008-472a-bf0b-f72c3b2b8447" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_c33f2e8d-9a09-4b5e-911b-20430d2a9a2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_72a7d9c7-b008-472a-bf0b-f72c3b2b8447" xlink:to="loc_us-gaap_SeniorNotesMember_c33f2e8d-9a09-4b5e-911b-20430d2a9a2a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_3581e4b2-66cb-4d57-a038-8140c68f0a80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_fdaa4ec9-59a7-473b-bfac-67f9da29be23" xlink:to="loc_us-gaap_DebtInstrumentAxis_3581e4b2-66cb-4d57-a038-8140c68f0a80" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3581e4b2-66cb-4d57-a038-8140c68f0a80_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_3581e4b2-66cb-4d57-a038-8140c68f0a80" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3581e4b2-66cb-4d57-a038-8140c68f0a80_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6586cc55-6f3e-4de6-8be1-4a839d39133d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_3581e4b2-66cb-4d57-a038-8140c68f0a80" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6586cc55-6f3e-4de6-8be1-4a839d39133d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2020EuroSeniorNotesMember_90e898b5-5c0c-406d-9400-eac88f963def" xlink:href="vtrs-20211231.xsd#vtrs_A2020EuroSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6586cc55-6f3e-4de6-8be1-4a839d39133d" xlink:to="loc_vtrs_A2020EuroSeniorNotesMember_90e898b5-5c0c-406d-9400-eac88f963def" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2022EuroSeniorNotesMember_85e03c96-2f2f-4d0b-98ee-1e754a3df47e" xlink:href="vtrs-20211231.xsd#vtrs_A2022EuroSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6586cc55-6f3e-4de6-8be1-4a839d39133d" xlink:to="loc_vtrs_A2022EuroSeniorNotesMember_85e03c96-2f2f-4d0b-98ee-1e754a3df47e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2024EuroSeniorNotesMember_646258ae-aab0-47e1-beb3-9cd13aa3747c" xlink:href="vtrs-20211231.xsd#vtrs_A2024EuroSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6586cc55-6f3e-4de6-8be1-4a839d39133d" xlink:to="loc_vtrs_A2024EuroSeniorNotesMember_646258ae-aab0-47e1-beb3-9cd13aa3747c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2024EuroSeniorNotes1023Member_6be60ec8-b0b8-46c9-86de-04921d92c991" xlink:href="vtrs-20211231.xsd#vtrs_A2024EuroSeniorNotes1023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6586cc55-6f3e-4de6-8be1-4a839d39133d" xlink:to="loc_vtrs_A2024EuroSeniorNotes1023Member_6be60ec8-b0b8-46c9-86de-04921d92c991" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2025EuroSeniorNotesMember_e9d50729-7ba5-47d8-9943-12fcce7fba1f" xlink:href="vtrs-20211231.xsd#vtrs_A2025EuroSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6586cc55-6f3e-4de6-8be1-4a839d39133d" xlink:to="loc_vtrs_A2025EuroSeniorNotesMember_e9d50729-7ba5-47d8-9943-12fcce7fba1f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2028SeniorNotesMember_74792e0e-9f73-4458-b3c5-dfb0cb963bd3" xlink:href="vtrs-20211231.xsd#vtrs_A2028SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6586cc55-6f3e-4de6-8be1-4a839d39133d" xlink:to="loc_vtrs_A2028SeniorNotesMember_74792e0e-9f73-4458-b3c5-dfb0cb963bd3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2027EuroSeniorNotesMember_269ba71b-3cad-4a36-9ed8-12bb9f2d14ec" xlink:href="vtrs-20211231.xsd#vtrs_A2027EuroSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6586cc55-6f3e-4de6-8be1-4a839d39133d" xlink:to="loc_vtrs_A2027EuroSeniorNotesMember_269ba71b-3cad-4a36-9ed8-12bb9f2d14ec" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2032EuroSeniorNotesMember_67c2b74a-4020-43ba-90e8-234d674986b8" xlink:href="vtrs-20211231.xsd#vtrs_A2032EuroSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6586cc55-6f3e-4de6-8be1-4a839d39133d" xlink:to="loc_vtrs_A2032EuroSeniorNotesMember_67c2b74a-4020-43ba-90e8-234d674986b8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2028EuroSeniorNotesMember_8b550215-9003-487f-890a-ff97c1d50ed3" xlink:href="vtrs-20211231.xsd#vtrs_A2028EuroSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6586cc55-6f3e-4de6-8be1-4a839d39133d" xlink:to="loc_vtrs_A2028EuroSeniorNotesMember_8b550215-9003-487f-890a-ff97c1d50ed3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2020FloatingRateEuroNotesMember_345ae3b0-7871-4ac4-9061-489f29d82729" xlink:href="vtrs-20211231.xsd#vtrs_A2020FloatingRateEuroNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6586cc55-6f3e-4de6-8be1-4a839d39133d" xlink:to="loc_vtrs_A2020FloatingRateEuroNotesMember_345ae3b0-7871-4ac4-9061-489f29d82729" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember_cb78be0c-d0dc-4eaa-b9d8-6cf9a0bdf595" xlink:href="vtrs-20211231.xsd#vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6586cc55-6f3e-4de6-8be1-4a839d39133d" xlink:to="loc_vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember_cb78be0c-d0dc-4eaa-b9d8-6cf9a0bdf595" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_YENTermLoanMember_e23d368e-fded-4398-8cc9-b662a77d4a5d" xlink:href="vtrs-20211231.xsd#vtrs_YENTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6586cc55-6f3e-4de6-8be1-4a839d39133d" xlink:to="loc_vtrs_YENTermLoanMember_e23d368e-fded-4398-8cc9-b662a77d4a5d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_28a2b7c8-118d-4b73-8a34-dc1cd985f098" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_fdaa4ec9-59a7-473b-bfac-67f9da29be23" xlink:to="loc_us-gaap_HedgingDesignationAxis_28a2b7c8-118d-4b73-8a34-dc1cd985f098" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_28a2b7c8-118d-4b73-8a34-dc1cd985f098_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_28a2b7c8-118d-4b73-8a34-dc1cd985f098" xlink:to="loc_us-gaap_HedgingDesignationDomain_28a2b7c8-118d-4b73-8a34-dc1cd985f098_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_ab80d2f9-50d2-4b72-9acc-32c831116fcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_28a2b7c8-118d-4b73-8a34-dc1cd985f098" xlink:to="loc_us-gaap_HedgingDesignationDomain_ab80d2f9-50d2-4b72-9acc-32c831116fcb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_e8d981b4-d923-4f0b-b3f5-9d26212ff49a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_ab80d2f9-50d2-4b72-9acc-32c831116fcb" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_e8d981b4-d923-4f0b-b3f5-9d26212ff49a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_c29c461e-e688-4645-995a-ab5459bfe15a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_fdaa4ec9-59a7-473b-bfac-67f9da29be23" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_c29c461e-e688-4645-995a-ab5459bfe15a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c29c461e-e688-4645-995a-ab5459bfe15a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c29c461e-e688-4645-995a-ab5459bfe15a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c29c461e-e688-4645-995a-ab5459bfe15a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e2ac5cdb-04dd-4528-87d0-dc1bd330fe8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c29c461e-e688-4645-995a-ab5459bfe15a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e2ac5cdb-04dd-4528-87d0-dc1bd330fe8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AgilaSpecialtiesPrivateLimitedMember_c68ab678-4b4b-4a83-9153-f46c97751a14" xlink:href="vtrs-20211231.xsd#vtrs_AgilaSpecialtiesPrivateLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e2ac5cdb-04dd-4528-87d0-dc1bd330fe8a" xlink:to="loc_vtrs_AgilaSpecialtiesPrivateLimitedMember_c68ab678-4b4b-4a83-9153-f46c97751a14" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_JaiPharmaLimitedMember_34c8492e-3e6c-476c-aacb-f28884b1b242" xlink:href="vtrs-20211231.xsd#vtrs_JaiPharmaLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e2ac5cdb-04dd-4528-87d0-dc1bd330fe8a" xlink:to="loc_vtrs_JaiPharmaLimitedMember_34c8492e-3e6c-476c-aacb-f28884b1b242" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RespiratorydeliveryplatformMember_ddc764fa-d4c9-498d-abb5-1ee59f21687c" xlink:href="vtrs-20211231.xsd#vtrs_RespiratorydeliveryplatformMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e2ac5cdb-04dd-4528-87d0-dc1bd330fe8a" xlink:to="loc_vtrs_RespiratorydeliveryplatformMember_ddc764fa-d4c9-498d-abb5-1ee59f21687c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4bec20b9-fe08-496b-b648-148616497ddc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_fdaa4ec9-59a7-473b-bfac-67f9da29be23" xlink:to="loc_srt_RangeAxis_4bec20b9-fe08-496b-b648-148616497ddc" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4bec20b9-fe08-496b-b648-148616497ddc_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_4bec20b9-fe08-496b-b648-148616497ddc" xlink:to="loc_srt_RangeMember_4bec20b9-fe08-496b-b648-148616497ddc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_602228fc-adf7-455c-8ae6-2ea50cb452d5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_4bec20b9-fe08-496b-b648-148616497ddc" xlink:to="loc_srt_RangeMember_602228fc-adf7-455c-8ae6-2ea50cb452d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_29b5cfe5-b048-4041-9cf4-23ab5fd7a359" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_602228fc-adf7-455c-8ae6-2ea50cb452d5" xlink:to="loc_srt_MinimumMember_29b5cfe5-b048-4041-9cf4-23ab5fd7a359" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c87b3586-511f-409f-8f88-e63141bb37c7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_602228fc-adf7-455c-8ae6-2ea50cb452d5" xlink:to="loc_srt_MaximumMember_c87b3586-511f-409f-8f88-e63141bb37c7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementDerivativesDesignatedasHedgingInstrumentsFairValuesofDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#FinancialInstrumentsandRiskManagementDerivativesDesignatedasHedgingInstrumentsFairValuesofDerivativeInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementDerivativesDesignatedasHedgingInstrumentsFairValuesofDerivativeInstrumentsDetails" xlink:type="extended" id="i3f0ed7de7324405298319357bb69c60c_FinancialInstrumentsandRiskManagementDerivativesDesignatedasHedgingInstrumentsFairValuesofDerivativeInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_41377d5f-dbf0-4a46-8ea0-ad7df5ceb14c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_a978f67f-6d1b-4d14-89db-1315a2ffb5cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_41377d5f-dbf0-4a46-8ea0-ad7df5ceb14c" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_a978f67f-6d1b-4d14-89db-1315a2ffb5cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_72c7371d-0bb6-48f8-8920-c460277e43cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_41377d5f-dbf0-4a46-8ea0-ad7df5ceb14c" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_72c7371d-0bb6-48f8-8920-c460277e43cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_7b5335d2-bb91-4dc2-bbf8-a692a30c91bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_41377d5f-dbf0-4a46-8ea0-ad7df5ceb14c" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_7b5335d2-bb91-4dc2-bbf8-a692a30c91bd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_13c64e5f-dc0b-426f-a180-dde7ed6c29d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_7b5335d2-bb91-4dc2-bbf8-a692a30c91bd" xlink:to="loc_us-gaap_HedgingDesignationAxis_13c64e5f-dc0b-426f-a180-dde7ed6c29d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_13c64e5f-dc0b-426f-a180-dde7ed6c29d8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_13c64e5f-dc0b-426f-a180-dde7ed6c29d8" xlink:to="loc_us-gaap_HedgingDesignationDomain_13c64e5f-dc0b-426f-a180-dde7ed6c29d8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_fb1097b2-8fef-47cc-9952-a2721ea646df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_13c64e5f-dc0b-426f-a180-dde7ed6c29d8" xlink:to="loc_us-gaap_HedgingDesignationDomain_fb1097b2-8fef-47cc-9952-a2721ea646df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_aab4ed80-7da8-4f15-b133-ee94d017d588" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_fb1097b2-8fef-47cc-9952-a2721ea646df" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_aab4ed80-7da8-4f15-b133-ee94d017d588" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_9b71ad5f-0167-44d2-a35b-5a6e940ec219" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_7b5335d2-bb91-4dc2-bbf8-a692a30c91bd" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_9b71ad5f-0167-44d2-a35b-5a6e940ec219" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_9b71ad5f-0167-44d2-a35b-5a6e940ec219_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_9b71ad5f-0167-44d2-a35b-5a6e940ec219" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_9b71ad5f-0167-44d2-a35b-5a6e940ec219_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_2c9038d2-42d5-4ad0-8c28-da646a34dfd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_9b71ad5f-0167-44d2-a35b-5a6e940ec219" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_2c9038d2-42d5-4ad0-8c28-da646a34dfd6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_0bde090e-91b4-43d8-ae9d-3f5071a32a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_2c9038d2-42d5-4ad0-8c28-da646a34dfd6" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_0bde090e-91b4-43d8-ae9d-3f5071a32a9d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_ced2f9f4-2ad9-4f2a-b3a1-b0100a725e23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_2c9038d2-42d5-4ad0-8c28-da646a34dfd6" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_ced2f9f4-2ad9-4f2a-b3a1-b0100a725e23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_becb0305-5120-4087-a2eb-5eca155942cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_7b5335d2-bb91-4dc2-bbf8-a692a30c91bd" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_becb0305-5120-4087-a2eb-5eca155942cb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_becb0305-5120-4087-a2eb-5eca155942cb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_becb0305-5120-4087-a2eb-5eca155942cb" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_becb0305-5120-4087-a2eb-5eca155942cb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c910c8fa-3f91-448a-9a66-8ce675cafee4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_becb0305-5120-4087-a2eb-5eca155942cb" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c910c8fa-3f91-448a-9a66-8ce675cafee4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_2d1bc01e-4587-4f1a-a6fe-0098a342a060" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c910c8fa-3f91-448a-9a66-8ce675cafee4" xlink:to="loc_us-gaap_InterestRateSwapMember_2d1bc01e-4587-4f1a-a6fe-0098a342a060" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_bf0465ea-9faa-4122-818b-35aceadc7452" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c910c8fa-3f91-448a-9a66-8ce675cafee4" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_bf0465ea-9faa-4122-818b-35aceadc7452" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementDerivativesNotDesignatedasHedgingInstrumentsFairValuesofDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#FinancialInstrumentsandRiskManagementDerivativesNotDesignatedasHedgingInstrumentsFairValuesofDerivativeInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementDerivativesNotDesignatedasHedgingInstrumentsFairValuesofDerivativeInstrumentsDetails" xlink:type="extended" id="i0f3614d0f2fa4b7ba58872c04388b973_FinancialInstrumentsandRiskManagementDerivativesNotDesignatedasHedgingInstrumentsFairValuesofDerivativeInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_764dd8f1-eced-4dce-9e80-d2552dbdbba1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_79ced589-e12e-47b3-983e-4f457d43abe7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_764dd8f1-eced-4dce-9e80-d2552dbdbba1" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_79ced589-e12e-47b3-983e-4f457d43abe7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_ea986d75-8749-482e-8ad9-e0bb3d4beb64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_764dd8f1-eced-4dce-9e80-d2552dbdbba1" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_ea986d75-8749-482e-8ad9-e0bb3d4beb64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_71a7cd09-5e7f-4f1f-acde-7ebd3e641e40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_764dd8f1-eced-4dce-9e80-d2552dbdbba1" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_71a7cd09-5e7f-4f1f-acde-7ebd3e641e40" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_11ea26e2-9eb6-460e-91d1-3a9fedf86b48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_71a7cd09-5e7f-4f1f-acde-7ebd3e641e40" xlink:to="loc_us-gaap_HedgingDesignationAxis_11ea26e2-9eb6-460e-91d1-3a9fedf86b48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_11ea26e2-9eb6-460e-91d1-3a9fedf86b48_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_11ea26e2-9eb6-460e-91d1-3a9fedf86b48" xlink:to="loc_us-gaap_HedgingDesignationDomain_11ea26e2-9eb6-460e-91d1-3a9fedf86b48_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_37823aa7-95e4-45f5-a6e6-9d61be54e609" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_11ea26e2-9eb6-460e-91d1-3a9fedf86b48" xlink:to="loc_us-gaap_HedgingDesignationDomain_37823aa7-95e4-45f5-a6e6-9d61be54e609" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_f5af890f-7670-4b66-9785-4f59bfa93a99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_37823aa7-95e4-45f5-a6e6-9d61be54e609" xlink:to="loc_us-gaap_NondesignatedMember_f5af890f-7670-4b66-9785-4f59bfa93a99" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_c8f99a67-1d29-49cc-a6d2-08ac9db95dfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_71a7cd09-5e7f-4f1f-acde-7ebd3e641e40" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_c8f99a67-1d29-49cc-a6d2-08ac9db95dfd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c8f99a67-1d29-49cc-a6d2-08ac9db95dfd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c8f99a67-1d29-49cc-a6d2-08ac9db95dfd" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c8f99a67-1d29-49cc-a6d2-08ac9db95dfd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_ace4bb6f-b763-4786-a3f6-fb9ec57d455c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c8f99a67-1d29-49cc-a6d2-08ac9db95dfd" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_ace4bb6f-b763-4786-a3f6-fb9ec57d455c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_657930b9-c463-496d-bef3-24979beba9ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_ace4bb6f-b763-4786-a3f6-fb9ec57d455c" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_657930b9-c463-496d-bef3-24979beba9ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_651f0881-53b8-44fb-a5b9-71b77df86fc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_ace4bb6f-b763-4786-a3f6-fb9ec57d455c" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_651f0881-53b8-44fb-a5b9-71b77df86fc1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8b809bc4-4a18-4bfa-abe2-087ecfd1c3dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_71a7cd09-5e7f-4f1f-acde-7ebd3e641e40" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8b809bc4-4a18-4bfa-abe2-087ecfd1c3dd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8b809bc4-4a18-4bfa-abe2-087ecfd1c3dd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8b809bc4-4a18-4bfa-abe2-087ecfd1c3dd" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8b809bc4-4a18-4bfa-abe2-087ecfd1c3dd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0f97477e-6b0a-4784-9167-5f307aaef668" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8b809bc4-4a18-4bfa-abe2-087ecfd1c3dd" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0f97477e-6b0a-4784-9167-5f307aaef668" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_45693331-be3d-4b35-a2db-1ec03047cae8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0f97477e-6b0a-4784-9167-5f307aaef668" xlink:to="loc_us-gaap_ForeignExchangeContractMember_45693331-be3d-4b35-a2db-1ec03047cae8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails" xlink:type="extended" id="i0c1529f6fb304c90a080e8f614c0269e_FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_86ba2d5a-aa48-4a1e-a9be-b4ab81a149f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_1ae3c708-493d-483b-b44e-f9d363528af3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_86ba2d5a-aa48-4a1e-a9be-b4ab81a149f8" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_1ae3c708-493d-483b-b44e-f9d363528af3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_4d429f9a-ab48-48cc-a6b8-e7b2daaef07e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_86ba2d5a-aa48-4a1e-a9be-b4ab81a149f8" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_4d429f9a-ab48-48cc-a6b8-e7b2daaef07e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_5e056563-29c5-46a3-a6c7-40fdba4370f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_86ba2d5a-aa48-4a1e-a9be-b4ab81a149f8" xlink:to="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_5e056563-29c5-46a3-a6c7-40fdba4370f8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_bd9390a4-d4d9-4354-8bcd-f10ca0361579" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_86ba2d5a-aa48-4a1e-a9be-b4ab81a149f8" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_bd9390a4-d4d9-4354-8bcd-f10ca0361579" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e66047ef-7719-4443-a2b9-26aece08d566" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_bd9390a4-d4d9-4354-8bcd-f10ca0361579" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e66047ef-7719-4443-a2b9-26aece08d566" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_e66047ef-7719-4443-a2b9-26aece08d566_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e66047ef-7719-4443-a2b9-26aece08d566" xlink:to="loc_us-gaap_HedgingRelationshipDomain_e66047ef-7719-4443-a2b9-26aece08d566_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_ed0a132c-6d63-4f07-803f-53f1ad68f846" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e66047ef-7719-4443-a2b9-26aece08d566" xlink:to="loc_us-gaap_HedgingRelationshipDomain_ed0a132c-6d63-4f07-803f-53f1ad68f846" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_3318f31b-7c66-4e86-9b58-acbb05b756ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_ed0a132c-6d63-4f07-803f-53f1ad68f846" xlink:to="loc_us-gaap_FairValueHedgingMember_3318f31b-7c66-4e86-9b58-acbb05b756ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_47452790-9fbd-4342-8c79-732dd312f2c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_bd9390a4-d4d9-4354-8bcd-f10ca0361579" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_47452790-9fbd-4342-8c79-732dd312f2c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_47452790-9fbd-4342-8c79-732dd312f2c1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_47452790-9fbd-4342-8c79-732dd312f2c1" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_47452790-9fbd-4342-8c79-732dd312f2c1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_577400da-e2b8-40d9-97aa-6f0bf9203a4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_47452790-9fbd-4342-8c79-732dd312f2c1" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_577400da-e2b8-40d9-97aa-6f0bf9203a4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_e8de72d4-0356-45ea-b024-0859268bcb29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_577400da-e2b8-40d9-97aa-6f0bf9203a4c" xlink:to="loc_us-gaap_InterestExpenseMember_e8de72d4-0356-45ea-b024-0859268bcb29" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenseMember_ebea0b72-c894-4107-af00-d089ad1176b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_577400da-e2b8-40d9-97aa-6f0bf9203a4c" xlink:to="loc_us-gaap_OtherExpenseMember_ebea0b72-c894-4107-af00-d089ad1176b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_a7398035-78fc-4d0e-8dea-6ed5ec2e9b2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_bd9390a4-d4d9-4354-8bcd-f10ca0361579" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_a7398035-78fc-4d0e-8dea-6ed5ec2e9b2a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a7398035-78fc-4d0e-8dea-6ed5ec2e9b2a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_a7398035-78fc-4d0e-8dea-6ed5ec2e9b2a" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a7398035-78fc-4d0e-8dea-6ed5ec2e9b2a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c784d4d3-ce4a-47b1-be2b-e83fe5f5b4fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_a7398035-78fc-4d0e-8dea-6ed5ec2e9b2a" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c784d4d3-ce4a-47b1-be2b-e83fe5f5b4fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_31793d1c-9207-437e-9619-a852554884bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c784d4d3-ce4a-47b1-be2b-e83fe5f5b4fb" xlink:to="loc_us-gaap_InterestRateSwapMember_31793d1c-9207-437e-9619-a852554884bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember_40e00c16-0d04-483f-965c-5713dc4e3e53" xlink:href="vtrs-20211231.xsd#vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c784d4d3-ce4a-47b1-be2b-e83fe5f5b4fb" xlink:to="loc_vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember_40e00c16-0d04-483f-965c-5713dc4e3e53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_6960e4c7-6094-4637-a9ac-c0a9ae282a5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c784d4d3-ce4a-47b1-be2b-e83fe5f5b4fb" xlink:to="loc_us-gaap_ForeignExchangeContractMember_6960e4c7-6094-4637-a9ac-c0a9ae282a5c" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofComprehensiveEarningsDerivativesinCashFlowHedgingRelationshipsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofComprehensiveEarningsDerivativesinCashFlowHedgingRelationshipsDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofComprehensiveEarningsDerivativesinCashFlowHedgingRelationshipsDetails" xlink:type="extended" id="ie113d71431934cdba1b5b29399590785_FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofComprehensiveEarningsDerivativesinCashFlowHedgingRelationshipsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c3cc7f0e-1b31-4d56-82b3-846a96135c2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet_1435c8ce-3c86-4705-975a-280f0b7c10e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c3cc7f0e-1b31-4d56-82b3-846a96135c2b" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet_1435c8ce-3c86-4705-975a-280f0b7c10e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_da78c9f4-7d81-473a-b798-ff86f7be9ada" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c3cc7f0e-1b31-4d56-82b3-846a96135c2b" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_da78c9f4-7d81-473a-b798-ff86f7be9ada" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_7634cb0d-b8b1-42dc-8fdf-b8c1941eb5f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_da78c9f4-7d81-473a-b798-ff86f7be9ada" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_7634cb0d-b8b1-42dc-8fdf-b8c1941eb5f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7634cb0d-b8b1-42dc-8fdf-b8c1941eb5f3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7634cb0d-b8b1-42dc-8fdf-b8c1941eb5f3" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7634cb0d-b8b1-42dc-8fdf-b8c1941eb5f3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c5336f7d-56ef-4372-b920-0f4ba6f4b9ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7634cb0d-b8b1-42dc-8fdf-b8c1941eb5f3" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c5336f7d-56ef-4372-b920-0f4ba6f4b9ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_4b6ac326-c682-4eb4-b86f-e1ed0b66cc11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c5336f7d-56ef-4372-b920-0f4ba6f4b9ad" xlink:to="loc_us-gaap_ForeignExchangeContractMember_4b6ac326-c682-4eb4-b86f-e1ed0b66cc11" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_ca98a199-928a-4089-8a60-245ee940867e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_da78c9f4-7d81-473a-b798-ff86f7be9ada" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_ca98a199-928a-4089-8a60-245ee940867e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_ca98a199-928a-4089-8a60-245ee940867e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_ca98a199-928a-4089-8a60-245ee940867e" xlink:to="loc_us-gaap_HedgingRelationshipDomain_ca98a199-928a-4089-8a60-245ee940867e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_e6a0131b-222e-4177-9331-d2d713fc79fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_ca98a199-928a-4089-8a60-245ee940867e" xlink:to="loc_us-gaap_HedgingRelationshipDomain_e6a0131b-222e-4177-9331-d2d713fc79fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_7805a7bd-d3d4-4d65-95fb-39da1646aaa7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_e6a0131b-222e-4177-9331-d2d713fc79fd" xlink:to="loc_us-gaap_CashFlowHedgingMember_7805a7bd-d3d4-4d65-95fb-39da1646aaa7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_b87eb870-43b0-4898-b8c6-64388f7e99c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_da78c9f4-7d81-473a-b798-ff86f7be9ada" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_b87eb870-43b0-4898-b8c6-64388f7e99c0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b87eb870-43b0-4898-b8c6-64388f7e99c0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b87eb870-43b0-4898-b8c6-64388f7e99c0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b87eb870-43b0-4898-b8c6-64388f7e99c0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8ba4ddb6-e137-4b8c-9a61-45f756a5c27c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b87eb870-43b0-4898-b8c6-64388f7e99c0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8ba4ddb6-e137-4b8c-9a61-45f756a5c27c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenseMember_4f20f6e3-7b6b-4aa8-ae77-b4a164367d12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8ba4ddb6-e137-4b8c-9a61-45f756a5c27c" xlink:to="loc_us-gaap_OtherExpenseMember_4f20f6e3-7b6b-4aa8-ae77-b4a164367d12" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinNetInvestmentHedgingRelationshipDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinNetInvestmentHedgingRelationshipDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinNetInvestmentHedgingRelationshipDetails" xlink:type="extended" id="iad8b2523f87d43f580ebc1f1e88f6f59_FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinNetInvestmentHedgingRelationshipDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_f474208d-12ae-4a9b-83e5-bfd5f55bb6ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_60254f5b-4b57-40b8-b9e2-331b7f7e5dd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_f474208d-12ae-4a9b-83e5-bfd5f55bb6ce" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_60254f5b-4b57-40b8-b9e2-331b7f7e5dd7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_732238c1-93cf-477a-b34b-2bb283a3a939" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_f474208d-12ae-4a9b-83e5-bfd5f55bb6ce" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_732238c1-93cf-477a-b34b-2bb283a3a939" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_2e2c39af-bb6f-45ac-82dc-b0c3f002c7ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_f474208d-12ae-4a9b-83e5-bfd5f55bb6ce" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_2e2c39af-bb6f-45ac-82dc-b0c3f002c7ec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_c3140acf-d198-4fe7-9a7e-eee4dd8ec7fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_f474208d-12ae-4a9b-83e5-bfd5f55bb6ce" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_c3140acf-d198-4fe7-9a7e-eee4dd8ec7fc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a5a92143-4dca-4801-9c33-9fd8ebeec224" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_c3140acf-d198-4fe7-9a7e-eee4dd8ec7fc" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a5a92143-4dca-4801-9c33-9fd8ebeec224" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a5a92143-4dca-4801-9c33-9fd8ebeec224_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a5a92143-4dca-4801-9c33-9fd8ebeec224" xlink:to="loc_us-gaap_EquityComponentDomain_a5a92143-4dca-4801-9c33-9fd8ebeec224_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_53025a8e-0b37-47ae-81a4-357ad30ab19c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a5a92143-4dca-4801-9c33-9fd8ebeec224" xlink:to="loc_us-gaap_EquityComponentDomain_53025a8e-0b37-47ae-81a4-357ad30ab19c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_34d5377c-8b96-4a13-9202-b2a726341e8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_53025a8e-0b37-47ae-81a4-357ad30ab19c" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_34d5377c-8b96-4a13-9202-b2a726341e8e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_c53a4e04-db8e-443b-a761-d639c54a9bd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_c3140acf-d198-4fe7-9a7e-eee4dd8ec7fc" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_c53a4e04-db8e-443b-a761-d639c54a9bd6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c53a4e04-db8e-443b-a761-d639c54a9bd6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c53a4e04-db8e-443b-a761-d639c54a9bd6" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c53a4e04-db8e-443b-a761-d639c54a9bd6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ee7ee172-1041-42eb-bdee-7b31aeac3e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c53a4e04-db8e-443b-a761-d639c54a9bd6" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ee7ee172-1041-42eb-bdee-7b31aeac3e1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_b7df3eb2-4eab-40f7-bae2-784d5d6bf536" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ee7ee172-1041-42eb-bdee-7b31aeac3e1b" xlink:to="loc_us-gaap_ForeignExchangeContractMember_b7df3eb2-4eab-40f7-bae2-784d5d6bf536" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_c88c4d65-6fa6-4a3e-a98b-ff26a60bbd89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ee7ee172-1041-42eb-bdee-7b31aeac3e1b" xlink:to="loc_us-gaap_InterestRateSwapMember_c88c4d65-6fa6-4a3e-a98b-ff26a60bbd89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7926d364-0f9d-40a7-9b75-9d13ab8171cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_c3140acf-d198-4fe7-9a7e-eee4dd8ec7fc" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7926d364-0f9d-40a7-9b75-9d13ab8171cd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_7926d364-0f9d-40a7-9b75-9d13ab8171cd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7926d364-0f9d-40a7-9b75-9d13ab8171cd" xlink:to="loc_us-gaap_HedgingRelationshipDomain_7926d364-0f9d-40a7-9b75-9d13ab8171cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_d9ec91fe-6204-469d-9ecb-74682ccacb4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7926d364-0f9d-40a7-9b75-9d13ab8171cd" xlink:to="loc_us-gaap_HedgingRelationshipDomain_d9ec91fe-6204-469d-9ecb-74682ccacb4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_5c21f89f-b0a5-4bee-a497-42c54a46ddf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_d9ec91fe-6204-469d-9ecb-74682ccacb4f" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_5c21f89f-b0a5-4bee-a497-42c54a46ddf5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_caf9f5f0-4a4b-4214-a033-2730843b31f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_d9ec91fe-6204-469d-9ecb-74682ccacb4f" xlink:to="loc_us-gaap_CashFlowHedgingMember_caf9f5f0-4a4b-4214-a033-2730843b31f9" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails" xlink:type="extended" id="i9f77c6d60ad34ed390627fae51ae3afa_FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_8f9b7f4a-d1ef-460b-83b4-3f786e6cd9af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet_31a6ce98-7a45-4726-81e5-444f72fa63a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_8f9b7f4a-d1ef-460b-83b4-3f786e6cd9af" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet_31a6ce98-7a45-4726-81e5-444f72fa63a7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_cd166b32-d8a3-43e0-9c3b-0accbadcb6e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_8f9b7f4a-d1ef-460b-83b4-3f786e6cd9af" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_cd166b32-d8a3-43e0-9c3b-0accbadcb6e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_c3863d45-5c90-4ab8-9f40-574911701831" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_8f9b7f4a-d1ef-460b-83b4-3f786e6cd9af" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_c3863d45-5c90-4ab8-9f40-574911701831" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_716117b8-aa6c-431d-9a5b-7a6705efc11d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_8f9b7f4a-d1ef-460b-83b4-3f786e6cd9af" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_716117b8-aa6c-431d-9a5b-7a6705efc11d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_269a49b8-143d-4f75-b214-86c5a36b0cea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_8f9b7f4a-d1ef-460b-83b4-3f786e6cd9af" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_269a49b8-143d-4f75-b214-86c5a36b0cea" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_18b2f2e6-6136-4ca2-8c34-e46b5cdca026" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_269a49b8-143d-4f75-b214-86c5a36b0cea" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_18b2f2e6-6136-4ca2-8c34-e46b5cdca026" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_18b2f2e6-6136-4ca2-8c34-e46b5cdca026_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_18b2f2e6-6136-4ca2-8c34-e46b5cdca026" xlink:to="loc_us-gaap_HedgingRelationshipDomain_18b2f2e6-6136-4ca2-8c34-e46b5cdca026_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_e0b5f686-774b-4229-a0a6-a959ab9085e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_18b2f2e6-6136-4ca2-8c34-e46b5cdca026" xlink:to="loc_us-gaap_HedgingRelationshipDomain_e0b5f686-774b-4229-a0a6-a959ab9085e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_d19d4df1-e503-4f3d-8265-aa25094c9294" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_e0b5f686-774b-4229-a0a6-a959ab9085e9" xlink:to="loc_us-gaap_CashFlowHedgingMember_d19d4df1-e503-4f3d-8265-aa25094c9294" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_5a6923b5-5e88-4b98-8f35-8180e6195b76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_269a49b8-143d-4f75-b214-86c5a36b0cea" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_5a6923b5-5e88-4b98-8f35-8180e6195b76" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5a6923b5-5e88-4b98-8f35-8180e6195b76_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5a6923b5-5e88-4b98-8f35-8180e6195b76" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5a6923b5-5e88-4b98-8f35-8180e6195b76_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b6ca6750-6912-4109-88b4-b17d1c2620ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5a6923b5-5e88-4b98-8f35-8180e6195b76" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b6ca6750-6912-4109-88b4-b17d1c2620ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_6bffddf1-69e5-4790-b63d-f34ccc73eceb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b6ca6750-6912-4109-88b4-b17d1c2620ec" xlink:to="loc_us-gaap_ForeignExchangeContractMember_6bffddf1-69e5-4790-b63d-f34ccc73eceb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_859d30c2-c981-49ca-acd0-1c42f6d3225b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b6ca6750-6912-4109-88b4-b17d1c2620ec" xlink:to="loc_us-gaap_InterestRateSwapMember_859d30c2-c981-49ca-acd0-1c42f6d3225b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_bc81e2fb-9dd2-4085-9df8-6bd14eb74dcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_269a49b8-143d-4f75-b214-86c5a36b0cea" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_bc81e2fb-9dd2-4085-9df8-6bd14eb74dcd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_bc81e2fb-9dd2-4085-9df8-6bd14eb74dcd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_bc81e2fb-9dd2-4085-9df8-6bd14eb74dcd" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_bc81e2fb-9dd2-4085-9df8-6bd14eb74dcd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2cc3ad3c-3a65-4131-9e4b-f4e492213c3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_bc81e2fb-9dd2-4085-9df8-6bd14eb74dcd" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2cc3ad3c-3a65-4131-9e4b-f4e492213c3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember_ebca3525-00c8-4c55-8fb6-b55783f99dc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2cc3ad3c-3a65-4131-9e4b-f4e492213c3f" xlink:to="loc_us-gaap_SalesMember_ebca3525-00c8-4c55-8fb6-b55783f99dc2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_42f999aa-68d1-4b09-adaa-88fafea679b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2cc3ad3c-3a65-4131-9e4b-f4e492213c3f" xlink:to="loc_us-gaap_InterestExpenseMember_42f999aa-68d1-4b09-adaa-88fafea679b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenseMember_954e480b-e329-41e8-8bc8-6d533a9bbd9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2cc3ad3c-3a65-4131-9e4b-f4e492213c3f" xlink:to="loc_us-gaap_OtherExpenseMember_954e480b-e329-41e8-8bc8-6d533a9bbd9c" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesNotDesignatedasHedgingInstrumentsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesNotDesignatedasHedgingInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesNotDesignatedasHedgingInstrumentsDetails" xlink:type="extended" id="i362a97272a654cefa2e860753447ddf4_FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesNotDesignatedasHedgingInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_8488be37-eec9-4e7e-b32a-aaa1abdeda6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_25bffdcc-09c0-4e6f-9ced-44084502869d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_8488be37-eec9-4e7e-b32a-aaa1abdeda6c" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_25bffdcc-09c0-4e6f-9ced-44084502869d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_d113bf07-fce7-4ab5-8e91-d2a4b17ae77f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_8488be37-eec9-4e7e-b32a-aaa1abdeda6c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_d113bf07-fce7-4ab5-8e91-d2a4b17ae77f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_10b31922-3109-411d-881a-b0848b11406e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_8488be37-eec9-4e7e-b32a-aaa1abdeda6c" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_10b31922-3109-411d-881a-b0848b11406e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b92977fe-b1a4-4595-bcea-4554a524ad68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_10b31922-3109-411d-881a-b0848b11406e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b92977fe-b1a4-4595-bcea-4554a524ad68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_b92977fe-b1a4-4595-bcea-4554a524ad68_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b92977fe-b1a4-4595-bcea-4554a524ad68" xlink:to="loc_us-gaap_HedgingRelationshipDomain_b92977fe-b1a4-4595-bcea-4554a524ad68_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_152a76f6-2a55-4229-8e49-1504217650d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b92977fe-b1a4-4595-bcea-4554a524ad68" xlink:to="loc_us-gaap_HedgingRelationshipDomain_152a76f6-2a55-4229-8e49-1504217650d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_303a1954-3e26-42d1-aa5f-6e144f22a76f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_152a76f6-2a55-4229-8e49-1504217650d2" xlink:to="loc_us-gaap_CashFlowHedgingMember_303a1954-3e26-42d1-aa5f-6e144f22a76f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_2c2e9cfb-64cd-4436-bf34-8efaa4f54aea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_10b31922-3109-411d-881a-b0848b11406e" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_2c2e9cfb-64cd-4436-bf34-8efaa4f54aea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_2c2e9cfb-64cd-4436-bf34-8efaa4f54aea_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_2c2e9cfb-64cd-4436-bf34-8efaa4f54aea" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_2c2e9cfb-64cd-4436-bf34-8efaa4f54aea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b1973fc3-c1fe-4417-84a2-dfb13d6b73de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_2c2e9cfb-64cd-4436-bf34-8efaa4f54aea" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b1973fc3-c1fe-4417-84a2-dfb13d6b73de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_d730fce1-b1e2-4b60-9a68-87ab0811464b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b1973fc3-c1fe-4417-84a2-dfb13d6b73de" xlink:to="loc_us-gaap_ForeignExchangeContractMember_d730fce1-b1e2-4b60-9a68-87ab0811464b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_7ef51d6e-8637-402c-93c3-898a10ac5a8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b1973fc3-c1fe-4417-84a2-dfb13d6b73de" xlink:to="loc_us-gaap_InterestRateSwapMember_7ef51d6e-8637-402c-93c3-898a10ac5a8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_28d8846a-9594-4ef7-90f0-dfa71a530050" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_10b31922-3109-411d-881a-b0848b11406e" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_28d8846a-9594-4ef7-90f0-dfa71a530050" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_28d8846a-9594-4ef7-90f0-dfa71a530050_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_28d8846a-9594-4ef7-90f0-dfa71a530050" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_28d8846a-9594-4ef7-90f0-dfa71a530050_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c812f693-270a-4770-b4ce-8a677b383fed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_28d8846a-9594-4ef7-90f0-dfa71a530050" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c812f693-270a-4770-b4ce-8a677b383fed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember_adb94f61-2aa0-4c04-8750-84176d858ceb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c812f693-270a-4770-b4ce-8a677b383fed" xlink:to="loc_us-gaap_SalesMember_adb94f61-2aa0-4c04-8750-84176d858ceb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_f5af5bd9-16c9-4440-902b-47d192c5d925" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c812f693-270a-4770-b4ce-8a677b383fed" xlink:to="loc_us-gaap_InterestExpenseMember_f5af5bd9-16c9-4440-902b-47d192c5d925" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails" xlink:type="extended" id="i8329d70230084d68a035c791770f7c75_FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1776a89e-c6a4-4ce5-b5bd-bc01cfbb8d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_b1e162da-497d-4c47-ae01-a8e8fd4ff59a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1776a89e-c6a4-4ce5-b5bd-bc01cfbb8d5e" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_b1e162da-497d-4c47-ae01-a8e8fd4ff59a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_ef4090fa-9f4d-43a1-8763-a306c284202f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1776a89e-c6a4-4ce5-b5bd-bc01cfbb8d5e" xlink:to="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_ef4090fa-9f4d-43a1-8763-a306c284202f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_75674cc2-46e5-4116-9c4e-15cb9b981568" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1776a89e-c6a4-4ce5-b5bd-bc01cfbb8d5e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_75674cc2-46e5-4116-9c4e-15cb9b981568" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_ff3a6207-3c42-4153-ad38-c8bac91833fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1776a89e-c6a4-4ce5-b5bd-bc01cfbb8d5e" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_ff3a6207-3c42-4153-ad38-c8bac91833fc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_8b4355b8-4b75-4ed5-bf89-8fff499d72fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1776a89e-c6a4-4ce5-b5bd-bc01cfbb8d5e" xlink:to="loc_us-gaap_DerivativeAssets_8b4355b8-4b75-4ed5-bf89-8fff499d72fb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_b9721dce-2962-4cb0-8cbf-34923bd88a5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1776a89e-c6a4-4ce5-b5bd-bc01cfbb8d5e" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_b9721dce-2962-4cb0-8cbf-34923bd88a5a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_f84a35c6-735f-4675-9b5d-9d06796b6e50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1776a89e-c6a4-4ce5-b5bd-bc01cfbb8d5e" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_f84a35c6-735f-4675-9b5d-9d06796b6e50" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesFairValueDisclosure_80bc0782-18d5-4ce0-a8cb-99361e9ce44c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1776a89e-c6a4-4ce5-b5bd-bc01cfbb8d5e" xlink:to="loc_us-gaap_OtherLiabilitiesFairValueDisclosure_80bc0782-18d5-4ce0-a8cb-99361e9ce44c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_8b234e72-80f4-4697-9ee7-6d56cfd2de41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1776a89e-c6a4-4ce5-b5bd-bc01cfbb8d5e" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_8b234e72-80f4-4697-9ee7-6d56cfd2de41" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_de93329f-f03e-4025-9153-271d114f400a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1776a89e-c6a4-4ce5-b5bd-bc01cfbb8d5e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_de93329f-f03e-4025-9153-271d114f400a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7fd64082-9cef-42cb-a2bc-3cb514673fee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_de93329f-f03e-4025-9153-271d114f400a" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7fd64082-9cef-42cb-a2bc-3cb514673fee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7fd64082-9cef-42cb-a2bc-3cb514673fee_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7fd64082-9cef-42cb-a2bc-3cb514673fee" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7fd64082-9cef-42cb-a2bc-3cb514673fee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_21bfcc2a-e2f9-4881-9c5a-b5176eb48405" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7fd64082-9cef-42cb-a2bc-3cb514673fee" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_21bfcc2a-e2f9-4881-9c5a-b5176eb48405" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_50220a39-3021-412f-b496-e97965065d6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_21bfcc2a-e2f9-4881-9c5a-b5176eb48405" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_50220a39-3021-412f-b496-e97965065d6c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_d0fbaf2e-2aa6-442b-bad7-f76c64750c28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_21bfcc2a-e2f9-4881-9c5a-b5176eb48405" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_d0fbaf2e-2aa6-442b-bad7-f76c64750c28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_5ec36a85-cad9-495d-9d12-f876cf38d3b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_21bfcc2a-e2f9-4881-9c5a-b5176eb48405" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_5ec36a85-cad9-495d-9d12-f876cf38d3b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_2c2c93e8-84cf-4ee3-b15f-66b0e5359b77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_de93329f-f03e-4025-9153-271d114f400a" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_2c2c93e8-84cf-4ee3-b15f-66b0e5359b77" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_2c2c93e8-84cf-4ee3-b15f-66b0e5359b77_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_2c2c93e8-84cf-4ee3-b15f-66b0e5359b77" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_2c2c93e8-84cf-4ee3-b15f-66b0e5359b77_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_fb0b5d1d-bfec-4db2-ac19-b84fde48760f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_2c2c93e8-84cf-4ee3-b15f-66b0e5359b77" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_fb0b5d1d-bfec-4db2-ac19-b84fde48760f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_9b6e4187-1d8a-46b0-8154-fc3846d3f7cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_fb0b5d1d-bfec-4db2-ac19-b84fde48760f" xlink:to="loc_us-gaap_MoneyMarketFundsMember_9b6e4187-1d8a-46b0-8154-fc3846d3f7cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExchangeTradedFundsMember_337a6792-9a37-42d9-9371-fa41684d1d27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExchangeTradedFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_fb0b5d1d-bfec-4db2-ac19-b84fde48760f" xlink:to="loc_us-gaap_ExchangeTradedFundsMember_337a6792-9a37-42d9-9371-fa41684d1d27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_b496af8f-84bc-4c08-8b6d-7239799a4716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_fb0b5d1d-bfec-4db2-ac19-b84fde48760f" xlink:to="loc_us-gaap_DebtSecuritiesMember_b496af8f-84bc-4c08-8b6d-7239799a4716" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_ab4d3901-ae43-44bc-bfab-94124425c239" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_b496af8f-84bc-4c08-8b6d-7239799a4716" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_ab4d3901-ae43-44bc-bfab-94124425c239" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_9e552933-ad41-4552-b4cb-3dc4270ec72f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_b496af8f-84bc-4c08-8b6d-7239799a4716" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_9e552933-ad41-4552-b4cb-3dc4270ec72f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesMember_bca02b55-4235-4069-9c12-261b6730e7ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_b496af8f-84bc-4c08-8b6d-7239799a4716" xlink:to="loc_us-gaap_MortgageBackedSecuritiesMember_bca02b55-4235-4069-9c12-261b6730e7ed" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_1460b864-4b2f-48e8-9194-50b7f784dcae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_b496af8f-84bc-4c08-8b6d-7239799a4716" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_1460b864-4b2f-48e8-9194-50b7f784dcae" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember_1744ca08-b4ea-4386-b57a-66326df4f1c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_b496af8f-84bc-4c08-8b6d-7239799a4716" xlink:to="loc_us-gaap_OtherDebtSecuritiesMember_1744ca08-b4ea-4386-b57a-66326df4f1c1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_43702ef6-79bc-4e4e-933d-5b1ab78cf5ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_fb0b5d1d-bfec-4db2-ac19-b84fde48760f" xlink:to="loc_us-gaap_EquitySecuritiesMember_43702ef6-79bc-4e4e-933d-5b1ab78cf5ce" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_d3336ea3-fd53-4410-aa2f-b810e35a96ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesMember_43702ef6-79bc-4e4e-933d-5b1ab78cf5ce" xlink:to="loc_us-gaap_CommonStockMember_d3336ea3-fd53-4410-aa2f-b810e35a96ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_962ff65e-50b8-4b6d-a135-3932f19a2bfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_fb0b5d1d-bfec-4db2-ac19-b84fde48760f" xlink:to="loc_us-gaap_InterestRateSwapMember_962ff65e-50b8-4b6d-a135-3932f19a2bfd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_MarketableSecuritiesMember_af47ee65-e48a-4954-90cf-7d38d3f55c72" xlink:href="vtrs-20211231.xsd#vtrs_MarketableSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_fb0b5d1d-bfec-4db2-ac19-b84fde48760f" xlink:to="loc_vtrs_MarketableSecuritiesMember_af47ee65-e48a-4954-90cf-7d38d3f55c72" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_d099fc6a-9880-4fef-bcb8-72cec41e93cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_de93329f-f03e-4025-9153-271d114f400a" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_d099fc6a-9880-4fef-bcb8-72cec41e93cb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_d099fc6a-9880-4fef-bcb8-72cec41e93cb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_d099fc6a-9880-4fef-bcb8-72cec41e93cb" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_d099fc6a-9880-4fef-bcb8-72cec41e93cb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_1a987101-cc27-41ae-a1eb-ce3db531f537" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_d099fc6a-9880-4fef-bcb8-72cec41e93cb" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_1a987101-cc27-41ae-a1eb-ce3db531f537" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_4fe096e0-0557-4c96-b0c1-373b172935ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_1a987101-cc27-41ae-a1eb-ce3db531f537" xlink:to="loc_us-gaap_ForeignExchangeContractMember_4fe096e0-0557-4c96-b0c1-373b172935ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_d29cec51-e7a5-47ab-a3ef-7b90fb08ff22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_1a987101-cc27-41ae-a1eb-ce3db531f537" xlink:to="loc_us-gaap_InterestRateSwapMember_d29cec51-e7a5-47ab-a3ef-7b90fb08ff22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ContingentConsiderationMember_ffd80bea-abb8-40da-912e-a1cf41582511" xlink:href="vtrs-20211231.xsd#vtrs_ContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_1a987101-cc27-41ae-a1eb-ce3db531f537" xlink:to="loc_vtrs_ContingentConsiderationMember_ffd80bea-abb8-40da-912e-a1cf41582511" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_5cebd3c9-d206-43df-b809-d8b3b1a25866" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_de93329f-f03e-4025-9153-271d114f400a" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_5cebd3c9-d206-43df-b809-d8b3b1a25866" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5cebd3c9-d206-43df-b809-d8b3b1a25866_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5cebd3c9-d206-43df-b809-d8b3b1a25866" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5cebd3c9-d206-43df-b809-d8b3b1a25866_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8e3a25d5-a0be-4ce8-b2fe-5863e1076252" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5cebd3c9-d206-43df-b809-d8b3b1a25866" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8e3a25d5-a0be-4ce8-b2fe-5863e1076252" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_ce73c7a0-7621-4148-a52c-624fe309ef67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8e3a25d5-a0be-4ce8-b2fe-5863e1076252" xlink:to="loc_us-gaap_ForeignExchangeContractMember_ce73c7a0-7621-4148-a52c-624fe309ef67" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails" xlink:type="extended" id="i8d8fd3859ca04fd2a9d02894fd56a3c8_FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_db6a6977-344d-4797-b182-49f75dc3e03d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofActivityinContingentConsiderationRollForward_301f145d-5565-4c7e-9306-de11fac50ac2" xlink:href="vtrs-20211231.xsd#vtrs_ScheduleofActivityinContingentConsiderationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_db6a6977-344d-4797-b182-49f75dc3e03d" xlink:to="loc_vtrs_ScheduleofActivityinContingentConsiderationRollForward_301f145d-5565-4c7e-9306-de11fac50ac2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_24f82200-5051-4d1a-9009-fbdc6e9d0dc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofActivityinContingentConsiderationRollForward_301f145d-5565-4c7e-9306-de11fac50ac2" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_24f82200-5051-4d1a-9009-fbdc6e9d0dc8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments_c5d74304-7bba-41f4-9b24-d9529e5396d9" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationContingentConsiderationLiabilityPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofActivityinContingentConsiderationRollForward_301f145d-5565-4c7e-9306-de11fac50ac2" xlink:to="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments_c5d74304-7bba-41f4-9b24-d9529e5396d9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionExpense_3b848909-a56f-4591-9a02-b93e1bc6fdd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofActivityinContingentConsiderationRollForward_301f145d-5565-4c7e-9306-de11fac50ac2" xlink:to="loc_us-gaap_AccretionExpense_3b848909-a56f-4591-9a02-b93e1bc6fdd9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications_9ebf5ca0-4d83-4b5e-aace-87ebb09caa65" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofActivityinContingentConsiderationRollForward_301f145d-5565-4c7e-9306-de11fac50ac2" xlink:to="loc_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications_9ebf5ca0-4d83-4b5e-aace-87ebb09caa65" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss_0746f2a9-13a6-4273-8ec6-e59016cafe1b" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ScheduleofActivityinContingentConsiderationRollForward_301f145d-5565-4c7e-9306-de11fac50ac2" xlink:to="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss_0746f2a9-13a6-4273-8ec6-e59016cafe1b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_05278995-f8b3-4cf0-900e-ee3f6e61389c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9c48aad7-2ebb-4813-b1cc-5ac3babd93ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_db6a6977-344d-4797-b182-49f75dc3e03d" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9c48aad7-2ebb-4813-b1cc-5ac3babd93ad" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1331327b-90ee-462e-9c25-f6f5d41b9229" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9c48aad7-2ebb-4813-b1cc-5ac3babd93ad" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1331327b-90ee-462e-9c25-f6f5d41b9229" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1331327b-90ee-462e-9c25-f6f5d41b9229_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1331327b-90ee-462e-9c25-f6f5d41b9229" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1331327b-90ee-462e-9c25-f6f5d41b9229_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_eab3e812-62f6-4dfd-b43c-1ad91d12b964" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1331327b-90ee-462e-9c25-f6f5d41b9229" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_eab3e812-62f6-4dfd-b43c-1ad91d12b964" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_JaiPharmaLimitedMember_2ca2dcfa-6909-4af8-93ee-0a2b86383feb" xlink:href="vtrs-20211231.xsd#vtrs_JaiPharmaLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_eab3e812-62f6-4dfd-b43c-1ad91d12b964" xlink:to="loc_vtrs_JaiPharmaLimitedMember_2ca2dcfa-6909-4af8-93ee-0a2b86383feb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_f6286589-beb1-4373-8217-db5d72d7b14a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9c48aad7-2ebb-4813-b1cc-5ac3babd93ad" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_f6286589-beb1-4373-8217-db5d72d7b14a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_f6286589-beb1-4373-8217-db5d72d7b14a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_f6286589-beb1-4373-8217-db5d72d7b14a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_f6286589-beb1-4373-8217-db5d72d7b14a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b6f07e1d-812d-4445-8cd3-8f9841a9c12e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_f6286589-beb1-4373-8217-db5d72d7b14a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b6f07e1d-812d-4445-8cd3-8f9841a9c12e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_ed0c385b-bd81-40e1-8411-0f935e21a2dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b6f07e1d-812d-4445-8cd3-8f9841a9c12e" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_ed0c385b-bd81-40e1-8411-0f935e21a2dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_33008c4f-e3c9-4387-9ed6-84a9e31d886e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b6f07e1d-812d-4445-8cd3-8f9841a9c12e" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_33008c4f-e3c9-4387-9ed6-84a9e31d886e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementScheduleofAvailableforsaleSecuritiesReconciliationDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#FinancialInstrumentsandRiskManagementScheduleofAvailableforsaleSecuritiesReconciliationDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementScheduleofAvailableforsaleSecuritiesReconciliationDetails" xlink:type="extended" id="i5758fc11c0b1476fb497a9cc1a0363cd_FinancialInstrumentsandRiskManagementScheduleofAvailableforsaleSecuritiesReconciliationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0477b712-e176-4a6e-aef4-5e6896603748" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_8cb6e0b7-ef85-4522-b1b8-c9f8fe92e05f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0477b712-e176-4a6e-aef4-5e6896603748" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_8cb6e0b7-ef85-4522-b1b8-c9f8fe92e05f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_5331d058-e0e1-4a7d-b1eb-bd69f37d1bb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0477b712-e176-4a6e-aef4-5e6896603748" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_5331d058-e0e1-4a7d-b1eb-bd69f37d1bb7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_3d4100a7-cb2a-4dee-ac80-8d2201038b26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0477b712-e176-4a6e-aef4-5e6896603748" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_3d4100a7-cb2a-4dee-ac80-8d2201038b26" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_4c832308-9c60-41fe-bab2-5f5cac008481" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0477b712-e176-4a6e-aef4-5e6896603748" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_4c832308-9c60-41fe-bab2-5f5cac008481" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_1ce0a6d2-c5c4-4206-97c3-2e506d589b66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0477b712-e176-4a6e-aef4-5e6896603748" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_1ce0a6d2-c5c4-4206-97c3-2e506d589b66" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_c3d9914c-0245-4b7b-a078-b8a35cb25500" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_1ce0a6d2-c5c4-4206-97c3-2e506d589b66" xlink:to="loc_us-gaap_FinancialInstrumentAxis_c3d9914c-0245-4b7b-a078-b8a35cb25500" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c3d9914c-0245-4b7b-a078-b8a35cb25500_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_c3d9914c-0245-4b7b-a078-b8a35cb25500" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c3d9914c-0245-4b7b-a078-b8a35cb25500_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_921b3c8e-c33a-489f-9065-87ab010896dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_c3d9914c-0245-4b7b-a078-b8a35cb25500" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_921b3c8e-c33a-489f-9065-87ab010896dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_bfd6c5c2-e581-4e40-9771-e0297bf1eb17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_921b3c8e-c33a-489f-9065-87ab010896dd" xlink:to="loc_us-gaap_DebtSecuritiesMember_bfd6c5c2-e581-4e40-9771-e0297bf1eb17" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_c23f9bce-f9ea-47bf-b313-fd23e7a2b5c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_921b3c8e-c33a-489f-9065-87ab010896dd" xlink:to="loc_us-gaap_EquitySecuritiesMember_c23f9bce-f9ea-47bf-b313-fd23e7a2b5c0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/DebtTables" xlink:type="simple" xlink:href="vtrs-20211231.xsd#DebtTables"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/DebtTables" xlink:type="extended" id="i7cfae52dd209424386eddabe46ecddf6_DebtTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_3aa067fb-0b57-45b4-a06a-0114a08f8181" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTextBlock_8bfa3c2f-c37a-48a4-8cb8-d698b920ce3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3aa067fb-0b57-45b4-a06a-0114a08f8181" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTextBlock_8bfa3c2f-c37a-48a4-8cb8-d698b920ce3d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_a9fcf8f0-e6b3-4161-b6ba-47a60aa48e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3aa067fb-0b57-45b4-a06a-0114a08f8181" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_a9fcf8f0-e6b3-4161-b6ba-47a60aa48e1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_4a11714b-6e2a-48ee-abd4-65a7f5c18644" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3aa067fb-0b57-45b4-a06a-0114a08f8181" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_4a11714b-6e2a-48ee-abd4-65a7f5c18644" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_c9f3a4fa-5f85-4743-a9a9-b6b5c46fc151" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3aa067fb-0b57-45b4-a06a-0114a08f8181" xlink:to="loc_us-gaap_DebtInstrumentTable_c9f3a4fa-5f85-4743-a9a9-b6b5c46fc151" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_76f62fac-0185-46ee-b44e-11a10bbd585e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c9f3a4fa-5f85-4743-a9a9-b6b5c46fc151" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_76f62fac-0185-46ee-b44e-11a10bbd585e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_76f62fac-0185-46ee-b44e-11a10bbd585e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_76f62fac-0185-46ee-b44e-11a10bbd585e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_76f62fac-0185-46ee-b44e-11a10bbd585e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8371f5f8-f90d-49a3-8f8b-122f86b5c510" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_76f62fac-0185-46ee-b44e-11a10bbd585e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8371f5f8-f90d-49a3-8f8b-122f86b5c510" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_UpjohnInc.Member_38a070ee-d8b8-4fe7-ac1d-e45b14094743" xlink:href="vtrs-20211231.xsd#vtrs_UpjohnInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8371f5f8-f90d-49a3-8f8b-122f86b5c510" xlink:to="loc_vtrs_UpjohnInc.Member_38a070ee-d8b8-4fe7-ac1d-e45b14094743" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/DebtShorttermborrowingsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#DebtShorttermborrowingsDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/DebtShorttermborrowingsDetails" xlink:type="extended" id="iaf4ca6c0e29d48c68281fdd6df860124_DebtShorttermborrowingsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems_08026aea-f2d9-45f2-9a0f-147f81e1cdc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_9b56a8ae-3daa-41fb-93f8-27319ee2e0ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_08026aea-f2d9-45f2-9a0f-147f81e1cdc9" xlink:to="loc_us-gaap_ShortTermBorrowings_9b56a8ae-3daa-41fb-93f8-27319ee2e0ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_136d943c-b131-4d18-aa41-be50bd5b0e49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShortTermDebtLineItems_08026aea-f2d9-45f2-9a0f-147f81e1cdc9" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_136d943c-b131-4d18-aa41-be50bd5b0e49" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_6db624ac-02a7-4885-a633-ade1bf95a2ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_136d943c-b131-4d18-aa41-be50bd5b0e49" xlink:to="loc_us-gaap_DebtInstrumentAxis_6db624ac-02a7-4885-a633-ade1bf95a2ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6db624ac-02a7-4885-a633-ade1bf95a2ee_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_6db624ac-02a7-4885-a633-ade1bf95a2ee" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6db624ac-02a7-4885-a633-ade1bf95a2ee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ffdd4dd8-0c9e-4187-9fab-2da1f62e8a59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_6db624ac-02a7-4885-a633-ade1bf95a2ee" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ffdd4dd8-0c9e-4187-9fab-2da1f62e8a59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherCurrentPortionofLongtermDebtMember_5d8d4994-423b-4ee0-b40b-5d34c32a192e" xlink:href="vtrs-20211231.xsd#vtrs_OtherCurrentPortionofLongtermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ffdd4dd8-0c9e-4187-9fab-2da1f62e8a59" xlink:to="loc_vtrs_OtherCurrentPortionofLongtermDebtMember_5d8d4994-423b-4ee0-b40b-5d34c32a192e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_3990d618-c00f-4ad4-8fe3-cdfbbed94f28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_136d943c-b131-4d18-aa41-be50bd5b0e49" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_3990d618-c00f-4ad4-8fe3-cdfbbed94f28" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_3990d618-c00f-4ad4-8fe3-cdfbbed94f28_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_3990d618-c00f-4ad4-8fe3-cdfbbed94f28" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_3990d618-c00f-4ad4-8fe3-cdfbbed94f28_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_a1017d6f-8bbe-4651-91a6-cd0166b6d58b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_3990d618-c00f-4ad4-8fe3-cdfbbed94f28" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_a1017d6f-8bbe-4651-91a6-cd0166b6d58b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_d4671623-8df5-4f17-8d2f-9eb4c644dcc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_a1017d6f-8bbe-4651-91a6-cd0166b6d58b" xlink:to="loc_us-gaap_CommercialPaperMember_d4671623-8df5-4f17-8d2f-9eb4c644dcc2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ReceivablesFacilityMember_3fc6c5a6-7fbf-4959-b46f-96e4c82419a7" xlink:href="vtrs-20211231.xsd#vtrs_ReceivablesFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_a1017d6f-8bbe-4651-91a6-cd0166b6d58b" xlink:to="loc_vtrs_ReceivablesFacilityMember_3fc6c5a6-7fbf-4959-b46f-96e4c82419a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NoteSecuritizationFacilityMember_b4cdfff3-d1ae-48de-8b34-ed8fbd4beaa7" xlink:href="vtrs-20211231.xsd#vtrs_NoteSecuritizationFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_a1017d6f-8bbe-4651-91a6-cd0166b6d58b" xlink:to="loc_vtrs_NoteSecuritizationFacilityMember_b4cdfff3-d1ae-48de-8b34-ed8fbd4beaa7" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/DebtDebtReceivablesFacilityandCommercialPaperProgramDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#DebtDebtReceivablesFacilityandCommercialPaperProgramDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/DebtDebtReceivablesFacilityandCommercialPaperProgramDetails" xlink:type="extended" id="i4cb7093557604a7cac57d04dc7de4984_DebtDebtReceivablesFacilityandCommercialPaperProgramDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_2a935e98-00ba-4cb7-9e07-f7e6ccbf7647" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_e550b4b1-3613-46c6-84e4-37871b63bbdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2a935e98-00ba-4cb7-9e07-f7e6ccbf7647" xlink:to="loc_us-gaap_ShortTermBorrowings_e550b4b1-3613-46c6-84e4-37871b63bbdf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity_e675e462-4a90-4ff6-ac3f-c8aa4ed46ec6" xlink:href="vtrs-20211231.xsd#vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2a935e98-00ba-4cb7-9e07-f7e6ccbf7647" xlink:to="loc_vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity_e675e462-4a90-4ff6-ac3f-c8aa4ed46ec6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_037a8bb5-e852-47a0-8a07-ff05354a8649" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2a935e98-00ba-4cb7-9e07-f7e6ccbf7647" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_037a8bb5-e852-47a0-8a07-ff05354a8649" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableFromSecuritization_cd2d6436-076f-43d2-990c-aaedf0dac0d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableFromSecuritization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2a935e98-00ba-4cb7-9e07-f7e6ccbf7647" xlink:to="loc_us-gaap_AccountsReceivableFromSecuritization_cd2d6436-076f-43d2-990c-aaedf0dac0d2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_283cc2ce-95e7-432f-9730-d903b1e78a53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2a935e98-00ba-4cb7-9e07-f7e6ccbf7647" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_283cc2ce-95e7-432f-9730-d903b1e78a53" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_e0f64533-7601-418b-829a-1e6474ba0209" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2a935e98-00ba-4cb7-9e07-f7e6ccbf7647" xlink:to="loc_us-gaap_DebtInstrumentTerm_e0f64533-7601-418b-829a-1e6474ba0209" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_3e8531e1-07f3-4c41-a13a-23b81bf8effa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2a935e98-00ba-4cb7-9e07-f7e6ccbf7647" xlink:to="loc_us-gaap_DebtInstrumentTable_3e8531e1-07f3-4c41-a13a-23b81bf8effa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_d2062d98-e7df-4d4e-a88a-392a23ece241" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_3e8531e1-07f3-4c41-a13a-23b81bf8effa" xlink:to="loc_us-gaap_VariableRateAxis_d2062d98-e7df-4d4e-a88a-392a23ece241" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_d2062d98-e7df-4d4e-a88a-392a23ece241_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_d2062d98-e7df-4d4e-a88a-392a23ece241" xlink:to="loc_us-gaap_VariableRateDomain_d2062d98-e7df-4d4e-a88a-392a23ece241_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_c23cd8c1-5ed9-4462-be11-532b28f1b8d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_d2062d98-e7df-4d4e-a88a-392a23ece241" xlink:to="loc_us-gaap_VariableRateDomain_c23cd8c1-5ed9-4462-be11-532b28f1b8d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_95960be5-7235-4191-8511-4d8484d188ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_c23cd8c1-5ed9-4462-be11-532b28f1b8d3" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_95960be5-7235-4191-8511-4d8484d188ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_1a3798ea-e5ca-49d6-981a-24f09b169e4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_3e8531e1-07f3-4c41-a13a-23b81bf8effa" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_1a3798ea-e5ca-49d6-981a-24f09b169e4b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_1a3798ea-e5ca-49d6-981a-24f09b169e4b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_1a3798ea-e5ca-49d6-981a-24f09b169e4b" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_1a3798ea-e5ca-49d6-981a-24f09b169e4b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_d521b8b4-ab01-4ead-b046-60f37a1ee049" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_1a3798ea-e5ca-49d6-981a-24f09b169e4b" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_d521b8b4-ab01-4ead-b046-60f37a1ee049" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ReceivablesFacilityMember_79a0ce9b-784b-4df3-8900-666af735435d" xlink:href="vtrs-20211231.xsd#vtrs_ReceivablesFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_d521b8b4-ab01-4ead-b046-60f37a1ee049" xlink:to="loc_vtrs_ReceivablesFacilityMember_79a0ce9b-784b-4df3-8900-666af735435d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NoteSecuritizationFacilityMember_0b573a2f-24a1-479b-9e36-d74a520a3b87" xlink:href="vtrs-20211231.xsd#vtrs_NoteSecuritizationFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_d521b8b4-ab01-4ead-b046-60f37a1ee049" xlink:to="loc_vtrs_NoteSecuritizationFacilityMember_0b573a2f-24a1-479b-9e36-d74a520a3b87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_6383ebcc-fa64-41ef-91b5-5dd5f0631a2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_3e8531e1-07f3-4c41-a13a-23b81bf8effa" xlink:to="loc_us-gaap_DebtInstrumentAxis_6383ebcc-fa64-41ef-91b5-5dd5f0631a2d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6383ebcc-fa64-41ef-91b5-5dd5f0631a2d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_6383ebcc-fa64-41ef-91b5-5dd5f0631a2d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6383ebcc-fa64-41ef-91b5-5dd5f0631a2d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d2b30c12-b4d6-434e-af53-08e82f091d7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_6383ebcc-fa64-41ef-91b5-5dd5f0631a2d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d2b30c12-b4d6-434e-af53-08e82f091d7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CommercialPaperProgramMember_faa02ec0-0df0-4540-9df1-83c25694a68b" xlink:href="vtrs-20211231.xsd#vtrs_CommercialPaperProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d2b30c12-b4d6-434e-af53-08e82f091d7f" xlink:to="loc_vtrs_CommercialPaperProgramMember_faa02ec0-0df0-4540-9df1-83c25694a68b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#DebtSummaryofLongtermDebtDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails" xlink:type="extended" id="i85dda8b87d9e491fabe7110c4f8f187d_DebtSummaryofLongtermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_8d6ccb56-c2f8-4977-8456-ceb826848ac1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_560ef60a-560f-4d4b-bccb-d3421ca09a09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8d6ccb56-c2f8-4977-8456-ceb826848ac1" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_560ef60a-560f-4d4b-bccb-d3421ca09a09" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_4559750b-9651-42ae-af94-2e258602cfa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8d6ccb56-c2f8-4977-8456-ceb826848ac1" xlink:to="loc_us-gaap_DebtCurrent_4559750b-9651-42ae-af94-2e258602cfa0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_74bc677a-3914-4dcf-a9db-7a50f22f4b00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8d6ccb56-c2f8-4977-8456-ceb826848ac1" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_74bc677a-3914-4dcf-a9db-7a50f22f4b00" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_927c9e7d-06e7-41f6-87c4-e6dbeced11e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8d6ccb56-c2f8-4977-8456-ceb826848ac1" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_927c9e7d-06e7-41f6-87c4-e6dbeced11e9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_4ea8f1a6-97ea-4f95-9b17-40486b511b24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8d6ccb56-c2f8-4977-8456-ceb826848ac1" xlink:to="loc_us-gaap_LongTermDebt_4ea8f1a6-97ea-4f95-9b17-40486b511b24" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_3d44fa6c-ade2-43f8-aa5b-cfa025cfd6fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8d6ccb56-c2f8-4977-8456-ceb826848ac1" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_3d44fa6c-ade2-43f8-aa5b-cfa025cfd6fd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_230a36c0-63cc-4c06-b014-f14a76218359" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8d6ccb56-c2f8-4977-8456-ceb826848ac1" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_230a36c0-63cc-4c06-b014-f14a76218359" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_154d94e1-1f3b-480b-8af6-b4de331a44e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8d6ccb56-c2f8-4977-8456-ceb826848ac1" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_154d94e1-1f3b-480b-8af6-b4de331a44e1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_50001572-3914-4b2e-90ef-27052c045367" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8d6ccb56-c2f8-4977-8456-ceb826848ac1" xlink:to="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_50001572-3914-4b2e-90ef-27052c045367" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_c16a381a-0bf0-4ef1-8b37-8c32480385d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8d6ccb56-c2f8-4977-8456-ceb826848ac1" xlink:to="loc_us-gaap_DebtInstrumentTable_c16a381a-0bf0-4ef1-8b37-8c32480385d6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f2abd40e-30a1-4d21-a1dc-0ab7e50af1d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c16a381a-0bf0-4ef1-8b37-8c32480385d6" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f2abd40e-30a1-4d21-a1dc-0ab7e50af1d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f2abd40e-30a1-4d21-a1dc-0ab7e50af1d6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f2abd40e-30a1-4d21-a1dc-0ab7e50af1d6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f2abd40e-30a1-4d21-a1dc-0ab7e50af1d6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_866e1d97-23bb-46a6-ac44-5663e453e0ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f2abd40e-30a1-4d21-a1dc-0ab7e50af1d6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_866e1d97-23bb-46a6-ac44-5663e453e0ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_2b4cec8b-ada0-4ba4-8e20-fc3a9705949c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_866e1d97-23bb-46a6-ac44-5663e453e0ad" xlink:to="loc_us-gaap_SeniorNotesMember_2b4cec8b-ada0-4ba4-8e20-fc3a9705949c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CurrentPortionofLongTermDebtMember_eaa20926-c675-44b5-b65e-7a3407e6c470" xlink:href="vtrs-20211231.xsd#vtrs_CurrentPortionofLongTermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_866e1d97-23bb-46a6-ac44-5663e453e0ad" xlink:to="loc_vtrs_CurrentPortionofLongTermDebtMember_eaa20926-c675-44b5-b65e-7a3407e6c470" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_6fd7a2bc-ed23-4be6-b524-3fd084a24822" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c16a381a-0bf0-4ef1-8b37-8c32480385d6" xlink:to="loc_us-gaap_DebtInstrumentAxis_6fd7a2bc-ed23-4be6-b524-3fd084a24822" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6fd7a2bc-ed23-4be6-b524-3fd084a24822_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_6fd7a2bc-ed23-4be6-b524-3fd084a24822" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6fd7a2bc-ed23-4be6-b524-3fd084a24822_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_6fd7a2bc-ed23-4be6-b524-3fd084a24822" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2016TermLoansMember_47c5361b-8197-4c23-ba16-d193bb0061b8" xlink:href="vtrs-20211231.xsd#vtrs_A2016TermLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_A2016TermLoansMember_47c5361b-8197-4c23-ba16-d193bb0061b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherCurrentPortionofLongtermDebtMember_975ad726-d097-4a6a-8d4f-f9977f4656f7" xlink:href="vtrs-20211231.xsd#vtrs_OtherCurrentPortionofLongtermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_OtherCurrentPortionofLongtermDebtMember_975ad726-d097-4a6a-8d4f-f9977f4656f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandEighteen2.6PercentMember_a9f08922-f0f3-4971-956e-f66ee3d0b838" xlink:href="vtrs-20211231.xsd#vtrs_SeniorNotesTwoThousandEighteen2.6PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_SeniorNotesTwoThousandEighteen2.6PercentMember_a9f08922-f0f3-4971-956e-f66ee3d0b838" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandEighteen3.0PercentMember_fa563d64-7e62-4093-9e90-0ba94e6e2bdf" xlink:href="vtrs-20211231.xsd#vtrs_SeniorNotesTwoThousandEighteen3.0PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_SeniorNotesTwoThousandEighteen3.0PercentMember_fa563d64-7e62-4093-9e90-0ba94e6e2bdf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandNineteen2.50PrecentMember_96dec108-18d7-4b2b-9d48-52468ce65cf3" xlink:href="vtrs-20211231.xsd#vtrs_SeniorNotesTwoThousandNineteen2.50PrecentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_SeniorNotesTwoThousandNineteen2.50PrecentMember_96dec108-18d7-4b2b-9d48-52468ce65cf3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandNineteenMember_77c24246-6fe3-46e3-8355-6e9a7c9312e4" xlink:href="vtrs-20211231.xsd#vtrs_SeniorNotesTwoThousandNineteenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_SeniorNotesTwoThousandNineteenMember_77c24246-6fe3-46e3-8355-6e9a7c9312e4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2020EuroSeniorNotesMember_003c771f-fc22-43c4-94c5-0033947f3ccf" xlink:href="vtrs-20211231.xsd#vtrs_A2020EuroSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_A2020EuroSeniorNotesMember_003c771f-fc22-43c4-94c5-0033947f3ccf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandTwenty3.75PercentMember_9bd7551b-7cb1-4959-85d2-38fc3fc68d19" xlink:href="vtrs-20211231.xsd#vtrs_SeniorNotesTwoThousandTwenty3.75PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_SeniorNotesTwoThousandTwenty3.75PercentMember_9bd7551b-7cb1-4959-85d2-38fc3fc68d19" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandTwentyOne3.15PrecentMember_d796927b-788d-483c-9f8b-86955d55eba4" xlink:href="vtrs-20211231.xsd#vtrs_SeniorNotesTwoThousandTwentyOne3.15PrecentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_SeniorNotesTwoThousandTwentyOne3.15PrecentMember_d796927b-788d-483c-9f8b-86955d55eba4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember_e916b0e9-dc84-4548-a4b5-bf8433a16093" xlink:href="vtrs-20211231.xsd#vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember_e916b0e9-dc84-4548-a4b5-bf8433a16093" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember_a41c7924-1968-4710-bdc7-1c48be5ba105" xlink:href="vtrs-20211231.xsd#vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember_a41c7924-1968-4710-bdc7-1c48be5ba105" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2024EuroSeniorNotesMember_c4616a29-4234-4284-a487-9664b6f1313d" xlink:href="vtrs-20211231.xsd#vtrs_A2024EuroSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_A2024EuroSeniorNotesMember_c4616a29-4234-4284-a487-9664b6f1313d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2025EuroSeniorNotesMember_f8cb67c7-1f16-49e2-83c4-33aa8d179fb7" xlink:href="vtrs-20211231.xsd#vtrs_A2025EuroSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_A2025EuroSeniorNotesMember_f8cb67c7-1f16-49e2-83c4-33aa8d179fb7" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember_13cebd68-b0c4-41c2-9419-8bfa5301190b" xlink:href="vtrs-20211231.xsd#vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember_13cebd68-b0c4-41c2-9419-8bfa5301190b" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2028EuroSeniorNotesMember_ee437250-0c6b-4a50-a5d1-973ae6ca6aaa" xlink:href="vtrs-20211231.xsd#vtrs_A2028EuroSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_A2028EuroSeniorNotesMember_ee437250-0c6b-4a50-a5d1-973ae6ca6aaa" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2028SeniorNotesMember_534ffe97-6654-4075-9365-16877e4464f7" xlink:href="vtrs-20211231.xsd#vtrs_A2028SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_A2028SeniorNotesMember_534ffe97-6654-4075-9365-16877e4464f7" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandFortyThreeMember_e6d36ad8-0d33-4af6-ade0-81cc7fb0a0f9" xlink:href="vtrs-20211231.xsd#vtrs_SeniorNotesTwoThousandFortyThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_SeniorNotesTwoThousandFortyThreeMember_e6d36ad8-0d33-4af6-ade0-81cc7fb0a0f9" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember_3c889c60-00df-40de-b19f-15df066096a6" xlink:href="vtrs-20211231.xsd#vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember_3c889c60-00df-40de-b19f-15df066096a6" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2048SeniorNotesMember_337226eb-a623-47c1-a89b-a3ccdf4b4d2c" xlink:href="vtrs-20211231.xsd#vtrs_A2048SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_A2048SeniorNotesMember_337226eb-a623-47c1-a89b-a3ccdf4b4d2c" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherLongTermDebtMember_5ff9bf97-0f53-48a4-9895-fdfbb5ade778" xlink:href="vtrs-20211231.xsd#vtrs_OtherLongTermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_OtherLongTermDebtMember_5ff9bf97-0f53-48a4-9895-fdfbb5ade778" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2020FloatingRateEuroNotesMember_95475139-01c5-4b3a-a9aa-b51e0a4629ab" xlink:href="vtrs-20211231.xsd#vtrs_A2020FloatingRateEuroNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_A2020FloatingRateEuroNotesMember_95475139-01c5-4b3a-a9aa-b51e0a4629ab" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotes2021Member_cdc75a06-3420-41aa-af94-09c820bc1d35" xlink:href="vtrs-20211231.xsd#vtrs_SeniorNotes2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_SeniorNotes2021Member_cdc75a06-3420-41aa-af94-09c820bc1d35" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2022EuroSeniorNotesMember_888fa930-f744-4f60-b0f9-3e1200a71f05" xlink:href="vtrs-20211231.xsd#vtrs_A2022EuroSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_A2022EuroSeniorNotesMember_888fa930-f744-4f60-b0f9-3e1200a71f05" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotes2022Member_8d439368-fa90-4c5f-a228-e70742b13691" xlink:href="vtrs-20211231.xsd#vtrs_SeniorNotes2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_SeniorNotes2022Member_8d439368-fa90-4c5f-a228-e70742b13691" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2024EuroSeniorNotes1023Member_f76896ee-7382-409e-b42d-444259e5c63f" xlink:href="vtrs-20211231.xsd#vtrs_A2024EuroSeniorNotes1023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_A2024EuroSeniorNotes1023Member_f76896ee-7382-409e-b42d-444259e5c63f" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2027EuroSeniorNotesMember_5779643c-086b-4b45-a880-3ee5e90c0510" xlink:href="vtrs-20211231.xsd#vtrs_A2027EuroSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_A2027EuroSeniorNotesMember_5779643c-086b-4b45-a880-3ee5e90c0510" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2027SeniorNotesMember_9efc5bed-61b0-410a-afd6-0dcb3da1d45e" xlink:href="vtrs-20211231.xsd#vtrs_A2027SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_A2027SeniorNotesMember_9efc5bed-61b0-410a-afd6-0dcb3da1d45e" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2030SeniorNotesMember_c6a3d908-4260-475c-b712-a700f7aed9b8" xlink:href="vtrs-20211231.xsd#vtrs_A2030SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_A2030SeniorNotesMember_c6a3d908-4260-475c-b712-a700f7aed9b8" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2032EuroSeniorNotesMember_295f11d0-137a-45a9-9ea6-17b8f52d2bc7" xlink:href="vtrs-20211231.xsd#vtrs_A2032EuroSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_A2032EuroSeniorNotesMember_295f11d0-137a-45a9-9ea6-17b8f52d2bc7" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2040SeniorNotesMember_d9b11aee-244f-4bbf-9e1b-36fa545dacbd" xlink:href="vtrs-20211231.xsd#vtrs_A2040SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_A2040SeniorNotesMember_d9b11aee-244f-4bbf-9e1b-36fa545dacbd" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2050SeniorNotesMember_e32165d0-a1da-4add-b74a-739e80e61365" xlink:href="vtrs-20211231.xsd#vtrs_A2050SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_A2050SeniorNotesMember_e32165d0-a1da-4add-b74a-739e80e61365" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_TermLoanMember_3c61d431-28dd-4060-a549-2fe7d2914e54" xlink:href="vtrs-20211231.xsd#vtrs_TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_TermLoanMember_3c61d431-28dd-4060-a549-2fe7d2914e54" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2025SeniorNotesMember_6e079f63-5b29-40b9-a4a1-5fd507d5cc1a" xlink:href="vtrs-20211231.xsd#vtrs_A2025SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_A2025SeniorNotesMember_6e079f63-5b29-40b9-a4a1-5fd507d5cc1a" xlink:type="arc" order="32"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/DebtRevolvingFacilitiesandTermFacilitiesDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#DebtRevolvingFacilitiesandTermFacilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/DebtRevolvingFacilitiesandTermFacilitiesDetails" xlink:type="extended" id="ibe880aab589446799e05644a7b049b3a_DebtRevolvingFacilitiesandTermFacilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_e9060d2d-5f93-4452-86a3-d7988b1d24af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_c9fe220b-79b3-420e-9515-135316e0f5a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e9060d2d-5f93-4452-86a3-d7988b1d24af" xlink:to="loc_us-gaap_RepaymentsOfDebt_c9fe220b-79b3-420e-9515-135316e0f5a3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c140c15f-2579-4e16-b542-437648f8a808" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e9060d2d-5f93-4452-86a3-d7988b1d24af" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c140c15f-2579-4e16-b542-437648f8a808" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_4c548081-95d8-4f34-b9ec-deadfece9e07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e9060d2d-5f93-4452-86a3-d7988b1d24af" xlink:to="loc_us-gaap_DebtCurrent_4c548081-95d8-4f34-b9ec-deadfece9e07" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCovenantDescription_e214a9b7-e116-4933-a954-49bce577048a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCovenantDescription"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e9060d2d-5f93-4452-86a3-d7988b1d24af" xlink:to="loc_us-gaap_DebtInstrumentCovenantDescription_e214a9b7-e116-4933-a954-49bce577048a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_73e76971-da47-498c-8b8e-dc0b6d0e7278" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e9060d2d-5f93-4452-86a3-d7988b1d24af" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_73e76971-da47-498c-8b8e-dc0b6d0e7278" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PeriodAxis_ebd87950-41b1-48be-81f7-9d3e31ee7a37" xlink:href="vtrs-20211231.xsd#vtrs_PeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_73e76971-da47-498c-8b8e-dc0b6d0e7278" xlink:to="loc_vtrs_PeriodAxis_ebd87950-41b1-48be-81f7-9d3e31ee7a37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PeriodDomain_ebd87950-41b1-48be-81f7-9d3e31ee7a37_default" xlink:href="vtrs-20211231.xsd#vtrs_PeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_vtrs_PeriodAxis_ebd87950-41b1-48be-81f7-9d3e31ee7a37" xlink:to="loc_vtrs_PeriodDomain_ebd87950-41b1-48be-81f7-9d3e31ee7a37_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PeriodDomain_22370235-e5a6-4e6c-b673-45aff51a9427" xlink:href="vtrs-20211231.xsd#vtrs_PeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_vtrs_PeriodAxis_ebd87950-41b1-48be-81f7-9d3e31ee7a37" xlink:to="loc_vtrs_PeriodDomain_22370235-e5a6-4e6c-b673-45aff51a9427" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_TrailingFourQuartersMember_3e2f7a1f-894d-42af-a245-9ea89becddbd" xlink:href="vtrs-20211231.xsd#vtrs_TrailingFourQuartersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_PeriodDomain_22370235-e5a6-4e6c-b673-45aff51a9427" xlink:to="loc_vtrs_TrailingFourQuartersMember_3e2f7a1f-894d-42af-a245-9ea89becddbd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ThreeFullFiscalQuartersFollowingQualifyingAcquisitionMember_8b32053f-7b8b-49de-9401-0807d6140fd5" xlink:href="vtrs-20211231.xsd#vtrs_ThreeFullFiscalQuartersFollowingQualifyingAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_PeriodDomain_22370235-e5a6-4e6c-b673-45aff51a9427" xlink:to="loc_vtrs_ThreeFullFiscalQuartersFollowingQualifyingAcquisitionMember_8b32053f-7b8b-49de-9401-0807d6140fd5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_fb051d71-f14c-433a-b1d8-8ed8db4b4920" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_73e76971-da47-498c-8b8e-dc0b6d0e7278" xlink:to="loc_us-gaap_DebtInstrumentAxis_fb051d71-f14c-433a-b1d8-8ed8db4b4920" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_fb051d71-f14c-433a-b1d8-8ed8db4b4920_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_fb051d71-f14c-433a-b1d8-8ed8db4b4920" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_fb051d71-f14c-433a-b1d8-8ed8db4b4920_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_cd1be606-4570-4d4f-8c35-f424822e6b5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_fb051d71-f14c-433a-b1d8-8ed8db4b4920" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_cd1be606-4570-4d4f-8c35-f424822e6b5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2016SeniorRevolvingCreditFacilityMember_f17b1e9b-b270-482d-a112-ec44d8bb3cba" xlink:href="vtrs-20211231.xsd#vtrs_A2016SeniorRevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cd1be606-4570-4d4f-8c35-f424822e6b5d" xlink:to="loc_vtrs_A2016SeniorRevolvingCreditFacilityMember_f17b1e9b-b270-482d-a112-ec44d8bb3cba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2016TermLoansMember_bbecf67b-c000-478a-8073-69aef2fea5e8" xlink:href="vtrs-20211231.xsd#vtrs_A2016TermLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cd1be606-4570-4d4f-8c35-f424822e6b5d" xlink:to="loc_vtrs_A2016TermLoansMember_bbecf67b-c000-478a-8073-69aef2fea5e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_25ba764a-438a-485b-8986-86f1afca14a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cd1be606-4570-4d4f-8c35-f424822e6b5d" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_25ba764a-438a-485b-8986-86f1afca14a3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2018SeniorRevolvingCreditFacilityMember_4f4e1f69-73dc-4119-aaa5-ab59e522e25c" xlink:href="vtrs-20211231.xsd#vtrs_A2018SeniorRevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cd1be606-4570-4d4f-8c35-f424822e6b5d" xlink:to="loc_vtrs_A2018SeniorRevolvingCreditFacilityMember_4f4e1f69-73dc-4119-aaa5-ab59e522e25c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d93d3812-aa8e-48f3-8127-6ca6a9d9b678" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_73e76971-da47-498c-8b8e-dc0b6d0e7278" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d93d3812-aa8e-48f3-8127-6ca6a9d9b678" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d93d3812-aa8e-48f3-8127-6ca6a9d9b678_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d93d3812-aa8e-48f3-8127-6ca6a9d9b678" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d93d3812-aa8e-48f3-8127-6ca6a9d9b678_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_53192cb7-0e79-4c5b-b664-8321fe2b7390" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d93d3812-aa8e-48f3-8127-6ca6a9d9b678" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_53192cb7-0e79-4c5b-b664-8321fe2b7390" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_73c1da56-e45f-47d9-b21f-4c4fd785007a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_53192cb7-0e79-4c5b-b664-8321fe2b7390" xlink:to="loc_us-gaap_LineOfCreditMember_73c1da56-e45f-47d9-b21f-4c4fd785007a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/DebtIssuanceof2018SeniorNotesDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#DebtIssuanceof2018SeniorNotesDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/DebtIssuanceof2018SeniorNotesDetails" xlink:type="extended" id="i4d18327ff7d641f685c2b3bf3c4a2c19_DebtIssuanceof2018SeniorNotesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_b0efe726-c3ab-44fd-8895-31a58d46ac1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_3c7c6d96-7083-4ea6-a139-68f77a709478" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b0efe726-c3ab-44fd-8895-31a58d46ac1b" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_3c7c6d96-7083-4ea6-a139-68f77a709478" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_828a063e-1178-4af8-8326-6fa57ed6bcc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b0efe726-c3ab-44fd-8895-31a58d46ac1b" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_828a063e-1178-4af8-8326-6fa57ed6bcc0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_57a0db70-45fd-4ea1-b80f-e5be62fb4b6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b0efe726-c3ab-44fd-8895-31a58d46ac1b" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_57a0db70-45fd-4ea1-b80f-e5be62fb4b6c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_332f26ed-be3a-4dde-ab37-f980d76c6fa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b0efe726-c3ab-44fd-8895-31a58d46ac1b" xlink:to="loc_us-gaap_DebtInstrumentTable_332f26ed-be3a-4dde-ab37-f980d76c6fa2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_65fbe88b-b668-417c-95dd-dee7c8337262" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_332f26ed-be3a-4dde-ab37-f980d76c6fa2" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_65fbe88b-b668-417c-95dd-dee7c8337262" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_65fbe88b-b668-417c-95dd-dee7c8337262_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_65fbe88b-b668-417c-95dd-dee7c8337262" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_65fbe88b-b668-417c-95dd-dee7c8337262_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_afa31f81-2a1e-422c-a549-fe7b0d47ef8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_65fbe88b-b668-417c-95dd-dee7c8337262" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_afa31f81-2a1e-422c-a549-fe7b0d47ef8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_3da66208-b1b2-4030-ac5f-fc209b9ce8b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_afa31f81-2a1e-422c-a549-fe7b0d47ef8a" xlink:to="loc_us-gaap_SeniorNotesMember_3da66208-b1b2-4030-ac5f-fc209b9ce8b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d4b5a6b8-599e-4fdd-9f27-adf19fbf964d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_332f26ed-be3a-4dde-ab37-f980d76c6fa2" xlink:to="loc_us-gaap_DebtInstrumentAxis_d4b5a6b8-599e-4fdd-9f27-adf19fbf964d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d4b5a6b8-599e-4fdd-9f27-adf19fbf964d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_d4b5a6b8-599e-4fdd-9f27-adf19fbf964d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d4b5a6b8-599e-4fdd-9f27-adf19fbf964d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_809e2612-d38f-4c46-8234-28b05ec3361d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_d4b5a6b8-599e-4fdd-9f27-adf19fbf964d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_809e2612-d38f-4c46-8234-28b05ec3361d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2028SeniorNotesMember_0acdc0aa-e78d-4c27-9c81-23e3fb903309" xlink:href="vtrs-20211231.xsd#vtrs_A2028SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_809e2612-d38f-4c46-8234-28b05ec3361d" xlink:to="loc_vtrs_A2028SeniorNotesMember_0acdc0aa-e78d-4c27-9c81-23e3fb903309" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2048SeniorNotesMember_92093a5c-10ea-4370-88f9-0c5f44dfb067" xlink:href="vtrs-20211231.xsd#vtrs_A2048SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_809e2612-d38f-4c46-8234-28b05ec3361d" xlink:to="loc_vtrs_A2048SeniorNotesMember_92093a5c-10ea-4370-88f9-0c5f44dfb067" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_April2018SeniorNotesMember_01c083fd-629f-4c8b-95ce-87edccc4a869" xlink:href="vtrs-20211231.xsd#vtrs_April2018SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_809e2612-d38f-4c46-8234-28b05ec3361d" xlink:to="loc_vtrs_April2018SeniorNotesMember_01c083fd-629f-4c8b-95ce-87edccc4a869" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/DebtSeniorNotesDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#DebtSeniorNotesDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/DebtSeniorNotesDetails" xlink:type="extended" id="ibb4433a144c4486c84948da5977844f5_DebtSeniorNotesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_86e06ebe-2d57-4c19-a753-fc64e0238da0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_55962702-5e7f-453b-847c-674f0c174510" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_86e06ebe-2d57-4c19-a753-fc64e0238da0" xlink:to="loc_us-gaap_RepaymentsOfDebt_55962702-5e7f-453b-847c-674f0c174510" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_666de966-d8a0-436b-8d50-6bd0096ecce0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_86e06ebe-2d57-4c19-a753-fc64e0238da0" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_666de966-d8a0-436b-8d50-6bd0096ecce0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a4ee7cfe-d5c4-4836-8fb5-e982225b513c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_86e06ebe-2d57-4c19-a753-fc64e0238da0" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a4ee7cfe-d5c4-4836-8fb5-e982225b513c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_841a0b32-c1fa-4dcb-afd2-d7f2419aef53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_86e06ebe-2d57-4c19-a753-fc64e0238da0" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_841a0b32-c1fa-4dcb-afd2-d7f2419aef53" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_f16bd6bb-5441-4e61-8c99-2b215a254f02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_86e06ebe-2d57-4c19-a753-fc64e0238da0" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_f16bd6bb-5441-4e61-8c99-2b215a254f02" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_526ffed4-bdee-4632-a48a-bfeb1468fc89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_86e06ebe-2d57-4c19-a753-fc64e0238da0" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_526ffed4-bdee-4632-a48a-bfeb1468fc89" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_e7a3983c-2390-4f29-b6f7-46519501b241" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_86e06ebe-2d57-4c19-a753-fc64e0238da0" xlink:to="loc_us-gaap_LongTermDebt_e7a3983c-2390-4f29-b6f7-46519501b241" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_5d955d11-246a-451a-8340-8da8d24ca49f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_86e06ebe-2d57-4c19-a753-fc64e0238da0" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_5d955d11-246a-451a-8340-8da8d24ca49f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_748611d9-a7ee-4044-84f0-cf08cb7d6c64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_86e06ebe-2d57-4c19-a753-fc64e0238da0" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_748611d9-a7ee-4044-84f0-cf08cb7d6c64" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_MaximumLeverageRatioPeriodTwo_b4756dfa-e5cc-4355-a7f9-ad31274442e7" xlink:href="vtrs-20211231.xsd#vtrs_MaximumLeverageRatioPeriodTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_86e06ebe-2d57-4c19-a753-fc64e0238da0" xlink:to="loc_vtrs_MaximumLeverageRatioPeriodTwo_b4756dfa-e5cc-4355-a7f9-ad31274442e7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_MaximumLeverageRatioPeriodOne_ef742b4b-9376-4a65-83d4-d636162908cd" xlink:href="vtrs-20211231.xsd#vtrs_MaximumLeverageRatioPeriodOne"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_86e06ebe-2d57-4c19-a753-fc64e0238da0" xlink:to="loc_vtrs_MaximumLeverageRatioPeriodOne_ef742b4b-9376-4a65-83d4-d636162908cd" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_MaximumLeverageRatioPeriodThree_f45b8290-1594-4842-b6bf-40ab6d4253db" xlink:href="vtrs-20211231.xsd#vtrs_MaximumLeverageRatioPeriodThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_86e06ebe-2d57-4c19-a753-fc64e0238da0" xlink:to="loc_vtrs_MaximumLeverageRatioPeriodThree_f45b8290-1594-4842-b6bf-40ab6d4253db" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_8d342224-1d27-4010-9475-94ceba41fbc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_86e06ebe-2d57-4c19-a753-fc64e0238da0" xlink:to="loc_us-gaap_DebtInstrumentTable_8d342224-1d27-4010-9475-94ceba41fbc9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_ea4d7a2f-355c-4a03-b2c0-8119c8f5a239" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_8d342224-1d27-4010-9475-94ceba41fbc9" xlink:to="loc_us-gaap_VariableRateAxis_ea4d7a2f-355c-4a03-b2c0-8119c8f5a239" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_ea4d7a2f-355c-4a03-b2c0-8119c8f5a239_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_ea4d7a2f-355c-4a03-b2c0-8119c8f5a239" xlink:to="loc_us-gaap_VariableRateDomain_ea4d7a2f-355c-4a03-b2c0-8119c8f5a239_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_8baf1d63-dae4-4d33-92ee-a3d5ebe37fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_ea4d7a2f-355c-4a03-b2c0-8119c8f5a239" xlink:to="loc_us-gaap_VariableRateDomain_8baf1d63-dae4-4d33-92ee-a3d5ebe37fc4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EURIBORMember_fad02dd7-45af-45d8-b694-d29b15275309" xlink:href="vtrs-20211231.xsd#vtrs_EURIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_8baf1d63-dae4-4d33-92ee-a3d5ebe37fc4" xlink:to="loc_vtrs_EURIBORMember_fad02dd7-45af-45d8-b694-d29b15275309" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_118c51fe-c80d-4ae2-8a4b-43da6c789e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_8d342224-1d27-4010-9475-94ceba41fbc9" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_118c51fe-c80d-4ae2-8a4b-43da6c789e5b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_118c51fe-c80d-4ae2-8a4b-43da6c789e5b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_118c51fe-c80d-4ae2-8a4b-43da6c789e5b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_118c51fe-c80d-4ae2-8a4b-43da6c789e5b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7dfbd2f4-602f-4f17-b207-24dcff390b6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_118c51fe-c80d-4ae2-8a4b-43da6c789e5b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7dfbd2f4-602f-4f17-b207-24dcff390b6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_4e692ddd-a09c-42c4-99df-24cc7a29e7e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7dfbd2f4-602f-4f17-b207-24dcff390b6a" xlink:to="loc_us-gaap_SeniorNotesMember_4e692ddd-a09c-42c4-99df-24cc7a29e7e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_8b9c3c39-721d-4f95-b56a-5a895074c403" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7dfbd2f4-602f-4f17-b207-24dcff390b6a" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_8b9c3c39-721d-4f95-b56a-5a895074c403" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_ba28db9f-821f-40e6-a6ab-8e75955bb7af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MediumTermNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7dfbd2f4-602f-4f17-b207-24dcff390b6a" xlink:to="loc_us-gaap_MediumTermNotesMember_ba28db9f-821f-40e6-a6ab-8e75955bb7af" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_3dd5795d-9816-4b24-9d68-085da7db8991" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_8d342224-1d27-4010-9475-94ceba41fbc9" xlink:to="loc_us-gaap_DebtInstrumentAxis_3dd5795d-9816-4b24-9d68-085da7db8991" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3dd5795d-9816-4b24-9d68-085da7db8991_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_3dd5795d-9816-4b24-9d68-085da7db8991" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3dd5795d-9816-4b24-9d68-085da7db8991_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1e704dc3-d0dd-484a-9004-dbbba50652ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_3dd5795d-9816-4b24-9d68-085da7db8991" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1e704dc3-d0dd-484a-9004-dbbba50652ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandEighteen2.6PercentMember_e9b3f3f9-6ca0-490d-a33f-f4d7327a95d4" xlink:href="vtrs-20211231.xsd#vtrs_SeniorNotesTwoThousandEighteen2.6PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e704dc3-d0dd-484a-9004-dbbba50652ec" xlink:to="loc_vtrs_SeniorNotesTwoThousandEighteen2.6PercentMember_e9b3f3f9-6ca0-490d-a33f-f4d7327a95d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2020FloatingRateEuroNotesMember_a61071dd-dc1c-49ff-ba9d-f9a26e8b4501" xlink:href="vtrs-20211231.xsd#vtrs_A2020FloatingRateEuroNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e704dc3-d0dd-484a-9004-dbbba50652ec" xlink:to="loc_vtrs_A2020FloatingRateEuroNotesMember_a61071dd-dc1c-49ff-ba9d-f9a26e8b4501" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2020EuroSeniorNotesMember_f6328399-6de3-403a-b521-b8bca06d1068" xlink:href="vtrs-20211231.xsd#vtrs_A2020EuroSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e704dc3-d0dd-484a-9004-dbbba50652ec" xlink:to="loc_vtrs_A2020EuroSeniorNotesMember_f6328399-6de3-403a-b521-b8bca06d1068" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2024EuroSeniorNotesMember_92d50647-e28c-4b0a-afad-38e86df1590e" xlink:href="vtrs-20211231.xsd#vtrs_A2024EuroSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e704dc3-d0dd-484a-9004-dbbba50652ec" xlink:to="loc_vtrs_A2024EuroSeniorNotesMember_92d50647-e28c-4b0a-afad-38e86df1590e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2028EuroSeniorNotesMember_d0a81bb9-5f72-4ef0-a174-1f979b031d01" xlink:href="vtrs-20211231.xsd#vtrs_A2028EuroSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e704dc3-d0dd-484a-9004-dbbba50652ec" xlink:to="loc_vtrs_A2028EuroSeniorNotesMember_d0a81bb9-5f72-4ef0-a174-1f979b031d01" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandEighteen3.0PercentMember_15201495-4847-49a8-8326-04172e7ed2ad" xlink:href="vtrs-20211231.xsd#vtrs_SeniorNotesTwoThousandEighteen3.0PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e704dc3-d0dd-484a-9004-dbbba50652ec" xlink:to="loc_vtrs_SeniorNotesTwoThousandEighteen3.0PercentMember_15201495-4847-49a8-8326-04172e7ed2ad" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandNineteenMember_94e71f00-6816-47e4-885f-f39310530e15" xlink:href="vtrs-20211231.xsd#vtrs_SeniorNotesTwoThousandNineteenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e704dc3-d0dd-484a-9004-dbbba50652ec" xlink:to="loc_vtrs_SeniorNotesTwoThousandNineteenMember_94e71f00-6816-47e4-885f-f39310530e15" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandNineteen2.50PrecentMember_70084bb7-4486-46da-9a71-1dfdecac2620" xlink:href="vtrs-20211231.xsd#vtrs_SeniorNotesTwoThousandNineteen2.50PrecentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e704dc3-d0dd-484a-9004-dbbba50652ec" xlink:to="loc_vtrs_SeniorNotesTwoThousandNineteen2.50PrecentMember_70084bb7-4486-46da-9a71-1dfdecac2620" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2028SeniorNotesMember_e698de5e-34fc-404a-9e98-945a16ccd7fe" xlink:href="vtrs-20211231.xsd#vtrs_A2028SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e704dc3-d0dd-484a-9004-dbbba50652ec" xlink:to="loc_vtrs_A2028SeniorNotesMember_e698de5e-34fc-404a-9e98-945a16ccd7fe" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2048SeniorNotesMember_ebb0e3ad-4428-4f53-aac5-41ea3095db5b" xlink:href="vtrs-20211231.xsd#vtrs_A2048SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e704dc3-d0dd-484a-9004-dbbba50652ec" xlink:to="loc_vtrs_A2048SeniorNotesMember_ebb0e3ad-4428-4f53-aac5-41ea3095db5b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2025EuroSeniorNotesMember_8f41f29a-ff68-4ad8-80f5-e4abf3430a8c" xlink:href="vtrs-20211231.xsd#vtrs_A2025EuroSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e704dc3-d0dd-484a-9004-dbbba50652ec" xlink:to="loc_vtrs_A2025EuroSeniorNotesMember_8f41f29a-ff68-4ad8-80f5-e4abf3430a8c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_TwentyTwentyOneRevolvingFacilityMember_c73b5e81-3c58-4764-9f20-ec00ab1f5771" xlink:href="vtrs-20211231.xsd#vtrs_TwentyTwentyOneRevolvingFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e704dc3-d0dd-484a-9004-dbbba50652ec" xlink:to="loc_vtrs_TwentyTwentyOneRevolvingFacilityMember_c73b5e81-3c58-4764-9f20-ec00ab1f5771" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_YENTermLoanMember_753225a7-00ed-4ede-8212-dd5557438aba" xlink:href="vtrs-20211231.xsd#vtrs_YENTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e704dc3-d0dd-484a-9004-dbbba50652ec" xlink:to="loc_vtrs_YENTermLoanMember_753225a7-00ed-4ede-8212-dd5557438aba" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_TwentyTwentyOneLoanFacilitiesMember_52810c8d-e340-4c5c-8961-481945ddb3e9" xlink:href="vtrs-20211231.xsd#vtrs_TwentyTwentyOneLoanFacilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e704dc3-d0dd-484a-9004-dbbba50652ec" xlink:to="loc_vtrs_TwentyTwentyOneLoanFacilitiesMember_52810c8d-e340-4c5c-8961-481945ddb3e9" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_USDTermLoanFacilityMember_e20cc8cf-60b4-4eac-ab7a-83b37bce03f5" xlink:href="vtrs-20211231.xsd#vtrs_USDTermLoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e704dc3-d0dd-484a-9004-dbbba50652ec" xlink:to="loc_vtrs_USDTermLoanFacilityMember_e20cc8cf-60b4-4eac-ab7a-83b37bce03f5" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2020RevolvingFacilityMember_e42864ec-3b7e-485c-b005-e90879d31a0d" xlink:href="vtrs-20211231.xsd#vtrs_A2020RevolvingFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e704dc3-d0dd-484a-9004-dbbba50652ec" xlink:to="loc_vtrs_A2020RevolvingFacilityMember_e42864ec-3b7e-485c-b005-e90879d31a0d" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cfb4e26a-bfaf-43c0-aabc-2f44fee9428b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_8d342224-1d27-4010-9475-94ceba41fbc9" xlink:to="loc_srt_RangeAxis_cfb4e26a-bfaf-43c0-aabc-2f44fee9428b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cfb4e26a-bfaf-43c0-aabc-2f44fee9428b_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_cfb4e26a-bfaf-43c0-aabc-2f44fee9428b" xlink:to="loc_srt_RangeMember_cfb4e26a-bfaf-43c0-aabc-2f44fee9428b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a0ef7d15-dd29-433e-894d-a23094b4146d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_cfb4e26a-bfaf-43c0-aabc-2f44fee9428b" xlink:to="loc_srt_RangeMember_a0ef7d15-dd29-433e-894d-a23094b4146d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_11086e26-010b-46d4-b607-e5bb3ae52cd6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a0ef7d15-dd29-433e-894d-a23094b4146d" xlink:to="loc_srt_MinimumMember_11086e26-010b-46d4-b607-e5bb3ae52cd6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_d354ffd1-2983-45fb-a468-98cdff4b37e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_8d342224-1d27-4010-9475-94ceba41fbc9" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_d354ffd1-2983-45fb-a468-98cdff4b37e0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d354ffd1-2983-45fb-a468-98cdff4b37e0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d354ffd1-2983-45fb-a468-98cdff4b37e0" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d354ffd1-2983-45fb-a468-98cdff4b37e0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1c874272-a743-48c7-ac52-82a99eb428ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d354ffd1-2983-45fb-a468-98cdff4b37e0" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1c874272-a743-48c7-ac52-82a99eb428ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_UpjohnInc.Member_c6baaf61-0370-45b4-b916-ba616c6c6739" xlink:href="vtrs-20211231.xsd#vtrs_UpjohnInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1c874272-a743-48c7-ac52-82a99eb428ab" xlink:to="loc_vtrs_UpjohnInc.Member_c6baaf61-0370-45b4-b916-ba616c6c6739" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/DebtFairValueNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#DebtFairValueNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/DebtFairValueNarrativeDetails" xlink:type="extended" id="iae1624b7446b46c78598366799875d36_DebtFairValueNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_3c8982ad-1166-4899-b93d-4540d73cf2bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_9611de80-26ab-4af6-8966-b4c330dc5a6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3c8982ad-1166-4899-b93d-4540d73cf2bb" xlink:to="loc_us-gaap_DebtInstrumentFairValue_9611de80-26ab-4af6-8966-b4c330dc5a6b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_89278c80-cea0-41d9-a416-7e4802e4d654" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3c8982ad-1166-4899-b93d-4540d73cf2bb" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_89278c80-cea0-41d9-a416-7e4802e4d654" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_df4d70b3-489d-42a9-a90f-50632e6d6e15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3c8982ad-1166-4899-b93d-4540d73cf2bb" xlink:to="loc_us-gaap_DebtInstrumentTable_df4d70b3-489d-42a9-a90f-50632e6d6e15" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_73a22811-d82f-4521-9da3-4f02335012fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_df4d70b3-489d-42a9-a90f-50632e6d6e15" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_73a22811-d82f-4521-9da3-4f02335012fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_73a22811-d82f-4521-9da3-4f02335012fd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_73a22811-d82f-4521-9da3-4f02335012fd" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_73a22811-d82f-4521-9da3-4f02335012fd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_acbea7a0-b9df-4124-a60e-56f4a045d172" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_73a22811-d82f-4521-9da3-4f02335012fd" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_acbea7a0-b9df-4124-a60e-56f4a045d172" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_535ef052-c0fd-42cc-8a0c-fe7bbbba5215" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_acbea7a0-b9df-4124-a60e-56f4a045d172" xlink:to="loc_us-gaap_SeniorNotesMember_535ef052-c0fd-42cc-8a0c-fe7bbbba5215" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b07d70ac-c9ca-4a2a-be21-a4b152926a7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_df4d70b3-489d-42a9-a90f-50632e6d6e15" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b07d70ac-c9ca-4a2a-be21-a4b152926a7c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b07d70ac-c9ca-4a2a-be21-a4b152926a7c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b07d70ac-c9ca-4a2a-be21-a4b152926a7c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b07d70ac-c9ca-4a2a-be21-a4b152926a7c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_af658dee-5ec5-4729-afca-816adef3cb18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b07d70ac-c9ca-4a2a-be21-a4b152926a7c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_af658dee-5ec5-4729-afca-816adef3cb18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_UpjohnInc.Member_b7353107-828c-49da-86dd-08c20e446d0c" xlink:href="vtrs-20211231.xsd#vtrs_UpjohnInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_af658dee-5ec5-4729-afca-816adef3cb18" xlink:to="loc_vtrs_UpjohnInc.Member_b7353107-828c-49da-86dd-08c20e446d0c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/DebtUpjohnSeniorNotesDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#DebtUpjohnSeniorNotesDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/DebtUpjohnSeniorNotesDetails" xlink:type="extended" id="if63a0de06fa7418abf21b53983cf6967_DebtUpjohnSeniorNotesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_0b473132-8d62-41cc-a025-f66ccddba213" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_25c6d7ab-b47c-4449-9251-1ae9752e23d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0b473132-8d62-41cc-a025-f66ccddba213" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_25c6d7ab-b47c-4449-9251-1ae9752e23d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DebtInstrumentConversionOfUnregisteredNotesToRegisteredNotesAsAPercentage_f2601128-a445-4699-b67e-bd81ce1a77ba" xlink:href="vtrs-20211231.xsd#vtrs_DebtInstrumentConversionOfUnregisteredNotesToRegisteredNotesAsAPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0b473132-8d62-41cc-a025-f66ccddba213" xlink:to="loc_vtrs_DebtInstrumentConversionOfUnregisteredNotesToRegisteredNotesAsAPercentage_f2601128-a445-4699-b67e-bd81ce1a77ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_6ce807e4-eb29-425f-8a68-04300db5bfef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0b473132-8d62-41cc-a025-f66ccddba213" xlink:to="loc_us-gaap_DebtInstrumentTable_6ce807e4-eb29-425f-8a68-04300db5bfef" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f4c84bd3-829f-4e79-beac-424c23913628" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_6ce807e4-eb29-425f-8a68-04300db5bfef" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f4c84bd3-829f-4e79-beac-424c23913628" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f4c84bd3-829f-4e79-beac-424c23913628_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f4c84bd3-829f-4e79-beac-424c23913628" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f4c84bd3-829f-4e79-beac-424c23913628_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c225c772-f6f6-433e-94e7-c0ab2dc521fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f4c84bd3-829f-4e79-beac-424c23913628" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c225c772-f6f6-433e-94e7-c0ab2dc521fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_UpjohnInc.Member_51ccb382-35f2-4ed1-9554-fa3c0cb41504" xlink:href="vtrs-20211231.xsd#vtrs_UpjohnInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c225c772-f6f6-433e-94e7-c0ab2dc521fb" xlink:to="loc_vtrs_UpjohnInc.Member_51ccb382-35f2-4ed1-9554-fa3c0cb41504" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_df71c24d-2009-42cc-ae41-729a9c8fe04f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_6ce807e4-eb29-425f-8a68-04300db5bfef" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_df71c24d-2009-42cc-ae41-729a9c8fe04f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_df71c24d-2009-42cc-ae41-729a9c8fe04f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_df71c24d-2009-42cc-ae41-729a9c8fe04f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_df71c24d-2009-42cc-ae41-729a9c8fe04f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e05c9604-9c13-43ea-af92-ba60fda2bc43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_df71c24d-2009-42cc-ae41-729a9c8fe04f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e05c9604-9c13-43ea-af92-ba60fda2bc43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_0b685904-0e46-4dbf-b555-1f3306fc9040" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e05c9604-9c13-43ea-af92-ba60fda2bc43" xlink:to="loc_us-gaap_SeniorNotesMember_0b685904-0e46-4dbf-b555-1f3306fc9040" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_116e032f-cbe6-4ff1-8e79-7357031bbbb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_6ce807e4-eb29-425f-8a68-04300db5bfef" xlink:to="loc_us-gaap_DebtInstrumentAxis_116e032f-cbe6-4ff1-8e79-7357031bbbb2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_116e032f-cbe6-4ff1-8e79-7357031bbbb2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_116e032f-cbe6-4ff1-8e79-7357031bbbb2" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_116e032f-cbe6-4ff1-8e79-7357031bbbb2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_35dc5be7-2d12-41c2-a7ae-e89af62f6759" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_116e032f-cbe6-4ff1-8e79-7357031bbbb2" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_35dc5be7-2d12-41c2-a7ae-e89af62f6759" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2022SeniorNotesMember_4c01c556-3c29-404e-bb86-97ff9df049d0" xlink:href="vtrs-20211231.xsd#vtrs_A2022SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35dc5be7-2d12-41c2-a7ae-e89af62f6759" xlink:to="loc_vtrs_A2022SeniorNotesMember_4c01c556-3c29-404e-bb86-97ff9df049d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2025SeniorNotesMember_2bc84c35-c933-491c-bc0a-43cad2be7048" xlink:href="vtrs-20211231.xsd#vtrs_A2025SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35dc5be7-2d12-41c2-a7ae-e89af62f6759" xlink:to="loc_vtrs_A2025SeniorNotesMember_2bc84c35-c933-491c-bc0a-43cad2be7048" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2027SeniorNotesMember_a5d26553-6974-4cda-973c-1867d104a761" xlink:href="vtrs-20211231.xsd#vtrs_A2027SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35dc5be7-2d12-41c2-a7ae-e89af62f6759" xlink:to="loc_vtrs_A2027SeniorNotesMember_a5d26553-6974-4cda-973c-1867d104a761" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2030SeniorNotesMember_e3affc6e-7fff-42df-b9cf-3e78a8133f9d" xlink:href="vtrs-20211231.xsd#vtrs_A2030SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35dc5be7-2d12-41c2-a7ae-e89af62f6759" xlink:to="loc_vtrs_A2030SeniorNotesMember_e3affc6e-7fff-42df-b9cf-3e78a8133f9d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2040SeniorNotesMember_9a170bf8-bd3b-4c5f-ad06-aa1f4c03a543" xlink:href="vtrs-20211231.xsd#vtrs_A2040SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35dc5be7-2d12-41c2-a7ae-e89af62f6759" xlink:to="loc_vtrs_A2040SeniorNotesMember_9a170bf8-bd3b-4c5f-ad06-aa1f4c03a543" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2050SeniorNotesMember_f6a2e7c2-7d26-49bf-920f-149bf5cfb3b2" xlink:href="vtrs-20211231.xsd#vtrs_A2050SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35dc5be7-2d12-41c2-a7ae-e89af62f6759" xlink:to="loc_vtrs_A2050SeniorNotesMember_f6a2e7c2-7d26-49bf-920f-149bf5cfb3b2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2022EuroSeniorNotesMember_d95c941c-7869-4857-a464-24086cb85127" xlink:href="vtrs-20211231.xsd#vtrs_A2022EuroSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35dc5be7-2d12-41c2-a7ae-e89af62f6759" xlink:to="loc_vtrs_A2022EuroSeniorNotesMember_d95c941c-7869-4857-a464-24086cb85127" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2027EuroSeniorNotesMember_5164bdad-24bb-4081-af38-1b4950e8f789" xlink:href="vtrs-20211231.xsd#vtrs_A2027EuroSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35dc5be7-2d12-41c2-a7ae-e89af62f6759" xlink:to="loc_vtrs_A2027EuroSeniorNotesMember_5164bdad-24bb-4081-af38-1b4950e8f789" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2024EuroSeniorNotesMember_358ee39e-1a1f-42cc-aa1e-9c9549ba7635" xlink:href="vtrs-20211231.xsd#vtrs_A2024EuroSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35dc5be7-2d12-41c2-a7ae-e89af62f6759" xlink:to="loc_vtrs_A2024EuroSeniorNotesMember_358ee39e-1a1f-42cc-aa1e-9c9549ba7635" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2032EuroSeniorNotesMember_425f3c98-ab75-4a9b-b086-7016063bb18e" xlink:href="vtrs-20211231.xsd#vtrs_A2032EuroSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35dc5be7-2d12-41c2-a7ae-e89af62f6759" xlink:to="loc_vtrs_A2032EuroSeniorNotesMember_425f3c98-ab75-4a9b-b086-7016063bb18e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_UpjohnEuroNotesMember_d65beb55-eba8-4ee9-89ec-fc770c1eaa32" xlink:href="vtrs-20211231.xsd#vtrs_UpjohnEuroNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35dc5be7-2d12-41c2-a7ae-e89af62f6759" xlink:to="loc_vtrs_UpjohnEuroNotesMember_d65beb55-eba8-4ee9-89ec-fc770c1eaa32" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_UnregisteredUpjohnUSDollarNotesMember_930f4875-d546-4cf4-afa6-265fb9cd7ed1" xlink:href="vtrs-20211231.xsd#vtrs_UnregisteredUpjohnUSDollarNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35dc5be7-2d12-41c2-a7ae-e89af62f6759" xlink:to="loc_vtrs_UnregisteredUpjohnUSDollarNotesMember_930f4875-d546-4cf4-afa6-265fb9cd7ed1" xlink:type="arc" order="11"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails" xlink:type="extended" id="i2be76a907d1c45dc8a63eb993d823394_ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_3dc45a26-538a-4da9-9847-316685ebb2e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b0daee50-3d05-4faf-9b98-ec3b1ff29645" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3dc45a26-538a-4da9-9847-316685ebb2e9" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b0daee50-3d05-4faf-9b98-ec3b1ff29645" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2e7240d5-d881-40f6-b337-3ca236ae97e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3dc45a26-538a-4da9-9847-316685ebb2e9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2e7240d5-d881-40f6-b337-3ca236ae97e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_e6c26fb0-38da-43c4-ba67-a173415af812" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3dc45a26-538a-4da9-9847-316685ebb2e9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_e6c26fb0-38da-43c4-ba67-a173415af812" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_6981c968-0454-46b6-b78e-b43caf179b97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3dc45a26-538a-4da9-9847-316685ebb2e9" xlink:to="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_6981c968-0454-46b6-b78e-b43caf179b97" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax_5e4a2faa-f5bd-43c7-b5f2-9f1a1081a160" xlink:href="vtrs-20211231.xsd#vtrs_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3dc45a26-538a-4da9-9847-316685ebb2e9" xlink:to="loc_vtrs_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax_5e4a2faa-f5bd-43c7-b5f2-9f1a1081a160" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_bae9ac0c-7b97-4df6-bd0f-a749d634d353" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3dc45a26-538a-4da9-9847-316685ebb2e9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_bae9ac0c-7b97-4df6-bd0f-a749d634d353" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1aba39e3-7ffc-4354-b675-a3b505d87666" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3dc45a26-538a-4da9-9847-316685ebb2e9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1aba39e3-7ffc-4354-b675-a3b505d87666" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeOtherNetOfTax_ad155c85-ec82-4994-bd8b-6cfa375c495e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeOtherNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3dc45a26-538a-4da9-9847-316685ebb2e9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeOtherNetOfTax_ad155c85-ec82-4994-bd8b-6cfa375c495e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_14ed927e-c0c8-4ac0-9aaa-849579eff0d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3dc45a26-538a-4da9-9847-316685ebb2e9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_14ed927e-c0c8-4ac0-9aaa-849579eff0d2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e8c92af1-28d4-458a-ade5-ccb8106cbf67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_3dc45a26-538a-4da9-9847-316685ebb2e9" xlink:to="loc_us-gaap_StatementTable_e8c92af1-28d4-458a-ade5-ccb8106cbf67" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a9004c6f-6681-4dc7-b875-86d7cd798840" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_e8c92af1-28d4-458a-ade5-ccb8106cbf67" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a9004c6f-6681-4dc7-b875-86d7cd798840" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_a9004c6f-6681-4dc7-b875-86d7cd798840_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a9004c6f-6681-4dc7-b875-86d7cd798840" xlink:to="loc_us-gaap_HedgingRelationshipDomain_a9004c6f-6681-4dc7-b875-86d7cd798840_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_6e8dc97c-3bdd-4bcc-9fa6-df8620774ff5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a9004c6f-6681-4dc7-b875-86d7cd798840" xlink:to="loc_us-gaap_HedgingRelationshipDomain_6e8dc97c-3bdd-4bcc-9fa6-df8620774ff5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_408e9395-4878-46ba-b675-61dca7afee41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_6e8dc97c-3bdd-4bcc-9fa6-df8620774ff5" xlink:to="loc_us-gaap_CashFlowHedgingMember_408e9395-4878-46ba-b675-61dca7afee41" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_9f8e9adc-161d-4d4f-9b17-a80304cd6a24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_6e8dc97c-3bdd-4bcc-9fa6-df8620774ff5" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_9f8e9adc-161d-4d4f-9b17-a80304cd6a24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_0ac0b9c8-c112-4f85-8803-210d59267432" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_e8c92af1-28d4-458a-ade5-ccb8106cbf67" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_0ac0b9c8-c112-4f85-8803-210d59267432" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0ac0b9c8-c112-4f85-8803-210d59267432_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0ac0b9c8-c112-4f85-8803-210d59267432" xlink:to="loc_us-gaap_EquityComponentDomain_0ac0b9c8-c112-4f85-8803-210d59267432_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_163f5c99-c866-456f-9ef7-0698345e28e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0ac0b9c8-c112-4f85-8803-210d59267432" xlink:to="loc_us-gaap_EquityComponentDomain_163f5c99-c866-456f-9ef7-0698345e28e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_5eeaea8d-599b-4aa1-b33f-135f958bf16a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_163f5c99-c866-456f-9ef7-0698345e28e8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_5eeaea8d-599b-4aa1-b33f-135f958bf16a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_1494935c-4ef7-4ac0-aafd-9f2622f6b75d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_163f5c99-c866-456f-9ef7-0698345e28e8" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_1494935c-4ef7-4ac0-aafd-9f2622f6b75d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_4e8d2095-24cd-4ec6-b2f2-d718adbb6df9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_163f5c99-c866-456f-9ef7-0698345e28e8" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_4e8d2095-24cd-4ec6-b2f2-d718adbb6df9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_6dbcd659-7598-4a01-a6ba-6c751a2dce3a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_e8c92af1-28d4-458a-ade5-ccb8106cbf67" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_6dbcd659-7598-4a01-a6ba-6c751a2dce3a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6dbcd659-7598-4a01-a6ba-6c751a2dce3a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_6dbcd659-7598-4a01-a6ba-6c751a2dce3a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6dbcd659-7598-4a01-a6ba-6c751a2dce3a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1241c33a-190e-4578-9aac-5358d7e8c882" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_6dbcd659-7598-4a01-a6ba-6c751a2dce3a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1241c33a-190e-4578-9aac-5358d7e8c882" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_ee386fd7-1eaf-4aa7-8647-847d59b5a2d8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1241c33a-190e-4578-9aac-5358d7e8c882" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_ee386fd7-1eaf-4aa7-8647-847d59b5a2d8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails" xlink:type="extended" id="iab3451d213a444c9ac98f2089967ff73_ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdfc7d26-5d77-4b46-b8db-b01cc3c51a75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e4b7cbdf-61ce-44da-b8d8-ab8846d5d268" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdfc7d26-5d77-4b46-b8db-b01cc3c51a75" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e4b7cbdf-61ce-44da-b8d8-ab8846d5d268" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax_e1b0f210-1a7a-406c-b051-f16cc6f2c698" xlink:href="vtrs-20211231.xsd#vtrs_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdfc7d26-5d77-4b46-b8db-b01cc3c51a75" xlink:to="loc_vtrs_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax_e1b0f210-1a7a-406c-b051-f16cc6f2c698" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_f9fb2198-d512-487c-94a6-c4884a23df39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdfc7d26-5d77-4b46-b8db-b01cc3c51a75" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_f9fb2198-d512-487c-94a6-c4884a23df39" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_bf3bdf58-02a2-4dca-9f91-3e81214d2494" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdfc7d26-5d77-4b46-b8db-b01cc3c51a75" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_bf3bdf58-02a2-4dca-9f91-3e81214d2494" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_c8af8706-6947-47e0-bf7a-b55a588c80bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdfc7d26-5d77-4b46-b8db-b01cc3c51a75" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_c8af8706-6947-47e0-bf7a-b55a588c80bc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_3786bf1a-eb7b-465b-b742-33033da5bfe2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdfc7d26-5d77-4b46-b8db-b01cc3c51a75" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_3786bf1a-eb7b-465b-b742-33033da5bfe2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6e2452a7-7a03-44ef-a9d8-813d6e6af7d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdfc7d26-5d77-4b46-b8db-b01cc3c51a75" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6e2452a7-7a03-44ef-a9d8-813d6e6af7d7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_f90f632b-ea94-48aa-9b4f-57086eccf715" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdfc7d26-5d77-4b46-b8db-b01cc3c51a75" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_f90f632b-ea94-48aa-9b4f-57086eccf715" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c2c62988-f387-4ce4-b924-ec6b177cabea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdfc7d26-5d77-4b46-b8db-b01cc3c51a75" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c2c62988-f387-4ce4-b924-ec6b177cabea" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_32a76d63-2ebc-43bd-a33b-71c5221dbb23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdfc7d26-5d77-4b46-b8db-b01cc3c51a75" xlink:to="loc_us-gaap_InterestExpense_32a76d63-2ebc-43bd-a33b-71c5221dbb23" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_9a80a9b3-1cc3-4d4b-b84a-11a038c05c1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdfc7d26-5d77-4b46-b8db-b01cc3c51a75" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_9a80a9b3-1cc3-4d4b-b84a-11a038c05c1a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_6bd1f8b1-982d-4c64-9a20-37a994899f4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdfc7d26-5d77-4b46-b8db-b01cc3c51a75" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_6bd1f8b1-982d-4c64-9a20-37a994899f4b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_7795f746-57fc-4646-925d-a784d0597fd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdfc7d26-5d77-4b46-b8db-b01cc3c51a75" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_7795f746-57fc-4646-925d-a784d0597fd6" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_3192cf81-aabb-47e9-9c3b-afc44780a405" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdfc7d26-5d77-4b46-b8db-b01cc3c51a75" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_3192cf81-aabb-47e9-9c3b-afc44780a405" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_da8e1e41-f65c-4357-89cd-f4a6bf37ee09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_79095298-05f5-42af-8b68-735397a53f37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_3dd8003d-87e3-435e-848b-c561c38a0c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_58c9ca3a-4e7a-438f-9b0d-156dd789e4a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_43ca7f1e-cbe8-419a-8497-86f78d596b17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax_1cb76087-62d9-49db-ba35-1b661f640f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdfc7d26-5d77-4b46-b8db-b01cc3c51a75" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax_1cb76087-62d9-49db-ba35-1b661f640f5a" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_fe2f2e89-b996-46f7-a46f-a7a88e20ed7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdfc7d26-5d77-4b46-b8db-b01cc3c51a75" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_fe2f2e89-b996-46f7-a46f-a7a88e20ed7e" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_9d8d0f26-f664-49fb-b6ba-21a7f636b4df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdfc7d26-5d77-4b46-b8db-b01cc3c51a75" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_9d8d0f26-f664-49fb-b6ba-21a7f636b4df" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_d2400718-647e-4bfc-ab8a-f5f6bba0371b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdfc7d26-5d77-4b46-b8db-b01cc3c51a75" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_d2400718-647e-4bfc-ab8a-f5f6bba0371b" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_7eb20b88-462e-4003-aaf9-bcddbf8382be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdfc7d26-5d77-4b46-b8db-b01cc3c51a75" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_7eb20b88-462e-4003-aaf9-bcddbf8382be" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeOtherNetOfTax_0a8f588d-3474-43fd-bd19-1fb3a6a6b331" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeOtherNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdfc7d26-5d77-4b46-b8db-b01cc3c51a75" xlink:to="loc_us-gaap_OtherComprehensiveIncomeOtherNetOfTax_0a8f588d-3474-43fd-bd19-1fb3a6a6b331" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_edeb0c88-9dab-43df-a480-fa41da89a69b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdfc7d26-5d77-4b46-b8db-b01cc3c51a75" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_edeb0c88-9dab-43df-a480-fa41da89a69b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_e7f700b6-e722-4f83-bae5-b35dc8aecf26" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_edeb0c88-9dab-43df-a480-fa41da89a69b" xlink:to="loc_srt_ConsolidatedEntitiesAxis_e7f700b6-e722-4f83-bae5-b35dc8aecf26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_e7f700b6-e722-4f83-bae5-b35dc8aecf26_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_e7f700b6-e722-4f83-bae5-b35dc8aecf26" xlink:to="loc_srt_ConsolidatedEntitiesDomain_e7f700b6-e722-4f83-bae5-b35dc8aecf26_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_fe86106a-aee7-4841-9035-0eb2734d1761" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_e7f700b6-e722-4f83-bae5-b35dc8aecf26" xlink:to="loc_srt_ConsolidatedEntitiesDomain_fe86106a-aee7-4841-9035-0eb2734d1761" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_2a025158-096f-4060-94d8-5cb9ce9b5881" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_fe86106a-aee7-4841-9035-0eb2734d1761" xlink:to="loc_srt_ParentCompanyMember_2a025158-096f-4060-94d8-5cb9ce9b5881" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_dd57d72c-c090-45e8-baed-8fd72d59de5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_edeb0c88-9dab-43df-a480-fa41da89a69b" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_dd57d72c-c090-45e8-baed-8fd72d59de5b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_dd57d72c-c090-45e8-baed-8fd72d59de5b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_dd57d72c-c090-45e8-baed-8fd72d59de5b" xlink:to="loc_us-gaap_HedgingRelationshipDomain_dd57d72c-c090-45e8-baed-8fd72d59de5b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_1b771358-308c-4511-a26a-94bfc793876f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_dd57d72c-c090-45e8-baed-8fd72d59de5b" xlink:to="loc_us-gaap_HedgingRelationshipDomain_1b771358-308c-4511-a26a-94bfc793876f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_e0c54c07-2068-42d8-83fb-3f63fcac697f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_1b771358-308c-4511-a26a-94bfc793876f" xlink:to="loc_us-gaap_CashFlowHedgingMember_e0c54c07-2068-42d8-83fb-3f63fcac697f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_0b0d62c7-0c62-4a9d-a41d-716dda66a92a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_1b771358-308c-4511-a26a-94bfc793876f" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_0b0d62c7-0c62-4a9d-a41d-716dda66a92a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_21db2d0c-843c-4878-be73-dbb8aaedc9a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_edeb0c88-9dab-43df-a480-fa41da89a69b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_21db2d0c-843c-4878-be73-dbb8aaedc9a0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_21db2d0c-843c-4878-be73-dbb8aaedc9a0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_21db2d0c-843c-4878-be73-dbb8aaedc9a0" xlink:to="loc_us-gaap_EquityComponentDomain_21db2d0c-843c-4878-be73-dbb8aaedc9a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e3c53416-cb35-4515-a6ba-0b986c3a4caa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_21db2d0c-843c-4878-be73-dbb8aaedc9a0" xlink:to="loc_us-gaap_EquityComponentDomain_e3c53416-cb35-4515-a6ba-0b986c3a4caa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_9c3b16c0-7b39-44f2-bd57-37e60b2acd89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e3c53416-cb35-4515-a6ba-0b986c3a4caa" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_9c3b16c0-7b39-44f2-bd57-37e60b2acd89" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_a697126d-ff24-4c8c-9d48-c47d9e1d49ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e3c53416-cb35-4515-a6ba-0b986c3a4caa" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_a697126d-ff24-4c8c-9d48-c47d9e1d49ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_2dedf918-39cf-486d-a10c-a5c183fb6572" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e3c53416-cb35-4515-a6ba-0b986c3a4caa" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_2dedf918-39cf-486d-a10c-a5c183fb6572" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_6a04b00b-d8df-41e7-a1a8-042ebed5032c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e3c53416-cb35-4515-a6ba-0b986c3a4caa" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_6a04b00b-d8df-41e7-a1a8-042ebed5032c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f1e4ed48-0eef-4726-b04d-e84fd0acf63a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e3c53416-cb35-4515-a6ba-0b986c3a4caa" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f1e4ed48-0eef-4726-b04d-e84fd0acf63a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_7d556cb4-42d0-4706-b178-ee54613eabd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_edeb0c88-9dab-43df-a480-fa41da89a69b" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_7d556cb4-42d0-4706-b178-ee54613eabd6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7d556cb4-42d0-4706-b178-ee54613eabd6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7d556cb4-42d0-4706-b178-ee54613eabd6" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7d556cb4-42d0-4706-b178-ee54613eabd6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_48c39687-71b5-46cb-bcf3-7509d003aec4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7d556cb4-42d0-4706-b178-ee54613eabd6" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_48c39687-71b5-46cb-bcf3-7509d003aec4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_bde6b258-4d7f-4404-9315-285437c354a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_48c39687-71b5-46cb-bcf3-7509d003aec4" xlink:to="loc_us-gaap_ForeignExchangeContractMember_bde6b258-4d7f-4404-9315-285437c354a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_150c4f33-85ed-48dc-8b48-f5fcbe83a8f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_48c39687-71b5-46cb-bcf3-7509d003aec4" xlink:to="loc_us-gaap_InterestRateSwapMember_150c4f33-85ed-48dc-8b48-f5fcbe83a8f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_aea5a68e-7038-4ddf-b200-25c90e1883b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_edeb0c88-9dab-43df-a480-fa41da89a69b" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_aea5a68e-7038-4ddf-b200-25c90e1883b6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_aea5a68e-7038-4ddf-b200-25c90e1883b6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_aea5a68e-7038-4ddf-b200-25c90e1883b6" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_aea5a68e-7038-4ddf-b200-25c90e1883b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_2ca39957-c979-41f1-a33e-75201297d7c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_aea5a68e-7038-4ddf-b200-25c90e1883b6" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_2ca39957-c979-41f1-a33e-75201297d7c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_e0292dbd-4f93-4c0b-8f7c-2795a971eac3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_2ca39957-c979-41f1-a33e-75201297d7c3" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_e0292dbd-4f93-4c0b-8f7c-2795a971eac3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_588052e4-553c-4f5a-9375-b2c2b7d16e04" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_edeb0c88-9dab-43df-a480-fa41da89a69b" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_588052e4-553c-4f5a-9375-b2c2b7d16e04" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_588052e4-553c-4f5a-9375-b2c2b7d16e04_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_588052e4-553c-4f5a-9375-b2c2b7d16e04" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_588052e4-553c-4f5a-9375-b2c2b7d16e04_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1b547193-13c1-49e3-a061-8c09eb0a7675" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_588052e4-553c-4f5a-9375-b2c2b7d16e04" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1b547193-13c1-49e3-a061-8c09eb0a7675" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_34c68395-084d-4f7f-9c60-4e2016341d63" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1b547193-13c1-49e3-a061-8c09eb0a7675" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_34c68395-084d-4f7f-9c60-4e2016341d63" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended" id="i78782baf132d4487b4cbd0f0315112f7_IncomeTaxesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_ee1c792b-1866-49e2-9c5a-c17403cbc6d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries_50aab59e-378a-4277-afd9-4041ef92994e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ee1c792b-1866-49e2-9c5a-c17403cbc6d6" xlink:to="loc_us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries_50aab59e-378a-4277-afd9-4041ef92994e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_baed1f8f-38c3-4b2b-a864-3c88632c7245" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ee1c792b-1866-49e2-9c5a-c17403cbc6d6" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_baed1f8f-38c3-4b2b-a864-3c88632c7245" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_025cec36-a172-47e1-90ca-c7ec9fbfee1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ee1c792b-1866-49e2-9c5a-c17403cbc6d6" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_025cec36-a172-47e1-90ca-c7ec9fbfee1a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_00076c56-c28b-4b2a-b2ff-60e2c34d03d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ee1c792b-1866-49e2-9c5a-c17403cbc6d6" xlink:to="loc_us-gaap_OperatingLossCarryforwards_00076c56-c28b-4b2a-b2ff-60e2c34d03d0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpense_a5e14eb4-529b-4f8c-8c27-68e183ae55b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ee1c792b-1866-49e2-9c5a-c17403cbc6d6" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpense_a5e14eb4-529b-4f8c-8c27-68e183ae55b4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_4be1b83c-8e6f-453e-9b6e-afe613f59a12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ee1c792b-1866-49e2-9c5a-c17403cbc6d6" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_4be1b83c-8e6f-453e-9b6e-afe613f59a12" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_805b2ed0-4646-4500-adb8-6704b297ec4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ee1c792b-1866-49e2-9c5a-c17403cbc6d6" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_805b2ed0-4646-4500-adb8-6704b297ec4e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_42a3a697-597b-4e11-9293-1a7d7ab70c77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ee1c792b-1866-49e2-9c5a-c17403cbc6d6" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_42a3a697-597b-4e11-9293-1a7d7ab70c77" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_b3dd7025-f039-4fc6-a46f-1bd4f976a7d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ee1c792b-1866-49e2-9c5a-c17403cbc6d6" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_b3dd7025-f039-4fc6-a46f-1bd4f976a7d6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_1e4d431d-2736-4846-b085-f9260beeb959" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ee1c792b-1866-49e2-9c5a-c17403cbc6d6" xlink:to="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_1e4d431d-2736-4846-b085-f9260beeb959" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationInterestExpense_7d8cc00d-7824-4fab-ac55-f965de65744f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ee1c792b-1866-49e2-9c5a-c17403cbc6d6" xlink:to="loc_us-gaap_IncomeTaxExaminationInterestExpense_7d8cc00d-7824-4fab-ac55-f965de65744f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_bf57dd4a-8e2c-4328-bbd7-a8970c5bce27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ee1c792b-1866-49e2-9c5a-c17403cbc6d6" xlink:to="loc_us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_bf57dd4a-8e2c-4328-bbd7-a8970c5bce27" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DeductionlimitofGILTItax_362d7de3-0920-4f66-a52c-ea0026290100" xlink:href="vtrs-20211231.xsd#vtrs_DeductionlimitofGILTItax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ee1c792b-1866-49e2-9c5a-c17403cbc6d6" xlink:to="loc_vtrs_DeductionlimitofGILTItax_362d7de3-0920-4f66-a52c-ea0026290100" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_18a3243a-54bc-4001-a203-2b1bef148f12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_53125ab4-ff5a-4e50-ba12-b4237ea85588" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense_8a21116f-403c-45c2-bed0-cb3c00a2e415" xlink:href="vtrs-20211231.xsd#vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ee1c792b-1866-49e2-9c5a-c17403cbc6d6" xlink:to="loc_vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense_8a21116f-403c-45c2-bed0-cb3c00a2e415" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_IncomeTaxExaminationReserveForUncertainTaxPosition_8c099402-f48f-494c-bb89-c0f9c15b8d19" xlink:href="vtrs-20211231.xsd#vtrs_IncomeTaxExaminationReserveForUncertainTaxPosition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ee1c792b-1866-49e2-9c5a-c17403cbc6d6" xlink:to="loc_vtrs_IncomeTaxExaminationReserveForUncertainTaxPosition_8c099402-f48f-494c-bb89-c0f9c15b8d19" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_IncomeTaxExaminationReserveImpactOnIncomeTaxProvision_23b3464c-574f-4f30-8371-b0657b5d8b40" xlink:href="vtrs-20211231.xsd#vtrs_IncomeTaxExaminationReserveImpactOnIncomeTaxProvision"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ee1c792b-1866-49e2-9c5a-c17403cbc6d6" xlink:to="loc_vtrs_IncomeTaxExaminationReserveImpactOnIncomeTaxProvision_23b3464c-574f-4f30-8371-b0657b5d8b40" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties_b2dba3dc-3ba6-43bf-91b8-908e3ed50eb8" xlink:href="vtrs-20211231.xsd#vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ee1c792b-1866-49e2-9c5a-c17403cbc6d6" xlink:to="loc_vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties_b2dba3dc-3ba6-43bf-91b8-908e3ed50eb8" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CARESActIncomeTaxExpenseBenefit_fb14abd4-8ece-42ab-8524-2a4c29a2d5bc" xlink:href="vtrs-20211231.xsd#vtrs_CARESActIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ee1c792b-1866-49e2-9c5a-c17403cbc6d6" xlink:to="loc_vtrs_CARESActIncomeTaxExpenseBenefit_fb14abd4-8ece-42ab-8524-2a4c29a2d5bc" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_f458dfbb-7786-4e16-b7a9-9c311c37b364" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ee1c792b-1866-49e2-9c5a-c17403cbc6d6" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_f458dfbb-7786-4e16-b7a9-9c311c37b364" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_af9bdc06-ede6-4016-ba45-ab90163fcd45" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_f458dfbb-7786-4e16-b7a9-9c311c37b364" xlink:to="loc_srt_StatementScenarioAxis_af9bdc06-ede6-4016-ba45-ab90163fcd45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_af9bdc06-ede6-4016-ba45-ab90163fcd45_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_af9bdc06-ede6-4016-ba45-ab90163fcd45" xlink:to="loc_srt_ScenarioUnspecifiedDomain_af9bdc06-ede6-4016-ba45-ab90163fcd45_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_256f0b63-83ef-43f0-9fec-c4dd8b4d347b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_af9bdc06-ede6-4016-ba45-ab90163fcd45" xlink:to="loc_srt_ScenarioUnspecifiedDomain_256f0b63-83ef-43f0-9fec-c4dd8b4d347b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_03e70b41-d81c-4c05-a2bc-153fcd19f089" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_256f0b63-83ef-43f0-9fec-c4dd8b4d347b" xlink:to="loc_srt_ScenarioForecastMember_03e70b41-d81c-4c05-a2bc-153fcd19f089" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_dba9a75e-366d-49e0-bedf-8abddc01905c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_f458dfbb-7786-4e16-b7a9-9c311c37b364" xlink:to="loc_us-gaap_TaxPeriodAxis_dba9a75e-366d-49e0-bedf-8abddc01905c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_dba9a75e-366d-49e0-bedf-8abddc01905c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxPeriodAxis_dba9a75e-366d-49e0-bedf-8abddc01905c" xlink:to="loc_us-gaap_TaxPeriodDomain_dba9a75e-366d-49e0-bedf-8abddc01905c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_8edcd145-d2d8-437d-b538-c08cbf85f1a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxPeriodAxis_dba9a75e-366d-49e0-bedf-8abddc01905c" xlink:to="loc_us-gaap_TaxPeriodDomain_8edcd145-d2d8-437d-b538-c08cbf85f1a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_IndefiniteMember_bf71faae-98de-4261-882f-38227ecbbc2c" xlink:href="vtrs-20211231.xsd#vtrs_IndefiniteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxPeriodDomain_8edcd145-d2d8-437d-b538-c08cbf85f1a6" xlink:to="loc_vtrs_IndefiniteMember_bf71faae-98de-4261-882f-38227ecbbc2c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_FutureyearsMember_dea8ecd1-28e2-4c93-93f3-c754b02907cf" xlink:href="vtrs-20211231.xsd#vtrs_FutureyearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxPeriodDomain_8edcd145-d2d8-437d-b538-c08cbf85f1a6" xlink:to="loc_vtrs_FutureyearsMember_dea8ecd1-28e2-4c93-93f3-c754b02907cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxYear2015Member_02d28c13-9e6b-4b53-9086-6e3607a1106c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxYear2015Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxPeriodDomain_8edcd145-d2d8-437d-b538-c08cbf85f1a6" xlink:to="loc_us-gaap_TaxYear2015Member_02d28c13-9e6b-4b53-9086-6e3607a1106c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_ec5551da-afe7-435f-969d-f21788a167de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_f458dfbb-7786-4e16-b7a9-9c311c37b364" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_ec5551da-afe7-435f-969d-f21788a167de" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_ec5551da-afe7-435f-969d-f21788a167de_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_ec5551da-afe7-435f-969d-f21788a167de" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_ec5551da-afe7-435f-969d-f21788a167de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_cdd90dfa-dc0a-45c4-af2b-992aca7b18ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_ec5551da-afe7-435f-969d-f21788a167de" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_cdd90dfa-dc0a-45c4-af2b-992aca7b18ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_U.S.FederalTaxAuthorityMember_5b591bfb-f823-49a9-9415-4999ba154e77" xlink:href="vtrs-20211231.xsd#vtrs_U.S.FederalTaxAuthorityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_cdd90dfa-dc0a-45c4-af2b-992aca7b18ce" xlink:to="loc_vtrs_U.S.FederalTaxAuthorityMember_5b591bfb-f823-49a9-9415-4999ba154e77" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_U.S.StateTaxAuthorityMember_40833305-41f8-4ccc-b49e-eb36509eed91" xlink:href="vtrs-20211231.xsd#vtrs_U.S.StateTaxAuthorityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_cdd90dfa-dc0a-45c4-af2b-992aca7b18ce" xlink:to="loc_vtrs_U.S.StateTaxAuthorityMember_40833305-41f8-4ccc-b49e-eb36509eed91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_6b5e76f0-e162-4bbc-bc4e-42239f9a0684" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_cdd90dfa-dc0a-45c4-af2b-992aca7b18ce" xlink:to="loc_us-gaap_ForeignCountryMember_6b5e76f0-e162-4bbc-bc4e-42239f9a0684" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_e7c98554-6ff2-4206-bc6d-06c83437c864" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_cdd90dfa-dc0a-45c4-af2b-992aca7b18ce" xlink:to="loc_us-gaap_DomesticCountryMember_e7c98554-6ff2-4206-bc6d-06c83437c864" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_cd96b20a-9267-4455-bf6d-73945c57d469" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_f458dfbb-7786-4e16-b7a9-9c311c37b364" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_cd96b20a-9267-4455-bf6d-73945c57d469" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_cd96b20a-9267-4455-bf6d-73945c57d469_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_cd96b20a-9267-4455-bf6d-73945c57d469" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_cd96b20a-9267-4455-bf6d-73945c57d469_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_936c1a7b-6152-47ec-9444-14a684323569" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_cd96b20a-9267-4455-bf6d-73945c57d469" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_936c1a7b-6152-47ec-9444-14a684323569" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AustralianTaxationOfficeMember_ed1f1894-102e-41d1-8463-6a17e0e6ceee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AustralianTaxationOfficeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_936c1a7b-6152-47ec-9444-14a684323569" xlink:to="loc_us-gaap_AustralianTaxationOfficeMember_ed1f1894-102e-41d1-8463-6a17e0e6ceee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_ed86a59f-2039-40ea-b91c-805d82744aca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_936c1a7b-6152-47ec-9444-14a684323569" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_ed86a59f-2039-40ea-b91c-805d82744aca" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails" xlink:type="extended" id="iecdf12ecfc04438fa4ef490f750ce984_IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_7a54be15-3fdb-4bf8-8a60-276c5cc06658" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_42e714d4-eb06-48fa-a13c-010bd0f818ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_7a54be15-3fdb-4bf8-8a60-276c5cc06658" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_42e714d4-eb06-48fa-a13c-010bd0f818ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_43736e2f-d56b-4dc4-9f16-aa6cc584a1cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_7a54be15-3fdb-4bf8-8a60-276c5cc06658" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_43736e2f-d56b-4dc4-9f16-aa6cc584a1cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_44760c56-99cc-40bf-8954-a2866739a7ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_7a54be15-3fdb-4bf8-8a60-276c5cc06658" xlink:to="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_44760c56-99cc-40bf-8954-a2866739a7ee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_15828c1f-7e47-4f9c-ae70-d3ec3449ee43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_7a54be15-3fdb-4bf8-8a60-276c5cc06658" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_15828c1f-7e47-4f9c-ae70-d3ec3449ee43" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_9e1aadfe-5a4f-4c30-be45-c5f5f40638be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_7a54be15-3fdb-4bf8-8a60-276c5cc06658" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_9e1aadfe-5a4f-4c30-be45-c5f5f40638be" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_24f25719-5862-4e41-870c-448c2f1da923" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_7a54be15-3fdb-4bf8-8a60-276c5cc06658" xlink:to="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_24f25719-5862-4e41-870c-448c2f1da923" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_99bc6efc-155f-44f7-a271-7ff6f726fe22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_7a54be15-3fdb-4bf8-8a60-276c5cc06658" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_99bc6efc-155f-44f7-a271-7ff6f726fe22" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_e8276126-e6b7-49b6-a543-8330e934f51f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_7a54be15-3fdb-4bf8-8a60-276c5cc06658" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_e8276126-e6b7-49b6-a543-8330e934f51f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_9c3924b2-6f50-4995-a971-e22ccbda848e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_7a54be15-3fdb-4bf8-8a60-276c5cc06658" xlink:to="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_9c3924b2-6f50-4995-a971-e22ccbda848e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_4b0ad293-5909-423a-ba24-6242ee08e3da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_7a54be15-3fdb-4bf8-8a60-276c5cc06658" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_4b0ad293-5909-423a-ba24-6242ee08e3da" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_04d35a02-512c-49a9-a2e9-00490994d017" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_7a54be15-3fdb-4bf8-8a60-276c5cc06658" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_04d35a02-512c-49a9-a2e9-00490994d017" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_9391af98-239d-416a-bae9-aad904b22a94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_04d35a02-512c-49a9-a2e9-00490994d017" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_9391af98-239d-416a-bae9-aad904b22a94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_7f56b65d-4942-479a-b49b-d21a71751bff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_04d35a02-512c-49a9-a2e9-00490994d017" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_7f56b65d-4942-479a-b49b-d21a71751bff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f63766bb-5ca8-4c92-841a-f3c0916fab43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_7a54be15-3fdb-4bf8-8a60-276c5cc06658" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f63766bb-5ca8-4c92-841a-f3c0916fab43" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_e71f9e3f-eebf-4bc8-8ff7-6437f3f8e432" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_7a54be15-3fdb-4bf8-8a60-276c5cc06658" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_e71f9e3f-eebf-4bc8-8ff7-6437f3f8e432" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_7d31a695-d302-4885-8d16-66afca3c08af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_e71f9e3f-eebf-4bc8-8ff7-6437f3f8e432" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_7d31a695-d302-4885-8d16-66afca3c08af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_7d31a695-d302-4885-8d16-66afca3c08af_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_7d31a695-d302-4885-8d16-66afca3c08af" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_7d31a695-d302-4885-8d16-66afca3c08af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_5c4a642c-00d6-4956-82f8-acb8fda25940" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_7d31a695-d302-4885-8d16-66afca3c08af" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_5c4a642c-00d6-4956-82f8-acb8fda25940" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_11863b02-8037-4f15-9ec7-5a4da1dd46aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_5c4a642c-00d6-4956-82f8-acb8fda25940" xlink:to="loc_us-gaap_ForeignCountryMember_11863b02-8037-4f15-9ec7-5a4da1dd46aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_U.S.StateTaxAuthorityMember_b79b6477-4b80-4ba5-834b-cb41474c8bac" xlink:href="vtrs-20211231.xsd#vtrs_U.S.StateTaxAuthorityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_5c4a642c-00d6-4956-82f8-acb8fda25940" xlink:to="loc_vtrs_U.S.StateTaxAuthorityMember_b79b6477-4b80-4ba5-834b-cb41474c8bac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NonU.S.statetaxauthorityMember_d6bb8dd5-4fc8-45bd-a139-c6e9b85033c9" xlink:href="vtrs-20211231.xsd#vtrs_NonU.S.statetaxauthorityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_5c4a642c-00d6-4956-82f8-acb8fda25940" xlink:to="loc_vtrs_NonU.S.statetaxauthorityMember_d6bb8dd5-4fc8-45bd-a139-c6e9b85033c9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherMember_72c67cd7-e6a4-406f-ad96-1e062a7fecb0" xlink:href="vtrs-20211231.xsd#vtrs_OtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_5c4a642c-00d6-4956-82f8-acb8fda25940" xlink:to="loc_vtrs_OtherMember_72c67cd7-e6a4-406f-ad96-1e062a7fecb0" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/IncomeTaxesStatutoryTaxRatetoEffectiveTaxRateReconciliationDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#IncomeTaxesStatutoryTaxRatetoEffectiveTaxRateReconciliationDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/IncomeTaxesStatutoryTaxRatetoEffectiveTaxRateReconciliationDetails" xlink:type="extended" id="ic04994f3a3cd45c487582878b9e521e9_IncomeTaxesStatutoryTaxRatetoEffectiveTaxRateReconciliationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_43d01ef0-4e19-4c36-8cb1-975166949729" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_9f6c708e-d725-4650-b795-d90f0ffe1be1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_43d01ef0-4e19-4c36-8cb1-975166949729" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_9f6c708e-d725-4650-b795-d90f0ffe1be1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_575da804-7d10-4391-9079-700d13881f6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_43d01ef0-4e19-4c36-8cb1-975166949729" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_575da804-7d10-4391-9079-700d13881f6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_a846b92f-3611-4049-9ce4-4d32f1467594" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_43d01ef0-4e19-4c36-8cb1-975166949729" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_a846b92f-3611-4049-9ce4-4d32f1467594" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_27c24746-3794-469d-a849-4cef59a6f19e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_43d01ef0-4e19-4c36-8cb1-975166949729" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_27c24746-3794-469d-a849-4cef59a6f19e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_bab7f6cd-9100-4f44-8e24-38dcf99458e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_43d01ef0-4e19-4c36-8cb1-975166949729" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_bab7f6cd-9100-4f44-8e24-38dcf99458e0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_651c5010-a1da-44cd-b5c6-bde4e0e7aae2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_43d01ef0-4e19-4c36-8cb1-975166949729" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_651c5010-a1da-44cd-b5c6-bde4e0e7aae2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements_ddddc2dc-f6e9-4a07-b22c-e02b78caf0c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_43d01ef0-4e19-4c36-8cb1-975166949729" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements_ddddc2dc-f6e9-4a07-b22c-e02b78caf0c4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EffectiveIncomeTaxRateReconciliationGILTIPercent_9b4878b8-90ab-4c4a-ac8e-ed2bc00b671e" xlink:href="vtrs-20211231.xsd#vtrs_EffectiveIncomeTaxRateReconciliationGILTIPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_43d01ef0-4e19-4c36-8cb1-975166949729" xlink:to="loc_vtrs_EffectiveIncomeTaxRateReconciliationGILTIPercent_9b4878b8-90ab-4c4a-ac8e-ed2bc00b671e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EffectiveIncomeTaxRateReconciliationWaivedDeductionsPercent_a0ad1163-76be-4ea3-9ad7-22d6fe4fe28d" xlink:href="vtrs-20211231.xsd#vtrs_EffectiveIncomeTaxRateReconciliationWaivedDeductionsPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_43d01ef0-4e19-4c36-8cb1-975166949729" xlink:to="loc_vtrs_EffectiveIncomeTaxRateReconciliationWaivedDeductionsPercent_a0ad1163-76be-4ea3-9ad7-22d6fe4fe28d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_1f303f6c-e124-4964-813b-ca74a4d2aa76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_43d01ef0-4e19-4c36-8cb1-975166949729" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_1f303f6c-e124-4964-813b-ca74a4d2aa76" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_4d7c5ccd-0a5f-4002-886a-00d2a992a512" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_43d01ef0-4e19-4c36-8cb1-975166949729" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_4d7c5ccd-0a5f-4002-886a-00d2a992a512" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign_cb5ee3a5-0748-4e3e-b4a7-dcfff50694a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_43d01ef0-4e19-4c36-8cb1-975166949729" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign_cb5ee3a5-0748-4e3e-b4a7-dcfff50694a7" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_f24e1b6f-2694-4ed9-ac0e-260498a7ca2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_43d01ef0-4e19-4c36-8cb1-975166949729" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_f24e1b6f-2694-4ed9-ac0e-260498a7ca2a" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EffectiveIncomeTaxRateReconciliationWithholdingTaxesPercent_739929b8-7e66-489e-b08c-ab042d44f3b3" xlink:href="vtrs-20211231.xsd#vtrs_EffectiveIncomeTaxRateReconciliationWithholdingTaxesPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_43d01ef0-4e19-4c36-8cb1-975166949729" xlink:to="loc_vtrs_EffectiveIncomeTaxRateReconciliationWithholdingTaxesPercent_739929b8-7e66-489e-b08c-ab042d44f3b3" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EffectiveIncomeTaxRateReconciliationIndiaAmagulation_23f3966c-9b99-4ecb-b67c-842e45c450a9" xlink:href="vtrs-20211231.xsd#vtrs_EffectiveIncomeTaxRateReconciliationIndiaAmagulation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_43d01ef0-4e19-4c36-8cb1-975166949729" xlink:to="loc_vtrs_EffectiveIncomeTaxRateReconciliationIndiaAmagulation_23f3966c-9b99-4ecb-b67c-842e45c450a9" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_b7a31837-dfad-4256-9013-0aad0656fa64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_43d01ef0-4e19-4c36-8cb1-975166949729" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_b7a31837-dfad-4256-9013-0aad0656fa64" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_bdb7d7f5-3338-4eaa-852b-d1df4554c6cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_43d01ef0-4e19-4c36-8cb1-975166949729" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_bdb7d7f5-3338-4eaa-852b-d1df4554c6cc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_f589c691-a153-4130-bfa3-f9061c4d243d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_bdb7d7f5-3338-4eaa-852b-d1df4554c6cc" xlink:to="loc_srt_StatementGeographicalAxis_f589c691-a153-4130-bfa3-f9061c4d243d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f589c691-a153-4130-bfa3-f9061c4d243d_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_f589c691-a153-4130-bfa3-f9061c4d243d" xlink:to="loc_srt_SegmentGeographicalDomain_f589c691-a153-4130-bfa3-f9061c4d243d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_dd238284-076b-4375-b29e-26a826698491" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_f589c691-a153-4130-bfa3-f9061c4d243d" xlink:to="loc_srt_SegmentGeographicalDomain_dd238284-076b-4375-b29e-26a826698491" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_05edb380-7616-40b1-b5f5-33b5b625af73" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_dd238284-076b-4375-b29e-26a826698491" xlink:to="loc_country_US_05edb380-7616-40b1-b5f5-33b5b625af73" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_LU_9f1cc752-c844-4e2e-8ea1-10c42d3cb95a" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_LU"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_dd238284-076b-4375-b29e-26a826698491" xlink:to="loc_country_LU_9f1cc752-c844-4e2e-8ea1-10c42d3cb95a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GI_14103072-8dec-4a69-80e1-46a181d0e137" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GI"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_dd238284-076b-4375-b29e-26a826698491" xlink:to="loc_country_GI_14103072-8dec-4a69-80e1-46a181d0e137" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_0fd7debf-d73e-482c-83f0-b6a64174ba1d" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_dd238284-076b-4375-b29e-26a826698491" xlink:to="loc_country_IE_0fd7debf-d73e-482c-83f0-b6a64174ba1d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_c7d10d9a-2f93-40bc-91c0-74d053989ebd" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_FR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_dd238284-076b-4375-b29e-26a826698491" xlink:to="loc_country_FR_c7d10d9a-2f93-40bc-91c0-74d053989ebd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherforeignMember_a9afa429-fd64-4e11-8378-60c390c0eabc" xlink:href="vtrs-20211231.xsd#vtrs_OtherforeignMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_dd238284-076b-4375-b29e-26a826698491" xlink:to="loc_vtrs_OtherforeignMember_a9afa429-fd64-4e11-8378-60c390c0eabc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_578bdc69-6cf9-4cc3-8c38-bc9f6c57eca3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_dd238284-076b-4375-b29e-26a826698491" xlink:to="loc_us-gaap_NonUsMember_578bdc69-6cf9-4cc3-8c38-bc9f6c57eca3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_PR_73077fed-37fc-4bc1-9c98-8b246436080a" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_PR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_dd238284-076b-4375-b29e-26a826698491" xlink:to="loc_country_PR_73077fed-37fc-4bc1-9c98-8b246436080a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_85eb9d9b-772c-46b5-925f-bd897433e0a9" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CH"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_dd238284-076b-4375-b29e-26a826698491" xlink:to="loc_country_CH_85eb9d9b-772c-46b5-925f-bd897433e0a9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_SG_5736996f-b0db-47de-822e-f4a3bd3fc80b" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_SG"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_dd238284-076b-4375-b29e-26a826698491" xlink:to="loc_country_SG_5736996f-b0db-47de-822e-f4a3bd3fc80b" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ShareBasedIncentivePlanTables" xlink:type="simple" xlink:href="vtrs-20211231.xsd#ShareBasedIncentivePlanTables"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/ShareBasedIncentivePlanTables" xlink:type="extended" id="i8bc245209eda49a18b555a6f8e772bb0_ShareBasedIncentivePlanTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c446398f-d8d5-473f-b1f5-2b2df9e81d3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_d9c12369-2820-4a9d-bfa8-28530e6f4f88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c446398f-d8d5-473f-b1f5-2b2df9e81d3b" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_d9c12369-2820-4a9d-bfa8-28530e6f4f88" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_92492919-70a4-4839-8294-a9d7085a0475" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c446398f-d8d5-473f-b1f5-2b2df9e81d3b" xlink:to="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_92492919-70a4-4839-8294-a9d7085a0475" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_e64ec747-b732-4a87-bc59-e8da758d44d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c446398f-d8d5-473f-b1f5-2b2df9e81d3b" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_e64ec747-b732-4a87-bc59-e8da758d44d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_409f2cdd-ae72-401d-ae92-27064791db41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c446398f-d8d5-473f-b1f5-2b2df9e81d3b" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_409f2cdd-ae72-401d-ae92-27064791db41" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ProgramNameAxis_35f21bd1-d165-4392-b5b6-71561339f179" xlink:href="vtrs-20211231.xsd#vtrs_ProgramNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_409f2cdd-ae72-401d-ae92-27064791db41" xlink:to="loc_vtrs_ProgramNameAxis_35f21bd1-d165-4392-b5b6-71561339f179" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ProgramNameDomain_35f21bd1-d165-4392-b5b6-71561339f179_default" xlink:href="vtrs-20211231.xsd#vtrs_ProgramNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_vtrs_ProgramNameAxis_35f21bd1-d165-4392-b5b6-71561339f179" xlink:to="loc_vtrs_ProgramNameDomain_35f21bd1-d165-4392-b5b6-71561339f179_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ProgramNameDomain_33c97b33-e48b-4a84-b93e-cfa702cc81fe" xlink:href="vtrs-20211231.xsd#vtrs_ProgramNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_vtrs_ProgramNameAxis_35f21bd1-d165-4392-b5b6-71561339f179" xlink:to="loc_vtrs_ProgramNameDomain_33c97b33-e48b-4a84-b93e-cfa702cc81fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2014ProgramMember_85554d38-4bd2-45df-90d4-610db1b0c22f" xlink:href="vtrs-20211231.xsd#vtrs_A2014ProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ProgramNameDomain_33c97b33-e48b-4a84-b93e-cfa702cc81fe" xlink:to="loc_vtrs_A2014ProgramMember_85554d38-4bd2-45df-90d4-610db1b0c22f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_6ef47259-fbe4-47c2-a155-0912644ed5cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_409f2cdd-ae72-401d-ae92-27064791db41" xlink:to="loc_us-gaap_PlanNameAxis_6ef47259-fbe4-47c2-a155-0912644ed5cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_6ef47259-fbe4-47c2-a155-0912644ed5cb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_6ef47259-fbe4-47c2-a155-0912644ed5cb" xlink:to="loc_us-gaap_PlanNameDomain_6ef47259-fbe4-47c2-a155-0912644ed5cb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_1c37ef9b-3d13-4622-8054-e6771d80c580" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_6ef47259-fbe4-47c2-a155-0912644ed5cb" xlink:to="loc_us-gaap_PlanNameDomain_1c37ef9b-3d13-4622-8054-e6771d80c580" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_LongTermIncentivePlan2003Member_52472416-9370-46ac-a74e-c258f3687d4c" xlink:href="vtrs-20211231.xsd#vtrs_LongTermIncentivePlan2003Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_1c37ef9b-3d13-4622-8054-e6771d80c580" xlink:to="loc_vtrs_LongTermIncentivePlan2003Member_52472416-9370-46ac-a74e-c258f3687d4c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#ShareBasedIncentivePlanNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails" xlink:type="extended" id="i57f5182ad51046fb9d1135cf93c94998_ShareBasedIncentivePlanNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fcc782d6-e74e-407e-a5cf-8f8c777366b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_7fbebc5c-a5e7-4ec3-b073-c00e023ba199" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fcc782d6-e74e-407e-a5cf-8f8c777366b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_7fbebc5c-a5e7-4ec3-b073-c00e023ba199" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_94f40e9f-0e43-431d-9bd8-37fa9241f35a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fcc782d6-e74e-407e-a5cf-8f8c777366b6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_94f40e9f-0e43-431d-9bd8-37fa9241f35a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_9d09cac8-c7db-46a7-a7be-67debb7eb159" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fcc782d6-e74e-407e-a5cf-8f8c777366b6" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_9d09cac8-c7db-46a7-a7be-67debb7eb159" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_7d41f61e-b754-442b-b289-ebad6f917a17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fcc782d6-e74e-407e-a5cf-8f8c777366b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_7d41f61e-b754-442b-b289-ebad6f917a17" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_c7db740d-671b-454a-9237-7dd0c383b328" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fcc782d6-e74e-407e-a5cf-8f8c777366b6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_c7db740d-671b-454a-9237-7dd0c383b328" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_e3dbfd1d-7da7-4b82-8f39-0013cc89620f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fcc782d6-e74e-407e-a5cf-8f8c777366b6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_e3dbfd1d-7da7-4b82-8f39-0013cc89620f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_35fb722b-df91-43be-b53c-6fed78e95397" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fcc782d6-e74e-407e-a5cf-8f8c777366b6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_35fb722b-df91-43be-b53c-6fed78e95397" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_cf993c4d-ce6d-4bb6-8157-32b41b827c69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fcc782d6-e74e-407e-a5cf-8f8c777366b6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_cf993c4d-ce6d-4bb6-8157-32b41b827c69" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_42817ab7-0daf-41f9-a566-995749bf0f1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fcc782d6-e74e-407e-a5cf-8f8c777366b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_42817ab7-0daf-41f9-a566-995749bf0f1c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_0bbe6bb2-f6f3-45d9-89eb-c8aec997648c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fcc782d6-e74e-407e-a5cf-8f8c777366b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_0bbe6bb2-f6f3-45d9-89eb-c8aec997648c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_adf1cb1c-59bf-490c-81b0-a3fc918a805c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fcc782d6-e74e-407e-a5cf-8f8c777366b6" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_adf1cb1c-59bf-490c-81b0-a3fc918a805c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_d483634f-70ba-4ae5-81ce-ef5c46c04bde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fcc782d6-e74e-407e-a5cf-8f8c777366b6" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_d483634f-70ba-4ae5-81ce-ef5c46c04bde" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue_45f3c28d-8acc-4b1c-be7a-e0973fc3964e" xlink:href="vtrs-20211231.xsd#vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fcc782d6-e74e-407e-a5cf-8f8c777366b6" xlink:to="loc_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue_45f3c28d-8acc-4b1c-be7a-e0973fc3964e" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ReductioninSharebasedCompensationExpense_aea64364-933a-4652-8ce6-dcda67634837" xlink:href="vtrs-20211231.xsd#vtrs_ReductioninSharebasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fcc782d6-e74e-407e-a5cf-8f8c777366b6" xlink:to="loc_vtrs_ReductioninSharebasedCompensationExpense_aea64364-933a-4652-8ce6-dcda67634837" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_546af484-7cf6-46e0-b398-e6b00445e9d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fcc782d6-e74e-407e-a5cf-8f8c777366b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_546af484-7cf6-46e0-b398-e6b00445e9d8" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_907c9963-86da-4a1f-814a-086244a1e06a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fcc782d6-e74e-407e-a5cf-8f8c777366b6" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_907c9963-86da-4a1f-814a-086244a1e06a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SubjecttoMarketConditionsAxis_7b140fcf-c48e-42be-8282-fa1c9a037614" xlink:href="vtrs-20211231.xsd#vtrs_SubjecttoMarketConditionsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_907c9963-86da-4a1f-814a-086244a1e06a" xlink:to="loc_vtrs_SubjecttoMarketConditionsAxis_7b140fcf-c48e-42be-8282-fa1c9a037614" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SubjecttoMarketConditionsDomain_7b140fcf-c48e-42be-8282-fa1c9a037614_default" xlink:href="vtrs-20211231.xsd#vtrs_SubjecttoMarketConditionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_vtrs_SubjecttoMarketConditionsAxis_7b140fcf-c48e-42be-8282-fa1c9a037614" xlink:to="loc_vtrs_SubjecttoMarketConditionsDomain_7b140fcf-c48e-42be-8282-fa1c9a037614_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SubjecttoMarketConditionsDomain_b08dd0c4-e84e-4c45-b368-98866f5c056b" xlink:href="vtrs-20211231.xsd#vtrs_SubjecttoMarketConditionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_vtrs_SubjecttoMarketConditionsAxis_7b140fcf-c48e-42be-8282-fa1c9a037614" xlink:to="loc_vtrs_SubjecttoMarketConditionsDomain_b08dd0c4-e84e-4c45-b368-98866f5c056b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NotSubjecttoMarketConditionsMember_4b880580-669f-4eb2-9bed-06130b979991" xlink:href="vtrs-20211231.xsd#vtrs_NotSubjecttoMarketConditionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_SubjecttoMarketConditionsDomain_b08dd0c4-e84e-4c45-b368-98866f5c056b" xlink:to="loc_vtrs_NotSubjecttoMarketConditionsMember_4b880580-669f-4eb2-9bed-06130b979991" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SubjectToMarketConditionsMember_21d4a100-9853-48d3-8f92-5e18f08be18b" xlink:href="vtrs-20211231.xsd#vtrs_SubjectToMarketConditionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_SubjecttoMarketConditionsDomain_b08dd0c4-e84e-4c45-b368-98866f5c056b" xlink:to="loc_vtrs_SubjectToMarketConditionsMember_21d4a100-9853-48d3-8f92-5e18f08be18b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ProgramNameAxis_3b447d6b-a353-4609-b9e5-0fd444e2d974" xlink:href="vtrs-20211231.xsd#vtrs_ProgramNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_907c9963-86da-4a1f-814a-086244a1e06a" xlink:to="loc_vtrs_ProgramNameAxis_3b447d6b-a353-4609-b9e5-0fd444e2d974" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ProgramNameDomain_3b447d6b-a353-4609-b9e5-0fd444e2d974_default" xlink:href="vtrs-20211231.xsd#vtrs_ProgramNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_vtrs_ProgramNameAxis_3b447d6b-a353-4609-b9e5-0fd444e2d974" xlink:to="loc_vtrs_ProgramNameDomain_3b447d6b-a353-4609-b9e5-0fd444e2d974_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ProgramNameDomain_89100e87-2b74-42f3-9efa-ab4a4b89298b" xlink:href="vtrs-20211231.xsd#vtrs_ProgramNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_vtrs_ProgramNameAxis_3b447d6b-a353-4609-b9e5-0fd444e2d974" xlink:to="loc_vtrs_ProgramNameDomain_89100e87-2b74-42f3-9efa-ab4a4b89298b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2014ProgramMember_0dcb2bfb-620d-4858-8997-cd7027137be6" xlink:href="vtrs-20211231.xsd#vtrs_A2014ProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ProgramNameDomain_89100e87-2b74-42f3-9efa-ab4a4b89298b" xlink:to="loc_vtrs_A2014ProgramMember_0dcb2bfb-620d-4858-8997-cd7027137be6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_c0b0c46c-795c-4e17-bad0-f3676f8cc141" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_907c9963-86da-4a1f-814a-086244a1e06a" xlink:to="loc_us-gaap_PlanNameAxis_c0b0c46c-795c-4e17-bad0-f3676f8cc141" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_c0b0c46c-795c-4e17-bad0-f3676f8cc141_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_c0b0c46c-795c-4e17-bad0-f3676f8cc141" xlink:to="loc_us-gaap_PlanNameDomain_c0b0c46c-795c-4e17-bad0-f3676f8cc141_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_09cc4669-8b3a-4910-bec3-d33986af7702" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_c0b0c46c-795c-4e17-bad0-f3676f8cc141" xlink:to="loc_us-gaap_PlanNameDomain_09cc4669-8b3a-4910-bec3-d33986af7702" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_LongTermIncentivePlan2003Member_60facc99-a4d1-4e21-8eb4-85684ef4bf72" xlink:href="vtrs-20211231.xsd#vtrs_LongTermIncentivePlan2003Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_09cc4669-8b3a-4910-bec3-d33986af7702" xlink:to="loc_vtrs_LongTermIncentivePlan2003Member_60facc99-a4d1-4e21-8eb4-85684ef4bf72" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OneTimeSpecialPerformanceBasedFiveYearRealizableValueIncentiveProgramMember_25ae2150-2b37-4a6a-b824-546ad12f906d" xlink:href="vtrs-20211231.xsd#vtrs_OneTimeSpecialPerformanceBasedFiveYearRealizableValueIncentiveProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_09cc4669-8b3a-4910-bec3-d33986af7702" xlink:to="loc_vtrs_OneTimeSpecialPerformanceBasedFiveYearRealizableValueIncentiveProgramMember_25ae2150-2b37-4a6a-b824-546ad12f906d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember_ce879d7d-2876-4d31-8770-d7547a0b2c8b" xlink:href="vtrs-20211231.xsd#vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_09cc4669-8b3a-4910-bec3-d33986af7702" xlink:to="loc_vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember_ce879d7d-2876-4d31-8770-d7547a0b2c8b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_bae33c28-3be8-4c31-af19-ed0ee4a03a29" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_907c9963-86da-4a1f-814a-086244a1e06a" xlink:to="loc_srt_RangeAxis_bae33c28-3be8-4c31-af19-ed0ee4a03a29" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bae33c28-3be8-4c31-af19-ed0ee4a03a29_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_bae33c28-3be8-4c31-af19-ed0ee4a03a29" xlink:to="loc_srt_RangeMember_bae33c28-3be8-4c31-af19-ed0ee4a03a29_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fc017cf2-0754-44cb-b6ee-476407aa6122" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_bae33c28-3be8-4c31-af19-ed0ee4a03a29" xlink:to="loc_srt_RangeMember_fc017cf2-0754-44cb-b6ee-476407aa6122" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_53d9329e-7d02-438d-a684-5db10ca1db3c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_fc017cf2-0754-44cb-b6ee-476407aa6122" xlink:to="loc_srt_MinimumMember_53d9329e-7d02-438d-a684-5db10ca1db3c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_0837e2d1-f2c3-47ad-8e5e-8cc98da71d86" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_fc017cf2-0754-44cb-b6ee-476407aa6122" xlink:to="loc_srt_MaximumMember_0837e2d1-f2c3-47ad-8e5e-8cc98da71d86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_ebbc40b2-c172-455d-81a2-9e205f46829c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_907c9963-86da-4a1f-814a-086244a1e06a" xlink:to="loc_us-gaap_AwardTypeAxis_ebbc40b2-c172-455d-81a2-9e205f46829c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ebbc40b2-c172-455d-81a2-9e205f46829c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_ebbc40b2-c172-455d-81a2-9e205f46829c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ebbc40b2-c172-455d-81a2-9e205f46829c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_23f9ead7-f505-4d45-a7a2-beef002a8dde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_ebbc40b2-c172-455d-81a2-9e205f46829c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_23f9ead7-f505-4d45-a7a2-beef002a8dde" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_f045b7be-5c43-4d8d-bb3b-19ce7ce910a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_23f9ead7-f505-4d45-a7a2-beef002a8dde" xlink:to="loc_us-gaap_EmployeeStockOptionMember_f045b7be-5c43-4d8d-bb3b-19ce7ce910a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_StockappreciationrightsandperformancesharesMember_e626b9af-925c-4a8a-b5b5-96b9ed2f98a5" xlink:href="vtrs-20211231.xsd#vtrs_StockappreciationrightsandperformancesharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_23f9ead7-f505-4d45-a7a2-beef002a8dde" xlink:to="loc_vtrs_StockappreciationrightsandperformancesharesMember_e626b9af-925c-4a8a-b5b5-96b9ed2f98a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_626094af-b19b-4b7d-85e0-f371d821400c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_23f9ead7-f505-4d45-a7a2-beef002a8dde" xlink:to="loc_us-gaap_RestrictedStockMember_626094af-b19b-4b7d-85e0-f371d821400c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_8f8c40c1-307a-45e7-a600-812b8358bd29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_23f9ead7-f505-4d45-a7a2-beef002a8dde" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_8f8c40c1-307a-45e7-a600-812b8358bd29" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_1eba0fd1-d605-4624-8fe2-dabe091a03e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_23f9ead7-f505-4d45-a7a2-beef002a8dde" xlink:to="loc_us-gaap_PerformanceSharesMember_1eba0fd1-d605-4624-8fe2-dabe091a03e5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NotSubjecttoMarketConditionsMember_a5586b14-b521-4181-bb5d-589d13de9055" xlink:href="vtrs-20211231.xsd#vtrs_NotSubjecttoMarketConditionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_23f9ead7-f505-4d45-a7a2-beef002a8dde" xlink:to="loc_vtrs_NotSubjecttoMarketConditionsMember_a5586b14-b521-4181-bb5d-589d13de9055" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VestingPeriodAxis_37ca4bc9-9196-4330-8779-e500fdf6f1e9" xlink:href="vtrs-20211231.xsd#vtrs_VestingPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_907c9963-86da-4a1f-814a-086244a1e06a" xlink:to="loc_vtrs_VestingPeriodAxis_37ca4bc9-9196-4330-8779-e500fdf6f1e9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VestingPeriodDomain_37ca4bc9-9196-4330-8779-e500fdf6f1e9_default" xlink:href="vtrs-20211231.xsd#vtrs_VestingPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_vtrs_VestingPeriodAxis_37ca4bc9-9196-4330-8779-e500fdf6f1e9" xlink:to="loc_vtrs_VestingPeriodDomain_37ca4bc9-9196-4330-8779-e500fdf6f1e9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VestingPeriodDomain_82776c3c-3ba6-4c43-ac49-2f8d31de8629" xlink:href="vtrs-20211231.xsd#vtrs_VestingPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_vtrs_VestingPeriodAxis_37ca4bc9-9196-4330-8779-e500fdf6f1e9" xlink:to="loc_vtrs_VestingPeriodDomain_82776c3c-3ba6-4c43-ac49-2f8d31de8629" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VestratablyinfiveyearsorlessMember_0e6d0393-8d18-479e-b84c-63571f723f6b" xlink:href="vtrs-20211231.xsd#vtrs_VestratablyinfiveyearsorlessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_VestingPeriodDomain_82776c3c-3ba6-4c43-ac49-2f8d31de8629" xlink:to="loc_vtrs_VestratablyinfiveyearsorlessMember_0e6d0393-8d18-479e-b84c-63571f723f6b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VestinthreeyearsorlessMember_98a3f673-4c73-45fe-8e11-77b845048f27" xlink:href="vtrs-20211231.xsd#vtrs_VestinthreeyearsorlessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_VestingPeriodDomain_82776c3c-3ba6-4c43-ac49-2f8d31de8629" xlink:to="loc_vtrs_VestinthreeyearsorlessMember_98a3f673-4c73-45fe-8e11-77b845048f27" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails" xlink:type="extended" id="i28e62a8bc7ac4bbc8d6fd510c9e0acb1_ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2418ca90-48bb-407e-a0f9-97a5118b7d01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9d913ca9-758b-4bf0-aac2-b66157917fc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2418ca90-48bb-407e-a0f9-97a5118b7d01" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9d913ca9-758b-4bf0-aac2-b66157917fc5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6d780244-06de-4079-93a1-bb14dc02f55c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9d913ca9-758b-4bf0-aac2-b66157917fc5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6d780244-06de-4079-93a1-bb14dc02f55c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_7dc64799-1d60-4e4d-a8fc-ef7b169a2051" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9d913ca9-758b-4bf0-aac2-b66157917fc5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_7dc64799-1d60-4e4d-a8fc-ef7b169a2051" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_bfa7e57b-8688-4004-b43c-c1d8f5e36ea7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9d913ca9-758b-4bf0-aac2-b66157917fc5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_bfa7e57b-8688-4004-b43c-c1d8f5e36ea7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0d0f8618-ee1f-4756-80b4-c42836d078bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9d913ca9-758b-4bf0-aac2-b66157917fc5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0d0f8618-ee1f-4756-80b4-c42836d078bd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_82b8daa8-fcab-4aae-9b84-e4faa6450495" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9d913ca9-758b-4bf0-aac2-b66157917fc5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_82b8daa8-fcab-4aae-9b84-e4faa6450495" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_52431320-1b06-4236-94fb-026fb644ce60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9d913ca9-758b-4bf0-aac2-b66157917fc5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_52431320-1b06-4236-94fb-026fb644ce60" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_59943245-8a66-42b7-983c-01a07ae6ee84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9d913ca9-758b-4bf0-aac2-b66157917fc5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_59943245-8a66-42b7-983c-01a07ae6ee84" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_6d007a92-0167-4485-ae2e-decebc5ba4f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9d913ca9-758b-4bf0-aac2-b66157917fc5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_6d007a92-0167-4485-ae2e-decebc5ba4f2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_9769c083-f652-48d2-b446-d9ab190685d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_27a21958-e852-4c52-ab0f-a74ce3f7e37f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e98c7820-f076-4dde-8fcd-fc9ff79aeaad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2418ca90-48bb-407e-a0f9-97a5118b7d01" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e98c7820-f076-4dde-8fcd-fc9ff79aeaad" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_618947af-8d66-413b-9c07-f46ba2418b51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e98c7820-f076-4dde-8fcd-fc9ff79aeaad" xlink:to="loc_us-gaap_AwardTypeAxis_618947af-8d66-413b-9c07-f46ba2418b51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_618947af-8d66-413b-9c07-f46ba2418b51_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_618947af-8d66-413b-9c07-f46ba2418b51" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_618947af-8d66-413b-9c07-f46ba2418b51_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b6bef024-69b5-4d73-965f-3365e5d0ea4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_618947af-8d66-413b-9c07-f46ba2418b51" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b6bef024-69b5-4d73-965f-3365e5d0ea4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_1d46f629-1ab9-4d0f-a6d1-6270160019e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b6bef024-69b5-4d73-965f-3365e5d0ea4b" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_1d46f629-1ab9-4d0f-a6d1-6270160019e9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ShareBasedIncentivePlanValuationAssumptionsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#ShareBasedIncentivePlanValuationAssumptionsDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/ShareBasedIncentivePlanValuationAssumptionsDetails" xlink:type="extended" id="i20fd738b2a744856b464aaa03a3735f4_ShareBasedIncentivePlanValuationAssumptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_760d53c7-201f-4736-9e1f-ae1578ec99a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_fd157880-0e96-4824-bb71-82f9282f2f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_760d53c7-201f-4736-9e1f-ae1578ec99a2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_fd157880-0e96-4824-bb71-82f9282f2f8f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_6dc3f8a1-9825-42bc-8c20-079c460dda05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_760d53c7-201f-4736-9e1f-ae1578ec99a2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_6dc3f8a1-9825-42bc-8c20-079c460dda05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_cdadaf33-c09b-43f5-bd18-efe881c8d779" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_760d53c7-201f-4736-9e1f-ae1578ec99a2" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_cdadaf33-c09b-43f5-bd18-efe881c8d779" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate_9572cd40-4ed1-4284-80f3-de3cb2aec4d5" xlink:href="vtrs-20211231.xsd#vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_760d53c7-201f-4736-9e1f-ae1578ec99a2" xlink:to="loc_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate_9572cd40-4ed1-4284-80f3-de3cb2aec4d5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_8a540c03-20e6-4bab-8db0-9018bde7ef70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_760d53c7-201f-4736-9e1f-ae1578ec99a2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_8a540c03-20e6-4bab-8db0-9018bde7ef70" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e1b725e1-ee7a-4dea-8ccf-437b02ccb7a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_760d53c7-201f-4736-9e1f-ae1578ec99a2" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e1b725e1-ee7a-4dea-8ccf-437b02ccb7a6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_e800d002-58b8-4ce4-a82d-f830025204c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e1b725e1-ee7a-4dea-8ccf-437b02ccb7a6" xlink:to="loc_us-gaap_PlanNameAxis_e800d002-58b8-4ce4-a82d-f830025204c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_e800d002-58b8-4ce4-a82d-f830025204c6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_e800d002-58b8-4ce4-a82d-f830025204c6" xlink:to="loc_us-gaap_PlanNameDomain_e800d002-58b8-4ce4-a82d-f830025204c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_d65edb4d-02d5-4207-babf-06fe1e4a9af9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_e800d002-58b8-4ce4-a82d-f830025204c6" xlink:to="loc_us-gaap_PlanNameDomain_d65edb4d-02d5-4207-babf-06fe1e4a9af9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_LongTermIncentivePlan2003Member_d7eb03a6-0a03-431b-963f-bdfc643de0fb" xlink:href="vtrs-20211231.xsd#vtrs_LongTermIncentivePlan2003Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_d65edb4d-02d5-4207-babf-06fe1e4a9af9" xlink:to="loc_vtrs_LongTermIncentivePlan2003Member_d7eb03a6-0a03-431b-963f-bdfc643de0fb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ProgramNameAxis_fc746548-a377-4ae7-a096-b1356135015c" xlink:href="vtrs-20211231.xsd#vtrs_ProgramNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e1b725e1-ee7a-4dea-8ccf-437b02ccb7a6" xlink:to="loc_vtrs_ProgramNameAxis_fc746548-a377-4ae7-a096-b1356135015c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ProgramNameDomain_fc746548-a377-4ae7-a096-b1356135015c_default" xlink:href="vtrs-20211231.xsd#vtrs_ProgramNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_vtrs_ProgramNameAxis_fc746548-a377-4ae7-a096-b1356135015c" xlink:to="loc_vtrs_ProgramNameDomain_fc746548-a377-4ae7-a096-b1356135015c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ProgramNameDomain_006a728b-2562-44b8-9c91-5f18b48fadff" xlink:href="vtrs-20211231.xsd#vtrs_ProgramNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_vtrs_ProgramNameAxis_fc746548-a377-4ae7-a096-b1356135015c" xlink:to="loc_vtrs_ProgramNameDomain_006a728b-2562-44b8-9c91-5f18b48fadff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2014ProgramMember_6bf25176-c269-4c39-91ef-49fa665e0680" xlink:href="vtrs-20211231.xsd#vtrs_A2014ProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_ProgramNameDomain_006a728b-2562-44b8-9c91-5f18b48fadff" xlink:to="loc_vtrs_A2014ProgramMember_6bf25176-c269-4c39-91ef-49fa665e0680" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_3209e667-6f41-4529-b3b6-b13be19c3230" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e1b725e1-ee7a-4dea-8ccf-437b02ccb7a6" xlink:to="loc_us-gaap_AwardTypeAxis_3209e667-6f41-4529-b3b6-b13be19c3230" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3209e667-6f41-4529-b3b6-b13be19c3230_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_3209e667-6f41-4529-b3b6-b13be19c3230" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3209e667-6f41-4529-b3b6-b13be19c3230_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b4d2dcad-29e2-4d44-a61e-5d259c8456f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_3209e667-6f41-4529-b3b6-b13be19c3230" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b4d2dcad-29e2-4d44-a61e-5d259c8456f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_2580dff7-c629-4f0f-bf41-51bdd7989e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b4d2dcad-29e2-4d44-a61e-5d259c8456f0" xlink:to="loc_us-gaap_EmployeeStockOptionMember_2580dff7-c629-4f0f-bf41-51bdd7989e5c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_StockappreciationrightsandperformancesharesMember_8229cd7c-8bef-4dc0-964d-f17059109075" xlink:href="vtrs-20211231.xsd#vtrs_StockappreciationrightsandperformancesharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b4d2dcad-29e2-4d44-a61e-5d259c8456f0" xlink:to="loc_vtrs_StockappreciationrightsandperformancesharesMember_8229cd7c-8bef-4dc0-964d-f17059109075" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_852b69dd-ec02-4f68-a709-3cc94df3f478" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b4d2dcad-29e2-4d44-a61e-5d259c8456f0" xlink:to="loc_us-gaap_PerformanceSharesMember_852b69dd-ec02-4f68-a709-3cc94df3f478" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EmployeeBenefitPlansNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#EmployeeBenefitPlansNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/EmployeeBenefitPlansNarrativeDetails" xlink:type="extended" id="i50121af7d19144ba8a106fd4dcdabb23_EmployeeBenefitPlansNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d0988e92-4a00-45b6-b977-e12fa18ed813" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear_8dea67bf-499c-4a77-89cb-3453a406e046" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d0988e92-4a00-45b6-b977-e12fa18ed813" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear_8dea67bf-499c-4a77-89cb-3453a406e046" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear_1f50637d-f4c9-4223-8de0-8f657249404c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d0988e92-4a00-45b6-b977-e12fa18ed813" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear_1f50637d-f4c9-4223-8de0-8f657249404c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccumulatednetactuariallossesexceedhigherofmarketvalueofplanassetsorPBO_b4a5522b-29ab-466b-8f44-4ac48fa324d1" xlink:href="vtrs-20211231.xsd#vtrs_AccumulatednetactuariallossesexceedhigherofmarketvalueofplanassetsorPBO"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d0988e92-4a00-45b6-b977-e12fa18ed813" xlink:to="loc_vtrs_AccumulatednetactuariallossesexceedhigherofmarketvalueofplanassetsorPBO_b4a5522b-29ab-466b-8f44-4ac48fa324d1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_be1d976c-504b-4323-bc7c-2c4155ddf55a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d0988e92-4a00-45b6-b977-e12fa18ed813" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_be1d976c-504b-4323-bc7c-2c4155ddf55a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear_a1f0dc52-2fb8-4d56-903f-660e70e364bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d0988e92-4a00-45b6-b977-e12fa18ed813" xlink:to="loc_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear_a1f0dc52-2fb8-4d56-903f-660e70e364bf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1_2e4f33eb-679a-4053-928c-bd9d6a346b6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d0988e92-4a00-45b6-b977-e12fa18ed813" xlink:to="loc_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1_2e4f33eb-679a-4053-928c-bd9d6a346b6b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_f6b805c8-e340-4375-a6c5-0c1304697472" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d0988e92-4a00-45b6-b977-e12fa18ed813" xlink:to="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_f6b805c8-e340-4375-a6c5-0c1304697472" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_eee82d9f-f0bd-4074-994e-fd46c96a9efd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d0988e92-4a00-45b6-b977-e12fa18ed813" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_eee82d9f-f0bd-4074-994e-fd46c96a9efd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MultiemployerPlansWithdrawalObligation_ee3c8cf4-c523-449e-9154-a0d2dc7b66c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MultiemployerPlansWithdrawalObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d0988e92-4a00-45b6-b977-e12fa18ed813" xlink:to="loc_us-gaap_MultiemployerPlansWithdrawalObligation_ee3c8cf4-c523-449e-9154-a0d2dc7b66c1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_24fe24f0-3335-4f5a-8d42-88c1e2b3a076" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d0988e92-4a00-45b6-b977-e12fa18ed813" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_24fe24f0-3335-4f5a-8d42-88c1e2b3a076" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis_f5a47223-f78c-4f84-81dc-bcf10ebef885" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_24fe24f0-3335-4f5a-8d42-88c1e2b3a076" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis_f5a47223-f78c-4f84-81dc-bcf10ebef885" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain_f5a47223-f78c-4f84-81dc-bcf10ebef885_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis_f5a47223-f78c-4f84-81dc-bcf10ebef885" xlink:to="loc_us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain_f5a47223-f78c-4f84-81dc-bcf10ebef885_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain_327542cb-b6b1-4a47-9449-551f79bb06c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis_f5a47223-f78c-4f84-81dc-bcf10ebef885" xlink:to="loc_us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain_327542cb-b6b1-4a47-9449-551f79bb06c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DeferredBaseSalaryMember_37edfd3a-2196-4701-b4c4-cd57082516cd" xlink:href="vtrs-20211231.xsd#vtrs_DeferredBaseSalaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain_327542cb-b6b1-4a47-9449-551f79bb06c1" xlink:to="loc_vtrs_DeferredBaseSalaryMember_37edfd3a-2196-4701-b4c4-cd57082516cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredBonusMember_4529a12e-0c74-4c34-8e5a-2c8d647607e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredBonusMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain_327542cb-b6b1-4a47-9449-551f79bb06c1" xlink:to="loc_us-gaap_DeferredBonusMember_4529a12e-0c74-4c34-8e5a-2c8d647607e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PeriodAxis_752e6d97-bedb-45fa-8292-ac027b5854ae" xlink:href="vtrs-20211231.xsd#vtrs_PeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_24fe24f0-3335-4f5a-8d42-88c1e2b3a076" xlink:to="loc_vtrs_PeriodAxis_752e6d97-bedb-45fa-8292-ac027b5854ae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PeriodDomain_752e6d97-bedb-45fa-8292-ac027b5854ae_default" xlink:href="vtrs-20211231.xsd#vtrs_PeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_vtrs_PeriodAxis_752e6d97-bedb-45fa-8292-ac027b5854ae" xlink:to="loc_vtrs_PeriodDomain_752e6d97-bedb-45fa-8292-ac027b5854ae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PeriodDomain_291f9cb2-81a9-477b-9f1f-07e230042925" xlink:href="vtrs-20211231.xsd#vtrs_PeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_vtrs_PeriodAxis_752e6d97-bedb-45fa-8292-ac027b5854ae" xlink:to="loc_vtrs_PeriodDomain_291f9cb2-81a9-477b-9f1f-07e230042925" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_FiscalYear2017Member_8644f725-47c9-4bb2-974d-7863f132058b" xlink:href="vtrs-20211231.xsd#vtrs_FiscalYear2017Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_PeriodDomain_291f9cb2-81a9-477b-9f1f-07e230042925" xlink:to="loc_vtrs_FiscalYear2017Member_8644f725-47c9-4bb2-974d-7863f132058b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EmployeeBenefitPlansAccumulatedOtherComprehensiveIncomeLossPretaxAmountsNotYetReclassifiedinNetPeriodicBenefitCostDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#EmployeeBenefitPlansAccumulatedOtherComprehensiveIncomeLossPretaxAmountsNotYetReclassifiedinNetPeriodicBenefitCostDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/EmployeeBenefitPlansAccumulatedOtherComprehensiveIncomeLossPretaxAmountsNotYetReclassifiedinNetPeriodicBenefitCostDetails" xlink:type="extended" id="idb01ebc76d134e0aa91bd088630bb8f4_EmployeeBenefitPlansAccumulatedOtherComprehensiveIncomeLossPretaxAmountsNotYetReclassifiedinNetPeriodicBenefitCostDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_0d75ffdf-2b52-464b-acca-c30da6149a5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_3afd485c-1e9a-46d5-abb4-36320bdfd968" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_0d75ffdf-2b52-464b-acca-c30da6149a5b" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_3afd485c-1e9a-46d5-abb4-36320bdfd968" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_47652f4e-2380-4e7d-84d1-8f17284708d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_0d75ffdf-2b52-464b-acca-c30da6149a5b" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_47652f4e-2380-4e7d-84d1-8f17284708d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_b1ec693b-abcc-4f62-8184-5dd76b13d1ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_0d75ffdf-2b52-464b-acca-c30da6149a5b" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_b1ec693b-abcc-4f62-8184-5dd76b13d1ae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_0e268011-0ec9-4769-8178-493f8575450a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_0d75ffdf-2b52-464b-acca-c30da6149a5b" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_0e268011-0ec9-4769-8178-493f8575450a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_178e2d4d-16ce-4197-90fd-1cf348ebb795" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_0e268011-0ec9-4769-8178-493f8575450a" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_178e2d4d-16ce-4197-90fd-1cf348ebb795" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_178e2d4d-16ce-4197-90fd-1cf348ebb795_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_178e2d4d-16ce-4197-90fd-1cf348ebb795" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_178e2d4d-16ce-4197-90fd-1cf348ebb795_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_7b0ebac3-5b6a-430e-8f5d-c68f915a5540" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_178e2d4d-16ce-4197-90fd-1cf348ebb795" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_7b0ebac3-5b6a-430e-8f5d-c68f915a5540" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_ceadcddd-95d2-4392-94ef-0c8bd84400a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_7b0ebac3-5b6a-430e-8f5d-c68f915a5540" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_ceadcddd-95d2-4392-94ef-0c8bd84400a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_12ae7f28-07ac-4c13-b83b-7db4a697218f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_7b0ebac3-5b6a-430e-8f5d-c68f915a5540" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_12ae7f28-07ac-4c13-b83b-7db4a697218f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EmployeeBenefitPlansChangeinAccumulatedIncomeLossRelatingtoDefinedBenefitPensionandOtherPostretirementBenefitsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#EmployeeBenefitPlansChangeinAccumulatedIncomeLossRelatingtoDefinedBenefitPensionandOtherPostretirementBenefitsDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/EmployeeBenefitPlansChangeinAccumulatedIncomeLossRelatingtoDefinedBenefitPensionandOtherPostretirementBenefitsDetails" xlink:type="extended" id="iee9cb1b5297d4a74952192bf604b7646_EmployeeBenefitPlansChangeinAccumulatedIncomeLossRelatingtoDefinedBenefitPensionandOtherPostretirementBenefitsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_ead502fe-196a-42a3-830b-d3e11eb6e156" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_e8e5f71f-6dc9-422d-9a14-0c47437aa199" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_ead502fe-196a-42a3-830b-d3e11eb6e156" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_e8e5f71f-6dc9-422d-9a14-0c47437aa199" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_9dd6b58f-f6f0-487f-90d2-e595f6d0c6e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_ead502fe-196a-42a3-830b-d3e11eb6e156" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_9dd6b58f-f6f0-487f-90d2-e595f6d0c6e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_99330c72-e754-45d1-b7d6-6893f0c86d1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_ead502fe-196a-42a3-830b-d3e11eb6e156" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_99330c72-e754-45d1-b7d6-6893f0c86d1f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax_cdf72e4b-9f2c-4906-8e40-4de26e48d621" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_ead502fe-196a-42a3-830b-d3e11eb6e156" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax_cdf72e4b-9f2c-4906-8e40-4de26e48d621" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherComprehensiveIncomeDefinedBenefitPlanForeignCurrencyTranslationBeforeTax_c14b209d-3c16-424c-a2db-46692695595f" xlink:href="vtrs-20211231.xsd#vtrs_OtherComprehensiveIncomeDefinedBenefitPlanForeignCurrencyTranslationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_ead502fe-196a-42a3-830b-d3e11eb6e156" xlink:to="loc_vtrs_OtherComprehensiveIncomeDefinedBenefitPlanForeignCurrencyTranslationBeforeTax_c14b209d-3c16-424c-a2db-46692695595f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_ebb3da7c-e101-4805-983f-99a0ace0c4d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_ead502fe-196a-42a3-830b-d3e11eb6e156" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_ebb3da7c-e101-4805-983f-99a0ace0c4d9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_83bdb476-de88-40d7-af9b-be9b5f8716da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_ead502fe-196a-42a3-830b-d3e11eb6e156" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_83bdb476-de88-40d7-af9b-be9b5f8716da" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_3bb85904-2408-472a-9f38-58584e4789a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_83bdb476-de88-40d7-af9b-be9b5f8716da" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_3bb85904-2408-472a-9f38-58584e4789a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_3bb85904-2408-472a-9f38-58584e4789a1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_3bb85904-2408-472a-9f38-58584e4789a1" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_3bb85904-2408-472a-9f38-58584e4789a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_d8da7ef5-30a6-4e47-9166-351c8e37bcaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_3bb85904-2408-472a-9f38-58584e4789a1" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_d8da7ef5-30a6-4e47-9166-351c8e37bcaf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_205d8117-ecc4-4dec-91e5-f604cb9115a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_d8da7ef5-30a6-4e47-9166-351c8e37bcaf" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_205d8117-ecc4-4dec-91e5-f604cb9115a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_3ae57b71-0ec1-4f8d-a152-b7e649aa19b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_d8da7ef5-30a6-4e47-9166-351c8e37bcaf" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_3ae57b71-0ec1-4f8d-a152-b7e649aa19b2" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EmployeeBenefitPlansNetPeriodicBenefitCostsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#EmployeeBenefitPlansNetPeriodicBenefitCostsDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/EmployeeBenefitPlansNetPeriodicBenefitCostsDetails" xlink:type="extended" id="i4137cbbffeef4e96a24befe616803c93_EmployeeBenefitPlansNetPeriodicBenefitCostsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_efaac62d-7cb0-41a0-aa5f-5630745814c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_64fed9b4-910d-4898-810e-cc96627c10ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_efaac62d-7cb0-41a0-aa5f-5630745814c2" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_64fed9b4-910d-4898-810e-cc96627c10ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_ef11b9f6-c806-4ac8-a4dc-755be1b5efa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_efaac62d-7cb0-41a0-aa5f-5630745814c2" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_ef11b9f6-c806-4ac8-a4dc-755be1b5efa2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_c0eac9b0-6b83-4192-8852-4a6bf55af822" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_efaac62d-7cb0-41a0-aa5f-5630745814c2" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_c0eac9b0-6b83-4192-8852-4a6bf55af822" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCurtailments_1b5c6f04-3c7a-4176-a163-2ddedbaf3dba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanCurtailments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_efaac62d-7cb0-41a0-aa5f-5630745814c2" xlink:to="loc_us-gaap_DefinedBenefitPlanCurtailments_1b5c6f04-3c7a-4176-a163-2ddedbaf3dba" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_1147f2ef-94d1-4502-9563-e3487b0737bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_efaac62d-7cb0-41a0-aa5f-5630745814c2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_1147f2ef-94d1-4502-9563-e3487b0737bf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_0fbb0cf0-ec2c-4807-b52b-529ef4a51dfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_efaac62d-7cb0-41a0-aa5f-5630745814c2" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_0fbb0cf0-ec2c-4807-b52b-529ef4a51dfb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_0b7d68e5-f073-4c3b-8284-0162baba8179" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_efaac62d-7cb0-41a0-aa5f-5630745814c2" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_0b7d68e5-f073-4c3b-8284-0162baba8179" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_68dbe95b-c5a4-4375-8ca5-8bcb73cee4b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_efaac62d-7cb0-41a0-aa5f-5630745814c2" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_68dbe95b-c5a4-4375-8ca5-8bcb73cee4b0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_06387610-3fbb-4468-ac8b-2f581f186f8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_68dbe95b-c5a4-4375-8ca5-8bcb73cee4b0" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_06387610-3fbb-4468-ac8b-2f581f186f8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_06387610-3fbb-4468-ac8b-2f581f186f8d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_06387610-3fbb-4468-ac8b-2f581f186f8d" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_06387610-3fbb-4468-ac8b-2f581f186f8d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_a45a7f7d-d93e-4beb-beb7-2d33483af7d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_06387610-3fbb-4468-ac8b-2f581f186f8d" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_a45a7f7d-d93e-4beb-beb7-2d33483af7d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember_e964a91b-9323-4be6-b6f6-3d71d5da3261" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_a45a7f7d-d93e-4beb-beb7-2d33483af7d5" xlink:to="loc_us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember_e964a91b-9323-4be6-b6f6-3d71d5da3261" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_6368838a-f993-47aa-89b0-0cae4146f04d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_a45a7f7d-d93e-4beb-beb7-2d33483af7d5" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_6368838a-f993-47aa-89b0-0cae4146f04d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_72961e4a-6904-4dba-a5b9-38b39bf30ead" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_a45a7f7d-d93e-4beb-beb7-2d33483af7d5" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_72961e4a-6904-4dba-a5b9-38b39bf30ead" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EmployeeBenefitPlansChangesinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#EmployeeBenefitPlansChangesinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/EmployeeBenefitPlansChangesinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails" xlink:type="extended" id="i6eb9b69e3b444bd9bff30cf33f00da09_EmployeeBenefitPlansChangesinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_c9022b2a-1577-47df-b2d6-488558bcf006" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f01528ac-f1a3-453e-903c-bb8ed2021ad4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_c9022b2a-1577-47df-b2d6-488558bcf006" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f01528ac-f1a3-453e-903c-bb8ed2021ad4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_91d1e241-86d9-4816-8b81-0df150451331" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f01528ac-f1a3-453e-903c-bb8ed2021ad4" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_91d1e241-86d9-4816-8b81-0df150451331" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_c54f051d-9b79-4576-9c0b-bc19202a406a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f01528ac-f1a3-453e-903c-bb8ed2021ad4" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_c54f051d-9b79-4576-9c0b-bc19202a406a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_fc70e8be-7176-488b-964c-6f75e968e3da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f01528ac-f1a3-453e-903c-bb8ed2021ad4" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_fc70e8be-7176-488b-964c-6f75e968e3da" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DefinedBenefitPlanContributionsByPlanParticipantsBenefitObligation_96a16bf3-91e1-475f-9df7-0fe39a2ef158" xlink:href="vtrs-20211231.xsd#vtrs_DefinedBenefitPlanContributionsByPlanParticipantsBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f01528ac-f1a3-453e-903c-bb8ed2021ad4" xlink:to="loc_vtrs_DefinedBenefitPlanContributionsByPlanParticipantsBenefitObligation_96a16bf3-91e1-475f-9df7-0fe39a2ef158" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAssetsTransferredtofromPlan_8dce51b0-afc7-4034-8c8b-2d4a27da0e37" xlink:href="vtrs-20211231.xsd#vtrs_DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAssetsTransferredtofromPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f01528ac-f1a3-453e-903c-bb8ed2021ad4" xlink:to="loc_vtrs_DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAssetsTransferredtofromPlan_8dce51b0-afc7-4034-8c8b-2d4a27da0e37" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_d2385f1e-ac64-4fb1-bc02-232a3064d7e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f01528ac-f1a3-453e-903c-bb8ed2021ad4" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_d2385f1e-ac64-4fb1-bc02-232a3064d7e1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_70c8a88f-5b70-496d-ac79-4ce66938deee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f01528ac-f1a3-453e-903c-bb8ed2021ad4" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_70c8a88f-5b70-496d-ac79-4ce66938deee" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_d1fcdc6e-c35e-4e46-b9ea-a81c249a9190" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f01528ac-f1a3-453e-903c-bb8ed2021ad4" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_d1fcdc6e-c35e-4e46-b9ea-a81c249a9190" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_38911312-115e-4264-b728-6d73c358e4cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f01528ac-f1a3-453e-903c-bb8ed2021ad4" xlink:to="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_38911312-115e-4264-b728-6d73c358e4cd" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_236dad45-bc12-4c78-be83-0fee556d5e33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_be171d3b-07b4-464a-86e0-e98e98f59de1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_c9022b2a-1577-47df-b2d6-488558bcf006" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_be171d3b-07b4-464a-86e0-e98e98f59de1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_7581f41b-74ae-49ef-bd31-b7e7b4baeccc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_be171d3b-07b4-464a-86e0-e98e98f59de1" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_7581f41b-74ae-49ef-bd31-b7e7b4baeccc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_d6bd019e-ea14-41fa-ad2a-451634b00da9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_be171d3b-07b4-464a-86e0-e98e98f59de1" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_d6bd019e-ea14-41fa-ad2a-451634b00da9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_005773d6-ac85-4b08-8332-fa4fb996fe4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_be171d3b-07b4-464a-86e0-e98e98f59de1" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_005773d6-ac85-4b08-8332-fa4fb996fe4a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_6b55296f-c5d2-4f8c-b885-884adc4396f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_be171d3b-07b4-464a-86e0-e98e98f59de1" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_6b55296f-c5d2-4f8c-b885-884adc4396f0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets_73044789-cfde-43ed-a8e4-06d001b66579" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_be171d3b-07b4-464a-86e0-e98e98f59de1" xlink:to="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets_73044789-cfde-43ed-a8e4-06d001b66579" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan_0bc72795-1dbe-4d16-a15c-466d2d9ad959" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_be171d3b-07b4-464a-86e0-e98e98f59de1" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan_0bc72795-1dbe-4d16-a15c-466d2d9ad959" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_4e0a1ac7-142e-4050-91f0-8c2f69cb0c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_be171d3b-07b4-464a-86e0-e98e98f59de1" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_4e0a1ac7-142e-4050-91f0-8c2f69cb0c6e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanOtherCosts_de2976dc-781e-40e9-a3fb-3d031dbf3c01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanOtherCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_be171d3b-07b4-464a-86e0-e98e98f59de1" xlink:to="loc_us-gaap_DefinedBenefitPlanOtherCosts_de2976dc-781e-40e9-a3fb-3d031dbf3c01" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DefinedBenefitPlanForeignCurrencyTranslationImpactonPlanAssets_893c68a5-9af7-424e-9b84-66a7136d7066" xlink:href="vtrs-20211231.xsd#vtrs_DefinedBenefitPlanForeignCurrencyTranslationImpactonPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_be171d3b-07b4-464a-86e0-e98e98f59de1" xlink:to="loc_vtrs_DefinedBenefitPlanForeignCurrencyTranslationImpactonPlanAssets_893c68a5-9af7-424e-9b84-66a7136d7066" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_7e98b36b-7262-40de-962a-9cce2d553e09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_04e57c30-7c78-41bd-9448-c5b21fb7a22a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_c9022b2a-1577-47df-b2d6-488558bcf006" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_04e57c30-7c78-41bd-9448-c5b21fb7a22a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_5732cd41-0488-44d1-bcdd-a4623490a854" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_c9022b2a-1577-47df-b2d6-488558bcf006" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_5732cd41-0488-44d1-bcdd-a4623490a854" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_d1ce574c-b92b-447b-ae55-4f61a32f90b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_5732cd41-0488-44d1-bcdd-a4623490a854" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_d1ce574c-b92b-447b-ae55-4f61a32f90b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_d1ce574c-b92b-447b-ae55-4f61a32f90b8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_d1ce574c-b92b-447b-ae55-4f61a32f90b8" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_d1ce574c-b92b-447b-ae55-4f61a32f90b8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_5c64a869-1e25-4d2c-9391-86fb4fbfa2c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_d1ce574c-b92b-447b-ae55-4f61a32f90b8" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_5c64a869-1e25-4d2c-9391-86fb4fbfa2c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_27bca679-5109-4c38-a7bd-9fa24883aeb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_5c64a869-1e25-4d2c-9391-86fb4fbfa2c8" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_27bca679-5109-4c38-a7bd-9fa24883aeb8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_d8837617-ab1f-469a-9207-319f489b60a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_5c64a869-1e25-4d2c-9391-86fb4fbfa2c8" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_d8837617-ab1f-469a-9207-319f489b60a5" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EmployeeBenefitPlansNetAccruedBenefitCostsClassificationonBalanceSheetDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#EmployeeBenefitPlansNetAccruedBenefitCostsClassificationonBalanceSheetDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/EmployeeBenefitPlansNetAccruedBenefitCostsClassificationonBalanceSheetDetails" xlink:type="extended" id="if5e806956cae4a46a4dd96da73001582_EmployeeBenefitPlansNetAccruedBenefitCostsClassificationonBalanceSheetDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_f2f16d1e-ffce-4f36-b038-2575524bbc4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_1960c463-3e0f-47d5-824f-892ff142e053" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_f2f16d1e-ffce-4f36-b038-2575524bbc4e" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_1960c463-3e0f-47d5-824f-892ff142e053" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_fd500dfe-1015-4a64-a114-02cfb9ee7927" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_f2f16d1e-ffce-4f36-b038-2575524bbc4e" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_fd500dfe-1015-4a64-a114-02cfb9ee7927" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_2d53c9f0-2ac0-40b6-ab39-4488a4d380fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_f2f16d1e-ffce-4f36-b038-2575524bbc4e" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_2d53c9f0-2ac0-40b6-ab39-4488a4d380fd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Netaccruedbenefitcosts_cd088270-166b-4ae2-b8e9-31138d4178f6" xlink:href="vtrs-20211231.xsd#vtrs_Netaccruedbenefitcosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_f2f16d1e-ffce-4f36-b038-2575524bbc4e" xlink:to="loc_vtrs_Netaccruedbenefitcosts_cd088270-166b-4ae2-b8e9-31138d4178f6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_a37f8849-d413-45a3-8797-c87b87689b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_f2f16d1e-ffce-4f36-b038-2575524bbc4e" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_a37f8849-d413-45a3-8797-c87b87689b5b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_31fe6580-80ac-47a1-93d5-bef13ba4acda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_a37f8849-d413-45a3-8797-c87b87689b5b" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_31fe6580-80ac-47a1-93d5-bef13ba4acda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_31fe6580-80ac-47a1-93d5-bef13ba4acda_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_31fe6580-80ac-47a1-93d5-bef13ba4acda" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_31fe6580-80ac-47a1-93d5-bef13ba4acda_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_079e0fd8-e2c5-40fc-beab-509f93405082" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_31fe6580-80ac-47a1-93d5-bef13ba4acda" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_079e0fd8-e2c5-40fc-beab-509f93405082" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_31987cfb-4bc8-4497-9a69-99743dc8f170" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_079e0fd8-e2c5-40fc-beab-509f93405082" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_31987cfb-4bc8-4497-9a69-99743dc8f170" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_612a1646-f528-4b8d-a4ae-65ac5469c522" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_079e0fd8-e2c5-40fc-beab-509f93405082" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_612a1646-f528-4b8d-a4ae-65ac5469c522" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EmployeeBenefitPlansPlanswithPBOinExcessofPlanAssetsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#EmployeeBenefitPlansPlanswithPBOinExcessofPlanAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/EmployeeBenefitPlansPlanswithPBOinExcessofPlanAssetsDetails" xlink:type="extended" id="iba0a5e10163a4583ac7a33cd4ae277bf_EmployeeBenefitPlansPlanswithPBOinExcessofPlanAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_37725971-b4f2-49c1-a594-aedae5136dd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_bf5c7590-f65f-464c-b149-d9364fcc7a59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_37725971-b4f2-49c1-a594-aedae5136dd3" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_bf5c7590-f65f-464c-b149-d9364fcc7a59" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DefinedBenefitPensionPlanswithProjectedBenefitObligationInExcessofPlanAssetsAggregateProjectedBenefitObligation_da921afb-ce1f-4cbe-bcca-f1533748bc5b" xlink:href="vtrs-20211231.xsd#vtrs_DefinedBenefitPensionPlanswithProjectedBenefitObligationInExcessofPlanAssetsAggregateProjectedBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_37725971-b4f2-49c1-a594-aedae5136dd3" xlink:to="loc_vtrs_DefinedBenefitPensionPlanswithProjectedBenefitObligationInExcessofPlanAssetsAggregateProjectedBenefitObligation_da921afb-ce1f-4cbe-bcca-f1533748bc5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets_b2b95e4a-d26c-4098-a08b-8ef5d5ef36c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_37725971-b4f2-49c1-a594-aedae5136dd3" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets_b2b95e4a-d26c-4098-a08b-8ef5d5ef36c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_59402d04-5863-4b8e-8ba8-fb9600376d18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_37725971-b4f2-49c1-a594-aedae5136dd3" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_59402d04-5863-4b8e-8ba8-fb9600376d18" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_453b192b-8c98-443c-b180-5b58483c6db9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_59402d04-5863-4b8e-8ba8-fb9600376d18" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_453b192b-8c98-443c-b180-5b58483c6db9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_453b192b-8c98-443c-b180-5b58483c6db9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_453b192b-8c98-443c-b180-5b58483c6db9" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_453b192b-8c98-443c-b180-5b58483c6db9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_b4c499e2-2412-4ed4-8fdb-b26dc0b0daf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_453b192b-8c98-443c-b180-5b58483c6db9" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_b4c499e2-2412-4ed4-8fdb-b26dc0b0daf2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_8d5858bb-23c8-4fbd-a4ec-d2fca095257e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_b4c499e2-2412-4ed4-8fdb-b26dc0b0daf2" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_8d5858bb-23c8-4fbd-a4ec-d2fca095257e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EmployeeBenefitPlansFairValuesofPlanAssetsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#EmployeeBenefitPlansFairValuesofPlanAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/EmployeeBenefitPlansFairValuesofPlanAssetsDetails" xlink:type="extended" id="if6712ca64dbd4ec19f81a0333242ea87_EmployeeBenefitPlansFairValuesofPlanAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ba40f7d6-2b9f-41d7-9139-f07e67454aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_85bb03b4-5860-4567-ad46-cbb0cf6601cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ba40f7d6-2b9f-41d7-9139-f07e67454aa3" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_85bb03b4-5860-4567-ad46-cbb0cf6601cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_77353c48-96a7-41e1-acd6-8069c59b0afe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ba40f7d6-2b9f-41d7-9139-f07e67454aa3" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_77353c48-96a7-41e1-acd6-8069c59b0afe" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_91ea2066-378e-4fb0-ba2c-82f739310af9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_77353c48-96a7-41e1-acd6-8069c59b0afe" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_91ea2066-378e-4fb0-ba2c-82f739310af9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_91ea2066-378e-4fb0-ba2c-82f739310af9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_91ea2066-378e-4fb0-ba2c-82f739310af9" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_91ea2066-378e-4fb0-ba2c-82f739310af9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_81f167a3-3b41-4c57-bb3c-c2468e48abd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_91ea2066-378e-4fb0-ba2c-82f739310af9" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_81f167a3-3b41-4c57-bb3c-c2468e48abd0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_8fe29edd-57b5-4ca6-a0b8-5cc865a1ecd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_81f167a3-3b41-4c57-bb3c-c2468e48abd0" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_8fe29edd-57b5-4ca6-a0b8-5cc865a1ecd8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_212b0cca-df59-4ef8-b7c1-a19f8323d540" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_81f167a3-3b41-4c57-bb3c-c2468e48abd0" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_212b0cca-df59-4ef8-b7c1-a19f8323d540" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_7061ba0e-2f47-41df-b904-cd75183478ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_81f167a3-3b41-4c57-bb3c-c2468e48abd0" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_7061ba0e-2f47-41df-b904-cd75183478ae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_6fd2ee43-1206-4a2f-a8a1-b549e328cd6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_77353c48-96a7-41e1-acd6-8069c59b0afe" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_6fd2ee43-1206-4a2f-a8a1-b549e328cd6a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_6fd2ee43-1206-4a2f-a8a1-b549e328cd6a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_6fd2ee43-1206-4a2f-a8a1-b549e328cd6a" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_6fd2ee43-1206-4a2f-a8a1-b549e328cd6a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_0ed8d20d-50c0-40fa-b97d-8da86d8ef430" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_6fd2ee43-1206-4a2f-a8a1-b549e328cd6a" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_0ed8d20d-50c0-40fa-b97d-8da86d8ef430" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_072694c9-1996-40de-a42e-442e53688267" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_0ed8d20d-50c0-40fa-b97d-8da86d8ef430" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_072694c9-1996-40de-a42e-442e53688267" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_7e9445bd-a5d7-4ec6-9708-c76ed464cfd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_0ed8d20d-50c0-40fa-b97d-8da86d8ef430" xlink:to="loc_us-gaap_EquitySecuritiesMember_7e9445bd-a5d7-4ec6-9708-c76ed464cfd2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_c81adf55-88f9-4ddf-98a7-07b3594e4120" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_0ed8d20d-50c0-40fa-b97d-8da86d8ef430" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_c81adf55-88f9-4ddf-98a7-07b3594e4120" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AssetsheldbyinsurancecompaniesandotherMember_0f976649-8337-43d7-8a55-790166552115" xlink:href="vtrs-20211231.xsd#vtrs_AssetsheldbyinsurancecompaniesandotherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_0ed8d20d-50c0-40fa-b97d-8da86d8ef430" xlink:to="loc_vtrs_AssetsheldbyinsurancecompaniesandotherMember_0f976649-8337-43d7-8a55-790166552115" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EmployeeBenefitPlansWeightedAverageAssumptionsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#EmployeeBenefitPlansWeightedAverageAssumptionsDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/EmployeeBenefitPlansWeightedAverageAssumptionsDetails" xlink:type="extended" id="i45db2419d2794d00a27f99796eecec8f_EmployeeBenefitPlansWeightedAverageAssumptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a6a27a2d-fe51-4d60-953b-ffc1b70f3cad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_0bf69a06-71ec-4290-9051-05f92605a81a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a6a27a2d-fe51-4d60-953b-ffc1b70f3cad" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_0bf69a06-71ec-4290-9051-05f92605a81a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationExpectedLongtermReturnonAssets_a350577f-2877-4749-bcdd-3913a3b8a4a8" xlink:href="vtrs-20211231.xsd#vtrs_DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationExpectedLongtermReturnonAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a6a27a2d-fe51-4d60-953b-ffc1b70f3cad" xlink:to="loc_vtrs_DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationExpectedLongtermReturnonAssets_a350577f-2877-4749-bcdd-3913a3b8a4a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_870042e5-7e30-4c9a-a970-314c350d56cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a6a27a2d-fe51-4d60-953b-ffc1b70f3cad" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_870042e5-7e30-4c9a-a970-314c350d56cf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_c4142381-ab02-4b98-b3c2-1acc5689cd46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a6a27a2d-fe51-4d60-953b-ffc1b70f3cad" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_c4142381-ab02-4b98-b3c2-1acc5689cd46" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_cafab373-af08-4848-b2bd-f3a882acd59e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a6a27a2d-fe51-4d60-953b-ffc1b70f3cad" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_cafab373-af08-4848-b2bd-f3a882acd59e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_12818a20-16a6-4382-b2d7-5695432c08c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a6a27a2d-fe51-4d60-953b-ffc1b70f3cad" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_12818a20-16a6-4382-b2d7-5695432c08c8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_e24a8061-7409-4a8f-8398-4b6f1b4f247d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a6a27a2d-fe51-4d60-953b-ffc1b70f3cad" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_e24a8061-7409-4a8f-8398-4b6f1b4f247d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_d67e352f-a021-46f7-9543-6c6efad5846d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_e24a8061-7409-4a8f-8398-4b6f1b4f247d" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_d67e352f-a021-46f7-9543-6c6efad5846d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_d67e352f-a021-46f7-9543-6c6efad5846d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_d67e352f-a021-46f7-9543-6c6efad5846d" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_d67e352f-a021-46f7-9543-6c6efad5846d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_6b0c57ff-99a7-4c6f-8bf4-b9f877b5530f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_d67e352f-a021-46f7-9543-6c6efad5846d" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_6b0c57ff-99a7-4c6f-8bf4-b9f877b5530f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_b8c4ae4a-a6bf-4fdc-b4dd-cb3ee0a09039" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_6b0c57ff-99a7-4c6f-8bf4-b9f877b5530f" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_b8c4ae4a-a6bf-4fdc-b4dd-cb3ee0a09039" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_42cf0315-4cf0-49fb-913c-53c2495c74a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_6b0c57ff-99a7-4c6f-8bf4-b9f877b5530f" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_42cf0315-4cf0-49fb-913c-53c2495c74a1" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EmployeeBenefitPlansEffectofOnePercentagePointIncreaseorDecreaseinHealthCareCostTrendRatesDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#EmployeeBenefitPlansEffectofOnePercentagePointIncreaseorDecreaseinHealthCareCostTrendRatesDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/EmployeeBenefitPlansEffectofOnePercentagePointIncreaseorDecreaseinHealthCareCostTrendRatesDetails" xlink:type="extended" id="i0c5185516a254a799aa74077eaf16591_EmployeeBenefitPlansEffectofOnePercentagePointIncreaseorDecreaseinHealthCareCostTrendRatesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_c816426c-92a0-4558-898f-fe6d9ff87b82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation_69d05adf-4562-4b18-9081-128baf60a1c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_c816426c-92a0-4558-898f-fe6d9ff87b82" xlink:to="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation_69d05adf-4562-4b18-9081-128baf60a1c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnAccumulatedPostretirementBenefitObligation1_58ec3248-06f3-46d1-8759-0e800ba345f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnAccumulatedPostretirementBenefitObligation1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_c816426c-92a0-4558-898f-fe6d9ff87b82" xlink:to="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnAccumulatedPostretirementBenefitObligation1_58ec3248-06f3-46d1-8759-0e800ba345f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnServiceAndInterestCostComponents_a5a1308b-a847-4dfa-a0e9-ac24da9df48e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnServiceAndInterestCostComponents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_c816426c-92a0-4558-898f-fe6d9ff87b82" xlink:to="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnServiceAndInterestCostComponents_a5a1308b-a847-4dfa-a0e9-ac24da9df48e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnServiceAndInterestCostComponents1_c92df033-9823-463a-afca-d7387fe576b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnServiceAndInterestCostComponents1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_c816426c-92a0-4558-898f-fe6d9ff87b82" xlink:to="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnServiceAndInterestCostComponents1_c92df033-9823-463a-afca-d7387fe576b1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_de255f35-491a-4849-a3c7-187c7b067938" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_c816426c-92a0-4558-898f-fe6d9ff87b82" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_de255f35-491a-4849-a3c7-187c7b067938" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_b0d8589b-f253-4cf5-b45d-d1a7c214959b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_de255f35-491a-4849-a3c7-187c7b067938" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_b0d8589b-f253-4cf5-b45d-d1a7c214959b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_b0d8589b-f253-4cf5-b45d-d1a7c214959b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_b0d8589b-f253-4cf5-b45d-d1a7c214959b" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_b0d8589b-f253-4cf5-b45d-d1a7c214959b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_0fdda068-847d-40e6-a787-56e7218bb38d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_b0d8589b-f253-4cf5-b45d-d1a7c214959b" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_0fdda068-847d-40e6-a787-56e7218bb38d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_ae2b6a49-1373-469d-8786-c96975a344a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_0fdda068-847d-40e6-a787-56e7218bb38d" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_ae2b6a49-1373-469d-8786-c96975a344a3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EmployeeBenefitPlansEstimatedFutureBenefitPaymentsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#EmployeeBenefitPlansEstimatedFutureBenefitPaymentsDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/EmployeeBenefitPlansEstimatedFutureBenefitPaymentsDetails" xlink:type="extended" id="i01bfa80260ab421ab1ad4db00505dc60_EmployeeBenefitPlansEstimatedFutureBenefitPaymentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d0267790-9803-4285-8939-34a5ea8a0e29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_88a35160-3b42-4ab5-9d09-625badfba8f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d0267790-9803-4285-8939-34a5ea8a0e29" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_88a35160-3b42-4ab5-9d09-625badfba8f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_11448c0e-ed08-486c-815f-88bfbbf3f5e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d0267790-9803-4285-8939-34a5ea8a0e29" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_11448c0e-ed08-486c-815f-88bfbbf3f5e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_9a3cd6d7-0e8f-4f82-b4f6-e5b3efc729b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d0267790-9803-4285-8939-34a5ea8a0e29" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_9a3cd6d7-0e8f-4f82-b4f6-e5b3efc729b2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_459b6bb2-cfef-4940-87c2-1d5b160b7712" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d0267790-9803-4285-8939-34a5ea8a0e29" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_459b6bb2-cfef-4940-87c2-1d5b160b7712" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_353180bd-979a-46ac-9b0e-dfc53fdbbb5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d0267790-9803-4285-8939-34a5ea8a0e29" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_353180bd-979a-46ac-9b0e-dfc53fdbbb5b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_d9cc3f6b-5ccd-4c58-b11f-115228150ec3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d0267790-9803-4285-8939-34a5ea8a0e29" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_d9cc3f6b-5ccd-4c58-b11f-115228150ec3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ExpectedFutureBenefitPayments_9737dbf8-e0a5-4c48-a6ff-01582fbb5eb1" xlink:href="vtrs-20211231.xsd#vtrs_ExpectedFutureBenefitPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d0267790-9803-4285-8939-34a5ea8a0e29" xlink:to="loc_vtrs_ExpectedFutureBenefitPayments_9737dbf8-e0a5-4c48-a6ff-01582fbb5eb1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_df1340ca-7ef5-46ac-a8cc-18c69e2ad461" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d0267790-9803-4285-8939-34a5ea8a0e29" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_df1340ca-7ef5-46ac-a8cc-18c69e2ad461" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_27bb0759-3dcd-4714-a9ac-52ab1b190341" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_df1340ca-7ef5-46ac-a8cc-18c69e2ad461" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_27bb0759-3dcd-4714-a9ac-52ab1b190341" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_27bb0759-3dcd-4714-a9ac-52ab1b190341_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_27bb0759-3dcd-4714-a9ac-52ab1b190341" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_27bb0759-3dcd-4714-a9ac-52ab1b190341_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_a7e4a125-4d09-4a3f-b2d2-735cba878552" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_27bb0759-3dcd-4714-a9ac-52ab1b190341" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_a7e4a125-4d09-4a3f-b2d2-735cba878552" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_16e48db0-c906-42f0-997f-c66cfc5d6693" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_a7e4a125-4d09-4a3f-b2d2-735cba878552" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_16e48db0-c906-42f0-997f-c66cfc5d6693" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_b1d91c1b-e970-47b3-9a8a-a028aed721df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_a7e4a125-4d09-4a3f-b2d2-735cba878552" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_b1d91c1b-e970-47b3-9a8a-a028aed721df" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/SegmentInformationReconciliationofSegmentInformationtoTotalConsolidatedInformationDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#SegmentInformationReconciliationofSegmentInformationtoTotalConsolidatedInformationDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/SegmentInformationReconciliationofSegmentInformationtoTotalConsolidatedInformationDetails" xlink:type="extended" id="ic6b71771d4a54fd2ac2609f331085c1c_SegmentInformationReconciliationofSegmentInformationtoTotalConsolidatedInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_34a802f9-b3e6-49f8-8a49-4ffc09fd2f1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5d180f9a-fc49-499c-95eb-4c0c66978f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_34a802f9-b3e6-49f8-8a49-4ffc09fd2f1a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5d180f9a-fc49-499c-95eb-4c0c66978f3f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_d07d564c-ab0a-4663-a777-45f53da2ade6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_34a802f9-b3e6-49f8-8a49-4ffc09fd2f1a" xlink:to="loc_us-gaap_OperatingIncomeLoss_d07d564c-ab0a-4663-a777-45f53da2ade6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_4fbcd8cd-255a-4680-a8b2-4eb4637666e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_34a802f9-b3e6-49f8-8a49-4ffc09fd2f1a" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_4fbcd8cd-255a-4680-a8b2-4eb4637666e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_6f07d5d6-39c6-4e5e-8cd0-9ad5174214f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_34a802f9-b3e6-49f8-8a49-4ffc09fd2f1a" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_6f07d5d6-39c6-4e5e-8cd0-9ad5174214f3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_f2bf4021-8f46-4b18-aeeb-9449ba30e9e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_34a802f9-b3e6-49f8-8a49-4ffc09fd2f1a" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_f2bf4021-8f46-4b18-aeeb-9449ba30e9e9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_adf66fa1-6a26-4b10-a5a5-70b8c57bce52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_34a802f9-b3e6-49f8-8a49-4ffc09fd2f1a" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_adf66fa1-6a26-4b10-a5a5-70b8c57bce52" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherOneTimeNonoperatingExpense_cd13b9e9-d6e8-4650-9de6-ee655b71cae9" xlink:href="vtrs-20211231.xsd#vtrs_OtherOneTimeNonoperatingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_34a802f9-b3e6-49f8-8a49-4ffc09fd2f1a" xlink:to="loc_vtrs_OtherOneTimeNonoperatingExpense_cd13b9e9-d6e8-4650-9de6-ee655b71cae9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Corporatecosts_eb4e5ab0-e11a-45f6-af4e-b50fb4ae6333" xlink:href="vtrs-20211231.xsd#vtrs_Corporatecosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_34a802f9-b3e6-49f8-8a49-4ffc09fd2f1a" xlink:to="loc_vtrs_Corporatecosts_eb4e5ab0-e11a-45f6-af4e-b50fb4ae6333" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9e44db20-6643-478d-9c75-057171b229c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_34a802f9-b3e6-49f8-8a49-4ffc09fd2f1a" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9e44db20-6643-478d-9c75-057171b229c5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_cee340a7-27b9-41bd-af43-7ffefc75d571" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9e44db20-6643-478d-9c75-057171b229c5" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_cee340a7-27b9-41bd-af43-7ffefc75d571" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_cee340a7-27b9-41bd-af43-7ffefc75d571_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_cee340a7-27b9-41bd-af43-7ffefc75d571" xlink:to="loc_us-gaap_SegmentDomain_cee340a7-27b9-41bd-af43-7ffefc75d571_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_bf0a4ddf-0d59-44ef-9a05-cfacc3b2b2e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_cee340a7-27b9-41bd-af43-7ffefc75d571" xlink:to="loc_us-gaap_SegmentDomain_bf0a4ddf-0d59-44ef-9a05-cfacc3b2b2e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DevelopedMarketsSegmentMember_f3e2b10a-0e3b-445e-b355-f90f83fcf89d" xlink:href="vtrs-20211231.xsd#vtrs_DevelopedMarketsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_bf0a4ddf-0d59-44ef-9a05-cfacc3b2b2e7" xlink:to="loc_vtrs_DevelopedMarketsSegmentMember_f3e2b10a-0e3b-445e-b355-f90f83fcf89d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GreaterChinaSegmentMember_7cb2c2df-3aa9-41a5-a7cb-82c2cc09604b" xlink:href="vtrs-20211231.xsd#vtrs_GreaterChinaSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_bf0a4ddf-0d59-44ef-9a05-cfacc3b2b2e7" xlink:to="loc_vtrs_GreaterChinaSegmentMember_7cb2c2df-3aa9-41a5-a7cb-82c2cc09604b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_3e854dfd-f18d-45e2-99bb-0eab6964a3aa" xlink:href="vtrs-20211231.xsd#vtrs_JapanAustraliaAndNewZealandSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_bf0a4ddf-0d59-44ef-9a05-cfacc3b2b2e7" xlink:to="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_3e854dfd-f18d-45e2-99bb-0eab6964a3aa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EmergingMarketsSegmentMember_580f4546-7076-4e2c-9de3-3ebf8d5739c0" xlink:href="vtrs-20211231.xsd#vtrs_EmergingMarketsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_bf0a4ddf-0d59-44ef-9a05-cfacc3b2b2e7" xlink:to="loc_vtrs_EmergingMarketsSegmentMember_580f4546-7076-4e2c-9de3-3ebf8d5739c0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_6f64f8e2-ac2a-4b3b-837c-e65ebd7e297d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9e44db20-6643-478d-9c75-057171b229c5" xlink:to="loc_srt_ConsolidationItemsAxis_6f64f8e2-ac2a-4b3b-837c-e65ebd7e297d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_6f64f8e2-ac2a-4b3b-837c-e65ebd7e297d_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_6f64f8e2-ac2a-4b3b-837c-e65ebd7e297d" xlink:to="loc_srt_ConsolidationItemsDomain_6f64f8e2-ac2a-4b3b-837c-e65ebd7e297d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_d72f00fc-57a7-4198-838a-2a8c5cbeb8dc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_6f64f8e2-ac2a-4b3b-837c-e65ebd7e297d" xlink:to="loc_srt_ConsolidationItemsDomain_d72f00fc-57a7-4198-838a-2a8c5cbeb8dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_1558fec1-6862-4dd6-bac2-a270ad5d42b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_d72f00fc-57a7-4198-838a-2a8c5cbeb8dc" xlink:to="loc_us-gaap_OperatingSegmentsMember_1558fec1-6862-4dd6-bac2-a270ad5d42b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_22b14c5d-06e6-49c3-8bea-35d59b6017a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_d72f00fc-57a7-4198-838a-2a8c5cbeb8dc" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_22b14c5d-06e6-49c3-8bea-35d59b6017a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_f360a256-8fe9-42ae-9a41-45c54bad06f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_d72f00fc-57a7-4198-838a-2a8c5cbeb8dc" xlink:to="loc_us-gaap_CorporateNonSegmentMember_f360a256-8fe9-42ae-9a41-45c54bad06f8" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/SegmentInformationThirdPartyNetSalesbyMajorCustomersDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#SegmentInformationThirdPartyNetSalesbyMajorCustomersDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/SegmentInformationThirdPartyNetSalesbyMajorCustomersDetails" xlink:type="extended" id="i4f88d434c0bd44069862b30cc8a57b11_SegmentInformationThirdPartyNetSalesbyMajorCustomersDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_779fecd6-077d-4615-8c39-668a18d0ac32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_51ad88bd-3c9a-4b8b-aa3e-d38a5588f2a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_779fecd6-077d-4615-8c39-668a18d0ac32" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_51ad88bd-3c9a-4b8b-aa3e-d38a5588f2a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_181169cb-7469-4709-a0e9-826d0570fc1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_779fecd6-077d-4615-8c39-668a18d0ac32" xlink:to="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_181169cb-7469-4709-a0e9-826d0570fc1b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c9edbcd1-da76-475f-bbb7-7ae7e27999d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_181169cb-7469-4709-a0e9-826d0570fc1b" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c9edbcd1-da76-475f-bbb7-7ae7e27999d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c9edbcd1-da76-475f-bbb7-7ae7e27999d5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c9edbcd1-da76-475f-bbb7-7ae7e27999d5" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c9edbcd1-da76-475f-bbb7-7ae7e27999d5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_4fff0bc5-ac78-427b-8c10-154f4a36b6b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c9edbcd1-da76-475f-bbb7-7ae7e27999d5" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_4fff0bc5-ac78-427b-8c10-154f4a36b6b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_c12b22d8-3f7c-4606-9051-7c7662dec977" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_4fff0bc5-ac78-427b-8c10-154f4a36b6b0" xlink:to="loc_us-gaap_SalesRevenueNetMember_c12b22d8-3f7c-4606-9051-7c7662dec977" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_bb62f8d0-77b8-47fb-8f07-56cdef79a0b7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_181169cb-7469-4709-a0e9-826d0570fc1b" xlink:to="loc_srt_MajorCustomersAxis_bb62f8d0-77b8-47fb-8f07-56cdef79a0b7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_bb62f8d0-77b8-47fb-8f07-56cdef79a0b7_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_bb62f8d0-77b8-47fb-8f07-56cdef79a0b7" xlink:to="loc_srt_NameOfMajorCustomerDomain_bb62f8d0-77b8-47fb-8f07-56cdef79a0b7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_ecba9a19-b447-4f37-9699-4536c456e2f6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_bb62f8d0-77b8-47fb-8f07-56cdef79a0b7" xlink:to="loc_srt_NameOfMajorCustomerDomain_ecba9a19-b447-4f37-9699-4536c456e2f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_MckessonCorporationMember_54000f01-2583-4e49-9630-14e32b657cc8" xlink:href="vtrs-20211231.xsd#vtrs_MckessonCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_ecba9a19-b447-4f37-9699-4536c456e2f6" xlink:to="loc_vtrs_MckessonCorporationMember_54000f01-2583-4e49-9630-14e32b657cc8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AmeriSourceBergenCorporationMember_ed394644-4b6e-42c8-958b-4e51d195d457" xlink:href="vtrs-20211231.xsd#vtrs_AmeriSourceBergenCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_ecba9a19-b447-4f37-9699-4536c456e2f6" xlink:to="loc_vtrs_AmeriSourceBergenCorporationMember_ed394644-4b6e-42c8-958b-4e51d195d457" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CardinalHealthIncMember_16f51cf9-fec6-4259-b79d-b324087499b6" xlink:href="vtrs-20211231.xsd#vtrs_CardinalHealthIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_ecba9a19-b447-4f37-9699-4536c456e2f6" xlink:to="loc_vtrs_CardinalHealthIncMember_16f51cf9-fec6-4259-b79d-b324087499b6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_8d0088cd-b48c-48f2-8d78-dc8db70a108a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_181169cb-7469-4709-a0e9-826d0570fc1b" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_8d0088cd-b48c-48f2-8d78-dc8db70a108a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_8d0088cd-b48c-48f2-8d78-dc8db70a108a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_8d0088cd-b48c-48f2-8d78-dc8db70a108a" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_8d0088cd-b48c-48f2-8d78-dc8db70a108a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_0e57e57d-89f3-4ca6-824b-b85d40f02973" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_8d0088cd-b48c-48f2-8d78-dc8db70a108a" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_0e57e57d-89f3-4ca6-824b-b85d40f02973" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_2ec03d9e-c94f-4db4-ac47-30cfece62e6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_0e57e57d-89f3-4ca6-824b-b85d40f02973" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_2ec03d9e-c94f-4db4-ac47-30cfece62e6e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/SegmentInformationNetThirdPartySalesClassifiedBasedonGeographicLocationofEntityDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#SegmentInformationNetThirdPartySalesClassifiedBasedonGeographicLocationofEntityDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/SegmentInformationNetThirdPartySalesClassifiedBasedonGeographicLocationofEntityDetails" xlink:type="extended" id="i4d90501d79b34121965177ae7637570f_SegmentInformationNetThirdPartySalesClassifiedBasedonGeographicLocationofEntityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_ada2a960-785c-4e21-83bb-84564b8cb612" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_97f3b7e9-b35c-4c91-9779-3a13abc2f172" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_ada2a960-785c-4e21-83bb-84564b8cb612" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_97f3b7e9-b35c-4c91-9779-3a13abc2f172" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_4ed312f7-7d0f-4c31-973b-54f86fc4a5cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_ada2a960-785c-4e21-83bb-84564b8cb612" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_4ed312f7-7d0f-4c31-973b-54f86fc4a5cb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_ad7ff875-35aa-42da-afd0-1506359d4957" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_4ed312f7-7d0f-4c31-973b-54f86fc4a5cb" xlink:to="loc_srt_StatementGeographicalAxis_ad7ff875-35aa-42da-afd0-1506359d4957" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_ad7ff875-35aa-42da-afd0-1506359d4957_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_ad7ff875-35aa-42da-afd0-1506359d4957" xlink:to="loc_srt_SegmentGeographicalDomain_ad7ff875-35aa-42da-afd0-1506359d4957_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_b9368a09-f44a-4623-a12d-51b101a29a7a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_ad7ff875-35aa-42da-afd0-1506359d4957" xlink:to="loc_srt_SegmentGeographicalDomain_b9368a09-f44a-4623-a12d-51b101a29a7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_e050b1da-dd33-4a9a-85b1-ed14cb1dbeb6" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_b9368a09-f44a-4623-a12d-51b101a29a7a" xlink:to="loc_country_US_e050b1da-dd33-4a9a-85b1-ed14cb1dbeb6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IN_bd4f99cd-9e60-4ec6-ba08-45ba4404633e" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IN"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_b9368a09-f44a-4623-a12d-51b101a29a7a" xlink:to="loc_country_IN_bd4f99cd-9e60-4ec6-ba08-45ba4404633e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_b16ee29b-0d85-4c64-a4f7-3dce286d6476" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_FR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_b9368a09-f44a-4623-a12d-51b101a29a7a" xlink:to="loc_country_FR_b16ee29b-0d85-4c64-a4f7-3dce286d6476" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN_70629ad0-ed4a-4fbb-beee-5b8abe7e449e" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CN"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_b9368a09-f44a-4623-a12d-51b101a29a7a" xlink:to="loc_country_CN_70629ad0-ed4a-4fbb-beee-5b8abe7e449e" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/CommitmentsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#CommitmentsDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/CommitmentsDetails" xlink:type="extended" id="ide299b7cbe8845b3b650abd5c018e961_CommitmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_b6a17b4d-df4d-4d1e-adfd-9c7aaa263304" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationLimitedTransitionServicesPaymentPeriod_20654234-ff3f-41fd-a22f-b52c946b35ff" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationLimitedTransitionServicesPaymentPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_b6a17b4d-df4d-4d1e-adfd-9c7aaa263304" xlink:to="loc_vtrs_BusinessCombinationLimitedTransitionServicesPaymentPeriod_20654234-ff3f-41fd-a22f-b52c946b35ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationContractualReimbursementAmountTrancheOne_798053d5-438c-4f28-88a8-c3571a343a72" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationContractualReimbursementAmountTrancheOne"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_b6a17b4d-df4d-4d1e-adfd-9c7aaa263304" xlink:to="loc_vtrs_BusinessCombinationContractualReimbursementAmountTrancheOne_798053d5-438c-4f28-88a8-c3571a343a72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationContractualReimbursementAmountAmountsExpensed_2be641ae-6626-43fc-a948-c524b4290014" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationContractualReimbursementAmountAmountsExpensed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_b6a17b4d-df4d-4d1e-adfd-9c7aaa263304" xlink:to="loc_vtrs_BusinessCombinationContractualReimbursementAmountAmountsExpensed_2be641ae-6626-43fc-a948-c524b4290014" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationContractualReimbursementAmountAmountsAccrued_5a4f31fd-cf56-4903-aa63-871108565f71" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationContractualReimbursementAmountAmountsAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_b6a17b4d-df4d-4d1e-adfd-9c7aaa263304" xlink:to="loc_vtrs_BusinessCombinationContractualReimbursementAmountAmountsAccrued_5a4f31fd-cf56-4903-aa63-871108565f71" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_7cdf9a69-0af1-4284-adeb-8308e448b3d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_b6a17b4d-df4d-4d1e-adfd-9c7aaa263304" xlink:to="loc_us-gaap_OtherCommitmentsTable_7cdf9a69-0af1-4284-adeb-8308e448b3d2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis_cfd3cf10-bfe7-425f-9ea4-bd176f01701b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_7cdf9a69-0af1-4284-adeb-8308e448b3d2" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis_cfd3cf10-bfe7-425f-9ea4-bd176f01701b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalEntityTypeOfCounterpartyDomain_cfd3cf10-bfe7-425f-9ea4-bd176f01701b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LegalEntityTypeOfCounterpartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis_cfd3cf10-bfe7-425f-9ea4-bd176f01701b" xlink:to="loc_us-gaap_LegalEntityTypeOfCounterpartyDomain_cfd3cf10-bfe7-425f-9ea4-bd176f01701b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalEntityTypeOfCounterpartyDomain_8f5fb22d-aab3-4aea-9149-1ae3e1bc370f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LegalEntityTypeOfCounterpartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis_cfd3cf10-bfe7-425f-9ea4-bd176f01701b" xlink:to="loc_us-gaap_LegalEntityTypeOfCounterpartyDomain_8f5fb22d-aab3-4aea-9149-1ae3e1bc370f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PfizerInc.Member_72b0b9dd-8ee3-4bba-bd68-1607c8938518" xlink:href="vtrs-20211231.xsd#vtrs_PfizerInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LegalEntityTypeOfCounterpartyDomain_8f5fb22d-aab3-4aea-9149-1ae3e1bc370f" xlink:to="loc_vtrs_PfizerInc.Member_72b0b9dd-8ee3-4bba-bd68-1607c8938518" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsAxis_ba186b3b-8ae5-42b5-9ff9-34f1602c52ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_7cdf9a69-0af1-4284-adeb-8308e448b3d2" xlink:to="loc_us-gaap_OtherCommitmentsAxis_ba186b3b-8ae5-42b5-9ff9-34f1602c52ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain_ba186b3b-8ae5-42b5-9ff9-34f1602c52ca_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OtherCommitmentsAxis_ba186b3b-8ae5-42b5-9ff9-34f1602c52ca" xlink:to="loc_us-gaap_OtherCommitmentsDomain_ba186b3b-8ae5-42b5-9ff9-34f1602c52ca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain_d74ebce3-e550-41f7-9832-1672d2dc0230" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OtherCommitmentsAxis_ba186b3b-8ae5-42b5-9ff9-34f1602c52ca" xlink:to="loc_us-gaap_OtherCommitmentsDomain_d74ebce3-e550-41f7-9832-1672d2dc0230" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_TransitionServiceAgreementsMember_d4322603-c968-4b62-9b2e-b4c014e0cb61" xlink:href="vtrs-20211231.xsd#vtrs_TransitionServiceAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsDomain_d74ebce3-e550-41f7-9832-1672d2dc0230" xlink:to="loc_vtrs_TransitionServiceAgreementsMember_d4322603-c968-4b62-9b2e-b4c014e0cb61" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/RestructuringNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#RestructuringNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/RestructuringNarrativeDetails" xlink:type="extended" id="i4fb583f6d2954a388c7f6ad6b92b4da9_RestructuringNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_c0163b7d-754a-432e-856e-83d744c58325" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_fcbb9fad-d0e8-45ea-8a23-d4187b2fe40f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c0163b7d-754a-432e-856e-83d744c58325" xlink:to="loc_us-gaap_PaymentsForRestructuring_fcbb9fad-d0e8-45ea-8a23-d4187b2fe40f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReservePeriodIncreaseDecrease_a7ad7b7f-8e24-45a2-a4b4-6a6d55543465" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReservePeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c0163b7d-754a-432e-856e-83d744c58325" xlink:to="loc_us-gaap_RestructuringReservePeriodIncreaseDecrease_a7ad7b7f-8e24-45a2-a4b4-6a6d55543465" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_8002ca3d-7700-4260-8cfb-be6234d665c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c0163b7d-754a-432e-856e-83d744c58325" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_8002ca3d-7700-4260-8cfb-be6234d665c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_933a6611-79bd-464a-a43b-1b41950a48c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveTranslationAndOtherAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c0163b7d-754a-432e-856e-83d744c58325" xlink:to="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_933a6611-79bd-464a-a43b-1b41950a48c6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_cb864563-e7e0-44ff-87ca-d62ed53ef80a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c0163b7d-754a-432e-856e-83d744c58325" xlink:to="loc_us-gaap_RestructuringCharges_cb864563-e7e0-44ff-87ca-d62ed53ef80a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_9a8b6d61-96dd-4736-a8d7-0471c705ed19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c0163b7d-754a-432e-856e-83d744c58325" xlink:to="loc_us-gaap_RestructuringReserve_9a8b6d61-96dd-4736-a8d7-0471c705ed19" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOnFutureCashFlowsAmount_7d3eaf77-de2e-4008-bb18-13b485dae75b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOnFutureCashFlowsAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c0163b7d-754a-432e-856e-83d744c58325" xlink:to="loc_us-gaap_EffectOnFutureCashFlowsAmount_7d3eaf77-de2e-4008-bb18-13b485dae75b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_3a66e682-5932-4d4d-9d51-b2f38836acd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c0163b7d-754a-432e-856e-83d744c58325" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_3a66e682-5932-4d4d-9d51-b2f38836acd6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f885b089-6bbf-4c1a-b6c4-676622302236" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_3a66e682-5932-4d4d-9d51-b2f38836acd6" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f885b089-6bbf-4c1a-b6c4-676622302236" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f885b089-6bbf-4c1a-b6c4-676622302236_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f885b089-6bbf-4c1a-b6c4-676622302236" xlink:to="loc_us-gaap_SegmentDomain_f885b089-6bbf-4c1a-b6c4-676622302236_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e69a9812-3fb9-4402-8b43-8f2ba776f66f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f885b089-6bbf-4c1a-b6c4-676622302236" xlink:to="loc_us-gaap_SegmentDomain_e69a9812-3fb9-4402-8b43-8f2ba776f66f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NorthAmericaSegmentMember_001b82f4-edb9-44d8-8048-2b4593395c45" xlink:href="vtrs-20211231.xsd#vtrs_NorthAmericaSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e69a9812-3fb9-4402-8b43-8f2ba776f66f" xlink:to="loc_vtrs_NorthAmericaSegmentMember_001b82f4-edb9-44d8-8048-2b4593395c45" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EuropeSegmentMember_b2077a22-5589-417b-a54c-68516afca08c" xlink:href="vtrs-20211231.xsd#vtrs_EuropeSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e69a9812-3fb9-4402-8b43-8f2ba776f66f" xlink:to="loc_vtrs_EuropeSegmentMember_b2077a22-5589-417b-a54c-68516afca08c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RestofWorldSegmentMember_82f35714-438f-486a-99a6-de39cae8a9b8" xlink:href="vtrs-20211231.xsd#vtrs_RestofWorldSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e69a9812-3fb9-4402-8b43-8f2ba776f66f" xlink:to="loc_vtrs_RestofWorldSegmentMember_82f35714-438f-486a-99a6-de39cae8a9b8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DevelopedMarketsSegmentMember_823d4b11-dc3f-4c19-8979-2041b2622431" xlink:href="vtrs-20211231.xsd#vtrs_DevelopedMarketsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e69a9812-3fb9-4402-8b43-8f2ba776f66f" xlink:to="loc_vtrs_DevelopedMarketsSegmentMember_823d4b11-dc3f-4c19-8979-2041b2622431" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_f110f5fa-dec2-47cf-844d-04f727bde6c3" xlink:href="vtrs-20211231.xsd#vtrs_JapanAustraliaAndNewZealandSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e69a9812-3fb9-4402-8b43-8f2ba776f66f" xlink:to="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_f110f5fa-dec2-47cf-844d-04f727bde6c3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GreaterChinaSegmentMember_9510917d-229e-40f0-9390-98e59afd452d" xlink:href="vtrs-20211231.xsd#vtrs_GreaterChinaSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e69a9812-3fb9-4402-8b43-8f2ba776f66f" xlink:to="loc_vtrs_GreaterChinaSegmentMember_9510917d-229e-40f0-9390-98e59afd452d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_df9b8e05-34ca-4c4f-b232-2075dde41d05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_3a66e682-5932-4d4d-9d51-b2f38836acd6" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_df9b8e05-34ca-4c4f-b232-2075dde41d05" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_df9b8e05-34ca-4c4f-b232-2075dde41d05_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_df9b8e05-34ca-4c4f-b232-2075dde41d05" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_df9b8e05-34ca-4c4f-b232-2075dde41d05_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_f4ade0b2-4375-4868-a5fc-69bd0e8e67a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_df9b8e05-34ca-4c4f-b232-2075dde41d05" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_f4ade0b2-4375-4868-a5fc-69bd0e8e67a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_84c6a626-878f-4d89-9799-1a6c7a44d8dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_f4ade0b2-4375-4868-a5fc-69bd0e8e67a5" xlink:to="loc_us-gaap_EmployeeSeveranceMember_84c6a626-878f-4d89-9799-1a6c7a44d8dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_f01ea876-4da4-442a-8b4e-e1c0b871f503" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherRestructuringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_f4ade0b2-4375-4868-a5fc-69bd0e8e67a5" xlink:to="loc_us-gaap_OtherRestructuringMember_f01ea876-4da4-442a-8b4e-e1c0b871f503" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_0ef0ad2a-c0d0-4fd3-9d86-2d7e54fcd67c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_3a66e682-5932-4d4d-9d51-b2f38836acd6" xlink:to="loc_us-gaap_RestructuringPlanAxis_0ef0ad2a-c0d0-4fd3-9d86-2d7e54fcd67c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_0ef0ad2a-c0d0-4fd3-9d86-2d7e54fcd67c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_0ef0ad2a-c0d0-4fd3-9d86-2d7e54fcd67c" xlink:to="loc_us-gaap_RestructuringPlanDomain_0ef0ad2a-c0d0-4fd3-9d86-2d7e54fcd67c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_d5d42356-a288-4b33-9b14-20f83912c96f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_0ef0ad2a-c0d0-4fd3-9d86-2d7e54fcd67c" xlink:to="loc_us-gaap_RestructuringPlanDomain_d5d42356-a288-4b33-9b14-20f83912c96f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2016RestructuringProgramMember_c391fed6-8233-4eba-93b6-127940d0a8f5" xlink:href="vtrs-20211231.xsd#vtrs_A2016RestructuringProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_d5d42356-a288-4b33-9b14-20f83912c96f" xlink:to="loc_vtrs_A2016RestructuringProgramMember_c391fed6-8233-4eba-93b6-127940d0a8f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_46e1c6d1-8368-41f1-b12c-e7b02380be7a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_3a66e682-5932-4d4d-9d51-b2f38836acd6" xlink:to="loc_srt_ConsolidationItemsAxis_46e1c6d1-8368-41f1-b12c-e7b02380be7a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_46e1c6d1-8368-41f1-b12c-e7b02380be7a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_46e1c6d1-8368-41f1-b12c-e7b02380be7a" xlink:to="loc_srt_ConsolidationItemsDomain_46e1c6d1-8368-41f1-b12c-e7b02380be7a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_83cdd34b-2df0-4e08-8c9d-c62a96740944" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_46e1c6d1-8368-41f1-b12c-e7b02380be7a" xlink:to="loc_srt_ConsolidationItemsDomain_83cdd34b-2df0-4e08-8c9d-c62a96740944" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_1d77de40-adfc-4768-8f10-60bede3283bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_83cdd34b-2df0-4e08-8c9d-c62a96740944" xlink:to="loc_us-gaap_OperatingSegmentsMember_1d77de40-adfc-4768-8f10-60bede3283bc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/Restructuring2020RestructuringPlanDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#Restructuring2020RestructuringPlanDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/Restructuring2020RestructuringPlanDetails" xlink:type="extended" id="i536dd69d93294fe196130c83fe822088_Restructuring2020RestructuringPlanDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_dc3cd54f-33d8-477b-a4d8-4ae8aa645720" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_6a807739-9230-4b41-8493-fde25aa825a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_dc3cd54f-33d8-477b-a4d8-4ae8aa645720" xlink:to="loc_us-gaap_RestructuringReserve_6a807739-9230-4b41-8493-fde25aa825a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_b0f6391c-8b75-4cd0-ae3c-b7477e340725" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_dc3cd54f-33d8-477b-a4d8-4ae8aa645720" xlink:to="loc_us-gaap_PaymentsForRestructuring_b0f6391c-8b75-4cd0-ae3c-b7477e340725" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_ab439209-cf14-4f8c-bb36-79f951d10557" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_dc3cd54f-33d8-477b-a4d8-4ae8aa645720" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_ab439209-cf14-4f8c-bb36-79f951d10557" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_1cf474df-2d9c-40b0-9ce2-0f9f30fa2ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveTranslationAndOtherAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_dc3cd54f-33d8-477b-a4d8-4ae8aa645720" xlink:to="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_1cf474df-2d9c-40b0-9ce2-0f9f30fa2ce9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_7d6ec851-0a1d-4510-bc56-d3806dd15d58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_dc3cd54f-33d8-477b-a4d8-4ae8aa645720" xlink:to="loc_us-gaap_RestructuringCharges_7d6ec851-0a1d-4510-bc56-d3806dd15d58" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RestructuringReserveAcquiredDuringPeriod_50c6191d-ede1-4aec-8577-6e1f240459bc" xlink:href="vtrs-20211231.xsd#vtrs_RestructuringReserveAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_dc3cd54f-33d8-477b-a4d8-4ae8aa645720" xlink:to="loc_vtrs_RestructuringReserveAcquiredDuringPeriod_50c6191d-ede1-4aec-8577-6e1f240459bc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated_a674f1cb-d0d5-4197-a4be-d8702e85fe17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_dc3cd54f-33d8-477b-a4d8-4ae8aa645720" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated_a674f1cb-d0d5-4197-a4be-d8702e85fe17" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RestructuringAndRelatedCostExpectedNumberOfFacilitiesToBeEliminated_eaf4c2db-3070-4ded-9673-baada2a8429c" xlink:href="vtrs-20211231.xsd#vtrs_RestructuringAndRelatedCostExpectedNumberOfFacilitiesToBeEliminated"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_dc3cd54f-33d8-477b-a4d8-4ae8aa645720" xlink:to="loc_vtrs_RestructuringAndRelatedCostExpectedNumberOfFacilitiesToBeEliminated_eaf4c2db-3070-4ded-9673-baada2a8429c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminatedPercent_4df7cc2c-7fa4-429c-81e0-046e55ffdeba" xlink:href="vtrs-20211231.xsd#vtrs_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminatedPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_dc3cd54f-33d8-477b-a4d8-4ae8aa645720" xlink:to="loc_vtrs_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminatedPercent_4df7cc2c-7fa4-429c-81e0-046e55ffdeba" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_5ed06aec-425e-4e8b-9031-710eb4fbf580" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_dc3cd54f-33d8-477b-a4d8-4ae8aa645720" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash2_5ed06aec-425e-4e8b-9031-710eb4fbf580" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1_f670b7ff-f15b-45ce-8d37-62196101d8a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_dc3cd54f-33d8-477b-a4d8-4ae8aa645720" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1_f670b7ff-f15b-45ce-8d37-62196101d8a9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RestructuringReserveReimbursableRestructuringCharges_74ac6e80-eede-4cec-b433-7c922e390b94" xlink:href="vtrs-20211231.xsd#vtrs_RestructuringReserveReimbursableRestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_dc3cd54f-33d8-477b-a4d8-4ae8aa645720" xlink:to="loc_vtrs_RestructuringReserveReimbursableRestructuringCharges_74ac6e80-eede-4cec-b433-7c922e390b94" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7d8d867b-0cd4-4961-8071-c0f09951a864" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_dc3cd54f-33d8-477b-a4d8-4ae8aa645720" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7d8d867b-0cd4-4961-8071-c0f09951a864" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_a095bf68-58b6-4d02-be40-fdd2d5644cd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7d8d867b-0cd4-4961-8071-c0f09951a864" xlink:to="loc_us-gaap_RestructuringPlanAxis_a095bf68-58b6-4d02-be40-fdd2d5644cd0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_a095bf68-58b6-4d02-be40-fdd2d5644cd0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_a095bf68-58b6-4d02-be40-fdd2d5644cd0" xlink:to="loc_us-gaap_RestructuringPlanDomain_a095bf68-58b6-4d02-be40-fdd2d5644cd0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_69aa44d6-5edd-49ea-b1be-ad8b81972bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_a095bf68-58b6-4d02-be40-fdd2d5644cd0" xlink:to="loc_us-gaap_RestructuringPlanDomain_69aa44d6-5edd-49ea-b1be-ad8b81972bb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2020RestructuringPlanMember_5ab8e536-8949-4323-90b8-01ddb5f28252" xlink:href="vtrs-20211231.xsd#vtrs_A2020RestructuringPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_69aa44d6-5edd-49ea-b1be-ad8b81972bb9" xlink:to="loc_vtrs_A2020RestructuringPlanMember_5ab8e536-8949-4323-90b8-01ddb5f28252" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_1d52aa09-c5e7-48a4-9d05-dfcc93d8cae6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7d8d867b-0cd4-4961-8071-c0f09951a864" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_1d52aa09-c5e7-48a4-9d05-dfcc93d8cae6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_1d52aa09-c5e7-48a4-9d05-dfcc93d8cae6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_1d52aa09-c5e7-48a4-9d05-dfcc93d8cae6" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_1d52aa09-c5e7-48a4-9d05-dfcc93d8cae6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_41c7b60e-6d66-4790-a57a-b4bdf6d09b19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_1d52aa09-c5e7-48a4-9d05-dfcc93d8cae6" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_41c7b60e-6d66-4790-a57a-b4bdf6d09b19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_61814406-1bfa-4670-b864-cf0ce6e7927d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_41c7b60e-6d66-4790-a57a-b4bdf6d09b19" xlink:to="loc_us-gaap_EmployeeSeveranceMember_61814406-1bfa-4670-b864-cf0ce6e7927d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_feb83f25-7adf-476c-9529-0ce1c6bfd445" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherRestructuringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_41c7b60e-6d66-4790-a57a-b4bdf6d09b19" xlink:to="loc_us-gaap_OtherRestructuringMember_feb83f25-7adf-476c-9529-0ce1c6bfd445" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_8f449126-3604-4c46-9e43-ac3807e3afc8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7d8d867b-0cd4-4961-8071-c0f09951a864" xlink:to="loc_srt_RangeAxis_8f449126-3604-4c46-9e43-ac3807e3afc8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8f449126-3604-4c46-9e43-ac3807e3afc8_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_8f449126-3604-4c46-9e43-ac3807e3afc8" xlink:to="loc_srt_RangeMember_8f449126-3604-4c46-9e43-ac3807e3afc8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_278093f1-41f8-4105-adfb-7389721e5da7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_8f449126-3604-4c46-9e43-ac3807e3afc8" xlink:to="loc_srt_RangeMember_278093f1-41f8-4105-adfb-7389721e5da7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8ccffc1c-06a7-40c1-bac0-cf247b11e854" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_278093f1-41f8-4105-adfb-7389721e5da7" xlink:to="loc_srt_MinimumMember_8ccffc1c-06a7-40c1-bac0-cf247b11e854" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8b06f27d-fc32-4499-9c24-1710623d4d11" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_278093f1-41f8-4105-adfb-7389721e5da7" xlink:to="loc_srt_MaximumMember_8b06f27d-fc32-4499-9c24-1710623d4d11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_205d734d-4b15-4468-94ae-957f7fc1912f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7d8d867b-0cd4-4961-8071-c0f09951a864" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_205d734d-4b15-4468-94ae-957f7fc1912f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_205d734d-4b15-4468-94ae-957f7fc1912f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_205d734d-4b15-4468-94ae-957f7fc1912f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_205d734d-4b15-4468-94ae-957f7fc1912f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4e898927-8162-4fb6-8b01-6ab293b67f3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_205d734d-4b15-4468-94ae-957f7fc1912f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4e898927-8162-4fb6-8b01-6ab293b67f3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_UpjohnInc.Member_8d25dfdf-546e-4439-9921-f5e337fce131" xlink:href="vtrs-20211231.xsd#vtrs_UpjohnInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4e898927-8162-4fb6-8b01-6ab293b67f3c" xlink:to="loc_vtrs_UpjohnInc.Member_8d25dfdf-546e-4439-9921-f5e337fce131" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_d572922c-69ca-475b-8edd-231484877bad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7d8d867b-0cd4-4961-8071-c0f09951a864" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_d572922c-69ca-475b-8edd-231484877bad" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d572922c-69ca-475b-8edd-231484877bad_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_d572922c-69ca-475b-8edd-231484877bad" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d572922c-69ca-475b-8edd-231484877bad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_ca96dde4-3054-41a4-91cf-c19f6282e6d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_d572922c-69ca-475b-8edd-231484877bad" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_ca96dde4-3054-41a4-91cf-c19f6282e6d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_86d55800-f42d-4236-bac7-24ab192e11d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_ca96dde4-3054-41a4-91cf-c19f6282e6d1" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_86d55800-f42d-4236-bac7-24ab192e11d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_251359c8-c14c-4441-baa1-fe315e407d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_ca96dde4-3054-41a4-91cf-c19f6282e6d1" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_251359c8-c14c-4441-baa1-fe315e407d5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_4a510c13-dc06-4360-9742-0e1425e22d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7d8d867b-0cd4-4961-8071-c0f09951a864" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_4a510c13-dc06-4360-9742-0e1425e22d5c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4a510c13-dc06-4360-9742-0e1425e22d5c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4a510c13-dc06-4360-9742-0e1425e22d5c" xlink:to="loc_us-gaap_SegmentDomain_4a510c13-dc06-4360-9742-0e1425e22d5c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5d95e366-b101-4c76-8940-5d5bf70f1271" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4a510c13-dc06-4360-9742-0e1425e22d5c" xlink:to="loc_us-gaap_SegmentDomain_5d95e366-b101-4c76-8940-5d5bf70f1271" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EmergingMarketsSegmentMember_f4ad6bcc-9d8a-4074-bb2b-aadde6e31037" xlink:href="vtrs-20211231.xsd#vtrs_EmergingMarketsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5d95e366-b101-4c76-8940-5d5bf70f1271" xlink:to="loc_vtrs_EmergingMarketsSegmentMember_f4ad6bcc-9d8a-4074-bb2b-aadde6e31037" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GreaterChinaSegmentMember_6597b7cc-83d6-42b4-b332-640a894110a5" xlink:href="vtrs-20211231.xsd#vtrs_GreaterChinaSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5d95e366-b101-4c76-8940-5d5bf70f1271" xlink:to="loc_vtrs_GreaterChinaSegmentMember_6597b7cc-83d6-42b4-b332-640a894110a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_00b83db8-e1e7-4563-a71f-12c3599f848b" xlink:href="vtrs-20211231.xsd#vtrs_JapanAustraliaAndNewZealandSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5d95e366-b101-4c76-8940-5d5bf70f1271" xlink:to="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_00b83db8-e1e7-4563-a71f-12c3599f848b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DevelopedMarketsSegmentMember_f2206d2f-2335-4f2a-8a6c-df57683c7418" xlink:href="vtrs-20211231.xsd#vtrs_DevelopedMarketsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5d95e366-b101-4c76-8940-5d5bf70f1271" xlink:to="loc_vtrs_DevelopedMarketsSegmentMember_f2206d2f-2335-4f2a-8a6c-df57683c7418" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_5de1fed1-b39a-4950-ae2c-bcd8c3e55263" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7d8d867b-0cd4-4961-8071-c0f09951a864" xlink:to="loc_srt_ConsolidationItemsAxis_5de1fed1-b39a-4950-ae2c-bcd8c3e55263" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_5de1fed1-b39a-4950-ae2c-bcd8c3e55263_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_5de1fed1-b39a-4950-ae2c-bcd8c3e55263" xlink:to="loc_srt_ConsolidationItemsDomain_5de1fed1-b39a-4950-ae2c-bcd8c3e55263_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_dc34e4ec-7634-4559-844e-252161102e62" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_5de1fed1-b39a-4950-ae2c-bcd8c3e55263" xlink:to="loc_srt_ConsolidationItemsDomain_dc34e4ec-7634-4559-844e-252161102e62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_a5febd57-ef97-4879-83ae-027d7b75927c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_dc34e4ec-7634-4559-844e-252161102e62" xlink:to="loc_us-gaap_OperatingSegmentsMember_a5febd57-ef97-4879-83ae-027d7b75927c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_5a7f8fde-611b-41ca-896c-9aee89b8124a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_dc34e4ec-7634-4559-844e-252161102e62" xlink:to="loc_us-gaap_CorporateNonSegmentMember_5a7f8fde-611b-41ca-896c-9aee89b8124a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#CollaborationandLicensingAgreementsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails" xlink:type="extended" id="i06de528abadb4407bf9fbabcedfc33dc_CollaborationandLicensingAgreementsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_8b783744-148e-4277-837c-68aeca23743f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Developmentandsalesmilestonepayments_d1c8557b-eeef-4ee9-8970-943f1d8b38d3" xlink:href="vtrs-20211231.xsd#vtrs_Developmentandsalesmilestonepayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_8b783744-148e-4277-837c-68aeca23743f" xlink:to="loc_vtrs_Developmentandsalesmilestonepayments_d1c8557b-eeef-4ee9-8970-943f1d8b38d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_ff3a50e6-405d-479d-9100-779668ed96f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_8b783744-148e-4277-837c-68aeca23743f" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_ff3a50e6-405d-479d-9100-779668ed96f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NumberOfDrugs_a0d19cd8-6a37-4e6c-8286-02477d95b237" xlink:href="vtrs-20211231.xsd#vtrs_NumberOfDrugs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_8b783744-148e-4277-837c-68aeca23743f" xlink:to="loc_vtrs_NumberOfDrugs_a0d19cd8-6a37-4e6c-8286-02477d95b237" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PaymentsToAcquireCollaborativeAgreement_ab276c63-50cd-4c03-b60c-fc777e04e231" xlink:href="vtrs-20211231.xsd#vtrs_PaymentsToAcquireCollaborativeAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_8b783744-148e-4277-837c-68aeca23743f" xlink:to="loc_vtrs_PaymentsToAcquireCollaborativeAgreement_ab276c63-50cd-4c03-b60c-fc777e04e231" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_58d5ed7c-c765-43a7-b068-3810dff4dc60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_8b783744-148e-4277-837c-68aeca23743f" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_58d5ed7c-c765-43a7-b068-3810dff4dc60" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_InsulinAnalogProducts_4c6c833c-47d3-4bec-8236-5e9a283733d2" xlink:href="vtrs-20211231.xsd#vtrs_InsulinAnalogProducts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_8b783744-148e-4277-837c-68aeca23743f" xlink:to="loc_vtrs_InsulinAnalogProducts_4c6c833c-47d3-4bec-8236-5e9a283733d2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_7152b051-360b-4e74-a58b-9f5b2e8435a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_8b783744-148e-4277-837c-68aeca23743f" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_7152b051-360b-4e74-a58b-9f5b2e8435a3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_c126d569-803e-446e-a114-ea67f19b467a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_8b783744-148e-4277-837c-68aeca23743f" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_c126d569-803e-446e-a114-ea67f19b467a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_32cf065b-842d-4c45-81bc-6443a6aac8b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_8b783744-148e-4277-837c-68aeca23743f" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_32cf065b-842d-4c45-81bc-6443a6aac8b7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1_53b5cbee-f374-4230-8ee4-fae7ee4e3fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_8b783744-148e-4277-837c-68aeca23743f" xlink:to="loc_us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1_53b5cbee-f374-4230-8ee4-fae7ee4e3fe2" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DivestitureOfBusinessDeferredCashConsideration_1193221f-4c30-4564-a4e1-74091bfaa535" xlink:href="vtrs-20211231.xsd#vtrs_DivestitureOfBusinessDeferredCashConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_8b783744-148e-4277-837c-68aeca23743f" xlink:to="loc_vtrs_DivestitureOfBusinessDeferredCashConsideration_1193221f-4c30-4564-a4e1-74091bfaa535" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DivestitureOfBusinessPercentageOwnershipInCombinedCompanyAfterTransaction_30d922ef-f158-4d87-aa54-504fe43c49ca" xlink:href="vtrs-20211231.xsd#vtrs_DivestitureOfBusinessPercentageOwnershipInCombinedCompanyAfterTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_8b783744-148e-4277-837c-68aeca23743f" xlink:to="loc_vtrs_DivestitureOfBusinessPercentageOwnershipInCombinedCompanyAfterTransaction_30d922ef-f158-4d87-aa54-504fe43c49ca" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DivestitureOfBusinessTransitionServicesAgreementTerm_8a6d1953-858d-4da4-afbc-80cb68502763" xlink:href="vtrs-20211231.xsd#vtrs_DivestitureOfBusinessTransitionServicesAgreementTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_8b783744-148e-4277-837c-68aeca23743f" xlink:to="loc_vtrs_DivestitureOfBusinessTransitionServicesAgreementTerm_8a6d1953-858d-4da4-afbc-80cb68502763" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_f062101b-7ce5-42be-98e2-aac22cff564b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_8b783744-148e-4277-837c-68aeca23743f" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_f062101b-7ce5-42be-98e2-aac22cff564b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a60def24-b6a5-4b6e-8cda-7872293ccd0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_f062101b-7ce5-42be-98e2-aac22cff564b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a60def24-b6a5-4b6e-8cda-7872293ccd0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a60def24-b6a5-4b6e-8cda-7872293ccd0c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a60def24-b6a5-4b6e-8cda-7872293ccd0c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a60def24-b6a5-4b6e-8cda-7872293ccd0c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1bfe47c4-a66f-42cc-af1c-f7f9278f3d0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a60def24-b6a5-4b6e-8cda-7872293ccd0c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1bfe47c4-a66f-42cc-af1c-f7f9278f3d0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_49778bc9-0215-4fe7-a764-61e8b436947b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1bfe47c4-a66f-42cc-af1c-f7f9278f3d0a" xlink:to="loc_us-gaap_LicensingAgreementsMember_49778bc9-0215-4fe7-a764-61e8b436947b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e38ef1cb-0380-4712-acd3-22c5575484ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_f062101b-7ce5-42be-98e2-aac22cff564b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e38ef1cb-0380-4712-acd3-22c5575484ff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e38ef1cb-0380-4712-acd3-22c5575484ff_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e38ef1cb-0380-4712-acd3-22c5575484ff" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e38ef1cb-0380-4712-acd3-22c5575484ff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0e99f534-cb05-44f3-aaca-8fcdc9f7dd72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e38ef1cb-0380-4712-acd3-22c5575484ff" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0e99f534-cb05-44f3-aaca-8fcdc9f7dd72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherCompaniesMember_6ffc04be-f571-41d6-a92b-dd6c8e9b91d3" xlink:href="vtrs-20211231.xsd#vtrs_OtherCompaniesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0e99f534-cb05-44f3-aaca-8fcdc9f7dd72" xlink:to="loc_vtrs_OtherCompaniesMember_6ffc04be-f571-41d6-a92b-dd6c8e9b91d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RespiratorydeliveryplatformMember_4e12e5c5-45b8-47e2-ac3d-18851614c2d0" xlink:href="vtrs-20211231.xsd#vtrs_RespiratorydeliveryplatformMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0e99f534-cb05-44f3-aaca-8fcdc9f7dd72" xlink:to="loc_vtrs_RespiratorydeliveryplatformMember_4e12e5c5-45b8-47e2-ac3d-18851614c2d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_17fc81d7-2332-4aaa-aa99-f57ab4356877" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_f062101b-7ce5-42be-98e2-aac22cff564b" xlink:to="loc_us-gaap_AssetAcquisitionAxis_17fc81d7-2332-4aaa-aa99-f57ab4356877" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_17fc81d7-2332-4aaa-aa99-f57ab4356877_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AssetAcquisitionAxis_17fc81d7-2332-4aaa-aa99-f57ab4356877" xlink:to="loc_us-gaap_AssetAcquisitionDomain_17fc81d7-2332-4aaa-aa99-f57ab4356877_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_c4934745-4bb9-44ec-848d-92009e5d6a9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AssetAcquisitionAxis_17fc81d7-2332-4aaa-aa99-f57ab4356877" xlink:to="loc_us-gaap_AssetAcquisitionDomain_c4934745-4bb9-44ec-848d-92009e5d6a9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RespiratorydeliveryplatformMember_413c8d0d-a64c-47c5-94d1-ab688cf99463" xlink:href="vtrs-20211231.xsd#vtrs_RespiratorydeliveryplatformMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_c4934745-4bb9-44ec-848d-92009e5d6a9f" xlink:to="loc_vtrs_RespiratorydeliveryplatformMember_413c8d0d-a64c-47c5-94d1-ab688cf99463" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplyCommitmentAxis_87ba5520-5458-43e1-b655-e79b82ec6853" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplyCommitmentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_f062101b-7ce5-42be-98e2-aac22cff564b" xlink:to="loc_us-gaap_SupplyCommitmentAxis_87ba5520-5458-43e1-b655-e79b82ec6853" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplyCommitmentArrangementMember_87ba5520-5458-43e1-b655-e79b82ec6853_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplyCommitmentArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SupplyCommitmentAxis_87ba5520-5458-43e1-b655-e79b82ec6853" xlink:to="loc_us-gaap_SupplyCommitmentArrangementMember_87ba5520-5458-43e1-b655-e79b82ec6853_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplyCommitmentArrangementMember_b26be105-18b6-4c5b-9ad6-f349796d2323" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplyCommitmentArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SupplyCommitmentAxis_87ba5520-5458-43e1-b655-e79b82ec6853" xlink:to="loc_us-gaap_SupplyCommitmentArrangementMember_b26be105-18b6-4c5b-9ad6-f349796d2323" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GenericBiologicCompoundsCollaborationMember_0a5a7315-6626-4ea2-98b5-f85c3baec3a7" xlink:href="vtrs-20211231.xsd#vtrs_GenericBiologicCompoundsCollaborationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplyCommitmentArrangementMember_b26be105-18b6-4c5b-9ad6-f349796d2323" xlink:to="loc_vtrs_GenericBiologicCompoundsCollaborationMember_0a5a7315-6626-4ea2-98b5-f85c3baec3a7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PeriodAxis_628361b5-c648-4d2f-ac37-47538f4f34db" xlink:href="vtrs-20211231.xsd#vtrs_PeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_f062101b-7ce5-42be-98e2-aac22cff564b" xlink:to="loc_vtrs_PeriodAxis_628361b5-c648-4d2f-ac37-47538f4f34db" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PeriodDomain_628361b5-c648-4d2f-ac37-47538f4f34db_default" xlink:href="vtrs-20211231.xsd#vtrs_PeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_vtrs_PeriodAxis_628361b5-c648-4d2f-ac37-47538f4f34db" xlink:to="loc_vtrs_PeriodDomain_628361b5-c648-4d2f-ac37-47538f4f34db_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PeriodDomain_4772abcc-10d0-4f53-b55f-461962fc4806" xlink:href="vtrs-20211231.xsd#vtrs_PeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_vtrs_PeriodAxis_628361b5-c648-4d2f-ac37-47538f4f34db" xlink:to="loc_vtrs_PeriodDomain_4772abcc-10d0-4f53-b55f-461962fc4806" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_FiscalYear2017Member_de6a0e8d-26e0-4316-97b8-f72176cc6aed" xlink:href="vtrs-20211231.xsd#vtrs_FiscalYear2017Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vtrs_PeriodDomain_4772abcc-10d0-4f53-b55f-461962fc4806" xlink:to="loc_vtrs_FiscalYear2017Member_de6a0e8d-26e0-4316-97b8-f72176cc6aed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9febd48a-6dab-493b-8dbb-fd195de87f6e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_f062101b-7ce5-42be-98e2-aac22cff564b" xlink:to="loc_srt_RangeAxis_9febd48a-6dab-493b-8dbb-fd195de87f6e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9febd48a-6dab-493b-8dbb-fd195de87f6e_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_9febd48a-6dab-493b-8dbb-fd195de87f6e" xlink:to="loc_srt_RangeMember_9febd48a-6dab-493b-8dbb-fd195de87f6e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d722f3d3-0bce-4eae-b82d-65cfefd75bc3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_9febd48a-6dab-493b-8dbb-fd195de87f6e" xlink:to="loc_srt_RangeMember_d722f3d3-0bce-4eae-b82d-65cfefd75bc3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_0d09845b-33ed-4d16-ba4c-8a687700706d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d722f3d3-0bce-4eae-b82d-65cfefd75bc3" xlink:to="loc_srt_MaximumMember_0d09845b-33ed-4d16-ba4c-8a687700706d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_0511a62d-564a-4b80-8553-e04de95b7baf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_f062101b-7ce5-42be-98e2-aac22cff564b" xlink:to="loc_us-gaap_TypeOfArrangementAxis_0511a62d-564a-4b80-8553-e04de95b7baf" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_0511a62d-564a-4b80-8553-e04de95b7baf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_0511a62d-564a-4b80-8553-e04de95b7baf" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_0511a62d-564a-4b80-8553-e04de95b7baf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e0c82355-25e3-4903-8efd-495ec6058011" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_0511a62d-564a-4b80-8553-e04de95b7baf" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e0c82355-25e3-4903-8efd-495ec6058011" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_da29ef72-67b0-43e5-92c1-38549f9d46fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e0c82355-25e3-4903-8efd-495ec6058011" xlink:to="loc_us-gaap_CollaborativeArrangementMember_da29ef72-67b0-43e5-92c1-38549f9d46fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_MomentaMember_e67cbe95-096c-4666-a886-e2850bdcfbaf" xlink:href="vtrs-20211231.xsd#vtrs_MomentaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e0c82355-25e3-4903-8efd-495ec6058011" xlink:to="loc_vtrs_MomentaMember_e67cbe95-096c-4666-a886-e2850bdcfbaf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_TheravanceBiopharmaMember_c14191e4-6b90-4ce0-a69c-87c0861bcdef" xlink:href="vtrs-20211231.xsd#vtrs_TheravanceBiopharmaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e0c82355-25e3-4903-8efd-495ec6058011" xlink:to="loc_vtrs_TheravanceBiopharmaMember_c14191e4-6b90-4ce0-a69c-87c0861bcdef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_FKBMember_84dc0f9d-090a-4fb4-bb56-7acd41564305" xlink:href="vtrs-20211231.xsd#vtrs_FKBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e0c82355-25e3-4903-8efd-495ec6058011" xlink:to="loc_vtrs_FKBMember_84dc0f9d-090a-4fb4-bb56-7acd41564305" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_20016683-5232-4bc3-a52f-466a04a0109b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e0c82355-25e3-4903-8efd-495ec6058011" xlink:to="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_20016683-5232-4bc3-a52f-466a04a0109b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_057a37d0-4ee0-4bfe-ba90-7e4e66c6e6e7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_f062101b-7ce5-42be-98e2-aac22cff564b" xlink:to="loc_srt_CounterpartyNameAxis_057a37d0-4ee0-4bfe-ba90-7e4e66c6e6e7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_057a37d0-4ee0-4bfe-ba90-7e4e66c6e6e7_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_057a37d0-4ee0-4bfe-ba90-7e4e66c6e6e7" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_057a37d0-4ee0-4bfe-ba90-7e4e66c6e6e7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b389d19c-d442-4d0f-9ece-880fe0c38471" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_057a37d0-4ee0-4bfe-ba90-7e4e66c6e6e7" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b389d19c-d442-4d0f-9ece-880fe0c38471" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RevanceMember_8808169d-8be7-4058-8a56-60229aafbf62" xlink:href="vtrs-20211231.xsd#vtrs_RevanceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b389d19c-d442-4d0f-9ece-880fe0c38471" xlink:to="loc_vtrs_RevanceMember_8808169d-8be7-4058-8a56-60229aafbf62" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_TheravanceBiopharmaMember_fb0df2de-49da-44c6-bfb0-a68dcef7c0de" xlink:href="vtrs-20211231.xsd#vtrs_TheravanceBiopharmaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b389d19c-d442-4d0f-9ece-880fe0c38471" xlink:to="loc_vtrs_TheravanceBiopharmaMember_fb0df2de-49da-44c6-bfb0-a68dcef7c0de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_fd4b73e8-15df-4aaa-ad4d-59dafda15199" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_f062101b-7ce5-42be-98e2-aac22cff564b" xlink:to="loc_srt_StatementScenarioAxis_fd4b73e8-15df-4aaa-ad4d-59dafda15199" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_fd4b73e8-15df-4aaa-ad4d-59dafda15199_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_fd4b73e8-15df-4aaa-ad4d-59dafda15199" xlink:to="loc_srt_ScenarioUnspecifiedDomain_fd4b73e8-15df-4aaa-ad4d-59dafda15199_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_8112a382-3756-40de-839a-a766c7349bf5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_fd4b73e8-15df-4aaa-ad4d-59dafda15199" xlink:to="loc_srt_ScenarioUnspecifiedDomain_8112a382-3756-40de-839a-a766c7349bf5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_c550fcb5-17f0-445d-818f-dcdb5b471994" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_8112a382-3756-40de-839a-a766c7349bf5" xlink:to="loc_srt_ScenarioForecastMember_c550fcb5-17f0-445d-818f-dcdb5b471994" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_8e5ec6c2-cd23-4c1f-8c6c-443769129bc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_f062101b-7ce5-42be-98e2-aac22cff564b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_8e5ec6c2-cd23-4c1f-8c6c-443769129bc9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8e5ec6c2-cd23-4c1f-8c6c-443769129bc9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_8e5ec6c2-cd23-4c1f-8c6c-443769129bc9" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8e5ec6c2-cd23-4c1f-8c6c-443769129bc9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e56583c3-3650-45bc-9a09-e9b2d9fb68be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_8e5ec6c2-cd23-4c1f-8c6c-443769129bc9" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e56583c3-3650-45bc-9a09-e9b2d9fb68be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BiosimilarsBusinessMember_40fe165a-8dc5-4307-b9c9-8680c32a921e" xlink:href="vtrs-20211231.xsd#vtrs_BiosimilarsBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e56583c3-3650-45bc-9a09-e9b2d9fb68be" xlink:to="loc_vtrs_BiosimilarsBusinessMember_40fe165a-8dc5-4307-b9c9-8680c32a921e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_bbb19d7b-8163-4eae-9375-93c81b0800df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_f062101b-7ce5-42be-98e2-aac22cff564b" xlink:to="loc_us-gaap_StatementClassOfStockAxis_bbb19d7b-8163-4eae-9375-93c81b0800df" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_bbb19d7b-8163-4eae-9375-93c81b0800df_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_bbb19d7b-8163-4eae-9375-93c81b0800df" xlink:to="loc_us-gaap_ClassOfStockDomain_bbb19d7b-8163-4eae-9375-93c81b0800df_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_6d2a539e-9880-415c-b483-0363b6f289f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_bbb19d7b-8163-4eae-9375-93c81b0800df" xlink:to="loc_us-gaap_ClassOfStockDomain_6d2a539e-9880-415c-b483-0363b6f289f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember_884f7ad9-b4be-4dba-a19a-828480dfc355" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_6d2a539e-9880-415c-b483-0363b6f289f7" xlink:to="loc_us-gaap_ConvertiblePreferredStockMember_884f7ad9-b4be-4dba-a19a-828480dfc355" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LitigationNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#LitigationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/LitigationNarrativeDetails" xlink:type="extended" id="i5e63adf1d0bd47b8a2aacbec2c284364_LitigationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_8a3d1f76-7eb8-45b2-acb5-eb3af1f8f995" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_be8e1ce9-1282-45d7-83af-30c00c13ed9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8a3d1f76-7eb8-45b2-acb5-eb3af1f8f995" xlink:to="loc_us-gaap_LitigationReserve_be8e1ce9-1282-45d7-83af-30c00c13ed9a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_2a8c4e06-15ab-4905-86c0-0a8ba42df26b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8a3d1f76-7eb8-45b2-acb5-eb3af1f8f995" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_2a8c4e06-15ab-4905-86c0-0a8ba42df26b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_fd8b763b-8e2c-4dcd-8049-c8bf88ac0ce4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_d940161f-d3d5-47f0-aad6-7ac302b2ac59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8a3d1f76-7eb8-45b2-acb5-eb3af1f8f995" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_d940161f-d3d5-47f0-aad6-7ac302b2ac59" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_6b690204-11a3-4003-960f-634cfa3c4917" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Numberofstates_8f691635-9f3d-4968-aeb7-55f84b31619d" xlink:href="vtrs-20211231.xsd#vtrs_Numberofstates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8a3d1f76-7eb8-45b2-acb5-eb3af1f8f995" xlink:to="loc_vtrs_Numberofstates_8f691635-9f3d-4968-aeb7-55f84b31619d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Numberofcases_d5bae2d2-a3ca-474e-8d72-92ffb2aa0a99" xlink:href="vtrs-20211231.xsd#vtrs_Numberofcases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8a3d1f76-7eb8-45b2-acb5-eb3af1f8f995" xlink:to="loc_vtrs_Numberofcases_d5bae2d2-a3ca-474e-8d72-92ffb2aa0a99" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesPaidValue_aa49412f-49c5-4996-8eaf-d431fe0048a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesPaidValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8a3d1f76-7eb8-45b2-acb5-eb3af1f8f995" xlink:to="loc_us-gaap_LossContingencyDamagesPaidValue_aa49412f-49c5-4996-8eaf-d431fe0048a3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement_93eb78ab-9966-4422-a247-9856c715d41c" xlink:href="vtrs-20211231.xsd#vtrs_NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8a3d1f76-7eb8-45b2-acb5-eb3af1f8f995" xlink:to="loc_vtrs_NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement_93eb78ab-9966-4422-a247-9856c715d41c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_d4ffaef7-7d6b-4c3b-ad51-35da61006525" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPatentsAllegedlyInfringedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8a3d1f76-7eb8-45b2-acb5-eb3af1f8f995" xlink:to="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_d4ffaef7-7d6b-4c3b-ad51-35da61006525" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPatentsFoundNotInfringedNumber_5cf1d10c-67bf-4900-9ebb-b8f35ab2eea0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPatentsFoundNotInfringedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8a3d1f76-7eb8-45b2-acb5-eb3af1f8f995" xlink:to="loc_us-gaap_LossContingencyPatentsFoundNotInfringedNumber_5cf1d10c-67bf-4900-9ebb-b8f35ab2eea0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_LossContingencyRemainingClaimsNumber_5a3c75d2-b5b4-4331-b955-d9d732a775d1" xlink:href="vtrs-20211231.xsd#vtrs_LossContingencyRemainingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8a3d1f76-7eb8-45b2-acb5-eb3af1f8f995" xlink:to="loc_vtrs_LossContingencyRemainingClaimsNumber_5a3c75d2-b5b4-4331-b955-d9d732a775d1" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_LossContingencyOtherAssertedPatentsNumber_5900e4ff-f4c9-44bd-adf8-2cd295c5422d" xlink:href="vtrs-20211231.xsd#vtrs_LossContingencyOtherAssertedPatentsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8a3d1f76-7eb8-45b2-acb5-eb3af1f8f995" xlink:to="loc_vtrs_LossContingencyOtherAssertedPatentsNumber_5900e4ff-f4c9-44bd-adf8-2cd295c5422d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_LossContingencyNumberOfStates_ea3fe0b3-3de6-41b1-91b5-f96b5deabe6d" xlink:href="vtrs-20211231.xsd#vtrs_LossContingencyNumberOfStates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8a3d1f76-7eb8-45b2-acb5-eb3af1f8f995" xlink:to="loc_vtrs_LossContingencyNumberOfStates_ea3fe0b3-3de6-41b1-91b5-f96b5deabe6d" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_7b44f00d-125c-4e01-bbc9-cf975dd1675e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8a3d1f76-7eb8-45b2-acb5-eb3af1f8f995" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_7b44f00d-125c-4e01-bbc9-cf975dd1675e" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_LossContingencyDamagesAwardedOnAppealValue_9fa58f4a-9ef4-47a3-9dda-39e217bd16c9" xlink:href="vtrs-20211231.xsd#vtrs_LossContingencyDamagesAwardedOnAppealValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8a3d1f76-7eb8-45b2-acb5-eb3af1f8f995" xlink:to="loc_vtrs_LossContingencyDamagesAwardedOnAppealValue_9fa58f4a-9ef4-47a3-9dda-39e217bd16c9" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_b7b00fd0-4009-4ef3-8a39-cc475eb52bbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_8a3d1f76-7eb8-45b2-acb5-eb3af1f8f995" xlink:to="loc_us-gaap_LossContingenciesTable_b7b00fd0-4009-4ef3-8a39-cc475eb52bbd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_2e6b9661-0fd5-4de0-97b1-56314d78d5f5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_b7b00fd0-4009-4ef3-8a39-cc475eb52bbd" xlink:to="loc_srt_LitigationCaseAxis_2e6b9661-0fd5-4de0-97b1-56314d78d5f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_2e6b9661-0fd5-4de0-97b1-56314d78d5f5_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_2e6b9661-0fd5-4de0-97b1-56314d78d5f5" xlink:to="loc_srt_LitigationCaseTypeDomain_2e6b9661-0fd5-4de0-97b1-56314d78d5f5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_dd337b2e-8f5c-40ed-9b5a-757d67954c0b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_2e6b9661-0fd5-4de0-97b1-56314d78d5f5" xlink:to="loc_srt_LitigationCaseTypeDomain_dd337b2e-8f5c-40ed-9b5a-757d67954c0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_MultiDistrictLitigationMember_e928fc68-4cf6-4d1f-b8a0-b157da7a7ddc" xlink:href="vtrs-20211231.xsd#vtrs_MultiDistrictLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_dd337b2e-8f5c-40ed-9b5a-757d67954c0b" xlink:to="loc_vtrs_MultiDistrictLitigationMember_e928fc68-4cf6-4d1f-b8a0-b157da7a7ddc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember_8903abaa-d4d7-4466-a34c-5055574617c1" xlink:href="vtrs-20211231.xsd#vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_dd337b2e-8f5c-40ed-9b5a-757d67954c0b" xlink:to="loc_vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember_8903abaa-d4d7-4466-a34c-5055574617c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AnticompetitiveConductwithGenericDrugsMember_d4651d8e-d4b4-4766-8586-72c5d540f55b" xlink:href="vtrs-20211231.xsd#vtrs_AnticompetitiveConductwithGenericDrugsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_dd337b2e-8f5c-40ed-9b5a-757d67954c0b" xlink:to="loc_vtrs_AnticompetitiveConductwithGenericDrugsMember_d4651d8e-d4b4-4766-8586-72c5d540f55b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember_f339b792-0949-47a5-9565-152bcf42e045" xlink:href="vtrs-20211231.xsd#vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_dd337b2e-8f5c-40ed-9b5a-757d67954c0b" xlink:to="loc_vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember_f339b792-0949-47a5-9565-152bcf42e045" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AnticompetitiveConductWithRespectToAdditionalGenericDrugsMember_96ae2800-2aeb-4c78-8d18-b4468a90956e" xlink:href="vtrs-20211231.xsd#vtrs_AnticompetitiveConductWithRespectToAdditionalGenericDrugsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_dd337b2e-8f5c-40ed-9b5a-757d67954c0b" xlink:to="loc_vtrs_AnticompetitiveConductWithRespectToAdditionalGenericDrugsMember_96ae2800-2aeb-4c78-8d18-b4468a90956e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EUCommissionProceedingsPerindorprilMember_4d303635-ab93-41a0-9086-a5988a5caca7" xlink:href="vtrs-20211231.xsd#vtrs_EUCommissionProceedingsPerindorprilMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_dd337b2e-8f5c-40ed-9b5a-757d67954c0b" xlink:to="loc_vtrs_EUCommissionProceedingsPerindorprilMember_4d303635-ab93-41a0-9086-a5988a5caca7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_U.K.CompetitionandMarketsAuthorityProceedingsParoxetineMember_8e2d68f4-8783-4bc5-8472-6b9ab41c92eb" xlink:href="vtrs-20211231.xsd#vtrs_U.K.CompetitionandMarketsAuthorityProceedingsParoxetineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_dd337b2e-8f5c-40ed-9b5a-757d67954c0b" xlink:to="loc_vtrs_U.K.CompetitionandMarketsAuthorityProceedingsParoxetineMember_8e2d68f4-8783-4bc5-8472-6b9ab41c92eb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EUCommissionProceedingsCitalopramMember_e9d22405-082a-43e5-a884-f76d89720372" xlink:href="vtrs-20211231.xsd#vtrs_EUCommissionProceedingsCitalopramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_dd337b2e-8f5c-40ed-9b5a-757d67954c0b" xlink:to="loc_vtrs_EUCommissionProceedingsCitalopramMember_e9d22405-082a-43e5-a884-f76d89720372" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DimethylFumarateMember_7070e837-8b9f-4884-bb7a-897bbe03001a" xlink:href="vtrs-20211231.xsd#vtrs_DimethylFumarateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_dd337b2e-8f5c-40ed-9b5a-757d67954c0b" xlink:to="loc_vtrs_DimethylFumarateMember_7070e837-8b9f-4884-bb7a-897bbe03001a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_InsulinGlargineMember_d296d8e1-2196-401f-b065-c3c2552de038" xlink:href="vtrs-20211231.xsd#vtrs_InsulinGlargineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_dd337b2e-8f5c-40ed-9b5a-757d67954c0b" xlink:to="loc_vtrs_InsulinGlargineMember_d296d8e1-2196-401f-b065-c3c2552de038" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EpiPenAutoInjectorLitigationMember_d21cae86-bab8-4c6f-a1f3-25b20261d523" xlink:href="vtrs-20211231.xsd#vtrs_EpiPenAutoInjectorLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_dd337b2e-8f5c-40ed-9b5a-757d67954c0b" xlink:to="loc_vtrs_EpiPenAutoInjectorLitigationMember_d21cae86-bab8-4c6f-a1f3-25b20261d523" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_bcbcf83d-4fb4-4df4-a928-8b602f94fc24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_b7b00fd0-4009-4ef3-8a39-cc475eb52bbd" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_bcbcf83d-4fb4-4df4-a928-8b602f94fc24" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_bcbcf83d-4fb4-4df4-a928-8b602f94fc24_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_bcbcf83d-4fb4-4df4-a928-8b602f94fc24" xlink:to="loc_us-gaap_LossContingencyNatureDomain_bcbcf83d-4fb4-4df4-a928-8b602f94fc24_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_059618b8-08e0-45b0-a95b-dbc2dfca1718" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_bcbcf83d-4fb4-4df4-a928-8b602f94fc24" xlink:to="loc_us-gaap_LossContingencyNatureDomain_059618b8-08e0-45b0-a95b-dbc2dfca1718" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AntitrustProceedingsMember_608d183f-f8b4-4a96-91ca-412cecef7f53" xlink:href="vtrs-20211231.xsd#vtrs_AntitrustProceedingsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_059618b8-08e0-45b0-a95b-dbc2dfca1718" xlink:to="loc_vtrs_AntitrustProceedingsMember_608d183f-f8b4-4a96-91ca-412cecef7f53" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ProductLiabilityMember_10703757-5666-4f6a-87ee-9f8f13440545" xlink:href="vtrs-20211231.xsd#vtrs_ProductLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_059618b8-08e0-45b0-a95b-dbc2dfca1718" xlink:to="loc_vtrs_ProductLiabilityMember_10703757-5666-4f6a-87ee-9f8f13440545" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_87bc3884-6ae5-4743-a81b-b2fde71cd7c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_059618b8-08e0-45b0-a95b-dbc2dfca1718" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_87bc3884-6ae5-4743-a81b-b2fde71cd7c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherMember_b35a46bb-df8c-4ea8-bc44-ae8e68d02645" xlink:href="vtrs-20211231.xsd#vtrs_OtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_059618b8-08e0-45b0-a95b-dbc2dfca1718" xlink:to="loc_vtrs_OtherMember_b35a46bb-df8c-4ea8-bc44-ae8e68d02645" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_878ff08c-d11d-487c-8dc3-68f18990df04" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_b7b00fd0-4009-4ef3-8a39-cc475eb52bbd" xlink:to="loc_srt_ConsolidatedEntitiesAxis_878ff08c-d11d-487c-8dc3-68f18990df04" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_878ff08c-d11d-487c-8dc3-68f18990df04_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_878ff08c-d11d-487c-8dc3-68f18990df04" xlink:to="loc_srt_ConsolidatedEntitiesDomain_878ff08c-d11d-487c-8dc3-68f18990df04_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_5d2d81eb-32f5-4402-a52a-f80612798141" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_878ff08c-d11d-487c-8dc3-68f18990df04" xlink:to="loc_srt_ConsolidatedEntitiesDomain_5d2d81eb-32f5-4402-a52a-f80612798141" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember_0298d285-e42b-4dd3-85c3-01d068316aa7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SubsidiariesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_5d2d81eb-32f5-4402-a52a-f80612798141" xlink:to="loc_srt_SubsidiariesMember_0298d285-e42b-4dd3-85c3-01d068316aa7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_68a2057b-8098-4674-8b86-e9ac7367752a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_5d2d81eb-32f5-4402-a52a-f80612798141" xlink:to="loc_srt_ParentCompanyMember_68a2057b-8098-4674-8b86-e9ac7367752a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_3b0d53ea-c0f7-40ff-9241-89c28e71a4ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_b7b00fd0-4009-4ef3-8a39-cc475eb52bbd" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_3b0d53ea-c0f7-40ff-9241-89c28e71a4ed" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_3b0d53ea-c0f7-40ff-9241-89c28e71a4ed_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_3b0d53ea-c0f7-40ff-9241-89c28e71a4ed" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_3b0d53ea-c0f7-40ff-9241-89c28e71a4ed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_f2c2c54d-1e60-434a-92e1-70a109af43f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_3b0d53ea-c0f7-40ff-9241-89c28e71a4ed" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_f2c2c54d-1e60-434a-92e1-70a109af43f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_4f504fc5-5da7-4602-8b36-b9e9e80793c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_f2c2c54d-1e60-434a-92e1-70a109af43f6" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_4f504fc5-5da7-4602-8b36-b9e9e80793c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_b1e1164a-9f1b-4a27-a77b-8a009d3ac728" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_b7b00fd0-4009-4ef3-8a39-cc475eb52bbd" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_b1e1164a-9f1b-4a27-a77b-8a009d3ac728" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_b1e1164a-9f1b-4a27-a77b-8a009d3ac728_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_b1e1164a-9f1b-4a27-a77b-8a009d3ac728" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_b1e1164a-9f1b-4a27-a77b-8a009d3ac728_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_6d186151-8951-43de-a5e2-7845236e55b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_b1e1164a-9f1b-4a27-a77b-8a009d3ac728" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_6d186151-8951-43de-a5e2-7845236e55b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_d4445845-2d23-4a34-9a90-10d5ed3b267d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_6d186151-8951-43de-a5e2-7845236e55b6" xlink:to="loc_us-gaap_SubsequentEventMember_d4445845-2d23-4a34-9a90-10d5ed3b267d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ValuationandQualifyingAccountsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#ValuationandQualifyingAccountsDetails"/>
  <link:definitionLink xlink:role="http://www.viatris.com/role/ValuationandQualifyingAccountsDetails" xlink:type="extended" id="i2f8c871f2af94e0d958464f5df3ab71e_ValuationandQualifyingAccountsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_857dcda1-79bf-4d25-a922-e87651676c52" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_72991c87-8f89-4a49-9cb3-231ea62b5194" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_857dcda1-79bf-4d25-a922-e87651676c52" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_72991c87-8f89-4a49-9cb3-231ea62b5194" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_59d6c460-ac9e-4eb1-ab82-ab9c701e2c39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_72991c87-8f89-4a49-9cb3-231ea62b5194" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_59d6c460-ac9e-4eb1-ab82-ab9c701e2c39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_479e3691-37ed-4f7d-8812-b3281c83aad9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_72991c87-8f89-4a49-9cb3-231ea62b5194" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_479e3691-37ed-4f7d-8812-b3281c83aad9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_49b90970-1a4b-4225-8c50-e579d235e3c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_72991c87-8f89-4a49-9cb3-231ea62b5194" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_49b90970-1a4b-4225-8c50-e579d235e3c5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_6643373f-6e4b-485b-ae83-66a6d013e4b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_72991c87-8f89-4a49-9cb3-231ea62b5194" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_6643373f-6e4b-485b-ae83-66a6d013e4b2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_cde0f449-017f-42b1-a70a-deb2e449d810" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_4dcec9a9-e144-402f-bccb-69c9b9ffd174" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_857dcda1-79bf-4d25-a922-e87651676c52" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_4dcec9a9-e144-402f-bccb-69c9b9ffd174" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_062b0904-1a85-47a5-86d9-999e2e78e681" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_4dcec9a9-e144-402f-bccb-69c9b9ffd174" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_062b0904-1a85-47a5-86d9-999e2e78e681" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_062b0904-1a85-47a5-86d9-999e2e78e681_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_062b0904-1a85-47a5-86d9-999e2e78e681" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_062b0904-1a85-47a5-86d9-999e2e78e681_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_073ea4d7-2e4b-43f1-ac7c-c13de6f863fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_062b0904-1a85-47a5-86d9-999e2e78e681" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_073ea4d7-2e4b-43f1-ac7c-c13de6f863fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_f3085241-1849-4e15-aaa5-007ca841025b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_073ea4d7-2e4b-43f1-ac7c-c13de6f863fa" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_f3085241-1849-4e15-aaa5-007ca841025b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_708b283d-5bd9-4535-8bc0-6cd4fc7fa04d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_073ea4d7-2e4b-43f1-ac7c-c13de6f863fa" xlink:to="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_708b283d-5bd9-4535-8bc0-6cd4fc7fa04d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>vtrs-20211231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:7d588a56-150d-4ea9-a97c-5b39f92c59e0,g:83cb92d0-838c-40d0-a420-8487c2f4fc1b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_b6345b17-053b-4906-828c-14e61285cc5d_verboseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid during the period for:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_940aacfc-f051-4b93-ab1b-0dad02f152d1_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_4e0e4c79-0d14-43bc-b1bf-003172c7bd47_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains and Losses on Marketable Securities</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:to="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_AccountsReceivableVariableConsiderationRollForward_94631d51-315e-4d78-a113-db7f2ed2933b_terseLabel_en-US" xlink:label="lab_vtrs_AccountsReceivableVariableConsiderationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Variable Consideration [Roll Forward]</link:label>
    <link:label id="lab_vtrs_AccountsReceivableVariableConsiderationRollForward_label_en-US" xlink:label="lab_vtrs_AccountsReceivableVariableConsiderationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Variable Consideration [Roll Forward]</link:label>
    <link:label id="lab_vtrs_AccountsReceivableVariableConsiderationRollForward_documentation_en-US" xlink:label="lab_vtrs_AccountsReceivableVariableConsiderationRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Variable Consideration [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccountsReceivableVariableConsiderationRollForward" xlink:href="vtrs-20211231.xsd#vtrs_AccountsReceivableVariableConsiderationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_AccountsReceivableVariableConsiderationRollForward" xlink:to="lab_vtrs_AccountsReceivableVariableConsiderationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_572f467d-ec97-495a-92a2-1a52dadf60c4_terseLabel_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies</link:label>
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_label_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Matters and Contingencies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LegalMattersAndContingenciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:to="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_c068faf8-acc0-4817-adea-a7e3853319f0_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial (gains) losses</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_NorthAmericaGenericsMember_365ada23-3472-4b40-9b88-a84e81d15b3a_terseLabel_en-US" xlink:label="lab_vtrs_NorthAmericaGenericsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North America Generics [Member]</link:label>
    <link:label id="lab_vtrs_NorthAmericaGenericsMember_label_en-US" xlink:label="lab_vtrs_NorthAmericaGenericsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North America Generics [Member]</link:label>
    <link:label id="lab_vtrs_NorthAmericaGenericsMember_documentation_en-US" xlink:label="lab_vtrs_NorthAmericaGenericsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North America Generics [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NorthAmericaGenericsMember" xlink:href="vtrs-20211231.xsd#vtrs_NorthAmericaGenericsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_NorthAmericaGenericsMember" xlink:to="lab_vtrs_NorthAmericaGenericsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_3b47ff48-ce5e-46a4-85a3-95f5dd04888b_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents [Axis]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_df088db4-a18d-40e8-8f46-92831627570e_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of restricted stock awards, released</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_09116a8f-ac32-4f9a-87aa-d01484d33ef2_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. State Current</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_d9b7ac8a-e03c-40f4-88fa-bd3e09dc751a_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet_ab556ae9-4942-4dc6-a577-27935f7b33be_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes related to the net share settlement of equity awards</link:label>
    <link:label id="lab_us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet_label_en-US" xlink:label="lab_us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet" xlink:to="lab_us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_39893977-7ec8-4e9a-87f1-1e9040d58b60_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale fixed income securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_c1e03c0b-de73-43ff-888e-a43108d2743b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in usd per share)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_6c337c5c-0e7a-4487-a3bf-3883aa7ff013_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_label_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_4bfc55bc-4f7e-4e28-bd11-4789bc69f1cb_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_RespiratorydeliveryplatformMember_8e466813-3722-4aa2-9cc6-6489f4eb7e42_terseLabel_en-US" xlink:label="lab_vtrs_RespiratorydeliveryplatformMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Respiratory delivery platform [Member]</link:label>
    <link:label id="lab_vtrs_RespiratorydeliveryplatformMember_label_en-US" xlink:label="lab_vtrs_RespiratorydeliveryplatformMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Respiratory delivery platform [Member]</link:label>
    <link:label id="lab_vtrs_RespiratorydeliveryplatformMember_documentation_en-US" xlink:label="lab_vtrs_RespiratorydeliveryplatformMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Respiratory delivery platform [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RespiratorydeliveryplatformMember" xlink:href="vtrs-20211231.xsd#vtrs_RespiratorydeliveryplatformMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_RespiratorydeliveryplatformMember" xlink:to="lab_vtrs_RespiratorydeliveryplatformMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertySubjectToOrAvailableForOperatingLeaseTextBlock_c2139671-d0b1-41b9-800c-6b0c1a04c173_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertySubjectToOrAvailableForOperatingLeaseTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property Subject to or Available for Operating Lease</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertySubjectToOrAvailableForOperatingLeaseTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertySubjectToOrAvailableForOperatingLeaseTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment, Lessor Asset under Operating Lease [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertySubjectToOrAvailableForOperatingLeaseTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertySubjectToOrAvailableForOperatingLeaseTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertySubjectToOrAvailableForOperatingLeaseTextBlock" xlink:to="lab_us-gaap_ScheduleOfPropertySubjectToOrAvailableForOperatingLeaseTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_22c606fc-3b0c-4ad1-b256-d7e9784cfda5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends declared, $0.33 per common share</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_13559281-fae2-4cfe-b63b-aaf3beae5d27_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_b8f5a33b-d986-4fde-84f4-ee574cadbb66_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant-date fair value per share, forfeited</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_a924e938-066b-47a6-93ff-a64bf310cf8b_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Financing Activities</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_YupelriMember_057d543b-be38-4a5e-a57d-eed407ec6bcb_terseLabel_en-US" xlink:label="lab_vtrs_YupelriMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yupelri &#174;</link:label>
    <link:label id="lab_vtrs_YupelriMember_label_en-US" xlink:label="lab_vtrs_YupelriMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yupelri &#174; [Member]</link:label>
    <link:label id="lab_vtrs_YupelriMember_documentation_en-US" xlink:label="lab_vtrs_YupelriMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yupelri &#174;</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_YupelriMember" xlink:href="vtrs-20211231.xsd#vtrs_YupelriMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_YupelriMember" xlink:to="lab_vtrs_YupelriMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_649208c5-b5c8-4cea-9862-96696d045107_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares under stock awards, forfeited</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_d3e750cc-1dda-4313-a687-0dab2cc4a51d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining lease term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_0bf85509-56f7-4621-be58-38cdc135b6c5_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currencies Policy</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_d91ad820-814e-4650-a7db-4a11d52bd170_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Patents Allegedly Infringed, Number</link:label>
    <link:label id="lab_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Patents Allegedly Infringed, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPatentsAllegedlyInfringedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber" xlink:to="lab_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_45fa3d52-acff-4ee8-8c34-0d7238e2fc16_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_23498a49-7943-44fc-9216-e13faa8c4459_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_967858b6-cbc4-470d-a2d0-d21c98a1dc5d_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_012b346c-d028-4792-ab20-ebc0cf9c3c1d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Policy</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_baadb366-2f9f-48b0-be87-e071f2087e2a_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (decrease) increase in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_VariableConsiderationCategoryDomain_f1d3046b-2019-4cfd-9dc2-74b38bb82b4b_terseLabel_en-US" xlink:label="lab_vtrs_VariableConsiderationCategoryDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Consideration Category [Domain]</link:label>
    <link:label id="lab_vtrs_VariableConsiderationCategoryDomain_label_en-US" xlink:label="lab_vtrs_VariableConsiderationCategoryDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Consideration Category [Domain]</link:label>
    <link:label id="lab_vtrs_VariableConsiderationCategoryDomain_documentation_en-US" xlink:label="lab_vtrs_VariableConsiderationCategoryDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Variable Consideration Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VariableConsiderationCategoryDomain" xlink:href="vtrs-20211231.xsd#vtrs_VariableConsiderationCategoryDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_VariableConsiderationCategoryDomain" xlink:to="lab_vtrs_VariableConsiderationCategoryDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_bf9877cc-0a82-4946-8350-7da267d6fd56_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ReductioninSharebasedCompensationExpense_0d15e6ad-bd67-4d23-a559-bd285759e565_terseLabel_en-US" xlink:label="lab_vtrs_ReductioninSharebasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction in Share-based Compensation Expense</link:label>
    <link:label id="lab_vtrs_ReductioninSharebasedCompensationExpense_label_en-US" xlink:label="lab_vtrs_ReductioninSharebasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction in Share-based Compensation Expense</link:label>
    <link:label id="lab_vtrs_ReductioninSharebasedCompensationExpense_documentation_en-US" xlink:label="lab_vtrs_ReductioninSharebasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction in Share-based Compensation Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ReductioninSharebasedCompensationExpense" xlink:href="vtrs-20211231.xsd#vtrs_ReductioninSharebasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ReductioninSharebasedCompensationExpense" xlink:to="lab_vtrs_ReductioninSharebasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_VestingPeriodDomain_28d065be-4011-4730-90d2-8feea88155b1_terseLabel_en-US" xlink:label="lab_vtrs_VestingPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting Period [Domain]</link:label>
    <link:label id="lab_vtrs_VestingPeriodDomain_label_en-US" xlink:label="lab_vtrs_VestingPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting Period [Domain]</link:label>
    <link:label id="lab_vtrs_VestingPeriodDomain_documentation_en-US" xlink:label="lab_vtrs_VestingPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Vesting Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VestingPeriodDomain" xlink:href="vtrs-20211231.xsd#vtrs_VestingPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_VestingPeriodDomain" xlink:to="lab_vtrs_VestingPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense_6ad82e20-3529-42ad-94dc-e36b0098dcfd_terseLabel_en-US" xlink:label="lab_vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partial payment of anticipated tax expense</link:label>
    <link:label id="lab_vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense_label_en-US" xlink:label="lab_vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Partial Payment Of Income Tax Expense</link:label>
    <link:label id="lab_vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense_documentation_en-US" xlink:label="lab_vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Partial Payment Of Income Tax Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense" xlink:href="vtrs-20211231.xsd#vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense" xlink:to="lab_vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_U.S.StateTaxAuthorityMember_00a2d038-db85-445e-9d1e-006bd33f8562_terseLabel_en-US" xlink:label="lab_vtrs_U.S.StateTaxAuthorityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. State Tax Authority</link:label>
    <link:label id="lab_vtrs_U.S.StateTaxAuthorityMember_label_en-US" xlink:label="lab_vtrs_U.S.StateTaxAuthorityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. State Tax Authority [Member]</link:label>
    <link:label id="lab_vtrs_U.S.StateTaxAuthorityMember_documentation_en-US" xlink:label="lab_vtrs_U.S.StateTaxAuthorityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. State Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_U.S.StateTaxAuthorityMember" xlink:href="vtrs-20211231.xsd#vtrs_U.S.StateTaxAuthorityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_U.S.StateTaxAuthorityMember" xlink:to="lab_vtrs_U.S.StateTaxAuthorityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_4f5f6e5f-ad72-484b-9771-d10b82601809_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_921ddef6-2d82-4339-b331-7ddd2fbbc0b7_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets and goodwill</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_62f4c207-46ab-4943-a6e9-cae698a9b6fa_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_4d7a239c-a550-44a9-94ed-1ea89105aad8_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange derivative liabilities</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contracts, Liability, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:to="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2032EuroSeniorNotesMember_1f0a273c-f6ee-48c0-a631-9b890161352c_terseLabel_en-US" xlink:label="lab_vtrs_A2032EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2032 Euro Senior Notes</link:label>
    <link:label id="lab_vtrs_A2032EuroSeniorNotesMember_label_en-US" xlink:label="lab_vtrs_A2032EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2032 Euro Senior Notes [Member]</link:label>
    <link:label id="lab_vtrs_A2032EuroSeniorNotesMember_documentation_en-US" xlink:label="lab_vtrs_A2032EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2032 Euro Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2032EuroSeniorNotesMember" xlink:href="vtrs-20211231.xsd#vtrs_A2032EuroSeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2032EuroSeniorNotesMember" xlink:to="lab_vtrs_A2032EuroSeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredBonusMember_c551bb78-ff8c-479d-8ee6-23398663af38_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredBonusMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Bonus</link:label>
    <link:label id="lab_us-gaap_DeferredBonusMember_label_en-US" xlink:label="lab_us-gaap_DeferredBonusMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Bonus [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredBonusMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredBonusMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredBonusMember" xlink:to="lab_us-gaap_DeferredBonusMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandFortyThreeMember_61703492-db1d-411f-9ad2-d2ce3ee436f7_terseLabel_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandFortyThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2043 Senior Notes (5.400%)</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandFortyThreeMember_label_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandFortyThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SeniorNotesTwoThousandFortyThree [Member]</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandFortyThreeMember_documentation_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandFortyThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes two thousand forty three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandFortyThreeMember" xlink:href="vtrs-20211231.xsd#vtrs_SeniorNotesTwoThousandFortyThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_SeniorNotesTwoThousandFortyThreeMember" xlink:to="lab_vtrs_SeniorNotesTwoThousandFortyThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_OtherCompaniesMember_b6de4d5e-3a8f-4bc6-abab-8f48c9c8f776_terseLabel_en-US" xlink:label="lab_vtrs_OtherCompaniesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other companies</link:label>
    <link:label id="lab_vtrs_OtherCompaniesMember_label_en-US" xlink:label="lab_vtrs_OtherCompaniesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Companies [Member]</link:label>
    <link:label id="lab_vtrs_OtherCompaniesMember_documentation_en-US" xlink:label="lab_vtrs_OtherCompaniesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other companies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherCompaniesMember" xlink:href="vtrs-20211231.xsd#vtrs_OtherCompaniesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_OtherCompaniesMember" xlink:to="lab_vtrs_OtherCompaniesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueHedgingMember_39812a4f-c14b-40db-8aaa-97ea80388c43_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value hedging relationships</link:label>
    <link:label id="lab_us-gaap_FairValueHedgingMember_label_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueHedgingMember" xlink:to="lab_us-gaap_FairValueHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_a901bc8e-0a96-4e01-be29-9587aa869e83_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions Charged to Costs and Expenses</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeOtherNetOfTax_01ad194a-acdc-4f52-98c8-d8a17b234ca0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeOtherNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income, Other, Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeOtherNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeOtherNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income, Other, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeOtherNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeOtherNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeOtherNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeOtherNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_e7cbc7fa-4f64-4a41-9824-05dee78810f5_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_49095497-4f98-4cd6-b99e-860eb37ab05d_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_73431c26-9eb1-457f-9878-84c1b62bc324_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_61366c98-56a8-44c3-8059-7a7d7f404ae6_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_28d7e71f-9c01-429b-9faa-6b1d429e6e98_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_8b62f18c-c056-4771-b7ee-9d1a41e72872_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Identified intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_0215fb63-b468-4c44-81c1-8e82b57a96e5_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired intangible assets, weighted average useful life, in years</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_9080926d-3c2b-4cd2-8e86-e8ae295251c0_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions for prior year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ProgramNameAxis_8c83147d-87a9-4fb7-8984-e69a02092227_terseLabel_en-US" xlink:label="lab_vtrs_ProgramNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Program Name [Axis]</link:label>
    <link:label id="lab_vtrs_ProgramNameAxis_label_en-US" xlink:label="lab_vtrs_ProgramNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Program Name [Axis]</link:label>
    <link:label id="lab_vtrs_ProgramNameAxis_documentation_en-US" xlink:label="lab_vtrs_ProgramNameAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Program Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ProgramNameAxis" xlink:href="vtrs-20211231.xsd#vtrs_ProgramNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ProgramNameAxis" xlink:to="lab_vtrs_ProgramNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_bca3202d-05d2-4510-a3fe-83c71f1fda93_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average discount rate</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_3775685a-7bd0-45e1-a581-b88734988423_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_81f77519-5d51-499b-99d1-3aabd2795278_verboseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-dilutive securities excluded from computation of earnings per share</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_PaymentsToAcquireCollaborativeAgreement_5d4187b8-d833-4737-8f90-07ebc61c2972_terseLabel_en-US" xlink:label="lab_vtrs_PaymentsToAcquireCollaborativeAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront payments</link:label>
    <link:label id="lab_vtrs_PaymentsToAcquireCollaborativeAgreement_label_en-US" xlink:label="lab_vtrs_PaymentsToAcquireCollaborativeAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments To Acquire Collaborative Agreement</link:label>
    <link:label id="lab_vtrs_PaymentsToAcquireCollaborativeAgreement_documentation_en-US" xlink:label="lab_vtrs_PaymentsToAcquireCollaborativeAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments To Acquire Collaborative Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PaymentsToAcquireCollaborativeAgreement" xlink:href="vtrs-20211231.xsd#vtrs_PaymentsToAcquireCollaborativeAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_PaymentsToAcquireCollaborativeAgreement" xlink:to="lab_vtrs_PaymentsToAcquireCollaborativeAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_a084b431-b585-4a42-9f3d-97da9ef9e49c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_0f2e1421-c457-4bc6-b460-730ba4853d6c_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_4d77a624-8e87-4181-b659-e8b3a74c2531_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LegalEntityTypeOfCounterpartyDomain_0ab3523a-4996-4b2c-91a6-383192b2068d_terseLabel_en-US" xlink:label="lab_us-gaap_LegalEntityTypeOfCounterpartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity Type of Counterparty [Domain]</link:label>
    <link:label id="lab_us-gaap_LegalEntityTypeOfCounterpartyDomain_label_en-US" xlink:label="lab_us-gaap_LegalEntityTypeOfCounterpartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity Type of Counterparty [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalEntityTypeOfCounterpartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LegalEntityTypeOfCounterpartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LegalEntityTypeOfCounterpartyDomain" xlink:to="lab_us-gaap_LegalEntityTypeOfCounterpartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_b8959b68-cb03-48ef-b506-d3be7e0f7bd6_verboseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow hedging relationships</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_1f1c3f42-3962-4e8d-b47f-78f371faa053_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Mem</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_NorthAmericaSegmentMember_0ef81293-f6e6-4a4c-a613-b2a14183a2f4_terseLabel_en-US" xlink:label="lab_vtrs_NorthAmericaSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North America Segment</link:label>
    <link:label id="lab_vtrs_NorthAmericaSegmentMember_label_en-US" xlink:label="lab_vtrs_NorthAmericaSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North America Segment [Member]</link:label>
    <link:label id="lab_vtrs_NorthAmericaSegmentMember_documentation_en-US" xlink:label="lab_vtrs_NorthAmericaSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North America Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NorthAmericaSegmentMember" xlink:href="vtrs-20211231.xsd#vtrs_NorthAmericaSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_NorthAmericaSegmentMember" xlink:to="lab_vtrs_NorthAmericaSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ThreeCustomersMember_5ac13d05-470a-4201-b181-c4df30838f84_terseLabel_en-US" xlink:label="lab_vtrs_ThreeCustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Customers</link:label>
    <link:label id="lab_vtrs_ThreeCustomersMember_label_en-US" xlink:label="lab_vtrs_ThreeCustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Customers [Member]</link:label>
    <link:label id="lab_vtrs_ThreeCustomersMember_documentation_en-US" xlink:label="lab_vtrs_ThreeCustomersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Customers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ThreeCustomersMember" xlink:href="vtrs-20211231.xsd#vtrs_ThreeCustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ThreeCustomersMember" xlink:to="lab_vtrs_ThreeCustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_d62be11c-68e0-47d6-86fc-b19391a62f1c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fe38011e-5ff4-4b66-ab7a-eda71c3a8d5a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_40a7e028-a2e7-400b-8773-518126ed20e4_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_b6ecd626-cbe3-4a98-b4fb-2eceb1dd213f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-Sale Securities Reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_76d8d6ee-fdb8-435c-b340-6d02b8df5157_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of actuarial gain/(loss)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_b9fd0969-746f-4111-844d-26911cf16e9b_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares under stock awards, exercisable at period end</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_3cd1131b-49b4-476b-8534-c5c05de1dfe4_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets and Goodwill Policy</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_ba0820e9-981b-4d74-a581-7507d2640e23_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities Of Available-for-Sale Debt Securities At Fair Value</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanOtherCosts_3809f61f-449c-40ce-adeb-500e86102c91_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanOtherCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanOtherCosts_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanOtherCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Other Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanOtherCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanOtherCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanOtherCosts" xlink:to="lab_us-gaap_DefinedBenefitPlanOtherCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis_25e2f3e6-7a26-477a-9a76-141f1f459251_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity of Counterparty, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis_label_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity of Counterparty, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis" xlink:to="lab_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesAwardedValue_1b614001-0b99-40a8-a7d6-15c2ae832e07_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Damages awarded</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesAwardedValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Awarded, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesAwardedValue" xlink:to="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_DeferredBaseSalaryMember_bea59616-95d9-40b1-97ab-2767e59eaa66_terseLabel_en-US" xlink:label="lab_vtrs_DeferredBaseSalaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Base Salary</link:label>
    <link:label id="lab_vtrs_DeferredBaseSalaryMember_label_en-US" xlink:label="lab_vtrs_DeferredBaseSalaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Base Salary [Member]</link:label>
    <link:label id="lab_vtrs_DeferredBaseSalaryMember_documentation_en-US" xlink:label="lab_vtrs_DeferredBaseSalaryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Base Salary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DeferredBaseSalaryMember" xlink:href="vtrs-20211231.xsd#vtrs_DeferredBaseSalaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_DeferredBaseSalaryMember" xlink:to="lab_vtrs_DeferredBaseSalaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_cb7abdc3-dc3d-4181-a527-53ad544a1901_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_7f811c3c-9e8d-4c7e-80dc-7fdcb4330449_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of long-term debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CN_882fe0c2-1389-4c3b-a1df-3fbc7622b280_terseLabel_en-US" xlink:label="lab_country_CN" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CHINA</link:label>
    <link:label id="lab_country_CN_label_en-US" xlink:label="lab_country_CN" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CHINA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CN"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CN" xlink:to="lab_country_CN" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2020EuroSeniorNotesMember_2b4b9848-9966-4125-8eb9-192e893c01c2_terseLabel_en-US" xlink:label="lab_vtrs_A2020EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Euro Senior Notes</link:label>
    <link:label id="lab_vtrs_A2020EuroSeniorNotesMember_label_en-US" xlink:label="lab_vtrs_A2020EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Euro Senior Notes [Member]</link:label>
    <link:label id="lab_vtrs_A2020EuroSeniorNotesMember_documentation_en-US" xlink:label="lab_vtrs_A2020EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Euro Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2020EuroSeniorNotesMember" xlink:href="vtrs-20211231.xsd#vtrs_A2020EuroSeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2020EuroSeniorNotesMember" xlink:to="lab_vtrs_A2020EuroSeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ScheduleofOtherAssetsTable_08848e3e-79a5-4db4-b2de-9c021806ee12_terseLabel_en-US" xlink:label="lab_vtrs_ScheduleofOtherAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets [Table]</link:label>
    <link:label id="lab_vtrs_ScheduleofOtherAssetsTable_label_en-US" xlink:label="lab_vtrs_ScheduleofOtherAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets [Table]</link:label>
    <link:label id="lab_vtrs_ScheduleofOtherAssetsTable_documentation_en-US" xlink:label="lab_vtrs_ScheduleofOtherAssetsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofOtherAssetsTable" xlink:href="vtrs-20211231.xsd#vtrs_ScheduleofOtherAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ScheduleofOtherAssetsTable" xlink:to="lab_vtrs_ScheduleofOtherAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ChargebacksMember_648c1571-7a58-4136-8d2b-15a52585f4b9_terseLabel_en-US" xlink:label="lab_vtrs_ChargebacksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chargebacks [Member]</link:label>
    <link:label id="lab_vtrs_ChargebacksMember_label_en-US" xlink:label="lab_vtrs_ChargebacksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chargebacks [Member]</link:label>
    <link:label id="lab_vtrs_ChargebacksMember_documentation_en-US" xlink:label="lab_vtrs_ChargebacksMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chargebacks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ChargebacksMember" xlink:href="vtrs-20211231.xsd#vtrs_ChargebacksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ChargebacksMember" xlink:to="lab_vtrs_ChargebacksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_358ad1e4-006d-4277-aec3-f4747b25ba2a_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Parent</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_94ef5281-d581-4248-a8e5-ec4de529e49d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale fixed income investments</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_6e431229-34ea-4fd5-a8c1-7e42cc5f6f21_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesMember" xlink:to="lab_us-gaap_DebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_e5c65051-21ed-4717-bc56-101d5e01f6d5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (loss) before income taxes and noncontrolling interest:</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_34e42e1c-eb39-4116-a2b9-dcd72c2ce7e9_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_UpjohnInc.Member_2e117190-3918-47aa-bfc6-f88b15073efe_terseLabel_en-US" xlink:label="lab_vtrs_UpjohnInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upjohn Inc.</link:label>
    <link:label id="lab_vtrs_UpjohnInc.Member_label_en-US" xlink:label="lab_vtrs_UpjohnInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upjohn Inc. [Member]</link:label>
    <link:label id="lab_vtrs_UpjohnInc.Member_documentation_en-US" xlink:label="lab_vtrs_UpjohnInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upjohn Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_UpjohnInc.Member" xlink:href="vtrs-20211231.xsd#vtrs_UpjohnInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_UpjohnInc.Member" xlink:to="lab_vtrs_UpjohnInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_Concentrationrisknumberofmajorcustomers_62fe7082-12a0-452b-917d-75477d83f7ed_terseLabel_en-US" xlink:label="lab_vtrs_Concentrationrisknumberofmajorcustomers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk, number of major customers</link:label>
    <link:label id="lab_vtrs_Concentrationrisknumberofmajorcustomers_label_en-US" xlink:label="lab_vtrs_Concentrationrisknumberofmajorcustomers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk, number of major customers</link:label>
    <link:label id="lab_vtrs_Concentrationrisknumberofmajorcustomers_documentation_en-US" xlink:label="lab_vtrs_Concentrationrisknumberofmajorcustomers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk, number of major customers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Concentrationrisknumberofmajorcustomers" xlink:href="vtrs-20211231.xsd#vtrs_Concentrationrisknumberofmajorcustomers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_Concentrationrisknumberofmajorcustomers" xlink:to="lab_vtrs_Concentrationrisknumberofmajorcustomers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_6c685c66-0ddc-4904-9f68-84978062953f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_0c52857a-af85-48cb-8dbe-ea44c29b99f4_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_77755534-67aa-4aca-b292-ecebbf8ae255_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_b7dcd9e7-62cc-49e6-aea5-30318eeb7680_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_MeasurementInputEstimatedTaxRateMember_dafd7dd6-e4cf-4cd4-8a22-df746d27527d_terseLabel_en-US" xlink:label="lab_vtrs_MeasurementInputEstimatedTaxRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Estimated Tax Rate [Member]</link:label>
    <link:label id="lab_vtrs_MeasurementInputEstimatedTaxRateMember_label_en-US" xlink:label="lab_vtrs_MeasurementInputEstimatedTaxRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Estimated Tax Rate [Member]</link:label>
    <link:label id="lab_vtrs_MeasurementInputEstimatedTaxRateMember_documentation_en-US" xlink:label="lab_vtrs_MeasurementInputEstimatedTaxRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Estimated Tax Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_MeasurementInputEstimatedTaxRateMember" xlink:href="vtrs-20211231.xsd#vtrs_MeasurementInputEstimatedTaxRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_MeasurementInputEstimatedTaxRateMember" xlink:to="lab_vtrs_MeasurementInputEstimatedTaxRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_32bb96db-504c-4ae3-99f6-4a932e165ac7_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive earnings</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxPeriodDomain_0d86e876-a5ec-4480-9dd4-2be3b21d089e_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodDomain_label_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodDomain" xlink:to="lab_us-gaap_TaxPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_NumberOfManufacturingSites_9f555453-699c-4d36-850e-2dd80429dd06_terseLabel_en-US" xlink:label="lab_vtrs_NumberOfManufacturingSites" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Manufacturing Sites</link:label>
    <link:label id="lab_vtrs_NumberOfManufacturingSites_label_en-US" xlink:label="lab_vtrs_NumberOfManufacturingSites" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Manufacturing Sites</link:label>
    <link:label id="lab_vtrs_NumberOfManufacturingSites_documentation_en-US" xlink:label="lab_vtrs_NumberOfManufacturingSites" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Manufacturing Sites</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NumberOfManufacturingSites" xlink:href="vtrs-20211231.xsd#vtrs_NumberOfManufacturingSites"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_NumberOfManufacturingSites" xlink:to="lab_vtrs_NumberOfManufacturingSites" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2020RestructuringPlanMember_116309fd-5494-4f31-9e51-c75e1d1436fa_terseLabel_en-US" xlink:label="lab_vtrs_A2020RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Restructuring Plan</link:label>
    <link:label id="lab_vtrs_A2020RestructuringPlanMember_label_en-US" xlink:label="lab_vtrs_A2020RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Restructuring Plan [Member]</link:label>
    <link:label id="lab_vtrs_A2020RestructuringPlanMember_documentation_en-US" xlink:label="lab_vtrs_A2020RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Restructuring Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2020RestructuringPlanMember" xlink:href="vtrs-20211231.xsd#vtrs_A2020RestructuringPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2020RestructuringPlanMember" xlink:to="lab_vtrs_A2020RestructuringPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_d6015cb7-883e-4bf3-9d12-adb4a7208e66_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_22b411a6-df0c-48e0-965f-0035e7818f9b_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (loss) earnings per share attributable to Viatris Inc. shareholders</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_064e9d5d-9959-4f5e-9ed3-4a130f10fa92_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition and Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_GoodwillImpairmentMeasurementInputTerm_0e300ea4-cb77-492c-a890-c3f133b54b77_terseLabel_en-US" xlink:label="lab_vtrs_GoodwillImpairmentMeasurementInputTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Impairment, Measurement Input, Term</link:label>
    <link:label id="lab_vtrs_GoodwillImpairmentMeasurementInputTerm_label_en-US" xlink:label="lab_vtrs_GoodwillImpairmentMeasurementInputTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Impairment, Measurement Input, Term</link:label>
    <link:label id="lab_vtrs_GoodwillImpairmentMeasurementInputTerm_documentation_en-US" xlink:label="lab_vtrs_GoodwillImpairmentMeasurementInputTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Impairment, Measurement Input, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GoodwillImpairmentMeasurementInputTerm" xlink:href="vtrs-20211231.xsd#vtrs_GoodwillImpairmentMeasurementInputTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_GoodwillImpairmentMeasurementInputTerm" xlink:to="lab_vtrs_GoodwillImpairmentMeasurementInputTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_0f442889-8572-4670-bbfa-086e481e648e_terseLabel_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Acquired from Acquisition</link:label>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_label_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Acquired from Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAcquiredFromAcquisition" xlink:to="lab_us-gaap_CashAcquiredFromAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5d9b76b7-4a15-4a61-ae42-99148f1de323_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of restricted stock awards, nonvested beginning balance</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2373a25c-da09-4cec-b1e0-4c84ab629b51_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of restricted stock awards, nonvested ending balance</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_CollaborationsAbstract_bbad121c-0d6d-45fe-b27f-96039b462f4b_terseLabel_en-US" xlink:label="lab_vtrs_CollaborationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborations [Abstract]</link:label>
    <link:label id="lab_vtrs_CollaborationsAbstract_label_en-US" xlink:label="lab_vtrs_CollaborationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborations [Abstract]</link:label>
    <link:label id="lab_vtrs_CollaborationsAbstract_documentation_en-US" xlink:label="lab_vtrs_CollaborationsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CollaborationsAbstract" xlink:href="vtrs-20211231.xsd#vtrs_CollaborationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_CollaborationsAbstract" xlink:to="lab_vtrs_CollaborationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_698d915a-f759-40d0-82e6-f2e6396a5a97_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_f8dfcae1-3f7e-4e8b-b623-1812500ead7f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized Debt Issuance Expense</link:label>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_label_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized Debt Issuance Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:to="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_OtherCurrentPortionofLongtermDebtMember_cf5a6adb-2a04-4f35-a93f-877b23971ac2_terseLabel_en-US" xlink:label="lab_vtrs_OtherCurrentPortionofLongtermDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Portion of Long-term Debt</link:label>
    <link:label id="lab_vtrs_OtherCurrentPortionofLongtermDebtMember_label_en-US" xlink:label="lab_vtrs_OtherCurrentPortionofLongtermDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Portion of Long-term Debt [Member]</link:label>
    <link:label id="lab_vtrs_OtherCurrentPortionofLongtermDebtMember_documentation_en-US" xlink:label="lab_vtrs_OtherCurrentPortionofLongtermDebtMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Portion of Long-term Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherCurrentPortionofLongtermDebtMember" xlink:href="vtrs-20211231.xsd#vtrs_OtherCurrentPortionofLongtermDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_OtherCurrentPortionofLongtermDebtMember" xlink:to="lab_vtrs_OtherCurrentPortionofLongtermDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsCurrent_9c2edb0f-97fa-4f20-9f47-0f6f0394e576_terseLabel_en-US" xlink:label="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets (excluding inventories and net of cash acquired)</link:label>
    <link:label id="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsCurrent_label_en-US" xlink:label="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets, Current</link:label>
    <link:label id="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsCurrent_documentation_en-US" xlink:label="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsCurrent" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsCurrent" xlink:to="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CH_8fd0ee55-dc81-49a1-aff8-65b9e399f19a_terseLabel_en-US" xlink:label="lab_country_CH" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SWITZERLAND</link:label>
    <link:label id="lab_country_CH_label_en-US" xlink:label="lab_country_CH" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SWITZERLAND</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CH"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CH" xlink:to="lab_country_CH" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_493ea0ec-0a87-4482-a9ba-0a5ac92e14ac_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_f0b8b568-bb72-4ee0-a3d9-477d3939b88d_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule II - Valuation and Qualifying Accounts</link:label>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_label_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:to="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_6a05dcc7-77c2-4e5f-80a7-851a41f8157d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Pension Plan, Noncurrent</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Pension Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:to="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_MeasurementInputTerminalYearRevenueGrowthRateMember_e5511dbd-bd24-4d74-abc8-940c083ce879_terseLabel_en-US" xlink:label="lab_vtrs_MeasurementInputTerminalYearRevenueGrowthRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Terminal Year Revenue Growth Rate</link:label>
    <link:label id="lab_vtrs_MeasurementInputTerminalYearRevenueGrowthRateMember_label_en-US" xlink:label="lab_vtrs_MeasurementInputTerminalYearRevenueGrowthRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Terminal Year Revenue Growth Rate [Member]</link:label>
    <link:label id="lab_vtrs_MeasurementInputTerminalYearRevenueGrowthRateMember_documentation_en-US" xlink:label="lab_vtrs_MeasurementInputTerminalYearRevenueGrowthRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Terminal Year Revenue Growth Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_MeasurementInputTerminalYearRevenueGrowthRateMember" xlink:href="vtrs-20211231.xsd#vtrs_MeasurementInputTerminalYearRevenueGrowthRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_MeasurementInputTerminalYearRevenueGrowthRateMember" xlink:to="lab_vtrs_MeasurementInputTerminalYearRevenueGrowthRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_80a74610-e899-488a-a7ae-0a05dcc28aab_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_69fc9bd6-af7f-49ca-abc1-1740516a16c0_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets for Plan Benefits, Defined Benefit Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:to="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_8752c33b-dc9f-48dd-99d8-40d3209ced87_verboseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember" xlink:to="lab_us-gaap_MachineryAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_f46ef186-668c-4e31-86fa-323f8ce757c3_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_f7e3a17b-3d10-462e-a149-2b0c5e50aca0_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities, net</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_bc6f2732-d5e9-458f-bd7a-c451ae7bb52f_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-cash items</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_38e375bd-a965-4a1a-90fb-bbf694794ed9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of financial instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Gross Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_BusinessCombinationAbstract_862d1b0b-dc9c-4ff7-bf58-5c258bfe6dce_terseLabel_en-US" xlink:label="lab_vtrs_BusinessCombinationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination [Abstract]</link:label>
    <link:label id="lab_vtrs_BusinessCombinationAbstract_label_en-US" xlink:label="lab_vtrs_BusinessCombinationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination [Abstract]</link:label>
    <link:label id="lab_vtrs_BusinessCombinationAbstract_documentation_en-US" xlink:label="lab_vtrs_BusinessCombinationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationAbstract" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_BusinessCombinationAbstract" xlink:to="lab_vtrs_BusinessCombinationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_6d951984-4275-4a5d-87c9-9f56d05a7f4f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plant and equipment</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_f6138c62-696d-46dd-8016-228da02db435_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrecognized gain (loss) on derivatives in hedging relationships</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_PeriodDomain_6d40083e-9008-458b-8b9c-151fd5f8172d_terseLabel_en-US" xlink:label="lab_vtrs_PeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period [Domain]</link:label>
    <link:label id="lab_vtrs_PeriodDomain_label_en-US" xlink:label="lab_vtrs_PeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period [Domain]</link:label>
    <link:label id="lab_vtrs_PeriodDomain_documentation_en-US" xlink:label="lab_vtrs_PeriodDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PeriodDomain" xlink:href="vtrs-20211231.xsd#vtrs_PeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_PeriodDomain" xlink:to="lab_vtrs_PeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableOtherCurrentAndNoncurrent_99e6bd26-78da-4432-9e7d-a19d1ebe3cd3_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableOtherCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other payables</link:label>
    <link:label id="lab_us-gaap_AccountsPayableOtherCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableOtherCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableOtherCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableOtherCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableOtherCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccountsPayableOtherCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_a00b608b-7784-4d04-a7e2-6d3cbf483335_verboseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_4bb8f8d4-aba1-4670-b5ca-f1600e7cadf2_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade receivables, net</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesNetCurrent" xlink:to="lab_us-gaap_ReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_TermLoanMember_2d219515-785a-4145-b29f-62fb7a0c0c81_terseLabel_en-US" xlink:label="lab_vtrs_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan</link:label>
    <link:label id="lab_vtrs_TermLoanMember_label_en-US" xlink:label="lab_vtrs_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan [Member]</link:label>
    <link:label id="lab_vtrs_TermLoanMember_documentation_en-US" xlink:label="lab_vtrs_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_TermLoanMember" xlink:href="vtrs-20211231.xsd#vtrs_TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_TermLoanMember" xlink:to="lab_vtrs_TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_TransitionServiceAgreementsMember_3aa85fb3-e823-4027-9ff1-95458cce19e4_terseLabel_en-US" xlink:label="lab_vtrs_TransitionServiceAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition Service Agreements</link:label>
    <link:label id="lab_vtrs_TransitionServiceAgreementsMember_label_en-US" xlink:label="lab_vtrs_TransitionServiceAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition Service Agreements [Member]</link:label>
    <link:label id="lab_vtrs_TransitionServiceAgreementsMember_documentation_en-US" xlink:label="lab_vtrs_TransitionServiceAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition Service Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_TransitionServiceAgreementsMember" xlink:href="vtrs-20211231.xsd#vtrs_TransitionServiceAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_TransitionServiceAgreementsMember" xlink:to="lab_vtrs_TransitionServiceAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_72f0a0ae-8364-47a6-8128-3a9c9464282e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Third Party Sales Classified Based on Geographic Location of Subsidiaries</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_e243841f-a49a-4060-b8f3-52d610060516_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_a66d237b-ba1e-469e-8fca-b1d789199397_terseLabel_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_label_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain" xlink:to="lab_us-gaap_PlanAssetCategoriesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_1e3288c4-d2fa-41da-9757-3eb1b37d4462_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_576cd63e-2bfc-43e5-b056-81055ab33128_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_f7903706-f18a-483b-9f2f-08fea540e933_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Other than Long-term Debt, Noncurrent</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Other than Long-term Debt, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:to="lab_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_26da236a-7e75-43b5-9b11-e93ca29fd0b0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f25c5f81-c46b-4bbe-8764-1daed40472a4_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilities_b504758c-f1a1-4953-9e81-31995584003a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilities_label_en-US" xlink:label="lab_us-gaap_OtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilities" xlink:to="lab_us-gaap_OtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_ece71b9b-dc41-4913-be50-91b7623152c5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock_892f3b0d-7d74-4d96-85e9-e1af5b522571_terseLabel_en-US" xlink:label="lab_vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash, Cash Equivalents, and Restricted Cash</link:label>
    <link:label id="lab_vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock_label_en-US" xlink:label="lab_vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash, Cash Equivalents and Restricted Cash [Table Text Block]</link:label>
    <link:label id="lab_vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock_documentation_en-US" xlink:label="lab_vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Table Text Block] for Schedule of Cash, Cash Equivalents and Restricted Cash [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock" xlink:href="vtrs-20211231.xsd#vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock" xlink:to="lab_vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_19ab9dfd-3234-4ae5-a956-60983269e13c_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_281f1ce7-4198-48af-ab16-177cd3f96623_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsMember" xlink:to="lab_us-gaap_CashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesCurrent_145de679-0bd3-4c54-9081-588b669a9495_terseLabel_en-US" xlink:label="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesCurrent_label_en-US" xlink:label="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities, Current</link:label>
    <link:label id="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesCurrent_documentation_en-US" xlink:label="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesCurrent" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesCurrent" xlink:to="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_OtherComprehensiveIncomeDefinedBenefitPlanForeignCurrencyTranslationBeforeTax_034f6cf2-85dc-4d16-aaf5-696b29f3cf26_negatedTerseLabel_en-US" xlink:label="lab_vtrs_OtherComprehensiveIncomeDefinedBenefitPlanForeignCurrencyTranslationBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of foreign currency translation</link:label>
    <link:label id="lab_vtrs_OtherComprehensiveIncomeDefinedBenefitPlanForeignCurrencyTranslationBeforeTax_label_en-US" xlink:label="lab_vtrs_OtherComprehensiveIncomeDefinedBenefitPlanForeignCurrencyTranslationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OtherComprehensiveIncomeDefinedBenefitPlanForeignCurrencyTranslationBeforeTax</link:label>
    <link:label id="lab_vtrs_OtherComprehensiveIncomeDefinedBenefitPlanForeignCurrencyTranslationBeforeTax_documentation_en-US" xlink:label="lab_vtrs_OtherComprehensiveIncomeDefinedBenefitPlanForeignCurrencyTranslationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Defined Benefit Plan Foreign Currency Translation Before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherComprehensiveIncomeDefinedBenefitPlanForeignCurrencyTranslationBeforeTax" xlink:href="vtrs-20211231.xsd#vtrs_OtherComprehensiveIncomeDefinedBenefitPlanForeignCurrencyTranslationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_OtherComprehensiveIncomeDefinedBenefitPlanForeignCurrencyTranslationBeforeTax" xlink:to="lab_vtrs_OtherComprehensiveIncomeDefinedBenefitPlanForeignCurrencyTranslationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_261bbb1b-b61e-4025-b21b-dab6e7da9df2_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions for current year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_EquityMethodInvestmentsNetGainLossFromImpairmentandReductionInObligations_41ff10f8-eb06-4cd0-b393-4778e8cfa88a_terseLabel_en-US" xlink:label="lab_vtrs_EquityMethodInvestmentsNetGainLossFromImpairmentandReductionInObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments Net Gain (Loss) From Impairment and Reduction In Obligations</link:label>
    <link:label id="lab_vtrs_EquityMethodInvestmentsNetGainLossFromImpairmentandReductionInObligations_label_en-US" xlink:label="lab_vtrs_EquityMethodInvestmentsNetGainLossFromImpairmentandReductionInObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments Net Gain (Loss) From Impairment and Reduction In Obligations</link:label>
    <link:label id="lab_vtrs_EquityMethodInvestmentsNetGainLossFromImpairmentandReductionInObligations_documentation_en-US" xlink:label="lab_vtrs_EquityMethodInvestmentsNetGainLossFromImpairmentandReductionInObligations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments Net Gain (Loss) From Impairment and Reduction In Obligations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EquityMethodInvestmentsNetGainLossFromImpairmentandReductionInObligations" xlink:href="vtrs-20211231.xsd#vtrs_EquityMethodInvestmentsNetGainLossFromImpairmentandReductionInObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_EquityMethodInvestmentsNetGainLossFromImpairmentandReductionInObligations" xlink:to="lab_vtrs_EquityMethodInvestmentsNetGainLossFromImpairmentandReductionInObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_EffectiveIncomeTaxRateReconciliationGILTIPercent_6bda2d4a-7f7b-4263-b15d-02dd576ab650_terseLabel_en-US" xlink:label="lab_vtrs_EffectiveIncomeTaxRateReconciliationGILTIPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental US Tax on Foreign Earnings</link:label>
    <link:label id="lab_vtrs_EffectiveIncomeTaxRateReconciliationGILTIPercent_label_en-US" xlink:label="lab_vtrs_EffectiveIncomeTaxRateReconciliationGILTIPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, GILTI, Percent</link:label>
    <link:label id="lab_vtrs_EffectiveIncomeTaxRateReconciliationGILTIPercent_documentation_en-US" xlink:label="lab_vtrs_EffectiveIncomeTaxRateReconciliationGILTIPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, GILTI, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EffectiveIncomeTaxRateReconciliationGILTIPercent" xlink:href="vtrs-20211231.xsd#vtrs_EffectiveIncomeTaxRateReconciliationGILTIPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_EffectiveIncomeTaxRateReconciliationGILTIPercent" xlink:to="lab_vtrs_EffectiveIncomeTaxRateReconciliationGILTIPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_aabd0a19-ad76-495e-8cdf-80ce5e786c90_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Excluding Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsDisclosureTextBlock_f158287a-da2d-4d4a-9d87-176b25876af4_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments</link:label>
    <link:label id="lab_us-gaap_CommitmentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_7cfa82d7-ec14-4cfd-877e-058728b0cbde_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1_47a35ddb-83cc-4ab6-a22d-22ebcea127ae_terseLabel_en-US" xlink:label="lab_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued for the Combination</link:label>
    <link:label id="lab_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1_label_en-US" xlink:label="lab_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Significant Noncash Transaction, Value of Consideration Given</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" xlink:to="lab_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_NumberOfMolecules_c51fec9a-c633-42cd-88df-ac8c6ec7cf20_terseLabel_en-US" xlink:label="lab_vtrs_NumberOfMolecules" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Molecules</link:label>
    <link:label id="lab_vtrs_NumberOfMolecules_label_en-US" xlink:label="lab_vtrs_NumberOfMolecules" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Molecules</link:label>
    <link:label id="lab_vtrs_NumberOfMolecules_documentation_en-US" xlink:label="lab_vtrs_NumberOfMolecules" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Molecules</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NumberOfMolecules" xlink:href="vtrs-20211231.xsd#vtrs_NumberOfMolecules"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_NumberOfMolecules" xlink:to="lab_vtrs_NumberOfMolecules" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_83eab6ff-af82-48a5-9872-49ffa9a47347_verboseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_b63b458a-b64a-4dc5-afe2-c7a04a1cb269_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPR&amp;D intangible asset impairment charges</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_2565d0cd-27b3-4e20-aba8-9d5f05f28faf_negatedLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset impairment charges</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5491e2ef-e59b-4cb3-ad96-2da2e423706c_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_dd0cc6f4-cc97-4156-ac4c-7486584dbf29_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits that impact effective tax rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_Numberofequitymethodinvestments_cf86ebf6-baa3-482c-bd59-a939dae78b7d_terseLabel_en-US" xlink:label="lab_vtrs_Numberofequitymethodinvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of equity method investments</link:label>
    <link:label id="lab_vtrs_Numberofequitymethodinvestments_label_en-US" xlink:label="lab_vtrs_Numberofequitymethodinvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of equity method investments</link:label>
    <link:label id="lab_vtrs_Numberofequitymethodinvestments_documentation_en-US" xlink:label="lab_vtrs_Numberofequitymethodinvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of equity method investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Numberofequitymethodinvestments" xlink:href="vtrs-20211231.xsd#vtrs_Numberofequitymethodinvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_Numberofequitymethodinvestments" xlink:to="lab_vtrs_Numberofequitymethodinvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_7b8f8f41-f860-47ed-97ae-9115d121c6ab_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swaps</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_8e22b768-1b85-47d2-bf38-faaa5ff67123_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swap derivatives</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_04bd8a1d-5c26-445d-958d-76c5f0bcc49a_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_1de54995-4e22-4256-b5bf-07d2853fb83d_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember_5d14b833-6f21-429d-a6b8-fbd6412318b0_terseLabel_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026 Senior Notes (3.950%)</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember_label_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SeniorNotesTwoThousandTwentySix3.95Precent [Member]</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember_documentation_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026 Senior Notes 3.950%</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember" xlink:href="vtrs-20211231.xsd#vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember" xlink:to="lab_vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageBackedSecuritiesMember_ce92c36c-4510-4fc4-807b-9b7dc0e1d96c_terseLabel_en-US" xlink:label="lab_us-gaap_MortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agency mortgage-backed securities</link:label>
    <link:label id="lab_us-gaap_MortgageBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_MortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collateralized Mortgage Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageBackedSecuritiesMember" xlink:to="lab_us-gaap_MortgageBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_c599f7bf-5056-48b3-8d94-af9b862ddbe2_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_e03b3281-bfc0-4a67-a90c-60bbb24a921f_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_bc7ff4a5-db2d-4459-bc6c-5a8ce4375acf_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_58e4b018-3edc-4cb3-b04e-04374b567640_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clean energy and research credits</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_3f521cff-a60a-4b52-a94c-2f543c2d6479_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_91a95011-4ede-4a95-9d43-993ae4a9c06a_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of restricted stock and stock options exercised, net</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_ac668142-eda9-4de5-8aad-69edc0ee1ddb_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognized net actuarial losses</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:to="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_DeductionlimitofGILTItax_c05d2645-8d26-4c1e-9d63-7e5fd282f53b_terseLabel_en-US" xlink:label="lab_vtrs_DeductionlimitofGILTItax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deduction limit of GILTI tax</link:label>
    <link:label id="lab_vtrs_DeductionlimitofGILTItax_label_en-US" xlink:label="lab_vtrs_DeductionlimitofGILTItax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deduction limit of GILTI tax</link:label>
    <link:label id="lab_vtrs_DeductionlimitofGILTItax_documentation_en-US" xlink:label="lab_vtrs_DeductionlimitofGILTItax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deduction limit of GILTI tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DeductionlimitofGILTItax" xlink:href="vtrs-20211231.xsd#vtrs_DeductionlimitofGILTItax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_DeductionlimitofGILTItax" xlink:to="lab_vtrs_DeductionlimitofGILTItax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_098f7623-7c87-4ecf-99b6-1a52a2de3e99_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Uncertainty in Income Taxes, Noncurrent</link:label>
    <link:label id="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_label_en-US" xlink:label="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Uncertainty in Income Taxes, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:to="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_BusinessCombinationLimitedTransitionServicesPaymentPeriod_04d6c608-c804-40fb-bc22-8434b0d66b1f_terseLabel_en-US" xlink:label="lab_vtrs_BusinessCombinationLimitedTransitionServicesPaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limited transition services period</link:label>
    <link:label id="lab_vtrs_BusinessCombinationLimitedTransitionServicesPaymentPeriod_label_en-US" xlink:label="lab_vtrs_BusinessCombinationLimitedTransitionServicesPaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Limited Transition Services Payment Period</link:label>
    <link:label id="lab_vtrs_BusinessCombinationLimitedTransitionServicesPaymentPeriod_documentation_en-US" xlink:label="lab_vtrs_BusinessCombinationLimitedTransitionServicesPaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Limited Transition Services Payment Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationLimitedTransitionServicesPaymentPeriod" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationLimitedTransitionServicesPaymentPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_BusinessCombinationLimitedTransitionServicesPaymentPeriod" xlink:to="lab_vtrs_BusinessCombinationLimitedTransitionServicesPaymentPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_NotSubjecttoMarketConditionsMember_6370511c-2af7-4140-be51-a78448b9912a_terseLabel_en-US" xlink:label="lab_vtrs_NotSubjecttoMarketConditionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not subject to market conditions</link:label>
    <link:label id="lab_vtrs_NotSubjecttoMarketConditionsMember_label_en-US" xlink:label="lab_vtrs_NotSubjecttoMarketConditionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Subject to Market Conditions [Member]</link:label>
    <link:label id="lab_vtrs_NotSubjecttoMarketConditionsMember_documentation_en-US" xlink:label="lab_vtrs_NotSubjecttoMarketConditionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Subject to Market Conditions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NotSubjecttoMarketConditionsMember" xlink:href="vtrs-20211231.xsd#vtrs_NotSubjecttoMarketConditionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_NotSubjecttoMarketConditionsMember" xlink:to="lab_vtrs_NotSubjecttoMarketConditionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_6b75e464-e32b-49ad-b2c2-6b16f975ca54_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SubsidiariesMember_6219fd83-0b4e-4a28-b6c1-1804cb805dd9_terseLabel_en-US" xlink:label="lab_srt_SubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mylan Laboratories Limited</link:label>
    <link:label id="lab_srt_SubsidiariesMember_label_en-US" xlink:label="lab_srt_SubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiaries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SubsidiariesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SubsidiariesMember" xlink:to="lab_srt_SubsidiariesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_1e808d18-8a32-4881-9a41-5f942c6befbe_verboseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefit</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_85bfa268-8175-42d0-a965-a71604dfea21_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefit&#160;&#8212; beginning of year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_d521381d-9ae6-45b7-8126-22e5d93c37c8_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefit&#160;&#8212; end of year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_610cf4e7-b18a-4895-8e95-c4f2bdba8fba_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax assets, gross</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_de255886-010c-4662-b6fd-6e6c47c8e77e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandNineteenMember_af38d2e3-d7ff-487b-97a3-264b1fc28748_terseLabel_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandNineteenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Senior Notes (2.550%)</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandNineteenMember_label_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandNineteenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SeniorNotesTwoThousandNineteen [Member]</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandNineteenMember_documentation_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandNineteenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes two thousand nineteen</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandNineteenMember" xlink:href="vtrs-20211231.xsd#vtrs_SeniorNotesTwoThousandNineteenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_SeniorNotesTwoThousandNineteenMember" xlink:to="lab_vtrs_SeniorNotesTwoThousandNineteenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_country_FR_b8a68628-a07a-4638-a0f5-22e36dc6492b_terseLabel_en-US" xlink:label="lab_country_FR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">France</link:label>
    <link:label id="lab_country_FR_label_en-US" xlink:label="lab_country_FR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FRANCE</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_FR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_FR" xlink:to="lab_country_FR" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_6b99ebf2-bba6-47d5-8a81-3442d9f32c33_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_2f3f0aa4-6f3c-4a80-8fb7-0819749ebaa7_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_599e6f7f-7654-4a9a-95e8-491b300907c6_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_fc06528f-8d5c-490f-86e1-ee7569a7c171_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_SeniorNotes2022Member_0188d952-a4b0-4a71-b282-a05b87718921_terseLabel_en-US" xlink:label="lab_vtrs_SeniorNotes2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2022</link:label>
    <link:label id="lab_vtrs_SeniorNotes2022Member_label_en-US" xlink:label="lab_vtrs_SeniorNotes2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2022 [Member]</link:label>
    <link:label id="lab_vtrs_SeniorNotes2022Member_documentation_en-US" xlink:label="lab_vtrs_SeniorNotes2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotes2022Member" xlink:href="vtrs-20211231.xsd#vtrs_SeniorNotes2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_SeniorNotes2022Member" xlink:to="lab_vtrs_SeniorNotes2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesOfLesseeDisclosureTextBlock_3d768447-42d8-40bd-95c8-12dcb5836d6f_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesOfLesseeDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LeasesOfLesseeDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_LeasesOfLesseeDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases of Lessee Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesOfLesseeDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesOfLesseeDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesOfLesseeDisclosureTextBlock" xlink:to="lab_us-gaap_LeasesOfLesseeDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_90aa6d3e-b265-4285-874b-cedd4be5faf0_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax benefit</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_8861da84-8112-473a-b211-120632892128_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for the Combination</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_fdd1510c-302a-4d5a-8541-0609791c7b92_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivableTypeDomain_65d46d47-8514-4191-b03d-b3452a9e1702_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Domain]</link:label>
    <link:label id="lab_us-gaap_ReceivableTypeDomain_label_en-US" xlink:label="lab_us-gaap_ReceivableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivableTypeDomain" xlink:to="lab_us-gaap_ReceivableTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_31b966db-75c7-4293-9199-035d9eb75d44_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_country_GI_e81f15dd-a7a7-4883-8b7d-63ad0b720161_terseLabel_en-US" xlink:label="lab_country_GI" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GIBRALTAR</link:label>
    <link:label id="lab_country_GI_label_en-US" xlink:label="lab_country_GI" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GIBRALTAR</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_GI" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GI"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_GI" xlink:to="lab_country_GI" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2018SeniorRevolvingCreditFacilityMember_c3873556-713b-4387-8bb6-4bb1c7d3db12_terseLabel_en-US" xlink:label="lab_vtrs_A2018SeniorRevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Senior Revolving Credit Facility [Member]</link:label>
    <link:label id="lab_vtrs_A2018SeniorRevolvingCreditFacilityMember_label_en-US" xlink:label="lab_vtrs_A2018SeniorRevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Senior Revolving Credit Facility [Member]</link:label>
    <link:label id="lab_vtrs_A2018SeniorRevolvingCreditFacilityMember_documentation_en-US" xlink:label="lab_vtrs_A2018SeniorRevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Senior Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2018SeniorRevolvingCreditFacilityMember" xlink:href="vtrs-20211231.xsd#vtrs_A2018SeniorRevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2018SeniorRevolvingCreditFacilityMember" xlink:to="lab_vtrs_A2018SeniorRevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_293f89a2-cbba-420b-8e00-8b65ca290418_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price per share, exercisable at period end</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveSettledWithoutCash2_d6fef1e0-0b77-44f9-b1d2-6ff964b9e10d_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Settled without Cash</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveSettledWithoutCash2_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Settled without Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:to="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_fd50d9bb-2646-477e-ac1f-926cdde78732_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_b2846030-8961-49df-ae16-85098bc2ef7f_verboseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesMember" xlink:to="lab_us-gaap_EquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_28dd5cd1-f239-4cd5-9b14-95c9e3e47c72_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1_7798c57c-48d4-4a8e-8682-ca099bb7a477_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity consideration</link:label>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1_label_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash Divestiture, Amount of Consideration Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" xlink:to="lab_us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_4e3dc8c4-04ee-4999-8e87-667b2101e8a3_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_37e10b24-37ce-4c8e-b3cc-eb0c9415b856_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average remaining contractual term for options outstanding, in years</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_b1b52bcf-7e27-4782-9989-bc332d7d673a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_EffectiveIncomeTaxRateReconciliationWithholdingTaxesPercent_3441445a-abcf-424b-9309-b9ac5b8420da_terseLabel_en-US" xlink:label="lab_vtrs_EffectiveIncomeTaxRateReconciliationWithholdingTaxesPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Withholding taxes</link:label>
    <link:label id="lab_vtrs_EffectiveIncomeTaxRateReconciliationWithholdingTaxesPercent_label_en-US" xlink:label="lab_vtrs_EffectiveIncomeTaxRateReconciliationWithholdingTaxesPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Withholding Taxes, Percent</link:label>
    <link:label id="lab_vtrs_EffectiveIncomeTaxRateReconciliationWithholdingTaxesPercent_documentation_en-US" xlink:label="lab_vtrs_EffectiveIncomeTaxRateReconciliationWithholdingTaxesPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Withholding Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EffectiveIncomeTaxRateReconciliationWithholdingTaxesPercent" xlink:href="vtrs-20211231.xsd#vtrs_EffectiveIncomeTaxRateReconciliationWithholdingTaxesPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_EffectiveIncomeTaxRateReconciliationWithholdingTaxesPercent" xlink:to="lab_vtrs_EffectiveIncomeTaxRateReconciliationWithholdingTaxesPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_16609470-6fb2-426a-84c6-ce24a07c22a4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPatentsFoundNotInfringedNumber_b1391247-6996-4770-9fd0-d00b0a289adb_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPatentsFoundNotInfringedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Patents Found Not Infringed, Number</link:label>
    <link:label id="lab_us-gaap_LossContingencyPatentsFoundNotInfringedNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPatentsFoundNotInfringedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Patents Found Not Infringed, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPatentsFoundNotInfringedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPatentsFoundNotInfringedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPatentsFoundNotInfringedNumber" xlink:to="lab_us-gaap_LossContingencyPatentsFoundNotInfringedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_VestratablyinfiveyearsorlessMember_95e96200-2aa7-45f7-9cf6-ebb3dafd6bfa_terseLabel_en-US" xlink:label="lab_vtrs_VestratablyinfiveyearsorlessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vest ratably in five years or less [Member]</link:label>
    <link:label id="lab_vtrs_VestratablyinfiveyearsorlessMember_label_en-US" xlink:label="lab_vtrs_VestratablyinfiveyearsorlessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vest ratably in five years or less [Member]</link:label>
    <link:label id="lab_vtrs_VestratablyinfiveyearsorlessMember_documentation_en-US" xlink:label="lab_vtrs_VestratablyinfiveyearsorlessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vest ratably in five years or less [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VestratablyinfiveyearsorlessMember" xlink:href="vtrs-20211231.xsd#vtrs_VestratablyinfiveyearsorlessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_VestratablyinfiveyearsorlessMember" xlink:to="lab_vtrs_VestratablyinfiveyearsorlessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_c78ef203-0656-467c-95f1-13df71472e75_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Federal Current</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_318f2810-4ac7-47d0-93c7-f1ed16ee9508_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_BalanceSheetComponentsAbstract_2d2605e3-5265-4c9b-8e1e-6cab15364a49_terseLabel_en-US" xlink:label="lab_vtrs_BalanceSheetComponentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Components [Abstract]</link:label>
    <link:label id="lab_vtrs_BalanceSheetComponentsAbstract_label_en-US" xlink:label="lab_vtrs_BalanceSheetComponentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Components [Abstract]</link:label>
    <link:label id="lab_vtrs_BalanceSheetComponentsAbstract_documentation_en-US" xlink:label="lab_vtrs_BalanceSheetComponentsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Components</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BalanceSheetComponentsAbstract" xlink:href="vtrs-20211231.xsd#vtrs_BalanceSheetComponentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_BalanceSheetComponentsAbstract" xlink:to="lab_vtrs_BalanceSheetComponentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_1777dcd8-f7b8-414e-965a-224232cfd459_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear_7886d131-e993-49d2-b210-b958dbabaaa9_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income expected to be recognized as net periodic benefit costs</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Amortization of Gain (Loss), Next Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_97e2dcc3-efe8-414c-880d-26dc8555890c_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock: $0.01 par value, 3,000,000,000 shares authorized; shares issued and outstanding: 1,209,507,463 and 1,206,895,644, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_MaximumLeverageRatioPeriodThree_1049a697-093d-4f2c-9b62-c31a7943f29b_terseLabel_en-US" xlink:label="lab_vtrs_MaximumLeverageRatioPeriodThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Leverage Ratio, Period Three</link:label>
    <link:label id="lab_vtrs_MaximumLeverageRatioPeriodThree_label_en-US" xlink:label="lab_vtrs_MaximumLeverageRatioPeriodThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Leverage Ratio, Period Three</link:label>
    <link:label id="lab_vtrs_MaximumLeverageRatioPeriodThree_documentation_en-US" xlink:label="lab_vtrs_MaximumLeverageRatioPeriodThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Leverage Ratio, Period Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_MaximumLeverageRatioPeriodThree" xlink:href="vtrs-20211231.xsd#vtrs_MaximumLeverageRatioPeriodThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_MaximumLeverageRatioPeriodThree" xlink:to="lab_vtrs_MaximumLeverageRatioPeriodThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_816838fe-dfde-40ba-8f66-b262076ac0b6_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average period over which total unrecognized compensation expense expected to be recognized (years)</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_bdf21dc3-a2b0-4d8f-b79f-d754f1a7b14d_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_631f3e7e-95ba-4e88-adb5-df294853127e_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant-date fair value per share, nonvested beginning balance</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e6c28995-37d7-4fee-9047-ca131612c335_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant-date fair value per share, nonvested ending balance</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_6f8966be-5999-4492-9628-628e358c0d81_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_AccountsReceivableEffectsofForeignExchangeRates_de0ff103-6bf7-4f66-bf76-accdbe367e54_terseLabel_en-US" xlink:label="lab_vtrs_AccountsReceivableEffectsofForeignExchangeRates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effects of Foreign Exchange</link:label>
    <link:label id="lab_vtrs_AccountsReceivableEffectsofForeignExchangeRates_label_en-US" xlink:label="lab_vtrs_AccountsReceivableEffectsofForeignExchangeRates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Effects of Foreign Exchange Rates</link:label>
    <link:label id="lab_vtrs_AccountsReceivableEffectsofForeignExchangeRates_documentation_en-US" xlink:label="lab_vtrs_AccountsReceivableEffectsofForeignExchangeRates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Effects of Foreign Exchange Rates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccountsReceivableEffectsofForeignExchangeRates" xlink:href="vtrs-20211231.xsd#vtrs_AccountsReceivableEffectsofForeignExchangeRates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_AccountsReceivableEffectsofForeignExchangeRates" xlink:to="lab_vtrs_AccountsReceivableEffectsofForeignExchangeRates" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_AccruedSalesAllowances_498817a6-3073-4c41-8eda-ddb8a40842f0_negatedNetLabel_en-US" xlink:label="lab_vtrs_AccruedSalesAllowances" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rebates, promotional programs and other sales allowances</link:label>
    <link:label id="lab_vtrs_AccruedSalesAllowances_label_en-US" xlink:label="lab_vtrs_AccruedSalesAllowances" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Sales Allowances</link:label>
    <link:label id="lab_vtrs_AccruedSalesAllowances_documentation_en-US" xlink:label="lab_vtrs_AccruedSalesAllowances" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Sales Allowances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccruedSalesAllowances" xlink:href="vtrs-20211231.xsd#vtrs_AccruedSalesAllowances"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_AccruedSalesAllowances" xlink:to="lab_vtrs_AccruedSalesAllowances" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableAmountPerShare_ad93d975-06b7-4190-a30c-3343bc329734_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableAmountPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Amount Per Share</link:label>
    <link:label id="lab_us-gaap_DividendsPayableAmountPerShare_label_en-US" xlink:label="lab_us-gaap_DividendsPayableAmountPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Amount Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableAmountPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableAmountPerShare" xlink:to="lab_us-gaap_DividendsPayableAmountPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_ef1c1645-0c32-4cdf-b020-83725c228d01_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funded status of plans</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funded (Unfunded) Status of Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:to="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets_ef54eaf9-9984-45e5-a6ea-d0566bc9c8a0_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Business Combination</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Business Combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandTwenty3.75PercentMember_45f333a3-cf95-4489-a657-7231a9a5c165_verboseLabel_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandTwenty3.75PercentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Senior Notes (3.750% coupon)</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandTwenty3.75PercentMember_label_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandTwenty3.75PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Two Thousand Twenty - 3.75 Percent [Member]</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandTwenty3.75PercentMember_documentation_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandTwenty3.75PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Two Thousand Twenty - 3.75 Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandTwenty3.75PercentMember" xlink:href="vtrs-20211231.xsd#vtrs_SeniorNotesTwoThousandTwenty3.75PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_SeniorNotesTwoThousandTwenty3.75PercentMember" xlink:to="lab_vtrs_SeniorNotesTwoThousandTwenty3.75PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_RevenuefromContractwithCustomerReturns_dfaf2ab3-62df-464b-b8f6-15d0a9bf9231_negatedTerseLabel_en-US" xlink:label="lab_vtrs_RevenuefromContractwithCustomerReturns" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Returns</link:label>
    <link:label id="lab_vtrs_RevenuefromContractwithCustomerReturns_label_en-US" xlink:label="lab_vtrs_RevenuefromContractwithCustomerReturns" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Returns</link:label>
    <link:label id="lab_vtrs_RevenuefromContractwithCustomerReturns_documentation_en-US" xlink:label="lab_vtrs_RevenuefromContractwithCustomerReturns" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Returns</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RevenuefromContractwithCustomerReturns" xlink:href="vtrs-20211231.xsd#vtrs_RevenuefromContractwithCustomerReturns"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_RevenuefromContractwithCustomerReturns" xlink:to="lab_vtrs_RevenuefromContractwithCustomerReturns" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_561ae3d9-2a7f-4788-831f-f27ad05d75cc_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions and Other Transactions</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_a00e5285-0369-404b-b912-886b60fd1ea1_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Axis]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_810768fa-6296-4f74-843d-41490a5d3e04_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLineItems_label_en-US" xlink:label="lab_dei_AuditorLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLineItems" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLineItems" xlink:to="lab_dei_AuditorLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_6866855c-ad93-48ca-8647-67cc663546f6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsTable" xlink:to="lab_us-gaap_OtherCommitmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_52598d5c-4342-4f39-b537-6cf614311706_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation Plans, Valuation Assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2027SeniorNotesMember_1613bb7f-3ab4-4185-abfd-d5ae752efa73_terseLabel_en-US" xlink:label="lab_vtrs_A2027SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027 Senior Notes</link:label>
    <link:label id="lab_vtrs_A2027SeniorNotesMember_label_en-US" xlink:label="lab_vtrs_A2027SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027 Senior Notes [Member]</link:label>
    <link:label id="lab_vtrs_A2027SeniorNotesMember_documentation_en-US" xlink:label="lab_vtrs_A2027SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027 Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2027SeniorNotesMember" xlink:href="vtrs-20211231.xsd#vtrs_A2027SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2027SeniorNotesMember" xlink:to="lab_vtrs_A2027SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2024EuroSeniorNotesMember_0132cdb6-433b-4a5c-93db-14a646a7a8ad_terseLabel_en-US" xlink:label="lab_vtrs_A2024EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.250% Euro Senior Notes due 2024</link:label>
    <link:label id="lab_vtrs_A2024EuroSeniorNotesMember_label_en-US" xlink:label="lab_vtrs_A2024EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024 Euro Senior Notes [Member]</link:label>
    <link:label id="lab_vtrs_A2024EuroSeniorNotesMember_documentation_en-US" xlink:label="lab_vtrs_A2024EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024 Euro Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2024EuroSeniorNotesMember" xlink:href="vtrs-20211231.xsd#vtrs_A2024EuroSeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2024EuroSeniorNotesMember" xlink:to="lab_vtrs_A2024EuroSeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_ffd30bb6-e13e-4e16-906f-bfb8337fab0b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets, Noncurrent [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_11142a44-d66a-4934-be1b-58c5ad37041b_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_d7c36f62-7256-44c8-b7c7-52f3b36041fc_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S. Deferred</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_AspenGlobalIncorporatedMember_620ac232-8b3b-4bc9-a22b-929589e958ae_terseLabel_en-US" xlink:label="lab_vtrs_AspenGlobalIncorporatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aspen Global Incorporated</link:label>
    <link:label id="lab_vtrs_AspenGlobalIncorporatedMember_label_en-US" xlink:label="lab_vtrs_AspenGlobalIncorporatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aspen Global Incorporated [Member]</link:label>
    <link:label id="lab_vtrs_AspenGlobalIncorporatedMember_documentation_en-US" xlink:label="lab_vtrs_AspenGlobalIncorporatedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aspen Global Incorporated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AspenGlobalIncorporatedMember" xlink:href="vtrs-20211231.xsd#vtrs_AspenGlobalIncorporatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_AspenGlobalIncorporatedMember" xlink:to="lab_vtrs_AspenGlobalIncorporatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_bd5c58c9-9bdf-43be-a162-f6cf297c61ca_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number diluted shares outstanding adjustment, stock-based awards and warrants</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_e0ebbdab-9870-41eb-897c-18295027b57c_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax_8cca80aa-3b2e-4527-8c5c-34a8b91e29b9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of prior service costs</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear_aea4ee29-e6f7-40ed-a9f0-6ae92ea84be3_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit plan, ultimate health care cost trend rate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Health Care Cost Trend Rate Assumed, Next Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesPolicy_655172c2-578b-4484-8957-6fc4aa552e35_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities Policy</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesPolicy_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesPolicy" xlink:to="lab_us-gaap_MarketableSecuritiesPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_18288b77-5b09-4f61-838a-f58488be748c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_bce15eb6-9807-44c4-ac20-03aa92064b88_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_8bed1b84-918c-484f-a34c-8d8e8073c595_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Arrangement and Non-arrangement Transactions [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_b2b8e651-0720-4a18-b4b7-c86a802d48f9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:to="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_6b1d2b95-9827-413e-a63f-4bc5d8685fc6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_42967142-8b0d-4f1f-b703-b696c3178cca_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_MultiDistrictLitigationMember_6fc91bed-c7b4-4270-90bc-81428f9b1c22_terseLabel_en-US" xlink:label="lab_vtrs_MultiDistrictLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MDL</link:label>
    <link:label id="lab_vtrs_MultiDistrictLitigationMember_label_en-US" xlink:label="lab_vtrs_MultiDistrictLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Multi District Litigation [Member]</link:label>
    <link:label id="lab_vtrs_MultiDistrictLitigationMember_documentation_en-US" xlink:label="lab_vtrs_MultiDistrictLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Multi District Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_MultiDistrictLitigationMember" xlink:href="vtrs-20211231.xsd#vtrs_MultiDistrictLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_MultiDistrictLitigationMember" xlink:to="lab_vtrs_MultiDistrictLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_SeniorNotes2021Member_2282b9e0-3423-4bb8-ae07-0a16216d8d3e_terseLabel_en-US" xlink:label="lab_vtrs_SeniorNotes2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2021</link:label>
    <link:label id="lab_vtrs_SeniorNotes2021Member_label_en-US" xlink:label="lab_vtrs_SeniorNotes2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2021 [Member]</link:label>
    <link:label id="lab_vtrs_SeniorNotes2021Member_documentation_en-US" xlink:label="lab_vtrs_SeniorNotes2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotes2021Member" xlink:href="vtrs-20211231.xsd#vtrs_SeniorNotes2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_SeniorNotes2021Member" xlink:to="lab_vtrs_SeniorNotes2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_StockExchangedDuringPeriodSharesExchanged_4ae9590f-3080-4d33-90fd-6642e03925e5_negatedTerseLabel_en-US" xlink:label="lab_vtrs_StockExchangedDuringPeriodSharesExchanged" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange of Mylan N.V. ordinary shares for Viatris Inc. common stock (in shares)</link:label>
    <link:label id="lab_vtrs_StockExchangedDuringPeriodSharesExchanged_label_en-US" xlink:label="lab_vtrs_StockExchangedDuringPeriodSharesExchanged" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Exchanged During Period, Shares, Exchanged</link:label>
    <link:label id="lab_vtrs_StockExchangedDuringPeriodSharesExchanged_documentation_en-US" xlink:label="lab_vtrs_StockExchangedDuringPeriodSharesExchanged" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Exchanged During Period, Shares, Exchanged</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_StockExchangedDuringPeriodSharesExchanged" xlink:href="vtrs-20211231.xsd#vtrs_StockExchangedDuringPeriodSharesExchanged"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_StockExchangedDuringPeriodSharesExchanged" xlink:to="lab_vtrs_StockExchangedDuringPeriodSharesExchanged" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_9f0c6c69-3e40-40ba-93ae-61c47502dd29_verboseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_077dd365-a935-49e9-9ed8-57a44c00bc4d_totalLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_19e76725-e405-40cf-be53-d0c20b64cf17_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_31424bf9-3c1e-450e-af05-69f90443d87d_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8628536c-adfc-4974-9e5c-38342cc08613_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_PaymentsForNonContingentConsiderationForProductRightsFinancingActivities_45573721-96df-443b-9f1f-bdf6d0c4cd5d_negatedTerseLabel_en-US" xlink:label="lab_vtrs_PaymentsForNonContingentConsiderationForProductRightsFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-contingent payments for product rights</link:label>
    <link:label id="lab_vtrs_PaymentsForNonContingentConsiderationForProductRightsFinancingActivities_label_en-US" xlink:label="lab_vtrs_PaymentsForNonContingentConsiderationForProductRightsFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Non-Contingent Consideration for Product Rights, Financing Activities</link:label>
    <link:label id="lab_vtrs_PaymentsForNonContingentConsiderationForProductRightsFinancingActivities_documentation_en-US" xlink:label="lab_vtrs_PaymentsForNonContingentConsiderationForProductRightsFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Non-Contingent Consideration for Product Rights, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PaymentsForNonContingentConsiderationForProductRightsFinancingActivities" xlink:href="vtrs-20211231.xsd#vtrs_PaymentsForNonContingentConsiderationForProductRightsFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_PaymentsForNonContingentConsiderationForProductRightsFinancingActivities" xlink:to="lab_vtrs_PaymentsForNonContingentConsiderationForProductRightsFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ScheduleofOtherNoncurrentLiabilitiesTable_ef2b6c8e-8949-4992-be85-305550f9379f_terseLabel_en-US" xlink:label="lab_vtrs_ScheduleofOtherNoncurrentLiabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Noncurrent Liabilities [Table]</link:label>
    <link:label id="lab_vtrs_ScheduleofOtherNoncurrentLiabilitiesTable_label_en-US" xlink:label="lab_vtrs_ScheduleofOtherNoncurrentLiabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Noncurrent Liabilities [Table]</link:label>
    <link:label id="lab_vtrs_ScheduleofOtherNoncurrentLiabilitiesTable_documentation_en-US" xlink:label="lab_vtrs_ScheduleofOtherNoncurrentLiabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Noncurrent Liabilities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesTable" xlink:href="vtrs-20211231.xsd#vtrs_ScheduleofOtherNoncurrentLiabilitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesTable" xlink:to="lab_vtrs_ScheduleofOtherNoncurrentLiabilitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_0b645611-fd08-4052-bb08-77e946b62dcc_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest and penalties</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Penalties and Interest Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_eb3b3c79-6839-4a10-a28b-f72027ae2e97_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_Corporatecosts_f6cb8afb-3289-4556-bc7f-6e896b27ff4a_negatedTerseLabel_en-US" xlink:label="lab_vtrs_Corporatecosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate costs</link:label>
    <link:label id="lab_vtrs_Corporatecosts_label_en-US" xlink:label="lab_vtrs_Corporatecosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate costs</link:label>
    <link:label id="lab_vtrs_Corporatecosts_documentation_en-US" xlink:label="lab_vtrs_Corporatecosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Corporatecosts" xlink:href="vtrs-20211231.xsd#vtrs_Corporatecosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_Corporatecosts" xlink:to="lab_vtrs_Corporatecosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidatedEntityExcludingVieMember_c9fedc4e-0b4b-4dfe-9c8f-c5b977ad4d1b_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidatedEntityExcludingVieMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entity</link:label>
    <link:label id="lab_us-gaap_ConsolidatedEntityExcludingVieMember_label_en-US" xlink:label="lab_us-gaap_ConsolidatedEntityExcludingVieMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entity, Excluding VIE [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidatedEntityExcludingVieMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidatedEntityExcludingVieMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidatedEntityExcludingVieMember" xlink:to="lab_us-gaap_ConsolidatedEntityExcludingVieMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_f30de4ea-85a4-4990-9f87-5bf257f40268_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_db7a12f0-8ac4-4dea-acd3-fcf2d24c2764_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_05209379-46ea-4546-af9c-03ad0633300b_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_4d61d10b-e85a-4f75-8c94-e528a924d082_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_80701985-5626-46cc-99d4-a4d35b6f8c38_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_f0436a85-6f4c-4ad9-9b03-3e2592c8df17_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State income taxes and credits</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_89e8bc7a-b0af-40d8-b57b-0894462dc32f_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_540ae779-02f3-4faf-9f07-2cbf333cce81_verboseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect on cash of changes in exchange rates</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_country_LU_b5989835-8389-48d5-994f-ef7f26bb994e_terseLabel_en-US" xlink:label="lab_country_LU" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LUXEMBOURG</link:label>
    <link:label id="lab_country_LU_label_en-US" xlink:label="lab_country_LU" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LUXEMBOURG</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_LU" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_LU"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_LU" xlink:to="lab_country_LU" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_RestofWorldSegmentMember_14748c0a-4e57-4d12-8a43-4f4acc485cc5_terseLabel_en-US" xlink:label="lab_vtrs_RestofWorldSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of World Segment</link:label>
    <link:label id="lab_vtrs_RestofWorldSegmentMember_label_en-US" xlink:label="lab_vtrs_RestofWorldSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of World Segment [Member]</link:label>
    <link:label id="lab_vtrs_RestofWorldSegmentMember_documentation_en-US" xlink:label="lab_vtrs_RestofWorldSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of World Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RestofWorldSegmentMember" xlink:href="vtrs-20211231.xsd#vtrs_RestofWorldSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_RestofWorldSegmentMember" xlink:to="lab_vtrs_RestofWorldSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_ff4ab5f6-d073-4a9d-9a56-f8149fd74fe3_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableFromSecuritization_2992a9dc-9aa4-4488-9cd3-39d6bc5283d9_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableFromSecuritization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securitized accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableFromSecuritization_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableFromSecuritization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable from Securitization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableFromSecuritization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableFromSecuritization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableFromSecuritization" xlink:to="lab_us-gaap_AccountsReceivableFromSecuritization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_2d9583a7-0d5a-4d44-a343-c91a55665df1_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c1193e6c-1e32-4810-bd61-1c06a2c26069_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2024EuroSeniorNotes1023Member_12cb2374-10d7-4773-bbbc-87ddf6c00da3_terseLabel_en-US" xlink:label="lab_vtrs_A2024EuroSeniorNotes1023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.125% Euro Senior Notes due 2025</link:label>
    <link:label id="lab_vtrs_A2024EuroSeniorNotes1023Member_label_en-US" xlink:label="lab_vtrs_A2024EuroSeniorNotes1023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024 Euro Senior Notes, 1.023% [Member]</link:label>
    <link:label id="lab_vtrs_A2024EuroSeniorNotes1023Member_documentation_en-US" xlink:label="lab_vtrs_A2024EuroSeniorNotes1023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024 Euro Senior Notes, 1.023%</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2024EuroSeniorNotes1023Member" xlink:href="vtrs-20211231.xsd#vtrs_A2024EuroSeniorNotes1023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2024EuroSeniorNotes1023Member" xlink:to="lab_vtrs_A2024EuroSeniorNotes1023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9120a54f-e188-471c-b8d6-470816b6ff00_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_f256e728-e3e0-4e51-a038-3a118d471be6_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mature in one to five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_TrailingFourQuartersMember_7b09c995-cf51-4923-a5be-d3b094fe7f23_terseLabel_en-US" xlink:label="lab_vtrs_TrailingFourQuartersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trailing Four Quarters</link:label>
    <link:label id="lab_vtrs_TrailingFourQuartersMember_label_en-US" xlink:label="lab_vtrs_TrailingFourQuartersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trailing Four Quarters [Member]</link:label>
    <link:label id="lab_vtrs_TrailingFourQuartersMember_documentation_en-US" xlink:label="lab_vtrs_TrailingFourQuartersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trailing Four Quarters</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_TrailingFourQuartersMember" xlink:href="vtrs-20211231.xsd#vtrs_TrailingFourQuartersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_TrailingFourQuartersMember" xlink:to="lab_vtrs_TrailingFourQuartersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_VariableConsiderationReturnsMember_efe7c6c4-5d71-4251-9d2f-319670a52954_terseLabel_en-US" xlink:label="lab_vtrs_VariableConsiderationReturnsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Consideration Returns [Member]</link:label>
    <link:label id="lab_vtrs_VariableConsiderationReturnsMember_label_en-US" xlink:label="lab_vtrs_VariableConsiderationReturnsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Consideration Returns [Member]</link:label>
    <link:label id="lab_vtrs_VariableConsiderationReturnsMember_documentation_en-US" xlink:label="lab_vtrs_VariableConsiderationReturnsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Consideration Returns [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VariableConsiderationReturnsMember" xlink:href="vtrs-20211231.xsd#vtrs_VariableConsiderationReturnsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_VariableConsiderationReturnsMember" xlink:to="lab_vtrs_VariableConsiderationReturnsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_6f004a9e-7bd8-4df6-88e0-0438b776adeb_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_b10eab9d-b48e-44d1-b254-c1746ca2a278_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_4f859239-8859-429b-bee1-e1036ef96fa5_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_e8120a0e-266f-4e78-927b-3a796af38317_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_DeferredTaxAssetsIntangibleAssets_c0424a4c-93d2-4974-957d-da6c8258a3f0_terseLabel_en-US" xlink:label="lab_vtrs_DeferredTaxAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_vtrs_DeferredTaxAssetsIntangibleAssets_label_en-US" xlink:label="lab_vtrs_DeferredTaxAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets Intangible Assets</link:label>
    <link:label id="lab_vtrs_DeferredTaxAssetsIntangibleAssets_documentation_en-US" xlink:label="lab_vtrs_DeferredTaxAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DeferredTaxAssetsIntangibleAssets" xlink:href="vtrs-20211231.xsd#vtrs_DeferredTaxAssetsIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_DeferredTaxAssetsIntangibleAssets" xlink:to="lab_vtrs_DeferredTaxAssetsIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_BiosimilarsBusinessMember_a769a0fc-8283-4168-b2d2-12e8453521d1_terseLabel_en-US" xlink:label="lab_vtrs_BiosimilarsBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biosimilars Business</link:label>
    <link:label id="lab_vtrs_BiosimilarsBusinessMember_label_en-US" xlink:label="lab_vtrs_BiosimilarsBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biosimilars Business [Member]</link:label>
    <link:label id="lab_vtrs_BiosimilarsBusinessMember_documentation_en-US" xlink:label="lab_vtrs_BiosimilarsBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biosimilars Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BiosimilarsBusinessMember" xlink:href="vtrs-20211231.xsd#vtrs_BiosimilarsBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_BiosimilarsBusinessMember" xlink:to="lab_vtrs_BiosimilarsBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_f4e3d314-3da2-430f-8d53-bb7530428580_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrecognized gains (losses) on derivatives, net of tax, beginning of period</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_a2e7c8bf-940f-492f-9a6f-a392b155a346_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrecognized gains (losses) on derivatives, net of tax, end of period</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_327d0bcc-f423-4048-b553-a37465fe6fa2_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_23ff808e-ce32-4f36-90e9-f61753469be6_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_94a0acfe-0c48-43de-9bbd-533f9209f316_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid per share</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Cash Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:to="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_9be84fe6-7fa8-4c47-bd33-76ed0d677a15_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAbstract_e83bd938-8b4e-422e-b91e-b3aeb380a155_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Abstract]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashAndCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_CommercialPaperProgramMember_a6791347-119e-48ed-9a2a-a95be55e2b25_terseLabel_en-US" xlink:label="lab_vtrs_CommercialPaperProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper Program [Member]</link:label>
    <link:label id="lab_vtrs_CommercialPaperProgramMember_label_en-US" xlink:label="lab_vtrs_CommercialPaperProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper Program [Member]</link:label>
    <link:label id="lab_vtrs_CommercialPaperProgramMember_documentation_en-US" xlink:label="lab_vtrs_CommercialPaperProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper Program [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CommercialPaperProgramMember" xlink:href="vtrs-20211231.xsd#vtrs_CommercialPaperProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_CommercialPaperProgramMember" xlink:to="lab_vtrs_CommercialPaperProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_GenericsMember_b875a49c-defa-4bb4-8db1-432e240008de_terseLabel_en-US" xlink:label="lab_vtrs_GenericsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Generics</link:label>
    <link:label id="lab_vtrs_GenericsMember_label_en-US" xlink:label="lab_vtrs_GenericsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Generics [Member]</link:label>
    <link:label id="lab_vtrs_GenericsMember_documentation_en-US" xlink:label="lab_vtrs_GenericsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Generics</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GenericsMember" xlink:href="vtrs-20211231.xsd#vtrs_GenericsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_GenericsMember" xlink:to="lab_vtrs_GenericsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillTransfers_6bee98c9-33cc-4055-9756-681cca1b5bd1_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillTransfers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Transfers</link:label>
    <link:label id="lab_us-gaap_GoodwillTransfers_label_en-US" xlink:label="lab_us-gaap_GoodwillTransfers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Transfers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTransfers" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillTransfers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillTransfers" xlink:to="lab_us-gaap_GoodwillTransfers" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_DeferredTaxLiabilitiesOperatingLeaseLiability_7f5c89df-201a-45da-8493-e86de5c99b14_terseLabel_en-US" xlink:label="lab_vtrs_DeferredTaxLiabilitiesOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_vtrs_DeferredTaxLiabilitiesOperatingLeaseLiability_label_en-US" xlink:label="lab_vtrs_DeferredTaxLiabilitiesOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Operating Lease, Liability</link:label>
    <link:label id="lab_vtrs_DeferredTaxLiabilitiesOperatingLeaseLiability_documentation_en-US" xlink:label="lab_vtrs_DeferredTaxLiabilitiesOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DeferredTaxLiabilitiesOperatingLeaseLiability" xlink:href="vtrs-20211231.xsd#vtrs_DeferredTaxLiabilitiesOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_DeferredTaxLiabilitiesOperatingLeaseLiability" xlink:to="lab_vtrs_DeferredTaxLiabilitiesOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMember_0c0cd754-8c0d-4bfe-ac8e-60af798b1246_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMember" xlink:to="lab_us-gaap_OtherAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_EffectiveIncomeTaxRateReconciliationWaivedDeductionsPercent_d3ecebb3-4930-42f4-97d8-81130a6f254e_terseLabel_en-US" xlink:label="lab_vtrs_EffectiveIncomeTaxRateReconciliationWaivedDeductionsPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Waived deductions under IRC &#167; 59A</link:label>
    <link:label id="lab_vtrs_EffectiveIncomeTaxRateReconciliationWaivedDeductionsPercent_label_en-US" xlink:label="lab_vtrs_EffectiveIncomeTaxRateReconciliationWaivedDeductionsPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Waived Deductions, Percent</link:label>
    <link:label id="lab_vtrs_EffectiveIncomeTaxRateReconciliationWaivedDeductionsPercent_documentation_en-US" xlink:label="lab_vtrs_EffectiveIncomeTaxRateReconciliationWaivedDeductionsPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Waived Deductions, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EffectiveIncomeTaxRateReconciliationWaivedDeductionsPercent" xlink:href="vtrs-20211231.xsd#vtrs_EffectiveIncomeTaxRateReconciliationWaivedDeductionsPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_EffectiveIncomeTaxRateReconciliationWaivedDeductionsPercent" xlink:to="lab_vtrs_EffectiveIncomeTaxRateReconciliationWaivedDeductionsPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_3cd480f3-e07d-4bbb-9c5d-f58df0e0c568_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income) expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember_4924ab3f-ab29-4780-93e1-2d31406608ab_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Pension, Postretirement and Supplemental Plans</link:label>
    <link:label id="lab_us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Pension, Postretirement and Supplemental Plans [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember" xlink:to="lab_us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRecallExpense_f81094e3-0440-40ff-99b5-11163bd35b57_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRecallExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Recall Expense</link:label>
    <link:label id="lab_us-gaap_InventoryRecallExpense_label_en-US" xlink:label="lab_us-gaap_InventoryRecallExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Recall Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRecallExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRecallExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRecallExpense" xlink:to="lab_us-gaap_InventoryRecallExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_9d64f97d-bbd6-4d01-a4bf-0550b63b9331_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for product rights and other, net</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_afcc5382-8719-49f0-8f40-c0f003b1a22a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination</link:label>
    <link:label id="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:to="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_0a0b3c2d-4b79-412f-8700-1c62cdf7df22_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_64498d4e-9657-46ac-a356-69e273af3bb7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_43f219e0-08f9-4c6f-b18b-2efadcdbf66d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_RebatesPromotionalProgramsandOtherSalesAllowancesMember_0898d7be-7f85-4b1b-8dc9-dd5af7b7bda5_terseLabel_en-US" xlink:label="lab_vtrs_RebatesPromotionalProgramsandOtherSalesAllowancesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rebates, Promotional Programs and Other Sales Allowances [Member]</link:label>
    <link:label id="lab_vtrs_RebatesPromotionalProgramsandOtherSalesAllowancesMember_label_en-US" xlink:label="lab_vtrs_RebatesPromotionalProgramsandOtherSalesAllowancesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rebates, Promotional Programs and Other Sales Allowances [Member]</link:label>
    <link:label id="lab_vtrs_RebatesPromotionalProgramsandOtherSalesAllowancesMember_documentation_en-US" xlink:label="lab_vtrs_RebatesPromotionalProgramsandOtherSalesAllowancesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rebates, Promotional Programs and Other Sales Allowances [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RebatesPromotionalProgramsandOtherSalesAllowancesMember" xlink:href="vtrs-20211231.xsd#vtrs_RebatesPromotionalProgramsandOtherSalesAllowancesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_RebatesPromotionalProgramsandOtherSalesAllowancesMember" xlink:to="lab_vtrs_RebatesPromotionalProgramsandOtherSalesAllowancesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_87de40e4-05ad-4823-83de-0f91c17f812e_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_633c49cb-3bd9-4b11-a02b-adfab241dfe2_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2028EuroSeniorNotesMember_96c60b47-7067-4f01-a503-c4b3ae0280b7_terseLabel_en-US" xlink:label="lab_vtrs_A2028EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 Euro Senior Notes</link:label>
    <link:label id="lab_vtrs_A2028EuroSeniorNotesMember_label_en-US" xlink:label="lab_vtrs_A2028EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 Euro Senior Notes [Member]</link:label>
    <link:label id="lab_vtrs_A2028EuroSeniorNotesMember_documentation_en-US" xlink:label="lab_vtrs_A2028EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 Euro Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2028EuroSeniorNotesMember" xlink:href="vtrs-20211231.xsd#vtrs_A2028EuroSeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2028EuroSeniorNotesMember" xlink:to="lab_vtrs_A2028EuroSeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_c42fe34e-90e5-4946-88ee-7854295b5537_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain" xlink:to="lab_us-gaap_LossContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_2b316479-0b58-4126-9794-81048845bed0_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_914a636f-fe0e-462c-aed5-019fdd014d4d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_9ebdb8a6-33fe-4181-9211-bb27047f6b77_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_GoodwillImpairmentTestMeasurementInput_1485e8c6-2ce7-4ed4-af0c-5a5d765721af_terseLabel_en-US" xlink:label="lab_vtrs_GoodwillImpairmentTestMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rate used to discount net cash inflows to present values</link:label>
    <link:label id="lab_vtrs_GoodwillImpairmentTestMeasurementInput_label_en-US" xlink:label="lab_vtrs_GoodwillImpairmentTestMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Impairment Test, Measurement Input</link:label>
    <link:label id="lab_vtrs_GoodwillImpairmentTestMeasurementInput_documentation_en-US" xlink:label="lab_vtrs_GoodwillImpairmentTestMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Impairment Test, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GoodwillImpairmentTestMeasurementInput" xlink:href="vtrs-20211231.xsd#vtrs_GoodwillImpairmentTestMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_GoodwillImpairmentTestMeasurementInput" xlink:to="lab_vtrs_GoodwillImpairmentTestMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b6d17b2a-3794-4999-a8b7-e354770b7197_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_81ecca56-f40b-48cb-a339-7e6c6ecd2ef6_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_23571455-da69-42e5-a5a7-d48178f059d8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Major Customers by Reporting Segments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1_49ce911b-e8fa-428f-9ab8-0697276c644d_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Cost Remaining</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Cost Remaining</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_00e4b34b-9a10-42ac-b69e-e017533f2c13_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_1a659e85-160f-4578-9d91-50086cf11052_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash, included in other current and non-current assets</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_19cd838d-809a-4d23-8654-65ad30081fbd_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_3b752368-5c7b-490a-ab78-a7bf7ea02a62_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_ac910f45-744f-428d-a7c2-054a0c512e4c_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as hedging instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9b6e7f01-82bd-48ae-94b4-a925fef49d38_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_country_IE_3b76daff-d615-4d84-a39f-ce63740b7210_terseLabel_en-US" xlink:label="lab_country_IE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IRELAND</link:label>
    <link:label id="lab_country_IE_label_en-US" xlink:label="lab_country_IE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IRELAND</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IE"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_IE" xlink:to="lab_country_IE" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_96f5c34b-cbef-437d-afc5-822b2f3021d2_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, estimated service life (years)</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_country_IN_7c7d67dc-3809-4dc3-9b01-194450edfdcb_terseLabel_en-US" xlink:label="lab_country_IN" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">India</link:label>
    <link:label id="lab_country_IN_label_en-US" xlink:label="lab_country_IN" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INDIA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_IN" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IN"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_IN" xlink:to="lab_country_IN" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_3e782211-cabd-4b11-a923-c52e6eba775e_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Viatris Inc. shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_Numberofstates_4452d7c8-dbc9-41d6-b710-076f0e04c1c0_terseLabel_en-US" xlink:label="lab_vtrs_Numberofstates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states</link:label>
    <link:label id="lab_vtrs_Numberofstates_label_en-US" xlink:label="lab_vtrs_Numberofstates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states</link:label>
    <link:label id="lab_vtrs_Numberofstates_documentation_en-US" xlink:label="lab_vtrs_Numberofstates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Numberofstates" xlink:href="vtrs-20211231.xsd#vtrs_Numberofstates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_Numberofstates" xlink:to="lab_vtrs_Numberofstates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_e5bf6007-325a-475a-9706-3824964ec06a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_588785ae-fe2d-4970-93bd-3051cd47b622_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentrations of Credit Risk Policy</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_e4eb27fe-f902-49d0-b589-a3f0002c857f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_d0090f82-4ca1-4ade-b18f-0622440814d9_terseLabel_en-US" xlink:label="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets acquired</link:label>
    <link:label id="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_label_en-US" xlink:label="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets</link:label>
    <link:label id="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_documentation_en-US" xlink:label="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets" xlink:to="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_GovernmentalRebateProgramsMember_684013cf-1f55-40ef-85c9-1d6799b45f9d_terseLabel_en-US" xlink:label="lab_vtrs_GovernmentalRebateProgramsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Governmental Rebate Programs [Member]</link:label>
    <link:label id="lab_vtrs_GovernmentalRebateProgramsMember_label_en-US" xlink:label="lab_vtrs_GovernmentalRebateProgramsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Governmental Rebate Programs [Member]</link:label>
    <link:label id="lab_vtrs_GovernmentalRebateProgramsMember_documentation_en-US" xlink:label="lab_vtrs_GovernmentalRebateProgramsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Governmental Rebate Programs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GovernmentalRebateProgramsMember" xlink:href="vtrs-20211231.xsd#vtrs_GovernmentalRebateProgramsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_GovernmentalRebateProgramsMember" xlink:to="lab_vtrs_GovernmentalRebateProgramsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_AccumulatednetactuariallossesexceedhigherofmarketvalueofplanassetsorPBO_10f6ee20-4830-4207-95cf-0b6a871c44cd_terseLabel_en-US" xlink:label="lab_vtrs_AccumulatednetactuariallossesexceedhigherofmarketvalueofplanassetsorPBO" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized net actuarial losses exceed higher of market value of plan assets or the projected benefit obligation at the beginning of the year</link:label>
    <link:label id="lab_vtrs_AccumulatednetactuariallossesexceedhigherofmarketvalueofplanassetsorPBO_label_en-US" xlink:label="lab_vtrs_AccumulatednetactuariallossesexceedhigherofmarketvalueofplanassetsorPBO" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated net actuarial losses exceed higher of market value of plan assets or PBO</link:label>
    <link:label id="lab_vtrs_AccumulatednetactuariallossesexceedhigherofmarketvalueofplanassetsorPBO_documentation_en-US" xlink:label="lab_vtrs_AccumulatednetactuariallossesexceedhigherofmarketvalueofplanassetsorPBO" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated net actuarial losses exceed higher of market value of plan assets or PBO</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccumulatednetactuariallossesexceedhigherofmarketvalueofplanassetsorPBO" xlink:href="vtrs-20211231.xsd#vtrs_AccumulatednetactuariallossesexceedhigherofmarketvalueofplanassetsorPBO"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_AccumulatednetactuariallossesexceedhigherofmarketvalueofplanassetsorPBO" xlink:to="lab_vtrs_AccumulatednetactuariallossesexceedhigherofmarketvalueofplanassetsorPBO" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_e44e47c1-f273-40e8-b4a3-47f60414ec93_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_8ba6cdb5-0018-4560-a122-776d2241601f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_U.K.CompetitionandMarketsAuthorityProceedingsParoxetineMember_047819a7-9c6b-4659-b190-abfc8f613d27_terseLabel_en-US" xlink:label="lab_vtrs_U.K.CompetitionandMarketsAuthorityProceedingsParoxetineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.K. Competition and Markets Authority Proceedings Paroxetine</link:label>
    <link:label id="lab_vtrs_U.K.CompetitionandMarketsAuthorityProceedingsParoxetineMember_label_en-US" xlink:label="lab_vtrs_U.K.CompetitionandMarketsAuthorityProceedingsParoxetineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.K. Competition and Markets Authority Proceedings Paroxetine [Member]</link:label>
    <link:label id="lab_vtrs_U.K.CompetitionandMarketsAuthorityProceedingsParoxetineMember_documentation_en-US" xlink:label="lab_vtrs_U.K.CompetitionandMarketsAuthorityProceedingsParoxetineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.K. Competition and Markets Authority Proceedings Paroxetine</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_U.K.CompetitionandMarketsAuthorityProceedingsParoxetineMember" xlink:href="vtrs-20211231.xsd#vtrs_U.K.CompetitionandMarketsAuthorityProceedingsParoxetineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_U.K.CompetitionandMarketsAuthorityProceedingsParoxetineMember" xlink:to="lab_vtrs_U.K.CompetitionandMarketsAuthorityProceedingsParoxetineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_e425277b-49c9-4541-81dd-ea4d26244beb_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic benefit cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_de5e7951-6b9c-48e7-a1fb-94b167c75150_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_268ea506-15cc-4233-9eb9-173d1e5174d4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrecognized (loss) gain and prior service cost related to defined benefit plans, net of tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_4d5b064b-6285-4bd9-85fc-1bc831aced0c_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrecognized losses and prior service cost related to defined benefit plans, net of tax, beginning of period</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_0f2e12a9-32bb-4b29-a884-e5fa9d3ebb34_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized gains on marketable securities, net of tax, end of period</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_CardinalHealthIncMember_2df7ad4d-bd6b-427c-84fa-6d7103a90306_terseLabel_en-US" xlink:label="lab_vtrs_CardinalHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardinal Health Inc</link:label>
    <link:label id="lab_vtrs_CardinalHealthIncMember_label_en-US" xlink:label="lab_vtrs_CardinalHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardinal Health Inc [Member]</link:label>
    <link:label id="lab_vtrs_CardinalHealthIncMember_documentation_en-US" xlink:label="lab_vtrs_CardinalHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardinal Health Inc [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CardinalHealthIncMember" xlink:href="vtrs-20211231.xsd#vtrs_CardinalHealthIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_CardinalHealthIncMember" xlink:to="lab_vtrs_CardinalHealthIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnServiceAndInterestCostComponents1_b47cafc0-1349-4ff5-90b6-fd87360c8591_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnServiceAndInterestCostComponents1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in the aggregate of service and interest cost components of annual expense</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnServiceAndInterestCostComponents1_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnServiceAndInterestCostComponents1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Effect of One Percentage Point Decrease on Service and Interest Cost Components</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnServiceAndInterestCostComponents1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnServiceAndInterestCostComponents1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnServiceAndInterestCostComponents1" xlink:to="lab_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnServiceAndInterestCostComponents1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationInterestExpense_c5067f23-c167-4c68-8f0c-8098e8f850d6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense (income) related to uncertain tax positions</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationInterestExpense_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationInterestExpense" xlink:to="lab_us-gaap_IncomeTaxExaminationInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_9e45e89f-96ff-4a5e-aad3-8e50f3366164_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_a8cde284-bc74-45c0-872f-5bf280a047d4_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_a6341425-d889-42c8-84ea-5f77e43367d5_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Period Increase (Decrease)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_dbc3422c-7abf-4aa7-9069-a787a30dfff3_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining lease terms</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_country_PR_78faf3c5-3298-407c-88ca-b1a9a631b1e8_terseLabel_en-US" xlink:label="lab_country_PR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PUERTO RICO</link:label>
    <link:label id="lab_country_PR_label_en-US" xlink:label="lab_country_PR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PUERTO RICO</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_PR" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_PR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_PR" xlink:to="lab_country_PR" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_2f0918ff-8374-4d26-bbb4-067a6821ad18_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesFairValueLineItems" xlink:to="lab_us-gaap_DerivativesFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_4cb7f333-7670-4a03-b992-0415bc581fa6_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Awards</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_9a2c4673-2446-4e60-af89-a7040bc0e3e1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_c78b4aa6-7560-4d99-b123-88f2eff5f447_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions Charged to Other Accounts</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_AnticompetitiveConductwithGenericDrugsMember_92a89055-bc92-4b59-8dd3-99f14defebca_terseLabel_en-US" xlink:label="lab_vtrs_AnticompetitiveConductwithGenericDrugsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anticompetitive Conduct with Generic Drugs</link:label>
    <link:label id="lab_vtrs_AnticompetitiveConductwithGenericDrugsMember_label_en-US" xlink:label="lab_vtrs_AnticompetitiveConductwithGenericDrugsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anticompetitive Conduct with Generic Drugs [Member]</link:label>
    <link:label id="lab_vtrs_AnticompetitiveConductwithGenericDrugsMember_documentation_en-US" xlink:label="lab_vtrs_AnticompetitiveConductwithGenericDrugsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anticompetitive Conduct with Generic Drugs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AnticompetitiveConductwithGenericDrugsMember" xlink:href="vtrs-20211231.xsd#vtrs_AnticompetitiveConductwithGenericDrugsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_AnticompetitiveConductwithGenericDrugsMember" xlink:to="lab_vtrs_AnticompetitiveConductwithGenericDrugsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets_a829cb91-75b6-43e4-951b-09dae9656c6e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_SubjecttoMarketConditionsDomain_da4c7909-da5b-439a-ab8d-f1155b244814_terseLabel_en-US" xlink:label="lab_vtrs_SubjecttoMarketConditionsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subject to Market Conditions [Domain]</link:label>
    <link:label id="lab_vtrs_SubjecttoMarketConditionsDomain_label_en-US" xlink:label="lab_vtrs_SubjecttoMarketConditionsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subject to Market Conditions [Domain]</link:label>
    <link:label id="lab_vtrs_SubjecttoMarketConditionsDomain_documentation_en-US" xlink:label="lab_vtrs_SubjecttoMarketConditionsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Subject to Market Conditions [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SubjecttoMarketConditionsDomain" xlink:href="vtrs-20211231.xsd#vtrs_SubjecttoMarketConditionsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_SubjecttoMarketConditionsDomain" xlink:to="lab_vtrs_SubjecttoMarketConditionsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_855b4227-4ed1-4cd4-bef0-bd1ba0b5b041_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_b1c84866-8b1e-4bb9-a51f-8eb2a26ef07c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_OtherLongTermDebtMember_893b282e-7f9d-4598-b372-31a4ad0ff953_terseLabel_en-US" xlink:label="lab_vtrs_OtherLongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long Term Debt</link:label>
    <link:label id="lab_vtrs_OtherLongTermDebtMember_label_en-US" xlink:label="lab_vtrs_OtherLongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long Term Debt [Member]</link:label>
    <link:label id="lab_vtrs_OtherLongTermDebtMember_documentation_en-US" xlink:label="lab_vtrs_OtherLongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long term debt.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherLongTermDebtMember" xlink:href="vtrs-20211231.xsd#vtrs_OtherLongTermDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_OtherLongTermDebtMember" xlink:to="lab_vtrs_OtherLongTermDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember_7b4a7d52-ab56-4469-a081-c6e531bb17a9_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Technique, Discounted Cash Flow</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Technique, Discounted Cash Flow [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:to="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_a3ccc971-c1b6-4eb6-a6a8-ade74b0d518b_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in subsidiaries</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_4d6d9426-6852-4cbb-b0d7-6566a63abe45_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_6ef53fef-5813-4f18-b9a9-3e5661c49e1b_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_14a38e9a-ce53-4632-b26e-050a1fd1077f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_33a23383-bb28-4600-8080-5bc8c3570bcf_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_60989594-5736-4dac-9c88-2708fde7f4fa_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deductions</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_8cd2ccc5-3aaa-45b7-a1ae-26bc3193ec3a_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price per share, forfeited</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_4142a693-0a2e-49a0-b6cf-ae0c2382f402_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax provision (benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_0aabb984-3a0a-41ff-a461-d54b7d94ff6e_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax related to items of other comprehensive (loss) earnings, derivatives</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsDomain_882c55dd-ddf4-444f-89a4-44be7ad8ad65_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Domain]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsDomain_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsDomain" xlink:to="lab_us-gaap_OtherCommitmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_3bcb7976-5e4c-4322-a47a-a955604b6c4d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_7b825395-7daa-4281-bd90-93228e051ca8_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_e0e7f432-cd29-4eef-a1fa-0cd07d3429ab_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_558f44af-d254-4ece-ae6c-bf8aefd9ee00_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning of period</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_0f8ea5d5-ab51-40c7-8999-a7c2ecc8c0bb_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">End of period</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_db041f81-6e97-421c-b5e5-f50e381b3b19_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsInventory" xlink:to="lab_us-gaap_DeferredTaxAssetsInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_0ef343eb-246a-4553-a2d5-95921bedffc0_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_003c2be7-7780-4abc-811b-7bddfb084365_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageBasicSharesOutstandingProForma_f8866f71-e5db-443a-a60a-7cbc8e48b300_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageBasicSharesOutstandingProForma" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageBasicSharesOutstandingProForma_label_en-US" xlink:label="lab_us-gaap_WeightedAverageBasicSharesOutstandingProForma" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Basic Shares Outstanding, Pro Forma</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageBasicSharesOutstandingProForma" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageBasicSharesOutstandingProForma"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageBasicSharesOutstandingProForma" xlink:to="lab_us-gaap_WeightedAverageBasicSharesOutstandingProForma" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_14b13f9a-4e17-4573-9c4b-64172613f98a_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Plan Assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets_9b222666-a0e1-4cb2-9fb3-39f19c8e586c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financial Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_fafe7a3b-cd9f-4c83-a280-b001616b711a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) earnings, before tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_46cb749b-0af2-466a-8ff4-d83ffc7ede43_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_8402522e-237a-40dd-9b1d-2cf84db575bc_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_a370a1a8-5b8e-4155-805c-6a67ff803a06_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_dd1c37a3-99bd-4ca5-aa06-75367bbb6c85_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5b3482e8-9e00-4aa0-bd02-6ef4aba8e5d9_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrentAndNoncurrent_cf62baa4-78d4-48ff-be68-b029d499fc65_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Trade</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableTradeCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccountsPayableTradeCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_4b9a3430-4774-48de-a752-300c0885d20c_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_32114f58-1b63-4189-ae5f-333f4dde8f52_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of restricted stock awards, forfeited</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_StockappreciationrightsandperformancesharesMember_966c60f0-01b3-40e7-a62b-c424eadaa2b9_terseLabel_en-US" xlink:label="lab_vtrs_StockappreciationrightsandperformancesharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock appreciation rights and performance shares</link:label>
    <link:label id="lab_vtrs_StockappreciationrightsandperformancesharesMember_label_en-US" xlink:label="lab_vtrs_StockappreciationrightsandperformancesharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock appreciation rights and performance shares [Member]</link:label>
    <link:label id="lab_vtrs_StockappreciationrightsandperformancesharesMember_documentation_en-US" xlink:label="lab_vtrs_StockappreciationrightsandperformancesharesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock appreciation rights and performance shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_StockappreciationrightsandperformancesharesMember" xlink:href="vtrs-20211231.xsd#vtrs_StockappreciationrightsandperformancesharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_StockappreciationrightsandperformancesharesMember" xlink:to="lab_vtrs_StockappreciationrightsandperformancesharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_FutureyearsMember_8ba3e219-562b-4c87-97a0-42817e2b7897_terseLabel_en-US" xlink:label="lab_vtrs_FutureyearsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 through 2035</link:label>
    <link:label id="lab_vtrs_FutureyearsMember_label_en-US" xlink:label="lab_vtrs_FutureyearsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future years [Member]</link:label>
    <link:label id="lab_vtrs_FutureyearsMember_documentation_en-US" xlink:label="lab_vtrs_FutureyearsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future years [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_FutureyearsMember" xlink:href="vtrs-20211231.xsd#vtrs_FutureyearsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_FutureyearsMember" xlink:to="lab_vtrs_FutureyearsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ProductRightsAndLicensesByTherapeuticCategoryTableTextBlock_2f900e31-3964-492e-9518-54a1c7f0e7c1_terseLabel_en-US" xlink:label="lab_vtrs_ProductRightsAndLicensesByTherapeuticCategoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product rights and licenses by therapeutic category</link:label>
    <link:label id="lab_vtrs_ProductRightsAndLicensesByTherapeuticCategoryTableTextBlock_label_en-US" xlink:label="lab_vtrs_ProductRightsAndLicensesByTherapeuticCategoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Rights And Licenses By Therapeutic Category [Table Text Block]</link:label>
    <link:label id="lab_vtrs_ProductRightsAndLicensesByTherapeuticCategoryTableTextBlock_documentation_en-US" xlink:label="lab_vtrs_ProductRightsAndLicensesByTherapeuticCategoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product rights and licenses by therapeutic category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ProductRightsAndLicensesByTherapeuticCategoryTableTextBlock" xlink:href="vtrs-20211231.xsd#vtrs_ProductRightsAndLicensesByTherapeuticCategoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ProductRightsAndLicensesByTherapeuticCategoryTableTextBlock" xlink:to="lab_vtrs_ProductRightsAndLicensesByTherapeuticCategoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_ab992822-799d-4b97-9ed0-a6e3466a0633_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation Policy</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_91ad077f-865b-47e2-a1d3-e40f1604244a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_f483ca39-ce84-433a-b1ac-c4030e598bba_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:to="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_ba09bbaf-dff9-4693-a5a3-0137bf883ce5_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt and other long-term obligations</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_LossContingencyNumberOfStates_12583d7f-b6bd-43eb-9051-00cdab08b123_terseLabel_en-US" xlink:label="lab_vtrs_LossContingencyNumberOfStates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States</link:label>
    <link:label id="lab_vtrs_LossContingencyNumberOfStates_label_en-US" xlink:label="lab_vtrs_LossContingencyNumberOfStates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States</link:label>
    <link:label id="lab_vtrs_LossContingencyNumberOfStates_documentation_en-US" xlink:label="lab_vtrs_LossContingencyNumberOfStates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_LossContingencyNumberOfStates" xlink:href="vtrs-20211231.xsd#vtrs_LossContingencyNumberOfStates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_LossContingencyNumberOfStates" xlink:to="lab_vtrs_LossContingencyNumberOfStates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_383426b9-bc4c-45c8-a2f8-57f1d1597813_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_00353134-b5d0-435a-98b6-e5e6c6131693_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_LyricaMember_14e4ab92-5d8e-4c57-9caa-a36fcf60b775_terseLabel_en-US" xlink:label="lab_vtrs_LyricaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lyrica &#174;</link:label>
    <link:label id="lab_vtrs_LyricaMember_label_en-US" xlink:label="lab_vtrs_LyricaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lyrica &#174; [Member]</link:label>
    <link:label id="lab_vtrs_LyricaMember_documentation_en-US" xlink:label="lab_vtrs_LyricaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lyrica &#174;</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_LyricaMember" xlink:href="vtrs-20211231.xsd#vtrs_LyricaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_LyricaMember" xlink:to="lab_vtrs_LyricaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_7665730c-30e1-4e5f-aec6-746d1eb7dcca_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_PfizerInc.Member_d1ee0aa6-2976-404d-8c9f-fab872b8786d_terseLabel_en-US" xlink:label="lab_vtrs_PfizerInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfizer, Inc.</link:label>
    <link:label id="lab_vtrs_PfizerInc.Member_label_en-US" xlink:label="lab_vtrs_PfizerInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfizer, Inc. [Member]</link:label>
    <link:label id="lab_vtrs_PfizerInc.Member_documentation_en-US" xlink:label="lab_vtrs_PfizerInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfizer, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PfizerInc.Member" xlink:href="vtrs-20211231.xsd#vtrs_PfizerInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_PfizerInc.Member" xlink:to="lab_vtrs_PfizerInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_85796e6d-9566-4ad7-a95e-9285d29538ae_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third party net sales</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7ae74a14-f4bb-4786-a120-c03f7f5b8bc0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant date fair value per option</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_49aef1ca-a14f-44e7-943e-d9e92a87a529_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_8db749f7-ba9a-49aa-8c41-2ee0637ac1a2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_dcb6807f-72db-4392-be94-8e179e735a68_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_8cdc0714-b384-445d-8beb-819c8cf1ed25_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_RevanceMember_09c2649a-7d5f-43f4-aaed-375d1be8ea7c_terseLabel_en-US" xlink:label="lab_vtrs_RevanceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revance [Member]</link:label>
    <link:label id="lab_vtrs_RevanceMember_label_en-US" xlink:label="lab_vtrs_RevanceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revance [Member]</link:label>
    <link:label id="lab_vtrs_RevanceMember_documentation_en-US" xlink:label="lab_vtrs_RevanceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RevanceMember" xlink:href="vtrs-20211231.xsd#vtrs_RevanceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_RevanceMember" xlink:to="lab_vtrs_RevanceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MultiemployerPlansWithdrawalObligation_412e4c10-1661-4136-86f8-a5d4a342004c_terseLabel_en-US" xlink:label="lab_us-gaap_MultiemployerPlansWithdrawalObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Multiemployer plans, withdrawal obligation</link:label>
    <link:label id="lab_us-gaap_MultiemployerPlansWithdrawalObligation_label_en-US" xlink:label="lab_us-gaap_MultiemployerPlansWithdrawalObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Multiemployer Plans, Withdrawal Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MultiemployerPlansWithdrawalObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MultiemployerPlansWithdrawalObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MultiemployerPlansWithdrawalObligation" xlink:to="lab_us-gaap_MultiemployerPlansWithdrawalObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_85468982-dc31-4888-9e7e-73b1ae58885b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_315dff77-6e32-4315-a611-f1ca38649c41_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:to="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_AspenPharmacareHoldingsLimitedMember_2a963d92-1c24-4d0f-9583-4a94cda7e15b_terseLabel_en-US" xlink:label="lab_vtrs_AspenPharmacareHoldingsLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aspen Pharmacare Holdings Limited</link:label>
    <link:label id="lab_vtrs_AspenPharmacareHoldingsLimitedMember_label_en-US" xlink:label="lab_vtrs_AspenPharmacareHoldingsLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aspen Pharmacare Holdings Limited [Member]</link:label>
    <link:label id="lab_vtrs_AspenPharmacareHoldingsLimitedMember_documentation_en-US" xlink:label="lab_vtrs_AspenPharmacareHoldingsLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aspen Pharmacare Holdings Limited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AspenPharmacareHoldingsLimitedMember" xlink:href="vtrs-20211231.xsd#vtrs_AspenPharmacareHoldingsLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_AspenPharmacareHoldingsLimitedMember" xlink:to="lab_vtrs_AspenPharmacareHoldingsLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_d034e228-0629-4f92-a643-93b54bec9598_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_VariableConsiderationCategoryAxis_5f11e1b4-e93a-45f1-80b7-2ab187009dd9_terseLabel_en-US" xlink:label="lab_vtrs_VariableConsiderationCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Consideration Category [Axis]</link:label>
    <link:label id="lab_vtrs_VariableConsiderationCategoryAxis_label_en-US" xlink:label="lab_vtrs_VariableConsiderationCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Consideration Category [Axis]</link:label>
    <link:label id="lab_vtrs_VariableConsiderationCategoryAxis_documentation_en-US" xlink:label="lab_vtrs_VariableConsiderationCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Consideration Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VariableConsiderationCategoryAxis" xlink:href="vtrs-20211231.xsd#vtrs_VariableConsiderationCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_VariableConsiderationCategoryAxis" xlink:to="lab_vtrs_VariableConsiderationCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_a0d44246-4fbc-4055-b2e6-6530703986fe_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_8373bca7-4a54-43f9-bb93-4e68d91ebba4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments in Cash Flow Hedging Relationships (2) :</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_47547f06-2430-4e9e-abc5-2680b8f85055_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for the Combination (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_2c4915c2-637d-4e62-8772-d892ec6ee3b9_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of products rights and licenses intangible assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Finite-lived</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ZoloftMember_af7d20f9-1233-4cab-8ef9-4db50df4e876_terseLabel_en-US" xlink:label="lab_vtrs_ZoloftMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zoloft &#174;</link:label>
    <link:label id="lab_vtrs_ZoloftMember_label_en-US" xlink:label="lab_vtrs_ZoloftMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zoloft &#174; [Member]</link:label>
    <link:label id="lab_vtrs_ZoloftMember_documentation_en-US" xlink:label="lab_vtrs_ZoloftMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zoloft &#174;</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ZoloftMember" xlink:href="vtrs-20211231.xsd#vtrs_ZoloftMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ZoloftMember" xlink:to="lab_vtrs_ZoloftMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2040SeniorNotesMember_d4beee5a-67c2-49c6-abfd-35088af8a049_terseLabel_en-US" xlink:label="lab_vtrs_A2040SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2040 Senior Notes</link:label>
    <link:label id="lab_vtrs_A2040SeniorNotesMember_label_en-US" xlink:label="lab_vtrs_A2040SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2040 Senior Notes [Member]</link:label>
    <link:label id="lab_vtrs_A2040SeniorNotesMember_documentation_en-US" xlink:label="lab_vtrs_A2040SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2040 Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2040SeniorNotesMember" xlink:href="vtrs-20211231.xsd#vtrs_A2040SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2040SeniorNotesMember" xlink:to="lab_vtrs_A2040SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostIncurredCost_97e4d13a-4279-473b-aa28-da4436fb5663_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Incurred Cost</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostIncurredCost_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Incurred Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:to="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromAcquisition_3ad2598c-e58e-49b2-a2ee-dd3460b065b8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromAcquisition" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Acquisition</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromAcquisition_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromAcquisition" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromAcquisition" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_9c1f7709-01f5-4af2-9bc5-101c399e80a5_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount</link:label>
    <link:label id="lab_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_label_en-US" xlink:label="lab_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount" xlink:to="lab_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_8d4bb7a8-3447-4c8d-96b8-969d2d3be046_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis" xlink:to="lab_us-gaap_ShortTermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_76e38c6c-c552-499d-a512-c486f9b623ac_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_44748e6f-4610-44ac-b915-58defb62ba28_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Allocation of Plan Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Allocation of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_bcb5abfe-18fa-4787-9d8c-f12d8d5b3423_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities_bc64ea2e-190a-40ac-8cb1-ab266d240bbb_terseLabel_en-US" xlink:label="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities_label_en-US" xlink:label="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Liabilities</link:label>
    <link:label id="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities_documentation_en-US" xlink:label="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities" xlink:to="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFirmPurchaseCommitmentLoss_281b37b4-096c-4860-86aa-19a87b074f6e_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFirmPurchaseCommitmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Firm Purchase Commitment, Loss</link:label>
    <link:label id="lab_us-gaap_InventoryFirmPurchaseCommitmentLoss_label_en-US" xlink:label="lab_us-gaap_InventoryFirmPurchaseCommitmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Firm Purchase Commitment, Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFirmPurchaseCommitmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFirmPurchaseCommitmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFirmPurchaseCommitmentLoss" xlink:to="lab_us-gaap_InventoryFirmPurchaseCommitmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_95478653-c774-4aed-86e4-08107b01e28d_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockRetiredCostMethodAmount_a20a9549-135c-4c4c-b8c7-545568d884f2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement of Mylan N.V. treasury stock, net</link:label>
    <link:label id="lab_us-gaap_TreasuryStockRetiredCostMethodAmount_label_en-US" xlink:label="lab_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Retired, Cost Method, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockRetiredCostMethodAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:to="lab_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_95627f9e-2fc9-4a70-b957-3a7556b9526c_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, gross, excluding goodwill</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_12a9c4ab-6a5c-447b-aa0a-32ebccb5121b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2025SeniorNotesMember_32c1782e-0b2a-4c0e-9dd3-a3eca6a6e6c7_terseLabel_en-US" xlink:label="lab_vtrs_A2025SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 Senior Notes</link:label>
    <link:label id="lab_vtrs_A2025SeniorNotesMember_label_en-US" xlink:label="lab_vtrs_A2025SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 Senior Notes [Member]</link:label>
    <link:label id="lab_vtrs_A2025SeniorNotesMember_documentation_en-US" xlink:label="lab_vtrs_A2025SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2025SeniorNotesMember" xlink:href="vtrs-20211231.xsd#vtrs_A2025SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2025SeniorNotesMember" xlink:to="lab_vtrs_A2025SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_cfdc2da0-4250-4363-b756-4a5435a5bd9c_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of marketable securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_efab65f9-df52-4bf1-aac1-a4b2b5792cd3_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Long-term Revenue Growth Rate [Member]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Long-term Revenue Growth Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputLongTermRevenueGrowthRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember" xlink:to="lab_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f7c6dc7d-ff3b-4af8-a8f9-f25371a95ee9_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Loss) earnings before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_159905f3-01ab-4309-957d-5335814fc7b0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating and non-operating expense</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_c1913f47-a258-46c3-9132-1b8d75fca7da_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ReductioninEquityMethodInvestmentLongTermObligation_6d40f1a8-20c3-4640-a429-6cb7de547452_terseLabel_en-US" xlink:label="lab_vtrs_ReductioninEquityMethodInvestmentLongTermObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction in Equity Method Investment Long-Term Obligation</link:label>
    <link:label id="lab_vtrs_ReductioninEquityMethodInvestmentLongTermObligation_label_en-US" xlink:label="lab_vtrs_ReductioninEquityMethodInvestmentLongTermObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction in Equity Method Investment Long-Term Obligation</link:label>
    <link:label id="lab_vtrs_ReductioninEquityMethodInvestmentLongTermObligation_documentation_en-US" xlink:label="lab_vtrs_ReductioninEquityMethodInvestmentLongTermObligation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction in Equity Method Investment Long-Term Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ReductioninEquityMethodInvestmentLongTermObligation" xlink:href="vtrs-20211231.xsd#vtrs_ReductioninEquityMethodInvestmentLongTermObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ReductioninEquityMethodInvestmentLongTermObligation" xlink:to="lab_vtrs_ReductioninEquityMethodInvestmentLongTermObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_d9285f6a-8507-4750-84e5-09787e10eb77_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_USDTermLoanFacilityMember_c863d115-e09d-4907-a123-37a50916fb9c_terseLabel_en-US" xlink:label="lab_vtrs_USDTermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Term Loan Facility</link:label>
    <link:label id="lab_vtrs_USDTermLoanFacilityMember_label_en-US" xlink:label="lab_vtrs_USDTermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Term Loan Facility [Member]</link:label>
    <link:label id="lab_vtrs_USDTermLoanFacilityMember_documentation_en-US" xlink:label="lab_vtrs_USDTermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Term Loan Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_USDTermLoanFacilityMember" xlink:href="vtrs-20211231.xsd#vtrs_USDTermLoanFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_USDTermLoanFacilityMember" xlink:to="lab_vtrs_USDTermLoanFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_77ee5153-eea8-484f-8630-b5f89dac9b30_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of loss recognized in earnings on derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_e3e69224-bbbf-4110-adda-9639f1c8571f_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_StockExchangedDuringPeriodValue_3990e11b-99aa-465b-a1e8-14ab9a0c0337_negatedTerseLabel_en-US" xlink:label="lab_vtrs_StockExchangedDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange of Mylan N.V. ordinary shares for Viatris Inc. common stock</link:label>
    <link:label id="lab_vtrs_StockExchangedDuringPeriodValue_label_en-US" xlink:label="lab_vtrs_StockExchangedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Exchanged During Period, Value</link:label>
    <link:label id="lab_vtrs_StockExchangedDuringPeriodValue_documentation_en-US" xlink:label="lab_vtrs_StockExchangedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Exchanged During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_StockExchangedDuringPeriodValue" xlink:href="vtrs-20211231.xsd#vtrs_StockExchangedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_StockExchangedDuringPeriodValue" xlink:to="lab_vtrs_StockExchangedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_ec10f665-56dd-4a87-969d-8e207a06c254_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_06a2849e-1a1b-4cc4-b06c-a7c190cf0249_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_OneTimeSpecialPerformanceBasedFiveYearRealizableValueIncentiveProgramMember_4c7be31a-e27c-45f8-b155-0a44e9991475_terseLabel_en-US" xlink:label="lab_vtrs_OneTimeSpecialPerformanceBasedFiveYearRealizableValueIncentiveProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One-Time Special Performance-Based Five-Year Realizable Value Incentive Program</link:label>
    <link:label id="lab_vtrs_OneTimeSpecialPerformanceBasedFiveYearRealizableValueIncentiveProgramMember_label_en-US" xlink:label="lab_vtrs_OneTimeSpecialPerformanceBasedFiveYearRealizableValueIncentiveProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One-Time Special Performance-Based Five-Year Realizable Value Incentive Program [Member]</link:label>
    <link:label id="lab_vtrs_OneTimeSpecialPerformanceBasedFiveYearRealizableValueIncentiveProgramMember_documentation_en-US" xlink:label="lab_vtrs_OneTimeSpecialPerformanceBasedFiveYearRealizableValueIncentiveProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One-Time Special Performance-Based Five-Year Realizable Value Incentive Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OneTimeSpecialPerformanceBasedFiveYearRealizableValueIncentiveProgramMember" xlink:href="vtrs-20211231.xsd#vtrs_OneTimeSpecialPerformanceBasedFiveYearRealizableValueIncentiveProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_OneTimeSpecialPerformanceBasedFiveYearRealizableValueIncentiveProgramMember" xlink:to="lab_vtrs_OneTimeSpecialPerformanceBasedFiveYearRealizableValueIncentiveProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_SubjectToMarketConditionsMember_e8297cbd-3a84-4084-b15b-ea82c16167f5_terseLabel_en-US" xlink:label="lab_vtrs_SubjectToMarketConditionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subject to Market Conditions</link:label>
    <link:label id="lab_vtrs_SubjectToMarketConditionsMember_label_en-US" xlink:label="lab_vtrs_SubjectToMarketConditionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subject to Market Conditions [Member]</link:label>
    <link:label id="lab_vtrs_SubjectToMarketConditionsMember_documentation_en-US" xlink:label="lab_vtrs_SubjectToMarketConditionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subject to Market Conditions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SubjectToMarketConditionsMember" xlink:href="vtrs-20211231.xsd#vtrs_SubjectToMarketConditionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_SubjectToMarketConditionsMember" xlink:to="lab_vtrs_SubjectToMarketConditionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e16bfd7c-4fc8-4efb-a9ab-5f84013f6856_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_908d3158-4741-4ea0-b084-68f564d9d120_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible asset, estimated useful life, in years</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_6260447c-4072-4a84-b7b9-a63eb79e4d3f_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates in the Preparation of Financial Statements Policy</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_b4dc32e8-a948-44af-a184-9a11f80e582e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Common Share Attributable To Mylan</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_7414b524-53c3-476a-b35f-97cf4db05784_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Translation and Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_AntitrustProceedingsMember_95cd3ba7-edce-4584-802a-0e49f16682da_terseLabel_en-US" xlink:label="lab_vtrs_AntitrustProceedingsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antitrust Proceedings</link:label>
    <link:label id="lab_vtrs_AntitrustProceedingsMember_label_en-US" xlink:label="lab_vtrs_AntitrustProceedingsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antitrust Proceedings [Member]</link:label>
    <link:label id="lab_vtrs_AntitrustProceedingsMember_documentation_en-US" xlink:label="lab_vtrs_AntitrustProceedingsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antitrust proceedings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AntitrustProceedingsMember" xlink:href="vtrs-20211231.xsd#vtrs_AntitrustProceedingsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_AntitrustProceedingsMember" xlink:to="lab_vtrs_AntitrustProceedingsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_11b78756-c3eb-49b1-bb55-f6030209577f_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_136916e2-5009-4593-9677-1e7e049d5e08_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected foreign tax credits</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_18399e6a-a865-428a-80a6-2bad3309cf79_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_CARESActIncomeTaxExpenseBenefit_d45ecd51-f60a-4ed8-9dcf-0d39b3b1b71b_terseLabel_en-US" xlink:label="lab_vtrs_CARESActIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARES Act, Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_vtrs_CARESActIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_vtrs_CARESActIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARES Act, Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_vtrs_CARESActIncomeTaxExpenseBenefit_documentation_en-US" xlink:label="lab_vtrs_CARESActIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARES Act, Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CARESActIncomeTaxExpenseBenefit" xlink:href="vtrs-20211231.xsd#vtrs_CARESActIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_CARESActIncomeTaxExpenseBenefit" xlink:to="lab_vtrs_CARESActIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_85f0c55c-bcab-439e-8ece-127058b75d4f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends paid</link:label>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToMinorityShareholders" xlink:to="lab_us-gaap_PaymentsToMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_e56273a8-86dd-471b-8c5a-1d8326042969_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, number of shares authorized</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements_7c2b7609-1cc3-4de1-8183-8e60f96f47cb_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax settlements and resolution of certain tax positions</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Settlement, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_country_SG_a22b73e3-1bcc-4526-9b0e-e77fddcf285f_terseLabel_en-US" xlink:label="lab_country_SG" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SINGAPORE</link:label>
    <link:label id="lab_country_SG_label_en-US" xlink:label="lab_country_SG" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SINGAPORE</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_SG" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_SG"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_SG" xlink:to="lab_country_SG" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_cbcc87ff-92f6-4cfc-bb77-cf6c4c25d4ca_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_1a38e360-da1e-4eeb-a4a9-19d4f00c5793_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:to="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_8dda1833-b6e0-4998-9322-2a86378acc80_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss_ada09d02-efdc-486c-a659-1a3c9d5159b0_terseLabel_en-US" xlink:label="lab_vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value loss (gain)</link:label>
    <link:label id="lab_vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss_label_en-US" xlink:label="lab_vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Fair Value Gain (Loss)</link:label>
    <link:label id="lab_vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss_documentation_en-US" xlink:label="lab_vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Fair Value Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss" xlink:to="lab_vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_204bd6ad-c0e7-4554-8fa7-2ac8fc0e5305_verboseLabel_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Components</link:label>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_1871a020-2b46-44fd-8f35-bb3b73ff2dc7_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized prior service credit (cost)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Reclassification Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_4915da4d-b187-41c9-99c7-70496c72f00a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, interest rate, stated percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_c9ded45e-67f5-4580-9413-6093a5bf56fe_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_0680b880-6867-4786-870f-c3e3a8a9f5c5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_a0b25f01-14ff-45e7-930d-fcd54239042e_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase consideration, contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_ff600425-49e0-43fc-9d7d-565ed1956434_periodStartLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_da48a23d-d6a6-472b-879d-c2224a91c1a1_periodEndLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5d4fab63-42c2-4d81-aca6-750f4e458f2d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_Changeinnoncashlitigationsettlementsnet_24bda8f9-9407-4f43-9009-13f0b5ddba37_negatedLabel_en-US" xlink:label="lab_vtrs_Changeinnoncashlitigationsettlementsnet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation settlements and other contingencies, net</link:label>
    <link:label id="lab_vtrs_Changeinnoncashlitigationsettlementsnet_label_en-US" xlink:label="lab_vtrs_Changeinnoncashlitigationsettlementsnet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in noncash litigation settlements, net</link:label>
    <link:label id="lab_vtrs_Changeinnoncashlitigationsettlementsnet_documentation_en-US" xlink:label="lab_vtrs_Changeinnoncashlitigationsettlementsnet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in noncash litigation settlements, net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Changeinnoncashlitigationsettlementsnet" xlink:href="vtrs-20211231.xsd#vtrs_Changeinnoncashlitigationsettlementsnet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_Changeinnoncashlitigationsettlementsnet" xlink:to="lab_vtrs_Changeinnoncashlitigationsettlementsnet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_df002dfd-0798-4805-8c6e-0d3f5453d8e2_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember_0889c053-bac1-4b07-bdd6-d1f293135a56_terseLabel_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 Senior Notes (4.200%)</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember_label_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SeniorNotesTwoThousandTwentyThree4.2Percent [Member]</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember_documentation_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes two thousand twenty three - 4.2 percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember" xlink:href="vtrs-20211231.xsd#vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember" xlink:to="lab_vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_0ebf7aee-388a-46b8-ba64-c41651c01617_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance for deferred tax assets</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:to="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_c13525d5-1a48-4d77-ae35-b0c2733d1ff0_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateBondSecuritiesMember_5af26b04-7448-4f1e-aa11-32c455c3b4ce_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateBondSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate bonds</link:label>
    <link:label id="lab_us-gaap_CorporateBondSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateBondSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Bond Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateBondSecuritiesMember" xlink:to="lab_us-gaap_CorporateBondSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_b2441826-b308-49bd-917f-e530fd919422_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_d798c46a-67e6-4833-a657-71564cec7cf8_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Securities, Operating Activities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Securities, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities" xlink:to="lab_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_bd0fbeca-6858-439b-a3ab-a59aee47ba60_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_SalesRevenueGrosstonetadjustments_b0f57475-cb66-47ee-a0ae-34cd160fd99c_totalLabel_en-US" xlink:label="lab_vtrs_SalesRevenueGrosstonetadjustments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Revenue, Gross to net adjustments</link:label>
    <link:label id="lab_vtrs_SalesRevenueGrosstonetadjustments_label_en-US" xlink:label="lab_vtrs_SalesRevenueGrosstonetadjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Revenue, Gross to net adjustments</link:label>
    <link:label id="lab_vtrs_SalesRevenueGrosstonetadjustments_documentation_en-US" xlink:label="lab_vtrs_SalesRevenueGrosstonetadjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Revenue, Gross to net adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SalesRevenueGrosstonetadjustments" xlink:href="vtrs-20211231.xsd#vtrs_SalesRevenueGrosstonetadjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_SalesRevenueGrosstonetadjustments" xlink:to="lab_vtrs_SalesRevenueGrosstonetadjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductMember_24008336-2b01-45ea-a33c-349fa8277773_terseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_ProductMember_label_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember" xlink:to="lab_us-gaap_ProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_b8e76710-6874-4f92-9a14-8865142979a8_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_SubjecttoMarketConditionsAxis_e84b5db7-10c7-4b44-91ae-52a8ddefea0d_terseLabel_en-US" xlink:label="lab_vtrs_SubjecttoMarketConditionsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subject to Market Conditions [Axis]</link:label>
    <link:label id="lab_vtrs_SubjecttoMarketConditionsAxis_label_en-US" xlink:label="lab_vtrs_SubjecttoMarketConditionsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subject to Market Conditions [Axis]</link:label>
    <link:label id="lab_vtrs_SubjecttoMarketConditionsAxis_documentation_en-US" xlink:label="lab_vtrs_SubjecttoMarketConditionsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subject to Market Conditions [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SubjecttoMarketConditionsAxis" xlink:href="vtrs-20211231.xsd#vtrs_SubjecttoMarketConditionsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_SubjecttoMarketConditionsAxis" xlink:to="lab_vtrs_SubjecttoMarketConditionsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_454630be-7798-490c-b003-d3fdda6b0816_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Weighted Average Interest Rate, at Point in Time</link:label>
    <link:label id="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_label_en-US" xlink:label="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Weighted Average Interest Rate, at Point in Time</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:to="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d2b92700-81e1-45c5-b8f4-e3ce80b1d7d7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_0c8c2668-fa3f-4a3e-b339-bca1f11e98b2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_c56d408e-138c-402b-8ab8-22f2f16e0d4f_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAndLaterFairValue_e75483d1-ad88-4a02-80a9-a2c363fd4c47_terseLabel_en-US" xlink:label="lab_vtrs_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAndLaterFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mature in five years and later</link:label>
    <link:label id="lab_vtrs_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAndLaterFairValue_label_en-US" xlink:label="lab_vtrs_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAndLaterFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available for Sale Securities Debt Maturities after Five Years and Later Fair Value</link:label>
    <link:label id="lab_vtrs_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAndLaterFairValue_documentation_en-US" xlink:label="lab_vtrs_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAndLaterFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available for sale securities debt maturities after five years and later fair value.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAndLaterFairValue" xlink:href="vtrs-20211231.xsd#vtrs_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAndLaterFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAndLaterFairValue" xlink:to="lab_vtrs_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAndLaterFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_4be795bf-f391-45cb-a3d9-189e52a72664_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of prior service costs included in SG&amp;A</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_46a9f18d-25cb-4407-9d66-1abb73f6b664_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandNineteen2.50PrecentMember_f7d5365f-0a90-459d-ae5a-c945c58e55d0_terseLabel_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandNineteen2.50PrecentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Senior Notes (2.500%)</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandNineteen2.50PrecentMember_label_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandNineteen2.50PrecentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SeniorNotesTwoThousandNineteen2.50Precent [Member]</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandNineteen2.50PrecentMember_documentation_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandNineteen2.50PrecentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Senior Notes (2.500%)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandNineteen2.50PrecentMember" xlink:href="vtrs-20211231.xsd#vtrs_SeniorNotesTwoThousandNineteen2.50PrecentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_SeniorNotesTwoThousandNineteen2.50PrecentMember" xlink:to="lab_vtrs_SeniorNotesTwoThousandNineteen2.50PrecentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ContingentConsiderationMember_5f41d487-97cf-4483-8adb-b58c5154837c_terseLabel_en-US" xlink:label="lab_vtrs_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_vtrs_ContingentConsiderationMember_label_en-US" xlink:label="lab_vtrs_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration [Member]</link:label>
    <link:label id="lab_vtrs_ContingentConsiderationMember_documentation_en-US" xlink:label="lab_vtrs_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ContingentConsiderationMember" xlink:href="vtrs-20211231.xsd#vtrs_ContingentConsiderationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ContingentConsiderationMember" xlink:to="lab_vtrs_ContingentConsiderationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_9f4d8b42-a125-4452-9ab5-28d2d8122735_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_eb79fd4f-a5fb-47f5-b7e7-a681db313592_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option award vesting period, in years</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_VariableConsiderationMember_d4f1c2fb-0717-4d7c-b492-363dbf3b3554_terseLabel_en-US" xlink:label="lab_vtrs_VariableConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Consideration [Member]</link:label>
    <link:label id="lab_vtrs_VariableConsiderationMember_label_en-US" xlink:label="lab_vtrs_VariableConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Consideration [Member]</link:label>
    <link:label id="lab_vtrs_VariableConsiderationMember_documentation_en-US" xlink:label="lab_vtrs_VariableConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Consideration [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VariableConsiderationMember" xlink:href="vtrs-20211231.xsd#vtrs_VariableConsiderationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_VariableConsiderationMember" xlink:to="lab_vtrs_VariableConsiderationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2030SeniorNotesMember_6cae5bc2-f93d-4145-8419-fac40c2f2a48_terseLabel_en-US" xlink:label="lab_vtrs_A2030SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2030 Senior Notes</link:label>
    <link:label id="lab_vtrs_A2030SeniorNotesMember_label_en-US" xlink:label="lab_vtrs_A2030SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2030 Senior Notes [Member]</link:label>
    <link:label id="lab_vtrs_A2030SeniorNotesMember_documentation_en-US" xlink:label="lab_vtrs_A2030SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2030 Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2030SeniorNotesMember" xlink:href="vtrs-20211231.xsd#vtrs_A2030SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2030SeniorNotesMember" xlink:to="lab_vtrs_A2030SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_0f86a47c-0bb1-4eb7-b425-edb232364808_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from equity method investments</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExchangeTradedFundsMember_cfb020f6-4d15-41f7-909b-188485ef0851_terseLabel_en-US" xlink:label="lab_us-gaap_ExchangeTradedFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities &#8212; exchange traded funds</link:label>
    <link:label id="lab_us-gaap_ExchangeTradedFundsMember_label_en-US" xlink:label="lab_us-gaap_ExchangeTradedFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange Traded Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExchangeTradedFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExchangeTradedFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExchangeTradedFundsMember" xlink:to="lab_us-gaap_ExchangeTradedFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_7803929b-f741-4d6c-b295-ed5911fb6b75_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested Restricted Stock and Restricted Stock Unit, Including Performance Units, Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_PeriodAxis_e284d19a-d66f-4b21-9250-2431e1371afa_terseLabel_en-US" xlink:label="lab_vtrs_PeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period [Axis]</link:label>
    <link:label id="lab_vtrs_PeriodAxis_label_en-US" xlink:label="lab_vtrs_PeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period [Axis]</link:label>
    <link:label id="lab_vtrs_PeriodAxis_documentation_en-US" xlink:label="lab_vtrs_PeriodAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PeriodAxis" xlink:href="vtrs-20211231.xsd#vtrs_PeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_PeriodAxis" xlink:to="lab_vtrs_PeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_6c9f4204-ed29-47a6-805f-090594596002_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Cost Incurred to Date</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_418b776f-5dbe-41dc-857f-b8c2d42c6325_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_005f34b7-41b5-4862-9208-7837d1615b99_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_aee13d4f-b240-4968-b448-74ff3cb10977_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_9135cc3d-dc10-40d2-999a-3fa4ebdcf215_verboseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserveCurrent_5194a37a-e7dd-4113-b639-d785731eea0a_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability, Current</link:label>
    <link:label id="lab_us-gaap_LitigationReserveCurrent_label_en-US" xlink:label="lab_us-gaap_LitigationReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserveCurrent" xlink:to="lab_us-gaap_LitigationReserveCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrentAbstract_64cb23da-d0f2-443b-9976-9afb281c2527_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrentAbstract" xlink:to="lab_us-gaap_AccountsPayableCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_c051cae0-976f-4cce-8fb4-6554e05c9089_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Policy</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsPolicy" xlink:to="lab_us-gaap_BusinessCombinationsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_fc457d7c-6fc7-4045-8b6a-8949a5a8f3d8_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesRetired_c6235013-f864-4a07-9a7e-2c33da7d0b68_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesRetired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancellation of restricted stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesRetired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesRetired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Retired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesRetired" xlink:to="lab_us-gaap_TreasuryStockSharesRetired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_5419423f-9504-4651-9483-8bc7c1d8cb20_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Value Assigned</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Value Assigned</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_ea854028-478b-47ba-9702-4428e8e3e1e9_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesNetAbstract_ca93d22a-139a-47ad-af57-fae1a2de16eb_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesNetAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_1c809717-46e7-4334-b629-6de568819942_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemDomain_d526b870-2af0-4172-99b8-e9d50b567496_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Domain]</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemDomain_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain" xlink:to="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_21fb32ba-1b71-4383-980b-6b1497c151e8_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_e21527c5-bf88-49da-8e43-a05672b63047_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Projected benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Pension Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndCollectionOfReceivables_dd93f8b0-c191-4209-ba39-1e62035eb07a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndCollectionOfReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Collection of Receivables</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndCollectionOfReceivables_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndCollectionOfReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Collection of Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndCollectionOfReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndCollectionOfReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndCollectionOfReceivables" xlink:to="lab_us-gaap_ProceedsFromSaleAndCollectionOfReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FixedIncomeSecuritiesMember_8b5f18de-83ff-423a-8802-0dc8d4bf88c3_terseLabel_en-US" xlink:label="lab_us-gaap_FixedIncomeSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed income securities</link:label>
    <link:label id="lab_us-gaap_FixedIncomeSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_FixedIncomeSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Income Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FixedIncomeSecuritiesMember" xlink:to="lab_us-gaap_FixedIncomeSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_4bd5cfd5-2d5b-4926-907f-f45296dc94c0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_618cdcd3-bda6-4448-bfa0-f663faf8715e_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_InsulinAnalogProducts_d1bc7501-c2e5-4b44-ab4f-5faed0ccbd30_terseLabel_en-US" xlink:label="lab_vtrs_InsulinAnalogProducts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insulin Analog Products</link:label>
    <link:label id="lab_vtrs_InsulinAnalogProducts_label_en-US" xlink:label="lab_vtrs_InsulinAnalogProducts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insulin Analog Products</link:label>
    <link:label id="lab_vtrs_InsulinAnalogProducts_documentation_en-US" xlink:label="lab_vtrs_InsulinAnalogProducts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insulin Analog Products</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_InsulinAnalogProducts" xlink:href="vtrs-20211231.xsd#vtrs_InsulinAnalogProducts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_InsulinAnalogProducts" xlink:to="lab_vtrs_InsulinAnalogProducts" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ExpectedFutureBenefitPayments_5070ca05-1a5c-4082-962a-ed6a80f7d3de_totalLabel_en-US" xlink:label="lab_vtrs_ExpectedFutureBenefitPayments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_vtrs_ExpectedFutureBenefitPayments_label_en-US" xlink:label="lab_vtrs_ExpectedFutureBenefitPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Future Benefit Payments</link:label>
    <link:label id="lab_vtrs_ExpectedFutureBenefitPayments_documentation_en-US" xlink:label="lab_vtrs_ExpectedFutureBenefitPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Future Benefit Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ExpectedFutureBenefitPayments" xlink:href="vtrs-20211231.xsd#vtrs_ExpectedFutureBenefitPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ExpectedFutureBenefitPayments" xlink:to="lab_vtrs_ExpectedFutureBenefitPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ComplexGXAndBiosimilarsMember_854be5fe-799e-4b1a-a48a-eadd2f246671_terseLabel_en-US" xlink:label="lab_vtrs_ComplexGXAndBiosimilarsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Complex Gx and Biosimilars</link:label>
    <link:label id="lab_vtrs_ComplexGXAndBiosimilarsMember_label_en-US" xlink:label="lab_vtrs_ComplexGXAndBiosimilarsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Complex GX and Biosimilars [Member]</link:label>
    <link:label id="lab_vtrs_ComplexGXAndBiosimilarsMember_documentation_en-US" xlink:label="lab_vtrs_ComplexGXAndBiosimilarsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Complex GX and Biosimilars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ComplexGXAndBiosimilarsMember" xlink:href="vtrs-20211231.xsd#vtrs_ComplexGXAndBiosimilarsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ComplexGXAndBiosimilarsMember" xlink:to="lab_vtrs_ComplexGXAndBiosimilarsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_e82c382a-4052-4ecb-92fb-1da57aa2f4ca_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. State Deferred</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_EmergingMarketsSegmentMember_f6ad636b-df32-45bb-b162-48362a10051e_terseLabel_en-US" xlink:label="lab_vtrs_EmergingMarketsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Markets</link:label>
    <link:label id="lab_vtrs_EmergingMarketsSegmentMember_label_en-US" xlink:label="lab_vtrs_EmergingMarketsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Markets Segment [Member]</link:label>
    <link:label id="lab_vtrs_EmergingMarketsSegmentMember_documentation_en-US" xlink:label="lab_vtrs_EmergingMarketsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Markets Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EmergingMarketsSegmentMember" xlink:href="vtrs-20211231.xsd#vtrs_EmergingMarketsSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_EmergingMarketsSegmentMember" xlink:to="lab_vtrs_EmergingMarketsSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_da7609e1-add0-4fe1-9954-ef4ab2143884_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_GreaterChinaSegmentMember_791081d6-9849-4476-a3be-b5c8622f7146_terseLabel_en-US" xlink:label="lab_vtrs_GreaterChinaSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater China</link:label>
    <link:label id="lab_vtrs_GreaterChinaSegmentMember_label_en-US" xlink:label="lab_vtrs_GreaterChinaSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater China Segment [Member]</link:label>
    <link:label id="lab_vtrs_GreaterChinaSegmentMember_documentation_en-US" xlink:label="lab_vtrs_GreaterChinaSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater China Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GreaterChinaSegmentMember" xlink:href="vtrs-20211231.xsd#vtrs_GreaterChinaSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_GreaterChinaSegmentMember" xlink:to="lab_vtrs_GreaterChinaSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ReceivablesFacilityMember_6892ec3e-be7d-4c1e-b611-5511a60d60c6_terseLabel_en-US" xlink:label="lab_vtrs_ReceivablesFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables Facility [Member]</link:label>
    <link:label id="lab_vtrs_ReceivablesFacilityMember_label_en-US" xlink:label="lab_vtrs_ReceivablesFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables Facility [Member]</link:label>
    <link:label id="lab_vtrs_ReceivablesFacilityMember_documentation_en-US" xlink:label="lab_vtrs_ReceivablesFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables facility.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ReceivablesFacilityMember" xlink:href="vtrs-20211231.xsd#vtrs_ReceivablesFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ReceivablesFacilityMember" xlink:to="lab_vtrs_ReceivablesFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_1ec84995-2f0a-4a1c-9388-c9fe8f0cee1e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_3f3621d9-e8fb-4de2-b516-4b50134188aa_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_Medicaidandothergovernmentalrebates_fc3e9dbf-9eb9-43a7-91cd-d40121f5f6b5_negatedTerseLabel_en-US" xlink:label="lab_vtrs_Medicaidandothergovernmentalrebates" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid and other governmental rebates</link:label>
    <link:label id="lab_vtrs_Medicaidandothergovernmentalrebates_label_en-US" xlink:label="lab_vtrs_Medicaidandothergovernmentalrebates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid and other governmental rebates</link:label>
    <link:label id="lab_vtrs_Medicaidandothergovernmentalrebates_documentation_en-US" xlink:label="lab_vtrs_Medicaidandothergovernmentalrebates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid and other governmental rebates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Medicaidandothergovernmentalrebates" xlink:href="vtrs-20211231.xsd#vtrs_Medicaidandothergovernmentalrebates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_Medicaidandothergovernmentalrebates" xlink:to="lab_vtrs_Medicaidandothergovernmentalrebates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetLiabilityNetMeasurementInput_73822a95-b800-4a84-a1db-2e63be104dce_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetLiabilityNetMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset (Liability) Net, Measurement Input</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetLiabilityNetMeasurementInput_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetLiabilityNetMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset (Liability) Net, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetLiabilityNetMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetLiabilityNetMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetLiabilityNetMeasurementInput" xlink:to="lab_us-gaap_DerivativeAssetLiabilityNetMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_fb71144e-a2e6-4dfa-80aa-afd9885b2742_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_b723d4ee-7a0e-4b61-af23-2a1077ee3019_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_7bf03d87-b405-46e8-9c60-4a20b9c16c07_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandAndLandImprovementsMember_edebeb90-d53a-4042-a901-7e06ca970be5_terseLabel_en-US" xlink:label="lab_us-gaap_LandAndLandImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land and improvements</link:label>
    <link:label id="lab_us-gaap_LandAndLandImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LandAndLandImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land and Land Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAndLandImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandAndLandImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandAndLandImprovementsMember" xlink:to="lab_us-gaap_LandAndLandImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_1b761a52-70d5-4854-8ee4-3c2e87c2c7b8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_a4178037-0370-4f33-8c6e-0043512c51af_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_GoodwillImpairedChangeinEstimatePeriod_c7c3b10d-62ca-4af5-8b05-c06f98c46e48_terseLabel_en-US" xlink:label="lab_vtrs_GoodwillImpairedChangeinEstimatePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Change in Estimate, Period</link:label>
    <link:label id="lab_vtrs_GoodwillImpairedChangeinEstimatePeriod_label_en-US" xlink:label="lab_vtrs_GoodwillImpairedChangeinEstimatePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Change in Estimate, Period</link:label>
    <link:label id="lab_vtrs_GoodwillImpairedChangeinEstimatePeriod_documentation_en-US" xlink:label="lab_vtrs_GoodwillImpairedChangeinEstimatePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Change in Estimate, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GoodwillImpairedChangeinEstimatePeriod" xlink:href="vtrs-20211231.xsd#vtrs_GoodwillImpairedChangeinEstimatePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_GoodwillImpairedChangeinEstimatePeriod" xlink:to="lab_vtrs_GoodwillImpairedChangeinEstimatePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_80bb3795-3eda-4abe-9c34-fe4bd891a618_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Loss) earnings per share attributable to Viatris Inc. shareholders</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_f9aaf041-f1ab-4235-a476-b42911355373_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementMember_28a4d7b3-43fb-42ae-b6f6-9516521bfa51_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementMember_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementMember" xlink:to="lab_us-gaap_CollaborativeArrangementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_a5a5b3ac-3d3b-491f-a6ea-000350585195_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIndefiniteLivedIntangibleAssetsMeasurementInput_82d884e2-742a-4971-ac55-ecf4ba4ab87f_terseLabel_en-US" xlink:label="lab_vtrs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIndefiniteLivedIntangibleAssetsMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rate used to discount net cash inflows to present values</link:label>
    <link:label id="lab_vtrs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIndefiniteLivedIntangibleAssetsMeasurementInput_label_en-US" xlink:label="lab_vtrs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIndefiniteLivedIntangibleAssetsMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets, Measurement Input</link:label>
    <link:label id="lab_vtrs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIndefiniteLivedIntangibleAssetsMeasurementInput_documentation_en-US" xlink:label="lab_vtrs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIndefiniteLivedIntangibleAssetsMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIndefiniteLivedIntangibleAssetsMeasurementInput" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIndefiniteLivedIntangibleAssetsMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIndefiniteLivedIntangibleAssetsMeasurementInput" xlink:to="lab_vtrs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIndefiniteLivedIntangibleAssetsMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_d917cbc8-739a-41f1-aedb-95878a8032c9_totalLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_b7abd570-85a0-4d61-83d4-1f7d22545095_verboseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_bb6fe070-9df0-4f60-8851-f4a153e35ea2_totalLabel_en-US" xlink:label="lab_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax provision (benefit), Non-U.S.</link:label>
    <link:label id="lab_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_label_en-US" xlink:label="lab_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Income Tax Expense (Benefit), Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:to="lab_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesFairValueDisclosure_65a19a8b-8818-46c8-bb18-d9bd626d3373_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_85641787-2aef-4295-8138-c7d669568043_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_48518a03-894a-4d2a-959b-2c53eb94c8b0_verboseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency borrowings and forward contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_4d3419e7-32ad-4baf-b321-ea57f6634cf6_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency accrual</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2022EuroSeniorNotesMember_d7725eb8-c112-4389-aaf3-0281f522eca1_terseLabel_en-US" xlink:label="lab_vtrs_A2022EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Euro Senior Notes</link:label>
    <link:label id="lab_vtrs_A2022EuroSeniorNotesMember_label_en-US" xlink:label="lab_vtrs_A2022EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Euro Senior Notes [Member]</link:label>
    <link:label id="lab_vtrs_A2022EuroSeniorNotesMember_documentation_en-US" xlink:label="lab_vtrs_A2022EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Euro Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2022EuroSeniorNotesMember" xlink:href="vtrs-20211231.xsd#vtrs_A2022EuroSeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2022EuroSeniorNotesMember" xlink:to="lab_vtrs_A2022EuroSeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_FiscalYear2017Member_446b08b7-0f79-4be8-8b61-c0ba0a764f15_terseLabel_en-US" xlink:label="lab_vtrs_FiscalYear2017Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Year 2017</link:label>
    <link:label id="lab_vtrs_FiscalYear2017Member_label_en-US" xlink:label="lab_vtrs_FiscalYear2017Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Year 2017 [Member]</link:label>
    <link:label id="lab_vtrs_FiscalYear2017Member_documentation_en-US" xlink:label="lab_vtrs_FiscalYear2017Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Year 2017 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_FiscalYear2017Member" xlink:href="vtrs-20211231.xsd#vtrs_FiscalYear2017Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_FiscalYear2017Member" xlink:to="lab_vtrs_FiscalYear2017Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_a78abc52-50c5-4daf-8de0-80bda9a59966_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsLineItems" xlink:to="lab_us-gaap_OtherCommitmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_9435f715-6a4f-49c1-90f6-1cdf535f9a31_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weightedaverage exercise price per share, outstanding at beginning of period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b87c776e-6215-43b1-a22d-d7624ccf3778_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price per share, outstanding at end of period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_71412ff5-cd7e-41f1-8f9b-d7fb463081fa_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_2253f3e7-6c5a-481c-a6bf-eaf36d64824a_terseLabel_en-US" xlink:label="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax benefit</link:label>
    <link:label id="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_label_en-US" xlink:label="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets</link:label>
    <link:label id="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_documentation_en-US" xlink:label="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets" xlink:to="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionDomain_a76cbbc3-8ae7-4025-a4a5-177479c5f068_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionDomain_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionDomain" xlink:to="lab_us-gaap_AssetAcquisitionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_fbaa0c77-224d-4a41-a92e-0cadfb034827_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_5aaaa0ba-9b49-4531-8592-e5d5a66af046_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicLineItems_788813d7-1230-4792-8899-d5dafd16099f_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicLineItems_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems" xlink:to="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_83e36d22-c5b3-49a6-bad4-acd612ff9547_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets, beginning of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_1978c30e-b0df-4a67-999d-cac37e9c1f52_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets, end of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_9af3e667-ebfb-435b-bdcc-02345eee7e1f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_c94fa2c5-1ec5-4f53-b3ff-c285e2b2917a_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_Netaccruedbenefitcosts_add4725f-b348-4440-a729-a8cdc1acf578_negatedTotalLabel_en-US" xlink:label="lab_vtrs_Netaccruedbenefitcosts" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net accrued benefit costs</link:label>
    <link:label id="lab_vtrs_Netaccruedbenefitcosts_label_en-US" xlink:label="lab_vtrs_Netaccruedbenefitcosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net accrued benefit costs</link:label>
    <link:label id="lab_vtrs_Netaccruedbenefitcosts_documentation_en-US" xlink:label="lab_vtrs_Netaccruedbenefitcosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net accrued benefit costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Netaccruedbenefitcosts" xlink:href="vtrs-20211231.xsd#vtrs_Netaccruedbenefitcosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_Netaccruedbenefitcosts" xlink:to="lab_vtrs_Netaccruedbenefitcosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherDebtSecuritiesMember_cb88edc7-2256-43d5-9916-dd5b7d791069_terseLabel_en-US" xlink:label="lab_us-gaap_OtherDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_OtherDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Debt Obligations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherDebtSecuritiesMember" xlink:to="lab_us-gaap_OtherDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtCurrent_18456d26-15f4-4f34-9fae-73269cdfc7ec_terseLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_label_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtCurrent" xlink:to="lab_us-gaap_DebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_2718efca-a64d-4e18-bd19-3556a7716887_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_0929e6bf-6faa-4b96-a1ed-097f402310c8_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from the sale of marketable securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_DymistaMember_c3f4d9b6-fe1c-4f39-9b5f-220d46cf9613_terseLabel_en-US" xlink:label="lab_vtrs_DymistaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dymista &#174;</link:label>
    <link:label id="lab_vtrs_DymistaMember_label_en-US" xlink:label="lab_vtrs_DymistaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dymista &#174; [Member]</link:label>
    <link:label id="lab_vtrs_DymistaMember_documentation_en-US" xlink:label="lab_vtrs_DymistaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dymista &#174;</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DymistaMember" xlink:href="vtrs-20211231.xsd#vtrs_DymistaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_DymistaMember" xlink:to="lab_vtrs_DymistaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssued_97dd1bc6-7bf2-45ae-bb6b-61250a49366a_terseLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued</link:label>
    <link:label id="lab_us-gaap_SharesIssued_587de7a7-e232-43e1-a39c-b969c4c76d07_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_7be4b2d7-afde-41af-91d2-c9ac3822f082_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_label_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_BusinessCombinationContractualReimbursementAmountAmountsAccrued_92f011e8-89ad-468d-9d02-6004a2e40e14_terseLabel_en-US" xlink:label="lab_vtrs_BusinessCombinationContractualReimbursementAmountAmountsAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts accrued</link:label>
    <link:label id="lab_vtrs_BusinessCombinationContractualReimbursementAmountAmountsAccrued_label_en-US" xlink:label="lab_vtrs_BusinessCombinationContractualReimbursementAmountAmountsAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contractual Reimbursement Amount, Amounts Accrued</link:label>
    <link:label id="lab_vtrs_BusinessCombinationContractualReimbursementAmountAmountsAccrued_documentation_en-US" xlink:label="lab_vtrs_BusinessCombinationContractualReimbursementAmountAmountsAccrued" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contractual Reimbursement Amount, Amounts Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationContractualReimbursementAmountAmountsAccrued" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationContractualReimbursementAmountAmountsAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_BusinessCombinationContractualReimbursementAmountAmountsAccrued" xlink:to="lab_vtrs_BusinessCombinationContractualReimbursementAmountAmountsAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_af1684bd-39b0-44d9-bc7e-35a512f58987_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_a3e0809e-82f3-4a8d-bc28-fee72fcc6b20_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:to="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_BusinessCombinationContractualReimbursementAmountAmountsExpensed_7c14529b-16d6-4125-8041-79503819da61_terseLabel_en-US" xlink:label="lab_vtrs_BusinessCombinationContractualReimbursementAmountAmountsExpensed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts incurred</link:label>
    <link:label id="lab_vtrs_BusinessCombinationContractualReimbursementAmountAmountsExpensed_label_en-US" xlink:label="lab_vtrs_BusinessCombinationContractualReimbursementAmountAmountsExpensed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contractual Reimbursement Amount, Amounts Expensed</link:label>
    <link:label id="lab_vtrs_BusinessCombinationContractualReimbursementAmountAmountsExpensed_documentation_en-US" xlink:label="lab_vtrs_BusinessCombinationContractualReimbursementAmountAmountsExpensed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contractual Reimbursement Amount, Amounts Expensed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationContractualReimbursementAmountAmountsExpensed" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationContractualReimbursementAmountAmountsExpensed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_BusinessCombinationContractualReimbursementAmountAmountsExpensed" xlink:to="lab_vtrs_BusinessCombinationContractualReimbursementAmountAmountsExpensed" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_RestructuringReserveReimbursableRestructuringCharges_796d0c1a-18b5-4eed-b0c3-f43a8208e1aa_terseLabel_en-US" xlink:label="lab_vtrs_RestructuringReserveReimbursableRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Reimbursable Restructuring Charges</link:label>
    <link:label id="lab_vtrs_RestructuringReserveReimbursableRestructuringCharges_label_en-US" xlink:label="lab_vtrs_RestructuringReserveReimbursableRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Reimbursable Restructuring Charges</link:label>
    <link:label id="lab_vtrs_RestructuringReserveReimbursableRestructuringCharges_documentation_en-US" xlink:label="lab_vtrs_RestructuringReserveReimbursableRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Reimbursable Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RestructuringReserveReimbursableRestructuringCharges" xlink:href="vtrs-20211231.xsd#vtrs_RestructuringReserveReimbursableRestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_RestructuringReserveReimbursableRestructuringCharges" xlink:to="lab_vtrs_RestructuringReserveReimbursableRestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_018e88a4-a51f-44e2-a6db-f1dfce36e4a5_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock shares reserved for issuance to employees</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_951804c7-649a-49a9-a3b7-f214a8dedf7d_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_4c248636-4ab1-4394-8881-ecd0179e3548_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Policy</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_0abaabd9-c0f3-483f-b184-0d24dde05fe0_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_54f1ad3e-5eb7-4abe-8a76-a3a0bc1acd47_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis_efa5270e-3c11-4b78-9be6-49882dd346ee_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits, Individual Contracts, Type of Deferred Compensation [Axis]</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits, Individual Contracts, Type of Deferred Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis" xlink:to="lab_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_5bb43cf3-89bf-41c7-ab7c-f836669e6dcd_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_5443a554-958c-4611-b4ff-8a9393ec1bf8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_60d3feeb-407a-4e40-a381-9fc4d0765175_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition Policy</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_614b1bbe-c229-4344-a0b5-101ef311efdc_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e75fa262-b24f-4719-9033-06f8128e6a72_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total dilutive shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_a9a42046-35b5-49c8-9270-95ff4420b8be_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings before income taxes and noncontrolling interest, United States</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_364600f9-4f7b-497f-9c14-68aa10840b80_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total intangible asset amortization expense (including impairment charges)</link:label>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_label_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForAmortization" xlink:to="lab_us-gaap_AdjustmentForAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_8303fa2f-dbd8-4ded-8782-1defe1c47425_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_40b3aead-1655-4630-8cdf-249188631b09_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_96c815cc-62c4-4c50-9d8d-9f6d8c795c99_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Awards Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_75666e86-f680-49cc-a4fa-4f645736a6b5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_InsulinGlargineMember_062d75de-36b1-40f1-89a7-8b3b9d5d35db_terseLabel_en-US" xlink:label="lab_vtrs_InsulinGlargineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insulin Glargine</link:label>
    <link:label id="lab_vtrs_InsulinGlargineMember_label_en-US" xlink:label="lab_vtrs_InsulinGlargineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insulin Glargine [Member]</link:label>
    <link:label id="lab_vtrs_InsulinGlargineMember_documentation_en-US" xlink:label="lab_vtrs_InsulinGlargineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insulin Glargine</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_InsulinGlargineMember" xlink:href="vtrs-20211231.xsd#vtrs_InsulinGlargineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_InsulinGlargineMember" xlink:to="lab_vtrs_InsulinGlargineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_a3f89c19-6fcb-41ee-8027-87c3e179b3ea_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Periodic Benefit Cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Benefit Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandEighteen2.6PercentMember_c6c579e4-45df-44fe-b9c0-91ca2a0d1754_terseLabel_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandEighteen2.6PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Senior Notes (2.600%)</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandEighteen2.6PercentMember_label_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandEighteen2.6PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Two Thousand Eighteen - 2.6 Percent [Member]</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandEighteen2.6PercentMember_documentation_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandEighteen2.6PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Two Thousand Eighteen - 2.6% [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandEighteen2.6PercentMember" xlink:href="vtrs-20211231.xsd#vtrs_SeniorNotesTwoThousandEighteen2.6PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_SeniorNotesTwoThousandEighteen2.6PercentMember" xlink:to="lab_vtrs_SeniorNotesTwoThousandEighteen2.6PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_b243665b-7169-4aeb-8855-be3c425268cf_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_GoodwillImpairmentMeasurementInput_4498fb48-fb71-4f09-b3fc-606bb2af8055_terseLabel_en-US" xlink:label="lab_vtrs_GoodwillImpairmentMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Impairment, Measurement Input</link:label>
    <link:label id="lab_vtrs_GoodwillImpairmentMeasurementInput_label_en-US" xlink:label="lab_vtrs_GoodwillImpairmentMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Impairment, Measurement Input</link:label>
    <link:label id="lab_vtrs_GoodwillImpairmentMeasurementInput_documentation_en-US" xlink:label="lab_vtrs_GoodwillImpairmentMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Impairment, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GoodwillImpairmentMeasurementInput" xlink:href="vtrs-20211231.xsd#vtrs_GoodwillImpairmentMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_GoodwillImpairmentMeasurementInput" xlink:to="lab_vtrs_GoodwillImpairmentMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2020FloatingRateEuroNotesMember_6ad62a40-c315-4e86-bd93-0daabcef0d1a_terseLabel_en-US" xlink:label="lab_vtrs_A2020FloatingRateEuroNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Floating Rate Euro Notes</link:label>
    <link:label id="lab_vtrs_A2020FloatingRateEuroNotesMember_label_en-US" xlink:label="lab_vtrs_A2020FloatingRateEuroNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Floating Rate Euro Notes [Member]</link:label>
    <link:label id="lab_vtrs_A2020FloatingRateEuroNotesMember_documentation_en-US" xlink:label="lab_vtrs_A2020FloatingRateEuroNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Floating Rate Euro Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2020FloatingRateEuroNotesMember" xlink:href="vtrs-20211231.xsd#vtrs_A2020FloatingRateEuroNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2020FloatingRateEuroNotesMember" xlink:to="lab_vtrs_A2020FloatingRateEuroNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_429b0974-9961-449d-b20b-b88441755f11_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not designated as hedging instrument</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_85bfde3b-50a4-4892-a068-cf7064b97808_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_9c463999-324a-492c-b408-4545c284fb7d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveNoncurrent_5e1ecef4-9530-4024-ad2e-641160240bb1_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Noncurrent</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveNoncurrent" xlink:to="lab_us-gaap_RestructuringReserveNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_f79ed91f-edd6-4f27-98e3-be0ad7a24dfb_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_9a1114f3-d10d-421d-b169-9c64f1c59e21_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:to="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c2fa2acf-e001-47bd-b46d-e0276ac1e652_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_4b82eb3f-459b-4009-83b7-32fba1ef9cd6_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles of Consolidation Policy</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_590712a0-d0f6-41da-9853-fdabf85e3dcc_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTextBlock_c3ff9ee0-f5c8-4af3-8a1d-3db922adba82_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:to="lab_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_EquityMethodInvestmentSummarizedFinancialInformationNetAssets_1fe73ead-9223-4631-b3e9-320594e7dde6_terseLabel_en-US" xlink:label="lab_vtrs_EquityMethodInvestmentSummarizedFinancialInformationNetAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net assets</link:label>
    <link:label id="lab_vtrs_EquityMethodInvestmentSummarizedFinancialInformationNetAssets_label_en-US" xlink:label="lab_vtrs_EquityMethodInvestmentSummarizedFinancialInformationNetAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment Summarized Financial Information, Net Assets</link:label>
    <link:label id="lab_vtrs_EquityMethodInvestmentSummarizedFinancialInformationNetAssets_documentation_en-US" xlink:label="lab_vtrs_EquityMethodInvestmentSummarizedFinancialInformationNetAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment Summarized Financial Information, Net Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EquityMethodInvestmentSummarizedFinancialInformationNetAssets" xlink:href="vtrs-20211231.xsd#vtrs_EquityMethodInvestmentSummarizedFinancialInformationNetAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_EquityMethodInvestmentSummarizedFinancialInformationNetAssets" xlink:to="lab_vtrs_EquityMethodInvestmentSummarizedFinancialInformationNetAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_c0bb0088-6a1d-4169-9468-0255398bf31b_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected term (years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_8ea40529-2d1c-4ae5-a936-67403b93c83a_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_54b5c8db-7d50-45c3-927d-0899e50651fa_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_fbbc017b-d24f-4350-8729-db822eaf2622_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes paid related to net share settlement of equity awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplyCommitmentAxis_89e8117a-aafa-4751-9a3c-1f4cb4cf997f_terseLabel_en-US" xlink:label="lab_us-gaap_SupplyCommitmentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supply Commitment [Axis]</link:label>
    <link:label id="lab_us-gaap_SupplyCommitmentAxis_label_en-US" xlink:label="lab_us-gaap_SupplyCommitmentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supply Commitment [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplyCommitmentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplyCommitmentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplyCommitmentAxis" xlink:to="lab_us-gaap_SupplyCommitmentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_7980503b-63b6-4c9f-b769-760934f90067_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember" xlink:to="lab_us-gaap_ForeignExchangeForwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_EURIBORMember_eea0842e-6f7a-4199-b102-793e118f90b8_terseLabel_en-US" xlink:label="lab_vtrs_EURIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EURIBOR [Member]</link:label>
    <link:label id="lab_vtrs_EURIBORMember_label_en-US" xlink:label="lab_vtrs_EURIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EURIBOR [Member]</link:label>
    <link:label id="lab_vtrs_EURIBORMember_documentation_en-US" xlink:label="lab_vtrs_EURIBORMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EURIBOR [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EURIBORMember" xlink:href="vtrs-20211231.xsd#vtrs_EURIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_EURIBORMember" xlink:to="lab_vtrs_EURIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_581134ac-cf71-45df-870b-7d069308f2be_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_074f0fce-b0a9-4945-bc2c-343d2187fe1e_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_d8df7559-a297-46ce-ae25-2db0741111ae_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Trade, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableTradeCurrent" xlink:to="lab_us-gaap_AccountsPayableTradeCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_014dee26-92b9-46aa-9897-9b67805de49b_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_3cfc009e-3b4d-4e22-a03e-74766ec9473f_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_64fb4676-4044-4579-9802-82a9c0d6f2fa_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plans with Accumulated Benefit Obligation in Excess of Plan Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan with Projected Benefit Obligation in Excess of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_3fdd5844-9a5b-4bd9-81f1-6c1790d75d61_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_7a8bb001-cf67-4606-874a-48a4a9e41c91_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments And Risk Management</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:to="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_LossContingencyDamagesAwardedOnAppealValue_c44a4676-19e1-414d-a674-43de416ed5b1_terseLabel_en-US" xlink:label="lab_vtrs_LossContingencyDamagesAwardedOnAppealValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Awarded On Appeal, Value</link:label>
    <link:label id="lab_vtrs_LossContingencyDamagesAwardedOnAppealValue_label_en-US" xlink:label="lab_vtrs_LossContingencyDamagesAwardedOnAppealValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Awarded On Appeal, Value</link:label>
    <link:label id="lab_vtrs_LossContingencyDamagesAwardedOnAppealValue_documentation_en-US" xlink:label="lab_vtrs_LossContingencyDamagesAwardedOnAppealValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Awarded On Appeal, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_LossContingencyDamagesAwardedOnAppealValue" xlink:href="vtrs-20211231.xsd#vtrs_LossContingencyDamagesAwardedOnAppealValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_LossContingencyDamagesAwardedOnAppealValue" xlink:to="lab_vtrs_LossContingencyDamagesAwardedOnAppealValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_45da092c-ea60-4779-b4ec-ac90dc415d30_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_LongTermIncentivePlan2003Member_352f92fb-9216-4c08-a881-647bf474ea1c_terseLabel_en-US" xlink:label="lab_vtrs_LongTermIncentivePlan2003Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Incentive Plan 2003</link:label>
    <link:label id="lab_vtrs_LongTermIncentivePlan2003Member_label_en-US" xlink:label="lab_vtrs_LongTermIncentivePlan2003Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Incentive Plan 2003 [Member]</link:label>
    <link:label id="lab_vtrs_LongTermIncentivePlan2003Member_documentation_en-US" xlink:label="lab_vtrs_LongTermIncentivePlan2003Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Incentive 2003 Plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_LongTermIncentivePlan2003Member" xlink:href="vtrs-20211231.xsd#vtrs_LongTermIncentivePlan2003Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_LongTermIncentivePlan2003Member" xlink:to="lab_vtrs_LongTermIncentivePlan2003Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_3ad85138-83f9-451e-890e-6ff9dbb184cb_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_a826fb3e-8258-4c46-b376-6040bf312856_verboseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_BusinessAcquisitionexpectedfuturepaymentsnexttwelvemonths_a5061856-f200-490a-88be-284b4aa5cd37_terseLabel_en-US" xlink:label="lab_vtrs_BusinessAcquisitionexpectedfuturepaymentsnexttwelvemonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, expected future payments, next twelve months</link:label>
    <link:label id="lab_vtrs_BusinessAcquisitionexpectedfuturepaymentsnexttwelvemonths_label_en-US" xlink:label="lab_vtrs_BusinessAcquisitionexpectedfuturepaymentsnexttwelvemonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, expected future payments, next twelve months</link:label>
    <link:label id="lab_vtrs_BusinessAcquisitionexpectedfuturepaymentsnexttwelvemonths_documentation_en-US" xlink:label="lab_vtrs_BusinessAcquisitionexpectedfuturepaymentsnexttwelvemonths" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, expected future payments, next twelve months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessAcquisitionexpectedfuturepaymentsnexttwelvemonths" xlink:href="vtrs-20211231.xsd#vtrs_BusinessAcquisitionexpectedfuturepaymentsnexttwelvemonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_BusinessAcquisitionexpectedfuturepaymentsnexttwelvemonths" xlink:to="lab_vtrs_BusinessAcquisitionexpectedfuturepaymentsnexttwelvemonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_18906810-1b9a-4a91-8702-a28a7025a359_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Collaborative Arrangements and Non-collaborative Arrangement Transactions [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_7f3af7bd-ee95-4dc9-bc31-cee5715e9c02_verboseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_ea30664e-5c3e-488f-80e3-b48accae29d1_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsAxis_41aea9d1-14a7-427a-bb21-711d89978c0b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Axis]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsAxis_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsAxis" xlink:to="lab_us-gaap_OtherCommitmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_03be0c13-efe8-4df0-b187-09d161cc84f6_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillMember_73fb92c7-03c2-4323-88db-1b15ac2dc5b4_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Member]</link:label>
    <link:label id="lab_us-gaap_GoodwillMember_label_en-US" xlink:label="lab_us-gaap_GoodwillMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillMember" xlink:to="lab_us-gaap_GoodwillMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_9f16fd64-2c3a-43fa-872e-9416dd0e1b23_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total unrecognized compensation expense, net of estimated forfeitures</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_1dcd7a0f-0ebe-4659-9d97-18fa71d8af78_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accumulated Income (Loss) Relating to Defined Benefit Pension and Other Postretirement Benefits</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_280263c9-abef-4689-b4dd-133d87ee96a7_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_6856df84-a318-499e-9fe7-2f8f51b7b89c_terseLabel_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_label_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminatedPercent_d27f087d-2748-438b-9c74-ef460a5169c8_terseLabel_en-US" xlink:label="lab_vtrs_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminatedPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Number of Positions Eliminated, Percent</link:label>
    <link:label id="lab_vtrs_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminatedPercent_label_en-US" xlink:label="lab_vtrs_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminatedPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Number of Positions Eliminated, Percent</link:label>
    <link:label id="lab_vtrs_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminatedPercent_documentation_en-US" xlink:label="lab_vtrs_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminatedPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Number of Positions Eliminated, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminatedPercent" xlink:href="vtrs-20211231.xsd#vtrs_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminatedPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminatedPercent" xlink:to="lab_vtrs_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminatedPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_5eb2dbf3-2346-40ff-a911-0a93c74f2772_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax_171f0bff-3395-4219-ab6b-2848b45ac8d5_terseLabel_en-US" xlink:label="lab_vtrs_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, before Tax</link:label>
    <link:label id="lab_vtrs_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax_label_en-US" xlink:label="lab_vtrs_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Net Investment Hedges, Effect Net of Tax</link:label>
    <link:label id="lab_vtrs_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax_documentation_en-US" xlink:label="lab_vtrs_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Net Investment Hedges, Effect Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax" xlink:href="vtrs-20211231.xsd#vtrs_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax" xlink:to="lab_vtrs_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_a3d835da-10b9-4dda-957f-1ec53b0c52d4_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_55df573a-0dd1-4e17-94bc-5c80d42fb656_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets, net book value</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_65d8e8f2-0069-46aa-af52-911553b0d356_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_2efb7f64-dc56-4b13-b505-7a72c0f07663_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, net, ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_c991520f-e446-4b69-8958-7fec74ed46d0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_MeasurementInputIncreaseInDiscountRateMember_1656f7de-7266-404e-b6c3-ad7d67ab8606_terseLabel_en-US" xlink:label="lab_vtrs_MeasurementInputIncreaseInDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Increase in Discount Rate</link:label>
    <link:label id="lab_vtrs_MeasurementInputIncreaseInDiscountRateMember_label_en-US" xlink:label="lab_vtrs_MeasurementInputIncreaseInDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Increase in Discount Rate [Member]</link:label>
    <link:label id="lab_vtrs_MeasurementInputIncreaseInDiscountRateMember_documentation_en-US" xlink:label="lab_vtrs_MeasurementInputIncreaseInDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Increase in Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_MeasurementInputIncreaseInDiscountRateMember" xlink:href="vtrs-20211231.xsd#vtrs_MeasurementInputIncreaseInDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_MeasurementInputIncreaseInDiscountRateMember" xlink:to="lab_vtrs_MeasurementInputIncreaseInDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_0d4f7c49-44ef-49ce-84f3-6e83167cfe92_verboseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. rate differentials</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_e5f0eed4-fcb0-4c5e-801f-2de1e1cb1991_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in carrying amount of goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_019b84e9-debb-4bb4-b969-e77df524094c_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario, Unspecified [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ThreeFullFiscalQuartersFollowingQualifyingAcquisitionMember_1b100724-f5b3-4d5a-8718-e896fa7543cd_terseLabel_en-US" xlink:label="lab_vtrs_ThreeFullFiscalQuartersFollowingQualifyingAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Full Fiscal Quarters Following Qualifying Acquisition</link:label>
    <link:label id="lab_vtrs_ThreeFullFiscalQuartersFollowingQualifyingAcquisitionMember_label_en-US" xlink:label="lab_vtrs_ThreeFullFiscalQuartersFollowingQualifyingAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Full Fiscal Quarters Following Qualifying Acquisition [Member]</link:label>
    <link:label id="lab_vtrs_ThreeFullFiscalQuartersFollowingQualifyingAcquisitionMember_documentation_en-US" xlink:label="lab_vtrs_ThreeFullFiscalQuartersFollowingQualifyingAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Full Fiscal Quarters Following Qualifying Acquisition [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ThreeFullFiscalQuartersFollowingQualifyingAcquisitionMember" xlink:href="vtrs-20211231.xsd#vtrs_ThreeFullFiscalQuartersFollowingQualifyingAcquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ThreeFullFiscalQuartersFollowingQualifyingAcquisitionMember" xlink:to="lab_vtrs_ThreeFullFiscalQuartersFollowingQualifyingAcquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_42c18155-d61a-4da1-a4bf-c5c7b3171ca6_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_0b47e9fb-d371-4772-8f65-e666b98b009a_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_8744464c-e2c0-44c3-a502-a5210edb32a1_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Pension Plan Items</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_97b2fefd-dc21-407c-9e19-163bddf5158c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined contribution plan, maximum annual contribution per employee, percent</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:to="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fbaef3fc-8afd-4609-a9a5-d80267229ea7_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_65b2c1c0-8a1c-43c6-92fd-2c7e796272a8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_73db17fa-32d2-4ddc-a562-c7130a9db8ac_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average remaining contractual term for options vested and expected to vest, in years</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_XalabrandsMember_af6ec305-752e-4a88-92c3-91edc3c64bbd_terseLabel_en-US" xlink:label="lab_vtrs_XalabrandsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Xalabrands</link:label>
    <link:label id="lab_vtrs_XalabrandsMember_label_en-US" xlink:label="lab_vtrs_XalabrandsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Xalabrands [Member]</link:label>
    <link:label id="lab_vtrs_XalabrandsMember_documentation_en-US" xlink:label="lab_vtrs_XalabrandsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Xalabrands</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_XalabrandsMember" xlink:href="vtrs-20211231.xsd#vtrs_XalabrandsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_XalabrandsMember" xlink:to="lab_vtrs_XalabrandsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AustralianTaxationOfficeMember_46f10757-2321-4841-b547-9c6019a3d383_terseLabel_en-US" xlink:label="lab_us-gaap_AustralianTaxationOfficeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Australian Taxation Office</link:label>
    <link:label id="lab_us-gaap_AustralianTaxationOfficeMember_label_en-US" xlink:label="lab_us-gaap_AustralianTaxationOfficeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Australian Taxation Office [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AustralianTaxationOfficeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AustralianTaxationOfficeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AustralianTaxationOfficeMember" xlink:to="lab_us-gaap_AustralianTaxationOfficeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_51f9447c-cd15-4ad1-af4f-fa1878b04208_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax benefit</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_a69c2fd6-fdce-4988-8a29-ed09f8c0cc82_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_5f0f2ecf-3a12-4a5b-9a62-f8eba778fdf8_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionAxis_6061b99e-50fe-4beb-be9a-4527d354e528_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionAxis" xlink:to="lab_us-gaap_AssetAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_41a5d8d1-461a-4df2-8709-3166f673fb82_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other noncurrent liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_NumberOfDrugs_9309d795-e695-4c95-83bf-5c1d658ffbaf_terseLabel_en-US" xlink:label="lab_vtrs_NumberOfDrugs" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of drugs</link:label>
    <link:label id="lab_vtrs_NumberOfDrugs_label_en-US" xlink:label="lab_vtrs_NumberOfDrugs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of drugs</link:label>
    <link:label id="lab_vtrs_NumberOfDrugs_documentation_en-US" xlink:label="lab_vtrs_NumberOfDrugs" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of drugs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NumberOfDrugs" xlink:href="vtrs-20211231.xsd#vtrs_NumberOfDrugs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_NumberOfDrugs" xlink:to="lab_vtrs_NumberOfDrugs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_3f252901-2c6b-4c97-8409-9e5ad24b6d07_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_645b6315-836c-415b-b0b4-5a3300378df3_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Common Share Policy</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_RestructuringReserveAcquiredDuringPeriod_ef62f14d-f23b-42d7-bce6-77756305eddb_terseLabel_en-US" xlink:label="lab_vtrs_RestructuringReserveAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Acquired During Period</link:label>
    <link:label id="lab_vtrs_RestructuringReserveAcquiredDuringPeriod_label_en-US" xlink:label="lab_vtrs_RestructuringReserveAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Acquired During Period</link:label>
    <link:label id="lab_vtrs_RestructuringReserveAcquiredDuringPeriod_documentation_en-US" xlink:label="lab_vtrs_RestructuringReserveAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RestructuringReserveAcquiredDuringPeriod" xlink:href="vtrs-20211231.xsd#vtrs_RestructuringReserveAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_RestructuringReserveAcquiredDuringPeriod" xlink:to="lab_vtrs_RestructuringReserveAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_TOBIMember_419714ed-23d7-424c-b9ab-455466de2c54_terseLabel_en-US" xlink:label="lab_vtrs_TOBIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOBI</link:label>
    <link:label id="lab_vtrs_TOBIMember_label_en-US" xlink:label="lab_vtrs_TOBIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOBI [Member]</link:label>
    <link:label id="lab_vtrs_TOBIMember_documentation_en-US" xlink:label="lab_vtrs_TOBIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOBI [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_TOBIMember" xlink:href="vtrs-20211231.xsd#vtrs_TOBIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_TOBIMember" xlink:to="lab_vtrs_TOBIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_77c06fc4-2f26-4fbf-a2fe-d192ee2dc932_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_2bfb1263-904a-47ba-8ceb-bf0089ae253a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_2a51c415-1e4b-4b37-909c-bfbcd4c01aca_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use asset</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_4196dfb5-41ce-4411-a30a-47f6bb7356d7_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_47059107-c8b2-48e3-bfca-0bb710e23926_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesNetCurrentAbstract_dcaf66de-0d46-44ea-ad15-e03c26cf388b_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Net, Current [Abstract]</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Net, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesNetCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesNetCurrentAbstract" xlink:to="lab_us-gaap_ReceivablesNetCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_b8a0fd98-b5b8-40f0-a9cd-d3ba54b3f658_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_434dbd7d-5b05-428a-862b-f75b7f84105f_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets, accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_cff680db-a3d4-4f4e-8039-72110332e2e5_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_EUCommissionProceedingsPerindorprilMember_5d21297f-7576-42ce-ac62-ff5d133525a8_terseLabel_en-US" xlink:label="lab_vtrs_EUCommissionProceedingsPerindorprilMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EU Commission Proceedings Perindorpril</link:label>
    <link:label id="lab_vtrs_EUCommissionProceedingsPerindorprilMember_label_en-US" xlink:label="lab_vtrs_EUCommissionProceedingsPerindorprilMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EU Commission Proceedings Perindorpril [Member]</link:label>
    <link:label id="lab_vtrs_EUCommissionProceedingsPerindorprilMember_documentation_en-US" xlink:label="lab_vtrs_EUCommissionProceedingsPerindorprilMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EU Commission Proceedings Perindorpril</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EUCommissionProceedingsPerindorprilMember" xlink:href="vtrs-20211231.xsd#vtrs_EUCommissionProceedingsPerindorprilMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_EUCommissionProceedingsPerindorprilMember" xlink:to="lab_vtrs_EUCommissionProceedingsPerindorprilMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_42a86405-d3a4-4bab-a4ec-6f250b3328a4_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum Repayments on Outstanding Borrowings</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_1b1922ed-064a-4b54-aa10-1a628c827ffb_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember_ec2be012-3c3c-43ab-8247-2631fdd34586_terseLabel_en-US" xlink:label="lab_vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Stock Incentive Plan and 2003 Long-Term Incentive Plan</link:label>
    <link:label id="lab_vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember_label_en-US" xlink:label="lab_vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Stock Incentive Plan and 2003 Long-Term Incentive Plan [Member]</link:label>
    <link:label id="lab_vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember_documentation_en-US" xlink:label="lab_vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Stock Incentive Plan and 2003 Long-Term Incentive Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember" xlink:href="vtrs-20211231.xsd#vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember" xlink:to="lab_vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember_97fd52d0-a71b-4637-9e47-0db0ab99a117_verboseLabel_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2023 3.125%</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember_label_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SeniorNotesTwoThousandTwentyThree3.125Percent [Member]</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember_documentation_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes two thousand twenty three - 3.125 percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember" xlink:href="vtrs-20211231.xsd#vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember" xlink:to="lab_vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_8d0cfad6-14c1-4506-8561-944a62c4b9d2_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_630777c6-b5b3-4fb3-82d9-6131d0c15510_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_a6aff8bd-5d50-4b7e-95f9-957b91cbaf85_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_678154fe-bb16-4da8-b0b1-477595fa8e94_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_fd6d79b0-8145-4ad9-8bc9-8549c2e5c156_totalLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_e532c8e7-af99-48b1-8865-510609e1f1ea_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1_21091942-2831-40e8-9f6f-0b59753bad3d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit plan, ultimate health care cost trend rate, projected</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Ultimate Health Care Cost Trend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1" xlink:to="lab_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_6c037e11-a69a-4de6-a53d-1ae87a9f6174_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_23d127fe-c540-4422-93fa-cb8fe2d9a247_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_46ed9fe2-0221-4cfd-a09f-8c75bddfd717_verboseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-process research and development</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_e8be304b-8059-487d-a744-9e6e326936c8_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandTwentyOne3.15PrecentMember_ddb06e87-2f8b-419d-83cf-34adb8e01530_terseLabel_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandTwentyOne3.15PrecentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Senior Notes (3.150%)</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandTwentyOne3.15PrecentMember_label_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandTwentyOne3.15PrecentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SeniorNotesTwoThousandTwentyOne3.15Precent [Member]</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandTwentyOne3.15PrecentMember_documentation_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandTwentyOne3.15PrecentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Senior Notes 3.15%</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandTwentyOne3.15PrecentMember" xlink:href="vtrs-20211231.xsd#vtrs_SeniorNotesTwoThousandTwentyOne3.15PrecentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_SeniorNotesTwoThousandTwentyOne3.15PrecentMember" xlink:to="lab_vtrs_SeniorNotesTwoThousandTwentyOne3.15PrecentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_5ba40184-9fce-4364-96fc-a198e2d42ddd_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_30b47f46-bb4c-4de8-8d06-406b79f62598_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ViagraMember_6eaafa44-f037-4ed8-9f95-a845fedb780f_terseLabel_en-US" xlink:label="lab_vtrs_ViagraMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Viagra &#174;</link:label>
    <link:label id="lab_vtrs_ViagraMember_label_en-US" xlink:label="lab_vtrs_ViagraMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Viagra &#174; [Member]</link:label>
    <link:label id="lab_vtrs_ViagraMember_documentation_en-US" xlink:label="lab_vtrs_ViagraMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Viagra &#174;</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ViagraMember" xlink:href="vtrs-20211231.xsd#vtrs_ViagraMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ViagraMember" xlink:to="lab_vtrs_ViagraMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOnFutureCashFlowsAmount_85e5c866-fcc3-4f52-b319-4be62e048a71_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOnFutureCashFlowsAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect on Future Cash Flows, Amount</link:label>
    <link:label id="lab_us-gaap_EffectOnFutureCashFlowsAmount_label_en-US" xlink:label="lab_us-gaap_EffectOnFutureCashFlowsAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect on Future Cash Flows, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOnFutureCashFlowsAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOnFutureCashFlowsAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOnFutureCashFlowsAmount" xlink:to="lab_us-gaap_EffectOnFutureCashFlowsAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditConcentrationRiskMember_4dc609fe-2833-44b4-a8c6-5f40d3b2a061_terseLabel_en-US" xlink:label="lab_us-gaap_CreditConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CreditConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CreditConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditConcentrationRiskMember" xlink:to="lab_us-gaap_CreditConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_DefinedBenefitPensionPlanswithProjectedBenefitObligationInExcessofPlanAssetsAggregateProjectedBenefitObligation_6325e178-7512-40ab-991b-e228dfcd2c6b_terseLabel_en-US" xlink:label="lab_vtrs_DefinedBenefitPensionPlanswithProjectedBenefitObligationInExcessofPlanAssetsAggregateProjectedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated benefit obligation</link:label>
    <link:label id="lab_vtrs_DefinedBenefitPensionPlanswithProjectedBenefitObligationInExcessofPlanAssetsAggregateProjectedBenefitObligation_label_en-US" xlink:label="lab_vtrs_DefinedBenefitPensionPlanswithProjectedBenefitObligationInExcessofPlanAssetsAggregateProjectedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Pension Plans with Projected Benefit Obligation In Excess of Plan Assets Aggregate Projected Benefit Obligation</link:label>
    <link:label id="lab_vtrs_DefinedBenefitPensionPlanswithProjectedBenefitObligationInExcessofPlanAssetsAggregateProjectedBenefitObligation_documentation_en-US" xlink:label="lab_vtrs_DefinedBenefitPensionPlanswithProjectedBenefitObligationInExcessofPlanAssetsAggregateProjectedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Pension Plans with Projected Benefit Obligation In Excess of Plan Assets Aggregate Projected Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DefinedBenefitPensionPlanswithProjectedBenefitObligationInExcessofPlanAssetsAggregateProjectedBenefitObligation" xlink:href="vtrs-20211231.xsd#vtrs_DefinedBenefitPensionPlanswithProjectedBenefitObligationInExcessofPlanAssetsAggregateProjectedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_DefinedBenefitPensionPlanswithProjectedBenefitObligationInExcessofPlanAssetsAggregateProjectedBenefitObligation" xlink:to="lab_vtrs_DefinedBenefitPensionPlanswithProjectedBenefitObligationInExcessofPlanAssetsAggregateProjectedBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ba1153be-5a18-4b0e-9e03-803df684e8e0_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_VestingPeriodAxis_4c67432b-092e-44ba-a9f2-0fde9cab94d4_terseLabel_en-US" xlink:label="lab_vtrs_VestingPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting Period [Axis]</link:label>
    <link:label id="lab_vtrs_VestingPeriodAxis_label_en-US" xlink:label="lab_vtrs_VestingPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting Period [Axis]</link:label>
    <link:label id="lab_vtrs_VestingPeriodAxis_documentation_en-US" xlink:label="lab_vtrs_VestingPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VestingPeriodAxis" xlink:href="vtrs-20211231.xsd#vtrs_VestingPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_VestingPeriodAxis" xlink:to="lab_vtrs_VestingPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_bb67fad9-69c1-4db5-92f6-cef6a676c482_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Major Customers, by Reporting Segments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Major Customers, by Reporting Segments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:to="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_4034d649-3240-43a0-9bb9-43db05fca211_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueDomain" xlink:to="lab_us-gaap_ValuationTechniqueDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfFinancingCosts_c3b0a8e1-4625-49fe-b4ae-04baa45b4235_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfFinancingCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of financing fees</link:label>
    <link:label id="lab_us-gaap_PaymentsOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Financing Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfFinancingCosts" xlink:to="lab_us-gaap_PaymentsOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits_4dcfa548-d613-444e-b66d-4bc5f52564a0_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee benefits</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_CleanEnergyPartnershipsMember_196e5d07-8c90-4b4a-8ad0-a46b4e6137a7_terseLabel_en-US" xlink:label="lab_vtrs_CleanEnergyPartnershipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clean energy investments</link:label>
    <link:label id="lab_vtrs_CleanEnergyPartnershipsMember_label_en-US" xlink:label="lab_vtrs_CleanEnergyPartnershipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clean Energy Partnerships [Member]</link:label>
    <link:label id="lab_vtrs_CleanEnergyPartnershipsMember_documentation_en-US" xlink:label="lab_vtrs_CleanEnergyPartnershipsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clean Energy Partnerships</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CleanEnergyPartnershipsMember" xlink:href="vtrs-20211231.xsd#vtrs_CleanEnergyPartnershipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_CleanEnergyPartnershipsMember" xlink:to="lab_vtrs_CleanEnergyPartnershipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_136178fe-c4a2-4884-9446-cc6e3fed84c1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingMember_4e947447-8124-4b64-abcf-37d7a26ebd4a_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building</link:label>
    <link:label id="lab_us-gaap_BuildingMember_label_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingMember" xlink:to="lab_us-gaap_BuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_TwentyTwentyOneLoanFacilitiesMember_c5300a34-0e0b-4732-964d-880aceb0ac3e_terseLabel_en-US" xlink:label="lab_vtrs_TwentyTwentyOneLoanFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Twenty Twenty One Loan Facilities</link:label>
    <link:label id="lab_vtrs_TwentyTwentyOneLoanFacilitiesMember_label_en-US" xlink:label="lab_vtrs_TwentyTwentyOneLoanFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Twenty Twenty One Loan Facilities [Member]</link:label>
    <link:label id="lab_vtrs_TwentyTwentyOneLoanFacilitiesMember_documentation_en-US" xlink:label="lab_vtrs_TwentyTwentyOneLoanFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Twenty Twenty One Loan Facilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_TwentyTwentyOneLoanFacilitiesMember" xlink:href="vtrs-20211231.xsd#vtrs_TwentyTwentyOneLoanFacilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_TwentyTwentyOneLoanFacilitiesMember" xlink:to="lab_vtrs_TwentyTwentyOneLoanFacilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_EpiPenAutoInjectorsMember_a8949e6b-2d6e-433a-a4b0-0d5edb05fed4_terseLabel_en-US" xlink:label="lab_vtrs_EpiPenAutoInjectorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EpiPen&#174; Auto-Injectors</link:label>
    <link:label id="lab_vtrs_EpiPenAutoInjectorsMember_label_en-US" xlink:label="lab_vtrs_EpiPenAutoInjectorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EpiPen&#174; Auto-Injectors [Member]</link:label>
    <link:label id="lab_vtrs_EpiPenAutoInjectorsMember_documentation_en-US" xlink:label="lab_vtrs_EpiPenAutoInjectorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EpiPen&#174; Auto-Injectors</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EpiPenAutoInjectorsMember" xlink:href="vtrs-20211231.xsd#vtrs_EpiPenAutoInjectorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_EpiPenAutoInjectorsMember" xlink:to="lab_vtrs_EpiPenAutoInjectorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_39c94c43-68e3-4613-a427-df8be82ca4b0_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Other than Temporary Impairment</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Other than Temporary Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:to="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_AccretionExpenseToBeRecognizedWithinTheNextTwelveMonths_524e7c48-9093-4a9f-a2dc-2fe5f1cf272c_terseLabel_en-US" xlink:label="lab_vtrs_AccretionExpenseToBeRecognizedWithinTheNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion expense expected within 12 months</link:label>
    <link:label id="lab_vtrs_AccretionExpenseToBeRecognizedWithinTheNextTwelveMonths_label_en-US" xlink:label="lab_vtrs_AccretionExpenseToBeRecognizedWithinTheNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion Expense to be Recognized within the Next Twelve Months</link:label>
    <link:label id="lab_vtrs_AccretionExpenseToBeRecognizedWithinTheNextTwelveMonths_documentation_en-US" xlink:label="lab_vtrs_AccretionExpenseToBeRecognizedWithinTheNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion Expense to be Recognized within the Next Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccretionExpenseToBeRecognizedWithinTheNextTwelveMonths" xlink:href="vtrs-20211231.xsd#vtrs_AccretionExpenseToBeRecognizedWithinTheNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_AccretionExpenseToBeRecognizedWithinTheNextTwelveMonths" xlink:to="lab_vtrs_AccretionExpenseToBeRecognizedWithinTheNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_5752824e-92cc-4bde-b1bb-e09302b6299e_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant-date fair value per share, granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_c7439bf5-0ad4-4fcc-9c97-558e02a371b1_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_DefinedBenefitPlanForeignCurrencyTranslationImpactonPlanAssets_3e16e698-129b-42f1-ba11-0eef0182c8ef_terseLabel_en-US" xlink:label="lab_vtrs_DefinedBenefitPlanForeignCurrencyTranslationImpactonPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of foreign currency translation</link:label>
    <link:label id="lab_vtrs_DefinedBenefitPlanForeignCurrencyTranslationImpactonPlanAssets_label_en-US" xlink:label="lab_vtrs_DefinedBenefitPlanForeignCurrencyTranslationImpactonPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Foreign Currency Translation Impact on Plan Assets</link:label>
    <link:label id="lab_vtrs_DefinedBenefitPlanForeignCurrencyTranslationImpactonPlanAssets_documentation_en-US" xlink:label="lab_vtrs_DefinedBenefitPlanForeignCurrencyTranslationImpactonPlanAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Foreign Currency Translation Impact on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DefinedBenefitPlanForeignCurrencyTranslationImpactonPlanAssets" xlink:href="vtrs-20211231.xsd#vtrs_DefinedBenefitPlanForeignCurrencyTranslationImpactonPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_DefinedBenefitPlanForeignCurrencyTranslationImpactonPlanAssets" xlink:to="lab_vtrs_DefinedBenefitPlanForeignCurrencyTranslationImpactonPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_682af43e-bc3f-4640-937f-2a99eee8701b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_91d9b62c-dd5b-479b-9f49-14522b8c7d96_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent liabilities</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_e643624e-7089-4026-a94b-016f193c4bb3_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments Not Designated as Hedging Instruments:</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:to="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_f0c1b27a-17f8-4b4f-aeab-aece9238466e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_3a71724a-df2d-4521-8970-4423347fbb0c_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_BusinessCombinationContractualReimbursementAmountTrancheOne_56afd03b-95e3-4e78-a533-49a81155905c_terseLabel_en-US" xlink:label="lab_vtrs_BusinessCombinationContractualReimbursementAmountTrancheOne" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reimbursement amount, tranche one</link:label>
    <link:label id="lab_vtrs_BusinessCombinationContractualReimbursementAmountTrancheOne_label_en-US" xlink:label="lab_vtrs_BusinessCombinationContractualReimbursementAmountTrancheOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contractual Reimbursement Amount, Tranche One</link:label>
    <link:label id="lab_vtrs_BusinessCombinationContractualReimbursementAmountTrancheOne_documentation_en-US" xlink:label="lab_vtrs_BusinessCombinationContractualReimbursementAmountTrancheOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contractual Reimbursement Amount, Tranche One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationContractualReimbursementAmountTrancheOne" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationContractualReimbursementAmountTrancheOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_BusinessCombinationContractualReimbursementAmountTrancheOne" xlink:to="lab_vtrs_BusinessCombinationContractualReimbursementAmountTrancheOne" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_22316816-b465-4f74-b51d-33519a538733_terseLabel_en-US" xlink:label="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_label_en-US" xlink:label="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill</link:label>
    <link:label id="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_documentation_en-US" xlink:label="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" xlink:to="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_b4e2c388-336e-42b7-8da6-cd3d83300a85_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_992e5bf5-0894-4928-9348-6c5bc374916d_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_6d54449f-cdc7-4d9d-b718-c19f63a4df72_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated impairment losses, beginning balance</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_64985beb-3945-47d9-b986-7f6ed07b1fd6_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated impairment losses, ending balance</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_c56e368c-53e4-4d46-bf8e-52ce15c98222_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price per share, vested and expected to vest at period end</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCovenantDescription_5a8d84e5-19bc-4450-8a5c-f09e2357271f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCovenantDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Description</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCovenantDescription_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCovenantDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Description</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCovenantDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCovenantDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCovenantDescription" xlink:to="lab_us-gaap_DebtInstrumentCovenantDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_4b0ce744-a19e-4bac-b016-293b8389948c_terseLabel_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reconciling</link:label>
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_label_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reconciling Items [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaterialReconcilingItemsMember" xlink:to="lab_us-gaap_MaterialReconcilingItemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1cf9ce12-c520-4fe7-a4c7-e097257da2d8_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of restricted stock awards, granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_MaximumLeverageRatioPeriodOne_c31c6d1d-b1ba-462d-b2b9-bea6a061f8d3_terseLabel_en-US" xlink:label="lab_vtrs_MaximumLeverageRatioPeriodOne" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Leverage Ratio, Period One</link:label>
    <link:label id="lab_vtrs_MaximumLeverageRatioPeriodOne_label_en-US" xlink:label="lab_vtrs_MaximumLeverageRatioPeriodOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Leverage Ratio, Period One</link:label>
    <link:label id="lab_vtrs_MaximumLeverageRatioPeriodOne_documentation_en-US" xlink:label="lab_vtrs_MaximumLeverageRatioPeriodOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Leverage Ratio, Period One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_MaximumLeverageRatioPeriodOne" xlink:href="vtrs-20211231.xsd#vtrs_MaximumLeverageRatioPeriodOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_MaximumLeverageRatioPeriodOne" xlink:to="lab_vtrs_MaximumLeverageRatioPeriodOne" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_AnticompetitiveConductWithRespectToAdditionalGenericDrugsMember_ad503a4c-f8ab-40ef-b594-0881ed755b38_terseLabel_en-US" xlink:label="lab_vtrs_AnticompetitiveConductWithRespectToAdditionalGenericDrugsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anticompetitive conduct with respect to additional generic drugs</link:label>
    <link:label id="lab_vtrs_AnticompetitiveConductWithRespectToAdditionalGenericDrugsMember_label_en-US" xlink:label="lab_vtrs_AnticompetitiveConductWithRespectToAdditionalGenericDrugsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anticompetitive conduct with respect to additional generic drugs [Member]</link:label>
    <link:label id="lab_vtrs_AnticompetitiveConductWithRespectToAdditionalGenericDrugsMember_documentation_en-US" xlink:label="lab_vtrs_AnticompetitiveConductWithRespectToAdditionalGenericDrugsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anticompetitive conduct with respect to additional generic drugs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AnticompetitiveConductWithRespectToAdditionalGenericDrugsMember" xlink:href="vtrs-20211231.xsd#vtrs_AnticompetitiveConductWithRespectToAdditionalGenericDrugsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_AnticompetitiveConductWithRespectToAdditionalGenericDrugsMember" xlink:to="lab_vtrs_AnticompetitiveConductWithRespectToAdditionalGenericDrugsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_ae2607c8-173d-45ac-81a3-b768b256756d_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_f7df0d1c-b463-44b2-b434-88de5a091230_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk, percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_3ce5fcd9-36f8-4926-90ce-af884403efce_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Policy</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain_25c289bf-f509-40c0-a744-385b6720450d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits, Individual Contracts, Type of Deferred Compensation [Domain]</link:label>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain_label_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits, Individual Contracts, Type of Deferred Compensation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain" xlink:to="lab_us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ImpairmentofEquityMethodInvestments_39077aa3-86c3-40f8-9a88-929bbdc84533_terseLabel_en-US" xlink:label="lab_vtrs_ImpairmentofEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Equity Method Investments</link:label>
    <link:label id="lab_vtrs_ImpairmentofEquityMethodInvestments_label_en-US" xlink:label="lab_vtrs_ImpairmentofEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Equity Method Investments</link:label>
    <link:label id="lab_vtrs_ImpairmentofEquityMethodInvestments_documentation_en-US" xlink:label="lab_vtrs_ImpairmentofEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ImpairmentofEquityMethodInvestments" xlink:href="vtrs-20211231.xsd#vtrs_ImpairmentofEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ImpairmentofEquityMethodInvestments" xlink:to="lab_vtrs_ImpairmentofEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_87cfd5e7-6f68-459f-89b4-a638d30462b4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3dfe6c40-592f-424f-8d28-63ad6330182b_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares under stock awards, outstanding at beginning of period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_69bf752c-2004-4074-a827-8033b4e37faa_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares under stock awards, outstanding at end of period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_4035675e-8b01-4e70-909d-00d516bf82a3_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_06d476d4-2b01-4109-ab57-0dc9cfe86634_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_1d14a76a-f1b2-4d55-8082-cbaca33f796f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of operating leases not yet commenced</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:to="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation_41346f8f-9287-411b-94bc-8af994bc1fcf_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in the benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Effect of One Percentage Point Increase on Accumulated Postretirement Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_DefinedBenefitPlanContributionsByPlanParticipantsBenefitObligation_e4bdde13-2ded-4ea2-b449-334c00d3c7e7_terseLabel_en-US" xlink:label="lab_vtrs_DefinedBenefitPlanContributionsByPlanParticipantsBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participant contributions</link:label>
    <link:label id="lab_vtrs_DefinedBenefitPlanContributionsByPlanParticipantsBenefitObligation_label_en-US" xlink:label="lab_vtrs_DefinedBenefitPlanContributionsByPlanParticipantsBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DefinedBenefitPlanContributionsByPlanParticipantsBenefitObligation</link:label>
    <link:label id="lab_vtrs_DefinedBenefitPlanContributionsByPlanParticipantsBenefitObligation_documentation_en-US" xlink:label="lab_vtrs_DefinedBenefitPlanContributionsByPlanParticipantsBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Contributions By Plan Participants Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DefinedBenefitPlanContributionsByPlanParticipantsBenefitObligation" xlink:href="vtrs-20211231.xsd#vtrs_DefinedBenefitPlanContributionsByPlanParticipantsBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_DefinedBenefitPlanContributionsByPlanParticipantsBenefitObligation" xlink:to="lab_vtrs_DefinedBenefitPlanContributionsByPlanParticipantsBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_f0a43e29-7b3c-44c9-a49d-c47ff4f58456_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series of Individually Immaterial Business Acquisitions</link:label>
    <link:label id="lab_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_label_en-US" xlink:label="lab_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series of Individually Immaterial Business Acquisitions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:to="lab_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity_8c9c1f60-8c95-415e-9854-957a72d143ad_terseLabel_en-US" xlink:label="lab_vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable securitization facility maximum borrowing capacity</link:label>
    <link:label id="lab_vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable Facility Maximum Borrowing Capacity</link:label>
    <link:label id="lab_vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity_documentation_en-US" xlink:label="lab_vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable facility maximum borrowing capacity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity" xlink:href="vtrs-20211231.xsd#vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity" xlink:to="lab_vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_IncreasedDiscountRateDomain_c8d20518-2759-458a-8857-c862a0046bf2_terseLabel_en-US" xlink:label="lab_vtrs_IncreasedDiscountRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increased Discount Rate [Domain]</link:label>
    <link:label id="lab_vtrs_IncreasedDiscountRateDomain_label_en-US" xlink:label="lab_vtrs_IncreasedDiscountRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increased Discount Rate [Domain]</link:label>
    <link:label id="lab_vtrs_IncreasedDiscountRateDomain_documentation_en-US" xlink:label="lab_vtrs_IncreasedDiscountRateDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increased Discount Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_IncreasedDiscountRateDomain" xlink:href="vtrs-20211231.xsd#vtrs_IncreasedDiscountRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_IncreasedDiscountRateDomain" xlink:to="lab_vtrs_IncreasedDiscountRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_257356ab-3468-4960-935c-fcc36b7bf347_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rate used to discount net cash inflows to present values</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMember_923991e8-b484-489b-9a09-bb59ebff0b12_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMember" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_4bb774c8-36c1-4164-9762-3859433609b8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net assets acquired (net of $415.8 of cash acquired)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_DeferredTaxAssetsDeferredtaxexpenseinterestexpense_bb16dbfb-898f-44e3-9b75-e7cea86ab284_terseLabel_en-US" xlink:label="lab_vtrs_DeferredTaxAssetsDeferredtaxexpenseinterestexpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_vtrs_DeferredTaxAssetsDeferredtaxexpenseinterestexpense_label_en-US" xlink:label="lab_vtrs_DeferredTaxAssetsDeferredtaxexpenseinterestexpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Deferred tax expense, interest expense</link:label>
    <link:label id="lab_vtrs_DeferredTaxAssetsDeferredtaxexpenseinterestexpense_documentation_en-US" xlink:label="lab_vtrs_DeferredTaxAssetsDeferredtaxexpenseinterestexpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from interest expense.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DeferredTaxAssetsDeferredtaxexpenseinterestexpense" xlink:href="vtrs-20211231.xsd#vtrs_DeferredTaxAssetsDeferredtaxexpenseinterestexpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_DeferredTaxAssetsDeferredtaxexpenseinterestexpense" xlink:to="lab_vtrs_DeferredTaxAssetsDeferredtaxexpenseinterestexpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_602adb82-5f2a-47fa-a78d-02f73a8df6e4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_a8b3f1f0-504f-4589-a895-5fb4f4c2056b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Information</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_b0ffa066-c06f-43c3-85e3-3eaed32ba0b7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b7520c99-a7b0-4d6a-ac57-61f9a0ce6771_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_2e256bb6-022d-4bf0-82c7-2378eb8af730_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized actuarial (gain) loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d347108f-c1e2-4fee-8305-d49c32eb4732_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_39c3159b-bd41-4ced-b720-a1f677d90b55_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other noncurrent liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock_b70df425-c731-445e-a16c-6de3c2f1a1fd_terseLabel_en-US" xlink:label="lab_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status of Plan</link:label>
    <link:label id="lab_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status of Plan [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" xlink:to="lab_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_f0522669-3490-433f-a52e-402d75f38ec3_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent" xlink:to="lab_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_EffectiveIncomeTaxRateReconciliationIndiaAmagulation_35a54d81-bc7f-4072-90ff-dedf927f3cd3_terseLabel_en-US" xlink:label="lab_vtrs_EffectiveIncomeTaxRateReconciliationIndiaAmagulation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax settlements and resolution of certain tax positions</link:label>
    <link:label id="lab_vtrs_EffectiveIncomeTaxRateReconciliationIndiaAmagulation_label_en-US" xlink:label="lab_vtrs_EffectiveIncomeTaxRateReconciliationIndiaAmagulation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, India Amagulation</link:label>
    <link:label id="lab_vtrs_EffectiveIncomeTaxRateReconciliationIndiaAmagulation_documentation_en-US" xlink:label="lab_vtrs_EffectiveIncomeTaxRateReconciliationIndiaAmagulation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, India Amagulation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EffectiveIncomeTaxRateReconciliationIndiaAmagulation" xlink:href="vtrs-20211231.xsd#vtrs_EffectiveIncomeTaxRateReconciliationIndiaAmagulation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_EffectiveIncomeTaxRateReconciliationIndiaAmagulation" xlink:to="lab_vtrs_EffectiveIncomeTaxRateReconciliationIndiaAmagulation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax_d9f56517-a6e7-4e75-89f0-e26b63268880_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) earnings, before tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax_db45d630-125f-40ad-9212-a74796d31b55_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) earnings, before tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_IndefiniteMember_2aed0da7-2238-4313-a73c-69eb19d2d67f_terseLabel_en-US" xlink:label="lab_vtrs_IndefiniteMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite</link:label>
    <link:label id="lab_vtrs_IndefiniteMember_label_en-US" xlink:label="lab_vtrs_IndefiniteMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite [Member]</link:label>
    <link:label id="lab_vtrs_IndefiniteMember_documentation_en-US" xlink:label="lab_vtrs_IndefiniteMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite amount of time</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_IndefiniteMember" xlink:href="vtrs-20211231.xsd#vtrs_IndefiniteMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_IndefiniteMember" xlink:to="lab_vtrs_IndefiniteMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_8ec2fb7d-d341-4b15-9e9b-1afb97716cd6_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_LossContingencyRemainingClaimsNumber_e20ece74-c6c2-497d-8123-a817e3c2b004_terseLabel_en-US" xlink:label="lab_vtrs_LossContingencyRemainingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Remaining Claims, Number</link:label>
    <link:label id="lab_vtrs_LossContingencyRemainingClaimsNumber_label_en-US" xlink:label="lab_vtrs_LossContingencyRemainingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Remaining Claims, Number</link:label>
    <link:label id="lab_vtrs_LossContingencyRemainingClaimsNumber_documentation_en-US" xlink:label="lab_vtrs_LossContingencyRemainingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Remaining Claims, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_LossContingencyRemainingClaimsNumber" xlink:href="vtrs-20211231.xsd#vtrs_LossContingencyRemainingClaimsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_LossContingencyRemainingClaimsNumber" xlink:to="lab_vtrs_LossContingencyRemainingClaimsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_ce6769cb-845b-48b0-8f0e-6ae6c44bb822_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2014ProgramMember_f81120ac-f489-40ca-b85b-bdea4ed57d4c_terseLabel_en-US" xlink:label="lab_vtrs_A2014ProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2014 Program</link:label>
    <link:label id="lab_vtrs_A2014ProgramMember_label_en-US" xlink:label="lab_vtrs_A2014ProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2014 Program [Member]</link:label>
    <link:label id="lab_vtrs_A2014ProgramMember_documentation_en-US" xlink:label="lab_vtrs_A2014ProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2014 Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2014ProgramMember" xlink:href="vtrs-20211231.xsd#vtrs_A2014ProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2014ProgramMember" xlink:to="lab_vtrs_A2014ProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForCreditLossMember_63b49be8-a8db-48b1-911c-1d6dbafde17a_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForCreditLossMember_label_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Credit Loss [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForCreditLossMember" xlink:to="lab_us-gaap_AllowanceForCreditLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_e5d6f8db-a7be-409d-9e53-3833090df7eb_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationExpectedLongtermReturnonAssets_f40e8710-2878-4891-ac7d-53a31ea18a39_terseLabel_en-US" xlink:label="lab_vtrs_DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationExpectedLongtermReturnonAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_vtrs_DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationExpectedLongtermReturnonAssets_label_en-US" xlink:label="lab_vtrs_DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationExpectedLongtermReturnonAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Projected Benefit Obligation, Expected Long-term Return on Assets</link:label>
    <link:label id="lab_vtrs_DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationExpectedLongtermReturnonAssets_documentation_en-US" xlink:label="lab_vtrs_DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationExpectedLongtermReturnonAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Expected Long-term Return on Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationExpectedLongtermReturnonAssets" xlink:href="vtrs-20211231.xsd#vtrs_DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationExpectedLongtermReturnonAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationExpectedLongtermReturnonAssets" xlink:to="lab_vtrs_DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationExpectedLongtermReturnonAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_5a80e79d-c340-4ad7-9855-31ef1b81e0c6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_9d662539-2f02-4d05-b14a-269a031b0e12_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent" xlink:to="lab_us-gaap_PrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_d1c3a146-2e18-4fcb-9560-f41e9a8b20ab_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_ccb2d351-4a28-442a-a16d-74475321556c_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_68a118f7-efe5-4efe-b9e0-27abbc603d46_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total employer contributions</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount_451507bb-0e94-4d88-95b4-c49bd2dcae7f_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit, Amount of Fair Value in Excess of Carrying Amount</link:label>
    <link:label id="lab_us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount_label_en-US" xlink:label="lab_us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit, Amount of Fair Value in Excess of Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount" xlink:to="lab_us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_979262f8-63e9-496b-915a-90b5dc3ea6ef_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_7246499d-a558-4461-82d7-4595398edc0b_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_ad186dfe-ad1e-4274-9488-b71fe02968ca_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credit and loss carry-forwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_3e47a8b9-8746-473f-8edb-72622e8614d7_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of common stock shares authorized</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_92b438cd-277e-44be-9e7c-5f9c1ed8ee68_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in short-term borrowings, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_Numberofcases_45cf36c8-7e8f-401a-85ce-6e3aa0e643b7_terseLabel_en-US" xlink:label="lab_vtrs_Numberofcases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of cases</link:label>
    <link:label id="lab_vtrs_Numberofcases_label_en-US" xlink:label="lab_vtrs_Numberofcases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of cases</link:label>
    <link:label id="lab_vtrs_Numberofcases_documentation_en-US" xlink:label="lab_vtrs_Numberofcases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of cases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Numberofcases" xlink:href="vtrs-20211231.xsd#vtrs_Numberofcases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_Numberofcases" xlink:to="lab_vtrs_Numberofcases" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_JapanAustraliaAndNewZealandSegmentMember_068f074e-aaab-428b-8fb4-a2eda5ef144f_terseLabel_en-US" xlink:label="lab_vtrs_JapanAustraliaAndNewZealandSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">JANZ</link:label>
    <link:label id="lab_vtrs_JapanAustraliaAndNewZealandSegmentMember_label_en-US" xlink:label="lab_vtrs_JapanAustraliaAndNewZealandSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Japan, Australia and New Zealand Segment [Member]</link:label>
    <link:label id="lab_vtrs_JapanAustraliaAndNewZealandSegmentMember_documentation_en-US" xlink:label="lab_vtrs_JapanAustraliaAndNewZealandSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Japan, Australia and New Zealand Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember" xlink:href="vtrs-20211231.xsd#vtrs_JapanAustraliaAndNewZealandSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember" xlink:to="lab_vtrs_JapanAustraliaAndNewZealandSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_e144e9ec-d6a5-4dce-a9af-a6aa89c34113_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Policy</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_TheravanceBiopharmaMember_d932b2e7-d47b-4abc-bfcc-5aa2606cb6da_terseLabel_en-US" xlink:label="lab_vtrs_TheravanceBiopharmaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Theravance</link:label>
    <link:label id="lab_vtrs_TheravanceBiopharmaMember_label_en-US" xlink:label="lab_vtrs_TheravanceBiopharmaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Theravance Biopharma [Member]</link:label>
    <link:label id="lab_vtrs_TheravanceBiopharmaMember_documentation_en-US" xlink:label="lab_vtrs_TheravanceBiopharmaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Theravance Biopharma</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_TheravanceBiopharmaMember" xlink:href="vtrs-20211231.xsd#vtrs_TheravanceBiopharmaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_TheravanceBiopharmaMember" xlink:to="lab_vtrs_TheravanceBiopharmaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_9ee20a62-afe9-404b-8537-1318fcd566f9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition purchase price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_e00229cb-e313-4530-b5da-04499fcb3a67_totalLabel_en-US" xlink:label="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax provision (benefit), U.S. Federal</link:label>
    <link:label id="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_label_en-US" xlink:label="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Income Tax Expense (Benefit), Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:to="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ScheduleofothercurrentliabilitiesTable_01acbe53-18e0-49ae-aa0e-dbce59b91690_terseLabel_en-US" xlink:label="lab_vtrs_ScheduleofothercurrentliabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of other current liabilities [Table]</link:label>
    <link:label id="lab_vtrs_ScheduleofothercurrentliabilitiesTable_label_en-US" xlink:label="lab_vtrs_ScheduleofothercurrentliabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of other current liabilities [Table]</link:label>
    <link:label id="lab_vtrs_ScheduleofothercurrentliabilitiesTable_documentation_en-US" xlink:label="lab_vtrs_ScheduleofothercurrentliabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of other current liabilities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofothercurrentliabilitiesTable" xlink:href="vtrs-20211231.xsd#vtrs_ScheduleofothercurrentliabilitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesTable" xlink:to="lab_vtrs_ScheduleofothercurrentliabilitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_VoluntaryRecallofValsartanandCertainCombinationsValsartanMedicinesMember_ad4f5640-b97c-42c5-ba2f-3d8765eed70a_terseLabel_en-US" xlink:label="lab_vtrs_VoluntaryRecallofValsartanandCertainCombinationsValsartanMedicinesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voluntary Recall of Valsartan and Certain Combinations Valsartan Medicines [Member]</link:label>
    <link:label id="lab_vtrs_VoluntaryRecallofValsartanandCertainCombinationsValsartanMedicinesMember_label_en-US" xlink:label="lab_vtrs_VoluntaryRecallofValsartanandCertainCombinationsValsartanMedicinesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voluntary Recall of Valsartan and Certain Combinations Valsartan Medicines [Member]</link:label>
    <link:label id="lab_vtrs_VoluntaryRecallofValsartanandCertainCombinationsValsartanMedicinesMember_documentation_en-US" xlink:label="lab_vtrs_VoluntaryRecallofValsartanandCertainCombinationsValsartanMedicinesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voluntary Recall of Valsartan and Certain Combinations Valsartan Medicines [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VoluntaryRecallofValsartanandCertainCombinationsValsartanMedicinesMember" xlink:href="vtrs-20211231.xsd#vtrs_VoluntaryRecallofValsartanandCertainCombinationsValsartanMedicinesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_VoluntaryRecallofValsartanandCertainCombinationsValsartanMedicinesMember" xlink:to="lab_vtrs_VoluntaryRecallofValsartanandCertainCombinationsValsartanMedicinesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_ddf83103-d442-45eb-bd17-d0d18c0492fd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_ab5167d8-5fde-4261-9981-08bee776b0cd_totalLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentLiabilities_53dfb374-710f-4236-85c5-7ad0541daab7_terseLabel_en-US" xlink:label="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other noncurrent liabilities</link:label>
    <link:label id="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentLiabilities_label_en-US" xlink:label="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Noncurrent Liabilities</link:label>
    <link:label id="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentLiabilities_documentation_en-US" xlink:label="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Noncurrent Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentLiabilities" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentLiabilities" xlink:to="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_3771eb6d-b7a6-4bfb-9db6-6c257bdcc621_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets at recurring fair value measurement</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2020RevolvingFacilityMember_72f5ea7b-1a0d-488b-9eb9-6bc8892fbf4b_terseLabel_en-US" xlink:label="lab_vtrs_A2020RevolvingFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Revolving Facility</link:label>
    <link:label id="lab_vtrs_A2020RevolvingFacilityMember_label_en-US" xlink:label="lab_vtrs_A2020RevolvingFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Revolving Facility [Member]</link:label>
    <link:label id="lab_vtrs_A2020RevolvingFacilityMember_documentation_en-US" xlink:label="lab_vtrs_A2020RevolvingFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Revolving Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2020RevolvingFacilityMember" xlink:href="vtrs-20211231.xsd#vtrs_A2020RevolvingFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2020RevolvingFacilityMember" xlink:to="lab_vtrs_A2020RevolvingFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_f72f6fcf-0b37-4e96-87e9-e3bc62b71d86_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_4633b6af-eea6-448d-a2ff-10c4fb56e1d2_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_4a7e3804-fa48-41bf-a6e2-dd9c40b950a0_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_b0cf914c-f76a-49f6-863a-d1b31d836857_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_AmeriSourceBergenCorporationMember_59d75c4d-1b92-4cab-9587-b5c5d673a02f_terseLabel_en-US" xlink:label="lab_vtrs_AmeriSourceBergenCorporationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AmeriSourceBergen Corporation</link:label>
    <link:label id="lab_vtrs_AmeriSourceBergenCorporationMember_label_en-US" xlink:label="lab_vtrs_AmeriSourceBergenCorporationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AmeriSourceBergen Corporation [Member]</link:label>
    <link:label id="lab_vtrs_AmeriSourceBergenCorporationMember_documentation_en-US" xlink:label="lab_vtrs_AmeriSourceBergenCorporationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AmeriSourceBergen Corporation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AmeriSourceBergenCorporationMember" xlink:href="vtrs-20211231.xsd#vtrs_AmeriSourceBergenCorporationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_AmeriSourceBergenCorporationMember" xlink:to="lab_vtrs_AmeriSourceBergenCorporationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_d3b62f33-447f-48f2-bc2a-161ba6408278_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrecognized loss on derivatives in cash flow hedging relationships, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_b8604ddd-81c6-4e8d-aed1-608de164434d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_bb212b10-2174-4b34-a522-c00e106f3485_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized (loss) gain on marketable securities</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_411e7811-34e8-4317-8175-2367afee6c91_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price per share, exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCash_35e42df1-28b1-4dc0-808c-3313415e97bc_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCash_label_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCash" xlink:to="lab_us-gaap_RestrictedCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_fcae606b-be7b-4f6e-a5e5-7a533da8c152_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_260be779-53f4-47d3-94fd-000a5f74de60_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosures of cash flow information &#8212;</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_GenericBiologicCompoundsCollaborationMember_a77b784c-caee-4bac-b5f0-f7af8e153aa1_terseLabel_en-US" xlink:label="lab_vtrs_GenericBiologicCompoundsCollaborationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Generic Biologic Compounds Collaboration [Member]</link:label>
    <link:label id="lab_vtrs_GenericBiologicCompoundsCollaborationMember_label_en-US" xlink:label="lab_vtrs_GenericBiologicCompoundsCollaborationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Generic Biologic Compounds Collaboration [Member]</link:label>
    <link:label id="lab_vtrs_GenericBiologicCompoundsCollaborationMember_documentation_en-US" xlink:label="lab_vtrs_GenericBiologicCompoundsCollaborationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Generic Biologic Compounds Collaboration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GenericBiologicCompoundsCollaborationMember" xlink:href="vtrs-20211231.xsd#vtrs_GenericBiologicCompoundsCollaborationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_GenericBiologicCompoundsCollaborationMember" xlink:to="lab_vtrs_GenericBiologicCompoundsCollaborationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2022SeniorNotesMember_a549fd6b-f97f-419b-973a-a1a483545288_terseLabel_en-US" xlink:label="lab_vtrs_A2022SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Senior Notes</link:label>
    <link:label id="lab_vtrs_A2022SeniorNotesMember_label_en-US" xlink:label="lab_vtrs_A2022SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Senior Notes [Member]</link:label>
    <link:label id="lab_vtrs_A2022SeniorNotesMember_documentation_en-US" xlink:label="lab_vtrs_A2022SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2022SeniorNotesMember" xlink:href="vtrs-20211231.xsd#vtrs_A2022SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2022SeniorNotesMember" xlink:to="lab_vtrs_A2022SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2025EuroSeniorNotesMember_63348b61-99bd-49b3-9199-4642931d8566_terseLabel_en-US" xlink:label="lab_vtrs_A2025EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 Euro Senior Notes</link:label>
    <link:label id="lab_vtrs_A2025EuroSeniorNotesMember_label_en-US" xlink:label="lab_vtrs_A2025EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 Euro Senior Notes [Member]</link:label>
    <link:label id="lab_vtrs_A2025EuroSeniorNotesMember_documentation_en-US" xlink:label="lab_vtrs_A2025EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 Euro Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2025EuroSeniorNotesMember" xlink:href="vtrs-20211231.xsd#vtrs_A2025EuroSeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2025EuroSeniorNotesMember" xlink:to="lab_vtrs_A2025EuroSeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_9313c142-93f0-4b35-848d-bbe2fd4a2105_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_ca68e75d-a210-481e-a403-590c39c85844_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange derivative assets</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contract, Asset, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:to="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_AccountsReceivableSalesProvisionsCurrent_48536762-fa9b-4013-ba83-057d5dd72f07_terseLabel_en-US" xlink:label="lab_vtrs_AccountsReceivableSalesProvisionsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Provision Related to Sales Made in the Current Period</link:label>
    <link:label id="lab_vtrs_AccountsReceivableSalesProvisionsCurrent_label_en-US" xlink:label="lab_vtrs_AccountsReceivableSalesProvisionsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Sales Provisions, Current</link:label>
    <link:label id="lab_vtrs_AccountsReceivableSalesProvisionsCurrent_documentation_en-US" xlink:label="lab_vtrs_AccountsReceivableSalesProvisionsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Sales Provisions, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccountsReceivableSalesProvisionsCurrent" xlink:href="vtrs-20211231.xsd#vtrs_AccountsReceivableSalesProvisionsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_AccountsReceivableSalesProvisionsCurrent" xlink:to="lab_vtrs_AccountsReceivableSalesProvisionsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_0c67a0fa-6421-4622-a5e4-12f5f6c82e2b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Current Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Current Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_014fc73f-370f-46a4-9edc-10c177c21ba7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyTable" xlink:to="lab_us-gaap_IncomeTaxContingencyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_6ae41059-b705-4288-9495-a682be8e7fdb_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain" xlink:to="lab_us-gaap_ShortTermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnServiceAndInterestCostComponents_9fbde796-f12d-428c-9f78-2e5294e84de8_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnServiceAndInterestCostComponents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in the aggregate of service and interest cost components of annual expense</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnServiceAndInterestCostComponents_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnServiceAndInterestCostComponents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Effect of One Percentage Point Increase on Service and Interest Cost Components</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnServiceAndInterestCostComponents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnServiceAndInterestCostComponents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnServiceAndInterestCostComponents" xlink:to="lab_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnServiceAndInterestCostComponents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_0fdd4bf3-92dd-4e3d-8afb-154536386cf1_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_72b731f2-572e-43a5-9596-92db91e6c90f_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_61c85596-255b-43f3-8add-a571e774d4b6_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current [Abstract]</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_f398d1bf-0363-46b2-bd29-bbbf766ac622_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_7694ab32-3f5b-431c-bc4e-da9bcdb66b56_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_1bcdca7e-bb39-4ce3-9ae5-d4017c1c3e32_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating assets and liabilities, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReservePeriodIncreaseDecrease_80fd1da4-5043-48a2-8597-6b3884dff57a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReservePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Period Increase (Decrease)</link:label>
    <link:label id="lab_us-gaap_RestructuringReservePeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_RestructuringReservePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReservePeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReservePeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReservePeriodIncreaseDecrease" xlink:to="lab_us-gaap_RestructuringReservePeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_NoteSecuritizationFacilityMember_5dcce8fb-db46-487e-9671-f3f41cd634ba_terseLabel_en-US" xlink:label="lab_vtrs_NoteSecuritizationFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note Securitization Facility [Member]</link:label>
    <link:label id="lab_vtrs_NoteSecuritizationFacilityMember_label_en-US" xlink:label="lab_vtrs_NoteSecuritizationFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note Securitization Facility [Member]</link:label>
    <link:label id="lab_vtrs_NoteSecuritizationFacilityMember_documentation_en-US" xlink:label="lab_vtrs_NoteSecuritizationFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note Securitization Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NoteSecuritizationFacilityMember" xlink:href="vtrs-20211231.xsd#vtrs_NoteSecuritizationFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_NoteSecuritizationFacilityMember" xlink:to="lab_vtrs_NoteSecuritizationFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_3ff98bc9-3fc9-4736-a5c8-960424082351_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_3bb18e9b-25e5-4fc1-a53e-8f92d9fc4b04_terseLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross loss</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_45c9e871-dd24-471e-abc3-03610719c073_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_b0b5f5f9-ea23-41a9-90dd-08a7ac22e7a5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_5cb2fe46-3f71-4529-9f1f-f4373907c664_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities at recurring fair value measurement</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_0cda10c4-662f-49bf-ae00-b1848741a104_verboseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_942544df-f54f-4290-9e67-b3f5042d7c02_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_Netrealizablevalueofinventoryrecognizedasexpense_4c2e3001-c4e6-41b6-80ad-8a504057c9ab_terseLabel_en-US" xlink:label="lab_vtrs_Netrealizablevalueofinventoryrecognizedasexpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net realizable value of inventory recognized as expense</link:label>
    <link:label id="lab_vtrs_Netrealizablevalueofinventoryrecognizedasexpense_label_en-US" xlink:label="lab_vtrs_Netrealizablevalueofinventoryrecognizedasexpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net realizable value of inventory recognized as expense</link:label>
    <link:label id="lab_vtrs_Netrealizablevalueofinventoryrecognizedasexpense_documentation_en-US" xlink:label="lab_vtrs_Netrealizablevalueofinventoryrecognizedasexpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net realizable value of inventory recognized as expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Netrealizablevalueofinventoryrecognizedasexpense" xlink:href="vtrs-20211231.xsd#vtrs_Netrealizablevalueofinventoryrecognizedasexpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_Netrealizablevalueofinventoryrecognizedasexpense" xlink:to="lab_vtrs_Netrealizablevalueofinventoryrecognizedasexpense" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_April2018SeniorNotesMember_eb6b83ba-cfc4-4f3e-8fd2-225887a1fbe5_terseLabel_en-US" xlink:label="lab_vtrs_April2018SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">April 2018 Senior Notes [Member]</link:label>
    <link:label id="lab_vtrs_April2018SeniorNotesMember_label_en-US" xlink:label="lab_vtrs_April2018SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">April 2018 Senior Notes [Member]</link:label>
    <link:label id="lab_vtrs_April2018SeniorNotesMember_documentation_en-US" xlink:label="lab_vtrs_April2018SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">April 2018 Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_April2018SeniorNotesMember" xlink:href="vtrs-20211231.xsd#vtrs_April2018SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_April2018SeniorNotesMember" xlink:to="lab_vtrs_April2018SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_b1f4e051-835b-426b-8221-94b67f5b0988_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrentAbstract_af510a81-4c8b-4410-a358-bfe1d0aa34c3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract" xlink:to="lab_us-gaap_OtherAssetsNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_InfluvacMember_9561b1e5-6e78-4295-8c29-8d97771a6d20_terseLabel_en-US" xlink:label="lab_vtrs_InfluvacMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Influvac &#174;</link:label>
    <link:label id="lab_vtrs_InfluvacMember_label_en-US" xlink:label="lab_vtrs_InfluvacMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Influvac &#174; [Member]</link:label>
    <link:label id="lab_vtrs_InfluvacMember_documentation_en-US" xlink:label="lab_vtrs_InfluvacMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Influvac &#174;</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_InfluvacMember" xlink:href="vtrs-20211231.xsd#vtrs_InfluvacMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_InfluvacMember" xlink:to="lab_vtrs_InfluvacMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_31aa9ee7-649a-4a08-b9fc-9beb78f41912_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Translation and Other Adjustment</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Translation and Other Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveTranslationAndOtherAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:to="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_13ea311b-8556-434d-b9d1-70ada5962714_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive earnings (loss) before reclassifications, before tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_U.S.FederalTaxAuthorityMember_0e39c4be-fdd1-45be-8e2d-2163aaa43725_terseLabel_en-US" xlink:label="lab_vtrs_U.S.FederalTaxAuthorityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Federal Tax Authority</link:label>
    <link:label id="lab_vtrs_U.S.FederalTaxAuthorityMember_label_en-US" xlink:label="lab_vtrs_U.S.FederalTaxAuthorityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Federal Tax Authority [Member]</link:label>
    <link:label id="lab_vtrs_U.S.FederalTaxAuthorityMember_documentation_en-US" xlink:label="lab_vtrs_U.S.FederalTaxAuthorityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Federal Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_U.S.FederalTaxAuthorityMember" xlink:href="vtrs-20211231.xsd#vtrs_U.S.FederalTaxAuthorityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_U.S.FederalTaxAuthorityMember" xlink:to="lab_vtrs_U.S.FederalTaxAuthorityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_fb9e126c-3db5-496d-b39d-29ef9f8242ab_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_c2ebc99e-8c7e-4e88-af22-c92d16f7daf6_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_2bf6e4f6-3552-4d1f-ab11-37f21ce97f9f_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear_725bf1af-c47f-4152-b8e8-38095780aa96_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future unrecognized actuarial losses</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Amortization of Prior Service Cost (Credit), Next Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_AccountsReceivableIncreaseDueToAcquisitionCurrent_1f633ce6-1b1e-4bc7-bb12-cedd070e232e_terseLabel_en-US" xlink:label="lab_vtrs_AccountsReceivableIncreaseDueToAcquisitionCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Period Adjustments and Reclasses</link:label>
    <link:label id="lab_vtrs_AccountsReceivableIncreaseDueToAcquisitionCurrent_label_en-US" xlink:label="lab_vtrs_AccountsReceivableIncreaseDueToAcquisitionCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Increase Due to Acquisition, Current</link:label>
    <link:label id="lab_vtrs_AccountsReceivableIncreaseDueToAcquisitionCurrent_documentation_en-US" xlink:label="lab_vtrs_AccountsReceivableIncreaseDueToAcquisitionCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Increase Due to Acquisition, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccountsReceivableIncreaseDueToAcquisitionCurrent" xlink:href="vtrs-20211231.xsd#vtrs_AccountsReceivableIncreaseDueToAcquisitionCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_AccountsReceivableIncreaseDueToAcquisitionCurrent" xlink:to="lab_vtrs_AccountsReceivableIncreaseDueToAcquisitionCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_e12434e4-5a6d-49dc-864e-0fa1ba9b59ee_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash received (paid) for acquisitions, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_05f86200-a80f-4bf3-8e9a-08eb66f62146_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Adjustment</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_d4e1a69a-2057-4376-9b6d-f1e2202f039f_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherRestructuringMember_c062b089-bf2a-4c9b-979c-4cdb985a40a3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring</link:label>
    <link:label id="lab_us-gaap_OtherRestructuringMember_label_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherRestructuringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherRestructuringMember" xlink:to="lab_us-gaap_OtherRestructuringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_8e6b2f09-b330-4fbb-8fa2-f7fe8f7c5e8f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Provision</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_a1bcc101-c10c-4a3f-b547-774aa05b0029_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScenarioPlanMember_8708b4d3-b565-4098-9de6-58fb3d1c16cc_terseLabel_en-US" xlink:label="lab_us-gaap_ScenarioPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario, Plan</link:label>
    <link:label id="lab_us-gaap_ScenarioPlanMember_label_en-US" xlink:label="lab_us-gaap_ScenarioPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario, Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScenarioPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScenarioPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScenarioPlanMember" xlink:to="lab_us-gaap_ScenarioPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_a2b30706-fc22-4a2c-826a-8a1910f6cbe5_verboseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Incentive Plan</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_e9900cc4-b6b7-47ef-8456-9ef87cdcc53a_verboseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_ae4b4c2b-abe1-4002-bedb-dc93e8d792ef_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_DivestitureOfBusinessDeferredCashConsideration_86552ea5-a968-494c-a33e-18d23472f9a7_terseLabel_en-US" xlink:label="lab_vtrs_DivestitureOfBusinessDeferredCashConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture of Business, Deferred Cash Consideration.</link:label>
    <link:label id="lab_vtrs_DivestitureOfBusinessDeferredCashConsideration_label_en-US" xlink:label="lab_vtrs_DivestitureOfBusinessDeferredCashConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture of Business, Deferred Cash Consideration.</link:label>
    <link:label id="lab_vtrs_DivestitureOfBusinessDeferredCashConsideration_documentation_en-US" xlink:label="lab_vtrs_DivestitureOfBusinessDeferredCashConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture of Business, Deferred Cash Consideration.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DivestitureOfBusinessDeferredCashConsideration" xlink:href="vtrs-20211231.xsd#vtrs_DivestitureOfBusinessDeferredCashConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_DivestitureOfBusinessDeferredCashConsideration" xlink:to="lab_vtrs_DivestitureOfBusinessDeferredCashConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxYear2015Member_bae2f2f0-68cd-41eb-b876-539eeb193e72_terseLabel_en-US" xlink:label="lab_us-gaap_TaxYear2015Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Year 2015</link:label>
    <link:label id="lab_us-gaap_TaxYear2015Member_label_en-US" xlink:label="lab_us-gaap_TaxYear2015Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Year 2015 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxYear2015Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxYear2015Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxYear2015Member" xlink:to="lab_us-gaap_TaxYear2015Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_dce2626b-1333-484a-a72d-44a377587618_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized gain on marketable securities, net of tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_8da5c4f7-0831-4c49-9bc5-8bbfe832731d_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized gains on marketable securities, net of tax, beginning of period</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2bcff5c9-81a9-4273-aa92-88c1ec98fb67_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized gains on marketable securities, net of tax, end of period</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_2b60286c-2907-4793-bdf8-865ab6bfe63b_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock to Mylan N.V. shareholders (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ScheduleofothercurrentliabilitiesLineItems_66afd5c0-887d-4c55-92c0-61437a2567f6_terseLabel_en-US" xlink:label="lab_vtrs_ScheduleofothercurrentliabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of other current liabilities [Line Items]</link:label>
    <link:label id="lab_vtrs_ScheduleofothercurrentliabilitiesLineItems_label_en-US" xlink:label="lab_vtrs_ScheduleofothercurrentliabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of other current liabilities [Line Items]</link:label>
    <link:label id="lab_vtrs_ScheduleofothercurrentliabilitiesLineItems_documentation_en-US" xlink:label="lab_vtrs_ScheduleofothercurrentliabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Schedule of other current liabilities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems" xlink:href="vtrs-20211231.xsd#vtrs_ScheduleofothercurrentliabilitiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems" xlink:to="lab_vtrs_ScheduleofothercurrentliabilitiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_611213e6-ff9b-4d07-9968-6217ac66e087_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNetAbstract_6fecbf57-2aa4-42a0-a9a4-d545b60008f3_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryNetAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNetAbstract" xlink:to="lab_us-gaap_InventoryNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_a324c7e6-d497-480e-91e7-03b6ae04d30e_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_826b03a8-4a6d-4ce8-afd7-70846085db45_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits</link:label>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:to="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_484b156b-bd24-4b5f-9761-a1504acc8ff0_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsNoncurrent_c1127b4f-0d93-46f8-98a4-1a8614343f78_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent assets</link:label>
    <link:label id="lab_us-gaap_AssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_AssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrent" xlink:to="lab_us-gaap_AssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractualRightsMember_9537e7fb-a368-441c-9535-224e57e82904_terseLabel_en-US" xlink:label="lab_us-gaap_ContractualRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Rights</link:label>
    <link:label id="lab_us-gaap_ContractualRightsMember_label_en-US" xlink:label="lab_us-gaap_ContractualRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractualRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualRightsMember" xlink:to="lab_us-gaap_ContractualRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2430cd05-6e92-4a7d-9a77-42d65f1ed7f2_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_91b48718-fffd-46b8-969d-f240dfd48886_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5c104855-3f45-4a9c-b377-2d6af9d96131_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss, net of tax, beginning of period</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_fa242d8d-f73b-45f9-a4ea-e8cda0274c6b_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss, net of tax, end of period</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_5eb72427-6e43-4e91-b82b-82f229dc7c66_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplyCommitmentArrangementMember_961d67d9-110f-42c4-bcb7-fdac62302914_terseLabel_en-US" xlink:label="lab_us-gaap_SupplyCommitmentArrangementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supply Commitment Arrangement [Domain]</link:label>
    <link:label id="lab_us-gaap_SupplyCommitmentArrangementMember_label_en-US" xlink:label="lab_us-gaap_SupplyCommitmentArrangementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supply Commitment Arrangement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplyCommitmentArrangementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplyCommitmentArrangementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplyCommitmentArrangementMember" xlink:to="lab_us-gaap_SupplyCommitmentArrangementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MediumTermNotesMember_e043c24b-6087-47d6-9657-f70c56a98f08_terseLabel_en-US" xlink:label="lab_us-gaap_MediumTermNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medium-term Notes</link:label>
    <link:label id="lab_us-gaap_MediumTermNotesMember_label_en-US" xlink:label="lab_us-gaap_MediumTermNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medium-term Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MediumTermNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MediumTermNotesMember" xlink:to="lab_us-gaap_MediumTermNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_094513dd-7670-4a62-9ece-45d3bfb50981_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of foreign currency translation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_fc1d6975-f5cc-4c03-b0ec-dc8bec09c168_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongTermDebt_90d9918c-06b5-4396-973f-c9117da9c4ce_terseLabel_en-US" xlink:label="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Long-Term Debt</link:label>
    <link:label id="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongTermDebt_label_en-US" xlink:label="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Long-Term Debt</link:label>
    <link:label id="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongTermDebt_documentation_en-US" xlink:label="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongTermDebt" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongTermDebt" xlink:to="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_9a9e43af-0f50-42c4-a583-553d5d3d2a9e_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_e435c543-d69e-4108-9cce-44cc48391c25_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted_f101093a-3cdf-4c7d-a871-dafa6bf6c055_terseLabel_en-US" xlink:label="lab_us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted_label_en-US" xlink:label="lab_us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro Forma Weighted Average Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted" xlink:to="lab_us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_6df6625d-1278-48b5-95e5-7fa7a4e69a26_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_befb97a7-0fb4-4db0-9c87-ad2c48bd0b3a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments in Net Investment Hedging Relationships:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_b000af82-709f-44d9-9763-938a2a253f88_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents Policy</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_9f8e6683-8b06-4ba7-a533-6ae948eed9d3_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_34a7e9a6-9e4c-4d17-85c1-e6e0dd24d252_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rate of compensation increase</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock_4c8a53a1-08bb-41f3-a905-1908a4c71c9c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) Pretax Amounts Not Yet Reclassified in Net Periodic Benefit Cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Periodic Benefit Cost Not yet Recognized [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisGainLossIncludedInEarnings_1154d525-725d-459e-80da-5c39eeaf4f10_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value loss (gain)</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring Basis, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_76a34f2e-14ca-46e9-9b30-8c5261d429e3_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities, Major Types of Debt and Equity Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtLineItems_ac45043b-4925-4b8b-8c3c-5e82602e6157_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtLineItems_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtLineItems" xlink:to="lab_us-gaap_ShortTermDebtLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_f80f63aa-d46e-4f9c-aa52-9d97e458abda_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ScheduleofOtherAssetsLineItems_634d07e1-19f1-488b-957e-c07762733c09_terseLabel_en-US" xlink:label="lab_vtrs_ScheduleofOtherAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets [Line Items]</link:label>
    <link:label id="lab_vtrs_ScheduleofOtherAssetsLineItems_label_en-US" xlink:label="lab_vtrs_ScheduleofOtherAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets [Line Items]</link:label>
    <link:label id="lab_vtrs_ScheduleofOtherAssetsLineItems_documentation_en-US" xlink:label="lab_vtrs_ScheduleofOtherAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Schedule of Other Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofOtherAssetsLineItems" xlink:href="vtrs-20211231.xsd#vtrs_ScheduleofOtherAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ScheduleofOtherAssetsLineItems" xlink:to="lab_vtrs_ScheduleofOtherAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_f34859c6-09c1-4d5b-85aa-2cb8d62703f3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueNotFromContractWithCustomer_74ecad26-1302-47f2-ac36-7061c380c0a2_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueNotFromContractWithCustomer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other revenues</link:label>
    <link:label id="lab_us-gaap_RevenueNotFromContractWithCustomer_label_en-US" xlink:label="lab_us-gaap_RevenueNotFromContractWithCustomer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Not from Contract with Customer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueNotFromContractWithCustomer" xlink:to="lab_us-gaap_RevenueNotFromContractWithCustomer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_0dee8aae-ae2a-4676-a4cb-e01d4cc044c3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign_2995370f-cff1-43d6-a44f-b659a4f965d1_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Foreign Operations</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_065745e9-9e13-4bb4-a739-103eb194ecaf_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_8fd4a469-278f-498e-8de2-42a60573a4d1_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_SalesMilestonePayments_039606d6-0ce8-4b2d-840f-5e0fff0b3c27_terseLabel_en-US" xlink:label="lab_vtrs_SalesMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Milestone Payments</link:label>
    <link:label id="lab_vtrs_SalesMilestonePayments_label_en-US" xlink:label="lab_vtrs_SalesMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Milestone Payments</link:label>
    <link:label id="lab_vtrs_SalesMilestonePayments_documentation_en-US" xlink:label="lab_vtrs_SalesMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Milestone Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SalesMilestonePayments" xlink:href="vtrs-20211231.xsd#vtrs_SalesMilestonePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_SalesMilestonePayments" xlink:to="lab_vtrs_SalesMilestonePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_9d6a763b-ee02-4d7d-b2fb-7fd9e9bcdc75_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings before income taxes and noncontrolling interest, foreign</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_77999a19-914b-4724-b4ab-b57563057133_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Loss) earnings from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_2535bf90-391b-41d4-9ddb-cda7e6b9aef7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment profitability</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandEighteen3.0PercentMember_d86da5c5-81dd-4b56-a518-fb11d48b5208_verboseLabel_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandEighteen3.0PercentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Senior Notes (3.000% coupon)</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandEighteen3.0PercentMember_label_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandEighteen3.0PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Two Thousand Eighteen - 3.0 Percent [Member]</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandEighteen3.0PercentMember_documentation_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandEighteen3.0PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Two Thousand Eighteen - 3.0 Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandEighteen3.0PercentMember" xlink:href="vtrs-20211231.xsd#vtrs_SeniorNotesTwoThousandEighteen3.0PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_SeniorNotesTwoThousandEighteen3.0PercentMember" xlink:to="lab_vtrs_SeniorNotesTwoThousandEighteen3.0PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet_504136cc-c556-4d7e-a7d2-fff193f77048_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of Gain Excluded from the Assessment of Hedge Effectiveness</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_79c4cc2e-e0c9-4d2c-afee-a67849985816_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_b75cf783-fd1e-47e9-b12b-3b06ed8eda62_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_7c68bfe9-b805-4ab4-8a63-365201e22750_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative and Licensing Agreements</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c447126d-23f0-40ce-a696-c025cb91581f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_MeasurementInputReductionInTerminalYearRevenueGrowthRateMember_4fd4c35e-4613-4cd3-97f8-a4a776781182_terseLabel_en-US" xlink:label="lab_vtrs_MeasurementInputReductionInTerminalYearRevenueGrowthRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Reduction in Terminal Year Revenue Growth Rate</link:label>
    <link:label id="lab_vtrs_MeasurementInputReductionInTerminalYearRevenueGrowthRateMember_label_en-US" xlink:label="lab_vtrs_MeasurementInputReductionInTerminalYearRevenueGrowthRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Reduction in Terminal Year Revenue Growth Rate [Member]</link:label>
    <link:label id="lab_vtrs_MeasurementInputReductionInTerminalYearRevenueGrowthRateMember_documentation_en-US" xlink:label="lab_vtrs_MeasurementInputReductionInTerminalYearRevenueGrowthRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Reduction in Terminal Year Revenue Growth Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_MeasurementInputReductionInTerminalYearRevenueGrowthRateMember" xlink:href="vtrs-20211231.xsd#vtrs_MeasurementInputReductionInTerminalYearRevenueGrowthRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_MeasurementInputReductionInTerminalYearRevenueGrowthRateMember" xlink:to="lab_vtrs_MeasurementInputReductionInTerminalYearRevenueGrowthRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_4acf4c75-1e4c-4372-95d3-5777527b3f54_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_a754115b-68bc-437d-9ca3-5abb7dd410d5_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_7b5cc386-a824-4ae0-9879-17ebe2e0a4b2_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment, beginning of period</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_d732af80-4f62-459f-9dbe-54805418e5ab_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment, end of period</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_ac1ff9a9-196a-47d2-97b5-3f557ddfa9ed_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_eddda171-6d8b-4b14-8f8d-a0eb383b0a53_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_9dfcd437-fe17-4e4f-b4d9-de10d403c6ec_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_85fbb990-1630-4b06-9f7c-e067ae7a8008_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_84939a30-8cfe-432c-8db7-7be7f12f446d_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_OtherforeignMember_e2a53900-2008-430f-9f9b-34c3be9276b7_terseLabel_en-US" xlink:label="lab_vtrs_OtherforeignMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other foreign</link:label>
    <link:label id="lab_vtrs_OtherforeignMember_label_en-US" xlink:label="lab_vtrs_OtherforeignMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other foreign [Member]</link:label>
    <link:label id="lab_vtrs_OtherforeignMember_documentation_en-US" xlink:label="lab_vtrs_OtherforeignMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other foreign [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherforeignMember" xlink:href="vtrs-20211231.xsd#vtrs_OtherforeignMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_OtherforeignMember" xlink:to="lab_vtrs_OtherforeignMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember_555b135f-8920-43b4-bed2-6c8cf827d3ae_terseLabel_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2046 Senior Notes (5.250%)</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember_label_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SeniorNotesTwoThousandFortySix5.25Precent [Member]</link:label>
    <link:label id="lab_vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember_documentation_en-US" xlink:label="lab_vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2046 Senior Note (5.250%)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember" xlink:href="vtrs-20211231.xsd#vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember" xlink:to="lab_vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_05deb1df-542e-47eb-a0e1-a9837197f5c6_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_7a685e6e-9639-4bb1-b3a3-237afb288cae_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arrangements and Non-arrangement Transactions [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_DimethylFumarateMember_916fd914-60dd-4abd-8fd3-30d7f7cbe247_terseLabel_en-US" xlink:label="lab_vtrs_DimethylFumarateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dimethyl Fumarate</link:label>
    <link:label id="lab_vtrs_DimethylFumarateMember_label_en-US" xlink:label="lab_vtrs_DimethylFumarateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dimethyl Fumarate [Member]</link:label>
    <link:label id="lab_vtrs_DimethylFumarateMember_documentation_en-US" xlink:label="lab_vtrs_DimethylFumarateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dimethyl Fumarate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DimethylFumarateMember" xlink:href="vtrs-20211231.xsd#vtrs_DimethylFumarateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_DimethylFumarateMember" xlink:to="lab_vtrs_DimethylFumarateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_cd6be667-7cc7-4ec0-b1c5-fcc4d04431fd_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_MckessonCorporationMember_ef8c9c1e-89d2-4220-bf1a-8dee10b47367_terseLabel_en-US" xlink:label="lab_vtrs_MckessonCorporationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">McKesson Corporation</link:label>
    <link:label id="lab_vtrs_MckessonCorporationMember_label_en-US" xlink:label="lab_vtrs_MckessonCorporationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">McKesson Corporation [Member]</link:label>
    <link:label id="lab_vtrs_MckessonCorporationMember_documentation_en-US" xlink:label="lab_vtrs_MckessonCorporationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">McKesson Corporation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_MckessonCorporationMember" xlink:href="vtrs-20211231.xsd#vtrs_MckessonCorporationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_MckessonCorporationMember" xlink:to="lab_vtrs_MckessonCorporationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_5235ce3b-8f1f-4c4a-8172-a9994596dbe1_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_IncomeTaxExaminationReserveImpactOnIncomeTaxProvision_b5b4400d-6d5f-4f9e-9aee-6b81fc88017a_terseLabel_en-US" xlink:label="lab_vtrs_IncomeTaxExaminationReserveImpactOnIncomeTaxProvision" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Reserve Impact On Income Tax Provision</link:label>
    <link:label id="lab_vtrs_IncomeTaxExaminationReserveImpactOnIncomeTaxProvision_label_en-US" xlink:label="lab_vtrs_IncomeTaxExaminationReserveImpactOnIncomeTaxProvision" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Reserve Impact On Income Tax Provision</link:label>
    <link:label id="lab_vtrs_IncomeTaxExaminationReserveImpactOnIncomeTaxProvision_documentation_en-US" xlink:label="lab_vtrs_IncomeTaxExaminationReserveImpactOnIncomeTaxProvision" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Reserve Impact On Income Tax Provision</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_IncomeTaxExaminationReserveImpactOnIncomeTaxProvision" xlink:href="vtrs-20211231.xsd#vtrs_IncomeTaxExaminationReserveImpactOnIncomeTaxProvision"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_IncomeTaxExaminationReserveImpactOnIncomeTaxProvision" xlink:to="lab_vtrs_IncomeTaxExaminationReserveImpactOnIncomeTaxProvision" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_706b3805-d8dc-4836-b4f8-ba469b94e088_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCurtailments_5814ef3d-0851-42f1-b773-9c44eda45337_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCurtailments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan curtailment, settlement and termination</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCurtailments_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCurtailments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Curtailment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCurtailments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanCurtailments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanCurtailments" xlink:to="lab_us-gaap_DefinedBenefitPlanCurtailments" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_UnregisteredUpjohnUSDollarNotesMember_7a509c60-801e-4246-aa19-e8d2ac312825_terseLabel_en-US" xlink:label="lab_vtrs_UnregisteredUpjohnUSDollarNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unregistered Upjohn U.S. Dollar Notes</link:label>
    <link:label id="lab_vtrs_UnregisteredUpjohnUSDollarNotesMember_label_en-US" xlink:label="lab_vtrs_UnregisteredUpjohnUSDollarNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unregistered Upjohn U.S. Dollar Notes [Member]</link:label>
    <link:label id="lab_vtrs_UnregisteredUpjohnUSDollarNotesMember_documentation_en-US" xlink:label="lab_vtrs_UnregisteredUpjohnUSDollarNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unregistered Upjohn U.S. Dollar Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_UnregisteredUpjohnUSDollarNotesMember" xlink:href="vtrs-20211231.xsd#vtrs_UnregisteredUpjohnUSDollarNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_UnregisteredUpjohnUSDollarNotesMember" xlink:to="lab_vtrs_UnregisteredUpjohnUSDollarNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_fdf49907-7f2d-468e-8e8b-3fe2244655d5_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_e9784ec2-4984-41bd-9746-608fe5eec6e1_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_3f9d6118-059b-495f-8613-a46379964afb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_707e8a4f-9e99-4e89-94cb-24ea8ba23c3b_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueAxis" xlink:to="lab_us-gaap_ValuationTechniqueAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_dce5b6c9-41ad-40de-85ac-0fe19573de0b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_9d8fcfa5-99dc-4fb9-8f14-1b586c3ca4d3_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_BusinessCombinationsNumberOfAgreements_c7927656-fae0-4379-853c-7a136dd7ce39_terseLabel_en-US" xlink:label="lab_vtrs_BusinessCombinationsNumberOfAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations, Number of Agreements</link:label>
    <link:label id="lab_vtrs_BusinessCombinationsNumberOfAgreements_label_en-US" xlink:label="lab_vtrs_BusinessCombinationsNumberOfAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations, Number of Agreements</link:label>
    <link:label id="lab_vtrs_BusinessCombinationsNumberOfAgreements_documentation_en-US" xlink:label="lab_vtrs_BusinessCombinationsNumberOfAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations, Number of Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationsNumberOfAgreements" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationsNumberOfAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_BusinessCombinationsNumberOfAgreements" xlink:to="lab_vtrs_BusinessCombinationsNumberOfAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesRentExpenseNet_4922c834-7e51-44f5-acc8-3a3385f753b3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesRentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesRentExpenseNet_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesRentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Rent Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesRentExpenseNet" xlink:to="lab_us-gaap_OperatingLeasesRentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_0955b177-14cd-4d93-ae0e-0e84d304a564_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_6272d25c-030f-4a50-a11f-e505b2ffcb00_terseLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetAbstract_48946898-4dd8-42bf-8bad-e6859ff9255c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0c06f3d7-2c51-4af3-9f72-c2f588efbeb2_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_61d2a801-f0d8-4487-8f57-4862676ac00e_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price per share, granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_5ec7cd84-e3d1-4846-afcb-e298e90a337a_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value for options outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_GoodwillImpairmentTestMeasurementInputIncrease_8267da14-4d02-4064-a80c-db40f87c9924_terseLabel_en-US" xlink:label="lab_vtrs_GoodwillImpairmentTestMeasurementInputIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Impairment Test, Measurement Input, Increase</link:label>
    <link:label id="lab_vtrs_GoodwillImpairmentTestMeasurementInputIncrease_label_en-US" xlink:label="lab_vtrs_GoodwillImpairmentTestMeasurementInputIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Impairment Test, Measurement Input, Increase</link:label>
    <link:label id="lab_vtrs_GoodwillImpairmentTestMeasurementInputIncrease_documentation_en-US" xlink:label="lab_vtrs_GoodwillImpairmentTestMeasurementInputIncrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Impairment Test, Measurement Input, Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GoodwillImpairmentTestMeasurementInputIncrease" xlink:href="vtrs-20211231.xsd#vtrs_GoodwillImpairmentTestMeasurementInputIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_GoodwillImpairmentTestMeasurementInputIncrease" xlink:to="lab_vtrs_GoodwillImpairmentTestMeasurementInputIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ScheduleofActivityinContingentConsiderationRollForward_a4b8d857-a1fb-44d1-8317-b2b4094b6926_terseLabel_en-US" xlink:label="lab_vtrs_ScheduleofActivityinContingentConsiderationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Activity in Contingent Consideration [Roll Forward]</link:label>
    <link:label id="lab_vtrs_ScheduleofActivityinContingentConsiderationRollForward_label_en-US" xlink:label="lab_vtrs_ScheduleofActivityinContingentConsiderationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Activity in Contingent Consideration [Roll Forward]</link:label>
    <link:label id="lab_vtrs_ScheduleofActivityinContingentConsiderationRollForward_documentation_en-US" xlink:label="lab_vtrs_ScheduleofActivityinContingentConsiderationRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Activity in Contingent Consideration [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofActivityinContingentConsiderationRollForward" xlink:href="vtrs-20211231.xsd#vtrs_ScheduleofActivityinContingentConsiderationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ScheduleofActivityinContingentConsiderationRollForward" xlink:to="lab_vtrs_ScheduleofActivityinContingentConsiderationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_cb483bed-0c26-4095-a6e2-e84d6df5a904_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_0f3d04f8-820a-4311-837c-62c510dde055_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_CreonMember_9bf20ec7-3426-48b6-bd52-bf66313e6395_terseLabel_en-US" xlink:label="lab_vtrs_CreonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Creon &#174;</link:label>
    <link:label id="lab_vtrs_CreonMember_label_en-US" xlink:label="lab_vtrs_CreonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Creon &#174; [Member]</link:label>
    <link:label id="lab_vtrs_CreonMember_documentation_en-US" xlink:label="lab_vtrs_CreonMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Creon &#174;</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CreonMember" xlink:href="vtrs-20211231.xsd#vtrs_CreonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_CreonMember" xlink:to="lab_vtrs_CreonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_98ee23e1-d31e-4972-b6bc-e603c3808df3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_8bce6071-b2a4-4fb1-b615-5b636737b355_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_19b5c59b-5935-4e5e-bfb0-809e8588f8f5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in unrecognized loss and prior service cost related to defined benefit plans</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_08e58a97-4113-43f1-a4c3-d3fc3bf93e8b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_79f5aa1f-a0d2-46ff-a6ea-edd592903117_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_3cfdc0da-7acc-44d0-9c11-17769ec8b355_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assumptions Used</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_b189795e-73fc-4287-92d0-8b667777cc54_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_8ba7fc1d-8b15-476a-9dd8-780f8a186642_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Expected Benefit Payments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Expected Benefit Payments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_CurrentPortionofLongTermDebtMember_62108e25-81e8-400f-a593-bb6af6058de3_terseLabel_en-US" xlink:label="lab_vtrs_CurrentPortionofLongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_vtrs_CurrentPortionofLongTermDebtMember_label_en-US" xlink:label="lab_vtrs_CurrentPortionofLongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Portion of Long-Term Debt [Member]</link:label>
    <link:label id="lab_vtrs_CurrentPortionofLongTermDebtMember_documentation_en-US" xlink:label="lab_vtrs_CurrentPortionofLongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US"></link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CurrentPortionofLongTermDebtMember" xlink:href="vtrs-20211231.xsd#vtrs_CurrentPortionofLongTermDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_CurrentPortionofLongTermDebtMember" xlink:to="lab_vtrs_CurrentPortionofLongTermDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_e1969c2c-3f60-44c4-802d-bed58123e3c2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_0719562a-cf5b-473d-bcf5-a75d2a615165_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_1bebdedb-19e1-47b2-a61c-4e6d6a669467_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash transactions:</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_NorthAmericaSpecialtyMember_d1bddd66-3c7c-44ae-9ae2-db1819a5b082_terseLabel_en-US" xlink:label="lab_vtrs_NorthAmericaSpecialtyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North America Specialty [Member]</link:label>
    <link:label id="lab_vtrs_NorthAmericaSpecialtyMember_label_en-US" xlink:label="lab_vtrs_NorthAmericaSpecialtyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North America Specialty [Member]</link:label>
    <link:label id="lab_vtrs_NorthAmericaSpecialtyMember_documentation_en-US" xlink:label="lab_vtrs_NorthAmericaSpecialtyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North America Specialty [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NorthAmericaSpecialtyMember" xlink:href="vtrs-20211231.xsd#vtrs_NorthAmericaSpecialtyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_NorthAmericaSpecialtyMember" xlink:to="lab_vtrs_NorthAmericaSpecialtyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_00af8a3b-556a-4ae9-b2a4-9c355ec6927f_terseLabel_en-US" xlink:label="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software</link:label>
    <link:label id="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_label_en-US" xlink:label="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software and Software Development Costs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:to="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_8b6e159d-51ca-4350-9dc7-c28ef5a4a6ef_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_0c66e4fa-e241-4bdb-9178-00a7cdccda2a_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Earnings</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2050SeniorNotesMember_a0270964-2ef2-49df-a3d5-1d22b6c1caac_terseLabel_en-US" xlink:label="lab_vtrs_A2050SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2050 Senior Notes</link:label>
    <link:label id="lab_vtrs_A2050SeniorNotesMember_label_en-US" xlink:label="lab_vtrs_A2050SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2050 Senior Notes [Member]</link:label>
    <link:label id="lab_vtrs_A2050SeniorNotesMember_documentation_en-US" xlink:label="lab_vtrs_A2050SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2050 Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2050SeniorNotesMember" xlink:href="vtrs-20211231.xsd#vtrs_A2050SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2050SeniorNotesMember" xlink:to="lab_vtrs_A2050SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTable_b961f205-7495-4b0e-b099-55f4fd1190b4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:to="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_65cffbe7-36ac-4a12-bc8b-6de04d4cd9ff_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_e81ec197-515e-46e3-8b14-779948b6c5e5_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_e1ff87b0-23c5-45df-b872-bb9ba6981d85_terseLabel_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product rights and licenses</link:label>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_label_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicensingAgreementsMember" xlink:to="lab_us-gaap_LicensingAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_5ba56ebd-056a-4341-97eb-fba47d98ce0b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_6ae34793-6b42-4787-a01b-13db24474177_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Reduction) addition due to acquisition</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_84792587-3e75-485f-9c48-3456d0642af1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, interest rate at period end</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentAssets_172a9ae0-2b3a-4bf3-b7ec-124c24ccde7b_terseLabel_en-US" xlink:label="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentAssets_label_en-US" xlink:label="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Noncurrent Assets</link:label>
    <link:label id="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentAssets_documentation_en-US" xlink:label="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentAssets" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentAssets" xlink:to="lab_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_64c84aea-dd93-4643-b4f6-eedf65a7bc7a_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_BusinessAcquisitionexpectedfuturepaymentyeartwo_e8925e53-0f86-4047-b1c4-c4e3472889f7_terseLabel_en-US" xlink:label="lab_vtrs_BusinessAcquisitionexpectedfuturepaymentyeartwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, expected future payment, year two</link:label>
    <link:label id="lab_vtrs_BusinessAcquisitionexpectedfuturepaymentyeartwo_label_en-US" xlink:label="lab_vtrs_BusinessAcquisitionexpectedfuturepaymentyeartwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, expected future payment, year two</link:label>
    <link:label id="lab_vtrs_BusinessAcquisitionexpectedfuturepaymentyeartwo_documentation_en-US" xlink:label="lab_vtrs_BusinessAcquisitionexpectedfuturepaymentyeartwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US"></link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessAcquisitionexpectedfuturepaymentyeartwo" xlink:href="vtrs-20211231.xsd#vtrs_BusinessAcquisitionexpectedfuturepaymentyeartwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_BusinessAcquisitionexpectedfuturepaymentyeartwo" xlink:to="lab_vtrs_BusinessAcquisitionexpectedfuturepaymentyeartwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_c28c5abb-44d9-4b6a-8034-5575abe9058b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_a9016507-882f-450f-b3cd-a11116a126ee_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_297931bf-2dcb-4d42-a22b-9a4624d5c13a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of unrecognized deferred tax liability</link:label>
    <link:label id="lab_us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_label_en-US" xlink:label="lab_us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in Unrecognized Tax Benefits is Reasonably Possible</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:to="lab_us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_44778ab9-a1cb-4557-97df-e9dda6e1ab6b_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_5e2e1e59-e5cc-4020-8a65-e24adaf919ce_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option award expiration period, in years</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities_afb05b95-4c40-4b71-b3f5-5edea775a271_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration payments</link:label>
    <link:label id="lab_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Merger Related Costs, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities" xlink:to="lab_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_739358db-55aa-4829-b73b-6f8afdfcbdf6_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_74160ad3-b5d1-4573-9bf7-9bd8d2a65081_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_35218f9b-5e04-4a57-b61e-631234f95cba_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_DevelopedMarketsSegmentMember_f3edf704-4d33-4cb2-a0af-7cca63c50b20_terseLabel_en-US" xlink:label="lab_vtrs_DevelopedMarketsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Markets</link:label>
    <link:label id="lab_vtrs_DevelopedMarketsSegmentMember_label_en-US" xlink:label="lab_vtrs_DevelopedMarketsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Markets Segment [Member]</link:label>
    <link:label id="lab_vtrs_DevelopedMarketsSegmentMember_documentation_en-US" xlink:label="lab_vtrs_DevelopedMarketsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Markets Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DevelopedMarketsSegmentMember" xlink:href="vtrs-20211231.xsd#vtrs_DevelopedMarketsSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_DevelopedMarketsSegmentMember" xlink:to="lab_vtrs_DevelopedMarketsSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_4d82e750-91ca-43bc-aea8-375866a96876_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_8fb3a83d-48b1-40de-9299-7e603add13e8_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Derivative Instruments on the Consolidated Statements of Operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_49698ca2-5f8f-4979-babd-80bc28758554_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Treasuries</link:label>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasurySecuritiesMember" xlink:to="lab_us-gaap_USTreasurySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_CelebrexMember_7e166e68-97ad-4b17-bad3-2223e64f38be_terseLabel_en-US" xlink:label="lab_vtrs_CelebrexMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Celebrex &#174;</link:label>
    <link:label id="lab_vtrs_CelebrexMember_label_en-US" xlink:label="lab_vtrs_CelebrexMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Celebrex &#174; [Member]</link:label>
    <link:label id="lab_vtrs_CelebrexMember_documentation_en-US" xlink:label="lab_vtrs_CelebrexMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Celebrex &#174;</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CelebrexMember" xlink:href="vtrs-20211231.xsd#vtrs_CelebrexMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_CelebrexMember" xlink:to="lab_vtrs_CelebrexMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2028SeniorNotesMember_0ccdc48e-3d3b-4965-8646-2dd86afce4fb_terseLabel_en-US" xlink:label="lab_vtrs_A2028SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 Senior Notes</link:label>
    <link:label id="lab_vtrs_A2028SeniorNotesMember_label_en-US" xlink:label="lab_vtrs_A2028SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 Senior Notes [Member]</link:label>
    <link:label id="lab_vtrs_A2028SeniorNotesMember_documentation_en-US" xlink:label="lab_vtrs_A2028SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 Senior Notes [Member] [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2028SeniorNotesMember" xlink:href="vtrs-20211231.xsd#vtrs_A2028SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2028SeniorNotesMember" xlink:to="lab_vtrs_A2028SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccretionExpense_c3529e76-46f9-47ac-9053-a89055e1f58d_terseLabel_en-US" xlink:label="lab_us-gaap_AccretionExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion</link:label>
    <link:label id="lab_us-gaap_AccretionExpense_label_en-US" xlink:label="lab_us-gaap_AccretionExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccretionExpense" xlink:to="lab_us-gaap_AccretionExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_db217c38-d006-455e-bf3b-a678c82bd455_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-process research and development</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareNet_58e6f35a-bb56-44e0-b961-02b236adedcb_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Computer Software, Net</link:label>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareNet_label_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Computer Software, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareNet" xlink:to="lab_us-gaap_CapitalizedComputerSoftwareNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_a7338bf9-3e8f-42be-a134-93b88a9562f7_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember_e172ad1e-de57-4adb-bd5f-efe455668c8b_terseLabel_en-US" xlink:label="lab_vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anticompetitive Conduct with Doxycycline Hyclate Delayed Release, Doxycycline Monohydrate, Glipizide-Metformin and Verapamil</link:label>
    <link:label id="lab_vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember_label_en-US" xlink:label="lab_vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anticompetitive Conduct with Doxycycline Hyclate Delayed Release, Doxycycline Monohydrate, Glipizide-Metformin and Verapamil [Member]</link:label>
    <link:label id="lab_vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember_documentation_en-US" xlink:label="lab_vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anticompetitive Conduct with Doxycycline Hyclate Delayed Release, Doxycycline Monohydrate, Glipizide-Metformin and Verapamil [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember" xlink:href="vtrs-20211231.xsd#vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember" xlink:to="lab_vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e9fd9063-2fe1-4f9d-9e37-5eaa2481b12a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f46b90b4-5d10-4473-a125-8db88fc114bd_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7e2a5c44-93d2-4b6a-959e-6af56c149f0f_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2f54f7ab-59e8-4d29-af95-66577e0a7b7c_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6e787aaf-016b-4c30-b425-44e1dd0726f0_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_8149d14f-72ba-400e-b5bd-1beafd553755_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_4382b9ff-414f-4cac-a69e-1005d9c7d690_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_00bf20d1-8be5-465c-9fa0-5a605fc40116_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_a5354fab-0634-45e2-a580-d6cb447eeb10_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:to="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_e1d51dfe-ee9b-49dc-8bc1-4b8781e17c56_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_134d3455-8fc7-4038-b78e-0ca6078408b9_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains and Losses on Derivatives in Cash Flow Hedging Relationships</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:to="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_2604f42a-e28d-4485-933f-c2b31d038f6a_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_1c312abc-336d-40dc-860b-b8437e47afef_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_c211b991-8b91-4995-8b2f-fb204bd76c9f_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_b2fa05ca-afe1-4f19-8cc7-66add21352cd_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_59f179f1-c892-44ff-accd-9278154135cc_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Segment Information to Total Consolidated Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c785b622-ddaa-4a22-933b-a5b1c1262020_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares under stock awards, granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_46d28d19-7e6a-4610-8d6f-7d9e5f1e48c0_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Federal Deferred</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9a5dc328-14cf-4c6d-9302-2246e5418583_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_f7a46cb1-ee03-4a39-8e82-8db114ef10a4_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_d9ceaece-14c6-4d67-aaa9-1dc8067bf85c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_1c22138c-dfb6-42c3-983c-119f4126a32a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_EUCommissionProceedingsCitalopramMember_45d6853b-68f7-46de-86b9-6dd244b00fff_terseLabel_en-US" xlink:label="lab_vtrs_EUCommissionProceedingsCitalopramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EU Commission Proceedings Citalopram</link:label>
    <link:label id="lab_vtrs_EUCommissionProceedingsCitalopramMember_label_en-US" xlink:label="lab_vtrs_EUCommissionProceedingsCitalopramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EU Commission Proceedings Citalopram [Member]</link:label>
    <link:label id="lab_vtrs_EUCommissionProceedingsCitalopramMember_documentation_en-US" xlink:label="lab_vtrs_EUCommissionProceedingsCitalopramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EU Commission Proceedings Citalopram</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EUCommissionProceedingsCitalopramMember" xlink:href="vtrs-20211231.xsd#vtrs_EUCommissionProceedingsCitalopramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_EUCommissionProceedingsCitalopramMember" xlink:to="lab_vtrs_EUCommissionProceedingsCitalopramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications_74cd273e-ce37-414a-a530-0799e50fc7ba_terseLabel_en-US" xlink:label="lab_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications</link:label>
    <link:label id="lab_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications_label_en-US" xlink:label="lab_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Reclassifications</link:label>
    <link:label id="lab_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications_documentation_en-US" xlink:label="lab_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Reclassifications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications" xlink:to="lab_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries_4771b3e2-c115-4d7c-9b76-d472b4f48233_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liability not recognized, amount of unrecognized deferred tax liability, undistributed earnings of foreign subsidiaries</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liability Not Recognized, Amount of Unrecognized Deferred Tax Liability, Undistributed Earnings of Foreign Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries" xlink:to="lab_us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_71df46f4-0ab8-4ec8-bedd-fa3e45db097a_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_5aebf802-e618-4114-a64d-6fe674aea8f3_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_987f0412-aab7-43e7-a509-a8746e6ae467_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan_76f68d69-787d-4e79-a8f6-625b87fc68d8_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transferred assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Increase (Decrease) for Assets Transferred to (from) Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan" xlink:to="lab_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_JaiPharmaLimitedMember_f25ccd2b-abf7-4579-bf32-59dc88ac50c9_terseLabel_en-US" xlink:label="lab_vtrs_JaiPharmaLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jai Pharma Limited</link:label>
    <link:label id="lab_vtrs_JaiPharmaLimitedMember_label_en-US" xlink:label="lab_vtrs_JaiPharmaLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jai Pharma Limited [Member]</link:label>
    <link:label id="lab_vtrs_JaiPharmaLimitedMember_documentation_en-US" xlink:label="lab_vtrs_JaiPharmaLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jai Pharma Limited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_JaiPharmaLimitedMember" xlink:href="vtrs-20211231.xsd#vtrs_JaiPharmaLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_JaiPharmaLimitedMember" xlink:to="lab_vtrs_JaiPharmaLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_bcd3ec02-488e-470f-a726-95b8c71634a5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustments [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_a0116790-888b-4574-aadc-9fd54613d946_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2016TermLoansMember_e0c27994-eb30-4c7d-93fa-217a01191f32_terseLabel_en-US" xlink:label="lab_vtrs_A2016TermLoansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Term Loans</link:label>
    <link:label id="lab_vtrs_A2016TermLoansMember_label_en-US" xlink:label="lab_vtrs_A2016TermLoansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Term Loans [Member]</link:label>
    <link:label id="lab_vtrs_A2016TermLoansMember_documentation_en-US" xlink:label="lab_vtrs_A2016TermLoansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Term Loans [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2016TermLoansMember" xlink:href="vtrs-20211231.xsd#vtrs_A2016TermLoansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2016TermLoansMember" xlink:to="lab_vtrs_A2016TermLoansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_09f3d73c-4373-4709-b8fd-957629f93b48_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_5fffd37a-41ac-4bf9-9944-2398c7c18492_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_DivestitureOfBusinessTransitionServicesAgreementTerm_34c26945-ca5e-43aa-929e-b9c234b63617_terseLabel_en-US" xlink:label="lab_vtrs_DivestitureOfBusinessTransitionServicesAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture Of Business, Transition Services Agreement, Term</link:label>
    <link:label id="lab_vtrs_DivestitureOfBusinessTransitionServicesAgreementTerm_label_en-US" xlink:label="lab_vtrs_DivestitureOfBusinessTransitionServicesAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture Of Business, Transition Services Agreement, Term</link:label>
    <link:label id="lab_vtrs_DivestitureOfBusinessTransitionServicesAgreementTerm_documentation_en-US" xlink:label="lab_vtrs_DivestitureOfBusinessTransitionServicesAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture Of Business, Transition Services Agreement, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DivestitureOfBusinessTransitionServicesAgreementTerm" xlink:href="vtrs-20211231.xsd#vtrs_DivestitureOfBusinessTransitionServicesAgreementTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_DivestitureOfBusinessTransitionServicesAgreementTerm" xlink:to="lab_vtrs_DivestitureOfBusinessTransitionServicesAgreementTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_1d24c204-c34d-4969-bb9c-f032d8a6f61c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets (excluding inventories and net of cash acquired)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_f0c96319-914c-4141-ad6e-09e25c1ce956_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount awarded to other party</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:to="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_LossContingencyOtherAssertedPatentsNumber_52a6ffec-1a57-486d-9b68-f82e7d3620f6_terseLabel_en-US" xlink:label="lab_vtrs_LossContingencyOtherAssertedPatentsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Other Asserted Patents, Number</link:label>
    <link:label id="lab_vtrs_LossContingencyOtherAssertedPatentsNumber_label_en-US" xlink:label="lab_vtrs_LossContingencyOtherAssertedPatentsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Other Asserted Patents, Number</link:label>
    <link:label id="lab_vtrs_LossContingencyOtherAssertedPatentsNumber_documentation_en-US" xlink:label="lab_vtrs_LossContingencyOtherAssertedPatentsNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Other Asserted Patents, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_LossContingencyOtherAssertedPatentsNumber" xlink:href="vtrs-20211231.xsd#vtrs_LossContingencyOtherAssertedPatentsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_LossContingencyOtherAssertedPatentsNumber" xlink:to="lab_vtrs_LossContingencyOtherAssertedPatentsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_3e8ae604-6e08-4a7d-8089-a6f44c2e31a7_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_36bd2769-2446-4ba3-b6fa-63b1ed2d8859_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_45fe9e4f-f245-4af4-acce-6b53cfb23b26_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_252acaef-31f7-4197-9698-af44213e7461_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale securities, debt securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_YENTermLoanMember_86e9fa70-533f-4475-970d-e21511e5b398_terseLabel_en-US" xlink:label="lab_vtrs_YENTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">YEN Term Loan</link:label>
    <link:label id="lab_vtrs_YENTermLoanMember_label_en-US" xlink:label="lab_vtrs_YENTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">YEN Term Loan [Member]</link:label>
    <link:label id="lab_vtrs_YENTermLoanMember_documentation_en-US" xlink:label="lab_vtrs_YENTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">YEN Term Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_YENTermLoanMember" xlink:href="vtrs-20211231.xsd#vtrs_YENTermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_YENTermLoanMember" xlink:to="lab_vtrs_YENTermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_DebtInstrumentConversionOfUnregisteredNotesToRegisteredNotesAsAPercentage_70460786-cb2d-45ee-97ca-10a95d44ce91_terseLabel_en-US" xlink:label="lab_vtrs_DebtInstrumentConversionOfUnregisteredNotesToRegisteredNotesAsAPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Conversion Of Unregistered Notes To Registered Notes, As A Percentage</link:label>
    <link:label id="lab_vtrs_DebtInstrumentConversionOfUnregisteredNotesToRegisteredNotesAsAPercentage_label_en-US" xlink:label="lab_vtrs_DebtInstrumentConversionOfUnregisteredNotesToRegisteredNotesAsAPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Conversion Of Unregistered Notes To Registered Notes, As A Percentage</link:label>
    <link:label id="lab_vtrs_DebtInstrumentConversionOfUnregisteredNotesToRegisteredNotesAsAPercentage_documentation_en-US" xlink:label="lab_vtrs_DebtInstrumentConversionOfUnregisteredNotesToRegisteredNotesAsAPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Conversion Of Unregistered Notes To Registered Notes, As A Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DebtInstrumentConversionOfUnregisteredNotesToRegisteredNotesAsAPercentage" xlink:href="vtrs-20211231.xsd#vtrs_DebtInstrumentConversionOfUnregisteredNotesToRegisteredNotesAsAPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_DebtInstrumentConversionOfUnregisteredNotesToRegisteredNotesAsAPercentage" xlink:to="lab_vtrs_DebtInstrumentConversionOfUnregisteredNotesToRegisteredNotesAsAPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_8c1009de-e0e0-42aa-8bb8-06d21a5d9b1d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_Chargebacks_a32ad4f4-528f-4e4c-89e6-2a3062346b33_negatedTerseLabel_en-US" xlink:label="lab_vtrs_Chargebacks" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chargebacks</link:label>
    <link:label id="lab_vtrs_Chargebacks_label_en-US" xlink:label="lab_vtrs_Chargebacks" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chargebacks</link:label>
    <link:label id="lab_vtrs_Chargebacks_documentation_en-US" xlink:label="lab_vtrs_Chargebacks" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chargebacks</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Chargebacks" xlink:href="vtrs-20211231.xsd#vtrs_Chargebacks"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_Chargebacks" xlink:to="lab_vtrs_Chargebacks" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxPeriodAxis_800c27bb-e426-49d3-8d5d-9548b575016b_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodAxis_label_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodAxis" xlink:to="lab_us-gaap_TaxPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7ef4188e-7892-45de-80ab-c516a8421a4b_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_303b87e0-834e-4423-bed2-0609b093027c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance, amount</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_edcfb4e1-2b8b-40d8-bee4-386f5d23b401_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_f1131186-9eca-473a-83b8-8874c529cfb4_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate (Other)</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_MarketableSecuritiesMember_75f0b6b2-98e1-4ddc-9f41-3e67c17563f7_terseLabel_en-US" xlink:label="lab_vtrs_MarketableSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities</link:label>
    <link:label id="lab_vtrs_MarketableSecuritiesMember_label_en-US" xlink:label="lab_vtrs_MarketableSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities [Member]</link:label>
    <link:label id="lab_vtrs_MarketableSecuritiesMember_documentation_en-US" xlink:label="lab_vtrs_MarketableSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_MarketableSecuritiesMember" xlink:href="vtrs-20211231.xsd#vtrs_MarketableSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_MarketableSecuritiesMember" xlink:to="lab_vtrs_MarketableSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_BusinessCombinationNumberOfMarketsServed_5b53cc15-0eb7-420e-bcb7-1e1e1bc26aad_terseLabel_en-US" xlink:label="lab_vtrs_BusinessCombinationNumberOfMarketsServed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Markets</link:label>
    <link:label id="lab_vtrs_BusinessCombinationNumberOfMarketsServed_label_en-US" xlink:label="lab_vtrs_BusinessCombinationNumberOfMarketsServed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Number Of Markets Served</link:label>
    <link:label id="lab_vtrs_BusinessCombinationNumberOfMarketsServed_documentation_en-US" xlink:label="lab_vtrs_BusinessCombinationNumberOfMarketsServed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Number Of Markets Served</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationNumberOfMarketsServed" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationNumberOfMarketsServed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_BusinessCombinationNumberOfMarketsServed" xlink:to="lab_vtrs_BusinessCombinationNumberOfMarketsServed" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnAccumulatedPostretirementBenefitObligation1_0258b1e5-f594-426e-aadd-543331004f65_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnAccumulatedPostretirementBenefitObligation1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in the benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnAccumulatedPostretirementBenefitObligation1_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnAccumulatedPostretirementBenefitObligation1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Effect of One Percentage Point Decrease on Accumulated Postretirement Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnAccumulatedPostretirementBenefitObligation1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnAccumulatedPostretirementBenefitObligation1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnAccumulatedPostretirementBenefitObligation1" xlink:to="lab_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnAccumulatedPostretirementBenefitObligation1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherExpenseMember_1a0a5688-f225-41f1-b83f-a464f5e27097_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherExpenseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense</link:label>
    <link:label id="lab_us-gaap_OtherExpenseMember_912ff55c-576b-43d4-a218-425397ee0498_terseLabel_en-US" xlink:label="lab_us-gaap_OtherExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income</link:label>
    <link:label id="lab_us-gaap_OtherExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherExpenseMember" xlink:to="lab_us-gaap_OtherExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_e21064b2-f1cf-4166-9758-d436a6eb4052_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_be3c897b-1afc-4011-8f59-4159b0e40ac7_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_6edb511e-6c8a-4be6-bce3-80f0a600dc6f_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Benefits</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade_6905016f-361c-4e47-971c-16e96fb561d5_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable, Trade</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4bf337a5-49fc-4009-b60e-32841aba02e1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_TwentyTwentyOneRevolvingFacilityMember_99d37c0c-baa4-48a1-bfcf-5dd05ff8a8af_terseLabel_en-US" xlink:label="lab_vtrs_TwentyTwentyOneRevolvingFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Twenty Twenty One Revolving Facility</link:label>
    <link:label id="lab_vtrs_TwentyTwentyOneRevolvingFacilityMember_label_en-US" xlink:label="lab_vtrs_TwentyTwentyOneRevolvingFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Twenty Twenty One Revolving Facility [Member]</link:label>
    <link:label id="lab_vtrs_TwentyTwentyOneRevolvingFacilityMember_documentation_en-US" xlink:label="lab_vtrs_TwentyTwentyOneRevolvingFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Twenty Twenty One Revolving Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_TwentyTwentyOneRevolvingFacilityMember" xlink:href="vtrs-20211231.xsd#vtrs_TwentyTwentyOneRevolvingFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_TwentyTwentyOneRevolvingFacilityMember" xlink:to="lab_vtrs_TwentyTwentyOneRevolvingFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_1122c48f-9a02-43b8-9ad2-00a06cd5aac5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByAssetClassAxis" xlink:to="lab_us-gaap_FairValueByAssetClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_27ab1b70-ee08-4f99-9692-20ebf280c6a9_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_5d023fd1-d23a-4827-8c7a-8fcb8fe37d8f_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario, Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_c11f592e-af3f-4483-9e0e-ba399459968f_totalLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax provision (benefit), U.S. State</link:label>
    <link:label id="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_label_en-US" xlink:label="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Income Tax Expense (Benefit), Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:to="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ProgramNameDomain_cac6e1ec-45dc-481b-8ebe-9af7f93231af_terseLabel_en-US" xlink:label="lab_vtrs_ProgramNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Program Name [Domain]</link:label>
    <link:label id="lab_vtrs_ProgramNameDomain_label_en-US" xlink:label="lab_vtrs_ProgramNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Program Name [Domain]</link:label>
    <link:label id="lab_vtrs_ProgramNameDomain_documentation_en-US" xlink:label="lab_vtrs_ProgramNameDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Program Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ProgramNameDomain" xlink:href="vtrs-20211231.xsd#vtrs_ProgramNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ProgramNameDomain" xlink:to="lab_vtrs_ProgramNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_875341a4-3d74-47e4-a6ba-2f3a1fcf43d6_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax net losses on cash flow hedges to be reclassified from AOCE into earnings in next twelve months</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:to="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_e0e0d9c1-0275-40ef-ace2-e67b855dc756_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_7dfbb039-8445-4d70-bd0c-412e2884765c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax provision (benefit)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_a3ec9709-d404-4dd1-84fd-351b1bf254c2_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_9e7806f8-b79f-4711-bbe2-3d66ca380c4a_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_02d0bd6c-3ada-4297-b68a-39e5979c3495_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation settlements and other contingencies, net</link:label>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_86ff1706-4f4d-47a9-834e-76f6f269d148_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation settlements &amp; other contingencies</link:label>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_label_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) Related to Litigation Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:to="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_EpiPenAutoInjectorLitigationMember_f365b31f-8a40-47aa-a9f9-674b150168e7_terseLabel_en-US" xlink:label="lab_vtrs_EpiPenAutoInjectorLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EpiPen Auto-Injector Litigation</link:label>
    <link:label id="lab_vtrs_EpiPenAutoInjectorLitigationMember_label_en-US" xlink:label="lab_vtrs_EpiPenAutoInjectorLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EpiPen Auto-Injector Litigation [Member]</link:label>
    <link:label id="lab_vtrs_EpiPenAutoInjectorLitigationMember_documentation_en-US" xlink:label="lab_vtrs_EpiPenAutoInjectorLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EpiPen Auto-Injector Litigation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EpiPenAutoInjectorLitigationMember" xlink:href="vtrs-20211231.xsd#vtrs_EpiPenAutoInjectorLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_EpiPenAutoInjectorLitigationMember" xlink:to="lab_vtrs_EpiPenAutoInjectorLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_860aedd1-1699-4ae5-8ead-cebe294d526a_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_bdcbbf85-ccfa-4c18-8e74-5fe4493d5b22_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_d282f11a-20a1-4f5d-b45b-7463ae847675_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ParentCompanyMember_1b6af0f7-4d1d-4adf-a439-f052bc727fdc_verboseLabel_en-US" xlink:label="lab_srt_ParentCompanyMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mylan N.V.</link:label>
    <link:label id="lab_srt_ParentCompanyMember_33d13d09-36d1-4ea4-9958-11f53c7d1b1d_terseLabel_en-US" xlink:label="lab_srt_ParentCompanyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mylan</link:label>
    <link:label id="lab_srt_ParentCompanyMember_label_en-US" xlink:label="lab_srt_ParentCompanyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent Company [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ParentCompanyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ParentCompanyMember" xlink:to="lab_srt_ParentCompanyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_be2e8094-a49f-49fc-946b-2aca16a286fc_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_314481c2-85f8-4e43-ac26-a8ac0df85cf8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Globally managed research and development costs</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_93b10553-e1b4-45d4-90d1-a870998100e9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts Receivable, Net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_dbcbca44-9900-4e27-a67b-9bb3c6f4fceb_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized prior service cost (credit)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, Prior Service Cost (Credit), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_4f32f7d0-8ddb-40fe-9e46-5152e74f8a30_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract Type [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_FKBMember_2bbc6174-081d-4ce9-849d-ea8ec36c0b09_terseLabel_en-US" xlink:label="lab_vtrs_FKBMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FKB</link:label>
    <link:label id="lab_vtrs_FKBMember_label_en-US" xlink:label="lab_vtrs_FKBMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FKB [Member]</link:label>
    <link:label id="lab_vtrs_FKBMember_documentation_en-US" xlink:label="lab_vtrs_FKBMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FKB [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_FKBMember" xlink:href="vtrs-20211231.xsd#vtrs_FKBMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_FKBMember" xlink:to="lab_vtrs_FKBMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAssetsTransferredtofromPlan_fee48b7e-0c65-4aee-a5d0-d2c75f17067a_terseLabel_en-US" xlink:label="lab_vtrs_DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAssetsTransferredtofromPlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_vtrs_DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAssetsTransferredtofromPlan_label_en-US" xlink:label="lab_vtrs_DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAssetsTransferredtofromPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Assets Transferred to (from) Plan</link:label>
    <link:label id="lab_vtrs_DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAssetsTransferredtofromPlan_documentation_en-US" xlink:label="lab_vtrs_DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAssetsTransferredtofromPlan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Assets Transferred to (from) Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAssetsTransferredtofromPlan" xlink:href="vtrs-20211231.xsd#vtrs_DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAssetsTransferredtofromPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAssetsTransferredtofromPlan" xlink:to="lab_vtrs_DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAssetsTransferredtofromPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_Otherlongtermassets_9284f068-edfb-4cc2-8c53-926210953665_terseLabel_en-US" xlink:label="lab_vtrs_Otherlongtermassets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_vtrs_Otherlongtermassets_label_en-US" xlink:label="lab_vtrs_Otherlongtermassets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_vtrs_Otherlongtermassets_documentation_en-US" xlink:label="lab_vtrs_Otherlongtermassets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Otherlongtermassets" xlink:href="vtrs-20211231.xsd#vtrs_Otherlongtermassets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_Otherlongtermassets" xlink:to="lab_vtrs_Otherlongtermassets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_4f393122-982c-469b-bbee-27f9739af1ba_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrent" xlink:to="lab_us-gaap_LiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_c384a51e-3ed8-4a50-adf4-bda4459cb26f_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_90abe625-6080-4282-947a-307fdf82be7a_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_5f0fef01-71d3-43be-8646-889902e7eab0_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowings_d6281aeb-cd8e-44e7-a50d-c1ab80e4e2bf_verboseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term borrowings</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_2b56b2ef-a9b6-4c0e-b976-6d2aec25c589_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term borrowings</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowings" xlink:to="lab_us-gaap_ShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_3a2fcae9-d9f4-4e87-8b64-aca847a74a16_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit carryforward</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:to="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_23eb7c35-a675-4f96-acdb-723bc1712321_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition And Accounts Receivable [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_e3d082d0-b30a-4726-a37c-443e47aeca46_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_label_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_1d2d052a-d662-4e84-8839-54f7ccc90afd_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3df4da5b-0466-49ef-8b76-7436bebaf8be_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_0f026071-e23d-40dc-909e-d76bdbd14f64_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_2811dd10-3f43-4342-ba25-32ac361b3d87_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivablesNetCurrent" xlink:to="lab_us-gaap_OtherReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_AgilaSpecialtiesPrivateLimitedMember_568a2905-19e3-431e-ba31-972b1397cb82_terseLabel_en-US" xlink:label="lab_vtrs_AgilaSpecialtiesPrivateLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agila Specialties</link:label>
    <link:label id="lab_vtrs_AgilaSpecialtiesPrivateLimitedMember_label_en-US" xlink:label="lab_vtrs_AgilaSpecialtiesPrivateLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agila Specialties Private Limited [Member]</link:label>
    <link:label id="lab_vtrs_AgilaSpecialtiesPrivateLimitedMember_documentation_en-US" xlink:label="lab_vtrs_AgilaSpecialtiesPrivateLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agila Specialties Private Limited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AgilaSpecialtiesPrivateLimitedMember" xlink:href="vtrs-20211231.xsd#vtrs_AgilaSpecialtiesPrivateLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_AgilaSpecialtiesPrivateLimitedMember" xlink:to="lab_vtrs_AgilaSpecialtiesPrivateLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_68b4c80b-0ca3-42c5-99d6-113ec94795de_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of the Combination and Divestitures</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_252d70c6-6443-4b20-961d-9130b7cb1d63_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_daa70203-c8e2-428f-83f9-bc8eabf926e5_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_7168af8b-b785-4d8e-ac5c-b29fc20db8a8_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_1e1448dc-7059-4490-b8ad-c9e9812ca158_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (loss) earnings per share attributable to Viatris Inc. shareholders</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_e950eb00-ab59-4f3e-84e2-fb3fa0036c6c_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_0907974a-478d-470f-b594-00b77501b2ff_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesPaidValue_82e4305e-b469-4f6a-b62d-b40e07c6b1e1_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesPaidValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency accrual</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesPaidValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesPaidValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Paid, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesPaidValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesPaidValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesPaidValue" xlink:to="lab_us-gaap_LossContingencyDamagesPaidValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_c83bb889-7e41-4087-8539-c31e3dda8253_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized actuarial (gain) loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_b38cc98c-5fba-404e-9e60-0f176951534d_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_9adfe6c7-956c-4150-b00b-602ca9fbce8c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_XanaxMember_6db03b76-f064-42f5-a866-e55bfcabfe37_terseLabel_en-US" xlink:label="lab_vtrs_XanaxMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Xanax &#174;</link:label>
    <link:label id="lab_vtrs_XanaxMember_label_en-US" xlink:label="lab_vtrs_XanaxMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Xanax &#174; [Member]</link:label>
    <link:label id="lab_vtrs_XanaxMember_documentation_en-US" xlink:label="lab_vtrs_XanaxMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Xanax &#174;</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_XanaxMember" xlink:href="vtrs-20211231.xsd#vtrs_XanaxMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_XanaxMember" xlink:to="lab_vtrs_XanaxMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesMember_5ed63114-4297-413b-b481-60ea891082c6_terseLabel_en-US" xlink:label="lab_us-gaap_SalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales [Member]</link:label>
    <link:label id="lab_us-gaap_SalesMember_label_en-US" xlink:label="lab_us-gaap_SalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesMember" xlink:to="lab_us-gaap_SalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_0d9dd788-b484-47be-82b2-52e33d4f986d_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Foreign Operations</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_c7669ef4-7ce7-4604-aee1-b4d31040f19b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Date of Acquisition [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Date of Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e5b140ba-ea1f-4163-83ea-239d8aea3f92_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_aab710f4-fb83-436a-8b6e-97d9f1dc441b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets Amortization Expense [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_f3aaef8e-f35d-40c5-9402-29f8202c2d57_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_167ed8b9-97bb-4e8d-ae43-082aa05205ca_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net book value, excluding goodwill</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_cf34a1e6-740f-4f59-bfe5-eff78d78200a_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember" xlink:to="lab_us-gaap_EmployeeSeveranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveCurrent_83826f07-3a17-4fd3-886c-5954848cf03c_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Current</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveCurrent_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveCurrent" xlink:to="lab_us-gaap_RestructuringReserveCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated_62fce46d-01ed-49e9-878b-07429bbad927_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Number of Positions Eliminated</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Number of Positions Eliminated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated" xlink:to="lab_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue_2848378a-ab78-4195-95bf-3becd39de3b8_verboseLabel_en-US" xlink:label="lab_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intrinsic value of stock-based awards exercised and restricted stock units converted</link:label>
    <link:label id="lab_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue_label_en-US" xlink:label="lab_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period, Total Intrinsic Value And Equity Instruments Other Than Options, Vested In Period, Intrinsic Value</link:label>
    <link:label id="lab_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue_documentation_en-US" xlink:label="lab_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period, Total Intrinsic Value And Equity Instruments Other Than Options, Vested In Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue" xlink:href="vtrs-20211231.xsd#vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue" xlink:to="lab_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_30cedf58-a7df-4215-ab51-37e8c53c2b6b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Accrued Benefit Costs Classification on Balance Sheet</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amounts Recognized in Balance Sheet [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtPolicyTextBlock_679f5c89-dab4-40c6-9c4f-285d93fef833_terseLabel_en-US" xlink:label="lab_us-gaap_DebtPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Borrowings</link:label>
    <link:label id="lab_us-gaap_DebtPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtPolicyTextBlock" xlink:to="lab_us-gaap_DebtPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_baebf3ed-024c-4592-a7c7-c4077dbe2068_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax liability</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_7cf95d68-9a65-4982-bbc3-f1725894aa09_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_082a8681-44f6-440a-93f2-ca6cad61842f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_e5cdee48-b254-44e0-9a43-d872bb6e9ec6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_8d82bd2d-a569-4a5d-a868-7dbf37687d81_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_bcc90594-4f2d-4b73-9b68-3cb63ee0ddcd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Tax Rate to Effective Tax Rate Reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2027EuroSeniorNotesMember_d3effce9-207e-46ce-a644-e4895891cb9d_terseLabel_en-US" xlink:label="lab_vtrs_A2027EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027 Euro Senior Notes</link:label>
    <link:label id="lab_vtrs_A2027EuroSeniorNotesMember_label_en-US" xlink:label="lab_vtrs_A2027EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027 Euro Senior Notes [Member]</link:label>
    <link:label id="lab_vtrs_A2027EuroSeniorNotesMember_documentation_en-US" xlink:label="lab_vtrs_A2027EuroSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027 Euro Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2027EuroSeniorNotesMember" xlink:href="vtrs-20211231.xsd#vtrs_A2027EuroSeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2027EuroSeniorNotesMember" xlink:to="lab_vtrs_A2027EuroSeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_0e0c759a-4208-47f7-bb42-434f12639ac4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable allowances</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_27abca1b-3645-4f7f-9fb5-bda9e1fb01ad_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputControlPremiumMember_92c59b14-013a-4f97-8bc3-39021976eca5_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputControlPremiumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Control Premium [Member]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputControlPremiumMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputControlPremiumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Control Premium [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputControlPremiumMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputControlPremiumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputControlPremiumMember" xlink:to="lab_us-gaap_MeasurementInputControlPremiumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement_0e5856b7-8fe0-4de8-b962-cf5ebe7d7690_terseLabel_en-US" xlink:label="lab_vtrs_NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of times damages may be increased in cases of willful infringement</link:label>
    <link:label id="lab_vtrs_NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement_label_en-US" xlink:label="lab_vtrs_NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of times damages may be increased in cases of willful infringement</link:label>
    <link:label id="lab_vtrs_NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement_documentation_en-US" xlink:label="lab_vtrs_NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of times damages may be increased in cases of willful infringement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement" xlink:href="vtrs-20211231.xsd#vtrs_NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement" xlink:to="lab_vtrs_NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems_904b0ad4-7ae0-4f2c-973d-6c711bf22928_terseLabel_en-US" xlink:label="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Major Customer [Line Items]</link:label>
    <link:label id="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems_label_en-US" xlink:label="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Major Customer [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:to="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_0d9d6e4f-a872-4246-b807-97fdad0e1596_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of changes in legislation</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_478b1278-2369-4881-868c-d368b610f46a_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Assets and Liabilities Carried at Fair Value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d41eabc7-f988-4d4f-a4fa-daeb646d296a_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1010db38-7c1c-4b03-ad2e-129d42236720_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_FairValueInputsLongtermRevenueGrowthRateTerminalYear_3909cbc8-5dee-496f-a68e-88e3b10e2427_terseLabel_en-US" xlink:label="lab_vtrs_FairValueInputsLongtermRevenueGrowthRateTerminalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Inputs, Long-term Revenue Growth Rate, Terminal Year</link:label>
    <link:label id="lab_vtrs_FairValueInputsLongtermRevenueGrowthRateTerminalYear_label_en-US" xlink:label="lab_vtrs_FairValueInputsLongtermRevenueGrowthRateTerminalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Inputs, Long-term Revenue Growth Rate, Terminal Year</link:label>
    <link:label id="lab_vtrs_FairValueInputsLongtermRevenueGrowthRateTerminalYear_documentation_en-US" xlink:label="lab_vtrs_FairValueInputsLongtermRevenueGrowthRateTerminalYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Inputs, Long-term Revenue Growth Rate, Terminal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_FairValueInputsLongtermRevenueGrowthRateTerminalYear" xlink:href="vtrs-20211231.xsd#vtrs_FairValueInputsLongtermRevenueGrowthRateTerminalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_FairValueInputsLongtermRevenueGrowthRateTerminalYear" xlink:to="lab_vtrs_FairValueInputsLongtermRevenueGrowthRateTerminalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_93324197-5e1b-40c7-a9a0-5a99e3ab1ba8_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_2f2431b6-6581-455a-b95f-1b51eb32c852_terseLabel_en-US" xlink:label="lab_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Noncurrent Liabilities [Line Items]</link:label>
    <link:label id="lab_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_label_en-US" xlink:label="lab_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Noncurrent Liabilities [Line Items]</link:label>
    <link:label id="lab_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_documentation_en-US" xlink:label="lab_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Schedule of Other Noncurrent Liabilities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems" xlink:href="vtrs-20211231.xsd#vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems" xlink:to="lab_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockMember_82684216-2bd4-4a59-a033-2d7acf8aa2c4_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock</link:label>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockMember_label_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertiblePreferredStockMember" xlink:to="lab_us-gaap_ConvertiblePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_4623a1e5-8b0e-4c2e-8b75-aa1cedefac1d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3f2fb670-9c1a-4785-95a3-17af601bd312_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_916649cd-ac69-4fc1-82b5-392a9b5609d0_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassLineItems_b9a4b652-6f60-46c3-9d1f-1aa6b23b60de_terseLabel_en-US" xlink:label="lab_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Rights and Licenses by Therapeutic Class [Line Items]</link:label>
    <link:label id="lab_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassLineItems_label_en-US" xlink:label="lab_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Rights and Licenses by Therapeutic Class [Line Items]</link:label>
    <link:label id="lab_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassLineItems_documentation_en-US" xlink:label="lab_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Schedule of Product Rights and Licenses by Therapeutic Class</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassLineItems" xlink:href="vtrs-20211231.xsd#vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassLineItems" xlink:to="lab_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_c64e811b-de78-408b-87c7-60bb4ccc1045_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_aeb30551-d9cc-4411-90a1-c650e0c49417_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of assets and subsidiaries</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_ad7e0e96-d85f-4b95-be9c-71a4d71c770b_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_8948d785-983e-44a1-9257-bf1af401731f_terseLabel_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other revenues</link:label>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_label_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductAndServiceOtherMember" xlink:to="lab_us-gaap_ProductAndServiceOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ReductioninTerminalValueGrowthRateDomain_c099bf4a-cf33-4b2c-b0f8-e726b49f7ea9_terseLabel_en-US" xlink:label="lab_vtrs_ReductioninTerminalValueGrowthRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction in Terminal Value Growth Rate [Domain]</link:label>
    <link:label id="lab_vtrs_ReductioninTerminalValueGrowthRateDomain_label_en-US" xlink:label="lab_vtrs_ReductioninTerminalValueGrowthRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction in Terminal Value Growth Rate [Domain]</link:label>
    <link:label id="lab_vtrs_ReductioninTerminalValueGrowthRateDomain_documentation_en-US" xlink:label="lab_vtrs_ReductioninTerminalValueGrowthRateDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction in Terminal Value Growth Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ReductioninTerminalValueGrowthRateDomain" xlink:href="vtrs-20211231.xsd#vtrs_ReductioninTerminalValueGrowthRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ReductioninTerminalValueGrowthRateDomain" xlink:to="lab_vtrs_ReductioninTerminalValueGrowthRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_AmitizaMember_15f2ad3a-c6e1-4b61-84b7-eceb6590ea8a_terseLabel_en-US" xlink:label="lab_vtrs_AmitizaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amitiza &#174;</link:label>
    <link:label id="lab_vtrs_AmitizaMember_label_en-US" xlink:label="lab_vtrs_AmitizaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amitiza &#174; [Member]</link:label>
    <link:label id="lab_vtrs_AmitizaMember_documentation_en-US" xlink:label="lab_vtrs_AmitizaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amitiza &#174;</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AmitizaMember" xlink:href="vtrs-20211231.xsd#vtrs_AmitizaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_AmitizaMember" xlink:to="lab_vtrs_AmitizaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_7225a71f-fb9f-4a71-ba1e-32714a728866_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan settlements and terminations</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_d126e4f9-e07f-4465-8558-46a316e56cbe_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_bd2fd033-ebe2-4c5f-bf2f-a55936a4b8f8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions for prior year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_fe99ecbb-9073-4187-8016-46a005c9a587_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpense_b5004806-723e-4dfa-bc86-640c958dc7ac_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign deductible attributes</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpense_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_Developmentandsalesmilestonepayments_a285a1fc-f1ec-4a90-b29c-e08ee3c6c701_terseLabel_en-US" xlink:label="lab_vtrs_Developmentandsalesmilestonepayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development and sales milestone payments</link:label>
    <link:label id="lab_vtrs_Developmentandsalesmilestonepayments_label_en-US" xlink:label="lab_vtrs_Developmentandsalesmilestonepayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development and sales milestone payments</link:label>
    <link:label id="lab_vtrs_Developmentandsalesmilestonepayments_documentation_en-US" xlink:label="lab_vtrs_Developmentandsalesmilestonepayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development and sales milestone payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Developmentandsalesmilestonepayments" xlink:href="vtrs-20211231.xsd#vtrs_Developmentandsalesmilestonepayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_Developmentandsalesmilestonepayments" xlink:to="lab_vtrs_Developmentandsalesmilestonepayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_94347452-26bc-4bb0-b2bb-11cb76f12007_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, including current portion</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_0b5901ec-a8f2-4885-89ad-7e2f538b855c_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term obligations</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_8d902b0d-5dcb-4d99-a9c0-27b684b3554b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_AssetsheldbyinsurancecompaniesandotherMember_39d314b8-db39-4b1e-8552-4de696ed6e28_terseLabel_en-US" xlink:label="lab_vtrs_AssetsheldbyinsurancecompaniesandotherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held by insurance companies and other</link:label>
    <link:label id="lab_vtrs_AssetsheldbyinsurancecompaniesandotherMember_label_en-US" xlink:label="lab_vtrs_AssetsheldbyinsurancecompaniesandotherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held by insurance companies and other [Member]</link:label>
    <link:label id="lab_vtrs_AssetsheldbyinsurancecompaniesandotherMember_documentation_en-US" xlink:label="lab_vtrs_AssetsheldbyinsurancecompaniesandotherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held by insurance companies and other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AssetsheldbyinsurancecompaniesandotherMember" xlink:href="vtrs-20211231.xsd#vtrs_AssetsheldbyinsurancecompaniesandotherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_AssetsheldbyinsurancecompaniesandotherMember" xlink:to="lab_vtrs_AssetsheldbyinsurancecompaniesandotherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_2a7b08a5-f6e7-4705-9e60-7bef402c30b9_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Projected benefit obligation, beginning of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_746853b1-3248-4eeb-80f3-e1404c228bc7_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Projected benefit obligation, end of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_6de5bed8-d19b-4764-bfc2-d59b5ea60790_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_e3dbf92c-15df-402b-bb79-2f6315efce54_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock_4deaf3f4-9fc0-474c-a0a7-cf673990ef80_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_bd8c327c-9ec9-466e-9a54-1c678cef0da9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swap derivative assets</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_42f57605-dcc0-4485-b0de-4d1829902548_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_ba0c2495-141c-4902-a0c2-9cedf824ef98_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_f4d8f649-6daf-4d30-ae2e-75476c8cf596_terseLabel_en-US" xlink:label="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax</link:label>
    <link:label id="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_label_en-US" xlink:label="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:to="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2016RestructuringProgramMember_ba0d1b68-c191-4d11-b02c-24e95bff3954_terseLabel_en-US" xlink:label="lab_vtrs_A2016RestructuringProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Restructuring Program</link:label>
    <link:label id="lab_vtrs_A2016RestructuringProgramMember_label_en-US" xlink:label="lab_vtrs_A2016RestructuringProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Restructuring Program [Member]</link:label>
    <link:label id="lab_vtrs_A2016RestructuringProgramMember_documentation_en-US" xlink:label="lab_vtrs_A2016RestructuringProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Restructuring Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2016RestructuringProgramMember" xlink:href="vtrs-20211231.xsd#vtrs_A2016RestructuringProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2016RestructuringProgramMember" xlink:to="lab_vtrs_A2016RestructuringProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_803169ee-f950-4b85-bd7e-ff35ccc1fe69_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares under stock awards, vested and expected to vest at period end</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_ecf1498e-3860-424f-8297-678ef0141da3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_0fc757fb-0f4d-4a6d-8273-2081a48cb2a2_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uncertain tax positions</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Contingency, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_c3d02bb7-f81a-4638-8938-33de2b37f9a3_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of restricted stock and stock options exercised, net</link:label>
    <link:label id="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_label_en-US" xlink:label="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock, Value, Shares Issued Net of Tax Withholdings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:to="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_93d3e049-b353-47ba-990d-2c94185a1adb_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_NonU.S.statetaxauthorityMember_df8716ea-b909-474c-8d63-ba4ab35e8e50_terseLabel_en-US" xlink:label="lab_vtrs_NonU.S.statetaxauthorityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S. state tax authority</link:label>
    <link:label id="lab_vtrs_NonU.S.statetaxauthorityMember_label_en-US" xlink:label="lab_vtrs_NonU.S.statetaxauthorityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S. state tax authority [Member]</link:label>
    <link:label id="lab_vtrs_NonU.S.statetaxauthorityMember_documentation_en-US" xlink:label="lab_vtrs_NonU.S.statetaxauthorityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S. state tax authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NonU.S.statetaxauthorityMember" xlink:href="vtrs-20211231.xsd#vtrs_NonU.S.statetaxauthorityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_NonU.S.statetaxauthorityMember" xlink:to="lab_vtrs_NonU.S.statetaxauthorityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_1aedfb6e-8339-4692-ac4b-e4358bcb65fb_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of actuarial loss included in SG&amp;A</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_a3f6e210-8abd-40dd-becd-0bf800948964_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participant contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Plan Participant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillGross_8ccff9bf-bd48-4b57-a955-ac15a1ad48e9_periodStartLabel_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, gross, beginning balance</link:label>
    <link:label id="lab_us-gaap_GoodwillGross_52f2d170-066d-49a0-bcaf-553708349b86_periodEndLabel_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, gross, ending balance</link:label>
    <link:label id="lab_us-gaap_GoodwillGross_label_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillGross" xlink:to="lab_us-gaap_GoodwillGross" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_LipitorMember_e4b695d4-9402-43c5-aece-7b99e157be84_terseLabel_en-US" xlink:label="lab_vtrs_LipitorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lipitor &#174;</link:label>
    <link:label id="lab_vtrs_LipitorMember_label_en-US" xlink:label="lab_vtrs_LipitorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lipitor &#174; [Member]</link:label>
    <link:label id="lab_vtrs_LipitorMember_documentation_en-US" xlink:label="lab_vtrs_LipitorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lipitor &#174;</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_LipitorMember" xlink:href="vtrs-20211231.xsd#vtrs_LipitorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_LipitorMember" xlink:to="lab_vtrs_LipitorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_16d9a028-314b-4ec1-801b-5773a0d376b4_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_223f2acf-0a23-48f3-af6d-cc5cbf09dd2a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_UpjohnEuroNotesMember_6d5bf8d8-e955-47b5-a801-d6a6fd301d67_terseLabel_en-US" xlink:label="lab_vtrs_UpjohnEuroNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upjohn Euro Notes</link:label>
    <link:label id="lab_vtrs_UpjohnEuroNotesMember_label_en-US" xlink:label="lab_vtrs_UpjohnEuroNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upjohn Euro Notes [Member]</link:label>
    <link:label id="lab_vtrs_UpjohnEuroNotesMember_documentation_en-US" xlink:label="lab_vtrs_UpjohnEuroNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upjohn Euro Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_UpjohnEuroNotesMember" xlink:href="vtrs-20211231.xsd#vtrs_UpjohnEuroNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_UpjohnEuroNotesMember" xlink:to="lab_vtrs_UpjohnEuroNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemAxis_8356b9db-f457-45d4-a506-10fd26be86cb_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Axis]</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemAxis_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis" xlink:to="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_DivestitureOfBusinessPercentageOwnershipInCombinedCompanyAfterTransaction_34744cbd-22a8-42ef-bd26-7ebebc287802_terseLabel_en-US" xlink:label="lab_vtrs_DivestitureOfBusinessPercentageOwnershipInCombinedCompanyAfterTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture Of Business, Percentage Ownership In Combined Company After Transaction</link:label>
    <link:label id="lab_vtrs_DivestitureOfBusinessPercentageOwnershipInCombinedCompanyAfterTransaction_label_en-US" xlink:label="lab_vtrs_DivestitureOfBusinessPercentageOwnershipInCombinedCompanyAfterTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture Of Business, Percentage Ownership In Combined Company After Transaction</link:label>
    <link:label id="lab_vtrs_DivestitureOfBusinessPercentageOwnershipInCombinedCompanyAfterTransaction_documentation_en-US" xlink:label="lab_vtrs_DivestitureOfBusinessPercentageOwnershipInCombinedCompanyAfterTransaction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture Of Business, Percentage Ownership In Combined Company After Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DivestitureOfBusinessPercentageOwnershipInCombinedCompanyAfterTransaction" xlink:href="vtrs-20211231.xsd#vtrs_DivestitureOfBusinessPercentageOwnershipInCombinedCompanyAfterTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_DivestitureOfBusinessPercentageOwnershipInCombinedCompanyAfterTransaction" xlink:to="lab_vtrs_DivestitureOfBusinessPercentageOwnershipInCombinedCompanyAfterTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties_6ae25eab-bd41-4242-9813-c501023d0aca_terseLabel_en-US" xlink:label="lab_vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserve for Uncertain Tax Positions, Including Interest And Penalties</link:label>
    <link:label id="lab_vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties_label_en-US" xlink:label="lab_vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserve for Uncertain Tax Positions, Including Interest And Penalties</link:label>
    <link:label id="lab_vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties_documentation_en-US" xlink:label="lab_vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserve for Uncertain Tax Positions, Including Interest And Penalties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties" xlink:href="vtrs-20211231.xsd#vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties" xlink:to="lab_vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_b7e858d9-605f-43c3-b8f3-2e5da5cc087f_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average remaining contractual term for options exercisable, in years</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_RestructuringAndRelatedCostExpectedNumberOfFacilitiesToBeEliminated_3b8a9dbb-25c7-4cb4-b394-b9cef944a0d2_terseLabel_en-US" xlink:label="lab_vtrs_RestructuringAndRelatedCostExpectedNumberOfFacilitiesToBeEliminated" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Number of Facilities to be Eliminated</link:label>
    <link:label id="lab_vtrs_RestructuringAndRelatedCostExpectedNumberOfFacilitiesToBeEliminated_label_en-US" xlink:label="lab_vtrs_RestructuringAndRelatedCostExpectedNumberOfFacilitiesToBeEliminated" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Number of Facilities to be Eliminated</link:label>
    <link:label id="lab_vtrs_RestructuringAndRelatedCostExpectedNumberOfFacilitiesToBeEliminated_documentation_en-US" xlink:label="lab_vtrs_RestructuringAndRelatedCostExpectedNumberOfFacilitiesToBeEliminated" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Number of Facilities to be Eliminated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RestructuringAndRelatedCostExpectedNumberOfFacilitiesToBeEliminated" xlink:href="vtrs-20211231.xsd#vtrs_RestructuringAndRelatedCostExpectedNumberOfFacilitiesToBeEliminated"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_RestructuringAndRelatedCostExpectedNumberOfFacilitiesToBeEliminated" xlink:to="lab_vtrs_RestructuringAndRelatedCostExpectedNumberOfFacilitiesToBeEliminated" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_5080e388-ca80-4302-bc92-2207a0193b4b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan settlements</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Payment for Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_DevelopmentMilestonePayments_cc708d14-d5c2-4a83-b01c-5321350bbb2f_terseLabel_en-US" xlink:label="lab_vtrs_DevelopmentMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development Milestone Payments</link:label>
    <link:label id="lab_vtrs_DevelopmentMilestonePayments_label_en-US" xlink:label="lab_vtrs_DevelopmentMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development Milestone Payments</link:label>
    <link:label id="lab_vtrs_DevelopmentMilestonePayments_documentation_en-US" xlink:label="lab_vtrs_DevelopmentMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development Milestone Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DevelopmentMilestonePayments" xlink:href="vtrs-20211231.xsd#vtrs_DevelopmentMilestonePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_DevelopmentMilestonePayments" xlink:to="lab_vtrs_DevelopmentMilestonePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrentAbstract_d8eed775-9f86-41f7-b343-4ffcea4540be_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_AmortizationOfInventoryStepUp_83092782-30a8-4f5d-9f2d-6ac50e7a4a02_terseLabel_en-US" xlink:label="lab_vtrs_AmortizationOfInventoryStepUp" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Inventory Step Up</link:label>
    <link:label id="lab_vtrs_AmortizationOfInventoryStepUp_label_en-US" xlink:label="lab_vtrs_AmortizationOfInventoryStepUp" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Inventory Step Up</link:label>
    <link:label id="lab_vtrs_AmortizationOfInventoryStepUp_documentation_en-US" xlink:label="lab_vtrs_AmortizationOfInventoryStepUp" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Inventory Step Up</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AmortizationOfInventoryStepUp" xlink:href="vtrs-20211231.xsd#vtrs_AmortizationOfInventoryStepUp"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_AmortizationOfInventoryStepUp" xlink:to="lab_vtrs_AmortizationOfInventoryStepUp" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_OtherMember_c6791f7b-d751-4c05-ba18-4e3cb3b164b8_terseLabel_en-US" xlink:label="lab_vtrs_OtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Foreign Operations</link:label>
    <link:label id="lab_vtrs_OtherMember_label_en-US" xlink:label="lab_vtrs_OtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other [Member]</link:label>
    <link:label id="lab_vtrs_OtherMember_documentation_en-US" xlink:label="lab_vtrs_OtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US"></link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherMember" xlink:href="vtrs-20211231.xsd#vtrs_OtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_OtherMember" xlink:to="lab_vtrs_OtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_8401d7d3-fba3-4963-be90-c8cf48a9a84d_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Domain]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_2f04773c-98a2-44f1-ba29-14f7830eff15_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) earnings</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_3cd746b6-f758-49ee-af8f-a59fb740c47f_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_702b7239-dea4-42f3-8923-80c77d31071c_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_a7738b81-a181-4050-8f59-ee324df9f160_netLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) earnings</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_LesseeOperatingLeaseLeaseNotyetCommencedAmount_a76a9e88-eae5-4472-925b-510c77d47770_terseLabel_en-US" xlink:label="lab_vtrs_LesseeOperatingLeaseLeaseNotyetCommencedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of operating leases not yet commenced</link:label>
    <link:label id="lab_vtrs_LesseeOperatingLeaseLeaseNotyetCommencedAmount_label_en-US" xlink:label="lab_vtrs_LesseeOperatingLeaseLeaseNotyetCommencedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not yet Commenced, Amount</link:label>
    <link:label id="lab_vtrs_LesseeOperatingLeaseLeaseNotyetCommencedAmount_documentation_en-US" xlink:label="lab_vtrs_LesseeOperatingLeaseLeaseNotyetCommencedAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not yet Commenced, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_LesseeOperatingLeaseLeaseNotyetCommencedAmount" xlink:href="vtrs-20211231.xsd#vtrs_LesseeOperatingLeaseLeaseNotyetCommencedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_LesseeOperatingLeaseLeaseNotyetCommencedAmount" xlink:to="lab_vtrs_LesseeOperatingLeaseLeaseNotyetCommencedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_BrandsMember_44826dab-a9cf-4fa3-8693-dede8103dfc4_terseLabel_en-US" xlink:label="lab_vtrs_BrandsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Brands</link:label>
    <link:label id="lab_vtrs_BrandsMember_label_en-US" xlink:label="lab_vtrs_BrandsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Brands [Member]</link:label>
    <link:label id="lab_vtrs_BrandsMember_documentation_en-US" xlink:label="lab_vtrs_BrandsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Brands</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BrandsMember" xlink:href="vtrs-20211231.xsd#vtrs_BrandsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_BrandsMember" xlink:to="lab_vtrs_BrandsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryValuationReserves_706bdb02-eca7-4912-b52e-b3872a60c02b_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory reserves</link:label>
    <link:label id="lab_us-gaap_InventoryValuationReserves_label_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Valuation Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryValuationReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryValuationReserves" xlink:to="lab_us-gaap_InventoryValuationReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_VestinthreeyearsorlessMember_7076be27-3cb5-4270-9b7b-90223c93a273_terseLabel_en-US" xlink:label="lab_vtrs_VestinthreeyearsorlessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vest after three years</link:label>
    <link:label id="lab_vtrs_VestinthreeyearsorlessMember_label_en-US" xlink:label="lab_vtrs_VestinthreeyearsorlessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vest in three years or less [Member]</link:label>
    <link:label id="lab_vtrs_VestinthreeyearsorlessMember_documentation_en-US" xlink:label="lab_vtrs_VestinthreeyearsorlessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vest in three years or less</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VestinthreeyearsorlessMember" xlink:href="vtrs-20211231.xsd#vtrs_VestinthreeyearsorlessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_VestinthreeyearsorlessMember" xlink:to="lab_vtrs_VestinthreeyearsorlessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_dae99459-916b-4799-84ee-cfd6a10be489_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_83e6c463-c5ed-413a-8fc7-f1b54bf7519a_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash &#8212; beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1aafeb95-0530-4ec7-b215-30c9e46c421f_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash &#8212; end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_066e3ce7-b648-488a-ace7-2efc759cab4b_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_0edd300a-a7d9-4757-b269-0ad77b0c2d9b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_dfe455a7-9bc3-4ded-8643-a2feb97a10fb_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, par value, in USD per share</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_c623be4a-0f97-4509-ba8a-fe6bfec6cd36_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_DeferredTaxAssetsOperatingLeaseRightofUseAssets_5a6e314a-2711-4e13-a3dc-b53be70b410d_terseLabel_en-US" xlink:label="lab_vtrs_DeferredTaxAssetsOperatingLeaseRightofUseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease assets</link:label>
    <link:label id="lab_vtrs_DeferredTaxAssetsOperatingLeaseRightofUseAssets_label_en-US" xlink:label="lab_vtrs_DeferredTaxAssetsOperatingLeaseRightofUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Lease, Right-of-Use Assets</link:label>
    <link:label id="lab_vtrs_DeferredTaxAssetsOperatingLeaseRightofUseAssets_documentation_en-US" xlink:label="lab_vtrs_DeferredTaxAssetsOperatingLeaseRightofUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Lease, Right-of-Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DeferredTaxAssetsOperatingLeaseRightofUseAssets" xlink:href="vtrs-20211231.xsd#vtrs_DeferredTaxAssetsOperatingLeaseRightofUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_DeferredTaxAssetsOperatingLeaseRightofUseAssets" xlink:to="lab_vtrs_DeferredTaxAssetsOperatingLeaseRightofUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputEbitdaMultipleMember_410c509f-3e86-4d77-8afe-f67c13d8b63e_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputEbitdaMultipleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, EBITDA Multiple [Member]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputEbitdaMultipleMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputEbitdaMultipleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, EBITDA Multiple [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputEbitdaMultipleMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputEbitdaMultipleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputEbitdaMultipleMember" xlink:to="lab_us-gaap_MeasurementInputEbitdaMultipleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_28cd644c-16af-47c1-9b67-24a3e5984f17_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_70a3a986-93b8-4000-82a9-23448e13df4b_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_bbd3ae4c-d6f5-4161-9eba-1be4b4cf4cb1_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other items, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_3134ab70-a350-45f3-978c-e53d587632b3_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets, original cost</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_NumberOfProducts_05190404-4fd3-4b52-885f-9bba2914ce91_terseLabel_en-US" xlink:label="lab_vtrs_NumberOfProducts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Products</link:label>
    <link:label id="lab_vtrs_NumberOfProducts_label_en-US" xlink:label="lab_vtrs_NumberOfProducts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Products</link:label>
    <link:label id="lab_vtrs_NumberOfProducts_documentation_en-US" xlink:label="lab_vtrs_NumberOfProducts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Products</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NumberOfProducts" xlink:href="vtrs-20211231.xsd#vtrs_NumberOfProducts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_NumberOfProducts" xlink:to="lab_vtrs_NumberOfProducts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_e3c0b80e-5338-4e3a-b23c-d0696f14c042_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of intangible assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_e8a6233d-b40b-44ca-9ba5-7a0910e07104_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Long-Lived Assets Policy</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_f3add966-36a9-4551-8860-3013207f052c_terseLabel_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Revenue Service (IRS)</link:label>
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_label_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Revenue Service (IRS) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InternalRevenueServiceIRSMember" xlink:to="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_5ca903d6-a28d-4b08-9293-db7d6351da1d_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0ccde901-7dc0-47df-9296-e39249429247_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares exercised</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b961f7e8-d53b-4545-81cb-63b45edd5419_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares under stock awards, exercised</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments_10b85198-e369-41c7-a6d2-eb1d3532890f_terseLabel_en-US" xlink:label="lab_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration payments</link:label>
    <link:label id="lab_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments_9bd9c083-0b39-4a09-af9a-7d2d5d3773ce_negatedTerseLabel_en-US" xlink:label="lab_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments_label_en-US" xlink:label="lab_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Contingent Consideration Liability Payments</link:label>
    <link:label id="lab_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments_documentation_en-US" xlink:label="lab_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Contingent Consideration Liability Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationContingentConsiderationLiabilityPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments" xlink:to="lab_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_024e8d9f-841d-45af-b4df-1fa979e87c82_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) earnings, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_952c5cd8-e8e7-4aa1-bdae-0ab098ee3219_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserve_00df2510-13a3-4760-9961-ff2681fa5eab_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability</link:label>
    <link:label id="lab_us-gaap_LitigationReserve_label_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserve" xlink:to="lab_us-gaap_LitigationReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember_a6fedb5c-6b6f-4332-88e2-e9063f2a8256_terseLabel_en-US" xlink:label="lab_vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended Anticompetitive Conduct with Generic Drugs</link:label>
    <link:label id="lab_vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember_label_en-US" xlink:label="lab_vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended Anticompetitive Conduct with Generic Drugs [Member]</link:label>
    <link:label id="lab_vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember_documentation_en-US" xlink:label="lab_vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended Anticompetitive Conduct with Generic Drugs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember" xlink:href="vtrs-20211231.xsd#vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember" xlink:to="lab_vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_MaximumLeverageRatioPeriodTwo_bafc2cbe-39e8-4054-9ca5-6a48410b16cc_terseLabel_en-US" xlink:label="lab_vtrs_MaximumLeverageRatioPeriodTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Leverage Ratio, Period Two</link:label>
    <link:label id="lab_vtrs_MaximumLeverageRatioPeriodTwo_label_en-US" xlink:label="lab_vtrs_MaximumLeverageRatioPeriodTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Leverage Ratio, Period Two</link:label>
    <link:label id="lab_vtrs_MaximumLeverageRatioPeriodTwo_documentation_en-US" xlink:label="lab_vtrs_MaximumLeverageRatioPeriodTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Leverage Ratio, Period Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_MaximumLeverageRatioPeriodTwo" xlink:href="vtrs-20211231.xsd#vtrs_MaximumLeverageRatioPeriodTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_MaximumLeverageRatioPeriodTwo" xlink:to="lab_vtrs_MaximumLeverageRatioPeriodTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPayableCurrent_84b86f2c-0562-4529-b423-6288578410af_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest</link:label>
    <link:label id="lab_us-gaap_InterestPayableCurrent_label_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPayableCurrent" xlink:to="lab_us-gaap_InterestPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_9f606d6c-dfc9-4dab-8fa9-92060e8ff905_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Fair Value Hedges Recognized in Earnings</link:label>
    <link:label id="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_label_en-US" xlink:label="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Fair Value Hedges Recognized in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:to="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_PaymentsforBusinessSeparation_53640441-c5e7-4036-a2b9-a77d03f23a46_terseLabel_en-US" xlink:label="lab_vtrs_PaymentsforBusinessSeparation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Business Separation</link:label>
    <link:label id="lab_vtrs_PaymentsforBusinessSeparation_label_en-US" xlink:label="lab_vtrs_PaymentsforBusinessSeparation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Business Separation</link:label>
    <link:label id="lab_vtrs_PaymentsforBusinessSeparation_documentation_en-US" xlink:label="lab_vtrs_PaymentsforBusinessSeparation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Business Separation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PaymentsforBusinessSeparation" xlink:href="vtrs-20211231.xsd#vtrs_PaymentsforBusinessSeparation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_PaymentsforBusinessSeparation" xlink:to="lab_vtrs_PaymentsforBusinessSeparation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_ec3b5877-d385-4c22-b5dd-720ba911343e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions due to expirations of statute of limitations</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_061a8298-e1ab-451f-9846-fc6e78894a7d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentAssetsTextBlock_20040f69-3c85-40d5-aef8-d7da9fa21b2b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherCurrentAssetsTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentAssetsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentAssetsTextBlock" xlink:to="lab_us-gaap_OtherCurrentAssetsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_e5da2a59-4de1-4ffc-b262-93a1081d8a5b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments Policy</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_221aefae-6fb4-421f-8cb9-5ff420c88195_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ProductLiabilityMember_ac66982c-7b97-4a84-bc8c-c80b2d8b6dd1_terseLabel_en-US" xlink:label="lab_vtrs_ProductLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability</link:label>
    <link:label id="lab_vtrs_ProductLiabilityMember_label_en-US" xlink:label="lab_vtrs_ProductLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability [Member]</link:label>
    <link:label id="lab_vtrs_ProductLiabilityMember_documentation_en-US" xlink:label="lab_vtrs_ProductLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ProductLiabilityMember" xlink:href="vtrs-20211231.xsd#vtrs_ProductLiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ProductLiabilityMember" xlink:to="lab_vtrs_ProductLiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_b2aa53c1-d342-4824-9cd7-14330098064a_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_13400d2f-5cb5-4b20-b85b-569ec55fee2f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Projected benefit obligation, beginning of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_5d0d1ce8-0df8-422b-a14a-6f2d44f0eed8_verboseLabel_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and improvements</link:label>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_label_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and Building Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:to="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_46bf0d29-9ace-4cf5-af21-0957ece55f1f_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment_4f5687b0-aa9f-46fc-8ca3-9774bbdc01bd_terseLabel_en-US" xlink:label="lab_vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of restricted stock and stock options exercised, net (in shares)</link:label>
    <link:label id="lab_vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment_label_en-US" xlink:label="lab_vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised, Net of Shares Tendered for Payment</link:label>
    <link:label id="lab_vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment_documentation_en-US" xlink:label="lab_vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised, Net of Shares Tendered for Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment" xlink:href="vtrs-20211231.xsd#vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment" xlink:to="lab_vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_28af3d85-5b7d-4b77-9038-8a4f0aa578ab_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amount of derivative</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:to="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_EuropeSegmentMember_5c56bd6e-6ca6-4c5d-8054-572e9995047e_terseLabel_en-US" xlink:label="lab_vtrs_EuropeSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe Segment</link:label>
    <link:label id="lab_vtrs_EuropeSegmentMember_label_en-US" xlink:label="lab_vtrs_EuropeSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe Segment [Member]</link:label>
    <link:label id="lab_vtrs_EuropeSegmentMember_documentation_en-US" xlink:label="lab_vtrs_EuropeSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EuropeSegmentMember" xlink:href="vtrs-20211231.xsd#vtrs_EuropeSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_EuropeSegmentMember" xlink:to="lab_vtrs_EuropeSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_4119bd28-0ed9-4da1-a338-395bf5822e7e_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant-date fair value per share, released</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax_35482086-182b-4937-b898-2828245027ac_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_EffexorMember_1e2484aa-8aae-4d78-b1f7-be5b8b7c8c5b_terseLabel_en-US" xlink:label="lab_vtrs_EffexorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effexor &#174;</link:label>
    <link:label id="lab_vtrs_EffexorMember_label_en-US" xlink:label="lab_vtrs_EffexorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effexor &#174; [Member]</link:label>
    <link:label id="lab_vtrs_EffexorMember_documentation_en-US" xlink:label="lab_vtrs_EffexorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effexor &#174;</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EffexorMember" xlink:href="vtrs-20211231.xsd#vtrs_EffexorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_EffexorMember" xlink:to="lab_vtrs_EffexorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_3a9bf158-a5d4-4686-aeb4-708c513ae44a_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_0cdd901b-1a89-42aa-bc5f-77f189fb45f1_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid to acquire asset</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_NorvascMember_9c61cf9b-b254-48ef-b13b-cee6e416dea8_terseLabel_en-US" xlink:label="lab_vtrs_NorvascMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Norvasc &#174;</link:label>
    <link:label id="lab_vtrs_NorvascMember_label_en-US" xlink:label="lab_vtrs_NorvascMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Norvasc &#174; [Member]</link:label>
    <link:label id="lab_vtrs_NorvascMember_documentation_en-US" xlink:label="lab_vtrs_NorvascMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Norvasc &#174;</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NorvascMember" xlink:href="vtrs-20211231.xsd#vtrs_NorvascMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_NorvascMember" xlink:to="lab_vtrs_NorvascMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d68fd9f6-b21b-4914-9337-e2edabd147da_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_7afa344a-666b-48bd-b3fc-9890975f2f8b_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_0d719331-79bc-4276-989a-a1d98286606e_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_AccountsReceivableCreditsIssuedtoThirdParties_52b1f177-40cf-40e9-9647-18bb7c186442_negatedTerseLabel_en-US" xlink:label="lab_vtrs_AccountsReceivableCreditsIssuedtoThirdParties" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Checks/ Credits Issued to Third Parties</link:label>
    <link:label id="lab_vtrs_AccountsReceivableCreditsIssuedtoThirdParties_label_en-US" xlink:label="lab_vtrs_AccountsReceivableCreditsIssuedtoThirdParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credits Issued to Third Parties</link:label>
    <link:label id="lab_vtrs_AccountsReceivableCreditsIssuedtoThirdParties_documentation_en-US" xlink:label="lab_vtrs_AccountsReceivableCreditsIssuedtoThirdParties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credits Issued to Third Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccountsReceivableCreditsIssuedtoThirdParties" xlink:href="vtrs-20211231.xsd#vtrs_AccountsReceivableCreditsIssuedtoThirdParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_AccountsReceivableCreditsIssuedtoThirdParties" xlink:to="lab_vtrs_AccountsReceivableCreditsIssuedtoThirdParties" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_RevenuefromContractwithCustomerGross_36b02fbd-cb3e-450e-90ce-e4d536028215_terseLabel_en-US" xlink:label="lab_vtrs_RevenuefromContractwithCustomerGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross sales</link:label>
    <link:label id="lab_vtrs_RevenuefromContractwithCustomerGross_label_en-US" xlink:label="lab_vtrs_RevenuefromContractwithCustomerGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Gross</link:label>
    <link:label id="lab_vtrs_RevenuefromContractwithCustomerGross_documentation_en-US" xlink:label="lab_vtrs_RevenuefromContractwithCustomerGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RevenuefromContractwithCustomerGross" xlink:href="vtrs-20211231.xsd#vtrs_RevenuefromContractwithCustomerGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_RevenuefromContractwithCustomerGross" xlink:to="lab_vtrs_RevenuefromContractwithCustomerGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_947c6a88-07bc-4df3-9f6f-5bd8d8f7bb38_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_89593380-162a-47ca-818a-1e5c09417bc4_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_96bb708f-7020-4c6b-8443-09143a18fd23_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_2dc4e4fc-f0c4-4bb7-8be6-261fe16c6628_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_9a845dd1-30d5-4076-a2a0-12f5abd132d5_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rate of compensation increase</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_EquityMethodInvestmentsReductionInLongTermObligations_26d15995-a0ff-4238-bca1-2eaa23276359_terseLabel_en-US" xlink:label="lab_vtrs_EquityMethodInvestmentsReductionInLongTermObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments, Reduction In Long-Term Obligations</link:label>
    <link:label id="lab_vtrs_EquityMethodInvestmentsReductionInLongTermObligations_label_en-US" xlink:label="lab_vtrs_EquityMethodInvestmentsReductionInLongTermObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments, Reduction In Long-Term Obligations</link:label>
    <link:label id="lab_vtrs_EquityMethodInvestmentsReductionInLongTermObligations_documentation_en-US" xlink:label="lab_vtrs_EquityMethodInvestmentsReductionInLongTermObligations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments, Reduction In Long-Term Obligations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EquityMethodInvestmentsReductionInLongTermObligations" xlink:href="vtrs-20211231.xsd#vtrs_EquityMethodInvestmentsReductionInLongTermObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_EquityMethodInvestmentsReductionInLongTermObligations" xlink:to="lab_vtrs_EquityMethodInvestmentsReductionInLongTermObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies_4167f83c-34a8-4657-9fad-03218bad76cc_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation reserves</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_2ed5a7e7-a424-4ad4-8d4c-1f095854a5e2_terseLabel_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-backed Securities [Member]</link:label>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetBackedSecuritiesMember" xlink:to="lab_us-gaap_AssetBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_398f7d08-cf82-4c6a-b4f8-752f0b918667_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_42311c68-cddc-4625-8ea7-61a79c382555_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability derivatives, fair value</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Gross Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate_ae2abe48-c06e-4f4d-b1ba-927946701750_terseLabel_en-US" xlink:label="lab_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeiture rate</link:label>
    <link:label id="lab_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate_label_en-US" xlink:label="lab_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Forfeiture Rate</link:label>
    <link:label id="lab_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate_documentation_en-US" xlink:label="lab_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation arrangement by Share-based payment award, fair value assumptions, Forfeiture rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate" xlink:href="vtrs-20211231.xsd#vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate" xlink:to="lab_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_IncomeTaxExaminationReserveForUncertainTaxPosition_e927bde6-6e64-4909-9089-09a1f6f89933_terseLabel_en-US" xlink:label="lab_vtrs_IncomeTaxExaminationReserveForUncertainTaxPosition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Reserve for Uncertain Tax Position</link:label>
    <link:label id="lab_vtrs_IncomeTaxExaminationReserveForUncertainTaxPosition_label_en-US" xlink:label="lab_vtrs_IncomeTaxExaminationReserveForUncertainTaxPosition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Reserve for Uncertain Tax Position</link:label>
    <link:label id="lab_vtrs_IncomeTaxExaminationReserveForUncertainTaxPosition_documentation_en-US" xlink:label="lab_vtrs_IncomeTaxExaminationReserveForUncertainTaxPosition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Reserve for Uncertain Tax Position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_IncomeTaxExaminationReserveForUncertainTaxPosition" xlink:href="vtrs-20211231.xsd#vtrs_IncomeTaxExaminationReserveForUncertainTaxPosition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_IncomeTaxExaminationReserveForUncertainTaxPosition" xlink:to="lab_vtrs_IncomeTaxExaminationReserveForUncertainTaxPosition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_6f304480-e936-4d33-b88d-cf9eb20437c6_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_171e3654-6e06-4399-8166-f565f7b3d98a_periodStartLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_b13fe96b-e4ec-4290-aa58-9bcd81cb59cd_periodEndLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRent_0e48731b-8b5f-4838-b2e4-ac93505cd568_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Rent</link:label>
    <link:label id="lab_us-gaap_PaymentsForRent_label_en-US" xlink:label="lab_us-gaap_PaymentsForRent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Rent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRent" xlink:to="lab_us-gaap_PaymentsForRent" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassTable_4c7dd873-f0c1-49f7-a336-feb84030fd76_terseLabel_en-US" xlink:label="lab_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Rights and Licenses by Therapeutic Class [Table]</link:label>
    <link:label id="lab_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassTable_label_en-US" xlink:label="lab_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Rights and Licenses by Therapeutic Class [Table]</link:label>
    <link:label id="lab_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassTable_documentation_en-US" xlink:label="lab_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Rights and Licenses by Therapeutic Class</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassTable" xlink:href="vtrs-20211231.xsd#vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassTable" xlink:to="lab_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_918d6bac-bce0-4155-a74c-20c7412daecb_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2016SeniorRevolvingCreditFacilityMember_958cc337-51fe-4bff-9a0d-052913e42f2d_terseLabel_en-US" xlink:label="lab_vtrs_A2016SeniorRevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Senior Revolving Credit Facility</link:label>
    <link:label id="lab_vtrs_A2016SeniorRevolvingCreditFacilityMember_label_en-US" xlink:label="lab_vtrs_A2016SeniorRevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Senior Revolving Credit Facility [Member]</link:label>
    <link:label id="lab_vtrs_A2016SeniorRevolvingCreditFacilityMember_documentation_en-US" xlink:label="lab_vtrs_A2016SeniorRevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Senior Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2016SeniorRevolvingCreditFacilityMember" xlink:href="vtrs-20211231.xsd#vtrs_A2016SeniorRevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2016SeniorRevolvingCreditFacilityMember" xlink:to="lab_vtrs_A2016SeniorRevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_1950cfb5-eed9-43e8-809a-5e21101cd323_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories Policy</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_b18bad49-9d89-43be-8c6e-176c67632cba_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S. Current</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfOperations_61e63de2-77d5-4d15-9a86-2170681c0322_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_label_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations" xlink:to="lab_us-gaap_NatureOfOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_05e48ea3-a922-4b5a-8e24-08d29816a519_terseLabel_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Benefits</link:label>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:to="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_be31b7b8-f1e2-46ae-8cd1-107fbe6343e6_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intellectual Property</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_579e009e-de42-4fad-b07e-31e97b837250_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mature within one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_1bb2ddf3-6242-475d-b4d4-0fdfea0fc789_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_GoodwillImpairmentTestMeasurementInputReduction_bee7b3d6-48df-45ef-b685-947758b7d0f8_terseLabel_en-US" xlink:label="lab_vtrs_GoodwillImpairmentTestMeasurementInputReduction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Impairment Test, Measurement Input, Reduction</link:label>
    <link:label id="lab_vtrs_GoodwillImpairmentTestMeasurementInputReduction_label_en-US" xlink:label="lab_vtrs_GoodwillImpairmentTestMeasurementInputReduction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Impairment Test, Measurement Input, Reduction</link:label>
    <link:label id="lab_vtrs_GoodwillImpairmentTestMeasurementInputReduction_documentation_en-US" xlink:label="lab_vtrs_GoodwillImpairmentTestMeasurementInputReduction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Impairment Test, Measurement Input, Reduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GoodwillImpairmentTestMeasurementInputReduction" xlink:href="vtrs-20211231.xsd#vtrs_GoodwillImpairmentTestMeasurementInputReduction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_GoodwillImpairmentTestMeasurementInputReduction" xlink:to="lab_vtrs_GoodwillImpairmentTestMeasurementInputReduction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c7ca0857-2c1c-4497-a798-b0574c40fe13_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_OtherOneTimeNonoperatingExpense_310e4a4f-d1e4-4356-8e40-1706529eec9e_negatedTerseLabel_en-US" xlink:label="lab_vtrs_OtherOneTimeNonoperatingExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction related and other special items</link:label>
    <link:label id="lab_vtrs_OtherOneTimeNonoperatingExpense_label_en-US" xlink:label="lab_vtrs_OtherOneTimeNonoperatingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other One-Time Nonoperating Expense</link:label>
    <link:label id="lab_vtrs_OtherOneTimeNonoperatingExpense_documentation_en-US" xlink:label="lab_vtrs_OtherOneTimeNonoperatingExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other One-Time Nonoperating Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherOneTimeNonoperatingExpense" xlink:href="vtrs-20211231.xsd#vtrs_OtherOneTimeNonoperatingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_OtherOneTimeNonoperatingExpense" xlink:to="lab_vtrs_OtherOneTimeNonoperatingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_828e2dd4-8cf7-4582-a00a-b6b66d4c2baa_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net earnings to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_MomentaMember_5b494799-a6be-441f-9d01-8caf114a54fe_terseLabel_en-US" xlink:label="lab_vtrs_MomentaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Momenta</link:label>
    <link:label id="lab_vtrs_MomentaMember_label_en-US" xlink:label="lab_vtrs_MomentaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Momenta [Member]</link:label>
    <link:label id="lab_vtrs_MomentaMember_documentation_en-US" xlink:label="lab_vtrs_MomentaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Momenta [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_MomentaMember" xlink:href="vtrs-20211231.xsd#vtrs_MomentaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_MomentaMember" xlink:to="lab_vtrs_MomentaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vtrs_A2048SeniorNotesMember_4b84790f-2c26-4247-8fd9-63c49da0e053_terseLabel_en-US" xlink:label="lab_vtrs_A2048SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2048 Senior Notes [Member]</link:label>
    <link:label id="lab_vtrs_A2048SeniorNotesMember_label_en-US" xlink:label="lab_vtrs_A2048SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2048 Senior Notes [Member]</link:label>
    <link:label id="lab_vtrs_A2048SeniorNotesMember_documentation_en-US" xlink:label="lab_vtrs_A2048SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2048 Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2048SeniorNotesMember" xlink:href="vtrs-20211231.xsd#vtrs_A2048SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vtrs_A2048SeniorNotesMember" xlink:to="lab_vtrs_A2048SeniorNotesMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>vtrs-20211231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:7d588a56-150d-4ea9-a97c-5b39f92c59e0,g:83cb92d0-838c-40d0-a420-8487c2f4fc1b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.viatris.com/role/Cover" xlink:type="simple" xlink:href="vtrs-20211231.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_527ca0ed-b143-41b9-977d-b45f486811ba" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_d6c8f152-e19a-498d-901d-cd545f156330" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_527ca0ed-b143-41b9-977d-b45f486811ba" xlink:to="loc_dei_DocumentType_d6c8f152-e19a-498d-901d-cd545f156330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_350796e1-4f90-4f85-bb28-5a51e8bfe652" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_527ca0ed-b143-41b9-977d-b45f486811ba" xlink:to="loc_dei_DocumentAnnualReport_350796e1-4f90-4f85-bb28-5a51e8bfe652" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_eae59fb2-f147-4570-9597-b8bcd04fb4f7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_527ca0ed-b143-41b9-977d-b45f486811ba" xlink:to="loc_dei_DocumentPeriodEndDate_eae59fb2-f147-4570-9597-b8bcd04fb4f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_c545d669-79a4-427c-a425-102a28c9edfd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_527ca0ed-b143-41b9-977d-b45f486811ba" xlink:to="loc_dei_DocumentTransitionReport_c545d669-79a4-427c-a425-102a28c9edfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_22c75b62-9bfc-4121-b2bf-4705b8a317e0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_527ca0ed-b143-41b9-977d-b45f486811ba" xlink:to="loc_dei_EntityFileNumber_22c75b62-9bfc-4121-b2bf-4705b8a317e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_b5ca3000-0e60-46f9-8bdd-aebe3f9cfb1f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_527ca0ed-b143-41b9-977d-b45f486811ba" xlink:to="loc_dei_EntityRegistrantName_b5ca3000-0e60-46f9-8bdd-aebe3f9cfb1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_20c15868-bc56-4427-83fa-ed8166d75acb" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_527ca0ed-b143-41b9-977d-b45f486811ba" xlink:to="loc_dei_EntityIncorporationStateCountryCode_20c15868-bc56-4427-83fa-ed8166d75acb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_bd852836-acd6-49ea-8768-e3329f88889d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_527ca0ed-b143-41b9-977d-b45f486811ba" xlink:to="loc_dei_EntityTaxIdentificationNumber_bd852836-acd6-49ea-8768-e3329f88889d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_165cb310-152b-479b-b406-4b2e6aa3efcd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_527ca0ed-b143-41b9-977d-b45f486811ba" xlink:to="loc_dei_EntityAddressAddressLine1_165cb310-152b-479b-b406-4b2e6aa3efcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_b7ccc73a-cc66-4601-8923-b1373e4fa25e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_527ca0ed-b143-41b9-977d-b45f486811ba" xlink:to="loc_dei_EntityAddressCityOrTown_b7ccc73a-cc66-4601-8923-b1373e4fa25e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_7d99dd22-321d-4d70-89e7-504628cf2bd7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_527ca0ed-b143-41b9-977d-b45f486811ba" xlink:to="loc_dei_EntityAddressStateOrProvince_7d99dd22-321d-4d70-89e7-504628cf2bd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_b877294a-d992-4ff3-bafc-258e72e4eed7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_527ca0ed-b143-41b9-977d-b45f486811ba" xlink:to="loc_dei_EntityAddressPostalZipCode_b877294a-d992-4ff3-bafc-258e72e4eed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_5c5b2d04-d385-4eea-b003-bb6b2735adfd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_527ca0ed-b143-41b9-977d-b45f486811ba" xlink:to="loc_dei_CityAreaCode_5c5b2d04-d385-4eea-b003-bb6b2735adfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_adc1c9c4-882d-4f39-99a7-44cf59e6b190" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_527ca0ed-b143-41b9-977d-b45f486811ba" xlink:to="loc_dei_LocalPhoneNumber_adc1c9c4-882d-4f39-99a7-44cf59e6b190" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_3ef03c66-6096-44d2-b00e-09dcea8fac0a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_527ca0ed-b143-41b9-977d-b45f486811ba" xlink:to="loc_dei_Security12bTitle_3ef03c66-6096-44d2-b00e-09dcea8fac0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_35518f1c-9346-4f80-8da8-0b5a5907485e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_527ca0ed-b143-41b9-977d-b45f486811ba" xlink:to="loc_dei_TradingSymbol_35518f1c-9346-4f80-8da8-0b5a5907485e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_d898cbbc-23c8-4b09-8809-66f2b9aab47a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_527ca0ed-b143-41b9-977d-b45f486811ba" xlink:to="loc_dei_SecurityExchangeName_d898cbbc-23c8-4b09-8809-66f2b9aab47a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_a380323a-cc92-44fe-a730-3a744db8b321" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_527ca0ed-b143-41b9-977d-b45f486811ba" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_a380323a-cc92-44fe-a730-3a744db8b321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_a25dff8c-9186-4e08-9409-c5a7263077ee" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_527ca0ed-b143-41b9-977d-b45f486811ba" xlink:to="loc_dei_EntityVoluntaryFilers_a25dff8c-9186-4e08-9409-c5a7263077ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_924179a0-17ee-4914-9342-3860712df639" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_527ca0ed-b143-41b9-977d-b45f486811ba" xlink:to="loc_dei_EntityCurrentReportingStatus_924179a0-17ee-4914-9342-3860712df639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_56bed2dc-a136-47d1-8dd9-47d1909d1082" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_527ca0ed-b143-41b9-977d-b45f486811ba" xlink:to="loc_dei_EntityInteractiveDataCurrent_56bed2dc-a136-47d1-8dd9-47d1909d1082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_a3c185db-22f1-47c9-bcf2-39e21683278b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_527ca0ed-b143-41b9-977d-b45f486811ba" xlink:to="loc_dei_EntityFilerCategory_a3c185db-22f1-47c9-bcf2-39e21683278b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_25658a73-b1c4-463d-91ef-79c44aac3d51" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_527ca0ed-b143-41b9-977d-b45f486811ba" xlink:to="loc_dei_EntitySmallBusiness_25658a73-b1c4-463d-91ef-79c44aac3d51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_c1fcbb51-6d7c-4ba8-8ebe-c10227ac5610" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_527ca0ed-b143-41b9-977d-b45f486811ba" xlink:to="loc_dei_EntityEmergingGrowthCompany_c1fcbb51-6d7c-4ba8-8ebe-c10227ac5610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_d3cf6bd8-4781-4846-9c0a-bc70fa05ec5b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_527ca0ed-b143-41b9-977d-b45f486811ba" xlink:to="loc_dei_IcfrAuditorAttestationFlag_d3cf6bd8-4781-4846-9c0a-bc70fa05ec5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_a6ed193f-34d2-46d6-ac31-71ac24b54209" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_527ca0ed-b143-41b9-977d-b45f486811ba" xlink:to="loc_dei_EntityShellCompany_a6ed193f-34d2-46d6-ac31-71ac24b54209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_7b100c16-8792-4926-9c22-a1ac20b66b45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_527ca0ed-b143-41b9-977d-b45f486811ba" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_7b100c16-8792-4926-9c22-a1ac20b66b45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_38687ef9-8519-482b-a327-e9d2c68fd519" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_527ca0ed-b143-41b9-977d-b45f486811ba" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_38687ef9-8519-482b-a327-e9d2c68fd519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_155c6401-0cf6-4c3f-8d00-d9a74f3b68d4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_527ca0ed-b143-41b9-977d-b45f486811ba" xlink:to="loc_dei_EntityPublicFloat_155c6401-0cf6-4c3f-8d00-d9a74f3b68d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_86db17be-a267-4133-8e4e-c39f8754b33c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_527ca0ed-b143-41b9-977d-b45f486811ba" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_86db17be-a267-4133-8e4e-c39f8754b33c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_f88ee129-0c94-4433-b748-28a8b7daca6b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_527ca0ed-b143-41b9-977d-b45f486811ba" xlink:to="loc_dei_EntityCentralIndexKey_f88ee129-0c94-4433-b748-28a8b7daca6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_410f3f40-8ace-4b91-866a-c2843999bfc8" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_527ca0ed-b143-41b9-977d-b45f486811ba" xlink:to="loc_dei_AmendmentFlag_410f3f40-8ace-4b91-866a-c2843999bfc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_050299d0-80d1-4197-98d9-69b75b5153ce" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_527ca0ed-b143-41b9-977d-b45f486811ba" xlink:to="loc_dei_DocumentFiscalYearFocus_050299d0-80d1-4197-98d9-69b75b5153ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_8a46ea0e-0670-4b1d-9696-8950f3392342" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_527ca0ed-b143-41b9-977d-b45f486811ba" xlink:to="loc_dei_DocumentFiscalPeriodFocus_8a46ea0e-0670-4b1d-9696-8950f3392342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_7ceb146e-d1b3-4fc7-a9a9-dbaf8e5ce82f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_527ca0ed-b143-41b9-977d-b45f486811ba" xlink:to="loc_dei_CurrentFiscalYearEndDate_7ceb146e-d1b3-4fc7-a9a9-dbaf8e5ce82f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="vtrs-20211231.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_d2df03e0-991c-4a79-a53a-e089ce220843" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_7a8c063e-9bc0-4db0-a05b-564cb91cb1c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d2df03e0-991c-4a79-a53a-e089ce220843" xlink:to="loc_us-gaap_AssetsAbstract_7a8c063e-9bc0-4db0-a05b-564cb91cb1c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_f03ee142-dfe4-46e0-af03-5b765cbd7bbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7a8c063e-9bc0-4db0-a05b-564cb91cb1c4" xlink:to="loc_us-gaap_AssetsCurrentAbstract_f03ee142-dfe4-46e0-af03-5b765cbd7bbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b824aae6-8f43-492f-a58b-8484bcd98cac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f03ee142-dfe4-46e0-af03-5b765cbd7bbf" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b824aae6-8f43-492f-a58b-8484bcd98cac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_e7b93be8-3e3a-4b21-8882-873946fb576c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f03ee142-dfe4-46e0-af03-5b765cbd7bbf" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_e7b93be8-3e3a-4b21-8882-873946fb576c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_3fd38d5e-78af-46cb-80db-4117cb506a0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f03ee142-dfe4-46e0-af03-5b765cbd7bbf" xlink:to="loc_us-gaap_InventoryNet_3fd38d5e-78af-46cb-80db-4117cb506a0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_7ddab9c7-413b-474c-9fbb-048dc39c55a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f03ee142-dfe4-46e0-af03-5b765cbd7bbf" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_7ddab9c7-413b-474c-9fbb-048dc39c55a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_f692a4c9-5b3e-4cac-abd5-5cd2c02b4840" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f03ee142-dfe4-46e0-af03-5b765cbd7bbf" xlink:to="loc_us-gaap_AssetsCurrent_f692a4c9-5b3e-4cac-abd5-5cd2c02b4840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_17e57404-ae71-4949-95c4-29a6aa89b73e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7a8c063e-9bc0-4db0-a05b-564cb91cb1c4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_17e57404-ae71-4949-95c4-29a6aa89b73e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_641b9798-dea3-4aa9-b86b-73abf9d0eb80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7a8c063e-9bc0-4db0-a05b-564cb91cb1c4" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_641b9798-dea3-4aa9-b86b-73abf9d0eb80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_dfac1f59-21b2-42c7-b1a0-cc786ca62f37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7a8c063e-9bc0-4db0-a05b-564cb91cb1c4" xlink:to="loc_us-gaap_Goodwill_dfac1f59-21b2-42c7-b1a0-cc786ca62f37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_f2c15a6b-aae1-4d14-9bf3-8a8c8627b62f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7a8c063e-9bc0-4db0-a05b-564cb91cb1c4" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_f2c15a6b-aae1-4d14-9bf3-8a8c8627b62f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_bf9a62f6-a6b1-4a9d-8ed5-e5958c2bb446" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7a8c063e-9bc0-4db0-a05b-564cb91cb1c4" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_bf9a62f6-a6b1-4a9d-8ed5-e5958c2bb446" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_68ea9576-2e60-454d-8301-e480c45c4119" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7a8c063e-9bc0-4db0-a05b-564cb91cb1c4" xlink:to="loc_us-gaap_Assets_68ea9576-2e60-454d-8301-e480c45c4119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_39d2be11-85d9-4f08-9d91-2a4366b9f69f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d2df03e0-991c-4a79-a53a-e089ce220843" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_39d2be11-85d9-4f08-9d91-2a4366b9f69f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_a098efb2-8138-4e3c-af72-fc33b89f77f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_39d2be11-85d9-4f08-9d91-2a4366b9f69f" xlink:to="loc_us-gaap_LiabilitiesAbstract_a098efb2-8138-4e3c-af72-fc33b89f77f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_b9b3b240-bb63-4610-89c7-1bcc984ee2dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_a098efb2-8138-4e3c-af72-fc33b89f77f1" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_b9b3b240-bb63-4610-89c7-1bcc984ee2dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_2e6a6a09-e06e-4e79-8587-5e8831bc857d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b9b3b240-bb63-4610-89c7-1bcc984ee2dd" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_2e6a6a09-e06e-4e79-8587-5e8831bc857d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_be0b538b-fad6-4041-93e0-27f235996d46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b9b3b240-bb63-4610-89c7-1bcc984ee2dd" xlink:to="loc_us-gaap_ShortTermBorrowings_be0b538b-fad6-4041-93e0-27f235996d46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_db0990ca-74b1-4b6b-ba9a-7a2282be13fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b9b3b240-bb63-4610-89c7-1bcc984ee2dd" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_db0990ca-74b1-4b6b-ba9a-7a2282be13fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_f49bd791-11d8-4d7d-8512-55c43cb16b15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b9b3b240-bb63-4610-89c7-1bcc984ee2dd" xlink:to="loc_us-gaap_LongTermDebtCurrent_f49bd791-11d8-4d7d-8512-55c43cb16b15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_508d9a14-b0af-4f56-9475-b357cf1b94f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b9b3b240-bb63-4610-89c7-1bcc984ee2dd" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_508d9a14-b0af-4f56-9475-b357cf1b94f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_9ff855fd-c5c2-4953-a177-88a73774125d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b9b3b240-bb63-4610-89c7-1bcc984ee2dd" xlink:to="loc_us-gaap_LiabilitiesCurrent_9ff855fd-c5c2-4953-a177-88a73774125d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_f496b4e1-9065-4b27-8faf-c28ae84c9a4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_a098efb2-8138-4e3c-af72-fc33b89f77f1" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_f496b4e1-9065-4b27-8faf-c28ae84c9a4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_7b8ec299-1fcc-4112-8dfe-2649eda1a2ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_a098efb2-8138-4e3c-af72-fc33b89f77f1" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_7b8ec299-1fcc-4112-8dfe-2649eda1a2ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_62a0d877-e25a-4162-9874-3916751a9d4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_a098efb2-8138-4e3c-af72-fc33b89f77f1" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_62a0d877-e25a-4162-9874-3916751a9d4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_9440abab-6d86-4c86-b029-a030effc06a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_a098efb2-8138-4e3c-af72-fc33b89f77f1" xlink:to="loc_us-gaap_Liabilities_9440abab-6d86-4c86-b029-a030effc06a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_1bb6dfa5-d5d7-4d13-a1a4-0b6ad7cf6eff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_39d2be11-85d9-4f08-9d91-2a4366b9f69f" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_1bb6dfa5-d5d7-4d13-a1a4-0b6ad7cf6eff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_bf96503a-3530-4995-a7b7-ac215f8fea92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_1bb6dfa5-d5d7-4d13-a1a4-0b6ad7cf6eff" xlink:to="loc_us-gaap_StockholdersEquityAbstract_bf96503a-3530-4995-a7b7-ac215f8fea92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_a9005f27-3943-4ff8-aea0-7ff44d6268a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_bf96503a-3530-4995-a7b7-ac215f8fea92" xlink:to="loc_us-gaap_CommonStockValue_a9005f27-3943-4ff8-aea0-7ff44d6268a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_0ad1d7ed-c98c-4267-9d89-7e87bf72c488" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_bf96503a-3530-4995-a7b7-ac215f8fea92" xlink:to="loc_us-gaap_AdditionalPaidInCapital_0ad1d7ed-c98c-4267-9d89-7e87bf72c488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_87731d3e-aa27-4a8d-a1b6-39bf39618fff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_bf96503a-3530-4995-a7b7-ac215f8fea92" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_87731d3e-aa27-4a8d-a1b6-39bf39618fff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_bb09d90c-0858-4f1e-843e-d8fa1175ee71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_bf96503a-3530-4995-a7b7-ac215f8fea92" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_bb09d90c-0858-4f1e-843e-d8fa1175ee71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_02dc544f-ab0d-4112-af25-974cc124cdbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_1bb6dfa5-d5d7-4d13-a1a4-0b6ad7cf6eff" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_02dc544f-ab0d-4112-af25-974cc124cdbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_37b653fc-4b9b-401f-a456-4fed3b4449f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_39d2be11-85d9-4f08-9d91-2a4366b9f69f" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_37b653fc-4b9b-401f-a456-4fed3b4449f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="vtrs-20211231.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_bf969dcd-d085-43a3-b054-9b92560e0014" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f070a775-ead4-461d-8bb3-f48669e6e0f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bf969dcd-d085-43a3-b054-9b92560e0014" xlink:to="loc_us-gaap_StatementTable_f070a775-ead4-461d-8bb3-f48669e6e0f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2593d148-6e5d-465c-9dbb-e399ee9adca4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f070a775-ead4-461d-8bb3-f48669e6e0f3" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2593d148-6e5d-465c-9dbb-e399ee9adca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2f212373-dff6-48ac-bec5-c3af454828c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2593d148-6e5d-465c-9dbb-e399ee9adca4" xlink:to="loc_us-gaap_EquityComponentDomain_2f212373-dff6-48ac-bec5-c3af454828c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_b73fcd55-3005-4b0a-96de-34affb6000e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2f212373-dff6-48ac-bec5-c3af454828c4" xlink:to="loc_us-gaap_CommonStockMember_b73fcd55-3005-4b0a-96de-34affb6000e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_c8fc063e-64fb-4ca2-b1ef-8e80a5262e9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2f212373-dff6-48ac-bec5-c3af454828c4" xlink:to="loc_us-gaap_TreasuryStockMember_c8fc063e-64fb-4ca2-b1ef-8e80a5262e9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_9185dde5-34fb-4d36-80f2-df4aee9fa43b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f070a775-ead4-461d-8bb3-f48669e6e0f3" xlink:to="loc_us-gaap_StatementLineItems_9185dde5-34fb-4d36-80f2-df4aee9fa43b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_f8267515-7d51-4842-a316-201348c6cbcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9185dde5-34fb-4d36-80f2-df4aee9fa43b" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_f8267515-7d51-4842-a316-201348c6cbcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_baa7b8b8-9ffc-4690-8e3f-e903e82b612b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9185dde5-34fb-4d36-80f2-df4aee9fa43b" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_baa7b8b8-9ffc-4690-8e3f-e903e82b612b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_ff12bff8-b6b0-4a83-ba57-499ae1946a87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9185dde5-34fb-4d36-80f2-df4aee9fa43b" xlink:to="loc_us-gaap_SharesIssued_ff12bff8-b6b0-4a83-ba57-499ae1946a87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="vtrs-20211231.xsd#ConsolidatedStatementsofOperations"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_510d56a5-49af-44e8-bb23-2b8eb2745157" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_59bada12-23b1-4a49-9081-6a4d65cf1787" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_510d56a5-49af-44e8-bb23-2b8eb2745157" xlink:to="loc_us-gaap_StatementTable_59bada12-23b1-4a49-9081-6a4d65cf1787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_70a3419c-8f2e-457c-bc26-60a5d4ccffa8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_59bada12-23b1-4a49-9081-6a4d65cf1787" xlink:to="loc_srt_ProductOrServiceAxis_70a3419c-8f2e-457c-bc26-60a5d4ccffa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c4ed81e0-b696-447f-9817-890cdce5abe7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_70a3419c-8f2e-457c-bc26-60a5d4ccffa8" xlink:to="loc_srt_ProductsAndServicesDomain_c4ed81e0-b696-447f-9817-890cdce5abe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_22d223a6-6b48-45b0-bedb-b39e3637ba4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c4ed81e0-b696-447f-9817-890cdce5abe7" xlink:to="loc_us-gaap_ProductMember_22d223a6-6b48-45b0-bedb-b39e3637ba4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_f98316df-4677-45de-84f5-b067b0121bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c4ed81e0-b696-447f-9817-890cdce5abe7" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_f98316df-4677-45de-84f5-b067b0121bdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_adf9484d-8baf-4a63-adfe-25d1ec0594f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_59bada12-23b1-4a49-9081-6a4d65cf1787" xlink:to="loc_us-gaap_StatementLineItems_adf9484d-8baf-4a63-adfe-25d1ec0594f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_9fc96218-ed98-4456-a0f5-d24eac9c99d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_adf9484d-8baf-4a63-adfe-25d1ec0594f2" xlink:to="loc_us-gaap_RevenuesAbstract_9fc96218-ed98-4456-a0f5-d24eac9c99d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_24407d64-090f-46a8-b24c-af395e0952a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_9fc96218-ed98-4456-a0f5-d24eac9c99d9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_24407d64-090f-46a8-b24c-af395e0952a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer_e69e6c87-665b-40dd-bb52-e30b3c73e963" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_9fc96218-ed98-4456-a0f5-d24eac9c99d9" xlink:to="loc_us-gaap_RevenueNotFromContractWithCustomer_e69e6c87-665b-40dd-bb52-e30b3c73e963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_41e10ce1-731f-462f-8d0b-400bb88457d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_9fc96218-ed98-4456-a0f5-d24eac9c99d9" xlink:to="loc_us-gaap_Revenues_41e10ce1-731f-462f-8d0b-400bb88457d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_376784aa-71e3-4b72-864a-124a7f3710d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_adf9484d-8baf-4a63-adfe-25d1ec0594f2" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_376784aa-71e3-4b72-864a-124a7f3710d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_c6b6d2d4-114b-4a86-9c25-6fb0bfa7d536" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_adf9484d-8baf-4a63-adfe-25d1ec0594f2" xlink:to="loc_us-gaap_GrossProfit_c6b6d2d4-114b-4a86-9c25-6fb0bfa7d536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_3752b867-8f27-4362-b782-3c1bb84e5b81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_adf9484d-8baf-4a63-adfe-25d1ec0594f2" xlink:to="loc_us-gaap_OperatingExpensesAbstract_3752b867-8f27-4362-b782-3c1bb84e5b81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_30b68773-4c46-4b42-b6d8-b2d8ee7022ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_3752b867-8f27-4362-b782-3c1bb84e5b81" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_30b68773-4c46-4b42-b6d8-b2d8ee7022ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_5f6abacd-12a8-4446-a6af-933d0cffe0d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_3752b867-8f27-4362-b782-3c1bb84e5b81" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_5f6abacd-12a8-4446-a6af-933d0cffe0d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_ecf89a6f-8649-4eed-829a-2e92c359afc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_3752b867-8f27-4362-b782-3c1bb84e5b81" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_ecf89a6f-8649-4eed-829a-2e92c359afc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_e9deb54f-09b8-472e-9f5a-b7f55bddf561" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_3752b867-8f27-4362-b782-3c1bb84e5b81" xlink:to="loc_us-gaap_OperatingExpenses_e9deb54f-09b8-472e-9f5a-b7f55bddf561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_88666693-2f65-4d71-8564-9f0070f781ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_adf9484d-8baf-4a63-adfe-25d1ec0594f2" xlink:to="loc_us-gaap_OperatingIncomeLoss_88666693-2f65-4d71-8564-9f0070f781ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_24aec18d-f296-41b0-8860-19090e622d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_adf9484d-8baf-4a63-adfe-25d1ec0594f2" xlink:to="loc_us-gaap_InterestExpense_24aec18d-f296-41b0-8860-19090e622d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_1572d2e9-1e44-4e88-b61f-2b217a4b48f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_adf9484d-8baf-4a63-adfe-25d1ec0594f2" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_1572d2e9-1e44-4e88-b61f-2b217a4b48f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e5448695-f9c5-46f2-8438-1d5298963e28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_adf9484d-8baf-4a63-adfe-25d1ec0594f2" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e5448695-f9c5-46f2-8438-1d5298963e28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_734c541a-f2db-439f-a9af-e069b84ea224" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_adf9484d-8baf-4a63-adfe-25d1ec0594f2" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_734c541a-f2db-439f-a9af-e069b84ea224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_70014ef6-d6d2-45a1-b7aa-ae3f47888ce0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_adf9484d-8baf-4a63-adfe-25d1ec0594f2" xlink:to="loc_us-gaap_ProfitLoss_70014ef6-d6d2-45a1-b7aa-ae3f47888ce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_2a547c5c-d254-4e14-ae19-e0c7e80dbea4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_adf9484d-8baf-4a63-adfe-25d1ec0594f2" xlink:to="loc_us-gaap_EarningsPerShareAbstract_2a547c5c-d254-4e14-ae19-e0c7e80dbea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_b5dfd9db-06b0-4d6c-9ae2-d7028c33cb01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2a547c5c-d254-4e14-ae19-e0c7e80dbea4" xlink:to="loc_us-gaap_EarningsPerShareBasic_b5dfd9db-06b0-4d6c-9ae2-d7028c33cb01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_71361ecc-b727-4ff1-9c42-634840d6e510" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2a547c5c-d254-4e14-ae19-e0c7e80dbea4" xlink:to="loc_us-gaap_EarningsPerShareDiluted_71361ecc-b727-4ff1-9c42-634840d6e510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_f0c5af6d-c079-4ac9-9cf3-d41f43f89288" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_adf9484d-8baf-4a63-adfe-25d1ec0594f2" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_f0c5af6d-c079-4ac9-9cf3-d41f43f89288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_390ea1fe-3324-495a-98ee-1f95857d7122" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_f0c5af6d-c079-4ac9-9cf3-d41f43f89288" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_390ea1fe-3324-495a-98ee-1f95857d7122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_00e9b73a-cfc8-4293-bba4-3bf13f102e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_f0c5af6d-c079-4ac9-9cf3-d41f43f89288" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_00e9b73a-cfc8-4293-bba4-3bf13f102e5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ConsolidatedStatementsofComprehensiveEarnings" xlink:type="simple" xlink:href="vtrs-20211231.xsd#ConsolidatedStatementsofComprehensiveEarnings"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/ConsolidatedStatementsofComprehensiveEarnings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_124ee103-a55f-4f19-ac6d-7705c04bbcc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e1186eaf-0e25-471f-a025-6e41163eda36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_124ee103-a55f-4f19-ac6d-7705c04bbcc2" xlink:to="loc_us-gaap_StatementTable_e1186eaf-0e25-471f-a025-6e41163eda36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6efa85f0-71dc-4faf-9bae-39d09d0804b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e1186eaf-0e25-471f-a025-6e41163eda36" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6efa85f0-71dc-4faf-9bae-39d09d0804b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_ef664cae-bc80-4aff-9ca7-df69ae8b889e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6efa85f0-71dc-4faf-9bae-39d09d0804b4" xlink:to="loc_us-gaap_HedgingRelationshipDomain_ef664cae-bc80-4aff-9ca7-df69ae8b889e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_6804d967-fdcf-4e65-9c11-f545c6b3f956" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_ef664cae-bc80-4aff-9ca7-df69ae8b889e" xlink:to="loc_us-gaap_CashFlowHedgingMember_6804d967-fdcf-4e65-9c11-f545c6b3f956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_6c67c92d-3f1e-41f0-9b00-344055cd1957" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_ef664cae-bc80-4aff-9ca7-df69ae8b889e" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_6c67c92d-3f1e-41f0-9b00-344055cd1957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_79213795-71df-417f-ba5f-089951a68e67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e1186eaf-0e25-471f-a025-6e41163eda36" xlink:to="loc_us-gaap_StatementLineItems_79213795-71df-417f-ba5f-089951a68e67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_9062e93d-16a7-483e-884f-34f8e393b92e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_79213795-71df-417f-ba5f-089951a68e67" xlink:to="loc_us-gaap_ProfitLoss_9062e93d-16a7-483e-884f-34f8e393b92e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_24d4ef07-1bd6-4a37-b0c6-989f26a417c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_79213795-71df-417f-ba5f-089951a68e67" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_24d4ef07-1bd6-4a37-b0c6-989f26a417c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_148f2334-a588-4442-aca8-de95e71ec5c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_24d4ef07-1bd6-4a37-b0c6-989f26a417c1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_148f2334-a588-4442-aca8-de95e71ec5c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_2ae38a55-f80c-43a9-bf23-f9486396bad6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_24d4ef07-1bd6-4a37-b0c6-989f26a417c1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_2ae38a55-f80c-43a9-bf23-f9486396bad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_35596636-9c82-4822-a999-9232fbfdb9a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_24d4ef07-1bd6-4a37-b0c6-989f26a417c1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_35596636-9c82-4822-a999-9232fbfdb9a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_844d4014-bb26-4e2c-abd9-465586eac1a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_24d4ef07-1bd6-4a37-b0c6-989f26a417c1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_844d4014-bb26-4e2c-abd9-465586eac1a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_e49035d2-0106-425a-b716-68ac913d0baf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_24d4ef07-1bd6-4a37-b0c6-989f26a417c1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_e49035d2-0106-425a-b716-68ac913d0baf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_e33bf1ba-0164-473d-8d65-8c79a5ee4e24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_79213795-71df-417f-ba5f-089951a68e67" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_e33bf1ba-0164-473d-8d65-8c79a5ee4e24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_32f51770-13e3-446d-8469-2abd1ef1a549" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_79213795-71df-417f-ba5f-089951a68e67" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_32f51770-13e3-446d-8469-2abd1ef1a549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_02448911-c95a-4d2e-b3ab-448a6bee643b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_79213795-71df-417f-ba5f-089951a68e67" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_02448911-c95a-4d2e-b3ab-448a6bee643b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ConsolidatedStatementsofEquity" xlink:type="simple" xlink:href="vtrs-20211231.xsd#ConsolidatedStatementsofEquity"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/ConsolidatedStatementsofEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_b8378607-7696-4279-824d-6da85d3c2b92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_82106073-07b8-4eed-88eb-f3a526f9d5b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_b8378607-7696-4279-824d-6da85d3c2b92" xlink:to="loc_us-gaap_StatementTable_82106073-07b8-4eed-88eb-f3a526f9d5b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_eb7d9bd4-f9a3-4708-9a3e-6b9636f55166" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_82106073-07b8-4eed-88eb-f3a526f9d5b0" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_eb7d9bd4-f9a3-4708-9a3e-6b9636f55166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b512308d-b1fc-4feb-866e-b3541ab7db20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_eb7d9bd4-f9a3-4708-9a3e-6b9636f55166" xlink:to="loc_us-gaap_EquityComponentDomain_b512308d-b1fc-4feb-866e-b3541ab7db20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_ed96a069-133d-4019-b7b0-ef57c20dc153" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b512308d-b1fc-4feb-866e-b3541ab7db20" xlink:to="loc_us-gaap_CommonStockMember_ed96a069-133d-4019-b7b0-ef57c20dc153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_157a417e-932f-4a39-9f2b-348c6ca27bbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b512308d-b1fc-4feb-866e-b3541ab7db20" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_157a417e-932f-4a39-9f2b-348c6ca27bbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_6a33b3a6-bb67-41c9-9989-b77996b1d69f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b512308d-b1fc-4feb-866e-b3541ab7db20" xlink:to="loc_us-gaap_RetainedEarningsMember_6a33b3a6-bb67-41c9-9989-b77996b1d69f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_7525e9db-b38e-40f9-b752-984c4f89a904" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b512308d-b1fc-4feb-866e-b3541ab7db20" xlink:to="loc_us-gaap_TreasuryStockMember_7525e9db-b38e-40f9-b752-984c4f89a904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_135d8377-cc23-4113-9269-20be010ffef0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b512308d-b1fc-4feb-866e-b3541ab7db20" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_135d8377-cc23-4113-9269-20be010ffef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f71b576e-34dc-479b-b6f3-356b5a4e1457" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_82106073-07b8-4eed-88eb-f3a526f9d5b0" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f71b576e-34dc-479b-b6f3-356b5a4e1457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_4703e4f4-c318-443b-b853-e7c3ddde67e0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f71b576e-34dc-479b-b6f3-356b5a4e1457" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_4703e4f4-c318-443b-b853-e7c3ddde67e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_450b8d17-7e44-4c5a-b35b-0bb9fd20db72" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_4703e4f4-c318-443b-b853-e7c3ddde67e0" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_450b8d17-7e44-4c5a-b35b-0bb9fd20db72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_8ee952ac-5d27-4747-a3f7-8a0d75767726" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_82106073-07b8-4eed-88eb-f3a526f9d5b0" xlink:to="loc_us-gaap_StatementLineItems_8ee952ac-5d27-4747-a3f7-8a0d75767726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9e714754-3a31-4e38-8c54-b009d9de834d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8ee952ac-5d27-4747-a3f7-8a0d75767726" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9e714754-3a31-4e38-8c54-b009d9de834d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_7188a5b3-9f0d-4172-8d6b-fdc8497b33cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8ee952ac-5d27-4747-a3f7-8a0d75767726" xlink:to="loc_us-gaap_SharesIssued_7188a5b3-9f0d-4172-8d6b-fdc8497b33cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_df25cc1c-6794-4dde-9aff-a189609987a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8ee952ac-5d27-4747-a3f7-8a0d75767726" xlink:to="loc_us-gaap_ProfitLoss_df25cc1c-6794-4dde-9aff-a189609987a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3e0af63c-b4b0-41e0-a890-6d1ead3d43b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8ee952ac-5d27-4747-a3f7-8a0d75767726" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3e0af63c-b4b0-41e0-a890-6d1ead3d43b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_7f0e72f0-94d2-460b-8629-a3a62564640a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8ee952ac-5d27-4747-a3f7-8a0d75767726" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_7f0e72f0-94d2-460b-8629-a3a62564640a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_28772b11-7f91-4f5d-aefb-c548e5428080" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8ee952ac-5d27-4747-a3f7-8a0d75767726" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_28772b11-7f91-4f5d-aefb-c548e5428080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_9e9ee6cf-10ff-4980-9ca0-021ceddd3112" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8ee952ac-5d27-4747-a3f7-8a0d75767726" xlink:to="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_9e9ee6cf-10ff-4980-9ca0-021ceddd3112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment_51f61bf8-57a5-4e1d-ac02-d3c6588a0811" xlink:href="vtrs-20211231.xsd#vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8ee952ac-5d27-4747-a3f7-8a0d75767726" xlink:to="loc_vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment_51f61bf8-57a5-4e1d-ac02-d3c6588a0811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet_14c4b9f2-ea17-4e05-b16c-96a516bdbf19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8ee952ac-5d27-4747-a3f7-8a0d75767726" xlink:to="loc_us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet_14c4b9f2-ea17-4e05-b16c-96a516bdbf19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired_f37833f6-f5c6-4896-9336-13e742905a6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8ee952ac-5d27-4747-a3f7-8a0d75767726" xlink:to="loc_us-gaap_TreasuryStockSharesRetired_f37833f6-f5c6-4896-9336-13e742905a6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_StockExchangedDuringPeriodValue_29ba89b1-7417-4e2d-836d-6210afb76f42" xlink:href="vtrs-20211231.xsd#vtrs_StockExchangedDuringPeriodValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8ee952ac-5d27-4747-a3f7-8a0d75767726" xlink:to="loc_vtrs_StockExchangedDuringPeriodValue_29ba89b1-7417-4e2d-836d-6210afb76f42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_StockExchangedDuringPeriodSharesExchanged_63d08af5-d34c-4c7b-b6d4-e06d42881a45" xlink:href="vtrs-20211231.xsd#vtrs_StockExchangedDuringPeriodSharesExchanged"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8ee952ac-5d27-4747-a3f7-8a0d75767726" xlink:to="loc_vtrs_StockExchangedDuringPeriodSharesExchanged_63d08af5-d34c-4c7b-b6d4-e06d42881a45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_4292618d-02d1-4933-ac0b-be8e3644a061" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8ee952ac-5d27-4747-a3f7-8a0d75767726" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_4292618d-02d1-4933-ac0b-be8e3644a061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_db16f538-5b54-4883-9dcd-c5a9cbb0feff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8ee952ac-5d27-4747-a3f7-8a0d75767726" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_db16f538-5b54-4883-9dcd-c5a9cbb0feff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_2ebef1cb-fe9d-41ec-ba77-57158c3c7e27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8ee952ac-5d27-4747-a3f7-8a0d75767726" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_2ebef1cb-fe9d-41ec-ba77-57158c3c7e27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_5e1fa22a-a965-4a02-82c1-939124a5117c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8ee952ac-5d27-4747-a3f7-8a0d75767726" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_5e1fa22a-a965-4a02-82c1-939124a5117c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_aceb9cde-e8de-4b1b-ab24-ed3fdb4ccd1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockRetiredCostMethodAmount"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8ee952ac-5d27-4747-a3f7-8a0d75767726" xlink:to="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_aceb9cde-e8de-4b1b-ab24-ed3fdb4ccd1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_e3155d7b-88d3-4fc1-a469-abc250a807b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8ee952ac-5d27-4747-a3f7-8a0d75767726" xlink:to="loc_us-gaap_DividendsCommonStockCash_e3155d7b-88d3-4fc1-a469-abc250a807b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1abadd5c-9272-4db0-b600-d630d2c44527" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8ee952ac-5d27-4747-a3f7-8a0d75767726" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1abadd5c-9272-4db0-b600-d630d2c44527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_b5f87d16-acad-48a9-b276-f376c5eacb1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8ee952ac-5d27-4747-a3f7-8a0d75767726" xlink:to="loc_us-gaap_SharesIssued_b5f87d16-acad-48a9-b276-f376c5eacb1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ConsolidatedStatementsofEquityParenthetical" xlink:type="simple" xlink:href="vtrs-20211231.xsd#ConsolidatedStatementsofEquityParenthetical"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/ConsolidatedStatementsofEquityParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_a5df5543-ab9a-4207-8117-d7cc50109d7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_81217e31-a7b7-4526-a31f-0f5215c97cfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_a5df5543-ab9a-4207-8117-d7cc50109d7b" xlink:to="loc_us-gaap_StatementTable_81217e31-a7b7-4526-a31f-0f5215c97cfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_13c3c1c4-b31a-413c-939e-3415aee1dd15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_81217e31-a7b7-4526-a31f-0f5215c97cfe" xlink:to="loc_us-gaap_StatementClassOfStockAxis_13c3c1c4-b31a-413c-939e-3415aee1dd15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_2a6146f1-00bc-4970-8f6f-8afab7e280df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_13c3c1c4-b31a-413c-939e-3415aee1dd15" xlink:to="loc_us-gaap_ClassOfStockDomain_2a6146f1-00bc-4970-8f6f-8afab7e280df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_ec16e220-c7e4-4bb1-ae99-18aa2bc9180b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_2a6146f1-00bc-4970-8f6f-8afab7e280df" xlink:to="loc_us-gaap_CommonStockMember_ec16e220-c7e4-4bb1-ae99-18aa2bc9180b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_110a0904-7a03-4c97-aff2-16b20ce046ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_81217e31-a7b7-4526-a31f-0f5215c97cfe" xlink:to="loc_us-gaap_StatementLineItems_110a0904-7a03-4c97-aff2-16b20ce046ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_d69bf914-3a81-4a0a-8be2-9a433c142746" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_110a0904-7a03-4c97-aff2-16b20ce046ca" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_d69bf914-3a81-4a0a-8be2-9a433c142746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="vtrs-20211231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_e2d07c71-c45c-47b7-b539-357bb543e2b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f6986436-217e-4386-b6b0-eb86d213c9c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e2d07c71-c45c-47b7-b539-357bb543e2b5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f6986436-217e-4386-b6b0-eb86d213c9c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_1764384a-f311-4469-a132-cdd542cebabb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f6986436-217e-4386-b6b0-eb86d213c9c4" xlink:to="loc_us-gaap_ProfitLoss_1764384a-f311-4469-a132-cdd542cebabb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e96f7198-f1ca-48a0-8008-2a3f834c96de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f6986436-217e-4386-b6b0-eb86d213c9c4" xlink:to="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e96f7198-f1ca-48a0-8008-2a3f834c96de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_eced7a90-788d-4a46-8839-d06d353dc969" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e96f7198-f1ca-48a0-8008-2a3f834c96de" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_eced7a90-788d-4a46-8839-d06d353dc969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_07cd2469-2dad-45ae-b948-77b2fe49029e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e96f7198-f1ca-48a0-8008-2a3f834c96de" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_07cd2469-2dad-45ae-b948-77b2fe49029e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Changeinnoncashlitigationsettlementsnet_83406dbf-5f40-46db-8d0d-72884e37d276" xlink:href="vtrs-20211231.xsd#vtrs_Changeinnoncashlitigationsettlementsnet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e96f7198-f1ca-48a0-8008-2a3f834c96de" xlink:to="loc_vtrs_Changeinnoncashlitigationsettlementsnet_83406dbf-5f40-46db-8d0d-72884e37d276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_91e7d330-85f8-4760-bab1-3b85a695d6bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e96f7198-f1ca-48a0-8008-2a3f834c96de" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_91e7d330-85f8-4760-bab1-3b85a695d6bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_ece81635-8a77-4957-b0c8-703425b11036" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e96f7198-f1ca-48a0-8008-2a3f834c96de" xlink:to="loc_us-gaap_ShareBasedCompensation_ece81635-8a77-4957-b0c8-703425b11036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_9c86a101-8ece-45d2-866a-a024ed4bd4cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e96f7198-f1ca-48a0-8008-2a3f834c96de" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_9c86a101-8ece-45d2-866a-a024ed4bd4cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_226bf337-14e2-4535-92cb-a9f50d45459d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e96f7198-f1ca-48a0-8008-2a3f834c96de" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_226bf337-14e2-4535-92cb-a9f50d45459d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_a1df393d-1bc3-40ae-a891-4e39078d9181" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_226bf337-14e2-4535-92cb-a9f50d45459d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_a1df393d-1bc3-40ae-a891-4e39078d9181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_2b71a307-ed25-4583-af73-1f4afb81623f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_226bf337-14e2-4535-92cb-a9f50d45459d" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_2b71a307-ed25-4583-af73-1f4afb81623f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_129f35a9-4f45-4225-ae82-6bd8c1c77930" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_226bf337-14e2-4535-92cb-a9f50d45459d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_129f35a9-4f45-4225-ae82-6bd8c1c77930" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_2126f815-3d5e-446a-8807-5397ddd7bb46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_226bf337-14e2-4535-92cb-a9f50d45459d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_2126f815-3d5e-446a-8807-5397ddd7bb46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_e391c7ea-13c2-4d11-947f-a1359f14acd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_226bf337-14e2-4535-92cb-a9f50d45459d" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_e391c7ea-13c2-4d11-947f-a1359f14acd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c1dd0f22-6409-4867-9119-c3dd4cc26a3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_226bf337-14e2-4535-92cb-a9f50d45459d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c1dd0f22-6409-4867-9119-c3dd4cc26a3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ed04d7ba-85fc-45df-b940-2078abe5e90d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e2d07c71-c45c-47b7-b539-357bb543e2b5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ed04d7ba-85fc-45df-b940-2078abe5e90d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_1ae3745c-3cdd-4898-bd79-14d917036701" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ed04d7ba-85fc-45df-b940-2078abe5e90d" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_1ae3745c-3cdd-4898-bd79-14d917036701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_91f1cebc-a472-43c8-a6c2-6e5c8c36d664" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ed04d7ba-85fc-45df-b940-2078abe5e90d" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_91f1cebc-a472-43c8-a6c2-6e5c8c36d664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_9059173c-af59-402a-8d73-55bd58d1954a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ed04d7ba-85fc-45df-b940-2078abe5e90d" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_9059173c-af59-402a-8d73-55bd58d1954a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_bf9745bc-d94f-454e-8c03-f212f8562c95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ed04d7ba-85fc-45df-b940-2078abe5e90d" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_bf9745bc-d94f-454e-8c03-f212f8562c95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_6dfc971c-c593-44b4-871d-4d1881107120" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ed04d7ba-85fc-45df-b940-2078abe5e90d" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_6dfc971c-c593-44b4-871d-4d1881107120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_2381dd20-a56e-4a4e-a954-37d50344a44e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ed04d7ba-85fc-45df-b940-2078abe5e90d" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_2381dd20-a56e-4a4e-a954-37d50344a44e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_db672a87-67a8-4b99-9ecb-a53e71cc518c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ed04d7ba-85fc-45df-b940-2078abe5e90d" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_db672a87-67a8-4b99-9ecb-a53e71cc518c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4f8c295a-9bcc-451a-ac5e-f1fa96d871ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ed04d7ba-85fc-45df-b940-2078abe5e90d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4f8c295a-9bcc-451a-ac5e-f1fa96d871ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a2ba17ce-c4aa-4088-8b34-f7eda6418545" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e2d07c71-c45c-47b7-b539-357bb543e2b5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a2ba17ce-c4aa-4088-8b34-f7eda6418545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_c356b0e8-589f-44f8-9149-8f567973d8ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a2ba17ce-c4aa-4088-8b34-f7eda6418545" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_c356b0e8-589f-44f8-9149-8f567973d8ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_7803485e-18a6-477b-95e8-a8873097d80c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a2ba17ce-c4aa-4088-8b34-f7eda6418545" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_7803485e-18a6-477b-95e8-a8873097d80c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_86353081-209b-45c9-bcfa-838a4e3cb861" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a2ba17ce-c4aa-4088-8b34-f7eda6418545" xlink:to="loc_us-gaap_PaymentsOfFinancingCosts_86353081-209b-45c9-bcfa-838a4e3cb861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_aba16fef-6c24-4e80-aac1-d6bd50ac594d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a2ba17ce-c4aa-4088-8b34-f7eda6418545" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_aba16fef-6c24-4e80-aac1-d6bd50ac594d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_135860b9-4e7f-4dc5-bdaf-119d690ab17f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a2ba17ce-c4aa-4088-8b34-f7eda6418545" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_135860b9-4e7f-4dc5-bdaf-119d690ab17f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_95ee4327-c30a-49c0-b22e-518e56c9aace" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a2ba17ce-c4aa-4088-8b34-f7eda6418545" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_95ee4327-c30a-49c0-b22e-518e56c9aace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities_c70aac9d-0cc9-488e-85db-c22abe162e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a2ba17ce-c4aa-4088-8b34-f7eda6418545" xlink:to="loc_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities_c70aac9d-0cc9-488e-85db-c22abe162e8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_5039ef33-6edc-4f47-a6aa-668733402c43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a2ba17ce-c4aa-4088-8b34-f7eda6418545" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_5039ef33-6edc-4f47-a6aa-668733402c43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PaymentsForNonContingentConsiderationForProductRightsFinancingActivities_af5ab73d-615e-40b5-aa26-9a17d3633fa2" xlink:href="vtrs-20211231.xsd#vtrs_PaymentsForNonContingentConsiderationForProductRightsFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a2ba17ce-c4aa-4088-8b34-f7eda6418545" xlink:to="loc_vtrs_PaymentsForNonContingentConsiderationForProductRightsFinancingActivities_af5ab73d-615e-40b5-aa26-9a17d3633fa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_18b2c312-a608-4dca-af62-c75a1fb07cf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a2ba17ce-c4aa-4088-8b34-f7eda6418545" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_18b2c312-a608-4dca-af62-c75a1fb07cf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_36d6c413-a4c7-4ec3-8037-e0c392733a86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a2ba17ce-c4aa-4088-8b34-f7eda6418545" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_36d6c413-a4c7-4ec3-8037-e0c392733a86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_1972377b-69f0-478c-ba77-224aaa83ed06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e2d07c71-c45c-47b7-b539-357bb543e2b5" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_1972377b-69f0-478c-ba77-224aaa83ed06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_03aadf06-929c-494e-81ba-fa6b791df5be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e2d07c71-c45c-47b7-b539-357bb543e2b5" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_03aadf06-929c-494e-81ba-fa6b791df5be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e85e99db-d3c6-408c-8509-57a28ea54074" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e2d07c71-c45c-47b7-b539-357bb543e2b5" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e85e99db-d3c6-408c-8509-57a28ea54074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4fa46fe7-0680-4ba1-b928-a6c946c05ff9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e2d07c71-c45c-47b7-b539-357bb543e2b5" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4fa46fe7-0680-4ba1-b928-a6c946c05ff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_96f63dd1-dee8-405e-ba3f-20456824ad40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e2d07c71-c45c-47b7-b539-357bb543e2b5" xlink:to="loc_us-gaap_SupplementalCashFlowElementsAbstract_96f63dd1-dee8-405e-ba3f-20456824ad40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_33b9a549-7175-4c31-97ee-ddd65271bf8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_96f63dd1-dee8-405e-ba3f-20456824ad40" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_33b9a549-7175-4c31-97ee-ddd65271bf8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1_ff5920ff-fecd-41f7-9e50-07eb50fa72ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_33b9a549-7175-4c31-97ee-ddd65271bf8f" xlink:to="loc_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1_ff5920ff-fecd-41f7-9e50-07eb50fa72ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_c74bc0c3-9d9c-4f68-8359-2cfa995ba7e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_96f63dd1-dee8-405e-ba3f-20456824ad40" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_c74bc0c3-9d9c-4f68-8359-2cfa995ba7e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_8948ed89-5644-4350-ae06-a2b312a58e95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_c74bc0c3-9d9c-4f68-8359-2cfa995ba7e3" xlink:to="loc_us-gaap_IncomeTaxesPaid_8948ed89-5644-4350-ae06-a2b312a58e95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_5f091aa1-bf30-45ab-b7ca-eee7e963c3a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_c74bc0c3-9d9c-4f68-8359-2cfa995ba7e3" xlink:to="loc_us-gaap_InterestPaidNet_5f091aa1-bf30-45ab-b7ca-eee7e963c3a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/NatureofOperations" xlink:type="simple" xlink:href="vtrs-20211231.xsd#NatureofOperations"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/NatureofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_999add8f-f3fe-4dbb-ba7f-4445b5e0df06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_68fdc5e9-faa0-4090-a524-8ae725bcc0bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_999add8f-f3fe-4dbb-ba7f-4445b5e0df06" xlink:to="loc_us-gaap_NatureOfOperations_68fdc5e9-faa0-4090-a524-8ae725bcc0bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/NatureofOperationsNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#NatureofOperationsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/NatureofOperationsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c46d39b8-a04e-41d7-9ffd-5524c2de9515" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NumberOfMolecules_869e4246-9e2e-44b7-909c-25776623ccee" xlink:href="vtrs-20211231.xsd#vtrs_NumberOfMolecules"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c46d39b8-a04e-41d7-9ffd-5524c2de9515" xlink:to="loc_vtrs_NumberOfMolecules_869e4246-9e2e-44b7-909c-25776623ccee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NumberOfManufacturingSites_9efed674-de62-4861-a5c6-46a9914d52c8" xlink:href="vtrs-20211231.xsd#vtrs_NumberOfManufacturingSites"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c46d39b8-a04e-41d7-9ffd-5524c2de9515" xlink:to="loc_vtrs_NumberOfManufacturingSites_9efed674-de62-4861-a5c6-46a9914d52c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="vtrs-20211231.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_2693df87-d06a-4c50-a9c7-0ae148f7231a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_9d4f5b7a-384e-46c4-891b-5c470cffceef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2693df87-d06a-4c50-a9c7-0ae148f7231a" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_9d4f5b7a-384e-46c4-891b-5c470cffceef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="vtrs-20211231.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d153d3d2-8214-4285-a464-f1cad76b82db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_68423021-8a1b-441b-9b1e-ccbd41d5f3e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d153d3d2-8214-4285-a464-f1cad76b82db" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_68423021-8a1b-441b-9b1e-ccbd41d5f3e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_cb0bb77a-fe5f-4c0d-b8d3-0073cfb79682" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d153d3d2-8214-4285-a464-f1cad76b82db" xlink:to="loc_us-gaap_UseOfEstimates_cb0bb77a-fe5f-4c0d-b8d3-0073cfb79682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_d834ff5c-411c-47b9-9dee-262f32ef5b60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d153d3d2-8214-4285-a464-f1cad76b82db" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_d834ff5c-411c-47b9-9dee-262f32ef5b60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_74677d31-2a4a-4e84-92f5-5367071a6774" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d153d3d2-8214-4285-a464-f1cad76b82db" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_74677d31-2a4a-4e84-92f5-5367071a6774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy_6e6fcda7-6402-4441-8e96-966a649d1ea6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d153d3d2-8214-4285-a464-f1cad76b82db" xlink:to="loc_us-gaap_MarketableSecuritiesPolicy_6e6fcda7-6402-4441-8e96-966a649d1ea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_f5b03190-3aab-4809-b65e-af1f66ffd059" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d153d3d2-8214-4285-a464-f1cad76b82db" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_f5b03190-3aab-4809-b65e-af1f66ffd059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_3a58bb59-2aa0-4936-90f5-d8464ba2f7a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d153d3d2-8214-4285-a464-f1cad76b82db" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_3a58bb59-2aa0-4936-90f5-d8464ba2f7a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_a9df5ff0-55a4-47fe-8240-87b02fcc8c11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d153d3d2-8214-4285-a464-f1cad76b82db" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_a9df5ff0-55a4-47fe-8240-87b02fcc8c11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_3b69be25-c3ae-4f12-af02-21b679245983" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d153d3d2-8214-4285-a464-f1cad76b82db" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_3b69be25-c3ae-4f12-af02-21b679245983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_5d11cdc6-a4cb-471b-a5b8-6c7dd169230c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d153d3d2-8214-4285-a464-f1cad76b82db" xlink:to="loc_us-gaap_BusinessCombinationsPolicy_5d11cdc6-a4cb-471b-a5b8-6c7dd169230c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_0714b15e-a642-4bff-b04e-f2dfb0268588" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d153d3d2-8214-4285-a464-f1cad76b82db" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_0714b15e-a642-4bff-b04e-f2dfb0268588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_f735e99a-77a0-4aa0-a6ca-8f1f05098f6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d153d3d2-8214-4285-a464-f1cad76b82db" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_f735e99a-77a0-4aa0-a6ca-8f1f05098f6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtPolicyTextBlock_7cdfab5d-e541-4281-925d-cf17cbad1544" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d153d3d2-8214-4285-a464-f1cad76b82db" xlink:to="loc_us-gaap_DebtPolicyTextBlock_7cdfab5d-e541-4281-925d-cf17cbad1544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_f6def2cc-87af-49bf-bc71-5888b98abc4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d153d3d2-8214-4285-a464-f1cad76b82db" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_f6def2cc-87af-49bf-bc71-5888b98abc4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_dbea7bfa-2f20-463d-9333-6285638e4ff9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d153d3d2-8214-4285-a464-f1cad76b82db" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_dbea7bfa-2f20-463d-9333-6285638e4ff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_fa6177d4-dde1-4277-b106-050141361471" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d153d3d2-8214-4285-a464-f1cad76b82db" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_fa6177d4-dde1-4277-b106-050141361471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_2c4a9564-77d2-4cd1-ae61-7739367f9b35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d153d3d2-8214-4285-a464-f1cad76b82db" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_2c4a9564-77d2-4cd1-ae61-7739367f9b35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_0d30e489-634d-42b2-a7fb-8ad8ffe8f980" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d153d3d2-8214-4285-a464-f1cad76b82db" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_0d30e489-634d-42b2-a7fb-8ad8ffe8f980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_23aa177b-6045-49af-9580-f098fabb9364" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d153d3d2-8214-4285-a464-f1cad76b82db" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_23aa177b-6045-49af-9580-f098fabb9364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_1dc09849-bb67-405c-8c2d-29e013dc2edc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d153d3d2-8214-4285-a464-f1cad76b82db" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_1dc09849-bb67-405c-8c2d-29e013dc2edc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="vtrs-20211231.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_e53a6264-98ae-45a3-af97-e35ac8e7559b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_cd3baae6-b449-4f1b-9da1-ac97b134c07c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e53a6264-98ae-45a3-af97-e35ac8e7559b" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_cd3baae6-b449-4f1b-9da1-ac97b134c07c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_32aa72bf-7c08-4167-aa5f-7d629c447a3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_c0b256c7-84f0-47a9-b810-8a00205d76cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_32aa72bf-7c08-4167-aa5f-7d629c447a3e" xlink:to="loc_us-gaap_StatementTable_c0b256c7-84f0-47a9-b810-8a00205d76cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d78a1962-dc3a-4d49-9540-372b4bdc685b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c0b256c7-84f0-47a9-b810-8a00205d76cd" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d78a1962-dc3a-4d49-9540-372b4bdc685b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5a7fdf79-4d9f-4ef7-bcbf-ca990aafeada" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d78a1962-dc3a-4d49-9540-372b4bdc685b" xlink:to="loc_us-gaap_EquityComponentDomain_5a7fdf79-4d9f-4ef7-bcbf-ca990aafeada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_5769b9f0-00c3-4b81-bebe-921b875adc50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_5a7fdf79-4d9f-4ef7-bcbf-ca990aafeada" xlink:to="loc_us-gaap_RetainedEarningsMember_5769b9f0-00c3-4b81-bebe-921b875adc50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ceadb2ba-7d83-4f68-a998-34b6316ed7f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c0b256c7-84f0-47a9-b810-8a00205d76cd" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ceadb2ba-7d83-4f68-a998-34b6316ed7f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_47210bb1-2061-4f90-af5a-98f948b8b1ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ceadb2ba-7d83-4f68-a998-34b6316ed7f4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_47210bb1-2061-4f90-af5a-98f948b8b1ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_2f81143e-e36b-4b66-99b9-d838d9b79610" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_47210bb1-2061-4f90-af5a-98f948b8b1ff" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_2f81143e-e36b-4b66-99b9-d838d9b79610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_251b2cc7-6f1b-4c80-b40b-2b463f85659a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_47210bb1-2061-4f90-af5a-98f948b8b1ff" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_251b2cc7-6f1b-4c80-b40b-2b463f85659a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_6f67cee3-e9fd-4ea2-ba00-4670cff2f6a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_47210bb1-2061-4f90-af5a-98f948b8b1ff" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_6f67cee3-e9fd-4ea2-ba00-4670cff2f6a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_38f00756-6fc6-44c0-af02-44b642918098" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c0b256c7-84f0-47a9-b810-8a00205d76cd" xlink:to="loc_srt_RangeAxis_38f00756-6fc6-44c0-af02-44b642918098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e3721aef-33ad-4497-9a88-af84cb57ad49" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_38f00756-6fc6-44c0-af02-44b642918098" xlink:to="loc_srt_RangeMember_e3721aef-33ad-4497-9a88-af84cb57ad49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_14cdddfc-f5b1-48e0-a72f-1498d759abe3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e3721aef-33ad-4497-9a88-af84cb57ad49" xlink:to="loc_srt_MinimumMember_14cdddfc-f5b1-48e0-a72f-1498d759abe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5389f13b-ef5f-414e-ba60-906baafa6718" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e3721aef-33ad-4497-9a88-af84cb57ad49" xlink:to="loc_srt_MaximumMember_5389f13b-ef5f-414e-ba60-906baafa6718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_7d90ffdb-07ee-4be1-8fe6-ffe9022393a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c0b256c7-84f0-47a9-b810-8a00205d76cd" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_7d90ffdb-07ee-4be1-8fe6-ffe9022393a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_62209343-9c7f-4daf-b139-1e8c86f01341" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_7d90ffdb-07ee-4be1-8fe6-ffe9022393a8" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_62209343-9c7f-4daf-b139-1e8c86f01341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_4e4a7d89-bdad-4609-9255-2d795a4b19ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_62209343-9c7f-4daf-b139-1e8c86f01341" xlink:to="loc_us-gaap_SubsequentEventMember_4e4a7d89-bdad-4609-9255-2d795a4b19ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9cf909e5-767d-4a2a-b115-299d425c1bab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c0b256c7-84f0-47a9-b810-8a00205d76cd" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9cf909e5-767d-4a2a-b115-299d425c1bab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_e61a196d-c229-4b00-9b00-bf95aeb504d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9cf909e5-767d-4a2a-b115-299d425c1bab" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_e61a196d-c229-4b00-9b00-bf95aeb504d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_33ecf3cb-443c-4127-bcbd-8c382874e140" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9cf909e5-767d-4a2a-b115-299d425c1bab" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_33ecf3cb-443c-4127-bcbd-8c382874e140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_db8ee26e-a133-479e-a874-ccc1fe36c007" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9cf909e5-767d-4a2a-b115-299d425c1bab" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_db8ee26e-a133-479e-a874-ccc1fe36c007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_3804336f-22f0-4833-85a9-5bf344f99c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9cf909e5-767d-4a2a-b115-299d425c1bab" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_3804336f-22f0-4833-85a9-5bf344f99c8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_60385321-3b1b-4c67-8ced-2fa519e9416e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9cf909e5-767d-4a2a-b115-299d425c1bab" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_60385321-3b1b-4c67-8ced-2fa519e9416e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableAmountPerShare_e28c91dd-eae3-4e0f-9616-9139fc49ab61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9cf909e5-767d-4a2a-b115-299d425c1bab" xlink:to="loc_us-gaap_DividendsPayableAmountPerShare_e28c91dd-eae3-4e0f-9616-9139fc49ab61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_41c97b31-15a6-4deb-a935-1c25e6ec9759" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9cf909e5-767d-4a2a-b115-299d425c1bab" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_41c97b31-15a6-4deb-a935-1c25e6ec9759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesBasicAndDilutedEarningsPerOrdinaryShareAttributableToMylanNVDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#SummaryofSignificantAccountingPoliciesBasicAndDilutedEarningsPerOrdinaryShareAttributableToMylanNVDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesBasicAndDilutedEarningsPerOrdinaryShareAttributableToMylanNVDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_e4f45ee7-56ab-424f-940a-4fb8b0ae9967" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_cbf23a2b-8f97-4004-a5ea-3b06f2eef8d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e4f45ee7-56ab-424f-940a-4fb8b0ae9967" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_cbf23a2b-8f97-4004-a5ea-3b06f2eef8d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_f564f491-0390-4a80-b999-d517b18a235e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_cbf23a2b-8f97-4004-a5ea-3b06f2eef8d1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_f564f491-0390-4a80-b999-d517b18a235e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_21d99926-045b-4ed5-a39c-fddc44ef54e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f564f491-0390-4a80-b999-d517b18a235e" xlink:to="loc_us-gaap_EquityComponentDomain_21d99926-045b-4ed5-a39c-fddc44ef54e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_5a77a4bd-470b-4fb4-ac3c-b3ed17d5ed27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_21d99926-045b-4ed5-a39c-fddc44ef54e7" xlink:to="loc_us-gaap_RetainedEarningsMember_5a77a4bd-470b-4fb4-ac3c-b3ed17d5ed27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems_e8222ea4-9ac8-4f8a-a5b5-87f3b8f18389" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_cbf23a2b-8f97-4004-a5ea-3b06f2eef8d1" xlink:to="loc_us-gaap_EarningsPerShareBasicLineItems_e8222ea4-9ac8-4f8a-a5b5-87f3b8f18389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_091ddbad-753b-48be-b3cd-2d3b4cb0f01a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_e8222ea4-9ac8-4f8a-a5b5-87f3b8f18389" xlink:to="loc_us-gaap_ProfitLoss_091ddbad-753b-48be-b3cd-2d3b4cb0f01a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d6c9f398-34db-48c4-bfa9-bf8ad008c5a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_e8222ea4-9ac8-4f8a-a5b5-87f3b8f18389" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d6c9f398-34db-48c4-bfa9-bf8ad008c5a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_7b6caca0-624d-4272-8e45-d61e692db01f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_e8222ea4-9ac8-4f8a-a5b5-87f3b8f18389" xlink:to="loc_us-gaap_EarningsPerShareBasic_7b6caca0-624d-4272-8e45-d61e692db01f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_294b714c-1876-4f54-b50c-1b219b506787" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_e8222ea4-9ac8-4f8a-a5b5-87f3b8f18389" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_294b714c-1876-4f54-b50c-1b219b506787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b6ff3917-617c-4cad-937f-d39d3fa8652e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_e8222ea4-9ac8-4f8a-a5b5-87f3b8f18389" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b6ff3917-617c-4cad-937f-d39d3fa8652e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_3bccc436-f6bc-4579-9dfb-162866223932" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_e8222ea4-9ac8-4f8a-a5b5-87f3b8f18389" xlink:to="loc_us-gaap_EarningsPerShareDiluted_3bccc436-f6bc-4579-9dfb-162866223932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/AcquisitionsandOtherTransactions" xlink:type="simple" xlink:href="vtrs-20211231.xsd#AcquisitionsandOtherTransactions"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/AcquisitionsandOtherTransactions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_f8f5f436-9c4b-4d18-98fe-74a65ac414e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_a81069d6-b774-4c19-8a7f-ccec63bf6e94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_f8f5f436-9c4b-4d18-98fe-74a65ac414e1" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_a81069d6-b774-4c19-8a7f-ccec63bf6e94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/AcquisitionsandOtherTransactionsTables" xlink:type="simple" xlink:href="vtrs-20211231.xsd#AcquisitionsandOtherTransactionsTables"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/AcquisitionsandOtherTransactionsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_f2a36112-4e87-4e33-a08f-2c8c468b0e8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_dad15772-787a-40f3-931a-098a333e671c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_f2a36112-4e87-4e33-a08f-2c8c468b0e8b" xlink:to="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_dad15772-787a-40f3-931a-098a333e671c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_92c5d104-87ac-4b82-9977-46d001aa403e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_f2a36112-4e87-4e33-a08f-2c8c468b0e8b" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_92c5d104-87ac-4b82-9977-46d001aa403e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_2b8a3844-288c-474b-a230-07b7b28d8625" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_f2a36112-4e87-4e33-a08f-2c8c468b0e8b" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_2b8a3844-288c-474b-a230-07b7b28d8625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationAbstract_a6d99235-905a-4766-8713-ebc8443afdbc" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_47ee6ab2-6da2-49f5-9495-813cf94d1ed2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_BusinessCombinationAbstract_a6d99235-905a-4766-8713-ebc8443afdbc" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_47ee6ab2-6da2-49f5-9495-813cf94d1ed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_63077047-3a33-4d48-9278-7ea7ec82b828" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_47ee6ab2-6da2-49f5-9495-813cf94d1ed2" xlink:to="loc_srt_StatementScenarioAxis_63077047-3a33-4d48-9278-7ea7ec82b828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_895543a5-597b-428d-99d9-90ddf5ee5551" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_63077047-3a33-4d48-9278-7ea7ec82b828" xlink:to="loc_srt_ScenarioUnspecifiedDomain_895543a5-597b-428d-99d9-90ddf5ee5551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScenarioPlanMember_5c98d0b3-1a2e-44f2-acb3-30ed6311684c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScenarioPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_895543a5-597b-428d-99d9-90ddf5ee5551" xlink:to="loc_us-gaap_ScenarioPlanMember_5c98d0b3-1a2e-44f2-acb3-30ed6311684c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_dddc3b97-7c9f-409c-bcbf-582cf732642d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_47ee6ab2-6da2-49f5-9495-813cf94d1ed2" xlink:to="loc_srt_CounterpartyNameAxis_dddc3b97-7c9f-409c-bcbf-582cf732642d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1d539995-cebd-427d-9716-b807e527b543" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_dddc3b97-7c9f-409c-bcbf-582cf732642d" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1d539995-cebd-427d-9716-b807e527b543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_UpjohnInc.Member_0a00b55c-9e62-4129-bb55-2e4a6f1cfd67" xlink:href="vtrs-20211231.xsd#vtrs_UpjohnInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1d539995-cebd-427d-9716-b807e527b543" xlink:to="loc_vtrs_UpjohnInc.Member_0a00b55c-9e62-4129-bb55-2e4a6f1cfd67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis_24205f22-df4e-440c-87e6-c67e777d5187" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_47ee6ab2-6da2-49f5-9495-813cf94d1ed2" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis_24205f22-df4e-440c-87e6-c67e777d5187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalEntityTypeOfCounterpartyDomain_e0988aec-5ed8-4970-afe1-1e67c082a69f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LegalEntityTypeOfCounterpartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis_24205f22-df4e-440c-87e6-c67e777d5187" xlink:to="loc_us-gaap_LegalEntityTypeOfCounterpartyDomain_e0988aec-5ed8-4970-afe1-1e67c082a69f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PfizerInc.Member_999d9a27-007f-4eeb-8970-f1693f353556" xlink:href="vtrs-20211231.xsd#vtrs_PfizerInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LegalEntityTypeOfCounterpartyDomain_e0988aec-5ed8-4970-afe1-1e67c082a69f" xlink:to="loc_vtrs_PfizerInc.Member_999d9a27-007f-4eeb-8970-f1693f353556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_908b5c1a-1178-4c9d-95e2-762f5730c308" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_47ee6ab2-6da2-49f5-9495-813cf94d1ed2" xlink:to="loc_srt_ProductOrServiceAxis_908b5c1a-1178-4c9d-95e2-762f5730c308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5de51408-ed8e-40f9-87b6-5a2fff5b0728" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_908b5c1a-1178-4c9d-95e2-762f5730c308" xlink:to="loc_srt_ProductsAndServicesDomain_5de51408-ed8e-40f9-87b6-5a2fff5b0728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_732a4908-d6fd-49b9-857c-fdc3f50c92db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5de51408-ed8e-40f9-87b6-5a2fff5b0728" xlink:to="loc_us-gaap_ProductMember_732a4908-d6fd-49b9-857c-fdc3f50c92db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_f69ad8e2-5b10-4edc-b54c-34b40f8ae572" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_47ee6ab2-6da2-49f5-9495-813cf94d1ed2" xlink:to="loc_us-gaap_TypeOfArrangementAxis_f69ad8e2-5b10-4edc-b54c-34b40f8ae572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_166d5f47-a7d6-43a6-bca4-651ef9e4694a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_f69ad8e2-5b10-4edc-b54c-34b40f8ae572" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_166d5f47-a7d6-43a6-bca4-651ef9e4694a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RevanceMember_53d975d1-b7e8-4e39-92e7-75855faa7708" xlink:href="vtrs-20211231.xsd#vtrs_RevanceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_166d5f47-a7d6-43a6-bca4-651ef9e4694a" xlink:to="loc_vtrs_RevanceMember_53d975d1-b7e8-4e39-92e7-75855faa7708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherCompaniesMember_7ddcb42b-740a-426e-90fb-d5671b91fd3f" xlink:href="vtrs-20211231.xsd#vtrs_OtherCompaniesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_166d5f47-a7d6-43a6-bca4-651ef9e4694a" xlink:to="loc_vtrs_OtherCompaniesMember_7ddcb42b-740a-426e-90fb-d5671b91fd3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_FKBMember_3aba836d-7cbd-440c-8c8b-ddf197456bc5" xlink:href="vtrs-20211231.xsd#vtrs_FKBMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_166d5f47-a7d6-43a6-bca4-651ef9e4694a" xlink:to="loc_vtrs_FKBMember_3aba836d-7cbd-440c-8c8b-ddf197456bc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0bcae202-8f07-40a7-8630-4a856f2d6063" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_47ee6ab2-6da2-49f5-9495-813cf94d1ed2" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0bcae202-8f07-40a7-8630-4a856f2d6063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_63905beb-d5aa-4d68-a332-15a3b5258f22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0bcae202-8f07-40a7-8630-4a856f2d6063" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_63905beb-d5aa-4d68-a332-15a3b5258f22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_UpjohnInc.Member_e7494069-e30a-4592-92d4-45315d1402b6" xlink:href="vtrs-20211231.xsd#vtrs_UpjohnInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_63905beb-d5aa-4d68-a332-15a3b5258f22" xlink:to="loc_vtrs_UpjohnInc.Member_e7494069-e30a-4592-92d4-45315d1402b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_c3f1f720-811c-4f93-a388-fe1ebc174643" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_63905beb-d5aa-4d68-a332-15a3b5258f22" xlink:to="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_c3f1f720-811c-4f93-a388-fe1ebc174643" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherCompaniesMember_eb61ea40-9a95-4452-8353-60fca3b39d4f" xlink:href="vtrs-20211231.xsd#vtrs_OtherCompaniesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_63905beb-d5aa-4d68-a332-15a3b5258f22" xlink:to="loc_vtrs_OtherCompaniesMember_eb61ea40-9a95-4452-8353-60fca3b39d4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AspenGlobalIncorporatedMember_10cb760f-e10d-411d-80c0-99420763f7d3" xlink:href="vtrs-20211231.xsd#vtrs_AspenGlobalIncorporatedMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_63905beb-d5aa-4d68-a332-15a3b5258f22" xlink:to="loc_vtrs_AspenGlobalIncorporatedMember_10cb760f-e10d-411d-80c0-99420763f7d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_TOBIMember_e141f471-5fdd-473d-8176-1eabb6870bf0" xlink:href="vtrs-20211231.xsd#vtrs_TOBIMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_63905beb-d5aa-4d68-a332-15a3b5258f22" xlink:to="loc_vtrs_TOBIMember_e141f471-5fdd-473d-8176-1eabb6870bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AspenPharmacareHoldingsLimitedMember_6bc3d90c-1192-4466-8a15-bef3bda292ae" xlink:href="vtrs-20211231.xsd#vtrs_AspenPharmacareHoldingsLimitedMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_63905beb-d5aa-4d68-a332-15a3b5258f22" xlink:to="loc_vtrs_AspenPharmacareHoldingsLimitedMember_6bc3d90c-1192-4466-8a15-bef3bda292ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f72dfa9d-4156-40bd-8849-fce4fd3e1316" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_47ee6ab2-6da2-49f5-9495-813cf94d1ed2" xlink:to="loc_srt_RangeAxis_f72dfa9d-4156-40bd-8849-fce4fd3e1316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ad005993-fb5d-46cd-85da-6434dff8b8c3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_f72dfa9d-4156-40bd-8849-fce4fd3e1316" xlink:to="loc_srt_RangeMember_ad005993-fb5d-46cd-85da-6434dff8b8c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9b00ab70-7f03-4e13-878a-e0fbebf52175" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ad005993-fb5d-46cd-85da-6434dff8b8c3" xlink:to="loc_srt_MaximumMember_9b00ab70-7f03-4e13-878a-e0fbebf52175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f02e0912-3a49-46ed-badb-23695a03c061" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ad005993-fb5d-46cd-85da-6434dff8b8c3" xlink:to="loc_srt_MinimumMember_f02e0912-3a49-46ed-badb-23695a03c061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ec968c3f-3bdc-4cfd-9b72-d6ce2e636419" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_47ee6ab2-6da2-49f5-9495-813cf94d1ed2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ec968c3f-3bdc-4cfd-9b72-d6ce2e636419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fa8a2600-f798-4c46-9308-038d6e512509" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ec968c3f-3bdc-4cfd-9b72-d6ce2e636419" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fa8a2600-f798-4c46-9308-038d6e512509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_edb509c0-8c9a-4b67-8a5c-36c8718b2801" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fa8a2600-f798-4c46-9308-038d6e512509" xlink:to="loc_us-gaap_LicensingAgreementsMember_edb509c0-8c9a-4b67-8a5c-36c8718b2801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember_64b78316-926c-46bd-91f1-47e88bd2c372" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractualRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fa8a2600-f798-4c46-9308-038d6e512509" xlink:to="loc_us-gaap_ContractualRightsMember_64b78316-926c-46bd-91f1-47e88bd2c372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_872b7464-7a5f-4952-abef-1f4906e52d22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_47ee6ab2-6da2-49f5-9495-813cf94d1ed2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_872b7464-7a5f-4952-abef-1f4906e52d22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_aba42942-db06-413d-8380-e5132889d494" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_872b7464-7a5f-4952-abef-1f4906e52d22" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_aba42942-db06-413d-8380-e5132889d494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_818922f8-c6bf-4d80-9ad2-a02fbdf05fc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_aba42942-db06-413d-8380-e5132889d494" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_818922f8-c6bf-4d80-9ad2-a02fbdf05fc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_22ff6d68-780d-42ea-a2e4-bfcd28f6e183" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_aba42942-db06-413d-8380-e5132889d494" xlink:to="loc_us-gaap_BuildingMember_22ff6d68-780d-42ea-a2e4-bfcd28f6e183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMember_be294007-44ea-47ef-9718-00cd163c4f76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_aba42942-db06-413d-8380-e5132889d494" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMember_be294007-44ea-47ef-9718-00cd163c4f76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_c61faa84-ed2f-42af-aa43-51a3f64d8aaf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_47ee6ab2-6da2-49f5-9495-813cf94d1ed2" xlink:to="loc_srt_OwnershipAxis_c61faa84-ed2f-42af-aa43-51a3f64d8aaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_f554f4e9-5b22-442e-8fc3-b8452d0bacad" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_c61faa84-ed2f-42af-aa43-51a3f64d8aaf" xlink:to="loc_srt_OwnershipDomain_f554f4e9-5b22-442e-8fc3-b8452d0bacad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_UpjohnInc.Member_d44380cf-bd3c-474c-9459-23e8506b0710" xlink:href="vtrs-20211231.xsd#vtrs_UpjohnInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_f554f4e9-5b22-442e-8fc3-b8452d0bacad" xlink:to="loc_vtrs_UpjohnInc.Member_d44380cf-bd3c-474c-9459-23e8506b0710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_47ee6ab2-6da2-49f5-9495-813cf94d1ed2" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NumberOfProducts_ca5e7251-d4a4-4c92-843d-7d3a274ab3f3" xlink:href="vtrs-20211231.xsd#vtrs_NumberOfProducts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_vtrs_NumberOfProducts_ca5e7251-d4a4-4c92-843d-7d3a274ab3f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_d2506653-0be1-482e-a5dc-346cc336b5f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_d2506653-0be1-482e-a5dc-346cc336b5f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_be679d05-c046-4066-b68c-b651db15acb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_be679d05-c046-4066-b68c-b651db15acb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_0ef5a7b5-2ddd-42cc-a35b-c7780ab20b31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_0ef5a7b5-2ddd-42cc-a35b-c7780ab20b31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_d68a6a87-d926-4f0c-b215-9ae7b7b0b051" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_d68a6a87-d926-4f0c-b215-9ae7b7b0b051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PaymentsToAcquireCollaborativeAgreement_1ceb6911-1275-48a7-a8f0-697544b44a70" xlink:href="vtrs-20211231.xsd#vtrs_PaymentsToAcquireCollaborativeAgreement"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_vtrs_PaymentsToAcquireCollaborativeAgreement_1ceb6911-1275-48a7-a8f0-697544b44a70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_79b8786a-afb1-4509-a907-02edaac24188" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_79b8786a-afb1-4509-a907-02edaac24188" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DevelopmentMilestonePayments_47e6dd9a-7b42-4048-8bed-22913ad10a6b" xlink:href="vtrs-20211231.xsd#vtrs_DevelopmentMilestonePayments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_vtrs_DevelopmentMilestonePayments_47e6dd9a-7b42-4048-8bed-22913ad10a6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SalesMilestonePayments_23b90e52-fcde-4907-b642-293c631967dd" xlink:href="vtrs-20211231.xsd#vtrs_SalesMilestonePayments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_vtrs_SalesMilestonePayments_23b90e52-fcde-4907-b642-293c631967dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_02544d25-7dbf-43bd-8c0b-4c2b05c15b51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_02544d25-7dbf-43bd-8c0b-4c2b05c15b51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_47868fca-2511-4c3e-8ac2-e72364a5b575" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_47868fca-2511-4c3e-8ac2-e72364a5b575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_ec070cab-642c-40b2-83c6-6340913ab7b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_ec070cab-642c-40b2-83c6-6340913ab7b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_befbbf2c-b8c3-43eb-a712-e9aaefc5d140" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_befbbf2c-b8c3-43eb-a712-e9aaefc5d140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PaymentsforBusinessSeparation_1ce04bdc-5fc8-4b3e-b178-35c8603744ac" xlink:href="vtrs-20211231.xsd#vtrs_PaymentsforBusinessSeparation"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_vtrs_PaymentsforBusinessSeparation_1ce04bdc-5fc8-4b3e-b178-35c8603744ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessAcquisitionexpectedfuturepaymentsnexttwelvemonths_b243abe4-05d6-4b99-b13e-0aa5bad10c81" xlink:href="vtrs-20211231.xsd#vtrs_BusinessAcquisitionexpectedfuturepaymentsnexttwelvemonths"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_vtrs_BusinessAcquisitionexpectedfuturepaymentsnexttwelvemonths_b243abe4-05d6-4b99-b13e-0aa5bad10c81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessAcquisitionexpectedfuturepaymentyeartwo_16e6f2cf-2ddc-452a-a60c-faedad01622d" xlink:href="vtrs-20211231.xsd#vtrs_BusinessAcquisitionexpectedfuturepaymentyeartwo"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_vtrs_BusinessAcquisitionexpectedfuturepaymentyeartwo_16e6f2cf-2ddc-452a-a60c-faedad01622d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_cf8d287d-b0be-4c38-81d0-1d21aa957069" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_cf8d287d-b0be-4c38-81d0-1d21aa957069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_eff49b5b-7b8d-41aa-bc45-9964a9b53beb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_eff49b5b-7b8d-41aa-bc45-9964a9b53beb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFirmPurchaseCommitmentLoss_038365f8-aded-4fe1-a397-4f07f7b0b822" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFirmPurchaseCommitmentLoss"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_us-gaap_InventoryFirmPurchaseCommitmentLoss_038365f8-aded-4fe1-a397-4f07f7b0b822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_f304a7d9-0405-401b-8ad2-700e4bf61458" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_f304a7d9-0405-401b-8ad2-700e4bf61458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_96b7b60b-3be6-43c2-bdae-f570e765f5f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_96b7b60b-3be6-43c2-bdae-f570e765f5f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_a50eb285-4788-4126-aee0-de80198f123d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_a50eb285-4788-4126-aee0-de80198f123d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationsNumberOfAgreements_7e9338fc-1869-4549-bc8d-6d480adb8504" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationsNumberOfAgreements"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_vtrs_BusinessCombinationsNumberOfAgreements_7e9338fc-1869-4549-bc8d-6d480adb8504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_a37b2ec5-44ea-4bbb-949d-ad14c2e60452" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_a37b2ec5-44ea-4bbb-949d-ad14c2e60452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_08ebfed9-e495-42b9-b759-d2e0226e260f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_08ebfed9-e495-42b9-b759-d2e0226e260f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d435e6b3-02c8-4c9f-b88c-6a77494f2cb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_us-gaap_Goodwill_d435e6b3-02c8-4c9f-b88c-6a77494f2cb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_4f2caf90-5e3c-4861-9cf1-957331300fb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_4f2caf90-5e3c-4861-9cf1-957331300fb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_c5ae76e5-79fe-48d0-8f0c-3d3f735aa12f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_c5ae76e5-79fe-48d0-8f0c-3d3f735aa12f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_4770eb8f-427a-4b97-9469-b78a3e2c0be6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_4770eb8f-427a-4b97-9469-b78a3e2c0be6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongTermDebt_390aa094-fe6e-46b0-9202-c7ac7906c7a1" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongTermDebt"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongTermDebt_390aa094-fe6e-46b0-9202-c7ac7906c7a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AmortizationOfInventoryStepUp_a1c3bdec-dd89-44b4-850e-e3c1306667f9" xlink:href="vtrs-20211231.xsd#vtrs_AmortizationOfInventoryStepUp"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_vtrs_AmortizationOfInventoryStepUp_a1c3bdec-dd89-44b4-850e-e3c1306667f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationNumberOfMarketsServed_00176a07-4924-4626-a36f-8c5a34a53a22" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationNumberOfMarketsServed"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b7d339dc-5af3-4434-ab07-20445f27926e" xlink:to="loc_vtrs_BusinessCombinationNumberOfMarketsServed_00176a07-4924-4626-a36f-8c5a34a53a22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationAbstract_dbdd1e41-2ada-473c-b8cd-1200d5ea39b4" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d1fa3c2c-48ee-477f-b96d-16394c09ebb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_BusinessCombinationAbstract_dbdd1e41-2ada-473c-b8cd-1200d5ea39b4" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d1fa3c2c-48ee-477f-b96d-16394c09ebb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_98c75f5d-552a-4865-9790-aea6d7cfd0de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d1fa3c2c-48ee-477f-b96d-16394c09ebb3" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_98c75f5d-552a-4865-9790-aea6d7cfd0de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_07359235-c5c0-4776-a677-718f83b11411" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_98c75f5d-552a-4865-9790-aea6d7cfd0de" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_07359235-c5c0-4776-a677-718f83b11411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_UpjohnInc.Member_f8caac2a-800b-4f9d-aa13-558ec4907de6" xlink:href="vtrs-20211231.xsd#vtrs_UpjohnInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_07359235-c5c0-4776-a677-718f83b11411" xlink:to="loc_vtrs_UpjohnInc.Member_f8caac2a-800b-4f9d-aa13-558ec4907de6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_TOBIMember_1f2cbac3-ad5d-4cc0-9406-48f281b10ac0" xlink:href="vtrs-20211231.xsd#vtrs_TOBIMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_07359235-c5c0-4776-a677-718f83b11411" xlink:to="loc_vtrs_TOBIMember_1f2cbac3-ad5d-4cc0-9406-48f281b10ac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_a17ceb3a-74a5-4ff0-ad6e-7a7a44378b9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_07359235-c5c0-4776-a677-718f83b11411" xlink:to="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_a17ceb3a-74a5-4ff0-ad6e-7a7a44378b9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AspenPharmacareHoldingsLimitedMember_290194d3-7151-4094-9241-a3652d2dfab1" xlink:href="vtrs-20211231.xsd#vtrs_AspenPharmacareHoldingsLimitedMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_07359235-c5c0-4776-a677-718f83b11411" xlink:to="loc_vtrs_AspenPharmacareHoldingsLimitedMember_290194d3-7151-4094-9241-a3652d2dfab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_d38be229-21b2-4fd9-981f-db265bb0b6c3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d1fa3c2c-48ee-477f-b96d-16394c09ebb3" xlink:to="loc_srt_CounterpartyNameAxis_d38be229-21b2-4fd9-981f-db265bb0b6c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_aa1cc9d0-f023-4139-9f12-ada878f2c332" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_d38be229-21b2-4fd9-981f-db265bb0b6c3" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_aa1cc9d0-f023-4139-9f12-ada878f2c332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_UpjohnInc.Member_bcb2400e-ffa4-4645-ab0d-3ce53979b70c" xlink:href="vtrs-20211231.xsd#vtrs_UpjohnInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_aa1cc9d0-f023-4139-9f12-ada878f2c332" xlink:to="loc_vtrs_UpjohnInc.Member_bcb2400e-ffa4-4645-ab0d-3ce53979b70c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis_5383c348-5637-4a6d-be9f-fbd00919e11d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d1fa3c2c-48ee-477f-b96d-16394c09ebb3" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis_5383c348-5637-4a6d-be9f-fbd00919e11d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalEntityTypeOfCounterpartyDomain_1ccf737b-3d6d-4937-833e-ab6952e75498" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LegalEntityTypeOfCounterpartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis_5383c348-5637-4a6d-be9f-fbd00919e11d" xlink:to="loc_us-gaap_LegalEntityTypeOfCounterpartyDomain_1ccf737b-3d6d-4937-833e-ab6952e75498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PfizerInc.Member_ab5991f4-0e97-4293-abf3-c7468d692ce3" xlink:href="vtrs-20211231.xsd#vtrs_PfizerInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LegalEntityTypeOfCounterpartyDomain_1ccf737b-3d6d-4937-833e-ab6952e75498" xlink:to="loc_vtrs_PfizerInc.Member_ab5991f4-0e97-4293-abf3-c7468d692ce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_7a76fa56-e358-4576-b9a6-b6059de4c854" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d1fa3c2c-48ee-477f-b96d-16394c09ebb3" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_7a76fa56-e358-4576-b9a6-b6059de4c854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_dbc7d7be-cc57-488c-a289-50e03b9017d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a76fa56-e358-4576-b9a6-b6059de4c854" xlink:to="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_dbc7d7be-cc57-488c-a289-50e03b9017d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_25579e39-b682-49c0-9c2b-d8cddc9057a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_dbc7d7be-cc57-488c-a289-50e03b9017d1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_25579e39-b682-49c0-9c2b-d8cddc9057a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_ae130c7f-5363-402e-97e1-b197273ff652" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_dbc7d7be-cc57-488c-a289-50e03b9017d1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_ae130c7f-5363-402e-97e1-b197273ff652" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_09407691-b48e-47e2-8a89-162a5c4f6b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_dbc7d7be-cc57-488c-a289-50e03b9017d1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_09407691-b48e-47e2-8a89-162a5c4f6b6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_8ef303a7-3983-4407-bce2-45f65868ffbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_dbc7d7be-cc57-488c-a289-50e03b9017d1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_8ef303a7-3983-4407-bce2-45f65868ffbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_8ad4d515-850f-48f1-9d1c-44268528e0fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_dbc7d7be-cc57-488c-a289-50e03b9017d1" xlink:to="loc_us-gaap_Goodwill_8ad4d515-850f-48f1-9d1c-44268528e0fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_7fd07af9-5108-40c4-b20c-5b900422484d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_dbc7d7be-cc57-488c-a289-50e03b9017d1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_7fd07af9-5108-40c4-b20c-5b900422484d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_08145a11-c678-449e-b80a-dfc5525e4960" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_dbc7d7be-cc57-488c-a289-50e03b9017d1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_08145a11-c678-449e-b80a-dfc5525e4960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_aa7849fc-cac1-4e5d-b436-c69f0c0cb374" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_dbc7d7be-cc57-488c-a289-50e03b9017d1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_aa7849fc-cac1-4e5d-b436-c69f0c0cb374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_5bbad8ec-388b-4de3-b4ea-3659504a43f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_dbc7d7be-cc57-488c-a289-50e03b9017d1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_5bbad8ec-388b-4de3-b4ea-3659504a43f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_6a3ed7fd-50bb-4632-9971-30f82ac14c44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_dbc7d7be-cc57-488c-a289-50e03b9017d1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_6a3ed7fd-50bb-4632-9971-30f82ac14c44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_01534497-23b8-4176-b805-744a30023e10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_dbc7d7be-cc57-488c-a289-50e03b9017d1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_01534497-23b8-4176-b805-744a30023e10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_11254a44-1fea-4ead-805b-f1cf3a956b65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_dbc7d7be-cc57-488c-a289-50e03b9017d1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_11254a44-1fea-4ead-805b-f1cf3a956b65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_54040386-e9a4-4dd3-829c-ef2ad6dd5da2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_dbc7d7be-cc57-488c-a289-50e03b9017d1" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_54040386-e9a4-4dd3-829c-ef2ad6dd5da2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets_ee0c2900-116b-49f7-88e6-168f6f8b231b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract_dbc7d7be-cc57-488c-a289-50e03b9017d1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets_ee0c2900-116b-49f7-88e6-168f6f8b231b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7fcaff51-11eb-45c0-9e3c-94220f817f8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a76fa56-e358-4576-b9a6-b6059de4c854" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7fcaff51-11eb-45c0-9e3c-94220f817f8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsCurrent_3e15bad8-4bf1-4671-94b4-c3685b6d7218" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7fcaff51-11eb-45c0-9e3c-94220f817f8e" xlink:to="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsCurrent_3e15bad8-4bf1-4671-94b4-c3685b6d7218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_f029147c-7da8-4a02-9a5d-dadbf3391614" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7fcaff51-11eb-45c0-9e3c-94220f817f8e" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_f029147c-7da8-4a02-9a5d-dadbf3391614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_beb52430-4d5d-41b8-9803-03363f1231fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7fcaff51-11eb-45c0-9e3c-94220f817f8e" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_beb52430-4d5d-41b8-9803-03363f1231fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_577e0bf6-6ef7-4e21-9673-9b445efe9f28" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7fcaff51-11eb-45c0-9e3c-94220f817f8e" xlink:to="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_577e0bf6-6ef7-4e21-9673-9b445efe9f28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_1c47b310-e292-487a-a51f-ebd94f5b0227" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7fcaff51-11eb-45c0-9e3c-94220f817f8e" xlink:to="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_1c47b310-e292-487a-a51f-ebd94f5b0227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentAssets_e2d18228-1e3f-4180-9b3a-f7f288a227e3" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7fcaff51-11eb-45c0-9e3c-94220f817f8e" xlink:to="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentAssets_e2d18228-1e3f-4180-9b3a-f7f288a227e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_47c8aefa-07b0-4b26-bc95-834e56760fbe" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7fcaff51-11eb-45c0-9e3c-94220f817f8e" xlink:to="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets_47c8aefa-07b0-4b26-bc95-834e56760fbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesCurrent_b8e67590-db22-4b33-a761-88b43fcaade4" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7fcaff51-11eb-45c0-9e3c-94220f817f8e" xlink:to="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesCurrent_b8e67590-db22-4b33-a761-88b43fcaade4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities_40430600-8055-45a0-bff8-3e034b029484" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7fcaff51-11eb-45c0-9e3c-94220f817f8e" xlink:to="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities_40430600-8055-45a0-bff8-3e034b029484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentLiabilities_3717a0ae-8547-4890-b57f-13bb1bfbdc3d" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentLiabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7fcaff51-11eb-45c0-9e3c-94220f817f8e" xlink:to="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentLiabilities_3717a0ae-8547-4890-b57f-13bb1bfbdc3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_812f1488-05cb-4271-b576-6ab175ece288" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7fcaff51-11eb-45c0-9e3c-94220f817f8e" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_812f1488-05cb-4271-b576-6ab175ece288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_9eb55602-1ac0-4493-8465-5b7d79aefd38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3bf4c8ba-0714-453e-b009-18c0f739f180" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_9eb55602-1ac0-4493-8465-5b7d79aefd38" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3bf4c8ba-0714-453e-b009-18c0f739f180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_ff6511be-61a9-4c27-838b-12b84fd8885c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3bf4c8ba-0714-453e-b009-18c0f739f180" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_ff6511be-61a9-4c27-838b-12b84fd8885c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_769bb719-56d9-4bc6-aa79-5014166124f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ff6511be-61a9-4c27-838b-12b84fd8885c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_769bb719-56d9-4bc6-aa79-5014166124f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_UpjohnInc.Member_6ddb639f-dcbc-4164-b3c9-32ce776b95bf" xlink:href="vtrs-20211231.xsd#vtrs_UpjohnInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_769bb719-56d9-4bc6-aa79-5014166124f5" xlink:to="loc_vtrs_UpjohnInc.Member_6ddb639f-dcbc-4164-b3c9-32ce776b95bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_3901288a-c5d1-4da1-956a-d48b1b5d0c8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3bf4c8ba-0714-453e-b009-18c0f739f180" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_3901288a-c5d1-4da1-956a-d48b1b5d0c8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_7125931d-2deb-49ff-8cc3-a0abcb7515f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3901288a-c5d1-4da1-956a-d48b1b5d0c8b" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_7125931d-2deb-49ff-8cc3-a0abcb7515f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_c9ab52b4-0484-40c9-b6f8-a97cb2448f83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3901288a-c5d1-4da1-956a-d48b1b5d0c8b" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_c9ab52b4-0484-40c9-b6f8-a97cb2448f83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_6884b3cb-8edf-4d18-bb6c-82adcd71a01b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3901288a-c5d1-4da1-956a-d48b1b5d0c8b" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_6884b3cb-8edf-4d18-bb6c-82adcd71a01b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_04aca583-d0d0-401b-a5db-f6bb2ab94559" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3901288a-c5d1-4da1-956a-d48b1b5d0c8b" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_04aca583-d0d0-401b-a5db-f6bb2ab94559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageBasicSharesOutstandingProForma_cb2192fa-3a4d-429d-9997-60e7da13ca3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageBasicSharesOutstandingProForma"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3901288a-c5d1-4da1-956a-d48b1b5d0c8b" xlink:to="loc_us-gaap_WeightedAverageBasicSharesOutstandingProForma_cb2192fa-3a4d-429d-9997-60e7da13ca3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted_8299eab7-6436-4656-9f43-0b6e04cdd85c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3901288a-c5d1-4da1-956a-d48b1b5d0c8b" xlink:to="loc_us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted_8299eab7-6436-4656-9f43-0b6e04cdd85c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivable" xlink:type="simple" xlink:href="vtrs-20211231.xsd#RevenueRecognitionandAccountsReceivable"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivable" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c0931690-2347-457d-b457-e2fa3d766a4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_f512aadf-614a-4301-943b-e8417e54c0a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c0931690-2347-457d-b457-e2fa3d766a4e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_f512aadf-614a-4301-943b-e8417e54c0a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableTables" xlink:type="simple" xlink:href="vtrs-20211231.xsd#RevenueRecognitionandAccountsReceivableTables"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_07c02741-61c7-484d-addb-850b11755786" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_1b2313f7-cc95-4489-b89c-c9a36857a468" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_07c02741-61c7-484d-addb-850b11755786" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_1b2313f7-cc95-4489-b89c-c9a36857a468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_48115062-676f-4907-af83-c321d071c695" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_07c02741-61c7-484d-addb-850b11755786" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_48115062-676f-4907-af83-c321d071c695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#RevenueRecognitionandAccountsReceivableRevenueDisaggregationDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_383279c6-5ade-4307-b276-eeab3ec6d715" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_2313563c-f5fd-4e8a-9abb-6ec4d9d2f98e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_383279c6-5ade-4307-b276-eeab3ec6d715" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_2313563c-f5fd-4e8a-9abb-6ec4d9d2f98e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_2a17b05c-4ded-4c3f-9f7f-0f4205ec9c01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2313563c-f5fd-4e8a-9abb-6ec4d9d2f98e" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_2a17b05c-4ded-4c3f-9f7f-0f4205ec9c01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7fd3350d-bba5-49d6-97e0-74fcafb84b8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2a17b05c-4ded-4c3f-9f7f-0f4205ec9c01" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7fd3350d-bba5-49d6-97e0-74fcafb84b8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember_05ef42c3-c540-4f7e-a5f3-d20246de2bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7fd3350d-bba5-49d6-97e0-74fcafb84b8d" xlink:to="loc_us-gaap_SalesMember_05ef42c3-c540-4f7e-a5f3-d20246de2bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_29d18d59-f3f6-490a-9992-fad065436eac" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2313563c-f5fd-4e8a-9abb-6ec4d9d2f98e" xlink:to="loc_srt_ConsolidationItemsAxis_29d18d59-f3f6-490a-9992-fad065436eac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_2d55efb2-de31-4124-9693-bd8088131b8d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_29d18d59-f3f6-490a-9992-fad065436eac" xlink:to="loc_srt_ConsolidationItemsDomain_2d55efb2-de31-4124-9693-bd8088131b8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_2e0f9f0e-c059-484d-88b8-4dc99b220797" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_2d55efb2-de31-4124-9693-bd8088131b8d" xlink:to="loc_us-gaap_OperatingSegmentsMember_2e0f9f0e-c059-484d-88b8-4dc99b220797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_83f5c7a8-dd74-49aa-9b15-7938b00de4ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2313563c-f5fd-4e8a-9abb-6ec4d9d2f98e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_83f5c7a8-dd74-49aa-9b15-7938b00de4ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1a35a772-a757-4f2e-9690-48713010a35b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_83f5c7a8-dd74-49aa-9b15-7938b00de4ae" xlink:to="loc_us-gaap_SegmentDomain_1a35a772-a757-4f2e-9690-48713010a35b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DevelopedMarketsSegmentMember_a96bec0c-ba44-4b19-9b25-b43069984f66" xlink:href="vtrs-20211231.xsd#vtrs_DevelopedMarketsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1a35a772-a757-4f2e-9690-48713010a35b" xlink:to="loc_vtrs_DevelopedMarketsSegmentMember_a96bec0c-ba44-4b19-9b25-b43069984f66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GreaterChinaSegmentMember_11e3de9d-fc7e-4ac1-a6e8-38f24ad694c5" xlink:href="vtrs-20211231.xsd#vtrs_GreaterChinaSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1a35a772-a757-4f2e-9690-48713010a35b" xlink:to="loc_vtrs_GreaterChinaSegmentMember_11e3de9d-fc7e-4ac1-a6e8-38f24ad694c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_c7fa47b0-ce97-49e1-879c-fd79a5c16db1" xlink:href="vtrs-20211231.xsd#vtrs_JapanAustraliaAndNewZealandSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1a35a772-a757-4f2e-9690-48713010a35b" xlink:to="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_c7fa47b0-ce97-49e1-879c-fd79a5c16db1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EmergingMarketsSegmentMember_609cc239-9569-4b0c-a852-41652c4400bd" xlink:href="vtrs-20211231.xsd#vtrs_EmergingMarketsSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1a35a772-a757-4f2e-9690-48713010a35b" xlink:to="loc_vtrs_EmergingMarketsSegmentMember_609cc239-9569-4b0c-a852-41652c4400bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_86fc3dad-d71f-433a-bb6b-c747ce130764" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2313563c-f5fd-4e8a-9abb-6ec4d9d2f98e" xlink:to="loc_srt_ProductOrServiceAxis_86fc3dad-d71f-433a-bb6b-c747ce130764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_df666598-945a-4b88-9a75-51e4e6f7a701" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_86fc3dad-d71f-433a-bb6b-c747ce130764" xlink:to="loc_srt_ProductsAndServicesDomain_df666598-945a-4b88-9a75-51e4e6f7a701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BrandsMember_3d5b43f8-e8f7-46dc-a8e9-5270fe08110b" xlink:href="vtrs-20211231.xsd#vtrs_BrandsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_df666598-945a-4b88-9a75-51e4e6f7a701" xlink:to="loc_vtrs_BrandsMember_3d5b43f8-e8f7-46dc-a8e9-5270fe08110b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ComplexGXAndBiosimilarsMember_e35cfdba-a4fb-4f78-8a85-80c74e6bf719" xlink:href="vtrs-20211231.xsd#vtrs_ComplexGXAndBiosimilarsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_df666598-945a-4b88-9a75-51e4e6f7a701" xlink:to="loc_vtrs_ComplexGXAndBiosimilarsMember_e35cfdba-a4fb-4f78-8a85-80c74e6bf719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GenericsMember_5016fa59-b321-4cee-b054-9bc43538544a" xlink:href="vtrs-20211231.xsd#vtrs_GenericsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_df666598-945a-4b88-9a75-51e4e6f7a701" xlink:to="loc_vtrs_GenericsMember_5016fa59-b321-4cee-b054-9bc43538544a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_401eef69-c8d1-4355-bc1d-038aec995ad5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_df666598-945a-4b88-9a75-51e4e6f7a701" xlink:to="loc_us-gaap_ProductMember_401eef69-c8d1-4355-bc1d-038aec995ad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_c1388fe4-de10-4f55-b31a-e2ba6039e3ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2313563c-f5fd-4e8a-9abb-6ec4d9d2f98e" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_c1388fe4-de10-4f55-b31a-e2ba6039e3ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b767cfd2-207f-416b-82c9-f3e426cbbb28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c1388fe4-de10-4f55-b31a-e2ba6039e3ba" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b767cfd2-207f-416b-82c9-f3e426cbbb28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableDisaggregationofRevenuebyKeyProductsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#RevenueRecognitionandAccountsReceivableDisaggregationofRevenuebyKeyProductsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableDisaggregationofRevenuebyKeyProductsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_27ebd686-ee74-48cc-bc17-f46ed09a47c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_576c9ac2-bb23-4826-8383-edd65d1f2030" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_27ebd686-ee74-48cc-bc17-f46ed09a47c6" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_576c9ac2-bb23-4826-8383-edd65d1f2030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_70fa9486-5d73-47d6-a165-945523a61b2f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_576c9ac2-bb23-4826-8383-edd65d1f2030" xlink:to="loc_srt_ProductOrServiceAxis_70fa9486-5d73-47d6-a165-945523a61b2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_8005a9d2-a278-4c17-b725-ec46ddc8d9fd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_70fa9486-5d73-47d6-a165-945523a61b2f" xlink:to="loc_srt_ProductsAndServicesDomain_8005a9d2-a278-4c17-b725-ec46ddc8d9fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_LipitorMember_2a23068e-31ce-4f87-8e61-bb804ba71a64" xlink:href="vtrs-20211231.xsd#vtrs_LipitorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8005a9d2-a278-4c17-b725-ec46ddc8d9fd" xlink:to="loc_vtrs_LipitorMember_2a23068e-31ce-4f87-8e61-bb804ba71a64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NorvascMember_0ab0e18a-979a-4415-b4da-cd1cfb78dd64" xlink:href="vtrs-20211231.xsd#vtrs_NorvascMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8005a9d2-a278-4c17-b725-ec46ddc8d9fd" xlink:to="loc_vtrs_NorvascMember_0ab0e18a-979a-4415-b4da-cd1cfb78dd64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_LyricaMember_7b1e52a6-e5b8-4160-881e-e3a298723a9c" xlink:href="vtrs-20211231.xsd#vtrs_LyricaMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8005a9d2-a278-4c17-b725-ec46ddc8d9fd" xlink:to="loc_vtrs_LyricaMember_7b1e52a6-e5b8-4160-881e-e3a298723a9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ViagraMember_3d4e632a-12cd-47fa-9414-12e1bec7670d" xlink:href="vtrs-20211231.xsd#vtrs_ViagraMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8005a9d2-a278-4c17-b725-ec46ddc8d9fd" xlink:to="loc_vtrs_ViagraMember_3d4e632a-12cd-47fa-9414-12e1bec7670d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EpiPenAutoInjectorsMember_76faa4ef-9e30-4c74-b828-89c9f3d7adf4" xlink:href="vtrs-20211231.xsd#vtrs_EpiPenAutoInjectorsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8005a9d2-a278-4c17-b725-ec46ddc8d9fd" xlink:to="loc_vtrs_EpiPenAutoInjectorsMember_76faa4ef-9e30-4c74-b828-89c9f3d7adf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CelebrexMember_93edf688-42de-4eee-8945-9e15d205284e" xlink:href="vtrs-20211231.xsd#vtrs_CelebrexMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8005a9d2-a278-4c17-b725-ec46ddc8d9fd" xlink:to="loc_vtrs_CelebrexMember_93edf688-42de-4eee-8945-9e15d205284e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CreonMember_809b471c-b345-438d-ab60-80f31f6d1d03" xlink:href="vtrs-20211231.xsd#vtrs_CreonMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8005a9d2-a278-4c17-b725-ec46ddc8d9fd" xlink:to="loc_vtrs_CreonMember_809b471c-b345-438d-ab60-80f31f6d1d03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ZoloftMember_72882b72-72e9-4cc0-8ce3-dfad365bf6d5" xlink:href="vtrs-20211231.xsd#vtrs_ZoloftMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8005a9d2-a278-4c17-b725-ec46ddc8d9fd" xlink:to="loc_vtrs_ZoloftMember_72882b72-72e9-4cc0-8ce3-dfad365bf6d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EffexorMember_a305f192-920d-4d68-b40d-8b364021461e" xlink:href="vtrs-20211231.xsd#vtrs_EffexorMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8005a9d2-a278-4c17-b725-ec46ddc8d9fd" xlink:to="loc_vtrs_EffexorMember_a305f192-920d-4d68-b40d-8b364021461e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_XalabrandsMember_3d967ab1-14ee-4859-9f22-ff24969c6049" xlink:href="vtrs-20211231.xsd#vtrs_XalabrandsMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8005a9d2-a278-4c17-b725-ec46ddc8d9fd" xlink:to="loc_vtrs_XalabrandsMember_3d967ab1-14ee-4859-9f22-ff24969c6049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_InfluvacMember_b89335bb-defc-4c2f-8344-735f32a1a1fe" xlink:href="vtrs-20211231.xsd#vtrs_InfluvacMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8005a9d2-a278-4c17-b725-ec46ddc8d9fd" xlink:to="loc_vtrs_InfluvacMember_b89335bb-defc-4c2f-8344-735f32a1a1fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AmitizaMember_8dc7f8be-c6d0-4789-98e1-adb487b2c13a" xlink:href="vtrs-20211231.xsd#vtrs_AmitizaMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8005a9d2-a278-4c17-b725-ec46ddc8d9fd" xlink:to="loc_vtrs_AmitizaMember_8dc7f8be-c6d0-4789-98e1-adb487b2c13a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_XanaxMember_93e62939-1320-440e-a6a4-0ddb6b5d3bd9" xlink:href="vtrs-20211231.xsd#vtrs_XanaxMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8005a9d2-a278-4c17-b725-ec46ddc8d9fd" xlink:to="loc_vtrs_XanaxMember_93e62939-1320-440e-a6a4-0ddb6b5d3bd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_YupelriMember_4872cfa6-2d39-4ec8-8544-2c527fa3c022" xlink:href="vtrs-20211231.xsd#vtrs_YupelriMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8005a9d2-a278-4c17-b725-ec46ddc8d9fd" xlink:to="loc_vtrs_YupelriMember_4872cfa6-2d39-4ec8-8544-2c527fa3c022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DymistaMember_2945aafc-f008-4a2a-95e9-a81f1e92aec0" xlink:href="vtrs-20211231.xsd#vtrs_DymistaMember"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8005a9d2-a278-4c17-b725-ec46ddc8d9fd" xlink:to="loc_vtrs_DymistaMember_2945aafc-f008-4a2a-95e9-a81f1e92aec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_7f51fb24-8811-4193-aae2-60c126302966" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_576c9ac2-bb23-4826-8383-edd65d1f2030" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_7f51fb24-8811-4193-aae2-60c126302966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_bdb79ed5-5dde-4d45-a214-c818e1bc366c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_7f51fb24-8811-4193-aae2-60c126302966" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_bdb79ed5-5dde-4d45-a214-c818e1bc366c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#RevenueRecognitionandAccountsReceivableNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_705d16a2-b93a-4b7e-ae84-de20960cf1e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_8a0c83a1-5bec-4622-87b6-98a7d7782427" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_705d16a2-b93a-4b7e-ae84-de20960cf1e4" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_8a0c83a1-5bec-4622-87b6-98a7d7782427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_7d5ec295-d6ac-4a4a-8c31-15b8499c1e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_8a0c83a1-5bec-4622-87b6-98a7d7782427" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_7d5ec295-d6ac-4a4a-8c31-15b8499c1e5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_a163269f-cade-4de8-8e74-027ccfd414c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_7d5ec295-d6ac-4a4a-8c31-15b8499c1e5a" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_a163269f-cade-4de8-8e74-027ccfd414c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ReceivablesFacilityMember_13234c09-3829-4579-839b-a55cdb642974" xlink:href="vtrs-20211231.xsd#vtrs_ReceivablesFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_a163269f-cade-4de8-8e74-027ccfd414c0" xlink:to="loc_vtrs_ReceivablesFacilityMember_13234c09-3829-4579-839b-a55cdb642974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c7228adf-43d1-42d4-be5c-a1ffb0036200" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_8a0c83a1-5bec-4622-87b6-98a7d7782427" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c7228adf-43d1-42d4-be5c-a1ffb0036200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity_023e8d59-7c86-4ae7-8953-8e387dbe6939" xlink:href="vtrs-20211231.xsd#vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c7228adf-43d1-42d4-be5c-a1ffb0036200" xlink:to="loc_vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity_023e8d59-7c86-4ae7-8953-8e387dbe6939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableFromSecuritization_0c197d7c-7895-46db-b5b1-81b239db5ce0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableFromSecuritization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c7228adf-43d1-42d4-be5c-a1ffb0036200" xlink:to="loc_us-gaap_AccountsReceivableFromSecuritization_0c197d7c-7895-46db-b5b1-81b239db5ce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#RevenueRecognitionandAccountsReceivableVariableConsiderationDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_fd9d9efc-6774-4562-8712-54ee87e470e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_1bdaa4a4-a6c1-4d96-ae92-2c855c7e5b8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_fd9d9efc-6774-4562-8712-54ee87e470e3" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_1bdaa4a4-a6c1-4d96-ae92-2c855c7e5b8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_8a865ec2-177d-4b5e-98f2-13c1fda71867" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1bdaa4a4-a6c1-4d96-ae92-2c855c7e5b8f" xlink:to="loc_srt_ConsolidationItemsAxis_8a865ec2-177d-4b5e-98f2-13c1fda71867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_e800fc60-541b-4f06-980a-f588a7ca0bda" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_8a865ec2-177d-4b5e-98f2-13c1fda71867" xlink:to="loc_srt_ConsolidationItemsDomain_e800fc60-541b-4f06-980a-f588a7ca0bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_f5c554d9-acfe-41c0-9524-e841e2061b84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_e800fc60-541b-4f06-980a-f588a7ca0bda" xlink:to="loc_us-gaap_OperatingSegmentsMember_f5c554d9-acfe-41c0-9524-e841e2061b84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c3cc8c4d-2ca7-4f1e-be00-1feeb0e4f60a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1bdaa4a4-a6c1-4d96-ae92-2c855c7e5b8f" xlink:to="loc_srt_ProductOrServiceAxis_c3cc8c4d-2ca7-4f1e-be00-1feeb0e4f60a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4d8f34e1-083e-4fc3-a7af-2b044d7f8714" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_c3cc8c4d-2ca7-4f1e-be00-1feeb0e4f60a" xlink:to="loc_srt_ProductsAndServicesDomain_4d8f34e1-083e-4fc3-a7af-2b044d7f8714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_627b566a-e859-40c3-b90e-5b3e9bdd4d86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_4d8f34e1-083e-4fc3-a7af-2b044d7f8714" xlink:to="loc_us-gaap_ProductMember_627b566a-e859-40c3-b90e-5b3e9bdd4d86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_823eec14-f883-4b38-bf55-709b1ad7f6ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1bdaa4a4-a6c1-4d96-ae92-2c855c7e5b8f" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_823eec14-f883-4b38-bf55-709b1ad7f6ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RevenuefromContractwithCustomerGross_0788cbb6-d59c-4849-a9a6-9736bed17fe9" xlink:href="vtrs-20211231.xsd#vtrs_RevenuefromContractwithCustomerGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_823eec14-f883-4b38-bf55-709b1ad7f6ec" xlink:to="loc_vtrs_RevenuefromContractwithCustomerGross_0788cbb6-d59c-4849-a9a6-9736bed17fe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Chargebacks_3191e981-a17a-4c59-b88e-78b501ddc46d" xlink:href="vtrs-20211231.xsd#vtrs_Chargebacks"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_823eec14-f883-4b38-bf55-709b1ad7f6ec" xlink:to="loc_vtrs_Chargebacks_3191e981-a17a-4c59-b88e-78b501ddc46d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccruedSalesAllowances_1202d420-b73f-49c3-9343-b44f9193e302" xlink:href="vtrs-20211231.xsd#vtrs_AccruedSalesAllowances"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_823eec14-f883-4b38-bf55-709b1ad7f6ec" xlink:to="loc_vtrs_AccruedSalesAllowances_1202d420-b73f-49c3-9343-b44f9193e302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RevenuefromContractwithCustomerReturns_16340c51-753f-4602-8103-0b4bec998e03" xlink:href="vtrs-20211231.xsd#vtrs_RevenuefromContractwithCustomerReturns"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_823eec14-f883-4b38-bf55-709b1ad7f6ec" xlink:to="loc_vtrs_RevenuefromContractwithCustomerReturns_16340c51-753f-4602-8103-0b4bec998e03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Medicaidandothergovernmentalrebates_e6a2f54a-fe5f-467f-8796-e492894d92a3" xlink:href="vtrs-20211231.xsd#vtrs_Medicaidandothergovernmentalrebates"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_823eec14-f883-4b38-bf55-709b1ad7f6ec" xlink:to="loc_vtrs_Medicaidandothergovernmentalrebates_e6a2f54a-fe5f-467f-8796-e492894d92a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SalesRevenueGrosstonetadjustments_dd57b271-8626-41f1-81be-d0034685bf97" xlink:href="vtrs-20211231.xsd#vtrs_SalesRevenueGrosstonetadjustments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_823eec14-f883-4b38-bf55-709b1ad7f6ec" xlink:to="loc_vtrs_SalesRevenueGrosstonetadjustments_dd57b271-8626-41f1-81be-d0034685bf97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_eeee9cda-853c-4162-96f7-47c23dff2f4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_823eec14-f883-4b38-bf55-709b1ad7f6ec" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_eeee9cda-853c-4162-96f7-47c23dff2f4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c15fa779-08c6-4269-846f-b33118325abd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_17cf5ece-0538-4059-aa07-4ca9bc4629c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c15fa779-08c6-4269-846f-b33118325abd" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_17cf5ece-0538-4059-aa07-4ca9bc4629c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_17ea5730-33ec-4e2e-a279-99f50b762294" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_17cf5ece-0538-4059-aa07-4ca9bc4629c5" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_17ea5730-33ec-4e2e-a279-99f50b762294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_4e0b29bc-eea8-44a8-a9f6-078885c02516" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_17ea5730-33ec-4e2e-a279-99f50b762294" xlink:to="loc_us-gaap_ReceivableTypeDomain_4e0b29bc-eea8-44a8-a9f6-078885c02516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VariableConsiderationMember_0758abf8-9b84-4098-881e-28bfc40bf36c" xlink:href="vtrs-20211231.xsd#vtrs_VariableConsiderationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_4e0b29bc-eea8-44a8-a9f6-078885c02516" xlink:to="loc_vtrs_VariableConsiderationMember_0758abf8-9b84-4098-881e-28bfc40bf36c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_88a6d134-f050-418a-b5ba-fd60bcc0b073" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_17cf5ece-0538-4059-aa07-4ca9bc4629c5" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_88a6d134-f050-418a-b5ba-fd60bcc0b073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_5050bd39-87ec-4a29-b261-5b2e1b2041b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_88a6d134-f050-418a-b5ba-fd60bcc0b073" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_5050bd39-87ec-4a29-b261-5b2e1b2041b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditConcentrationRiskMember_ec83de08-e74a-45d6-9254-668df5b491f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_5050bd39-87ec-4a29-b261-5b2e1b2041b3" xlink:to="loc_us-gaap_CreditConcentrationRiskMember_ec83de08-e74a-45d6-9254-668df5b491f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c859ff32-63a8-449e-8615-b69114b86ace" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_17cf5ece-0538-4059-aa07-4ca9bc4629c5" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c859ff32-63a8-449e-8615-b69114b86ace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_9011abd0-6a79-47d1-a041-5078bcc66578" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c859ff32-63a8-449e-8615-b69114b86ace" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_9011abd0-6a79-47d1-a041-5078bcc66578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_03892a32-05ed-4349-b1d6-bac4ad25eed8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_9011abd0-6a79-47d1-a041-5078bcc66578" xlink:to="loc_us-gaap_AccountsReceivableMember_03892a32-05ed-4349-b1d6-bac4ad25eed8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_453c24a3-d07f-434c-ac35-113df362990f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_17cf5ece-0538-4059-aa07-4ca9bc4629c5" xlink:to="loc_srt_MajorCustomersAxis_453c24a3-d07f-434c-ac35-113df362990f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_8fdc4092-d808-4b06-a4d7-447c7d607214" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_453c24a3-d07f-434c-ac35-113df362990f" xlink:to="loc_srt_NameOfMajorCustomerDomain_8fdc4092-d808-4b06-a4d7-447c7d607214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ThreeCustomersMember_3bc78d8c-dd63-4593-855f-836546a4a7b9" xlink:href="vtrs-20211231.xsd#vtrs_ThreeCustomersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_8fdc4092-d808-4b06-a4d7-447c7d607214" xlink:to="loc_vtrs_ThreeCustomersMember_3bc78d8c-dd63-4593-855f-836546a4a7b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_dff43c09-c7f8-41d0-8f32-02a77a341c85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_17cf5ece-0538-4059-aa07-4ca9bc4629c5" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_dff43c09-c7f8-41d0-8f32-02a77a341c85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_b784be68-b67d-42c8-9c01-298a1958aceb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_dff43c09-c7f8-41d0-8f32-02a77a341c85" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_b784be68-b67d-42c8-9c01-298a1958aceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_e7968fe5-c04a-41f7-8697-cd79647dc3b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_b784be68-b67d-42c8-9c01-298a1958aceb" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_e7968fe5-c04a-41f7-8697-cd79647dc3b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_4848da59-1fc5-44c9-be78-055e60f9c0e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_17cf5ece-0538-4059-aa07-4ca9bc4629c5" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_4848da59-1fc5-44c9-be78-055e60f9c0e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_df4e5cf3-22f8-4354-8eb3-880acff3a8a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_4848da59-1fc5-44c9-be78-055e60f9c0e5" xlink:to="loc_us-gaap_ReceivablesNetCurrent_df4e5cf3-22f8-4354-8eb3-880acff3a8a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_5dfbc64d-17dd-4e7b-aa20-4938bfeb84b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_4848da59-1fc5-44c9-be78-055e60f9c0e5" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_5dfbc64d-17dd-4e7b-aa20-4938bfeb84b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_9f100e50-71ec-4beb-9962-d234ae508150" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_4848da59-1fc5-44c9-be78-055e60f9c0e5" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_9f100e50-71ec-4beb-9962-d234ae508150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_451002f7-0600-487d-9efb-616ede046456" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_4848da59-1fc5-44c9-be78-055e60f9c0e5" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_451002f7-0600-487d-9efb-616ede046456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_06983405-0c39-470c-9c71-9b97447c057f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_4848da59-1fc5-44c9-be78-055e60f9c0e5" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_06983405-0c39-470c-9c71-9b97447c057f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndCollectionOfReceivables_3f2c2561-50ec-41d9-b47b-7bb81b3669e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndCollectionOfReceivables"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_4848da59-1fc5-44c9-be78-055e60f9c0e5" xlink:to="loc_us-gaap_ProceedsFromSaleAndCollectionOfReceivables_3f2c2561-50ec-41d9-b47b-7bb81b3669e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationRollforwardDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#RevenueRecognitionandAccountsReceivableVariableConsiderationRollforwardDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationRollforwardDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_d9f97008-a5f6-4b7e-a600-52417870a5fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_8d2094f6-db0a-4259-b704-786b7da4c39a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_d9f97008-a5f6-4b7e-a600-52417870a5fe" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_8d2094f6-db0a-4259-b704-786b7da4c39a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_502d7f17-340d-488f-a12c-f4cbf8ac4d3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_8d2094f6-db0a-4259-b704-786b7da4c39a" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_502d7f17-340d-488f-a12c-f4cbf8ac4d3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_9ba1228f-c701-48c1-bfb9-68e6d40343d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_502d7f17-340d-488f-a12c-f4cbf8ac4d3e" xlink:to="loc_us-gaap_ReceivableTypeDomain_9ba1228f-c701-48c1-bfb9-68e6d40343d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VariableConsiderationMember_f940be40-2c3d-4aae-9eef-10694e5bd7e0" xlink:href="vtrs-20211231.xsd#vtrs_VariableConsiderationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_9ba1228f-c701-48c1-bfb9-68e6d40343d4" xlink:to="loc_vtrs_VariableConsiderationMember_f940be40-2c3d-4aae-9eef-10694e5bd7e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VariableConsiderationCategoryAxis_1e906490-3e93-4042-86b7-4e9aeebdaeba" xlink:href="vtrs-20211231.xsd#vtrs_VariableConsiderationCategoryAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_8d2094f6-db0a-4259-b704-786b7da4c39a" xlink:to="loc_vtrs_VariableConsiderationCategoryAxis_1e906490-3e93-4042-86b7-4e9aeebdaeba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VariableConsiderationCategoryDomain_fc364d5c-5f9c-464a-b8a4-8fbad04b2147" xlink:href="vtrs-20211231.xsd#vtrs_VariableConsiderationCategoryDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_VariableConsiderationCategoryAxis_1e906490-3e93-4042-86b7-4e9aeebdaeba" xlink:to="loc_vtrs_VariableConsiderationCategoryDomain_fc364d5c-5f9c-464a-b8a4-8fbad04b2147" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ChargebacksMember_563823cb-2d15-479e-b3bb-01877303f232" xlink:href="vtrs-20211231.xsd#vtrs_ChargebacksMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_VariableConsiderationCategoryDomain_fc364d5c-5f9c-464a-b8a4-8fbad04b2147" xlink:to="loc_vtrs_ChargebacksMember_563823cb-2d15-479e-b3bb-01877303f232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RebatesPromotionalProgramsandOtherSalesAllowancesMember_fabc71d9-dc89-455f-b771-bd10065d89fb" xlink:href="vtrs-20211231.xsd#vtrs_RebatesPromotionalProgramsandOtherSalesAllowancesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_VariableConsiderationCategoryDomain_fc364d5c-5f9c-464a-b8a4-8fbad04b2147" xlink:to="loc_vtrs_RebatesPromotionalProgramsandOtherSalesAllowancesMember_fabc71d9-dc89-455f-b771-bd10065d89fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VariableConsiderationReturnsMember_f7839a13-c391-4541-95c3-73c7b037777e" xlink:href="vtrs-20211231.xsd#vtrs_VariableConsiderationReturnsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_VariableConsiderationCategoryDomain_fc364d5c-5f9c-464a-b8a4-8fbad04b2147" xlink:to="loc_vtrs_VariableConsiderationReturnsMember_f7839a13-c391-4541-95c3-73c7b037777e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GovernmentalRebateProgramsMember_51688ae3-cb08-42b0-8d4f-85778f47ddcf" xlink:href="vtrs-20211231.xsd#vtrs_GovernmentalRebateProgramsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_VariableConsiderationCategoryDomain_fc364d5c-5f9c-464a-b8a4-8fbad04b2147" xlink:to="loc_vtrs_GovernmentalRebateProgramsMember_51688ae3-cb08-42b0-8d4f-85778f47ddcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_02217bed-c454-46e1-8615-a08351cf3cc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_8d2094f6-db0a-4259-b704-786b7da4c39a" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_02217bed-c454-46e1-8615-a08351cf3cc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccountsReceivableVariableConsiderationRollForward_a43eba96-65e7-40c4-8d27-530b7b463c13" xlink:href="vtrs-20211231.xsd#vtrs_AccountsReceivableVariableConsiderationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_02217bed-c454-46e1-8615-a08351cf3cc8" xlink:to="loc_vtrs_AccountsReceivableVariableConsiderationRollForward_a43eba96-65e7-40c4-8d27-530b7b463c13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_e2d81160-51c4-409e-ae8e-7bf8bf668779" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_AccountsReceivableVariableConsiderationRollForward_a43eba96-65e7-40c4-8d27-530b7b463c13" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_e2d81160-51c4-409e-ae8e-7bf8bf668779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccountsReceivableSalesProvisionsCurrent_644e3c22-64c6-4d45-ae7c-6bf454a17a36" xlink:href="vtrs-20211231.xsd#vtrs_AccountsReceivableSalesProvisionsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_AccountsReceivableVariableConsiderationRollForward_a43eba96-65e7-40c4-8d27-530b7b463c13" xlink:to="loc_vtrs_AccountsReceivableSalesProvisionsCurrent_644e3c22-64c6-4d45-ae7c-6bf454a17a36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccountsReceivableIncreaseDueToAcquisitionCurrent_85df3fe2-40d5-45fd-9f01-8b268651a35c" xlink:href="vtrs-20211231.xsd#vtrs_AccountsReceivableIncreaseDueToAcquisitionCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_AccountsReceivableVariableConsiderationRollForward_a43eba96-65e7-40c4-8d27-530b7b463c13" xlink:to="loc_vtrs_AccountsReceivableIncreaseDueToAcquisitionCurrent_85df3fe2-40d5-45fd-9f01-8b268651a35c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccountsReceivableCreditsIssuedtoThirdParties_58dd2dc4-eea5-4e3a-85d1-5ddb3f2d4f38" xlink:href="vtrs-20211231.xsd#vtrs_AccountsReceivableCreditsIssuedtoThirdParties"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_AccountsReceivableVariableConsiderationRollForward_a43eba96-65e7-40c4-8d27-530b7b463c13" xlink:to="loc_vtrs_AccountsReceivableCreditsIssuedtoThirdParties_58dd2dc4-eea5-4e3a-85d1-5ddb3f2d4f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccountsReceivableEffectsofForeignExchangeRates_6743a8a5-b429-4f8e-975e-b3b8781774ca" xlink:href="vtrs-20211231.xsd#vtrs_AccountsReceivableEffectsofForeignExchangeRates"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_AccountsReceivableVariableConsiderationRollForward_a43eba96-65e7-40c4-8d27-530b7b463c13" xlink:to="loc_vtrs_AccountsReceivableEffectsofForeignExchangeRates_6743a8a5-b429-4f8e-975e-b3b8781774ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_236d0865-0346-48e8-a601-27e606bebca2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_AccountsReceivableVariableConsiderationRollForward_a43eba96-65e7-40c4-8d27-530b7b463c13" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_236d0865-0346-48e8-a601-27e606bebca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponents" xlink:type="simple" xlink:href="vtrs-20211231.xsd#BalanceSheetComponents"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BalanceSheetComponentsAbstract_fe60e6d4-0841-4c01-bc6c-9495c42da7d7" xlink:href="vtrs-20211231.xsd#vtrs_BalanceSheetComponentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_d6fc534a-d4b1-4bea-b00f-b29a0db2c48e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_BalanceSheetComponentsAbstract_fe60e6d4-0841-4c01-bc6c-9495c42da7d7" xlink:to="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_d6fc534a-d4b1-4bea-b00f-b29a0db2c48e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsTables" xlink:type="simple" xlink:href="vtrs-20211231.xsd#BalanceSheetComponentsTables"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BalanceSheetComponentsAbstract_ddcafd2d-8e9a-409a-ac49-f0245cc6d97a" xlink:href="vtrs-20211231.xsd#vtrs_BalanceSheetComponentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock_12d7c77e-d1c1-4df0-9c64-9b067508bf06" xlink:href="vtrs-20211231.xsd#vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_BalanceSheetComponentsAbstract_ddcafd2d-8e9a-409a-ac49-f0245cc6d97a" xlink:to="loc_vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock_12d7c77e-d1c1-4df0-9c64-9b067508bf06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_ec2757b8-86a5-468c-9485-9411ba967cee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_BalanceSheetComponentsAbstract_ddcafd2d-8e9a-409a-ac49-f0245cc6d97a" xlink:to="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_ec2757b8-86a5-468c-9485-9411ba967cee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_16210f8d-5523-4890-9337-f6119638d78d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_BalanceSheetComponentsAbstract_ddcafd2d-8e9a-409a-ac49-f0245cc6d97a" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_16210f8d-5523-4890-9337-f6119638d78d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsTextBlock_98085a6e-c3b8-4c3c-99a7-568e21b55f2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentAssetsTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_BalanceSheetComponentsAbstract_ddcafd2d-8e9a-409a-ac49-f0245cc6d97a" xlink:to="loc_us-gaap_OtherCurrentAssetsTextBlock_98085a6e-c3b8-4c3c-99a7-568e21b55f2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_c072d864-0253-4348-8fe9-7a60e7389936" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_BalanceSheetComponentsAbstract_ddcafd2d-8e9a-409a-ac49-f0245cc6d97a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_c072d864-0253-4348-8fe9-7a60e7389936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_324dccd4-2b37-4559-9d02-a62fd4093ac2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_BalanceSheetComponentsAbstract_ddcafd2d-8e9a-409a-ac49-f0245cc6d97a" xlink:to="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_324dccd4-2b37-4559-9d02-a62fd4093ac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_a66ce26a-7eb9-4367-a6ce-ab2fa2655ddd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_BalanceSheetComponentsAbstract_ddcafd2d-8e9a-409a-ac49-f0245cc6d97a" xlink:to="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_a66ce26a-7eb9-4367-a6ce-ab2fa2655ddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_1fd3a66a-443b-43c9-a960-577170062346" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_BalanceSheetComponentsAbstract_ddcafd2d-8e9a-409a-ac49-f0245cc6d97a" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_1fd3a66a-443b-43c9-a960-577170062346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_a2b9d1cf-d5f5-4b88-b01b-2b114277cc7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_BalanceSheetComponentsAbstract_ddcafd2d-8e9a-409a-ac49-f0245cc6d97a" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_a2b9d1cf-d5f5-4b88-b01b-2b114277cc7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_389f0d74-64ff-429c-9856-c7ce02be7bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_BalanceSheetComponentsAbstract_ddcafd2d-8e9a-409a-ac49-f0245cc6d97a" xlink:to="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_389f0d74-64ff-429c-9856-c7ce02be7bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_479cc338-a5d3-47c1-90be-c7d42e076244" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_BalanceSheetComponentsAbstract_ddcafd2d-8e9a-409a-ac49-f0245cc6d97a" xlink:to="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_479cc338-a5d3-47c1-90be-c7d42e076244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#BalanceSheetComponentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BalanceSheetComponentsAbstract_ca2d73dc-0291-494d-9467-6b7cebeca8b4" xlink:href="vtrs-20211231.xsd#vtrs_BalanceSheetComponentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_4fbba7b1-0809-480e-8c8c-84ab0c1dd531" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_BalanceSheetComponentsAbstract_ca2d73dc-0291-494d-9467-6b7cebeca8b4" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_4fbba7b1-0809-480e-8c8c-84ab0c1dd531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_72da806d-ace4-4bcd-91b1-4475e322745f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_4fbba7b1-0809-480e-8c8c-84ab0c1dd531" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_72da806d-ace4-4bcd-91b1-4475e322745f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_03353b90-2a71-471c-865b-37aacea62b31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_72da806d-ace4-4bcd-91b1-4475e322745f" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_03353b90-2a71-471c-865b-37aacea62b31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ContingentConsiderationMember_97a3c564-6b93-4cff-a81e-13261157fad1" xlink:href="vtrs-20211231.xsd#vtrs_ContingentConsiderationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_03353b90-2a71-471c-865b-37aacea62b31" xlink:to="loc_vtrs_ContingentConsiderationMember_97a3c564-6b93-4cff-a81e-13261157fad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_c8254bb5-8e45-48bf-8ced-5b4657250d43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_4fbba7b1-0809-480e-8c8c-84ab0c1dd531" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_c8254bb5-8e45-48bf-8ced-5b4657250d43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_fa612e44-575e-4944-bded-954afb5a8a1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_c8254bb5-8e45-48bf-8ced-5b4657250d43" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_fa612e44-575e-4944-bded-954afb5a8a1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_20cd50d0-fe8c-4e2c-8743-f36c101655c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_fa612e44-575e-4944-bded-954afb5a8a1c" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_20cd50d0-fe8c-4e2c-8743-f36c101655c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_39afba33-2154-419b-ae17-e8f923d0527a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_4fbba7b1-0809-480e-8c8c-84ab0c1dd531" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_39afba33-2154-419b-ae17-e8f923d0527a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_0e1e75c6-c891-4464-9f48-230ddaebd7b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_39afba33-2154-419b-ae17-e8f923d0527a" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_0e1e75c6-c891-4464-9f48-230ddaebd7b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_85db7a36-ea44-4c1a-9e5e-dfe07dbcdb0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_0e1e75c6-c891-4464-9f48-230ddaebd7b1" xlink:to="loc_us-gaap_AccountsReceivableMember_85db7a36-ea44-4c1a-9e5e-dfe07dbcdb0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_dbf55480-06b6-4d57-8add-f995ab12417e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_4fbba7b1-0809-480e-8c8c-84ab0c1dd531" xlink:to="loc_srt_StatementGeographicalAxis_dbf55480-06b6-4d57-8add-f995ab12417e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_71ed88e6-1e4f-42cd-ab0c-44d856d30b10" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_dbf55480-06b6-4d57-8add-f995ab12417e" xlink:to="loc_srt_SegmentGeographicalDomain_71ed88e6-1e4f-42cd-ab0c-44d856d30b10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IN_abc2ccfb-3649-40eb-9634-efae59bf40c0" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IN"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_71ed88e6-1e4f-42cd-ab0c-44d856d30b10" xlink:to="loc_country_IN_abc2ccfb-3649-40eb-9634-efae59bf40c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_c32c4521-b6eb-456b-af23-483154399f2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_4fbba7b1-0809-480e-8c8c-84ab0c1dd531" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_c32c4521-b6eb-456b-af23-483154399f2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_36d9297a-370f-4bc6-91f2-dc2cc5204824" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_c32c4521-b6eb-456b-af23-483154399f2e" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_36d9297a-370f-4bc6-91f2-dc2cc5204824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VoluntaryRecallofValsartanandCertainCombinationsValsartanMedicinesMember_c924b02a-09a3-4e84-84d6-c7cc1551cb76" xlink:href="vtrs-20211231.xsd#vtrs_VoluntaryRecallofValsartanandCertainCombinationsValsartanMedicinesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_36d9297a-370f-4bc6-91f2-dc2cc5204824" xlink:to="loc_vtrs_VoluntaryRecallofValsartanandCertainCombinationsValsartanMedicinesMember_c924b02a-09a3-4e84-84d6-c7cc1551cb76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_03e0fe2e-2d0b-4b62-abe7-add5c804739e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_4fbba7b1-0809-480e-8c8c-84ab0c1dd531" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_03e0fe2e-2d0b-4b62-abe7-add5c804739e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_75b5d284-46d3-4da9-ae33-841a9ee5fa71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_03e0fe2e-2d0b-4b62-abe7-add5c804739e" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_75b5d284-46d3-4da9-ae33-841a9ee5fa71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_4d2def4f-2257-4c94-bf32-ec04faddc453" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_03e0fe2e-2d0b-4b62-abe7-add5c804739e" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_4d2def4f-2257-4c94-bf32-ec04faddc453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Concentrationrisknumberofmajorcustomers_6da3ef96-6a4e-4a60-8b93-1aa3f73372a8" xlink:href="vtrs-20211231.xsd#vtrs_Concentrationrisknumberofmajorcustomers"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_03e0fe2e-2d0b-4b62-abe7-add5c804739e" xlink:to="loc_vtrs_Concentrationrisknumberofmajorcustomers_6da3ef96-6a4e-4a60-8b93-1aa3f73372a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareNet_7dc5031f-fd04-4e55-95d6-2ad23de279bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_03e0fe2e-2d0b-4b62-abe7-add5c804739e" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareNet_7dc5031f-fd04-4e55-95d6-2ad23de279bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Netrealizablevalueofinventoryrecognizedasexpense_b459b373-b5ad-4f65-adc9-38c6cde9b5b2" xlink:href="vtrs-20211231.xsd#vtrs_Netrealizablevalueofinventoryrecognizedasexpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_03e0fe2e-2d0b-4b62-abe7-add5c804739e" xlink:to="loc_vtrs_Netrealizablevalueofinventoryrecognizedasexpense_b459b373-b5ad-4f65-adc9-38c6cde9b5b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_b275cfbd-e662-4c8c-9712-7c2fc7d7ac99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_03e0fe2e-2d0b-4b62-abe7-add5c804739e" xlink:to="loc_us-gaap_Depreciation_b275cfbd-e662-4c8c-9712-7c2fc7d7ac99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_ab575b14-ed8e-401c-a70b-8da7eb5be1fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_03e0fe2e-2d0b-4b62-abe7-add5c804739e" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_ab575b14-ed8e-401c-a70b-8da7eb5be1fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_1e2b546c-e7e6-424b-a49d-2d8b3d57e8d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCash"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_03e0fe2e-2d0b-4b62-abe7-add5c804739e" xlink:to="loc_us-gaap_RestrictedCash_1e2b546c-e7e6-424b-a49d-2d8b3d57e8d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsBalanceSheetComponentsCashandCashEquivalentsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#BalanceSheetComponentsBalanceSheetComponentsCashandCashEquivalentsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsBalanceSheetComponentsCashandCashEquivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_a39e2580-8264-462d-82d8-e866101e7fed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6969f797-d11e-449b-a298-bb31241dfb6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_a39e2580-8264-462d-82d8-e866101e7fed" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6969f797-d11e-449b-a298-bb31241dfb6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_e63d49d5-2547-46d7-9277-14faf7be7fbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_a39e2580-8264-462d-82d8-e866101e7fed" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_e63d49d5-2547-46d7-9277-14faf7be7fbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b17ff181-83a0-4d74-bbe7-27b878b35c64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_a39e2580-8264-462d-82d8-e866101e7fed" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b17ff181-83a0-4d74-bbe7-27b878b35c64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsAccountsreceivablenetDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#BalanceSheetComponentsAccountsreceivablenetDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsAccountsreceivablenetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrentAbstract_9392fc8d-3adb-4186-b2c5-cf4e43800b19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesNetCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_eb3f3638-57d0-41da-bf7f-891c3ab11701" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesNetCurrentAbstract_9392fc8d-3adb-4186-b2c5-cf4e43800b19" xlink:to="loc_us-gaap_ReceivablesNetCurrent_eb3f3638-57d0-41da-bf7f-891c3ab11701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_0c643909-f76e-4b0d-bc94-e82dedd797ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesNetCurrentAbstract_9392fc8d-3adb-4186-b2c5-cf4e43800b19" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_0c643909-f76e-4b0d-bc94-e82dedd797ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_ae75e313-b96a-44aa-b4ae-a43192fd9741" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesNetCurrentAbstract_9392fc8d-3adb-4186-b2c5-cf4e43800b19" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_ae75e313-b96a-44aa-b4ae-a43192fd9741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_99554a13-a102-4a96-ad03-2f583fb05c20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesNetCurrentAbstract_9392fc8d-3adb-4186-b2c5-cf4e43800b19" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_99554a13-a102-4a96-ad03-2f583fb05c20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_a518312a-7bec-481e-9e64-2c61e2e2f428" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_99554a13-a102-4a96-ad03-2f583fb05c20" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_a518312a-7bec-481e-9e64-2c61e2e2f428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e44379a1-3cf6-425a-9496-dda06ff0cf35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_a518312a-7bec-481e-9e64-2c61e2e2f428" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e44379a1-3cf6-425a-9496-dda06ff0cf35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_29cabf1f-eaa6-4f5f-b8a8-ef706719e1ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e44379a1-3cf6-425a-9496-dda06ff0cf35" xlink:to="loc_us-gaap_AccountsReceivableMember_29cabf1f-eaa6-4f5f-b8a8-ef706719e1ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_2ef125c7-27f8-4942-b364-b3e115b979b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_99554a13-a102-4a96-ad03-2f583fb05c20" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_2ef125c7-27f8-4942-b364-b3e115b979b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Concentrationrisknumberofmajorcustomers_667c2129-7925-4a24-b17b-747683d1aa3f" xlink:href="vtrs-20211231.xsd#vtrs_Concentrationrisknumberofmajorcustomers"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_2ef125c7-27f8-4942-b364-b3e115b979b9" xlink:to="loc_vtrs_Concentrationrisknumberofmajorcustomers_667c2129-7925-4a24-b17b-747683d1aa3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndCollectionOfReceivables_3ce04cb2-d723-447f-a9cc-ed255abe9e47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndCollectionOfReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_2ef125c7-27f8-4942-b364-b3e115b979b9" xlink:to="loc_us-gaap_ProceedsFromSaleAndCollectionOfReceivables_3ce04cb2-d723-447f-a9cc-ed255abe9e47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsInventoriesDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#BalanceSheetComponentsInventoriesDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract_92faa88a-69db-4701-ba79-137d456e893b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_accda775-b762-46be-a1b9-6d7627655d58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_92faa88a-69db-4701-ba79-137d456e893b" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_accda775-b762-46be-a1b9-6d7627655d58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_7616ffbb-6355-4b07-9aa2-6f00fde4f5fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_92faa88a-69db-4701-ba79-137d456e893b" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_7616ffbb-6355-4b07-9aa2-6f00fde4f5fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_00918f1b-2923-4733-a3d1-a81106307b7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_92faa88a-69db-4701-ba79-137d456e893b" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_00918f1b-2923-4733-a3d1-a81106307b7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_88005433-4947-48ea-a342-acbfb18e20e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_92faa88a-69db-4701-ba79-137d456e893b" xlink:to="loc_us-gaap_InventoryNet_88005433-4947-48ea-a342-acbfb18e20e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_288fcb10-6f14-4578-96ce-60488f89a223" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryValuationReserves"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_92faa88a-69db-4701-ba79-137d456e893b" xlink:to="loc_us-gaap_InventoryValuationReserves_288fcb10-6f14-4578-96ce-60488f89a223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Netrealizablevalueofinventoryrecognizedasexpense_ddd25943-5f27-4b6f-b125-da86ba308885" xlink:href="vtrs-20211231.xsd#vtrs_Netrealizablevalueofinventoryrecognizedasexpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_92faa88a-69db-4701-ba79-137d456e893b" xlink:to="loc_vtrs_Netrealizablevalueofinventoryrecognizedasexpense_ddd25943-5f27-4b6f-b125-da86ba308885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsPrepaidsandothercurrentassetsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#BalanceSheetComponentsPrepaidsandothercurrentassetsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsPrepaidsandothercurrentassetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_1d8b7b57-c0f1-4b88-8ca0-d583024c97eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_208a7dad-52c8-4d71-962b-833943902f38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_1d8b7b57-c0f1-4b88-8ca0-d583024c97eb" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_208a7dad-52c8-4d71-962b-833943902f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_744d8c99-d2b5-441c-867b-11092103508c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_1d8b7b57-c0f1-4b88-8ca0-d583024c97eb" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_744d8c99-d2b5-441c-867b-11092103508c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_f92d6893-07da-4e69-af31-9871a4146a8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_1d8b7b57-c0f1-4b88-8ca0-d583024c97eb" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_f92d6893-07da-4e69-af31-9871a4146a8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_e4259988-9af1-4195-8a6b-0bdee80bf040" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_1d8b7b57-c0f1-4b88-8ca0-d583024c97eb" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_e4259988-9af1-4195-8a6b-0bdee80bf040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_6efa7e89-346d-426e-8e01-25916dcbe827" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_1d8b7b57-c0f1-4b88-8ca0-d583024c97eb" xlink:to="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_6efa7e89-346d-426e-8e01-25916dcbe827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_0083bf2f-fbc2-4229-b03e-63316889bfa7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_1d8b7b57-c0f1-4b88-8ca0-d583024c97eb" xlink:to="loc_us-gaap_OtherAssetsCurrent_0083bf2f-fbc2-4229-b03e-63316889bfa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_9b166c7d-5e5f-41de-addf-32b6180d47d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_1d8b7b57-c0f1-4b88-8ca0-d583024c97eb" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_9b166c7d-5e5f-41de-addf-32b6180d47d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#BalanceSheetComponentsPropertyPlantandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_9c1c9749-eff0-4890-a09b-3537f2630d3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_fb0e2ab4-3b18-42aa-b00b-59da0d55fef1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_9c1c9749-eff0-4890-a09b-3537f2630d3b" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_fb0e2ab4-3b18-42aa-b00b-59da0d55fef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b11b774e-cc1d-4e3a-a2c9-426f5b1a4389" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_fb0e2ab4-3b18-42aa-b00b-59da0d55fef1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b11b774e-cc1d-4e3a-a2c9-426f5b1a4389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4ecc9d58-c8af-4827-ba2e-2ac5592406bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b11b774e-cc1d-4e3a-a2c9-426f5b1a4389" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4ecc9d58-c8af-4827-ba2e-2ac5592406bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAndLandImprovementsMember_c228c593-babc-437d-8933-127e7ebc5dfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandAndLandImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4ecc9d58-c8af-4827-ba2e-2ac5592406bb" xlink:to="loc_us-gaap_LandAndLandImprovementsMember_c228c593-babc-437d-8933-127e7ebc5dfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_1f934906-7ef0-40dd-86da-a3a7edb1f049" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4ecc9d58-c8af-4827-ba2e-2ac5592406bb" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_1f934906-7ef0-40dd-86da-a3a7edb1f049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_3e995934-e184-435a-9f1b-33cb39d9d33c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4ecc9d58-c8af-4827-ba2e-2ac5592406bb" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_3e995934-e184-435a-9f1b-33cb39d9d33c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_020c0475-6337-477b-9d65-ae9c0d26814c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4ecc9d58-c8af-4827-ba2e-2ac5592406bb" xlink:to="loc_us-gaap_ConstructionInProgressMember_020c0475-6337-477b-9d65-ae9c0d26814c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ccb54475-ec11-4048-94ea-0c819905755a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_fb0e2ab4-3b18-42aa-b00b-59da0d55fef1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ccb54475-ec11-4048-94ea-0c819905755a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_ffe4554f-7723-4b16-b48f-bb843c4d4261" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ccb54475-ec11-4048-94ea-0c819905755a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_ffe4554f-7723-4b16-b48f-bb843c4d4261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_258a5bcf-18f7-4b11-a778-f0ca4639bc29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ccb54475-ec11-4048-94ea-0c819905755a" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_258a5bcf-18f7-4b11-a778-f0ca4639bc29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_bda13f5e-e3b1-433a-a394-2b4c064e4215" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ccb54475-ec11-4048-94ea-0c819905755a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_bda13f5e-e3b1-433a-a394-2b4c064e4215" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#BalanceSheetComponentsOtherAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrentAbstract_a74ea739-d037-432d-9230-2b2750315d09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofOtherAssetsTable_7df75294-c832-4078-8dc9-74df09c01377" xlink:href="vtrs-20211231.xsd#vtrs_ScheduleofOtherAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_a74ea739-d037-432d-9230-2b2750315d09" xlink:to="loc_vtrs_ScheduleofOtherAssetsTable_7df75294-c832-4078-8dc9-74df09c01377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_536ebcc3-6d5a-471e-8781-f460a7edf4ac" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofOtherAssetsTable_7df75294-c832-4078-8dc9-74df09c01377" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_536ebcc3-6d5a-471e-8781-f460a7edf4ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_4de456ca-0c33-4b64-9fcd-3778ac5a28aa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_536ebcc3-6d5a-471e-8781-f460a7edf4ac" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_4de456ca-0c33-4b64-9fcd-3778ac5a28aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CleanEnergyPartnershipsMember_b6d1b723-8ba0-497a-947e-532600d0a177" xlink:href="vtrs-20211231.xsd#vtrs_CleanEnergyPartnershipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4de456ca-0c33-4b64-9fcd-3778ac5a28aa" xlink:to="loc_vtrs_CleanEnergyPartnershipsMember_b6d1b723-8ba0-497a-947e-532600d0a177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_de7a0ff5-1323-4f8c-a9ae-0ff3fe70438a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofOtherAssetsTable_7df75294-c832-4078-8dc9-74df09c01377" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_de7a0ff5-1323-4f8c-a9ae-0ff3fe70438a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_01de1726-c153-4ea9-bd34-00c148df4d95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_de7a0ff5-1323-4f8c-a9ae-0ff3fe70438a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_01de1726-c153-4ea9-bd34-00c148df4d95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_7eb6d13e-12c4-4ee4-be0b-7680d0f816ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_01de1726-c153-4ea9-bd34-00c148df4d95" xlink:to="loc_us-gaap_OtherAssetsMember_7eb6d13e-12c4-4ee4-be0b-7680d0f816ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofOtherAssetsLineItems_c5346461-05c6-41b6-9cce-aef088d6fe30" xlink:href="vtrs-20211231.xsd#vtrs_ScheduleofOtherAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofOtherAssetsTable_7df75294-c832-4078-8dc9-74df09c01377" xlink:to="loc_vtrs_ScheduleofOtherAssetsLineItems_c5346461-05c6-41b6-9cce-aef088d6fe30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_bd1f4cd7-dbd5-4abf-a70f-903a4798c2fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofOtherAssetsLineItems_c5346461-05c6-41b6-9cce-aef088d6fe30" xlink:to="loc_us-gaap_EquityMethodInvestments_bd1f4cd7-dbd5-4abf-a70f-903a4798c2fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_bcb93abe-e1ae-4c8b-a05f-fb212c8f06c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofOtherAssetsLineItems_c5346461-05c6-41b6-9cce-aef088d6fe30" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_bcb93abe-e1ae-4c8b-a05f-fb212c8f06c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Otherlongtermassets_847f0ac6-ee4e-42b0-b65c-302a4d6ff2c0" xlink:href="vtrs-20211231.xsd#vtrs_Otherlongtermassets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofOtherAssetsLineItems_c5346461-05c6-41b6-9cce-aef088d6fe30" xlink:to="loc_vtrs_Otherlongtermassets_847f0ac6-ee4e-42b0-b65c-302a4d6ff2c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_e9ae8096-684e-4f21-bd23-e59e2347e8dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofOtherAssetsLineItems_c5346461-05c6-41b6-9cce-aef088d6fe30" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_e9ae8096-684e-4f21-bd23-e59e2347e8dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsTradeAccountsPayableDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#BalanceSheetComponentsTradeAccountsPayableDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsTradeAccountsPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrentAbstract_38b55e6f-e0a6-48c9-b81d-469c44b8fdde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrentAndNoncurrent_cad5aea8-292e-4fd6-b179-b3e64bf824b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrentAndNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableCurrentAbstract_38b55e6f-e0a6-48c9-b81d-469c44b8fdde" xlink:to="loc_us-gaap_AccountsPayableTradeCurrentAndNoncurrent_cad5aea8-292e-4fd6-b179-b3e64bf824b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableOtherCurrentAndNoncurrent_54aac869-44e3-4e2b-b9d2-fba4382beed3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableOtherCurrentAndNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableCurrentAbstract_38b55e6f-e0a6-48c9-b81d-469c44b8fdde" xlink:to="loc_us-gaap_AccountsPayableOtherCurrentAndNoncurrent_54aac869-44e3-4e2b-b9d2-fba4382beed3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_505e7e98-462e-4a1a-ac72-474b058e48dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableCurrentAbstract_38b55e6f-e0a6-48c9-b81d-469c44b8fdde" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_505e7e98-462e-4a1a-ac72-474b058e48dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#BalanceSheetComponentsOtherCurrentLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrentAbstract_c7d68e6c-ae7d-4fde-938d-0ff02e5c52ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofothercurrentliabilitiesTable_b11a912c-3f76-4342-b1cb-c6f53031919c" xlink:href="vtrs-20211231.xsd#vtrs_ScheduleofothercurrentliabilitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_c7d68e6c-ae7d-4fde-938d-0ff02e5c52ce" xlink:to="loc_vtrs_ScheduleofothercurrentliabilitiesTable_b11a912c-3f76-4342-b1cb-c6f53031919c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_e226e52e-d66a-4a15-a006-34ebf6141efb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesTable_b11a912c-3f76-4342-b1cb-c6f53031919c" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_e226e52e-d66a-4a15-a006-34ebf6141efb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_db27d359-80ad-44ac-9338-11dae2562747" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_e226e52e-d66a-4a15-a006-34ebf6141efb" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_db27d359-80ad-44ac-9338-11dae2562747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VoluntaryRecallofValsartanandCertainCombinationsValsartanMedicinesMember_c0fc0a13-4a57-40f6-9725-b7f5c02d51a2" xlink:href="vtrs-20211231.xsd#vtrs_VoluntaryRecallofValsartanandCertainCombinationsValsartanMedicinesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_db27d359-80ad-44ac-9338-11dae2562747" xlink:to="loc_vtrs_VoluntaryRecallofValsartanandCertainCombinationsValsartanMedicinesMember_c0fc0a13-4a57-40f6-9725-b7f5c02d51a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_92bd6b8c-d143-4868-b0f1-481a7a751863" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesTable_b11a912c-3f76-4342-b1cb-c6f53031919c" xlink:to="loc_srt_StatementGeographicalAxis_92bd6b8c-d143-4868-b0f1-481a7a751863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_9f14421e-dfa4-4e08-9bbe-c675f3d1bf50" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_92bd6b8c-d143-4868-b0f1-481a7a751863" xlink:to="loc_srt_SegmentGeographicalDomain_9f14421e-dfa4-4e08-9bbe-c675f3d1bf50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IN_e974e5b5-58f0-4cca-a854-56768602fef8" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IN"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_9f14421e-dfa4-4e08-9bbe-c675f3d1bf50" xlink:to="loc_country_IN_e974e5b5-58f0-4cca-a854-56768602fef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_b648df82-1c2b-4f22-a627-7745c8c861c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesTable_b11a912c-3f76-4342-b1cb-c6f53031919c" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_b648df82-1c2b-4f22-a627-7745c8c861c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_9b1418ea-5af0-4e7e-9a1d-f5aea960d6fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_b648df82-1c2b-4f22-a627-7745c8c861c7" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_9b1418ea-5af0-4e7e-9a1d-f5aea960d6fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_812620fb-ddf8-4238-a9ed-c01838637d91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9b1418ea-5af0-4e7e-9a1d-f5aea960d6fb" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_812620fb-ddf8-4238-a9ed-c01838637d91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_17cc03ef-a6eb-4057-ac2f-0d9e4126d66e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesTable_b11a912c-3f76-4342-b1cb-c6f53031919c" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_17cc03ef-a6eb-4057-ac2f-0d9e4126d66e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_28746429-259f-4a4d-8975-d8f8cec9e087" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_17cc03ef-a6eb-4057-ac2f-0d9e4126d66e" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_28746429-259f-4a4d-8975-d8f8cec9e087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CleanEnergyPartnershipsMember_76c70c31-9324-497b-9bb5-8401e7ad000f" xlink:href="vtrs-20211231.xsd#vtrs_CleanEnergyPartnershipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_28746429-259f-4a4d-8975-d8f8cec9e087" xlink:to="loc_vtrs_CleanEnergyPartnershipsMember_76c70c31-9324-497b-9bb5-8401e7ad000f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_edae1434-c6b6-4652-8c18-988d49b97a83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesTable_b11a912c-3f76-4342-b1cb-c6f53031919c" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_edae1434-c6b6-4652-8c18-988d49b97a83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_510cea0d-0ff6-491e-a508-4f1464c267b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_edae1434-c6b6-4652-8c18-988d49b97a83" xlink:to="loc_us-gaap_ReceivableTypeDomain_510cea0d-0ff6-491e-a508-4f1464c267b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VariableConsiderationMember_f8f4dc0c-3e74-4484-bd9b-30097d123df9" xlink:href="vtrs-20211231.xsd#vtrs_VariableConsiderationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_510cea0d-0ff6-491e-a508-4f1464c267b7" xlink:to="loc_vtrs_VariableConsiderationMember_f8f4dc0c-3e74-4484-bd9b-30097d123df9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_0f3d9418-5bee-4c66-a9ef-31dd3989992e" xlink:href="vtrs-20211231.xsd#vtrs_ScheduleofothercurrentliabilitiesLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesTable_b11a912c-3f76-4342-b1cb-c6f53031919c" xlink:to="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_0f3d9418-5bee-4c66-a9ef-31dd3989992e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_0c7d48ed-6825-4621-97a6-8609488e5fea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_0f3d9418-5bee-4c66-a9ef-31dd3989992e" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_0c7d48ed-6825-4621-97a6-8609488e5fea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_cfb1dae7-01ae-4afe-a9df-45f1d2c73aab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_0f3d9418-5bee-4c66-a9ef-31dd3989992e" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_cfb1dae7-01ae-4afe-a9df-45f1d2c73aab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent_08553921-c9c1-489c-8674-57ff4769c00f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_0f3d9418-5bee-4c66-a9ef-31dd3989992e" xlink:to="loc_us-gaap_LitigationReserveCurrent_08553921-c9c1-489c-8674-57ff4769c00f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_4a4e35b1-2037-4b30-a7b7-eb368d7ff59f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_0f3d9418-5bee-4c66-a9ef-31dd3989992e" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_4a4e35b1-2037-4b30-a7b7-eb368d7ff59f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent_aa46f101-7bf7-4565-9557-cd7e96788c5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_0f3d9418-5bee-4c66-a9ef-31dd3989992e" xlink:to="loc_us-gaap_RestructuringReserveCurrent_aa46f101-7bf7-4565-9557-cd7e96788c5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities_cc3e532a-5590-4f2d-a2aa-6d2a4de32e46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_0f3d9418-5bee-4c66-a9ef-31dd3989992e" xlink:to="loc_us-gaap_OtherLiabilities_cc3e532a-5590-4f2d-a2aa-6d2a4de32e46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_1a6c7509-2460-4229-ad8f-12b70b3f333c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_0f3d9418-5bee-4c66-a9ef-31dd3989992e" xlink:to="loc_us-gaap_InterestPayableCurrent_1a6c7509-2460-4229-ad8f-12b70b3f333c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_c23d0f1d-6d92-4021-adb4-e58c771c9dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_0f3d9418-5bee-4c66-a9ef-31dd3989992e" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_c23d0f1d-6d92-4021-adb4-e58c771c9dcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_11fa7d07-c114-4b75-bd67-a83c8d15cdf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_0f3d9418-5bee-4c66-a9ef-31dd3989992e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_11fa7d07-c114-4b75-bd67-a83c8d15cdf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_134ced5d-1d9b-43e4-b182-0cdd10821225" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_0f3d9418-5bee-4c66-a9ef-31dd3989992e" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_134ced5d-1d9b-43e4-b182-0cdd10821225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_0a690dab-9add-4d4f-9421-8c1d3bf31e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_0f3d9418-5bee-4c66-a9ef-31dd3989992e" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_0a690dab-9add-4d4f-9421-8c1d3bf31e5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRecallExpense_d174f368-a345-4bbe-8764-e3396e5c186b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRecallExpense"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofothercurrentliabilitiesLineItems_0f3d9418-5bee-4c66-a9ef-31dd3989992e" xlink:to="loc_us-gaap_InventoryRecallExpense_d174f368-a345-4bbe-8764-e3396e5c186b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/BalanceSheetComponentsOthernoncurrentliabilitiesDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#BalanceSheetComponentsOthernoncurrentliabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/BalanceSheetComponentsOthernoncurrentliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BalanceSheetComponentsAbstract_382cd695-b288-4e29-9836-2b85ba8cfdcf" xlink:href="vtrs-20211231.xsd#vtrs_BalanceSheetComponentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesTable_888899f6-93d0-4e96-9e0b-9fecb6fe603a" xlink:href="vtrs-20211231.xsd#vtrs_ScheduleofOtherNoncurrentLiabilitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_BalanceSheetComponentsAbstract_382cd695-b288-4e29-9836-2b85ba8cfdcf" xlink:to="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesTable_888899f6-93d0-4e96-9e0b-9fecb6fe603a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_aeeab195-4f2e-4788-843b-17950938ec9c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesTable_888899f6-93d0-4e96-9e0b-9fecb6fe603a" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_aeeab195-4f2e-4788-843b-17950938ec9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_a1248151-5b04-497a-9de9-64063d3062ac" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_aeeab195-4f2e-4788-843b-17950938ec9c" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_a1248151-5b04-497a-9de9-64063d3062ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CleanEnergyPartnershipsMember_7e7a1afe-9426-4440-9f04-7db9e83f49d1" xlink:href="vtrs-20211231.xsd#vtrs_CleanEnergyPartnershipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_a1248151-5b04-497a-9de9-64063d3062ac" xlink:to="loc_vtrs_CleanEnergyPartnershipsMember_7e7a1afe-9426-4440-9f04-7db9e83f49d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_35d15c1e-1743-49c8-b86f-abea20c04ddc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesTable_888899f6-93d0-4e96-9e0b-9fecb6fe603a" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_35d15c1e-1743-49c8-b86f-abea20c04ddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_5de47372-7cba-4887-ad95-fbfad7b66bc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_35d15c1e-1743-49c8-b86f-abea20c04ddc" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_5de47372-7cba-4887-ad95-fbfad7b66bc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_013ff9b4-3d92-4da7-bbbf-c0ff312aa773" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_5de47372-7cba-4887-ad95-fbfad7b66bc5" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_013ff9b4-3d92-4da7-bbbf-c0ff312aa773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_b5b921e4-eefd-4951-8e5b-3f1063d36f2a" xlink:href="vtrs-20211231.xsd#vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesTable_888899f6-93d0-4e96-9e0b-9fecb6fe603a" xlink:to="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_b5b921e4-eefd-4951-8e5b-3f1063d36f2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_6529b7af-bdcb-451d-9de1-9fc38d706ba8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_b5b921e4-eefd-4951-8e5b-3f1063d36f2a" xlink:to="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_6529b7af-bdcb-451d-9de1-9fc38d706ba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_23b2812a-3dcf-4277-8f3f-ce0ad52366f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_b5b921e4-eefd-4951-8e5b-3f1063d36f2a" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_23b2812a-3dcf-4277-8f3f-ce0ad52366f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_f4dee7a0-32e2-4a1c-bd69-d22f2cb3c8e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_b5b921e4-eefd-4951-8e5b-3f1063d36f2a" xlink:to="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_f4dee7a0-32e2-4a1c-bd69-d22f2cb3c8e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_dc607618-61df-419f-90b6-e6f5e06b6baa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_b5b921e4-eefd-4951-8e5b-3f1063d36f2a" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_dc607618-61df-419f-90b6-e6f5e06b6baa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveNoncurrent_35caa3fc-73f0-48c6-bcf3-c53929ffc87d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_b5b921e4-eefd-4951-8e5b-3f1063d36f2a" xlink:to="loc_us-gaap_RestructuringReserveNoncurrent_35caa3fc-73f0-48c6-bcf3-c53929ffc87d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_df7fefe3-adee-4917-9e1f-ef923e39ea75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_b5b921e4-eefd-4951-8e5b-3f1063d36f2a" xlink:to="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_df7fefe3-adee-4917-9e1f-ef923e39ea75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_4c5c10ca-6521-4d58-ab0e-90f94e45c0ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems_b5b921e4-eefd-4951-8e5b-3f1063d36f2a" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_4c5c10ca-6521-4d58-ab0e-90f94e45c0ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/Leases" xlink:type="simple" xlink:href="vtrs-20211231.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_5cf82157-c062-4733-baa7-22e7b4c0be6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesOfLesseeDisclosureTextBlock_4514affd-1359-4fd2-9e7e-4aa9aea5ff75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesOfLesseeDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5cf82157-c062-4733-baa7-22e7b4c0be6e" xlink:to="loc_us-gaap_LeasesOfLesseeDisclosureTextBlock_4514affd-1359-4fd2-9e7e-4aa9aea5ff75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_ccead965-00aa-4d04-a335-908ebc6c5d45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5cf82157-c062-4733-baa7-22e7b4c0be6e" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_ccead965-00aa-4d04-a335-908ebc6c5d45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LeasesTables" xlink:type="simple" xlink:href="vtrs-20211231.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_ed0f932e-6f70-4e97-b081-8c4f374d0050" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_4e3d2f78-0075-4c70-ad94-3fb3d1f6a250" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ed0f932e-6f70-4e97-b081-8c4f374d0050" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_4e3d2f78-0075-4c70-ad94-3fb3d1f6a250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_3c2e6ccc-aaed-48c5-b1a2-11beb31bad68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ed0f932e-6f70-4e97-b081-8c4f374d0050" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_3c2e6ccc-aaed-48c5-b1a2-11beb31bad68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertySubjectToOrAvailableForOperatingLeaseTextBlock_247db0e7-8e7c-477e-b041-b32c8b7c1a39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertySubjectToOrAvailableForOperatingLeaseTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ed0f932e-6f70-4e97-b081-8c4f374d0050" xlink:to="loc_us-gaap_ScheduleOfPropertySubjectToOrAvailableForOperatingLeaseTextBlock_247db0e7-8e7c-477e-b041-b32c8b7c1a39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_bd0804eb-c225-41f6-af25-efd52b1a2001" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_6c960b63-c803-4120-894b-4f0562822e30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_bd0804eb-c225-41f6-af25-efd52b1a2001" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_6c960b63-c803-4120-894b-4f0562822e30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c8329984-97ba-4fd9-b838-92e4df34ea7b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_6c960b63-c803-4120-894b-4f0562822e30" xlink:to="loc_srt_RangeAxis_c8329984-97ba-4fd9-b838-92e4df34ea7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b48a13ff-501c-45bd-b0da-e142d714f541" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_c8329984-97ba-4fd9-b838-92e4df34ea7b" xlink:to="loc_srt_RangeMember_b48a13ff-501c-45bd-b0da-e142d714f541" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8f8510a4-13fd-45b4-9946-dd050e8e7894" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b48a13ff-501c-45bd-b0da-e142d714f541" xlink:to="loc_srt_MinimumMember_8f8510a4-13fd-45b4-9946-dd050e8e7894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_cacf60dd-7c81-4100-a01d-09d1ff5d4a9d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b48a13ff-501c-45bd-b0da-e142d714f541" xlink:to="loc_srt_MaximumMember_cacf60dd-7c81-4100-a01d-09d1ff5d4a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_ed44299d-93f7-4f1d-b460-22ebeca7f2a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_6c960b63-c803-4120-894b-4f0562822e30" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_ed44299d-93f7-4f1d-b460-22ebeca7f2a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_461391fa-9ce7-4161-abe9-370f624e84c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ed44299d-93f7-4f1d-b460-22ebeca7f2a7" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_461391fa-9ce7-4161-abe9-370f624e84c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_e8698e33-49be-413f-9e1b-e8a4693f9dc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ed44299d-93f7-4f1d-b460-22ebeca7f2a7" xlink:to="loc_us-gaap_OperatingLeaseLiability_e8698e33-49be-413f-9e1b-e8a4693f9dc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_LesseeOperatingLeaseLeaseNotyetCommencedAmount_750b8e49-3c46-46ef-b6a0-f8f59920af63" xlink:href="vtrs-20211231.xsd#vtrs_LesseeOperatingLeaseLeaseNotyetCommencedAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ed44299d-93f7-4f1d-b460-22ebeca7f2a7" xlink:to="loc_vtrs_LesseeOperatingLeaseLeaseNotyetCommencedAmount_750b8e49-3c46-46ef-b6a0-f8f59920af63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_143bfefd-8b9a-4c9e-9bce-e7235db50d88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ed44299d-93f7-4f1d-b460-22ebeca7f2a7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_143bfefd-8b9a-4c9e-9bce-e7235db50d88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseNet_8755e32b-70af-4145-b52f-d361d726d2d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ed44299d-93f7-4f1d-b460-22ebeca7f2a7" xlink:to="loc_us-gaap_OperatingLeasesRentExpenseNet_8755e32b-70af-4145-b52f-d361d726d2d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_f3cf1bb8-891d-469b-8909-dfa4105c8182" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ed44299d-93f7-4f1d-b460-22ebeca7f2a7" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_f3cf1bb8-891d-469b-8909-dfa4105c8182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_e75b80a1-cf5a-4292-adc4-6e84a186d073" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ed44299d-93f7-4f1d-b460-22ebeca7f2a7" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_e75b80a1-cf5a-4292-adc4-6e84a186d073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_e61d8ae8-d09d-47f9-93a1-bf95597cc5db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ed44299d-93f7-4f1d-b460-22ebeca7f2a7" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_e61d8ae8-d09d-47f9-93a1-bf95597cc5db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRent_373ee6d3-2e04-4a18-a2c3-55510ffdd621" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ed44299d-93f7-4f1d-b460-22ebeca7f2a7" xlink:to="loc_us-gaap_PaymentsForRent_373ee6d3-2e04-4a18-a2c3-55510ffdd621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LeasesLeaseInformationDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#LeasesLeaseInformationDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/LeasesLeaseInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_887e8edb-f071-438b-9601-9eb61e2fc9b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_2894fbe3-b0d8-40d5-84f7-ae4528c5bf28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_887e8edb-f071-438b-9601-9eb61e2fc9b4" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_2894fbe3-b0d8-40d5-84f7-ae4528c5bf28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4450fe7f-7a04-4ec5-9ea3-1856b8cb4266" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_2894fbe3-b0d8-40d5-84f7-ae4528c5bf28" xlink:to="loc_srt_RangeAxis_4450fe7f-7a04-4ec5-9ea3-1856b8cb4266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_526d3333-b7d9-4da3-a56e-18233901f998" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_4450fe7f-7a04-4ec5-9ea3-1856b8cb4266" xlink:to="loc_srt_RangeMember_526d3333-b7d9-4da3-a56e-18233901f998" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_3aa7b80b-4533-4536-98e9-39436928a8ff" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_526d3333-b7d9-4da3-a56e-18233901f998" xlink:to="loc_srt_MinimumMember_3aa7b80b-4533-4536-98e9-39436928a8ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_0d5fa82b-5ed8-44b9-b1d5-8f8271d45d35" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_526d3333-b7d9-4da3-a56e-18233901f998" xlink:to="loc_srt_MaximumMember_0d5fa82b-5ed8-44b9-b1d5-8f8271d45d35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_69cf5866-f159-4d9d-b26a-699d2326586f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_2894fbe3-b0d8-40d5-84f7-ae4528c5bf28" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_69cf5866-f159-4d9d-b26a-699d2326586f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_a7fa7379-cc3d-4376-b385-a041a5c3a91e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_69cf5866-f159-4d9d-b26a-699d2326586f" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_a7fa7379-cc3d-4376-b385-a041a5c3a91e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_0157a1a6-73eb-4373-933b-351bab44b811" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_69cf5866-f159-4d9d-b26a-699d2326586f" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_0157a1a6-73eb-4373-933b-351bab44b811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_4f6c9d21-d883-4210-9ccb-5cee73f34386" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_69cf5866-f159-4d9d-b26a-699d2326586f" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_4f6c9d21-d883-4210-9ccb-5cee73f34386" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LeasesLeaseMaturitiesDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#LeasesLeaseMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/LeasesLeaseMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_71848df5-8692-4912-bb8c-a9ec3788fe21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1493e025-db8d-4373-9d78-444363997738" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_71848df5-8692-4912-bb8c-a9ec3788fe21" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1493e025-db8d-4373-9d78-444363997738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_3c20a1f7-3947-4269-aee5-1f9fba46a83e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_71848df5-8692-4912-bb8c-a9ec3788fe21" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_3c20a1f7-3947-4269-aee5-1f9fba46a83e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_b486381d-7a71-483f-8aaa-587433a112dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_71848df5-8692-4912-bb8c-a9ec3788fe21" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_b486381d-7a71-483f-8aaa-587433a112dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_013f2295-7e07-46d7-91ce-c943a5346dcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_71848df5-8692-4912-bb8c-a9ec3788fe21" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_013f2295-7e07-46d7-91ce-c943a5346dcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_03276862-e517-4590-9e59-b7074355b035" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_71848df5-8692-4912-bb8c-a9ec3788fe21" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_03276862-e517-4590-9e59-b7074355b035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_71fa7900-07f4-40de-b89b-850260859a5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_71848df5-8692-4912-bb8c-a9ec3788fe21" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_71fa7900-07f4-40de-b89b-850260859a5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2f28f34f-61c9-44ff-beef-101622f979fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_71848df5-8692-4912-bb8c-a9ec3788fe21" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2f28f34f-61c9-44ff-beef-101622f979fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_f7c64eec-3816-4cc7-8c6e-4803dd534d99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_71848df5-8692-4912-bb8c-a9ec3788fe21" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_f7c64eec-3816-4cc7-8c6e-4803dd534d99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_b3f663ce-ef8b-496f-adf5-ddb7e13f8ff9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_71848df5-8692-4912-bb8c-a9ec3788fe21" xlink:to="loc_us-gaap_OperatingLeaseLiability_b3f663ce-ef8b-496f-adf5-ddb7e13f8ff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LeasesLeaseMaturitiesDetails_1" xlink:type="simple" xlink:href="vtrs-20211231.xsd#LeasesLeaseMaturitiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/LeasesLeaseMaturitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.viatris.com/role/EquityMethodInvestments" xlink:type="simple" xlink:href="vtrs-20211231.xsd#EquityMethodInvestments"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/EquityMethodInvestments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_d1246b41-b7bd-4eae-8d89-a273cf84880b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_b5ea8d00-6265-4ada-b4d9-bc46caa0eda6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_d1246b41-b7bd-4eae-8d89-a273cf84880b" xlink:to="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_b5ea8d00-6265-4ada-b4d9-bc46caa0eda6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EquityMethodInvestmentsTables" xlink:type="simple" xlink:href="vtrs-20211231.xsd#EquityMethodInvestmentsTables"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/EquityMethodInvestmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_1b5b2ef0-bbdb-4649-80df-d660766dbdf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock_2e29f2ce-e271-4321-8081-c46c4201e15e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_1b5b2ef0-bbdb-4649-80df-d660766dbdf4" xlink:to="loc_us-gaap_EquityMethodInvestmentsTextBlock_2e29f2ce-e271-4321-8081-c46c4201e15e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EquityMethodInvestmentsNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#EquityMethodInvestmentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/EquityMethodInvestmentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_ada20ed9-41b8-4cce-be6a-9f1cd30afe1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_255bcba5-a932-4dfd-a52e-6fa7461ef716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_ada20ed9-41b8-4cce-be6a-9f1cd30afe1f" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_255bcba5-a932-4dfd-a52e-6fa7461ef716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d0169132-256b-4d79-9216-fa876a9fe49e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_255bcba5-a932-4dfd-a52e-6fa7461ef716" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d0169132-256b-4d79-9216-fa876a9fe49e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_e3e7d99e-0d6e-4da8-82b7-62155fbb6969" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d0169132-256b-4d79-9216-fa876a9fe49e" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_e3e7d99e-0d6e-4da8-82b7-62155fbb6969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CleanEnergyPartnershipsMember_30ff2474-c767-4e9a-a7b6-6df0ef624494" xlink:href="vtrs-20211231.xsd#vtrs_CleanEnergyPartnershipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_e3e7d99e-0d6e-4da8-82b7-62155fbb6969" xlink:to="loc_vtrs_CleanEnergyPartnershipsMember_30ff2474-c767-4e9a-a7b6-6df0ef624494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_33944dfe-57f2-4879-9bda-42914d472629" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_255bcba5-a932-4dfd-a52e-6fa7461ef716" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_33944dfe-57f2-4879-9bda-42914d472629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6c17f2a3-7b9e-4514-b3b0-7a78bc72e187" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_33944dfe-57f2-4879-9bda-42914d472629" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6c17f2a3-7b9e-4514-b3b0-7a78bc72e187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_04fe97fd-1f80-4873-8325-432cbe0cadfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6c17f2a3-7b9e-4514-b3b0-7a78bc72e187" xlink:to="loc_us-gaap_OtherAssetsMember_04fe97fd-1f80-4873-8325-432cbe0cadfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_01ae6a44-f03b-48d5-ab15-caac5cb6a9b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_255bcba5-a932-4dfd-a52e-6fa7461ef716" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_01ae6a44-f03b-48d5-ab15-caac5cb6a9b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EquityMethodInvestmentsReductionInLongTermObligations_aea83b84-ecf2-451d-bc34-8f63f9ab4e3c" xlink:href="vtrs-20211231.xsd#vtrs_EquityMethodInvestmentsReductionInLongTermObligations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_01ae6a44-f03b-48d5-ab15-caac5cb6a9b1" xlink:to="loc_vtrs_EquityMethodInvestmentsReductionInLongTermObligations_aea83b84-ecf2-451d-bc34-8f63f9ab4e3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Numberofequitymethodinvestments_148e90d3-266f-49fe-901e-e2e583658495" xlink:href="vtrs-20211231.xsd#vtrs_Numberofequitymethodinvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_01ae6a44-f03b-48d5-ab15-caac5cb6a9b1" xlink:to="loc_vtrs_Numberofequitymethodinvestments_148e90d3-266f-49fe-901e-e2e583658495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EquityMethodInvestmentsNetGainLossFromImpairmentandReductionInObligations_7807e8ff-b83b-439f-b6d7-bc9c40e88880" xlink:href="vtrs-20211231.xsd#vtrs_EquityMethodInvestmentsNetGainLossFromImpairmentandReductionInObligations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_01ae6a44-f03b-48d5-ab15-caac5cb6a9b1" xlink:to="loc_vtrs_EquityMethodInvestmentsNetGainLossFromImpairmentandReductionInObligations_7807e8ff-b83b-439f-b6d7-bc9c40e88880" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_7f80e05f-e7d2-4d03-a010-f648ffcec93f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_01ae6a44-f03b-48d5-ab15-caac5cb6a9b1" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_7f80e05f-e7d2-4d03-a010-f648ffcec93f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ImpairmentofEquityMethodInvestments_e83f904f-9026-484d-8293-5baf2dafe0a2" xlink:href="vtrs-20211231.xsd#vtrs_ImpairmentofEquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_01ae6a44-f03b-48d5-ab15-caac5cb6a9b1" xlink:to="loc_vtrs_ImpairmentofEquityMethodInvestments_e83f904f-9026-484d-8293-5baf2dafe0a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ReductioninEquityMethodInvestmentLongTermObligation_0c8d70a7-5b00-4d7f-ba1f-cfafdcca6dfb" xlink:href="vtrs-20211231.xsd#vtrs_ReductioninEquityMethodInvestmentLongTermObligation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_01ae6a44-f03b-48d5-ab15-caac5cb6a9b1" xlink:to="loc_vtrs_ReductioninEquityMethodInvestmentLongTermObligation_0c8d70a7-5b00-4d7f-ba1f-cfafdcca6dfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_9eba9842-6e96-4924-8524-ccc216ebd711" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_01ae6a44-f03b-48d5-ab15-caac5cb6a9b1" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_9eba9842-6e96-4924-8524-ccc216ebd711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EquityMethodInvestmentsBalanceSheetDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#EquityMethodInvestmentsBalanceSheetDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/EquityMethodInvestmentsBalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_7754e8e0-f176-4666-9989-248fcfa2e9af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_95cd94ed-f7e3-467a-a99e-e9b48585b50f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_7754e8e0-f176-4666-9989-248fcfa2e9af" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_95cd94ed-f7e3-467a-a99e-e9b48585b50f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_261ecd9e-0383-4d22-9dee-b8a1f66b80d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_95cd94ed-f7e3-467a-a99e-e9b48585b50f" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_261ecd9e-0383-4d22-9dee-b8a1f66b80d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_9c1390b9-0a0c-4ced-a0f2-c43cf868ee32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_261ecd9e-0383-4d22-9dee-b8a1f66b80d8" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_9c1390b9-0a0c-4ced-a0f2-c43cf868ee32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_9e6b4674-b6ef-49ef-8ce1-c187476e55a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9c1390b9-0a0c-4ced-a0f2-c43cf868ee32" xlink:to="loc_us-gaap_OtherAssetsMember_9e6b4674-b6ef-49ef-8ce1-c187476e55a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_c723a437-284b-48b1-a248-514f2475f4f3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_95cd94ed-f7e3-467a-a99e-e9b48585b50f" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_c723a437-284b-48b1-a248-514f2475f4f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_193930a9-32ec-425e-a62b-de1d1a997faa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_c723a437-284b-48b1-a248-514f2475f4f3" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_193930a9-32ec-425e-a62b-de1d1a997faa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CleanEnergyPartnershipsMember_454ce755-bcbc-482d-89c0-65ba576c6c44" xlink:href="vtrs-20211231.xsd#vtrs_CleanEnergyPartnershipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_193930a9-32ec-425e-a62b-de1d1a997faa" xlink:to="loc_vtrs_CleanEnergyPartnershipsMember_454ce755-bcbc-482d-89c0-65ba576c6c44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_1c26a877-df93-4d7f-8fb1-368a2fee96e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_95cd94ed-f7e3-467a-a99e-e9b48585b50f" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_1c26a877-df93-4d7f-8fb1-368a2fee96e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_37f572bb-1e36-4770-9894-1c0bd051e99e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_1c26a877-df93-4d7f-8fb1-368a2fee96e0" xlink:to="loc_us-gaap_EquityMethodInvestments_37f572bb-1e36-4770-9894-1c0bd051e99e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities_60a5eb0d-7852-447e-8846-ed4df96ac046" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_1c26a877-df93-4d7f-8fb1-368a2fee96e0" xlink:to="loc_us-gaap_OtherLiabilities_60a5eb0d-7852-447e-8846-ed4df96ac046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_0f95ae72-def3-488d-8b44-25e74450fd92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_1c26a877-df93-4d7f-8fb1-368a2fee96e0" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_0f95ae72-def3-488d-8b44-25e74450fd92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_908f32aa-27d8-41de-933f-ad50f821621d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_1c26a877-df93-4d7f-8fb1-368a2fee96e0" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_908f32aa-27d8-41de-933f-ad50f821621d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EquityMethodInvestmentsNetAssetsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#EquityMethodInvestmentsNetAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/EquityMethodInvestmentsNetAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_2b9bec04-9624-4bc1-8b31-3c44f12ae4a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_6129ae1a-9cbf-4999-b93e-8ba5b2607e7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_2b9bec04-9624-4bc1-8b31-3c44f12ae4a9" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_6129ae1a-9cbf-4999-b93e-8ba5b2607e7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_577f395f-f841-4437-959e-85f09bf4cfff" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_6129ae1a-9cbf-4999-b93e-8ba5b2607e7e" xlink:to="loc_srt_ConsolidatedEntitiesAxis_577f395f-f841-4437-959e-85f09bf4cfff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_9fb3ff40-7c01-4f52-b0d2-45702c4bccdd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_577f395f-f841-4437-959e-85f09bf4cfff" xlink:to="loc_srt_ConsolidatedEntitiesDomain_9fb3ff40-7c01-4f52-b0d2-45702c4bccdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidatedEntityExcludingVieMember_55610c37-0fa8-4ff1-a84d-b289fd59c6c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidatedEntityExcludingVieMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_9fb3ff40-7c01-4f52-b0d2-45702c4bccdd" xlink:to="loc_us-gaap_ConsolidatedEntityExcludingVieMember_55610c37-0fa8-4ff1-a84d-b289fd59c6c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e80bd09e-27cb-4041-b639-ffbd712e0ddc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_6129ae1a-9cbf-4999-b93e-8ba5b2607e7e" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e80bd09e-27cb-4041-b639-ffbd712e0ddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_25416852-7f1e-4fa0-af5e-ab6f9645baa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e80bd09e-27cb-4041-b639-ffbd712e0ddc" xlink:to="loc_us-gaap_AssetsCurrent_25416852-7f1e-4fa0-af5e-ab6f9645baa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_bb361248-88b5-4541-88fd-ff5bff2ac57e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e80bd09e-27cb-4041-b639-ffbd712e0ddc" xlink:to="loc_us-gaap_AssetsNoncurrent_bb361248-88b5-4541-88fd-ff5bff2ac57e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_d1511dc9-e46d-48eb-b945-a2dc671fcd63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e80bd09e-27cb-4041-b639-ffbd712e0ddc" xlink:to="loc_us-gaap_Assets_d1511dc9-e46d-48eb-b945-a2dc671fcd63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_1de4fe0c-6dc2-4229-a5d9-5c5f9a7c1b83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e80bd09e-27cb-4041-b639-ffbd712e0ddc" xlink:to="loc_us-gaap_LiabilitiesCurrent_1de4fe0c-6dc2-4229-a5d9-5c5f9a7c1b83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_a0e9c2b3-a224-490f-810a-69699baaf991" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e80bd09e-27cb-4041-b639-ffbd712e0ddc" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_a0e9c2b3-a224-490f-810a-69699baaf991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_2300429a-5c70-41c5-984d-c3d5227a37b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e80bd09e-27cb-4041-b639-ffbd712e0ddc" xlink:to="loc_us-gaap_Liabilities_2300429a-5c70-41c5-984d-c3d5227a37b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EquityMethodInvestmentSummarizedFinancialInformationNetAssets_2abc0b9f-ce1f-4397-8bf7-73eb79ab8774" xlink:href="vtrs-20211231.xsd#vtrs_EquityMethodInvestmentSummarizedFinancialInformationNetAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e80bd09e-27cb-4041-b639-ffbd712e0ddc" xlink:to="loc_vtrs_EquityMethodInvestmentSummarizedFinancialInformationNetAssets_2abc0b9f-ce1f-4397-8bf7-73eb79ab8774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EquityMethodInvestmentsIncomeStatementDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#EquityMethodInvestmentsIncomeStatementDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/EquityMethodInvestmentsIncomeStatementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_0b36754b-fa3e-46eb-8e74-6beb301d8e31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8fd7a1f9-0515-4d0b-bd24-d645dd8e6a29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_0b36754b-fa3e-46eb-8e74-6beb301d8e31" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8fd7a1f9-0515-4d0b-bd24-d645dd8e6a29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_a893a46d-e8ad-4e29-85ae-3415c399b681" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8fd7a1f9-0515-4d0b-bd24-d645dd8e6a29" xlink:to="loc_srt_ConsolidatedEntitiesAxis_a893a46d-e8ad-4e29-85ae-3415c399b681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_17cb840d-d598-41f8-a809-f79ad8aeb796" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_a893a46d-e8ad-4e29-85ae-3415c399b681" xlink:to="loc_srt_ConsolidatedEntitiesDomain_17cb840d-d598-41f8-a809-f79ad8aeb796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidatedEntityExcludingVieMember_07555a73-3b85-4918-b123-5c1d623e3835" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidatedEntityExcludingVieMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_17cb840d-d598-41f8-a809-f79ad8aeb796" xlink:to="loc_us-gaap_ConsolidatedEntityExcludingVieMember_07555a73-3b85-4918-b123-5c1d623e3835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3d3fb361-a82a-4e02-9343-6b77fd83508a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8fd7a1f9-0515-4d0b-bd24-d645dd8e6a29" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3d3fb361-a82a-4e02-9343-6b77fd83508a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_dd75877c-5d0d-433f-b8ed-b2d10c89d788" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3d3fb361-a82a-4e02-9343-6b77fd83508a" xlink:to="loc_us-gaap_Revenues_dd75877c-5d0d-433f-b8ed-b2d10c89d788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_f0290b2f-f3ad-4464-878a-d337f51d50bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3d3fb361-a82a-4e02-9343-6b77fd83508a" xlink:to="loc_us-gaap_GrossProfit_f0290b2f-f3ad-4464-878a-d337f51d50bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d8566528-a48c-463f-88b7-165b224bfeb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3d3fb361-a82a-4e02-9343-6b77fd83508a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d8566528-a48c-463f-88b7-165b224bfeb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a978576c-a7cb-4843-b033-66eae6e57fe3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3d3fb361-a82a-4e02-9343-6b77fd83508a" xlink:to="loc_us-gaap_ProfitLoss_a978576c-a7cb-4843-b033-66eae6e57fe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/GoodwillandOtherIntangibleAssets" xlink:type="simple" xlink:href="vtrs-20211231.xsd#GoodwillandOtherIntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/GoodwillandOtherIntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_44fc72cf-1287-4e2f-afe3-24ef41ca7a62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_2fd0247e-1455-4924-b70b-a41fd1abbee9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_44fc72cf-1287-4e2f-afe3-24ef41ca7a62" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_2fd0247e-1455-4924-b70b-a41fd1abbee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsTables" xlink:type="simple" xlink:href="vtrs-20211231.xsd#GoodwillandOtherIntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7ab3827c-e2e4-4f7c-8f7e-aba2dd229a8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_88a55175-6ef7-4417-9801-61b7c1a1f470" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7ab3827c-e2e4-4f7c-8f7e-aba2dd229a8d" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_88a55175-6ef7-4417-9801-61b7c1a1f470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_1d54acdc-6a66-40e4-9839-8b4bf37b3a44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7ab3827c-e2e4-4f7c-8f7e-aba2dd229a8d" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_1d54acdc-6a66-40e4-9839-8b4bf37b3a44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ProductRightsAndLicensesByTherapeuticCategoryTableTextBlock_7e117a2b-9f40-4bbf-b34b-a5f7eeaea30b" xlink:href="vtrs-20211231.xsd#vtrs_ProductRightsAndLicensesByTherapeuticCategoryTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7ab3827c-e2e4-4f7c-8f7e-aba2dd229a8d" xlink:to="loc_vtrs_ProductRightsAndLicensesByTherapeuticCategoryTableTextBlock_7e117a2b-9f40-4bbf-b34b-a5f7eeaea30b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_b3db9790-c02a-41a0-bb5f-b83de98f1c14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7ab3827c-e2e4-4f7c-8f7e-aba2dd229a8d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_b3db9790-c02a-41a0-bb5f-b83de98f1c14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_de876d65-b7ed-4552-a973-ebb1b7019d32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7ab3827c-e2e4-4f7c-8f7e-aba2dd229a8d" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_de876d65-b7ed-4552-a973-ebb1b7019d32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#GoodwillandOtherIntangibleAssetsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_da0abca1-34ee-45b2-8c94-1ea63522b9b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d53c7bef-c101-465d-8b1c-445c8883925a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_da0abca1-34ee-45b2-8c94-1ea63522b9b2" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d53c7bef-c101-465d-8b1c-445c8883925a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_2e8786e2-6054-497a-ba31-30b6ea89e809" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d53c7bef-c101-465d-8b1c-445c8883925a" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_2e8786e2-6054-497a-ba31-30b6ea89e809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b0192635-ba9b-423f-95ac-471f80b5a3fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_2e8786e2-6054-497a-ba31-30b6ea89e809" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b0192635-ba9b-423f-95ac-471f80b5a3fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_81bc9f13-99bb-4b7a-b37b-6a3494e9cb62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b0192635-ba9b-423f-95ac-471f80b5a3fe" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_81bc9f13-99bb-4b7a-b37b-6a3494e9cb62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0d552c33-c839-4a9f-95d8-563fdb5cc182" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d53c7bef-c101-465d-8b1c-445c8883925a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0d552c33-c839-4a9f-95d8-563fdb5cc182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a9231f24-99d5-4cb8-9394-4b8e6b86255a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0d552c33-c839-4a9f-95d8-563fdb5cc182" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a9231f24-99d5-4cb8-9394-4b8e6b86255a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RespiratorydeliveryplatformMember_0208cabb-75d4-4a0c-8442-8d9e98b65a50" xlink:href="vtrs-20211231.xsd#vtrs_RespiratorydeliveryplatformMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a9231f24-99d5-4cb8-9394-4b8e6b86255a" xlink:to="loc_vtrs_RespiratorydeliveryplatformMember_0208cabb-75d4-4a0c-8442-8d9e98b65a50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_b6726176-2c5e-4d94-bde1-53efd70e2537" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d53c7bef-c101-465d-8b1c-445c8883925a" xlink:to="loc_srt_StatementScenarioAxis_b6726176-2c5e-4d94-bde1-53efd70e2537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_57772b7f-a0f1-482e-b54f-c83ff40ddc8f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_b6726176-2c5e-4d94-bde1-53efd70e2537" xlink:to="loc_srt_ScenarioUnspecifiedDomain_57772b7f-a0f1-482e-b54f-c83ff40ddc8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_IncreasedDiscountRateDomain_d3c00963-307a-42eb-ae48-e12e86df27d5" xlink:href="vtrs-20211231.xsd#vtrs_IncreasedDiscountRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_57772b7f-a0f1-482e-b54f-c83ff40ddc8f" xlink:to="loc_vtrs_IncreasedDiscountRateDomain_d3c00963-307a-42eb-ae48-e12e86df27d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ReductioninTerminalValueGrowthRateDomain_eeb5c145-3d15-4aea-8af4-4707b7488f45" xlink:href="vtrs-20211231.xsd#vtrs_ReductioninTerminalValueGrowthRateDomain"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_57772b7f-a0f1-482e-b54f-c83ff40ddc8f" xlink:to="loc_vtrs_ReductioninTerminalValueGrowthRateDomain_eeb5c145-3d15-4aea-8af4-4707b7488f45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_0c88c4a1-a994-48bd-8624-742635d370c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d53c7bef-c101-465d-8b1c-445c8883925a" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_0c88c4a1-a994-48bd-8624-742635d370c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_b88217e5-4233-4d5d-a7b0-8bf6ffd3e994" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_0c88c4a1-a994-48bd-8624-742635d370c0" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_b88217e5-4233-4d5d-a7b0-8bf6ffd3e994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_083d2afd-cf6c-4dfe-86c8-28bfbd40d8d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_b88217e5-4233-4d5d-a7b0-8bf6ffd3e994" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_083d2afd-cf6c-4dfe-86c8-28bfbd40d8d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_b90866c6-f4ed-453d-9abf-9166123795d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputLongTermRevenueGrowthRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_b88217e5-4233-4d5d-a7b0-8bf6ffd3e994" xlink:to="loc_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_b90866c6-f4ed-453d-9abf-9166123795d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_MeasurementInputEstimatedTaxRateMember_b56d1f86-fc31-4e6a-8b46-6e902d842488" xlink:href="vtrs-20211231.xsd#vtrs_MeasurementInputEstimatedTaxRateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_b88217e5-4233-4d5d-a7b0-8bf6ffd3e994" xlink:to="loc_vtrs_MeasurementInputEstimatedTaxRateMember_b56d1f86-fc31-4e6a-8b46-6e902d842488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputEbitdaMultipleMember_8f8679f8-71eb-425f-a200-0aa29d4b94c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputEbitdaMultipleMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_b88217e5-4233-4d5d-a7b0-8bf6ffd3e994" xlink:to="loc_us-gaap_MeasurementInputEbitdaMultipleMember_8f8679f8-71eb-425f-a200-0aa29d4b94c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputControlPremiumMember_6984cd22-b017-4b94-8aa2-286c43d5e9e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputControlPremiumMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_b88217e5-4233-4d5d-a7b0-8bf6ffd3e994" xlink:to="loc_us-gaap_MeasurementInputControlPremiumMember_6984cd22-b017-4b94-8aa2-286c43d5e9e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_MeasurementInputTerminalYearRevenueGrowthRateMember_f3f2e151-9914-45fe-92a1-45d380943f88" xlink:href="vtrs-20211231.xsd#vtrs_MeasurementInputTerminalYearRevenueGrowthRateMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_b88217e5-4233-4d5d-a7b0-8bf6ffd3e994" xlink:to="loc_vtrs_MeasurementInputTerminalYearRevenueGrowthRateMember_f3f2e151-9914-45fe-92a1-45d380943f88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_MeasurementInputReductionInTerminalYearRevenueGrowthRateMember_1bbd36ad-a2bb-47fe-956b-df5a8462ee10" xlink:href="vtrs-20211231.xsd#vtrs_MeasurementInputReductionInTerminalYearRevenueGrowthRateMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_b88217e5-4233-4d5d-a7b0-8bf6ffd3e994" xlink:to="loc_vtrs_MeasurementInputReductionInTerminalYearRevenueGrowthRateMember_1bbd36ad-a2bb-47fe-956b-df5a8462ee10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_MeasurementInputIncreaseInDiscountRateMember_558a83f3-ab23-48c6-9134-1ce6b93850b1" xlink:href="vtrs-20211231.xsd#vtrs_MeasurementInputIncreaseInDiscountRateMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_b88217e5-4233-4d5d-a7b0-8bf6ffd3e994" xlink:to="loc_vtrs_MeasurementInputIncreaseInDiscountRateMember_558a83f3-ab23-48c6-9134-1ce6b93850b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_784c8e39-f456-4e2e-8a0e-2710e032aceb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d53c7bef-c101-465d-8b1c-445c8883925a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_784c8e39-f456-4e2e-8a0e-2710e032aceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_413a75c2-ba26-407d-a6bf-55d6278c0c2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_784c8e39-f456-4e2e-8a0e-2710e032aceb" xlink:to="loc_us-gaap_SegmentDomain_413a75c2-ba26-407d-a6bf-55d6278c0c2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NorthAmericaGenericsMember_73c78344-8e52-4c87-b341-9fa6e4f02ec3" xlink:href="vtrs-20211231.xsd#vtrs_NorthAmericaGenericsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_413a75c2-ba26-407d-a6bf-55d6278c0c2e" xlink:to="loc_vtrs_NorthAmericaGenericsMember_73c78344-8e52-4c87-b341-9fa6e4f02ec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NorthAmericaSpecialtyMember_600bf3be-12e1-4571-9c1f-1c588c515c14" xlink:href="vtrs-20211231.xsd#vtrs_NorthAmericaSpecialtyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_413a75c2-ba26-407d-a6bf-55d6278c0c2e" xlink:to="loc_vtrs_NorthAmericaSpecialtyMember_600bf3be-12e1-4571-9c1f-1c588c515c14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EuropeSegmentMember_0e812ca4-d288-41bb-acd8-d4941b762a71" xlink:href="vtrs-20211231.xsd#vtrs_EuropeSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_413a75c2-ba26-407d-a6bf-55d6278c0c2e" xlink:to="loc_vtrs_EuropeSegmentMember_0e812ca4-d288-41bb-acd8-d4941b762a71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RestofWorldSegmentMember_23e66f34-225d-46e2-af76-cc2f6054128e" xlink:href="vtrs-20211231.xsd#vtrs_RestofWorldSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_413a75c2-ba26-407d-a6bf-55d6278c0c2e" xlink:to="loc_vtrs_RestofWorldSegmentMember_23e66f34-225d-46e2-af76-cc2f6054128e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NorthAmericaSegmentMember_2fb946c6-ed52-4d93-87d9-a8cd94d4d7d9" xlink:href="vtrs-20211231.xsd#vtrs_NorthAmericaSegmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_413a75c2-ba26-407d-a6bf-55d6278c0c2e" xlink:to="loc_vtrs_NorthAmericaSegmentMember_2fb946c6-ed52-4d93-87d9-a8cd94d4d7d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_928d20d8-11bd-49f5-abdb-a05ec9386f47" xlink:href="vtrs-20211231.xsd#vtrs_JapanAustraliaAndNewZealandSegmentMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_413a75c2-ba26-407d-a6bf-55d6278c0c2e" xlink:to="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_928d20d8-11bd-49f5-abdb-a05ec9386f47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d41d6f3d-0e0b-4db3-ba70-a5ec21837c58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d53c7bef-c101-465d-8b1c-445c8883925a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d41d6f3d-0e0b-4db3-ba70-a5ec21837c58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_441caf13-8664-4701-9078-1b7f30da38db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d41d6f3d-0e0b-4db3-ba70-a5ec21837c58" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_441caf13-8664-4701-9078-1b7f30da38db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_7b4fdf89-9b26-43a5-9eda-4ce91639c39b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_441caf13-8664-4701-9078-1b7f30da38db" xlink:to="loc_us-gaap_LicensingAgreementsMember_7b4fdf89-9b26-43a5-9eda-4ce91639c39b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_85498f66-6c48-47fc-8eeb-6428c75ee0ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d53c7bef-c101-465d-8b1c-445c8883925a" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_85498f66-6c48-47fc-8eeb-6428c75ee0ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_601b6abb-cff9-41e2-805d-f8d3985813c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_85498f66-6c48-47fc-8eeb-6428c75ee0ff" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_601b6abb-cff9-41e2-805d-f8d3985813c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_72eb05bd-73f6-4f37-a38d-4d899326a1ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_601b6abb-cff9-41e2-805d-f8d3985813c9" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_72eb05bd-73f6-4f37-a38d-4d899326a1ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillMember_4b07c0d8-7dbf-4eb6-a6cf-c02148f8e5b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_601b6abb-cff9-41e2-805d-f8d3985813c9" xlink:to="loc_us-gaap_GoodwillMember_4b07c0d8-7dbf-4eb6-a6cf-c02148f8e5b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_94f6fb6d-117e-447d-80cc-cf72a8d7d1cc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d53c7bef-c101-465d-8b1c-445c8883925a" xlink:to="loc_srt_RangeAxis_94f6fb6d-117e-447d-80cc-cf72a8d7d1cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_94ccf4a9-6958-410d-99b0-6c38343da882" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_94f6fb6d-117e-447d-80cc-cf72a8d7d1cc" xlink:to="loc_srt_RangeMember_94ccf4a9-6958-410d-99b0-6c38343da882" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_4b7e48bc-752d-4df7-ab87-a7c1a26526d4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_94ccf4a9-6958-410d-99b0-6c38343da882" xlink:to="loc_srt_MinimumMember_4b7e48bc-752d-4df7-ab87-a7c1a26526d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ff513ef5-d58d-4269-93dd-aad65b21120b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_94ccf4a9-6958-410d-99b0-6c38343da882" xlink:to="loc_srt_MaximumMember_ff513ef5-d58d-4269-93dd-aad65b21120b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_82fa90b7-1ef9-479c-8b22-17ff8b3f9ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d53c7bef-c101-465d-8b1c-445c8883925a" xlink:to="loc_us-gaap_ValuationTechniqueAxis_82fa90b7-1ef9-479c-8b22-17ff8b3f9ff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_2539b670-e40c-450c-982d-5d76926f3c26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueAxis_82fa90b7-1ef9-479c-8b22-17ff8b3f9ff1" xlink:to="loc_us-gaap_ValuationTechniqueDomain_2539b670-e40c-450c-982d-5d76926f3c26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_1cadd7bf-384e-4448-9e50-c053fd8eaa8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueDomain_2539b670-e40c-450c-982d-5d76926f3c26" xlink:to="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_1cadd7bf-384e-4448-9e50-c053fd8eaa8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_16ea2298-cb1e-459d-bf5e-0af352ad05d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d53c7bef-c101-465d-8b1c-445c8883925a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_16ea2298-cb1e-459d-bf5e-0af352ad05d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_571108a9-89ce-4b49-acfc-d464fdb3d076" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_16ea2298-cb1e-459d-bf5e-0af352ad05d7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_571108a9-89ce-4b49-acfc-d464fdb3d076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_2a9990d6-9b85-4c6c-9c42-dc1a0fd74768" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_16ea2298-cb1e-459d-bf5e-0af352ad05d7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_2a9990d6-9b85-4c6c-9c42-dc1a0fd74768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_33db1cfc-b77e-47b6-a86a-866868872faa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_16ea2298-cb1e-459d-bf5e-0af352ad05d7" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_33db1cfc-b77e-47b6-a86a-866868872faa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_2b91ca81-05d4-4b30-a364-be95b27ee19d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_16ea2298-cb1e-459d-bf5e-0af352ad05d7" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_2b91ca81-05d4-4b30-a364-be95b27ee19d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_22fced06-b26c-464a-8830-cb3fce985c99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_16ea2298-cb1e-459d-bf5e-0af352ad05d7" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_22fced06-b26c-464a-8830-cb3fce985c99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments_1b3657ba-e44c-42d8-9f7e-b426bff581d8" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationContingentConsiderationLiabilityPayments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_16ea2298-cb1e-459d-bf5e-0af352ad05d7" xlink:to="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments_1b3657ba-e44c-42d8-9f7e-b426bff581d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIndefiniteLivedIntangibleAssetsMeasurementInput_b9cddf4a-3759-4027-b7c3-e3f23d9ccdaf" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIndefiniteLivedIntangibleAssetsMeasurementInput"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_16ea2298-cb1e-459d-bf5e-0af352ad05d7" xlink:to="loc_vtrs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIndefiniteLivedIntangibleAssetsMeasurementInput_b9cddf4a-3759-4027-b7c3-e3f23d9ccdaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_f8faa5ad-49b0-4d14-b90f-f4d93dc464cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_16ea2298-cb1e-459d-bf5e-0af352ad05d7" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_f8faa5ad-49b0-4d14-b90f-f4d93dc464cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_aff92477-aae1-4c0b-b9b5-9f7be4dc3b8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_16ea2298-cb1e-459d-bf5e-0af352ad05d7" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_aff92477-aae1-4c0b-b9b5-9f7be4dc3b8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount_661fb92d-12cb-4780-aac3-ce0d4001175c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_16ea2298-cb1e-459d-bf5e-0af352ad05d7" xlink:to="loc_us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount_661fb92d-12cb-4780-aac3-ce0d4001175c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_2e46e26b-5267-47b3-9e7f-7a94408324f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_16ea2298-cb1e-459d-bf5e-0af352ad05d7" xlink:to="loc_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_2e46e26b-5267-47b3-9e7f-7a94408324f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GoodwillImpairedChangeinEstimatePeriod_6297639c-1244-41a4-bafd-fcf0d945fd48" xlink:href="vtrs-20211231.xsd#vtrs_GoodwillImpairedChangeinEstimatePeriod"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_16ea2298-cb1e-459d-bf5e-0af352ad05d7" xlink:to="loc_vtrs_GoodwillImpairedChangeinEstimatePeriod_6297639c-1244-41a4-bafd-fcf0d945fd48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GoodwillImpairmentTestMeasurementInput_604d16cc-1668-46a3-bff2-e7d650f80381" xlink:href="vtrs-20211231.xsd#vtrs_GoodwillImpairmentTestMeasurementInput"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_16ea2298-cb1e-459d-bf5e-0af352ad05d7" xlink:to="loc_vtrs_GoodwillImpairmentTestMeasurementInput_604d16cc-1668-46a3-bff2-e7d650f80381" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_FairValueInputsLongtermRevenueGrowthRateTerminalYear_7923c996-8ee9-4b3c-a0b8-5bd5ef40f8e2" xlink:href="vtrs-20211231.xsd#vtrs_FairValueInputsLongtermRevenueGrowthRateTerminalYear"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_16ea2298-cb1e-459d-bf5e-0af352ad05d7" xlink:to="loc_vtrs_FairValueInputsLongtermRevenueGrowthRateTerminalYear_7923c996-8ee9-4b3c-a0b8-5bd5ef40f8e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GoodwillImpairmentTestMeasurementInputReduction_3fdc5873-552c-4f0b-a324-c73cad67bf6a" xlink:href="vtrs-20211231.xsd#vtrs_GoodwillImpairmentTestMeasurementInputReduction"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_16ea2298-cb1e-459d-bf5e-0af352ad05d7" xlink:to="loc_vtrs_GoodwillImpairmentTestMeasurementInputReduction_3fdc5873-552c-4f0b-a324-c73cad67bf6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GoodwillImpairmentTestMeasurementInputIncrease_750ef2bf-ed8c-42ec-a2f9-6b237c031075" xlink:href="vtrs-20211231.xsd#vtrs_GoodwillImpairmentTestMeasurementInputIncrease"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_16ea2298-cb1e-459d-bf5e-0af352ad05d7" xlink:to="loc_vtrs_GoodwillImpairmentTestMeasurementInputIncrease_750ef2bf-ed8c-42ec-a2f9-6b237c031075" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_fb9ac7bc-261c-4a8b-acaa-592df3781e37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_16ea2298-cb1e-459d-bf5e-0af352ad05d7" xlink:to="loc_us-gaap_Goodwill_fb9ac7bc-261c-4a8b-acaa-592df3781e37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GoodwillImpairmentMeasurementInput_d6000a73-07ad-4399-88d5-6d10086e15bf" xlink:href="vtrs-20211231.xsd#vtrs_GoodwillImpairmentMeasurementInput"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_16ea2298-cb1e-459d-bf5e-0af352ad05d7" xlink:to="loc_vtrs_GoodwillImpairmentMeasurementInput_d6000a73-07ad-4399-88d5-6d10086e15bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GoodwillImpairmentMeasurementInputTerm_7c87781a-a9d5-42f5-8179-dba8c768bd50" xlink:href="vtrs-20211231.xsd#vtrs_GoodwillImpairmentMeasurementInputTerm"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_16ea2298-cb1e-459d-bf5e-0af352ad05d7" xlink:to="loc_vtrs_GoodwillImpairmentMeasurementInputTerm_7c87781a-a9d5-42f5-8179-dba8c768bd50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountOfGoodwillDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#GoodwillandOtherIntangibleAssetsChangesinCarryingAmountOfGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountOfGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e7e07dbb-6033-4070-984b-efc9af997678" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_1f2a6398-4150-465b-ba09-badb0bccafc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e7e07dbb-6033-4070-984b-efc9af997678" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_1f2a6398-4150-465b-ba09-badb0bccafc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a396ef6f-8209-48e4-be9b-abf896823310" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_1f2a6398-4150-465b-ba09-badb0bccafc4" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a396ef6f-8209-48e4-be9b-abf896823310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c80dc357-757d-403e-afac-95c25f9589af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a396ef6f-8209-48e4-be9b-abf896823310" xlink:to="loc_us-gaap_SegmentDomain_c80dc357-757d-403e-afac-95c25f9589af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DevelopedMarketsSegmentMember_3d4b2a87-ff26-49b5-a0e4-5d4f5686bf92" xlink:href="vtrs-20211231.xsd#vtrs_DevelopedMarketsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c80dc357-757d-403e-afac-95c25f9589af" xlink:to="loc_vtrs_DevelopedMarketsSegmentMember_3d4b2a87-ff26-49b5-a0e4-5d4f5686bf92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GreaterChinaSegmentMember_d4a86eff-c985-4efd-85fb-32c037927e6f" xlink:href="vtrs-20211231.xsd#vtrs_GreaterChinaSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c80dc357-757d-403e-afac-95c25f9589af" xlink:to="loc_vtrs_GreaterChinaSegmentMember_d4a86eff-c985-4efd-85fb-32c037927e6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_6699dc8b-3965-4f42-9409-a6e71503c0d8" xlink:href="vtrs-20211231.xsd#vtrs_JapanAustraliaAndNewZealandSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c80dc357-757d-403e-afac-95c25f9589af" xlink:to="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_6699dc8b-3965-4f42-9409-a6e71503c0d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EmergingMarketsSegmentMember_2566474c-e0b2-494f-8d03-8e6ddaf59e6e" xlink:href="vtrs-20211231.xsd#vtrs_EmergingMarketsSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c80dc357-757d-403e-afac-95c25f9589af" xlink:to="loc_vtrs_EmergingMarketsSegmentMember_2566474c-e0b2-494f-8d03-8e6ddaf59e6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_d85abcc3-cfdf-41b5-8857-a70c2befd28a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_1f2a6398-4150-465b-ba09-badb0bccafc4" xlink:to="loc_us-gaap_GoodwillLineItems_d85abcc3-cfdf-41b5-8857-a70c2befd28a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_95820704-48e4-4e96-a8f0-7f44d34b3804" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_d85abcc3-cfdf-41b5-8857-a70c2befd28a" xlink:to="loc_us-gaap_GoodwillGross_95820704-48e4-4e96-a8f0-7f44d34b3804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_fb03e9be-7d2b-4f81-b2ec-e54a8f7774cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_d85abcc3-cfdf-41b5-8857-a70c2befd28a" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_fb03e9be-7d2b-4f81-b2ec-e54a8f7774cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_747fc658-ed71-44d7-99bc-da277d6887a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_d85abcc3-cfdf-41b5-8857-a70c2befd28a" xlink:to="loc_us-gaap_Goodwill_747fc658-ed71-44d7-99bc-da277d6887a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_38cf12e6-8db4-435f-bfd4-f3585d790c8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_d85abcc3-cfdf-41b5-8857-a70c2befd28a" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_38cf12e6-8db4-435f-bfd4-f3585d790c8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_a428dcb7-a3de-4ade-a4b1-114415025d1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_d85abcc3-cfdf-41b5-8857-a70c2befd28a" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_a428dcb7-a3de-4ade-a4b1-114415025d1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_8d7781ad-c457-4e18-b465-6c9a2a57d5d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_d85abcc3-cfdf-41b5-8857-a70c2befd28a" xlink:to="loc_us-gaap_GoodwillGross_8d7781ad-c457-4e18-b465-6c9a2a57d5d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTransfers_7408da90-f1a2-44bf-a8ab-151aceea47f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillTransfers"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_d85abcc3-cfdf-41b5-8857-a70c2befd28a" xlink:to="loc_us-gaap_GoodwillTransfers_7408da90-f1a2-44bf-a8ab-151aceea47f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_79b8f4ca-b9c8-4c02-95a2-b51da645aa88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_d85abcc3-cfdf-41b5-8857-a70c2befd28a" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_79b8f4ca-b9c8-4c02-95a2-b51da645aa88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_05fcfeb6-2e56-47ed-bd82-8e59f6fb1528" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_d85abcc3-cfdf-41b5-8857-a70c2befd28a" xlink:to="loc_us-gaap_Goodwill_05fcfeb6-2e56-47ed-bd82-8e59f6fb1528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_e2c78f07-11a9-468b-9151-c7c3de4d24ac" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_d85abcc3-cfdf-41b5-8857-a70c2befd28a" xlink:to="loc_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_e2c78f07-11a9-468b-9151-c7c3de4d24ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsComponentsofIntangibleAssetsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#GoodwillandOtherIntangibleAssetsComponentsofIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsComponentsofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e70c9fee-a9ad-462c-b61a-6b3a718fd874" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_6c6f7781-a430-48eb-a91d-19c16a26e59c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e70c9fee-a9ad-462c-b61a-6b3a718fd874" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_6c6f7781-a430-48eb-a91d-19c16a26e59c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_724adf75-dcd2-458c-ba0d-b7edd5996176" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e70c9fee-a9ad-462c-b61a-6b3a718fd874" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_724adf75-dcd2-458c-ba0d-b7edd5996176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_4549f88f-03ef-4e3a-997d-afcdbffba7a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e70c9fee-a9ad-462c-b61a-6b3a718fd874" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_4549f88f-03ef-4e3a-997d-afcdbffba7a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2f1e91a9-1334-442c-8ce2-78ab650779a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e70c9fee-a9ad-462c-b61a-6b3a718fd874" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2f1e91a9-1334-442c-8ce2-78ab650779a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_cc31b96d-2e77-42a4-bfd1-91e869b45066" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e70c9fee-a9ad-462c-b61a-6b3a718fd874" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_cc31b96d-2e77-42a4-bfd1-91e869b45066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_a59f74b6-7405-4ec6-b448-c3bf91e52fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e70c9fee-a9ad-462c-b61a-6b3a718fd874" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_a59f74b6-7405-4ec6-b448-c3bf91e52fc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6ac8f049-0aa7-4e87-b2f3-b88d311fcdcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e70c9fee-a9ad-462c-b61a-6b3a718fd874" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6ac8f049-0aa7-4e87-b2f3-b88d311fcdcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsProductRightsandLicensebyTherapeuticCategoryDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#GoodwillandOtherIntangibleAssetsProductRightsandLicensebyTherapeuticCategoryDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsProductRightsandLicensebyTherapeuticCategoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9ea447de-d15c-47e8-b8fa-a2ce7445e178" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassTable_9c568fe3-a7c4-4ba0-b2c7-dc056af811d2" xlink:href="vtrs-20211231.xsd#vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9ea447de-d15c-47e8-b8fa-a2ce7445e178" xlink:to="loc_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassTable_9c568fe3-a7c4-4ba0-b2c7-dc056af811d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3f67b2c1-21c3-44e4-ac87-a1380f7fed27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassTable_9c568fe3-a7c4-4ba0-b2c7-dc056af811d2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3f67b2c1-21c3-44e4-ac87-a1380f7fed27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_af993cff-ce56-4580-ba3d-7ee45edfcc2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3f67b2c1-21c3-44e4-ac87-a1380f7fed27" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_af993cff-ce56-4580-ba3d-7ee45edfcc2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_69ed9edf-eed8-48b3-bb3b-307e7a0fa5a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_af993cff-ce56-4580-ba3d-7ee45edfcc2b" xlink:to="loc_us-gaap_LicensingAgreementsMember_69ed9edf-eed8-48b3-bb3b-307e7a0fa5a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4c9ddb82-abf4-4bb4-a060-e03e9e5b890d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassTable_9c568fe3-a7c4-4ba0-b2c7-dc056af811d2" xlink:to="loc_srt_ProductOrServiceAxis_4c9ddb82-abf4-4bb4-a060-e03e9e5b890d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_42e8ef8d-eab4-4e0e-9589-cdd7c63ca896" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_4c9ddb82-abf4-4bb4-a060-e03e9e5b890d" xlink:to="loc_srt_ProductsAndServicesDomain_42e8ef8d-eab4-4e0e-9589-cdd7c63ca896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BrandsMember_195fe4dc-5c59-489c-8106-9b2df9065043" xlink:href="vtrs-20211231.xsd#vtrs_BrandsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_42e8ef8d-eab4-4e0e-9589-cdd7c63ca896" xlink:to="loc_vtrs_BrandsMember_195fe4dc-5c59-489c-8106-9b2df9065043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ComplexGXAndBiosimilarsMember_fb830ab8-02e1-4c6b-9de3-7348aa8b2e1e" xlink:href="vtrs-20211231.xsd#vtrs_ComplexGXAndBiosimilarsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_42e8ef8d-eab4-4e0e-9589-cdd7c63ca896" xlink:to="loc_vtrs_ComplexGXAndBiosimilarsMember_fb830ab8-02e1-4c6b-9de3-7348aa8b2e1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GenericsMember_f7d6297d-8f7a-41a3-8af5-7e4b28103859" xlink:href="vtrs-20211231.xsd#vtrs_GenericsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_42e8ef8d-eab4-4e0e-9589-cdd7c63ca896" xlink:to="loc_vtrs_GenericsMember_f7d6297d-8f7a-41a3-8af5-7e4b28103859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a65311c3-4858-45f3-b261-177574f79e90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassTable_9c568fe3-a7c4-4ba0-b2c7-dc056af811d2" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a65311c3-4858-45f3-b261-177574f79e90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_70195998-763d-4363-9f0d-ea05e46b593e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a65311c3-4858-45f3-b261-177574f79e90" xlink:to="loc_us-gaap_SegmentDomain_70195998-763d-4363-9f0d-ea05e46b593e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DevelopedMarketsSegmentMember_5d115df9-b3e1-4e87-ac3c-f3e418ba4892" xlink:href="vtrs-20211231.xsd#vtrs_DevelopedMarketsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_70195998-763d-4363-9f0d-ea05e46b593e" xlink:to="loc_vtrs_DevelopedMarketsSegmentMember_5d115df9-b3e1-4e87-ac3c-f3e418ba4892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GreaterChinaSegmentMember_2385797a-5a77-42e0-b01a-ed3248225151" xlink:href="vtrs-20211231.xsd#vtrs_GreaterChinaSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_70195998-763d-4363-9f0d-ea05e46b593e" xlink:to="loc_vtrs_GreaterChinaSegmentMember_2385797a-5a77-42e0-b01a-ed3248225151" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_310e94c8-22c6-4255-ad28-13b9e9c82075" xlink:href="vtrs-20211231.xsd#vtrs_JapanAustraliaAndNewZealandSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_70195998-763d-4363-9f0d-ea05e46b593e" xlink:to="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_310e94c8-22c6-4255-ad28-13b9e9c82075" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EmergingMarketsSegmentMember_2fd410c0-eed9-4ef7-a4c7-3dbb2aaf5d0b" xlink:href="vtrs-20211231.xsd#vtrs_EmergingMarketsSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_70195998-763d-4363-9f0d-ea05e46b593e" xlink:to="loc_vtrs_EmergingMarketsSegmentMember_2fd410c0-eed9-4ef7-a4c7-3dbb2aaf5d0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassLineItems_0371291a-712d-4840-ae92-60bdba2cb1ba" xlink:href="vtrs-20211231.xsd#vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassTable_9c568fe3-a7c4-4ba0-b2c7-dc056af811d2" xlink:to="loc_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassLineItems_0371291a-712d-4840-ae92-60bdba2cb1ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f05f52cf-7b50-41ab-a484-8415ad0b9de9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassLineItems_0371291a-712d-4840-ae92-60bdba2cb1ba" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f05f52cf-7b50-41ab-a484-8415ad0b9de9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_01e2fb0f-e474-45e2-8f52-f072ef0daa1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b2649365-f4c0-4f23-a0f0-b57f7da6af55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_01e2fb0f-e474-45e2-8f52-f072ef0daa1f" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b2649365-f4c0-4f23-a0f0-b57f7da6af55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_78c80eb4-7441-47ed-a9e0-a854dfbda9ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b2649365-f4c0-4f23-a0f0-b57f7da6af55" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_78c80eb4-7441-47ed-a9e0-a854dfbda9ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f17364b3-47a1-45b4-bdea-e66e39db98ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_78c80eb4-7441-47ed-a9e0-a854dfbda9ce" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f17364b3-47a1-45b4-bdea-e66e39db98ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_c643a0c7-4001-4c9f-9853-81c1b7ab5590" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f17364b3-47a1-45b4-bdea-e66e39db98ac" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_c643a0c7-4001-4c9f-9853-81c1b7ab5590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3d591e07-d278-4a27-84e7-eca218c22f34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b2649365-f4c0-4f23-a0f0-b57f7da6af55" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3d591e07-d278-4a27-84e7-eca218c22f34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_dcf7dcd4-c7d4-48f9-b726-86b4ef4e1fcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3d591e07-d278-4a27-84e7-eca218c22f34" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_dcf7dcd4-c7d4-48f9-b726-86b4ef4e1fcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_1596650a-66d6-432e-9906-943e615a1ee8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3d591e07-d278-4a27-84e7-eca218c22f34" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_1596650a-66d6-432e-9906-943e615a1ee8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_e92a3cf7-43b9-4f72-8ad3-62be39377f98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3d591e07-d278-4a27-84e7-eca218c22f34" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_e92a3cf7-43b9-4f72-8ad3-62be39377f98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_e985f0b5-55a3-4880-856d-4664c6e66a6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3d591e07-d278-4a27-84e7-eca218c22f34" xlink:to="loc_us-gaap_AdjustmentForAmortization_e985f0b5-55a3-4880-856d-4664c6e66a6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsGoodwillandOtherIntangibleAssetsFutureamortizationexpenseDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#GoodwillandOtherIntangibleAssetsGoodwillandOtherIntangibleAssetsFutureamortizationexpenseDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsGoodwillandOtherIntangibleAssetsFutureamortizationexpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1806fcb2-58d3-4a90-9dde-190a77e7336c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_6da3632d-4ec0-40f1-a45a-b4a65d073662" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1806fcb2-58d3-4a90-9dde-190a77e7336c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_6da3632d-4ec0-40f1-a45a-b4a65d073662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_812bd291-f763-49fe-843a-6c9f59bd8591" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1806fcb2-58d3-4a90-9dde-190a77e7336c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_812bd291-f763-49fe-843a-6c9f59bd8591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_d4a6ec7e-b4ce-4446-9199-8b1122848c8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1806fcb2-58d3-4a90-9dde-190a77e7336c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_d4a6ec7e-b4ce-4446-9199-8b1122848c8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_c5fc7586-705f-40fe-81b2-f96b9c791857" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1806fcb2-58d3-4a90-9dde-190a77e7336c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_c5fc7586-705f-40fe-81b2-f96b9c791857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_7a2afc93-255f-494e-98a1-341a4bf61537" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1806fcb2-58d3-4a90-9dde-190a77e7336c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_7a2afc93-255f-494e-98a1-341a4bf61537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagement" xlink:type="simple" xlink:href="vtrs-20211231.xsd#FinancialInstrumentsandRiskManagement"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_17c7e31a-b5f1-44c7-b35d-4570986f4130" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_dfaef210-dde2-46ea-bf24-5ce6d0c54072" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_17c7e31a-b5f1-44c7-b35d-4570986f4130" xlink:to="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_dfaef210-dde2-46ea-bf24-5ce6d0c54072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables" xlink:type="simple" xlink:href="vtrs-20211231.xsd#FinancialInstrumentsandRiskManagementTables"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_606306f5-3149-4e2c-ba7e-def6d394b6ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_17f8118d-09a8-48c3-bcd2-3d8a27f9c712" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_606306f5-3149-4e2c-ba7e-def6d394b6ae" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_17f8118d-09a8-48c3-bcd2-3d8a27f9c712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_f2e81558-75c9-4a4c-90c6-fff74d0f684a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_17f8118d-09a8-48c3-bcd2-3d8a27f9c712" xlink:to="loc_us-gaap_HedgingDesignationAxis_f2e81558-75c9-4a4c-90c6-fff74d0f684a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_d6cbba10-e71d-402e-9433-5af951e2a307" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_f2e81558-75c9-4a4c-90c6-fff74d0f684a" xlink:to="loc_us-gaap_HedgingDesignationDomain_d6cbba10-e71d-402e-9433-5af951e2a307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_0c392336-b6b9-44b5-ae76-218f476918dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_d6cbba10-e71d-402e-9433-5af951e2a307" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_0c392336-b6b9-44b5-ae76-218f476918dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_b70466c1-189e-4768-b1ff-c2f904fdc838" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_d6cbba10-e71d-402e-9433-5af951e2a307" xlink:to="loc_us-gaap_NondesignatedMember_b70466c1-189e-4768-b1ff-c2f904fdc838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_06517ca8-a2b2-49e3-9088-7d2b90e9ffc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_17f8118d-09a8-48c3-bcd2-3d8a27f9c712" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_06517ca8-a2b2-49e3-9088-7d2b90e9ffc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_5205e463-4fa8-41a6-a5c5-d13eb9e0a379" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_06517ca8-a2b2-49e3-9088-7d2b90e9ffc8" xlink:to="loc_us-gaap_HedgingRelationshipDomain_5205e463-4fa8-41a6-a5c5-d13eb9e0a379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_67ef2019-12c1-484d-932e-e1019a043bdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_5205e463-4fa8-41a6-a5c5-d13eb9e0a379" xlink:to="loc_us-gaap_FairValueHedgingMember_67ef2019-12c1-484d-932e-e1019a043bdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_76d1cd0c-c38b-4937-bff2-b288c2562654" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_5205e463-4fa8-41a6-a5c5-d13eb9e0a379" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_76d1cd0c-c38b-4937-bff2-b288c2562654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_b8383c20-24d8-4c46-972f-b6e831b0537a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_5205e463-4fa8-41a6-a5c5-d13eb9e0a379" xlink:to="loc_us-gaap_CashFlowHedgingMember_b8383c20-24d8-4c46-972f-b6e831b0537a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_bbebc39f-77c6-492a-b270-bb5b9388179b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_17f8118d-09a8-48c3-bcd2-3d8a27f9c712" xlink:to="loc_us-gaap_DerivativeLineItems_bbebc39f-77c6-492a-b270-bb5b9388179b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_8f9120f0-730e-4223-88ed-7d1f6ecd0d58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_bbebc39f-77c6-492a-b270-bb5b9388179b" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_8f9120f0-730e-4223-88ed-7d1f6ecd0d58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_e9edce87-97ad-4252-a6e9-7b719cc102c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_bbebc39f-77c6-492a-b270-bb5b9388179b" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_e9edce87-97ad-4252-a6e9-7b719cc102c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_079a5dbc-1c1d-4ffb-afc7-caebf310c476" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_bbebc39f-77c6-492a-b270-bb5b9388179b" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_079a5dbc-1c1d-4ffb-afc7-caebf310c476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_8ab858d7-3ed7-4656-8cf0-931751fa85fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_bbebc39f-77c6-492a-b270-bb5b9388179b" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_8ab858d7-3ed7-4656-8cf0-931751fa85fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_c989b74d-50c8-46ba-8694-e4efb51056e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_bbebc39f-77c6-492a-b270-bb5b9388179b" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_c989b74d-50c8-46ba-8694-e4efb51056e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_84f3871c-a271-4f99-9006-127206734b49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_bbebc39f-77c6-492a-b270-bb5b9388179b" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_84f3871c-a271-4f99-9006-127206734b49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#FinancialInstrumentsandRiskManagementNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_fb103b6b-8f78-4134-b128-19d5d8a7ad29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_fdaa4ec9-59a7-473b-bfac-67f9da29be23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_fb103b6b-8f78-4134-b128-19d5d8a7ad29" xlink:to="loc_us-gaap_DerivativeTable_fdaa4ec9-59a7-473b-bfac-67f9da29be23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_f06f79bc-f792-4507-addf-862e9532ff24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_fdaa4ec9-59a7-473b-bfac-67f9da29be23" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_f06f79bc-f792-4507-addf-862e9532ff24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_87a099f1-bbaa-4892-a94a-13b00b26818f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_f06f79bc-f792-4507-addf-862e9532ff24" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_87a099f1-bbaa-4892-a94a-13b00b26818f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_5591c01a-fe87-4c67-84ad-73bb10a9fb84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_87a099f1-bbaa-4892-a94a-13b00b26818f" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_5591c01a-fe87-4c67-84ad-73bb10a9fb84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_761ebade-c5bd-429e-867f-ecd6c423447f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_fdaa4ec9-59a7-473b-bfac-67f9da29be23" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_761ebade-c5bd-429e-867f-ecd6c423447f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_df3a11bc-895e-4c41-acda-630cd3ec5631" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_761ebade-c5bd-429e-867f-ecd6c423447f" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_df3a11bc-895e-4c41-acda-630cd3ec5631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ContingentConsiderationMember_fc5dc7f4-5af1-411d-8b6d-cb32038cfce9" xlink:href="vtrs-20211231.xsd#vtrs_ContingentConsiderationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_df3a11bc-895e-4c41-acda-630cd3ec5631" xlink:to="loc_vtrs_ContingentConsiderationMember_fc5dc7f4-5af1-411d-8b6d-cb32038cfce9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_48e97dd0-9bcb-4365-a647-5e36dd0da872" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_df3a11bc-895e-4c41-acda-630cd3ec5631" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_48e97dd0-9bcb-4365-a647-5e36dd0da872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_01b98bf3-e0bf-493a-a285-dee92b9e8efb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_df3a11bc-895e-4c41-acda-630cd3ec5631" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_01b98bf3-e0bf-493a-a285-dee92b9e8efb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1dab26d7-f782-4372-8b0c-42f52ba0ebf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_fdaa4ec9-59a7-473b-bfac-67f9da29be23" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1dab26d7-f782-4372-8b0c-42f52ba0ebf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_851bf7cb-53aa-44fc-af65-a7d80c840b83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1dab26d7-f782-4372-8b0c-42f52ba0ebf7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_851bf7cb-53aa-44fc-af65-a7d80c840b83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenseMember_78091ff6-4e8d-4239-acbe-0d5bb2fa9436" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_851bf7cb-53aa-44fc-af65-a7d80c840b83" xlink:to="loc_us-gaap_OtherExpenseMember_78091ff6-4e8d-4239-acbe-0d5bb2fa9436" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8bae6584-be30-4437-8856-299dcb14a0f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_fdaa4ec9-59a7-473b-bfac-67f9da29be23" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8bae6584-be30-4437-8856-299dcb14a0f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_2aecf1b6-fed7-411f-8ed5-9650f5c7e167" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8bae6584-be30-4437-8856-299dcb14a0f1" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_2aecf1b6-fed7-411f-8ed5-9650f5c7e167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_8bfb981e-97af-4dbc-9cb2-24610834e28e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2aecf1b6-fed7-411f-8ed5-9650f5c7e167" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_8bfb981e-97af-4dbc-9cb2-24610834e28e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_05a79d74-c07b-493f-a4fe-abd78166fdf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2aecf1b6-fed7-411f-8ed5-9650f5c7e167" xlink:to="loc_us-gaap_InterestRateSwapMember_05a79d74-c07b-493f-a4fe-abd78166fdf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_fa155591-233c-43c3-8d24-f441b4c10abe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_fdaa4ec9-59a7-473b-bfac-67f9da29be23" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_fa155591-233c-43c3-8d24-f441b4c10abe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_72a7d9c7-b008-472a-bf0b-f72c3b2b8447" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_fa155591-233c-43c3-8d24-f441b4c10abe" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_72a7d9c7-b008-472a-bf0b-f72c3b2b8447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_c33f2e8d-9a09-4b5e-911b-20430d2a9a2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_72a7d9c7-b008-472a-bf0b-f72c3b2b8447" xlink:to="loc_us-gaap_SeniorNotesMember_c33f2e8d-9a09-4b5e-911b-20430d2a9a2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_3581e4b2-66cb-4d57-a038-8140c68f0a80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_fdaa4ec9-59a7-473b-bfac-67f9da29be23" xlink:to="loc_us-gaap_DebtInstrumentAxis_3581e4b2-66cb-4d57-a038-8140c68f0a80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6586cc55-6f3e-4de6-8be1-4a839d39133d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_3581e4b2-66cb-4d57-a038-8140c68f0a80" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6586cc55-6f3e-4de6-8be1-4a839d39133d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2020EuroSeniorNotesMember_90e898b5-5c0c-406d-9400-eac88f963def" xlink:href="vtrs-20211231.xsd#vtrs_A2020EuroSeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6586cc55-6f3e-4de6-8be1-4a839d39133d" xlink:to="loc_vtrs_A2020EuroSeniorNotesMember_90e898b5-5c0c-406d-9400-eac88f963def" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2022EuroSeniorNotesMember_85e03c96-2f2f-4d0b-98ee-1e754a3df47e" xlink:href="vtrs-20211231.xsd#vtrs_A2022EuroSeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6586cc55-6f3e-4de6-8be1-4a839d39133d" xlink:to="loc_vtrs_A2022EuroSeniorNotesMember_85e03c96-2f2f-4d0b-98ee-1e754a3df47e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2024EuroSeniorNotesMember_646258ae-aab0-47e1-beb3-9cd13aa3747c" xlink:href="vtrs-20211231.xsd#vtrs_A2024EuroSeniorNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6586cc55-6f3e-4de6-8be1-4a839d39133d" xlink:to="loc_vtrs_A2024EuroSeniorNotesMember_646258ae-aab0-47e1-beb3-9cd13aa3747c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2024EuroSeniorNotes1023Member_6be60ec8-b0b8-46c9-86de-04921d92c991" xlink:href="vtrs-20211231.xsd#vtrs_A2024EuroSeniorNotes1023Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6586cc55-6f3e-4de6-8be1-4a839d39133d" xlink:to="loc_vtrs_A2024EuroSeniorNotes1023Member_6be60ec8-b0b8-46c9-86de-04921d92c991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2025EuroSeniorNotesMember_e9d50729-7ba5-47d8-9943-12fcce7fba1f" xlink:href="vtrs-20211231.xsd#vtrs_A2025EuroSeniorNotesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6586cc55-6f3e-4de6-8be1-4a839d39133d" xlink:to="loc_vtrs_A2025EuroSeniorNotesMember_e9d50729-7ba5-47d8-9943-12fcce7fba1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2028SeniorNotesMember_74792e0e-9f73-4458-b3c5-dfb0cb963bd3" xlink:href="vtrs-20211231.xsd#vtrs_A2028SeniorNotesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6586cc55-6f3e-4de6-8be1-4a839d39133d" xlink:to="loc_vtrs_A2028SeniorNotesMember_74792e0e-9f73-4458-b3c5-dfb0cb963bd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2027EuroSeniorNotesMember_269ba71b-3cad-4a36-9ed8-12bb9f2d14ec" xlink:href="vtrs-20211231.xsd#vtrs_A2027EuroSeniorNotesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6586cc55-6f3e-4de6-8be1-4a839d39133d" xlink:to="loc_vtrs_A2027EuroSeniorNotesMember_269ba71b-3cad-4a36-9ed8-12bb9f2d14ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2032EuroSeniorNotesMember_67c2b74a-4020-43ba-90e8-234d674986b8" xlink:href="vtrs-20211231.xsd#vtrs_A2032EuroSeniorNotesMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6586cc55-6f3e-4de6-8be1-4a839d39133d" xlink:to="loc_vtrs_A2032EuroSeniorNotesMember_67c2b74a-4020-43ba-90e8-234d674986b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2028EuroSeniorNotesMember_8b550215-9003-487f-890a-ff97c1d50ed3" xlink:href="vtrs-20211231.xsd#vtrs_A2028EuroSeniorNotesMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6586cc55-6f3e-4de6-8be1-4a839d39133d" xlink:to="loc_vtrs_A2028EuroSeniorNotesMember_8b550215-9003-487f-890a-ff97c1d50ed3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2020FloatingRateEuroNotesMember_345ae3b0-7871-4ac4-9061-489f29d82729" xlink:href="vtrs-20211231.xsd#vtrs_A2020FloatingRateEuroNotesMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6586cc55-6f3e-4de6-8be1-4a839d39133d" xlink:to="loc_vtrs_A2020FloatingRateEuroNotesMember_345ae3b0-7871-4ac4-9061-489f29d82729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember_cb78be0c-d0dc-4eaa-b9d8-6cf9a0bdf595" xlink:href="vtrs-20211231.xsd#vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6586cc55-6f3e-4de6-8be1-4a839d39133d" xlink:to="loc_vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember_cb78be0c-d0dc-4eaa-b9d8-6cf9a0bdf595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_YENTermLoanMember_e23d368e-fded-4398-8cc9-b662a77d4a5d" xlink:href="vtrs-20211231.xsd#vtrs_YENTermLoanMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6586cc55-6f3e-4de6-8be1-4a839d39133d" xlink:to="loc_vtrs_YENTermLoanMember_e23d368e-fded-4398-8cc9-b662a77d4a5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_28a2b7c8-118d-4b73-8a34-dc1cd985f098" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_fdaa4ec9-59a7-473b-bfac-67f9da29be23" xlink:to="loc_us-gaap_HedgingDesignationAxis_28a2b7c8-118d-4b73-8a34-dc1cd985f098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_ab80d2f9-50d2-4b72-9acc-32c831116fcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_28a2b7c8-118d-4b73-8a34-dc1cd985f098" xlink:to="loc_us-gaap_HedgingDesignationDomain_ab80d2f9-50d2-4b72-9acc-32c831116fcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_e8d981b4-d923-4f0b-b3f5-9d26212ff49a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_ab80d2f9-50d2-4b72-9acc-32c831116fcb" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_e8d981b4-d923-4f0b-b3f5-9d26212ff49a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_c29c461e-e688-4645-995a-ab5459bfe15a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_fdaa4ec9-59a7-473b-bfac-67f9da29be23" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_c29c461e-e688-4645-995a-ab5459bfe15a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e2ac5cdb-04dd-4528-87d0-dc1bd330fe8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c29c461e-e688-4645-995a-ab5459bfe15a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e2ac5cdb-04dd-4528-87d0-dc1bd330fe8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AgilaSpecialtiesPrivateLimitedMember_c68ab678-4b4b-4a83-9153-f46c97751a14" xlink:href="vtrs-20211231.xsd#vtrs_AgilaSpecialtiesPrivateLimitedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e2ac5cdb-04dd-4528-87d0-dc1bd330fe8a" xlink:to="loc_vtrs_AgilaSpecialtiesPrivateLimitedMember_c68ab678-4b4b-4a83-9153-f46c97751a14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_JaiPharmaLimitedMember_34c8492e-3e6c-476c-aacb-f28884b1b242" xlink:href="vtrs-20211231.xsd#vtrs_JaiPharmaLimitedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e2ac5cdb-04dd-4528-87d0-dc1bd330fe8a" xlink:to="loc_vtrs_JaiPharmaLimitedMember_34c8492e-3e6c-476c-aacb-f28884b1b242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RespiratorydeliveryplatformMember_ddc764fa-d4c9-498d-abb5-1ee59f21687c" xlink:href="vtrs-20211231.xsd#vtrs_RespiratorydeliveryplatformMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e2ac5cdb-04dd-4528-87d0-dc1bd330fe8a" xlink:to="loc_vtrs_RespiratorydeliveryplatformMember_ddc764fa-d4c9-498d-abb5-1ee59f21687c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4bec20b9-fe08-496b-b648-148616497ddc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_fdaa4ec9-59a7-473b-bfac-67f9da29be23" xlink:to="loc_srt_RangeAxis_4bec20b9-fe08-496b-b648-148616497ddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_602228fc-adf7-455c-8ae6-2ea50cb452d5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_4bec20b9-fe08-496b-b648-148616497ddc" xlink:to="loc_srt_RangeMember_602228fc-adf7-455c-8ae6-2ea50cb452d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_29b5cfe5-b048-4041-9cf4-23ab5fd7a359" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_602228fc-adf7-455c-8ae6-2ea50cb452d5" xlink:to="loc_srt_MinimumMember_29b5cfe5-b048-4041-9cf4-23ab5fd7a359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c87b3586-511f-409f-8f88-e63141bb37c7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_602228fc-adf7-455c-8ae6-2ea50cb452d5" xlink:to="loc_srt_MaximumMember_c87b3586-511f-409f-8f88-e63141bb37c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_842cf934-b5c7-4b3e-b17b-83648ef416dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_fdaa4ec9-59a7-473b-bfac-67f9da29be23" xlink:to="loc_us-gaap_DerivativeLineItems_842cf934-b5c7-4b3e-b17b-83648ef416dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_7e09d24b-2f15-4d7f-aab8-a1f181625c82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_842cf934-b5c7-4b3e-b17b-83648ef416dd" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_7e09d24b-2f15-4d7f-aab8-a1f181625c82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_2ea3c976-a3fb-466d-a018-56c4ff24da83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_842cf934-b5c7-4b3e-b17b-83648ef416dd" xlink:to="loc_us-gaap_LongTermDebt_2ea3c976-a3fb-466d-a018-56c4ff24da83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_5f758884-7e85-45d2-b836-9952c7a225ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_842cf934-b5c7-4b3e-b17b-83648ef416dd" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_5f758884-7e85-45d2-b836-9952c7a225ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_549b9be9-0fc1-40a6-8d33-682e3c6a23fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_842cf934-b5c7-4b3e-b17b-83648ef416dd" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_549b9be9-0fc1-40a6-8d33-682e3c6a23fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_00ad76da-5eae-489a-879f-d57794f23c2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_842cf934-b5c7-4b3e-b17b-83648ef416dd" xlink:to="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_00ad76da-5eae-489a-879f-d57794f23c2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_5131986c-e06e-4505-8645-9f7b740f8052" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_842cf934-b5c7-4b3e-b17b-83648ef416dd" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_5131986c-e06e-4505-8645-9f7b740f8052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_92b7d042-1a42-433d-88a3-63bef606dceb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_842cf934-b5c7-4b3e-b17b-83648ef416dd" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_92b7d042-1a42-433d-88a3-63bef606dceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_7015dce5-a6aa-4c1a-8f0f-ec72840f706e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_842cf934-b5c7-4b3e-b17b-83648ef416dd" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_7015dce5-a6aa-4c1a-8f0f-ec72840f706e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_f540bb76-0b23-45ef-a3e2-4a4b4c7ecf0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_842cf934-b5c7-4b3e-b17b-83648ef416dd" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_f540bb76-0b23-45ef-a3e2-4a4b4c7ecf0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_36c131bf-6396-459c-a3da-edb9abfbc502" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_842cf934-b5c7-4b3e-b17b-83648ef416dd" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_36c131bf-6396-459c-a3da-edb9abfbc502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications_70ae11d7-95a4-4bac-aa0e-7a3cf141e1c9" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_842cf934-b5c7-4b3e-b17b-83648ef416dd" xlink:to="loc_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications_70ae11d7-95a4-4bac-aa0e-7a3cf141e1c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionExpense_c7da9dcc-6087-4a9b-929c-7653eda1c081" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionExpense"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_842cf934-b5c7-4b3e-b17b-83648ef416dd" xlink:to="loc_us-gaap_AccretionExpense_c7da9dcc-6087-4a9b-929c-7653eda1c081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_7ba4fff5-25b7-4b6b-a54e-715247021869" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_842cf934-b5c7-4b3e-b17b-83648ef416dd" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_7ba4fff5-25b7-4b6b-a54e-715247021869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments_c1593fe5-6855-4c33-93aa-0249e0dcca2d" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationContingentConsiderationLiabilityPayments"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_842cf934-b5c7-4b3e-b17b-83648ef416dd" xlink:to="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments_c1593fe5-6855-4c33-93aa-0249e0dcca2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetLiabilityNetMeasurementInput_5e84ba3d-9280-492c-85d2-297d62e0b640" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetLiabilityNetMeasurementInput"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_842cf934-b5c7-4b3e-b17b-83648ef416dd" xlink:to="loc_us-gaap_DerivativeAssetLiabilityNetMeasurementInput_5e84ba3d-9280-492c-85d2-297d62e0b640" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisGainLossIncludedInEarnings_acdc59d6-410e-424a-b1e6-a716ee27dead" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisGainLossIncludedInEarnings"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_842cf934-b5c7-4b3e-b17b-83648ef416dd" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisGainLossIncludedInEarnings_acdc59d6-410e-424a-b1e6-a716ee27dead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccretionExpenseToBeRecognizedWithinTheNextTwelveMonths_681b4eef-5608-4159-9005-3fb9e56e2be4" xlink:href="vtrs-20211231.xsd#vtrs_AccretionExpenseToBeRecognizedWithinTheNextTwelveMonths"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_842cf934-b5c7-4b3e-b17b-83648ef416dd" xlink:to="loc_vtrs_AccretionExpenseToBeRecognizedWithinTheNextTwelveMonths_681b4eef-5608-4159-9005-3fb9e56e2be4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementDerivativesDesignatedasHedgingInstrumentsFairValuesofDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#FinancialInstrumentsandRiskManagementDerivativesDesignatedasHedgingInstrumentsFairValuesofDerivativeInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementDerivativesDesignatedasHedgingInstrumentsFairValuesofDerivativeInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_80969d1a-f0c4-4a89-82c5-a96c7b8f61dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_7b5335d2-bb91-4dc2-bbf8-a692a30c91bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_80969d1a-f0c4-4a89-82c5-a96c7b8f61dd" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_7b5335d2-bb91-4dc2-bbf8-a692a30c91bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_13c64e5f-dc0b-426f-a180-dde7ed6c29d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_7b5335d2-bb91-4dc2-bbf8-a692a30c91bd" xlink:to="loc_us-gaap_HedgingDesignationAxis_13c64e5f-dc0b-426f-a180-dde7ed6c29d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_fb1097b2-8fef-47cc-9952-a2721ea646df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_13c64e5f-dc0b-426f-a180-dde7ed6c29d8" xlink:to="loc_us-gaap_HedgingDesignationDomain_fb1097b2-8fef-47cc-9952-a2721ea646df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_aab4ed80-7da8-4f15-b133-ee94d017d588" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_fb1097b2-8fef-47cc-9952-a2721ea646df" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_aab4ed80-7da8-4f15-b133-ee94d017d588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_9b71ad5f-0167-44d2-a35b-5a6e940ec219" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_7b5335d2-bb91-4dc2-bbf8-a692a30c91bd" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_9b71ad5f-0167-44d2-a35b-5a6e940ec219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_2c9038d2-42d5-4ad0-8c28-da646a34dfd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_9b71ad5f-0167-44d2-a35b-5a6e940ec219" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_2c9038d2-42d5-4ad0-8c28-da646a34dfd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_0bde090e-91b4-43d8-ae9d-3f5071a32a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_2c9038d2-42d5-4ad0-8c28-da646a34dfd6" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_0bde090e-91b4-43d8-ae9d-3f5071a32a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_ced2f9f4-2ad9-4f2a-b3a1-b0100a725e23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_2c9038d2-42d5-4ad0-8c28-da646a34dfd6" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_ced2f9f4-2ad9-4f2a-b3a1-b0100a725e23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_becb0305-5120-4087-a2eb-5eca155942cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_7b5335d2-bb91-4dc2-bbf8-a692a30c91bd" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_becb0305-5120-4087-a2eb-5eca155942cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c910c8fa-3f91-448a-9a66-8ce675cafee4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_becb0305-5120-4087-a2eb-5eca155942cb" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c910c8fa-3f91-448a-9a66-8ce675cafee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_2d1bc01e-4587-4f1a-a6fe-0098a342a060" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c910c8fa-3f91-448a-9a66-8ce675cafee4" xlink:to="loc_us-gaap_InterestRateSwapMember_2d1bc01e-4587-4f1a-a6fe-0098a342a060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_bf0465ea-9faa-4122-818b-35aceadc7452" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c910c8fa-3f91-448a-9a66-8ce675cafee4" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_bf0465ea-9faa-4122-818b-35aceadc7452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_41377d5f-dbf0-4a46-8ea0-ad7df5ceb14c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_7b5335d2-bb91-4dc2-bbf8-a692a30c91bd" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_41377d5f-dbf0-4a46-8ea0-ad7df5ceb14c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_a978f67f-6d1b-4d14-89db-1315a2ffb5cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_41377d5f-dbf0-4a46-8ea0-ad7df5ceb14c" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_a978f67f-6d1b-4d14-89db-1315a2ffb5cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_72c7371d-0bb6-48f8-8920-c460277e43cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_41377d5f-dbf0-4a46-8ea0-ad7df5ceb14c" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_72c7371d-0bb6-48f8-8920-c460277e43cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementDerivativesNotDesignatedasHedgingInstrumentsFairValuesofDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#FinancialInstrumentsandRiskManagementDerivativesNotDesignatedasHedgingInstrumentsFairValuesofDerivativeInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementDerivativesNotDesignatedasHedgingInstrumentsFairValuesofDerivativeInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_c6915db9-dffd-47ad-a789-35560c6cbd56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_71a7cd09-5e7f-4f1f-acde-7ebd3e641e40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_c6915db9-dffd-47ad-a789-35560c6cbd56" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_71a7cd09-5e7f-4f1f-acde-7ebd3e641e40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_11ea26e2-9eb6-460e-91d1-3a9fedf86b48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_71a7cd09-5e7f-4f1f-acde-7ebd3e641e40" xlink:to="loc_us-gaap_HedgingDesignationAxis_11ea26e2-9eb6-460e-91d1-3a9fedf86b48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_37823aa7-95e4-45f5-a6e6-9d61be54e609" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_11ea26e2-9eb6-460e-91d1-3a9fedf86b48" xlink:to="loc_us-gaap_HedgingDesignationDomain_37823aa7-95e4-45f5-a6e6-9d61be54e609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_f5af890f-7670-4b66-9785-4f59bfa93a99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_37823aa7-95e4-45f5-a6e6-9d61be54e609" xlink:to="loc_us-gaap_NondesignatedMember_f5af890f-7670-4b66-9785-4f59bfa93a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_c8f99a67-1d29-49cc-a6d2-08ac9db95dfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_71a7cd09-5e7f-4f1f-acde-7ebd3e641e40" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_c8f99a67-1d29-49cc-a6d2-08ac9db95dfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_ace4bb6f-b763-4786-a3f6-fb9ec57d455c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c8f99a67-1d29-49cc-a6d2-08ac9db95dfd" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_ace4bb6f-b763-4786-a3f6-fb9ec57d455c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_657930b9-c463-496d-bef3-24979beba9ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_ace4bb6f-b763-4786-a3f6-fb9ec57d455c" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_657930b9-c463-496d-bef3-24979beba9ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_651f0881-53b8-44fb-a5b9-71b77df86fc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_ace4bb6f-b763-4786-a3f6-fb9ec57d455c" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_651f0881-53b8-44fb-a5b9-71b77df86fc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8b809bc4-4a18-4bfa-abe2-087ecfd1c3dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_71a7cd09-5e7f-4f1f-acde-7ebd3e641e40" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8b809bc4-4a18-4bfa-abe2-087ecfd1c3dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0f97477e-6b0a-4784-9167-5f307aaef668" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8b809bc4-4a18-4bfa-abe2-087ecfd1c3dd" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0f97477e-6b0a-4784-9167-5f307aaef668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_45693331-be3d-4b35-a2db-1ec03047cae8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0f97477e-6b0a-4784-9167-5f307aaef668" xlink:to="loc_us-gaap_ForeignExchangeContractMember_45693331-be3d-4b35-a2db-1ec03047cae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_764dd8f1-eced-4dce-9e80-d2552dbdbba1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_71a7cd09-5e7f-4f1f-acde-7ebd3e641e40" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_764dd8f1-eced-4dce-9e80-d2552dbdbba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_79ced589-e12e-47b3-983e-4f457d43abe7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_764dd8f1-eced-4dce-9e80-d2552dbdbba1" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_79ced589-e12e-47b3-983e-4f457d43abe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_ea986d75-8749-482e-8ad9-e0bb3d4beb64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_764dd8f1-eced-4dce-9e80-d2552dbdbba1" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_ea986d75-8749-482e-8ad9-e0bb3d4beb64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_aff4746c-da59-4bf5-8183-54ef0f65ffd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_bd9390a4-d4d9-4354-8bcd-f10ca0361579" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_aff4746c-da59-4bf5-8183-54ef0f65ffd9" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_bd9390a4-d4d9-4354-8bcd-f10ca0361579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e66047ef-7719-4443-a2b9-26aece08d566" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_bd9390a4-d4d9-4354-8bcd-f10ca0361579" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e66047ef-7719-4443-a2b9-26aece08d566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_ed0a132c-6d63-4f07-803f-53f1ad68f846" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e66047ef-7719-4443-a2b9-26aece08d566" xlink:to="loc_us-gaap_HedgingRelationshipDomain_ed0a132c-6d63-4f07-803f-53f1ad68f846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_3318f31b-7c66-4e86-9b58-acbb05b756ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_ed0a132c-6d63-4f07-803f-53f1ad68f846" xlink:to="loc_us-gaap_FairValueHedgingMember_3318f31b-7c66-4e86-9b58-acbb05b756ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_47452790-9fbd-4342-8c79-732dd312f2c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_bd9390a4-d4d9-4354-8bcd-f10ca0361579" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_47452790-9fbd-4342-8c79-732dd312f2c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_577400da-e2b8-40d9-97aa-6f0bf9203a4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_47452790-9fbd-4342-8c79-732dd312f2c1" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_577400da-e2b8-40d9-97aa-6f0bf9203a4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_e8de72d4-0356-45ea-b024-0859268bcb29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_577400da-e2b8-40d9-97aa-6f0bf9203a4c" xlink:to="loc_us-gaap_InterestExpenseMember_e8de72d4-0356-45ea-b024-0859268bcb29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenseMember_ebea0b72-c894-4107-af00-d089ad1176b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_577400da-e2b8-40d9-97aa-6f0bf9203a4c" xlink:to="loc_us-gaap_OtherExpenseMember_ebea0b72-c894-4107-af00-d089ad1176b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_a7398035-78fc-4d0e-8dea-6ed5ec2e9b2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_bd9390a4-d4d9-4354-8bcd-f10ca0361579" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_a7398035-78fc-4d0e-8dea-6ed5ec2e9b2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c784d4d3-ce4a-47b1-be2b-e83fe5f5b4fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_a7398035-78fc-4d0e-8dea-6ed5ec2e9b2a" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c784d4d3-ce4a-47b1-be2b-e83fe5f5b4fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_31793d1c-9207-437e-9619-a852554884bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c784d4d3-ce4a-47b1-be2b-e83fe5f5b4fb" xlink:to="loc_us-gaap_InterestRateSwapMember_31793d1c-9207-437e-9619-a852554884bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember_40e00c16-0d04-483f-965c-5713dc4e3e53" xlink:href="vtrs-20211231.xsd#vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c784d4d3-ce4a-47b1-be2b-e83fe5f5b4fb" xlink:to="loc_vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember_40e00c16-0d04-483f-965c-5713dc4e3e53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_6960e4c7-6094-4637-a9ac-c0a9ae282a5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c784d4d3-ce4a-47b1-be2b-e83fe5f5b4fb" xlink:to="loc_us-gaap_ForeignExchangeContractMember_6960e4c7-6094-4637-a9ac-c0a9ae282a5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_86ba2d5a-aa48-4a1e-a9be-b4ab81a149f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_bd9390a4-d4d9-4354-8bcd-f10ca0361579" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_86ba2d5a-aa48-4a1e-a9be-b4ab81a149f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_1ae3c708-493d-483b-b44e-f9d363528af3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_86ba2d5a-aa48-4a1e-a9be-b4ab81a149f8" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_1ae3c708-493d-483b-b44e-f9d363528af3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_4d429f9a-ab48-48cc-a6b8-e7b2daaef07e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_86ba2d5a-aa48-4a1e-a9be-b4ab81a149f8" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_4d429f9a-ab48-48cc-a6b8-e7b2daaef07e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_5e056563-29c5-46a3-a6c7-40fdba4370f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_86ba2d5a-aa48-4a1e-a9be-b4ab81a149f8" xlink:to="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_5e056563-29c5-46a3-a6c7-40fdba4370f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofComprehensiveEarningsDerivativesinCashFlowHedgingRelationshipsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofComprehensiveEarningsDerivativesinCashFlowHedgingRelationshipsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofComprehensiveEarningsDerivativesinCashFlowHedgingRelationshipsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1ca73af7-8171-4de2-aeaf-739ff41cfa87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_da78c9f4-7d81-473a-b798-ff86f7be9ada" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1ca73af7-8171-4de2-aeaf-739ff41cfa87" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_da78c9f4-7d81-473a-b798-ff86f7be9ada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_7634cb0d-b8b1-42dc-8fdf-b8c1941eb5f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_da78c9f4-7d81-473a-b798-ff86f7be9ada" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_7634cb0d-b8b1-42dc-8fdf-b8c1941eb5f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c5336f7d-56ef-4372-b920-0f4ba6f4b9ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7634cb0d-b8b1-42dc-8fdf-b8c1941eb5f3" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c5336f7d-56ef-4372-b920-0f4ba6f4b9ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_4b6ac326-c682-4eb4-b86f-e1ed0b66cc11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c5336f7d-56ef-4372-b920-0f4ba6f4b9ad" xlink:to="loc_us-gaap_ForeignExchangeContractMember_4b6ac326-c682-4eb4-b86f-e1ed0b66cc11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_ca98a199-928a-4089-8a60-245ee940867e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_da78c9f4-7d81-473a-b798-ff86f7be9ada" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_ca98a199-928a-4089-8a60-245ee940867e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_e6a0131b-222e-4177-9331-d2d713fc79fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_ca98a199-928a-4089-8a60-245ee940867e" xlink:to="loc_us-gaap_HedgingRelationshipDomain_e6a0131b-222e-4177-9331-d2d713fc79fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_7805a7bd-d3d4-4d65-95fb-39da1646aaa7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_e6a0131b-222e-4177-9331-d2d713fc79fd" xlink:to="loc_us-gaap_CashFlowHedgingMember_7805a7bd-d3d4-4d65-95fb-39da1646aaa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_b87eb870-43b0-4898-b8c6-64388f7e99c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_da78c9f4-7d81-473a-b798-ff86f7be9ada" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_b87eb870-43b0-4898-b8c6-64388f7e99c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8ba4ddb6-e137-4b8c-9a61-45f756a5c27c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b87eb870-43b0-4898-b8c6-64388f7e99c0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8ba4ddb6-e137-4b8c-9a61-45f756a5c27c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenseMember_4f20f6e3-7b6b-4aa8-ae77-b4a164367d12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8ba4ddb6-e137-4b8c-9a61-45f756a5c27c" xlink:to="loc_us-gaap_OtherExpenseMember_4f20f6e3-7b6b-4aa8-ae77-b4a164367d12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c3cc7f0e-1b31-4d56-82b3-846a96135c2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_da78c9f4-7d81-473a-b798-ff86f7be9ada" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c3cc7f0e-1b31-4d56-82b3-846a96135c2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet_1435c8ce-3c86-4705-975a-280f0b7c10e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c3cc7f0e-1b31-4d56-82b3-846a96135c2b" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet_1435c8ce-3c86-4705-975a-280f0b7c10e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinNetInvestmentHedgingRelationshipDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinNetInvestmentHedgingRelationshipDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinNetInvestmentHedgingRelationshipDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a95c4a01-fc03-459e-9d37-1a2b0407b691" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_c3140acf-d198-4fe7-9a7e-eee4dd8ec7fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a95c4a01-fc03-459e-9d37-1a2b0407b691" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_c3140acf-d198-4fe7-9a7e-eee4dd8ec7fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a5a92143-4dca-4801-9c33-9fd8ebeec224" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_c3140acf-d198-4fe7-9a7e-eee4dd8ec7fc" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a5a92143-4dca-4801-9c33-9fd8ebeec224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_53025a8e-0b37-47ae-81a4-357ad30ab19c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a5a92143-4dca-4801-9c33-9fd8ebeec224" xlink:to="loc_us-gaap_EquityComponentDomain_53025a8e-0b37-47ae-81a4-357ad30ab19c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_34d5377c-8b96-4a13-9202-b2a726341e8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_53025a8e-0b37-47ae-81a4-357ad30ab19c" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_34d5377c-8b96-4a13-9202-b2a726341e8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_c53a4e04-db8e-443b-a761-d639c54a9bd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_c3140acf-d198-4fe7-9a7e-eee4dd8ec7fc" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_c53a4e04-db8e-443b-a761-d639c54a9bd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ee7ee172-1041-42eb-bdee-7b31aeac3e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c53a4e04-db8e-443b-a761-d639c54a9bd6" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ee7ee172-1041-42eb-bdee-7b31aeac3e1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_b7df3eb2-4eab-40f7-bae2-784d5d6bf536" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ee7ee172-1041-42eb-bdee-7b31aeac3e1b" xlink:to="loc_us-gaap_ForeignExchangeContractMember_b7df3eb2-4eab-40f7-bae2-784d5d6bf536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_c88c4d65-6fa6-4a3e-a98b-ff26a60bbd89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ee7ee172-1041-42eb-bdee-7b31aeac3e1b" xlink:to="loc_us-gaap_InterestRateSwapMember_c88c4d65-6fa6-4a3e-a98b-ff26a60bbd89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7926d364-0f9d-40a7-9b75-9d13ab8171cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_c3140acf-d198-4fe7-9a7e-eee4dd8ec7fc" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7926d364-0f9d-40a7-9b75-9d13ab8171cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_d9ec91fe-6204-469d-9ecb-74682ccacb4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7926d364-0f9d-40a7-9b75-9d13ab8171cd" xlink:to="loc_us-gaap_HedgingRelationshipDomain_d9ec91fe-6204-469d-9ecb-74682ccacb4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_5c21f89f-b0a5-4bee-a497-42c54a46ddf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_d9ec91fe-6204-469d-9ecb-74682ccacb4f" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_5c21f89f-b0a5-4bee-a497-42c54a46ddf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_caf9f5f0-4a4b-4214-a033-2730843b31f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_d9ec91fe-6204-469d-9ecb-74682ccacb4f" xlink:to="loc_us-gaap_CashFlowHedgingMember_caf9f5f0-4a4b-4214-a033-2730843b31f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_f474208d-12ae-4a9b-83e5-bfd5f55bb6ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_c3140acf-d198-4fe7-9a7e-eee4dd8ec7fc" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_f474208d-12ae-4a9b-83e5-bfd5f55bb6ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_60254f5b-4b57-40b8-b9e2-331b7f7e5dd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_f474208d-12ae-4a9b-83e5-bfd5f55bb6ce" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_60254f5b-4b57-40b8-b9e2-331b7f7e5dd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_732238c1-93cf-477a-b34b-2bb283a3a939" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_f474208d-12ae-4a9b-83e5-bfd5f55bb6ce" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_732238c1-93cf-477a-b34b-2bb283a3a939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_2e2c39af-bb6f-45ac-82dc-b0c3f002c7ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_f474208d-12ae-4a9b-83e5-bfd5f55bb6ce" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_2e2c39af-bb6f-45ac-82dc-b0c3f002c7ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_46a05393-b72f-4060-8007-007dbdaebb9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_269a49b8-143d-4f75-b214-86c5a36b0cea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_46a05393-b72f-4060-8007-007dbdaebb9b" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_269a49b8-143d-4f75-b214-86c5a36b0cea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_18b2f2e6-6136-4ca2-8c34-e46b5cdca026" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_269a49b8-143d-4f75-b214-86c5a36b0cea" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_18b2f2e6-6136-4ca2-8c34-e46b5cdca026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_e0b5f686-774b-4229-a0a6-a959ab9085e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_18b2f2e6-6136-4ca2-8c34-e46b5cdca026" xlink:to="loc_us-gaap_HedgingRelationshipDomain_e0b5f686-774b-4229-a0a6-a959ab9085e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_d19d4df1-e503-4f3d-8265-aa25094c9294" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_e0b5f686-774b-4229-a0a6-a959ab9085e9" xlink:to="loc_us-gaap_CashFlowHedgingMember_d19d4df1-e503-4f3d-8265-aa25094c9294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_5a6923b5-5e88-4b98-8f35-8180e6195b76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_269a49b8-143d-4f75-b214-86c5a36b0cea" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_5a6923b5-5e88-4b98-8f35-8180e6195b76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b6ca6750-6912-4109-88b4-b17d1c2620ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5a6923b5-5e88-4b98-8f35-8180e6195b76" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b6ca6750-6912-4109-88b4-b17d1c2620ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_6bffddf1-69e5-4790-b63d-f34ccc73eceb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b6ca6750-6912-4109-88b4-b17d1c2620ec" xlink:to="loc_us-gaap_ForeignExchangeContractMember_6bffddf1-69e5-4790-b63d-f34ccc73eceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_859d30c2-c981-49ca-acd0-1c42f6d3225b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b6ca6750-6912-4109-88b4-b17d1c2620ec" xlink:to="loc_us-gaap_InterestRateSwapMember_859d30c2-c981-49ca-acd0-1c42f6d3225b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_bc81e2fb-9dd2-4085-9df8-6bd14eb74dcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_269a49b8-143d-4f75-b214-86c5a36b0cea" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_bc81e2fb-9dd2-4085-9df8-6bd14eb74dcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2cc3ad3c-3a65-4131-9e4b-f4e492213c3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_bc81e2fb-9dd2-4085-9df8-6bd14eb74dcd" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2cc3ad3c-3a65-4131-9e4b-f4e492213c3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember_ebca3525-00c8-4c55-8fb6-b55783f99dc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2cc3ad3c-3a65-4131-9e4b-f4e492213c3f" xlink:to="loc_us-gaap_SalesMember_ebca3525-00c8-4c55-8fb6-b55783f99dc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_42f999aa-68d1-4b09-adaa-88fafea679b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2cc3ad3c-3a65-4131-9e4b-f4e492213c3f" xlink:to="loc_us-gaap_InterestExpenseMember_42f999aa-68d1-4b09-adaa-88fafea679b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenseMember_954e480b-e329-41e8-8bc8-6d533a9bbd9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2cc3ad3c-3a65-4131-9e4b-f4e492213c3f" xlink:to="loc_us-gaap_OtherExpenseMember_954e480b-e329-41e8-8bc8-6d533a9bbd9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_8f9b7f4a-d1ef-460b-83b4-3f786e6cd9af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_269a49b8-143d-4f75-b214-86c5a36b0cea" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_8f9b7f4a-d1ef-460b-83b4-3f786e6cd9af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet_31a6ce98-7a45-4726-81e5-444f72fa63a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_8f9b7f4a-d1ef-460b-83b4-3f786e6cd9af" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet_31a6ce98-7a45-4726-81e5-444f72fa63a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_cd166b32-d8a3-43e0-9c3b-0accbadcb6e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_8f9b7f4a-d1ef-460b-83b4-3f786e6cd9af" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_cd166b32-d8a3-43e0-9c3b-0accbadcb6e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_c3863d45-5c90-4ab8-9f40-574911701831" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_8f9b7f4a-d1ef-460b-83b4-3f786e6cd9af" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_c3863d45-5c90-4ab8-9f40-574911701831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_716117b8-aa6c-431d-9a5b-7a6705efc11d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_8f9b7f4a-d1ef-460b-83b4-3f786e6cd9af" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_716117b8-aa6c-431d-9a5b-7a6705efc11d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesNotDesignatedasHedgingInstrumentsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesNotDesignatedasHedgingInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesNotDesignatedasHedgingInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a2488fea-8584-4477-a28a-786a2ab7f5b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_10b31922-3109-411d-881a-b0848b11406e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a2488fea-8584-4477-a28a-786a2ab7f5b5" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_10b31922-3109-411d-881a-b0848b11406e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b92977fe-b1a4-4595-bcea-4554a524ad68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_10b31922-3109-411d-881a-b0848b11406e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b92977fe-b1a4-4595-bcea-4554a524ad68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_152a76f6-2a55-4229-8e49-1504217650d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b92977fe-b1a4-4595-bcea-4554a524ad68" xlink:to="loc_us-gaap_HedgingRelationshipDomain_152a76f6-2a55-4229-8e49-1504217650d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_303a1954-3e26-42d1-aa5f-6e144f22a76f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_152a76f6-2a55-4229-8e49-1504217650d2" xlink:to="loc_us-gaap_CashFlowHedgingMember_303a1954-3e26-42d1-aa5f-6e144f22a76f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_2c2e9cfb-64cd-4436-bf34-8efaa4f54aea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_10b31922-3109-411d-881a-b0848b11406e" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_2c2e9cfb-64cd-4436-bf34-8efaa4f54aea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b1973fc3-c1fe-4417-84a2-dfb13d6b73de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_2c2e9cfb-64cd-4436-bf34-8efaa4f54aea" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b1973fc3-c1fe-4417-84a2-dfb13d6b73de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_d730fce1-b1e2-4b60-9a68-87ab0811464b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b1973fc3-c1fe-4417-84a2-dfb13d6b73de" xlink:to="loc_us-gaap_ForeignExchangeContractMember_d730fce1-b1e2-4b60-9a68-87ab0811464b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_7ef51d6e-8637-402c-93c3-898a10ac5a8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b1973fc3-c1fe-4417-84a2-dfb13d6b73de" xlink:to="loc_us-gaap_InterestRateSwapMember_7ef51d6e-8637-402c-93c3-898a10ac5a8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_28d8846a-9594-4ef7-90f0-dfa71a530050" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_10b31922-3109-411d-881a-b0848b11406e" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_28d8846a-9594-4ef7-90f0-dfa71a530050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c812f693-270a-4770-b4ce-8a677b383fed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_28d8846a-9594-4ef7-90f0-dfa71a530050" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c812f693-270a-4770-b4ce-8a677b383fed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember_adb94f61-2aa0-4c04-8750-84176d858ceb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c812f693-270a-4770-b4ce-8a677b383fed" xlink:to="loc_us-gaap_SalesMember_adb94f61-2aa0-4c04-8750-84176d858ceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_f5af5bd9-16c9-4440-902b-47d192c5d925" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c812f693-270a-4770-b4ce-8a677b383fed" xlink:to="loc_us-gaap_InterestExpenseMember_f5af5bd9-16c9-4440-902b-47d192c5d925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_8488be37-eec9-4e7e-b32a-aaa1abdeda6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_10b31922-3109-411d-881a-b0848b11406e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_8488be37-eec9-4e7e-b32a-aaa1abdeda6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_25bffdcc-09c0-4e6f-9ced-44084502869d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_8488be37-eec9-4e7e-b32a-aaa1abdeda6c" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_25bffdcc-09c0-4e6f-9ced-44084502869d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_d113bf07-fce7-4ab5-8e91-d2a4b17ae77f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_8488be37-eec9-4e7e-b32a-aaa1abdeda6c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_d113bf07-fce7-4ab5-8e91-d2a4b17ae77f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1fbddbe0-6217-4be6-af95-817e7a72eb4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_de93329f-f03e-4025-9153-271d114f400a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1fbddbe0-6217-4be6-af95-817e7a72eb4d" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_de93329f-f03e-4025-9153-271d114f400a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7fd64082-9cef-42cb-a2bc-3cb514673fee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_de93329f-f03e-4025-9153-271d114f400a" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7fd64082-9cef-42cb-a2bc-3cb514673fee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_21bfcc2a-e2f9-4881-9c5a-b5176eb48405" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7fd64082-9cef-42cb-a2bc-3cb514673fee" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_21bfcc2a-e2f9-4881-9c5a-b5176eb48405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_50220a39-3021-412f-b496-e97965065d6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_21bfcc2a-e2f9-4881-9c5a-b5176eb48405" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_50220a39-3021-412f-b496-e97965065d6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_d0fbaf2e-2aa6-442b-bad7-f76c64750c28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_21bfcc2a-e2f9-4881-9c5a-b5176eb48405" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_d0fbaf2e-2aa6-442b-bad7-f76c64750c28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_5ec36a85-cad9-495d-9d12-f876cf38d3b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_21bfcc2a-e2f9-4881-9c5a-b5176eb48405" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_5ec36a85-cad9-495d-9d12-f876cf38d3b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_2c2c93e8-84cf-4ee3-b15f-66b0e5359b77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_de93329f-f03e-4025-9153-271d114f400a" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_2c2c93e8-84cf-4ee3-b15f-66b0e5359b77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_fb0b5d1d-bfec-4db2-ac19-b84fde48760f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_2c2c93e8-84cf-4ee3-b15f-66b0e5359b77" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_fb0b5d1d-bfec-4db2-ac19-b84fde48760f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_9b6e4187-1d8a-46b0-8154-fc3846d3f7cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_fb0b5d1d-bfec-4db2-ac19-b84fde48760f" xlink:to="loc_us-gaap_MoneyMarketFundsMember_9b6e4187-1d8a-46b0-8154-fc3846d3f7cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExchangeTradedFundsMember_337a6792-9a37-42d9-9371-fa41684d1d27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExchangeTradedFundsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_fb0b5d1d-bfec-4db2-ac19-b84fde48760f" xlink:to="loc_us-gaap_ExchangeTradedFundsMember_337a6792-9a37-42d9-9371-fa41684d1d27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_b496af8f-84bc-4c08-8b6d-7239799a4716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_fb0b5d1d-bfec-4db2-ac19-b84fde48760f" xlink:to="loc_us-gaap_DebtSecuritiesMember_b496af8f-84bc-4c08-8b6d-7239799a4716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_ab4d3901-ae43-44bc-bfab-94124425c239" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_b496af8f-84bc-4c08-8b6d-7239799a4716" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_ab4d3901-ae43-44bc-bfab-94124425c239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_9e552933-ad41-4552-b4cb-3dc4270ec72f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_b496af8f-84bc-4c08-8b6d-7239799a4716" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_9e552933-ad41-4552-b4cb-3dc4270ec72f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesMember_bca02b55-4235-4069-9c12-261b6730e7ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageBackedSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_b496af8f-84bc-4c08-8b6d-7239799a4716" xlink:to="loc_us-gaap_MortgageBackedSecuritiesMember_bca02b55-4235-4069-9c12-261b6730e7ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_1460b864-4b2f-48e8-9194-50b7f784dcae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_b496af8f-84bc-4c08-8b6d-7239799a4716" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_1460b864-4b2f-48e8-9194-50b7f784dcae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember_1744ca08-b4ea-4386-b57a-66326df4f1c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_b496af8f-84bc-4c08-8b6d-7239799a4716" xlink:to="loc_us-gaap_OtherDebtSecuritiesMember_1744ca08-b4ea-4386-b57a-66326df4f1c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_43702ef6-79bc-4e4e-933d-5b1ab78cf5ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_fb0b5d1d-bfec-4db2-ac19-b84fde48760f" xlink:to="loc_us-gaap_EquitySecuritiesMember_43702ef6-79bc-4e4e-933d-5b1ab78cf5ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_d3336ea3-fd53-4410-aa2f-b810e35a96ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesMember_43702ef6-79bc-4e4e-933d-5b1ab78cf5ce" xlink:to="loc_us-gaap_CommonStockMember_d3336ea3-fd53-4410-aa2f-b810e35a96ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_962ff65e-50b8-4b6d-a135-3932f19a2bfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_fb0b5d1d-bfec-4db2-ac19-b84fde48760f" xlink:to="loc_us-gaap_InterestRateSwapMember_962ff65e-50b8-4b6d-a135-3932f19a2bfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_MarketableSecuritiesMember_af47ee65-e48a-4954-90cf-7d38d3f55c72" xlink:href="vtrs-20211231.xsd#vtrs_MarketableSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_fb0b5d1d-bfec-4db2-ac19-b84fde48760f" xlink:to="loc_vtrs_MarketableSecuritiesMember_af47ee65-e48a-4954-90cf-7d38d3f55c72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_d099fc6a-9880-4fef-bcb8-72cec41e93cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_de93329f-f03e-4025-9153-271d114f400a" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_d099fc6a-9880-4fef-bcb8-72cec41e93cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_1a987101-cc27-41ae-a1eb-ce3db531f537" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_d099fc6a-9880-4fef-bcb8-72cec41e93cb" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_1a987101-cc27-41ae-a1eb-ce3db531f537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_4fe096e0-0557-4c96-b0c1-373b172935ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_1a987101-cc27-41ae-a1eb-ce3db531f537" xlink:to="loc_us-gaap_ForeignExchangeContractMember_4fe096e0-0557-4c96-b0c1-373b172935ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_d29cec51-e7a5-47ab-a3ef-7b90fb08ff22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_1a987101-cc27-41ae-a1eb-ce3db531f537" xlink:to="loc_us-gaap_InterestRateSwapMember_d29cec51-e7a5-47ab-a3ef-7b90fb08ff22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ContingentConsiderationMember_ffd80bea-abb8-40da-912e-a1cf41582511" xlink:href="vtrs-20211231.xsd#vtrs_ContingentConsiderationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_1a987101-cc27-41ae-a1eb-ce3db531f537" xlink:to="loc_vtrs_ContingentConsiderationMember_ffd80bea-abb8-40da-912e-a1cf41582511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_5cebd3c9-d206-43df-b809-d8b3b1a25866" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_de93329f-f03e-4025-9153-271d114f400a" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_5cebd3c9-d206-43df-b809-d8b3b1a25866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8e3a25d5-a0be-4ce8-b2fe-5863e1076252" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5cebd3c9-d206-43df-b809-d8b3b1a25866" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8e3a25d5-a0be-4ce8-b2fe-5863e1076252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_ce73c7a0-7621-4148-a52c-624fe309ef67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8e3a25d5-a0be-4ce8-b2fe-5863e1076252" xlink:to="loc_us-gaap_ForeignExchangeContractMember_ce73c7a0-7621-4148-a52c-624fe309ef67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1776a89e-c6a4-4ce5-b5bd-bc01cfbb8d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_de93329f-f03e-4025-9153-271d114f400a" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1776a89e-c6a4-4ce5-b5bd-bc01cfbb8d5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_b1e162da-497d-4c47-ae01-a8e8fd4ff59a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1776a89e-c6a4-4ce5-b5bd-bc01cfbb8d5e" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_b1e162da-497d-4c47-ae01-a8e8fd4ff59a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_ef4090fa-9f4d-43a1-8763-a306c284202f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1776a89e-c6a4-4ce5-b5bd-bc01cfbb8d5e" xlink:to="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_ef4090fa-9f4d-43a1-8763-a306c284202f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_75674cc2-46e5-4116-9c4e-15cb9b981568" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1776a89e-c6a4-4ce5-b5bd-bc01cfbb8d5e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_75674cc2-46e5-4116-9c4e-15cb9b981568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_ff3a6207-3c42-4153-ad38-c8bac91833fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1776a89e-c6a4-4ce5-b5bd-bc01cfbb8d5e" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_ff3a6207-3c42-4153-ad38-c8bac91833fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_8b4355b8-4b75-4ed5-bf89-8fff499d72fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1776a89e-c6a4-4ce5-b5bd-bc01cfbb8d5e" xlink:to="loc_us-gaap_DerivativeAssets_8b4355b8-4b75-4ed5-bf89-8fff499d72fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_b9721dce-2962-4cb0-8cbf-34923bd88a5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1776a89e-c6a4-4ce5-b5bd-bc01cfbb8d5e" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_b9721dce-2962-4cb0-8cbf-34923bd88a5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_f84a35c6-735f-4675-9b5d-9d06796b6e50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1776a89e-c6a4-4ce5-b5bd-bc01cfbb8d5e" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_f84a35c6-735f-4675-9b5d-9d06796b6e50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesFairValueDisclosure_80bc0782-18d5-4ce0-a8cb-99361e9ce44c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1776a89e-c6a4-4ce5-b5bd-bc01cfbb8d5e" xlink:to="loc_us-gaap_OtherLiabilitiesFairValueDisclosure_80bc0782-18d5-4ce0-a8cb-99361e9ce44c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_8b234e72-80f4-4697-9ee7-6d56cfd2de41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1776a89e-c6a4-4ce5-b5bd-bc01cfbb8d5e" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_8b234e72-80f4-4697-9ee7-6d56cfd2de41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_a91a19f0-a2e2-4942-bdd0-cb365ff553b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9c48aad7-2ebb-4813-b1cc-5ac3babd93ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_a91a19f0-a2e2-4942-bdd0-cb365ff553b4" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9c48aad7-2ebb-4813-b1cc-5ac3babd93ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1331327b-90ee-462e-9c25-f6f5d41b9229" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9c48aad7-2ebb-4813-b1cc-5ac3babd93ad" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1331327b-90ee-462e-9c25-f6f5d41b9229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_eab3e812-62f6-4dfd-b43c-1ad91d12b964" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1331327b-90ee-462e-9c25-f6f5d41b9229" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_eab3e812-62f6-4dfd-b43c-1ad91d12b964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_JaiPharmaLimitedMember_2ca2dcfa-6909-4af8-93ee-0a2b86383feb" xlink:href="vtrs-20211231.xsd#vtrs_JaiPharmaLimitedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_eab3e812-62f6-4dfd-b43c-1ad91d12b964" xlink:to="loc_vtrs_JaiPharmaLimitedMember_2ca2dcfa-6909-4af8-93ee-0a2b86383feb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_f6286589-beb1-4373-8217-db5d72d7b14a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9c48aad7-2ebb-4813-b1cc-5ac3babd93ad" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_f6286589-beb1-4373-8217-db5d72d7b14a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b6f07e1d-812d-4445-8cd3-8f9841a9c12e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_f6286589-beb1-4373-8217-db5d72d7b14a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b6f07e1d-812d-4445-8cd3-8f9841a9c12e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_ed0c385b-bd81-40e1-8411-0f935e21a2dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b6f07e1d-812d-4445-8cd3-8f9841a9c12e" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_ed0c385b-bd81-40e1-8411-0f935e21a2dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_33008c4f-e3c9-4387-9ed6-84a9e31d886e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b6f07e1d-812d-4445-8cd3-8f9841a9c12e" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_33008c4f-e3c9-4387-9ed6-84a9e31d886e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_db6a6977-344d-4797-b182-49f75dc3e03d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9c48aad7-2ebb-4813-b1cc-5ac3babd93ad" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_db6a6977-344d-4797-b182-49f75dc3e03d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ScheduleofActivityinContingentConsiderationRollForward_301f145d-5565-4c7e-9306-de11fac50ac2" xlink:href="vtrs-20211231.xsd#vtrs_ScheduleofActivityinContingentConsiderationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_db6a6977-344d-4797-b182-49f75dc3e03d" xlink:to="loc_vtrs_ScheduleofActivityinContingentConsiderationRollForward_301f145d-5565-4c7e-9306-de11fac50ac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_24f82200-5051-4d1a-9009-fbdc6e9d0dc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofActivityinContingentConsiderationRollForward_301f145d-5565-4c7e-9306-de11fac50ac2" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_24f82200-5051-4d1a-9009-fbdc6e9d0dc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments_c5d74304-7bba-41f4-9b24-d9529e5396d9" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationContingentConsiderationLiabilityPayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofActivityinContingentConsiderationRollForward_301f145d-5565-4c7e-9306-de11fac50ac2" xlink:to="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments_c5d74304-7bba-41f4-9b24-d9529e5396d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionExpense_3b848909-a56f-4591-9a02-b93e1bc6fdd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofActivityinContingentConsiderationRollForward_301f145d-5565-4c7e-9306-de11fac50ac2" xlink:to="loc_us-gaap_AccretionExpense_3b848909-a56f-4591-9a02-b93e1bc6fdd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications_9ebf5ca0-4d83-4b5e-aace-87ebb09caa65" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofActivityinContingentConsiderationRollForward_301f145d-5565-4c7e-9306-de11fac50ac2" xlink:to="loc_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications_9ebf5ca0-4d83-4b5e-aace-87ebb09caa65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss_0746f2a9-13a6-4273-8ec6-e59016cafe1b" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofActivityinContingentConsiderationRollForward_301f145d-5565-4c7e-9306-de11fac50ac2" xlink:to="loc_vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss_0746f2a9-13a6-4273-8ec6-e59016cafe1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_05278995-f8b3-4cf0-900e-ee3f6e61389c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ScheduleofActivityinContingentConsiderationRollForward_301f145d-5565-4c7e-9306-de11fac50ac2" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_05278995-f8b3-4cf0-900e-ee3f6e61389c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementScheduleofAvailableforsaleSecuritiesReconciliationDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#FinancialInstrumentsandRiskManagementScheduleofAvailableforsaleSecuritiesReconciliationDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementScheduleofAvailableforsaleSecuritiesReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_c2c811f8-bc7a-43a8-a77f-c56a0428a464" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_1ce0a6d2-c5c4-4206-97c3-2e506d589b66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_c2c811f8-bc7a-43a8-a77f-c56a0428a464" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_1ce0a6d2-c5c4-4206-97c3-2e506d589b66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_c3d9914c-0245-4b7b-a078-b8a35cb25500" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_1ce0a6d2-c5c4-4206-97c3-2e506d589b66" xlink:to="loc_us-gaap_FinancialInstrumentAxis_c3d9914c-0245-4b7b-a078-b8a35cb25500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_921b3c8e-c33a-489f-9065-87ab010896dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_c3d9914c-0245-4b7b-a078-b8a35cb25500" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_921b3c8e-c33a-489f-9065-87ab010896dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_bfd6c5c2-e581-4e40-9771-e0297bf1eb17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_921b3c8e-c33a-489f-9065-87ab010896dd" xlink:to="loc_us-gaap_DebtSecuritiesMember_bfd6c5c2-e581-4e40-9771-e0297bf1eb17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_c23f9bce-f9ea-47bf-b313-fd23e7a2b5c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_921b3c8e-c33a-489f-9065-87ab010896dd" xlink:to="loc_us-gaap_EquitySecuritiesMember_c23f9bce-f9ea-47bf-b313-fd23e7a2b5c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0477b712-e176-4a6e-aef4-5e6896603748" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_1ce0a6d2-c5c4-4206-97c3-2e506d589b66" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0477b712-e176-4a6e-aef4-5e6896603748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_8cb6e0b7-ef85-4522-b1b8-c9f8fe92e05f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0477b712-e176-4a6e-aef4-5e6896603748" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_8cb6e0b7-ef85-4522-b1b8-c9f8fe92e05f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_5331d058-e0e1-4a7d-b1eb-bd69f37d1bb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0477b712-e176-4a6e-aef4-5e6896603748" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_5331d058-e0e1-4a7d-b1eb-bd69f37d1bb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_3d4100a7-cb2a-4dee-ac80-8d2201038b26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0477b712-e176-4a6e-aef4-5e6896603748" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_3d4100a7-cb2a-4dee-ac80-8d2201038b26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_4c832308-9c60-41fe-bab2-5f5cac008481" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0477b712-e176-4a6e-aef4-5e6896603748" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_4c832308-9c60-41fe-bab2-5f5cac008481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementMaturitiesofAvailableforsaleDebtSecuritiesatFairValueDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#FinancialInstrumentsandRiskManagementMaturitiesofAvailableforsaleDebtSecuritiesatFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/FinancialInstrumentsandRiskManagementMaturitiesofAvailableforsaleDebtSecuritiesatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0bea341c-da48-47ec-a9c9-9c6af2194f3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_dd0a5c8c-6624-4547-86e1-8f950d8f8a54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0bea341c-da48-47ec-a9c9-9c6af2194f3e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_dd0a5c8c-6624-4547-86e1-8f950d8f8a54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_bd0e8535-3175-4a52-83df-2744929ffdfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0bea341c-da48-47ec-a9c9-9c6af2194f3e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_bd0e8535-3175-4a52-83df-2744929ffdfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAndLaterFairValue_63442192-fbde-422c-9110-fc1cb3a34c86" xlink:href="vtrs-20211231.xsd#vtrs_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAndLaterFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0bea341c-da48-47ec-a9c9-9c6af2194f3e" xlink:to="loc_vtrs_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAndLaterFairValue_63442192-fbde-422c-9110-fc1cb3a34c86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_b4d39613-7f96-4aad-a207-8b3aac2e222d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0bea341c-da48-47ec-a9c9-9c6af2194f3e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_b4d39613-7f96-4aad-a207-8b3aac2e222d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/Debt" xlink:type="simple" xlink:href="vtrs-20211231.xsd#Debt"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/Debt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2be8b524-37ca-41af-bd7b-cbf0880b3dad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_5d5fcfc8-78ce-45b2-99d1-92586a76d3ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2be8b524-37ca-41af-bd7b-cbf0880b3dad" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_5d5fcfc8-78ce-45b2-99d1-92586a76d3ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/DebtTables" xlink:type="simple" xlink:href="vtrs-20211231.xsd#DebtTables"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/DebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_e58d0386-8f6f-47a1-8e90-0096dcbb65ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_c9f3a4fa-5f85-4743-a9a9-b6b5c46fc151" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e58d0386-8f6f-47a1-8e90-0096dcbb65ee" xlink:to="loc_us-gaap_DebtInstrumentTable_c9f3a4fa-5f85-4743-a9a9-b6b5c46fc151" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_76f62fac-0185-46ee-b44e-11a10bbd585e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c9f3a4fa-5f85-4743-a9a9-b6b5c46fc151" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_76f62fac-0185-46ee-b44e-11a10bbd585e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8371f5f8-f90d-49a3-8f8b-122f86b5c510" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_76f62fac-0185-46ee-b44e-11a10bbd585e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8371f5f8-f90d-49a3-8f8b-122f86b5c510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_UpjohnInc.Member_38a070ee-d8b8-4fe7-ac1d-e45b14094743" xlink:href="vtrs-20211231.xsd#vtrs_UpjohnInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8371f5f8-f90d-49a3-8f8b-122f86b5c510" xlink:to="loc_vtrs_UpjohnInc.Member_38a070ee-d8b8-4fe7-ac1d-e45b14094743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_3aa067fb-0b57-45b4-a06a-0114a08f8181" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c9f3a4fa-5f85-4743-a9a9-b6b5c46fc151" xlink:to="loc_us-gaap_DebtInstrumentLineItems_3aa067fb-0b57-45b4-a06a-0114a08f8181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTextBlock_8bfa3c2f-c37a-48a4-8cb8-d698b920ce3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3aa067fb-0b57-45b4-a06a-0114a08f8181" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTextBlock_8bfa3c2f-c37a-48a4-8cb8-d698b920ce3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_a9fcf8f0-e6b3-4161-b6ba-47a60aa48e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3aa067fb-0b57-45b4-a06a-0114a08f8181" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_a9fcf8f0-e6b3-4161-b6ba-47a60aa48e1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_4a11714b-6e2a-48ee-abd4-65a7f5c18644" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3aa067fb-0b57-45b4-a06a-0114a08f8181" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_4a11714b-6e2a-48ee-abd4-65a7f5c18644" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/DebtShorttermborrowingsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#DebtShorttermborrowingsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/DebtShorttermborrowingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_6ce50926-bac2-462a-ac2c-014ee3dfed5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_136d943c-b131-4d18-aa41-be50bd5b0e49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_6ce50926-bac2-462a-ac2c-014ee3dfed5d" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_136d943c-b131-4d18-aa41-be50bd5b0e49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_6db624ac-02a7-4885-a633-ade1bf95a2ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_136d943c-b131-4d18-aa41-be50bd5b0e49" xlink:to="loc_us-gaap_DebtInstrumentAxis_6db624ac-02a7-4885-a633-ade1bf95a2ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ffdd4dd8-0c9e-4187-9fab-2da1f62e8a59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_6db624ac-02a7-4885-a633-ade1bf95a2ee" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ffdd4dd8-0c9e-4187-9fab-2da1f62e8a59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherCurrentPortionofLongtermDebtMember_5d8d4994-423b-4ee0-b40b-5d34c32a192e" xlink:href="vtrs-20211231.xsd#vtrs_OtherCurrentPortionofLongtermDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ffdd4dd8-0c9e-4187-9fab-2da1f62e8a59" xlink:to="loc_vtrs_OtherCurrentPortionofLongtermDebtMember_5d8d4994-423b-4ee0-b40b-5d34c32a192e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_3990d618-c00f-4ad4-8fe3-cdfbbed94f28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_136d943c-b131-4d18-aa41-be50bd5b0e49" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_3990d618-c00f-4ad4-8fe3-cdfbbed94f28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_a1017d6f-8bbe-4651-91a6-cd0166b6d58b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_3990d618-c00f-4ad4-8fe3-cdfbbed94f28" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_a1017d6f-8bbe-4651-91a6-cd0166b6d58b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_d4671623-8df5-4f17-8d2f-9eb4c644dcc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_a1017d6f-8bbe-4651-91a6-cd0166b6d58b" xlink:to="loc_us-gaap_CommercialPaperMember_d4671623-8df5-4f17-8d2f-9eb4c644dcc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ReceivablesFacilityMember_3fc6c5a6-7fbf-4959-b46f-96e4c82419a7" xlink:href="vtrs-20211231.xsd#vtrs_ReceivablesFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_a1017d6f-8bbe-4651-91a6-cd0166b6d58b" xlink:to="loc_vtrs_ReceivablesFacilityMember_3fc6c5a6-7fbf-4959-b46f-96e4c82419a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NoteSecuritizationFacilityMember_b4cdfff3-d1ae-48de-8b34-ed8fbd4beaa7" xlink:href="vtrs-20211231.xsd#vtrs_NoteSecuritizationFacilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_a1017d6f-8bbe-4651-91a6-cd0166b6d58b" xlink:to="loc_vtrs_NoteSecuritizationFacilityMember_b4cdfff3-d1ae-48de-8b34-ed8fbd4beaa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems_08026aea-f2d9-45f2-9a0f-147f81e1cdc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_136d943c-b131-4d18-aa41-be50bd5b0e49" xlink:to="loc_us-gaap_ShortTermDebtLineItems_08026aea-f2d9-45f2-9a0f-147f81e1cdc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_9b56a8ae-3daa-41fb-93f8-27319ee2e0ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_08026aea-f2d9-45f2-9a0f-147f81e1cdc9" xlink:to="loc_us-gaap_ShortTermBorrowings_9b56a8ae-3daa-41fb-93f8-27319ee2e0ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/DebtDebtReceivablesFacilityandCommercialPaperProgramDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#DebtDebtReceivablesFacilityandCommercialPaperProgramDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/DebtDebtReceivablesFacilityandCommercialPaperProgramDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_a80f1638-08bc-4ac9-b336-e0163c99d5a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_3e8531e1-07f3-4c41-a13a-23b81bf8effa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a80f1638-08bc-4ac9-b336-e0163c99d5a7" xlink:to="loc_us-gaap_DebtInstrumentTable_3e8531e1-07f3-4c41-a13a-23b81bf8effa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_d2062d98-e7df-4d4e-a88a-392a23ece241" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3e8531e1-07f3-4c41-a13a-23b81bf8effa" xlink:to="loc_us-gaap_VariableRateAxis_d2062d98-e7df-4d4e-a88a-392a23ece241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_c23cd8c1-5ed9-4462-be11-532b28f1b8d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_d2062d98-e7df-4d4e-a88a-392a23ece241" xlink:to="loc_us-gaap_VariableRateDomain_c23cd8c1-5ed9-4462-be11-532b28f1b8d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_95960be5-7235-4191-8511-4d8484d188ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_c23cd8c1-5ed9-4462-be11-532b28f1b8d3" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_95960be5-7235-4191-8511-4d8484d188ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_1a3798ea-e5ca-49d6-981a-24f09b169e4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3e8531e1-07f3-4c41-a13a-23b81bf8effa" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_1a3798ea-e5ca-49d6-981a-24f09b169e4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_d521b8b4-ab01-4ead-b046-60f37a1ee049" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_1a3798ea-e5ca-49d6-981a-24f09b169e4b" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_d521b8b4-ab01-4ead-b046-60f37a1ee049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ReceivablesFacilityMember_79a0ce9b-784b-4df3-8900-666af735435d" xlink:href="vtrs-20211231.xsd#vtrs_ReceivablesFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_d521b8b4-ab01-4ead-b046-60f37a1ee049" xlink:to="loc_vtrs_ReceivablesFacilityMember_79a0ce9b-784b-4df3-8900-666af735435d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NoteSecuritizationFacilityMember_0b573a2f-24a1-479b-9e36-d74a520a3b87" xlink:href="vtrs-20211231.xsd#vtrs_NoteSecuritizationFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_d521b8b4-ab01-4ead-b046-60f37a1ee049" xlink:to="loc_vtrs_NoteSecuritizationFacilityMember_0b573a2f-24a1-479b-9e36-d74a520a3b87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_6383ebcc-fa64-41ef-91b5-5dd5f0631a2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3e8531e1-07f3-4c41-a13a-23b81bf8effa" xlink:to="loc_us-gaap_DebtInstrumentAxis_6383ebcc-fa64-41ef-91b5-5dd5f0631a2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d2b30c12-b4d6-434e-af53-08e82f091d7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_6383ebcc-fa64-41ef-91b5-5dd5f0631a2d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d2b30c12-b4d6-434e-af53-08e82f091d7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CommercialPaperProgramMember_faa02ec0-0df0-4540-9df1-83c25694a68b" xlink:href="vtrs-20211231.xsd#vtrs_CommercialPaperProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d2b30c12-b4d6-434e-af53-08e82f091d7f" xlink:to="loc_vtrs_CommercialPaperProgramMember_faa02ec0-0df0-4540-9df1-83c25694a68b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_2a935e98-00ba-4cb7-9e07-f7e6ccbf7647" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3e8531e1-07f3-4c41-a13a-23b81bf8effa" xlink:to="loc_us-gaap_DebtInstrumentLineItems_2a935e98-00ba-4cb7-9e07-f7e6ccbf7647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_e550b4b1-3613-46c6-84e4-37871b63bbdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2a935e98-00ba-4cb7-9e07-f7e6ccbf7647" xlink:to="loc_us-gaap_ShortTermBorrowings_e550b4b1-3613-46c6-84e4-37871b63bbdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity_e675e462-4a90-4ff6-ac3f-c8aa4ed46ec6" xlink:href="vtrs-20211231.xsd#vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2a935e98-00ba-4cb7-9e07-f7e6ccbf7647" xlink:to="loc_vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity_e675e462-4a90-4ff6-ac3f-c8aa4ed46ec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_037a8bb5-e852-47a0-8a07-ff05354a8649" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2a935e98-00ba-4cb7-9e07-f7e6ccbf7647" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_037a8bb5-e852-47a0-8a07-ff05354a8649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableFromSecuritization_cd2d6436-076f-43d2-990c-aaedf0dac0d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableFromSecuritization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2a935e98-00ba-4cb7-9e07-f7e6ccbf7647" xlink:to="loc_us-gaap_AccountsReceivableFromSecuritization_cd2d6436-076f-43d2-990c-aaedf0dac0d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_283cc2ce-95e7-432f-9730-d903b1e78a53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2a935e98-00ba-4cb7-9e07-f7e6ccbf7647" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_283cc2ce-95e7-432f-9730-d903b1e78a53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_e0f64533-7601-418b-829a-1e6474ba0209" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2a935e98-00ba-4cb7-9e07-f7e6ccbf7647" xlink:to="loc_us-gaap_DebtInstrumentTerm_e0f64533-7601-418b-829a-1e6474ba0209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#DebtSummaryofLongtermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_709ec760-3581-477c-b339-0af59369aa59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_c16a381a-0bf0-4ef1-8b37-8c32480385d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_709ec760-3581-477c-b339-0af59369aa59" xlink:to="loc_us-gaap_DebtInstrumentTable_c16a381a-0bf0-4ef1-8b37-8c32480385d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f2abd40e-30a1-4d21-a1dc-0ab7e50af1d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c16a381a-0bf0-4ef1-8b37-8c32480385d6" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f2abd40e-30a1-4d21-a1dc-0ab7e50af1d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_866e1d97-23bb-46a6-ac44-5663e453e0ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f2abd40e-30a1-4d21-a1dc-0ab7e50af1d6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_866e1d97-23bb-46a6-ac44-5663e453e0ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_2b4cec8b-ada0-4ba4-8e20-fc3a9705949c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_866e1d97-23bb-46a6-ac44-5663e453e0ad" xlink:to="loc_us-gaap_SeniorNotesMember_2b4cec8b-ada0-4ba4-8e20-fc3a9705949c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CurrentPortionofLongTermDebtMember_eaa20926-c675-44b5-b65e-7a3407e6c470" xlink:href="vtrs-20211231.xsd#vtrs_CurrentPortionofLongTermDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_866e1d97-23bb-46a6-ac44-5663e453e0ad" xlink:to="loc_vtrs_CurrentPortionofLongTermDebtMember_eaa20926-c675-44b5-b65e-7a3407e6c470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_6fd7a2bc-ed23-4be6-b524-3fd084a24822" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c16a381a-0bf0-4ef1-8b37-8c32480385d6" xlink:to="loc_us-gaap_DebtInstrumentAxis_6fd7a2bc-ed23-4be6-b524-3fd084a24822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_6fd7a2bc-ed23-4be6-b524-3fd084a24822" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2016TermLoansMember_47c5361b-8197-4c23-ba16-d193bb0061b8" xlink:href="vtrs-20211231.xsd#vtrs_A2016TermLoansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_A2016TermLoansMember_47c5361b-8197-4c23-ba16-d193bb0061b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherCurrentPortionofLongtermDebtMember_975ad726-d097-4a6a-8d4f-f9977f4656f7" xlink:href="vtrs-20211231.xsd#vtrs_OtherCurrentPortionofLongtermDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_OtherCurrentPortionofLongtermDebtMember_975ad726-d097-4a6a-8d4f-f9977f4656f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandEighteen2.6PercentMember_a9f08922-f0f3-4971-956e-f66ee3d0b838" xlink:href="vtrs-20211231.xsd#vtrs_SeniorNotesTwoThousandEighteen2.6PercentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_SeniorNotesTwoThousandEighteen2.6PercentMember_a9f08922-f0f3-4971-956e-f66ee3d0b838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandEighteen3.0PercentMember_fa563d64-7e62-4093-9e90-0ba94e6e2bdf" xlink:href="vtrs-20211231.xsd#vtrs_SeniorNotesTwoThousandEighteen3.0PercentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_SeniorNotesTwoThousandEighteen3.0PercentMember_fa563d64-7e62-4093-9e90-0ba94e6e2bdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandNineteen2.50PrecentMember_96dec108-18d7-4b2b-9d48-52468ce65cf3" xlink:href="vtrs-20211231.xsd#vtrs_SeniorNotesTwoThousandNineteen2.50PrecentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_SeniorNotesTwoThousandNineteen2.50PrecentMember_96dec108-18d7-4b2b-9d48-52468ce65cf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandNineteenMember_77c24246-6fe3-46e3-8355-6e9a7c9312e4" xlink:href="vtrs-20211231.xsd#vtrs_SeniorNotesTwoThousandNineteenMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_SeniorNotesTwoThousandNineteenMember_77c24246-6fe3-46e3-8355-6e9a7c9312e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2020EuroSeniorNotesMember_003c771f-fc22-43c4-94c5-0033947f3ccf" xlink:href="vtrs-20211231.xsd#vtrs_A2020EuroSeniorNotesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_A2020EuroSeniorNotesMember_003c771f-fc22-43c4-94c5-0033947f3ccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandTwenty3.75PercentMember_9bd7551b-7cb1-4959-85d2-38fc3fc68d19" xlink:href="vtrs-20211231.xsd#vtrs_SeniorNotesTwoThousandTwenty3.75PercentMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_SeniorNotesTwoThousandTwenty3.75PercentMember_9bd7551b-7cb1-4959-85d2-38fc3fc68d19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandTwentyOne3.15PrecentMember_d796927b-788d-483c-9f8b-86955d55eba4" xlink:href="vtrs-20211231.xsd#vtrs_SeniorNotesTwoThousandTwentyOne3.15PrecentMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_SeniorNotesTwoThousandTwentyOne3.15PrecentMember_d796927b-788d-483c-9f8b-86955d55eba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember_e916b0e9-dc84-4548-a4b5-bf8433a16093" xlink:href="vtrs-20211231.xsd#vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember_e916b0e9-dc84-4548-a4b5-bf8433a16093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember_a41c7924-1968-4710-bdc7-1c48be5ba105" xlink:href="vtrs-20211231.xsd#vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember_a41c7924-1968-4710-bdc7-1c48be5ba105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2024EuroSeniorNotesMember_c4616a29-4234-4284-a487-9664b6f1313d" xlink:href="vtrs-20211231.xsd#vtrs_A2024EuroSeniorNotesMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_A2024EuroSeniorNotesMember_c4616a29-4234-4284-a487-9664b6f1313d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2025EuroSeniorNotesMember_f8cb67c7-1f16-49e2-83c4-33aa8d179fb7" xlink:href="vtrs-20211231.xsd#vtrs_A2025EuroSeniorNotesMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_A2025EuroSeniorNotesMember_f8cb67c7-1f16-49e2-83c4-33aa8d179fb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember_13cebd68-b0c4-41c2-9419-8bfa5301190b" xlink:href="vtrs-20211231.xsd#vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember_13cebd68-b0c4-41c2-9419-8bfa5301190b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2028EuroSeniorNotesMember_ee437250-0c6b-4a50-a5d1-973ae6ca6aaa" xlink:href="vtrs-20211231.xsd#vtrs_A2028EuroSeniorNotesMember"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_A2028EuroSeniorNotesMember_ee437250-0c6b-4a50-a5d1-973ae6ca6aaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2028SeniorNotesMember_534ffe97-6654-4075-9365-16877e4464f7" xlink:href="vtrs-20211231.xsd#vtrs_A2028SeniorNotesMember"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_A2028SeniorNotesMember_534ffe97-6654-4075-9365-16877e4464f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandFortyThreeMember_e6d36ad8-0d33-4af6-ade0-81cc7fb0a0f9" xlink:href="vtrs-20211231.xsd#vtrs_SeniorNotesTwoThousandFortyThreeMember"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_SeniorNotesTwoThousandFortyThreeMember_e6d36ad8-0d33-4af6-ade0-81cc7fb0a0f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember_3c889c60-00df-40de-b19f-15df066096a6" xlink:href="vtrs-20211231.xsd#vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember_3c889c60-00df-40de-b19f-15df066096a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2048SeniorNotesMember_337226eb-a623-47c1-a89b-a3ccdf4b4d2c" xlink:href="vtrs-20211231.xsd#vtrs_A2048SeniorNotesMember"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_A2048SeniorNotesMember_337226eb-a623-47c1-a89b-a3ccdf4b4d2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherLongTermDebtMember_5ff9bf97-0f53-48a4-9895-fdfbb5ade778" xlink:href="vtrs-20211231.xsd#vtrs_OtherLongTermDebtMember"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_OtherLongTermDebtMember_5ff9bf97-0f53-48a4-9895-fdfbb5ade778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2020FloatingRateEuroNotesMember_95475139-01c5-4b3a-a9aa-b51e0a4629ab" xlink:href="vtrs-20211231.xsd#vtrs_A2020FloatingRateEuroNotesMember"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_A2020FloatingRateEuroNotesMember_95475139-01c5-4b3a-a9aa-b51e0a4629ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotes2021Member_cdc75a06-3420-41aa-af94-09c820bc1d35" xlink:href="vtrs-20211231.xsd#vtrs_SeniorNotes2021Member"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_SeniorNotes2021Member_cdc75a06-3420-41aa-af94-09c820bc1d35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2022EuroSeniorNotesMember_888fa930-f744-4f60-b0f9-3e1200a71f05" xlink:href="vtrs-20211231.xsd#vtrs_A2022EuroSeniorNotesMember"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_A2022EuroSeniorNotesMember_888fa930-f744-4f60-b0f9-3e1200a71f05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotes2022Member_8d439368-fa90-4c5f-a228-e70742b13691" xlink:href="vtrs-20211231.xsd#vtrs_SeniorNotes2022Member"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_SeniorNotes2022Member_8d439368-fa90-4c5f-a228-e70742b13691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2024EuroSeniorNotes1023Member_f76896ee-7382-409e-b42d-444259e5c63f" xlink:href="vtrs-20211231.xsd#vtrs_A2024EuroSeniorNotes1023Member"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_A2024EuroSeniorNotes1023Member_f76896ee-7382-409e-b42d-444259e5c63f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2027EuroSeniorNotesMember_5779643c-086b-4b45-a880-3ee5e90c0510" xlink:href="vtrs-20211231.xsd#vtrs_A2027EuroSeniorNotesMember"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_A2027EuroSeniorNotesMember_5779643c-086b-4b45-a880-3ee5e90c0510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2027SeniorNotesMember_9efc5bed-61b0-410a-afd6-0dcb3da1d45e" xlink:href="vtrs-20211231.xsd#vtrs_A2027SeniorNotesMember"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_A2027SeniorNotesMember_9efc5bed-61b0-410a-afd6-0dcb3da1d45e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2030SeniorNotesMember_c6a3d908-4260-475c-b712-a700f7aed9b8" xlink:href="vtrs-20211231.xsd#vtrs_A2030SeniorNotesMember"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_A2030SeniorNotesMember_c6a3d908-4260-475c-b712-a700f7aed9b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2032EuroSeniorNotesMember_295f11d0-137a-45a9-9ea6-17b8f52d2bc7" xlink:href="vtrs-20211231.xsd#vtrs_A2032EuroSeniorNotesMember"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_A2032EuroSeniorNotesMember_295f11d0-137a-45a9-9ea6-17b8f52d2bc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2040SeniorNotesMember_d9b11aee-244f-4bbf-9e1b-36fa545dacbd" xlink:href="vtrs-20211231.xsd#vtrs_A2040SeniorNotesMember"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_A2040SeniorNotesMember_d9b11aee-244f-4bbf-9e1b-36fa545dacbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2050SeniorNotesMember_e32165d0-a1da-4add-b74a-739e80e61365" xlink:href="vtrs-20211231.xsd#vtrs_A2050SeniorNotesMember"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_A2050SeniorNotesMember_e32165d0-a1da-4add-b74a-739e80e61365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_TermLoanMember_3c61d431-28dd-4060-a549-2fe7d2914e54" xlink:href="vtrs-20211231.xsd#vtrs_TermLoanMember"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_TermLoanMember_3c61d431-28dd-4060-a549-2fe7d2914e54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2025SeniorNotesMember_6e079f63-5b29-40b9-a4a1-5fd507d5cc1a" xlink:href="vtrs-20211231.xsd#vtrs_A2025SeniorNotesMember"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dba5dda0-dca1-4820-9f28-9a582e3281fa" xlink:to="loc_vtrs_A2025SeniorNotesMember_6e079f63-5b29-40b9-a4a1-5fd507d5cc1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_8d6ccb56-c2f8-4977-8456-ceb826848ac1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c16a381a-0bf0-4ef1-8b37-8c32480385d6" xlink:to="loc_us-gaap_DebtInstrumentLineItems_8d6ccb56-c2f8-4977-8456-ceb826848ac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_560ef60a-560f-4d4b-bccb-d3421ca09a09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8d6ccb56-c2f8-4977-8456-ceb826848ac1" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_560ef60a-560f-4d4b-bccb-d3421ca09a09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_4559750b-9651-42ae-af94-2e258602cfa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8d6ccb56-c2f8-4977-8456-ceb826848ac1" xlink:to="loc_us-gaap_DebtCurrent_4559750b-9651-42ae-af94-2e258602cfa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_74bc677a-3914-4dcf-a9db-7a50f22f4b00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8d6ccb56-c2f8-4977-8456-ceb826848ac1" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_74bc677a-3914-4dcf-a9db-7a50f22f4b00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_927c9e7d-06e7-41f6-87c4-e6dbeced11e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8d6ccb56-c2f8-4977-8456-ceb826848ac1" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_927c9e7d-06e7-41f6-87c4-e6dbeced11e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_4ea8f1a6-97ea-4f95-9b17-40486b511b24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8d6ccb56-c2f8-4977-8456-ceb826848ac1" xlink:to="loc_us-gaap_LongTermDebt_4ea8f1a6-97ea-4f95-9b17-40486b511b24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_3d44fa6c-ade2-43f8-aa5b-cfa025cfd6fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8d6ccb56-c2f8-4977-8456-ceb826848ac1" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_3d44fa6c-ade2-43f8-aa5b-cfa025cfd6fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_230a36c0-63cc-4c06-b014-f14a76218359" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8d6ccb56-c2f8-4977-8456-ceb826848ac1" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_230a36c0-63cc-4c06-b014-f14a76218359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_154d94e1-1f3b-480b-8af6-b4de331a44e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8d6ccb56-c2f8-4977-8456-ceb826848ac1" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_154d94e1-1f3b-480b-8af6-b4de331a44e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_50001572-3914-4b2e-90ef-27052c045367" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8d6ccb56-c2f8-4977-8456-ceb826848ac1" xlink:to="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_50001572-3914-4b2e-90ef-27052c045367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/DebtRevolvingFacilitiesandTermFacilitiesDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#DebtRevolvingFacilitiesandTermFacilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/DebtRevolvingFacilitiesandTermFacilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_f4791197-490d-42c5-a890-4e92a79fb8f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_73e76971-da47-498c-8b8e-dc0b6d0e7278" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f4791197-490d-42c5-a890-4e92a79fb8f8" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_73e76971-da47-498c-8b8e-dc0b6d0e7278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PeriodAxis_ebd87950-41b1-48be-81f7-9d3e31ee7a37" xlink:href="vtrs-20211231.xsd#vtrs_PeriodAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_73e76971-da47-498c-8b8e-dc0b6d0e7278" xlink:to="loc_vtrs_PeriodAxis_ebd87950-41b1-48be-81f7-9d3e31ee7a37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PeriodDomain_22370235-e5a6-4e6c-b673-45aff51a9427" xlink:href="vtrs-20211231.xsd#vtrs_PeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_PeriodAxis_ebd87950-41b1-48be-81f7-9d3e31ee7a37" xlink:to="loc_vtrs_PeriodDomain_22370235-e5a6-4e6c-b673-45aff51a9427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_TrailingFourQuartersMember_3e2f7a1f-894d-42af-a245-9ea89becddbd" xlink:href="vtrs-20211231.xsd#vtrs_TrailingFourQuartersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_PeriodDomain_22370235-e5a6-4e6c-b673-45aff51a9427" xlink:to="loc_vtrs_TrailingFourQuartersMember_3e2f7a1f-894d-42af-a245-9ea89becddbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ThreeFullFiscalQuartersFollowingQualifyingAcquisitionMember_8b32053f-7b8b-49de-9401-0807d6140fd5" xlink:href="vtrs-20211231.xsd#vtrs_ThreeFullFiscalQuartersFollowingQualifyingAcquisitionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_PeriodDomain_22370235-e5a6-4e6c-b673-45aff51a9427" xlink:to="loc_vtrs_ThreeFullFiscalQuartersFollowingQualifyingAcquisitionMember_8b32053f-7b8b-49de-9401-0807d6140fd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_fb051d71-f14c-433a-b1d8-8ed8db4b4920" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_73e76971-da47-498c-8b8e-dc0b6d0e7278" xlink:to="loc_us-gaap_DebtInstrumentAxis_fb051d71-f14c-433a-b1d8-8ed8db4b4920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_cd1be606-4570-4d4f-8c35-f424822e6b5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_fb051d71-f14c-433a-b1d8-8ed8db4b4920" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_cd1be606-4570-4d4f-8c35-f424822e6b5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2016SeniorRevolvingCreditFacilityMember_f17b1e9b-b270-482d-a112-ec44d8bb3cba" xlink:href="vtrs-20211231.xsd#vtrs_A2016SeniorRevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cd1be606-4570-4d4f-8c35-f424822e6b5d" xlink:to="loc_vtrs_A2016SeniorRevolvingCreditFacilityMember_f17b1e9b-b270-482d-a112-ec44d8bb3cba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2016TermLoansMember_bbecf67b-c000-478a-8073-69aef2fea5e8" xlink:href="vtrs-20211231.xsd#vtrs_A2016TermLoansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cd1be606-4570-4d4f-8c35-f424822e6b5d" xlink:to="loc_vtrs_A2016TermLoansMember_bbecf67b-c000-478a-8073-69aef2fea5e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_25ba764a-438a-485b-8986-86f1afca14a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cd1be606-4570-4d4f-8c35-f424822e6b5d" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_25ba764a-438a-485b-8986-86f1afca14a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2018SeniorRevolvingCreditFacilityMember_4f4e1f69-73dc-4119-aaa5-ab59e522e25c" xlink:href="vtrs-20211231.xsd#vtrs_A2018SeniorRevolvingCreditFacilityMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cd1be606-4570-4d4f-8c35-f424822e6b5d" xlink:to="loc_vtrs_A2018SeniorRevolvingCreditFacilityMember_4f4e1f69-73dc-4119-aaa5-ab59e522e25c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d93d3812-aa8e-48f3-8127-6ca6a9d9b678" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_73e76971-da47-498c-8b8e-dc0b6d0e7278" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d93d3812-aa8e-48f3-8127-6ca6a9d9b678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_53192cb7-0e79-4c5b-b664-8321fe2b7390" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d93d3812-aa8e-48f3-8127-6ca6a9d9b678" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_53192cb7-0e79-4c5b-b664-8321fe2b7390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_73c1da56-e45f-47d9-b21f-4c4fd785007a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_53192cb7-0e79-4c5b-b664-8321fe2b7390" xlink:to="loc_us-gaap_LineOfCreditMember_73c1da56-e45f-47d9-b21f-4c4fd785007a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_e9060d2d-5f93-4452-86a3-d7988b1d24af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_73e76971-da47-498c-8b8e-dc0b6d0e7278" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_e9060d2d-5f93-4452-86a3-d7988b1d24af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_c9fe220b-79b3-420e-9515-135316e0f5a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e9060d2d-5f93-4452-86a3-d7988b1d24af" xlink:to="loc_us-gaap_RepaymentsOfDebt_c9fe220b-79b3-420e-9515-135316e0f5a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c140c15f-2579-4e16-b542-437648f8a808" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e9060d2d-5f93-4452-86a3-d7988b1d24af" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c140c15f-2579-4e16-b542-437648f8a808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_4c548081-95d8-4f34-b9ec-deadfece9e07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e9060d2d-5f93-4452-86a3-d7988b1d24af" xlink:to="loc_us-gaap_DebtCurrent_4c548081-95d8-4f34-b9ec-deadfece9e07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCovenantDescription_e214a9b7-e116-4933-a954-49bce577048a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCovenantDescription"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e9060d2d-5f93-4452-86a3-d7988b1d24af" xlink:to="loc_us-gaap_DebtInstrumentCovenantDescription_e214a9b7-e116-4933-a954-49bce577048a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/DebtIssuanceof2018SeniorNotesDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#DebtIssuanceof2018SeniorNotesDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/DebtIssuanceof2018SeniorNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_0bc04db0-55d2-4d63-8d42-bb8d6660be77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_332f26ed-be3a-4dde-ab37-f980d76c6fa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0bc04db0-55d2-4d63-8d42-bb8d6660be77" xlink:to="loc_us-gaap_DebtInstrumentTable_332f26ed-be3a-4dde-ab37-f980d76c6fa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_65fbe88b-b668-417c-95dd-dee7c8337262" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_332f26ed-be3a-4dde-ab37-f980d76c6fa2" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_65fbe88b-b668-417c-95dd-dee7c8337262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_afa31f81-2a1e-422c-a549-fe7b0d47ef8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_65fbe88b-b668-417c-95dd-dee7c8337262" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_afa31f81-2a1e-422c-a549-fe7b0d47ef8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_3da66208-b1b2-4030-ac5f-fc209b9ce8b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_afa31f81-2a1e-422c-a549-fe7b0d47ef8a" xlink:to="loc_us-gaap_SeniorNotesMember_3da66208-b1b2-4030-ac5f-fc209b9ce8b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d4b5a6b8-599e-4fdd-9f27-adf19fbf964d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_332f26ed-be3a-4dde-ab37-f980d76c6fa2" xlink:to="loc_us-gaap_DebtInstrumentAxis_d4b5a6b8-599e-4fdd-9f27-adf19fbf964d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_809e2612-d38f-4c46-8234-28b05ec3361d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_d4b5a6b8-599e-4fdd-9f27-adf19fbf964d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_809e2612-d38f-4c46-8234-28b05ec3361d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2028SeniorNotesMember_0acdc0aa-e78d-4c27-9c81-23e3fb903309" xlink:href="vtrs-20211231.xsd#vtrs_A2028SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_809e2612-d38f-4c46-8234-28b05ec3361d" xlink:to="loc_vtrs_A2028SeniorNotesMember_0acdc0aa-e78d-4c27-9c81-23e3fb903309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2048SeniorNotesMember_92093a5c-10ea-4370-88f9-0c5f44dfb067" xlink:href="vtrs-20211231.xsd#vtrs_A2048SeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_809e2612-d38f-4c46-8234-28b05ec3361d" xlink:to="loc_vtrs_A2048SeniorNotesMember_92093a5c-10ea-4370-88f9-0c5f44dfb067" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_April2018SeniorNotesMember_01c083fd-629f-4c8b-95ce-87edccc4a869" xlink:href="vtrs-20211231.xsd#vtrs_April2018SeniorNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_809e2612-d38f-4c46-8234-28b05ec3361d" xlink:to="loc_vtrs_April2018SeniorNotesMember_01c083fd-629f-4c8b-95ce-87edccc4a869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_b0efe726-c3ab-44fd-8895-31a58d46ac1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_332f26ed-be3a-4dde-ab37-f980d76c6fa2" xlink:to="loc_us-gaap_DebtInstrumentLineItems_b0efe726-c3ab-44fd-8895-31a58d46ac1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_3c7c6d96-7083-4ea6-a139-68f77a709478" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b0efe726-c3ab-44fd-8895-31a58d46ac1b" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_3c7c6d96-7083-4ea6-a139-68f77a709478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_828a063e-1178-4af8-8326-6fa57ed6bcc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b0efe726-c3ab-44fd-8895-31a58d46ac1b" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_828a063e-1178-4af8-8326-6fa57ed6bcc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_57a0db70-45fd-4ea1-b80f-e5be62fb4b6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b0efe726-c3ab-44fd-8895-31a58d46ac1b" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_57a0db70-45fd-4ea1-b80f-e5be62fb4b6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/DebtSeniorNotesDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#DebtSeniorNotesDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/DebtSeniorNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_47720d16-a5e3-42e1-83a3-a96b9a45f148" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_8d342224-1d27-4010-9475-94ceba41fbc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_47720d16-a5e3-42e1-83a3-a96b9a45f148" xlink:to="loc_us-gaap_DebtInstrumentTable_8d342224-1d27-4010-9475-94ceba41fbc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_ea4d7a2f-355c-4a03-b2c0-8119c8f5a239" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8d342224-1d27-4010-9475-94ceba41fbc9" xlink:to="loc_us-gaap_VariableRateAxis_ea4d7a2f-355c-4a03-b2c0-8119c8f5a239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_8baf1d63-dae4-4d33-92ee-a3d5ebe37fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_ea4d7a2f-355c-4a03-b2c0-8119c8f5a239" xlink:to="loc_us-gaap_VariableRateDomain_8baf1d63-dae4-4d33-92ee-a3d5ebe37fc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EURIBORMember_fad02dd7-45af-45d8-b694-d29b15275309" xlink:href="vtrs-20211231.xsd#vtrs_EURIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_8baf1d63-dae4-4d33-92ee-a3d5ebe37fc4" xlink:to="loc_vtrs_EURIBORMember_fad02dd7-45af-45d8-b694-d29b15275309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_118c51fe-c80d-4ae2-8a4b-43da6c789e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8d342224-1d27-4010-9475-94ceba41fbc9" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_118c51fe-c80d-4ae2-8a4b-43da6c789e5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7dfbd2f4-602f-4f17-b207-24dcff390b6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_118c51fe-c80d-4ae2-8a4b-43da6c789e5b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7dfbd2f4-602f-4f17-b207-24dcff390b6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_4e692ddd-a09c-42c4-99df-24cc7a29e7e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7dfbd2f4-602f-4f17-b207-24dcff390b6a" xlink:to="loc_us-gaap_SeniorNotesMember_4e692ddd-a09c-42c4-99df-24cc7a29e7e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_8b9c3c39-721d-4f95-b56a-5a895074c403" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7dfbd2f4-602f-4f17-b207-24dcff390b6a" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_8b9c3c39-721d-4f95-b56a-5a895074c403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_ba28db9f-821f-40e6-a6ab-8e75955bb7af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MediumTermNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7dfbd2f4-602f-4f17-b207-24dcff390b6a" xlink:to="loc_us-gaap_MediumTermNotesMember_ba28db9f-821f-40e6-a6ab-8e75955bb7af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_3dd5795d-9816-4b24-9d68-085da7db8991" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8d342224-1d27-4010-9475-94ceba41fbc9" xlink:to="loc_us-gaap_DebtInstrumentAxis_3dd5795d-9816-4b24-9d68-085da7db8991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1e704dc3-d0dd-484a-9004-dbbba50652ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_3dd5795d-9816-4b24-9d68-085da7db8991" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1e704dc3-d0dd-484a-9004-dbbba50652ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandEighteen2.6PercentMember_e9b3f3f9-6ca0-490d-a33f-f4d7327a95d4" xlink:href="vtrs-20211231.xsd#vtrs_SeniorNotesTwoThousandEighteen2.6PercentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e704dc3-d0dd-484a-9004-dbbba50652ec" xlink:to="loc_vtrs_SeniorNotesTwoThousandEighteen2.6PercentMember_e9b3f3f9-6ca0-490d-a33f-f4d7327a95d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2020FloatingRateEuroNotesMember_a61071dd-dc1c-49ff-ba9d-f9a26e8b4501" xlink:href="vtrs-20211231.xsd#vtrs_A2020FloatingRateEuroNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e704dc3-d0dd-484a-9004-dbbba50652ec" xlink:to="loc_vtrs_A2020FloatingRateEuroNotesMember_a61071dd-dc1c-49ff-ba9d-f9a26e8b4501" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2020EuroSeniorNotesMember_f6328399-6de3-403a-b521-b8bca06d1068" xlink:href="vtrs-20211231.xsd#vtrs_A2020EuroSeniorNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e704dc3-d0dd-484a-9004-dbbba50652ec" xlink:to="loc_vtrs_A2020EuroSeniorNotesMember_f6328399-6de3-403a-b521-b8bca06d1068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2024EuroSeniorNotesMember_92d50647-e28c-4b0a-afad-38e86df1590e" xlink:href="vtrs-20211231.xsd#vtrs_A2024EuroSeniorNotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e704dc3-d0dd-484a-9004-dbbba50652ec" xlink:to="loc_vtrs_A2024EuroSeniorNotesMember_92d50647-e28c-4b0a-afad-38e86df1590e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2028EuroSeniorNotesMember_d0a81bb9-5f72-4ef0-a174-1f979b031d01" xlink:href="vtrs-20211231.xsd#vtrs_A2028EuroSeniorNotesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e704dc3-d0dd-484a-9004-dbbba50652ec" xlink:to="loc_vtrs_A2028EuroSeniorNotesMember_d0a81bb9-5f72-4ef0-a174-1f979b031d01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandEighteen3.0PercentMember_15201495-4847-49a8-8326-04172e7ed2ad" xlink:href="vtrs-20211231.xsd#vtrs_SeniorNotesTwoThousandEighteen3.0PercentMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e704dc3-d0dd-484a-9004-dbbba50652ec" xlink:to="loc_vtrs_SeniorNotesTwoThousandEighteen3.0PercentMember_15201495-4847-49a8-8326-04172e7ed2ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandNineteenMember_94e71f00-6816-47e4-885f-f39310530e15" xlink:href="vtrs-20211231.xsd#vtrs_SeniorNotesTwoThousandNineteenMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e704dc3-d0dd-484a-9004-dbbba50652ec" xlink:to="loc_vtrs_SeniorNotesTwoThousandNineteenMember_94e71f00-6816-47e4-885f-f39310530e15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SeniorNotesTwoThousandNineteen2.50PrecentMember_70084bb7-4486-46da-9a71-1dfdecac2620" xlink:href="vtrs-20211231.xsd#vtrs_SeniorNotesTwoThousandNineteen2.50PrecentMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e704dc3-d0dd-484a-9004-dbbba50652ec" xlink:to="loc_vtrs_SeniorNotesTwoThousandNineteen2.50PrecentMember_70084bb7-4486-46da-9a71-1dfdecac2620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2028SeniorNotesMember_e698de5e-34fc-404a-9e98-945a16ccd7fe" xlink:href="vtrs-20211231.xsd#vtrs_A2028SeniorNotesMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e704dc3-d0dd-484a-9004-dbbba50652ec" xlink:to="loc_vtrs_A2028SeniorNotesMember_e698de5e-34fc-404a-9e98-945a16ccd7fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2048SeniorNotesMember_ebb0e3ad-4428-4f53-aac5-41ea3095db5b" xlink:href="vtrs-20211231.xsd#vtrs_A2048SeniorNotesMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e704dc3-d0dd-484a-9004-dbbba50652ec" xlink:to="loc_vtrs_A2048SeniorNotesMember_ebb0e3ad-4428-4f53-aac5-41ea3095db5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2025EuroSeniorNotesMember_8f41f29a-ff68-4ad8-80f5-e4abf3430a8c" xlink:href="vtrs-20211231.xsd#vtrs_A2025EuroSeniorNotesMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e704dc3-d0dd-484a-9004-dbbba50652ec" xlink:to="loc_vtrs_A2025EuroSeniorNotesMember_8f41f29a-ff68-4ad8-80f5-e4abf3430a8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_TwentyTwentyOneRevolvingFacilityMember_c73b5e81-3c58-4764-9f20-ec00ab1f5771" xlink:href="vtrs-20211231.xsd#vtrs_TwentyTwentyOneRevolvingFacilityMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e704dc3-d0dd-484a-9004-dbbba50652ec" xlink:to="loc_vtrs_TwentyTwentyOneRevolvingFacilityMember_c73b5e81-3c58-4764-9f20-ec00ab1f5771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_YENTermLoanMember_753225a7-00ed-4ede-8212-dd5557438aba" xlink:href="vtrs-20211231.xsd#vtrs_YENTermLoanMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e704dc3-d0dd-484a-9004-dbbba50652ec" xlink:to="loc_vtrs_YENTermLoanMember_753225a7-00ed-4ede-8212-dd5557438aba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_TwentyTwentyOneLoanFacilitiesMember_52810c8d-e340-4c5c-8961-481945ddb3e9" xlink:href="vtrs-20211231.xsd#vtrs_TwentyTwentyOneLoanFacilitiesMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e704dc3-d0dd-484a-9004-dbbba50652ec" xlink:to="loc_vtrs_TwentyTwentyOneLoanFacilitiesMember_52810c8d-e340-4c5c-8961-481945ddb3e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_USDTermLoanFacilityMember_e20cc8cf-60b4-4eac-ab7a-83b37bce03f5" xlink:href="vtrs-20211231.xsd#vtrs_USDTermLoanFacilityMember"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e704dc3-d0dd-484a-9004-dbbba50652ec" xlink:to="loc_vtrs_USDTermLoanFacilityMember_e20cc8cf-60b4-4eac-ab7a-83b37bce03f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2020RevolvingFacilityMember_e42864ec-3b7e-485c-b005-e90879d31a0d" xlink:href="vtrs-20211231.xsd#vtrs_A2020RevolvingFacilityMember"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e704dc3-d0dd-484a-9004-dbbba50652ec" xlink:to="loc_vtrs_A2020RevolvingFacilityMember_e42864ec-3b7e-485c-b005-e90879d31a0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cfb4e26a-bfaf-43c0-aabc-2f44fee9428b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8d342224-1d27-4010-9475-94ceba41fbc9" xlink:to="loc_srt_RangeAxis_cfb4e26a-bfaf-43c0-aabc-2f44fee9428b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a0ef7d15-dd29-433e-894d-a23094b4146d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_cfb4e26a-bfaf-43c0-aabc-2f44fee9428b" xlink:to="loc_srt_RangeMember_a0ef7d15-dd29-433e-894d-a23094b4146d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_11086e26-010b-46d4-b607-e5bb3ae52cd6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a0ef7d15-dd29-433e-894d-a23094b4146d" xlink:to="loc_srt_MinimumMember_11086e26-010b-46d4-b607-e5bb3ae52cd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_d354ffd1-2983-45fb-a468-98cdff4b37e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8d342224-1d27-4010-9475-94ceba41fbc9" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_d354ffd1-2983-45fb-a468-98cdff4b37e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1c874272-a743-48c7-ac52-82a99eb428ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d354ffd1-2983-45fb-a468-98cdff4b37e0" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1c874272-a743-48c7-ac52-82a99eb428ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_UpjohnInc.Member_c6baaf61-0370-45b4-b916-ba616c6c6739" xlink:href="vtrs-20211231.xsd#vtrs_UpjohnInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1c874272-a743-48c7-ac52-82a99eb428ab" xlink:to="loc_vtrs_UpjohnInc.Member_c6baaf61-0370-45b4-b916-ba616c6c6739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_86e06ebe-2d57-4c19-a753-fc64e0238da0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8d342224-1d27-4010-9475-94ceba41fbc9" xlink:to="loc_us-gaap_DebtInstrumentLineItems_86e06ebe-2d57-4c19-a753-fc64e0238da0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_55962702-5e7f-453b-847c-674f0c174510" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_86e06ebe-2d57-4c19-a753-fc64e0238da0" xlink:to="loc_us-gaap_RepaymentsOfDebt_55962702-5e7f-453b-847c-674f0c174510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_666de966-d8a0-436b-8d50-6bd0096ecce0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_86e06ebe-2d57-4c19-a753-fc64e0238da0" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_666de966-d8a0-436b-8d50-6bd0096ecce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a4ee7cfe-d5c4-4836-8fb5-e982225b513c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_86e06ebe-2d57-4c19-a753-fc64e0238da0" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a4ee7cfe-d5c4-4836-8fb5-e982225b513c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_841a0b32-c1fa-4dcb-afd2-d7f2419aef53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_86e06ebe-2d57-4c19-a753-fc64e0238da0" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_841a0b32-c1fa-4dcb-afd2-d7f2419aef53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_f16bd6bb-5441-4e61-8c99-2b215a254f02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_86e06ebe-2d57-4c19-a753-fc64e0238da0" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_f16bd6bb-5441-4e61-8c99-2b215a254f02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_526ffed4-bdee-4632-a48a-bfeb1468fc89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_86e06ebe-2d57-4c19-a753-fc64e0238da0" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_526ffed4-bdee-4632-a48a-bfeb1468fc89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_e7a3983c-2390-4f29-b6f7-46519501b241" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_86e06ebe-2d57-4c19-a753-fc64e0238da0" xlink:to="loc_us-gaap_LongTermDebt_e7a3983c-2390-4f29-b6f7-46519501b241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_5d955d11-246a-451a-8340-8da8d24ca49f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_86e06ebe-2d57-4c19-a753-fc64e0238da0" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_5d955d11-246a-451a-8340-8da8d24ca49f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_748611d9-a7ee-4044-84f0-cf08cb7d6c64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_86e06ebe-2d57-4c19-a753-fc64e0238da0" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_748611d9-a7ee-4044-84f0-cf08cb7d6c64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_MaximumLeverageRatioPeriodTwo_b4756dfa-e5cc-4355-a7f9-ad31274442e7" xlink:href="vtrs-20211231.xsd#vtrs_MaximumLeverageRatioPeriodTwo"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_86e06ebe-2d57-4c19-a753-fc64e0238da0" xlink:to="loc_vtrs_MaximumLeverageRatioPeriodTwo_b4756dfa-e5cc-4355-a7f9-ad31274442e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_MaximumLeverageRatioPeriodOne_ef742b4b-9376-4a65-83d4-d636162908cd" xlink:href="vtrs-20211231.xsd#vtrs_MaximumLeverageRatioPeriodOne"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_86e06ebe-2d57-4c19-a753-fc64e0238da0" xlink:to="loc_vtrs_MaximumLeverageRatioPeriodOne_ef742b4b-9376-4a65-83d4-d636162908cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_MaximumLeverageRatioPeriodThree_f45b8290-1594-4842-b6bf-40ab6d4253db" xlink:href="vtrs-20211231.xsd#vtrs_MaximumLeverageRatioPeriodThree"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_86e06ebe-2d57-4c19-a753-fc64e0238da0" xlink:to="loc_vtrs_MaximumLeverageRatioPeriodThree_f45b8290-1594-4842-b6bf-40ab6d4253db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/DebtFairValueNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#DebtFairValueNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/DebtFairValueNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_ba97e1f0-4274-4e94-a57c-2355a08c54cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_df4d70b3-489d-42a9-a90f-50632e6d6e15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ba97e1f0-4274-4e94-a57c-2355a08c54cf" xlink:to="loc_us-gaap_DebtInstrumentTable_df4d70b3-489d-42a9-a90f-50632e6d6e15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_73a22811-d82f-4521-9da3-4f02335012fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_df4d70b3-489d-42a9-a90f-50632e6d6e15" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_73a22811-d82f-4521-9da3-4f02335012fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_acbea7a0-b9df-4124-a60e-56f4a045d172" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_73a22811-d82f-4521-9da3-4f02335012fd" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_acbea7a0-b9df-4124-a60e-56f4a045d172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_535ef052-c0fd-42cc-8a0c-fe7bbbba5215" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_acbea7a0-b9df-4124-a60e-56f4a045d172" xlink:to="loc_us-gaap_SeniorNotesMember_535ef052-c0fd-42cc-8a0c-fe7bbbba5215" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b07d70ac-c9ca-4a2a-be21-a4b152926a7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_df4d70b3-489d-42a9-a90f-50632e6d6e15" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b07d70ac-c9ca-4a2a-be21-a4b152926a7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_af658dee-5ec5-4729-afca-816adef3cb18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b07d70ac-c9ca-4a2a-be21-a4b152926a7c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_af658dee-5ec5-4729-afca-816adef3cb18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_UpjohnInc.Member_b7353107-828c-49da-86dd-08c20e446d0c" xlink:href="vtrs-20211231.xsd#vtrs_UpjohnInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_af658dee-5ec5-4729-afca-816adef3cb18" xlink:to="loc_vtrs_UpjohnInc.Member_b7353107-828c-49da-86dd-08c20e446d0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_3c8982ad-1166-4899-b93d-4540d73cf2bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_df4d70b3-489d-42a9-a90f-50632e6d6e15" xlink:to="loc_us-gaap_DebtInstrumentLineItems_3c8982ad-1166-4899-b93d-4540d73cf2bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_9611de80-26ab-4af6-8966-b4c330dc5a6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3c8982ad-1166-4899-b93d-4540d73cf2bb" xlink:to="loc_us-gaap_DebtInstrumentFairValue_9611de80-26ab-4af6-8966-b4c330dc5a6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_89278c80-cea0-41d9-a416-7e4802e4d654" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3c8982ad-1166-4899-b93d-4540d73cf2bb" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_89278c80-cea0-41d9-a416-7e4802e4d654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/DebtUpjohnSeniorNotesDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#DebtUpjohnSeniorNotesDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/DebtUpjohnSeniorNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_8a70acaa-bb21-45dc-9864-98923d6ceaee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_6ce807e4-eb29-425f-8a68-04300db5bfef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8a70acaa-bb21-45dc-9864-98923d6ceaee" xlink:to="loc_us-gaap_DebtInstrumentTable_6ce807e4-eb29-425f-8a68-04300db5bfef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f4c84bd3-829f-4e79-beac-424c23913628" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6ce807e4-eb29-425f-8a68-04300db5bfef" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f4c84bd3-829f-4e79-beac-424c23913628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c225c772-f6f6-433e-94e7-c0ab2dc521fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f4c84bd3-829f-4e79-beac-424c23913628" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c225c772-f6f6-433e-94e7-c0ab2dc521fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_UpjohnInc.Member_51ccb382-35f2-4ed1-9554-fa3c0cb41504" xlink:href="vtrs-20211231.xsd#vtrs_UpjohnInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c225c772-f6f6-433e-94e7-c0ab2dc521fb" xlink:to="loc_vtrs_UpjohnInc.Member_51ccb382-35f2-4ed1-9554-fa3c0cb41504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_df71c24d-2009-42cc-ae41-729a9c8fe04f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6ce807e4-eb29-425f-8a68-04300db5bfef" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_df71c24d-2009-42cc-ae41-729a9c8fe04f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e05c9604-9c13-43ea-af92-ba60fda2bc43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_df71c24d-2009-42cc-ae41-729a9c8fe04f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e05c9604-9c13-43ea-af92-ba60fda2bc43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_0b685904-0e46-4dbf-b555-1f3306fc9040" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e05c9604-9c13-43ea-af92-ba60fda2bc43" xlink:to="loc_us-gaap_SeniorNotesMember_0b685904-0e46-4dbf-b555-1f3306fc9040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_116e032f-cbe6-4ff1-8e79-7357031bbbb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6ce807e4-eb29-425f-8a68-04300db5bfef" xlink:to="loc_us-gaap_DebtInstrumentAxis_116e032f-cbe6-4ff1-8e79-7357031bbbb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_35dc5be7-2d12-41c2-a7ae-e89af62f6759" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_116e032f-cbe6-4ff1-8e79-7357031bbbb2" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_35dc5be7-2d12-41c2-a7ae-e89af62f6759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2022SeniorNotesMember_4c01c556-3c29-404e-bb86-97ff9df049d0" xlink:href="vtrs-20211231.xsd#vtrs_A2022SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35dc5be7-2d12-41c2-a7ae-e89af62f6759" xlink:to="loc_vtrs_A2022SeniorNotesMember_4c01c556-3c29-404e-bb86-97ff9df049d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2025SeniorNotesMember_2bc84c35-c933-491c-bc0a-43cad2be7048" xlink:href="vtrs-20211231.xsd#vtrs_A2025SeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35dc5be7-2d12-41c2-a7ae-e89af62f6759" xlink:to="loc_vtrs_A2025SeniorNotesMember_2bc84c35-c933-491c-bc0a-43cad2be7048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2027SeniorNotesMember_a5d26553-6974-4cda-973c-1867d104a761" xlink:href="vtrs-20211231.xsd#vtrs_A2027SeniorNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35dc5be7-2d12-41c2-a7ae-e89af62f6759" xlink:to="loc_vtrs_A2027SeniorNotesMember_a5d26553-6974-4cda-973c-1867d104a761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2030SeniorNotesMember_e3affc6e-7fff-42df-b9cf-3e78a8133f9d" xlink:href="vtrs-20211231.xsd#vtrs_A2030SeniorNotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35dc5be7-2d12-41c2-a7ae-e89af62f6759" xlink:to="loc_vtrs_A2030SeniorNotesMember_e3affc6e-7fff-42df-b9cf-3e78a8133f9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2040SeniorNotesMember_9a170bf8-bd3b-4c5f-ad06-aa1f4c03a543" xlink:href="vtrs-20211231.xsd#vtrs_A2040SeniorNotesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35dc5be7-2d12-41c2-a7ae-e89af62f6759" xlink:to="loc_vtrs_A2040SeniorNotesMember_9a170bf8-bd3b-4c5f-ad06-aa1f4c03a543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2050SeniorNotesMember_f6a2e7c2-7d26-49bf-920f-149bf5cfb3b2" xlink:href="vtrs-20211231.xsd#vtrs_A2050SeniorNotesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35dc5be7-2d12-41c2-a7ae-e89af62f6759" xlink:to="loc_vtrs_A2050SeniorNotesMember_f6a2e7c2-7d26-49bf-920f-149bf5cfb3b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2022EuroSeniorNotesMember_d95c941c-7869-4857-a464-24086cb85127" xlink:href="vtrs-20211231.xsd#vtrs_A2022EuroSeniorNotesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35dc5be7-2d12-41c2-a7ae-e89af62f6759" xlink:to="loc_vtrs_A2022EuroSeniorNotesMember_d95c941c-7869-4857-a464-24086cb85127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2027EuroSeniorNotesMember_5164bdad-24bb-4081-af38-1b4950e8f789" xlink:href="vtrs-20211231.xsd#vtrs_A2027EuroSeniorNotesMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35dc5be7-2d12-41c2-a7ae-e89af62f6759" xlink:to="loc_vtrs_A2027EuroSeniorNotesMember_5164bdad-24bb-4081-af38-1b4950e8f789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2024EuroSeniorNotesMember_358ee39e-1a1f-42cc-aa1e-9c9549ba7635" xlink:href="vtrs-20211231.xsd#vtrs_A2024EuroSeniorNotesMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35dc5be7-2d12-41c2-a7ae-e89af62f6759" xlink:to="loc_vtrs_A2024EuroSeniorNotesMember_358ee39e-1a1f-42cc-aa1e-9c9549ba7635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2032EuroSeniorNotesMember_425f3c98-ab75-4a9b-b086-7016063bb18e" xlink:href="vtrs-20211231.xsd#vtrs_A2032EuroSeniorNotesMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35dc5be7-2d12-41c2-a7ae-e89af62f6759" xlink:to="loc_vtrs_A2032EuroSeniorNotesMember_425f3c98-ab75-4a9b-b086-7016063bb18e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_UpjohnEuroNotesMember_d65beb55-eba8-4ee9-89ec-fc770c1eaa32" xlink:href="vtrs-20211231.xsd#vtrs_UpjohnEuroNotesMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35dc5be7-2d12-41c2-a7ae-e89af62f6759" xlink:to="loc_vtrs_UpjohnEuroNotesMember_d65beb55-eba8-4ee9-89ec-fc770c1eaa32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_UnregisteredUpjohnUSDollarNotesMember_930f4875-d546-4cf4-afa6-265fb9cd7ed1" xlink:href="vtrs-20211231.xsd#vtrs_UnregisteredUpjohnUSDollarNotesMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35dc5be7-2d12-41c2-a7ae-e89af62f6759" xlink:to="loc_vtrs_UnregisteredUpjohnUSDollarNotesMember_930f4875-d546-4cf4-afa6-265fb9cd7ed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_0b473132-8d62-41cc-a025-f66ccddba213" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6ce807e4-eb29-425f-8a68-04300db5bfef" xlink:to="loc_us-gaap_DebtInstrumentLineItems_0b473132-8d62-41cc-a025-f66ccddba213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_25c6d7ab-b47c-4449-9251-1ae9752e23d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0b473132-8d62-41cc-a025-f66ccddba213" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_25c6d7ab-b47c-4449-9251-1ae9752e23d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DebtInstrumentConversionOfUnregisteredNotesToRegisteredNotesAsAPercentage_f2601128-a445-4699-b67e-bd81ce1a77ba" xlink:href="vtrs-20211231.xsd#vtrs_DebtInstrumentConversionOfUnregisteredNotesToRegisteredNotesAsAPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0b473132-8d62-41cc-a025-f66ccddba213" xlink:to="loc_vtrs_DebtInstrumentConversionOfUnregisteredNotesToRegisteredNotesAsAPercentage_f2601128-a445-4699-b67e-bd81ce1a77ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#DebtMinimumRepaymentsonOutstandingBorrowingsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_a099289e-c16c-430f-adbf-e64d824de699" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_e7fc033b-feb6-4e30-a219-b85ff2cd5704" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a099289e-c16c-430f-adbf-e64d824de699" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_e7fc033b-feb6-4e30-a219-b85ff2cd5704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_2370f5de-21e3-46c3-9c74-601bec78fda5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a099289e-c16c-430f-adbf-e64d824de699" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_2370f5de-21e3-46c3-9c74-601bec78fda5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_b80202ff-891d-4a7c-8937-f97bf0d965c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a099289e-c16c-430f-adbf-e64d824de699" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_b80202ff-891d-4a7c-8937-f97bf0d965c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_40c03013-fc64-442c-8f33-08991374f38b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a099289e-c16c-430f-adbf-e64d824de699" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_40c03013-fc64-442c-8f33-08991374f38b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_13581dfc-2a7f-44a3-8431-774a464c369c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a099289e-c16c-430f-adbf-e64d824de699" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_13581dfc-2a7f-44a3-8431-774a464c369c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_b8a7ae8b-ffbc-4abe-81fd-b4a077c8919e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a099289e-c16c-430f-adbf-e64d824de699" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_b8a7ae8b-ffbc-4abe-81fd-b4a077c8919e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_711d1b4b-2298-4df7-b248-eb35d8b4fcd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a099289e-c16c-430f-adbf-e64d824de699" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_711d1b4b-2298-4df7-b248-eb35d8b4fcd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ComprehensiveEarnings" xlink:type="simple" xlink:href="vtrs-20211231.xsd#ComprehensiveEarnings"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/ComprehensiveEarnings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_a15a36e3-3aaf-4ce9-beac-6aca247ce754" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_7390d8e6-9211-4f20-8eed-bf82c2d1b226" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a15a36e3-3aaf-4ce9-beac-6aca247ce754" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_7390d8e6-9211-4f20-8eed-bf82c2d1b226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ComprehensiveEarningsTables" xlink:type="simple" xlink:href="vtrs-20211231.xsd#ComprehensiveEarningsTables"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/ComprehensiveEarningsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_f2abc83b-f354-4d63-9798-c2fc92ba771c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_993dfa56-3667-4fc7-9935-2656ea0aeff0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f2abc83b-f354-4d63-9798-c2fc92ba771c" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_993dfa56-3667-4fc7-9935-2656ea0aeff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_46d82170-bd89-40be-a9c8-69d3582b80dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f2abc83b-f354-4d63-9798-c2fc92ba771c" xlink:to="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_46d82170-bd89-40be-a9c8-69d3582b80dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_37fc618e-a619-477b-ba1f-128db3b045cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e8c92af1-28d4-458a-ade5-ccb8106cbf67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_37fc618e-a619-477b-ba1f-128db3b045cb" xlink:to="loc_us-gaap_StatementTable_e8c92af1-28d4-458a-ade5-ccb8106cbf67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a9004c6f-6681-4dc7-b875-86d7cd798840" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e8c92af1-28d4-458a-ade5-ccb8106cbf67" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a9004c6f-6681-4dc7-b875-86d7cd798840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_6e8dc97c-3bdd-4bcc-9fa6-df8620774ff5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a9004c6f-6681-4dc7-b875-86d7cd798840" xlink:to="loc_us-gaap_HedgingRelationshipDomain_6e8dc97c-3bdd-4bcc-9fa6-df8620774ff5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_408e9395-4878-46ba-b675-61dca7afee41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_6e8dc97c-3bdd-4bcc-9fa6-df8620774ff5" xlink:to="loc_us-gaap_CashFlowHedgingMember_408e9395-4878-46ba-b675-61dca7afee41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_9f8e9adc-161d-4d4f-9b17-a80304cd6a24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_6e8dc97c-3bdd-4bcc-9fa6-df8620774ff5" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_9f8e9adc-161d-4d4f-9b17-a80304cd6a24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_0ac0b9c8-c112-4f85-8803-210d59267432" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e8c92af1-28d4-458a-ade5-ccb8106cbf67" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_0ac0b9c8-c112-4f85-8803-210d59267432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_163f5c99-c866-456f-9ef7-0698345e28e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0ac0b9c8-c112-4f85-8803-210d59267432" xlink:to="loc_us-gaap_EquityComponentDomain_163f5c99-c866-456f-9ef7-0698345e28e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_5eeaea8d-599b-4aa1-b33f-135f958bf16a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_163f5c99-c866-456f-9ef7-0698345e28e8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_5eeaea8d-599b-4aa1-b33f-135f958bf16a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_1494935c-4ef7-4ac0-aafd-9f2622f6b75d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_163f5c99-c866-456f-9ef7-0698345e28e8" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_1494935c-4ef7-4ac0-aafd-9f2622f6b75d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_4e8d2095-24cd-4ec6-b2f2-d718adbb6df9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_163f5c99-c866-456f-9ef7-0698345e28e8" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_4e8d2095-24cd-4ec6-b2f2-d718adbb6df9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_6dbcd659-7598-4a01-a6ba-6c751a2dce3a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e8c92af1-28d4-458a-ade5-ccb8106cbf67" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_6dbcd659-7598-4a01-a6ba-6c751a2dce3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1241c33a-190e-4578-9aac-5358d7e8c882" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_6dbcd659-7598-4a01-a6ba-6c751a2dce3a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1241c33a-190e-4578-9aac-5358d7e8c882" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_ee386fd7-1eaf-4aa7-8647-847d59b5a2d8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1241c33a-190e-4578-9aac-5358d7e8c882" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_ee386fd7-1eaf-4aa7-8647-847d59b5a2d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_3dc45a26-538a-4da9-9847-316685ebb2e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e8c92af1-28d4-458a-ade5-ccb8106cbf67" xlink:to="loc_us-gaap_StatementLineItems_3dc45a26-538a-4da9-9847-316685ebb2e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b0daee50-3d05-4faf-9b98-ec3b1ff29645" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3dc45a26-538a-4da9-9847-316685ebb2e9" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b0daee50-3d05-4faf-9b98-ec3b1ff29645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2e7240d5-d881-40f6-b337-3ca236ae97e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3dc45a26-538a-4da9-9847-316685ebb2e9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2e7240d5-d881-40f6-b337-3ca236ae97e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_e6c26fb0-38da-43c4-ba67-a173415af812" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3dc45a26-538a-4da9-9847-316685ebb2e9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_e6c26fb0-38da-43c4-ba67-a173415af812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_6981c968-0454-46b6-b78e-b43caf179b97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3dc45a26-538a-4da9-9847-316685ebb2e9" xlink:to="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_6981c968-0454-46b6-b78e-b43caf179b97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax_5e4a2faa-f5bd-43c7-b5f2-9f1a1081a160" xlink:href="vtrs-20211231.xsd#vtrs_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3dc45a26-538a-4da9-9847-316685ebb2e9" xlink:to="loc_vtrs_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax_5e4a2faa-f5bd-43c7-b5f2-9f1a1081a160" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_bae9ac0c-7b97-4df6-bd0f-a749d634d353" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3dc45a26-538a-4da9-9847-316685ebb2e9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_bae9ac0c-7b97-4df6-bd0f-a749d634d353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1aba39e3-7ffc-4354-b675-a3b505d87666" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3dc45a26-538a-4da9-9847-316685ebb2e9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1aba39e3-7ffc-4354-b675-a3b505d87666" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeOtherNetOfTax_ad155c85-ec82-4994-bd8b-6cfa375c495e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeOtherNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3dc45a26-538a-4da9-9847-316685ebb2e9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeOtherNetOfTax_ad155c85-ec82-4994-bd8b-6cfa375c495e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_14ed927e-c0c8-4ac0-9aaa-849579eff0d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3dc45a26-538a-4da9-9847-316685ebb2e9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_14ed927e-c0c8-4ac0-9aaa-849579eff0d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_8286238b-e0e4-4765-8ae8-4b6af11449e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_37fc618e-a619-477b-ba1f-128db3b045cb" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_8286238b-e0e4-4765-8ae8-4b6af11449e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_762d4b36-ce2b-4bc6-bff3-bebe43f6af89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_37fc618e-a619-477b-ba1f-128db3b045cb" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_762d4b36-ce2b-4bc6-bff3-bebe43f6af89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_c5e911f5-6aff-40fb-abcd-c58a555a88ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_37fc618e-a619-477b-ba1f-128db3b045cb" xlink:to="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_c5e911f5-6aff-40fb-abcd-c58a555a88ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_df53dc2d-33b3-48b3-8cb6-9b1d73be82b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_37fc618e-a619-477b-ba1f-128db3b045cb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_df53dc2d-33b3-48b3-8cb6-9b1d73be82b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax_f86d60ff-35cd-4913-a58b-fc85fb2d8fa7" xlink:href="vtrs-20211231.xsd#vtrs_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_37fc618e-a619-477b-ba1f-128db3b045cb" xlink:to="loc_vtrs_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax_f86d60ff-35cd-4913-a58b-fc85fb2d8fa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_da7188a3-051a-41bc-8709-efe754dd29d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_37fc618e-a619-477b-ba1f-128db3b045cb" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_da7188a3-051a-41bc-8709-efe754dd29d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_31788fc4-1add-4eeb-bc9c-e35564a17af5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_37fc618e-a619-477b-ba1f-128db3b045cb" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_31788fc4-1add-4eeb-bc9c-e35564a17af5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_417cc90a-a98b-42af-9b82-353eb0e670e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_edeb0c88-9dab-43df-a480-fa41da89a69b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_417cc90a-a98b-42af-9b82-353eb0e670e2" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_edeb0c88-9dab-43df-a480-fa41da89a69b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_e7f700b6-e722-4f83-bae5-b35dc8aecf26" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_edeb0c88-9dab-43df-a480-fa41da89a69b" xlink:to="loc_srt_ConsolidatedEntitiesAxis_e7f700b6-e722-4f83-bae5-b35dc8aecf26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_fe86106a-aee7-4841-9035-0eb2734d1761" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_e7f700b6-e722-4f83-bae5-b35dc8aecf26" xlink:to="loc_srt_ConsolidatedEntitiesDomain_fe86106a-aee7-4841-9035-0eb2734d1761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_2a025158-096f-4060-94d8-5cb9ce9b5881" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_fe86106a-aee7-4841-9035-0eb2734d1761" xlink:to="loc_srt_ParentCompanyMember_2a025158-096f-4060-94d8-5cb9ce9b5881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_dd57d72c-c090-45e8-baed-8fd72d59de5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_edeb0c88-9dab-43df-a480-fa41da89a69b" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_dd57d72c-c090-45e8-baed-8fd72d59de5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_1b771358-308c-4511-a26a-94bfc793876f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_dd57d72c-c090-45e8-baed-8fd72d59de5b" xlink:to="loc_us-gaap_HedgingRelationshipDomain_1b771358-308c-4511-a26a-94bfc793876f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_e0c54c07-2068-42d8-83fb-3f63fcac697f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_1b771358-308c-4511-a26a-94bfc793876f" xlink:to="loc_us-gaap_CashFlowHedgingMember_e0c54c07-2068-42d8-83fb-3f63fcac697f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_0b0d62c7-0c62-4a9d-a41d-716dda66a92a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_1b771358-308c-4511-a26a-94bfc793876f" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_0b0d62c7-0c62-4a9d-a41d-716dda66a92a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_21db2d0c-843c-4878-be73-dbb8aaedc9a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_edeb0c88-9dab-43df-a480-fa41da89a69b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_21db2d0c-843c-4878-be73-dbb8aaedc9a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e3c53416-cb35-4515-a6ba-0b986c3a4caa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_21db2d0c-843c-4878-be73-dbb8aaedc9a0" xlink:to="loc_us-gaap_EquityComponentDomain_e3c53416-cb35-4515-a6ba-0b986c3a4caa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_9c3b16c0-7b39-44f2-bd57-37e60b2acd89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e3c53416-cb35-4515-a6ba-0b986c3a4caa" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_9c3b16c0-7b39-44f2-bd57-37e60b2acd89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_a697126d-ff24-4c8c-9d48-c47d9e1d49ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e3c53416-cb35-4515-a6ba-0b986c3a4caa" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_a697126d-ff24-4c8c-9d48-c47d9e1d49ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_2dedf918-39cf-486d-a10c-a5c183fb6572" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e3c53416-cb35-4515-a6ba-0b986c3a4caa" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_2dedf918-39cf-486d-a10c-a5c183fb6572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_6a04b00b-d8df-41e7-a1a8-042ebed5032c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e3c53416-cb35-4515-a6ba-0b986c3a4caa" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_6a04b00b-d8df-41e7-a1a8-042ebed5032c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f1e4ed48-0eef-4726-b04d-e84fd0acf63a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e3c53416-cb35-4515-a6ba-0b986c3a4caa" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f1e4ed48-0eef-4726-b04d-e84fd0acf63a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_7d556cb4-42d0-4706-b178-ee54613eabd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_edeb0c88-9dab-43df-a480-fa41da89a69b" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_7d556cb4-42d0-4706-b178-ee54613eabd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_48c39687-71b5-46cb-bcf3-7509d003aec4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7d556cb4-42d0-4706-b178-ee54613eabd6" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_48c39687-71b5-46cb-bcf3-7509d003aec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_bde6b258-4d7f-4404-9315-285437c354a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_48c39687-71b5-46cb-bcf3-7509d003aec4" xlink:to="loc_us-gaap_ForeignExchangeContractMember_bde6b258-4d7f-4404-9315-285437c354a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_150c4f33-85ed-48dc-8b48-f5fcbe83a8f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_48c39687-71b5-46cb-bcf3-7509d003aec4" xlink:to="loc_us-gaap_InterestRateSwapMember_150c4f33-85ed-48dc-8b48-f5fcbe83a8f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_aea5a68e-7038-4ddf-b200-25c90e1883b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_edeb0c88-9dab-43df-a480-fa41da89a69b" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_aea5a68e-7038-4ddf-b200-25c90e1883b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_2ca39957-c979-41f1-a33e-75201297d7c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_aea5a68e-7038-4ddf-b200-25c90e1883b6" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_2ca39957-c979-41f1-a33e-75201297d7c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_e0292dbd-4f93-4c0b-8f7c-2795a971eac3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_2ca39957-c979-41f1-a33e-75201297d7c3" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_e0292dbd-4f93-4c0b-8f7c-2795a971eac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_588052e4-553c-4f5a-9375-b2c2b7d16e04" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_edeb0c88-9dab-43df-a480-fa41da89a69b" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_588052e4-553c-4f5a-9375-b2c2b7d16e04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1b547193-13c1-49e3-a061-8c09eb0a7675" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_588052e4-553c-4f5a-9375-b2c2b7d16e04" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1b547193-13c1-49e3-a061-8c09eb0a7675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_34c68395-084d-4f7f-9c60-4e2016341d63" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1b547193-13c1-49e3-a061-8c09eb0a7675" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_34c68395-084d-4f7f-9c60-4e2016341d63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdfc7d26-5d77-4b46-b8db-b01cc3c51a75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_edeb0c88-9dab-43df-a480-fa41da89a69b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdfc7d26-5d77-4b46-b8db-b01cc3c51a75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e4b7cbdf-61ce-44da-b8d8-ab8846d5d268" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdfc7d26-5d77-4b46-b8db-b01cc3c51a75" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e4b7cbdf-61ce-44da-b8d8-ab8846d5d268" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax_e1b0f210-1a7a-406c-b051-f16cc6f2c698" xlink:href="vtrs-20211231.xsd#vtrs_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdfc7d26-5d77-4b46-b8db-b01cc3c51a75" xlink:to="loc_vtrs_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax_e1b0f210-1a7a-406c-b051-f16cc6f2c698" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_f9fb2198-d512-487c-94a6-c4884a23df39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdfc7d26-5d77-4b46-b8db-b01cc3c51a75" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_f9fb2198-d512-487c-94a6-c4884a23df39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_bf3bdf58-02a2-4dca-9f91-3e81214d2494" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdfc7d26-5d77-4b46-b8db-b01cc3c51a75" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_bf3bdf58-02a2-4dca-9f91-3e81214d2494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_c8af8706-6947-47e0-bf7a-b55a588c80bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdfc7d26-5d77-4b46-b8db-b01cc3c51a75" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_c8af8706-6947-47e0-bf7a-b55a588c80bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_3786bf1a-eb7b-465b-b742-33033da5bfe2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdfc7d26-5d77-4b46-b8db-b01cc3c51a75" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_3786bf1a-eb7b-465b-b742-33033da5bfe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6e2452a7-7a03-44ef-a9d8-813d6e6af7d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdfc7d26-5d77-4b46-b8db-b01cc3c51a75" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6e2452a7-7a03-44ef-a9d8-813d6e6af7d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_f90f632b-ea94-48aa-9b4f-57086eccf715" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdfc7d26-5d77-4b46-b8db-b01cc3c51a75" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_f90f632b-ea94-48aa-9b4f-57086eccf715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c2c62988-f387-4ce4-b924-ec6b177cabea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdfc7d26-5d77-4b46-b8db-b01cc3c51a75" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c2c62988-f387-4ce4-b924-ec6b177cabea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_32a76d63-2ebc-43bd-a33b-71c5221dbb23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdfc7d26-5d77-4b46-b8db-b01cc3c51a75" xlink:to="loc_us-gaap_InterestExpense_32a76d63-2ebc-43bd-a33b-71c5221dbb23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_9a80a9b3-1cc3-4d4b-b84a-11a038c05c1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdfc7d26-5d77-4b46-b8db-b01cc3c51a75" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_9a80a9b3-1cc3-4d4b-b84a-11a038c05c1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_6bd1f8b1-982d-4c64-9a20-37a994899f4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdfc7d26-5d77-4b46-b8db-b01cc3c51a75" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_6bd1f8b1-982d-4c64-9a20-37a994899f4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_7795f746-57fc-4646-925d-a784d0597fd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdfc7d26-5d77-4b46-b8db-b01cc3c51a75" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_7795f746-57fc-4646-925d-a784d0597fd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_3192cf81-aabb-47e9-9c3b-afc44780a405" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdfc7d26-5d77-4b46-b8db-b01cc3c51a75" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_3192cf81-aabb-47e9-9c3b-afc44780a405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_da8e1e41-f65c-4357-89cd-f4a6bf37ee09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdfc7d26-5d77-4b46-b8db-b01cc3c51a75" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_da8e1e41-f65c-4357-89cd-f4a6bf37ee09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_79095298-05f5-42af-8b68-735397a53f37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdfc7d26-5d77-4b46-b8db-b01cc3c51a75" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_79095298-05f5-42af-8b68-735397a53f37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_3dd8003d-87e3-435e-848b-c561c38a0c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdfc7d26-5d77-4b46-b8db-b01cc3c51a75" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_3dd8003d-87e3-435e-848b-c561c38a0c7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_58c9ca3a-4e7a-438f-9b0d-156dd789e4a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdfc7d26-5d77-4b46-b8db-b01cc3c51a75" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_58c9ca3a-4e7a-438f-9b0d-156dd789e4a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_43ca7f1e-cbe8-419a-8497-86f78d596b17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdfc7d26-5d77-4b46-b8db-b01cc3c51a75" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_43ca7f1e-cbe8-419a-8497-86f78d596b17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax_1cb76087-62d9-49db-ba35-1b661f640f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdfc7d26-5d77-4b46-b8db-b01cc3c51a75" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax_1cb76087-62d9-49db-ba35-1b661f640f5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_fe2f2e89-b996-46f7-a46f-a7a88e20ed7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdfc7d26-5d77-4b46-b8db-b01cc3c51a75" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_fe2f2e89-b996-46f7-a46f-a7a88e20ed7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_9d8d0f26-f664-49fb-b6ba-21a7f636b4df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdfc7d26-5d77-4b46-b8db-b01cc3c51a75" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_9d8d0f26-f664-49fb-b6ba-21a7f636b4df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_d2400718-647e-4bfc-ab8a-f5f6bba0371b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdfc7d26-5d77-4b46-b8db-b01cc3c51a75" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_d2400718-647e-4bfc-ab8a-f5f6bba0371b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_7eb20b88-462e-4003-aaf9-bcddbf8382be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdfc7d26-5d77-4b46-b8db-b01cc3c51a75" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_7eb20b88-462e-4003-aaf9-bcddbf8382be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeOtherNetOfTax_0a8f588d-3474-43fd-bd19-1fb3a6a6b331" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeOtherNetOfTax"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_fdfc7d26-5d77-4b46-b8db-b01cc3c51a75" xlink:to="loc_us-gaap_OtherComprehensiveIncomeOtherNetOfTax_0a8f588d-3474-43fd-bd19-1fb3a6a6b331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/IncomeTaxes" xlink:type="simple" xlink:href="vtrs-20211231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_27e698e9-fddc-4d2f-b1d6-5f292015a1fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_ddd4f75f-62df-4d03-b2c6-c5e458e31bf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_27e698e9-fddc-4d2f-b1d6-5f292015a1fc" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_ddd4f75f-62df-4d03-b2c6-c5e458e31bf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="vtrs-20211231.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_cdf23f7d-a2c7-4dc0-b223-b53e31caed98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_7b83933b-668e-4e9e-ba1b-0fb3f0aafbec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_cdf23f7d-a2c7-4dc0-b223-b53e31caed98" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_7b83933b-668e-4e9e-ba1b-0fb3f0aafbec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_d7859f10-3944-4afa-a4c7-50b39914338f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_cdf23f7d-a2c7-4dc0-b223-b53e31caed98" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_d7859f10-3944-4afa-a4c7-50b39914338f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_9fb80bae-aff2-4702-8969-c3cd661a5bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_cdf23f7d-a2c7-4dc0-b223-b53e31caed98" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_9fb80bae-aff2-4702-8969-c3cd661a5bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock_12eab772-4bae-45b9-bcac-455a67711a99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_cdf23f7d-a2c7-4dc0-b223-b53e31caed98" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock_12eab772-4bae-45b9-bcac-455a67711a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_781c5776-d327-433b-aae9-c6b373a84577" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_f458dfbb-7786-4e16-b7a9-9c311c37b364" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_781c5776-d327-433b-aae9-c6b373a84577" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_f458dfbb-7786-4e16-b7a9-9c311c37b364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_af9bdc06-ede6-4016-ba45-ab90163fcd45" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_f458dfbb-7786-4e16-b7a9-9c311c37b364" xlink:to="loc_srt_StatementScenarioAxis_af9bdc06-ede6-4016-ba45-ab90163fcd45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_256f0b63-83ef-43f0-9fec-c4dd8b4d347b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_af9bdc06-ede6-4016-ba45-ab90163fcd45" xlink:to="loc_srt_ScenarioUnspecifiedDomain_256f0b63-83ef-43f0-9fec-c4dd8b4d347b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_03e70b41-d81c-4c05-a2bc-153fcd19f089" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_256f0b63-83ef-43f0-9fec-c4dd8b4d347b" xlink:to="loc_srt_ScenarioForecastMember_03e70b41-d81c-4c05-a2bc-153fcd19f089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_dba9a75e-366d-49e0-bedf-8abddc01905c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_f458dfbb-7786-4e16-b7a9-9c311c37b364" xlink:to="loc_us-gaap_TaxPeriodAxis_dba9a75e-366d-49e0-bedf-8abddc01905c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_8edcd145-d2d8-437d-b538-c08cbf85f1a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodAxis_dba9a75e-366d-49e0-bedf-8abddc01905c" xlink:to="loc_us-gaap_TaxPeriodDomain_8edcd145-d2d8-437d-b538-c08cbf85f1a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_IndefiniteMember_bf71faae-98de-4261-882f-38227ecbbc2c" xlink:href="vtrs-20211231.xsd#vtrs_IndefiniteMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_8edcd145-d2d8-437d-b538-c08cbf85f1a6" xlink:to="loc_vtrs_IndefiniteMember_bf71faae-98de-4261-882f-38227ecbbc2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_FutureyearsMember_dea8ecd1-28e2-4c93-93f3-c754b02907cf" xlink:href="vtrs-20211231.xsd#vtrs_FutureyearsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_8edcd145-d2d8-437d-b538-c08cbf85f1a6" xlink:to="loc_vtrs_FutureyearsMember_dea8ecd1-28e2-4c93-93f3-c754b02907cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxYear2015Member_02d28c13-9e6b-4b53-9086-6e3607a1106c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxYear2015Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_8edcd145-d2d8-437d-b538-c08cbf85f1a6" xlink:to="loc_us-gaap_TaxYear2015Member_02d28c13-9e6b-4b53-9086-6e3607a1106c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_ec5551da-afe7-435f-969d-f21788a167de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_f458dfbb-7786-4e16-b7a9-9c311c37b364" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_ec5551da-afe7-435f-969d-f21788a167de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_cdd90dfa-dc0a-45c4-af2b-992aca7b18ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_ec5551da-afe7-435f-969d-f21788a167de" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_cdd90dfa-dc0a-45c4-af2b-992aca7b18ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_U.S.FederalTaxAuthorityMember_5b591bfb-f823-49a9-9415-4999ba154e77" xlink:href="vtrs-20211231.xsd#vtrs_U.S.FederalTaxAuthorityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_cdd90dfa-dc0a-45c4-af2b-992aca7b18ce" xlink:to="loc_vtrs_U.S.FederalTaxAuthorityMember_5b591bfb-f823-49a9-9415-4999ba154e77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_U.S.StateTaxAuthorityMember_40833305-41f8-4ccc-b49e-eb36509eed91" xlink:href="vtrs-20211231.xsd#vtrs_U.S.StateTaxAuthorityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_cdd90dfa-dc0a-45c4-af2b-992aca7b18ce" xlink:to="loc_vtrs_U.S.StateTaxAuthorityMember_40833305-41f8-4ccc-b49e-eb36509eed91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_6b5e76f0-e162-4bbc-bc4e-42239f9a0684" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_cdd90dfa-dc0a-45c4-af2b-992aca7b18ce" xlink:to="loc_us-gaap_ForeignCountryMember_6b5e76f0-e162-4bbc-bc4e-42239f9a0684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_e7c98554-6ff2-4206-bc6d-06c83437c864" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_cdd90dfa-dc0a-45c4-af2b-992aca7b18ce" xlink:to="loc_us-gaap_DomesticCountryMember_e7c98554-6ff2-4206-bc6d-06c83437c864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_cd96b20a-9267-4455-bf6d-73945c57d469" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_f458dfbb-7786-4e16-b7a9-9c311c37b364" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_cd96b20a-9267-4455-bf6d-73945c57d469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_936c1a7b-6152-47ec-9444-14a684323569" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_cd96b20a-9267-4455-bf6d-73945c57d469" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_936c1a7b-6152-47ec-9444-14a684323569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AustralianTaxationOfficeMember_ed1f1894-102e-41d1-8463-6a17e0e6ceee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AustralianTaxationOfficeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_936c1a7b-6152-47ec-9444-14a684323569" xlink:to="loc_us-gaap_AustralianTaxationOfficeMember_ed1f1894-102e-41d1-8463-6a17e0e6ceee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_ed86a59f-2039-40ea-b91c-805d82744aca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_936c1a7b-6152-47ec-9444-14a684323569" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_ed86a59f-2039-40ea-b91c-805d82744aca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_ee1c792b-1866-49e2-9c5a-c17403cbc6d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_f458dfbb-7786-4e16-b7a9-9c311c37b364" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_ee1c792b-1866-49e2-9c5a-c17403cbc6d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries_50aab59e-378a-4277-afd9-4041ef92994e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ee1c792b-1866-49e2-9c5a-c17403cbc6d6" xlink:to="loc_us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries_50aab59e-378a-4277-afd9-4041ef92994e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_baed1f8f-38c3-4b2b-a864-3c88632c7245" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ee1c792b-1866-49e2-9c5a-c17403cbc6d6" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_baed1f8f-38c3-4b2b-a864-3c88632c7245" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_025cec36-a172-47e1-90ca-c7ec9fbfee1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ee1c792b-1866-49e2-9c5a-c17403cbc6d6" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_025cec36-a172-47e1-90ca-c7ec9fbfee1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_00076c56-c28b-4b2a-b2ff-60e2c34d03d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ee1c792b-1866-49e2-9c5a-c17403cbc6d6" xlink:to="loc_us-gaap_OperatingLossCarryforwards_00076c56-c28b-4b2a-b2ff-60e2c34d03d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpense_a5e14eb4-529b-4f8c-8c27-68e183ae55b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ee1c792b-1866-49e2-9c5a-c17403cbc6d6" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpense_a5e14eb4-529b-4f8c-8c27-68e183ae55b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_4be1b83c-8e6f-453e-9b6e-afe613f59a12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ee1c792b-1866-49e2-9c5a-c17403cbc6d6" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_4be1b83c-8e6f-453e-9b6e-afe613f59a12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_805b2ed0-4646-4500-adb8-6704b297ec4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ee1c792b-1866-49e2-9c5a-c17403cbc6d6" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_805b2ed0-4646-4500-adb8-6704b297ec4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_42a3a697-597b-4e11-9293-1a7d7ab70c77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ee1c792b-1866-49e2-9c5a-c17403cbc6d6" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_42a3a697-597b-4e11-9293-1a7d7ab70c77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_b3dd7025-f039-4fc6-a46f-1bd4f976a7d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ee1c792b-1866-49e2-9c5a-c17403cbc6d6" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_b3dd7025-f039-4fc6-a46f-1bd4f976a7d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_1e4d431d-2736-4846-b085-f9260beeb959" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ee1c792b-1866-49e2-9c5a-c17403cbc6d6" xlink:to="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_1e4d431d-2736-4846-b085-f9260beeb959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationInterestExpense_7d8cc00d-7824-4fab-ac55-f965de65744f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationInterestExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ee1c792b-1866-49e2-9c5a-c17403cbc6d6" xlink:to="loc_us-gaap_IncomeTaxExaminationInterestExpense_7d8cc00d-7824-4fab-ac55-f965de65744f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_bf57dd4a-8e2c-4328-bbd7-a8970c5bce27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ee1c792b-1866-49e2-9c5a-c17403cbc6d6" xlink:to="loc_us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_bf57dd4a-8e2c-4328-bbd7-a8970c5bce27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DeductionlimitofGILTItax_362d7de3-0920-4f66-a52c-ea0026290100" xlink:href="vtrs-20211231.xsd#vtrs_DeductionlimitofGILTItax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ee1c792b-1866-49e2-9c5a-c17403cbc6d6" xlink:to="loc_vtrs_DeductionlimitofGILTItax_362d7de3-0920-4f66-a52c-ea0026290100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_18a3243a-54bc-4001-a203-2b1bef148f12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ee1c792b-1866-49e2-9c5a-c17403cbc6d6" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_18a3243a-54bc-4001-a203-2b1bef148f12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_53125ab4-ff5a-4e50-ba12-b4237ea85588" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense_8a21116f-403c-45c2-bed0-cb3c00a2e415" xlink:href="vtrs-20211231.xsd#vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ee1c792b-1866-49e2-9c5a-c17403cbc6d6" xlink:to="loc_vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense_8a21116f-403c-45c2-bed0-cb3c00a2e415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_IncomeTaxExaminationReserveForUncertainTaxPosition_8c099402-f48f-494c-bb89-c0f9c15b8d19" xlink:href="vtrs-20211231.xsd#vtrs_IncomeTaxExaminationReserveForUncertainTaxPosition"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ee1c792b-1866-49e2-9c5a-c17403cbc6d6" xlink:to="loc_vtrs_IncomeTaxExaminationReserveForUncertainTaxPosition_8c099402-f48f-494c-bb89-c0f9c15b8d19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_IncomeTaxExaminationReserveImpactOnIncomeTaxProvision_23b3464c-574f-4f30-8371-b0657b5d8b40" xlink:href="vtrs-20211231.xsd#vtrs_IncomeTaxExaminationReserveImpactOnIncomeTaxProvision"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ee1c792b-1866-49e2-9c5a-c17403cbc6d6" xlink:to="loc_vtrs_IncomeTaxExaminationReserveImpactOnIncomeTaxProvision_23b3464c-574f-4f30-8371-b0657b5d8b40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties_b2dba3dc-3ba6-43bf-91b8-908e3ed50eb8" xlink:href="vtrs-20211231.xsd#vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ee1c792b-1866-49e2-9c5a-c17403cbc6d6" xlink:to="loc_vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties_b2dba3dc-3ba6-43bf-91b8-908e3ed50eb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CARESActIncomeTaxExpenseBenefit_fb14abd4-8ece-42ab-8524-2a4c29a2d5bc" xlink:href="vtrs-20211231.xsd#vtrs_CARESActIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ee1c792b-1866-49e2-9c5a-c17403cbc6d6" xlink:to="loc_vtrs_CARESActIncomeTaxExpenseBenefit_fb14abd4-8ece-42ab-8524-2a4c29a2d5bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_04231cab-3fd7-4f91-ae96-700d80ff9f7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_e71f9e3f-eebf-4bc8-8ff7-6437f3f8e432" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_04231cab-3fd7-4f91-ae96-700d80ff9f7d" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_e71f9e3f-eebf-4bc8-8ff7-6437f3f8e432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_7d31a695-d302-4885-8d16-66afca3c08af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_e71f9e3f-eebf-4bc8-8ff7-6437f3f8e432" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_7d31a695-d302-4885-8d16-66afca3c08af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_5c4a642c-00d6-4956-82f8-acb8fda25940" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_7d31a695-d302-4885-8d16-66afca3c08af" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_5c4a642c-00d6-4956-82f8-acb8fda25940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_11863b02-8037-4f15-9ec7-5a4da1dd46aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_5c4a642c-00d6-4956-82f8-acb8fda25940" xlink:to="loc_us-gaap_ForeignCountryMember_11863b02-8037-4f15-9ec7-5a4da1dd46aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_U.S.StateTaxAuthorityMember_b79b6477-4b80-4ba5-834b-cb41474c8bac" xlink:href="vtrs-20211231.xsd#vtrs_U.S.StateTaxAuthorityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_5c4a642c-00d6-4956-82f8-acb8fda25940" xlink:to="loc_vtrs_U.S.StateTaxAuthorityMember_b79b6477-4b80-4ba5-834b-cb41474c8bac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NonU.S.statetaxauthorityMember_d6bb8dd5-4fc8-45bd-a139-c6e9b85033c9" xlink:href="vtrs-20211231.xsd#vtrs_NonU.S.statetaxauthorityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_5c4a642c-00d6-4956-82f8-acb8fda25940" xlink:to="loc_vtrs_NonU.S.statetaxauthorityMember_d6bb8dd5-4fc8-45bd-a139-c6e9b85033c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherMember_72c67cd7-e6a4-406f-ad96-1e062a7fecb0" xlink:href="vtrs-20211231.xsd#vtrs_OtherMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_5c4a642c-00d6-4956-82f8-acb8fda25940" xlink:to="loc_vtrs_OtherMember_72c67cd7-e6a4-406f-ad96-1e062a7fecb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_7a54be15-3fdb-4bf8-8a60-276c5cc06658" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_e71f9e3f-eebf-4bc8-8ff7-6437f3f8e432" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_7a54be15-3fdb-4bf8-8a60-276c5cc06658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_42e714d4-eb06-48fa-a13c-010bd0f818ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_7a54be15-3fdb-4bf8-8a60-276c5cc06658" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_42e714d4-eb06-48fa-a13c-010bd0f818ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_43736e2f-d56b-4dc4-9f16-aa6cc584a1cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_7a54be15-3fdb-4bf8-8a60-276c5cc06658" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_43736e2f-d56b-4dc4-9f16-aa6cc584a1cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_44760c56-99cc-40bf-8954-a2866739a7ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_7a54be15-3fdb-4bf8-8a60-276c5cc06658" xlink:to="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_44760c56-99cc-40bf-8954-a2866739a7ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_15828c1f-7e47-4f9c-ae70-d3ec3449ee43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_7a54be15-3fdb-4bf8-8a60-276c5cc06658" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_15828c1f-7e47-4f9c-ae70-d3ec3449ee43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_9e1aadfe-5a4f-4c30-be45-c5f5f40638be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_7a54be15-3fdb-4bf8-8a60-276c5cc06658" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_9e1aadfe-5a4f-4c30-be45-c5f5f40638be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_24f25719-5862-4e41-870c-448c2f1da923" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_7a54be15-3fdb-4bf8-8a60-276c5cc06658" xlink:to="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_24f25719-5862-4e41-870c-448c2f1da923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_99bc6efc-155f-44f7-a271-7ff6f726fe22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_7a54be15-3fdb-4bf8-8a60-276c5cc06658" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_99bc6efc-155f-44f7-a271-7ff6f726fe22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_e8276126-e6b7-49b6-a543-8330e934f51f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_7a54be15-3fdb-4bf8-8a60-276c5cc06658" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_e8276126-e6b7-49b6-a543-8330e934f51f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_9c3924b2-6f50-4995-a971-e22ccbda848e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_7a54be15-3fdb-4bf8-8a60-276c5cc06658" xlink:to="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_9c3924b2-6f50-4995-a971-e22ccbda848e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_4b0ad293-5909-423a-ba24-6242ee08e3da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_7a54be15-3fdb-4bf8-8a60-276c5cc06658" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_4b0ad293-5909-423a-ba24-6242ee08e3da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_04d35a02-512c-49a9-a2e9-00490994d017" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_7a54be15-3fdb-4bf8-8a60-276c5cc06658" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_04d35a02-512c-49a9-a2e9-00490994d017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_9391af98-239d-416a-bae9-aad904b22a94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_04d35a02-512c-49a9-a2e9-00490994d017" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_9391af98-239d-416a-bae9-aad904b22a94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_7f56b65d-4942-479a-b49b-d21a71751bff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_04d35a02-512c-49a9-a2e9-00490994d017" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_7f56b65d-4942-479a-b49b-d21a71751bff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f63766bb-5ca8-4c92-841a-f3c0916fab43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_7a54be15-3fdb-4bf8-8a60-276c5cc06658" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f63766bb-5ca8-4c92-841a-f3c0916fab43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_572ee8f8-c00e-4f65-bca2-ceaa27229711" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetAbstract_90000a8b-c9cf-448c-98ff-4829a54be06c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_572ee8f8-c00e-4f65-bca2-ceaa27229711" xlink:to="loc_us-gaap_DeferredTaxAssetsNetAbstract_90000a8b-c9cf-448c-98ff-4829a54be06c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits_3c023766-cb23-4072-af6c-7fdf4638020c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_90000a8b-c9cf-448c-98ff-4829a54be06c" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits_3c023766-cb23-4072-af6c-7fdf4638020c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies_ecd653b4-08a5-4f73-943d-d2f145ee21a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_90000a8b-c9cf-448c-98ff-4829a54be06c" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies_ecd653b4-08a5-4f73-943d-d2f145ee21a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_9ace6d42-c26c-4896-91f0-a509d5a488fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_90000a8b-c9cf-448c-98ff-4829a54be06c" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_9ace6d42-c26c-4896-91f0-a509d5a488fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_5b60a59b-a803-4629-88f6-fcdbc806269a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_90000a8b-c9cf-448c-98ff-4829a54be06c" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_5b60a59b-a803-4629-88f6-fcdbc806269a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_40853def-d4a8-4c52-9ce3-21c52048024c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_90000a8b-c9cf-448c-98ff-4829a54be06c" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_40853def-d4a8-4c52-9ce3-21c52048024c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DeferredTaxAssetsOperatingLeaseRightofUseAssets_03563dfb-0fbe-4379-90c7-83d6438c9659" xlink:href="vtrs-20211231.xsd#vtrs_DeferredTaxAssetsOperatingLeaseRightofUseAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_90000a8b-c9cf-448c-98ff-4829a54be06c" xlink:to="loc_vtrs_DeferredTaxAssetsOperatingLeaseRightofUseAssets_03563dfb-0fbe-4379-90c7-83d6438c9659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DeferredTaxAssetsDeferredtaxexpenseinterestexpense_b593d76b-4881-4ca5-b0ef-b5e1e488262d" xlink:href="vtrs-20211231.xsd#vtrs_DeferredTaxAssetsDeferredtaxexpenseinterestexpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_90000a8b-c9cf-448c-98ff-4829a54be06c" xlink:to="loc_vtrs_DeferredTaxAssetsDeferredtaxexpenseinterestexpense_b593d76b-4881-4ca5-b0ef-b5e1e488262d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DeferredTaxAssetsIntangibleAssets_6d6bad32-a7e2-41d6-86e5-9b1709a17d08" xlink:href="vtrs-20211231.xsd#vtrs_DeferredTaxAssetsIntangibleAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_90000a8b-c9cf-448c-98ff-4829a54be06c" xlink:to="loc_vtrs_DeferredTaxAssetsIntangibleAssets_6d6bad32-a7e2-41d6-86e5-9b1709a17d08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_8e5f8ca5-25ce-4567-85e5-d60fc748c74d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_90000a8b-c9cf-448c-98ff-4829a54be06c" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_8e5f8ca5-25ce-4567-85e5-d60fc748c74d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_c34d2ae4-ce24-4bc0-99a7-f237a2927bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_90000a8b-c9cf-448c-98ff-4829a54be06c" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_c34d2ae4-ce24-4bc0-99a7-f237a2927bf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_610cd10c-1f17-4445-be58-476fe7f5ca07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_90000a8b-c9cf-448c-98ff-4829a54be06c" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_610cd10c-1f17-4445-be58-476fe7f5ca07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_97eaca3a-3323-475e-b0e4-9ed5cafacbb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_90000a8b-c9cf-448c-98ff-4829a54be06c" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_97eaca3a-3323-475e-b0e4-9ed5cafacbb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_f2249e90-5313-462e-a98b-7bde4573d565" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNetAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_572ee8f8-c00e-4f65-bca2-ceaa27229711" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_f2249e90-5313-462e-a98b-7bde4573d565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_837cb6fd-b28d-451b-a828-cd44bb7cf880" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_f2249e90-5313-462e-a98b-7bde4573d565" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_837cb6fd-b28d-451b-a828-cd44bb7cf880" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DeferredTaxLiabilitiesOperatingLeaseLiability_93a2a639-ebf0-4ee7-a531-0beed1cb6435" xlink:href="vtrs-20211231.xsd#vtrs_DeferredTaxLiabilitiesOperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_f2249e90-5313-462e-a98b-7bde4573d565" xlink:to="loc_vtrs_DeferredTaxLiabilitiesOperatingLeaseLiability_93a2a639-ebf0-4ee7-a531-0beed1cb6435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_b2edba02-85ea-4e86-80d9-fa23c501c24d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_f2249e90-5313-462e-a98b-7bde4573d565" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_b2edba02-85ea-4e86-80d9-fa23c501c24d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_146263a6-f826-4cee-8592-1f6a9a38cca2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_f2249e90-5313-462e-a98b-7bde4573d565" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_146263a6-f826-4cee-8592-1f6a9a38cca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_47a95b69-f0de-4509-89d4-ef8f10ea6333" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_f2249e90-5313-462e-a98b-7bde4573d565" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_47a95b69-f0de-4509-89d4-ef8f10ea6333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_383009ec-849e-48c6-b913-314a395b6ccd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_572ee8f8-c00e-4f65-bca2-ceaa27229711" xlink:to="loc_us-gaap_DeferredTaxLiabilities_383009ec-849e-48c6-b913-314a395b6ccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/IncomeTaxesStatutoryTaxRatetoEffectiveTaxRateReconciliationDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#IncomeTaxesStatutoryTaxRatetoEffectiveTaxRateReconciliationDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/IncomeTaxesStatutoryTaxRatetoEffectiveTaxRateReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_7082ff48-56a8-409a-9d99-e9cc8f8ded8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_bdb7d7f5-3338-4eaa-852b-d1df4554c6cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7082ff48-56a8-409a-9d99-e9cc8f8ded8b" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_bdb7d7f5-3338-4eaa-852b-d1df4554c6cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_f589c691-a153-4130-bfa3-f9061c4d243d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_bdb7d7f5-3338-4eaa-852b-d1df4554c6cc" xlink:to="loc_srt_StatementGeographicalAxis_f589c691-a153-4130-bfa3-f9061c4d243d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_dd238284-076b-4375-b29e-26a826698491" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_f589c691-a153-4130-bfa3-f9061c4d243d" xlink:to="loc_srt_SegmentGeographicalDomain_dd238284-076b-4375-b29e-26a826698491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_05edb380-7616-40b1-b5f5-33b5b625af73" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_dd238284-076b-4375-b29e-26a826698491" xlink:to="loc_country_US_05edb380-7616-40b1-b5f5-33b5b625af73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_LU_9f1cc752-c844-4e2e-8ea1-10c42d3cb95a" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_LU"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_dd238284-076b-4375-b29e-26a826698491" xlink:to="loc_country_LU_9f1cc752-c844-4e2e-8ea1-10c42d3cb95a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GI_14103072-8dec-4a69-80e1-46a181d0e137" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GI"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_dd238284-076b-4375-b29e-26a826698491" xlink:to="loc_country_GI_14103072-8dec-4a69-80e1-46a181d0e137" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_0fd7debf-d73e-482c-83f0-b6a64174ba1d" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IE"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_dd238284-076b-4375-b29e-26a826698491" xlink:to="loc_country_IE_0fd7debf-d73e-482c-83f0-b6a64174ba1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_c7d10d9a-2f93-40bc-91c0-74d053989ebd" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_FR"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_dd238284-076b-4375-b29e-26a826698491" xlink:to="loc_country_FR_c7d10d9a-2f93-40bc-91c0-74d053989ebd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherforeignMember_a9afa429-fd64-4e11-8378-60c390c0eabc" xlink:href="vtrs-20211231.xsd#vtrs_OtherforeignMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_dd238284-076b-4375-b29e-26a826698491" xlink:to="loc_vtrs_OtherforeignMember_a9afa429-fd64-4e11-8378-60c390c0eabc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_578bdc69-6cf9-4cc3-8c38-bc9f6c57eca3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_dd238284-076b-4375-b29e-26a826698491" xlink:to="loc_us-gaap_NonUsMember_578bdc69-6cf9-4cc3-8c38-bc9f6c57eca3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_PR_73077fed-37fc-4bc1-9c98-8b246436080a" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_PR"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_dd238284-076b-4375-b29e-26a826698491" xlink:to="loc_country_PR_73077fed-37fc-4bc1-9c98-8b246436080a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_85eb9d9b-772c-46b5-925f-bd897433e0a9" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CH"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_dd238284-076b-4375-b29e-26a826698491" xlink:to="loc_country_CH_85eb9d9b-772c-46b5-925f-bd897433e0a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_SG_5736996f-b0db-47de-822e-f4a3bd3fc80b" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_SG"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_dd238284-076b-4375-b29e-26a826698491" xlink:to="loc_country_SG_5736996f-b0db-47de-822e-f4a3bd3fc80b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_43d01ef0-4e19-4c36-8cb1-975166949729" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_bdb7d7f5-3338-4eaa-852b-d1df4554c6cc" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_43d01ef0-4e19-4c36-8cb1-975166949729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_9f6c708e-d725-4650-b795-d90f0ffe1be1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_43d01ef0-4e19-4c36-8cb1-975166949729" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_9f6c708e-d725-4650-b795-d90f0ffe1be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_575da804-7d10-4391-9079-700d13881f6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_43d01ef0-4e19-4c36-8cb1-975166949729" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_575da804-7d10-4391-9079-700d13881f6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_a846b92f-3611-4049-9ce4-4d32f1467594" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_43d01ef0-4e19-4c36-8cb1-975166949729" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_a846b92f-3611-4049-9ce4-4d32f1467594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_27c24746-3794-469d-a849-4cef59a6f19e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_43d01ef0-4e19-4c36-8cb1-975166949729" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_27c24746-3794-469d-a849-4cef59a6f19e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_bab7f6cd-9100-4f44-8e24-38dcf99458e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_43d01ef0-4e19-4c36-8cb1-975166949729" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_bab7f6cd-9100-4f44-8e24-38dcf99458e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_651c5010-a1da-44cd-b5c6-bde4e0e7aae2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_43d01ef0-4e19-4c36-8cb1-975166949729" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_651c5010-a1da-44cd-b5c6-bde4e0e7aae2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements_ddddc2dc-f6e9-4a07-b22c-e02b78caf0c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_43d01ef0-4e19-4c36-8cb1-975166949729" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements_ddddc2dc-f6e9-4a07-b22c-e02b78caf0c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EffectiveIncomeTaxRateReconciliationGILTIPercent_9b4878b8-90ab-4c4a-ac8e-ed2bc00b671e" xlink:href="vtrs-20211231.xsd#vtrs_EffectiveIncomeTaxRateReconciliationGILTIPercent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_43d01ef0-4e19-4c36-8cb1-975166949729" xlink:to="loc_vtrs_EffectiveIncomeTaxRateReconciliationGILTIPercent_9b4878b8-90ab-4c4a-ac8e-ed2bc00b671e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EffectiveIncomeTaxRateReconciliationWaivedDeductionsPercent_a0ad1163-76be-4ea3-9ad7-22d6fe4fe28d" xlink:href="vtrs-20211231.xsd#vtrs_EffectiveIncomeTaxRateReconciliationWaivedDeductionsPercent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_43d01ef0-4e19-4c36-8cb1-975166949729" xlink:to="loc_vtrs_EffectiveIncomeTaxRateReconciliationWaivedDeductionsPercent_a0ad1163-76be-4ea3-9ad7-22d6fe4fe28d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_1f303f6c-e124-4964-813b-ca74a4d2aa76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_43d01ef0-4e19-4c36-8cb1-975166949729" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_1f303f6c-e124-4964-813b-ca74a4d2aa76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_4d7c5ccd-0a5f-4002-886a-00d2a992a512" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_43d01ef0-4e19-4c36-8cb1-975166949729" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_4d7c5ccd-0a5f-4002-886a-00d2a992a512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign_cb5ee3a5-0748-4e3e-b4a7-dcfff50694a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_43d01ef0-4e19-4c36-8cb1-975166949729" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign_cb5ee3a5-0748-4e3e-b4a7-dcfff50694a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_f24e1b6f-2694-4ed9-ac0e-260498a7ca2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_43d01ef0-4e19-4c36-8cb1-975166949729" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_f24e1b6f-2694-4ed9-ac0e-260498a7ca2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EffectiveIncomeTaxRateReconciliationWithholdingTaxesPercent_739929b8-7e66-489e-b08c-ab042d44f3b3" xlink:href="vtrs-20211231.xsd#vtrs_EffectiveIncomeTaxRateReconciliationWithholdingTaxesPercent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_43d01ef0-4e19-4c36-8cb1-975166949729" xlink:to="loc_vtrs_EffectiveIncomeTaxRateReconciliationWithholdingTaxesPercent_739929b8-7e66-489e-b08c-ab042d44f3b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EffectiveIncomeTaxRateReconciliationIndiaAmagulation_23f3966c-9b99-4ecb-b67c-842e45c450a9" xlink:href="vtrs-20211231.xsd#vtrs_EffectiveIncomeTaxRateReconciliationIndiaAmagulation"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_43d01ef0-4e19-4c36-8cb1-975166949729" xlink:to="loc_vtrs_EffectiveIncomeTaxRateReconciliationIndiaAmagulation_23f3966c-9b99-4ecb-b67c-842e45c450a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_b7a31837-dfad-4256-9013-0aad0656fa64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_43d01ef0-4e19-4c36-8cb1-975166949729" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_b7a31837-dfad-4256-9013-0aad0656fa64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_5d145a23-69f8-49ec-a3d5-9753e3fdea16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_522b98e3-76d4-496c-a4b4-64b16e34a7c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5d145a23-69f8-49ec-a3d5-9753e3fdea16" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_522b98e3-76d4-496c-a4b4-64b16e34a7c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_693a38d8-ce3c-42ed-a9c4-4521e16834b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5d145a23-69f8-49ec-a3d5-9753e3fdea16" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_693a38d8-ce3c-42ed-a9c4-4521e16834b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_0f750330-5606-4efd-b7aa-a308ed5919d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5d145a23-69f8-49ec-a3d5-9753e3fdea16" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_0f750330-5606-4efd-b7aa-a308ed5919d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_0c4b4641-3ed8-49f2-a486-42f2a1541289" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5d145a23-69f8-49ec-a3d5-9753e3fdea16" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_0c4b4641-3ed8-49f2-a486-42f2a1541289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_e6c6d4a0-1ed0-4a29-82f0-603efdb43204" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5d145a23-69f8-49ec-a3d5-9753e3fdea16" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_e6c6d4a0-1ed0-4a29-82f0-603efdb43204" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_c7cad0d9-401f-4df1-a708-37c2bc50b38c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5d145a23-69f8-49ec-a3d5-9753e3fdea16" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_c7cad0d9-401f-4df1-a708-37c2bc50b38c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromAcquisition_5e0d71a8-b710-42e7-ae82-b44f24c1e7ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromAcquisition"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5d145a23-69f8-49ec-a3d5-9753e3fdea16" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromAcquisition_5e0d71a8-b710-42e7-ae82-b44f24c1e7ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_92d815f0-8aff-4dc8-b882-297729ba1640" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5d145a23-69f8-49ec-a3d5-9753e3fdea16" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_92d815f0-8aff-4dc8-b882-297729ba1640" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_0720cafe-0034-4f71-afd4-dcc861781db7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5d145a23-69f8-49ec-a3d5-9753e3fdea16" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_0720cafe-0034-4f71-afd4-dcc861781db7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ShareBasedIncentivePlan" xlink:type="simple" xlink:href="vtrs-20211231.xsd#ShareBasedIncentivePlan"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/ShareBasedIncentivePlan" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a8d6d132-7e4c-432d-8dbf-cc1062434290" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_85d8dd14-a8f1-4ebf-95d6-5f1cdf1dae06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a8d6d132-7e4c-432d-8dbf-cc1062434290" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_85d8dd14-a8f1-4ebf-95d6-5f1cdf1dae06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ShareBasedIncentivePlanTables" xlink:type="simple" xlink:href="vtrs-20211231.xsd#ShareBasedIncentivePlanTables"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/ShareBasedIncentivePlanTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_928354f6-ced0-4ad5-80b6-6785442d172e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_409f2cdd-ae72-401d-ae92-27064791db41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_928354f6-ced0-4ad5-80b6-6785442d172e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_409f2cdd-ae72-401d-ae92-27064791db41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ProgramNameAxis_35f21bd1-d165-4392-b5b6-71561339f179" xlink:href="vtrs-20211231.xsd#vtrs_ProgramNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_409f2cdd-ae72-401d-ae92-27064791db41" xlink:to="loc_vtrs_ProgramNameAxis_35f21bd1-d165-4392-b5b6-71561339f179" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ProgramNameDomain_33c97b33-e48b-4a84-b93e-cfa702cc81fe" xlink:href="vtrs-20211231.xsd#vtrs_ProgramNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ProgramNameAxis_35f21bd1-d165-4392-b5b6-71561339f179" xlink:to="loc_vtrs_ProgramNameDomain_33c97b33-e48b-4a84-b93e-cfa702cc81fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2014ProgramMember_85554d38-4bd2-45df-90d4-610db1b0c22f" xlink:href="vtrs-20211231.xsd#vtrs_A2014ProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ProgramNameDomain_33c97b33-e48b-4a84-b93e-cfa702cc81fe" xlink:to="loc_vtrs_A2014ProgramMember_85554d38-4bd2-45df-90d4-610db1b0c22f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_6ef47259-fbe4-47c2-a155-0912644ed5cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_409f2cdd-ae72-401d-ae92-27064791db41" xlink:to="loc_us-gaap_PlanNameAxis_6ef47259-fbe4-47c2-a155-0912644ed5cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_1c37ef9b-3d13-4622-8054-e6771d80c580" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_6ef47259-fbe4-47c2-a155-0912644ed5cb" xlink:to="loc_us-gaap_PlanNameDomain_1c37ef9b-3d13-4622-8054-e6771d80c580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_LongTermIncentivePlan2003Member_52472416-9370-46ac-a74e-c258f3687d4c" xlink:href="vtrs-20211231.xsd#vtrs_LongTermIncentivePlan2003Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_1c37ef9b-3d13-4622-8054-e6771d80c580" xlink:to="loc_vtrs_LongTermIncentivePlan2003Member_52472416-9370-46ac-a74e-c258f3687d4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c446398f-d8d5-473f-b1f5-2b2df9e81d3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_409f2cdd-ae72-401d-ae92-27064791db41" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c446398f-d8d5-473f-b1f5-2b2df9e81d3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_d9c12369-2820-4a9d-bfa8-28530e6f4f88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c446398f-d8d5-473f-b1f5-2b2df9e81d3b" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_d9c12369-2820-4a9d-bfa8-28530e6f4f88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_92492919-70a4-4839-8294-a9d7085a0475" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c446398f-d8d5-473f-b1f5-2b2df9e81d3b" xlink:to="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_92492919-70a4-4839-8294-a9d7085a0475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_e64ec747-b732-4a87-bc59-e8da758d44d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c446398f-d8d5-473f-b1f5-2b2df9e81d3b" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_e64ec747-b732-4a87-bc59-e8da758d44d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#ShareBasedIncentivePlanNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e19e3601-b9d3-4d2d-8c29-d85386394df0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_907c9963-86da-4a1f-814a-086244a1e06a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e19e3601-b9d3-4d2d-8c29-d85386394df0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_907c9963-86da-4a1f-814a-086244a1e06a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SubjecttoMarketConditionsAxis_7b140fcf-c48e-42be-8282-fa1c9a037614" xlink:href="vtrs-20211231.xsd#vtrs_SubjecttoMarketConditionsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_907c9963-86da-4a1f-814a-086244a1e06a" xlink:to="loc_vtrs_SubjecttoMarketConditionsAxis_7b140fcf-c48e-42be-8282-fa1c9a037614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SubjecttoMarketConditionsDomain_b08dd0c4-e84e-4c45-b368-98866f5c056b" xlink:href="vtrs-20211231.xsd#vtrs_SubjecttoMarketConditionsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_SubjecttoMarketConditionsAxis_7b140fcf-c48e-42be-8282-fa1c9a037614" xlink:to="loc_vtrs_SubjecttoMarketConditionsDomain_b08dd0c4-e84e-4c45-b368-98866f5c056b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NotSubjecttoMarketConditionsMember_4b880580-669f-4eb2-9bed-06130b979991" xlink:href="vtrs-20211231.xsd#vtrs_NotSubjecttoMarketConditionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_SubjecttoMarketConditionsDomain_b08dd0c4-e84e-4c45-b368-98866f5c056b" xlink:to="loc_vtrs_NotSubjecttoMarketConditionsMember_4b880580-669f-4eb2-9bed-06130b979991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_SubjectToMarketConditionsMember_21d4a100-9853-48d3-8f92-5e18f08be18b" xlink:href="vtrs-20211231.xsd#vtrs_SubjectToMarketConditionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_SubjecttoMarketConditionsDomain_b08dd0c4-e84e-4c45-b368-98866f5c056b" xlink:to="loc_vtrs_SubjectToMarketConditionsMember_21d4a100-9853-48d3-8f92-5e18f08be18b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ProgramNameAxis_3b447d6b-a353-4609-b9e5-0fd444e2d974" xlink:href="vtrs-20211231.xsd#vtrs_ProgramNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_907c9963-86da-4a1f-814a-086244a1e06a" xlink:to="loc_vtrs_ProgramNameAxis_3b447d6b-a353-4609-b9e5-0fd444e2d974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ProgramNameDomain_89100e87-2b74-42f3-9efa-ab4a4b89298b" xlink:href="vtrs-20211231.xsd#vtrs_ProgramNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ProgramNameAxis_3b447d6b-a353-4609-b9e5-0fd444e2d974" xlink:to="loc_vtrs_ProgramNameDomain_89100e87-2b74-42f3-9efa-ab4a4b89298b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2014ProgramMember_0dcb2bfb-620d-4858-8997-cd7027137be6" xlink:href="vtrs-20211231.xsd#vtrs_A2014ProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ProgramNameDomain_89100e87-2b74-42f3-9efa-ab4a4b89298b" xlink:to="loc_vtrs_A2014ProgramMember_0dcb2bfb-620d-4858-8997-cd7027137be6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_c0b0c46c-795c-4e17-bad0-f3676f8cc141" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_907c9963-86da-4a1f-814a-086244a1e06a" xlink:to="loc_us-gaap_PlanNameAxis_c0b0c46c-795c-4e17-bad0-f3676f8cc141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_09cc4669-8b3a-4910-bec3-d33986af7702" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_c0b0c46c-795c-4e17-bad0-f3676f8cc141" xlink:to="loc_us-gaap_PlanNameDomain_09cc4669-8b3a-4910-bec3-d33986af7702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_LongTermIncentivePlan2003Member_60facc99-a4d1-4e21-8eb4-85684ef4bf72" xlink:href="vtrs-20211231.xsd#vtrs_LongTermIncentivePlan2003Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_09cc4669-8b3a-4910-bec3-d33986af7702" xlink:to="loc_vtrs_LongTermIncentivePlan2003Member_60facc99-a4d1-4e21-8eb4-85684ef4bf72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OneTimeSpecialPerformanceBasedFiveYearRealizableValueIncentiveProgramMember_25ae2150-2b37-4a6a-b824-546ad12f906d" xlink:href="vtrs-20211231.xsd#vtrs_OneTimeSpecialPerformanceBasedFiveYearRealizableValueIncentiveProgramMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_09cc4669-8b3a-4910-bec3-d33986af7702" xlink:to="loc_vtrs_OneTimeSpecialPerformanceBasedFiveYearRealizableValueIncentiveProgramMember_25ae2150-2b37-4a6a-b824-546ad12f906d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember_ce879d7d-2876-4d31-8770-d7547a0b2c8b" xlink:href="vtrs-20211231.xsd#vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_09cc4669-8b3a-4910-bec3-d33986af7702" xlink:to="loc_vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember_ce879d7d-2876-4d31-8770-d7547a0b2c8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_bae33c28-3be8-4c31-af19-ed0ee4a03a29" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_907c9963-86da-4a1f-814a-086244a1e06a" xlink:to="loc_srt_RangeAxis_bae33c28-3be8-4c31-af19-ed0ee4a03a29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fc017cf2-0754-44cb-b6ee-476407aa6122" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_bae33c28-3be8-4c31-af19-ed0ee4a03a29" xlink:to="loc_srt_RangeMember_fc017cf2-0754-44cb-b6ee-476407aa6122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_53d9329e-7d02-438d-a684-5db10ca1db3c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_fc017cf2-0754-44cb-b6ee-476407aa6122" xlink:to="loc_srt_MinimumMember_53d9329e-7d02-438d-a684-5db10ca1db3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_0837e2d1-f2c3-47ad-8e5e-8cc98da71d86" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_fc017cf2-0754-44cb-b6ee-476407aa6122" xlink:to="loc_srt_MaximumMember_0837e2d1-f2c3-47ad-8e5e-8cc98da71d86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_ebbc40b2-c172-455d-81a2-9e205f46829c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_907c9963-86da-4a1f-814a-086244a1e06a" xlink:to="loc_us-gaap_AwardTypeAxis_ebbc40b2-c172-455d-81a2-9e205f46829c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_23f9ead7-f505-4d45-a7a2-beef002a8dde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_ebbc40b2-c172-455d-81a2-9e205f46829c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_23f9ead7-f505-4d45-a7a2-beef002a8dde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_f045b7be-5c43-4d8d-bb3b-19ce7ce910a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_23f9ead7-f505-4d45-a7a2-beef002a8dde" xlink:to="loc_us-gaap_EmployeeStockOptionMember_f045b7be-5c43-4d8d-bb3b-19ce7ce910a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_StockappreciationrightsandperformancesharesMember_e626b9af-925c-4a8a-b5b5-96b9ed2f98a5" xlink:href="vtrs-20211231.xsd#vtrs_StockappreciationrightsandperformancesharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_23f9ead7-f505-4d45-a7a2-beef002a8dde" xlink:to="loc_vtrs_StockappreciationrightsandperformancesharesMember_e626b9af-925c-4a8a-b5b5-96b9ed2f98a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_626094af-b19b-4b7d-85e0-f371d821400c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_23f9ead7-f505-4d45-a7a2-beef002a8dde" xlink:to="loc_us-gaap_RestrictedStockMember_626094af-b19b-4b7d-85e0-f371d821400c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_8f8c40c1-307a-45e7-a600-812b8358bd29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_23f9ead7-f505-4d45-a7a2-beef002a8dde" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_8f8c40c1-307a-45e7-a600-812b8358bd29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_1eba0fd1-d605-4624-8fe2-dabe091a03e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_23f9ead7-f505-4d45-a7a2-beef002a8dde" xlink:to="loc_us-gaap_PerformanceSharesMember_1eba0fd1-d605-4624-8fe2-dabe091a03e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NotSubjecttoMarketConditionsMember_a5586b14-b521-4181-bb5d-589d13de9055" xlink:href="vtrs-20211231.xsd#vtrs_NotSubjecttoMarketConditionsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_23f9ead7-f505-4d45-a7a2-beef002a8dde" xlink:to="loc_vtrs_NotSubjecttoMarketConditionsMember_a5586b14-b521-4181-bb5d-589d13de9055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VestingPeriodAxis_37ca4bc9-9196-4330-8779-e500fdf6f1e9" xlink:href="vtrs-20211231.xsd#vtrs_VestingPeriodAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_907c9963-86da-4a1f-814a-086244a1e06a" xlink:to="loc_vtrs_VestingPeriodAxis_37ca4bc9-9196-4330-8779-e500fdf6f1e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VestingPeriodDomain_82776c3c-3ba6-4c43-ac49-2f8d31de8629" xlink:href="vtrs-20211231.xsd#vtrs_VestingPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_VestingPeriodAxis_37ca4bc9-9196-4330-8779-e500fdf6f1e9" xlink:to="loc_vtrs_VestingPeriodDomain_82776c3c-3ba6-4c43-ac49-2f8d31de8629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VestratablyinfiveyearsorlessMember_0e6d0393-8d18-479e-b84c-63571f723f6b" xlink:href="vtrs-20211231.xsd#vtrs_VestratablyinfiveyearsorlessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_VestingPeriodDomain_82776c3c-3ba6-4c43-ac49-2f8d31de8629" xlink:to="loc_vtrs_VestratablyinfiveyearsorlessMember_0e6d0393-8d18-479e-b84c-63571f723f6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_VestinthreeyearsorlessMember_98a3f673-4c73-45fe-8e11-77b845048f27" xlink:href="vtrs-20211231.xsd#vtrs_VestinthreeyearsorlessMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_VestingPeriodDomain_82776c3c-3ba6-4c43-ac49-2f8d31de8629" xlink:to="loc_vtrs_VestinthreeyearsorlessMember_98a3f673-4c73-45fe-8e11-77b845048f27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fcc782d6-e74e-407e-a5cf-8f8c777366b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_907c9963-86da-4a1f-814a-086244a1e06a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fcc782d6-e74e-407e-a5cf-8f8c777366b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_7fbebc5c-a5e7-4ec3-b073-c00e023ba199" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fcc782d6-e74e-407e-a5cf-8f8c777366b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_7fbebc5c-a5e7-4ec3-b073-c00e023ba199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_94f40e9f-0e43-431d-9bd8-37fa9241f35a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fcc782d6-e74e-407e-a5cf-8f8c777366b6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_94f40e9f-0e43-431d-9bd8-37fa9241f35a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_9d09cac8-c7db-46a7-a7be-67debb7eb159" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fcc782d6-e74e-407e-a5cf-8f8c777366b6" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_9d09cac8-c7db-46a7-a7be-67debb7eb159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_7d41f61e-b754-442b-b289-ebad6f917a17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fcc782d6-e74e-407e-a5cf-8f8c777366b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_7d41f61e-b754-442b-b289-ebad6f917a17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_c7db740d-671b-454a-9237-7dd0c383b328" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fcc782d6-e74e-407e-a5cf-8f8c777366b6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_c7db740d-671b-454a-9237-7dd0c383b328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_e3dbfd1d-7da7-4b82-8f39-0013cc89620f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fcc782d6-e74e-407e-a5cf-8f8c777366b6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_e3dbfd1d-7da7-4b82-8f39-0013cc89620f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_35fb722b-df91-43be-b53c-6fed78e95397" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fcc782d6-e74e-407e-a5cf-8f8c777366b6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_35fb722b-df91-43be-b53c-6fed78e95397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_cf993c4d-ce6d-4bb6-8157-32b41b827c69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fcc782d6-e74e-407e-a5cf-8f8c777366b6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_cf993c4d-ce6d-4bb6-8157-32b41b827c69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_42817ab7-0daf-41f9-a566-995749bf0f1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fcc782d6-e74e-407e-a5cf-8f8c777366b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_42817ab7-0daf-41f9-a566-995749bf0f1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_0bbe6bb2-f6f3-45d9-89eb-c8aec997648c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fcc782d6-e74e-407e-a5cf-8f8c777366b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_0bbe6bb2-f6f3-45d9-89eb-c8aec997648c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_adf1cb1c-59bf-490c-81b0-a3fc918a805c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fcc782d6-e74e-407e-a5cf-8f8c777366b6" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_adf1cb1c-59bf-490c-81b0-a3fc918a805c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_d483634f-70ba-4ae5-81ce-ef5c46c04bde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fcc782d6-e74e-407e-a5cf-8f8c777366b6" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_d483634f-70ba-4ae5-81ce-ef5c46c04bde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue_45f3c28d-8acc-4b1c-be7a-e0973fc3964e" xlink:href="vtrs-20211231.xsd#vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fcc782d6-e74e-407e-a5cf-8f8c777366b6" xlink:to="loc_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue_45f3c28d-8acc-4b1c-be7a-e0973fc3964e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ReductioninSharebasedCompensationExpense_aea64364-933a-4652-8ce6-dcda67634837" xlink:href="vtrs-20211231.xsd#vtrs_ReductioninSharebasedCompensationExpense"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fcc782d6-e74e-407e-a5cf-8f8c777366b6" xlink:to="loc_vtrs_ReductioninSharebasedCompensationExpense_aea64364-933a-4652-8ce6-dcda67634837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_546af484-7cf6-46e0-b398-e6b00445e9d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fcc782d6-e74e-407e-a5cf-8f8c777366b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_546af484-7cf6-46e0-b398-e6b00445e9d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#ShareBasedIncentivePlanStockAwardsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6dd25742-eb06-422f-97a6-f909fe0850e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f62906fe-20f8-4127-b650-07298e5073e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6dd25742-eb06-422f-97a6-f909fe0850e2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f62906fe-20f8-4127-b650-07298e5073e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_7aa9a9df-2613-4f2d-9f95-9d1e525c6d74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f62906fe-20f8-4127-b650-07298e5073e4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_7aa9a9df-2613-4f2d-9f95-9d1e525c6d74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_a90bc34b-ad79-471a-9698-25dcd8da198c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f62906fe-20f8-4127-b650-07298e5073e4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_a90bc34b-ad79-471a-9698-25dcd8da198c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_b1e7dbfc-0b5d-4acd-9c93-aa4e27fd8749" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f62906fe-20f8-4127-b650-07298e5073e4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_b1e7dbfc-0b5d-4acd-9c93-aa4e27fd8749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_eb473900-d65b-4fa6-84cf-602827a7f1a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f62906fe-20f8-4127-b650-07298e5073e4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_eb473900-d65b-4fa6-84cf-602827a7f1a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2e14ed92-4813-4f28-bef6-955377ec35a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f62906fe-20f8-4127-b650-07298e5073e4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2e14ed92-4813-4f28-bef6-955377ec35a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_6a68dd4d-bf82-4e3d-a4d6-e0d2a4c4a4e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f62906fe-20f8-4127-b650-07298e5073e4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_6a68dd4d-bf82-4e3d-a4d6-e0d2a4c4a4e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_443599b2-1c2f-4b0b-83c2-afe8fe608f2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f62906fe-20f8-4127-b650-07298e5073e4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_443599b2-1c2f-4b0b-83c2-afe8fe608f2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_27211bc7-be6d-4405-84aa-2c0ad98ac9bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f62906fe-20f8-4127-b650-07298e5073e4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_27211bc7-be6d-4405-84aa-2c0ad98ac9bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_05f91829-9719-4726-9008-273240861e6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f62906fe-20f8-4127-b650-07298e5073e4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_05f91829-9719-4726-9008-273240861e6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_09281c70-2bd9-4f82-b286-5628d39e3cb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f62906fe-20f8-4127-b650-07298e5073e4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_09281c70-2bd9-4f82-b286-5628d39e3cb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_b908de1c-6af2-4ae4-87e6-d6a4a11b0ab1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f62906fe-20f8-4127-b650-07298e5073e4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_b908de1c-6af2-4ae4-87e6-d6a4a11b0ab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_a0be7c29-47fb-4f4e-8ae1-1d69f513d86b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f62906fe-20f8-4127-b650-07298e5073e4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_a0be7c29-47fb-4f4e-8ae1-1d69f513d86b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_20dcea38-17ce-4e12-8538-d7500f16cf65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f62906fe-20f8-4127-b650-07298e5073e4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_20dcea38-17ce-4e12-8538-d7500f16cf65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_efe5a84e-787f-4a84-be36-44cf11c5e51a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f62906fe-20f8-4127-b650-07298e5073e4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_efe5a84e-787f-4a84-be36-44cf11c5e51a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c8f134e3-f797-4f71-b64e-562686bca062" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e98c7820-f076-4dde-8fcd-fc9ff79aeaad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c8f134e3-f797-4f71-b64e-562686bca062" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e98c7820-f076-4dde-8fcd-fc9ff79aeaad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_618947af-8d66-413b-9c07-f46ba2418b51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e98c7820-f076-4dde-8fcd-fc9ff79aeaad" xlink:to="loc_us-gaap_AwardTypeAxis_618947af-8d66-413b-9c07-f46ba2418b51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b6bef024-69b5-4d73-965f-3365e5d0ea4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_618947af-8d66-413b-9c07-f46ba2418b51" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b6bef024-69b5-4d73-965f-3365e5d0ea4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_1d46f629-1ab9-4d0f-a6d1-6270160019e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b6bef024-69b5-4d73-965f-3365e5d0ea4b" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_1d46f629-1ab9-4d0f-a6d1-6270160019e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2418ca90-48bb-407e-a0f9-97a5118b7d01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e98c7820-f076-4dde-8fcd-fc9ff79aeaad" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2418ca90-48bb-407e-a0f9-97a5118b7d01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9d913ca9-758b-4bf0-aac2-b66157917fc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2418ca90-48bb-407e-a0f9-97a5118b7d01" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9d913ca9-758b-4bf0-aac2-b66157917fc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6d780244-06de-4079-93a1-bb14dc02f55c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9d913ca9-758b-4bf0-aac2-b66157917fc5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6d780244-06de-4079-93a1-bb14dc02f55c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_7dc64799-1d60-4e4d-a8fc-ef7b169a2051" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9d913ca9-758b-4bf0-aac2-b66157917fc5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_7dc64799-1d60-4e4d-a8fc-ef7b169a2051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_bfa7e57b-8688-4004-b43c-c1d8f5e36ea7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9d913ca9-758b-4bf0-aac2-b66157917fc5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_bfa7e57b-8688-4004-b43c-c1d8f5e36ea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0d0f8618-ee1f-4756-80b4-c42836d078bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9d913ca9-758b-4bf0-aac2-b66157917fc5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0d0f8618-ee1f-4756-80b4-c42836d078bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_82b8daa8-fcab-4aae-9b84-e4faa6450495" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9d913ca9-758b-4bf0-aac2-b66157917fc5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_82b8daa8-fcab-4aae-9b84-e4faa6450495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_52431320-1b06-4236-94fb-026fb644ce60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9d913ca9-758b-4bf0-aac2-b66157917fc5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_52431320-1b06-4236-94fb-026fb644ce60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_59943245-8a66-42b7-983c-01a07ae6ee84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9d913ca9-758b-4bf0-aac2-b66157917fc5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_59943245-8a66-42b7-983c-01a07ae6ee84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_6d007a92-0167-4485-ae2e-decebc5ba4f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9d913ca9-758b-4bf0-aac2-b66157917fc5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_6d007a92-0167-4485-ae2e-decebc5ba4f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_9769c083-f652-48d2-b446-d9ab190685d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9d913ca9-758b-4bf0-aac2-b66157917fc5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_9769c083-f652-48d2-b446-d9ab190685d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_27a21958-e852-4c52-ab0f-a74ce3f7e37f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9d913ca9-758b-4bf0-aac2-b66157917fc5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_27a21958-e852-4c52-ab0f-a74ce3f7e37f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ShareBasedIncentivePlanValuationAssumptionsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#ShareBasedIncentivePlanValuationAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/ShareBasedIncentivePlanValuationAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_af39438c-41a4-47ae-8b28-79993897d229" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e1b725e1-ee7a-4dea-8ccf-437b02ccb7a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_af39438c-41a4-47ae-8b28-79993897d229" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e1b725e1-ee7a-4dea-8ccf-437b02ccb7a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_e800d002-58b8-4ce4-a82d-f830025204c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e1b725e1-ee7a-4dea-8ccf-437b02ccb7a6" xlink:to="loc_us-gaap_PlanNameAxis_e800d002-58b8-4ce4-a82d-f830025204c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_d65edb4d-02d5-4207-babf-06fe1e4a9af9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_e800d002-58b8-4ce4-a82d-f830025204c6" xlink:to="loc_us-gaap_PlanNameDomain_d65edb4d-02d5-4207-babf-06fe1e4a9af9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_LongTermIncentivePlan2003Member_d7eb03a6-0a03-431b-963f-bdfc643de0fb" xlink:href="vtrs-20211231.xsd#vtrs_LongTermIncentivePlan2003Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_d65edb4d-02d5-4207-babf-06fe1e4a9af9" xlink:to="loc_vtrs_LongTermIncentivePlan2003Member_d7eb03a6-0a03-431b-963f-bdfc643de0fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ProgramNameAxis_fc746548-a377-4ae7-a096-b1356135015c" xlink:href="vtrs-20211231.xsd#vtrs_ProgramNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e1b725e1-ee7a-4dea-8ccf-437b02ccb7a6" xlink:to="loc_vtrs_ProgramNameAxis_fc746548-a377-4ae7-a096-b1356135015c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ProgramNameDomain_006a728b-2562-44b8-9c91-5f18b48fadff" xlink:href="vtrs-20211231.xsd#vtrs_ProgramNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ProgramNameAxis_fc746548-a377-4ae7-a096-b1356135015c" xlink:to="loc_vtrs_ProgramNameDomain_006a728b-2562-44b8-9c91-5f18b48fadff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2014ProgramMember_6bf25176-c269-4c39-91ef-49fa665e0680" xlink:href="vtrs-20211231.xsd#vtrs_A2014ProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_ProgramNameDomain_006a728b-2562-44b8-9c91-5f18b48fadff" xlink:to="loc_vtrs_A2014ProgramMember_6bf25176-c269-4c39-91ef-49fa665e0680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_3209e667-6f41-4529-b3b6-b13be19c3230" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e1b725e1-ee7a-4dea-8ccf-437b02ccb7a6" xlink:to="loc_us-gaap_AwardTypeAxis_3209e667-6f41-4529-b3b6-b13be19c3230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b4d2dcad-29e2-4d44-a61e-5d259c8456f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_3209e667-6f41-4529-b3b6-b13be19c3230" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b4d2dcad-29e2-4d44-a61e-5d259c8456f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_2580dff7-c629-4f0f-bf41-51bdd7989e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b4d2dcad-29e2-4d44-a61e-5d259c8456f0" xlink:to="loc_us-gaap_EmployeeStockOptionMember_2580dff7-c629-4f0f-bf41-51bdd7989e5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_StockappreciationrightsandperformancesharesMember_8229cd7c-8bef-4dc0-964d-f17059109075" xlink:href="vtrs-20211231.xsd#vtrs_StockappreciationrightsandperformancesharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b4d2dcad-29e2-4d44-a61e-5d259c8456f0" xlink:to="loc_vtrs_StockappreciationrightsandperformancesharesMember_8229cd7c-8bef-4dc0-964d-f17059109075" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_852b69dd-ec02-4f68-a709-3cc94df3f478" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b4d2dcad-29e2-4d44-a61e-5d259c8456f0" xlink:to="loc_us-gaap_PerformanceSharesMember_852b69dd-ec02-4f68-a709-3cc94df3f478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_760d53c7-201f-4736-9e1f-ae1578ec99a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e1b725e1-ee7a-4dea-8ccf-437b02ccb7a6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_760d53c7-201f-4736-9e1f-ae1578ec99a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_fd157880-0e96-4824-bb71-82f9282f2f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_760d53c7-201f-4736-9e1f-ae1578ec99a2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_fd157880-0e96-4824-bb71-82f9282f2f8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_6dc3f8a1-9825-42bc-8c20-079c460dda05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_760d53c7-201f-4736-9e1f-ae1578ec99a2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_6dc3f8a1-9825-42bc-8c20-079c460dda05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_cdadaf33-c09b-43f5-bd18-efe881c8d779" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_760d53c7-201f-4736-9e1f-ae1578ec99a2" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_cdadaf33-c09b-43f5-bd18-efe881c8d779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate_9572cd40-4ed1-4284-80f3-de3cb2aec4d5" xlink:href="vtrs-20211231.xsd#vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_760d53c7-201f-4736-9e1f-ae1578ec99a2" xlink:to="loc_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate_9572cd40-4ed1-4284-80f3-de3cb2aec4d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_8a540c03-20e6-4bab-8db0-9018bde7ef70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_760d53c7-201f-4736-9e1f-ae1578ec99a2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_8a540c03-20e6-4bab-8db0-9018bde7ef70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EmployeeBenefitPlans" xlink:type="simple" xlink:href="vtrs-20211231.xsd#EmployeeBenefitPlans"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/EmployeeBenefitPlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_42fc6e9c-966b-40b9-b5a6-bc04aacf7854" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_b6b05155-5351-4eef-8da1-7025f936be6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_42fc6e9c-966b-40b9-b5a6-bc04aacf7854" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_b6b05155-5351-4eef-8da1-7025f936be6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EmployeeBenefitPlansTables" xlink:type="simple" xlink:href="vtrs-20211231.xsd#EmployeeBenefitPlansTables"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/EmployeeBenefitPlansTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4b76e405-5ee6-48bf-87df-864bb6113d40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock_a02762ce-c77c-45fa-921f-6eac71ffb2b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4b76e405-5ee6-48bf-87df-864bb6113d40" xlink:to="loc_us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock_a02762ce-c77c-45fa-921f-6eac71ffb2b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_652d5db3-004a-4798-9734-166243e8ca39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4b76e405-5ee6-48bf-87df-864bb6113d40" xlink:to="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_652d5db3-004a-4798-9734-166243e8ca39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_adf58a6f-ae26-44dd-bb4d-c9c9800fa1db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4b76e405-5ee6-48bf-87df-864bb6113d40" xlink:to="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_adf58a6f-ae26-44dd-bb4d-c9c9800fa1db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock_ad0d739f-5961-4152-877a-34babb9eb08c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4b76e405-5ee6-48bf-87df-864bb6113d40" xlink:to="loc_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock_ad0d739f-5961-4152-877a-34babb9eb08c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_774a8e3f-470d-4d51-979e-f37184d40198" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4b76e405-5ee6-48bf-87df-864bb6113d40" xlink:to="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_774a8e3f-470d-4d51-979e-f37184d40198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_1b113853-3c45-47ff-9842-ecb488df1569" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4b76e405-5ee6-48bf-87df-864bb6113d40" xlink:to="loc_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_1b113853-3c45-47ff-9842-ecb488df1569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_95532a36-4e56-4c1c-89ab-c3309e011701" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4b76e405-5ee6-48bf-87df-864bb6113d40" xlink:to="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_95532a36-4e56-4c1c-89ab-c3309e011701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_b9e98ee9-b0c7-48f1-a76a-7982a160a84b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4b76e405-5ee6-48bf-87df-864bb6113d40" xlink:to="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_b9e98ee9-b0c7-48f1-a76a-7982a160a84b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_406c1e28-6975-47bc-a8fc-08ec39993fc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4b76e405-5ee6-48bf-87df-864bb6113d40" xlink:to="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_406c1e28-6975-47bc-a8fc-08ec39993fc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EmployeeBenefitPlansNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#EmployeeBenefitPlansNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/EmployeeBenefitPlansNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_2285ecfb-6ed5-4c98-b040-d900f05450ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_24fe24f0-3335-4f5a-8d42-88c1e2b3a076" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_2285ecfb-6ed5-4c98-b040-d900f05450ee" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_24fe24f0-3335-4f5a-8d42-88c1e2b3a076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis_f5a47223-f78c-4f84-81dc-bcf10ebef885" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_24fe24f0-3335-4f5a-8d42-88c1e2b3a076" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis_f5a47223-f78c-4f84-81dc-bcf10ebef885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain_327542cb-b6b1-4a47-9449-551f79bb06c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis_f5a47223-f78c-4f84-81dc-bcf10ebef885" xlink:to="loc_us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain_327542cb-b6b1-4a47-9449-551f79bb06c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DeferredBaseSalaryMember_37edfd3a-2196-4701-b4c4-cd57082516cd" xlink:href="vtrs-20211231.xsd#vtrs_DeferredBaseSalaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain_327542cb-b6b1-4a47-9449-551f79bb06c1" xlink:to="loc_vtrs_DeferredBaseSalaryMember_37edfd3a-2196-4701-b4c4-cd57082516cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredBonusMember_4529a12e-0c74-4c34-8e5a-2c8d647607e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredBonusMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain_327542cb-b6b1-4a47-9449-551f79bb06c1" xlink:to="loc_us-gaap_DeferredBonusMember_4529a12e-0c74-4c34-8e5a-2c8d647607e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PeriodAxis_752e6d97-bedb-45fa-8292-ac027b5854ae" xlink:href="vtrs-20211231.xsd#vtrs_PeriodAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_24fe24f0-3335-4f5a-8d42-88c1e2b3a076" xlink:to="loc_vtrs_PeriodAxis_752e6d97-bedb-45fa-8292-ac027b5854ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PeriodDomain_291f9cb2-81a9-477b-9f1f-07e230042925" xlink:href="vtrs-20211231.xsd#vtrs_PeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_PeriodAxis_752e6d97-bedb-45fa-8292-ac027b5854ae" xlink:to="loc_vtrs_PeriodDomain_291f9cb2-81a9-477b-9f1f-07e230042925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_FiscalYear2017Member_8644f725-47c9-4bb2-974d-7863f132058b" xlink:href="vtrs-20211231.xsd#vtrs_FiscalYear2017Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_PeriodDomain_291f9cb2-81a9-477b-9f1f-07e230042925" xlink:to="loc_vtrs_FiscalYear2017Member_8644f725-47c9-4bb2-974d-7863f132058b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d0988e92-4a00-45b6-b977-e12fa18ed813" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_24fe24f0-3335-4f5a-8d42-88c1e2b3a076" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d0988e92-4a00-45b6-b977-e12fa18ed813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear_8dea67bf-499c-4a77-89cb-3453a406e046" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d0988e92-4a00-45b6-b977-e12fa18ed813" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear_8dea67bf-499c-4a77-89cb-3453a406e046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear_1f50637d-f4c9-4223-8de0-8f657249404c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d0988e92-4a00-45b6-b977-e12fa18ed813" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear_1f50637d-f4c9-4223-8de0-8f657249404c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AccumulatednetactuariallossesexceedhigherofmarketvalueofplanassetsorPBO_b4a5522b-29ab-466b-8f44-4ac48fa324d1" xlink:href="vtrs-20211231.xsd#vtrs_AccumulatednetactuariallossesexceedhigherofmarketvalueofplanassetsorPBO"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d0988e92-4a00-45b6-b977-e12fa18ed813" xlink:to="loc_vtrs_AccumulatednetactuariallossesexceedhigherofmarketvalueofplanassetsorPBO_b4a5522b-29ab-466b-8f44-4ac48fa324d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_be1d976c-504b-4323-bc7c-2c4155ddf55a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d0988e92-4a00-45b6-b977-e12fa18ed813" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_be1d976c-504b-4323-bc7c-2c4155ddf55a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear_a1f0dc52-2fb8-4d56-903f-660e70e364bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d0988e92-4a00-45b6-b977-e12fa18ed813" xlink:to="loc_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear_a1f0dc52-2fb8-4d56-903f-660e70e364bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1_2e4f33eb-679a-4053-928c-bd9d6a346b6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d0988e92-4a00-45b6-b977-e12fa18ed813" xlink:to="loc_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1_2e4f33eb-679a-4053-928c-bd9d6a346b6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_f6b805c8-e340-4375-a6c5-0c1304697472" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d0988e92-4a00-45b6-b977-e12fa18ed813" xlink:to="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_f6b805c8-e340-4375-a6c5-0c1304697472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_eee82d9f-f0bd-4074-994e-fd46c96a9efd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d0988e92-4a00-45b6-b977-e12fa18ed813" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_eee82d9f-f0bd-4074-994e-fd46c96a9efd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MultiemployerPlansWithdrawalObligation_ee3c8cf4-c523-449e-9154-a0d2dc7b66c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MultiemployerPlansWithdrawalObligation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d0988e92-4a00-45b6-b977-e12fa18ed813" xlink:to="loc_us-gaap_MultiemployerPlansWithdrawalObligation_ee3c8cf4-c523-449e-9154-a0d2dc7b66c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EmployeeBenefitPlansAccumulatedOtherComprehensiveIncomeLossPretaxAmountsNotYetReclassifiedinNetPeriodicBenefitCostDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#EmployeeBenefitPlansAccumulatedOtherComprehensiveIncomeLossPretaxAmountsNotYetReclassifiedinNetPeriodicBenefitCostDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/EmployeeBenefitPlansAccumulatedOtherComprehensiveIncomeLossPretaxAmountsNotYetReclassifiedinNetPeriodicBenefitCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_45f60d9d-0f0b-4fb3-804d-ee7f9b9dcf6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_0e268011-0ec9-4769-8178-493f8575450a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_45f60d9d-0f0b-4fb3-804d-ee7f9b9dcf6e" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_0e268011-0ec9-4769-8178-493f8575450a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_178e2d4d-16ce-4197-90fd-1cf348ebb795" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_0e268011-0ec9-4769-8178-493f8575450a" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_178e2d4d-16ce-4197-90fd-1cf348ebb795" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_7b0ebac3-5b6a-430e-8f5d-c68f915a5540" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_178e2d4d-16ce-4197-90fd-1cf348ebb795" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_7b0ebac3-5b6a-430e-8f5d-c68f915a5540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_ceadcddd-95d2-4392-94ef-0c8bd84400a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_7b0ebac3-5b6a-430e-8f5d-c68f915a5540" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_ceadcddd-95d2-4392-94ef-0c8bd84400a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_12ae7f28-07ac-4c13-b83b-7db4a697218f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_7b0ebac3-5b6a-430e-8f5d-c68f915a5540" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_12ae7f28-07ac-4c13-b83b-7db4a697218f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_0d75ffdf-2b52-464b-acca-c30da6149a5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_0e268011-0ec9-4769-8178-493f8575450a" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_0d75ffdf-2b52-464b-acca-c30da6149a5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_3afd485c-1e9a-46d5-abb4-36320bdfd968" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_0d75ffdf-2b52-464b-acca-c30da6149a5b" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_3afd485c-1e9a-46d5-abb4-36320bdfd968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_47652f4e-2380-4e7d-84d1-8f17284708d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_0d75ffdf-2b52-464b-acca-c30da6149a5b" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_47652f4e-2380-4e7d-84d1-8f17284708d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_b1ec693b-abcc-4f62-8184-5dd76b13d1ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_0d75ffdf-2b52-464b-acca-c30da6149a5b" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_b1ec693b-abcc-4f62-8184-5dd76b13d1ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EmployeeBenefitPlansChangeinAccumulatedIncomeLossRelatingtoDefinedBenefitPensionandOtherPostretirementBenefitsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#EmployeeBenefitPlansChangeinAccumulatedIncomeLossRelatingtoDefinedBenefitPensionandOtherPostretirementBenefitsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/EmployeeBenefitPlansChangeinAccumulatedIncomeLossRelatingtoDefinedBenefitPensionandOtherPostretirementBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_957195ad-935e-4bf3-a2dd-d35198b9991e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_83bdb476-de88-40d7-af9b-be9b5f8716da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_957195ad-935e-4bf3-a2dd-d35198b9991e" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_83bdb476-de88-40d7-af9b-be9b5f8716da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_3bb85904-2408-472a-9f38-58584e4789a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_83bdb476-de88-40d7-af9b-be9b5f8716da" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_3bb85904-2408-472a-9f38-58584e4789a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_d8da7ef5-30a6-4e47-9166-351c8e37bcaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_3bb85904-2408-472a-9f38-58584e4789a1" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_d8da7ef5-30a6-4e47-9166-351c8e37bcaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_205d8117-ecc4-4dec-91e5-f604cb9115a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_d8da7ef5-30a6-4e47-9166-351c8e37bcaf" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_205d8117-ecc4-4dec-91e5-f604cb9115a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_3ae57b71-0ec1-4f8d-a152-b7e649aa19b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_d8da7ef5-30a6-4e47-9166-351c8e37bcaf" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_3ae57b71-0ec1-4f8d-a152-b7e649aa19b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_ead502fe-196a-42a3-830b-d3e11eb6e156" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_83bdb476-de88-40d7-af9b-be9b5f8716da" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_ead502fe-196a-42a3-830b-d3e11eb6e156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_e8e5f71f-6dc9-422d-9a14-0c47437aa199" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_ead502fe-196a-42a3-830b-d3e11eb6e156" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_e8e5f71f-6dc9-422d-9a14-0c47437aa199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_9dd6b58f-f6f0-487f-90d2-e595f6d0c6e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_ead502fe-196a-42a3-830b-d3e11eb6e156" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_9dd6b58f-f6f0-487f-90d2-e595f6d0c6e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_99330c72-e754-45d1-b7d6-6893f0c86d1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_ead502fe-196a-42a3-830b-d3e11eb6e156" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_99330c72-e754-45d1-b7d6-6893f0c86d1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax_cdf72e4b-9f2c-4906-8e40-4de26e48d621" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_ead502fe-196a-42a3-830b-d3e11eb6e156" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax_cdf72e4b-9f2c-4906-8e40-4de26e48d621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherComprehensiveIncomeDefinedBenefitPlanForeignCurrencyTranslationBeforeTax_c14b209d-3c16-424c-a2db-46692695595f" xlink:href="vtrs-20211231.xsd#vtrs_OtherComprehensiveIncomeDefinedBenefitPlanForeignCurrencyTranslationBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_ead502fe-196a-42a3-830b-d3e11eb6e156" xlink:to="loc_vtrs_OtherComprehensiveIncomeDefinedBenefitPlanForeignCurrencyTranslationBeforeTax_c14b209d-3c16-424c-a2db-46692695595f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_ebb3da7c-e101-4805-983f-99a0ace0c4d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_ead502fe-196a-42a3-830b-d3e11eb6e156" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_ebb3da7c-e101-4805-983f-99a0ace0c4d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EmployeeBenefitPlansNetPeriodicBenefitCostsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#EmployeeBenefitPlansNetPeriodicBenefitCostsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/EmployeeBenefitPlansNetPeriodicBenefitCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_5e1171e8-e631-4ffe-9ee2-0b4f328d8292" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_68dbe95b-c5a4-4375-8ca5-8bcb73cee4b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_5e1171e8-e631-4ffe-9ee2-0b4f328d8292" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_68dbe95b-c5a4-4375-8ca5-8bcb73cee4b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_06387610-3fbb-4468-ac8b-2f581f186f8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_68dbe95b-c5a4-4375-8ca5-8bcb73cee4b0" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_06387610-3fbb-4468-ac8b-2f581f186f8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_a45a7f7d-d93e-4beb-beb7-2d33483af7d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_06387610-3fbb-4468-ac8b-2f581f186f8d" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_a45a7f7d-d93e-4beb-beb7-2d33483af7d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember_e964a91b-9323-4be6-b6f6-3d71d5da3261" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_a45a7f7d-d93e-4beb-beb7-2d33483af7d5" xlink:to="loc_us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember_e964a91b-9323-4be6-b6f6-3d71d5da3261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_6368838a-f993-47aa-89b0-0cae4146f04d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_a45a7f7d-d93e-4beb-beb7-2d33483af7d5" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_6368838a-f993-47aa-89b0-0cae4146f04d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_72961e4a-6904-4dba-a5b9-38b39bf30ead" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_a45a7f7d-d93e-4beb-beb7-2d33483af7d5" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_72961e4a-6904-4dba-a5b9-38b39bf30ead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_efaac62d-7cb0-41a0-aa5f-5630745814c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_68dbe95b-c5a4-4375-8ca5-8bcb73cee4b0" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_efaac62d-7cb0-41a0-aa5f-5630745814c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_64fed9b4-910d-4898-810e-cc96627c10ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_efaac62d-7cb0-41a0-aa5f-5630745814c2" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_64fed9b4-910d-4898-810e-cc96627c10ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_ef11b9f6-c806-4ac8-a4dc-755be1b5efa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_efaac62d-7cb0-41a0-aa5f-5630745814c2" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_ef11b9f6-c806-4ac8-a4dc-755be1b5efa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_c0eac9b0-6b83-4192-8852-4a6bf55af822" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_efaac62d-7cb0-41a0-aa5f-5630745814c2" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_c0eac9b0-6b83-4192-8852-4a6bf55af822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCurtailments_1b5c6f04-3c7a-4176-a163-2ddedbaf3dba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanCurtailments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_efaac62d-7cb0-41a0-aa5f-5630745814c2" xlink:to="loc_us-gaap_DefinedBenefitPlanCurtailments_1b5c6f04-3c7a-4176-a163-2ddedbaf3dba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_1147f2ef-94d1-4502-9563-e3487b0737bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_efaac62d-7cb0-41a0-aa5f-5630745814c2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_1147f2ef-94d1-4502-9563-e3487b0737bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_0fbb0cf0-ec2c-4807-b52b-529ef4a51dfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_efaac62d-7cb0-41a0-aa5f-5630745814c2" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_0fbb0cf0-ec2c-4807-b52b-529ef4a51dfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_0b7d68e5-f073-4c3b-8284-0162baba8179" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_efaac62d-7cb0-41a0-aa5f-5630745814c2" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_0b7d68e5-f073-4c3b-8284-0162baba8179" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EmployeeBenefitPlansChangesinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#EmployeeBenefitPlansChangesinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/EmployeeBenefitPlansChangesinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_60e07dd1-8713-4b53-90d6-eb11b289bd1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_5732cd41-0488-44d1-bcdd-a4623490a854" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_60e07dd1-8713-4b53-90d6-eb11b289bd1f" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_5732cd41-0488-44d1-bcdd-a4623490a854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_d1ce574c-b92b-447b-ae55-4f61a32f90b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_5732cd41-0488-44d1-bcdd-a4623490a854" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_d1ce574c-b92b-447b-ae55-4f61a32f90b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_5c64a869-1e25-4d2c-9391-86fb4fbfa2c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_d1ce574c-b92b-447b-ae55-4f61a32f90b8" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_5c64a869-1e25-4d2c-9391-86fb4fbfa2c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_27bca679-5109-4c38-a7bd-9fa24883aeb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_5c64a869-1e25-4d2c-9391-86fb4fbfa2c8" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_27bca679-5109-4c38-a7bd-9fa24883aeb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_d8837617-ab1f-469a-9207-319f489b60a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_5c64a869-1e25-4d2c-9391-86fb4fbfa2c8" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_d8837617-ab1f-469a-9207-319f489b60a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_c9022b2a-1577-47df-b2d6-488558bcf006" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_5732cd41-0488-44d1-bcdd-a4623490a854" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_c9022b2a-1577-47df-b2d6-488558bcf006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f01528ac-f1a3-453e-903c-bb8ed2021ad4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_c9022b2a-1577-47df-b2d6-488558bcf006" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f01528ac-f1a3-453e-903c-bb8ed2021ad4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_91d1e241-86d9-4816-8b81-0df150451331" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f01528ac-f1a3-453e-903c-bb8ed2021ad4" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_91d1e241-86d9-4816-8b81-0df150451331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_c54f051d-9b79-4576-9c0b-bc19202a406a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f01528ac-f1a3-453e-903c-bb8ed2021ad4" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_c54f051d-9b79-4576-9c0b-bc19202a406a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_fc70e8be-7176-488b-964c-6f75e968e3da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f01528ac-f1a3-453e-903c-bb8ed2021ad4" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_fc70e8be-7176-488b-964c-6f75e968e3da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DefinedBenefitPlanContributionsByPlanParticipantsBenefitObligation_96a16bf3-91e1-475f-9df7-0fe39a2ef158" xlink:href="vtrs-20211231.xsd#vtrs_DefinedBenefitPlanContributionsByPlanParticipantsBenefitObligation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f01528ac-f1a3-453e-903c-bb8ed2021ad4" xlink:to="loc_vtrs_DefinedBenefitPlanContributionsByPlanParticipantsBenefitObligation_96a16bf3-91e1-475f-9df7-0fe39a2ef158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAssetsTransferredtofromPlan_8dce51b0-afc7-4034-8c8b-2d4a27da0e37" xlink:href="vtrs-20211231.xsd#vtrs_DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAssetsTransferredtofromPlan"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f01528ac-f1a3-453e-903c-bb8ed2021ad4" xlink:to="loc_vtrs_DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAssetsTransferredtofromPlan_8dce51b0-afc7-4034-8c8b-2d4a27da0e37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_d2385f1e-ac64-4fb1-bc02-232a3064d7e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsBenefitObligation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f01528ac-f1a3-453e-903c-bb8ed2021ad4" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_d2385f1e-ac64-4fb1-bc02-232a3064d7e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_70c8a88f-5b70-496d-ac79-4ce66938deee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f01528ac-f1a3-453e-903c-bb8ed2021ad4" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_70c8a88f-5b70-496d-ac79-4ce66938deee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_d1fcdc6e-c35e-4e46-b9ea-a81c249a9190" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f01528ac-f1a3-453e-903c-bb8ed2021ad4" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_d1fcdc6e-c35e-4e46-b9ea-a81c249a9190" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_38911312-115e-4264-b728-6d73c358e4cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f01528ac-f1a3-453e-903c-bb8ed2021ad4" xlink:to="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_38911312-115e-4264-b728-6d73c358e4cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_236dad45-bc12-4c78-be83-0fee556d5e33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f01528ac-f1a3-453e-903c-bb8ed2021ad4" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_236dad45-bc12-4c78-be83-0fee556d5e33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_be171d3b-07b4-464a-86e0-e98e98f59de1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_c9022b2a-1577-47df-b2d6-488558bcf006" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_be171d3b-07b4-464a-86e0-e98e98f59de1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_7581f41b-74ae-49ef-bd31-b7e7b4baeccc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_be171d3b-07b4-464a-86e0-e98e98f59de1" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_7581f41b-74ae-49ef-bd31-b7e7b4baeccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_d6bd019e-ea14-41fa-ad2a-451634b00da9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_be171d3b-07b4-464a-86e0-e98e98f59de1" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_d6bd019e-ea14-41fa-ad2a-451634b00da9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_005773d6-ac85-4b08-8332-fa4fb996fe4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_be171d3b-07b4-464a-86e0-e98e98f59de1" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_005773d6-ac85-4b08-8332-fa4fb996fe4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_6b55296f-c5d2-4f8c-b885-884adc4396f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_be171d3b-07b4-464a-86e0-e98e98f59de1" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_6b55296f-c5d2-4f8c-b885-884adc4396f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets_73044789-cfde-43ed-a8e4-06d001b66579" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_be171d3b-07b4-464a-86e0-e98e98f59de1" xlink:to="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets_73044789-cfde-43ed-a8e4-06d001b66579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan_0bc72795-1dbe-4d16-a15c-466d2d9ad959" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_be171d3b-07b4-464a-86e0-e98e98f59de1" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan_0bc72795-1dbe-4d16-a15c-466d2d9ad959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_4e0a1ac7-142e-4050-91f0-8c2f69cb0c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_be171d3b-07b4-464a-86e0-e98e98f59de1" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_4e0a1ac7-142e-4050-91f0-8c2f69cb0c6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanOtherCosts_de2976dc-781e-40e9-a3fb-3d031dbf3c01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanOtherCosts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_be171d3b-07b4-464a-86e0-e98e98f59de1" xlink:to="loc_us-gaap_DefinedBenefitPlanOtherCosts_de2976dc-781e-40e9-a3fb-3d031dbf3c01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DefinedBenefitPlanForeignCurrencyTranslationImpactonPlanAssets_893c68a5-9af7-424e-9b84-66a7136d7066" xlink:href="vtrs-20211231.xsd#vtrs_DefinedBenefitPlanForeignCurrencyTranslationImpactonPlanAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_be171d3b-07b4-464a-86e0-e98e98f59de1" xlink:to="loc_vtrs_DefinedBenefitPlanForeignCurrencyTranslationImpactonPlanAssets_893c68a5-9af7-424e-9b84-66a7136d7066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_7e98b36b-7262-40de-962a-9cce2d553e09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_be171d3b-07b4-464a-86e0-e98e98f59de1" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_7e98b36b-7262-40de-962a-9cce2d553e09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_04e57c30-7c78-41bd-9448-c5b21fb7a22a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_c9022b2a-1577-47df-b2d6-488558bcf006" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_04e57c30-7c78-41bd-9448-c5b21fb7a22a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EmployeeBenefitPlansNetAccruedBenefitCostsClassificationonBalanceSheetDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#EmployeeBenefitPlansNetAccruedBenefitCostsClassificationonBalanceSheetDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/EmployeeBenefitPlansNetAccruedBenefitCostsClassificationonBalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_8180a870-d599-4189-9333-4e029177b56e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_a37f8849-d413-45a3-8797-c87b87689b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_8180a870-d599-4189-9333-4e029177b56e" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_a37f8849-d413-45a3-8797-c87b87689b5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_31fe6580-80ac-47a1-93d5-bef13ba4acda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_a37f8849-d413-45a3-8797-c87b87689b5b" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_31fe6580-80ac-47a1-93d5-bef13ba4acda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_079e0fd8-e2c5-40fc-beab-509f93405082" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_31fe6580-80ac-47a1-93d5-bef13ba4acda" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_079e0fd8-e2c5-40fc-beab-509f93405082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_31987cfb-4bc8-4497-9a69-99743dc8f170" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_079e0fd8-e2c5-40fc-beab-509f93405082" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_31987cfb-4bc8-4497-9a69-99743dc8f170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_612a1646-f528-4b8d-a4ae-65ac5469c522" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_079e0fd8-e2c5-40fc-beab-509f93405082" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_612a1646-f528-4b8d-a4ae-65ac5469c522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_f2f16d1e-ffce-4f36-b038-2575524bbc4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_a37f8849-d413-45a3-8797-c87b87689b5b" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_f2f16d1e-ffce-4f36-b038-2575524bbc4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_1960c463-3e0f-47d5-824f-892ff142e053" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_f2f16d1e-ffce-4f36-b038-2575524bbc4e" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_1960c463-3e0f-47d5-824f-892ff142e053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_fd500dfe-1015-4a64-a114-02cfb9ee7927" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_f2f16d1e-ffce-4f36-b038-2575524bbc4e" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_fd500dfe-1015-4a64-a114-02cfb9ee7927" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_2d53c9f0-2ac0-40b6-ab39-4488a4d380fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_f2f16d1e-ffce-4f36-b038-2575524bbc4e" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_2d53c9f0-2ac0-40b6-ab39-4488a4d380fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Netaccruedbenefitcosts_cd088270-166b-4ae2-b8e9-31138d4178f6" xlink:href="vtrs-20211231.xsd#vtrs_Netaccruedbenefitcosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_f2f16d1e-ffce-4f36-b038-2575524bbc4e" xlink:to="loc_vtrs_Netaccruedbenefitcosts_cd088270-166b-4ae2-b8e9-31138d4178f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EmployeeBenefitPlansPlanswithPBOinExcessofPlanAssetsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#EmployeeBenefitPlansPlanswithPBOinExcessofPlanAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/EmployeeBenefitPlansPlanswithPBOinExcessofPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e02f001f-b230-4398-b083-bc956ae3d9c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_59402d04-5863-4b8e-8ba8-fb9600376d18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e02f001f-b230-4398-b083-bc956ae3d9c0" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_59402d04-5863-4b8e-8ba8-fb9600376d18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_453b192b-8c98-443c-b180-5b58483c6db9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_59402d04-5863-4b8e-8ba8-fb9600376d18" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_453b192b-8c98-443c-b180-5b58483c6db9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_b4c499e2-2412-4ed4-8fdb-b26dc0b0daf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_453b192b-8c98-443c-b180-5b58483c6db9" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_b4c499e2-2412-4ed4-8fdb-b26dc0b0daf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_8d5858bb-23c8-4fbd-a4ec-d2fca095257e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_b4c499e2-2412-4ed4-8fdb-b26dc0b0daf2" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_8d5858bb-23c8-4fbd-a4ec-d2fca095257e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_37725971-b4f2-49c1-a594-aedae5136dd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_59402d04-5863-4b8e-8ba8-fb9600376d18" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_37725971-b4f2-49c1-a594-aedae5136dd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_bf5c7590-f65f-464c-b149-d9364fcc7a59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_37725971-b4f2-49c1-a594-aedae5136dd3" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_bf5c7590-f65f-464c-b149-d9364fcc7a59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DefinedBenefitPensionPlanswithProjectedBenefitObligationInExcessofPlanAssetsAggregateProjectedBenefitObligation_da921afb-ce1f-4cbe-bcca-f1533748bc5b" xlink:href="vtrs-20211231.xsd#vtrs_DefinedBenefitPensionPlanswithProjectedBenefitObligationInExcessofPlanAssetsAggregateProjectedBenefitObligation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_37725971-b4f2-49c1-a594-aedae5136dd3" xlink:to="loc_vtrs_DefinedBenefitPensionPlanswithProjectedBenefitObligationInExcessofPlanAssetsAggregateProjectedBenefitObligation_da921afb-ce1f-4cbe-bcca-f1533748bc5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets_b2b95e4a-d26c-4098-a08b-8ef5d5ef36c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_37725971-b4f2-49c1-a594-aedae5136dd3" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets_b2b95e4a-d26c-4098-a08b-8ef5d5ef36c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EmployeeBenefitPlansFairValuesofPlanAssetsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#EmployeeBenefitPlansFairValuesofPlanAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/EmployeeBenefitPlansFairValuesofPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_1c4cdc2a-2106-45a1-9b6a-73be9ec68967" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_77353c48-96a7-41e1-acd6-8069c59b0afe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_1c4cdc2a-2106-45a1-9b6a-73be9ec68967" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_77353c48-96a7-41e1-acd6-8069c59b0afe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_91ea2066-378e-4fb0-ba2c-82f739310af9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_77353c48-96a7-41e1-acd6-8069c59b0afe" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_91ea2066-378e-4fb0-ba2c-82f739310af9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_81f167a3-3b41-4c57-bb3c-c2468e48abd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_91ea2066-378e-4fb0-ba2c-82f739310af9" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_81f167a3-3b41-4c57-bb3c-c2468e48abd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_8fe29edd-57b5-4ca6-a0b8-5cc865a1ecd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_81f167a3-3b41-4c57-bb3c-c2468e48abd0" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_8fe29edd-57b5-4ca6-a0b8-5cc865a1ecd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_212b0cca-df59-4ef8-b7c1-a19f8323d540" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_81f167a3-3b41-4c57-bb3c-c2468e48abd0" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_212b0cca-df59-4ef8-b7c1-a19f8323d540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_7061ba0e-2f47-41df-b904-cd75183478ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_81f167a3-3b41-4c57-bb3c-c2468e48abd0" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_7061ba0e-2f47-41df-b904-cd75183478ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_6fd2ee43-1206-4a2f-a8a1-b549e328cd6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_77353c48-96a7-41e1-acd6-8069c59b0afe" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_6fd2ee43-1206-4a2f-a8a1-b549e328cd6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_0ed8d20d-50c0-40fa-b97d-8da86d8ef430" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_6fd2ee43-1206-4a2f-a8a1-b549e328cd6a" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_0ed8d20d-50c0-40fa-b97d-8da86d8ef430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_072694c9-1996-40de-a42e-442e53688267" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_0ed8d20d-50c0-40fa-b97d-8da86d8ef430" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_072694c9-1996-40de-a42e-442e53688267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_7e9445bd-a5d7-4ec6-9708-c76ed464cfd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_0ed8d20d-50c0-40fa-b97d-8da86d8ef430" xlink:to="loc_us-gaap_EquitySecuritiesMember_7e9445bd-a5d7-4ec6-9708-c76ed464cfd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_c81adf55-88f9-4ddf-98a7-07b3594e4120" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_0ed8d20d-50c0-40fa-b97d-8da86d8ef430" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_c81adf55-88f9-4ddf-98a7-07b3594e4120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AssetsheldbyinsurancecompaniesandotherMember_0f976649-8337-43d7-8a55-790166552115" xlink:href="vtrs-20211231.xsd#vtrs_AssetsheldbyinsurancecompaniesandotherMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_0ed8d20d-50c0-40fa-b97d-8da86d8ef430" xlink:to="loc_vtrs_AssetsheldbyinsurancecompaniesandotherMember_0f976649-8337-43d7-8a55-790166552115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ba40f7d6-2b9f-41d7-9139-f07e67454aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_77353c48-96a7-41e1-acd6-8069c59b0afe" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ba40f7d6-2b9f-41d7-9139-f07e67454aa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_85bb03b4-5860-4567-ad46-cbb0cf6601cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ba40f7d6-2b9f-41d7-9139-f07e67454aa3" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_85bb03b4-5860-4567-ad46-cbb0cf6601cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EmployeeBenefitPlansWeightedAverageAssumptionsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#EmployeeBenefitPlansWeightedAverageAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/EmployeeBenefitPlansWeightedAverageAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_cbb29bec-bf97-483d-b89c-e048b10b56c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_e24a8061-7409-4a8f-8398-4b6f1b4f247d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_cbb29bec-bf97-483d-b89c-e048b10b56c0" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_e24a8061-7409-4a8f-8398-4b6f1b4f247d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_d67e352f-a021-46f7-9543-6c6efad5846d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_e24a8061-7409-4a8f-8398-4b6f1b4f247d" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_d67e352f-a021-46f7-9543-6c6efad5846d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_6b0c57ff-99a7-4c6f-8bf4-b9f877b5530f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_d67e352f-a021-46f7-9543-6c6efad5846d" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_6b0c57ff-99a7-4c6f-8bf4-b9f877b5530f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_b8c4ae4a-a6bf-4fdc-b4dd-cb3ee0a09039" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_6b0c57ff-99a7-4c6f-8bf4-b9f877b5530f" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_b8c4ae4a-a6bf-4fdc-b4dd-cb3ee0a09039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_42cf0315-4cf0-49fb-913c-53c2495c74a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_6b0c57ff-99a7-4c6f-8bf4-b9f877b5530f" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_42cf0315-4cf0-49fb-913c-53c2495c74a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a6a27a2d-fe51-4d60-953b-ffc1b70f3cad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_e24a8061-7409-4a8f-8398-4b6f1b4f247d" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a6a27a2d-fe51-4d60-953b-ffc1b70f3cad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_0bf69a06-71ec-4290-9051-05f92605a81a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a6a27a2d-fe51-4d60-953b-ffc1b70f3cad" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_0bf69a06-71ec-4290-9051-05f92605a81a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationExpectedLongtermReturnonAssets_a350577f-2877-4749-bcdd-3913a3b8a4a8" xlink:href="vtrs-20211231.xsd#vtrs_DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationExpectedLongtermReturnonAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a6a27a2d-fe51-4d60-953b-ffc1b70f3cad" xlink:to="loc_vtrs_DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationExpectedLongtermReturnonAssets_a350577f-2877-4749-bcdd-3913a3b8a4a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_870042e5-7e30-4c9a-a970-314c350d56cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a6a27a2d-fe51-4d60-953b-ffc1b70f3cad" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_870042e5-7e30-4c9a-a970-314c350d56cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_c4142381-ab02-4b98-b3c2-1acc5689cd46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a6a27a2d-fe51-4d60-953b-ffc1b70f3cad" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_c4142381-ab02-4b98-b3c2-1acc5689cd46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_cafab373-af08-4848-b2bd-f3a882acd59e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a6a27a2d-fe51-4d60-953b-ffc1b70f3cad" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_cafab373-af08-4848-b2bd-f3a882acd59e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_12818a20-16a6-4382-b2d7-5695432c08c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a6a27a2d-fe51-4d60-953b-ffc1b70f3cad" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_12818a20-16a6-4382-b2d7-5695432c08c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EmployeeBenefitPlansEffectofOnePercentagePointIncreaseorDecreaseinHealthCareCostTrendRatesDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#EmployeeBenefitPlansEffectofOnePercentagePointIncreaseorDecreaseinHealthCareCostTrendRatesDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/EmployeeBenefitPlansEffectofOnePercentagePointIncreaseorDecreaseinHealthCareCostTrendRatesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_452b5972-c32a-45d1-b707-57239c4ca59a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_de255f35-491a-4849-a3c7-187c7b067938" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_452b5972-c32a-45d1-b707-57239c4ca59a" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_de255f35-491a-4849-a3c7-187c7b067938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_b0d8589b-f253-4cf5-b45d-d1a7c214959b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_de255f35-491a-4849-a3c7-187c7b067938" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_b0d8589b-f253-4cf5-b45d-d1a7c214959b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_0fdda068-847d-40e6-a787-56e7218bb38d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_b0d8589b-f253-4cf5-b45d-d1a7c214959b" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_0fdda068-847d-40e6-a787-56e7218bb38d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_ae2b6a49-1373-469d-8786-c96975a344a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_0fdda068-847d-40e6-a787-56e7218bb38d" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_ae2b6a49-1373-469d-8786-c96975a344a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_c816426c-92a0-4558-898f-fe6d9ff87b82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_de255f35-491a-4849-a3c7-187c7b067938" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_c816426c-92a0-4558-898f-fe6d9ff87b82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation_69d05adf-4562-4b18-9081-128baf60a1c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_c816426c-92a0-4558-898f-fe6d9ff87b82" xlink:to="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation_69d05adf-4562-4b18-9081-128baf60a1c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnAccumulatedPostretirementBenefitObligation1_58ec3248-06f3-46d1-8759-0e800ba345f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnAccumulatedPostretirementBenefitObligation1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_c816426c-92a0-4558-898f-fe6d9ff87b82" xlink:to="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnAccumulatedPostretirementBenefitObligation1_58ec3248-06f3-46d1-8759-0e800ba345f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnServiceAndInterestCostComponents_a5a1308b-a847-4dfa-a0e9-ac24da9df48e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnServiceAndInterestCostComponents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_c816426c-92a0-4558-898f-fe6d9ff87b82" xlink:to="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnServiceAndInterestCostComponents_a5a1308b-a847-4dfa-a0e9-ac24da9df48e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnServiceAndInterestCostComponents1_c92df033-9823-463a-afca-d7387fe576b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnServiceAndInterestCostComponents1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_c816426c-92a0-4558-898f-fe6d9ff87b82" xlink:to="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnServiceAndInterestCostComponents1_c92df033-9823-463a-afca-d7387fe576b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/EmployeeBenefitPlansEstimatedFutureBenefitPaymentsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#EmployeeBenefitPlansEstimatedFutureBenefitPaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/EmployeeBenefitPlansEstimatedFutureBenefitPaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_d0d96b26-f110-47db-ba87-b02c3cf93987" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_df1340ca-7ef5-46ac-a8cc-18c69e2ad461" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_d0d96b26-f110-47db-ba87-b02c3cf93987" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_df1340ca-7ef5-46ac-a8cc-18c69e2ad461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_27bb0759-3dcd-4714-a9ac-52ab1b190341" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_df1340ca-7ef5-46ac-a8cc-18c69e2ad461" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_27bb0759-3dcd-4714-a9ac-52ab1b190341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_a7e4a125-4d09-4a3f-b2d2-735cba878552" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_27bb0759-3dcd-4714-a9ac-52ab1b190341" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_a7e4a125-4d09-4a3f-b2d2-735cba878552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_16e48db0-c906-42f0-997f-c66cfc5d6693" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_a7e4a125-4d09-4a3f-b2d2-735cba878552" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_16e48db0-c906-42f0-997f-c66cfc5d6693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_b1d91c1b-e970-47b3-9a8a-a028aed721df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_a7e4a125-4d09-4a3f-b2d2-735cba878552" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_b1d91c1b-e970-47b3-9a8a-a028aed721df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d0267790-9803-4285-8939-34a5ea8a0e29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_df1340ca-7ef5-46ac-a8cc-18c69e2ad461" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d0267790-9803-4285-8939-34a5ea8a0e29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_88a35160-3b42-4ab5-9d09-625badfba8f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d0267790-9803-4285-8939-34a5ea8a0e29" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_88a35160-3b42-4ab5-9d09-625badfba8f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_11448c0e-ed08-486c-815f-88bfbbf3f5e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d0267790-9803-4285-8939-34a5ea8a0e29" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_11448c0e-ed08-486c-815f-88bfbbf3f5e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_9a3cd6d7-0e8f-4f82-b4f6-e5b3efc729b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d0267790-9803-4285-8939-34a5ea8a0e29" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_9a3cd6d7-0e8f-4f82-b4f6-e5b3efc729b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_459b6bb2-cfef-4940-87c2-1d5b160b7712" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d0267790-9803-4285-8939-34a5ea8a0e29" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_459b6bb2-cfef-4940-87c2-1d5b160b7712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_353180bd-979a-46ac-9b0e-dfc53fdbbb5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d0267790-9803-4285-8939-34a5ea8a0e29" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_353180bd-979a-46ac-9b0e-dfc53fdbbb5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_d9cc3f6b-5ccd-4c58-b11f-115228150ec3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d0267790-9803-4285-8939-34a5ea8a0e29" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_d9cc3f6b-5ccd-4c58-b11f-115228150ec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ExpectedFutureBenefitPayments_9737dbf8-e0a5-4c48-a6ff-01582fbb5eb1" xlink:href="vtrs-20211231.xsd#vtrs_ExpectedFutureBenefitPayments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d0267790-9803-4285-8939-34a5ea8a0e29" xlink:to="loc_vtrs_ExpectedFutureBenefitPayments_9737dbf8-e0a5-4c48-a6ff-01582fbb5eb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/SegmentInformation" xlink:type="simple" xlink:href="vtrs-20211231.xsd#SegmentInformation"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/SegmentInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_8da35aed-3d67-49d7-8efe-1d5a3caa1fac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_9a2182c4-e62f-451e-bdc2-b97f896bbf35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8da35aed-3d67-49d7-8efe-1d5a3caa1fac" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_9a2182c4-e62f-451e-bdc2-b97f896bbf35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/SegmentInformationTables" xlink:type="simple" xlink:href="vtrs-20211231.xsd#SegmentInformationTables"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/SegmentInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_bf0c2eb9-8a85-47b3-a879-ed3424cf6fc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_5ae2e06a-fdf9-44ac-ba17-72930acde328" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_bf0c2eb9-8a85-47b3-a879-ed3424cf6fc2" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_5ae2e06a-fdf9-44ac-ba17-72930acde328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_6b8ba620-f61b-4f6a-a574-f0e05ddf3df1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_bf0c2eb9-8a85-47b3-a879-ed3424cf6fc2" xlink:to="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_6b8ba620-f61b-4f6a-a574-f0e05ddf3df1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_bbb16a55-2560-40ec-a75a-d152e40e4df6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_bf0c2eb9-8a85-47b3-a879-ed3424cf6fc2" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_bbb16a55-2560-40ec-a75a-d152e40e4df6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/SegmentInformationReconciliationofSegmentInformationtoTotalConsolidatedInformationDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#SegmentInformationReconciliationofSegmentInformationtoTotalConsolidatedInformationDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/SegmentInformationReconciliationofSegmentInformationtoTotalConsolidatedInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_acc9b598-f723-4287-86a9-3c8fd83889f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9e44db20-6643-478d-9c75-057171b229c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_acc9b598-f723-4287-86a9-3c8fd83889f6" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9e44db20-6643-478d-9c75-057171b229c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_cee340a7-27b9-41bd-af43-7ffefc75d571" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9e44db20-6643-478d-9c75-057171b229c5" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_cee340a7-27b9-41bd-af43-7ffefc75d571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_bf0a4ddf-0d59-44ef-9a05-cfacc3b2b2e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_cee340a7-27b9-41bd-af43-7ffefc75d571" xlink:to="loc_us-gaap_SegmentDomain_bf0a4ddf-0d59-44ef-9a05-cfacc3b2b2e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DevelopedMarketsSegmentMember_f3e2b10a-0e3b-445e-b355-f90f83fcf89d" xlink:href="vtrs-20211231.xsd#vtrs_DevelopedMarketsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_bf0a4ddf-0d59-44ef-9a05-cfacc3b2b2e7" xlink:to="loc_vtrs_DevelopedMarketsSegmentMember_f3e2b10a-0e3b-445e-b355-f90f83fcf89d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GreaterChinaSegmentMember_7cb2c2df-3aa9-41a5-a7cb-82c2cc09604b" xlink:href="vtrs-20211231.xsd#vtrs_GreaterChinaSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_bf0a4ddf-0d59-44ef-9a05-cfacc3b2b2e7" xlink:to="loc_vtrs_GreaterChinaSegmentMember_7cb2c2df-3aa9-41a5-a7cb-82c2cc09604b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_3e854dfd-f18d-45e2-99bb-0eab6964a3aa" xlink:href="vtrs-20211231.xsd#vtrs_JapanAustraliaAndNewZealandSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_bf0a4ddf-0d59-44ef-9a05-cfacc3b2b2e7" xlink:to="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_3e854dfd-f18d-45e2-99bb-0eab6964a3aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EmergingMarketsSegmentMember_580f4546-7076-4e2c-9de3-3ebf8d5739c0" xlink:href="vtrs-20211231.xsd#vtrs_EmergingMarketsSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_bf0a4ddf-0d59-44ef-9a05-cfacc3b2b2e7" xlink:to="loc_vtrs_EmergingMarketsSegmentMember_580f4546-7076-4e2c-9de3-3ebf8d5739c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_6f64f8e2-ac2a-4b3b-837c-e65ebd7e297d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9e44db20-6643-478d-9c75-057171b229c5" xlink:to="loc_srt_ConsolidationItemsAxis_6f64f8e2-ac2a-4b3b-837c-e65ebd7e297d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_d72f00fc-57a7-4198-838a-2a8c5cbeb8dc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_6f64f8e2-ac2a-4b3b-837c-e65ebd7e297d" xlink:to="loc_srt_ConsolidationItemsDomain_d72f00fc-57a7-4198-838a-2a8c5cbeb8dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_1558fec1-6862-4dd6-bac2-a270ad5d42b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_d72f00fc-57a7-4198-838a-2a8c5cbeb8dc" xlink:to="loc_us-gaap_OperatingSegmentsMember_1558fec1-6862-4dd6-bac2-a270ad5d42b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_22b14c5d-06e6-49c3-8bea-35d59b6017a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_d72f00fc-57a7-4198-838a-2a8c5cbeb8dc" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_22b14c5d-06e6-49c3-8bea-35d59b6017a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_f360a256-8fe9-42ae-9a41-45c54bad06f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_d72f00fc-57a7-4198-838a-2a8c5cbeb8dc" xlink:to="loc_us-gaap_CorporateNonSegmentMember_f360a256-8fe9-42ae-9a41-45c54bad06f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_34a802f9-b3e6-49f8-8a49-4ffc09fd2f1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9e44db20-6643-478d-9c75-057171b229c5" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_34a802f9-b3e6-49f8-8a49-4ffc09fd2f1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5d180f9a-fc49-499c-95eb-4c0c66978f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_34a802f9-b3e6-49f8-8a49-4ffc09fd2f1a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5d180f9a-fc49-499c-95eb-4c0c66978f3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_d07d564c-ab0a-4663-a777-45f53da2ade6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_34a802f9-b3e6-49f8-8a49-4ffc09fd2f1a" xlink:to="loc_us-gaap_OperatingIncomeLoss_d07d564c-ab0a-4663-a777-45f53da2ade6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_4fbcd8cd-255a-4680-a8b2-4eb4637666e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_34a802f9-b3e6-49f8-8a49-4ffc09fd2f1a" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_4fbcd8cd-255a-4680-a8b2-4eb4637666e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_6f07d5d6-39c6-4e5e-8cd0-9ad5174214f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_34a802f9-b3e6-49f8-8a49-4ffc09fd2f1a" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_6f07d5d6-39c6-4e5e-8cd0-9ad5174214f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_f2bf4021-8f46-4b18-aeeb-9449ba30e9e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_34a802f9-b3e6-49f8-8a49-4ffc09fd2f1a" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_f2bf4021-8f46-4b18-aeeb-9449ba30e9e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_adf66fa1-6a26-4b10-a5a5-70b8c57bce52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_34a802f9-b3e6-49f8-8a49-4ffc09fd2f1a" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_adf66fa1-6a26-4b10-a5a5-70b8c57bce52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherOneTimeNonoperatingExpense_cd13b9e9-d6e8-4650-9de6-ee655b71cae9" xlink:href="vtrs-20211231.xsd#vtrs_OtherOneTimeNonoperatingExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_34a802f9-b3e6-49f8-8a49-4ffc09fd2f1a" xlink:to="loc_vtrs_OtherOneTimeNonoperatingExpense_cd13b9e9-d6e8-4650-9de6-ee655b71cae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Corporatecosts_eb4e5ab0-e11a-45f6-af4e-b50fb4ae6333" xlink:href="vtrs-20211231.xsd#vtrs_Corporatecosts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_34a802f9-b3e6-49f8-8a49-4ffc09fd2f1a" xlink:to="loc_vtrs_Corporatecosts_eb4e5ab0-e11a-45f6-af4e-b50fb4ae6333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/SegmentInformationThirdPartyNetSalesbyMajorCustomersDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#SegmentInformationThirdPartyNetSalesbyMajorCustomersDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/SegmentInformationThirdPartyNetSalesbyMajorCustomersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_58fd7403-81c7-4c3a-922c-a4be5177cb22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_181169cb-7469-4709-a0e9-826d0570fc1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_58fd7403-81c7-4c3a-922c-a4be5177cb22" xlink:to="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_181169cb-7469-4709-a0e9-826d0570fc1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c9edbcd1-da76-475f-bbb7-7ae7e27999d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_181169cb-7469-4709-a0e9-826d0570fc1b" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c9edbcd1-da76-475f-bbb7-7ae7e27999d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_4fff0bc5-ac78-427b-8c10-154f4a36b6b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c9edbcd1-da76-475f-bbb7-7ae7e27999d5" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_4fff0bc5-ac78-427b-8c10-154f4a36b6b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_c12b22d8-3f7c-4606-9051-7c7662dec977" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_4fff0bc5-ac78-427b-8c10-154f4a36b6b0" xlink:to="loc_us-gaap_SalesRevenueNetMember_c12b22d8-3f7c-4606-9051-7c7662dec977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_bb62f8d0-77b8-47fb-8f07-56cdef79a0b7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_181169cb-7469-4709-a0e9-826d0570fc1b" xlink:to="loc_srt_MajorCustomersAxis_bb62f8d0-77b8-47fb-8f07-56cdef79a0b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_ecba9a19-b447-4f37-9699-4536c456e2f6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_bb62f8d0-77b8-47fb-8f07-56cdef79a0b7" xlink:to="loc_srt_NameOfMajorCustomerDomain_ecba9a19-b447-4f37-9699-4536c456e2f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_MckessonCorporationMember_54000f01-2583-4e49-9630-14e32b657cc8" xlink:href="vtrs-20211231.xsd#vtrs_MckessonCorporationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_ecba9a19-b447-4f37-9699-4536c456e2f6" xlink:to="loc_vtrs_MckessonCorporationMember_54000f01-2583-4e49-9630-14e32b657cc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AmeriSourceBergenCorporationMember_ed394644-4b6e-42c8-958b-4e51d195d457" xlink:href="vtrs-20211231.xsd#vtrs_AmeriSourceBergenCorporationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_ecba9a19-b447-4f37-9699-4536c456e2f6" xlink:to="loc_vtrs_AmeriSourceBergenCorporationMember_ed394644-4b6e-42c8-958b-4e51d195d457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CardinalHealthIncMember_16f51cf9-fec6-4259-b79d-b324087499b6" xlink:href="vtrs-20211231.xsd#vtrs_CardinalHealthIncMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_ecba9a19-b447-4f37-9699-4536c456e2f6" xlink:to="loc_vtrs_CardinalHealthIncMember_16f51cf9-fec6-4259-b79d-b324087499b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_8d0088cd-b48c-48f2-8d78-dc8db70a108a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_181169cb-7469-4709-a0e9-826d0570fc1b" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_8d0088cd-b48c-48f2-8d78-dc8db70a108a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_0e57e57d-89f3-4ca6-824b-b85d40f02973" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_8d0088cd-b48c-48f2-8d78-dc8db70a108a" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_0e57e57d-89f3-4ca6-824b-b85d40f02973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_2ec03d9e-c94f-4db4-ac47-30cfece62e6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_0e57e57d-89f3-4ca6-824b-b85d40f02973" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_2ec03d9e-c94f-4db4-ac47-30cfece62e6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_779fecd6-077d-4615-8c39-668a18d0ac32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_181169cb-7469-4709-a0e9-826d0570fc1b" xlink:to="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_779fecd6-077d-4615-8c39-668a18d0ac32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_51ad88bd-3c9a-4b8b-aa3e-d38a5588f2a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_779fecd6-077d-4615-8c39-668a18d0ac32" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_51ad88bd-3c9a-4b8b-aa3e-d38a5588f2a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/SegmentInformationNetThirdPartySalesClassifiedBasedonGeographicLocationofEntityDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#SegmentInformationNetThirdPartySalesClassifiedBasedonGeographicLocationofEntityDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/SegmentInformationNetThirdPartySalesClassifiedBasedonGeographicLocationofEntityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_79fd30a7-6435-4b42-a223-fb249537f369" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_4ed312f7-7d0f-4c31-973b-54f86fc4a5cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_79fd30a7-6435-4b42-a223-fb249537f369" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_4ed312f7-7d0f-4c31-973b-54f86fc4a5cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_ad7ff875-35aa-42da-afd0-1506359d4957" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_4ed312f7-7d0f-4c31-973b-54f86fc4a5cb" xlink:to="loc_srt_StatementGeographicalAxis_ad7ff875-35aa-42da-afd0-1506359d4957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_b9368a09-f44a-4623-a12d-51b101a29a7a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_ad7ff875-35aa-42da-afd0-1506359d4957" xlink:to="loc_srt_SegmentGeographicalDomain_b9368a09-f44a-4623-a12d-51b101a29a7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_e050b1da-dd33-4a9a-85b1-ed14cb1dbeb6" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_b9368a09-f44a-4623-a12d-51b101a29a7a" xlink:to="loc_country_US_e050b1da-dd33-4a9a-85b1-ed14cb1dbeb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IN_bd4f99cd-9e60-4ec6-ba08-45ba4404633e" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IN"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_b9368a09-f44a-4623-a12d-51b101a29a7a" xlink:to="loc_country_IN_bd4f99cd-9e60-4ec6-ba08-45ba4404633e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_b16ee29b-0d85-4c64-a4f7-3dce286d6476" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_FR"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_b9368a09-f44a-4623-a12d-51b101a29a7a" xlink:to="loc_country_FR_b16ee29b-0d85-4c64-a4f7-3dce286d6476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN_70629ad0-ed4a-4fbb-beee-5b8abe7e449e" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CN"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_b9368a09-f44a-4623-a12d-51b101a29a7a" xlink:to="loc_country_CN_70629ad0-ed4a-4fbb-beee-5b8abe7e449e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_ada2a960-785c-4e21-83bb-84564b8cb612" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_4ed312f7-7d0f-4c31-973b-54f86fc4a5cb" xlink:to="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_ada2a960-785c-4e21-83bb-84564b8cb612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_97f3b7e9-b35c-4c91-9779-3a13abc2f172" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_ada2a960-785c-4e21-83bb-84564b8cb612" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_97f3b7e9-b35c-4c91-9779-3a13abc2f172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/Commitments" xlink:type="simple" xlink:href="vtrs-20211231.xsd#Commitments"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/Commitments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ee5b285a-f47a-448e-8eb4-a89f818a450d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsDisclosureTextBlock_6d988c0f-2ddc-474f-be5a-92fd885c5ba3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ee5b285a-f47a-448e-8eb4-a89f818a450d" xlink:to="loc_us-gaap_CommitmentsDisclosureTextBlock_6d988c0f-2ddc-474f-be5a-92fd885c5ba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/CommitmentsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#CommitmentsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/CommitmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ee70df64-a307-4f78-8998-b511bb25dd63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_7cdf9a69-0af1-4284-adeb-8308e448b3d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ee70df64-a307-4f78-8998-b511bb25dd63" xlink:to="loc_us-gaap_OtherCommitmentsTable_7cdf9a69-0af1-4284-adeb-8308e448b3d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis_cfd3cf10-bfe7-425f-9ea4-bd176f01701b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_7cdf9a69-0af1-4284-adeb-8308e448b3d2" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis_cfd3cf10-bfe7-425f-9ea4-bd176f01701b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalEntityTypeOfCounterpartyDomain_8f5fb22d-aab3-4aea-9149-1ae3e1bc370f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LegalEntityTypeOfCounterpartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis_cfd3cf10-bfe7-425f-9ea4-bd176f01701b" xlink:to="loc_us-gaap_LegalEntityTypeOfCounterpartyDomain_8f5fb22d-aab3-4aea-9149-1ae3e1bc370f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PfizerInc.Member_72b0b9dd-8ee3-4bba-bd68-1607c8938518" xlink:href="vtrs-20211231.xsd#vtrs_PfizerInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LegalEntityTypeOfCounterpartyDomain_8f5fb22d-aab3-4aea-9149-1ae3e1bc370f" xlink:to="loc_vtrs_PfizerInc.Member_72b0b9dd-8ee3-4bba-bd68-1607c8938518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsAxis_ba186b3b-8ae5-42b5-9ff9-34f1602c52ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_7cdf9a69-0af1-4284-adeb-8308e448b3d2" xlink:to="loc_us-gaap_OtherCommitmentsAxis_ba186b3b-8ae5-42b5-9ff9-34f1602c52ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain_d74ebce3-e550-41f7-9832-1672d2dc0230" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsAxis_ba186b3b-8ae5-42b5-9ff9-34f1602c52ca" xlink:to="loc_us-gaap_OtherCommitmentsDomain_d74ebce3-e550-41f7-9832-1672d2dc0230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_TransitionServiceAgreementsMember_d4322603-c968-4b62-9b2e-b4c014e0cb61" xlink:href="vtrs-20211231.xsd#vtrs_TransitionServiceAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsDomain_d74ebce3-e550-41f7-9832-1672d2dc0230" xlink:to="loc_vtrs_TransitionServiceAgreementsMember_d4322603-c968-4b62-9b2e-b4c014e0cb61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_b6a17b4d-df4d-4d1e-adfd-9c7aaa263304" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_7cdf9a69-0af1-4284-adeb-8308e448b3d2" xlink:to="loc_us-gaap_OtherCommitmentsLineItems_b6a17b4d-df4d-4d1e-adfd-9c7aaa263304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationLimitedTransitionServicesPaymentPeriod_20654234-ff3f-41fd-a22f-b52c946b35ff" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationLimitedTransitionServicesPaymentPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_b6a17b4d-df4d-4d1e-adfd-9c7aaa263304" xlink:to="loc_vtrs_BusinessCombinationLimitedTransitionServicesPaymentPeriod_20654234-ff3f-41fd-a22f-b52c946b35ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationContractualReimbursementAmountTrancheOne_798053d5-438c-4f28-88a8-c3571a343a72" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationContractualReimbursementAmountTrancheOne"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_b6a17b4d-df4d-4d1e-adfd-9c7aaa263304" xlink:to="loc_vtrs_BusinessCombinationContractualReimbursementAmountTrancheOne_798053d5-438c-4f28-88a8-c3571a343a72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationContractualReimbursementAmountAmountsExpensed_2be641ae-6626-43fc-a948-c524b4290014" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationContractualReimbursementAmountAmountsExpensed"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_b6a17b4d-df4d-4d1e-adfd-9c7aaa263304" xlink:to="loc_vtrs_BusinessCombinationContractualReimbursementAmountAmountsExpensed_2be641ae-6626-43fc-a948-c524b4290014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BusinessCombinationContractualReimbursementAmountAmountsAccrued_5a4f31fd-cf56-4903-aa63-871108565f71" xlink:href="vtrs-20211231.xsd#vtrs_BusinessCombinationContractualReimbursementAmountAmountsAccrued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_b6a17b4d-df4d-4d1e-adfd-9c7aaa263304" xlink:to="loc_vtrs_BusinessCombinationContractualReimbursementAmountAmountsAccrued_5a4f31fd-cf56-4903-aa63-871108565f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/Restructuring" xlink:type="simple" xlink:href="vtrs-20211231.xsd#Restructuring"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/Restructuring" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_715b4adb-b41f-4d13-a773-88270b3095ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_64b53247-131b-4e0b-a75c-eb14f95ca828" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_715b4adb-b41f-4d13-a773-88270b3095ce" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_64b53247-131b-4e0b-a75c-eb14f95ca828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/RestructuringTables" xlink:type="simple" xlink:href="vtrs-20211231.xsd#RestructuringTables"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/RestructuringTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_a9823dc0-5b8b-4ae2-afb7-1fe70ba489ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_52484d65-a9f1-4da9-9fee-c6e0f33e27c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_a9823dc0-5b8b-4ae2-afb7-1fe70ba489ff" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_52484d65-a9f1-4da9-9fee-c6e0f33e27c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/RestructuringNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#RestructuringNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/RestructuringNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_246e8b81-4c0e-4c20-99e3-3fec6cdb2682" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_3a66e682-5932-4d4d-9d51-b2f38836acd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_246e8b81-4c0e-4c20-99e3-3fec6cdb2682" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_3a66e682-5932-4d4d-9d51-b2f38836acd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f885b089-6bbf-4c1a-b6c4-676622302236" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_3a66e682-5932-4d4d-9d51-b2f38836acd6" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f885b089-6bbf-4c1a-b6c4-676622302236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e69a9812-3fb9-4402-8b43-8f2ba776f66f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f885b089-6bbf-4c1a-b6c4-676622302236" xlink:to="loc_us-gaap_SegmentDomain_e69a9812-3fb9-4402-8b43-8f2ba776f66f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NorthAmericaSegmentMember_001b82f4-edb9-44d8-8048-2b4593395c45" xlink:href="vtrs-20211231.xsd#vtrs_NorthAmericaSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e69a9812-3fb9-4402-8b43-8f2ba776f66f" xlink:to="loc_vtrs_NorthAmericaSegmentMember_001b82f4-edb9-44d8-8048-2b4593395c45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EuropeSegmentMember_b2077a22-5589-417b-a54c-68516afca08c" xlink:href="vtrs-20211231.xsd#vtrs_EuropeSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e69a9812-3fb9-4402-8b43-8f2ba776f66f" xlink:to="loc_vtrs_EuropeSegmentMember_b2077a22-5589-417b-a54c-68516afca08c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RestofWorldSegmentMember_82f35714-438f-486a-99a6-de39cae8a9b8" xlink:href="vtrs-20211231.xsd#vtrs_RestofWorldSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e69a9812-3fb9-4402-8b43-8f2ba776f66f" xlink:to="loc_vtrs_RestofWorldSegmentMember_82f35714-438f-486a-99a6-de39cae8a9b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DevelopedMarketsSegmentMember_823d4b11-dc3f-4c19-8979-2041b2622431" xlink:href="vtrs-20211231.xsd#vtrs_DevelopedMarketsSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e69a9812-3fb9-4402-8b43-8f2ba776f66f" xlink:to="loc_vtrs_DevelopedMarketsSegmentMember_823d4b11-dc3f-4c19-8979-2041b2622431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_f110f5fa-dec2-47cf-844d-04f727bde6c3" xlink:href="vtrs-20211231.xsd#vtrs_JapanAustraliaAndNewZealandSegmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e69a9812-3fb9-4402-8b43-8f2ba776f66f" xlink:to="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_f110f5fa-dec2-47cf-844d-04f727bde6c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GreaterChinaSegmentMember_9510917d-229e-40f0-9390-98e59afd452d" xlink:href="vtrs-20211231.xsd#vtrs_GreaterChinaSegmentMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e69a9812-3fb9-4402-8b43-8f2ba776f66f" xlink:to="loc_vtrs_GreaterChinaSegmentMember_9510917d-229e-40f0-9390-98e59afd452d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_df9b8e05-34ca-4c4f-b232-2075dde41d05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_3a66e682-5932-4d4d-9d51-b2f38836acd6" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_df9b8e05-34ca-4c4f-b232-2075dde41d05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_f4ade0b2-4375-4868-a5fc-69bd0e8e67a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_df9b8e05-34ca-4c4f-b232-2075dde41d05" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_f4ade0b2-4375-4868-a5fc-69bd0e8e67a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_84c6a626-878f-4d89-9799-1a6c7a44d8dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_f4ade0b2-4375-4868-a5fc-69bd0e8e67a5" xlink:to="loc_us-gaap_EmployeeSeveranceMember_84c6a626-878f-4d89-9799-1a6c7a44d8dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_f01ea876-4da4-442a-8b4e-e1c0b871f503" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherRestructuringMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_f4ade0b2-4375-4868-a5fc-69bd0e8e67a5" xlink:to="loc_us-gaap_OtherRestructuringMember_f01ea876-4da4-442a-8b4e-e1c0b871f503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_0ef0ad2a-c0d0-4fd3-9d86-2d7e54fcd67c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_3a66e682-5932-4d4d-9d51-b2f38836acd6" xlink:to="loc_us-gaap_RestructuringPlanAxis_0ef0ad2a-c0d0-4fd3-9d86-2d7e54fcd67c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_d5d42356-a288-4b33-9b14-20f83912c96f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_0ef0ad2a-c0d0-4fd3-9d86-2d7e54fcd67c" xlink:to="loc_us-gaap_RestructuringPlanDomain_d5d42356-a288-4b33-9b14-20f83912c96f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2016RestructuringProgramMember_c391fed6-8233-4eba-93b6-127940d0a8f5" xlink:href="vtrs-20211231.xsd#vtrs_A2016RestructuringProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_d5d42356-a288-4b33-9b14-20f83912c96f" xlink:to="loc_vtrs_A2016RestructuringProgramMember_c391fed6-8233-4eba-93b6-127940d0a8f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_46e1c6d1-8368-41f1-b12c-e7b02380be7a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_3a66e682-5932-4d4d-9d51-b2f38836acd6" xlink:to="loc_srt_ConsolidationItemsAxis_46e1c6d1-8368-41f1-b12c-e7b02380be7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_83cdd34b-2df0-4e08-8c9d-c62a96740944" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_46e1c6d1-8368-41f1-b12c-e7b02380be7a" xlink:to="loc_srt_ConsolidationItemsDomain_83cdd34b-2df0-4e08-8c9d-c62a96740944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_1d77de40-adfc-4768-8f10-60bede3283bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_83cdd34b-2df0-4e08-8c9d-c62a96740944" xlink:to="loc_us-gaap_OperatingSegmentsMember_1d77de40-adfc-4768-8f10-60bede3283bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_c0163b7d-754a-432e-856e-83d744c58325" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_3a66e682-5932-4d4d-9d51-b2f38836acd6" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_c0163b7d-754a-432e-856e-83d744c58325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_fcbb9fad-d0e8-45ea-8a23-d4187b2fe40f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c0163b7d-754a-432e-856e-83d744c58325" xlink:to="loc_us-gaap_PaymentsForRestructuring_fcbb9fad-d0e8-45ea-8a23-d4187b2fe40f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReservePeriodIncreaseDecrease_a7ad7b7f-8e24-45a2-a4b4-6a6d55543465" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReservePeriodIncreaseDecrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c0163b7d-754a-432e-856e-83d744c58325" xlink:to="loc_us-gaap_RestructuringReservePeriodIncreaseDecrease_a7ad7b7f-8e24-45a2-a4b4-6a6d55543465" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_8002ca3d-7700-4260-8cfb-be6234d665c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c0163b7d-754a-432e-856e-83d744c58325" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_8002ca3d-7700-4260-8cfb-be6234d665c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_933a6611-79bd-464a-a43b-1b41950a48c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveTranslationAndOtherAdjustment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c0163b7d-754a-432e-856e-83d744c58325" xlink:to="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_933a6611-79bd-464a-a43b-1b41950a48c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_cb864563-e7e0-44ff-87ca-d62ed53ef80a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c0163b7d-754a-432e-856e-83d744c58325" xlink:to="loc_us-gaap_RestructuringCharges_cb864563-e7e0-44ff-87ca-d62ed53ef80a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_9a8b6d61-96dd-4736-a8d7-0471c705ed19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c0163b7d-754a-432e-856e-83d744c58325" xlink:to="loc_us-gaap_RestructuringReserve_9a8b6d61-96dd-4736-a8d7-0471c705ed19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOnFutureCashFlowsAmount_7d3eaf77-de2e-4008-bb18-13b485dae75b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOnFutureCashFlowsAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_c0163b7d-754a-432e-856e-83d744c58325" xlink:to="loc_us-gaap_EffectOnFutureCashFlowsAmount_7d3eaf77-de2e-4008-bb18-13b485dae75b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/Restructuring2020RestructuringPlanDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#Restructuring2020RestructuringPlanDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/Restructuring2020RestructuringPlanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_6f2691e0-7b71-4a09-b9e1-3a941cd975e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7d8d867b-0cd4-4961-8071-c0f09951a864" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_6f2691e0-7b71-4a09-b9e1-3a941cd975e5" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7d8d867b-0cd4-4961-8071-c0f09951a864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_a095bf68-58b6-4d02-be40-fdd2d5644cd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7d8d867b-0cd4-4961-8071-c0f09951a864" xlink:to="loc_us-gaap_RestructuringPlanAxis_a095bf68-58b6-4d02-be40-fdd2d5644cd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_69aa44d6-5edd-49ea-b1be-ad8b81972bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_a095bf68-58b6-4d02-be40-fdd2d5644cd0" xlink:to="loc_us-gaap_RestructuringPlanDomain_69aa44d6-5edd-49ea-b1be-ad8b81972bb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_A2020RestructuringPlanMember_5ab8e536-8949-4323-90b8-01ddb5f28252" xlink:href="vtrs-20211231.xsd#vtrs_A2020RestructuringPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_69aa44d6-5edd-49ea-b1be-ad8b81972bb9" xlink:to="loc_vtrs_A2020RestructuringPlanMember_5ab8e536-8949-4323-90b8-01ddb5f28252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_1d52aa09-c5e7-48a4-9d05-dfcc93d8cae6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7d8d867b-0cd4-4961-8071-c0f09951a864" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_1d52aa09-c5e7-48a4-9d05-dfcc93d8cae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_41c7b60e-6d66-4790-a57a-b4bdf6d09b19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_1d52aa09-c5e7-48a4-9d05-dfcc93d8cae6" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_41c7b60e-6d66-4790-a57a-b4bdf6d09b19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_61814406-1bfa-4670-b864-cf0ce6e7927d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_41c7b60e-6d66-4790-a57a-b4bdf6d09b19" xlink:to="loc_us-gaap_EmployeeSeveranceMember_61814406-1bfa-4670-b864-cf0ce6e7927d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_feb83f25-7adf-476c-9529-0ce1c6bfd445" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherRestructuringMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_41c7b60e-6d66-4790-a57a-b4bdf6d09b19" xlink:to="loc_us-gaap_OtherRestructuringMember_feb83f25-7adf-476c-9529-0ce1c6bfd445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_8f449126-3604-4c46-9e43-ac3807e3afc8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7d8d867b-0cd4-4961-8071-c0f09951a864" xlink:to="loc_srt_RangeAxis_8f449126-3604-4c46-9e43-ac3807e3afc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_278093f1-41f8-4105-adfb-7389721e5da7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_8f449126-3604-4c46-9e43-ac3807e3afc8" xlink:to="loc_srt_RangeMember_278093f1-41f8-4105-adfb-7389721e5da7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8ccffc1c-06a7-40c1-bac0-cf247b11e854" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_278093f1-41f8-4105-adfb-7389721e5da7" xlink:to="loc_srt_MinimumMember_8ccffc1c-06a7-40c1-bac0-cf247b11e854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8b06f27d-fc32-4499-9c24-1710623d4d11" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_278093f1-41f8-4105-adfb-7389721e5da7" xlink:to="loc_srt_MaximumMember_8b06f27d-fc32-4499-9c24-1710623d4d11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_205d734d-4b15-4468-94ae-957f7fc1912f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7d8d867b-0cd4-4961-8071-c0f09951a864" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_205d734d-4b15-4468-94ae-957f7fc1912f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4e898927-8162-4fb6-8b01-6ab293b67f3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_205d734d-4b15-4468-94ae-957f7fc1912f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4e898927-8162-4fb6-8b01-6ab293b67f3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_UpjohnInc.Member_8d25dfdf-546e-4439-9921-f5e337fce131" xlink:href="vtrs-20211231.xsd#vtrs_UpjohnInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4e898927-8162-4fb6-8b01-6ab293b67f3c" xlink:to="loc_vtrs_UpjohnInc.Member_8d25dfdf-546e-4439-9921-f5e337fce131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_d572922c-69ca-475b-8edd-231484877bad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7d8d867b-0cd4-4961-8071-c0f09951a864" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_d572922c-69ca-475b-8edd-231484877bad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_ca96dde4-3054-41a4-91cf-c19f6282e6d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_d572922c-69ca-475b-8edd-231484877bad" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_ca96dde4-3054-41a4-91cf-c19f6282e6d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_86d55800-f42d-4236-bac7-24ab192e11d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_ca96dde4-3054-41a4-91cf-c19f6282e6d1" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_86d55800-f42d-4236-bac7-24ab192e11d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_251359c8-c14c-4441-baa1-fe315e407d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_ca96dde4-3054-41a4-91cf-c19f6282e6d1" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_251359c8-c14c-4441-baa1-fe315e407d5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_4a510c13-dc06-4360-9742-0e1425e22d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7d8d867b-0cd4-4961-8071-c0f09951a864" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_4a510c13-dc06-4360-9742-0e1425e22d5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5d95e366-b101-4c76-8940-5d5bf70f1271" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4a510c13-dc06-4360-9742-0e1425e22d5c" xlink:to="loc_us-gaap_SegmentDomain_5d95e366-b101-4c76-8940-5d5bf70f1271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EmergingMarketsSegmentMember_f4ad6bcc-9d8a-4074-bb2b-aadde6e31037" xlink:href="vtrs-20211231.xsd#vtrs_EmergingMarketsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5d95e366-b101-4c76-8940-5d5bf70f1271" xlink:to="loc_vtrs_EmergingMarketsSegmentMember_f4ad6bcc-9d8a-4074-bb2b-aadde6e31037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GreaterChinaSegmentMember_6597b7cc-83d6-42b4-b332-640a894110a5" xlink:href="vtrs-20211231.xsd#vtrs_GreaterChinaSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5d95e366-b101-4c76-8940-5d5bf70f1271" xlink:to="loc_vtrs_GreaterChinaSegmentMember_6597b7cc-83d6-42b4-b332-640a894110a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_00b83db8-e1e7-4563-a71f-12c3599f848b" xlink:href="vtrs-20211231.xsd#vtrs_JapanAustraliaAndNewZealandSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5d95e366-b101-4c76-8940-5d5bf70f1271" xlink:to="loc_vtrs_JapanAustraliaAndNewZealandSegmentMember_00b83db8-e1e7-4563-a71f-12c3599f848b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DevelopedMarketsSegmentMember_f2206d2f-2335-4f2a-8a6c-df57683c7418" xlink:href="vtrs-20211231.xsd#vtrs_DevelopedMarketsSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5d95e366-b101-4c76-8940-5d5bf70f1271" xlink:to="loc_vtrs_DevelopedMarketsSegmentMember_f2206d2f-2335-4f2a-8a6c-df57683c7418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_5de1fed1-b39a-4950-ae2c-bcd8c3e55263" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7d8d867b-0cd4-4961-8071-c0f09951a864" xlink:to="loc_srt_ConsolidationItemsAxis_5de1fed1-b39a-4950-ae2c-bcd8c3e55263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_dc34e4ec-7634-4559-844e-252161102e62" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_5de1fed1-b39a-4950-ae2c-bcd8c3e55263" xlink:to="loc_srt_ConsolidationItemsDomain_dc34e4ec-7634-4559-844e-252161102e62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_a5febd57-ef97-4879-83ae-027d7b75927c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_dc34e4ec-7634-4559-844e-252161102e62" xlink:to="loc_us-gaap_OperatingSegmentsMember_a5febd57-ef97-4879-83ae-027d7b75927c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_5a7f8fde-611b-41ca-896c-9aee89b8124a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_dc34e4ec-7634-4559-844e-252161102e62" xlink:to="loc_us-gaap_CorporateNonSegmentMember_5a7f8fde-611b-41ca-896c-9aee89b8124a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_dc3cd54f-33d8-477b-a4d8-4ae8aa645720" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7d8d867b-0cd4-4961-8071-c0f09951a864" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_dc3cd54f-33d8-477b-a4d8-4ae8aa645720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_6a807739-9230-4b41-8493-fde25aa825a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_dc3cd54f-33d8-477b-a4d8-4ae8aa645720" xlink:to="loc_us-gaap_RestructuringReserve_6a807739-9230-4b41-8493-fde25aa825a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_b0f6391c-8b75-4cd0-ae3c-b7477e340725" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_dc3cd54f-33d8-477b-a4d8-4ae8aa645720" xlink:to="loc_us-gaap_PaymentsForRestructuring_b0f6391c-8b75-4cd0-ae3c-b7477e340725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_ab439209-cf14-4f8c-bb36-79f951d10557" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_dc3cd54f-33d8-477b-a4d8-4ae8aa645720" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_ab439209-cf14-4f8c-bb36-79f951d10557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_1cf474df-2d9c-40b0-9ce2-0f9f30fa2ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveTranslationAndOtherAdjustment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_dc3cd54f-33d8-477b-a4d8-4ae8aa645720" xlink:to="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_1cf474df-2d9c-40b0-9ce2-0f9f30fa2ce9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_7d6ec851-0a1d-4510-bc56-d3806dd15d58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_dc3cd54f-33d8-477b-a4d8-4ae8aa645720" xlink:to="loc_us-gaap_RestructuringCharges_7d6ec851-0a1d-4510-bc56-d3806dd15d58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RestructuringReserveAcquiredDuringPeriod_50c6191d-ede1-4aec-8577-6e1f240459bc" xlink:href="vtrs-20211231.xsd#vtrs_RestructuringReserveAcquiredDuringPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_dc3cd54f-33d8-477b-a4d8-4ae8aa645720" xlink:to="loc_vtrs_RestructuringReserveAcquiredDuringPeriod_50c6191d-ede1-4aec-8577-6e1f240459bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated_a674f1cb-d0d5-4197-a4be-d8702e85fe17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_dc3cd54f-33d8-477b-a4d8-4ae8aa645720" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated_a674f1cb-d0d5-4197-a4be-d8702e85fe17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RestructuringAndRelatedCostExpectedNumberOfFacilitiesToBeEliminated_eaf4c2db-3070-4ded-9673-baada2a8429c" xlink:href="vtrs-20211231.xsd#vtrs_RestructuringAndRelatedCostExpectedNumberOfFacilitiesToBeEliminated"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_dc3cd54f-33d8-477b-a4d8-4ae8aa645720" xlink:to="loc_vtrs_RestructuringAndRelatedCostExpectedNumberOfFacilitiesToBeEliminated_eaf4c2db-3070-4ded-9673-baada2a8429c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminatedPercent_4df7cc2c-7fa4-429c-81e0-046e55ffdeba" xlink:href="vtrs-20211231.xsd#vtrs_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminatedPercent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_dc3cd54f-33d8-477b-a4d8-4ae8aa645720" xlink:to="loc_vtrs_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminatedPercent_4df7cc2c-7fa4-429c-81e0-046e55ffdeba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_5ed06aec-425e-4e8b-9031-710eb4fbf580" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_dc3cd54f-33d8-477b-a4d8-4ae8aa645720" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash2_5ed06aec-425e-4e8b-9031-710eb4fbf580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1_f670b7ff-f15b-45ce-8d37-62196101d8a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_dc3cd54f-33d8-477b-a4d8-4ae8aa645720" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1_f670b7ff-f15b-45ce-8d37-62196101d8a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RestructuringReserveReimbursableRestructuringCharges_74ac6e80-eede-4cec-b433-7c922e390b94" xlink:href="vtrs-20211231.xsd#vtrs_RestructuringReserveReimbursableRestructuringCharges"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_dc3cd54f-33d8-477b-a4d8-4ae8aa645720" xlink:to="loc_vtrs_RestructuringReserveReimbursableRestructuringCharges_74ac6e80-eede-4cec-b433-7c922e390b94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/CollaborationandLicensingAgreements" xlink:type="simple" xlink:href="vtrs-20211231.xsd#CollaborationandLicensingAgreements"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/CollaborationandLicensingAgreements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b1d7d84d-0ebe-4a63-818d-62e73f96431a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_550aa219-ec53-480d-9cea-527e147acd5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b1d7d84d-0ebe-4a63-818d-62e73f96431a" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_550aa219-ec53-480d-9cea-527e147acd5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#CollaborationandLicensingAgreementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_CollaborationsAbstract_fbef99a5-97c0-498a-a28e-b5f1611739c6" xlink:href="vtrs-20211231.xsd#vtrs_CollaborationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_f062101b-7ce5-42be-98e2-aac22cff564b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_CollaborationsAbstract_fbef99a5-97c0-498a-a28e-b5f1611739c6" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_f062101b-7ce5-42be-98e2-aac22cff564b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a60def24-b6a5-4b6e-8cda-7872293ccd0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_f062101b-7ce5-42be-98e2-aac22cff564b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a60def24-b6a5-4b6e-8cda-7872293ccd0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1bfe47c4-a66f-42cc-af1c-f7f9278f3d0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a60def24-b6a5-4b6e-8cda-7872293ccd0c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1bfe47c4-a66f-42cc-af1c-f7f9278f3d0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_49778bc9-0215-4fe7-a764-61e8b436947b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1bfe47c4-a66f-42cc-af1c-f7f9278f3d0a" xlink:to="loc_us-gaap_LicensingAgreementsMember_49778bc9-0215-4fe7-a764-61e8b436947b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e38ef1cb-0380-4712-acd3-22c5575484ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_f062101b-7ce5-42be-98e2-aac22cff564b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e38ef1cb-0380-4712-acd3-22c5575484ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0e99f534-cb05-44f3-aaca-8fcdc9f7dd72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e38ef1cb-0380-4712-acd3-22c5575484ff" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0e99f534-cb05-44f3-aaca-8fcdc9f7dd72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherCompaniesMember_6ffc04be-f571-41d6-a92b-dd6c8e9b91d3" xlink:href="vtrs-20211231.xsd#vtrs_OtherCompaniesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0e99f534-cb05-44f3-aaca-8fcdc9f7dd72" xlink:to="loc_vtrs_OtherCompaniesMember_6ffc04be-f571-41d6-a92b-dd6c8e9b91d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RespiratorydeliveryplatformMember_4e12e5c5-45b8-47e2-ac3d-18851614c2d0" xlink:href="vtrs-20211231.xsd#vtrs_RespiratorydeliveryplatformMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0e99f534-cb05-44f3-aaca-8fcdc9f7dd72" xlink:to="loc_vtrs_RespiratorydeliveryplatformMember_4e12e5c5-45b8-47e2-ac3d-18851614c2d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_17fc81d7-2332-4aaa-aa99-f57ab4356877" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_f062101b-7ce5-42be-98e2-aac22cff564b" xlink:to="loc_us-gaap_AssetAcquisitionAxis_17fc81d7-2332-4aaa-aa99-f57ab4356877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_c4934745-4bb9-44ec-848d-92009e5d6a9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionAxis_17fc81d7-2332-4aaa-aa99-f57ab4356877" xlink:to="loc_us-gaap_AssetAcquisitionDomain_c4934745-4bb9-44ec-848d-92009e5d6a9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RespiratorydeliveryplatformMember_413c8d0d-a64c-47c5-94d1-ab688cf99463" xlink:href="vtrs-20211231.xsd#vtrs_RespiratorydeliveryplatformMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_c4934745-4bb9-44ec-848d-92009e5d6a9f" xlink:to="loc_vtrs_RespiratorydeliveryplatformMember_413c8d0d-a64c-47c5-94d1-ab688cf99463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplyCommitmentAxis_87ba5520-5458-43e1-b655-e79b82ec6853" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplyCommitmentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_f062101b-7ce5-42be-98e2-aac22cff564b" xlink:to="loc_us-gaap_SupplyCommitmentAxis_87ba5520-5458-43e1-b655-e79b82ec6853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplyCommitmentArrangementMember_b26be105-18b6-4c5b-9ad6-f349796d2323" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplyCommitmentArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplyCommitmentAxis_87ba5520-5458-43e1-b655-e79b82ec6853" xlink:to="loc_us-gaap_SupplyCommitmentArrangementMember_b26be105-18b6-4c5b-9ad6-f349796d2323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_GenericBiologicCompoundsCollaborationMember_0a5a7315-6626-4ea2-98b5-f85c3baec3a7" xlink:href="vtrs-20211231.xsd#vtrs_GenericBiologicCompoundsCollaborationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplyCommitmentArrangementMember_b26be105-18b6-4c5b-9ad6-f349796d2323" xlink:to="loc_vtrs_GenericBiologicCompoundsCollaborationMember_0a5a7315-6626-4ea2-98b5-f85c3baec3a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PeriodAxis_628361b5-c648-4d2f-ac37-47538f4f34db" xlink:href="vtrs-20211231.xsd#vtrs_PeriodAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_f062101b-7ce5-42be-98e2-aac22cff564b" xlink:to="loc_vtrs_PeriodAxis_628361b5-c648-4d2f-ac37-47538f4f34db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PeriodDomain_4772abcc-10d0-4f53-b55f-461962fc4806" xlink:href="vtrs-20211231.xsd#vtrs_PeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_PeriodAxis_628361b5-c648-4d2f-ac37-47538f4f34db" xlink:to="loc_vtrs_PeriodDomain_4772abcc-10d0-4f53-b55f-461962fc4806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_FiscalYear2017Member_de6a0e8d-26e0-4316-97b8-f72176cc6aed" xlink:href="vtrs-20211231.xsd#vtrs_FiscalYear2017Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vtrs_PeriodDomain_4772abcc-10d0-4f53-b55f-461962fc4806" xlink:to="loc_vtrs_FiscalYear2017Member_de6a0e8d-26e0-4316-97b8-f72176cc6aed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9febd48a-6dab-493b-8dbb-fd195de87f6e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_f062101b-7ce5-42be-98e2-aac22cff564b" xlink:to="loc_srt_RangeAxis_9febd48a-6dab-493b-8dbb-fd195de87f6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d722f3d3-0bce-4eae-b82d-65cfefd75bc3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_9febd48a-6dab-493b-8dbb-fd195de87f6e" xlink:to="loc_srt_RangeMember_d722f3d3-0bce-4eae-b82d-65cfefd75bc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_0d09845b-33ed-4d16-ba4c-8a687700706d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d722f3d3-0bce-4eae-b82d-65cfefd75bc3" xlink:to="loc_srt_MaximumMember_0d09845b-33ed-4d16-ba4c-8a687700706d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_0511a62d-564a-4b80-8553-e04de95b7baf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_f062101b-7ce5-42be-98e2-aac22cff564b" xlink:to="loc_us-gaap_TypeOfArrangementAxis_0511a62d-564a-4b80-8553-e04de95b7baf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e0c82355-25e3-4903-8efd-495ec6058011" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_0511a62d-564a-4b80-8553-e04de95b7baf" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e0c82355-25e3-4903-8efd-495ec6058011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_da29ef72-67b0-43e5-92c1-38549f9d46fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e0c82355-25e3-4903-8efd-495ec6058011" xlink:to="loc_us-gaap_CollaborativeArrangementMember_da29ef72-67b0-43e5-92c1-38549f9d46fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_MomentaMember_e67cbe95-096c-4666-a886-e2850bdcfbaf" xlink:href="vtrs-20211231.xsd#vtrs_MomentaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e0c82355-25e3-4903-8efd-495ec6058011" xlink:to="loc_vtrs_MomentaMember_e67cbe95-096c-4666-a886-e2850bdcfbaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_TheravanceBiopharmaMember_c14191e4-6b90-4ce0-a69c-87c0861bcdef" xlink:href="vtrs-20211231.xsd#vtrs_TheravanceBiopharmaMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e0c82355-25e3-4903-8efd-495ec6058011" xlink:to="loc_vtrs_TheravanceBiopharmaMember_c14191e4-6b90-4ce0-a69c-87c0861bcdef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_FKBMember_84dc0f9d-090a-4fb4-bb56-7acd41564305" xlink:href="vtrs-20211231.xsd#vtrs_FKBMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e0c82355-25e3-4903-8efd-495ec6058011" xlink:to="loc_vtrs_FKBMember_84dc0f9d-090a-4fb4-bb56-7acd41564305" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_20016683-5232-4bc3-a52f-466a04a0109b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e0c82355-25e3-4903-8efd-495ec6058011" xlink:to="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_20016683-5232-4bc3-a52f-466a04a0109b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_057a37d0-4ee0-4bfe-ba90-7e4e66c6e6e7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_f062101b-7ce5-42be-98e2-aac22cff564b" xlink:to="loc_srt_CounterpartyNameAxis_057a37d0-4ee0-4bfe-ba90-7e4e66c6e6e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b389d19c-d442-4d0f-9ece-880fe0c38471" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_057a37d0-4ee0-4bfe-ba90-7e4e66c6e6e7" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b389d19c-d442-4d0f-9ece-880fe0c38471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_RevanceMember_8808169d-8be7-4058-8a56-60229aafbf62" xlink:href="vtrs-20211231.xsd#vtrs_RevanceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b389d19c-d442-4d0f-9ece-880fe0c38471" xlink:to="loc_vtrs_RevanceMember_8808169d-8be7-4058-8a56-60229aafbf62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_TheravanceBiopharmaMember_fb0df2de-49da-44c6-bfb0-a68dcef7c0de" xlink:href="vtrs-20211231.xsd#vtrs_TheravanceBiopharmaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b389d19c-d442-4d0f-9ece-880fe0c38471" xlink:to="loc_vtrs_TheravanceBiopharmaMember_fb0df2de-49da-44c6-bfb0-a68dcef7c0de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_fd4b73e8-15df-4aaa-ad4d-59dafda15199" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_f062101b-7ce5-42be-98e2-aac22cff564b" xlink:to="loc_srt_StatementScenarioAxis_fd4b73e8-15df-4aaa-ad4d-59dafda15199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_8112a382-3756-40de-839a-a766c7349bf5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_fd4b73e8-15df-4aaa-ad4d-59dafda15199" xlink:to="loc_srt_ScenarioUnspecifiedDomain_8112a382-3756-40de-839a-a766c7349bf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_c550fcb5-17f0-445d-818f-dcdb5b471994" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_8112a382-3756-40de-839a-a766c7349bf5" xlink:to="loc_srt_ScenarioForecastMember_c550fcb5-17f0-445d-818f-dcdb5b471994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_8e5ec6c2-cd23-4c1f-8c6c-443769129bc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_f062101b-7ce5-42be-98e2-aac22cff564b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_8e5ec6c2-cd23-4c1f-8c6c-443769129bc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e56583c3-3650-45bc-9a09-e9b2d9fb68be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_8e5ec6c2-cd23-4c1f-8c6c-443769129bc9" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e56583c3-3650-45bc-9a09-e9b2d9fb68be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_BiosimilarsBusinessMember_40fe165a-8dc5-4307-b9c9-8680c32a921e" xlink:href="vtrs-20211231.xsd#vtrs_BiosimilarsBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e56583c3-3650-45bc-9a09-e9b2d9fb68be" xlink:to="loc_vtrs_BiosimilarsBusinessMember_40fe165a-8dc5-4307-b9c9-8680c32a921e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_bbb19d7b-8163-4eae-9375-93c81b0800df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_f062101b-7ce5-42be-98e2-aac22cff564b" xlink:to="loc_us-gaap_StatementClassOfStockAxis_bbb19d7b-8163-4eae-9375-93c81b0800df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_6d2a539e-9880-415c-b483-0363b6f289f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_bbb19d7b-8163-4eae-9375-93c81b0800df" xlink:to="loc_us-gaap_ClassOfStockDomain_6d2a539e-9880-415c-b483-0363b6f289f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember_884f7ad9-b4be-4dba-a19a-828480dfc355" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_6d2a539e-9880-415c-b483-0363b6f289f7" xlink:to="loc_us-gaap_ConvertiblePreferredStockMember_884f7ad9-b4be-4dba-a19a-828480dfc355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_8b783744-148e-4277-837c-68aeca23743f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_f062101b-7ce5-42be-98e2-aac22cff564b" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_8b783744-148e-4277-837c-68aeca23743f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Developmentandsalesmilestonepayments_d1c8557b-eeef-4ee9-8970-943f1d8b38d3" xlink:href="vtrs-20211231.xsd#vtrs_Developmentandsalesmilestonepayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_8b783744-148e-4277-837c-68aeca23743f" xlink:to="loc_vtrs_Developmentandsalesmilestonepayments_d1c8557b-eeef-4ee9-8970-943f1d8b38d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_ff3a50e6-405d-479d-9100-779668ed96f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_8b783744-148e-4277-837c-68aeca23743f" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_ff3a50e6-405d-479d-9100-779668ed96f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NumberOfDrugs_a0d19cd8-6a37-4e6c-8286-02477d95b237" xlink:href="vtrs-20211231.xsd#vtrs_NumberOfDrugs"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_8b783744-148e-4277-837c-68aeca23743f" xlink:to="loc_vtrs_NumberOfDrugs_a0d19cd8-6a37-4e6c-8286-02477d95b237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_PaymentsToAcquireCollaborativeAgreement_ab276c63-50cd-4c03-b60c-fc777e04e231" xlink:href="vtrs-20211231.xsd#vtrs_PaymentsToAcquireCollaborativeAgreement"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_8b783744-148e-4277-837c-68aeca23743f" xlink:to="loc_vtrs_PaymentsToAcquireCollaborativeAgreement_ab276c63-50cd-4c03-b60c-fc777e04e231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_58d5ed7c-c765-43a7-b068-3810dff4dc60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_8b783744-148e-4277-837c-68aeca23743f" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_58d5ed7c-c765-43a7-b068-3810dff4dc60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_InsulinAnalogProducts_4c6c833c-47d3-4bec-8236-5e9a283733d2" xlink:href="vtrs-20211231.xsd#vtrs_InsulinAnalogProducts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_8b783744-148e-4277-837c-68aeca23743f" xlink:to="loc_vtrs_InsulinAnalogProducts_4c6c833c-47d3-4bec-8236-5e9a283733d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_7152b051-360b-4e74-a58b-9f5b2e8435a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_8b783744-148e-4277-837c-68aeca23743f" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_7152b051-360b-4e74-a58b-9f5b2e8435a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_c126d569-803e-446e-a114-ea67f19b467a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_8b783744-148e-4277-837c-68aeca23743f" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_c126d569-803e-446e-a114-ea67f19b467a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_32cf065b-842d-4c45-81bc-6443a6aac8b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_8b783744-148e-4277-837c-68aeca23743f" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_32cf065b-842d-4c45-81bc-6443a6aac8b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1_53b5cbee-f374-4230-8ee4-fae7ee4e3fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_8b783744-148e-4277-837c-68aeca23743f" xlink:to="loc_us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1_53b5cbee-f374-4230-8ee4-fae7ee4e3fe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DivestitureOfBusinessDeferredCashConsideration_1193221f-4c30-4564-a4e1-74091bfaa535" xlink:href="vtrs-20211231.xsd#vtrs_DivestitureOfBusinessDeferredCashConsideration"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_8b783744-148e-4277-837c-68aeca23743f" xlink:to="loc_vtrs_DivestitureOfBusinessDeferredCashConsideration_1193221f-4c30-4564-a4e1-74091bfaa535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DivestitureOfBusinessPercentageOwnershipInCombinedCompanyAfterTransaction_30d922ef-f158-4d87-aa54-504fe43c49ca" xlink:href="vtrs-20211231.xsd#vtrs_DivestitureOfBusinessPercentageOwnershipInCombinedCompanyAfterTransaction"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_8b783744-148e-4277-837c-68aeca23743f" xlink:to="loc_vtrs_DivestitureOfBusinessPercentageOwnershipInCombinedCompanyAfterTransaction_30d922ef-f158-4d87-aa54-504fe43c49ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DivestitureOfBusinessTransitionServicesAgreementTerm_8a6d1953-858d-4da4-afbc-80cb68502763" xlink:href="vtrs-20211231.xsd#vtrs_DivestitureOfBusinessTransitionServicesAgreementTerm"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_8b783744-148e-4277-837c-68aeca23743f" xlink:to="loc_vtrs_DivestitureOfBusinessTransitionServicesAgreementTerm_8a6d1953-858d-4da4-afbc-80cb68502763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/Litigation" xlink:type="simple" xlink:href="vtrs-20211231.xsd#Litigation"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/Litigation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3697736c-10d0-49f1-94d5-b588120d0987" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock_fb6004ae-e421-4127-b197-8dd13d2c0d99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LegalMattersAndContingenciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3697736c-10d0-49f1-94d5-b588120d0987" xlink:to="loc_us-gaap_LegalMattersAndContingenciesTextBlock_fb6004ae-e421-4127-b197-8dd13d2c0d99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/LitigationNarrativeDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#LitigationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/LitigationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_12488f9b-1acb-4315-800a-ca6dd86e117b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_b7b00fd0-4009-4ef3-8a39-cc475eb52bbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_12488f9b-1acb-4315-800a-ca6dd86e117b" xlink:to="loc_us-gaap_LossContingenciesTable_b7b00fd0-4009-4ef3-8a39-cc475eb52bbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_2e6b9661-0fd5-4de0-97b1-56314d78d5f5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_b7b00fd0-4009-4ef3-8a39-cc475eb52bbd" xlink:to="loc_srt_LitigationCaseAxis_2e6b9661-0fd5-4de0-97b1-56314d78d5f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_dd337b2e-8f5c-40ed-9b5a-757d67954c0b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_2e6b9661-0fd5-4de0-97b1-56314d78d5f5" xlink:to="loc_srt_LitigationCaseTypeDomain_dd337b2e-8f5c-40ed-9b5a-757d67954c0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_MultiDistrictLitigationMember_e928fc68-4cf6-4d1f-b8a0-b157da7a7ddc" xlink:href="vtrs-20211231.xsd#vtrs_MultiDistrictLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_dd337b2e-8f5c-40ed-9b5a-757d67954c0b" xlink:to="loc_vtrs_MultiDistrictLitigationMember_e928fc68-4cf6-4d1f-b8a0-b157da7a7ddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember_8903abaa-d4d7-4466-a34c-5055574617c1" xlink:href="vtrs-20211231.xsd#vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_dd337b2e-8f5c-40ed-9b5a-757d67954c0b" xlink:to="loc_vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember_8903abaa-d4d7-4466-a34c-5055574617c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AnticompetitiveConductwithGenericDrugsMember_d4651d8e-d4b4-4766-8586-72c5d540f55b" xlink:href="vtrs-20211231.xsd#vtrs_AnticompetitiveConductwithGenericDrugsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_dd337b2e-8f5c-40ed-9b5a-757d67954c0b" xlink:to="loc_vtrs_AnticompetitiveConductwithGenericDrugsMember_d4651d8e-d4b4-4766-8586-72c5d540f55b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember_f339b792-0949-47a5-9565-152bcf42e045" xlink:href="vtrs-20211231.xsd#vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_dd337b2e-8f5c-40ed-9b5a-757d67954c0b" xlink:to="loc_vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember_f339b792-0949-47a5-9565-152bcf42e045" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AnticompetitiveConductWithRespectToAdditionalGenericDrugsMember_96ae2800-2aeb-4c78-8d18-b4468a90956e" xlink:href="vtrs-20211231.xsd#vtrs_AnticompetitiveConductWithRespectToAdditionalGenericDrugsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_dd337b2e-8f5c-40ed-9b5a-757d67954c0b" xlink:to="loc_vtrs_AnticompetitiveConductWithRespectToAdditionalGenericDrugsMember_96ae2800-2aeb-4c78-8d18-b4468a90956e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EUCommissionProceedingsPerindorprilMember_4d303635-ab93-41a0-9086-a5988a5caca7" xlink:href="vtrs-20211231.xsd#vtrs_EUCommissionProceedingsPerindorprilMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_dd337b2e-8f5c-40ed-9b5a-757d67954c0b" xlink:to="loc_vtrs_EUCommissionProceedingsPerindorprilMember_4d303635-ab93-41a0-9086-a5988a5caca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_U.K.CompetitionandMarketsAuthorityProceedingsParoxetineMember_8e2d68f4-8783-4bc5-8472-6b9ab41c92eb" xlink:href="vtrs-20211231.xsd#vtrs_U.K.CompetitionandMarketsAuthorityProceedingsParoxetineMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_dd337b2e-8f5c-40ed-9b5a-757d67954c0b" xlink:to="loc_vtrs_U.K.CompetitionandMarketsAuthorityProceedingsParoxetineMember_8e2d68f4-8783-4bc5-8472-6b9ab41c92eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EUCommissionProceedingsCitalopramMember_e9d22405-082a-43e5-a884-f76d89720372" xlink:href="vtrs-20211231.xsd#vtrs_EUCommissionProceedingsCitalopramMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_dd337b2e-8f5c-40ed-9b5a-757d67954c0b" xlink:to="loc_vtrs_EUCommissionProceedingsCitalopramMember_e9d22405-082a-43e5-a884-f76d89720372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_DimethylFumarateMember_7070e837-8b9f-4884-bb7a-897bbe03001a" xlink:href="vtrs-20211231.xsd#vtrs_DimethylFumarateMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_dd337b2e-8f5c-40ed-9b5a-757d67954c0b" xlink:to="loc_vtrs_DimethylFumarateMember_7070e837-8b9f-4884-bb7a-897bbe03001a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_InsulinGlargineMember_d296d8e1-2196-401f-b065-c3c2552de038" xlink:href="vtrs-20211231.xsd#vtrs_InsulinGlargineMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_dd337b2e-8f5c-40ed-9b5a-757d67954c0b" xlink:to="loc_vtrs_InsulinGlargineMember_d296d8e1-2196-401f-b065-c3c2552de038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_EpiPenAutoInjectorLitigationMember_d21cae86-bab8-4c6f-a1f3-25b20261d523" xlink:href="vtrs-20211231.xsd#vtrs_EpiPenAutoInjectorLitigationMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_dd337b2e-8f5c-40ed-9b5a-757d67954c0b" xlink:to="loc_vtrs_EpiPenAutoInjectorLitigationMember_d21cae86-bab8-4c6f-a1f3-25b20261d523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_bcbcf83d-4fb4-4df4-a928-8b602f94fc24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_b7b00fd0-4009-4ef3-8a39-cc475eb52bbd" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_bcbcf83d-4fb4-4df4-a928-8b602f94fc24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_059618b8-08e0-45b0-a95b-dbc2dfca1718" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_bcbcf83d-4fb4-4df4-a928-8b602f94fc24" xlink:to="loc_us-gaap_LossContingencyNatureDomain_059618b8-08e0-45b0-a95b-dbc2dfca1718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_AntitrustProceedingsMember_608d183f-f8b4-4a96-91ca-412cecef7f53" xlink:href="vtrs-20211231.xsd#vtrs_AntitrustProceedingsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_059618b8-08e0-45b0-a95b-dbc2dfca1718" xlink:to="loc_vtrs_AntitrustProceedingsMember_608d183f-f8b4-4a96-91ca-412cecef7f53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_ProductLiabilityMember_10703757-5666-4f6a-87ee-9f8f13440545" xlink:href="vtrs-20211231.xsd#vtrs_ProductLiabilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_059618b8-08e0-45b0-a95b-dbc2dfca1718" xlink:to="loc_vtrs_ProductLiabilityMember_10703757-5666-4f6a-87ee-9f8f13440545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_87bc3884-6ae5-4743-a81b-b2fde71cd7c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_059618b8-08e0-45b0-a95b-dbc2dfca1718" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_87bc3884-6ae5-4743-a81b-b2fde71cd7c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_OtherMember_b35a46bb-df8c-4ea8-bc44-ae8e68d02645" xlink:href="vtrs-20211231.xsd#vtrs_OtherMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_059618b8-08e0-45b0-a95b-dbc2dfca1718" xlink:to="loc_vtrs_OtherMember_b35a46bb-df8c-4ea8-bc44-ae8e68d02645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_878ff08c-d11d-487c-8dc3-68f18990df04" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_b7b00fd0-4009-4ef3-8a39-cc475eb52bbd" xlink:to="loc_srt_ConsolidatedEntitiesAxis_878ff08c-d11d-487c-8dc3-68f18990df04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_5d2d81eb-32f5-4402-a52a-f80612798141" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_878ff08c-d11d-487c-8dc3-68f18990df04" xlink:to="loc_srt_ConsolidatedEntitiesDomain_5d2d81eb-32f5-4402-a52a-f80612798141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember_0298d285-e42b-4dd3-85c3-01d068316aa7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SubsidiariesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_5d2d81eb-32f5-4402-a52a-f80612798141" xlink:to="loc_srt_SubsidiariesMember_0298d285-e42b-4dd3-85c3-01d068316aa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_68a2057b-8098-4674-8b86-e9ac7367752a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_5d2d81eb-32f5-4402-a52a-f80612798141" xlink:to="loc_srt_ParentCompanyMember_68a2057b-8098-4674-8b86-e9ac7367752a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_3b0d53ea-c0f7-40ff-9241-89c28e71a4ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_b7b00fd0-4009-4ef3-8a39-cc475eb52bbd" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_3b0d53ea-c0f7-40ff-9241-89c28e71a4ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_f2c2c54d-1e60-434a-92e1-70a109af43f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_3b0d53ea-c0f7-40ff-9241-89c28e71a4ed" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_f2c2c54d-1e60-434a-92e1-70a109af43f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_4f504fc5-5da7-4602-8b36-b9e9e80793c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_f2c2c54d-1e60-434a-92e1-70a109af43f6" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_4f504fc5-5da7-4602-8b36-b9e9e80793c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_b1e1164a-9f1b-4a27-a77b-8a009d3ac728" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_b7b00fd0-4009-4ef3-8a39-cc475eb52bbd" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_b1e1164a-9f1b-4a27-a77b-8a009d3ac728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_6d186151-8951-43de-a5e2-7845236e55b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_b1e1164a-9f1b-4a27-a77b-8a009d3ac728" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_6d186151-8951-43de-a5e2-7845236e55b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_d4445845-2d23-4a34-9a90-10d5ed3b267d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_6d186151-8951-43de-a5e2-7845236e55b6" xlink:to="loc_us-gaap_SubsequentEventMember_d4445845-2d23-4a34-9a90-10d5ed3b267d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_8a3d1f76-7eb8-45b2-acb5-eb3af1f8f995" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_b7b00fd0-4009-4ef3-8a39-cc475eb52bbd" xlink:to="loc_us-gaap_LossContingenciesLineItems_8a3d1f76-7eb8-45b2-acb5-eb3af1f8f995" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_be8e1ce9-1282-45d7-83af-30c00c13ed9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8a3d1f76-7eb8-45b2-acb5-eb3af1f8f995" xlink:to="loc_us-gaap_LitigationReserve_be8e1ce9-1282-45d7-83af-30c00c13ed9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_2a8c4e06-15ab-4905-86c0-0a8ba42df26b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8a3d1f76-7eb8-45b2-acb5-eb3af1f8f995" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_2a8c4e06-15ab-4905-86c0-0a8ba42df26b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_fd8b763b-8e2c-4dcd-8049-c8bf88ac0ce4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_d940161f-d3d5-47f0-aad6-7ac302b2ac59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8a3d1f76-7eb8-45b2-acb5-eb3af1f8f995" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_d940161f-d3d5-47f0-aad6-7ac302b2ac59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_6b690204-11a3-4003-960f-634cfa3c4917" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Numberofstates_8f691635-9f3d-4968-aeb7-55f84b31619d" xlink:href="vtrs-20211231.xsd#vtrs_Numberofstates"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8a3d1f76-7eb8-45b2-acb5-eb3af1f8f995" xlink:to="loc_vtrs_Numberofstates_8f691635-9f3d-4968-aeb7-55f84b31619d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_Numberofcases_d5bae2d2-a3ca-474e-8d72-92ffb2aa0a99" xlink:href="vtrs-20211231.xsd#vtrs_Numberofcases"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8a3d1f76-7eb8-45b2-acb5-eb3af1f8f995" xlink:to="loc_vtrs_Numberofcases_d5bae2d2-a3ca-474e-8d72-92ffb2aa0a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesPaidValue_aa49412f-49c5-4996-8eaf-d431fe0048a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesPaidValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8a3d1f76-7eb8-45b2-acb5-eb3af1f8f995" xlink:to="loc_us-gaap_LossContingencyDamagesPaidValue_aa49412f-49c5-4996-8eaf-d431fe0048a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement_93eb78ab-9966-4422-a247-9856c715d41c" xlink:href="vtrs-20211231.xsd#vtrs_NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8a3d1f76-7eb8-45b2-acb5-eb3af1f8f995" xlink:to="loc_vtrs_NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement_93eb78ab-9966-4422-a247-9856c715d41c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_d4ffaef7-7d6b-4c3b-ad51-35da61006525" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPatentsAllegedlyInfringedNumber"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8a3d1f76-7eb8-45b2-acb5-eb3af1f8f995" xlink:to="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_d4ffaef7-7d6b-4c3b-ad51-35da61006525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPatentsFoundNotInfringedNumber_5cf1d10c-67bf-4900-9ebb-b8f35ab2eea0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPatentsFoundNotInfringedNumber"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8a3d1f76-7eb8-45b2-acb5-eb3af1f8f995" xlink:to="loc_us-gaap_LossContingencyPatentsFoundNotInfringedNumber_5cf1d10c-67bf-4900-9ebb-b8f35ab2eea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_LossContingencyRemainingClaimsNumber_5a3c75d2-b5b4-4331-b955-d9d732a775d1" xlink:href="vtrs-20211231.xsd#vtrs_LossContingencyRemainingClaimsNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8a3d1f76-7eb8-45b2-acb5-eb3af1f8f995" xlink:to="loc_vtrs_LossContingencyRemainingClaimsNumber_5a3c75d2-b5b4-4331-b955-d9d732a775d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_LossContingencyOtherAssertedPatentsNumber_5900e4ff-f4c9-44bd-adf8-2cd295c5422d" xlink:href="vtrs-20211231.xsd#vtrs_LossContingencyOtherAssertedPatentsNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8a3d1f76-7eb8-45b2-acb5-eb3af1f8f995" xlink:to="loc_vtrs_LossContingencyOtherAssertedPatentsNumber_5900e4ff-f4c9-44bd-adf8-2cd295c5422d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_LossContingencyNumberOfStates_ea3fe0b3-3de6-41b1-91b5-f96b5deabe6d" xlink:href="vtrs-20211231.xsd#vtrs_LossContingencyNumberOfStates"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8a3d1f76-7eb8-45b2-acb5-eb3af1f8f995" xlink:to="loc_vtrs_LossContingencyNumberOfStates_ea3fe0b3-3de6-41b1-91b5-f96b5deabe6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_7b44f00d-125c-4e01-bbc9-cf975dd1675e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8a3d1f76-7eb8-45b2-acb5-eb3af1f8f995" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_7b44f00d-125c-4e01-bbc9-cf975dd1675e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtrs_LossContingencyDamagesAwardedOnAppealValue_9fa58f4a-9ef4-47a3-9dda-39e217bd16c9" xlink:href="vtrs-20211231.xsd#vtrs_LossContingencyDamagesAwardedOnAppealValue"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8a3d1f76-7eb8-45b2-acb5-eb3af1f8f995" xlink:to="loc_vtrs_LossContingencyDamagesAwardedOnAppealValue_9fa58f4a-9ef4-47a3-9dda-39e217bd16c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ValuationandQualifyingAccounts" xlink:type="simple" xlink:href="vtrs-20211231.xsd#ValuationandQualifyingAccounts"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/ValuationandQualifyingAccounts" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_5c0db3aa-cb37-4504-ad63-1ef059ce1b84" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_fb6bbac6-fe0f-4b86-96e0-8761612a9fce" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_5c0db3aa-cb37-4504-ad63-1ef059ce1b84" xlink:to="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_fb6bbac6-fe0f-4b86-96e0-8761612a9fce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/ValuationandQualifyingAccountsDetails" xlink:type="simple" xlink:href="vtrs-20211231.xsd#ValuationandQualifyingAccountsDetails"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/ValuationandQualifyingAccountsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_961ecfd3-5df5-4dd5-991c-4bc405c173ce" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_4dcec9a9-e144-402f-bccb-69c9b9ffd174" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_961ecfd3-5df5-4dd5-991c-4bc405c173ce" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_4dcec9a9-e144-402f-bccb-69c9b9ffd174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_062b0904-1a85-47a5-86d9-999e2e78e681" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_4dcec9a9-e144-402f-bccb-69c9b9ffd174" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_062b0904-1a85-47a5-86d9-999e2e78e681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_073ea4d7-2e4b-43f1-ac7c-c13de6f863fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_062b0904-1a85-47a5-86d9-999e2e78e681" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_073ea4d7-2e4b-43f1-ac7c-c13de6f863fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_f3085241-1849-4e15-aaa5-007ca841025b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_073ea4d7-2e4b-43f1-ac7c-c13de6f863fa" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_f3085241-1849-4e15-aaa5-007ca841025b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_708b283d-5bd9-4535-8bc0-6cd4fc7fa04d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_073ea4d7-2e4b-43f1-ac7c-c13de6f863fa" xlink:to="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_708b283d-5bd9-4535-8bc0-6cd4fc7fa04d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_857dcda1-79bf-4d25-a922-e87651676c52" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_4dcec9a9-e144-402f-bccb-69c9b9ffd174" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_857dcda1-79bf-4d25-a922-e87651676c52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_72991c87-8f89-4a49-9cb3-231ea62b5194" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_857dcda1-79bf-4d25-a922-e87651676c52" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_72991c87-8f89-4a49-9cb3-231ea62b5194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_59d6c460-ac9e-4eb1-ab82-ab9c701e2c39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_72991c87-8f89-4a49-9cb3-231ea62b5194" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_59d6c460-ac9e-4eb1-ab82-ab9c701e2c39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_479e3691-37ed-4f7d-8812-b3281c83aad9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_72991c87-8f89-4a49-9cb3-231ea62b5194" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_479e3691-37ed-4f7d-8812-b3281c83aad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_49b90970-1a4b-4225-8c50-e579d235e3c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_72991c87-8f89-4a49-9cb3-231ea62b5194" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_49b90970-1a4b-4225-8c50-e579d235e3c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_6643373f-6e4b-485b-ae83-66a6d013e4b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_72991c87-8f89-4a49-9cb3-231ea62b5194" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_6643373f-6e4b-485b-ae83-66a6d013e4b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_cde0f449-017f-42b1-a70a-deb2e449d810" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_72991c87-8f89-4a49-9cb3-231ea62b5194" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_cde0f449-017f-42b1-a70a-deb2e449d810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/AuditInformation" xlink:type="simple" xlink:href="vtrs-20211231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLineItems_750a79b5-e4d2-4b37-bd70-94963620cdd6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_561bae43-73d8-4260-859d-882810558142" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_AuditorLineItems_750a79b5-e4d2-4b37-bd70-94963620cdd6" xlink:to="loc_dei_AuditorName_561bae43-73d8-4260-859d-882810558142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_e18c1b5f-8f20-4d8a-9898-63b61b305a78" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_AuditorLineItems_750a79b5-e4d2-4b37-bd70-94963620cdd6" xlink:to="loc_dei_AuditorLocation_e18c1b5f-8f20-4d8a-9898-63b61b305a78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.viatris.com/role/AuditInformation_1" xlink:type="simple" xlink:href="vtrs-20211231.xsd#AuditInformation_1"/>
  <link:presentationLink xlink:role="http://www.viatris.com/role/AuditInformation_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLineItems_98e82391-b5a6-4a70-9f04-4b9034f8c5fb" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_186f01a1-f791-41b4-851c-055eb611c7ba" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_AuditorLineItems_98e82391-b5a6-4a70-9f04-4b9034f8c5fb" xlink:to="loc_dei_AuditorFirmId_186f01a1-f791-41b4-851c-055eb611c7ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>vtrs-20211231_g1.jpg
<TEXT>
begin 644 vtrs-20211231_g1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" (P A,# 2(  A$! Q$!_\0
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MB[A5JOXTDG%V9^-[:!1112$%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110!%=-MMY#_LG^5?E'^V9
MJKZEX\4,V?+++7ZMW8S;2C_9/\J_)K]L"S>T\>L6&-S,:_9O"]1>:R;WL?9<
M,)?6F_(\\^">E'5OB7H46,J;@ _D:_9+P=I::3H-M;HNT*,8K\=_@'J2Z?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%0W5K'>0M%*NY&ZBIJ*:;3N@/SV_; _9GEL;V37=*MP5E)EDV#)[^E?%,L-Q
MI=UAU:*5#_$"*_=#6M%M=>T^:SNXEDBE7:=R@FOB+]H3]C![VXN-2T"#(R6(
M)QQ7]%\%\=4U3CE^92M;12?ZGZ+DN>Q45A\2_1GS]\&/VI-:^'$T4,]R[6:\
M;5!)K[*^'O[:GA_Q)'$+AI$;H?,./YBOSD\5?#C6/"MY)#=6KKM/4*<5SBS7
M-J<+)+$1Z,17Z#FG"&3Y]^_BK2?5'T&*RC!X_P!];OJC]F+?X]>%Y[<2"]A
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M1G./6NKK^8.+.**W$6)NM*<=E^I^8YKFD\QJ7VBM@HHHKX,\$**** "BBB@
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M%??Y+P+G-+&4<1.%HQ:;/?P61XR-:%1QT3/G#6O^0M=_]=#7Z#_L$0LVEWI
MX 7^E?GA=3&YN))3U=LU[5\&?VD;WX4PRQ0K*RR8!V'Z?X5^]<695B<VRIX7
M#*\M#[W-L+4Q6%=*GN?KS17Y]:-^WM-(Z^=#*![M_P#7KTOPS^W%I%P5%S'M
MS_>>OYDQ/ ^=897=*_H?F53(\;3W@?75%>0^&/VD_#'B14VWD$1;U>O1M/\
M%VDZE&K07\,F?[K5\CB,OQ>%?+6IM?(\BIAZM)VG%HV**9'(LBAD8,/:GUYQ
MSA1110 4444 %%%% !1110 4444 %07URMG:33.<!$+?D*GKRG]H[QDW@SX>
MW-W&^V0Y3@\\BNW!8:6,Q,,/#>3L;T:;K5(TUU/A+]L'XUW7BCQ%+ID$S+;J
M&1E4\9'%?-6BZ/<:]J45K K22RG QUJSXNUF37->N[F5BS-*QY]S7TO^Q?\
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M2YJ4K'XU?%#]G_Q'\-;B4WEL6A4DCRU)X[5YI'-<6,@(,D+CZJ:_;OQ5\/\
M2/%UL\5[:Q/N&,F,$U\<_'7]B-+KSK_0HI))!E@BC K^B>'O$?#8U1P^9+EE
MWZ'Z)E_$=*M:GB='W/FOX0_M)^(?AS?1A+DO;DC=O);BN@^.W[46I_%"U%J)
MOW2MG"\5X_XV^'>L>!;YH-2MO((; Y-<P,LP'4U^D0R7*L5B8YE3IIRZ-'T<
M<%A:M18F,4WW+>FV,VL:A%!&K.\C@<#/4U^D/[(G[.MOX8TR#6+ZW_TG(9=P
M['FO!_V-O@/_ ,)9K$.L7D+&WQD9&1D<U^E&EZ=%I=E%;PHJ*B!<*,=!BOQ[
MQ$XI<7_96$E_B?Z'Q_$6:6_V6D_4LQQK$@11A0, "G445_.I^=A1110 5Y5\
M<_C;I_PI\/SRM,!?;-T8R#7<^,/$]KX3T.>_NY/+B0'YO?%?DY^TA\9KSXD>
M+KE?./V:!VC4*W!%?HW!G#,L_P 9S55^ZAOY^1]%DV6/,*UY?"MS"^+OQFU7
MXC:Y<3S7#&%G)4*Q Q7!:3HMYKEY%;VT,DLDC!1A2:T/!OA"^\9:S!8V<1E:
M1]IQ7Z2?LX_LLZ?X1TFVO=4MMUV5Y61-V#^-?T=G6>Y?PCA(TXI7MI%'Z/C<
M=A\IHJ*6O1'S/\*?V)]:\2+%<:M"!;OZ'!KZ=\&_L/\ A/P^J/)#(TO4Y.17
MTO::?;V,*QPQ(BC^ZN*LU_.&:<=9OF,WRU.2/9'YQBL\QF(;M*R\CR.']F_P
MO%$$%J,?[HKE/%7['/A'Q%"ZM;LI(XVX%?0]%?-4L_S.C/GA7DGZGFQQ^)@^
M:,V?GA\3/V#9M-AEDT"+(7)^=J^3/&7P]UCP/J4EGJ%NRR(>653BOV^DA292
M'16!]17D?QB^ >C?$+2;C_1D2Y*L0R1C)..*_4^'_$C%4*BHYE[T7UZH^IR_
MB2K3DH8G5=S\F/"/C34/".I17-G.\90@XW$=Z_2K]EO]IRU^(6G0:5J<X_M
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MC;]GTZ#IT>M:E#B25 R<<YK[( P *XOX?^.O#/B'3XX]#N%:%5X  7C\#7:
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M[H^\_P!O/QI;:GX9:TM9A(C;6X/TKX"MXVEF55&YC73>*?B)JGBR$1WUS),
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MB6KM:QMD?NGQ7S[JWB*_UJX:6ZN9)68Y.YLUK^'/AKX@\2W$<=IIL\B,<%U
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M-EPIX;CT/M7W>7>)M+&5Z>'G1LY-(]W#<31K5(TW#<_+8@J<'@U;M-(O;_\
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MOT%_8)_Y!MY]%_I7]2<?_P#(AE\OT/U'/_\ <&?:]%%%?QZ?CX4444 %%%%
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M_P#6K](Z*[\1XEYQ6@XQ2CZ&]3B7&35E9'@?PQ_9*\.>!/+:ZA@U%U'5E/\
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M]5J/9:'C8K-<5B])RT&1QK"H5%VJ.PI]%%?('D!1110 4444 %%%% !1110
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M4\CD<R.68Y).376>#_B5K/@R3-C=2Q*3R%<@&O>K?]A77)K?S#/.IQ]W8/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ KF?B%XPM_!/A>[U2=@%A7.,XKI:^+OV^/BE)H>GKH,$N%O(?F
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ,F7?$Z^H-?F'
M^W=X9?1_&UI)LPLJLV:_3^OE']N+X5GQ1X7FUN&/?):0X  R>E?HW >91R[.
M:;J.T9:??L?19#B5A\9'FV>A^='P[U8:'XTTJ]+;1#,&)_ U^Q'P8\4Q^*O!
M&GWD;A]Z9XK\6KB&2QNF1@4D0XYK[B_8M_:&ALXXO#NH2^4L2!$:1L D^E?M
M7B-DE3,L#'%T%>5/\C[7B/!2Q-!58*[C^1^@%%06EW%>0K)$X=6&<K4]?R@T
MT[,_* HHHI %4-<OETW2[F=S@)&S?D*NLXC4LQP!7S7^U9\?K'P+X;GLK>99
M;M]T95&Y&1BO7RK+JV:8N&&H1NVSKPN'GBJL:<%>Y\-_M9^,AXO^)4L\4FZ-
M%*$ \<'']*YK]GW16U[XGZ3:*N[>V/U%<'J^I2ZQJ4]Q*Q=I)&89]SFOL#]A
M'X1R:IKT/B.>+"VLN/F'O_\ 6K^Q,SJTN'L@E!NW+#E7K8_8<5*&7Y>XOHK'
MZ ^#K$Z;X;T^V(P8X@M;5-1!&H51@"G5_%%2;J3<WU/Q64N9MA11169(4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>vtrs-20211231_g2.jpg
<TEXT>
begin 644 vtrs-20211231_g2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1"X17AI9@  34T *@    @ ! $[  (
M   7   (2H=I  0    !   (8IR=  $    N   0@NH<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $-H<FES=&]P
M:&5R($-A<F%C8VEO;&\    !ZAP !P  " P   AT     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M8-6LTFMWW97)K\XS3*ZF J=X]&?.8K"RH2\B_1117C'&%%%% !1110 4444
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M%51@ 5)117PS=]6>&%%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** *][90WUNT4\:NI!ZBO!_B'\/)=.G:ZLD+QG+':.!7T!5>^LH;^U
M>"X7<CC!%>IEN95<#5YH[=4=6&Q,J$KK8^.&5XI,-E6!KO\ P!X]GT>[CMKI
MRT3'EF/2K_Q$^'DFFS/>6,>(6/  R17F+HT;E6!!!QR*_38RPV:X;NG^!],G
M3Q5,^P=*U6WU6T2:"16W#/%7J^</ /C^?1KI+:ZD8PDA5 KZ$TS4(]2LUGBS
M@@=:_-LTRRI@*EG\+V9\WBL+*A+R+=%%%>.<84444 %%%% !1110 4444 %%
M%% !1110 445C^(==AT/3Y)Y<_*,\5=.G*I)0BM65&+D[(3Q#XAM=$L7DFE5
M6P< ^M?.7C'QC=>(+]L,R1*2-H/!I?&?C*Y\1WK@2$VV<JIKEX()+B4)&I+'
MT%?IF39-#!P]K5^+\CZ7!X-45S3W%M[>2YF6.)2S,<<5[-\./AUM\N_U!,%3
M_JW'44GPY^' PE]J4096&5&.0:]DAB6&-408"C KRL\SS?#X=^K.7'8[_EW3
M$A@2WB6.)0JKT J2BBOAFVW=GA!1112 **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** *U[90WUNT4Z*P8$<C.*\'^(7P\DTZX>
MZL49XN6)':OH&J]Y907]NT-RF^-NHKU<MS*K@:O-';JCJPV)E0E=;'S?X)\"
M7>L:BKW$;1HA# CO7T5I.G+IEBL"L6P!UIUCI5IIJXM(]@QBKE:9IFM3'SUT
MBNA6*Q4L1+R"BBBO&.,**0D*,L<#U-<=XL\?V/A]'0G>X_N'-;T,/5Q$^2FK
MLTITY5)<L4=@SJ@RQP*KMJ-JIP917SSK/Q4U6[D;[%<M&A/ (-<^WCG7F.3>
M'-?44>%L1*-YR2/3AE=1J[9]2_VG:?\ /44?VG:?\]17RS_PF^N_\_AH_P"$
MWUW_ )_#6W^JE7^=%_V5+N?4W]IVG_/44Y+^V<X60&OE?_A-]=_Y_#3X_'>O
M1L"+PTGPI5MI-!_94^Y]6A@PR*6OGK0?BU>VDB_VE,\JCJ!FO8_#7B^R\06X
M:%@K8Y#-S7AX[)\3@]9JZ[G#7P=6CJUH=%1117CG&%8?B?05US3)868J67'%
M;E%:4ZDJ4U..Z*C)Q=T?*WB/P;>Z/JC0I$S1;@JL>_->A?#GX<[2E]J*%64Y
M"L.HKU:^T*PU%@UW"'(.1]:O10I!&$C&% P!7TN*XBK5\,J4='U9Z57,9SI\
MBW$A@CMXPD2A5'0 5)117R[;>K/+"BBBD 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%1SRB&%G;@
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M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%0W-U%:1&2=U0
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M_L5Q_P \S7ZA#)L XIN)]/'!X=I:'K/_  N27_GJ:/\ A<DO_/4UY-]BN/\
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MW<5Z>99=+%QYZ,VI>NATXG#NJN:#LSZ5'P_\.D9%H#^(_P */^%?^'O^?/\
M4?X5@>#/B3:ZI"D-](L<@& /4UZ%%*DR!HSD&OSK%2QV%FX59-?-GSM5UZ4N
M639SG_"O_#W_ #Y_J/\ "C_A7_A[_GS_ %'^%=-17+]=Q/\ ._O,O;5/YF<S
M_P *_P##W_/G^H_PH_X5_P"'O^?/]1_A7344?7<3_._O#VU3^9G,_P#"O_#W
M_/G^H_PH_P"%?^'O^?/]1_A7344?7<3_ #O[P]M4_F9S/_"O_#W_ #Y_J/\
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M7^[/T/H$=**!THK\D/D@HHHH ****  ]#7RW\0O^1DNO^NE?4AZ&OEOXA?\
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M$B2,808I]%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M$1IX54^K/5S.HHTN7N=-1117YH?-!1110 4444 %%%% !1110 4444 %%%%
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M0_\ ?5'_  G6D_\ /U#_ -]5\L>;)_?;\Z/-D_OM^='^JM#^=A_95/N?4_\
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ME^+.QRHX6'89\,/!$MW=?;+N,J(R&7<.M>]1HL:!5& *K:=I\.G6B00* J#
MXJW7YGF683QU9SEMT/F<3B'7GS,****\PY@HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
1BB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>vtrs-20211231_g3.jpg
<TEXT>
begin 644 vtrs-20211231_g3.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" (? CL# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=Y?120V,;C+ 9&*_2?P%\+M%\ Z3!9V=K"6B7;YNP!C4WPV\$V7@?PS9V5K
ML3K$JR%1]XCO765_-7%'%6*S[$R7-:DGHC\US3-:N/J/6T5L@HHHKX$\$*0C
M(P>E+10!QOC[X8:-X\TF6UO+2'>P/[PID]*_-G]I+]EV^^&5[<:A8123Z<<R
M/(1PN><5^K%<O\0O EEX^\/7.F7<:.LPQEJ^]X7XJQ608B/O7I/='O97FM7
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBDH 6BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH 1FVJ37R;\=/VR)_A/XXN]$CTZ.X6''S,?<^_M7U;=,5MY".H%?E3^V5
MI>IZI\:-6DAL9I(L##JO'4U^E\!Y3@\VS&5+'1O!1;U=M;H^ER'"4<7B'&NK
MJQ[O9_\ !11I% DTJ%?^!?\ UZW+/_@H!938\VU@C_X%_P#7K\[WT#48_O6<
MR_5:A;3;I/O0./PK]XEX?\/U/AA;Y_\ !/NWP_E\MHGZ9V?[=&A3X\UK>/\
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M;E$*+P$%&][V=SY3B# 8;!Q@\.K7.SHHHK\4/B@HHHH **** "BBB@ HHHH
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MKJ:$C!C=D_(XJ*O0/C;X#G\ ^-KNSG0H99'E4'T+9_K7"6MK)>7"0Q+ND8X
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M^=J5JE7XY7"BBBN,Q"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQ)8^)=/BN[*XCF210WR-G&:U:_ IPE3DXS5FCX%IQ=F%%%%0(**** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M95\9/X;^)6E6^\K'<7 W<\=*_7>SNDO;=9HR&5NA%?">)&6K!9O[:*LJBO\
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M>"]K@*6*2UB[?+4^NXIH\U"-5=&?1]%%%?RZ?EX4444 %%%% !1110 4444
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MF=5,]S">)F_=Z+LC\HS+&RQV(E5>W0****^6/+"BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHHHKD,0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MHK\0/B0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!P_QAT7^VO
M^J)MW%;>0_I7XQ>);%]/UN\BD&#YS_\ H1K]QM>M/M^BWMOC)EA9/S%?D/\
MM.^!YO!GQ$N;=HBB-E\X]37]!^%..4:E?!R>KLU\C]!X5KI2G1?4]?\ V"?&
M::5X@32&?#7,V0OXU^D]?BI\%?&C>!O'^FZF9-D4+9//':OV!^&OC"V\9>$[
M"_@E61I8]S =J\CQ.RJ>'Q\<=%>[-:^IQ\385T\0JZ6DCJZ***_$SXH****
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MQ$ "@ # %+117YD?,A1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M  3Q<;Q-0HWCAUS,^+O@S^P;,WV>^\2I#/"<,%4@'^=?5<WAWPM\#?",TUI
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MPU3U5:/W?\ 'G&6Q^VON/C";6KZX_P!9=2/]351Y&D.6;)K] =+_ .">#V[
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FBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>vtrs-20211231_g4.jpg
<TEXT>
begin 644 vtrs-20211231_g4.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" (\ R$# 2(  A$! Q$!_\0
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M>V?V/_;EQB*XW";'F>?%;NF]XA%%L63S)'V_*1R ?:M%?'_[2G_!132_@O\
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M5ZKXR_X1;_A$OL.M2Z1]B_M#[;OV002^9O\ *CQGS\;=I^[G/. ?LX_M7?\
M#0/Q4^-'@W_A%O[!_P"%<:T-(^V_VA]I_M#,]W%YFSRD\K_CUSMW/]_&>,D
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M>GC&02 0#Z HKY?\$_MHWWQ*_8YE^-?A'X>7'BKQ##,;:3P'HFHM>7:2B]6
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M^&?[/WQ6TOQ5_8<GB'X?^-/# C_LY;C9/;7M_<V1RROG?>W5G_  OD_,Q1W
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M\,IS$2_#2,WZ4^//V7_"OQ*^/7@CXJZ_?ZQ?:EX.A:/2]!EFBDTA)6\P_:3
M\3$3AGC82*ZG=;P'_EF*/VCOV7_"O[36E>&[?7[_ %C0-2\.:FNJZ7KWAN:*
MVU*TE"D;8YWB<HI;RW(7!+0Q'/R"@#\P/!T/[1EG\=/VOO$'[/\ K=O9OHWB
MVYGUO2%LX+J^U)3?W_DBUCF@D#LBBX8H&1FR HD8JM>P?LG^'=#UC]A']I_X
MKV_B[4/%?B_QSHVL2>)UO-,2P2ROXK"XFDB1$+*^6O7D\U"%9)(AY<3*ZU]O
M_!3]E_PK\!_'WQ.\7:!?ZQ>:E\0=3&JZI%J4T3PPRB6XEVP!(D*KNNI.&+G
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M<<U/$W[+_A7Q5^TOX3^.%W?ZQ'XL\-:8^E6=G#-$+&2)EN5+2(8BY;%W)R)
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M9)\$?%#]G'1_@OK;ZA)X;TBRT^RL=10P'4;?[(J)'*DCQ,BRLB%&94&5ED4
M!J /D#]O'X9Z'X3^*G["WP]\C^V?#>FZU'H/D:LB3_:K6.?2(-LZ[0C[D7##
M:%.3Q@XKY@_;$NK[X$_!?6OV8==>XE3PGXY@\0>#KRX1B;W0;JVOF/SBWC1V
MBFE D?)W2SRH@VP5^G^K?L.^#=>M_@=%J?B/Q1>O\()DET"9I[1&G6.2W>*.
MZV6P#JBVD,8*!&*@[F9B6JU^U)^Q!\-/VN/['N/&$&H:;K6EYC@UO0I8H+QH
M#N)MY&DCD5XMS;P"N5;=M*AW# 'T!1110 4444 %%%% !1110 4444 %%%%
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M)\*WGB3PW\/_ (J:UI-[XIDGT?Q"DEII<G]K:NM^MW$7M[QHI8UB6/RBC?\
M'Q(/.(CS+W]K\$=4U;PCHGA&[B\/^!/"FG;=433? MJL(BU);MKFV6(2Q>6L
M5K*L,WF>7_I<ZAGB@B$EO. >J^%O$'_"4:#:ZJ--U#2H[G<T5MJD'D7'E[B$
MD>(G='O4*X20+(H<+(D;AD76K)\+?VX-!M5\2?V>VM)NCGETOS!;S;6(65$?
MYH]ZA7,19_++%/,E"^8VM0 4444 %%%% !1110 4444 %%%% !1110 4444
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M61%+))&XRKJ3\_\ Q%^"OB+6O$GB+6I=#UC4]-A^(T/B:*Q\.ZV--U._LO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M5+/5K'4KB_M[2\M[JXL)A;7D4,JNUM*8TE$<@!RC&.6-]IP=LBGHP- %NBBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH Y?X6_\DR\(_\ 8'L__1*5U%<O\+?^29>$?^P/9_\ HE*ZB@ HHHH
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MIQ3L^ZM^!W4:T:]-5(II/NFG]S"BBBM3<**** "BBB@ HHHH **** "BBB@
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M_DF7A'_L#V?_ *)2NHKE_A;_ ,DR\(_]@>S_ /1*5U% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%4-8U[3/#MH;K5=1M-,M1UFO
M)UB0?\"8@5Y!XN_;0^#_ (/WI+XOM]5N%Z0Z1&]UN^CH-GYM6%7$4J*O5FEZ
MLYJV*H8=7K34?5I'MU%?)4G[=FI>,7:+X;_";Q+XIR=JW4Z&.-?<B-9!CZLM
M-^W?M:?$C_467AOX<6<GW7E*22[?<$S$'_@*_A7#_:5&7\%2GZ)_F[+\3S?[
M7H3_ ($95/\ #%V^]V7XGUO7!^+OCQ\// N\:YXST:QF3[UO]K628?\ ;-"7
M_2O!/^&)?%GCCY_B1\9-?UR)_OV%@62$>NTNQ7_R&*[OPC^PU\'_  GL=O#;
MZW<+_P MM7NGFS]4!6,_]\T>VQM3X*2C_B?Z*_YA]8S&K_#H*'G*7Z1O^9S7
MB+_@H9\-[&X^R>'K+7/%MXQQ$MC9^6CGZR$/^2&L?_AHC]H+XA<>"O@S_8EO
M)]VZ\0NP^7^\/,,(_1OQKZA\.^#= \'V_D:%HFG:+#C'EZ?:1P+^2 5JS31V
M\9>5UC0=6<@ ?C2>'Q4U>M7LO[J2_%W8?4\=6_C8BWE"*7XOF9\D_P#"F?VF
M?B%SXG^*MEX2M)/^7?0D(EC'IF)8\_\ ?PU<TG_@GGX2NKI;WQCXL\2>,+_^
M)[BX$2/ZYX9__'Z^A]2^)?A;2<_:=>L@PZK%*)6'X+DURU_^T-X7MVV6D=]J
M4AX400;0?^^B#^E>#B,9D.$?^UXF,I?WI\S_ / ;_H>K0X2J8GWG0G4\Y<S7
MX^Z1^$_V6_A1X+V'3? VDM*GW9KZ(WD@/J&F+$'Z5Z=:VL-E;I!;PQP0H,+'
M$H55'H .E>4_\+:\6ZSQHO@:ZVG[LUX6"G_QU1_X]1]G^+FN_>GTO0$;JJ[6
M(_23^=*GQ#@K6P&'J5%_<IM+[Y<J_$^@I<//"JTY4Z7ES1_*-V>MT5R7@+PO
MKGAT7SZYK\FMRW&S8K A8=N[.W)[Y'0#[M=;7U.$K5,10C5JTW3D_LNS:UZV
M;6JUW/-Q%.%&HX4YJ:757L_OL_(****[#G"BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ KE/!_P *O"'P_P!>\4ZUX;\.:?HNJ^*+T:AK-W9PA'O9PH4.
MY_[Z; P"\DKXWR.S=710!D^'_">A^$_[2_L31M/T;^TKV34K[^S[5(/M5U)C
MS+B78!OE;:-SMEC@9/%95U\)_!%]H.MZ)<>#?#]QHNN7K:EJNG2Z7 UOJ%TS
M*[7$\93;+*6C1B[@L2BG.0*ZNB@#)\+>$]#\#Z#:Z)X;T;3_  _HMKN\C3M+
MM4MK>'<Q=MD: *N69F.!R6)ZFM:BB@#E_A;_ ,DR\(_]@>S_ /1*5U%<O\+?
M^29>$?\ L#V?_HE*ZB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHJIJ>K6.BVK76HW
MMO86R_>FNI5C0?5F(%)NVK$VDKLMT5XWXM_; ^$/@[>MUXUL;Z9>D6E!KPL?
M3=$&4?B17E]U^W];^)+A[7X>?#7Q-XQN0=H;RO+7/KB,2G'U _"N"IF&%INT
MJBOV6K^Y7/+JYI@J+Y955?LM7]RNSZTHKY&_X2K]K#XD<:9X;T'X>64GW+B^
M*-,H_P!H.9#_ .0A1_PQS\1?'GS_ !%^-.KWT+_ZS3M)WK"?7&YE0?\ ?JL?
MKU2I_!HR?K[J_'7\##^T:M3_ '?#SEYNT5^.OX'T-XN^,W@3P'O&O^+M'TN5
M.L$UXGG?A&"6/X"O&/$W_!0?X7Z3-]FT5=8\5W;';&NFV116;TS*4/Y*:U/"
M/[!OP@\*['GT2Z\03ITEU:\=_P T38A_%:]6TO2/ ?PPA,6G6>@>&$ P5MHH
M;8GZX )-9U*F+C'GJSA2CW>OXNR-(4\VQ3Y8\L+]DYO]$?.__#2GQV^(7R^!
M?@M)I<#_ '+SQ"[JI7^\-_DK^1;\:7_A3O[3/Q&Y\3_%*Q\'6<G_ "[:#&?.
MC'<9C5#_ .137N^J?'7P?IN0NHO>N/X;6%F_4@#]:Q?^%Z7>K<>'_"&IZD#T
MD<%0/<[0P_6OFZV<Y1&7)6QSJ2[0;?X4TV>Q3X1S+$+FQ#J->;5./_MOYGF.
MC_\ !/7P9->+?>,/$OB+QE?_ ,;W5UY2/]<9?_Q^O7_"/[-_PP\"[#H_@C1X
M94^[<7%N+F8?227<P_.LW^UOBQKW_'OI>G:%$W228J6'U!9O_0:/^%7>-=;Y
MUKQS-$I^]%8*P4^W!0?I12S&%_\ 8,MJ2?>45!??-I_@=U'AC+\&^:I5I1?E
M><OP3_,]/O-2T_1H5^U75M8Q*,#SI%C4#\2*Y;4_C+X/TO(?68IW'\-JK2Y_
M%1C]:Q+']GGPU#)YM]-?ZG*>6,\^T'_OD _K75:9\-/"VCX-MH5D&7HTL?FL
M/Q?)KN]KQ%B/@I4J*_O2E-_=%17XGI>SRBC\4YU'Y)17XMO\#C9?V@K*\D,>
MB:!JFKRCC"H%!_[YW']*9_PF7Q,UWC3O"=OID;?QWS?,O_?3+_Z#7K$4201A
M(T6-%X"J, ?A3Z/[(S.O_O682MVIQC#\6I/\0_M#!4OX&$5^\I2E^'NK\#R3
M_A"OB7KG_(2\70Z;&W\%BIW+_P!\JO\ Z%3X?V>]/NY!+K6NZIJTHYRT@4'\
M]Q_6O6**:X5RR;OB5*L^]2<I?@W;\!?VYC8Z46J:_NQC'\4K_B<5IOP:\'Z7
M@IHL4[C^*Y=I<_@QQ^E=38:/8:4NVRLK>S7IMMXE0?H*N45[V&RW!8+_ ':C
M&'^&*7Y(\NMC,3B/XU24O5MA1117HG(%%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%<IX/\ BKX0^(&O>*=%\-^(]/UK5?"]Z-/UFTLY
M@[V4Y4,$<?\ ?2Y&0'CE3.^-U4 ZNBN?MOB%X5O-*U[4[?Q+H\^F^'YKBVUB
M\COXFATV6!=T\=PX;$31KRZN05')Q659_&[X=:EX-O\ Q=:>/O"]UX3L)A;7
MFO0ZS;/8VTI* 1R3A]B,3+'\I(/[Q?[PH [6BLGPMXLT/QQH-KK?AO6=/\0:
M+=;O(U'2[I+FWFVL4;9(A*MAE93@\%2.HK6H Y?X6_\ ),O"/_8'L_\ T2E=
M17+_  M_Y)EX1_[ ]G_Z)2NHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBD)"@D\"@!:*XCQ-\;_ (?>#=XUKQIH=A*O
M6"2^C,O_ '[!+'\J\B\4?\%!/A+H+-'I]WJGB2;.T+IEBR@MZ9F,?Z9_&N.I
MC,/1_B5$OF<%;,,)A_XM6*^:O]Q]*45\C_\ #7GQ1\<?+X"^"&K30O\ ZJ_U
M<R+"WI_ B_\ D2E_L#]K3XA?\?NN>'/A]:O]^&U"22 >BE5F.?\ @8^M<W]H
MTY?P82GZ1=OO=D<?]K4I_P "G.?I%V^]V1];%@H))P!U-<'XJ^/7PY\$[QK7
MC71+.5/O6_VQ))A_VS0EOTKY\O/V);K7E$WQ/^-&OZY&W+0>?Y,:^P,SR#'T
M4?2M71_V>?V;O >UIK6#7;E/^6MY=37F[ZHG[L_]\UP8G-98?^,X4O\ '-+\
M%_F=5&&<XW3"X6WJV_PBG^9=\2?\%"OAEIT_V;0H-;\5W;';&NGV1C1S]92K
M?DIK%_X:5^/'Q X\#_!232X).$N_$+NJD?WAO\E?R+?C7I.B_%'P)X24V?@S
MP=Y)Q@1Z7I\5LK?]\C/Z5J?\+#^(6N?\@GP5]B5NC:@Q''K\Q2OGWQ%A:SY8
M8EU'VHTY2_&TE^)ZJX7SNIKBZRI1_P"W8?C)M_@>0_\ "I?VG_B)SXC^)FG>
M#;-_^7;14_?1_C&BD_\ ?TU:TW_@GKX7O;I;[QKXR\2>,;U1\TD]P(D;USG>
M_P#X_7JO_"._%37/^/S7['1X3UCME!<?B%_]FH'P%?5"&U_Q7JFJGJ5#;1_X
M\7I*MB,1K1RZI/SJSC!?=>3_ /)1KA;*H:XW%*;_ .WZG^43&T7X(_ 7X9[3
M%H/AQ9X^0VH.+V8'U E+D'Z"NDN?CMX+T.!;;3_.N8XQM2&QM=B#V ;:,?2M
M'3/@;X.TW!.F-=N/XKJ9F_0$+^E=;IOAW2M& %AIMI98[P0*A_,"O0IX?/YK
MEA[&@O[JE-_^V(]2E1R+!JU&G.7_ (#!?@I,\U_X7%XCUGC0O!%[,A^[/<[@
MGZ*!_P"/4;?BYKW5M+\/(W^ZQ _\B5ZW16O]A8JOKC,?5EY1Y::_\E5__)C?
M^U*%/_=\+!?XKS?XNWX'DG_"F=?UCG7O&U]<*?O06^X)^K8_\=K3TS]G_P (
MV&#-;W.H,.]S.1^B;:](HK6GPMD].7/.@IR[S;F__)FR)YYF$ERQJ\J[12C_
M .DI&)I?@GP_HN#9:-8V[#HZP+O_ .^B,_K6W117TE&A1P\>2C!179)+\CQZ
ME6I6?-4DV_-W"BBBMS(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ K\ZOV*?#_B?1/B!\2?@MXAU+3_
M !!HMQHUPOAGXL^%9XK:_%JNF:';^7;,H;R_]"GT64.OR^9#G?<$!T_16N4\
M'_"KPA\/]>\4ZUX;\.:?HNJ^*+T:AK-W9PA'O9PH4.Y_[Z; P"\DKXWR.S '
MQK^R#I/PN^%OP%_:4TSQI9:/;?"OPY\4]<MI;/7HOMMI':V_V-;>-DE#F9@R
M1!%(9V?8!N<C/FOC3P+XON-2^''QE^(6@_\ "'^+_B;\<_!]R/#"S%_[,TVT
MM[B&R28,@9;DJTC29/=/DB;?&OZ*77PG\$7V@ZWHEQX-\/W&BZY>MJ6JZ=+I
M<#6^H73,KM<3QE-LLI:-&+N"Q**<Y K*T[]GOX6:/H.KZ)8?#3P?9:+K'D_V
MEIUOH-K';WOE,7B\Z,1[9-C$LNX':3D8- 'BO[ O_-QO_99O$?\ [;U],:U/
MJ\$49TFQLKV0GYUO;Q[8*/4%8I,GVP*C\+>$]#\#Z#:Z)X;T;3_#^BVN[R-.
MTNU2VMX=S%VV1H JY9F8X')8GJ:UJ .7^%O_ "3+PC_V![/_ -$I745R_P +
M?^29>$?^P/9_^B4KJ* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBHKJ[@L8'GN9H[>%!EI)6"JOU)H EHKS/Q/^TU\)/!NX:U\2_"E
MA(O6!]8@,O\ W[#%C^5>2>*/^"FW[/'AK>B>-I=9G7K%I>F7,GY.T:H?^^J]
M"EE^,K_PJ,GZ19#G%;L^IZ*^$[C_ (*V>"=9G>#P9\-O'/BR93M_=V<4:D^V
MQY&_-1]*B/[=G[0/BWCPG^RMX@MD;[EQK4EPJ/[_ #01#_QX_6O0_L',%K."
MC_BE%?FR?:QZ,^\:*^##\1/V]?&?_'G\-_!G@VW;[DMQ/$\@'N&NI#_XX/I1
M_P *?_;N\5<ZE\8_"/AZW;K#96T9D7\5LL_^/T?V.H_Q,327_;U__24P]IV3
M/O.BO@O_ (83_:%\3<^)/VK?$-H#]Z+24N0I]OEN(A^E._X=2V.M9/BCXU>.
MM>=OOMYRKN]?]89*/J.7Q^/&+Y0D_P [!S3_ )3[BU/Q!I>BKG4-2L[ =<W4
MZ1_^A$5R6J?M ?"_0\C4?B1X1L".OVK7;6/'_?4@KY:TS_@C_P#!&S8-=:KX
MQU-NK?:=2@4$_P# (%/ZUUVE_P#!+3]G;3\>?X3O]3_Z^M:NUS_W[D2CV&4P
M^*O.7I!+\Y!>IV/4KS]L7X&V.?-^+/A!L?\ /'5X9?\ T!C6'>?M\?L_6.?-
M^*.BMC/^I\V7I_N(:SK+_@G3^SI88\KX9638_P">U_>2_P#H<QK<LOV&_@)8
M8\KX5>'6QC_76QEZ?[Y-'_",NM5_^ +_ ##]YY'.3?\ !2+]G&WW[OB7;G;U
MV:7?/^6(#G\*IR?\%-OV;%0D?$8N1_"NA:ED_G;UZ/!^R/\ !&WV;?A)X+.W
MIYFA6S_GE#G\:M']F'X+6@\X_";P'"$^;S/^$;LEV^^?*XHYLF_EJ_\ @4/_
M )$/WGD>3?\ #T#]G'_H>KC_ ,$E_P#_ !FI8/\ @IU^S=-NW?$&2''3S-#U
M Y_*W-=9KGA;]F3PSN&JZ%\*[%UZQS6&G!_P7;D_E7F_B3XA?L;Z7\L_A7P+
MJDJ9Q':>#XI_R;[/M_6N6>-X?I_'SK_M^'_R)Q5,;1H_Q*L5ZO\ X)U4/_!2
M3]G"=5*_$J ;NF_2K]?SS!Q^-:MC^W]^SYJ+;8OBAI"'./WZ30C\WC'K7SUJ
M7Q>_9;U&XDM_#_[/5EX@NC_#;>%K*)3]-N6'_?-<_JOA'1_&\)_X1S]C72M/
MA(PMWJL#VT;>^0L([_W_ ,:Y'FW#?V75?IRR_*)Q?VQAI.U.?._[L9/\DS[*
MT[]KSX(:ICR/BUX-4GH)];MX3^3N*ZC3?C=\.M:91I_C[PO?%CA1;:S;29^F
MUS7YFZW^P[=>,9-]]X7^'7P_).XQV^M3EE]ML<T]:V@_L%_#_1]K:KXZLG=>
ML6DZ%).?PEE9?Y&OG\;Q-PYAX^Y4FG_?=./_ +??\#T:/]K8K_=<!4EZQY5^
M)^G5[XOT+3;(7EWK6G6MHW2XFNXTC/\ P(G%>>>(OVL?A#X7W?;/'NDS%>JZ
M>[7A^G[D/7QO=?LB_#>_T];?0+WQU->J"/-CCM/+)]D$3$?G7-6__!.C7M8O
M%D76/%R19R%9+>V/YF,#]*^=I<483%7]E57HH5:C_P#)(<O_ ),>@\GXCEK*
MC3I+^_47Y:'U!K/_  40^'L=Q]D\/:/XA\47C?ZM;2S6-&_[Z;?_ ..5G_\
M#3/QV\;\>#?@=/IT;_ZNXU^2148=F^?R!C_@1^M7/A'^S[\3/A=IQMM*\47J
MQ!"!#J]Y#*#QQ_JX2/QKE_B=#^U#:F5=%\$CQ-'_ 'X/%L-NI'_7)@F?SI0Q
M>:X^I[/"4:C7>2IT5]]6=_P#^PJ]KXW,X17:G%R?WVE^9JW?AG]J;Q9'YFN>
M.O#/@"Q?[T-OY?F+]&".?_(@KG+[]F/0]8.[XC?'S7/%(/,D%G,S*/8;FF'_
M (Z/I7DG_"T/C3X*NGF\:_LQ>*==B!_>2:3J$DH4>N8H)<_F/K72Z!_P40^"
M'ANZCL_&'PD\6>$;[^);^R2Z1?7/F2*_Y)7I_P"J_%6*7-'#4VO[U9U7_P"
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MRE4DE]T>5?@=_P#;5:'\"G"GZ05_OE=GEUE^SQX;CD\R]N-0U*4\L9I@H/\
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M"_OS%"OY2'ZTOG?M^_$0DK%X(^&:2=,^1-L'YW1KZ&NOVTOA%#D0>)+F_?\
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M)&P]F4D&O(K86OAG:O3<7YIK\S124MF6Z***YAA1110 4444 %%%% !1110
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M@:8A_O"TCS^>*W:*]*GE> H_P\/!>D8K]#CGCL54^.K)^LG_ )E2WTBQM?\
M4V5O#_USB5?Y"K=%%>C&$8*T58Y)2E)WD[A1115DA1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+D./Q6N'$99C<+K6HR2[VT^_8I3C+9GI=%%%>86%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !17BFG_MC?"B[L_'-_<^)/[)TKPC
M^\NM2U*VD@M[V#R;:7[18N1_I<1^V6R@Q;BQG@*ADN+=Y=:W_:D^&$GA7QEX
MANO$W]CV'@WR_P"WX=<L+K3;S3O,C5X?,M+B))_WH=1%A#YK':FY@10!ZK17
M%?#GXR>$OBM<:Y:>'=0N'U+0YHX-4TO4M.N=.OK)I(Q+$9;:YCCE170[D<IM
M;#;2=K8[6@#E_A;_ ,DR\(_]@>S_ /1*5U%<O\+?^29>$?\ L#V?_HE*ZB@
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M=17+_"W_ ))EX1_[ ]G_ .B4KJ* "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Y?X6_
M\DR\(_\ 8'L__1*5U%<O\+?^29>$?^P/9_\ HE*ZB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7/I= '+_  M_Y)EX1_[ ]G_Z)2NHKE_A;_R3+PC_ -@>S_\ 1*5U% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MC_V![/\ ]$I745R_PM_Y)EX1_P"P/9_^B4KJ* "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% '+_  M_Y)EX1_[ ]G_Z)2NH
MKE_A;_R3+PC_ -@>S_\ 1*5U% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M  KG2O\ G[U[_P *&_\ _C]'_"N=*_Y^]>_\*&__ /C]=110!R__  KG2O\
MG[U[_P *&_\ _C]'_"N=*_Y^]>_\*&__ /C]=110!R__  KG2O\ G[U[_P *
M&_\ _C]'_"N=*_Y^]>_\*&__ /C]=110!R__  KG2O\ G[U[_P *&_\ _C]'
M_"N=*_Y^]>_\*&__ /C]=110!R__  KG2O\ G[U[_P *&_\ _C]'_"N=*_Y^
M]>_\*&__ /C]=110!R__  KG2O\ G[U[_P *&_\ _C]'_"N=*_Y^]>_\*&__
M /C]=110!R__  KG2O\ G[U[_P *&_\ _C]'_"N=*_Y^]>_\*&__ /C]=110
M!R__  KG2O\ G[U[_P *&_\ _C]'_"N=*_Y^]>_\*&__ /C]=110!R__  KG
M2O\ G[U[_P *&_\ _C]'_"N=*_Y^]>_\*&__ /C]=110!R__  KG2O\ G[U[
M_P *&_\ _C]'_"N=*_Y^]>_\*&__ /C]=110!R__  KG2O\ G[U[_P *&_\
M_C]'_"N=*_Y^]>_\*&__ /C]=110!R__  KG2O\ G[U[_P *&_\ _C]'_"N=
M*_Y^]>_\*&__ /C]=110!R__  KG2O\ G[U[_P *&_\ _C]'_"N=*_Y^]>_\
M*&__ /C]=110!R__  KG2O\ G[U[_P *&_\ _C]'_"N=*_Y^]>_\*&__ /C]
M=110!R__  KG2O\ G[U[_P *&_\ _C]'_"N=*_Y^]>_\*&__ /C]=110!R__
M  KG2O\ G[U[_P *&_\ _C]'_"N=*_Y^]>_\*&__ /C]=110!R__  KG2O\
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MX4-__P#'Z/\ A7.E?\_>O?\ A0W_ /\ 'ZZBB@#E_P#A7.E?\_>O?^%#?_\
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MX4-__P#'Z/\ A7.E?\_>O?\ A0W_ /\ 'ZZBB@#E_P#A7.E?\_>O?^%#?_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:;:L2DN8X^6(VX7<WM=%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH ***^5_P!H+]KSXD_!_P")%UX;
M\-?LZ>+/B)I4,$4J:]I;S_9YF=0S*OE6LP^4G:<L#D'C&">O"X6KC)^SHI-[
MZM+\6TB9245=GU117P?_ ,/#/C3_ -&=^//^^[W_ .5U'_#PSXT_]&=^//\
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MKLCPP\M-I\6?V6?A1\=/%6@>)/'?@G3_ !'K6AX%E<W)D7Y!()!%,J,%GB#
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M_!7P%\&Q^%? 7A^W\.Z$DTER;>%WD:25S\TDDDC,\C8"KN=B0JJHPJJ!VM%
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M]H^S;_(\W/S[_+W>9^\SO^:O:Z* "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
7"BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942901959224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Feb. 22, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">VIATRIS INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">83-4364296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1000 Mylan Boulevard<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Canonsburg<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">PA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">15317<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(724)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">514-1800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">VTRS<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,209,576,280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,237,737,213<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.705%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.095%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Document</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Part&#160;of&#160;Form&#160;10-K into Which<br/>Document&#160;is Incorporated</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">An amendment to this Form 10-K will be filed no later than 120 days after the close of registrant&#8217;s fiscal year.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">III</span></td></tr></table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001792044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942908007560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorLineItems', window );"><strong>Auditor [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">DELOITTE & TOUCHE LLP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Pittsburgh, Pennsylvania<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942907611896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorLineItems', window );"><strong>Auditor [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">34<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942902307224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 701,200<span></span>
</td>
<td class="nump">$ 844,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">4,266,400<span></span>
</td>
<td class="nump">4,843,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">3,977,700<span></span>
</td>
<td class="nump">5,471,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">1,957,600<span></span>
</td>
<td class="nump">1,707,400<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">10,902,900<span></span>
</td>
<td class="nump">12,867,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">3,188,600<span></span>
</td>
<td class="nump">3,459,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">26,134,200<span></span>
</td>
<td class="nump">29,683,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">12,113,700<span></span>
</td>
<td class="nump">12,347,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred income tax benefit</a></td>
<td class="nump">1,332,700<span></span>
</td>
<td class="nump">2,147,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">1,170,700<span></span>
</td>
<td class="nump">1,047,500<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">54,842,800<span></span>
</td>
<td class="nump">61,553,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Accounts payable</a></td>
<td class="nump">1,657,400<span></span>
</td>
<td class="nump">1,904,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term borrowings</a></td>
<td class="nump">1,493,000<span></span>
</td>
<td class="nump">1,100,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes payable</a></td>
<td class="nump">236,900<span></span>
</td>
<td class="nump">288,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt and other long-term obligations</a></td>
<td class="nump">1,877,500<span></span>
</td>
<td class="nump">2,308,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">4,619,600<span></span>
</td>
<td class="nump">4,960,700<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">9,884,400<span></span>
</td>
<td class="nump">10,562,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">19,717,100<span></span>
</td>
<td class="nump">22,429,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income tax liability</a></td>
<td class="nump">2,815,000<span></span>
</td>
<td class="nump">3,123,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term obligations</a></td>
<td class="nump">1,933,600<span></span>
</td>
<td class="nump">2,483,100<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">34,350,100<span></span>
</td>
<td class="nump">38,598,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Viatris Inc. shareholders&#8217; equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock: $0.01 par value, 3,000,000,000 shares authorized; shares issued and outstanding: 1,209,507,463 and 1,206,895,644, respectively</a></td>
<td class="nump">12,100<span></span>
</td>
<td class="nump">12,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">18,536,100<span></span>
</td>
<td class="nump">18,438,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">3,688,800<span></span>
</td>
<td class="nump">5,361,200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(1,744,300)<span></span>
</td>
<td class="num">(858,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="nump">20,492,700<span></span>
</td>
<td class="nump">22,954,100<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity</a></td>
<td class="nump">$ 54,842,800<span></span>
</td>
<td class="nump">$ 61,553,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942901943528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value, in USD per share | $ / shares</a></td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary shares, number of shares authorized</a></td>
<td class="nump">3,000,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Shares issued</a></td>
<td class="nump">1,209,507,463<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember', window );">Treasury Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Shares issued</a></td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942902002408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 17,813.6<span></span>
</td>
<td class="nump">$ 11,819.9<span></span>
</td>
<td class="nump">$ 11,370.3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">17,886.3<span></span>
</td>
<td class="nump">11,946.0<span></span>
</td>
<td class="nump">11,500.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">12,310.8<span></span>
</td>
<td class="nump">8,149.3<span></span>
</td>
<td class="nump">7,602.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">5,575.5<span></span>
</td>
<td class="nump">3,796.7<span></span>
</td>
<td class="nump">3,897.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">751.1<span></span>
</td>
<td class="nump">555.1<span></span>
</td>
<td class="nump">639.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">4,529.2<span></span>
</td>
<td class="nump">3,344.6<span></span>
</td>
<td class="nump">2,563.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Litigation settlements and other contingencies, net</a></td>
<td class="nump">329.2<span></span>
</td>
<td class="nump">107.8<span></span>
</td>
<td class="num">(21.4)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">5,609.5<span></span>
</td>
<td class="nump">4,007.5<span></span>
</td>
<td class="nump">3,182.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">(Loss) earnings from operations</a></td>
<td class="num">(34.0)<span></span>
</td>
<td class="num">(210.8)<span></span>
</td>
<td class="nump">715.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">636.2<span></span>
</td>
<td class="nump">497.8<span></span>
</td>
<td class="nump">517.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
<td class="num">(5.8)<span></span>
</td>
<td class="nump">12.6<span></span>
</td>
<td class="nump">43.8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">(Loss) earnings before income taxes</a></td>
<td class="num">(664.4)<span></span>
</td>
<td class="num">(721.2)<span></span>
</td>
<td class="nump">154.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision (benefit)</a></td>
<td class="nump">604.7<span></span>
</td>
<td class="num">(51.3)<span></span>
</td>
<td class="nump">137.6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) earnings</a></td>
<td class="num">$ (1,269.1)<span></span>
</td>
<td class="num">$ (669.9)<span></span>
</td>
<td class="nump">$ 16.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>(Loss) earnings per share attributable to Viatris Inc. shareholders</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in USD per share)</a></td>
<td class="num">$ (1.05)<span></span>
</td>
<td class="num">$ (1.11)<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in USD per share)</a></td>
<td class="num">$ (1.05)<span></span>
</td>
<td class="num">$ (1.11)<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">1,208.8<span></span>
</td>
<td class="nump">601.2<span></span>
</td>
<td class="nump">515.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">1,208.8<span></span>
</td>
<td class="nump">601.2<span></span>
</td>
<td class="nump">516.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 17,813.6<span></span>
</td>
<td class="nump">$ 11,819.9<span></span>
</td>
<td class="nump">$ 11,370.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueNotFromContractWithCustomer', window );">Other revenues</a></td>
<td class="nump">$ 72.7<span></span>
</td>
<td class="nump">$ 126.1<span></span>
</td>
<td class="nump">$ 130.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueNotFromContractWithCustomer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue that is not accounted for under Topic 606.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueNotFromContractWithCustomer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942903513224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Earnings - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (1,269.1)<span></span>
</td>
<td class="num">$ (669.9)<span></span>
</td>
<td class="nump">$ 16.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive (loss) earnings, before tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="num">(1,340.9)<span></span>
</td>
<td class="nump">1,213.0<span></span>
</td>
<td class="num">(415.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax', window );">Change in unrecognized loss and prior service cost related to defined benefit plans</a></td>
<td class="nump">73.9<span></span>
</td>
<td class="num">(14.0)<span></span>
</td>
<td class="num">(24.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax', window );">Net unrealized (loss) gain on marketable securities</a></td>
<td class="num">(1.1)<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax', window );">Other comprehensive (loss) earnings, before tax</a></td>
<td class="num">(775.2)<span></span>
</td>
<td class="nump">912.6<span></span>
</td>
<td class="num">(343.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Income tax provision (benefit)</a></td>
<td class="nump">111.1<span></span>
</td>
<td class="num">(26.6)<span></span>
</td>
<td class="nump">9.2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive (loss) earnings, net of tax</a></td>
<td class="num">(886.3)<span></span>
</td>
<td class="nump">939.2<span></span>
</td>
<td class="num">(352.3)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive earnings</a></td>
<td class="num">(2,155.4)<span></span>
</td>
<td class="nump">269.3<span></span>
</td>
<td class="num">(335.5)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash flow hedging relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive (loss) earnings, before tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Net unrecognized gain (loss) on derivatives in hedging relationships</a></td>
<td class="nump">36.1<span></span>
</td>
<td class="nump">18.2<span></span>
</td>
<td class="nump">37.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive (loss) earnings, before tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Net unrecognized gain (loss) on derivatives in hedging relationships</a></td>
<td class="nump">$ 456.8<span></span>
</td>
<td class="num">$ (305.2)<span></span>
</td>
<td class="nump">$ 59.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28129-110885<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and after adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33775-111570<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e39076-109324<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942898638200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Equity - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Cumulative Effect, Period of Adoption, Adjustment</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th">
<div>Retained Earnings </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th">
<div>Accumulated Other Comprehensive Loss </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Dec. 31, 2018</a></td>
<td class="nump">$ 12,167.1<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 6.0<span></span>
</td>
<td class="nump">$ 8,591.4<span></span>
</td>
<td class="nump">$ 6,010.7<span></span>
</td>
<td class="nump">$ 3.6<span></span>
</td>
<td class="num">$ (999.7)<span></span>
</td>
<td class="num">$ (1,441.3)<span></span>
</td>
<td class="num">$ (3.6)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">539,289,665<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,490,867<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">16.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss, net of tax</a></td>
<td class="num">(352.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(352.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">56.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of restricted stock and stock options exercised, net</a></td>
<td class="nump">8.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">8.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment', window );">Issuance of restricted stock and stock options exercised, net (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,457,206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet', window );">Taxes related to the net share settlement of equity awards</a></td>
<td class="num">(12.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesRetired', window );">Cancellation of restricted stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,107,207)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Dec. 31, 2019</a></td>
<td class="nump">11,883.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.1<span></span>
</td>
<td class="nump">8,643.5<span></span>
</td>
<td class="nump">6,031.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (999.7)<span></span>
</td>
<td class="num">(1,797.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">540,746,871<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,598,074<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="num">(669.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(669.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss, net of tax</a></td>
<td class="nump">939.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">939.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">79.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings', window );">Issuance of restricted stock and stock options exercised, net</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment', window );">Issuance of restricted stock and stock options exercised, net (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">872,802<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet', window );">Taxes related to the net share settlement of equity awards</a></td>
<td class="num">(6.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesRetired', window );">Cancellation of restricted stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24,598,074)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24,598,074)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_StockExchangedDuringPeriodValue', window );">Exchange of Mylan N.V. ordinary shares for Viatris Inc. common stock</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (6.1)<span></span>
</td>
<td class="nump">6.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_StockExchangedDuringPeriodSharesExchanged', window );">Exchange of Mylan N.V. ordinary shares for Viatris Inc. common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(541,619,673)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.2<span></span>
</td>
<td class="num">(5.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock to Mylan N.V. shareholders (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">541,619,673<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issuance of common stock for the Combination</a></td>
<td class="nump">10,727.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.9<span></span>
</td>
<td class="nump">10,720.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Issuance of common stock for the Combination (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">689,874,045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockRetiredCostMethodAmount', window );">Retirement of Mylan N.V. treasury stock, net</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(999.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 999.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Dec. 31, 2020</a></td>
<td class="nump">22,954.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.1<span></span>
</td>
<td class="nump">18,438.8<span></span>
</td>
<td class="nump">5,361.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,206,895,644<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="num">(1,269.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,269.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss, net of tax</a></td>
<td class="num">(886.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(886.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">111.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">111.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment', window );">Issuance of restricted stock and stock options exercised, net (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,611,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet', window );">Taxes related to the net share settlement of equity awards</a></td>
<td class="num">(13.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared, $0.33 per common share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(403.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Dec. 31, 2021</a></td>
<td class="nump">$ 20,492.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.1<span></span>
</td>
<td class="nump">$ 18,536.1<span></span>
</td>
<td class="nump">$ 3,688.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="num">$ (1,744.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,209,507,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in additional paid in capital (APIC) resulting from a tax benefit (deficiency) associated with an share-based compensation plan other than an employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after value of shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockRetiredCostMethodAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease of par value, additional paid in capital (APIC) and retained earnings of common and preferred stock retired from treasury when treasury stock is accounted for under the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockRetiredCostMethodAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesRetired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common and preferred stock retired from treasury during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesRetired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_StockExchangedDuringPeriodSharesExchanged">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Exchanged During Period, Shares, Exchanged</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_StockExchangedDuringPeriodSharesExchanged</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_StockExchangedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Exchanged During Period, Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_StockExchangedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Value, Stock Options Exercised, Net of Shares Tendered for Payment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942905123512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) earnings</a></td>
<td class="num">$ (1,269.1)<span></span>
</td>
<td class="num">$ (669.9)<span></span>
</td>
<td class="nump">$ 16.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net earnings to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">4,506.5<span></span>
</td>
<td class="nump">2,216.1<span></span>
</td>
<td class="nump">2,019.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax expense (benefit)</a></td>
<td class="nump">675.7<span></span>
</td>
<td class="num">(213.2)<span></span>
</td>
<td class="num">(192.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_Changeinnoncashlitigationsettlementsnet', window );">Litigation settlements and other contingencies, net</a></td>
<td class="nump">323.7<span></span>
</td>
<td class="nump">101.1<span></span>
</td>
<td class="num">(11.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Loss from equity method investments</a></td>
<td class="nump">61.9<span></span>
</td>
<td class="nump">48.4<span></span>
</td>
<td class="nump">62.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation expense</a></td>
<td class="nump">111.2<span></span>
</td>
<td class="nump">79.2<span></span>
</td>
<td class="nump">56.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other non-cash items</a></td>
<td class="nump">411.8<span></span>
</td>
<td class="nump">366.4<span></span>
</td>
<td class="nump">360.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">59.3<span></span>
</td>
<td class="nump">78.7<span></span>
</td>
<td class="num">(20.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(427.6)<span></span>
</td>
<td class="num">(741.9)<span></span>
</td>
<td class="num">(512.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade', window );">Trade accounts payable</a></td>
<td class="num">(70.4)<span></span>
</td>
<td class="num">(82.7)<span></span>
</td>
<td class="num">(96.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income taxes</a></td>
<td class="num">(699.6)<span></span>
</td>
<td class="nump">3.6<span></span>
</td>
<td class="nump">57.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other operating assets and liabilities, net</a></td>
<td class="num">(666.5)<span></span>
</td>
<td class="nump">46.0<span></span>
</td>
<td class="nump">63.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">3,016.9<span></span>
</td>
<td class="nump">1,231.8<span></span>
</td>
<td class="nump">1,803.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash received (paid) for acquisitions, net of cash acquired</a></td>
<td class="nump">277.0<span></span>
</td>
<td class="nump">415.8<span></span>
</td>
<td class="num">(148.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="num">(457.2)<span></span>
</td>
<td class="num">(243.0)<span></span>
</td>
<td class="num">(213.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Payments for product rights and other, net</a></td>
<td class="num">(52.2)<span></span>
</td>
<td class="num">(438.2)<span></span>
</td>
<td class="num">(192.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sale of property, plant and equipment</a></td>
<td class="nump">18.3<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from sale of assets and subsidiaries</a></td>
<td class="nump">96.7<span></span>
</td>
<td class="nump">20.0<span></span>
</td>
<td class="nump">28.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchase of marketable securities</a></td>
<td class="num">(30.2)<span></span>
</td>
<td class="num">(104.8)<span></span>
</td>
<td class="num">(25.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Proceeds from the sale of marketable securities</a></td>
<td class="nump">29.8<span></span>
</td>
<td class="nump">47.0<span></span>
</td>
<td class="nump">27.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(117.8)<span></span>
</td>
<td class="num">(301.1)<span></span>
</td>
<td class="num">(525.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of long-term debt</a></td>
<td class="nump">1,710.1<span></span>
</td>
<td class="nump">983.3<span></span>
</td>
<td class="nump">7.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Payments of long-term debt</a></td>
<td class="num">(4,201.3)<span></span>
</td>
<td class="num">(2,484.2)<span></span>
</td>
<td class="num">(1,108.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfFinancingCosts', window );">Payments of financing fees</a></td>
<td class="num">(7.0)<span></span>
</td>
<td class="num">(2.0)<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt', window );">Change in short-term borrowings, net</a></td>
<td class="nump">392.1<span></span>
</td>
<td class="nump">1,099.6<span></span>
</td>
<td class="num">(1.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">8.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Taxes paid related to net share settlement of equity awards</a></td>
<td class="num">(17.4)<span></span>
</td>
<td class="num">(7.9)<span></span>
</td>
<td class="num">(8.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities', window );">Contingent consideration payments</a></td>
<td class="num">(28.6)<span></span>
</td>
<td class="num">(48.5)<span></span>
</td>
<td class="num">(60.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Cash dividends paid</a></td>
<td class="num">(399.0)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_PaymentsForNonContingentConsiderationForProductRightsFinancingActivities', window );">Non-contingent payments for product rights</a></td>
<td class="num">(456.0)<span></span>
</td>
<td class="num">(143.3)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other items, net</a></td>
<td class="num">(4.9)<span></span>
</td>
<td class="num">(3.3)<span></span>
</td>
<td class="num">(2.5)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(3,012.0)<span></span>
</td>
<td class="num">(605.7)<span></span>
</td>
<td class="num">(1,169.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents', window );">Effect on cash of changes in exchange rates</a></td>
<td class="num">(30.9)<span></span>
</td>
<td class="nump">33.8<span></span>
</td>
<td class="num">(7.5)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net (decrease) increase in cash, cash equivalents and restricted cash</a></td>
<td class="num">(143.8)<span></span>
</td>
<td class="nump">358.8<span></span>
</td>
<td class="nump">101.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash &#8212; beginning of period</a></td>
<td class="nump">850.0<span></span>
</td>
<td class="nump">491.1<span></span>
</td>
<td class="nump">389.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash &#8212; end of period</a></td>
<td class="nump">706.2<span></span>
</td>
<td class="nump">850.0<span></span>
</td>
<td class="nump">491.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Non-cash transactions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1', window );">Common stock issued for the Combination</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">10,727.5<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Cash paid during the period for:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes</a></td>
<td class="nump">641.7<span></span>
</td>
<td class="nump">324.4<span></span>
</td>
<td class="nump">278.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest</a></td>
<td class="nump">$ 684.8<span></span>
</td>
<td class="nump">$ 555.4<span></span>
</td>
<td class="nump">$ 470.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableTrade</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the noncash (or part noncash) consideration given (for example, liability, equity) in a transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of a transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for loan and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for financing costs associated with business combinations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_Changeinnoncashlitigationsettlementsnet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in noncash litigation settlements, net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_Changeinnoncashlitigationsettlementsnet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_PaymentsForNonContingentConsiderationForProductRightsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments for Non-Contingent Consideration for Product Rights, Financing Activities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_PaymentsForNonContingentConsiderationForProductRightsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139943002732120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Equity (Parenthetical)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>$ / shares</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareCashPaid', window );">Dividends paid per share</a></td>
<td class="nump">$ 0.33<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareCashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends paid during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareCashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942903353560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Operations<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Nature of Operations</a></td>
<td class="text">Nature of Operations<div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Viatris is a global healthcare company formed in November 2020 whose mission is to empower people worldwide to live healthier at every stage of life, regardless of geography or circumstance. Improving the ability of patients to gain access to sustainable and high-quality healthcare is our relentless pursuit. One that rests on visionary thinking, determination and best-in-class capabilities that were strategically built to remove barriers across the health spectrum and advance access globally. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Viatris&#8217; portfolio comprises more than 1,400 approved molecules across a wide range of key therapeutic areas, including globally recognized iconic and key brands, generics, complex generics, and biosimilars. The Company operates approximately 40 manufacturing sites worldwide that produce oral solid doses, injectables, complex dosage forms and APIs. We conduct our business through four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. Viatris is headquartered in the U.S., with global centers in Pittsburgh, Pennsylvania, Shanghai, China and Hyderabad, India.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC 805, Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Mylan is considered the accounting acquirer of the Upjohn Business and all historical financial information of the Company prior to November 16, 2020 represents Mylan&#8217;s historical results and the Company&#8217;s thereafter.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942908153992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary Of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of Consolidation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The consolidated financial statements include the accounts of Viatris and those of its wholly owned and majority-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. Investments in equity method affiliates are recorded at cost and adjusted for the Company&#8217;s share of the affiliates&#8217; cumulative results of operations, capital contributions and distributions.  </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates in the Preparation of Financial Statements.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The preparation of financial statements, in conformity with U.S. GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Because of the uncertainty inherent in such estimates, actual results could differ from those estimates.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currencies.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The consolidated financial statements are presented in U.S.&#160;Dollars, the reporting currency of Viatris. Statements of Operations and Cash Flows of all of the Company&#8217;s subsidiaries that have functional currencies other than U.S.&#160;Dollars are translated at a weighted average exchange rate for the period for inclusion in the consolidated statements of operations and cash flows, whereas assets and liabilities are translated at the end of the period exchange rates for inclusion in the consolidated balance sheets. Translation differences are recorded directly in shareholders&#8217; equity as foreign currency translation adjustments. Gains or losses on transactions denominated in a currency other than the subsidiaries&#8217; functional currency, which arise as a result of changes in foreign currency exchange rates, are recorded in the consolidated statements of operations.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Cash and cash equivalents are comprised of highly liquid investments with an original maturity of three months or less at the date of purchase.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt and Equity Securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Debt securities classified as available-for-sale on the date of purchase are recorded at fair value, with net unrealized gains and losses, net of income taxes, reflected in accumulated other comprehensive loss as a component of shareholders&#8217; equity. Net realized gains and losses on sales of available-for-sale debt securities are computed on a specific security basis and are included in other expense, net, in the consolidated statements of operations. Debt securities classified as trading securities are valued using the quoted market price from broker or dealer quotations or transparent pricing sources at the reporting date, with gains and losses included in other expense, net, in the consolidated statements of operations. Fair value is determined based on observable market quotes or valuation models using assessments of counterparty credit worthiness, credit risk or underlying security and overall capital market liquidity. Debt securities are reviewed for impairment by assessing if the decline in market value of the investment below the carrying value is other than temporary.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in equity securities with readily determinable fair values are recorded at fair value with changes in fair value recorded in other expense, net in the consolidated statements of operations. Investments in equity securities without readily determinable fair values are recorded at cost minus any impairment, plus or minus changes in their estimated fair value resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. Investments in entities are accounted for using the equity method of accounting when the ability to exercise significant influence over the operating and financial decisions of the investee is maintained. The share of net income or losses of equity method investments are included in other expense, net in the consolidated statements of operations. Investments in equity securities without readily determinable fair values and investments in equity accounted for using the equity method are assessed for potential impairment on a quarterly basis based on qualitative factors.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Financial instruments that potentially subject the Company to credit risk consist principally of interest-bearing investments, derivatives and accounts receivable.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Viatris invests its excess cash in high-quality, liquid money market instruments, principally overnight deposits and highly rated money market funds. The Company maintains deposit balances at certain financial institutions in excess of federally insured amounts. Periodically, the Company reviews the creditworthiness of its counterparties to derivative transactions, and it does not expect to incur a loss from failure of any counterparties to perform under agreements it has with such counterparties.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Inventories are stated at the lower of cost and net realizable value, with cost principally determined by the weighted average cost method. Provisions for potentially obsolete or slow-moving inventory, including pre-launch inventory, are made based on our analysis of product dating, inventory levels, historical obsolescence and future sales forecasts. Included as a component of cost of sales is expense related to the net realizable value of inventories. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Plant and Equipment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Property, plant and equipment are stated at cost less accumulated depreciation. Depreciation is computed and recorded on a straight-line basis over the assets&#8217; estimated service lives (3 to 18 years for machinery and equipment and other fixed assets and 15 to 39 years for buildings and improvements). Capitalized software is included in property, plant and equipment and is amortized over estimated useful lives ranging from 3 to 7 years. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets and Goodwill.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Intangible assets are stated at cost less accumulated amortization. Amortization is generally recorded on a straight-line basis over estimated useful lives ranging from 3 to 20 years. The Company periodically reviews the estimated useful lives of intangible assets and makes adjustments when events indicate that a shorter life is appropriate.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for acquired businesses using the acquisition method of accounting in accordance with the provisions of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC 805, Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which requires that the assets acquired and liabilities assumed be recorded at the date of acquisition at their respective estimated fair values. The cost to acquire businesses is allocated to the underlying net assets of the acquired business based on estimates of their respective fair values. Amounts allocated to acquired IPR&amp;D are capitalized at the date of acquisition and, at that time, such IPR&amp;D assets have indefinite lives. As products in development are approved for sale, amounts are allocated to product rights and licenses and will be amortized over their estimated useful lives. Finite-lived intangible assets are amortized over the expected life of the asset. Any excess of the purchase price over the estimated fair values of the net assets acquired is recorded as goodwill.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchases of developed products and licenses that are accounted for as asset acquisitions are capitalized as intangible assets and amortized over an estimated useful life. IPR&amp;D assets acquired as part of an asset acquisition are expensed immediately if they have no alternative future uses.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews goodwill for impairment at least annually or more frequently if events or changes in circumstances indicate that the carrying value of goodwill may not be recoverable based on management's assessment of the fair value of the Company's reporting units as compared to their related carrying value. Under the authoritative guidance issued by the FASB, we have the option to first assess the qualitative factors to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform a quantitative goodwill impairment test. If we choose to use qualitative factors and determine that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, then the goodwill impairment test would be required. The goodwill impairment test requires the Company to estimate the fair value of the reporting unit and to compare the fair value of the reporting unit with its carrying amount. If the carrying amount is less than its fair value, then no impairment is recognized. If the carrying amount recorded exceeds the fair value calculated, an impairment charge is recorded for the difference. The judgments made in determining the projected cash flows used to estimate the fair value can materially impact the Company&#8217;s financial condition and results of operations. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite-lived intangibles, principally IPR&amp;D, are tested at least annually for impairment or upon the occurrence of a triggering event. The impairment test for IPR&amp;D consists of a comparison of the asset&#8217;s fair value with its carrying value. Impairment is determined to exist when the fair value of IPR&amp;D assets, which is based upon updated forecasts and commercial development plans, is less than the carrying value of the assets being tested.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Consideration.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Viatris records contingent consideration resulting from business acquisitions at its estimated fair value on the acquisition date. Each reporting period thereafter, the Company revalues these obligations and records increases or decreases in their fair value as adjustments to litigation settlements and other contingencies, net within the consolidated statements of operations. Changes in the fair value of the contingent consideration obligations can result from adjustments to the discount rates, payment periods and adjustments in the probability of achieving future development steps, regulatory approvals, market launches, sales targets and profitability. These fair value measurements represent Level 3 measurements as they are based on significant inputs not observable in the market. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant judgment is employed in determining the assumptions utilized as of the acquisition date and for each subsequent measurement period. Accordingly, changes in the assumptions described above could have a material impact on the Company&#8217;s consolidated financial condition and results of operations.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment of Long-Lived Assets.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The carrying values of long-lived assets, which include property, plant and equipment and intangible assets with finite lives, are evaluated periodically in relation to the expected future undiscounted cash flows of the underlying assets and monitored for other potential triggering events. The assessment for impairment is based on our ability to recover the carrying value of the long-lived assets or asset grouping by analyzing the expected future undiscounted pre-tax cash flows specific to the asset or asset grouping. If the carrying amount is greater than the undiscounted cash flows, the Company recognizes an impairment loss for the excess of the carrying amount over the estimated fair value based on discounted cash flows.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant management judgment is involved in estimating the recoverability of these assets and is dependent upon the accuracy of the assumptions used in making these estimates, as well as how the estimates compare to the eventual future operating performance of the specific asset or asset grouping. Any future long-lived assets impairment charges could have a material impact on the Company&#8217;s consolidated financial condition and results of operations.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-Term Borrowings.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The Company&#8217;s subsidiaries in India have working capital facilities with several banks which are secured by its current assets. The Company also has the CP Notes, Receivables Facility, which will expire in April 2022 and the Note Securitization Facility, which will expire in August 2022. Under the terms of each of the Receivables Facility and Note Securitization Facility, certain of our accounts receivable secure the amounts borrowed and cannot be used to pay our other debts or liabilities. As the accounts receivable do not transfer to the banks, any amounts outstanding under the facilities are recorded as borrowings and the underlying receivables continue to be included in accounts receivable, net, in the consolidated balance sheets.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenues in accordance with ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Under ASC 606, the Company recognizes net revenue for product sales when control of the promised goods or services is transferred to our customers in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. Revenues are recorded net of provisions for variable consideration, including discounts, rebates, governmental rebate programs, price adjustments, returns, chargebacks, promotional programs and other sales allowances. Accruals for these provisions are presented in the consolidated financial statements as reductions in determining net sales and as a contra asset in accounts receivable, net (if settled via credit) and other current liabilities (if paid in cash). Amounts recorded for revenue deductions can result from a complex series of judgements about future events and uncertainties and can rely heavily on estimates and assumptions. The following section briefly describes the nature of our provisions for variable consideration and how such provisions are estimated:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Chargebacks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: the Company has agreements with certain indirect customers, such as independent pharmacies, retail pharmacy chains, managed care organizations, hospitals, nursing homes, governmental agencies and pharmacy benefit managers, which establish contract prices for certain products. The indirect customers then independently select a wholesaler from which to purchase the products at these contracted prices. Alternatively, certain wholesalers may enter into agreements with indirect customers that establish contract pricing for certain products, which the wholesalers provide. Under either arrangement, Viatris will provide credit to the wholesaler for any difference between the contracted price with the indirect party and the wholesaler&#8217;s invoice price. Such credits are called chargebacks. The provision for chargebacks is based on expected sell-through levels by our wholesaler customers to indirect customers, as well as estimated wholesaler inventory levels.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Rebates, promotional programs and other sales allowances</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: this category includes rebate and other programs to assist in product sales. These programs generally provide that the customer receives credit directly related to the amount of purchases or credits upon the attainment of pre-established volumes. Also included in this category are prompt pay discounts, administrative fees and price adjustments to reflect decreases in the selling prices of products. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Returns</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: consistent with industry practice, Viatris maintains a return policy that allows customers to return a product, which varies country by country in accordance with local practices, generally within a specified period prior (six months) and subsequent (twelve months) to the expiration date. The Company&#8217;s estimate of the provision for returns is generally based upon historical experience with actual returns. Generally, returned products are destroyed and customers are refunded the sales price in the form of a credit.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Governmental rebate programs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: government reimbursement programs in the U.S. include Medicare, Medicaid, and State Pharmacy Assistance Programs established according to statute, regulations and policy. Manufacturers of pharmaceutical products that are covered by the Medicaid program are required to pay rebates to each state based on a statutory formula set forth in the Social Security Act. Medicare beneficiaries are eligible to obtain discounted prescription drug coverage from private sector providers. In addition, certain states have also implemented supplemental rebate programs that obligate manufacturers to pay rebates in excess of those required under federal law. Our estimate of these rebates is based on the historical trends of rebates paid as well as on changes in wholesaler inventory levels and increases or decreases in the level of sales. We estimate discounts on branded prescription drug sales to Medicare Part D participants in the Medicare &#8220;coverage gap&#8221; based on historical experience of prescriptions and utilization expected to result in the discount of the &#8220;coverage gap&#8221;.</span></div><div style="margin-bottom:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outside the U.S., the majority of our pharmaceutical sales are contractually or legislatively governed. In certain European countries, certain rebates are calculated on the governments total pharmaceutical spending or on specific product sale thresholds. We utilize historical data and obtain third party information to determine the adequacy of these accruals. Also, this provision includes price reductions that are mandated by law outside of the U.S. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our net sales may be impacted by wholesaler and distributor inventory levels of our products, which can fluctuate throughout the year due to the seasonality of certain products, pricing, the timing of product demand, purchasing decisions and other factors. Such fluctuations may impact the comparability of our net sales between periods.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consideration received from licenses of intellectual property is recorded as other revenues. Royalty or profit share amounts, which are based on sales of licensed products or technology, are recorded when the customer&#8217;s subsequent sales or usages occur. Such consideration is included in other revenues in the consolidated statements of operations. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;R&amp;D expenses are charged to operations as incurred.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Income taxes have been provided for using an asset and liability approach in which deferred income taxes reflect the tax consequences on future years of events that the Company has already recognized in the financial statements or tax returns. Changes in enacted tax rates or laws may result in adjustments to the recorded tax assets or liabilities in the period that the new tax law is enacted.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Earnings per Share.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Basic earnings per share is computed by dividing net earnings attributable to holders of Viatris Inc. common stock by the weighted average number of shares outstanding during the period. Diluted earnings per share is computed by dividing net earnings attributable to holders of Viatris Inc. common stock by the weighted average number of shares outstanding during the period increased by the number of additional shares that would have been outstanding related to potentially dilutive securities or instruments, if the impact is dilutive.</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted earnings per share attributable to Viatris Inc. are calculated as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.261%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions, except per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Basic (loss) earnings attributable to Viatris Inc. common shareholders (numerator):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) earnings attributable to Viatris Inc. common shareholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,269.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(669.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares (denominator):</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,208.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic (loss) earnings per share attributable to Viatris Inc. shareholders</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.05)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.11)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Diluted (loss) earnings attributable to Viatris Inc. common shareholders (numerator):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) earnings attributable to Viatris Inc. common shareholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,269.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(669.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares (denominator):</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,208.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total dilutive shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,208.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted (loss) earnings per share attributable to Viatris Inc. shareholders</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.05)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.11)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average shares outstanding used in the computation of earnings per share for the year ended December 31, 2020 includes the effect of the 689.9 million shares issued for the closing of the Combination.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional stock awards and restricted ordinary shares were outstanding during the years ended December&#160;31, 2021, 2020 and 2019 but were not included in the computation of diluted earnings per share for each respective period because the effect would be anti-dilutive. Excluded shares also include certain share-based compensation awards and restricted shares whose performance conditions had not been fully met. Such excluded shares and anti-dilutive awards represented 12.7 million, 10.3 million and 9.1 million shares for the years ended December&#160;31, 2021, 2020 and 2019, respectively. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company paid quarterly cash dividends of $0.11 per share on the Company&#8217;s issued and outstanding common stock on June 16, 2021, September 16, 2021, and December 16, 2021. On January 4, 2022, the Company&#8217;s Board of Directors declared a quarterly cash dividend of $0.12 per share on the Company&#8217;s issued and outstanding common stock, which will be payable on March 16, 2022 to shareholders of record as of the close of business on February 24, 2022. The declaration and payment of future dividends to holders of the Company&#8217;s common stock will be at the discretion of the Board of Directors, and will depend upon factors, including but not limited to, the Company&#8217;s financial condition, earnings, capital requirements of its businesses, legal requirements, regulatory constraints, industry practice, and other factors that the Board of Directors deems relevant.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 28, 2022, the Company announced that its Board of Directors had authorized a share repurchase program for the repurchase of up to $1.0 billion of the Company&#8217;s shares of common stock. The Company has not yet repurchased any shares of common stock under the share repurchase program and the share repurchase program does not obligate the Company to acquire any particular amount of common stock. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The fair value of share-based compensation is recognized as expense in the consolidated statements of operations over the vesting period.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivatives.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;From time to time the Company may enter into derivative financial instruments (mainly foreign currency exchange forward contracts, interest rate swaps and purchased equity call options) designed to: 1) hedge the cash flows resulting from existing assets and liabilities and transactions expected to be entered into over the next 24 months in currencies other than the functional currency, 2) hedge the variability in interest expense on floating rate debt, 3) hedge the fair value of fixed-rate notes, 4) hedge against changes in interest rates that could impact future debt issuances, 5) hedge cash or share payments required on conversion of issued convertible notes, 6) hedge a net investment in a foreign operation, or 7) economically hedge the foreign currency exposure associated with the purchase price of non-U.S. acquisitions. Derivatives are recognized as assets or liabilities in the consolidated balance sheets at their fair value. When the derivative instrument qualifies as a cash flow hedge, changes in the fair value are deferred through other comprehensive earnings. If a derivative instrument qualifies as a fair value hedge, the changes in the fair value, as well as the offsetting changes in the fair value of the hedged items, are generally included in interest expense. When such instruments do not qualify for hedge accounting the changes in fair value are recorded in the consolidated statements of operations within other expense, net. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instruments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The Company&#8217;s financial instruments consist primarily of short-term and long-term debt, interest rate swaps, forward contracts and option contracts. The Company&#8217;s financial instruments also include cash and cash equivalents as well as accounts and other receivables and accounts payable, the fair values of which approximate their carrying values. As a policy, the Company does not engage in speculative or leveraged transactions.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company carries derivative instruments in the consolidated balance sheets at fair value, determined by reference to market data such as forward rates for currencies, implied volatilities, and interest rate swap yield curves. The accounting for changes in the fair value of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and, if so, the reason for holding&#160;it. In addition, the Company has designated certain long-term debt instruments as net investment hedges.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adoption of New Accounting Standards</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued Accounting Standards Update 2020-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Clarifying the Interactions Between Topic 321, Topic 323, and Topic 815 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2020-01&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which clarifies that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting for the purposes of applying the measurement alternative in accordance with Topic 321 immediately before applying or upon discontinuing the equity method. In addition, ASU 2020-01 states that for the purpose of applying paragraph 815-10-15-141(a) an entity should not consider whether, upon the settlement of the forward contract or exercise of the purchased option, individually or with existing investments, the underlying securities would be accounted for under the equity method in Topic 323 or the fair value option in accordance with the financial instruments guidance in Topic 825. The Company applied the provisions of ASU 2020-01 as of January 1, 2021. The adoption of this guidance did not have a material impact on the Company&#8217;s consolidated financial statements and disclosures. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued Accounting Standards Update 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which is intended to simplify the accounting for income taxes by eliminating certain exceptions and simplifying certain requirements under Topic 740. The Company applied the provisions of ASU 2019-12 on a prospective basis as of January 1, 2021. The adoption of this guidance did not have a material impact on the Company&#8217;s consolidated financial statements and disclosures.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting Standards Issued Not Yet Adopted&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued Accounting Standards Update 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform on Financial Reporting </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2020-04&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which provides optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. ASU 2020-04 applies only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. Entities can apply the provisions of ASU 2020-04 immediately, as applicable, and generally the provisions of the guidance are available through December 31, 2022 as entities transition away from reference rates that are expected to be discontinued. The Company is currently assessing the impact of the adoption of this guidance on its consolidated financial statements and disclosures. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued Accounting Standards Update 2021-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2021-08&#8221;), which requires entities (acquirers) to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with ASC Topic 606. ASU 2021-08 will be effective for fiscal years, including interim periods within those fiscal years, beginning after December 15, 2022 with early adoption permitted. The Company is currently assessing the impact of the adoption of this guidance on its consolidated financial statements and disclosures.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, the FASB issued Accounting Standards Update 2021-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2021-10&#8221;), which requires entities to provide annual disclosures about transactions with a government that are accounted for by applying a grant or contribution accounting model by analogy. ASU 2021-10 will be effective for fiscal years beginning after December 15, 2021 with early adoption permitted. The Company is currently assessing the impact of the adoption of this guidance on its disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942903322760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Other Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Acquisitions and Other Transactions</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">Acquisitions and Other Transactions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Upjohn Business Combination Agreement</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 29, 2019, Mylan, Pfizer, Upjohn, a wholly-owned subsidiary of Pfizer, and certain other affiliated entities entered into a Business Combination Agreement pursuant to which Mylan would combine with the Upjohn Business in a Reverse Morris Trust transaction. The Upjohn Business was a global, primarily off-patent branded and generic established medicines business, which includes 20 primarily off-patent solid oral dose legacy brands, such as Lyrica&#174;, Lipitor&#174;, Celebrex&#174; and Viagra&#174;. The Combination was completed on November 16, 2020. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Combination and pursuant to a Separation and Distribution Agreement, Pfizer had, among other things, transferred to Viatris substantially all of the assets and liabilities comprising the Upjohn Business (the Separation) and, thereafter, Pfizer had distributed to Pfizer stockholders all of the issued and outstanding shares of Viatris (the Distribution). When the Distribution and Combination were complete, Pfizer stockholders as of the record date of the Distribution owned 57% of the outstanding shares of Viatris common stock and Mylan shareholders as of immediately before the Combination owned 43% of the outstanding shares of Viatris common stock, in each case on a fully diluted basis. Viatris also made a cash payment to Pfizer equal to $12 billion, which was funded with the proceeds of debt incurred by Upjohn prior to the Combination.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction involved multiple legal entity restructuring transactions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and a reverse merger acquisition with Viatris representing the legal acquirer and Mylan representing the accounting acquirer of the Upjohn Business. In accordance with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC 805, Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Mylan is considered the accounting acquirer of the Upjohn Business and Viatris applied purchase accounting to the acquired assets and assumed liabilities of the Upjohn Business as of November 16, 2020. The debt incurred by Upjohn prior to the Combination was a liability assumed in purchase accounting. The fair value of the debt as of November 16, 2020 was $13.08&#160;billion.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purchase price consists of the issuance of approximately 689.9&#160;million Viatris shares of common stock at a fair value of approximately $10.73&#160;billion based on the closing price of Mylan&#8217;s ordinary shares on November 13, 2020, as reported by the NASDAQ. In accordance with U.S. GAAP, the Company used the acquisition method of accounting to account for this transaction. Under the acquisition method of accounting, the assets acquired and liabilities assumed in the transaction have been recorded at their respective estimated fair values at the acquisition date. During the twelve months ended December&#160;31, 2021 and 2020, the Company incurred acquisition related costs of approximately $234.6 million and $602.9&#160;million, respectively. Acquisition related costs were recorded primarily in SG&amp;A in the consolidated statements of operations for such periods.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2021, adjustments were made to the preliminary purchase price recorded at December 31, 2020, and are reflected as &#8220;Measurement Period and Other Adjustments&#8221; in the table below. The allocation of the $10.73&#160;billion purchase price to the assets acquired and liabilities assumed under the Combination is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.046%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.981%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.131%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Preliminary Purchase Price Allocation as of December 31, 2020 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Measurement Period and Other Adjustments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Purchase Price Allocation as of December 31, 2021 (as adjusted)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets (excluding inventories and net of cash acquired)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,841.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,803.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,588.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,554.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,394.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,389.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identified intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,040.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,040.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,107.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,403.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,481.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,678.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">792.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">784.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,246.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,653.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,760.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,179.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, including current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,076.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,076.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,656.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,657.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other noncurrent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,441.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,427.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired (net of $415.8 of cash acquired)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,311.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,311.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">____________</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.8pt">As previously reported in Viatris&#8217; Annual Report on Form 10-K for the fiscal year ended December 31, 2020.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">The measurement period adjustments are primarily for 1) certain working capital adjustments, an increase in litigation reserves to reflect facts and circumstances that existed as of the date of the Combination, and other adjustments and 2) the tax implications of these and other adjustments. These adjustments did not have a significant impact on the Company&#8217;s previously reported consolidated financial statements and accordingly, the Company has not retrospectively adjusted those consolidated financial statements.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Combination enhanced each businesses&#8217; ability to serve patients&#8217; needs and expand their capabilities across more than 165 markets. Mylan brought a diverse portfolio across many geographies and key therapeutic areas, such as central nervous system and anesthesia, infectious disease and cardiovascular, as well as a robust pipeline, high-quality manufacturing and supply chain excellence. The Upjohn Business brought trusted, iconic brands, such as Lipitor&#174; (atorvastatin calcium), Celebrex&#174; (celecoxib) and Viagra&#174; (sildenafil), and proven commercialization capabilities, including leadership positions in China and other emerging markets. </span></div><div style="text-indent:39.6pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded a step-up in the fair value of inventory of approximately $1.43&#160;billion at the acquisition date. During the twelve months ended December 31, 2021 and 2020, the Company recorded amortization of the inventory step-up of approximately $1.19&#160;billion and $238.2 million, respectively, which is included in cost of sales in the consolidated statements of operations. The inventory step-up was fully amortized during 2021. In addition, a step-up in the fair value of property, plant and equipment of approximately $385.0&#160;million was recognized. The related depreciation is being expensed over a service life of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzQ2NzE_7b74b1b4-9fe4-486d-b533-a57949c797fb">five</span> years for machinery and equipment and between 10 and 20 years for buildings.</span></div><div style="text-indent:39.6pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The identified intangible assets of $18.04&#160;billion are comprised of product rights and are being amortized over a weighted average useful life of 15 years. Significant assumptions utilized in the valuation of identified intangible assets were based on company specific information and projections which are not observable in the market and are thus considered Level 3 measurements as defined by U.S. GAAP. The goodwill of $2.40&#160;billion arising from the Combination consisted largely of the value of the employee workforce and products to be sold in new markets leveraging the combined entity. In addition, an allocation of the goodwill was assigned to the respective segments. None of the goodwill recognized in this transaction is expected to be deductible for income tax purposes.</span></div><div style="text-indent:39.6pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded a fair value adjustment of approximately $759.4&#160;million related to the long-term debt assumed as part of the acquisition. The fair value of long-term debt as of the Combination date was determined by broker or dealer quotations, which is classified as Level 2 in the fair value hierarchy. The total fair value adjustment is being amortized as a reduction to interest expense over the maturity dates of the related debt instruments.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operating results of the Upjohn Business have been included in the Company&#8217;s consolidated statements of operations since the acquisition date. The total revenues of the Upjohn Business for the period from the acquisition date to December 31, 2020, were $866.5&#160;million and net loss, net of tax, was approximately $360.9&#160;million. The net loss for the period includes the effect of the purchase accounting adjustments and acquisition related costs.</span></div><div style="text-indent:39.6pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Unaudited Pro Forma Financial Results</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents supplemental unaudited pro forma information for the Combination, as if it had occurred on January 1, 2019. The unaudited pro forma results reflect certain adjustments related to past operating performance and acquisition accounting adjustments, such as increased depreciation and amortization expense based on the fair value of assets acquired, the impact of transaction costs and the related income tax effects. The unaudited pro forma results do not include any anticipated synergies which may be achievable, or have been achieved, subsequent to the closing of the Combination. Accordingly, the unaudited pro forma results are not necessarily indicative of the results that actually would have occurred had the acquisitions been completed on the stated date above, nor are they indicative of the future operating results of Viatris and its subsidiaries.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.145%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.914%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(Unaudited, in millions, except per share amounts) </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,284.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,582.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,483.7&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,873.5&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.23&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.55&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,206.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,205.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,207.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,206.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Transactions</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, Viatris and Pfizer terminated their strategic collaboration for generic drugs in Japan pursuant to an amendment and termination agreement. Under the prior collaboration agreement, both parties contributed products, which Pfizer distributed to third-parties in the Japan market. Under the terms of the amendment and termination agreement, Viatris purchased all collaboration related inventory held by Pfizer. As a result of the termination, and the repurchase of collaboration inventory, the Company reduced revenue by $86.5&#160;million during the year ended December 31, 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020, the Company entered into an agreement to acquire the related intellectual property and commercialization rights of Aspen&#8217;s thrombosis product portfolio in Europe for &#8364;641.9&#160;million. The portfolio consists of well-established injectable anticoagulants sold in Europe under the brand names, and variations of the brand names, Arixtra&#174;, Fraxiparine&#174;, Mono-Embolex&#174; and Orgaran&#174;. Upon closing of the transaction in November 2020, the Company made a payment of &#8364;263.2&#160;million to Aspen and the remaining payment of &#8364;378.7&#160;million was made on June 25, 2021. The Company accounted for this transaction as an asset acquisition and recognized an intangible asset of &#8364;641.9&#160;million for the product rights, which is being amortized over a useful life of 8 years.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942898476856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition and Accounts Receivable<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue Recognition and Accounts Receivable</a></td>
<td class="text">Revenue Recognition and Accounts Receivable<div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s net sales by product category for each of our reportable segments for the years ended December&#160;31, 2021, 2020, and 2019, respectively:</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:37.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.669%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021 Net Sales</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Product Category</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Developed Markets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Greater China</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">JANZ</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Emerging Markets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brands</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,759.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,207.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,197.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,677.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,841.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Complex Gx and Biosimilars</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,241.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,342.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,427.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">783.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,413.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,630.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Viatris</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,428.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,212.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,027.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,144.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,813.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:37.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.669%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020 Net Sales</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Product Category</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Developed Markets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Greater China</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">JANZ</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Emerging Markets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brands</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,920.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,234.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Complex Gx and Biosimilars</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,202.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,295.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,387.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,361.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,289.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Viatris</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,510.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,195.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,853.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,819.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:37.191%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.684%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019 Net Sales</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Product Category</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Developed Markets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Greater China</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">JANZ</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Emerging Markets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brands</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,199.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">422.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,362.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Complex Gx and Biosimilars</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,127.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,211.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,913.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">635.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,241.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,796.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Viatris</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,240.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,192.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,723.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,370.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents net sales on a consolidated basis for select key products for the year ended December&#160;31, 2021:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:83.110%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.106%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Select Key Global Products</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lipitor &#174;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,663.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Norvasc &#174;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">824.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lyrica &#174;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">728.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viagra &#174;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EpiPen&#174; Auto-Injectors</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Celebrex &#174;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effexor &#174;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Creon &#174;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zoloft &#174;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Xalabrands</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Select Key Segment Products</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Influvac &#174;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amitiza &#174;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Xanax &#174;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dymista &#174;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yupelri &#174;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">____________</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.8pt">The Company does not disclose net sales for any products considered competitively sensitive.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Products disclosed may change in future periods, including as a result of seasonality, competition or new product launches.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.8pt">Prior periods are not presented due to significance of products acquired as part of the Combination.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Variable Consideration and Accounts Receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a reconciliation of gross sales to net sales by each significant category of variable consideration during the years ended December&#160;31, 2021, 2020 and 2019, respectively:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:67.475%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.887%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross sales</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,553.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,899.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,012.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross to net adjustments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chargebacks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,530.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,656.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,309.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates, promotional programs and other sales allowances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,135.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,765.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,629.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Returns</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(384.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(329.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(237.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Governmental rebate programs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(689.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(327.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(465.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total gross to net adjustments</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,739.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,079.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,641.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,813.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,819.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,370.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a rollforward of the categories of variable consideration during 2021:</span></div><div style="margin-bottom:7pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.433%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current Provision Related to Sales Made in the Current Period </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Measurement Period Adjustments and Reclasses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Checks/ Credits Issued to Third Parties </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effects of Foreign Exchange</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chargebacks</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">585.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,530.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,585.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">591.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates, promotional programs and other sales allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,576.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,135.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,267.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,373.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Returns</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">539.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">384.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(499.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">686.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Governmental rebate programs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">689.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(705.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,014.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,739.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,056.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,050.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accruals for these provisions are presented in the consolidated financial statements as reductions in determining net revenues and as a contra-asset in accounts receivable, net (if settled via credit) and other current liabilities (if paid in cash). Accounts receivable are presented net of allowances relating to these provisions, which were comprised of the following at December&#160;31, 2021 and 2020, respectively:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:76.661%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.652%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,688.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,802.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,362.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,211.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,050.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,014.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>We have not made and do not anticipate making any significant changes to the methodologies that we use to measure provisions for variable consideration; however, the balances within these reserves can fluctuate significantly through the consistent application of our methodologies. Historically, we have not recorded in any current period any material amounts related to adjustments made to prior period reserves.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942901802168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BalanceSheetComponentsAbstract', window );"><strong>Balance Sheet Components [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">Balance Sheet Components</a></td>
<td class="text">Balance Sheet Components <div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selected balance sheet components consist of the following:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and restricted cash</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.576%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">844.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash, included in other current and non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">706.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:76.759%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">922.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">958.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">993.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,438.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,062.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,075.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,977.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,471.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory reserves totaled $519.0 million and $353.6 million at December&#160;31, 2021 and 2020, respectively. Included as a component of cost of sales is expense related to the net realizable value of inventories of $474.9 million, $206.1 million and $399.2 million for the years ended December&#160;31, 2021, 2020 and 2019, respectively.</span></div><div><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prepaid expenses and other current assets</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:77.052%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.458%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale fixed income securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of financial instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,467.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,236.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,957.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,707.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses consist primarily of prepaid rent, insurance and other individually insignificant items.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, plant and equipment, net</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:77.052%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.458%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,054.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,235.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,808.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,954.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">588.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,589.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,721.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,400.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,262.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,188.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,459.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capitalized software costs included in our consolidated balance sheets were $62.3 million and $70.9 million, net of accumulated depreciation, at December&#160;31, 2021 and 2020, respectively. The Company periodically reviews the estimated useful lives of assets and makes adjustments when appropriate. Depreciation expense was approximately $509.5 million, $289.7 million and $256.1 million for the years ended December&#160;31, 2021, 2020 and 2019, respectively.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other assets</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:76.759%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments, clean energy investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">879.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,170.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,047.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts payable</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:76.759%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,056.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,345.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other payables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">558.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,657.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,904.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other current liabilities</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:76.759%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued sales allowances</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,362.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,211.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll and employee benefit liabilities </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">828.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal and professional accruals, including litigation accruals</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued restructuring</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments, clean energy investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of financial instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,254.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,973.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,619.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,960.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other long-term obligations</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:76.759%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee benefit liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">876.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,020.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax related items, including contingencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued restructuring</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other long-term obligations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,933.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,483.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -URI http://asc.fasb.org/topic&amp;trid=2122208<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_BalanceSheetComponentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Balance Sheet Components</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_BalanceSheetComponentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942903278152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Lessee, Operating Leases</a></td>
<td class="text">Leases<div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has operating leases of real estate, consisting primarily of administrative offices, manufacturing and distribution facilities, and R&amp;D facilities. We also have operating leases of certain equipment, primarily automobiles, and certain limited supply arrangements.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We elected to apply the practical expedient to not separate lease and non-lease components for our leases except for those related to certain limited supply arrangements. We have also elected to apply the short-term lease recognition exemption which means we will not recognize ROU assets or lease liabilities for leases with an initial term of 12 months of less.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company recognized ROU assets of $290.8 million and total lease liabilities of $287.6 million. The Company&#8217;s ROU assets are recorded in other assets. The related lease liability balances are recorded in other current liabilities and other long-term obligations in the consolidated balance sheets. Refer to Note 5 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Balance Sheet Components</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ROU assets and liabilities are recognized at the present value of the future minimum lease payments over the lease term at commencement date. As most of our leases do not provide an implicit rate, we use an applicable incremental borrowing rate based on the information available at commencement date in determining the present value of future payments. Options to extend or terminate the ROU assets are reviewed at lease inception and these options are accounted for when they are reasonably certain of being exercised.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other information related to leases was as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:82.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining lease terms</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 year to 23 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, maturities of lease liabilities were as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:89.047%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.753%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liability</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, we have additional operating leases, primarily for administrative offices, that have not yet commenced totaling approximately $13.6 million. These leases are expected to commence in 2022 and have lease terms of 5 to 9 years. For the years ended December&#160;31, 2021, 2020 and 2019, the Company had operating lease expense of approximately $97.6 million, $80.7 million and $87.6 million, respectively. Operating lease costs are classified primarily as selling, general and administrative expenses and cost of sales in the consolidated statements of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942903253272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Method Investments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock', window );">Equity Method Investments</a></td>
<td class="text">Equity Method Investments<div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had three equity method investments in limited liability companies that owned refined coal production plants whose activities qualified for income tax credits under Section 45 of the Code. The Company did not consolidate these entities as we had determined that we were not the primary beneficiary of these entities and did not have the power to individually direct the activities of these entities. Accordingly, these investments were accounted for under the equity method of accounting. For each of the clean energy investments, the Company had entered into notes payable with the respective project sponsor, which in part were paid to the sponsor as certain production levels were met. The law that provides for IRC Section 45 tax credits expired during the year ended December 31, 2021 for all three clean energy investments and all of the clean energy investments have wound down operations.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December 31, 2021, 2020, and 2019, the Company reduced its long-term obligations for its three investments as a result of lower than anticipated production levels and lower expected future variable debt payments to the respective project sponsor. The Company recognized a net gain of approximately $5.7&#160;million, $21.4&#160;million and&#160;$7.0 million, respectively, which was recognized as a component of the net loss of the equity method investments in the consolidated statements of operations.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values and respective balance sheet locations of the Company&#8217;s clean energy investments were as follows at December&#160;31, 2021 and 2020, respectively:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:76.759%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Summarized financial information, in the aggregate, for the Company&#8217;s significant equity method investments on a 100% basis as of December&#160;31, 2021 and 2020 and for the years ended December&#160;31, 2021, 2020 and 2019 are as follows:</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:76.759%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:65.272%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating and non-operating expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.4)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.4)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s net losses from its equity method investments include amortization expense related to the excess of the cost basis of the Company&#8217;s investment over the underlying assets of each individual investee. For the years ended December&#160;31, 2021, 2020 and 2019, the Company recognized net losses from equity method investments of $61.9 million, $48.4 million, and $62.1 million, respectively, which were recognized as a component of other expense, net in the consolidated statements of operations. The Company recognizes the income tax credits and benefits from the clean energy investments as part of its provision for income taxes.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -URI http://asc.fasb.org/topic&amp;trid=2196965<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942903344936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments and Risk Management<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsDisclosureTextBlock', window );">Financial Instruments And Risk Management</a></td>
<td class="text">Financial Instruments and Risk ManagementThe Company is exposed to certain financial risks relating to its ongoing business operations. The primary financial risks that are managed by using derivative instruments are foreign currency risk and interest rate risk.<div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Risk Management</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to manage certain foreign currency risks, the Company enters into foreign exchange forward contracts to mitigate risk associated with changes in spot exchange rates of mainly non-functional currency denominated assets or liabilities. The foreign exchange forward contracts are measured at fair value and reported as current assets or current liabilities in the consolidated balance sheets. Any gains or losses on the foreign exchange forward contracts are recognized in earnings in the period incurred in the consolidated statements of operations.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has also entered into forward contracts to hedge forecasted foreign currency denominated sales from certain international subsidiaries and a portion of forecasted intercompany inventory sales denominated in Euro, Japanese Yen and Chinese Renminbi for up to eighteen months. These contracts are designated as cash flow hedges to manage foreign currency transaction risk and are measured at fair value and reported as current assets or current liabilities in the consolidated balance sheets. Any changes in the fair value of designated cash flow hedges are deferred in AOCE and are reclassified into earnings when the hedged item impacts earnings.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Investment Hedges</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may hedge the foreign currency risk associated with certain net investment positions in foreign subsidiaries by either borrowing directly in foreign currencies and designating all or a portion of the foreign currency debt as a hedge of the applicable net investment position or entering into foreign currency swaps that are designated as hedges of net investments.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has designated certain Euro and Yen borrowings as a hedge of its investment in certain Euro-functional and Yen-functional currency subsidiaries in order to manage foreign currency translation risk. Borrowings designated as net investment hedges are marked-to-market using the current spot exchange rate as of the end of the period, with gains and losses included in the foreign currency translation component of AOCE until the sale or substantial liquidation of the underlying net investments. In addition, the Company manages the related foreign exchange risk of the Euro and Yen borrowings not designated as net investment hedges through certain Euro and Yen denominated financial assets and forward currency swaps. </span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the principal amounts of the Company&#8217;s outstanding Euro and Yen borrowings and the notional amounts of the Euro and Yen borrowings designated as net investment hedges:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:62.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.210%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount Designated as a Net Investment Hedge</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Principal Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Euro</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.250% Euro Senior Notes due 2024</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8364;</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8364;</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8364;</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.125% Euro Senior Notes due 2028</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.125% Euro Senior Notes due 2025</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.816% Euro Senior Notes due 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.023% Euro Senior Notes due 2024</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.362% Euro Senior Notes due 2027</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.908% Euro Senior Notes due 2032</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8364;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,955.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8364;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,850.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8364;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,955.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Yen</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">YEN Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#165;</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,000.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#165;</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,000.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#165;</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yen Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#165;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,000.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#165;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,000.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#165;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31,2021, the principal amount of the Company&#8217;s outstanding Yen borrowings and the notional amount of the Yen borrowings designated as net investment hedge was $347.6&#160;million.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk Management</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into interest rate swaps from time to time in order to manage interest rate risk associated with the Company&#8217;s fixed-rate and floating-rate debt. Interest rate swaps that meet specific accounting criteria are accounted for as fair value or cash flow hedges. All derivative instruments used to manage interest rate risk are measured at fair value and reported as current assets or current liabilities in the consolidated balance sheets. For fair value hedges, the changes in the fair value of both the hedging instrument and the underlying debt obligations are included in interest expense. For cash flow hedges, the change in fair value of the hedging instrument is deferred through AOCE and is reclassified into earnings when the hedged item impacts earnings.</span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flow Hedging Relationships</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s interest rate swaps designated as cash flow hedges fix the interest rate on a portion of the Company&#8217;s variable-rate debt or hedge part of the Company&#8217;s interest rate exposure associated with the variability in the future cash flows attributable to changes in interest rates. Any changes in fair value are included in earnings or deferred through AOCE, depending on the nature and effectiveness of the offset. Any ineffectiveness in a cash flow hedging relationship is recognized immediately in earnings in the consolidated statements of operations. </span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Hedging Relationships</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's interest rate swaps designated as fair value hedges convert the fixed rate on a portion of the Company's fixed-rate senior notes to a variable rate. Any changes in the fair value of these derivative instruments, as well as the offsetting change in fair value of the portion of the fixed-rate debt being hedged, is included in interest expense. The Company&#8217;s fair value hedge was terminated during 2020.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Risk Management</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company regularly reviews the creditworthiness of its financial counterparties and does not expect to incur a significant loss from the failure of any counterparties to perform under any agreements. The Company is not subject to any obligations to post collateral under derivative instrument contracts. Certain derivative instrument contracts entered into by the Company are governed by master agreements, which contain credit-risk-related contingent features that would allow the counterparties to terminate the contracts early and request immediate payment should the Company trigger an event of default on other specified borrowings. The Company records all derivative instruments on a gross basis in the consolidated balance sheets. Accordingly, there are no offsetting amounts that net assets against liabilities. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the classification and fair values of derivative instruments in our consolidated balance sheets:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.116%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset Derivatives </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability Derivatives</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021 Fair Value</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020 Fair Value</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021 Fair Value</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020 Fair Value</span></td></tr><tr style="height:15pt"><td colspan="24" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses &amp; other current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total derivatives designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives not designated as hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses &amp; other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.8</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total derivatives not designated as hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total derivatives </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize information about the gains/(losses) incurred to hedge or offset operational foreign exchange or interest rate risk:</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:34.738%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.819%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.414%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.414%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.414%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.414%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.414%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.417%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gains/(Losses) Recognized in Earnings</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain Excluded from the Assessment of Hedge Effectiveness</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain/(Loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivative Financial Instruments in Fair Value Hedge Relationships </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> :</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 Senior Notes (3.125% coupon)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivative Financial Instruments in Cash Flow Hedging Relationships</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivative Financial Instruments Not Designated as Hedging Instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option and forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gains/(Losses) Recognized in AOCE (Net of Tax) on Derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gains/(Losses) Reclassified from AOCE into Earnings</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain/(Loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivative Financial Instruments in Cash Flow Hedging Relationships </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivative Financial Instruments in Net Investment Hedging Relationships:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency borrowings and forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(346.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">479.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(325.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">In the first quarter of 2020, the Company terminated interest rate swaps designated as a fair value hedge resulting in net proceeds of approximately $45 million. The amount included in the above tables represents the fair value adjustment recognized at the date the interest rate swaps were settled. </span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">At December&#160;31, 2021, the Company expects that approximately $21.0 million of pre-tax net gains on cash flow hedges will be reclassified from AOCE into earnings during the next twelve months.</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Represents the location of the gain/(loss) recognized in earnings on derivatives.</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Represents the location of the gain/(loss) reclassified from AOCE into earnings.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Represents the location of the gain excluded from the assessment of hedge effectiveness.</span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is based on the price that would be received from the sale of an identical asset or paid to transfer an identical liability in an orderly transaction between market participants at the measurement date. In order to increase consistency and comparability in fair value measurements, a fair value hierarchy has been established that prioritizes observable and unobservable inputs used to measure fair value into three broad levels, which are described below:</span></div><div style="margin-bottom:6pt;padding-left:81pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level&#160;1:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities. The fair value hierarchy gives the highest priority to Level&#160;1 inputs.</span></div><div style="margin-bottom:6pt;padding-left:81pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level&#160;2:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Observable market-based inputs other than quoted prices in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:12pt;padding-left:81pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level&#160;3:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level&#160;3 inputs.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible, as well as considers counterparty credit risk in its assessment of fair value.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities carried at fair value are classified in the tables below in one of the three categories described above:</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:57.465%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.712%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Recurring fair value measurements</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="24" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange traded funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale fixed income investments:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasuries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale fixed income investments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange derivative assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at recurring fair value measurement</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="24" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange derivative liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities at recurring fair value measurement</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:57.465%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.712%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Recurring fair value measurements</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="24" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange traded funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale fixed income investments:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasuries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale fixed income investments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange derivative assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at recurring fair value measurement</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="24" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange derivative liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities at recurring fair value measurement</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For financial assets and liabilities that utilize Level&#160;2 inputs, the Company utilizes both direct and indirect observable price quotes, including the LIBOR yield curve, foreign exchange forward prices, and bank price quotes. For the years ended December&#160;31, 2021 and 2020, there were no transfers between Level 1 and 2 of the fair value hierarchy. Below is a summary of valuation techniques for Level&#160;1 and Level&#160;2 financial assets and liabilities:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212;&#160;valued at observable net asset value prices.</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Equity securities, exchange traded funds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212;&#160;valued at the active quoted market prices from broker or dealer quotations or transparent pricing sources at the reporting date. Unrealized gains and losses attributable to changes in fair value are included in other expense, net, in the consolidated statements of operations.</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Equity securities, marketable securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">valued using quoted stock prices from public exchanges at the reporting date. Unrealized gains and losses attributable to changes in fair value are included in other expense, net, in the consolidated statements of operations.</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Available-for-sale fixed income investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212;&#160;valued at the quoted market prices from broker or dealer quotations or transparent pricing sources at the reporting date. Unrealized gains and losses attributable to changes in fair value, net of income taxes, are included in accumulated other comprehensive loss as a component of shareholders&#8217; equity.</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Interest rate swap derivative assets and liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212;&#160;valued using the LIBOR/EURIBOR yield curves at the reporting date. Counterparties to these contracts are highly rated financial institutions.</span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Foreign exchange derivative assets and liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212;&#160;valued using quoted forward foreign exchange prices and spot rates at the reporting date. Counterparties to these contracts are highly rated financial institutions.</span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent Consideration</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2011, the Company completed the acquisition of the exclusive worldwide rights to develop, manufacture and commercialize a generic equivalent to GlaxoSmithKline&#8217;s Advair&#174; Diskus incorporating Pfizer&#8217;s respiratory delivery platform. The Company accounted for this transaction as a purchase of a business and utilized the acquisition method of accounting. On January 30, 2019, the Company received FDA approval of Wixela&#174; Inhub&#174; (fluticasone propionate and salmeterol inhalation powder, USP), the first generic of GlaxoSmithKline&#8217;s Advair Diskus&#174;. The commercial launch of the Wixela&#174; Inhub&#174; occurred in February 2019. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company has a contingent consideration liability of $177.8 million related to the respiratory delivery platform. The fair value measurement of contingent consideration is determined using Level 3 inputs. The Company&#8217;s contingent consideration represents a component of the total purchase consideration for Pfizer&#8217;s respiratory delivery platform and certain other acquisitions. The measurement is calculated using unobservable inputs based on the Company&#8217;s own assumptions primarily related to the probability and timing of future development and commercial milestones and future profit-sharing payments which are discounted using a market rate of return. At December&#160;31, 2021 and 2020, discount rates ranging from 8.0% to 10.5% were utilized in the valuations. Significant changes in unobservable inputs could result in material changes to the contingent consideration liability. </span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A rollforward of the activity in the Company&#8217;s fair value of contingent consideration from December&#160;31, 2019 to December&#160;31, 2021 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:65.272%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current Portion </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-Term Portion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Contingent Consideration</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassifications</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value loss </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value loss </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Included in other current liabilities in the consolidated balance sheets.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Included in other long-term obligations in the consolidated balance sheets.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Included in litigation settlements and other contingencies, net in the consolidated statements of operations.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expects to incur approximately $6 million to $8 million of non-cash accretion expense related to the increase in the net present value of the contingent consideration liabilities in 2022.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Company has not elected the fair value option for financial assets and liabilities, any future transacted financial asset or liability will be evaluated for the fair value election.</span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Available-for-Sale Securities</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost and estimated fair value of available-for-sale fixed income securities, included in prepaid expenses and other current assets, were as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:57.465%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.712%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of available-for-sale debt securities at fair value as of December&#160;31, 2021, were as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:89.090%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.710%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature within one year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature in one to five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature in five years and later</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942903175224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Comprehensive Earnings<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Comprehensive Earnings</a></td>
<td class="text">Comprehensive (Loss) Earnings<div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated other comprehensive loss, as reflected in the consolidated balance sheets, is comprised of the following:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:76.661%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.652%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized gain on marketable securities, net of tax</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrecognized (loss) gain and prior service cost related to defined benefit plans, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrecognized loss on derivatives in cash flow hedging relationships, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrecognized loss on derivatives in net investment hedging relationships, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(353.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,802.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(461.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,744.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(858.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of accumulated other comprehensive (loss) earnings, before tax, consist of the following:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.993%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.332%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.063%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.684%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr style="height:36pt"><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Derivatives in Cash Flow Hedging Relationships</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Net Investment Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Marketable Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Defined Pension Plan Items</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Totals</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Forward Contracts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020, net of tax</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(353.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(461.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(858.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (loss) before reclassifications, before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,340.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(755.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive earnings (loss), before tax:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on foreign exchange forward contracts classified as cash flow hedges, included in net sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on interest rate swaps classified as cash flow hedges, included in interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service costs included in SG&amp;A </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial loss included in SG&amp;A </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive earnings (loss), before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,340.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(775.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,802.4)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,744.3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.993%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.332%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.063%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.684%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr style="height:36pt"><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Derivatives in Cash Flow Hedging Relationships</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Net Investment Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Marketable Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Defined Pension Plan Items</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Totals</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Forward Contracts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019, net of tax</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,674.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,797.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) earnings before reclassifications, before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(305.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,213.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">914.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive (loss) earnings, before tax:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on foreign exchange forward contracts classified as cash flow hedges, included in net sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on interest rate swaps classified as cash flow hedges, included in interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service costs included in SG&amp;A </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial loss included in SG&amp;A </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive (loss) earnings, before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(305.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,213.0&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">912.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision (benefit)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.0)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(353.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(461.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(858.0)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.993%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.332%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.063%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.684%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Derivatives in Cash Flow Hedging Relationships</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Net Investment Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Marketable Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Defined Pension Plan Items</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Totals</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Forward Contracts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2018, net of tax</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,259.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,441.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (loss) before reclassifications, before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(415.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(347.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive (loss) earnings, before tax:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on foreign exchange forward contracts classified as cash flow hedges, included in net sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on interest rate swaps classified as cash flow hedges, included in interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service costs included in SG&amp;A </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial loss included in SG&amp;A </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive earnings (loss), before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(415.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(343.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision (benefit) </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative effect of the adoption of new accounting standards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,674.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,797.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI http://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942903171480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes <div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax provision (benefit) consisted of the following components:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:65.272%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Federal:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(182.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(277.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(170.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(283.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. State:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">777.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision (benefit)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income taxes:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,982.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(945.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,031.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign - Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,318.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,185.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total (loss) earnings before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(664.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(721.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For all periods presented, the allocation of earnings before income taxes between U.S. and non-U.S. operations includes intercompany interest allocations between certain domestic and foreign subsidiaries. These amounts are eliminated on a consolidated basis. </span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Temporary differences and carry-forwards that result in deferred tax assets and liabilities were as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:76.759%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee benefits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">393.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,187.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credit and loss carry-forwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,256.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,080.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,889.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,665.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(780.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(443.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,109.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,221.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets and goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,468.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,058.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,591.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,197.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,482.3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(975.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For those foreign subsidiaries whose investments are permanent in duration, income and foreign withholding taxes have not been provided on the unremitted earnings of those subsidiaries. This amount may become taxable upon a repatriation of assets from the subsidiary or a sale or liquidation of the subsidiary. The amount of such unremitted earnings is approximately $3.4 billion at December&#160;31, 2021. Determination of the amount of any unrecognized deferred income tax liability on these unremitted earnings is not practicable as such determination involves material uncertainties about the potential extent and timing of any distributions, the availability and complexity of calculating foreign tax credits, and the potential indirect tax consequences of such distributions, including withholding taxes.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Combination, the applicable income tax rate to Mylan was the U.K. rate of 19%, and following the Combination, the statutory income tax rate applicable to Viatris Inc. is the U.S. rate of 21% for the years ended December 31, 2021 and 2020.  A reconciliation of the statutory tax rate to the effective tax rate is as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:65.272%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statutory tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States Operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clean energy and research credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. rate differentials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of changes in legislation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes and credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax settlements and resolution of certain tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incremental US Tax on Foreign Earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Waived deductions under IRC &#167; 59A</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of the Combination and Divestitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other U.S. items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Foreign Operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Luxembourg</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gibraltar</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Puerto Rico</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Switzerland</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Singapore</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax impact of tax law changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of the Combination and divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Withholding taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax settlements and resolution of certain tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other foreign items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In all years, our effective tax rate is impacted by the jurisdictional location of earnings and the corresponding tax rates in those jurisdictions. Subsequent to the Combination, the Company realizes benefits from lower tax rates in Singapore and Puerto Rico due to manufacturing and other incentives..</span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tax Act</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 22, 2017, the U.S. government enacted the Tax Act. The Tax Act makes broad and complex changes to the Code including, but not limited to, reducing the U.S. federal corporate income tax rate and requiring a one-time transition tax on certain unrepatriated earnings of non-U.S. corporate subsidiaries of large U.S. shareholders that may electively be paid over eight years. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Tax Act also puts in place new tax laws that impact our taxable income beginning in 2018, which include, but are not limited to (1) creating a BEAT, which is a new minimum tax, (2) generally eliminating U.S. federal income taxes on dividends from foreign subsidiaries, (3) a new provision designed to tax currently GILTI earned by non-U.S. corporate subsidiaries of large U.S. shareholders and a deduction generally equal to 50 percent of GILTI (37.5 percent for tax years beginning after December 31, 2025) to offset the income tax liability, (4) a provision limiting the amount of deductible interest expense in the U.S., (5) limitations on the deductibility of certain executive compensation, and (6) limitations on the utilization of foreign tax credits to reduce the U.S. income tax liability. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, no U.S. deferred income taxes or foreign withholding taxes were recorded on earnings in the Company&#8217;s non-U.S. subsidiaries where there would be no U.S. or foreign tax upon repatriation or where the Company&#8217;s practice and intention was to reinvest the earnings outside of the U.S. The transition tax noted above resulted in the previously untaxed foreign earnings of U.S. subsidiaries being included in federal and state taxable income. We analyze on an ongoing basis our global working capital requirements and the potential tax liabilities that would be incurred if the non-U.S. subsidiaries repatriate cash, which include potential local country withholding taxes and U.S. state taxation.  The Company has elected to not record deferred taxes associated with the GILTI provision of the Tax Act.</span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Valuation Allowance</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A valuation allowance is provided when it is more likely than not that some portion or all of the deferred tax assets will not be realized. At December&#160;31, 2021, a valuation allowance has been applied to certain deferred tax assets in the amount of $780.4 million.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When assessing the realizability of deferred tax assets, management considers all available evidence, including historical information, long-term forecasts of future taxable income and possible tax planning strategies. Amounts recorded for valuation allowances can result from a complex series of estimates, assumptions and judgments about future events. Due to the inherent uncertainty involved in making these estimates, assumptions and judgments, actual results could differ materially. Any future increases to the Company&#8217;s valuation allowances could materially impact the Company&#8217;s consolidated financial condition and results of operations.</span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Operating Losses</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of December&#160;31, 2021, the Company had the following carryforwards and attributes: </span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. federal net operating loss carryforwards of  $7.9 million.</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. state income tax loss carryforwards of approximately  $3.10 billion, which are largely offset by a valuation allowance.</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Non-U.S. net operating loss carryforwards of approximately  $1.57 billion, of which $748.4 million can be carried forward indefinitely, with the remaining $817.8 million expiring in years 2022 through 2041.</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Foreign deductible attributes of $39.6 million that can be carried forward indefinitely, which are offset by a full valuation allowance.</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. and foreign credit carryovers of $329.2 million, expiring in various amounts through 2041.</span></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Anticipatory foreign tax credits of $230.3 million which will generate from the reversal of future taxable income in certain non-U.S. jurisdictions which are taxed both in their local jurisdictions and in the U.S.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 16, 2020, the Company had a change in ownership pursuant to Section 382 of the Code. Under this provision of the Code, the utilization of any NOL or tax credit carryforwards incurred prior to the date of ownership change may be limited. Analyses of the limits for each ownership change indicates the annual limitation would not impair the Company's ability to utilize our U.S. federal credit carryovers.  While state loss carryforwards may be limited by Section 382 of the Code, the carryforwards are largely offset by a valuation allowance.</span></div><div style="margin-bottom:12pt;padding-left:18pt;padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CARES Act</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 27, 2020, the CARES Act was enacted and signed into law. The CARES Act includes several provisions, including increasing the amount of deductible interest, allowing companies to carryback certain NOLs, and increasing the amount of NOLs that corporations can use to offset income.During the year ended December 31, 2020, the CARES Act reduced the Company&#8217;s 2020 income tax expense by $22.1&#160;million resulting from additional deductible interest. </span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tax Examinations</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to income taxes and tax audits in many jurisdictions. A certain degree of estimation is thus required in recording the assets and liabilities related to income taxes. Tax audits and examinations can involve complex issues, interpretations, and judgments and the resolution of matters that may span multiple years, particularly if subject to litigation or negotiation. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Although the Company believes that adequate provisions have been made for these uncertain tax positions, the Company&#8217;s assessment of uncertain tax positions, including those arising from legal entity restructuring transactions in connection with the Combination, is based on estimates and assumptions that the Company believes are reasonable but the estimates for unrecognized tax benefits and potential tax benefits may not be representative of actual outcomes, and variations from such estimates could materially affect the Company&#8217;s financial condition, results of operations or cash flows in the period of resolution, settlement or when the statutes of limitations expire. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to ongoing IRS examinations. The years 2015 through 2018 are open years under examination. The years 2012, 2013 and 2014 have one matter open, and a Tax Court petition was filed regarding the matter and a trial was held in December 2018 and is discussed further below. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2019, Mylan reached an agreement in principle with the IRS to resolve all issues relating to our positions on the February 27, 2015 acquisition by Mylan N.V. of Mylan Inc. and Abbott Laboratories&#8217; non-U.S. developed markets specialty and branded generics business. Under the agreement in principle, which was finalized as part of a closing agreement with the IRS on October 11, 2019, Mylan&#8217;s status as a non-U.S. corporation for U.S. Federal income tax purposes was confirmed, and we have adjusted the interest rates used for intercompany loans as necessary. During the year ended December 31, 2019, the Company recorded a reserve of approximately $155.0&#160;million as part of its liability for uncertain tax positions, with a net impact to the income tax provision of approximately $144.9&#160;million related to this matter. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Several international audits are currently in progress. In some cases, the tax auditors have proposed adjustments </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or issued assessments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to our tax positions, including with respect to intercompany transactions, and we are in ongoing discussions with some of the auditors regarding the validity of their positions. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In instances where assessments have been issued, we disagree with these assessments and believe they are without merit and incorrect as a matter of law. As a result, we anticipate that certain of these matters may become the subject of litigation before tax courts where we intend to vigorously defend our position.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In Australia, the tax authorities have issued notices of assessments to the Company for the years ended December 2009 to December 2019, subject to additional interest and penalties, concerning our tax position with respect to certain intercompany transactions. The tax authorities denied our objections to the assessments and we have commenced litigation in the Australian Federal Court challenging that decision. During 2021, the Company made a partial payment of $56.0&#160;million in order to stay potential interest and penalties resulting from this litigation.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In France, the tax authorities have issued notices of assessments to the Company for the years ended December 2013 to December 2016 concerning our tax position with respect to (i) certain intercompany transactions and (ii) whether income earned by a Company entity not domiciled in France should be subject to French tax. We have resolved our position concerning certain intercompany transactions with the tax authorities. Concerning the remaining issue, we have commenced litigation before the French tax courts where the tax authorities will seek unpaid taxes, penalties, and interest.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In India, the tax authorities have issued notices of assessments to the Company seeking unpaid taxes and interest for the financial years covering 2013 to 2018 concerning our tax position with respect to certain corporate tax deductions and certain intercompany transactions. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of these assessments remain in the audit phase where we are challenging them before the tax authorities while we are challenging some of the other assessments in the Indian tax courts.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has recorded a net reserve for uncertain tax positions of $315.6&#160;million, including interest and penalties, in connection with its international audits at December&#160;31, 2021. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reserve balance at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> reflects the impact of current year settlement payments. In connection with our international tax audits, it is possible that we will incur material losses above the amounts reserved.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s major U.S. state taxing jurisdictions remain open from fiscal year 2013 through 2020, with several state audits currently in progress. The Company&#8217;s major international taxing jurisdictions remain open from 2012 through 2020.</span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tax Court Proceedings </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's U.S. federal income tax returns for 2012 through 2014 had been subject to proceedings in U.S. Tax Court involving a dispute with the IRS regarding whether certain costs related to ANDAs were eligible to be expensed and deducted immediately or required to be amortized over longer periods. A trial was held in U.S. Tax Court in December 2018 and on April 27, 2021, the Court affirmed Mylan&#8217;s position and held that patent litigation expenses related to ANDAs are immediately deductible. The IRS has appealed this decision.</span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for Uncertainty in Income Taxes</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact of an uncertain tax position that is more likely than not of being sustained upon audit by the relevant taxing authority must be recognized at the largest amount that is more likely than not to be sustained. No portion of an uncertain tax position will be recognized if the position has less than a 50% likelihood of being sustained.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020, the Company&#8217;s consolidated balance sheets reflect net liabilities for unrecognized tax benefits of $322.9 million and $391.1 million, respectively, of which $230.2&#160;million as of December 31, 2021 would affect the Company&#8217;s effective tax rate if recognized, with the remainder being offset by potential correlative adjustments. Related accrued interest and penalties included in the consolidated balance sheets were $96.8 million and $86.7 million as of December&#160;31, 2021 and 2020, respectively. For the years ended December&#160;31, 2021, 2020 and 2019, the Company recognized $18.5 million of tax expense, $6.0 million, and $35.2 million of tax benefits, respectively, related to interest and penalties on uncertain tax positions. Interest and penalties related to income taxes are included in the tax provision.</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the unrecognized tax benefits is as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:68.006%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.712%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefit&#160;&#8212; beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions for current year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions for prior year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions for prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(112.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions due to expirations of statute of limitations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Reduction) addition due to acquisition</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefit&#160;&#8212; end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that it is reasonably possible that the amount of unrecognized tax benefits will decrease in the next twelve months by approximately $55.0 million, involving international and state audits and settlements and expiring statutes of limitations. The Company does not anticipate significant increases to the reserve within the next twelve months.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942903357560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Incentive Plan<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-Based Incentive Plan</a></td>
<td class="text">Share-Based Incentive Plan<div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Distribution, Viatris adopted and Pfizer, in the capacity as Viatris&#8217; sole stockholder at such time, approved the Plan (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Viatris Inc. 2020 Stock Incentive Plan) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which became effective as of the Distribution. In connection with the Combination, as of November 16, 2020, the Company assumed the 2003 LTIP (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mylan N.V. Amended and Restated 2003 Long-Term Incentive Plan)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which had previously been approved by Mylan shareholders. The Plan and 2003 LTIP include (i) 72,500,000 shares of Common Stock authorized for grant pursuant to the Plan, which may include dividend payments payable in Common Stock on unvested shares granted under awards, (ii) 6,757,640 shares of Common Stock to be issued pursuant to the exercise of outstanding stock options granted to participants under the 2003 LTIP and assumed by Viatris in connection with the Combination and (iii) 13,535,627 shares of Common Stock subject to outstanding equity-based awards, other than stock options, assumed by Viatris in connection with the Combination, or that otherwise remain available for issuance under the 2003 LTIP.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Plan and 2003 LTIP, shares are reserved for issuance to key employees, consultants, independent contractors and non-employee directors of the Company through a variety of incentive awards, including: stock options, SARs, restricted stock and units, PSUs, other stock-based awards and short-term cash awards. Stock option awards are granted with an exercise price equal to the fair market value of the shares underlying the stock options at the date of the grant, generally become exercisable over periods ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzE2Mjc_08ccde51-39fc-462c-a345-1572757200f2">three</span> to four years, and generally expire in ten years.</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock awards (stock options and SARs) activity under the Plan and 2003 LTIP:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:71.187%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.389%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.391%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of&#160;Shares<br/>Under Stock Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise&#160;Price<br/>per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2018</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,815,278&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.61&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">829,322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(580,950)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(715,941)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,347,709&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">814,351&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,615)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(422,714)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,711,731&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,135,241)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,576,490&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,487,788&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,969,602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, stock awards outstanding, stock awards vested and expected to vest and stock awards exercisable had average remaining contractual terms of 4.6 years, 4.6 years and 4.2 years, respectively. Also, at December&#160;31, 2021, stock awards outstanding, stock awards vested and expected to vest and stock awards exercisable had no aggregate intrinsic value.</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the status of the Company&#8217;s nonvested restricted stock awards (restricted stock and restricted stock unit awards, including PSUs), as of December&#160;31, 2020 and the changes during the year ended December&#160;31, 2021 are presented below:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:65.029%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.468%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.470%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of&#160;Restricted<br/>Stock Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Grant-Date<br/>Fair&#160;Value&#160;Per&#160;Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,073,790&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,850,443&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Released</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,168,152)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,897,953)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,858,128&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Of the 9,850,443 restricted stock awards granted during the year ended December&#160;31, 2021, 6,057,602 vest ratably in three years or less and are not subject to market or performance conditions. Of the remaining restricted stock awards granted, 587,025 are not subject to market conditions and will cliff vest within a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzI2NDI_f3b767c1-16ad-4e4f-bd76-18f9bc8ce9a6">three</span>-year period, and 3,205,816 are subject to market or performance conditions and will cliff vest in <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzEyNjQ0MzgzNzI3MzQ5_f3b767c1-16ad-4e4f-bd76-18f9bc8ce9a6">three</span> years or less.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company had $143.1 million of total unrecognized compensation expense, net of estimated forfeitures, related to all of its stock-based awards, which we expect to recognize over the remaining weighted average vesting period of 1.7 years. The total intrinsic value of stock awards exercised and restricted stock units released during the years ended December&#160;31, 2021 and 2020 was $78.1 million and $20.9 million, respectively.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to options granted under the Plan and 2003 LTIP, the fair value of each option grant was estimated at the date of grant using the Black-Scholes option pricing model. Black-Scholes utilizes assumptions related to volatility, the risk-free interest rate, the dividend yield and employee exercise behavior. Expected volatilities utilized in the model are based mainly on the implied volatility of the Company&#8217;s stock price and other factors. The risk-free interest rate is derived from the U.S.&#160;Treasury yield curve in effect at the time of grant. The model incorporates exercise and post-vesting forfeiture assumptions based on an analysis of historical data. The expected lives of the grants are derived from historical and other factors.</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no options granted during the year ended December 31, 2021. The assumptions used for options granted under the Plan and 2003 LTIP during the years ended December 31, 2020 and 2019, respectively, are as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.578%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.697%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.7%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.1%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeiture rate </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average grant date fair value per option</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$8.07</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$11.03</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942903166680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Employee Benefits</a></td>
<td class="text">Employee Benefit Plans<div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Defined Benefit Plans</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sponsors various defined benefit pension plans in several countries. Benefits provided generally depend on length of service, pay grade and remuneration levels. Employees in the U.S., Puerto Rico and certain international locations are also provided retirement benefits through defined contribution plans.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also sponsors other postretirement benefit plans including plans that provide for postretirement supplemental medical coverage. Benefits from these plans are provided to employees and their spouses and dependents who meet various minimum age and service requirements. In addition, the Company sponsors other plans that provide for life insurance benefits and postretirement medical coverage for certain officers and management employees.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Combination, the Company assumed certain post retirement defined benefit pension plans sponsored by Upjohn. The most significant plans include those in Puerto Rico, Ireland and Japan. Upjohn is also the sponsor of one postretirement medical plan in Puerto Rico. As part of the acquisition accounting, the Company has recorded the fair value of these plans. Upon completion of the Combination, the excess of projected benefit obligation over the plan assets was recognized as a liability and any existing unrecognized actuarial gains or losses and unrecognized service costs or benefits were eliminated in purchase accounting.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for Defined Benefit Pension and Other Postretirement Plans</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes on its balance sheet an asset or liability equal to the over- or under-funded benefit obligation of each defined benefit pension and other postretirement plan. Actuarial gains or losses and prior service costs or credits that arise during the period are not recognized as components of net periodic benefit cost, but are recognized, net of tax, as a component of other comprehensive (loss) earnings.</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in accumulated other comprehensive loss as of December&#160;31, 2021 and 2020 are:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:53.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Postretirement Benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized actuarial (gain) loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized prior service cost (credit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unrecognized net actuarial losses exceeded&#160;10%&#160;of the higher of the market value of plan assets or the projected benefit obligation at the beginning of the year for certain of the plans, therefore, amortization of such excess has been included in net periodic benefit costs for pension and other postretirement benefits in each of the last three years. The amortization period is the average remaining service period that active employees are expected to receive benefits, unless a plan is mostly inactive in which case the amortization period is the average remaining life expectancy of the plan participants. Unrecognized prior service cost is amortized over the future service periods of those employees who are active at the dates of the plan amendments and who are expected to receive benefits. If all or almost all of a plan's participants are inactive, unrecognized prior service cost is amortized over the remaining life expectancy of those participants. The increase in accumulated other comprehensive loss in 2021 relating to pension benefits and other postretirement benefits consists of:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:75.879%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.043%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.045%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Postretirement Benefits</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized actuarial (gain) loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial gain/(loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized prior service credit (cost)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of net periodic benefit cost, change in projected benefit obligation, change in plan assets, funded status, fair value of plan assets, assumptions used to determine net periodic benefit cost, funding policy and estimated future benefit payments are summarized below for the Company&#8217;s pension plans and other postretirement plans.</span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Periodic Benefit Cost</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of net periodic benefit cost for the years ended December&#160;31, 2021, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:30.858%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.503%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.655%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Postretirement Benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan curtailment, settlement and termination</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized net actuarial losses (gains) </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2021, the Company recognized a settlement gain as a result of cash payments from lump sum elections related to the U.S. and Puerto Rico pension plans.</span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Change in Projected Benefit Obligation, Change in Plan Assets and Funded Status</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents components of the change in projected benefit obligation, change in plan assets and funded status at December&#160;31, 2021 and 2020.</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:53.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Postretirement Benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in Projected Benefit Obligation</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligation, beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,145.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participant contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,389.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan settlements and terminations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(128.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial (gains) losses </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligation, end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,946.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,145.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in Plan Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets, beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,354.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Company contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participant contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">959.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(128.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets, end of year</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,366.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,354.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status of plans</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(580.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(791.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net accrued benefit costs for pension plans and other postretirement benefits are reported in the following components of the Company&#8217;s consolidated balance sheets at December&#160;31, 2021 and 2020:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:53.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Postretirement Benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(682.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(846.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net accrued benefit costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(580.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(791.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188.4)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The projected benefit obligation is the actuarial present value of benefits attributable to employee service rendered to date, including the effects of estimated future pay increases. The accumulated benefit obligation is the actuarial present value of benefits attributable to employee service rendered to date, but does not include the effects of estimated future pay increases.&#160;The accumulated benefit obligation for the Company&#8217;s pension plans was $1.86 billion and $2.04 billion at December&#160;31, 2021 and 2020, respectively.</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The projected benefit obligation, accumulated benefit obligation and fair value of plan assets for pension plans with an accumulated benefit obligation in excess of the fair value of plan assets at December&#160;31, 2021 and 2020 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:78.078%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.019%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Plans with accumulated benefit obligation in excess of plan assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,591.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,747.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated benefit obligation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,546.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,678.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">904.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">893.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value of Plan Assets</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures the fair value of plan assets based on the prices that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value measurements are based on a three-tier hierarchy described in Note 9 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments and Risk Management</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The table below presents total plan assets by investment category as of December&#160;31, 2021&#160;and&#160;2020&#160;and the classification of each investment category within the fair value hierarchy with respect to the inputs used to measure fair value:</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:53.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">551.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held by insurance companies and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">946.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,366.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:53.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">613.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">592.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held by insurance companies and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">788.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,354.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk tolerance on invested pension plan assets is established through careful consideration of plan liabilities, plan funded status and corporate financial condition. Investment risk is measured and monitored on an ongoing basis through annual liability measures, periodic asset/liability studies and investment portfolio reviews. The Company&#8217;s investment strategy is to maintain, where possible, a diversified investment portfolio across several asset classes that, when combined with the Company&#8217;s contributions to the plans, will ensure that required benefit obligations are met.</span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assumptions</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following weighted average assumptions were used to determine the benefit obligations for the Company&#8217;s defined benefit pension and other postretirement plans as of December&#160;31, 2021&#160;and&#160;2020:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.609%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.034%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Postretirement Benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following weighted average assumptions were used to determine the net periodic benefit cost for the Company&#8217;s defined benefit pension and other postretirement benefit plans for the three years in the period ended&#160;December&#160;31, 2021:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:35.170%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.035%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Postretirement Benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assumptions for each plan are reviewed on an annual basis. The discount rate reflects the current rate at which the pension and other benefit liabilities could be effectively settled at the measurement date. In setting the discount rates, we utilize comparable corporate bond indices as an indication of interest rate movements and levels. Corporate bond indices were selected based on individual plan census data and duration. The expected return on plan assets was determined using historical market returns and long-term historical relationships between equities and fixed income securities. The Company compares the expected return on plan assets assumption to actual historic returns to ensure reasonableness. Current market factors such as inflation and interest rates are also evaluated. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average healthcare cost trend rate used for&#160;2021&#160;was&#160;5.7%&#160;declining to a projected&#160;4.5%&#160;in the year&#160;2037. For&#160;2022, the assumed weighted-average healthcare cost trend rate used will be&#160;6.3%&#160;declining to a projected&#160;4.0%&#160;in the year&#160;2045. In selecting rates for current and long-term healthcare cost assumptions, the Company takes into consideration a number of factors including the Company&#8217;s actual healthcare cost increases, the design of the Company&#8217;s benefit programs, the demographics of the Company&#8217;s active and retiree populations and external expectations of future medical cost inflation rates.</span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Estimated Future Benefit Payments</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s funding policy for its funded pension plans is based upon&#160;local statutory requirements. The Company&#8217;s funding policy is subject to certain statutory regulations with respect to annual minimum and maximum company contributions. Plan benefits for the non-qualified plans are paid as they come due. </span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated benefit payments over the next ten years for the Company&#8217;s pension plans and retiree health plan are as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:75.879%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.043%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.045%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Postretirement Benefits</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,035.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Defined Contribution Plans</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sponsors defined contribution plans covering its employees in the U.S. and Puerto Rico, as well as certain employees in a number of countries outside the U.S.&#160;The Company&#8217;s domestic defined contribution plans consist primarily of a Profit Sharing 401(k) Plan and a 401(k) retirement plan for union-represented employees. Profit sharing contributions are made at the discretion of the Board of Directors. The Company&#8217;s non-domestic plans vary in form depending on local legal requirements. The Company&#8217;s contributions are based upon employee contributions, service hours, or pre-determined amounts depending upon the plan. Obligations for contributions to defined contribution plans are recognized as expense in the consolidated statements of operations when they are earned.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a 401(k) Restoration Plan, which permits employees who earn compensation in excess of the limits imposed by Section&#160;401(a)(17) of the Code to (i)&#160;defer a portion of base salary and bonus compensation, (ii)&#160;be credited with a Company matching contribution in respect of deferrals under the Restoration Plan, and (iii)&#160;be credited with Company non-elective contributions (to the extent so made by the Company), in each case, to the extent that participants otherwise would be able to defer or be credited with such amounts, as applicable, under the Profit Sharing 401(k) Plan if not for the limits on contributions and deferrals imposed by the Code.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains an Income Deferral Plan, which permits certain management or highly compensated employees who are designated by the plan administrator to participate in the Income Deferral Plan to elect to defer up to 50% of base salary and up to 100% of bonus compensation, in each case, in addition to any amounts that may be deferred by such participants under the Profit Sharing 401(k) Plan and the Restoration Plan. In addition, under the Income Deferral Plan, eligible participants may be granted employee deferral awards, which awards will be subject to the terms and conditions (including vesting) as determined by the plan administrator at the time such awards are granted.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total employer contributions to defined contribution plans were approximately $107.4 million, $115.5 million and $95.6 million for the years ended December&#160;31, 2021, 2020 and 2019, respectively.</span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Benefit Arrangements</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company participated in a multi-employer pension plan under previous collective bargaining agreements. The PACE Industry Union-Management Pension Fund (the &#8220;PACE Plan&#8221;) provides defined benefits to certain retirees and certain production and maintenance employees at the Company&#8217;s manufacturing plant in Morgantown, West Virginia who were covered by the previous collective bargaining agreements. Pursuant to a collective bargaining agreement entered into on April 16, 2012, the Company withdrew from the PACE Plan effective May 10, 2012. In 2013, the PACE Plan trustee notified the Company that its withdrawal liability was approximately $27.3 million, which was accrued by the Company in 2013. The withdrawal liability is being paid over a period of approximately nine years; payments began in March 2014. The withdrawal liability was approximately $5.5 million and $8.9 million at December&#160;31, 2021 and 2020, respectively. The Employer Identification Number for the PACE Plan is 11-6166763.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942903292744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Information</a></td>
<td class="text">ment Information<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Viatris has four reportable segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The Company reports segment information on the basis of markets and geography, which reflects its focus on bringing its broad and diversified portfolio of branded, complex generics and biosimilars, and generic products to people in markets everywhere. Our Developed Markets segment comprises our operations primarily in North America and Europe. Our Greater China segment includes our operations in China, Taiwan and Hong Kong. Our JANZ segment reflects our operations in Japan, Australia and New Zealand. Our Emerging Markets segment encompasses our presence in more than 125 countries with developing markets and emerging economies including in Asia, Africa, Eastern Europe, Latin America and the Middle East as well as the Company&#8217;s ARV franchise. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s chief operating decision maker is the Chief Executive Officer, who evaluates the performance of its segments based on total revenues and segment profitability.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain costs are not included in the measurement of segment profitability, such as costs, if any, associated with the following:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Intangible asset amortization expense and impairments of intangible assets;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">R&amp;D expense;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Net charges or net gains for litigation settlements and other contingencies;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Certain costs related to transactions and events such as (i) purchase accounting adjustments, where we incur expenses associated with the amortization of fair value adjustments to inventory and property, plant and equipment; (ii) acquisition-related costs, where we incur costs for executing the transaction, integrating the acquired operations and restructuring the combined company; and (iii) other significant items, which are substantive and/or unusual, and in some cases recurring, items (such as restructuring) that are evaluated on an individual basis by management and that either as a result of their nature or size, would not be expected to occur as part of our normal business on a regular basis. Such special items can include, but are not limited to, non-acquisition-related restructuring costs, as well as costs incurred for asset impairments and disposals of assets or businesses, including, as applicable, any associated transition activities. </span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Corporate and other unallocated costs associated with platform functions (such as digital, facilities, legal, finance, human resources, insurance, public affairs and procurement), patient advocacy activities and certain compensation and other corporate costs (such as interest income and expense, and gains and losses on investments, as well as overhead expenses associated with our manufacturing, which include manufacturing variances associated with production) and operations that are not directly assessed to an operating segment as business unit (segment) management does not manage these costs.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not report depreciation expense, total assets and capital expenditures by segment, as such information is not used by the chief operating decision maker. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accounting policies of the segments are the same as those described in Note&#160;2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Presented in the table below is segment information for the periods identified and a reconciliation of segment information to total consolidated information.</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.702%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="15" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="15" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Segment Profitability</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31, </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31, </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reportable Segments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed Markets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,428.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,510.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,240.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,143.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,243.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,137.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater China</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,212.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,397.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JANZ</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,027.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,195.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,192.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">762.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Markets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,144.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,853.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,723.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,402.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">561.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reportable segments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,813.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,819.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,370.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,705.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,271.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,112.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reconciling items:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset amortization expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,702.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,605.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,582.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset impairment charges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(180.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Globally managed research and development costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(751.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(555.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(639.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation settlements &amp; other contingencies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(329.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(107.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction related and other special items</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,832.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,739.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(682.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and other unallocated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,021.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,391.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,332.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) earnings from operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34.0)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(210.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the percentage of consolidated net sales to Viatris&#8217; major customers during the years ended December&#160;31, 2021, 2020, and 2019:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:65.272%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage of Consolidated Net Sales</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson Corporation</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AmerisourceBergen Corporation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health, Inc.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sales by Country Information</span></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales by country are presented on the basis of geographic location of our subsidiaries: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:65.272%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,176.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,746.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,965.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,981.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div>No other country&#8217;s net sales represents more than 10% of consolidated net sales.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942989551592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring and Related Activities Disclosure [Text Block]</a></td>
<td class="text">Restructuring <div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2020 Restructuring Program</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the fourth quarter of 2020, Viatris announced a significant global restructuring program in order to achieve synergies and ensure that the organization is optimally structured and efficiently resourced to deliver sustainable value to patients, shareholders, customers, and other stakeholders. Viatris&#8217; restructuring initiative incorporates and expands on the restructuring program announced by Mylan N.V. earlier in 2020 as part of its business transformation efforts. As part of the restructuring, the Company is optimizing its commercial capabilities and enabling functions, and closing, downsizing or divesting certain manufacturing facilities globally that are deemed to be no longer viable either due to surplus capacity, challenging market dynamics or a shift in its product portfolio toward more complex products. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the committed restructuring actions, the Company expects to incur total pre-tax charges of up to approximately $1.4&#160;billion. Such charges are expected to include up to approximately $450&#160;million of non-cash charges mainly related to accelerated depreciation and asset impairment charges, including inventory write-offs. The remaining estimated cash costs of up to approximately $950&#160;million are expected to be primarily related to severance and employee benefits expense, as well as other costs, including those related to contract terminations and other plant disposal costs. In addition, management believes the potential annual savings related to these committed restructuring activities to be up to approximately $900&#160;million once fully implemented, with most of these savings expected to improve operating cash flow.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the restructuring charges and the reserve activity for the 2020 restructuring program:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:68.006%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.712%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Related Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Exit Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired in the Combination</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utilization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">892.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reimbursable restructuring charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(385.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(537.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utilization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(345.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(345.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As part of the Combination, the Company acquired reserve balances related to restructuring activities initiated by the Upjohn Business prior to the Combination, primarily related to accrued severance. </span></div><div style="text-indent:24.5pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">2016 Restructuring Program</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mylan previously announced a restructuring program representing a series of actions in certain locations to further streamline its operations globally. We incurred total restructuring related costs of approximately $733.0&#160;million through December 31, 2020. The 2016 Restructuring Program was substantially completed at December 31, 2020. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2018, the FDA completed an inspection at Mylan&#8217;s plant in Morgantown, West Virginia and made observations through a Form 483. In the fourth quarter of 2018, Mylan received a warning letter related to the previously disclosed observations at the plant. The issues raised in the warning letter were addressed within the context of the Mylan&#8217;s comprehensive restructuring and remediation activities. On May 11, 2020, Mylan received the close-out of the warning letter. On December 11, 2020, the Company announced that it expects the Morgantown plant to be closed or divested as part of the 2020 Restructuring Program. The Morgantown plant was closed during the third quarter of 2021.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the restructuring charges and the reserve activity for the 2016 restructuring program from December 31, 2018 to December 31, 2020:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:68.006%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.712%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Related Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Exit Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2018:</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utilization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019:</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utilization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020:</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;For the year ended December&#160;31, 2021, total restructuring charges for the 2020 Restructuring Program, in Developed Markets, Greater China, JANZ, Emerging Markets, and Corporate/Other were approximately $623.8 million, $5.8 million, $138.1 million, $94.1 million, and $30.4 million, respectively. </span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;For the year ended December&#160;31, 2020, total restructuring charges, for both programs, in Developed Markets, Greater China, JANZ, and Emerging Markets were approximately $292.1 million, $18.4 million, $2.9 million, and $8.4 million, respectively. </span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;For the year ended December 31, 2019, total restructuring charges for the 2016 Restructuring Program in Developed Markets and JANZ were approximately $100.4&#160;million and $4.2&#160;million, respectively.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 2020, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">accrued liabilities for restructuring and other cost reduction programs were primarily included in other current liabilities and other long-term obligations in the consolidated balance sheets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI http://asc.fasb.org/topic&amp;trid=2175745<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942903196168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Valuation and Qualifying Accounts<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsAbstract', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock', window );">Schedule II - Valuation and Qualifying Accounts</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIATRIS INC. AND SUBSIDIARIES</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE&#160;II&#160;&#8212; VALUATION AND QUALIFYING ACCOUNTS</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">(In millions)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.935%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.578%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Beginning<br/>Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additions Charged to Costs and Expenses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additions Charged to Other<br/>Accounts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deductions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ending<br/>Balance</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2021</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2019</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance for deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2021</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">780.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">603.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(198.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2019</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">806.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(239.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">603.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 09<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942898624408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation Policy</a></td>
<td class="text">Principles of Consolidation.&#160;The consolidated financial statements include the accounts of Viatris and those of its wholly owned and majority-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. Investments in equity method affiliates are recorded at cost and adjusted for the Company&#8217;s share of the affiliates&#8217; cumulative results of operations, capital contributions and distributions.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates in the Preparation of Financial Statements Policy</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates in the Preparation of Financial Statements.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The preparation of financial statements, in conformity with U.S. GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Because of the uncertainty inherent in such estimates, actual results could differ from those estimates.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currencies Policy</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currencies.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The consolidated financial statements are presented in U.S.&#160;Dollars, the reporting currency of Viatris. Statements of Operations and Cash Flows of all of the Company&#8217;s subsidiaries that have functional currencies other than U.S.&#160;Dollars are translated at a weighted average exchange rate for the period for inclusion in the consolidated statements of operations and cash flows, whereas assets and liabilities are translated at the end of the period exchange rates for inclusion in the consolidated balance sheets. Translation differences are recorded directly in shareholders&#8217; equity as foreign currency translation adjustments. Gains or losses on transactions denominated in a currency other than the subsidiaries&#8217; functional currency, which arise as a result of changes in foreign currency exchange rates, are recorded in the consolidated statements of operations.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents Policy</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Cash and cash equivalents are comprised of highly liquid investments with an original maturity of three months or less at the date of purchase.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Marketable Securities Policy</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt and Equity Securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Debt securities classified as available-for-sale on the date of purchase are recorded at fair value, with net unrealized gains and losses, net of income taxes, reflected in accumulated other comprehensive loss as a component of shareholders&#8217; equity. Net realized gains and losses on sales of available-for-sale debt securities are computed on a specific security basis and are included in other expense, net, in the consolidated statements of operations. Debt securities classified as trading securities are valued using the quoted market price from broker or dealer quotations or transparent pricing sources at the reporting date, with gains and losses included in other expense, net, in the consolidated statements of operations. Fair value is determined based on observable market quotes or valuation models using assessments of counterparty credit worthiness, credit risk or underlying security and overall capital market liquidity. Debt securities are reviewed for impairment by assessing if the decline in market value of the investment below the carrying value is other than temporary.</span>Investments in equity securities with readily determinable fair values are recorded at fair value with changes in fair value recorded in other expense, net in the consolidated statements of operations. Investments in equity securities without readily determinable fair values are recorded at cost minus any impairment, plus or minus changes in their estimated fair value resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. Investments in entities are accounted for using the equity method of accounting when the ability to exercise significant influence over the operating and financial decisions of the investee is maintained. The share of net income or losses of equity method investments are included in other expense, net in the consolidated statements of operations. Investments in equity securities without readily determinable fair values and investments in equity accounted for using the equity method are assessed for potential impairment on a quarterly basis based on qualitative factors.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations of Credit Risk Policy</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Financial instruments that potentially subject the Company to credit risk consist principally of interest-bearing investments, derivatives and accounts receivable.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Viatris invests its excess cash in high-quality, liquid money market instruments, principally overnight deposits and highly rated money market funds. The Company maintains deposit balances at certain financial institutions in excess of federally insured amounts. Periodically, the Company reviews the creditworthiness of its counterparties to derivative transactions, and it does not expect to incur a loss from failure of any counterparties to perform under agreements it has with such counterparties.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories Policy</a></td>
<td class="text">Inventories.&#160;Inventories are stated at the lower of cost and net realizable value, with cost principally determined by the weighted average cost method. Provisions for potentially obsolete or slow-moving inventory, including pre-launch inventory, are made based on our analysis of product dating, inventory levels, historical obsolescence and future sales forecasts. Included as a component of cost of sales is expense related to the net realizable value of inventories.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant and Equipment Policy</a></td>
<td class="text">Property, Plant and Equipment.&#160;Property, plant and equipment are stated at cost less accumulated depreciation. Depreciation is computed and recorded on a straight-line basis over the assets&#8217; estimated service lives (3 to 18 years for machinery and equipment and other fixed assets and 15 to 39 years for buildings and improvements). Capitalized software is included in property, plant and equipment and is amortized over estimated useful lives ranging from 3 to 7 years.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Intangible Assets and Goodwill Policy</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets and Goodwill.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Intangible assets are stated at cost less accumulated amortization. Amortization is generally recorded on a straight-line basis over estimated useful lives ranging from 3 to 20 years. The Company periodically reviews the estimated useful lives of intangible assets and makes adjustments when events indicate that a shorter life is appropriate.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for acquired businesses using the acquisition method of accounting in accordance with the provisions of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC 805, Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which requires that the assets acquired and liabilities assumed be recorded at the date of acquisition at their respective estimated fair values. The cost to acquire businesses is allocated to the underlying net assets of the acquired business based on estimates of their respective fair values. Amounts allocated to acquired IPR&amp;D are capitalized at the date of acquisition and, at that time, such IPR&amp;D assets have indefinite lives. As products in development are approved for sale, amounts are allocated to product rights and licenses and will be amortized over their estimated useful lives. Finite-lived intangible assets are amortized over the expected life of the asset. Any excess of the purchase price over the estimated fair values of the net assets acquired is recorded as goodwill.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchases of developed products and licenses that are accounted for as asset acquisitions are capitalized as intangible assets and amortized over an estimated useful life. IPR&amp;D assets acquired as part of an asset acquisition are expensed immediately if they have no alternative future uses.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews goodwill for impairment at least annually or more frequently if events or changes in circumstances indicate that the carrying value of goodwill may not be recoverable based on management's assessment of the fair value of the Company's reporting units as compared to their related carrying value. Under the authoritative guidance issued by the FASB, we have the option to first assess the qualitative factors to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform a quantitative goodwill impairment test. If we choose to use qualitative factors and determine that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, then the goodwill impairment test would be required. The goodwill impairment test requires the Company to estimate the fair value of the reporting unit and to compare the fair value of the reporting unit with its carrying amount. If the carrying amount is less than its fair value, then no impairment is recognized. If the carrying amount recorded exceeds the fair value calculated, an impairment charge is recorded for the difference. The judgments made in determining the projected cash flows used to estimate the fair value can materially impact the Company&#8217;s financial condition and results of operations. </span></div>Indefinite-lived intangibles, principally IPR&amp;D, are tested at least annually for impairment or upon the occurrence of a triggering event. The impairment test for IPR&amp;D consists of a comparison of the asset&#8217;s fair value with its carrying value. Impairment is determined to exist when the fair value of IPR&amp;D assets, which is based upon updated forecasts and commercial development plans, is less than the carrying value of the assets being tested.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">Contingent Consideration Policy</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Consideration.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Viatris records contingent consideration resulting from business acquisitions at its estimated fair value on the acquisition date. Each reporting period thereafter, the Company revalues these obligations and records increases or decreases in their fair value as adjustments to litigation settlements and other contingencies, net within the consolidated statements of operations. Changes in the fair value of the contingent consideration obligations can result from adjustments to the discount rates, payment periods and adjustments in the probability of achieving future development steps, regulatory approvals, market launches, sales targets and profitability. These fair value measurements represent Level 3 measurements as they are based on significant inputs not observable in the market. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant judgment is employed in determining the assumptions utilized as of the acquisition date and for each subsequent measurement period. Accordingly, changes in the assumptions described above could have a material impact on the Company&#8217;s consolidated financial condition and results of operations.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets Policy</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment of Long-Lived Assets.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The carrying values of long-lived assets, which include property, plant and equipment and intangible assets with finite lives, are evaluated periodically in relation to the expected future undiscounted cash flows of the underlying assets and monitored for other potential triggering events. The assessment for impairment is based on our ability to recover the carrying value of the long-lived assets or asset grouping by analyzing the expected future undiscounted pre-tax cash flows specific to the asset or asset grouping. If the carrying amount is greater than the undiscounted cash flows, the Company recognizes an impairment loss for the excess of the carrying amount over the estimated fair value based on discounted cash flows.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant management judgment is involved in estimating the recoverability of these assets and is dependent upon the accuracy of the assumptions used in making these estimates, as well as how the estimates compare to the eventual future operating performance of the specific asset or asset grouping. Any future long-lived assets impairment charges could have a material impact on the Company&#8217;s consolidated financial condition and results of operations.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Policy</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;R&amp;D expenses are charged to operations as incurred.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtPolicyTextBlock', window );">Short-Term Borrowings</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-Term Borrowings.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The Company&#8217;s subsidiaries in India have working capital facilities with several banks which are secured by its current assets. The Company also has the CP Notes, Receivables Facility, which will expire in April 2022 and the Note Securitization Facility, which will expire in August 2022. Under the terms of each of the Receivables Facility and Note Securitization Facility, certain of our accounts receivable secure the amounts borrowed and cannot be used to pay our other debts or liabilities. As the accounts receivable do not transfer to the banks, any amounts outstanding under the facilities are recorded as borrowings and the underlying receivables continue to be included in accounts receivable, net, in the consolidated balance sheets.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition Policy</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenues in accordance with ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Under ASC 606, the Company recognizes net revenue for product sales when control of the promised goods or services is transferred to our customers in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. Revenues are recorded net of provisions for variable consideration, including discounts, rebates, governmental rebate programs, price adjustments, returns, chargebacks, promotional programs and other sales allowances. Accruals for these provisions are presented in the consolidated financial statements as reductions in determining net sales and as a contra asset in accounts receivable, net (if settled via credit) and other current liabilities (if paid in cash). Amounts recorded for revenue deductions can result from a complex series of judgements about future events and uncertainties and can rely heavily on estimates and assumptions. The following section briefly describes the nature of our provisions for variable consideration and how such provisions are estimated:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Chargebacks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: the Company has agreements with certain indirect customers, such as independent pharmacies, retail pharmacy chains, managed care organizations, hospitals, nursing homes, governmental agencies and pharmacy benefit managers, which establish contract prices for certain products. The indirect customers then independently select a wholesaler from which to purchase the products at these contracted prices. Alternatively, certain wholesalers may enter into agreements with indirect customers that establish contract pricing for certain products, which the wholesalers provide. Under either arrangement, Viatris will provide credit to the wholesaler for any difference between the contracted price with the indirect party and the wholesaler&#8217;s invoice price. Such credits are called chargebacks. The provision for chargebacks is based on expected sell-through levels by our wholesaler customers to indirect customers, as well as estimated wholesaler inventory levels.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Rebates, promotional programs and other sales allowances</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: this category includes rebate and other programs to assist in product sales. These programs generally provide that the customer receives credit directly related to the amount of purchases or credits upon the attainment of pre-established volumes. Also included in this category are prompt pay discounts, administrative fees and price adjustments to reflect decreases in the selling prices of products. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Returns</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: consistent with industry practice, Viatris maintains a return policy that allows customers to return a product, which varies country by country in accordance with local practices, generally within a specified period prior (six months) and subsequent (twelve months) to the expiration date. The Company&#8217;s estimate of the provision for returns is generally based upon historical experience with actual returns. Generally, returned products are destroyed and customers are refunded the sales price in the form of a credit.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Governmental rebate programs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: government reimbursement programs in the U.S. include Medicare, Medicaid, and State Pharmacy Assistance Programs established according to statute, regulations and policy. Manufacturers of pharmaceutical products that are covered by the Medicaid program are required to pay rebates to each state based on a statutory formula set forth in the Social Security Act. Medicare beneficiaries are eligible to obtain discounted prescription drug coverage from private sector providers. In addition, certain states have also implemented supplemental rebate programs that obligate manufacturers to pay rebates in excess of those required under federal law. Our estimate of these rebates is based on the historical trends of rebates paid as well as on changes in wholesaler inventory levels and increases or decreases in the level of sales. We estimate discounts on branded prescription drug sales to Medicare Part D participants in the Medicare &#8220;coverage gap&#8221; based on historical experience of prescriptions and utilization expected to result in the discount of the &#8220;coverage gap&#8221;.</span></div><div style="margin-bottom:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outside the U.S., the majority of our pharmaceutical sales are contractually or legislatively governed. In certain European countries, certain rebates are calculated on the governments total pharmaceutical spending or on specific product sale thresholds. We utilize historical data and obtain third party information to determine the adequacy of these accruals. Also, this provision includes price reductions that are mandated by law outside of the U.S. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our net sales may be impacted by wholesaler and distributor inventory levels of our products, which can fluctuate throughout the year due to the seasonality of certain products, pricing, the timing of product demand, purchasing decisions and other factors. Such fluctuations may impact the comparability of our net sales between periods.</span></div>Consideration received from licenses of intellectual property is recorded as other revenues. Royalty or profit share amounts, which are based on sales of licensed products or technology, are recorded when the customer&#8217;s subsequent sales or usages occur. Such consideration is included in other revenues in the consolidated statements of operations.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes Policy</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Income taxes have been provided for using an asset and liability approach in which deferred income taxes reflect the tax consequences on future years of events that the Company has already recognized in the financial statements or tax returns. Changes in enacted tax rates or laws may result in adjustments to the recorded tax assets or liabilities in the period that the new tax law is enacted.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Common Share Policy</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Earnings per Share.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Basic earnings per share is computed by dividing net earnings attributable to holders of Viatris Inc. common stock by the weighted average number of shares outstanding during the period. Diluted earnings per share is computed by dividing net earnings attributable to holders of Viatris Inc. common stock by the weighted average number of shares outstanding during the period increased by the number of additional shares that would have been outstanding related to potentially dilutive securities or instruments, if the impact is dilutive.</span><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted earnings per share attributable to Viatris Inc. are calculated as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.261%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions, except per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Basic (loss) earnings attributable to Viatris Inc. common shareholders (numerator):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) earnings attributable to Viatris Inc. common shareholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,269.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(669.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares (denominator):</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,208.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic (loss) earnings per share attributable to Viatris Inc. shareholders</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.05)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.11)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Diluted (loss) earnings attributable to Viatris Inc. common shareholders (numerator):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) earnings attributable to Viatris Inc. common shareholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,269.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(669.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares (denominator):</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,208.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total dilutive shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,208.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted (loss) earnings per share attributable to Viatris Inc. shareholders</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.05)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.11)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average shares outstanding used in the computation of earnings per share for the year ended December 31, 2020 includes the effect of the 689.9 million shares issued for the closing of the Combination.</span></div>Additional stock awards and restricted ordinary shares were outstanding during the years ended December&#160;31, 2021, 2020 and 2019 but were not included in the computation of diluted earnings per share for each respective period because the effect would be anti-dilutive. Excluded shares also include certain share-based compensation awards and restricted shares whose performance conditions had not been fully met. Such excluded shares and anti-dilutive awards represented 12.7 million, 10.3 million and 9.1 million shares for the years ended December&#160;31, 2021, 2020 and 2019, respectively<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation Policy</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The fair value of share-based compensation is recognized as expense in the consolidated statements of operations over the vesting period.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivatives Policy</a></td>
<td class="text">Derivatives.&#160;From time to time the Company may enter into derivative financial instruments (mainly foreign currency exchange forward contracts, interest rate swaps and purchased equity call options) designed to: 1) hedge the cash flows resulting from existing assets and liabilities and transactions expected to be entered into over the next 24 months in currencies other than the functional currency, 2) hedge the variability in interest expense on floating rate debt, 3) hedge the fair value of fixed-rate notes, 4) hedge against changes in interest rates that could impact future debt issuances, 5) hedge cash or share payments required on conversion of issued convertible notes, 6) hedge a net investment in a foreign operation, or 7) economically hedge the foreign currency exposure associated with the purchase price of non-U.S. acquisitions. Derivatives are recognized as assets or liabilities in the consolidated balance sheets at their fair value. When the derivative instrument qualifies as a cash flow hedge, changes in the fair value are deferred through other comprehensive earnings. If a derivative instrument qualifies as a fair value hedge, the changes in the fair value, as well as the offsetting changes in the fair value of the hedged items, are generally included in interest expense. When such instruments do not qualify for hedge accounting the changes in fair value are recorded in the consolidated statements of operations within other expense, net<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Financial Instruments Policy</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instruments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The Company&#8217;s financial instruments consist primarily of short-term and long-term debt, interest rate swaps, forward contracts and option contracts. The Company&#8217;s financial instruments also include cash and cash equivalents as well as accounts and other receivables and accounts payable, the fair values of which approximate their carrying values. As a policy, the Company does not engage in speculative or leveraged transactions.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company carries derivative instruments in the consolidated balance sheets at fair value, determined by reference to market data such as forward rates for currencies, implied volatilities, and interest rate swap yield curves. The accounting for changes in the fair value of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and, if so, the reason for holding&#160;it. In addition, the Company has designated certain long-term debt instruments as net investment hedges.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is based on the price that would be received from the sale of an identical asset or paid to transfer an identical liability in an orderly transaction between market participants at the measurement date. In order to increase consistency and comparability in fair value measurements, a fair value hierarchy has been established that prioritizes observable and unobservable inputs used to measure fair value into three broad levels, which are described below:</span></div><div style="margin-bottom:6pt;padding-left:81pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level&#160;1:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities. The fair value hierarchy gives the highest priority to Level&#160;1 inputs.</span></div><div style="margin-bottom:6pt;padding-left:81pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level&#160;2:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Observable market-based inputs other than quoted prices in active markets for identical assets or liabilities.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level&#160;3:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level&#160;3 inputs.</span>In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible, as well as considers counterparty credit risk in its assessment of fair value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adoption of New Accounting Standards</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued Accounting Standards Update 2020-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Clarifying the Interactions Between Topic 321, Topic 323, and Topic 815 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2020-01&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which clarifies that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting for the purposes of applying the measurement alternative in accordance with Topic 321 immediately before applying or upon discontinuing the equity method. In addition, ASU 2020-01 states that for the purpose of applying paragraph 815-10-15-141(a) an entity should not consider whether, upon the settlement of the forward contract or exercise of the purchased option, individually or with existing investments, the underlying securities would be accounted for under the equity method in Topic 323 or the fair value option in accordance with the financial instruments guidance in Topic 825. The Company applied the provisions of ASU 2020-01 as of January 1, 2021. The adoption of this guidance did not have a material impact on the Company&#8217;s consolidated financial statements and disclosures. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued Accounting Standards Update 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which is intended to simplify the accounting for income taxes by eliminating certain exceptions and simplifying certain requirements under Topic 740. The Company applied the provisions of ASU 2019-12 on a prospective basis as of January 1, 2021. The adoption of this guidance did not have a material impact on the Company&#8217;s consolidated financial statements and disclosures.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting Standards Issued Not Yet Adopted&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued Accounting Standards Update 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform on Financial Reporting </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2020-04&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which provides optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. ASU 2020-04 applies only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. Entities can apply the provisions of ASU 2020-04 immediately, as applicable, and generally the provisions of the guidance are available through December 31, 2022 as entities transition away from reference rates that are expected to be discontinued. The Company is currently assessing the impact of the adoption of this guidance on its consolidated financial statements and disclosures. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued Accounting Standards Update 2021-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2021-08&#8221;), which requires entities (acquirers) to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with ASC Topic 606. ASU 2021-08 will be effective for fiscal years, including interim periods within those fiscal years, beginning after December 15, 2022 with early adoption permitted. The Company is currently assessing the impact of the adoption of this guidance on its consolidated financial statements and disclosures.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, the FASB issued Accounting Standards Update 2021-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2021-10&#8221;), which requires entities to provide annual disclosures about transactions with a government that are accounted for by applying a grant or contribution accounting model by analogy. ASU 2021-10 will be effective for fiscal years beginning after December 15, 2021 with early adoption permitted. The Company is currently assessing the impact of the adoption of this guidance on its disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)-(d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6909625&amp;loc=d3e227-128457<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123345438&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI http://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124437754&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=d3e62652-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942903238120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Earnings Per Common Share Attributable To Mylan</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted earnings per share attributable to Viatris Inc. are calculated as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.261%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions, except per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Basic (loss) earnings attributable to Viatris Inc. common shareholders (numerator):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) earnings attributable to Viatris Inc. common shareholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,269.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(669.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares (denominator):</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,208.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic (loss) earnings per share attributable to Viatris Inc. shareholders</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.05)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.11)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Diluted (loss) earnings attributable to Viatris Inc. common shareholders (numerator):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) earnings attributable to Viatris Inc. common shareholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,269.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(669.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares (denominator):</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,208.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total dilutive shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,208.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted (loss) earnings per share attributable to Viatris Inc. shareholders</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.05)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.11)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942898616808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Other Transactions (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</a></td>
<td class="text"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2021, adjustments were made to the preliminary purchase price recorded at December 31, 2020, and are reflected as &#8220;Measurement Period and Other Adjustments&#8221; in the table below. The allocation of the $10.73&#160;billion purchase price to the assets acquired and liabilities assumed under the Combination is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.046%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.981%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.131%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Preliminary Purchase Price Allocation as of December 31, 2020 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Measurement Period and Other Adjustments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Purchase Price Allocation as of December 31, 2021 (as adjusted)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets (excluding inventories and net of cash acquired)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,841.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,803.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,588.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,554.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,394.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,389.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identified intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,040.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,040.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,107.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,403.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,481.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,678.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">792.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">784.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,246.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,653.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,760.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,179.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, including current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,076.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,076.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,656.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,657.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other noncurrent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,441.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,427.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired (net of $415.8 of cash acquired)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,311.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,311.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">____________</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.8pt">As previously reported in Viatris&#8217; Annual Report on Form 10-K for the fiscal year ended December 31, 2020.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">The measurement period adjustments are primarily for 1) certain working capital adjustments, an increase in litigation reserves to reflect facts and circumstances that existed as of the date of the Combination, and other adjustments and 2) the tax implications of these and other adjustments. These adjustments did not have a significant impact on the Company&#8217;s previously reported consolidated financial statements and accordingly, the Company has not retrospectively adjusted those consolidated financial statements.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">Business Acquisition, Pro Forma Information</a></td>
<td class="text">Accordingly, the unaudited pro forma results are not necessarily indicative of the results that actually would have occurred had the acquisitions been completed on the stated date above, nor are they indicative of the future operating results of Viatris and its subsidiaries.<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.145%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.914%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(Unaudited, in millions, except per share amounts) </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,284.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,582.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,483.7&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,873.5&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.23&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.55&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,206.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,205.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,207.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,206.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942908143672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition and Accounts Receivable (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s net sales by product category for each of our reportable segments for the years ended December&#160;31, 2021, 2020, and 2019, respectively:</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:37.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.669%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021 Net Sales</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Product Category</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Developed Markets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Greater China</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">JANZ</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Emerging Markets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brands</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,759.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,207.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,197.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,677.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,841.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Complex Gx and Biosimilars</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,241.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,342.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,427.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">783.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,413.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,630.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Viatris</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,428.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,212.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,027.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,144.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,813.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:37.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.669%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020 Net Sales</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Product Category</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Developed Markets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Greater China</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">JANZ</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Emerging Markets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brands</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,920.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,234.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Complex Gx and Biosimilars</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,202.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,295.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,387.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,361.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,289.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Viatris</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,510.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,195.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,853.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,819.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:37.191%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.684%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019 Net Sales</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Product Category</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Developed Markets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Greater China</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">JANZ</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Emerging Markets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brands</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,199.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">422.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,362.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Complex Gx and Biosimilars</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,127.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,211.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,913.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">635.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,241.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,796.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Viatris</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,240.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,192.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,723.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,370.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents net sales on a consolidated basis for select key products for the year ended December&#160;31, 2021:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:83.110%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.106%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Select Key Global Products</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lipitor &#174;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,663.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Norvasc &#174;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">824.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lyrica &#174;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">728.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Viagra &#174;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EpiPen&#174; Auto-Injectors</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Celebrex &#174;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effexor &#174;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Creon &#174;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zoloft &#174;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Xalabrands</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Select Key Segment Products</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Influvac &#174;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amitiza &#174;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Xanax &#174;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dymista &#174;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yupelri &#174;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">____________</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.8pt">The Company does not disclose net sales for any products considered competitively sensitive.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Products disclosed may change in future periods, including as a result of seasonality, competition or new product launches.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.8pt">Prior periods are not presented due to significance of products acquired as part of the Combination.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a rollforward of the categories of variable consideration during 2021:</span></div><div style="margin-bottom:7pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.433%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current Provision Related to Sales Made in the Current Period </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Measurement Period Adjustments and Reclasses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Checks/ Credits Issued to Third Parties </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effects of Foreign Exchange</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chargebacks</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">585.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,530.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,585.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">591.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates, promotional programs and other sales allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,576.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,135.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,267.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,373.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Returns</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">539.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">384.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(499.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">686.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Governmental rebate programs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">689.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(705.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,014.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,739.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,056.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,050.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule of Accounts Receivable, Net</a></td>
<td class="text">Accounts receivable are presented net of allowances relating to these provisions, which were comprised of the following at December&#160;31, 2021 and 2020, respectively:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:76.661%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.652%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,688.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,802.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,362.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,211.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,050.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,014.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942901959160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BalanceSheetComponentsAbstract', window );"><strong>Balance Sheet Components [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock', window );">Schedule of Cash, Cash Equivalents, and Restricted Cash</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and restricted cash</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.576%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">844.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash, included in other current and non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">706.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Inventories</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:76.759%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">922.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">958.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">993.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,438.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,062.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,075.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,977.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,471.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, plant and equipment</a></td>
<td class="text"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, plant and equipment, net</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:77.052%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.458%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,054.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,235.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,808.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,954.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">588.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,589.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,721.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,400.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,262.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,188.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,459.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock', window );">Other assets</a></td>
<td class="text"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other assets</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:76.759%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments, clean energy investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">879.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,170.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,047.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Other current liabilities</a></td>
<td class="text"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other current liabilities</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:76.759%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued sales allowances</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,362.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,211.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll and employee benefit liabilities </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">828.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal and professional accruals, including litigation accruals</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued restructuring</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments, clean energy investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of financial instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,254.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,973.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,619.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,960.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock', window );">Other noncurrent liabilities</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:76.759%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee benefit liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">876.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,020.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax related items, including contingencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued restructuring</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other long-term obligations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,933.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,483.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock', window );">Schedule of Other Current Assets</a></td>
<td class="text"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prepaid expenses and other current assets</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:77.052%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.458%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale fixed income securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of financial instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,467.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,236.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,957.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,707.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of Accounts Payable and Accrued Liabilities</a></td>
<td class="text"><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts payable</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:76.759%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,056.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,345.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other payables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">558.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,657.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,904.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other noncurrent liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other current assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_BalanceSheetComponentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Balance Sheet Components</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_BalanceSheetComponentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Table Text Block] for Schedule of Cash, Cash Equivalents and Restricted Cash [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942901848536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Lease, Cost</a></td>
<td class="text"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other information related to leases was as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:82.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining lease terms</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 year to 23 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Lessee, Operating Lease, Liability, Maturity</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, maturities of lease liabilities were as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:89.047%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.753%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liability</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942903296568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Method Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsTextBlock', window );">Equity Method Investments</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values and respective balance sheet locations of the Company&#8217;s clean energy investments were as follows at December&#160;31, 2021 and 2020, respectively:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:76.759%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Summarized financial information, in the aggregate, for the Company&#8217;s significant equity method investments on a 100% basis as of December&#160;31, 2021 and 2020 and for the years ended December&#160;31, 2021, 2020 and 2019 are as follows:</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:76.759%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:65.272%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating and non-operating expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.4)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.4)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942908941640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Changes in carrying amount of goodwill</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill for the years ended December&#160;31, 2021 and 2020 are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.859%"><tr><td style="width:1.0%"/><td style="width:38.931%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.270%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.270%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.270%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.270%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.277%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Developed Markets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Greater China</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">JANZ</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Emerging Markets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,258.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,065.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,975.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(385.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(385.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,873.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,065.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,590.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">704.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,107.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">648.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,184.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">864.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,560.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,347.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,569.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">864.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,560.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,732.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(385.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(385.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,184.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">864.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,560.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,347.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement period and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(528.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(528.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,723.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">969.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">776.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,644.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,113.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,108.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">969.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">776.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,644.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,498.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(385.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(385.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,723.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">969.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">776.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,644.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,113.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Components of intangible assets</a></td>
<td class="text"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consist of the following components at December&#160;31, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:53.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Life (Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Book Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product rights, licenses and other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,006.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,918.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,087.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,052.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,918.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,134.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product rights, licenses and other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,404.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,801.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,602.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,484.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,801.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,683.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Represents amortizable intangible assets. Other intangibles consist principally of customer lists and contractual rights.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ProductRightsAndLicensesByTherapeuticCategoryTableTextBlock', window );">Product rights and licenses by therapeutic category</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product rights and licenses are primarily comprised of the products marketed at the time of acquisition. These product rights and licenses relate to numerous individual products, the net book value of which, by product category, is as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Developed Markets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Greater China</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">JANZ</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Emerging Markets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brands</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,066.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,102.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,174.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,801.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,146.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Complex Gx and Biosimilars</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,020.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,710.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Product Rights and Licenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,313.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,115.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,495.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,160.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,084.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Developed Markets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Greater China</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">JANZ</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Emerging Markets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brands</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,988.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,372.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,377.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,478.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,216.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Complex Gx and Biosimilars</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,253.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,107.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Product Rights and Licenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,514.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,385.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,803.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,896.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,598.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock', window );">Finite-lived Intangible Assets Amortization Expense [Table Text Block]</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense and intangible asset impairment charges, which are included as a component of amortization expense, which is classified primarily within cost of sales in the consolidated statements of operations, for the years ended December&#160;31, 2021, 2020 and 2019 was as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:65.272%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset amortization expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,702.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,605.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,582.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D intangible asset impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finite-lived intangible asset impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible asset amortization expense (including impairment charges)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,805.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,688.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,763.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Intangible asset amortization expense for the years ending December&#160;31, 2022 through 2026 is estimated to be as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:88.782%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.018%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,320&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,222&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_ProductRightsAndLicensesByTherapeuticCategoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Product rights and licenses by therapeutic category</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_ProductRightsAndLicensesByTherapeuticCategoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942898584600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments and Risk Management (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock', window );">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A rollforward of the activity in the Company&#8217;s fair value of contingent consideration from December&#160;31, 2019 to December&#160;31, 2021 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:65.272%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current Portion </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-Term Portion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Contingent Consideration</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassifications</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value loss </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value loss </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Included in other current liabilities in the consolidated balance sheets.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Included in other long-term obligations in the consolidated balance sheets.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Included in litigation settlements and other contingencies, net in the consolidated statements of operations.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Financial Assets and Liabilities Carried at Fair Value</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities carried at fair value are classified in the tables below in one of the three categories described above:</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:57.465%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.712%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Recurring fair value measurements</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="24" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange traded funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale fixed income investments:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasuries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale fixed income investments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange derivative assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at recurring fair value measurement</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="24" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange derivative liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities at recurring fair value measurement</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:57.465%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.712%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Recurring fair value measurements</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="24" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange traded funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale fixed income investments:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasuries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale fixed income investments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange derivative assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at recurring fair value measurement</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="24" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange derivative liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities at recurring fair value measurement</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock', window );">Schedule of Available-for-Sale Securities Reconciliation</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost and estimated fair value of available-for-sale fixed income securities, included in prepaid expenses and other current assets, were as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:57.465%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.712%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Maturities Of Available-for-Sale Debt Securities At Fair Value</a></td>
<td class="text"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of available-for-sale debt securities at fair value as of December&#160;31, 2021, were as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:89.090%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.710%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature within one year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature in one to five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature in five years and later</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash flow hedging relationships</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Effect of Derivative Instruments on the Consolidated Statements of Operations</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize information about the gains/(losses) incurred to hedge or offset operational foreign exchange or interest rate risk:</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:34.738%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.819%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.414%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.414%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.414%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.414%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.414%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.417%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gains/(Losses) Recognized in Earnings</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain Excluded from the Assessment of Hedge Effectiveness</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain/(Loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivative Financial Instruments in Fair Value Hedge Relationships </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> :</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 Senior Notes (3.125% coupon)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivative Financial Instruments in Cash Flow Hedging Relationships</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivative Financial Instruments Not Designated as Hedging Instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option and forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gains/(Losses) Recognized in AOCE (Net of Tax) on Derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gains/(Losses) Reclassified from AOCE into Earnings</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain/(Loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivative Financial Instruments in Cash Flow Hedging Relationships </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivative Financial Instruments in Net Investment Hedging Relationships:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency borrowings and forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(346.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">479.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(325.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">In the first quarter of 2020, the Company terminated interest rate swaps designated as a fair value hedge resulting in net proceeds of approximately $45 million. The amount included in the above tables represents the fair value adjustment recognized at the date the interest rate swaps were settled. </span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">At December&#160;31, 2021, the Company expects that approximately $21.0 million of pre-tax net gains on cash flow hedges will be reclassified from AOCE into earnings during the next twelve months.</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Represents the location of the gain/(loss) recognized in earnings on derivatives.</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Represents the location of the gain/(loss) reclassified from AOCE into earnings.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Represents the location of the gain excluded from the assessment of hedge effectiveness.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942908944744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShortTermDebtTextBlock', window );">Schedule of Short-term Debt</a></td>
<td class="text"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-Term Borrowings</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had $1.49&#160;billion and $1.10&#160;billion of borrowings as of December&#160;31, 2021 and 2020, respectively.</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.575%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper notes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,173.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">651.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables Facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Note Securitization Facility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term borrowings</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,493.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>The following provides an overview of the Company&#8217;s short-term credit facilities.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Minimum Repayments on Outstanding Borrowings</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mandatory minimum repayments remaining on the notional amount of outstanding long-term debt at December&#160;31, 2021 were as follows for each of the periods ending December 31:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:89.090%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.710%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,853&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,990&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,318&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,598&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,940&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,949&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vtrs_UpjohnInc.Member', window );">Upjohn Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Summary of Long-Term Debt</a></td>
<td class="text"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about the Upjohn Senior Notes issued in June 2020:</span></div><div style="margin-bottom:10pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 Senior Notes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2030 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,450.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2040 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2050 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 Euro Senior Note</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">916.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Euro Senior Note</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">916.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Euro Senior Note</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,038.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2032 Euro Senior Note</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,527.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,847.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShortTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShortTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=vtrs_UpjohnInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=vtrs_UpjohnInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942903356168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Comprehensive Earnings (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Accumulated Other Comprehensive Loss</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated other comprehensive loss, as reflected in the consolidated balance sheets, is comprised of the following:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:76.661%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.652%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized gain on marketable securities, net of tax</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrecognized (loss) gain and prior service cost related to defined benefit plans, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrecognized loss on derivatives in cash flow hedging relationships, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrecognized loss on derivatives in net investment hedging relationships, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(353.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,802.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(461.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,744.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(858.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock', window );">Components of Other Comprehensive Loss</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of accumulated other comprehensive (loss) earnings, before tax, consist of the following:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.993%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.332%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.063%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.684%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr style="height:36pt"><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Derivatives in Cash Flow Hedging Relationships</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Net Investment Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Marketable Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Defined Pension Plan Items</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Totals</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Forward Contracts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020, net of tax</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(353.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(461.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(858.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (loss) before reclassifications, before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,340.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(755.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive earnings (loss), before tax:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on foreign exchange forward contracts classified as cash flow hedges, included in net sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on interest rate swaps classified as cash flow hedges, included in interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service costs included in SG&amp;A </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial loss included in SG&amp;A </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive earnings (loss), before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,340.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(775.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,802.4)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,744.3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.993%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.332%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.063%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.684%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr style="height:36pt"><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Derivatives in Cash Flow Hedging Relationships</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Net Investment Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Marketable Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Defined Pension Plan Items</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Totals</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Forward Contracts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019, net of tax</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,674.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,797.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) earnings before reclassifications, before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(305.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,213.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">914.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive (loss) earnings, before tax:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on foreign exchange forward contracts classified as cash flow hedges, included in net sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on interest rate swaps classified as cash flow hedges, included in interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service costs included in SG&amp;A </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial loss included in SG&amp;A </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive (loss) earnings, before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(305.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,213.0&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">912.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision (benefit)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.0)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(353.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(461.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(858.0)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.993%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.332%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.063%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.684%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Derivatives in Cash Flow Hedging Relationships</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Net Investment Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains and Losses on Marketable Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Defined Pension Plan Items</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Totals</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Forward Contracts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2018, net of tax</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,259.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,441.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (loss) before reclassifications, before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(415.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(347.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive (loss) earnings, before tax:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on foreign exchange forward contracts classified as cash flow hedges, included in net sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on interest rate swaps classified as cash flow hedges, included in interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service costs included in SG&amp;A </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial loss included in SG&amp;A </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive earnings (loss), before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(415.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(343.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision (benefit) </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative effect of the adoption of new accounting standards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,674.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,797.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions  designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e526-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942906649864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Components of Income Tax Provision</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax provision (benefit) consisted of the following components:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:65.272%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Federal:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(182.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(277.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(170.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(283.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. State:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">777.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision (benefit)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income taxes:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,982.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(945.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,031.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign - Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,318.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,185.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total (loss) earnings before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(664.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(721.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Temporary differences and carry-forwards that result in deferred tax assets and liabilities were as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:76.759%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee benefits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">393.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,187.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credit and loss carry-forwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,256.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,080.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,889.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,665.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(780.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(443.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,109.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,221.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets and goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,468.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,058.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,591.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,197.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,482.3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(975.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Statutory Tax Rate to Effective Tax Rate Reconciliation</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Combination, the applicable income tax rate to Mylan was the U.K. rate of 19%, and following the Combination, the statutory income tax rate applicable to Viatris Inc. is the U.S. rate of 21% for the years ended December 31, 2021 and 2020.  A reconciliation of the statutory tax rate to the effective tax rate is as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:65.272%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statutory tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States Operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clean energy and research credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. rate differentials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of changes in legislation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes and credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax settlements and resolution of certain tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incremental US Tax on Foreign Earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Waived deductions under IRC &#167; 59A</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of the Combination and Divestitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other U.S. items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Foreign Operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Luxembourg</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gibraltar</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Puerto Rico</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Switzerland</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Singapore</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax impact of tax law changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of the Combination and divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Withholding taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax settlements and resolution of certain tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other foreign items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock', window );">Schedule of Unrecognized Tax Benefits</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the unrecognized tax benefits is as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:68.006%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.712%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefit&#160;&#8212; beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions for current year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions for prior year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions for prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(112.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions due to expirations of statute of limitations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Reduction) addition due to acquisition</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefit&#160;&#8212; end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits, excluding amounts pertaining to examined tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942908947976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Incentive Plan (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Stock Awards Activity</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock awards (stock options and SARs) activity under the Plan and 2003 LTIP:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:71.187%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.389%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.391%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of&#160;Shares<br/>Under Stock Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise&#160;Price<br/>per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2018</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,815,278&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.61&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">829,322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(580,950)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(715,941)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,347,709&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">814,351&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,615)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(422,714)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,711,731&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,135,241)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,576,490&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,487,788&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,969,602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock', window );">Nonvested Restricted Stock and Restricted Stock Unit, Including Performance Units, Activity</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the status of the Company&#8217;s nonvested restricted stock awards (restricted stock and restricted stock unit awards, including PSUs), as of December&#160;31, 2020 and the changes during the year ended December&#160;31, 2021 are presented below:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:65.029%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.468%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.470%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of&#160;Restricted<br/>Stock Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Grant-Date<br/>Fair&#160;Value&#160;Per&#160;Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,073,790&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,850,443&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Released</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,168,152)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,897,953)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,858,128&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=vtrs_LongTermIncentivePlan2003Member', window );">Long Term Incentive Plan 2003</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Stock-Based Compensation Plans, Valuation Assumptions</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no options granted during the year ended December 31, 2021. The assumptions used for options granted under the Plan and 2003 LTIP during the years ended December 31, 2020 and 2019, respectively, are as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.578%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.697%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.7%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.1%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeiture rate </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average grant date fair value per option</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$8.07</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$11.03</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=vtrs_LongTermIncentivePlan2003Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=vtrs_LongTermIncentivePlan2003Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942906792936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock', window );">Accumulated Other Comprehensive Income (Loss) Pretax Amounts Not Yet Reclassified in Net Periodic Benefit Cost</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in accumulated other comprehensive loss as of December&#160;31, 2021 and 2020 are:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:53.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Postretirement Benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized actuarial (gain) loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized prior service cost (credit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock', window );">Change in Accumulated Income (Loss) Relating to Defined Benefit Pension and Other Postretirement Benefits</a></td>
<td class="text">The increase in accumulated other comprehensive loss in 2021 relating to pension benefits and other postretirement benefits consists of:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:75.879%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.043%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.045%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Postretirement Benefits</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized actuarial (gain) loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial gain/(loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized prior service credit (cost)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock', window );">Net Periodic Benefit Cost</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of net periodic benefit cost for the years ended December&#160;31, 2021, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:30.858%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.503%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.655%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Postretirement Benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan curtailment, settlement and termination</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized net actuarial losses (gains) </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2021, the Company recognized a settlement gain as a result of cash payments from lump sum elections related to the U.S. and Puerto Rico pension plans.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock', window );">Changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status of Plan</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents components of the change in projected benefit obligation, change in plan assets and funded status at December&#160;31, 2021 and 2020.</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:53.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Postretirement Benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in Projected Benefit Obligation</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligation, beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,145.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participant contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,389.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan settlements and terminations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(128.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial (gains) losses </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligation, end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,946.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,145.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in Plan Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets, beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,354.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Company contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participant contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">959.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(128.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets, end of year</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,366.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,354.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status of plans</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(580.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(791.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock', window );">Net Accrued Benefit Costs Classification on Balance Sheet</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net accrued benefit costs for pension plans and other postretirement benefits are reported in the following components of the Company&#8217;s consolidated balance sheets at December&#160;31, 2021 and 2020:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:53.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Postretirement Benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(682.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(846.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net accrued benefit costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(580.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(791.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188.4)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock', window );">Plans with Accumulated Benefit Obligation in Excess of Plan Assets</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The projected benefit obligation, accumulated benefit obligation and fair value of plan assets for pension plans with an accumulated benefit obligation in excess of the fair value of plan assets at December&#160;31, 2021 and 2020 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:78.078%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.019%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Plans with accumulated benefit obligation in excess of plan assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,591.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,747.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated benefit obligation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,546.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,678.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">904.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">893.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock', window );">Schedule of Allocation of Plan Assets</a></td>
<td class="text">The table below presents total plan assets by investment category as of December&#160;31, 2021&#160;and&#160;2020&#160;and the classification of each investment category within the fair value hierarchy with respect to the inputs used to measure fair value:<div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:53.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">551.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held by insurance companies and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">946.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,366.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:53.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">613.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">592.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held by insurance companies and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">788.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,354.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock', window );">Schedule of Assumptions Used</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following weighted average assumptions were used to determine the benefit obligations for the Company&#8217;s defined benefit pension and other postretirement plans as of December&#160;31, 2021&#160;and&#160;2020:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.609%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.034%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Postretirement Benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following weighted average assumptions were used to determine the net periodic benefit cost for the Company&#8217;s defined benefit pension and other postretirement benefit plans for the three years in the period ended&#160;December&#160;31, 2021:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:35.170%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.035%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Postretirement Benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock', window );">Schedule of Expected Benefit Payments</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated benefit payments over the next ten years for the Company&#8217;s pension plans and retiree health plan are as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:75.879%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.043%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.045%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Postretirement Benefits</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,035.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in the benefit obligation, fair value of plan assets, and funded status of pension plans or other employee benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(b)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans.  This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts that are recognized in the balance sheet (or statement of financial position) for pension plans and/or other employee benefit plans, showing separately the assets and current and noncurrent liabilities (if applicable) recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAssumptionsUsedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of benefit obligation and plan assets for defined benefit pension plan with projected benefit obligation in excess of plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetBenefitCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts related to pension plans and/or other employee benefit plans in accumulated other comprehensive income or loss that have not yet been recognized as components of net periodic benefit cost, such as the net gain (loss), net prior service cost or credit, and net transition asset or obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942905039480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Reconciliation of Segment Information to Total Consolidated Information</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Presented in the table below is segment information for the periods identified and a reconciliation of segment information to total consolidated information.</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.702%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="15" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="15" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Segment Profitability</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31, </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31, </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reportable Segments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed Markets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,428.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,510.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,240.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,143.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,243.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,137.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater China</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,212.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,397.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JANZ</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,027.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,195.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,192.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">762.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Markets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,144.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,853.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,723.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,402.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">561.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reportable segments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,813.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,819.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,370.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,705.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,271.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,112.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reconciling items:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset amortization expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,702.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,605.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,582.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset impairment charges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(180.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Globally managed research and development costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(751.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(555.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(639.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation settlements &amp; other contingencies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(329.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(107.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction related and other special items</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,832.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,739.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(682.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and other unallocated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,021.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,391.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,332.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) earnings from operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34.0)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(210.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock', window );">Schedule of Revenue by Major Customers by Reporting Segments</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the percentage of consolidated net sales to Viatris&#8217; major customers during the years ended December&#160;31, 2021, 2020, and 2019:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:65.272%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage of Consolidated Net Sales</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson Corporation</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AmerisourceBergen Corporation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health, Inc.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock', window );">Net Third Party Sales Classified Based on Geographic Location of Subsidiaries</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales by country are presented on the basis of geographic location of our subsidiaries: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:65.272%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,176.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,746.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,965.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,981.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div>No other country&#8217;s net sales represents more than 10% of consolidated net sales.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942903344936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Restructuring and Related Costs [Table Text Block]</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the restructuring charges and the reserve activity for the 2020 restructuring program:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:68.006%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.712%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Related Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Exit Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired in the Combination</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utilization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">892.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reimbursable restructuring charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(385.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(537.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utilization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(345.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(345.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:68.006%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.712%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Related Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Exit Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2018:</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utilization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019:</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utilization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020:</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;For the year ended December&#160;31, 2021, total restructuring charges for the 2020 Restructuring Program, in Developed Markets, Greater China, JANZ, Emerging Markets, and Corporate/Other were approximately $623.8 million, $5.8 million, $138.1 million, $94.1 million, and $30.4 million, respectively. </span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;For the year ended December&#160;31, 2020, total restructuring charges, for both programs, in Developed Markets, Greater China, JANZ, and Emerging Markets were approximately $292.1 million, $18.4 million, $2.9 million, and $8.4 million, respectively. </span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;For the year ended December 31, 2019, total restructuring charges for the 2016 Restructuring Program in Developed Markets and JANZ were approximately $100.4&#160;million and $4.2&#160;million, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942903403576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Nature of Operations (Narrative) (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>molecule </div>
<div>site</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_NumberOfMolecules', window );">Number Of Molecules | molecule</a></td>
<td class="nump">1,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_NumberOfManufacturingSites', window );">Number Of Manufacturing Sites | site</a></td>
<td class="nump">40<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_NumberOfManufacturingSites">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Manufacturing Sites</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_NumberOfManufacturingSites</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_NumberOfMolecules">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Molecules</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_NumberOfMolecules</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942898001528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Narrative) (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Billions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 06, 2022</div></th>
<th class="th"><div>Dec. 16, 2021</div></th>
<th class="th"><div>Sep. 16, 2021</div></th>
<th class="th"><div>Jun. 16, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Mar. 16, 2022</div></th>
<th class="th"><div>Feb. 28, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, estimated useful life, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from computation of earnings per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.7<span></span>
</td>
<td class="nump">10.3<span></span>
</td>
<td class="nump">9.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareCashPaid', window );">Dividends paid per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.11<span></span>
</td>
<td class="nump">$ 0.11<span></span>
</td>
<td class="nump">$ 0.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Common Stock, Dividends, Per Share, Declared</a></td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableAmountPerShare', window );">Dividends Payable, Amount Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock Repurchase Program, Authorized Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, estimated useful life, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, estimated useful life, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, estimated service life (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, estimated service life (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Buildings and improvements | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, estimated service life (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Buildings and improvements | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, estimated service life (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">39 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember', window );">Capitalized software | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, estimated service life (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember', window );">Capitalized software | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, estimated service life (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareCashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends paid during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareCashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableAmountPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The per share amount of a dividend declared, but not paid, as of the financial reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableAmountPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942903522424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Basic And Diluted Earnings Per Ordinary Share Attributable To Mylan N.V.) (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="num">$ (1,269.1)<span></span>
</td>
<td class="num">$ (669.9)<span></span>
</td>
<td class="nump">$ 16.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding</a></td>
<td class="nump">1,208.8<span></span>
</td>
<td class="nump">601.2<span></span>
</td>
<td class="nump">515.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (loss) earnings per share attributable to Viatris Inc. shareholders</a></td>
<td class="num">$ (1.05)<span></span>
</td>
<td class="num">$ (1.11)<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Weighted average number diluted shares outstanding adjustment, stock-based awards and warrants</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Total dilutive shares outstanding</a></td>
<td class="nump">1,208.8<span></span>
</td>
<td class="nump">601.2<span></span>
</td>
<td class="nump">516.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (loss) earnings per share attributable to Viatris Inc. shareholders</a></td>
<td class="num">$ (1.05)<span></span>
</td>
<td class="num">$ (1.11)<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="num">$ (1,269.1)<span></span>
</td>
<td class="num">$ (669.9)<span></span>
</td>
<td class="nump">$ 16.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942895468248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Other Transactions (Other Transactions) (Narrative) (Details)<br> &#8364; in Millions, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 13, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 29, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 27, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 20, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>market</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 25, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 751.1<span></span>
</td>
<td class="nump">$ 555.1<span></span>
</td>
<td class="nump">$ 639.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 223.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 223.6<span></span>
</td>
<td class="nump">199.7<span></span>
</td>
<td class="nump">223.6<span></span>
</td>
<td class="nump">250.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,347.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,347.0<span></span>
</td>
<td class="nump">12,113.7<span></span>
</td>
<td class="nump">12,347.0<span></span>
</td>
<td class="nump">$ 9,590.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired intangible assets, weighted average useful life, in years</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FiniteLivedIntangibleAssetsMember', window );">Finite-Lived Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired intangible assets, weighted average useful life, in years</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Building</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired intangible assets, weighted average useful life, in years</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Building</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired intangible assets, weighted average useful life, in years</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vtrs_UpjohnInc.Member', window );">Upjohn Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid to acquire asset</a></td>
<td class="nump">$ 12,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Business Acquisition, Percentage of Voting Interests Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,394.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,394.1<span></span>
</td>
<td class="nump">1,389.1<span></span>
</td>
<td class="nump">1,394.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Business Combination, Acquisition Related Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">234.6<span></span>
</td>
<td class="nump">602.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable</a></td>
<td class="nump">$ 10,730.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares | shares</a></td>
<td class="nump">689.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">360.9<span></span>
</td>
<td class="nump">1,483.7<span></span>
</td>
<td class="nump">1,873.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">866.5<span></span>
</td>
<td class="nump">18,284.8<span></span>
</td>
<td class="nump">21,582.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 2,400.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,107.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,107.5<span></span>
</td>
<td class="nump">2,403.1<span></span>
</td>
<td class="nump">2,107.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory', window );">Inventories</a></td>
<td class="nump">1,430.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(34.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="nump">385.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identified intangible assets</a></td>
<td class="nump">18,040.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,040.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,040.0<span></span>
</td>
<td class="nump">18,040.0<span></span>
</td>
<td class="nump">18,040.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongTermDebt', window );">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Long-Term Debt</a></td>
<td class="nump">$ 759.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_AmortizationOfInventoryStepUp', window );">Amortization of Inventory Step Up</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,190.0<span></span>
</td>
<td class="nump">$ 238.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BusinessCombinationNumberOfMarketsServed', window );">Number Of Markets | market</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vtrs_OtherCompaniesMember', window );">Other companies | Product rights and licenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Acquisition purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vtrs_AspenGlobalIncorporatedMember', window );">Aspen Global Incorporated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Acquisition purchase price | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 641.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid to acquire asset | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 263.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vtrs_AspenGlobalIncorporatedMember', window );">Aspen Global Incorporated | Contractual Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired intangible assets, weighted average useful life, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=vtrs_FKBMember', window );">FKB</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_PaymentsToAcquireCollaborativeAgreement', window );">Upfront payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33.0<span></span>
</td>
<td class="nump">$ 25.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Net sales | Upjohn Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_NumberOfProducts', window );">Number Of Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis=vtrs_PfizerInc.Member', window );">Pfizer, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFirmPurchaseCommitmentLoss', window );">Inventory, Firm Purchase Commitment, Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 86.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis=vtrs_PfizerInc.Member', window );">Pfizer, Inc. | Upjohn Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Noncontrolling Interest, Ownership Percentage by Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=vtrs_UpjohnInc.Member', window );">Upjohn Inc. | Pfizer, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_PaymentsforBusinessSeparation', window );">Payments for Business Separation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=us-gaap_ScenarioPlanMember', window );">Scenario, Plan | Aspen Global Incorporated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liability | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 378.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to inventory acquired in connection with a business combination for which the initial accounting was incomplete.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=SL65897772-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to property, plant, and equipment acquired in connection with a business combination for which the initial accounting was incomplete.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=SL65897772-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFirmPurchaseCommitmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss recognized on firm purchase commitment for inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4578-108314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFirmPurchaseCommitmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_AmortizationOfInventoryStepUp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization of Inventory Step Up</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_AmortizationOfInventoryStepUp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_BusinessCombinationNumberOfMarketsServed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Number Of Markets Served</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_BusinessCombinationNumberOfMarketsServed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Long-Term Debt</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_NumberOfProducts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Products</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_NumberOfProducts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_PaymentsToAcquireCollaborativeAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments To Acquire Collaborative Agreement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_PaymentsToAcquireCollaborativeAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_PaymentsforBusinessSeparation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments for Business Separation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_PaymentsforBusinessSeparation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FiniteLivedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FiniteLivedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=vtrs_UpjohnInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=vtrs_UpjohnInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=vtrs_OtherCompaniesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=vtrs_OtherCompaniesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=vtrs_AspenGlobalIncorporatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=vtrs_AspenGlobalIncorporatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=vtrs_FKBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=vtrs_FKBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis=vtrs_PfizerInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis=vtrs_PfizerInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=vtrs_UpjohnInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=vtrs_UpjohnInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=vtrs_UpjohnInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=vtrs_UpjohnInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=us-gaap_ScenarioPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=us-gaap_ScenarioPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942898294664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Other Transactions (Purchase Price Allocations) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Nov. 13, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Nov. 16, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>May 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract', window );"><strong>Business Acquisition, Date of Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 12,347.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,113.7<span></span>
</td>
<td class="nump">$ 12,347.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,590.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash Acquired from Acquisition</a></td>
<td class="nump">415.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract', window );"><strong>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">295.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=vtrs_UpjohnInc.Member', window );">Upjohn Inc. | Pfizer, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract', window );"><strong>Business Acquisition, Date of Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt', window );">Long-term debt, including current portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,080.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vtrs_UpjohnInc.Member', window );">Upjohn Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract', window );"><strong>Business Acquisition, Date of Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets', window );">Current assets (excluding inventories and net of cash acquired)</a></td>
<td class="nump">2,841.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,803.2<span></span>
</td>
<td class="nump">2,841.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventories</a></td>
<td class="nump">2,588.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,554.7<span></span>
</td>
<td class="nump">2,588.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="nump">1,394.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,389.1<span></span>
</td>
<td class="nump">1,394.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identified intangible assets</a></td>
<td class="nump">18,040.0<span></span>
</td>
<td class="nump">$ 18,040.0<span></span>
</td>
<td class="nump">18,040.0<span></span>
</td>
<td class="nump">18,040.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">2,107.5<span></span>
</td>
<td class="nump">2,400.0<span></span>
</td>
<td class="nump">2,403.1<span></span>
</td>
<td class="nump">2,107.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets', window );">Deferred income tax benefit</a></td>
<td class="nump">1,481.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,678.2<span></span>
</td>
<td class="nump">1,481.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="nump">792.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">784.7<span></span>
</td>
<td class="nump">792.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets acquired</a></td>
<td class="nump">29,246.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,653.0<span></span>
</td>
<td class="nump">29,246.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Current liabilities</a></td>
<td class="nump">2,760.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,179.9<span></span>
</td>
<td class="nump">2,760.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt', window );">Long-term debt, including current portion</a></td>
<td class="nump">13,076.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,076.2<span></span>
</td>
<td class="nump">13,076.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="nump">1,656.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,657.9<span></span>
</td>
<td class="nump">1,656.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities', window );">Other noncurrent liabilities</a></td>
<td class="nump">1,441.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,427.4<span></span>
</td>
<td class="nump">1,441.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets', window );">Net assets acquired</a></td>
<td class="nump">$ 10,311.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,311.6<span></span>
</td>
<td class="nump">$ 10,311.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,730.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract', window );"><strong>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsCurrent', window );">Current assets (excluding inventories and net of cash acquired)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(38.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory', window );">Inventories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,430.0<span></span>
</td>
<td class="num">(34.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 385.0<span></span>
</td>
<td class="num">(5.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">295.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets', window );">Deferred income tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">196.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets', window );">Total assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">406.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesCurrent', window );">Current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">419.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentLiabilities', window );">Other noncurrent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred', window );">Net assets acquired (net of $415.8 of cash acquired)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to items of consideration transferred in connection with a business combination for which the initial accounting was incomplete.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=SL65897772-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to inventory acquired in connection with a business combination for which the initial accounting was incomplete.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=SL65897772-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to property, plant, and equipment acquired in connection with a business combination for which the initial accounting was incomplete.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=SL65897772-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of financial assets (as defined) recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -URI http://asc.fasb.org/topic&amp;trid=2134543<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Noncurrent Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Noncurrent Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=vtrs_UpjohnInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=vtrs_UpjohnInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis=vtrs_PfizerInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis=vtrs_PfizerInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=vtrs_UpjohnInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=vtrs_UpjohnInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942901781112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Other Transactions (Unaudited Pro Forma Financial Results) (Details) - Upjohn Inc. - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Total revenues</a></td>
<td class="nump">$ 866.5<span></span>
</td>
<td class="nump">$ 18,284.8<span></span>
</td>
<td class="nump">$ 21,582.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net earnings</a></td>
<td class="nump">$ 360.9<span></span>
</td>
<td class="nump">$ 1,483.7<span></span>
</td>
<td class="nump">$ 1,873.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic', window );">Basic (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.23<span></span>
</td>
<td class="nump">$ 1.55<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted', window );">Diluted (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.23<span></span>
</td>
<td class="nump">$ 1.55<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageBasicSharesOutstandingProForma', window );">Basic (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,206.8<span></span>
</td>
<td class="nump">1,205.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted', window );">Diluted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,207.7<span></span>
</td>
<td class="nump">1,206.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average number of shares or units and dilutive common stock or unit equivalents outstanding in the calculation of proforma diluted earnings per share (earnings per unit), which is commonly presented in initial public offerings based on the terms of the offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageBasicSharesOutstandingProForma">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average number of shares (units) outstanding in the calculation of pro forma basic earnings per share (earnings per unit), which is commonly presented in initial public offerings based on the terms of the offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageBasicSharesOutstandingProForma</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=vtrs_UpjohnInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=vtrs_UpjohnInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942898774552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition and Accounts Receivable Revenue Disaggregation (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 17,813.6<span></span>
</td>
<td class="nump">$ 11,819.9<span></span>
</td>
<td class="nump">$ 11,370.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_BrandsMember', window );">Brands</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">10,841.3<span></span>
</td>
<td class="nump">5,234.9<span></span>
</td>
<td class="nump">5,362.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_ComplexGXAndBiosimilarsMember', window );">Complex Gx and Biosimilars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,342.1<span></span>
</td>
<td class="nump">1,295.5<span></span>
</td>
<td class="nump">1,211.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_GenericsMember', window );">Generics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">5,630.2<span></span>
</td>
<td class="nump">5,289.5<span></span>
</td>
<td class="nump">4,796.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">17,813.6<span></span>
</td>
<td class="nump">11,819.9<span></span>
</td>
<td class="nump">11,370.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_DevelopedMarketsSegmentMember', window );">Developed Markets | Brands</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">5,759.2<span></span>
</td>
<td class="nump">3,920.7<span></span>
</td>
<td class="nump">4,199.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_DevelopedMarketsSegmentMember', window );">Developed Markets | Complex Gx and Biosimilars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,241.6<span></span>
</td>
<td class="nump">1,202.6<span></span>
</td>
<td class="nump">1,127.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_DevelopedMarketsSegmentMember', window );">Developed Markets | Generics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">3,427.9<span></span>
</td>
<td class="nump">3,387.6<span></span>
</td>
<td class="nump">2,913.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember', window );">Greater China | Brands</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2,207.8<span></span>
</td>
<td class="nump">253.9<span></span>
</td>
<td class="nump">207.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember', window );">Greater China | Complex Gx and Biosimilars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember', window );">Greater China | Generics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">4.8<span></span>
</td>
<td class="nump">5.3<span></span>
</td>
<td class="nump">6.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember', window );">JANZ | Brands</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,197.1<span></span>
</td>
<td class="nump">617.0<span></span>
</td>
<td class="nump">533.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember', window );">JANZ | Complex Gx and Biosimilars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">46.5<span></span>
</td>
<td class="nump">42.8<span></span>
</td>
<td class="nump">23.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember', window );">JANZ | Generics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">783.8<span></span>
</td>
<td class="nump">535.5<span></span>
</td>
<td class="nump">635.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember', window );">Emerging Markets | Brands</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,677.2<span></span>
</td>
<td class="nump">443.3<span></span>
</td>
<td class="nump">422.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember', window );">Emerging Markets | Complex Gx and Biosimilars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">53.8<span></span>
</td>
<td class="nump">49.4<span></span>
</td>
<td class="nump">59.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember', window );">Emerging Markets | Generics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,413.7<span></span>
</td>
<td class="nump">1,361.1<span></span>
</td>
<td class="nump">1,241.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">17,813.6<span></span>
</td>
<td class="nump">11,819.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Developed Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">10,428.7<span></span>
</td>
<td class="nump">8,510.9<span></span>
</td>
<td class="nump">8,240.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Greater China</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2,212.8<span></span>
</td>
<td class="nump">259.9<span></span>
</td>
<td class="nump">214.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | JANZ</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2,027.4<span></span>
</td>
<td class="nump">1,195.3<span></span>
</td>
<td class="nump">1,192.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Emerging Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 3,144.7<span></span>
</td>
<td class="nump">$ 1,853.8<span></span>
</td>
<td class="nump">$ 1,723.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_BrandsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_BrandsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_ComplexGXAndBiosimilarsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_ComplexGXAndBiosimilarsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_GenericsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_GenericsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_DevelopedMarketsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_DevelopedMarketsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942897946072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition and Accounts Receivable - Disaggregation of Revenue by Key Products (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 17,813.6<span></span>
</td>
<td class="nump">$ 11,819.9<span></span>
</td>
<td class="nump">$ 11,370.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_LipitorMember', window );">Lipitor &#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,663.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_NorvascMember', window );">Norvasc &#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">824.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_LyricaMember', window );">Lyrica &#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">728.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_ViagraMember', window );">Viagra &#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">533.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_EpiPenAutoInjectorsMember', window );">EpiPen&#174; Auto-Injectors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">391.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_CelebrexMember', window );">Celebrex &#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">344.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_CreonMember', window );">Creon &#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">316.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_ZoloftMember', window );">Zoloft &#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">309.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_EffexorMember', window );">Effexor &#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">284.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_XalabrandsMember', window );">Xalabrands</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">226.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_InfluvacMember', window );">Influvac &#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">299.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_AmitizaMember', window );">Amitiza &#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">201.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_XanaxMember', window );">Xanax &#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">185.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_YupelriMember', window );">Yupelri &#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">168.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vtrs_DymistaMember', window );">Dymista &#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 161.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_LipitorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_LipitorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_NorvascMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_NorvascMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_LyricaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_LyricaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_ViagraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_ViagraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_EpiPenAutoInjectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_EpiPenAutoInjectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_CelebrexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_CelebrexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_CreonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_CreonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_ZoloftMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_ZoloftMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_EffexorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_EffexorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_XalabrandsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_XalabrandsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_InfluvacMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_InfluvacMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_AmitizaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_AmitizaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_XanaxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_XanaxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_YupelriMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_YupelriMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_DymistaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_DymistaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942908905832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revenue Recognition and Accounts Receivable (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Revenue Recognition And Accounts Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableFromSecuritization', window );">Securitized accounts receivable</a></td>
<td class="nump">$ 388.9<span></span>
</td>
<td class="nump">$ 389.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=vtrs_ReceivablesFacilityMember', window );">Receivables Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Revenue Recognition And Accounts Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity', window );">Accounts receivable securitization facility maximum borrowing capacity</a></td>
<td class="nump">$ 400.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableFromSecuritization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount owed to the reporting entity by counterparties in securitized loan transactions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableFromSecuritization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts receivable facility maximum borrowing capacity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=vtrs_ReceivablesFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=vtrs_ReceivablesFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942895409240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition and Accounts Receivable Variable Consideration (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_RevenuefromContractwithCustomerGross', window );">Gross sales</a></td>
<td class="nump">$ 30,553.4<span></span>
</td>
<td class="nump">$ 19,899.1<span></span>
</td>
<td class="nump">$ 19,012.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_Chargebacks', window );">Chargebacks</a></td>
<td class="num">(5,530.1)<span></span>
</td>
<td class="num">(3,656.2)<span></span>
</td>
<td class="num">(3,309.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_AccruedSalesAllowances', window );">Rebates, promotional programs and other sales allowances</a></td>
<td class="num">(6,135.6)<span></span>
</td>
<td class="num">(3,765.5)<span></span>
</td>
<td class="num">(3,629.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_RevenuefromContractwithCustomerReturns', window );">Returns</a></td>
<td class="num">(384.6)<span></span>
</td>
<td class="num">(329.7)<span></span>
</td>
<td class="num">(237.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_Medicaidandothergovernmentalrebates', window );">Medicaid and other governmental rebates</a></td>
<td class="num">(689.5)<span></span>
</td>
<td class="num">(327.8)<span></span>
</td>
<td class="num">(465.1)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_SalesRevenueGrosstonetadjustments', window );">Sales Revenue, Gross to net adjustments</a></td>
<td class="nump">12,739.8<span></span>
</td>
<td class="nump">8,079.2<span></span>
</td>
<td class="nump">7,641.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">17,813.6<span></span>
</td>
<td class="nump">11,819.9<span></span>
</td>
<td class="nump">11,370.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">17,813.6<span></span>
</td>
<td class="nump">11,819.9<span></span>
</td>
<td class="nump">$ 11,370.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 17,813.6<span></span>
</td>
<td class="nump">$ 11,819.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_AccruedSalesAllowances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Sales Allowances</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_AccruedSalesAllowances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_Chargebacks">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Chargebacks</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_Chargebacks</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_Medicaidandothergovernmentalrebates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Medicaid and other governmental rebates</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_Medicaidandothergovernmentalrebates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_RevenuefromContractwithCustomerGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue from Contract with Customer, Gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_RevenuefromContractwithCustomerGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_RevenuefromContractwithCustomerReturns">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue from Contract with Customer, Returns</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_RevenuefromContractwithCustomerReturns</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_SalesRevenueGrosstonetadjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sales Revenue, Gross to net adjustments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_SalesRevenueGrosstonetadjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942899077832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition and Accounts Receivable (Accounts Receivable, Net) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">$ 3,774.4<span></span>
</td>
<td class="nump">$ 3,891.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">492.0<span></span>
</td>
<td class="nump">952.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">4,266.4<span></span>
</td>
<td class="nump">4,843.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndCollectionOfReceivables', window );">Proceeds from Sale and Collection of Receivables</a></td>
<td class="nump">29.6<span></span>
</td>
<td class="nump">153.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember', window );">Allowance for doubtful accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</a></td>
<td class="nump">$ 154.5<span></span>
</td>
<td class="nump">$ 159.9<span></span>
</td>
<td class="nump">$ 72.8<span></span>
</td>
<td class="nump">$ 98.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CreditConcentrationRiskMember', window );">Credit Concentration Risk | Accounts Receivable | Three Customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">18.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=vtrs_VariableConsiderationMember', window );">Variable Consideration [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">$ 1,688.6<span></span>
</td>
<td class="nump">$ 1,802.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">1,362.1<span></span>
</td>
<td class="nump">1,211.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">$ 3,050.7<span></span>
</td>
<td class="nump">$ 3,014.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndCollectionOfReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the proceeds from sale and collection of receivables during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndCollectionOfReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604059-122996<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CreditConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CreditConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=vtrs_ThreeCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=vtrs_ThreeCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=vtrs_VariableConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=vtrs_VariableConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942898387832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition and Accounts Receivable Variable Consideration Rollforward (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_AccountsReceivableVariableConsiderationRollForward', window );"><strong>Accounts Receivable, Variable Consideration [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Beginning of period</a></td>
<td class="nump">$ 4,843.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">End of period</a></td>
<td class="nump">4,266.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=vtrs_VariableConsiderationMember', window );">Variable Consideration [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_AccountsReceivableVariableConsiderationRollForward', window );"><strong>Accounts Receivable, Variable Consideration [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Beginning of period</a></td>
<td class="nump">3,014.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_AccountsReceivableSalesProvisionsCurrent', window );">Current Provision Related to Sales Made in the Current Period</a></td>
<td class="nump">12,739.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_AccountsReceivableIncreaseDueToAcquisitionCurrent', window );">Measurement Period Adjustments and Reclasses</a></td>
<td class="nump">385.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_AccountsReceivableCreditsIssuedtoThirdParties', window );">Checks/ Credits Issued to Third Parties</a></td>
<td class="num">(13,056.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_AccountsReceivableEffectsofForeignExchangeRates', window );">Effects of Foreign Exchange</a></td>
<td class="num">(32.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">End of period</a></td>
<td class="nump">3,050.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=vtrs_VariableConsiderationMember', window );">Variable Consideration [Member] | Chargebacks [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_AccountsReceivableVariableConsiderationRollForward', window );"><strong>Accounts Receivable, Variable Consideration [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Beginning of period</a></td>
<td class="nump">585.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_AccountsReceivableSalesProvisionsCurrent', window );">Current Provision Related to Sales Made in the Current Period</a></td>
<td class="nump">5,530.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_AccountsReceivableIncreaseDueToAcquisitionCurrent', window );">Measurement Period Adjustments and Reclasses</a></td>
<td class="nump">63.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_AccountsReceivableCreditsIssuedtoThirdParties', window );">Checks/ Credits Issued to Third Parties</a></td>
<td class="num">(5,585.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_AccountsReceivableEffectsofForeignExchangeRates', window );">Effects of Foreign Exchange</a></td>
<td class="num">(1.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">End of period</a></td>
<td class="nump">591.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=vtrs_VariableConsiderationMember', window );">Variable Consideration [Member] | Rebates, Promotional Programs and Other Sales Allowances [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_AccountsReceivableVariableConsiderationRollForward', window );"><strong>Accounts Receivable, Variable Consideration [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Beginning of period</a></td>
<td class="nump">1,576.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_AccountsReceivableSalesProvisionsCurrent', window );">Current Provision Related to Sales Made in the Current Period</a></td>
<td class="nump">6,135.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_AccountsReceivableIncreaseDueToAcquisitionCurrent', window );">Measurement Period Adjustments and Reclasses</a></td>
<td class="num">(57.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_AccountsReceivableCreditsIssuedtoThirdParties', window );">Checks/ Credits Issued to Third Parties</a></td>
<td class="num">(6,267.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_AccountsReceivableEffectsofForeignExchangeRates', window );">Effects of Foreign Exchange</a></td>
<td class="num">(14.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">End of period</a></td>
<td class="nump">1,373.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=vtrs_VariableConsiderationMember', window );">Variable Consideration [Member] | Variable Consideration Returns [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_AccountsReceivableVariableConsiderationRollForward', window );"><strong>Accounts Receivable, Variable Consideration [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Beginning of period</a></td>
<td class="nump">539.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_AccountsReceivableSalesProvisionsCurrent', window );">Current Provision Related to Sales Made in the Current Period</a></td>
<td class="nump">384.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_AccountsReceivableIncreaseDueToAcquisitionCurrent', window );">Measurement Period Adjustments and Reclasses</a></td>
<td class="nump">269.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_AccountsReceivableCreditsIssuedtoThirdParties', window );">Checks/ Credits Issued to Third Parties</a></td>
<td class="num">(499.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_AccountsReceivableEffectsofForeignExchangeRates', window );">Effects of Foreign Exchange</a></td>
<td class="num">(7.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">End of period</a></td>
<td class="nump">686.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=vtrs_VariableConsiderationMember', window );">Variable Consideration [Member] | Governmental Rebate Programs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_AccountsReceivableVariableConsiderationRollForward', window );"><strong>Accounts Receivable, Variable Consideration [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Beginning of period</a></td>
<td class="nump">313.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_AccountsReceivableSalesProvisionsCurrent', window );">Current Provision Related to Sales Made in the Current Period</a></td>
<td class="nump">689.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_AccountsReceivableIncreaseDueToAcquisitionCurrent', window );">Measurement Period Adjustments and Reclasses</a></td>
<td class="nump">110.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_AccountsReceivableCreditsIssuedtoThirdParties', window );">Checks/ Credits Issued to Third Parties</a></td>
<td class="num">(705.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_AccountsReceivableEffectsofForeignExchangeRates', window );">Effects of Foreign Exchange</a></td>
<td class="num">(9.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">End of period</a></td>
<td class="nump">$ 399.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_AccountsReceivableCreditsIssuedtoThirdParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable, Credits Issued to Third Parties</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_AccountsReceivableCreditsIssuedtoThirdParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_AccountsReceivableEffectsofForeignExchangeRates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable, Effects of Foreign Exchange Rates</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_AccountsReceivableEffectsofForeignExchangeRates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_AccountsReceivableIncreaseDueToAcquisitionCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable, Increase Due to Acquisition, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_AccountsReceivableIncreaseDueToAcquisitionCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_AccountsReceivableSalesProvisionsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable, Sales Provisions, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_AccountsReceivableSalesProvisionsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_AccountsReceivableVariableConsiderationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable, Variable Consideration [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_AccountsReceivableVariableConsiderationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=vtrs_VariableConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=vtrs_VariableConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_VariableConsiderationCategoryAxis=vtrs_ChargebacksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_VariableConsiderationCategoryAxis=vtrs_ChargebacksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_VariableConsiderationCategoryAxis=vtrs_RebatesPromotionalProgramsandOtherSalesAllowancesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_VariableConsiderationCategoryAxis=vtrs_RebatesPromotionalProgramsandOtherSalesAllowancesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_VariableConsiderationCategoryAxis=vtrs_VariableConsiderationReturnsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_VariableConsiderationCategoryAxis=vtrs_VariableConsiderationReturnsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_VariableConsiderationCategoryAxis=vtrs_GovernmentalRebateProgramsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_VariableConsiderationCategoryAxis=vtrs_GovernmentalRebateProgramsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942905021112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareNet', window );">Capitalized Computer Software, Net</a></td>
<td class="nump">$ 62.3<span></span>
</td>
<td class="nump">$ 70.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_Netrealizablevalueofinventoryrecognizedasexpense', window );">Net realizable value of inventory recognized as expense</a></td>
<td class="nump">474.9<span></span>
</td>
<td class="nump">206.1<span></span>
</td>
<td class="nump">$ 399.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">509.5<span></span>
</td>
<td class="nump">289.7<span></span>
</td>
<td class="nump">256.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other Liabilities, Current</a></td>
<td class="nump">4,619.6<span></span>
</td>
<td class="nump">4,960.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember', window );">Allowance for doubtful accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</a></td>
<td class="nump">$ 154.5<span></span>
</td>
<td class="nump">$ 159.9<span></span>
</td>
<td class="nump">$ 72.8<span></span>
</td>
<td class="nump">$ 98.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of capitalized computer software costs net of accumulated amortization as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_Netrealizablevalueofinventoryrecognizedasexpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net realizable value of inventory recognized as expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_Netrealizablevalueofinventoryrecognizedasexpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942907905800">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components Balance Sheet Components (Cash and Cash Equivalents) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 701.2<span></span>
</td>
<td class="nump">$ 844.4<span></span>
</td>
<td class="nump">$ 475.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted cash, included in other current and non-current assets</a></td>
<td class="nump">5.0<span></span>
</td>
<td class="nump">5.6<span></span>
</td>
<td class="nump">15.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</a></td>
<td class="nump">$ 706.2<span></span>
</td>
<td class="nump">$ 850.0<span></span>
</td>
<td class="nump">$ 491.1<span></span>
</td>
<td class="nump">$ 389.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942906559944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components (Accounts receivable, net) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrentAbstract', window );"><strong>Receivables, Net, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Trade receivables, net</a></td>
<td class="nump">$ 3,774.4<span></span>
</td>
<td class="nump">$ 3,891.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">492.0<span></span>
</td>
<td class="nump">952.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">4,266.4<span></span>
</td>
<td class="nump">4,843.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndCollectionOfReceivables', window );">Proceeds from Sale and Collection of Receivables</a></td>
<td class="nump">$ 29.6<span></span>
</td>
<td class="nump">$ 153.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndCollectionOfReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the proceeds from sale and collection of receivables during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndCollectionOfReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604059-122996<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942904968552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components (Inventories) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNetAbstract', window );"><strong>Inventory, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 922.4<span></span>
</td>
<td class="nump">$ 958.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in process</a></td>
<td class="nump">993.3<span></span>
</td>
<td class="nump">1,438.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">2,062.0<span></span>
</td>
<td class="nump">3,075.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">3,977.7<span></span>
</td>
<td class="nump">5,471.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Inventory reserves</a></td>
<td class="nump">519.0<span></span>
</td>
<td class="nump">353.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_Netrealizablevalueofinventoryrecognizedasexpense', window );">Net realizable value of inventory recognized as expense</a></td>
<td class="nump">$ 474.9<span></span>
</td>
<td class="nump">$ 206.1<span></span>
</td>
<td class="nump">$ 399.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_Netrealizablevalueofinventoryrecognizedasexpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net realizable value of inventory recognized as expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_Netrealizablevalueofinventoryrecognizedasexpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942906701672">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components (Prepaids and other current assets) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract', window );"><strong>Prepaid Expense and Other Assets, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">$ 256.7<span></span>
</td>
<td class="nump">$ 267.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted cash</a></td>
<td class="nump">5.0<span></span>
</td>
<td class="nump">5.6<span></span>
</td>
<td class="nump">$ 15.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Available-for-sale fixed income securities</a></td>
<td class="nump">38.2<span></span>
</td>
<td class="nump">39.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of financial instruments</a></td>
<td class="nump">144.6<span></span>
</td>
<td class="nump">118.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent', window );">Equity securities</a></td>
<td class="nump">51.0<span></span>
</td>
<td class="nump">45.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">1,467.1<span></span>
</td>
<td class="nump">1,236.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">$ 1,957.6<span></span>
</td>
<td class="nump">$ 1,707.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6787-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123349782&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942903443080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components (Property, Plant and Equipment) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 5,589.1<span></span>
</td>
<td class="nump">$ 5,721.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="nump">2,400.5<span></span>
</td>
<td class="nump">2,262.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">3,188.6<span></span>
</td>
<td class="nump">3,459.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandAndLandImprovementsMember', window );">Land and improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">137.9<span></span>
</td>
<td class="nump">155.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Buildings and improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">1,808.5<span></span>
</td>
<td class="nump">1,954.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">3,054.0<span></span>
</td>
<td class="nump">3,235.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 588.7<span></span>
</td>
<td class="nump">$ 376.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandAndLandImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandAndLandImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942902282200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components (Other Assets) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ScheduleofOtherAssetsLineItems', window );"><strong>Schedule of Other Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating Lease, Right-of-Use Asset</a></td>
<td class="nump">$ 290.8<span></span>
</td>
<td class="nump">$ 323.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_Otherlongtermassets', window );">Other long-term assets</a></td>
<td class="nump">879.9<span></span>
</td>
<td class="nump">676.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">1,170.7<span></span>
</td>
<td class="nump">1,047.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=vtrs_CleanEnergyPartnershipsMember', window );">Clean energy investments | Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ScheduleofOtherAssetsLineItems', window );"><strong>Schedule of Other Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in subsidiaries</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 47.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_Otherlongtermassets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other long-term assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_Otherlongtermassets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_ScheduleofOtherAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Schedule of Other Assets [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_ScheduleofOtherAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=vtrs_CleanEnergyPartnershipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=vtrs_CleanEnergyPartnershipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942903418040">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components (Trade Accounts Payable) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrentAbstract', window );"><strong>Accounts Payable, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrentAndNoncurrent', window );">Trade accounts payable</a></td>
<td class="nump">$ 1,056.1<span></span>
</td>
<td class="nump">$ 1,345.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableOtherCurrentAndNoncurrent', window );">Other payables</a></td>
<td class="nump">601.3<span></span>
</td>
<td class="nump">558.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Accounts payable</a></td>
<td class="nump">$ 1,657.4<span></span>
</td>
<td class="nump">$ 1,904.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableOtherCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligations incurred and payable classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableOtherCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942897988392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components (Other Current Liabilities) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ScheduleofothercurrentliabilitiesLineItems', window );"><strong>Schedule of other current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">$ 492.0<span></span>
</td>
<td class="nump">$ 952.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Employee-related Liabilities, Current</a></td>
<td class="nump">741.9<span></span>
</td>
<td class="nump">828.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserveCurrent', window );">Estimated Litigation Liability, Current</a></td>
<td class="nump">715.6<span></span>
</td>
<td class="nump">362.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liability</a></td>
<td class="nump">199.7<span></span>
</td>
<td class="nump">223.6<span></span>
</td>
<td class="nump">$ 250.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveCurrent', window );">Restructuring Reserve, Current</a></td>
<td class="nump">233.5<span></span>
</td>
<td class="nump">149.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Accrued interest</a></td>
<td class="nump">86.6<span></span>
</td>
<td class="nump">90.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Liability derivatives, fair value</a></td>
<td class="nump">61.0<span></span>
</td>
<td class="nump">103.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating Lease, Liability, Current</a></td>
<td class="nump">86.7<span></span>
</td>
<td class="nump">92.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other Accrued Liabilities, Current</a></td>
<td class="nump">1,254.6<span></span>
</td>
<td class="nump">1,973.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">4,619.6<span></span>
</td>
<td class="nump">4,960.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=vtrs_VariableConsiderationMember', window );">Variable Consideration [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ScheduleofothercurrentliabilitiesLineItems', window );"><strong>Schedule of other current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">1,362.1<span></span>
</td>
<td class="nump">1,211.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=vtrs_CleanEnergyPartnershipsMember', window );">Clean energy investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ScheduleofothercurrentliabilitiesLineItems', window );"><strong>Schedule of other current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Other liabilities</a></td>
<td class="nump">10.9<span></span>
</td>
<td class="nump">47.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember', window );">Other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ScheduleofothercurrentliabilitiesLineItems', window );"><strong>Schedule of other current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liability</a></td>
<td class="nump">$ 66.7<span></span>
</td>
<td class="nump">$ 100.5<span></span>
</td>
<td class="nump">$ 120.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserveCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 55<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=116646759&amp;loc=d3e15243-108350<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserveCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_ScheduleofothercurrentliabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Schedule of other current liabilities [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_ScheduleofothercurrentliabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=vtrs_VariableConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=vtrs_VariableConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=vtrs_CleanEnergyPartnershipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=vtrs_CleanEnergyPartnershipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942897919816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components (Other noncurrent liabilities) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems', window );"><strong>Schedule of Other Noncurrent Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent', window );">Liability, Defined Benefit Pension Plan, Noncurrent</a></td>
<td class="nump">$ 876.4<span></span>
</td>
<td class="nump">$ 1,020.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liability</a></td>
<td class="nump">199.7<span></span>
</td>
<td class="nump">223.6<span></span>
</td>
<td class="nump">$ 250.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent', window );">Liability for Uncertainty in Income Taxes, Noncurrent</a></td>
<td class="nump">426.1<span></span>
</td>
<td class="nump">469.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating Lease, Liability, Noncurrent</a></td>
<td class="nump">200.9<span></span>
</td>
<td class="nump">229.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveNoncurrent', window );">Restructuring Reserve, Noncurrent</a></td>
<td class="nump">64.3<span></span>
</td>
<td class="nump">134.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent', window );">Liabilities, Other than Long-term Debt, Noncurrent</a></td>
<td class="nump">232.9<span></span>
</td>
<td class="nump">505.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other Liabilities, Noncurrent</a></td>
<td class="nump">1,933.6<span></span>
</td>
<td class="nump">2,483.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember', window );">Other Noncurrent Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems', window );"><strong>Schedule of Other Noncurrent Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liability</a></td>
<td class="nump">$ 133.0<span></span>
</td>
<td class="nump">$ 123.1<span></span>
</td>
<td class="nump">$ 130.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension plan, classified as noncurrent. Excludes other postretirement benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregated carrying amounts of obligations as of the balance sheet date, excluding long-term debt, incurred as part of the normal operations that are expected to be paid after one year or beyond the normal operating cycle, if longer. Alternate captions include Total Deferred Credits and Other Liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for uncertainty in income taxes classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUncertainTaxPositionsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of known and estimated costs associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid after one year or beyond the next operating cycle, if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph 210-10-S99-1(SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Schedule of Other Noncurrent Liabilities [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942898418904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Narrative) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use asset</a></td>
<td class="nump">$ 290,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 323,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liability</a></td>
<td class="nump">287,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_LesseeOperatingLeaseLeaseNotyetCommencedAmount', window );">Amount of operating leases not yet commenced</a></td>
<td class="nump">$ 13,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Other Assets, Noncurrent<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Other Assets, Noncurrent<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Other Liabilities, Current<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Other Liabilities, Current<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Other Liabilities, Noncurrent<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Other Liabilities, Noncurrent<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRent', window );">Payments for Rent</a></td>
<td class="nump">$ 97,600<span></span>
</td>
<td class="nump">$ 80,700<span></span>
</td>
<td class="nump">$ 87,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1', window );">Term of operating leases not yet commenced</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1', window );">Term of operating leases not yet commenced</a></td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease not yet commenced, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes operating lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash payments to lessor's for use of assets under operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_LesseeOperatingLeaseLeaseNotyetCommencedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Lease Not yet Commenced, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_LesseeOperatingLeaseLeaseNotyetCommencedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942901893144">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases (Lease Information) (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term</a></td>
<td class="text">6 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate</a></td>
<td class="nump">2.60%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Remaining lease terms</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Remaining lease terms</a></td>
<td class="text">23 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942907876792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases (Lease Maturities) (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 82,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">65,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">42,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="nump">28,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2026</a></td>
<td class="nump">23,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">68,200<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">310,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="nump">23,200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liability</a></td>
<td class="nump">$ 287,600<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942898756024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Method Investments (Narrative) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_EquityMethodInvestmentsNetGainLossFromImpairmentandReductionInObligations', window );">Equity Method Investments Net Gain (Loss) From Impairment and Reduction In Obligations</a></td>
<td class="nump">$ 5.7<span></span>
</td>
<td class="nump">$ 21.4<span></span>
</td>
<td class="nump">$ 7.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Loss from equity method investments</a></td>
<td class="nump">$ 61.9<span></span>
</td>
<td class="nump">$ 48.4<span></span>
</td>
<td class="nump">$ 62.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=vtrs_CleanEnergyPartnershipsMember', window );">Clean energy investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_Numberofequitymethodinvestments', window );">Number of equity method investments</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_EquityMethodInvestmentsNetGainLossFromImpairmentandReductionInObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investments Net Gain (Loss) From Impairment and Reduction In Obligations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_EquityMethodInvestmentsNetGainLossFromImpairmentandReductionInObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_Numberofequitymethodinvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of equity method investments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_Numberofequitymethodinvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=vtrs_CleanEnergyPartnershipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=vtrs_CleanEnergyPartnershipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942907962040">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Equity Method Investments (Balance Sheet) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">$ 4,619.6<span></span>
</td>
<td class="nump">$ 4,960.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other Liabilities, Noncurrent</a></td>
<td class="nump">1,933.6<span></span>
</td>
<td class="nump">2,483.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=vtrs_CleanEnergyPartnershipsMember', window );">Clean energy investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Other liabilities</a></td>
<td class="nump">10.9<span></span>
</td>
<td class="nump">47.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember', window );">Other assets | Clean energy investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in subsidiaries</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 47.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=vtrs_CleanEnergyPartnershipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=vtrs_CleanEnergyPartnershipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942898418600">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Equity Method Investments (Net Assets) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Assets, Current</a></td>
<td class="nump">$ 10,902.9<span></span>
</td>
<td class="nump">$ 12,867.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">54,842.8<span></span>
</td>
<td class="nump">61,553.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Current liabilities</a></td>
<td class="nump">9,884.4<span></span>
</td>
<td class="nump">10,562.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">34,350.1<span></span>
</td>
<td class="nump">38,598.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_ConsolidatedEntityExcludingVieMember', window );">Consolidated Entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Assets, Current</a></td>
<td class="nump">4.2<span></span>
</td>
<td class="nump">38.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Noncurrent assets</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">4.7<span></span>
</td>
<td class="nump">39.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Current liabilities</a></td>
<td class="nump">2.8<span></span>
</td>
<td class="nump">33.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Noncurrent liabilities</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">2.8<span></span>
</td>
<td class="nump">34.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_EquityMethodInvestmentSummarizedFinancialInformationNetAssets', window );">Net assets</a></td>
<td class="nump">$ 1.9<span></span>
</td>
<td class="nump">$ 5.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_EquityMethodInvestmentSummarizedFinancialInformationNetAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment Summarized Financial Information, Net Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_EquityMethodInvestmentSummarizedFinancialInformationNetAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_ConsolidatedEntityExcludingVieMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_ConsolidatedEntityExcludingVieMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942902061768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Method Investments (Income Statement) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">$ 17,886.3<span></span>
</td>
<td class="nump">$ 11,946.0<span></span>
</td>
<td class="nump">$ 11,500.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross loss</a></td>
<td class="nump">5,575.5<span></span>
</td>
<td class="nump">3,796.7<span></span>
</td>
<td class="nump">3,897.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Operating and non-operating expense</a></td>
<td class="num">(664.4)<span></span>
</td>
<td class="num">(721.2)<span></span>
</td>
<td class="nump">154.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(1,269.1)<span></span>
</td>
<td class="num">(669.9)<span></span>
</td>
<td class="nump">16.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_ConsolidatedEntityExcludingVieMember', window );">Consolidated Entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">326.7<span></span>
</td>
<td class="nump">374.5<span></span>
</td>
<td class="nump">385.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross loss</a></td>
<td class="num">(4.6)<span></span>
</td>
<td class="num">(4.6)<span></span>
</td>
<td class="num">(4.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Operating and non-operating expense</a></td>
<td class="nump">16.8<span></span>
</td>
<td class="nump">19.0<span></span>
</td>
<td class="nump">20.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (21.4)<span></span>
</td>
<td class="num">$ (23.6)<span></span>
</td>
<td class="num">$ (24.4)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_ConsolidatedEntityExcludingVieMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_ConsolidatedEntityExcludingVieMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942895838664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Apr. 01, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Intangible Assets Excluding Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,087,700,000<span></span>
</td>
<td class="nump">$ 29,602,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">199,700,000<span></span>
</td>
<td class="nump">223,600,000<span></span>
</td>
<td class="nump">$ 250,700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments', window );">Contingent consideration payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(83,200,000)<span></span>
</td>
<td class="num">(111,800,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,500,000<span></span>
</td>
<td class="nump">80,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Goodwill, Impaired, Accumulated Impairment Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">385,000,000.0<span></span>
</td>
<td class="nump">385,000,000.0<span></span>
</td>
<td class="nump">385,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,113,700,000<span></span>
</td>
<td class="nump">12,347,000,000<span></span>
</td>
<td class="nump">9,590,600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Intangible Assets Excluding Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">IPR&amp;D intangible asset impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,400,000<span></span>
</td>
<td class="nump">37,400,000<span></span>
</td>
<td class="nump">138,300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Product rights and licenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Intangible Assets Excluding Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,084,500,000<span></span>
</td>
<td class="nump">29,598,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment of products rights and licenses intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83,400,000<span></span>
</td>
<td class="nump">45,000,000.0<span></span>
</td>
<td class="nump">42,300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EuropeSegmentMember', window );">Europe Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Intangible Assets Excluding Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount', window );">Reporting Unit, Amount of Fair Value in Excess of Carrying Amount</a></td>
<td class="nump">$ 910,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount', window );">Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount</a></td>
<td class="nump">5.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 5,150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EuropeSegmentMember', window );">Europe Segment | Valuation Technique, Discounted Cash Flow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Intangible Assets Excluding Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_GoodwillImpairmentMeasurementInputTerm', window );">Goodwill Impairment, Measurement Input, Term</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_NorthAmericaSegmentMember', window );">North America Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Intangible Assets Excluding Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 3,660,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember', window );">JANZ</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Intangible Assets Excluding Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Goodwill, Impaired, Accumulated Impairment Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount', window );">Reporting Unit, Amount of Fair Value in Excess of Carrying Amount</a></td>
<td class="nump">$ 230,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount', window );">Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 820,000,000<span></span>
</td>
<td class="nump">776,300,000<span></span>
</td>
<td class="nump">864,000,000.0<span></span>
</td>
<td class="nump">$ 584,800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember', window );">JANZ | Valuation Technique, Discounted Cash Flow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Intangible Assets Excluding Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_GoodwillImpairmentMeasurementInputTerm', window );">Goodwill Impairment, Measurement Input, Term</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember', window );">JANZ | Product rights and licenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Intangible Assets Excluding Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,495,800,000<span></span>
</td>
<td class="nump">$ 2,803,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Measurement Input, Discount Rate [Member] | In-process research and development | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Intangible Assets Excluding Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIndefiniteLivedIntangibleAssetsMeasurementInput', window );">Rate used to discount net cash inflows to present values</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.070<span></span>
</td>
<td class="nump">0.090<span></span>
</td>
<td class="nump">0.090<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Measurement Input, Discount Rate [Member] | In-process research and development | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Intangible Assets Excluding Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIndefiniteLivedIntangibleAssetsMeasurementInput', window );">Rate used to discount net cash inflows to present values</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.090<span></span>
</td>
<td class="nump">0.110<span></span>
</td>
<td class="nump">0.110<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Measurement Input, Discount Rate [Member] | Product rights and licenses | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Intangible Assets Excluding Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.090<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Measurement Input, Discount Rate [Member] | Product rights and licenses | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Intangible Assets Excluding Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Measurement Input, Discount Rate [Member] | JANZ | Valuation Technique, Discounted Cash Flow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Intangible Assets Excluding Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_GoodwillImpairmentMeasurementInput', window );">Goodwill Impairment, Measurement Input</a></td>
<td class="nump">0.085<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputLongTermRevenueGrowthRateMember', window );">Measurement Input, Long-term Revenue Growth Rate [Member] | Europe Segment | Valuation Technique, Discounted Cash Flow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Intangible Assets Excluding Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_GoodwillImpairmentMeasurementInput', window );">Goodwill Impairment, Measurement Input</a></td>
<td class="nump">0.030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputLongTermRevenueGrowthRateMember', window );">Measurement Input, Long-term Revenue Growth Rate [Member] | JANZ | Valuation Technique, Discounted Cash Flow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Intangible Assets Excluding Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_GoodwillImpairmentMeasurementInput', window );">Goodwill Impairment, Measurement Input</a></td>
<td class="nump">0.015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=vtrs_MeasurementInputEstimatedTaxRateMember', window );">Measurement Input, Estimated Tax Rate [Member] | Europe Segment | Valuation Technique, Discounted Cash Flow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Intangible Assets Excluding Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_GoodwillImpairmentMeasurementInput', window );">Goodwill Impairment, Measurement Input</a></td>
<td class="nump">0.190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=vtrs_MeasurementInputEstimatedTaxRateMember', window );">Measurement Input, Estimated Tax Rate [Member] | JANZ | Valuation Technique, Discounted Cash Flow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Intangible Assets Excluding Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_GoodwillImpairmentMeasurementInput', window );">Goodwill Impairment, Measurement Input</a></td>
<td class="nump">0.305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputEbitdaMultipleMember', window );">Measurement Input, EBITDA Multiple [Member] | Europe Segment | Minimum | Valuation Technique, Discounted Cash Flow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Intangible Assets Excluding Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_GoodwillImpairmentMeasurementInput', window );">Goodwill Impairment, Measurement Input</a></td>
<td class="nump">7.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputEbitdaMultipleMember', window );">Measurement Input, EBITDA Multiple [Member] | Europe Segment | Maximum | Valuation Technique, Discounted Cash Flow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Intangible Assets Excluding Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_GoodwillImpairmentMeasurementInput', window );">Goodwill Impairment, Measurement Input</a></td>
<td class="nump">8.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputEbitdaMultipleMember', window );">Measurement Input, EBITDA Multiple [Member] | JANZ | Valuation Technique, Discounted Cash Flow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Intangible Assets Excluding Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_GoodwillImpairmentMeasurementInput', window );">Goodwill Impairment, Measurement Input</a></td>
<td class="nump">6.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputControlPremiumMember', window );">Measurement Input, Control Premium [Member] | Europe Segment | Valuation Technique, Discounted Cash Flow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Intangible Assets Excluding Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_GoodwillImpairmentMeasurementInput', window );">Goodwill Impairment, Measurement Input</a></td>
<td class="nump">0.150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputControlPremiumMember', window );">Measurement Input, Control Premium [Member] | JANZ | Valuation Technique, Discounted Cash Flow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Intangible Assets Excluding Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_GoodwillImpairmentMeasurementInput', window );">Goodwill Impairment, Measurement Input</a></td>
<td class="nump">0.150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=vtrs_MeasurementInputTerminalYearRevenueGrowthRateMember', window );">Measurement Input, Terminal Year Revenue Growth Rate | Europe Segment | Valuation Technique, Discounted Cash Flow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Intangible Assets Excluding Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_GoodwillImpairmentMeasurementInput', window );">Goodwill Impairment, Measurement Input</a></td>
<td class="nump">0.009<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=vtrs_MeasurementInputTerminalYearRevenueGrowthRateMember', window );">Measurement Input, Terminal Year Revenue Growth Rate | JANZ | Valuation Technique, Discounted Cash Flow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Intangible Assets Excluding Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_GoodwillImpairmentMeasurementInput', window );">Goodwill Impairment, Measurement Input</a></td>
<td class="nump">0.007<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=vtrs_MeasurementInputReductionInTerminalYearRevenueGrowthRateMember', window );">Measurement Input, Reduction in Terminal Year Revenue Growth Rate | Europe Segment | Valuation Technique, Discounted Cash Flow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Intangible Assets Excluding Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_GoodwillImpairmentMeasurementInput', window );">Goodwill Impairment, Measurement Input</a></td>
<td class="num">(0.029)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=vtrs_MeasurementInputReductionInTerminalYearRevenueGrowthRateMember', window );">Measurement Input, Reduction in Terminal Year Revenue Growth Rate | JANZ | Valuation Technique, Discounted Cash Flow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Intangible Assets Excluding Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_GoodwillImpairmentMeasurementInput', window );">Goodwill Impairment, Measurement Input</a></td>
<td class="num">(0.042)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=vtrs_MeasurementInputIncreaseInDiscountRateMember', window );">Measurement Input, Increase in Discount Rate | Europe Segment | Valuation Technique, Discounted Cash Flow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Intangible Assets Excluding Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_GoodwillImpairmentMeasurementInput', window );">Goodwill Impairment, Measurement Input</a></td>
<td class="nump">0.015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=vtrs_MeasurementInputIncreaseInDiscountRateMember', window );">Measurement Input, Increase in Discount Rate | JANZ | Valuation Technique, Discounted Cash Flow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Intangible Assets Excluding Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_GoodwillImpairmentMeasurementInput', window );">Goodwill Impairment, Measurement Input</a></td>
<td class="nump">0.020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vtrs_RespiratorydeliveryplatformMember', window );">Respiratory delivery platform [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Intangible Assets Excluding Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">177,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember', window );">Other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Intangible Assets Excluding Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,700,000<span></span>
</td>
<td class="nump">$ 100,500,000<span></span>
</td>
<td class="nump">$ 120,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments', window );">Contingent consideration payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (83,200,000)<span></span>
</td>
<td class="num">$ (111,800,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of fair value of reporting unit in excess of carrying amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of fair value of reporting unit in excess of carrying amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination Contingent Consideration Liability Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_BusinessCombinationContingentConsiderationLiabilityPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIndefiniteLivedIntangibleAssetsMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets, Measurement Input</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIndefiniteLivedIntangibleAssetsMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_GoodwillImpairmentMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Goodwill Impairment, Measurement Input</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_GoodwillImpairmentMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_GoodwillImpairmentMeasurementInputTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Goodwill Impairment, Measurement Input, Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_GoodwillImpairmentMeasurementInputTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EuropeSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_EuropeSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_NorthAmericaSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_NorthAmericaSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputLongTermRevenueGrowthRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputLongTermRevenueGrowthRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=vtrs_MeasurementInputEstimatedTaxRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=vtrs_MeasurementInputEstimatedTaxRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputEbitdaMultipleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputEbitdaMultipleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputControlPremiumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputControlPremiumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=vtrs_MeasurementInputTerminalYearRevenueGrowthRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=vtrs_MeasurementInputTerminalYearRevenueGrowthRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=vtrs_MeasurementInputReductionInTerminalYearRevenueGrowthRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=vtrs_MeasurementInputReductionInTerminalYearRevenueGrowthRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=vtrs_MeasurementInputIncreaseInDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=vtrs_MeasurementInputIncreaseInDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=vtrs_RespiratorydeliveryplatformMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=vtrs_RespiratorydeliveryplatformMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942898888280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Changes in Carrying Amount Of Goodwill) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Apr. 01, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill, gross, beginning balance</a></td>
<td class="nump">$ 12,732.0<span></span>
</td>
<td class="nump">$ 9,975.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment losses, beginning balance</a></td>
<td class="num">(385.0)<span></span>
</td>
<td class="num">(385.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">12,113.7<span></span>
</td>
<td class="nump">12,347.0<span></span>
</td>
<td class="nump">$ 9,590.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,107.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign currency translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(528.9)<span></span>
</td>
<td class="nump">648.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill, gross, ending balance</a></td>
<td class="nump">12,498.7<span></span>
</td>
<td class="nump">12,732.0<span></span>
</td>
<td class="nump">9,975.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment losses, ending balance</a></td>
<td class="num">(385.0)<span></span>
</td>
<td class="num">(385.0)<span></span>
</td>
<td class="num">(385.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net, ending balance</a></td>
<td class="nump">12,113.7<span></span>
</td>
<td class="nump">12,347.0<span></span>
</td>
<td class="nump">9,590.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">295.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_DevelopedMarketsSegmentMember', window );">Developed Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill, gross, beginning balance</a></td>
<td class="nump">9,569.5<span></span>
</td>
<td class="nump">8,258.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment losses, beginning balance</a></td>
<td class="num">(385.0)<span></span>
</td>
<td class="num">(385.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">8,723.4<span></span>
</td>
<td class="nump">9,184.5<span></span>
</td>
<td class="nump">7,873.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">704.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign currency translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(528.8)<span></span>
</td>
<td class="nump">607.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill, gross, ending balance</a></td>
<td class="nump">9,108.4<span></span>
</td>
<td class="nump">9,569.5<span></span>
</td>
<td class="nump">8,258.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment losses, ending balance</a></td>
<td class="num">(385.0)<span></span>
</td>
<td class="num">(385.0)<span></span>
</td>
<td class="num">(385.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net, ending balance</a></td>
<td class="nump">8,723.4<span></span>
</td>
<td class="nump">9,184.5<span></span>
</td>
<td class="nump">7,873.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember', window );">Greater China</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill, gross, beginning balance</a></td>
<td class="nump">738.3<span></span>
</td>
<td class="nump">67.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment losses, beginning balance</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">969.5<span></span>
</td>
<td class="nump">738.3<span></span>
</td>
<td class="nump">67.8<span></span>
</td>
<td class="nump">$ 700.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">652.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign currency translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.8<span></span>
</td>
<td class="nump">17.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill, gross, ending balance</a></td>
<td class="nump">969.5<span></span>
</td>
<td class="nump">738.3<span></span>
</td>
<td class="nump">67.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment losses, ending balance</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net, ending balance</a></td>
<td class="nump">969.5<span></span>
</td>
<td class="nump">738.3<span></span>
</td>
<td class="nump">67.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">220.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember', window );">JANZ</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill, gross, beginning balance</a></td>
<td class="nump">864.0<span></span>
</td>
<td class="nump">584.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment losses, beginning balance</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">776.3<span></span>
</td>
<td class="nump">864.0<span></span>
</td>
<td class="nump">584.8<span></span>
</td>
<td class="nump">820.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">217.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign currency translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(56.8)<span></span>
</td>
<td class="nump">61.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill, gross, ending balance</a></td>
<td class="nump">776.3<span></span>
</td>
<td class="nump">864.0<span></span>
</td>
<td class="nump">584.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment losses, ending balance</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net, ending balance</a></td>
<td class="nump">776.3<span></span>
</td>
<td class="nump">864.0<span></span>
</td>
<td class="nump">584.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(30.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember', window );">Emerging Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill, gross, beginning balance</a></td>
<td class="nump">1,560.2<span></span>
</td>
<td class="nump">1,065.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment losses, beginning balance</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">1,644.5<span></span>
</td>
<td class="nump">1,560.2<span></span>
</td>
<td class="nump">1,065.0<span></span>
</td>
<td class="nump">$ 1,580.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">533.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign currency translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45.9<span></span>
</td>
<td class="num">(37.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill, gross, ending balance</a></td>
<td class="nump">1,644.5<span></span>
</td>
<td class="nump">1,560.2<span></span>
</td>
<td class="nump">1,065.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment losses, ending balance</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net, ending balance</a></td>
<td class="nump">$ 1,644.5<span></span>
</td>
<td class="nump">1,560.2<span></span>
</td>
<td class="nump">$ 1,065.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_DevelopedMarketsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_DevelopedMarketsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942907965480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Components of Intangible Assets) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, estimated useful life, in years</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">15 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived intangible assets, original cost</a></td>
<td class="nump">$ 39,006.2<span></span>
</td>
<td class="nump">$ 40,404.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-lived intangible assets, accumulated amortization</a></td>
<td class="nump">12,918.5<span></span>
</td>
<td class="nump">10,801.6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net book value</a></td>
<td class="nump">26,087.7<span></span>
</td>
<td class="nump">29,602.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">In-process research and development</a></td>
<td class="nump">46.5<span></span>
</td>
<td class="nump">80.7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, gross, excluding goodwill</a></td>
<td class="nump">39,052.7<span></span>
</td>
<td class="nump">40,484.8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net book value, excluding goodwill</a></td>
<td class="nump">$ 26,134.2<span></span>
</td>
<td class="nump">$ 29,683.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942898641640">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Product Rights and License by Therapeutic Category) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassLineItems', window );"><strong>Schedule of Product Rights and Licenses by Therapeutic Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net</a></td>
<td class="nump">$ 26,087.7<span></span>
</td>
<td class="nump">$ 29,602.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Product rights and licenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassLineItems', window );"><strong>Schedule of Product Rights and Licenses by Therapeutic Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net</a></td>
<td class="nump">26,084.5<span></span>
</td>
<td class="nump">29,598.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Product rights and licenses | Developed Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassLineItems', window );"><strong>Schedule of Product Rights and Licenses by Therapeutic Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net</a></td>
<td class="nump">14,313.6<span></span>
</td>
<td class="nump">17,514.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Product rights and licenses | Greater China</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassLineItems', window );"><strong>Schedule of Product Rights and Licenses by Therapeutic Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net</a></td>
<td class="nump">6,115.0<span></span>
</td>
<td class="nump">4,385.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Product rights and licenses | JANZ</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassLineItems', window );"><strong>Schedule of Product Rights and Licenses by Therapeutic Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net</a></td>
<td class="nump">1,495.8<span></span>
</td>
<td class="nump">2,803.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Product rights and licenses | Emerging Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassLineItems', window );"><strong>Schedule of Product Rights and Licenses by Therapeutic Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net</a></td>
<td class="nump">4,160.1<span></span>
</td>
<td class="nump">4,896.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Product rights and licenses | Brands</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassLineItems', window );"><strong>Schedule of Product Rights and Licenses by Therapeutic Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net</a></td>
<td class="nump">21,146.0<span></span>
</td>
<td class="nump">22,216.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Product rights and licenses | Brands | Developed Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassLineItems', window );"><strong>Schedule of Product Rights and Licenses by Therapeutic Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net</a></td>
<td class="nump">10,066.6<span></span>
</td>
<td class="nump">10,988.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Product rights and licenses | Brands | Greater China</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassLineItems', window );"><strong>Schedule of Product Rights and Licenses by Therapeutic Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net</a></td>
<td class="nump">6,102.9<span></span>
</td>
<td class="nump">4,372.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Product rights and licenses | Brands | JANZ</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassLineItems', window );"><strong>Schedule of Product Rights and Licenses by Therapeutic Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net</a></td>
<td class="nump">1,174.8<span></span>
</td>
<td class="nump">2,377.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Product rights and licenses | Brands | Emerging Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassLineItems', window );"><strong>Schedule of Product Rights and Licenses by Therapeutic Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net</a></td>
<td class="nump">3,801.7<span></span>
</td>
<td class="nump">4,478.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Product rights and licenses | Complex Gx and Biosimilars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassLineItems', window );"><strong>Schedule of Product Rights and Licenses by Therapeutic Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net</a></td>
<td class="nump">228.3<span></span>
</td>
<td class="nump">274.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Product rights and licenses | Complex Gx and Biosimilars | Developed Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassLineItems', window );"><strong>Schedule of Product Rights and Licenses by Therapeutic Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net</a></td>
<td class="nump">226.8<span></span>
</td>
<td class="nump">272.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Product rights and licenses | Complex Gx and Biosimilars | Greater China</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassLineItems', window );"><strong>Schedule of Product Rights and Licenses by Therapeutic Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Product rights and licenses | Complex Gx and Biosimilars | JANZ</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassLineItems', window );"><strong>Schedule of Product Rights and Licenses by Therapeutic Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Product rights and licenses | Complex Gx and Biosimilars | Emerging Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassLineItems', window );"><strong>Schedule of Product Rights and Licenses by Therapeutic Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Product rights and licenses | Generics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassLineItems', window );"><strong>Schedule of Product Rights and Licenses by Therapeutic Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net</a></td>
<td class="nump">4,710.2<span></span>
</td>
<td class="nump">7,107.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Product rights and licenses | Generics | Developed Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassLineItems', window );"><strong>Schedule of Product Rights and Licenses by Therapeutic Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net</a></td>
<td class="nump">4,020.2<span></span>
</td>
<td class="nump">6,253.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Product rights and licenses | Generics | Greater China</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassLineItems', window );"><strong>Schedule of Product Rights and Licenses by Therapeutic Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net</a></td>
<td class="nump">12.1<span></span>
</td>
<td class="nump">12.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Product rights and licenses | Generics | JANZ</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassLineItems', window );"><strong>Schedule of Product Rights and Licenses by Therapeutic Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net</a></td>
<td class="nump">319.5<span></span>
</td>
<td class="nump">423.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Product rights and licenses | Generics | Emerging Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassLineItems', window );"><strong>Schedule of Product Rights and Licenses by Therapeutic Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net</a></td>
<td class="nump">$ 358.4<span></span>
</td>
<td class="nump">$ 417.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Schedule of Product Rights and Licenses by Therapeutic Class</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_DevelopedMarketsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_DevelopedMarketsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_BrandsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_BrandsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_ComplexGXAndBiosimilarsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_ComplexGXAndBiosimilarsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vtrs_GenericsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vtrs_GenericsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942904968296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Amortization Expense) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Intangible Assets Excluding Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Intangible asset amortization expense</a></td>
<td class="nump">$ 2,702.2<span></span>
</td>
<td class="nump">$ 1,605.8<span></span>
</td>
<td class="nump">$ 1,582.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Total intangible asset amortization expense (including impairment charges)</a></td>
<td class="nump">2,805.0<span></span>
</td>
<td class="nump">1,688.2<span></span>
</td>
<td class="nump">1,763.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Intangible Assets Excluding Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">IPR&amp;D intangible asset impairment charges</a></td>
<td class="nump">$ 19.4<span></span>
</td>
<td class="nump">$ 37.4<span></span>
</td>
<td class="nump">$ 138.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942903418200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets Goodwill and Other Intangible Assets (Future amortization expense) (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 2,577<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2023</a></td>
<td class="nump">2,414<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2024</a></td>
<td class="nump">2,320<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2025</a></td>
<td class="nump">2,222<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2026</a></td>
<td class="nump">$ 2,164<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942893249384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments and Risk Management (Narrative) (Details)<br> &#8364; in Millions, &#165; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>JPY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>JPY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amount of derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings', window );">Gain (Loss) on Fair Value Hedges Recognized in Earnings</a></td>
<td class="nump">$ 39.3<span></span>
</td>
<td class="num">(10.1)<span></span>
</td>
<td class="num">$ (17.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths', window );">Pre-tax net losses on cash flow hedges to be reclassified from AOCE into earnings in next twelve months</a></td>
<td class="nump">21.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Purchase consideration, contingent consideration</a></td>
<td class="nump">199.7<span></span>
</td>
<td class="nump">223.6<span></span>
</td>
<td class="nump">250.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications', window );">Reclassifications</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionExpense', window );">Accretion</a></td>
<td class="nump">9.0<span></span>
</td>
<td class="nump">11.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments', window );">Contingent consideration payments</a></td>
<td class="num">(83.2)<span></span>
</td>
<td class="num">(111.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionExpense', window );">Accretion</a></td>
<td class="nump">6.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionExpense', window );">Accretion</a></td>
<td class="nump">8.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vtrs_RespiratorydeliveryplatformMember', window );">Respiratory delivery platform [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Purchase consideration, contingent consideration</a></td>
<td class="nump">$ 177.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=vtrs_A2020EuroSeniorNotesMember', window );">2020 Euro Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="nump">0.816%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.816%<span></span>
</td>
<td class="nump">0.816%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=vtrs_A2022EuroSeniorNotesMember', window );">2022 Euro Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">928.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="nump">0.816%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.816%<span></span>
</td>
<td class="nump">0.816%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=vtrs_A2024EuroSeniorNotes1023Member', window );">2.125% Euro Senior Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="nump">1.023%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.023%<span></span>
</td>
<td class="nump">1.023%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=vtrs_A2027EuroSeniorNotesMember', window );">2027 Euro Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="nump">1.362%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.362%<span></span>
</td>
<td class="nump">1.362%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=vtrs_YENTermLoanMember', window );">YEN Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 347.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.250% Euro Senior Notes due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 1,135.8<span></span>
</td>
<td class="nump">1,219.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.25%<span></span>
</td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.125% Euro Senior Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 871.6<span></span>
</td>
<td class="nump">944.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2025 Euro Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 567.8<span></span>
</td>
<td class="nump">609.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="nump">2.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.125%<span></span>
</td>
<td class="nump">2.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2028 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 748.7<span></span>
</td>
<td class="nump">748.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="nump">4.55%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.55%<span></span>
</td>
<td class="nump">4.55%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2027 Euro Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 1,013.0<span></span>
</td>
<td class="nump">1,097.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2032 Euro Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 1,546.6<span></span>
</td>
<td class="nump">1,672.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="nump">1.908%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.908%<span></span>
</td>
<td class="nump">1.908%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2028 Euro Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 847.4<span></span>
</td>
<td class="nump">909.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="nump">3.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.125%<span></span>
</td>
<td class="nump">3.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Senior Notes 2023 3.125%</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 766.1<span></span>
</td>
<td class="nump">781.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="nump">3.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.125%<span></span>
</td>
<td class="nump">3.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amount of derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 5,850.0<span></span>
</td>
<td class="nump">&#165; 40,000<span></span>
</td>
<td class="nump">&#8364; 5,955.6<span></span>
</td>
<td class="nump">&#165; 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,955.6<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | 2022 Euro Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amount of derivative | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | 2.250% Euro Senior Notes due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amount of derivative | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | 2.125% Euro Senior Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amount of derivative | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | 2025 Euro Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amount of derivative | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | 2028 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amount of derivative | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | 2027 Euro Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amount of derivative | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">850.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">850.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">850.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | 2032 Euro Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amount of derivative | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | 2020 Floating Rate Euro Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amount of derivative | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 105.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 105.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | YEN Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amount of derivative | &#165;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt | &#165;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember', window );">Other Noncurrent Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Purchase consideration, contingent consideration</a></td>
<td class="nump">$ 133.0<span></span>
</td>
<td class="nump">123.1<span></span>
</td>
<td class="nump">130.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications', window );">Reclassifications</a></td>
<td class="num">(49.4)<span></span>
</td>
<td class="num">(58.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionExpense', window );">Accretion</a></td>
<td class="nump">9.0<span></span>
</td>
<td class="nump">11.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments', window );">Contingent consideration payments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember', window );">Other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Purchase consideration, contingent consideration</a></td>
<td class="nump">66.7<span></span>
</td>
<td class="nump">100.5<span></span>
</td>
<td class="nump">$ 120.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications', window );">Reclassifications</a></td>
<td class="nump">49.4<span></span>
</td>
<td class="nump">58.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionExpense', window );">Accretion</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments', window );">Contingent consideration payments</a></td>
<td class="num">$ (83.2)<span></span>
</td>
<td class="num">$ (111.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Measurement Input, Discount Rate [Member] | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetLiabilityNetMeasurementInput', window );">Derivative Asset (Liability) Net, Measurement Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.021<span></span>
</td>
<td class="nump">0.021<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Measurement Input, Discount Rate [Member] | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetLiabilityNetMeasurementInput', window );">Derivative Asset (Liability) Net, Measurement Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.105<span></span>
</td>
<td class="nump">0.105<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Measurement Input, Discount Rate [Member] | Contingent consideration | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Rate used to discount net cash inflows to present values</a></td>
<td class="nump">0.080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.080<span></span>
</td>
<td class="nump">0.080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Measurement Input, Discount Rate [Member] | Contingent consideration | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Rate used to discount net cash inflows to present values</a></td>
<td class="nump">0.105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.105<span></span>
</td>
<td class="nump">0.105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6392676&amp;loc=d3e7480-110848<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 35<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6394232&amp;loc=d3e17558-110866<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure contingent consideration liability from business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetLiabilityNetMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure net derivative asset (liability).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetLiabilityNetMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total amount of gain (loss) derived from fair value hedges recognized in earnings in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration Arrangements, Reclassifications</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination Contingent Consideration Liability Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_BusinessCombinationContingentConsiderationLiabilityPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=vtrs_RespiratorydeliveryplatformMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=vtrs_RespiratorydeliveryplatformMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2020EuroSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2020EuroSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2022EuroSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2022EuroSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2024EuroSeniorNotes1023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2024EuroSeniorNotes1023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2027EuroSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2027EuroSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_YENTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_YENTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2024EuroSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2024EuroSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2025EuroSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2025EuroSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2028SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2028SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2032EuroSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2032EuroSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2028EuroSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2028EuroSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2020FloatingRateEuroNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2020FloatingRateEuroNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=vtrs_ContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=vtrs_ContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942901985048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments and Risk Management (Derivatives Designated as Hedging Instruments Fair Values of Derivative Instruments) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of financial instruments</a></td>
<td class="nump">$ 144.6<span></span>
</td>
<td class="nump">$ 118.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Liability derivatives, fair value</a></td>
<td class="nump">61.0<span></span>
</td>
<td class="nump">103.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as hedging instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of financial instruments</a></td>
<td class="nump">62.0<span></span>
</td>
<td class="nump">28.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as hedging instrument | Prepaid expenses and other current assets | Foreign Exchange Forward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of financial instruments</a></td>
<td class="nump">62.0<span></span>
</td>
<td class="nump">28.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as hedging instrument | Other current liabilities | Foreign Exchange Forward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Liability derivatives, fair value</a></td>
<td class="nump">$ 4.3<span></span>
</td>
<td class="nump">$ 0.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942899065512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments and Risk Management (Derivatives Not Designated as Hedging Instruments Fair Values of Derivative Instruments) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of financial instruments</a></td>
<td class="nump">$ 144.6<span></span>
</td>
<td class="nump">$ 118.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Liability derivatives, fair value</a></td>
<td class="nump">61.0<span></span>
</td>
<td class="nump">103.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not designated as hedging instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of financial instruments</a></td>
<td class="nump">82.6<span></span>
</td>
<td class="nump">90.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Liability derivatives, fair value</a></td>
<td class="nump">56.7<span></span>
</td>
<td class="nump">102.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not designated as hedging instrument | Prepaid expenses and other current assets | Foreign Exchange Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of financial instruments</a></td>
<td class="nump">82.6<span></span>
</td>
<td class="nump">90.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not designated as hedging instrument | Other current liabilities | Foreign Exchange Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Liability derivatives, fair value</a></td>
<td class="nump">$ 56.7<span></span>
</td>
<td class="nump">$ 102.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942907811128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments and Risk Management (Effect of Derivative Instruments on the Consolidated Statements of Operations Derivatives in Fair Value Hedging Relationships) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings', window );">Gain (Loss) on Fair Value Hedges Recognized in Earnings</a></td>
<td class="nump">$ 39.3<span></span>
</td>
<td class="num">$ (10.1)<span></span>
</td>
<td class="num">$ (17.3)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherExpenseMember', window );">Other income | Foreign Exchange Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Derivative Financial Instruments Not Designated as Hedging Instruments:</a></td>
<td class="nump">39.3<span></span>
</td>
<td class="num">(10.1)<span></span>
</td>
<td class="num">(17.3)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair value hedging relationships | Interest Expense [Member] | Interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Derivative, Gain (Loss) on Derivative, Net</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">22.1<span></span>
</td>
<td class="nump">18.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair value hedging relationships | Interest Expense [Member] | Senior Notes 2023 3.125%</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings', window );">Gain (Loss) on Fair Value Hedges Recognized in Earnings</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="num">$ (22.1)<span></span>
</td>
<td class="num">$ (18.7)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998890-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total amount of gain (loss) derived from fair value hedges recognized in earnings in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942908622952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments and Risk Management (Effect of Derivative Instruments on the Consolidated Statements of Comprehensive Earnings Derivatives in Cash Flow Hedging Relationships) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Exchange Contract | Cash flow hedging relationships | Other income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet', window );">Amount of Gain Excluded from the Assessment of Hedge Effectiveness</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 7.1<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of gains and losses (net) on derivative instruments designated and qualifying as hedging instruments representing (a) the amount of the hedge ineffectiveness and (b) the amount, if any, excluded from the assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 25<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1),(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121577467&amp;loc=d3e76258-113986<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942901987336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments and Risk Management (Effect of Derivative Instruments on the Condensed Consolidated Statements of Comprehensive Earnings Derivatives in Net Investment Hedging Relationship) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Derivative Financial Instruments in Net Investment Hedging Relationships:</a></td>
<td class="nump">$ 479.0<span></span>
</td>
<td class="num">$ (325.8)<span></span>
</td>
<td class="nump">$ 76.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign currency borrowings and forward contracts | Cash Flow Hedging [Mem</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Derivative Financial Instruments in Cash Flow Hedging Relationships (2) :</a></td>
<td class="nump">45.8<span></span>
</td>
<td class="nump">20.6<span></span>
</td>
<td class="nump">16.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swaps | Cash Flow Hedging [Mem</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Derivative Financial Instruments in Cash Flow Hedging Relationships (2) :</a></td>
<td class="num">(3.4)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember', window );">Gains and Losses on Derivatives in Cash Flow Hedging Relationships | Foreign currency borrowings and forward contracts | Net Investment Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</a></td>
<td class="nump">$ 436.6<span></span>
</td>
<td class="num">$ (346.4)<span></span>
</td>
<td class="nump">$ 56.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942898740632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments and Risk Management (Effect of Derivative Instruments on the Consolidated Statements of Operations Derivatives in Cash Flow Hedging Relationships) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Derivative Financial Instruments in Net Investment Hedging Relationships:</a></td>
<td class="nump">$ 479.0<span></span>
</td>
<td class="num">$ (325.8)<span></span>
</td>
<td class="nump">$ 76.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash flow hedging relationships | Foreign Exchange Contract | Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net</a></td>
<td class="nump">30.9<span></span>
</td>
<td class="nump">4.8<span></span>
</td>
<td class="num">(0.7)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash flow hedging relationships | Foreign Exchange Contract | Other income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet', window );">Amount of Gain Excluded from the Assessment of Hedge Effectiveness</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">7.1<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash flow hedging relationships | Interest rate swaps | Interest Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net</a></td>
<td class="num">$ (4.3)<span></span>
</td>
<td class="num">$ (4.5)<span></span>
</td>
<td class="num">$ (7.1)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624177-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of gains and losses (net) on derivative instruments designated and qualifying as hedging instruments representing (a) the amount of the hedge ineffectiveness and (b) the amount, if any, excluded from the assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 25<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1),(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121577467&amp;loc=d3e76258-113986<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942908660376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments and Risk Management (Effect of Derivative Instruments on the Consolidated Statements of Operations Derivatives Not Designated as Hedging Instruments) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax', window );">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax</a></td>
<td class="nump">$ 26.6<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="num">$ (7.8)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Mem | Foreign Exchange Contract | Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net</a></td>
<td class="nump">30.9<span></span>
</td>
<td class="nump">4.8<span></span>
</td>
<td class="num">(0.7)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Mem | Interest rate swaps | Interest Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net</a></td>
<td class="num">$ (4.3)<span></span>
</td>
<td class="num">$ (4.5)<span></span>
</td>
<td class="num">$ (7.1)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624177-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL34724391-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942897523912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments and Risk Management (Financial Assets and Liabilities Carried at Fair Value) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">$ 50.9<span></span>
</td>
<td class="nump">$ 0.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent', window );">Equity securities</a></td>
<td class="nump">51.0<span></span>
</td>
<td class="nump">45.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">38.2<span></span>
</td>
<td class="nump">39.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets at recurring fair value measurement</a></td>
<td class="nump">284.7<span></span>
</td>
<td class="nump">204.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities at recurring fair value measurement</a></td>
<td class="nump">260.7<span></span>
</td>
<td class="nump">327.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Exchange Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign exchange derivative assets</a></td>
<td class="nump">144.6<span></span>
</td>
<td class="nump">118.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Exchange Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign exchange derivative liabilities</a></td>
<td class="nump">61.0<span></span>
</td>
<td class="nump">103.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=vtrs_ContingentConsiderationMember', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Contingent consideration</a></td>
<td class="nump">199.7<span></span>
</td>
<td class="nump">223.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">50.9<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_ExchangeTradedFundsMember', window );">Equity securities &#8212; exchange traded funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent', window );">Equity securities</a></td>
<td class="nump">50.3<span></span>
</td>
<td class="nump">45.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_DebtSecuritiesMember', window );">Available-for-sale fixed income investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">38.2<span></span>
</td>
<td class="nump">39.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. Treasuries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">14.6<span></span>
</td>
<td class="nump">14.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CorporateBondSecuritiesMember', window );">Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">16.6<span></span>
</td>
<td class="nump">17.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_MortgageBackedSecuritiesMember', window );">Agency mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_AssetBackedSecuritiesMember', window );">Asset-backed Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">4.6<span></span>
</td>
<td class="nump">4.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_OtherDebtSecuritiesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_EquitySecuritiesMember', window );">Total equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent', window );">Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CommonStockMember', window );">Marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent', window );">Equity securities</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=vtrs_MarketableSecuritiesMember', window );">Marketable Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent', window );">Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">50.9<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent', window );">Equity securities</a></td>
<td class="nump">51.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets at recurring fair value measurement</a></td>
<td class="nump">101.9<span></span>
</td>
<td class="nump">46.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">50.9<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Equity securities &#8212; exchange traded funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent', window );">Equity securities</a></td>
<td class="nump">50.3<span></span>
</td>
<td class="nump">45.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Total equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent', window );">Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent', window );">Equity securities</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Marketable Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent', window );">Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets at recurring fair value measurement</a></td>
<td class="nump">182.8<span></span>
</td>
<td class="nump">157.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities at recurring fair value measurement</a></td>
<td class="nump">61.0<span></span>
</td>
<td class="nump">103.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Foreign Exchange Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign exchange derivative assets</a></td>
<td class="nump">144.6<span></span>
</td>
<td class="nump">118.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Foreign Exchange Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign exchange derivative liabilities</a></td>
<td class="nump">61.0<span></span>
</td>
<td class="nump">103.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Available-for-sale fixed income investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">38.2<span></span>
</td>
<td class="nump">39.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | U.S. Treasuries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">14.6<span></span>
</td>
<td class="nump">14.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">16.6<span></span>
</td>
<td class="nump">17.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Agency mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Asset-backed Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">4.6<span></span>
</td>
<td class="nump">4.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities at recurring fair value measurement</a></td>
<td class="nump">199.7<span></span>
</td>
<td class="nump">223.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Contingent consideration</a></td>
<td class="nump">$ 199.7<span></span>
</td>
<td class="nump">$ 223.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractAssetFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of other liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=vtrs_ContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=vtrs_ContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_ExchangeTradedFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_ExchangeTradedFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CorporateBondSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_CorporateBondSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_MortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_MortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_OtherDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_OtherDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=vtrs_MarketableSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=vtrs_MarketableSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942898306360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments and Risk Management (Rollforward of Contingent Consideration) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ScheduleofActivityinContingentConsiderationRollForward', window );"><strong>Schedule of Activity in Contingent Consideration [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Balance at beginning of period</a></td>
<td class="nump">$ 223.6<span></span>
</td>
<td class="nump">$ 250.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments', window );">Payments</a></td>
<td class="nump">83.2<span></span>
</td>
<td class="nump">111.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionExpense', window );">Accretion</a></td>
<td class="nump">9.0<span></span>
</td>
<td class="nump">11.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications', window );">Reclassifications</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss', window );">Fair value loss (gain)</a></td>
<td class="nump">50.3<span></span>
</td>
<td class="nump">73.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Balance at end of period</a></td>
<td class="nump">199.7<span></span>
</td>
<td class="nump">223.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember', window );">Other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ScheduleofActivityinContingentConsiderationRollForward', window );"><strong>Schedule of Activity in Contingent Consideration [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Balance at beginning of period</a></td>
<td class="nump">100.5<span></span>
</td>
<td class="nump">120.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments', window );">Payments</a></td>
<td class="nump">83.2<span></span>
</td>
<td class="nump">111.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionExpense', window );">Accretion</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications', window );">Reclassifications</a></td>
<td class="nump">49.4<span></span>
</td>
<td class="nump">58.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss', window );">Fair value loss (gain)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">33.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Balance at end of period</a></td>
<td class="nump">66.7<span></span>
</td>
<td class="nump">100.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember', window );">Other Noncurrent Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ScheduleofActivityinContingentConsiderationRollForward', window );"><strong>Schedule of Activity in Contingent Consideration [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Balance at beginning of period</a></td>
<td class="nump">123.1<span></span>
</td>
<td class="nump">130.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments', window );">Payments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionExpense', window );">Accretion</a></td>
<td class="nump">9.0<span></span>
</td>
<td class="nump">11.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications', window );">Reclassifications</a></td>
<td class="num">(49.4)<span></span>
</td>
<td class="num">(58.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss', window );">Fair value loss (gain)</a></td>
<td class="nump">50.3<span></span>
</td>
<td class="nump">39.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Balance at end of period</a></td>
<td class="nump">$ 133.0<span></span>
</td>
<td class="nump">$ 123.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6392676&amp;loc=d3e7480-110848<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 35<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6394232&amp;loc=d3e17558-110866<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration Arrangements, Reclassifications</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Liability, Fair Value Gain (Loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_BusinessCombinationContingentConsiderationLiabilityPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination Contingent Consideration Liability Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_BusinessCombinationContingentConsiderationLiabilityPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_ScheduleofActivityinContingentConsiderationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Activity in Contingent Consideration [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_ScheduleofActivityinContingentConsiderationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942895344760">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments and Risk Management (Schedule of Available-for-sale Securities Reconciliation) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">$ 38.1<span></span>
</td>
<td class="nump">$ 37.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">38.2<span></span>
</td>
<td class="nump">39.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DebtSecuritiesMember', window );">Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">38.1<span></span>
</td>
<td class="nump">37.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">$ 38.2<span></span>
</td>
<td class="nump">$ 39.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942907944648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments and Risk Management (Maturities of Available-for-sale Debt Securities at Fair Value) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Mature within one year</a></td>
<td class="nump">$ 1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">Mature in one to five years</a></td>
<td class="nump">19.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAndLaterFairValue', window );">Mature in five years and later</a></td>
<td class="nump">17.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale securities, debt securities</a></td>
<td class="nump">$ 38.2<span></span>
</td>
<td class="nump">$ 39.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAndLaterFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Available for sale securities debt maturities after five years and later fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAndLaterFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942906687912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt (Short-term borrowings) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term borrowings</a></td>
<td class="nump">$ 1,493,000<span></span>
</td>
<td class="nump">$ 1,100,900<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember', window );">Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term borrowings</a></td>
<td class="nump">1,173,400<span></span>
</td>
<td class="nump">651,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=vtrs_ReceivablesFacilityMember', window );">Receivables Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term borrowings</a></td>
<td class="nump">318,500<span></span>
</td>
<td class="nump">248,400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=vtrs_NoteSecuritizationFacilityMember', window );">Note Securitization Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term borrowings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=vtrs_OtherCurrentPortionofLongtermDebtMember', window );">Other Current Portion of Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term borrowings</a></td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=vtrs_ReceivablesFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=vtrs_ReceivablesFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=vtrs_NoteSecuritizationFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=vtrs_NoteSecuritizationFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_OtherCurrentPortionofLongtermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_OtherCurrentPortionofLongtermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942898172152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt Debt (Receivables Facility and Commercial Paper Program) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 06, 2017</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,493,000<span></span>
</td>
<td class="nump">$ 1,100,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableFromSecuritization', window );">Securitized accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">388,900<span></span>
</td>
<td class="nump">389,400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=vtrs_CommercialPaperProgramMember', window );">Commercial Paper Program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="nump">$ 1,650,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt Instrument, Term</a></td>
<td class="text">364 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=vtrs_ReceivablesFacilityMember', window );">Receivables Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">318,500<span></span>
</td>
<td class="nump">248,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity', window );">Accounts receivable securitization facility maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=vtrs_NoteSecuritizationFacilityMember', window );">Note Securitization Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity', window );">Accounts receivable securitization facility maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember', window );">London Interbank Offered Rate (LIBOR) [Member] | Receivables Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt Instrument, Basis Spread on Variable Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.925%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember', window );">London Interbank Offered Rate (LIBOR) [Member] | Note Securitization Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt Instrument, Basis Spread on Variable Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableFromSecuritization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount owed to the reporting entity by counterparties in securitized loan transactions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableFromSecuritization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts receivable facility maximum borrowing capacity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_CommercialPaperProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_CommercialPaperProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=vtrs_ReceivablesFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=vtrs_ReceivablesFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=vtrs_NoteSecuritizationFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=vtrs_NoteSecuritizationFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942896738392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Summary of Long-term Debt) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Debt, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,860.3<span></span>
</td>
<td class="nump">$ 2,256.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Unamortized Debt Issuance Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(42.3)<span></span>
</td>
<td class="num">(47.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,717.1<span></span>
</td>
<td class="nump">22,429.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities', window );">Proceeds from Sale of Securities, Operating Activities</a></td>
<td class="nump">$ 45.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=vtrs_OtherCurrentPortionofLongtermDebtMember', window );">Other Current Portion of Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Debt, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">8.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=vtrs_A2020EuroSeniorNotesMember', window );">2020 Euro Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Debt, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 856.6<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.816%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=vtrs_SeniorNotesTwoThousandTwenty3.75PercentMember', window );">2020 Senior Notes (3.750% coupon)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Debt, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,002.9<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=vtrs_OtherLongTermDebtMember', window );">Other Long Term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.9<span></span>
</td>
<td class="nump">17.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=vtrs_A2020FloatingRateEuroNotesMember', window );">2020 Floating Rate Euro Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Debt, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">2,249.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=vtrs_SeniorNotes2021Member', window );">Senior Notes 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=vtrs_A2022EuroSeniorNotesMember', window );">2022 Euro Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.816%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">928.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=vtrs_SeniorNotes2022Member', window );">Senior Notes 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">1,008.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=vtrs_A2024EuroSeniorNotes1023Member', window );">2.125% Euro Senior Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.023%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=vtrs_A2027EuroSeniorNotesMember', window );">2027 Euro Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.362%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=vtrs_A2027SeniorNotesMember', window );">2027 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=vtrs_TermLoanMember', window );">Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Senior Notes 2023 3.125%</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 766.1<span></span>
</td>
<td class="nump">781.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2023 Senior Notes (4.200%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 499.6<span></span>
</td>
<td class="nump">499.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.250% Euro Senior Notes due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,135.8<span></span>
</td>
<td class="nump">1,219.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2025 Euro Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 567.8<span></span>
</td>
<td class="nump">609.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2026 Senior Notes (3.950%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,241.4<span></span>
</td>
<td class="nump">2,239.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2028 Euro Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 847.4<span></span>
</td>
<td class="nump">909.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2028 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.55%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 748.7<span></span>
</td>
<td class="nump">748.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2043 Senior Notes (5.400%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 497.3<span></span>
</td>
<td class="nump">497.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2046 Senior Notes (5.250%)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 999.9<span></span>
</td>
<td class="nump">999.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2048 Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 747.8<span></span>
</td>
<td class="nump">747.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.125% Euro Senior Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">871.6<span></span>
</td>
<td class="nump">944.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2027 Euro Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,013.0<span></span>
</td>
<td class="nump">1,097.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2027 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 780.8<span></span>
</td>
<td class="nump">786.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2030 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,520.5<span></span>
</td>
<td class="nump">1,528.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2032 Euro Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.908%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,546.6<span></span>
</td>
<td class="nump">1,672.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2040 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,657.1<span></span>
</td>
<td class="nump">1,663.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2050 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,205.1<span></span>
</td>
<td class="nump">2,209.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2025 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 763.4<span></span>
</td>
<td class="nump">767.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=vtrs_CurrentPortionofLongTermDebtMember', window );">Current portion of long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Unamortized Debt Issuance Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.1)<span></span>
</td>
<td class="num">$ (1.4)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received from sale of investments in debt and equity securities, classified as operating activities, during the period; includes trading securities and any other investments classified as operating.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnamortizedDebtIssuanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnamortizedDebtIssuanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_OtherCurrentPortionofLongtermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_OtherCurrentPortionofLongtermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2020EuroSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2020EuroSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_SeniorNotesTwoThousandTwenty3.75PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_SeniorNotesTwoThousandTwenty3.75PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_OtherLongTermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_OtherLongTermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2020FloatingRateEuroNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2020FloatingRateEuroNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_SeniorNotes2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_SeniorNotes2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2022EuroSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2022EuroSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_SeniorNotes2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_SeniorNotes2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2024EuroSeniorNotes1023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2024EuroSeniorNotes1023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2027EuroSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2027EuroSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2027SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2027SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2024EuroSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2024EuroSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2025EuroSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2025EuroSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2028EuroSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2028EuroSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2028SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2028SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_SeniorNotesTwoThousandFortyThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_SeniorNotesTwoThousandFortyThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2048SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2048SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2030SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2030SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2032EuroSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2032EuroSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2040SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2040SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2050SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2050SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2025SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2025SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=vtrs_CurrentPortionofLongTermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=vtrs_CurrentPortionofLongTermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942903656840">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt (Revolving Facilities and Term Facilities) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Debt, Current</a></td>
<td class="nump">$ 1,860.3<span></span>
</td>
<td class="nump">$ 2,256.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942899130904">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt (Issuance of 2018 Senior Notes) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 19,717.1<span></span>
</td>
<td class="nump">$ 22,429.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2028 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="nump">4.55%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2048 Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="nump">5.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2028SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2028SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2048SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2048SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942895612072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt (Senior Notes) (Details)<br> $ in Millions, &#165; in Billions</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 31, 2021 </div>
<div>JPY (&#165;) </div>
<div>Rate</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 19,717.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,429.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term Debt, Gross</a></td>
<td class="nump">$ 20,949.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vtrs_UpjohnInc.Member', window );">Upjohn Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,847.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=vtrs_A2020EuroSeniorNotesMember', window );">2020 Euro Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="nump">0.816%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=vtrs_YENTermLoanMember', window );">YEN Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 347.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Upjohn Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,450.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.250% Euro Senior Notes due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 1,135.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,219.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.250% Euro Senior Notes due 2024 | Upjohn Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">916.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2028 Euro Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="nump">3.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 847.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">909.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2028 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="nump">4.55%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 748.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">748.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2048 Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="nump">5.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 747.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">747.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2025 Euro Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="nump">2.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 567.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 609.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | USD Term Loan Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Twenty Twenty One Revolving Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | 2020 Revolving Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember', window );">Medium-term Notes | YEN Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount | &#165;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember', window );">Medium-term Notes | Twenty Twenty One Loan Facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_MaximumLeverageRatioPeriodTwo', window );">Maximum Leverage Ratio, Period Two | Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_MaximumLeverageRatioPeriodOne', window );">Maximum Leverage Ratio, Period One | Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">425.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_MaximumLeverageRatioPeriodThree', window );">Maximum Leverage Ratio, Period Three | Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">375.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_MaximumLeverageRatioPeriodOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum Leverage Ratio, Period One</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_MaximumLeverageRatioPeriodOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_MaximumLeverageRatioPeriodThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum Leverage Ratio, Period Three</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_MaximumLeverageRatioPeriodThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_MaximumLeverageRatioPeriodTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum Leverage Ratio, Period Two</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_MaximumLeverageRatioPeriodTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=vtrs_UpjohnInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=vtrs_UpjohnInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2020EuroSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2020EuroSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_YENTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_YENTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2024EuroSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2024EuroSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2028EuroSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2028EuroSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2028SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2028SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2048SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2048SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2025EuroSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2025EuroSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_USDTermLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_USDTermLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_TwentyTwentyOneRevolvingFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_TwentyTwentyOneRevolvingFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2020RevolvingFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2020RevolvingFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_TwentyTwentyOneLoanFacilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_TwentyTwentyOneLoanFacilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942908944744">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt (Fair Value) (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Nov. 13, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vtrs_UpjohnInc.Member', window );">Upjohn Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid to acquire asset</a></td>
<td class="nump">$ 12,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair value of long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,010<span></span>
</td>
<td class="nump">$ 25,900<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=vtrs_UpjohnInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=vtrs_UpjohnInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942897856328">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt (Upjohn Senior Notes) (Details)<br> &#8364; in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Oct. 29, 2021</div></th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_DebtInstrumentConversionOfUnregisteredNotesToRegisteredNotesAsAPercentage', window );">Debt Instrument, Conversion Of Unregistered Notes To Registered Notes, As A Percentage</a></td>
<td class="nump">99.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vtrs_UpjohnInc.Member', window );">Upjohn Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,847.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vtrs_UpjohnInc.Member', window );">Upjohn Inc. | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,450.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vtrs_UpjohnInc.Member', window );">Upjohn Inc. | Senior Notes | 2022 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vtrs_UpjohnInc.Member', window );">Upjohn Inc. | Senior Notes | 2025 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vtrs_UpjohnInc.Member', window );">Upjohn Inc. | Senior Notes | 2027 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vtrs_UpjohnInc.Member', window );">Upjohn Inc. | Senior Notes | 2030 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,450.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vtrs_UpjohnInc.Member', window );">Upjohn Inc. | Senior Notes | 2040 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vtrs_UpjohnInc.Member', window );">Upjohn Inc. | Senior Notes | 2050 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vtrs_UpjohnInc.Member', window );">Upjohn Inc. | Senior Notes | 2022 Euro Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">916.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vtrs_UpjohnInc.Member', window );">Upjohn Inc. | Senior Notes | 2027 Euro Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,038.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vtrs_UpjohnInc.Member', window );">Upjohn Inc. | Senior Notes | 2.250% Euro Senior Notes due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">916.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vtrs_UpjohnInc.Member', window );">Upjohn Inc. | Senior Notes | 2032 Euro Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,527.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vtrs_UpjohnInc.Member', window );">Upjohn Inc. | Senior Notes | Upjohn Euro Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 3,600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vtrs_UpjohnInc.Member', window );">Upjohn Inc. | Senior Notes | Unregistered Upjohn U.S. Dollar Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,450.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_DebtInstrumentConversionOfUnregisteredNotesToRegisteredNotesAsAPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Conversion Of Unregistered Notes To Registered Notes, As A Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_DebtInstrumentConversionOfUnregisteredNotesToRegisteredNotesAsAPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=vtrs_UpjohnInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=vtrs_UpjohnInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2022SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2022SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2025SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2025SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2027SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2027SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2030SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2030SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2040SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2040SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2050SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2050SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2022EuroSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2022EuroSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2027EuroSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2027EuroSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2024EuroSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2024EuroSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_A2032EuroSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_A2032EuroSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_UpjohnEuroNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_UpjohnEuroNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vtrs_UnregisteredUpjohnUSDollarNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vtrs_UnregisteredUpjohnUSDollarNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942905096696">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt (Minimum Repayments on Outstanding Borrowings) (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2021</a></td>
<td class="nump">$ 1,853<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2022</a></td>
<td class="nump">1,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2023</a></td>
<td class="nump">1,990<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2024</a></td>
<td class="nump">1,318<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2025</a></td>
<td class="nump">2,598<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Thereafter</a></td>
<td class="nump">11,940<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total</a></td>
<td class="nump">$ 20,949<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942898083336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Comprehensive Earnings (Accumulated Other Comprehensive Loss) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="nump">$ 20,492.7<span></span>
</td>
<td class="nump">$ 22,954.1<span></span>
</td>
<td class="nump">$ 11,883.8<span></span>
</td>
<td class="nump">$ 12,167.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Net unrealized gain on marketable securities, net of tax</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</a></td>
<td class="num">(32.2)<span></span>
</td>
<td class="nump">26.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="num">(1,802.4)<span></span>
</td>
<td class="num">(461.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="num">(1,744.3)<span></span>
</td>
<td class="num">(858.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Net unrealized gain on marketable securities, net of tax</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Net unrecognized (loss) gain and prior service cost related to defined benefit plans, net of tax</a></td>
<td class="nump">32.2<span></span>
</td>
<td class="num">(26.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="num">(1,802.4)<span></span>
</td>
<td class="num">(461.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="num">(1,744.3)<span></span>
</td>
<td class="num">(858.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Net unrecognized (loss) gain and prior service cost related to defined benefit plans, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">AOCI Attributable to Parent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="num">(1,744.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,797.2)<span></span>
</td>
<td class="num">(1,441.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,797.2)<span></span>
</td>
<td class="num">(1,441.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,797.2)<span></span>
</td>
<td class="num">(1,441.3)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">AOCI Attributable to Parent [Member] | Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.6)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign Currency Translation Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,674.5)<span></span>
</td>
<td class="num">(1,259.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax', window );">Foreign currency translation adjustment</a></td>
<td class="num">(1,340.9)<span></span>
</td>
<td class="nump">1,213.0<span></span>
</td>
<td class="num">(415.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,674.5)<span></span>
</td>
<td class="num">(1,259.0)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash flow hedging relationships | Gains and Losses on Derivatives in Cash Flow Hedging Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax', window );">AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax</a></td>
<td class="nump">9.2<span></span>
</td>
<td class="num">(18.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax', window );">AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax</a></td>
<td class="nump">9.2<span></span>
</td>
<td class="num">(18.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash flow hedging relationships | Gains and Losses on Derivatives in Cash Flow Hedging Relationships | Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeOtherNetOfTax', window );">Other Comprehensive Income, Other, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax', window );">Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, before Tax</a></td>
<td class="nump">16.7<span></span>
</td>
<td class="num">(353.6)<span></span>
</td>
<td class="num">(74.3)<span></span>
</td>
<td class="num">(130.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax', window );">Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, before Tax</a></td>
<td class="nump">$ 16.7<span></span>
</td>
<td class="num">$ (353.6)<span></span>
</td>
<td class="num">$ (74.3)<span></span>
</td>
<td class="num">$ (130.9)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=123594809&amp;loc=SL116692626-108610<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated gain (loss) on derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeOtherNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in other comprehensive income, after tax, from changes classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeOtherNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Net Investment Hedges, Effect Net of Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942894814280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Comprehensive Earnings (Components of Other Comprehensive Loss) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="nump">$ 20,492.7<span></span>
</td>
<td class="nump">$ 22,954.1<span></span>
</td>
<td class="nump">$ 11,883.8<span></span>
</td>
<td class="nump">$ 12,167.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Net unrealized gains on marketable securities, net of tax, beginning of period</a></td>
<td class="nump">1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Net unrecognized losses and prior service cost related to defined benefit plans, net of tax, beginning of period</a></td>
<td class="num">(26.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment, beginning of period</a></td>
<td class="num">(461.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss, net of tax, beginning of period</a></td>
<td class="num">(858.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (loss) before reclassifications, before tax</a></td>
<td class="num">(1.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">17,813.6<span></span>
</td>
<td class="nump">11,819.9<span></span>
</td>
<td class="nump">11,370.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(636.2)<span></span>
</td>
<td class="num">(497.8)<span></span>
</td>
<td class="num">(517.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax', window );">Amortization of prior service costs included in SG&amp;A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax', window );">Other comprehensive (loss) earnings, before tax</a></td>
<td class="num">(775.2)<span></span>
</td>
<td class="nump">912.6<span></span>
</td>
<td class="num">(343.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax related to items of other comprehensive (loss) earnings, derivatives</a></td>
<td class="num">(604.7)<span></span>
</td>
<td class="nump">51.3<span></span>
</td>
<td class="num">(137.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Net unrealized gains on marketable securities, net of tax, end of period</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Net unrealized gains on marketable securities, net of tax, end of period</a></td>
<td class="nump">32.2<span></span>
</td>
<td class="num">(26.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment, end of period</a></td>
<td class="num">(1,802.4)<span></span>
</td>
<td class="num">(461.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss, net of tax, end of period</a></td>
<td class="num">(1,744.3)<span></span>
</td>
<td class="num">(858.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax', window );">Net unrealized (loss) gain on marketable securities</a></td>
<td class="num">(1.1)<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax', window );">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax</a></td>
<td class="num">(73.9)<span></span>
</td>
<td class="nump">14.0<span></span>
</td>
<td class="nump">24.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Income tax provision (benefit)</a></td>
<td class="nump">111.1<span></span>
</td>
<td class="num">(26.6)<span></span>
</td>
<td class="nump">9.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Net unrecognized losses and prior service cost related to defined benefit plans, net of tax, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss, net of tax, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Net unrealized gains on marketable securities, net of tax, end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss, net of tax, end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Reclassification out of Accumulated Other Comprehensive Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax related to items of other comprehensive (loss) earnings, derivatives</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember', window );">Gains and Losses on Derivatives in Cash Flow Hedging Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax', window );">Net unrecognized gains (losses) on derivatives, net of tax, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(31.6)<span></span>
</td>
<td class="num">(53.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (loss) before reclassifications, before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax related to items of other comprehensive (loss) earnings, derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax', window );">Net unrecognized gains (losses) on derivatives, net of tax, end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(31.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember', window );">Gains and Losses on Derivatives in Cash Flow Hedging Relationships | Reclassification out of Accumulated Other Comprehensive Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax related to items of other comprehensive (loss) earnings, derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember', window );">Gains and Losses on Derivatives in Cash Flow Hedging Relationships | Foreign Exchange Contract | Reclassification out of Accumulated Other Comprehensive Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="num">(30.9)<span></span>
</td>
<td class="num">(4.8)<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember', window );">Gains and Losses on Derivatives in Cash Flow Hedging Relationships | Interest rate swaps | Reclassification out of Accumulated Other Comprehensive Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(4.3)<span></span>
</td>
<td class="num">(4.5)<span></span>
</td>
<td class="nump">7.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">Gains and Losses on Marketable Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Net unrealized gains on marketable securities, net of tax, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (loss) before reclassifications, before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Net unrealized gains on marketable securities, net of tax, end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax', window );">Net unrealized (loss) gain on marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">Gains and Losses on Marketable Securities | Reclassification out of Accumulated Other Comprehensive Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax related to items of other comprehensive (loss) earnings, derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Defined Pension Plan Items</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Net unrecognized losses and prior service cost related to defined benefit plans, net of tax, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17.4)<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (loss) before reclassifications, before tax</a></td>
<td class="nump">67.0<span></span>
</td>
<td class="num">(12.1)<span></span>
</td>
<td class="num">(21.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Net unrealized gains on marketable securities, net of tax, end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax', window );">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Defined Pension Plan Items | Reclassification out of Accumulated Other Comprehensive Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax', window );">Amortization of prior service costs included in SG&amp;A</a></td>
<td class="num">(0.5)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax', window );">Amortization of actuarial loss included in SG&amp;A</a></td>
<td class="nump">7.4<span></span>
</td>
<td class="num">(1.9)<span></span>
</td>
<td class="num">(2.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax related to items of other comprehensive (loss) earnings, derivatives</a></td>
<td class="num">(15.6)<span></span>
</td>
<td class="num">(5.3)<span></span>
</td>
<td class="num">(5.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign Currency Translation Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,674.5)<span></span>
</td>
<td class="num">(1,259.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (loss) before reclassifications, before tax</a></td>
<td class="num">(1,340.9)<span></span>
</td>
<td class="nump">1,213.0<span></span>
</td>
<td class="num">(415.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax related to items of other comprehensive (loss) earnings, derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment, end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,674.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax', window );">Foreign currency translation adjustment</a></td>
<td class="num">(1,340.9)<span></span>
</td>
<td class="nump">1,213.0<span></span>
</td>
<td class="num">(415.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign Currency Translation Adjustment | Reclassification out of Accumulated Other Comprehensive Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax related to items of other comprehensive (loss) earnings, derivatives</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated Other Comprehensive Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="num">(1,744.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,797.2)<span></span>
</td>
<td class="num">(1,441.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss, net of tax, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,797.2)<span></span>
</td>
<td class="num">(1,441.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (loss) before reclassifications, before tax</a></td>
<td class="num">(755.5)<span></span>
</td>
<td class="nump">914.8<span></span>
</td>
<td class="num">(347.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax', window );">Other comprehensive (loss) earnings, before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">912.6<span></span>
</td>
<td class="num">(343.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss, net of tax, end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,797.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated Other Comprehensive Loss | Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.6)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated Other Comprehensive Loss | Reclassification out of Accumulated Other Comprehensive Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax', window );">Amortization of prior service costs included in SG&amp;A</a></td>
<td class="num">(0.5)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax', window );">Amortization of actuarial loss included in SG&amp;A</a></td>
<td class="nump">7.4<span></span>
</td>
<td class="num">(1.9)<span></span>
</td>
<td class="num">(2.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Income tax provision (benefit)</a></td>
<td class="nump">111.1<span></span>
</td>
<td class="num">(26.6)<span></span>
</td>
<td class="nump">9.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated Other Comprehensive Loss | Foreign Exchange Contract | Reclassification out of Accumulated Other Comprehensive Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="num">(30.9)<span></span>
</td>
<td class="num">(4.8)<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated Other Comprehensive Loss | Interest rate swaps | Reclassification out of Accumulated Other Comprehensive Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(4.3)<span></span>
</td>
<td class="num">(4.5)<span></span>
</td>
<td class="nump">7.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash flow hedging relationships | Gains and Losses on Derivatives in Cash Flow Hedging Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (loss) before reclassifications, before tax</a></td>
<td class="nump">62.7<span></span>
</td>
<td class="nump">18.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax', window );">Other comprehensive (loss) earnings, before tax</a></td>
<td class="nump">36.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax related to items of other comprehensive (loss) earnings, derivatives</a></td>
<td class="num">(8.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax', window );">Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, before Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash flow hedging relationships | Gains and Losses on Derivatives in Cash Flow Hedging Relationships | Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeOtherNetOfTax', window );">Other Comprehensive Income, Other, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash flow hedging relationships | Gains and Losses on Derivatives in Cash Flow Hedging Relationships | Foreign Exchange Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="num">(30.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash flow hedging relationships | Gains and Losses on Derivatives in Cash Flow Hedging Relationships | Foreign Exchange Contract | Reclassification out of Accumulated Other Comprehensive Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash flow hedging relationships | Gains and Losses on Derivatives in Cash Flow Hedging Relationships | Interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(4.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash flow hedging relationships | Gains and Losses on Derivatives in Cash Flow Hedging Relationships | Interest rate swaps | Reclassification out of Accumulated Other Comprehensive Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax', window );">Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, before Tax</a></td>
<td class="nump">16.7<span></span>
</td>
<td class="num">(353.6)<span></span>
</td>
<td class="num">(74.3)<span></span>
</td>
<td class="num">$ (130.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (loss) before reclassifications, before tax</a></td>
<td class="nump">456.8<span></span>
</td>
<td class="num">(305.2)<span></span>
</td>
<td class="nump">59.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax related to items of other comprehensive (loss) earnings, derivatives</a></td>
<td class="num">$ (86.5)<span></span>
</td>
<td class="nump">$ 25.9<span></span>
</td>
<td class="num">$ (3.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change, net of tax, in accumulated gains and losses from derivative instruments designated and qualifying as the effective portion of cash flow hedges. Includes an entity's share of an equity investee's Increase or Decrease in deferred hedging gains or losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=123594809&amp;loc=SL116692626-108610<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL34724391-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and after adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33775-111570<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e39076-109324<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeOtherNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in other comprehensive income, after tax, from changes classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeOtherNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Net Investment Hedges, Effect Net of Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942897452184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="5">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries', window );">Deferred tax liability not recognized, amount of unrecognized deferred tax liability, undistributed earnings of foreign subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,400.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">19.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 780.4<span></span>
</td>
<td class="nump">$ 443.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign', window );">Expected foreign tax credits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">230.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">322.9<span></span>
</td>
<td class="nump">391.1<span></span>
</td>
<td class="nump">$ 92.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 96.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that impact effective tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">230.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued', window );">Accrued interest and penalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96.8<span></span>
</td>
<td class="nump">86.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationInterestExpense', window );">Interest expense (income) related to uncertain tax positions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.0<span></span>
</td>
<td class="nump">$ 35.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible', window );">Amount of unrecognized deferred tax liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_DeductionlimitofGILTItax', window );">Deduction limit of GILTI tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefit&#160;&#8212; beginning of year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 322.9<span></span>
</td>
<td class="nump">391.1<span></span>
</td>
<td class="nump">92.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 96.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties', window );">Reserve for Uncertain Tax Positions, Including Interest And Penalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">315.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_CARESActIncomeTaxExpenseBenefit', window );">CARES Act, Income Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=vtrs_U.S.FederalTaxAuthorityMember', window );">U.S. Federal Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=vtrs_U.S.StateTaxAuthorityMember', window );">U.S. State Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,100.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,570.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpense', window );">Foreign deductible attributes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Credit carryforward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">329.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign | Australian Taxation Office</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense', window );">Partial payment of anticipated tax expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxPeriodAxis=vtrs_IndefiniteMember', window );">Indefinite | Foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">748.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxPeriodAxis=vtrs_FutureyearsMember', window );">2016 through 2035 | Foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 817.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxPeriodAxis=us-gaap_TaxYear2015Member', window );">Tax Year 2015 | Domestic Tax Authority | Internal Revenue Service (IRS)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_IncomeTaxExaminationReserveForUncertainTaxPosition', window );">Income Tax Examination, Reserve for Uncertain Tax Position</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">155.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_IncomeTaxExaminationReserveImpactOnIncomeTaxProvision', window );">Income Tax Examination, Reserve Impact On Income Tax Provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 144.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Scenario, Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_DeductionlimitofGILTItax', window );">Deduction limit of GILTI tax</a></td>
<td class="nump">37.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowances, of deferred tax asset attributable to deductible differences from reserves and accruals, compensation and benefit costs, and other provisions, reserves, and allowances.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability not recognized because of the exceptions to comprehensive recognition of deferred taxes related to undistributed earnings of foreign subsidiaries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of estimated interest recognized in the period arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase reasonably possible in the next twelve months for the unrecognized tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_CARESActIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>CARES Act, Income Tax Expense (Benefit)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_CARESActIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_DeductionlimitofGILTItax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deduction limit of GILTI tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_DeductionlimitofGILTItax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Tax Examination, Partial Payment Of Income Tax Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_IncomeTaxExaminationReserveForUncertainTaxPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Tax Examination, Reserve for Uncertain Tax Position</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_IncomeTaxExaminationReserveForUncertainTaxPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_IncomeTaxExaminationReserveImpactOnIncomeTaxProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Tax Examination, Reserve Impact On Income Tax Provision</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_IncomeTaxExaminationReserveImpactOnIncomeTaxProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reserve for Uncertain Tax Positions, Including Interest And Penalties</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=vtrs_U.S.FederalTaxAuthorityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=vtrs_U.S.FederalTaxAuthorityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=vtrs_U.S.StateTaxAuthorityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=vtrs_U.S.StateTaxAuthorityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_AustralianTaxationOfficeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_AustralianTaxationOfficeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=vtrs_IndefiniteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=vtrs_IndefiniteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=vtrs_FutureyearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=vtrs_FutureyearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=us-gaap_TaxYear2015Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=us-gaap_TaxYear2015Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942899053096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Schedule of Components of Income Tax Provision) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision (benefit)</a></td>
<td class="nump">$ 604.7<span></span>
</td>
<td class="num">$ (51.3)<span></span>
</td>
<td class="nump">$ 137.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract', window );"><strong>Earnings (loss) before income taxes and noncontrolling interest:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Operating and non-operating expense</a></td>
<td class="num">(664.4)<span></span>
</td>
<td class="num">(721.2)<span></span>
</td>
<td class="nump">154.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">U.S. Federal Current</a></td>
<td class="nump">12.6<span></span>
</td>
<td class="num">(6.4)<span></span>
</td>
<td class="nump">118.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">U.S. Federal Deferred</a></td>
<td class="num">(182.7)<span></span>
</td>
<td class="num">(277.0)<span></span>
</td>
<td class="num">(165.5)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations', window );">Income tax provision (benefit), U.S. Federal</a></td>
<td class="num">(170.1)<span></span>
</td>
<td class="num">(283.4)<span></span>
</td>
<td class="num">(47.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract', window );"><strong>Earnings (loss) before income taxes and noncontrolling interest:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Earnings before income taxes and noncontrolling interest, United States</a></td>
<td class="num">(1,982.5)<span></span>
</td>
<td class="num">(945.5)<span></span>
</td>
<td class="num">(1,031.4)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=vtrs_U.S.StateTaxAuthorityMember', window );">U.S. State Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">U.S. State Current</a></td>
<td class="nump">7.7<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">21.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">U.S. State Deferred</a></td>
<td class="num">(10.8)<span></span>
</td>
<td class="nump">7.7<span></span>
</td>
<td class="num">(13.6)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations', window );">Income tax provision (benefit), U.S. State</a></td>
<td class="num">(3.1)<span></span>
</td>
<td class="nump">7.6<span></span>
</td>
<td class="nump">7.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=vtrs_NonU.S.statetaxauthorityMember', window );">Non-U.S. state tax authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Non-U.S. Current</a></td>
<td class="num">(91.3)<span></span>
</td>
<td class="nump">168.7<span></span>
</td>
<td class="nump">191.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Non-U.S. Deferred</a></td>
<td class="nump">869.2<span></span>
</td>
<td class="nump">55.8<span></span>
</td>
<td class="num">(13.5)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations', window );">Income tax provision (benefit), Non-U.S.</a></td>
<td class="nump">777.9<span></span>
</td>
<td class="nump">224.5<span></span>
</td>
<td class="nump">177.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=vtrs_OtherMember', window );">Other Foreign Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract', window );"><strong>Earnings (loss) before income taxes and noncontrolling interest:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Earnings before income taxes and noncontrolling interest, foreign</a></td>
<td class="nump">$ 1,318.1<span></span>
</td>
<td class="nump">$ 224.3<span></span>
</td>
<td class="nump">$ 1,185.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current and deferred federal income tax expense (benefit) attributable to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current and deferred foreign income tax expense (benefit) attributable to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of state and local current and deferred income tax expense (benefit) attributable to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=vtrs_U.S.StateTaxAuthorityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=vtrs_U.S.StateTaxAuthorityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=vtrs_NonU.S.statetaxauthorityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=vtrs_NonU.S.statetaxauthorityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=vtrs_OtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=vtrs_OtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942898705688">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes (Schedule of Deferred Tax Assets and Liabilities) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits', window );">Employee benefits</a></td>
<td class="nump">$ 271.3<span></span>
</td>
<td class="nump">$ 273.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies', window );">Litigation reserves</a></td>
<td class="nump">94.4<span></span>
</td>
<td class="nump">43.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts', window );">Accounts receivable allowances</a></td>
<td class="nump">425.9<span></span>
</td>
<td class="nump">393.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInventory', window );">Inventory</a></td>
<td class="nump">187.8<span></span>
</td>
<td class="nump">1,187.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Tax credit and loss carry-forwards</a></td>
<td class="nump">1,256.0<span></span>
</td>
<td class="nump">1,080.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_DeferredTaxAssetsOperatingLeaseRightofUseAssets', window );">Operating lease assets</a></td>
<td class="nump">63.6<span></span>
</td>
<td class="nump">66.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_DeferredTaxAssetsDeferredtaxexpenseinterestexpense', window );">Interest expense</a></td>
<td class="nump">111.6<span></span>
</td>
<td class="nump">67.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_DeferredTaxAssetsIntangibleAssets', window );">Intangible assets</a></td>
<td class="nump">151.1<span></span>
</td>
<td class="nump">156.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">327.8<span></span>
</td>
<td class="nump">396.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets, gross</a></td>
<td class="nump">2,889.5<span></span>
</td>
<td class="nump">3,665.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less: Valuation allowance</a></td>
<td class="num">(780.4)<span></span>
</td>
<td class="num">(443.6)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Total deferred tax assets</a></td>
<td class="nump">2,109.1<span></span>
</td>
<td class="nump">3,221.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesNetAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Plant and equipment</a></td>
<td class="nump">19.6<span></span>
</td>
<td class="nump">50.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_DeferredTaxLiabilitiesOperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="nump">63.6<span></span>
</td>
<td class="nump">66.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets', window );">Intangible assets and goodwill</a></td>
<td class="nump">3,468.3<span></span>
</td>
<td class="nump">4,058.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Other</a></td>
<td class="nump">39.9<span></span>
</td>
<td class="nump">22.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="nump">3,591.4<span></span>
</td>
<td class="nump">4,197.4<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Deferred tax liabilities, net</a></td>
<td class="num">$ (1,482.3)<span></span>
</td>
<td class="num">$ (975.8)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from employee benefits, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from contingent liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_DeferredTaxAssetsDeferredtaxexpenseinterestexpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_DeferredTaxAssetsDeferredtaxexpenseinterestexpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_DeferredTaxAssetsIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets Intangible Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_DeferredTaxAssetsIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_DeferredTaxAssetsOperatingLeaseRightofUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Operating Lease, Right-of-Use Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_DeferredTaxAssetsOperatingLeaseRightofUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_DeferredTaxLiabilitiesOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Operating Lease, Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_DeferredTaxLiabilitiesOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942895557704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Statutory Tax Rate to Effective Tax Rate Reconciliation) (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">19.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(106.90%)<span></span>
</td>
<td class="num">(42.20%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_EffectiveIncomeTaxRateReconciliationGILTIPercent', window );">Incremental US Tax on Foreign Earnings</a></td>
<td class="num">(36.90%)<span></span>
</td>
<td class="num">(3.60%)<span></span>
</td>
<td class="num">(8.60%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_EffectiveIncomeTaxRateReconciliationWaivedDeductionsPercent', window );">Waived deductions under IRC &#167; 59A</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(3.30%)<span></span>
</td>
<td class="nump">64.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense', window );">Impact of the Combination and Divestitures</a></td>
<td class="num">(2.80%)<span></span>
</td>
<td class="nump">5.80%<span></span>
</td>
<td class="nump">7.70%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="num">(91.00%)<span></span>
</td>
<td class="nump">7.10%<span></span>
</td>
<td class="nump">89.10%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch', window );">Clean energy and research credits</a></td>
<td class="nump">9.80%<span></span>
</td>
<td class="nump">12.80%<span></span>
</td>
<td class="num">(43.40%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">U.S. rate differentials</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(3.10%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate', window );">Impact of changes in legislation</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(9.20%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits', window );">State income taxes and credits</a></td>
<td class="num">(0.60%)<span></span>
</td>
<td class="num">(1.60%)<span></span>
</td>
<td class="num">(4.10%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(0.10%)<span></span>
</td>
<td class="nump">8.60%<span></span>
</td>
<td class="num">(118.50%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements', window );">Tax settlements and resolution of certain tax positions</a></td>
<td class="nump">0.10%<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="nump">199.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other</a></td>
<td class="num">(6.10%)<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="nump">6.90%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_LU', window );">LUXEMBOURG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign', window );">Other Foreign Operations</a></td>
<td class="num">(6.70%)<span></span>
</td>
<td class="num">(5.00%)<span></span>
</td>
<td class="num">(14.80%)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_GI', window );">GIBRALTAR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign', window );">Other Foreign Operations</a></td>
<td class="nump">9.40%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="num">(38.80%)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IE', window );">IRELAND</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign', window );">Other Foreign Operations</a></td>
<td class="nump">5.80%<span></span>
</td>
<td class="nump">8.20%<span></span>
</td>
<td class="num">(13.70%)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_FR', window );">France</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign', window );">Other Foreign Operations</a></td>
<td class="num">(1.10%)<span></span>
</td>
<td class="num">(2.80%)<span></span>
</td>
<td class="nump">15.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=vtrs_OtherforeignMember', window );">Other foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign', window );">Other Foreign Operations</a></td>
<td class="num">(10.20%)<span></span>
</td>
<td class="num">(0.40%)<span></span>
</td>
<td class="nump">12.80%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">Other Foreign Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(8.30%)<span></span>
</td>
<td class="nump">16.10%<span></span>
</td>
<td class="num">(9.90%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other</a></td>
<td class="nump">1.90%<span></span>
</td>
<td class="num">(1.80%)<span></span>
</td>
<td class="nump">2.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies', window );">Uncertain tax positions</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="num">(0.10%)<span></span>
</td>
<td class="nump">36.70%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_EffectiveIncomeTaxRateReconciliationWithholdingTaxesPercent', window );">Withholding taxes</a></td>
<td class="num">(1.30%)<span></span>
</td>
<td class="num">(1.60%)<span></span>
</td>
<td class="nump">7.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_EffectiveIncomeTaxRateReconciliationIndiaAmagulation', window );">Tax settlements and resolution of certain tax positions</a></td>
<td class="nump">0.80%<span></span>
</td>
<td class="num">(3.90%)<span></span>
</td>
<td class="num">(27.60%)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_PR', window );">PUERTO RICO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign', window );">Other Foreign Operations</a></td>
<td class="nump">4.40%<span></span>
</td>
<td class="num">(2.50%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CH', window );">SWITZERLAND</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign', window );">Other Foreign Operations</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_SG', window );">SINGAPORE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign', window );">Other Foreign Operations</a></td>
<td class="nump">28.80%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income tax contingencies. Includes, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign tax credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income tax settlements. Including, but not limited to, domestic tax settlement, foreign tax settlement, state and local tax settlement, and other tax settlements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_EffectiveIncomeTaxRateReconciliationGILTIPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, GILTI, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_EffectiveIncomeTaxRateReconciliationGILTIPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_EffectiveIncomeTaxRateReconciliationIndiaAmagulation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, India Amagulation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_EffectiveIncomeTaxRateReconciliationIndiaAmagulation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_EffectiveIncomeTaxRateReconciliationWaivedDeductionsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Waived Deductions, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_EffectiveIncomeTaxRateReconciliationWaivedDeductionsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_EffectiveIncomeTaxRateReconciliationWithholdingTaxesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Withholding Taxes, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_EffectiveIncomeTaxRateReconciliationWithholdingTaxesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_LU">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_LU</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_GI">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_GI</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_FR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_FR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=vtrs_OtherforeignMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=vtrs_OtherforeignMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_PR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_PR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CH">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CH</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_SG">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_SG</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942898070200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Schedule of Unrecognized Tax Benefits) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefit&#160;&#8212; beginning of year</a></td>
<td class="nump">$ 322.9<span></span>
</td>
<td class="nump">$ 391.1<span></span>
</td>
<td class="nump">$ 92.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 96.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Additions for current year tax positions</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.4<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Additions for prior year tax positions</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.7<span></span>
</td>
<td class="nump">154.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Reductions for prior year tax positions</a></td>
<td class="num">(9.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5.2)<span></span>
</td>
<td class="num">(11.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities', window );">Settlements</a></td>
<td class="num">(47.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8.9)<span></span>
</td>
<td class="num">(112.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Reductions due to expirations of statute of limitations</a></td>
<td class="num">(7.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">$ (34.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromAcquisition', window );">Unrecognized Tax Benefits, Decrease Resulting from Acquisition</a></td>
<td class="num">(4.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition', window );">(Reduction) addition due to acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">264.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefit&#160;&#8212; end of year</a></td>
<td class="nump">$ 322.9<span></span>
</td>
<td class="nump">$ 391.1<span></span>
</td>
<td class="nump">$ 92.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942897553784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Incentive Plan (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 16, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of shares exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,615<span></span>
</td>
<td class="nump">580,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,576,490<span></span>
</td>
<td class="nump">6,711,731<span></span>
</td>
<td class="nump">6,347,709<span></span>
</td>
<td class="nump">6,815,278<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted stock | Vest ratably in five years or less [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock option award vesting period, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Number of restricted stock awards, granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,057,602<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Number of restricted stock awards, granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,850,443<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=vtrs_LongTermIncentivePlan2003Member', window );">Long Term Incentive Plan 2003</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of shares exercised</a></td>
<td class="nump">6,757,640<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock shares reserved for issuance to employees</a></td>
<td class="nump">13,535,627<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Total unrecognized compensation expense, net of estimated forfeitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 143.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period over which total unrecognized compensation expense expected to be recognized (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue', window );">Intrinsic value of stock-based awards exercised and restricted stock units converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 78.1<span></span>
</td>
<td class="nump">$ 20.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=vtrs_LongTermIncentivePlan2003Member', window );">Long Term Incentive Plan 2003 | Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Stock option award expiration period, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Average remaining contractual term for options outstanding, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Average remaining contractual term for options vested and expected to vest, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Average remaining contractual term for options exercisable, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=vtrs_LongTermIncentivePlan2003Member', window );">Long Term Incentive Plan 2003 | Minimum | Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock option award vesting period, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=vtrs_LongTermIncentivePlan2003Member', window );">Long Term Incentive Plan 2003 | Maximum | Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock option award vesting period, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember', window );">2020 Stock Incentive Plan and 2003 Long-Term Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Amount of common stock shares authorized</a></td>
<td class="nump">72,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ProgramNameAxis=vtrs_A2014ProgramMember', window );">2014 Program | Stock appreciation rights and performance shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock option award vesting period, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_SubjecttoMarketConditionsAxis=vtrs_NotSubjecttoMarketConditionsMember', window );">Not subject to market conditions | Performance Shares | Vest after three years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Number of restricted stock awards, granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">587,025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_SubjecttoMarketConditionsAxis=vtrs_SubjectToMarketConditionsMember', window );">Subject to Market Conditions | Performance Shares | Vest after three years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock option award vesting period, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Number of restricted stock awards, granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,205,816<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period, Total Intrinsic Value And Equity Instruments Other Than Options, Vested In Period, Intrinsic Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_VestingPeriodAxis=vtrs_VestratablyinfiveyearsorlessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_VestingPeriodAxis=vtrs_VestratablyinfiveyearsorlessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=vtrs_LongTermIncentivePlan2003Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=vtrs_LongTermIncentivePlan2003Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_ProgramNameAxis=vtrs_A2014ProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_ProgramNameAxis=vtrs_A2014ProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=vtrs_StockappreciationrightsandperformancesharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=vtrs_StockappreciationrightsandperformancesharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_SubjecttoMarketConditionsAxis=vtrs_NotSubjecttoMarketConditionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_SubjecttoMarketConditionsAxis=vtrs_NotSubjecttoMarketConditionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_VestingPeriodAxis=vtrs_VestinthreeyearsorlessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_VestingPeriodAxis=vtrs_VestinthreeyearsorlessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_SubjecttoMarketConditionsAxis=vtrs_SubjectToMarketConditionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_SubjecttoMarketConditionsAxis=vtrs_SubjectToMarketConditionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R106.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942895548024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Incentive Plan (Stock Awards) (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of shares under stock awards, outstanding at beginning of period</a></td>
<td class="nump">6,711,731<span></span>
</td>
<td class="nump">6,347,709<span></span>
</td>
<td class="nump">6,815,278<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weightedaverage exercise price per share, outstanding at beginning of period</a></td>
<td class="nump">$ 35.36<span></span>
</td>
<td class="nump">$ 36.97<span></span>
</td>
<td class="nump">$ 36.61<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Number of shares under stock awards, granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">814,351<span></span>
</td>
<td class="nump">829,322<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price per share, granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17.37<span></span>
</td>
<td class="nump">$ 26.18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of shares under stock awards, exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(27,615)<span></span>
</td>
<td class="num">(580,950)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price per share, exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21.13<span></span>
</td>
<td class="nump">$ 14.40<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Number of shares under stock awards, forfeited</a></td>
<td class="num">(1,135,241)<span></span>
</td>
<td class="num">(422,714)<span></span>
</td>
<td class="num">(715,941)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price per share, forfeited</a></td>
<td class="nump">$ 26.39<span></span>
</td>
<td class="nump">$ 25.74<span></span>
</td>
<td class="nump">$ 39.40<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of shares under stock awards, outstanding at end of period</a></td>
<td class="nump">5,576,490<span></span>
</td>
<td class="nump">6,711,731<span></span>
</td>
<td class="nump">6,347,709<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price per share, outstanding at end of period</a></td>
<td class="nump">$ 37.19<span></span>
</td>
<td class="nump">$ 35.36<span></span>
</td>
<td class="nump">$ 36.97<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Number of shares under stock awards, vested and expected to vest at period end</a></td>
<td class="nump">5,487,788<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price per share, vested and expected to vest at period end</a></td>
<td class="nump">$ 37.45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number of shares under stock awards, exercisable at period end</a></td>
<td class="nump">4,969,602<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted average exercise price per share, exercisable at period end</a></td>
<td class="nump">$ 39.21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R107.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942897965208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Incentive Plan (Nonvested Restricted Stock, Restricted Stock Units and PSUs Activity) (Details) - Restricted Stock Awards<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number of restricted stock awards, nonvested beginning balance | shares</a></td>
<td class="nump">12,073,790<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted average grant-date fair value per share, nonvested beginning balance | $ / shares</a></td>
<td class="nump">$ 18.34<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Number of restricted stock awards, granted | shares</a></td>
<td class="nump">9,850,443<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant-date fair value per share, granted | $ / shares</a></td>
<td class="nump">$ 14.46<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Number of restricted stock awards, released | shares</a></td>
<td class="num">(3,168,152)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant-date fair value per share, released | $ / shares</a></td>
<td class="nump">$ 24.65<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Number of restricted stock awards, forfeited | shares</a></td>
<td class="num">(1,897,953)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Weighted average grant-date fair value per share, forfeited | $ / shares</a></td>
<td class="nump">$ 15.33<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number of restricted stock awards, nonvested ending balance | shares</a></td>
<td class="nump">16,858,128<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted average grant-date fair value per share, nonvested ending balance | $ / shares</a></td>
<td class="nump">$ 15.12<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R108.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942908905704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Incentive Plan (Valuation Assumptions) (Details) - Long Term Incentive Plan 2003 - Stock options - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Volatility</a></td>
<td class="nump">46.70%<span></span>
</td>
<td class="nump">38.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (years)</a></td>
<td class="text">6 years 6 months<span></span>
</td>
<td class="text">6 years 6 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate', window );">Forfeiture rate</a></td>
<td class="nump">5.50%<span></span>
</td>
<td class="nump">5.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value per option</a></td>
<td class="nump">$ 8.07<span></span>
</td>
<td class="nump">$ 11.03<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based compensation arrangement by Share-based payment award, fair value assumptions, Forfeiture rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=vtrs_LongTermIncentivePlan2003Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=vtrs_LongTermIncentivePlan2003Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R109.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942907787976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_AccumulatednetactuariallossesexceedhigherofmarketvalueofplanassetsorPBO', window );">Unrecognized net actuarial losses exceed higher of market value of plan assets or the projected benefit obligation at the beginning of the year</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation', window );">Accumulated benefit obligation</a></td>
<td class="nump">$ 1,860.0<span></span>
</td>
<td class="nump">$ 2,040.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear', window );">Defined benefit plan, ultimate health care cost trend rate</a></td>
<td class="nump">5.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1', window );">Defined benefit plan, ultimate health care cost trend rate, projected</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Total employer contributions</a></td>
<td class="nump">$ 107.4<span></span>
</td>
<td class="nump">115.5<span></span>
</td>
<td class="nump">$ 95.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MultiemployerPlansWithdrawalObligation', window );">Multiemployer plans, withdrawal obligation</a></td>
<td class="nump">$ 5.5<span></span>
</td>
<td class="nump">$ 8.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_PeriodAxis=vtrs_FiscalYear2017Member', window );">Fiscal Year 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear', window );">Defined benefit plan, ultimate health care cost trend rate</a></td>
<td class="nump">6.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1', window );">Defined benefit plan, ultimate health care cost trend rate, projected</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis=vtrs_DeferredBaseSalaryMember', window );">Deferred Base Salary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent', window );">Defined contribution plan, maximum annual contribution per employee, percent</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis=us-gaap_DeferredBonusMember', window );">Deferred Bonus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent', window );">Defined contribution plan, maximum annual contribution per employee, percent</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Assumed rate, for next fiscal year, based on annual change in cost of health care cost benefits used to measure expected cost of benefits covered by defined benefit postretirement plan. Factors include, but are not limited to, estimate of health care inflation, change in health care utilization or delivery pattern, technological advances, and change in health status of participant. Excludes factors for change in composition of plan population by age and dependency status.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ultimate trend rate for health care cost for defined benefit postretirement plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MultiemployerPlansWithdrawalObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the obligation recognized by withdrawing from a pension or postretirement benefit plan to which two or more unrelated employers contribute where assets contributed by one participating employer may be used to provide benefits to employees of other participating employers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MultiemployerPlansWithdrawalObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_AccumulatednetactuariallossesexceedhigherofmarketvalueofplanassetsorPBO">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated net actuarial losses exceed higher of market value of plan assets or PBO</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_AccumulatednetactuariallossesexceedhigherofmarketvalueofplanassetsorPBO</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_PeriodAxis=vtrs_FiscalYear2017Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_PeriodAxis=vtrs_FiscalYear2017Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis=vtrs_DeferredBaseSalaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis=vtrs_DeferredBaseSalaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis=us-gaap_DeferredBonusMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis=us-gaap_DeferredBonusMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R110.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942903417448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Employee Benefit Plans (Accumulated Other Comprehensive Income (Loss) Pretax Amounts Not Yet Reclassified in Net Periodic Benefit Cost (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax', window );">Unrecognized actuarial (gain) loss</a></td>
<td class="num">$ (59.9)<span></span>
</td>
<td class="nump">$ 33.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax', window );">Unrecognized prior service cost (credit)</a></td>
<td class="nump">6.6<span></span>
</td>
<td class="num">(1.4)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax', window );">Total</a></td>
<td class="num">(53.3)<span></span>
</td>
<td class="nump">32.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other Postretirement Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax', window );">Unrecognized actuarial (gain) loss</a></td>
<td class="nump">21.7<span></span>
</td>
<td class="nump">5.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax', window );">Unrecognized prior service cost (credit)</a></td>
<td class="num">(3.7)<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax', window );">Total</a></td>
<td class="nump">$ 18.0<span></span>
</td>
<td class="nump">$ 6.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive (income) loss for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R111.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942897921832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans (Change in Accumulated Income (Loss) Relating to Defined Benefit Pension and Other Postretirement Benefits) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax', window );">Net change</a></td>
<td class="nump">$ 73.9<span></span>
</td>
<td class="num">$ (14.0)<span></span>
</td>
<td class="num">$ (24.8)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax', window );">Unrecognized actuarial (gain) loss</a></td>
<td class="num">(102.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Amortization of actuarial gain/(loss)</a></td>
<td class="nump">7.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax', window );">Unrecognized prior service credit (cost)</a></td>
<td class="num">(8.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax', window );">Amortization of prior service costs</a></td>
<td class="num">(0.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_OtherComprehensiveIncomeDefinedBenefitPlanForeignCurrencyTranslationBeforeTax', window );">Impact of foreign currency translation</a></td>
<td class="nump">1.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax', window );">Net change</a></td>
<td class="num">(85.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other Postretirement Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax', window );">Unrecognized actuarial (gain) loss</a></td>
<td class="nump">16.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Amortization of actuarial gain/(loss)</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax', window );">Unrecognized prior service credit (cost)</a></td>
<td class="nump">4.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax', window );">Amortization of prior service costs</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_OtherComprehensiveIncomeDefinedBenefitPlanForeignCurrencyTranslationBeforeTax', window );">Impact of foreign currency translation</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax', window );">Net change</a></td>
<td class="nump">$ 11.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income from prior service cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL34724391-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_OtherComprehensiveIncomeDefinedBenefitPlanForeignCurrencyTranslationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income Defined Benefit Plan Foreign Currency Translation Before Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_OtherComprehensiveIncomeDefinedBenefitPlanForeignCurrencyTranslationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R112.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942904092952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans (Net Periodic Benefit Costs) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanCurtailments', window );">Plan curtailment, settlement and termination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax', window );">Amortization of prior service costs included in SG&amp;A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Recognized net actuarial losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember', window );">Other Pension, Postretirement and Supplemental Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">$ 3.4<span></span>
</td>
<td class="nump">$ 1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">2.6<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanCurtailments', window );">Plan curtailment, settlement and termination</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax', window );">Amortization of prior service costs included in SG&amp;A</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Recognized net actuarial losses</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
<td class="nump">6.2<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">38.6<span></span>
</td>
<td class="nump">23.5<span></span>
</td>
<td class="nump">20.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">31.6<span></span>
</td>
<td class="nump">13.5<span></span>
</td>
<td class="nump">13.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(66.1)<span></span>
</td>
<td class="num">(19.9)<span></span>
</td>
<td class="num">(12.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanCurtailments', window );">Plan curtailment, settlement and termination</a></td>
<td class="num">(16.5)<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax', window );">Amortization of prior service costs included in SG&amp;A</a></td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Recognized net actuarial losses</a></td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="num">(0.8)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
<td class="num">(10.2)<span></span>
</td>
<td class="nump">18.6<span></span>
</td>
<td class="nump">$ 22.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other Postretirement Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">3.4<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">$ 2.6<span></span>
</td>
<td class="nump">$ 1.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanCurtailments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of (increase) decrease in benefit obligation of defined benefit plan from event reducing expected years of future service of present employees or eliminating accrual of benefits for some or all future services of present employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(10)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanCurtailments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL34724391-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R113.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942898641464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans (Changes in Projected Benefit Obligations, Plan Assets and Funded Status) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Projected benefit obligation, beginning of year</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in Plan Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, beginning of year</a></td>
<td class="nump">$ 1,354.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, end of year</a></td>
<td class="nump">1,366.4<span></span>
</td>
<td class="nump">$ 1,354.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Projected benefit obligation, beginning of year</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Projected benefit obligation, beginning of year</a></td>
<td class="nump">2,145.8<span></span>
</td>
<td class="nump">674.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">38.6<span></span>
</td>
<td class="nump">23.5<span></span>
</td>
<td class="nump">20.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">31.6<span></span>
</td>
<td class="nump">13.5<span></span>
</td>
<td class="nump">13.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_DefinedBenefitPlanContributionsByPlanParticipantsBenefitObligation', window );">Participant contributions</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAssetsTransferredtofromPlan', window );">Acquisitions</a></td>
<td class="nump">4.0<span></span>
</td>
<td class="nump">1,389.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation', window );">Plan settlements and terminations</a></td>
<td class="num">(128.6)<span></span>
</td>
<td class="num">(23.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial (gains) losses</a></td>
<td class="num">(26.1)<span></span>
</td>
<td class="nump">37.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(52.8)<span></span>
</td>
<td class="num">(24.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation', window );">Impact of foreign currency translation</a></td>
<td class="num">(67.9)<span></span>
</td>
<td class="nump">53.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Projected benefit obligation, end of year</a></td>
<td class="nump">1,946.6<span></span>
</td>
<td class="nump">2,145.8<span></span>
</td>
<td class="nump">674.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in Plan Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, beginning of year</a></td>
<td class="nump">1,354.6<span></span>
</td>
<td class="nump">315.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return on plan assets</a></td>
<td class="nump">141.7<span></span>
</td>
<td class="nump">46.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Company contributions</a></td>
<td class="nump">97.0<span></span>
</td>
<td class="nump">58.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant', window );">Participant contributions</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets', window );">Defined Benefit Plan, Plan Assets, Business Combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">959.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan', window );">Transferred assets</a></td>
<td class="num">(2.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets', window );">Plan settlements</a></td>
<td class="num">(128.9)<span></span>
</td>
<td class="num">(23.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_DefinedBenefitPlanForeignCurrencyTranslationImpactonPlanAssets', window );">Impact of foreign currency translation</a></td>
<td class="num">(45.1)<span></span>
</td>
<td class="nump">21.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, end of year</a></td>
<td class="nump">1,366.4<span></span>
</td>
<td class="nump">1,354.6<span></span>
</td>
<td class="nump">315.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status of plans</a></td>
<td class="num">(580.2)<span></span>
</td>
<td class="num">(791.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other Postretirement Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Projected benefit obligation, beginning of year</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Projected benefit obligation, beginning of year</a></td>
<td class="nump">188.8<span></span>
</td>
<td class="nump">33.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">3.4<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">2.6<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_DefinedBenefitPlanContributionsByPlanParticipantsBenefitObligation', window );">Participant contributions</a></td>
<td class="nump">2.4<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAssetsTransferredtofromPlan', window );">Acquisitions</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">153.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation', window );">Plan settlements and terminations</a></td>
<td class="num">(4.3)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial (gains) losses</a></td>
<td class="nump">16.2<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(20.7)<span></span>
</td>
<td class="num">(1.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation', window );">Impact of foreign currency translation</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Projected benefit obligation, end of year</a></td>
<td class="nump">188.4<span></span>
</td>
<td class="nump">188.8<span></span>
</td>
<td class="nump">33.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in Plan Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, beginning of year</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return on plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Company contributions</a></td>
<td class="nump">18.3<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant', window );">Participant contributions</a></td>
<td class="nump">2.4<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets', window );">Defined Benefit Plan, Plan Assets, Business Combination</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets', window );">Plan settlements</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_DefinedBenefitPlanForeignCurrencyTranslationImpactonPlanAssets', window );">Impact of foreign currency translation</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, end of year</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status of plans</a></td>
<td class="num">$ (188.4)<span></span>
</td>
<td class="num">$ (188.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in plan assets of defined benefit plan from assets transferred into (from) plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(6)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in plan assets of defined benefit plan from business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(6)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedStatusOfPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions received by defined benefit plan from participant which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of (increase) decrease to benefit obligation of defined benefit plan from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Includes, but is not limited to, lump-sum cash payment to participant in exchange for right to receive specified benefits, purchase of nonparticipating annuity contract and change from remeasurement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(10)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanSettlementsBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanSettlementsPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAssetsTransferredtofromPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Assets Transferred to (from) Plan</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAssetsTransferredtofromPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_DefinedBenefitPlanContributionsByPlanParticipantsBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan Contributions By Plan Participants Benefit Obligation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_DefinedBenefitPlanContributionsByPlanParticipantsBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_DefinedBenefitPlanForeignCurrencyTranslationImpactonPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Foreign Currency Translation Impact on Plan Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_DefinedBenefitPlanForeignCurrencyTranslationImpactonPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R114.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942908566248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Employee Benefit Plans (Net Accrued Benefit Costs Classification on Balance Sheet) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent', window );">Noncurrent assets</a></td>
<td class="nump">$ 117.2<span></span>
</td>
<td class="nump">$ 70.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities', window );">Current liabilities</a></td>
<td class="num">(14.6)<span></span>
</td>
<td class="num">(15.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Noncurrent liabilities</a></td>
<td class="num">(682.8)<span></span>
</td>
<td class="num">(846.8)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_Netaccruedbenefitcosts', window );">Net accrued benefit costs</a></td>
<td class="num">(580.2)<span></span>
</td>
<td class="num">(791.2)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other Postretirement Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent', window );">Noncurrent assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities', window );">Current liabilities</a></td>
<td class="num">(16.1)<span></span>
</td>
<td class="num">(16.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Noncurrent liabilities</a></td>
<td class="num">(172.3)<span></span>
</td>
<td class="num">(172.5)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_Netaccruedbenefitcosts', window );">Net accrued benefit costs</a></td>
<td class="num">$ (188.4)<span></span>
</td>
<td class="num">$ (188.8)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_Netaccruedbenefitcosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net accrued benefit costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_Netaccruedbenefitcosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R115.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942901734088">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Employee Benefit Plans (Plans with PBO in Excess of Plan Assets) (Details) - Pension Benefits - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation', window );">Projected benefit obligation</a></td>
<td class="nump">$ 1,591.8<span></span>
</td>
<td class="nump">$ 1,747.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_DefinedBenefitPensionPlanswithProjectedBenefitObligationInExcessofPlanAssetsAggregateProjectedBenefitObligation', window );">Accumulated benefit obligation</a></td>
<td class="nump">1,546.4<span></span>
</td>
<td class="nump">1,678.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 904.1<span></span>
</td>
<td class="nump">$ 893.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of plan asset for defined benefit plan with accumulated benefit obligation in excess of plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of projected benefit obligation for defined benefit pension plan with accumulated benefit obligation in excess of plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_DefinedBenefitPensionPlanswithProjectedBenefitObligationInExcessofPlanAssetsAggregateProjectedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Pension Plans with Projected Benefit Obligation In Excess of Plan Assets Aggregate Projected Benefit Obligation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_DefinedBenefitPensionPlanswithProjectedBenefitObligationInExcessofPlanAssetsAggregateProjectedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R116.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942904883368">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Employee Benefit Plans (Fair Values of Plan Assets) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 1,366.4<span></span>
</td>
<td class="nump">$ 1,354.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">65.0<span></span>
</td>
<td class="nump">51.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember', window );">Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">551.1<span></span>
</td>
<td class="nump">613.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_FixedIncomeSecuritiesMember', window );">Fixed income securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">616.9<span></span>
</td>
<td class="nump">592.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=vtrs_AssetsheldbyinsurancecompaniesandotherMember', window );">Assets held by insurance companies and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">133.4<span></span>
</td>
<td class="nump">97.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">338.6<span></span>
</td>
<td class="nump">493.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">63.1<span></span>
</td>
<td class="nump">51.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">53.9<span></span>
</td>
<td class="nump">145.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Fixed income securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">211.4<span></span>
</td>
<td class="nump">292.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Assets held by insurance companies and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">10.2<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">946.2<span></span>
</td>
<td class="nump">788.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">1.9<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">497.2<span></span>
</td>
<td class="nump">468.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Fixed income securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">405.5<span></span>
</td>
<td class="nump">299.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Assets held by insurance companies and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">41.6<span></span>
</td>
<td class="nump">20.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">81.6<span></span>
</td>
<td class="nump">73.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Fixed income securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Assets held by insurance companies and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 81.6<span></span>
</td>
<td class="nump">$ 73.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_FixedIncomeSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_FixedIncomeSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=vtrs_AssetsheldbyinsurancecompaniesandotherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=vtrs_AssetsheldbyinsurancecompaniesandotherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R117.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942898243016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans (Weighted Average Assumptions) (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate</a></td>
<td class="nump">2.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.90%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationExpectedLongtermReturnonAssets', window );">Expected return on plan assets</a></td>
<td class="nump">5.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease', window );">Rate of compensation increase</a></td>
<td class="nump">3.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.90%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Discount rate</a></td>
<td class="nump">1.90%<span></span>
</td>
<td class="nump">1.60%<span></span>
</td>
<td class="nump">2.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected return on plan assets</a></td>
<td class="nump">5.10%<span></span>
</td>
<td class="nump">4.30%<span></span>
</td>
<td class="nump">4.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease', window );">Rate of compensation increase</a></td>
<td class="nump">2.90%<span></span>
</td>
<td class="nump">2.70%<span></span>
</td>
<td class="nump">2.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other Postretirement Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate</a></td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.90%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationExpectedLongtermReturnonAssets', window );">Expected return on plan assets</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease', window );">Rate of compensation increase</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Discount rate</a></td>
<td class="nump">1.90%<span></span>
</td>
<td class="nump">3.30%<span></span>
</td>
<td class="nump">4.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected return on plan assets</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease', window );">Rate of compensation increase</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2919-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationExpectedLongtermReturnonAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Expected Long-term Return on Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationExpectedLongtermReturnonAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R118.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942908626376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Employee Benefit Plans (Estimated Future Benefit Payments) (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">2019</a></td>
<td class="nump">$ 101.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">2020</a></td>
<td class="nump">97.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">2021</a></td>
<td class="nump">103.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">2022</a></td>
<td class="nump">100.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">2023</a></td>
<td class="nump">104.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">Thereafter</a></td>
<td class="nump">528.5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ExpectedFutureBenefitPayments', window );">Total</a></td>
<td class="nump">1,035.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other Postretirement Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">2019</a></td>
<td class="nump">16.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">2020</a></td>
<td class="nump">16.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">2021</a></td>
<td class="nump">16.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">2022</a></td>
<td class="nump">16.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">2023</a></td>
<td class="nump">16.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">Thereafter</a></td>
<td class="nump">73.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_ExpectedFutureBenefitPayments', window );">Total</a></td>
<td class="nump">$ 155.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_ExpectedFutureBenefitPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected Future Benefit Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_ExpectedFutureBenefitPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>R119.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942897433576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Reconciliation of Segment Information to Total Consolidated Information) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 17,813.6<span></span>
</td>
<td class="nump">$ 11,819.9<span></span>
</td>
<td class="nump">$ 11,370.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Segment profitability</a></td>
<td class="num">(34.0)<span></span>
</td>
<td class="num">(210.8)<span></span>
</td>
<td class="nump">715.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Intangible asset amortization expense</a></td>
<td class="num">(2,702.2)<span></span>
</td>
<td class="num">(1,605.8)<span></span>
</td>
<td class="num">(1,582.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Globally managed research and development costs</a></td>
<td class="num">(751.1)<span></span>
</td>
<td class="num">(555.1)<span></span>
</td>
<td class="num">(639.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Litigation settlements &amp; other contingencies</a></td>
<td class="num">(329.2)<span></span>
</td>
<td class="num">(107.8)<span></span>
</td>
<td class="nump">21.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">17,813.6<span></span>
</td>
<td class="nump">11,819.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Segment profitability</a></td>
<td class="nump">8,705.0<span></span>
</td>
<td class="nump">5,271.6<span></span>
</td>
<td class="nump">5,112.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember', window );">Segment Reconciling</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Intangible asset amortization expense</a></td>
<td class="num">(2,702.2)<span></span>
</td>
<td class="num">(1,605.8)<span></span>
</td>
<td class="num">(1,582.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Intangible asset impairment charges</a></td>
<td class="num">(102.8)<span></span>
</td>
<td class="num">(82.4)<span></span>
</td>
<td class="num">(180.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Globally managed research and development costs</a></td>
<td class="num">(751.1)<span></span>
</td>
<td class="num">(555.1)<span></span>
</td>
<td class="num">(639.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Litigation settlements &amp; other contingencies</a></td>
<td class="num">(329.2)<span></span>
</td>
<td class="num">(107.8)<span></span>
</td>
<td class="nump">21.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_OtherOneTimeNonoperatingExpense', window );">Transaction related and other special items</a></td>
<td class="num">(2,832.2)<span></span>
</td>
<td class="num">(1,739.7)<span></span>
</td>
<td class="num">(682.2)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate (Other)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_Corporatecosts', window );">Corporate costs</a></td>
<td class="num">(2,021.5)<span></span>
</td>
<td class="num">(1,391.6)<span></span>
</td>
<td class="num">(1,332.8)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_DevelopedMarketsSegmentMember', window );">Developed Markets | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">10,428.7<span></span>
</td>
<td class="nump">8,510.9<span></span>
</td>
<td class="nump">8,240.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Segment profitability</a></td>
<td class="nump">5,143.1<span></span>
</td>
<td class="nump">4,243.9<span></span>
</td>
<td class="nump">4,137.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember', window );">Greater China | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2,212.8<span></span>
</td>
<td class="nump">259.9<span></span>
</td>
<td class="nump">214.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Segment profitability</a></td>
<td class="nump">1,397.1<span></span>
</td>
<td class="nump">52.7<span></span>
</td>
<td class="nump">89.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember', window );">JANZ | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2,027.4<span></span>
</td>
<td class="nump">1,195.3<span></span>
</td>
<td class="nump">1,192.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Segment profitability</a></td>
<td class="nump">762.4<span></span>
</td>
<td class="nump">364.6<span></span>
</td>
<td class="nump">323.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember', window );">Emerging Markets | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">3,144.7<span></span>
</td>
<td class="nump">1,853.8<span></span>
</td>
<td class="nump">1,723.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Segment profitability</a></td>
<td class="nump">$ 1,402.4<span></span>
</td>
<td class="nump">$ 610.4<span></span>
</td>
<td class="nump">$ 561.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_Corporatecosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Corporate costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_Corporatecosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_OtherOneTimeNonoperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other One-Time Nonoperating Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_OtherOneTimeNonoperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_DevelopedMarketsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_DevelopedMarketsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>R120.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942907620408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Third Party Net Sales by Major Customers) (Details) - Third party net sales - Customer Concentration Risk<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">McKesson Corporation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">9.00%<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">AmeriSourceBergen Corporation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">9.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Cardinal Health Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideRevenueMajorCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideRevenueMajorCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=vtrs_MckessonCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=vtrs_MckessonCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=vtrs_AmeriSourceBergenCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=vtrs_AmeriSourceBergenCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=vtrs_CardinalHealthIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=vtrs_CardinalHealthIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>R121.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942897998088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Net Third Party Sales Classified Based on Geographic Location of Entity) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 17,813.6<span></span>
</td>
<td class="nump">$ 11,819.9<span></span>
</td>
<td class="nump">$ 11,370.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">4,176.4<span></span>
</td>
<td class="nump">3,746.1<span></span>
</td>
<td class="nump">3,965.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CN', window );">CHINA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 1,981.5<span></span>
</td>
<td class="nump">$ 216.1<span></span>
</td>
<td class="nump">$ 171.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>R122.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942908146520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments (Details) - Pfizer, Inc. - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BusinessCombinationContractualReimbursementAmountTrancheOne', window );">Reimbursement amount, tranche one</a></td>
<td class="nump">$ 380.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BusinessCombinationContractualReimbursementAmountAmountsExpensed', window );">Amounts incurred</a></td>
<td class="nump">30.4<span></span>
</td>
<td class="nump">$ 53.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BusinessCombinationContractualReimbursementAmountAmountsAccrued', window );">Amounts accrued</a></td>
<td class="nump">$ 26.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis=vtrs_PfizerInc.Member', window );">Transition Service Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_BusinessCombinationLimitedTransitionServicesPaymentPeriod', window );">Limited transition services period</a></td>
<td class="text">24 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_BusinessCombinationContractualReimbursementAmountAmountsAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contractual Reimbursement Amount, Amounts Accrued</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_BusinessCombinationContractualReimbursementAmountAmountsAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_BusinessCombinationContractualReimbursementAmountAmountsExpensed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contractual Reimbursement Amount, Amounts Expensed</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_BusinessCombinationContractualReimbursementAmountAmountsExpensed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_BusinessCombinationContractualReimbursementAmountTrancheOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contractual Reimbursement Amount, Tranche One</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_BusinessCombinationContractualReimbursementAmountTrancheOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_BusinessCombinationLimitedTransitionServicesPaymentPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Limited Transition Services Payment Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_BusinessCombinationLimitedTransitionServicesPaymentPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis=vtrs_PfizerInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis=vtrs_PfizerInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsAxis=vtrs_TransitionServiceAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsAxis=vtrs_TransitionServiceAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>139
<FILENAME>R123.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942898651128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1">60 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments for Restructuring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (25.7)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (59.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReservePeriodIncreaseDecrease', window );">Restructuring Reserve, Period Increase (Decrease)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">8.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Restructuring and Related Cost, Incurred Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(32.9)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(78.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Restructuring Reserve, Translation and Other Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring and Related Cost, Cost Incurred to Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.5<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">104.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22.8<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">29.2<span></span>
</td>
<td class="nump">$ 22.8<span></span>
</td>
<td class="nump">$ 72.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOnFutureCashFlowsAmount', window );">Effect on Future Cash Flows, Amount</a></td>
<td class="nump">$ 900.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=vtrs_A2016RestructuringProgramMember', window );">2016 Restructuring Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring and Related Cost, Cost Incurred to Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">733.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee Severance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments for Restructuring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18.1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(48.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReservePeriodIncreaseDecrease', window );">Restructuring Reserve, Period Increase (Decrease)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Restructuring and Related Cost, Incurred Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Restructuring Reserve, Translation and Other Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring and Related Cost, Cost Incurred to Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.9<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">16.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">26.4<span></span>
</td>
<td class="nump">20.0<span></span>
</td>
<td class="nump">60.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember', window );">Other Restructuring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments for Restructuring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7.6)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(10.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReservePeriodIncreaseDecrease', window );">Restructuring Reserve, Period Increase (Decrease)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">8.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Restructuring and Related Cost, Incurred Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(32.9)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(78.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Restructuring Reserve, Translation and Other Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring and Related Cost, Cost Incurred to Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">88.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.8<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2.8<span></span>
</td>
<td class="nump">$ 2.8<span></span>
</td>
<td class="nump">$ 11.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_DevelopedMarketsSegmentMember', window );">Developed Markets | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring and Related Cost, Cost Incurred to Date</a></td>
<td class="nump">623.8<span></span>
</td>
<td class="nump">292.1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">100.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember', window );">JANZ | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring and Related Cost, Cost Incurred to Date</a></td>
<td class="nump">138.1<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 4.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember', window );">Greater China | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring and Related Cost, Cost Incurred to Date</a></td>
<td class="nump">$ 5.8<span></span>
</td>
<td class="nump">$ 18.4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">For the year ended December&#160;31, 2021, total restructuring charges for the 2020 Restructuring Program, in Developed Markets, Greater China, JANZ, Emerging Markets, and Corporate/Other were approximately $623.8 million, $5.8 million, $138.1 million, $94.1 million, and $30.4 million, respectively. <div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;For the year ended December&#160;31, 2020, total restructuring charges, for both programs, in Developed Markets, Greater China, JANZ, and Emerging Markets were approximately $292.1 million, $18.4 million, $2.9 million, and $8.4 million, respectively. </span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;For the year ended December 31, 2019, total restructuring charges for the 2016 Restructuring Program in Developed Markets and JANZ were approximately $100.4&#160;million and $4.2&#160;million, respectively.</span></div></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOnFutureCashFlowsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The quantified amount of the future effect on cash flows.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOnFutureCashFlowsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostIncurredCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostIncurredCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReservePeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the accrual for restructuring costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReservePeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the restructuring reserve related to foreign currency translation (gain) loss and other increases (decreases).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveTranslationAndOtherAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=vtrs_A2016RestructuringProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=vtrs_A2016RestructuringProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_DevelopedMarketsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_DevelopedMarketsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>140
<FILENAME>R124.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942893036232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring (2020 Restructuring Plan) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22.8<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 29.2<span></span>
</td>
<td class="nump">$ 72.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments for Restructuring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25.7)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(59.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Restructuring and Related Cost, Incurred Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(32.9)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(78.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Restructuring Reserve, Translation and Other Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring and Related Cost, Cost Incurred to Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.5<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">104.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_RestructuringReserveReimbursableRestructuringCharges', window );">Restructuring Reserve, Reimbursable Restructuring Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate (Other)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring and Related Cost, Cost Incurred to Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember', window );">Emerging Markets | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring and Related Cost, Cost Incurred to Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94.1<span></span>
</td>
<td class="nump">8.4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember', window );">Greater China | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring and Related Cost, Cost Incurred to Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.8<span></span>
</td>
<td class="nump">18.4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember', window );">JANZ | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring and Related Cost, Cost Incurred to Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">138.1<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_DevelopedMarketsSegmentMember', window );">Developed Markets | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring and Related Cost, Cost Incurred to Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">623.8<span></span>
</td>
<td class="nump">292.1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">100.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee Severance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">26.4<span></span>
</td>
<td class="nump">60.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments for Restructuring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18.1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(48.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Restructuring and Related Cost, Incurred Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Restructuring Reserve, Translation and Other Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring and Related Cost, Cost Incurred to Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.9<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">16.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_RestructuringReserveReimbursableRestructuringCharges', window );">Restructuring Reserve, Reimbursable Restructuring Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember', window );">Other Restructuring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.8<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2.8<span></span>
</td>
<td class="nump">$ 11.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments for Restructuring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7.6)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(10.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Restructuring and Related Cost, Incurred Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(32.9)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(78.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Restructuring Reserve, Translation and Other Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring and Related Cost, Cost Incurred to Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 88.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_RestructuringReserveReimbursableRestructuringCharges', window );">Restructuring Reserve, Reimbursable Restructuring Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=vtrs_A2020RestructuringPlanMember', window );">2020 Restructuring Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve</a></td>
<td class="nump">$ 296.7<span></span>
</td>
<td class="nump">296.7<span></span>
</td>
<td class="nump">267.4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments for Restructuring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(537.2)<span></span>
</td>
<td class="num">(25.5)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Restructuring and Related Cost, Incurred Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(345.0)<span></span>
</td>
<td class="num">(70.8)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Restructuring Reserve, Translation and Other Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7.1)<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring and Related Cost, Cost Incurred to Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">892.2<span></span>
</td>
<td class="nump">271.3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_RestructuringReserveAcquiredDuringPeriod', window );">Restructuring Reserve, Acquired During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=vtrs_A2020RestructuringPlanMember', window );">2020 Restructuring Plan | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring and Related Cost, Cost Incurred to Date</a></td>
<td class="nump">1,400.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Restructuring Reserve, Settled without Cash</a></td>
<td class="nump">450.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1', window );">Restructuring and Related Cost, Expected Cost Remaining</a></td>
<td class="nump">950.0<span></span>
</td>
<td class="nump">950.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=vtrs_A2020RestructuringPlanMember', window );">2020 Restructuring Plan | Employee Severance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve</a></td>
<td class="nump">292.6<span></span>
</td>
<td class="nump">292.6<span></span>
</td>
<td class="nump">262.6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments for Restructuring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(385.5)<span></span>
</td>
<td class="num">(25.1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Restructuring and Related Cost, Incurred Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Restructuring Reserve, Translation and Other Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7.0)<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring and Related Cost, Cost Incurred to Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">396.1<span></span>
</td>
<td class="nump">195.6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_RestructuringReserveAcquiredDuringPeriod', window );">Restructuring Reserve, Acquired During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91.7<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=vtrs_A2020RestructuringPlanMember', window );">2020 Restructuring Plan | Other Restructuring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve</a></td>
<td class="nump">$ 4.1<span></span>
</td>
<td class="nump">4.1<span></span>
</td>
<td class="nump">4.8<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments for Restructuring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(151.7)<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Restructuring and Related Cost, Incurred Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(345.0)<span></span>
</td>
<td class="num">(70.8)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Restructuring Reserve, Translation and Other Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring and Related Cost, Cost Incurred to Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 496.1<span></span>
</td>
<td class="nump">75.7<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_RestructuringReserveAcquiredDuringPeriod', window );">Restructuring Reserve, Acquired During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">For the year ended December&#160;31, 2021, total restructuring charges for the 2020 Restructuring Program, in Developed Markets, Greater China, JANZ, Emerging Markets, and Corporate/Other were approximately $623.8 million, $5.8 million, $138.1 million, $94.1 million, and $30.4 million, respectively. <div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;For the year ended December&#160;31, 2020, total restructuring charges, for both programs, in Developed Markets, Greater China, JANZ, and Emerging Markets were approximately $292.1 million, $18.4 million, $2.9 million, and $8.4 million, respectively. </span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;For the year ended December 31, 2019, total restructuring charges for the 2016 Restructuring Program in Developed Markets and JANZ were approximately $100.4&#160;million and $4.2&#160;million, respectively.</span></div></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expected cost remaining for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostIncurredCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostIncurredCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveSettledWithoutCash2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the reserve for full or partial settlement through consideration other than cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveSettledWithoutCash2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the restructuring reserve related to foreign currency translation (gain) loss and other increases (decreases).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveTranslationAndOtherAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_RestructuringReserveAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring Reserve, Acquired During Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_RestructuringReserveAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_RestructuringReserveReimbursableRestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring Reserve, Reimbursable Restructuring Charges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_RestructuringReserveReimbursableRestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_EmergingMarketsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_GreaterChinaSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_JapanAustraliaAndNewZealandSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=vtrs_DevelopedMarketsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=vtrs_DevelopedMarketsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=vtrs_A2020RestructuringPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=vtrs_A2020RestructuringPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>141
<FILENAME>R125.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942897196280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration and Licensing Agreements (Narrative) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 27, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 20, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 30, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 12, 2013 </div>
<div>Product</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 08, 2016 </div>
<div>drugs</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 199.7<span></span>
</td>
<td class="nump">$ 223.6<span></span>
</td>
<td class="nump">$ 250.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">751.1<span></span>
</td>
<td class="nump">555.1<span></span>
</td>
<td class="nump">639.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from sale of assets and subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96.7<span></span>
</td>
<td class="nump">20.0<span></span>
</td>
<td class="nump">$ 28.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=vtrs_MomentaMember', window );">Momenta</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_NumberOfDrugs', window );">Number of drugs | drugs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=vtrs_TheravanceBiopharmaMember', window );">Theravance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_PaymentsToAcquireCollaborativeAgreement', window );">Upfront payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=vtrs_FKBMember', window );">FKB</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_Developmentandsalesmilestonepayments', window );">Development and sales milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_PaymentsToAcquireCollaborativeAgreement', window );">Upfront payments</a></td>
<td class="nump">$ 33.0<span></span>
</td>
<td class="nump">$ 25.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 23.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember', window );">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember', window );">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | Scenario, Forecast | Biosimilars Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from sale of assets and subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_DivestitureOfBusinessDeferredCashConsideration', window );">Divestiture of Business, Deferred Cash Consideration.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 335.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_DivestitureOfBusinessPercentageOwnershipInCombinedCompanyAfterTransaction', window );">Divestiture Of Business, Percentage Ownership In Combined Company After Transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_DivestitureOfBusinessTransitionServicesAgreementTerm', window );">Divestiture Of Business, Transition Services Agreement, Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember', window );">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | Scenario, Forecast | Biosimilars Business | Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1', window );">Equity consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember', window );">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | Revance [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember', window );">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | Theravance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_Developmentandsalesmilestonepayments', window );">Development and sales milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">351.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Theravance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_Developmentandsalesmilestonepayments', window );">Development and sales milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 293.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_PeriodAxis=vtrs_FiscalYear2017Member', window );">Fiscal Year 2017 | Maximum | Collaborative Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_Developmentandsalesmilestonepayments', window );">Development and sales milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplyCommitmentAxis=vtrs_GenericBiologicCompoundsCollaborationMember', window );">Generic Biologic Compounds Collaboration [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_InsulinAnalogProducts', window );">Insulin Analog Products | Product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vtrs_RespiratorydeliveryplatformMember', window );">Respiratory delivery platform [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">177.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Product rights and licenses | Other companies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Acquisition purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned', window );">Business Acquisition, Equity Interest Issued or Issuable, Value Assigned</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash consideration received for selling an asset or business through a noncash (or part noncash) transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_Developmentandsalesmilestonepayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Development and sales milestone payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_Developmentandsalesmilestonepayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_DivestitureOfBusinessDeferredCashConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Divestiture of Business, Deferred Cash Consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_DivestitureOfBusinessDeferredCashConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_DivestitureOfBusinessPercentageOwnershipInCombinedCompanyAfterTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Divestiture Of Business, Percentage Ownership In Combined Company After Transaction</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_DivestitureOfBusinessPercentageOwnershipInCombinedCompanyAfterTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_DivestitureOfBusinessTransitionServicesAgreementTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Divestiture Of Business, Transition Services Agreement, Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_DivestitureOfBusinessTransitionServicesAgreementTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_InsulinAnalogProducts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Insulin Analog Products</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_InsulinAnalogProducts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_NumberOfDrugs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of drugs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_NumberOfDrugs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_PaymentsToAcquireCollaborativeAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments To Acquire Collaborative Agreement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_PaymentsToAcquireCollaborativeAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=vtrs_MomentaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=vtrs_MomentaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=vtrs_TheravanceBiopharmaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=vtrs_TheravanceBiopharmaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=vtrs_FKBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=vtrs_FKBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=vtrs_BiosimilarsBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=vtrs_BiosimilarsBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=vtrs_RevanceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=vtrs_RevanceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=vtrs_TheravanceBiopharmaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=vtrs_TheravanceBiopharmaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_PeriodAxis=vtrs_FiscalYear2017Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_PeriodAxis=vtrs_FiscalYear2017Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplyCommitmentAxis=vtrs_GenericBiologicCompoundsCollaborationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplyCommitmentAxis=vtrs_GenericBiologicCompoundsCollaborationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=vtrs_RespiratorydeliveryplatformMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=vtrs_RespiratorydeliveryplatformMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=vtrs_OtherCompaniesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=vtrs_OtherCompaniesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>142
<FILENAME>R126.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942896531784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Litigation (Narrative) (Details)<br> &#163; in Thousands, case in Thousands, &#8364; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 17, 2019 </div>
<div>patent </div>
<div>agreement</div>
</th>
<th class="th">
<div>Jun. 17, 2019 </div>
<div>patent</div>
</th>
<th class="th">
<div>Sep. 10, 2018 </div>
<div>patent</div>
</th>
<th class="th">
<div>Oct. 24, 2017 </div>
<div>patent</div>
</th>
<th class="th">
<div>Jun. 30, 2017 </div>
<div>patent</div>
</th>
<th class="th">
<div>Feb. 12, 2016 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Jul. 09, 2014 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Feb. 28, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 19, 2013 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2014 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>state </div>
<div>agreement </div>
<div>case </div>
<div>increase</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>GBP (&#163;) </div>
<div>state </div>
<div>case</div>
</th>
<th class="th">
<div>Apr. 02, 2020 </div>
<div>patent</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_Numberofcases', window );">Number of cases | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=vtrs_ProductLiabilityMember', window );">Product Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Loss contingency accrual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Intellectual Property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesPaidValue', window );">Loss contingency accrual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 226.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement', window );">Number of times damages may be increased in cases of willful infringement | increase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=vtrs_OtherMember', window );">Other Foreign Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Loss contingency accrual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=vtrs_MultiDistrictLitigationMember', window );">MDL</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_Numberofstates', window );">Number of states | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember', window );">Anticompetitive Conduct with Doxycycline Hyclate Delayed Release, Doxycycline Monohydrate, Glipizide-Metformin and Verapamil</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_Numberofstates', window );">Number of states | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=vtrs_AnticompetitiveConductwithGenericDrugsMember', window );">Anticompetitive Conduct with Generic Drugs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_Numberofstates', window );">Number of states | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember', window );">Amended Anticompetitive Conduct with Generic Drugs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_Numberofstates', window );">Number of states | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=vtrs_EUCommissionProceedingsPerindorprilMember', window );">EU Commission Proceedings Perindorpril | Antitrust Proceedings | Mylan Laboratories Limited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 17.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesPaidValue', window );">Loss contingency accrual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=vtrs_U.K.CompetitionandMarketsAuthorityProceedingsParoxetineMember', window );">U.K. Competition and Markets Authority Proceedings Paroxetine</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded | &#163;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 5,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_LossContingencyDamagesAwardedOnAppealValue', window );">Loss Contingency, Damages Awarded On Appeal, Value | &#163;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=vtrs_U.K.CompetitionandMarketsAuthorityProceedingsParoxetineMember', window );">U.K. Competition and Markets Authority Proceedings Paroxetine | Mylan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Loss contingency accrual | &#163;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 8,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded | &#163;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_LossContingencyDamagesAwardedOnAppealValue', window );">Loss Contingency, Damages Awarded On Appeal, Value | &#163;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 2,050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=vtrs_EUCommissionProceedingsCitalopramMember', window );">EU Commission Proceedings Citalopram</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Loss contingency accrual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 7.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=vtrs_DimethylFumarateMember', window );">Dimethyl Fumarate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber', window );">Loss Contingency, Patents Allegedly Infringed, Number | patent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=vtrs_InsulinGlargineMember', window );">Insulin Glargine</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber', window );">Loss Contingency, Patents Allegedly Infringed, Number | patent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPatentsFoundNotInfringedNumber', window );">Loss Contingency, Patents Found Not Infringed, Number</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_LossContingencyRemainingClaimsNumber', window );">Loss Contingency, Remaining Claims, Number | patent</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_LossContingencyOtherAssertedPatentsNumber', window );">Loss Contingency, Other Asserted Patents, Number | patent</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=vtrs_EpiPenAutoInjectorLitigationMember', window );">EpiPen Auto-Injector Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Loss contingency accrual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 264.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vtrs_LossContingencyNumberOfStates', window );">Loss Contingency, Number of States | agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=vtrs_EpiPenAutoInjectorLitigationMember', window );">EpiPen Auto-Injector Litigation | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Amount awarded to other party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 264.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=vtrs_EpiPenAutoInjectorLitigationMember', window );">EpiPen Auto-Injector Litigation | Other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserve', window );">Estimated Litigation Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 274.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount awarded to other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedToOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of damages awarded to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesPaidValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of damages paid to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesPaidValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of another entity's patents that the entity has allegedly infringed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPatentsAllegedlyInfringedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPatentsFoundNotInfringedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of another entity's patents that the entity was found not to have infringed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPatentsFoundNotInfringedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_LossContingencyDamagesAwardedOnAppealValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Damages Awarded On Appeal, Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_LossContingencyDamagesAwardedOnAppealValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_LossContingencyNumberOfStates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of States</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_LossContingencyNumberOfStates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_LossContingencyOtherAssertedPatentsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Other Asserted Patents, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_LossContingencyOtherAssertedPatentsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_LossContingencyRemainingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Remaining Claims, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_LossContingencyRemainingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of times damages may be increased in cases of willful infringement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_Numberofcases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of cases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_Numberofcases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vtrs_Numberofstates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of states</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vtrs_Numberofstates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vtrs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=vtrs_ProductLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=vtrs_ProductLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=vtrs_OtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=vtrs_OtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=vtrs_MultiDistrictLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=vtrs_MultiDistrictLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=vtrs_AnticompetitiveConductwithGenericDrugsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=vtrs_AnticompetitiveConductwithGenericDrugsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=vtrs_EUCommissionProceedingsPerindorprilMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=vtrs_EUCommissionProceedingsPerindorprilMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=vtrs_AntitrustProceedingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=vtrs_AntitrustProceedingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=vtrs_U.K.CompetitionandMarketsAuthorityProceedingsParoxetineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=vtrs_U.K.CompetitionandMarketsAuthorityProceedingsParoxetineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=vtrs_EUCommissionProceedingsCitalopramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=vtrs_EUCommissionProceedingsCitalopramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=vtrs_DimethylFumarateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=vtrs_DimethylFumarateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=vtrs_InsulinGlargineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=vtrs_InsulinGlargineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=vtrs_EpiPenAutoInjectorLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=vtrs_EpiPenAutoInjectorLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>143
<FILENAME>R127.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139942904788968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Valuation and Qualifying Accounts (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember', window );">Allowance for doubtful accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Beginning balance</a></td>
<td class="nump">$ 159.9<span></span>
</td>
<td class="nump">$ 72.8<span></span>
</td>
<td class="nump">$ 98.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Additions Charged to Costs and Expenses</a></td>
<td class="nump">16.0<span></span>
</td>
<td class="nump">16.9<span></span>
</td>
<td class="nump">14.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts', window );">Additions Charged to Other Accounts</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">77.3<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions</a></td>
<td class="num">(21.4)<span></span>
</td>
<td class="num">(7.1)<span></span>
</td>
<td class="num">(39.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Ending balance</a></td>
<td class="nump">154.5<span></span>
</td>
<td class="nump">159.9<span></span>
</td>
<td class="nump">72.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember', window );">Valuation allowance for deferred tax assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Beginning balance</a></td>
<td class="nump">443.6<span></span>
</td>
<td class="nump">603.5<span></span>
</td>
<td class="nump">806.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Additions Charged to Costs and Expenses</a></td>
<td class="nump">82.2<span></span>
</td>
<td class="nump">39.0<span></span>
</td>
<td class="nump">36.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts', window );">Additions Charged to Other Accounts</a></td>
<td class="nump">260.8<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions</a></td>
<td class="num">(6.2)<span></span>
</td>
<td class="num">(198.9)<span></span>
</td>
<td class="num">(239.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Ending balance</a></td>
<td class="nump">$ 780.4<span></span>
</td>
<td class="nump">$ 443.6<span></span>
</td>
<td class="nump">$ 603.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInValuationAllowancesAndReservesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to accounts other than cost and expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column D))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>144
<FILENAME>vtrs-20211231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:vtrs="http://www.viatris.com/20211231"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="vtrs-20211231.xsd" xlink:type="simple"/>
    <context id="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i13f4973de7d347c1990aa06418f9a87d_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i9b5b6f53dc884bc28cf189d394d6db66_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idb49b3416a6648899c9dbb31e728c519_I20220222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
        </entity>
        <period>
            <instant>2022-02-22</instant>
        </period>
    </context>
    <context id="i36d66b81144849148d1319e8bfed3c96_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3d077e089f704543858c47bf4c5566bf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i39d4f9fa88c04ae0856b7faa1bf73798_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic25b2c6a9a1244738c1de493abb87705_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9f25078033394f518263d14867ea4eb6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iadb0452c57794c5498c4248d6691b32c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if2b4674a5a824635bbb161ea5fe82fea_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie779f16aabc14a74b5468853e37f6dd2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id568b4f1929446b9942b42b58b8e069f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ibbe7edb935be4af4a3721e260440024e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5b0e6896d0904a51b7f3d01a54c4ddc3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie99d2b10b5fa41a2b69de441e703d1be_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i72a4e38013274704acf3fce567aec1b6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie12ac8dbb8e34d9bbb1bb903a175a2c8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i57c4f10b75634ea68f1dca6a931ad8e6_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4c63b953f9ab4ca380c2a6718f3499d2_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ia50f87af01074210b75c18963d37110d_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i0df3c349ea2b4fbfba28ebfb584419f0_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ib23cdc694f6547709893256e80430c38_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ibadea9a32ce84dc48523b37b0f0b23ce_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="if8ec92ba24d848d697ba737aeed13c05_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i4f90527bae0344d981ff43fd2126b229_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5143c6332d7249db9f3409e36def6483_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib0cf1109448e4942a109317479a8de2d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic877d36b0d2e41a293e8217247ace76e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i759302137d4347189f09b28fddcb4d55_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i676ac4a93e7c42cf8130b6170dc1899a_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i5f069b3a590b4f41809c068d4484a771_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i37a67212c0ef46a4ad4f6aa75d225fed_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i00d14723d68d4566b474e37cf199d470_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia780b2ac8321464bae70f392c4b8e0ac_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibd43c5aaf4d94827a901e78c27e732f7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib85f7a5cf6f64a0e84c35ebc74cd0576_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic39189fc54504b53be3c4281e5dd8f82_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iac503b6d629d4bafb262ea6ec0b8a25e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="idc41db043d3e4f84b4c531fda801f18c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0e5cd61854a54e59a6e1744de70eab75_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie4251244738d4104aa6f320d2729ecf7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1aaa5a37c6f4415aaac4b207251f9e26_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i614ccdb2c5cd4297b966274861517991_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia12703913f6e4df58b4262b9bbb6ea77_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3d45fba46a924824a984d4a911f8510f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iba866be0d0f04d0cbdf171873fd7fd0b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i14dba6c874d24fcfae05dbedf70952aa_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i92e45e4918604661b681cd5b227d7bcc_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ifcb976e09f3943ed918be4bf207b55e3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i09fc106c667c4de189765013dc4a94ef_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if7c969d8800446acace677aeab6fa885_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7428ecd34bd643bfb53dd62a4bce788c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if13be5161c804163b4305d5d326bef7e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1a6cdd4c97954d22af41797509ecf7fb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i87a0adf309ee48cab4e379bd487453b4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8c96921a8e77407497a3fe28076245b9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i982f994b896949038225ee2127e449b8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i17e28a6fde804fee9a50f41480db4409_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2f9c5e0f0ba44c18819a8dd18e51076c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i33eb2ebb7c134785bb1904a27dee8446_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0ecc2d6f42a84a91b65e020dbcaad871_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i84ab0bd68a334690be79969b61dd4796_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i500214b091fd4491a3e5f7c09d556da9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i52196ab9082e4abaa0b8161e828c13e6_D20211216-20211216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
        </entity>
        <period>
            <startDate>2021-12-16</startDate>
            <endDate>2021-12-16</endDate>
        </period>
    </context>
    <context id="i0914e4cffd32443cb84e261c6290c882_D20210616-20210616">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
        </entity>
        <period>
            <startDate>2021-06-16</startDate>
            <endDate>2021-06-16</endDate>
        </period>
    </context>
    <context id="i49c23bc660594338939e7cd39689f85c_D20210916-20210916">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
        </entity>
        <period>
            <startDate>2021-09-16</startDate>
            <endDate>2021-09-16</endDate>
        </period>
    </context>
    <context id="i85acd539c52b4ddd8dbb4b2c90aedaa6_D20220106-20220106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-06</startDate>
            <endDate>2022-01-06</endDate>
        </period>
    </context>
    <context id="id1b5d3649e684795b5f4c627d6ba66fa_I20220316">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-16</instant>
        </period>
    </context>
    <context id="ia473d9dc16fb4846abacc46ab07e5dd4_I20220228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="i90374f5d9f1b4c92a65a560a42412201_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iead6205586b04557a8ada1d7b914b227_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2f125b5601ba485fa87e1359408bb169_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icdcd2c5e3dc049c9af2e2879fc06a18a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8d43c5886aae45d78bf51b4acef73ab6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i96fc2bf65c384f6d95e6f124e5de94a4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ifc09cb425c1a4b00bebeb7a3b1d088e4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i773e23ec8b4f40d2892b90d9c9b32095_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7b2cacb9811a4855a05fcf61e040a1d7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idbdc76c08f4f4be1a89d1b41630e9c46_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1cdfba9175504c2887d1d60461bee852_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i269ffde73a154b28805576347563a5cb_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic535a9058568425bb3eb5f0763a47e3d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie684c80cdcef4397b8798cbb98e6a796_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if2a6d40b5f364731b5c17ef708876be7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1ac0bcd2e1264e8b8347af73e216d016_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7ed92dccf2314bd48c7373be7cf33d4e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3ccdc9914af44b1bb1229e19c17326d8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i02b3f133daa24190abd49dfdef6bb6ce_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id2ddd71cee624b009233ae18ff01bcdb_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i97c939970b2a44ec93ec3adde4f66f7a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1831edfa3a5a49a4bb77c12a7484690f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if9abda492c204a6db32dc9d58d9d3283_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i05eae9ce2c1146cda2761d09e8dfafec_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i86d67a91f60c42daae98c579adcd3ce6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i835c7b50b49142419f07188c47c94df3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i27e66858837c4e0e95198bd461c39df7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic3131c3ac2a04122b50238e3e2e46c6e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4108be32c0e74b899efbefe5401e783f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i226439d9ee1a49f6b1bb3182d0a8d06d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i105959ab42be4a4484a43c24d4643610_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib26272e8a91e4d71b3b831cda82ccb89_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3a9efc1a735d41babd68b5c507c58032_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibe1b26c10c8d49dcb8d293449427f7d1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7d668c3c2f2946a49634c6f0bfb9cdee_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iec0737b261124d3f87ea9adcdb407b5a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4e0c5048f8f84f26a1949d61f3285173_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2d06b2c023334d92a7c83b2943f0232b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i281863eb67c44d0fbc00294dfaf0049c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icdd7bc10185c4685b4d14c9b6ac151b1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i61ed8d945a654397b38ffd9a5155cc8a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7a4ad71e069349d4bc77dedb205f5b6e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i75185d8bca2c4c33b481ec3ed8ab4bc2_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9929171805eb41e3845525fcedeefdd7_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iac08a240cf724732a33d7e4c11a51983_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic72949e3219d4b0db2547334d44e5760_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic570f6e38a0546fb9e89a31a80462c9b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1f7590527ef14168a6dd4e6a2b81c5c7_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie1614ddc606441f19d547ba1a785e380_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i11d08a6a376f45179f8e6bb95bd31c27_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i309244cf155a4aba9fca199455319a32_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i67d9cb8141084c58ac541cde4d576c50_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3166a2866ade49869d6aad191a5c8ef2_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iecf0266755484cffb55ddc7ba73da178_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iff24ee1fc1974d94b68eb9cffe4e3dbf_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i864642c0e47a4b87a88be339d6673670_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie4221a0900a14ced8a5c91eac2fcdf4f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i94d3655a9cb44f37b3319f0d91bf87b1_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6f91beda5d054492aed05bdaf3b7936e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i84058a24993540f0abbe391aeff14baa_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:LipitorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iac2df693fdec46b2a004f4136d918a15_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:NorvascMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i02f7c66517fd42e99c981b2754110472_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:LyricaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2fb4efa6d51f4b0d81d894b26998702c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ViagraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic5b45e5acb5a43d086ab1d31fe635f90_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:EpiPenAutoInjectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i32b74097924040a6a3b293c9de50757b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:CelebrexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i29c8e33fbfc54cebb3298eb792f30230_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:CreonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2b3ecbda1fdf4ee18c4b7043b1c74bd3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ZoloftMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i45c0dc93080d496b936cfa154fdd5d2f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:EffexorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4f3025b784d24010ab35acb02af8509d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:XalabrandsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1b1907e0d66348049123902a21dcf855_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:InfluvacMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i40e3530192d947059647f2b6af9576ce_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:AmitizaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5bb2b10fff8b4b20b4933b549ff5105e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:XanaxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i09fb6f5ceb234f24b3a2fd5497a71b54_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:YupelriMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8c6990bf97834a12a1ac825a254bf046_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:DymistaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia30145a9cfd34adf9f91e6f9a1d897d6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">vtrs:VariableConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="vtrs:VariableConsiderationCategoryAxis">vtrs:ChargebacksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i81f43377851f4e9cbe28368c42243f3f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">vtrs:VariableConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="vtrs:VariableConsiderationCategoryAxis">vtrs:ChargebacksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if864aa5c3fc0487aa3a78da7140b6dae_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">vtrs:VariableConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="vtrs:VariableConsiderationCategoryAxis">vtrs:ChargebacksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i59d64e28e4b04c0d99f30844bbc4e104_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">vtrs:VariableConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="vtrs:VariableConsiderationCategoryAxis">vtrs:RebatesPromotionalProgramsandOtherSalesAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i67c331d11f9e4f3a92ca17c2d501cc83_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">vtrs:VariableConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="vtrs:VariableConsiderationCategoryAxis">vtrs:RebatesPromotionalProgramsandOtherSalesAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id58d328313c7408dbd05e2611ee1d266_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">vtrs:VariableConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="vtrs:VariableConsiderationCategoryAxis">vtrs:RebatesPromotionalProgramsandOtherSalesAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie0a5fc9ab1014cc9828221ef14219272_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">vtrs:VariableConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="vtrs:VariableConsiderationCategoryAxis">vtrs:VariableConsiderationReturnsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i62c2d36cecfc429d8366c26884930d60_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">vtrs:VariableConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="vtrs:VariableConsiderationCategoryAxis">vtrs:VariableConsiderationReturnsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3efb27c0d9ce4732970b87f4f7b6cadf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">vtrs:VariableConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="vtrs:VariableConsiderationCategoryAxis">vtrs:VariableConsiderationReturnsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iab5c4046b8d2456db70b484a5adc2c29_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">vtrs:VariableConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="vtrs:VariableConsiderationCategoryAxis">vtrs:GovernmentalRebateProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie03fd9221eda4da4a0b73570d90c8f67_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">vtrs:VariableConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="vtrs:VariableConsiderationCategoryAxis">vtrs:GovernmentalRebateProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie35e86a55b3646a392f2363a1ff84e7f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">vtrs:VariableConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="vtrs:VariableConsiderationCategoryAxis">vtrs:GovernmentalRebateProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib8299fb24ad740a0bc5299022149cc89_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">vtrs:VariableConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i25df0d0412f4491d87734041970219e9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">vtrs:VariableConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib4f62d5c61184fe0a10c432fdf606fac_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">vtrs:VariableConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic23fe954f12a4fafb334644ca65a1579_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8aaae8d197ef43d0880965d47a937ced_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8023e485af7e4af6b209e877aaef3977_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">vtrs:ThreeCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i594757645c9e47d297a0b656a9168fb9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">vtrs:ThreeCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic831d526d86b425a838a3b514a51aa9b_I20190729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-29</instant>
        </period>
    </context>
    <context id="ic08788a5b48c49cd8ad76565947aec25_I20190729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis">vtrs:PfizerInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-29</instant>
        </period>
    </context>
    <context id="id1612a93b9c54c9ea53906da30119111_I20190729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-29</instant>
        </period>
    </context>
    <context id="i35d0a01da1c741dc96caa2bc7d221b6f_D20190729-20190729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis">vtrs:PfizerInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-29</startDate>
            <endDate>2019-07-29</endDate>
        </period>
    </context>
    <context id="i14c83873ae33424385c0f6babd91bbf8_I20201116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis">vtrs:PfizerInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-16</instant>
        </period>
    </context>
    <context id="i73d9cbc916614385999dea1173262904_D20201113-20201113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-13</startDate>
            <endDate>2020-11-13</endDate>
        </period>
    </context>
    <context id="i383cdb78da1740a096ade479d7d4de29_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i28f0f2ea42204c5aa8a8ebd404f312a7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if6458ce2b0d942738f7ba444119cf196_I20190528">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-05-28</instant>
        </period>
    </context>
    <context id="i511ad858abed4134961216e0250f69b8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0d755baaf2e14f4bab1de91a766aa0e6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5b06121292274e728651da9462422d99_D20201231-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
        </entity>
        <period>
            <startDate>2020-12-31</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2d63a308e1b544aa993161c92d8cb125_D20201113-20201113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-13</startDate>
            <endDate>2020-11-13</endDate>
        </period>
    </context>
    <context id="i06a1fb578d3742f48890eaae2166c53a_D20201113-20201113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-13</startDate>
            <endDate>2020-11-13</endDate>
        </period>
    </context>
    <context id="i796a35bd5773494f8cda6075e5980668_D20201113-20201113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-13</startDate>
            <endDate>2020-11-13</endDate>
        </period>
    </context>
    <context id="ib6b3029e4d7b457386fcdfda005379fc_I20201113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-13</instant>
        </period>
    </context>
    <context id="ibd8cc0a590a946f6ada83bcfa5b58725_D20201113-20201113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FiniteLivedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-13</startDate>
            <endDate>2020-11-13</endDate>
        </period>
    </context>
    <context id="i54dfb4c408114c26bed39da8f1d171f2_D20201113-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-13</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if4bd4b5ab32b4597b343305c1a782d79_D20201201-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis">vtrs:PfizerInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i41666c68e32e49d291f852ff50719863_D20200901-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:AspenGlobalIncorporatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3210d91021fb432dbd047ea2f8487a57_I20210625">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">us-gaap:ScenarioPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:AspenGlobalIncorporatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-25</instant>
        </period>
    </context>
    <context id="i3789042552e84c75b2b33ac579e33b2f_D20200901-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:AspenGlobalIncorporatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0ccfb22de62b4dbfb381e7e2a79f34d0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i97ba3f8ae46a4aaab4fc9b30066a831a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8bf94f5dfaca4ac4a4aee298a2a67610_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9b4491a3703940ab85025237197bb24e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie99bf64200a74c20a3b7166e800c0872_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id8ad288402464acb99bb2fd89ae7fe54_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5ebc8189c1fd4f9aaed3d986d6412d72_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0bb3fb3a406f4ceab9b6b622c49f1572_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i500543a4ebe64602995d53387c0524dd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">vtrs:CleanEnergyPartnershipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i123b716b2a804024a0f1c41058fde09a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">vtrs:CleanEnergyPartnershipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2c198dc35fb64539904dc17b63908f02_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i869e9de1ba0e414a8a1c0e4653ab950f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2de25d7ac8784fa18767316538f59631_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">vtrs:CleanEnergyPartnershipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i43ea997ac5374cbbb9e8b44ce8488e9c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">vtrs:CleanEnergyPartnershipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8416dfbb7a5942b691bd8f0154ec826e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia89d28ed480a4556840f217684004588_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id8227b4a3c2c48d0b659fec7ce3966a0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if35fa5c71ccb4d9cbe31d2dd6c8f7b48_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i284387cf86b54bd4adfef2f32bb9c670_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="i0853510f8095410c8cab4556a87f5fab_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:ConsolidatedEntityExcludingVieMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6259ebc7ed26431991c3b2aa187c0c91_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:ConsolidatedEntityExcludingVieMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia0185425b6174d78bfd3fbdefaaaea64_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:ConsolidatedEntityExcludingVieMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iae859ab23c9340b096f1af4c4f554c62_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:ConsolidatedEntityExcludingVieMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i09587ab064ca42a8bec631ae169a3af9_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:ConsolidatedEntityExcludingVieMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i315c417d4b374c99bb802f2ca94fe20c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i19b7b956b6644bcdb10d4dea546f710e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4ca0195877e7427d95d7bf2d7026caa1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia340ab16326e432db33adc76e7d83306_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i38a0011834694e8599d458b848606328_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i25616a483e2e4a3da1bdb481fdcdc776_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i93e12956332b44a59bb64bc33354f7ee_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iec758a60e4bd425e896c1f35e907763b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ibcede0739e844bf0be1dd96355937b5b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i257d82c8b1324095a90197f7a7cfb225_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i783790c3f4764f4f86bb8f68bcb4fff2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i98548692221d4033bf9d5dc6b6466a25_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id71374cb5c304b1b8b38cd06a22b2e88_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8ca13749baf74114b35b0784dde6edb1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i283b1cce431d414ab5f875e9a4bcbd90_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ieade6f9a084b4f2eb5b23630a93f657d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia10b2e6ad58c4c4bb99c064d555b97da_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6bf87e450da84c279d1a95ba5e923d3e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i55f2fb13e460418aa9bf86f68ca38852_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5caf17f0c9ca41c58ddd4ef0394bdc79_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id11e45101185446494c54622bb9b8177_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iade66ffae6e040cfa629525230c6273c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib5450616961442a2b1ea8144698c669c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0395335aee314265a48396d57455b625_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idd3f720b0b1c41c799a80daa8a9b8e4b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i24495761b1564b3aaeeb420062790b06_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i95eaf84899294b5cb1284e1df6d5d766_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i31d60f66b7ca4f7b854b44502d7569c6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4832437dbcd3485cb386c3787124ef0c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i83aed7ea547a47a2b816fee23196130f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6fe4acec3d334f5c9bf8565f72ff2a83_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i955ba774e0a548c287a702e8c5749900_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iaceccbde3b074329b263bcda37586891_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1479b6b2aacb40b29f35cd42b1e22f9f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifaa8db533b7d4f489edaa8a8c7c3b889_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6c77a702a1dc4bd4b4d96321e085c678_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9674aa9104274c98b38914ca35d5f4c1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iec67624464a845eeafd1548788c90737_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib511387dd7a949499aa59b3b5b4db16a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i42391df0c964452ab8b60c6d0285b8cc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2edb03cf70c94cf8b258388ec10a11e8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia550848323274182a3d6c7ce2c204b4c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id180e5c47b5b4590aaabfb4d1aa9d1d3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic210cb32648544a095a3760cee270d5a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2c23648696d148ada1075eba8138fa3b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:BrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaae8f6a141fc4440a2e80e908354b800_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icf0dfbd7e212478fa3e85821b257efa9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9ef03cc41bdf4f279229b376fbb43600_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i53980f6dd1b44213ad5171bcab656699_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7318ad9d646d42ab8e2f84f2d4ed08e5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:ComplexGXAndBiosimilarsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie81b4ce4914e4839924a78d8798397a9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib9c761912e804561a14aa3acea5045c2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibbd726794242461a918bc026656e8819_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibd0a85ff305c485ea29c4a037baa7ebf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaa491650e0184ee0b2d04a336fcd9159_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vtrs:GenericsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifa41c4de25dd421eb1ae018322f86643_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:DevelopedMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i03aa196073ab4bffb46b9ece7f3ece15_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8e7e1f56b7f54755a3741e3d317a47f4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia1948994457e4a7d899f19777bc25f52_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib8c6a1c4d0f5419a84aa95ca8cfce91e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i484f17d8c76443b28b80fc7cc73a4065_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2fcad26472544896b5f80c3807d319ee_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2c1b06002c614ec0a7355c6ffde49cad_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9d3ab4b3183547369e21bc16353ca096_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i58799d0aadbb4faf8ae9cbb1ffa7e5c9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i06896c6d773e4c648b6098ee68fc18cc_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8931abe1fc4c41e283d3f620f5185481_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i914407dcbd0742cea3b5fcdd61f4b1ed_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8894e39eabee436d9b912bcc70604238_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4b0764905b0442fb808444acc20375f5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia93f6572cba64cc187e20095aeebe69b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie2d0511984ae4ebb9a94c4f5aaa12d9d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibb7025b0eca84850a521bee0487fc7b2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i05e0f2d1f02d4ed3b1d3cd7d269a0f9f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i97cf21063a7648e88dd9c911711f174d_I20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-01</instant>
        </period>
    </context>
    <context id="ie6266e509f1d44dc9a60daacdb22a350_I20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-01</instant>
        </period>
    </context>
    <context id="ieadb084d06104ed894bd8527a64a8317_I20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EmergingMarketsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-01</instant>
        </period>
    </context>
    <context id="i784ed4be5e4640478be661b277b7af18_I20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-01</instant>
        </period>
    </context>
    <context id="i6f3c6cd031f7442181059f100dfd8aa7_I20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:GreaterChinaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-01</instant>
        </period>
    </context>
    <context id="i4d71ef0b70eb4d1a88d365784c2806c2_D20210401-20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EuropeSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-01</endDate>
        </period>
    </context>
    <context id="ib215f03d4a004bb190d0b0c9e1810626_I20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputLongTermRevenueGrowthRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EuropeSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-01</instant>
        </period>
    </context>
    <context id="i47d220da3337425183ad3fe98cff519f_I20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">vtrs:MeasurementInputTerminalYearRevenueGrowthRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EuropeSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-01</instant>
        </period>
    </context>
    <context id="i2e4d9eb373ac4cf5915b1ac7e264cb55_I20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">vtrs:MeasurementInputEstimatedTaxRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EuropeSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-01</instant>
        </period>
    </context>
    <context id="iedf8aaffd2f2406782984df0b60eedee_I20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputEbitdaMultipleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EuropeSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-01</instant>
        </period>
    </context>
    <context id="ib890b7b1cb504759a309b083b68548ab_I20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputEbitdaMultipleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EuropeSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-01</instant>
        </period>
    </context>
    <context id="ia6d4f61859ba465d955863c12418c41b_I20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputControlPremiumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EuropeSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-01</instant>
        </period>
    </context>
    <context id="idf56c4919fb14633bbf6386bb070262c_I20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">vtrs:MeasurementInputReductionInTerminalYearRevenueGrowthRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EuropeSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-01</instant>
        </period>
    </context>
    <context id="i15608e6da3164b4dae3c3a578cacf736_I20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">vtrs:MeasurementInputIncreaseInDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:EuropeSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-01</instant>
        </period>
    </context>
    <context id="i7ca2f0e0d1e2416f955e5ebad2fa3692_D20210401-20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-01</endDate>
        </period>
    </context>
    <context id="ic0ea4341bffa478086acdce9a047ead6_I20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputLongTermRevenueGrowthRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-01</instant>
        </period>
    </context>
    <context id="i0b46955e83674aeab67ff94b9709968a_I20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">vtrs:MeasurementInputTerminalYearRevenueGrowthRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-01</instant>
        </period>
    </context>
    <context id="ib16a3b6e8149409999a629fdf76b5e40_I20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-01</instant>
        </period>
    </context>
    <context id="i3e5e76e30a1e4232835b08cc5aa3dd1f_I20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">vtrs:MeasurementInputEstimatedTaxRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-01</instant>
        </period>
    </context>
    <context id="i2faca452b6d7490fb6088b57bdba3eab_I20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputEbitdaMultipleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-01</instant>
        </period>
    </context>
    <context id="ide52f85dc07b4fe0b82c8b1da6c36f02_I20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputControlPremiumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-01</instant>
        </period>
    </context>
    <context id="iae70f297cb494e99b52ef9e2d4abc258_I20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">vtrs:MeasurementInputReductionInTerminalYearRevenueGrowthRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-01</instant>
        </period>
    </context>
    <context id="i0d259dda285943ceaa0938936cf8aa47_I20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">vtrs:MeasurementInputIncreaseInDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">vtrs:JapanAustraliaAndNewZealandSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-01</instant>
        </period>
    </context>
    <context id="i9a9dac0334bc477ea0a456bbe46c3173_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6259c702de2f4a35b534481f8d19ba9a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib50d1f6af058476a9a20d36e4aeb1f1b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4e35649af2d149e5a110744b54afb44e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2028EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i65ebef80378f40ed961aba03c5a4b30c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2028SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8c0d6145de9e46a7aee08ead29783fcb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2028SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iea56cbd0617d400094855281cdd9e614_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2025EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifd922556c9674ce280730c7b73219cfa_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2025EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9dbb1d37817941cfb609b9b9279f1790_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2025EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib435a6d77cd34f869cedbd596bf31419_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2022EuroSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i55b472eecaf147e68499e6e2321e7f65_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2022EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i90dc4ad103024e6ea6ce10f50ae8d262_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2022EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i17b748819db1409f90ab44c1656a6844_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotes1023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie0df9f683c964ad68f7f6e10a639905c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotes1023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i44be44738c944446a28c9e1a66f849ae_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotes1023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iae4433500527462f9a53c262b4a193e2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027EuroSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i15c58cf1262f420e80cbba022d020953_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i001cf1788fa14d23b2b35d333f8e42c9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if487c6ee083b40a88448340cd281fb87_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2032EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if483dc28a41d4a0fa6122644fd1ff629_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2032EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i738291780fb644b188734a680f12c170_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2032EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3f150c27f3c842779f26851f4cf85e68_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2020FloatingRateEuroNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iaea18053fed0452db5be6e9583326824_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2020FloatingRateEuroNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibef3bf81fb8c41a7a5b434d67be2e8f6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i05cbcb5d225f4a1e8421221f4405ebae_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i203444b86c864e92be2fd1ad7307b680_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:YENTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifa97038cc597436695cbf1346cc9a0ab_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:YENTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie77d3b2d673e467fbbf3c091f8ded489_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:YENTermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2ab96945884b453e862399993bf9898b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4da71023bae940f99c4faea351670e06_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic0ad6012a5fa43a49ad0a2980a19ddb3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icf29789408364be881b52abb508e5de3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2274eaab76e54e488ce05bb95778a8cd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i42eae6da7fc24ce694d83020bfe37e2b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaf8418c5909549baad168bf445e46d9a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if6a61ecb28ac40db9a5d31a3a4ad8e76_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4f884def881b445f90dd9534fe3fb188_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib7327d7b6283478083ef6d071f79ff32_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7e4405916ad540b9a7f953c2af935d2a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i481467d95c4545e5bb497389f9859d4c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if732b369611b40bcad116753c69a9845_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i25fbe74eb4264d7daff50e624f791260_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2629746dda6747b385fc80d8be9b7149_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0e1bb69f19ec4a6298efcee5d069b518_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">vtrs:SeniorNotesTwoThousandTwentyThree3.125PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2f9bb026157949c78212217fe9b44bb4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">vtrs:SeniorNotesTwoThousandTwentyThree3.125PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i56846d199ffb4f219d37ebf51599c34f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">vtrs:SeniorNotesTwoThousandTwentyThree3.125PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib8d0d63150a443a9a2d4e20b655c9e2f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6faa273322f64371a812153577418b44_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9654acb9de7d4ca493374d0d74ccd282_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i80c54ac8020646d2ab7569f426de2da7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if06aa643a0dd4bd7a0bb9445a80b41e1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i237668ce34d742348fc490c31a89179a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5eac979dacba469ba19bc637404defc4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2fad0ea862684b18988c02daa98065dc_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8efba978bebc47919ee66621c13ee179_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if3ebbb8721854743a8cb2b760433c11e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia9ae6a7ac5cd4083b3bdd4eeba1b2668_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i32ea16aa6d414c73a3f0814961d0178d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if6ef68015996425387540c85e3abd584_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i51898b0e23db4285b98783fe25f8e36f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i46a7b47f4bfd48e38e1a40a09cc02687_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib281974ea08948ca9b385c9fbf70eb76_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i61adc213c3bb41c1b79b08b95374ec05_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i50e722bd905e484a9e5b58ca42df1a48_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie86e478f62084256bbe03e843d36bfd4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if871dc9d84a946f19d267f938caa03bb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iac5b711af87d47b4909f4910be28f8fd_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="idd50cfa1e1e34150bb7e6bf364a6cf02_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2f1f3ba4d1c44a5ea869a805433ebbbc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9dcaff92c9304ccca2976819941da18b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5387ecd95f1b4b21af4525dd7eb447b8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1fafcde031c3487c96b095c7e9b1a4b7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icbc15c77f512432996fe6c2792f89851_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6ef24702815341caa5d222e324cde377_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8ee5436ebc91401299dbc66fb31d1ba1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i93a9254901ed49de952eda7653f907ac_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i21551c21cb5b4b48afb8bf862247798d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4fde47ed57994e7aa756ac70c39cbf8d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib97e2eb7978744c19ab31e5a8376b5a1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i18a3ddb5107448a099979738cf774b3f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifa7cf902531e404f8bad7f6968475c58_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8966d648d0f54ce1b447b567d34e2402_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5981a6477d5e43cd8437a6506268400c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i32084c41b5404f8390dcf56f0215f989_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i858b714a7a1546fa86606e2c701719ee_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iaf0a8e4e52d64933bcd2cc97aa5788fe_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i329520eeb0a04b5bad45f6974d90de1a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if095f8bb1f1b41eab2ce30dfe31f5273_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie24e749ab05a4833892ad719d96c300b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idd4f324d5afb475e82b0026903ef73a7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie1ad37b49c494d5c8be906abfac6dc4c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if24b49e0068e4eb481af75b6062f9456_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vtrs:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i288c304410434dbe813214bf4eef76f1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vtrs:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i42e5f527f22943e5b9d7a7a7685c1fba_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i997a640a9bd547beaed71dc4ba211d11_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8c903b289b914375b5edd04b08ed0db1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifb3ec9725b8947ae894c70cb9fb96fc0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibaee0ac5194a4c1491943ee3a6348a76_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ice252435f6954b3dafd70d47c4bfa455_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8fa346806c0a487197a11cf349c436db_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">vtrs:MarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic423a7424c864666be50a0a4f390acc3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">vtrs:MarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie58356c472ef49b48d4e2508fa52d3b6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie3f56b439929457fba15cc320189f428_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibb52f941e1874849b1e0f0c993cf6266_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifa911871a605402e901504a7b4ac61d7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i76e72c40fc9145b7a9caf8a61f156082_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i35168e44d21d481481a247e34dfc73e0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i57fa96c988344f0e818a196d4896959e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5b458f3612f1402784b53aeac8a369dc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6e3f3d362ea642ed9e7f8f139947c56d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i353b586581cf44dca4cb825b92b6aafd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8cae512912394bf5b5d2ebf918860db3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ide391512e22947ccac25df3c07cb9228_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i561ba56147034042ab3232502e02546e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idd529d4efdc24298b90ec1d3fc7c7068_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iba340d0dfb4648819a3e1ddf13ac641e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic1b09c1f40b047ff8dddca2986b053a3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7064536ad58d434ca55e232aa46556fb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7154adf94728411fa895c551c3a5e9c9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8da2ec9305974c688991d4d33e6a27db_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i666a97b1659e4674b1610db7c741b7b2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vtrs:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if75d03b186fe47ba9d810bcb281f1f3d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">vtrs:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if70694466104422da2d7abde7dda9ee2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i898cd302e4b34c6896647b6396e46f83_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:RespiratorydeliveryplatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3052adbd4310483f8c87f27b0a935413_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">vtrs:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id01941d6bb0f45a4b724bf9f4a330e96_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">vtrs:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3f4eb4a955334d9ba1854bafa06369c8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i400815bb3ce2404ea55584df1faffd10_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i00babded181a4889991307d7e9be7b3e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i56e83e9054ce46708f56540239a6c805_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icd90ca69608a471ebdd2665fb68a10f0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic9987758e9374f87a70ef8c4aca1fc6b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8d7336def5e24f00b2fa9c82f8a246d0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i04586f5a3ee649afbdb486e4d10a000a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib1bca36d1f664aa5be8e32facac152b9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iae67483ac8724d79b23607cbe3f99173_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6348c0871c354006bbb77663df6a8f55_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i42c49c74e2aa485b82eb650616e9a5ed_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iba8eb8ec1ddc4b67a8a39164a81b8561_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">vtrs:ReceivablesFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0333343531a84c508ec66fd2d2e00992_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">vtrs:ReceivablesFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i83bd5820907e45cbbb4ea0f8abe30112_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">vtrs:NoteSecuritizationFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i761c7931f4534948be5b4250f7b81ef1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">vtrs:NoteSecuritizationFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie1f6c291ccc34af59e5c6bbc708d16ed_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:OtherCurrentPortionofLongtermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie02ffa5a286a4854b0f6a8ae8fb7875b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:OtherCurrentPortionofLongtermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia14591b7ed4e4ed5b2119d20257b6803_I20170606">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:CommercialPaperProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-06-06</instant>
        </period>
    </context>
    <context id="ied6eaf81eabd467eb19851b626292fa8_D20170606-20170606">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:CommercialPaperProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-06-06</startDate>
            <endDate>2017-06-06</endDate>
        </period>
    </context>
    <context id="i58f2993346b2437da3921482cd53781f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">vtrs:ReceivablesFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie3ae820bb2f84caeb01b1f76cfa70fc8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">vtrs:NoteSecuritizationFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2ab05aad91f84733ae6b5e8d48936298_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotes2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i44658e6f80d547aaa1d6f5eade2a3003_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2020FloatingRateEuroNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2463e684b0924c04a93cc915be90fe1b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2020FloatingRateEuroNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic818a0a0c1d2464bb6ef3218b78cc20e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2020EuroSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1422ee4965c4486e9d857d1e0ef2b079_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2020EuroSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i205f2aac79b04016b1da176b6a7fb1fa_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwenty3.75PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if007a084b1e34ea384fb202e6e9d6c38_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwenty3.75PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5cd223f958b74eae95243319a27d31f0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">vtrs:CurrentPortionofLongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic8f7a9b488f94289a8d5b7710a4447af_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">vtrs:CurrentPortionofLongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iab602c854a75461ab1e9ab8870796980_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2022EuroSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i377027e221df4b5fbf54f4ccd718ed6e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotes2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia70edf5b85c1412c9e994cc32f0ac58b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotes2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i10c40610432e48caaea6544a94cc0ff7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwentyThree3.125PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if0c235dec46b409c9b237d080763da78_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwentyThree3.125PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaa49209541544d93ba10801830d5f5a1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwentyThree4.2PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9ca2c72c048b4966924c4641a6c8e4c3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwentyThree4.2PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i78adee273e00402683245dff9ebb774d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9743aa24ff1b459f9b29bba570aa1521_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotes1023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib01fe9fec3ea48b998ccf8a7121177c3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotes1023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i31ff8d2943a647b3927af7a7fc9ceb67_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2025EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1428d03b2da74d5a877a86979e4dd692_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2025SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iad4fd165662b43738af77427b3894ed9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2025SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2c630e4787804a5baafb37dfba1e9941_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwentySix3.95PrecentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if885e24274984b748d622171dad0e341_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandTwentySix3.95PrecentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icd92e4609f2347c481397989d4d41bb5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i02db2d48980748f2a8c4583ff56233ac_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic36c2f77ef1a4f429be7552a4ffdaf63_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iec4db0b19b8f485ca0d0961ae936700c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic23232bd104348af9f1c272ee35c0c7c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i18dc290bd62a46ed929e318042c29293_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2028EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9d56a00686f94581be68c9eba8a25301_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2028SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id0ded5c651e24a53b16c65e31f034e19_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2028SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia571e0c9398945dd93a699d5a8d8ca2f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2030SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4e9d0561e01b4afb9c271809518e9c3a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2030SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i01addae58bf447a1be4cf07b1417127c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2032EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i04a235c228ea4cbe8dd8f7c77da0efca_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2040SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iae33c84f581c444991bd3e6161e49454_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2040SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i29c286b2a49347658e466f3c15ed9e36_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandFortyThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i64f377462f4d49f9911bffc37608cd6d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandFortyThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0c5902c6ea4c409c95333fd6263b9aa6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandFortySix5.25PrecentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6838f10691984228bc7b35ce8cf2c986_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:SeniorNotesTwoThousandFortySix5.25PrecentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id459a294731e48d8a0be383eb2bd5a03_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2048SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5884d0b22a724fbea35305a07e9ec8d0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2048SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i02e45f2fba7e4eaa8262e45ee8ba765e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2050SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i334d1da043744144986b7f8f561ca005_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2050SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i74057de14b554e19bbd06da1ecb3f7f6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i11a32a3e965842e590fc770eeb365fa6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic54954704318489dbfab83d2b541d300_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:OtherLongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3950381ba5bc4ae0902d2fcdc22dd1cc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:OtherLongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie66cc87b7d3e4499960b357a925f9705_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="if8fd6f22b8424a83b40aff917e8d37be_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:UnregisteredUpjohnUSDollarNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i29d46e9d61754785892f1c72d3742cca_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:UpjohnEuroNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i3c0b7c74c50145a7a9f8bcb989137313_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i74907a0e3a4245c29c61474d06752931_I20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
        </entity>
        <period>
            <instant>2021-10-29</instant>
        </period>
    </context>
    <context id="ide9302296aa644ea9e1bdea342face9a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2022SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i86acbd5fe13c4222ac75586b553e6158_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2025SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic43055109f72489cb27f40c7c7d4de3c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if2c9dbf2c41f4039ae995c0da9b29464_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2030SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i377de9a7ca4747a9bb0851b1789fcf71_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2040SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i90b2414ad8e14d89af5f6b93c78866b8_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2050SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ifc91d97ca69b44cb8428d304cc80e7ff_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2022EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i012d654e3d7e4404bb0b696b2beb3cbb_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2024EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iaf2e4abfbda046d1983677a1e0f26357_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2027EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i4c5cbc4a7ad247e1816ce79abab0f406_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2032EuroSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i848b6b54a3a148dba6adff4fa331012e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:UpjohnInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i3861691874974533b0f4beb0f744696d_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:USDTermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ia9e52c1741c94fa0880ca65abe054094_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:A2020RevolvingFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="id4070295d773487892f0a0dafa6fb391_I20210731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:YENTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="i7883883a0a384706bef726bfa103f3b5_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:TwentyTwentyOneRevolvingFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i5bb284525f0d40259f76a744fbd30263_I20210731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vtrs:TwentyTwentyOneLoanFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="i20a65018b503434b88c9fd17e0c1dd18_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib7f720468bec473f88d7a755ce8a5ae1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9c4b4c0b310e423483a0fc1a47ab012a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i976d65e83c19475783582ea166af72a4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i56fdbd1f3d9e4c75876f8cf6831038f3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2c0da8410b1d4621bf16fd27e6c27d7f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1df50837d39f4ce5b1c56c576becf8f5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ifdef52c121a44daba62d16f7a225ea09_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id9752ebd80b74eb987fba8598e4bf4a2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i45d796a115fe452291c016b2351113f4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ieba8727d1a644f5981104c3b153e5919_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i62110eec7c9843279ebc30fd8c8fa53f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i43ffbc95ec5f4ed288d39bc9f96f6c51_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if6ab091030ea4646909dc299bb408d0a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i25e2d0bb39cd4c969048c3e9ffe0f1c7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7c05a74c19dd474e9110514b3ceb45a0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4e35c11727664c4ea9b3141cf19e2205_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic1b8be0d1b2a44c1902af29f75363f53_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i90f54d9de46f4354845f2d01a1f04798_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic989ea6602bd4856815f90f895e12304_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4c1519bf270f496eacbc594c4a0b7a1c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia3917c4bfc784a928c09f599e63910fb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0257efc303d94390b5707bbcdb863e52_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia7ff2cf5a8154924b32963fb78602f3a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i34f962bd787c40be86356d0feb3e5e5d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i28fba30d8dfb4cd0851b24ff8fafab59_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id107db472b49491e9da06a69c94e6b07_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1c5bfbeaa4b84f669ddcb52c7676aa3a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3048feb477df4b8aa1d56be7df44692f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6b952231de244bb5b8417597c8764975_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7bd68519c5854bc58140fde2099d16e2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic20e72bb356c49d2a349292f49d443ab_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iff87963fcab3463b90b3aec7f030e7e8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia95c695111874fdbb3c0f5b149b44326_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2d41891210be43e2af666133ce0c96d7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5ee696baa8c049df95516f082b5ca622_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i32ef6703441a420db1866b7d7f4c494b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i321781565b4145808e327741d1625660_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5344c15e24b24e80990c2d8787392123_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ie6e565a95dd740df9577e0def6a5bfda_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i7af73de9524c46c4b62467c275aebbd7_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i41551e1e6fcd44d8adc77b1cfa48df2e_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ib0b0232bc9844e1fa3ea1d7b1ad31528_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ifb3ef4f6ed9f4ba49c083bede6eb5223_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4995b4611c2e4646adfd8b95ba3bf328_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1d888ff098f442bcb4dc242559173835_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7c03788583d749e2ab730831ee5d6f58_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i09f02030d9994171b347d6d8fbc28c23_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ibe6488fc910b43d8b1655226467f1718_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i112fdb77391647eb924a8c3214c34e98_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="idb74362ce50848929419e79a2423af29_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="icd18a8e6cd32428db5246e85e1f56f15_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iab6607a4159c4340888408df548e14fd_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i120ca88ef29b44beab20b026621f6293_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8483166a8454418b9ca018a1b3791f84_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0092b09635f64545a5710335f85fb20d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ieab322d23a1c4d299859bb9ae133d4c8_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0e27b51cd41a46a5a7deacf015486759_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib319269ea5d64fedbf03374a044144ba_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9f40df9e1eb0444887127461f9ea3abe_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i67d592a057184ff99b89d543e49e0118_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i80866432756d4d8b99967ae5f95350a1_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i31acc6e59ca047cbb296182a44e66784_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">vtrs:U.S.StateTaxAuthorityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0f057c6cfa374421b697de391e7da037_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">vtrs:U.S.StateTaxAuthorityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icba6cc749c5c4336a2e5b99546806e1c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">vtrs:U.S.StateTaxAuthorityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ibd60fe8dbaf14660a60843e414c261cc_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">vtrs:NonU.S.statetaxauthorityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3fbb159e759f42c694ac12a036cae1b4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">vtrs:NonU.S.statetaxauthorityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib0fabb51dcaa430e9611ab2f4e9a374e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">vtrs:NonU.S.statetaxauthorityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5a8034bfa30e47bca846a18601de12b5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">vtrs:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7b9f43ebce0a4eb1ba92976f05741fb0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">vtrs:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8f5339a530fb4bbca97be48fbe5dff35_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">vtrs:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5705c46a88bf43f9b604c129b6396c1b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4373191f73a844d0aa8b62bcce8c341d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icc53a28205ae4633a9527b98ec393f1e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i541721ab11fa46dba8a4f58aa82b8be6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:LU</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8c017853d633417e84dadf12741d19be_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:LU</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i530b9bc93bc34ea6809e028e6321324d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:LU</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i690c125540df43569fe6e0ce50a677ab_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GI</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i854628b6099f4e6b8fede6d5c536249f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GI</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id11628fae2674f80be59cec699d8e459_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GI</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5823091b3fcd49398f313d160daadec4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i603a7cae6d9d4de3b979e27445a94107_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i66146c05086e4529856e742dff83f191_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i48d28293b4b04d2fb0191c06495228ce_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7fccea3458334b2ebd3c74f8a019e6de_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iffea22471c5c4e24861294dc6660f471_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i26e9bb2c528b43d78cadc7fb8c8321fd_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:PR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id9609b95c853486895e94e6a62b3157b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:PR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i543541ffe73f47e6872e055ae7bcffda_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:PR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="icf311f44a7fe473a9670fb0c3ff9a43c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iaa740ef330234878af7d2583fa1e040c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7234668fd9e1415280aed391af195c71_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0d23542c1c7d4aa7afeff16b251e1769_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SG</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie9e6322b8a51430198f1ea68537c7250_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SG</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i89506361322145bba725864306af6680_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SG</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i44835a71bdf64a59b0834e858746c694_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">vtrs:OtherforeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5804a0802eb7426eb85b8c6c303e8343_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">vtrs:OtherforeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i279ca6fa27f643e494543992d85cb2fc_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">vtrs:OtherforeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i17563b55bf4c44c896a9a3066b542e39_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0f870207d18e4404afdd0b0926003cbf_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icc73a3ee0a3a41ee8832f3c122143ec1_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i11b5aa7232f744ff861551a17b6a355f_D20250101-20251231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="i205d721df41548169e4385e88938943b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">vtrs:U.S.FederalTaxAuthorityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icde9ccadb7ab473e9a5c2e38da57d5e0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">vtrs:U.S.StateTaxAuthorityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifc7dfe40ed754a63957fa18d5cc47e7b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic92f6b9e1fe14acdbdc8bec1f348d9d6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">vtrs:IndefiniteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8b804447ccbf4433b4fe613034758f52_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">vtrs:FutureyearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib6ea526be10f4f0a866f5c6137509461_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:TaxYear2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i472d18e59f014ecfa0204966aa273da0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:AustralianTaxationOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2a20c8f3803144d58ca34d0fcee823ce_I20161231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="icf4cadf4931e4608b5a75d3c9e76220c_I20201116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-16</instant>
        </period>
    </context>
    <context id="ide54256d4c4e4fd1bebbeda254f7381b_D20201116-20201116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-16</startDate>
            <endDate>2020-11-16</endDate>
        </period>
    </context>
    <context id="i58936cbb4f69447d95f57e98537ab978_I20201116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-16</instant>
        </period>
    </context>
    <context id="i9ac84504406d464583bea255d4678e35_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iff2871529dca49568da0067c4e5a5e0f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2ee490046709489aa5f4269ad8f50ae8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i108f18c1c1f24f03914b8e2a90171783_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6030f8107f684fe8afa39a9cb5b4ce23_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i59f89db7c1cf4fbbbb690f556ab2557f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib1c2d553da14496cb03b6b87eb3cd0c0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="vtrs:VestingPeriodAxis">vtrs:VestratablyinfiveyearsorlessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i391ac2a5652949d58e918cbb11120117_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="vtrs:SubjecttoMarketConditionsAxis">vtrs:NotSubjecttoMarketConditionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="vtrs:VestingPeriodAxis">vtrs:VestinthreeyearsorlessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ide9073c6a7c5441b8fcaffca6958c382_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="vtrs:SubjecttoMarketConditionsAxis">vtrs:SubjectToMarketConditionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="vtrs:VestingPeriodAxis">vtrs:VestinthreeyearsorlessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie5c3b0237a83415cb42661ae906c1ba7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9267df240f8949458673188e0cc47584_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i149651f6a4da4798a97a769739151b62_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i10a62822cebc4558b2338681f573875e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6da6a8af22304e098fe4c7c2f12e2ce6_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vtrs:LongTermIncentivePlan2003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2a6462103eda4e1aaf682901857ca256_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">vtrs:StockappreciationrightsandperformancesharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="vtrs:ProgramNameAxis">vtrs:A2014ProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia9d424a72c6e4901a7dafb47ebf3c114_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4ec108614a384362b6aac78bfa61c46c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iec1504795a9c4c6693434e98197e0e95_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3db1d00ed7f642dcaf9157d146275821_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i52ec07ca99e44636af66cf7c46bf1f5a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie04b72f184f64b9bb48662c33d2c6a24_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2229a1acd15a481eb03d17e8a82e053c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i35e6c4cb2eb24b3083832b9f47b4f963_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ica964033412a493d86144cd4f4685a99_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1c56f90e02e14a18921a2b1fca1e4610_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i355af96d788e4eeaa662de6eabe91582_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2798085fac7a40bab607ca83a2fad67d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i28361d88d14b44089d36a57c1d48a43d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0632cc54c5f54fbd8e82f58805b62de5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i194aa174ea9b4388bf2c16656d0150bf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iddab1d45dd6b4fdfaf6d0678d30eb8fc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if31a3af97d384ae08362cb4f324929b3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib0be4e5a0f374fbea197c3659a4244d6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i113dbdd80d9d47d3a985b193d972938c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifaf8f068b6c14aafac4baf76995e06d1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ice0b7aa6647047d0a7d2a82e05dd4199_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib712c6ec443747a98c9f948545566ae1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifa37ab3dc9b74f588ce944ce366fad65_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iea17365cc1064f1e8c0e3efbd1f7ccc0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i30c18481b70448689ae9ec9f6c97ed57_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">vtrs:AssetsheldbyinsurancecompaniesandotherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia734afe5a0b94354a9267f684d7d593d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">vtrs:AssetsheldbyinsurancecompaniesandotherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib1eef6ae4e1e4c43a6e2a37669db59f5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">vtrs:AssetsheldbyinsurancecompaniesandotherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i89cce06582894866abc89dbadb2375fd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">vtrs:AssetsheldbyinsurancecompaniesandotherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if1dd9e8a009f47628454dddf41a73509_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia3676ae37352452a8c662f20b8fe3454_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4f47061824334d3b9c233d127ac9201d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i67df6863d3524e03bbe619803176d157_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6b6e49e382c6413e8c432cb0c7d2a826_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie786a2024a274c5ebfea306dfddbac8f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if795583e146340668c945e4b814573bf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8945bf4fb0664758943f130a6664b9d9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8396afe5d3e94d92869781e35bbfc3bf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i21a085c7f0f844d58b2d8d28f4fdebec_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3b6ff9d1e6224b069f644c2dbd578b93_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia960324dc2a146a685f0dce110779fec_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic88bd3b21dd5437a90e5efdc21490b13_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">vtrs:AssetsheldbyinsurancecompaniesandotherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6a800cd4602a4c15a8b533080cc7dd5f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">vtrs:AssetsheldbyinsurancecompaniesandotherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i644407156089438c9633f7019f15ae8f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">vtrs:AssetsheldbyinsurancecompaniesandotherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i525cf7cf63b54048a311ff3fde50c3d0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">vtrs:AssetsheldbyinsurancecompaniesandotherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0793dad309c04eeaab5ad95a6c7e0ace_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="i93fbd6aab228484480456d99cf697974_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8bb2b64c86464df1acb153f81b9bd1a2_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="i0beee820b7a44a2586a141b35bd7d70b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="vtrs:PeriodAxis">vtrs:FiscalYear2017Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i98bb7963bee64ebb90779de770b2639f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis">vtrs:DeferredBaseSalaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1e7e31d22fda4457bb400e7c5b5a9279_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis">us-gaap:DeferredBonusMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ieeeb5a9479d24a7d8d17e6b3b937cfa1_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i920f0f119ac84408803bd50b9d0ab091_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i22c52f21b85d4673a433d7b10508a1c0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib677e81a48d44a41987cce709676230a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="icd84b99acf144bc78660b64776c157a5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia0acbb674a1248c0922f52ddee735cd9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0d6ec2d7d94e40788a144ae7c9ec8647_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i18815e8bb5a745709ff95e3d9c2c08e4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">vtrs:MckessonCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id731b23309e14cbdaad5c8a9b50a21be_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">vtrs:MckessonCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id209d8fb79664069a0121c7006665f1f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">vtrs:MckessonCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6dd5ebb08da94a34a07b74dd124ac3ee_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">vtrs:AmeriSourceBergenCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6901420439ef429ea919459425a5d402_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">vtrs:AmeriSourceBergenCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idf1e59f7845645108df1bc93dddee7c7_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">vtrs:AmeriSourceBergenCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic5e40498906e45c788a40df231de121f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">vtrs:CardinalHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i27fa8b92853d48fb94b00143112c4a79_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">vtrs:CardinalHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i76cdb8e6f69a4d70b0de5af0064a60da_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">vtrs:CardinalHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i674ccad3b1334a35b429888309d5e766_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia4bb4b6b6b5a4fe694af194311457a02_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i94d6d4b3556e404b89c54e423c77d4f6_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9a70f778cb3e42faa8640420190123d8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis">vtrs:PfizerInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">vtrs:TransitionServiceAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3bc8daf6f604468691d4e166c4089a06_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis">vtrs:PfizerInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie41a5079981b44deba916400b5db52f8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis">vtrs:PfizerInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6fb7985a0fed413082603dbe3300009f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis">vtrs:PfizerInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib89e351abdca4a2a8a91f6f3d20bc1e2_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">vtrs:A2020RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie59342892624442b9a277a53f425c7e3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">vtrs:A2020RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5a2ed382584440da959bd00009045f49_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">vtrs:A2020RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i18f47482de9e477aa4d85300745fbad3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">vtrs:A2020RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0d1d75a5c8a447008aeaeea8bcbacd37_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">vtrs:A2020RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i45a292f6066c4a5cae5e925da85f5c71_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">vtrs:A2020RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia07fba1fd0dd43ebabc004e6c0858d88_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">vtrs:A2020RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i681ce63aa00c4c9498e214af93461780_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">vtrs:A2020RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaa3cdc4e3b274003ae2d838d289e9c7d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">vtrs:A2020RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ieae368cfdd6248869144a96949edde48_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">vtrs:A2020RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5b60006ae2c94bff820d1335a546ccba_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">vtrs:A2020RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i254bde0424ca475ebacf28a1bc15b3b1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0685a0412faf4f3b90366905bbeab604_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id51cb348481d4ec48766bf86b6cc391d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">vtrs:A2020RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie6a9f98858454485bf0c770c4fd2c57c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">vtrs:A2020RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia84d707224a5471abcb6fb8f26708db5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">vtrs:A2020RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9ad19c7802c7406b96da1212d434f4e3_D20160101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">vtrs:A2016RestructuringProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i266beeff762940c594ad7e6cb70ba95a_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i8a2f026c5d984a4baa08a46d2b7a633d_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ie111b220c8104243b43abb19a557ed31_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ied43c8ca68ed4621b226737a5d334eaf_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic88f207a9dad4e4d801b44cf3af9f10c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic46fb38f58024911a0b78897bd8338eb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i74053317be7e49ca93f4eade0b20f377_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9a14e7286e034496b3144a5acc8932d1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id700bedb414840799b353bf9084701c9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i864f1b9d64574c8c88114fc001040dd2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i65836be0391145f5a3e61375cecd6594_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="vtrs:PeriodAxis">vtrs:FiscalYear2017Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i26f84e3d52854c23bc765376727d547d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">vtrs:RevanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i86776889abae4015b5e341878a1f94e0_I20160108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">vtrs:MomentaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-01-08</instant>
        </period>
    </context>
    <context id="i20265a72ee5044e7aae84f97919d0147_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">vtrs:TheravanceBiopharmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8c6221856b4642fdaae580491808b3ca_D20150130-20150130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">vtrs:TheravanceBiopharmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-01-30</startDate>
            <endDate>2015-01-30</endDate>
        </period>
    </context>
    <context id="i1c6036278a4b49a4901cdd582be7d9f0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">vtrs:TheravanceBiopharmaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i13a8322297064621abf63668185d09b7_D20130211-20130212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SupplyCommitmentAxis">vtrs:GenericBiologicCompoundsCollaborationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-02-11</startDate>
            <endDate>2013-02-12</endDate>
        </period>
    </context>
    <context id="i9e5713b803ec4eaf933db1df619dac04_D20180920-20180920">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">vtrs:FKBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-20</startDate>
            <endDate>2018-09-20</endDate>
        </period>
    </context>
    <context id="i1060ce14d7454734a57fb560f05c5dc2_D20190227-20190227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">vtrs:FKBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-27</startDate>
            <endDate>2019-02-27</endDate>
        </period>
    </context>
    <context id="idf043a2e2c394069bf7b417157fabff5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:OtherCompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idc22e99190de4591a027585c2ec34f85_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vtrs:OtherCompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6d1a10fafb2f499895da7c0d46a48ae3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ida50edb50e464fd8bfedb0e9bb7be1aa_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">vtrs:BiosimilarsBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i07eb4f1ce070466a990b0cd1a54b7b81_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">vtrs:BiosimilarsBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6d397ca7ee644114993a26171508834d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">vtrs:BiosimilarsBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2b28bb833a94474bbc11b88b345af593_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:EpiPenAutoInjectorLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i12d72077c53340de89fc310d8eef6974_D20220201-20220228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:EpiPenAutoInjectorLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-01</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="i6a9f5404bef24f4984a0f8f1a0ff008c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:EpiPenAutoInjectorLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i948e502442cc4e7ab6948ef233636a44_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:EpiPenAutoInjectorLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6fb31abf3cd3486d8d73aaca15da3160_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:MultiDistrictLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1370ea34e27342908b81e9cd1ce42f04_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9b8d7536128a476ab103cb2abe72db8f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:AnticompetitiveConductwithGenericDrugsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i34298ab2efbf46afb7c78ba25e12f901_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:AmendedAnticompetitiveConductwithGenericDrugsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i13c638ed56d343c18493f03648ee836f_D20140708-20140709">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:EUCommissionProceedingsPerindorprilMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">vtrs:AntitrustProceedingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-07-08</startDate>
            <endDate>2014-07-09</endDate>
        </period>
    </context>
    <context id="i2fc086de1758443786ac3ba535a5b44a_D20141001-20141231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:EUCommissionProceedingsPerindorprilMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">vtrs:AntitrustProceedingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-10-01</startDate>
            <endDate>2014-12-31</endDate>
        </period>
    </context>
    <context id="i27d7d7f87c3b47c29d865299535c55cc_D20130601-20130619">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:EUCommissionProceedingsCitalopramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-06-01</startDate>
            <endDate>2013-06-19</endDate>
        </period>
    </context>
    <context id="ib6585ef5edb5465980d61d05bc81776b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:EUCommissionProceedingsCitalopramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9abf215c0b25446ba1f1eee1bfce3634_D20160212-20160212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:U.K.CompetitionandMarketsAuthorityProceedingsParoxetineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-02-12</startDate>
            <endDate>2016-02-12</endDate>
        </period>
    </context>
    <context id="if4052220c0bc4de89dc871350ec90cb2_D20160212-20160212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:U.K.CompetitionandMarketsAuthorityProceedingsParoxetineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-02-12</startDate>
            <endDate>2016-02-12</endDate>
        </period>
    </context>
    <context id="if54570ea2c7a42cc914556ebc926584c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:U.K.CompetitionandMarketsAuthorityProceedingsParoxetineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i42721f7bfaa74a20b33b1b57026a7ec6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">vtrs:ProductLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3ab3ba0c16f64666aae7af1ec4b0cb80_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2c861875a03848f989ff86d891f1a81c_D20171024-20171024">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:InsulinGlargineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-24</startDate>
            <endDate>2017-10-24</endDate>
        </period>
    </context>
    <context id="i6531f624fba049f9a437e4af1aa3247a_I20171024">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:InsulinGlargineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-10-24</instant>
        </period>
    </context>
    <context id="i3c7914355ab94f1e9bb9a332a6d51ac5_I20190617">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:InsulinGlargineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-17</instant>
        </period>
    </context>
    <context id="i13e9207c6fef454e969d51bd9b9e9635_D20190617-20190617">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:InsulinGlargineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-17</startDate>
            <endDate>2019-06-17</endDate>
        </period>
    </context>
    <context id="i368a17b2f56f4f73a262f1f28352eca3_D20180910-20180910">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:InsulinGlargineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-10</startDate>
            <endDate>2018-09-10</endDate>
        </period>
    </context>
    <context id="i7341b8c6cd5240ccad4baad654635cb8_I20200402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:InsulinGlargineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-02</instant>
        </period>
    </context>
    <context id="i9357aa4ee46c43e4a8bacdddc6635174_D20170630-20170630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">vtrs:DimethylFumarateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-06-30</startDate>
            <endDate>2017-06-30</endDate>
        </period>
    </context>
    <context id="i03c3c6915b9e41e286944ec9d4c597df_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">vtrs:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idaab369eeea042ca842eb8d98bec6dfb_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i91018ff0be4748fdb394a71a73560ff1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i166cc270ce584702a76fe3b6fb475148_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic453dbe2bf5946b286bdd9f5cb841293_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ia516f232fddf46f39a2dbdf6d82abbc9_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i450c01c12e2d40dcadab0111243d7980_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie71711028fa94d6fb804d5ada3c39b46_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i431eb8d7201c49618c010a346ae6a384_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0c9701f467284632ac6d7745e16a0f7d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifb67bdbafd2140308ea8ef185a517da0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iebbc9cdf0d824f2db02b60856d24cfa2_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i816570cccc0745fcb3c38ba989d87af4_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="molecule">
        <measure>vtrs:molecule</measure>
    </unit>
    <unit id="site">
        <measure>vtrs:site</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="market">
        <measure>vtrs:market</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="jpy">
        <measure>iso4217:JPY</measure>
    </unit>
    <unit id="rate">
        <measure>utr:Rate</measure>
    </unit>
    <unit id="drugs">
        <measure>vtrs:drugs</measure>
    </unit>
    <unit id="product">
        <measure>vtrs:Product</measure>
    </unit>
    <unit id="agreement">
        <measure>vtrs:agreement</measure>
    </unit>
    <unit id="state">
        <measure>vtrs:state</measure>
    </unit>
    <unit id="case">
        <measure>vtrs:case</measure>
    </unit>
    <unit id="gbp">
        <measure>iso4217:GBP</measure>
    </unit>
    <unit id="increase">
        <measure>vtrs:increase</measure>
    </unit>
    <unit id="patent">
        <measure>vtrs:patent</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml83L2ZyYWc6MzNiOWUxYTlmOWZkNGJkYzk4YjJhYWFiNjA0OTQxNmIvdGFibGU6Mjk3ZTc4YzViODNmNDI3NWE2MzhjMzQwMjgwYzFiNzQvdGFibGVyYW5nZToyOTdlNzhjNWI4M2Y0Mjc1YTYzOGMzNDAyODBjMWI3NF8yLTEtMS0xLTMxNDIy_e66f2b19-5be2-411d-8461-223689120c55">0001792044</dei:EntityCentralIndexKey>
    <dei:DocumentPeriodEndDate
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml83L2ZyYWc6MzNiOWUxYTlmOWZkNGJkYzk4YjJhYWFiNjA0OTQxNmIvdGFibGU6Mjk3ZTc4YzViODNmNDI3NWE2MzhjMzQwMjgwYzFiNzQvdGFibGVyYW5nZToyOTdlNzhjNWI4M2Y0Mjc1YTYzOGMzNDAyODBjMWI3NF80LTMtMS0xLTMxNDIy_3b8314a4-63de-4401-b41f-7a99ecb33608">2021-12-31</dei:DocumentPeriodEndDate>
    <dei:AmendmentFlag
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml83L2ZyYWc6MzNiOWUxYTlmOWZkNGJkYzk4YjJhYWFiNjA0OTQxNmIvdGFibGU6Mjk3ZTc4YzViODNmNDI3NWE2MzhjMzQwMjgwYzFiNzQvdGFibGVyYW5nZToyOTdlNzhjNWI4M2Y0Mjc1YTYzOGMzNDAyODBjMWI3NF81LTEtMS0xLTMxNDIy_febcfdeb-b0fb-408f-9b30-9859d8b2b3a7">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml83L2ZyYWc6MzNiOWUxYTlmOWZkNGJkYzk4YjJhYWFiNjA0OTQxNmIvdGFibGU6Mjk3ZTc4YzViODNmNDI3NWE2MzhjMzQwMjgwYzFiNzQvdGFibGVyYW5nZToyOTdlNzhjNWI4M2Y0Mjc1YTYzOGMzNDAyODBjMWI3NF82LTEtMS0xLTMxNDIy_1564e39a-a112-4b48-8dcd-238cf46f5777">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml83L2ZyYWc6MzNiOWUxYTlmOWZkNGJkYzk4YjJhYWFiNjA0OTQxNmIvdGFibGU6Mjk3ZTc4YzViODNmNDI3NWE2MzhjMzQwMjgwYzFiNzQvdGFibGVyYW5nZToyOTdlNzhjNWI4M2Y0Mjc1YTYzOGMzNDAyODBjMWI3NF83LTEtMS0xLTMxNDIy_705edd04-80d7-4cd0-8da2-bcce1b17e920">FY</dei:DocumentFiscalPeriodFocus>
    <dei:CurrentFiscalYearEndDate
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml83L2ZyYWc6MzNiOWUxYTlmOWZkNGJkYzk4YjJhYWFiNjA0OTQxNmIvdGFibGU6Mjk3ZTc4YzViODNmNDI3NWE2MzhjMzQwMjgwYzFiNzQvdGFibGVyYW5nZToyOTdlNzhjNWI4M2Y0Mjc1YTYzOGMzNDAyODBjMWI3NF84LTEtMS0xLTMxNDIy_76605119-2725-450e-abb2-52211d9a70bd">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i2d63a308e1b544aa993161c92d8cb125_D20201113-20201113"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzQ2NzE_7b74b1b4-9fe4-486d-b533-a57949c797fb">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTMvZnJhZzo2ZWFmNDE2OTBmODU0ZGZlODEzNTY2MTVhNzRiNTI2ZC90YWJsZTo5ODM1Nzk3ZDRjY2I0ZTkyOGI2YzkyYWVhZTQ0MmJmNy90YWJsZXJhbmdlOjk4MzU3OTdkNGNjYjRlOTI4YjZjOTJhZWFlNDQyYmY3XzEtMC0xLTEtMzE0MjI_5d3710a9-3cc1-4033-a1c1-2c401012a753">http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTMvZnJhZzo2ZWFmNDE2OTBmODU0ZGZlODEzNTY2MTVhNzRiNTI2ZC90YWJsZTo5ODM1Nzk3ZDRjY2I0ZTkyOGI2YzkyYWVhZTQ0MmJmNy90YWJsZXJhbmdlOjk4MzU3OTdkNGNjYjRlOTI4YjZjOTJhZWFlNDQyYmY3XzEtMC0xLTEtMzE0MjI_d91afb44-c711-4a5d-bbbf-c4f2ea533df5">http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTMvZnJhZzo2ZWFmNDE2OTBmODU0ZGZlODEzNTY2MTVhNzRiNTI2ZC90YWJsZTo5ODM1Nzk3ZDRjY2I0ZTkyOGI2YzkyYWVhZTQ0MmJmNy90YWJsZXJhbmdlOjk4MzU3OTdkNGNjYjRlOTI4YjZjOTJhZWFlNDQyYmY3XzItMC0xLTEtMzE0MjI_055cf0e5-821f-4b2e-b5d4-feef52c31120">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTMvZnJhZzo2ZWFmNDE2OTBmODU0ZGZlODEzNTY2MTVhNzRiNTI2ZC90YWJsZTo5ODM1Nzk3ZDRjY2I0ZTkyOGI2YzkyYWVhZTQ0MmJmNy90YWJsZXJhbmdlOjk4MzU3OTdkNGNjYjRlOTI4YjZjOTJhZWFlNDQyYmY3XzItMC0xLTEtMzE0MjI_f0eb0100-3b43-4acb-a28a-b753e8c626a9">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTMvZnJhZzo2ZWFmNDE2OTBmODU0ZGZlODEzNTY2MTVhNzRiNTI2ZC90YWJsZTo5ODM1Nzk3ZDRjY2I0ZTkyOGI2YzkyYWVhZTQ0MmJmNy90YWJsZXJhbmdlOjk4MzU3OTdkNGNjYjRlOTI4YjZjOTJhZWFlNDQyYmY3XzMtMC0xLTEtMzE0MjI_126f3dd7-c76c-4f67-8736-69a850308556">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTMvZnJhZzo2ZWFmNDE2OTBmODU0ZGZlODEzNTY2MTVhNzRiNTI2ZC90YWJsZTo5ODM1Nzk3ZDRjY2I0ZTkyOGI2YzkyYWVhZTQ0MmJmNy90YWJsZXJhbmdlOjk4MzU3OTdkNGNjYjRlOTI4YjZjOTJhZWFlNDQyYmY3XzMtMC0xLTEtMzE0MjI_22a8adf1-c271-499b-bf41-e81a3d3d7e3a">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDUvZnJhZzozMDMwNmJhZmM1ZjA0ZjkyOTg0NWNjNTE2MjQzNDRkNy90YWJsZTpkOTQ5NDdkZjM2MGQ0NGFjOTkzNzhiOWYyM2FlOGFhZS90YWJsZXJhbmdlOmQ5NDk0N2RmMzYwZDQ0YWM5OTM3OGI5ZjIzYWU4YWFlXzAtMi0xLTEtMzE0MjI_8f8f2dca-8292-47ef-af0f-e53c2fdf5259"
      unitRef="usd">750000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetLiabilityNetMeasurementInput
      contextRef="ib1bca36d1f664aa5be8e32facac152b9_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDUvZnJhZzozMDMwNmJhZmM1ZjA0ZjkyOTg0NWNjNTE2MjQzNDRkNy90YWJsZTpkOTQ5NDdkZjM2MGQ0NGFjOTkzNzhiOWYyM2FlOGFhZS90YWJsZXJhbmdlOmQ5NDk0N2RmMzYwZDQ0YWM5OTM3OGI5ZjIzYWU4YWFlXzEtMi0xLTEtMzE0MjI_02e76f85-d199-417f-8c9f-6c2eaa4efdae"
      unitRef="number">0.021</us-gaap:DerivativeAssetLiabilityNetMeasurementInput>
    <us-gaap:DerivativeAssetLiabilityNetMeasurementInput
      contextRef="iae67483ac8724d79b23607cbe3f99173_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDUvZnJhZzozMDMwNmJhZmM1ZjA0ZjkyOTg0NWNjNTE2MjQzNDRkNy90YWJsZTpkOTQ5NDdkZjM2MGQ0NGFjOTkzNzhiOWYyM2FlOGFhZS90YWJsZXJhbmdlOmQ5NDk0N2RmMzYwZDQ0YWM5OTM3OGI5ZjIzYWU4YWFlXzItMi0xLTEtMzE0MjI_abbab120-0d2c-4a1c-a210-90ed6df88342"
      unitRef="number">0.105</us-gaap:DerivativeAssetLiabilityNetMeasurementInput>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i9ac84504406d464583bea255d4678e35_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzE2Mjc_08ccde51-39fc-462c-a345-1572757200f2">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ide9073c6a7c5441b8fcaffca6958c382_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzI2NDI_f3b767c1-16ad-4e4f-bd76-18f9bc8ce9a6">P3Y0M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ide9073c6a7c5441b8fcaffca6958c382_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzEyNjQ0MzgzNzI3MzQ5_f3b767c1-16ad-4e4f-bd76-18f9bc8ce9a6">P3Y0M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i9ac84504406d464583bea255d4678e35_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjMvZnJhZzphNGMyZDEyYTg1OTI0YTkyYmQwZDgzODM3YWMzNzdmMy90ZXh0cmVnaW9uOmE0YzJkMTJhODU5MjRhOTJiZDBkODM4MzdhYzM3N2YzXzIxOA_08ccde51-39fc-462c-a345-1572757200f2">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="iff2871529dca49568da0067c4e5a5e0f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjMvZnJhZzphNGMyZDEyYTg1OTI0YTkyYmQwZDgzODM3YWMzNzdmMy90ZXh0cmVnaW9uOmE0YzJkMTJhODU5MjRhOTJiZDBkODM4MzdhYzM3N2YzXzIyNA_03cba3f3-9320-42e2-9c6d-f9bd91619a00">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i2ee490046709489aa5f4269ad8f50ae8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjMvZnJhZzphNGMyZDEyYTg1OTI0YTkyYmQwZDgzODM3YWMzNzdmMy90ZXh0cmVnaW9uOmE0YzJkMTJhODU5MjRhOTJiZDBkODM4MzdhYzM3N2YzXzI1Mg_c6be35ff-7474-4d0a-8808-913aaece6ea7">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i2a6462103eda4e1aaf682901857ca256_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjMvZnJhZzphNGMyZDEyYTg1OTI0YTkyYmQwZDgzODM3YWMzNzdmMy90ZXh0cmVnaW9uOmE0YzJkMTJhODU5MjRhOTJiZDBkODM4MzdhYzM3N2YzXzMyMA_6cfb86d3-e4b8-496a-8391-ba38a4d15673">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <dei:DocumentType
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGV4dHJlZ2lvbjo2YTQyZDk0ZTZjM2Q0ZDAyYjA5MjJiMGNkYWI0NDdmNV8yNzUw_86025e02-5ed5-4c63-b42f-d74c2ffb6835">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGFibGU6MjU2YmRmMzNmNWU0NDMzMWFiMDllNDZkOWRlM2ZmMDAvdGFibGVyYW5nZToyNTZiZGYzM2Y1ZTQ0MzMxYWIwOWU0NmQ5ZGUzZmYwMF8wLTAtMS0xLTMxNDIy_1bbb98d9-22a1-4782-a783-a1d7c14fbd8a">true</dei:DocumentAnnualReport>
    <dei:DocumentTransitionReport
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGFibGU6MmMwNjQ0MmFmNzk2NGQ2MDk3NmQwN2ZhY2M3ZTdiYmEvdGFibGVyYW5nZToyYzA2NDQyYWY3OTY0ZDYwOTc2ZDA3ZmFjYzdlN2JiYV8wLTAtMS0xLTMxNDIy_1b581a9f-2b57-4770-8a3d-e837cb21a9f5">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGV4dHJlZ2lvbjo2YTQyZDk0ZTZjM2Q0ZDAyYjA5MjJiMGNkYWI0NDdmNV8yNzU0_e7bd9b99-3990-4e3b-8203-2ec7de68ba64">001-39695</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGV4dHJlZ2lvbjo2YTQyZDk0ZTZjM2Q0ZDAyYjA5MjJiMGNkYWI0NDdmNV8xMzI_afe7166e-096c-48d6-a162-ce5750c1aa2d">VIATRIS INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGFibGU6OWU0ODk1ZDM4ZjZkNDIwOWJkNGQ1MTJhZjZmNTVjZmQvdGFibGVyYW5nZTo5ZTQ4OTVkMzhmNmQ0MjA5YmQ0ZDUxMmFmNmY1NWNmZF8wLTAtMS0xLTMxNDIy_b2b9be07-919d-4903-9753-3de62cc644fb">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGFibGU6OWU0ODk1ZDM4ZjZkNDIwOWJkNGQ1MTJhZjZmNTVjZmQvdGFibGVyYW5nZTo5ZTQ4OTVkMzhmNmQ0MjA5YmQ0ZDUxMmFmNmY1NWNmZF8wLTItMS0xLTMxNDIy_f87e3fc4-3cdd-4e50-acfa-20fd7c5e1f62">83-4364296</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGV4dHJlZ2lvbjo2YTQyZDk0ZTZjM2Q0ZDAyYjA5MjJiMGNkYWI0NDdmNV8yNzUx_0b31bf0b-70ae-416c-ab0b-4a279013d448">1000 Mylan Boulevard</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGV4dHJlZ2lvbjo2YTQyZDk0ZTZjM2Q0ZDAyYjA5MjJiMGNkYWI0NDdmNV8yNzQ1_729f476a-d6e8-4f09-9b1e-17ddd0b7af3f">Canonsburg</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGV4dHJlZ2lvbjo2YTQyZDk0ZTZjM2Q0ZDAyYjA5MjJiMGNkYWI0NDdmNV8yNzQ2_3315759c-d79b-4146-9027-527e25a73657">PA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGV4dHJlZ2lvbjo2YTQyZDk0ZTZjM2Q0ZDAyYjA5MjJiMGNkYWI0NDdmNV8yNzQ3_392b1a3e-a66a-4547-a12b-0c9fd947baf3">15317</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGV4dHJlZ2lvbjo2YTQyZDk0ZTZjM2Q0ZDAyYjA5MjJiMGNkYWI0NDdmNV8yNzUy_62c2a50d-1ff9-43b9-9f5b-2ae1803419da">(724)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGV4dHJlZ2lvbjo2YTQyZDk0ZTZjM2Q0ZDAyYjA5MjJiMGNkYWI0NDdmNV8yNzQ0_e0af01a2-02e4-492f-ae21-901cb94943e3">514-1800</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGFibGU6YmRlNmNjMDU3NmY1NGNlYTk3MTgxMmM3MzZhZGM1NjcvdGFibGVyYW5nZTpiZGU2Y2MwNTc2ZjU0Y2VhOTcxODEyYzczNmFkYzU2N18xLTAtMS0xLTMxNDIy_d5abccc6-1a6d-4e88-8fae-71603557f053">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGFibGU6YmRlNmNjMDU3NmY1NGNlYTk3MTgxMmM3MzZhZGM1NjcvdGFibGVyYW5nZTpiZGU2Y2MwNTc2ZjU0Y2VhOTcxODEyYzczNmFkYzU2N18xLTItMS0xLTMxNDIy_2292b041-ca41-4f0d-ba53-14bced84b84f">VTRS</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGFibGU6YmRlNmNjMDU3NmY1NGNlYTk3MTgxMmM3MzZhZGM1NjcvdGFibGVyYW5nZTpiZGU2Y2MwNTc2ZjU0Y2VhOTcxODEyYzczNmFkYzU2N18xLTQtMS0xLTMxNDIy_414d9b9a-f49c-4598-b51b-1c76ab18cc6d">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGV4dHJlZ2lvbjo2YTQyZDk0ZTZjM2Q0ZDAyYjA5MjJiMGNkYWI0NDdmNV8xNjQ5MjY3NDQ0NDU0_002de428-ab8c-427e-b23d-d7fe5e780532">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGV4dHJlZ2lvbjo2YTQyZDk0ZTZjM2Q0ZDAyYjA5MjJiMGNkYWI0NDdmNV8yNzQx_28e90019-ded9-40ab-9c5b-12a7dd9ee227">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGV4dHJlZ2lvbjo2YTQyZDk0ZTZjM2Q0ZDAyYjA5MjJiMGNkYWI0NDdmNV8yNzM5_f55e825a-5861-45f3-9aaa-bdc60e90cfb7">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGV4dHJlZ2lvbjo2YTQyZDk0ZTZjM2Q0ZDAyYjA5MjJiMGNkYWI0NDdmNV8yNzQ4_6f9eb3fa-62f6-4129-8e68-d998f0cf3932">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGFibGU6MTM4ZGI2MThiNTAyNDI3MmFkYzdhZWM2OTVhM2U2NDkvdGFibGVyYW5nZToxMzhkYjYxOGI1MDI0MjcyYWRjN2FlYzY5NWEzZTY0OV8wLTAtMS0xLTQwMTQw_59166f11-b7e7-4789-bfb0-84576f2a75b7">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGFibGU6MTM4ZGI2MThiNTAyNDI3MmFkYzdhZWM2OTVhM2U2NDkvdGFibGVyYW5nZToxMzhkYjYxOGI1MDI0MjcyYWRjN2FlYzY5NWEzZTY0OV8xLTYtMS0xLTMxNDIy_2820a2bf-9063-4afd-b629-5848dc3ff5b7">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGFibGU6MTM4ZGI2MThiNTAyNDI3MmFkYzdhZWM2OTVhM2U2NDkvdGFibGVyYW5nZToxMzhkYjYxOGI1MDI0MjcyYWRjN2FlYzY5NWEzZTY0OV8yLTYtMS0xLTMxNDIy_22f45d64-eaa6-41d9-8606-5330aa438472">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGV4dHJlZ2lvbjo2YTQyZDk0ZTZjM2Q0ZDAyYjA5MjJiMGNkYWI0NDdmNV8yNzQy_3fe43157-ad79-4aeb-a2d3-b7553cc2d17f">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGV4dHJlZ2lvbjo2YTQyZDk0ZTZjM2Q0ZDAyYjA5MjJiMGNkYWI0NDdmNV8yNzQ5_d0d76082-0fff-441e-a228-387a9d9bdf11">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="i13f4973de7d347c1990aa06418f9a87d_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGV4dHJlZ2lvbjo2YTQyZDk0ZTZjM2Q0ZDAyYjA5MjJiMGNkYWI0NDdmNV8xMDk5NTExNjMwNzAy_81cacd9a-6622-48b8-b947-b7da8c614dab"
      unitRef="usd">17237737213</dei:EntityPublicFloat>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGV4dHJlZ2lvbjo2YTQyZDk0ZTZjM2Q0ZDAyYjA5MjJiMGNkYWI0NDdmNV8yNjU5_29580505-9394-4a84-b4a3-5b4c01d69e36"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="idb49b3416a6648899c9dbb31e728c519_I20220222"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGV4dHJlZ2lvbjo2YTQyZDk0ZTZjM2Q0ZDAyYjA5MjJiMGNkYWI0NDdmNV8yNzA0_f30c1507-7c97-43bc-b1da-696eab48066d"
      unitRef="shares">1209576280</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xL2ZyYWc6NmE0MmQ5NGU2YzNkNGQwMmIwOTIyYjBjZGFiNDQ3ZjUvdGV4dHJlZ2lvbjo2YTQyZDk0ZTZjM2Q0ZDAyYjA5MjJiMGNkYWI0NDdmNV8yNzQz_ffa72fba-22f2-4a5a-ba17-6e0b00b8a0e1">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.095%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Document&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Part&#160;of&#160;Form&#160;10-K into Which&lt;br/&gt;Document&#160;is Incorporated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;An amendment to this Form 10-K will be filed no later than 120 days after the close of registrant&#x2019;s fiscal year.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;III&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorFirmId
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNDIvZnJhZzpkOGM4MjZjNTEwYzQ0N2I3YTQ1NGMwYjZjOWRhYTdkZi90YWJsZTpmODYzYTA0ZDg0MzY0Zjk3YjE3NTIxZmRhMzg3NTVlZi90YWJsZXJhbmdlOmY4NjNhMDRkODQzNjRmOTdiMTc1MjFmZGEzODc1NWVmXzQtMC0xLTEtNTIwOTMvdGV4dHJlZ2lvbjoxOGE2YzNjYmI5NTk0MjM2OTdhYzZlY2ZmZGQwMTY1MF8xMDk5NTExNjI3ODU2_46fe6219-37b9-4484-bd07-30c2848c21b0">34</dei:AuditorFirmId>
    <dei:AuditorFirmId
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNDUvZnJhZzowYmRhMzgxMGEyMWM0MDI5OGNmNmEwMGE3YjJmNzc5ZS90ZXh0cmVnaW9uOjBiZGEzODEwYTIxYzQwMjk4Y2Y2YTAwYTdiMmY3NzllXzE2NDkyNjc0NDUyMTA_46fe6219-37b9-4484-bd07-30c2848c21b0">34</dei:AuditorFirmId>
    <dei:AuditorName
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTEvZnJhZzpiOTMzYjFjOTY5NjE0MjIxYWRiMGI1ZTBlYmU0YmFjYy90ZXh0cmVnaW9uOmI5MzNiMWM5Njk2MTQyMjFhZGIwYjVlMGViZTRiYWNjXzEwOTk1MTE2MzI0MDQ_e3e1aa0d-3f81-4c2f-a3f1-4b63e4de6308">DELOITTE &amp; TOUCHE LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTEvZnJhZzpiOTMzYjFjOTY5NjE0MjIxYWRiMGI1ZTBlYmU0YmFjYy90ZXh0cmVnaW9uOmI5MzNiMWM5Njk2MTQyMjFhZGIwYjVlMGViZTRiYWNjXzEwOTk1MTE2MzI0MDU_d6ab792c-4b92-4a80-834d-05c56a78fd0a">Pittsburgh, Pennsylvania</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzQtMS0xLTEtMzE0MjI_06e1e2e3-93cf-49d2-ae5c-00d175b8d2ad"
      unitRef="usd">701200000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzQtMy0xLTEtMzE0MjI_57ad48e7-4078-4bdc-8dff-26197b10c6a3"
      unitRef="usd">844400000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzUtMS0xLTEtMzE0MjI_a91113de-31d7-4520-8489-7647cf781bd2"
      unitRef="usd">4266400000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzUtMy0xLTEtMzE0MjI_817f9dc4-5e7d-4609-8621-1ce8bc2b9c9f"
      unitRef="usd">4843800000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzYtMS0xLTEtMzE0MjI_099fe197-b28e-4fbf-8ad2-50542d633d67"
      unitRef="usd">3977700000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzYtMy0xLTEtMzE0MjI_944346c4-e068-42e1-96ac-85ceed41694e"
      unitRef="usd">5471900000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzctMS0xLTEtMzE0MjI_de737564-7fa7-4719-aec1-594729581372"
      unitRef="usd">1957600000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzctMy0xLTEtMzE0MjI_2915e38f-6c9a-45db-b389-7c4ae23801ce"
      unitRef="usd">1707400000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzgtMS0xLTEtMzE0MjI_5ce03c51-5805-499d-8fce-a36f57c00959"
      unitRef="usd">10902900000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzgtMy0xLTEtMzE0MjI_5f5b6bb1-427f-41f9-a439-aaf0fd685eec"
      unitRef="usd">12867500000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzktMS0xLTEtMzE0MjI_07d376fc-fd6f-4cc0-8fb9-2262ee82b301"
      unitRef="usd">3188600000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzktMy0xLTEtMzE0MjI_7deef311-29a5-49dc-ba4e-95eb4b2a21b9"
      unitRef="usd">3459900000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzEwLTEtMS0xLTMxNDIy_e596d9c0-eb43-41e4-ae7b-7ce6238236c8"
      unitRef="usd">26134200000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzEwLTMtMS0xLTMxNDIy_2fc5b2ba-3f3d-41c9-b39e-40ffc392de75"
      unitRef="usd">29683200000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzExLTEtMS0xLTMxNDIy_e7eb6ff1-26b9-436e-bd2a-698abcf2d5f9"
      unitRef="usd">12113700000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzExLTMtMS0xLTMxNDIy_8c6484cf-2ef7-4c02-80e8-6081263b9931"
      unitRef="usd">12347000000</us-gaap:Goodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzEyLTEtMS0xLTMxNDIy_34aec302-f9e1-40ba-95fe-7097ed39f1ab"
      unitRef="usd">1332700000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzEyLTMtMS0xLTMxNDIy_c4f4cd97-b90b-4667-b54b-3e0ef01db98a"
      unitRef="usd">2147900000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzEzLTEtMS0xLTMxNDIy_5f30d052-bb9a-4051-9803-605d32a834ef"
      unitRef="usd">1170700000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzEzLTMtMS0xLTMxNDIy_50cec800-9969-401f-90ea-8287dd7085dc"
      unitRef="usd">1047500000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzE0LTEtMS0xLTMxNDIy_d8bae2c8-d9be-49f8-b87d-7a37f8adac36"
      unitRef="usd">54842800000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzE0LTMtMS0xLTMxNDIy_d3508224-3366-46d1-8892-c32ac0d5ada0"
      unitRef="usd">61553000000</us-gaap:Assets>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzE4LTEtMS0xLTMxNDIy_613ee762-1aec-40cb-a455-3cda6e4a1e53"
      unitRef="usd">1657400000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzE4LTMtMS0xLTMxNDIy_83dbc6ba-8d63-4f1b-af3c-99e9095f73cf"
      unitRef="usd">1904200000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:ShortTermBorrowings
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzE5LTEtMS0xLTMxNDIy_6072a6e0-5435-463d-a60c-8e2d50ab5fd9"
      unitRef="usd">1493000000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzE5LTMtMS0xLTMxNDIy_55b92a71-75cf-4adc-bf67-5f1da1b18f8b"
      unitRef="usd">1100900000</us-gaap:ShortTermBorrowings>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzIwLTEtMS0xLTMxNDIy_88bf8b4f-f62e-4197-b055-787dd2fba637"
      unitRef="usd">236900000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzIwLTMtMS0xLTMxNDIy_18735572-ec82-47a1-8e71-46fcd0c7eb56"
      unitRef="usd">288600000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzIxLTEtMS0xLTMxNDIy_d7bdd05e-3468-4623-8315-36a0fefe8268"
      unitRef="usd">1877500000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzIxLTMtMS0xLTMxNDIy_cb2d3f89-1d24-435b-a79f-9d10ab4d7222"
      unitRef="usd">2308500000</us-gaap:LongTermDebtCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzIzLTEtMS0xLTMxNDIy_19c5bf17-b683-4657-a392-18ed73a211ef"
      unitRef="usd">4619600000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzIzLTMtMS0xLTMxNDIy_3e87b56b-c02c-4cad-abf8-beaad471c475"
      unitRef="usd">4960700000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzI0LTEtMS0xLTMxNDIy_57a67119-b215-4963-b909-a07e7df62a9d"
      unitRef="usd">9884400000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzI0LTMtMS0xLTMxNDIy_33049929-c5c0-463e-9e00-1f411c9e9c85"
      unitRef="usd">10562900000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzI1LTEtMS0xLTMxNDIy_28f60400-ed1f-44fc-871f-3bcb0490c10e"
      unitRef="usd">19717100000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzI1LTMtMS0xLTMxNDIy_942bc338-3e7e-43b4-9c54-b021093cd7bf"
      unitRef="usd">22429200000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzI2LTEtMS0xLTMxNDIy_b72ad144-d34f-4dce-a45a-bc795ab87d83"
      unitRef="usd">2815000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzI2LTMtMS0xLTMxNDIy_f1897962-556e-44e9-80ee-677eb3329df1"
      unitRef="usd">3123700000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzI3LTEtMS0xLTMxNDIy_e52675df-777c-4c56-bc28-58ec291e222d"
      unitRef="usd">1933600000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzI3LTMtMS0xLTMxNDIy_114ce50f-e2bb-4cfb-9f49-e868652a7b28"
      unitRef="usd">2483100000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzI4LTEtMS0xLTMxNDIy_c168db01-d2bf-4c85-bc9e-b693262dc330"
      unitRef="usd">34350100000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzI4LTMtMS0xLTMxNDIy_a3cd52db-5ea3-4099-8b5a-2dc67478820e"
      unitRef="usd">38598900000</us-gaap:Liabilities>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzM2LTAtMS0xLTMxNDIyL3RleHRyZWdpb246ZmQ2Y2YwMjNmNTM0NDFjYWI4YjAxZjE5NDcyMTdlMjNfMTA5OTUxMTYyNzk1NA_63235522-e64e-4195-b01a-758d4833ecdd"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzM2LTAtMS0xLTMxNDIyL3RleHRyZWdpb246ZmQ2Y2YwMjNmNTM0NDFjYWI4YjAxZjE5NDcyMTdlMjNfMTA5OTUxMTYyNzk0Nw_db36512c-a4fd-43a4-8e27-46d7209f0a6c"
      unitRef="shares">3000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:SharesIssued
      contextRef="i3d077e089f704543858c47bf4c5566bf_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzM2LTAtMS0xLTMxNDIyL3RleHRyZWdpb246ZmQ2Y2YwMjNmNTM0NDFjYWI4YjAxZjE5NDcyMTdlMjNfMTk_c7a7818c-684f-4e99-87d7-c769d7e2f3f1"
      unitRef="shares">1209507463</us-gaap:SharesIssued>
    <us-gaap:SharesIssued
      contextRef="i39d4f9fa88c04ae0856b7faa1bf73798_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzM2LTAtMS0xLTMxNDIyL3RleHRyZWdpb246ZmQ2Y2YwMjNmNTM0NDFjYWI4YjAxZjE5NDcyMTdlMjNfMjY_e111d640-a897-4a57-a009-9f1488a053c6"
      unitRef="shares">1206895644</us-gaap:SharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzM2LTEtMS0xLTMxNDIy_7ec7d08d-7e17-42c3-be55-252d960e30ee"
      unitRef="usd">12100000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzM2LTMtMS0xLTMxNDIy_fc1d733d-5cce-41bf-873d-5e418119f3f8"
      unitRef="usd">12100000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzM3LTEtMS0xLTMxNDIy_b5e62ea0-8c9c-444a-86c7-cba27d32a18c"
      unitRef="usd">18536100000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzM3LTMtMS0xLTMxNDIy_27697876-8354-409d-8fd8-a5901187e28c"
      unitRef="usd">18438800000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzM4LTEtMS0xLTMxNDIy_7bd9b5fc-a0be-4bef-8169-795fece78b9c"
      unitRef="usd">3688800000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzM4LTMtMS0xLTMxNDIy_2a9cf1bd-f1d5-4b1d-a2f7-1878e8bc1495"
      unitRef="usd">5361200000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzM5LTEtMS0xLTMxNDIy_4b68c904-625b-4b96-a785-11fbf8721a83"
      unitRef="usd">-1744300000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzM5LTMtMS0xLTMxNDIy_3f3457a0-383b-4529-98f1-eedbc4dc2028"
      unitRef="usd">-858000000.0</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzQ0LTEtMS0xLTMxNDIy_93043268-219a-4acc-8a0e-a6a2d41a8452"
      unitRef="usd">20492700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzQ0LTMtMS0xLTMxNDIy_884173b0-c3b6-42ef-9d2b-bb1e1d52873b"
      unitRef="usd">22954100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzQ1LTEtMS0xLTMxNDIy_6011b164-b509-482b-8617-de7aeaea82c2"
      unitRef="usd">54842800000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTQvZnJhZzoyODA3MjAwZTM2YmE0NTdlYTE3Y2I4N2UxNzhjNmZlYy90YWJsZTo4ZjcyZjQ4MTU0OTc0ODU5OWZmYzYyMDg4ODdmMDA5YS90YWJsZXJhbmdlOjhmNzJmNDgxNTQ5NzQ4NTk5ZmZjNjIwODg4N2YwMDlhXzQ1LTMtMS0xLTMxNDIy_ba057d4a-37be-4584-87bd-f7a21774c29c"
      unitRef="usd">61553000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic25b2c6a9a1244738c1de493abb87705_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzMtMS0xLTEtMzE0MjI_7aa79eb2-d382-4529-8fc9-aa4d63f2ec2a"
      unitRef="usd">17813600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9f25078033394f518263d14867ea4eb6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzMtMy0xLTEtMzE0MjI_54a369d6-0ccd-44fd-b9ac-55ef2df479e5"
      unitRef="usd">11819900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iadb0452c57794c5498c4248d6691b32c_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzMtNS0xLTEtMzE0MjI_39d62a6d-a618-4b98-90a3-4446d6b752b8"
      unitRef="usd">11370300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueNotFromContractWithCustomer
      contextRef="if2b4674a5a824635bbb161ea5fe82fea_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzQtMS0xLTEtMzE0MjI_2741cb1b-bb75-44d0-b57e-5bb2a6fb2e4c"
      unitRef="usd">72700000</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:RevenueNotFromContractWithCustomer
      contextRef="ie779f16aabc14a74b5468853e37f6dd2_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzQtMy0xLTEtMzE0MjI_16453323-6658-495c-9d16-8028eb017734"
      unitRef="usd">126100000</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:RevenueNotFromContractWithCustomer
      contextRef="id568b4f1929446b9942b42b58b8e069f_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzQtNS0xLTEtMzE0MjI_4a9de4c1-fc37-4d51-a11c-b39dfad95c5f"
      unitRef="usd">130200000</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:Revenues
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzUtMS0xLTEtMzE0MjI_b581e2e5-ccb0-4125-a906-67be94574159"
      unitRef="usd">17886300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzUtMy0xLTEtMzE0MjI_2b5ac7e3-3fd5-4b3a-b160-56b667175750"
      unitRef="usd">11946000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzUtNS0xLTEtMzE0MjI_4762ec1c-9af6-4af6-a461-eda678fa0594"
      unitRef="usd">11500500000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzYtMS0xLTEtMzE0MjI_c37bce58-a8b3-47f5-b891-6fe7bf789bec"
      unitRef="usd">12310800000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzYtMy0xLTEtMzE0MjI_7cae7a23-ce32-43cb-8b30-6ab4ecd39f50"
      unitRef="usd">8149300000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzYtNS0xLTEtMzE0MjI_95747363-24f5-451b-9619-520f6da13307"
      unitRef="usd">7602900000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzctMS0xLTEtMzE0MjI_27ac0d21-3c21-42a2-9998-ee0a432a2562"
      unitRef="usd">5575500000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzctMy0xLTEtMzE0MjI_11796364-3009-4b0e-8906-45c135e5fbf2"
      unitRef="usd">3796700000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzctNS0xLTEtMzE0MjI_01fd9098-f101-4948-9f39-33cba0ac42a6"
      unitRef="usd">3897600000</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzktMS0xLTEtMzE0MjI_3c3f1df9-cb89-4045-9e3b-7e69158264db"
      unitRef="usd">751100000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzktMy0xLTEtMzE0MjI_24315cf0-286e-414f-94d0-95c095153826"
      unitRef="usd">555100000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzktNS0xLTEtMzE0MjI_98cf197b-9721-455f-a897-b92dc2e0f09a"
      unitRef="usd">639900000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzEwLTEtMS0xLTMxNDIy_66c4d8a0-1add-4905-9bdf-9e728bedfea0"
      unitRef="usd">4529200000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzEwLTMtMS0xLTMxNDIy_e80db6f2-a7a6-4f01-834c-6f90a949856c"
      unitRef="usd">3344600000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzEwLTUtMS0xLTMxNDIy_be7490a7-dc26-4f47-abb8-8fab142fab4a"
      unitRef="usd">2563600000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzExLTEtMS0xLTMxNDIy_3b5a4d79-92e0-43a3-8d74-3bfefc76896f"
      unitRef="usd">-329200000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzExLTMtMS0xLTMxNDIy_c4e2d957-5ffe-4ccd-9f4b-65d8efced816"
      unitRef="usd">-107800000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzExLTUtMS0xLTMxNDIy_01054cdb-2a05-4165-b9d4-7cb5ea149e73"
      unitRef="usd">21400000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:OperatingExpenses
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzEyLTEtMS0xLTMxNDIy_bf6bbd58-1c74-41a0-8f6a-a69400953024"
      unitRef="usd">5609500000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzEyLTMtMS0xLTMxNDIy_b4750ebc-18fc-4246-85db-eece3f9888ed"
      unitRef="usd">4007500000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzEyLTUtMS0xLTMxNDIy_82516ebd-eb6b-4afb-880c-30578a16dc68"
      unitRef="usd">3182100000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzEzLTEtMS0xLTMxNDIy_661a6ba2-8993-4823-8ac6-4ad1bf37891c"
      unitRef="usd">-34000000.0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzEzLTMtMS0xLTMxNDIy_c715fac0-a2c1-40d7-868c-33109a351f64"
      unitRef="usd">-210800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzEzLTUtMS0xLTMxNDIy_ed224eb0-3f51-4c57-823a-7e1b9af25823"
      unitRef="usd">715500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzE0LTEtMS0xLTMxNDIy_60675b64-43df-4f0b-a4a8-4fdfa3974582"
      unitRef="usd">636200000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzE0LTMtMS0xLTMxNDIy_6ff4a43a-6d0c-4064-8559-942212b705f3"
      unitRef="usd">497800000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzE0LTUtMS0xLTMxNDIy_27c2d51d-de50-4170-8ac0-ed3bf66ad413"
      unitRef="usd">517300000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzE1LTEtMS0xLTMxNDIy_580953b6-00d6-4533-9656-b64c9cf18b5c"
      unitRef="usd">5800000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzE1LTMtMS0xLTMxNDIy_1da376a0-7b48-4e2d-9ca6-48c27173f1ac"
      unitRef="usd">-12600000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzE1LTUtMS0xLTMxNDIy_7349a1b1-87dc-446d-979a-5ee0d82ba9af"
      unitRef="usd">-43800000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzE2LTEtMS0xLTMxNDIy_d31e412f-fa12-41d9-a277-b7475ab8b90e"
      unitRef="usd">-664400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzE2LTMtMS0xLTMxNDIy_ebced4b1-8190-4aa2-a856-8765d8d1e1d2"
      unitRef="usd">-721200000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzE2LTUtMS0xLTMxNDIy_2cbfa2d8-bf1b-475d-90a8-78422e394e9e"
      unitRef="usd">154400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzE3LTEtMS0xLTMxNDIy_ab6219ab-4771-4540-bd66-9513921c2565"
      unitRef="usd">604700000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzE3LTMtMS0xLTMxNDIy_5970843c-768c-447e-8c17-b588db3bf5b7"
      unitRef="usd">-51300000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzE3LTUtMS0xLTMxNDIy_53d4c8a0-f6f7-4462-8d42-fe5f88c1bb11"
      unitRef="usd">137600000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzE4LTEtMS0xLTMxNDIy_ffa27d12-facd-4f39-ad7d-f29722788122"
      unitRef="usd">-1269100000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzE4LTMtMS0xLTMxNDIy_d3964732-7a5a-4e5b-b453-0710d9cdb176"
      unitRef="usd">-669900000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzE4LTUtMS0xLTMxNDIy_1deb761f-119b-437b-91f1-d98bb88df93c"
      unitRef="usd">16800000</us-gaap:ProfitLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzIyLTEtMS0xLTMxNDIy_83a56312-efc8-4c7c-8992-c89fc01be0f6"
      unitRef="usdPerShare">-1.05</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzIyLTMtMS0xLTMxNDIy_c5ddd91b-63c8-4bc7-81fc-322dc5e7ac2b"
      unitRef="usdPerShare">-1.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzIyLTUtMS0xLTMxNDIy_a2850713-93e3-41e4-bb99-8401a21f7a65"
      unitRef="usdPerShare">0.03</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzIzLTEtMS0xLTMxNDIy_dc094c6e-593d-4700-8f8f-bf19abe72cba"
      unitRef="usdPerShare">-1.05</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzIzLTMtMS0xLTMxNDIy_a9e78228-852b-4b03-974a-87f5df89e659"
      unitRef="usdPerShare">-1.11</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzIzLTUtMS0xLTMxNDIy_d9bd64aa-f57a-40db-bf31-bffd7d9f9166"
      unitRef="usdPerShare">0.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzI1LTEtMS0xLTMxNDIy_8ef8d9a4-49c3-4abd-a284-236ef377f112"
      unitRef="shares">1208800000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzI1LTMtMS0xLTMxNDIy_c5bdb6eb-0912-432b-adee-c98b880cf10f"
      unitRef="shares">601200000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzI1LTUtMS0xLTMxNDIy_d286c930-1552-4da4-8348-235f7f5c1cba"
      unitRef="shares">515700000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzI2LTEtMS0xLTMxNDIy_3178fee6-4548-4899-8968-113aa36003f6"
      unitRef="shares">1208800000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzI2LTMtMS0xLTMxNDIy_859e6723-314f-4b73-a244-f3df085c4e22"
      unitRef="shares">601200000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNTcvZnJhZzoyZmZkMmE2NzJjNDg0ZTAxYTliYTdiYjY5YWI3Y2U0OS90YWJsZToyMDk2MWYwODhhNmY0YTUzOGYyN2UyMTNmNzBhNDZmMy90YWJsZXJhbmdlOjIwOTYxZjA4OGE2ZjRhNTM4ZjI3ZTIxM2Y3MGE0NmYzXzI2LTUtMS0xLTMxNDIy_9d746273-3e48-4f4d-b888-89d70754042d"
      unitRef="shares">516500000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzItMS0xLTEtMzE0MjI_ffa27d12-facd-4f39-ad7d-f29722788122"
      unitRef="usd">-1269100000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzItMy0xLTEtMzE0MjI_d3964732-7a5a-4e5b-b453-0710d9cdb176"
      unitRef="usd">-669900000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzItNS0xLTEtMzE0MjI_1deb761f-119b-437b-91f1-d98bb88df93c"
      unitRef="usd">16800000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzQtMS0xLTEtMzE0MjI_bacb7182-15bf-417b-8def-39853212ce52"
      unitRef="usd">-1340900000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzQtMy0xLTEtMzE0MjI_8ca10a93-1da7-4ba5-9e1b-e6ae7034f5ac"
      unitRef="usd">1213000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzQtNS0xLTEtMzE0MjI_64f62894-74ec-452b-a325-e28776dde071"
      unitRef="usd">-415500000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzUtMS0xLTEtMzE0MjI_bbf2c8fc-440a-44ff-a82b-c94221b4d23a"
      unitRef="usd">-73900000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzUtMy0xLTEtMzE0MjI_3346e7b2-e4d3-4ca0-948c-59783a466401"
      unitRef="usd">14000000.0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzUtNS0xLTEtMzE0MjI_64697ea8-2c71-4ecd-a87b-66a849a9f640"
      unitRef="usd">24800000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ibbe7edb935be4af4a3721e260440024e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzYtMS0xLTEtMzE0MjI_7a194794-1a41-4801-a832-fdda82331ff2"
      unitRef="usd">36100000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i5b0e6896d0904a51b7f3d01a54c4ddc3_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzYtMy0xLTEtMzE0MjI_c22a7418-4827-44ac-83b7-6ef3e74592b3"
      unitRef="usd">18200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ie99d2b10b5fa41a2b69de441e703d1be_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzYtNS0xLTEtMzE0MjI_13c3ad07-96f6-49b7-94db-3cb339922946"
      unitRef="usd">37100000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i72a4e38013274704acf3fce567aec1b6_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzctMS0xLTEtMzE0MjI_16ec1624-a1ed-4788-b152-45e5ba54667b"
      unitRef="usd">456800000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ie12ac8dbb8e34d9bbb1bb903a175a2c8_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzctMy0xLTEtMzE0MjI_f7fa54bb-04aa-476d-a45d-0c9890c38041"
      unitRef="usd">-305200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i57c4f10b75634ea68f1dca6a931ad8e6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzctNS0xLTEtMzE0MjI_0a02ec3e-1b48-47ce-b2d6-89139c29e009"
      unitRef="usd">59600000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzgtMS0xLTEtMzE0MjI_2a1e26b2-5f56-4f6d-b55e-bee04b1f9707"
      unitRef="usd">-1100000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzgtMy0xLTEtMzE0MjI_7b3568ce-12e0-4e70-843d-4b0cf9c57117"
      unitRef="usd">600000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzgtNS0xLTEtMzE0MjI_1a11cd4c-4d30-49f4-abe8-159725496566"
      unitRef="usd">500000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzktMS0xLTEtMzE0MjI_859f2352-946b-495a-b276-d28cc45ece97"
      unitRef="usd">-775200000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzktMy0xLTEtMzE0MjI_a4f13abe-022a-46ef-bc72-8e70084567e0"
      unitRef="usd">912600000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzktNS0xLTEtMzE0MjI_27b13b0b-f739-46ea-821d-c52ffc90972f"
      unitRef="usd">-343100000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzEwLTEtMS0xLTMxNDIy_2d0bd743-f215-46f0-96da-32b28f815b74"
      unitRef="usd">111100000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzEwLTMtMS0xLTMxNDIy_9c2e174d-73cd-43db-b8ac-eace1a297590"
      unitRef="usd">-26600000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzEwLTUtMS0xLTMxNDIy_319194bd-3d1e-49bf-8e61-c0fca121953f"
      unitRef="usd">9200000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzExLTEtMS0xLTMxNDIy_52cf9061-bad7-4eef-aeeb-ceeeb6de4c1e"
      unitRef="usd">-886300000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzExLTMtMS0xLTMxNDIy_342e671c-5202-4ce5-a274-d030defbcd82"
      unitRef="usd">939200000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzExLTUtMS0xLTMxNDIy_796206db-97e7-413e-b847-931e71ea03dd"
      unitRef="usd">-352300000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzEyLTEtMS0xLTMxNDIy_8085f783-2ec2-434e-b9eb-dff1f5bb6ace"
      unitRef="usd">-2155400000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzEyLTMtMS0xLTMxNDIy_5d7501f0-1764-435c-915f-597a2086f915"
      unitRef="usd">269300000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjAvZnJhZzo0YTA0ZTU5YWYyMjg0ODkyOWMxNjQyYWM2ZmE3ZDM4MS90YWJsZTowNzkxMzQ4ZDQ1MjI0MWQ2OTEzZGM1MDA5ZGYzNmVjYi90YWJsZXJhbmdlOjA3OTEzNDhkNDUyMjQxZDY5MTNkYzUwMDlkZjM2ZWNiXzEyLTUtMS0xLTMxNDIy_a0d2fe9f-eb51-46c1-be5e-64b12e1a8b5b"
      unitRef="usd">-335500000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="i4c63b953f9ab4ca380c2a6718f3499d2_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzMtMS0xLTEtMzE0MjI_2abca13c-7d8f-4982-abd8-f3917f183f4a"
      unitRef="shares">539289665</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4c63b953f9ab4ca380c2a6718f3499d2_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzMtMy0xLTEtMzE0MjI_f836f236-ace3-4ae8-b020-ed7a945448ed"
      unitRef="usd">6000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia50f87af01074210b75c18963d37110d_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzMtNS0xLTEtMzE0MjI_12b0bddf-4d35-45f5-8b4c-0a1026fb1eda"
      unitRef="usd">8591400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0df3c349ea2b4fbfba28ebfb584419f0_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzMtNy0xLTEtMzE0MjI_bacc4c53-8500-4039-95ed-a6bd63d596c8"
      unitRef="usd">6010700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="ib23cdc694f6547709893256e80430c38_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzMtOS0xLTEtMzE0MjI_36376471-b30f-4172-960f-dfeb7da7722f"
      unitRef="shares">23490867</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib23cdc694f6547709893256e80430c38_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzMtMTEtMS0xLTMxNDIy_0fd7a420-9dcb-424b-84eb-f148c4e6cabb"
      unitRef="usd">-999700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibadea9a32ce84dc48523b37b0f0b23ce_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzMtMTMtMS0xLTMxNDIy_72126d1d-6a6c-46a5-8b77-972de12c7229"
      unitRef="usd">-1441300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if8ec92ba24d848d697ba737aeed13c05_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzMtMTctMS0xLTMxNDIy_cb9e2f3f-f1cc-4fd5-9211-012370367e3d"
      unitRef="usd">12167100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i4f90527bae0344d981ff43fd2126b229_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzQtNy0xLTEtMzE0MjI_a9e0d3cf-5152-4f9a-bfa4-cab43ab20e7a"
      unitRef="usd">16800000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzQtMTctMS0xLTMxNDIy_48eca2c2-acd9-40c8-aea2-b9bd2d09ecd4"
      unitRef="usd">16800000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5143c6332d7249db9f3409e36def6483_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzUtMTMtMS0xLTMxNDIy_1d6ea2f7-82b5-4f0d-a2c6-f0533518e1b6"
      unitRef="usd">-352300000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzUtMTctMS0xLTMxNDIy_796206db-97e7-413e-b847-931e71ea03dd"
      unitRef="usd">-352300000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ib0cf1109448e4942a109317479a8de2d_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzctNS0xLTEtMzk3Mjg_1230ad6a-8c82-469a-aed2-af675645765f"
      unitRef="usd">56800000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzctMTctMS0xLTM5NzI4_b27292aa-f0ee-49b6-99e5-12945360403e"
      unitRef="usd">56800000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <vtrs:StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment
      contextRef="ic877d36b0d2e41a293e8217247ace76e_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzYtMS0xLTEtMzE0MjI_696a90f9-9e30-4ef5-aaa9-a4c3eb7d369c"
      unitRef="shares">1457206</vtrs:StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ic877d36b0d2e41a293e8217247ace76e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzYtMy0xLTEtMzE0MjI_c7f8f0ff-ddae-47d1-b62d-4a36db5d8828"
      unitRef="usd">100000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ib0cf1109448e4942a109317479a8de2d_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzYtNS0xLTEtMzE0MjI_4ef57e41-d6ed-4a31-a704-2713cf0f0663"
      unitRef="usd">8100000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzYtMTctMS0xLTMxNDIy_55be6878-cf56-4d12-8a49-f6c302ab1d63"
      unitRef="usd">8200000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
      contextRef="ib0cf1109448e4942a109317479a8de2d_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzctNS0xLTEtMzE0MjI_a41d90c7-c185-4974-9719-bd97bef3876a"
      unitRef="usd">-12800000</us-gaap:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet>
    <us-gaap:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzctMTctMS0xLTMxNDIy_9278a9ad-40be-4877-a829-e140236732a7"
      unitRef="usd">-12800000</us-gaap:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet>
    <us-gaap:TreasuryStockSharesRetired
      contextRef="i759302137d4347189f09b28fddcb4d55_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzktOS0xLTEtMzE0MjI_4de5c5e0-eb95-4349-ae35-6dceba4988b2"
      unitRef="shares">1107207</us-gaap:TreasuryStockSharesRetired>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i676ac4a93e7c42cf8130b6170dc1899a_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzEyLTctMS0xLTMxNDIy_1bcc778b-7c6d-44f4-8b37-00f000883a59"
      unitRef="usd">3600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5f069b3a590b4f41809c068d4484a771_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzEyLTEzLTEtMS0zMTQyMg_8bd7bfab-139f-488a-aa28-bb535bc94b08"
      unitRef="usd">-3600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i37a67212c0ef46a4ad4f6aa75d225fed_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzEyLTE3LTEtMS0zMTQyMg_7e8629a5-3cd7-4f30-93ba-48a7757d7353"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="i00d14723d68d4566b474e37cf199d470_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzEzLTEtMS0xLTMxNDIy_cc02e5fe-a84b-4cb4-b0fe-2b12f391045e"
      unitRef="shares">540746871</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i00d14723d68d4566b474e37cf199d470_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzEzLTMtMS0xLTMxNDIy_e2903fd3-0a0e-476d-aabc-02c6f9fa251e"
      unitRef="usd">6100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia780b2ac8321464bae70f392c4b8e0ac_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzEzLTUtMS0xLTMxNDIy_451e5808-f662-4fd1-9575-2d8cea25d8da"
      unitRef="usd">8643500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibd43c5aaf4d94827a901e78c27e732f7_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzEzLTctMS0xLTMxNDIy_2ecf38c6-d30e-4523-b096-11a8b48aa6ab"
      unitRef="usd">6031100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="ib85f7a5cf6f64a0e84c35ebc74cd0576_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzEzLTktMS0xLTMxNDIy_e8b6eb5d-c145-4775-a483-315429c2939e"
      unitRef="shares">24598074</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib85f7a5cf6f64a0e84c35ebc74cd0576_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzEzLTExLTEtMS0zMTQyMg_9bf3fc8e-4d77-495c-9acd-685dd98697c7"
      unitRef="usd">-999700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic39189fc54504b53be3c4281e5dd8f82_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzEzLTEzLTEtMS0zMTQyMg_8ca5ed1e-c6df-48db-a86c-02fc51b82f21"
      unitRef="usd">-1797200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iac503b6d629d4bafb262ea6ec0b8a25e_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzEzLTE3LTEtMS0zMTQyMg_0cefecc0-273a-4825-9def-ec7b03d571da"
      unitRef="usd">11883800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="idc41db043d3e4f84b4c531fda801f18c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzE0LTctMS0xLTMxNDIy_ccc00b2a-1344-4a84-ba86-c515c64b09c1"
      unitRef="usd">-669900000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzE0LTE3LTEtMS0zMTQyMg_d8d223bc-5b63-4c06-9c4a-93a99c719aa4"
      unitRef="usd">-669900000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0e5cd61854a54e59a6e1744de70eab75_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzE1LTEzLTEtMS0zMTQyMg_0f7c4b0a-b01e-4303-ae52-9dcae1804d2d"
      unitRef="usd">939200000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzE1LTE3LTEtMS0zMTQyMg_f00215e9-bc7c-41ae-b11e-cafdabda0451"
      unitRef="usd">939200000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ie4251244738d4104aa6f320d2729ecf7_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzE3LTUtMS0xLTMxNDIy_a66978a5-c438-4b78-9227-9d1b6cf63d3f"
      unitRef="usd">79200000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzE3LTE3LTEtMS0zMTQyMg_acf6631c-1a3a-46d2-afbe-d9589d0ae58e"
      unitRef="usd">79200000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <vtrs:StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment
      contextRef="i1aaa5a37c6f4415aaac4b207251f9e26_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzE5LTEtMS0xLTM5ODAz_6346de63-da5d-4431-a7b3-78ac82a7a491"
      unitRef="shares">872802</vtrs:StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="ie4251244738d4104aa6f320d2729ecf7_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzE5LTUtMS0xLTM5ODAz_986bfa29-79d9-4047-aa85-035c55481cea"
      unitRef="usd">600000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzE5LTE3LTEtMS0zOTgwMw_1b5bb865-01c7-48cf-bb3f-084cb1836d5f"
      unitRef="usd">600000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
      contextRef="ie4251244738d4104aa6f320d2729ecf7_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzIwLTUtMS0xLTM5Nzg0_8b809489-1d73-4ff4-9076-d4663d0e137c"
      unitRef="usd">-6300000</us-gaap:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet>
    <us-gaap:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzIwLTE3LTEtMS0zOTc4NA_d18d9b19-b0bf-4514-95b4-89b824312231"
      unitRef="usd">-6300000</us-gaap:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet>
    <vtrs:StockExchangedDuringPeriodSharesExchanged
      contextRef="i1aaa5a37c6f4415aaac4b207251f9e26_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzIxLTEtMS0xLTM5ODE4_d9fa79f7-ca00-46cc-8fba-e06cebc4fb2e"
      unitRef="shares">541619673</vtrs:StockExchangedDuringPeriodSharesExchanged>
    <vtrs:StockExchangedDuringPeriodValue
      contextRef="i1aaa5a37c6f4415aaac4b207251f9e26_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzIxLTMtMS0xLTM5ODE4_78ad13e2-4906-4e3a-ba86-6a907b930d34"
      unitRef="usd">6100000</vtrs:StockExchangedDuringPeriodValue>
    <vtrs:StockExchangedDuringPeriodValue
      contextRef="ie4251244738d4104aa6f320d2729ecf7_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzIxLTUtMS0xLTM5ODE4_7dec9346-6b6e-4b6a-bee4-42478eae4dd5"
      unitRef="usd">-6100000</vtrs:StockExchangedDuringPeriodValue>
    <vtrs:StockExchangedDuringPeriodValue
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzIxLTE3LTEtMS0zOTgxOA_ee6dc070-06ba-4428-9f42-ccd9538155f4"
      unitRef="usd">0</vtrs:StockExchangedDuringPeriodValue>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i1aaa5a37c6f4415aaac4b207251f9e26_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzE5LTEtMS0xLTMxNDIy_30e9a759-b6af-498f-9f8d-c402e59ce380"
      unitRef="shares">541619673</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i1aaa5a37c6f4415aaac4b207251f9e26_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzE5LTMtMS0xLTMxNDIy_5e88d977-89bd-49f0-b581-2dc3771dcdc3"
      unitRef="usd">5200000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ie4251244738d4104aa6f320d2729ecf7_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzE5LTUtMS0xLTMxNDIy_9a47b12c-8711-42f1-8edd-2de67890338c"
      unitRef="usd">-5200000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzE5LTE3LTEtMS0zMTQyMg_e9119b74-6dfa-4c7e-b094-e5b1532db63e"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="i1aaa5a37c6f4415aaac4b207251f9e26_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzIwLTEtMS0xLTMxNDIy_39298a73-9abb-4399-aa1f-ba426b3379c0"
      unitRef="shares">689874045</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i1aaa5a37c6f4415aaac4b207251f9e26_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzIwLTMtMS0xLTMxNDIy_169dcc8d-c355-476d-8160-77d8541dc092"
      unitRef="usd">6900000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="ie4251244738d4104aa6f320d2729ecf7_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzIwLTUtMS0xLTMxNDIy_ffcd5185-7fd5-498d-bf34-7366a30f8f5f"
      unitRef="usd">10720600000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzIwLTE3LTEtMS0zMTQyMg_24d1e204-a1b3-4d7e-b38c-ea8873ffbb9b"
      unitRef="usd">10727500000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:TreasuryStockSharesRetired
      contextRef="i1aaa5a37c6f4415aaac4b207251f9e26_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzIxLTEtMS0xLTMxNDIy_cee31966-f48a-41bb-9dbe-e51e4927b8a0"
      unitRef="shares">24598074</us-gaap:TreasuryStockSharesRetired>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="ie4251244738d4104aa6f320d2729ecf7_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzIxLTUtMS0xLTMxNDIy_190e85fc-e5bc-46ad-841c-9490b90f062c"
      unitRef="usd">999700000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockSharesRetired
      contextRef="i614ccdb2c5cd4297b966274861517991_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzIxLTktMS0xLTMxNDIy_a675b144-6612-490b-bfbe-406da6741767"
      unitRef="shares">24598074</us-gaap:TreasuryStockSharesRetired>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i614ccdb2c5cd4297b966274861517991_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzIxLTExLTEtMS0zMTQyMg_724dcd4c-658d-4912-958d-a49bfd06ed79"
      unitRef="usd">-999700000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzIxLTE3LTEtMS0zMTQyMg_4c5845a4-f7e9-4d91-8a26-b6c7ccee8b14"
      unitRef="usd">0</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:SharesIssued
      contextRef="i39d4f9fa88c04ae0856b7faa1bf73798_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzIyLTEtMS0xLTMxNDIy_e111d640-a897-4a57-a009-9f1488a053c6"
      unitRef="shares">1206895644</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i39d4f9fa88c04ae0856b7faa1bf73798_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzIyLTMtMS0xLTMxNDIy_bb90273f-858a-447a-adb3-4d55d4b44a47"
      unitRef="usd">12100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia12703913f6e4df58b4262b9bbb6ea77_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzIyLTUtMS0xLTMxNDIy_633454b2-d898-462f-97a0-5a3d28b7daaa"
      unitRef="usd">18438800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3d45fba46a924824a984d4a911f8510f_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzIyLTctMS0xLTMxNDIy_b1787e6b-2572-4bbb-b3d6-5f291bcb9052"
      unitRef="usd">5361200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="iba866be0d0f04d0cbdf171873fd7fd0b_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzIyLTktMS0xLTMxNDIy_61b1e3fb-5f24-4db9-8f96-03121c2e302d"
      unitRef="shares">0</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iba866be0d0f04d0cbdf171873fd7fd0b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzIyLTExLTEtMS0zMTQyMg_85372474-d0b0-48b8-90b9-d4029ff099e7"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzIyLTEzLTEtMS0zMTQyMg_3f3457a0-383b-4529-98f1-eedbc4dc2028"
      unitRef="usd">-858000000.0</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzIyLTE3LTEtMS0zMTQyMg_884173b0-c3b6-42ef-9d2b-bb1e1d52873b"
      unitRef="usd">22954100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i14dba6c874d24fcfae05dbedf70952aa_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzIzLTctMS0xLTMxNDIy_2de4079b-7e4b-412f-ae17-b4df2b272175"
      unitRef="usd">-1269100000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzIzLTE3LTEtMS0zMTQyMg_2d7b90dc-c320-48e4-adb8-6d763708681f"
      unitRef="usd">-1269100000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i92e45e4918604661b681cd5b227d7bcc_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzI0LTEzLTEtMS0zMTQyMg_525ac6c1-0b51-4fb6-99c5-d86d94f94737"
      unitRef="usd">-886300000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzI0LTE3LTEtMS0zMTQyMg_01ddd282-ba16-4ac8-8114-101124980aac"
      unitRef="usd">-886300000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ifcb976e09f3943ed918be4bf207b55e3_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzI3LTUtMS0xLTMxNDIy_42c5e05c-3058-4a45-8227-71e9a473209e"
      unitRef="usd">111200000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzI3LTE3LTEtMS0zMTQyMg_71f71290-055f-4c38-bf56-92667e78466c"
      unitRef="usd">111200000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <vtrs:StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment
      contextRef="i09fc106c667c4de189765013dc4a94ef_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzI4LTEtMS0xLTMxNDIy_0bb27dcd-73c4-4edd-bc4c-eac1aeea2e39"
      unitRef="shares">2611819</vtrs:StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment>
    <us-gaap:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
      contextRef="ifcb976e09f3943ed918be4bf207b55e3_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzI5LTUtMS0xLTMxNDIy_83b77a84-7e97-4f99-a1a6-bcd735c161b1"
      unitRef="usd">-13900000</us-gaap:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet>
    <us-gaap:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzI5LTE3LTEtMS0zMTQyMg_5a4d7bde-597e-45db-8f91-f27d4109d80e"
      unitRef="usd">-13900000</us-gaap:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="if7c969d8800446acace677aeab6fa885_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzMwLTAtMS0xLTMxNDIyL3RleHRyZWdpb246NjIxNzgzZDZiZGRlNDBhZGFhM2M0YWZmYjcxNWFkYjBfMTA5OTUxMTYyNzgyMg_a61abc5a-e933-4b2a-a025-2a22f86c78cc"
      unitRef="usdPerShare">0.33</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:DividendsCommonStockCash
      contextRef="i14dba6c874d24fcfae05dbedf70952aa_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzMwLTctMS0xLTMxNDIy_9d3eb719-8e17-4aad-b511-e3996f3df1ab"
      unitRef="usd">403300000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i14dba6c874d24fcfae05dbedf70952aa_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzMwLTE3LTEtMS0zMTQyMg_1d0a73ee-a95a-4549-9665-e21ece81ade9"
      unitRef="usd">403300000</us-gaap:DividendsCommonStockCash>
    <us-gaap:SharesIssued
      contextRef="i3d077e089f704543858c47bf4c5566bf_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzM1LTEtMS0xLTMxNDIy_c7a7818c-684f-4e99-87d7-c769d7e2f3f1"
      unitRef="shares">1209507463</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3d077e089f704543858c47bf4c5566bf_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzM1LTMtMS0xLTMxNDIy_3bc40279-b5ea-49d9-bd54-82d04da7c927"
      unitRef="usd">12100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7428ecd34bd643bfb53dd62a4bce788c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzM1LTUtMS0xLTMxNDIy_9cfcd4ca-1385-4946-bb93-7f13410eb3a4"
      unitRef="usd">18536100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if13be5161c804163b4305d5d326bef7e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzM1LTctMS0xLTMxNDIy_52ec3f9b-fdf3-4c13-97a4-b44918a38e49"
      unitRef="usd">3688800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="i1a6cdd4c97954d22af41797509ecf7fb_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzM1LTktMS0xLTMxNDIy_ee7978f9-d6d6-4f72-bb38-3a596d2cf22e"
      unitRef="shares">0</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1a6cdd4c97954d22af41797509ecf7fb_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzM1LTExLTEtMS0zMTQyMg_ba0ac367-ce62-412d-855f-430ea247e588"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i87a0adf309ee48cab4e379bd487453b4_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzM1LTEzLTEtMS0zMTQyMg_c5ce1d88-266b-47e5-b0d9-67b52eed3a5e"
      unitRef="usd">-1744300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjMvZnJhZzpmMDg0MWJjODE4NjE0ODNmODE0NTUwOTM0ODBmOGNkZi90YWJsZTpkNjRiNmQyOGUxYTk0NDUwYjY2YTQyN2E5NDNmMTgyZi90YWJsZXJhbmdlOmQ2NGI2ZDI4ZTFhOTQ0NTBiNjZhNDI3YTk0M2YxODJmXzM1LTE3LTEtMS0zMTQyMg_93043268-219a-4acc-8a0e-a6a2d41a8452"
      unitRef="usd">20492700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzMtMS0xLTEtMzE0MjI_0307ae27-48d6-4697-af7d-3819c150958e"
      unitRef="usd">-1269100000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzMtMy0xLTEtMzE0MjI_d3964732-7a5a-4e5b-b453-0710d9cdb176"
      unitRef="usd">-669900000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzMtNS0xLTEtMzE0MjI_1deb761f-119b-437b-91f1-d98bb88df93c"
      unitRef="usd">16800000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzUtMS0xLTEtMzE0MjI_60a789f9-5111-4d93-bf56-60eabc3a55a1"
      unitRef="usd">4506500000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzUtMy0xLTEtMzE0MjI_d49abcf5-6445-43c3-a452-cbe0ab5c78ce"
      unitRef="usd">2216100000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzUtNS0xLTEtMzE0MjI_d71b5145-8b9a-44cd-8eeb-1dfcce143ec9"
      unitRef="usd">2019300000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzYtMS0xLTEtMzE0MjI_13c875be-a3d1-43d2-aab5-5836b8102005"
      unitRef="usd">675700000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzYtMS0xLTEtMzE0MjI_b027852c-f2ea-4bac-a00e-24220a12184e"
      unitRef="usd">675700000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzYtMy0xLTEtMzE0MjI_f19f7636-bf2b-450c-b7a4-1ebaff764cae"
      unitRef="usd">-213200000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzYtNS0xLTEtMzE0MjI_d6724e5c-88f5-4c87-b66b-29d72d774c62"
      unitRef="usd">-192600000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <vtrs:Changeinnoncashlitigationsettlementsnet
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzctMS0xLTEtMzE0MjI_75d79249-663b-43dd-b21c-3354a699bf1c"
      unitRef="usd">-323700000</vtrs:Changeinnoncashlitigationsettlementsnet>
    <vtrs:Changeinnoncashlitigationsettlementsnet
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzctMy0xLTEtMzE0MjI_60eb8703-2116-4eb0-9464-346a79621803"
      unitRef="usd">-101100000</vtrs:Changeinnoncashlitigationsettlementsnet>
    <vtrs:Changeinnoncashlitigationsettlementsnet
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzctNS0xLTEtMzE0MjI_eaa1be23-4350-4c5b-9d72-388f30deeb6c"
      unitRef="usd">11500000</vtrs:Changeinnoncashlitigationsettlementsnet>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzgtMS0xLTEtMzE0MjI_361d8db0-63e7-478a-8064-41b9a3a575a2"
      unitRef="usd">-61900000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzgtMy0xLTEtMzE0MjI_e2a03f1e-1c95-452d-a3ff-d46763affe0d"
      unitRef="usd">-48400000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzgtNS0xLTEtMzE0MjI_51bc5362-bc09-4535-a97a-9787be8a9167"
      unitRef="usd">-62100000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:ShareBasedCompensation
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzktMS0xLTEtMzE0MjI_240d3df5-6bba-4ce1-9a15-333b7667a67e"
      unitRef="usd">111200000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzktMy0xLTEtMzE0MjI_7186ad54-3c63-4b04-893d-fa36ac65bb56"
      unitRef="usd">79200000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzktNS0xLTEtMzE0MjI_aac2e81f-cfb8-452d-991f-9e4d5730f769"
      unitRef="usd">56800000</us-gaap:ShareBasedCompensation>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzExLTEtMS0xLTMxNDIy_892af3d5-ccaa-4387-826e-6ff476365667"
      unitRef="usd">-411800000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzExLTEtMS0xLTMxNDIy_d2d84a33-3e36-47af-9895-fc83e10f7be5"
      unitRef="usd">-411800000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzExLTMtMS0xLTMxNDIy_c70bd4ab-26ef-4dbe-8792-e49a71a905e5"
      unitRef="usd">-366400000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzExLTUtMS0xLTMxNDIy_beadcd92-3527-4c38-81bb-3cd8c6fd45f5"
      unitRef="usd">-360600000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzEzLTEtMS0xLTMxNDIy_1f2457d2-1cd0-4604-8478-5e4804593345"
      unitRef="usd">-59300000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzEzLTEtMS0xLTMxNDIy_a5362394-fd2f-45f1-a9d6-d348c22e7428"
      unitRef="usd">-59300000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzEzLTMtMS0xLTMxNDIy_a532b3a0-bd56-44ba-b192-916d51f3eef0"
      unitRef="usd">-78700000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzEzLTUtMS0xLTMxNDIy_cd6b5019-7d75-4287-ad56-6f4efe04dfb2"
      unitRef="usd">20000000.0</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzE0LTEtMS0xLTMxNDIy_9be48501-5400-4949-8f0e-ccd5fa881688"
      unitRef="usd">427600000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzE0LTMtMS0xLTMxNDIy_d608d5dd-d44b-46db-bbb8-c9521838763d"
      unitRef="usd">741900000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzE0LTUtMS0xLTMxNDIy_8de00285-b32c-4b91-b058-20b12187771e"
      unitRef="usd">512900000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzE1LTEtMS0xLTMxNDIy_ac63e4aa-de20-4545-9e11-b92174036e33"
      unitRef="usd">-70400000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzE1LTEtMS0xLTMxNDIy_e024cc6c-8718-4030-94a6-1fde56a2af6d"
      unitRef="usd">-70400000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzE1LTMtMS0xLTMxNDIy_8d655338-0f24-4d5e-a7eb-bc184a91fcc3"
      unitRef="usd">-82700000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzE1LTUtMS0xLTMxNDIy_ab6c896d-3f98-4514-86e8-0995d5526ec0"
      unitRef="usd">-96300000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzE2LTEtMS0xLTMxNDIy_4daa8eb0-8afb-4267-9d22-747e198b9162"
      unitRef="usd">-699600000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzE2LTEtMS0xLTMxNDIy_56024c4d-1219-4b1a-99a2-0a7a5ded0c5d"
      unitRef="usd">-699600000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzE2LTMtMS0xLTMxNDIy_1ec98692-7060-4e2f-a267-8c76307c9f7d"
      unitRef="usd">3600000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzE2LTUtMS0xLTMxNDIy_4eb5916d-ad44-4745-97e9-a70098639a3a"
      unitRef="usd">57900000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzE3LTEtMS0xLTMxNDIy_58316ab4-8196-4838-88ff-8bf5aa6b4381"
      unitRef="usd">666500000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzE3LTEtMS0xLTMxNDIy_f3ab04e4-dd6a-4290-ae11-b7528cf4e95e"
      unitRef="usd">666500000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzE3LTMtMS0xLTMxNDIy_11e9e3d8-de61-4c2a-a4cb-80aa220bbd58"
      unitRef="usd">-46000000.0</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzE3LTUtMS0xLTMxNDIy_bb9e7b45-dbfc-4912-b534-3c7622a9dfe5"
      unitRef="usd">-63500000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzE4LTEtMS0xLTMxNDIy_880f1dbb-348c-4dcc-b5a1-1b666a84bc03"
      unitRef="usd">3016900000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzE4LTEtMS0xLTMxNDIy_f8cad04d-71fd-46bb-923e-4808391f9a87"
      unitRef="usd">3016900000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzE4LTMtMS0xLTMxNDIy_1a484cf2-0b19-465b-8348-ac580548f85e"
      unitRef="usd">1231800000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzE4LTUtMS0xLTMxNDIy_58825ec9-05e1-4e39-ab42-4c1b7a3827a8"
      unitRef="usd">1803700000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzIwLTEtMS0xLTMxNDIy_8ba8fbea-d4b8-40c1-8667-58c6f6d0c456"
      unitRef="usd">-277000000.0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzIwLTMtMS0xLTMxNDIy_b045637c-39c2-41f9-884e-e2fa96e94cd5"
      unitRef="usd">-415800000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzIwLTUtMS0xLTMxNDIy_67a16517-591c-4985-b5e3-708e9225108f"
      unitRef="usd">148700000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzIxLTEtMS0xLTMxNDIy_edf0f26e-2995-4e67-af9f-d1b26cbb2406"
      unitRef="usd">457200000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzIxLTMtMS0xLTMxNDIy_03257c53-45da-4c0f-acb3-382c5c18f479"
      unitRef="usd">243000000.0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzIxLTUtMS0xLTMxNDIy_0d316223-73a5-46e6-8360-c2e0f896a0bb"
      unitRef="usd">213200000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzIyLTEtMS0xLTMxNDIy_3504a5d1-388f-4e95-92ee-5ae4d7834b20"
      unitRef="usd">52200000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzIyLTMtMS0xLTMxNDIy_83b4ce69-79c9-48b1-b2bc-f052c60b886f"
      unitRef="usd">438200000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzIyLTUtMS0xLTMxNDIy_0b5e7987-fa96-49ea-8b41-0393ff728ad1"
      unitRef="usd">192800000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzIzLTEtMS0xLTMxNDIy_2e50d6cd-b89b-447e-aadc-7869d5916a31"
      unitRef="usd">18300000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzIzLTMtMS0xLTMxNDIy_4a0b6d1f-7c2e-40a6-b270-47334eb523ee"
      unitRef="usd">2100000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzIzLTUtMS0xLTMxNDIy_0c901954-07d2-4ceb-894e-6411c927cfbc"
      unitRef="usd">0</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzI0LTEtMS0xLTMxNDIy_78b05ad1-170e-48c9-826a-212cc2c2565e"
      unitRef="usd">96700000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzI0LTMtMS0xLTMxNDIy_62eaa971-f2de-447f-b0a8-192dffde8242"
      unitRef="usd">20000000.0</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzI0LTUtMS0xLTMxNDIy_ca795139-a60c-44b0-9b52-3a55745fab34"
      unitRef="usd">28000000.0</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzI1LTEtMS0xLTMxNDIy_295c1256-5821-41df-ba3e-cfcfb0f42d77"
      unitRef="usd">30200000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzI1LTMtMS0xLTMxNDIy_9a1c34b5-d7dc-4e47-8166-fd3c5b983b44"
      unitRef="usd">104800000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzI1LTUtMS0xLTMxNDIy_b5e4cb88-8bae-42be-919c-eaca050a2f30"
      unitRef="usd">25800000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzI2LTEtMS0xLTMxNDIy_12a17127-24db-4262-8bee-a8ddd43655c5"
      unitRef="usd">29800000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzI2LTMtMS0xLTMxNDIy_f2136368-e7b4-4fe8-b92f-2572f2c294cb"
      unitRef="usd">47000000.0</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzI2LTUtMS0xLTMxNDIy_11bec288-8921-4d2b-87af-c91c8c006c8b"
      unitRef="usd">27100000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzI3LTEtMS0xLTMxNDIy_48273a2b-7ad5-4073-9e16-67cfaaba514c"
      unitRef="usd">-117800000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzI3LTMtMS0xLTMxNDIy_48d8d13f-9fbd-41f4-972b-0b342ffc0c31"
      unitRef="usd">-301100000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzI3LTUtMS0xLTMxNDIy_dcbdd751-694e-471a-baf5-a4210fb6de54"
      unitRef="usd">-525400000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzI5LTEtMS0xLTMxNDIy_af7999a2-106f-4990-bd4c-981451e07711"
      unitRef="usd">1710100000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzI5LTMtMS0xLTMxNDIy_03dfeb0a-c265-478c-8142-ff68e1559e17"
      unitRef="usd">983300000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzI5LTUtMS0xLTMxNDIy_1b1cb8be-7883-4ef6-875a-e632e29e3100"
      unitRef="usd">7400000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzMwLTEtMS0xLTMxNDIy_72caf5b4-2f50-4629-bcb6-a55124e8726d"
      unitRef="usd">4201300000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzMwLTMtMS0xLTMxNDIy_e74d062c-fecc-463e-8d3e-b2363fb832d1"
      unitRef="usd">2484200000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzMwLTUtMS0xLTMxNDIy_efbf646e-9c60-404b-b402-9df16572b644"
      unitRef="usd">1108500000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzMxLTEtMS0xLTMxNDIy_e48e9942-c740-4ee8-ada2-7f598be7aca5"
      unitRef="usd">7000000.0</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzMxLTMtMS0xLTMxNDIy_5810dc31-df18-4e77-a176-8acfde919af3"
      unitRef="usd">2000000.0</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzMxLTUtMS0xLTMxNDIy_89118f96-f9d6-403a-955c-f39ac42c4cbb"
      unitRef="usd">3000000.0</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzMyLTEtMS0xLTMxNDIy_36d91701-8274-4e0d-b529-fd9f9e41d231"
      unitRef="usd">392100000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzMyLTMtMS0xLTMxNDIy_957c9295-9c1c-4e8c-a94b-4eee2da7f25c"
      unitRef="usd">1099600000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzMyLTUtMS0xLTMxNDIy_5ff4b94e-99cc-46da-a107-d5ed1ff76585"
      unitRef="usd">-1800000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzM0LTEtMS0xLTMxNDIy_ee5cd4ef-607f-4e73-a806-f7f68b03a097"
      unitRef="usd">0</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzM0LTMtMS0xLTMxNDIy_662c558a-4b45-476f-8895-0b6baab92e98"
      unitRef="usd">600000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzM0LTUtMS0xLTMxNDIy_64601915-c9ae-415a-812c-97fc7e5ed9c4"
      unitRef="usd">8100000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzM1LTEtMS0xLTMxNDIy_8fdc15a4-1787-4014-94db-e5ea75a881fc"
      unitRef="usd">17400000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzM1LTMtMS0xLTMxNDIy_05ae8efa-929b-4a62-9b74-16bc142b7952"
      unitRef="usd">7900000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzM1LTUtMS0xLTMxNDIy_e0c37a46-bc99-4e45-8d30-25e5b18d437d"
      unitRef="usd">8400000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzM2LTEtMS0xLTMxNDIy_b3cd440f-a4b5-4f12-bdf4-9d8dd2df9b80"
      unitRef="usd">28600000</us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities>
    <us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzM2LTMtMS0xLTMxNDIy_1b1df502-8ee6-4be5-a6b1-5334681a9350"
      unitRef="usd">48500000</us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities>
    <us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzM2LTUtMS0xLTMxNDIy_056a3b47-f7b7-406b-98d4-30958fc7c613"
      unitRef="usd">60300000</us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzM3LTEtMS0xLTMxNDIy_3af83d22-47be-48ca-8fea-7c2baf72bf58"
      unitRef="usd">399000000.0</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzM3LTMtMS0xLTMxNDIy_60d356de-e213-42f9-84fe-33b2dcbdfdc1"
      unitRef="usd">0</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzM3LTUtMS0xLTMxNDIy_e43d22fd-1be4-403f-83ee-76fa4697e062"
      unitRef="usd">0</us-gaap:PaymentsToMinorityShareholders>
    <vtrs:PaymentsForNonContingentConsiderationForProductRightsFinancingActivities
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzM4LTEtMS0xLTMxNDIy_e8781326-5249-4cf2-92fd-fa42c2aacf2b"
      unitRef="usd">456000000.0</vtrs:PaymentsForNonContingentConsiderationForProductRightsFinancingActivities>
    <vtrs:PaymentsForNonContingentConsiderationForProductRightsFinancingActivities
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzM4LTMtMS0xLTMxNDIy_4e16b08b-0ac2-40e2-b7f8-4b3bdc44155e"
      unitRef="usd">143300000</vtrs:PaymentsForNonContingentConsiderationForProductRightsFinancingActivities>
    <vtrs:PaymentsForNonContingentConsiderationForProductRightsFinancingActivities
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzM4LTUtMS0xLTMxNDIy_dfc571c1-934c-481d-a1c4-0aa8f8df51f5"
      unitRef="usd">0</vtrs:PaymentsForNonContingentConsiderationForProductRightsFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzM5LTEtMS0xLTMxNDIy_7e29b21a-dd75-444d-88b3-f45ba58e53cc"
      unitRef="usd">-4900000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzM5LTMtMS0xLTMxNDIy_4db02086-3918-4f43-85e7-287e0ca8d337"
      unitRef="usd">-3300000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzM5LTUtMS0xLTMxNDIy_3ef5abde-36dc-41fe-98c6-74c3ecaeb5d6"
      unitRef="usd">-2500000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzQwLTEtMS0xLTMxNDIy_4bf47bcf-a914-45a8-8a15-794238f0a8a9"
      unitRef="usd">-3012000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzQwLTMtMS0xLTMxNDIy_41a435ff-5ae3-440b-bc18-4d6140b06c84"
      unitRef="usd">-605700000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzQwLTUtMS0xLTMxNDIy_75ac939c-fed9-4a80-9b6c-441fe8af379b"
      unitRef="usd">-1169000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzQxLTEtMS0xLTMxNDIy_2b266964-1635-4f35-a379-27ef70092895"
      unitRef="usd">-30900000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzQxLTMtMS0xLTMxNDIy_1ab1679b-5894-4075-bb2b-89e03ff16d56"
      unitRef="usd">33800000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzQxLTUtMS0xLTMxNDIy_d681cc47-817d-495d-a308-e0830a5386e2"
      unitRef="usd">-7500000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzQyLTEtMS0xLTMxNDIy_7b88a911-0b55-4434-b5ce-47810f9629b8"
      unitRef="usd">-143800000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzQyLTMtMS0xLTMxNDIy_ec553a6d-fa47-4948-b56c-520657711023"
      unitRef="usd">358800000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzQyLTUtMS0xLTMxNDIy_f3968f21-0a05-417e-9730-34b86e6198c3"
      unitRef="usd">101800000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzQzLTEtMS0xLTMxNDIy_59b59538-62d7-47ae-bc9f-5f77173edd00"
      unitRef="usd">850000000.0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iac503b6d629d4bafb262ea6ec0b8a25e_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzQzLTMtMS0xLTMxNDIy_e10049a2-3baf-4632-8ead-12c6a7ecdcbe"
      unitRef="usd">491100000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if8ec92ba24d848d697ba737aeed13c05_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzQzLTUtMS0xLTMxNDIy_634a0b0e-a6f2-4bf5-a620-d6cb28b870f4"
      unitRef="usd">389300000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzQ0LTEtMS0xLTMxNDIy_5e036a2b-d585-474f-bc5a-e0c597d6cc2a"
      unitRef="usd">706200000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzQ0LTMtMS0xLTMxNDIy_59b59538-62d7-47ae-bc9f-5f77173edd00"
      unitRef="usd">850000000.0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iac503b6d629d4bafb262ea6ec0b8a25e_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzQ0LTUtMS0xLTMxNDIy_80c682de-cad0-43b4-abaf-576e56af9442"
      unitRef="usd">491100000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzQ3LTEtMS0xLTMxNDIy_5c6dc49a-ef91-4dd3-a6bb-ed5df03b581c"
      unitRef="usd">0</us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1>
    <us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzQ3LTMtMS0xLTMxNDIy_75214f9d-4f96-45c1-98c4-ae9a03ff114f"
      unitRef="usd">10727500000</us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1>
    <us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzQ3LTUtMS0xLTMxNDIy_80276eff-c6f6-424b-a00d-ef1313f1d0da"
      unitRef="usd">0</us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1>
    <us-gaap:IncomeTaxesPaid
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzUwLTEtMS0xLTMxNDIy_ffaa55ac-4738-4981-ad86-fd4e1e6ad8f3"
      unitRef="usd">641700000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzUwLTMtMS0xLTMxNDIy_68e2e90c-de00-45ad-8c17-4543887421ba"
      unitRef="usd">324400000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzUwLTUtMS0xLTMxNDIy_3c154236-5b9c-4997-946c-fc3d149b1473"
      unitRef="usd">278600000</us-gaap:IncomeTaxesPaid>
    <us-gaap:InterestPaidNet
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzUxLTEtMS0xLTMxNDIy_171a3671-799c-42aa-a82e-10975ca68726"
      unitRef="usd">684800000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzUxLTMtMS0xLTMxNDIy_b8ef20e5-25ae-44a1-8399-db194d6831a3"
      unitRef="usd">555400000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNjYvZnJhZzo1MmM1NmIwZTFhMDA0MTdiOGVhNGNmMjg4NDhlMmYxMi90YWJsZTpkYWE2OTFiZGJkN2E0YThkYWQzMjZlOTEyYjRkMDFmYi90YWJsZXJhbmdlOmRhYTY5MWJkYmQ3YTRhOGRhZDMyNmU5MTJiNGQwMWZiXzUxLTUtMS0xLTMxNDIy_7cb47842-1715-4a03-b2c0-23042d940777"
      unitRef="usd">470600000</us-gaap:InterestPaidNet>
    <us-gaap:NatureOfOperations
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzIvZnJhZzoxZGRmNDEyZTE3NDQ0Zjg5OTVhYWI5NThlM2JhZTgzZC90ZXh0cmVnaW9uOjFkZGY0MTJlMTc0NDRmODk5NWFhYjk1OGUzYmFlODNkXzI1NDA_3e0e07d9-46fe-40eb-aee8-d7e857d27174">Nature of Operations&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Viatris is a global healthcare company formed in November 2020 whose mission is to empower people worldwide to live healthier at every stage of life, regardless of geography or circumstance. Improving the ability of patients to gain access to sustainable and high-quality healthcare is our relentless pursuit. One that rests on visionary thinking, determination and best-in-class capabilities that were strategically built to remove barriers across the health spectrum and advance access globally. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Viatris&#x2019; portfolio comprises more than 1,400 approved molecules across a wide range of key therapeutic areas, including globally recognized iconic and key brands, generics, complex generics, and biosimilars. The Company operates approximately 40 manufacturing sites worldwide that produce oral solid doses, injectables, complex dosage forms and APIs. We conduct our business through four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. Viatris is headquartered in the U.S., with global centers in Pittsburgh, Pennsylvania, Shanghai, China and Hyderabad, India.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ASC 805, Business Combinations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, Mylan is considered the accounting acquirer of the Upjohn Business and all historical financial information of the Company prior to November 16, 2020 represents Mylan&#x2019;s historical results and the Company&#x2019;s thereafter.&lt;/span&gt;&lt;/div&gt;</us-gaap:NatureOfOperations>
    <vtrs:NumberOfMolecules
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzIvZnJhZzoxZGRmNDEyZTE3NDQ0Zjg5OTVhYWI5NThlM2JhZTgzZC90ZXh0cmVnaW9uOjFkZGY0MTJlMTc0NDRmODk5NWFhYjk1OGUzYmFlODNkXzgzMA_ed0d64a9-505d-4810-9829-3276c851fa31"
      unitRef="molecule">1400</vtrs:NumberOfMolecules>
    <vtrs:NumberOfManufacturingSites
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzIvZnJhZzoxZGRmNDEyZTE3NDQ0Zjg5OTVhYWI5NThlM2JhZTgzZC90ZXh0cmVnaW9uOjFkZGY0MTJlMTc0NDRmODk5NWFhYjk1OGUzYmFlODNkXzEwMzM_1ec0279e-0f50-4cd5-ae52-e1e607e99e10"
      unitRef="site">40</vtrs:NumberOfManufacturingSites>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzMzNjMw_fc8156d3-ec94-4a62-a3a5-be81c07bea14">Summary of Significant Accounting Policies&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Principles of Consolidation.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;The consolidated financial statements include the accounts of Viatris and those of its wholly owned and majority-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. Investments in equity method affiliates are recorded at cost and adjusted for the Company&#x2019;s share of the affiliates&#x2019; cumulative results of operations, capital contributions and distributions.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates in the Preparation of Financial Statements.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;The preparation of financial statements, in conformity with U.S. GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Because of the uncertainty inherent in such estimates, actual results could differ from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currencies.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;The consolidated financial statements are presented in U.S.&#160;Dollars, the reporting currency of Viatris. Statements of Operations and Cash Flows of all of the Company&#x2019;s subsidiaries that have functional currencies other than U.S.&#160;Dollars are translated at a weighted average exchange rate for the period for inclusion in the consolidated statements of operations and cash flows, whereas assets and liabilities are translated at the end of the period exchange rates for inclusion in the consolidated balance sheets. Translation differences are recorded directly in shareholders&#x2019; equity as foreign currency translation adjustments. Gains or losses on transactions denominated in a currency other than the subsidiaries&#x2019; functional currency, which arise as a result of changes in foreign currency exchange rates, are recorded in the consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;Cash and cash equivalents are comprised of highly liquid investments with an original maturity of three months or less at the date of purchase.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Debt and Equity Securities.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;Debt securities classified as available-for-sale on the date of purchase are recorded at fair value, with net unrealized gains and losses, net of income taxes, reflected in accumulated other comprehensive loss as a component of shareholders&#x2019; equity. Net realized gains and losses on sales of available-for-sale debt securities are computed on a specific security basis and are included in other expense, net, in the consolidated statements of operations. Debt securities classified as trading securities are valued using the quoted market price from broker or dealer quotations or transparent pricing sources at the reporting date, with gains and losses included in other expense, net, in the consolidated statements of operations. Fair value is determined based on observable market quotes or valuation models using assessments of counterparty credit worthiness, credit risk or underlying security and overall capital market liquidity. Debt securities are reviewed for impairment by assessing if the decline in market value of the investment below the carrying value is other than temporary.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investments in equity securities with readily determinable fair values are recorded at fair value with changes in fair value recorded in other expense, net in the consolidated statements of operations. Investments in equity securities without readily determinable fair values are recorded at cost minus any impairment, plus or minus changes in their estimated fair value resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. Investments in entities are accounted for using the equity method of accounting when the ability to exercise significant influence over the operating and financial decisions of the investee is maintained. The share of net income or losses of equity method investments are included in other expense, net in the consolidated statements of operations. Investments in equity securities without readily determinable fair values and investments in equity accounted for using the equity method are assessed for potential impairment on a quarterly basis based on qualitative factors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentrations of Credit Risk.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;Financial instruments that potentially subject the Company to credit risk consist principally of interest-bearing investments, derivatives and accounts receivable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Viatris invests its excess cash in high-quality, liquid money market instruments, principally overnight deposits and highly rated money market funds. The Company maintains deposit balances at certain financial institutions in excess of federally insured amounts. Periodically, the Company reviews the creditworthiness of its counterparties to derivative transactions, and it does not expect to incur a loss from failure of any counterparties to perform under agreements it has with such counterparties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventories.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;Inventories are stated at the lower of cost and net realizable value, with cost principally determined by the weighted average cost method. Provisions for potentially obsolete or slow-moving inventory, including pre-launch inventory, are made based on our analysis of product dating, inventory levels, historical obsolescence and future sales forecasts. Included as a component of cost of sales is expense related to the net realizable value of inventories. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property, Plant and Equipment.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;Property, plant and equipment are stated at cost less accumulated depreciation. Depreciation is computed and recorded on a straight-line basis over the assets&#x2019; estimated service lives (3 to 18 years for machinery and equipment and other fixed assets and 15 to 39 years for buildings and improvements). Capitalized software is included in property, plant and equipment and is amortized over estimated useful lives ranging from 3 to 7 years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible Assets and Goodwill.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;Intangible assets are stated at cost less accumulated amortization. Amortization is generally recorded on a straight-line basis over estimated useful lives ranging from 3 to 20 years. The Company periodically reviews the estimated useful lives of intangible assets and makes adjustments when events indicate that a shorter life is appropriate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for acquired businesses using the acquisition method of accounting in accordance with the provisions of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ASC 805, Business Combinations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which requires that the assets acquired and liabilities assumed be recorded at the date of acquisition at their respective estimated fair values. The cost to acquire businesses is allocated to the underlying net assets of the acquired business based on estimates of their respective fair values. Amounts allocated to acquired IPR&amp;amp;D are capitalized at the date of acquisition and, at that time, such IPR&amp;amp;D assets have indefinite lives. As products in development are approved for sale, amounts are allocated to product rights and licenses and will be amortized over their estimated useful lives. Finite-lived intangible assets are amortized over the expected life of the asset. Any excess of the purchase price over the estimated fair values of the net assets acquired is recorded as goodwill.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Purchases of developed products and licenses that are accounted for as asset acquisitions are capitalized as intangible assets and amortized over an estimated useful life. IPR&amp;amp;D assets acquired as part of an asset acquisition are expensed immediately if they have no alternative future uses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviews goodwill for impairment at least annually or more frequently if events or changes in circumstances indicate that the carrying value of goodwill may not be recoverable based on management's assessment of the fair value of the Company's reporting units as compared to their related carrying value. Under the authoritative guidance issued by the FASB, we have the option to first assess the qualitative factors to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform a quantitative goodwill impairment test. If we choose to use qualitative factors and determine that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, then the goodwill impairment test would be required. The goodwill impairment test requires the Company to estimate the fair value of the reporting unit and to compare the fair value of the reporting unit with its carrying amount. If the carrying amount is less than its fair value, then no impairment is recognized. If the carrying amount recorded exceeds the fair value calculated, an impairment charge is recorded for the difference. The judgments made in determining the projected cash flows used to estimate the fair value can materially impact the Company&#x2019;s financial condition and results of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Indefinite-lived intangibles, principally IPR&amp;amp;D, are tested at least annually for impairment or upon the occurrence of a triggering event. The impairment test for IPR&amp;amp;D consists of a comparison of the asset&#x2019;s fair value with its carrying value. Impairment is determined to exist when the fair value of IPR&amp;amp;D assets, which is based upon updated forecasts and commercial development plans, is less than the carrying value of the assets being tested.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contingent Consideration.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Viatris records contingent consideration resulting from business acquisitions at its estimated fair value on the acquisition date. Each reporting period thereafter, the Company revalues these obligations and records increases or decreases in their fair value as adjustments to litigation settlements and other contingencies, net within the consolidated statements of operations. Changes in the fair value of the contingent consideration obligations can result from adjustments to the discount rates, payment periods and adjustments in the probability of achieving future development steps, regulatory approvals, market launches, sales targets and profitability. These fair value measurements represent Level 3 measurements as they are based on significant inputs not observable in the market. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant judgment is employed in determining the assumptions utilized as of the acquisition date and for each subsequent measurement period. Accordingly, changes in the assumptions described above could have a material impact on the Company&#x2019;s consolidated financial condition and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Impairment of Long-Lived Assets.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;The carrying values of long-lived assets, which include property, plant and equipment and intangible assets with finite lives, are evaluated periodically in relation to the expected future undiscounted cash flows of the underlying assets and monitored for other potential triggering events. The assessment for impairment is based on our ability to recover the carrying value of the long-lived assets or asset grouping by analyzing the expected future undiscounted pre-tax cash flows specific to the asset or asset grouping. If the carrying amount is greater than the undiscounted cash flows, the Company recognizes an impairment loss for the excess of the carrying amount over the estimated fair value based on discounted cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant management judgment is involved in estimating the recoverability of these assets and is dependent upon the accuracy of the assumptions used in making these estimates, as well as how the estimates compare to the eventual future operating performance of the specific asset or asset grouping. Any future long-lived assets impairment charges could have a material impact on the Company&#x2019;s consolidated financial condition and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Short-Term Borrowings.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;The Company&#x2019;s subsidiaries in India have working capital facilities with several banks which are secured by its current assets. The Company also has the CP Notes, Receivables Facility, which will expire in April 2022 and the Note Securitization Facility, which will expire in August 2022. Under the terms of each of the Receivables Facility and Note Securitization Facility, certain of our accounts receivable secure the amounts borrowed and cannot be used to pay our other debts or liabilities. As the accounts receivable do not transfer to the banks, any amounts outstanding under the facilities are recorded as borrowings and the underlying receivables continue to be included in accounts receivable, net, in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenues in accordance with ASC 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Under ASC 606, the Company recognizes net revenue for product sales when control of the promised goods or services is transferred to our customers in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. Revenues are recorded net of provisions for variable consideration, including discounts, rebates, governmental rebate programs, price adjustments, returns, chargebacks, promotional programs and other sales allowances. Accruals for these provisions are presented in the consolidated financial statements as reductions in determining net sales and as a contra asset in accounts receivable, net (if settled via credit) and other current liabilities (if paid in cash). Amounts recorded for revenue deductions can result from a complex series of judgements about future events and uncertainties and can rely heavily on estimates and assumptions. The following section briefly describes the nature of our provisions for variable consideration and how such provisions are estimated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Chargebacks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: the Company has agreements with certain indirect customers, such as independent pharmacies, retail pharmacy chains, managed care organizations, hospitals, nursing homes, governmental agencies and pharmacy benefit managers, which establish contract prices for certain products. The indirect customers then independently select a wholesaler from which to purchase the products at these contracted prices. Alternatively, certain wholesalers may enter into agreements with indirect customers that establish contract pricing for certain products, which the wholesalers provide. Under either arrangement, Viatris will provide credit to the wholesaler for any difference between the contracted price with the indirect party and the wholesaler&#x2019;s invoice price. Such credits are called chargebacks. The provision for chargebacks is based on expected sell-through levels by our wholesaler customers to indirect customers, as well as estimated wholesaler inventory levels.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Rebates, promotional programs and other sales allowances&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: this category includes rebate and other programs to assist in product sales. These programs generally provide that the customer receives credit directly related to the amount of purchases or credits upon the attainment of pre-established volumes. Also included in this category are prompt pay discounts, administrative fees and price adjustments to reflect decreases in the selling prices of products. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Returns&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: consistent with industry practice, Viatris maintains a return policy that allows customers to return a product, which varies country by country in accordance with local practices, generally within a specified period prior (six months) and subsequent (twelve months) to the expiration date. The Company&#x2019;s estimate of the provision for returns is generally based upon historical experience with actual returns. Generally, returned products are destroyed and customers are refunded the sales price in the form of a credit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Governmental rebate programs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: government reimbursement programs in the U.S. include Medicare, Medicaid, and State Pharmacy Assistance Programs established according to statute, regulations and policy. Manufacturers of pharmaceutical products that are covered by the Medicaid program are required to pay rebates to each state based on a statutory formula set forth in the Social Security Act. Medicare beneficiaries are eligible to obtain discounted prescription drug coverage from private sector providers. In addition, certain states have also implemented supplemental rebate programs that obligate manufacturers to pay rebates in excess of those required under federal law. Our estimate of these rebates is based on the historical trends of rebates paid as well as on changes in wholesaler inventory levels and increases or decreases in the level of sales. We estimate discounts on branded prescription drug sales to Medicare Part D participants in the Medicare &#x201c;coverage gap&#x201d; based on historical experience of prescriptions and utilization expected to result in the discount of the &#x201c;coverage gap&#x201d;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outside the U.S., the majority of our pharmaceutical sales are contractually or legislatively governed. In certain European countries, certain rebates are calculated on the governments total pharmaceutical spending or on specific product sale thresholds. We utilize historical data and obtain third party information to determine the adequacy of these accruals. Also, this provision includes price reductions that are mandated by law outside of the U.S. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our net sales may be impacted by wholesaler and distributor inventory levels of our products, which can fluctuate throughout the year due to the seasonality of certain products, pricing, the timing of product demand, purchasing decisions and other factors. Such fluctuations may impact the comparability of our net sales between periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Consideration received from licenses of intellectual property is recorded as other revenues. Royalty or profit share amounts, which are based on sales of licensed products or technology, are recorded when the customer&#x2019;s subsequent sales or usages occur. Such consideration is included in other revenues in the consolidated statements of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and Development.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;R&amp;amp;D expenses are charged to operations as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;Income taxes have been provided for using an asset and liability approach in which deferred income taxes reflect the tax consequences on future years of events that the Company has already recognized in the financial statements or tax returns. Changes in enacted tax rates or laws may result in adjustments to the recorded tax assets or liabilities in the period that the new tax law is enacted.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Earnings per Share.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;Basic earnings per share is computed by dividing net earnings attributable to holders of Viatris Inc. common stock by the weighted average number of shares outstanding during the period. Diluted earnings per share is computed by dividing net earnings attributable to holders of Viatris Inc. common stock by the weighted average number of shares outstanding during the period increased by the number of additional shares that would have been outstanding related to potentially dilutive securities or instruments, if the impact is dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic and diluted earnings per share attributable to Viatris Inc. are calculated as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Basic (loss) earnings attributable to Viatris Inc. common shareholders (numerator):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (loss) earnings attributable to Viatris Inc. common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,269.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(669.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares (denominator):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,208.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;515.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic (loss) earnings per share attributable to Viatris Inc. shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.05)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Diluted (loss) earnings attributable to Viatris Inc. common shareholders (numerator):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (loss) earnings attributable to Viatris Inc. common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,269.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(669.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares (denominator):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,208.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;515.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total dilutive shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,208.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted (loss) earnings per share attributable to Viatris Inc. shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.05)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average shares outstanding used in the computation of earnings per share for the year ended December 31, 2020 includes the effect of the 689.9 million shares issued for the closing of the Combination.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additional stock awards and restricted ordinary shares were outstanding during the years ended December&#160;31, 2021, 2020 and 2019 but were not included in the computation of diluted earnings per share for each respective period because the effect would be anti-dilutive. Excluded shares also include certain share-based compensation awards and restricted shares whose performance conditions had not been fully met. Such excluded shares and anti-dilutive awards represented 12.7 million, 10.3 million and 9.1 million shares for the years ended December&#160;31, 2021, 2020 and 2019, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company paid quarterly cash dividends of $0.11 per share on the Company&#x2019;s issued and outstanding common stock on June 16, 2021, September 16, 2021, and December 16, 2021. On January 4, 2022, the Company&#x2019;s Board of Directors declared a quarterly cash dividend of $0.12 per share on the Company&#x2019;s issued and outstanding common stock, which will be payable on March 16, 2022 to shareholders of record as of the close of business on February 24, 2022. The declaration and payment of future dividends to holders of the Company&#x2019;s common stock will be at the discretion of the Board of Directors, and will depend upon factors, including but not limited to, the Company&#x2019;s financial condition, earnings, capital requirements of its businesses, legal requirements, regulatory constraints, industry practice, and other factors that the Board of Directors deems relevant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 28, 2022, the Company announced that its Board of Directors had authorized a share repurchase program for the repurchase of up to $1.0 billion of the Company&#x2019;s shares of common stock. The Company has not yet repurchased any shares of common stock under the share repurchase program and the share repurchase program does not obligate the Company to acquire any particular amount of common stock. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-Based Compensation.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;The fair value of share-based compensation is recognized as expense in the consolidated statements of operations over the vesting period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Derivatives.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;From time to time the Company may enter into derivative financial instruments (mainly foreign currency exchange forward contracts, interest rate swaps and purchased equity call options) designed to: 1) hedge the cash flows resulting from existing assets and liabilities and transactions expected to be entered into over the next 24 months in currencies other than the functional currency, 2) hedge the variability in interest expense on floating rate debt, 3) hedge the fair value of fixed-rate notes, 4) hedge against changes in interest rates that could impact future debt issuances, 5) hedge cash or share payments required on conversion of issued convertible notes, 6) hedge a net investment in a foreign operation, or 7) economically hedge the foreign currency exposure associated with the purchase price of non-U.S. acquisitions. Derivatives are recognized as assets or liabilities in the consolidated balance sheets at their fair value. When the derivative instrument qualifies as a cash flow hedge, changes in the fair value are deferred through other comprehensive earnings. If a derivative instrument qualifies as a fair value hedge, the changes in the fair value, as well as the offsetting changes in the fair value of the hedged items, are generally included in interest expense. When such instruments do not qualify for hedge accounting the changes in fair value are recorded in the consolidated statements of operations within other expense, net. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial Instruments.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;The Company&#x2019;s financial instruments consist primarily of short-term and long-term debt, interest rate swaps, forward contracts and option contracts. The Company&#x2019;s financial instruments also include cash and cash equivalents as well as accounts and other receivables and accounts payable, the fair values of which approximate their carrying values. As a policy, the Company does not engage in speculative or leveraged transactions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company carries derivative instruments in the consolidated balance sheets at fair value, determined by reference to market data such as forward rates for currencies, implied volatilities, and interest rate swap yield curves. The accounting for changes in the fair value of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and, if so, the reason for holding&#160;it. In addition, the Company has designated certain long-term debt instruments as net investment hedges.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Adoption of New Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2020, the FASB issued Accounting Standards Update 2020-01, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Clarifying the Interactions Between Topic 321, Topic 323, and Topic 815 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASU 2020-01&#x201d;)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; which clarifies that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting for the purposes of applying the measurement alternative in accordance with Topic 321 immediately before applying or upon discontinuing the equity method. In addition, ASU 2020-01 states that for the purpose of applying paragraph 815-10-15-141(a) an entity should not consider whether, upon the settlement of the forward contract or exercise of the purchased option, individually or with existing investments, the underlying securities would be accounted for under the equity method in Topic 323 or the fair value option in accordance with the financial instruments guidance in Topic 825. The Company applied the provisions of ASU 2020-01 as of January 1, 2021. The adoption of this guidance did not have a material impact on the Company&#x2019;s consolidated financial statements and disclosures. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued Accounting Standards Update 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; which is intended to simplify the accounting for income taxes by eliminating certain exceptions and simplifying certain requirements under Topic 740. The Company applied the provisions of ASU 2019-12 on a prospective basis as of January 1, 2021. The adoption of this guidance did not have a material impact on the Company&#x2019;s consolidated financial statements and disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounting Standards Issued Not Yet Adopted&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued Accounting Standards Update 2020-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform on Financial Reporting &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASU 2020-04&#x201d;)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; which provides optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. ASU 2020-04 applies only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. Entities can apply the provisions of ASU 2020-04 immediately, as applicable, and generally the provisions of the guidance are available through December 31, 2022 as entities transition away from reference rates that are expected to be discontinued. The Company is currently assessing the impact of the adoption of this guidance on its consolidated financial statements and disclosures. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2021, the FASB issued Accounting Standards Update 2021-08, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASU 2021-08&#x201d;), which requires entities (acquirers) to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with ASC Topic 606. ASU 2021-08 will be effective for fiscal years, including interim periods within those fiscal years, beginning after December 15, 2022 with early adoption permitted. The Company is currently assessing the impact of the adoption of this guidance on its consolidated financial statements and disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2021, the FASB issued Accounting Standards Update 2021-10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASU 2021-10&#x201d;), which requires entities to provide annual disclosures about transactions with a government that are accounted for by applying a grant or contribution accounting model by analogy. ASU 2021-10 will be effective for fiscal years beginning after December 15, 2021 with early adoption permitted. The Company is currently assessing the impact of the adoption of this guidance on its disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzMzNTI2_02432d60-da06-4d99-a9a6-8ca675321074">Principles of Consolidation.&#160;The consolidated financial statements include the accounts of Viatris and those of its wholly owned and majority-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. Investments in equity method affiliates are recorded at cost and adjusted for the Company&#x2019;s share of the affiliates&#x2019; cumulative results of operations, capital contributions and distributions.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzMzNjMx_179527ff-8119-4ca4-8f61-b6206563e867">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates in the Preparation of Financial Statements.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;The preparation of financial statements, in conformity with U.S. GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Because of the uncertainty inherent in such estimates, actual results could differ from those estimates.&lt;/span&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzMzNjM5_dd87a94f-e212-4c86-9c3e-c3727e2d299b">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currencies.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;The consolidated financial statements are presented in U.S.&#160;Dollars, the reporting currency of Viatris. Statements of Operations and Cash Flows of all of the Company&#x2019;s subsidiaries that have functional currencies other than U.S.&#160;Dollars are translated at a weighted average exchange rate for the period for inclusion in the consolidated statements of operations and cash flows, whereas assets and liabilities are translated at the end of the period exchange rates for inclusion in the consolidated balance sheets. Translation differences are recorded directly in shareholders&#x2019; equity as foreign currency translation adjustments. Gains or losses on transactions denominated in a currency other than the subsidiaries&#x2019; functional currency, which arise as a result of changes in foreign currency exchange rates, are recorded in the consolidated statements of operations.&lt;/span&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzMzNTU4_ce486d88-2332-46a8-961c-332d8d4ab0bd">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;Cash and cash equivalents are comprised of highly liquid investments with an original maturity of three months or less at the date of purchase.&lt;/span&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:MarketableSecuritiesPolicy
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzMzNTk1_2260a856-aebc-47a0-b2c8-8146c1b2cf5c">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Debt and Equity Securities.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;Debt securities classified as available-for-sale on the date of purchase are recorded at fair value, with net unrealized gains and losses, net of income taxes, reflected in accumulated other comprehensive loss as a component of shareholders&#x2019; equity. Net realized gains and losses on sales of available-for-sale debt securities are computed on a specific security basis and are included in other expense, net, in the consolidated statements of operations. Debt securities classified as trading securities are valued using the quoted market price from broker or dealer quotations or transparent pricing sources at the reporting date, with gains and losses included in other expense, net, in the consolidated statements of operations. Fair value is determined based on observable market quotes or valuation models using assessments of counterparty credit worthiness, credit risk or underlying security and overall capital market liquidity. Debt securities are reviewed for impairment by assessing if the decline in market value of the investment below the carrying value is other than temporary.&lt;/span&gt;Investments in equity securities with readily determinable fair values are recorded at fair value with changes in fair value recorded in other expense, net in the consolidated statements of operations. Investments in equity securities without readily determinable fair values are recorded at cost minus any impairment, plus or minus changes in their estimated fair value resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. Investments in entities are accounted for using the equity method of accounting when the ability to exercise significant influence over the operating and financial decisions of the investee is maintained. The share of net income or losses of equity method investments are included in other expense, net in the consolidated statements of operations. Investments in equity securities without readily determinable fair values and investments in equity accounted for using the equity method are assessed for potential impairment on a quarterly basis based on qualitative factors.</us-gaap:MarketableSecuritiesPolicy>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzMzNTIy_2aa85eda-eda9-448b-8815-d38724dca41b">&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentrations of Credit Risk.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;Financial instruments that potentially subject the Company to credit risk consist principally of interest-bearing investments, derivatives and accounts receivable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Viatris invests its excess cash in high-quality, liquid money market instruments, principally overnight deposits and highly rated money market funds. The Company maintains deposit balances at certain financial institutions in excess of federally insured amounts. Periodically, the Company reviews the creditworthiness of its counterparties to derivative transactions, and it does not expect to incur a loss from failure of any counterparties to perform under agreements it has with such counterparties.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzMzNjA2_70a32e7b-466c-43f8-8a05-38d542f62b84">Inventories.&#160;Inventories are stated at the lower of cost and net realizable value, with cost principally determined by the weighted average cost method. Provisions for potentially obsolete or slow-moving inventory, including pre-launch inventory, are made based on our analysis of product dating, inventory levels, historical obsolescence and future sales forecasts. Included as a component of cost of sales is expense related to the net realizable value of inventories.</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzMzNTQ1_0644f8e8-5b3c-430b-b203-937ef95ad966">Property, Plant and Equipment.&#160;Property, plant and equipment are stated at cost less accumulated depreciation. Depreciation is computed and recorded on a straight-line basis over the assets&#x2019; estimated service lives (3 to 18 years for machinery and equipment and other fixed assets and 15 to 39 years for buildings and improvements). Capitalized software is included in property, plant and equipment and is amortized over estimated useful lives ranging from 3 to 7 years.</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i8c96921a8e77407497a3fe28076245b9_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzUzNzM_8d8b0d44-ab35-464f-9fbd-444c700ee548">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i982f994b896949038225ee2127e449b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzUzNzk_3ee9d6ec-6c04-4cbf-a7de-07534d463857">P18Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i17e28a6fde804fee9a50f41480db4409_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzU0Mzc_45eb0383-d534-49e6-9f74-daf01b55df58">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i2f9c5e0f0ba44c18819a8dd18e51076c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzU0NDM_24a2600f-f2c0-4cb6-a100-4fe1e210fc09">P39Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i33eb2ebb7c134785bb1904a27dee8446_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzU2MDM_c1a11fd0-7301-433c-ae3a-0bd973a7b94c">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i0ecc2d6f42a84a91b65e020dbcaad871_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzU2MDk_7ff96b0b-0907-4699-af86-7ba78b8c343d">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzMzNjcx_71428961-e430-47fc-a852-5858c33cba0d">&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible Assets and Goodwill.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;Intangible assets are stated at cost less accumulated amortization. Amortization is generally recorded on a straight-line basis over estimated useful lives ranging from 3 to 20 years. The Company periodically reviews the estimated useful lives of intangible assets and makes adjustments when events indicate that a shorter life is appropriate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for acquired businesses using the acquisition method of accounting in accordance with the provisions of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ASC 805, Business Combinations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which requires that the assets acquired and liabilities assumed be recorded at the date of acquisition at their respective estimated fair values. The cost to acquire businesses is allocated to the underlying net assets of the acquired business based on estimates of their respective fair values. Amounts allocated to acquired IPR&amp;amp;D are capitalized at the date of acquisition and, at that time, such IPR&amp;amp;D assets have indefinite lives. As products in development are approved for sale, amounts are allocated to product rights and licenses and will be amortized over their estimated useful lives. Finite-lived intangible assets are amortized over the expected life of the asset. Any excess of the purchase price over the estimated fair values of the net assets acquired is recorded as goodwill.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Purchases of developed products and licenses that are accounted for as asset acquisitions are capitalized as intangible assets and amortized over an estimated useful life. IPR&amp;amp;D assets acquired as part of an asset acquisition are expensed immediately if they have no alternative future uses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviews goodwill for impairment at least annually or more frequently if events or changes in circumstances indicate that the carrying value of goodwill may not be recoverable based on management's assessment of the fair value of the Company's reporting units as compared to their related carrying value. Under the authoritative guidance issued by the FASB, we have the option to first assess the qualitative factors to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform a quantitative goodwill impairment test. If we choose to use qualitative factors and determine that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, then the goodwill impairment test would be required. The goodwill impairment test requires the Company to estimate the fair value of the reporting unit and to compare the fair value of the reporting unit with its carrying amount. If the carrying amount is less than its fair value, then no impairment is recognized. If the carrying amount recorded exceeds the fair value calculated, an impairment charge is recorded for the difference. The judgments made in determining the projected cash flows used to estimate the fair value can materially impact the Company&#x2019;s financial condition and results of operations. &lt;/span&gt;&lt;/div&gt;Indefinite-lived intangibles, principally IPR&amp;amp;D, are tested at least annually for impairment or upon the occurrence of a triggering event. The impairment test for IPR&amp;amp;D consists of a comparison of the asset&#x2019;s fair value with its carrying value. Impairment is determined to exist when the fair value of IPR&amp;amp;D assets, which is based upon updated forecasts and commercial development plans, is less than the carrying value of the assets being tested.</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i84ab0bd68a334690be79969b61dd4796_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzU4MTU_cebe7f78-c79c-4f53-9607-44e57ff0d59e">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i500214b091fd4491a3e5f7c09d556da9_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzU4MjE_23b66a8d-8d56-4bb0-9107-73b8b7e54b7c">P20Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:BusinessCombinationsPolicy
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzMzNTQ3_03d4fdd3-eb32-4e72-850d-c250010804e5">&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contingent Consideration.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Viatris records contingent consideration resulting from business acquisitions at its estimated fair value on the acquisition date. Each reporting period thereafter, the Company revalues these obligations and records increases or decreases in their fair value as adjustments to litigation settlements and other contingencies, net within the consolidated statements of operations. Changes in the fair value of the contingent consideration obligations can result from adjustments to the discount rates, payment periods and adjustments in the probability of achieving future development steps, regulatory approvals, market launches, sales targets and profitability. These fair value measurements represent Level 3 measurements as they are based on significant inputs not observable in the market. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant judgment is employed in determining the assumptions utilized as of the acquisition date and for each subsequent measurement period. Accordingly, changes in the assumptions described above could have a material impact on the Company&#x2019;s consolidated financial condition and results of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzMzNTQy_1fd38058-d4bf-4e65-ab14-f4741d0fc6ff">&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Impairment of Long-Lived Assets.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;The carrying values of long-lived assets, which include property, plant and equipment and intangible assets with finite lives, are evaluated periodically in relation to the expected future undiscounted cash flows of the underlying assets and monitored for other potential triggering events. The assessment for impairment is based on our ability to recover the carrying value of the long-lived assets or asset grouping by analyzing the expected future undiscounted pre-tax cash flows specific to the asset or asset grouping. If the carrying amount is greater than the undiscounted cash flows, the Company recognizes an impairment loss for the excess of the carrying amount over the estimated fair value based on discounted cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant management judgment is involved in estimating the recoverability of these assets and is dependent upon the accuracy of the assumptions used in making these estimates, as well as how the estimates compare to the eventual future operating performance of the specific asset or asset grouping. Any future long-lived assets impairment charges could have a material impact on the Company&#x2019;s consolidated financial condition and results of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:DebtPolicyTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzMzNjU3_52c788a9-d704-4584-9397-83b94652b84f">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Short-Term Borrowings.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;The Company&#x2019;s subsidiaries in India have working capital facilities with several banks which are secured by its current assets. The Company also has the CP Notes, Receivables Facility, which will expire in April 2022 and the Note Securitization Facility, which will expire in August 2022. Under the terms of each of the Receivables Facility and Note Securitization Facility, certain of our accounts receivable secure the amounts borrowed and cannot be used to pay our other debts or liabilities. As the accounts receivable do not transfer to the banks, any amounts outstanding under the facilities are recorded as borrowings and the underlying receivables continue to be included in accounts receivable, net, in the consolidated balance sheets.&lt;/span&gt;</us-gaap:DebtPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzMzNzA3_7827473b-ca13-4390-b4ba-1630190160d7">&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenues in accordance with ASC 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Under ASC 606, the Company recognizes net revenue for product sales when control of the promised goods or services is transferred to our customers in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. Revenues are recorded net of provisions for variable consideration, including discounts, rebates, governmental rebate programs, price adjustments, returns, chargebacks, promotional programs and other sales allowances. Accruals for these provisions are presented in the consolidated financial statements as reductions in determining net sales and as a contra asset in accounts receivable, net (if settled via credit) and other current liabilities (if paid in cash). Amounts recorded for revenue deductions can result from a complex series of judgements about future events and uncertainties and can rely heavily on estimates and assumptions. The following section briefly describes the nature of our provisions for variable consideration and how such provisions are estimated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Chargebacks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: the Company has agreements with certain indirect customers, such as independent pharmacies, retail pharmacy chains, managed care organizations, hospitals, nursing homes, governmental agencies and pharmacy benefit managers, which establish contract prices for certain products. The indirect customers then independently select a wholesaler from which to purchase the products at these contracted prices. Alternatively, certain wholesalers may enter into agreements with indirect customers that establish contract pricing for certain products, which the wholesalers provide. Under either arrangement, Viatris will provide credit to the wholesaler for any difference between the contracted price with the indirect party and the wholesaler&#x2019;s invoice price. Such credits are called chargebacks. The provision for chargebacks is based on expected sell-through levels by our wholesaler customers to indirect customers, as well as estimated wholesaler inventory levels.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Rebates, promotional programs and other sales allowances&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: this category includes rebate and other programs to assist in product sales. These programs generally provide that the customer receives credit directly related to the amount of purchases or credits upon the attainment of pre-established volumes. Also included in this category are prompt pay discounts, administrative fees and price adjustments to reflect decreases in the selling prices of products. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Returns&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: consistent with industry practice, Viatris maintains a return policy that allows customers to return a product, which varies country by country in accordance with local practices, generally within a specified period prior (six months) and subsequent (twelve months) to the expiration date. The Company&#x2019;s estimate of the provision for returns is generally based upon historical experience with actual returns. Generally, returned products are destroyed and customers are refunded the sales price in the form of a credit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Governmental rebate programs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: government reimbursement programs in the U.S. include Medicare, Medicaid, and State Pharmacy Assistance Programs established according to statute, regulations and policy. Manufacturers of pharmaceutical products that are covered by the Medicaid program are required to pay rebates to each state based on a statutory formula set forth in the Social Security Act. Medicare beneficiaries are eligible to obtain discounted prescription drug coverage from private sector providers. In addition, certain states have also implemented supplemental rebate programs that obligate manufacturers to pay rebates in excess of those required under federal law. Our estimate of these rebates is based on the historical trends of rebates paid as well as on changes in wholesaler inventory levels and increases or decreases in the level of sales. We estimate discounts on branded prescription drug sales to Medicare Part D participants in the Medicare &#x201c;coverage gap&#x201d; based on historical experience of prescriptions and utilization expected to result in the discount of the &#x201c;coverage gap&#x201d;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outside the U.S., the majority of our pharmaceutical sales are contractually or legislatively governed. In certain European countries, certain rebates are calculated on the governments total pharmaceutical spending or on specific product sale thresholds. We utilize historical data and obtain third party information to determine the adequacy of these accruals. Also, this provision includes price reductions that are mandated by law outside of the U.S. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our net sales may be impacted by wholesaler and distributor inventory levels of our products, which can fluctuate throughout the year due to the seasonality of certain products, pricing, the timing of product demand, purchasing decisions and other factors. Such fluctuations may impact the comparability of our net sales between periods.&lt;/span&gt;&lt;/div&gt;Consideration received from licenses of intellectual property is recorded as other revenues. Royalty or profit share amounts, which are based on sales of licensed products or technology, are recorded when the customer&#x2019;s subsequent sales or usages occur. Such consideration is included in other revenues in the consolidated statements of operations.</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzMzNTI0_b3eb24b6-0ed2-4fcf-9843-690dd865de53">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and Development.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;R&amp;amp;D expenses are charged to operations as incurred.&lt;/span&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzMzNjkz_c97371c6-fca7-46cf-a020-a3975f85b8a4">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;Income taxes have been provided for using an asset and liability approach in which deferred income taxes reflect the tax consequences on future years of events that the Company has already recognized in the financial statements or tax returns. Changes in enacted tax rates or laws may result in adjustments to the recorded tax assets or liabilities in the period that the new tax law is enacted.&lt;/span&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzMzNTUy_3c9eb375-a007-49e7-a4e8-a6590182fb7e">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Earnings per Share.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;Basic earnings per share is computed by dividing net earnings attributable to holders of Viatris Inc. common stock by the weighted average number of shares outstanding during the period. Diluted earnings per share is computed by dividing net earnings attributable to holders of Viatris Inc. common stock by the weighted average number of shares outstanding during the period increased by the number of additional shares that would have been outstanding related to potentially dilutive securities or instruments, if the impact is dilutive.&lt;/span&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic and diluted earnings per share attributable to Viatris Inc. are calculated as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Basic (loss) earnings attributable to Viatris Inc. common shareholders (numerator):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (loss) earnings attributable to Viatris Inc. common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,269.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(669.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares (denominator):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,208.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;515.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic (loss) earnings per share attributable to Viatris Inc. shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.05)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Diluted (loss) earnings attributable to Viatris Inc. common shareholders (numerator):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (loss) earnings attributable to Viatris Inc. common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,269.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(669.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares (denominator):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,208.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;515.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total dilutive shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,208.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted (loss) earnings per share attributable to Viatris Inc. shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.05)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average shares outstanding used in the computation of earnings per share for the year ended December 31, 2020 includes the effect of the 689.9 million shares issued for the closing of the Combination.&lt;/span&gt;&lt;/div&gt;Additional stock awards and restricted ordinary shares were outstanding during the years ended December&#160;31, 2021, 2020 and 2019 but were not included in the computation of diluted earnings per share for each respective period because the effect would be anti-dilutive. Excluded shares also include certain share-based compensation awards and restricted shares whose performance conditions had not been fully met. Such excluded shares and anti-dilutive awards represented 12.7 million, 10.3 million and 9.1 million shares for the years ended December&#160;31, 2021, 2020 and 2019, respectively</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzMzNjEx_deefdf92-5ff3-4b90-9af9-dd70e78ab632">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic and diluted earnings per share attributable to Viatris Inc. are calculated as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Basic (loss) earnings attributable to Viatris Inc. common shareholders (numerator):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (loss) earnings attributable to Viatris Inc. common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,269.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(669.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares (denominator):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,208.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;515.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic (loss) earnings per share attributable to Viatris Inc. shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.05)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Diluted (loss) earnings attributable to Viatris Inc. common shareholders (numerator):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (loss) earnings attributable to Viatris Inc. common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,269.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(669.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares (denominator):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,208.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;515.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total dilutive shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,208.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted (loss) earnings per share attributable to Viatris Inc. shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.05)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:ProfitLoss
      contextRef="i14dba6c874d24fcfae05dbedf70952aa_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90YWJsZTo4M2E5YTM0ZTcyYzA0NzU2YjNkMGQ2OGQ2NmMzMDg1Zi90YWJsZXJhbmdlOjgzYTlhMzRlNzJjMDQ3NTZiM2QwZDY4ZDY2YzMwODVmXzMtMS0xLTEtMzE0MjI_2de4079b-7e4b-412f-ae17-b4df2b272175"
      unitRef="usd">-1269100000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="idc41db043d3e4f84b4c531fda801f18c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90YWJsZTo4M2E5YTM0ZTcyYzA0NzU2YjNkMGQ2OGQ2NmMzMDg1Zi90YWJsZXJhbmdlOjgzYTlhMzRlNzJjMDQ3NTZiM2QwZDY4ZDY2YzMwODVmXzMtMy0xLTEtMzE0MjI_ccc00b2a-1344-4a84-ba86-c515c64b09c1"
      unitRef="usd">-669900000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i4f90527bae0344d981ff43fd2126b229_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90YWJsZTo4M2E5YTM0ZTcyYzA0NzU2YjNkMGQ2OGQ2NmMzMDg1Zi90YWJsZXJhbmdlOjgzYTlhMzRlNzJjMDQ3NTZiM2QwZDY4ZDY2YzMwODVmXzMtNS0xLTEtMzE0MjI_a9e0d3cf-5152-4f9a-bfa4-cab43ab20e7a"
      unitRef="usd">16800000</us-gaap:ProfitLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90YWJsZTo4M2E5YTM0ZTcyYzA0NzU2YjNkMGQ2OGQ2NmMzMDg1Zi90YWJsZXJhbmdlOjgzYTlhMzRlNzJjMDQ3NTZiM2QwZDY4ZDY2YzMwODVmXzUtMS0xLTEtMzE0MjI_8ef8d9a4-49c3-4abd-a284-236ef377f112"
      unitRef="shares">1208800000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90YWJsZTo4M2E5YTM0ZTcyYzA0NzU2YjNkMGQ2OGQ2NmMzMDg1Zi90YWJsZXJhbmdlOjgzYTlhMzRlNzJjMDQ3NTZiM2QwZDY4ZDY2YzMwODVmXzUtMy0xLTEtMzE0MjI_c5bdb6eb-0912-432b-adee-c98b880cf10f"
      unitRef="shares">601200000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90YWJsZTo4M2E5YTM0ZTcyYzA0NzU2YjNkMGQ2OGQ2NmMzMDg1Zi90YWJsZXJhbmdlOjgzYTlhMzRlNzJjMDQ3NTZiM2QwZDY4ZDY2YzMwODVmXzUtNS0xLTEtMzE0MjI_d286c930-1552-4da4-8348-235f7f5c1cba"
      unitRef="shares">515700000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90YWJsZTo4M2E5YTM0ZTcyYzA0NzU2YjNkMGQ2OGQ2NmMzMDg1Zi90YWJsZXJhbmdlOjgzYTlhMzRlNzJjMDQ3NTZiM2QwZDY4ZDY2YzMwODVmXzYtMS0xLTEtMzE0MjI_83a56312-efc8-4c7c-8992-c89fc01be0f6"
      unitRef="usdPerShare">-1.05</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90YWJsZTo4M2E5YTM0ZTcyYzA0NzU2YjNkMGQ2OGQ2NmMzMDg1Zi90YWJsZXJhbmdlOjgzYTlhMzRlNzJjMDQ3NTZiM2QwZDY4ZDY2YzMwODVmXzYtMy0xLTEtMzE0MjI_c5ddd91b-63c8-4bc7-81fc-322dc5e7ac2b"
      unitRef="usdPerShare">-1.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90YWJsZTo4M2E5YTM0ZTcyYzA0NzU2YjNkMGQ2OGQ2NmMzMDg1Zi90YWJsZXJhbmdlOjgzYTlhMzRlNzJjMDQ3NTZiM2QwZDY4ZDY2YzMwODVmXzYtNS0xLTEtMzE0MjI_a2850713-93e3-41e4-bb99-8401a21f7a65"
      unitRef="usdPerShare">0.03</us-gaap:EarningsPerShareBasic>
    <us-gaap:ProfitLoss
      contextRef="i14dba6c874d24fcfae05dbedf70952aa_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90YWJsZTo4M2E5YTM0ZTcyYzA0NzU2YjNkMGQ2OGQ2NmMzMDg1Zi90YWJsZXJhbmdlOjgzYTlhMzRlNzJjMDQ3NTZiM2QwZDY4ZDY2YzMwODVmXzktMS0xLTEtMzE0MjI_2de4079b-7e4b-412f-ae17-b4df2b272175"
      unitRef="usd">-1269100000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="idc41db043d3e4f84b4c531fda801f18c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90YWJsZTo4M2E5YTM0ZTcyYzA0NzU2YjNkMGQ2OGQ2NmMzMDg1Zi90YWJsZXJhbmdlOjgzYTlhMzRlNzJjMDQ3NTZiM2QwZDY4ZDY2YzMwODVmXzktMy0xLTEtMzE0MjI_ccc00b2a-1344-4a84-ba86-c515c64b09c1"
      unitRef="usd">-669900000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i4f90527bae0344d981ff43fd2126b229_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90YWJsZTo4M2E5YTM0ZTcyYzA0NzU2YjNkMGQ2OGQ2NmMzMDg1Zi90YWJsZXJhbmdlOjgzYTlhMzRlNzJjMDQ3NTZiM2QwZDY4ZDY2YzMwODVmXzktNS0xLTEtMzE0MjI_a9e0d3cf-5152-4f9a-bfa4-cab43ab20e7a"
      unitRef="usd">16800000</us-gaap:ProfitLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90YWJsZTo4M2E5YTM0ZTcyYzA0NzU2YjNkMGQ2OGQ2NmMzMDg1Zi90YWJsZXJhbmdlOjgzYTlhMzRlNzJjMDQ3NTZiM2QwZDY4ZDY2YzMwODVmXzExLTEtMS0xLTMxNDIy_8ef8d9a4-49c3-4abd-a284-236ef377f112"
      unitRef="shares">1208800000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90YWJsZTo4M2E5YTM0ZTcyYzA0NzU2YjNkMGQ2OGQ2NmMzMDg1Zi90YWJsZXJhbmdlOjgzYTlhMzRlNzJjMDQ3NTZiM2QwZDY4ZDY2YzMwODVmXzExLTMtMS0xLTMxNDIy_c5bdb6eb-0912-432b-adee-c98b880cf10f"
      unitRef="shares">601200000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90YWJsZTo4M2E5YTM0ZTcyYzA0NzU2YjNkMGQ2OGQ2NmMzMDg1Zi90YWJsZXJhbmdlOjgzYTlhMzRlNzJjMDQ3NTZiM2QwZDY4ZDY2YzMwODVmXzExLTUtMS0xLTMxNDIy_d286c930-1552-4da4-8348-235f7f5c1cba"
      unitRef="shares">515700000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90YWJsZTo4M2E5YTM0ZTcyYzA0NzU2YjNkMGQ2OGQ2NmMzMDg1Zi90YWJsZXJhbmdlOjgzYTlhMzRlNzJjMDQ3NTZiM2QwZDY4ZDY2YzMwODVmXzEyLTEtMS0xLTMxNDIy_673e2cfa-aae9-4d47-8301-316fe053cc08"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90YWJsZTo4M2E5YTM0ZTcyYzA0NzU2YjNkMGQ2OGQ2NmMzMDg1Zi90YWJsZXJhbmdlOjgzYTlhMzRlNzJjMDQ3NTZiM2QwZDY4ZDY2YzMwODVmXzEyLTMtMS0xLTMxNDIy_708f9fc7-fcee-4343-8143-7ef82a8f88fa"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90YWJsZTo4M2E5YTM0ZTcyYzA0NzU2YjNkMGQ2OGQ2NmMzMDg1Zi90YWJsZXJhbmdlOjgzYTlhMzRlNzJjMDQ3NTZiM2QwZDY4ZDY2YzMwODVmXzEyLTUtMS0xLTMxNDIy_ffa34af3-9e7c-48f5-b93a-a195037f3839"
      unitRef="shares">800000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90YWJsZTo4M2E5YTM0ZTcyYzA0NzU2YjNkMGQ2OGQ2NmMzMDg1Zi90YWJsZXJhbmdlOjgzYTlhMzRlNzJjMDQ3NTZiM2QwZDY4ZDY2YzMwODVmXzEzLTEtMS0xLTMxNDIy_3178fee6-4548-4899-8968-113aa36003f6"
      unitRef="shares">1208800000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90YWJsZTo4M2E5YTM0ZTcyYzA0NzU2YjNkMGQ2OGQ2NmMzMDg1Zi90YWJsZXJhbmdlOjgzYTlhMzRlNzJjMDQ3NTZiM2QwZDY4ZDY2YzMwODVmXzEzLTMtMS0xLTMxNDIy_859e6723-314f-4b73-a244-f3df085c4e22"
      unitRef="shares">601200000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90YWJsZTo4M2E5YTM0ZTcyYzA0NzU2YjNkMGQ2OGQ2NmMzMDg1Zi90YWJsZXJhbmdlOjgzYTlhMzRlNzJjMDQ3NTZiM2QwZDY4ZDY2YzMwODVmXzEzLTUtMS0xLTMxNDIy_9d746273-3e48-4f4d-b888-89d70754042d"
      unitRef="shares">516500000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90YWJsZTo4M2E5YTM0ZTcyYzA0NzU2YjNkMGQ2OGQ2NmMzMDg1Zi90YWJsZXJhbmdlOjgzYTlhMzRlNzJjMDQ3NTZiM2QwZDY4ZDY2YzMwODVmXzE0LTEtMS0xLTMxNDIy_dc094c6e-593d-4700-8f8f-bf19abe72cba"
      unitRef="usdPerShare">-1.05</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90YWJsZTo4M2E5YTM0ZTcyYzA0NzU2YjNkMGQ2OGQ2NmMzMDg1Zi90YWJsZXJhbmdlOjgzYTlhMzRlNzJjMDQ3NTZiM2QwZDY4ZDY2YzMwODVmXzE0LTMtMS0xLTMxNDIy_a9e78228-852b-4b03-974a-87f5df89e659"
      unitRef="usdPerShare">-1.11</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90YWJsZTo4M2E5YTM0ZTcyYzA0NzU2YjNkMGQ2OGQ2NmMzMDg1Zi90YWJsZXJhbmdlOjgzYTlhMzRlNzJjMDQ3NTZiM2QwZDY4ZDY2YzMwODVmXzE0LTUtMS0xLTMxNDIy_d9bd64aa-f57a-40db-bf31-bffd7d9f9166"
      unitRef="usdPerShare">0.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzE5NTky_b16fe42c-332c-4114-adad-b22088ad7b54"
      unitRef="shares">12700000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzE5NTk2_bc1c807f-7a52-42db-a507-4426bed98c2b"
      unitRef="shares">10300000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzE5NjAz_1f6b4246-d19d-4706-a853-520460d2897a"
      unitRef="shares">9100000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="i52196ab9082e4abaa0b8161e828c13e6_D20211216-20211216"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzU0OTc1NTgyMDI2NDY_6b27730b-9e60-4dd8-b27a-cef3af68e83c"
      unitRef="usdPerShare">0.11</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="i0914e4cffd32443cb84e261c6290c882_D20210616-20210616"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzU0OTc1NTgyMDI2NDY_e369b560-9b2d-4220-b910-556d9921560f"
      unitRef="usdPerShare">0.11</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="i49c23bc660594338939e7cd39689f85c_D20210916-20210916"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzU0OTc1NTgyMDI2NDY_f4fc6cad-986a-4d43-aa14-5c0b178c0851"
      unitRef="usdPerShare">0.11</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i85acd539c52b4ddd8dbb4b2c90aedaa6_D20220106-20220106"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzU0OTc1NTgyMDI2NTM_4e733960-1317-41ca-bbc5-9acaf8e2f186"
      unitRef="usdPerShare">0.12</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="id1b5d3649e684795b5f4c627d6ba66fa_I20220316"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzU0OTc1NTgyMDI2NTM_7540c336-b1f1-4c9d-bd75-22ee1a1e9c2d"
      unitRef="usdPerShare">0.12</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="ia473d9dc16fb4846abacc46ab07e5dd4_I20220228"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzE2NDkyNjc1MDcyMjM_c64d2072-4ba3-421b-a88f-76cf63e0e01a"
      unitRef="usd">1000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzMzNjkw_3e923945-d13f-4074-b699-e06de4d66608">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-Based Compensation.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;The fair value of share-based compensation is recognized as expense in the consolidated statements of operations over the vesting period.&lt;/span&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzMzNjU4_12067134-da9e-456a-b4d6-b6525f1c67ec">Derivatives.&#160;From time to time the Company may enter into derivative financial instruments (mainly foreign currency exchange forward contracts, interest rate swaps and purchased equity call options) designed to: 1) hedge the cash flows resulting from existing assets and liabilities and transactions expected to be entered into over the next 24 months in currencies other than the functional currency, 2) hedge the variability in interest expense on floating rate debt, 3) hedge the fair value of fixed-rate notes, 4) hedge against changes in interest rates that could impact future debt issuances, 5) hedge cash or share payments required on conversion of issued convertible notes, 6) hedge a net investment in a foreign operation, or 7) economically hedge the foreign currency exposure associated with the purchase price of non-U.S. acquisitions. Derivatives are recognized as assets or liabilities in the consolidated balance sheets at their fair value. When the derivative instrument qualifies as a cash flow hedge, changes in the fair value are deferred through other comprehensive earnings. If a derivative instrument qualifies as a fair value hedge, the changes in the fair value, as well as the offsetting changes in the fair value of the hedged items, are generally included in interest expense. When such instruments do not qualify for hedge accounting the changes in fair value are recorded in the consolidated statements of operations within other expense, net</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzMzNjkx_0348997c-5f77-455e-8136-6923e30d2af6">&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial Instruments.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;The Company&#x2019;s financial instruments consist primarily of short-term and long-term debt, interest rate swaps, forward contracts and option contracts. The Company&#x2019;s financial instruments also include cash and cash equivalents as well as accounts and other receivables and accounts payable, the fair values of which approximate their carrying values. As a policy, the Company does not engage in speculative or leveraged transactions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company carries derivative instruments in the consolidated balance sheets at fair value, determined by reference to market data such as forward rates for currencies, implied volatilities, and interest rate swap yield curves. The accounting for changes in the fair value of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and, if so, the reason for holding&#160;it. In addition, the Company has designated certain long-term debt instruments as net investment hedges.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is based on the price that would be received from the sale of an identical asset or paid to transfer an identical liability in an orderly transaction between market participants at the measurement date. In order to increase consistency and comparability in fair value measurements, a fair value hierarchy has been established that prioritizes observable and unobservable inputs used to measure fair value into three broad levels, which are described below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:81pt;text-indent:-45pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level&#160;1:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities. The fair value hierarchy gives the highest priority to Level&#160;1 inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:81pt;text-indent:-45pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level&#160;2:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Observable market-based inputs other than quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level&#160;3:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level&#160;3 inputs.&lt;/span&gt;In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible, as well as considers counterparty credit risk in its assessment of fair value</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzUvZnJhZzphYzI0ODU4Yzk0MGE0N2RlOWZkZjJlNzg1MTExMjkzOC90ZXh0cmVnaW9uOmFjMjQ4NThjOTQwYTQ3ZGU5ZmRmMmU3ODUxMTEyOTM4XzMzNTc2_ed5b99fd-4dc6-4665-991c-1700a27f8748">&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Adoption of New Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2020, the FASB issued Accounting Standards Update 2020-01, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Clarifying the Interactions Between Topic 321, Topic 323, and Topic 815 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASU 2020-01&#x201d;)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; which clarifies that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting for the purposes of applying the measurement alternative in accordance with Topic 321 immediately before applying or upon discontinuing the equity method. In addition, ASU 2020-01 states that for the purpose of applying paragraph 815-10-15-141(a) an entity should not consider whether, upon the settlement of the forward contract or exercise of the purchased option, individually or with existing investments, the underlying securities would be accounted for under the equity method in Topic 323 or the fair value option in accordance with the financial instruments guidance in Topic 825. The Company applied the provisions of ASU 2020-01 as of January 1, 2021. The adoption of this guidance did not have a material impact on the Company&#x2019;s consolidated financial statements and disclosures. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued Accounting Standards Update 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; which is intended to simplify the accounting for income taxes by eliminating certain exceptions and simplifying certain requirements under Topic 740. The Company applied the provisions of ASU 2019-12 on a prospective basis as of January 1, 2021. The adoption of this guidance did not have a material impact on the Company&#x2019;s consolidated financial statements and disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounting Standards Issued Not Yet Adopted&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued Accounting Standards Update 2020-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform on Financial Reporting &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASU 2020-04&#x201d;)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; which provides optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. ASU 2020-04 applies only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. Entities can apply the provisions of ASU 2020-04 immediately, as applicable, and generally the provisions of the guidance are available through December 31, 2022 as entities transition away from reference rates that are expected to be discontinued. The Company is currently assessing the impact of the adoption of this guidance on its consolidated financial statements and disclosures. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2021, the FASB issued Accounting Standards Update 2021-08, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASU 2021-08&#x201d;), which requires entities (acquirers) to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with ASC Topic 606. ASU 2021-08 will be effective for fiscal years, including interim periods within those fiscal years, beginning after December 15, 2022 with early adoption permitted. The Company is currently assessing the impact of the adoption of this guidance on its consolidated financial statements and disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2021, the FASB issued Accounting Standards Update 2021-10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASU 2021-10&#x201d;), which requires entities to provide annual disclosures about transactions with a government that are accounted for by applying a grant or contribution accounting model by analogy. ASU 2021-10 will be effective for fiscal years beginning after December 15, 2021 with early adoption permitted. The Company is currently assessing the impact of the adoption of this guidance on its disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90ZXh0cmVnaW9uOjkyYTgzOGNmNmU1NDRiMTZhOWU5YjgyZjAwNmQ2MjMwXzEyMzU_aa74d83d-3f9a-47b4-9f9f-026fc56a9b1d">Revenue Recognition and Accounts Receivable&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the Company&#x2019;s net sales by product category for each of our reportable segments for the years ended December&#160;31, 2021, 2020, and 2019, respectively:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021 Net Sales&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Product Category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Developed Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Greater China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;JANZ&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Brands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,759.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,207.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,197.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,677.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,841.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Complex Gx and Biosimilars&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,241.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,342.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Generics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,427.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;783.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,413.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,630.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Viatris&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,428.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,212.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,027.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,144.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,813.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020 Net Sales&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Product Category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Developed Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Greater China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;JANZ&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Brands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,920.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;617.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;443.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,234.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Complex Gx and Biosimilars&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,202.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,295.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Generics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,387.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;535.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,361.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,289.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Viatris&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,510.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,195.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,853.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,819.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.191%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.684%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019 Net Sales&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Product Category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Developed Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Greater China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;JANZ&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Brands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,199.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;422.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,362.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Complex Gx and Biosimilars&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,127.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,211.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Generics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,913.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;635.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,241.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,796.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Viatris&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,240.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,192.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,723.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,370.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents net sales on a consolidated basis for select key products for the year ended December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:83.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.106%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Select Key Global Products&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lipitor &#xae;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,663.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Norvasc &#xae;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;824.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lyrica &#xae;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;728.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Viagra &#xae;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EpiPen&#xae; Auto-Injectors&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;391.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Celebrex &#xae;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;344.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effexor &#xae;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Creon &#xae;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Zoloft &#xae;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Xalabrands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Select Key Segment Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Influvac &#xae;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amitiza &#xae;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Xanax &#xae;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dymista &#xae;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Yupelri &#xae;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;____________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.8pt"&gt;The Company does not disclose net sales for any products considered competitively sensitive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;Products disclosed may change in future periods, including as a result of seasonality, competition or new product launches.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.8pt"&gt;Prior periods are not presented due to significance of products acquired as part of the Combination.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Variable Consideration and Accounts Receivable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents a reconciliation of gross sales to net sales by each significant category of variable consideration during the years ended December&#160;31, 2021, 2020 and 2019, respectively:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.887%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,553.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,899.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,012.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross to net adjustments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Chargebacks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,530.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,656.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,309.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rebates, promotional programs and other sales allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,135.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,765.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,629.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Returns&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(384.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(329.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(237.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Governmental rebate programs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(689.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(327.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(465.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total gross to net adjustments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,739.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,079.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,641.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,813.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,819.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,370.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a rollforward of the categories of variable consideration during 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.433%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Current Provision Related to Sales Made in the Current Period &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Measurement Period Adjustments and Reclasses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Checks/ Credits Issued to Third Parties &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effects of Foreign Exchange&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Chargebacks&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;585.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,530.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,585.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;591.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rebates, promotional programs and other sales allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,576.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,135.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,267.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,373.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Returns&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;539.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;384.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(499.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;686.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Governmental rebate programs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;689.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(705.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,014.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,739.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;385.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,056.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,050.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accruals for these provisions are presented in the consolidated financial statements as reductions in determining net revenues and as a contra-asset in accounts receivable, net (if settled via credit) and other current liabilities (if paid in cash). Accounts receivable are presented net of allowances relating to these provisions, which were comprised of the following at December&#160;31, 2021 and 2020, respectively:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.661%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.652%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,688.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,802.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,362.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,211.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,050.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,014.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;We have not made and do not anticipate making any significant changes to the methodologies that we use to measure provisions for variable consideration; however, the balances within these reserves can fluctuate significantly through the consistent application of our methodologies. Historically, we have not recorded in any current period any material amounts related to adjustments made to prior period reserves.</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90ZXh0cmVnaW9uOjkyYTgzOGNmNmU1NDRiMTZhOWU5YjgyZjAwNmQ2MjMwXzEyMjk_8ed968bf-e9e0-47e0-9416-d3d29a88138f">&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the Company&#x2019;s net sales by product category for each of our reportable segments for the years ended December&#160;31, 2021, 2020, and 2019, respectively:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021 Net Sales&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Product Category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Developed Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Greater China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;JANZ&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Brands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,759.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,207.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,197.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,677.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,841.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Complex Gx and Biosimilars&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,241.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,342.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Generics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,427.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;783.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,413.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,630.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Viatris&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,428.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,212.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,027.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,144.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,813.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020 Net Sales&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Product Category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Developed Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Greater China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;JANZ&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Brands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,920.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;617.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;443.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,234.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Complex Gx and Biosimilars&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,202.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,295.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Generics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,387.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;535.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,361.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,289.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Viatris&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,510.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,195.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,853.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,819.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.191%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.684%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019 Net Sales&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Product Category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Developed Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Greater China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;JANZ&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Brands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,199.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;422.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,362.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Complex Gx and Biosimilars&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,127.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,211.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Generics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,913.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;635.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,241.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,796.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Viatris&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,240.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,192.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,723.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,370.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents net sales on a consolidated basis for select key products for the year ended December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:83.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.106%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Select Key Global Products&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lipitor &#xae;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,663.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Norvasc &#xae;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;824.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lyrica &#xae;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;728.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Viagra &#xae;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EpiPen&#xae; Auto-Injectors&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;391.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Celebrex &#xae;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;344.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effexor &#xae;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Creon &#xae;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Zoloft &#xae;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Xalabrands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Select Key Segment Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Influvac &#xae;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amitiza &#xae;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Xanax &#xae;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dymista &#xae;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Yupelri &#xae;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;____________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.8pt"&gt;The Company does not disclose net sales for any products considered competitively sensitive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;Products disclosed may change in future periods, including as a result of seasonality, competition or new product launches.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.8pt"&gt;Prior periods are not presented due to significance of products acquired as part of the Combination.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a rollforward of the categories of variable consideration during 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.433%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Current Provision Related to Sales Made in the Current Period &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Measurement Period Adjustments and Reclasses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Checks/ Credits Issued to Third Parties &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effects of Foreign Exchange&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Chargebacks&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;585.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,530.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,585.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;591.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rebates, promotional programs and other sales allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,576.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,135.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,267.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,373.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Returns&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;539.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;384.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(499.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;686.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Governmental rebate programs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;689.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(705.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,014.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,739.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;385.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,056.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,050.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i90374f5d9f1b4c92a65a560a42412201_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo0NzBmZDBjNTljMGY0MjM5YTZiNmRjMjhiNTk4MmNmYy90YWJsZXJhbmdlOjQ3MGZkMGM1OWMwZjQyMzlhNmI2ZGMyOGI1OTgyY2ZjXzItMS0xLTEtMzE0MjI_5b50823a-dcdb-4d6f-bf98-6224ce949128"
      unitRef="usd">5759200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iead6205586b04557a8ada1d7b914b227_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo0NzBmZDBjNTljMGY0MjM5YTZiNmRjMjhiNTk4MmNmYy90YWJsZXJhbmdlOjQ3MGZkMGM1OWMwZjQyMzlhNmI2ZGMyOGI1OTgyY2ZjXzItMy0xLTEtMzE0MjI_91f4266e-46fd-4858-b221-ddd5569edc5e"
      unitRef="usd">2207800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2f125b5601ba485fa87e1359408bb169_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo0NzBmZDBjNTljMGY0MjM5YTZiNmRjMjhiNTk4MmNmYy90YWJsZXJhbmdlOjQ3MGZkMGM1OWMwZjQyMzlhNmI2ZGMyOGI1OTgyY2ZjXzItNS0xLTEtMzE0MjI_b49f17e4-fa18-4b8e-89ac-ff2559856f7d"
      unitRef="usd">1197100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icdcd2c5e3dc049c9af2e2879fc06a18a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo0NzBmZDBjNTljMGY0MjM5YTZiNmRjMjhiNTk4MmNmYy90YWJsZXJhbmdlOjQ3MGZkMGM1OWMwZjQyMzlhNmI2ZGMyOGI1OTgyY2ZjXzItNy0xLTEtMzE0MjI_b90a524d-9998-432b-b0c5-c576212b41ef"
      unitRef="usd">1677200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8d43c5886aae45d78bf51b4acef73ab6_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo0NzBmZDBjNTljMGY0MjM5YTZiNmRjMjhiNTk4MmNmYy90YWJsZXJhbmdlOjQ3MGZkMGM1OWMwZjQyMzlhNmI2ZGMyOGI1OTgyY2ZjXzItOS0xLTEtMzE0MjI_ab4084f6-b6b8-419d-816d-274c9585e863"
      unitRef="usd">10841300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i96fc2bf65c384f6d95e6f124e5de94a4_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo0NzBmZDBjNTljMGY0MjM5YTZiNmRjMjhiNTk4MmNmYy90YWJsZXJhbmdlOjQ3MGZkMGM1OWMwZjQyMzlhNmI2ZGMyOGI1OTgyY2ZjXzMtMS0xLTEtMzE0MjI_2c233bdb-60dd-4f93-bf30-b038d9e6c94e"
      unitRef="usd">1241600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifc09cb425c1a4b00bebeb7a3b1d088e4_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo0NzBmZDBjNTljMGY0MjM5YTZiNmRjMjhiNTk4MmNmYy90YWJsZXJhbmdlOjQ3MGZkMGM1OWMwZjQyMzlhNmI2ZGMyOGI1OTgyY2ZjXzMtMy0xLTEtMzE0MjI_73fc6fe4-3731-4ac3-9016-b27916ef04b7"
      unitRef="usd">200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i773e23ec8b4f40d2892b90d9c9b32095_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo0NzBmZDBjNTljMGY0MjM5YTZiNmRjMjhiNTk4MmNmYy90YWJsZXJhbmdlOjQ3MGZkMGM1OWMwZjQyMzlhNmI2ZGMyOGI1OTgyY2ZjXzMtNS0xLTEtMzE0MjI_af259596-1b24-424f-a0d1-a92c762a714a"
      unitRef="usd">46500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7b2cacb9811a4855a05fcf61e040a1d7_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo0NzBmZDBjNTljMGY0MjM5YTZiNmRjMjhiNTk4MmNmYy90YWJsZXJhbmdlOjQ3MGZkMGM1OWMwZjQyMzlhNmI2ZGMyOGI1OTgyY2ZjXzMtNy0xLTEtMzE0MjI_dcbb233e-0b37-4f3b-924c-f48d445a9482"
      unitRef="usd">53800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idbdc76c08f4f4be1a89d1b41630e9c46_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo0NzBmZDBjNTljMGY0MjM5YTZiNmRjMjhiNTk4MmNmYy90YWJsZXJhbmdlOjQ3MGZkMGM1OWMwZjQyMzlhNmI2ZGMyOGI1OTgyY2ZjXzMtOS0xLTEtMzE0MjI_fdee210d-e227-470c-b497-61f1a6a53bd7"
      unitRef="usd">1342100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1cdfba9175504c2887d1d60461bee852_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo0NzBmZDBjNTljMGY0MjM5YTZiNmRjMjhiNTk4MmNmYy90YWJsZXJhbmdlOjQ3MGZkMGM1OWMwZjQyMzlhNmI2ZGMyOGI1OTgyY2ZjXzQtMS0xLTEtMzE0MjI_e7b8e4c0-9e63-43cd-932f-b6011a520b31"
      unitRef="usd">3427900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i269ffde73a154b28805576347563a5cb_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo0NzBmZDBjNTljMGY0MjM5YTZiNmRjMjhiNTk4MmNmYy90YWJsZXJhbmdlOjQ3MGZkMGM1OWMwZjQyMzlhNmI2ZGMyOGI1OTgyY2ZjXzQtMy0xLTEtMzE0MjI_423bcd3c-6f72-4890-8a0a-ea45f2d9af60"
      unitRef="usd">4800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic535a9058568425bb3eb5f0763a47e3d_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo0NzBmZDBjNTljMGY0MjM5YTZiNmRjMjhiNTk4MmNmYy90YWJsZXJhbmdlOjQ3MGZkMGM1OWMwZjQyMzlhNmI2ZGMyOGI1OTgyY2ZjXzQtNS0xLTEtMzE0MjI_ba5be30c-6d4c-42f7-9811-008aa7421c71"
      unitRef="usd">783800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie684c80cdcef4397b8798cbb98e6a796_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo0NzBmZDBjNTljMGY0MjM5YTZiNmRjMjhiNTk4MmNmYy90YWJsZXJhbmdlOjQ3MGZkMGM1OWMwZjQyMzlhNmI2ZGMyOGI1OTgyY2ZjXzQtNy0xLTEtMzE0MjI_24aacefe-7aa4-4c1a-b5f6-01f4d519c4e9"
      unitRef="usd">1413700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if2a6d40b5f364731b5c17ef708876be7_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo0NzBmZDBjNTljMGY0MjM5YTZiNmRjMjhiNTk4MmNmYy90YWJsZXJhbmdlOjQ3MGZkMGM1OWMwZjQyMzlhNmI2ZGMyOGI1OTgyY2ZjXzQtOS0xLTEtMzE0MjI_9f431396-6b52-48ff-82c5-a9588a84f5c6"
      unitRef="usd">5630200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1ac0bcd2e1264e8b8347af73e216d016_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo0NzBmZDBjNTljMGY0MjM5YTZiNmRjMjhiNTk4MmNmYy90YWJsZXJhbmdlOjQ3MGZkMGM1OWMwZjQyMzlhNmI2ZGMyOGI1OTgyY2ZjXzUtMS0xLTEtMzE0MjI_46c03a2c-0102-4d26-ae91-2955f064ae86"
      unitRef="usd">10428700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7ed92dccf2314bd48c7373be7cf33d4e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo0NzBmZDBjNTljMGY0MjM5YTZiNmRjMjhiNTk4MmNmYy90YWJsZXJhbmdlOjQ3MGZkMGM1OWMwZjQyMzlhNmI2ZGMyOGI1OTgyY2ZjXzUtMy0xLTEtMzE0MjI_b5fddbfc-5bd6-474e-adb7-5954522cfcb5"
      unitRef="usd">2212800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3ccdc9914af44b1bb1229e19c17326d8_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo0NzBmZDBjNTljMGY0MjM5YTZiNmRjMjhiNTk4MmNmYy90YWJsZXJhbmdlOjQ3MGZkMGM1OWMwZjQyMzlhNmI2ZGMyOGI1OTgyY2ZjXzUtNS0xLTEtMzE0MjI_832e8028-33d7-4964-9d86-3be4b2e20f6a"
      unitRef="usd">2027400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i02b3f133daa24190abd49dfdef6bb6ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo0NzBmZDBjNTljMGY0MjM5YTZiNmRjMjhiNTk4MmNmYy90YWJsZXJhbmdlOjQ3MGZkMGM1OWMwZjQyMzlhNmI2ZGMyOGI1OTgyY2ZjXzUtNy0xLTEtMzE0MjI_e2aa8960-461c-48f3-adbe-1eb7d3f7cf8f"
      unitRef="usd">3144700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id2ddd71cee624b009233ae18ff01bcdb_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo0NzBmZDBjNTljMGY0MjM5YTZiNmRjMjhiNTk4MmNmYy90YWJsZXJhbmdlOjQ3MGZkMGM1OWMwZjQyMzlhNmI2ZGMyOGI1OTgyY2ZjXzUtOS0xLTEtMzE0MjI_99252933-6b88-4f07-abb6-fb664e180d7c"
      unitRef="usd">17813600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i97c939970b2a44ec93ec3adde4f66f7a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpiYjAwNmY2ZWYzNjE0NzBiYWRjZDQzZmQwMWZiMDY4ZC90YWJsZXJhbmdlOmJiMDA2ZjZlZjM2MTQ3MGJhZGNkNDNmZDAxZmIwNjhkXzItMS0xLTEtMzE0MjI_01a340f1-b75d-45a6-a849-75845525f7bb"
      unitRef="usd">3920700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1831edfa3a5a49a4bb77c12a7484690f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpiYjAwNmY2ZWYzNjE0NzBiYWRjZDQzZmQwMWZiMDY4ZC90YWJsZXJhbmdlOmJiMDA2ZjZlZjM2MTQ3MGJhZGNkNDNmZDAxZmIwNjhkXzItMy0xLTEtMzE0MjI_4971999a-d644-4f4d-a926-30e5ba0e587f"
      unitRef="usd">253900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if9abda492c204a6db32dc9d58d9d3283_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpiYjAwNmY2ZWYzNjE0NzBiYWRjZDQzZmQwMWZiMDY4ZC90YWJsZXJhbmdlOmJiMDA2ZjZlZjM2MTQ3MGJhZGNkNDNmZDAxZmIwNjhkXzItNS0xLTEtMzE0MjI_3418fd6f-5513-48ab-962b-be7915d4279c"
      unitRef="usd">617000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i05eae9ce2c1146cda2761d09e8dfafec_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpiYjAwNmY2ZWYzNjE0NzBiYWRjZDQzZmQwMWZiMDY4ZC90YWJsZXJhbmdlOmJiMDA2ZjZlZjM2MTQ3MGJhZGNkNDNmZDAxZmIwNjhkXzItNy0xLTEtMzE0MjI_7b18ba0d-7366-4b84-bc4c-64b9df32531b"
      unitRef="usd">443300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i86d67a91f60c42daae98c579adcd3ce6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpiYjAwNmY2ZWYzNjE0NzBiYWRjZDQzZmQwMWZiMDY4ZC90YWJsZXJhbmdlOmJiMDA2ZjZlZjM2MTQ3MGJhZGNkNDNmZDAxZmIwNjhkXzItOS0xLTEtMzE0MjI_a44d5faf-7b08-4df9-81a1-c2cf6a3194c7"
      unitRef="usd">5234900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i835c7b50b49142419f07188c47c94df3_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpiYjAwNmY2ZWYzNjE0NzBiYWRjZDQzZmQwMWZiMDY4ZC90YWJsZXJhbmdlOmJiMDA2ZjZlZjM2MTQ3MGJhZGNkNDNmZDAxZmIwNjhkXzMtMS0xLTEtMzE0MjI_e67d83b3-6781-4952-967e-a5fd72cd4934"
      unitRef="usd">1202600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i27e66858837c4e0e95198bd461c39df7_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpiYjAwNmY2ZWYzNjE0NzBiYWRjZDQzZmQwMWZiMDY4ZC90YWJsZXJhbmdlOmJiMDA2ZjZlZjM2MTQ3MGJhZGNkNDNmZDAxZmIwNjhkXzMtMy0xLTEtMzE0MjI_42cf2605-3521-4d14-9335-0a9bd1b35575"
      unitRef="usd">700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic3131c3ac2a04122b50238e3e2e46c6e_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpiYjAwNmY2ZWYzNjE0NzBiYWRjZDQzZmQwMWZiMDY4ZC90YWJsZXJhbmdlOmJiMDA2ZjZlZjM2MTQ3MGJhZGNkNDNmZDAxZmIwNjhkXzMtNS0xLTEtMzE0MjI_685c73cf-b918-4257-abb0-dbb9bafc11a0"
      unitRef="usd">42800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4108be32c0e74b899efbefe5401e783f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpiYjAwNmY2ZWYzNjE0NzBiYWRjZDQzZmQwMWZiMDY4ZC90YWJsZXJhbmdlOmJiMDA2ZjZlZjM2MTQ3MGJhZGNkNDNmZDAxZmIwNjhkXzMtNy0xLTEtMzE0MjI_82f231dc-7b26-4408-bc2b-537e1774968b"
      unitRef="usd">49400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i226439d9ee1a49f6b1bb3182d0a8d06d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpiYjAwNmY2ZWYzNjE0NzBiYWRjZDQzZmQwMWZiMDY4ZC90YWJsZXJhbmdlOmJiMDA2ZjZlZjM2MTQ3MGJhZGNkNDNmZDAxZmIwNjhkXzMtOS0xLTEtMzE0MjI_fd1c1ced-5cb9-4a17-9654-a4cfc6683870"
      unitRef="usd">1295500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i105959ab42be4a4484a43c24d4643610_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpiYjAwNmY2ZWYzNjE0NzBiYWRjZDQzZmQwMWZiMDY4ZC90YWJsZXJhbmdlOmJiMDA2ZjZlZjM2MTQ3MGJhZGNkNDNmZDAxZmIwNjhkXzQtMS0xLTEtMzE0MjI_121c73ca-14b8-4e4b-a04b-08054bcc5e48"
      unitRef="usd">3387600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib26272e8a91e4d71b3b831cda82ccb89_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpiYjAwNmY2ZWYzNjE0NzBiYWRjZDQzZmQwMWZiMDY4ZC90YWJsZXJhbmdlOmJiMDA2ZjZlZjM2MTQ3MGJhZGNkNDNmZDAxZmIwNjhkXzQtMy0xLTEtMzE0MjI_b0b4ea75-9ba5-4ac8-af1d-49beaa93a113"
      unitRef="usd">5300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3a9efc1a735d41babd68b5c507c58032_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpiYjAwNmY2ZWYzNjE0NzBiYWRjZDQzZmQwMWZiMDY4ZC90YWJsZXJhbmdlOmJiMDA2ZjZlZjM2MTQ3MGJhZGNkNDNmZDAxZmIwNjhkXzQtNS0xLTEtMzE0MjI_a6986bb1-6c03-4c20-921a-6ea480e9a79c"
      unitRef="usd">535500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibe1b26c10c8d49dcb8d293449427f7d1_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpiYjAwNmY2ZWYzNjE0NzBiYWRjZDQzZmQwMWZiMDY4ZC90YWJsZXJhbmdlOmJiMDA2ZjZlZjM2MTQ3MGJhZGNkNDNmZDAxZmIwNjhkXzQtNy0xLTEtMzE0MjI_2c382a9d-24ed-4ddb-a878-20b93188e43a"
      unitRef="usd">1361100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7d668c3c2f2946a49634c6f0bfb9cdee_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpiYjAwNmY2ZWYzNjE0NzBiYWRjZDQzZmQwMWZiMDY4ZC90YWJsZXJhbmdlOmJiMDA2ZjZlZjM2MTQ3MGJhZGNkNDNmZDAxZmIwNjhkXzQtOS0xLTEtMzE0MjI_dcf3bdfc-da7e-40e1-a3e8-bfbfef7666bb"
      unitRef="usd">5289500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iec0737b261124d3f87ea9adcdb407b5a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpiYjAwNmY2ZWYzNjE0NzBiYWRjZDQzZmQwMWZiMDY4ZC90YWJsZXJhbmdlOmJiMDA2ZjZlZjM2MTQ3MGJhZGNkNDNmZDAxZmIwNjhkXzUtMS0xLTEtMzE0MjI_8855b6ca-b209-4e56-89d4-0f1788c0bc9e"
      unitRef="usd">8510900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4e0c5048f8f84f26a1949d61f3285173_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpiYjAwNmY2ZWYzNjE0NzBiYWRjZDQzZmQwMWZiMDY4ZC90YWJsZXJhbmdlOmJiMDA2ZjZlZjM2MTQ3MGJhZGNkNDNmZDAxZmIwNjhkXzUtMy0xLTEtMzE0MjI_c9a38177-8ba3-474f-b1cf-386cbeaaab0d"
      unitRef="usd">259900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2d06b2c023334d92a7c83b2943f0232b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpiYjAwNmY2ZWYzNjE0NzBiYWRjZDQzZmQwMWZiMDY4ZC90YWJsZXJhbmdlOmJiMDA2ZjZlZjM2MTQ3MGJhZGNkNDNmZDAxZmIwNjhkXzUtNS0xLTEtMzE0MjI_dcaecec0-9b96-49e1-bce2-bbd488dde2ec"
      unitRef="usd">1195300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i281863eb67c44d0fbc00294dfaf0049c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpiYjAwNmY2ZWYzNjE0NzBiYWRjZDQzZmQwMWZiMDY4ZC90YWJsZXJhbmdlOmJiMDA2ZjZlZjM2MTQ3MGJhZGNkNDNmZDAxZmIwNjhkXzUtNy0xLTEtMzE0MjI_d5698ea0-885c-4096-a21a-84095100a476"
      unitRef="usd">1853800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icdd7bc10185c4685b4d14c9b6ac151b1_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpiYjAwNmY2ZWYzNjE0NzBiYWRjZDQzZmQwMWZiMDY4ZC90YWJsZXJhbmdlOmJiMDA2ZjZlZjM2MTQ3MGJhZGNkNDNmZDAxZmIwNjhkXzUtOS0xLTEtMzE0MjI_1e9e31e6-814c-4ede-af82-58603d87ec1d"
      unitRef="usd">11819900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i61ed8d945a654397b38ffd9a5155cc8a_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyOWRlZGNhZjNkYjg0NGJkYjMxYzJmYjU4ZTQwMjVhMy90YWJsZXJhbmdlOjI5ZGVkY2FmM2RiODQ0YmRiMzFjMmZiNThlNDAyNWEzXzItMS0xLTEtMzE0MjI_1e960b2b-3882-475c-8f54-314abd0e8cf8"
      unitRef="usd">4199100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7a4ad71e069349d4bc77dedb205f5b6e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyOWRlZGNhZjNkYjg0NGJkYjMxYzJmYjU4ZTQwMjVhMy90YWJsZXJhbmdlOjI5ZGVkY2FmM2RiODQ0YmRiMzFjMmZiNThlNDAyNWEzXzItMy0xLTEtMzE0MjI_55520bab-ca18-47fd-8559-05c4f19169d7"
      unitRef="usd">207600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i75185d8bca2c4c33b481ec3ed8ab4bc2_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyOWRlZGNhZjNkYjg0NGJkYjMxYzJmYjU4ZTQwMjVhMy90YWJsZXJhbmdlOjI5ZGVkY2FmM2RiODQ0YmRiMzFjMmZiNThlNDAyNWEzXzItNS0xLTEtMzE0MjI_bc8703e1-c579-44cb-8ca3-ac2dd3c64287"
      unitRef="usd">533300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9929171805eb41e3845525fcedeefdd7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyOWRlZGNhZjNkYjg0NGJkYjMxYzJmYjU4ZTQwMjVhMy90YWJsZXJhbmdlOjI5ZGVkY2FmM2RiODQ0YmRiMzFjMmZiNThlNDAyNWEzXzItNy0xLTEtMzE0MjI_dd48baf9-285a-4eb4-b8e8-a4d874018244"
      unitRef="usd">422100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iac08a240cf724732a33d7e4c11a51983_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyOWRlZGNhZjNkYjg0NGJkYjMxYzJmYjU4ZTQwMjVhMy90YWJsZXJhbmdlOjI5ZGVkY2FmM2RiODQ0YmRiMzFjMmZiNThlNDAyNWEzXzItOS0xLTEtMzE0MjI_9360b61a-4357-426a-a0d1-4618f1a7f01c"
      unitRef="usd">5362100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic72949e3219d4b0db2547334d44e5760_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyOWRlZGNhZjNkYjg0NGJkYjMxYzJmYjU4ZTQwMjVhMy90YWJsZXJhbmdlOjI5ZGVkY2FmM2RiODQ0YmRiMzFjMmZiNThlNDAyNWEzXzMtMS0xLTEtMzE0MjI_3f213c9e-3b06-4291-a501-041deb719e93"
      unitRef="usd">1127400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic570f6e38a0546fb9e89a31a80462c9b_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyOWRlZGNhZjNkYjg0NGJkYjMxYzJmYjU4ZTQwMjVhMy90YWJsZXJhbmdlOjI5ZGVkY2FmM2RiODQ0YmRiMzFjMmZiNThlNDAyNWEzXzMtMy0xLTEtMzE0MjI_43a8f60a-8c61-4d15-ace8-2278ceeda697"
      unitRef="usd">400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1f7590527ef14168a6dd4e6a2b81c5c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyOWRlZGNhZjNkYjg0NGJkYjMxYzJmYjU4ZTQwMjVhMy90YWJsZXJhbmdlOjI5ZGVkY2FmM2RiODQ0YmRiMzFjMmZiNThlNDAyNWEzXzMtNS0xLTEtMzE0MjI_61563da3-4bce-4c4d-b138-2b571cabd463"
      unitRef="usd">23800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie1614ddc606441f19d547ba1a785e380_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyOWRlZGNhZjNkYjg0NGJkYjMxYzJmYjU4ZTQwMjVhMy90YWJsZXJhbmdlOjI5ZGVkY2FmM2RiODQ0YmRiMzFjMmZiNThlNDAyNWEzXzMtNy0xLTEtMzE0MjI_2804ee8d-7e8b-4a6b-9135-3f3ae7c51867"
      unitRef="usd">59700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i11d08a6a376f45179f8e6bb95bd31c27_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyOWRlZGNhZjNkYjg0NGJkYjMxYzJmYjU4ZTQwMjVhMy90YWJsZXJhbmdlOjI5ZGVkY2FmM2RiODQ0YmRiMzFjMmZiNThlNDAyNWEzXzMtOS0xLTEtMzE0MjI_97107ef3-731b-43aa-9b08-3873bd9d88ba"
      unitRef="usd">1211300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i309244cf155a4aba9fca199455319a32_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyOWRlZGNhZjNkYjg0NGJkYjMxYzJmYjU4ZTQwMjVhMy90YWJsZXJhbmdlOjI5ZGVkY2FmM2RiODQ0YmRiMzFjMmZiNThlNDAyNWEzXzQtMS0xLTEtMzE0MjI_571f45bd-ccc1-4c8b-bab3-e0e324b54377"
      unitRef="usd">2913500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i67d9cb8141084c58ac541cde4d576c50_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyOWRlZGNhZjNkYjg0NGJkYjMxYzJmYjU4ZTQwMjVhMy90YWJsZXJhbmdlOjI5ZGVkY2FmM2RiODQ0YmRiMzFjMmZiNThlNDAyNWEzXzQtMy0xLTEtMzE0MjI_ee0d9726-fb5b-433b-aaf8-31ad023ea734"
      unitRef="usd">6600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3166a2866ade49869d6aad191a5c8ef2_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyOWRlZGNhZjNkYjg0NGJkYjMxYzJmYjU4ZTQwMjVhMy90YWJsZXJhbmdlOjI5ZGVkY2FmM2RiODQ0YmRiMzFjMmZiNThlNDAyNWEzXzQtNS0xLTEtMzE0MjI_e4a231f3-7a17-4f1e-ba1e-d2daae8711a6"
      unitRef="usd">635400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iecf0266755484cffb55ddc7ba73da178_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyOWRlZGNhZjNkYjg0NGJkYjMxYzJmYjU4ZTQwMjVhMy90YWJsZXJhbmdlOjI5ZGVkY2FmM2RiODQ0YmRiMzFjMmZiNThlNDAyNWEzXzQtNy0xLTEtMzE0MjI_801ee8c3-1b7c-4791-a0aa-4b5cc0cec0c0"
      unitRef="usd">1241400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iff24ee1fc1974d94b68eb9cffe4e3dbf_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyOWRlZGNhZjNkYjg0NGJkYjMxYzJmYjU4ZTQwMjVhMy90YWJsZXJhbmdlOjI5ZGVkY2FmM2RiODQ0YmRiMzFjMmZiNThlNDAyNWEzXzQtOS0xLTEtMzE0MjI_1041a4e3-00d6-4c47-b1fc-bae507459b76"
      unitRef="usd">4796900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i864642c0e47a4b87a88be339d6673670_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyOWRlZGNhZjNkYjg0NGJkYjMxYzJmYjU4ZTQwMjVhMy90YWJsZXJhbmdlOjI5ZGVkY2FmM2RiODQ0YmRiMzFjMmZiNThlNDAyNWEzXzUtMS0xLTEtMzE0MjI_b1f04a9b-386e-4402-8ff8-d794b4e8414e"
      unitRef="usd">8240000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie4221a0900a14ced8a5c91eac2fcdf4f_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyOWRlZGNhZjNkYjg0NGJkYjMxYzJmYjU4ZTQwMjVhMy90YWJsZXJhbmdlOjI5ZGVkY2FmM2RiODQ0YmRiMzFjMmZiNThlNDAyNWEzXzUtMy0xLTEtMzE0MjI_5410c4c5-e5fa-498f-a17b-2a06a0eb2360"
      unitRef="usd">214600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i94d3655a9cb44f37b3319f0d91bf87b1_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyOWRlZGNhZjNkYjg0NGJkYjMxYzJmYjU4ZTQwMjVhMy90YWJsZXJhbmdlOjI5ZGVkY2FmM2RiODQ0YmRiMzFjMmZiNThlNDAyNWEzXzUtNS0xLTEtMzE0MjI_cfa3e91f-83bf-4d61-881d-6e8648e3664a"
      unitRef="usd">1192500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6f91beda5d054492aed05bdaf3b7936e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyOWRlZGNhZjNkYjg0NGJkYjMxYzJmYjU4ZTQwMjVhMy90YWJsZXJhbmdlOjI5ZGVkY2FmM2RiODQ0YmRiMzFjMmZiNThlNDAyNWEzXzUtNy0xLTEtMzE0MjI_2b929035-1483-4f1b-879e-2be5db9f7fad"
      unitRef="usd">1723200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iadb0452c57794c5498c4248d6691b32c_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyOWRlZGNhZjNkYjg0NGJkYjMxYzJmYjU4ZTQwMjVhMy90YWJsZXJhbmdlOjI5ZGVkY2FmM2RiODQ0YmRiMzFjMmZiNThlNDAyNWEzXzUtOS0xLTEtMzE0MjI_39d62a6d-a618-4b98-90a3-4446d6b752b8"
      unitRef="usd">11370300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i84058a24993540f0abbe391aeff14baa_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpmMGJhYTM2MTJkNzE0NGE3YjM5NjQ1MjQxYTYyZmFmNi90YWJsZXJhbmdlOmYwYmFhMzYxMmQ3MTQ0YTdiMzk2NDUyNDFhNjJmYWY2XzMtNC0xLTEtMzYyNTE_e756f3c2-a253-4cc9-a7dd-79362e5ef58c"
      unitRef="usd">1663200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iac2df693fdec46b2a004f4136d918a15_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpmMGJhYTM2MTJkNzE0NGE3YjM5NjQ1MjQxYTYyZmFmNi90YWJsZXJhbmdlOmYwYmFhMzYxMmQ3MTQ0YTdiMzk2NDUyNDFhNjJmYWY2XzQtNC0xLTEtMzYyNTE_ca272147-9618-419c-a8b5-7e3fcfd47b79"
      unitRef="usd">824700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i02f7c66517fd42e99c981b2754110472_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpmMGJhYTM2MTJkNzE0NGE3YjM5NjQ1MjQxYTYyZmFmNi90YWJsZXJhbmdlOmYwYmFhMzYxMmQ3MTQ0YTdiMzk2NDUyNDFhNjJmYWY2XzUtNC0xLTEtMzYyNTE_eda4851b-80ce-4e76-aa96-37b579bf732b"
      unitRef="usd">728500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2fb4efa6d51f4b0d81d894b26998702c_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpmMGJhYTM2MTJkNzE0NGE3YjM5NjQ1MjQxYTYyZmFmNi90YWJsZXJhbmdlOmYwYmFhMzYxMmQ3MTQ0YTdiMzk2NDUyNDFhNjJmYWY2XzYtNC0xLTEtMzYyNTE_fc0f9eaa-6b9b-42b7-ba4f-6776a47c8b66"
      unitRef="usd">533800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic5b45e5acb5a43d086ab1d31fe635f90_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpmMGJhYTM2MTJkNzE0NGE3YjM5NjQ1MjQxYTYyZmFmNi90YWJsZXJhbmdlOmYwYmFhMzYxMmQ3MTQ0YTdiMzk2NDUyNDFhNjJmYWY2XzctNC0xLTEtMzYyNTE_672772d9-7e6c-4921-8ca9-4c7eb02b72d3"
      unitRef="usd">391700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i32b74097924040a6a3b293c9de50757b_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpmMGJhYTM2MTJkNzE0NGE3YjM5NjQ1MjQxYTYyZmFmNi90YWJsZXJhbmdlOmYwYmFhMzYxMmQ3MTQ0YTdiMzk2NDUyNDFhNjJmYWY2XzgtNC0xLTEtMzYyNTE_3de3970d-edb2-429f-b11f-c2f9c1106a30"
      unitRef="usd">344400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i29c8e33fbfc54cebb3298eb792f30230_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpmMGJhYTM2MTJkNzE0NGE3YjM5NjQ1MjQxYTYyZmFmNi90YWJsZXJhbmdlOmYwYmFhMzYxMmQ3MTQ0YTdiMzk2NDUyNDFhNjJmYWY2XzktNC0xLTEtMzYyNTE_0cb8b375-db1f-4b24-9c73-796202a3a9c6"
      unitRef="usd">316800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2b3ecbda1fdf4ee18c4b7043b1c74bd3_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpmMGJhYTM2MTJkNzE0NGE3YjM5NjQ1MjQxYTYyZmFmNi90YWJsZXJhbmdlOmYwYmFhMzYxMmQ3MTQ0YTdiMzk2NDUyNDFhNjJmYWY2XzEwLTQtMS0xLTQ2MjY3_96b7d9d1-3929-4954-8f50-1459c2da222c"
      unitRef="usd">309800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i45c0dc93080d496b936cfa154fdd5d2f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpmMGJhYTM2MTJkNzE0NGE3YjM5NjQ1MjQxYTYyZmFmNi90YWJsZXJhbmdlOmYwYmFhMzYxMmQ3MTQ0YTdiMzk2NDUyNDFhNjJmYWY2XzEwLTQtMS0xLTM2MjUx_5ea1cbbb-5e2d-40c3-9553-9795f4906314"
      unitRef="usd">284300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4f3025b784d24010ab35acb02af8509d_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpmMGJhYTM2MTJkNzE0NGE3YjM5NjQ1MjQxYTYyZmFmNi90YWJsZXJhbmdlOmYwYmFhMzYxMmQ3MTQ0YTdiMzk2NDUyNDFhNjJmYWY2XzEyLTQtMS0xLTM2MjUx_43c051c9-10a8-4e95-a1e0-3bf1fdbe844d"
      unitRef="usd">226000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1b1907e0d66348049123902a21dcf855_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpmMGJhYTM2MTJkNzE0NGE3YjM5NjQ1MjQxYTYyZmFmNi90YWJsZXJhbmdlOmYwYmFhMzYxMmQ3MTQ0YTdiMzk2NDUyNDFhNjJmYWY2XzE1LTQtMS0xLTM2MjU4_49bd2e26-d801-482e-811c-c621d6fe65d2"
      unitRef="usd">299300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i40e3530192d947059647f2b6af9576ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpmMGJhYTM2MTJkNzE0NGE3YjM5NjQ1MjQxYTYyZmFmNi90YWJsZXJhbmdlOmYwYmFhMzYxMmQ3MTQ0YTdiMzk2NDUyNDFhNjJmYWY2XzE2LTQtMS0xLTM2MjU4_5db9e84d-d2a8-47ce-9fad-a405d4450507"
      unitRef="usd">201500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5bb2b10fff8b4b20b4933b549ff5105e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpmMGJhYTM2MTJkNzE0NGE3YjM5NjQ1MjQxYTYyZmFmNi90YWJsZXJhbmdlOmYwYmFhMzYxMmQ3MTQ0YTdiMzk2NDUyNDFhNjJmYWY2XzE3LTQtMS0xLTM2MjU4_612e469b-e3b5-4a60-8875-215c96d3c3a8"
      unitRef="usd">185900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i09fb6f5ceb234f24b3a2fd5497a71b54_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpmMGJhYTM2MTJkNzE0NGE3YjM5NjQ1MjQxYTYyZmFmNi90YWJsZXJhbmdlOmYwYmFhMzYxMmQ3MTQ0YTdiMzk2NDUyNDFhNjJmYWY2XzE4LTQtMS0xLTM2MjU4_d68f67fe-7bff-459f-a1a2-1a2cd3cd8444"
      unitRef="usd">168000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8c6990bf97834a12a1ac825a254bf046_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTpmMGJhYTM2MTJkNzE0NGE3YjM5NjQ1MjQxYTYyZmFmNi90YWJsZXJhbmdlOmYwYmFhMzYxMmQ3MTQ0YTdiMzk2NDUyNDFhNjJmYWY2XzE5LTQtMS0xLTM2MjU4_de00ed2f-e95e-4a71-862b-9d411b6ef69c"
      unitRef="usd">161900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <vtrs:RevenuefromContractwithCustomerGross
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo4ZDg1ZDY0YjU4MTI0MjdkOWM3NWM2NTNiNmMzMTZiYS90YWJsZXJhbmdlOjhkODVkNjRiNTgxMjQyN2Q5Yzc1YzY1M2I2YzMxNmJhXzItMS0xLTEtMzE0MjI_e55d3349-145a-4cb7-9e1f-5aa470ebdad2"
      unitRef="usd">30553400000</vtrs:RevenuefromContractwithCustomerGross>
    <vtrs:RevenuefromContractwithCustomerGross
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo4ZDg1ZDY0YjU4MTI0MjdkOWM3NWM2NTNiNmMzMTZiYS90YWJsZXJhbmdlOjhkODVkNjRiNTgxMjQyN2Q5Yzc1YzY1M2I2YzMxNmJhXzItMy0xLTEtMzE0MjI_fd74876c-1279-4cbe-b129-aeefc77f6295"
      unitRef="usd">19899100000</vtrs:RevenuefromContractwithCustomerGross>
    <vtrs:RevenuefromContractwithCustomerGross
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo4ZDg1ZDY0YjU4MTI0MjdkOWM3NWM2NTNiNmMzMTZiYS90YWJsZXJhbmdlOjhkODVkNjRiNTgxMjQyN2Q5Yzc1YzY1M2I2YzMxNmJhXzItNS0xLTEtMzE0MjI_805a0984-efd6-41b0-b487-f8c0a5dbb48d"
      unitRef="usd">19012200000</vtrs:RevenuefromContractwithCustomerGross>
    <vtrs:Chargebacks
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo4ZDg1ZDY0YjU4MTI0MjdkOWM3NWM2NTNiNmMzMTZiYS90YWJsZXJhbmdlOjhkODVkNjRiNTgxMjQyN2Q5Yzc1YzY1M2I2YzMxNmJhXzQtMS0xLTEtMzE0MjI_e353e615-c572-4116-8e1d-f4b7073de5a0"
      unitRef="usd">5530100000</vtrs:Chargebacks>
    <vtrs:Chargebacks
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo4ZDg1ZDY0YjU4MTI0MjdkOWM3NWM2NTNiNmMzMTZiYS90YWJsZXJhbmdlOjhkODVkNjRiNTgxMjQyN2Q5Yzc1YzY1M2I2YzMxNmJhXzQtMy0xLTEtMzE0MjI_4b9524c3-b0f4-4334-bc89-1fa99c9a3e14"
      unitRef="usd">3656200000</vtrs:Chargebacks>
    <vtrs:Chargebacks
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo4ZDg1ZDY0YjU4MTI0MjdkOWM3NWM2NTNiNmMzMTZiYS90YWJsZXJhbmdlOjhkODVkNjRiNTgxMjQyN2Q5Yzc1YzY1M2I2YzMxNmJhXzQtNS0xLTEtMzE0MjI_43d3c54c-7f36-4ca3-bba8-9de9af97285e"
      unitRef="usd">3309600000</vtrs:Chargebacks>
    <vtrs:AccruedSalesAllowances
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo4ZDg1ZDY0YjU4MTI0MjdkOWM3NWM2NTNiNmMzMTZiYS90YWJsZXJhbmdlOjhkODVkNjRiNTgxMjQyN2Q5Yzc1YzY1M2I2YzMxNmJhXzUtMS0xLTEtMzE0MjI_6cf91727-0122-4369-8383-0439b6cb35a7"
      unitRef="usd">6135600000</vtrs:AccruedSalesAllowances>
    <vtrs:AccruedSalesAllowances
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo4ZDg1ZDY0YjU4MTI0MjdkOWM3NWM2NTNiNmMzMTZiYS90YWJsZXJhbmdlOjhkODVkNjRiNTgxMjQyN2Q5Yzc1YzY1M2I2YzMxNmJhXzUtMy0xLTEtMzE0MjI_3c987a3a-aa00-4e30-b396-401a9b1b50ea"
      unitRef="usd">3765500000</vtrs:AccruedSalesAllowances>
    <vtrs:AccruedSalesAllowances
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo4ZDg1ZDY0YjU4MTI0MjdkOWM3NWM2NTNiNmMzMTZiYS90YWJsZXJhbmdlOjhkODVkNjRiNTgxMjQyN2Q5Yzc1YzY1M2I2YzMxNmJhXzUtNS0xLTEtMzE0MjI_c685cb4e-d40e-459e-85e1-443e5cab2b3d"
      unitRef="usd">3629300000</vtrs:AccruedSalesAllowances>
    <vtrs:RevenuefromContractwithCustomerReturns
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo4ZDg1ZDY0YjU4MTI0MjdkOWM3NWM2NTNiNmMzMTZiYS90YWJsZXJhbmdlOjhkODVkNjRiNTgxMjQyN2Q5Yzc1YzY1M2I2YzMxNmJhXzYtMS0xLTEtMzE0MjI_508f86f4-28b3-4d6a-83d6-d156920fe613"
      unitRef="usd">384600000</vtrs:RevenuefromContractwithCustomerReturns>
    <vtrs:RevenuefromContractwithCustomerReturns
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo4ZDg1ZDY0YjU4MTI0MjdkOWM3NWM2NTNiNmMzMTZiYS90YWJsZXJhbmdlOjhkODVkNjRiNTgxMjQyN2Q5Yzc1YzY1M2I2YzMxNmJhXzYtMy0xLTEtMzE0MjI_25a2d99e-e574-4e50-98ee-7aeb8c592d86"
      unitRef="usd">329700000</vtrs:RevenuefromContractwithCustomerReturns>
    <vtrs:RevenuefromContractwithCustomerReturns
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo4ZDg1ZDY0YjU4MTI0MjdkOWM3NWM2NTNiNmMzMTZiYS90YWJsZXJhbmdlOjhkODVkNjRiNTgxMjQyN2Q5Yzc1YzY1M2I2YzMxNmJhXzYtNS0xLTEtMzE0MjI_709194db-c510-4e0a-91fd-cb56eafc3fc1"
      unitRef="usd">237900000</vtrs:RevenuefromContractwithCustomerReturns>
    <vtrs:Medicaidandothergovernmentalrebates
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo4ZDg1ZDY0YjU4MTI0MjdkOWM3NWM2NTNiNmMzMTZiYS90YWJsZXJhbmdlOjhkODVkNjRiNTgxMjQyN2Q5Yzc1YzY1M2I2YzMxNmJhXzctMS0xLTEtMzE0MjI_98712ed5-cc3a-4704-b307-385f95268e81"
      unitRef="usd">689500000</vtrs:Medicaidandothergovernmentalrebates>
    <vtrs:Medicaidandothergovernmentalrebates
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo4ZDg1ZDY0YjU4MTI0MjdkOWM3NWM2NTNiNmMzMTZiYS90YWJsZXJhbmdlOjhkODVkNjRiNTgxMjQyN2Q5Yzc1YzY1M2I2YzMxNmJhXzctMy0xLTEtMzE0MjI_0840ce46-e2d9-4d14-8bc4-564d837cecea"
      unitRef="usd">327800000</vtrs:Medicaidandothergovernmentalrebates>
    <vtrs:Medicaidandothergovernmentalrebates
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo4ZDg1ZDY0YjU4MTI0MjdkOWM3NWM2NTNiNmMzMTZiYS90YWJsZXJhbmdlOjhkODVkNjRiNTgxMjQyN2Q5Yzc1YzY1M2I2YzMxNmJhXzctNS0xLTEtMzE0MjI_562b9738-7f07-4bd5-bb64-28ba962748c3"
      unitRef="usd">465100000</vtrs:Medicaidandothergovernmentalrebates>
    <vtrs:SalesRevenueGrosstonetadjustments
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo4ZDg1ZDY0YjU4MTI0MjdkOWM3NWM2NTNiNmMzMTZiYS90YWJsZXJhbmdlOjhkODVkNjRiNTgxMjQyN2Q5Yzc1YzY1M2I2YzMxNmJhXzgtMS0xLTEtMzE0MjI_067940c2-5c9d-4dfc-b2d2-26129e53183f"
      unitRef="usd">12739800000</vtrs:SalesRevenueGrosstonetadjustments>
    <vtrs:SalesRevenueGrosstonetadjustments
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo4ZDg1ZDY0YjU4MTI0MjdkOWM3NWM2NTNiNmMzMTZiYS90YWJsZXJhbmdlOjhkODVkNjRiNTgxMjQyN2Q5Yzc1YzY1M2I2YzMxNmJhXzgtMy0xLTEtMzE0MjI_04d17d07-4ce1-4615-849f-aafec8243387"
      unitRef="usd">8079200000</vtrs:SalesRevenueGrosstonetadjustments>
    <vtrs:SalesRevenueGrosstonetadjustments
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo4ZDg1ZDY0YjU4MTI0MjdkOWM3NWM2NTNiNmMzMTZiYS90YWJsZXJhbmdlOjhkODVkNjRiNTgxMjQyN2Q5Yzc1YzY1M2I2YzMxNmJhXzgtNS0xLTEtMzE0MjI_2b3ebf9e-13d8-4bdd-9a0a-0a2cdc5b656f"
      unitRef="usd">7641900000</vtrs:SalesRevenueGrosstonetadjustments>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic25b2c6a9a1244738c1de493abb87705_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo4ZDg1ZDY0YjU4MTI0MjdkOWM3NWM2NTNiNmMzMTZiYS90YWJsZXJhbmdlOjhkODVkNjRiNTgxMjQyN2Q5Yzc1YzY1M2I2YzMxNmJhXzktMS0xLTEtMzE0MjI_7aa79eb2-d382-4529-8fc9-aa4d63f2ec2a"
      unitRef="usd">17813600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9f25078033394f518263d14867ea4eb6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo4ZDg1ZDY0YjU4MTI0MjdkOWM3NWM2NTNiNmMzMTZiYS90YWJsZXJhbmdlOjhkODVkNjRiNTgxMjQyN2Q5Yzc1YzY1M2I2YzMxNmJhXzktMy0xLTEtMzE0MjI_54a369d6-0ccd-44fd-b9ac-55ef2df479e5"
      unitRef="usd">11819900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iadb0452c57794c5498c4248d6691b32c_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTo4ZDg1ZDY0YjU4MTI0MjdkOWM3NWM2NTNiNmMzMTZiYS90YWJsZXJhbmdlOjhkODVkNjRiNTgxMjQyN2Q5Yzc1YzY1M2I2YzMxNmJhXzktNS0xLTEtMzE0MjI_39d62a6d-a618-4b98-90a3-4446d6b752b8"
      unitRef="usd">11370300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ia30145a9cfd34adf9f91e6f9a1d897d6_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzEtMS0xLTEtMzE0MjI_f820a324-a129-4071-9e34-7e1855a7e394"
      unitRef="usd">585200000</us-gaap:AccountsReceivableNetCurrent>
    <vtrs:AccountsReceivableSalesProvisionsCurrent
      contextRef="i81f43377851f4e9cbe28368c42243f3f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzEtMy0xLTEtMzE0MjI_3e8e2d28-4bc9-46af-89dd-e42e62b721b9"
      unitRef="usd">5530100000</vtrs:AccountsReceivableSalesProvisionsCurrent>
    <vtrs:AccountsReceivableIncreaseDueToAcquisitionCurrent
      contextRef="i81f43377851f4e9cbe28368c42243f3f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzEtNS0xLTEtMzE0MjI_8f9074c8-57d6-43ff-b85a-afc07d9468e3"
      unitRef="usd">63400000</vtrs:AccountsReceivableIncreaseDueToAcquisitionCurrent>
    <vtrs:AccountsReceivableCreditsIssuedtoThirdParties
      contextRef="i81f43377851f4e9cbe28368c42243f3f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzEtNy0xLTEtMzE0MjI_1f73e02c-a785-4612-9e67-72cdeb0c791c"
      unitRef="usd">5585400000</vtrs:AccountsReceivableCreditsIssuedtoThirdParties>
    <vtrs:AccountsReceivableEffectsofForeignExchangeRates
      contextRef="i81f43377851f4e9cbe28368c42243f3f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzEtOS0xLTEtMzE0MjI_1896b889-ae27-4c42-b814-919336c7ce42"
      unitRef="usd">-1600000</vtrs:AccountsReceivableEffectsofForeignExchangeRates>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="if864aa5c3fc0487aa3a78da7140b6dae_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzEtMTEtMS0xLTMxNDIy_f4a42e12-8943-4ca1-b6c5-8e20757de32a"
      unitRef="usd">591700000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i59d64e28e4b04c0d99f30844bbc4e104_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzItMS0xLTEtMzE0MjI_8cb83522-a5e0-4945-9a2e-a9ded635c1e3"
      unitRef="usd">1576300000</us-gaap:AccountsReceivableNetCurrent>
    <vtrs:AccountsReceivableSalesProvisionsCurrent
      contextRef="i67c331d11f9e4f3a92ca17c2d501cc83_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzItMy0xLTEtMzE0MjI_10b4c23d-d9ca-476d-b070-f0195d92f6b4"
      unitRef="usd">6135600000</vtrs:AccountsReceivableSalesProvisionsCurrent>
    <vtrs:AccountsReceivableIncreaseDueToAcquisitionCurrent
      contextRef="i67c331d11f9e4f3a92ca17c2d501cc83_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzItNS0xLTEtMzE0MjI_4c6323ab-0a1d-417e-8928-f24d8402ee6d"
      unitRef="usd">-57600000</vtrs:AccountsReceivableIncreaseDueToAcquisitionCurrent>
    <vtrs:AccountsReceivableCreditsIssuedtoThirdParties
      contextRef="i67c331d11f9e4f3a92ca17c2d501cc83_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzItNy0xLTEtMzE0MjI_4a424c7a-0542-4b3d-93c7-cfcbd5488876"
      unitRef="usd">6267100000</vtrs:AccountsReceivableCreditsIssuedtoThirdParties>
    <vtrs:AccountsReceivableEffectsofForeignExchangeRates
      contextRef="i67c331d11f9e4f3a92ca17c2d501cc83_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzItOS0xLTEtMzE0MjI_e76c03eb-2157-41a4-8eea-1baa4db3ca67"
      unitRef="usd">-14200000</vtrs:AccountsReceivableEffectsofForeignExchangeRates>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="id58d328313c7408dbd05e2611ee1d266_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzItMTEtMS0xLTMxNDIy_eaa97f80-892d-440d-98e9-cdb99347cabf"
      unitRef="usd">1373000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ie0a5fc9ab1014cc9828221ef14219272_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzMtMS0xLTEtMzE0MjI_6c984e80-4b67-4233-b011-f3324ab8b6c6"
      unitRef="usd">539900000</us-gaap:AccountsReceivableNetCurrent>
    <vtrs:AccountsReceivableSalesProvisionsCurrent
      contextRef="i62c2d36cecfc429d8366c26884930d60_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzMtMy0xLTEtMzE0MjI_7c40a8a2-3b8a-4947-86e8-4f7e58615642"
      unitRef="usd">384600000</vtrs:AccountsReceivableSalesProvisionsCurrent>
    <vtrs:AccountsReceivableIncreaseDueToAcquisitionCurrent
      contextRef="i62c2d36cecfc429d8366c26884930d60_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzMtNS0xLTEtMzE0MjI_6d518113-3b95-4518-8c51-de91ec9b07c9"
      unitRef="usd">269000000.0</vtrs:AccountsReceivableIncreaseDueToAcquisitionCurrent>
    <vtrs:AccountsReceivableCreditsIssuedtoThirdParties
      contextRef="i62c2d36cecfc429d8366c26884930d60_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzMtNy0xLTEtMzE0MjI_c00a0f63-9f07-4e3c-99b2-cf9a8c2fe3f8"
      unitRef="usd">499000000.0</vtrs:AccountsReceivableCreditsIssuedtoThirdParties>
    <vtrs:AccountsReceivableEffectsofForeignExchangeRates
      contextRef="i62c2d36cecfc429d8366c26884930d60_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzMtOS0xLTEtMzE0MjI_72bc98d4-1925-49f2-a92f-5b93314172c0"
      unitRef="usd">-7700000</vtrs:AccountsReceivableEffectsofForeignExchangeRates>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i3efb27c0d9ce4732970b87f4f7b6cadf_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzMtMTEtMS0xLTMxNDIy_79c99bfb-9b1f-4d92-83d0-e85b2e854e62"
      unitRef="usd">686800000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="iab5c4046b8d2456db70b484a5adc2c29_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzQtMS0xLTEtMzE0MjI_ec4bfa2c-a0ec-48cc-bb2f-3d61c2a40d9b"
      unitRef="usd">313300000</us-gaap:AccountsReceivableNetCurrent>
    <vtrs:AccountsReceivableSalesProvisionsCurrent
      contextRef="ie03fd9221eda4da4a0b73570d90c8f67_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzQtMy0xLTEtMzE0MjI_e4be7394-3991-472d-880d-29289529ecf6"
      unitRef="usd">689500000</vtrs:AccountsReceivableSalesProvisionsCurrent>
    <vtrs:AccountsReceivableIncreaseDueToAcquisitionCurrent
      contextRef="ie03fd9221eda4da4a0b73570d90c8f67_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzQtNS0xLTEtMzE0MjI_02bbd01e-0046-4fdc-b318-cc8ff742a50c"
      unitRef="usd">110600000</vtrs:AccountsReceivableIncreaseDueToAcquisitionCurrent>
    <vtrs:AccountsReceivableCreditsIssuedtoThirdParties
      contextRef="ie03fd9221eda4da4a0b73570d90c8f67_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzQtNy0xLTEtMzE0MjI_3b737542-c8b2-4263-8c71-b0e5f22c89b3"
      unitRef="usd">705200000</vtrs:AccountsReceivableCreditsIssuedtoThirdParties>
    <vtrs:AccountsReceivableEffectsofForeignExchangeRates
      contextRef="ie03fd9221eda4da4a0b73570d90c8f67_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzQtOS0xLTEtMzE0MjI_37e292c9-050b-44f0-9295-07190295ae2e"
      unitRef="usd">-9000000.0</vtrs:AccountsReceivableEffectsofForeignExchangeRates>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ie35e86a55b3646a392f2363a1ff84e7f_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzQtMTEtMS0xLTMxNDIy_ed1d3200-a8c9-4da2-9cac-04a80735f853"
      unitRef="usd">399200000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ib8299fb24ad740a0bc5299022149cc89_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzUtMS0xLTEtMzE0MjI_de25a40c-cbe2-4531-9719-06e498a37551"
      unitRef="usd">3014700000</us-gaap:AccountsReceivableNetCurrent>
    <vtrs:AccountsReceivableSalesProvisionsCurrent
      contextRef="i25df0d0412f4491d87734041970219e9_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzUtMy0xLTEtMzE0MjI_c46af580-3320-45c0-9fe0-e3bf7ad73af6"
      unitRef="usd">12739800000</vtrs:AccountsReceivableSalesProvisionsCurrent>
    <vtrs:AccountsReceivableIncreaseDueToAcquisitionCurrent
      contextRef="i25df0d0412f4491d87734041970219e9_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzUtNS0xLTEtMzE0MjI_2df387f7-19d1-4714-bf2a-9583307180e2"
      unitRef="usd">385400000</vtrs:AccountsReceivableIncreaseDueToAcquisitionCurrent>
    <vtrs:AccountsReceivableCreditsIssuedtoThirdParties
      contextRef="i25df0d0412f4491d87734041970219e9_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzUtNy0xLTEtMzE0MjI_c2c5dcec-aa69-45e8-803a-757faa8ecdb2"
      unitRef="usd">13056700000</vtrs:AccountsReceivableCreditsIssuedtoThirdParties>
    <vtrs:AccountsReceivableEffectsofForeignExchangeRates
      contextRef="i25df0d0412f4491d87734041970219e9_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzUtOS0xLTEtMzE0MjI_dd22b4f4-6c15-48e3-988a-9b881115d84a"
      unitRef="usd">-32500000</vtrs:AccountsReceivableEffectsofForeignExchangeRates>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ib4f62d5c61184fe0a10c432fdf606fac_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOGUyOTRiNzg1YTY0N2E3YTY3ZmIzMWJiYTYwNjM1Ni90YWJsZXJhbmdlOjA4ZTI5NGI3ODVhNjQ3YTdhNjdmYjMxYmJhNjA2MzU2XzUtMTEtMS0xLTMxNDIy_56fd3fb7-bb54-4c4c-b66f-da98be3638e1"
      unitRef="usd">3050700000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90ZXh0cmVnaW9uOjkyYTgzOGNmNmU1NDRiMTZhOWU5YjgyZjAwNmQ2MjMwXzEyMzM_342c378c-9927-49a1-8f6d-3aefe56861a3">Accounts receivable are presented net of allowances relating to these provisions, which were comprised of the following at December&#160;31, 2021 and 2020, respectively:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.661%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.652%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,688.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,802.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,362.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,211.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,050.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,014.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:ReceivablesNetCurrent
      contextRef="ib4f62d5c61184fe0a10c432fdf606fac_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyNWM5YTQ0OTUwYWE0ZDM1YjQxOWRhNmU4NzIyNzJlNi90YWJsZXJhbmdlOjI1YzlhNDQ5NTBhYTRkMzViNDE5ZGE2ZTg3MjI3MmU2XzEtMS0xLTEtMzE0MjI_b8de2bbb-bd17-46ce-8821-974746823788"
      unitRef="usd">1688600000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="ib8299fb24ad740a0bc5299022149cc89_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyNWM5YTQ0OTUwYWE0ZDM1YjQxOWRhNmU4NzIyNzJlNi90YWJsZXJhbmdlOjI1YzlhNDQ5NTBhYTRkMzViNDE5ZGE2ZTg3MjI3MmU2XzEtMy0xLTEtMzE0MjI_a7eb53c4-c231-41c1-9581-2194a26bf78a"
      unitRef="usd">1802900000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="ib4f62d5c61184fe0a10c432fdf606fac_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyNWM5YTQ0OTUwYWE0ZDM1YjQxOWRhNmU4NzIyNzJlNi90YWJsZXJhbmdlOjI1YzlhNDQ5NTBhYTRkMzViNDE5ZGE2ZTg3MjI3MmU2XzItMS0xLTEtMzE0MjI_2fb5bb83-0d1e-4667-a0f7-13c28ad2d896"
      unitRef="usd">1362100000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="ib8299fb24ad740a0bc5299022149cc89_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyNWM5YTQ0OTUwYWE0ZDM1YjQxOWRhNmU4NzIyNzJlNi90YWJsZXJhbmdlOjI1YzlhNDQ5NTBhYTRkMzViNDE5ZGE2ZTg3MjI3MmU2XzItMy0xLTEtMzE0MjI_89c69ddc-c38d-442b-9375-a8122ac327a8"
      unitRef="usd">1211800000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ib4f62d5c61184fe0a10c432fdf606fac_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyNWM5YTQ0OTUwYWE0ZDM1YjQxOWRhNmU4NzIyNzJlNi90YWJsZXJhbmdlOjI1YzlhNDQ5NTBhYTRkMzViNDE5ZGE2ZTg3MjI3MmU2XzMtMS0xLTEtMzE0MjI_52d67ab4-6537-4a41-919b-da69b5e208be"
      unitRef="usd">3050700000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ib8299fb24ad740a0bc5299022149cc89_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZToyNWM5YTQ0OTUwYWE0ZDM1YjQxOWRhNmU4NzIyNzJlNi90YWJsZXJhbmdlOjI1YzlhNDQ5NTBhYTRkMzViNDE5ZGE2ZTg3MjI3MmU2XzMtMy0xLTEtMzE0MjI_0b263ba3-dbab-4bd1-838f-c33bac641033"
      unitRef="usd">3014700000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOTI5NmJhYzRkMDc0ZTQyYmFlN2Y2NWE5NGY3MzBmOS90YWJsZXJhbmdlOjA5Mjk2YmFjNGQwNzRlNDJiYWU3ZjY1YTk0ZjczMGY5XzEtMS0xLTEtMzg0NTI_00b80f2d-97e7-4407-93b6-eef61f303475"
      unitRef="usd">3774400000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOTI5NmJhYzRkMDc0ZTQyYmFlN2Y2NWE5NGY3MzBmOS90YWJsZXJhbmdlOjA5Mjk2YmFjNGQwNzRlNDJiYWU3ZjY1YTk0ZjczMGY5XzEtMy0xLTEtMzg0NTI_a3139904-b002-4b5d-89b0-a6db149d3946"
      unitRef="usd">3891300000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOTI5NmJhYzRkMDc0ZTQyYmFlN2Y2NWE5NGY3MzBmOS90YWJsZXJhbmdlOjA5Mjk2YmFjNGQwNzRlNDJiYWU3ZjY1YTk0ZjczMGY5XzItMS0xLTEtMzg0NTI_1a92e25c-c954-494d-94ce-75c49e9a119a"
      unitRef="usd">492000000.0</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOTI5NmJhYzRkMDc0ZTQyYmFlN2Y2NWE5NGY3MzBmOS90YWJsZXJhbmdlOjA5Mjk2YmFjNGQwNzRlNDJiYWU3ZjY1YTk0ZjczMGY5XzItMy0xLTEtMzg0NTI_cf2bde30-290b-4cea-8e29-1ea18fd6b87b"
      unitRef="usd">952500000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOTI5NmJhYzRkMDc0ZTQyYmFlN2Y2NWE5NGY3MzBmOS90YWJsZXJhbmdlOjA5Mjk2YmFjNGQwNzRlNDJiYWU3ZjY1YTk0ZjczMGY5XzMtMS0xLTEtMzg0NTI_a91113de-31d7-4520-8489-7647cf781bd2"
      unitRef="usd">4266400000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90YWJsZTowOTI5NmJhYzRkMDc0ZTQyYmFlN2Y2NWE5NGY3MzBmOS90YWJsZXJhbmdlOjA5Mjk2YmFjNGQwNzRlNDJiYWU3ZjY1YTk0ZjczMGY5XzMtMy0xLTEtMzg0NTI_817f9dc4-5e7d-4609-8621-1ce8bc2b9c9f"
      unitRef="usd">4843800000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ic23fe954f12a4fafb334644ca65a1579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90ZXh0cmVnaW9uOjkyYTgzOGNmNmU1NDRiMTZhOWU5YjgyZjAwNmQ2MjMwXzMyOTg1MzQ4ODY5MDY_a63546b3-9446-4928-a5b8-55ca953e804b"
      unitRef="usd">154500000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i8aaae8d197ef43d0880965d47a937ced_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90ZXh0cmVnaW9uOjkyYTgzOGNmNmU1NDRiMTZhOWU5YjgyZjAwNmQ2MjMwXzMyOTg1MzQ4ODY5MTQ_3df7413c-f864-440d-a949-ad20423c8f45"
      unitRef="usd">159900000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i8023e485af7e4af6b209e877aaef3977_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90ZXh0cmVnaW9uOjkyYTgzOGNmNmU1NDRiMTZhOWU5YjgyZjAwNmQ2MjMwXzEwOTk1MTE2MzIwOTk_5696f291-4570-4648-9a4e-955d051e8945"
      unitRef="number">0.18</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i594757645c9e47d297a0b656a9168fb9_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90ZXh0cmVnaW9uOjkyYTgzOGNmNmU1NDRiMTZhOWU5YjgyZjAwNmQ2MjMwXzE2NDkyNjc0NDU5Nzk_60fe109f-4148-4ccc-afb8-75c70744b20c"
      unitRef="number">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ProceedsFromSaleAndCollectionOfReceivables
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90ZXh0cmVnaW9uOjkyYTgzOGNmNmU1NDRiMTZhOWU5YjgyZjAwNmQ2MjMwXzMyOTg1MzQ4ODcyMjg_363f040d-6d81-4759-a3dc-b3663529d04c"
      unitRef="usd">29600000</us-gaap:ProceedsFromSaleAndCollectionOfReceivables>
    <us-gaap:ProceedsFromSaleAndCollectionOfReceivables
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xNzgvZnJhZzo5MmE4MzhjZjZlNTQ0YjE2YTllOWI4MmYwMDZkNjIzMC90ZXh0cmVnaW9uOjkyYTgzOGNmNmU1NDRiMTZhOWU5YjgyZjAwNmQ2MjMwXzMyOTg1MzQ4ODcyMzY_3f0f7215-4c5a-416c-80f5-aa145e122051"
      unitRef="usd">153000000</us-gaap:ProceedsFromSaleAndCollectionOfReceivables>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzE3MjYz_3d1056c9-0563-439c-9c89-a56c1acdda63">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt"&gt;Acquisitions and Other Transactions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Upjohn Business Combination Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 29, 2019, Mylan, Pfizer, Upjohn, a wholly-owned subsidiary of Pfizer, and certain other affiliated entities entered into a Business Combination Agreement pursuant to which Mylan would combine with the Upjohn Business in a Reverse Morris Trust transaction. The Upjohn Business was a global, primarily off-patent branded and generic established medicines business, which includes 20 primarily off-patent solid oral dose legacy brands, such as Lyrica&#xae;, Lipitor&#xae;, Celebrex&#xae; and Viagra&#xae;. The Combination was completed on November 16, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to the Combination and pursuant to a Separation and Distribution Agreement, Pfizer had, among other things, transferred to Viatris substantially all of the assets and liabilities comprising the Upjohn Business (the Separation) and, thereafter, Pfizer had distributed to Pfizer stockholders all of the issued and outstanding shares of Viatris (the Distribution). When the Distribution and Combination were complete, Pfizer stockholders as of the record date of the Distribution owned 57% of the outstanding shares of Viatris common stock and Mylan shareholders as of immediately before the Combination owned 43% of the outstanding shares of Viatris common stock, in each case on a fully diluted basis. Viatris also made a cash payment to Pfizer equal to $12 billion, which was funded with the proceeds of debt incurred by Upjohn prior to the Combination.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The transaction involved multiple legal entity restructuring transactions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and a reverse merger acquisition with Viatris representing the legal acquirer and Mylan representing the accounting acquirer of the Upjohn Business. In accordance with &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ASC 805, Business Combinations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, Mylan is considered the accounting acquirer of the Upjohn Business and Viatris applied purchase accounting to the acquired assets and assumed liabilities of the Upjohn Business as of November 16, 2020. The debt incurred by Upjohn prior to the Combination was a liability assumed in purchase accounting. The fair value of the debt as of November 16, 2020 was $13.08&#160;billion.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The purchase price consists of the issuance of approximately 689.9&#160;million Viatris shares of common stock at a fair value of approximately $10.73&#160;billion based on the closing price of Mylan&#x2019;s ordinary shares on November 13, 2020, as reported by the NASDAQ. In accordance with U.S. GAAP, the Company used the acquisition method of accounting to account for this transaction. Under the acquisition method of accounting, the assets acquired and liabilities assumed in the transaction have been recorded at their respective estimated fair values at the acquisition date. During the twelve months ended December&#160;31, 2021 and 2020, the Company incurred acquisition related costs of approximately $234.6 million and $602.9&#160;million, respectively. Acquisition related costs were recorded primarily in SG&amp;amp;A in the consolidated statements of operations for such periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2021, adjustments were made to the preliminary purchase price recorded at December 31, 2020, and are reflected as &#x201c;Measurement Period and Other Adjustments&#x201d; in the table below. The allocation of the $10.73&#160;billion purchase price to the assets acquired and liabilities assumed under the Combination is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.046%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.981%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.131%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Preliminary Purchase Price Allocation as of December 31, 2020 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Measurement Period and Other Adjustments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Purchase Price Allocation as of December 31, 2021 (as adjusted)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets (excluding inventories and net of cash acquired)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,841.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,803.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,588.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,554.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,394.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,389.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identified intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,040.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,040.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,107.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,403.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,481.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,678.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;792.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;784.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,246.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;406.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,653.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,760.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;419.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,179.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt, including current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,076.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,076.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,656.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,657.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other noncurrent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,441.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,427.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net assets acquired (net of $415.8 of cash acquired)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,311.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,311.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;____________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.8pt"&gt;As previously reported in Viatris&#x2019; Annual Report on Form 10-K for the fiscal year ended December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;The measurement period adjustments are primarily for 1) certain working capital adjustments, an increase in litigation reserves to reflect facts and circumstances that existed as of the date of the Combination, and other adjustments and 2) the tax implications of these and other adjustments. These adjustments did not have a significant impact on the Company&#x2019;s previously reported consolidated financial statements and accordingly, the Company has not retrospectively adjusted those consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Combination enhanced each businesses&#x2019; ability to serve patients&#x2019; needs and expand their capabilities across more than 165 markets. Mylan brought a diverse portfolio across many geographies and key therapeutic areas, such as central nervous system and anesthesia, infectious disease and cardiovascular, as well as a robust pipeline, high-quality manufacturing and supply chain excellence. The Upjohn Business brought trusted, iconic brands, such as Lipitor&#xae; (atorvastatin calcium), Celebrex&#xae; (celecoxib) and Viagra&#xae; (sildenafil), and proven commercialization capabilities, including leadership positions in China and other emerging markets. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:39.6pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded a step-up in the fair value of inventory of approximately $1.43&#160;billion at the acquisition date. During the twelve months ended December 31, 2021 and 2020, the Company recorded amortization of the inventory step-up of approximately $1.19&#160;billion and $238.2 million, respectively, which is included in cost of sales in the consolidated statements of operations. The inventory step-up was fully amortized during 2021. In addition, a step-up in the fair value of property, plant and equipment of approximately $385.0&#160;million was recognized. The related depreciation is being expensed over a service life of &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzQ2NzE_7b74b1b4-9fe4-486d-b533-a57949c797fb"&gt;five&lt;/span&gt; years for machinery and equipment and between 10 and 20 years for buildings.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:39.6pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The identified intangible assets of $18.04&#160;billion are comprised of product rights and are being amortized over a weighted average useful life of 15 years. Significant assumptions utilized in the valuation of identified intangible assets were based on company specific information and projections which are not observable in the market and are thus considered Level 3 measurements as defined by U.S. GAAP. The goodwill of $2.40&#160;billion arising from the Combination consisted largely of the value of the employee workforce and products to be sold in new markets leveraging the combined entity. In addition, an allocation of the goodwill was assigned to the respective segments. None of the goodwill recognized in this transaction is expected to be deductible for income tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:39.6pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded a fair value adjustment of approximately $759.4&#160;million related to the long-term debt assumed as part of the acquisition. The fair value of long-term debt as of the Combination date was determined by broker or dealer quotations, which is classified as Level 2 in the fair value hierarchy. The total fair value adjustment is being amortized as a reduction to interest expense over the maturity dates of the related debt instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The operating results of the Upjohn Business have been included in the Company&#x2019;s consolidated statements of operations since the acquisition date. The total revenues of the Upjohn Business for the period from the acquisition date to December 31, 2020, were $866.5&#160;million and net loss, net of tax, was approximately $360.9&#160;million. The net loss for the period includes the effect of the purchase accounting adjustments and acquisition related costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:39.6pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Unaudited Pro Forma Financial Results&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents supplemental unaudited pro forma information for the Combination, as if it had occurred on January 1, 2019. The unaudited pro forma results reflect certain adjustments related to past operating performance and acquisition accounting adjustments, such as increased depreciation and amortization expense based on the fair value of assets acquired, the impact of transaction costs and the related income tax effects. The unaudited pro forma results do not include any anticipated synergies which may be achievable, or have been achieved, subsequent to the closing of the Combination. Accordingly, the unaudited pro forma results are not necessarily indicative of the results that actually would have occurred had the acquisitions been completed on the stated date above, nor are they indicative of the future operating results of Viatris and its subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.914%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(Unaudited, in millions, except per share amounts) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,284.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,582.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,483.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,873.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,206.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,205.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,207.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,206.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Transactions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2020, Viatris and Pfizer terminated their strategic collaboration for generic drugs in Japan pursuant to an amendment and termination agreement. Under the prior collaboration agreement, both parties contributed products, which Pfizer distributed to third-parties in the Japan market. Under the terms of the amendment and termination agreement, Viatris purchased all collaboration related inventory held by Pfizer. As a result of the termination, and the repurchase of collaboration inventory, the Company reduced revenue by $86.5&#160;million during the year ended December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2020, the Company entered into an agreement to acquire the related intellectual property and commercialization rights of Aspen&#x2019;s thrombosis product portfolio in Europe for &#x20ac;641.9&#160;million. The portfolio consists of well-established injectable anticoagulants sold in Europe under the brand names, and variations of the brand names, Arixtra&#xae;, Fraxiparine&#xae;, Mono-Embolex&#xae; and Orgaran&#xae;. Upon closing of the transaction in November 2020, the Company made a payment of &#x20ac;263.2&#160;million to Aspen and the remaining payment of &#x20ac;378.7&#160;million was made on June 25, 2021. The Company accounted for this transaction as an asset acquisition and recognized an intangible asset of &#x20ac;641.9&#160;million for the product rights, which is being amortized over a useful life of 8 years.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <vtrs:NumberOfProducts
      contextRef="ic831d526d86b425a838a3b514a51aa9b_I20190729"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzQ3OA_224dd55c-8d9f-4f4f-b416-8c64a0f8ba9c"
      unitRef="number">20</vtrs:NumberOfProducts>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="ic08788a5b48c49cd8ad76565947aec25_I20190729"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzExMjE_bda100b3-ed63-4af7-bb02-466a5b226a71"
      unitRef="number">0.57</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="id1612a93b9c54c9ea53906da30119111_I20190729"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzEyNDQ_cd0aa444-5441-4356-aef0-69a014349218"
      unitRef="number">0.43</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <vtrs:PaymentsforBusinessSeparation
      contextRef="i35d0a01da1c741dc96caa2bc7d221b6f_D20190729-20190729"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzEzODk_42976a89-449f-4034-9e75-357351f695fc"
      unitRef="usd">12000000000</vtrs:PaymentsforBusinessSeparation>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt
      contextRef="i14c83873ae33424385c0f6babd91bbf8_I20201116"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzIxMTM_76470b6b-06f1-453a-9c01-e5893777495c"
      unitRef="usd">13080000000.00</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="i73d9cbc916614385999dea1173262904_D20201113-20201113"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzIxNzk_482cdbac-7604-4ed2-8e7f-0bb83402d44d"
      unitRef="shares">689900000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="i73d9cbc916614385999dea1173262904_D20201113-20201113"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzIyNDY_4788f2f7-240a-4882-a236-18d7c6ac872b"
      unitRef="usd">10730000000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i383cdb78da1740a096ade479d7d4de29_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzMyOTg1MzQ5MDE3NzA_2c137aca-3eab-4bf0-8a89-ea69ccb3b520"
      unitRef="usd">234600000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i28f0f2ea42204c5aa8a8ebd404f312a7_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzI3MDU_8fae2cca-d800-4d02-b4e4-a6a012059db7"
      unitRef="usd">602900000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzE3Mjgw_865f03f9-ebec-4cb4-956c-d42505aba670">&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2021, adjustments were made to the preliminary purchase price recorded at December 31, 2020, and are reflected as &#x201c;Measurement Period and Other Adjustments&#x201d; in the table below. The allocation of the $10.73&#160;billion purchase price to the assets acquired and liabilities assumed under the Combination is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.046%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.981%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.131%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Preliminary Purchase Price Allocation as of December 31, 2020 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Measurement Period and Other Adjustments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Purchase Price Allocation as of December 31, 2021 (as adjusted)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets (excluding inventories and net of cash acquired)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,841.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,803.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,588.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,554.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,394.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,389.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identified intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,040.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,040.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,107.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,403.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,481.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,678.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;792.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;784.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,246.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;406.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,653.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,760.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;419.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,179.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt, including current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,076.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,076.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,656.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,657.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other noncurrent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,441.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,427.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net assets acquired (net of $415.8 of cash acquired)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,311.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,311.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;____________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.8pt"&gt;As previously reported in Viatris&#x2019; Annual Report on Form 10-K for the fiscal year ended December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;The measurement period adjustments are primarily for 1) certain working capital adjustments, an increase in litigation reserves to reflect facts and circumstances that existed as of the date of the Combination, and other adjustments and 2) the tax implications of these and other adjustments. These adjustments did not have a significant impact on the Company&#x2019;s previously reported consolidated financial statements and accordingly, the Company has not retrospectively adjusted those consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets
      contextRef="if6458ce2b0d942738f7ba444119cf196_I20190528"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzI4OTE_9ec17a8c-3732-43c1-8473-6630d9450e62"
      unitRef="usd">10730000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets
      contextRef="i511ad858abed4134961216e0250f69b8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzEtMS0xLTEtMzE0MjI_0f840c27-0a2c-4394-a14a-56eeb949ab5a"
      unitRef="usd">2841900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets>
    <vtrs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsCurrent
      contextRef="i383cdb78da1740a096ade479d7d4de29_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzEtMy0xLTEtMzY0MDY_c8791e6b-8962-4c4b-9888-1748e344aa87"
      unitRef="usd">-38700000</vtrs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsCurrent>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets
      contextRef="i0d755baaf2e14f4bab1de91a766aa0e6_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzEtNS0xLTEtMzY0MDY_6c7d3a34-8909-4284-afa8-611298035245"
      unitRef="usd">2803200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i511ad858abed4134961216e0250f69b8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzItMS0xLTEtMzE0MjI_ae2167d0-6225-4daa-9d57-7152897ddc9e"
      unitRef="usd">2588900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory
      contextRef="i383cdb78da1740a096ade479d7d4de29_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzItMy0xLTEtMzYzOTI_b8356384-dbd8-437b-a3fa-49a0e35f065c"
      unitRef="usd">-34200000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i0d755baaf2e14f4bab1de91a766aa0e6_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzItNS0xLTEtMzY0MDY_f7b40055-200f-4f41-9902-958dce076ca5"
      unitRef="usd">2554700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i511ad858abed4134961216e0250f69b8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzMtMS0xLTEtMzE0MjI_a040c712-2727-48c2-b528-d1ae7160e712"
      unitRef="usd">1394100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment
      contextRef="i383cdb78da1740a096ade479d7d4de29_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzMtMy0xLTEtMzYzOTM_098f2351-1175-463f-883a-6429242b7352"
      unitRef="usd">-5000000.0</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i0d755baaf2e14f4bab1de91a766aa0e6_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzMtNS0xLTEtMzY0MDY_f6f881ce-ecca-4804-9963-610241a51fe0"
      unitRef="usd">1389100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i511ad858abed4134961216e0250f69b8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzQtMS0xLTEtMzE0MjI_15a26bad-76e3-4525-824a-2cd3a7ef0456"
      unitRef="usd">18040000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i0d755baaf2e14f4bab1de91a766aa0e6_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzQtNS0xLTEtMzY0MDY_a13b514c-1adc-4993-963a-487dc41f10aa"
      unitRef="usd">18040000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:Goodwill
      contextRef="i511ad858abed4134961216e0250f69b8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzUtMS0xLTEtMzE0MjI_a0c43976-6e1a-4969-a758-8647ccf6f47b"
      unitRef="usd">2107500000</us-gaap:Goodwill>
    <vtrs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill
      contextRef="i383cdb78da1740a096ade479d7d4de29_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzUtMy0xLTEtMzY0MDY_235a5a40-61ac-4100-80d4-0aa39ccddafb"
      unitRef="usd">295600000</vtrs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill>
    <us-gaap:Goodwill
      contextRef="i0d755baaf2e14f4bab1de91a766aa0e6_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzUtNS0xLTEtMzY0MDY_9e1da8d0-af04-4535-9d07-d05dfb99e074"
      unitRef="usd">2403100000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets
      contextRef="i511ad858abed4134961216e0250f69b8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzYtMS0xLTEtMzE0MjI_f6574049-7580-4156-a8e6-bf20b4299cf8"
      unitRef="usd">1481900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets>
    <vtrs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets
      contextRef="i383cdb78da1740a096ade479d7d4de29_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzYtMy0xLTEtMzY0MDY_2a5958d3-a0ee-4ec1-bc76-6a9fc5ef7796"
      unitRef="usd">196300000</vtrs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets
      contextRef="i0d755baaf2e14f4bab1de91a766aa0e6_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzYtNS0xLTEtMzY0MDY_21063623-5516-4e61-adb1-87892664a17a"
      unitRef="usd">1678200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i511ad858abed4134961216e0250f69b8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzctMS0xLTEtMzE0MjI_b742a9d6-afbd-4a87-a93c-249883c06ebc"
      unitRef="usd">792100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <vtrs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentAssets
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzctMy0xLTEtMzY0MDY_0e9689a7-f008-43d6-a476-80eb0abf39da"
      unitRef="usd">-7400000</vtrs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i0d755baaf2e14f4bab1de91a766aa0e6_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzctNS0xLTEtMzY0MDY_b2aeb819-f852-4a9e-ab53-660df62c2b02"
      unitRef="usd">784700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="i511ad858abed4134961216e0250f69b8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzgtMS0xLTEtMzE0MjI_84a3bd7e-3194-4d6d-8a0a-3c4e66223bd0"
      unitRef="usd">29246400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <vtrs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets
      contextRef="i383cdb78da1740a096ade479d7d4de29_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzgtMy0xLTEtMzY0MDY_1f5ed306-ada8-44c5-a010-94e958ba3823"
      unitRef="usd">406600000</vtrs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="i0d755baaf2e14f4bab1de91a766aa0e6_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzgtNS0xLTEtMzY0MDY_348492f0-6239-4155-88e8-61b4263effa7"
      unitRef="usd">29653000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
      contextRef="i511ad858abed4134961216e0250f69b8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzktMS0xLTEtMzE0MjI_a5165c26-316f-46c3-be1c-406c2e10a218"
      unitRef="usd">2760200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <vtrs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesCurrent
      contextRef="i383cdb78da1740a096ade479d7d4de29_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzktMy0xLTEtMzY0MDY_ea5594ba-1a23-4e0f-8089-92a5fd279c06"
      unitRef="usd">419700000</vtrs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesCurrent>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
      contextRef="i0d755baaf2e14f4bab1de91a766aa0e6_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzktNS0xLTEtMzY0MDY_583321bd-29df-423b-ad3c-2c8db8875f87"
      unitRef="usd">3179900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt
      contextRef="i511ad858abed4134961216e0250f69b8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzEwLTEtMS0xLTMxNDIy_40294015-ff02-4547-9183-5d1caf05cfdd"
      unitRef="usd">13076200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt
      contextRef="i0d755baaf2e14f4bab1de91a766aa0e6_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzEwLTUtMS0xLTM2NDA2_f2271df3-6b1b-4e7c-a249-afc4eed1788d"
      unitRef="usd">13076200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i511ad858abed4134961216e0250f69b8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzExLTEtMS0xLTMxNDIy_025dd0e5-bee8-4134-876d-b6284983e1ab"
      unitRef="usd">1656900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <vtrs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzExLTMtMS0xLTM2NDA2_2cee92df-e250-4f67-bb18-49a2fc160934"
      unitRef="usd">1000000.0</vtrs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i0d755baaf2e14f4bab1de91a766aa0e6_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzExLTUtMS0xLTM2NDA2_3ce319b7-4069-4d1f-bff9-e4258e5c3cf8"
      unitRef="usd">1657900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities
      contextRef="i511ad858abed4134961216e0250f69b8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzEyLTEtMS0xLTMxNDIy_f93b7fb8-c750-4717-adf2-51465deff9fb"
      unitRef="usd">1441500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities>
    <vtrs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentLiabilities
      contextRef="i383cdb78da1740a096ade479d7d4de29_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzEyLTMtMS0xLTM2NDA2_532c1f13-b347-434d-a5fe-d463b5e68df1"
      unitRef="usd">-14100000</vtrs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities
      contextRef="i0d755baaf2e14f4bab1de91a766aa0e6_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzEyLTUtMS0xLTM2NDA2_20294ebc-facc-41ca-ac60-c714ab4c8499"
      unitRef="usd">1427400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="i5b06121292274e728651da9462422d99_D20201231-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzEzLTAtMS0xLTU3NDQyL3RleHRyZWdpb246NjY2NWE1ZGE0Y2ZkNDczZWJjZDllNGE2NWJmNTgxZDBfMjE5OTAyMzI1NTYwMg_8a36ec8d-c659-461c-9127-6ed4feb49424"
      unitRef="usd">415800000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets
      contextRef="i511ad858abed4134961216e0250f69b8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzEzLTEtMS0xLTMxNDIy_b6d9c7a0-855f-421e-a55f-79ed70113241"
      unitRef="usd">10311600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred
      contextRef="i383cdb78da1740a096ade479d7d4de29_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzEzLTMtMS0xLTM2NDA2_1689a0fe-1666-4747-b696-a132fed1f11a"
      unitRef="usd">0</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets
      contextRef="i0d755baaf2e14f4bab1de91a766aa0e6_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZTo4YTliMjRkNmJjNDc0OWQ5ODhjYTgwZTRkMGY5MjU0Ni90YWJsZXJhbmdlOjhhOWIyNGQ2YmM0NzQ5ZDk4OGNhODBlNGQwZjkyNTQ2XzEzLTUtMS0xLTM2NDA2_d4972907-291e-4cba-ba2f-d4a48f0e30d0"
      unitRef="usd">10311600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets>
    <vtrs:BusinessCombinationNumberOfMarketsServed
      contextRef="i0d755baaf2e14f4bab1de91a766aa0e6_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzM2MjM_a67e218e-cef8-4219-904d-af3414dda819"
      unitRef="market">165</vtrs:BusinessCombinationNumberOfMarketsServed>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory
      contextRef="i73d9cbc916614385999dea1173262904_D20201113-20201113"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzQyNzI_a1bc93f4-a46b-416c-82e0-b233f6df9c3c"
      unitRef="usd">1430000000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory>
    <vtrs:AmortizationOfInventoryStepUp
      contextRef="i383cdb78da1740a096ade479d7d4de29_D20210101-20211231"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzU0OTc1NTgxODQxMzY_8d9b1d4f-3989-47e3-955f-ade01fe98c9a"
      unitRef="usd">1190000000</vtrs:AmortizationOfInventoryStepUp>
    <vtrs:AmortizationOfInventoryStepUp
      contextRef="i28f0f2ea42204c5aa8a8ebd404f312a7_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzQ0MDI_ec73d659-0922-4a55-91a6-f3be1bac3aa8"
      unitRef="usd">238200000</vtrs:AmortizationOfInventoryStepUp>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment
      contextRef="i73d9cbc916614385999dea1173262904_D20201113-20201113"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzQ1ODY_28dc8855-657d-4dda-98ea-3caf24c7d25e"
      unitRef="usd">385000000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i06a1fb578d3742f48890eaae2166c53a_D20201113-20201113"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzQ3MjA_419bb957-6d04-4a36-9cbe-91a870bc3a65">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i796a35bd5773494f8cda6075e5980668_D20201113-20201113"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzQ3Mjc_3d55c7c5-6c20-4ca2-8964-78eb9608853b">P20Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="ib6b3029e4d7b457386fcdfda005379fc_I20201113"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzQ3ODg_05f21d1f-90cb-4b29-9931-c48bf80c1b38"
      unitRef="usd">18040000000.00</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ibd8cc0a590a946f6ada83bcfa5b58725_D20201113-20201113"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzQ4ODY_b4bbf9c3-e35e-4f01-865d-71c85d00a7f9">P15Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:Goodwill
      contextRef="ib6b3029e4d7b457386fcdfda005379fc_I20201113"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzUxNjI_0b2cd6b1-9bba-465f-983a-b0bc7c9afff6"
      unitRef="usd">2400000000</us-gaap:Goodwill>
    <vtrs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongTermDebt
      contextRef="i73d9cbc916614385999dea1173262904_D20201113-20201113"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzU3MDk_84ee124d-a35a-4a02-bd1f-77b1ff9878a6"
      unitRef="usd">759400000</vtrs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongTermDebt>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="i54dfb4c408114c26bed39da8f1d171f2_D20201113-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzYzNDU_754eb99a-ba13-43a4-8b6c-fdd66d507fef"
      unitRef="usd">866500000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="i54dfb4c408114c26bed39da8f1d171f2_D20201113-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzYzOTI_869c67fe-37f2-4e2b-89c3-85a9887895cc"
      unitRef="usd">360900000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionProFormaInformationTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzE3Mjcw_2cf6918a-aeda-4514-90fe-d3dcb6fc767c">Accordingly, the unaudited pro forma results are not necessarily indicative of the results that actually would have occurred had the acquisitions been completed on the stated date above, nor are they indicative of the future operating results of Viatris and its subsidiaries.&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.914%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(Unaudited, in millions, except per share amounts) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,284.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,582.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,483.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,873.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,206.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,205.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,207.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,206.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="i383cdb78da1740a096ade479d7d4de29_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZToxMTAxMDUxYmVkMDI0MjY1ODdiZTUyMjFhZTFjNTg5Ni90YWJsZXJhbmdlOjExMDEwNTFiZWQwMjQyNjU4N2JlNTIyMWFlMWM1ODk2XzItMS0xLTEtMzE0MjI_786435fd-2074-45d8-aa82-157a87f1b923"
      unitRef="usd">18284800000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="i28f0f2ea42204c5aa8a8ebd404f312a7_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZToxMTAxMDUxYmVkMDI0MjY1ODdiZTUyMjFhZTFjNTg5Ni90YWJsZXJhbmdlOjExMDEwNTFiZWQwMjQyNjU4N2JlNTIyMWFlMWM1ODk2XzItMy0xLTEtMzE0MjI_bacbad88-98c6-474e-973b-661b0ab2a3d6"
      unitRef="usd">21582700000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="i383cdb78da1740a096ade479d7d4de29_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZToxMTAxMDUxYmVkMDI0MjY1ODdiZTUyMjFhZTFjNTg5Ni90YWJsZXJhbmdlOjExMDEwNTFiZWQwMjQyNjU4N2JlNTIyMWFlMWM1ODk2XzMtMS0xLTEtMzE0MjI_c3d7405f-24c2-4fe1-9e54-6c85dc07a46c"
      unitRef="usd">1483700000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="i28f0f2ea42204c5aa8a8ebd404f312a7_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZToxMTAxMDUxYmVkMDI0MjY1ODdiZTUyMjFhZTFjNTg5Ni90YWJsZXJhbmdlOjExMDEwNTFiZWQwMjQyNjU4N2JlNTIyMWFlMWM1ODk2XzMtMy0xLTEtMzE0MjI_a9061638-a289-4d73-9c61-06aee278a870"
      unitRef="usd">1873500000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic
      contextRef="i383cdb78da1740a096ade479d7d4de29_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZToxMTAxMDUxYmVkMDI0MjY1ODdiZTUyMjFhZTFjNTg5Ni90YWJsZXJhbmdlOjExMDEwNTFiZWQwMjQyNjU4N2JlNTIyMWFlMWM1ODk2XzUtMS0xLTEtMzE0MjI_1550d59f-2d3f-4c66-8967-3eee5f21bded"
      unitRef="usdPerShare">1.23</us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic
      contextRef="i28f0f2ea42204c5aa8a8ebd404f312a7_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZToxMTAxMDUxYmVkMDI0MjY1ODdiZTUyMjFhZTFjNTg5Ni90YWJsZXJhbmdlOjExMDEwNTFiZWQwMjQyNjU4N2JlNTIyMWFlMWM1ODk2XzUtMy0xLTEtMzE0MjI_b9cd0c81-76dc-4237-91a1-ada47aa241c2"
      unitRef="usdPerShare">1.55</us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted
      contextRef="i383cdb78da1740a096ade479d7d4de29_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZToxMTAxMDUxYmVkMDI0MjY1ODdiZTUyMjFhZTFjNTg5Ni90YWJsZXJhbmdlOjExMDEwNTFiZWQwMjQyNjU4N2JlNTIyMWFlMWM1ODk2XzYtMS0xLTEtMzE0MjI_91639af3-9825-4108-92c0-7689cdb6e7cc"
      unitRef="usdPerShare">1.23</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted
      contextRef="i28f0f2ea42204c5aa8a8ebd404f312a7_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZToxMTAxMDUxYmVkMDI0MjY1ODdiZTUyMjFhZTFjNTg5Ni90YWJsZXJhbmdlOjExMDEwNTFiZWQwMjQyNjU4N2JlNTIyMWFlMWM1ODk2XzYtMy0xLTEtMzE0MjI_ef4bcf39-51fe-4b7b-8d29-fce2c544eba4"
      unitRef="usdPerShare">1.55</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
    <us-gaap:WeightedAverageBasicSharesOutstandingProForma
      contextRef="i383cdb78da1740a096ade479d7d4de29_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZToxMTAxMDUxYmVkMDI0MjY1ODdiZTUyMjFhZTFjNTg5Ni90YWJsZXJhbmdlOjExMDEwNTFiZWQwMjQyNjU4N2JlNTIyMWFlMWM1ODk2XzgtMS0xLTEtMzE0MjI_118cc9d8-7d90-40fb-a6d8-dcde1d086e55"
      unitRef="shares">1206800000</us-gaap:WeightedAverageBasicSharesOutstandingProForma>
    <us-gaap:WeightedAverageBasicSharesOutstandingProForma
      contextRef="i28f0f2ea42204c5aa8a8ebd404f312a7_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZToxMTAxMDUxYmVkMDI0MjY1ODdiZTUyMjFhZTFjNTg5Ni90YWJsZXJhbmdlOjExMDEwNTFiZWQwMjQyNjU4N2JlNTIyMWFlMWM1ODk2XzgtMy0xLTEtMzE0MjI_18703827-709c-404f-a953-e849c759ffa4"
      unitRef="shares">1205600000</us-gaap:WeightedAverageBasicSharesOutstandingProForma>
    <us-gaap:ProFormaWeightedAverageSharesOutstandingDiluted
      contextRef="i383cdb78da1740a096ade479d7d4de29_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZToxMTAxMDUxYmVkMDI0MjY1ODdiZTUyMjFhZTFjNTg5Ni90YWJsZXJhbmdlOjExMDEwNTFiZWQwMjQyNjU4N2JlNTIyMWFlMWM1ODk2XzktMS0xLTEtMzE0MjI_574dc6bd-e106-4e32-9c9a-ac4d354b75d0"
      unitRef="shares">1207700000</us-gaap:ProFormaWeightedAverageSharesOutstandingDiluted>
    <us-gaap:ProFormaWeightedAverageSharesOutstandingDiluted
      contextRef="i28f0f2ea42204c5aa8a8ebd404f312a7_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90YWJsZToxMTAxMDUxYmVkMDI0MjY1ODdiZTUyMjFhZTFjNTg5Ni90YWJsZXJhbmdlOjExMDEwNTFiZWQwMjQyNjU4N2JlNTIyMWFlMWM1ODk2XzktMy0xLTEtMzE0MjI_9de831cc-7566-4f49-bbe3-7a91a94fdd06"
      unitRef="shares">1206400000</us-gaap:ProFormaWeightedAverageSharesOutstandingDiluted>
    <us-gaap:InventoryFirmPurchaseCommitmentLoss
      contextRef="if4bd4b5ab32b4597b343305c1a782d79_D20201201-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzExMzc1_fb1a2187-16db-4b24-ab76-09cd632e6f52"
      unitRef="usd">86500000</us-gaap:InventoryFirmPurchaseCommitmentLoss>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i41666c68e32e49d291f852ff50719863_D20200901-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzExNTYz_ef75b6f0-dcea-4439-b23d-04953dba4966"
      unitRef="eur">641900000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i41666c68e32e49d291f852ff50719863_D20200901-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzExODM3_4737f124-6601-45bc-a24e-f180a85a715f"
      unitRef="eur">263200000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i3210d91021fb432dbd047ea2f8487a57_I20210625"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzExODc5_8889601e-6f93-43e8-bba8-65fe386f57cb"
      unitRef="eur">378700000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i41666c68e32e49d291f852ff50719863_D20200901-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzEyMDA5_ef75b6f0-dcea-4439-b23d-04953dba4966"
      unitRef="eur">641900000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i3789042552e84c75b2b33ac579e33b2f_D20200901-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODEvZnJhZzo0ZDA3ZDA0NmRiNjI0NmI4YmVhOTQyM2Y1NmIyMmExZS90ZXh0cmVnaW9uOjRkMDdkMDQ2ZGI2MjQ2YjhiZWE5NDIzZjU2YjIyYTFlXzEyMDgz_f10bb66f-7c2d-424b-aec4-58459b82c13c">P8Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90ZXh0cmVnaW9uOmNmNTk1OTZmZWI0ZjQwMThiZTUzZmY0NWEzOWNkN2ViXzIwNjE_7d52a78e-0b62-4677-b050-d6152b4d8dca">Balance Sheet Components &lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Selected balance sheet components consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and restricted cash&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;701.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;844.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;475.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash, included in other current and non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;706.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;491.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;922.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;958.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;993.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,438.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,062.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,075.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,977.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,471.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory reserves totaled $519.0 million and $353.6 million at December&#160;31, 2021 and 2020, respectively. Included as a component of cost of sales is expense related to the net realizable value of inventories of $474.9 million, $206.1 million and $399.2 million for the years ended December&#160;31, 2021, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.458%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale fixed income securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of financial instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,467.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,236.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,957.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,707.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid expenses consist primarily of prepaid rent, insurance and other individually insignificant items.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.458%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,054.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,235.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,808.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,954.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;588.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,589.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,721.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,400.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,262.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,188.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,459.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Capitalized software costs included in our consolidated balance sheets were $62.3 million and $70.9 million, net of accumulated depreciation, at December&#160;31, 2021 and 2020, respectively. The Company periodically reviews the estimated useful lives of assets and makes adjustments when appropriate. Depreciation expense was approximately $509.5 million, $289.7 million and $256.1 million for the years ended December&#160;31, 2021, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investments, clean energy investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;879.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;676.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,170.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,047.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts payable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,056.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,345.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other payables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;558.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,657.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,904.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other current liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued sales allowances&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,362.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,211.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payroll and employee benefit liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;741.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;828.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal and professional accruals, including litigation accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;715.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;362.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued restructuring&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investments, clean energy investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of financial instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,254.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,973.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,619.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,960.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other long-term obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee benefit liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;876.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,020.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax related items, including contingencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;426.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;469.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued restructuring&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other long-term obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,933.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,483.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <vtrs:ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90ZXh0cmVnaW9uOmNmNTk1OTZmZWI0ZjQwMThiZTUzZmY0NWEzOWNkN2ViXzIwNTg_ad6e74ce-ce68-407c-8ec0-a151ee66f57e">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and restricted cash&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;701.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;844.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;475.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash, included in other current and non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;706.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;491.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</vtrs:ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTphMGUzMjQ3YTA0NGY0ZmI1ODAxMzUzMzc1NGFkN2M4Mi90YWJsZXJhbmdlOmEwZTMyNDdhMDQ0ZjRmYjU4MDEzNTMzNzU0YWQ3YzgyXzEtMS0xLTEtMzE0MjI_06e1e2e3-93cf-49d2-ae5c-00d175b8d2ad"
      unitRef="usd">701200000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTphMGUzMjQ3YTA0NGY0ZmI1ODAxMzUzMzc1NGFkN2M4Mi90YWJsZXJhbmdlOmEwZTMyNDdhMDQ0ZjRmYjU4MDEzNTMzNzU0YWQ3YzgyXzEtMy0xLTEtMzE0MjI_57ad48e7-4078-4bdc-8dff-26197b10c6a3"
      unitRef="usd">844400000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="iac503b6d629d4bafb262ea6ec0b8a25e_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTphMGUzMjQ3YTA0NGY0ZmI1ODAxMzUzMzc1NGFkN2M4Mi90YWJsZXJhbmdlOmEwZTMyNDdhMDQ0ZjRmYjU4MDEzNTMzNzU0YWQ3YzgyXzEtNS0xLTEtMzE0MjI_f144d637-7864-4487-8eeb-f24e7eff14f0"
      unitRef="usd">475600000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTphMGUzMjQ3YTA0NGY0ZmI1ODAxMzUzMzc1NGFkN2M4Mi90YWJsZXJhbmdlOmEwZTMyNDdhMDQ0ZjRmYjU4MDEzNTMzNzU0YWQ3YzgyXzItMS0xLTEtMzE0MjI_6620a1d8-4fb2-4548-b554-81e0d164bcf9"
      unitRef="usd">5000000.0</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTphMGUzMjQ3YTA0NGY0ZmI1ODAxMzUzMzc1NGFkN2M4Mi90YWJsZXJhbmdlOmEwZTMyNDdhMDQ0ZjRmYjU4MDEzNTMzNzU0YWQ3YzgyXzItMy0xLTEtMzE0MjI_9b132816-0ed1-43af-8065-e63ce9a99aee"
      unitRef="usd">5600000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="iac503b6d629d4bafb262ea6ec0b8a25e_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTphMGUzMjQ3YTA0NGY0ZmI1ODAxMzUzMzc1NGFkN2M4Mi90YWJsZXJhbmdlOmEwZTMyNDdhMDQ0ZjRmYjU4MDEzNTMzNzU0YWQ3YzgyXzItNS0xLTEtMzE0MjI_bc0bfe37-32b5-4be6-ae73-cdb33686ea20"
      unitRef="usd">15500000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTphMGUzMjQ3YTA0NGY0ZmI1ODAxMzUzMzc1NGFkN2M4Mi90YWJsZXJhbmdlOmEwZTMyNDdhMDQ0ZjRmYjU4MDEzNTMzNzU0YWQ3YzgyXzMtMS0xLTEtMzE0MjI_8a6c8a91-c440-4261-a29e-8f2ab14325b7"
      unitRef="usd">706200000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTphMGUzMjQ3YTA0NGY0ZmI1ODAxMzUzMzc1NGFkN2M4Mi90YWJsZXJhbmdlOmEwZTMyNDdhMDQ0ZjRmYjU4MDEzNTMzNzU0YWQ3YzgyXzMtMy0xLTEtMzE0MjI_59b59538-62d7-47ae-bc9f-5f77173edd00"
      unitRef="usd">850000000.0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iac503b6d629d4bafb262ea6ec0b8a25e_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTphMGUzMjQ3YTA0NGY0ZmI1ODAxMzUzMzc1NGFkN2M4Mi90YWJsZXJhbmdlOmEwZTMyNDdhMDQ0ZjRmYjU4MDEzNTMzNzU0YWQ3YzgyXzMtNS0xLTEtMzE0MjI_af047b45-1fea-4bb4-b1a0-2d92570ce3bb"
      unitRef="usd">491100000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90ZXh0cmVnaW9uOmNmNTk1OTZmZWI0ZjQwMThiZTUzZmY0NWEzOWNkN2ViXzIwNTk_83d91b0f-b20e-40b4-a1e6-65e480232ffc">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;922.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;958.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;993.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,438.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,062.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,075.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,977.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,471.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZToyMjJjYjBkNTVlN2E0ZDlhYWI4ZGQ3YWQ1ZDNiNjkyMy90YWJsZXJhbmdlOjIyMmNiMGQ1NWU3YTRkOWFhYjhkZDdhZDVkM2I2OTIzXzEtMS0xLTEtMzE0MjI_164501df-3f04-4331-82f2-5b50731da217"
      unitRef="usd">922400000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZToyMjJjYjBkNTVlN2E0ZDlhYWI4ZGQ3YWQ1ZDNiNjkyMy90YWJsZXJhbmdlOjIyMmNiMGQ1NWU3YTRkOWFhYjhkZDdhZDVkM2I2OTIzXzEtMy0xLTEtMzE0MjI_1eec09d6-695a-443b-bfeb-4c1cc49dc693"
      unitRef="usd">958400000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZToyMjJjYjBkNTVlN2E0ZDlhYWI4ZGQ3YWQ1ZDNiNjkyMy90YWJsZXJhbmdlOjIyMmNiMGQ1NWU3YTRkOWFhYjhkZDdhZDVkM2I2OTIzXzItMS0xLTEtMzE0MjI_a68e3105-f6fd-4a52-b878-34d07843f258"
      unitRef="usd">993300000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZToyMjJjYjBkNTVlN2E0ZDlhYWI4ZGQ3YWQ1ZDNiNjkyMy90YWJsZXJhbmdlOjIyMmNiMGQ1NWU3YTRkOWFhYjhkZDdhZDVkM2I2OTIzXzItMy0xLTEtMzE0MjI_f281a8d7-118b-4ab2-8a62-a86a49a10ad4"
      unitRef="usd">1438100000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZToyMjJjYjBkNTVlN2E0ZDlhYWI4ZGQ3YWQ1ZDNiNjkyMy90YWJsZXJhbmdlOjIyMmNiMGQ1NWU3YTRkOWFhYjhkZDdhZDVkM2I2OTIzXzMtMS0xLTEtMzE0MjI_1a4c860e-c040-41f0-b91b-a7499da06ed7"
      unitRef="usd">2062000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZToyMjJjYjBkNTVlN2E0ZDlhYWI4ZGQ3YWQ1ZDNiNjkyMy90YWJsZXJhbmdlOjIyMmNiMGQ1NWU3YTRkOWFhYjhkZDdhZDVkM2I2OTIzXzMtMy0xLTEtMzE0MjI_6304bf4c-650a-4ea7-bba0-7801c4d8e1e8"
      unitRef="usd">3075400000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZToyMjJjYjBkNTVlN2E0ZDlhYWI4ZGQ3YWQ1ZDNiNjkyMy90YWJsZXJhbmdlOjIyMmNiMGQ1NWU3YTRkOWFhYjhkZDdhZDVkM2I2OTIzXzQtMS0xLTEtMzE0MjI_099fe197-b28e-4fbf-8ad2-50542d633d67"
      unitRef="usd">3977700000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZToyMjJjYjBkNTVlN2E0ZDlhYWI4ZGQ3YWQ1ZDNiNjkyMy90YWJsZXJhbmdlOjIyMmNiMGQ1NWU3YTRkOWFhYjhkZDdhZDVkM2I2OTIzXzQtMy0xLTEtMzE0MjI_944346c4-e068-42e1-96ac-85ceed41694e"
      unitRef="usd">5471900000</us-gaap:InventoryNet>
    <us-gaap:InventoryValuationReserves
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90ZXh0cmVnaW9uOmNmNTk1OTZmZWI0ZjQwMThiZTUzZmY0NWEzOWNkN2ViXzExODU_a3b4aea9-5fa3-473a-83b0-000124263a44"
      unitRef="usd">519000000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryValuationReserves
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90ZXh0cmVnaW9uOmNmNTk1OTZmZWI0ZjQwMThiZTUzZmY0NWEzOWNkN2ViXzExOTI_1799ad47-d60a-45b5-9b78-f75e89a97ebb"
      unitRef="usd">353600000</us-gaap:InventoryValuationReserves>
    <vtrs:Netrealizablevalueofinventoryrecognizedasexpense
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90ZXh0cmVnaW9uOmNmNTk1OTZmZWI0ZjQwMThiZTUzZmY0NWEzOWNkN2ViXzEzMjk_49aa6739-c2bc-4f7f-a711-2624b1a724b0"
      unitRef="usd">474900000</vtrs:Netrealizablevalueofinventoryrecognizedasexpense>
    <vtrs:Netrealizablevalueofinventoryrecognizedasexpense
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90ZXh0cmVnaW9uOmNmNTk1OTZmZWI0ZjQwMThiZTUzZmY0NWEzOWNkN2ViXzEzMzM_d7ee2916-1ce7-4891-acd9-cf6b646bbd5a"
      unitRef="usd">206100000</vtrs:Netrealizablevalueofinventoryrecognizedasexpense>
    <vtrs:Netrealizablevalueofinventoryrecognizedasexpense
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90ZXh0cmVnaW9uOmNmNTk1OTZmZWI0ZjQwMThiZTUzZmY0NWEzOWNkN2ViXzEzNDA_081785a3-66ac-407b-8147-2540f03d8b3e"
      unitRef="usd">399200000</vtrs:Netrealizablevalueofinventoryrecognizedasexpense>
    <us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90ZXh0cmVnaW9uOmNmNTk1OTZmZWI0ZjQwMThiZTUzZmY0NWEzOWNkN2ViXzIwNDI_b766b466-8c0f-409b-b112-4b02ae3479d7">&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.458%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale fixed income securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of financial instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,467.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,236.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,957.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,707.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTo5NTU3YWVjYTk1N2E0NWNhOGNmYTc4MDQ4NWQyZDBlMy90YWJsZXJhbmdlOjk1NTdhZWNhOTU3YTQ1Y2E4Y2ZhNzgwNDg1ZDJkMGUzXzEtMS0xLTEtMzE0MjI_98e24883-efcf-4f0f-b4d5-be9c6eacf190"
      unitRef="usd">256700000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTo5NTU3YWVjYTk1N2E0NWNhOGNmYTc4MDQ4NWQyZDBlMy90YWJsZXJhbmdlOjk1NTdhZWNhOTU3YTQ1Y2E4Y2ZhNzgwNDg1ZDJkMGUzXzEtMy0xLTEtMzE0MjI_8f2edeef-0631-4edb-b146-20002d68299a"
      unitRef="usd">267800000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTo5NTU3YWVjYTk1N2E0NWNhOGNmYTc4MDQ4NWQyZDBlMy90YWJsZXJhbmdlOjk1NTdhZWNhOTU3YTQ1Y2E4Y2ZhNzgwNDg1ZDJkMGUzXzMtMS0xLTEtMzE0MjI_5687849e-00b2-4b45-90fc-fa52e8f66c8b"
      unitRef="usd">38200000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTo5NTU3YWVjYTk1N2E0NWNhOGNmYTc4MDQ4NWQyZDBlMy90YWJsZXJhbmdlOjk1NTdhZWNhOTU3YTQ1Y2E4Y2ZhNzgwNDg1ZDJkMGUzXzMtMy0xLTEtMzE0MjI_cbf2168c-4b0f-4f69-90bc-d29127135af6"
      unitRef="usd">39100000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTo5NTU3YWVjYTk1N2E0NWNhOGNmYTc4MDQ4NWQyZDBlMy90YWJsZXJhbmdlOjk1NTdhZWNhOTU3YTQ1Y2E4Y2ZhNzgwNDg1ZDJkMGUzXzQtMS0xLTEtMzE0MjI_406b5836-de20-4cb3-8b3a-81ca4ece0767"
      unitRef="usd">144600000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTo5NTU3YWVjYTk1N2E0NWNhOGNmYTc4MDQ4NWQyZDBlMy90YWJsZXJhbmdlOjk1NTdhZWNhOTU3YTQ1Y2E4Y2ZhNzgwNDg1ZDJkMGUzXzQtMy0xLTEtMzE0MjI_1f81a41f-a56d-4f95-94e9-cd131026bc5c"
      unitRef="usd">118600000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTo5NTU3YWVjYTk1N2E0NWNhOGNmYTc4MDQ4NWQyZDBlMy90YWJsZXJhbmdlOjk1NTdhZWNhOTU3YTQ1Y2E4Y2ZhNzgwNDg1ZDJkMGUzXzUtMS0xLTEtMzE0MjI_bf938a30-8572-4bda-9a62-b718a9db7cf8"
      unitRef="usd">51000000.0</us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent>
    <us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTo5NTU3YWVjYTk1N2E0NWNhOGNmYTc4MDQ4NWQyZDBlMy90YWJsZXJhbmdlOjk1NTdhZWNhOTU3YTQ1Y2E4Y2ZhNzgwNDg1ZDJkMGUzXzUtMy0xLTEtMzE0MjI_ba46d00f-614b-419f-8b2b-9b979f6e1267"
      unitRef="usd">45800000</us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTo5NTU3YWVjYTk1N2E0NWNhOGNmYTc4MDQ4NWQyZDBlMy90YWJsZXJhbmdlOjk1NTdhZWNhOTU3YTQ1Y2E4Y2ZhNzgwNDg1ZDJkMGUzXzYtMS0xLTEtMzE0MjI_4d06d3d2-bc67-4ea0-a530-ac263f9be484"
      unitRef="usd">1467100000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTo5NTU3YWVjYTk1N2E0NWNhOGNmYTc4MDQ4NWQyZDBlMy90YWJsZXJhbmdlOjk1NTdhZWNhOTU3YTQ1Y2E4Y2ZhNzgwNDg1ZDJkMGUzXzYtMy0xLTEtMzE0MjI_1d86aeed-b992-4ca1-9167-5fcb6b307db0"
      unitRef="usd">1236100000</us-gaap:OtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTo5NTU3YWVjYTk1N2E0NWNhOGNmYTc4MDQ4NWQyZDBlMy90YWJsZXJhbmdlOjk1NTdhZWNhOTU3YTQ1Y2E4Y2ZhNzgwNDg1ZDJkMGUzXzctMS0xLTEtMzE0MjI_de737564-7fa7-4719-aec1-594729581372"
      unitRef="usd">1957600000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTo5NTU3YWVjYTk1N2E0NWNhOGNmYTc4MDQ4NWQyZDBlMy90YWJsZXJhbmdlOjk1NTdhZWNhOTU3YTQ1Y2E4Y2ZhNzgwNDg1ZDJkMGUzXzctMy0xLTEtMzE0MjI_2915e38f-6c9a-45db-b389-7c4ae23801ce"
      unitRef="usd">1707400000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90ZXh0cmVnaW9uOmNmNTk1OTZmZWI0ZjQwMThiZTUzZmY0NWEzOWNkN2ViXzIwMzY_22b3e3a2-d983-4852-97a8-e55d58df8792">&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.458%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,054.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,235.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,808.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,954.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;588.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,589.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,721.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,400.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,262.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,188.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,459.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i0ccfb22de62b4dbfb381e7e2a79f34d0_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplNmEzNGZlYTEyNWM0YzQ4OThkMDE5NjMwNjA3YWM4My90YWJsZXJhbmdlOmU2YTM0ZmVhMTI1YzRjNDg5OGQwMTk2MzA2MDdhYzgzXzEtMS0xLTEtMzE0MjI_9954e468-305e-4df0-a507-24aae2f5e272"
      unitRef="usd">3054000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i97ba3f8ae46a4aaab4fc9b30066a831a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplNmEzNGZlYTEyNWM0YzQ4OThkMDE5NjMwNjA3YWM4My90YWJsZXJhbmdlOmU2YTM0ZmVhMTI1YzRjNDg5OGQwMTk2MzA2MDdhYzgzXzEtMy0xLTEtMzE0MjI_dee77fff-3c49-4032-b503-885219c2e2c6"
      unitRef="usd">3235000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i8bf94f5dfaca4ac4a4aee298a2a67610_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplNmEzNGZlYTEyNWM0YzQ4OThkMDE5NjMwNjA3YWM4My90YWJsZXJhbmdlOmU2YTM0ZmVhMTI1YzRjNDg5OGQwMTk2MzA2MDdhYzgzXzItMS0xLTEtMzE0MjI_72254c5e-3d18-4c71-ba82-aa4fa0f9d450"
      unitRef="usd">1808500000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i9b4491a3703940ab85025237197bb24e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplNmEzNGZlYTEyNWM0YzQ4OThkMDE5NjMwNjA3YWM4My90YWJsZXJhbmdlOmU2YTM0ZmVhMTI1YzRjNDg5OGQwMTk2MzA2MDdhYzgzXzItMy0xLTEtMzE0MjI_e27744b5-99a1-4b95-9be0-4e7764067c3f"
      unitRef="usd">1954800000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ie99bf64200a74c20a3b7166e800c0872_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplNmEzNGZlYTEyNWM0YzQ4OThkMDE5NjMwNjA3YWM4My90YWJsZXJhbmdlOmU2YTM0ZmVhMTI1YzRjNDg5OGQwMTk2MzA2MDdhYzgzXzMtMS0xLTEtMzE0MjI_a525b8ee-fb25-4aed-a8d0-30d591423b73"
      unitRef="usd">588700000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="id8ad288402464acb99bb2fd89ae7fe54_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplNmEzNGZlYTEyNWM0YzQ4OThkMDE5NjMwNjA3YWM4My90YWJsZXJhbmdlOmU2YTM0ZmVhMTI1YzRjNDg5OGQwMTk2MzA2MDdhYzgzXzMtMy0xLTEtMzE0MjI_1d5e4d83-58c5-411d-ab5a-70f5b4ca922a"
      unitRef="usd">376300000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i5ebc8189c1fd4f9aaed3d986d6412d72_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplNmEzNGZlYTEyNWM0YzQ4OThkMDE5NjMwNjA3YWM4My90YWJsZXJhbmdlOmU2YTM0ZmVhMTI1YzRjNDg5OGQwMTk2MzA2MDdhYzgzXzQtMS0xLTEtMzE0MjI_00c7dc92-0136-461d-b145-87ae75a48724"
      unitRef="usd">137900000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i0bb3fb3a406f4ceab9b6b622c49f1572_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplNmEzNGZlYTEyNWM0YzQ4OThkMDE5NjMwNjA3YWM4My90YWJsZXJhbmdlOmU2YTM0ZmVhMTI1YzRjNDg5OGQwMTk2MzA2MDdhYzgzXzQtMy0xLTEtMzE0MjI_d7b3b703-3149-4848-8bd8-2003bfb3408d"
      unitRef="usd">155800000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplNmEzNGZlYTEyNWM0YzQ4OThkMDE5NjMwNjA3YWM4My90YWJsZXJhbmdlOmU2YTM0ZmVhMTI1YzRjNDg5OGQwMTk2MzA2MDdhYzgzXzUtMS0xLTEtMzE0MjI_1c10b1d5-a6dd-4642-bb3f-7d236041ac95"
      unitRef="usd">5589100000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplNmEzNGZlYTEyNWM0YzQ4OThkMDE5NjMwNjA3YWM4My90YWJsZXJhbmdlOmU2YTM0ZmVhMTI1YzRjNDg5OGQwMTk2MzA2MDdhYzgzXzUtMy0xLTEtMzE0MjI_c56b22fe-fc5b-4c14-b58b-d3a01602b662"
      unitRef="usd">5721900000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplNmEzNGZlYTEyNWM0YzQ4OThkMDE5NjMwNjA3YWM4My90YWJsZXJhbmdlOmU2YTM0ZmVhMTI1YzRjNDg5OGQwMTk2MzA2MDdhYzgzXzYtMS0xLTEtMzE0MjI_c8285580-e971-49f9-a4f3-9570d18f0aff"
      unitRef="usd">2400500000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplNmEzNGZlYTEyNWM0YzQ4OThkMDE5NjMwNjA3YWM4My90YWJsZXJhbmdlOmU2YTM0ZmVhMTI1YzRjNDg5OGQwMTk2MzA2MDdhYzgzXzYtMy0xLTEtMzE0MjI_11528869-5891-4a0e-877a-cadf6ec76ad2"
      unitRef="usd">2262000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplNmEzNGZlYTEyNWM0YzQ4OThkMDE5NjMwNjA3YWM4My90YWJsZXJhbmdlOmU2YTM0ZmVhMTI1YzRjNDg5OGQwMTk2MzA2MDdhYzgzXzctMS0xLTEtMzE0MjI_07d376fc-fd6f-4cc0-8fb9-2262ee82b301"
      unitRef="usd">3188600000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplNmEzNGZlYTEyNWM0YzQ4OThkMDE5NjMwNjA3YWM4My90YWJsZXJhbmdlOmU2YTM0ZmVhMTI1YzRjNDg5OGQwMTk2MzA2MDdhYzgzXzctMy0xLTEtMzE0MjI_7deef311-29a5-49dc-ba4e-95eb4b2a21b9"
      unitRef="usd">3459900000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:CapitalizedComputerSoftwareNet
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90ZXh0cmVnaW9uOmNmNTk1OTZmZWI0ZjQwMThiZTUzZmY0NWEzOWNkN2ViXzE2MzE_9d9f1794-6cfe-4816-b028-29c2a278329d"
      unitRef="usd">62300000</us-gaap:CapitalizedComputerSoftwareNet>
    <us-gaap:CapitalizedComputerSoftwareNet
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90ZXh0cmVnaW9uOmNmNTk1OTZmZWI0ZjQwMThiZTUzZmY0NWEzOWNkN2ViXzE2Mzg_1b192a5b-a3e3-46a5-9761-f21ad286014a"
      unitRef="usd">70900000</us-gaap:CapitalizedComputerSoftwareNet>
    <us-gaap:Depreciation
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90ZXh0cmVnaW9uOmNmNTk1OTZmZWI0ZjQwMThiZTUzZmY0NWEzOWNkN2ViXzE4NTI_aac1ce53-8bc8-454e-a937-5b7c6f4054fc"
      unitRef="usd">509500000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90ZXh0cmVnaW9uOmNmNTk1OTZmZWI0ZjQwMThiZTUzZmY0NWEzOWNkN2ViXzE4NTY_ea28f140-997b-4de3-a4ee-3078db0cfb61"
      unitRef="usd">289700000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90ZXh0cmVnaW9uOmNmNTk1OTZmZWI0ZjQwMThiZTUzZmY0NWEzOWNkN2ViXzE4NjM_e9602172-66f1-4e04-868b-2d6a6e8f7f07"
      unitRef="usd">256100000</us-gaap:Depreciation>
    <us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90ZXh0cmVnaW9uOmNmNTk1OTZmZWI0ZjQwMThiZTUzZmY0NWEzOWNkN2ViXzIwMjU_f505963a-9dac-4a5c-880b-a8ee0bb70a6a">&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investments, clean energy investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;879.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;676.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,170.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,047.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock>
    <us-gaap:EquityMethodInvestments
      contextRef="i500543a4ebe64602995d53387c0524dd_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTo0MmJiNzk0N2M3YjU0NTNjYmNjODkwZWZhNWIwNDkzYi90YWJsZXJhbmdlOjQyYmI3OTQ3YzdiNTQ1M2NiY2M4OTBlZmE1YjA0OTNiXzEtMS0xLTEtMzE0MjI_a935307b-a38d-42fc-80c6-4cd97f2ec284"
      unitRef="usd">0</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i123b716b2a804024a0f1c41058fde09a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTo0MmJiNzk0N2M3YjU0NTNjYmNjODkwZWZhNWIwNDkzYi90YWJsZXJhbmdlOjQyYmI3OTQ3YzdiNTQ1M2NiY2M4OTBlZmE1YjA0OTNiXzEtMy0xLTEtMzE0MjI_a806ec17-a434-4737-959e-054804cd794b"
      unitRef="usd">47900000</us-gaap:EquityMethodInvestments>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTo0MmJiNzk0N2M3YjU0NTNjYmNjODkwZWZhNWIwNDkzYi90YWJsZXJhbmdlOjQyYmI3OTQ3YzdiNTQ1M2NiY2M4OTBlZmE1YjA0OTNiXzItMS0xLTEtMzE0MjI_e8c1d9f0-07c3-4ad8-a02a-5bc4be4288be"
      unitRef="usd">290800000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTo0MmJiNzk0N2M3YjU0NTNjYmNjODkwZWZhNWIwNDkzYi90YWJsZXJhbmdlOjQyYmI3OTQ3YzdiNTQ1M2NiY2M4OTBlZmE1YjA0OTNiXzItMy0xLTEtMzE0MjI_ef063561-f27d-466f-88ba-7562048c0097"
      unitRef="usd">323600000</us-gaap:OperatingLeaseRightOfUseAsset>
    <vtrs:Otherlongtermassets
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTo0MmJiNzk0N2M3YjU0NTNjYmNjODkwZWZhNWIwNDkzYi90YWJsZXJhbmdlOjQyYmI3OTQ3YzdiNTQ1M2NiY2M4OTBlZmE1YjA0OTNiXzQtMS0xLTEtMzE0MjI_dfca15f2-fa75-448e-ad91-0a8a702da82d"
      unitRef="usd">879900000</vtrs:Otherlongtermassets>
    <vtrs:Otherlongtermassets
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTo0MmJiNzk0N2M3YjU0NTNjYmNjODkwZWZhNWIwNDkzYi90YWJsZXJhbmdlOjQyYmI3OTQ3YzdiNTQ1M2NiY2M4OTBlZmE1YjA0OTNiXzQtMy0xLTEtMzE0MjI_0ad81a83-e178-47ad-86ec-c1f932560146"
      unitRef="usd">676000000.0</vtrs:Otherlongtermassets>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTo0MmJiNzk0N2M3YjU0NTNjYmNjODkwZWZhNWIwNDkzYi90YWJsZXJhbmdlOjQyYmI3OTQ3YzdiNTQ1M2NiY2M4OTBlZmE1YjA0OTNiXzUtMS0xLTEtMzE0MjI_5f30d052-bb9a-4051-9803-605d32a834ef"
      unitRef="usd">1170700000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTo0MmJiNzk0N2M3YjU0NTNjYmNjODkwZWZhNWIwNDkzYi90YWJsZXJhbmdlOjQyYmI3OTQ3YzdiNTQ1M2NiY2M4OTBlZmE1YjA0OTNiXzUtMy0xLTEtMzE0MjI_50cec800-9969-401f-90ea-8287dd7085dc"
      unitRef="usd">1047500000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90ZXh0cmVnaW9uOmNmNTk1OTZmZWI0ZjQwMThiZTUzZmY0NWEzOWNkN2ViXzIwNTA_e77138a0-c8c7-4f07-80f2-1c5c043d1663">&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts payable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,056.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,345.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other payables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;558.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,657.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,904.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccountsPayableTradeCurrentAndNoncurrent
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTpiZTY1OGRlMjgyZjQ0NzM4YThkM2Q4M2Y3ZTdkMzBkNS90YWJsZXJhbmdlOmJlNjU4ZGUyODJmNDQ3MzhhOGQzZDgzZjdlN2QzMGQ1XzEtMS0xLTEtMzE0MjI_4bf772db-075c-4963-a6a5-2311df0a1c90"
      unitRef="usd">1056100000</us-gaap:AccountsPayableTradeCurrentAndNoncurrent>
    <us-gaap:AccountsPayableTradeCurrentAndNoncurrent
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTpiZTY1OGRlMjgyZjQ0NzM4YThkM2Q4M2Y3ZTdkMzBkNS90YWJsZXJhbmdlOmJlNjU4ZGUyODJmNDQ3MzhhOGQzZDgzZjdlN2QzMGQ1XzEtMy0xLTEtMzE0MjI_4d0b266a-3145-4b82-a512-af04e561289d"
      unitRef="usd">1345700000</us-gaap:AccountsPayableTradeCurrentAndNoncurrent>
    <us-gaap:AccountsPayableOtherCurrentAndNoncurrent
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTpiZTY1OGRlMjgyZjQ0NzM4YThkM2Q4M2Y3ZTdkMzBkNS90YWJsZXJhbmdlOmJlNjU4ZGUyODJmNDQ3MzhhOGQzZDgzZjdlN2QzMGQ1XzItMS0xLTEtMzE0MjI_5abac1fb-6fec-485b-a64a-8f3fdcbbe22d"
      unitRef="usd">601300000</us-gaap:AccountsPayableOtherCurrentAndNoncurrent>
    <us-gaap:AccountsPayableOtherCurrentAndNoncurrent
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTpiZTY1OGRlMjgyZjQ0NzM4YThkM2Q4M2Y3ZTdkMzBkNS90YWJsZXJhbmdlOmJlNjU4ZGUyODJmNDQ3MzhhOGQzZDgzZjdlN2QzMGQ1XzItMy0xLTEtMzE0MjI_86ef32ab-f902-4d91-af2f-a57f41f2e069"
      unitRef="usd">558500000</us-gaap:AccountsPayableOtherCurrentAndNoncurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTpiZTY1OGRlMjgyZjQ0NzM4YThkM2Q4M2Y3ZTdkMzBkNS90YWJsZXJhbmdlOmJlNjU4ZGUyODJmNDQ3MzhhOGQzZDgzZjdlN2QzMGQ1XzMtMS0xLTEtMzE0MjI_613ee762-1aec-40cb-a455-3cda6e4a1e53"
      unitRef="usd">1657400000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTpiZTY1OGRlMjgyZjQ0NzM4YThkM2Q4M2Y3ZTdkMzBkNS90YWJsZXJhbmdlOmJlNjU4ZGUyODJmNDQ3MzhhOGQzZDgzZjdlN2QzMGQ1XzMtMy0xLTEtMzE0MjI_83dbc6ba-8d63-4f1b-af3c-99e9095f73cf"
      unitRef="usd">1904200000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90ZXh0cmVnaW9uOmNmNTk1OTZmZWI0ZjQwMThiZTUzZmY0NWEzOWNkN2ViXzIwNjA_3f01e7e8-4be4-421a-990d-e3f7a10a1077">&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other current liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued sales allowances&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,362.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,211.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payroll and employee benefit liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;741.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;828.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal and professional accruals, including litigation accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;715.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;362.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued restructuring&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investments, clean energy investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of financial instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,254.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,973.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,619.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,960.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="ib4f62d5c61184fe0a10c432fdf606fac_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplYTgzMjA1M2NiM2M0MGMzYjMwYTM5ODk3ZGVhOTcwMi90YWJsZXJhbmdlOmVhODMyMDUzY2IzYzQwYzNiMzBhMzk4OTdkZWE5NzAyXzEtMS0xLTEtMzE0MjI_2fb5bb83-0d1e-4667-a0f7-13c28ad2d896"
      unitRef="usd">1362100000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="ib8299fb24ad740a0bc5299022149cc89_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplYTgzMjA1M2NiM2M0MGMzYjMwYTM5ODk3ZGVhOTcwMi90YWJsZXJhbmdlOmVhODMyMDUzY2IzYzQwYzNiMzBhMzk4OTdkZWE5NzAyXzEtMy0xLTEtMzE0MjI_89c69ddc-c38d-442b-9375-a8122ac327a8"
      unitRef="usd">1211800000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplYTgzMjA1M2NiM2M0MGMzYjMwYTM5ODk3ZGVhOTcwMi90YWJsZXJhbmdlOmVhODMyMDUzY2IzYzQwYzNiMzBhMzk4OTdkZWE5NzAyXzItMS0xLTEtMzE0MjI_4e38103a-9989-4e0f-9b95-4a7ccf7c3f41"
      unitRef="usd">741900000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplYTgzMjA1M2NiM2M0MGMzYjMwYTM5ODk3ZGVhOTcwMi90YWJsZXJhbmdlOmVhODMyMDUzY2IzYzQwYzNiMzBhMzk4OTdkZWE5NzAyXzItMy0xLTEtMzE0MjI_05acc20a-b359-4897-bb29-b3ed221e083b"
      unitRef="usd">828200000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:LitigationReserveCurrent
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplYTgzMjA1M2NiM2M0MGMzYjMwYTM5ODk3ZGVhOTcwMi90YWJsZXJhbmdlOmVhODMyMDUzY2IzYzQwYzNiMzBhMzk4OTdkZWE5NzAyXzMtMS0xLTEtMzE0MjI_44997036-2dd0-4040-a07b-7ad1eceaf594"
      unitRef="usd">715600000</us-gaap:LitigationReserveCurrent>
    <us-gaap:LitigationReserveCurrent
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplYTgzMjA1M2NiM2M0MGMzYjMwYTM5ODk3ZGVhOTcwMi90YWJsZXJhbmdlOmVhODMyMDUzY2IzYzQwYzNiMzBhMzk4OTdkZWE5NzAyXzMtMy0xLTEtMzE0MjI_a7cf312d-b65e-4ba2-8578-99093880d778"
      unitRef="usd">362900000</us-gaap:LitigationReserveCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i2c198dc35fb64539904dc17b63908f02_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplYTgzMjA1M2NiM2M0MGMzYjMwYTM5ODk3ZGVhOTcwMi90YWJsZXJhbmdlOmVhODMyMDUzY2IzYzQwYzNiMzBhMzk4OTdkZWE5NzAyXzQtMS0xLTEtMzE0MjI_b79b03fd-7b34-41bc-ae50-18450b4d96d7"
      unitRef="usd">66700000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i869e9de1ba0e414a8a1c0e4653ab950f_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplYTgzMjA1M2NiM2M0MGMzYjMwYTM5ODk3ZGVhOTcwMi90YWJsZXJhbmdlOmVhODMyMDUzY2IzYzQwYzNiMzBhMzk4OTdkZWE5NzAyXzQtMy0xLTEtMzE0MjI_748f2fce-85d5-4c7c-ab50-4e0ae6e3d255"
      unitRef="usd">100500000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:RestructuringReserveCurrent
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplYTgzMjA1M2NiM2M0MGMzYjMwYTM5ODk3ZGVhOTcwMi90YWJsZXJhbmdlOmVhODMyMDUzY2IzYzQwYzNiMzBhMzk4OTdkZWE5NzAyXzUtMS0xLTEtMzE0MjI_247071bf-67cc-4ecf-a7fd-43141d14d153"
      unitRef="usd">233500000</us-gaap:RestructuringReserveCurrent>
    <us-gaap:RestructuringReserveCurrent
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplYTgzMjA1M2NiM2M0MGMzYjMwYTM5ODk3ZGVhOTcwMi90YWJsZXJhbmdlOmVhODMyMDUzY2IzYzQwYzNiMzBhMzk4OTdkZWE5NzAyXzUtMy0xLTEtMzE0MjI_dda2ab1c-6dd9-4790-9bd7-0ad981b31780"
      unitRef="usd">149200000</us-gaap:RestructuringReserveCurrent>
    <us-gaap:OtherLiabilities
      contextRef="i2de25d7ac8784fa18767316538f59631_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplYTgzMjA1M2NiM2M0MGMzYjMwYTM5ODk3ZGVhOTcwMi90YWJsZXJhbmdlOmVhODMyMDUzY2IzYzQwYzNiMzBhMzk4OTdkZWE5NzAyXzYtMS0xLTEtMzE0MjI_2ba28b6e-5410-4d42-99e8-361ab243d31f"
      unitRef="usd">10900000</us-gaap:OtherLiabilities>
    <us-gaap:OtherLiabilities
      contextRef="i43ea997ac5374cbbb9e8b44ce8488e9c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplYTgzMjA1M2NiM2M0MGMzYjMwYTM5ODk3ZGVhOTcwMi90YWJsZXJhbmdlOmVhODMyMDUzY2IzYzQwYzNiMzBhMzk4OTdkZWE5NzAyXzYtMy0xLTEtMzE0MjI_b2199be0-ec5a-4ee7-ae7f-83f52f00811f"
      unitRef="usd">47500000</us-gaap:OtherLiabilities>
    <us-gaap:InterestPayableCurrent
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplYTgzMjA1M2NiM2M0MGMzYjMwYTM5ODk3ZGVhOTcwMi90YWJsZXJhbmdlOmVhODMyMDUzY2IzYzQwYzNiMzBhMzk4OTdkZWE5NzAyXzctMS0xLTEtMzE0MjI_833e35d6-90fc-4218-b687-0dec7619c5f7"
      unitRef="usd">86600000</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplYTgzMjA1M2NiM2M0MGMzYjMwYTM5ODk3ZGVhOTcwMi90YWJsZXJhbmdlOmVhODMyMDUzY2IzYzQwYzNiMzBhMzk4OTdkZWE5NzAyXzctMy0xLTEtMzE0MjI_aa398e40-2648-4459-8845-89cdeae2169d"
      unitRef="usd">90900000</us-gaap:InterestPayableCurrent>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplYTgzMjA1M2NiM2M0MGMzYjMwYTM5ODk3ZGVhOTcwMi90YWJsZXJhbmdlOmVhODMyMDUzY2IzYzQwYzNiMzBhMzk4OTdkZWE5NzAyXzgtMS0xLTEtMzE0MjI_310ee247-a63d-4420-857d-7de7a325a0fe"
      unitRef="usd">61000000.0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplYTgzMjA1M2NiM2M0MGMzYjMwYTM5ODk3ZGVhOTcwMi90YWJsZXJhbmdlOmVhODMyMDUzY2IzYzQwYzNiMzBhMzk4OTdkZWE5NzAyXzgtMy0xLTEtMzE0MjI_5c7989cc-4a6a-45a6-a996-23cd7c0db23d"
      unitRef="usd">103600000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplYTgzMjA1M2NiM2M0MGMzYjMwYTM5ODk3ZGVhOTcwMi90YWJsZXJhbmdlOmVhODMyMDUzY2IzYzQwYzNiMzBhMzk4OTdkZWE5NzAyXzktMS0xLTEtMzE0MjI_f580282d-ef39-456f-b999-d367b38d124d"
      unitRef="usd">86700000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplYTgzMjA1M2NiM2M0MGMzYjMwYTM5ODk3ZGVhOTcwMi90YWJsZXJhbmdlOmVhODMyMDUzY2IzYzQwYzNiMzBhMzk4OTdkZWE5NzAyXzktMy0xLTEtMzE0MjI_7c2b75c1-e9fa-4f77-ae67-28a492a8850c"
      unitRef="usd">92900000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplYTgzMjA1M2NiM2M0MGMzYjMwYTM5ODk3ZGVhOTcwMi90YWJsZXJhbmdlOmVhODMyMDUzY2IzYzQwYzNiMzBhMzk4OTdkZWE5NzAyXzEwLTEtMS0xLTMxNDIy_07e48323-3bd7-4c59-8182-b2102f321f4e"
      unitRef="usd">1254600000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplYTgzMjA1M2NiM2M0MGMzYjMwYTM5ODk3ZGVhOTcwMi90YWJsZXJhbmdlOmVhODMyMDUzY2IzYzQwYzNiMzBhMzk4OTdkZWE5NzAyXzEwLTMtMS0xLTMxNDIy_34233dd3-565c-4f91-9704-d18b9e8453d0"
      unitRef="usd">1973200000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplYTgzMjA1M2NiM2M0MGMzYjMwYTM5ODk3ZGVhOTcwMi90YWJsZXJhbmdlOmVhODMyMDUzY2IzYzQwYzNiMzBhMzk4OTdkZWE5NzAyXzExLTEtMS0xLTMxNDIy_19c5bf17-b683-4657-a392-18ed73a211ef"
      unitRef="usd">4619600000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTplYTgzMjA1M2NiM2M0MGMzYjMwYTM5ODk3ZGVhOTcwMi90YWJsZXJhbmdlOmVhODMyMDUzY2IzYzQwYzNiMzBhMzk4OTdkZWE5NzAyXzExLTMtMS0xLTMxNDIy_3e87b56b-c02c-4cad-abf8-beaad471c475"
      unitRef="usd">4960700000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherNoncurrentLiabilitiesTableTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90ZXh0cmVnaW9uOmNmNTk1OTZmZWI0ZjQwMThiZTUzZmY0NWEzOWNkN2ViXzIwMjQ_11abcba6-81b5-4e6c-a627-18cd3282b2b5">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee benefit liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;876.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,020.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax related items, including contingencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;426.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;469.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued restructuring&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other long-term obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,933.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,483.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:OtherNoncurrentLiabilitiesTableTextBlock>
    <us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTpkOTYwM2FhNWI4MWU0YjY2YTE0ODQwOTJjYTRhMmFhMy90YWJsZXJhbmdlOmQ5NjAzYWE1YjgxZTRiNjZhMTQ4NDA5MmNhNGEyYWEzXzEtMS0xLTEtMzE0MjI_6670a58e-62db-4e60-b24e-d9a1608e39b3"
      unitRef="usd">876400000</us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent>
    <us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTpkOTYwM2FhNWI4MWU0YjY2YTE0ODQwOTJjYTRhMmFhMy90YWJsZXJhbmdlOmQ5NjAzYWE1YjgxZTRiNjZhMTQ4NDA5MmNhNGEyYWEzXzEtMy0xLTEtMzE0MjI_76786508-ef20-4d8d-a0fa-d63860c6beea"
      unitRef="usd">1020400000</us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i8416dfbb7a5942b691bd8f0154ec826e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTpkOTYwM2FhNWI4MWU0YjY2YTE0ODQwOTJjYTRhMmFhMy90YWJsZXJhbmdlOmQ5NjAzYWE1YjgxZTRiNjZhMTQ4NDA5MmNhNGEyYWEzXzMtMS0xLTEtMzE0MjI_cbe5954d-cb2f-406f-95c6-57b98acbe32c"
      unitRef="usd">133000000.0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ia89d28ed480a4556840f217684004588_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTpkOTYwM2FhNWI4MWU0YjY2YTE0ODQwOTJjYTRhMmFhMy90YWJsZXJhbmdlOmQ5NjAzYWE1YjgxZTRiNjZhMTQ4NDA5MmNhNGEyYWEzXzMtMy0xLTEtMzE0MjI_ac5db8ea-da89-4ca3-9320-9f8775d95749"
      unitRef="usd">123100000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:LiabilityForUncertainTaxPositionsNoncurrent
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTpkOTYwM2FhNWI4MWU0YjY2YTE0ODQwOTJjYTRhMmFhMy90YWJsZXJhbmdlOmQ5NjAzYWE1YjgxZTRiNjZhMTQ4NDA5MmNhNGEyYWEzXzQtMS0xLTEtMzE0MjI_e84effd9-7a3c-40c3-ad60-2d390eb33cc0"
      unitRef="usd">426100000</us-gaap:LiabilityForUncertainTaxPositionsNoncurrent>
    <us-gaap:LiabilityForUncertainTaxPositionsNoncurrent
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTpkOTYwM2FhNWI4MWU0YjY2YTE0ODQwOTJjYTRhMmFhMy90YWJsZXJhbmdlOmQ5NjAzYWE1YjgxZTRiNjZhMTQ4NDA5MmNhNGEyYWEzXzQtMy0xLTEtMzE0MjI_49f18046-c801-4f21-b3ae-2bb6711c7a65"
      unitRef="usd">469500000</us-gaap:LiabilityForUncertainTaxPositionsNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTpkOTYwM2FhNWI4MWU0YjY2YTE0ODQwOTJjYTRhMmFhMy90YWJsZXJhbmdlOmQ5NjAzYWE1YjgxZTRiNjZhMTQ4NDA5MmNhNGEyYWEzXzUtMS0xLTEtMzE0MjI_8b5dc6bc-1206-4186-ac60-c34bcf6e1c19"
      unitRef="usd">200900000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTpkOTYwM2FhNWI4MWU0YjY2YTE0ODQwOTJjYTRhMmFhMy90YWJsZXJhbmdlOmQ5NjAzYWE1YjgxZTRiNjZhMTQ4NDA5MmNhNGEyYWEzXzUtMy0xLTEtMzE0MjI_d808dea1-6d5b-40ed-8b22-8624ab151147"
      unitRef="usd">229500000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:RestructuringReserveNoncurrent
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTpkOTYwM2FhNWI4MWU0YjY2YTE0ODQwOTJjYTRhMmFhMy90YWJsZXJhbmdlOmQ5NjAzYWE1YjgxZTRiNjZhMTQ4NDA5MmNhNGEyYWEzXzYtMS0xLTEtMzE0MjI_d9b1a5b9-6688-4428-ae43-b69020bbf9d6"
      unitRef="usd">64300000</us-gaap:RestructuringReserveNoncurrent>
    <us-gaap:RestructuringReserveNoncurrent
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTpkOTYwM2FhNWI4MWU0YjY2YTE0ODQwOTJjYTRhMmFhMy90YWJsZXJhbmdlOmQ5NjAzYWE1YjgxZTRiNjZhMTQ4NDA5MmNhNGEyYWEzXzYtMy0xLTEtMzE0MjI_34ba86a9-0e99-47f2-8d0e-42db58da73e1"
      unitRef="usd">134800000</us-gaap:RestructuringReserveNoncurrent>
    <us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTpkOTYwM2FhNWI4MWU0YjY2YTE0ODQwOTJjYTRhMmFhMy90YWJsZXJhbmdlOmQ5NjAzYWE1YjgxZTRiNjZhMTQ4NDA5MmNhNGEyYWEzXzctMS0xLTEtMzE0MjI_91c3c179-e90a-4605-aa35-3ca59ded5316"
      unitRef="usd">232900000</us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent>
    <us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTpkOTYwM2FhNWI4MWU0YjY2YTE0ODQwOTJjYTRhMmFhMy90YWJsZXJhbmdlOmQ5NjAzYWE1YjgxZTRiNjZhMTQ4NDA5MmNhNGEyYWEzXzctMy0xLTEtMzE0MjI_2c899f08-a4ff-4228-803b-8d8eaf3499ee"
      unitRef="usd">505800000</us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTpkOTYwM2FhNWI4MWU0YjY2YTE0ODQwOTJjYTRhMmFhMy90YWJsZXJhbmdlOmQ5NjAzYWE1YjgxZTRiNjZhMTQ4NDA5MmNhNGEyYWEzXzgtMS0xLTEtMzE0MjI_e52675df-777c-4c56-bc28-58ec291e222d"
      unitRef="usd">1933600000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xODQvZnJhZzpjZjU5NTk2ZmViNGY0MDE4YmU1M2ZmNDVhMzljZDdlYi90YWJsZTpkOTYwM2FhNWI4MWU0YjY2YTE0ODQwOTJjYTRhMmFhMy90YWJsZXJhbmdlOmQ5NjAzYWE1YjgxZTRiNjZhMTQ4NDA5MmNhNGEyYWEzXzgtMy0xLTEtMzE0MjI_114ce50f-e2bb-4cfb-9f49-e868652a7b28"
      unitRef="usd">2483100000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTAvZnJhZzozNjczMjc1N2I5MDE0MTgwODFjMDAyZDFiNDE2Y2IwYi90ZXh0cmVnaW9uOjM2NzMyNzU3YjkwMTQxODA4MWMwMDJkMWI0MTZjYjBiXzE3MzA_6a10e2c6-cbd0-4e3f-8380-8b9aeb0692b9">Leases&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has operating leases of real estate, consisting primarily of administrative offices, manufacturing and distribution facilities, and R&amp;amp;D facilities. We also have operating leases of certain equipment, primarily automobiles, and certain limited supply arrangements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We elected to apply the practical expedient to not separate lease and non-lease components for our leases except for those related to certain limited supply arrangements. We have also elected to apply the short-term lease recognition exemption which means we will not recognize ROU assets or lease liabilities for leases with an initial term of 12 months of less.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, the Company recognized ROU assets of $290.8 million and total lease liabilities of $287.6 million. The Company&#x2019;s ROU assets are recorded in other assets. The related lease liability balances are recorded in other current liabilities and other long-term obligations in the consolidated balance sheets. Refer to Note 5 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Balance Sheet Components&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ROU assets and liabilities are recognized at the present value of the future minimum lease payments over the lease term at commencement date. As most of our leases do not provide an implicit rate, we use an applicable incremental borrowing rate based on the information available at commencement date in determining the present value of future payments. Options to extend or terminate the ROU assets are reviewed at lease inception and these options are accounted for when they are reasonably certain of being exercised.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remaining lease terms&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1 year to 23 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, maturities of lease liabilities were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:89.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.753%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, we have additional operating leases, primarily for administrative offices, that have not yet commenced totaling approximately $13.6 million. These leases are expected to commence in 2022 and have lease terms of 5 to 9 years. For the years ended December&#160;31, 2021, 2020 and 2019, the Company had operating lease expense of approximately $97.6 million, $80.7 million and $87.6 million, respectively. Operating lease costs are classified primarily as selling, general and administrative expenses and cost of sales in the consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTAvZnJhZzozNjczMjc1N2I5MDE0MTgwODFjMDAyZDFiNDE2Y2IwYi90ZXh0cmVnaW9uOjM2NzMyNzU3YjkwMTQxODA4MWMwMDJkMWI0MTZjYjBiXzMzNw_e8c1d9f0-07c3-4ad8-a02a-5bc4be4288be"
      unitRef="usd">290800000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTAvZnJhZzozNjczMjc1N2I5MDE0MTgwODFjMDAyZDFiNDE2Y2IwYi90ZXh0cmVnaW9uOjM2NzMyNzU3YjkwMTQxODA4MWMwMDJkMWI0MTZjYjBiXzM3MQ_83f9fbb6-461f-4154-b070-e9f94406db72"
      unitRef="usd">287600000</us-gaap:OperatingLeaseLiability>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTAvZnJhZzozNjczMjc1N2I5MDE0MTgwODFjMDAyZDFiNDE2Y2IwYi90ZXh0cmVnaW9uOjM2NzMyNzU3YjkwMTQxODA4MWMwMDJkMWI0MTZjYjBiXzE3MzE_53739172-5012-42a2-b40d-c9f7688044a2">&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remaining lease terms&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1 year to 23 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="id8227b4a3c2c48d0b659fec7ce3966a0_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTAvZnJhZzozNjczMjc1N2I5MDE0MTgwODFjMDAyZDFiNDE2Y2IwYi90YWJsZTplMGNiZTEzNDJiMWE0ODcwYTFlNzNiZGVmYTdmOTdhNC90YWJsZXJhbmdlOmUwY2JlMTM0MmIxYTQ4NzBhMWU3M2JkZWZhN2Y5N2E0XzEtMS0xLTEtMzE0MjIvdGV4dHJlZ2lvbjozOGVkNTRlZDZhNDk0ZGZhOWQyZjMzYWUwYWFkZmI0YV80_6bcb0b71-e1c4-4ebb-9524-c8655ea3536e">P1Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="if35fa5c71ccb4d9cbe31d2dd6c8f7b48_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTAvZnJhZzozNjczMjc1N2I5MDE0MTgwODFjMDAyZDFiNDE2Y2IwYi90YWJsZTplMGNiZTEzNDJiMWE0ODcwYTFlNzNiZGVmYTdmOTdhNC90YWJsZXJhbmdlOmUwY2JlMTM0MmIxYTQ4NzBhMWU3M2JkZWZhN2Y5N2E0XzEtMS0xLTEtMzE0MjIvdGV4dHJlZ2lvbjozOGVkNTRlZDZhNDk0ZGZhOWQyZjMzYWUwYWFkZmI0YV8xNQ_804cfa36-57d1-4193-9ac1-2a2be2ea69fe">P23Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTAvZnJhZzozNjczMjc1N2I5MDE0MTgwODFjMDAyZDFiNDE2Y2IwYi90YWJsZTplMGNiZTEzNDJiMWE0ODcwYTFlNzNiZGVmYTdmOTdhNC90YWJsZXJhbmdlOmUwY2JlMTM0MmIxYTQ4NzBhMWU3M2JkZWZhN2Y5N2E0XzItMS0xLTEtMzE0MjI_4d135ebe-f440-4256-8866-ac55e6ef9d84">P6Y</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTAvZnJhZzozNjczMjc1N2I5MDE0MTgwODFjMDAyZDFiNDE2Y2IwYi90YWJsZTplMGNiZTEzNDJiMWE0ODcwYTFlNzNiZGVmYTdmOTdhNC90YWJsZXJhbmdlOmUwY2JlMTM0MmIxYTQ4NzBhMWU3M2JkZWZhN2Y5N2E0XzMtMS0xLTEtMzE0MjI_8e8bdd37-4d63-4a0f-9643-b70e83fc9c92"
      unitRef="number">0.026</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTAvZnJhZzozNjczMjc1N2I5MDE0MTgwODFjMDAyZDFiNDE2Y2IwYi90ZXh0cmVnaW9uOjM2NzMyNzU3YjkwMTQxODA4MWMwMDJkMWI0MTZjYjBiXzE3MzI_3d50f5af-6872-44d3-a390-17fc2b027e9c">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, maturities of lease liabilities were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:89.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.753%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTAvZnJhZzozNjczMjc1N2I5MDE0MTgwODFjMDAyZDFiNDE2Y2IwYi90YWJsZTphMTk5OTcwMTFjMzA0NWFmODg3YTI3YTBmN2FhMTBhNS90YWJsZXJhbmdlOmExOTk5NzAxMWMzMDQ1YWY4ODdhMjdhMGY3YWExMGE1XzItMS0xLTEtMzE0MjI_bfb092d5-49a7-4e3d-b0a9-f1562d4cde39"
      unitRef="usd">82000000.0</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTAvZnJhZzozNjczMjc1N2I5MDE0MTgwODFjMDAyZDFiNDE2Y2IwYi90YWJsZTphMTk5OTcwMTFjMzA0NWFmODg3YTI3YTBmN2FhMTBhNS90YWJsZXJhbmdlOmExOTk5NzAxMWMzMDQ1YWY4ODdhMjdhMGY3YWExMGE1XzMtMS0xLTEtMzE0MjI_98f7ae1f-a8c8-4ee0-8a5e-f52cc8f832a1"
      unitRef="usd">65000000.0</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTAvZnJhZzozNjczMjc1N2I5MDE0MTgwODFjMDAyZDFiNDE2Y2IwYi90YWJsZTphMTk5OTcwMTFjMzA0NWFmODg3YTI3YTBmN2FhMTBhNS90YWJsZXJhbmdlOmExOTk5NzAxMWMzMDQ1YWY4ODdhMjdhMGY3YWExMGE1XzQtMS0xLTEtMzE0MjI_94c49255-6fde-4994-86d1-574972c0873d"
      unitRef="usd">42900000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTAvZnJhZzozNjczMjc1N2I5MDE0MTgwODFjMDAyZDFiNDE2Y2IwYi90YWJsZTphMTk5OTcwMTFjMzA0NWFmODg3YTI3YTBmN2FhMTBhNS90YWJsZXJhbmdlOmExOTk5NzAxMWMzMDQ1YWY4ODdhMjdhMGY3YWExMGE1XzUtMS0xLTEtMzE0MjI_9f762e60-6c84-4ed9-86df-0293574014f2"
      unitRef="usd">28800000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTAvZnJhZzozNjczMjc1N2I5MDE0MTgwODFjMDAyZDFiNDE2Y2IwYi90YWJsZTphMTk5OTcwMTFjMzA0NWFmODg3YTI3YTBmN2FhMTBhNS90YWJsZXJhbmdlOmExOTk5NzAxMWMzMDQ1YWY4ODdhMjdhMGY3YWExMGE1XzYtMS0xLTEtMzE0MjI_988a3be1-a967-4803-9ae7-434c04696b52"
      unitRef="usd">23900000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTAvZnJhZzozNjczMjc1N2I5MDE0MTgwODFjMDAyZDFiNDE2Y2IwYi90YWJsZTphMTk5OTcwMTFjMzA0NWFmODg3YTI3YTBmN2FhMTBhNS90YWJsZXJhbmdlOmExOTk5NzAxMWMzMDQ1YWY4ODdhMjdhMGY3YWExMGE1XzctMS0xLTEtMzE0MjI_f229b62b-afb2-4014-8f5a-bf218dbf76ea"
      unitRef="usd">68200000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTAvZnJhZzozNjczMjc1N2I5MDE0MTgwODFjMDAyZDFiNDE2Y2IwYi90YWJsZTphMTk5OTcwMTFjMzA0NWFmODg3YTI3YTBmN2FhMTBhNS90YWJsZXJhbmdlOmExOTk5NzAxMWMzMDQ1YWY4ODdhMjdhMGY3YWExMGE1XzgtMS0xLTEtMzE0MjI_2ec9a09a-c393-40ca-9f74-7b1224e9a646"
      unitRef="usd">310800000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTAvZnJhZzozNjczMjc1N2I5MDE0MTgwODFjMDAyZDFiNDE2Y2IwYi90YWJsZTphMTk5OTcwMTFjMzA0NWFmODg3YTI3YTBmN2FhMTBhNS90YWJsZXJhbmdlOmExOTk5NzAxMWMzMDQ1YWY4ODdhMjdhMGY3YWExMGE1XzktMS0xLTEtNTQxNzU_60a62e52-bd87-4d9c-9259-bf933bf0368b"
      unitRef="usd">23200000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTAvZnJhZzozNjczMjc1N2I5MDE0MTgwODFjMDAyZDFiNDE2Y2IwYi90YWJsZTphMTk5OTcwMTFjMzA0NWFmODg3YTI3YTBmN2FhMTBhNS90YWJsZXJhbmdlOmExOTk5NzAxMWMzMDQ1YWY4ODdhMjdhMGY3YWExMGE1XzEwLTEtMS0xLTU0MTg0_7ae53ced-25ce-47cb-9c41-3b83187da6f0"
      unitRef="usd">287600000</us-gaap:OperatingLeaseLiability>
    <vtrs:LesseeOperatingLeaseLeaseNotyetCommencedAmount
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTAvZnJhZzozNjczMjc1N2I5MDE0MTgwODFjMDAyZDFiNDE2Y2IwYi90ZXh0cmVnaW9uOjM2NzMyNzU3YjkwMTQxODA4MWMwMDJkMWI0MTZjYjBiXzE0MTA_50de222b-6f17-4ac0-92e1-22b1939a1159"
      unitRef="usd">13600000</vtrs:LesseeOperatingLeaseLeaseNotyetCommencedAmount>
    <us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1
      contextRef="id8227b4a3c2c48d0b659fec7ce3966a0_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTAvZnJhZzozNjczMjc1N2I5MDE0MTgwODFjMDAyZDFiNDE2Y2IwYi90ZXh0cmVnaW9uOjM2NzMyNzU3YjkwMTQxODA4MWMwMDJkMWI0MTZjYjBiXzE0ODQ_ae5cb41b-4582-4a79-9530-b80e62979c1c">P5Y</us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1>
    <us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1
      contextRef="if35fa5c71ccb4d9cbe31d2dd6c8f7b48_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTAvZnJhZzozNjczMjc1N2I5MDE0MTgwODFjMDAyZDFiNDE2Y2IwYi90ZXh0cmVnaW9uOjM2NzMyNzU3YjkwMTQxODA4MWMwMDJkMWI0MTZjYjBiXzE0OTA_5b2809d4-bb7a-4bba-bd85-8db8627067cd">P9Y</us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1>
    <us-gaap:PaymentsForRent
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTAvZnJhZzozNjczMjc1N2I5MDE0MTgwODFjMDAyZDFiNDE2Y2IwYi90ZXh0cmVnaW9uOjM2NzMyNzU3YjkwMTQxODA4MWMwMDJkMWI0MTZjYjBiXzE1ODY_0320d78b-a61a-44e5-b5ab-ba9a02066c16"
      unitRef="usd">97600000</us-gaap:PaymentsForRent>
    <us-gaap:PaymentsForRent
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTAvZnJhZzozNjczMjc1N2I5MDE0MTgwODFjMDAyZDFiNDE2Y2IwYi90ZXh0cmVnaW9uOjM2NzMyNzU3YjkwMTQxODA4MWMwMDJkMWI0MTZjYjBiXzE1OTA_43f2dc23-887d-446d-b791-a552151b23a9"
      unitRef="usd">80700000</us-gaap:PaymentsForRent>
    <us-gaap:PaymentsForRent
      contextRef="i284387cf86b54bd4adfef2f32bb9c670_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTAvZnJhZzozNjczMjc1N2I5MDE0MTgwODFjMDAyZDFiNDE2Y2IwYi90ZXh0cmVnaW9uOjM2NzMyNzU3YjkwMTQxODA4MWMwMDJkMWI0MTZjYjBiXzE1OTc_ea10b532-7185-440f-8123-133fdd3d8b46"
      unitRef="usd">87600000</us-gaap:PaymentsForRent>
    <us-gaap:EquityMethodInvestmentsDisclosureTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90ZXh0cmVnaW9uOjM5Y2Y1MjExZDNiNDQ3MzliZDkwN2U5NWZkYjk3ZTFiXzIyMjM_5159b627-d5b8-4403-ab70-6bd7dfd70ed2">Equity Method Investments&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had three equity method investments in limited liability companies that owned refined coal production plants whose activities qualified for income tax credits under Section 45 of the Code. The Company did not consolidate these entities as we had determined that we were not the primary beneficiary of these entities and did not have the power to individually direct the activities of these entities. Accordingly, these investments were accounted for under the equity method of accounting. For each of the clean energy investments, the Company had entered into notes payable with the respective project sponsor, which in part were paid to the sponsor as certain production levels were met. The law that provides for IRC Section 45 tax credits expired during the year ended December 31, 2021 for all three clean energy investments and all of the clean energy investments have wound down operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December 31, 2021, 2020, and 2019, the Company reduced its long-term obligations for its three investments as a result of lower than anticipated production levels and lower expected future variable debt payments to the respective project sponsor. The Company recognized a net gain of approximately $5.7&#160;million, $21.4&#160;million and&#160;$7.0 million, respectively, which was recognized as a component of the net loss of the equity method investments in the consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying values and respective balance sheet locations of the Company&#x2019;s clean energy investments were as follows at December&#160;31, 2021 and 2020, respectively:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Summarized financial information, in the aggregate, for the Company&#x2019;s significant equity method investments on a 100% basis as of December&#160;31, 2021 and 2020 and for the years ended December&#160;31, 2021, 2020 and 2019 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.272%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;385.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating and non-operating expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s net losses from its equity method investments include amortization expense related to the excess of the cost basis of the Company&#x2019;s investment over the underlying assets of each individual investee. For the years ended December&#160;31, 2021, 2020 and 2019, the Company recognized net losses from equity method investments of $61.9 million, $48.4 million, and $62.1 million, respectively, which were recognized as a component of other expense, net in the consolidated statements of operations. The Company recognizes the income tax credits and benefits from the clean energy investments as part of its provision for income taxes.&lt;/span&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsDisclosureTextBlock>
    <vtrs:Numberofequitymethodinvestments
      contextRef="i2de25d7ac8784fa18767316538f59631_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90ZXh0cmVnaW9uOjM5Y2Y1MjExZDNiNDQ3MzliZDkwN2U5NWZkYjk3ZTFiXzU4_6097e572-4970-46b5-a6de-8dc4b12bfe34"
      unitRef="number">3</vtrs:Numberofequitymethodinvestments>
    <vtrs:EquityMethodInvestmentsNetGainLossFromImpairmentandReductionInObligations
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90ZXh0cmVnaW9uOjM5Y2Y1MjExZDNiNDQ3MzliZDkwN2U5NWZkYjk3ZTFiXzEwOTk1MTE2MzA0ODY_b204a970-7121-43e0-a281-be20ba621b9a"
      unitRef="usd">5700000</vtrs:EquityMethodInvestmentsNetGainLossFromImpairmentandReductionInObligations>
    <vtrs:EquityMethodInvestmentsNetGainLossFromImpairmentandReductionInObligations
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90ZXh0cmVnaW9uOjM5Y2Y1MjExZDNiNDQ3MzliZDkwN2U5NWZkYjk3ZTFiXzExNzY_d184b678-7dae-4b60-b7d4-96dca72d1d6b"
      unitRef="usd">21400000</vtrs:EquityMethodInvestmentsNetGainLossFromImpairmentandReductionInObligations>
    <vtrs:EquityMethodInvestmentsNetGainLossFromImpairmentandReductionInObligations
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90ZXh0cmVnaW9uOjM5Y2Y1MjExZDNiNDQ3MzliZDkwN2U5NWZkYjk3ZTFiXzExODM_68173ce5-5198-4229-9d7f-1ed3575abfd9"
      unitRef="usd">7000000</vtrs:EquityMethodInvestmentsNetGainLossFromImpairmentandReductionInObligations>
    <us-gaap:EquityMethodInvestmentsTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90ZXh0cmVnaW9uOjM5Y2Y1MjExZDNiNDQ3MzliZDkwN2U5NWZkYjk3ZTFiXzIyMjA_24c0e71f-52a2-4ff1-a58d-5a7703710530">&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying values and respective balance sheet locations of the Company&#x2019;s clean energy investments were as follows at December&#160;31, 2021 and 2020, respectively:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Summarized financial information, in the aggregate, for the Company&#x2019;s significant equity method investments on a 100% basis as of December&#160;31, 2021 and 2020 and for the years ended December&#160;31, 2021, 2020 and 2019 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.272%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;385.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating and non-operating expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsTextBlock>
    <us-gaap:EquityMethodInvestments
      contextRef="i500543a4ebe64602995d53387c0524dd_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZTpiYjYwODg2ZWQ4NGQ0ODU4OTdhN2M1MGMxMzhiOTRhOC90YWJsZXJhbmdlOmJiNjA4ODZlZDg0ZDQ4NTg5N2E3YzUwYzEzOGI5NGE4XzEtMS0xLTEtMzE0MjI_eb6e51a0-9472-4f58-9582-305d94c39a0a"
      unitRef="usd">0</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i123b716b2a804024a0f1c41058fde09a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZTpiYjYwODg2ZWQ4NGQ0ODU4OTdhN2M1MGMxMzhiOTRhOC90YWJsZXJhbmdlOmJiNjA4ODZlZDg0ZDQ4NTg5N2E3YzUwYzEzOGI5NGE4XzEtMy0xLTEtMzE0MjI_35069db7-c74e-403a-a285-ecbe5b005d43"
      unitRef="usd">47900000</us-gaap:EquityMethodInvestments>
    <us-gaap:OtherLiabilities
      contextRef="i2de25d7ac8784fa18767316538f59631_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZTpiYjYwODg2ZWQ4NGQ0ODU4OTdhN2M1MGMxMzhiOTRhOC90YWJsZXJhbmdlOmJiNjA4ODZlZDg0ZDQ4NTg5N2E3YzUwYzEzOGI5NGE4XzItMS0xLTEtMzE0MjI_2ba28b6e-5410-4d42-99e8-361ab243d31f"
      unitRef="usd">10900000</us-gaap:OtherLiabilities>
    <us-gaap:OtherLiabilities
      contextRef="i43ea997ac5374cbbb9e8b44ce8488e9c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZTpiYjYwODg2ZWQ4NGQ0ODU4OTdhN2M1MGMxMzhiOTRhOC90YWJsZXJhbmdlOmJiNjA4ODZlZDg0ZDQ4NTg5N2E3YzUwYzEzOGI5NGE4XzItMy0xLTEtMzE0MjI_b2199be0-ec5a-4ee7-ae7f-83f52f00811f"
      unitRef="usd">47500000</us-gaap:OtherLiabilities>
    <us-gaap:AssetsCurrent
      contextRef="i0853510f8095410c8cab4556a87f5fab_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZTo3ZGQ1YWIyMzg1YjE0MmFkODVkMDAzM2M1ZmZlZTkyZC90YWJsZXJhbmdlOjdkZDVhYjIzODViMTQyYWQ4NWQwMDMzYzVmZmVlOTJkXzEtMS0xLTEtMzE0MjI_1f1ebec6-7d8c-4eab-b595-2bf46691baf6"
      unitRef="usd">4200000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i6259ebc7ed26431991c3b2aa187c0c91_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZTo3ZGQ1YWIyMzg1YjE0MmFkODVkMDAzM2M1ZmZlZTkyZC90YWJsZXJhbmdlOjdkZDVhYjIzODViMTQyYWQ4NWQwMDMzYzVmZmVlOTJkXzEtMy0xLTEtMzE0MjI_83512e2e-100a-48f7-ba9b-b9720d823a0b"
      unitRef="usd">38900000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="i0853510f8095410c8cab4556a87f5fab_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZTo3ZGQ1YWIyMzg1YjE0MmFkODVkMDAzM2M1ZmZlZTkyZC90YWJsZXJhbmdlOjdkZDVhYjIzODViMTQyYWQ4NWQwMDMzYzVmZmVlOTJkXzItMS0xLTEtMzE0MjI_f421b472-68fb-4a94-843b-48e4f1cb07a8"
      unitRef="usd">500000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="i6259ebc7ed26431991c3b2aa187c0c91_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZTo3ZGQ1YWIyMzg1YjE0MmFkODVkMDAzM2M1ZmZlZTkyZC90YWJsZXJhbmdlOjdkZDVhYjIzODViMTQyYWQ4NWQwMDMzYzVmZmVlOTJkXzItMy0xLTEtMzE0MjI_e041851b-d258-44ef-9f9d-36269a552b57"
      unitRef="usd">1000000.0</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i0853510f8095410c8cab4556a87f5fab_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZTo3ZGQ1YWIyMzg1YjE0MmFkODVkMDAzM2M1ZmZlZTkyZC90YWJsZXJhbmdlOjdkZDVhYjIzODViMTQyYWQ4NWQwMDMzYzVmZmVlOTJkXzMtMS0xLTEtMzE0MjI_afe0bf53-9cb2-4b23-80d9-c31685091799"
      unitRef="usd">4700000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i6259ebc7ed26431991c3b2aa187c0c91_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZTo3ZGQ1YWIyMzg1YjE0MmFkODVkMDAzM2M1ZmZlZTkyZC90YWJsZXJhbmdlOjdkZDVhYjIzODViMTQyYWQ4NWQwMDMzYzVmZmVlOTJkXzMtMy0xLTEtMzE0MjI_dfd6188d-533b-443f-95de-c09eddabee99"
      unitRef="usd">39900000</us-gaap:Assets>
    <us-gaap:LiabilitiesCurrent
      contextRef="i0853510f8095410c8cab4556a87f5fab_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZTo3ZGQ1YWIyMzg1YjE0MmFkODVkMDAzM2M1ZmZlZTkyZC90YWJsZXJhbmdlOjdkZDVhYjIzODViMTQyYWQ4NWQwMDMzYzVmZmVlOTJkXzQtMS0xLTEtMzE0MjI_c71e30f4-73ec-4cee-8d2b-317438215b7d"
      unitRef="usd">2800000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i6259ebc7ed26431991c3b2aa187c0c91_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZTo3ZGQ1YWIyMzg1YjE0MmFkODVkMDAzM2M1ZmZlZTkyZC90YWJsZXJhbmdlOjdkZDVhYjIzODViMTQyYWQ4NWQwMDMzYzVmZmVlOTJkXzQtMy0xLTEtMzE0MjI_e4de5dcb-7ae9-47da-97d7-942f51005bd7"
      unitRef="usd">33000000.0</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="i0853510f8095410c8cab4556a87f5fab_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZTo3ZGQ1YWIyMzg1YjE0MmFkODVkMDAzM2M1ZmZlZTkyZC90YWJsZXJhbmdlOjdkZDVhYjIzODViMTQyYWQ4NWQwMDMzYzVmZmVlOTJkXzUtMS0xLTEtMzE0MjI_a332cc65-eeb0-4c82-9a76-f0e6c9788f2a"
      unitRef="usd">0</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="i6259ebc7ed26431991c3b2aa187c0c91_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZTo3ZGQ1YWIyMzg1YjE0MmFkODVkMDAzM2M1ZmZlZTkyZC90YWJsZXJhbmdlOjdkZDVhYjIzODViMTQyYWQ4NWQwMDMzYzVmZmVlOTJkXzUtMy0xLTEtMzE0MjI_a9978e88-7c7d-4223-92f9-45e0cb3e1b00"
      unitRef="usd">1800000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i0853510f8095410c8cab4556a87f5fab_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZTo3ZGQ1YWIyMzg1YjE0MmFkODVkMDAzM2M1ZmZlZTkyZC90YWJsZXJhbmdlOjdkZDVhYjIzODViMTQyYWQ4NWQwMDMzYzVmZmVlOTJkXzYtMS0xLTEtMzE0MjI_d05e8a39-78e2-4433-8b9f-a82539efaf20"
      unitRef="usd">2800000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i6259ebc7ed26431991c3b2aa187c0c91_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZTo3ZGQ1YWIyMzg1YjE0MmFkODVkMDAzM2M1ZmZlZTkyZC90YWJsZXJhbmdlOjdkZDVhYjIzODViMTQyYWQ4NWQwMDMzYzVmZmVlOTJkXzYtMy0xLTEtMzE0MjI_8b3e3f3a-8ff5-473f-89c1-a675d71297aa"
      unitRef="usd">34800000</us-gaap:Liabilities>
    <vtrs:EquityMethodInvestmentSummarizedFinancialInformationNetAssets
      contextRef="i0853510f8095410c8cab4556a87f5fab_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZTo3ZGQ1YWIyMzg1YjE0MmFkODVkMDAzM2M1ZmZlZTkyZC90YWJsZXJhbmdlOjdkZDVhYjIzODViMTQyYWQ4NWQwMDMzYzVmZmVlOTJkXzctMS0xLTEtMzE0MjI_3fcfb1e3-7163-4d27-a688-141e38f6ee22"
      unitRef="usd">1900000</vtrs:EquityMethodInvestmentSummarizedFinancialInformationNetAssets>
    <vtrs:EquityMethodInvestmentSummarizedFinancialInformationNetAssets
      contextRef="i6259ebc7ed26431991c3b2aa187c0c91_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZTo3ZGQ1YWIyMzg1YjE0MmFkODVkMDAzM2M1ZmZlZTkyZC90YWJsZXJhbmdlOjdkZDVhYjIzODViMTQyYWQ4NWQwMDMzYzVmZmVlOTJkXzctMy0xLTEtMzE0MjI_216f0e70-78aa-4350-936f-379e8294c85b"
      unitRef="usd">5100000</vtrs:EquityMethodInvestmentSummarizedFinancialInformationNetAssets>
    <us-gaap:Revenues
      contextRef="ia0185425b6174d78bfd3fbdefaaaea64_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZToxMTMxYWIxZDcxOTg0N2U2OTNkYmM5NmRkYjk1ZTMxOC90YWJsZXJhbmdlOjExMzFhYjFkNzE5ODQ3ZTY5M2RiYzk2ZGRiOTVlMzE4XzItMS0xLTEtMzE0MjI_b196df03-a0ec-4853-aa0a-c67199fb9b1b"
      unitRef="usd">326700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iae859ab23c9340b096f1af4c4f554c62_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZToxMTMxYWIxZDcxOTg0N2U2OTNkYmM5NmRkYjk1ZTMxOC90YWJsZXJhbmdlOjExMzFhYjFkNzE5ODQ3ZTY5M2RiYzk2ZGRiOTVlMzE4XzItMy0xLTEtMzE0MjI_e0d44e81-cf4f-4616-8d47-10bcaa1b632a"
      unitRef="usd">374500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i09587ab064ca42a8bec631ae169a3af9_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZToxMTMxYWIxZDcxOTg0N2U2OTNkYmM5NmRkYjk1ZTMxOC90YWJsZXJhbmdlOjExMzFhYjFkNzE5ODQ3ZTY5M2RiYzk2ZGRiOTVlMzE4XzItNS0xLTEtMzE0MjI_9d27c4e2-4cf6-478f-8af5-362613e354d1"
      unitRef="usd">385000000.0</us-gaap:Revenues>
    <us-gaap:GrossProfit
      contextRef="ia0185425b6174d78bfd3fbdefaaaea64_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZToxMTMxYWIxZDcxOTg0N2U2OTNkYmM5NmRkYjk1ZTMxOC90YWJsZXJhbmdlOjExMzFhYjFkNzE5ODQ3ZTY5M2RiYzk2ZGRiOTVlMzE4XzMtMS0xLTEtMzE0MjI_ea43110a-5570-4f19-865c-a04b3cee13b3"
      unitRef="usd">-4600000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="iae859ab23c9340b096f1af4c4f554c62_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZToxMTMxYWIxZDcxOTg0N2U2OTNkYmM5NmRkYjk1ZTMxOC90YWJsZXJhbmdlOjExMzFhYjFkNzE5ODQ3ZTY5M2RiYzk2ZGRiOTVlMzE4XzMtMy0xLTEtMzE0MjI_8ac19b35-ecec-4d95-8b5b-d3af07c2dd72"
      unitRef="usd">-4600000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i09587ab064ca42a8bec631ae169a3af9_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZToxMTMxYWIxZDcxOTg0N2U2OTNkYmM5NmRkYjk1ZTMxOC90YWJsZXJhbmdlOjExMzFhYjFkNzE5ODQ3ZTY5M2RiYzk2ZGRiOTVlMzE4XzMtNS0xLTEtMzE0MjI_e2b50770-9f2f-4a37-826a-421d45758e94"
      unitRef="usd">-4400000</us-gaap:GrossProfit>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ia0185425b6174d78bfd3fbdefaaaea64_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZToxMTMxYWIxZDcxOTg0N2U2OTNkYmM5NmRkYjk1ZTMxOC90YWJsZXJhbmdlOjExMzFhYjFkNzE5ODQ3ZTY5M2RiYzk2ZGRiOTVlMzE4XzQtMS0xLTEtMzE0MjI_56cac91f-f912-4312-b451-6253d8171c5b"
      unitRef="usd">16800000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="iae859ab23c9340b096f1af4c4f554c62_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZToxMTMxYWIxZDcxOTg0N2U2OTNkYmM5NmRkYjk1ZTMxOC90YWJsZXJhbmdlOjExMzFhYjFkNzE5ODQ3ZTY5M2RiYzk2ZGRiOTVlMzE4XzQtMy0xLTEtMzE0MjI_dac9429e-6ba1-4aca-8c73-15bf04d02779"
      unitRef="usd">19000000.0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i09587ab064ca42a8bec631ae169a3af9_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZToxMTMxYWIxZDcxOTg0N2U2OTNkYmM5NmRkYjk1ZTMxOC90YWJsZXJhbmdlOjExMzFhYjFkNzE5ODQ3ZTY5M2RiYzk2ZGRiOTVlMzE4XzQtNS0xLTEtMzE0MjI_369c9928-7638-4e5f-bb7e-e120b9a3a06d"
      unitRef="usd">20000000.0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="ia0185425b6174d78bfd3fbdefaaaea64_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZToxMTMxYWIxZDcxOTg0N2U2OTNkYmM5NmRkYjk1ZTMxOC90YWJsZXJhbmdlOjExMzFhYjFkNzE5ODQ3ZTY5M2RiYzk2ZGRiOTVlMzE4XzUtMS0xLTEtMzE0MjI_6dd3a4ef-d999-479b-aef1-7329f5c709f9"
      unitRef="usd">-21400000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="iae859ab23c9340b096f1af4c4f554c62_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZToxMTMxYWIxZDcxOTg0N2U2OTNkYmM5NmRkYjk1ZTMxOC90YWJsZXJhbmdlOjExMzFhYjFkNzE5ODQ3ZTY5M2RiYzk2ZGRiOTVlMzE4XzUtMy0xLTEtMzE0MjI_4aa6284d-cfd1-4a13-9232-dee8d78d937b"
      unitRef="usd">-23600000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i09587ab064ca42a8bec631ae169a3af9_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90YWJsZToxMTMxYWIxZDcxOTg0N2U2OTNkYmM5NmRkYjk1ZTMxOC90YWJsZXJhbmdlOjExMzFhYjFkNzE5ODQ3ZTY5M2RiYzk2ZGRiOTVlMzE4XzUtNS0xLTEtMzE0MjI_3131fd04-e83e-4c43-983a-0fdd115da05b"
      unitRef="usd">-24400000</us-gaap:ProfitLoss>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90ZXh0cmVnaW9uOjM5Y2Y1MjExZDNiNDQ3MzliZDkwN2U5NWZkYjk3ZTFiXzE5ODU_361d8db0-63e7-478a-8064-41b9a3a575a2"
      unitRef="usd">-61900000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90ZXh0cmVnaW9uOjM5Y2Y1MjExZDNiNDQ3MzliZDkwN2U5NWZkYjk3ZTFiXzE5ODk_e2a03f1e-1c95-452d-a3ff-d46763affe0d"
      unitRef="usd">-48400000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTYvZnJhZzozOWNmNTIxMWQzYjQ0NzM5YmQ5MDdlOTVmZGI5N2UxYi90ZXh0cmVnaW9uOjM5Y2Y1MjExZDNiNDQ3MzliZDkwN2U5NWZkYjk3ZTFiXzE5OTc_51bc5362-bc09-4535-a97a-9787be8a9167"
      unitRef="usd">-62100000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3Xzc1Njc_8e808bdb-345a-40d4-820a-9587ee3ac85f">&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the carrying amount of goodwill for the years ended December&#160;31, 2021 and 2020 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.859%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.931%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.277%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Developed Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Greater China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;JANZ&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,258.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;584.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,065.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,975.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated impairment losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(385.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(385.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,873.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;584.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,065.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,590.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;704.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;652.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,107.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;607.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;648.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,184.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;738.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;864.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,560.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,347.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,569.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;738.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;864.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,560.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,732.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated impairment losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(385.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(385.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,184.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;738.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;864.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,560.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,347.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Measurement period and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(528.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(528.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,723.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;969.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;776.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,644.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,113.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,108.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;969.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;776.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,644.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,498.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated impairment losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(385.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(385.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,723.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;969.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;776.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,644.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,113.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:GoodwillGross
      contextRef="i315c417d4b374c99bb802f2ca94fe20c_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzItMS0xLTEtMzE0MjI_e5a5b60c-2917-4706-8c35-1946853f7dd1"
      unitRef="usd">8258000000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="i19b7b956b6644bcdb10d4dea546f710e_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzItMy0xLTEtMzE0MjI_da50ce8b-0f3c-4d00-aadb-8c1e4fb11fde"
      unitRef="usd">67800000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="i4ca0195877e7427d95d7bf2d7026caa1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzItNS0xLTEtMzE0MjI_42d37bb2-eb0d-4950-9ba6-35b7a0bd8c02"
      unitRef="usd">584800000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="ia340ab16326e432db33adc76e7d83306_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzItNy0xLTEtMzE0MjI_1206bce0-8579-4799-923b-46264daf1955"
      unitRef="usd">1065000000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="iac503b6d629d4bafb262ea6ec0b8a25e_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzItOS0xLTEtMzE0MjI_fcde58c2-4dab-49be-abe7-07084ea43689"
      unitRef="usd">9975600000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i315c417d4b374c99bb802f2ca94fe20c_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzMtMS0xLTEtMzE0MjI_07bfdb7a-356c-456d-8222-e0901cd4ab1c"
      unitRef="usd">385000000.0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i19b7b956b6644bcdb10d4dea546f710e_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzMtMy0xLTEtMzE0MjI_f8b4fdd2-eb7a-4a43-be9e-6b347c00cfbb"
      unitRef="usd">0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i4ca0195877e7427d95d7bf2d7026caa1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzMtNS0xLTEtMzE0MjI_1637ebdf-3a65-4678-9e44-c381150dd320"
      unitRef="usd">0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="ia340ab16326e432db33adc76e7d83306_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzMtNy0xLTEtMzE0MjI_75fb5420-a707-427a-a02d-134305b06983"
      unitRef="usd">0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="iac503b6d629d4bafb262ea6ec0b8a25e_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzMtOS0xLTEtMzE0MjI_112d42c0-2365-445c-aa5d-b1cf94714986"
      unitRef="usd">385000000.0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="i315c417d4b374c99bb802f2ca94fe20c_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzQtMS0xLTEtMzE0MjI_dfed7b68-46cb-4a7c-81ee-c922d1b1efcf"
      unitRef="usd">7873000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i19b7b956b6644bcdb10d4dea546f710e_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzQtMy0xLTEtMzE0MjI_79142ee6-424d-45e2-888e-b9f44df99278"
      unitRef="usd">67800000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i4ca0195877e7427d95d7bf2d7026caa1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzQtNS0xLTEtMzE0MjI_dc0721ea-ded5-4e50-9f6f-9babf77d0215"
      unitRef="usd">584800000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ia340ab16326e432db33adc76e7d83306_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzQtNy0xLTEtMzE0MjI_c1210eb4-9f4c-47af-aa6d-0b09671be0c1"
      unitRef="usd">1065000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="iac503b6d629d4bafb262ea6ec0b8a25e_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzQtOS0xLTEtMzE0MjI_10d31966-1347-4bd3-96c0-2e790e765a12"
      unitRef="usd">9590600000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i38a0011834694e8599d458b848606328_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzUtMS0xLTEtMzE0MjI_e14926a7-09b6-4c79-86a9-feac56c88fdd"
      unitRef="usd">704300000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i25616a483e2e4a3da1bdb481fdcdc776_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzUtMy0xLTEtMzE0MjI_b3b0324e-4737-4955-a6f3-b10e6469d5dd"
      unitRef="usd">652800000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i93e12956332b44a59bb64bc33354f7ee_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzUtNS0xLTEtMzE0MjI_80a91083-6529-4813-ad1c-4939c648d067"
      unitRef="usd">217400000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="iec758a60e4bd425e896c1f35e907763b_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzUtNy0xLTEtMzE0MjI_bf5213a0-a2ad-44c3-8777-b16bd8a76ccd"
      unitRef="usd">533000000.0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzUtOS0xLTEtMzE0MjI_6f9fa972-4082-4d40-be89-27f714fcd2e9"
      unitRef="usd">2107500000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i38a0011834694e8599d458b848606328_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzYtMS0xLTEtMzE0MjI_79d83919-f73e-4cfe-b42c-fdce136d5f9b"
      unitRef="usd">607200000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i25616a483e2e4a3da1bdb481fdcdc776_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzYtMy0xLTEtMzE0MjI_e4060b03-d7c4-4398-b79d-11862be89780"
      unitRef="usd">17700000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i93e12956332b44a59bb64bc33354f7ee_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzYtNS0xLTEtMzE0MjI_c7881019-c53e-409f-ad99-18774602caeb"
      unitRef="usd">61800000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="iec758a60e4bd425e896c1f35e907763b_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzYtNy0xLTEtMzE0MjI_8ede23c2-18ab-4b2f-9cd1-f55b4964dbd2"
      unitRef="usd">-37800000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzYtOS0xLTEtMzE0MjI_36864574-e20f-46af-9dea-291890b59491"
      unitRef="usd">648900000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:Goodwill
      contextRef="ibcede0739e844bf0be1dd96355937b5b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzctMS0xLTEtMzE0MjI_e839cc87-7912-438e-bbdb-cde705ff7f91"
      unitRef="usd">9184500000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i257d82c8b1324095a90197f7a7cfb225_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzctMy0xLTEtMzE0MjI_8b93418d-9e9b-4b62-9e5b-a7846503201d"
      unitRef="usd">738300000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i783790c3f4764f4f86bb8f68bcb4fff2_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzctNS0xLTEtMzE0MjI_63eecf35-db3b-4105-8fc3-cd8d75ec8bc7"
      unitRef="usd">864000000.0</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i98548692221d4033bf9d5dc6b6466a25_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzctNy0xLTEtMzE0MjI_9238fb79-202f-4979-bad2-71bccb946d12"
      unitRef="usd">1560200000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzctOS0xLTEtMzE0MjI_8c6484cf-2ef7-4c02-80e8-6081263b9931"
      unitRef="usd">12347000000</us-gaap:Goodwill>
    <us-gaap:GoodwillGross
      contextRef="ibcede0739e844bf0be1dd96355937b5b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzktMS0xLTEtMzE0MjI_bf4213d5-88fb-465f-a255-69bce8bd518f"
      unitRef="usd">9569500000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="i257d82c8b1324095a90197f7a7cfb225_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzktMy0xLTEtMzE0MjI_3591960b-d037-4a85-bcbc-e1ac29e413f3"
      unitRef="usd">738300000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="i783790c3f4764f4f86bb8f68bcb4fff2_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzktNS0xLTEtMzE0MjI_df3f3f35-79c2-4e6b-8dae-f1765e50a4eb"
      unitRef="usd">864000000.0</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="i98548692221d4033bf9d5dc6b6466a25_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzktNy0xLTEtMzE0MjI_83e48b20-b94f-444f-aa9c-55833f50d326"
      unitRef="usd">1560200000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzktOS0xLTEtMzE0MjI_f8f7fedb-c50a-4459-8da9-f63911c6f482"
      unitRef="usd">12732000000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="ibcede0739e844bf0be1dd96355937b5b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzEwLTEtMS0xLTMxNDIy_6f2754e2-9715-4ad9-b02b-2a3ed4179034"
      unitRef="usd">385000000.0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i257d82c8b1324095a90197f7a7cfb225_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzEwLTMtMS0xLTMxNDIy_e092842d-3f6f-4ec1-a173-d4ebddb9c1ec"
      unitRef="usd">0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i783790c3f4764f4f86bb8f68bcb4fff2_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzEwLTUtMS0xLTMxNDIy_3b9031ff-3473-4a5f-9ad5-11890c18c4eb"
      unitRef="usd">0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i98548692221d4033bf9d5dc6b6466a25_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzEwLTctMS0xLTMxNDIy_f11f6fba-6380-497f-bfd4-3e3b50e83db4"
      unitRef="usd">0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzEwLTktMS0xLTMxNDIy_b2b5b076-aec1-421e-bfbc-a6c9ebd92203"
      unitRef="usd">385000000.0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="ibcede0739e844bf0be1dd96355937b5b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzExLTEtMS0xLTMxNDIy_0b0117ee-e172-483d-af5f-51f90cff04ea"
      unitRef="usd">9184500000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i257d82c8b1324095a90197f7a7cfb225_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzExLTMtMS0xLTMxNDIy_d2e24d6d-a8cd-4a5e-9408-2f60a6e5ff29"
      unitRef="usd">738300000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i783790c3f4764f4f86bb8f68bcb4fff2_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzExLTUtMS0xLTMxNDIy_0664935c-2b9e-45f4-bb51-475c1f016ef6"
      unitRef="usd">864000000.0</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i98548692221d4033bf9d5dc6b6466a25_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzExLTctMS0xLTMxNDIy_ae9c9a01-b506-4feb-acbf-5e4b17a4173c"
      unitRef="usd">1560200000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzExLTktMS0xLTMxNDIy_8c6484cf-2ef7-4c02-80e8-6081263b9931"
      unitRef="usd">12347000000</us-gaap:Goodwill>
    <vtrs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill
      contextRef="id71374cb5c304b1b8b38cd06a22b2e88_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzEyLTEtMS0xLTMxNDIy_a916976b-c8dc-45f1-be80-417cbe2b982a"
      unitRef="usd">67700000</vtrs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill>
    <vtrs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill
      contextRef="i8ca13749baf74114b35b0784dde6edb1_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzEyLTMtMS0xLTMxNDIy_a82808ff-5da0-493c-9cfe-8a90494d6ccc"
      unitRef="usd">220400000</vtrs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill>
    <vtrs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill
      contextRef="i283b1cce431d414ab5f875e9a4bcbd90_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzEyLTUtMS0xLTMxNDIy_1d0f1c5c-6f51-423f-961a-f23c6b6de898"
      unitRef="usd">-30900000</vtrs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill>
    <vtrs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill
      contextRef="ieade6f9a084b4f2eb5b23630a93f657d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzEyLTctMS0xLTMxNDIy_2030d477-9e35-4234-b41a-30665e831224"
      unitRef="usd">38400000</vtrs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill>
    <vtrs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzEyLTktMS0xLTMxNDIy_fe1fbe0e-26fa-48be-80ec-1a8f6f3c98c9"
      unitRef="usd">295600000</vtrs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="id71374cb5c304b1b8b38cd06a22b2e88_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzE0LTEtMS0xLTMxNDIy_92b89151-0682-4a3f-a36a-71807c63de0a"
      unitRef="usd">-528800000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i8ca13749baf74114b35b0784dde6edb1_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzE0LTMtMS0xLTMxNDIy_972e21a3-e2fd-41ab-a2fc-3415cc254fb6"
      unitRef="usd">10800000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i283b1cce431d414ab5f875e9a4bcbd90_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzE0LTUtMS0xLTMxNDIy_71954a61-2f79-4e38-b2a1-6540eb0e5965"
      unitRef="usd">-56800000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="ieade6f9a084b4f2eb5b23630a93f657d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzE0LTctMS0xLTMxNDIy_e60771b9-a077-494e-9ccd-2b95f75508a3"
      unitRef="usd">45900000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzE0LTktMS0xLTMxNDIy_5b816640-ff68-4e1c-a0c1-a83a445c0b3e"
      unitRef="usd">-528900000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:Goodwill
      contextRef="ia10b2e6ad58c4c4bb99c064d555b97da_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzE1LTEtMS0xLTMxNDIy_1d41b109-ec3d-4178-828d-6af24efcbe8b"
      unitRef="usd">8723400000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i6bf87e450da84c279d1a95ba5e923d3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzE1LTMtMS0xLTMxNDIy_caf0250c-2e0e-4625-9c78-f206ab8d3289"
      unitRef="usd">969500000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i55f2fb13e460418aa9bf86f68ca38852_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzE1LTUtMS0xLTMxNDIy_ba9134f8-c63d-4122-955a-35ed7a71af55"
      unitRef="usd">776300000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i5caf17f0c9ca41c58ddd4ef0394bdc79_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzE1LTctMS0xLTMxNDIy_dfa0a540-e16a-4acd-9608-e3cf92db9ad0"
      unitRef="usd">1644500000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzE1LTktMS0xLTMxNDIy_e7eb6ff1-26b9-436e-bd2a-698abcf2d5f9"
      unitRef="usd">12113700000</us-gaap:Goodwill>
    <us-gaap:GoodwillGross
      contextRef="ia10b2e6ad58c4c4bb99c064d555b97da_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzE3LTEtMS0xLTMxNDIy_28dd8642-012c-45d2-a9c8-9c6ed5c3d015"
      unitRef="usd">9108400000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="i6bf87e450da84c279d1a95ba5e923d3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzE3LTMtMS0xLTMxNDIy_c677f1c6-c55c-4131-9224-6138cf5db508"
      unitRef="usd">969500000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="i55f2fb13e460418aa9bf86f68ca38852_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzE3LTUtMS0xLTMxNDIy_1418ee93-3b67-4143-bd91-0df3c0b60eb5"
      unitRef="usd">776300000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="i5caf17f0c9ca41c58ddd4ef0394bdc79_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzE3LTctMS0xLTMxNDIy_c52238c0-bd28-46d4-a936-78f9549b9b62"
      unitRef="usd">1644500000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzE3LTktMS0xLTMxNDIy_de74846d-ad07-4b61-a42e-2ca10b581fb3"
      unitRef="usd">12498700000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="ia10b2e6ad58c4c4bb99c064d555b97da_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzE4LTEtMS0xLTMxNDIy_a62bc0c9-2fae-4e33-abf8-b6bd5f6a3d69"
      unitRef="usd">385000000.0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i6bf87e450da84c279d1a95ba5e923d3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzE4LTMtMS0xLTMxNDIy_0196e262-6088-4f89-9faf-4d014391de00"
      unitRef="usd">0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i55f2fb13e460418aa9bf86f68ca38852_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzE4LTUtMS0xLTMxNDIy_bdfa7b0e-a92d-4ea4-a076-19da5d80a2f4"
      unitRef="usd">0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i5caf17f0c9ca41c58ddd4ef0394bdc79_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzE4LTctMS0xLTMxNDIy_74049b70-82f2-4121-a649-494d6f955934"
      unitRef="usd">0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzE4LTktMS0xLTMxNDIy_5a751dbb-786b-493c-b59c-f0fd294bb7b9"
      unitRef="usd">385000000.0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="ia10b2e6ad58c4c4bb99c064d555b97da_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzE5LTEtMS0xLTMxNDIy_d279bea0-13fc-4397-9c63-599b7a9c2b45"
      unitRef="usd">8723400000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i6bf87e450da84c279d1a95ba5e923d3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzE5LTMtMS0xLTMxNDIy_13028102-35e9-4bed-95e8-d2b0b4cf878e"
      unitRef="usd">969500000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i55f2fb13e460418aa9bf86f68ca38852_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzE5LTUtMS0xLTMxNDIy_ff911f9a-176f-4a62-a370-9368d3f143dd"
      unitRef="usd">776300000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i5caf17f0c9ca41c58ddd4ef0394bdc79_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzE5LTctMS0xLTMxNDIy_07e9aba7-5401-4346-be50-f024e4d43c41"
      unitRef="usd">1644500000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpkOTY2MmJjZjkzNTU0ZmQwOWQwN2VkZThiNGMxZTZjNC90YWJsZXJhbmdlOmQ5NjYyYmNmOTM1NTRmZDA5ZDA3ZWRlOGI0YzFlNmM0XzE5LTktMS0xLTMxNDIy_e7eb6ff1-26b9-436e-bd2a-698abcf2d5f9"
      unitRef="usd">12113700000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3Xzc2MTY_1aec8ac8-0984-4924-bbe0-566a225219ed">&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets consist of the following components at December&#160;31, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Life (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Book Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Product rights, licenses and other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,006.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,918.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,087.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,052.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,918.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,134.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Product rights, licenses and other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,404.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,801.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,602.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,484.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,801.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,683.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;____________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;Represents amortizable intangible assets. Other intangibles consist principally of customer lists and contractual rights.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTo5ZWExZmFmM2NkM2M0ZDc0YWFlMWFkYmQ0MTM1YzY4Ny90YWJsZXJhbmdlOjllYTFmYWYzY2QzYzRkNzRhYWUxYWRiZDQxMzVjNjg3XzItMS0xLTEtMzE0MjI_088fd8b2-b8d9-4459-a095-7e40de1270b6">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTo5ZWExZmFmM2NkM2M0ZDc0YWFlMWFkYmQ0MTM1YzY4Ny90YWJsZXJhbmdlOjllYTFmYWYzY2QzYzRkNzRhYWUxYWRiZDQxMzVjNjg3XzItMy0xLTEtMzE0MjI_802f137d-a551-4611-9d42-14408cbcd0ac"
      unitRef="usd">39006200000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTo5ZWExZmFmM2NkM2M0ZDc0YWFlMWFkYmQ0MTM1YzY4Ny90YWJsZXJhbmdlOjllYTFmYWYzY2QzYzRkNzRhYWUxYWRiZDQxMzVjNjg3XzItNS0xLTEtMzE0MjI_f2eeb6d3-e06b-4a6d-8792-65d93c54e4d7"
      unitRef="usd">12918500000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTo5ZWExZmFmM2NkM2M0ZDc0YWFlMWFkYmQ0MTM1YzY4Ny90YWJsZXJhbmdlOjllYTFmYWYzY2QzYzRkNzRhYWUxYWRiZDQxMzVjNjg3XzItNy0xLTEtMzE0MjI_2fe1ca60-5fcb-470a-90e0-f9f9b2ed6573"
      unitRef="usd">26087700000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTo5ZWExZmFmM2NkM2M0ZDc0YWFlMWFkYmQ0MTM1YzY4Ny90YWJsZXJhbmdlOjllYTFmYWYzY2QzYzRkNzRhYWUxYWRiZDQxMzVjNjg3XzMtMy0xLTEtMzE0MjI_929f1590-0a75-4d37-ae4e-70236ef99fe0"
      unitRef="usd">46500000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTo5ZWExZmFmM2NkM2M0ZDc0YWFlMWFkYmQ0MTM1YzY4Ny90YWJsZXJhbmdlOjllYTFmYWYzY2QzYzRkNzRhYWUxYWRiZDQxMzVjNjg3XzMtNy0xLTEtMzE0MjI_d6874e5b-d675-4e66-a4e8-9935c8acf015"
      unitRef="usd">46500000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTo5ZWExZmFmM2NkM2M0ZDc0YWFlMWFkYmQ0MTM1YzY4Ny90YWJsZXJhbmdlOjllYTFmYWYzY2QzYzRkNzRhYWUxYWRiZDQxMzVjNjg3XzQtMy0xLTEtMzE0MjI_4a07fac0-617d-49fb-8a63-37d634795988"
      unitRef="usd">39052700000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTo5ZWExZmFmM2NkM2M0ZDc0YWFlMWFkYmQ0MTM1YzY4Ny90YWJsZXJhbmdlOjllYTFmYWYzY2QzYzRkNzRhYWUxYWRiZDQxMzVjNjg3XzQtNS0xLTEtMzE0MjI_c05ee97e-5190-4a18-8f56-6fd69f96915d"
      unitRef="usd">12918500000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTo5ZWExZmFmM2NkM2M0ZDc0YWFlMWFkYmQ0MTM1YzY4Ny90YWJsZXJhbmdlOjllYTFmYWYzY2QzYzRkNzRhYWUxYWRiZDQxMzVjNjg3XzQtNy0xLTEtMzE0MjI_e596d9c0-eb43-41e4-ae7b-7ce6238236c8"
      unitRef="usd">26134200000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTo5ZWExZmFmM2NkM2M0ZDc0YWFlMWFkYmQ0MTM1YzY4Ny90YWJsZXJhbmdlOjllYTFmYWYzY2QzYzRkNzRhYWUxYWRiZDQxMzVjNjg3XzYtMS0xLTEtMzE0MjI_461c25b3-4c87-4c6e-81ef-9704ffa6ff6c">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTo5ZWExZmFmM2NkM2M0ZDc0YWFlMWFkYmQ0MTM1YzY4Ny90YWJsZXJhbmdlOjllYTFmYWYzY2QzYzRkNzRhYWUxYWRiZDQxMzVjNjg3XzYtMy0xLTEtMzE0MjI_5755a626-a2ac-489d-88a8-fd2931ed818b"
      unitRef="usd">40404100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTo5ZWExZmFmM2NkM2M0ZDc0YWFlMWFkYmQ0MTM1YzY4Ny90YWJsZXJhbmdlOjllYTFmYWYzY2QzYzRkNzRhYWUxYWRiZDQxMzVjNjg3XzYtNS0xLTEtMzE0MjI_d886e0c1-558a-48e4-adac-08c12e6fe161"
      unitRef="usd">10801600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTo5ZWExZmFmM2NkM2M0ZDc0YWFlMWFkYmQ0MTM1YzY4Ny90YWJsZXJhbmdlOjllYTFmYWYzY2QzYzRkNzRhYWUxYWRiZDQxMzVjNjg3XzYtNy0xLTEtMzE0MjI_96105f6d-0221-4e01-ada4-3e67fa660eec"
      unitRef="usd">29602500000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTo5ZWExZmFmM2NkM2M0ZDc0YWFlMWFkYmQ0MTM1YzY4Ny90YWJsZXJhbmdlOjllYTFmYWYzY2QzYzRkNzRhYWUxYWRiZDQxMzVjNjg3XzctMy0xLTEtMzE0MjI_0574b7e9-4202-40e2-9768-1958cf06d85f"
      unitRef="usd">80700000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTo5ZWExZmFmM2NkM2M0ZDc0YWFlMWFkYmQ0MTM1YzY4Ny90YWJsZXJhbmdlOjllYTFmYWYzY2QzYzRkNzRhYWUxYWRiZDQxMzVjNjg3XzctNy0xLTEtMzE0MjI_50ad0966-0436-40cd-9e61-929e99166085"
      unitRef="usd">80700000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTo5ZWExZmFmM2NkM2M0ZDc0YWFlMWFkYmQ0MTM1YzY4Ny90YWJsZXJhbmdlOjllYTFmYWYzY2QzYzRkNzRhYWUxYWRiZDQxMzVjNjg3XzgtMy0xLTEtMzE0MjI_c746cbb9-26a6-4395-b53c-905747c9c205"
      unitRef="usd">40484800000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTo5ZWExZmFmM2NkM2M0ZDc0YWFlMWFkYmQ0MTM1YzY4Ny90YWJsZXJhbmdlOjllYTFmYWYzY2QzYzRkNzRhYWUxYWRiZDQxMzVjNjg3XzgtNS0xLTEtMzE0MjI_156049cb-ad83-405f-a8ce-0edbed906f99"
      unitRef="usd">10801600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTo5ZWExZmFmM2NkM2M0ZDc0YWFlMWFkYmQ0MTM1YzY4Ny90YWJsZXJhbmdlOjllYTFmYWYzY2QzYzRkNzRhYWUxYWRiZDQxMzVjNjg3XzgtNy0xLTEtMzE0MjI_2fc5b2ba-3f3d-41c9-b39e-40ffc392de75"
      unitRef="usd">29683200000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <vtrs:ProductRightsAndLicensesByTherapeuticCategoryTableTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3Xzc1NTg_a7fc46d2-1068-4d30-a83e-6a3675fe9302">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Product rights and licenses are primarily comprised of the products marketed at the time of acquisition. These product rights and licenses relate to numerous individual products, the net book value of which, by product category, is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Developed Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Greater China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;JANZ&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Brands&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,066.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,102.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,174.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,801.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,146.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Complex Gx and Biosimilars&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Generics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,020.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;358.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,710.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Product Rights and Licenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,313.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,115.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,495.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,160.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,084.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Developed Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Greater China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;JANZ&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Brands&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,988.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,372.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,377.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,478.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,216.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Complex Gx and Biosimilars&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;272.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Generics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,253.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;423.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,107.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Product Rights and Licenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,514.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,385.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,803.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,896.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,598.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</vtrs:ProductRightsAndLicensesByTherapeuticCategoryTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="id11e45101185446494c54622bb9b8177_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTphNjkwZTE3ZmJkYmE0ZDM1OTEwODUyMTkxYzU3NzdlNi90YWJsZXJhbmdlOmE2OTBlMTdmYmRiYTRkMzU5MTA4NTIxOTFjNTc3N2U2XzEtMS0xLTEtMzE0MjI_7320e575-d12b-40a6-921a-0534c193ce90"
      unitRef="usd">10066600000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iade66ffae6e040cfa629525230c6273c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTphNjkwZTE3ZmJkYmE0ZDM1OTEwODUyMTkxYzU3NzdlNi90YWJsZXJhbmdlOmE2OTBlMTdmYmRiYTRkMzU5MTA4NTIxOTFjNTc3N2U2XzEtMy0xLTEtMzE0MjI_5778001f-a4c4-4773-998e-3e960127d755"
      unitRef="usd">6102900000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ib5450616961442a2b1ea8144698c669c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTphNjkwZTE3ZmJkYmE0ZDM1OTEwODUyMTkxYzU3NzdlNi90YWJsZXJhbmdlOmE2OTBlMTdmYmRiYTRkMzU5MTA4NTIxOTFjNTc3N2U2XzEtNS0xLTEtMzE0MjI_039db44c-918b-4185-9f5a-d3aa6d7d21b2"
      unitRef="usd">1174800000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i0395335aee314265a48396d57455b625_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTphNjkwZTE3ZmJkYmE0ZDM1OTEwODUyMTkxYzU3NzdlNi90YWJsZXJhbmdlOmE2OTBlMTdmYmRiYTRkMzU5MTA4NTIxOTFjNTc3N2U2XzEtNy0xLTEtMzE0MjI_f7d064e9-29a6-4a06-8a98-66c6f569ee30"
      unitRef="usd">3801700000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="idd3f720b0b1c41c799a80daa8a9b8e4b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTphNjkwZTE3ZmJkYmE0ZDM1OTEwODUyMTkxYzU3NzdlNi90YWJsZXJhbmdlOmE2OTBlMTdmYmRiYTRkMzU5MTA4NTIxOTFjNTc3N2U2XzEtOS0xLTEtMzE0MjI_59b42569-4a90-41dc-90e7-517baee55068"
      unitRef="usd">21146000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i24495761b1564b3aaeeb420062790b06_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTphNjkwZTE3ZmJkYmE0ZDM1OTEwODUyMTkxYzU3NzdlNi90YWJsZXJhbmdlOmE2OTBlMTdmYmRiYTRkMzU5MTA4NTIxOTFjNTc3N2U2XzItMS0xLTEtMzE0MjI_e3d3def7-fca3-442e-8f5f-8b698717aa67"
      unitRef="usd">226800000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i95eaf84899294b5cb1284e1df6d5d766_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTphNjkwZTE3ZmJkYmE0ZDM1OTEwODUyMTkxYzU3NzdlNi90YWJsZXJhbmdlOmE2OTBlMTdmYmRiYTRkMzU5MTA4NTIxOTFjNTc3N2U2XzItMy0xLTEtMzE0MjI_f3e02aef-e693-4a6d-beb1-9548673fc6b2"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i31d60f66b7ca4f7b854b44502d7569c6_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTphNjkwZTE3ZmJkYmE0ZDM1OTEwODUyMTkxYzU3NzdlNi90YWJsZXJhbmdlOmE2OTBlMTdmYmRiYTRkMzU5MTA4NTIxOTFjNTc3N2U2XzItNS0xLTEtMzE0MjI_a7ba675d-2fe7-45ba-89d9-dcce99c8633b"
      unitRef="usd">1500000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i4832437dbcd3485cb386c3787124ef0c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTphNjkwZTE3ZmJkYmE0ZDM1OTEwODUyMTkxYzU3NzdlNi90YWJsZXJhbmdlOmE2OTBlMTdmYmRiYTRkMzU5MTA4NTIxOTFjNTc3N2U2XzItNy0xLTEtMzE0MjI_21ece253-c99d-4cb1-b276-94ce7f71b586"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i83aed7ea547a47a2b816fee23196130f_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTphNjkwZTE3ZmJkYmE0ZDM1OTEwODUyMTkxYzU3NzdlNi90YWJsZXJhbmdlOmE2OTBlMTdmYmRiYTRkMzU5MTA4NTIxOTFjNTc3N2U2XzItOS0xLTEtMzE0MjI_23b4f52e-5024-4028-8b46-cb1dea006f88"
      unitRef="usd">228300000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i6fe4acec3d334f5c9bf8565f72ff2a83_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTphNjkwZTE3ZmJkYmE0ZDM1OTEwODUyMTkxYzU3NzdlNi90YWJsZXJhbmdlOmE2OTBlMTdmYmRiYTRkMzU5MTA4NTIxOTFjNTc3N2U2XzMtMS0xLTEtMzE0MjI_2d8edd94-a1eb-48e6-b536-82c9771164c9"
      unitRef="usd">4020200000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i955ba774e0a548c287a702e8c5749900_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTphNjkwZTE3ZmJkYmE0ZDM1OTEwODUyMTkxYzU3NzdlNi90YWJsZXJhbmdlOmE2OTBlMTdmYmRiYTRkMzU5MTA4NTIxOTFjNTc3N2U2XzMtMy0xLTEtMzE0MjI_8a322fef-7806-4666-8331-5a3ccf3ec472"
      unitRef="usd">12100000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iaceccbde3b074329b263bcda37586891_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTphNjkwZTE3ZmJkYmE0ZDM1OTEwODUyMTkxYzU3NzdlNi90YWJsZXJhbmdlOmE2OTBlMTdmYmRiYTRkMzU5MTA4NTIxOTFjNTc3N2U2XzMtNS0xLTEtMzE0MjI_edfa3305-e52f-4ab8-bfe6-bc054988ae81"
      unitRef="usd">319500000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i1479b6b2aacb40b29f35cd42b1e22f9f_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTphNjkwZTE3ZmJkYmE0ZDM1OTEwODUyMTkxYzU3NzdlNi90YWJsZXJhbmdlOmE2OTBlMTdmYmRiYTRkMzU5MTA4NTIxOTFjNTc3N2U2XzMtNy0xLTEtMzE0MjI_a521eb3b-4a38-430f-a2b4-b4c935dfd93a"
      unitRef="usd">358400000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ifaa8db533b7d4f489edaa8a8c7c3b889_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTphNjkwZTE3ZmJkYmE0ZDM1OTEwODUyMTkxYzU3NzdlNi90YWJsZXJhbmdlOmE2OTBlMTdmYmRiYTRkMzU5MTA4NTIxOTFjNTc3N2U2XzMtOS0xLTEtMzE0MjI_502358ed-ef58-40a4-9fd1-826310330bd0"
      unitRef="usd">4710200000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i6c77a702a1dc4bd4b4d96321e085c678_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTphNjkwZTE3ZmJkYmE0ZDM1OTEwODUyMTkxYzU3NzdlNi90YWJsZXJhbmdlOmE2OTBlMTdmYmRiYTRkMzU5MTA4NTIxOTFjNTc3N2U2XzQtMS0xLTEtMzE0MjI_1041d9e2-5752-4957-9779-6b164a7f7883"
      unitRef="usd">14313600000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i9674aa9104274c98b38914ca35d5f4c1_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTphNjkwZTE3ZmJkYmE0ZDM1OTEwODUyMTkxYzU3NzdlNi90YWJsZXJhbmdlOmE2OTBlMTdmYmRiYTRkMzU5MTA4NTIxOTFjNTc3N2U2XzQtMy0xLTEtMzE0MjI_af24ca16-cdaa-4034-ae29-8db9b9a161ce"
      unitRef="usd">6115000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iec67624464a845eeafd1548788c90737_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTphNjkwZTE3ZmJkYmE0ZDM1OTEwODUyMTkxYzU3NzdlNi90YWJsZXJhbmdlOmE2OTBlMTdmYmRiYTRkMzU5MTA4NTIxOTFjNTc3N2U2XzQtNS0xLTEtMzE0MjI_b6b6b832-4eb1-4fc7-a4ba-929bcb171bb3"
      unitRef="usd">1495800000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ib511387dd7a949499aa59b3b5b4db16a_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTphNjkwZTE3ZmJkYmE0ZDM1OTEwODUyMTkxYzU3NzdlNi90YWJsZXJhbmdlOmE2OTBlMTdmYmRiYTRkMzU5MTA4NTIxOTFjNTc3N2U2XzQtNy0xLTEtMzE0MjI_900d2624-87dd-4726-acec-436426648bae"
      unitRef="usd">4160100000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i42391df0c964452ab8b60c6d0285b8cc_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTphNjkwZTE3ZmJkYmE0ZDM1OTEwODUyMTkxYzU3NzdlNi90YWJsZXJhbmdlOmE2OTBlMTdmYmRiYTRkMzU5MTA4NTIxOTFjNTc3N2U2XzQtOS0xLTEtMzE0MjI_6ac906d0-7da6-431b-825f-f4294e1ce45a"
      unitRef="usd">26084500000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i2edb03cf70c94cf8b258388ec10a11e8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpjNjBiNmUyM2Q0YzI0ZGIwODE2MmVmNjg1MTBjMWJhZC90YWJsZXJhbmdlOmM2MGI2ZTIzZDRjMjRkYjA4MTYyZWY2ODUxMGMxYmFkXzEtMS0xLTEtMzE0MjI_26c48fe6-cf3d-4521-a4b3-7e1d60c96dd0"
      unitRef="usd">10988100000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ia550848323274182a3d6c7ce2c204b4c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpjNjBiNmUyM2Q0YzI0ZGIwODE2MmVmNjg1MTBjMWJhZC90YWJsZXJhbmdlOmM2MGI2ZTIzZDRjMjRkYjA4MTYyZWY2ODUxMGMxYmFkXzEtMy0xLTEtMzE0MjI_3ac0c972-ea24-4ae4-8434-cb2cffa2304c"
      unitRef="usd">4372300000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="id180e5c47b5b4590aaabfb4d1aa9d1d3_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpjNjBiNmUyM2Q0YzI0ZGIwODE2MmVmNjg1MTBjMWJhZC90YWJsZXJhbmdlOmM2MGI2ZTIzZDRjMjRkYjA4MTYyZWY2ODUxMGMxYmFkXzEtNS0xLTEtMzE0MjI_4d16dcdf-e227-407a-8545-10a917151dfd"
      unitRef="usd">2377000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ic210cb32648544a095a3760cee270d5a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpjNjBiNmUyM2Q0YzI0ZGIwODE2MmVmNjg1MTBjMWJhZC90YWJsZXJhbmdlOmM2MGI2ZTIzZDRjMjRkYjA4MTYyZWY2ODUxMGMxYmFkXzEtNy0xLTEtMzE0MjI_2ce76fe2-1dc9-44d5-93a0-6d31d999eaae"
      unitRef="usd">4478700000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i2c23648696d148ada1075eba8138fa3b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpjNjBiNmUyM2Q0YzI0ZGIwODE2MmVmNjg1MTBjMWJhZC90YWJsZXJhbmdlOmM2MGI2ZTIzZDRjMjRkYjA4MTYyZWY2ODUxMGMxYmFkXzEtOS0xLTEtMzE0MjI_9b4bd3d8-e7a4-4fbf-a2d6-737dcaa342e4"
      unitRef="usd">22216100000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iaae8f6a141fc4440a2e80e908354b800_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpjNjBiNmUyM2Q0YzI0ZGIwODE2MmVmNjg1MTBjMWJhZC90YWJsZXJhbmdlOmM2MGI2ZTIzZDRjMjRkYjA4MTYyZWY2ODUxMGMxYmFkXzItMS0xLTEtMzE0MjI_4905231c-d2e9-45f8-944e-d70f0926b51c"
      unitRef="usd">272500000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="icf0dfbd7e212478fa3e85821b257efa9_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpjNjBiNmUyM2Q0YzI0ZGIwODE2MmVmNjg1MTBjMWJhZC90YWJsZXJhbmdlOmM2MGI2ZTIzZDRjMjRkYjA4MTYyZWY2ODUxMGMxYmFkXzItMy0xLTEtMzE0MjI_56b40c76-1130-40bc-acd0-f94bf37e942b"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i9ef03cc41bdf4f279229b376fbb43600_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpjNjBiNmUyM2Q0YzI0ZGIwODE2MmVmNjg1MTBjMWJhZC90YWJsZXJhbmdlOmM2MGI2ZTIzZDRjMjRkYjA4MTYyZWY2ODUxMGMxYmFkXzItNS0xLTEtMzE0MjI_6f839167-8e86-4e96-b411-d68d6dc84ddd"
      unitRef="usd">2300000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i53980f6dd1b44213ad5171bcab656699_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpjNjBiNmUyM2Q0YzI0ZGIwODE2MmVmNjg1MTBjMWJhZC90YWJsZXJhbmdlOmM2MGI2ZTIzZDRjMjRkYjA4MTYyZWY2ODUxMGMxYmFkXzItNy0xLTEtMzE0MjI_2b10bd44-32c9-4389-bfa7-19ad867703dc"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i7318ad9d646d42ab8e2f84f2d4ed08e5_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpjNjBiNmUyM2Q0YzI0ZGIwODE2MmVmNjg1MTBjMWJhZC90YWJsZXJhbmdlOmM2MGI2ZTIzZDRjMjRkYjA4MTYyZWY2ODUxMGMxYmFkXzItOS0xLTEtMzE0MjI_38f24bca-aa2f-408c-b05b-46ae1152ea46"
      unitRef="usd">274800000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ie81b4ce4914e4839924a78d8798397a9_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpjNjBiNmUyM2Q0YzI0ZGIwODE2MmVmNjg1MTBjMWJhZC90YWJsZXJhbmdlOmM2MGI2ZTIzZDRjMjRkYjA4MTYyZWY2ODUxMGMxYmFkXzMtMS0xLTEtMzE0MjI_71239a36-2644-4916-877b-c97f7916eba2"
      unitRef="usd">6253900000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ib9c761912e804561a14aa3acea5045c2_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpjNjBiNmUyM2Q0YzI0ZGIwODE2MmVmNjg1MTBjMWJhZC90YWJsZXJhbmdlOmM2MGI2ZTIzZDRjMjRkYjA4MTYyZWY2ODUxMGMxYmFkXzMtMy0xLTEtMzE0MjI_ba105d6c-d699-4f4a-9642-99ddda21e177"
      unitRef="usd">12700000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ibbd726794242461a918bc026656e8819_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpjNjBiNmUyM2Q0YzI0ZGIwODE2MmVmNjg1MTBjMWJhZC90YWJsZXJhbmdlOmM2MGI2ZTIzZDRjMjRkYjA4MTYyZWY2ODUxMGMxYmFkXzMtNS0xLTEtMzE0MjI_433f4a58-1b10-41e6-8b7a-bf81b2fe0841"
      unitRef="usd">423900000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ibd0a85ff305c485ea29c4a037baa7ebf_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpjNjBiNmUyM2Q0YzI0ZGIwODE2MmVmNjg1MTBjMWJhZC90YWJsZXJhbmdlOmM2MGI2ZTIzZDRjMjRkYjA4MTYyZWY2ODUxMGMxYmFkXzMtNy0xLTEtMzE0MjI_7a42aae0-0d81-42ad-8970-a876738701b1"
      unitRef="usd">417300000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iaa491650e0184ee0b2d04a336fcd9159_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpjNjBiNmUyM2Q0YzI0ZGIwODE2MmVmNjg1MTBjMWJhZC90YWJsZXJhbmdlOmM2MGI2ZTIzZDRjMjRkYjA4MTYyZWY2ODUxMGMxYmFkXzMtOS0xLTEtMzE0MjI_04ac5b0d-ad3f-4424-84ab-ae3e82de6944"
      unitRef="usd">7107800000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ifa41c4de25dd421eb1ae018322f86643_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpjNjBiNmUyM2Q0YzI0ZGIwODE2MmVmNjg1MTBjMWJhZC90YWJsZXJhbmdlOmM2MGI2ZTIzZDRjMjRkYjA4MTYyZWY2ODUxMGMxYmFkXzQtMS0xLTEtMzE0MjI_f35e2120-9225-4aec-ba6b-dcb8d7ddca11"
      unitRef="usd">17514500000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i03aa196073ab4bffb46b9ece7f3ece15_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpjNjBiNmUyM2Q0YzI0ZGIwODE2MmVmNjg1MTBjMWJhZC90YWJsZXJhbmdlOmM2MGI2ZTIzZDRjMjRkYjA4MTYyZWY2ODUxMGMxYmFkXzQtMy0xLTEtMzE0MjI_f15566a0-5ce6-40fe-8ca3-734c0c87f967"
      unitRef="usd">4385000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i8e7e1f56b7f54755a3741e3d317a47f4_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpjNjBiNmUyM2Q0YzI0ZGIwODE2MmVmNjg1MTBjMWJhZC90YWJsZXJhbmdlOmM2MGI2ZTIzZDRjMjRkYjA4MTYyZWY2ODUxMGMxYmFkXzQtNS0xLTEtMzE0MjI_def687d9-623f-42c9-bc2d-b24b88fc988d"
      unitRef="usd">2803200000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ia1948994457e4a7d899f19777bc25f52_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpjNjBiNmUyM2Q0YzI0ZGIwODE2MmVmNjg1MTBjMWJhZC90YWJsZXJhbmdlOmM2MGI2ZTIzZDRjMjRkYjA4MTYyZWY2ODUxMGMxYmFkXzQtNy0xLTEtMzE0MjI_5959bccc-e23e-45db-b9bb-2781920f2264"
      unitRef="usd">4896000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ib8c6a1c4d0f5419a84aa95ca8cfce91e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTpjNjBiNmUyM2Q0YzI0ZGIwODE2MmVmNjg1MTBjMWJhZC90YWJsZXJhbmdlOmM2MGI2ZTIzZDRjMjRkYjA4MTYyZWY2ODUxMGMxYmFkXzQtOS0xLTEtMzE0MjI_8c72e97c-6cc3-4dfa-8739-c4510ead9419"
      unitRef="usd">29598700000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3Xzc1NTk_16419880-f29f-4181-beb1-6a9e30326460">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense and intangible asset impairment charges, which are included as a component of amortization expense, which is classified primarily within cost of sales in the consolidated statements of operations, for the years ended December&#160;31, 2021, 2020 and 2019 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.272%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible asset amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,702.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,605.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,582.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IPR&amp;amp;D intangible asset impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finite-lived intangible asset impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible asset amortization expense (including impairment charges)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,805.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,688.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,763.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZToyZmEzODQ1MWVhZDc0ZTQyYmI3MWZkOTQ0YTFmZWUyYi90YWJsZXJhbmdlOjJmYTM4NDUxZWFkNzRlNDJiYjcxZmQ5NDRhMWZlZTJiXzItMS0xLTEtMzE0MjI_356ba8ee-bb2e-4ee9-a0b7-552d58cff8dd"
      unitRef="usd">2702200000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZToyZmEzODQ1MWVhZDc0ZTQyYmI3MWZkOTQ0YTFmZWUyYi90YWJsZXJhbmdlOjJmYTM4NDUxZWFkNzRlNDJiYjcxZmQ5NDRhMWZlZTJiXzItMy0xLTEtMzE0MjI_dc14e039-d53c-4d86-bde1-5b84ef33c09a"
      unitRef="usd">1605800000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZToyZmEzODQ1MWVhZDc0ZTQyYmI3MWZkOTQ0YTFmZWUyYi90YWJsZXJhbmdlOjJmYTM4NDUxZWFkNzRlNDJiYjcxZmQ5NDRhMWZlZTJiXzItNS0xLTEtMzE0MjI_2e5f97b3-965e-4ac7-b575-6247c25fa1fd"
      unitRef="usd">1582700000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i484f17d8c76443b28b80fc7cc73a4065_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZToyZmEzODQ1MWVhZDc0ZTQyYmI3MWZkOTQ0YTFmZWUyYi90YWJsZXJhbmdlOjJmYTM4NDUxZWFkNzRlNDJiYjcxZmQ5NDRhMWZlZTJiXzMtMS0xLTEtMzE0MjI_3624fd85-62aa-408e-bc18-14a11cb52557"
      unitRef="usd">19400000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i2fcad26472544896b5f80c3807d319ee_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZToyZmEzODQ1MWVhZDc0ZTQyYmI3MWZkOTQ0YTFmZWUyYi90YWJsZXJhbmdlOjJmYTM4NDUxZWFkNzRlNDJiYjcxZmQ5NDRhMWZlZTJiXzMtMy0xLTEtMzE0MjI_55fdb57d-1cb6-4a63-8362-fe7916a1628b"
      unitRef="usd">37400000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i2c1b06002c614ec0a7355c6ffde49cad_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZToyZmEzODQ1MWVhZDc0ZTQyYmI3MWZkOTQ0YTFmZWUyYi90YWJsZXJhbmdlOjJmYTM4NDUxZWFkNzRlNDJiYjcxZmQ5NDRhMWZlZTJiXzMtNS0xLTEtMzE0MjI_d13d414b-f3d1-4da8-a0aa-38ee1c0cd8ce"
      unitRef="usd">138300000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="i9d3ab4b3183547369e21bc16353ca096_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZToyZmEzODQ1MWVhZDc0ZTQyYmI3MWZkOTQ0YTFmZWUyYi90YWJsZXJhbmdlOjJmYTM4NDUxZWFkNzRlNDJiYjcxZmQ5NDRhMWZlZTJiXzQtMS0xLTEtMzE0MjI_93cf9ab3-18b6-4dae-862d-2b17c0bbf9dd"
      unitRef="usd">83400000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="i58799d0aadbb4faf8ae9cbb1ffa7e5c9_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZToyZmEzODQ1MWVhZDc0ZTQyYmI3MWZkOTQ0YTFmZWUyYi90YWJsZXJhbmdlOjJmYTM4NDUxZWFkNzRlNDJiYjcxZmQ5NDRhMWZlZTJiXzQtMy0xLTEtMzE0MjI_d18fe9e3-0271-4355-91d1-069977af356f"
      unitRef="usd">45000000.0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="i06896c6d773e4c648b6098ee68fc18cc_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZToyZmEzODQ1MWVhZDc0ZTQyYmI3MWZkOTQ0YTFmZWUyYi90YWJsZXJhbmdlOjJmYTM4NDUxZWFkNzRlNDJiYjcxZmQ5NDRhMWZlZTJiXzQtNS0xLTEtMzE0MjI_2f205fe7-5af1-4fb6-9379-0682e1abd753"
      unitRef="usd">42300000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:AdjustmentForAmortization
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZToyZmEzODQ1MWVhZDc0ZTQyYmI3MWZkOTQ0YTFmZWUyYi90YWJsZXJhbmdlOjJmYTM4NDUxZWFkNzRlNDJiYjcxZmQ5NDRhMWZlZTJiXzUtMS0xLTEtMzE0MjI_ff4e5e22-f1df-4aa0-adbf-f45b606123a7"
      unitRef="usd">2805000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZToyZmEzODQ1MWVhZDc0ZTQyYmI3MWZkOTQ0YTFmZWUyYi90YWJsZXJhbmdlOjJmYTM4NDUxZWFkNzRlNDJiYjcxZmQ5NDRhMWZlZTJiXzUtMy0xLTEtMzE0MjI_897fe2c3-8c34-40cb-ac2d-ac69f06b61d9"
      unitRef="usd">1688200000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZToyZmEzODQ1MWVhZDc0ZTQyYmI3MWZkOTQ0YTFmZWUyYi90YWJsZXJhbmdlOjJmYTM4NDUxZWFkNzRlNDJiYjcxZmQ5NDRhMWZlZTJiXzUtNS0xLTEtMzE0MjI_95d4ac60-0f4e-48d4-87b5-bf4914031134"
      unitRef="usd">1763300000</us-gaap:AdjustmentForAmortization>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i8931abe1fc4c41e283d3f620f5185481_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzIyODY_d5409acc-0a05-4b44-8c40-381bd08284b1"
      unitRef="usd">0.090</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i914407dcbd0742cea3b5fcdd61f4b1ed_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzIyOTM_3378250b-4ebb-41af-b22f-d168727d0d0c"
      unitRef="usd">0.110</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="i9d3ab4b3183547369e21bc16353ca096_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzEwOTk1MTE2NTA3Nzg_93cf9ab3-18b6-4dae-862d-2b17c0bbf9dd"
      unitRef="usd">83400000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <vtrs:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIndefiniteLivedIntangibleAssetsMeasurementInput
      contextRef="i8894e39eabee436d9b912bcc70604238_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzMzNTE_0611e434-d97f-4f86-b48e-cccbfa761896"
      unitRef="number">0.070</vtrs:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIndefiniteLivedIntangibleAssetsMeasurementInput>
    <vtrs:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIndefiniteLivedIntangibleAssetsMeasurementInput
      contextRef="i4b0764905b0442fb808444acc20375f5_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzMzNTg_2d2e08d0-47ed-4831-99de-a997bd8339dd"
      unitRef="number">0.090</vtrs:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIndefiniteLivedIntangibleAssetsMeasurementInput>
    <vtrs:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIndefiniteLivedIntangibleAssetsMeasurementInput
      contextRef="ia93f6572cba64cc187e20095aeebe69b_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzMzNjI_079ef4eb-cc00-4a78-84cc-e66508da64f2"
      unitRef="number">0.090</vtrs:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIndefiniteLivedIntangibleAssetsMeasurementInput>
    <vtrs:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIndefiniteLivedIntangibleAssetsMeasurementInput
      contextRef="ie2d0511984ae4ebb9a94c4f5aaa12d9d_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzMzNjk_590a5898-eb5a-499c-b38c-e65ebae190ef"
      unitRef="number">0.110</vtrs:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIndefiniteLivedIntangibleAssetsMeasurementInput>
    <vtrs:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIndefiniteLivedIntangibleAssetsMeasurementInput
      contextRef="ibb7025b0eca84850a521bee0487fc7b2_I20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzMzNzc_7d4c54a9-aa3e-4046-b895-0e70e07d628b"
      unitRef="number">0.090</vtrs:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIndefiniteLivedIntangibleAssetsMeasurementInput>
    <vtrs:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIndefiniteLivedIntangibleAssetsMeasurementInput
      contextRef="i05e0f2d1f02d4ed3b1d3cd7d269a0f9f_I20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzMzODQ_396b76e5-e8dc-4213-a20c-fb33d90a0e0e"
      unitRef="number">0.110</vtrs:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIndefiniteLivedIntangibleAssetsMeasurementInput>
    <us-gaap:Goodwill
      contextRef="i97cf21063a7648e88dd9c911711f174d_I20210401"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTU2ODQ_0fb8348a-3f3f-49a0-8ce9-603e8666d074"
      unitRef="usd">3660000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ie6266e509f1d44dc9a60daacdb22a350_I20210401"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTU3MDI_2b4efd4d-ab6a-40dd-b421-45145e329957"
      unitRef="usd">5150000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ieadb084d06104ed894bd8527a64a8317_I20210401"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTU3MTk_f5636b6d-b78a-4d86-b189-7df69787a1f9"
      unitRef="usd">1580000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i784ed4be5e4640478be661b277b7af18_I20210401"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTU3MzY_37e146bd-1ad4-4fa8-aa07-4570d024ea07"
      unitRef="usd">820000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i6f3c6cd031f7442181059f100dfd8aa7_I20210401"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTU3NTM_2529d1ba-59ab-4422-8c3b-3952a6d9ae53"
      unitRef="usd">700000000</us-gaap:Goodwill>
    <us-gaap:ReportingUnitAmountOfFairValueInExcessOfCarryingAmount
      contextRef="ie6266e509f1d44dc9a60daacdb22a350_I20210401"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTU5NDA_ed28f443-020b-4f7e-bb17-20b197c92f3a"
      unitRef="usd">910000000</us-gaap:ReportingUnitAmountOfFairValueInExcessOfCarryingAmount>
    <us-gaap:ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount
      contextRef="ie6266e509f1d44dc9a60daacdb22a350_I20210401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTU5NTA_e949af0c-12a1-46fe-af41-aea900f6ff97"
      unitRef="number">0.058</us-gaap:ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount>
    <vtrs:GoodwillImpairmentMeasurementInputTerm
      contextRef="i4d71ef0b70eb4d1a88d365784c2806c2_D20210401-20210401"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTU5NzM_1b89cff4-a6d3-49e9-bf37-16d62c8cbb6a">P10Y</vtrs:GoodwillImpairmentMeasurementInputTerm>
    <vtrs:GoodwillImpairmentMeasurementInput
      contextRef="ib215f03d4a004bb190d0b0c9e1810626_I20210401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTU5ODY_16ea2c29-7c04-4629-9fae-7d1f40098264"
      unitRef="number">0.030</vtrs:GoodwillImpairmentMeasurementInput>
    <vtrs:GoodwillImpairmentMeasurementInput
      contextRef="i47d220da3337425183ad3fe98cff519f_I20210401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTU5OTM_63088ff8-a32d-4f6e-bec6-96b322eab46b"
      unitRef="number">0.009</vtrs:GoodwillImpairmentMeasurementInput>
    <vtrs:GoodwillImpairmentMeasurementInput
      contextRef="i2e4d9eb373ac4cf5915b1ac7e264cb55_I20210401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTYwMDk_910d14b1-a004-4723-97af-4bf2f867b6b7"
      unitRef="number">0.190</vtrs:GoodwillImpairmentMeasurementInput>
    <vtrs:GoodwillImpairmentMeasurementInput
      contextRef="iedf8aaffd2f2406782984df0b60eedee_I20210401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTYwMTU_88c00026-3a8f-4a6c-803c-a3f21b203928"
      unitRef="number">7.5</vtrs:GoodwillImpairmentMeasurementInput>
    <vtrs:GoodwillImpairmentMeasurementInput
      contextRef="ib890b7b1cb504759a309b083b68548ab_I20210401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTYwMjE_562953e1-8733-44e5-934e-abb14bcbff03"
      unitRef="number">8.5</vtrs:GoodwillImpairmentMeasurementInput>
    <vtrs:GoodwillImpairmentMeasurementInput
      contextRef="ia6d4f61859ba465d955863c12418c41b_I20210401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTYwMjk_09245c79-37c9-4a26-b59e-6f1da76e95ce"
      unitRef="number">0.150</vtrs:GoodwillImpairmentMeasurementInput>
    <vtrs:GoodwillImpairmentMeasurementInput
      contextRef="idf56c4919fb14633bbf6386bb070262c_I20210401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTYwMzY_8015d1fe-62cd-4eb9-b6a1-1df5a53df60c"
      unitRef="number">-0.029</vtrs:GoodwillImpairmentMeasurementInput>
    <vtrs:GoodwillImpairmentMeasurementInput
      contextRef="i15608e6da3164b4dae3c3a578cacf736_I20210401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTYwNDM_b900a6f6-be8b-44de-b3b2-d9470d200788"
      unitRef="number">0.015</vtrs:GoodwillImpairmentMeasurementInput>
    <us-gaap:ReportingUnitAmountOfFairValueInExcessOfCarryingAmount
      contextRef="i784ed4be5e4640478be661b277b7af18_I20210401"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTYwNTk_211262a0-5c94-4bbe-aa5c-932d7e73d1a6"
      unitRef="usd">230000000</us-gaap:ReportingUnitAmountOfFairValueInExcessOfCarryingAmount>
    <us-gaap:ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount
      contextRef="i784ed4be5e4640478be661b277b7af18_I20210401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTYwNjg_4ab2f9b5-b10c-428d-805a-a7307b2915a3"
      unitRef="number">0.070</us-gaap:ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount>
    <vtrs:GoodwillImpairmentMeasurementInputTerm
      contextRef="i7ca2f0e0d1e2416f955e5ebad2fa3692_D20210401-20210401"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTYzMTU_675fa4d8-ba49-4be1-b19b-fb071a9477ac">P10Y</vtrs:GoodwillImpairmentMeasurementInputTerm>
    <vtrs:GoodwillImpairmentMeasurementInput
      contextRef="ic0ea4341bffa478086acdce9a047ead6_I20210401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTYxMDU_e3ab75b6-0508-41d9-9cad-2960a1b5e06c"
      unitRef="number">0.015</vtrs:GoodwillImpairmentMeasurementInput>
    <vtrs:GoodwillImpairmentMeasurementInput
      contextRef="i0b46955e83674aeab67ff94b9709968a_I20210401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTYxMTI_18d0f31a-5846-4214-9184-c7268c503d0e"
      unitRef="number">0.007</vtrs:GoodwillImpairmentMeasurementInput>
    <vtrs:GoodwillImpairmentMeasurementInput
      contextRef="ib16a3b6e8149409999a629fdf76b5e40_I20210401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTYxMjc_a036c3fa-ad47-4b2b-b059-9b7fdc7b7a7e"
      unitRef="number">0.085</vtrs:GoodwillImpairmentMeasurementInput>
    <vtrs:GoodwillImpairmentMeasurementInput
      contextRef="i3e5e76e30a1e4232835b08cc5aa3dd1f_I20210401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTYxMzU_894031be-8d77-4cdf-93ad-c8a99c59d08c"
      unitRef="number">0.305</vtrs:GoodwillImpairmentMeasurementInput>
    <vtrs:GoodwillImpairmentMeasurementInput
      contextRef="i2faca452b6d7490fb6088b57bdba3eab_I20210401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTYxNDE_53443ff3-ef26-42a7-9506-691dd6f78c15"
      unitRef="number">6.0</vtrs:GoodwillImpairmentMeasurementInput>
    <vtrs:GoodwillImpairmentMeasurementInput
      contextRef="ide52f85dc07b4fe0b82c8b1da6c36f02_I20210401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTYxNDk_9f470a54-b342-4af4-b0b4-fe4b63a2df92"
      unitRef="number">0.150</vtrs:GoodwillImpairmentMeasurementInput>
    <vtrs:GoodwillImpairmentMeasurementInput
      contextRef="iae70f297cb494e99b52ef9e2d4abc258_I20210401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTYxNTY_d28df3e6-a60a-4843-accc-8ae517a67c5d"
      unitRef="number">-0.042</vtrs:GoodwillImpairmentMeasurementInput>
    <vtrs:GoodwillImpairmentMeasurementInput
      contextRef="i0d259dda285943ceaa0938936cf8aa47_I20210401"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3XzE2NDkyNjc0NTYxNjM_ded74d17-fd34-455b-b98b-e582d1b7a1c0"
      unitRef="number">0.020</vtrs:GoodwillImpairmentMeasurementInput>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90ZXh0cmVnaW9uOjgzMGJiZGFkOTQ0YTQ5ZDZhZDMwY2MzYmYxYjJhNTM3Xzc1NzQ_e06acd28-8796-4b0f-ab59-ff848518fb8b">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Intangible asset amortization expense for the years ending December&#160;31, 2022 through 2026 is estimated to be as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:88.782%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.018%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTozZmY0MWVjOWMxM2I0YTU5OWY2NjJjZWIyNTAzMWNmYS90YWJsZXJhbmdlOjNmZjQxZWM5YzEzYjRhNTk5ZjY2MmNlYjI1MDMxY2ZhXzEtMS0xLTEtMzE0MjI_312174c2-96db-40ba-9b76-60fa6a23ad85"
      unitRef="usd">2577000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTozZmY0MWVjOWMxM2I0YTU5OWY2NjJjZWIyNTAzMWNmYS90YWJsZXJhbmdlOjNmZjQxZWM5YzEzYjRhNTk5ZjY2MmNlYjI1MDMxY2ZhXzItMS0xLTEtMzE0MjI_f5a920b6-0195-4b09-bb57-1c20cb6750a8"
      unitRef="usd">2414000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTozZmY0MWVjOWMxM2I0YTU5OWY2NjJjZWIyNTAzMWNmYS90YWJsZXJhbmdlOjNmZjQxZWM5YzEzYjRhNTk5ZjY2MmNlYjI1MDMxY2ZhXzMtMS0xLTEtMzE0MjI_87c50ef9-00cf-49b7-a7ad-66eb33e6297b"
      unitRef="usd">2320000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTozZmY0MWVjOWMxM2I0YTU5OWY2NjJjZWIyNTAzMWNmYS90YWJsZXJhbmdlOjNmZjQxZWM5YzEzYjRhNTk5ZjY2MmNlYjI1MDMxY2ZhXzQtMS0xLTEtMzE0MjI_7e807907-a0b2-46ca-907c-85202270dce7"
      unitRef="usd">2222000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8xOTkvZnJhZzo4MzBiYmRhZDk0NGE0OWQ2YWQzMGNjM2JmMWIyYTUzNy90YWJsZTozZmY0MWVjOWMxM2I0YTU5OWY2NjJjZWIyNTAzMWNmYS90YWJsZXJhbmdlOjNmZjQxZWM5YzEzYjRhNTk5ZjY2MmNlYjI1MDMxY2ZhXzUtMS0xLTEtMzE0MjI_c2c0d766-1b48-4dca-8c80-7bf91d8145f9"
      unitRef="usd">2164000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FinancialInstrumentsDisclosureTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90ZXh0cmVnaW9uOmZmZGUwNDVjYjEzYjQ2YWQ5ZWE4Njk3OTNlZWQ1OTY3XzEyNTA3_06c93a23-319c-44ea-98dc-f9edf9c6a84f">Financial Instruments and Risk ManagementThe Company is exposed to certain financial risks relating to its ongoing business operations. The primary financial risks that are managed by using derivative instruments are foreign currency risk and interest rate risk.&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency Risk Management&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In order to manage certain foreign currency risks, the Company enters into foreign exchange forward contracts to mitigate risk associated with changes in spot exchange rates of mainly non-functional currency denominated assets or liabilities. The foreign exchange forward contracts are measured at fair value and reported as current assets or current liabilities in the consolidated balance sheets. Any gains or losses on the foreign exchange forward contracts are recognized in earnings in the period incurred in the consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has also entered into forward contracts to hedge forecasted foreign currency denominated sales from certain international subsidiaries and a portion of forecasted intercompany inventory sales denominated in Euro, Japanese Yen and Chinese Renminbi for up to eighteen months. These contracts are designated as cash flow hedges to manage foreign currency transaction risk and are measured at fair value and reported as current assets or current liabilities in the consolidated balance sheets. Any changes in the fair value of designated cash flow hedges are deferred in AOCE and are reclassified into earnings when the hedged item impacts earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Investment Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may hedge the foreign currency risk associated with certain net investment positions in foreign subsidiaries by either borrowing directly in foreign currencies and designating all or a portion of the foreign currency debt as a hedge of the applicable net investment position or entering into foreign currency swaps that are designated as hedges of net investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has designated certain Euro and Yen borrowings as a hedge of its investment in certain Euro-functional and Yen-functional currency subsidiaries in order to manage foreign currency translation risk. Borrowings designated as net investment hedges are marked-to-market using the current spot exchange rate as of the end of the period, with gains and losses included in the foreign currency translation component of AOCE until the sale or substantial liquidation of the underlying net investments. In addition, the Company manages the related foreign exchange risk of the Euro and Yen borrowings not designated as net investment hedges through certain Euro and Yen denominated financial assets and forward currency swaps. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the principal amounts of the Company&#x2019;s outstanding Euro and Yen borrowings and the notional amounts of the Euro and Yen borrowings designated as net investment hedges:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.776%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.210%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional Amount Designated as a Net Investment Hedge&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Principal Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Euro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.250% Euro Senior Notes due 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x20ac;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x20ac;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x20ac;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.125% Euro Senior Notes due 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.125% Euro Senior Notes due 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.816% Euro Senior Notes due 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.023% Euro Senior Notes due 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.362% Euro Senior Notes due 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.908% Euro Senior Notes due 2032&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Euro Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x20ac;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,955.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x20ac;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,850.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x20ac;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,955.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Yen&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;YEN Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#xa5;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,000.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#xa5;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,000.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#xa5;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Yen Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#xa5;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,000.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#xa5;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,000.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#xa5;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December 31,2021, the principal amount of the Company&#x2019;s outstanding Yen borrowings and the notional amount of the Yen borrowings designated as net investment hedge was $347.6&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Risk Management&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company enters into interest rate swaps from time to time in order to manage interest rate risk associated with the Company&#x2019;s fixed-rate and floating-rate debt. Interest rate swaps that meet specific accounting criteria are accounted for as fair value or cash flow hedges. All derivative instruments used to manage interest rate risk are measured at fair value and reported as current assets or current liabilities in the consolidated balance sheets. For fair value hedges, the changes in the fair value of both the hedging instrument and the underlying debt obligations are included in interest expense. For cash flow hedges, the change in fair value of the hedging instrument is deferred through AOCE and is reclassified into earnings when the hedged item impacts earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash Flow Hedging Relationships&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s interest rate swaps designated as cash flow hedges fix the interest rate on a portion of the Company&#x2019;s variable-rate debt or hedge part of the Company&#x2019;s interest rate exposure associated with the variability in the future cash flows attributable to changes in interest rates. Any changes in fair value are included in earnings or deferred through AOCE, depending on the nature and effectiveness of the offset. Any ineffectiveness in a cash flow hedging relationship is recognized immediately in earnings in the consolidated statements of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Hedging Relationships&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's interest rate swaps designated as fair value hedges convert the fixed rate on a portion of the Company's fixed-rate senior notes to a variable rate. Any changes in the fair value of these derivative instruments, as well as the offsetting change in fair value of the portion of the fixed-rate debt being hedged, is included in interest expense. The Company&#x2019;s fair value hedge was terminated during 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Credit Risk Management&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company regularly reviews the creditworthiness of its financial counterparties and does not expect to incur a significant loss from the failure of any counterparties to perform under any agreements. The Company is not subject to any obligations to post collateral under derivative instrument contracts. Certain derivative instrument contracts entered into by the Company are governed by master agreements, which contain credit-risk-related contingent features that would allow the counterparties to terminate the contracts early and request immediate payment should the Company trigger an event of default on other specified borrowings. The Company records all derivative instruments on a gross basis in the consolidated balance sheets. Accordingly, there are no offsetting amounts that net assets against liabilities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the classification and fair values of derivative instruments in our consolidated balance sheets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.116%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset Derivatives &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liability Derivatives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021 Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020 Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021 Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020 Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="24" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses &amp;amp; other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total derivatives designated as hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives not designated as hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses &amp;amp; other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total derivatives not designated as hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total derivatives &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize information about the gains/(losses) incurred to hedge or offset operational foreign exchange or interest rate risk:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.738%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.819%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gains/(Losses) Recognized in Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gain Excluded from the Assessment of Hedge Effectiveness&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of Gain/(Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivative Financial Instruments in Fair Value Hedge Relationships &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt; :&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 Senior Notes (3.125% coupon)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivative Financial Instruments in Cash Flow Hedging Relationships&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivative Financial Instruments Not Designated as Hedging Instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option and forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gains/(Losses) Recognized in AOCE (Net of Tax) on Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gains/(Losses) Reclassified from AOCE into Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of Gain/(Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivative Financial Instruments in Cash Flow Hedging Relationships &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivative Financial Instruments in Net Investment Hedging Relationships:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency borrowings and forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;436.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(346.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;479.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(325.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;____________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;In the first quarter of 2020, the Company terminated interest rate swaps designated as a fair value hedge resulting in net proceeds of approximately $45 million. The amount included in the above tables represents the fair value adjustment recognized at the date the interest rate swaps were settled. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;At December&#160;31, 2021, the Company expects that approximately $21.0 million of pre-tax net gains on cash flow hedges will be reclassified from AOCE into earnings during the next twelve months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;Represents the location of the gain/(loss) recognized in earnings on derivatives.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;Represents the location of the gain/(loss) reclassified from AOCE into earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;Represents the location of the gain excluded from the assessment of hedge effectiveness.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is based on the price that would be received from the sale of an identical asset or paid to transfer an identical liability in an orderly transaction between market participants at the measurement date. In order to increase consistency and comparability in fair value measurements, a fair value hierarchy has been established that prioritizes observable and unobservable inputs used to measure fair value into three broad levels, which are described below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:81pt;text-indent:-45pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level&#160;1:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities. The fair value hierarchy gives the highest priority to Level&#160;1 inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:81pt;text-indent:-45pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level&#160;2:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Observable market-based inputs other than quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:81pt;text-indent:-45pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level&#160;3:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level&#160;3 inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible, as well as considers counterparty credit risk in its assessment of fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial assets and liabilities carried at fair value are classified in the tables below in one of the three categories described above:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.465%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Recurring fair value measurements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="24" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exchange traded funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale fixed income investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasuries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Agency mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total available-for-sale fixed income investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets at recurring fair value measurement&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="24" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities at recurring fair value measurement&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.465%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Recurring fair value measurements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="24" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exchange traded funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale fixed income investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasuries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Agency mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total available-for-sale fixed income investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets at recurring fair value measurement&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="24" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities at recurring fair value measurement&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;327.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For financial assets and liabilities that utilize Level&#160;2 inputs, the Company utilizes both direct and indirect observable price quotes, including the LIBOR yield curve, foreign exchange forward prices, and bank price quotes. For the years ended December&#160;31, 2021 and 2020, there were no transfers between Level 1 and 2 of the fair value hierarchy. Below is a summary of valuation techniques for Level&#160;1 and Level&#160;2 financial assets and liabilities:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Cash equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014;&#160;valued at observable net asset value prices.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Equity securities, exchange traded funds&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014;&#160;valued at the active quoted market prices from broker or dealer quotations or transparent pricing sources at the reporting date. Unrealized gains and losses attributable to changes in fair value are included in other expense, net, in the consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Equity securities, marketable securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;valued using quoted stock prices from public exchanges at the reporting date. Unrealized gains and losses attributable to changes in fair value are included in other expense, net, in the consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Available-for-sale fixed income investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014;&#160;valued at the quoted market prices from broker or dealer quotations or transparent pricing sources at the reporting date. Unrealized gains and losses attributable to changes in fair value, net of income taxes, are included in accumulated other comprehensive loss as a component of shareholders&#x2019; equity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Interest rate swap derivative assets and liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014;&#160;valued using the LIBOR/EURIBOR yield curves at the reporting date. Counterparties to these contracts are highly rated financial institutions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Foreign exchange derivative assets and liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014;&#160;valued using quoted forward foreign exchange prices and spot rates at the reporting date. Counterparties to these contracts are highly rated financial institutions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingent Consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2011, the Company completed the acquisition of the exclusive worldwide rights to develop, manufacture and commercialize a generic equivalent to GlaxoSmithKline&#x2019;s Advair&#xae; Diskus incorporating Pfizer&#x2019;s respiratory delivery platform. The Company accounted for this transaction as a purchase of a business and utilized the acquisition method of accounting. On January 30, 2019, the Company received FDA approval of Wixela&#xae; Inhub&#xae; (fluticasone propionate and salmeterol inhalation powder, USP), the first generic of GlaxoSmithKline&#x2019;s Advair Diskus&#xae;. The commercial launch of the Wixela&#xae; Inhub&#xae; occurred in February 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, the Company has a contingent consideration liability of $177.8 million related to the respiratory delivery platform. The fair value measurement of contingent consideration is determined using Level 3 inputs. The Company&#x2019;s contingent consideration represents a component of the total purchase consideration for Pfizer&#x2019;s respiratory delivery platform and certain other acquisitions. The measurement is calculated using unobservable inputs based on the Company&#x2019;s own assumptions primarily related to the probability and timing of future development and commercial milestones and future profit-sharing payments which are discounted using a market rate of return. At December&#160;31, 2021 and 2020, discount rates ranging from 8.0% to 10.5% were utilized in the valuations. Significant changes in unobservable inputs could result in material changes to the contingent consideration liability. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A rollforward of the activity in the Company&#x2019;s fair value of contingent consideration from December&#160;31, 2019 to December&#160;31, 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.272%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Current Portion &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-Term Portion&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Contingent Consideration&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(111.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(111.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accretion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value loss &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(83.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(83.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accretion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value loss &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;____________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;Included in other current liabilities in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;Included in other long-term obligations in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;Included in litigation settlements and other contingencies, net in the consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company expects to incur approximately $6 million to $8 million of non-cash accretion expense related to the increase in the net present value of the contingent consideration liabilities in 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although the Company has not elected the fair value option for financial assets and liabilities, any future transacted financial asset or liability will be evaluated for the fair value election.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Available-for-Sale Securities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amortized cost and estimated fair value of available-for-sale fixed income securities, included in prepaid expenses and other current assets, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.465%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of available-for-sale debt securities at fair value as of December&#160;31, 2021, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:89.090%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mature within one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mature in one to five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mature in five years and later&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FinancialInstrumentsDisclosureTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9a9dac0334bc477ea0a456bbe46c3173_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzMtMC0xLTEtMzY1NTYvdGV4dHJlZ2lvbjo1Y2MyMTg1NDA1NGU0ODFkYTE3ZjQ1NzdiMDQzZDhjNl80_8ae3d38a-f779-4705-8374-4082196e4a46"
      unitRef="number">0.02250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i6259c702de2f4a35b534481f8d19ba9a_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzMtMi0xLTEtMzY1NzA_9c07f22b-af27-4ddb-ac74-683f58857212"
      unitRef="eur">1000000000</us-gaap:LongTermDebt>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i6259c702de2f4a35b534481f8d19ba9a_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzMtNC0xLTEtMzY1NzA_7b9ebd9b-e8d8-417f-9586-351b9c94d067"
      unitRef="eur">1000000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ib50d1f6af058476a9a20d36e4aeb1f1b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzMtNi0xLTEtMzY1NzA_80e26c9e-1f33-4ba6-8775-1a2c779d995b"
      unitRef="eur">1000000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4e35649af2d149e5a110744b54afb44e_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzQtMC0xLTEtMzY1NTkvdGV4dHJlZ2lvbjowMzc3YjI4ZDMyYzI0ZmYxYjAyOWZlZTA1NDI0MWY3ZV80_b18df3d2-8e18-43ea-984b-c280040ebe15"
      unitRef="number">0.03125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i65ebef80378f40ed961aba03c5a4b30c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzQtMi0xLTEtMzY1NTk_218b2220-083d-4aa3-a7fe-7ae5ef00d4a1"
      unitRef="eur">750000000.0</us-gaap:LongTermDebt>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i65ebef80378f40ed961aba03c5a4b30c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzQtNC0xLTEtMzY1NTk_763087f2-e58e-40fc-a52a-33cad5f86b8f"
      unitRef="eur">750000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i8c0d6145de9e46a7aee08ead29783fcb_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzQtNi0xLTEtMzY1NTk_ba298819-3221-4e72-b6b7-9a7e291814b5"
      unitRef="eur">750000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iea56cbd0617d400094855281cdd9e614_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzUtMC0xLTEtMzY1NjQvdGV4dHJlZ2lvbjo2ZDQ0NDliN2MyNWM0NjViYjYyODhmZDI1NDMwZGUwYV80_1ed194b5-5a8c-4532-9e57-dae164b8a336"
      unitRef="number">0.02125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ifd922556c9674ce280730c7b73219cfa_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzUtMi0xLTEtMzY1NjQ_8bb6b46a-3ffd-4e88-92df-e6b15e64580b"
      unitRef="eur">500000000.0</us-gaap:LongTermDebt>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ifd922556c9674ce280730c7b73219cfa_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzUtNC0xLTEtMzY1NjQ_66113583-6ebf-4fbc-b8ad-b71d39ec9d6a"
      unitRef="eur">500000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i9dbb1d37817941cfb609b9b9279f1790_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzUtNi0xLTEtMzY1NjQ_f4778459-7d58-421b-a317-104f3e6ed087"
      unitRef="eur">500000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib435a6d77cd34f869cedbd596bf31419_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzMtMC0xLTEtMzE0MjIvdGV4dHJlZ2lvbjphZjJkZjZkZjk3YzQ0YjZiYTY1YTU2MzE3YmY1ZTBmZl80_544f2cb7-4cd0-41c0-9e8b-e8b1173a3fb3"
      unitRef="number">0.00816</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i55b472eecaf147e68499e6e2321e7f65_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzMtMi0xLTEtMzE0MjI_391839eb-2828-41a8-b704-be15386bd39f"
      unitRef="eur">750000000.0</us-gaap:LongTermDebt>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i55b472eecaf147e68499e6e2321e7f65_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzMtNC0xLTEtMzE0MjI_eb09059d-fb88-4dc9-b075-d20b7d8e1e2d"
      unitRef="eur">750000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i90dc4ad103024e6ea6ce10f50ae8d262_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzMtNi0xLTEtMzE0MjI_1ad80f16-ad9b-47cb-8a25-f7b024293f4f"
      unitRef="eur">750000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i17b748819db1409f90ab44c1656a6844_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzUtMC0xLTEtMzE0MjIvdGV4dHJlZ2lvbjowMzdlY2Q0YTA0ZGQ0MjdiYmM2NWE0MjAzOGQzNTM2OV80_1cf28c8b-38ba-46c5-9232-a7b529fdb96f"
      unitRef="number">0.01023</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ie0df9f683c964ad68f7f6e10a639905c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzUtMi0xLTEtMzE0MjI_d2842b8a-bbe8-4bb4-a5c5-436f54015f61"
      unitRef="eur">750000000.0</us-gaap:LongTermDebt>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ie0df9f683c964ad68f7f6e10a639905c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzUtNC0xLTEtMzE0MjI_27732d94-9855-4feb-a67f-594e2fa36b13"
      unitRef="eur">750000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i44be44738c944446a28c9e1a66f849ae_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzUtNi0xLTEtMzE0MjI_c4d6c161-6ad6-46c0-8852-b7d5bfe75b6a"
      unitRef="eur">750000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iae4433500527462f9a53c262b4a193e2_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzctMC0xLTEtMzE0MjIvdGV4dHJlZ2lvbjpiNWM5Mzk4NGVhZjU0ZjNmYjhiY2JmOTU1NmZjMjYxN180_b45e55fb-405e-4f27-95c6-c1c328550fcf"
      unitRef="number">0.01362</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i15c58cf1262f420e80cbba022d020953_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzctMi0xLTEtMzE0MjI_7cc03649-ab65-4fe2-af6e-034f51ba848a"
      unitRef="eur">850000000.0</us-gaap:LongTermDebt>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i15c58cf1262f420e80cbba022d020953_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzctNC0xLTEtMzE0MjI_546b2511-ff12-47c8-b288-792d0b610651"
      unitRef="eur">850000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i001cf1788fa14d23b2b35d333f8e42c9_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzctNi0xLTEtMzE0MjI_e29f482b-4d14-4f19-b09e-86ecdf1b2e7e"
      unitRef="eur">850000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if487c6ee083b40a88448340cd281fb87_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzktMC0xLTEtMzE0MjIvdGV4dHJlZ2lvbjphOTFlMWZiNzg0YzM0YjFmODhiNzkzZjIyN2Y5MTM1MF80_69afbe02-9255-4cac-90e3-62e5fd034b56"
      unitRef="number">0.01908</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="if483dc28a41d4a0fa6122644fd1ff629_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzktMi0xLTEtMzE0MjI_fc3b20a6-58e1-431d-b54d-32eb059ce7dc"
      unitRef="eur">1250000000</us-gaap:LongTermDebt>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="if483dc28a41d4a0fa6122644fd1ff629_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzktNC0xLTEtMzE0MjI_ccdf9f6c-0c85-495b-a643-05aef9aded6b"
      unitRef="eur">1250000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i738291780fb644b188734a680f12c170_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzktNi0xLTEtMzE0MjI_b4c14d6f-08b1-457a-b912-d5a66b155956"
      unitRef="eur">1250000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:LongTermDebt
      contextRef="i3f150c27f3c842779f26851f4cf85e68_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzEwLTItMS0xLTMxNDIy_33493137-2749-4d3e-adb2-5d401ddcf125"
      unitRef="eur">105600000</us-gaap:LongTermDebt>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i3f150c27f3c842779f26851f4cf85e68_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzEwLTQtMS0xLTMxNDIy_3a931f20-159f-4be7-ad84-f877f569d6d6"
      unitRef="eur">0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="iaea18053fed0452db5be6e9583326824_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzEwLTYtMS0xLTMxNDIy_a662a4f3-becf-476f-aa80-0edd6c7c0b9a"
      unitRef="eur">105600000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:LongTermDebt
      contextRef="ibef3bf81fb8c41a7a5b434d67be2e8f6_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzExLTItMS0xLTMxNDIy_b51d44cd-f690-4da2-a540-e181e17fac9c"
      unitRef="eur">5955600000</us-gaap:LongTermDebt>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ibef3bf81fb8c41a7a5b434d67be2e8f6_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzExLTQtMS0xLTMxNDIy_c5aabee6-c109-48a5-8d3c-446628cc9013"
      unitRef="eur">5850000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i05cbcb5d225f4a1e8421221f4405ebae_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzExLTYtMS0xLTMxNDIy_18fe0875-e19b-46c0-bf32-f1cb9847c714"
      unitRef="eur">5955600000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:LongTermDebt
      contextRef="i203444b86c864e92be2fd1ad7307b680_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzE0LTItMS0xLTM2NjE4_e7a56e76-3d49-46db-8fc5-0cb5703770ac"
      unitRef="jpy">40000000000</us-gaap:LongTermDebt>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i203444b86c864e92be2fd1ad7307b680_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzE0LTQtMS0xLTM2NjI0_9e4e6449-ed74-4f74-9486-c5edc231d9ca"
      unitRef="jpy">40000000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ifa97038cc597436695cbf1346cc9a0ab_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzE0LTYtMS0xLTM2NjMw_075c89e1-9c1b-4896-9ab8-acdb124c48b6"
      unitRef="jpy">0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:LongTermDebt
      contextRef="ibef3bf81fb8c41a7a5b434d67be2e8f6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzE1LTItMS0xLTM2NjE4_82e72c60-5d1d-41df-a3bb-177e458f396f"
      unitRef="jpy">40000000000</us-gaap:LongTermDebt>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ibef3bf81fb8c41a7a5b434d67be2e8f6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzE1LTQtMS0xLTM2NjI0_f4555a98-58d4-42a4-aea4-a303fbb65c3a"
      unitRef="jpy">40000000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i05cbcb5d225f4a1e8421221f4405ebae_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo2NDI2ZjI5OGE4ZTU0MzNlOWY0ODIzM2ExZmNkOTFhMi90YWJsZXJhbmdlOjY0MjZmMjk4YThlNTQzM2U5ZjQ4MjMzYTFmY2Q5MWEyXzE1LTYtMS0xLTM2NjMw_8fb7af8a-eb34-4d3d-8626-4b3017be7a46"
      unitRef="jpy">0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:LongTermDebt
      contextRef="ie77d3b2d673e467fbbf3c091f8ded489_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90ZXh0cmVnaW9uOmZmZGUwNDVjYjEzYjQ2YWQ5ZWE4Njk3OTNlZWQ1OTY3XzEwOTk1MTE2NDI0MDk_804834a6-8681-4fd5-a3aa-2b62b309302b"
      unitRef="usd">347600000</us-gaap:LongTermDebt>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i2ab96945884b453e862399993bf9898b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo5YTk5ZGM0MjE0MTg0YTc1OWZiZjQyOTFjODA0YWI2Yi90YWJsZXJhbmdlOjlhOTlkYzQyMTQxODRhNzU5ZmJmNDI5MWM4MDRhYjZiXzUtMi0xLTEtMzY3MDQ_cc134bb8-e881-492e-91a4-6e2cca7a03ae"
      unitRef="usd">62000000.0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i4da71023bae940f99c4faea351670e06_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo5YTk5ZGM0MjE0MTg0YTc1OWZiZjQyOTFjODA0YWI2Yi90YWJsZXJhbmdlOjlhOTlkYzQyMTQxODRhNzU5ZmJmNDI5MWM4MDRhYjZiXzUtMy0xLTEtMzY3MDQ_f097c370-bc64-4aae-a0e4-83f4f023f4b4"
      unitRef="usd">28300000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ic0ad6012a5fa43a49ad0a2980a19ddb3_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo5YTk5ZGM0MjE0MTg0YTc1OWZiZjQyOTFjODA0YWI2Yi90YWJsZXJhbmdlOjlhOTlkYzQyMTQxODRhNzU5ZmJmNDI5MWM4MDRhYjZiXzUtNi0xLTEtMzY3MDQ_a127e821-4b16-4f40-a9b1-7aa953d48743"
      unitRef="usd">4300000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="icf29789408364be881b52abb508e5de3_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo5YTk5ZGM0MjE0MTg0YTc1OWZiZjQyOTFjODA0YWI2Yi90YWJsZXJhbmdlOjlhOTlkYzQyMTQxODRhNzU5ZmJmNDI5MWM4MDRhYjZiXzUtNy0xLTEtMzY3MDQ_c043f2f3-cb38-4100-bcf2-ade448b18093"
      unitRef="usd">800000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i2274eaab76e54e488ce05bb95778a8cd_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo5YTk5ZGM0MjE0MTg0YTc1OWZiZjQyOTFjODA0YWI2Yi90YWJsZXJhbmdlOjlhOTlkYzQyMTQxODRhNzU5ZmJmNDI5MWM4MDRhYjZiXzYtMi0xLTEtMzY3MDQ_687f2c04-7fb6-4331-a87e-bc7691f3bc84"
      unitRef="usd">62000000.0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i42eae6da7fc24ce694d83020bfe37e2b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo5YTk5ZGM0MjE0MTg0YTc1OWZiZjQyOTFjODA0YWI2Yi90YWJsZXJhbmdlOjlhOTlkYzQyMTQxODRhNzU5ZmJmNDI5MWM4MDRhYjZiXzYtMy0xLTEtMzY3MDQ_35c5c3c5-fd19-43f5-9a44-0051c498a569"
      unitRef="usd">28300000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="iaf8418c5909549baad168bf445e46d9a_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo5YTk5ZGM0MjE0MTg0YTc1OWZiZjQyOTFjODA0YWI2Yi90YWJsZXJhbmdlOjlhOTlkYzQyMTQxODRhNzU5ZmJmNDI5MWM4MDRhYjZiXzgtMi0xLTEtMzY3MDQ_e1e25449-d414-45c5-87db-35d78c9a43b4"
      unitRef="usd">82600000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="if6a61ecb28ac40db9a5d31a3a4ad8e76_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo5YTk5ZGM0MjE0MTg0YTc1OWZiZjQyOTFjODA0YWI2Yi90YWJsZXJhbmdlOjlhOTlkYzQyMTQxODRhNzU5ZmJmNDI5MWM4MDRhYjZiXzgtMy0xLTEtMzY3MDQ_002a3639-778e-4e5e-82b0-bd2ce8cb337a"
      unitRef="usd">90300000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i4f884def881b445f90dd9534fe3fb188_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo5YTk5ZGM0MjE0MTg0YTc1OWZiZjQyOTFjODA0YWI2Yi90YWJsZXJhbmdlOjlhOTlkYzQyMTQxODRhNzU5ZmJmNDI5MWM4MDRhYjZiXzgtNi0xLTEtMzY3MDQ_bfcba6fb-d409-43a2-bbed-57f8c07c61a9"
      unitRef="usd">56700000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ib7327d7b6283478083ef6d071f79ff32_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo5YTk5ZGM0MjE0MTg0YTc1OWZiZjQyOTFjODA0YWI2Yi90YWJsZXJhbmdlOjlhOTlkYzQyMTQxODRhNzU5ZmJmNDI5MWM4MDRhYjZiXzgtNy0xLTEtMzY3MDQ_5fb6b7d7-3b92-4651-990d-1cfdc3bbdd71"
      unitRef="usd">102800000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i7e4405916ad540b9a7f953c2af935d2a_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo5YTk5ZGM0MjE0MTg0YTc1OWZiZjQyOTFjODA0YWI2Yi90YWJsZXJhbmdlOjlhOTlkYzQyMTQxODRhNzU5ZmJmNDI5MWM4MDRhYjZiXzktMi0xLTEtMzY3MDQ_564466c6-dc31-4481-9668-625b30c93741"
      unitRef="usd">82600000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i481467d95c4545e5bb497389f9859d4c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo5YTk5ZGM0MjE0MTg0YTc1OWZiZjQyOTFjODA0YWI2Yi90YWJsZXJhbmdlOjlhOTlkYzQyMTQxODRhNzU5ZmJmNDI5MWM4MDRhYjZiXzktMy0xLTEtMzY3MDQ_5ba310b1-2709-49ea-80c9-30fbb1a1ed52"
      unitRef="usd">90300000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i7e4405916ad540b9a7f953c2af935d2a_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo5YTk5ZGM0MjE0MTg0YTc1OWZiZjQyOTFjODA0YWI2Yi90YWJsZXJhbmdlOjlhOTlkYzQyMTQxODRhNzU5ZmJmNDI5MWM4MDRhYjZiXzktNi0xLTEtMzY3MDQ_06e3a398-9f36-46d7-8a3f-381ba0fd513f"
      unitRef="usd">56700000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i481467d95c4545e5bb497389f9859d4c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo5YTk5ZGM0MjE0MTg0YTc1OWZiZjQyOTFjODA0YWI2Yi90YWJsZXJhbmdlOjlhOTlkYzQyMTQxODRhNzU5ZmJmNDI5MWM4MDRhYjZiXzktNy0xLTEtMzY3MDQ_c465a4d2-b30a-470f-8667-5988c83b91ce"
      unitRef="usd">102800000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo5YTk5ZGM0MjE0MTg0YTc1OWZiZjQyOTFjODA0YWI2Yi90YWJsZXJhbmdlOjlhOTlkYzQyMTQxODRhNzU5ZmJmNDI5MWM4MDRhYjZiXzEwLTItMS0xLTM2NzA0_9ed51bef-4fcb-4651-8fb3-f5e058187158"
      unitRef="usd">144600000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo5YTk5ZGM0MjE0MTg0YTc1OWZiZjQyOTFjODA0YWI2Yi90YWJsZXJhbmdlOjlhOTlkYzQyMTQxODRhNzU5ZmJmNDI5MWM4MDRhYjZiXzEwLTMtMS0xLTM2NzA0_87e171c0-946d-44b9-9483-bc4b1d89b20f"
      unitRef="usd">118600000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo5YTk5ZGM0MjE0MTg0YTc1OWZiZjQyOTFjODA0YWI2Yi90YWJsZXJhbmdlOjlhOTlkYzQyMTQxODRhNzU5ZmJmNDI5MWM4MDRhYjZiXzEwLTYtMS0xLTM2NzA0_39460e51-645d-49a3-b4e9-57651642895d"
      unitRef="usd">61000000.0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo5YTk5ZGM0MjE0MTg0YTc1OWZiZjQyOTFjODA0YWI2Yi90YWJsZXJhbmdlOjlhOTlkYzQyMTQxODRhNzU5ZmJmNDI5MWM4MDRhYjZiXzEwLTctMS0xLTM2NzA0_3d143e0c-2e91-48cb-a5d3-e4b082592b62"
      unitRef="usd">103600000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="ibbe7edb935be4af4a3721e260440024e_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90ZXh0cmVnaW9uOmZmZGUwNDVjYjEzYjQ2YWQ5ZWE4Njk3OTNlZWQ1OTY3XzEyNDM5_6024932f-c710-4b5c-aa6b-d37b0463d00a">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize information about the gains/(losses) incurred to hedge or offset operational foreign exchange or interest rate risk:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.738%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.819%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gains/(Losses) Recognized in Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gain Excluded from the Assessment of Hedge Effectiveness&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of Gain/(Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivative Financial Instruments in Fair Value Hedge Relationships &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt; :&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 Senior Notes (3.125% coupon)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivative Financial Instruments in Cash Flow Hedging Relationships&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivative Financial Instruments Not Designated as Hedging Instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option and forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gains/(Losses) Recognized in AOCE (Net of Tax) on Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gains/(Losses) Reclassified from AOCE into Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of Gain/(Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivative Financial Instruments in Cash Flow Hedging Relationships &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivative Financial Instruments in Net Investment Hedging Relationships:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency borrowings and forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;436.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(346.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;479.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(325.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;____________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;In the first quarter of 2020, the Company terminated interest rate swaps designated as a fair value hedge resulting in net proceeds of approximately $45 million. The amount included in the above tables represents the fair value adjustment recognized at the date the interest rate swaps were settled. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;At December&#160;31, 2021, the Company expects that approximately $21.0 million of pre-tax net gains on cash flow hedges will be reclassified from AOCE into earnings during the next twelve months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;Represents the location of the gain/(loss) recognized in earnings on derivatives.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;Represents the location of the gain/(loss) reclassified from AOCE into earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;Represents the location of the gain excluded from the assessment of hedge effectiveness.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="if732b369611b40bcad116753c69a9845_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzQtMi0xLTEtMzY3MDg_54cdd19b-2204-49f9-9593-03cdd32523c3"
      unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i25fbe74eb4264d7daff50e624f791260_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzQtMy0xLTEtMzY3MDg_a7fa1c21-9cce-483b-bc00-9eb11cbc6759"
      unitRef="usd">22100000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i2629746dda6747b385fc80d8be9b7149_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzQtNS0xLTEtMzk5MzQ_9c38c3af-f52d-4d02-a4ac-8b2aa8c8dcb6"
      unitRef="usd">18700000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings
      contextRef="i0e1bb69f19ec4a6298efcee5d069b518_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzUtMi0xLTEtMzY3MDg_db8ca472-1492-4762-9448-f71daade97ec"
      unitRef="usd">0</us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings>
    <us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings
      contextRef="i2f9bb026157949c78212217fe9b44bb4_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzUtMy0xLTEtMzY3MDg_17a15d59-82e0-4422-aa16-67d6ca53a0ff"
      unitRef="usd">-22100000</us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings>
    <us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings
      contextRef="i56846d199ffb4f219d37ebf51599c34f_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzUtNS0xLTEtMzk5NDA_f559896e-4b2a-48a9-b350-1890e7f810fe"
      unitRef="usd">-18700000</us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings>
    <us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet
      contextRef="ib8d0d63150a443a9a2d4e20b655c9e2f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzctNy0xLTEtNDAwMDc_7be552b9-8620-4698-a39b-98bf79053541"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet>
    <us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet
      contextRef="i6faa273322f64371a812153577418b44_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzctOC0xLTEtNDAwMDk_5f7a7fe7-7d72-4d30-98d6-fd0310cf748b"
      unitRef="usd">7100000</us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet>
    <us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet
      contextRef="i9654acb9de7d4ca493374d0d74ccd282_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzctOS0xLTEtNDAwMTE_4533e585-17fd-4d70-a51a-b77d4e69b240"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i80c54ac8020646d2ab7569f426de2da7_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzEyLTItMS0xLTM2NzA4_ca814d2d-970b-4fdf-8f9e-54abb0c73f4d"
      unitRef="usd">39300000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="if06aa643a0dd4bd7a0bb9445a80b41e1_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzEyLTMtMS0xLTM2NzA4_18e29964-c3c7-489f-9b5a-f7f1060651e8"
      unitRef="usd">-10100000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i237668ce34d742348fc490c31a89179a_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzktNS0xLTEtNDAwMjQ_fa550e1e-abb5-456b-aca2-07590436786d"
      unitRef="usd">-17300000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzEwLTMtMS0xLTQwMDMx_446cf192-20dd-4577-a5a1-2b72e3b489fa"
      unitRef="usd">39300000</us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings>
    <us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzEwLTQtMS0xLTQwMDMz_25c02b7a-695f-41bd-8b8d-289b02dae94a"
      unitRef="usd">-10100000</us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings>
    <us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzEwLTUtMS0xLTQwMDM1_88269c7b-b890-4419-91ed-9d43d2846bda"
      unitRef="usd">-17300000</us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings>
    <us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet
      contextRef="ib8d0d63150a443a9a2d4e20b655c9e2f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzEwLTctMS0xLTQwMDQz_ee3b5318-8eb6-4d35-9520-737a98022837"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet>
    <us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet
      contextRef="i6faa273322f64371a812153577418b44_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzEwLTgtMS0xLTQwMDQz_75b47e3f-93cf-44ae-91d7-64dd9c2205ea"
      unitRef="usd">7100000</us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet>
    <us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet
      contextRef="i9654acb9de7d4ca493374d0d74ccd282_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzEwLTktMS0xLTQwMDQz_5c4bfad0-43ef-40b7-b56c-e2b09727431a"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i5eac979dacba469ba19bc637404defc4_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzE2LTMtMS0xLTM5OTcz_ecd39cbe-b8d6-44bc-a3af-55267c3c6149"
      unitRef="usd">45800000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i2fad0ea862684b18988c02daa98065dc_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzE2LTQtMS0xLTM5OTc1_b6115cf1-047f-4201-b2b1-ad1cc909fa28"
      unitRef="usd">20600000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i8efba978bebc47919ee66621c13ee179_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzE2LTUtMS0xLTM5OTc3_d5d2f569-d5d3-43a0-88a9-1767f2aa0692"
      unitRef="usd">16600000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="if3ebbb8721854743a8cb2b760433c11e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzE2LTctMS0xLTM5OTg4_859f703b-2f3d-484f-ad2a-8d5d005a1559"
      unitRef="usd">30900000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="ia9ae6a7ac5cd4083b3bdd4eeba1b2668_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzE2LTgtMS0xLTM5OTkw_d809aeef-442d-4a87-ac46-875931e3130e"
      unitRef="usd">4800000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i32ea16aa6d414c73a3f0814961d0178d_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzE2LTktMS0xLTM5OTky_7192f4f2-fd30-447d-8f97-b081f69cec7e"
      unitRef="usd">-700000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="if6ef68015996425387540c85e3abd584_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzE3LTMtMS0xLTM5OTc5_ed85f839-da45-4b57-9d7b-041acf5ec25c"
      unitRef="usd">-3400000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i51898b0e23db4285b98783fe25f8e36f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzE3LTQtMS0xLTM5OTgx_d98ca3b1-0d23-4897-9562-ea5a6524b0bf"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i46a7b47f4bfd48e38e1a40a09cc02687_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzE3LTUtMS0xLTM5OTgz_85e97517-6730-4a3b-a0c5-491c792120fe"
      unitRef="usd">3000000.0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="ib281974ea08948ca9b385c9fbf70eb76_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzE3LTctMS0xLTM5OTk5_ade0bdd3-0bb2-4771-8812-2f837d5f981a"
      unitRef="usd">-4300000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i61adc213c3bb41c1b79b08b95374ec05_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzE3LTgtMS0xLTQwMDAx_aab7678b-61b6-4ebf-bc6c-e4b7dcacbfff"
      unitRef="usd">-4500000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i50e722bd905e484a9e5b58ca42df1a48_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzE3LTktMS0xLTUyMzY3_934be23f-f386-4e63-a27c-2205fce9aa59"
      unitRef="usd">-7100000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ie86e478f62084256bbe03e843d36bfd4_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzE5LTMtMS0xLTM5OTUx_861e0e30-d925-473d-8bb5-cf6082886b6b"
      unitRef="usd">436600000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="if871dc9d84a946f19d267f938caa03bb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzE5LTQtMS0xLTM5OTUz_b19252ae-f992-4759-87fc-65a32517e360"
      unitRef="usd">-346400000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="iac5b711af87d47b4909f4910be28f8fd_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzE5LTUtMS0xLTM5OTU1_25e69ec8-ee5e-4f92-a0f5-4e7b07d7fff1"
      unitRef="usd">56700000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzIwLTMtMS0xLTQwMDM3_f4fe5eb1-cd26-499a-9554-303679a7c37f"
      unitRef="usd">479000000.0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzIwLTQtMS0xLTQwMDM5_d0348726-ec1a-426b-a409-b9c551c74837"
      unitRef="usd">-325800000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzIwLTUtMS0xLTQwMDQx_2dfdfa43-cb23-4fad-a319-74651ed9ba68"
      unitRef="usd">76300000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzIwLTctMS0xLTQwMDQ1_6f842bbf-83b4-44da-b583-d07c9ef8f4bb"
      unitRef="usd">26600000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzIwLTgtMS0xLTQwMDQ3_1dc0c15e-7aa4-45e5-8745-0cba8ad8ab3e"
      unitRef="usd">300000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo1ZDRiY2EyMTAwZTg0MDQ5ODAzOWEyZmQxOTVlMWJkMy90YWJsZXJhbmdlOjVkNGJjYTIxMDBlODQwNDk4MDM5YTJmZDE5NWUxYmQzXzIwLTktMS0xLTQwMDQ5_1fe6a4fc-d2a2-4b98-adc3-22405afa3d30"
      unitRef="usd">-7800000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90ZXh0cmVnaW9uOmZmZGUwNDVjYjEzYjQ2YWQ5ZWE4Njk3OTNlZWQ1OTY3XzEwOTk1MTE2NDUyOTY_94fcf5bf-3e7c-4ba3-8fab-baadd2c7b558"
      unitRef="usd">21000000</us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90ZXh0cmVnaW9uOmZmZGUwNDVjYjEzYjQ2YWQ5ZWE4Njk3OTNlZWQ1OTY3XzEyNTMy_135b956c-491e-4e44-82f0-a7eb77738097">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial assets and liabilities carried at fair value are classified in the tables below in one of the three categories described above:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.465%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Recurring fair value measurements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="24" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exchange traded funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale fixed income investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasuries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Agency mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total available-for-sale fixed income investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets at recurring fair value measurement&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="24" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities at recurring fair value measurement&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.465%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Recurring fair value measurements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="24" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exchange traded funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale fixed income investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasuries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Agency mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total available-for-sale fixed income investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets at recurring fair value measurement&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="24" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities at recurring fair value measurement&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;327.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="idd50cfa1e1e34150bb7e6bf364a6cf02_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzUtMS0xLTEtMzE0MjI_17758c4c-cb9d-4d92-9ae8-e7f0df35237f"
      unitRef="usd">50900000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i2f1f3ba4d1c44a5ea869a805433ebbbc_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzUtNy0xLTEtMzE0MjI_d11939d1-9600-4897-966f-73e88fdb380a"
      unitRef="usd">50900000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i9dcaff92c9304ccca2976819941da18b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzYtMS0xLTEtMzE0MjI_e4d23585-957d-4291-bd99-f5ae9e5450d1"
      unitRef="usd">50900000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzYtNy0xLTEtMzE0MjI_0c3dc327-1181-43d1-947d-08f6f85b531c"
      unitRef="usd">50900000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent
      contextRef="i5387ecd95f1b4b21af4525dd7eb447b8_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzgtMS0xLTEtMzE0MjI_cc8abe94-7697-44fd-aac9-1d9a59ade9a7"
      unitRef="usd">50300000</us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent>
    <us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent
      contextRef="i1fafcde031c3487c96b095c7e9b1a4b7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzgtNy0xLTEtMzE0MjI_116b3d2c-b046-4398-87ee-635944151c31"
      unitRef="usd">50300000</us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent>
    <us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent
      contextRef="icbc15c77f512432996fe6c2792f89851_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzktMS0xLTEtMzE0MjI_64b5647c-464b-4d85-ab1a-91abb69b8563"
      unitRef="usd">700000</us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent>
    <us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent
      contextRef="i6ef24702815341caa5d222e324cde377_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzktNy0xLTEtMzE0MjI_6d92dcc3-8846-411a-bef6-87e7caa9a44f"
      unitRef="usd">700000</us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent>
    <us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent
      contextRef="i9dcaff92c9304ccca2976819941da18b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzEwLTEtMS0xLTMxNDIy_449994c2-27d6-4f09-bc50-6f0d841115db"
      unitRef="usd">51000000.0</us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent>
    <us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzEwLTctMS0xLTMxNDIy_bf938a30-8572-4bda-9a62-b718a9db7cf8"
      unitRef="usd">51000000.0</us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8ee5436ebc91401299dbc66fb31d1ba1_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzEyLTMtMS0xLTMxNDIy_d359bd63-27c0-4c30-b6e5-fcf581094c44"
      unitRef="usd">16600000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i93a9254901ed49de952eda7653f907ac_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzEyLTctMS0xLTMxNDIy_f02641eb-efb7-490e-be74-a5588439845f"
      unitRef="usd">16600000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i21551c21cb5b4b48afb8bf862247798d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzEzLTMtMS0xLTMxNDIy_a128921a-701f-4ccd-88b3-39ee4e59dba4"
      unitRef="usd">14600000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4fde47ed57994e7aa756ac70c39cbf8d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzEzLTctMS0xLTMxNDIy_1ece020b-1ca5-4711-8b52-1cc9c7a6e9c4"
      unitRef="usd">14600000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib97e2eb7978744c19ab31e5a8376b5a1_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzE0LTMtMS0xLTMxNDIy_f7f30c56-27ee-4725-aad5-43a80706f4a1"
      unitRef="usd">2000000.0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i18a3ddb5107448a099979738cf774b3f_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzE0LTctMS0xLTMxNDIy_a2dbdea5-45f0-4a6a-8595-ec03d31c6d47"
      unitRef="usd">2000000.0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifa7cf902531e404f8bad7f6968475c58_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzE1LTMtMS0xLTMxNDIy_be86e9d9-996b-42e2-8ac5-c8e1137ee0f4"
      unitRef="usd">4600000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8966d648d0f54ce1b447b567d34e2402_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzE1LTctMS0xLTMxNDIy_7b9781fd-335b-4426-9ef5-7443e702f1a9"
      unitRef="usd">4600000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5981a6477d5e43cd8437a6506268400c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzE2LTMtMS0xLTMxNDIy_07e8830d-afa1-43d9-ac70-1337398dd624"
      unitRef="usd">400000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i32084c41b5404f8390dcf56f0215f989_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzE2LTctMS0xLTMxNDIy_863e3f98-021b-49bc-a70e-a45c8cd0dbd7"
      unitRef="usd">400000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i858b714a7a1546fa86606e2c701719ee_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzE3LTMtMS0xLTMxNDIy_3e184767-8bb9-4494-acf4-e32b540058ce"
      unitRef="usd">38200000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iaf0a8e4e52d64933bcd2cc97aa5788fe_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzE3LTctMS0xLTMxNDIy_da040f9b-4b8f-431a-9c4f-c7eab1712115"
      unitRef="usd">38200000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i329520eeb0a04b5bad45f6974d90de1a_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzE4LTMtMS0xLTMxNDIy_6eb7db22-6a8a-460c-835b-058a1750e3ff"
      unitRef="usd">144600000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="if095f8bb1f1b41eab2ce30dfe31f5273_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzE4LTctMS0xLTMxNDIy_450bf069-7b46-4e73-bebc-dba4b9b96e2b"
      unitRef="usd">144600000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i9dcaff92c9304ccca2976819941da18b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzIwLTEtMS0xLTMxNDIy_2e8db5b9-b4ce-4dab-9786-aef983a2e987"
      unitRef="usd">101900000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ie24e749ab05a4833892ad719d96c300b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzIwLTMtMS0xLTMxNDIy_b94a7e1b-1d2d-4b0e-ab55-3c9c1bfef857"
      unitRef="usd">182800000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzIwLTctMS0xLTMxNDIy_3876375e-43c8-47d2-ae2d-b5140776b8ef"
      unitRef="usd">284700000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="idd4f324d5afb475e82b0026903ef73a7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzIyLTMtMS0xLTMxNDIy_6ba7cdf1-e5a1-477d-bdcd-f9419bc61def"
      unitRef="usd">61000000.0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="ie1ad37b49c494d5c8be906abfac6dc4c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzIyLTctMS0xLTMxNDIy_3f3a97e1-4774-4357-b6f7-953363eded9a"
      unitRef="usd">61000000.0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="if24b49e0068e4eb481af75b6062f9456_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzIzLTUtMS0xLTMxNDIy_14fae5f8-e648-495d-b743-1cad9da71be9"
      unitRef="usd">199700000</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="i288c304410434dbe813214bf4eef76f1_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzIzLTctMS0xLTMxNDIy_52d725aa-d2de-4367-be11-41846bbbe842"
      unitRef="usd">199700000</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ie24e749ab05a4833892ad719d96c300b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzI0LTMtMS0xLTMxNDIy_54ad51d4-c8b2-4ca6-890d-0a0142d44adb"
      unitRef="usd">61000000.0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i42e5f527f22943e5b9d7a7a7685c1fba_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzI0LTUtMS0xLTMxNDIy_aaff1fbe-61ef-418a-8edb-4ffb2bac0893"
      unitRef="usd">199700000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjYmQ1MWM1OTFhMDI0ODk3ODc4YTQyZTRiYzk5NDQ4Yi90YWJsZXJhbmdlOmNiZDUxYzU5MWEwMjQ4OTc4NzhhNDJlNGJjOTk0NDhiXzI0LTctMS0xLTMxNDIy_2ba90504-8d65-4713-9a8c-1f486d2e9c6f"
      unitRef="usd">260700000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i997a640a9bd547beaed71dc4ba211d11_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzUtMS0xLTEtMzE0MjI_c585fcfc-923b-43ad-ac97-7c074a990ef8"
      unitRef="usd">900000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i8c903b289b914375b5edd04b08ed0db1_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzUtNy0xLTEtMzE0MjI_af114d7d-a97b-4bb6-ac16-d279ffaf7684"
      unitRef="usd">900000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ifb3ec9725b8947ae894c70cb9fb96fc0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzYtMS0xLTEtMzE0MjI_e4ac8924-6beb-467c-8007-93faf8fc6e2a"
      unitRef="usd">900000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzYtNy0xLTEtMzE0MjI_48914118-7438-4d83-90a0-7e8f8e039320"
      unitRef="usd">900000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent
      contextRef="ibaee0ac5194a4c1491943ee3a6348a76_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzgtMS0xLTEtMzE0MjI_d764aa50-0711-4c0a-916c-25610e595e9b"
      unitRef="usd">45100000</us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent>
    <us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent
      contextRef="ice252435f6954b3dafd70d47c4bfa455_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzgtNy0xLTEtMzE0MjI_eb84fdfa-5e8e-4477-aa6f-b7e15b4671bc"
      unitRef="usd">45100000</us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent>
    <us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent
      contextRef="i8fa346806c0a487197a11cf349c436db_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzktMS0xLTEtMzE0MjI_729c386a-7407-48db-a831-7b110e48af30"
      unitRef="usd">700000</us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent>
    <us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent
      contextRef="ic423a7424c864666be50a0a4f390acc3_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzktNy0xLTEtMzE0MjI_58e67204-d5ee-4cac-9ba7-6f834983af14"
      unitRef="usd">700000</us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent>
    <us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent
      contextRef="ie58356c472ef49b48d4e2508fa52d3b6_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzEwLTEtMS0xLTMxNDIy_a752e0ef-4cd4-4254-b0bf-495e5b1c666f"
      unitRef="usd">45800000</us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent>
    <us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent
      contextRef="ie3f56b439929457fba15cc320189f428_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzEwLTctMS0xLTMxNDIy_98390d01-3ec5-42b9-aa1f-1d317db65c87"
      unitRef="usd">45800000</us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibb52f941e1874849b1e0f0c993cf6266_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzEyLTMtMS0xLTMxNDIy_ddcaf334-cc78-464d-9734-ce902aaa8829"
      unitRef="usd">17800000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifa911871a605402e901504a7b4ac61d7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzEyLTctMS0xLTMxNDIy_6a4286a7-a88c-451d-b80d-cbdf8db6d52e"
      unitRef="usd">17800000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i76e72c40fc9145b7a9caf8a61f156082_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzEzLTMtMS0xLTMxNDIy_edd3eba5-43ad-4323-bc5f-790c7d08f7b9"
      unitRef="usd">14400000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i35168e44d21d481481a247e34dfc73e0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzEzLTctMS0xLTMxNDIy_92174277-0182-471c-bbb8-2b273ba50334"
      unitRef="usd">14400000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i57fa96c988344f0e818a196d4896959e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzE0LTMtMS0xLTMxNDIy_58651571-a935-49fd-838a-b8e9a7ff0e56"
      unitRef="usd">1900000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5b458f3612f1402784b53aeac8a369dc_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzE0LTctMS0xLTMxNDIy_5ab0ab17-d2bf-4e26-b9f6-7b624ac0a7e0"
      unitRef="usd">1900000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6e3f3d362ea642ed9e7f8f139947c56d_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzE1LTMtMS0xLTMxNDIy_db0f44a5-86ce-4bcf-af1f-eb5a3d46c52c"
      unitRef="usd">4600000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i353b586581cf44dca4cb825b92b6aafd_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzE1LTctMS0xLTMxNDIy_f0ad89ec-8dc0-4139-88ab-658a42df146c"
      unitRef="usd">4600000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8cae512912394bf5b5d2ebf918860db3_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzE2LTMtMS0xLTMxNDIy_b1c60ef6-e278-426f-858e-bfd5b1d038f1"
      unitRef="usd">400000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ide391512e22947ccac25df3c07cb9228_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzE2LTctMS0xLTMxNDIy_7f518da0-ed80-4219-b495-65af6177b18a"
      unitRef="usd">400000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i561ba56147034042ab3232502e02546e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzE3LTMtMS0xLTMxNDIy_6587fbf8-c5a3-450f-9493-dcac3fbe9028"
      unitRef="usd">39100000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="idd529d4efdc24298b90ec1d3fc7c7068_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzE3LTctMS0xLTMxNDIy_932a4e15-3610-4af6-aa0a-be1e4e5044fe"
      unitRef="usd">39100000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="iba340d0dfb4648819a3e1ddf13ac641e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzE4LTMtMS0xLTMxNDIy_ddec82df-e318-4719-83fc-27d4a9fec1fc"
      unitRef="usd">118600000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="ic1b09c1f40b047ff8dddca2986b053a3_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzE4LTctMS0xLTMxNDIy_cf5ac588-e011-4ec0-9563-7c90d59b63d6"
      unitRef="usd">118600000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ifb3ec9725b8947ae894c70cb9fb96fc0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzIwLTEtMS0xLTMxNDIy_0587943f-3849-4ea6-b74d-0c5bc93fdd21"
      unitRef="usd">46700000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i7064536ad58d434ca55e232aa46556fb_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzIwLTMtMS0xLTMxNDIy_8162ec59-08d2-44b8-98b3-877e969c58b0"
      unitRef="usd">157700000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzIwLTctMS0xLTMxNDIy_4d136e74-99eb-44c1-af70-69a59a451fd9"
      unitRef="usd">204400000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i7154adf94728411fa895c551c3a5e9c9_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzIyLTMtMS0xLTMxNDIy_271e0da3-92d7-47d4-a6c5-f9ee4c9379e2"
      unitRef="usd">103600000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i8da2ec9305974c688991d4d33e6a27db_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzIyLTctMS0xLTMxNDIy_864a8fbc-5ddf-4673-b021-02c2ff3b756e"
      unitRef="usd">103600000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="i666a97b1659e4674b1610db7c741b7b2_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzIzLTUtMS0xLTMxNDIy_99bb41d3-476b-4110-859e-721ccb78a518"
      unitRef="usd">223600000</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="if75d03b186fe47ba9d810bcb281f1f3d_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzIzLTctMS0xLTMxNDIy_01e0ac0b-c589-4070-959e-d59706009a61"
      unitRef="usd">223600000</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i7064536ad58d434ca55e232aa46556fb_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzI0LTMtMS0xLTMxNDIy_4cca78dd-3a36-4330-911d-314a98c49aa9"
      unitRef="usd">103600000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="if70694466104422da2d7abde7dda9ee2_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzI0LTUtMS0xLTMxNDIy_ca53de4a-97c7-43ae-a1fc-85e88c15c2f6"
      unitRef="usd">223600000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0OWRlNzU0NDBkMGY0ODQ4ODAzMGEzMTU3YjIyM2YwMS90YWJsZXJhbmdlOjQ5ZGU3NTQ0MGQwZjQ4NDg4MDMwYTMxNTdiMjIzZjAxXzI0LTctMS0xLTMxNDIy_994a7633-0e25-460e-ad36-274172018ee2"
      unitRef="usd">327200000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i898cd302e4b34c6896647b6396e46f83_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90ZXh0cmVnaW9uOmZmZGUwNDVjYjEzYjQ2YWQ5ZWE4Njk3OTNlZWQ1OTY3Xzk5MzE_545962c5-5792-4f03-a91c-0f14fee149b7"
      unitRef="usd">177800000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i3052adbd4310483f8c87f27b0a935413_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90ZXh0cmVnaW9uOmZmZGUwNDVjYjEzYjQ2YWQ5ZWE4Njk3OTNlZWQ1OTY3XzEwNTY0_71bdc53c-34c9-4556-93e7-3e3542ef7c10"
      unitRef="number">0.080</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="id01941d6bb0f45a4b724bf9f4a330e96_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90ZXh0cmVnaW9uOmZmZGUwNDVjYjEzYjQ2YWQ5ZWE4Njk3OTNlZWQ1OTY3XzEwNTcw_f39fbf9f-5c0f-4a2e-9592-29bd3eee6ac1"
      unitRef="number">0.105</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90ZXh0cmVnaW9uOmZmZGUwNDVjYjEzYjQ2YWQ5ZWE4Njk3OTNlZWQ1OTY3XzEyNDYx_1f54c65c-0872-4c8c-8371-dbb25b590ade">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A rollforward of the activity in the Company&#x2019;s fair value of contingent consideration from December&#160;31, 2019 to December&#160;31, 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.272%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Current Portion &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-Term Portion&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Contingent Consideration&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(111.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(111.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accretion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value loss &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(83.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(83.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accretion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value loss &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;____________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;Included in other current liabilities in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;Included in other long-term obligations in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;Included in litigation settlements and other contingencies, net in the consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i3f4eb4a955334d9ba1854bafa06369c8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzEtMS0xLTEtMzE0MjI_2f8f30c0-4a92-4c2f-8370-a796f4707a09"
      unitRef="usd">120400000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i400815bb3ce2404ea55584df1faffd10_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzEtMy0xLTEtMzE0MjI_b0511207-c1f4-44ee-86b6-6591a3e2c8cc"
      unitRef="usd">130300000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="iac503b6d629d4bafb262ea6ec0b8a25e_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzEtNS0xLTEtMzE0MjI_629fbd7c-ad4a-40aa-84cf-af090e7a151f"
      unitRef="usd">250700000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <vtrs:BusinessCombinationContingentConsiderationLiabilityPayments
      contextRef="i00babded181a4889991307d7e9be7b3e_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzMtMS0xLTEtMzE0MjI_8a5f14f4-100e-4099-8019-75c4c4a762d1"
      unitRef="usd">-111800000</vtrs:BusinessCombinationContingentConsiderationLiabilityPayments>
    <vtrs:BusinessCombinationContingentConsiderationLiabilityPayments
      contextRef="i56e83e9054ce46708f56540239a6c805_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzMtMy0xLTEtMzE0MjI_53e6d3dc-6690-4cc4-a604-b745b6d4a710"
      unitRef="usd">0</vtrs:BusinessCombinationContingentConsiderationLiabilityPayments>
    <vtrs:BusinessCombinationContingentConsiderationLiabilityPayments
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzMtNS0xLTEtMzE0MjI_4ecd75ae-857c-40fd-8e1f-0223446fea08"
      unitRef="usd">-111800000</vtrs:BusinessCombinationContingentConsiderationLiabilityPayments>
    <vtrs:BusinessCombinationContingentConsiderationArrangementsReclassifications
      contextRef="i00babded181a4889991307d7e9be7b3e_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzQtMS0xLTEtMzE0MjI_d5a9324f-9ede-44e1-a8b2-1c88af7aad71"
      unitRef="usd">58100000</vtrs:BusinessCombinationContingentConsiderationArrangementsReclassifications>
    <vtrs:BusinessCombinationContingentConsiderationArrangementsReclassifications
      contextRef="i56e83e9054ce46708f56540239a6c805_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzQtMy0xLTEtMzE0MjI_e8678bc4-2bf3-4d6f-b8fd-eb759511ac36"
      unitRef="usd">-58100000</vtrs:BusinessCombinationContingentConsiderationArrangementsReclassifications>
    <vtrs:BusinessCombinationContingentConsiderationArrangementsReclassifications
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzQtNS0xLTEtMzE0MjI_6e02fc15-68ee-4245-9c91-5d50eaee5863"
      unitRef="usd">0</vtrs:BusinessCombinationContingentConsiderationArrangementsReclassifications>
    <us-gaap:AccretionExpense
      contextRef="i00babded181a4889991307d7e9be7b3e_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzUtMS0xLTEtMzE0MjI_3e621ae1-93a5-4eb5-9419-635eb4a08da9"
      unitRef="usd">0</us-gaap:AccretionExpense>
    <us-gaap:AccretionExpense
      contextRef="i56e83e9054ce46708f56540239a6c805_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzUtMy0xLTEtMzE0MjI_864a9294-645a-4101-bbc1-6f6ff16a16c5"
      unitRef="usd">11600000</us-gaap:AccretionExpense>
    <us-gaap:AccretionExpense
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzUtNS0xLTEtMzE0MjI_21326e08-acc6-413c-af94-e0ea0cae457a"
      unitRef="usd">11600000</us-gaap:AccretionExpense>
    <vtrs:BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss
      contextRef="i00babded181a4889991307d7e9be7b3e_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzYtMS0xLTEtMzE0MjI_552e3403-0d87-4dca-bfaa-c79e0d083591"
      unitRef="usd">33800000</vtrs:BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss>
    <vtrs:BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss
      contextRef="i56e83e9054ce46708f56540239a6c805_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzYtMy0xLTEtMzE0MjI_614d3858-c390-4ba3-bc90-e4d20aaa9313"
      unitRef="usd">39300000</vtrs:BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss>
    <vtrs:BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzYtNS0xLTEtMzE0MjI_8757fdee-9e90-437b-9e6b-6ceb61135dde"
      unitRef="usd">73100000</vtrs:BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i869e9de1ba0e414a8a1c0e4653ab950f_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzgtMS0xLTEtMzE0MjI_748f2fce-85d5-4c7c-ab50-4e0ae6e3d255"
      unitRef="usd">100500000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ia89d28ed480a4556840f217684004588_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzgtMy0xLTEtMzE0MjI_ac5db8ea-da89-4ca3-9320-9f8775d95749"
      unitRef="usd">123100000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzgtNS0xLTEtMzE0MjI_386dee79-f0ff-4ef9-83f7-774511b2419e"
      unitRef="usd">223600000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <vtrs:BusinessCombinationContingentConsiderationLiabilityPayments
      contextRef="icd90ca69608a471ebdd2665fb68a10f0_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzktMS0xLTEtMzE0MjI_151da1f5-39e4-4d2a-8bc8-61d529d407ad"
      unitRef="usd">-83200000</vtrs:BusinessCombinationContingentConsiderationLiabilityPayments>
    <vtrs:BusinessCombinationContingentConsiderationLiabilityPayments
      contextRef="ic9987758e9374f87a70ef8c4aca1fc6b_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzktMy0xLTEtMzE0MjI_f06f5313-7028-42d1-866e-0d0ac4970bd4"
      unitRef="usd">0</vtrs:BusinessCombinationContingentConsiderationLiabilityPayments>
    <vtrs:BusinessCombinationContingentConsiderationLiabilityPayments
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzktNS0xLTEtMzE0MjI_a3362b91-83d2-4cae-be79-aa30a16c67c0"
      unitRef="usd">-83200000</vtrs:BusinessCombinationContingentConsiderationLiabilityPayments>
    <vtrs:BusinessCombinationContingentConsiderationArrangementsReclassifications
      contextRef="icd90ca69608a471ebdd2665fb68a10f0_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzEwLTEtMS0xLTMxNDIy_390056b7-d762-4376-8db6-41af040604d9"
      unitRef="usd">49400000</vtrs:BusinessCombinationContingentConsiderationArrangementsReclassifications>
    <vtrs:BusinessCombinationContingentConsiderationArrangementsReclassifications
      contextRef="ic9987758e9374f87a70ef8c4aca1fc6b_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzEwLTMtMS0xLTMxNDIy_394510b9-4d40-4e97-b3b9-5bc0639816d9"
      unitRef="usd">-49400000</vtrs:BusinessCombinationContingentConsiderationArrangementsReclassifications>
    <vtrs:BusinessCombinationContingentConsiderationArrangementsReclassifications
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzEwLTUtMS0xLTMxNDIy_08cc351b-21f4-4f40-81e2-a13bf96d9bcb"
      unitRef="usd">0</vtrs:BusinessCombinationContingentConsiderationArrangementsReclassifications>
    <us-gaap:AccretionExpense
      contextRef="icd90ca69608a471ebdd2665fb68a10f0_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzExLTEtMS0xLTMxNDIy_ae8d8af1-8fcf-4c85-9e77-333ba3f89e1f"
      unitRef="usd">0</us-gaap:AccretionExpense>
    <us-gaap:AccretionExpense
      contextRef="ic9987758e9374f87a70ef8c4aca1fc6b_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzExLTMtMS0xLTMxNDIy_c4fa9daf-56e6-4335-8b9c-98bfa0d6df55"
      unitRef="usd">9000000.0</us-gaap:AccretionExpense>
    <us-gaap:AccretionExpense
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzExLTUtMS0xLTMxNDIy_2eff890d-fdaf-452b-95eb-08e3cda6ede0"
      unitRef="usd">9000000.0</us-gaap:AccretionExpense>
    <vtrs:BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss
      contextRef="icd90ca69608a471ebdd2665fb68a10f0_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzEyLTEtMS0xLTMxNDIy_776b3783-1e2d-456a-ab68-23a9de417158"
      unitRef="usd">0</vtrs:BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss>
    <vtrs:BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss
      contextRef="ic9987758e9374f87a70ef8c4aca1fc6b_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzEyLTMtMS0xLTMxNDIy_13bb45ae-403c-49a5-abde-5213a7a16372"
      unitRef="usd">50300000</vtrs:BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss>
    <vtrs:BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzEyLTUtMS0xLTMxNDIy_b66bd61f-ce69-4daf-9c18-9b290fedcb77"
      unitRef="usd">50300000</vtrs:BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i2c198dc35fb64539904dc17b63908f02_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzEzLTEtMS0xLTMxNDIy_b79b03fd-7b34-41bc-ae50-18450b4d96d7"
      unitRef="usd">66700000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i8416dfbb7a5942b691bd8f0154ec826e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzEzLTMtMS0xLTMxNDIy_cbe5954d-cb2f-406f-95c6-57b98acbe32c"
      unitRef="usd">133000000.0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTpjY2I5NDhmODQ2OWU0YjE3OTJjNzQzYmE2OGE4OTM0NC90YWJsZXJhbmdlOmNjYjk0OGY4NDY5ZTRiMTc5MmM3NDNiYTY4YTg5MzQ0XzEzLTUtMS0xLTMxNDIy_c64401db-7c91-4967-9ec3-6e3ca5aa3ea7"
      unitRef="usd">199700000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:AccretionExpense
      contextRef="i84ab0bd68a334690be79969b61dd4796_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90ZXh0cmVnaW9uOmZmZGUwNDVjYjEzYjQ2YWQ5ZWE4Njk3OTNlZWQ1OTY3XzEwOTk1MTE2NDY0ODU_e959f3b5-9e50-4d19-aadd-67837100649d"
      unitRef="usd">6000000</us-gaap:AccretionExpense>
    <us-gaap:AccretionExpense
      contextRef="i500214b091fd4491a3e5f7c09d556da9_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90ZXh0cmVnaW9uOmZmZGUwNDVjYjEzYjQ2YWQ5ZWE4Njk3OTNlZWQ1OTY3XzEwOTk1MTE2NDY0OTk_fccf2415-bb72-402f-bdd4-7f4bb11fced8"
      unitRef="usd">8000000</us-gaap:AccretionExpense>
    <us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90ZXh0cmVnaW9uOmZmZGUwNDVjYjEzYjQ2YWQ5ZWE4Njk3OTNlZWQ1OTY3XzEyNTI2_b3efa5cc-6415-463c-a37f-706086aa3725">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amortized cost and estimated fair value of available-for-sale fixed income securities, included in prepaid expenses and other current assets, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.465%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i8d7336def5e24f00b2fa9c82f8a246d0_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTphZmMzYTQ1YThhMjQ0NmY1OGRiMWQ5M2ZjMjA4NTJkZC90YWJsZXJhbmdlOmFmYzNhNDVhOGEyNDQ2ZjU4ZGIxZDkzZmMyMDg1MmRkXzItMS0xLTEtMzE0MjI_dae01ffb-9e11-4bb1-b5b9-c00e810d8cfd"
      unitRef="usd">38100000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i8d7336def5e24f00b2fa9c82f8a246d0_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTphZmMzYTQ1YThhMjQ0NmY1OGRiMWQ5M2ZjMjA4NTJkZC90YWJsZXJhbmdlOmFmYzNhNDVhOGEyNDQ2ZjU4ZGIxZDkzZmMyMDg1MmRkXzItMy0xLTEtMzE0MjI_7a88734e-943f-4707-9da3-3ec749a191ea"
      unitRef="usd">100000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i8d7336def5e24f00b2fa9c82f8a246d0_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTphZmMzYTQ1YThhMjQ0NmY1OGRiMWQ5M2ZjMjA4NTJkZC90YWJsZXJhbmdlOmFmYzNhNDVhOGEyNDQ2ZjU4ZGIxZDkzZmMyMDg1MmRkXzItNS0xLTEtMzE0MjI_a74e9ac7-8381-41f8-b3c4-4fcb311c3ce7"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8d7336def5e24f00b2fa9c82f8a246d0_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTphZmMzYTQ1YThhMjQ0NmY1OGRiMWQ5M2ZjMjA4NTJkZC90YWJsZXJhbmdlOmFmYzNhNDVhOGEyNDQ2ZjU4ZGIxZDkzZmMyMDg1MmRkXzItNy0xLTEtMzE0MjI_a9009fd5-7813-4e74-b88a-3e341d79422e"
      unitRef="usd">38200000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTphZmMzYTQ1YThhMjQ0NmY1OGRiMWQ5M2ZjMjA4NTJkZC90YWJsZXJhbmdlOmFmYzNhNDVhOGEyNDQ2ZjU4ZGIxZDkzZmMyMDg1MmRkXzMtMS0xLTEtMzE0MjI_86fc51ad-d64d-411b-9682-b7d2774916d8"
      unitRef="usd">38100000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTphZmMzYTQ1YThhMjQ0NmY1OGRiMWQ5M2ZjMjA4NTJkZC90YWJsZXJhbmdlOmFmYzNhNDVhOGEyNDQ2ZjU4ZGIxZDkzZmMyMDg1MmRkXzMtMy0xLTEtMzE0MjI_2ff2b152-1ee2-40f8-b20f-882107fa8b7e"
      unitRef="usd">100000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTphZmMzYTQ1YThhMjQ0NmY1OGRiMWQ5M2ZjMjA4NTJkZC90YWJsZXJhbmdlOmFmYzNhNDVhOGEyNDQ2ZjU4ZGIxZDkzZmMyMDg1MmRkXzMtNS0xLTEtMzE0MjI_93ea36f7-9da0-4cf1-8e0c-a9093aa879de"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTphZmMzYTQ1YThhMjQ0NmY1OGRiMWQ5M2ZjMjA4NTJkZC90YWJsZXJhbmdlOmFmYzNhNDVhOGEyNDQ2ZjU4ZGIxZDkzZmMyMDg1MmRkXzMtNy0xLTEtMzE0MjI_7f2c9f77-7447-418d-bb1f-18451fdb6c70"
      unitRef="usd">38200000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i04586f5a3ee649afbdb486e4d10a000a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTphZmMzYTQ1YThhMjQ0NmY1OGRiMWQ5M2ZjMjA4NTJkZC90YWJsZXJhbmdlOmFmYzNhNDVhOGEyNDQ2ZjU4ZGIxZDkzZmMyMDg1MmRkXzUtMS0xLTEtMzE0MjI_2048b7ec-bca0-4c92-8c6b-52c629280103"
      unitRef="usd">37500000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i04586f5a3ee649afbdb486e4d10a000a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTphZmMzYTQ1YThhMjQ0NmY1OGRiMWQ5M2ZjMjA4NTJkZC90YWJsZXJhbmdlOmFmYzNhNDVhOGEyNDQ2ZjU4ZGIxZDkzZmMyMDg1MmRkXzUtMy0xLTEtMzE0MjI_0edc086b-9e86-46cb-abaf-f41842a0ab56"
      unitRef="usd">1600000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i04586f5a3ee649afbdb486e4d10a000a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTphZmMzYTQ1YThhMjQ0NmY1OGRiMWQ5M2ZjMjA4NTJkZC90YWJsZXJhbmdlOmFmYzNhNDVhOGEyNDQ2ZjU4ZGIxZDkzZmMyMDg1MmRkXzUtNS0xLTEtMzE0MjI_4b8cab02-466d-48f2-99bf-cd89a57ad482"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i04586f5a3ee649afbdb486e4d10a000a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTphZmMzYTQ1YThhMjQ0NmY1OGRiMWQ5M2ZjMjA4NTJkZC90YWJsZXJhbmdlOmFmYzNhNDVhOGEyNDQ2ZjU4ZGIxZDkzZmMyMDg1MmRkXzUtNy0xLTEtMzE0MjI_8006d031-afb6-46e2-96b0-e76added5c12"
      unitRef="usd">39100000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTphZmMzYTQ1YThhMjQ0NmY1OGRiMWQ5M2ZjMjA4NTJkZC90YWJsZXJhbmdlOmFmYzNhNDVhOGEyNDQ2ZjU4ZGIxZDkzZmMyMDg1MmRkXzYtMS0xLTEtMzE0MjI_3333d9dc-2567-404b-8817-4a3bffdb9fbb"
      unitRef="usd">37500000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTphZmMzYTQ1YThhMjQ0NmY1OGRiMWQ5M2ZjMjA4NTJkZC90YWJsZXJhbmdlOmFmYzNhNDVhOGEyNDQ2ZjU4ZGIxZDkzZmMyMDg1MmRkXzYtMy0xLTEtMzE0MjI_b98d394d-4ba7-4e23-9e2c-31f33832a6ad"
      unitRef="usd">1600000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTphZmMzYTQ1YThhMjQ0NmY1OGRiMWQ5M2ZjMjA4NTJkZC90YWJsZXJhbmdlOmFmYzNhNDVhOGEyNDQ2ZjU4ZGIxZDkzZmMyMDg1MmRkXzYtNS0xLTEtMzE0MjI_96da0f4d-a9e2-4991-bf9b-ba6551e18a54"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTphZmMzYTQ1YThhMjQ0NmY1OGRiMWQ5M2ZjMjA4NTJkZC90YWJsZXJhbmdlOmFmYzNhNDVhOGEyNDQ2ZjU4ZGIxZDkzZmMyMDg1MmRkXzYtNy0xLTEtMzE0MjI_016b5436-b2fd-4429-9430-8ce061658fd6"
      unitRef="usd">39100000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90ZXh0cmVnaW9uOmZmZGUwNDVjYjEzYjQ2YWQ5ZWE4Njk3OTNlZWQ1OTY3XzEyNDY1_09cd29a9-5eb5-4aa4-aa47-948b91f0e06d">&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of available-for-sale debt securities at fair value as of December&#160;31, 2021, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:89.090%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mature within one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mature in one to five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mature in five years and later&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0YmQxYTExNDNhMTc0NDcwYjczOTgzMjQwNDVjNzhmNC90YWJsZXJhbmdlOjRiZDFhMTE0M2ExNzQ0NzBiNzM5ODMyNDA0NWM3OGY0XzEtMS0xLTEtMzE0MjI_04a27d16-2cae-4297-8057-58986720de2f"
      unitRef="usd">1200000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0YmQxYTExNDNhMTc0NDcwYjczOTgzMjQwNDVjNzhmNC90YWJsZXJhbmdlOjRiZDFhMTE0M2ExNzQ0NzBiNzM5ODMyNDA0NWM3OGY0XzItMS0xLTEtMzE0MjI_a632acc9-64df-49e3-892d-28f9366f0620"
      unitRef="usd">19700000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <vtrs:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAndLaterFairValue
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0YmQxYTExNDNhMTc0NDcwYjczOTgzMjQwNDVjNzhmNC90YWJsZXJhbmdlOjRiZDFhMTE0M2ExNzQ0NzBiNzM5ODMyNDA0NWM3OGY0XzMtMS0xLTEtMzE0MjI_5ca175fe-b632-41ca-b91a-7f740cf1e7e4"
      unitRef="usd">17300000</vtrs:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAndLaterFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDIvZnJhZzpmZmRlMDQ1Y2IxM2I0NmFkOWVhODY5NzkzZWVkNTk2Ny90YWJsZTo0YmQxYTExNDNhMTc0NDcwYjczOTgzMjQwNDVjNzhmNC90YWJsZXJhbmdlOjRiZDFhMTE0M2ExNzQ0NzBiNzM5ODMyNDA0NWM3OGY0XzQtMS0xLTEtMzE0MjI_8b8aad0e-eeef-4908-82f8-44084e09fb38"
      unitRef="usd">38200000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:ScheduleOfShortTermDebtTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2Xzk2NDQ_e39a5440-e875-4394-8ed4-42e9e2290b99">&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Short-Term Borrowings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had $1.49&#160;billion and $1.10&#160;billion of borrowings as of December&#160;31, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.575%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,173.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;651.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables Facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;318.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Note Securitization Facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Short-term borrowings&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,493.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,100.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The following provides an overview of the Company&#x2019;s short-term credit facilities.</us-gaap:ScheduleOfShortTermDebtTextBlock>
    <us-gaap:ShortTermBorrowings
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2XzQ5_9b496d51-d30a-4fc9-971e-a8df9bfad63e"
      unitRef="usd">1490000000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2XzEwOTk1MTE2NTM5MTA_dfa769e1-4fd2-46f7-aaa0-90218d9c998e"
      unitRef="usd">1100000000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i6348c0871c354006bbb77663df6a8f55_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTo3Zjc5YTFiYWEyMTY0OGI1OGU2M2JiOWY3MjYwYjIzMC90YWJsZXJhbmdlOjdmNzlhMWJhYTIxNjQ4YjU4ZTYzYmI5ZjcyNjBiMjMwXzEtMS0xLTEtMzE0MjI_80d9f41f-8769-491b-b7d5-eb2a2c75ab44"
      unitRef="usd">1173400000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i42c49c74e2aa485b82eb650616e9a5ed_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTo3Zjc5YTFiYWEyMTY0OGI1OGU2M2JiOWY3MjYwYjIzMC90YWJsZXJhbmdlOjdmNzlhMWJhYTIxNjQ4YjU4ZTYzYmI5ZjcyNjBiMjMwXzEtMy0xLTEtMzE0MjI_e1df4e74-37fc-4217-b428-3ce806092779"
      unitRef="usd">651300000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="iba8eb8ec1ddc4b67a8a39164a81b8561_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTo3Zjc5YTFiYWEyMTY0OGI1OGU2M2JiOWY3MjYwYjIzMC90YWJsZXJhbmdlOjdmNzlhMWJhYTIxNjQ4YjU4ZTYzYmI5ZjcyNjBiMjMwXzItMS0xLTEtMzE0MjI_13376767-89c3-4c4c-a384-a60ccab74ed8"
      unitRef="usd">318500000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i0333343531a84c508ec66fd2d2e00992_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTo3Zjc5YTFiYWEyMTY0OGI1OGU2M2JiOWY3MjYwYjIzMC90YWJsZXJhbmdlOjdmNzlhMWJhYTIxNjQ4YjU4ZTYzYmI5ZjcyNjBiMjMwXzItMy0xLTEtMzE0MjI_8c6d710d-c63f-4f78-8cb8-03850402c545"
      unitRef="usd">248400000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i83bd5820907e45cbbb4ea0f8abe30112_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTo3Zjc5YTFiYWEyMTY0OGI1OGU2M2JiOWY3MjYwYjIzMC90YWJsZXJhbmdlOjdmNzlhMWJhYTIxNjQ4YjU4ZTYzYmI5ZjcyNjBiMjMwXzMtMS0xLTEtMzE0MjI_8fc991de-e819-476b-a5ab-6715035eb668"
      unitRef="usd">0</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i761c7931f4534948be5b4250f7b81ef1_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTo3Zjc5YTFiYWEyMTY0OGI1OGU2M2JiOWY3MjYwYjIzMC90YWJsZXJhbmdlOjdmNzlhMWJhYTIxNjQ4YjU4ZTYzYmI5ZjcyNjBiMjMwXzMtMy0xLTEtMzE0MjI_103b23b1-3198-43f0-809c-8ed59309d99c"
      unitRef="usd">200000000.0</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="ie1f6c291ccc34af59e5c6bbc708d16ed_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTo3Zjc5YTFiYWEyMTY0OGI1OGU2M2JiOWY3MjYwYjIzMC90YWJsZXJhbmdlOjdmNzlhMWJhYTIxNjQ4YjU4ZTYzYmI5ZjcyNjBiMjMwXzQtMS0xLTEtMzE0MjI_02376cab-50ef-4930-9d08-b3b1279bf936"
      unitRef="usd">1100000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="ie02ffa5a286a4854b0f6a8ae8fb7875b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTo3Zjc5YTFiYWEyMTY0OGI1OGU2M2JiOWY3MjYwYjIzMC90YWJsZXJhbmdlOjdmNzlhMWJhYTIxNjQ4YjU4ZTYzYmI5ZjcyNjBiMjMwXzQtMy0xLTEtMzE0MjI_bf486dc1-93cd-4132-bb55-b434ec65df5d"
      unitRef="usd">1200000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTo3Zjc5YTFiYWEyMTY0OGI1OGU2M2JiOWY3MjYwYjIzMC90YWJsZXJhbmdlOjdmNzlhMWJhYTIxNjQ4YjU4ZTYzYmI5ZjcyNjBiMjMwXzUtMS0xLTEtMzE0MjI_6072a6e0-5435-463d-a60c-8e2d50ab5fd9"
      unitRef="usd">1493000000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTo3Zjc5YTFiYWEyMTY0OGI1OGU2M2JiOWY3MjYwYjIzMC90YWJsZXJhbmdlOjdmNzlhMWJhYTIxNjQ4YjU4ZTYzYmI5ZjcyNjBiMjMwXzUtMy0xLTEtMzE0MjI_55b92a71-75cf-4adc-bf67-5f1da1b18f8b"
      unitRef="usd">1100900000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i6348c0871c354006bbb77663df6a8f55_I20211231"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2XzEwOTk1MTE2NTM5NDU_6696e5ad-f900-4162-bb97-6455095b8deb"
      unitRef="usd">1170000000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i42c49c74e2aa485b82eb650616e9a5ed_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2XzMyOTg1MzQ4OTk4MTI_e1df4e74-37fc-4217-b428-3ce806092779"
      unitRef="usd">651300000</us-gaap:ShortTermBorrowings>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ia14591b7ed4e4ed5b2119d20257b6803_I20170606"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2XzcyNA_80bad2c2-f9d4-4838-a558-57245448f228"
      unitRef="usd">1650000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="ied6eaf81eabd467eb19851b626292fa8_D20170606-20170606"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2Xzg2NQ_afb2bb08-dea7-4301-bccd-296da12df14c">P364D</us-gaap:DebtInstrumentTerm>
    <vtrs:AccountsReceivableFacilityMaximumBorrowingCapacity
      contextRef="iba8eb8ec1ddc4b67a8a39164a81b8561_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2Xzk3MQ_60446673-8cd2-410e-bf99-1d591040d907"
      unitRef="usd">400000000</vtrs:AccountsReceivableFacilityMaximumBorrowingCapacity>
    <vtrs:AccountsReceivableFacilityMaximumBorrowingCapacity
      contextRef="i83bd5820907e45cbbb4ea0f8abe30112_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2XzE3NDA_2eafe133-af64-45d9-9977-8b7b249bc697"
      unitRef="usd">200000000</vtrs:AccountsReceivableFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i58f2993346b2437da3921482cd53781f_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2XzIyMTQ_39da2395-ed2e-40a3-b017-1c5aa1a7a9e4"
      unitRef="number">0.00925</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ie3ae820bb2f84caeb01b1f76cfa70fc8_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2XzEwOTk1MTE2NDcxMjc_6b6b1b88-cdbd-4b01-bda9-018eb92eca9f"
      unitRef="number">0.0085</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:AccountsReceivableFromSecuritization
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2XzI4MTE_c9913687-7bab-4e99-8369-da4d061ad804"
      unitRef="usd">388900000</us-gaap:AccountsReceivableFromSecuritization>
    <us-gaap:AccountsReceivableFromSecuritization
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2XzI4MTg_5aacea87-b606-4183-98c2-5a767830f761"
      unitRef="usd">389400000</us-gaap:AccountsReceivableFromSecuritization>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2ab05aad91f84733ae6b5e8d48936298_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzQtMS0xLTEtMzcyNjY_bb07866b-01b7-4578-a91c-ceeeed1ffb93"
      unitRef="number">0.03150</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtCurrent
      contextRef="i44658e6f80d547aaa1d6f5eade2a3003_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzQtMy0xLTEtMzE0MjI_17b9f218-c07c-42b2-bd37-9fe676188039"
      unitRef="usd">0</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="i2463e684b0924c04a93cc915be90fe1b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzQtNS0xLTEtMzE0MjI_fa494967-ee6b-4b15-986f-ab1ccfa4e69a"
      unitRef="usd">2249700000</us-gaap:DebtCurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic818a0a0c1d2464bb6ef3218b78cc20e_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzUtMS0xLTEtMzE0MjI_a795c106-f8cf-40f5-96af-aff9718ac4fd"
      unitRef="number">0.00816</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtCurrent
      contextRef="ic818a0a0c1d2464bb6ef3218b78cc20e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzUtMy0xLTEtMzE0MjI_35bbd8fb-a1ee-4ff3-9008-e7d56da4e8fa"
      unitRef="usd">856600000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="i1422ee4965c4486e9d857d1e0ef2b079_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzUtNS0xLTEtMzE0MjI_48820318-1273-49b5-84bb-0040b5a82a49"
      unitRef="usd">0</us-gaap:DebtCurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i205f2aac79b04016b1da176b6a7fb1fa_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzYtMS0xLTEtMzE0MjI_a4bd0b2b-4061-45bf-aa10-2637ca15b373"
      unitRef="number">0.01125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtCurrent
      contextRef="i205f2aac79b04016b1da176b6a7fb1fa_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzYtMy0xLTEtMzE0MjI_0340e7fe-a8de-4815-bd43-0d6a3e7b678a"
      unitRef="usd">1002900000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="if007a084b1e34ea384fb202e6e9d6c38_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzYtNS0xLTEtMzE0MjI_19aa181e-be33-42b7-8f10-52d6fdab51ab"
      unitRef="usd">0</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="ie1f6c291ccc34af59e5c6bbc708d16ed_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzgtMy0xLTEtMzE0MjI_0bc88246-8ac7-4944-8f96-35accef6be4e"
      unitRef="usd">900000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="ie02ffa5a286a4854b0f6a8ae8fb7875b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzgtNS0xLTEtMzE0MjI_32b90399-6c85-4115-bd53-609cf02bf24f"
      unitRef="usd">8000000.0</us-gaap:DebtCurrent>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="i5cd223f958b74eae95243319a27d31f0_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzktMy0xLTEtMzE0MjI_5da037fd-a344-4096-a1e3-9927857073af"
      unitRef="usd">100000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="ic8f7a9b488f94289a8d5b7710a4447af_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzktNS0xLTEtMzE0MjI_601a1e1a-90a7-41f7-8804-69ecfa7ba76f"
      unitRef="usd">1400000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:DebtCurrent
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzEwLTMtMS0xLTMxNDIy_cb8beec3-e88b-43fe-811d-3282e52d93b9"
      unitRef="usd">1860300000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzEwLTUtMS0xLTMxNDIy_edcd23f3-a96c-47fe-b6b0-6aa6e3fe4d9f"
      unitRef="usd">2256300000</us-gaap:DebtCurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib435a6d77cd34f869cedbd596bf31419_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzE3LTEtMS0xLTMxNDIy_544f2cb7-4cd0-41c0-9e8b-e8b1173a3fb3"
      unitRef="number">0.00816</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ib435a6d77cd34f869cedbd596bf31419_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzE3LTMtMS0xLTMxNDIy_4a1b28fe-a75b-47d8-ae3e-1c69fb0d7ee7"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="iab602c854a75461ab1e9ab8870796980_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzE3LTUtMS0xLTMxNDIy_231aa2a0-41f0-4b09-980e-4dd19d35302f"
      unitRef="usd">928800000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i377027e221df4b5fbf54f4ccd718ed6e_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzE4LTEtMS0xLTMxNDIy_03c06c86-d5d8-4e6f-8dfd-e0cc1397def2"
      unitRef="number">0.01125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i377027e221df4b5fbf54f4ccd718ed6e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzE4LTMtMS0xLTMxNDIy_d4890b8e-fa66-45e4-a09e-3f675784eb9b"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ia70edf5b85c1412c9e994cc32f0ac58b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzE4LTUtMS0xLTMxNDIy_662a0428-3dbf-4129-a8a1-50aaf0ec5791"
      unitRef="usd">1008800000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i10c40610432e48caaea6544a94cc0ff7_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzE5LTEtMS0xLTMxNDIy_f26043a9-19fa-45e9-82dd-26c3a95e8a91"
      unitRef="number">0.03125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i10c40610432e48caaea6544a94cc0ff7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzE5LTMtMS0xLTMxNDIy_65f4899c-7bfe-4f2c-8cd6-e9914231670e"
      unitRef="usd">766100000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="if0c235dec46b409c9b237d080763da78_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzE5LTUtMS0xLTMxNDIy_52267909-8bc1-4a3d-82ae-638f71cb35f9"
      unitRef="usd">781600000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iaa49209541544d93ba10801830d5f5a1_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzIwLTEtMS0xLTMxNDIy_a04847d5-e603-43d2-acd8-06fc28a59185"
      unitRef="number">0.04200</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="iaa49209541544d93ba10801830d5f5a1_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzIwLTMtMS0xLTMxNDIy_9bcb1e95-00ec-4bd2-8887-03d3e807ae1d"
      unitRef="usd">499600000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i9ca2c72c048b4966924c4641a6c8e4c3_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzIwLTUtMS0xLTMxNDIy_90a9dd01-5fb0-4d65-812a-1d16dc2b2e8f"
      unitRef="usd">499300000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9a9dac0334bc477ea0a456bbe46c3173_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzIxLTEtMS0xLTMxNDIy_8ae3d38a-f779-4705-8374-4082196e4a46"
      unitRef="number">0.02250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i9a9dac0334bc477ea0a456bbe46c3173_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzIxLTMtMS0xLTMxNDIy_f5c5d939-8685-497c-b0ce-5a82a84c0537"
      unitRef="usd">1135800000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i78adee273e00402683245dff9ebb774d_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzIxLTUtMS0xLTMxNDIy_78ec8056-1dfa-4bc0-94ad-bbcfdec1cc60"
      unitRef="usd">1219900000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i17b748819db1409f90ab44c1656a6844_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzIyLTEtMS0xLTMxNDIy_1cf28c8b-38ba-46c5-9232-a7b529fdb96f"
      unitRef="number">0.01023</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i9743aa24ff1b459f9b29bba570aa1521_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzIyLTMtMS0xLTMxNDIy_19bb56e4-8b2a-457c-93e5-eae8e4fc3da0"
      unitRef="usd">871600000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ib01fe9fec3ea48b998ccf8a7121177c3_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzIyLTUtMS0xLTMxNDIy_174e3bcd-1ff3-406d-abfa-5cdc2c89a240"
      unitRef="usd">944600000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iea56cbd0617d400094855281cdd9e614_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzIzLTEtMS0xLTMxNDIy_1ed194b5-5a8c-4532-9e57-dae164b8a336"
      unitRef="number">0.02125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="iea56cbd0617d400094855281cdd9e614_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzIzLTMtMS0xLTMxNDIy_d2db85aa-e6e5-4139-b4b7-48e35d3745d9"
      unitRef="usd">567800000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i31ff8d2943a647b3927af7a7fc9ceb67_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzIzLTUtMS0xLTMxNDIy_cc69a49c-3dc8-4d40-af96-3b7a01a9f853"
      unitRef="usd">609900000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1428d03b2da74d5a877a86979e4dd692_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzI0LTEtMS0xLTMxNDIy_c3abef01-6ddb-4083-be0b-51213c85d5a8"
      unitRef="number">0.01650</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i1428d03b2da74d5a877a86979e4dd692_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzI0LTMtMS0xLTMxNDIy_62973969-b80b-4f5f-9e24-906ce252c497"
      unitRef="usd">763400000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="iad4fd165662b43738af77427b3894ed9_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzI0LTUtMS0xLTMxNDIy_15032800-05fb-4512-8b40-b872f2f145e7"
      unitRef="usd">767100000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2c630e4787804a5baafb37dfba1e9941_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzI1LTEtMS0xLTMxNDIy_ef5fa11a-1467-4315-a8e4-57b58d9d719b"
      unitRef="number">0.03950</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i2c630e4787804a5baafb37dfba1e9941_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzI1LTMtMS0xLTMxNDIy_47a8f6f3-c0b2-4b55-91a6-2c55e339c684"
      unitRef="usd">2241400000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="if885e24274984b748d622171dad0e341_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzI1LTUtMS0xLTMxNDIy_9dfa5101-b895-43d8-84f3-d01322c9da2a"
      unitRef="usd">2239700000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iae4433500527462f9a53c262b4a193e2_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzI2LTEtMS0xLTMxNDIy_b45e55fb-405e-4f27-95c6-c1c328550fcf"
      unitRef="number">0.01362</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="icd92e4609f2347c481397989d4d41bb5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzI2LTMtMS0xLTMxNDIy_23785553-c00a-403f-a298-caeb5d9670b7"
      unitRef="usd">1013000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i02db2d48980748f2a8c4583ff56233ac_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzI2LTUtMS0xLTMxNDIy_9865f635-1923-42f9-997c-e904320a2474"
      unitRef="usd">1097400000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic36c2f77ef1a4f429be7552a4ffdaf63_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzI3LTEtMS0xLTMxNDIy_923d4142-8bd0-4bc3-946f-ff2169a07ad6"
      unitRef="number">0.02300</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="iec4db0b19b8f485ca0d0961ae936700c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzI3LTMtMS0xLTMxNDIy_48b48234-c70c-4883-9443-e1cbe0f00633"
      unitRef="usd">780800000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ic23232bd104348af9f1c272ee35c0c7c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzI3LTUtMS0xLTMxNDIy_07dc4224-6108-407e-b086-04e4a4bfbf77"
      unitRef="usd">786100000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4e35649af2d149e5a110744b54afb44e_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzI4LTEtMS0xLTMxNDIy_b18df3d2-8e18-43ea-984b-c280040ebe15"
      unitRef="number">0.03125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i4e35649af2d149e5a110744b54afb44e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzI4LTMtMS0xLTMxNDIy_fca5e5cb-1e8f-48c6-a267-4fdc11c57d37"
      unitRef="usd">847400000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i18dc290bd62a46ed929e318042c29293_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzI4LTUtMS0xLTMxNDIy_17c194d3-71bc-4afe-b263-985d3e344c7b"
      unitRef="usd">909700000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9d56a00686f94581be68c9eba8a25301_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzI5LTEtMS0xLTM3NTE0_3bf5d9f1-91ed-41e6-aa1e-1460dbfcf01d"
      unitRef="number">0.04550</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i9d56a00686f94581be68c9eba8a25301_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzI5LTMtMS0xLTM3NTE4_e43319cb-f46e-44fc-a6a4-7b778e1bceb9"
      unitRef="usd">748700000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="id0ded5c651e24a53b16c65e31f034e19_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzI5LTUtMS0xLTM3NTE4_4c5eaf81-742d-4a47-a093-eb61a988d335"
      unitRef="usd">748600000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia571e0c9398945dd93a699d5a8d8ca2f_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzI5LTEtMS0xLTMxNDIy_efe92da1-53ed-4948-8497-c97b3db96d0d"
      unitRef="number">0.02700</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ia571e0c9398945dd93a699d5a8d8ca2f_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzI5LTMtMS0xLTMxNDIy_d46c63a6-1c35-4fbe-a170-d6050686491b"
      unitRef="usd">1520500000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i4e9d0561e01b4afb9c271809518e9c3a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzI5LTUtMS0xLTMxNDIy_c4b525be-f502-4979-be3a-101f05ab5d5a"
      unitRef="usd">1528000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if487c6ee083b40a88448340cd281fb87_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzMwLTEtMS0xLTMxNDIy_69afbe02-9255-4cac-90e3-62e5fd034b56"
      unitRef="number">0.01908</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="if487c6ee083b40a88448340cd281fb87_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzMwLTMtMS0xLTMxNDIy_35649ee0-92e8-42ab-b751-25b5d24661e6"
      unitRef="usd">1546600000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i01addae58bf447a1be4cf07b1417127c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzMwLTUtMS0xLTMxNDIy_c387ee9d-ae4e-4a93-9d36-7905505af80b"
      unitRef="usd">1672600000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i04a235c228ea4cbe8dd8f7c77da0efca_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzMxLTEtMS0xLTMxNDIy_9ddec012-4237-4299-9de4-a282c9cc13cb"
      unitRef="number">0.03850</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i04a235c228ea4cbe8dd8f7c77da0efca_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzMxLTMtMS0xLTMxNDIy_d255d722-b113-4744-a2be-3e3e8005323a"
      unitRef="usd">1657100000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="iae33c84f581c444991bd3e6161e49454_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzMxLTUtMS0xLTMxNDIy_1f1c205a-dc87-42ab-985c-ccb4a46c117f"
      unitRef="usd">1663300000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i29c286b2a49347658e466f3c15ed9e36_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzMzLTEtMS0xLTMxNDIy_e33d9b1b-86e7-400a-861d-30df4d011c8d"
      unitRef="number">0.05400</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i29c286b2a49347658e466f3c15ed9e36_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzMzLTMtMS0xLTMxNDIy_69b3a3de-4151-41a8-92c8-da863bbb2f76"
      unitRef="usd">497300000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i64f377462f4d49f9911bffc37608cd6d_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzMzLTUtMS0xLTMxNDIy_6930bb85-2c3d-451a-b6fa-b6e0b4d1121c"
      unitRef="usd">497300000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0c5902c6ea4c409c95333fd6263b9aa6_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzM0LTEtMS0xLTMxNDIy_b5583a97-0eb2-406d-9857-fb221a526811"
      unitRef="number">0.05250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i0c5902c6ea4c409c95333fd6263b9aa6_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzM0LTMtMS0xLTMxNDIy_81c70c1b-d96d-4dea-afc7-da6a06f1402f"
      unitRef="usd">999900000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i6838f10691984228bc7b35ce8cf2c986_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzM0LTUtMS0xLTMxNDIy_aed48c3b-a41a-443c-8503-a6dac948dcfe"
      unitRef="usd">999900000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id459a294731e48d8a0be383eb2bd5a03_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzM1LTEtMS0xLTMxNDIy_9abba238-d471-49fe-87d1-f0561399af3f"
      unitRef="number">0.05200</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="id459a294731e48d8a0be383eb2bd5a03_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzM1LTMtMS0xLTMxNDIy_a6929aaf-5cdd-455c-950f-425ff0477732"
      unitRef="usd">747800000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i5884d0b22a724fbea35305a07e9ec8d0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzM1LTUtMS0xLTMxNDIy_980cc17e-71d1-4126-b139-8014d211542f"
      unitRef="usd">747700000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i02e45f2fba7e4eaa8262e45ee8ba765e_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzM2LTEtMS0xLTMxNDIy_1ded1ae7-c1b2-4dc9-9588-bedbacaff7fc"
      unitRef="number">0.04000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i02e45f2fba7e4eaa8262e45ee8ba765e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzM2LTMtMS0xLTMxNDIy_094368d5-767b-4f85-b35e-df49ae988fd1"
      unitRef="usd">2205100000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i334d1da043744144986b7f8f561ca005_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzM2LTUtMS0xLTMxNDIy_4807e747-3779-4d52-a704-22f0f1cf5042"
      unitRef="usd">2209300000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i74057de14b554e19bbd06da1ecb3f7f6_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzM3LTMtMS0xLTMxNDIy_00ae4d2a-eedc-47d8-a31d-32296922f893"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i11a32a3e965842e590fc770eeb365fa6_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzM3LTUtMS0xLTMxNDIy_1ee8d1fa-d5f1-4e31-8e17-9963ba2cd0d7"
      unitRef="usd">600000000.0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ic54954704318489dbfab83d2b541d300_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzM4LTMtMS0xLTMxNDIy_a87a4ca1-e1c8-4463-bf29-9d96f53e953b"
      unitRef="usd">1900000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i3950381ba5bc4ae0902d2fcdc22dd1cc_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzM4LTUtMS0xLTMxNDIy_1f813a97-8a69-4d24-a39c-fa97bda3d617"
      unitRef="usd">17400000</us-gaap:LongTermDebt>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzM5LTMtMS0xLTMxNDIy_2995ba72-59f9-4829-a9a9-ccf7c91bd415"
      unitRef="usd">42300000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzM5LTUtMS0xLTMxNDIy_77beb95e-78b4-473a-9655-286fbbe31123"
      unitRef="usd">47800000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzQwLTMtMS0xLTMxNDIy_28f60400-ed1f-44fc-871f-3bcb0490c10e"
      unitRef="usd">19717100000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTowY2YwODVhZTBhMTc0MDdiYjU5ZDFlNGMxY2FmYWQ3Yi90YWJsZXJhbmdlOjBjZjA4NWFlMGExNzQwN2JiNTlkMWU0YzFjYWZhZDdiXzQwLTUtMS0xLTMxNDIy_942bc338-3e7e-43b4-9c54-b021093cd7bf"
      unitRef="usd">22429200000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:ProceedsFromSaleOfSecuritiesOperatingActivities
      contextRef="ie66cc87b7d3e4499960b357a925f9705_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2XzEwOTk1MTE2MzgxNTg_0252d9f1-f9b3-422f-b50b-d28251eb5d18"
      unitRef="usd">45000000</us-gaap:ProceedsFromSaleOfSecuritiesOperatingActivities>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="if8fd6f22b8424a83b40aff917e8d37be_I20210630"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2XzM5MDQ_94d4c1e2-040f-44a2-b48d-606e3e37b8c5"
      unitRef="usd">7450000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i29d46e9d61754785892f1c72d3742cca_I20210630"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2XzU0OTc1NTgxNzQwNDU_48741b15-9e8b-4908-a092-d97685857fc4"
      unitRef="eur">3600000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i3c0b7c74c50145a7a9f8bcb989137313_I20210930"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2XzEwOTk1MTE2NjI4NjA_b5297690-70e2-4c81-8bc8-6b262d4d1aa1"
      unitRef="usd">7450000000</us-gaap:DebtInstrumentFaceAmount>
    <vtrs:DebtInstrumentConversionOfUnregisteredNotesToRegisteredNotesAsAPercentage
      contextRef="i74907a0e3a4245c29c61474d06752931_I20211029"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2XzEwOTk1MTE2NjI5MzM_11ee286a-06bd-42d6-9449-dd73c259d5ff"
      unitRef="number">0.999</vtrs:DebtInstrumentConversionOfUnregisteredNotesToRegisteredNotesAsAPercentage>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="i383cdb78da1740a096ade479d7d4de29_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2Xzk2NjE_98170b2e-f455-45f1-8b63-c361a6db0578">&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information about the Upjohn Senior Notes issued in June 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2030 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,450.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2040 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2050 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022 Euro Senior Note&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;916.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024 Euro Senior Note&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;916.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 Euro Senior Note&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,038.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2032 Euro Senior Note&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,527.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,847.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ide9302296aa644ea9e1bdea342face9a_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTphODQ0NTFkYjg1NDM0MTc5OGM4ZGJlM2Q4NjE1NTQ4Ny90YWJsZXJhbmdlOmE4NDQ1MWRiODU0MzQxNzk4YzhkYmUzZDg2MTU1NDg3XzMtMS0xLTEtMzE0MjI_f5a91299-f4c4-4f6e-8704-2f68ad4855be"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i86acbd5fe13c4222ac75586b553e6158_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTphODQ0NTFkYjg1NDM0MTc5OGM4ZGJlM2Q4NjE1NTQ4Ny90YWJsZXJhbmdlOmE4NDQ1MWRiODU0MzQxNzk4YzhkYmUzZDg2MTU1NDg3XzQtMS0xLTEtMzE0MjI_6af95d5e-1293-4860-bc53-e80198e6efd1"
      unitRef="usd">750000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ic43055109f72489cb27f40c7c7d4de3c_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTphODQ0NTFkYjg1NDM0MTc5OGM4ZGJlM2Q4NjE1NTQ4Ny90YWJsZXJhbmdlOmE4NDQ1MWRiODU0MzQxNzk4YzhkYmUzZDg2MTU1NDg3XzUtMS0xLTEtMzE0MjI_865cc3b0-d825-4a59-b3d3-3c8e9f69093b"
      unitRef="usd">750000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="if2c9dbf2c41f4039ae995c0da9b29464_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTphODQ0NTFkYjg1NDM0MTc5OGM4ZGJlM2Q4NjE1NTQ4Ny90YWJsZXJhbmdlOmE4NDQ1MWRiODU0MzQxNzk4YzhkYmUzZDg2MTU1NDg3XzYtMS0xLTEtMzE0MjI_5819796a-4ed5-4bb7-a9aa-4982da82be85"
      unitRef="usd">1450000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i377de9a7ca4747a9bb0851b1789fcf71_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTphODQ0NTFkYjg1NDM0MTc5OGM4ZGJlM2Q4NjE1NTQ4Ny90YWJsZXJhbmdlOmE4NDQ1MWRiODU0MzQxNzk4YzhkYmUzZDg2MTU1NDg3XzctMS0xLTEtMzE0MjI_9098fc8c-df85-4d46-bdd1-aa70b8346177"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i90b2414ad8e14d89af5f6b93c78866b8_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTphODQ0NTFkYjg1NDM0MTc5OGM4ZGJlM2Q4NjE1NTQ4Ny90YWJsZXJhbmdlOmE4NDQ1MWRiODU0MzQxNzk4YzhkYmUzZDg2MTU1NDg3XzgtMS0xLTEtMzE0MjI_d7121a3d-4505-41d4-b9d8-993475e5ba35"
      unitRef="usd">2000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ifc91d97ca69b44cb8428d304cc80e7ff_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTphODQ0NTFkYjg1NDM0MTc5OGM4ZGJlM2Q4NjE1NTQ4Ny90YWJsZXJhbmdlOmE4NDQ1MWRiODU0MzQxNzk4YzhkYmUzZDg2MTU1NDg3XzktMS0xLTEtMzE0MjI_16f1fc36-3268-4c5c-a599-10ccf5b1a27e"
      unitRef="usd">916200000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i012d654e3d7e4404bb0b696b2beb3cbb_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTphODQ0NTFkYjg1NDM0MTc5OGM4ZGJlM2Q4NjE1NTQ4Ny90YWJsZXJhbmdlOmE4NDQ1MWRiODU0MzQxNzk4YzhkYmUzZDg2MTU1NDg3XzEwLTEtMS0xLTMxNDIy_747f1119-cf3a-41e0-b356-b2f18601ae2a"
      unitRef="usd">916200000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="iaf2e4abfbda046d1983677a1e0f26357_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTphODQ0NTFkYjg1NDM0MTc5OGM4ZGJlM2Q4NjE1NTQ4Ny90YWJsZXJhbmdlOmE4NDQ1MWRiODU0MzQxNzk4YzhkYmUzZDg2MTU1NDg3XzExLTEtMS0xLTMxNDIy_3a442b8d-ba3f-4efe-a424-2368d294483f"
      unitRef="usd">1038400000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i4c5cbc4a7ad247e1816ce79abab0f406_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTphODQ0NTFkYjg1NDM0MTc5OGM4ZGJlM2Q4NjE1NTQ4Ny90YWJsZXJhbmdlOmE4NDQ1MWRiODU0MzQxNzk4YzhkYmUzZDg2MTU1NDg3XzEyLTEtMS0xLTMxNDIy_9fcaf68f-1ab1-4a24-accd-2568c5890659"
      unitRef="usd">1527000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i848b6b54a3a148dba6adff4fa331012e_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTphODQ0NTFkYjg1NDM0MTc5OGM4ZGJlM2Q4NjE1NTQ4Ny90YWJsZXJhbmdlOmE4NDQ1MWRiODU0MzQxNzk4YzhkYmUzZDg2MTU1NDg3XzEzLTEtMS0xLTMxNDIy_5bf3ecc0-721d-47f0-843e-37667ed3ebd1"
      unitRef="usd">11847800000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i3861691874974533b0f4beb0f744696d_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2XzEwOTk1MTE2NjI4OTg_1b3542ba-865c-4d19-8812-ecaecb14aef3"
      unitRef="usd">600000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i73d9cbc916614385999dea1173262904_D20201113-20201113"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2XzU2Nzc_38230083-7c75-4f1f-b7a7-a53848c4419f"
      unitRef="usd">12000000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i3861691874974533b0f4beb0f744696d_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2Xzc2OTM_a8a2f1d9-d034-40d7-9bdc-06fa172bdc35"
      unitRef="usd">600000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ia9e52c1741c94fa0880ca65abe054094_I20200630"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2Xzc3Mjk_2a96c8f5-c13d-4619-ad67-28b09ff18f7c"
      unitRef="usd">4000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="id4070295d773487892f0a0dafa6fb391_I20210731"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2XzEwOTk1MTE2NDI4ODE_cd3861b9-d723-4caa-8708-eb5a4b3ebf99"
      unitRef="jpy">40000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i7883883a0a384706bef726bfa103f3b5_I20210630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2XzEwOTk1MTE2NDI4OTQ_fd61fb45-8836-4cd5-b5ee-86370de1b539"
      unitRef="usd">4000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <vtrs:MaximumLeverageRatioPeriodOne
      contextRef="i5bb284525f0d40259f76a744fbd30263_I20210731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2XzEwOTk1MTE2NDI5MDg_c745e7e4-4332-46cb-a43f-8c2bff6b034d"
      unitRef="rate">4.25</vtrs:MaximumLeverageRatioPeriodOne>
    <vtrs:MaximumLeverageRatioPeriodTwo
      contextRef="i5bb284525f0d40259f76a744fbd30263_I20210731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2XzEwOTk1MTE2NDI5MjA_a533a232-b015-4bcd-b554-1635ee84ea7f"
      unitRef="rate">4.0</vtrs:MaximumLeverageRatioPeriodTwo>
    <vtrs:MaximumLeverageRatioPeriodThree
      contextRef="i5bb284525f0d40259f76a744fbd30263_I20210731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2XzEwOTk1MTE2NDI5MzE_7d786d58-2865-4461-a121-cd3392d0b9e2"
      unitRef="rate">3.75</vtrs:MaximumLeverageRatioPeriodThree>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i20a65018b503434b88c9fd17e0c1dd18_I20211231"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2XzkyMzk_cdcea42b-5438-4bff-945e-1c3af3d8a351"
      unitRef="usd">22010000000.00</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ib7f720468bec473f88d7a755ce8a5ae1_I20201231"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2XzkyNDY_a27a7eb6-b0ef-4740-aff6-a7b012ee5836"
      unitRef="usd">25900000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90ZXh0cmVnaW9uOmIxODY1OTcxMjU1MTRlMGM4MGQ4Njk2NWZhNDZiNzE2Xzk2Mjc_87c1e481-e232-45ca-b853-b66e87197dac">&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Mandatory minimum repayments remaining on the notional amount of outstanding long-term debt at December&#160;31, 2021 were as follows for each of the periods ending December 31:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:89.090%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTpmNmM2NzUwNGY3Y2Q0NjA5YTZjYjg5ZjYwNDRmNWYxOC90YWJsZXJhbmdlOmY2YzY3NTA0ZjdjZDQ2MDlhNmNiODlmNjA0NGY1ZjE4XzEtMS0xLTEtMzE0MjI_9738490e-d026-4f36-8063-b54b6645840e"
      unitRef="usd">1853000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTpmNmM2NzUwNGY3Y2Q0NjA5YTZjYjg5ZjYwNDRmNWYxOC90YWJsZXJhbmdlOmY2YzY3NTA0ZjdjZDQ2MDlhNmNiODlmNjA0NGY1ZjE4XzItMS0xLTEtMzE0MjI_1398c11c-0b70-402a-9ef1-d6f1b1ebf475"
      unitRef="usd">1250000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTpmNmM2NzUwNGY3Y2Q0NjA5YTZjYjg5ZjYwNDRmNWYxOC90YWJsZXJhbmdlOmY2YzY3NTA0ZjdjZDQ2MDlhNmNiODlmNjA0NGY1ZjE4XzMtMS0xLTEtMzE0MjI_1c507ec2-a9d5-44c4-8bc2-8366af2bdbd0"
      unitRef="usd">1990000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTpmNmM2NzUwNGY3Y2Q0NjA5YTZjYjg5ZjYwNDRmNWYxOC90YWJsZXJhbmdlOmY2YzY3NTA0ZjdjZDQ2MDlhNmNiODlmNjA0NGY1ZjE4XzQtMS0xLTEtMzE0MjI_916b529c-23a6-45e5-ba8a-76b694c2faff"
      unitRef="usd">1318000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTpmNmM2NzUwNGY3Y2Q0NjA5YTZjYjg5ZjYwNDRmNWYxOC90YWJsZXJhbmdlOmY2YzY3NTA0ZjdjZDQ2MDlhNmNiODlmNjA0NGY1ZjE4XzUtMS0xLTEtMzE0MjI_0cad874e-4f40-4857-be11-632c5a0d61fc"
      unitRef="usd">2598000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTpmNmM2NzUwNGY3Y2Q0NjA5YTZjYjg5ZjYwNDRmNWYxOC90YWJsZXJhbmdlOmY2YzY3NTA0ZjdjZDQ2MDlhNmNiODlmNjA0NGY1ZjE4XzYtMS0xLTEtMzE0MjI_0dddd191-5d36-4785-818c-86fbc939698e"
      unitRef="usd">11940000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMDgvZnJhZzpiMTg2NTk3MTI1NTE0ZTBjODBkODY5NjVmYTQ2YjcxNi90YWJsZTpmNmM2NzUwNGY3Y2Q0NjA5YTZjYjg5ZjYwNDRmNWYxOC90YWJsZXJhbmdlOmY2YzY3NTA0ZjdjZDQ2MDlhNmNiODlmNjA0NGY1ZjE4XzctMS0xLTEtMzE0MjI_19910e9b-454a-43ba-97e8-01039a7b410f"
      unitRef="usd">20949000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90ZXh0cmVnaW9uOjI1NDU2MWI5YmE3MjQ0NzM4NDgxZDk3YzRkMGUxZWJjXzIxOA_af973097-23b3-4b28-bfde-2da1030a227c">Comprehensive (Loss) Earnings&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive loss, as reflected in the consolidated balance sheets, is comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.661%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.652%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrealized gain on marketable securities, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrecognized (loss) gain and prior service cost related to defined benefit plans, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrecognized loss on derivatives in cash flow hedging relationships, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrecognized loss on derivatives in net investment hedging relationships, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(353.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,802.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(461.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,744.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(858.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Components of accumulated other comprehensive (loss) earnings, before tax, consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.993%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.684%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:36pt"&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains and Losses on Derivatives in Cash Flow Hedging Relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains and Losses on Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains and Losses on Marketable Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Defined Pension Plan Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Forward Contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(353.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(461.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(858.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (loss) before reclassifications, before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;456.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,340.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(755.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive earnings (loss), before tax:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on foreign exchange forward contracts classified as cash flow hedges, included in net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on interest rate swaps classified as cash flow hedges, included in interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of prior service costs included in SG&amp;amp;A &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of actuarial loss included in SG&amp;amp;A &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net other comprehensive earnings (loss), before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;456.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,340.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(775.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,802.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,744.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.993%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.684%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:36pt"&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains and Losses on Derivatives in Cash Flow Hedging Relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains and Losses on Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains and Losses on Marketable Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Defined Pension Plan Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Forward Contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,674.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,797.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) earnings before reclassifications, before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(305.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,213.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;914.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive (loss) earnings, before tax:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on foreign exchange forward contracts classified as cash flow hedges, included in net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on interest rate swaps classified as cash flow hedges, included in interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of prior service costs included in SG&amp;amp;A &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of actuarial loss included in SG&amp;amp;A &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net other comprehensive (loss) earnings, before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(305.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,213.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;912.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax provision (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(353.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(461.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(858.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.993%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.684%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains and Losses on Derivatives in Cash Flow Hedging Relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains and Losses on Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains and Losses on Marketable Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Defined Pension Plan Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Forward Contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2018, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(130.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,259.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,441.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (loss) before reclassifications, before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(415.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(347.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive (loss) earnings, before tax:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on foreign exchange forward contracts classified as cash flow hedges, included in net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on interest rate swaps classified as cash flow hedges, included in interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of prior service costs included in SG&amp;amp;A &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of actuarial loss included in SG&amp;amp;A &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net other comprehensive earnings (loss), before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(415.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(343.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax provision (benefit) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cumulative effect of the adoption of new accounting standards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,674.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,797.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90ZXh0cmVnaW9uOjI1NDU2MWI5YmE3MjQ0NzM4NDgxZDk3YzRkMGUxZWJjXzIyNA_1af628be-fb30-4ae2-a7bd-e35a5192ec6f">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive loss, as reflected in the consolidated balance sheets, is comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.661%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.652%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrealized gain on marketable securities, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrecognized (loss) gain and prior service cost related to defined benefit plans, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrecognized loss on derivatives in cash flow hedging relationships, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrecognized loss on derivatives in net investment hedging relationships, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(353.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,802.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(461.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,744.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(858.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTo3ODk1MmMzOTFiMTE0NDEwYjllZTU4ZjU3ZjM1ODEwOS90YWJsZXJhbmdlOjc4OTUyYzM5MWIxMTQ0MTBiOWVlNThmNTdmMzU4MTA5XzItMS0xLTEtMzE0MjI_4795f6bd-d39b-4820-b089-0cc4a5d6d4db"
      unitRef="usd">0</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTo3ODk1MmMzOTFiMTE0NDEwYjllZTU4ZjU3ZjM1ODEwOS90YWJsZXJhbmdlOjc4OTUyYzM5MWIxMTQ0MTBiOWVlNThmNTdmMzU4MTA5XzItMy0xLTEtMzE0MjI_35fdf7ea-e8a8-46ab-87b9-eea34f208633"
      unitRef="usd">1200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTo3ODk1MmMzOTFiMTE0NDEwYjllZTU4ZjU3ZjM1ODEwOS90YWJsZXJhbmdlOjc4OTUyYzM5MWIxMTQ0MTBiOWVlNThmNTdmMzU4MTA5XzMtMS0xLTEtMzE0MjI_6d92ef88-dfbb-4347-917d-56bd16d19e10"
      unitRef="usd">-32200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTo3ODk1MmMzOTFiMTE0NDEwYjllZTU4ZjU3ZjM1ODEwOS90YWJsZXJhbmdlOjc4OTUyYzM5MWIxMTQ0MTBiOWVlNThmNTdmMzU4MTA5XzMtMy0xLTEtMzE0MjI_2de6e5c3-02d4-4b1c-a64f-8e31b0262df3"
      unitRef="usd">26100000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="i9c4b4c0b310e423483a0fc1a47ab012a_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTo3ODk1MmMzOTFiMTE0NDEwYjllZTU4ZjU3ZjM1ODEwOS90YWJsZXJhbmdlOjc4OTUyYzM5MWIxMTQ0MTBiOWVlNThmNTdmMzU4MTA5XzQtMS0xLTEtMzE0MjI_4799ff54-4531-4308-9fb7-cdf466fa10ef"
      unitRef="usd">9200000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="i976d65e83c19475783582ea166af72a4_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTo3ODk1MmMzOTFiMTE0NDEwYjllZTU4ZjU3ZjM1ODEwOS90YWJsZXJhbmdlOjc4OTUyYzM5MWIxMTQ0MTBiOWVlNThmNTdmMzU4MTA5XzQtMy0xLTEtMzE0MjI_dc0fb32d-450d-4a1d-922d-c49f1799dcf4"
      unitRef="usd">-18000000.0</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <vtrs:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax
      contextRef="i56fdbd1f3d9e4c75876f8cf6831038f3_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTo3ODk1MmMzOTFiMTE0NDEwYjllZTU4ZjU3ZjM1ODEwOS90YWJsZXJhbmdlOjc4OTUyYzM5MWIxMTQ0MTBiOWVlNThmNTdmMzU4MTA5XzUtMS0xLTEtMzE0MjI_6918df2b-298c-49cb-b35b-5af0ecf10d36"
      unitRef="usd">16700000</vtrs:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax>
    <vtrs:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax
      contextRef="i2c0da8410b1d4621bf16fd27e6c27d7f_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTo3ODk1MmMzOTFiMTE0NDEwYjllZTU4ZjU3ZjM1ODEwOS90YWJsZXJhbmdlOjc4OTUyYzM5MWIxMTQ0MTBiOWVlNThmNTdmMzU4MTA5XzUtMy0xLTEtMzE0MjI_bfcc8a24-b56a-443d-adb6-9c3924c44f92"
      unitRef="usd">-353600000</vtrs:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTo3ODk1MmMzOTFiMTE0NDEwYjllZTU4ZjU3ZjM1ODEwOS90YWJsZXJhbmdlOjc4OTUyYzM5MWIxMTQ0MTBiOWVlNThmNTdmMzU4MTA5XzYtMS0xLTEtMzE0MjI_a1ba6c7d-c9fa-46d7-964f-3f4856377b22"
      unitRef="usd">-1802400000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTo3ODk1MmMzOTFiMTE0NDEwYjllZTU4ZjU3ZjM1ODEwOS90YWJsZXJhbmdlOjc4OTUyYzM5MWIxMTQ0MTBiOWVlNThmNTdmMzU4MTA5XzYtMy0xLTEtMzE0MjI_ad419db1-4da7-42a5-92c1-7bad3d02b67a"
      unitRef="usd">-461500000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i87a0adf309ee48cab4e379bd487453b4_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTo3ODk1MmMzOTFiMTE0NDEwYjllZTU4ZjU3ZjM1ODEwOS90YWJsZXJhbmdlOjc4OTUyYzM5MWIxMTQ0MTBiOWVlNThmNTdmMzU4MTA5XzctMS0xLTEtMzE0MjI_c5ce1d88-266b-47e5-b0d9-67b52eed3a5e"
      unitRef="usd">-1744300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTo3ODk1MmMzOTFiMTE0NDEwYjllZTU4ZjU3ZjM1ODEwOS90YWJsZXJhbmdlOjc4OTUyYzM5MWIxMTQ0MTBiOWVlNThmNTdmMzU4MTA5XzctMy0xLTEtMzE0MjI_3f3457a0-383b-4529-98f1-eedbc4dc2028"
      unitRef="usd">-858000000.0</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90ZXh0cmVnaW9uOjI1NDU2MWI5YmE3MjQ0NzM4NDgxZDk3YzRkMGUxZWJjXzIyMA_b52c5df7-f229-49d9-9925-40d94d30c28e">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Components of accumulated other comprehensive (loss) earnings, before tax, consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.993%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.684%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:36pt"&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains and Losses on Derivatives in Cash Flow Hedging Relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains and Losses on Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains and Losses on Marketable Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Defined Pension Plan Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Forward Contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(353.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(461.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(858.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (loss) before reclassifications, before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;456.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,340.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(755.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive earnings (loss), before tax:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on foreign exchange forward contracts classified as cash flow hedges, included in net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on interest rate swaps classified as cash flow hedges, included in interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of prior service costs included in SG&amp;amp;A &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of actuarial loss included in SG&amp;amp;A &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net other comprehensive earnings (loss), before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;456.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,340.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(775.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,802.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,744.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.993%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.684%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:36pt"&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains and Losses on Derivatives in Cash Flow Hedging Relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains and Losses on Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains and Losses on Marketable Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Defined Pension Plan Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Forward Contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,674.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,797.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) earnings before reclassifications, before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(305.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,213.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;914.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive (loss) earnings, before tax:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on foreign exchange forward contracts classified as cash flow hedges, included in net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on interest rate swaps classified as cash flow hedges, included in interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of prior service costs included in SG&amp;amp;A &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of actuarial loss included in SG&amp;amp;A &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net other comprehensive (loss) earnings, before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(305.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,213.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;912.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax provision (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(353.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(461.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(858.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.993%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.684%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains and Losses on Derivatives in Cash Flow Hedging Relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains and Losses on Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains and Losses on Marketable Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Defined Pension Plan Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Forward Contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2018, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(130.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,259.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,441.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (loss) before reclassifications, before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(415.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(347.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive (loss) earnings, before tax:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on foreign exchange forward contracts classified as cash flow hedges, included in net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on interest rate swaps classified as cash flow hedges, included in interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of prior service costs included in SG&amp;amp;A &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of actuarial loss included in SG&amp;amp;A &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net other comprehensive earnings (loss), before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(415.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(343.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax provision (benefit) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cumulative effect of the adoption of new accounting standards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,674.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,797.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="i976d65e83c19475783582ea166af72a4_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzMtNS0xLTEtMzE0MjI_dc0fb32d-450d-4a1d-922d-c49f1799dcf4"
      unitRef="usd">-18000000.0</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <vtrs:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax
      contextRef="i2c0da8410b1d4621bf16fd27e6c27d7f_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzMtNy0xLTEtMzE0MjI_bfcc8a24-b56a-443d-adb6-9c3924c44f92"
      unitRef="usd">-353600000</vtrs:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzMtOS0xLTEtMzE0MjI_35fdf7ea-e8a8-46ab-87b9-eea34f208633"
      unitRef="usd">1200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzMtMTEtMS0xLTMxNDIy_2de6e5c3-02d4-4b1c-a64f-8e31b0262df3"
      unitRef="usd">26100000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzMtMTMtMS0xLTMxNDIy_ad419db1-4da7-42a5-92c1-7bad3d02b67a"
      unitRef="usd">-461500000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzMtMTUtMS0xLTMxNDIy_3f3457a0-383b-4529-98f1-eedbc4dc2028"
      unitRef="usd">-858000000.0</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i1df50837d39f4ce5b1c56c576becf8f5_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzQtNS0xLTEtMzE0MjI_8c983317-0a7a-4d52-be25-4833b0909a46"
      unitRef="usd">62700000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i72a4e38013274704acf3fce567aec1b6_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzQtNy0xLTEtMzE0MjI_7c1324e2-9927-4f3e-b515-faefcb2b6c25"
      unitRef="usd">456800000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzQtOS0xLTEtMzE0MjI_93350b42-fefb-47ed-8cf0-6809007e048f"
      unitRef="usd">-1100000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ifdef52c121a44daba62d16f7a225ea09_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzQtMTEtMS0xLTMxNDIy_0130e98a-908e-4f4a-9607-fbefb3b5fac5"
      unitRef="usd">67000000.0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="id9752ebd80b74eb987fba8598e4bf4a2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzQtMTMtMS0xLTMxNDIy_591892e5-da9a-4612-b3ba-ed64aa87190f"
      unitRef="usd">-1340900000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i92e45e4918604661b681cd5b227d7bcc_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzQtMTUtMS0xLTMxNDIy_a4aa203a-5da7-42a6-8259-a95189778593"
      unitRef="usd">-755500000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i45d796a115fe452291c016b2351113f4_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzYtMS0xLTEtMzE0MjI_61302cd1-b923-4c76-a9f7-a86a254600e1"
      unitRef="usd">-30900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieba8727d1a644f5981104c3b153e5919_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzYtNS0xLTEtMzE0MjI_fe844357-a245-4753-8558-94783e1ca039"
      unitRef="usd">-30900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i62110eec7c9843279ebc30fd8c8fa53f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzYtMTUtMS0xLTMxNDIy_864e0edf-65f6-4643-91a7-1d950b3ef7f0"
      unitRef="usd">-30900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:InterestExpense
      contextRef="i43ffbc95ec5f4ed288d39bc9f96f6c51_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzctMy0xLTEtMzE0MjI_c3992ccb-d5d2-4a57-bfe5-4a556da06238"
      unitRef="usd">4300000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="if6ab091030ea4646909dc299bb408d0a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzctNS0xLTEtMzE0MjI_4ef5e9b6-ea3f-4151-a24f-6e5a92f4f467"
      unitRef="usd">4300000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i25e2d0bb39cd4c969048c3e9ffe0f1c7_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzctMTUtMS0xLTMxNDIy_0a2c1dbb-e4bb-4b4e-955c-9bc9ac1977e6"
      unitRef="usd">4300000</us-gaap:InterestExpense>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="i7c05a74c19dd474e9110514b3ceb45a0_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzgtMTEtMS0xLTMxNDIy_dc48c379-107f-48f3-82c3-422be6f74c77"
      unitRef="usd">500000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="i4e35c11727664c4ea9b3141cf19e2205_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzgtMTUtMS0xLTMxNDIy_56afc341-543f-460b-8d25-1887afa980ce"
      unitRef="usd">500000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="i7c05a74c19dd474e9110514b3ceb45a0_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzktMTEtMS0xLTMxNDIy_78ed2627-020f-4196-bd50-842927829345"
      unitRef="usd">-7400000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="i4e35c11727664c4ea9b3141cf19e2205_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzktMTUtMS0xLTMxNDIy_97d155de-64ca-4122-9df3-91ddc557517a"
      unitRef="usd">-7400000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i1df50837d39f4ce5b1c56c576becf8f5_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzEwLTUtMS0xLTMxNDIy_284d95af-29c6-48cd-9251-2d46eb046e37"
      unitRef="usd">36100000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i72a4e38013274704acf3fce567aec1b6_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzEwLTctMS0xLTMxNDIy_16ec1624-a1ed-4788-b152-45e5ba54667b"
      unitRef="usd">456800000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzEwLTktMS0xLTMxNDIy_2a1e26b2-5f56-4f6d-b55e-bee04b1f9707"
      unitRef="usd">-1100000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzEwLTExLTEtMS0zMTQyMg_bbf2c8fc-440a-44ff-a82b-c94221b4d23a"
      unitRef="usd">-73900000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="id9752ebd80b74eb987fba8598e4bf4a2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzEwLTEzLTEtMS0zMTQyMg_40db388a-e86b-4f8d-87be-5813fa0a5b6e"
      unitRef="usd">-1340900000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzEwLTE1LTEtMS0zMTQyMg_859f2352-946b-495a-b276-d28cc45ece97"
      unitRef="usd">-775200000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i1df50837d39f4ce5b1c56c576becf8f5_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzExLTUtMS0xLTMxNDIy_2a0f829d-8334-4bbf-8b53-21007aeefc29"
      unitRef="usd">8900000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i72a4e38013274704acf3fce567aec1b6_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzExLTctMS0xLTMxNDIy_8cbb1902-7275-4f1d-8e8c-fa257deba2f3"
      unitRef="usd">86500000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic1b8be0d1b2a44c1902af29f75363f53_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzExLTktMS0xLTMxNDIy_45ff5fdd-e7a2-45b4-bf49-0730a142d22e"
      unitRef="usd">100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i7c05a74c19dd474e9110514b3ceb45a0_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzExLTExLTEtMS0zMTQyMg_88d0fad1-3f8f-465f-968e-6ae75958092c"
      unitRef="usd">15600000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i90f54d9de46f4354845f2d01a1f04798_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzExLTEzLTEtMS0zMTQyMg_4f4ec447-4e21-472c-99fc-8c184029dc9e"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i4e35c11727664c4ea9b3141cf19e2205_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzExLTE1LTEtMS0zMTQyMg_c02abd6a-85ec-452b-8f59-2177068870df"
      unitRef="usd">111100000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="i9c4b4c0b310e423483a0fc1a47ab012a_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzEzLTUtMS0xLTMxNDIy_4799ff54-4531-4308-9fb7-cdf466fa10ef"
      unitRef="usd">9200000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <vtrs:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax
      contextRef="i56fdbd1f3d9e4c75876f8cf6831038f3_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzEzLTctMS0xLTMxNDIy_6918df2b-298c-49cb-b35b-5af0ecf10d36"
      unitRef="usd">16700000</vtrs:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzEzLTktMS0xLTMxNDIy_4795f6bd-d39b-4820-b089-0cc4a5d6d4db"
      unitRef="usd">0</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzEzLTExLTEtMS0zMTQyMg_6d92ef88-dfbb-4347-917d-56bd16d19e10"
      unitRef="usd">-32200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzEzLTEzLTEtMS0zMTQyMg_a1ba6c7d-c9fa-46d7-964f-3f4856377b22"
      unitRef="usd">-1802400000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i87a0adf309ee48cab4e379bd487453b4_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTpjM2JiNThkMDU3YTQ0ZWY2YWVhMzgwOTJiZGVlZTc2My90YWJsZXJhbmdlOmMzYmI1OGQwNTdhNDRlZjZhZWEzODA5MmJkZWVlNzYzXzEzLTE1LTEtMS0zMTQyMg_c5ce1d88-266b-47e5-b0d9-67b52eed3a5e"
      unitRef="usd">-1744300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
      contextRef="ic989ea6602bd4856815f90f895e12304_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzMtNS0xLTEtMzE0MjI_a485cfde-133d-47ad-9ef4-533a968028f3"
      unitRef="usd">-31600000</us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax>
    <vtrs:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax
      contextRef="i4c1519bf270f496eacbc594c4a0b7a1c_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzMtNy0xLTEtMzE0MjI_7d30cf76-b6e8-4592-96c5-6c1b61d93a0d"
      unitRef="usd">-74300000</vtrs:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ia3917c4bfc784a928c09f599e63910fb_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzMtOS0xLTEtMzE0MjI_590d5334-9881-4bf7-aaaa-5106e7ced438"
      unitRef="usd">600000</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i0257efc303d94390b5707bbcdb863e52_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzMtMTEtMS0xLTMxNDIy_1b3f47af-da3b-41be-9ffe-a198f3a55301"
      unitRef="usd">17400000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="ia7ff2cf5a8154924b32963fb78602f3a_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzMtMTMtMS0xLTMxNDIy_15d9e157-02e2-4c1d-a0c4-18c2b49bdd93"
      unitRef="usd">-1674500000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ic39189fc54504b53be3c4281e5dd8f82_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzMtMTUtMS0xLTMxNDIy_b539d8a8-cce3-40f9-bf3d-85329d789e9d"
      unitRef="usd">-1797200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i34f962bd787c40be86356d0feb3e5e5d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzQtNS0xLTEtMzE0MjI_a387f50e-ddd8-4f1c-beea-c7280296acd8"
      unitRef="usd">18500000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ie12ac8dbb8e34d9bbb1bb903a175a2c8_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzQtNy0xLTEtMzE0MjI_d75ad2ec-8ace-45f7-b524-8dee31232d98"
      unitRef="usd">-305200000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i28fba30d8dfb4cd0851b24ff8fafab59_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzQtOS0xLTEtMzE0MjI_94c72d41-8ad5-45d8-b705-aff19d21352f"
      unitRef="usd">600000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="id107db472b49491e9da06a69c94e6b07_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzQtMTEtMS0xLTMxNDIy_a307e9d0-bbaf-4b8b-aaab-cfc0e27a3197"
      unitRef="usd">-12100000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i1c5bfbeaa4b84f669ddcb52c7676aa3a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzQtMTMtMS0xLTMxNDIy_85494727-0484-4ef5-9de7-19fe02b0198f"
      unitRef="usd">1213000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i0e5cd61854a54e59a6e1744de70eab75_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzQtMTUtMS0xLTMxNDIy_f0bfdef5-5177-499b-a676-aa09b956919a"
      unitRef="usd">914800000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3048feb477df4b8aa1d56be7df44692f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzYtMS0xLTEtMzE0MjI_807014ad-2399-4dfe-a926-e5e62fa93c41"
      unitRef="usd">-4800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6b952231de244bb5b8417597c8764975_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzYtNS0xLTEtMzE0MjI_4c8fca0b-ea57-4f7a-96cd-12623e558c3d"
      unitRef="usd">-4800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7bd68519c5854bc58140fde2099d16e2_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzYtMTUtMS0xLTMxNDIy_9fcd4cc8-1fbc-4c63-bb99-aab149915478"
      unitRef="usd">-4800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:InterestExpense
      contextRef="ic20e72bb356c49d2a349292f49d443ab_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzctMy0xLTEtMzE0MjI_5de84633-f693-4605-b9f9-d8da8e09f478"
      unitRef="usd">4500000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="iff87963fcab3463b90b3aec7f030e7e8_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzctNS0xLTEtMzE0MjI_7252ff99-b144-4b75-b019-1bb306874982"
      unitRef="usd">4500000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ia95c695111874fdbb3c0f5b149b44326_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzctMTUtMS0xLTMxNDIy_0a0d397e-93eb-4a4c-8387-3296e1474794"
      unitRef="usd">4500000</us-gaap:InterestExpense>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="i2d41891210be43e2af666133ce0c96d7_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzgtMTEtMS0xLTMxNDIy_73a7dc0f-59b2-4c60-9236-d5f3d28f6e2e"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="i5ee696baa8c049df95516f082b5ca622_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzgtMTUtMS0xLTMxNDIy_70728d34-cdb4-4a42-a261-a64962e00d98"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="i2d41891210be43e2af666133ce0c96d7_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzktMTEtMS0xLTMxNDIy_c318d5a2-4f10-4862-a4a8-d0e3a24904f1"
      unitRef="usd">1900000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="i5ee696baa8c049df95516f082b5ca622_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzktMTUtMS0xLTMxNDIy_ec842ee4-cb30-4c1d-875c-048737905133"
      unitRef="usd">1900000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i5b0e6896d0904a51b7f3d01a54c4ddc3_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzEwLTUtMS0xLTMxNDIy_c22a7418-4827-44ac-83b7-6ef3e74592b3"
      unitRef="usd">18200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ie12ac8dbb8e34d9bbb1bb903a175a2c8_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzEwLTctMS0xLTMxNDIy_f7fa54bb-04aa-476d-a45d-0c9890c38041"
      unitRef="usd">-305200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzEwLTktMS0xLTMxNDIy_7b3568ce-12e0-4e70-843d-4b0cf9c57117"
      unitRef="usd">600000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzEwLTExLTEtMS0zMTQyMg_3346e7b2-e4d3-4ca0-948c-59783a466401"
      unitRef="usd">14000000.0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="i1c5bfbeaa4b84f669ddcb52c7676aa3a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzEwLTEzLTEtMS01NDUyNw_20676964-1fcf-453a-93f9-cdb9f88b2946"
      unitRef="usd">1213000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i0e5cd61854a54e59a6e1744de70eab75_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzEwLTE1LTEtMS0zMTQyMg_86445e5a-64a5-4518-bad9-6747a92e2b84"
      unitRef="usd">912600000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i32ef6703441a420db1866b7d7f4c494b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzExLTUtMS0xLTMxNDIy_e6a4bf7e-099b-4690-ad51-192443dcfde9"
      unitRef="usd">4600000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ie12ac8dbb8e34d9bbb1bb903a175a2c8_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzExLTctMS0xLTMxNDIy_8189f02a-6a70-458f-ae07-116757fa68ca"
      unitRef="usd">-25900000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i321781565b4145808e327741d1625660_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzExLTktMS0xLTMxNDIy_dac3d3e8-f03b-49be-bd8d-928019a86f79"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i2d41891210be43e2af666133ce0c96d7_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzExLTExLTEtMS0zMTQyMg_0ff9124a-9a26-4d47-9484-c56551847495"
      unitRef="usd">5300000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i1c5bfbeaa4b84f669ddcb52c7676aa3a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzExLTEzLTEtMS0zMTQyMg_9a5d9f44-656a-4d5a-b32e-c798858a467e"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i5ee696baa8c049df95516f082b5ca622_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzExLTE1LTEtMS0zMTQyMg_a72f462d-43db-4755-b034-6bf1668c3eaa"
      unitRef="usd">-26600000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="i976d65e83c19475783582ea166af72a4_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzEzLTUtMS0xLTMxNDIy_dc0fb32d-450d-4a1d-922d-c49f1799dcf4"
      unitRef="usd">-18000000.0</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <vtrs:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax
      contextRef="i2c0da8410b1d4621bf16fd27e6c27d7f_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzEzLTctMS0xLTMxNDIy_bfcc8a24-b56a-443d-adb6-9c3924c44f92"
      unitRef="usd">-353600000</vtrs:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzEzLTktMS0xLTMxNDIy_35fdf7ea-e8a8-46ab-87b9-eea34f208633"
      unitRef="usd">1200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzEzLTExLTEtMS0zMTQyMg_2de6e5c3-02d4-4b1c-a64f-8e31b0262df3"
      unitRef="usd">26100000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzEzLTEzLTEtMS0zMTQyMg_ad419db1-4da7-42a5-92c1-7bad3d02b67a"
      unitRef="usd">-461500000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTphNmU4MWI3ODE5ZWU0NmY1YjE2MGU0N2IxZDFhZDJiNS90YWJsZXJhbmdlOmE2ZTgxYjc4MTllZTQ2ZjViMTYwZTQ3YjFkMWFkMmI1XzEzLTE1LTEtMS0zMTQyMg_3f3457a0-383b-4529-98f1-eedbc4dc2028"
      unitRef="usd">-858000000.0</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
      contextRef="i5344c15e24b24e80990c2d8787392123_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzMtNS0xLTEtMzE0MjI_59be65a5-d3bc-4f6c-ab82-82f762cdf764"
      unitRef="usd">-53100000</us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax>
    <vtrs:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax
      contextRef="ie6e565a95dd740df9577e0def6a5bfda_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzMtNy0xLTEtMzE0MjI_9a1693ac-acff-47b4-808d-fac71abd8c4e"
      unitRef="usd">-130900000</vtrs:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i7af73de9524c46c4b62467c275aebbd7_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzMtOS0xLTEtMzE0MjI_d68de815-0451-4118-b106-594b99ac2561"
      unitRef="usd">0</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i41551e1e6fcd44d8adc77b1cfa48df2e_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzMtMTEtMS0xLTMxNDIy_60b73525-3306-4050-b0a7-761c37670ae7"
      unitRef="usd">-1700000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="ib0b0232bc9844e1fa3ea1d7b1ad31528_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzMtMTMtMS0xLTMxNDIy_a419950c-3f28-4591-b041-4dfaffba696f"
      unitRef="usd">-1259000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ibadea9a32ce84dc48523b37b0f0b23ce_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzMtMTUtMS0xLTMxNDIy_f4a2c7f6-46ac-4586-8bbb-7d7e1b368487"
      unitRef="usd">-1441300000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ifb3ef4f6ed9f4ba49c083bede6eb5223_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzQtNS0xLTEtMzE0MjI_92b42343-e35a-4b3f-81d6-74fcf9502c1f"
      unitRef="usd">29300000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i57c4f10b75634ea68f1dca6a931ad8e6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzQtNy0xLTEtMzE0MjI_0f61dcfc-150c-4552-960b-a3654848ecce"
      unitRef="usd">59600000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i4995b4611c2e4646adfd8b95ba3bf328_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzQtOS0xLTEtMzE0MjI_e04d3692-4a78-4a1c-965e-6cd86b2864e4"
      unitRef="usd">500000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i1d888ff098f442bcb4dc242559173835_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzQtMTEtMS0xLTMxNDIy_e4166998-407b-49ca-b408-8c767acada03"
      unitRef="usd">-21000000.0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i7c03788583d749e2ab730831ee5d6f58_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzQtMTMtMS0xLTMxNDIy_f48ae633-b37e-44d2-94a0-e3adb3cccf9b"
      unitRef="usd">-415500000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i5143c6332d7249db9f3409e36def6483_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzQtMTUtMS0xLTMxNDIy_18770ef4-8298-4794-b24b-04a94a4d6914"
      unitRef="usd">-347100000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i09f02030d9994171b347d6d8fbc28c23_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzYtMS0xLTEtMzE0MjI_833f89de-5e48-448a-aa0e-2c2797c0b7ba"
      unitRef="usd">700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibe6488fc910b43d8b1655226467f1718_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzYtNS0xLTEtMzE0MjI_f4063bcd-ec37-4796-b1c5-a9ce098bee20"
      unitRef="usd">700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i112fdb77391647eb924a8c3214c34e98_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzYtMTUtMS0xLTMxNDIy_9a0f51f8-26ae-4a90-8000-f38b3ee6399e"
      unitRef="usd">700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:InterestExpense
      contextRef="idb74362ce50848929419e79a2423af29_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzctMy0xLTEtMzE0MjI_cea47285-3c15-4b33-8638-ff6831fa83ce"
      unitRef="usd">-7100000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ibe6488fc910b43d8b1655226467f1718_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzctNS0xLTEtMzE0MjI_01c44977-8f63-4b9a-b93b-91bb602cf490"
      unitRef="usd">-7100000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="icd18a8e6cd32428db5246e85e1f56f15_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzctMTUtMS0xLTMxNDIy_90d832bb-4712-4b24-8e43-7c1ca7b72e93"
      unitRef="usd">-7100000</us-gaap:InterestExpense>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="iab6607a4159c4340888408df548e14fd_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzgtMTEtMS0xLTMxNDIy_e6242065-c7cd-4a8f-922b-fef4e48cb676"
      unitRef="usd">900000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="i120ca88ef29b44beab20b026621f6293_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzgtMTUtMS0xLTMxNDIy_4826fe07-17e5-4303-bafc-06ae0ea88736"
      unitRef="usd">900000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="iab6607a4159c4340888408df548e14fd_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzktMTEtMS0xLTMxNDIy_733dc8b0-c77b-4aa5-ac37-ad861c23cc7d"
      unitRef="usd">2900000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="i120ca88ef29b44beab20b026621f6293_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzktMTUtMS0xLTMxNDIy_2be1e935-b7c9-4537-9d89-4d2da68278bc"
      unitRef="usd">2900000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax
      contextRef="i8483166a8454418b9ca018a1b3791f84_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzEwLTUtMS0xLTMxNDIy_b782820b-efbf-4f0b-bdaf-f1279d9e6ad4"
      unitRef="usd">37100000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i57c4f10b75634ea68f1dca6a931ad8e6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzEwLTctMS0xLTMxNDIy_0a02ec3e-1b48-47ce-b2d6-89139c29e009"
      unitRef="usd">59600000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="i4995b4611c2e4646adfd8b95ba3bf328_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzEwLTktMS0xLTMxNDIy_26cfedf9-4ca7-448b-abbb-9a0861e76824"
      unitRef="usd">500000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="i1d888ff098f442bcb4dc242559173835_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzEwLTExLTEtMS0zMTQyMg_a7e97bf5-fb0f-4f96-8cad-c364e944ccde"
      unitRef="usd">-24800000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="i7c03788583d749e2ab730831ee5d6f58_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzEwLTEzLTEtMS0zMTQyMg_3ac31799-ef79-4264-afe9-17675c52f036"
      unitRef="usd">-415500000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i5143c6332d7249db9f3409e36def6483_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzEwLTE1LTEtMS0zMTQyMg_0c81e82e-4b11-468e-a564-2e83162249e0"
      unitRef="usd">-343100000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ibe6488fc910b43d8b1655226467f1718_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzExLTUtMS0xLTMxNDIy_3f1cdda6-b949-4ede-b200-cd804ec377e8"
      unitRef="usd">-12200000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i57c4f10b75634ea68f1dca6a931ad8e6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzExLTctMS0xLTMxNDIy_49cb9c2f-2cfe-4168-affc-71d2939b6512"
      unitRef="usd">3000000.0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i0092b09635f64545a5710335f85fb20d_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzExLTktMS0xLTMxNDIy_5141acd3-89b4-4939-aac0-e75b5b92ea31"
      unitRef="usd">100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iab6607a4159c4340888408df548e14fd_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzExLTExLTEtMS0zMTQyMg_f912047a-d65e-4eb5-9725-244bfec0d5f3"
      unitRef="usd">5900000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ieab322d23a1c4d299859bb9ae133d4c8_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzExLTEzLTEtMS0zMTQyMg_b49582c6-c456-4720-b7a4-36b4b7a36661"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i120ca88ef29b44beab20b026621f6293_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzExLTE1LTEtMS0zMTQyMg_c003097c-f1a9-448c-9cd9-9d234beffcbf"
      unitRef="usd">9200000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeOtherNetOfTax
      contextRef="i0e27b51cd41a46a5a7deacf015486759_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzEyLTUtMS0xLTMxNDIy_929f06a2-0804-4098-9914-aaaf2b4c9ad2"
      unitRef="usd">-3400000</us-gaap:OtherComprehensiveIncomeOtherNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="ib319269ea5d64fedbf03374a044144ba_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzEyLTExLTEtMS0zMTQyMg_77cbacdc-67af-4d61-8c6e-1c83e14328f0"
      unitRef="usd">200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ib319269ea5d64fedbf03374a044144ba_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzEyLTE1LTEtMS0zMTQyMg_8a3e60b2-64aa-4f89-ac4a-8f70e4b72298"
      unitRef="usd">-3600000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
      contextRef="ic989ea6602bd4856815f90f895e12304_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzEzLTUtMS0xLTMxNDIy_d85f5d6b-f814-46de-ad8e-c4c9cfd5d017"
      unitRef="usd">-31600000</us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax>
    <vtrs:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax
      contextRef="i4c1519bf270f496eacbc594c4a0b7a1c_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzEzLTctMS0xLTMxNDIy_58c478db-dbae-488c-ae2f-01fd54be4c3e"
      unitRef="usd">-74300000</vtrs:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ia3917c4bfc784a928c09f599e63910fb_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzEzLTktMS0xLTMxNDIy_ce3021a6-d6a1-47a2-83b9-eab56d6264b8"
      unitRef="usd">600000</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i0257efc303d94390b5707bbcdb863e52_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzEzLTExLTEtMS0zMTQyMg_29f4e88e-a522-45b5-b261-29ac1c3110ab"
      unitRef="usd">17400000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="ia7ff2cf5a8154924b32963fb78602f3a_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzEzLTEzLTEtMS0zMTQyMg_439ff6ae-149f-438a-9938-30d830d8396f"
      unitRef="usd">-1674500000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ic39189fc54504b53be3c4281e5dd8f82_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTQvZnJhZzoyNTQ1NjFiOWJhNzI0NDczODQ4MWQ5N2M0ZDBlMWViYy90YWJsZTozMjQ4YzQ0MzYwOTg0MDhkOTgzODBhZWNmOWIxM2UyYy90YWJsZXJhbmdlOjMyNDhjNDQzNjA5ODQwOGQ5ODM4MGFlY2Y5YjEzZTJjXzEzLTE1LTEtMS0zMTQyMg_32af4fac-405b-4f0d-96a0-8a01a5601c6a"
      unitRef="usd">-1797200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzEyMTgw_f97d3dde-43ec-4544-9eaa-a7f60066e0e2">Income Taxes &lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The income tax provision (benefit) consisted of the following components:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.272%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Federal:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(182.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(277.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(165.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(170.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(283.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. State:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S.:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(91.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;869.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;777.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax provision (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;604.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings before income taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,982.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(945.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,031.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign - Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,318.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,185.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total (loss) earnings before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(664.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(721.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For all periods presented, the allocation of earnings before income taxes between U.S. and non-U.S. operations includes intercompany interest allocations between certain domestic and foreign subsidiaries. These amounts are eliminated on a consolidated basis. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Temporary differences and carry-forwards that result in deferred tax assets and liabilities were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Litigation reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;425.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;393.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,187.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax credit and loss carry-forwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,256.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,080.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;327.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,889.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,665.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(780.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(443.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,109.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,221.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets and goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,468.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,058.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,591.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,197.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,482.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(975.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For those foreign subsidiaries whose investments are permanent in duration, income and foreign withholding taxes have not been provided on the unremitted earnings of those subsidiaries. This amount may become taxable upon a repatriation of assets from the subsidiary or a sale or liquidation of the subsidiary. The amount of such unremitted earnings is approximately $3.4 billion at December&#160;31, 2021. Determination of the amount of any unrecognized deferred income tax liability on these unremitted earnings is not practicable as such determination involves material uncertainties about the potential extent and timing of any distributions, the availability and complexity of calculating foreign tax credits, and the potential indirect tax consequences of such distributions, including withholding taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to the Combination, the applicable income tax rate to Mylan was the U.K. rate of 19%, and following the Combination, the statutory income tax rate applicable to Viatris Inc. is the U.S. rate of 21% for the years ended December 31, 2021 and 2020.  A reconciliation of the statutory tax rate to the effective tax rate is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.272%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Statutory tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Clean energy and research credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. rate differentials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of changes in legislation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes and credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(118.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax settlements and resolution of certain tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Incremental US Tax on Foreign Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Waived deductions under IRC &#xa7; 59A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of the Combination and Divestitures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other U.S. items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Foreign Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Luxembourg&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gibraltar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Puerto Rico&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Switzerland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Singapore&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax impact of tax law changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of the Combination and divestitures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Withholding taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax settlements and resolution of certain tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other foreign items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(91.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In all years, our effective tax rate is impacted by the jurisdictional location of earnings and the corresponding tax rates in those jurisdictions. Subsequent to the Combination, the Company realizes benefits from lower tax rates in Singapore and Puerto Rico due to manufacturing and other incentives..&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Tax Act&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 22, 2017, the U.S. government enacted the Tax Act. The Tax Act makes broad and complex changes to the Code including, but not limited to, reducing the U.S. federal corporate income tax rate and requiring a one-time transition tax on certain unrepatriated earnings of non-U.S. corporate subsidiaries of large U.S. shareholders that may electively be paid over eight years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Tax Act also puts in place new tax laws that impact our taxable income beginning in 2018, which include, but are not limited to (1) creating a BEAT, which is a new minimum tax, (2) generally eliminating U.S. federal income taxes on dividends from foreign subsidiaries, (3) a new provision designed to tax currently GILTI earned by non-U.S. corporate subsidiaries of large U.S. shareholders and a deduction generally equal to 50 percent of GILTI (37.5 percent for tax years beginning after December 31, 2025) to offset the income tax liability, (4) a provision limiting the amount of deductible interest expense in the U.S., (5) limitations on the deductibility of certain executive compensation, and (6) limitations on the utilization of foreign tax credits to reduce the U.S. income tax liability. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, no U.S. deferred income taxes or foreign withholding taxes were recorded on earnings in the Company&#x2019;s non-U.S. subsidiaries where there would be no U.S. or foreign tax upon repatriation or where the Company&#x2019;s practice and intention was to reinvest the earnings outside of the U.S. The transition tax noted above resulted in the previously untaxed foreign earnings of U.S. subsidiaries being included in federal and state taxable income. We analyze on an ongoing basis our global working capital requirements and the potential tax liabilities that would be incurred if the non-U.S. subsidiaries repatriate cash, which include potential local country withholding taxes and U.S. state taxation.  The Company has elected to not record deferred taxes associated with the GILTI provision of the Tax Act.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Valuation Allowance&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A valuation allowance is provided when it is more likely than not that some portion or all of the deferred tax assets will not be realized. At December&#160;31, 2021, a valuation allowance has been applied to certain deferred tax assets in the amount of $780.4 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When assessing the realizability of deferred tax assets, management considers all available evidence, including historical information, long-term forecasts of future taxable income and possible tax planning strategies. Amounts recorded for valuation allowances can result from a complex series of estimates, assumptions and judgments about future events. Due to the inherent uncertainty involved in making these estimates, assumptions and judgments, actual results could differ materially. Any future increases to the Company&#x2019;s valuation allowances could materially impact the Company&#x2019;s consolidated financial condition and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net Operating Losses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;As of December&#160;31, 2021, the Company had the following carryforwards and attributes: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;U.S. federal net operating loss carryforwards of  $7.9 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;U.S. state income tax loss carryforwards of approximately  $3.10 billion, which are largely offset by a valuation allowance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Non-U.S. net operating loss carryforwards of approximately  $1.57 billion, of which $748.4 million can be carried forward indefinitely, with the remaining $817.8 million expiring in years 2022 through 2041.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Foreign deductible attributes of $39.6 million that can be carried forward indefinitely, which are offset by a full valuation allowance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;U.S. and foreign credit carryovers of $329.2 million, expiring in various amounts through 2041.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Anticipatory foreign tax credits of $230.3 million which will generate from the reversal of future taxable income in certain non-U.S. jurisdictions which are taxed both in their local jurisdictions and in the U.S.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 16, 2020, the Company had a change in ownership pursuant to Section 382 of the Code. Under this provision of the Code, the utilization of any NOL or tax credit carryforwards incurred prior to the date of ownership change may be limited. Analyses of the limits for each ownership change indicates the annual limitation would not impair the Company's ability to utilize our U.S. federal credit carryovers.  While state loss carryforwards may be limited by Section 382 of the Code, the carryforwards are largely offset by a valuation allowance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt;padding-right:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;CARES Act&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 27, 2020, the CARES Act was enacted and signed into law. The CARES Act includes several provisions, including increasing the amount of deductible interest, allowing companies to carryback certain NOLs, and increasing the amount of NOLs that corporations can use to offset income.During the year ended December 31, 2020, the CARES Act reduced the Company&#x2019;s 2020 income tax expense by $22.1&#160;million resulting from additional deductible interest. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Tax Examinations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to income taxes and tax audits in many jurisdictions. A certain degree of estimation is thus required in recording the assets and liabilities related to income taxes. Tax audits and examinations can involve complex issues, interpretations, and judgments and the resolution of matters that may span multiple years, particularly if subject to litigation or negotiation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Although the Company believes that adequate provisions have been made for these uncertain tax positions, the Company&#x2019;s assessment of uncertain tax positions, including those arising from legal entity restructuring transactions in connection with the Combination, is based on estimates and assumptions that the Company believes are reasonable but the estimates for unrecognized tax benefits and potential tax benefits may not be representative of actual outcomes, and variations from such estimates could materially affect the Company&#x2019;s financial condition, results of operations or cash flows in the period of resolution, settlement or when the statutes of limitations expire. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to ongoing IRS examinations. The years 2015 through 2018 are open years under examination. The years 2012, 2013 and 2014 have one matter open, and a Tax Court petition was filed regarding the matter and a trial was held in December 2018 and is discussed further below. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2019, Mylan reached an agreement in principle with the IRS to resolve all issues relating to our positions on the February 27, 2015 acquisition by Mylan N.V. of Mylan Inc. and Abbott Laboratories&#x2019; non-U.S. developed markets specialty and branded generics business. Under the agreement in principle, which was finalized as part of a closing agreement with the IRS on October 11, 2019, Mylan&#x2019;s status as a non-U.S. corporation for U.S. Federal income tax purposes was confirmed, and we have adjusted the interest rates used for intercompany loans as necessary. During the year ended December 31, 2019, the Company recorded a reserve of approximately $155.0&#160;million as part of its liability for uncertain tax positions, with a net impact to the income tax provision of approximately $144.9&#160;million related to this matter. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Several international audits are currently in progress. In some cases, the tax auditors have proposed adjustments &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;or issued assessments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;to our tax positions, including with respect to intercompany transactions, and we are in ongoing discussions with some of the auditors regarding the validity of their positions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In instances where assessments have been issued, we disagree with these assessments and believe they are without merit and incorrect as a matter of law. As a result, we anticipate that certain of these matters may become the subject of litigation before tax courts where we intend to vigorously defend our position.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In Australia, the tax authorities have issued notices of assessments to the Company for the years ended December 2009 to December 2019, subject to additional interest and penalties, concerning our tax position with respect to certain intercompany transactions. The tax authorities denied our objections to the assessments and we have commenced litigation in the Australian Federal Court challenging that decision. During 2021, the Company made a partial payment of $56.0&#160;million in order to stay potential interest and penalties resulting from this litigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In France, the tax authorities have issued notices of assessments to the Company for the years ended December 2013 to December 2016 concerning our tax position with respect to (i) certain intercompany transactions and (ii) whether income earned by a Company entity not domiciled in France should be subject to French tax. We have resolved our position concerning certain intercompany transactions with the tax authorities. Concerning the remaining issue, we have commenced litigation before the French tax courts where the tax authorities will seek unpaid taxes, penalties, and interest.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In India, the tax authorities have issued notices of assessments to the Company seeking unpaid taxes and interest for the financial years covering 2013 to 2018 concerning our tax position with respect to certain corporate tax deductions and certain intercompany transactions. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Some of these assessments remain in the audit phase where we are challenging them before the tax authorities while we are challenging some of the other assessments in the Indian tax courts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has recorded a net reserve for uncertain tax positions of $315.6&#160;million, including interest and penalties, in connection with its international audits at December&#160;31, 2021. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reserve balance at &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2021&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; reflects the impact of current year settlement payments. In connection with our international tax audits, it is possible that we will incur material losses above the amounts reserved.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s major U.S. state taxing jurisdictions remain open from fiscal year 2013 through 2020, with several state audits currently in progress. The Company&#x2019;s major international taxing jurisdictions remain open from 2012 through 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Tax Court Proceedings &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's U.S. federal income tax returns for 2012 through 2014 had been subject to proceedings in U.S. Tax Court involving a dispute with the IRS regarding whether certain costs related to ANDAs were eligible to be expensed and deducted immediately or required to be amortized over longer periods. A trial was held in U.S. Tax Court in December 2018 and on April 27, 2021, the Court affirmed Mylan&#x2019;s position and held that patent litigation expenses related to ANDAs are immediately deductible. The IRS has appealed this decision.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounting for Uncertainty in Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The impact of an uncertain tax position that is more likely than not of being sustained upon audit by the relevant taxing authority must be recognized at the largest amount that is more likely than not to be sustained. No portion of an uncertain tax position will be recognized if the position has less than a 50% likelihood of being sustained.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021 and 2020, the Company&#x2019;s consolidated balance sheets reflect net liabilities for unrecognized tax benefits of $322.9 million and $391.1 million, respectively, of which $230.2&#160;million as of December 31, 2021 would affect the Company&#x2019;s effective tax rate if recognized, with the remainder being offset by potential correlative adjustments. Related accrued interest and penalties included in the consolidated balance sheets were $96.8 million and $86.7 million as of December&#160;31, 2021 and 2020, respectively. For the years ended December&#160;31, 2021, 2020 and 2019, the Company recognized $18.5 million of tax expense, $6.0 million, and $35.2 million of tax benefits, respectively, related to interest and penalties on uncertain tax positions. Interest and penalties related to income taxes are included in the tax provision.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the unrecognized tax benefits is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.006%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefit&#160;&#x2014; beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;391.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions for current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions for prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions for prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(112.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions due to expirations of statute of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Reduction) addition due to acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefit&#160;&#x2014; end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;391.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company believes that it is reasonably possible that the amount of unrecognized tax benefits will decrease in the next twelve months by approximately $55.0 million, involving international and state audits and settlements and expiring statutes of limitations. The Company does not anticipate significant increases to the reserve within the next twelve months.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzEyMTc0_06f28348-b8ec-4535-9b99-aa301020531a">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The income tax provision (benefit) consisted of the following components:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.272%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Federal:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(182.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(277.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(165.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(170.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(283.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. State:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S.:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(91.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;869.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;777.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax provision (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;604.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings before income taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,982.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(945.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,031.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign - Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,318.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,185.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total (loss) earnings before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(664.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(721.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i9f40df9e1eb0444887127461f9ea3abe_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzMtMS0xLTEtMzE0MjI_fe0564c7-6d41-440c-bbea-c0f0133079ff"
      unitRef="usd">12600000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i67d592a057184ff99b89d543e49e0118_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzMtMy0xLTEtMzE0MjI_747f0bc0-e344-4af0-81e5-06df15df9727"
      unitRef="usd">-6400000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i80866432756d4d8b99967ae5f95350a1_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzMtNS0xLTEtMzE0MjI_10cca476-2018-405c-a537-68cacacbce93"
      unitRef="usd">118100000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i9f40df9e1eb0444887127461f9ea3abe_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzQtMS0xLTEtMzE0MjI_10f7270b-b51f-4352-85af-6ae10272c157"
      unitRef="usd">-182700000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i67d592a057184ff99b89d543e49e0118_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzQtMy0xLTEtMzE0MjI_e4e021d4-3854-41e9-8a3a-c474801386e4"
      unitRef="usd">-277000000.0</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i80866432756d4d8b99967ae5f95350a1_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzQtNS0xLTEtMzE0MjI_69ed426f-4b02-4ff7-bfb4-eec2378f5fe2"
      unitRef="usd">-165500000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="i9f40df9e1eb0444887127461f9ea3abe_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzUtMS0xLTEtMzE0MjI_2d94d0a6-a685-4e3a-9145-7fcf7c7aeb00"
      unitRef="usd">-170100000</us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="i67d592a057184ff99b89d543e49e0118_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzUtMy0xLTEtMzE0MjI_ad684808-b248-4781-b488-bc08fe5ee4b8"
      unitRef="usd">-283400000</us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="i80866432756d4d8b99967ae5f95350a1_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzUtNS0xLTEtMzE0MjI_419c1322-1851-40d7-b52b-28cee71cef0e"
      unitRef="usd">-47400000</us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i31acc6e59ca047cbb296182a44e66784_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzctMS0xLTEtMzE0MjI_2ae14a31-0c21-4953-aefa-5d8d66fa759a"
      unitRef="usd">7700000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i0f057c6cfa374421b697de391e7da037_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzctMy0xLTEtMzE0MjI_d505dd53-f3b5-47e3-aede-b672663c6dee"
      unitRef="usd">-100000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="icba6cc749c5c4336a2e5b99546806e1c_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzctNS0xLTEtMzE0MjI_bd3c02f2-7ef6-4afd-bace-1f240fe6e3a1"
      unitRef="usd">21100000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i31acc6e59ca047cbb296182a44e66784_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzgtMS0xLTEtMzE0MjI_9f5727e4-b330-4a15-87d0-a66b2dc4989d"
      unitRef="usd">-10800000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i0f057c6cfa374421b697de391e7da037_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzgtMy0xLTEtMzE0MjI_ad75edee-ab43-403f-9a9d-9b20aff413f2"
      unitRef="usd">7700000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="icba6cc749c5c4336a2e5b99546806e1c_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzgtNS0xLTEtMzE0MjI_b6103da5-d9e8-477d-a7bc-ced5d608c150"
      unitRef="usd">-13600000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="i31acc6e59ca047cbb296182a44e66784_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzktMS0xLTEtMzE0MjI_789f42b6-2f6c-44d0-b38e-cfb6e3ff0829"
      unitRef="usd">-3100000</us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="i0f057c6cfa374421b697de391e7da037_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzktMy0xLTEtMzE0MjI_dfa9630c-c093-4465-8bb4-35e2744f1a5b"
      unitRef="usd">7600000</us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="icba6cc749c5c4336a2e5b99546806e1c_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzktNS0xLTEtMzE0MjI_8eb14238-c624-4cfb-bf7a-f024cf1f3723"
      unitRef="usd">7500000</us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="ibd60fe8dbaf14660a60843e414c261cc_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzExLTEtMS0xLTMxNDIy_59bcea60-f4f8-4e74-a9fc-2f4f34df8e3f"
      unitRef="usd">-91300000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i3fbb159e759f42c694ac12a036cae1b4_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzExLTMtMS0xLTMxNDIy_f34b6d62-dd02-4542-9961-f36390e6ff0f"
      unitRef="usd">168700000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="ib0fabb51dcaa430e9611ab2f4e9a374e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzExLTUtMS0xLTMxNDIy_50530996-2287-4d0e-8cae-e6bfdc97682d"
      unitRef="usd">191000000.0</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="ibd60fe8dbaf14660a60843e414c261cc_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzEyLTEtMS0xLTMxNDIy_591cf4f0-5e09-4466-9e6a-2aba1e8b2bc6"
      unitRef="usd">869200000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i3fbb159e759f42c694ac12a036cae1b4_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzEyLTMtMS0xLTMxNDIy_fffa9083-a368-4111-b58f-7acc7e28689f"
      unitRef="usd">55800000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="ib0fabb51dcaa430e9611ab2f4e9a374e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzEyLTUtMS0xLTMxNDIy_69d2b3f2-1a55-4857-a112-7d1ec7b12ad5"
      unitRef="usd">-13500000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations
      contextRef="ibd60fe8dbaf14660a60843e414c261cc_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzEzLTEtMS0xLTMxNDIy_29d32769-fa11-4585-bdf7-054344fbeac8"
      unitRef="usd">777900000</us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations
      contextRef="i3fbb159e759f42c694ac12a036cae1b4_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzEzLTMtMS0xLTMxNDIy_c47c9254-95ea-4fa7-ab0f-af22528feebd"
      unitRef="usd">224500000</us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations
      contextRef="ib0fabb51dcaa430e9611ab2f4e9a374e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzEzLTUtMS0xLTMxNDIy_55acc1fc-eaf0-4a2f-81d9-80a1c0118f39"
      unitRef="usd">177500000</us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzE0LTEtMS0xLTMxNDIy_ab6219ab-4771-4540-bd66-9513921c2565"
      unitRef="usd">604700000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzE0LTMtMS0xLTMxNDIy_5970843c-768c-447e-8c17-b588db3bf5b7"
      unitRef="usd">-51300000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzE0LTUtMS0xLTMxNDIy_53d4c8a0-f6f7-4462-8d42-fe5f88c1bb11"
      unitRef="usd">137600000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i9f40df9e1eb0444887127461f9ea3abe_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzE3LTEtMS0xLTMxNDIy_86bd1186-3aab-48af-a58b-027234ff8ed4"
      unitRef="usd">-1982500000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i67d592a057184ff99b89d543e49e0118_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzE3LTMtMS0xLTMxNDIy_7207fd1c-f855-4137-a6e9-fb5918164526"
      unitRef="usd">-945500000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i80866432756d4d8b99967ae5f95350a1_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzE3LTUtMS0xLTMxNDIy_02a222c0-972a-4e4d-862c-3e0cb101e7e3"
      unitRef="usd">-1031400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i5a8034bfa30e47bca846a18601de12b5_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzE4LTEtMS0xLTMxNDIy_de610cd3-3cd0-4eb6-ab05-960479f3b91b"
      unitRef="usd">1318100000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i7b9f43ebce0a4eb1ba92976f05741fb0_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzE4LTMtMS0xLTMxNDIy_1bfe260b-f350-4521-8ffe-7a2b3501ee3a"
      unitRef="usd">224300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i8f5339a530fb4bbca97be48fbe5dff35_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzE4LTUtMS0xLTMxNDIy_968e74c2-e764-4ce9-90ce-13303b07fc0e"
      unitRef="usd">1185800000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzE5LTEtMS0xLTMxNDIy_d31e412f-fa12-41d9-a277-b7475ab8b90e"
      unitRef="usd">-664400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzE5LTMtMS0xLTMxNDIy_ebced4b1-8190-4aa2-a856-8765d8d1e1d2"
      unitRef="usd">-721200000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTphZjVjYjAyYWM1MjQ0NWQ3YTFlMTZmNWUwM2JiNGRhYi90YWJsZXJhbmdlOmFmNWNiMDJhYzUyNDQ1ZDdhMWUxNmY1ZTAzYmI0ZGFiXzE5LTUtMS0xLTMxNDIy_2cbfa2d8-bf1b-475d-90a8-78422e394e9e"
      unitRef="usd">154400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzEyMTQ3_0ab0ef70-cc0b-4187-bff1-c70d25e118a8">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Temporary differences and carry-forwards that result in deferred tax assets and liabilities were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Litigation reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;425.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;393.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,187.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax credit and loss carry-forwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,256.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,080.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;327.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,889.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,665.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(780.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(443.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,109.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,221.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets and goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,468.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,058.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,591.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,197.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,482.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(975.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzItMS0xLTEtMzE0MjI_2613df6e-7834-48fd-a02f-da5b7cf5c58a"
      unitRef="usd">271300000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzItMy0xLTEtMzE0MjI_eb22944a-e42c-4016-bcb1-e39450f52bea"
      unitRef="usd">273000000.0</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzMtMS0xLTEtMzE0MjI_748b6df6-6b5a-43cc-8ba7-4d9ca6f8305f"
      unitRef="usd">94400000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzMtMy0xLTEtMzE0MjI_60aa7330-a1df-4fa1-9d63-27f6346b52d1"
      unitRef="usd">43500000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzQtMS0xLTEtMzE0MjI_dcc55437-5e45-4c66-8d10-bdc90c6cbba9"
      unitRef="usd">425900000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzQtMy0xLTEtMzE0MjI_631ac44a-223d-4d3e-a602-e201c6aa04dd"
      unitRef="usd">393700000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzUtMS0xLTEtMzE0MjI_19d0b1ae-ff2a-4cc9-898d-bcff4607540b"
      unitRef="usd">187800000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzUtMy0xLTEtMzE0MjI_077fd18a-ec25-40b4-a4af-8c2b1973d71f"
      unitRef="usd">1187900000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzYtMS0xLTEtMzE0MjI_ec218a97-9a32-41f0-8f36-4a71d9a75fa3"
      unitRef="usd">1256000000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzYtMy0xLTEtMzE0MjI_3ef41e7e-dfd2-40d7-abb5-0c6767c6c3b8"
      unitRef="usd">1080400000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <vtrs:DeferredTaxAssetsOperatingLeaseRightofUseAssets
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzctMS0xLTEtMzE0MjI_920d8638-b8f1-471c-9800-55eed34d8315"
      unitRef="usd">63600000</vtrs:DeferredTaxAssetsOperatingLeaseRightofUseAssets>
    <vtrs:DeferredTaxAssetsOperatingLeaseRightofUseAssets
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzctMy0xLTEtMzE0MjI_146e6c52-d8f7-480a-bb74-19c97c7fb065"
      unitRef="usd">66500000</vtrs:DeferredTaxAssetsOperatingLeaseRightofUseAssets>
    <vtrs:DeferredTaxAssetsDeferredtaxexpenseinterestexpense
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzgtMS0xLTEtMzE0MjI_6fa88981-87a4-4e4c-ab9a-e3d330208684"
      unitRef="usd">111600000</vtrs:DeferredTaxAssetsDeferredtaxexpenseinterestexpense>
    <vtrs:DeferredTaxAssetsDeferredtaxexpenseinterestexpense
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzgtMy0xLTEtMzE0MjI_6fe087e9-85b9-4531-972e-0b9773cd5b93"
      unitRef="usd">67900000</vtrs:DeferredTaxAssetsDeferredtaxexpenseinterestexpense>
    <vtrs:DeferredTaxAssetsIntangibleAssets
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzktMS0xLTEtMzE0MjI_35a9063a-2cdf-4301-8058-793139b64d44"
      unitRef="usd">151100000</vtrs:DeferredTaxAssetsIntangibleAssets>
    <vtrs:DeferredTaxAssetsIntangibleAssets
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzktMy0xLTEtMzE0MjI_cf21b9bc-b8cf-4609-bd4a-1133c66900f5"
      unitRef="usd">156300000</vtrs:DeferredTaxAssetsIntangibleAssets>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzEwLTEtMS0xLTMxNDIy_6e72181b-468c-4f8d-8169-e448a1dc2999"
      unitRef="usd">327800000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzEwLTMtMS0xLTMxNDIy_60749d1c-4574-44f6-928f-1a5a9f4f9b20"
      unitRef="usd">396000000.0</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzExLTEtMS0xLTMxNDIy_debea257-3c27-44f1-8943-9ca19272942b"
      unitRef="usd">2889500000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzExLTMtMS0xLTMxNDIy_e0f902e6-681b-4e4a-a5c1-33b312376ad8"
      unitRef="usd">3665200000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzEyLTEtMS0xLTMxNDIy_e86532d6-feb9-4749-bf93-0cd68a2eab73"
      unitRef="usd">780400000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzEyLTMtMS0xLTMxNDIy_c9f3468a-aedc-4ed5-a105-7e4a87d4d33b"
      unitRef="usd">443600000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzEzLTEtMS0xLTMxNDIy_afbb6a12-82c7-4cfd-946c-d0be1b8916ee"
      unitRef="usd">2109100000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzEzLTMtMS0xLTMxNDIy_25584c3b-2be5-48e4-82d5-e5288238b129"
      unitRef="usd">3221600000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzE1LTEtMS0xLTMxNDIy_48a7ed35-53e9-4db8-95cf-d13aec75628b"
      unitRef="usd">19600000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzE1LTMtMS0xLTMxNDIy_08e59464-a5a2-4b97-87ec-973f1a759c8b"
      unitRef="usd">50200000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <vtrs:DeferredTaxLiabilitiesOperatingLeaseLiability
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzE2LTEtMS0xLTMxNDIy_e1811e91-7b2f-4280-826e-1af44cde6441"
      unitRef="usd">63600000</vtrs:DeferredTaxLiabilitiesOperatingLeaseLiability>
    <vtrs:DeferredTaxLiabilitiesOperatingLeaseLiability
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzE2LTMtMS0xLTMxNDIy_6036934a-64b0-45cf-944d-55e4331eb6a8"
      unitRef="usd">66500000</vtrs:DeferredTaxLiabilitiesOperatingLeaseLiability>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzE3LTEtMS0xLTMxNDIy_7c62c6ed-ed10-47f6-b94e-d72a7bbbe784"
      unitRef="usd">3468300000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzE3LTMtMS0xLTMxNDIy_0f41e4a3-5cc2-4c3c-8c38-8f443fe05ed3"
      unitRef="usd">4058600000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzE4LTEtMS0xLTMxNDIy_1043fce0-651c-41bd-ac7c-af967b7204ea"
      unitRef="usd">39900000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzE4LTMtMS0xLTMxNDIy_93c357b6-5a52-4e9a-bf80-07aca1aca984"
      unitRef="usd">22100000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzE5LTEtMS0xLTMxNDIy_08399594-b22d-43b8-b004-9983afe09087"
      unitRef="usd">3591400000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzE5LTMtMS0xLTMxNDIy_9f18c8f4-86f0-4040-95ca-b8383ddadf18"
      unitRef="usd">4197400000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzIwLTEtMS0xLTMxNDIy_ab568d09-011a-489c-90e9-8f3afdd74fbb"
      unitRef="usd">1482300000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo5ZDExOTQ2YzY3ZGY0NjM0YjdhZDBhZDU2ODk3ZDkwZC90YWJsZXJhbmdlOjlkMTE5NDZjNjdkZjQ2MzRiN2FkMGFkNTY4OTdkOTBkXzIwLTMtMS0xLTMxNDIy_f49d54b7-c679-4304-ad9d-c6c3d90c238f"
      unitRef="usd">975800000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzExODI_a0046801-5afd-485f-ae7d-2b5ccb96ffee"
      unitRef="usd">3400000000</us-gaap:DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzEyMTg0_12d97067-a43e-4263-b830-f3fe7847ce69">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to the Combination, the applicable income tax rate to Mylan was the U.K. rate of 19%, and following the Combination, the statutory income tax rate applicable to Viatris Inc. is the U.S. rate of 21% for the years ended December 31, 2021 and 2020.  A reconciliation of the statutory tax rate to the effective tax rate is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.272%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Statutory tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Clean energy and research credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. rate differentials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of changes in legislation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes and credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(118.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax settlements and resolution of certain tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Incremental US Tax on Foreign Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Waived deductions under IRC &#xa7; 59A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of the Combination and Divestitures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other U.S. items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Foreign Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Luxembourg&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gibraltar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Puerto Rico&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Switzerland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Singapore&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax impact of tax law changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of the Combination and divestitures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Withholding taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax settlements and resolution of certain tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other foreign items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(91.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzE4MDI_f0830b36-670f-487a-9a3c-de0981bdf198"
      unitRef="number">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzItMS0xLTEtMzE0MjI_f0830b36-670f-487a-9a3c-de0981bdf198"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzItMy0xLTEtMzE0MjI_149b6921-20b7-4fda-807f-d176e3fb2881"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzItNS0xLTEtMzE0MjI_b513ef8c-d848-412b-be18-2e34a5fa5bdc"
      unitRef="number">0.190</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="i5705c46a88bf43f9b604c129b6396c1b_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzUtMS0xLTEtMzE0MjI_536ff4c9-b283-48c3-875f-022cf197b3b2"
      unitRef="number">-0.098</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="i4373191f73a844d0aa8b62bcce8c341d_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzUtMy0xLTEtMzE0MjI_2db1bb5e-20ce-48ad-a35a-5ddffb278c77"
      unitRef="number">-0.128</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="icc53a28205ae4633a9527b98ec393f1e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzUtNS0xLTEtMzE0MjI_38a55f9b-7933-4be1-ac00-dcef903433c7"
      unitRef="number">0.434</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i5705c46a88bf43f9b604c129b6396c1b_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzYtMS0xLTEtMzE0MjI_d6f44b43-6d1a-4bb7-9125-dd2ae873e147"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i4373191f73a844d0aa8b62bcce8c341d_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzYtMy0xLTEtMzE0MjI_4a34ff11-8367-44ec-8ad3-e19bf58052f5"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="icc53a28205ae4633a9527b98ec393f1e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzYtNS0xLTEtMzE0MjI_7bfb9698-02ff-40c7-bc26-a06876e6f81d"
      unitRef="number">-0.031</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
      contextRef="i5705c46a88bf43f9b604c129b6396c1b_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzgtMS0xLTEtMzE0MjI_50e1d025-b670-4b60-9867-aea7bba8f5c1"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
      contextRef="i4373191f73a844d0aa8b62bcce8c341d_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzgtMy0xLTEtMzE0MjI_838d64be-46e2-4660-9922-623e63f50f95"
      unitRef="number">-0.092</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
      contextRef="icc53a28205ae4633a9527b98ec393f1e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzgtNS0xLTEtMzE0MjI_9d067d83-9e1a-443a-8ac2-de69b6a32530"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits
      contextRef="i5705c46a88bf43f9b604c129b6396c1b_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzktMS0xLTEtMzE0MjI_80fbdbc8-1b90-4537-bc9b-76733fb4f3c8"
      unitRef="number">-0.006</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits
      contextRef="i4373191f73a844d0aa8b62bcce8c341d_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzktMy0xLTEtMzE0MjI_00026efa-5b73-425f-b28b-fe64b25c16f3"
      unitRef="number">-0.016</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits
      contextRef="icc53a28205ae4633a9527b98ec393f1e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzktNS0xLTEtMzE0MjI_ee2171a2-b3c2-4461-9eb9-e0277dbd19f8"
      unitRef="number">-0.041</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i5705c46a88bf43f9b604c129b6396c1b_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzEwLTEtMS0xLTMxNDIy_f6792abc-e755-4d63-970c-cfe31e2a5c64"
      unitRef="number">-0.001</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i4373191f73a844d0aa8b62bcce8c341d_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzEwLTMtMS0xLTMxNDIy_10613831-dc46-4b3e-aea0-6634c2b9f57b"
      unitRef="number">0.086</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="icc53a28205ae4633a9527b98ec393f1e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzEwLTUtMS0xLTMxNDIy_6c6004a2-1437-4277-889f-76edef547db1"
      unitRef="number">-1.185</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlements
      contextRef="i5705c46a88bf43f9b604c129b6396c1b_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzExLTEtMS0xLTMxNDIy_87ef4a08-f6ab-4aa1-83d9-cf57d9f03034"
      unitRef="number">0.001</us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlements>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlements
      contextRef="i4373191f73a844d0aa8b62bcce8c341d_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzExLTMtMS0xLTMxNDIy_769e6479-926e-4a56-b9d8-d35c02108d93"
      unitRef="number">0.001</us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlements>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlements
      contextRef="icc53a28205ae4633a9527b98ec393f1e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzExLTUtMS0xLTMxNDIy_9f310f08-cc9d-4401-936d-240ce7adf3a8"
      unitRef="number">1.996</us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlements>
    <vtrs:EffectiveIncomeTaxRateReconciliationGILTIPercent
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzEyLTEtMS0xLTMxNDIy_b75a23d6-49de-4ebe-a4e1-393e88e99cf8"
      unitRef="number">-0.369</vtrs:EffectiveIncomeTaxRateReconciliationGILTIPercent>
    <vtrs:EffectiveIncomeTaxRateReconciliationGILTIPercent
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzEyLTMtMS0xLTMxNDIy_3c8e4054-6a2b-40f0-867c-98c2b70af85f"
      unitRef="number">-0.036</vtrs:EffectiveIncomeTaxRateReconciliationGILTIPercent>
    <vtrs:EffectiveIncomeTaxRateReconciliationGILTIPercent
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzEyLTUtMS0xLTMxNDIy_31968f91-96d3-4934-883b-7ae79442125b"
      unitRef="number">-0.086</vtrs:EffectiveIncomeTaxRateReconciliationGILTIPercent>
    <vtrs:EffectiveIncomeTaxRateReconciliationWaivedDeductionsPercent
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzEzLTEtMS0xLTMxNDIy_61cd83bb-d17e-42de-b04a-2b9d17f453b3"
      unitRef="number">0</vtrs:EffectiveIncomeTaxRateReconciliationWaivedDeductionsPercent>
    <vtrs:EffectiveIncomeTaxRateReconciliationWaivedDeductionsPercent
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzEzLTMtMS0xLTMxNDIy_c49c3709-c9d9-46ee-be1c-2bb9b41ff5a5"
      unitRef="number">-0.033</vtrs:EffectiveIncomeTaxRateReconciliationWaivedDeductionsPercent>
    <vtrs:EffectiveIncomeTaxRateReconciliationWaivedDeductionsPercent
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzEzLTUtMS0xLTMxNDIy_946e22d2-ba2d-4aa1-b258-d6a6b6076dfd"
      unitRef="number">0.645</vtrs:EffectiveIncomeTaxRateReconciliationWaivedDeductionsPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzE0LTEtMS0xLTMxNDIy_04c2f0c1-76e8-4efb-9005-42dc031bcf50"
      unitRef="number">-0.028</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzE0LTMtMS0xLTMxNDIy_cf6d66fa-7e99-4916-8691-6d1d439846b9"
      unitRef="number">0.058</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzE0LTUtMS0xLTMxNDIy_34e921c7-8421-4591-8f19-937c5ef60e06"
      unitRef="number">0.077</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i5705c46a88bf43f9b604c129b6396c1b_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzE1LTEtMS0xLTMxNDIy_0f63f79e-2b9e-4d87-bf11-5c228ea1d4b2"
      unitRef="number">-0.061</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i4373191f73a844d0aa8b62bcce8c341d_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzE1LTMtMS0xLTMxNDIy_8c3f245e-b1b3-4e12-a2db-991100030e55"
      unitRef="number">0.015</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="icc53a28205ae4633a9527b98ec393f1e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzE1LTUtMS0xLTMxNDIy_2fb6c841-e4e2-4c0f-a926-64e9dec49b1c"
      unitRef="number">0.069</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign
      contextRef="i541721ab11fa46dba8a4f58aa82b8be6_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzE3LTEtMS0xLTMxNDIy_3e5c3b78-4115-476d-9e5b-4b475b384ae2"
      unitRef="number">-0.067</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign
      contextRef="i8c017853d633417e84dadf12741d19be_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzE3LTMtMS0xLTMxNDIy_b072f909-5870-42b7-9293-98c2b1aecc48"
      unitRef="number">-0.050</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign
      contextRef="i530b9bc93bc34ea6809e028e6321324d_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzE3LTUtMS0xLTMxNDIy_a10ef838-552a-4851-a17c-9d361ef8c6e4"
      unitRef="number">-0.148</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign
      contextRef="i690c125540df43569fe6e0ce50a677ab_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzE4LTEtMS0xLTMxNDIy_f189d6d8-e8bf-4292-a2d2-635f8312bc0c"
      unitRef="number">0.094</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign
      contextRef="i854628b6099f4e6b8fede6d5c536249f_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzE4LTMtMS0xLTMxNDIy_af2b926b-082f-4f67-b297-f7c8392f1c48"
      unitRef="number">0.080</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign
      contextRef="id11628fae2674f80be59cec699d8e459_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzE4LTUtMS0xLTMxNDIy_3e8447a0-e1ee-470d-a881-a6e2f3429deb"
      unitRef="number">-0.388</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign
      contextRef="i5823091b3fcd49398f313d160daadec4_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzE5LTEtMS0xLTMxNDIy_c840ea3f-e37f-46c5-9195-b0e8933382da"
      unitRef="number">0.058</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign
      contextRef="i603a7cae6d9d4de3b979e27445a94107_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzE5LTMtMS0xLTMxNDIy_443a8d4d-1b0a-404b-8886-a40fc1032992"
      unitRef="number">0.082</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign
      contextRef="i66146c05086e4529856e742dff83f191_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzE5LTUtMS0xLTMxNDIy_684853b8-eb2a-420c-bada-8950bf727d12"
      unitRef="number">-0.137</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign
      contextRef="i48d28293b4b04d2fb0191c06495228ce_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzIwLTEtMS0xLTMxNDIy_d2dd88f5-6b2c-4b24-b3c1-6b1b0a3dce04"
      unitRef="number">-0.011</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign
      contextRef="i7fccea3458334b2ebd3c74f8a019e6de_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzIwLTMtMS0xLTMxNDIy_75ff422b-0770-4200-84b1-372ed18874e2"
      unitRef="number">-0.028</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign
      contextRef="iffea22471c5c4e24861294dc6660f471_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzIwLTUtMS0xLTMxNDIy_574e832c-f863-4bd1-9813-959ed00ed28d"
      unitRef="number">0.152</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign
      contextRef="i26e9bb2c528b43d78cadc7fb8c8321fd_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzIxLTEtMS0xLTMxNDIy_fa7d0ac0-c9c5-4321-a6a2-d83f322b7c82"
      unitRef="number">0.044</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign
      contextRef="id9609b95c853486895e94e6a62b3157b_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzIxLTMtMS0xLTMxNDIy_74143738-3646-44e2-a075-fe24543ced76"
      unitRef="number">-0.025</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign
      contextRef="i543541ffe73f47e6872e055ae7bcffda_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzIxLTUtMS0xLTMxNDIy_767911dd-f24c-469e-9f49-d502eec0e954"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign
      contextRef="icf311f44a7fe473a9670fb0c3ff9a43c_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzIyLTEtMS0xLTMxNDIy_4574ba6f-8921-4752-ba76-2819e63f37fe"
      unitRef="number">0.010</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign
      contextRef="iaa740ef330234878af7d2583fa1e040c_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzIyLTMtMS0xLTMxNDIy_5734196f-f30a-4c5c-8232-74e12ac77803"
      unitRef="number">0.020</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign
      contextRef="i7234668fd9e1415280aed391af195c71_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzIyLTUtMS0xLTMxNDIy_f39ba4a5-0575-48d2-b76b-09177e8ad0a4"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign
      contextRef="i0d23542c1c7d4aa7afeff16b251e1769_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzIyLTEtMS0xLTU2NTc3_239c2bb8-8d7e-4ed9-b1fe-d4072f1f9c6c"
      unitRef="number">0.288</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign
      contextRef="ie9e6322b8a51430198f1ea68537c7250_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzIyLTMtMS0xLTU2NTc3_a6422813-a09b-4194-af69-65f2c4bc8629"
      unitRef="number">0.010</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign
      contextRef="i89506361322145bba725864306af6680_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzIyLTUtMS0xLTU2NTc3_b9af2a8f-d109-4027-bce6-e2ff666d2ec5"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign
      contextRef="i44835a71bdf64a59b0834e858746c694_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzIzLTEtMS0xLTMxNDIy_ab4efc86-3114-4cbe-b760-812e1fc8290b"
      unitRef="number">-0.102</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign
      contextRef="i5804a0802eb7426eb85b8c6c303e8343_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzIzLTMtMS0xLTMxNDIy_517a347b-8623-4c5a-a926-71cd4982b5cf"
      unitRef="number">-0.004</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign
      contextRef="i279ca6fa27f643e494543992d85cb2fc_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzIzLTUtMS0xLTMxNDIy_cba9a378-f9b8-4055-8917-210b910eb371"
      unitRef="number">0.128</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies
      contextRef="i17563b55bf4c44c896a9a3066b542e39_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzI0LTEtMS0xLTMxNDIy_39e2df4e-560d-4818-9a28-977f80647f6c"
      unitRef="number">0.070</us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies
      contextRef="i0f870207d18e4404afdd0b0926003cbf_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzI0LTMtMS0xLTMxNDIy_1101e032-bf12-4b13-9b2b-4995c49b4531"
      unitRef="number">-0.001</us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies
      contextRef="icc73a3ee0a3a41ee8832f3c122143ec1_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzI0LTUtMS0xLTMxNDIy_aad2e166-7bab-4053-be0d-d7aca1fbf800"
      unitRef="number">0.367</us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i17563b55bf4c44c896a9a3066b542e39_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzI1LTEtMS0xLTMxNDIy_f73b8c61-7fec-49ce-bab6-307b9742612c"
      unitRef="number">-0.083</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i0f870207d18e4404afdd0b0926003cbf_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzI1LTMtMS0xLTMxNDIy_9de37ddc-5621-478b-b5fa-82ce802cef85"
      unitRef="number">0.161</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="icc73a3ee0a3a41ee8832f3c122143ec1_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzI1LTUtMS0xLTMxNDIy_0b80bd14-c7b8-42df-b216-ee12a39c6769"
      unitRef="number">-0.099</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzI2LTEtMS0xLTMxNDIy_05041a29-dc51-477b-91cb-60bdb8b551b3"
      unitRef="number">-1.069</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzI2LTMtMS0xLTMxNDIy_8b611de7-5188-4b2e-86c3-0102997eb5dc"
      unitRef="number">-0.422</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzI2LTUtMS0xLTMxNDIy_80472668-f24d-466f-b7a4-4b5f37ab9cfe"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <vtrs:EffectiveIncomeTaxRateReconciliationWithholdingTaxesPercent
      contextRef="i17563b55bf4c44c896a9a3066b542e39_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzI3LTEtMS0xLTMxNDIy_204af885-19a2-44bc-ad39-c6c153520f8e"
      unitRef="number">-0.013</vtrs:EffectiveIncomeTaxRateReconciliationWithholdingTaxesPercent>
    <vtrs:EffectiveIncomeTaxRateReconciliationWithholdingTaxesPercent
      contextRef="i0f870207d18e4404afdd0b0926003cbf_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzI3LTMtMS0xLTMxNDIy_184ea131-a591-47a9-bde6-cb9432acad50"
      unitRef="number">-0.016</vtrs:EffectiveIncomeTaxRateReconciliationWithholdingTaxesPercent>
    <vtrs:EffectiveIncomeTaxRateReconciliationWithholdingTaxesPercent
      contextRef="icc73a3ee0a3a41ee8832f3c122143ec1_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzI3LTUtMS0xLTMxNDIy_e28339a2-4fe7-46a0-86ce-8d7c5bed3030"
      unitRef="number">0.071</vtrs:EffectiveIncomeTaxRateReconciliationWithholdingTaxesPercent>
    <vtrs:EffectiveIncomeTaxRateReconciliationIndiaAmagulation
      contextRef="i17563b55bf4c44c896a9a3066b542e39_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzI4LTEtMS0xLTMxNDIy_7ffdf69b-ee30-4f35-868c-c8f7ad52d61c"
      unitRef="number">0.008</vtrs:EffectiveIncomeTaxRateReconciliationIndiaAmagulation>
    <vtrs:EffectiveIncomeTaxRateReconciliationIndiaAmagulation
      contextRef="i0f870207d18e4404afdd0b0926003cbf_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzI4LTMtMS0xLTMxNDIy_650da778-16c8-4aa7-8cc9-53ab7e5776fe"
      unitRef="number">-0.039</vtrs:EffectiveIncomeTaxRateReconciliationIndiaAmagulation>
    <vtrs:EffectiveIncomeTaxRateReconciliationIndiaAmagulation
      contextRef="icc73a3ee0a3a41ee8832f3c122143ec1_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzI4LTUtMS0xLTMxNDIy_c9a859f2-330c-4075-80e9-03ab7f405844"
      unitRef="number">-0.276</vtrs:EffectiveIncomeTaxRateReconciliationIndiaAmagulation>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i17563b55bf4c44c896a9a3066b542e39_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzI5LTEtMS0xLTMxNDIy_ed5e1daf-3426-4514-b277-afe6b209a069"
      unitRef="number">0.019</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i0f870207d18e4404afdd0b0926003cbf_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzI5LTMtMS0xLTMxNDIy_14225b98-1af0-4ff7-aeb3-08ca1547ef85"
      unitRef="number">-0.018</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="icc73a3ee0a3a41ee8832f3c122143ec1_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzI5LTUtMS0xLTMxNDIy_fbc6f1cf-7222-48e3-854b-2c9e065cdae2"
      unitRef="number">0.021</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzMwLTEtMS0xLTMxNDIy_41edad47-dbfd-4047-afa0-cfdb080189e8"
      unitRef="number">-0.910</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzMwLTMtMS0xLTMxNDIy_b3b9b090-f3d3-4548-8221-6ae3e496e23d"
      unitRef="number">0.071</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo0MGU3MmQ0MDMzMGE0NTg0YjQwMWIwNDAwODAyM2IyYy90YWJsZXJhbmdlOjQwZTcyZDQwMzMwYTQ1ODRiNDAxYjA0MDA4MDIzYjJjXzMwLTUtMS0xLTMxNDIy_7d4ab1a5-ba06-474b-8340-08d4a83a87fb"
      unitRef="number">0.891</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <vtrs:DeductionlimitofGILTItax
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzMwODc_790834b7-8e5b-49b4-9849-070db856fbcc"
      unitRef="number">0.50</vtrs:DeductionlimitofGILTItax>
    <vtrs:DeductionlimitofGILTItax
      contextRef="i11b5aa7232f744ff861551a17b6a355f_D20250101-20251231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzMxMDA_79aa47ed-1fff-40f7-9b85-c9283a695513"
      unitRef="number">0.375</vtrs:DeductionlimitofGILTItax>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzQ2MjM_d7e34190-5a90-496f-8f1b-0d22ff9b671c"
      unitRef="usd">780400000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i205d721df41548169e4385e88938943b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzU0MTY_b815d091-0334-411f-b89a-931e64564f1a"
      unitRef="usd">7900000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="icde9ccadb7ab473e9a5c2e38da57d5e0_I20211231"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzU0Nzk_6136a700-27bd-4427-9765-cf0cd72e919f"
      unitRef="usd">3100000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="ifc7dfe40ed754a63957fa18d5cc47e7b_I20211231"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzU1OTQ_30cd7733-ef81-4f40-aa3b-2c08783470a3"
      unitRef="usd">1570000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="ic92f6b9e1fe14acdbdc8bec1f348d9d6_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzU2MDc_7d6dcd1e-9f33-46ff-8510-307ef300e27a"
      unitRef="usd">748400000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i8b804447ccbf4433b4fe613034758f52_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzU2NjY_a866c12b-7dc4-4c0a-ac64-179b99fbc439"
      unitRef="usd">817800000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpense
      contextRef="ifc7dfe40ed754a63957fa18d5cc47e7b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzU3Mzk_d63da4d0-9c3c-4cd4-8e9a-ae73c0dd227d"
      unitRef="usd">39600000</us-gaap:DeferredTaxAssetsTaxDeferredExpense>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="ifc7dfe40ed754a63957fa18d5cc47e7b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzU4NzA_b327e12a-6f7e-4bb8-99bf-a2ce8c1d8790"
      unitRef="usd">329200000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzU5NTI_96fe470b-c8da-4726-a918-4e676e3ba6df"
      unitRef="usd">230300000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign>
    <vtrs:CARESActIncomeTaxExpenseBenefit
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzU0OTc1NTgxNjA5MDQ_4aa0fec5-d174-445a-9579-ba623ddd6dfa"
      unitRef="usd">22100000</vtrs:CARESActIncomeTaxExpenseBenefit>
    <vtrs:IncomeTaxExaminationReserveForUncertainTaxPosition
      contextRef="ib6ea526be10f4f0a866f5c6137509461_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzkyOTU_875b0ea7-8d7f-4bd7-b4b8-95ed5b07ec7c"
      unitRef="usd">155000000</vtrs:IncomeTaxExaminationReserveForUncertainTaxPosition>
    <vtrs:IncomeTaxExaminationReserveImpactOnIncomeTaxProvision
      contextRef="ib6ea526be10f4f0a866f5c6137509461_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzk0MTU_90b17f73-ea34-4701-8357-d1b9ce8a265a"
      unitRef="usd">144900000</vtrs:IncomeTaxExaminationReserveImpactOnIncomeTaxProvision>
    <vtrs:IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense
      contextRef="i472d18e59f014ecfa0204966aa273da0_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzE2NDkyNjc0NjMxOTQ_78151ac2-212b-42bb-9d99-7c5167f4adbc"
      unitRef="usd">56000000</vtrs:IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense>
    <vtrs:ReserveForUncertainTaxPositionsIncludingInterestAndPenalties
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzk3OTI_2912dc8a-11cb-45b3-b394-b63cc2905b16"
      unitRef="usd">315600000</vtrs:ReserveForUncertainTaxPositionsIncludingInterestAndPenalties>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzExMzI1_16b3fb85-aa61-4feb-b09d-ef6efc6c7261"
      unitRef="usd">322900000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzExMzMy_ad4e407e-7c9f-46f2-8998-aec6d990849a"
      unitRef="usd">391100000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzExMzQ1_ac3308ed-4c07-44f7-b65b-0f573bf82e65"
      unitRef="usd">230200000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzExNDk2_7dd09f39-b4db-4e57-abcd-475a2f1e6979"
      unitRef="usd">96800000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzExNTAz_8283abcb-14f0-4abc-a47f-7f97cd2a4734"
      unitRef="usd">86700000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
    <us-gaap:IncomeTaxExaminationInterestExpense
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzExNTk0_70e47ed0-e7f6-4e69-b4f3-b4184244e1e3"
      unitRef="usd">18500000</us-gaap:IncomeTaxExaminationInterestExpense>
    <us-gaap:IncomeTaxExaminationInterestExpense
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzExNTk4_982a3350-6fdf-45f5-bb11-a1803b0a674d"
      unitRef="usd">6000000</us-gaap:IncomeTaxExaminationInterestExpense>
    <us-gaap:IncomeTaxExaminationInterestExpense
      contextRef="i284387cf86b54bd4adfef2f32bb9c670_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzExNjA2_454a0b32-404b-435e-8c27-b909179d6a44"
      unitRef="usd">35200000</us-gaap:IncomeTaxExaminationInterestExpense>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzEyMTYy_95731898-2234-4bf5-9d44-b37158699323">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the unrecognized tax benefits is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.006%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefit&#160;&#x2014; beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;391.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions for current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions for prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions for prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(112.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions due to expirations of statute of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Reduction) addition due to acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefit&#160;&#x2014; end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;391.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo4NTJjYzFhYjNkZjY0MGY4OTJjMzcxNjc2Y2U2Mzk0Ni90YWJsZXJhbmdlOjg1MmNjMWFiM2RmNjQwZjg5MmMzNzE2NzZjZTYzOTQ2XzItMS0xLTEtMzE0MjI_ddfa5cfd-877e-4640-aa11-5c0466cc381f"
      unitRef="usd">391100000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="iac503b6d629d4bafb262ea6ec0b8a25e_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo4NTJjYzFhYjNkZjY0MGY4OTJjMzcxNjc2Y2U2Mzk0Ni90YWJsZXJhbmdlOjg1MmNjMWFiM2RmNjQwZjg5MmMzNzE2NzZjZTYzOTQ2XzItMy0xLTEtMzE0MjI_9a3393bd-11f3-4d52-b7b6-850efe772d34"
      unitRef="usd">92100000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i2a20c8f3803144d58ca34d0fcee823ce_I20161231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo4NTJjYzFhYjNkZjY0MGY4OTJjMzcxNjc2Y2U2Mzk0Ni90YWJsZXJhbmdlOjg1MmNjMWFiM2RmNjQwZjg5MmMzNzE2NzZjZTYzOTQ2XzItNS0xLTEtMzE0MjI_b0acc27b-17f9-4a53-9943-d7087e33a3ff"
      unitRef="usd">96300000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo4NTJjYzFhYjNkZjY0MGY4OTJjMzcxNjc2Y2U2Mzk0Ni90YWJsZXJhbmdlOjg1MmNjMWFiM2RmNjQwZjg5MmMzNzE2NzZjZTYzOTQ2XzMtMS0xLTEtMzE0MjI_b92ad8dc-5a56-404b-9542-1e9e1f18ebf6"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo4NTJjYzFhYjNkZjY0MGY4OTJjMzcxNjc2Y2U2Mzk0Ni90YWJsZXJhbmdlOjg1MmNjMWFiM2RmNjQwZjg5MmMzNzE2NzZjZTYzOTQ2XzMtMy0xLTEtMzE0MjI_94a08ce9-312e-4988-a169-3ef771ab62ae"
      unitRef="usd">13400000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i284387cf86b54bd4adfef2f32bb9c670_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo4NTJjYzFhYjNkZjY0MGY4OTJjMzcxNjc2Y2U2Mzk0Ni90YWJsZXJhbmdlOjg1MmNjMWFiM2RmNjQwZjg5MmMzNzE2NzZjZTYzOTQ2XzMtNS0xLTEtMzE0MjI_041822a8-f72c-4bbf-8161-4649f3ec9865"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo4NTJjYzFhYjNkZjY0MGY4OTJjMzcxNjc2Y2U2Mzk0Ni90YWJsZXJhbmdlOjg1MmNjMWFiM2RmNjQwZjg5MmMzNzE2NzZjZTYzOTQ2XzQtMS0xLTEtMzE0MjI_776e66e0-51ce-413d-ae3d-c8e87a302176"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo4NTJjYzFhYjNkZjY0MGY4OTJjMzcxNjc2Y2U2Mzk0Ni90YWJsZXJhbmdlOjg1MmNjMWFiM2RmNjQwZjg5MmMzNzE2NzZjZTYzOTQ2XzQtMy0xLTEtMzE0MjI_49bcaab8-0f79-40e2-9357-c71eb13d7a60"
      unitRef="usd">35700000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i284387cf86b54bd4adfef2f32bb9c670_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo4NTJjYzFhYjNkZjY0MGY4OTJjMzcxNjc2Y2U2Mzk0Ni90YWJsZXJhbmdlOjg1MmNjMWFiM2RmNjQwZjg5MmMzNzE2NzZjZTYzOTQ2XzQtNS0xLTEtMzE0MjI_552bc58e-447d-485b-a8f8-38b8c448b223"
      unitRef="usd">154900000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo4NTJjYzFhYjNkZjY0MGY4OTJjMzcxNjc2Y2U2Mzk0Ni90YWJsZXJhbmdlOjg1MmNjMWFiM2RmNjQwZjg5MmMzNzE2NzZjZTYzOTQ2XzUtMS0xLTEtMzE0MjI_7c751f22-5d2a-46f6-8bac-2e3f8fe738a3"
      unitRef="usd">9100000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo4NTJjYzFhYjNkZjY0MGY4OTJjMzcxNjc2Y2U2Mzk0Ni90YWJsZXJhbmdlOjg1MmNjMWFiM2RmNjQwZjg5MmMzNzE2NzZjZTYzOTQ2XzUtMy0xLTEtMzE0MjI_72d26224-ce86-4df1-a698-1b2745ecbc5f"
      unitRef="usd">5200000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i284387cf86b54bd4adfef2f32bb9c670_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo4NTJjYzFhYjNkZjY0MGY4OTJjMzcxNjc2Y2U2Mzk0Ni90YWJsZXJhbmdlOjg1MmNjMWFiM2RmNjQwZjg5MmMzNzE2NzZjZTYzOTQ2XzUtNS0xLTEtMzE0MjI_eaab45e5-6e0b-492a-8489-b2b49a8ef91a"
      unitRef="usd">11700000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo4NTJjYzFhYjNkZjY0MGY4OTJjMzcxNjc2Y2U2Mzk0Ni90YWJsZXJhbmdlOjg1MmNjMWFiM2RmNjQwZjg5MmMzNzE2NzZjZTYzOTQ2XzYtMS0xLTEtMzE0MjI_326f6ab0-089c-4e5f-ad6a-3fc1d2225a35"
      unitRef="usd">47300000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo4NTJjYzFhYjNkZjY0MGY4OTJjMzcxNjc2Y2U2Mzk0Ni90YWJsZXJhbmdlOjg1MmNjMWFiM2RmNjQwZjg5MmMzNzE2NzZjZTYzOTQ2XzYtMy0xLTEtMzE0MjI_a257fb00-9cc7-454f-a212-f9bc0bf565f0"
      unitRef="usd">8900000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i284387cf86b54bd4adfef2f32bb9c670_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo4NTJjYzFhYjNkZjY0MGY4OTJjMzcxNjc2Y2U2Mzk0Ni90YWJsZXJhbmdlOjg1MmNjMWFiM2RmNjQwZjg5MmMzNzE2NzZjZTYzOTQ2XzYtNS0xLTEtMzE0MjI_569b0ab9-c3ed-4022-8770-11d7ad7036c1"
      unitRef="usd">112500000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo4NTJjYzFhYjNkZjY0MGY4OTJjMzcxNjc2Y2U2Mzk0Ni90YWJsZXJhbmdlOjg1MmNjMWFiM2RmNjQwZjg5MmMzNzE2NzZjZTYzOTQ2XzctMS0xLTEtMzE0MjI_9a8fd167-6d0e-4fa9-a76d-4958df9ced27"
      unitRef="usd">7000000.0</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo4NTJjYzFhYjNkZjY0MGY4OTJjMzcxNjc2Y2U2Mzk0Ni90YWJsZXJhbmdlOjg1MmNjMWFiM2RmNjQwZjg5MmMzNzE2NzZjZTYzOTQ2XzctMy0xLTEtMzE0MjI_d3ce5532-2f6a-4e25-bff1-d787a21ec792"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i284387cf86b54bd4adfef2f32bb9c670_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo4NTJjYzFhYjNkZjY0MGY4OTJjMzcxNjc2Y2U2Mzk0Ni90YWJsZXJhbmdlOjg1MmNjMWFiM2RmNjQwZjg5MmMzNzE2NzZjZTYzOTQ2XzctNS0xLTEtMzE0MjI_7dde27b0-b17e-4f17-8eee-722b097cc6c2"
      unitRef="usd">34900000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromAcquisition
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo4NTJjYzFhYjNkZjY0MGY4OTJjMzcxNjc2Y2U2Mzk0Ni90YWJsZXJhbmdlOjg1MmNjMWFiM2RmNjQwZjg5MmMzNzE2NzZjZTYzOTQ2XzgtMS0xLTEtMzE0MjI_8a9f16ad-85b2-4c46-a1d4-092a18e99f3f"
      unitRef="usd">4800000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromAcquisition>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo4NTJjYzFhYjNkZjY0MGY4OTJjMzcxNjc2Y2U2Mzk0Ni90YWJsZXJhbmdlOjg1MmNjMWFiM2RmNjQwZjg5MmMzNzE2NzZjZTYzOTQ2XzgtMy0xLTEtMzE0MjI_e2181af1-2c66-4834-ad3f-41063e1261bf"
      unitRef="usd">264000000.0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo4NTJjYzFhYjNkZjY0MGY4OTJjMzcxNjc2Y2U2Mzk0Ni90YWJsZXJhbmdlOjg1MmNjMWFiM2RmNjQwZjg5MmMzNzE2NzZjZTYzOTQ2XzgtNS0xLTEtMzE0MjI_bc8643aa-2b25-455b-b277-4d5dbf348da8"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo4NTJjYzFhYjNkZjY0MGY4OTJjMzcxNjc2Y2U2Mzk0Ni90YWJsZXJhbmdlOjg1MmNjMWFiM2RmNjQwZjg5MmMzNzE2NzZjZTYzOTQ2XzktMS0xLTEtMzE0MjI_be5e4ede-3d45-4967-917a-aa1aca17fd7e"
      unitRef="usd">322900000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo4NTJjYzFhYjNkZjY0MGY4OTJjMzcxNjc2Y2U2Mzk0Ni90YWJsZXJhbmdlOjg1MmNjMWFiM2RmNjQwZjg5MmMzNzE2NzZjZTYzOTQ2XzktMy0xLTEtMzE0MjI_9ef90f48-72e8-4778-bb46-c0752e3b46f7"
      unitRef="usd">391100000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="iac503b6d629d4bafb262ea6ec0b8a25e_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90YWJsZTo4NTJjYzFhYjNkZjY0MGY4OTJjMzcxNjc2Y2U2Mzk0Ni90YWJsZXJhbmdlOjg1MmNjMWFiM2RmNjQwZjg5MmMzNzE2NzZjZTYzOTQ2XzktNS0xLTEtMzE0MjI_3b60809b-c2a6-4f87-9971-184e38a850ab"
      unitRef="usd">92100000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMTcvZnJhZzo1MGZkYzg5NThmNmQ0ZjNkYWQxODhlMjBmZmZhMTNlMS90ZXh0cmVnaW9uOjUwZmRjODk1OGY2ZDRmM2RhZDE4OGUyMGZmZmExM2UxXzEyMDA2_30e9b933-91dc-4a20-a345-de8c8e6344e2"
      unitRef="usd">55000000</us-gaap:IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzUwNzU_389edfea-cff4-422e-bbae-4d324387edd9">Share-Based Incentive Plan&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to the Distribution, Viatris adopted and Pfizer, in the capacity as Viatris&#x2019; sole stockholder at such time, approved the Plan (the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Viatris Inc. 2020 Stock Incentive Plan) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;which became effective as of the Distribution. In connection with the Combination, as of November 16, 2020, the Company assumed the 2003 LTIP (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Mylan N.V. Amended and Restated 2003 Long-Term Incentive Plan)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which had previously been approved by Mylan shareholders. The Plan and 2003 LTIP include (i) 72,500,000 shares of Common Stock authorized for grant pursuant to the Plan, which may include dividend payments payable in Common Stock on unvested shares granted under awards, (ii) 6,757,640 shares of Common Stock to be issued pursuant to the exercise of outstanding stock options granted to participants under the 2003 LTIP and assumed by Viatris in connection with the Combination and (iii) 13,535,627 shares of Common Stock subject to outstanding equity-based awards, other than stock options, assumed by Viatris in connection with the Combination, or that otherwise remain available for issuance under the 2003 LTIP.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Plan and 2003 LTIP, shares are reserved for issuance to key employees, consultants, independent contractors and non-employee directors of the Company through a variety of incentive awards, including: stock options, SARs, restricted stock and units, PSUs, other stock-based awards and short-term cash awards. Stock option awards are granted with an exercise price equal to the fair market value of the shares underlying the stock options at the date of the grant, generally become exercisable over periods ranging from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzE2Mjc_08ccde51-39fc-462c-a345-1572757200f2"&gt;three&lt;/span&gt; to four years, and generally expire in ten years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes stock awards (stock options and SARs) activity under the Plan and 2003 LTIP:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.187%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&#160;of&#160;Shares&lt;br/&gt;Under Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise&#160;Price&lt;br/&gt;per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,815,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;829,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(580,950)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(715,941)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,347,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;814,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,615)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(422,714)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,711,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,135,241)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,576,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and expected to vest at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,487,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,969,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, stock awards outstanding, stock awards vested and expected to vest and stock awards exercisable had average remaining contractual terms of 4.6 years, 4.6 years and 4.2 years, respectively. Also, at December&#160;31, 2021, stock awards outstanding, stock awards vested and expected to vest and stock awards exercisable had no aggregate intrinsic value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the status of the Company&#x2019;s nonvested restricted stock awards (restricted stock and restricted stock unit awards, including PSUs), as of December&#160;31, 2020 and the changes during the year ended December&#160;31, 2021 are presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.029%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.468%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.470%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&#160;of&#160;Restricted&lt;br/&gt;Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Grant-Date&lt;br/&gt;Fair&#160;Value&#160;Per&#160;Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,073,790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,850,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Released&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,168,152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,897,953)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,858,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Of the 9,850,443 restricted stock awards granted during the year ended December&#160;31, 2021, 6,057,602 vest ratably in three years or less and are not subject to market or performance conditions. Of the remaining restricted stock awards granted, 587,025 are not subject to market conditions and will cliff vest within a &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzI2NDI_f3b767c1-16ad-4e4f-bd76-18f9bc8ce9a6"&gt;three&lt;/span&gt;-year period, and 3,205,816 are subject to market or performance conditions and will cliff vest in &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzEyNjQ0MzgzNzI3MzQ5_f3b767c1-16ad-4e4f-bd76-18f9bc8ce9a6"&gt;three&lt;/span&gt; years or less.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, the Company had $143.1 million of total unrecognized compensation expense, net of estimated forfeitures, related to all of its stock-based awards, which we expect to recognize over the remaining weighted average vesting period of 1.7 years. The total intrinsic value of stock awards exercised and restricted stock units released during the years ended December&#160;31, 2021 and 2020 was $78.1 million and $20.9 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;With respect to options granted under the Plan and 2003 LTIP, the fair value of each option grant was estimated at the date of grant using the Black-Scholes option pricing model. Black-Scholes utilizes assumptions related to volatility, the risk-free interest rate, the dividend yield and employee exercise behavior. Expected volatilities utilized in the model are based mainly on the implied volatility of the Company&#x2019;s stock price and other factors. The risk-free interest rate is derived from the U.S.&#160;Treasury yield curve in effect at the time of grant. The model incorporates exercise and post-vesting forfeiture assumptions based on an analysis of historical data. The expected lives of the grants are derived from historical and other factors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no options granted during the year ended December 31, 2021. The assumptions used for options granted under the Plan and 2003 LTIP during the years ended December 31, 2020 and 2019, respectively, are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.697%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.7%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.1%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeiture rate &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average grant date fair value per option&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$8.07&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$11.03&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="icf4cadf4931e4608b5a75d3c9e76220c_I20201116"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzQ5OQ_1d72fe57-6add-42f3-9c7f-ce5f0ac04d7f"
      unitRef="shares">72500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ide54256d4c4e4fd1bebbeda254f7381b_D20201116-20201116"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzY3NA_6c014671-705f-4d8d-a49b-65ead44dd1e6"
      unitRef="shares">6757640</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i58936cbb4f69447d95f57e98537ab978_I20201116"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0Xzg3OQ_ecccdeb8-48ed-4d02-97b2-42e95dc2b0d3"
      unitRef="shares">13535627</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="iff2871529dca49568da0067c4e5a5e0f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzE2MzM_03cba3f3-9320-42e2-9c6d-f9bd91619a00">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i2ee490046709489aa5f4269ad8f50ae8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzE2NjE_c6be35ff-7474-4d0a-8808-913aaece6ea7">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzUwNzc_4409e516-062d-4688-9136-8e7b2a4c13b0">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes stock awards (stock options and SARs) activity under the Plan and 2003 LTIP:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.187%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&#160;of&#160;Shares&lt;br/&gt;Under Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise&#160;Price&lt;br/&gt;per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,815,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;829,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(580,950)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(715,941)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,347,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;814,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,615)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(422,714)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,711,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,135,241)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,576,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and expected to vest at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,487,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,969,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="if8ec92ba24d848d697ba737aeed13c05_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzEtMS0xLTEtMzE0MjI_514e7357-6ce8-4d87-b105-94d31cd66a77"
      unitRef="shares">6815278</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="if8ec92ba24d848d697ba737aeed13c05_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzEtMy0xLTEtMzE0MjI_8c747a99-92b1-467d-a44c-49cc287dc2ac"
      unitRef="usdPerShare">36.61</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzItMS0xLTEtMzE0MjI_553b6441-6710-462b-bcd1-45169c37680a"
      unitRef="shares">829322</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzItMy0xLTEtMzE0MjI_6d283387-b8ca-4c72-b6ec-b1443c7d15be"
      unitRef="usdPerShare">26.18</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzMtMS0xLTEtMzE0MjI_62f931e7-52ad-4f49-abd9-5ef1d84b7622"
      unitRef="shares">580950</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzMtMy0xLTEtMzE0MjI_93ef6cea-37e7-4953-85e7-8e19d862fc94"
      unitRef="usdPerShare">14.40</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzQtMS0xLTEtMzE0MjI_16b3f36e-20ec-42cd-b6b2-b3efb7a836b9"
      unitRef="shares">715941</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzQtMy0xLTEtMzE0MjI_d1b3474d-d5ea-4a8b-ac37-8011657845f0"
      unitRef="usdPerShare">39.40</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="iac503b6d629d4bafb262ea6ec0b8a25e_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzYtMS0xLTEtMzE0MjI_70cb5ee6-b3c4-4834-8818-60e85bdde82d"
      unitRef="shares">6347709</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="iac503b6d629d4bafb262ea6ec0b8a25e_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzYtMy0xLTEtMzE0MjI_185cd2b0-0f33-4775-82fb-9cccacb5d84c"
      unitRef="usdPerShare">36.97</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzctMS0xLTEtMzE0MjI_6c7f90df-e2fc-4ac4-9101-8265c1ac007f"
      unitRef="shares">814351</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzctMy0xLTEtMzE0MjI_af536599-2d48-4b69-9b5e-a95f28322040"
      unitRef="usdPerShare">17.37</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzgtMS0xLTEtMzE0MjI_f9841b9c-1ad6-4e2e-92ee-57df41ec3d64"
      unitRef="shares">27615</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzgtMy0xLTEtMzE0MjI_eccb56d3-68b6-4c60-8c4f-8eb13c910798"
      unitRef="usdPerShare">21.13</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzktMS0xLTEtMzE0MjI_9289f6e0-e429-4339-b956-b0f53b186fcd"
      unitRef="shares">422714</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzktMy0xLTEtMzE0MjI_bc8eb9d8-ce64-45cf-b4aa-b4fd3b9a9e37"
      unitRef="usdPerShare">25.74</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzEwLTEtMS0xLTMxNDIy_9fe1b400-6ec6-4f47-9a44-8f02d0e0a126"
      unitRef="shares">6711731</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzEwLTMtMS0xLTMxNDIy_0b35aaa3-abcd-4ea8-9517-572e57a068cc"
      unitRef="usdPerShare">35.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzEzLTEtMS0xLTMxNDIy_f3f765ce-f1a1-4e58-b902-8c0121cd6143"
      unitRef="shares">1135241</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzEzLTMtMS0xLTMxNDIy_ff03460a-5326-4f5e-a859-9634b36c32ce"
      unitRef="usdPerShare">26.39</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzE0LTEtMS0xLTMxNDIy_bd1ccd5f-0789-44bb-8b43-72287f0f906f"
      unitRef="shares">5576490</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzE0LTMtMS0xLTMxNDIy_dc4d66e4-b558-44e6-94f8-5d6717ddcef7"
      unitRef="usdPerShare">37.19</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzE1LTEtMS0xLTMxNDIy_29c4c12b-c157-4a7f-b839-35e1b5f3b00e"
      unitRef="shares">5487788</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzE1LTMtMS0xLTMxNDIy_271ba711-4356-45ae-b6fb-4a824d4581bb"
      unitRef="usdPerShare">37.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzE2LTEtMS0xLTMxNDIy_b969b6ba-e27f-47aa-b8f2-1fd09f96a818"
      unitRef="shares">4969602</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTozOWNjM2JhZTgyOTY0ZWRmOTMwOGZmYzNkOGU0MDZmOC90YWJsZXJhbmdlOjM5Y2MzYmFlODI5NjRlZGY5MzA4ZmZjM2Q4ZTQwNmY4XzE2LTMtMS0xLTMxNDIy_c66cddbd-d85f-4dae-8c6c-0a0ff914a530"
      unitRef="usdPerShare">39.21</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i2ee490046709489aa5f4269ad8f50ae8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzE5MzQ_e2911433-fa0b-4f60-b6ba-4108babfbf8a">P4Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="i2ee490046709489aa5f4269ad8f50ae8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzE5Mzg_f35d1b12-3cf9-4726-a0e1-1a924f101269">P4Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i2ee490046709489aa5f4269ad8f50ae8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzE5NDU_61e71807-a8c7-4300-bba0-29f76a48a4f7">P4Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzUwNzM_76c22bae-ad76-4f51-b3b1-e5aa6ef447fd">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the status of the Company&#x2019;s nonvested restricted stock awards (restricted stock and restricted stock unit awards, including PSUs), as of December&#160;31, 2020 and the changes during the year ended December&#160;31, 2021 are presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.029%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.468%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.470%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&#160;of&#160;Restricted&lt;br/&gt;Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Grant-Date&lt;br/&gt;Fair&#160;Value&#160;Per&#160;Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,073,790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,850,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Released&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,168,152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,897,953)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,858,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i108f18c1c1f24f03914b8e2a90171783_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTpiZGMwNjAwNzRkMWU0OTVhOWE4MWZkYjIzYTFlODAwNi90YWJsZXJhbmdlOmJkYzA2MDA3NGQxZTQ5NWE5YTgxZmRiMjNhMWU4MDA2XzEtMS0xLTEtMzE0MjI_af774a38-63df-4491-9d71-c2028dbc5aec"
      unitRef="shares">12073790</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i108f18c1c1f24f03914b8e2a90171783_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTpiZGMwNjAwNzRkMWU0OTVhOWE4MWZkYjIzYTFlODAwNi90YWJsZXJhbmdlOmJkYzA2MDA3NGQxZTQ5NWE5YTgxZmRiMjNhMWU4MDA2XzEtMy0xLTEtMzE0MjI_f714c3af-56c6-4f74-956b-c9cfbfae00ce"
      unitRef="usdPerShare">18.34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i6030f8107f684fe8afa39a9cb5b4ce23_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTpiZGMwNjAwNzRkMWU0OTVhOWE4MWZkYjIzYTFlODAwNi90YWJsZXJhbmdlOmJkYzA2MDA3NGQxZTQ5NWE5YTgxZmRiMjNhMWU4MDA2XzItMS0xLTEtMzE0MjI_ef526c62-c45f-41f4-b79d-a8b34d3fbfc3"
      unitRef="shares">9850443</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i6030f8107f684fe8afa39a9cb5b4ce23_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTpiZGMwNjAwNzRkMWU0OTVhOWE4MWZkYjIzYTFlODAwNi90YWJsZXJhbmdlOmJkYzA2MDA3NGQxZTQ5NWE5YTgxZmRiMjNhMWU4MDA2XzItMy0xLTEtMzE0MjI_de1e96a8-b8c0-4276-ae42-3ff220454f25"
      unitRef="usdPerShare">14.46</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i6030f8107f684fe8afa39a9cb5b4ce23_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTpiZGMwNjAwNzRkMWU0OTVhOWE4MWZkYjIzYTFlODAwNi90YWJsZXJhbmdlOmJkYzA2MDA3NGQxZTQ5NWE5YTgxZmRiMjNhMWU4MDA2XzMtMS0xLTEtMzE0MjI_ca9daa89-e242-4ba9-8bfd-c4390101426a"
      unitRef="shares">3168152</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i6030f8107f684fe8afa39a9cb5b4ce23_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTpiZGMwNjAwNzRkMWU0OTVhOWE4MWZkYjIzYTFlODAwNi90YWJsZXJhbmdlOmJkYzA2MDA3NGQxZTQ5NWE5YTgxZmRiMjNhMWU4MDA2XzMtMy0xLTEtMzE0MjI_d67dd298-975e-4768-b0f7-3d51e1cc35e8"
      unitRef="usdPerShare">24.65</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i6030f8107f684fe8afa39a9cb5b4ce23_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTpiZGMwNjAwNzRkMWU0OTVhOWE4MWZkYjIzYTFlODAwNi90YWJsZXJhbmdlOmJkYzA2MDA3NGQxZTQ5NWE5YTgxZmRiMjNhMWU4MDA2XzQtMS0xLTEtMzE0MjI_04821edf-ef88-42da-bc1a-1732714e7efa"
      unitRef="shares">1897953</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i6030f8107f684fe8afa39a9cb5b4ce23_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTpiZGMwNjAwNzRkMWU0OTVhOWE4MWZkYjIzYTFlODAwNi90YWJsZXJhbmdlOmJkYzA2MDA3NGQxZTQ5NWE5YTgxZmRiMjNhMWU4MDA2XzQtMy0xLTEtMzE0MjI_d8449ac4-4c32-4c50-8014-f05eb23efa26"
      unitRef="usdPerShare">15.33</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i59f89db7c1cf4fbbbb690f556ab2557f_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTpiZGMwNjAwNzRkMWU0OTVhOWE4MWZkYjIzYTFlODAwNi90YWJsZXJhbmdlOmJkYzA2MDA3NGQxZTQ5NWE5YTgxZmRiMjNhMWU4MDA2XzUtMS0xLTEtMzE0MjI_100998b0-2c96-4b34-b5df-9acbaa2d8dc5"
      unitRef="shares">16858128</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i59f89db7c1cf4fbbbb690f556ab2557f_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTpiZGMwNjAwNzRkMWU0OTVhOWE4MWZkYjIzYTFlODAwNi90YWJsZXJhbmdlOmJkYzA2MDA3NGQxZTQ5NWE5YTgxZmRiMjNhMWU4MDA2XzUtMy0xLTEtMzE0MjI_aad1b102-cd1e-4016-ad88-5f7e45f1ddd8"
      unitRef="usdPerShare">15.12</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i6030f8107f684fe8afa39a9cb5b4ce23_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzIzNzU_ef526c62-c45f-41f4-b79d-a8b34d3fbfc3"
      unitRef="shares">9850443</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ib1c2d553da14496cb03b6b87eb3cd0c0_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzI0MzY_eb416cae-d815-4f1e-a8eb-2264db343886"
      unitRef="shares">6057602</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ib1c2d553da14496cb03b6b87eb3cd0c0_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzI0NTU_1371c118-7309-4002-8e8b-3e465d288a87">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i391ac2a5652949d58e918cbb11120117_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzI1NzM_8f7f2727-bfae-4f08-ac89-0a253ab25c10"
      unitRef="shares">587025</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ide9073c6a7c5441b8fcaffca6958c382_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzI2NjI_64210ff7-5631-4c86-89aa-0b51dd114cef"
      unitRef="shares">3205816</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="ie5c3b0237a83415cb42661ae906c1ba7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzI3NzQ_4c43b82e-6c4f-40ce-a0c4-f83d12d50f6a"
      unitRef="usd">143100000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i9267df240f8949458673188e0cc47584_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzI5NzY_1ea1e2db-8399-4891-b4b0-4f4103a77ae1">P1Y8M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <vtrs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue
      contextRef="i9267df240f8949458673188e0cc47584_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzMxMDU_45554ae9-3dfc-4fce-8212-091c9c2476aa"
      unitRef="usd">78100000</vtrs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue>
    <vtrs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue
      contextRef="i149651f6a4da4798a97a769739151b62_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzMxMTI_bfa6da10-cfcc-4262-a2a4-b97e5c51fb06"
      unitRef="usd">20900000</vtrs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i9267df240f8949458673188e0cc47584_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90ZXh0cmVnaW9uOmQ1NWQyZTkxNTMyNjRkZjRiNmI3YzI2ZDgzM2QwNjU0XzUwNDY_b6b9c8b5-957c-4fdc-b468-fd4834118ca2">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no options granted during the year ended December 31, 2021. The assumptions used for options granted under the Plan and 2003 LTIP during the years ended December 31, 2020 and 2019, respectively, are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.697%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.7%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.1%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeiture rate &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average grant date fair value per option&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$8.07&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$11.03&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i10a62822cebc4558b2338681f573875e_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTo4ZTYyMDdiN2Y0N2E0ZGY2OWIyZTY2N2Q5NDFlYWU0OC90YWJsZXJhbmdlOjhlNjIwN2I3ZjQ3YTRkZjY5YjJlNjY3ZDk0MWVhZTQ4XzItMy0xLTEtMzE0MjI_402a912e-422d-482d-b7ca-9fe301144c15"
      unitRef="number">0.467</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i6da6a8af22304e098fe4c7c2f12e2ce6_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTo4ZTYyMDdiN2Y0N2E0ZGY2OWIyZTY2N2Q5NDFlYWU0OC90YWJsZXJhbmdlOjhlNjIwN2I3ZjQ3YTRkZjY5YjJlNjY3ZDk0MWVhZTQ4XzItNS0xLTEtMzE0MjI_7f4c3583-0a46-4d35-b0fa-7eb1a9fc5dad"
      unitRef="number">0.381</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i10a62822cebc4558b2338681f573875e_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTo4ZTYyMDdiN2Y0N2E0ZGY2OWIyZTY2N2Q5NDFlYWU0OC90YWJsZXJhbmdlOjhlNjIwN2I3ZjQ3YTRkZjY5YjJlNjY3ZDk0MWVhZTQ4XzMtMy0xLTEtMzE0MjI_4fa6d7d5-e791-4fd6-a7d2-d71089e54f44"
      unitRef="number">0.010</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i6da6a8af22304e098fe4c7c2f12e2ce6_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTo4ZTYyMDdiN2Y0N2E0ZGY2OWIyZTY2N2Q5NDFlYWU0OC90YWJsZXJhbmdlOjhlNjIwN2I3ZjQ3YTRkZjY5YjJlNjY3ZDk0MWVhZTQ4XzMtNS0xLTEtMzE0MjI_e80e94a9-4201-4f52-8701-d2876349cb3f"
      unitRef="number">0.025</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i10a62822cebc4558b2338681f573875e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTo4ZTYyMDdiN2Y0N2E0ZGY2OWIyZTY2N2Q5NDFlYWU0OC90YWJsZXJhbmdlOjhlNjIwN2I3ZjQ3YTRkZjY5YjJlNjY3ZDk0MWVhZTQ4XzQtMy0xLTEtMzE0MjI_f3d3d464-ae46-48ee-8087-0a8d047fe264">P6Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i6da6a8af22304e098fe4c7c2f12e2ce6_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTo4ZTYyMDdiN2Y0N2E0ZGY2OWIyZTY2N2Q5NDFlYWU0OC90YWJsZXJhbmdlOjhlNjIwN2I3ZjQ3YTRkZjY5YjJlNjY3ZDk0MWVhZTQ4XzQtNS0xLTEtMzE0MjI_2212ba0a-2c8a-4fd2-9314-97848cbdb3c3">P6Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <vtrs:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate
      contextRef="i10a62822cebc4558b2338681f573875e_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTo4ZTYyMDdiN2Y0N2E0ZGY2OWIyZTY2N2Q5NDFlYWU0OC90YWJsZXJhbmdlOjhlNjIwN2I3ZjQ3YTRkZjY5YjJlNjY3ZDk0MWVhZTQ4XzUtMy0xLTEtMzE0MjI_156c117f-624e-4075-85f5-0142c7eb6fde"
      unitRef="number">0.055</vtrs:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate>
    <vtrs:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate
      contextRef="i6da6a8af22304e098fe4c7c2f12e2ce6_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTo4ZTYyMDdiN2Y0N2E0ZGY2OWIyZTY2N2Q5NDFlYWU0OC90YWJsZXJhbmdlOjhlNjIwN2I3ZjQ3YTRkZjY5YjJlNjY3ZDk0MWVhZTQ4XzUtNS0xLTEtMzE0MjI_02b8e67e-5d21-47f3-b143-7d1ddb8b795f"
      unitRef="number">0.055</vtrs:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i10a62822cebc4558b2338681f573875e_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTo4ZTYyMDdiN2Y0N2E0ZGY2OWIyZTY2N2Q5NDFlYWU0OC90YWJsZXJhbmdlOjhlNjIwN2I3ZjQ3YTRkZjY5YjJlNjY3ZDk0MWVhZTQ4XzYtMy0xLTEtMzE0MjI_b332bd9f-b2d8-4814-84d2-ffa2f612ca67"
      unitRef="usdPerShare">8.07</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i6da6a8af22304e098fe4c7c2f12e2ce6_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjAvZnJhZzpkNTVkMmU5MTUzMjY0ZGY0YjZiN2MyNmQ4MzNkMDY1NC90YWJsZTo4ZTYyMDdiN2Y0N2E0ZGY2OWIyZTY2N2Q5NDFlYWU0OC90YWJsZXJhbmdlOjhlNjIwN2I3ZjQ3YTRkZjY5YjJlNjY3ZDk0MWVhZTQ4XzYtNS0xLTEtMzE0MjI_5be21b11-c42b-4e7e-b1c0-8659b7efc950"
      unitRef="usdPerShare">11.03</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90ZXh0cmVnaW9uOjUyMmUwNGFkZTJlODQ4YjBiNjhhZWM3NTEzMzZhZTI0XzExODI5_e1cb6373-4c3d-4c11-a9ea-5743f60523c7">Employee Benefit Plans&lt;div style="margin-bottom:12pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Defined Benefit Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company sponsors various defined benefit pension plans in several countries. Benefits provided generally depend on length of service, pay grade and remuneration levels. Employees in the U.S., Puerto Rico and certain international locations are also provided retirement benefits through defined contribution plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also sponsors other postretirement benefit plans including plans that provide for postretirement supplemental medical coverage. Benefits from these plans are provided to employees and their spouses and dependents who meet various minimum age and service requirements. In addition, the Company sponsors other plans that provide for life insurance benefits and postretirement medical coverage for certain officers and management employees.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Combination, the Company assumed certain post retirement defined benefit pension plans sponsored by Upjohn. The most significant plans include those in Puerto Rico, Ireland and Japan. Upjohn is also the sponsor of one postretirement medical plan in Puerto Rico. As part of the acquisition accounting, the Company has recorded the fair value of these plans. Upon completion of the Combination, the excess of projected benefit obligation over the plan assets was recognized as a liability and any existing unrecognized actuarial gains or losses and unrecognized service costs or benefits were eliminated in purchase accounting.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounting for Defined Benefit Pension and Other Postretirement Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes on its balance sheet an asset or liability equal to the over- or under-funded benefit obligation of each defined benefit pension and other postretirement plan. Actuarial gains or losses and prior service costs or credits that arise during the period are not recognized as components of net periodic benefit cost, but are recognized, net of tax, as a component of other comprehensive (loss) earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Included in accumulated other comprehensive loss as of December&#160;31, 2021 and 2020 are:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pension Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Postretirement Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized actuarial (gain) loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized prior service cost (credit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unrecognized net actuarial losses exceeded&#160;10%&#160;of the higher of the market value of plan assets or the projected benefit obligation at the beginning of the year for certain of the plans, therefore, amortization of such excess has been included in net periodic benefit costs for pension and other postretirement benefits in each of the last three years. The amortization period is the average remaining service period that active employees are expected to receive benefits, unless a plan is mostly inactive in which case the amortization period is the average remaining life expectancy of the plan participants. Unrecognized prior service cost is amortized over the future service periods of those employees who are active at the dates of the plan amendments and who are expected to receive benefits. If all or almost all of a plan's participants are inactive, unrecognized prior service cost is amortized over the remaining life expectancy of those participants. The increase in accumulated other comprehensive loss in 2021 relating to pension benefits and other postretirement benefits consists of:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.879%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.043%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.045%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pension Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Postretirement Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized actuarial (gain) loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(102.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of actuarial gain/(loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized prior service credit (cost)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of prior service costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net change&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Components of net periodic benefit cost, change in projected benefit obligation, change in plan assets, funded status, fair value of plan assets, assumptions used to determine net periodic benefit cost, funding policy and estimated future benefit payments are summarized below for the Company&#x2019;s pension plans and other postretirement plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net Periodic Benefit Cost&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Components of net periodic benefit cost for the years ended December&#160;31, 2021, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.858%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.503%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.655%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pension Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Postretirement Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan curtailment, settlement and termination&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of prior service costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized net actuarial losses (gains) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2021, the Company recognized a settlement gain as a result of cash payments from lump sum elections related to the U.S. and Puerto Rico pension plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Change in Projected Benefit Obligation, Change in Plan Assets and Funded Status&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents components of the change in projected benefit obligation, change in plan assets and funded status at December&#160;31, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pension Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Postretirement Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in Projected Benefit Obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected benefit obligation, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,145.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;674.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Participant contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,389.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan settlements and terminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(128.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial (gains) losses &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(67.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected benefit obligation, end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,946.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,145.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in Plan Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,354.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Company contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Participant contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;959.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(128.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets, end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,366.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,354.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Funded status of plans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(580.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(791.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(188.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(188.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net accrued benefit costs for pension plans and other postretirement benefits are reported in the following components of the Company&#x2019;s consolidated balance sheets at December&#160;31, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pension Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Postretirement Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(682.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(846.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(172.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(172.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net accrued benefit costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(580.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(791.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(188.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(188.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The projected benefit obligation is the actuarial present value of benefits attributable to employee service rendered to date, including the effects of estimated future pay increases. The accumulated benefit obligation is the actuarial present value of benefits attributable to employee service rendered to date, but does not include the effects of estimated future pay increases.&#160;The accumulated benefit obligation for the Company&#x2019;s pension plans was $1.86 billion and $2.04 billion at December&#160;31, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The projected benefit obligation, accumulated benefit obligation and fair value of plan assets for pension plans with an accumulated benefit obligation in excess of the fair value of plan assets at December&#160;31, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.078%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.019%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Plans with accumulated benefit obligation in excess of plan assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,591.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,747.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,546.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,678.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;904.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;893.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value of Plan Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company measures the fair value of plan assets based on the prices that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value measurements are based on a three-tier hierarchy described in Note 9 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments and Risk Management&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The table below presents total plan assets by investment category as of December&#160;31, 2021&#160;and&#160;2020&#160;and the classification of each investment category within the fair value hierarchy with respect to the inputs used to measure fair value:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;497.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;551.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed income securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;616.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets held by insurance companies and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;338.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;946.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,366.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;468.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;613.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed income securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;592.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets held by insurance companies and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;788.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,354.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Risk tolerance on invested pension plan assets is established through careful consideration of plan liabilities, plan funded status and corporate financial condition. Investment risk is measured and monitored on an ongoing basis through annual liability measures, periodic asset/liability studies and investment portfolio reviews. The Company&#x2019;s investment strategy is to maintain, where possible, a diversified investment portfolio across several asset classes that, when combined with the Company&#x2019;s contributions to the plans, will ensure that required benefit obligations are met.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assumptions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following weighted average assumptions were used to determine the benefit obligations for the Company&#x2019;s defined benefit pension and other postretirement plans as of December&#160;31, 2021&#160;and&#160;2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.609%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pension Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Postretirement Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following weighted average assumptions were used to determine the net periodic benefit cost for the Company&#x2019;s defined benefit pension and other postretirement benefit plans for the three years in the period ended&#160;December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.170%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.035%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pension Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Postretirement Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The assumptions for each plan are reviewed on an annual basis. The discount rate reflects the current rate at which the pension and other benefit liabilities could be effectively settled at the measurement date. In setting the discount rates, we utilize comparable corporate bond indices as an indication of interest rate movements and levels. Corporate bond indices were selected based on individual plan census data and duration. The expected return on plan assets was determined using historical market returns and long-term historical relationships between equities and fixed income securities. The Company compares the expected return on plan assets assumption to actual historic returns to ensure reasonableness. Current market factors such as inflation and interest rates are also evaluated. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average healthcare cost trend rate used for&#160;2021&#160;was&#160;5.7%&#160;declining to a projected&#160;4.5%&#160;in the year&#160;2037. For&#160;2022, the assumed weighted-average healthcare cost trend rate used will be&#160;6.3%&#160;declining to a projected&#160;4.0%&#160;in the year&#160;2045. In selecting rates for current and long-term healthcare cost assumptions, the Company takes into consideration a number of factors including the Company&#x2019;s actual healthcare cost increases, the design of the Company&#x2019;s benefit programs, the demographics of the Company&#x2019;s active and retiree populations and external expectations of future medical cost inflation rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Estimated Future Benefit Payments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s funding policy for its funded pension plans is based upon&#160;local statutory requirements. The Company&#x2019;s funding policy is subject to certain statutory regulations with respect to annual minimum and maximum company contributions. Plan benefits for the non-qualified plans are paid as they come due. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Estimated benefit payments over the next ten years for the Company&#x2019;s pension plans and retiree health plan are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.879%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.043%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.045%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pension Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Postretirement Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;528.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,035.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Defined Contribution Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company sponsors defined contribution plans covering its employees in the U.S. and Puerto Rico, as well as certain employees in a number of countries outside the U.S.&#160;The Company&#x2019;s domestic defined contribution plans consist primarily of a Profit Sharing 401(k) Plan and a 401(k) retirement plan for union-represented employees. Profit sharing contributions are made at the discretion of the Board of Directors. The Company&#x2019;s non-domestic plans vary in form depending on local legal requirements. The Company&#x2019;s contributions are based upon employee contributions, service hours, or pre-determined amounts depending upon the plan. Obligations for contributions to defined contribution plans are recognized as expense in the consolidated statements of operations when they are earned.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains a 401(k) Restoration Plan, which permits employees who earn compensation in excess of the limits imposed by Section&#160;401(a)(17) of the Code to (i)&#160;defer a portion of base salary and bonus compensation, (ii)&#160;be credited with a Company matching contribution in respect of deferrals under the Restoration Plan, and (iii)&#160;be credited with Company non-elective contributions (to the extent so made by the Company), in each case, to the extent that participants otherwise would be able to defer or be credited with such amounts, as applicable, under the Profit Sharing 401(k) Plan if not for the limits on contributions and deferrals imposed by the Code.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains an Income Deferral Plan, which permits certain management or highly compensated employees who are designated by the plan administrator to participate in the Income Deferral Plan to elect to defer up to 50% of base salary and up to 100% of bonus compensation, in each case, in addition to any amounts that may be deferred by such participants under the Profit Sharing 401(k) Plan and the Restoration Plan. In addition, under the Income Deferral Plan, eligible participants may be granted employee deferral awards, which awards will be subject to the terms and conditions (including vesting) as determined by the plan administrator at the time such awards are granted.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total employer contributions to defined contribution plans were approximately $107.4 million, $115.5 million and $95.6 million for the years ended December&#160;31, 2021, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Benefit Arrangements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company participated in a multi-employer pension plan under previous collective bargaining agreements. The PACE Industry Union-Management Pension Fund (the &#x201c;PACE Plan&#x201d;) provides defined benefits to certain retirees and certain production and maintenance employees at the Company&#x2019;s manufacturing plant in Morgantown, West Virginia who were covered by the previous collective bargaining agreements. Pursuant to a collective bargaining agreement entered into on April 16, 2012, the Company withdrew from the PACE Plan effective May 10, 2012. In 2013, the PACE Plan trustee notified the Company that its withdrawal liability was approximately $27.3 million, which was accrued by the Company in 2013. The withdrawal liability is being paid over a period of approximately nine years; payments began in March 2014. The withdrawal liability was approximately $5.5 million and $8.9 million at December&#160;31, 2021 and 2020, respectively. The Employer Identification Number for the PACE Plan is 11-6166763.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90ZXh0cmVnaW9uOjUyMmUwNGFkZTJlODQ4YjBiNjhhZWM3NTEzMzZhZTI0XzExODA4_96308474-cd9a-42d9-a859-33f1234912dd">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Included in accumulated other comprehensive loss as of December&#160;31, 2021 and 2020 are:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pension Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Postretirement Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized actuarial (gain) loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized prior service cost (credit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="ia9d424a72c6e4901a7dafb47ebf3c114_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmNjE0ZmE5NTNkMDM0MDdiOTk5NGE0NmQ5ZDYyNjQxOC90YWJsZXJhbmdlOmY2MTRmYTk1M2QwMzQwN2I5OTk0YTQ2ZDlkNjI2NDE4XzMtMS0xLTEtMzE0MjI_0eff2c64-eac1-4a93-8f9e-e05b1307de7c"
      unitRef="usd">59900000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="i4ec108614a384362b6aac78bfa61c46c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmNjE0ZmE5NTNkMDM0MDdiOTk5NGE0NmQ5ZDYyNjQxOC90YWJsZXJhbmdlOmY2MTRmYTk1M2QwMzQwN2I5OTk0YTQ2ZDlkNjI2NDE4XzMtMy0xLTEtMzE0MjI_dddbd1bc-7687-4324-9df2-567981895be4"
      unitRef="usd">-33900000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="iec1504795a9c4c6693434e98197e0e95_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmNjE0ZmE5NTNkMDM0MDdiOTk5NGE0NmQ5ZDYyNjQxOC90YWJsZXJhbmdlOmY2MTRmYTk1M2QwMzQwN2I5OTk0YTQ2ZDlkNjI2NDE4XzMtNS0xLTEtMzE0MjI_9863c7ed-ff30-4c04-be6c-5b5fab2d326d"
      unitRef="usd">-21700000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="i3db1d00ed7f642dcaf9157d146275821_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmNjE0ZmE5NTNkMDM0MDdiOTk5NGE0NmQ5ZDYyNjQxOC90YWJsZXJhbmdlOmY2MTRmYTk1M2QwMzQwN2I5OTk0YTQ2ZDlkNjI2NDE4XzMtNy0xLTEtMzE0MjI_49de61cd-da40-4b1b-8e93-a7d04f5abd8e"
      unitRef="usd">-5700000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax
      contextRef="ia9d424a72c6e4901a7dafb47ebf3c114_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmNjE0ZmE5NTNkMDM0MDdiOTk5NGE0NmQ5ZDYyNjQxOC90YWJsZXJhbmdlOmY2MTRmYTk1M2QwMzQwN2I5OTk0YTQ2ZDlkNjI2NDE4XzQtMS0xLTEtMzE0MjI_2d318dbf-b91a-4ee9-b373-f405b7cec9b5"
      unitRef="usd">6600000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax
      contextRef="i4ec108614a384362b6aac78bfa61c46c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmNjE0ZmE5NTNkMDM0MDdiOTk5NGE0NmQ5ZDYyNjQxOC90YWJsZXJhbmdlOmY2MTRmYTk1M2QwMzQwN2I5OTk0YTQ2ZDlkNjI2NDE4XzQtMy0xLTEtMzE0MjI_091ae81f-b04f-4d8e-943b-59ba0edc6f0c"
      unitRef="usd">-1400000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax
      contextRef="iec1504795a9c4c6693434e98197e0e95_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmNjE0ZmE5NTNkMDM0MDdiOTk5NGE0NmQ5ZDYyNjQxOC90YWJsZXJhbmdlOmY2MTRmYTk1M2QwMzQwN2I5OTk0YTQ2ZDlkNjI2NDE4XzQtNS0xLTEtMzE0MjI_36b14259-6a0a-43d2-8943-7a5894c46086"
      unitRef="usd">-3700000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax
      contextRef="i3db1d00ed7f642dcaf9157d146275821_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmNjE0ZmE5NTNkMDM0MDdiOTk5NGE0NmQ5ZDYyNjQxOC90YWJsZXJhbmdlOmY2MTRmYTk1M2QwMzQwN2I5OTk0YTQ2ZDlkNjI2NDE4XzQtNy0xLTEtMzE0MjI_dd6e2c85-1dfb-4b1b-a6f5-027b1224b4c0"
      unitRef="usd">600000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax
      contextRef="ia9d424a72c6e4901a7dafb47ebf3c114_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmNjE0ZmE5NTNkMDM0MDdiOTk5NGE0NmQ5ZDYyNjQxOC90YWJsZXJhbmdlOmY2MTRmYTk1M2QwMzQwN2I5OTk0YTQ2ZDlkNjI2NDE4XzUtMS0xLTEtMzE0MjI_c0a54084-ee62-4197-991f-6a06beb35c93"
      unitRef="usd">-53300000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax
      contextRef="i4ec108614a384362b6aac78bfa61c46c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmNjE0ZmE5NTNkMDM0MDdiOTk5NGE0NmQ5ZDYyNjQxOC90YWJsZXJhbmdlOmY2MTRmYTk1M2QwMzQwN2I5OTk0YTQ2ZDlkNjI2NDE4XzUtMy0xLTEtMzE0MjI_e71f8e7d-da98-4a8c-b304-06800113a18a"
      unitRef="usd">32500000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax
      contextRef="iec1504795a9c4c6693434e98197e0e95_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmNjE0ZmE5NTNkMDM0MDdiOTk5NGE0NmQ5ZDYyNjQxOC90YWJsZXJhbmdlOmY2MTRmYTk1M2QwMzQwN2I5OTk0YTQ2ZDlkNjI2NDE4XzUtNS0xLTEtMzE0MjI_4da641c4-60d8-4357-ae3c-4218ba0637c5"
      unitRef="usd">18000000.0</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax
      contextRef="i3db1d00ed7f642dcaf9157d146275821_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmNjE0ZmE5NTNkMDM0MDdiOTk5NGE0NmQ5ZDYyNjQxOC90YWJsZXJhbmdlOmY2MTRmYTk1M2QwMzQwN2I5OTk0YTQ2ZDlkNjI2NDE4XzUtNy0xLTEtMzE0MjI_5f7c004e-5ad0-475e-ae69-12bbd5377484"
      unitRef="usd">6300000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <vtrs:AccumulatednetactuariallossesexceedhigherofmarketvalueofplanassetsorPBO
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90ZXh0cmVnaW9uOjUyMmUwNGFkZTJlODQ4YjBiNjhhZWM3NTEzMzZhZTI0XzIzNjQ_73d9a3f3-ccd1-4d63-8412-3af55d3a60b9"
      unitRef="number">0.10</vtrs:AccumulatednetactuariallossesexceedhigherofmarketvalueofplanassetsorPBO>
    <us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90ZXh0cmVnaW9uOjUyMmUwNGFkZTJlODQ4YjBiNjhhZWM3NTEzMzZhZTI0XzExODEx_5e198da8-49ab-4f48-8817-48ab11315d2a">The increase in accumulated other comprehensive loss in 2021 relating to pension benefits and other postretirement benefits consists of:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.879%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.043%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.045%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pension Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Postretirement Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized actuarial (gain) loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(102.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of actuarial gain/(loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized prior service credit (cost)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of prior service costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net change&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo0MzY5YmFiZmUxOGE0OWQ4OWJjYTY1NDY5OGQwNWZhYy90YWJsZXJhbmdlOjQzNjliYWJmZTE4YTQ5ZDg5YmNhNjU0Njk4ZDA1ZmFjXzEtMS0xLTEtMzE0MjI_37cc5621-3955-4868-aac4-7d77eef9d624"
      unitRef="usd">-102200000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="i52ec07ca99e44636af66cf7c46bf1f5a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo0MzY5YmFiZmUxOGE0OWQ4OWJjYTY1NDY5OGQwNWZhYy90YWJsZXJhbmdlOjQzNjliYWJmZTE4YTQ5ZDg5YmNhNjU0Njk4ZDA1ZmFjXzEtMy0xLTEtMzE0MjI_975e271c-1d03-45bc-8cd1-573bf27691c5"
      unitRef="usd">16200000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo0MzY5YmFiZmUxOGE0OWQ4OWJjYTY1NDY5OGQwNWZhYy90YWJsZXJhbmdlOjQzNjliYWJmZTE4YTQ5ZDg5YmNhNjU0Njk4ZDA1ZmFjXzItMS0xLTEtMzE0MjI_f6b1e7f6-3fd7-4e19-b420-5a7c1dd6e415"
      unitRef="usd">7600000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i52ec07ca99e44636af66cf7c46bf1f5a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo0MzY5YmFiZmUxOGE0OWQ4OWJjYTY1NDY5OGQwNWZhYy90YWJsZXJhbmdlOjQzNjliYWJmZTE4YTQ5ZDg5YmNhNjU0Njk4ZDA1ZmFjXzItMy0xLTEtMzE0MjI_ea49b216-47b1-444a-850f-e21c10d00906"
      unitRef="usd">-200000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax
      contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo0MzY5YmFiZmUxOGE0OWQ4OWJjYTY1NDY5OGQwNWZhYy90YWJsZXJhbmdlOjQzNjliYWJmZTE4YTQ5ZDg5YmNhNjU0Njk4ZDA1ZmFjXzMtMS0xLTEtMzE0MjI_e2922068-e011-4605-9fd2-fa04e3c7c4fd"
      unitRef="usd">-8000000.0</us-gaap:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax
      contextRef="i52ec07ca99e44636af66cf7c46bf1f5a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo0MzY5YmFiZmUxOGE0OWQ4OWJjYTY1NDY5OGQwNWZhYy90YWJsZXJhbmdlOjQzNjliYWJmZTE4YTQ5ZDg5YmNhNjU0Njk4ZDA1ZmFjXzMtMy0xLTEtMzE0MjI_749aa797-7e56-48d9-9704-522035d51214"
      unitRef="usd">4300000</us-gaap:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax
      contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo0MzY5YmFiZmUxOGE0OWQ4OWJjYTY1NDY5OGQwNWZhYy90YWJsZXJhbmdlOjQzNjliYWJmZTE4YTQ5ZDg5YmNhNjU0Njk4ZDA1ZmFjXzQtMS0xLTEtMzE0MjI_68752c83-e2bf-43dd-9738-6bd9108fcf84"
      unitRef="usd">-500000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax
      contextRef="i52ec07ca99e44636af66cf7c46bf1f5a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo0MzY5YmFiZmUxOGE0OWQ4OWJjYTY1NDY5OGQwNWZhYy90YWJsZXJhbmdlOjQzNjliYWJmZTE4YTQ5ZDg5YmNhNjU0Njk4ZDA1ZmFjXzQtMy0xLTEtMzE0MjI_f8e5dc76-f9ab-4256-b1c2-16d86da2c2d9"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax>
    <vtrs:OtherComprehensiveIncomeDefinedBenefitPlanForeignCurrencyTranslationBeforeTax
      contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo0MzY5YmFiZmUxOGE0OWQ4OWJjYTY1NDY5OGQwNWZhYy90YWJsZXJhbmdlOjQzNjliYWJmZTE4YTQ5ZDg5YmNhNjU0Njk4ZDA1ZmFjXzUtMS0xLTEtMzE0MjI_6ca5787f-eecf-43aa-a900-669a2674eda3"
      unitRef="usd">-1300000</vtrs:OtherComprehensiveIncomeDefinedBenefitPlanForeignCurrencyTranslationBeforeTax>
    <vtrs:OtherComprehensiveIncomeDefinedBenefitPlanForeignCurrencyTranslationBeforeTax
      contextRef="i52ec07ca99e44636af66cf7c46bf1f5a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo0MzY5YmFiZmUxOGE0OWQ4OWJjYTY1NDY5OGQwNWZhYy90YWJsZXJhbmdlOjQzNjliYWJmZTE4YTQ5ZDg5YmNhNjU0Njk4ZDA1ZmFjXzUtMy0xLTEtMzE0MjI_ce416a7f-62b9-4031-85e6-487abe73d2ba"
      unitRef="usd">0</vtrs:OtherComprehensiveIncomeDefinedBenefitPlanForeignCurrencyTranslationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo0MzY5YmFiZmUxOGE0OWQ4OWJjYTY1NDY5OGQwNWZhYy90YWJsZXJhbmdlOjQzNjliYWJmZTE4YTQ5ZDg5YmNhNjU0Njk4ZDA1ZmFjXzYtMS0xLTEtMzE0MjI_072e1017-751f-4a6c-8564-db3ad2765b32"
      unitRef="usd">85800000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="i52ec07ca99e44636af66cf7c46bf1f5a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo0MzY5YmFiZmUxOGE0OWQ4OWJjYTY1NDY5OGQwNWZhYy90YWJsZXJhbmdlOjQzNjliYWJmZTE4YTQ5ZDg5YmNhNjU0Njk4ZDA1ZmFjXzYtMy0xLTEtMzE0MjI_2dd1b27a-c0c0-4a5e-b983-8ae9293d438b"
      unitRef="usd">-11700000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:ScheduleOfNetBenefitCostsTableTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90ZXh0cmVnaW9uOjUyMmUwNGFkZTJlODQ4YjBiNjhhZWM3NTEzMzZhZTI0XzExODI2_ea8a9786-dd87-4a57-9d18-ef198d43e52e">&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Components of net periodic benefit cost for the years ended December&#160;31, 2021, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.858%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.503%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.655%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pension Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Postretirement Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan curtailment, settlement and termination&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of prior service costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized net actuarial losses (gains) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2021, the Company recognized a settlement gain as a result of cash payments from lump sum elections related to the U.S. and Puerto Rico pension plans.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfNetBenefitCostsTableTextBlock>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzMtMS0xLTEtMzE0MjI_2c2850e5-dc1e-4a70-82f5-e5ab600eb431"
      unitRef="usd">38600000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ie04b72f184f64b9bb48662c33d2c6a24_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzMtMy0xLTEtMzE0MjI_16c6f4df-d242-4998-81b5-ac6c5ecc70a5"
      unitRef="usd">23500000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i2229a1acd15a481eb03d17e8a82e053c_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzMtNS0xLTEtMzE0MjI_aefa12b3-c966-4962-a599-ce37c3dc963c"
      unitRef="usd">20700000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i35e6c4cb2eb24b3083832b9f47b4f963_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzMtNy0xLTEtMzE0MjI_ccadb99a-cd1d-42b7-bb11-989071eb0286"
      unitRef="usd">3400000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ica964033412a493d86144cd4f4685a99_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzMtOS0xLTEtMzE0MjI_7155f79a-c380-4199-a2ae-4a66a8972821"
      unitRef="usd">1200000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzMtMTEtMS0xLTMxNDIy_9d7dbbcd-fc52-4c38-beb0-8badd5edd4f7"
      unitRef="usd">600000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzQtMS0xLTEtMzE0MjI_2c84cf87-7e82-4a26-b414-dced6a3dd0b1"
      unitRef="usd">31600000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ie04b72f184f64b9bb48662c33d2c6a24_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzQtMy0xLTEtMzE0MjI_7680c2c9-bfbb-4b38-af92-ed66e33bba07"
      unitRef="usd">13500000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i2229a1acd15a481eb03d17e8a82e053c_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzQtNS0xLTEtMzE0MjI_8ae6e468-df60-4c5b-bfe1-517ffc4cc97b"
      unitRef="usd">13600000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i35e6c4cb2eb24b3083832b9f47b4f963_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzQtNy0xLTEtMzE0MjI_386bb5d5-f14e-41ca-b598-a989a84307b9"
      unitRef="usd">2600000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ica964033412a493d86144cd4f4685a99_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzQtOS0xLTEtMzE0MjI_0dabb78c-9cde-4865-a922-1f470a7bad8b"
      unitRef="usd">1400000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzQtMTEtMS0xLTMxNDIy_7f7eccb6-f4ba-4500-aa70-3fc80d57eb7d"
      unitRef="usd">1500000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzUtMS0xLTEtMzE0MjI_7a5fbd1f-6248-4840-9ab1-9240d31e22b9"
      unitRef="usd">66100000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ie04b72f184f64b9bb48662c33d2c6a24_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzUtMy0xLTEtMzE0MjI_57cb6625-05fe-4c43-af49-45149a84a19d"
      unitRef="usd">19900000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i2229a1acd15a481eb03d17e8a82e053c_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzUtNS0xLTEtMzE0MjI_657e4d08-c96b-450f-9caf-dc875b9498df"
      unitRef="usd">12100000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i35e6c4cb2eb24b3083832b9f47b4f963_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzUtNy0xLTEtMzE0MjI_b6651c18-82ab-47ff-acf6-bce4344cfc57"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ica964033412a493d86144cd4f4685a99_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzUtOS0xLTEtMzE0MjI_ae09547c-6e63-4ce5-bd42-d943997cb098"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzUtMTEtMS0xLTMxNDIy_6f8d3330-b9ab-4367-b9ac-a0c740725318"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanCurtailments
      contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzYtMS0xLTEtMzE0MjI_2a458c74-a71f-4c1f-b8d7-486bc4f5410a"
      unitRef="usd">-16500000</us-gaap:DefinedBenefitPlanCurtailments>
    <us-gaap:DefinedBenefitPlanCurtailments
      contextRef="ie04b72f184f64b9bb48662c33d2c6a24_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzYtMy0xLTEtMzE0MjI_9b10b8f0-fab5-4947-9214-4796aa2d85dd"
      unitRef="usd">1100000</us-gaap:DefinedBenefitPlanCurtailments>
    <us-gaap:DefinedBenefitPlanCurtailments
      contextRef="i2229a1acd15a481eb03d17e8a82e053c_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzYtNS0xLTEtMzE0MjI_eb25898b-40d1-4ab3-91ae-0dd518a42504"
      unitRef="usd">-300000</us-gaap:DefinedBenefitPlanCurtailments>
    <us-gaap:DefinedBenefitPlanCurtailments
      contextRef="i35e6c4cb2eb24b3083832b9f47b4f963_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzYtNy0xLTEtMzE0MjI_b6f8a01f-d0f8-4419-b1a7-dc896dc0afd3"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanCurtailments>
    <us-gaap:DefinedBenefitPlanCurtailments
      contextRef="ica964033412a493d86144cd4f4685a99_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzYtOS0xLTEtMzE0MjI_68c04281-a01c-4b8c-9655-9feffb06014e"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanCurtailments>
    <us-gaap:DefinedBenefitPlanCurtailments
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzYtMTEtMS0xLTMxNDIy_40c972d8-81c8-4250-929d-e6e370e24d53"
      unitRef="usd">3200000</us-gaap:DefinedBenefitPlanCurtailments>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzctMS0xLTEtMzE0MjI_d165791f-57c2-4847-9a1d-a28c36ae1d9c"
      unitRef="usd">-900000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="ie04b72f184f64b9bb48662c33d2c6a24_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzctMy0xLTEtMzE0MjI_e45e1f6f-9820-4872-8dbf-89386d0659eb"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="i2229a1acd15a481eb03d17e8a82e053c_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzctNS0xLTEtMzE0MjI_5c0cee98-e3ba-4872-8449-6919f09956fe"
      unitRef="usd">-900000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="i35e6c4cb2eb24b3083832b9f47b4f963_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzctNy0xLTEtMzE0MjI_953220e6-5783-4e65-87ea-bab71cc6deae"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="ica964033412a493d86144cd4f4685a99_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzctOS0xLTEtMzE0MjI_340bb199-5f69-4269-9e67-1a65dfed08dc"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzctMTEtMS0xLTMxNDIy_f720f4a7-75af-4f84-a8dc-912d00e4a16f"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzgtMS0xLTEtMzE0MjI_21b745d2-9115-46f0-8769-137f0b36212d"
      unitRef="usd">-1300000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="ie04b72f184f64b9bb48662c33d2c6a24_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzgtMy0xLTEtMzE0MjI_bf799f75-8988-4969-b48a-e4e608a79cc7"
      unitRef="usd">-400000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="i2229a1acd15a481eb03d17e8a82e053c_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzgtNS0xLTEtMzE0MjI_a86f7778-823d-42f0-a057-fb37920904e1"
      unitRef="usd">800000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="i35e6c4cb2eb24b3083832b9f47b4f963_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzgtNy0xLTEtMzE0MjI_208a9ad4-9d69-4e14-8188-a605754e112d"
      unitRef="usd">-200000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="ica964033412a493d86144cd4f4685a99_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzgtOS0xLTEtMzE0MjI_75213333-57ef-4260-915c-d86eb5be668f"
      unitRef="usd">-300000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzgtMTEtMS0xLTMxNDIy_79acc11a-7ae1-42a6-a92c-31ef2d9bca22"
      unitRef="usd">-200000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzktMS0xLTEtMzE0MjI_c71c4b02-1f94-4a9e-acd6-c56b25f2347e"
      unitRef="usd">-10200000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ie04b72f184f64b9bb48662c33d2c6a24_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzktMy0xLTEtMzE0MjI_65a78b3d-6f39-43b3-b484-c8b37bc26805"
      unitRef="usd">18600000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i2229a1acd15a481eb03d17e8a82e053c_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzktNS0xLTEtMzE0MjI_6eb31735-fee2-41e0-9e1c-375737f9300c"
      unitRef="usd">22000000.0</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i35e6c4cb2eb24b3083832b9f47b4f963_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzktNy0xLTEtMzE0MjI_85f89771-065a-4b90-8c95-9df0303d5416"
      unitRef="usd">6200000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ica964033412a493d86144cd4f4685a99_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzktOS0xLTEtMzE0MjI_5623f690-02be-4a62-9b9c-67e58e014382"
      unitRef="usd">2900000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo5MWFmMzJiOGRhZTM0NjRiYTNlODc4OGYyNjI0NTBkZC90YWJsZXJhbmdlOjkxYWYzMmI4ZGFlMzQ2NGJhM2U4Nzg4ZjI2MjQ1MGRkXzktMTEtMS0xLTMxNDIy_d595acca-4f59-45ff-a51b-87a99a9b147e"
      unitRef="usd">5500000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90ZXh0cmVnaW9uOjUyMmUwNGFkZTJlODQ4YjBiNjhhZWM3NTEzMzZhZTI0XzExODE0_544f83d3-6ec4-4b4a-b2b2-754c2dbc7434">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents components of the change in projected benefit obligation, change in plan assets and funded status at December&#160;31, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pension Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Postretirement Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in Projected Benefit Obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected benefit obligation, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,145.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;674.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Participant contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,389.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan settlements and terminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(128.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial (gains) losses &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(67.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected benefit obligation, end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,946.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,145.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in Plan Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,354.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Company contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Participant contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;959.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(128.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets, end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,366.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,354.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Funded status of plans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(580.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(791.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(188.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(188.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i4ec108614a384362b6aac78bfa61c46c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzMtMS0xLTEtMzE0MjI_24829cce-a116-433a-922a-d09b2662c001"
      unitRef="usd">2145800000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i1c56f90e02e14a18921a2b1fca1e4610_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzMtMy0xLTEtMzE0MjI_e9f3844c-5cbe-471f-9665-6327df9d2edd"
      unitRef="usd">674700000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i3db1d00ed7f642dcaf9157d146275821_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzMtNS0xLTEtMzE0MjI_b7e2fc26-7e97-41fd-9b00-129e300da277"
      unitRef="usd">188800000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i355af96d788e4eeaa662de6eabe91582_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzMtNy0xLTEtMzE0MjI_57d4d526-d4ec-4d11-8a9c-d787aac39eda"
      unitRef="usd">33800000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzQtMS0xLTEtMzE0MjI_1f39c77e-e524-460f-bafb-14c29991fb47"
      unitRef="usd">38600000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ie04b72f184f64b9bb48662c33d2c6a24_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzQtMy0xLTEtMzE0MjI_529138da-9bd2-4844-9605-3bedc4602c9a"
      unitRef="usd">23500000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i52ec07ca99e44636af66cf7c46bf1f5a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzQtNS0xLTEtMzE0MjI_21e34b5b-e53b-4651-8846-6d22b4318d26"
      unitRef="usd">3400000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i2798085fac7a40bab607ca83a2fad67d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzQtNy0xLTEtMzE0MjI_de5db699-2405-4556-a923-c4411c6581f2"
      unitRef="usd">1100000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzUtMS0xLTEtMzE0MjI_54821cc2-94fa-4e22-90c7-77a1fe9d1c01"
      unitRef="usd">31600000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ie04b72f184f64b9bb48662c33d2c6a24_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzUtMy0xLTEtMzE0MjI_67cc1938-7ae7-4723-b258-5e5c0329ad72"
      unitRef="usd">13500000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i52ec07ca99e44636af66cf7c46bf1f5a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzUtNS0xLTEtMzE0MjI_3c085c49-323b-426e-bd77-52f5ba08fca4"
      unitRef="usd">2600000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i2798085fac7a40bab607ca83a2fad67d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzUtNy0xLTEtMzE0MjI_553711a9-309a-4dd9-bcc7-383329b1c559"
      unitRef="usd">1400000</us-gaap:DefinedBenefitPlanInterestCost>
    <vtrs:DefinedBenefitPlanContributionsByPlanParticipantsBenefitObligation
      contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzYtMS0xLTEtMzE0MjI_7ab18398-3a46-40d3-ad26-7f7cf8f56f72"
      unitRef="usd">2000000.0</vtrs:DefinedBenefitPlanContributionsByPlanParticipantsBenefitObligation>
    <vtrs:DefinedBenefitPlanContributionsByPlanParticipantsBenefitObligation
      contextRef="ie04b72f184f64b9bb48662c33d2c6a24_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzYtMy0xLTEtMzE0MjI_ca39845a-9c04-44a9-b459-6b62d7cb8fa4"
      unitRef="usd">1800000</vtrs:DefinedBenefitPlanContributionsByPlanParticipantsBenefitObligation>
    <vtrs:DefinedBenefitPlanContributionsByPlanParticipantsBenefitObligation
      contextRef="i52ec07ca99e44636af66cf7c46bf1f5a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzYtNS0xLTEtMzE0MjI_a9544a49-0388-4778-98e5-ecaaff1a0173"
      unitRef="usd">2400000</vtrs:DefinedBenefitPlanContributionsByPlanParticipantsBenefitObligation>
    <vtrs:DefinedBenefitPlanContributionsByPlanParticipantsBenefitObligation
      contextRef="i2798085fac7a40bab607ca83a2fad67d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzYtNy0xLTEtMzE0MjI_296e3aeb-d768-4bd1-835e-97066c78460f"
      unitRef="usd">100000</vtrs:DefinedBenefitPlanContributionsByPlanParticipantsBenefitObligation>
    <vtrs:DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAssetsTransferredtofromPlan
      contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzctMS0xLTEtMzE0MjI_edec2d20-df51-47c3-b4b6-494d0adb5647"
      unitRef="usd">4000000.0</vtrs:DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAssetsTransferredtofromPlan>
    <vtrs:DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAssetsTransferredtofromPlan
      contextRef="ie04b72f184f64b9bb48662c33d2c6a24_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzctMy0xLTEtMzE0MjI_aba0f227-dd90-4b34-a3b8-f5c50d831752"
      unitRef="usd">1389400000</vtrs:DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAssetsTransferredtofromPlan>
    <vtrs:DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAssetsTransferredtofromPlan
      contextRef="i52ec07ca99e44636af66cf7c46bf1f5a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzctNS0xLTEtMzE0MjI_3ef6f0ff-c2e0-49de-ac68-c0d99334e3c5"
      unitRef="usd">0</vtrs:DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAssetsTransferredtofromPlan>
    <vtrs:DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAssetsTransferredtofromPlan
      contextRef="i2798085fac7a40bab607ca83a2fad67d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzctNy0xLTEtMzE0MjI_2c11b494-9b43-4cd2-b363-246b43c062f8"
      unitRef="usd">153100000</vtrs:DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAssetsTransferredtofromPlan>
    <us-gaap:DefinedBenefitPlanSettlementsBenefitObligation
      contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzktMS0xLTEtMzE0MjI_88c7d47b-b991-4393-a46f-b09751426516"
      unitRef="usd">128600000</us-gaap:DefinedBenefitPlanSettlementsBenefitObligation>
    <us-gaap:DefinedBenefitPlanSettlementsBenefitObligation
      contextRef="ie04b72f184f64b9bb48662c33d2c6a24_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzktMy0xLTEtMzE0MjI_e4a4754e-c732-44d2-a63a-15e0bb71ebfb"
      unitRef="usd">23100000</us-gaap:DefinedBenefitPlanSettlementsBenefitObligation>
    <us-gaap:DefinedBenefitPlanSettlementsBenefitObligation
      contextRef="i52ec07ca99e44636af66cf7c46bf1f5a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzktNS0xLTEtMzE0MjI_cae65265-eb72-4d52-90d3-09033e60d4e9"
      unitRef="usd">4300000</us-gaap:DefinedBenefitPlanSettlementsBenefitObligation>
    <us-gaap:DefinedBenefitPlanSettlementsBenefitObligation
      contextRef="i2798085fac7a40bab607ca83a2fad67d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzktNy0xLTEtMzE0MjI_18350fd1-a844-4b4f-b41a-7de00be99164"
      unitRef="usd">200000</us-gaap:DefinedBenefitPlanSettlementsBenefitObligation>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzEwLTEtMS0xLTMxNDIy_6721810a-f687-4e6b-af78-29b7099186ef"
      unitRef="usd">-26100000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="ie04b72f184f64b9bb48662c33d2c6a24_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzEwLTMtMS0xLTMxNDIy_8af1d519-ec21-42e6-81e1-40c7e2af54e7"
      unitRef="usd">37200000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i52ec07ca99e44636af66cf7c46bf1f5a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzEwLTUtMS0xLTMxNDIy_1078eb83-adad-4230-94f1-b7f495414743"
      unitRef="usd">16200000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i2798085fac7a40bab607ca83a2fad67d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzEwLTctMS0xLTMxNDIy_1b663fd0-e460-4a3f-8cd3-6447728dff37"
      unitRef="usd">1100000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzExLTEtMS0xLTMxNDIy_e89400f9-274c-4acf-892f-951f533ec4f2"
      unitRef="usd">52800000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="ie04b72f184f64b9bb48662c33d2c6a24_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzExLTMtMS0xLTMxNDIy_0b0c360a-f5a6-43f8-85a7-3405c88909c7"
      unitRef="usd">24600000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i52ec07ca99e44636af66cf7c46bf1f5a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzExLTUtMS0xLTMxNDIy_4111a58b-e00f-460a-9afb-edea4a39a457"
      unitRef="usd">20700000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i2798085fac7a40bab607ca83a2fad67d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzExLTctMS0xLTMxNDIy_f17fa885-d4cc-44ff-8f76-2f8ebcb17ebf"
      unitRef="usd">1600000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzEyLTEtMS0xLTMxNDIy_204fb49f-4d3a-443b-b16d-08557c5fdd81"
      unitRef="usd">-67900000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="ie04b72f184f64b9bb48662c33d2c6a24_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzEyLTMtMS0xLTMxNDIy_93f88439-68ae-4023-aa24-75559f4cc8ac"
      unitRef="usd">53400000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="i52ec07ca99e44636af66cf7c46bf1f5a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzEyLTUtMS0xLTMxNDIy_520a59b8-3c95-4c0c-b0a8-28b3447416bb"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="i2798085fac7a40bab607ca83a2fad67d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzEyLTctMS0xLTMxNDIy_b93a4828-3961-4f92-af2d-284922ded508"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ia9d424a72c6e4901a7dafb47ebf3c114_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzEzLTEtMS0xLTMxNDIy_bc4d28ad-4a30-4cb5-a094-cfcc15f11cbd"
      unitRef="usd">1946600000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i4ec108614a384362b6aac78bfa61c46c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzEzLTMtMS0xLTMxNDIy_9adda20a-3ff1-4746-9dd7-ad91b78e7c23"
      unitRef="usd">2145800000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="iec1504795a9c4c6693434e98197e0e95_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzEzLTUtMS0xLTMxNDIy_dc90d088-640a-4a3c-b140-1ecae0be2fcf"
      unitRef="usd">188400000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i3db1d00ed7f642dcaf9157d146275821_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzEzLTctMS0xLTMxNDIy_f59c6a99-c301-41da-b44d-b4931d36910c"
      unitRef="usd">188800000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4ec108614a384362b6aac78bfa61c46c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzE2LTEtMS0xLTMxNDIy_ab5d4d9a-d0f9-4486-b764-469c6d934470"
      unitRef="usd">1354600000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1c56f90e02e14a18921a2b1fca1e4610_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzE2LTMtMS0xLTMxNDIy_9591f7cf-a4a2-4954-81bc-d6a4c1cbb743"
      unitRef="usd">315700000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i3db1d00ed7f642dcaf9157d146275821_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzE2LTUtMS0xLTMxNDIy_76c57387-913c-48f5-b33a-9ad409446693"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i355af96d788e4eeaa662de6eabe91582_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzE2LTctMS0xLTMxNDIy_1df207d9-6fa7-4ec9-a0eb-c4184995b29e"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzE3LTEtMS0xLTMxNDIy_46b4227e-c9c6-48af-8887-4878fe5308e4"
      unitRef="usd">141700000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="ie04b72f184f64b9bb48662c33d2c6a24_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzE3LTMtMS0xLTMxNDIy_f09dc9aa-2740-421a-a020-5f3722c5c23e"
      unitRef="usd">46000000.0</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i52ec07ca99e44636af66cf7c46bf1f5a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzE3LTUtMS0xLTMxNDIy_053bfaf2-37a8-46e7-94ae-419b5e0865f8"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i2798085fac7a40bab607ca83a2fad67d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzE3LTctMS0xLTMxNDIy_88150081-65e9-435b-a698-fd9a52b6e0bf"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzE4LTEtMS0xLTMxNDIy_1450f949-1b0b-4c28-ae49-7e262b89924b"
      unitRef="usd">97000000.0</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="ie04b72f184f64b9bb48662c33d2c6a24_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzE4LTMtMS0xLTMxNDIy_2377e723-ecc9-4cfc-9100-4b9117f2ce2e"
      unitRef="usd">58200000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i52ec07ca99e44636af66cf7c46bf1f5a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzE4LTUtMS0xLTMxNDIy_6edd87c5-9ae9-4593-b93e-ee42b8299f55"
      unitRef="usd">18300000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i2798085fac7a40bab607ca83a2fad67d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzE4LTctMS0xLTMxNDIy_aa51dcd5-20c0-4329-a656-6ac2ed2c6396"
      unitRef="usd">1700000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant
      contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzE5LTEtMS0xLTMxNDIy_7ab53686-1b5d-45c2-8d3f-372f7c4cd5c0"
      unitRef="usd">2000000.0</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant
      contextRef="ie04b72f184f64b9bb48662c33d2c6a24_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzE5LTMtMS0xLTMxNDIy_17f19936-e6b7-43ae-a431-d175d2e2dbf1"
      unitRef="usd">1800000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant
      contextRef="i52ec07ca99e44636af66cf7c46bf1f5a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzE5LTUtMS0xLTMxNDIy_2d84c52f-6a2a-4818-aeb4-f86eda8595c0"
      unitRef="usd">2400000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant
      contextRef="i2798085fac7a40bab607ca83a2fad67d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzE5LTctMS0xLTMxNDIy_709f3eeb-a178-4221-9b99-5d71ecbaaf89"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanAssetsTransferredToFromPlan
      contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzIwLTEtMS0xLTMxNDIy_ba476e11-9f21-4156-8138-26b36d9d2e74"
      unitRef="usd">-2100000</us-gaap:DefinedBenefitPlanAssetsTransferredToFromPlan>
    <us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets
      contextRef="ie04b72f184f64b9bb48662c33d2c6a24_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzIwLTMtMS0xLTMxNDIy_bcf5af1b-2763-4c87-a3e3-8a044d6ad253"
      unitRef="usd">959300000</us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets>
    <us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets
      contextRef="i52ec07ca99e44636af66cf7c46bf1f5a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzIwLTUtMS0xLTMxNDIy_bd7686c8-a22f-48fe-9edb-629f21846cc6"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets>
    <us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets
      contextRef="i2798085fac7a40bab607ca83a2fad67d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzIwLTctMS0xLTMxNDIy_271be86d-fc75-4511-8d3f-eb1b3eb14845"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzIyLTEtMS0xLTMxNDIy_d81da785-869c-4b85-ac19-7c21238c9e3f"
      unitRef="usd">128900000</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="ie04b72f184f64b9bb48662c33d2c6a24_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzIyLTMtMS0xLTMxNDIy_237db314-45d6-4243-bf23-c38d2651d177"
      unitRef="usd">23100000</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="i52ec07ca99e44636af66cf7c46bf1f5a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzIyLTUtMS0xLTMxNDIy_d8c941a6-4d79-457a-8d40-689202d1756c"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="i2798085fac7a40bab607ca83a2fad67d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzIyLTctMS0xLTMxNDIy_1bcf7f0c-edcb-45ce-b503-8da49c3377a4"
      unitRef="usd">200000</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzIzLTEtMS0xLTMxNDIy_697548bc-98c9-42c8-98a1-48c7d48a85de"
      unitRef="usd">52800000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="ie04b72f184f64b9bb48662c33d2c6a24_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzIzLTMtMS0xLTMxNDIy_79beb540-7054-4ddc-adad-64a68e82f25b"
      unitRef="usd">24600000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i52ec07ca99e44636af66cf7c46bf1f5a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzIzLTUtMS0xLTMxNDIy_a52cbba5-8c12-4cd7-af20-a5eb4b7763a2"
      unitRef="usd">20700000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i2798085fac7a40bab607ca83a2fad67d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzIzLTctMS0xLTMxNDIy_50520d72-738a-4813-ba63-e32dedf04b2b"
      unitRef="usd">1600000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <vtrs:DefinedBenefitPlanForeignCurrencyTranslationImpactonPlanAssets
      contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzI1LTEtMS0xLTMxNDIy_bb3c7af4-3347-4eca-a6d2-c6dcbe886701"
      unitRef="usd">-45100000</vtrs:DefinedBenefitPlanForeignCurrencyTranslationImpactonPlanAssets>
    <vtrs:DefinedBenefitPlanForeignCurrencyTranslationImpactonPlanAssets
      contextRef="ie04b72f184f64b9bb48662c33d2c6a24_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzI1LTMtMS0xLTMxNDIy_1d3b559b-6537-49d8-b522-0eaf6f6529da"
      unitRef="usd">21300000</vtrs:DefinedBenefitPlanForeignCurrencyTranslationImpactonPlanAssets>
    <vtrs:DefinedBenefitPlanForeignCurrencyTranslationImpactonPlanAssets
      contextRef="i52ec07ca99e44636af66cf7c46bf1f5a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzI1LTUtMS0xLTMxNDIy_4bdae649-6651-4723-aa7c-a4b9bc3685b9"
      unitRef="usd">0</vtrs:DefinedBenefitPlanForeignCurrencyTranslationImpactonPlanAssets>
    <vtrs:DefinedBenefitPlanForeignCurrencyTranslationImpactonPlanAssets
      contextRef="i2798085fac7a40bab607ca83a2fad67d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzI1LTctMS0xLTMxNDIy_682a0b28-bdc5-42ec-bf51-00ab419af985"
      unitRef="usd">0</vtrs:DefinedBenefitPlanForeignCurrencyTranslationImpactonPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia9d424a72c6e4901a7dafb47ebf3c114_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzI2LTEtMS0xLTMxNDIy_af6415fd-b79e-47fe-b397-28000083d333"
      unitRef="usd">1366400000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4ec108614a384362b6aac78bfa61c46c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzI2LTMtMS0xLTMxNDIy_9df22933-bbcd-4861-bc69-dfa5ebc2a7be"
      unitRef="usd">1354600000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iec1504795a9c4c6693434e98197e0e95_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzI2LTUtMS0xLTMxNDIy_0a5a83d7-16c0-44f3-b163-40c363917245"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i3db1d00ed7f642dcaf9157d146275821_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzI2LTctMS0xLTMxNDIy_d1dded2b-7824-411e-a43e-056519a1c47e"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="ia9d424a72c6e4901a7dafb47ebf3c114_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzI3LTEtMS0xLTMxNDIy_43d85e10-caba-4405-b214-f5bead87d826"
      unitRef="usd">-580200000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i4ec108614a384362b6aac78bfa61c46c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzI3LTMtMS0xLTMxNDIy_f0742f1f-3998-4552-9ed3-73e36f24808c"
      unitRef="usd">-791200000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="iec1504795a9c4c6693434e98197e0e95_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzI3LTUtMS0xLTMxNDIy_f2033184-a6bf-482e-be69-71bc927fa25b"
      unitRef="usd">-188400000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i3db1d00ed7f642dcaf9157d146275821_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphN2M0ZGE0YTA5ZTU0NWM2ODlmODRiYjAzOGNkMmUxNy90YWJsZXJhbmdlOmE3YzRkYTRhMDllNTQ1YzY4OWY4NGJiMDM4Y2QyZTE3XzI3LTctMS0xLTMxNDIy_a0db8c77-51cc-413f-8057-8746c298fba8"
      unitRef="usd">-188800000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90ZXh0cmVnaW9uOjUyMmUwNGFkZTJlODQ4YjBiNjhhZWM3NTEzMzZhZTI0XzExODE5_66d8af5e-032d-4d06-8b59-fedb29ef5605">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net accrued benefit costs for pension plans and other postretirement benefits are reported in the following components of the Company&#x2019;s consolidated balance sheets at December&#160;31, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pension Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Postretirement Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(682.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(846.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(172.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(172.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net accrued benefit costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(580.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(791.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(188.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(188.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="ia9d424a72c6e4901a7dafb47ebf3c114_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo1MGM2OGQzOTA5MzA0M2M0OTUwYTNjOTk2ZDY3OTRmYi90YWJsZXJhbmdlOjUwYzY4ZDM5MDkzMDQzYzQ5NTBhM2M5OTZkNjc5NGZiXzMtMS0xLTEtMzE0MjI_1f333c55-cdcf-4aa9-a835-7004a4214154"
      unitRef="usd">117200000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="i4ec108614a384362b6aac78bfa61c46c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo1MGM2OGQzOTA5MzA0M2M0OTUwYTNjOTk2ZDY3OTRmYi90YWJsZXJhbmdlOjUwYzY4ZDM5MDkzMDQzYzQ5NTBhM2M5OTZkNjc5NGZiXzMtMy0xLTEtMzE0MjI_04274f59-8580-4250-941e-cecbb09e5f7b"
      unitRef="usd">70700000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="iec1504795a9c4c6693434e98197e0e95_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo1MGM2OGQzOTA5MzA0M2M0OTUwYTNjOTk2ZDY3OTRmYi90YWJsZXJhbmdlOjUwYzY4ZDM5MDkzMDQzYzQ5NTBhM2M5OTZkNjc5NGZiXzMtNS0xLTEtMzE0MjI_155e7c2e-a7b8-4500-85bb-4ce4efc44c7c"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="i3db1d00ed7f642dcaf9157d146275821_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo1MGM2OGQzOTA5MzA0M2M0OTUwYTNjOTk2ZDY3OTRmYi90YWJsZXJhbmdlOjUwYzY4ZDM5MDkzMDQzYzQ5NTBhM2M5OTZkNjc5NGZiXzMtNy0xLTEtMzE0MjI_a432c224-38c9-4230-820f-5ec83ee5994c"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="ia9d424a72c6e4901a7dafb47ebf3c114_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo1MGM2OGQzOTA5MzA0M2M0OTUwYTNjOTk2ZDY3OTRmYi90YWJsZXJhbmdlOjUwYzY4ZDM5MDkzMDQzYzQ5NTBhM2M5OTZkNjc5NGZiXzQtMS0xLTEtMzE0MjI_c646674f-7de4-4892-84c7-ae24c00f0380"
      unitRef="usd">14600000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="i4ec108614a384362b6aac78bfa61c46c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo1MGM2OGQzOTA5MzA0M2M0OTUwYTNjOTk2ZDY3OTRmYi90YWJsZXJhbmdlOjUwYzY4ZDM5MDkzMDQzYzQ5NTBhM2M5OTZkNjc5NGZiXzQtMy0xLTEtMzE0MjI_7070f71e-24cb-487c-80dc-2db13345f9bb"
      unitRef="usd">15100000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="iec1504795a9c4c6693434e98197e0e95_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo1MGM2OGQzOTA5MzA0M2M0OTUwYTNjOTk2ZDY3OTRmYi90YWJsZXJhbmdlOjUwYzY4ZDM5MDkzMDQzYzQ5NTBhM2M5OTZkNjc5NGZiXzQtNS0xLTEtMzE0MjI_d02a476a-00b4-411b-84f2-7541a12e5734"
      unitRef="usd">16100000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="i3db1d00ed7f642dcaf9157d146275821_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo1MGM2OGQzOTA5MzA0M2M0OTUwYTNjOTk2ZDY3OTRmYi90YWJsZXJhbmdlOjUwYzY4ZDM5MDkzMDQzYzQ5NTBhM2M5OTZkNjc5NGZiXzQtNy0xLTEtMzE0MjI_5b8b8314-cb74-4a7b-aa6a-922de1fde511"
      unitRef="usd">16300000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="ia9d424a72c6e4901a7dafb47ebf3c114_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo1MGM2OGQzOTA5MzA0M2M0OTUwYTNjOTk2ZDY3OTRmYi90YWJsZXJhbmdlOjUwYzY4ZDM5MDkzMDQzYzQ5NTBhM2M5OTZkNjc5NGZiXzUtMS0xLTEtMzE0MjI_e5f9a292-ea92-4f4e-a23c-92fed19c0a55"
      unitRef="usd">682800000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="i4ec108614a384362b6aac78bfa61c46c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo1MGM2OGQzOTA5MzA0M2M0OTUwYTNjOTk2ZDY3OTRmYi90YWJsZXJhbmdlOjUwYzY4ZDM5MDkzMDQzYzQ5NTBhM2M5OTZkNjc5NGZiXzUtMy0xLTEtMzE0MjI_30f76f01-b06c-43e7-8ff1-bb9f6e5cd27f"
      unitRef="usd">846800000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="iec1504795a9c4c6693434e98197e0e95_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo1MGM2OGQzOTA5MzA0M2M0OTUwYTNjOTk2ZDY3OTRmYi90YWJsZXJhbmdlOjUwYzY4ZDM5MDkzMDQzYzQ5NTBhM2M5OTZkNjc5NGZiXzUtNS0xLTEtMzE0MjI_cb595f3f-c19e-4905-9028-2b55bdda7286"
      unitRef="usd">172300000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="i3db1d00ed7f642dcaf9157d146275821_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo1MGM2OGQzOTA5MzA0M2M0OTUwYTNjOTk2ZDY3OTRmYi90YWJsZXJhbmdlOjUwYzY4ZDM5MDkzMDQzYzQ5NTBhM2M5OTZkNjc5NGZiXzUtNy0xLTEtMzE0MjI_3ce1160b-f025-408a-8698-05187cfd3667"
      unitRef="usd">172500000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <vtrs:Netaccruedbenefitcosts
      contextRef="ia9d424a72c6e4901a7dafb47ebf3c114_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo1MGM2OGQzOTA5MzA0M2M0OTUwYTNjOTk2ZDY3OTRmYi90YWJsZXJhbmdlOjUwYzY4ZDM5MDkzMDQzYzQ5NTBhM2M5OTZkNjc5NGZiXzYtMS0xLTEtMzE0MjI_dd06a41e-0425-48c9-8037-56c2665a3f60"
      unitRef="usd">580200000</vtrs:Netaccruedbenefitcosts>
    <vtrs:Netaccruedbenefitcosts
      contextRef="i4ec108614a384362b6aac78bfa61c46c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo1MGM2OGQzOTA5MzA0M2M0OTUwYTNjOTk2ZDY3OTRmYi90YWJsZXJhbmdlOjUwYzY4ZDM5MDkzMDQzYzQ5NTBhM2M5OTZkNjc5NGZiXzYtMy0xLTEtMzE0MjI_7dde444a-29a1-4c6f-a148-029d68cda30e"
      unitRef="usd">791200000</vtrs:Netaccruedbenefitcosts>
    <vtrs:Netaccruedbenefitcosts
      contextRef="iec1504795a9c4c6693434e98197e0e95_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo1MGM2OGQzOTA5MzA0M2M0OTUwYTNjOTk2ZDY3OTRmYi90YWJsZXJhbmdlOjUwYzY4ZDM5MDkzMDQzYzQ5NTBhM2M5OTZkNjc5NGZiXzYtNS0xLTEtMzE0MjI_c61e9a18-8653-40cc-bbdd-d2b42f02821a"
      unitRef="usd">188400000</vtrs:Netaccruedbenefitcosts>
    <vtrs:Netaccruedbenefitcosts
      contextRef="i3db1d00ed7f642dcaf9157d146275821_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo1MGM2OGQzOTA5MzA0M2M0OTUwYTNjOTk2ZDY3OTRmYi90YWJsZXJhbmdlOjUwYzY4ZDM5MDkzMDQzYzQ5NTBhM2M5OTZkNjc5NGZiXzYtNy0xLTEtMzE0MjI_767c6a5c-a980-4be3-8004-24048b61215a"
      unitRef="usd">188800000</vtrs:Netaccruedbenefitcosts>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90ZXh0cmVnaW9uOjUyMmUwNGFkZTJlODQ4YjBiNjhhZWM3NTEzMzZhZTI0XzQ3MDY_747b814b-e8fe-4079-9fa0-031d43885686"
      unitRef="usd">1860000000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90ZXh0cmVnaW9uOjUyMmUwNGFkZTJlODQ4YjBiNjhhZWM3NTEzMzZhZTI0XzQ3MTM_6095b1e1-cec9-4584-b286-dc273d2a6347"
      unitRef="usd">2040000000.00</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90ZXh0cmVnaW9uOjUyMmUwNGFkZTJlODQ4YjBiNjhhZWM3NTEzMzZhZTI0XzExODMx_27849137-4e3a-4ad2-bd96-dfe1a1474f0a">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The projected benefit obligation, accumulated benefit obligation and fair value of plan assets for pension plans with an accumulated benefit obligation in excess of the fair value of plan assets at December&#160;31, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.078%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.019%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Plans with accumulated benefit obligation in excess of plan assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,591.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,747.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,546.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,678.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;904.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;893.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation
      contextRef="ia9d424a72c6e4901a7dafb47ebf3c114_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphMzM5MDgwMWM2NTA0NWY0ODc2ZTRhZDZmMzNlMTc2OC90YWJsZXJhbmdlOmEzMzkwODAxYzY1MDQ1ZjQ4NzZlNGFkNmYzM2UxNzY4XzMtMS0xLTEtMzE0MjI_f9145670-2e93-4152-a062-f0a55070046d"
      unitRef="usd">1591800000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation
      contextRef="i4ec108614a384362b6aac78bfa61c46c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphMzM5MDgwMWM2NTA0NWY0ODc2ZTRhZDZmMzNlMTc2OC90YWJsZXJhbmdlOmEzMzkwODAxYzY1MDQ1ZjQ4NzZlNGFkNmYzM2UxNzY4XzMtMy0xLTEtMzE0MjI_a6d2a59c-6885-46b3-b331-33d50921700c"
      unitRef="usd">1747200000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation>
    <vtrs:DefinedBenefitPensionPlanswithProjectedBenefitObligationInExcessofPlanAssetsAggregateProjectedBenefitObligation
      contextRef="ia9d424a72c6e4901a7dafb47ebf3c114_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphMzM5MDgwMWM2NTA0NWY0ODc2ZTRhZDZmMzNlMTc2OC90YWJsZXJhbmdlOmEzMzkwODAxYzY1MDQ1ZjQ4NzZlNGFkNmYzM2UxNzY4XzQtMS0xLTEtMzE0MjI_2e3aeb14-d9d0-4b0a-8491-156cc950f35f"
      unitRef="usd">1546400000</vtrs:DefinedBenefitPensionPlanswithProjectedBenefitObligationInExcessofPlanAssetsAggregateProjectedBenefitObligation>
    <vtrs:DefinedBenefitPensionPlanswithProjectedBenefitObligationInExcessofPlanAssetsAggregateProjectedBenefitObligation
      contextRef="i4ec108614a384362b6aac78bfa61c46c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphMzM5MDgwMWM2NTA0NWY0ODc2ZTRhZDZmMzNlMTc2OC90YWJsZXJhbmdlOmEzMzkwODAxYzY1MDQ1ZjQ4NzZlNGFkNmYzM2UxNzY4XzQtMy0xLTEtMzE0MjI_c64f2f96-9f8f-4903-9241-f1591c4a5aa6"
      unitRef="usd">1678200000</vtrs:DefinedBenefitPensionPlanswithProjectedBenefitObligationInExcessofPlanAssetsAggregateProjectedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets
      contextRef="ia9d424a72c6e4901a7dafb47ebf3c114_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphMzM5MDgwMWM2NTA0NWY0ODc2ZTRhZDZmMzNlMTc2OC90YWJsZXJhbmdlOmEzMzkwODAxYzY1MDQ1ZjQ4NzZlNGFkNmYzM2UxNzY4XzUtMS0xLTEtMzE0MjI_ab0aed0c-ef2f-4fce-91de-d3ca01a8eb52"
      unitRef="usd">904100000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets
      contextRef="i4ec108614a384362b6aac78bfa61c46c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTphMzM5MDgwMWM2NTA0NWY0ODc2ZTRhZDZmMzNlMTc2OC90YWJsZXJhbmdlOmEzMzkwODAxYzY1MDQ1ZjQ4NzZlNGFkNmYzM2UxNzY4XzUtMy0xLTEtMzE0MjI_d75fc065-a5f7-4b6b-8a8e-b00769907a92"
      unitRef="usd">893900000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets>
    <us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90ZXh0cmVnaW9uOjUyMmUwNGFkZTJlODQ4YjBiNjhhZWM3NTEzMzZhZTI0XzExODMz_e1d5ab7b-eeb1-4336-9419-d2ae23889d69">The table below presents total plan assets by investment category as of December&#160;31, 2021&#160;and&#160;2020&#160;and the classification of each investment category within the fair value hierarchy with respect to the inputs used to measure fair value:&lt;div style="margin-bottom:3pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;497.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;551.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed income securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;616.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets held by insurance companies and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;338.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;946.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,366.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;468.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;613.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed income securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;592.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets held by insurance companies and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;788.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,354.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i28361d88d14b44089d36a57c1d48a43d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo3YzAwNTM4YjliMTk0M2MxOWY2NWY2OGQxYWZiNTE4ZC90YWJsZXJhbmdlOjdjMDA1MzhiOWIxOTQzYzE5ZjY1ZjY4ZDFhZmI1MThkXzItMS0xLTEtMzE0MjI_d0cffd26-e3a0-4039-8021-40eea67c9f7a"
      unitRef="usd">63100000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i0632cc54c5f54fbd8e82f58805b62de5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo3YzAwNTM4YjliMTk0M2MxOWY2NWY2OGQxYWZiNTE4ZC90YWJsZXJhbmdlOjdjMDA1MzhiOWIxOTQzYzE5ZjY1ZjY4ZDFhZmI1MThkXzItMy0xLTEtMzE0MjI_fd608d38-6fd6-420d-a909-a9d28c49371d"
      unitRef="usd">1900000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i194aa174ea9b4388bf2c16656d0150bf_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo3YzAwNTM4YjliMTk0M2MxOWY2NWY2OGQxYWZiNTE4ZC90YWJsZXJhbmdlOjdjMDA1MzhiOWIxOTQzYzE5ZjY1ZjY4ZDFhZmI1MThkXzItNS0xLTEtMzE0MjI_04165010-e669-4fee-b40d-84b894da26ba"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iddab1d45dd6b4fdfaf6d0678d30eb8fc_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo3YzAwNTM4YjliMTk0M2MxOWY2NWY2OGQxYWZiNTE4ZC90YWJsZXJhbmdlOjdjMDA1MzhiOWIxOTQzYzE5ZjY1ZjY4ZDFhZmI1MThkXzItNy0xLTEtMzE0MjI_32276440-1b47-4b6e-9af9-65f791134ca3"
      unitRef="usd">65000000.0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if31a3af97d384ae08362cb4f324929b3_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo3YzAwNTM4YjliMTk0M2MxOWY2NWY2OGQxYWZiNTE4ZC90YWJsZXJhbmdlOjdjMDA1MzhiOWIxOTQzYzE5ZjY1ZjY4ZDFhZmI1MThkXzMtMS0xLTEtMzE0MjI_951e3cb4-2c50-4665-8092-fb24ad700f2d"
      unitRef="usd">53900000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib0be4e5a0f374fbea197c3659a4244d6_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo3YzAwNTM4YjliMTk0M2MxOWY2NWY2OGQxYWZiNTE4ZC90YWJsZXJhbmdlOjdjMDA1MzhiOWIxOTQzYzE5ZjY1ZjY4ZDFhZmI1MThkXzMtMy0xLTEtMzE0MjI_002326d4-19be-4af2-8a14-76f6c52df832"
      unitRef="usd">497200000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i113dbdd80d9d47d3a985b193d972938c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo3YzAwNTM4YjliMTk0M2MxOWY2NWY2OGQxYWZiNTE4ZC90YWJsZXJhbmdlOjdjMDA1MzhiOWIxOTQzYzE5ZjY1ZjY4ZDFhZmI1MThkXzMtNS0xLTEtMzE0MjI_f0846ce0-eef2-416b-867d-191645388734"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ifaf8f068b6c14aafac4baf76995e06d1_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo3YzAwNTM4YjliMTk0M2MxOWY2NWY2OGQxYWZiNTE4ZC90YWJsZXJhbmdlOjdjMDA1MzhiOWIxOTQzYzE5ZjY1ZjY4ZDFhZmI1MThkXzMtNy0xLTEtMzE0MjI_9d14a2cb-cf20-4154-a9b9-23f17e9e05a6"
      unitRef="usd">551100000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ice0b7aa6647047d0a7d2a82e05dd4199_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo3YzAwNTM4YjliMTk0M2MxOWY2NWY2OGQxYWZiNTE4ZC90YWJsZXJhbmdlOjdjMDA1MzhiOWIxOTQzYzE5ZjY1ZjY4ZDFhZmI1MThkXzQtMS0xLTEtMzE0MjI_5b7af05c-c443-49e6-8822-93448c09f2e7"
      unitRef="usd">211400000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib712c6ec443747a98c9f948545566ae1_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo3YzAwNTM4YjliMTk0M2MxOWY2NWY2OGQxYWZiNTE4ZC90YWJsZXJhbmdlOjdjMDA1MzhiOWIxOTQzYzE5ZjY1ZjY4ZDFhZmI1MThkXzQtMy0xLTEtMzE0MjI_18733bd1-f6c5-4105-9964-94ea6789bc1d"
      unitRef="usd">405500000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ifa37ab3dc9b74f588ce944ce366fad65_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo3YzAwNTM4YjliMTk0M2MxOWY2NWY2OGQxYWZiNTE4ZC90YWJsZXJhbmdlOjdjMDA1MzhiOWIxOTQzYzE5ZjY1ZjY4ZDFhZmI1MThkXzQtNS0xLTEtMzE0MjI_08fca0fa-cc50-4272-bfeb-502b9307fbb7"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iea17365cc1064f1e8c0e3efbd1f7ccc0_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo3YzAwNTM4YjliMTk0M2MxOWY2NWY2OGQxYWZiNTE4ZC90YWJsZXJhbmdlOjdjMDA1MzhiOWIxOTQzYzE5ZjY1ZjY4ZDFhZmI1MThkXzQtNy0xLTEtMzE0MjI_55cef487-a89f-4a1f-9813-93b6033b3f47"
      unitRef="usd">616900000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i30c18481b70448689ae9ec9f6c97ed57_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo3YzAwNTM4YjliMTk0M2MxOWY2NWY2OGQxYWZiNTE4ZC90YWJsZXJhbmdlOjdjMDA1MzhiOWIxOTQzYzE5ZjY1ZjY4ZDFhZmI1MThkXzUtMS0xLTEtMzE0MjI_c6ad6af5-2d98-4248-9507-a359ae3614e4"
      unitRef="usd">10200000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia734afe5a0b94354a9267f684d7d593d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo3YzAwNTM4YjliMTk0M2MxOWY2NWY2OGQxYWZiNTE4ZC90YWJsZXJhbmdlOjdjMDA1MzhiOWIxOTQzYzE5ZjY1ZjY4ZDFhZmI1MThkXzUtMy0xLTEtMzE0MjI_f26f9c24-715c-44f0-ae67-f511207c6e4f"
      unitRef="usd">41600000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib1eef6ae4e1e4c43a6e2a37669db59f5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo3YzAwNTM4YjliMTk0M2MxOWY2NWY2OGQxYWZiNTE4ZC90YWJsZXJhbmdlOjdjMDA1MzhiOWIxOTQzYzE5ZjY1ZjY4ZDFhZmI1MThkXzUtNS0xLTEtMzE0MjI_022a5fd7-f1bb-4ef5-8893-6958d969df21"
      unitRef="usd">81600000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i89cce06582894866abc89dbadb2375fd_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo3YzAwNTM4YjliMTk0M2MxOWY2NWY2OGQxYWZiNTE4ZC90YWJsZXJhbmdlOjdjMDA1MzhiOWIxOTQzYzE5ZjY1ZjY4ZDFhZmI1MThkXzUtNy0xLTEtMzE0MjI_c52d780b-0b9c-4f39-ac17-105ba68afd9f"
      unitRef="usd">133400000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9dcaff92c9304ccca2976819941da18b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo3YzAwNTM4YjliMTk0M2MxOWY2NWY2OGQxYWZiNTE4ZC90YWJsZXJhbmdlOjdjMDA1MzhiOWIxOTQzYzE5ZjY1ZjY4ZDFhZmI1MThkXzYtMS0xLTEtMzE0MjI_f9c85159-be0d-4add-be17-a343394ea679"
      unitRef="usd">338600000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie24e749ab05a4833892ad719d96c300b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo3YzAwNTM4YjliMTk0M2MxOWY2NWY2OGQxYWZiNTE4ZC90YWJsZXJhbmdlOjdjMDA1MzhiOWIxOTQzYzE5ZjY1ZjY4ZDFhZmI1MThkXzYtMy0xLTEtMzE0MjI_598c33ca-c706-490d-ae42-745771ab3903"
      unitRef="usd">946200000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i42e5f527f22943e5b9d7a7a7685c1fba_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo3YzAwNTM4YjliMTk0M2MxOWY2NWY2OGQxYWZiNTE4ZC90YWJsZXJhbmdlOjdjMDA1MzhiOWIxOTQzYzE5ZjY1ZjY4ZDFhZmI1MThkXzYtNS0xLTEtMzE0MjI_c8099d5a-5497-4c45-804c-7c9e5184bf17"
      unitRef="usd">81600000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTo3YzAwNTM4YjliMTk0M2MxOWY2NWY2OGQxYWZiNTE4ZC90YWJsZXJhbmdlOjdjMDA1MzhiOWIxOTQzYzE5ZjY1ZjY4ZDFhZmI1MThkXzYtNy0xLTEtMzE0MjI_85f00556-4b80-4f79-bd0d-379c53e25191"
      unitRef="usd">1366400000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if1dd9e8a009f47628454dddf41a73509_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmMGVjMGRjNzIxOGQ0ZDZiODk1ZjFiZTJmMjk5MmM0NS90YWJsZXJhbmdlOmYwZWMwZGM3MjE4ZDRkNmI4OTVmMWJlMmYyOTkyYzQ1XzItMS0xLTEtMzE0MjI_45c5ef62-0d58-4c94-a7bb-df7674504688"
      unitRef="usd">51200000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia3676ae37352452a8c662f20b8fe3454_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmMGVjMGRjNzIxOGQ0ZDZiODk1ZjFiZTJmMjk5MmM0NS90YWJsZXJhbmdlOmYwZWMwZGM3MjE4ZDRkNmI4OTVmMWJlMmYyOTkyYzQ1XzItMy0xLTEtMzE0MjI_ffdc9714-d9c8-46fa-b2cb-022bc608c9e7"
      unitRef="usd">600000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4f47061824334d3b9c233d127ac9201d_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmMGVjMGRjNzIxOGQ0ZDZiODk1ZjFiZTJmMjk5MmM0NS90YWJsZXJhbmdlOmYwZWMwZGM3MjE4ZDRkNmI4OTVmMWJlMmYyOTkyYzQ1XzItNS0xLTEtMzE0MjI_e9a1b798-9812-44bc-a77d-a644865faa35"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i67df6863d3524e03bbe619803176d157_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmMGVjMGRjNzIxOGQ0ZDZiODk1ZjFiZTJmMjk5MmM0NS90YWJsZXJhbmdlOmYwZWMwZGM3MjE4ZDRkNmI4OTVmMWJlMmYyOTkyYzQ1XzItNy0xLTEtMzE0MjI_e63c5b75-a01d-492b-bcb2-364598b65181"
      unitRef="usd">51800000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i6b6e49e382c6413e8c432cb0c7d2a826_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmMGVjMGRjNzIxOGQ0ZDZiODk1ZjFiZTJmMjk5MmM0NS90YWJsZXJhbmdlOmYwZWMwZGM3MjE4ZDRkNmI4OTVmMWJlMmYyOTkyYzQ1XzMtMS0xLTEtMzE0MjI_0e452870-5b8c-43d0-8adc-d652e0c91a8d"
      unitRef="usd">145300000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie786a2024a274c5ebfea306dfddbac8f_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmMGVjMGRjNzIxOGQ0ZDZiODk1ZjFiZTJmMjk5MmM0NS90YWJsZXJhbmdlOmYwZWMwZGM3MjE4ZDRkNmI4OTVmMWJlMmYyOTkyYzQ1XzMtMy0xLTEtMzE0MjI_183a9352-b55d-493f-8f4d-e61921b1c4f2"
      unitRef="usd">468100000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if795583e146340668c945e4b814573bf_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmMGVjMGRjNzIxOGQ0ZDZiODk1ZjFiZTJmMjk5MmM0NS90YWJsZXJhbmdlOmYwZWMwZGM3MjE4ZDRkNmI4OTVmMWJlMmYyOTkyYzQ1XzMtNS0xLTEtMzE0MjI_8088ecfc-3ffd-40e7-8865-54ae38c5c151"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i8945bf4fb0664758943f130a6664b9d9_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmMGVjMGRjNzIxOGQ0ZDZiODk1ZjFiZTJmMjk5MmM0NS90YWJsZXJhbmdlOmYwZWMwZGM3MjE4ZDRkNmI4OTVmMWJlMmYyOTkyYzQ1XzMtNy0xLTEtMzE0MjI_eed96305-e7ce-46d1-b429-fc81552ec747"
      unitRef="usd">613400000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i8396afe5d3e94d92869781e35bbfc3bf_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmMGVjMGRjNzIxOGQ0ZDZiODk1ZjFiZTJmMjk5MmM0NS90YWJsZXJhbmdlOmYwZWMwZGM3MjE4ZDRkNmI4OTVmMWJlMmYyOTkyYzQ1XzQtMS0xLTEtMzE0MjI_f32d4b35-aea5-431d-9775-f74665ac1ca0"
      unitRef="usd">292600000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i21a085c7f0f844d58b2d8d28f4fdebec_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmMGVjMGRjNzIxOGQ0ZDZiODk1ZjFiZTJmMjk5MmM0NS90YWJsZXJhbmdlOmYwZWMwZGM3MjE4ZDRkNmI4OTVmMWJlMmYyOTkyYzQ1XzQtMy0xLTEtMzE0MjI_7c2d704d-4581-44fb-9c8a-09bea74877af"
      unitRef="usd">299400000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i3b6ff9d1e6224b069f644c2dbd578b93_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmMGVjMGRjNzIxOGQ0ZDZiODk1ZjFiZTJmMjk5MmM0NS90YWJsZXJhbmdlOmYwZWMwZGM3MjE4ZDRkNmI4OTVmMWJlMmYyOTkyYzQ1XzQtNS0xLTEtMzE0MjI_1818ae13-3785-4732-a576-d7d6b7d84bd9"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia960324dc2a146a685f0dce110779fec_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmMGVjMGRjNzIxOGQ0ZDZiODk1ZjFiZTJmMjk5MmM0NS90YWJsZXJhbmdlOmYwZWMwZGM3MjE4ZDRkNmI4OTVmMWJlMmYyOTkyYzQ1XzQtNy0xLTEtMzE0MjI_c91a0bfa-2d3b-4197-822b-1d5a771ada0e"
      unitRef="usd">592000000.0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic88bd3b21dd5437a90e5efdc21490b13_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmMGVjMGRjNzIxOGQ0ZDZiODk1ZjFiZTJmMjk5MmM0NS90YWJsZXJhbmdlOmYwZWMwZGM3MjE4ZDRkNmI4OTVmMWJlMmYyOTkyYzQ1XzUtMS0xLTEtMzE0MjI_eaf3dcae-2e4a-45ca-b887-d05836214306"
      unitRef="usd">4000000.0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i6a800cd4602a4c15a8b533080cc7dd5f_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmMGVjMGRjNzIxOGQ0ZDZiODk1ZjFiZTJmMjk5MmM0NS90YWJsZXJhbmdlOmYwZWMwZGM3MjE4ZDRkNmI4OTVmMWJlMmYyOTkyYzQ1XzUtMy0xLTEtMzE0MjI_69228700-e299-4f65-be38-b3877af89f0b"
      unitRef="usd">20000000.0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i644407156089438c9633f7019f15ae8f_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmMGVjMGRjNzIxOGQ0ZDZiODk1ZjFiZTJmMjk5MmM0NS90YWJsZXJhbmdlOmYwZWMwZGM3MjE4ZDRkNmI4OTVmMWJlMmYyOTkyYzQ1XzUtNS0xLTEtMzE0MjI_62edd5ad-5568-452c-a5a2-4589bf73bb7f"
      unitRef="usd">73400000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i525cf7cf63b54048a311ff3fde50c3d0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmMGVjMGRjNzIxOGQ0ZDZiODk1ZjFiZTJmMjk5MmM0NS90YWJsZXJhbmdlOmYwZWMwZGM3MjE4ZDRkNmI4OTVmMWJlMmYyOTkyYzQ1XzUtNy0xLTEtMzE0MjI_330fabda-019a-4eb0-b908-145176372e43"
      unitRef="usd">97400000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ifb3ec9725b8947ae894c70cb9fb96fc0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmMGVjMGRjNzIxOGQ0ZDZiODk1ZjFiZTJmMjk5MmM0NS90YWJsZXJhbmdlOmYwZWMwZGM3MjE4ZDRkNmI4OTVmMWJlMmYyOTkyYzQ1XzYtMS0xLTEtMzE0MjI_3dc8b9b1-9429-4859-9fce-f530383d7ffb"
      unitRef="usd">493100000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i7064536ad58d434ca55e232aa46556fb_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmMGVjMGRjNzIxOGQ0ZDZiODk1ZjFiZTJmMjk5MmM0NS90YWJsZXJhbmdlOmYwZWMwZGM3MjE4ZDRkNmI4OTVmMWJlMmYyOTkyYzQ1XzYtMy0xLTEtMzE0MjI_a659c0c7-5196-43ef-bb6e-aa8a917b1e0a"
      unitRef="usd">788100000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if70694466104422da2d7abde7dda9ee2_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmMGVjMGRjNzIxOGQ0ZDZiODk1ZjFiZTJmMjk5MmM0NS90YWJsZXJhbmdlOmYwZWMwZGM3MjE4ZDRkNmI4OTVmMWJlMmYyOTkyYzQ1XzYtNS0xLTEtMzE0MjI_d632b99a-ddf6-49c9-9ff0-223aa3a021e7"
      unitRef="usd">73400000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpmMGVjMGRjNzIxOGQ0ZDZiODk1ZjFiZTJmMjk5MmM0NS90YWJsZXJhbmdlOmYwZWMwZGM3MjE4ZDRkNmI4OTVmMWJlMmYyOTkyYzQ1XzYtNy0xLTEtMzE0MjI_e3cf802d-9755-4c04-b79e-77127acf5814"
      unitRef="usd">1354600000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:ScheduleOfAssumptionsUsedTableTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90ZXh0cmVnaW9uOjUyMmUwNGFkZTJlODQ4YjBiNjhhZWM3NTEzMzZhZTI0XzExNzk0_4f0808f7-7608-45a2-8638-bc6693d01637">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following weighted average assumptions were used to determine the benefit obligations for the Company&#x2019;s defined benefit pension and other postretirement plans as of December&#160;31, 2021&#160;and&#160;2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.609%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pension Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Postretirement Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following weighted average assumptions were used to determine the net periodic benefit cost for the Company&#x2019;s defined benefit pension and other postretirement benefit plans for the three years in the period ended&#160;December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.170%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.035%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pension Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Postretirement Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAssumptionsUsedTableTextBlock>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="ia9d424a72c6e4901a7dafb47ebf3c114_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTowYjY2NzQ0OTQ2NTU0M2YzYTcxNjBlOWRhY2NkMGJlZC90YWJsZXJhbmdlOjBiNjY3NDQ5NDY1NTQzZjNhNzE2MGU5ZGFjY2QwYmVkXzItMS0xLTEtMzE0MjI_6233bd58-ccb9-4658-8e06-b50d56251719"
      unitRef="number">0.023</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i4ec108614a384362b6aac78bfa61c46c_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTowYjY2NzQ0OTQ2NTU0M2YzYTcxNjBlOWRhY2NkMGJlZC90YWJsZXJhbmdlOjBiNjY3NDQ5NDY1NTQzZjNhNzE2MGU5ZGFjY2QwYmVkXzItMy0xLTEtMzE0MjI_754b52b2-4387-4369-bb7a-0bbdbe0c0b36"
      unitRef="number">0.019</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="iec1504795a9c4c6693434e98197e0e95_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTowYjY2NzQ0OTQ2NTU0M2YzYTcxNjBlOWRhY2NkMGJlZC90YWJsZXJhbmdlOjBiNjY3NDQ5NDY1NTQzZjNhNzE2MGU5ZGFjY2QwYmVkXzItNS0xLTEtMzE0MjI_04619c5b-8918-49aa-81c9-f21e9ffb2f7c"
      unitRef="number">0.025</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i3db1d00ed7f642dcaf9157d146275821_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTowYjY2NzQ0OTQ2NTU0M2YzYTcxNjBlOWRhY2NkMGJlZC90YWJsZXJhbmdlOjBiNjY3NDQ5NDY1NTQzZjNhNzE2MGU5ZGFjY2QwYmVkXzItNy0xLTEtMzE0MjI_011045bd-40ac-4080-a365-fbb5e35eb3ee"
      unitRef="number">0.019</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <vtrs:DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationExpectedLongtermReturnonAssets
      contextRef="ia9d424a72c6e4901a7dafb47ebf3c114_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTowYjY2NzQ0OTQ2NTU0M2YzYTcxNjBlOWRhY2NkMGJlZC90YWJsZXJhbmdlOjBiNjY3NDQ5NDY1NTQzZjNhNzE2MGU5ZGFjY2QwYmVkXzMtMS0xLTEtMzE0MjI_e4b60dfb-1430-4c0c-98fe-9236a80487c8"
      unitRef="number">0.051</vtrs:DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationExpectedLongtermReturnonAssets>
    <vtrs:DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationExpectedLongtermReturnonAssets
      contextRef="i4ec108614a384362b6aac78bfa61c46c_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTowYjY2NzQ0OTQ2NTU0M2YzYTcxNjBlOWRhY2NkMGJlZC90YWJsZXJhbmdlOjBiNjY3NDQ5NDY1NTQzZjNhNzE2MGU5ZGFjY2QwYmVkXzMtMy0xLTEtMzE0MjI_82b954cf-42ec-4300-a13e-fe332ac061e3"
      unitRef="number">0.043</vtrs:DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationExpectedLongtermReturnonAssets>
    <vtrs:DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationExpectedLongtermReturnonAssets
      contextRef="iec1504795a9c4c6693434e98197e0e95_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTowYjY2NzQ0OTQ2NTU0M2YzYTcxNjBlOWRhY2NkMGJlZC90YWJsZXJhbmdlOjBiNjY3NDQ5NDY1NTQzZjNhNzE2MGU5ZGFjY2QwYmVkXzMtNS0xLTEtMzE0MjI_c10f6ec3-4f99-437d-90f4-a7b424c77e2a"
      unitRef="number">0</vtrs:DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationExpectedLongtermReturnonAssets>
    <vtrs:DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationExpectedLongtermReturnonAssets
      contextRef="i3db1d00ed7f642dcaf9157d146275821_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTowYjY2NzQ0OTQ2NTU0M2YzYTcxNjBlOWRhY2NkMGJlZC90YWJsZXJhbmdlOjBiNjY3NDQ5NDY1NTQzZjNhNzE2MGU5ZGFjY2QwYmVkXzMtNy0xLTEtMzE0MjI_73c870eb-76a0-4311-867a-4a3d67d5ec38"
      unitRef="number">0</vtrs:DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationExpectedLongtermReturnonAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="ia9d424a72c6e4901a7dafb47ebf3c114_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTowYjY2NzQ0OTQ2NTU0M2YzYTcxNjBlOWRhY2NkMGJlZC90YWJsZXJhbmdlOjBiNjY3NDQ5NDY1NTQzZjNhNzE2MGU5ZGFjY2QwYmVkXzQtMS0xLTEtMzE0MjI_19f1f803-cc78-49c7-a50f-1ce40ad9b6fd"
      unitRef="number">0.031</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="i4ec108614a384362b6aac78bfa61c46c_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTowYjY2NzQ0OTQ2NTU0M2YzYTcxNjBlOWRhY2NkMGJlZC90YWJsZXJhbmdlOjBiNjY3NDQ5NDY1NTQzZjNhNzE2MGU5ZGFjY2QwYmVkXzQtMy0xLTEtMzE0MjI_64096d13-757a-43bd-90b9-81ebc41f3872"
      unitRef="number">0.029</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="iec1504795a9c4c6693434e98197e0e95_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTowYjY2NzQ0OTQ2NTU0M2YzYTcxNjBlOWRhY2NkMGJlZC90YWJsZXJhbmdlOjBiNjY3NDQ5NDY1NTQzZjNhNzE2MGU5ZGFjY2QwYmVkXzQtNS0xLTEtMzE0MjI_a95a7a85-7d1e-4c12-856d-123ba925a53b"
      unitRef="number">0</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="i3db1d00ed7f642dcaf9157d146275821_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTowYjY2NzQ0OTQ2NTU0M2YzYTcxNjBlOWRhY2NkMGJlZC90YWJsZXJhbmdlOjBiNjY3NDQ5NDY1NTQzZjNhNzE2MGU5ZGFjY2QwYmVkXzQtNy0xLTEtMzE0MjI_94f377fb-2312-4d3f-8a94-db7f897d4405"
      unitRef="number">0</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpkMzU1OTQ4MWZjMjE0N2ViOTZhMzMyY2RlZWM2Yjc4My90YWJsZXJhbmdlOmQzNTU5NDgxZmMyMTQ3ZWI5NmEzMzJjZGVlYzZiNzgzXzItMS0xLTEtMzE0MjI_c48727e8-6764-47c4-ab9a-c638a4d53278"
      unitRef="number">0.019</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i2229a1acd15a481eb03d17e8a82e053c_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpkMzU1OTQ4MWZjMjE0N2ViOTZhMzMyY2RlZWM2Yjc4My90YWJsZXJhbmdlOmQzNTU5NDgxZmMyMTQ3ZWI5NmEzMzJjZGVlYzZiNzgzXzItMy0xLTEtMzE0MjI_605a31c3-abd4-4bd8-9ea8-79420eb506c4"
      unitRef="number">0.016</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i0793dad309c04eeaab5ad95a6c7e0ace_D20170101-20171231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpkMzU1OTQ4MWZjMjE0N2ViOTZhMzMyY2RlZWM2Yjc4My90YWJsZXJhbmdlOmQzNTU5NDgxZmMyMTQ3ZWI5NmEzMzJjZGVlYzZiNzgzXzItNS0xLTEtMzE0MjI_f637b97c-7fa8-4347-b34a-b5fe71be62de"
      unitRef="number">0.023</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i52ec07ca99e44636af66cf7c46bf1f5a_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpkMzU1OTQ4MWZjMjE0N2ViOTZhMzMyY2RlZWM2Yjc4My90YWJsZXJhbmdlOmQzNTU5NDgxZmMyMTQ3ZWI5NmEzMzJjZGVlYzZiNzgzXzItNy0xLTEtMzE0MjI_d33ad5b5-ae82-47f8-8442-f652179eb7ba"
      unitRef="number">0.019</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i93fbd6aab228484480456d99cf697974_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpkMzU1OTQ4MWZjMjE0N2ViOTZhMzMyY2RlZWM2Yjc4My90YWJsZXJhbmdlOmQzNTU5NDgxZmMyMTQ3ZWI5NmEzMzJjZGVlYzZiNzgzXzItOS0xLTEtMzE0MjI_79e9eebb-78f9-4366-b0be-deb7054e83e0"
      unitRef="number">0.033</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i8bb2b64c86464df1acb153f81b9bd1a2_D20170101-20171231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpkMzU1OTQ4MWZjMjE0N2ViOTZhMzMyY2RlZWM2Yjc4My90YWJsZXJhbmdlOmQzNTU5NDgxZmMyMTQ3ZWI5NmEzMzJjZGVlYzZiNzgzXzItMTEtMS0xLTMxNDIy_f24e3454-57c6-4500-b2cd-cb91f21d66b0"
      unitRef="number">0.043</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpkMzU1OTQ4MWZjMjE0N2ViOTZhMzMyY2RlZWM2Yjc4My90YWJsZXJhbmdlOmQzNTU5NDgxZmMyMTQ3ZWI5NmEzMzJjZGVlYzZiNzgzXzMtMS0xLTEtMzE0MjI_40d70af4-a8b9-483c-8637-b6f08e052d8b"
      unitRef="number">0.051</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i2229a1acd15a481eb03d17e8a82e053c_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpkMzU1OTQ4MWZjMjE0N2ViOTZhMzMyY2RlZWM2Yjc4My90YWJsZXJhbmdlOmQzNTU5NDgxZmMyMTQ3ZWI5NmEzMzJjZGVlYzZiNzgzXzMtMy0xLTEtMzE0MjI_f3ec7aa1-6c89-4ab4-b727-d1b4a033461d"
      unitRef="number">0.043</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i0793dad309c04eeaab5ad95a6c7e0ace_D20170101-20171231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpkMzU1OTQ4MWZjMjE0N2ViOTZhMzMyY2RlZWM2Yjc4My90YWJsZXJhbmdlOmQzNTU5NDgxZmMyMTQ3ZWI5NmEzMzJjZGVlYzZiNzgzXzMtNS0xLTEtMzE0MjI_74658b23-98d2-488f-905b-1b32e48da1bb"
      unitRef="number">0.043</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i52ec07ca99e44636af66cf7c46bf1f5a_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpkMzU1OTQ4MWZjMjE0N2ViOTZhMzMyY2RlZWM2Yjc4My90YWJsZXJhbmdlOmQzNTU5NDgxZmMyMTQ3ZWI5NmEzMzJjZGVlYzZiNzgzXzMtNy0xLTEtMzE0MjI_255454a2-f614-4ddf-98f2-f75f694fb1f2"
      unitRef="number">0</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i93fbd6aab228484480456d99cf697974_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpkMzU1OTQ4MWZjMjE0N2ViOTZhMzMyY2RlZWM2Yjc4My90YWJsZXJhbmdlOmQzNTU5NDgxZmMyMTQ3ZWI5NmEzMzJjZGVlYzZiNzgzXzMtOS0xLTEtMzE0MjI_2b11cd41-8c65-49f0-8d68-3101d960ef56"
      unitRef="number">0</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i8bb2b64c86464df1acb153f81b9bd1a2_D20170101-20171231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpkMzU1OTQ4MWZjMjE0N2ViOTZhMzMyY2RlZWM2Yjc4My90YWJsZXJhbmdlOmQzNTU5NDgxZmMyMTQ3ZWI5NmEzMzJjZGVlYzZiNzgzXzMtMTEtMS0xLTMxNDIy_218f76df-1961-4541-9487-197f543944d9"
      unitRef="number">0</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpkMzU1OTQ4MWZjMjE0N2ViOTZhMzMyY2RlZWM2Yjc4My90YWJsZXJhbmdlOmQzNTU5NDgxZmMyMTQ3ZWI5NmEzMzJjZGVlYzZiNzgzXzQtMS0xLTEtMzE0MjI_7876d4c5-46fd-4a61-874a-97915a9d3c05"
      unitRef="number">0.029</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="i2229a1acd15a481eb03d17e8a82e053c_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpkMzU1OTQ4MWZjMjE0N2ViOTZhMzMyY2RlZWM2Yjc4My90YWJsZXJhbmdlOmQzNTU5NDgxZmMyMTQ3ZWI5NmEzMzJjZGVlYzZiNzgzXzQtMy0xLTEtMzE0MjI_00ceb66d-b2f8-4032-b216-179a1e891c38"
      unitRef="number">0.027</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="i0793dad309c04eeaab5ad95a6c7e0ace_D20170101-20171231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpkMzU1OTQ4MWZjMjE0N2ViOTZhMzMyY2RlZWM2Yjc4My90YWJsZXJhbmdlOmQzNTU5NDgxZmMyMTQ3ZWI5NmEzMzJjZGVlYzZiNzgzXzQtNS0xLTEtMzE0MjI_bd22e6a1-07d4-4a4d-a766-7eb4c0609627"
      unitRef="number">0.029</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="i52ec07ca99e44636af66cf7c46bf1f5a_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpkMzU1OTQ4MWZjMjE0N2ViOTZhMzMyY2RlZWM2Yjc4My90YWJsZXJhbmdlOmQzNTU5NDgxZmMyMTQ3ZWI5NmEzMzJjZGVlYzZiNzgzXzQtNy0xLTEtMzE0MjI_14cf459e-d004-47a0-819a-fa108ec60b20"
      unitRef="number">0</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="i93fbd6aab228484480456d99cf697974_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpkMzU1OTQ4MWZjMjE0N2ViOTZhMzMyY2RlZWM2Yjc4My90YWJsZXJhbmdlOmQzNTU5NDgxZmMyMTQ3ZWI5NmEzMzJjZGVlYzZiNzgzXzQtOS0xLTEtMzE0MjI_fbb796ff-f968-480d-a75e-4c37ddfd002d"
      unitRef="number">0</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="i8bb2b64c86464df1acb153f81b9bd1a2_D20170101-20171231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZTpkMzU1OTQ4MWZjMjE0N2ViOTZhMzMyY2RlZWM2Yjc4My90YWJsZXJhbmdlOmQzNTU5NDgxZmMyMTQ3ZWI5NmEzMzJjZGVlYzZiNzgzXzQtMTEtMS0xLTMxNDIy_5470973f-2d88-40c9-b056-6b68f9439bcc"
      unitRef="number">0</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90ZXh0cmVnaW9uOjUyMmUwNGFkZTJlODQ4YjBiNjhhZWM3NTEzMzZhZTI0Xzc0MzI_6691b911-e6e2-4e51-8c51-45e34e388cc1"
      unitRef="number">0.057</us-gaap:DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear>
    <us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate1
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90ZXh0cmVnaW9uOjUyMmUwNGFkZTJlODQ4YjBiNjhhZWM3NTEzMzZhZTI0Xzc0NjA_0eb3d5cc-9124-477e-9fb2-04cc24b6e37b"
      unitRef="number">0.045</us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate1>
    <us-gaap:DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear
      contextRef="i0beee820b7a44a2586a141b35bd7d70b_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90ZXh0cmVnaW9uOjUyMmUwNGFkZTJlODQ4YjBiNjhhZWM3NTEzMzZhZTI0Xzc1NTY_e8e99fc4-7480-4288-9fd7-32f5dff22569"
      unitRef="number">0.063</us-gaap:DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear>
    <us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate1
      contextRef="i0beee820b7a44a2586a141b35bd7d70b_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90ZXh0cmVnaW9uOjUyMmUwNGFkZTJlODQ4YjBiNjhhZWM3NTEzMzZhZTI0Xzc1ODQ_9ef37fad-0ee0-4f34-b8d0-0c755b823f98"
      unitRef="number">0.040</us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate1>
    <us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90ZXh0cmVnaW9uOjUyMmUwNGFkZTJlODQ4YjBiNjhhZWM3NTEzMzZhZTI0XzExODE3_32355612-7187-4b55-98ae-3cae16ed7baa">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Estimated benefit payments over the next ten years for the Company&#x2019;s pension plans and retiree health plan are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.879%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.043%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.045%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pension Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Postretirement Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;528.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,035.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
      contextRef="ia9d424a72c6e4901a7dafb47ebf3c114_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZToxYTZkMTJmMDUyZDM0M2Y0YjA5NDYzZTYzMTY4ZGU1MS90YWJsZXJhbmdlOjFhNmQxMmYwNTJkMzQzZjRiMDk0NjNlNjMxNjhkZTUxXzEtMS0xLTEtMzE0MjI_740be2f1-cd25-431e-ac7e-37e83486f2a9"
      unitRef="usd">101800000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
      contextRef="iec1504795a9c4c6693434e98197e0e95_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZToxYTZkMTJmMDUyZDM0M2Y0YjA5NDYzZTYzMTY4ZGU1MS90YWJsZXJhbmdlOjFhNmQxMmYwNTJkMzQzZjRiMDk0NjNlNjMxNjhkZTUxXzEtMy0xLTEtMzE0MjI_55d1b543-475d-452d-8976-61577fd43fb4"
      unitRef="usd">16100000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
      contextRef="ia9d424a72c6e4901a7dafb47ebf3c114_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZToxYTZkMTJmMDUyZDM0M2Y0YjA5NDYzZTYzMTY4ZGU1MS90YWJsZXJhbmdlOjFhNmQxMmYwNTJkMzQzZjRiMDk0NjNlNjMxNjhkZTUxXzItMS0xLTEtMzE0MjI_4404cef5-0d0e-47fd-bfd2-5b46b084d5c5"
      unitRef="usd">97100000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
      contextRef="iec1504795a9c4c6693434e98197e0e95_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZToxYTZkMTJmMDUyZDM0M2Y0YjA5NDYzZTYzMTY4ZGU1MS90YWJsZXJhbmdlOjFhNmQxMmYwNTJkMzQzZjRiMDk0NjNlNjMxNjhkZTUxXzItMy0xLTEtMzE0MjI_5f699a64-5e1b-4de7-acd6-5a041fbe37e5"
      unitRef="usd">16500000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
      contextRef="ia9d424a72c6e4901a7dafb47ebf3c114_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZToxYTZkMTJmMDUyZDM0M2Y0YjA5NDYzZTYzMTY4ZGU1MS90YWJsZXJhbmdlOjFhNmQxMmYwNTJkMzQzZjRiMDk0NjNlNjMxNjhkZTUxXzMtMS0xLTEtMzE0MjI_93afe32e-ba6b-40c1-99d9-25825ff146e0"
      unitRef="usd">103000000.0</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
      contextRef="iec1504795a9c4c6693434e98197e0e95_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZToxYTZkMTJmMDUyZDM0M2Y0YjA5NDYzZTYzMTY4ZGU1MS90YWJsZXJhbmdlOjFhNmQxMmYwNTJkMzQzZjRiMDk0NjNlNjMxNjhkZTUxXzMtMy0xLTEtMzE0MjI_7cd1f61b-6cd8-4a77-a369-0c25cdaf07de"
      unitRef="usd">16900000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
      contextRef="ia9d424a72c6e4901a7dafb47ebf3c114_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZToxYTZkMTJmMDUyZDM0M2Y0YjA5NDYzZTYzMTY4ZGU1MS90YWJsZXJhbmdlOjFhNmQxMmYwNTJkMzQzZjRiMDk0NjNlNjMxNjhkZTUxXzQtMS0xLTEtMzE0MjI_120bf80e-1b8b-4f20-af15-1b2ec3d7f55c"
      unitRef="usd">100700000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
      contextRef="iec1504795a9c4c6693434e98197e0e95_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZToxYTZkMTJmMDUyZDM0M2Y0YjA5NDYzZTYzMTY4ZGU1MS90YWJsZXJhbmdlOjFhNmQxMmYwNTJkMzQzZjRiMDk0NjNlNjMxNjhkZTUxXzQtMy0xLTEtMzE0MjI_03760944-5d94-434b-81e5-b849d540686d"
      unitRef="usd">16800000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
      contextRef="ia9d424a72c6e4901a7dafb47ebf3c114_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZToxYTZkMTJmMDUyZDM0M2Y0YjA5NDYzZTYzMTY4ZGU1MS90YWJsZXJhbmdlOjFhNmQxMmYwNTJkMzQzZjRiMDk0NjNlNjMxNjhkZTUxXzUtMS0xLTEtMzE0MjI_77002f08-de03-4a6d-bac4-5ed8088810dc"
      unitRef="usd">104300000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
      contextRef="iec1504795a9c4c6693434e98197e0e95_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZToxYTZkMTJmMDUyZDM0M2Y0YjA5NDYzZTYzMTY4ZGU1MS90YWJsZXJhbmdlOjFhNmQxMmYwNTJkMzQzZjRiMDk0NjNlNjMxNjhkZTUxXzUtMy0xLTEtMzE0MjI_634ecbd5-54d5-4345-b29b-4b5a5335a009"
      unitRef="usd">16600000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
      contextRef="ia9d424a72c6e4901a7dafb47ebf3c114_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZToxYTZkMTJmMDUyZDM0M2Y0YjA5NDYzZTYzMTY4ZGU1MS90YWJsZXJhbmdlOjFhNmQxMmYwNTJkMzQzZjRiMDk0NjNlNjMxNjhkZTUxXzYtMS0xLTEtMzE0MjI_2972109a-567b-438b-a30e-9a7216a9e73b"
      unitRef="usd">528500000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
      contextRef="iec1504795a9c4c6693434e98197e0e95_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZToxYTZkMTJmMDUyZDM0M2Y0YjA5NDYzZTYzMTY4ZGU1MS90YWJsZXJhbmdlOjFhNmQxMmYwNTJkMzQzZjRiMDk0NjNlNjMxNjhkZTUxXzYtMy0xLTEtMzE0MjI_b7976f8a-a7e2-4b88-b3a6-473bbabcfeb2"
      unitRef="usd">73000000.0</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <vtrs:ExpectedFutureBenefitPayments
      contextRef="ia9d424a72c6e4901a7dafb47ebf3c114_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZToxYTZkMTJmMDUyZDM0M2Y0YjA5NDYzZTYzMTY4ZGU1MS90YWJsZXJhbmdlOjFhNmQxMmYwNTJkMzQzZjRiMDk0NjNlNjMxNjhkZTUxXzctMS0xLTEtMzE0MjI_23331a5e-dbbd-414a-b4a0-06260ccb29ee"
      unitRef="usd">1035400000</vtrs:ExpectedFutureBenefitPayments>
    <vtrs:ExpectedFutureBenefitPayments
      contextRef="iec1504795a9c4c6693434e98197e0e95_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90YWJsZToxYTZkMTJmMDUyZDM0M2Y0YjA5NDYzZTYzMTY4ZGU1MS90YWJsZXJhbmdlOjFhNmQxMmYwNTJkMzQzZjRiMDk0NjNlNjMxNjhkZTUxXzctMy0xLTEtMzE0MjI_e019bb06-7269-474c-be5b-b3d7b164f283"
      unitRef="usd">155900000</vtrs:ExpectedFutureBenefitPayments>
    <us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
      contextRef="i98bb7963bee64ebb90779de770b2639f_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90ZXh0cmVnaW9uOjUyMmUwNGFkZTJlODQ4YjBiNjhhZWM3NTEzMzZhZTI0XzEwMjI5_df342b80-deb8-4d88-b9e2-0f686d047160"
      unitRef="number">0.50</us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent>
    <us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
      contextRef="i1e7e31d22fda4457bb400e7c5b5a9279_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90ZXh0cmVnaW9uOjUyMmUwNGFkZTJlODQ4YjBiNjhhZWM3NTEzMzZhZTI0XzEwMjU3_40aaa5f1-5752-4ae3-8255-5ea172d67dfd"
      unitRef="number">1</us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90ZXh0cmVnaW9uOjUyMmUwNGFkZTJlODQ4YjBiNjhhZWM3NTEzMzZhZTI0XzEwNzY5_4df9f3be-635f-4122-b07d-4866ef695571"
      unitRef="usd">107400000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90ZXh0cmVnaW9uOjUyMmUwNGFkZTJlODQ4YjBiNjhhZWM3NTEzMzZhZTI0XzEwNzcz_55e91679-c533-45c4-a3e4-538fa3d4b0cf"
      unitRef="usd">115500000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90ZXh0cmVnaW9uOjUyMmUwNGFkZTJlODQ4YjBiNjhhZWM3NTEzMzZhZTI0XzEwNzgw_20f999a9-7029-47af-a0ad-df6be11b9f2a"
      unitRef="usd">95600000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:MultiemployerPlansWithdrawalObligation
      contextRef="i2a20c8f3803144d58ca34d0fcee823ce_I20161231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90ZXh0cmVnaW9uOjUyMmUwNGFkZTJlODQ4YjBiNjhhZWM3NTEzMzZhZTI0XzExNTAy_28ffe80c-46d7-4d07-b9b4-124e808cc04c"
      unitRef="usd">27300000</us-gaap:MultiemployerPlansWithdrawalObligation>
    <us-gaap:MultiemployerPlansWithdrawalObligation
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90ZXh0cmVnaW9uOjUyMmUwNGFkZTJlODQ4YjBiNjhhZWM3NTEzMzZhZTI0XzExNjgy_c7befdab-26c6-4d39-8f8b-ccfbea0d7cf3"
      unitRef="usd">5500000</us-gaap:MultiemployerPlansWithdrawalObligation>
    <us-gaap:MultiemployerPlansWithdrawalObligation
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjYvZnJhZzo1MjJlMDRhZGUyZTg0OGIwYjY4YWVjNzUxMzM2YWUyNC90ZXh0cmVnaW9uOjUyMmUwNGFkZTJlODQ4YjBiNjhhZWM3NTEzMzZhZTI0XzExNjg5_e1d901bb-69c1-4d13-915f-8aa115a4b394"
      unitRef="usd">8900000</us-gaap:MultiemployerPlansWithdrawalObligation>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90ZXh0cmVnaW9uOjFhNWE5OTI3MTU4NDQ5ODQ4YTUxM2EyZWQ4ZWIxODU2XzQwOTc_58bb9d91-ac72-46a0-a783-12d156c2dddc">ment Information&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Viatris has four reportable segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The Company reports segment information on the basis of markets and geography, which reflects its focus on bringing its broad and diversified portfolio of branded, complex generics and biosimilars, and generic products to people in markets everywhere. Our Developed Markets segment comprises our operations primarily in North America and Europe. Our Greater China segment includes our operations in China, Taiwan and Hong Kong. Our JANZ segment reflects our operations in Japan, Australia and New Zealand. Our Emerging Markets segment encompasses our presence in more than 125 countries with developing markets and emerging economies including in Asia, Africa, Eastern Europe, Latin America and the Middle East as well as the Company&#x2019;s ARV franchise. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s chief operating decision maker is the Chief Executive Officer, who evaluates the performance of its segments based on total revenues and segment profitability.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain costs are not included in the measurement of segment profitability, such as costs, if any, associated with the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25e6;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;Intangible asset amortization expense and impairments of intangible assets;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25e6;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;R&amp;amp;D expense;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25e6;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;Net charges or net gains for litigation settlements and other contingencies;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25e6;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;Certain costs related to transactions and events such as (i) purchase accounting adjustments, where we incur expenses associated with the amortization of fair value adjustments to inventory and property, plant and equipment; (ii) acquisition-related costs, where we incur costs for executing the transaction, integrating the acquired operations and restructuring the combined company; and (iii) other significant items, which are substantive and/or unusual, and in some cases recurring, items (such as restructuring) that are evaluated on an individual basis by management and that either as a result of their nature or size, would not be expected to occur as part of our normal business on a regular basis. Such special items can include, but are not limited to, non-acquisition-related restructuring costs, as well as costs incurred for asset impairments and disposals of assets or businesses, including, as applicable, any associated transition activities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:36pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25e6;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;Corporate and other unallocated costs associated with platform functions (such as digital, facilities, legal, finance, human resources, insurance, public affairs and procurement), patient advocacy activities and certain compensation and other corporate costs (such as interest income and expense, and gains and losses on investments, as well as overhead expenses associated with our manufacturing, which include manufacturing variances associated with production) and operations that are not directly assessed to an operating segment as business unit (segment) management does not manage these costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does not report depreciation expense, total assets and capital expenditures by segment, as such information is not used by the chief operating decision maker. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accounting policies of the segments are the same as those described in Note&#160;2 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Summary of Significant Accounting Policies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Presented in the table below is segment information for the periods identified and a reconciliation of segment information to total consolidated information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.702%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Segment Profitability&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Reportable Segments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,428.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,510.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,240.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,143.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,243.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,137.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,212.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,397.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;JANZ&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,027.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,195.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,192.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;762.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;364.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,144.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,853.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,723.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,402.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;610.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;561.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,813.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,819.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,370.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,705.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,271.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,112.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reconciling items:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible asset amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,702.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,605.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,582.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible asset impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(102.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(180.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Globally managed research and development costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(751.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(555.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(639.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Litigation settlements &amp;amp; other contingencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(329.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(107.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transaction related and other special items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,832.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,739.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(682.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate and other unallocated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,021.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,391.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,332.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Loss) earnings from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(210.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;715.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents the percentage of consolidated net sales to Viatris&#x2019; major customers during the years ended December&#160;31, 2021, 2020, and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.272%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Percentage of Consolidated Net Sales&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;McKesson Corporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;AmerisourceBergen Corporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardinal Health, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Sales by Country Information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net sales by country are presented on the basis of geographic location of our subsidiaries: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.272%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,176.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,746.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,965.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,981.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;____________&lt;/span&gt;&lt;/div&gt;No other country&#x2019;s net sales represents more than 10% of consolidated net sales.</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90ZXh0cmVnaW9uOjFhNWE5OTI3MTU4NDQ5ODQ4YTUxM2EyZWQ4ZWIxODU2XzQxMjE_536c4b23-bc73-425f-a01c-e0fef4c0c342">&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Presented in the table below is segment information for the periods identified and a reconciliation of segment information to total consolidated information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.702%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Segment Profitability&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Reportable Segments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,428.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,510.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,240.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,143.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,243.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,137.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,212.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,397.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;JANZ&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,027.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,195.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,192.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;762.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;364.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,144.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,853.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,723.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,402.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;610.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;561.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,813.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,819.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,370.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,705.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,271.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,112.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reconciling items:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible asset amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,702.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,605.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,582.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible asset impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(102.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(180.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Globally managed research and development costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(751.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(555.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(639.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Litigation settlements &amp;amp; other contingencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(329.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(107.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transaction related and other special items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,832.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,739.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(682.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate and other unallocated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,021.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,391.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,332.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Loss) earnings from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(210.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;715.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1ac0bcd2e1264e8b8347af73e216d016_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzUtMi0xLTEtMzE0MjI_42001303-821b-4966-a424-465a313c7e4f"
      unitRef="usd">10428700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iec0737b261124d3f87ea9adcdb407b5a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzUtNC0xLTEtMzE0MjI_0375464e-a6d2-4be2-80b3-9092b4342daf"
      unitRef="usd">8510900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i864642c0e47a4b87a88be339d6673670_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzUtNi0xLTEtMzE0MjI_edd3aea7-df04-4bf0-96fe-04481bb72c36"
      unitRef="usd">8240000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="i1ac0bcd2e1264e8b8347af73e216d016_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzUtOC0xLTEtMzE0MjI_dd14c8d4-7a0e-453d-9317-d285de7c8375"
      unitRef="usd">5143100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iec0737b261124d3f87ea9adcdb407b5a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzUtMTAtMS0xLTMxNDIy_a26daeb1-9e9f-4b15-8971-1c53e18d7909"
      unitRef="usd">4243900000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i864642c0e47a4b87a88be339d6673670_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzUtMTItMS0xLTMxNDIy_b94bb940-816f-4e31-b757-76cfccb8974e"
      unitRef="usd">4137300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7ed92dccf2314bd48c7373be7cf33d4e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzYtMi0xLTEtMzE0MjI_83dd2772-7c5f-4491-8d0c-a12b43faa4b7"
      unitRef="usd">2212800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4e0c5048f8f84f26a1949d61f3285173_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzYtNC0xLTEtMzE0MjI_c122199e-c437-401d-a2e6-368231240a27"
      unitRef="usd">259900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie4221a0900a14ced8a5c91eac2fcdf4f_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzYtNi0xLTEtMzE0MjI_2d16ae45-e48f-4aa4-b4df-f29062378c73"
      unitRef="usd">214600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="i7ed92dccf2314bd48c7373be7cf33d4e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzYtOC0xLTEtMzE0MjI_37db9599-9561-40f3-a587-da85042ac2f4"
      unitRef="usd">1397100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4e0c5048f8f84f26a1949d61f3285173_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzYtMTAtMS0xLTMxNDIy_8cbd0e36-20d5-4468-883c-3182acf101e4"
      unitRef="usd">52700000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie4221a0900a14ced8a5c91eac2fcdf4f_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzYtMTItMS0xLTMxNDIy_a5e9e4e8-4b40-4d9d-b4f4-fd1bd029e2e1"
      unitRef="usd">89900000</us-gaap:OperatingIncomeLoss>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3ccdc9914af44b1bb1229e19c17326d8_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzctMi0xLTEtMzE0MjI_ccdf6ff3-8bc2-4601-8141-c8e244557938"
      unitRef="usd">2027400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2d06b2c023334d92a7c83b2943f0232b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzctNC0xLTEtMzE0MjI_f0161eb1-7cd1-4ddf-94e0-25f3be263cce"
      unitRef="usd">1195300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i94d3655a9cb44f37b3319f0d91bf87b1_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzctNi0xLTEtMzE0MjI_43e04259-b3f4-4a21-8864-baed98b2a668"
      unitRef="usd">1192500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3ccdc9914af44b1bb1229e19c17326d8_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzctOC0xLTEtMzE0MjI_57b42ece-9883-4cee-b96e-0d6fc96c5435"
      unitRef="usd">762400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2d06b2c023334d92a7c83b2943f0232b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzctMTAtMS0xLTMxNDIy_f28f222d-4670-4e66-a3f9-7e57f0b1e902"
      unitRef="usd">364600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i94d3655a9cb44f37b3319f0d91bf87b1_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzctMTItMS0xLTMxNDIy_9b726652-7d79-411d-b4ac-0d0ecb42e899"
      unitRef="usd">323200000</us-gaap:OperatingIncomeLoss>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i02b3f133daa24190abd49dfdef6bb6ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzgtMi0xLTEtMzE0MjI_1c5bda28-c0ff-4452-9112-d81bcc26f76f"
      unitRef="usd">3144700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i281863eb67c44d0fbc00294dfaf0049c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzgtNC0xLTEtMzE0MjI_8fb7b2bd-0c3e-47a8-8c0c-5d1df6145661"
      unitRef="usd">1853800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6f91beda5d054492aed05bdaf3b7936e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzgtNi0xLTEtMzE0MjI_b79c0b10-f364-426d-a565-c21468aeab1c"
      unitRef="usd">1723200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="i02b3f133daa24190abd49dfdef6bb6ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzgtOC0xLTEtMzE0MjI_fc6cc61b-cc6e-46eb-9a5f-2bfdc645a6cc"
      unitRef="usd">1402400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i281863eb67c44d0fbc00294dfaf0049c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzgtMTAtMS0xLTMxNDIy_5fb59a75-a3e9-498c-9d8a-552b6f9ae1dc"
      unitRef="usd">610400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6f91beda5d054492aed05bdaf3b7936e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzgtMTItMS0xLTMxNDIy_61b26167-69f0-489e-8aac-8074afb88830"
      unitRef="usd">561900000</us-gaap:OperatingIncomeLoss>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzktMi0xLTEtMzE0MjI_f7412cb4-7edf-4e51-be90-2f49cfee9afb"
      unitRef="usd">17813600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzktNC0xLTEtMzE0MjI_3ac22bb5-b479-47dc-8c05-111ef82b7c76"
      unitRef="usd">11819900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzktNi0xLTEtMzE0MjI_8623bc55-6250-4ca5-8729-4075887bfff0"
      unitRef="usd">11370300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="id2ddd71cee624b009233ae18ff01bcdb_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzktOC0xLTEtMzE0MjI_c9796dc3-9082-41e4-a7f6-816dcd7a4340"
      unitRef="usd">8705000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="icdd7bc10185c4685b4d14c9b6ac151b1_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzktMTAtMS0xLTMxNDIy_bbeabfcb-574d-4966-aac8-b77cb9166658"
      unitRef="usd">5271600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ieeeb5a9479d24a7d8d17e6b3b937cfa1_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzktMTItMS0xLTMxNDIy_e54efdbe-46fb-4280-ac40-af08e4182aa0"
      unitRef="usd">5112300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i920f0f119ac84408803bd50b9d0ab091_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzEyLTgtMS0xLTMxNDIy_8d55403e-4a50-4b3a-b3e5-81dd668c1766"
      unitRef="usd">2702200000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i22c52f21b85d4673a433d7b10508a1c0_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzEyLTEwLTEtMS0zMTQyMg_c1932254-a123-4a32-9129-14dcd42bf09a"
      unitRef="usd">1605800000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ib677e81a48d44a41987cce709676230a_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzEyLTEyLTEtMS0zMTQyMg_f4e9cffd-4f56-47e8-badc-6c7ff8168034"
      unitRef="usd">1582700000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i920f0f119ac84408803bd50b9d0ab091_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzEzLTgtMS0xLTMxNDIy_561be6b2-96f2-4470-9f9d-d669f20224f1"
      unitRef="usd">102800000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i22c52f21b85d4673a433d7b10508a1c0_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzEzLTEwLTEtMS0zMTQyMg_41fccdee-6cfe-4398-81a5-61733f0ba266"
      unitRef="usd">82400000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="ib677e81a48d44a41987cce709676230a_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzEzLTEyLTEtMS0zMTQyMg_958dc134-b555-4d8f-84b2-c9a76eb18506"
      unitRef="usd">180600000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i920f0f119ac84408803bd50b9d0ab091_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzE0LTgtMS0xLTMxNDIy_71b4ef81-98a5-4da0-abbc-d2607a9038d5"
      unitRef="usd">751100000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i22c52f21b85d4673a433d7b10508a1c0_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzE0LTEwLTEtMS0zMTQyMg_2f48eac0-d6e6-481c-8bca-78d6278495fb"
      unitRef="usd">555100000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ib677e81a48d44a41987cce709676230a_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzE0LTEyLTEtMS0zMTQyMg_2cc77912-7fd5-4dce-915c-775cf5841d17"
      unitRef="usd">639900000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i920f0f119ac84408803bd50b9d0ab091_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzE1LTgtMS0xLTMxNDIy_90ee52b7-4ff4-42fe-a689-69baef36a163"
      unitRef="usd">-329200000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i22c52f21b85d4673a433d7b10508a1c0_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzE1LTEwLTEtMS0zMTQyMg_8359e042-a7b5-48c1-a263-11416e97a062"
      unitRef="usd">-107800000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="ib677e81a48d44a41987cce709676230a_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzE1LTEyLTEtMS0zMTQyMg_76311206-f159-49e7-b90a-a98ead686ac0"
      unitRef="usd">21400000</us-gaap:GainLossRelatedToLitigationSettlement>
    <vtrs:OtherOneTimeNonoperatingExpense
      contextRef="i920f0f119ac84408803bd50b9d0ab091_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzE2LTgtMS0xLTMxNDIy_d236bb68-8c36-4e3f-8a3e-20556cc14397"
      unitRef="usd">2832200000</vtrs:OtherOneTimeNonoperatingExpense>
    <vtrs:OtherOneTimeNonoperatingExpense
      contextRef="i22c52f21b85d4673a433d7b10508a1c0_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzE2LTEwLTEtMS0zMTQyMg_8c1bc13b-ba49-42be-bc83-d08736c654c1"
      unitRef="usd">1739700000</vtrs:OtherOneTimeNonoperatingExpense>
    <vtrs:OtherOneTimeNonoperatingExpense
      contextRef="ib677e81a48d44a41987cce709676230a_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzE2LTEyLTEtMS0zMTQyMg_21c5b033-648d-497e-a0e4-4eafd8b36bd1"
      unitRef="usd">682200000</vtrs:OtherOneTimeNonoperatingExpense>
    <vtrs:Corporatecosts
      contextRef="icd84b99acf144bc78660b64776c157a5_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzE3LTgtMS0xLTMxNDIy_ad21794c-b3f4-4ce5-ab35-70772673b58d"
      unitRef="usd">2021500000</vtrs:Corporatecosts>
    <vtrs:Corporatecosts
      contextRef="ia0acbb674a1248c0922f52ddee735cd9_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzE3LTEwLTEtMS0zMTQyMg_deca1036-8cc2-4eb1-b226-008c05cf883a"
      unitRef="usd">1391600000</vtrs:Corporatecosts>
    <vtrs:Corporatecosts
      contextRef="i0d6ec2d7d94e40788a144ae7c9ec8647_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzE3LTEyLTEtMS0zMTQyMg_12e86a12-78bc-491e-a055-e3fe6e68cbcc"
      unitRef="usd">1332800000</vtrs:Corporatecosts>
    <us-gaap:OperatingIncomeLoss
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzE4LTgtMS0xLTMxNDIy_7f79be6c-13dc-42d4-af11-9f58d59a13ff"
      unitRef="usd">-34000000.0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzE4LTEwLTEtMS0zMTQyMg_bfdf181b-f0c1-4ca5-85ed-00da746719b8"
      unitRef="usd">-210800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo2MmYxNzc2ZTllNTY0NmRlODhhMzc3NzhmY2FjMTM1YS90YWJsZXJhbmdlOjYyZjE3NzZlOWU1NjQ2ZGU4OGEzNzc3OGZjYWMxMzVhXzE4LTEyLTEtMS0zMTQyMg_dc140237-1b5e-49c1-b205-2ff690eebea2"
      unitRef="usd">715500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90ZXh0cmVnaW9uOjFhNWE5OTI3MTU4NDQ5ODQ4YTUxM2EyZWQ4ZWIxODU2XzQwODA_a00f92bf-2345-4cef-96ca-a527d8a8b166">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents the percentage of consolidated net sales to Viatris&#x2019; major customers during the years ended December&#160;31, 2021, 2020, and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.272%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Percentage of Consolidated Net Sales&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;McKesson Corporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;AmerisourceBergen Corporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardinal Health, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i18815e8bb5a745709ff95e3d9c2c08e4_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo3NDdlOTk5ZWJlOWY0NjIxOThkMTMxZDc3YTQ2NzQ4YS90YWJsZXJhbmdlOjc0N2U5OTllYmU5ZjQ2MjE5OGQxMzFkNzdhNDY3NDhhXzItMS0xLTEtMzE0MjI_b1107ed6-20d5-45b5-96df-5903b26eea70"
      unitRef="number">0.09</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="id731b23309e14cbdaad5c8a9b50a21be_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo3NDdlOTk5ZWJlOWY0NjIxOThkMTMxZDc3YTQ2NzQ4YS90YWJsZXJhbmdlOjc0N2U5OTllYmU5ZjQ2MjE5OGQxMzFkNzdhNDY3NDhhXzItMy0xLTEtMzE0MjI_996c64cb-bedb-46cd-b300-319b7c1ca46f"
      unitRef="number">0.13</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="id209d8fb79664069a0121c7006665f1f_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo3NDdlOTk5ZWJlOWY0NjIxOThkMTMxZDc3YTQ2NzQ4YS90YWJsZXJhbmdlOjc0N2U5OTllYmU5ZjQ2MjE5OGQxMzFkNzdhNDY3NDhhXzItNS0xLTEtMzE0MjI_da6881da-a78e-4b9e-86ab-7acb3f4f52e4"
      unitRef="number">0.15</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i6dd5ebb08da94a34a07b74dd124ac3ee_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo3NDdlOTk5ZWJlOWY0NjIxOThkMTMxZDc3YTQ2NzQ4YS90YWJsZXJhbmdlOjc0N2U5OTllYmU5ZjQ2MjE5OGQxMzFkNzdhNDY3NDhhXzMtMS0xLTEtMzE0MjI_4a782fc7-b77f-4c6f-96c4-f6a12ad8f4e3"
      unitRef="number">0.09</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i6901420439ef429ea919459425a5d402_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo3NDdlOTk5ZWJlOWY0NjIxOThkMTMxZDc3YTQ2NzQ4YS90YWJsZXJhbmdlOjc0N2U5OTllYmU5ZjQ2MjE5OGQxMzFkNzdhNDY3NDhhXzMtMy0xLTEtMzE0MjI_68a10a16-03e2-4e21-a667-64cf13eec3ef"
      unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="idf1e59f7845645108df1bc93dddee7c7_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo3NDdlOTk5ZWJlOWY0NjIxOThkMTMxZDc3YTQ2NzQ4YS90YWJsZXJhbmdlOjc0N2U5OTllYmU5ZjQ2MjE5OGQxMzFkNzdhNDY3NDhhXzMtNS0xLTEtMzE0MjI_1cbb5582-54b7-4055-93b8-3554767d1e02"
      unitRef="number">0.09</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ic5e40498906e45c788a40df231de121f_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo3NDdlOTk5ZWJlOWY0NjIxOThkMTMxZDc3YTQ2NzQ4YS90YWJsZXJhbmdlOjc0N2U5OTllYmU5ZjQ2MjE5OGQxMzFkNzdhNDY3NDhhXzQtMS0xLTEtMzE0MjI_e3b8f48d-2a9d-4026-b80d-cc782ebd4a46"
      unitRef="number">0.05</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i27fa8b92853d48fb94b00143112c4a79_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo3NDdlOTk5ZWJlOWY0NjIxOThkMTMxZDc3YTQ2NzQ4YS90YWJsZXJhbmdlOjc0N2U5OTllYmU5ZjQ2MjE5OGQxMzFkNzdhNDY3NDhhXzQtMy0xLTEtMzE0MjI_8a316367-99ff-4d6c-86d9-15f6f3ae4764"
      unitRef="number">0.08</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i76cdb8e6f69a4d70b0de5af0064a60da_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTo3NDdlOTk5ZWJlOWY0NjIxOThkMTMxZDc3YTQ2NzQ4YS90YWJsZXJhbmdlOjc0N2U5OTllYmU5ZjQ2MjE5OGQxMzFkNzdhNDY3NDhhXzQtNS0xLTEtMzE0MjI_d7aa5d02-2879-48bf-8e63-ac0c880b4aea"
      unitRef="number">0.08</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90ZXh0cmVnaW9uOjFhNWE5OTI3MTU4NDQ5ODQ4YTUxM2EyZWQ4ZWIxODU2XzQxMjA_0810fedf-6ad2-4604-a901-8a2648adf788">&lt;div style="margin-bottom:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net sales by country are presented on the basis of geographic location of our subsidiaries: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.272%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,176.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,746.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,965.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,981.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;____________&lt;/span&gt;&lt;/div&gt;No other country&#x2019;s net sales represents more than 10% of consolidated net sales.</us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5705c46a88bf43f9b604c129b6396c1b_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTpkMGY2NTE3ZDliZjQ0OGI1ODE1MzVkNmVjNTRjNmIyZS90YWJsZXJhbmdlOmQwZjY1MTdkOWJmNDQ4YjU4MTUzNWQ2ZWM1NGM2YjJlXzItMS0xLTEtMzE0MjI_7fa596a0-9b7d-41bb-b83e-06642b8a8762"
      unitRef="usd">4176400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4373191f73a844d0aa8b62bcce8c341d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTpkMGY2NTE3ZDliZjQ0OGI1ODE1MzVkNmVjNTRjNmIyZS90YWJsZXJhbmdlOmQwZjY1MTdkOWJmNDQ4YjU4MTUzNWQ2ZWM1NGM2YjJlXzItMy0xLTEtMzE0MjI_6b12aead-84d2-4115-94ab-b873ade7039b"
      unitRef="usd">3746100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icc53a28205ae4633a9527b98ec393f1e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTpkMGY2NTE3ZDliZjQ0OGI1ODE1MzVkNmVjNTRjNmIyZS90YWJsZXJhbmdlOmQwZjY1MTdkOWJmNDQ4YjU4MTUzNWQ2ZWM1NGM2YjJlXzItNS0xLTEtMzE0MjI_99cf8a5e-9a85-4476-8c72-32fe9a3ff0e8"
      unitRef="usd">3965900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i674ccad3b1334a35b429888309d5e766_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTpkMGY2NTE3ZDliZjQ0OGI1ODE1MzVkNmVjNTRjNmIyZS90YWJsZXJhbmdlOmQwZjY1MTdkOWJmNDQ4YjU4MTUzNWQ2ZWM1NGM2YjJlXzMtMS0xLTEtMzg3NDI_4156ec12-f1b9-4fac-8425-b8a21ef2294a"
      unitRef="usd">1981500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia4bb4b6b6b5a4fe694af194311457a02_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTpkMGY2NTE3ZDliZjQ0OGI1ODE1MzVkNmVjNTRjNmIyZS90YWJsZXJhbmdlOmQwZjY1MTdkOWJmNDQ4YjU4MTUzNWQ2ZWM1NGM2YjJlXzMtMy0xLTEtMzg3NDI_5c1c7604-2762-446d-af99-75e6f0bda7b9"
      unitRef="usd">216100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i94d6d4b3556e404b89c54e423c77d4f6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMjkvZnJhZzoxYTVhOTkyNzE1ODQ0OTg0OGE1MTNhMmVkOGViMTg1Ni90YWJsZTpkMGY2NTE3ZDliZjQ0OGI1ODE1MzVkNmVjNTRjNmIyZS90YWJsZXJhbmdlOmQwZjY1MTdkOWJmNDQ4YjU4MTUzNWQ2ZWM1NGM2YjJlXzMtNS0xLTEtMzg3NDI_b545c6d3-8bb5-42c3-bd43-b8b70892dbe0"
      unitRef="usd">171100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <vtrs:BusinessCombinationLimitedTransitionServicesPaymentPeriod
      contextRef="i9a70f778cb3e42faa8640420190123d8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzIvZnJhZzphNzQ1MDE2ZGExZDg0YmZjOGI5Mzk2MGZiYWQ3ZTA1Ni90ZXh0cmVnaW9uOmE3NDUwMTZkYTFkODRiZmM4YjkzOTYwZmJhZDdlMDU2XzU4MA_062a51c9-79e7-4697-9176-cb488582c67e">P24M</vtrs:BusinessCombinationLimitedTransitionServicesPaymentPeriod>
    <vtrs:BusinessCombinationContractualReimbursementAmountTrancheOne
      contextRef="i3bc8daf6f604468691d4e166c4089a06_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzIvZnJhZzphNzQ1MDE2ZGExZDg0YmZjOGI5Mzk2MGZiYWQ3ZTA1Ni90ZXh0cmVnaW9uOmE3NDUwMTZkYTFkODRiZmM4YjkzOTYwZmJhZDdlMDU2Xzc1MQ_276b7e78-5c18-4e34-9cf6-d1e1e60d086b"
      unitRef="usd">380000000</vtrs:BusinessCombinationContractualReimbursementAmountTrancheOne>
    <vtrs:BusinessCombinationContractualReimbursementAmountTrancheOne
      contextRef="i3bc8daf6f604468691d4e166c4089a06_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzIvZnJhZzphNzQ1MDE2ZGExZDg0YmZjOGI5Mzk2MGZiYWQ3ZTA1Ni90ZXh0cmVnaW9uOmE3NDUwMTZkYTFkODRiZmM4YjkzOTYwZmJhZDdlMDU2Xzg4OQ_23781831-7d69-459c-8164-20e41dd86538"
      unitRef="usd">380000000</vtrs:BusinessCombinationContractualReimbursementAmountTrancheOne>
    <vtrs:BusinessCombinationContractualReimbursementAmountAmountsExpensed
      contextRef="ie41a5079981b44deba916400b5db52f8_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzIvZnJhZzphNzQ1MDE2ZGExZDg0YmZjOGI5Mzk2MGZiYWQ3ZTA1Ni90ZXh0cmVnaW9uOmE3NDUwMTZkYTFkODRiZmM4YjkzOTYwZmJhZDdlMDU2XzM4NDgyOTA2OTk5MTE_1ab342ea-4fab-45e3-8734-c0d5754bc1a0"
      unitRef="usd">30400000</vtrs:BusinessCombinationContractualReimbursementAmountAmountsExpensed>
    <vtrs:BusinessCombinationContractualReimbursementAmountAmountsExpensed
      contextRef="i6fb7985a0fed413082603dbe3300009f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzIvZnJhZzphNzQ1MDE2ZGExZDg0YmZjOGI5Mzk2MGZiYWQ3ZTA1Ni90ZXh0cmVnaW9uOmE3NDUwMTZkYTFkODRiZmM4YjkzOTYwZmJhZDdlMDU2Xzk2MA_ca863399-9378-4fbe-a5a9-844760bd306c"
      unitRef="usd">53100000</vtrs:BusinessCombinationContractualReimbursementAmountAmountsExpensed>
    <vtrs:BusinessCombinationContractualReimbursementAmountAmountsAccrued
      contextRef="i3bc8daf6f604468691d4e166c4089a06_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzIvZnJhZzphNzQ1MDE2ZGExZDg0YmZjOGI5Mzk2MGZiYWQ3ZTA1Ni90ZXh0cmVnaW9uOmE3NDUwMTZkYTFkODRiZmM4YjkzOTYwZmJhZDdlMDU2XzExMTk_9b176427-87cb-44e8-890a-f9bcb92de555"
      unitRef="usd">26900000</vtrs:BusinessCombinationContractualReimbursementAmountAmountsAccrued>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90ZXh0cmVnaW9uOjQ3ZDBjNDk5MjMxODRjNTJhY2JiYTAzZTJmN2NjNTU4XzM0NjU_12ad0c27-ccc8-442e-8988-930f5f0e409e">Restructuring &lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2020 Restructuring Program&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;During the fourth quarter of 2020, Viatris announced a significant global restructuring program in order to achieve synergies and ensure that the organization is optimally structured and efficiently resourced to deliver sustainable value to patients, shareholders, customers, and other stakeholders. Viatris&#x2019; restructuring initiative incorporates and expands on the restructuring program announced by Mylan N.V. earlier in 2020 as part of its business transformation efforts. As part of the restructuring, the Company is optimizing its commercial capabilities and enabling functions, and closing, downsizing or divesting certain manufacturing facilities globally that are deemed to be no longer viable either due to surplus capacity, challenging market dynamics or a shift in its product portfolio toward more complex products. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the committed restructuring actions, the Company expects to incur total pre-tax charges of up to approximately $1.4&#160;billion. Such charges are expected to include up to approximately $450&#160;million of non-cash charges mainly related to accelerated depreciation and asset impairment charges, including inventory write-offs. The remaining estimated cash costs of up to approximately $950&#160;million are expected to be primarily related to severance and employee benefits expense, as well as other costs, including those related to contract terminations and other plant disposal costs. In addition, management believes the potential annual savings related to these committed restructuring activities to be up to approximately $900&#160;million once fully implemented, with most of these savings expected to improve operating cash flow.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the restructuring charges and the reserve activity for the 2020 restructuring program:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.006%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Employee Related Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Exit Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charges &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired in the Combination&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Utilization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charges &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;496.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;892.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reimbursable restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(385.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(151.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(537.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Utilization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(345.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(345.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;As part of the Combination, the Company acquired reserve balances related to restructuring activities initiated by the Upjohn Business prior to the Combination, primarily related to accrued severance. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:24.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;2016 Restructuring Program&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Mylan previously announced a restructuring program representing a series of actions in certain locations to further streamline its operations globally. We incurred total restructuring related costs of approximately $733.0&#160;million through December 31, 2020. The 2016 Restructuring Program was substantially completed at December 31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2018, the FDA completed an inspection at Mylan&#x2019;s plant in Morgantown, West Virginia and made observations through a Form 483. In the fourth quarter of 2018, Mylan received a warning letter related to the previously disclosed observations at the plant. The issues raised in the warning letter were addressed within the context of the Mylan&#x2019;s comprehensive restructuring and remediation activities. On May 11, 2020, Mylan received the close-out of the warning letter. On December 11, 2020, the Company announced that it expects the Morgantown plant to be closed or divested as part of the 2020 Restructuring Program. The Morgantown plant was closed during the third quarter of 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the restructuring charges and the reserve activity for the 2016 restructuring program from December 31, 2018 to December 31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.006%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Employee Related Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Exit Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2018:&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charges &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Utilization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019:&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charges &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Utilization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#160;&#160;&#160;&#160;For the year ended December&#160;31, 2021, total restructuring charges for the 2020 Restructuring Program, in Developed Markets, Greater China, JANZ, Emerging Markets, and Corporate/Other were approximately $623.8 million, $5.8 million, $138.1 million, $94.1 million, and $30.4 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#160;&#160;&#160;&#160;For the year ended December&#160;31, 2020, total restructuring charges, for both programs, in Developed Markets, Greater China, JANZ, and Emerging Markets were approximately $292.1 million, $18.4 million, $2.9 million, and $8.4 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#160;&#160;&#160;&#160;For the year ended December 31, 2019, total restructuring charges for the 2016 Restructuring Program in Developed Markets and JANZ were approximately $100.4&#160;million and $4.2&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2021&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and 2020, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;accrued liabilities for restructuring and other cost reduction programs were primarily included in other current liabilities and other long-term obligations in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:RestructuringCharges
      contextRef="ib89e351abdca4a2a8a91f6f3d20bc1e2_D20211001-20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90ZXh0cmVnaW9uOjQ3ZDBjNDk5MjMxODRjNTJhY2JiYTAzZTJmN2NjNTU4XzExMTk_53d90023-523e-4163-8e40-f7808ffa7e7e"
      unitRef="usd">1400000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="ib89e351abdca4a2a8a91f6f3d20bc1e2_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90ZXh0cmVnaW9uOjQ3ZDBjNDk5MjMxODRjNTJhY2JiYTAzZTJmN2NjNTU4XzExNzU_09186c32-0227-4596-bcd4-0c4506a94d81"
      unitRef="usd">450000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringAndRelatedCostExpectedCostRemaining1
      contextRef="ie59342892624442b9a277a53f425c7e3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90ZXh0cmVnaW9uOjQ3ZDBjNDk5MjMxODRjNTJhY2JiYTAzZTJmN2NjNTU4XzEzNTY_cdeba9a7-998b-41e2-9c01-cfa957b0fcd9"
      unitRef="usd">950000000</us-gaap:RestructuringAndRelatedCostExpectedCostRemaining1>
    <us-gaap:EffectOnFutureCashFlowsAmount
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90ZXh0cmVnaW9uOjQ3ZDBjNDk5MjMxODRjNTJhY2JiYTAzZTJmN2NjNTU4XzMyOTg1MzQ4OTAxOTk_8b7f6854-4709-4687-bf17-cffdd5cd155e"
      unitRef="usd">900000000</us-gaap:EffectOnFutureCashFlowsAmount>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90ZXh0cmVnaW9uOjQ3ZDBjNDk5MjMxODRjNTJhY2JiYTAzZTJmN2NjNTU4XzU0OTc1NTgxNDY4MDY_d8a2dec1-ae99-4f45-ad13-643f275b222b">&lt;div style="margin-bottom:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the restructuring charges and the reserve activity for the 2020 restructuring program:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.006%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Employee Related Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Exit Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charges &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired in the Combination&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Utilization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charges &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;496.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;892.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reimbursable restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(385.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(151.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(537.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Utilization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(345.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(345.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.006%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Employee Related Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Exit Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2018:&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charges &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Utilization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019:&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charges &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Utilization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#160;&#160;&#160;&#160;For the year ended December&#160;31, 2021, total restructuring charges for the 2020 Restructuring Program, in Developed Markets, Greater China, JANZ, Emerging Markets, and Corporate/Other were approximately $623.8 million, $5.8 million, $138.1 million, $94.1 million, and $30.4 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#160;&#160;&#160;&#160;For the year ended December&#160;31, 2020, total restructuring charges, for both programs, in Developed Markets, Greater China, JANZ, and Emerging Markets were approximately $292.1 million, $18.4 million, $2.9 million, and $8.4 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#160;&#160;&#160;&#160;For the year ended December 31, 2019, total restructuring charges for the 2016 Restructuring Program in Developed Markets and JANZ were approximately $100.4&#160;million and $4.2&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:RestructuringCharges
      contextRef="i5a2ed382584440da959bd00009045f49_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzEtMS0xLTEtMzE0MjI_a987bbc2-ce86-4d32-82e4-49762d87f65c"
      unitRef="usd">195600000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i18f47482de9e477aa4d85300745fbad3_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzEtMy0xLTEtMzE0MjI_b29a3dbc-3c3a-4bf7-884b-6f9da7f85dee"
      unitRef="usd">75700000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i0d1d75a5c8a447008aeaeea8bcbacd37_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzEtNS0xLTEtMzE0MjI_fc4bfb5c-5748-4cc7-9208-251010e8084b"
      unitRef="usd">271300000</us-gaap:RestructuringCharges>
    <vtrs:RestructuringReserveAcquiredDuringPeriod
      contextRef="i5a2ed382584440da959bd00009045f49_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzItMS0xLTEtMzE0MjI_c93dd8f3-6a88-4a0b-9aab-2398ca0412f1"
      unitRef="usd">91700000</vtrs:RestructuringReserveAcquiredDuringPeriod>
    <vtrs:RestructuringReserveAcquiredDuringPeriod
      contextRef="i18f47482de9e477aa4d85300745fbad3_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzItMy0xLTEtMzE0MjI_c6e3cdeb-8cf7-424e-964d-a1f3fa50ff15"
      unitRef="usd">300000</vtrs:RestructuringReserveAcquiredDuringPeriod>
    <vtrs:RestructuringReserveAcquiredDuringPeriod
      contextRef="i0d1d75a5c8a447008aeaeea8bcbacd37_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzItNS0xLTEtMzE0MjI_b36a5036-b335-4abf-baef-bf3e847623fb"
      unitRef="usd">92000000.0</vtrs:RestructuringReserveAcquiredDuringPeriod>
    <us-gaap:PaymentsForRestructuring
      contextRef="i5a2ed382584440da959bd00009045f49_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzMtMS0xLTEtMzE0MjI_b9bac704-8030-4a53-921b-e5c511534056"
      unitRef="usd">25100000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i18f47482de9e477aa4d85300745fbad3_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzMtMy0xLTEtMzE0MjI_3859f7c4-c5e5-4bfc-bbdd-c0c66dda52f0"
      unitRef="usd">400000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i0d1d75a5c8a447008aeaeea8bcbacd37_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzMtNS0xLTEtMzE0MjI_53016664-1fd0-411a-b65f-2d334605dd2d"
      unitRef="usd">25500000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i5a2ed382584440da959bd00009045f49_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzUtMS0xLTEtMzE0MjI_33f8567e-a676-4b0a-9316-25dec8c06ef1"
      unitRef="usd">0</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i18f47482de9e477aa4d85300745fbad3_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzUtMy0xLTEtMzE0MjI_e0eeb98b-197f-4b7a-8ac9-9f7e235cfb54"
      unitRef="usd">-70800000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i0d1d75a5c8a447008aeaeea8bcbacd37_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzUtNS0xLTEtMzE0MjI_b8a5f6ca-1658-45f4-a5c7-c64e9ebbcf1c"
      unitRef="usd">-70800000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i5a2ed382584440da959bd00009045f49_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzYtMS0xLTEtMzE0MjI_51dd773b-c50b-49ff-8013-63edb33da142"
      unitRef="usd">400000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i18f47482de9e477aa4d85300745fbad3_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzYtMy0xLTEtMzE0MjI_8d2a22ad-8b15-4ac7-8cd1-75b6d7f3cafc"
      unitRef="usd">0</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i0d1d75a5c8a447008aeaeea8bcbacd37_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzYtNS0xLTEtMzE0MjI_f19d09ff-2147-41b7-9c40-d88341e7ea5e"
      unitRef="usd">400000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserve
      contextRef="i45a292f6066c4a5cae5e925da85f5c71_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzctMS0xLTEtMzE0MjI_d150406d-ebab-4b9a-952d-75613f53ada6"
      unitRef="usd">262600000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ia07fba1fd0dd43ebabc004e6c0858d88_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzctMy0xLTEtMzE0MjI_d7d2f97f-1967-4e51-8360-d66ac7a325a5"
      unitRef="usd">4800000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i681ce63aa00c4c9498e214af93461780_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzctNS0xLTEtMzE0MjI_43a6f9e5-c99c-4dc5-a473-221278455ba7"
      unitRef="usd">267400000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="iaa3cdc4e3b274003ae2d838d289e9c7d_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzgtMS0xLTEtMzQxOTI_f920403a-0743-4f59-afc5-8b7beb01ccac"
      unitRef="usd">396100000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ieae368cfdd6248869144a96949edde48_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzgtMy0xLTEtMzQyMDQ_0592590f-c39e-4ff8-b551-6f89e35b2c9b"
      unitRef="usd">496100000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i5b60006ae2c94bff820d1335a546ccba_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzgtNS0xLTEtMzM3ODI_556f97dc-abf7-4d12-8754-72f9fcc89374"
      unitRef="usd">892200000</us-gaap:RestructuringCharges>
    <vtrs:RestructuringReserveReimbursableRestructuringCharges
      contextRef="i254bde0424ca475ebacf28a1bc15b3b1_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzktMS0xLTEtMzM3NzQ_b2d9c6dd-b615-476b-ae46-9922e624ed86"
      unitRef="usd">26400000</vtrs:RestructuringReserveReimbursableRestructuringCharges>
    <vtrs:RestructuringReserveReimbursableRestructuringCharges
      contextRef="i0685a0412faf4f3b90366905bbeab604_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzktMy0xLTEtMzM3OTg_8df9a865-5a8d-45ab-b3a5-84abe82a4f06"
      unitRef="usd">0</vtrs:RestructuringReserveReimbursableRestructuringCharges>
    <vtrs:RestructuringReserveReimbursableRestructuringCharges
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzktNS0xLTEtMzM3ODI_e430420a-07a1-40ed-a9bb-71c43b0141a1"
      unitRef="usd">26400000</vtrs:RestructuringReserveReimbursableRestructuringCharges>
    <us-gaap:PaymentsForRestructuring
      contextRef="iaa3cdc4e3b274003ae2d838d289e9c7d_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzEwLTEtMS0xLTM0MTky_31df610e-ce22-4fce-a500-5bf82403f74f"
      unitRef="usd">385500000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="ieae368cfdd6248869144a96949edde48_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzEwLTMtMS0xLTM0MjA0_5e4064ac-3828-4ab4-abe4-139616b69e26"
      unitRef="usd">151700000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i5b60006ae2c94bff820d1335a546ccba_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzEwLTUtMS0xLTMzNzgy_d2669f1a-6e4b-4503-9ec9-aa9e1f496bb9"
      unitRef="usd">537200000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="iaa3cdc4e3b274003ae2d838d289e9c7d_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzExLTEtMS0xLTMzODA5_bf03a001-3429-4769-9a6a-830d714fd0b8"
      unitRef="usd">0</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="ieae368cfdd6248869144a96949edde48_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzExLTMtMS0xLTM0MjA0_8129e816-4a37-492a-9012-931a1c20b26e"
      unitRef="usd">-345000000.0</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i5b60006ae2c94bff820d1335a546ccba_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzExLTUtMS0xLTMzNzgy_1c5e5412-a003-4312-a253-32b298e6c273"
      unitRef="usd">-345000000.0</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="iaa3cdc4e3b274003ae2d838d289e9c7d_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzEyLTEtMS0xLTM0MTky_9e6ee2dc-76bf-45d1-8d3e-d76deaaae772"
      unitRef="usd">-7000000.0</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="ieae368cfdd6248869144a96949edde48_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzEyLTMtMS0xLTM0MjA0_450c2ac8-81e2-4c7b-8ab6-7c521996b106"
      unitRef="usd">-100000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i5b60006ae2c94bff820d1335a546ccba_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzEyLTUtMS0xLTMzNzgy_1f078e47-b0ab-47f5-af0c-d91099e0400c"
      unitRef="usd">-7100000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserve
      contextRef="id51cb348481d4ec48766bf86b6cc391d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzEzLTEtMS0xLTMzODIw_12c0ccb5-098f-4777-aa55-accc82872488"
      unitRef="usd">292600000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ie6a9f98858454485bf0c770c4fd2c57c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzEzLTMtMS0xLTMzODI5_c78a15bb-f7ad-4b9e-a0e3-f2785db8b70c"
      unitRef="usd">4100000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ia84d707224a5471abcb6fb8f26708db5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTplYmI4YTY1NjJhMTk0NmZiYjQ4OTVmNjYwNDYzNTA4My90YWJsZXJhbmdlOmViYjhhNjU2MmExOTQ2ZmJiNDg5NWY2NjA0NjM1MDgzXzEzLTUtMS0xLTMzNzgy_49eb9c2b-1ef5-4353-9d4e-6432122c1837"
      unitRef="usd">296700000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="i9ad19c7802c7406b96da1212d434f4e3_D20160101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90ZXh0cmVnaW9uOjQ3ZDBjNDk5MjMxODRjNTJhY2JiYTAzZTJmN2NjNTU4XzIxMzQ_d15a3a8b-0a77-49d1-af29-c708f084ae98"
      unitRef="usd">733000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringReserve
      contextRef="i266beeff762940c594ad7e6cb70ba95a_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzEtMS0xLTEtNTEzNTA_0ed7662c-fcf5-4588-b5ee-a7979fcdf236"
      unitRef="usd">60800000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i8a2f026c5d984a4baa08a46d2b7a633d_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzEtMy0xLTEtNTEzNTA_b4cf3a66-bbd6-45d5-9e7d-2ea8bfd91b7e"
      unitRef="usd">11800000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="if8ec92ba24d848d697ba737aeed13c05_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzEtNS0xLTEtNTEzNTA_5d651e8e-825e-40c1-8f59-25ad81633186"
      unitRef="usd">72600000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="ie111b220c8104243b43abb19a557ed31_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzItMS0xLTEtNTEzNTA_4384931b-6ee7-4f00-be1d-8e8be54f69d3"
      unitRef="usd">16600000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ied43c8ca68ed4621b226737a5d334eaf_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzItMy0xLTEtNTEzNTA_ed91caf8-bff4-44d1-89d6-0a0523c75e88"
      unitRef="usd">88000000.0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzItNS0xLTEtNTEzNTA_0fa8b536-52ef-4dc5-8e47-1e794421f3e1"
      unitRef="usd">104600000</us-gaap:RestructuringCharges>
    <us-gaap:PaymentsForRestructuring
      contextRef="ie111b220c8104243b43abb19a557ed31_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzMtMS0xLTEtNTEzNTA_32cd0a89-0988-49c8-a027-79872851c09a"
      unitRef="usd">48900000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="ied43c8ca68ed4621b226737a5d334eaf_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzMtMy0xLTEtNTEzNTA_752c7f98-a203-4d2b-930f-c14773a8dca1"
      unitRef="usd">10500000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzMtNS0xLTEtNTEzNTA_db1dcee9-04c4-46d2-ab59-0b9169eb86e9"
      unitRef="usd">59400000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReservePeriodIncreaseDecrease
      contextRef="ie111b220c8104243b43abb19a557ed31_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzQtMS0xLTEtNTEzNTU_1ee600f2-ffbc-4c09-b4c0-985d307ea748"
      unitRef="usd">0</us-gaap:RestructuringReservePeriodIncreaseDecrease>
    <us-gaap:RestructuringReservePeriodIncreaseDecrease
      contextRef="ied43c8ca68ed4621b226737a5d334eaf_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzQtMy0xLTEtNTEzNTc_69b0415c-6882-4f57-840d-ac6d7a5ea598"
      unitRef="usd">-8100000</us-gaap:RestructuringReservePeriodIncreaseDecrease>
    <us-gaap:RestructuringReservePeriodIncreaseDecrease
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzQtNS0xLTEtNTEzNTk_6e1b8a30-8767-4237-ab13-c20c67d42ebf"
      unitRef="usd">-8100000</us-gaap:RestructuringReservePeriodIncreaseDecrease>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="ie111b220c8104243b43abb19a557ed31_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzUtMS0xLTEtNTEzNTM_5060df8e-78ee-411e-b2c4-8e2bb4dcf81b"
      unitRef="usd">0</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="ied43c8ca68ed4621b226737a5d334eaf_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzUtMy0xLTEtNTEzNTM_708216da-1ad5-4ad9-b0a0-effdcf302eaa"
      unitRef="usd">-78300000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzUtNS0xLTEtNTEzNTM_930ed417-81b9-4fac-929e-c18e47c30482"
      unitRef="usd">-78300000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="ie111b220c8104243b43abb19a557ed31_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzYtMS0xLTEtNTEzNTM_d14c7b4b-5db3-4bad-9594-aa413e6e8735"
      unitRef="usd">-2100000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="ied43c8ca68ed4621b226737a5d334eaf_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzYtMy0xLTEtNTEzNTM_51b0cc52-c99a-497e-ae15-d6581bea0939"
      unitRef="usd">-100000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzYtNS0xLTEtNTEzNTM_68274680-ecf0-45d1-80c7-57ef35d5e187"
      unitRef="usd">-2200000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserve
      contextRef="ic88f207a9dad4e4d801b44cf3af9f10c_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzEtMS0xLTEtMzE0MjI_68ef1dea-d455-41f3-bc47-ca75485e97e0"
      unitRef="usd">26400000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ic46fb38f58024911a0b78897bd8338eb_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzEtMy0xLTEtMzE0MjI_c44182d6-05d2-4c24-9328-d0b7f2b2e203"
      unitRef="usd">2800000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="iac503b6d629d4bafb262ea6ec0b8a25e_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzEtNS0xLTEtMzE0MjI_155beb7f-7923-4a02-8bc3-ace959579499"
      unitRef="usd">29200000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="i74053317be7e49ca93f4eade0b20f377_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzItMS0xLTEtMzE0MjI_ea7af4bd-9d7e-4e78-9fe9-e2f762f4be22"
      unitRef="usd">9900000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i9a14e7286e034496b3144a5acc8932d1_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzItMy0xLTEtMzE0MjI_98df128a-434f-454a-b819-2258135f740c"
      unitRef="usd">40600000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzItNS0xLTEtMzE0MjI_30210044-a509-4191-8764-cb3e6b6447b6"
      unitRef="usd">50500000</us-gaap:RestructuringCharges>
    <us-gaap:PaymentsForRestructuring
      contextRef="i74053317be7e49ca93f4eade0b20f377_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzMtMS0xLTEtMzE0MjI_0e89ccbe-d4cc-4c69-b7c3-36ad6ea4a63f"
      unitRef="usd">18100000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i9a14e7286e034496b3144a5acc8932d1_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzMtMy0xLTEtMzE0MjI_fd1be981-03ec-446b-a4ff-21007714204d"
      unitRef="usd">7600000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzMtNS0xLTEtMzE0MjI_14543499-75ea-41f5-aa4e-9956838538b6"
      unitRef="usd">25700000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i74053317be7e49ca93f4eade0b20f377_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzUtMS0xLTEtMzE0MjI_e7cbadd0-4404-4d7e-aa46-d5685fbe1ec3"
      unitRef="usd">0</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i9a14e7286e034496b3144a5acc8932d1_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzUtMy0xLTEtMzE0MjI_49ffd6a5-681a-4184-afe9-62bf30deeb17"
      unitRef="usd">-32900000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzUtNS0xLTEtMzE0MjI_04540337-88ab-439b-b184-9bbe34d6d213"
      unitRef="usd">-32900000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i74053317be7e49ca93f4eade0b20f377_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzYtMS0xLTEtMzE0MjI_a3e6ccd9-72d6-4b29-a3bd-b2fc205692b2"
      unitRef="usd">1800000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i9a14e7286e034496b3144a5acc8932d1_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzYtMy0xLTEtMzE0MjI_d9a8b37c-8612-4143-95bf-ad40d651ed6a"
      unitRef="usd">-100000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzYtNS0xLTEtMzE0MjI_4ceeab14-7805-4c38-a102-501174898195"
      unitRef="usd">1700000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserve
      contextRef="id700bedb414840799b353bf9084701c9_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzctMS0xLTEtMzE0MjI_fa0d9792-03c0-4320-a925-3e53164c95dd"
      unitRef="usd">20000000.0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i864f1b9d64574c8c88114fc001040dd2_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzctMy0xLTEtMzE0MjI_b06dd484-0e62-42aa-b242-9c1676175132"
      unitRef="usd">2800000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i36d66b81144849148d1319e8bfed3c96_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzctNS0xLTEtMzE0MjI_ec3cfc07-68d8-437f-b477-de2f8b037252"
      unitRef="usd">22800000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="i1ac0bcd2e1264e8b8347af73e216d016_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90ZXh0cmVnaW9uOjQ3ZDBjNDk5MjMxODRjNTJhY2JiYTAzZTJmN2NjNTU4XzMxNTU_de8c3256-7dd6-459d-9d53-9944f9a5b86b"
      unitRef="usd">623800000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i7ed92dccf2314bd48c7373be7cf33d4e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90ZXh0cmVnaW9uOjQ3ZDBjNDk5MjMxODRjNTJhY2JiYTAzZTJmN2NjNTU4XzMxNTk_fb2fd14a-328d-4380-9161-f957b0fcf7f1"
      unitRef="usd">5800000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i3ccdc9914af44b1bb1229e19c17326d8_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90ZXh0cmVnaW9uOjQ3ZDBjNDk5MjMxODRjNTJhY2JiYTAzZTJmN2NjNTU4XzMxNjM_aa4c1cc7-14f6-423b-a6cd-613a93443b23"
      unitRef="usd">138100000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i02b3f133daa24190abd49dfdef6bb6ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90ZXh0cmVnaW9uOjQ3ZDBjNDk5MjMxODRjNTJhY2JiYTAzZTJmN2NjNTU4XzMxNzA_617e7b27-b4d4-4de7-8b17-7fd691ea02b3"
      unitRef="usd">94100000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="icd84b99acf144bc78660b64776c157a5_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90ZXh0cmVnaW9uOjQ3ZDBjNDk5MjMxODRjNTJhY2JiYTAzZTJmN2NjNTU4XzMyOTg1MzQ4ODcxNTI_1395ef22-c549-4c0d-b483-b10b588576a1"
      unitRef="usd">30400000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="iec0737b261124d3f87ea9adcdb407b5a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90ZXh0cmVnaW9uOjQ3ZDBjNDk5MjMxODRjNTJhY2JiYTAzZTJmN2NjNTU4XzMyOTg1MzQ4ODcwNjk_70642c01-101d-45f6-bf91-6a987262a2d0"
      unitRef="usd">292100000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i4e0c5048f8f84f26a1949d61f3285173_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90ZXh0cmVnaW9uOjQ3ZDBjNDk5MjMxODRjNTJhY2JiYTAzZTJmN2NjNTU4XzMyOTg1MzQ4ODcwNzg_6d9df001-ca1f-4659-9810-3e155bda008c"
      unitRef="usd">18400000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i2d06b2c023334d92a7c83b2943f0232b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90ZXh0cmVnaW9uOjQ3ZDBjNDk5MjMxODRjNTJhY2JiYTAzZTJmN2NjNTU4XzMyOTg1MzQ4ODcwODM_824f206e-c7a6-4f1f-8c3a-e6e34bf722e8"
      unitRef="usd">2900000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i281863eb67c44d0fbc00294dfaf0049c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90ZXh0cmVnaW9uOjQ3ZDBjNDk5MjMxODRjNTJhY2JiYTAzZTJmN2NjNTU4XzMyOTg1MzQ4ODcwOTQ_5149bc27-40ff-4eb3-b4eb-58c0f3fcef93"
      unitRef="usd">8400000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i864642c0e47a4b87a88be339d6673670_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90ZXh0cmVnaW9uOjQ3ZDBjNDk5MjMxODRjNTJhY2JiYTAzZTJmN2NjNTU4XzU0OTc1NTgxNDY3NDA_d72e1a06-78e2-42fd-a158-ce515686dc80"
      unitRef="usd">100400000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i94d3655a9cb44f37b3319f0d91bf87b1_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90ZXh0cmVnaW9uOjQ3ZDBjNDk5MjMxODRjNTJhY2JiYTAzZTJmN2NjNTU4XzU0OTc1NTgxNDY3NTY_5aaa1086-58fb-4132-9d9a-d221848fd0ef"
      unitRef="usd">4200000</us-gaap:RestructuringCharges>
    <vtrs:Developmentandsalesmilestonepayments
      contextRef="i500214b091fd4491a3e5f7c09d556da9_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDEvZnJhZzplM2FlYTcwNGZkOWY0OTZlOGIyOGRkODZhZDYxMDkwNi90ZXh0cmVnaW9uOmUzYWVhNzA0ZmQ5ZjQ5NmU4YjI4ZGQ4NmFkNjEwOTA2XzEzNzc_64be736d-6398-44a9-8936-815d2c2a5dfb"
      unitRef="usd">351000000</vtrs:Developmentandsalesmilestonepayments>
    <vtrs:Developmentandsalesmilestonepayments
      contextRef="i65836be0391145f5a3e61375cecd6594_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDEvZnJhZzplM2FlYTcwNGZkOWY0OTZlOGIyOGRkODZhZDYxMDkwNi90ZXh0cmVnaW9uOmUzYWVhNzA0ZmQ5ZjQ5NmU4YjI4ZGQ4NmFkNjEwOTA2XzE0Nzc_46dc0141-68a1-496a-8071-aaeaf43e395a"
      unitRef="usd">18000000</vtrs:Developmentandsalesmilestonepayments>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i26f84e3d52854c23bc765376727d547d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDEvZnJhZzplM2FlYTcwNGZkOWY0OTZlOGIyOGRkODZhZDYxMDkwNi90ZXh0cmVnaW9uOmUzYWVhNzA0ZmQ5ZjQ5NmU4YjI4ZGQ4NmFkNjEwOTA2XzcxNDY4MjU1OTkzNTA_f013c0dd-b299-4003-8bec-d641d44454fa"
      unitRef="usd">30000000</us-gaap:ResearchAndDevelopmentExpense>
    <vtrs:NumberOfDrugs
      contextRef="i86776889abae4015b5e341878a1f94e0_I20160108"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDEvZnJhZzplM2FlYTcwNGZkOWY0OTZlOGIyOGRkODZhZDYxMDkwNi90ZXh0cmVnaW9uOmUzYWVhNzA0ZmQ5ZjQ5NmU4YjI4ZGQ4NmFkNjEwOTA2XzM1ODI_01deee21-173c-4f89-ac9e-b0449a6498a2"
      unitRef="drugs">6</vtrs:NumberOfDrugs>
    <vtrs:PaymentsToAcquireCollaborativeAgreement
      contextRef="i20265a72ee5044e7aae84f97919d0147_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDEvZnJhZzplM2FlYTcwNGZkOWY0OTZlOGIyOGRkODZhZDYxMDkwNi90ZXh0cmVnaW9uOmUzYWVhNzA0ZmQ5ZjQ5NmU4YjI4ZGQ4NmFkNjEwOTA2XzcxODk_29abf202-9df0-4a6b-9c9d-1920d8fb6444"
      unitRef="usd">18500000</vtrs:PaymentsToAcquireCollaborativeAgreement>
    <vtrs:Developmentandsalesmilestonepayments
      contextRef="i8c6221856b4642fdaae580491808b3ca_D20150130-20150130"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDEvZnJhZzplM2FlYTcwNGZkOWY0OTZlOGIyOGRkODZhZDYxMDkwNi90ZXh0cmVnaW9uOmUzYWVhNzA0ZmQ5ZjQ5NmU4YjI4ZGQ4NmFkNjEwOTA2Xzc3Njk_52c2c157-70b3-46d2-ae26-f7ced786c56a"
      unitRef="usd">293000000</vtrs:Developmentandsalesmilestonepayments>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i1c6036278a4b49a4901cdd582be7d9f0_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDEvZnJhZzplM2FlYTcwNGZkOWY0OTZlOGIyOGRkODZhZDYxMDkwNi90ZXh0cmVnaW9uOmUzYWVhNzA0ZmQ5ZjQ5NmU4YjI4ZGQ4NmFkNjEwOTA2Xzc4MjY_3842de4f-e6e6-460c-8a0e-61aa003213b5"
      unitRef="usd">50000000</us-gaap:ResearchAndDevelopmentExpense>
    <vtrs:InsulinAnalogProducts
      contextRef="i13a8322297064621abf63668185d09b7_D20130211-20130212"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDEvZnJhZzplM2FlYTcwNGZkOWY0OTZlOGIyOGRkODZhZDYxMDkwNi90ZXh0cmVnaW9uOmUzYWVhNzA0ZmQ5ZjQ5NmU4YjI4ZGQ4NmFkNjEwOTA2XzgwNDU_ab6b0f19-2491-4046-a9d4-bef959b2afb2"
      unitRef="product">3</vtrs:InsulinAnalogProducts>
    <vtrs:PaymentsToAcquireCollaborativeAgreement
      contextRef="i9e5713b803ec4eaf933db1df619dac04_D20180920-20180920"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDEvZnJhZzplM2FlYTcwNGZkOWY0OTZlOGIyOGRkODZhZDYxMDkwNi90ZXh0cmVnaW9uOmUzYWVhNzA0ZmQ5ZjQ5NmU4YjI4ZGQ4NmFkNjEwOTA2XzEwODk4_74bf2673-a2c3-4208-ae9c-53157530557c"
      unitRef="usd">25000000</vtrs:PaymentsToAcquireCollaborativeAgreement>
    <vtrs:Developmentandsalesmilestonepayments
      contextRef="i9e5713b803ec4eaf933db1df619dac04_D20180920-20180920"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDEvZnJhZzplM2FlYTcwNGZkOWY0OTZlOGIyOGRkODZhZDYxMDkwNi90ZXh0cmVnaW9uOmUzYWVhNzA0ZmQ5ZjQ5NmU4YjI4ZGQ4NmFkNjEwOTA2XzEwOTI3_ded1d7e3-55eb-4f58-b23b-eaab59bf0636"
      unitRef="usd">10000000</vtrs:Developmentandsalesmilestonepayments>
    <vtrs:PaymentsToAcquireCollaborativeAgreement
      contextRef="i1060ce14d7454734a57fb560f05c5dc2_D20190227-20190227"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDEvZnJhZzplM2FlYTcwNGZkOWY0OTZlOGIyOGRkODZhZDYxMDkwNi90ZXh0cmVnaW9uOmUzYWVhNzA0ZmQ5ZjQ5NmU4YjI4ZGQ4NmFkNjEwOTA2XzExMjM3_c46ac1e2-78b4-4a4e-8fb9-84908abe9b0f"
      unitRef="usd">33000000</vtrs:PaymentsToAcquireCollaborativeAgreement>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i1060ce14d7454734a57fb560f05c5dc2_D20190227-20190227"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDEvZnJhZzplM2FlYTcwNGZkOWY0OTZlOGIyOGRkODZhZDYxMDkwNi90ZXh0cmVnaW9uOmUzYWVhNzA0ZmQ5ZjQ5NmU4YjI4ZGQ4NmFkNjEwOTA2XzEwOTk1MTE2NjQ5ODA_36a59fe3-f239-4121-9e22-071677fe20bb"
      unitRef="usd">23300000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="idf043a2e2c394069bf7b417157fabff5_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDEvZnJhZzplM2FlYTcwNGZkOWY0OTZlOGIyOGRkODZhZDYxMDkwNi90ZXh0cmVnaW9uOmUzYWVhNzA0ZmQ5ZjQ5NmU4YjI4ZGQ4NmFkNjEwOTA2XzEyNTMz_389cab51-e896-4700-800f-9c21dc8cb7ab"
      unitRef="usd">10000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
      contextRef="idc22e99190de4591a027585c2ec34f85_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDEvZnJhZzplM2FlYTcwNGZkOWY0OTZlOGIyOGRkODZhZDYxMDkwNi90ZXh0cmVnaW9uOmUzYWVhNzA0ZmQ5ZjQ5NmU4YjI4ZGQ4NmFkNjEwOTA2XzEyNjky_250e911a-2280-4c72-89b6-ae5f0a2dc896"
      unitRef="usd">25000000</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i6d1a10fafb2f499895da7c0d46a48ae3_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDEvZnJhZzplM2FlYTcwNGZkOWY0OTZlOGIyOGRkODZhZDYxMDkwNi90ZXh0cmVnaW9uOmUzYWVhNzA0ZmQ5ZjQ5NmU4YjI4ZGQ4NmFkNjEwOTA2XzU0OTc1NTgxNjc1NTA_b1416de8-eff7-4046-bcc9-395e74000535"
      unitRef="usd">40000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="ida50edb50e464fd8bfedb0e9bb7be1aa_D20221001-20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDEvZnJhZzplM2FlYTcwNGZkOWY0OTZlOGIyOGRkODZhZDYxMDkwNi90ZXh0cmVnaW9uOmUzYWVhNzA0ZmQ5ZjQ5NmU4YjI4ZGQ4NmFkNjEwOTA2XzEwOTk1MTE2NjU5NTE_4ef9e5d6-d7c3-488a-80ad-4b64cfff7099"
      unitRef="usd">2000000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1
      contextRef="i07eb4f1ce070466a990b0cd1a54b7b81_D20221001-20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDEvZnJhZzplM2FlYTcwNGZkOWY0OTZlOGIyOGRkODZhZDYxMDkwNi90ZXh0cmVnaW9uOmUzYWVhNzA0ZmQ5ZjQ5NmU4YjI4ZGQ4NmFkNjEwOTA2XzEwOTk1MTE2NjU5NjU_dd4dfe16-7228-4ab3-aaee-5c755c5510e1"
      unitRef="usd">1000000000</us-gaap:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1>
    <vtrs:DivestitureOfBusinessDeferredCashConsideration
      contextRef="i6d397ca7ee644114993a26171508834d_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDEvZnJhZzplM2FlYTcwNGZkOWY0OTZlOGIyOGRkODZhZDYxMDkwNi90ZXh0cmVnaW9uOmUzYWVhNzA0ZmQ5ZjQ5NmU4YjI4ZGQ4NmFkNjEwOTA2XzEwOTk1MTE2NjU5Nzk_312d1a1f-4f96-49c2-8f6f-13d0851a2533"
      unitRef="usd">335000000</vtrs:DivestitureOfBusinessDeferredCashConsideration>
    <vtrs:DivestitureOfBusinessPercentageOwnershipInCombinedCompanyAfterTransaction
      contextRef="ida50edb50e464fd8bfedb0e9bb7be1aa_D20221001-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDEvZnJhZzplM2FlYTcwNGZkOWY0OTZlOGIyOGRkODZhZDYxMDkwNi90ZXh0cmVnaW9uOmUzYWVhNzA0ZmQ5ZjQ5NmU4YjI4ZGQ4NmFkNjEwOTA2XzEwOTk1MTE2NjU5OTM_c336e598-264a-4ef7-b3dd-4da97370dfa7"
      unitRef="number">0.129</vtrs:DivestitureOfBusinessPercentageOwnershipInCombinedCompanyAfterTransaction>
    <vtrs:DivestitureOfBusinessTransitionServicesAgreementTerm
      contextRef="i6d397ca7ee644114993a26171508834d_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDEvZnJhZzplM2FlYTcwNGZkOWY0OTZlOGIyOGRkODZhZDYxMDkwNi90ZXh0cmVnaW9uOmUzYWVhNzA0ZmQ5ZjQ5NmU4YjI4ZGQ4NmFkNjEwOTA2XzEzMTk0MTM5NTcxNTUz_aef04005-3074-4a6e-8f9b-c1b3b8ee4cf6">P2Y</vtrs:DivestitureOfBusinessTransitionServicesAgreementTerm>
    <vtrs:LossContingencyNumberOfStates
      contextRef="i2b28bb833a94474bbc11b88b345af593_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzM5MDY_c74828d3-8c9a-4c99-b73c-cd94a0517aff"
      unitRef="agreement">17</vtrs:LossContingencyNumberOfStates>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i12d72077c53340de89fc310d8eef6974_D20220201-20220228"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzU0OTc1NTgxODY2MzM_d985c537-1396-4975-ad3d-f7e6599c147d"
      unitRef="usd">264000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i6a9f5404bef24f4984a0f8f1a0ff008c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzMyOTg1MzQ5Mjc5Mzk_64732030-d0e6-4d51-80ba-18e2344a8e08"
      unitRef="usd">264000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LitigationReserve
      contextRef="i948e502442cc4e7ab6948ef233636a44_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzEwOTk1MTE2NzE0NjI_376acb54-2f03-4973-8ccf-5430746388c6"
      unitRef="usd">274000000</us-gaap:LitigationReserve>
    <vtrs:Numberofstates
      contextRef="i6fb31abf3cd3486d8d73aaca15da3160_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzk2NTE_af642830-36b7-4988-b9fd-780a1d7ba3e0"
      unitRef="state">47</vtrs:Numberofstates>
    <vtrs:Numberofstates
      contextRef="i1370ea34e27342908b81e9cd1ce42f04_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzk5MTA_01002c21-780c-4dcb-a181-2f3d458beade"
      unitRef="state">37</vtrs:Numberofstates>
    <vtrs:Numberofstates
      contextRef="i9b8d7536128a476ab103cb2abe72db8f_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzEwNzAw_dc892f10-9a8d-4974-9c00-6d599211362b"
      unitRef="state">48</vtrs:Numberofstates>
    <vtrs:Numberofstates
      contextRef="i34298ab2efbf46afb7c78ba25e12f901_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzEwODM3_89c3191f-7b44-4393-8b19-2ff9622dfb69"
      unitRef="state">43</vtrs:Numberofstates>
    <vtrs:Numberofstates
      contextRef="i6fb31abf3cd3486d8d73aaca15da3160_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzEwOTk1MTE2NzU1MjY_6be630ca-f5b1-43c1-96e2-7eaa04992506"
      unitRef="state">47</vtrs:Numberofstates>
    <vtrs:Numberofcases
      contextRef="i9b5b6f53dc884bc28cf189d394d6db66_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzE3MzA5_61f7a15f-2702-4bae-a1ae-899fb1869edc"
      unitRef="case">1000</vtrs:Numberofcases>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i13c638ed56d343c18493f03648ee836f_D20140708-20140709"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzEwOTk1MTE2NzE1NDQ_37b18e20-2b70-47a1-9dc9-9751c172255e"
      unitRef="eur">17200000</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesPaidValue
      contextRef="i2fc086de1758443786ac3ba535a5b44a_D20141001-20141231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzEwOTk1MTE2NzE1Nzg_9fa40fcc-a8a7-4baf-9565-2680e2b78f9b"
      unitRef="usd">21700000</us-gaap:LossContingencyDamagesPaidValue>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i27d7d7f87c3b47c29d865299535c55cc_D20130601-20130619"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzEwOTk1MTE2NzE2MTI_17d89e39-babd-487f-b257-ab1b1954d5da"
      unitRef="eur">7800000</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i27d7d7f87c3b47c29d865299535c55cc_D20130601-20130619"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzEwOTk1MTE2NzE2NDQ_17d89e39-babd-487f-b257-ab1b1954d5da"
      unitRef="eur">7800000</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="ib6585ef5edb5465980d61d05bc81776b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzEwOTk1MTE2NzE2NzQ_45dde0d0-d3aa-4055-8bd0-207ca3888316"
      unitRef="usd">11400000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i9abf215c0b25446ba1f1eee1bfce3634_D20160212-20160212"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzIxNDIw_a8253e87-34fe-418e-bb84-0b3efab4d05c"
      unitRef="gbp">5800000</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="if4052220c0bc4de89dc871350ec90cb2_D20160212-20160212"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzIxNTU5_52a4e03d-aae2-4306-9e68-29a1b30654d3"
      unitRef="gbp">2700000</us-gaap:LossContingencyDamagesAwardedValue>
    <vtrs:LossContingencyDamagesAwardedOnAppealValue
      contextRef="i9abf215c0b25446ba1f1eee1bfce3634_D20160212-20160212"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzEwOTk1MTE2NzE3MjU_2237fb2d-3b38-4157-9cbe-5c312fbf81e9"
      unitRef="gbp">3900000</vtrs:LossContingencyDamagesAwardedOnAppealValue>
    <vtrs:LossContingencyDamagesAwardedOnAppealValue
      contextRef="if4052220c0bc4de89dc871350ec90cb2_D20160212-20160212"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzEwOTk1MTE2NzE3Mzk_abe317e2-ecc5-4ff6-a05f-42abf9dce325"
      unitRef="gbp">2050000.00</vtrs:LossContingencyDamagesAwardedOnAppealValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="if54570ea2c7a42cc914556ebc926584c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzEwOTk1MTE2NzE3ODA_4ff4b53f-3252-4824-8862-541b58e3e9d7"
      unitRef="gbp">8800000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i42721f7bfaa74a20b33b1b57026a7ec6_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzEwOTk1MTE2NzE4MzM_247b6ef9-f502-48f1-9975-7e5bbb857e5a"
      unitRef="usd">74800000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <vtrs:NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement
      contextRef="i3ab3ba0c16f64666aae7af1ec4b0cb80_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzI3OTk5_f178c4eb-f028-4eb7-8d5b-3f3726179f3d"
      unitRef="increase">3</vtrs:NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement>
    <us-gaap:LossContingencyDamagesPaidValue
      contextRef="i3ab3ba0c16f64666aae7af1ec4b0cb80_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzEwOTk1MTE2NzE4ODc_e5086076-5d9c-4f0d-88fe-64c7097934e4"
      unitRef="usd">226900000</us-gaap:LossContingencyDamagesPaidValue>
    <us-gaap:LossContingencyPatentsAllegedlyInfringedNumber
      contextRef="i2c861875a03848f989ff86d891f1a81c_D20171024-20171024"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzI5NTEw_62d5062d-2fc2-4aca-ad5c-70beec71ff72"
      unitRef="patent">18</us-gaap:LossContingencyPatentsAllegedlyInfringedNumber>
    <us-gaap:LossContingencyPatentsAllegedlyInfringedNumber
      contextRef="i2c861875a03848f989ff86d891f1a81c_D20171024-20171024"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzI5NTM3_eb4fdd72-64dd-493d-b990-1f678aa460f5"
      unitRef="patent">18</us-gaap:LossContingencyPatentsAllegedlyInfringedNumber>
    <vtrs:LossContingencyRemainingClaimsNumber
      contextRef="i6531f624fba049f9a437e4af1aa3247a_I20171024"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzI5Njcz_b6557489-8805-40e7-8278-671a51a92129"
      unitRef="patent">2</vtrs:LossContingencyRemainingClaimsNumber>
    <vtrs:LossContingencyOtherAssertedPatentsNumber
      contextRef="i3c7914355ab94f1e9bb9a332a6d51ac5_I20190617"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzI5NzU0_78914d15-9101-4435-bf2a-d4825ac0d391"
      unitRef="patent">16</vtrs:LossContingencyOtherAssertedPatentsNumber>
    <us-gaap:LossContingencyPatentsFoundNotInfringedNumber
      contextRef="i13e9207c6fef454e969d51bd9b9e9635_D20190617-20190617"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzI5OTMx_5ae73c31-4496-40fd-bb01-2fa634b6aefe"
      unitRef="agreement">12</us-gaap:LossContingencyPatentsFoundNotInfringedNumber>
    <us-gaap:LossContingencyPatentsFoundNotInfringedNumber
      contextRef="i13e9207c6fef454e969d51bd9b9e9635_D20190617-20190617"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzMwMjEw_80c14001-d184-48c2-b183-1c3ec7b9b648"
      unitRef="patent">3</us-gaap:LossContingencyPatentsFoundNotInfringedNumber>
    <vtrs:LossContingencyRemainingClaimsNumber
      contextRef="i3c7914355ab94f1e9bb9a332a6d51ac5_I20190617"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzMwMjIw_c232ffd2-61fa-4f35-a99b-49bb3717d76f"
      unitRef="patent">4</vtrs:LossContingencyRemainingClaimsNumber>
    <us-gaap:LossContingencyPatentsAllegedlyInfringedNumber
      contextRef="i368a17b2f56f4f73a262f1f28352eca3_D20180910-20180910"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzMwNjY4_542b6657-14e6-4d70-afdb-514ae4af8068"
      unitRef="patent">5</us-gaap:LossContingencyPatentsAllegedlyInfringedNumber>
    <vtrs:LossContingencyRemainingClaimsNumber
      contextRef="i7341b8c6cd5240ccad4baad654635cb8_I20200402"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzMwODg2_16aa4ae4-5b78-498f-bbb3-8d6da51a7cca"
      unitRef="patent">2</vtrs:LossContingencyRemainingClaimsNumber>
    <us-gaap:LossContingencyPatentsAllegedlyInfringedNumber
      contextRef="i9357aa4ee46c43e4a8bacdddc6635174_D20170630-20170630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzMxNTI5_368121ff-f3a4-4290-9e69-b0064108bc93"
      unitRef="patent">6</us-gaap:LossContingencyPatentsAllegedlyInfringedNumber>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i03c3c6915b9e41e286944ec9d4c597df_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yNDQvZnJhZzo1YmM5NDQzNDE4NTI0YzgxODUzY2FjNGFiNTk1MWJjMC90ZXh0cmVnaW9uOjViYzk0NDM0MTg1MjRjODE4NTNjYWM0YWI1OTUxYmMwXzEwOTk1MTE2NzE5NDM_7fd94a95-6ba2-40b6-bea2-ab4b53a1c375"
      unitRef="usd">8400000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock
      contextRef="i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90ZXh0cmVnaW9uOjJiNGM3N2UwNDk2ZjRkNzM5NDcwY2U4MDk1ZGQ5NzdkXzQ4OA_68ee70a4-f46e-42ae-9be3-c2a4387fea83">&lt;div style="margin-bottom:3pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;VIATRIS INC. AND SUBSIDIARIES&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;SCHEDULE&#160;II&#160;&#x2014; VALUATION AND QUALIFYING ACCOUNTS&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Beginning&lt;br/&gt;Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Additions Charged to Costs and Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Additions Charged to Other&lt;br/&gt;Accounts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Deductions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Ending&lt;br/&gt;Balance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for doubtful accounts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance for deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;443.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;780.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;603.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(198.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;443.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;806.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(239.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;603.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i8aaae8d197ef43d0880965d47a937ced_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzItMS0xLTEtMzE0MjI_8463cf5d-914d-4da5-93d4-eb2ba58003f0"
      unitRef="usd">159900000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="idaab369eeea042ca842eb8d98bec6dfb_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzItMy0xLTEtMzE0MjI_e5e182fb-5e85-4c6b-a8ed-679bf8565036"
      unitRef="usd">16000000.0</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="idaab369eeea042ca842eb8d98bec6dfb_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzItNS0xLTEtMzE0MjI_5a90536c-1072-4da5-893d-ab7918200f14"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="idaab369eeea042ca842eb8d98bec6dfb_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzItNy0xLTEtMzE0MjI_43a544cc-a1a5-43d0-9991-22b0e99c3302"
      unitRef="usd">21400000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ic23fe954f12a4fafb334644ca65a1579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzItOS0xLTEtMzE0MjI_a63546b3-9446-4928-a5b8-55ca953e804b"
      unitRef="usd">154500000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i91018ff0be4748fdb394a71a73560ff1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzMtMS0xLTEtMzE0MjI_a27fd80d-c9bb-49c1-986b-151470bb8159"
      unitRef="usd">72800000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i166cc270ce584702a76fe3b6fb475148_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzMtMy0xLTEtMzE0MjI_7de01b11-d4c1-47f8-9142-b9c51628fbc7"
      unitRef="usd">16900000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i166cc270ce584702a76fe3b6fb475148_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzMtNS0xLTEtMzE0MjI_4b862aa8-f579-4576-8091-21bae3642471"
      unitRef="usd">77300000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i166cc270ce584702a76fe3b6fb475148_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzMtNy0xLTEtMzE0MjI_98bc0ff0-204c-42b7-890d-2d9c8e490c48"
      unitRef="usd">7100000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i8aaae8d197ef43d0880965d47a937ced_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzMtOS0xLTEtMzE0MjI_3df7413c-f864-440d-a949-ad20423c8f45"
      unitRef="usd">159900000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ic453dbe2bf5946b286bdd9f5cb841293_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzQtMS0xLTEtMzE0MjI_e7718e94-379c-47fa-9ea8-96ee1f42f561"
      unitRef="usd">98200000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="ia516f232fddf46f39a2dbdf6d82abbc9_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzQtMy0xLTEtMzE0MjI_35d21351-f337-468a-9dee-3f4f31307a8d"
      unitRef="usd">14200000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="ia516f232fddf46f39a2dbdf6d82abbc9_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzQtNS0xLTEtMzE0MjI_43be7b7e-3886-463a-aa54-e9fa798513b1"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="ia516f232fddf46f39a2dbdf6d82abbc9_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzQtNy0xLTEtMzE0MjI_9d3cddbf-9ef5-4a64-a63e-92c9a92e0196"
      unitRef="usd">39600000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i91018ff0be4748fdb394a71a73560ff1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzQtOS0xLTEtMzE0MjI_bbb45cd6-291a-4693-abd3-9d30a4eed3b4"
      unitRef="usd">72800000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i450c01c12e2d40dcadab0111243d7980_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzYtMS0xLTEtMzE0MjI_566dd4b5-512f-4ba7-a23a-d445076e4dbb"
      unitRef="usd">443600000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="ie71711028fa94d6fb804d5ada3c39b46_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzYtMy0xLTEtMzE0MjI_d633ac8c-fd33-43c7-af48-9f6d66f1c791"
      unitRef="usd">82200000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="ie71711028fa94d6fb804d5ada3c39b46_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzYtNS0xLTEtMzE0MjI_51011acb-9e0d-4496-bacf-e40d3a0b186d"
      unitRef="usd">260800000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="ie71711028fa94d6fb804d5ada3c39b46_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzYtNy0xLTEtMzE0MjI_e928faa5-c674-4e71-9998-ba1914b3ee0b"
      unitRef="usd">6200000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i431eb8d7201c49618c010a346ae6a384_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzYtOS0xLTEtMzE0MjI_9a34d336-3206-49b9-a69f-795ad7d2eabf"
      unitRef="usd">780400000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i0c9701f467284632ac6d7745e16a0f7d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzctMS0xLTEtMzE0MjI_8c6c2ffb-bbcc-437d-a931-7513608d10d7"
      unitRef="usd">603500000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="ifb67bdbafd2140308ea8ef185a517da0_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzctMy0xLTEtMzE0MjI_89783f8c-bde9-479b-8bfb-daac6973b23a"
      unitRef="usd">39000000.0</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="ifb67bdbafd2140308ea8ef185a517da0_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzctNS0xLTEtMzE0MjI_c30486f8-de66-4096-a319-db5ae4383b5f"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="ifb67bdbafd2140308ea8ef185a517da0_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzctNy0xLTEtMzE0MjI_be782e63-4d28-490a-b798-cd22b2433295"
      unitRef="usd">198900000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i450c01c12e2d40dcadab0111243d7980_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzctOS0xLTEtMzE0MjI_566dd4b5-512f-4ba7-a23a-d445076e4dbb"
      unitRef="usd">443600000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="iebbc9cdf0d824f2db02b60856d24cfa2_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzgtMS0xLTEtMzE0MjI_d044f6f5-0c9c-4ede-8f3f-a70ffb86c47b"
      unitRef="usd">806000000.0</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i816570cccc0745fcb3c38ba989d87af4_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzgtMy0xLTEtMzE0MjI_50b17804-3131-4ac0-ac7a-26eaad0ddc39"
      unitRef="usd">36800000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i816570cccc0745fcb3c38ba989d87af4_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzgtNS0xLTEtMzE0MjI_f3dfec5c-f9cd-42de-a48f-95ec4ca2a17c"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i816570cccc0745fcb3c38ba989d87af4_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzgtNy0xLTEtMzE0MjI_5ed02768-d130-4ebd-a9ad-0813fb03c2e1"
      unitRef="usd">239300000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i0c9701f467284632ac6d7745e16a0f7d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yODAvZnJhZzoyYjRjNzdlMDQ5NmY0ZDczOTQ3MGNlODA5NWRkOTc3ZC90YWJsZTo3NTQ2MTBlN2U3YmU0NzQ1YThlYjdhZDM2NmQwMTQzYS90YWJsZXJhbmdlOjc1NDYxMGU3ZTdiZTQ3NDVhOGViN2FkMzY2ZDAxNDNhXzgtOS0xLTEtMzE0MjI_3af063d9-47ce-4552-8c0d-8fb90578f81f"
      unitRef="usd">603500000</us-gaap:ValuationAllowancesAndReservesBalance>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzItMS0xLTEtMzE0MjI_ea7af4bd-9d7e-4e78-9fe9-e2f762f4be22"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzItMS0xLTEtMzE0MjI_ea7af4bd-9d7e-4e78-9fe9-e2f762f4be22"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzItMy0xLTEtMzE0MjI_98df128a-434f-454a-b819-2258135f740c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzItMy0xLTEtMzE0MjI_98df128a-434f-454a-b819-2258135f740c"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzItNS0xLTEtMzE0MjI_30210044-a509-4191-8764-cb3e6b6447b6"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzItNS0xLTEtMzE0MjI_30210044-a509-4191-8764-cb3e6b6447b6"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90ZXh0cmVnaW9uOjQ3ZDBjNDk5MjMxODRjNTJhY2JiYTAzZTJmN2NjNTU4XzM0Njc_53218c48-f2e9-4b86-9cac-d0d5943a00a2" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90ZXh0cmVnaW9uOjQ3ZDBjNDk5MjMxODRjNTJhY2JiYTAzZTJmN2NjNTU4XzM0Njc_53218c48-f2e9-4b86-9cac-d0d5943a00a2" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">For the year ended December&#160;31, 2021, total restructuring charges for the 2020 Restructuring Program, in Developed Markets, Greater China, JANZ, Emerging Markets, and Corporate/Other were approximately $623.8 million, $5.8 million, $138.1 million, $94.1 million, and $30.4 million, respectively. <xhtml:div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;For the year ended December&#160;31, 2020, total restructuring charges, for both programs, in Developed Markets, Greater China, JANZ, and Emerging Markets were approximately $292.1 million, $18.4 million, $2.9 million, and $8.4 million, respectively. </xhtml:span></xhtml:div><xhtml:div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;For the year ended December 31, 2019, total restructuring charges for the 2016 Restructuring Program in Developed Markets and JANZ were approximately $100.4&#160;million and $4.2&#160;million, respectively.</xhtml:span></xhtml:div></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzItMS0xLTEtMzE0MjI_ea7af4bd-9d7e-4e78-9fe9-e2f762f4be22"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90ZXh0cmVnaW9uOjQ3ZDBjNDk5MjMxODRjNTJhY2JiYTAzZTJmN2NjNTU4XzM0Njc_53218c48-f2e9-4b86-9cac-d0d5943a00a2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzItMy0xLTEtMzE0MjI_98df128a-434f-454a-b819-2258135f740c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90ZXh0cmVnaW9uOjQ3ZDBjNDk5MjMxODRjNTJhY2JiYTAzZTJmN2NjNTU4XzM0Njc_53218c48-f2e9-4b86-9cac-d0d5943a00a2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90YWJsZTo2NDM3ZmIyOTM2YWI0N2ZlYTQzYzA5OTAxNTQ1Y2VmMC90YWJsZXJhbmdlOjY0MzdmYjI5MzZhYjQ3ZmVhNDNjMDk5MDE1NDVjZWYwXzItNS0xLTEtMzE0MjI_30210044-a509-4191-8764-cb3e6b6447b6"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmUyZmRmYmYzZWQ0NzRmMjdiMjBlZjE2MTU1YmZkZjcyL3NlYzplMmZkZmJmM2VkNDc0ZjI3YjIwZWYxNjE1NWJmZGY3Ml8yMzgvZnJhZzo0N2QwYzQ5OTIzMTg0YzUyYWNiYmEwM2UyZjdjYzU1OC90ZXh0cmVnaW9uOjQ3ZDBjNDk5MjMxODRjNTJhY2JiYTAzZTJmN2NjNTU4XzM0Njc_53218c48-f2e9-4b86-9cac-d0d5943a00a2"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>145
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M75R_7[,KAN),R:=(^-6IQ#%G(XQ::0DNKN6OJ<VD-F -?T3KX^\'CNCV/'>
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M(A>U_OFGA.#X??<Y_=_(.)]K%"PR+5BWJBRAI&JCLN]7Z%UP&6#0@AI!+]Q
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M%18_LAS>['B140FWQ7XAC@6CV\HH2Q?$MOU%1I-\MEI6SYZ+U9*?9)KD[+E
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M#M5;&ZBDMP^,^T[K2XW]N(>I+P6%-#G[V>%A[]1EO?_N1@;A#'WW@AOK%<[
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M0@O ]S7GZOB@%VA&]?G?4$L#!!0    ( $6!7%3*>_DQ>P<  '\C   8
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M;-==&'5L7S_;*F/4H?VXEQE8;PN WW=*F><+>X/S*X\W_P-02P,$%     @
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MI!AGF7 _3O8X MPI)!['@ &^X6/X([<'4^4^FS6*._VGN3\[^OIJ&_,=0\N
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M]KS^!HZ+/*>#>$J-6 <6U_$.B];=4MBID+,D9UNVC+.6>R43\Y3B:@J;(R(
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M(8=*0*E<\>::';:T16([I<_[4,B-R3DW3)8-R,,RQ@H8A+\E=\6AUQ1:E'P
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M(3B*!^C[5=/T[A=,X/]<Z=?_ U!+ P04    " !%@5Q4#!1U$*<0  "I+0
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MW.@$)GP<-\)7F[HSK_I!P7'%.*U&N$')4;J680X4QPK>N.M8"9,%1OW)(#&
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MG8OSXIR[\3O5@I=?S=T_M4I\@>U?:&"&&T\CMSN(?.?%Z=S2TQ+&I'"G*Y>
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M'=("_+XRIHI?Z(#F[>Q7_PU02P,$%     @ 18%<5(N8B"]L"   0Q0  !D
M  !X;"]W;W)K<VAE971S+W-H965T,30N>&ULM5@-;]LV&OXKA%<,":#9$O6=
M)0&2-)?KW=H+FEYOV^%PH"7:YBJ)'DGG8[]^STO)LM,FV=V %FA,D>\WG_=#
M.K[3YI-=2>G8?=MT]F2R<FY]-)O9:B5;8:=Z+3N<++1IA<.C6<[LVDA1>Z:V
MF?$PS&:M4-WD]-CO79O38[UQC>KDM6%VT[;"/)S+1M^=3*+)=N.]6JX<;<Q.
MC]=B*6^D^^?ZVN!I-DJI52L[JW3'C%R<3,ZBH_.$Z#W!1R7O[-Z:D2=SK3_1
MPYOZ9!*20;*1E2,) C^W\D(V#0F"&;\.,B>C2F+<7V^E_\7[#E_FPLH+W?Q+
MU6YU,BDFK)8+L6G<>WWW5SGXDY*\2C?6_V5W/6V23UBUL4ZW S,L:%77_XK[
M(0Y[#$7X# ,?&+BWNU?DK7PMG#@]-OJ.&:*&-%IX5STWC%,=7<J-,SA5X'.G
M[^6M[#:2O9>57G:JCU17L[.JTIO.63J0ZE;,&WD\<U!(;+-J$'[>"^?/"(\X
M>ZL[M[+LLJME_5C #):.YO*MN>?\18FO935E<10P'O+H!7GQZ'[LY<5_X/["
MZ)9=P%8#F. *W(I=^.!+P_Y]-K=^_S\O*$Q&A8E7F'R=>+\HG!+XR*Y%)4\F
MR% KS:V<_#\:V8<50J$;9*KJELSY/2^)Z!P.+W2[%MW#M]\4/,J_MZQ#V;"B
MD9;-'T"IZPW"5PDGE]H\0)1A4E0KIA=,;PR2>*U-+]7*9>NE$@U)?I#"6"8)
M)PRW+-LY0K^]:?\W#+S=/(S* *+L6OJ,;AZ.V,&;#LG1-/#-'GH.]@Z6W7C+
MK@>S+K9FO49$&I2UFKT5YI.$$5>H9P[Z+E:J$^QO9^]^9I>X^B5%84OS03O1
ML',#&RQ+@SPMIYSQ@(?YM&!1$)7Y-,)OEN?8C\*@2*)I[ /6R'MV=>^-/U?:
M*EA*OD8!!TG&0M GV31E:>PEQ0F'I"O92:,JR^(@X?FT9 D.\Z(G2:)XFL.(
M+";FWK*/2CBC+'M%RA->@. 5V1=QL- JA)@$JSB(DL2?1GE00%+V9?S"KQR_
M."AY"!LX?"Y9%N73D"5)C("E 8\3[+T<N)#[P.4L(>^2$HYAMTP1Q;W Q44.
MLI2DQG2$V&818@L=18GGSP-7!&D40C>BA=NE7[I7XJ=5X>\'*RPC.OX\:E'Y
ME:.6P)H2]A/FX%=,\4HX]Q[%&?V^&+7( R#$?TZ>P,6<HA813L>H\: $)%*6
M04.&J"4#3A-HS\L,;G\9-9Z$N#]$+4K U4>-0P:M<NCB?=3B/(2F%VO,KIY0
ME6(5(JL;52-,-35?U=>+OJFS3W*L.8_KR'-EY/-"\1/17CY-RVYZ)7^'DJM&
MS^'R]5;7#VJM'/1]^TV4)]][-[.,W'RGS:VPU?:@X)1G/SP@L&*[ER,S4XK>
MTHQ[=),%NURK:]D-6V<;I[][T_T"$S0N+RXC2,+P(N<&USL0Q<CCA%TN%O)^
M9TT<91!V820BN-T*2VS]K!N]<-L]7B2XC!]%(^8]N#C/<(E[7M_T)7KG]IMN
MT6QN1;7SFP..,3MKT55^&[U!(L##'T4G1D.C(@5P7C^TRKJ1+LH**/QILY:-
M4;O-")3_W?O'#L2A!\W0>UBM 8]..U8K6S7:RCW4$ J(9H0%(4C5TN"**_!+
MI_J> 0SA@-93=C _W#FY%5ICRGI@U4IT2\E4QQ8;MS% *K)$US; 5M5L:H*P
ML$ J (PYD!J=E<+J3C3*/00[G;@,F-9A2MUVR49L.HS8%OHKTJ]P/DAG IK(
MPR$O8$R-#NXTLPHM? $X=94D9:.?HOIUH\A+6+,6QELR-.PYJ@L9,&4?A5$^
MWRZ&J(@_/PV0RPANI1K52X'"I='6#C<!8Q\-!WX.V)F_-R6 \79K6/7(L'IC
MO.;_;3QX=CIX+LV?F!J\'%_)K_9\0<\,@Q3EG]HGY!>^"OMEB/;*!^+!95'_
M@M'13S='J.W"+.5<5)\L.TB#% T[.F0'<9"EV93[%65G=HC SQ$1( MWVFKR
M'R4':]2)UGK?- )A!I,$70NA &*S($*ASKRP/$.CZQ5PY":)!6X[4,5(>$^#
M_1R_/,94<<BN]*TT'5D+=<;;L--ZD%&?]$R8<O";0#SL[UO \AFO$9F#B =Y
M7!(/'HH@S$OR%NL\R-!-H/C=B(Z]062ONS[;,I0''QZ1['?"U%NH#X!2U#S^
M"%)/=8-SU$)**^&^0%B(MP%CAF)XJ_P;Z7O9^+8$__N._U;4OE+XM-N2^X1F
M;U$34#W:O:VSO7C1Y2+O&F$MY%RL)- RHQ)>*RJ[UFYZ/1]6"NY>([W)2:K[
ME/IP%B^H>/WLV.7]4+!>\"5ZA,E7+$5MI@8]@!.KK <ZP15GB;^VB+ #(M^'
M_C14HR#-,USH@%BHR#TFLX!GN4\,3!# "5U\C.:P!6\:$R(\@AG/2IP<),C!
M$ PY@3DKJ.>]".4XHFG)XQG "DEY'J8^!;V@N"S'49IFY# :9N0!R+1)T?#!
MP#'2-_>1B3EEB&=):2)%)34;T8P3B?5&]*#I*_NNJ@]H>33F+%"N459A!GJE
MDP-"+!RB2N^%@*V6F!Q;U1&8*?U,_Y;71]]WI,J_S7Y'F'+$(;85WHP5/O"L
M!XJ:EG,-E-\J,'K<'>[=8S6@&:5^CGKOT4=<:Z&\#Y6PJ\/IKH?L-'SF+ZD#
M7/<082B+?)'77P0K8'<KA:YQA_;M.RGF33FF^ZX@/ GROAG02^-+KXJ/^!X]
M/.%,'RX_[17%,.@6>!,IV3^>#5,T#.;]G%WL \RC90>UISXNS/8^[-";@?]\
M14,-+.N_\8R[XQ>RL_[#T(Z\_[R&%PJ\6%C6R 58H3J=,--_LNH?G%[[ST1S
M[9QN_7(E4=(,$>!\H;7;/I""\;OAZ>]02P,$%     @ 18%<5.R<@-<:!P
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M']M*5N<"%C#K:!L_V';+7Y7X@RSG+ IGC <\?$5>=/0U\O*B-_K*_GVSM,X
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M.CU)HV-UG(W/>'2BLCEX"Z-3^(XYL G2LH1WZG0^SM3' 8MMV^8 YIGN^"+
M%=]&814HX8!F.[MZW_CH0"7FVQN*=7^,?".%^V?M\%A-_/'PF1]+%*D8XQ;=
MT+>VZ;A9K@(->O<.YB+!W,'LZ!XM!^HKC N63]O^8.N-<>M)H+G^9;MA9<'+
M$Y8^2X4R5J]=(IQ4-\2WQH?B@-^I6,RFL[/=,ZC4Q?V8"+ Z2)??\^AL<- <
MJH/Y=/QLYY0ZF.\((('L(@)I-^/!!:^_/X2."'(+5C!+ _2#2T[ ]<-R7 _5
MBFKH6MGC7H8ZL(G6\XY4@\8Q_.#A(E>^CJZ7O><0&#]TDYT,W@ 5^96\=(*2
M7DS/@>WL]C%UE=X0W\332^RM]BL#%K.TA"KBAK>+3Z^;]!%=(R^*A8NXW,FP
MQ(.0/ M@?>EP^G4?O,'VB7GY+U!+ P04    " !%@5Q4OVXQ@D4&  !D$
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M(_15/#ENQ>/Y^[5T"X751],<JL/^R;0C7#S3Q@=ORW".G%F/4VFXS4F":RR
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MD)M$QX3B3"8@$DJ0;0/<KH&G"Z"0L38 #^6+YNV)<J8BLTCU_RH4"*%DEH)
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MNEF@KPPMT7&[!23U;O0QW :A(G-JBQO 9"($)$#-YXJJV%Q+8T:8^1PTB[&
MC+PQ1"/#FYN#D#-ORZU8N<+(:J5BY!=G9>TBR9[5D%MDP5^)!<^*V9_W$;".
MWB,F#Q#&\NZA>7U6Q/[<L,,YQP0IQ02PO]))'@':([<OJ*C1;T./$>F-2C"
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M-TV3?>H'RY+,>^YX]]Q#FD=KI3^9A1"6W.1988X["VN7A_V^218BY\972U'
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M@]*(JP=A.'3LMMG!_JYRZD)7P,B_&?3+.#,PAA3[9U2WK@'U>"KN!/UXC,$
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M29.5LB2 ]RN#KMO<T ;=Y_C+_P)02P,$%     @ 18%<5)N2T]N&"0  0QD
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M-CECVG^R]P.K:O>9'.%M5>EN-P*MEZ8)>+]2.)2' 6W0_6]R_3]02P,$%
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MIK&"T,<_>;7F37N=-NOD6\(S(BIDW'1C]FQ(9 5%[-B\+6D#,1J,0V!312/
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M FJ5R*C_PRG=*!>0J&_3CS$W?*%=N2CC[TTTAJ96Y$W:N&/G".>'GDLQ53/
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MU \H565H/PC1$$7$K<7=*JO>:16SX=Y9!8.<I*&];+PFZ&$#Z?%2Z.^HXX?
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MJZW-DO,Y/>Y^/!<7([]>S2Z2IUKNO;[]Q0VNU=X3?QE0QG/Y>\!QW0BZL'=
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M^,>U20F.X@'Z?EE5K?L%$_B_4?K-?P-02P,$%     @ 18%<5*,X%4$J P
M<@@  !D   !X;"]W;W)K<VAE971S+W-H965T,C<N>&ULY5;;;MLX$/V5@;I8
MQ$!6-\>NX[4-V$F+YB&%4:<MBJ(/M#2VB%*DEJ3B].\[)&VM%XV- MVWOHC#
MRYQS.$-R--DI_=54B!:>:B'--*JL;<9)8HH*:V9BU:"DF8W2-;/4U=O$-!I9
MZ9UJD>1I.DQJQF4TF_BQI9Y-5&L%E[C48-JZ9OK; H7:3:,L.@R\X]O*NH%D
M-FG8%E=HWS=+3;VD0REYC=)P)4'C9AK-L_'BRJWW"SYPW)DC&]Q.UDI]=9V[
M<AJE3A *+*Q#8-0\X@T*X8!(QC][S*BC=([']@']M=\[[67-#-XH\9&7MII&
MHPA*W+!6V'=J]P;W^QDXO$()X[^P"VL'>01%:ZRJ]\ZDH.8RM.QI'X<CAU%Z
MPB'?.^1>=R#R*F^99;.)5CO0;C6A.<-OU7N3."Y=4E96TRPG/SM;A62 VL"*
M;R7?\())"_.B4*VT7&YAJ00O.!JX>&!K@:8W22P1._>DV),L DE^@B3+X5Y)
M6QEX)4LL_PN0D.).=GZ0O<C/(MYB$4,_NX0\S;,S>/TN#'V/US^!]]Q^/\_7
MQFHZ-E_.$%QU!%>>X.H$P2NF):$;6**&&U77=")7%=,(<VLU7[?6!1<>%-Q_
M$TP^%^.S!.[RCDW#"IQ&=#L-ZD>,9@MF> %,EE!RT5HL 0\Z&M)AO !V+, J
M^, 9#1BXDQ1CMZ!@HF@%<^[,P$8)NLEF#)\(*R04*!U8KPG1I>3B3M))%8(N
MG;D$?"JPL<=TM8NTZ?G4N4]*G^P:@M8+H0S-=3+/BBM"'#UNI42)FDZI;&O4
MS"K=&\-;>M5^&?$/N,@N\^%UG/6</23KVEG9,!Z%'!)KB5+1]=SS?O2/@8O7
M(VG98@ T0*^BL90.=\X(,QT1PC#-XAP&V2!^>2(&/YFJ'T3'Z: 7C,Q+3^.T
M#[?[@_![!]JC_>6><W+=,5T:^//%*,_RO[LV)9<'99D(=X=JQ\^ #^/!R1#_
MKWE\[DU*CNH Y6;KJYT!_[2%DM"-=@5U'NK(O\M#-;YG>LNE 8$;<DWCEX,(
M=*APH6-5XZO*6EFJ4=ZLZ*< M5M \QNE[*'C"+K?C-EW4$L#!!0    ( $6!
M7%3FRBE0I08  /8.   9    >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;)57
M:V_;-A3]*X07##:@RGKYE28!G+;;BK5;D+XP#,- 2[3-32)5DHJ3_?J=2TF.
MUJ39E@\Q29'WGGONBSP[:/.GW0OAV&U5*GL^VCM7GTZG-M^+BMM0UT+ARU:;
MBCM,S6YJ:R-XX0]5Y32)HOFTXE*-+L[\VI6Y.-.-*Z425X;9IJJXN;L4I3Z<
MC^)1OW M=WM'"].+LYKOQ#OA/M17!K/I44HA*Z&LU(H9L3T?K>/3RQGM]QL^
M2G&P@S$C2S9:_TF3U\7Y*") HA2Y(PD</S?BA2A+$@08GSN9HZ-*.C@<]]*_
M\[;#E@VWXH4N/\G"[<]'RQ$KQ)8WI;O6AQ]$9X\'F.O2^O_LT.Y=9".6-];I
MJCL,!)54[2^_[7@8'%A&7SF0= <2C[M5Y%&^Y(Y?G!E]8(9V0QH-O*G^-,!)
M14YYYPR^2IQS%^O\<R.M)(8LXZI@/[N],.R]X<KRO%T>O^>;4MC)V=1!(YV;
MYIWTRU9Z\A7I<<+>:N7VEKU2A2C^*6 *J$>\28_W,GE2XDN1ARR- Y9$2?R$
MO/1H?^KEI5^1=]E8K%C+7NAJ(Q5O+?YUO;'.P/[?GE"1'55D7D7V%17OD$A%
M4PJFM^Q:Y'JGY%^B8*\+H9S<2@S7U@IGF?>%P9S\\$;RC2SA&&'I>U-]25_+
MUM.J7S9&JAV#2]F=X(8)\@(#AZ+:P,L]CP'CQ1^(-20;8!R$$0BQ0C"G_5%D
M>RD1>TA:5C<FWR,+L"AS@;3,M2&9W#T0&P7>$&YHVY;2D/99]NTWRR2)GK\5
MW#9&D$YV)8S4Q2#^UO=X_/;X.9/*@W$4BVQ#U21D[[' RU+GWF]$,&TYB:-P
MD3+05]+J%Y [HWC+.1]R7@XXYRWGK %EQI\81 B3M(%M-70?["D;OU9(3J_.
M3MC5@*^K7OF55[Z^!XOSP/N -#;F$_9?N6'CS>1_JXBAPG8>%\6$O6B,(44=
M(V-QFY=-07$CU0T^:./Y@'Z%)@&!.;?[(W$3=L*28)G%X0JC<;H,%]U2E(8)
M>ST0D02SY1+;QFD6)A.:SK)P =AH,<;=!:PN.>& )@'AM3<_#M)5%@+S+(PF
M-%NN,!LDCU2.JYVDJ.@LB)=!E$5AY",M3I[?+WRO=7& GZ [CA;AC"6K63C'
M+ /8&$QMA3%>9JXKBK5;1)H26TDXLB79&*_F88K9?+&$>:U'.KV+54) %V$V
M88LEF?9>.UX^"#6PLPJ2;!YF&&;1' C\TGR6 F/OCF$P)L%B'D%=%J\@-0WB
MQ0I0WFBU>^:$J="&-BX@U)WC\DY&K8T/A#@-HL4< HZ,] M'D\G6H4I8.)N3
MO8!$XP7&K;5*J_P1C" (03!CXQCN(D]E"9A@/PGW@(!Q%T@G63P+EX^&5!P%
M:1Q[9GK,@\7?!W\^8=:6JM2-U(TM[U!NR'#O1_91<F>DKR+QXCE;*]7 )==^
M!P,UU-LA^-F/R.8VS[?2YMCR1,&,0I]X5'VJ0:;67:8.\I.*'\H.[CL2N$@#
MJ,D1[;@N^?N*]Q:OI8^3^X-4.LF?N&<AL;&72-ZU66V$%>8&C*.2=865;=&K
MVAS-I<F;RB(G<MJR1V$6M])VM;>KD 5WHA\/REI;L'4;TT,KL(J$;<OO+9-5
M7<J\:Y6M%(!\]*@OT?1Q(*V0J"3:L3V_P0=F)1KB%O+ ("3#$')+AZSFZJYS
MW>,>SH%!EY(,*N Y!;,EJ(3]3MR#YSFU*7!=HLH,1 .#]5B,<$;;6O@[(N3W
MU1&;->#_JY;PB7O"['A/F#W9K(]7D<&=+*#JZ&.4HY2V=W L/W83>%(XW>U/
M+<@5YZ.Z"Z 1+G]?T-(HC@)"1M90Z]51N.&&VX8R4:60#-:V 2U5X0/AYAA-
M_6X?>/ ED@W[#KHIB];A.O?%@V9%VXB'-]"-$ IL(\ $H>@"P?-<M%'+-_I&
M!$!B/")\?@S&MG'(2D:-!>O(L1X7OG<5P0>&Q))M-E86DE./"MDOE/:O'J;]
M^$//#17:8[</D%VYJ'WR,[LG2+S2#4)BTK;S)(I771] ^ K5("M/J",EZ!!+
M*OPQVF*"LDZ5$LH5X/HM:#@IEFFT7*2HK*_ZCT==I^R26YG3GC!)_<]LQE[*
MLG&^SPQ7/_D'"I6!&Y"R$ZT$,-(XJA84!KVX.$C0E9;^E_IC+Y#F"T!JOV?L
ML:"?#MXBE3 [_^*R\"DX:9\EQ]7CHV[=OF7NM[<OPK?<["2"HA1;',6=#B%N
MVE=6.W&Z]B^;C79X)_GA'@]386@#OF^U=OV$%!R?NA=_ U!+ P04    " !%
M@5Q4E;]=K80'   *$0  &0   'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6RU
M6&MOXS86_2N$6Q0)H-H2]9XF 9),-CN[G=D@F>VV72P6M$3;;"31)24[[J_?
M<RE9]LQDO)\:(!%%7M['N4_E8JO-LUU)V;*7NFKLY635MNLWLYDM5K(6=JK7
MLL')0IM:M'@URYE=&RE*=ZFN9MSWDUDM5#.YNG![#^;J0G=MI1KY8)CMZEJ8
MW8VL]/9R$DSV&X]JN6II8W9UL19+^23;?ZX?#-YF(Y=2U;*Q2C?,R,7EY#IX
M<Q,3O2/X2<FM/5HSLF2N]3.]O"LO)SXI)"M9M,1!X+&1M[*JB!'4^'W@.1E%
MTL7C]9[[7YSML&4NK+S5U;]4V:XN)]F$E7(ANJI]U-N_RL$>IV"A*^O^LFU/
M&X<35G2VU?5P&1K4JNF?XF7 X>A"YG_E A\N<*=W+\AI^5:TXNK"Z"TS1 UN
MM'"FNMM03C7DE*?6X%3A7GOU*#>RZ21[E(5>-JI'JBG9=5'HKFDM'4BU$?-*
MLK./]+#G%[,6DNG^K!BDW/12^%>D!)R]UTV[LNRN*67Y*8,95![UYGN];_A)
MCF]E,65AX#'N\^ $OW#$(73\PO^#P\+HFMU"5X-X@2_:%;MU7I"&_?MZ;MW^
M?TX(C$:!D1,8?<T 9<5R:>12.,SU@@TJO(;N25:4MV_L6A3R<H+$M-)LY.3J
MXPK&Z I)IYHE:YT#W2DYM<7AK:[7HME]]TW&@_0'RQI4 "O@7S;?@5*7'0 H
M1"N7VNS RC IBA4IJCN#?%QKTW.U<ED[KD1#G'=2&,LD>9K!3[*> [R]K]Q?
MWW-!QOT@]\#*KJ5+SFKWAIV]:Q#G5050[+F[P3Y LR>GV<.@UNU>K;? K$*%
M*ME[89XEE+A':6HA[W:E&L'^=OWA5W8'YRT)A3W-1]V*BMT8Z&!9[*5Q/N6,
M>]Q/IQD+O"!/IP&>29IB/_"]+ JFH0.LDB_L_L4I?Z.T5="4; T\#I*$^:"/
MDFG,XM!Q"B,.3O>RD485EH5>Q--ISB(<IEE/$@7A-(4224B7>\U^4J(URK)O
M27C$,Q!\2_H%'%=HY8--A%7H!5'D3H/4R\ I^1(__T_&+_1R[D,'#IMSE@3I
MU&=1% *PV.-AA+W3P/G< 9>RB*R+<AB&W3P&BD? A5D*LIBXAG0$;), V$)&
MEN/]<^ R+PY\R 9:\"X]R:]TGU:9\P]66 9T_#EJ0?XGHQ9!FQSZ4\S!KI#P
MBCAW%H4)/4^B%K@ \/'+R1*8F!)J <7IB!KW<H1$S!)(2(!:-,1I!.EIGL#L
M+U'CD0__ ;4@PJT>-0X>M$HAB_>HA:D/22=KS*&>4$MA!9#5E2H!4TE]5/7U
MHN_/[%F.->?3.O*U,O)YH?B%:.]>IV5/O9"_0\A]I><P^6$OZT>U5BWD??=-
MD$8_.#.3A,S\H,U&V&)_D''*LQ]W %;L]U)D9DSH+<VX1Y[,V-U:/<AFV+KN
M6OW]N^8WJ*#AO# /P ESB)P;N'<@"I''$;M;+.3+09LP2,#LUD@@N-_R<VS]
MJBN]:/=[/(O@C)]%)>9]<'&>P(E'5C_U)?I@]KMF474;41SLY@C'D%W7& '^
M&*U!(L#"GT4C1D6#+$;@O-W5RK8C79!D$/A+MY:548?- )3_/?IA9^+<!<W0
M>UBI$1Z-;EFI;%%I*X^BAJ* :,:PH A2I31P<8'[LE5]ST ,X8#64W8V/S\8
MN6=:8F#:L6(EFJ5DJF&+KNT,(A59HDOK8:NHNI)"6%A$*@(8(QTU.BN%U8VH
M5+OS#C*I6QLHNAV[9"6Z!M.RA?R"Y"N<#]R9@"2R<,@+*%-BS&@ULPKSU@+A
MU!22A(UVBN+W3I&5T&8MC--D:-AS5!=28/I9ZBFG-UX!VE:8<G]E:-^*DG#!
M-L(HEZ-[)/O1H^P,\7@MJVX04Z2>:+_(*A]SD3%#4&V4&](?9>72&];UE?.]
M*!WB3OT]N0.&O0>V\$)]M'5=_H91JY\EJ.1A]*R$M>!SNY+%LYU1*I2*PM?:
MKI?S<:5@[@-@(B,I?PA"&(N9'1-YP^Y>!L>?L 7%=B7,4LX%I" 78L0X%;K8
MB]&5 ZQ0$JC?GF$'9]$YK='PZ1F[?'[$Y58BF.#&6A.NJ#)8HS34O34:()@A
MM@4YCK2A6AZG"3(O\0*4:/3O."6^9XG'$XPA6*$2\W-J>&F()'N4"-X&8TM(
M?2O,J$SS),?)6804]G$AG:;G+,FH=MSKC30-00IUC-/QH%484-=)7/\,T"TA
M//5C$G;F&(5Y/HXD-&OXP3!K<"\-<]= 0T+#@8'C."'!> G1,<[[*S%U]A/C
M<CR.R_')<?D)^55VE<N45[Y-/&K7KTW.)[F^/CF/[,WATX>R^)#!5*2@QY$7
M#46^:X*:@MTZE/NL0$QL5PJ3\Q:ERU41]%HYIN@AB5\-S'Y,IH'YU)C\R;U/
M7EXQQG/ZNTZ794.3SS"%Y>P?+D2+(5$K% N%VJ=<E/9#23]C9,=!X3Q\"(_7
M?#T[^CZEJ<A]A5-!AV;]I^JX.W[H7_??MP?R_K\$&*8P5%E6R06N0C0<;/HO
M[_ZEU6OWM3O7+;[:W'(E488,$>!\H76[?R$!X[\_KOX'4$L#!!0    ( $6!
M7%167 ^^; 8  -X2   9    >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;*U8
MVV[;1A#]E84:%"E 2US>F=H&;"=I R2(8:?-0]&'%;F2%B&YRI*TK;_OF25%
MR[%$*$9?)%YVSMS.S"SW]%Z;;_5*RH8]E$55GTU63;-^,YO5V4J6HI[JM:SP
M9J%-*1K<FN6L7ALI<BM4%C//=:-9*50U.3^USZ[-^:ENFT)5\MJPNBU+83:7
MLM#W9Q,^V3ZX4<M50P]FYZ=KL92WLOEK?6UP-QM0<E7*JE:Z8D8NSB87_,TE
MMP)VQ=]*WM<[UXQ<F6O]C6X^Y&<3ERR2A<P:@A#XNY-7LB@("79\[T$G@TX2
MW+W>HK^WSL.9N:CEE2Z^JKQ9G4V2"<OE0K1%<Z/O_Y2]0R'A9;JH[2^[[]:&
MT81E;=WHLA>&!:6JNG_QT =B1R!Q#PAXO8!G[>X462O?BD:<GQI]SPRM!AI=
M6%>M-(Q3%67EMC%XJR#7G%^*0E299+>6 E>Z7.M*5DW-7G\1\T+6OYW.&JBA
MQ;.LA[SL(+T#D-QCGW35K&KVKLIE_A1@!OL&([VMD9?>*.);F4V9SQWFN1X?
MP?,'IWV+Y_^LT_]<S.O&@"G_CF@)!BV!U1(<T'*+"LK;0C*]8%>B7CGVE[W[
MWJH[49 ^AXDJ9S<2.E76R-PNV!?P4454N&_JM<CDV02564MS)R?G5A?!FT?X
MC)Z]_E"!2$6!FJA_8PBM+.?2V/ >OAG0+(1\=(&]8K'+IQ[^DR"8!O@/XG :
M[7J56>=5E14M^( +IIL5@+/6&&!8W$I7)\-]74L@AU.7$1(/IV$?P&?:]SE(
M%D6=1:$+#%B4\BEG(RD-AY2&HRG]4-U!K39*UOO2-"J\/TTCV2"R/WOBLAMQ
MCP;02*-$0>%//<^&/0T3_']%#Z0(KXW.9%VS-/6G/N-.X"<(P7M5*?2*G"VU
MSFOF.6[D(4*^XR)G =MQ#X"^D\;Q-,95Z 0QGZ9C$8R&"$:C$;PV&"BFV3AL
MC1KL<D\)7:/3-_MB.@JW/Z:C.AQ6H>9_/NR?1+:"<K-Y"F?CY(:!Y9GO>#ZQ
M]K)51:ZJ9<=/52(9=[*TA.5.XB;@,W=2""5H/A78VW8CJLO;TE#BPB1![/TX
M0OH^$LQS*#]&3G@8 N8/HR&S'G,<60R3%"0(G=BC;%YD65NVA:#"R27"EREA
MS?"<P'5AH^=XEAY'Q)-\Y[ XLE=!F(ZS)1[8$H^RY;/M$UT_V$>.4>G]Y-B%
M? $-J'LW&U;*9J6IE=VA^91=+\\**2HFP9'E9O<-0O+K+XG'O=]M<T1D/B.<
M"'6U9!"I)3.T=3C1BY,6-[UI7NHBK[[G(Z:=S86NEB>H^W*[)(DIS!$HXK(G
M;KT"O7CLVMKEC@N=X5@VDB$;R1'9V';I0HFY*E1SH!>.0HVE9@_^"_($<IL6
MQ*XQ*%"&!7:?-/*[V/B@-;=7'N>(\K78&%T4';'+=:$W4K(Y,KE03^V( RJ<
MQ$LP7C[*I>A$4'8+E"R,HP>D&)UY._!LEB&]%/TNM'O-8DZSC2Q)J0D0&\CK
M#!ZJW-(#JZ,(.>2V&+<.V6F'?M$:0O9\GYI)D,*@EU"3NU!O^;'%5Q4HAO<L
MB6!?2N_?"V48)FYKMS(+52&2&#Y82J9T0!$'";EKV?H#N[<!W!!DC'E%%6!3
MC?BC"4;4#&,?'APF  K'B7AJ^TO@I!%Q>X31Z<#H] A&8^]Q)*E'T?ZO ?]N
MC('8U*#>@ZZP/1=7!\G#P0WD!!V$LR_B <SI>KUJ9/F$GMD6(2,-@1=!((A2
MD.)P*O'5AS1Z7GJ0FE% &P^?AEP79L^GS(=N.#QY[&AZ7O05TE5HZOLVUQA%
MB3^^=^/NXZ>.>_2&O#/@JD_[Q<$),PYY:/\AUT*AE3S@V[F6W2[@ARWO2^?/
M,VS$*(QLI_>B&)&]N!.JH$^W$WRRGU#[0\4^V,+.="E9+6%#QR6?VIA/6X)C
M*IP'ME0Y#?F^U>Q@A53_P6-J?W 4&U!8QZGB?:+7\2&R; ACRP;NQ&X,RH^Q
M8>?#EQ_-!C!8M^0D)@'%SIJSI?7'\9XPKF8_0P9]ZU[?SQ/ABQ&YI''R%,CV
MA3#JQYN/C,1]1OH5:-7X7O-9&"9=Z3Z7C\*X[S"I&X B^\(]VSER*#%6[,%*
MS2Q:=_HP/!T.;RZZ(XO'Y=W)SR=AEB :6LP"HNCL^(PRW6%*=]/HM3W F.NF
MT:6]7$EX;V@!WB^T;K8WI& XTCK_#U!+ P04    " !%@5Q4$&S(,NX"  "U
M!@  &0   'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6R%57]OVC 0_2JG:)-:
MB27!_"A#@ 3MIE5JU:KM5DW3_C#D *N.G=FF*=]^9R=D="M,0N3LW'OW[LZ^
MC$IMGNP:T<%++I4=1VOGBF&2V,4:<VYC7:"B-TMM<NYH:5:)+0SR+(!RF; T
M[2<Y%RJ:C,+>K9F,],9)H?#6@-WD.3?;&4I=CJ-VM-NX$ZNU\QO)9%3P%=ZC
M^UK<&EHE#4LF<E16: 4&E^-HVA[.>MX_.'P36-H]&WPF<ZV?_.(R&T>I%X02
M%\XS<'H\XSE*Z8E(QJ^:,VI">N"^O6/_''*G7.;<XKF6CR)SZW$TB"##)=](
M=Z?++UCG$P0NM+3A'\K*M]N+8+&Q3N<UF!3D0E5/_E+780\P2 \ 6 U@07<5
M**B\X(Y/1D:78+PWL7DCI!K0)$XHWY1[9^BM()R;7"&E9.'D@<\EVM-1XHC4
MOTH6-<&L(F '"-H,KK5R:PN?5(;9:X*$U#22V$[2C!UEO,!%#)UV"UC*VD?X
M.DV*G<#7.9[BC^G<.D.GX.<1SF[#V0V<W6.<+3C7UKU5LN/@&[=& T)55ZHZ
MW9([S,!ID)7:DEN@WU)+NC9V"%,+>@E4&LSG!-Z5!^[0WSRA5A40')K<0ANV
MR(VG8YU@6G@,YQ.S#_P9#5TWBODO$OJ'O#-A%WJC'!@2"BSNP_LC9>PU9>S]
MIXS6(M7QIJ HSFNI"WLE^%Q(X;8MN.9N8\AZJ\Y'V?T\&]J"+W <T<"R:)XQ
MFAPH9(LN58@C,#A4-9&U#+]9HL%7+3FY5'0CI:0&VE/X[@N.*O-)_,W.X!T,
M6)QZNP/]7F5UH<OBC][J 1O$ V_UJ6&T]T '!/F26@+]0<S@03LN:TT%W])0
M=)8X.^V48+Z((/)BXT^04 1"ZSS/:]PNERT!V>",.OA6 Y.]49*C686!:2'T
MOIHJS6XSDZ?5*/KC7@WT:VY60ED*OR1H&I]1MTPU)*N%TT483'/M:,P%<TW?
M%33>@=XOM7:[A0_0?*DFOP%02P,$%     @ 18%<5'R]P4B6 P  .P@  !D
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M<N9*P8!:@B7ON:K63.[^^&V<)J.7!G*!3 )*U.4.>$>5+6H$9F"I!%4QA;%
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MZ3P/HC"?I@P, _Y ++3&R*9\9 BTQD)+8JX,6SC#J9QE$03LQT ]8%E23.>
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M)6X:IOL\UTV<7OE/8M?:H=/SPX44E32T >LW6KM^0@##-]*3_P!02P,$%
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M<D#46\I\1V@[1PM:MJ?(-PV"V JVC<PJ.WJ\"JY(V'[^,GMA)%CKLYV@H4Z
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MX/U"0I61#9!!\8<;5_\%4$L#!!0    ( $6!7%06 !)])P0  '<*   9
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M#,+*(+1Q.T<VRC?,L),C)==$X6A PQL[56L-P8D2BW)E%/PJP,Z<G,D"BKG
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M%_ZK*W<LZAZ,7-JCR*DT1A;V=L%9QA4.@-]G4IK- SJHSZ9/_@502P,$%
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M*5X$M?OLYFY,L[*?NF:-,<W2_EU(@39&&[ ^;QJSO2$!_;?/R_\!4$L#!!0
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MO5F?P)]$^O(5$-NF[F2!NUA0'PYC-SF"('79$5SG^O[]0@F!I< (*A:@N!'
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MF@_;_5I!1#HOK<[*ZLQU1P4U>BO-O%PC;0N(+LNW7AY;W%RLDCPG^,(J!KU
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M/!T.O^'!JJ4_<$Z514]X<H'?"T([!GR?*64W#T[!]A?(V?]02P,$%     @
M18%<5"KL;9>;!   )PP  !D   !X;"]W;W)K<VAE971S+W-H965T-#$N>&UL
MI5=M;]LV$/XKA&<,-F!(HEXL*7,,Q$[:=4"W($TW8$,_T#)M$:%$E:1CN[]^
M1TI6Y<P14NR+*9+W]CQWQUQF>R&?5$ZI1H>"E^IZD&M=7;FNRG):$.6(BI9P
MLQ&R(!JV<NNJ2E*RMDH%=WW/F[H%8>5@/K-G]W(^$SO-64GO)5*[HB#RN*!<
M[*\'>' Z>&#;7)L#=SZKR)9^HOIS=2]AY[96UJR@I6*B1))NK@<W^&H1&GDK
M\">C>]7Y1@;)2H@GL_FPOAYX)B#*:::-!0++,UU2SHTA".-K8W/0NC2*W>^3
M]7<6.V!9$467@O_%UCJ_'B0#M*8;LN/Z0>Q_I0V>R-C+!%?V%^UKV0@\9CNE
M1=$HP[Y@9;V20\-#1R'Q7E'P&P7?QET[LE'>$DWF,RGV2!IIL&8^+%2K#<&Q
MTB3EDY9PRT!/SQ^HTG*7Z9UDY1:-'LF*4S6>N1IL&PDW:^PL:CO^*W:PCSZ*
M4N<*W95KNCXWX$)0;63^*;*%WVOQEF8."O $^9Z/>^P%+=+ V@O>A)24:_1
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M.B*FOP3]P.DV--Y..VSC8#;X;H#Q#KA>:>V. ]_+XTN4_P902P,$%     @
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M!I#.^(V2O:Q< Y/*BO,W,W@,KCJNB8@PXBMC NNO';DEC!E+.HX?N=%.X=,
MJ]>?UN_3Y'4R*RS)+6>_TT!MKSKC#@C(&B=,O?#] \D3&AA[/F<R_03[?*[;
M 7XB%0]SL(X@I%'VC=_SA:@ 8/\( .4 U!;@Y0"O+:"? _IM 8,<,&@+&.:
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M]WJ7*UAC%3F%0,H-P4AX800WM"TB+X.L)$^HJLQO]NCF7GZ]H'F@OA(5'M3
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M.XI?H4#N^,J4!>OCWV+156<4UZI?[]N!*:QZ6,[+X>DA!/<FPO$FPG$!3EK
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MR*.#16Z\&2-V6E] 2S:'=*QH^LBG"4,TSYF"'/U<E+#PC#Y!"#PRM,[98IU
M'"Q87^?O%PAZ:_)VCQG:%+>L'V^L'SN1+GC*%7M[#57('$W,#$Z*&3@&\#U3
M'WD'6P2_5H7Y/V 9]@SJ[U\(WV09'^\)@V]\M5ZA/]'IFB=S(% 7K$DL/CF<
M^PWC^V[*/Y#[W8-B;[_[#2'[;D;^!)'0W?V&V_SH<.XW/.>/?H3[W8/Z'=QO
M6-1W4]I#]IM8ID!!LX$+S_":/SZ8W['A-NRY*QV:+U%&^1PI@6BY"*7C;?ZL
MP$9;6=;S/'OZQ(;[L)N&;'/MHULF9Y!&]8J+!?I5Z)),4SR#,YZJ9&'+V(Y[
M>\8+R,#S_NER8*VT=I/>K109D^JEC[*$0KWHJ #*XJC"VZIHR#C8+6PO.\I-
MK'+QN%%.[\?;]H#A9^RN_#>+=R964Y[2<O'JN_:.)53'[YG(=U-R-0?2+%%)
ML%O(?K2(11YN*_:QX7[LIF'[#,ZV*O^B];%@$C9<'[V'N:F7VEZ<Y/E:$Q0L
MOOY)@;ZL\1,TX\<;D;;X,=2/W=1OCY\=*U^-%')C8Q_=K%=3)G5\W9<MFC]1
M:Q/E%#>+\2AN/6QADV*PNWZ^80H!#Z<0W[9Q+ROU^K@D\FKC5KNH*>8'<?.H
M8).+1V00MLS#)#'LSB=?A*()DG#X3==6#UY6 /6AXRBJC5S-I"GFQS@.!O'N
M5)J"V ]CW':ZPR:=87<Z<YSO3BO5^C;&02T+5$076VSS1KN3O>PH-[')!1YI
M$MU>O&V7F(R,W4>-20H+JX3D+=$Q;AY! ^+MSF+<L.XM4!VV&T=,(B?N1/Z]
M>>BTPJN;2^)=GUN$WK;XD9AL3]S9=S('D_B"VZH]JZ5^T[&Q%^SNMVYBEY78
MR"TVZ8;V<:_8MH],64'<984])<$B/W']]@MH9I*6+^"*!Q,X!'.X>3*;B75:
M%4HSL<H2IH#E3^:_K7.E=T(?78OT\>T7)E?HG$WM.P-;^G/C0= RIUJ'T%TH
MG*R$5/R/,I]"QGF-IQ=TKUB&'C)KKY TE\L?-Y:AV0;$)&Z-*E,9$'=E4*7'
MSPOTJ6@RZ_S8VFZ>5&!;FR%J"Q>3W(D[N9>O7O1BTI07&1JVP7P]4TCJ<U'Y
MSB;A4"KGN\2T/:+)Q^1P1SYBLB7I<.2KP+.UG"UISE F82)6WXXLI5.+:TV2
M(WM:7WG&4O0A$=,BH&9"9D+J4M4U09,OR.%.<($A_L!-_.UNA)U2O42PO?FI
M8'7ORU1S@=_:.C?T'KCIO?U(N<<@OVD0CDA;$ >&2P,WE[:N,MBC._V2SM0:
M'A7?'[@B*#!4%QRN9Q74WE+\@)[5ASV#QGM[)H&AML!-;1=7IRX<0UC!X0@K
M,(05N GK(5M(V"ZPMU]T*K4Y[SQHTA0AV\GJO44&MV2)P%!9X*:R[WC_=EY!
M;6?+ 6DQP?!=X*Z/]3$NITF1HKIUPT+#<N'A>O"AH:[035TFW5<IUOHM0=BL
M^7!+*@H-285[^D@+_@>3_;T>,Q04'HZ"0D-!H9L--C5<'UUPJ"EO7S,0U*TK
MOBDY<YLC+\+FN] X:CNGA;4WDVY6J;NR^U8T9!,>CFQ"0S:AFVQN!"0JR$TB
M2>IMSS[Z_)PRF2]Y5N^/3E_0+97V<#_;,U(XVM,,#0T)A9U[X+I,[;BE#<&$
MARNH(D,UT9Z3=$7O",Y7:#/D/<MHV0JTN3CZKL9X9 @I<A/2/2PPE5S T0].
M]>#3_Z=BC0P)18?[4"0RS!2YSX'[OZYP%HK7%?Q6H4A&<:/G-:Q]$Z>_)X4C
MW"-/<Y2P!>AY@Q'0B"P_T2POE,B*S^2F0BFQ*GXN&07SM  \7PBA7B_TEW>;
M#V6/_P)02P,$%     @ 18%<5*ISO]4X!@  \QP  !D   !X;"]W;W)K<VAE
M971S+W-H965T-#8N>&ULS5E;;]LV&/TKA-&'%(AMD=2U2 +$ES8!VB[H97L8
M]B#+M,U6$EV*3M)A/WZ4Q%@WBE;6HMA+8DG?E?QTSI%T\<#XUVQ'B "/29QF
MEZ.=$/M7TVD6[4@29A.V)ZF\LF$\"84\Y-MIMN<D7!=.23Q%EN5.DY"FHZN+
MXMP=O[I@!Q'3E-QQD!V2).3?9R1F#Y<C.'HZ\8%N=R(_,;VZV(=;\I&(S_L[
M+H^FQRAKFI THRP%G&PN1]?PU0UV<X?"XG=*'K+:;Y"WLF+L:WYPN[X<67E%
M)":1R$.$\M\]F9,XSB/).KZIH*-CSMRQ_OLI^NNB>=G,*LS(G,5_T+7878[\
M$5B337B(Q0?V<$-40TX>+V)Q5OP%#\K6&H'HD F6*&=904+3\G_XJ!:BY@#M
M'@>D'-!0!ZP<\% '6SG80QT<Y> ,=7"5@SO4P5,.7ML!]SCXRL$O=K?<CF(O
M%Z$(KRXX>P \MY;1\A_%0!3><@MIFL_N1\'E52K]Q-5U].U ,YK/40;"= U^
M$SO"P2<>IED8E:?/[@X\VLD! 7><1@1<QS&+PN+:2W"V("*DL?PU!I\_+L#9
MBY?@!: I>$?C.#>YF I99YYM&JF:9F5-J*>F!8DF ,-S@"QD:=SG9O?W['X"
M(.YU7PS/#C7NRQ\K_O60XMU>]S>#L\- XWYC=G\7?@?(UWE/Y5P=APL=APL5
MX7!/N-DADV>R#-2F[!S(.26 ;>HGP9_7JTQP.7!_&=+B8UI<I+5[TKYA;/T@
MIT\W>:6G5WCFN'Y_!1&VO8OI?7U"2BN_804AGK3LEH.BO>E&"YS FKA'LT:7
M]K%+V]CE/,QVY1IRL@8;SI+ZBNIZ+^,%M3ILZ$Q\?1G.L0QGV![/6;*B:5CN
M\1UG]S3GMS &MVE)L<6%VU26)T]>1Q$[I(*F6WDJ8LD^)H*<@^OU%XEYDAM%
M-FPFW&.9[G^=B:7;61<4.'W;XQT3>L:$)8Z&64:$#@(77B?IV)O8^IS^,:=O
MS+D@&\+S:1#A(XAIN**Q7&VBS5]&<NNCJT\>'),'QN2?]U_8+LUW<P+^ 7<;
M^C?AY\6A8?N@5?&4]2NQ!-8($AK[>LO2[5@0GDA)M!+GDMJB^+#.!S<ZR,5.
M!=@SWG/+O5:Q&PB!+=_2+S6L@!6BH8MM:K)"3(A_Z>I6( 9/H)A:P_)& 6?D
M\6EU:7HO+S NY[<0)JD4\K*6*(>]4,'>2ZVXZ.(<\FTX"5H@K[6S\ 2U0/YT
MO&;O%7)"Q]C[;=6AM@^GF]?Q_6X?.CO'[I#5Z7C-/BIHA69LE6"_)UQ\/P?[
M.,SW4NX6D1NTSW%<VUD7<2$.[ EL=Z:S\X.VW?)TO&9G%89#,XC?KF4'=$,E
MI-)4A.F6KF+2#^HS%:Z!JKYE6\UZY\K,,YLMAD5;GC1K-E^1"32SB4E&*=?&
M+$'+FSCM3KLT@VRKTZ@FFBWOQ,X^G\S:;+6B+FCFKB-QTER+D((_5R0E&ZJ?
MWZ [;[:O01B-G>OY780Y&:\IORO21-:/B)"9<J\G]@+4N0]U9GX78$Y&:W91
M,3 R,_ G)J1B5 SQ!/W:=J!&R2';K>DJU1#LCF7@.KC=T.EXS99J#T9F_GZB
M/;-(FZDHC0(\UVH/T$)CAZ$7M =R>3I>LY]*/R#S(]>/B*29BMV$;\MSNVT.
M-%P.,&PV6ND59-8KSY#8,]05#M!UW Y,Z.V\[NZ=C-=LJA(BR"Q$2IA(61H-
M',NNDH"V5$1.NS&='?+:M^/R=+QF8Y4R069E\IZ(0;CA=I_W+0QA[1E0-:01
M&CK#Y="(-\JP(04L#_>0-ZJ4"_+^SX_EJ%(9R*PR?OX#P )U9<(8^S6Z:I9:
MJ01D5@EFO3Y7W@T=9N.VUD%=KA]CNP^8<$7UV$SUSQ7A<Q6O/GG8;]_!RJC>
MT[CGKL05GV,SGQN$Y0+K*+?W90RN"!>;"?=Y"F^!NT0) W>">\JHO9DT\^10
M*;/ 70:S+;=W'2K^PL.>MT^\'<*Z=X5!WRV$*Z;!/Y5I%KC+#&/8^V"'*V+
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M_8U5#@UR>[%(5/$+MM58OP?BM=(BK<!F!2G/RG_Z6!'1 ,"@!8 J /H10%H
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MJPRJHFZ>]%N[$#V"$FHG!"TAN"2,;A!(2R"O)8Q:PLBL3"/%K,.<2CJ=<'9
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M(J(8DZO_H V(8YST\FMD6($D\F]]1KA7Y?%_$7(>+3A%"WYL^<&G0H?)_W"
MO-8!"]#N +FN0(,.G HI'JZDOV_->:G.T1)RRW=Q'O94V?#X!UMQ*C]XN/X,
M6Q%>+YS="@OPPHHF/Z]WJ*U U6]].1#('$N;<U\WVEU 'LRQ^V+\45],S&'Y
M%*:YU3RI8T%1"U3"6H7TW4BM-6\N"DU'LJTY.J^85 =QT]RHRQ5P#5#OUXS)
M8T=/T%W7IO\"4$L#!!0    ( $6!7%22:=PA( 0   4/   9    >&PO=V]R
M:W-H965T<R]S:&5E=#4R+GAM;,5776_B.!3]*U8T*[52)XF=$)**(K70T8XT
MW:U@I_LPVH>07,!J$K.V@1EI?OS:20@!3,I*(_4%$N>>ZW,_[&,/MHR_BB6
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M@ P7I&#Z56S_Q1VACM67"J;</VQ+V:ZQF!9*BWP'-O.<\O)+WG8'<0 (XPN
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M ?W[1@AU&9B;7_FO@=DO4$L#!!0    ( $6!7%1@M;<?> ,  %4+   9
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MK![XYA^2)]0Q>"&/I?V%33[6<R!,I>))'JP5))1E__@E-Z(4$-0%^'F _R8
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M,=(7.B+, /U^R;G:-@Q!<44<_P)02P,$%     @ 18%<5#=?WHA+ @  $@<
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MIE* PEDGN(FN!RUG[PU^45SKK34X)A,I7]QFF'2"BDL(&4Z-0R#VL<(^,N:
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M@KF*HL ..M(&8+&';:\CK0_#8=O8B;*X41:?5?9>7VECF8G[<6$O2FS<B7\
M%VE8THF_#\.1/1D.?]*$/SD;_D(?=CRGF3X:,WUR*5V79^HN::PFOZ_8L?MR
M!;@_6>ZU@9//V^L5P6((%@?=DDIK6'12+".UCEL7&?Z):J_))Q]+8$== :]!
MI<.HD8+ WHL [U<4>VUU]/NNE7F]/<?=0AG F"MP4-7+_87]_UWH-;5]\%_I
M ZA[3@W"_'Y:AF#]O#BM9JD L2F;3HE6?,]4U64TJTUC^[9LYSKK-Z;A+9NP
M%S-5MWQ'Q(8R_3'"6IMT[5C?#J)J0*N)XKNR)7OD2C=XY7"KFW80!J#?KSE7
MSQ/CH/D;,/\/4$L#!!0    ( $6!7%04HJCJJPD  &%"   9    >&PO=V]R
M:W-H965T<R]S:&5E=#<Q+GAM;,U<:V_CN!7]*X31%K- $HMZ4MLD0!)[=E,D
MTR SLT6[V ^*S-C$ZN&1J#R*_?%+RK*O;%&T[+'5YL.,+5]>W<M#GD->BSY_
M3;/?\QFE'+W%49)?#&:<SW\<#O-P1N,@/TOG-!&?/*=9''#Q-IL.\WE&@TG9
M*(Z&IF&XPSA@R>#RO+SVD%V>IP6/6$(?,I07<1QD[]<T2E\O!GBPO/#(IC,N
M+PPOS^?!E'ZF_.O\(1/OABLO$Q;3)&=I@C+Z?#&XPC^.L>'(%J7)+XR^YK77
M2.;RE*:_RS>WDXN!(4.B$0VY]!&(_U[H#8TBZ4H$\JWR.EC=5#:LOUYZ_UAF
M+[)Y"G)ZDT;_8A,^NQB0 9K0YZ"(^&/Z^C.M,BH##-,H+_]%KY6M,4!AD?,T
MKAJ+"&*6+/X/WJJ>J#4P<4L#LVI@=FU@50VLK@WLJH'=M8%3-2A3'RYR+SMN
M%/#@\CQ+7U$FK84W^:+L_;*UZ"^6R)'RF6?B4R;:\<N?TG3RRJ((!<D$_9//
M:(9N$QXD4_844725YY3GZ,.G(,L"B>@/Z,.(\H!%^0_G0R[N+[T,P^I>UXM[
MF2WWNIIG9\C )\@T3/SU\PA]^(O*RXW>RXB&9\C:ZF74W8O1[F7<V0OVE5Z&
M H\5*.8*%+-T:[6X;2(P?@NC8L*2*5H!]NN=:(5N.8WSWS3WM%;WM,I[VBWW
M_,@2QNEI)$">( 8!!&4 )RBA7(75PJE7.I6L]')IN@;Q/$/^G0]?ZH@H;'W7
M,)UUV[7H[57TMC;ZFS3AHG=HPE&8"AJ;4#E>!1%%+'AB$>/OJN 7/MU:0-CW
ME:$W+4W3<A668[N9I&-XFA2=58K.?BG.@W=!W3Q79>@TXCXEEJG*4&&),2::
MP-U5X*XV\-OD=)ZE(<US(2TY#;)P5K+-A+X(H9K+V%6ANXV ;-=11=XT)-H.
M]U9Q>]JXES/M!-W&\X!E='*"KL*PB(LHX&*2+*[*\-%=FBN[WVN$9I%%#IM)
M=+8<=[%<RY>L\B6=\E4E0IHSQ<384LX5E:UE>\IDFK:^XQNN)AM_E8U_V%&W
M=A=L@'X:O7$UKJDVUF?W\/BW()[_?=2@:L1@6(:S()M2Y<BL_*]SGZV"4V%I
M>2K+L<JG12P-F!@4$9O:A!^R=%*$'&5RX9>72$8L%"O6S?36_8/Z8:L_&$&U
ML%ZV]A1=K) CH;JVDAY5QF*2$1U%8A EK%>E&@FFSVB^0"E7P=3,3YE:4X>(
MI1Z734M;S9@J2U,[+$':L%[;QD4F-FWH,YUN(Q10'>SU-Q*!^[&>_!_I/,WD
M^@)]%4-2"%V<%@M,/PI\T2]!5%"!H(Q%4JJX?B/V!.^RP<)4N1T@C<60CPV=
M5F&@=ZSG]\V 'V@FQAD7N]OO#5I_7^>,&'_5K?%!.4QC7[V]KIK6>\[!CK;K
M3! /4R\>ZX,6_5%VU&(M^86&LX1]*^@)&K$\E'TDF.DFR&?H8Y2^ZO*N;6[Z
MV]V80/"F?G^S\@R,=8+N:9 7&2V[X3:9%^+2%YK%2D3T[K&!WL4B0R=&)LB"
MJ9>%3V)DS\00I1D+@P[D8@)=FTY_?0\L:>I94CO2W<9(MUQ7/]*!2TW]$OX?
M5Y_^H\L Z-$D_?4;<)RIYYH#[$"J.]2U;U-(MYN,M2;KY0:@/TM/?T=1'*O)
MFY72MPTF"VC3TM/FT11GRWV],T.K.!8PKZ5?1.OF8=6TWG/$W.RYJN9C-D:#
MY[F6PG2D,"6NK5RE*0)PB*TK0%BUVI:>G24/'$CG+&!QR^ZOB@<,;^D7Y-^K
M<UO<=] Y"W3!TNM"!<M^>SL+5,#J;T5M@618^A7UO@75YIH9V[Y#E+.K:6L2
M8[.^MQX_B(^E%Q_%F%E.%?0HY ?]>D_C)YK])A#L4&P15O>B1^(BUO2N#>IA
M]U=VL4$"["T2(/,N<@$H3]%DV1L"211*ZF#)LR"/7'XXE_T@/GN1BJ!4YNI6
M&-=%]:RJ7*[^\&8A6MW*WZQ";S-;[P!0$%NO($<8%,';MD$!-&_W5\2Q:U\]
MZ%?K!QT4=A=X1VHSC#='P3:S]8Q!8VR]".PR"C3DWHT20$ULMS_T05QL_1;C
MNLC%%3'&;]+XB27E\N($/=(PG2;LOW*1/A'=Q)Y94 OL*OQ6R.5\V1UWU5=4
M3/2(^+R(Y3*_4H^[4CT@,_6@642(S6Z3'13,UBO8 6'>/LE!EVR_-Y@=T!M'
MOUOY/X"YBK#C;'9 U!R]J.T"\P$7T@Z(CM-?P<@!,7$.43!2+:$KQYLDOOR6
MKJ'LZP&"[CAZW5'@=I<FTU,N5O9B9+[01.Q%?Q)N^:R!XU%*@$[MJ^S^RE .
M"(33K0RU!Z*N$E&K!4(0#T<O'M\#X2&G(DB"TU\=S '*=[K5P?8 SE<"AYV6
M1QI #UR]'BB0&^><Q65=[DOPUL^,<X'D7=P;<"XPM]NMX+0[<)7C3;%K6=.X
MP.JNGM5WQNV T\P%:G?[*QVYP,KN(4I'2K0<%5J6T3;-:H\.Z2E;!=?U[9?1
M%;HO(L[FD7Z.5=N+0^$'O.[V5W%R@9S=;@_P[('?PK%?K^B>M8$'M.WN7$':
M";S%IN% X'E [5Y_I24/"-K3K\+W!Z]R7 >/M('G 75[.U=Z-. =D"4]X'*O
MOW*/!]SLZ9?=WP%4\TD<MP4FX&QOYU*,?% T2R.Q):<Q$_/GV(L0#]C<ZZ]"
MX]4>X^SV'.<>@'G*14C;W *B]G8NK&A .^3< N[V^JNR$*!>TNV1F-VA(NKB
M2 M4!&B9[%P<D=^<L22(T+]ID"EW:4>:: 3(F_17,2' Q^18%1.BKI@8Q%__
M:T$3N)OL7#+I@N8!9R !9B?]U4@(4#0Y5HV$J&LDAM<"&O WV;E(\DAEL5DB
MP9+_X7RL/5G?7]F$ (>38Y5-B*)L<BK -%MFH \,[^]<-]D9S -.1Q^$P.^O
M@.(#D?O'*J#XB@**A- V6R $FO=W+J'<)F$FKI://JU_=W"DJ><#Y?O]E5)\
M(&__6*447UE*::U8^L#L_LZE%!ULAYQD0/5^?W43']C9/U;=I'*\"5;;%*N=
M7=KV<'L^9UG T^P=3:A\A$B\F$<!ET?#5WL#[?FE^@&F'D\P&;4C3(9^:;W?
MF<VEU[531IZG>TX0&[5C1H:><!='H,,BRV1<$7QGJTVZ=LS(Z/&<D5$[:&0<
MXX#LTNM:R<)5GOI;FJX]N&88JB-)8Z6M:=A:#&M'DHPCG)1=.JW'U'965FG;
M=EIV6#N<+W]\X3[(IBS)442?16/C3!9XLL7/&2S>\'1>GM=_2CE/X_+EC 8B
M"6D@/G].4[Y\(W\"8/6K$I=_ E!+ P04    " !%@5Q4IU=4B@D'  !4*
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MH*[?"R&?#HJ7L^J7\:;_ 5!+ P04    " !%@5Q493INV0,#  "J"   &0
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ML>D@!F)(#6)D7M&P>65PA1S3\\K@"ZE+U)LL?7I+9G)-UOM#*9TT5RB,VS4
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M,&IG0-\72MF'B>NVZNYZ\@M02P,$%     @ 18%<5'XNM1BH P  *0P  !D
M  !X;"]W;W)K<VAE971S+W-H965T.# N>&ULO5?;;MLX$/V5@=$%4J"U;HXO
M@6V@B9-M@+H-;+3[4/2!D<86$8GTDK2=+O;C=T@IBAS+0EXV+Q8O<^&9,QR.
MQWNI'G2*:. QSX2>=%)C-A>>I^,4<Z:[<H."=E92Y<S05*T]O5'($J>49U[H
M^WTO9UQTIF.W=J>F8[DU&1=XIT!O\YRIWY>8R?VD$W2>%A9\G1J[X$W'&[;&
M)9KOFSM%,Z^RDO <A>92@,+5I/,IN)@%D55P$C\X[G5M#!;*O90/=G*;3#J^
M/1%F&!MK@M%GAU>89=82G>/OTFBG\FD5Z^,GZS<./(&Y9QJO9/873TPZZ0P[
MD."*;3.SD/O/6 (ZM_9BF6GW"_M2UN] O-5&YJ4RG2#GHOBRQS(0-86@?T(A
M+!7"EPJ]$PI1J1"]5J%7*O1<9 HH+@XS9MATK.0>E)4F:W;@@NFT"3X7EO>E
M4;3+2<],;[A@(N8L@UNAC=H2I48#$PDLN'Z .1/$OEV$L^O5BL@"N8(9*KYC
MEK #+:+1I A74FB9\8093&!IZ%-NK^#;!A6S?.N:#0U<P WC"GZP;(OP&9,U
M%VM88%;(IGRCW\/9# WC&8T^PO?E#,[>O8=W5G7.L\R*C3U# ;&PO+@$?UF
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M*K0 [B\Y5[N)=E#]E9G\"U!+ P04    " !%@5Q4!(\FA=P#  "U#   &0
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M--B#NF&._RNHL@*XGTEI7B?60/U/9?PW4$L#!!0    ( $6!7%01@79^IP,
M -L*   9    >&PO=V]R:W-H965T<R]S:&5E=#@T+GAM;,U66V_B.!3^*T?1
M/'0D2BY0+B- *M#N( U35&9V'T;[X"8.\=:Q6=L45MH?/\=.F@8*".W#:%_
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M21J<5-PRP^F3*BN ]ZF4YG5C#53S[.@G4$L#!!0    ( $6!7%2L6O%^* @
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MX);3#M1S.[GU=X&8KEE4MDN+JYOY>OYS^Z>!A>Z>K3S,^EVK60>8N9W<S;O
M2-<L'=M=[+J->L.L>T _STR_+WS%H]=_V,3Z8!O&X@&UO$[NPCU GV?6A6U2
M)YYV$[Z;.M%8-:9./""?=SSYKCTU.>HU["@]X)YGYMXI#G@\C5JT;'7J-.=F
MI/%JKAV<F55E_6I&_Z&#LH,>0-+KI*ST *6>&:6M+G%5-^HN<=6J^1('('MF
M=;D3IM,E"SU KM=)64H S.3 #*KV.%45GIIDH<:J.5E(@/3$K$]WHGBX7"7
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M:X#?%U*:EXEM6HHF=?0'4$L#!!0    ( $6!7%0+_/79G (  ( &   9
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ML!A),_-+ERGED"DJ,B1AUO,^X\L!;EB!B_A!8:TJ8V1+F0CQ9"<WTYX7V(R
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MN,C\#I)/M%BX8WPBM+D4N&%J[FT@;8!Y/Q/F&R@F]F90W@3[?P%02P,$%
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M!2[2420B!;C1(T5B6U_T#I_6NZQ/T:A(#/@74$;]*.M0S-7LW58!7704=%%
M%PVCZV@Z!/J((^*% P6643]GC%_I0;*! G?H*&(L!O[$83%VM*<#?02GYAAH
M%A]+L[8!WVB+798I*H>6-S' +/;#;'>P4=\E6TO<40 6 \#B$ZBS0!_!J3@&
MI,5^I.T1 CP< NX*UTB?X1@ -,;^12YM+M2E 9JM=!T3W.<#X&,L1HD)0%I\
M GD6Z(-$F,;>F !,QGYY9APK#B(P T"R400: Z0Q/])>Q-6!/D@4)]3G:@:0
M8T'%)O;V,D".C;.19^WDG0!R@3YH%&.ODX%QS,^X9HWQ)4\S7VO )#:*7&.
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MH%0>JT6EJT654LXS=.EJT6ZQKH& 8GF@%F7="07]<:V7=[KPWCQ J1Q%BTI
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MW%F77-+'J;?] V2WJYSW]Z5992(SI4P75*8+RF0=4[J\2U+!MY)' GRYD W
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MIC'-$A)M=R2$01O"H#.$!4JN--PHBZ8CHV%+-_P?@HU:^E%GM+XM=JXM0&U
M*+D]MZ@+FBO+8Y+-1F\D2Y(H_BM9_84>\1I\>2-L>-#3;@!?,[WETH# #>&B
MWHB$UO50JQ=6E;[-E\K2T/!F3O\!U,Z!SC>*1&\6;G*T?Y;I'U!+ P04
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MI@3@_9)SN;M1 Y3GII?_ %!+ P04    " !%@5Q4&5-@O) ,  !J6P  &0
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M>]Y!P1>NSW@BO,3U&4 (6)^!I*3K,QZ#H#<XL!MX.L(3602=C@#$H-,1@-C
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M3MC>GCXSV+HKIDY6D.@HS3(4P$'K&2KCB8K0G.3M/C2H[8GF:4EW(6+O0GE
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M@TN ?+^F5!QOR@':<\3YOU!+ P04    " !%@5Q48X$:JUT$   =$   &@
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M^.GEUS(7!:#_Z LH=/%D5LGZP &)#;J'#4@)Z^H9NE4*M$*T7*,'1E>,,\U
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MSN\@*P/S?".$?KNI3HC=+P++/U!+ P04    " !%@5Q4ZQI,(< &   I)P
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M_:/JO.S,$RW8,$\>X[E873;Z#31G"[I)Q"1__H-5'>J4\69Y4JB_Z+GZK==
MLTTA\K0"RR=(XVS[GWZOB-@#X*X%0"H ^1$06 !^!?"/!005(%#,;+NB>(BH
MH%<7/']&O/RUC%9^4&0JM.Q^G)5YOQ=<?AM+G+@:9[,\9>B!?F<%:MX+*C8B
MYR_E#32A@B&1H]%BP51Z]-T)F^79+$YB6F;O/6I&3- X*=Y?M(5\JC)V>U8]
MP?7V"8CE"3!!G_-,K HTRN9L7@_0EMW9]8F\]NF:@!$C-FLA'_^&B$>PX8&&
MQ\,] SPZ&HY#H#?^+D.^BN<[,X2&DJ<X6[)L]H+^OI&_0V/!TN(?H)5@UTJ@
M6@DLK>C,"]D0ESDV91*.07#+\]Z9"/])7 3C<'B(JW6^L^M\!PSTE28;NBU#
MB2R$-)L9>P\':6*OVPJ]=Z8I,'1  ](B9F0$(ST' ]T= UTPCAQDG,ER+FB"
MIO=JL$DV9&65=3-#(\HS.>X*$REPW*9OY\2%;'4ME#B ?0.P1DIO1TH/C/1(
M9<V;2Q69;Y1(%6@C*Q1'X\D0_?H+[O9^1YUP8"(%CFM(VI81&"89\2V,P,!N
MT.J HZ2_(Z0/CY)T+74:Y0LD5DQ6H_0ISJIYD\U1)-DJ1"PVG!E'"AR[25I]
MRT"!@9T29R(%AO5:/9"3<,=)",;1X@@53CA&,U05T-AY&-EK87/G85@_/,35
M>H\][1\\,-0TBX6<)*5^_)CV>L0]1X+/*'B8Z'8(^.3#A-$,L8SQY8L:P'+<
M,LIG*R1KX3P6QD'LB!E:!N/0@</$-HH=P&;@MP*XW&'M-+ /Y[)UWU)#&,UC
M.:RYU(.8)F8>X$C6$O>3N,B!D[41.UC03@C#MD)7N=F*RL%7H#A#"5O&1:**
MG9$..*2=#AC7#*V^X/06ZW1H;X1ABZ%FMJ1 34JAU@GE9('FB,/M>#9E'[J0
MV.H)7,C .3ZT5<*PP3C2+3JB2!8.GZAB 48J?V/DP-$BQOW2"( L:&^$85-1
MEN>""9$HVUB\%M \V2AJRMG#N%P39DH7UWD1*PME9,IEE\P:-_Q)7.3 X3 \
M9+C.DC9,&'89M](H<6.?'6ZH:Q\=,!(?>KVJUS!.^72HS]H08=A<W$S_''V^
MOIU./D%K>6TPB'=&.T"T[2#8G:K=DN=VS3BUCEA'*)F]GB5[+F3'9@0C%Q('
M!@-=YT);(P*[BD_CZ\G@YF$P@:)I6T'.N8-!M' 36/-.RB <*BQ-E3%_,*YO
M\R\.7-/O.[.G%9O 8C>>C&X&7R(HEA8[TCUG[K2<$+CHGI0[.)1M03ATX/JE
MUS+FSK$NQ[YANM=YT()!X#+\D1_ZB7HH78=)>,;4^;I ^_ *\)34.4))@V>3
M/1?2NGT0.9"X<YCW.A-:0OQC)&2Q90**J NQ3\Z9P[T]9GC]=%(.'4LQ[-D6
M+4,7U#.L9:LDPDC3^KE.A581_RU4I!Y<EV:_<\Y\ZK+MO\D:Q1&EV;?M. X=
M2-RUF6]7DZ%AO[A.@M84_PA-,7;;L0 XM,)5IUU"8*]!,)(XMN-\K1\^K!_3
M[.AEER-2S[9GX<#9%[:1 ^EW'7NROM8^'UZ#/,9BM<J3N9Q@VST+(P&.75EL
M'_U.I&V?PH$T[.?67^=I50Y@67O#];FC)<_FMQRXIF][-12YD*3G>L<3:-$.
M8-&^FXXF#[=H,A[>0O&T9 ?GE.Q 2W;P=I+M"!785CL.G#1=A_M)509/WN>M
MT[#WWMKQXOIQ_/#7:.)8\ 1:H8-S*G2@%3J A>ZD]#G$UOK:'<81ZVMW&.=,
MGE;H -:]^_&73X.[V\D(BJ:U+^B?,W5:7 *X2)^4.C@4Z5N+)PRT'YF <=;<
MM??.$*6,+]59K +-\DTFMD=O=G=WY[T&ZI33#_>O\8=H>VI+A]D>(OM,^3+.
M"I2PA0SIM7IR)O+MN:SMA<C7ZJ324RY$GJJ/*T;GC)<_D-\O\ER\7I0-[$['
M7?T/4$L#!!0    ( $6!7%1$X"NM[ ,  '8-   :    >&PO=V]R:W-H965T
M<R]S:&5E=#$P-"YX;6RM5]]OXC@0_E>L[&K52MLD=B"0+B#10K7[4*EJMWL/
MIWLPR0#6)C9K.Z5[?_TY/T@#&)H['0\0V_/-S#<>9B:CK9 _U1I H]<LY6KL
MK+7>7'N>BM>04>6*#7!SLA0RH]HLY<I3&PDT*4%9ZA'?#[V,,NY,1N7>@YR,
M1*Y3QN%!(I5G&96_;R 5V[&#G=W&(UNM=;'A348;NH(GT,^;!VE67J,E81EP
MQ01'$I9C9XJO[S I *7$#P9;U7I&!96%$#^+Q;=D[/B%1Y!"K L5U/R\P"VD
M::')^/&K5NHT-@M@^WFG_:XD;\@LJ();D?[!$KT>.T,');"D>:H?Q?8KU(3Z
MA;Y8I*K\1MM:UG=0G"LMLAIL/,@8KW[I:QV(%@"')P"D!I!#0.\$(*@!05=
MKP;TN@+Z-:#?%1#6@+",?16L,M(SJNED),46R4+::"L>RNLJT2; C!>9]:2E
M.64&IR??>"PR0-_I*RAT\602-\E30&*)GKF$6*PX^QN2XAS= (<ET^H27<Q
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M\@E(>D<A<*VLWK]6-TK,S?O"D5!*9.9RQMF82ST ?I\(H9YN]"O(U5OPT_\
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MN0:J,J8-U.]+QN2^HR=H_]F8? =02P,$%     @ 18%<5#<_/9&) P  F L
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M7J"R ?1\(:5YGM@-F@^6T1]02P,$%     @ 18%<5,X<L18Y!   7Q   !H
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MB]M9;EX(FX86\_R2G0J-5W;^F>"K"J0)P/%8"+UMF'N[?*>-_@!02P,$%
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M^2Q&6F&076%>S^*HJR;GX_'0G3;_#DLT^,#I<'I8H\D,#6%/D5JJD%VJWJH
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MDN='I;PAV38[;2R95&>7[':CCI? =8#J7S$F7QOZ %,<6,=_ %!+ P04
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MA;U,TZ9L*/XZ;N<W?8<;GMOA'NZ!L//QY!CN:, =?8I[C0E'&TP;T(U0ZT;
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M/K^24CWOE*_/F[]+S/\'4$L#!!0    ( $6!7%0> PH]JP,  +D1   :
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MRQVP$$3^ -[?<*Y>&OD U6G-_!=02P,$%     @ 18%<5(=S(ND? P  )PL
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M"$I!D.==&.597A-%YE/!#TB8U3J::>2EYFJ=',W,4WE00L]2K5/SFW3'^!L
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MN=4W61!F@9Y/.%?O'7.YJN[&\[]02P,$%     @ 18%<5%EWD/GW!0  01P
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M#J29@-]70NA=QP0H[X3#?U!+ P04    " !%@5Q4.5-0WA(#   U"0  &@
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M:F_#[X:\N9ZR??[^_F?R@C$-T*L1#=TFZ$6JZ:/VIG\P^.9RRN6#]DLLIZF
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M5SB88RH(^/<+0MCN02@H_FMA^!]02P,$%     @ 18%<5/G55%C4"   !#0
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M6$HSR7B&!)T?=4[PZ[=1H 6*%9\9O9.5:Z1-F7+^57^8S(XZGM:()C16&H+
MOS4]HTFBD4"/;P:T4SY3"U:O']#/"^/!F"F1](PG?[*96AYUAATTHW.2)^J&
MWUU08U"D\6*>R.(ONC-KO0Z*<ZEX:H1!@Y1EF__DN]F(BH"/&P1\(^"W%0B,
M0-!6(#0"85N!R A$;07Z1J#?5F!@! 9M!89&8-A68&0$1FT%L/?@.>^1"!XU
MB93.W@3=)DJ*$!L318X/!;]#0J\'/'U1Q&DA#Y'%,IU2MTK MPSDU#&$8D*F
M7)!-@&<S]([%.F.R!3I9"$HA?91$+]\3H=>LZ2OT<DP588E\A5X@EJ$KEB0@
M*P]["O31J+W8//MT\VR_X=GG=-I%_N  ^1X>?;H=HY<O7M6@G+E1;ND*4+P"
M9=B,,G:C7)*LBX(-2M2,\J:%1=@O4()KP6=YK&I0SMTH8QJ#+EBC^'ZS+G_\
M$I2+]BBX&672'L5K1KELC>**E[<M/.T-"Y3^3.2+1Y';@PPJT\@OT\@O0(.G
MTVA-T0GD2K8PJ:-SZCW/?H^;EJ"/<"E)46(D^O(.H-%$T53^[5 L*!4+"L7"
M1L4R!;FL'Q,#/)M1D^H)(U.6,'5?%Q,;S&&!J8OR^AB/1MW!86]=]?GN*M\/
MNOWM59<UJR*O@K5E5EB:%3K-NJ&2$A$OB]V=T36T!BN]EW7&;)!&%04&$>[B
M1\;LKHJBZ/&JR]U5_6#4'=4;$Y7&1$YC@"AB2F<2S05/D20)17R.B)34A(_,
MI^ Y1@2C=31[$>UH->KO>&NSJ%_U@_?(NLV2077)L-ZT?FE:WVG:%==>(8Y
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M*+]<4C*G0C6 WY\YE]L;]77,[I.YR_\!4$L#!!0    ( $6!7%3\_^:H\@,
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ME?A^&-H1P.P*?!]#8#7B"*8 -&"([Q?/P8WGD5<]I[SF;_/A7U!+ P04
M" !%@5Q4EXJ[',     3 @  "P   %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">
M, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]
M$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N&6:WO606IW.D5XA<
MUYVE/=LO3T%O@*\Z3'%":4A+,P[PS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A
M(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X
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M^BSW_@^8[]LNNT\^5+V/*,6$$\V&FA30GP04$RDH9580P&R;%L5$"DJYA^!
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M[0=94!D#8)+#&J"U*=<&\-H4; .(;4JV <PV1=L :INR;0"W3>$V@-RF=!O
M;E.\#:!W5+TC0.^H>D> WM%]V0;H'57O"- [JMX1H'=4O2- [ZAZ1X#>4?6.
M +VCZAT!>D?5.P+T3JIW NB=5.\$T#NIW@F@=W(_E@#T3JIW NB=5.\$T#NI
MW@F@=U*]$T#OI'HG@-Y)]4X O;/JG0%Z9]4[ _3.JG<&Z)U5[PS0.[L?NP%Z
M9]4[ _3.JG<&Z)U5[PS0.ZO>&:!W5KTS0.^B>A> WD7U+@"]B^I= 'H7U;L
M]"ZJ=P'H7=R?E0"]B^I= 'H7U;L ]"ZJ=P'H753O M"[JMX5H'=5O2M [ZIZ
M5X#>5?6N +VKZET!>E?5NP+TKNYF$X#>5?6N +VKZET!>E?5NP+T;JIW ^C=
M5.\&T+NIW@V@=U.]&T#OIGHW@-Y-]6X O9OJW0!Z-W>S($#OIGHW@-Y-]6X
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M;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ 18%<5-=_/3[N    *P(  !$
M             ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @
M18%<5)E<G",0!@  G"<  !,              ( !S $  'AL+W1H96UE+W1H
M96UE,2YX;6Q02P$"% ,4    " !%@5Q4O@1*4EL&  #H&0  &
M    @($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @
M18%<5#8\TJ 3 @  Z00  !@              ("!G@X  'AL+W=O<FMS:&5E
M=',O<VAE970R+GAM;%!+ 0(4 Q0    ( $6!7%16%G/WWP$  #@$   8
M          " @><0  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4
M    " !%@5Q4&;(D9.,%  !(%P  &               @('\$@  >&PO=V]R
M:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%     @ 18%<5'T49<E- @  P 4
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M965T.2YX;6Q02P$"% ,4    " !%@5Q4.B!XKPD"  !4!   &0
M    @(&"-P  >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    (
M $6!7%1OVBA0V@0  .@)   9              " @<(Y  !X;"]W;W)K<VAE
M971S+W-H965T,3$N>&UL4$L! A0#%     @ 18%<5'L?J5&F(P  NG0  !D
M             ("!TSX  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"
M% ,4    " !%@5Q4#!1U$*<0  "I+0  &0              @(&P8@  >&PO
M=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( $6!7%2+F(@O; @
M $,4   9              " @8YS  !X;"]W;W)K<VAE971S+W-H965T,30N
M>&UL4$L! A0#%     @ 18%<5.R<@-<:!P  (Q(  !D              ("!
M,7P  'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4    " !%@5Q4
MVI;K$?T%  !N#@  &0              @(&"@P  >&PO=V]R:W-H965T<R]S
M:&5E=#$V+GAM;%!+ 0(4 Q0    ( $6!7%2_;C&"108  &00   9
M      " @;:)  !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%
M  @ 18%<5#PSYK99%@  .$\  !D              ("!,I   'AL+W=O<FMS
M:&5E=',O<VAE970Q."YX;6Q02P$"% ,4    " !%@5Q46=W,NQX&   4%@
M&0              @('"I@  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+
M 0(4 Q0    ( $6!7%2NK/RH]Q@  %%(   9              " @1>M  !X
M;"]W;W)K<VAE971S+W-H965T,C N>&UL4$L! A0#%     @ 18%<5%[F8.96
M"0  6!@  !D              ("!1<8  'AL+W=O<FMS:&5E=',O<VAE970R
M,2YX;6Q02P$"% ,4    " !%@5Q4",WNX&05   41   &0
M@('2SP  >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( $6!
M7%1G]I9Y- H  )H7   9              " @6WE  !X;"]W;W)K<VAE971S
M+W-H965T,C,N>&UL4$L! A0#%     @ 18%<5)N2T]N&"0  0QD  !D
M         ("!V.\  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4
M    " !%@5Q4#XBW:T<#  !%!P  &0              @(&5^0  >&PO=V]R
M:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    ( $6!7%0&=)V=CB(  *]T
M   9              " @1/]  !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL
M4$L! A0#%     @ 18%<5*,X%4$J P  <@@  !D              ("!V!\!
M 'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6Q02P$"% ,4    " !%@5Q4YLHI
M4*4&  #V#@  &0              @($Y(P$ >&PO=V]R:W-H965T<R]S:&5E
M=#(X+GAM;%!+ 0(4 Q0    ( $6!7%25OUVMA <   H1   9
M  " @14J 0!X;"]W;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @
M18%<5%9<#[YL!@  WA(  !D              ("!T#$! 'AL+W=O<FMS:&5E
M=',O<VAE970S,"YX;6Q02P$"% ,4    " !%@5Q4$&S(,NX"  "U!@  &0
M            @(%S. $ >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4
M Q0    ( $6!7%1\O<%(E@,  #L(   9              " @9@[ 0!X;"]W
M;W)K<VAE971S+W-H965T,S(N>&UL4$L! A0#%     @ 18%<5!8GP8JK!P
M+Q4  !D              ("!93\! 'AL+W=O<FMS:&5E=',O<VAE970S,RYX
M;6Q02P$"% ,4    " !%@5Q4NY=CHA$*  #$(0  &0              @(%'
M1P$ >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( $6!7%06
M !)])P0  '<*   9              " @8]1 0!X;"]W;W)K<VAE971S+W-H
M965T,S4N>&UL4$L! A0#%     @ 18%<5*E#@>@[!@  IQ8  !D
M     ("![54! 'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( $6!7%0J[&V7FP0  "<,   9              "
M@?)Z 0!X;"]W;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @ 18%<
M5 9:2DHL @  E00  !D              ("!Q'\! 'AL+W=O<FMS:&5E=',O
M<VAE970T,BYX;6Q02P$"% ,4    " !%@5Q4J)X3"/8$  !.&   &0
M        @($G@@$ >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0
M   ( $6!7%1Z PIL[ ,  ,X,   9              " @52' 0!X;"]W;W)K
M<VAE971S+W-H965T-#0N>&UL4$L! A0#%     @ 18%<5+5)>'O0"   -"L
M !D              ("!=XL! 'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q0
M2P$"% ,4    " !%@5Q4JG._U3@&  #S'   &0              @(%^E $
M>&PO=V]R:W-H965T<R]S:&5E=#0V+GAM;%!+ 0(4 Q0    ( $6!7%2SY444
M,P,  *8)   9              " @>V: 0!X;"]W;W)K<VAE971S+W-H965T
M-#<N>&UL4$L! A0#%     @ 18%<5/C?:AYQ!@  2B8  !D
M ("!5YX! 'AL+W=O<FMS:&5E=',O<VAE970T."YX;6Q02P$"% ,4    " !%
M@5Q4/2*^-JH$  #<%P  &0              @('_I $ >&PO=V]R:W-H965T
M<R]S:&5E=#0Y+GAM;%!+ 0(4 Q0    ( $6!7%1G-FUZ:@(  #<&   9
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M970U-"YX;6Q02P$"% ,4    " !%@5Q4,O08HJD"  # !P  &0
M    @(%-O@$ >&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    (
M $6!7%395QD*[0(  +<'   9              " @2W! 0!X;"]W;W)K<VAE
M971S+W-H965T-38N>&UL4$L! A0#%     @ 18%<5#"!#\(8 P  Y0@  !D
M             ("!4<0! 'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6Q02P$"
M% ,4    " !%@5Q4ZIA9;Q(#   R"0  &0              @(&@QP$ >&PO
M=V]R:W-H965T<R]S:&5E=#4X+GAM;%!+ 0(4 Q0    ( $6!7%3->4[A-P,
M  0,   9              " @>G* 0!X;"]W;W)K<VAE971S+W-H965T-3DN
M>&UL4$L! A0#%     @ 18%<5";OLXRO @  1P<  !D              ("!
M5\X! 'AL+W=O<FMS:&5E=',O<VAE970V,"YX;6Q02P$"% ,4    " !%@5Q4
M055?$U("  #,!0  &0              @($]T0$ >&PO=V]R:W-H965T<R]S
M:&5E=#8Q+GAM;%!+ 0(4 Q0    ( $6!7%1$#0\/. 0  "80   9
M      " @<;3 0!X;"]W;W)K<VAE971S+W-H965T-C(N>&UL4$L! A0#%
M  @ 18%<5&"UMQ]X P  50L  !D              ("!-=@! 'AL+W=O<FMS
M:&5E=',O<VAE970V,RYX;6Q02P$"% ,4    " !%@5Q4"2O_3:X#   N#@
M&0              @('DVP$ >&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+
M 0(4 Q0    ( $6!7%0W7]Z(2P(  !('   9              " @<G? 0!X
M;"]W;W)K<VAE971S+W-H965T-C4N>&UL4$L! A0#%     @ 18%<5)(E4QZ#
M @  8 <  !D              ("!2^(! 'AL+W=O<FMS:&5E=',O<VAE970V
M-BYX;6Q02P$"% ,4    " !%@5Q4F:5D+]8"   Z"   &0
M@($%Y0$ >&PO=V]R:W-H965T<R]S:&5E=#8W+GAM;%!+ 0(4 Q0    ( $6!
M7%2J+0C*N@(  #P(   9              " @1+H 0!X;"]W;W)K<VAE971S
M+W-H965T-C@N>&UL4$L! A0#%     @ 18%<5.8V*0\_ P  D0L  !D
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M=#<S+GAM;%!+ 0(4 Q0    ( $6!7%0H7OE6R04  )@G   9
M  " @?(& @!X;"]W;W)K<VAE971S+W-H965T-S0N>&UL4$L! A0#%     @
M18%<5&4Z;MD# P  J@@  !D              ("!\@P" 'AL+W=O<FMS:&5E
M=',O<VAE970W-2YX;6Q02P$"% ,4    " !%@5Q40_68A4D"  #6!0  &0
M            @($L$ ( >&PO=V]R:W-H965T<R]S:&5E=#<V+GAM;%!+ 0(4
M Q0    ( $6!7%1+A0^[R L  *%.   9              " @:P2 @!X;"]W
M;W)K<VAE971S+W-H965T-S<N>&UL4$L! A0#%     @ 18%<5$%!6!P5 P
MA0H  !D              ("!JQX" 'AL+W=O<FMS:&5E=',O<VAE970W."YX
M;6Q02P$"% ,4    " !%@5Q4FF>5C30#  !I"P  &0              @('W
M(0( >&PO=V]R:W-H965T<R]S:&5E=#<Y+GAM;%!+ 0(4 Q0    ( $6!7%1^
M+K48J ,  "D,   9              " @6(E @!X;"]W;W)K<VAE971S+W-H
M965T.# N>&UL4$L! A0#%     @ 18%<5, &[?GM @  !0<  !D
M     ("!02D" 'AL+W=O<FMS:&5E=',O<VAE970X,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( $6!7%1K+K^]4 0  /01   9              "
M@<1  @!X;"]W;W)K<VAE971S+W-H965T.#8N>&UL4$L! A0#%     @ 18%<
M5-L>_ <& P  L H  !D              ("!2T4" 'AL+W=O<FMS:&5E=',O
M<VAE970X-RYX;6Q02P$"% ,4    " !%@5Q4"_SUV9P"  " !@  &0
M        @(&(2 ( >&PO=V]R:W-H965T<R]S:&5E=#@X+GAM;%!+ 0(4 Q0
M   ( $6!7%039\]KV@(  !4*   9              " @5M+ @!X;"]W;W)K
M<VAE971S+W-H965T.#DN>&UL4$L! A0#%     @ 18%<5-,EK]_0 P  , \
M !D              ("!;$X" 'AL+W=O<FMS:&5E=',O<VAE970Y,"YX;6Q0
M2P$"% ,4    " !%@5Q46F6+YW()   \00  &0              @(%S4@(
M>&PO=V]R:W-H965T<R]S:&5E=#DQ+GAM;%!+ 0(4 Q0    ( $6!7%1^J[\D
M$ (  (,$   9              " @1Q< @!X;"]W;W)K<VAE971S+W-H965T
M.3(N>&UL4$L! A0#%     @ 18%<5"?M(,E^ @  5@<  !D
M ("!8UX" 'AL+W=O<FMS:&5E=',O<VAE970Y,RYX;6Q02P$"% ,4    " !%
M@5Q4D<S>ZN(%  !@(   &0              @($880( >&PO=V]R:W-H965T
M<R]S:&5E=#DT+GAM;%!+ 0(4 Q0    ( $6!7%02R )3;P(  &4&   9
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M970Y.2YX;6Q02P$"% ,4    " !%@5Q4=* #B+L&  "F'   &@
M    @($2A ( >&PO=V]R:W-H965T<R]S:&5E=#$P,"YX;6Q02P$"% ,4
M" !%@5Q4F5H^+-<$  !3%   &@              @($%BP( >&PO=V]R:W-H
M965T<R]S:&5E=#$P,2YX;6Q02P$"% ,4    " !%@5Q48X$:JUT$   =$
M&@              @($4D ( >&PO=V]R:W-H965T<R]S:&5E=#$P,BYX;6Q0
M2P$"% ,4    " !%@5Q4ZQI,(< &   I)P  &@              @(&IE (
M>&PO=V]R:W-H965T<R]S:&5E=#$P,RYX;6Q02P$"% ,4    " !%@5Q41. K
MK>P#  !V#0  &@              @(&AFP( >&PO=V]R:W-H965T<R]S:&5E
M=#$P-"YX;6Q02P$"% ,4    " !%@5Q4!ZU8XUH&   1'P  &@
M    @('%GP( >&PO=V]R:W-H965T<R]S:&5E=#$P-2YX;6Q02P$"% ,4
M" !%@5Q4\[X1ET$$  #E$   &@              @(%7I@( >&PO=V]R:W-H
M965T<R]S:&5E=#$P-BYX;6Q02P$"% ,4    " !%@5Q4-S\]D8D#  "8"P
M&@              @('0J@( >&PO=V]R:W-H965T<R]S:&5E=#$P-RYX;6Q0
M2P$"% ,4    " !%@5Q4Q"DJAPP#  "\"   &@              @(&1K@(
M>&PO=V]R:W-H965T<R]S:&5E=#$P."YX;6Q02P$"% ,4    " !%@5Q4SARQ
M%CD$  !?$   &@              @('5L0( >&PO=V]R:W-H965T<R]S:&5E
M=#$P.2YX;6Q02P$"% ,4    " !%@5Q4A\.0L"@#  "S"0  &@
M    @(%&M@( >&PO=V]R:W-H965T<R]S:&5E=#$Q,"YX;6Q02P$"% ,4
M" !%@5Q4HYWWR? #  "U#@  &@              @(&FN0( >&PO=V]R:W-H
M965T<R]S:&5E=#$Q,2YX;6Q02P$"% ,4    " !%@5Q48L3V5Q,%  #P%@
M&@              @('.O0( >&PO=V]R:W-H965T<R]S:&5E=#$Q,BYX;6Q0
M2P$"% ,4    " !%@5Q4I.%FC?T&   *)0  &@              @($9PP(
M>&PO=V]R:W-H965T<R]S:&5E=#$Q,RYX;6Q02P$"% ,4    " !%@5Q4*#FK
M8BD#  "\"@  &@              @(%.R@( >&PO=V]R:W-H965T<R]S:&5E
M=#$Q-"YX;6Q02P$"% ,4    " !%@5Q47#C:C)$"  !#!@  &@
M    @(&OS0( >&PO=V]R:W-H965T<R]S:&5E=#$Q-2YX;6Q02P$"% ,4
M" !%@5Q4"(PW\ED%   Z(0  &@              @(%XT ( >&PO=V]R:W-H
M965T<R]S:&5E=#$Q-BYX;6Q02P$"% ,4    " !%@5Q4'@,*/:L#  "Y$0
M&@              @($)U@( >&PO=V]R:W-H965T<R]S:&5E=#$Q-RYX;6Q0
M2P$"% ,4    " !%@5Q4AW,BZ1\#   G"P  &@              @('LV0(
M>&PO=V]R:W-H965T<R]S:&5E=#$Q."YX;6Q02P$"% ,4    " !%@5Q467>0
M^?<%  !!'   &@              @(%#W0( >&PO=V]R:W-H965T<R]S:&5E
M=#$Q.2YX;6Q02P$"% ,4    " !%@5Q4B!MH[^8"   ?"@  &@
M    @(%RXP( >&PO=V]R:W-H965T<R]S:&5E=#$R,"YX;6Q02P$"% ,4
M" !%@5Q4.5-0WA(#   U"0  &@              @(&0Y@( >&PO=V]R:W-H
M965T<R]S:&5E=#$R,2YX;6Q02P$"% ,4    " !%@5Q4EP/2>+T"  !L!P
M&@              @(':Z0( >&PO=V]R:W-H965T<R]S:&5E=#$R,BYX;6Q0
M2P$"% ,4    " !%@5Q4==LS,H\&  #!(   &@              @('/[ (
M>&PO=V]R:W-H965T<R]S:&5E=#$R,RYX;6Q02P$"% ,4    " !%@5Q4^=54
M6-0(   $-   &@              @(&6\P( >&PO=V]R:W-H965T<R]S:&5E
M=#$R-"YX;6Q02P$"% ,4    " !%@5Q4(-RC' 4'   $)0  &@
M    @(&B_ ( >&PO=V]R:W-H965T<R]S:&5E=#$R-2YX;6Q02P$"% ,4
M" !%@5Q4@U<L,_('   ^)P  &@              @('? P, >&PO=V]R:W-H
M965T<R]S:&5E=#$R-BYX;6Q02P$"% ,4    " !%@5Q4_/_FJ/(#  !S#@
M&@              @($)# , >&PO=V]R:W-H965T<R]S:&5E=#$R-RYX;6Q0
M2P$"% ,4    " !%@5Q4-.OHKW0#  !#%P  #0              @ $S$ ,
M>&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( $6!7%27BKL<P    !,"   +
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4!08     AP"' $0E  #7(P,    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>146
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>147
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>148
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>807</ContextCount>
  <ElementCount>734</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>243</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>18</UnitCount>
  <MyReports>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000010001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>000020008 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>000030009 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/AuditInformation_1</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100010002 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100020003 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100030004 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/ConsolidatedStatementsofOperations</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>100040005 - Statement - Consolidated Statements of Comprehensive Earnings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/ConsolidatedStatementsofComprehensiveEarnings</Role>
      <ShortName>Consolidated Statements of Comprehensive Earnings</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>100050006 - Statement - Consolidated Statements of Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/ConsolidatedStatementsofEquity</Role>
      <ShortName>Consolidated Statements of Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>100070007 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>140064001 - Statement - Consolidated Statements of Equity (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/ConsolidatedStatementsofEquityParenthetical</Role>
      <ShortName>Consolidated Statements of Equity (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>210011001 - Disclosure - Nature of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/NatureofOperations</Role>
      <ShortName>Nature of Operations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>210031002 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>210081003 - Disclosure - Acquisitions and Other Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/AcquisitionsandOtherTransactions</Role>
      <ShortName>Acquisitions and Other Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>210131004 - Disclosure - Revenue Recognition and Accounts Receivable</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/RevenueRecognitionandAccountsReceivable</Role>
      <ShortName>Revenue Recognition and Accounts Receivable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>210211005 - Disclosure - Balance Sheet Components</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/BalanceSheetComponents</Role>
      <ShortName>Balance Sheet Components</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>210331006 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>210381007 - Disclosure - Equity Method Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/EquityMethodInvestments</Role>
      <ShortName>Equity Method Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>210521009 - Disclosure - Financial Instruments and Risk Management</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/FinancialInstrumentsandRiskManagement</Role>
      <ShortName>Financial Instruments and Risk Management</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>210771011 - Disclosure - Comprehensive Earnings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/ComprehensiveEarnings</Role>
      <ShortName>Comprehensive Earnings</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>210811012 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>210881013 - Disclosure - Share-Based Incentive Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/ShareBasedIncentivePlan</Role>
      <ShortName>Share-Based Incentive Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>210941014 - Disclosure - Employee Benefit Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/EmployeeBenefitPlans</Role>
      <ShortName>Employee Benefit Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>211071015 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/SegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>211141017 - Disclosure - Restructuring</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/Restructuring</Role>
      <ShortName>Restructuring</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>211221020 - Disclosure - Valuation and Qualifying Accounts</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/ValuationandQualifyingAccounts</Role>
      <ShortName>Valuation and Qualifying Accounts</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>220042001 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.viatris.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>230053001 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.viatris.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>230093002 - Disclosure - Acquisitions and Other Transactions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/AcquisitionsandOtherTransactionsTables</Role>
      <ShortName>Acquisitions and Other Transactions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.viatris.com/role/AcquisitionsandOtherTransactions</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>230143003 - Disclosure - Revenue Recognition and Accounts Receivable (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableTables</Role>
      <ShortName>Revenue Recognition and Accounts Receivable (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.viatris.com/role/RevenueRecognitionandAccountsReceivable</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>230223004 - Disclosure - Balance Sheet Components (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/BalanceSheetComponentsTables</Role>
      <ShortName>Balance Sheet Components (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.viatris.com/role/BalanceSheetComponents</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>230343005 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.viatris.com/role/Leases</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>230393006 - Disclosure - Equity Method Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/EquityMethodInvestmentsTables</Role>
      <ShortName>Equity Method Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.viatris.com/role/EquityMethodInvestments</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>230453007 - Disclosure - Goodwill and Other Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsTables</Role>
      <ShortName>Goodwill and Other Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>230533008 - Disclosure - Financial Instruments and Risk Management (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables</Role>
      <ShortName>Financial Instruments and Risk Management (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.viatris.com/role/FinancialInstrumentsandRiskManagement</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>230673009 - Disclosure - Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/DebtTables</Role>
      <ShortName>Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>230783010 - Disclosure - Comprehensive Earnings (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/ComprehensiveEarningsTables</Role>
      <ShortName>Comprehensive Earnings (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.viatris.com/role/ComprehensiveEarnings</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>230823011 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.viatris.com/role/IncomeTaxes</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>230893012 - Disclosure - Share-Based Incentive Plan (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/ShareBasedIncentivePlanTables</Role>
      <ShortName>Share-Based Incentive Plan (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.viatris.com/role/ShareBasedIncentivePlan</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>230953013 - Disclosure - Employee Benefit Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/EmployeeBenefitPlansTables</Role>
      <ShortName>Employee Benefit Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.viatris.com/role/EmployeeBenefitPlans</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>231083014 - Disclosure - Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/SegmentInformationTables</Role>
      <ShortName>Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.viatris.com/role/SegmentInformation</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>231153015 - Disclosure - Restructuring (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/RestructuringTables</Role>
      <ShortName>Restructuring (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.viatris.com/role/Restructuring</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>240024002 - Disclosure - Nature of Operations (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/NatureofOperationsNarrativeDetails</Role>
      <ShortName>Nature of Operations (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/NatureofOperations</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>240064003 - Disclosure - Summary of Significant Accounting Policies (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Summary of Significant Accounting Policies (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>240074004 - Disclosure - Summary of Significant Accounting Policies (Basic And Diluted Earnings Per Ordinary Share Attributable To Mylan N.V.) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesBasicAndDilutedEarningsPerOrdinaryShareAttributableToMylanNVDetails</Role>
      <ShortName>Summary of Significant Accounting Policies (Basic And Diluted Earnings Per Ordinary Share Attributable To Mylan N.V.) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>240104005 - Disclosure - Acquisitions and Other Transactions (Other Transactions) (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails</Role>
      <ShortName>Acquisitions and Other Transactions (Other Transactions) (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/AcquisitionsandOtherTransactionsTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>240114006 - Disclosure - Acquisitions and Other Transactions (Purchase Price Allocations) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails</Role>
      <ShortName>Acquisitions and Other Transactions (Purchase Price Allocations) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/AcquisitionsandOtherTransactionsTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>240124007 - Disclosure - Acquisitions and Other Transactions (Unaudited Pro Forma Financial Results) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails</Role>
      <ShortName>Acquisitions and Other Transactions (Unaudited Pro Forma Financial Results) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/AcquisitionsandOtherTransactionsTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>240154008 - Disclosure - Revenue Recognition and Accounts Receivable Revenue Disaggregation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationDetails</Role>
      <ShortName>Revenue Recognition and Accounts Receivable Revenue Disaggregation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>240164009 - Disclosure - Revenue Recognition and Accounts Receivable - Disaggregation of Revenue by Key Products (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableDisaggregationofRevenuebyKeyProductsDetails</Role>
      <ShortName>Revenue Recognition and Accounts Receivable - Disaggregation of Revenue by Key Products (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>240174010 - Disclosure - Revenue Recognition and Accounts Receivable (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableNarrativeDetails</Role>
      <ShortName>Revenue Recognition and Accounts Receivable (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>240184011 - Disclosure - Revenue Recognition and Accounts Receivable Variable Consideration (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails</Role>
      <ShortName>Revenue Recognition and Accounts Receivable Variable Consideration (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>240194012 - Disclosure - Revenue Recognition and Accounts Receivable (Accounts Receivable, Net) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails</Role>
      <ShortName>Revenue Recognition and Accounts Receivable (Accounts Receivable, Net) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>240204013 - Disclosure - Revenue Recognition and Accounts Receivable Variable Consideration Rollforward (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationRollforwardDetails</Role>
      <ShortName>Revenue Recognition and Accounts Receivable Variable Consideration Rollforward (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>240234014 - Disclosure - Balance Sheet Components (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/BalanceSheetComponentsNarrativeDetails</Role>
      <ShortName>Balance Sheet Components (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/BalanceSheetComponentsTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>240244015 - Disclosure - Balance Sheet Components Balance Sheet Components (Cash and Cash Equivalents) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/BalanceSheetComponentsBalanceSheetComponentsCashandCashEquivalentsDetails</Role>
      <ShortName>Balance Sheet Components Balance Sheet Components (Cash and Cash Equivalents) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>240254016 - Disclosure - Balance Sheet Components (Accounts receivable, net) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/BalanceSheetComponentsAccountsreceivablenetDetails</Role>
      <ShortName>Balance Sheet Components (Accounts receivable, net) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/BalanceSheetComponentsTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>240264017 - Disclosure - Balance Sheet Components (Inventories) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/BalanceSheetComponentsInventoriesDetails</Role>
      <ShortName>Balance Sheet Components (Inventories) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/BalanceSheetComponentsTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>240274018 - Disclosure - Balance Sheet Components (Prepaids and other current assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/BalanceSheetComponentsPrepaidsandothercurrentassetsDetails</Role>
      <ShortName>Balance Sheet Components (Prepaids and other current assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/BalanceSheetComponentsTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>240284019 - Disclosure - Balance Sheet Components (Property, Plant and Equipment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails</Role>
      <ShortName>Balance Sheet Components (Property, Plant and Equipment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/BalanceSheetComponentsTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>240294020 - Disclosure - Balance Sheet Components (Other Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails</Role>
      <ShortName>Balance Sheet Components (Other Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/BalanceSheetComponentsTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>240304021 - Disclosure - Balance Sheet Components (Trade Accounts Payable) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/BalanceSheetComponentsTradeAccountsPayableDetails</Role>
      <ShortName>Balance Sheet Components (Trade Accounts Payable) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/BalanceSheetComponentsTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>240314022 - Disclosure - Balance Sheet Components (Other Current Liabilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails</Role>
      <ShortName>Balance Sheet Components (Other Current Liabilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/BalanceSheetComponentsTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>240324023 - Disclosure - Balance Sheet Components (Other noncurrent liabilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/BalanceSheetComponentsOthernoncurrentliabilitiesDetails</Role>
      <ShortName>Balance Sheet Components (Other noncurrent liabilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/BalanceSheetComponentsTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>240354024 - Disclosure - Leases (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/LeasesTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>240364025 - Disclosure - Leases (Lease Information) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/LeasesLeaseInformationDetails</Role>
      <ShortName>Leases (Lease Information) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/LeasesTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>240374026 - Disclosure - Leases (Lease Maturities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/LeasesLeaseMaturitiesDetails</Role>
      <ShortName>Leases (Lease Maturities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/LeasesTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>240404027 - Disclosure - Equity Method Investments (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/EquityMethodInvestmentsNarrativeDetails</Role>
      <ShortName>Equity Method Investments (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/EquityMethodInvestmentsTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>240414028 - Disclosure - Equity Method Investments (Balance Sheet) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/EquityMethodInvestmentsBalanceSheetDetails</Role>
      <ShortName>Equity Method Investments (Balance Sheet) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/EquityMethodInvestmentsTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>240424029 - Disclosure - Equity Method Investments (Net Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/EquityMethodInvestmentsNetAssetsDetails</Role>
      <ShortName>Equity Method Investments (Net Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/EquityMethodInvestmentsTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>240434030 - Disclosure - Equity Method Investments (Income Statement) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/EquityMethodInvestmentsIncomeStatementDetails</Role>
      <ShortName>Equity Method Investments (Income Statement) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/EquityMethodInvestmentsTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>240464031 - Disclosure - Goodwill and Other Intangible Assets (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>240474032 - Disclosure - Goodwill and Other Intangible Assets (Changes in Carrying Amount Of Goodwill) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountOfGoodwillDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Changes in Carrying Amount Of Goodwill) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>240484033 - Disclosure - Goodwill and Other Intangible Assets (Components of Intangible Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsComponentsofIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Components of Intangible Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>240494034 - Disclosure - Goodwill and Other Intangible Assets (Product Rights and License by Therapeutic Category) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsProductRightsandLicensebyTherapeuticCategoryDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Product Rights and License by Therapeutic Category) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsTables</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>240504035 - Disclosure - Goodwill and Other Intangible Assets (Amortization Expense) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Amortization Expense) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>240514036 - Disclosure - Goodwill and Other Intangible Assets Goodwill and Other Intangible Assets (Future amortization expense) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsGoodwillandOtherIntangibleAssetsFutureamortizationexpenseDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets Goodwill and Other Intangible Assets (Future amortization expense) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>240544037 - Disclosure - Financial Instruments and Risk Management (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails</Role>
      <ShortName>Financial Instruments and Risk Management (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>240554038 - Disclosure - Financial Instruments and Risk Management (Derivatives Designated as Hedging Instruments Fair Values of Derivative Instruments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementDerivativesDesignatedasHedgingInstrumentsFairValuesofDerivativeInstrumentsDetails</Role>
      <ShortName>Financial Instruments and Risk Management (Derivatives Designated as Hedging Instruments Fair Values of Derivative Instruments) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>240564039 - Disclosure - Financial Instruments and Risk Management (Derivatives Not Designated as Hedging Instruments Fair Values of Derivative Instruments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementDerivativesNotDesignatedasHedgingInstrumentsFairValuesofDerivativeInstrumentsDetails</Role>
      <ShortName>Financial Instruments and Risk Management (Derivatives Not Designated as Hedging Instruments Fair Values of Derivative Instruments) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>240574040 - Disclosure - Financial Instruments and Risk Management (Effect of Derivative Instruments on the Consolidated Statements of Operations Derivatives in Fair Value Hedging Relationships) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails</Role>
      <ShortName>Financial Instruments and Risk Management (Effect of Derivative Instruments on the Consolidated Statements of Operations Derivatives in Fair Value Hedging Relationships) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables</ParentRole>
      <Position>80</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>240584041 - Disclosure - Financial Instruments and Risk Management (Effect of Derivative Instruments on the Consolidated Statements of Comprehensive Earnings Derivatives in Cash Flow Hedging Relationships) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofComprehensiveEarningsDerivativesinCashFlowHedgingRelationshipsDetails</Role>
      <ShortName>Financial Instruments and Risk Management (Effect of Derivative Instruments on the Consolidated Statements of Comprehensive Earnings Derivatives in Cash Flow Hedging Relationships) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables</ParentRole>
      <Position>81</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>240594042 - Disclosure - Financial Instruments and Risk Management (Effect of Derivative Instruments on the Condensed Consolidated Statements of Comprehensive Earnings Derivatives in Net Investment Hedging Relationship) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinNetInvestmentHedgingRelationshipDetails</Role>
      <ShortName>Financial Instruments and Risk Management (Effect of Derivative Instruments on the Condensed Consolidated Statements of Comprehensive Earnings Derivatives in Net Investment Hedging Relationship) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables</ParentRole>
      <Position>82</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>240604043 - Disclosure - Financial Instruments and Risk Management (Effect of Derivative Instruments on the Consolidated Statements of Operations Derivatives in Cash Flow Hedging Relationships) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails</Role>
      <ShortName>Financial Instruments and Risk Management (Effect of Derivative Instruments on the Consolidated Statements of Operations Derivatives in Cash Flow Hedging Relationships) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables</ParentRole>
      <Position>83</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>240614044 - Disclosure - Financial Instruments and Risk Management (Effect of Derivative Instruments on the Consolidated Statements of Operations Derivatives Not Designated as Hedging Instruments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesNotDesignatedasHedgingInstrumentsDetails</Role>
      <ShortName>Financial Instruments and Risk Management (Effect of Derivative Instruments on the Consolidated Statements of Operations Derivatives Not Designated as Hedging Instruments) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables</ParentRole>
      <Position>84</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>240624045 - Disclosure - Financial Instruments and Risk Management (Financial Assets and Liabilities Carried at Fair Value) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails</Role>
      <ShortName>Financial Instruments and Risk Management (Financial Assets and Liabilities Carried at Fair Value) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables</ParentRole>
      <Position>85</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>240634046 - Disclosure - Financial Instruments and Risk Management (Rollforward of Contingent Consideration) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails</Role>
      <ShortName>Financial Instruments and Risk Management (Rollforward of Contingent Consideration) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables</ParentRole>
      <Position>86</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>240644047 - Disclosure - Financial Instruments and Risk Management (Schedule of Available-for-sale Securities Reconciliation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementScheduleofAvailableforsaleSecuritiesReconciliationDetails</Role>
      <ShortName>Financial Instruments and Risk Management (Schedule of Available-for-sale Securities Reconciliation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables</ParentRole>
      <Position>87</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>240654048 - Disclosure - Financial Instruments and Risk Management (Maturities of Available-for-sale Debt Securities at Fair Value) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementMaturitiesofAvailableforsaleDebtSecuritiesatFairValueDetails</Role>
      <ShortName>Financial Instruments and Risk Management (Maturities of Available-for-sale Debt Securities at Fair Value) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables</ParentRole>
      <Position>88</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>240684049 - Disclosure - Debt (Short-term borrowings) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/DebtShorttermborrowingsDetails</Role>
      <ShortName>Debt (Short-term borrowings) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/DebtTables</ParentRole>
      <Position>89</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>240694050 - Disclosure - Debt Debt (Receivables Facility and Commercial Paper Program) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/DebtDebtReceivablesFacilityandCommercialPaperProgramDetails</Role>
      <ShortName>Debt Debt (Receivables Facility and Commercial Paper Program) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>240704051 - Disclosure - Debt (Summary of Long-term Debt) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails</Role>
      <ShortName>Debt (Summary of Long-term Debt) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/DebtTables</ParentRole>
      <Position>91</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>240714052 - Disclosure - Debt (Revolving Facilities and Term Facilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/DebtRevolvingFacilitiesandTermFacilitiesDetails</Role>
      <ShortName>Debt (Revolving Facilities and Term Facilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/DebtTables</ParentRole>
      <Position>92</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>240724053 - Disclosure - Debt (Issuance of 2018 Senior Notes) (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.viatris.com/role/DebtIssuanceof2018SeniorNotesDetails</Role>
      <ShortName>Debt (Issuance of 2018 Senior Notes) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/DebtTables</ParentRole>
      <Position>93</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>240734054 - Disclosure - Debt (Senior Notes) (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.viatris.com/role/DebtSeniorNotesDetails</Role>
      <ShortName>Debt (Senior Notes) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/DebtTables</ParentRole>
      <Position>94</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>240744055 - Disclosure - Debt (Fair Value) (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/DebtFairValueNarrativeDetails</Role>
      <ShortName>Debt (Fair Value) (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/DebtTables</ParentRole>
      <Position>95</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>240754056 - Disclosure - Debt (Upjohn Senior Notes) (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.viatris.com/role/DebtUpjohnSeniorNotesDetails</Role>
      <ShortName>Debt (Upjohn Senior Notes) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/DebtTables</ParentRole>
      <Position>96</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>240764057 - Disclosure - Debt (Minimum Repayments on Outstanding Borrowings) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails</Role>
      <ShortName>Debt (Minimum Repayments on Outstanding Borrowings) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/DebtTables</ParentRole>
      <Position>97</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>240794058 - Disclosure - Comprehensive Earnings (Accumulated Other Comprehensive Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails</Role>
      <ShortName>Comprehensive Earnings (Accumulated Other Comprehensive Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/ComprehensiveEarningsTables</ParentRole>
      <Position>98</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>240804059 - Disclosure - Comprehensive Earnings (Components of Other Comprehensive Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails</Role>
      <ShortName>Comprehensive Earnings (Components of Other Comprehensive Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/ComprehensiveEarningsTables</ParentRole>
      <Position>99</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>240834060 - Disclosure - Income Taxes (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/IncomeTaxesTables</ParentRole>
      <Position>100</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>240844061 - Disclosure - Income Taxes (Schedule of Components of Income Tax Provision) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails</Role>
      <ShortName>Income Taxes (Schedule of Components of Income Tax Provision) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/IncomeTaxesTables</ParentRole>
      <Position>101</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>240854062 - Disclosure - Income Taxes (Schedule of Deferred Tax Assets and Liabilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails</Role>
      <ShortName>Income Taxes (Schedule of Deferred Tax Assets and Liabilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/IncomeTaxesTables</ParentRole>
      <Position>102</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>240864063 - Disclosure - Income Taxes (Statutory Tax Rate to Effective Tax Rate Reconciliation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/IncomeTaxesStatutoryTaxRatetoEffectiveTaxRateReconciliationDetails</Role>
      <ShortName>Income Taxes (Statutory Tax Rate to Effective Tax Rate Reconciliation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/IncomeTaxesTables</ParentRole>
      <Position>103</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>240874064 - Disclosure - Income Taxes (Schedule of Unrecognized Tax Benefits) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails</Role>
      <ShortName>Income Taxes (Schedule of Unrecognized Tax Benefits) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/IncomeTaxesTables</ParentRole>
      <Position>104</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>240904065 - Disclosure - Share-Based Incentive Plan (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails</Role>
      <ShortName>Share-Based Incentive Plan (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/ShareBasedIncentivePlanTables</ParentRole>
      <Position>105</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R106.htm</HtmlFileName>
      <LongName>240914066 - Disclosure - Share-Based Incentive Plan (Stock Awards) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails</Role>
      <ShortName>Share-Based Incentive Plan (Stock Awards) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/ShareBasedIncentivePlanTables</ParentRole>
      <Position>106</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R107.htm</HtmlFileName>
      <LongName>240924067 - Disclosure - Share-Based Incentive Plan (Nonvested Restricted Stock, Restricted Stock Units and PSUs Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails</Role>
      <ShortName>Share-Based Incentive Plan (Nonvested Restricted Stock, Restricted Stock Units and PSUs Activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/ShareBasedIncentivePlanTables</ParentRole>
      <Position>107</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R108.htm</HtmlFileName>
      <LongName>240934068 - Disclosure - Share-Based Incentive Plan (Valuation Assumptions) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/ShareBasedIncentivePlanValuationAssumptionsDetails</Role>
      <ShortName>Share-Based Incentive Plan (Valuation Assumptions) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/ShareBasedIncentivePlanTables</ParentRole>
      <Position>108</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R109.htm</HtmlFileName>
      <LongName>240964069 - Disclosure - Employee Benefit Plans (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/EmployeeBenefitPlansNarrativeDetails</Role>
      <ShortName>Employee Benefit Plans (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/EmployeeBenefitPlansTables</ParentRole>
      <Position>109</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R110.htm</HtmlFileName>
      <LongName>240974070 - Disclosure - Employee Benefit Plans (Accumulated Other Comprehensive Income (Loss) Pretax Amounts Not Yet Reclassified in Net Periodic Benefit Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/EmployeeBenefitPlansAccumulatedOtherComprehensiveIncomeLossPretaxAmountsNotYetReclassifiedinNetPeriodicBenefitCostDetails</Role>
      <ShortName>Employee Benefit Plans (Accumulated Other Comprehensive Income (Loss) Pretax Amounts Not Yet Reclassified in Net Periodic Benefit Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/EmployeeBenefitPlansTables</ParentRole>
      <Position>110</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R111.htm</HtmlFileName>
      <LongName>240984071 - Disclosure - Employee Benefit Plans (Change in Accumulated Income (Loss) Relating to Defined Benefit Pension and Other Postretirement Benefits) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/EmployeeBenefitPlansChangeinAccumulatedIncomeLossRelatingtoDefinedBenefitPensionandOtherPostretirementBenefitsDetails</Role>
      <ShortName>Employee Benefit Plans (Change in Accumulated Income (Loss) Relating to Defined Benefit Pension and Other Postretirement Benefits) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/EmployeeBenefitPlansTables</ParentRole>
      <Position>111</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R112.htm</HtmlFileName>
      <LongName>240994072 - Disclosure - Employee Benefit Plans (Net Periodic Benefit Costs) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/EmployeeBenefitPlansNetPeriodicBenefitCostsDetails</Role>
      <ShortName>Employee Benefit Plans (Net Periodic Benefit Costs) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/EmployeeBenefitPlansTables</ParentRole>
      <Position>112</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R113.htm</HtmlFileName>
      <LongName>241004073 - Disclosure - Employee Benefit Plans (Changes in Projected Benefit Obligations, Plan Assets and Funded Status) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/EmployeeBenefitPlansChangesinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails</Role>
      <ShortName>Employee Benefit Plans (Changes in Projected Benefit Obligations, Plan Assets and Funded Status) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/EmployeeBenefitPlansTables</ParentRole>
      <Position>113</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R114.htm</HtmlFileName>
      <LongName>241014074 - Disclosure - Employee Benefit Plans (Net Accrued Benefit Costs Classification on Balance Sheet) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/EmployeeBenefitPlansNetAccruedBenefitCostsClassificationonBalanceSheetDetails</Role>
      <ShortName>Employee Benefit Plans (Net Accrued Benefit Costs Classification on Balance Sheet) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/EmployeeBenefitPlansTables</ParentRole>
      <Position>114</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R115.htm</HtmlFileName>
      <LongName>241024075 - Disclosure - Employee Benefit Plans (Plans with PBO in Excess of Plan Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/EmployeeBenefitPlansPlanswithPBOinExcessofPlanAssetsDetails</Role>
      <ShortName>Employee Benefit Plans (Plans with PBO in Excess of Plan Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/EmployeeBenefitPlansTables</ParentRole>
      <Position>115</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R116.htm</HtmlFileName>
      <LongName>241034076 - Disclosure - Employee Benefit Plans (Fair Values of Plan Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/EmployeeBenefitPlansFairValuesofPlanAssetsDetails</Role>
      <ShortName>Employee Benefit Plans (Fair Values of Plan Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/EmployeeBenefitPlansTables</ParentRole>
      <Position>116</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R117.htm</HtmlFileName>
      <LongName>241044077 - Disclosure - Employee Benefit Plans (Weighted Average Assumptions) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/EmployeeBenefitPlansWeightedAverageAssumptionsDetails</Role>
      <ShortName>Employee Benefit Plans (Weighted Average Assumptions) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/EmployeeBenefitPlansTables</ParentRole>
      <Position>117</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R118.htm</HtmlFileName>
      <LongName>241064079 - Disclosure - Employee Benefit Plans (Estimated Future Benefit Payments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/EmployeeBenefitPlansEstimatedFutureBenefitPaymentsDetails</Role>
      <ShortName>Employee Benefit Plans (Estimated Future Benefit Payments) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/EmployeeBenefitPlansTables</ParentRole>
      <Position>118</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R119.htm</HtmlFileName>
      <LongName>241094080 - Disclosure - Segment Information (Reconciliation of Segment Information to Total Consolidated Information) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/SegmentInformationReconciliationofSegmentInformationtoTotalConsolidatedInformationDetails</Role>
      <ShortName>Segment Information (Reconciliation of Segment Information to Total Consolidated Information) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/SegmentInformationTables</ParentRole>
      <Position>119</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R120.htm</HtmlFileName>
      <LongName>241104081 - Disclosure - Segment Information (Third Party Net Sales by Major Customers) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/SegmentInformationThirdPartyNetSalesbyMajorCustomersDetails</Role>
      <ShortName>Segment Information (Third Party Net Sales by Major Customers) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/SegmentInformationTables</ParentRole>
      <Position>120</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R121.htm</HtmlFileName>
      <LongName>241114082 - Disclosure - Segment Information (Net Third Party Sales Classified Based on Geographic Location of Entity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/SegmentInformationNetThirdPartySalesClassifiedBasedonGeographicLocationofEntityDetails</Role>
      <ShortName>Segment Information (Net Third Party Sales Classified Based on Geographic Location of Entity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/SegmentInformationTables</ParentRole>
      <Position>121</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R122.htm</HtmlFileName>
      <LongName>241134083 - Disclosure - Commitments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/CommitmentsDetails</Role>
      <ShortName>Commitments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>122</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R123.htm</HtmlFileName>
      <LongName>241164084 - Disclosure - Restructuring (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/RestructuringNarrativeDetails</Role>
      <ShortName>Restructuring (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/RestructuringTables</ParentRole>
      <Position>123</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R124.htm</HtmlFileName>
      <LongName>241174085 - Disclosure - Restructuring (2020 Restructuring Plan) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/Restructuring2020RestructuringPlanDetails</Role>
      <ShortName>Restructuring (2020 Restructuring Plan) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/RestructuringTables</ParentRole>
      <Position>124</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R125.htm</HtmlFileName>
      <LongName>241194086 - Disclosure - Collaboration and Licensing Agreements (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails</Role>
      <ShortName>Collaboration and Licensing Agreements (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>125</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R126.htm</HtmlFileName>
      <LongName>241214087 - Disclosure - Litigation (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/LitigationNarrativeDetails</Role>
      <ShortName>Litigation (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>126</Position>
    </Report>
    <Report instance="vtrs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R127.htm</HtmlFileName>
      <LongName>241234088 - Disclosure - Valuation and Qualifying Accounts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com/role/ValuationandQualifyingAccountsDetails</Role>
      <ShortName>Valuation and Qualifying Accounts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.viatris.com/role/ValuationandQualifyingAccounts</ParentRole>
      <Position>127</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="vtrs-20211231.htm">vtrs-20211231.htm</File>
    <File>ex_21xvtrsx20211231x10-k.htm</File>
    <File>ex_22xvtrsx20211231x10-k.htm</File>
    <File>ex_23-vtrsx20211231x10xk.htm</File>
    <File>vtrs-20211231.xsd</File>
    <File>vtrs-20211231_cal.xml</File>
    <File>vtrs-20211231_def.xml</File>
    <File>vtrs-20211231_lab.xml</File>
    <File>vtrs-20211231_pre.xml</File>
    <File>vtrs_ex311x20211231-10k.htm</File>
    <File>vtrs_ex312x20211231-10k.htm</File>
    <File>vtrs_ex32x20211231-10k.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>vtrs-20211231_g1.jpg</File>
    <File>vtrs-20211231_g2.jpg</File>
    <File>vtrs-20211231_g3.jpg</File>
    <File>vtrs-20211231_g4.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1">http://fasb.org/srt/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="2105">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="38">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>151
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "vtrs-20211231.htm": {
   "axisCustom": 5,
   "axisStandard": 56,
   "contextCount": 807,
   "dts": {
    "calculationLink": {
     "local": [
      "vtrs-20211231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "vtrs-20211231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "vtrs-20211231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "vtrs-20211231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "vtrs-20211231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "vtrs-20211231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 1229,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 17,
    "http://xbrl.sec.gov/dei/2021q4": 6,
    "total": 23
   },
   "keyCustom": 98,
   "keyStandard": 636,
   "memberCustom": 123,
   "memberStandard": 108,
   "nsprefix": "vtrs",
   "nsuri": "http://www.viatris.com/20211231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000010001 - Document - Cover",
     "role": "http://www.viatris.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "if7c969d8800446acace677aeab6fa885_D20210101-20211231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareCashPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "140064001 - Statement - Consolidated Statements of Equity (Parenthetical)",
     "role": "http://www.viatris.com/role/ConsolidatedStatementsofEquityParenthetical",
     "shortName": "Consolidated Statements of Equity (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "if7c969d8800446acace677aeab6fa885_D20210101-20211231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareCashPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R100": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240834060 - Disclosure - Income Taxes (Narrative) (Details)",
     "role": "http://www.viatris.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R101": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240844061 - Disclosure - Income Taxes (Schedule of Components of Income Tax Provision) (Details)",
     "role": "http://www.viatris.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails",
     "shortName": "Income Taxes (Schedule of Components of Income Tax Provision) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9f40df9e1eb0444887127461f9ea3abe_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R102": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240854062 - Disclosure - Income Taxes (Schedule of Deferred Tax Assets and Liabilities) (Details)",
     "role": "http://www.viatris.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails",
     "shortName": "Income Taxes (Schedule of Deferred Tax Assets and Liabilities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R103": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240864063 - Disclosure - Income Taxes (Statutory Tax Rate to Effective Tax Rate Reconciliation) (Details)",
     "role": "http://www.viatris.com/role/IncomeTaxesStatutoryTaxRatetoEffectiveTaxRateReconciliationDetails",
     "shortName": "Income Taxes (Statutory Tax Rate to Effective Tax Rate Reconciliation) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R104": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240874064 - Disclosure - Income Taxes (Schedule of Unrecognized Tax Benefits) (Details)",
     "role": "http://www.viatris.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails",
     "shortName": "Income Taxes (Schedule of Unrecognized Tax Benefits) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R105": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240904065 - Disclosure - Share-Based Incentive Plan (Narrative) (Details)",
     "role": "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails",
     "shortName": "Share-Based Incentive Plan (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "ib1c2d553da14496cb03b6b87eb3cd0c0_D20210101-20211231",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R106": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i36d66b81144849148d1319e8bfed3c96_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240914066 - Disclosure - Share-Based Incentive Plan (Stock Awards) (Details)",
     "role": "http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails",
     "shortName": "Share-Based Incentive Plan (Stock Awards) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "if8ec92ba24d848d697ba737aeed13c05_I20181231",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R107": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i108f18c1c1f24f03914b8e2a90171783_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240924067 - Disclosure - Share-Based Incentive Plan (Nonvested Restricted Stock, Restricted Stock Units and PSUs Activity) (Details)",
     "role": "http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails",
     "shortName": "Share-Based Incentive Plan (Nonvested Restricted Stock, Restricted Stock Units and PSUs Activity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i108f18c1c1f24f03914b8e2a90171783_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R108": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i10a62822cebc4558b2338681f573875e_D20200101-20201231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240934068 - Disclosure - Share-Based Incentive Plan (Valuation Assumptions) (Details)",
     "role": "http://www.viatris.com/role/ShareBasedIncentivePlanValuationAssumptionsDetails",
     "shortName": "Share-Based Incentive Plan (Valuation Assumptions) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i10a62822cebc4558b2338681f573875e_D20200101-20201231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R109": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "vtrs:AccumulatednetactuariallossesexceedhigherofmarketvalueofplanassetsorPBO",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240964069 - Disclosure - Employee Benefit Plans (Narrative) (Details)",
     "role": "http://www.viatris.com/role/EmployeeBenefitPlansNarrativeDetails",
     "shortName": "Employee Benefit Plans (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "vtrs:AccumulatednetactuariallossesexceedhigherofmarketvalueofplanassetsorPBO",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210011001 - Disclosure - Nature of Operations",
     "role": "http://www.viatris.com/role/NatureofOperations",
     "shortName": "Nature of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R110": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "ia9d424a72c6e4901a7dafb47ebf3c114_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240974070 - Disclosure - Employee Benefit Plans (Accumulated Other Comprehensive Income (Loss) Pretax Amounts Not Yet Reclassified in Net Periodic Benefit Cost (Details)",
     "role": "http://www.viatris.com/role/EmployeeBenefitPlansAccumulatedOtherComprehensiveIncomeLossPretaxAmountsNotYetReclassifiedinNetPeriodicBenefitCostDetails",
     "shortName": "Employee Benefit Plans (Accumulated Other Comprehensive Income (Loss) Pretax Amounts Not Yet Reclassified in Net Periodic Benefit Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "ia9d424a72c6e4901a7dafb47ebf3c114_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R111": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240984071 - Disclosure - Employee Benefit Plans (Change in Accumulated Income (Loss) Relating to Defined Benefit Pension and Other Postretirement Benefits) (Details)",
     "role": "http://www.viatris.com/role/EmployeeBenefitPlansChangeinAccumulatedIncomeLossRelatingtoDefinedBenefitPensionandOtherPostretirementBenefitsDetails",
     "shortName": "Employee Benefit Plans (Change in Accumulated Income (Loss) Relating to Defined Benefit Pension and Other Postretirement Benefits) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R112": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240994072 - Disclosure - Employee Benefit Plans (Net Periodic Benefit Costs) (Details)",
     "role": "http://www.viatris.com/role/EmployeeBenefitPlansNetPeriodicBenefitCostsDetails",
     "shortName": "Employee Benefit Plans (Net Periodic Benefit Costs) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R113": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241004073 - Disclosure - Employee Benefit Plans (Changes in Projected Benefit Obligations, Plan Assets and Funded Status) (Details)",
     "role": "http://www.viatris.com/role/EmployeeBenefitPlansChangesinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails",
     "shortName": "Employee Benefit Plans (Changes in Projected Benefit Obligations, Plan Assets and Funded Status) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "ib2876ac575224b07a3f951b9b7ad8f78_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "vtrs:DefinedBenefitPlanContributionsByPlanParticipantsBenefitObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R114": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "ia9d424a72c6e4901a7dafb47ebf3c114_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241014074 - Disclosure - Employee Benefit Plans (Net Accrued Benefit Costs Classification on Balance Sheet) (Details)",
     "role": "http://www.viatris.com/role/EmployeeBenefitPlansNetAccruedBenefitCostsClassificationonBalanceSheetDetails",
     "shortName": "Employee Benefit Plans (Net Accrued Benefit Costs Classification on Balance Sheet) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "ia9d424a72c6e4901a7dafb47ebf3c114_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R115": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "ia9d424a72c6e4901a7dafb47ebf3c114_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241024075 - Disclosure - Employee Benefit Plans (Plans with PBO in Excess of Plan Assets) (Details)",
     "role": "http://www.viatris.com/role/EmployeeBenefitPlansPlanswithPBOinExcessofPlanAssetsDetails",
     "shortName": "Employee Benefit Plans (Plans with PBO in Excess of Plan Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "ia9d424a72c6e4901a7dafb47ebf3c114_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R116": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241034076 - Disclosure - Employee Benefit Plans (Fair Values of Plan Assets) (Details)",
     "role": "http://www.viatris.com/role/EmployeeBenefitPlansFairValuesofPlanAssetsDetails",
     "shortName": "Employee Benefit Plans (Fair Values of Plan Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "iddab1d45dd6b4fdfaf6d0678d30eb8fc_I20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R117": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "ia9d424a72c6e4901a7dafb47ebf3c114_I20211231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241044077 - Disclosure - Employee Benefit Plans (Weighted Average Assumptions) (Details)",
     "role": "http://www.viatris.com/role/EmployeeBenefitPlansWeightedAverageAssumptionsDetails",
     "shortName": "Employee Benefit Plans (Weighted Average Assumptions) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "ia9d424a72c6e4901a7dafb47ebf3c114_I20211231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R118": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "ia9d424a72c6e4901a7dafb47ebf3c114_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241064079 - Disclosure - Employee Benefit Plans (Estimated Future Benefit Payments) (Details)",
     "role": "http://www.viatris.com/role/EmployeeBenefitPlansEstimatedFutureBenefitPaymentsDetails",
     "shortName": "Employee Benefit Plans (Estimated Future Benefit Payments) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "ia9d424a72c6e4901a7dafb47ebf3c114_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R119": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241094080 - Disclosure - Segment Information (Reconciliation of Segment Information to Total Consolidated Information) (Details)",
     "role": "http://www.viatris.com/role/SegmentInformationReconciliationofSegmentInformationtoTotalConsolidatedInformationDetails",
     "shortName": "Segment Information (Reconciliation of Segment Information to Total Consolidated Information) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "id2ddd71cee624b009233ae18ff01bcdb_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OperatingIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210031002 - Disclosure - Summary of Significant Accounting Policies",
     "role": "http://www.viatris.com/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R120": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i18815e8bb5a745709ff95e3d9c2c08e4_D20210101-20211231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241104081 - Disclosure - Segment Information (Third Party Net Sales by Major Customers) (Details)",
     "role": "http://www.viatris.com/role/SegmentInformationThirdPartyNetSalesbyMajorCustomersDetails",
     "shortName": "Segment Information (Third Party Net Sales by Major Customers) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i18815e8bb5a745709ff95e3d9c2c08e4_D20210101-20211231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R121": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241114082 - Disclosure - Segment Information (Net Third Party Sales Classified Based on Geographic Location of Entity) (Details)",
     "role": "http://www.viatris.com/role/SegmentInformationNetThirdPartySalesClassifiedBasedonGeographicLocationofEntityDetails",
     "shortName": "Segment Information (Net Third Party Sales Classified Based on Geographic Location of Entity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i5705c46a88bf43f9b604c129b6396c1b_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R122": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i3bc8daf6f604468691d4e166c4089a06_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "vtrs:BusinessCombinationContractualReimbursementAmountTrancheOne",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241134083 - Disclosure - Commitments (Details)",
     "role": "http://www.viatris.com/role/CommitmentsDetails",
     "shortName": "Commitments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i3bc8daf6f604468691d4e166c4089a06_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "vtrs:BusinessCombinationContractualReimbursementAmountTrancheOne",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R123": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i471cbeca3c824ca0b751c54c81e91480_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsForRestructuring",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241164084 - Disclosure - Restructuring (Narrative) (Details)",
     "role": "http://www.viatris.com/role/RestructuringNarrativeDetails",
     "shortName": "Restructuring (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RestructuringReservePeriodIncreaseDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R124": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i36d66b81144849148d1319e8bfed3c96_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241174085 - Disclosure - Restructuring (2020 Restructuring Plan) (Details)",
     "role": "http://www.viatris.com/role/Restructuring2020RestructuringPlanDetails",
     "shortName": "Restructuring (2020 Restructuring Plan) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "vtrs:RestructuringReserveReimbursableRestructuringCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R125": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241194086 - Disclosure - Collaboration and Licensing Agreements (Narrative) (Details)",
     "role": "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails",
     "shortName": "Collaboration and Licensing Agreements (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i86776889abae4015b5e341878a1f94e0_I20160108",
      "decimals": "0",
      "lang": "en-US",
      "name": "vtrs:NumberOfDrugs",
      "reportCount": 1,
      "unique": true,
      "unitRef": "drugs",
      "xsiNil": "false"
     }
    },
    "R126": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "vtrs:Numberofcases",
      "reportCount": 1,
      "unitRef": "case",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241214087 - Disclosure - Litigation (Narrative) (Details)",
     "role": "http://www.viatris.com/role/LitigationNarrativeDetails",
     "shortName": "Litigation (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i42721f7bfaa74a20b33b1b57026a7ec6_I20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R127": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i8aaae8d197ef43d0880965d47a937ced_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241234088 - Disclosure - Valuation and Qualifying Accounts (Details)",
     "role": "http://www.viatris.com/role/ValuationandQualifyingAccountsDetails",
     "shortName": "Valuation and Qualifying Accounts (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "idaab369eeea042ca842eb8d98bec6dfb_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210081003 - Disclosure - Acquisitions and Other Transactions",
     "role": "http://www.viatris.com/role/AcquisitionsandOtherTransactions",
     "shortName": "Acquisitions and Other Transactions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210131004 - Disclosure - Revenue Recognition and Accounts Receivable",
     "role": "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivable",
     "shortName": "Revenue Recognition and Accounts Receivable",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210211005 - Disclosure - Balance Sheet Components",
     "role": "http://www.viatris.com/role/BalanceSheetComponents",
     "shortName": "Balance Sheet Components",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210331006 - Disclosure - Leases",
     "role": "http://www.viatris.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210381007 - Disclosure - Equity Method Investments",
     "role": "http://www.viatris.com/role/EquityMethodInvestments",
     "shortName": "Equity Method Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210521009 - Disclosure - Financial Instruments and Risk Management",
     "role": "http://www.viatris.com/role/FinancialInstrumentsandRiskManagement",
     "shortName": "Financial Instruments and Risk Management",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210771011 - Disclosure - Comprehensive Earnings",
     "role": "http://www.viatris.com/role/ComprehensiveEarnings",
     "shortName": "Comprehensive Earnings",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "000020008 - Document - Audit Information",
     "role": "http://www.viatris.com/role/AuditInformation",
     "shortName": "Audit Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210811012 - Disclosure - Income Taxes",
     "role": "http://www.viatris.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210881013 - Disclosure - Share-Based Incentive Plan",
     "role": "http://www.viatris.com/role/ShareBasedIncentivePlan",
     "shortName": "Share-Based Incentive Plan",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210941014 - Disclosure - Employee Benefit Plans",
     "role": "http://www.viatris.com/role/EmployeeBenefitPlans",
     "shortName": "Employee Benefit Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211071015 - Disclosure - Segment Information",
     "role": "http://www.viatris.com/role/SegmentInformation",
     "shortName": "Segment Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211141017 - Disclosure - Restructuring",
     "role": "http://www.viatris.com/role/Restructuring",
     "shortName": "Restructuring",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211221020 - Disclosure - Valuation and Qualifying Accounts",
     "role": "http://www.viatris.com/role/ValuationandQualifyingAccounts",
     "shortName": "Valuation and Qualifying Accounts",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "220042001 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "role": "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230053001 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "role": "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesTables",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230093002 - Disclosure - Acquisitions and Other Transactions (Tables)",
     "role": "http://www.viatris.com/role/AcquisitionsandOtherTransactionsTables",
     "shortName": "Acquisitions and Other Transactions (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230143003 - Disclosure - Revenue Recognition and Accounts Receivable (Tables)",
     "role": "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableTables",
     "shortName": "Revenue Recognition and Accounts Receivable (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorFirmId",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "000030009 - Document - Audit Information",
     "role": "http://www.viatris.com/role/AuditInformation_1",
     "shortName": "Audit Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorFirmId",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "vtrs:ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230223004 - Disclosure - Balance Sheet Components (Tables)",
     "role": "http://www.viatris.com/role/BalanceSheetComponentsTables",
     "shortName": "Balance Sheet Components (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "vtrs:ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230343005 - Disclosure - Leases (Tables)",
     "role": "http://www.viatris.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230393006 - Disclosure - Equity Method Investments (Tables)",
     "role": "http://www.viatris.com/role/EquityMethodInvestmentsTables",
     "shortName": "Equity Method Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230453007 - Disclosure - Goodwill and Other Intangible Assets (Tables)",
     "role": "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsTables",
     "shortName": "Goodwill and Other Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230533008 - Disclosure - Financial Instruments and Risk Management (Tables)",
     "role": "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables",
     "shortName": "Financial Instruments and Risk Management (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShortTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230673009 - Disclosure - Debt (Tables)",
     "role": "http://www.viatris.com/role/DebtTables",
     "shortName": "Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShortTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230783010 - Disclosure - Comprehensive Earnings (Tables)",
     "role": "http://www.viatris.com/role/ComprehensiveEarningsTables",
     "shortName": "Comprehensive Earnings (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230823011 - Disclosure - Income Taxes (Tables)",
     "role": "http://www.viatris.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230893012 - Disclosure - Share-Based Incentive Plan (Tables)",
     "role": "http://www.viatris.com/role/ShareBasedIncentivePlanTables",
     "shortName": "Share-Based Incentive Plan (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230953013 - Disclosure - Employee Benefit Plans (Tables)",
     "role": "http://www.viatris.com/role/EmployeeBenefitPlansTables",
     "shortName": "Employee Benefit Plans (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100010002 - Statement - Consolidated Balance Sheets",
     "role": "http://www.viatris.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DeferredIncomeTaxAssetsNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "231083014 - Disclosure - Segment Information (Tables)",
     "role": "http://www.viatris.com/role/SegmentInformationTables",
     "shortName": "Segment Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "231153015 - Disclosure - Restructuring (Tables)",
     "role": "http://www.viatris.com/role/RestructuringTables",
     "shortName": "Restructuring (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "vtrs:NumberOfMolecules",
      "reportCount": 1,
      "unique": true,
      "unitRef": "molecule",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240024002 - Disclosure - Nature of Operations (Narrative) (Details)",
     "role": "http://www.viatris.com/role/NatureofOperationsNarrativeDetails",
     "shortName": "Nature of Operations (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "vtrs:NumberOfMolecules",
      "reportCount": 1,
      "unique": true,
      "unitRef": "molecule",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240064003 - Disclosure - Summary of Significant Accounting Policies (Narrative) (Details)",
     "role": "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Summary of Significant Accounting Policies (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240074004 - Disclosure - Summary of Significant Accounting Policies (Basic And Diluted Earnings Per Ordinary Share Attributable To Mylan N.V.) (Details)",
     "role": "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesBasicAndDilutedEarningsPerOrdinaryShareAttributableToMylanNVDetails",
     "shortName": "Summary of Significant Accounting Policies (Basic And Diluted Earnings Per Ordinary Share Attributable To Mylan N.V.) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240104005 - Disclosure - Acquisitions and Other Transactions (Other Transactions) (Narrative) (Details)",
     "role": "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails",
     "shortName": "Acquisitions and Other Transactions (Other Transactions) (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "ibd8cc0a590a946f6ada83bcfa5b58725_D20201113-20201113",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i36d66b81144849148d1319e8bfed3c96_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240114006 - Disclosure - Acquisitions and Other Transactions (Purchase Price Allocations) (Details)",
     "role": "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails",
     "shortName": "Acquisitions and Other Transactions (Purchase Price Allocations) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i5b06121292274e728651da9462422d99_D20201231-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:CashAcquiredFromAcquisition",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i54dfb4c408114c26bed39da8f1d171f2_D20201113-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240124007 - Disclosure - Acquisitions and Other Transactions (Unaudited Pro Forma Financial Results) (Details)",
     "role": "http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails",
     "shortName": "Acquisitions and Other Transactions (Unaudited Pro Forma Financial Results) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i383cdb78da1740a096ade479d7d4de29_D20210101-20211231",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240154008 - Disclosure - Revenue Recognition and Accounts Receivable Revenue Disaggregation (Details)",
     "role": "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationDetails",
     "shortName": "Revenue Recognition and Accounts Receivable Revenue Disaggregation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i8d43c5886aae45d78bf51b4acef73ab6_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240164009 - Disclosure - Revenue Recognition and Accounts Receivable - Disaggregation of Revenue by Key Products (Details)",
     "role": "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableDisaggregationofRevenuebyKeyProductsDetails",
     "shortName": "Revenue Recognition and Accounts Receivable - Disaggregation of Revenue by Key Products (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i84058a24993540f0abbe391aeff14baa_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100020003 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.viatris.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableFromSecuritization",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240174010 - Disclosure - Revenue Recognition and Accounts Receivable (Narrative) (Details)",
     "role": "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableNarrativeDetails",
     "shortName": "Revenue Recognition and Accounts Receivable (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "vtrs:RevenuefromContractwithCustomerGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240184011 - Disclosure - Revenue Recognition and Accounts Receivable Variable Consideration (Details)",
     "role": "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails",
     "shortName": "Revenue Recognition and Accounts Receivable Variable Consideration (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "vtrs:RevenuefromContractwithCustomerGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReceivablesNetCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240194012 - Disclosure - Revenue Recognition and Accounts Receivable (Accounts Receivable, Net) (Details)",
     "role": "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails",
     "shortName": "Revenue Recognition and Accounts Receivable (Accounts Receivable, Net) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i8023e485af7e4af6b209e877aaef3977_D20210101-20211231",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i36d66b81144849148d1319e8bfed3c96_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240204013 - Disclosure - Revenue Recognition and Accounts Receivable Variable Consideration Rollforward (Details)",
     "role": "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationRollforwardDetails",
     "shortName": "Revenue Recognition and Accounts Receivable Variable Consideration Rollforward (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i25df0d0412f4491d87734041970219e9_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "vtrs:AccountsReceivableSalesProvisionsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CapitalizedComputerSoftwareNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240234014 - Disclosure - Balance Sheet Components (Narrative) (Details)",
     "role": "http://www.viatris.com/role/BalanceSheetComponentsNarrativeDetails",
     "shortName": "Balance Sheet Components (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CapitalizedComputerSoftwareNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240244015 - Disclosure - Balance Sheet Components Balance Sheet Components (Cash and Cash Equivalents) (Details)",
     "role": "http://www.viatris.com/role/BalanceSheetComponentsBalanceSheetComponentsCashandCashEquivalentsDetails",
     "shortName": "Balance Sheet Components Balance Sheet Components (Cash and Cash Equivalents) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "vtrs:ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "iac503b6d629d4bafb262ea6ec0b8a25e_I20191231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReceivablesNetCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240254016 - Disclosure - Balance Sheet Components (Accounts receivable, net) (Details)",
     "role": "http://www.viatris.com/role/BalanceSheetComponentsAccountsreceivablenetDetails",
     "shortName": "Balance Sheet Components (Accounts receivable, net) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240264017 - Disclosure - Balance Sheet Components (Inventories) (Details)",
     "role": "http://www.viatris.com/role/BalanceSheetComponentsInventoriesDetails",
     "shortName": "Balance Sheet Components (Inventories) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PrepaidExpenseCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240274018 - Disclosure - Balance Sheet Components (Prepaids and other current assets) (Details)",
     "role": "http://www.viatris.com/role/BalanceSheetComponentsPrepaidsandothercurrentassetsDetails",
     "shortName": "Balance Sheet Components (Prepaids and other current assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PrepaidExpenseCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240284019 - Disclosure - Balance Sheet Components (Property, Plant and Equipment) (Details)",
     "role": "http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails",
     "shortName": "Balance Sheet Components (Property, Plant and Equipment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100030004 - Statement - Consolidated Statements of Operations",
     "role": "http://www.viatris.com/role/ConsolidatedStatementsofOperations",
     "shortName": "Consolidated Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240294020 - Disclosure - Balance Sheet Components (Other Assets) (Details)",
     "role": "http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails",
     "shortName": "Balance Sheet Components (Other Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "vtrs:Otherlongtermassets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableTradeCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240304021 - Disclosure - Balance Sheet Components (Trade Accounts Payable) (Details)",
     "role": "http://www.viatris.com/role/BalanceSheetComponentsTradeAccountsPayableDetails",
     "shortName": "Balance Sheet Components (Trade Accounts Payable) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableTradeCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherReceivablesNetCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240314022 - Disclosure - Balance Sheet Components (Other Current Liabilities) (Details)",
     "role": "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails",
     "shortName": "Balance Sheet Components (Other Current Liabilities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240324023 - Disclosure - Balance Sheet Components (Other noncurrent liabilities) (Details)",
     "role": "http://www.viatris.com/role/BalanceSheetComponentsOthernoncurrentliabilitiesDetails",
     "shortName": "Balance Sheet Components (Other noncurrent liabilities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240354024 - Disclosure - Leases (Narrative) (Details)",
     "role": "http://www.viatris.com/role/LeasesNarrativeDetails",
     "shortName": "Leases (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "vtrs:LesseeOperatingLeaseLeaseNotyetCommencedAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240364025 - Disclosure - Leases (Lease Information) (Details)",
     "role": "http://www.viatris.com/role/LeasesLeaseInformationDetails",
     "shortName": "Leases (Lease Information) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240374026 - Disclosure - Leases (Lease Maturities) (Details)",
     "role": "http://www.viatris.com/role/LeasesLeaseMaturitiesDetails",
     "shortName": "Leases (Lease Maturities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "vtrs:EquityMethodInvestmentsNetGainLossFromImpairmentandReductionInObligations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240404027 - Disclosure - Equity Method Investments (Narrative) (Details)",
     "role": "http://www.viatris.com/role/EquityMethodInvestmentsNarrativeDetails",
     "shortName": "Equity Method Investments (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "vtrs:EquityMethodInvestmentsNetGainLossFromImpairmentandReductionInObligations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240414028 - Disclosure - Equity Method Investments (Balance Sheet) (Details)",
     "role": "http://www.viatris.com/role/EquityMethodInvestmentsBalanceSheetDetails",
     "shortName": "Equity Method Investments (Balance Sheet) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetsCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240424029 - Disclosure - Equity Method Investments (Net Assets) (Details)",
     "role": "http://www.viatris.com/role/EquityMethodInvestmentsNetAssetsDetails",
     "shortName": "Equity Method Investments (Net Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:EquityMethodInvestmentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i0853510f8095410c8cab4556a87f5fab_I20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AssetsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100040005 - Statement - Consolidated Statements of Comprehensive Earnings",
     "role": "http://www.viatris.com/role/ConsolidatedStatementsofComprehensiveEarnings",
     "shortName": "Consolidated Statements of Comprehensive Earnings",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240434030 - Disclosure - Equity Method Investments (Income Statement) (Details)",
     "role": "http://www.viatris.com/role/EquityMethodInvestmentsIncomeStatementDetails",
     "shortName": "Equity Method Investments (Income Statement) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:EquityMethodInvestmentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "ia0185425b6174d78bfd3fbdefaaaea64_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240464031 - Disclosure - Goodwill and Other Intangible Assets (Narrative) (Details)",
     "role": "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
     "shortName": "Goodwill and Other Intangible Assets (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9d3ab4b3183547369e21bc16353ca096_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ImpairmentOfIntangibleAssetsFinitelived",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i36d66b81144849148d1319e8bfed3c96_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillGross",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240474032 - Disclosure - Goodwill and Other Intangible Assets (Changes in Carrying Amount Of Goodwill) (Details)",
     "role": "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountOfGoodwillDetails",
     "shortName": "Goodwill and Other Intangible Assets (Changes in Carrying Amount Of Goodwill) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "ifebd4eefd44247d191bd47ca2474ecda_D20190101-20191231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240484033 - Disclosure - Goodwill and Other Intangible Assets (Components of Intangible Assets) (Details)",
     "role": "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsComponentsofIntangibleAssetsDetails",
     "shortName": "Goodwill and Other Intangible Assets (Components of Intangible Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240494034 - Disclosure - Goodwill and Other Intangible Assets (Product Rights and License by Therapeutic Category) (Details)",
     "role": "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsProductRightsandLicensebyTherapeuticCategoryDetails",
     "shortName": "Goodwill and Other Intangible Assets (Product Rights and License by Therapeutic Category) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "vtrs:ProductRightsAndLicensesByTherapeuticCategoryTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i6c77a702a1dc4bd4b4d96321e085c678_I20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240504035 - Disclosure - Goodwill and Other Intangible Assets (Amortization Expense) (Details)",
     "role": "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails",
     "shortName": "Goodwill and Other Intangible Assets (Amortization Expense) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AdjustmentForAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240514036 - Disclosure - Goodwill and Other Intangible Assets Goodwill and Other Intangible Assets (Future amortization expense) (Details)",
     "role": "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsGoodwillandOtherIntangibleAssetsFutureamortizationexpenseDetails",
     "shortName": "Goodwill and Other Intangible Assets Goodwill and Other Intangible Assets (Future amortization expense) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240544037 - Disclosure - Financial Instruments and Risk Management (Narrative) (Details)",
     "role": "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
     "shortName": "Financial Instruments and Risk Management (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240554038 - Disclosure - Financial Instruments and Risk Management (Derivatives Designated as Hedging Instruments Fair Values of Derivative Instruments) (Details)",
     "role": "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementDerivativesDesignatedasHedgingInstrumentsFairValuesofDerivativeInstrumentsDetails",
     "shortName": "Financial Instruments and Risk Management (Derivatives Designated as Hedging Instruments Fair Values of Derivative Instruments) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i2274eaab76e54e488ce05bb95778a8cd_I20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240564039 - Disclosure - Financial Instruments and Risk Management (Derivatives Not Designated as Hedging Instruments Fair Values of Derivative Instruments) (Details)",
     "role": "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementDerivativesNotDesignatedasHedgingInstrumentsFairValuesofDerivativeInstrumentsDetails",
     "shortName": "Financial Instruments and Risk Management (Derivatives Not Designated as Hedging Instruments Fair Values of Derivative Instruments) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i7e4405916ad540b9a7f953c2af935d2a_I20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "if8ec92ba24d848d697ba737aeed13c05_I20181231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100050006 - Statement - Consolidated Statements of Equity",
     "role": "http://www.viatris.com/role/ConsolidatedStatementsofEquity",
     "shortName": "Consolidated Statements of Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i4c63b953f9ab4ca380c2a6718f3499d2_I20181231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240574040 - Disclosure - Financial Instruments and Risk Management (Effect of Derivative Instruments on the Consolidated Statements of Operations Derivatives in Fair Value Hedging Relationships) (Details)",
     "role": "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails",
     "shortName": "Financial Instruments and Risk Management (Effect of Derivative Instruments on the Consolidated Statements of Operations Derivatives in Fair Value Hedging Relationships) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i80c54ac8020646d2ab7569f426de2da7_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "ib8d0d63150a443a9a2d4e20b655c9e2f_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240584041 - Disclosure - Financial Instruments and Risk Management (Effect of Derivative Instruments on the Consolidated Statements of Comprehensive Earnings Derivatives in Cash Flow Hedging Relationships) (Details)",
     "role": "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofComprehensiveEarningsDerivativesinCashFlowHedgingRelationshipsDetails",
     "shortName": "Financial Instruments and Risk Management (Effect of Derivative Instruments on the Consolidated Statements of Comprehensive Earnings Derivatives in Cash Flow Hedging Relationships) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240594042 - Disclosure - Financial Instruments and Risk Management (Effect of Derivative Instruments on the Condensed Consolidated Statements of Comprehensive Earnings Derivatives in Net Investment Hedging Relationship) (Details)",
     "role": "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinNetInvestmentHedgingRelationshipDetails",
     "shortName": "Financial Instruments and Risk Management (Effect of Derivative Instruments on the Condensed Consolidated Statements of Comprehensive Earnings Derivatives in Net Investment Hedging Relationship) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i5eac979dacba469ba19bc637404defc4_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240604043 - Disclosure - Financial Instruments and Risk Management (Effect of Derivative Instruments on the Consolidated Statements of Operations Derivatives in Cash Flow Hedging Relationships) (Details)",
     "role": "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
     "shortName": "Financial Instruments and Risk Management (Effect of Derivative Instruments on the Consolidated Statements of Operations Derivatives in Cash Flow Hedging Relationships) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240614044 - Disclosure - Financial Instruments and Risk Management (Effect of Derivative Instruments on the Consolidated Statements of Operations Derivatives Not Designated as Hedging Instruments) (Details)",
     "role": "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesNotDesignatedasHedgingInstrumentsDetails",
     "shortName": "Financial Instruments and Risk Management (Effect of Derivative Instruments on the Consolidated Statements of Operations Derivatives Not Designated as Hedging Instruments) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240624045 - Disclosure - Financial Instruments and Risk Management (Financial Assets and Liabilities Carried at Fair Value) (Details)",
     "role": "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
     "shortName": "Financial Instruments and Risk Management (Financial Assets and Liabilities Carried at Fair Value) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i36d66b81144849148d1319e8bfed3c96_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240634046 - Disclosure - Financial Instruments and Risk Management (Rollforward of Contingent Consideration) (Details)",
     "role": "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails",
     "shortName": "Financial Instruments and Risk Management (Rollforward of Contingent Consideration) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "vtrs:BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240644047 - Disclosure - Financial Instruments and Risk Management (Schedule of Available-for-sale Securities Reconciliation) (Details)",
     "role": "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementScheduleofAvailableforsaleSecuritiesReconciliationDetails",
     "shortName": "Financial Instruments and Risk Management (Schedule of Available-for-sale Securities Reconciliation) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240654048 - Disclosure - Financial Instruments and Risk Management (Maturities of Available-for-sale Debt Securities at Fair Value) (Details)",
     "role": "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementMaturitiesofAvailableforsaleDebtSecuritiesatFairValueDetails",
     "shortName": "Financial Instruments and Risk Management (Maturities of Available-for-sale Debt Securities at Fair Value) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortTermBorrowings",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240684049 - Disclosure - Debt (Short-term borrowings) (Details)",
     "role": "http://www.viatris.com/role/DebtShorttermborrowingsDetails",
     "shortName": "Debt (Short-term borrowings) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShortTermDebtTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i6348c0871c354006bbb77663df6a8f55_I20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ShortTermBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100070007 - Statement - Consolidated Statements of Cash Flows",
     "role": "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortTermBorrowings",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240694050 - Disclosure - Debt Debt (Receivables Facility and Commercial Paper Program) (Details)",
     "role": "http://www.viatris.com/role/DebtDebtReceivablesFacilityandCommercialPaperProgramDetails",
     "shortName": "Debt Debt (Receivables Facility and Commercial Paper Program) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "ia14591b7ed4e4ed5b2119d20257b6803_I20170606",
      "decimals": "-7",
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240704051 - Disclosure - Debt (Summary of Long-term Debt) (Details)",
     "role": "http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails",
     "shortName": "Debt (Summary of Long-term Debt) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:UnamortizedDebtIssuanceExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240714052 - Disclosure - Debt (Revolving Facilities and Term Facilities) (Details)",
     "role": "http://www.viatris.com/role/DebtRevolvingFacilitiesandTermFacilitiesDetails",
     "shortName": "Debt (Revolving Facilities and Term Facilities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtNoncurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240724053 - Disclosure - Debt (Issuance of 2018 Senior Notes) (Details)",
     "role": "http://www.viatris.com/role/DebtIssuanceof2018SeniorNotesDetails",
     "shortName": "Debt (Issuance of 2018 Senior Notes) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtNoncurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240734054 - Disclosure - Debt (Senior Notes) (Details)",
     "role": "http://www.viatris.com/role/DebtSeniorNotesDetails",
     "shortName": "Debt (Senior Notes) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i3861691874974533b0f4beb0f744696d_I20200630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i73d9cbc916614385999dea1173262904_D20201113-20201113",
      "decimals": "-9",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240744055 - Disclosure - Debt (Fair Value) (Narrative) (Details)",
     "role": "http://www.viatris.com/role/DebtFairValueNarrativeDetails",
     "shortName": "Debt (Fair Value) (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i20a65018b503434b88c9fd17e0c1dd18_I20211231",
      "decimals": "-7",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i74907a0e3a4245c29c61474d06752931_I20211029",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "vtrs:DebtInstrumentConversionOfUnregisteredNotesToRegisteredNotesAsAPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240754056 - Disclosure - Debt (Upjohn Senior Notes) (Details)",
     "role": "http://www.viatris.com/role/DebtUpjohnSeniorNotesDetails",
     "shortName": "Debt (Upjohn Senior Notes) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i74907a0e3a4245c29c61474d06752931_I20211029",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "vtrs:DebtInstrumentConversionOfUnregisteredNotesToRegisteredNotesAsAPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240764057 - Disclosure - Debt (Minimum Repayments on Outstanding Borrowings) (Details)",
     "role": "http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails",
     "shortName": "Debt (Minimum Repayments on Outstanding Borrowings) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240794058 - Disclosure - Comprehensive Earnings (Accumulated Other Comprehensive Loss) (Details)",
     "role": "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
     "shortName": "Comprehensive Earnings (Accumulated Other Comprehensive Loss) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i9b5b6f53dc884bc28cf189d394d6db66_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240804059 - Disclosure - Comprehensive Earnings (Components of Other Comprehensive Loss) (Details)",
     "role": "http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails",
     "shortName": "Comprehensive Earnings (Components of Other Comprehensive Loss) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vtrs-20211231.htm",
      "contextRef": "i31f0c2ff371749c6802027ab5ab5bcf2_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 243,
   "tag": {
    "country_CH": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SWITZERLAND",
        "terseLabel": "SWITZERLAND"
       }
      }
     },
     "localname": "CH",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesStatutoryTaxRatetoEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_CN": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CHINA",
        "terseLabel": "CHINA"
       }
      }
     },
     "localname": "CN",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.viatris.com/role/SegmentInformationNetThirdPartySalesClassifiedBasedonGeographicLocationofEntityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_FR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "FRANCE",
        "terseLabel": "France"
       }
      }
     },
     "localname": "FR",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesStatutoryTaxRatetoEffectiveTaxRateReconciliationDetails",
      "http://www.viatris.com/role/SegmentInformationNetThirdPartySalesClassifiedBasedonGeographicLocationofEntityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_GI": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "GIBRALTAR",
        "terseLabel": "GIBRALTAR"
       }
      }
     },
     "localname": "GI",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesStatutoryTaxRatetoEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_IE": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "IRELAND",
        "terseLabel": "IRELAND"
       }
      }
     },
     "localname": "IE",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesStatutoryTaxRatetoEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_IN": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "INDIA",
        "terseLabel": "India"
       }
      }
     },
     "localname": "IN",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsNarrativeDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails",
      "http://www.viatris.com/role/SegmentInformationNetThirdPartySalesClassifiedBasedonGeographicLocationofEntityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_LU": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LUXEMBOURG",
        "terseLabel": "LUXEMBOURG"
       }
      }
     },
     "localname": "LU",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesStatutoryTaxRatetoEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_PR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "PUERTO RICO",
        "terseLabel": "PUERTO RICO"
       }
      }
     },
     "localname": "PR",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesStatutoryTaxRatetoEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_SG": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SINGAPORE",
        "terseLabel": "SINGAPORE"
       }
      }
     },
     "localname": "SG",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesStatutoryTaxRatetoEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesStatutoryTaxRatetoEffectiveTaxRateReconciliationDetails",
      "http://www.viatris.com/role/SegmentInformationNetThirdPartySalesClassifiedBasedonGeographicLocationofEntityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r976",
      "r977",
      "r978"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/AuditInformation_1"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Line Items]"
       }
      }
     },
     "localname": "AuditorLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r976",
      "r977",
      "r978"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r976",
      "r977",
      "r978"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r976",
      "r977",
      "r978"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r979"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r974"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r973"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r973"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r973"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r987"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r973"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r973"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r973"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r973"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r1013"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r976",
      "r977",
      "r978"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r972"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r975"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.viatris.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r183",
      "r408",
      "r413",
      "r421",
      "r727",
      "r728",
      "r734",
      "r735",
      "r840",
      "r967",
      "r990",
      "r1001",
      "r1010",
      "r1011"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by consolidated entity or group of entities.",
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/EquityMethodInvestmentsIncomeStatementDetails",
      "http://www.viatris.com/role/EquityMethodInvestmentsNetAssetsDetails",
      "http://www.viatris.com/role/LitigationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r183",
      "r408",
      "r413",
      "r421",
      "r727",
      "r728",
      "r734",
      "r735",
      "r840",
      "r967",
      "r990",
      "r1001",
      "r1010",
      "r1011"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity or group of entities consolidated into reporting entity.",
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities [Domain]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/EquityMethodInvestmentsIncomeStatementDetails",
      "http://www.viatris.com/role/EquityMethodInvestmentsNetAssetsDetails",
      "http://www.viatris.com/role/LitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r183",
      "r245",
      "r258",
      "r259",
      "r260",
      "r261",
      "r263",
      "r265",
      "r269",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r415",
      "r416",
      "r418",
      "r420",
      "r421",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1010",
      "r1011"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/Restructuring2020RestructuringPlanDetails",
      "http://www.viatris.com/role/RestructuringNarrativeDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails",
      "http://www.viatris.com/role/SegmentInformationReconciliationofSegmentInformationtoTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r183",
      "r245",
      "r258",
      "r259",
      "r260",
      "r261",
      "r263",
      "r265",
      "r269",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r415",
      "r416",
      "r418",
      "r420",
      "r421",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1010",
      "r1011"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/Restructuring2020RestructuringPlanDetails",
      "http://www.viatris.com/role/RestructuringNarrativeDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails",
      "http://www.viatris.com/role/SegmentInformationReconciliationofSegmentInformationtoTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r85",
      "r87",
      "r180",
      "r181",
      "r427",
      "r462",
      "r1012"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of counterparty. A counterparty is the other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.",
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails",
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r0",
      "r196",
      "r201",
      "r207",
      "r318",
      "r635",
      "r636",
      "r637",
      "r678",
      "r679",
      "r778",
      "r779",
      "r780",
      "r781",
      "r1014"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) to financial statements for cumulative-effect adjustment in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r0",
      "r196",
      "r201",
      "r207",
      "r318",
      "r635",
      "r636",
      "r637",
      "r678",
      "r679",
      "r778",
      "r779",
      "r780",
      "r781",
      "r1014"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r0",
      "r196",
      "r201",
      "r207",
      "r318",
      "r635",
      "r636",
      "r637",
      "r678",
      "r679",
      "r778",
      "r779",
      "r780",
      "r781",
      "r1014"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of investment including named security. Excludes entity that is consolidated.",
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsOthernoncurrentliabilitiesDetails",
      "http://www.viatris.com/role/EquityMethodInvestmentsBalanceSheetDetails",
      "http://www.viatris.com/role/EquityMethodInvestmentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of judicial proceeding, alternative dispute resolution or claim.",
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LitigationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Judicial proceeding, alternative dispute resolution or claim. For example, but not limited to, name of case, category of litigation, or other differentiating information.",
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r276",
      "r491",
      "r495",
      "r940"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name or description of a single external customer or a group of external customers.",
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails",
      "http://www.viatris.com/role/SegmentInformationThirdPartyNetSalesbyMajorCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r426",
      "r461",
      "r595",
      "r601",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r877",
      "r937",
      "r941",
      "r968",
      "r969"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upper limit of the provided range.",
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/LeasesLeaseInformationDetails",
      "http://www.viatris.com/role/LeasesNarrativeDetails",
      "http://www.viatris.com/role/Restructuring2020RestructuringPlanDetails",
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails",
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r426",
      "r461",
      "r595",
      "r601",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r877",
      "r937",
      "r941",
      "r968",
      "r969"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lower limit of the provided range.",
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/DebtSeniorNotesDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/LeasesLeaseInformationDetails",
      "http://www.viatris.com/role/LeasesNarrativeDetails",
      "http://www.viatris.com/role/Restructuring2020RestructuringPlanDetails",
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails",
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r276",
      "r491",
      "r495",
      "r940"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Single external customer or group of external customers.",
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails",
      "http://www.viatris.com/role/SegmentInformationThirdPartyNetSalesbyMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.",
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.",
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ParentCompanyMember": {
     "auth_ref": [
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The registrant that controls, directly or indirectly, another entity (or entities). The usual condition for control is ownership of a majority (over 50%) of the outstanding voting stock. The power to control may also exist with a lesser percentage of ownership, for example, by contract, lease, agreement with other stockholders or by court decree.",
        "label": "Parent Company [Member]",
        "terseLabel": "Mylan",
        "verboseLabel": "Mylan N.V."
       }
      }
     },
     "localname": "ParentCompanyMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/LitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r272",
      "r491",
      "r493",
      "r880",
      "r936",
      "r938"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by product and service, or group of similar products and similar services.",
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/ConsolidatedStatementsofOperations",
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsProductRightsandLicensebyTherapeuticCategoryDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableDisaggregationofRevenuebyKeyProductsDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r272",
      "r491",
      "r493",
      "r880",
      "r936",
      "r938"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services.",
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/ConsolidatedStatementsofOperations",
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsProductRightsandLicensebyTherapeuticCategoryDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableDisaggregationofRevenuebyKeyProductsDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r426",
      "r461",
      "r532",
      "r595",
      "r601",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r877",
      "r937",
      "r941",
      "r968",
      "r969"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Range [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails",
      "http://www.viatris.com/role/DebtSeniorNotesDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/LeasesLeaseInformationDetails",
      "http://www.viatris.com/role/LeasesNarrativeDetails",
      "http://www.viatris.com/role/Restructuring2020RestructuringPlanDetails",
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails",
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r426",
      "r461",
      "r532",
      "r595",
      "r601",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r877",
      "r937",
      "r941",
      "r968",
      "r969"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Range [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails",
      "http://www.viatris.com/role/DebtSeniorNotesDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/LeasesLeaseInformationDetails",
      "http://www.viatris.com/role/LeasesNarrativeDetails",
      "http://www.viatris.com/role/Restructuring2020RestructuringPlanDetails",
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails",
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r86",
      "r87",
      "r180",
      "r181",
      "r427",
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.",
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails",
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r202",
      "r596",
      "r988"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information reported for future period. Excludes information expected to be reported in future period for effect on historical fact.",
        "label": "Forecast [Member]",
        "terseLabel": "Scenario, Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails",
      "http://www.viatris.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r202",
      "r207",
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.",
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario, Unspecified [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails",
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of investment including named security. Excludes entity that is consolidated.",
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsOthernoncurrentliabilitiesDetails",
      "http://www.viatris.com/role/EquityMethodInvestmentsBalanceSheetDetails",
      "http://www.viatris.com/role/EquityMethodInvestmentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": {
     "auth_ref": [
      "r191",
      "r1000"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]",
        "terseLabel": "Schedule II - Valuation and Qualifying Accounts"
       }
      }
     },
     "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ValuationandQualifyingAccounts"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r273",
      "r274",
      "r491",
      "r494",
      "r939",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962",
      "r963",
      "r964",
      "r965",
      "r966",
      "r989",
      "r992",
      "r993",
      "r994",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Geographical area.",
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsNarrativeDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails",
      "http://www.viatris.com/role/IncomeTaxesStatutoryTaxRatetoEffectiveTaxRateReconciliationDetails",
      "http://www.viatris.com/role/SegmentInformationNetThirdPartySalesClassifiedBasedonGeographicLocationofEntityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r273",
      "r274",
      "r491",
      "r494",
      "r939",
      "r954",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962",
      "r963",
      "r964",
      "r965",
      "r966",
      "r989",
      "r991"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by geographical components.",
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsNarrativeDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails",
      "http://www.viatris.com/role/IncomeTaxesStatutoryTaxRatetoEffectiveTaxRateReconciliationDetails",
      "http://www.viatris.com/role/SegmentInformationNetThirdPartySalesClassifiedBasedonGeographicLocationofEntityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r202",
      "r207",
      "r393",
      "r596",
      "r845"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.",
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails",
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SubsidiariesMember": {
     "auth_ref": [
      "r561",
      "r837",
      "r838",
      "r839"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity owned or controlled by another entity.",
        "label": "Subsidiaries [Member]",
        "terseLabel": "Mylan Laboratories Limited"
       }
      }
     },
     "localname": "SubsidiariesMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ValuationAndQualifyingAccountsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsAbstract",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureLineItems",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureTable": {
     "auth_ref": [
      "r184",
      "r185",
      "r186",
      "r189",
      "r190",
      "r1000"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureTable",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "terseLabel": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "verboseLabel": "Revenue Recognition And Accounts Receivable [Line Items]"
       }
      }
     },
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAccountsreceivablenetDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableNarrativeDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationRollforwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of receivable.",
        "label": "Receivable Type [Axis]",
        "terseLabel": "Receivable Type [Axis]"
       }
      }
     },
     "localname": "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationRollforwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by legal entity of counterparty. A counterparty is the other party that participates in a financial transaction.",
        "label": "Legal Entity of Counterparty, Type [Axis]",
        "terseLabel": "Legal Entity of Counterparty, Type [Axis]"
       }
      }
     },
     "localname": "AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails",
      "http://www.viatris.com/role/CommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.",
        "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]",
        "terseLabel": "Trade accounts payable"
       }
      }
     },
     "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable, Current [Abstract]",
        "terseLabel": "Accounts Payable, Current [Abstract]"
       }
      }
     },
     "localname": "AccountsPayableCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableOtherCurrentAndNoncurrent": {
     "auth_ref": [
      "r895",
      "r929"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsTradeAccountsPayableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsPayableTradeCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligations incurred and payable classified as other.",
        "label": "Accounts Payable, Other",
        "terseLabel": "Other payables"
       }
      }
     },
     "localname": "AccountsPayableOtherCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsTradeAccountsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "auth_ref": [
      "r14",
      "r62"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsTradeAccountsPayableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.viatris.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Trade, Current",
        "totalLabel": "Accounts payable",
        "verboseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableTradeCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsTradeAccountsPayableDetails",
      "http://www.viatris.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableTradeCurrentAndNoncurrent": {
     "auth_ref": [
      "r895",
      "r929"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsTradeAccountsPayableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsPayableTradeCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Accounts Payable, Trade",
        "terseLabel": "Trade accounts payable"
       }
      }
     },
     "localname": "AccountsPayableTradeCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsTradeAccountsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableFromSecuritization": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount owed to the reporting entity by counterparties in securitized loan transactions.",
        "label": "Accounts Receivable from Securitization",
        "terseLabel": "Securitized accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableFromSecuritization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtDebtReceivablesFacilityandCommercialPaperProgramDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [
      "r955"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAccountsreceivablenetDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsNarrativeDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r6",
      "r42",
      "r278",
      "r279"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "periodEndLabel": "End of period",
        "periodStartLabel": "Beginning of period",
        "totalLabel": "Accounts receivable, net",
        "verboseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAccountsreceivablenetDetails",
      "http://www.viatris.com/role/ConsolidatedBalanceSheets",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationRollforwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionExpense": {
     "auth_ref": [
      "r371",
      "r372",
      "r376"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations.",
        "label": "Accretion Expense",
        "terseLabel": "Accretion"
       }
      }
     },
     "localname": "AccretionExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r32",
      "r889",
      "r919"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "verboseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r99",
      "r106",
      "r115",
      "r116",
      "r117",
      "r733"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Defined Pension Plan Items"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r60",
      "r366"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "verboseLabel": "Accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember": {
     "auth_ref": [
      "r94",
      "r106",
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges, attributable to the parent.",
        "label": "Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]",
        "terseLabel": "Gains and Losses on Derivatives in Cash Flow Hedging Relationships"
       }
      }
     },
     "localname": "AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinNetInvestmentHedgingRelationshipDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": {
     "auth_ref": [
      "r95",
      "r96",
      "r97",
      "r106",
      "r115",
      "r116",
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]",
        "terseLabel": "Gains and Losses on Marketable Securities"
       }
      }
     },
     "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r105"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax",
        "periodEndLabel": "Net unrealized gains on marketable securities, net of tax, end of period",
        "periodStartLabel": "Net unrealized gains on marketable securities, net of tax, beginning of period",
        "terseLabel": "Net unrealized gain on marketable securities, net of tax"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax": {
     "auth_ref": [
      "r94",
      "r103",
      "r105"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change, net of tax, in accumulated gains and losses from derivative instruments designated and qualifying as the effective portion of cash flow hedges. Includes an entity's share of an equity investee's Increase or Decrease in deferred hedging gains or losses.",
        "label": "Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax",
        "periodEndLabel": "Net unrecognized gains (losses) on derivatives, net of tax, end of period",
        "periodStartLabel": "Net unrecognized gains (losses) on derivatives, net of tax, beginning of period"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax": {
     "auth_ref": [
      "r100",
      "r106",
      "r553"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax",
        "negatedPeriodEndLabel": "Net unrealized gains on marketable securities, net of tax, end of period",
        "negatedPeriodStartLabel": "Net unrecognized losses and prior service cost related to defined benefit plans, net of tax, beginning of period",
        "negatedTerseLabel": "Net unrecognized (loss) gain and prior service cost related to defined benefit plans, net of tax",
        "terseLabel": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r91",
      "r103",
      "r105",
      "r106",
      "r794"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.",
        "label": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax",
        "periodEndLabel": "Foreign currency translation adjustment, end of period",
        "periodStartLabel": "Foreign currency translation adjustment, beginning of period",
        "terseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r45",
      "r103",
      "r105",
      "r106",
      "r924",
      "r946",
      "r947"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "periodEndLabel": "Accumulated other comprehensive loss, net of tax, end of period",
        "periodStartLabel": "Accumulated other comprehensive loss, net of tax, beginning of period",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "verboseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r115",
      "r116",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r812"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r102",
      "r106",
      "r115",
      "r116",
      "r117",
      "r193",
      "r194",
      "r195",
      "r733",
      "r942",
      "r943",
      "r1015"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "AOCI Attributable to Parent [Member]",
        "verboseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r92",
      "r106",
      "r115",
      "r116",
      "r117",
      "r733",
      "r807",
      "r808",
      "r809",
      "r810",
      "r812"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Foreign Currency Translation Adjustment"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Acquired intangible assets, weighted average useful life, in years"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r43",
      "r638",
      "r843"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "verboseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r193",
      "r194",
      "r195",
      "r635",
      "r636",
      "r637",
      "r780"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentForAmortization": {
     "auth_ref": [
      "r158",
      "r357"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.",
        "label": "Amortization",
        "terseLabel": "Total intangible asset amortization expense (including impairment charges)"
       }
      }
     },
     "localname": "AdjustmentForAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in additional paid in capital (APIC) resulting from a tax benefit (deficiency) associated with an share-based compensation plan other than an employee stock ownership plan (ESOP).",
        "label": "Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net",
        "terseLabel": "Taxes related to the net share settlement of equity awards"
       }
      }
     },
     "localname": "AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net earnings to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r603",
      "r605",
      "r640",
      "r641"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "verboseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForCreditLossMember": {
     "auth_ref": [
      "r184",
      "r185",
      "r186",
      "r189",
      "r190"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance for credit loss from right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "SEC Schedule, 12-09, Allowance, Credit Loss [Member]",
        "terseLabel": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForCreditLossMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsNarrativeDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails",
      "http://www.viatris.com/role/ValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r158",
      "r348",
      "r357"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "negatedTerseLabel": "Intangible asset amortization expense",
        "terseLabel": "Intangible asset amortization expense"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails",
      "http://www.viatris.com/role/SegmentInformationReconciliationofSegmentInformationtoTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "verboseLabel": "Anti-dilutive securities excluded from computation of earnings per share"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax": {
     "auth_ref": [
      "r103"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated gain (loss) on derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax",
        "terseLabel": "AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax"
       }
      }
     },
     "localname": "AociLossCashFlowHedgeCumulativeGainLossAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "terseLabel": "Arrangements and Non-arrangement Transactions [Domain]"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetAcquisitionAxis": {
     "auth_ref": [
      "r718"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by asset acquisition.",
        "label": "Asset Acquisition [Axis]",
        "terseLabel": "Asset Acquisition [Axis]"
       }
      }
     },
     "localname": "AssetAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetAcquisitionDomain": {
     "auth_ref": [
      "r718"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset acquisition.",
        "label": "Asset Acquisition [Domain]",
        "terseLabel": "Asset Acquisition [Domain]"
       }
      }
     },
     "localname": "AssetAcquisitionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetBackedSecuritiesMember": {
     "auth_ref": [
      "r299",
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans.",
        "label": "Asset-backed Securities [Member]",
        "terseLabel": "Asset-backed Securities [Member]"
       }
      }
     },
     "localname": "AssetBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r174",
      "r253",
      "r260",
      "r267",
      "r315",
      "r408",
      "r409",
      "r410",
      "r412",
      "r413",
      "r414",
      "r415",
      "r417",
      "r419",
      "r421",
      "r422",
      "r727",
      "r734",
      "r800",
      "r841",
      "r843",
      "r887",
      "r918"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Total assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedBalanceSheets",
      "http://www.viatris.com/role/EquityMethodInvestmentsNetAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "verboseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r8",
      "r10",
      "r80",
      "r174",
      "r315",
      "r408",
      "r409",
      "r410",
      "r412",
      "r413",
      "r414",
      "r415",
      "r417",
      "r419",
      "r421",
      "r422",
      "r727",
      "r734",
      "r800",
      "r841",
      "r843"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "terseLabel": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedBalanceSheets",
      "http://www.viatris.com/role/EquityMethodInvestmentsNetAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "verboseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r783"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "terseLabel": "Total assets at recurring fair value measurement"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsNoncurrent": {
     "auth_ref": [
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r27",
      "r28",
      "r174",
      "r315",
      "r408",
      "r409",
      "r410",
      "r412",
      "r413",
      "r414",
      "r415",
      "r417",
      "r419",
      "r421",
      "r422",
      "r727",
      "r734",
      "r800",
      "r841"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.",
        "label": "Assets, Noncurrent",
        "terseLabel": "Noncurrent assets"
       }
      }
     },
     "localname": "AssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EquityMethodInvestmentsNetAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AustralianTaxationOfficeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government of Australia.",
        "label": "Australian Taxation Office [Member]",
        "terseLabel": "Australian Taxation Office"
       }
      }
     },
     "localname": "AustralianTaxationOfficeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r292"
     ],
     "calculation": {
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementScheduleofAvailableforsaleSecuritiesReconciliationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementScheduleofAvailableforsaleSecuritiesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r293"
     ],
     "calculation": {
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementScheduleofAvailableforsaleSecuritiesReconciliationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedTerseLabel": "Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementScheduleofAvailableforsaleSecuritiesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r290",
      "r324"
     ],
     "calculation": {
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementScheduleofAvailableforsaleSecuritiesReconciliationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Amortized Cost",
        "totalLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementScheduleofAvailableforsaleSecuritiesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": {
     "auth_ref": [
      "r294",
      "r297",
      "r908"
     ],
     "calculation": {
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementMaturitiesofAvailableforsaleDebtSecuritiesatFairValueDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "verboseLabel": "Mature in one to five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementMaturitiesofAvailableforsaleDebtSecuritiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r294",
      "r296",
      "r907"
     ],
     "calculation": {
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementMaturitiesofAvailableforsaleDebtSecuritiesatFairValueDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "verboseLabel": "Mature within one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementMaturitiesofAvailableforsaleDebtSecuritiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r286",
      "r291",
      "r324",
      "r894"
     ],
     "calculation": {
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementMaturitiesofAvailableforsaleDebtSecuritiesatFairValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementScheduleofAvailableforsaleSecuritiesReconciliationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Fair Value",
        "totalLabel": "Available-for-sale securities, debt securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementMaturitiesofAvailableforsaleDebtSecuritiesatFairValueDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementScheduleofAvailableforsaleSecuritiesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": {
     "auth_ref": [
      "r288",
      "r324"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidsandothercurrentassetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.",
        "label": "Debt Securities, Available-for-sale, Current",
        "terseLabel": "Available-for-sale fixed income securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidsandothercurrentassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r606",
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails",
      "http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails",
      "http://www.viatris.com/role/ShareBasedIncentivePlanValuationAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsOthernoncurrentliabilitiesDetails",
      "http://www.viatris.com/role/EquityMethodInvestmentsBalanceSheetDetails",
      "http://www.viatris.com/role/EquityMethodInvestmentsNarrativeDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementDerivativesDesignatedasHedgingInstrumentsFairValuesofDerivativeInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementDerivativesNotDesignatedasHedgingInstrumentsFairValuesofDerivativeInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails",
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/LitigationNarrativeDetails",
      "http://www.viatris.com/role/Restructuring2020RestructuringPlanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r749",
      "r755"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsOthernoncurrentliabilitiesDetails",
      "http://www.viatris.com/role/EquityMethodInvestmentsBalanceSheetDetails",
      "http://www.viatris.com/role/EquityMethodInvestmentsNarrativeDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementDerivativesDesignatedasHedgingInstrumentsFairValuesofDerivativeInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementDerivativesNotDesignatedasHedgingInstrumentsFairValuesofDerivativeInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails",
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/LitigationNarrativeDetails",
      "http://www.viatris.com/role/Restructuring2020RestructuringPlanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingAndBuildingImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Building and Building Improvements [Member]",
        "verboseLabel": "Buildings and improvements"
       }
      }
     },
     "localname": "BuildingAndBuildingImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails",
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingMember": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building [Member]",
        "terseLabel": "Building"
       }
      }
     },
     "localname": "BuildingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r591",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails",
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails",
      "http://www.viatris.com/role/DebtFairValueNarrativeDetails",
      "http://www.viatris.com/role/DebtSeniorNotesDetails",
      "http://www.viatris.com/role/DebtTables",
      "http://www.viatris.com/role/DebtUpjohnSeniorNotesDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails",
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/Restructuring2020RestructuringPlanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r591",
      "r597",
      "r701",
      "r702"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails",
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails",
      "http://www.viatris.com/role/DebtFairValueNarrativeDetails",
      "http://www.viatris.com/role/DebtSeniorNotesDetails",
      "http://www.viatris.com/role/DebtTables",
      "http://www.viatris.com/role/DebtUpjohnSeniorNotesDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails",
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/Restructuring2020RestructuringPlanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionDateOfAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition, Date of Acquisition [Abstract]",
        "terseLabel": "Business Acquisition, Date of Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessAcquisitionDateOfAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned": {
     "auth_ref": [
      "r716"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Value Assigned",
        "terseLabel": "Business Acquisition, Equity Interest Issued or Issuable, Value Assigned"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "auth_ref": [
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity.",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares",
        "terseLabel": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "terseLabel": "Business Acquisition, Percentage of Voting Interests Acquired"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic": {
     "auth_ref": [
      "r699",
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Earnings Per Share, Basic",
        "terseLabel": "Basic (in usd per share)"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaEarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted": {
     "auth_ref": [
      "r699",
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in usd per share)"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaEarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": {
     "auth_ref": [
      "r699",
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.",
        "label": "Business Acquisition, Pro Forma Information [Table Text Block]",
        "terseLabel": "Business Acquisition, Pro Forma Information"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "auth_ref": [
      "r699",
      "r700"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Net Income (Loss)",
        "terseLabel": "Net earnings"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "auth_ref": [
      "r699",
      "r700"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.",
        "label": "Business Acquisition, Pro Forma Revenue",
        "terseLabel": "Total revenues"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "auth_ref": [
      "r697"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Business Combination, Acquisition Related Costs",
        "terseLabel": "Business Combination, Acquisition Related Costs"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r711",
      "r712",
      "r714"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Acquisition purchase price"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": {
     "auth_ref": [
      "r711",
      "r712"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.",
        "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable",
        "terseLabel": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r710",
      "r713",
      "r717"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period",
        "terseLabel": "Contingent consideration liability",
        "verboseLabel": "Purchase consideration, contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsOthernoncurrentliabilitiesDetails",
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails",
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput": {
     "auth_ref": [
      "r787"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure contingent consideration liability from business combination.",
        "label": "Business Combination, Contingent Consideration, Liability, Measurement Input",
        "terseLabel": "Rate used to discount net cash inflows to present values"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r719"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Acquisitions and Other Transactions"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred": {
     "auth_ref": [
      "r706"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to items of consideration transferred in connection with a business combination for which the initial accounting was incomplete.",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred",
        "terseLabel": "Net assets acquired (net of $415.8 of cash acquired)"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory": {
     "auth_ref": [
      "r706"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to inventory acquired in connection with a business combination for which the initial accounting was incomplete.",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment": {
     "auth_ref": [
      "r706"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to property, plant, and equipment acquired in connection with a business combination for which the initial accounting was incomplete.",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Property, Plant, and Equipment",
        "terseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustments [Abstract]",
        "terseLabel": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustments [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": {
     "auth_ref": [
      "r704"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets",
        "terseLabel": "Total assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets": {
     "auth_ref": [
      "r704"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets",
        "terseLabel": "Current assets (excluding inventories and net of cash acquired)"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities": {
     "auth_ref": [
      "r704"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities",
        "terseLabel": "Current liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets": {
     "auth_ref": [
      "r704"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.",
        "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets",
        "terseLabel": "Deferred income tax benefit"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r704"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "terseLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets": {
     "auth_ref": [
      "r703",
      "r704",
      "r801"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of financial assets (as defined) recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financial Assets",
        "terseLabel": "Net assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r704"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "terseLabel": "Identified intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r703",
      "r704"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "verboseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r703",
      "r704"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r703",
      "r704"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities": {
     "auth_ref": [
      "r704"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities",
        "terseLabel": "Other noncurrent liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt": {
     "auth_ref": [
      "r704"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt",
        "terseLabel": "Long-term debt, including current portion"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r704"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r703",
      "r704"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "auth_ref": [
      "r695"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.",
        "label": "Business Combinations Policy [Policy Text Block]",
        "terseLabel": "Contingent Consideration Policy"
       }
      }
     },
     "localname": "BusinessCombinationsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalizedComputerSoftwareNet": {
     "auth_ref": [
      "r970"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of capitalized computer software costs net of accumulated amortization as of the balance sheet date.",
        "label": "Capitalized Computer Software, Net",
        "terseLabel": "Capitalized Computer Software, Net"
       }
      }
     },
     "localname": "CapitalizedComputerSoftwareNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAcquiredFromAcquisition": {
     "auth_ref": [
      "r135"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).",
        "label": "Cash Acquired from Acquisition",
        "terseLabel": "Cash Acquired from Acquisition"
       }
      }
     },
     "localname": "CashAcquiredFromAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents [Abstract]",
        "terseLabel": "Cash and Cash Equivalents [Abstract]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r4",
      "r56",
      "r160"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsBalanceSheetComponentsCashandCashEquivalentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      },
      "http://www.viatris.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsBalanceSheetComponentsCashandCashEquivalentsDetails",
      "http://www.viatris.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Member]",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansFairValuesofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r20",
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents Policy"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r151",
      "r160",
      "r166"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsBalanceSheetComponentsCashandCashEquivalentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash \u2014 end of period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash \u2014 beginning of period",
        "totalLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsBalanceSheetComponentsCashandCashEquivalentsDetails",
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r151",
      "r804"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net (decrease) increase in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": {
     "auth_ref": [
      "r776"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.",
        "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months",
        "terseLabel": "Pre-tax net losses on cash flow hedges to be reclassified from AOCE into earnings in next twelve months"
       }
      }
     },
     "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r745"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging [Mem",
        "verboseLabel": "Cash flow hedging relationships"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ConsolidatedStatementsofComprehensiveEarnings",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinNetInvestmentHedgingRelationshipDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofComprehensiveEarningsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesNotDesignatedasHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock": {
     "auth_ref": [
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in the benefit obligation, fair value of plan assets, and funded status of pension plans or other employee benefit plans.",
        "label": "Changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status of Plan [Table Text Block]",
        "terseLabel": "Changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status of Plan"
       }
      }
     },
     "localname": "ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r172",
      "r174",
      "r210",
      "r214",
      "r215",
      "r216",
      "r218",
      "r225",
      "r226",
      "r227",
      "r315",
      "r408",
      "r413",
      "r414",
      "r415",
      "r421",
      "r422",
      "r459",
      "r460",
      "r463",
      "r464",
      "r800",
      "r980"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails",
      "http://www.viatris.com/role/ConsolidatedStatementsofEquityParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CollaborativeArrangementDisclosureTextBlock": {
     "auth_ref": [
      "r720",
      "r721",
      "r723"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.",
        "label": "Collaborative Arrangement Disclosure [Text Block]",
        "terseLabel": "Collaborative and Licensing Agreements"
       }
      }
     },
     "localname": "CollaborativeArrangementDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CollaborationandLicensingAgreements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CollaborativeArrangementMember": {
     "auth_ref": [
      "r722"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual arrangement that involves two or more parties that both: (i) actively participate in a joint operating activity and (ii) are exposed to significant risks and rewards that depend on the commercial success of the joint operating activity.",
        "label": "Collaborative Arrangement [Member]",
        "terseLabel": "Collaborative Arrangement"
       }
      }
     },
     "localname": "CollaborativeArrangementMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember": {
     "auth_ref": [
      "r722"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement transaction between parties to collaborative arrangement.",
        "label": "Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member]",
        "terseLabel": "Collaborative Arrangement, Transaction with Party to Collaborative Arrangement"
       }
      }
     },
     "localname": "CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "terseLabel": "Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]"
       }
      }
     },
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r405"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial Paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtShorttermborrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsDisclosureTextBlock": {
     "auth_ref": [
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights.",
        "label": "Commitments Disclosure [Text Block]",
        "terseLabel": "Commitments"
       }
      }
     },
     "localname": "CommitmentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/Commitments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r73"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Common stock shares reserved for issuance to employees"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockDividendsPerShareCashPaid": {
     "auth_ref": [
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends paid during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Cash Paid",
        "terseLabel": "Dividends paid per share"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareCashPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofEquityParenthetical",
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Common Stock, Dividends, Per Share, Declared"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r193",
      "r194",
      "r780"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock",
        "verboseLabel": "Marketable securities"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity",
      "http://www.viatris.com/role/ConsolidatedStatementsofEquityParenthetical",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r41"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common Stock, Par or Stated Value Per Share",
        "verboseLabel": "Ordinary shares, par value, in USD per share"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.viatris.com/role/Cover"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r41"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "verboseLabel": "Ordinary shares, number of shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r41",
      "r843"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Common stock: $0.01 par value, 3,000,000,000 shares authorized; shares issued and outstanding: 1,209,507,463 and 1,206,895,644, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r111",
      "r113",
      "r124",
      "r726",
      "r738",
      "r900",
      "r932"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofComprehensiveEarnings": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive earnings"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofComprehensiveEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r123",
      "r134",
      "r899",
      "r931"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Comprehensive Earnings"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarnings"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r235",
      "r236",
      "r276",
      "r797",
      "r798",
      "r955"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAccountsreceivablenetDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsNarrativeDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails",
      "http://www.viatris.com/role/SegmentInformationThirdPartyNetSalesbyMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r235",
      "r236",
      "r276",
      "r797",
      "r798",
      "r949",
      "r955"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAccountsreceivablenetDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsNarrativeDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails",
      "http://www.viatris.com/role/SegmentInformationThirdPartyNetSalesbyMajorCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r235",
      "r236",
      "r276",
      "r797",
      "r798",
      "r949",
      "r955"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails",
      "http://www.viatris.com/role/SegmentInformationThirdPartyNetSalesbyMajorCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r231",
      "r913"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentrations of Credit Risk Policy"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r235",
      "r236",
      "r276",
      "r797",
      "r798"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk, percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsNarrativeDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails",
      "http://www.viatris.com/role/SegmentInformationThirdPartyNetSalesbyMajorCustomersDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r235",
      "r236",
      "r276",
      "r797",
      "r798",
      "r955"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails",
      "http://www.viatris.com/role/SegmentInformationThirdPartyNetSalesbyMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidatedEntityExcludingVieMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consolidated entity, excluding variable interest entity (VIE) for which reporting entity is or is not primary beneficiary.",
        "label": "Consolidated Entity, Excluding VIE [Member]",
        "terseLabel": "Consolidated Entity"
       }
      }
     },
     "localname": "ConsolidatedEntityExcludingVieMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EquityMethodInvestmentsIncomeStatementDetails",
      "http://www.viatris.com/role/EquityMethodInvestmentsNetAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r168",
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation Policy"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction in progress"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractualRightsMember": {
     "auth_ref": [
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights that arise from a contractual arrangement with a third party (not including franchise rights and license agreements).",
        "label": "Contractual Rights [Member]",
        "terseLabel": "Contractual Rights"
       }
      }
     },
     "localname": "ContractualRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertiblePreferredStockMember": {
     "auth_ref": [
      "r459",
      "r460",
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option.",
        "label": "Convertible Preferred Stock [Member]",
        "terseLabel": "Convertible Preferred Stock"
       }
      }
     },
     "localname": "ConvertiblePreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateBondSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about long-term debt securities that are issued by either a domestic or foreign corporate business entity with a date certain promise of repayment and a return to the holder for the time value of money (for example, variable or fixed interest, original issue discount).",
        "label": "Corporate Bond Securities [Member]",
        "terseLabel": "Corporate bonds"
       }
      }
     },
     "localname": "CorporateBondSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r258",
      "r259",
      "r260",
      "r261",
      "r263",
      "r269",
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate (Other)"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/Restructuring2020RestructuringPlanDetails",
      "http://www.viatris.com/role/SegmentInformationReconciliationofSegmentInformationtoTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r128",
      "r880"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "verboseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditConcentrationRiskMember": {
     "auth_ref": [
      "r799"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that a specified receivable or amount at risk from a counterparty under a contractual arrangement is to a specified benchmark, such as total receivables, net revenues, pretax results. Risk is the materially adverse effects of loss attributable to (a) the failure to collect a significant receivable from a major customer or group of homogeneous accounts, or (b) a failure by a counterparty to perform under terms of a contractual arrangement.",
        "label": "Credit Concentration Risk [Member]",
        "terseLabel": "Credit Concentration Risk"
       }
      }
     },
     "localname": "CreditConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r175",
      "r674",
      "r682"
     ],
     "calculation": {
      "http://www.viatris.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "U.S. Federal Current"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r175",
      "r674"
     ],
     "calculation": {
      "http://www.viatris.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "Non-U.S. Current"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r175",
      "r674",
      "r682"
     ],
     "calculation": {
      "http://www.viatris.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "U.S. State Current"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r234",
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/SegmentInformationThirdPartyNetSalesbyMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtCurrent": {
     "auth_ref": [
      "r65"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.",
        "label": "Debt, Current",
        "terseLabel": "Debt, Current"
       }
      }
     },
     "localname": "DebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtRevolvingFacilitiesandTermFacilitiesDetails",
      "http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r171",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r440",
      "r447",
      "r448",
      "r450",
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "verboseLabel": "Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/Debt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r30",
      "r32",
      "r33",
      "r173",
      "r183",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r430",
      "r436",
      "r437",
      "r438",
      "r439",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r454",
      "r455",
      "r456",
      "r457",
      "r819",
      "r888",
      "r891",
      "r915"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtDebtReceivablesFacilityandCommercialPaperProgramDetails",
      "http://www.viatris.com/role/DebtIssuanceof2018SeniorNotesDetails",
      "http://www.viatris.com/role/DebtRevolvingFacilitiesandTermFacilitiesDetails",
      "http://www.viatris.com/role/DebtSeniorNotesDetails",
      "http://www.viatris.com/role/DebtShorttermborrowingsDetails",
      "http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails",
      "http://www.viatris.com/role/DebtUpjohnSeniorNotesDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Debt Instrument, Basis Spread on Variable Rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtDebtReceivablesFacilityandCommercialPaperProgramDetails",
      "http://www.viatris.com/role/DebtIssuanceof2018SeniorNotesDetails",
      "http://www.viatris.com/role/DebtSeniorNotesDetails",
      "http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r33",
      "r451",
      "r891",
      "r915"
     ],
     "calculation": {
      "http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Long-term Debt, Gross",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails",
      "http://www.viatris.com/role/DebtSeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentCovenantDescription": {
     "auth_ref": [
      "r33",
      "r911"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of minimum financial levels (for example, tangible net worth and working capital) and achievement of certain financial ratios (for example, working capital ratio and debt service coverage ratio), and adherence to certain clauses which generally require or restrict certain actions (for example, entering into a debt arrangement with equal or greater seniority, and selling or discontinuing a certain business segment or material subsidiary) to be in compliance with the covenant clauses of the debt agreement. May also include a discussion of the adverse consequences that would result if the entity violates or fails to satisfy the covenants.",
        "label": "Debt Instrument, Covenant Description",
        "terseLabel": "Debt Instrument, Covenant Description"
       }
      }
     },
     "localname": "DebtInstrumentCovenantDescription",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtRevolvingFacilitiesandTermFacilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r423",
      "r454",
      "r455",
      "r817",
      "r819",
      "r820"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Debt Instrument, Face Amount",
        "verboseLabel": "Aggregate principal amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtSeniorNotesDetails",
      "http://www.viatris.com/role/DebtUpjohnSeniorNotesDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r438",
      "r454",
      "r455",
      "r796"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Fair value of long-term debt"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtFairValueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r69",
      "r453",
      "r817",
      "r819"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Debt instrument, interest rate at period end"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtSeniorNotesDetails",
      "http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r69",
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt instrument, interest rate, stated percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtIssuanceof2018SeniorNotesDetails",
      "http://www.viatris.com/role/DebtSeniorNotesDetails",
      "http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtDebtReceivablesFacilityandCommercialPaperProgramDetails",
      "http://www.viatris.com/role/DebtFairValueNarrativeDetails",
      "http://www.viatris.com/role/DebtIssuanceof2018SeniorNotesDetails",
      "http://www.viatris.com/role/DebtSeniorNotesDetails",
      "http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails",
      "http://www.viatris.com/role/DebtTables",
      "http://www.viatris.com/role/DebtUpjohnSeniorNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r70",
      "r173",
      "r183",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r430",
      "r436",
      "r437",
      "r438",
      "r439",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r454",
      "r455",
      "r456",
      "r457",
      "r819"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtDebtReceivablesFacilityandCommercialPaperProgramDetails",
      "http://www.viatris.com/role/DebtIssuanceof2018SeniorNotesDetails",
      "http://www.viatris.com/role/DebtRevolvingFacilitiesandTermFacilitiesDetails",
      "http://www.viatris.com/role/DebtSeniorNotesDetails",
      "http://www.viatris.com/role/DebtShorttermborrowingsDetails",
      "http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails",
      "http://www.viatris.com/role/DebtUpjohnSeniorNotesDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r70",
      "r173",
      "r183",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r430",
      "r436",
      "r437",
      "r438",
      "r439",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r449",
      "r454",
      "r455",
      "r456",
      "r457",
      "r467",
      "r468",
      "r469",
      "r470",
      "r816",
      "r817",
      "r819",
      "r820",
      "r912"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtDebtReceivablesFacilityandCommercialPaperProgramDetails",
      "http://www.viatris.com/role/DebtFairValueNarrativeDetails",
      "http://www.viatris.com/role/DebtIssuanceof2018SeniorNotesDetails",
      "http://www.viatris.com/role/DebtSeniorNotesDetails",
      "http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails",
      "http://www.viatris.com/role/DebtTables",
      "http://www.viatris.com/role/DebtUpjohnSeniorNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Debt Instrument, Term"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtDebtReceivablesFacilityandCommercialPaperProgramDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtPolicyTextBlock": {
     "auth_ref": [
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.",
        "label": "Debt, Policy [Policy Text Block]",
        "terseLabel": "Short-Term Borrowings"
       }
      }
     },
     "localname": "DebtPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtSecuritiesMember": {
     "auth_ref": [
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument issued by corporations, governments and governmental agencies, municipalities, and other institutions.",
        "label": "Debt Securities [Member]",
        "terseLabel": "Available-for-sale fixed income investments",
        "verboseLabel": "Debt securities"
       }
      }
     },
     "localname": "DebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementScheduleofAvailableforsaleSecuritiesReconciliationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredBonusMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An contractual arrangement whereby an employee is entitled to receive in the future, subject to vesting and other restrictions, a bonus, as defined in the agreement, of the entity or portion thereof. Employer contributions may be discretionary or may be based on a fixed formula related to individual, group and entity-wide performance goals, compensation, or other factors. It is a form of incentive compensation to employees in addition to their regular salary and profit sharing.",
        "label": "Deferred Bonus [Member]",
        "terseLabel": "Deferred Bonus"
       }
      }
     },
     "localname": "DeferredBonusMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis": {
     "auth_ref": [
      "r501",
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of deferred compensation related to other postretirement benefit arrangements that are not equivalent to a defined benefit other postretirement benefit plan. Includes, but is not limited to, employment contracts with one or more selected officers or key employees. Excludes equity-based compensation plans, defined benefit pension plans and defined benefit other postretirement benefit plans.",
        "label": "Other Postretirement Benefits, Individual Contracts, Type of Deferred Compensation [Axis]",
        "terseLabel": "Other Postretirement Benefits, Individual Contracts, Type of Deferred Compensation [Axis]"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r175",
      "r675",
      "r682"
     ],
     "calculation": {
      "http://www.viatris.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "U.S. Federal Deferred"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r175",
      "r675",
      "r682"
     ],
     "calculation": {
      "http://www.viatris.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "terseLabel": "Non-U.S. Deferred"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r647",
      "r648"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "verboseLabel": "Deferred income tax benefit"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r158",
      "r175",
      "r675",
      "r682",
      "r683",
      "r684"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income tax expense (benefit)"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r37",
      "r38",
      "r665",
      "r890",
      "r914"
     ],
     "calculation": {
      "http://www.viatris.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "totalLabel": "Total deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r647",
      "r648"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "verboseLabel": "Deferred income tax liability"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r175",
      "r675",
      "r682"
     ],
     "calculation": {
      "http://www.viatris.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "U.S. State Deferred"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r666"
     ],
     "calculation": {
      "http://www.viatris.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total deferred tax assets, gross"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsInventory": {
     "auth_ref": [
      "r672",
      "r673"
     ],
     "calculation": {
      "http://www.viatris.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.",
        "label": "Deferred Tax Assets, Inventory",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "DeferredTaxAssetsInventory",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r668"
     ],
     "calculation": {
      "http://www.viatris.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Total deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Net [Abstract]",
        "terseLabel": "Deferred tax assets:"
       }
      }
     },
     "localname": "DeferredTaxAssetsNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r672",
      "r673"
     ],
     "calculation": {
      "http://www.viatris.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "auth_ref": [
      "r671",
      "r672",
      "r673"
     ],
     "calculation": {
      "http://www.viatris.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards",
        "terseLabel": "Tax credit and loss carry-forwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign": {
     "auth_ref": [
      "r671",
      "r672",
      "r673"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Foreign",
        "terseLabel": "Expected foreign tax credits"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsForeign",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpense": {
     "auth_ref": [
      "r672",
      "r673"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowances, of deferred tax asset attributable to deductible differences from reserves and accruals, compensation and benefit costs, and other provisions, reserves, and allowances.",
        "label": "Deferred Tax Assets, Tax Deferred Expense",
        "terseLabel": "Foreign deductible attributes"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits": {
     "auth_ref": [
      "r672",
      "r673"
     ],
     "calculation": {
      "http://www.viatris.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from employee benefits, classified as other.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Benefits",
        "terseLabel": "Employee benefits"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts": {
     "auth_ref": [
      "r672",
      "r673"
     ],
     "calculation": {
      "http://www.viatris.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.",
        "label": "Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss",
        "terseLabel": "Accounts receivable allowances"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies": {
     "auth_ref": [
      "r672",
      "r673"
     ],
     "calculation": {
      "http://www.viatris.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from contingent liabilities.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Contingencies",
        "terseLabel": "Litigation reserves"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r667"
     ],
     "calculation": {
      "http://www.viatris.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Less: Valuation allowance",
        "terseLabel": "Valuation allowance, amount"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesNarrativeDetails",
      "http://www.viatris.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r648",
      "r668"
     ],
     "calculation": {
      "http://www.viatris.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Deferred tax liabilities, net"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets": {
     "auth_ref": [
      "r672",
      "r673"
     ],
     "calculation": {
      "http://www.viatris.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.",
        "label": "Deferred Tax Liabilities, Intangible Assets",
        "terseLabel": "Intangible assets and goodwill"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Net [Abstract]",
        "terseLabel": "Deferred tax liabilities:"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "auth_ref": [
      "r672",
      "r673"
     ],
     "calculation": {
      "http://www.viatris.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.",
        "label": "Deferred Tax Liabilities, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r672",
      "r673"
     ],
     "calculation": {
      "http://www.viatris.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "terseLabel": "Plant and equipment"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries": {
     "auth_ref": [
      "r693"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability not recognized because of the exceptions to comprehensive recognition of deferred taxes related to undistributed earnings of foreign subsidiaries.",
        "label": "Deferred Tax Liability Not Recognized, Amount of Unrecognized Deferred Tax Liability, Undistributed Earnings of Foreign Subsidiaries",
        "terseLabel": "Deferred tax liability not recognized, amount of unrecognized deferred tax liability, undistributed earnings of foreign subsidiaries"
       }
      }
     },
     "localname": "DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent": {
     "auth_ref": [
      "r35",
      "r505",
      "r506",
      "r530"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension plan, classified as noncurrent. Excludes other postretirement benefit plan.",
        "label": "Liability, Defined Benefit Pension Plan, Noncurrent",
        "terseLabel": "Liability, Defined Benefit Pension Plan, Noncurrent"
       }
      }
     },
     "localname": "DefinedBenefitPensionPlanLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOthernoncurrentliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation": {
     "auth_ref": [
      "r541"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.",
        "label": "Defined Benefit Plan, Accumulated Benefit Obligation",
        "terseLabel": "Accumulated benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax": {
     "auth_ref": [
      "r100",
      "r106",
      "r553"
     ],
     "calculation": {
      "http://www.viatris.com/role/EmployeeBenefitPlansAccumulatedOtherComprehensiveIncomeLossPretaxAmountsNotYetReclassifiedinNetPeriodicBenefitCostDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansAccumulatedOtherComprehensiveIncomeLossPretaxAmountsNotYetReclassifiedinNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax": {
     "auth_ref": [
      "r106",
      "r553"
     ],
     "calculation": {
      "http://www.viatris.com/role/EmployeeBenefitPlansAccumulatedOtherComprehensiveIncomeLossPretaxAmountsNotYetReclassifiedinNetPeriodicBenefitCostDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax",
        "negatedTerseLabel": "Unrecognized actuarial (gain) loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansAccumulatedOtherComprehensiveIncomeLossPretaxAmountsNotYetReclassifiedinNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax": {
     "auth_ref": [
      "r106",
      "r553"
     ],
     "calculation": {
      "http://www.viatris.com/role/EmployeeBenefitPlansAccumulatedOtherComprehensiveIncomeLossPretaxAmountsNotYetReclassifiedinNetPeriodicBenefitCostDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of accumulated other comprehensive (income) loss for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, Prior Service Cost (Credit), before Tax",
        "terseLabel": "Unrecognized prior service cost (credit)"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansAccumulatedOtherComprehensiveIncomeLossPretaxAmountsNotYetReclassifiedinNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets": {
     "auth_ref": [
      "r522",
      "r584"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.",
        "label": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)",
        "terseLabel": "Actual return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanActualReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansChangesinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActuarialGainLoss": {
     "auth_ref": [
      "r514"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)",
        "terseLabel": "Actuarial (gains) losses"
       }
      }
     },
     "localname": "DefinedBenefitPlanActuarialGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansChangesinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": {
     "auth_ref": [
      "r507",
      "r548",
      "r578",
      "r584",
      "r585"
     ],
     "calculation": {
      "http://www.viatris.com/role/EmployeeBenefitPlansChangeinAccumulatedIncomeLossRelatingtoDefinedBenefitPensionandOtherPostretirementBenefitsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Gain (Loss)",
        "terseLabel": "Amortization of actuarial gain/(loss)"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansChangeinAccumulatedIncomeLossRelatingtoDefinedBenefitPensionandOtherPostretirementBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax": {
     "auth_ref": [
      "r101",
      "r103",
      "r552"
     ],
     "calculation": {
      "http://www.viatris.com/role/EmployeeBenefitPlansChangeinAccumulatedIncomeLossRelatingtoDefinedBenefitPensionandOtherPostretirementBenefitsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income from prior service cost (credit) of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Reclassification Adjustment, before Tax",
        "terseLabel": "Unrecognized prior service credit (cost)"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansChangeinAccumulatedIncomeLossRelatingtoDefinedBenefitPensionandOtherPostretirementBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent": {
     "auth_ref": [
      "r28",
      "r505",
      "r506",
      "r530",
      "r584",
      "r886",
      "r917"
     ],
     "calculation": {
      "http://www.viatris.com/role/EmployeeBenefitPlansNetAccruedBenefitCostsClassificationonBalanceSheetDetails": {
       "order": 1.0,
       "parentTag": "vtrs_Netaccruedbenefitcosts",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.",
        "label": "Assets for Plan Benefits, Defined Benefit Plan",
        "terseLabel": "Noncurrent assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansNetAccruedBenefitCostsClassificationonBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from assets transferred into (from) plan.",
        "label": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Assets Transferred to (from) Plan",
        "verboseLabel": "Transferred assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssetsTransferredToFromPlan",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansChangesinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate": {
     "auth_ref": [
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease": {
     "auth_ref": [
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase",
        "terseLabel": "Rate of compensation increase"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate": {
     "auth_ref": [
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": {
     "auth_ref": [
      "r557",
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets",
        "terseLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease": {
     "auth_ref": [
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase",
        "terseLabel": "Rate of compensation increase"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligation": {
     "auth_ref": [
      "r509"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation",
        "periodEndLabel": "Projected benefit obligation, end of year",
        "periodStartLabel": "Projected benefit obligation, beginning of year"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansChangesinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid": {
     "auth_ref": [
      "r516",
      "r588"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid",
        "negatedTerseLabel": "Benefits paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansChangesinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets": {
     "auth_ref": [
      "r527"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in plan assets of defined benefit plan from business combination.",
        "label": "Defined Benefit Plan, Plan Assets, Business Combination",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Business Combination"
       }
      }
     },
     "localname": "DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansChangesinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis": {
     "auth_ref": [
      "r532",
      "r533",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r561",
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Axis]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Axis]"
       }
      }
     },
     "localname": "DefinedBenefitPlanByPlanAssetCategoriesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansFairValuesofPlanAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]",
        "terseLabel": "Projected benefit obligation, beginning of year"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInBenefitObligationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansChangesinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]",
        "terseLabel": "Change in Plan Assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansChangesinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "auth_ref": [
      "r524",
      "r533",
      "r535",
      "r582",
      "r584",
      "r585"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "terseLabel": "Company contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansChangesinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanCurtailments": {
     "auth_ref": [
      "r511"
     ],
     "calculation": {
      "http://www.viatris.com/role/EmployeeBenefitPlansNetPeriodicBenefitCostsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of (increase) decrease in benefit obligation of defined benefit plan from event reducing expected years of future service of present employees or eliminating accrual of benefits for some or all future services of present employees.",
        "label": "Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Curtailment",
        "terseLabel": "Plan curtailment, settlement and termination"
       }
      }
     },
     "localname": "DefinedBenefitPlanCurtailments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansFairValuesofPlanAssetsDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnAccumulatedPostretirementBenefitObligation1": {
     "auth_ref": [
      "r560"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in accumulated postretirement benefit obligation from one-percentage-point decrease in assumed health care cost trend rate.",
        "label": "Defined Benefit Plan, Effect of One Percentage Point Decrease on Accumulated Postretirement Benefit Obligation",
        "negatedTerseLabel": "Decrease in the benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnAccumulatedPostretirementBenefitObligation1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansEffectofOnePercentagePointIncreaseorDecreaseinHealthCareCostTrendRatesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnServiceAndInterestCostComponents1": {
     "auth_ref": [
      "r560"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in service and interest cost components of net periodic postretirement benefit cost from one-percentage-point decrease in assumed health care cost trend rate.",
        "label": "Defined Benefit Plan, Effect of One Percentage Point Decrease on Service and Interest Cost Components",
        "negatedTerseLabel": "Decrease in the aggregate of service and interest cost components of annual expense"
       }
      }
     },
     "localname": "DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnServiceAndInterestCostComponents1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansEffectofOnePercentagePointIncreaseorDecreaseinHealthCareCostTrendRatesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation": {
     "auth_ref": [
      "r560"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in accumulated postretirement benefit obligation from one-percentage-point increase in assumed health care cost trend rate.",
        "label": "Defined Benefit Plan, Effect of One Percentage Point Increase on Accumulated Postretirement Benefit Obligation",
        "terseLabel": "Increase in the benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansEffectofOnePercentagePointIncreaseorDecreaseinHealthCareCostTrendRatesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnServiceAndInterestCostComponents": {
     "auth_ref": [
      "r560"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in service and interest cost components of net periodic postretirement benefit cost from one-percentage-point increase in assumed health care cost trend rate.",
        "label": "Defined Benefit Plan, Effect of One Percentage Point Increase on Service and Interest Cost Components",
        "terseLabel": "Increase in the aggregate of service and interest cost components of annual expense"
       }
      }
     },
     "localname": "DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnServiceAndInterestCostComponents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansEffectofOnePercentagePointIncreaseorDecreaseinHealthCareCostTrendRatesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear": {
     "auth_ref": [
      "r567"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount included in accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan expected to be recognized in net periodic benefit (cost) credit for fiscal year following most recent annual statement of financial position.",
        "label": "Defined Benefit Plan, Expected Amortization of Gain (Loss), Next Fiscal Year",
        "terseLabel": "Accumulated other comprehensive income expected to be recognized as net periodic benefit costs"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear": {
     "auth_ref": [
      "r567"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount included in accumulated other comprehensive (income) loss for prior service cost (credit) expected to be recognized in net periodic benefit cost (credit) for fiscal year following most recent annual statement of financial position.",
        "label": "Defined Benefit Plan, Expected Amortization of Prior Service Cost (Credit), Next Fiscal Year",
        "terseLabel": "Future unrecognized actuarial losses"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter": {
     "auth_ref": [
      "r542"
     ],
     "calculation": {
      "http://www.viatris.com/role/EmployeeBenefitPlansEstimatedFutureBenefitPaymentsDetails": {
       "order": 6.0,
       "parentTag": "vtrs_ExpectedFutureBenefitPayments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansEstimatedFutureBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths": {
     "auth_ref": [
      "r542"
     ],
     "calculation": {
      "http://www.viatris.com/role/EmployeeBenefitPlansEstimatedFutureBenefitPaymentsDetails": {
       "order": 1.0,
       "parentTag": "vtrs_ExpectedFutureBenefitPayments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year One",
        "terseLabel": "2019"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansEstimatedFutureBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive": {
     "auth_ref": [
      "r542"
     ],
     "calculation": {
      "http://www.viatris.com/role/EmployeeBenefitPlansEstimatedFutureBenefitPaymentsDetails": {
       "order": 5.0,
       "parentTag": "vtrs_ExpectedFutureBenefitPayments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Five",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansEstimatedFutureBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour": {
     "auth_ref": [
      "r542"
     ],
     "calculation": {
      "http://www.viatris.com/role/EmployeeBenefitPlansEstimatedFutureBenefitPaymentsDetails": {
       "order": 4.0,
       "parentTag": "vtrs_ExpectedFutureBenefitPayments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Four",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansEstimatedFutureBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree": {
     "auth_ref": [
      "r542"
     ],
     "calculation": {
      "http://www.viatris.com/role/EmployeeBenefitPlansEstimatedFutureBenefitPaymentsDetails": {
       "order": 3.0,
       "parentTag": "vtrs_ExpectedFutureBenefitPayments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Three",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansEstimatedFutureBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo": {
     "auth_ref": [
      "r542"
     ],
     "calculation": {
      "http://www.viatris.com/role/EmployeeBenefitPlansEstimatedFutureBenefitPaymentsDetails": {
       "order": 2.0,
       "parentTag": "vtrs_ExpectedFutureBenefitPayments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Two",
        "terseLabel": "2020"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansEstimatedFutureBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r507",
      "r547",
      "r577",
      "r584",
      "r585"
     ],
     "calculation": {
      "http://www.viatris.com/role/EmployeeBenefitPlansNetPeriodicBenefitCostsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedTerseLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": {
     "auth_ref": [
      "r521",
      "r533",
      "r535",
      "r536",
      "r584"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.",
        "label": "Defined Benefit Plan, Plan Assets, Amount",
        "periodEndLabel": "Fair value of plan assets, end of year",
        "periodStartLabel": "Fair value of plan assets, beginning of year",
        "terseLabel": "Fair value of plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanFairValueOfPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansChangesinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansFairValuesofPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation": {
     "auth_ref": [
      "r515"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Impact of foreign currency translation"
       }
      }
     },
     "localname": "DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansChangesinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": {
     "auth_ref": [
      "r505",
      "r530",
      "r584"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.",
        "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan",
        "terseLabel": "Funded status of plans"
       }
      }
     },
     "localname": "DefinedBenefitPlanFundedStatusOfPlan",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansChangesinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear": {
     "auth_ref": [
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assumed rate, for next fiscal year, based on annual change in cost of health care cost benefits used to measure expected cost of benefits covered by defined benefit postretirement plan. Factors include, but are not limited to, estimate of health care inflation, change in health care utilization or delivery pattern, technological advances, and change in health status of participant. Excludes factors for change in composition of plan population by age and dependency status.",
        "label": "Defined Benefit Plan, Health Care Cost Trend Rate Assumed, Next Fiscal Year",
        "terseLabel": "Defined benefit plan, ultimate health care cost trend rate"
       }
      }
     },
     "localname": "DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r507",
      "r512",
      "r546",
      "r576",
      "r584",
      "r585"
     ],
     "calculation": {
      "http://www.viatris.com/role/EmployeeBenefitPlansNetPeriodicBenefitCostsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "terseLabel": "Interest cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansChangesinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r544",
      "r574",
      "r584",
      "r585"
     ],
     "calculation": {
      "http://www.viatris.com/role/EmployeeBenefitPlansNetPeriodicBenefitCostsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "totalLabel": "Net periodic benefit cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanOtherCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of defined benefit plan cost (credit), classified as other.",
        "label": "Defined Benefit Plan, Other Cost (Credit)",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DefinedBenefitPlanOtherCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansChangesinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets": {
     "auth_ref": [
      "r570",
      "r571",
      "r584"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of plan asset for defined benefit plan with accumulated benefit obligation in excess of plan assets.",
        "label": "Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Plan Assets",
        "terseLabel": "Fair value of plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansPlanswithPBOinExcessofPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation": {
     "auth_ref": [
      "r570"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of projected benefit obligation for defined benefit pension plan with accumulated benefit obligation in excess of plan assets.",
        "label": "Defined Benefit Plan, Pension Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation",
        "terseLabel": "Projected benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansPlanswithPBOinExcessofPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant": {
     "auth_ref": [
      "r525"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contributions received by defined benefit plan from participant which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Plan Participant",
        "terseLabel": "Participant contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansChangesinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1": {
     "auth_ref": [
      "r508",
      "r551",
      "r581"
     ],
     "calculation": {
      "http://www.viatris.com/role/EmployeeBenefitPlansNetPeriodicBenefitCostsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement",
        "negatedLabel": "Recognized net actuarial losses"
       }
      }
     },
     "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "auth_ref": [
      "r510",
      "r545",
      "r575",
      "r584",
      "r585"
     ],
     "calculation": {
      "http://www.viatris.com/role/EmployeeBenefitPlansNetPeriodicBenefitCostsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Service Cost",
        "terseLabel": "Service cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanServiceCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansChangesinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanSettlementsBenefitObligation": {
     "auth_ref": [
      "r511"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of (increase) decrease to benefit obligation of defined benefit plan from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Includes, but is not limited to, lump-sum cash payment to participant in exchange for right to receive specified benefits, purchase of nonparticipating annuity contract and change from remeasurement.",
        "label": "Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement",
        "negatedTerseLabel": "Plan settlements and terminations"
       }
      }
     },
     "localname": "DefinedBenefitPlanSettlementsBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansChangesinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanSettlementsPlanAssets": {
     "auth_ref": [
      "r529"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract.",
        "label": "Defined Benefit Plan, Plan Assets, Payment for Settlement",
        "negatedTerseLabel": "Plan settlements"
       }
      }
     },
     "localname": "DefinedBenefitPlanSettlementsPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansChangesinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1": {
     "auth_ref": [
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ultimate trend rate for health care cost for defined benefit postretirement plan.",
        "label": "Defined Benefit Plan, Ultimate Health Care Cost Trend Rate",
        "terseLabel": "Defined benefit plan, ultimate health care cost trend rate, projected"
       }
      }
     },
     "localname": "DefinedBenefitPlanUltimateHealthCareCostTrendRate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r568",
      "r569",
      "r572",
      "r573",
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures and provisions pertaining to defined benefit pension plans or other postretirement defined benefit plans. The arrangements are generally based on terms and conditions stipulated by the entity, and which contain a promise by the employer to pay certain amounts or awards at designated future dates, including a period after retirement, upon compliance with stipulated requirements. Excludes disclosures pertaining to defined contribution plans.",
        "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]",
        "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansAccumulatedOtherComprehensiveIncomeLossPretaxAmountsNotYetReclassifiedinNetPeriodicBenefitCostDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansChangeinAccumulatedIncomeLossRelatingtoDefinedBenefitPensionandOtherPostretirementBenefitsDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansChangesinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansEffectofOnePercentagePointIncreaseorDecreaseinHealthCareCostTrendRatesDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansEstimatedFutureBenefitPaymentsDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansNarrativeDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansNetAccruedBenefitCostsClassificationonBalanceSheetDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansPlanswithPBOinExcessofPlanAssetsDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]",
        "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansAccumulatedOtherComprehensiveIncomeLossPretaxAmountsNotYetReclassifiedinNetPeriodicBenefitCostDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansChangeinAccumulatedIncomeLossRelatingtoDefinedBenefitPensionandOtherPostretirementBenefitsDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansChangesinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansEffectofOnePercentagePointIncreaseorDecreaseinHealthCareCostTrendRatesDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansEstimatedFutureBenefitPaymentsDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansNarrativeDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansNetAccruedBenefitCostsClassificationonBalanceSheetDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansPlanswithPBOinExcessofPlanAssetsDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "auth_ref": [
      "r589"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for defined contribution plan.",
        "label": "Defined Contribution Plan, Cost",
        "terseLabel": "Total employer contributions"
       }
      }
     },
     "localname": "DefinedContributionPlanCostRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.",
        "label": "Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent",
        "terseLabel": "Defined contribution plan, maximum annual contribution per employee, percent"
       }
      }
     },
     "localname": "DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r158",
      "r364"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r158",
      "r248"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "verboseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetLiabilityNetMeasurementInput": {
     "auth_ref": [
      "r787"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure net derivative asset (liability).",
        "label": "Derivative Asset (Liability) Net, Measurement Input",
        "terseLabel": "Derivative Asset (Liability) Net, Measurement Input"
       }
      }
     },
     "localname": "DerivativeAssetLiabilityNetMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_DerivativeAssetNotionalAmount": {
     "auth_ref": [
      "r740",
      "r741",
      "r743"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative asset.",
        "label": "Derivative Asset, Notional Amount",
        "terseLabel": "Notional amount of derivative"
       }
      }
     },
     "localname": "DerivativeAssetNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r83",
      "r84",
      "r87",
      "r796"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Interest rate swap derivative assets"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract Type [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementDerivativesDesignatedasHedgingInstrumentsFairValuesofDerivativeInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementDerivativesNotDesignatedasHedgingInstrumentsFairValuesofDerivativeInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinNetInvestmentHedgingRelationshipDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofComprehensiveEarningsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesNotDesignatedasHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r82",
      "r87",
      "r88",
      "r753",
      "r859"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidsandothercurrentassetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Fair Value, Gross Asset",
        "terseLabel": "Fair value of financial instruments"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidsandothercurrentassetsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementDerivativesDesignatedasHedgingInstrumentsFairValuesofDerivativeInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementDerivativesNotDesignatedasHedgingInstrumentsFairValuesofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r82",
      "r87",
      "r88",
      "r753",
      "r859"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Fair Value, Gross Liability",
        "terseLabel": "Liability derivatives, fair value"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementDerivativesDesignatedasHedgingInstrumentsFairValuesofDerivativeInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementDerivativesNotDesignatedasHedgingInstrumentsFairValuesofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r751"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "terseLabel": "Amount of loss recognized in earnings on derivatives",
        "verboseLabel": "Derivative, Gain (Loss) on Derivative, Net"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r87",
      "r750",
      "r754",
      "r762",
      "r767"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementDerivativesDesignatedasHedgingInstrumentsFairValuesofDerivativeInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementDerivativesNotDesignatedasHedgingInstrumentsFairValuesofDerivativeInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinNetInvestmentHedgingRelationshipDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofComprehensiveEarningsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesNotDesignatedasHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r747",
      "r750",
      "r762"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ConsolidatedStatementsofComprehensiveEarnings",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinNetInvestmentHedgingRelationshipDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofComprehensiveEarningsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesNotDesignatedasHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r747",
      "r750",
      "r762",
      "r767",
      "r768",
      "r772",
      "r775"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinNetInvestmentHedgingRelationshipDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofComprehensiveEarningsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesNotDesignatedasHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinNetInvestmentHedgingRelationshipDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofComprehensiveEarningsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesNotDesignatedasHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet": {
     "auth_ref": [
      "r759",
      "r766"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net",
        "terseLabel": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net",
        "verboseLabel": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesNotDesignatedasHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet": {
     "auth_ref": [
      "r760",
      "r774"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of gains and losses (net) on derivative instruments designated and qualifying as hedging instruments representing (a) the amount of the hedge ineffectiveness and (b) the amount, if any, excluded from the assessment of hedge effectiveness.",
        "label": "Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net",
        "terseLabel": "Amount of Gain Excluded from the Assessment of Hedge Effectiveness"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofComprehensiveEarningsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet": {
     "auth_ref": [
      "r761",
      "r763"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.",
        "label": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net",
        "terseLabel": "Derivative Financial Instruments Not Designated as Hedging Instruments:"
       }
      }
     },
     "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r739",
      "r742",
      "r743",
      "r747",
      "r748",
      "r756",
      "r762",
      "r769",
      "r771",
      "r775",
      "r777"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivatives, Fair Value [Line Items]",
        "terseLabel": "Derivatives, Fair Value [Line Items]"
       }
      }
     },
     "localname": "DerivativesFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementDerivativesDesignatedasHedgingInstrumentsFairValuesofDerivativeInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementDerivativesNotDesignatedasHedgingInstrumentsFairValuesofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r182",
      "r739",
      "r742",
      "r747",
      "r748",
      "r770"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivatives Policy"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated as hedging instrument"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementDerivativesDesignatedasHedgingInstrumentsFairValuesofDerivativeInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "auth_ref": [
      "r709"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.",
        "label": "Developed Technology Rights [Member]",
        "terseLabel": "Intellectual Property"
       }
      }
     },
     "localname": "DevelopedTechnologyRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableDisaggregationofRevenuebyKeyProductsDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r491",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableDisaggregationofRevenuebyKeyProductsDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "verboseLabel": "Share-Based Incentive Plan"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlan"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Disclosure of Compensation Related Costs, Share-based Payments [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r591",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r471"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedTerseLabel": "Cash dividends declared, $0.33 per common share"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPayableAmountPerShare": {
     "auth_ref": [
      "r163"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The per share amount of a dividend declared, but not paid, as of the financial reporting date.",
        "label": "Dividends Payable, Amount Per Share",
        "terseLabel": "Dividends Payable, Amount Per Share"
       }
      }
     },
     "localname": "DividendsPayableAmountPerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Domestic Tax Authority"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]",
        "verboseLabel": "(Loss) earnings per share attributable to Viatris Inc. shareholders"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r125",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r208",
      "r210",
      "r216",
      "r217",
      "r218",
      "r221",
      "r222",
      "r781",
      "r782",
      "r901",
      "r933"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (in USD per share)",
        "verboseLabel": "Basic (loss) earnings per share attributable to Viatris Inc. shareholders"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofOperations",
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesBasicAndDilutedEarningsPerOrdinaryShareAttributableToMylanNVDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]",
        "terseLabel": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]"
       }
      }
     },
     "localname": "EarningsPerShareBasicLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesBasicAndDilutedEarningsPerOrdinaryShareAttributableToMylanNVDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r125",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r210",
      "r216",
      "r217",
      "r218",
      "r221",
      "r222",
      "r781",
      "r782",
      "r901",
      "r933"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in USD per share)",
        "verboseLabel": "Diluted (loss) earnings per share attributable to Viatris Inc. shareholders"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofOperations",
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesBasicAndDilutedEarningsPerOrdinaryShareAttributableToMylanNVDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r219",
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Earnings Per Common Share Policy"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents": {
     "auth_ref": [
      "r804"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.",
        "label": "Effect of Exchange Rate on Cash and Cash Equivalents",
        "verboseLabel": "Effect on cash of changes in exchange rates"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectOnFutureCashFlowsAmount": {
     "auth_ref": [
      "r384"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The quantified amount of the future effect on cash flows.",
        "label": "Effect on Future Cash Flows, Amount",
        "terseLabel": "Effect on Future Cash Flows, Amount"
       }
      }
     },
     "localname": "EffectOnFutureCashFlowsAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesStatutoryTaxRatetoEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r177",
      "r650",
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Statutory tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesNarrativeDetails",
      "http://www.viatris.com/role/IncomeTaxesStatutoryTaxRatetoEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r650",
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "terseLabel": "Valuation allowance"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesStatutoryTaxRatetoEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate": {
     "auth_ref": [
      "r650",
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent",
        "terseLabel": "Impact of changes in legislation"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesStatutoryTaxRatetoEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r650",
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent",
        "verboseLabel": "U.S. rate differentials"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesStatutoryTaxRatetoEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense": {
     "auth_ref": [
      "r650",
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent",
        "terseLabel": "Impact of the Combination and Divestitures"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesStatutoryTaxRatetoEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r650",
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesStatutoryTaxRatetoEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies": {
     "auth_ref": [
      "r650",
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income tax contingencies. Includes, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Contingency, Percent",
        "terseLabel": "Uncertain tax positions"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesStatutoryTaxRatetoEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits": {
     "auth_ref": [
      "r650",
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Percent",
        "terseLabel": "State income taxes and credits"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCredits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesStatutoryTaxRatetoEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign": {
     "auth_ref": [
      "r650",
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign tax credit.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Percent",
        "terseLabel": "Other Foreign Operations"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsForeign",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesStatutoryTaxRatetoEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch": {
     "auth_ref": [
      "r650",
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent",
        "negatedTerseLabel": "Clean energy and research credits"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsResearch",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesStatutoryTaxRatetoEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements": {
     "auth_ref": [
      "r650",
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income tax settlements. Including, but not limited to, domestic tax settlement, foreign tax settlement, state and local tax settlement, and other tax settlements.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Settlement, Percent",
        "terseLabel": "Tax settlements and resolution of certain tax positions"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxSettlements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesStatutoryTaxRatetoEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r67"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Employee-related Liabilities, Current"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r632"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "verboseLabel": "Total unrecognized compensation expense, net of estimated forfeitures"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "verboseLabel": "Weighted-average period over which total unrecognized compensation expense expected to be recognized (years)"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeSeveranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Employee Severance [Member]",
        "terseLabel": "Employee Severance"
       }
      }
     },
     "localname": "EmployeeSeveranceMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/Restructuring2020RestructuringPlanDetails",
      "http://www.viatris.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails",
      "http://www.viatris.com/role/ShareBasedIncentivePlanValuationAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EntityWideRevenueMajorCustomerLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue, Major Customer [Line Items]",
        "terseLabel": "Revenue, Major Customer [Line Items]"
       }
      }
     },
     "localname": "EntityWideRevenueMajorCustomerLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/SegmentInformationThirdPartyNetSalesbyMajorCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r115",
      "r116",
      "r117",
      "r193",
      "r194",
      "r195",
      "r198",
      "r204",
      "r206",
      "r224",
      "r318",
      "r466",
      "r471",
      "r635",
      "r636",
      "r637",
      "r678",
      "r679",
      "r780",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r812",
      "r942",
      "r943",
      "r944",
      "r1015"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinNetInvestmentHedgingRelationshipDetails",
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesBasicAndDilutedEarningsPerOrdinaryShareAttributableToMylanNVDetails",
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment": {
     "auth_ref": [
      "r310"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.",
        "label": "Equity Method Investment, Other than Temporary Impairment",
        "terseLabel": "Equity Method Investment, Other than Temporary Impairment"
       }
      }
     },
     "localname": "EquityMethodInvestmentOtherThanTemporaryImpairment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EquityMethodInvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r57",
      "r254",
      "r311"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Investments in subsidiaries"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails",
      "http://www.viatris.com/role/EquityMethodInvestmentsBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investments and Joint Ventures [Abstract]",
        "terseLabel": "Equity Method Investments and Joint Ventures [Abstract]"
       }
      }
     },
     "localname": "EquityMethodInvestmentsAndJointVenturesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": {
     "auth_ref": [
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.",
        "label": "Equity Method Investments and Joint Ventures Disclosure [Text Block]",
        "terseLabel": "Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EquityMethodInvestments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityMethodInvestmentsTextBlock": {
     "auth_ref": [
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.",
        "label": "Equity Method Investments [Table Text Block]",
        "terseLabel": "Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EquityMethodInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent": {
     "auth_ref": [
      "r793"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidsandothercurrentassetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI",
        "terseLabel": "Equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidsandothercurrentassetsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesMember": {
     "auth_ref": [
      "r23",
      "r31",
      "r306",
      "r916",
      "r951",
      "r952",
      "r953"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants.",
        "label": "Equity Securities [Member]",
        "terseLabel": "Total equity securities",
        "verboseLabel": "Equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansFairValuesofPlanAssetsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementScheduleofAvailableforsaleSecuritiesReconciliationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ExchangeTradedFundsMember": {
     "auth_ref": [
      "r533",
      "r790"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment that follows an index, commodity or basket of assets that trades similar to a stock on an exchange.",
        "label": "Exchange Traded Funds [Member]",
        "terseLabel": "Equity securities \u2014 exchange traded funds"
       }
      }
     },
     "localname": "ExchangeTradedFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r783",
      "r784",
      "r785",
      "r791"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisGainLossIncludedInEarnings": {
     "auth_ref": [
      "r789"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from asset and liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring Basis, Gain (Loss) Included in Earnings",
        "verboseLabel": "Fair value loss (gain)"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "auth_ref": [
      "r788"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of asset.",
        "label": "Asset Class [Domain]",
        "terseLabel": "Asset Class [Domain]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "auth_ref": [
      "r783",
      "r791"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of asset.",
        "label": "Asset Class [Axis]",
        "terseLabel": "Asset Class [Axis]"
       }
      }
     },
     "localname": "FairValueByAssetClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r438",
      "r454",
      "r455",
      "r533",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r584",
      "r784",
      "r849",
      "r850",
      "r851"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansFairValuesofPlanAssetsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "auth_ref": [
      "r790",
      "r791"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of liability.",
        "label": "Liability Class [Axis]",
        "terseLabel": "Liability Class [Axis]"
       }
      }
     },
     "localname": "FairValueByLiabilityClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueHedgingMember": {
     "auth_ref": [
      "r744"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A hedge of the exposure to changes in the fair value of a recognized asset or liability, or of an unrecognized firm commitment, that are attributable to a particular risk.",
        "label": "Fair Value Hedging [Member]",
        "verboseLabel": "Fair value hedging relationships"
       }
      }
     },
     "localname": "FairValueHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r438",
      "r533",
      "r535",
      "r540",
      "r584",
      "r784",
      "r849"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level\u00a01"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansFairValuesofPlanAssetsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r438",
      "r454",
      "r455",
      "r533",
      "r535",
      "r540",
      "r584",
      "r784",
      "r850"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansFairValuesofPlanAssetsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r438",
      "r454",
      "r455",
      "r533",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r584",
      "r784",
      "r851"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansFairValuesofPlanAssetsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "auth_ref": [
      "r788"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value.",
        "label": "Fair Value by Liability Class [Domain]",
        "terseLabel": "Fair Value by Liability Class [Domain]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r438",
      "r454",
      "r455",
      "r533",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r584",
      "r849",
      "r850",
      "r851"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansFairValuesofPlanAssetsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r792",
      "r795"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Financial Instruments Policy"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r749",
      "r756",
      "r772"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementDerivativesDesignatedasHedgingInstrumentsFairValuesofDerivativeInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementDerivativesNotDesignatedasHedgingInstrumentsFairValuesofDerivativeInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations": {
     "auth_ref": [
      "r175",
      "r649"
     ],
     "calculation": {
      "http://www.viatris.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current and deferred federal income tax expense (benefit) attributable to income (loss) from continuing operations.",
        "label": "Federal Income Tax Expense (Benefit), Continuing Operations",
        "totalLabel": "Income tax provision (benefit), U.S. Federal"
       }
      }
     },
     "localname": "FederalIncomeTaxExpenseBenefitContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r299",
      "r300",
      "r307",
      "r308",
      "r309",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r326",
      "r327",
      "r328",
      "r329",
      "r449",
      "r465",
      "r777",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873",
      "r874",
      "r875",
      "r876",
      "r980",
      "r981",
      "r982",
      "r983",
      "r984",
      "r985",
      "r986"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Schedule of Available-for-sale Securities, Major Types of Debt and Equity Securities [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementScheduleofAvailableforsaleSecuritiesReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentsDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.",
        "label": "Financial Instruments Disclosure [Text Block]",
        "terseLabel": "Financial Instruments And Risk Management"
       }
      }
     },
     "localname": "FinancialInstrumentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagement"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of finite-lived and indefinite-lived intangible assets acquired as part of a business combination.",
        "label": "Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]",
        "terseLabel": "Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination"
       }
      }
     },
     "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "verboseLabel": "Finite-lived intangible asset, estimated useful life, in years"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsComponentsofIntangibleAssetsDetails",
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r356"
     ],
     "calculation": {
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsComponentsofIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "verboseLabel": "Finite-lived intangible assets, accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsComponentsofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r358"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsGoodwillandOtherIntangibleAssetsFutureamortizationexpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life.",
        "label": "Finite-lived Intangible Assets Amortization Expense [Table Text Block]",
        "terseLabel": "Finite-lived Intangible Assets Amortization Expense [Table Text Block]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r358"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsGoodwillandOtherIntangibleAssetsFutureamortizationexpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r358"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsGoodwillandOtherIntangibleAssetsFutureamortizationexpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r358"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsGoodwillandOtherIntangibleAssetsFutureamortizationexpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r358"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsGoodwillandOtherIntangibleAssetsFutureamortizationexpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r349",
      "r352",
      "r356",
      "r360",
      "r881",
      "r882"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails",
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsProductRightsandLicensebyTherapeuticCategoryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r356",
      "r882"
     ],
     "calculation": {
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsComponentsofIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "verboseLabel": "Finite-lived intangible assets, original cost"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsComponentsofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Intangible Assets Excluding Goodwill [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails",
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r349",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails",
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsProductRightsandLicensebyTherapeuticCategoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets, excluding financial assets, that lack physical substance, having a limited useful life.",
        "label": "Finite-Lived Intangible Assets [Member]",
        "terseLabel": "Finite-Lived Intangible Assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r356",
      "r881"
     ],
     "calculation": {
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsComponentsofIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Finite-lived intangible assets, net",
        "totalLabel": "Finite-lived intangible assets, net book value"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsComponentsofIntangibleAssetsDetails",
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsProductRightsandLicensebyTherapeuticCategoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in carrying value of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Period Increase (Decrease)",
        "terseLabel": "Finite-Lived Intangible Assets, Period Increase (Decrease)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FixedIncomeSecuritiesMember": {
     "auth_ref": [
      "r533",
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment that provides a return in the form of fixed periodic payments and eventual return of principal at maturity.",
        "label": "Fixed Income Securities [Member]",
        "terseLabel": "Fixed income securities"
       }
      }
     },
     "localname": "FixedIncomeSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansFairValuesofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Foreign",
        "verboseLabel": "Foreign Tax Authority"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesNarrativeDetails",
      "http://www.viatris.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyContractAssetFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.",
        "label": "Foreign Currency Contract, Asset, Fair Value Disclosure",
        "terseLabel": "Foreign exchange derivative assets"
       }
      }
     },
     "localname": "ForeignCurrencyContractAssetFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.",
        "label": "Foreign Currency Contracts, Liability, Fair Value Disclosure",
        "terseLabel": "Foreign exchange derivative liabilities"
       }
      }
     },
     "localname": "ForeignCurrencyContractsLiabilityFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r814"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currencies Policy"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r87",
      "r533",
      "r765"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Foreign Exchange Contract",
        "verboseLabel": "Foreign currency borrowings and forward contracts"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementDerivativesNotDesignatedasHedgingInstrumentsFairValuesofDerivativeInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinNetInvestmentHedgingRelationshipDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofComprehensiveEarningsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesNotDesignatedasHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.",
        "label": "Foreign Exchange Forward [Member]",
        "terseLabel": "Foreign Exchange Forward"
       }
      }
     },
     "localname": "ForeignExchangeForwardMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementDerivativesDesignatedasHedgingInstrumentsFairValuesofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations": {
     "auth_ref": [
      "r175"
     ],
     "calculation": {
      "http://www.viatris.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current and deferred foreign income tax expense (benefit) attributable to income (loss) from continuing operations.",
        "label": "Foreign Income Tax Expense (Benefit), Continuing Operations",
        "totalLabel": "Income tax provision (benefit), Non-U.S."
       }
      }
     },
     "localname": "ForeignIncomeTaxExpenseBenefitContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings": {
     "auth_ref": [
      "r757"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total amount of gain (loss) derived from fair value hedges recognized in earnings in the period.",
        "label": "Gain (Loss) on Fair Value Hedges Recognized in Earnings",
        "terseLabel": "Gain (Loss) on Fair Value Hedges Recognized in Earnings"
       }
      }
     },
     "localname": "GainLossOnFairValueHedgesRecognizedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossRelatedToLitigationSettlement": {
     "auth_ref": [
      "r392"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.",
        "label": "Gain (Loss) Related to Litigation Settlement",
        "negatedLabel": "Litigation settlements and other contingencies, net",
        "terseLabel": "Litigation settlements &amp; other contingencies"
       }
      }
     },
     "localname": "GainLossRelatedToLitigationSettlement",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofOperations",
      "http://www.viatris.com/role/SegmentInformationReconciliationofSegmentInformationtoTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r338",
      "r339",
      "r843",
      "r885"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, net, ending balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails",
      "http://www.viatris.com/role/ConsolidatedBalanceSheets",
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountOfGoodwillDetails",
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r341"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountOfGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "verboseLabel": "Goodwill and Other Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "auth_ref": [
      "r345",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Intangible Assets and Goodwill Policy"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillGross": {
     "auth_ref": [
      "r340",
      "r344"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Gross",
        "periodEndLabel": "Goodwill, gross, ending balance",
        "periodStartLabel": "Goodwill, gross, beginning balance"
       }
      }
     },
     "localname": "GoodwillGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountOfGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": {
     "auth_ref": [
      "r340",
      "r344"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impaired, Accumulated Impairment Loss",
        "negatedPeriodEndLabel": "Accumulated impairment losses, ending balance",
        "negatedPeriodStartLabel": "Accumulated impairment losses, beginning balance",
        "terseLabel": "Goodwill, Impaired, Accumulated Impairment Loss"
       }
      }
     },
     "localname": "GoodwillImpairedAccumulatedImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountOfGoodwillDetails",
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountOfGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill [Member]",
        "terseLabel": "Goodwill [Member]"
       }
      }
     },
     "localname": "GoodwillMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GoodwillTransfers": {
     "auth_ref": [
      "r343"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfers into (out of) an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Transfers",
        "terseLabel": "Goodwill, Transfers"
       }
      }
     },
     "localname": "GoodwillTransfers",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountOfGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r342",
      "r343",
      "r696"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Translation and Purchase Accounting Adjustments",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "GoodwillTranslationAndPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountOfGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r127",
      "r174",
      "r253",
      "r259",
      "r263",
      "r266",
      "r269",
      "r315",
      "r408",
      "r409",
      "r410",
      "r413",
      "r414",
      "r415",
      "r417",
      "r419",
      "r421",
      "r422",
      "r800"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "terseLabel": "Gross loss",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofOperations",
      "http://www.viatris.com/role/EquityMethodInvestmentsIncomeStatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r747",
      "r768"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementDerivativesDesignatedasHedgingInstrumentsFairValuesofDerivativeInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementDerivativesNotDesignatedasHedgingInstrumentsFairValuesofDerivativeInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementDerivativesDesignatedasHedgingInstrumentsFairValuesofDerivativeInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementDerivativesNotDesignatedasHedgingInstrumentsFairValuesofDerivativeInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ConsolidatedStatementsofComprehensiveEarnings",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinNetInvestmentHedgingRelationshipDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofComprehensiveEarningsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesNotDesignatedasHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": {
     "auth_ref": [
      "r158",
      "r361"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.",
        "label": "Impairment of Intangible Assets, Finite-lived",
        "terseLabel": "Impairment of products rights and licenses intangible assets"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsFinitelived",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails",
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": {
     "auth_ref": [
      "r158",
      "r361"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.",
        "label": "Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)",
        "negatedLabel": "Intangible asset impairment charges",
        "terseLabel": "IPR&amp;D intangible asset impairment charges"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails",
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/SegmentInformationReconciliationofSegmentInformationtoTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r363",
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "terseLabel": "Impairment of Long-Lived Assets Policy"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.",
        "label": "In Process Research and Development [Member]",
        "verboseLabel": "In-process research and development"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails",
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r176",
      "r685"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "Earnings before income taxes and noncontrolling interest, United States"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r121",
      "r253",
      "r259",
      "r263",
      "r266",
      "r269",
      "r883",
      "r898",
      "r903",
      "r934"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "Operating and non-operating expense",
        "totalLabel": "(Loss) earnings before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofOperations",
      "http://www.viatris.com/role/EquityMethodInvestmentsIncomeStatementDetails",
      "http://www.viatris.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r176",
      "r685"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Earnings before income taxes and noncontrolling interest, foreign"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]",
        "terseLabel": "Earnings (loss) before income taxes and noncontrolling interest:"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r122",
      "r158",
      "r250",
      "r311",
      "r897",
      "r930"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedTerseLabel": "Loss from equity method investments"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.viatris.com/role/EquityMethodInvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r591",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r368",
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofComprehensiveEarningsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesNotDesignatedasHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofComprehensiveEarningsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesNotDesignatedasHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesNarrativeDetails",
      "http://www.viatris.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesNarrativeDetails",
      "http://www.viatris.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "auth_ref": [
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of taxing authority.",
        "label": "Income Tax Authority, Name [Axis]",
        "terseLabel": "Income Tax Authority, Name [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority, Name [Domain]",
        "terseLabel": "Income Tax Authority, Name [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxContingencyLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Contingency [Line Items]",
        "terseLabel": "Income Tax Contingency [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxContingencyLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesNarrativeDetails",
      "http://www.viatris.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails",
      "http://www.viatris.com/role/IncomeTaxesStatutoryTaxRatetoEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxContingencyTable": {
     "auth_ref": [
      "r655",
      "r662",
      "r664",
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Income Tax Contingency [Table]",
        "terseLabel": "Income Tax Contingency [Table]"
       }
      }
     },
     "localname": "IncomeTaxContingencyTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesNarrativeDetails",
      "http://www.viatris.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails",
      "http://www.viatris.com/role/IncomeTaxesStatutoryTaxRatetoEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r177",
      "r651",
      "r663",
      "r670",
      "r680",
      "r687",
      "r691",
      "r692",
      "r694"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExaminationInterestExpense": {
     "auth_ref": [
      "r652"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of estimated interest recognized in the period arising from income tax examinations.",
        "label": "Income Tax Examination, Interest Expense",
        "terseLabel": "Interest expense (income) related to uncertain tax positions"
       }
      }
     },
     "localname": "IncomeTaxExaminationInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r652"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations.",
        "label": "Income Tax Examination, Penalties and Interest Accrued",
        "terseLabel": "Accrued interest and penalties"
       }
      }
     },
     "localname": "IncomeTaxExaminationPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r178",
      "r205",
      "r206",
      "r251",
      "r649",
      "r681",
      "r689",
      "r935"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Income tax related to items of other comprehensive (loss) earnings, derivatives",
        "verboseLabel": "Income tax provision (benefit)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ConsolidatedStatementsofOperations",
      "http://www.viatris.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r114",
      "r645",
      "r646",
      "r663",
      "r664",
      "r669",
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes Policy"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r154",
      "r162"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableTrade": {
     "auth_ref": [
      "r157"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Payable, Trade",
        "terseLabel": "Trade accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableTrade",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r157"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r157"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r157"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "verboseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r157"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedLabel": "Other operating assets and liabilities, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": {
     "auth_ref": [
      "r653"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase reasonably possible in the next twelve months for the unrecognized tax benefit.",
        "label": "Increase in Unrecognized Tax Benefits is Reasonably Possible",
        "terseLabel": "Amount of unrecognized deferred tax liability"
       }
      }
     },
     "localname": "IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r211",
      "r212",
      "r213",
      "r218"
     ],
     "calculation": {
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesBasicAndDilutedEarningsPerOrdinaryShareAttributableToMylanNVDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Weighted average number diluted shares outstanding adjustment, stock-based awards and warrants"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesBasicAndDilutedEarningsPerOrdinaryShareAttributableToMylanNVDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r351",
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails",
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r359"
     ],
     "calculation": {
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsComponentsofIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "In-process research and development"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsComponentsofIntangibleAssetsDetails",
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r351",
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails",
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsComponentsofIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "totalLabel": "Intangible assets, gross, excluding goodwill"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsComponentsofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r347",
      "r354"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsComponentsofIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net",
        "totalLabel": "Intangible assets, net book value, excluding goodwill"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedBalanceSheets",
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsComponentsofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r119",
      "r247",
      "r815",
      "r818",
      "r902"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense",
        "verboseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseMember": {
     "auth_ref": [
      "r766"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing interest expense.",
        "label": "Interest Expense [Member]",
        "terseLabel": "Interest Expense [Member]"
       }
      }
     },
     "localname": "InterestExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesNotDesignatedasHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r148",
      "r153",
      "r162"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPayableCurrent": {
     "auth_ref": [
      "r14",
      "r15",
      "r67"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Interest Payable, Current",
        "terseLabel": "Accrued interest"
       }
      }
     },
     "localname": "InterestPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r764"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest rate swaps",
        "verboseLabel": "Interest rate swap derivatives"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementDerivativesDesignatedasHedgingInstrumentsFairValuesofDerivativeInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinNetInvestmentHedgingRelationshipDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesNotDesignatedasHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InternalRevenueServiceIRSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the United States of America government entitled to levy and collect income taxes from the entity.",
        "label": "Internal Revenue Service (IRS) [Member]",
        "terseLabel": "Internal Revenue Service (IRS)"
       }
      }
     },
     "localname": "InternalRevenueServiceIRSMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r48",
      "r334"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsInventoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryFirmPurchaseCommitmentLoss": {
     "auth_ref": [
      "r332"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss recognized on firm purchase commitment for inventory.",
        "label": "Inventory, Firm Purchase Commitment, Loss",
        "terseLabel": "Inventory, Firm Purchase Commitment, Loss"
       }
      }
     },
     "localname": "InventoryFirmPurchaseCommitmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r5",
      "r77",
      "r843"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsInventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.viatris.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "totalLabel": "Inventories",
        "verboseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsInventoriesDetails",
      "http://www.viatris.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory, Net [Abstract]",
        "terseLabel": "Inventory, Net [Abstract]"
       }
      }
     },
     "localname": "InventoryNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r16",
      "r78",
      "r169",
      "r223",
      "r330",
      "r331",
      "r335",
      "r878"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventories Policy"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r50",
      "r334"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsInventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRecallExpense": {
     "auth_ref": [
      "r129"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the amount charged against earnings comprised of the costs to announce and effect a recall of defective merchandise.",
        "label": "Inventory Recall Expense",
        "terseLabel": "Inventory Recall Expense"
       }
      }
     },
     "localname": "InventoryRecallExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryValuationReserves": {
     "auth_ref": [
      "r77",
      "r333"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation reserve for inventory.",
        "label": "Inventory Valuation Reserves",
        "terseLabel": "Inventory reserves"
       }
      }
     },
     "localname": "InventoryValuationReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r49",
      "r334"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsInventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work in process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "terseLabel": "Maturities Of Available-for-Sale Debt Securities At Fair Value"
       }
      }
     },
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LandAndLandImprovementsMember": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Real estate held and assets that are an addition or improvement to real estate held.",
        "label": "Land and Land Improvements [Member]",
        "terseLabel": "Land and improvements"
       }
      }
     },
     "localname": "LandAndLandImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r832"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Lease, Cost"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeasesOfLesseeDisclosureTextBlock": {
     "auth_ref": [
      "r823"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for lessee entity's leasing arrangements including, but not limited to, all of the following: (a.) The basis on which contingent rental payments are determined, (b.) The existence and terms of renewal or purchase options and escalation clauses, (c.) Restrictions imposed by lease agreements, such as those concerning dividends, additional debt, and further leasing.",
        "label": "Leases of Lessee Disclosure [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LeasesOfLesseeDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LegalEntityTypeOfCounterpartyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature of the other party participating in a financial transaction.",
        "label": "Legal Entity Type of Counterparty [Domain]",
        "terseLabel": "Legal Entity Type of Counterparty [Domain]"
       }
      }
     },
     "localname": "LegalEntityTypeOfCounterpartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails",
      "http://www.viatris.com/role/CommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LegalMattersAndContingenciesTextBlock": {
     "auth_ref": [
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.",
        "label": "Legal Matters and Contingencies [Text Block]",
        "terseLabel": "Contingencies"
       }
      }
     },
     "localname": "LegalMattersAndContingenciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/Litigation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LeasesLeaseInformationDetails",
      "http://www.viatris.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r829"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LeasesLeaseInformationDetails",
      "http://www.viatris.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1": {
     "auth_ref": [
      "r828"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease not yet commenced, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract",
        "terseLabel": "Term of operating leases not yet commenced"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r833"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Lessee, Operating Lease, Liability, Maturity"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r833"
     ],
     "calculation": {
      "http://www.viatris.com/role/LeasesLeaseMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.viatris.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r833"
     ],
     "calculation": {
      "http://www.viatris.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r833"
     ],
     "calculation": {
      "http://www.viatris.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r833"
     ],
     "calculation": {
      "http://www.viatris.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r833"
     ],
     "calculation": {
      "http://www.viatris.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r833"
     ],
     "calculation": {
      "http://www.viatris.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r833"
     ],
     "calculation": {
      "http://www.viatris.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r833"
     ],
     "calculation": {
      "http://www.viatris.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "terseLabel": "Less imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r827"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Remaining lease terms"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LeasesLeaseInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r835"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Lessee, Operating Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r66",
      "r174",
      "r261",
      "r315",
      "r408",
      "r409",
      "r410",
      "r413",
      "r414",
      "r415",
      "r417",
      "r419",
      "r421",
      "r422",
      "r728",
      "r734",
      "r735",
      "r800",
      "r841",
      "r842"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "terseLabel": "Total liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedBalanceSheets",
      "http://www.viatris.com/role/EquityMethodInvestmentsNetAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "verboseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r46",
      "r174",
      "r315",
      "r800",
      "r843",
      "r893",
      "r926"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "verboseLabel": "LIABILITIES AND EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r68",
      "r174",
      "r315",
      "r408",
      "r409",
      "r410",
      "r413",
      "r414",
      "r415",
      "r417",
      "r419",
      "r421",
      "r422",
      "r728",
      "r734",
      "r735",
      "r800",
      "r841",
      "r842",
      "r843"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "terseLabel": "Current liabilities",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedBalanceSheets",
      "http://www.viatris.com/role/EquityMethodInvestmentsNetAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "verboseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r783"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure",
        "terseLabel": "Total liabilities at recurring fair value measurement"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "auth_ref": [
      "r17",
      "r18",
      "r19",
      "r33",
      "r34",
      "r174",
      "r315",
      "r408",
      "r409",
      "r410",
      "r413",
      "r414",
      "r415",
      "r417",
      "r419",
      "r421",
      "r422",
      "r728",
      "r734",
      "r735",
      "r800",
      "r841",
      "r842"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.",
        "label": "Liabilities, Noncurrent",
        "terseLabel": "Noncurrent liabilities"
       }
      }
     },
     "localname": "LiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EquityMethodInvestmentsNetAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregated carrying amounts of obligations as of the balance sheet date, excluding long-term debt, incurred as part of the normal operations that are expected to be paid after one year or beyond the normal operating cycle, if longer. Alternate captions include Total Deferred Credits and Other Liabilities.",
        "label": "Liabilities, Other than Long-term Debt, Noncurrent",
        "terseLabel": "Liabilities, Other than Long-term Debt, Noncurrent"
       }
      }
     },
     "localname": "LiabilitiesOtherThanLongtermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOthernoncurrentliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUncertainTaxPositionsNoncurrent": {
     "auth_ref": [
      "r71"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for uncertainty in income taxes classified as noncurrent.",
        "label": "Liability for Uncertainty in Income Taxes, Noncurrent",
        "terseLabel": "Liability for Uncertainty in Income Taxes, Noncurrent"
       }
      }
     },
     "localname": "LiabilityForUncertainTaxPositionsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOthernoncurrentliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LicensingAgreementsMember": {
     "auth_ref": [
      "r707"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).",
        "label": "Licensing Agreements [Member]",
        "terseLabel": "Product rights and licenses"
       }
      }
     },
     "localname": "LicensingAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails",
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsProductRightsandLicensebyTherapeuticCategoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtRevolvingFacilitiesandTermFacilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r63"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Line of Credit Facility, Maximum Borrowing Capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtDebtReceivablesFacilityandCommercialPaperProgramDetails",
      "http://www.viatris.com/role/DebtRevolvingFacilitiesandTermFacilitiesDetails",
      "http://www.viatris.com/role/DebtSeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r63",
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtRevolvingFacilitiesandTermFacilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtRevolvingFacilitiesandTermFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LitigationReserve": {
     "auth_ref": [
      "r72",
      "r392"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.",
        "label": "Estimated Litigation Liability",
        "terseLabel": "Estimated Litigation Liability"
       }
      }
     },
     "localname": "LitigationReserve",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LitigationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationReserveCurrent": {
     "auth_ref": [
      "r72",
      "r392",
      "r401"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position.",
        "label": "Estimated Litigation Liability, Current",
        "terseLabel": "Estimated Litigation Liability, Current"
       }
      }
     },
     "localname": "LitigationReserveCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementAmountAwardedToOtherParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount awarded to other party in judgment or settlement of litigation.",
        "label": "Litigation Settlement, Amount Awarded to Other Party",
        "terseLabel": "Amount awarded to other party"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedToOtherParty",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LitigationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "London Interbank Offered Rate (LIBOR) [Member]"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtDebtReceivablesFacilityandCommercialPaperProgramDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r33",
      "r437",
      "r452",
      "r454",
      "r455",
      "r891",
      "r921"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtSeniorNotesDetails",
      "http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "terseLabel": "Current portion of long-term debt and other long-term obligations"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": {
     "auth_ref": [
      "r183",
      "r406",
      "r442"
     ],
     "calculation": {
      "http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r183",
      "r406",
      "r442"
     ],
     "calculation": {
      "http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "verboseLabel": "2021"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [
      "r183",
      "r406",
      "r442"
     ],
     "calculation": {
      "http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Five",
        "verboseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r183",
      "r406",
      "r442"
     ],
     "calculation": {
      "http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "verboseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r183",
      "r406",
      "r442"
     ],
     "calculation": {
      "http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "verboseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r183",
      "r406",
      "r442"
     ],
     "calculation": {
      "http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "verboseLabel": "2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtMinimumRepaymentsonOutstandingBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedBalanceSheets",
      "http://www.viatris.com/role/DebtIssuanceof2018SeniorNotesDetails",
      "http://www.viatris.com/role/DebtSeniorNotesDetails",
      "http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtFairValueNarrativeDetails",
      "http://www.viatris.com/role/DebtIssuanceof2018SeniorNotesDetails",
      "http://www.viatris.com/role/DebtRevolvingFacilitiesandTermFacilitiesDetails",
      "http://www.viatris.com/role/DebtSeniorNotesDetails",
      "http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails",
      "http://www.viatris.com/role/DebtUpjohnSeniorNotesDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r70",
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtFairValueNarrativeDetails",
      "http://www.viatris.com/role/DebtIssuanceof2018SeniorNotesDetails",
      "http://www.viatris.com/role/DebtRevolvingFacilitiesandTermFacilitiesDetails",
      "http://www.viatris.com/role/DebtSeniorNotesDetails",
      "http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails",
      "http://www.viatris.com/role/DebtUpjohnSeniorNotesDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongtermDebtWeightedAverageInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average interest rate of long-term debt outstanding calculated at point in time.",
        "label": "Long-term Debt, Weighted Average Interest Rate, at Point in Time",
        "terseLabel": "Long-term Debt, Weighted Average Interest Rate, at Point in Time"
       }
      }
     },
     "localname": "LongtermDebtWeightedAverageInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r392",
      "r393",
      "r394",
      "r396",
      "r397",
      "r398",
      "r400",
      "r403",
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingency Nature [Axis]",
        "terseLabel": "Loss Contingency Nature [Axis]"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LitigationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LitigationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r392",
      "r393",
      "r394",
      "r396",
      "r397",
      "r398",
      "r400",
      "r403",
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LitigationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r392"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual",
        "terseLabel": "Loss contingency accrual"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LitigationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyDamagesAwardedValue": {
     "auth_ref": [
      "r392",
      "r395",
      "r399"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of damages awarded to the plaintiff in the legal matter.",
        "label": "Loss Contingency, Damages Awarded, Value",
        "terseLabel": "Damages awarded"
       }
      }
     },
     "localname": "LossContingencyDamagesAwardedValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LitigationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyDamagesPaidValue": {
     "auth_ref": [
      "r392",
      "r395",
      "r399"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of damages paid to the plaintiff in the legal matter.",
        "label": "Loss Contingency, Damages Paid, Value",
        "terseLabel": "Loss contingency accrual"
       }
      }
     },
     "localname": "LossContingencyDamagesPaidValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LitigationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r392",
      "r393",
      "r394",
      "r396",
      "r397",
      "r398",
      "r400",
      "r403",
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency, Nature [Domain]",
        "terseLabel": "Loss Contingency, Nature [Domain]"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyPatentsAllegedlyInfringedNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of another entity's patents that the entity has allegedly infringed.",
        "label": "Loss Contingency, Patents Allegedly Infringed, Number",
        "terseLabel": "Loss Contingency, Patents Allegedly Infringed, Number"
       }
      }
     },
     "localname": "LossContingencyPatentsAllegedlyInfringedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LitigationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossContingencyPatentsFoundNotInfringedNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of another entity's patents that the entity was found not to have infringed.",
        "label": "Loss Contingency, Patents Found Not Infringed, Number",
        "terseLabel": "Loss Contingency, Patents Found Not Infringed, Number"
       }
      }
     },
     "localname": "LossContingencyPatentsFoundNotInfringedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LitigationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment [Member]",
        "verboseLabel": "Machinery and equipment"
       }
      }
     },
     "localname": "MachineryAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails",
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MarketableSecuritiesPolicy": {
     "auth_ref": [
      "r909"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment classified as marketable security.",
        "label": "Marketable Securities, Policy [Policy Text Block]",
        "terseLabel": "Marketable Securities Policy"
       }
      }
     },
     "localname": "MarketableSecuritiesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MaterialReconcilingItemsMember": {
     "auth_ref": [
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Items used in reconciling reportable segments' amounts to consolidated amount. Excludes corporate-level activity.",
        "label": "Segment Reconciling Items [Member]",
        "terseLabel": "Segment Reconciling"
       }
      }
     },
     "localname": "MaterialReconcilingItemsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/SegmentInformationReconciliationofSegmentInformationtoTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputControlPremiumMember": {
     "auth_ref": [
      "r786"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using amount above fair value that investor seeking to acquire control of entity will pay.",
        "label": "Measurement Input, Control Premium [Member]",
        "terseLabel": "Measurement Input, Control Premium [Member]"
       }
      }
     },
     "localname": "MeasurementInputControlPremiumMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "auth_ref": [
      "r786"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate to determine present value of future cash flows.",
        "label": "Measurement Input, Discount Rate [Member]",
        "terseLabel": "Measurement Input, Discount Rate [Member]"
       }
      }
     },
     "localname": "MeasurementInputDiscountRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputEbitdaMultipleMember": {
     "auth_ref": [
      "r786"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using earnings before interest, tax, depreciation and amortization (EBITDA) multiple.",
        "label": "Measurement Input, EBITDA Multiple [Member]",
        "terseLabel": "Measurement Input, EBITDA Multiple [Member]"
       }
      }
     },
     "localname": "MeasurementInputEbitdaMultipleMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputLongTermRevenueGrowthRateMember": {
     "auth_ref": [
      "r786"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using compounded annualized rate of long-term growth in revenue.",
        "label": "Measurement Input, Long-term Revenue Growth Rate [Member]",
        "terseLabel": "Measurement Input, Long-term Revenue Growth Rate [Member]"
       }
      }
     },
     "localname": "MeasurementInputLongTermRevenueGrowthRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r786"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MediumTermNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instruments with maturities ranging from five to ten years.",
        "label": "Medium-term Notes [Member]",
        "terseLabel": "Medium-term Notes"
       }
      }
     },
     "localname": "MediumTermNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByParent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.",
        "label": "Noncontrolling Interest, Ownership Percentage by Parent",
        "terseLabel": "Noncontrolling Interest, Ownership Percentage by Parent"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money market funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MortgageBackedSecuritiesMember": {
     "auth_ref": [
      "r289",
      "r533",
      "r535",
      "r584",
      "r948"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities collateralized by mortgage loans.",
        "label": "Collateralized Mortgage Backed Securities [Member]",
        "terseLabel": "Agency mortgage-backed securities"
       }
      }
     },
     "localname": "MortgageBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MovementInValuationAllowancesAndReservesRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]",
        "terseLabel": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]"
       }
      }
     },
     "localname": "MovementInValuationAllowancesAndReservesRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MultiemployerPlansWithdrawalObligation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the obligation recognized by withdrawing from a pension or postretirement benefit plan to which two or more unrelated employers contribute where assets contributed by one participating employer may be used to provide benefits to employees of other participating employers.",
        "label": "Multiemployer Plans, Withdrawal Obligation",
        "terseLabel": "Multiemployer plans, withdrawal obligation"
       }
      }
     },
     "localname": "MultiemployerPlansWithdrawalObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r228",
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "Nature of Operations [Text Block]",
        "terseLabel": "Nature of Operations"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/NatureofOperations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r151"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "verboseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r151"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "verboseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r151",
      "r156",
      "r159"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "auth_ref": [
      "r746"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedges of a net investment in a foreign operation.",
        "label": "Net Investment Hedging [Member]",
        "terseLabel": "Net Investment Hedging"
       }
      }
     },
     "localname": "NetInvestmentHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ConsolidatedStatementsofComprehensiveEarnings",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinNetInvestmentHedgingRelationshipDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "verboseLabel": "Recent Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "Other Foreign Operations"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesStatutoryTaxRatetoEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "Non-cash transactions:"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1": {
     "auth_ref": [
      "r163",
      "r164",
      "r165"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash consideration received for selling an asset or business through a noncash (or part noncash) transaction.",
        "label": "Noncash or Part Noncash Divestiture, Amount of Consideration Received",
        "terseLabel": "Equity consideration"
       }
      }
     },
     "localname": "NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Not designated as hedging instrument"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementDerivativesNotDesignatedasHedgingInstrumentsFairValuesofDerivativeInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "verboseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r253",
      "r259",
      "r263",
      "r266",
      "r269"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Segment profitability",
        "totalLabel": "(Loss) earnings from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofOperations",
      "http://www.viatris.com/role/SegmentInformationReconciliationofSegmentInformationtoTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r825"
     ],
     "calculation": {
      "http://www.viatris.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Total lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LeasesLeaseMaturitiesDetails",
      "http://www.viatris.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r825"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating Lease, Liability, Current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r826"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current operating lease liability.",
        "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r825"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating Lease, Liability, Noncurrent"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOthernoncurrentliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r826"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes noncurrent operating lease liability.",
        "label": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r824"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating Lease, Right-of-Use Asset",
        "verboseLabel": "Right-of-use asset"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails",
      "http://www.viatris.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r826"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes operating lease right-of-use asset.",
        "label": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r831",
      "r834"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted-average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LeasesLeaseInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r830",
      "r834"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted-average remaining lease term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LeasesLeaseInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLeasesRentExpenseNet": {
     "auth_ref": [
      "r821"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.",
        "label": "Operating Leases, Rent Expense, Net",
        "terseLabel": "Operating leases expense"
       }
      }
     },
     "localname": "OperatingLeasesRentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r671"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r258",
      "r259",
      "r260",
      "r261",
      "r263",
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/Restructuring2020RestructuringPlanDetails",
      "http://www.viatris.com/role/RestructuringNarrativeDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails",
      "http://www.viatris.com/role/SegmentInformationReconciliationofSegmentInformationtoTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r13",
      "r14",
      "r15",
      "r67"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other Accrued Liabilities, Current"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r79",
      "r843"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidsandothercurrentassetsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidsandothercurrentassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsMember": {
     "auth_ref": [
      "r749",
      "r772"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other assets.",
        "label": "Other Assets [Member]",
        "verboseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails",
      "http://www.viatris.com/role/EquityMethodInvestmentsBalanceSheetDetails",
      "http://www.viatris.com/role/EquityMethodInvestmentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.viatris.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "totalLabel": "Other assets",
        "verboseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails",
      "http://www.viatris.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets, Noncurrent [Abstract]",
        "terseLabel": "Other Assets, Noncurrent [Abstract]"
       }
      }
     },
     "localname": "OtherAssetsNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherCommitmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of other commitment.",
        "label": "Other Commitments [Axis]",
        "terseLabel": "Other Commitments [Axis]"
       }
      }
     },
     "localname": "OtherCommitmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherCommitmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other future obligation.",
        "label": "Other Commitments [Domain]",
        "terseLabel": "Other Commitments [Domain]"
       }
      }
     },
     "localname": "OtherCommitmentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherCommitmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Other Commitments [Line Items]",
        "terseLabel": "Other Commitments [Line Items]"
       }
      }
     },
     "localname": "OtherCommitmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherCommitmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about obligations resulting from other commitments.",
        "label": "Other Commitments [Table]",
        "terseLabel": "Other Commitments [Table]"
       }
      }
     },
     "localname": "OtherCommitmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r93",
      "r103",
      "r802",
      "r803",
      "r805"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofComprehensiveEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax",
        "terseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofComprehensiveEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax": {
     "auth_ref": [
      "r103",
      "r107",
      "r108",
      "r552"
     ],
     "calculation": {
      "http://www.viatris.com/role/EmployeeBenefitPlansNetPeriodicBenefitCostsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax",
        "negatedTerseLabel": "Amortization of prior service costs included in SG&amp;A"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax": {
     "auth_ref": [
      "r103",
      "r107",
      "r108",
      "r552"
     ],
     "calculation": {
      "http://www.viatris.com/role/EmployeeBenefitPlansChangeinAccumulatedIncomeLossRelatingtoDefinedBenefitPensionandOtherPostretirementBenefitsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, after Tax",
        "terseLabel": "Amortization of prior service costs"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansChangeinAccumulatedIncomeLossRelatingtoDefinedBenefitPensionandOtherPostretirementBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax": {
     "auth_ref": [
      "r95",
      "r96",
      "r103"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofComprehensiveEarnings": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and after adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax",
        "terseLabel": "Net unrealized (loss) gain on marketable securities"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ConsolidatedStatementsofComprehensiveEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": {
     "auth_ref": [
      "r106",
      "r115",
      "r116",
      "r806",
      "r808",
      "r812"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, before Tax",
        "terseLabel": "Other comprehensive earnings (loss) before reclassifications, before tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r106",
      "r115",
      "r116",
      "r118",
      "r806",
      "r808",
      "r812"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "terseLabel": "Derivative Financial Instruments in Net Investment Hedging Relationships:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinNetInvestmentHedgingRelationshipDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeTax": {
     "auth_ref": [
      "r115",
      "r116",
      "r123",
      "r312",
      "r806",
      "r811",
      "r812",
      "r899",
      "r931"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofComprehensiveEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax, after reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Tax",
        "terseLabel": "Other comprehensive (loss) earnings, before tax",
        "totalLabel": "Other comprehensive (loss) earnings, before tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ConsolidatedStatementsofComprehensiveEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), before Tax [Abstract]",
        "terseLabel": "Other comprehensive (loss) earnings, before tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofComprehensiveEarnings"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r94",
      "r103"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Net unrecognized loss on derivatives in cash flow hedging relationships, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": {
     "auth_ref": [
      "r94",
      "r103"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax",
        "terseLabel": "Derivative Financial Instruments in Cash Flow Hedging Relationships (2) :"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinNetInvestmentHedgingRelationshipDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r94",
      "r103",
      "r752",
      "r758",
      "r773"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofComprehensiveEarnings": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Net unrecognized gain (loss) on derivatives in hedging relationships"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofComprehensiveEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax": {
     "auth_ref": [
      "r94"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax, after reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).",
        "label": "Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, before Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax": {
     "auth_ref": [
      "r91",
      "r103"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax",
        "terseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r91"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinNetInvestmentHedgingRelationshipDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r110",
      "r113",
      "r115",
      "r116",
      "r118",
      "r123",
      "r466",
      "r806",
      "r811",
      "r812",
      "r899",
      "r931"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofComprehensiveEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive loss, net of tax",
        "totalLabel": "Other comprehensive (loss) earnings, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofComprehensiveEarnings",
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax": {
     "auth_ref": [
      "r100",
      "r103",
      "r552",
      "r584"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofComprehensiveEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax",
       "weight": -1.0
      },
      "http://www.viatris.com/role/EmployeeBenefitPlansChangeinAccumulatedIncomeLossRelatingtoDefinedBenefitPensionandOtherPostretirementBenefitsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax",
        "negatedTerseLabel": "Change in unrecognized loss and prior service cost related to defined benefit plans",
        "negatedTotalLabel": "Net change",
        "terseLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ConsolidatedStatementsofComprehensiveEarnings",
      "http://www.viatris.com/role/EmployeeBenefitPlansChangeinAccumulatedIncomeLossRelatingtoDefinedBenefitPensionandOtherPostretirementBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax": {
     "auth_ref": [
      "r98",
      "r103",
      "r552"
     ],
     "calculation": {
      "http://www.viatris.com/role/EmployeeBenefitPlansChangeinAccumulatedIncomeLossRelatingtoDefinedBenefitPensionandOtherPostretirementBenefitsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax",
        "terseLabel": "Unrecognized actuarial (gain) loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansChangeinAccumulatedIncomeLossRelatingtoDefinedBenefitPensionandOtherPostretirementBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax": {
     "auth_ref": [
      "r103",
      "r107",
      "r108",
      "r552"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax",
        "negatedLabel": "Amortization of actuarial loss included in SG&amp;A"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax": {
     "auth_ref": [
      "r103",
      "r107",
      "r108",
      "r552"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesNotDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossTax": {
     "auth_ref": [
      "r104",
      "r115",
      "r123",
      "r649",
      "r688",
      "r690",
      "r806",
      "r809",
      "r812",
      "r899",
      "r931"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofComprehensiveEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Tax",
        "terseLabel": "Income tax provision (benefit)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ConsolidatedStatementsofComprehensiveEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeOtherNetOfTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in other comprehensive income, after tax, from changes classified as other.",
        "label": "Other Comprehensive Income, Other, Net of Tax",
        "terseLabel": "Other Comprehensive Income, Other, Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeOtherNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentAssetsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for other current assets.",
        "label": "Other Current Assets [Text Block]",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherCurrentAssetsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current liabilities.",
        "label": "Other Current Liabilities [Member]",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementDerivativesDesignatedasHedgingInstrumentsFairValuesofDerivativeInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementDerivativesNotDesignatedasHedgingInstrumentsFairValuesofDerivativeInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails",
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/LitigationNarrativeDetails",
      "http://www.viatris.com/role/Restructuring2020RestructuringPlanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherDebtSecuritiesMember": {
     "auth_ref": [
      "r301",
      "r325",
      "r533",
      "r790"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments in debt securities classified as other.",
        "label": "Other Debt Obligations [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherExpenseMember": {
     "auth_ref": [
      "r766"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other expense.",
        "label": "Other Expense [Member]",
        "terseLabel": "Other income",
        "verboseLabel": "Other expense"
       }
      }
     },
     "localname": "OtherExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofComprehensiveEarningsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilities": {
     "auth_ref": [
      "r896"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other.",
        "label": "Other Liabilities",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails",
      "http://www.viatris.com/role/EquityMethodInvestmentsBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r12",
      "r13",
      "r67",
      "r843"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other Liabilities, Current",
        "verboseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsNarrativeDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails",
      "http://www.viatris.com/role/ConsolidatedBalanceSheets",
      "http://www.viatris.com/role/EquityMethodInvestmentsBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities, Current [Abstract]",
        "terseLabel": "Other Liabilities, Current [Abstract]"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of other liabilities.",
        "label": "Other Liabilities, Fair Value Disclosure",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "OtherLiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other Liabilities, Noncurrent",
        "verboseLabel": "Other long-term obligations"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOthernoncurrentliabilitiesDetails",
      "http://www.viatris.com/role/ConsolidatedBalanceSheets",
      "http://www.viatris.com/role/EquityMethodInvestmentsBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r159"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedLabel": "Other non-cash items"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other Noncurrent Liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOthernoncurrentliabilitiesDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails",
      "http://www.viatris.com/role/Restructuring2020RestructuringPlanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Table Text Block]",
        "terseLabel": "Other noncurrent liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r132"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedLabel": "Other (income) expense, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pension plan, other postretirement plan, and supplemental retirement plan, classified as other. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Other Pension, Postretirement and Supplemental Plans [Member]",
        "terseLabel": "Other Pension, Postretirement and Supplemental Plans"
       }
      }
     },
     "localname": "OtherPensionPlansPostretirementOrSupplementalPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": {
     "auth_ref": [
      "r504",
      "r505",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r532",
      "r533",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r555",
      "r557",
      "r558",
      "r561",
      "r564",
      "r569",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.",
        "label": "Other Postretirement Benefits Plan [Member]",
        "terseLabel": "Other Postretirement Benefits"
       }
      }
     },
     "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansAccumulatedOtherComprehensiveIncomeLossPretaxAmountsNotYetReclassifiedinNetPeriodicBenefitCostDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansChangeinAccumulatedIncomeLossRelatingtoDefinedBenefitPensionandOtherPostretirementBenefitsDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansChangesinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansEstimatedFutureBenefitPaymentsDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansNetAccruedBenefitCostsClassificationonBalanceSheetDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansNetPeriodicBenefitCostsDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain": {
     "auth_ref": [
      "r501",
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred compensation related to other postretirement benefit arrangements that are not equivalent to a defined benefit other postretirement benefit plan. Includes, but is not limited to, employment contracts with one or more selected officers or key employees. Excludes equity-based compensation plans, defined benefit pension plans and defined benefit other postretirement benefit plans.",
        "label": "Other Postretirement Benefits, Individual Contracts, Type of Deferred Compensation [Domain]",
        "terseLabel": "Other Postretirement Benefits, Individual Contracts, Type of Deferred Compensation [Domain]"
       }
      }
     },
     "localname": "OtherPostretirementBenefitsIndividualContractsTypeOfDeferredCompensationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.",
        "label": "Other Receivables, Net, Current",
        "terseLabel": "Other receivables"
       }
      }
     },
     "localname": "OtherReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAccountsreceivablenetDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherRestructuringMember": {
     "auth_ref": [
      "r375",
      "r376",
      "r385",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring and related activities classified as other.",
        "label": "Other Restructuring [Member]",
        "terseLabel": "Other Restructuring"
       }
      }
     },
     "localname": "OtherRestructuringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/Restructuring2020RestructuringPlanDetails",
      "http://www.viatris.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1": {
     "auth_ref": [
      "r163",
      "r164",
      "r165"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of the noncash (or part noncash) consideration given (for example, liability, equity) in a transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of a transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Other Significant Noncash Transaction, Value of Consideration Given",
        "terseLabel": "Common stock issued for the Combination"
       }
      }
     },
     "localname": "OtherSignificantNoncashTransactionValueOfConsiderationGiven1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": {
     "auth_ref": [
      "r146"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
        "label": "Payment for Contingent Consideration Liability, Financing Activities",
        "terseLabel": "Payment for Contingent Consideration Liability, Financing Activities"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r137",
      "r140"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedLabel": "Payments for product rights and other, net"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRent": {
     "auth_ref": [
      "r155"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash payments to lessor's for use of assets under operating leases.",
        "label": "Payments for Rent",
        "terseLabel": "Payments for Rent"
       }
      }
     },
     "localname": "PaymentsForRent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r149",
      "r376"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedTerseLabel": "Payments for Restructuring"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/Restructuring2020RestructuringPlanDetails",
      "http://www.viatris.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfFinancingCosts": {
     "auth_ref": [
      "r147"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for loan and debt issuance costs.",
        "label": "Payments of Financing Costs",
        "negatedLabel": "Payments of financing fees"
       }
      }
     },
     "localname": "PaymentsOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities": {
     "auth_ref": [
      "r147"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for financing costs associated with business combinations.",
        "label": "Payments of Merger Related Costs, Financing Activities",
        "negatedTerseLabel": "Contingent consideration payments"
       }
      }
     },
     "localname": "PaymentsOfMergerRelatedCostsFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r144"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedTerseLabel": "Taxes paid related to net share settlement of equity awards"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r138",
      "r715"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Cash paid to acquire asset"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/DebtFairValueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r138"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Cash received (paid) for acquisitions, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "auth_ref": [
      "r287"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for purchase of marketable security.",
        "label": "Payments to Acquire Marketable Securities",
        "negatedLabel": "Purchase of marketable securities"
       }
      }
     },
     "localname": "PaymentsToAcquireMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r139"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToMinorityShareholders": {
     "auth_ref": [
      "r147"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.",
        "label": "Payments to Noncontrolling Interests",
        "negatedTerseLabel": "Cash dividends paid"
       }
      }
     },
     "localname": "PaymentsToMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r532",
      "r534",
      "r540",
      "r559",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r584",
      "r586",
      "r587",
      "r589",
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "Employee Benefits"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities": {
     "auth_ref": [
      "r32",
      "r505",
      "r506",
      "r530",
      "r584"
     ],
     "calculation": {
      "http://www.viatris.com/role/EmployeeBenefitPlansNetAccruedBenefitCostsClassificationonBalanceSheetDetails": {
       "order": 2.0,
       "parentTag": "vtrs_Netaccruedbenefitcosts",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.",
        "label": "Liability, Defined Benefit Plan, Current",
        "negatedTerseLabel": "Current liabilities"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansNetAccruedBenefitCostsClassificationonBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": {
     "auth_ref": [
      "r35",
      "r505",
      "r506",
      "r530",
      "r584"
     ],
     "calculation": {
      "http://www.viatris.com/role/EmployeeBenefitPlansNetAccruedBenefitCostsClassificationonBalanceSheetDetails": {
       "order": 3.0,
       "parentTag": "vtrs_Netaccruedbenefitcosts",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.",
        "label": "Liability, Defined Benefit Plan, Noncurrent",
        "negatedTerseLabel": "Noncurrent liabilities"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansNetAccruedBenefitCostsClassificationonBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionPlansDefinedBenefitMember": {
     "auth_ref": [
      "r503",
      "r505",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r532",
      "r533",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r555",
      "r557",
      "r558",
      "r561",
      "r564",
      "r569",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r589",
      "r590",
      "r597",
      "r598",
      "r599",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.",
        "label": "Pension Plan [Member]",
        "terseLabel": "Pension Benefits"
       }
      }
     },
     "localname": "PensionPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansAccumulatedOtherComprehensiveIncomeLossPretaxAmountsNotYetReclassifiedinNetPeriodicBenefitCostDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansChangeinAccumulatedIncomeLossRelatingtoDefinedBenefitPensionandOtherPostretirementBenefitsDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansChangesinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansEffectofOnePercentagePointIncreaseorDecreaseinHealthCareCostTrendRatesDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansEstimatedFutureBenefitPaymentsDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansNetAccruedBenefitCostsClassificationonBalanceSheetDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansNetPeriodicBenefitCostsDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansPlanswithPBOinExcessofPlanAssetsDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance Shares"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails",
      "http://www.viatris.com/role/ShareBasedIncentivePlanValuationAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanAssetCategoriesDomain": {
     "auth_ref": [
      "r532",
      "r533",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r561",
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Domain]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Domain]"
       }
      }
     },
     "localname": "PlanAssetCategoriesDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansFairValuesofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r606",
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails",
      "http://www.viatris.com/role/ShareBasedIncentivePlanTables",
      "http://www.viatris.com/role/ShareBasedIncentivePlanValuationAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails",
      "http://www.viatris.com/role/ShareBasedIncentivePlanTables",
      "http://www.viatris.com/role/ShareBasedIncentivePlanValuationAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r8",
      "r54",
      "r55"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidsandothercurrentassetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.viatris.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "totalLabel": "Prepaid expenses and other current assets",
        "verboseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidsandothercurrentassetsDetails",
      "http://www.viatris.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Expense and Other Assets, Current [Abstract]",
        "terseLabel": "Prepaid Expense and Other Assets, Current [Abstract]"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "auth_ref": [
      "r7",
      "r9",
      "r336",
      "r337"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidsandothercurrentassetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense, Current",
        "terseLabel": "Prepaid expenses"
       }
      }
     },
     "localname": "PrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidsandothercurrentassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementDerivativesDesignatedasHedgingInstrumentsFairValuesofDerivativeInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementDerivativesNotDesignatedasHedgingInstrumentsFairValuesofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average number of shares or units and dilutive common stock or unit equivalents outstanding in the calculation of proforma diluted earnings per share (earnings per unit), which is commonly presented in initial public offerings based on the terms of the offering.",
        "label": "Pro Forma Weighted Average Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)"
       }
      }
     },
     "localname": "ProFormaWeightedAverageSharesOutstandingDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r135"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "terseLabel": "Proceeds from sale of assets and subsidiaries"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails",
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r142"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-term Debt",
        "verboseLabel": "Proceeds from issuance of long-term debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r143",
      "r147"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other items, net"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfShortTermDebt": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Proceeds from (Repayments of) Short-term Debt",
        "terseLabel": "Change in short-term borrowings, net"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndCollectionOfReceivables": {
     "auth_ref": [
      "r137"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the proceeds from sale and collection of receivables during the period.",
        "label": "Proceeds from Sale and Collection of Receivables",
        "terseLabel": "Proceeds from Sale and Collection of Receivables"
       }
      }
     },
     "localname": "ProceedsFromSaleAndCollectionOfReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAccountsreceivablenetDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.",
        "label": "Proceeds from Sale and Maturity of Marketable Securities",
        "terseLabel": "Proceeds from the sale of marketable securities"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r136"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "terseLabel": "Proceeds from sale of property, plant and equipment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities": {
     "auth_ref": [
      "r152"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received from sale of investments in debt and equity securities, classified as operating activities, during the period; includes trading securities and any other investments classified as operating.",
        "label": "Proceeds from Sale of Securities, Operating Activities",
        "terseLabel": "Proceeds from Sale of Securities, Operating Activities"
       }
      }
     },
     "localname": "ProceedsFromSaleOfSecuritiesOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r141",
      "r634"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductAndServiceOtherMember": {
     "auth_ref": [
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery and act of providing assistance, classified as other.",
        "label": "Product and Service, Other [Member]",
        "terseLabel": "Other revenues"
       }
      }
     },
     "localname": "ProductAndServiceOtherMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]",
        "terseLabel": "Net sales"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/ConsolidatedStatementsofOperations",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r3",
      "r109",
      "r112",
      "r117",
      "r150",
      "r174",
      "r197",
      "r205",
      "r206",
      "r253",
      "r259",
      "r263",
      "r266",
      "r269",
      "r315",
      "r408",
      "r409",
      "r410",
      "r413",
      "r414",
      "r415",
      "r417",
      "r419",
      "r421",
      "r422",
      "r726",
      "r730",
      "r731",
      "r737",
      "r738",
      "r782",
      "r800",
      "r903"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.viatris.com/role/ConsolidatedStatementsofComprehensiveEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.viatris.com/role/ConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "netLabel": "Net (loss) earnings",
        "terseLabel": "Net earnings",
        "totalLabel": "Net (loss) earnings",
        "verboseLabel": "Net loss"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.viatris.com/role/ConsolidatedStatementsofComprehensiveEarnings",
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity",
      "http://www.viatris.com/role/ConsolidatedStatementsofOperations",
      "http://www.viatris.com/role/EquityMethodInvestmentsIncomeStatementDetails",
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesBasicAndDilutedEarningsPerOrdinaryShareAttributableToMylanNVDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r60",
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails",
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r59",
      "r365"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property, plant and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]",
        "verboseLabel": "Accounting Policies [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails",
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r24",
      "r25",
      "r367",
      "r843",
      "r910",
      "r928"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.viatris.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net",
        "totalLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails",
      "http://www.viatris.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r58",
      "r367",
      "r956",
      "r957"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property, Plant and Equipment Policy"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r24",
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r24",
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails",
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Property, plant and equipment, estimated service life (years)"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ReceivableTypeDomain": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates.",
        "label": "Receivable [Domain]",
        "terseLabel": "Receivable [Domain]"
       }
      }
     },
     "localname": "ReceivableTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationRollforwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReceivablesNetCurrent": {
     "auth_ref": [
      "r42",
      "r47",
      "r843",
      "r927",
      "r950"
     ],
     "calculation": {
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.",
        "label": "Receivables, Net, Current",
        "terseLabel": "Trade receivables, net",
        "verboseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "ReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAccountsreceivablenetDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesNetCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivables, Net, Current [Abstract]",
        "terseLabel": "Receivables, Net, Current [Abstract]"
       }
      }
     },
     "localname": "ReceivablesNetCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Axis]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Axis]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Domain]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Domain]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Member]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r145"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayments of Debt",
        "terseLabel": "Repayments of Debt"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtRevolvingFacilitiesandTermFacilitiesDetails",
      "http://www.viatris.com/role/DebtSeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r145"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedLabel": "Payments of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of fair value of reporting unit in excess of carrying amount.",
        "label": "Reporting Unit, Amount of Fair Value in Excess of Carrying Amount",
        "terseLabel": "Reporting Unit, Amount of Fair Value in Excess of Carrying Amount"
       }
      }
     },
     "localname": "ReportingUnitAmountOfFairValueInExcessOfCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of fair value of reporting unit in excess of carrying amount.",
        "label": "Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount",
        "terseLabel": "Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount"
       }
      }
     },
     "localname": "ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r643",
      "r879",
      "r971"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "negatedTerseLabel": "Globally managed research and development costs",
        "verboseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails",
      "http://www.viatris.com/role/ConsolidatedStatementsofOperations",
      "http://www.viatris.com/role/SegmentInformationReconciliationofSegmentInformationtoTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development Policy"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedCash": {
     "auth_ref": [
      "r166",
      "r884",
      "r923"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash",
        "terseLabel": "Restricted Cash"
       }
      }
     },
     "localname": "RestrictedCash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r4",
      "r20",
      "r160",
      "r166"
     ],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsBalanceSheetComponentsCashandCashEquivalentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents, Current",
        "terseLabel": "Restricted cash",
        "verboseLabel": "Restricted cash, included in other current and non-current assets"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsBalanceSheetComponentsCashandCashEquivalentsDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsPrepaidsandothercurrentassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis": {
     "auth_ref": [
      "r56"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by category of cash or cash equivalent items which are restricted as to withdrawal or usage.",
        "label": "Restricted Cash and Cash Equivalents [Axis]",
        "terseLabel": "Restricted Cash and Cash Equivalents [Axis]"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Domain]",
        "terseLabel": "Cash and Cash Equivalents [Domain]"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted stock"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Awards"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails",
      "http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after value of shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.",
        "label": "Restricted Stock, Value, Shares Issued Net of Tax Withholdings",
        "terseLabel": "Issuance of restricted stock and stock options exercised, net"
       }
      }
     },
     "localname": "RestrictedStockValueSharesIssuedNetOfTaxWithholdings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r374",
      "r376",
      "r379",
      "r389",
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Restructuring and Related Activities Disclosure [Text Block]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/Restructuring"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected cost remaining for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Expected Cost Remaining",
        "terseLabel": "Restructuring and Related Cost, Expected Cost Remaining"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostExpectedCostRemaining1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/Restructuring2020RestructuringPlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The expected number of positions to be eliminated as a result of restructuring activities.",
        "label": "Restructuring and Related Cost, Expected Number of Positions Eliminated",
        "terseLabel": "Restructuring and Related Cost, Expected Number of Positions Eliminated"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/Restructuring2020RestructuringPlanDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_RestructuringAndRelatedCostIncurredCost": {
     "auth_ref": [
      "r375",
      "r378",
      "r385",
      "r388"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost.",
        "label": "Restructuring and Related Cost, Incurred Cost",
        "terseLabel": "Restructuring and Related Cost, Incurred Cost"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostIncurredCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/Restructuring2020RestructuringPlanDetails",
      "http://www.viatris.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r158",
      "r373",
      "r382",
      "r385"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Restructuring and Related Cost, Cost Incurred to Date"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/Restructuring2020RestructuringPlanDetails",
      "http://www.viatris.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r375",
      "r376",
      "r385",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/Restructuring2020RestructuringPlanDetails",
      "http://www.viatris.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/Restructuring2020RestructuringPlanDetails",
      "http://www.viatris.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/Restructuring2020RestructuringPlanDetails",
      "http://www.viatris.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/Restructuring2020RestructuringPlanDetails",
      "http://www.viatris.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r376",
      "r383"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "terseLabel": "Restructuring Reserve"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/Restructuring2020RestructuringPlanDetails",
      "http://www.viatris.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveCurrent": {
     "auth_ref": [
      "r32",
      "r376",
      "r386"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.",
        "label": "Restructuring Reserve, Current",
        "terseLabel": "Restructuring Reserve, Current"
       }
      }
     },
     "localname": "RestructuringReserveCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveNoncurrent": {
     "auth_ref": [
      "r81",
      "r376",
      "r386"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of known and estimated costs associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid after one year or beyond the next operating cycle, if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.",
        "label": "Restructuring Reserve, Noncurrent",
        "terseLabel": "Restructuring Reserve, Noncurrent"
       }
      }
     },
     "localname": "RestructuringReserveNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOthernoncurrentliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReservePeriodIncreaseDecrease": {
     "auth_ref": [
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the accrual for restructuring costs.",
        "label": "Restructuring Reserve, Period Increase (Decrease)",
        "negatedTerseLabel": "Restructuring Reserve, Period Increase (Decrease)"
       }
      }
     },
     "localname": "RestructuringReservePeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveSettledWithoutCash2": {
     "auth_ref": [
      "r376",
      "r386"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in the reserve for full or partial settlement through consideration other than cash.",
        "label": "Restructuring Reserve, Settled without Cash",
        "terseLabel": "Restructuring Reserve, Settled without Cash"
       }
      }
     },
     "localname": "RestructuringReserveSettledWithoutCash2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/Restructuring2020RestructuringPlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveTranslationAndOtherAdjustment": {
     "auth_ref": [
      "r376",
      "r383"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the restructuring reserve related to foreign currency translation (gain) loss and other increases (decreases).",
        "label": "Restructuring Reserve, Translation and Other Adjustment",
        "terseLabel": "Restructuring Reserve, Translation and Other Adjustment"
       }
      }
     },
     "localname": "RestructuringReserveTranslationAndOtherAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/Restructuring2020RestructuringPlanDetails",
      "http://www.viatris.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r44",
      "r471",
      "r638",
      "r843",
      "r925",
      "r945",
      "r947"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r193",
      "r194",
      "r195",
      "r198",
      "r204",
      "r206",
      "r318",
      "r635",
      "r636",
      "r637",
      "r678",
      "r679",
      "r780",
      "r942",
      "r944"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "verboseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity",
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesBasicAndDilutedEarningsPerOrdinaryShareAttributableToMylanNVDetails",
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r503",
      "r504",
      "r505",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r532",
      "r533",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r555",
      "r557",
      "r558",
      "r561",
      "r564",
      "r569",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r597",
      "r598",
      "r599",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansAccumulatedOtherComprehensiveIncomeLossPretaxAmountsNotYetReclassifiedinNetPeriodicBenefitCostDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansChangeinAccumulatedIncomeLossRelatingtoDefinedBenefitPensionandOtherPostretirementBenefitsDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansChangesinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansEffectofOnePercentagePointIncreaseorDecreaseinHealthCareCostTrendRatesDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansEstimatedFutureBenefitPaymentsDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansNetAccruedBenefitCostsClassificationonBalanceSheetDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansNetPeriodicBenefitCostsDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansPlanswithPBOinExcessofPlanAssetsDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r503",
      "r504",
      "r505",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r532",
      "r533",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r555",
      "r557",
      "r558",
      "r561",
      "r564",
      "r569",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r597",
      "r598",
      "r599",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansAccumulatedOtherComprehensiveIncomeLossPretaxAmountsNotYetReclassifiedinNetPeriodicBenefitCostDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansChangeinAccumulatedIncomeLossRelatingtoDefinedBenefitPensionandOtherPostretirementBenefitsDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansChangesinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansEffectofOnePercentagePointIncreaseorDecreaseinHealthCareCostTrendRatesDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansEstimatedFutureBenefitPaymentsDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansNetAccruedBenefitCostsClassificationonBalanceSheetDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansNetPeriodicBenefitCostsDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansPlanswithPBOinExcessofPlanAssetsDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r244",
      "r245",
      "r258",
      "r264",
      "r265",
      "r272",
      "r273",
      "r276",
      "r490",
      "r491",
      "r880"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Net sales",
        "verboseLabel": "Net sales"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ConsolidatedStatementsofOperations",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableDisaggregationofRevenuebyKeyProductsDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails",
      "http://www.viatris.com/role/SegmentInformationNetThirdPartySalesClassifiedBasedonGeographicLocationofEntityDetails",
      "http://www.viatris.com/role/SegmentInformationReconciliationofSegmentInformationtoTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r170",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue Recognition Policy"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r492",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue Recognition and Accounts Receivable"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivable"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueNotFromContractWithCustomer": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue that is not accounted for under Topic 606.",
        "label": "Revenue Not from Contract with Customer",
        "terseLabel": "Other revenues"
       }
      }
     },
     "localname": "RevenueNotFromContractWithCustomer",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r120",
      "r174",
      "r244",
      "r245",
      "r258",
      "r264",
      "r265",
      "r272",
      "r273",
      "r276",
      "r315",
      "r408",
      "r409",
      "r410",
      "r413",
      "r414",
      "r415",
      "r417",
      "r419",
      "r421",
      "r422",
      "r800",
      "r903"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "totalLabel": "Total revenues",
        "verboseLabel": "Total revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofOperations",
      "http://www.viatris.com/role/EquityMethodInvestmentsIncomeStatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "verboseLabel": "Revenues:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenues from External Customers and Long-Lived Assets [Line Items]",
        "terseLabel": "Revenues from External Customers and Long-Lived Assets [Line Items]"
       }
      }
     },
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/SegmentInformationNetThirdPartySalesClassifiedBasedonGeographicLocationofEntityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtRevolvingFacilitiesandTermFacilitiesDetails",
      "http://www.viatris.com/role/DebtSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesMember": {
     "auth_ref": [
      "r766"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing revenue from sale of goods and services rendered in the normal course of business.",
        "label": "Sales [Member]",
        "terseLabel": "Sales [Member]"
       }
      }
     },
     "localname": "SalesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesNotDesignatedasHedgingInstrumentsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinCashFlowHedgingRelationshipsDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r235",
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Third party net sales"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/SegmentInformationThirdPartyNetSalesbyMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScenarioPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The scenario under which facts represent plans as distinct from actual.",
        "label": "Scenario, Plan [Member]",
        "terseLabel": "Scenario, Plan"
       }
      }
     },
     "localname": "ScenarioPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]",
        "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAccountsreceivablenetDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableNarrativeDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationRollforwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "terseLabel": "Schedule of Accounts Receivable, Net"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.",
        "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accounts Payable and Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r106",
      "r811",
      "r812"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans.  This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.",
        "label": "Schedule of Allocation of Plan Assets [Table Text Block]",
        "terseLabel": "Schedule of Allocation of Plan Assets"
       }
      }
     },
     "localname": "ScheduleOfAllocationOfPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock": {
     "auth_ref": [
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts that are recognized in the balance sheet (or statement of financial position) for pension plans and/or other employee benefit plans, showing separately the assets and current and noncurrent liabilities (if applicable) recognized.",
        "label": "Schedule of Amounts Recognized in Balance Sheet [Table Text Block]",
        "terseLabel": "Net Accrued Benefit Costs Classification on Balance Sheet"
       }
      }
     },
     "localname": "ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost.",
        "label": "Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Change in Accumulated Income (Loss) Relating to Defined Benefit Pension and Other Postretirement Benefits"
       }
      }
     },
     "localname": "ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAssumptionsUsedTableTextBlock": {
     "auth_ref": [
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.",
        "label": "Defined Benefit Plan, Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Assumptions Used"
       }
      }
     },
     "localname": "ScheduleOfAssumptionsUsedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementScheduleofAvailableforsaleSecuritiesReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.",
        "label": "Schedule of Available-for-sale Securities Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Available-for-Sale Securities Reconciliation"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesTable": {
     "auth_ref": [
      "r295",
      "r298",
      "r302",
      "r303",
      "r304",
      "r305",
      "r905",
      "r906"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.",
        "label": "Schedule of Available-for-sale Securities [Table]",
        "terseLabel": "Schedule of Available-for-sale Securities [Table]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementScheduleofAvailableforsaleSecuritiesReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r570",
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of benefit obligation and plan assets for defined benefit pension plan with projected benefit obligation in excess of plan assets.",
        "label": "Defined Benefit Plan, Plan with Projected Benefit Obligation in Excess of Plan Assets [Table Text Block]",
        "terseLabel": "Plans with Accumulated Benefit Obligation in Excess of Plan Assets"
       }
      }
     },
     "localname": "ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.",
        "label": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]",
        "terseLabel": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r701",
      "r702"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails",
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "auth_ref": [
      "r722"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "terseLabel": "Schedule of Collaborative Arrangements and Non-collaborative Arrangement Transactions [Table]"
       }
      }
     },
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of Components of Income Tax Provision"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions  designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.",
        "label": "Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Components of Other Comprehensive Loss"
       }
      }
     },
     "localname": "ScheduleOfComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "verboseLabel": "Summary of Long-Term Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r668"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r568",
      "r569",
      "r572",
      "r573",
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans.  Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansFairValuesofPlanAssetsDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r750",
      "r762",
      "r768"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "verboseLabel": "Effect of Derivative Instruments on the Consolidated Statements of Operations"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r756"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "verboseLabel": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Earnings Per Common Share Attributable To Mylan"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable": {
     "auth_ref": [
      "r210",
      "r214",
      "r216",
      "r218",
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The table contains disclosure pertaining to an entity's basic earnings per share.",
        "label": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]",
        "terseLabel": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicByCommonClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesBasicAndDilutedEarningsPerOrdinaryShareAttributableToMylanNVDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Statutory Tax Rate to Effective Tax Rate Reconciliation"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable": {
     "auth_ref": [
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure about the extent of the entity's reliance on its major customers.",
        "label": "Schedule of Revenue by Major Customers, by Reporting Segments [Table]",
        "terseLabel": "Schedule of Revenue by Major Customers, by Reporting Segments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/SegmentInformationThirdPartyNetSalesbyMajorCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Equity Method Investments [Line Items]",
        "terseLabel": "Schedule of Equity Method Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsNarrativeDetails",
      "http://www.viatris.com/role/EquityMethodInvestmentsBalanceSheetDetails",
      "http://www.viatris.com/role/EquityMethodInvestmentsIncomeStatementDetails",
      "http://www.viatris.com/role/EquityMethodInvestmentsNarrativeDetails",
      "http://www.viatris.com/role/EquityMethodInvestmentsNetAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsTable": {
     "auth_ref": [
      "r3",
      "r174",
      "r314",
      "r315",
      "r800"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.",
        "label": "Schedule of Equity Method Investments [Table]",
        "terseLabel": "Schedule of Equity Method Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsNarrativeDetails",
      "http://www.viatris.com/role/EquityMethodInvestmentsBalanceSheetDetails",
      "http://www.viatris.com/role/EquityMethodInvestmentsIncomeStatementDetails",
      "http://www.viatris.com/role/EquityMethodInvestmentsNarrativeDetails",
      "http://www.viatris.com/role/EquityMethodInvestmentsNetAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock": {
     "auth_ref": [
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.",
        "label": "Schedule of Expected Benefit Payments [Table Text Block]",
        "terseLabel": "Schedule of Expected Benefit Payments"
       }
      }
     },
     "localname": "ScheduleOfExpectedBenefitPaymentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r783",
      "r784"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "verboseLabel": "Financial Assets and Liabilities Carried at Fair Value"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r349",
      "r355",
      "r881"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r349",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "verboseLabel": "Components of intangible assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r345",
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountOfGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r345",
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "verboseLabel": "Changes in carrying amount of goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r16",
      "r51",
      "r52",
      "r53"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-term Debt [Table Text Block]",
        "verboseLabel": "Minimum Repayments on Outstanding Borrowings"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": {
     "auth_ref": [
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.",
        "label": "Schedule of Net Benefit Costs [Table Text Block]",
        "terseLabel": "Net Periodic Benefit Cost"
       }
      }
     },
     "localname": "ScheduleOfNetBenefitCostsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock": {
     "auth_ref": [
      "r553"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts related to pension plans and/or other employee benefit plans in accumulated other comprehensive income or loss that have not yet been recognized as components of net periodic benefit cost, such as the net gain (loss), net prior service cost or credit, and net transition asset or obligation.",
        "label": "Schedule of Net Periodic Benefit Cost Not yet Recognized [Table Text Block]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) Pretax Amounts Not Yet Reclassified in Net Periodic Benefit Cost"
       }
      }
     },
     "localname": "ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of noncurrent assets.",
        "label": "Schedule of Other Assets, Noncurrent [Table Text Block]",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "ScheduleOfOtherAssetsNoncurrentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amounts of other current assets.",
        "label": "Schedule of Other Current Assets [Table Text Block]",
        "terseLabel": "Schedule of Other Current Assets"
       }
      }
     },
     "localname": "ScheduleOfOtherCurrentAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r60",
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Schedule of Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfPropertySubjectToOrAvailableForOperatingLeaseTextBlock": {
     "auth_ref": [
      "r367",
      "r822",
      "r836"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessor's underlying asset for which right to use has been conveyed to lessee under operating lease.",
        "label": "Property, Plant, and Equipment, Lessor Asset under Operating Lease [Table Text Block]",
        "terseLabel": "Schedule of Property Subject to or Available for Operating Lease"
       }
      }
     },
     "localname": "ScheduleOfPropertySubjectToOrAvailableForOperatingLeaseTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r705"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r375",
      "r376",
      "r377",
      "r378",
      "r385",
      "r386",
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/Restructuring2020RestructuringPlanDetails",
      "http://www.viatris.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r380",
      "r381",
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Restructuring and Related Costs [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/RestructuringTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer.",
        "label": "Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]",
        "terseLabel": "Schedule of Revenue by Major Customers by Reporting Segments"
       }
      }
     },
     "localname": "ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock": {
     "auth_ref": [
      "r126",
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]",
        "terseLabel": "Net Third Party Sales Classified Based on Geographic Location of Subsidiaries"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "auth_ref": [
      "r120",
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/SegmentInformationNetThirdPartySalesClassifiedBasedonGeographicLocationofEntityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r253",
      "r256",
      "r262",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/SegmentInformationReconciliationofSegmentInformationtoTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r253",
      "r256",
      "r262",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "verboseLabel": "Reconciliation of Segment Information to Total Consolidated Information"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r606",
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails",
      "http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails",
      "http://www.viatris.com/role/ShareBasedIncentivePlanTables",
      "http://www.viatris.com/role/ShareBasedIncentivePlanValuationAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r612",
      "r623",
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "verboseLabel": "Stock Awards Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "verboseLabel": "Stock-Based Compensation Plans, Valuation Assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Nonvested Restricted Stock and Restricted Stock Unit, Including Performance Units, Activity"
       }
      }
     },
     "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShortTermDebtTable": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
        "label": "Schedule of Short-term Debt [Table]",
        "terseLabel": "Schedule of Short-term Debt [Table]"
       }
      }
     },
     "localname": "ScheduleOfShortTermDebtTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtShorttermborrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShortTermDebtTextBlock": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
        "label": "Schedule of Short-term Debt [Table Text Block]",
        "terseLabel": "Schedule of Short-term Debt"
       }
      }
     },
     "localname": "ScheduleOfShortTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock": {
     "auth_ref": [
      "r662"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits, excluding amounts pertaining to examined tax returns.",
        "label": "Schedule of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns Roll Forward [Table Text Block]",
        "terseLabel": "Schedule of Unrecognized Tax Benefits"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r241",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r258",
      "r259",
      "r260",
      "r261",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r269",
      "r276",
      "r378",
      "r388",
      "r936"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountOfGoodwillDetails",
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsProductRightsandLicensebyTherapeuticCategoryDetails",
      "http://www.viatris.com/role/Restructuring2020RestructuringPlanDetails",
      "http://www.viatris.com/role/RestructuringNarrativeDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationDetails",
      "http://www.viatris.com/role/SegmentInformationReconciliationofSegmentInformationtoTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r241",
      "r242",
      "r243",
      "r253",
      "r257",
      "r263",
      "r267",
      "r268",
      "r269",
      "r270",
      "r272",
      "r275",
      "r276",
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "verboseLabel": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/SegmentInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/SegmentInformationReconciliationofSegmentInformationtoTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r130"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "verboseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "verboseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtFairValueNarrativeDetails",
      "http://www.viatris.com/role/DebtIssuanceof2018SeniorNotesDetails",
      "http://www.viatris.com/role/DebtSeniorNotesDetails",
      "http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails",
      "http://www.viatris.com/role/DebtUpjohnSeniorNotesDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember": {
     "auth_ref": [
      "r702"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the aggregation and reporting of combined amounts of individually immaterial business combinations that were completed during the period.",
        "label": "Series of Individually Immaterial Business Acquisitions [Member]",
        "terseLabel": "Series of Individually Immaterial Business Acquisitions"
       }
      }
     },
     "localname": "SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r157"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "verboseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Stock option award vesting period, in years"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Number of restricted stock awards, forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "verboseLabel": "Weighted average grant-date fair value per share, forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r620"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "verboseLabel": "Number of restricted stock awards, granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails",
      "http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r620"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "verboseLabel": "Weighted average grant-date fair value per share, granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Number of restricted stock awards, nonvested ending balance",
        "periodStartLabel": "Number of restricted stock awards, nonvested beginning balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Weighted average grant-date fair value per share, nonvested ending balance",
        "periodStartLabel": "Weighted average grant-date fair value per share, nonvested beginning balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Number of restricted stock awards, released"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "verboseLabel": "Weighted average grant-date fair value per share, released"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails",
      "http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails",
      "http://www.viatris.com/role/ShareBasedIncentivePlanTables",
      "http://www.viatris.com/role/ShareBasedIncentivePlanValuationAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r609"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "verboseLabel": "Amount of common stock shares authorized"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r615"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "periodEndLabel": "Number of shares under stock awards, exercisable at period end"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r615"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "verboseLabel": "Weighted average exercise price per share, exercisable at period end"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Number of shares under stock awards, forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "verboseLabel": "Number of shares under stock awards, granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average grant date fair value per option"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanValuationAssumptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r633"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "verboseLabel": "Aggregate intrinsic value for options outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r614",
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Number of shares under stock awards, outstanding at end of period",
        "periodStartLabel": "Number of shares under stock awards, outstanding at beginning of period",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails",
      "http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Weighted average exercise price per share, outstanding at end of period",
        "periodStartLabel": "Weightedaverage exercise price per share, outstanding at beginning of period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r626"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "periodEndLabel": "Number of shares under stock awards, vested and expected to vest at period end"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r626"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Weighted average exercise price per share, vested and expected to vest at period end"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r604",
      "r610"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails",
      "http://www.viatris.com/role/ShareBasedIncentivePlanNonvestedRestrictedStockRestrictedStockUnitsandPSUsActivityDetails",
      "http://www.viatris.com/role/ShareBasedIncentivePlanValuationAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "verboseLabel": "Weighted average exercise price per share, exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "verboseLabel": "Weighted average exercise price per share, forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "verboseLabel": "Weighted average exercise price per share, granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r606",
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Stock-Based Compensation Policy"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Stock option award expiration period, in years"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r628",
      "r639"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term (years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanValuationAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "verboseLabel": "Average remaining contractual term for options exercisable, in years"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r626"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "verboseLabel": "Average remaining contractual term for options outstanding, in years"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r626"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "verboseLabel": "Average remaining contractual term for options vested and expected to vest, in years"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "periodEndLabel": "Balance (in shares)",
        "periodStartLabel": "Balance (in shares)",
        "terseLabel": "Shares issued"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermBorrowings": {
     "auth_ref": [
      "r29",
      "r843",
      "r888",
      "r920"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.",
        "label": "Short-term Debt",
        "terseLabel": "Short-term borrowings",
        "verboseLabel": "Short-term borrowings"
       }
      }
     },
     "localname": "ShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedBalanceSheets",
      "http://www.viatris.com/role/DebtDebtReceivablesFacilityandCommercialPaperProgramDetails",
      "http://www.viatris.com/role/DebtShorttermborrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermDebtLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Short-term Debt [Line Items]",
        "terseLabel": "Short-term Debt [Line Items]"
       }
      }
     },
     "localname": "ShortTermDebtLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtShorttermborrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of short-term debt arrangement.",
        "label": "Short-term Debt, Type [Axis]",
        "terseLabel": "Short-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "ShortTermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtDebtReceivablesFacilityandCommercialPaperProgramDetails",
      "http://www.viatris.com/role/DebtShorttermborrowingsDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "auth_ref": [
      "r62"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.",
        "label": "Short-term Debt, Type [Domain]",
        "terseLabel": "Short-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "ShortTermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtDebtReceivablesFacilityandCommercialPaperProgramDetails",
      "http://www.viatris.com/role/DebtShorttermborrowingsDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r167",
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary Of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use.",
        "label": "Software and Software Development Costs [Member]",
        "terseLabel": "Capitalized software"
       }
      }
     },
     "localname": "SoftwareAndSoftwareDevelopmentCostsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations": {
     "auth_ref": [
      "r175",
      "r649",
      "r681"
     ],
     "calculation": {
      "http://www.viatris.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of state and local current and deferred income tax expense (benefit) attributable to continuing operations.",
        "label": "State and Local Income Tax Expense (Benefit), Continuing Operations",
        "totalLabel": "Income tax provision (benefit), U.S. State"
       }
      }
     },
     "localname": "StateAndLocalIncomeTaxExpenseBenefitContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r2",
      "r241",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r258",
      "r259",
      "r260",
      "r261",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r269",
      "r276",
      "r345",
      "r369",
      "r378",
      "r388",
      "r936"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountOfGoodwillDetails",
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsProductRightsandLicensebyTherapeuticCategoryDetails",
      "http://www.viatris.com/role/Restructuring2020RestructuringPlanDetails",
      "http://www.viatris.com/role/RestructuringNarrativeDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationDetails",
      "http://www.viatris.com/role/SegmentInformationReconciliationofSegmentInformationtoTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r39",
      "r40",
      "r41",
      "r172",
      "r174",
      "r210",
      "r214",
      "r215",
      "r216",
      "r218",
      "r225",
      "r226",
      "r227",
      "r315",
      "r408",
      "r413",
      "r414",
      "r415",
      "r421",
      "r422",
      "r459",
      "r460",
      "r463",
      "r464",
      "r466",
      "r800",
      "r980"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails",
      "http://www.viatris.com/role/ConsolidatedStatementsofEquityParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r75",
      "r115",
      "r116",
      "r117",
      "r193",
      "r194",
      "r195",
      "r198",
      "r204",
      "r206",
      "r224",
      "r318",
      "r466",
      "r471",
      "r635",
      "r636",
      "r637",
      "r678",
      "r679",
      "r780",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r812",
      "r942",
      "r943",
      "r944",
      "r1015"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheCondensedConsolidatedStatementsofComprehensiveEarningsDerivativesinNetInvestmentHedgingRelationshipDetails",
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesBasicAndDilutedEarningsPerOrdinaryShareAttributableToMylanNVDetails",
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.viatris.com/role/ConsolidatedStatementsofComprehensiveEarnings",
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity",
      "http://www.viatris.com/role/ConsolidatedStatementsofEquityParenthetical",
      "http://www.viatris.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r193",
      "r194",
      "r195",
      "r224",
      "r880"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]",
        "verboseLabel": "Accounting Policies [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.viatris.com/role/ConsolidatedStatementsofComprehensiveEarnings",
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity",
      "http://www.viatris.com/role/ConsolidatedStatementsofEquityParenthetical",
      "http://www.viatris.com/role/ConsolidatedStatementsofOperations",
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "auth_ref": [
      "r40",
      "r41",
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.",
        "label": "Stock Issued During Period, Shares, Acquisitions",
        "terseLabel": "Issuance of common stock for the Combination (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r40",
      "r41",
      "r466",
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Issuance of common stock to Mylan N.V. shareholders (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r40",
      "r41",
      "r466",
      "r471",
      "r617"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Number of shares under stock awards, exercised",
        "terseLabel": "Number of shares exercised"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails",
      "http://www.viatris.com/role/ShareBasedIncentivePlanStockAwardsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "auth_ref": [
      "r75",
      "r466",
      "r471"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued pursuant to acquisitions during the period.",
        "label": "Stock Issued During Period, Value, Acquisitions",
        "terseLabel": "Issuance of common stock for the Combination"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r40",
      "r41",
      "r466",
      "r471"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Stock Issued During Period, Value, New Issues"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r75",
      "r466",
      "r471"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "verboseLabel": "Issuance of restricted stock and stock options exercised, net"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock Repurchase Program, Authorized Amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "verboseLabel": "Viatris Inc. shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r1",
      "r116",
      "r174",
      "r193",
      "r194",
      "r195",
      "r198",
      "r204",
      "r315",
      "r318",
      "r471",
      "r635",
      "r636",
      "r637",
      "r678",
      "r679",
      "r724",
      "r725",
      "r736",
      "r780",
      "r800",
      "r806",
      "r807",
      "r812",
      "r943",
      "r944",
      "r1015"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "terseLabel": "Total equity",
        "totalLabel": "Total equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ConsolidatedBalanceSheets",
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "verboseLabel": "Equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r813",
      "r844"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LitigationNarrativeDetails",
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r813",
      "r844"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LitigationNarrativeDetails",
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r813",
      "r844"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/LitigationNarrativeDetails",
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "auth_ref": [
      "r89"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "verboseLabel": "Balance Sheet Components"
       }
      }
     },
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Elements [Abstract]",
        "terseLabel": "Supplemental disclosures of cash flow information \u2014"
       }
      }
     },
     "localname": "SupplementalCashFlowElementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "verboseLabel": "Cash paid during the period for:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplyCommitmentArrangementMember": {
     "auth_ref": [
      "r36",
      "r892",
      "r922"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item is intended to be populated, by the entity, with Members identifying each supply commitment about which information required or determined to be disclosed is being provided. If only one such commitment exists, this item may be used to capture such information; if multiple commitments exist, this item is the dimensional default, which will aggregate such information, as appropriate.",
        "label": "Supply Commitment Arrangement [Domain]",
        "terseLabel": "Supply Commitment Arrangement [Domain]"
       }
      }
     },
     "localname": "SupplyCommitmentArrangementMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SupplyCommitmentAxis": {
     "auth_ref": [
      "r36",
      "r892",
      "r922"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by arrangements in which the entity has committed resources to supply goods or services to a customer.",
        "label": "Supply Commitment [Axis]",
        "terseLabel": "Supply Commitment [Axis]"
       }
      }
     },
     "localname": "SupplyCommitmentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "auth_ref": [
      "r671"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Tax Credit Carryforward, Amount",
        "terseLabel": "Credit carryforward"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxPeriodAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about the period subject to enacted tax laws.",
        "label": "Tax Period [Axis]",
        "terseLabel": "Tax Period [Axis]"
       }
      }
     },
     "localname": "TaxPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxPeriodDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identified tax period.",
        "label": "Tax Period [Domain]",
        "terseLabel": "Tax Period [Domain]"
       }
      }
     },
     "localname": "TaxPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TaxYear2015Member": {
     "auth_ref": [
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identified as tax year 2015.",
        "label": "Tax Year 2015 [Member]",
        "terseLabel": "Tax Year 2015"
       }
      }
     },
     "localname": "TaxYear2015Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "auth_ref": [
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for accounts receivable.",
        "label": "Accounts Receivable [Policy Text Block]",
        "terseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r299",
      "r300",
      "r307",
      "r308",
      "r309",
      "r449",
      "r465",
      "r777",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873",
      "r874",
      "r875",
      "r876",
      "r980",
      "r981",
      "r982",
      "r983",
      "r984",
      "r985",
      "r986"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementScheduleofAvailableforsaleSecuritiesReconciliationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r74",
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockRetiredCostMethodAmount": {
     "auth_ref": [
      "r41",
      "r466",
      "r472"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease of par value, additional paid in capital (APIC) and retained earnings of common and preferred stock retired from treasury when treasury stock is accounted for under the cost method.",
        "label": "Treasury Stock, Retired, Cost Method, Amount",
        "negatedTerseLabel": "Retirement of Mylan N.V. treasury stock, net"
       }
      }
     },
     "localname": "TreasuryStockRetiredCostMethodAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockSharesRetired": {
     "auth_ref": [
      "r41",
      "r466",
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common and preferred stock retired from treasury during the period.",
        "label": "Treasury Stock, Shares, Retired",
        "negatedTerseLabel": "Cancellation of restricted stock"
       }
      }
     },
     "localname": "TreasuryStockSharesRetired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r722"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "terseLabel": "Type of Arrangement and Non-arrangement Transactions [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r375",
      "r376",
      "r385",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/Restructuring2020RestructuringPlanDetails",
      "http://www.viatris.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "auth_ref": [
      "r179",
      "r533",
      "r584",
      "r904"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).",
        "label": "US Treasury Securities [Member]",
        "terseLabel": "U.S. Treasuries"
       }
      }
     },
     "localname": "USTreasurySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnamortizedDebtIssuanceExpense": {
     "auth_ref": [
      "r61"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.",
        "label": "Unamortized Debt Issuance Expense",
        "negatedTerseLabel": "Unamortized Debt Issuance Expense"
       }
      }
     },
     "localname": "UnamortizedDebtIssuanceExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r644",
      "r656"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Unrecognized tax benefit\u00a0\u2014 end of year",
        "terseLabel": "Unrecognized tax benefit\u00a0\u2014 beginning of year",
        "verboseLabel": "Unrecognized tax benefit"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesNarrativeDetails",
      "http://www.viatris.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromAcquisition": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from acquisitions.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Acquisition",
        "negatedTerseLabel": "Unrecognized Tax Benefits, Decrease Resulting from Acquisition"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r657"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "negatedTerseLabel": "Reductions for prior year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": {
     "auth_ref": [
      "r659"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities",
        "negatedTerseLabel": "Settlements"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from acquisitions.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Acquisition",
        "terseLabel": "(Reduction) addition due to acquisition"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r658"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Additions for current year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r657"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Additions for prior year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r660"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "negatedTerseLabel": "Reductions due to expirations of statute of limitations"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r661"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Unrecognized tax benefits that impact effective tax rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnusualOrInfrequentItemAxis": {
     "auth_ref": [
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by an event or transaction that is unusual in nature or infrequent in occurrence, or both.",
        "label": "Unusual or Infrequent Item, or Both [Axis]",
        "terseLabel": "Unusual or Infrequent Item, or Both [Axis]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsNarrativeDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnusualOrInfrequentItemDomain": {
     "auth_ref": [
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event or transaction that is unusual in nature or infrequent in occurrence, or both.",
        "label": "Unusual or Infrequent Item, or Both [Domain]",
        "terseLabel": "Unusual or Infrequent Item, or Both [Domain]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsNarrativeDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r229",
      "r230",
      "r232",
      "r233",
      "r237",
      "r238",
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates in the Preparation of Financial Statements Policy"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember": {
     "auth_ref": [
      "r184",
      "r185",
      "r186",
      "r189",
      "r190"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation allowance of deferred tax asset attributable to deductible temporary difference and carryforward.",
        "label": "SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]",
        "terseLabel": "Valuation allowance for deferred tax assets"
       }
      }
     },
     "localname": "ValuationAllowanceOfDeferredTaxAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "auth_ref": [
      "r184",
      "r190"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesBalance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsNarrativeDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails",
      "http://www.viatris.com/role/ValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": {
     "auth_ref": [
      "r187"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense",
        "terseLabel": "Additions Charged to Costs and Expenses"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts": {
     "auth_ref": [
      "r188"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to accounts other than cost and expense.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account",
        "terseLabel": "Additions Charged to Other Accounts"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToOtherAccounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDeductions": {
     "auth_ref": [
      "r189"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction",
        "negatedTerseLabel": "Deductions"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDeductions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDomain": {
     "auth_ref": [
      "r184",
      "r185",
      "r186",
      "r189",
      "r190"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsNarrativeDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails",
      "http://www.viatris.com/role/ValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesTypeAxis": {
     "auth_ref": [
      "r184",
      "r185",
      "r186",
      "r189",
      "r190"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsNarrativeDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails",
      "http://www.viatris.com/role/ValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ValuationTechniqueAxis": {
     "auth_ref": [
      "r786"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation approach and technique.",
        "label": "Valuation Approach and Technique [Axis]",
        "terseLabel": "Valuation Approach and Technique [Axis]"
       }
      }
     },
     "localname": "ValuationTechniqueAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ValuationTechniqueDiscountedCashFlowMember": {
     "auth_ref": [
      "r786"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation technique calculating present value of future cash flows.",
        "label": "Valuation Technique, Discounted Cash Flow [Member]",
        "terseLabel": "Valuation Technique, Discounted Cash Flow"
       }
      }
     },
     "localname": "ValuationTechniqueDiscountedCashFlowMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationTechniqueDomain": {
     "auth_ref": [
      "r786"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation approach and technique.",
        "label": "Valuation Approach and Technique [Domain]",
        "terseLabel": "Valuation Approach and Technique [Domain]"
       }
      }
     },
     "localname": "ValuationTechniqueDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtDebtReceivablesFacilityandCommercialPaperProgramDetails",
      "http://www.viatris.com/role/DebtSeniorNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/DebtDebtReceivablesFacilityandCommercialPaperProgramDetails",
      "http://www.viatris.com/role/DebtSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageBasicSharesOutstandingProForma": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average number of shares (units) outstanding in the calculation of pro forma basic earnings per share (earnings per unit), which is commonly presented in initial public offerings based on the terms of the offering.",
        "label": "Weighted Average Basic Shares Outstanding, Pro Forma",
        "terseLabel": "Basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageBasicSharesOutstandingProForma",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r209",
      "r218"
     ],
     "calculation": {
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesBasicAndDilutedEarningsPerOrdinaryShareAttributableToMylanNVDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "totalLabel": "Total dilutive shares outstanding",
        "verboseLabel": "Diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofOperations",
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesBasicAndDilutedEarningsPerOrdinaryShareAttributableToMylanNVDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "verboseLabel": "Weighted average shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r208",
      "r218"
     ],
     "calculation": {
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesBasicAndDilutedEarningsPerOrdinaryShareAttributableToMylanNVDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted average common shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofOperations",
      "http://www.viatris.com/role/SummaryofSignificantAccountingPoliciesBasicAndDilutedEarningsPerOrdinaryShareAttributableToMylanNVDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WriteOffOfDeferredDebtIssuanceCost": {
     "auth_ref": [
      "r131"
     ],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt."
       }
      }
     },
     "localname": "WriteOffOfDeferredDebtIssuanceCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "monetaryItemType"
    },
    "vtrs_A2014ProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2014 Program",
        "label": "2014 Program [Member]",
        "terseLabel": "2014 Program"
       }
      }
     },
     "localname": "A2014ProgramMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails",
      "http://www.viatris.com/role/ShareBasedIncentivePlanTables",
      "http://www.viatris.com/role/ShareBasedIncentivePlanValuationAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2016RestructuringProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2016 Restructuring Program",
        "label": "2016 Restructuring Program [Member]",
        "terseLabel": "2016 Restructuring Program"
       }
      }
     },
     "localname": "A2016RestructuringProgramMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2016SeniorRevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2016 Senior Revolving Credit Facility [Member]",
        "label": "2016 Senior Revolving Credit Facility [Member]",
        "terseLabel": "2016 Senior Revolving Credit Facility"
       }
      }
     },
     "localname": "A2016SeniorRevolvingCreditFacilityMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtRevolvingFacilitiesandTermFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2016TermLoansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2016 Term Loans [Member]",
        "label": "2016 Term Loans [Member]",
        "terseLabel": "2016 Term Loans"
       }
      }
     },
     "localname": "A2016TermLoansMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtRevolvingFacilitiesandTermFacilitiesDetails",
      "http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2018SeniorRevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2018 Senior Revolving Credit Facility [Member]",
        "label": "2018 Senior Revolving Credit Facility [Member]",
        "terseLabel": "2018 Senior Revolving Credit Facility [Member]"
       }
      }
     },
     "localname": "A2018SeniorRevolvingCreditFacilityMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtRevolvingFacilitiesandTermFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2020EuroSeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2020 Euro Senior Notes [Member]",
        "label": "2020 Euro Senior Notes [Member]",
        "terseLabel": "2020 Euro Senior Notes"
       }
      }
     },
     "localname": "A2020EuroSeniorNotesMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtSeniorNotesDetails",
      "http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2020FloatingRateEuroNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2020 Floating Rate Euro Notes",
        "label": "2020 Floating Rate Euro Notes [Member]",
        "terseLabel": "2020 Floating Rate Euro Notes"
       }
      }
     },
     "localname": "A2020FloatingRateEuroNotesMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtSeniorNotesDetails",
      "http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2020RestructuringPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2020 Restructuring Plan",
        "label": "2020 Restructuring Plan [Member]",
        "terseLabel": "2020 Restructuring Plan"
       }
      }
     },
     "localname": "A2020RestructuringPlanMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/Restructuring2020RestructuringPlanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2020RevolvingFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2020 Revolving Facility",
        "label": "2020 Revolving Facility [Member]",
        "terseLabel": "2020 Revolving Facility"
       }
      }
     },
     "localname": "A2020RevolvingFacilityMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2020 Stock Incentive Plan and 2003 Long-Term Incentive Plan",
        "label": "2020 Stock Incentive Plan and 2003 Long-Term Incentive Plan [Member]",
        "terseLabel": "2020 Stock Incentive Plan and 2003 Long-Term Incentive Plan"
       }
      }
     },
     "localname": "A2020StockIncentivePlanAnd2003LongTermIncentivePlanMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2022EuroSeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2022 Euro Senior Notes",
        "label": "2022 Euro Senior Notes [Member]",
        "terseLabel": "2022 Euro Senior Notes"
       }
      }
     },
     "localname": "A2022EuroSeniorNotesMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails",
      "http://www.viatris.com/role/DebtUpjohnSeniorNotesDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2022SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2022 Senior Notes",
        "label": "2022 Senior Notes [Member]",
        "terseLabel": "2022 Senior Notes"
       }
      }
     },
     "localname": "A2022SeniorNotesMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtUpjohnSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2024EuroSeniorNotes1023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2024 Euro Senior Notes, 1.023%",
        "label": "2024 Euro Senior Notes, 1.023% [Member]",
        "terseLabel": "2.125% Euro Senior Notes due 2025"
       }
      }
     },
     "localname": "A2024EuroSeniorNotes1023Member",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2024EuroSeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2024 Euro Senior Notes [Member]",
        "label": "2024 Euro Senior Notes [Member]",
        "terseLabel": "2.250% Euro Senior Notes due 2024"
       }
      }
     },
     "localname": "A2024EuroSeniorNotesMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtSeniorNotesDetails",
      "http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails",
      "http://www.viatris.com/role/DebtUpjohnSeniorNotesDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2025EuroSeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2025 Euro Senior Notes [Member]",
        "label": "2025 Euro Senior Notes [Member]",
        "terseLabel": "2025 Euro Senior Notes"
       }
      }
     },
     "localname": "A2025EuroSeniorNotesMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtSeniorNotesDetails",
      "http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2025SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2025 Senior Notes",
        "label": "2025 Senior Notes [Member]",
        "terseLabel": "2025 Senior Notes"
       }
      }
     },
     "localname": "A2025SeniorNotesMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails",
      "http://www.viatris.com/role/DebtUpjohnSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2027EuroSeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2027 Euro Senior Notes",
        "label": "2027 Euro Senior Notes [Member]",
        "terseLabel": "2027 Euro Senior Notes"
       }
      }
     },
     "localname": "A2027EuroSeniorNotesMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails",
      "http://www.viatris.com/role/DebtUpjohnSeniorNotesDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2027SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2027 Senior Notes",
        "label": "2027 Senior Notes [Member]",
        "terseLabel": "2027 Senior Notes"
       }
      }
     },
     "localname": "A2027SeniorNotesMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails",
      "http://www.viatris.com/role/DebtUpjohnSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2028EuroSeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2028 Euro Senior Notes [Member]",
        "label": "2028 Euro Senior Notes [Member]",
        "terseLabel": "2028 Euro Senior Notes"
       }
      }
     },
     "localname": "A2028EuroSeniorNotesMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtSeniorNotesDetails",
      "http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2028SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2028 Senior Notes [Member] [Member]",
        "label": "2028 Senior Notes [Member]",
        "terseLabel": "2028 Senior Notes"
       }
      }
     },
     "localname": "A2028SeniorNotesMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtIssuanceof2018SeniorNotesDetails",
      "http://www.viatris.com/role/DebtSeniorNotesDetails",
      "http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2030SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2030 Senior Notes",
        "label": "2030 Senior Notes [Member]",
        "terseLabel": "2030 Senior Notes"
       }
      }
     },
     "localname": "A2030SeniorNotesMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails",
      "http://www.viatris.com/role/DebtUpjohnSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2032EuroSeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2032 Euro Senior Notes",
        "label": "2032 Euro Senior Notes [Member]",
        "terseLabel": "2032 Euro Senior Notes"
       }
      }
     },
     "localname": "A2032EuroSeniorNotesMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails",
      "http://www.viatris.com/role/DebtUpjohnSeniorNotesDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2040SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2040 Senior Notes",
        "label": "2040 Senior Notes [Member]",
        "terseLabel": "2040 Senior Notes"
       }
      }
     },
     "localname": "A2040SeniorNotesMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails",
      "http://www.viatris.com/role/DebtUpjohnSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2048SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2048 Senior Notes [Member]",
        "label": "2048 Senior Notes [Member]",
        "terseLabel": "2048 Senior Notes [Member]"
       }
      }
     },
     "localname": "A2048SeniorNotesMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtIssuanceof2018SeniorNotesDetails",
      "http://www.viatris.com/role/DebtSeniorNotesDetails",
      "http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_A2050SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2050 Senior Notes",
        "label": "2050 Senior Notes [Member]",
        "terseLabel": "2050 Senior Notes"
       }
      }
     },
     "localname": "A2050SeniorNotesMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails",
      "http://www.viatris.com/role/DebtUpjohnSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_AccountsReceivableCreditsIssuedtoThirdParties": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Receivable, Credits Issued to Third Parties",
        "label": "Accounts Receivable, Credits Issued to Third Parties",
        "negatedTerseLabel": "Checks/ Credits Issued to Third Parties"
       }
      }
     },
     "localname": "AccountsReceivableCreditsIssuedtoThirdParties",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationRollforwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_AccountsReceivableEffectsofForeignExchangeRates": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Receivable, Effects of Foreign Exchange Rates",
        "label": "Accounts Receivable, Effects of Foreign Exchange Rates",
        "terseLabel": "Effects of Foreign Exchange"
       }
      }
     },
     "localname": "AccountsReceivableEffectsofForeignExchangeRates",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationRollforwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_AccountsReceivableFacilityMaximumBorrowingCapacity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts receivable facility maximum borrowing capacity.",
        "label": "Accounts Receivable Facility Maximum Borrowing Capacity",
        "terseLabel": "Accounts receivable securitization facility maximum borrowing capacity"
       }
      }
     },
     "localname": "AccountsReceivableFacilityMaximumBorrowingCapacity",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtDebtReceivablesFacilityandCommercialPaperProgramDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_AccountsReceivableIncreaseDueToAcquisitionCurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Receivable, Increase Due to Acquisition, Current",
        "label": "Accounts Receivable, Increase Due to Acquisition, Current",
        "terseLabel": "Measurement Period Adjustments and Reclasses"
       }
      }
     },
     "localname": "AccountsReceivableIncreaseDueToAcquisitionCurrent",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationRollforwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_AccountsReceivableSalesProvisionsCurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Receivable, Sales Provisions, Current",
        "label": "Accounts Receivable, Sales Provisions, Current",
        "terseLabel": "Current Provision Related to Sales Made in the Current Period"
       }
      }
     },
     "localname": "AccountsReceivableSalesProvisionsCurrent",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationRollforwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_AccountsReceivableVariableConsiderationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Receivable, Variable Consideration [Roll Forward]",
        "label": "Accounts Receivable, Variable Consideration [Roll Forward]",
        "terseLabel": "Accounts Receivable, Variable Consideration [Roll Forward]"
       }
      }
     },
     "localname": "AccountsReceivableVariableConsiderationRollForward",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationRollforwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "vtrs_AccretionExpenseToBeRecognizedWithinTheNextTwelveMonths": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accretion Expense to be Recognized within the Next Twelve Months",
        "label": "Accretion Expense to be Recognized within the Next Twelve Months",
        "terseLabel": "Accretion expense expected within 12 months"
       }
      }
     },
     "localname": "AccretionExpenseToBeRecognizedWithinTheNextTwelveMonths",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_AccruedSalesAllowances": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails": {
       "order": 2.0,
       "parentTag": "vtrs_SalesRevenueGrosstonetadjustments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Sales Allowances",
        "label": "Accrued Sales Allowances",
        "negatedNetLabel": "Rebates, promotional programs and other sales allowances"
       }
      }
     },
     "localname": "AccruedSalesAllowances",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Net Investment Hedges, Effect Net of Tax",
        "label": "Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Net Investment Hedges, Effect Net of Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, before Tax"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossCumulativeChangesinNetGainLossfromNetInvestmentHedgesEffectNetofTax",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/ComprehensiveEarningsAccumulatedOtherComprehensiveLossDetails",
      "http://www.viatris.com/role/ComprehensiveEarningsComponentsofOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_AccumulatednetactuariallossesexceedhigherofmarketvalueofplanassetsorPBO": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated net actuarial losses exceed higher of market value of plan assets or PBO",
        "label": "Accumulated net actuarial losses exceed higher of market value of plan assets or PBO",
        "terseLabel": "Unrecognized net actuarial losses exceed higher of market value of plan assets or the projected benefit obligation at the beginning of the year"
       }
      }
     },
     "localname": "AccumulatednetactuariallossesexceedhigherofmarketvalueofplanassetsorPBO",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "vtrs_AgilaSpecialtiesPrivateLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agila Specialties Private Limited",
        "label": "Agila Specialties Private Limited [Member]",
        "terseLabel": "Agila Specialties"
       }
      }
     },
     "localname": "AgilaSpecialtiesPrivateLimitedMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_AmendedAnticompetitiveConductwithGenericDrugsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amended Anticompetitive Conduct with Generic Drugs [Member]",
        "label": "Amended Anticompetitive Conduct with Generic Drugs [Member]",
        "terseLabel": "Amended Anticompetitive Conduct with Generic Drugs"
       }
      }
     },
     "localname": "AmendedAnticompetitiveConductwithGenericDrugsMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/LitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_AmeriSourceBergenCorporationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "AmeriSourceBergen Corporation",
        "label": "AmeriSourceBergen Corporation [Member]",
        "terseLabel": "AmeriSourceBergen Corporation"
       }
      }
     },
     "localname": "AmeriSourceBergenCorporationMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/SegmentInformationThirdPartyNetSalesbyMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_AmitizaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amitiza \u00ae",
        "label": "Amitiza \u00ae [Member]",
        "terseLabel": "Amitiza \u00ae"
       }
      }
     },
     "localname": "AmitizaMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableDisaggregationofRevenuebyKeyProductsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_AmortizationOfInventoryStepUp": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization of Inventory Step Up",
        "label": "Amortization of Inventory Step Up",
        "terseLabel": "Amortization of Inventory Step Up"
       }
      }
     },
     "localname": "AmortizationOfInventoryStepUp",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_AnticompetitiveConductWithRespectToAdditionalGenericDrugsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Anticompetitive conduct with respect to additional generic drugs",
        "label": "Anticompetitive conduct with respect to additional generic drugs [Member]",
        "terseLabel": "Anticompetitive conduct with respect to additional generic drugs"
       }
      }
     },
     "localname": "AnticompetitiveConductWithRespectToAdditionalGenericDrugsMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/LitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Anticompetitive Conduct with Doxycycline Hyclate Delayed Release, Doxycycline Monohydrate, Glipizide-Metformin and Verapamil [Member]",
        "label": "Anticompetitive Conduct with Doxycycline Hyclate Delayed Release, Doxycycline Monohydrate, Glipizide-Metformin and Verapamil [Member]",
        "terseLabel": "Anticompetitive Conduct with Doxycycline Hyclate Delayed Release, Doxycycline Monohydrate, Glipizide-Metformin and Verapamil"
       }
      }
     },
     "localname": "AnticompetitiveConductwithDoxycyclineHyclateDelayedReleaseDoxycyclineMonohydrateGlipizideMetforminandVerapamilMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/LitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_AnticompetitiveConductwithGenericDrugsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Anticompetitive Conduct with Generic Drugs [Member]",
        "label": "Anticompetitive Conduct with Generic Drugs [Member]",
        "terseLabel": "Anticompetitive Conduct with Generic Drugs"
       }
      }
     },
     "localname": "AnticompetitiveConductwithGenericDrugsMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/LitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_AntitrustProceedingsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Antitrust proceedings",
        "label": "Antitrust Proceedings [Member]",
        "terseLabel": "Antitrust Proceedings"
       }
      }
     },
     "localname": "AntitrustProceedingsMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/LitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_April2018SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "April 2018 Senior Notes [Member]",
        "label": "April 2018 Senior Notes [Member]",
        "terseLabel": "April 2018 Senior Notes [Member]"
       }
      }
     },
     "localname": "April2018SeniorNotesMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtIssuanceof2018SeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_AspenGlobalIncorporatedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aspen Global Incorporated",
        "label": "Aspen Global Incorporated [Member]",
        "terseLabel": "Aspen Global Incorporated"
       }
      }
     },
     "localname": "AspenGlobalIncorporatedMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_AspenPharmacareHoldingsLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aspen Pharmacare Holdings Limited",
        "label": "Aspen Pharmacare Holdings Limited [Member]",
        "terseLabel": "Aspen Pharmacare Holdings Limited"
       }
      }
     },
     "localname": "AspenPharmacareHoldingsLimitedMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_AssetsheldbyinsurancecompaniesandotherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets held by insurance companies and other [Member]",
        "label": "Assets held by insurance companies and other [Member]",
        "terseLabel": "Assets held by insurance companies and other"
       }
      }
     },
     "localname": "AssetsheldbyinsurancecompaniesandotherMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansFairValuesofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAndLaterFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementMaturitiesofAvailableforsaleDebtSecuritiesatFairValueDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Available for sale securities debt maturities after five years and later fair value.",
        "label": "Available for Sale Securities Debt Maturities after Five Years and Later Fair Value",
        "terseLabel": "Mature in five years and later"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAndLaterFairValue",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementMaturitiesofAvailableforsaleDebtSecuritiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_BalanceSheetComponentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Balance Sheet Components",
        "label": "Balance Sheet Components [Abstract]",
        "terseLabel": "Balance Sheet Components [Abstract]"
       }
      }
     },
     "localname": "BalanceSheetComponentsAbstract",
     "nsuri": "http://www.viatris.com/20211231",
     "xbrltype": "stringItemType"
    },
    "vtrs_BiosimilarsBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Biosimilars Business",
        "label": "Biosimilars Business [Member]",
        "terseLabel": "Biosimilars Business"
       }
      }
     },
     "localname": "BiosimilarsBusinessMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_BrandsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Brands",
        "label": "Brands [Member]",
        "terseLabel": "Brands"
       }
      }
     },
     "localname": "BrandsMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsProductRightsandLicensebyTherapeuticCategoryDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_BusinessAcquisitionexpectedfuturepaymentsnexttwelvemonths": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition, expected future payments, next twelve months",
        "label": "Business Acquisition, expected future payments, next twelve months",
        "terseLabel": "Business Acquisition, expected future payments, next twelve months"
       }
      }
     },
     "localname": "BusinessAcquisitionexpectedfuturepaymentsnexttwelvemonths",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_BusinessAcquisitionexpectedfuturepaymentyeartwo": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "",
        "label": "Business Acquisition, expected future payment, year two",
        "terseLabel": "Business Acquisition, expected future payment, year two"
       }
      }
     },
     "localname": "BusinessAcquisitionexpectedfuturepaymentyeartwo",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_BusinessCombinationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination [Abstract]",
        "label": "Business Combination [Abstract]",
        "terseLabel": "Business Combination [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAbstract",
     "nsuri": "http://www.viatris.com/20211231",
     "xbrltype": "stringItemType"
    },
    "vtrs_BusinessCombinationContingentConsiderationArrangementsReclassifications": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration Arrangements, Reclassifications",
        "label": "Business Combination, Contingent Consideration Arrangements, Reclassifications",
        "terseLabel": "Reclassifications"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsReclassifications",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Liability, Fair Value Gain (Loss)",
        "label": "Business Combination, Contingent Consideration, Liability, Fair Value Gain (Loss)",
        "terseLabel": "Fair value loss (gain)"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityFairValueGainLoss",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_BusinessCombinationContingentConsiderationLiabilityPayments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination Contingent Consideration Liability Payments",
        "label": "Business Combination Contingent Consideration Liability Payments",
        "negatedTerseLabel": "Payments",
        "terseLabel": "Contingent consideration payments"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityPayments",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails",
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_BusinessCombinationContractualReimbursementAmountAmountsAccrued": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contractual Reimbursement Amount, Amounts Accrued",
        "label": "Business Combination, Contractual Reimbursement Amount, Amounts Accrued",
        "terseLabel": "Amounts accrued"
       }
      }
     },
     "localname": "BusinessCombinationContractualReimbursementAmountAmountsAccrued",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/CommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_BusinessCombinationContractualReimbursementAmountAmountsExpensed": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contractual Reimbursement Amount, Amounts Expensed",
        "label": "Business Combination, Contractual Reimbursement Amount, Amounts Expensed",
        "terseLabel": "Amounts incurred"
       }
      }
     },
     "localname": "BusinessCombinationContractualReimbursementAmountAmountsExpensed",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/CommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_BusinessCombinationContractualReimbursementAmountTrancheOne": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contractual Reimbursement Amount, Tranche One",
        "label": "Business Combination, Contractual Reimbursement Amount, Tranche One",
        "terseLabel": "Reimbursement amount, tranche one"
       }
      }
     },
     "localname": "BusinessCombinationContractualReimbursementAmountTrancheOne",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/CommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_BusinessCombinationLimitedTransitionServicesPaymentPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Limited Transition Services Payment Period",
        "label": "Business Combination, Limited Transition Services Payment Period",
        "terseLabel": "Limited transition services period"
       }
      }
     },
     "localname": "BusinessCombinationLimitedTransitionServicesPaymentPeriod",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/CommitmentsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "vtrs_BusinessCombinationNumberOfMarketsServed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Number Of Markets Served",
        "label": "Business Combination, Number Of Markets Served",
        "terseLabel": "Number Of Markets"
       }
      }
     },
     "localname": "BusinessCombinationNumberOfMarketsServed",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets",
        "terseLabel": "Total assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssets",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsCurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets, Current",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets, Current",
        "terseLabel": "Current assets (excluding inventories and net of cash acquired)"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsCurrent",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets",
        "terseLabel": "Deferred income tax benefit"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Liabilities",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Liabilities",
        "terseLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails",
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountOfGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesCurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities, Current",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities, Current",
        "terseLabel": "Current liabilities"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesCurrent",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongTermDebt": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Long-Term Debt",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Long-Term Debt",
        "terseLabel": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Long-Term Debt"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLongTermDebt",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentAssets": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Noncurrent Assets",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Noncurrent Assets",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentAssets",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Noncurrent Liabilities",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Noncurrent Liabilities",
        "terseLabel": "Other noncurrent liabilities"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNoncurrentLiabilities",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIndefiniteLivedIntangibleAssetsMeasurementInput": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets, Measurement Input",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets, Measurement Input",
        "terseLabel": "Rate used to discount net cash inflows to present values"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIndefiniteLivedIntangibleAssetsMeasurementInput",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "vtrs_BusinessCombinationsNumberOfAgreements": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combinations, Number of Agreements",
        "label": "Business Combinations, Number of Agreements",
        "terseLabel": "Business Combinations, Number of Agreements"
       }
      }
     },
     "localname": "BusinessCombinationsNumberOfAgreements",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "vtrs_CARESActIncomeTaxExpenseBenefit": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CARES Act, Income Tax Expense (Benefit)",
        "label": "CARES Act, Income Tax Expense (Benefit)",
        "terseLabel": "CARES Act, Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "CARESActIncomeTaxExpenseBenefit",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_CardinalHealthIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cardinal Health Inc [Member]",
        "label": "Cardinal Health Inc [Member]",
        "terseLabel": "Cardinal Health Inc"
       }
      }
     },
     "localname": "CardinalHealthIncMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/SegmentInformationThirdPartyNetSalesbyMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_CelebrexMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Celebrex \u00ae",
        "label": "Celebrex \u00ae [Member]",
        "terseLabel": "Celebrex \u00ae"
       }
      }
     },
     "localname": "CelebrexMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableDisaggregationofRevenuebyKeyProductsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_Changeinnoncashlitigationsettlementsnet": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in noncash litigation settlements, net",
        "label": "Change in noncash litigation settlements, net",
        "negatedLabel": "Litigation settlements and other contingencies, net"
       }
      }
     },
     "localname": "Changeinnoncashlitigationsettlementsnet",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_Chargebacks": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails": {
       "order": 1.0,
       "parentTag": "vtrs_SalesRevenueGrosstonetadjustments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Chargebacks",
        "label": "Chargebacks",
        "negatedTerseLabel": "Chargebacks"
       }
      }
     },
     "localname": "Chargebacks",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_ChargebacksMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Chargebacks [Member]",
        "label": "Chargebacks [Member]",
        "terseLabel": "Chargebacks [Member]"
       }
      }
     },
     "localname": "ChargebacksMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationRollforwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_CleanEnergyPartnershipsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Clean Energy Partnerships",
        "label": "Clean Energy Partnerships [Member]",
        "terseLabel": "Clean energy investments"
       }
      }
     },
     "localname": "CleanEnergyPartnershipsMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsOthernoncurrentliabilitiesDetails",
      "http://www.viatris.com/role/EquityMethodInvestmentsBalanceSheetDetails",
      "http://www.viatris.com/role/EquityMethodInvestmentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_CollaborationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborations [Abstract]",
        "label": "Collaborations [Abstract]",
        "terseLabel": "Collaborations [Abstract]"
       }
      }
     },
     "localname": "CollaborationsAbstract",
     "nsuri": "http://www.viatris.com/20211231",
     "xbrltype": "stringItemType"
    },
    "vtrs_CommercialPaperProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial Paper Program [Member]",
        "label": "Commercial Paper Program [Member]",
        "terseLabel": "Commercial Paper Program [Member]"
       }
      }
     },
     "localname": "CommercialPaperProgramMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtDebtReceivablesFacilityandCommercialPaperProgramDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_ComplexGXAndBiosimilarsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Complex GX and Biosimilars",
        "label": "Complex GX and Biosimilars [Member]",
        "terseLabel": "Complex Gx and Biosimilars"
       }
      }
     },
     "localname": "ComplexGXAndBiosimilarsMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsProductRightsandLicensebyTherapeuticCategoryDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_Concentrationrisknumberofmajorcustomers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Concentration risk, number of major customers",
        "label": "Concentration risk, number of major customers",
        "terseLabel": "Concentration risk, number of major customers"
       }
      }
     },
     "localname": "Concentrationrisknumberofmajorcustomers",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsAccountsreceivablenetDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "vtrs_ContingentConsiderationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Consideration.",
        "label": "Contingent Consideration [Member]",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "ContingentConsiderationMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsNarrativeDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_Corporatecosts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate costs",
        "label": "Corporate costs",
        "negatedTerseLabel": "Corporate costs"
       }
      }
     },
     "localname": "Corporatecosts",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/SegmentInformationReconciliationofSegmentInformationtoTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_CreonMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Creon \u00ae",
        "label": "Creon \u00ae [Member]",
        "terseLabel": "Creon \u00ae"
       }
      }
     },
     "localname": "CreonMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableDisaggregationofRevenuebyKeyProductsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_CurrentPortionofLongTermDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "",
        "label": "Current Portion of Long-Term Debt [Member]",
        "terseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "CurrentPortionofLongTermDebtMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_DebtInstrumentConversionOfUnregisteredNotesToRegisteredNotesAsAPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Conversion Of Unregistered Notes To Registered Notes, As A Percentage",
        "label": "Debt Instrument, Conversion Of Unregistered Notes To Registered Notes, As A Percentage",
        "terseLabel": "Debt Instrument, Conversion Of Unregistered Notes To Registered Notes, As A Percentage"
       }
      }
     },
     "localname": "DebtInstrumentConversionOfUnregisteredNotesToRegisteredNotesAsAPercentage",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtUpjohnSeniorNotesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "vtrs_DeductionlimitofGILTItax": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deduction limit of GILTI tax",
        "label": "Deduction limit of GILTI tax",
        "terseLabel": "Deduction limit of GILTI tax"
       }
      }
     },
     "localname": "DeductionlimitofGILTItax",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "vtrs_DeferredBaseSalaryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Base Salary [Member]",
        "label": "Deferred Base Salary [Member]",
        "terseLabel": "Deferred Base Salary"
       }
      }
     },
     "localname": "DeferredBaseSalaryMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_DeferredTaxAssetsDeferredtaxexpenseinterestexpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from interest expense.",
        "label": "Deferred Tax Assets, Deferred tax expense, interest expense",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "DeferredTaxAssetsDeferredtaxexpenseinterestexpense",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_DeferredTaxAssetsIntangibleAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets Intangible Assets",
        "label": "Deferred Tax Assets Intangible Assets",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsIntangibleAssets",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_DeferredTaxAssetsOperatingLeaseRightofUseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Operating Lease, Right-of-Use Assets",
        "label": "Deferred Tax Assets, Operating Lease, Right-of-Use Assets",
        "terseLabel": "Operating lease assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLeaseRightofUseAssets",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_DeferredTaxLiabilitiesOperatingLeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities, Operating Lease, Liability",
        "label": "Deferred Tax Liabilities, Operating Lease, Liability",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOperatingLeaseLiability",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_DefinedBenefitPensionPlanswithProjectedBenefitObligationInExcessofPlanAssetsAggregateProjectedBenefitObligation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Pension Plans with Projected Benefit Obligation In Excess of Plan Assets Aggregate Projected Benefit Obligation",
        "label": "Defined Benefit Pension Plans with Projected Benefit Obligation In Excess of Plan Assets Aggregate Projected Benefit Obligation",
        "terseLabel": "Accumulated benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPensionPlanswithProjectedBenefitObligationInExcessofPlanAssetsAggregateProjectedBenefitObligation",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansPlanswithPBOinExcessofPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationExpectedLongtermReturnonAssets": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Expected Long-term Return on Assets",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Projected Benefit Obligation, Expected Long-term Return on Assets",
        "terseLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingProjectedBenefitObligationExpectedLongtermReturnonAssets",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "vtrs_DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAssetsTransferredtofromPlan": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Assets Transferred to (from) Plan",
        "label": "Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Assets Transferred to (from) Plan",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAssetsTransferredtofromPlan",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansChangesinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_DefinedBenefitPlanContributionsByPlanParticipantsBenefitObligation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan Contributions By Plan Participants Benefit Obligation",
        "label": "DefinedBenefitPlanContributionsByPlanParticipantsBenefitObligation",
        "terseLabel": "Participant contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsByPlanParticipantsBenefitObligation",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansChangesinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_DefinedBenefitPlanForeignCurrencyTranslationImpactonPlanAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Foreign Currency Translation Impact on Plan Assets",
        "label": "Defined Benefit Plan, Foreign Currency Translation Impact on Plan Assets",
        "terseLabel": "Impact of foreign currency translation"
       }
      }
     },
     "localname": "DefinedBenefitPlanForeignCurrencyTranslationImpactonPlanAssets",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansChangesinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_DevelopedMarketsSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Developed Markets Segment",
        "label": "Developed Markets Segment [Member]",
        "terseLabel": "Developed Markets"
       }
      }
     },
     "localname": "DevelopedMarketsSegmentMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountOfGoodwillDetails",
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsProductRightsandLicensebyTherapeuticCategoryDetails",
      "http://www.viatris.com/role/Restructuring2020RestructuringPlanDetails",
      "http://www.viatris.com/role/RestructuringNarrativeDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationDetails",
      "http://www.viatris.com/role/SegmentInformationReconciliationofSegmentInformationtoTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_DevelopmentMilestonePayments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Development Milestone Payments",
        "label": "Development Milestone Payments",
        "terseLabel": "Development Milestone Payments"
       }
      }
     },
     "localname": "DevelopmentMilestonePayments",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_Developmentandsalesmilestonepayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Development and sales milestone payments",
        "label": "Development and sales milestone payments",
        "terseLabel": "Development and sales milestone payments"
       }
      }
     },
     "localname": "Developmentandsalesmilestonepayments",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_DimethylFumarateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dimethyl Fumarate",
        "label": "Dimethyl Fumarate [Member]",
        "terseLabel": "Dimethyl Fumarate"
       }
      }
     },
     "localname": "DimethylFumarateMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/LitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_DivestitureOfBusinessDeferredCashConsideration": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Divestiture of Business, Deferred Cash Consideration.",
        "label": "Divestiture of Business, Deferred Cash Consideration.",
        "terseLabel": "Divestiture of Business, Deferred Cash Consideration."
       }
      }
     },
     "localname": "DivestitureOfBusinessDeferredCashConsideration",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_DivestitureOfBusinessPercentageOwnershipInCombinedCompanyAfterTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Divestiture Of Business, Percentage Ownership In Combined Company After Transaction",
        "label": "Divestiture Of Business, Percentage Ownership In Combined Company After Transaction",
        "terseLabel": "Divestiture Of Business, Percentage Ownership In Combined Company After Transaction"
       }
      }
     },
     "localname": "DivestitureOfBusinessPercentageOwnershipInCombinedCompanyAfterTransaction",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "vtrs_DivestitureOfBusinessTransitionServicesAgreementTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Divestiture Of Business, Transition Services Agreement, Term",
        "label": "Divestiture Of Business, Transition Services Agreement, Term",
        "terseLabel": "Divestiture Of Business, Transition Services Agreement, Term"
       }
      }
     },
     "localname": "DivestitureOfBusinessTransitionServicesAgreementTerm",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "vtrs_DymistaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dymista \u00ae",
        "label": "Dymista \u00ae [Member]",
        "terseLabel": "Dymista \u00ae"
       }
      }
     },
     "localname": "DymistaMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableDisaggregationofRevenuebyKeyProductsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_EUCommissionProceedingsCitalopramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "EU Commission Proceedings Citalopram",
        "label": "EU Commission Proceedings Citalopram [Member]",
        "terseLabel": "EU Commission Proceedings Citalopram"
       }
      }
     },
     "localname": "EUCommissionProceedingsCitalopramMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/LitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_EUCommissionProceedingsPerindorprilMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "EU Commission Proceedings Perindorpril",
        "label": "EU Commission Proceedings Perindorpril [Member]",
        "terseLabel": "EU Commission Proceedings Perindorpril"
       }
      }
     },
     "localname": "EUCommissionProceedingsPerindorprilMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/LitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_EURIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "EURIBOR [Member]",
        "label": "EURIBOR [Member]",
        "terseLabel": "EURIBOR [Member]"
       }
      }
     },
     "localname": "EURIBORMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_EffectiveIncomeTaxRateReconciliationGILTIPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, GILTI, Percent",
        "label": "Effective Income Tax Rate Reconciliation, GILTI, Percent",
        "terseLabel": "Incremental US Tax on Foreign Earnings"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationGILTIPercent",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesStatutoryTaxRatetoEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "vtrs_EffectiveIncomeTaxRateReconciliationIndiaAmagulation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, India Amagulation",
        "label": "Effective Income Tax Rate Reconciliation, India Amagulation",
        "terseLabel": "Tax settlements and resolution of certain tax positions"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationIndiaAmagulation",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesStatutoryTaxRatetoEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "vtrs_EffectiveIncomeTaxRateReconciliationWaivedDeductionsPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Waived Deductions, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Waived Deductions, Percent",
        "terseLabel": "Waived deductions under IRC \u00a7 59A"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationWaivedDeductionsPercent",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesStatutoryTaxRatetoEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "vtrs_EffectiveIncomeTaxRateReconciliationWithholdingTaxesPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Withholding Taxes, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Withholding Taxes, Percent",
        "terseLabel": "Withholding taxes"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationWithholdingTaxesPercent",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesStatutoryTaxRatetoEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "vtrs_EffexorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effexor \u00ae",
        "label": "Effexor \u00ae [Member]",
        "terseLabel": "Effexor \u00ae"
       }
      }
     },
     "localname": "EffexorMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableDisaggregationofRevenuebyKeyProductsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_EmergingMarketsSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Emerging Markets Segment",
        "label": "Emerging Markets Segment [Member]",
        "terseLabel": "Emerging Markets"
       }
      }
     },
     "localname": "EmergingMarketsSegmentMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountOfGoodwillDetails",
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsProductRightsandLicensebyTherapeuticCategoryDetails",
      "http://www.viatris.com/role/Restructuring2020RestructuringPlanDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationDetails",
      "http://www.viatris.com/role/SegmentInformationReconciliationofSegmentInformationtoTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_EpiPenAutoInjectorLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "EpiPen Auto-Injector Litigation",
        "label": "EpiPen Auto-Injector Litigation [Member]",
        "terseLabel": "EpiPen Auto-Injector Litigation"
       }
      }
     },
     "localname": "EpiPenAutoInjectorLitigationMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/LitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_EpiPenAutoInjectorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "EpiPen\u00ae Auto-Injectors",
        "label": "EpiPen\u00ae Auto-Injectors [Member]",
        "terseLabel": "EpiPen\u00ae Auto-Injectors"
       }
      }
     },
     "localname": "EpiPenAutoInjectorsMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableDisaggregationofRevenuebyKeyProductsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_EquityMethodInvestmentSummarizedFinancialInformationNetAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment Summarized Financial Information, Net Assets",
        "label": "Equity Method Investment Summarized Financial Information, Net Assets",
        "terseLabel": "Net assets"
       }
      }
     },
     "localname": "EquityMethodInvestmentSummarizedFinancialInformationNetAssets",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/EquityMethodInvestmentsNetAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_EquityMethodInvestmentsNetGainLossFromImpairmentandReductionInObligations": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investments Net Gain (Loss) From Impairment and Reduction In Obligations",
        "label": "Equity Method Investments Net Gain (Loss) From Impairment and Reduction In Obligations",
        "terseLabel": "Equity Method Investments Net Gain (Loss) From Impairment and Reduction In Obligations"
       }
      }
     },
     "localname": "EquityMethodInvestmentsNetGainLossFromImpairmentandReductionInObligations",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/EquityMethodInvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_EquityMethodInvestmentsReductionInLongTermObligations": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investments, Reduction In Long-Term Obligations",
        "label": "Equity Method Investments, Reduction In Long-Term Obligations",
        "terseLabel": "Equity Method Investments, Reduction In Long-Term Obligations"
       }
      }
     },
     "localname": "EquityMethodInvestmentsReductionInLongTermObligations",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/EquityMethodInvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_EuropeSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Europe Segment",
        "label": "Europe Segment [Member]",
        "terseLabel": "Europe Segment"
       }
      }
     },
     "localname": "EuropeSegmentMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_ExpectedFutureBenefitPayments": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/EmployeeBenefitPlansEstimatedFutureBenefitPaymentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected Future Benefit Payments",
        "label": "Expected Future Benefit Payments",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "ExpectedFutureBenefitPayments",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansEstimatedFutureBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_FKBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "FKB [Member]",
        "label": "FKB [Member]",
        "terseLabel": "FKB"
       }
      }
     },
     "localname": "FKBMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_FairValueInputsLongtermRevenueGrowthRateTerminalYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value Inputs, Long-term Revenue Growth Rate, Terminal Year",
        "label": "Fair Value Inputs, Long-term Revenue Growth Rate, Terminal Year",
        "terseLabel": "Fair Value Inputs, Long-term Revenue Growth Rate, Terminal Year"
       }
      }
     },
     "localname": "FairValueInputsLongtermRevenueGrowthRateTerminalYear",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "vtrs_FiscalYear2017Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal Year 2017 [Member]",
        "label": "Fiscal Year 2017 [Member]",
        "terseLabel": "Fiscal Year 2017"
       }
      }
     },
     "localname": "FiscalYear2017Member",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_FutureyearsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future years [Member]",
        "label": "Future years [Member]",
        "terseLabel": "2016 through 2035"
       }
      }
     },
     "localname": "FutureyearsMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_GenericBiologicCompoundsCollaborationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generic Biologic Compounds Collaboration",
        "label": "Generic Biologic Compounds Collaboration [Member]",
        "terseLabel": "Generic Biologic Compounds Collaboration [Member]"
       }
      }
     },
     "localname": "GenericBiologicCompoundsCollaborationMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_GenericsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generics",
        "label": "Generics [Member]",
        "terseLabel": "Generics"
       }
      }
     },
     "localname": "GenericsMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsProductRightsandLicensebyTherapeuticCategoryDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_GoodwillImpairedChangeinEstimatePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goodwill, Impaired, Change in Estimate, Period",
        "label": "Goodwill, Impaired, Change in Estimate, Period",
        "terseLabel": "Goodwill, Impaired, Change in Estimate, Period"
       }
      }
     },
     "localname": "GoodwillImpairedChangeinEstimatePeriod",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "vtrs_GoodwillImpairmentMeasurementInput": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goodwill Impairment, Measurement Input",
        "label": "Goodwill Impairment, Measurement Input",
        "terseLabel": "Goodwill Impairment, Measurement Input"
       }
      }
     },
     "localname": "GoodwillImpairmentMeasurementInput",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "vtrs_GoodwillImpairmentMeasurementInputTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goodwill Impairment, Measurement Input, Term",
        "label": "Goodwill Impairment, Measurement Input, Term",
        "terseLabel": "Goodwill Impairment, Measurement Input, Term"
       }
      }
     },
     "localname": "GoodwillImpairmentMeasurementInputTerm",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "vtrs_GoodwillImpairmentTestMeasurementInput": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goodwill Impairment Test, Measurement Input",
        "label": "Goodwill Impairment Test, Measurement Input",
        "terseLabel": "Rate used to discount net cash inflows to present values"
       }
      }
     },
     "localname": "GoodwillImpairmentTestMeasurementInput",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "vtrs_GoodwillImpairmentTestMeasurementInputIncrease": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goodwill Impairment Test, Measurement Input, Increase",
        "label": "Goodwill Impairment Test, Measurement Input, Increase",
        "terseLabel": "Goodwill Impairment Test, Measurement Input, Increase"
       }
      }
     },
     "localname": "GoodwillImpairmentTestMeasurementInputIncrease",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "vtrs_GoodwillImpairmentTestMeasurementInputReduction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goodwill Impairment Test, Measurement Input, Reduction",
        "label": "Goodwill Impairment Test, Measurement Input, Reduction",
        "terseLabel": "Goodwill Impairment Test, Measurement Input, Reduction"
       }
      }
     },
     "localname": "GoodwillImpairmentTestMeasurementInputReduction",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "vtrs_GovernmentalRebateProgramsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Governmental Rebate Programs [Member]",
        "label": "Governmental Rebate Programs [Member]",
        "terseLabel": "Governmental Rebate Programs [Member]"
       }
      }
     },
     "localname": "GovernmentalRebateProgramsMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationRollforwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_GreaterChinaSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Greater China Segment",
        "label": "Greater China Segment [Member]",
        "terseLabel": "Greater China"
       }
      }
     },
     "localname": "GreaterChinaSegmentMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountOfGoodwillDetails",
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsProductRightsandLicensebyTherapeuticCategoryDetails",
      "http://www.viatris.com/role/Restructuring2020RestructuringPlanDetails",
      "http://www.viatris.com/role/RestructuringNarrativeDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationDetails",
      "http://www.viatris.com/role/SegmentInformationReconciliationofSegmentInformationtoTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_ImpairmentofEquityMethodInvestments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impairment of Equity Method Investments",
        "label": "Impairment of Equity Method Investments",
        "terseLabel": "Impairment of Equity Method Investments"
       }
      }
     },
     "localname": "ImpairmentofEquityMethodInvestments",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/EquityMethodInvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Examination, Partial Payment Of Income Tax Expense",
        "label": "Income Tax Examination, Partial Payment Of Income Tax Expense",
        "terseLabel": "Partial payment of anticipated tax expense"
       }
      }
     },
     "localname": "IncomeTaxExaminationPartialPaymentOfIncomeTaxExpense",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_IncomeTaxExaminationReserveForUncertainTaxPosition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Examination, Reserve for Uncertain Tax Position",
        "label": "Income Tax Examination, Reserve for Uncertain Tax Position",
        "terseLabel": "Income Tax Examination, Reserve for Uncertain Tax Position"
       }
      }
     },
     "localname": "IncomeTaxExaminationReserveForUncertainTaxPosition",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_IncomeTaxExaminationReserveImpactOnIncomeTaxProvision": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Examination, Reserve Impact On Income Tax Provision",
        "label": "Income Tax Examination, Reserve Impact On Income Tax Provision",
        "terseLabel": "Income Tax Examination, Reserve Impact On Income Tax Provision"
       }
      }
     },
     "localname": "IncomeTaxExaminationReserveImpactOnIncomeTaxProvision",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_IncreasedDiscountRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increased Discount Rate [Domain]",
        "label": "Increased Discount Rate [Domain]",
        "terseLabel": "Increased Discount Rate [Domain]"
       }
      }
     },
     "localname": "IncreasedDiscountRateDomain",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_IndefiniteMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indefinite amount of time",
        "label": "Indefinite [Member]",
        "terseLabel": "Indefinite"
       }
      }
     },
     "localname": "IndefiniteMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_InfluvacMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Influvac \u00ae",
        "label": "Influvac \u00ae [Member]",
        "terseLabel": "Influvac \u00ae"
       }
      }
     },
     "localname": "InfluvacMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableDisaggregationofRevenuebyKeyProductsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_InsulinAnalogProducts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Insulin Analog Products",
        "label": "Insulin Analog Products",
        "terseLabel": "Insulin Analog Products"
       }
      }
     },
     "localname": "InsulinAnalogProducts",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "vtrs_InsulinGlargineMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Insulin Glargine",
        "label": "Insulin Glargine [Member]",
        "terseLabel": "Insulin Glargine"
       }
      }
     },
     "localname": "InsulinGlargineMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/LitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_JaiPharmaLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Jai Pharma Limited",
        "label": "Jai Pharma Limited [Member]",
        "terseLabel": "Jai Pharma Limited"
       }
      }
     },
     "localname": "JaiPharmaLimitedMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_JapanAustraliaAndNewZealandSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Japan, Australia and New Zealand Segment",
        "label": "Japan, Australia and New Zealand Segment [Member]",
        "terseLabel": "JANZ"
       }
      }
     },
     "localname": "JapanAustraliaAndNewZealandSegmentMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountOfGoodwillDetails",
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsProductRightsandLicensebyTherapeuticCategoryDetails",
      "http://www.viatris.com/role/Restructuring2020RestructuringPlanDetails",
      "http://www.viatris.com/role/RestructuringNarrativeDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableRevenueDisaggregationDetails",
      "http://www.viatris.com/role/SegmentInformationReconciliationofSegmentInformationtoTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_LesseeOperatingLeaseLeaseNotyetCommencedAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Lease Not yet Commenced, Amount",
        "label": "Lessee, Operating Lease, Lease Not yet Commenced, Amount",
        "terseLabel": "Amount of operating leases not yet commenced"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotyetCommencedAmount",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_LipitorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lipitor \u00ae",
        "label": "Lipitor \u00ae [Member]",
        "terseLabel": "Lipitor \u00ae"
       }
      }
     },
     "localname": "LipitorMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableDisaggregationofRevenuebyKeyProductsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_LongTermIncentivePlan2003Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Term Incentive 2003 Plan.",
        "label": "Long Term Incentive Plan 2003 [Member]",
        "terseLabel": "Long Term Incentive Plan 2003"
       }
      }
     },
     "localname": "LongTermIncentivePlan2003Member",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails",
      "http://www.viatris.com/role/ShareBasedIncentivePlanTables",
      "http://www.viatris.com/role/ShareBasedIncentivePlanValuationAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_LossContingencyDamagesAwardedOnAppealValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Damages Awarded On Appeal, Value",
        "label": "Loss Contingency, Damages Awarded On Appeal, Value",
        "terseLabel": "Loss Contingency, Damages Awarded On Appeal, Value"
       }
      }
     },
     "localname": "LossContingencyDamagesAwardedOnAppealValue",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/LitigationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_LossContingencyNumberOfStates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of States",
        "label": "Loss Contingency, Number of States",
        "terseLabel": "Loss Contingency, Number of States"
       }
      }
     },
     "localname": "LossContingencyNumberOfStates",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/LitigationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "vtrs_LossContingencyOtherAssertedPatentsNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Other Asserted Patents, Number",
        "label": "Loss Contingency, Other Asserted Patents, Number",
        "terseLabel": "Loss Contingency, Other Asserted Patents, Number"
       }
      }
     },
     "localname": "LossContingencyOtherAssertedPatentsNumber",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/LitigationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "vtrs_LossContingencyRemainingClaimsNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Remaining Claims, Number",
        "label": "Loss Contingency, Remaining Claims, Number",
        "terseLabel": "Loss Contingency, Remaining Claims, Number"
       }
      }
     },
     "localname": "LossContingencyRemainingClaimsNumber",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/LitigationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "vtrs_LyricaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lyrica \u00ae",
        "label": "Lyrica \u00ae [Member]",
        "terseLabel": "Lyrica \u00ae"
       }
      }
     },
     "localname": "LyricaMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableDisaggregationofRevenuebyKeyProductsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_MarketableSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Marketable Securities",
        "label": "Marketable Securities [Member]",
        "terseLabel": "Marketable Securities"
       }
      }
     },
     "localname": "MarketableSecuritiesMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementFinancialAssetsandLiabilitiesCarriedatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_MaximumLeverageRatioPeriodOne": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum Leverage Ratio, Period One",
        "label": "Maximum Leverage Ratio, Period One",
        "terseLabel": "Maximum Leverage Ratio, Period One"
       }
      }
     },
     "localname": "MaximumLeverageRatioPeriodOne",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtSeniorNotesDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "vtrs_MaximumLeverageRatioPeriodThree": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum Leverage Ratio, Period Three",
        "label": "Maximum Leverage Ratio, Period Three",
        "terseLabel": "Maximum Leverage Ratio, Period Three"
       }
      }
     },
     "localname": "MaximumLeverageRatioPeriodThree",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtSeniorNotesDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "vtrs_MaximumLeverageRatioPeriodTwo": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum Leverage Ratio, Period Two",
        "label": "Maximum Leverage Ratio, Period Two",
        "terseLabel": "Maximum Leverage Ratio, Period Two"
       }
      }
     },
     "localname": "MaximumLeverageRatioPeriodTwo",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtSeniorNotesDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "vtrs_MckessonCorporationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "McKesson Corporation [Member]",
        "label": "McKesson Corporation [Member]",
        "terseLabel": "McKesson Corporation"
       }
      }
     },
     "localname": "MckessonCorporationMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/SegmentInformationThirdPartyNetSalesbyMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_MeasurementInputEstimatedTaxRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement Input, Estimated Tax Rate [Member]",
        "label": "Measurement Input, Estimated Tax Rate [Member]",
        "terseLabel": "Measurement Input, Estimated Tax Rate [Member]"
       }
      }
     },
     "localname": "MeasurementInputEstimatedTaxRateMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_MeasurementInputIncreaseInDiscountRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement Input, Increase in Discount Rate",
        "label": "Measurement Input, Increase in Discount Rate [Member]",
        "terseLabel": "Measurement Input, Increase in Discount Rate"
       }
      }
     },
     "localname": "MeasurementInputIncreaseInDiscountRateMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_MeasurementInputReductionInTerminalYearRevenueGrowthRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement Input, Reduction in Terminal Year Revenue Growth Rate",
        "label": "Measurement Input, Reduction in Terminal Year Revenue Growth Rate [Member]",
        "terseLabel": "Measurement Input, Reduction in Terminal Year Revenue Growth Rate"
       }
      }
     },
     "localname": "MeasurementInputReductionInTerminalYearRevenueGrowthRateMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_MeasurementInputTerminalYearRevenueGrowthRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement Input, Terminal Year Revenue Growth Rate",
        "label": "Measurement Input, Terminal Year Revenue Growth Rate [Member]",
        "terseLabel": "Measurement Input, Terminal Year Revenue Growth Rate"
       }
      }
     },
     "localname": "MeasurementInputTerminalYearRevenueGrowthRateMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_Medicaidandothergovernmentalrebates": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails": {
       "order": 4.0,
       "parentTag": "vtrs_SalesRevenueGrosstonetadjustments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicaid and other governmental rebates",
        "label": "Medicaid and other governmental rebates",
        "negatedTerseLabel": "Medicaid and other governmental rebates"
       }
      }
     },
     "localname": "Medicaidandothergovernmentalrebates",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_MomentaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Momenta [Member]",
        "label": "Momenta [Member]",
        "terseLabel": "Momenta"
       }
      }
     },
     "localname": "MomentaMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_MultiDistrictLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Multi District Litigation [Member]",
        "label": "Multi District Litigation [Member]",
        "terseLabel": "MDL"
       }
      }
     },
     "localname": "MultiDistrictLitigationMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/LitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_Netaccruedbenefitcosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/EmployeeBenefitPlansNetAccruedBenefitCostsClassificationonBalanceSheetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net accrued benefit costs",
        "label": "Net accrued benefit costs",
        "negatedTotalLabel": "Net accrued benefit costs"
       }
      }
     },
     "localname": "Netaccruedbenefitcosts",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansNetAccruedBenefitCostsClassificationonBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_Netrealizablevalueofinventoryrecognizedasexpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net realizable value of inventory recognized as expense",
        "label": "Net realizable value of inventory recognized as expense",
        "terseLabel": "Net realizable value of inventory recognized as expense"
       }
      }
     },
     "localname": "Netrealizablevalueofinventoryrecognizedasexpense",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsInventoriesDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_NonU.S.statetaxauthorityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-U.S. state tax authority [Member]",
        "label": "Non-U.S. state tax authority [Member]",
        "terseLabel": "Non-U.S. state tax authority"
       }
      }
     },
     "localname": "NonU.S.statetaxauthorityMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_NorthAmericaGenericsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "North America Generics [Member]",
        "label": "North America Generics [Member]",
        "terseLabel": "North America Generics [Member]"
       }
      }
     },
     "localname": "NorthAmericaGenericsMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_NorthAmericaSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "North America Segment",
        "label": "North America Segment [Member]",
        "terseLabel": "North America Segment"
       }
      }
     },
     "localname": "NorthAmericaSegmentMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_NorthAmericaSpecialtyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "North America Specialty [Member]",
        "label": "North America Specialty [Member]",
        "terseLabel": "North America Specialty [Member]"
       }
      }
     },
     "localname": "NorthAmericaSpecialtyMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_NorvascMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Norvasc \u00ae",
        "label": "Norvasc \u00ae [Member]",
        "terseLabel": "Norvasc \u00ae"
       }
      }
     },
     "localname": "NorvascMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableDisaggregationofRevenuebyKeyProductsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_NotSubjecttoMarketConditionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Not Subject to Market Conditions [Member]",
        "label": "Not Subject to Market Conditions [Member]",
        "terseLabel": "Not subject to market conditions"
       }
      }
     },
     "localname": "NotSubjecttoMarketConditionsMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_NoteSecuritizationFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Note Securitization Facility [Member]",
        "label": "Note Securitization Facility [Member]",
        "terseLabel": "Note Securitization Facility [Member]"
       }
      }
     },
     "localname": "NoteSecuritizationFacilityMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtDebtReceivablesFacilityandCommercialPaperProgramDetails",
      "http://www.viatris.com/role/DebtShorttermborrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_NumberOfDrugs": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of drugs",
        "label": "Number of drugs",
        "terseLabel": "Number of drugs"
       }
      }
     },
     "localname": "NumberOfDrugs",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "vtrs_NumberOfManufacturingSites": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Manufacturing Sites",
        "label": "Number Of Manufacturing Sites",
        "terseLabel": "Number Of Manufacturing Sites"
       }
      }
     },
     "localname": "NumberOfManufacturingSites",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/NatureofOperationsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "vtrs_NumberOfMolecules": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Molecules",
        "label": "Number Of Molecules",
        "terseLabel": "Number Of Molecules"
       }
      }
     },
     "localname": "NumberOfMolecules",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/NatureofOperationsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "vtrs_NumberOfProducts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Products",
        "label": "Number Of Products",
        "terseLabel": "Number Of Products"
       }
      }
     },
     "localname": "NumberOfProducts",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "vtrs_NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of times damages may be increased in cases of willful infringement",
        "label": "Number of times damages may be increased in cases of willful infringement",
        "terseLabel": "Number of times damages may be increased in cases of willful infringement"
       }
      }
     },
     "localname": "NumberOfTimesDamagesMayBeIncreasedInCasesOfWillfulInfringement",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/LitigationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "vtrs_Numberofcases": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of cases",
        "label": "Number of cases",
        "terseLabel": "Number of cases"
       }
      }
     },
     "localname": "Numberofcases",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/LitigationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "vtrs_Numberofequitymethodinvestments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of equity method investments",
        "label": "Number of equity method investments",
        "terseLabel": "Number of equity method investments"
       }
      }
     },
     "localname": "Numberofequitymethodinvestments",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/EquityMethodInvestmentsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "vtrs_Numberofstates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of states",
        "label": "Number of states",
        "terseLabel": "Number of states"
       }
      }
     },
     "localname": "Numberofstates",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/LitigationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "vtrs_OneTimeSpecialPerformanceBasedFiveYearRealizableValueIncentiveProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One-Time Special Performance-Based Five-Year Realizable Value Incentive Program",
        "label": "One-Time Special Performance-Based Five-Year Realizable Value Incentive Program [Member]",
        "terseLabel": "One-Time Special Performance-Based Five-Year Realizable Value Incentive Program"
       }
      }
     },
     "localname": "OneTimeSpecialPerformanceBasedFiveYearRealizableValueIncentiveProgramMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_OtherCompaniesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other companies",
        "label": "Other Companies [Member]",
        "terseLabel": "Other companies"
       }
      }
     },
     "localname": "OtherCompaniesMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_OtherComprehensiveIncomeDefinedBenefitPlanForeignCurrencyTranslationBeforeTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/EmployeeBenefitPlansChangeinAccumulatedIncomeLossRelatingtoDefinedBenefitPensionandOtherPostretirementBenefitsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income Defined Benefit Plan Foreign Currency Translation Before Tax",
        "label": "OtherComprehensiveIncomeDefinedBenefitPlanForeignCurrencyTranslationBeforeTax",
        "negatedTerseLabel": "Impact of foreign currency translation"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlanForeignCurrencyTranslationBeforeTax",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/EmployeeBenefitPlansChangeinAccumulatedIncomeLossRelatingtoDefinedBenefitPensionandOtherPostretirementBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_OtherCurrentPortionofLongtermDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Current Portion of Long-term Debt [Member]",
        "label": "Other Current Portion of Long-term Debt [Member]",
        "terseLabel": "Other Current Portion of Long-term Debt"
       }
      }
     },
     "localname": "OtherCurrentPortionofLongtermDebtMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtShorttermborrowingsDetails",
      "http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_OtherLongTermDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other long term debt.",
        "label": "Other Long Term Debt [Member]",
        "terseLabel": "Other Long Term Debt"
       }
      }
     },
     "localname": "OtherLongTermDebtMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_OtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "",
        "label": "Other [Member]",
        "terseLabel": "Other Foreign Operations"
       }
      }
     },
     "localname": "OtherMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails",
      "http://www.viatris.com/role/LitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_OtherOneTimeNonoperatingExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other One-Time Nonoperating Expense",
        "label": "Other One-Time Nonoperating Expense",
        "negatedTerseLabel": "Transaction related and other special items"
       }
      }
     },
     "localname": "OtherOneTimeNonoperatingExpense",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/SegmentInformationReconciliationofSegmentInformationtoTotalConsolidatedInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_OtherforeignMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other foreign [Member]",
        "label": "Other foreign [Member]",
        "terseLabel": "Other foreign"
       }
      }
     },
     "localname": "OtherforeignMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesStatutoryTaxRatetoEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_Otherlongtermassets": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other long-term assets",
        "label": "Other long-term assets",
        "terseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "Otherlongtermassets",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_PaymentsForNonContingentConsiderationForProductRightsFinancingActivities": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments for Non-Contingent Consideration for Product Rights, Financing Activities",
        "label": "Payments for Non-Contingent Consideration for Product Rights, Financing Activities",
        "negatedTerseLabel": "Non-contingent payments for product rights"
       }
      }
     },
     "localname": "PaymentsForNonContingentConsiderationForProductRightsFinancingActivities",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_PaymentsToAcquireCollaborativeAgreement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments To Acquire Collaborative Agreement",
        "label": "Payments To Acquire Collaborative Agreement",
        "terseLabel": "Upfront payments"
       }
      }
     },
     "localname": "PaymentsToAcquireCollaborativeAgreement",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_PaymentsforBusinessSeparation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments for Business Separation",
        "label": "Payments for Business Separation",
        "terseLabel": "Payments for Business Separation"
       }
      }
     },
     "localname": "PaymentsforBusinessSeparation",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_PeriodAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period [Axis]",
        "label": "Period [Axis]",
        "terseLabel": "Period [Axis]"
       }
      }
     },
     "localname": "PeriodAxis",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails",
      "http://www.viatris.com/role/DebtRevolvingFacilitiesandTermFacilitiesDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "vtrs_PeriodDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Period [Axis]",
        "label": "Period [Domain]",
        "terseLabel": "Period [Domain]"
       }
      }
     },
     "localname": "PeriodDomain",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails",
      "http://www.viatris.com/role/DebtRevolvingFacilitiesandTermFacilitiesDetails",
      "http://www.viatris.com/role/EmployeeBenefitPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_PfizerInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pfizer, Inc. [Member]",
        "label": "Pfizer, Inc. [Member]",
        "terseLabel": "Pfizer, Inc."
       }
      }
     },
     "localname": "PfizerInc.Member",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails",
      "http://www.viatris.com/role/CommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_ProductLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product Liability",
        "label": "Product Liability [Member]",
        "terseLabel": "Product Liability"
       }
      }
     },
     "localname": "ProductLiabilityMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/LitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_ProductRightsAndLicensesByTherapeuticCategoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product rights and licenses by therapeutic category",
        "label": "Product Rights And Licenses By Therapeutic Category [Table Text Block]",
        "terseLabel": "Product rights and licenses by therapeutic category"
       }
      }
     },
     "localname": "ProductRightsAndLicensesByTherapeuticCategoryTableTextBlock",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "vtrs_ProgramNameAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Program Name",
        "label": "Program Name [Axis]",
        "terseLabel": "Program Name [Axis]"
       }
      }
     },
     "localname": "ProgramNameAxis",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails",
      "http://www.viatris.com/role/ShareBasedIncentivePlanTables",
      "http://www.viatris.com/role/ShareBasedIncentivePlanValuationAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "vtrs_ProgramNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Program Name",
        "label": "Program Name [Domain]",
        "terseLabel": "Program Name [Domain]"
       }
      }
     },
     "localname": "ProgramNameDomain",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails",
      "http://www.viatris.com/role/ShareBasedIncentivePlanTables",
      "http://www.viatris.com/role/ShareBasedIncentivePlanValuationAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_RebatesPromotionalProgramsandOtherSalesAllowancesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rebates, Promotional Programs and Other Sales Allowances [Member]",
        "label": "Rebates, Promotional Programs and Other Sales Allowances [Member]",
        "terseLabel": "Rebates, Promotional Programs and Other Sales Allowances [Member]"
       }
      }
     },
     "localname": "RebatesPromotionalProgramsandOtherSalesAllowancesMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationRollforwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_ReceivablesFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Receivables facility.",
        "label": "Receivables Facility [Member]",
        "terseLabel": "Receivables Facility [Member]"
       }
      }
     },
     "localname": "ReceivablesFacilityMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtDebtReceivablesFacilityandCommercialPaperProgramDetails",
      "http://www.viatris.com/role/DebtShorttermborrowingsDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_ReductioninEquityMethodInvestmentLongTermObligation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reduction in Equity Method Investment Long-Term Obligation",
        "label": "Reduction in Equity Method Investment Long-Term Obligation",
        "terseLabel": "Reduction in Equity Method Investment Long-Term Obligation"
       }
      }
     },
     "localname": "ReductioninEquityMethodInvestmentLongTermObligation",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/EquityMethodInvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_ReductioninSharebasedCompensationExpense": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reduction in Share-based Compensation Expense",
        "label": "Reduction in Share-based Compensation Expense",
        "terseLabel": "Reduction in Share-based Compensation Expense"
       }
      }
     },
     "localname": "ReductioninSharebasedCompensationExpense",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_ReductioninTerminalValueGrowthRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reduction in Terminal Value Growth Rate [Domain]",
        "label": "Reduction in Terminal Value Growth Rate [Domain]",
        "terseLabel": "Reduction in Terminal Value Growth Rate [Domain]"
       }
      }
     },
     "localname": "ReductioninTerminalValueGrowthRateDomain",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_ReserveForUncertainTaxPositionsIncludingInterestAndPenalties": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reserve for Uncertain Tax Positions, Including Interest And Penalties",
        "label": "Reserve for Uncertain Tax Positions, Including Interest And Penalties",
        "terseLabel": "Reserve for Uncertain Tax Positions, Including Interest And Penalties"
       }
      }
     },
     "localname": "ReserveForUncertainTaxPositionsIncludingInterestAndPenalties",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_RespiratorydeliveryplatformMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Respiratory delivery platform [Member]",
        "label": "Respiratory delivery platform [Member]",
        "terseLabel": "Respiratory delivery platform [Member]"
       }
      }
     },
     "localname": "RespiratorydeliveryplatformMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails",
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_RestofWorldSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rest of World Segment",
        "label": "Rest of World Segment [Member]",
        "terseLabel": "Rest of World Segment"
       }
      }
     },
     "localname": "RestofWorldSegmentMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.viatris.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_RestructuringAndRelatedCostExpectedNumberOfFacilitiesToBeEliminated": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring and Related Cost, Expected Number of Facilities to be Eliminated",
        "label": "Restructuring and Related Cost, Expected Number of Facilities to be Eliminated",
        "terseLabel": "Restructuring and Related Cost, Expected Number of Facilities to be Eliminated"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostExpectedNumberOfFacilitiesToBeEliminated",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/Restructuring2020RestructuringPlanDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "vtrs_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminatedPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring and Related Cost, Expected Number of Positions Eliminated, Percent",
        "label": "Restructuring and Related Cost, Expected Number of Positions Eliminated, Percent",
        "terseLabel": "Restructuring and Related Cost, Expected Number of Positions Eliminated, Percent"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostExpectedNumberOfPositionsEliminatedPercent",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/Restructuring2020RestructuringPlanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "vtrs_RestructuringReserveAcquiredDuringPeriod": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring Reserve, Acquired During Period",
        "label": "Restructuring Reserve, Acquired During Period",
        "terseLabel": "Restructuring Reserve, Acquired During Period"
       }
      }
     },
     "localname": "RestructuringReserveAcquiredDuringPeriod",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/Restructuring2020RestructuringPlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_RestructuringReserveReimbursableRestructuringCharges": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring Reserve, Reimbursable Restructuring Charges",
        "label": "Restructuring Reserve, Reimbursable Restructuring Charges",
        "terseLabel": "Restructuring Reserve, Reimbursable Restructuring Charges"
       }
      }
     },
     "localname": "RestructuringReserveReimbursableRestructuringCharges",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/Restructuring2020RestructuringPlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_RevanceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revance [Member]",
        "label": "Revance [Member]",
        "terseLabel": "Revance [Member]"
       }
      }
     },
     "localname": "RevanceMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_RevenuefromContractwithCustomerGross": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from Contract with Customer, Gross",
        "label": "Revenue from Contract with Customer, Gross",
        "terseLabel": "Gross sales"
       }
      }
     },
     "localname": "RevenuefromContractwithCustomerGross",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_RevenuefromContractwithCustomerReturns": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails": {
       "order": 3.0,
       "parentTag": "vtrs_SalesRevenueGrosstonetadjustments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from Contract with Customer, Returns",
        "label": "Revenue from Contract with Customer, Returns",
        "negatedTerseLabel": "Returns"
       }
      }
     },
     "localname": "RevenuefromContractwithCustomerReturns",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_SalesMilestonePayments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales Milestone Payments",
        "label": "Sales Milestone Payments",
        "terseLabel": "Sales Milestone Payments"
       }
      }
     },
     "localname": "SalesMilestonePayments",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_SalesRevenueGrosstonetadjustments": {
     "auth_ref": [],
     "calculation": {
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales Revenue, Gross to net adjustments",
        "label": "Sales Revenue, Gross to net adjustments",
        "totalLabel": "Sales Revenue, Gross to net adjustments"
       }
      }
     },
     "localname": "SalesRevenueGrosstonetadjustments",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Schedule of Product Rights and Licenses by Therapeutic Class",
        "label": "Schedule of Product Rights and Licenses by Therapeutic Class [Line Items]",
        "terseLabel": "Schedule of Product Rights and Licenses by Therapeutic Class [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfProductRightsAndLicensesByTherapeuticClassLineItems",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsProductRightsandLicensebyTherapeuticCategoryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "vtrs_ScheduleOfProductRightsAndLicensesByTherapeuticClassTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Product Rights and Licenses by Therapeutic Class",
        "label": "Schedule of Product Rights and Licenses by Therapeutic Class [Table]",
        "terseLabel": "Schedule of Product Rights and Licenses by Therapeutic Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfProductRightsAndLicensesByTherapeuticClassTable",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/GoodwillandOtherIntangibleAssetsProductRightsandLicensebyTherapeuticCategoryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "vtrs_ScheduleofActivityinContingentConsiderationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Activity in Contingent Consideration [Roll Forward]",
        "label": "Schedule of Activity in Contingent Consideration [Roll Forward]",
        "terseLabel": "Schedule of Activity in Contingent Consideration [Roll Forward]"
       }
      }
     },
     "localname": "ScheduleofActivityinContingentConsiderationRollForward",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementRollforwardofContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "vtrs_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Table Text Block] for Schedule of Cash, Cash Equivalents and Restricted Cash [Table]",
        "label": "Schedule of Cash, Cash Equivalents and Restricted Cash [Table Text Block]",
        "terseLabel": "Schedule of Cash, Cash Equivalents, and Restricted Cash"
       }
      }
     },
     "localname": "ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "vtrs_ScheduleofOtherAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Schedule of Other Assets [Table]",
        "label": "Schedule of Other Assets [Line Items]",
        "terseLabel": "Schedule of Other Assets [Line Items]"
       }
      }
     },
     "localname": "ScheduleofOtherAssetsLineItems",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "vtrs_ScheduleofOtherAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Other Assets [Table]",
        "label": "Schedule of Other Assets [Table]",
        "terseLabel": "Schedule of Other Assets [Table]"
       }
      }
     },
     "localname": "ScheduleofOtherAssetsTable",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "vtrs_ScheduleofOtherNoncurrentLiabilitiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Schedule of Other Noncurrent Liabilities [Table]",
        "label": "Schedule of Other Noncurrent Liabilities [Line Items]",
        "terseLabel": "Schedule of Other Noncurrent Liabilities [Line Items]"
       }
      }
     },
     "localname": "ScheduleofOtherNoncurrentLiabilitiesLineItems",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOthernoncurrentliabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "vtrs_ScheduleofOtherNoncurrentLiabilitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Other Noncurrent Liabilities [Table]",
        "label": "Schedule of Other Noncurrent Liabilities [Table]",
        "terseLabel": "Schedule of Other Noncurrent Liabilities [Table]"
       }
      }
     },
     "localname": "ScheduleofOtherNoncurrentLiabilitiesTable",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOthernoncurrentliabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "vtrs_ScheduleofothercurrentliabilitiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Schedule of other current liabilities [Table]",
        "label": "Schedule of other current liabilities [Line Items]",
        "terseLabel": "Schedule of other current liabilities [Line Items]"
       }
      }
     },
     "localname": "ScheduleofothercurrentliabilitiesLineItems",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "vtrs_ScheduleofothercurrentliabilitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of other current liabilities [Table]",
        "label": "Schedule of other current liabilities [Table]",
        "terseLabel": "Schedule of other current liabilities [Table]"
       }
      }
     },
     "localname": "ScheduleofothercurrentliabilitiesTable",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "vtrs_SeniorNotes2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2021",
        "label": "Senior Notes 2021 [Member]",
        "terseLabel": "Senior Notes 2021"
       }
      }
     },
     "localname": "SeniorNotes2021Member",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_SeniorNotes2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2022",
        "label": "Senior Notes 2022 [Member]",
        "terseLabel": "Senior Notes 2022"
       }
      }
     },
     "localname": "SeniorNotes2022Member",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_SeniorNotesTwoThousandEighteen2.6PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes Two Thousand Eighteen - 2.6% [Member]",
        "label": "Senior Notes Two Thousand Eighteen - 2.6 Percent [Member]",
        "terseLabel": "2018 Senior Notes (2.600%)"
       }
      }
     },
     "localname": "SeniorNotesTwoThousandEighteen2.6PercentMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtSeniorNotesDetails",
      "http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_SeniorNotesTwoThousandEighteen3.0PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes Two Thousand Eighteen - 3.0 Percent",
        "label": "Senior Notes Two Thousand Eighteen - 3.0 Percent [Member]",
        "verboseLabel": "2018 Senior Notes (3.000% coupon)"
       }
      }
     },
     "localname": "SeniorNotesTwoThousandEighteen3.0PercentMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtSeniorNotesDetails",
      "http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_SeniorNotesTwoThousandFortySix5.25PrecentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2046 Senior Note (5.250%)",
        "label": "SeniorNotesTwoThousandFortySix5.25Precent [Member]",
        "terseLabel": "2046 Senior Notes (5.250%)"
       }
      }
     },
     "localname": "SeniorNotesTwoThousandFortySix5.25PrecentMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_SeniorNotesTwoThousandFortyThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior notes two thousand forty three",
        "label": "SeniorNotesTwoThousandFortyThree [Member]",
        "terseLabel": "2043 Senior Notes (5.400%)"
       }
      }
     },
     "localname": "SeniorNotesTwoThousandFortyThreeMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_SeniorNotesTwoThousandNineteen2.50PrecentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2019 Senior Notes (2.500%)",
        "label": "SeniorNotesTwoThousandNineteen2.50Precent [Member]",
        "terseLabel": "2019 Senior Notes (2.500%)"
       }
      }
     },
     "localname": "SeniorNotesTwoThousandNineteen2.50PrecentMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtSeniorNotesDetails",
      "http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_SeniorNotesTwoThousandNineteenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior notes two thousand nineteen",
        "label": "SeniorNotesTwoThousandNineteen [Member]",
        "terseLabel": "2019 Senior Notes (2.550%)"
       }
      }
     },
     "localname": "SeniorNotesTwoThousandNineteenMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtSeniorNotesDetails",
      "http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_SeniorNotesTwoThousandTwenty3.75PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes Two Thousand Twenty - 3.75 Percent",
        "label": "Senior Notes Two Thousand Twenty - 3.75 Percent [Member]",
        "verboseLabel": "2020 Senior Notes (3.750% coupon)"
       }
      }
     },
     "localname": "SeniorNotesTwoThousandTwenty3.75PercentMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_SeniorNotesTwoThousandTwentyOne3.15PrecentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 Senior Notes 3.15%",
        "label": "SeniorNotesTwoThousandTwentyOne3.15Precent [Member]",
        "terseLabel": "2021 Senior Notes (3.150%)"
       }
      }
     },
     "localname": "SeniorNotesTwoThousandTwentyOne3.15PrecentMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_SeniorNotesTwoThousandTwentySix3.95PrecentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2026 Senior Notes 3.950%",
        "label": "SeniorNotesTwoThousandTwentySix3.95Precent [Member]",
        "terseLabel": "2026 Senior Notes (3.950%)"
       }
      }
     },
     "localname": "SeniorNotesTwoThousandTwentySix3.95PrecentMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_SeniorNotesTwoThousandTwentyThree3.125PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior notes two thousand twenty three - 3.125 percent",
        "label": "SeniorNotesTwoThousandTwentyThree3.125Percent [Member]",
        "verboseLabel": "Senior Notes 2023 3.125%"
       }
      }
     },
     "localname": "SeniorNotesTwoThousandTwentyThree3.125PercentMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementEffectofDerivativeInstrumentsontheConsolidatedStatementsofOperationsDerivativesinFairValueHedgingRelationshipsDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_SeniorNotesTwoThousandTwentyThree4.2PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior notes two thousand twenty three - 4.2 percent",
        "label": "SeniorNotesTwoThousandTwentyThree4.2Percent [Member]",
        "terseLabel": "2023 Senior Notes (4.200%)"
       }
      }
     },
     "localname": "SeniorNotesTwoThousandTwentyThree4.2PercentMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based compensation arrangement by Share-based payment award, fair value assumptions, Forfeiture rate",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Forfeiture Rate",
        "terseLabel": "Forfeiture rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "vtrs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period, Total Intrinsic Value And Equity Instruments Other Than Options, Vested In Period, Intrinsic Value",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period, Total Intrinsic Value And Equity Instruments Other Than Options, Vested In Period, Intrinsic Value",
        "verboseLabel": "Intrinsic value of stock-based awards exercised and restricted stock units converted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAndEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_StockExchangedDuringPeriodSharesExchanged": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Exchanged During Period, Shares, Exchanged",
        "label": "Stock Exchanged During Period, Shares, Exchanged",
        "negatedTerseLabel": "Exchange of Mylan N.V. ordinary shares for Viatris Inc. common stock (in shares)"
       }
      }
     },
     "localname": "StockExchangedDuringPeriodSharesExchanged",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "vtrs_StockExchangedDuringPeriodValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Exchanged During Period, Value",
        "label": "Stock Exchanged During Period, Value",
        "negatedTerseLabel": "Exchange of Mylan N.V. ordinary shares for Viatris Inc. common stock"
       }
      }
     },
     "localname": "StockExchangedDuringPeriodValue",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vtrs_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Value, Stock Options Exercised, Net of Shares Tendered for Payment",
        "label": "Stock Issued During Period, Value, Stock Options Exercised, Net of Shares Tendered for Payment",
        "terseLabel": "Issuance of restricted stock and stock options exercised, net (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesTenderedForPayment",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "vtrs_StockappreciationrightsandperformancesharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock appreciation rights and performance shares",
        "label": "Stock appreciation rights and performance shares [Member]",
        "terseLabel": "Stock appreciation rights and performance shares"
       }
      }
     },
     "localname": "StockappreciationrightsandperformancesharesMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails",
      "http://www.viatris.com/role/ShareBasedIncentivePlanValuationAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_SubjectToMarketConditionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subject to Market Conditions",
        "label": "Subject to Market Conditions [Member]",
        "terseLabel": "Subject to Market Conditions"
       }
      }
     },
     "localname": "SubjectToMarketConditionsMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_SubjecttoMarketConditionsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subject to Market Conditions [Axis]",
        "label": "Subject to Market Conditions [Axis]",
        "terseLabel": "Subject to Market Conditions [Axis]"
       }
      }
     },
     "localname": "SubjecttoMarketConditionsAxis",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "vtrs_SubjecttoMarketConditionsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Subject to Market Conditions [Axis]",
        "label": "Subject to Market Conditions [Domain]",
        "terseLabel": "Subject to Market Conditions [Domain]"
       }
      }
     },
     "localname": "SubjecttoMarketConditionsDomain",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_TOBIMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "TOBI [Member]",
        "label": "TOBI [Member]",
        "terseLabel": "TOBI"
       }
      }
     },
     "localname": "TOBIMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan",
        "label": "Term Loan [Member]",
        "terseLabel": "Term Loan"
       }
      }
     },
     "localname": "TermLoanMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtSummaryofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_TheravanceBiopharmaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Theravance Biopharma",
        "label": "Theravance Biopharma [Member]",
        "terseLabel": "Theravance"
       }
      }
     },
     "localname": "TheravanceBiopharmaMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/CollaborationandLicensingAgreementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_ThreeCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Three Customers",
        "label": "Three Customers [Member]",
        "terseLabel": "Three Customers"
       }
      }
     },
     "localname": "ThreeCustomersMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_ThreeFullFiscalQuartersFollowingQualifyingAcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Three Full Fiscal Quarters Following Qualifying Acquisition [Member]",
        "label": "Three Full Fiscal Quarters Following Qualifying Acquisition [Member]",
        "terseLabel": "Three Full Fiscal Quarters Following Qualifying Acquisition"
       }
      }
     },
     "localname": "ThreeFullFiscalQuartersFollowingQualifyingAcquisitionMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtRevolvingFacilitiesandTermFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_TrailingFourQuartersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trailing Four Quarters",
        "label": "Trailing Four Quarters [Member]",
        "terseLabel": "Trailing Four Quarters"
       }
      }
     },
     "localname": "TrailingFourQuartersMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtRevolvingFacilitiesandTermFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_TransitionServiceAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transition Service Agreements",
        "label": "Transition Service Agreements [Member]",
        "terseLabel": "Transition Service Agreements"
       }
      }
     },
     "localname": "TransitionServiceAgreementsMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/CommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_TwentyTwentyOneLoanFacilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Twenty Twenty One Loan Facilities",
        "label": "Twenty Twenty One Loan Facilities [Member]",
        "terseLabel": "Twenty Twenty One Loan Facilities"
       }
      }
     },
     "localname": "TwentyTwentyOneLoanFacilitiesMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_TwentyTwentyOneRevolvingFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Twenty Twenty One Revolving Facility",
        "label": "Twenty Twenty One Revolving Facility [Member]",
        "terseLabel": "Twenty Twenty One Revolving Facility"
       }
      }
     },
     "localname": "TwentyTwentyOneRevolvingFacilityMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_U.K.CompetitionandMarketsAuthorityProceedingsParoxetineMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U.K. Competition and Markets Authority Proceedings Paroxetine",
        "label": "U.K. Competition and Markets Authority Proceedings Paroxetine [Member]",
        "terseLabel": "U.K. Competition and Markets Authority Proceedings Paroxetine"
       }
      }
     },
     "localname": "U.K.CompetitionandMarketsAuthorityProceedingsParoxetineMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/LitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_U.S.FederalTaxAuthorityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U.S. Federal Tax Authority [Member]",
        "label": "U.S. Federal Tax Authority [Member]",
        "terseLabel": "U.S. Federal Tax Authority"
       }
      }
     },
     "localname": "U.S.FederalTaxAuthorityMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_U.S.StateTaxAuthorityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U.S. State Tax Authority [Member]",
        "label": "U.S. State Tax Authority [Member]",
        "terseLabel": "U.S. State Tax Authority"
       }
      }
     },
     "localname": "U.S.StateTaxAuthorityMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/IncomeTaxesNarrativeDetails",
      "http://www.viatris.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_USDTermLoanFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "USD Term Loan Facility",
        "label": "USD Term Loan Facility [Member]",
        "terseLabel": "USD Term Loan Facility"
       }
      }
     },
     "localname": "USDTermLoanFacilityMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_UnregisteredUpjohnUSDollarNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unregistered Upjohn U.S. Dollar Notes",
        "label": "Unregistered Upjohn U.S. Dollar Notes [Member]",
        "terseLabel": "Unregistered Upjohn U.S. Dollar Notes"
       }
      }
     },
     "localname": "UnregisteredUpjohnUSDollarNotesMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtUpjohnSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_UpjohnEuroNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upjohn Euro Notes",
        "label": "Upjohn Euro Notes [Member]",
        "terseLabel": "Upjohn Euro Notes"
       }
      }
     },
     "localname": "UpjohnEuroNotesMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtUpjohnSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_UpjohnInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upjohn Inc. [Member]",
        "label": "Upjohn Inc. [Member]",
        "terseLabel": "Upjohn Inc."
       }
      }
     },
     "localname": "UpjohnInc.Member",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsOtherTransactionsNarrativeDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsPurchasePriceAllocationsDetails",
      "http://www.viatris.com/role/AcquisitionsandOtherTransactionsUnauditedProFormaFinancialResultsDetails",
      "http://www.viatris.com/role/DebtFairValueNarrativeDetails",
      "http://www.viatris.com/role/DebtSeniorNotesDetails",
      "http://www.viatris.com/role/DebtTables",
      "http://www.viatris.com/role/DebtUpjohnSeniorNotesDetails",
      "http://www.viatris.com/role/Restructuring2020RestructuringPlanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_VariableConsiderationCategoryAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Consideration Category [Axis]",
        "label": "Variable Consideration Category [Axis]",
        "terseLabel": "Variable Consideration Category [Axis]"
       }
      }
     },
     "localname": "VariableConsiderationCategoryAxis",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationRollforwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "vtrs_VariableConsiderationCategoryDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Variable Consideration Category [Axis]",
        "label": "Variable Consideration Category [Domain]",
        "terseLabel": "Variable Consideration Category [Domain]"
       }
      }
     },
     "localname": "VariableConsiderationCategoryDomain",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationRollforwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_VariableConsiderationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Consideration [Member]",
        "label": "Variable Consideration [Member]",
        "terseLabel": "Variable Consideration [Member]"
       }
      }
     },
     "localname": "VariableConsiderationMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableAccountsReceivableNetDetails",
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationRollforwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_VariableConsiderationReturnsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Consideration Returns [Member]",
        "label": "Variable Consideration Returns [Member]",
        "terseLabel": "Variable Consideration Returns [Member]"
       }
      }
     },
     "localname": "VariableConsiderationReturnsMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableVariableConsiderationRollforwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_VestingPeriodAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting Period [Axis]",
        "label": "Vesting Period [Axis]",
        "terseLabel": "Vesting Period [Axis]"
       }
      }
     },
     "localname": "VestingPeriodAxis",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "vtrs_VestingPeriodDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Vesting Period [Axis]",
        "label": "Vesting Period [Domain]",
        "terseLabel": "Vesting Period [Domain]"
       }
      }
     },
     "localname": "VestingPeriodDomain",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_VestinthreeyearsorlessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vest in three years or less",
        "label": "Vest in three years or less [Member]",
        "terseLabel": "Vest after three years"
       }
      }
     },
     "localname": "VestinthreeyearsorlessMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_VestratablyinfiveyearsorlessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vest ratably in five years or less [Member]",
        "label": "Vest ratably in five years or less [Member]",
        "terseLabel": "Vest ratably in five years or less [Member]"
       }
      }
     },
     "localname": "VestratablyinfiveyearsorlessMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/ShareBasedIncentivePlanNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_ViagraMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Viagra \u00ae",
        "label": "Viagra \u00ae [Member]",
        "terseLabel": "Viagra \u00ae"
       }
      }
     },
     "localname": "ViagraMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableDisaggregationofRevenuebyKeyProductsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_VoluntaryRecallofValsartanandCertainCombinationsValsartanMedicinesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Voluntary Recall of Valsartan and Certain Combinations Valsartan Medicines [Member]",
        "label": "Voluntary Recall of Valsartan and Certain Combinations Valsartan Medicines [Member]",
        "terseLabel": "Voluntary Recall of Valsartan and Certain Combinations Valsartan Medicines [Member]"
       }
      }
     },
     "localname": "VoluntaryRecallofValsartanandCertainCombinationsValsartanMedicinesMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/BalanceSheetComponentsNarrativeDetails",
      "http://www.viatris.com/role/BalanceSheetComponentsOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_XalabrandsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Xalabrands",
        "label": "Xalabrands [Member]",
        "terseLabel": "Xalabrands"
       }
      }
     },
     "localname": "XalabrandsMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableDisaggregationofRevenuebyKeyProductsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_XanaxMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Xanax \u00ae",
        "label": "Xanax \u00ae [Member]",
        "terseLabel": "Xanax \u00ae"
       }
      }
     },
     "localname": "XanaxMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableDisaggregationofRevenuebyKeyProductsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_YENTermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "YEN Term Loan",
        "label": "YEN Term Loan [Member]",
        "terseLabel": "YEN Term Loan"
       }
      }
     },
     "localname": "YENTermLoanMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/DebtSeniorNotesDetails",
      "http://www.viatris.com/role/FinancialInstrumentsandRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_YupelriMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Yupelri \u00ae",
        "label": "Yupelri \u00ae [Member]",
        "terseLabel": "Yupelri \u00ae"
       }
      }
     },
     "localname": "YupelriMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableDisaggregationofRevenuebyKeyProductsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vtrs_ZoloftMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Zoloft \u00ae",
        "label": "Zoloft \u00ae [Member]",
        "terseLabel": "Zoloft \u00ae"
       }
      }
     },
     "localname": "ZoloftMember",
     "nsuri": "http://www.viatris.com/20211231",
     "presentation": [
      "http://www.viatris.com/role/RevenueRecognitionandAccountsReceivableDisaggregationofRevenuebyKeyProductsDetails"
     ],
     "xbrltype": "domainItemType"
    }
   },
   "unitCount": 18
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r1000": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "09"
  },
  "r1001": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "01"
  },
  "r1002": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "02"
  },
  "r1003": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(ii)",
   "Subsection": "01"
  },
  "r1004": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)",
   "Subsection": "01"
  },
  "r1005": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(A)",
   "Subsection": "01"
  },
  "r1006": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(A)",
   "Subsection": "02"
  },
  "r1007": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(B)",
   "Subsection": "01"
  },
  "r1008": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(B)",
   "Subsection": "02"
  },
  "r1009": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(C)",
   "Subsection": "02"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r1010": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "01"
  },
  "r1011": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "02"
  },
  "r1012": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(m)",
   "Publisher": "SEC",
   "Section": "4",
   "Subparagraph": "(1)(iii)",
   "Subsection": "08"
  },
  "r1013": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r1014": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848"
  },
  "r1015": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e640-108580"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e689-108580"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL34724391-108580"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=114868883&loc=SL114871943-224233"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "http://asc.fasb.org/topic&trid=2134417"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(25))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(26))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(10))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1707-109256"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1757-109256"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1500-109256"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(11))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e543-108305"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8475-108599"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e4975-111524"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5212-111524"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5093-111524"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26626-111562"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL6283291-111563"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27337-111563"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27340-111563"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27357-111563"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=124268079&loc=d3e32787-111569"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33775-111570"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(b)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "323",
   "URI": "http://asc.fasb.org/topic&trid=2196965"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4578-108314"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(23))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(25))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "410",
   "URI": "http://asc.fasb.org/extlink&oid=6392676&loc=d3e7480-110848"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394232&loc=d3e17558-110866"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "http://asc.fasb.org/topic&trid=2175745"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=116646759&loc=d3e15243-108350"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "http://asc.fasb.org/extlink&oid=6409733&loc=d3e19512-108361"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "http://asc.fasb.org/extlink&oid=6409875&loc=d3e20015-108363"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(b)(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(m)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(s)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=124434304&loc=d3e36027-109320"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e39076-109324"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=SL65897772-128472"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(4)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911878&loc=d3e8732-128492"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "808",
   "URI": "http://asc.fasb.org/topic&trid=5833765"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(i)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(iii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL109998890-113959"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123421605&loc=SL5629052-113961"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Subparagraph": "(a)(1),(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594809&loc=SL116692626-108610"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "825",
   "URI": "http://asc.fasb.org/topic&trid=2134543"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28129-110885"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123602790&loc=d3e30304-110892"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "210-10-S99-1(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "http://asc.fasb.org/topic&trid=2175825"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r820": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r821": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123406913&loc=d3e41499-112717"
  },
  "r822": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123405975&loc=d3e41551-112718"
  },
  "r823": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "840",
   "URI": "http://asc.fasb.org/topic&trid=2208923"
  },
  "r824": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r825": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r826": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977"
  },
  "r827": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r828": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r829": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r830": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r831": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r832": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r833": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r834": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r835": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r836": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919398-209981"
  },
  "r837": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r838": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r839": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r840": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764"
  },
  "r841": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r842": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r843": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r844": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r845": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r846": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r847": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r848": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r849": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r850": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r851": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r852": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r853": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r854": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r855": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r856": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r857": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r858": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r859": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313"
  },
  "r860": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r861": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r862": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r863": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r864": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r865": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r866": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r867": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r868": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r869": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r870": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r871": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r872": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r873": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r874": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r875": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r876": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r877": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r878": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411"
  },
  "r879": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
  },
  "r880": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r881": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r882": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r883": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r884": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r885": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r886": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r887": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r888": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r889": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "210",
   "URI": "http://asc.fasb.org/topic&trid=2122208"
  },
  "r890": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r891": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r892": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(17))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r893": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r894": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r895": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r896": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r897": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r898": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r899": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e526-108580"
  },
  "r900": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r901": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r902": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r903": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r904": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803"
  },
  "r905": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803"
  },
  "r906": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62586-112803"
  },
  "r907": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r908": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r909": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62652-112803"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r910": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r911": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "(g)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r912": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r913": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123345438&loc=d3e61044-112788"
  },
  "r914": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r915": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r916": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r917": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r918": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r919": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r920": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r921": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r922": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r923": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r924": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r925": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r926": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r927": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r928": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r929": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a-c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r930": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r931": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r932": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r933": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r934": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r935": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r936": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r937": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r938": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r939": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r940": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r941": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r942": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r943": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r944": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r945": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r946": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r947": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r948": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473"
  },
  "r949": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r950": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-06(3))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e604059-122996"
  },
  "r951": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r952": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r953": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r954": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r955": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594"
  },
  "r956": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r957": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r958": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r959": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r960": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r961": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r962": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r963": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r964": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r965": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r966": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r967": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r968": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r969": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r970": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r971": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r972": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r973": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r974": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r975": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r976": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r977": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r978": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r979": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r980": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r981": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r982": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r983": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r984": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r985": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r986": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r987": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r988": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "11",
   "Subsection": "03"
  },
  "r989": {
   "Footnote": "2",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r990": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r991": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "29"
  },
  "r992": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column B",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r993": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column C",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r994": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column D",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r995": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column E",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r996": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column F",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r997": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column G",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r998": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column H",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r999": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column I",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>152
<FILENAME>0001792044-22-000010-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001792044-22-000010-xbrl.zip
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MDHG,E0L9DP9"LZFB,?"$ADXY71^=*V.68,R"@:TR=2R1R3YJ=D%S"S6[H/D
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M*8RN4&;?#_^K?K/JNMA7GYB#"^_UE]8WE7305]K(W.%W(! SA6C"21\ WD$
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MT>_;$')3%K!]^\O=>@D#R[8?1TO;7D4K>!V]N0-_Z+@0*28T-UP*5MAVN!G
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MM;D,^<S</*W]".\^)A9_ 5!+ P04    " !%@5Q4[Z,GE9VU!@!.RT@ $0
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MH&EYN#S@^6.:\.+F9#)[+<CS]:;7^L*@#]E:7;2NR% MH<FD0S;%*9US[,-
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M/KS45'&-/6XT@.0'.145P&0F*UE#+L7K"DES&0CY]02@-Q<@0->HWA5"QHC
M%EF\)(/U!9,$NY1SD!0'C.U!HZ[N$?)"'FD+D[3+Z;F25/" RB7AC:DIJ@@
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M*6*A)M!<U .%U#A$TTPHH19WOI?J7-J[^&:'WF_LE[H]ERZW7_K1I5_4#=^
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M^CN,\W3ZQZJPX:@]&HQDLU\?M 9>O3N (WS0[W7J'3C$VZZ[U^WZHQ=OL(/
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MY:XJ+80_QHF8$C![Z1$!YJ%<:J5"V2I7I!.\,6P+U=^2,3#X&4TN8=$(3IW
M!I+<.CQ )+Y,,[S=TB-L;G?=MAIJR-XN;:6'PG$5^,:M]HX&03K..SE*<M3P
M[7T"=K4Q=8K55;@C&4NYM9:S<AN/;;AFNUER3H9EE8GZZ!CU9$1J583.^^GH
MIQK.7B@IF1'.K;"9TWA^<&SS]9ME3>FL\R1P%?EH5G:L/HZB^+J 6:&5VVXV
M!U;.S"G,4\SS8)!^.@HB-5GV:/X:L[=8BX#8_@$>PZU!!3:X!)FN+<*N3^:A
MB&K.N0]C2TBT-1 ;;@R'>  ?^CYA"FW.KK)"!\.+H\L*R-**\NJ)BA,XEZ^#
M)$^=8>#5D&$PD#X#\8[ 0HRG@>L47*J+,_K<Y<Q]?V++"3>)6 YN,[@P[^.8
M&'9S7V@$YWF"#H=KE5=UPJP)N(7:4JTNT+T8LVY:/("'^3A/,U4(V.K7'")/
MD%AZ!R>N]JC1&3X[?E__Z:>A.G%+%X;_O&1T,3SB0^.\X7R!K&J.@Y5+\80%
M^>>C>Z2GOW22GK"8'^5)/)/PW(,X3S(V)U-4F,LRN$34\YSI=CJ6;N=QC.71
MT>U8NA!+%[*E:1^BXI613,9S50LU7<)86]-L:=X^8M$7V%=<*D;F509:0.J\
MV51FD]@S9[12IS81E* +.7\-_Q4CKEEWZ8) JJZ9\0U6MG,UFAN+4.?_,!0#
M>Q=O>S.)4^F@AW$-YQ?\\-\YS(\_IZ1?$+G(0Y2)6T4FD3JDMM#7I9MT>RK*
M@D!6"Q6KV'4GUD'9Z*!48](G(ODL0<:&.4A_LDAC807JT@K4ABDB>SHEW76"
M=1I89OY?8CI[K?X,3,Y]*UO&3O0L<<866(./C<N&3M:&R+LCHYS//CP'6X/]
M/3-[846LJNQU&LA*VMU3=8$H*H)E<6S-I:G#6/!-D$U4JNN_$:#_5SR)G"+3
M!B:A(*%,P*0[B1/$P%PE&-XS$69P6Z0P*% R\-%I?"VG([#K-!^8E=RJY$YE
M0MP)YV(&LW3.P#DKQEN0;+4:>[V"92N/4DR2,>&%GM,9S:D"(U;#SYP=7I).
M)),I\K_H"J5I+A,S,%US/F9BX@Q=<*<X+N=<YJ/%F/7QL?.V\8G9M<:Y@#W"
MK:/-)+(G14@FQ6(BVFZ1A2T"JV!U^WVBU2NGS$J2PBY;6=HX5X4AX!J3I@,R
MB\9!R7%MY<V4M[/S0RMG&^9HDL11X#KQB)FEB%\C#Z=QA/!I+T@EEOQ9L:J(
MU>69%:LMC(8LD^0[7\ZPT14!7LZ2L8B"O[FKJU9G5XD4WHV8VW-SG<!].CZL
MMP96Z#;1 5Y+K) J$7U:?Q$$NF4AT!6I.@?O:Q$W:Z5J.9^G'=N:DT[B)*MC
M+Y!E)S?"N61WU5LB;M\JS/#<!?+PR&;5-LDBQJB)GO$(N4I=KHT;(DFH3:A5
M9$G"40#.>)EX3.78EG9LGCCE1V*KI5;_M3/2+J::/L8>!)$;YAXV@\H3!V8Y
M4?;<+ FF(H%!<5LCK"X.P_@&#;\I+\./<.8DV413X#/*GL(F5GQ-\7U_\,%*
MZJ8M'HH;3 *_1XP2G*P:$XV!D@_BQ@J4.5G87,*&WNX7>O.,24-+3M6AI5GL
M?I[$H4>=0,*0-)TR_(B2.\]2)-I"M4=$X.3HJIB=[<VP*)EG/UN!W,;JD]A0
MAL[@NV#PSUB2;,^$Q]4S@<26'A7)K.#\=EYB%]57U7X)>$$ET2$R_C>AU>&^
M:[&S-1/(2H,B;KJ7(S *_"![52MY:E3O!=+1GIPE6-14DMU,P2Y5@4F[J\Q=
M=7AN]]16"IJL!3=3M4HHUKB7CD2*D++R:]#>YS**TGEX+:) 6&$SA<T"J[<&
M&9QHLG(5_[%)NLHT3256*XUM_.<;QG]J\'V&Q@'VJ]85*UE<^Y*XT#E8M^0H
M#=- U.BJD\#S0M:@-><2W*H)'=6(!$=_OVBC./3YOQ1,4NK6!I66M\3Y80$9
ML=M@8TLD>+SS08PPHA1CDWB])2(PH.G ]XH8\U3KF*)0'D5QE CBN1EC? K9
MFO1FJN&&B*DU/99="0/).)HK_")LE)+$KMGJ64DV)?GBW$GGL-$M3G?33*'S
M ]*68O/H%-2R*ZDZD!#G*Z;PV4N6;2>PK?WY,;*N\J+P7!R_/;MPK AM%B&N
MM,+>V<Z9[U-9P 6&EJQ F1.E69J1QM%*U=V3I3C:L,Z],F]4O-?IVN*]34)&
M^]!*V>;"IQ@GBJ+2>NH(E!\E<ARD7.*DLGT<&$16E83!=D58\&+I6OJ^ICC?
M;P0A_Y'080%.)AQ^C$ITIQEH3?+,_2"$2ZF*$!]P>72 3L2EG&5<8=5NMEM&
M=96JI3+KJBJ54^3"W%UIY4D77@P9X6%"&#H>5Y[(Y-NMAH.S5DP63Y^\G07X
M6_C%F9O%YO5T<^Z*7/U^H.YG]Z\AD>^&EV_MKMTP1T6N:V4WK+<Q_,?2VFT]
MFP?WB-(_<E:[!VD2TJN(Y 'K^9(:14=)/S9^*57=0B,-2W?'<TET=UU+=_<X
MQF+I[BS=W:X>:A8ZM!7,X1VR6*.!3F4(0P\49N&-6+O<%*A?K%F^:8KROP)P
M6Z?.+_/X1CB_!$E@=F0ZB!O.A\Q&:RI3AO0^K6;]EUV2K0?LQ$>MPJ(<S.Q$
MSF+DD(Z<8@Z+:(P?I#!L9RY%XG!SDD/I<A"CT^*@@^UHMRR+5P<V*KW5F2D]
MJE"Y2H0G;97[ZIEZ?WA^8:5I<_3YZ*-"HJ1%Y=.AR 26%&>*NO="CO.0X\-6
MQ$P1._YP=6QE;,,DA?$(9"J(,A&-J?5K&-^ 3WQ+S&V(M;<R94Y7(D4&=L+!
M)(B$19D^DBIC6HV:<R6"&\$%'C]A9[E?X'^L])K2>VM%=<,,,7K3\9)\;.G5
MS)GY263NI/Z;N(4[683*%A-&$;/5+5O/!4; G2NDEKF@"KI*_];68+]K9<^4
MO>/SH8W7;IHD*<)LXAQ':9Z("*3N/$XRW4X$I4XEP_5'A; -]NAK/%N+>Y1E
MGE?2G408H^-&(D633*K-@%'@Z^O?V7Z9BW+[Z8?A\:'M]K!IGG(\5(+I-(]B
M;*3C!E3BQJQN0>0K1Y<J=Q&>1+32>+5TC,O3>>0EUF&I3NWQZ:F5O@U3Q%T@
M4,1 E9W&T3F5OLL,JW%.A16HZFS9N-U6 D4ECG#/1%X'TM(3+8@0M?*Q=,T;
M!:D^2V(78R6)3*5(W(F"XE(MXE+LZ=D+UH4UM;;)4"WU/5*MM*PP587)N<CA
M\_$NR=2#(5PQ6056TS66=84RPQ,PH=G39&FC.;F8.*TENQH5,(!NFX&);]#G
MZOY2NK<YMX\Y(06(K<TKG8ULBKX0V:M=$M6'.5$- JLBLF'UGC%%/P]/_["9
MK>^0V5J?S_I9P+O4G&&.4,LP8.)<'/(?4H3P;RNOQAI\&%H:J8US%$?C.G8-
M1"G+4U<D&+@%L<K$.$9$KT6.5*8+"_NM3&V4*2^.UE3V6W$R9RH(P[D5IPV%
MZ6'@T$1Q9HDY2:T8F6)T=F2%:)-.2LE3E+=@<J7!M>T\7YV?J;@-IOD4''08
ME1A+AVQ1"^78(K:AI\[%[F;P%A276)C'DF39C:]EA!P."7(9)VS=(S=Q1*EY
M$%%1W)%_"Q]5;IW%&>$R/3F"/\FK$$4/-8G$\W"/:.[\.\<\ Q%45'[/_-A%
MS0,X$@%%8WST0M2/Z):808T([4D74N4P]O6%HSS('#%.)#%.V,:Y=V^MDT/;
MPV/3%.5A%GB:&3D,LF!L"PF7)BG&W2:L+&TU3<[Y1"13X<J<1I;6;,N-I9DZ
MMT40FZ:(J) 61,E*TLIILK*TC2R=:DXMI/Q-\U$*YYY 7F$K4$MS=6SUTY;S
M1%1M-7 =7-6R!2NTN T:6.Q$S$(V?"AN"E?A5,+_)I@U2!E B6S37I!@PO5F
M$F/ );Y!^[^0TCG^5&4VL*&*(JD+Y5BXFK :^?8U_QR)>93%5K27EPS)\X@
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MU6H7D3686:)'1SV+#.BH,>D%=(=K<RLUG&&5F7R).T*/!!<N-=1,253UUB1
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M,RQ8WW?PJ/A-JJ8&BBZ>PM",*S<V2%AY_8I=LM0]XF[KKR 0K\BDP8Y9,U(
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MCHT4Z4+O?:;:IXZH4XKS[G#(JW!T,C2B$";$)@<EGA2%GG^!PDCA7KJ="IK
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MQA+,[_/.FRT?>ND3]Q?PJ,&2.U#=WLW&]8NKWM[\[EN+0]-9,3T)CNQ1S<^
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M]G-ONI,WI0SB]5XI .*KD(\=#T180- >E*PB7+*W*I=E*C%$E-&7HPB$N06
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M%?&4[)F F#M/R&34U28\4$?_XU<#)K_73N6GTLTR&4ZVW;9L.<4%!FJ1I#L
M 4)Y+PSHNCP(3JUBPQ_=\74?I%E().I@?D.'"+=9A0LF@"V4.S,T5\S;;E0M
M2!"(8?B3AK[/'?W5;^5!0BTES_J^/"P>):_LFLX'R;%3]H6@/?WU5@362NI%
MD/952@IQ555W6HSOUTKS2H79>,W;DON&EL$E!O[T&ELIL\=?CC?7Q<-:Z/M#
MUM]_\_Y6X^BL^MWE5S06/^AQSTH<<&S+X6J@"?TASF9["-3EP;BJQ5]( KI?
M?/;#SW_I/__3XMOH=+^()N.W=DOK[&]_^?;Y__F_L+Q^DT+#L[(#],/3 C).
M$E!)=@A=#[":]$1K(EV]\=,=9SG@':%>-MI#=%GRW2G]%<_(:I\V5#17)40P
M:<$G&N%"DF'7>"X#00CZ$UH31]?>>:6]YDK[-C!(:=5>->B %P?XST1,U$ME
M",U%O]$18R#9;VD"92EV/7B@IH?KFR(Q3]=_>U[63&S=.;C7^H- 21BXE%PE
M ;R--BMT.4L#-"16K5IWN#D<4VB#E'WXL( TB-Y(!:!GKES%\.2VD>LKU)?,
MDI)<[]NV5IR&BL""WJ/>^2=GX6LJZ//KLFU395ZK4].I2K09.G/EBD!BR&/+
MQ#J8K6<FYWF.A@I>5SK-[39<'2^!SZX5T3Y:( +T'@ P9+)S+O *]CJQCRM&
M/KVATU#=!+C-Z '(H1&A8<8GLKGJ+%!4&=<J=RW#8=]UA(@2TNXX%U5^3_9C
M>NZO_02V]/<L!2*]$.*!M<UK8VO>]58^\MR^=H-,)PC6=26&[;(K@=B[14 !
M=>GX+G%AKP="IK+N&(.E:3D:TF"DY6LKY+GY!_0HA*]K4<NDPA\R(CL6"]GD
MA(#B1XNF ?V),2"$#I$^%I&FX^HCZ9W]6X'>AP2 TKU+(.X;WITKC [QUZ/>
M00&P@L!O&$'BH94B'4"IH:L.G4!K:G.2M;(=D"OJ0-'/@!%,51>03Z4>?K%J
MY+01*-WE%0\4,.'4U\ZG55=ISQ ^(OWXOK>.<4:BUX#,7%=+0O/'5=->!<LD
MHTN?8B6L4@V,4BSDX7R&@KYJJ7"HM3&<%26RSX5:,H11T?KS4_.(R+-3-3.$
MFD.ZZ &WLCUH51(@GD\FT>!S7F^1N[Q(0;RHB$7GCC,NG9XHZ\W!]CXJJPHX
MID4IJ! L@XF1H>WL0]F .#^=_Y X8'FM\7J'73I@$W+!0[.NMMH*2^ZV CN[
MJ?J*!3J?-BK\J BO[W[Z[Z??7SSZXX*R[&$KA%_D\H#TA/@VANZ*]I?@0OD)
M6,(B^J:A$6Q%._2@<47[$)%&T6OHNZ6MX#@?X<M):2>^#K\UG"WQ+:AXQUU!
MIF>R'59\;Z!(HIGBOH(W7.4GL@*^#:MRZ!,J2H7U>*332M;3BT8K3CMD]K;P
MMW;1#&X)HE%([<K805&#%AZ2U%[+TBUF5^"NK:&' B*Q.MR4H'H@WIJ2@1/%
M0O_+@?KU$5VCJV4 =>XWT0=@W,$$%@1&E6EHX'&*8';WK4MR.5263+((BV@?
M;2)P+UV)1M(R\<;XDB AG45EEFAN8>.--M![-!4!)U&7(5^:>4^I^3;ZXKPW
M&#%!W0=$9*9C07YUG^ 5_:Z&LU!M*'6*!]Z0A$-<UY<+=)((N2^*-VLY#M:!
M.@AH;[^H]BOJ5G/2J#0^_QBNKD G'9^(.B2HT0YK$Z1Q:^ZR2)4B&D[JU(FG
M!B4CX[@7RJT+^ 2))^$D;NE F;1]&".=1 \<2L#W!SE<RY$(JS@@M/>R1F-]
M66>J$BB^PP;'S7DE8O D3J"JE)D071JH-9(P[=ONU_PD@2)_/ -%3N-9/AR@
MR$EZA&#Z?4*Y!\K2 /&J>9#XK*?N"CAG$"MB+QA(];ZREU%+C(,:@$NRDRXO
M ZD!']!0PGT7;3VLM:6'UHF9@1)N2"EQ_FOM6UCZ:-VCMX$5A]@-)ZLIF*'0
M>MW6:S1 FZ"/[^_HZ8B6KUPNJ%TVN3*E=!#S*5["I]D;O&_^O5G^AQHUD! D
M>37O^\28W\YP@0<O;E&-8IH&80]&#*M@X=6(:T^(]A/K@.D/@_\OA7AE12<8
M/P?)$7/ ^]J>Z2NV+7Q]TFT+/[P4=:@G*Z)R@>CN!P@[T,VH$',")MV&)1S(
ME/6\C&M#'+M#.R"LWU!=4YM&5708GEOJ$2U)2,N521W1(R#,?5J3O_SPW3%L
MNQ]IY,=Z:M(AQ[#G_:#M?VCF;AK.Q? #17M@J%GPN'1[(.IG_OY_:$-WZ#L<
M__4/%__%KT9<P.Z=6DG,R_<_4)P6\BRP0%E7\$WT^/GD;3@BDU6QZ0).XS@I
M$+$OB52OA3DC_0_JC$)RBHP=$U[ C:(0)A"L*MH:2>H#EH]V+T*\=!1[T*07
M -D-'7&U4!)RWQ:Z1#@]NA(_P&)%7:^2R<RH:98TV5D"*;[H$UXEO&VS1<(N
M^364YN*EHGE=$Y!\K;@!(.\5F)W8K?,U^@&N@^>R!QG(,6,,/KN]O;WLP^HR
MAMB?\W:V4HBL?Z107VK^/"TE=,X[-AL^*/TW8GA4=B+FTP^H<=$-L$!&B\9;
MC#?N&?_#XU<[6W+W[ZO?C>O?],G[:IM[_L./U&3_;@K@<\\P\HV_N'R$T?!-
M):^]$3A*_$=TK*K-X03V!G*OE#) ]B2P?Z5ML@CLQW+&OFK 3EAST]:4A0)C
M0B'T# K#1JX^'%K)P@M3#7>3:7&GH,.6,C+@%1(ZK&)>"R@>8F4TFYNZO:7=
MEJA-=M$I1%DJ'E^\#_\W,0_OV]4+%BP6$I5E,&ML1"J",^3GEFXU?IEJPSG_
M=A7/3ACNI7)/;"0[2V94#M:: >H-Y#9[?#W_JR+2V2EWCZ+G/MW6KFS5*3IX
MX/O&W_]C:+BSRPS%U-SH,>!<@Q'B6%[!O QG<U[?NI_DHD:[HA]-2*)S(*6,
M;GWUTC7J_RD7D/R%>A7#%;6^_:3+CU*HWQGS5;'X,]8MY[G^ F&O^XC'LK%Z
M]Z8U#LU=*91?ABV)M[_^*WR([&G(,GP;2 :=F1WYY4%'%L->;3=%CZ)G?61F
M&+0T-A(@(&LN7#&"\-2K56PAPLOKDD9,!,#BIR#OVE1C%TZ8PC9#W*P$#:5D
M?F84N&6?%>.X[[%(C#1O5D,YH^!>"P5WUPYR)F1!GL)Q%R&[\-?C+?%^!_V/
M7W_Q^)0&_7<P$.3#,T2A5-H!VBJ_[O[17C>+;Q4JPFI&AYJ"^+:N61M@/]8'
M'AV(=^7FF%R0!2?VF2E842 58EQT1VQ\GN?7G>>4LSG =D;OIU;Y">*(7%4[
M#GVUHF7$@W[W4?=;_-M=$WN>M+<_:>QE5\W*2[FAZBJ$.W14$A]B"_!B=+"?
M;>*].TZ7:V^F0"9=!L)UO*/&9JR\/LL\VN/QX@(72E=FYD4F6"KC*<^M>BB'
M$SH2IW_HJ'HY@9%2M!./]G@,2ZR><M<"*3*BSSH&_*O#Q#3%DY[?%K%!>CRC
M8E58D+(MT@<R/KNAZP?IK*!UN%7N*1H8_/+X4+SB0D]'_W&7_NP-O(8W8#'$
MF_D";VT6GE",^>^U8)V:W?D216EV"HYYY"Y5;R&N:C>#V*Q4DA1*86A'EV?\
MTA3%:Y\4I[J!3FL2]?"@8+VWO4+D0150&CE'7?:E:( 1A/>%^0G: E2B9B+E
M5'42SF?]VYNN3U/*^KQPWMK"\3&4T_M5PB=EZ(QKJ>U!9JY^%5OZJKEF E5.
MB0+5KL;;.) ]\+$^G&?Q[<WB=ZB,,EUIV35((7.RWB!]:)3J1=>"0P*V&*D4
M*FSF0GRE5=B'JPG,E 1>VRT^B47Q@?G +GE^SHB]Y9WXS.MRQ_VS!ZXS;H*P
MJ] )(&A?Z0O(W*G9SH$B$0+P 4D[UQ_O[V87SY7OU-FHMKM28.#'MOJ9/\XO
MWL=?G&'!I_$L)PH+/H>P;\,I$FP=S*:!)52"V*E\D0V;*+DP9<<ZCG5W*)SY
MI'Q>H\H#ICUS=F;?;E%I))>F$T$IZ7BTWE0 5(*)+23B JKUYL6@&&"^2A8*
MG7Z;#1"8U*E+>(+#1$4+C,=CC97SO+_5>8>6U0;)^MJ3[8GF#7%)LUM@>:>
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M:^X7E&MD+3Y*.L25(?\2C>6%TFMKZIZ3"\8RKCK5D_?)7D/2B78@QQ/H6JC
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M5,?''K#86M*"TDAJ'&Q1%$5SH2<%CZG=AT\E(I;ON;J-ZJ7=27^%8$_\87W
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MT"Y_018[NFH7[*I)UC\UPG+IB-N@QMG;HWD_1;>&'+@C'PB;#)>VUYEC1#=
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MER=/GGE^$Q\0FFUS"XID),A2 O6V)UV2CB((IE)NKYKX%'Q6T3M6FPKG7<G
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M<W8)7:W0C]IW(!(JN 6"+,^%E\!(>[KG"PP]HVI]%]*H/VA-IW"[RPD=H84
M.GPW -*JU%'$@G83*PG=<LR_)4 UPV_[>ZAMN:.&SF:Q(+R9P@&/1R][QKH^
M0"V/W $B;"=]Q#3'2$(*$;#(Q)V+ZP\!..6MK1U,RJ\:=Y8 &2653>&TQ'*;
MS7DF'GXF O7]P;-UG+>K<I?2CDA]I,)(%FY&$UV>9^D!9FG<*DO@["ZLXJ^Y
MSB(ICT3ZD/Y$@W(V8@\V*>HLG$?XW2Q[<=*0=XUW1C+EFVB^SL/_]H?_"A&=
MXTZF2#BZN=%9>OLATZ<(F/GRBS-@YC2>Y40!,R>2(<@8/IQ PB3\K]O;T%T
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MW<_PVJO\R/;G.;39XG<K4"U;!XQ<F2UX5^XJ&LO,[1B=*!-C6@B5L_,SMB4
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MW%1QSN,3NWOTPW);];W&Z/9B1=82=L:H>(S*XS-&Y32>Y40Q*J]DO]^3N<Z
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M\J9E4T _?)5(^E4B%'4;/A+;0$XA,O8PNZH5.+=[0#4T XH8>F\=&NJ>(3X
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MW?EWRD@UDF,FH)(T$IU)SYG;D4:[GQULNXJ?I#MF@%4RV7_(1Y-!0-L=R/:
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MP#I(:,ED3DL8X3]_D]0&5S>E,\G=PS:,/KOZ)?; <Z?IY>*9Z6W0U=&J:(^
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MKN60LJWH?-7"%D4%U-P:+].EN"M%Y=0BX\GN:.'2'T"EWH7-T/.&90=!TK\
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M5L5EF087L,FJD(H1[8,H:$#=J86-'OR9EOAXMX1"H+8&8"7NW.KBH>OW*(B
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MA]0><46E_9[]2<78D!@#WYEA\#C!(#!MNH!L> %FM]:)4[J_N2=@1S-SP"O
MECF,-[>9<YJR.I@SR-HM@^7=,.E#?LZ/&07*G)? !D@@*.*=(C%LR027-7'.
M.Z_<?-::FLLB6'#.&8\M,UF(I>BA*L2W:6 2 =* -JU+$+%3.X;]&)P&,]?H
MX7CE,!W[WRP]+T8.H/">G4D#QF8ER3'YGI@DQP[H#S>"""BI& O?)>KSN[2Q
M.?[T#?N'!! <W0,(;L:SW%  P:TZC22>#S9E'3Q7#5:09:+J7C"(&LVA[9B2
M=M*?DID(-SCJ?O6NH_MDVXH6PK@US:N!PTUAUX+X3(N!QAIZ919V*,T0*!!\
MBY\[H5+(5V'W+7;T,HR14UM*?TA;ZJ>3[T,\<TI1A1 ]\)FAM)@<P_*9P+?*
M/3BW3+-+_)"(@G8QK''')?F^>F)ZIVDP.#@O-8)P<#7D1N7O%CEI_$EZ $2G
MP9ABY]Y-)V_<4U9:F;*GD?)U$_M:().G9VZ,VM'%P2WQX="K*3) I4Z0C_M_
M%QO=Y=<V\&N(:KA85<\%X$$M]WH)-GN@T]I:HQSE'[C]9BE 016'%Y4/:!47
ME8!AUV#JY30=8Q/(X_%45G;&3B?_P+4C.X'/,\>A1;Y1I*=,-!8<>30=!N16
M& @3I- ;4Q]=O6U3$H*=+3E%F;(;1PN/]AHG#Y-5GNE*,;%45+_Q7(HCY0KX
M&0)A'VP;+..-[+3PE._5'9R\IJ5=I%0&$;- XWX"GGW 6\C?K?C;RI9;,*+S
MI&&R<!**SK@*#M>1F<+B'T$<,R\XJUPL.%T2V_2B%*S 576DZF;,4#A%[+6C
M0XO)+]8\Q!CKXC0'4RK#D?:LH^[;MBLV+>_%99%N0EA")WZ5LO$F-!IXFKCV
M.74%A6XU">$._]A1GS)-]-_R#>@G)B]"F ZJOX>'#P_)'&Q*&F'ICI-7\#ZB
MT!_'=)W4_N6)BP^;$A7-R=^V86N%JSX45I[!I73CU-5)K8OY/*)-6"H"M7.P
M72[SLW"J([^UQ8DSG=R-&"]IHAB8=:Y[,$<.IUS/K!60CS13L3RIZP5"OM@4
MAR.RRM>%UG]=HFM@LO(8M%&9KF0%6"Z9\"G/G3J#9X1:JAT&VI;H@%H#6@FT
MQ N"W]\V[KJZ4221]>#X RZ&:KV'F4Z>QSU-.5D4AO%;^8&$9%S;L%X)NF(T
M0VU?A3FBEY@*F1YL&UZTV4G)1:@S]X9';(?-WH27$UX6,:DRSM&F\GF671!P
M.>J-BZT61:^;G98)?7#NK-.#R;D2D3*+129_T%?V)YIUW1+I>.53>+&=0/N]
MT$B [.MMR=#=*O/QL^PX2]S1W%)S35/0,MY6EJOVI">D]75P6I]+&F^R:##L
MKCI??.#>.>U"](H#U.AC0N9E5=7,C6Q>,Q7[G<.:6?O>;'=1JA I=ZE@<GG0
M-#131!QT*E>4U[":NR47-0(0!HZ8_XE+W2(,-SCV3CLM9J0,.>1W,?L,/"&D
M7P:9%T.B<4):[ZRUG^GDA1(%1"J%.<D8-Y5&3J@&@7QY;[U?F[J$K;-4C=+]
M(]MSG4'/X)>)(O9L><31P)/&EJ=9 7M*RP?V"N'*2%XKUL=]XHRJO*,ZV(G\
MTJ %9YGTC24><Z)&?3<V="_GJXFWB[$?OE=6W %@;EFO3PZY&!6$#94S&HPB
M*TOT1OQJOU]2GD*IS2_F+U<G$5S*^+F SPS%+H_!Z00Q%A&]:4#2VD-R!<"Z
M"TLH^,TJOC?V',LF>#QHLONJF)Y0;9<OR?0BC%\:/<&E89*ZWC26'/G*<AA3
MCCS%@[2+S;HXQ2BL=DDX'S=<UMN:=;/'<']$4C;IH+Q=9_$-KI:]9I((H?WC
MZBGW&-:S5:D0!N?U*F,E]UY*]1:1\K)8(,QAQI>Y*#E32W&"P/DQ'"/T82;_
M)9@DVFO_.LY$&(AS&+D)(DMZPU73K7J<P(FY;[/?6DUM_5;%Z&'>Z3//02-X
MZ;#/3K;!IZV4Z'!Q)HRLG%BA[=\6*_:(][8-H$W!C:-"JKV&@&-YH369%H8G
M8;:E*^./741,5AA.A=@^</GZ[9\$^3@8VATB_15^[8M[.OE.\1Q;AQ?D=$F^
MFF_%07!\YJXK!@8G"CDIOBE%BDJG#;N!=DT6:KI@.WFZ+<YKPTUFB8/!I7KM
M3, 6A5U2-$TM< Q.[%F?QX;Z="01U><(VPTNAS08/Y*%G8+<&1T9S;W9!AKS
M<N%Q\:6''3W6^JU'M>0M>@<-S$!*#$"'63A=ZC62U['?X;Z<F)03']Z7$V_&
ML]R7$Z]!'"L<_Z/6!T[#-EC/AK%DL;E/"P*+3"E2]"\9\RD[?X +BDFXB(0G
M0R(=EDU @%G4.:X'[/4#G]^2G^*72!##_;M9K#;F7+BA*QB6GT5:NO(@!"K;
MA12:5G0Z<(V'(S?'-*("4.(X6R>9>3C^'$4'\, 9,BLN>1U-J/ZFP_G/DHKX
MU_%T\DX:<'K'"]X%^%7N;(Y$=B"!+P=X'>-L!'-2)Y41&JA>%J,]Q<@S[)1R
M">M9&?S.;F?$^,''0;]>?2[)J!"H@.6<SV ELX%JEK;0PHUY^"U@3>,/2)46
MQEKJ#?4WO=4L*YA3**CUY+%4R30D#(]T?]8""'U=V&O<X-7"S%I<MAZFDQ]&
M-Y;!\4'\JL<U:R+1G/?=C"QI]&7F2@D!!9SM?+V^;* Y -3O:J5V-)U R+6=
M.$DKVK=KK2QNPOJZ4E,HH AM*XZJ)-]FVJL9G)WG/[Z;V"(5YDJB9B87K2N4
MJ+DAR/HE\4C!C(*CRCA",Z0+P[8>-YO(G-QW;7X.(@?OM&OQF\-,5_%E)UBR
M3RX4*"M:W-JH-> EBR5':3!L3?_07QR+2"YT05'R#Q%KRJQ$_K)KFA\NE<7#
M/:4''G8F91%)XIL-!G2JF=",(8OWRY9"$>$E8PQJ.'8R/9;'..32;D+J*W/=
MKF,H]TU9ETGC(O4I-F$2R2(PQ7 DN5>N*BFE\6/PB%Y\* =;UQ3E>A8."^.N
M:S3V=^GS@2_$A0#55Y;4J]98_(QQ2PJ'PBK?6#?&.,?NAI8FLC%:$O<B'J6J
M9P,!Q>JJV,52;WCRLEA>TI%F2IEV*([=F@F#$T=HD+;0U>K68W22#C2MI\[2
M74$C*%UCJHN4[CT9/B*V+,\*=Q#2B>N&R]P.<:)^JC!+[SK6H"8"EMSU!\32
M$2](N0^)=S/9./^QK)R<#O.!3"?/=;:#3]-(;^$(*<Z?Q[@7L'HTA5DI8:5)
M"B4=[; >E@\M*^_J)HPD24OR.+N#4S2'7"$[7V&<8ZLR680TR\(H"&\BDYGY
MN6>CW#=[)9RV4P_8IP83V2LS3?R)>R%0-G;@*"29P>72 WM 4'] *)/P:M)3
M1R[($KV<JWRG[ 1BHMNBZU9JIEB>/3PT#21-8_PPA6CHI#91KB.;X,5+0?5%
M(!J]Y<N?^GR,\%9Y&%8$=UD1VWLAW8.:'DR2IYY;I['T&^/Y^E<1/O2PS.B\
MD4^T4[-T %K_AK.B.X=\Q!Z^"6G"+-;BA0C6PY6I6V9[5-S,66%-Z>+L1P'@
MO<P._9YHFF[&XS"_9'E"M*EUXU*^> Z OW:?N0P[R^>_G@"O>B V<8G_^_8F
MZ?ATCJOV-/==@13$K,.^B'$PCDU%6!"##YV7BL#C90@:3FJ\9,])/(5!:J.O
M+J)8U:C:(5H>2Y4=P9[41\'Z"B:,R34[\W7MD?W-IR9<<JK\0.FMA"163U%]
M9JR9HV^=F5&_3P+_0CFB2^4@&OQ67E?+RYS[+K7K7:UT(GE0'+SPGIB(^UXT
M0'X*KS)*.BZ?1_[DX966YF3LYE]^PYBRS7G!D;7H9:"$']9)1)!QD<0\8=:M
MB8W%L?]5&5^2DU(RA7*SL>68%,+%SH^0M8H+,!T=SR^""U6W+'TI.E7E;>D]
MX#E3OQASJCSYYC\U7R6"%HQFQ^'(DA%189H!.Z9257)V9H$N7H'ND$=5"DT=
M:650D,PHWV?9Y.'AT;.LOS%\:WX^=_5P9[22""IE"4ERM#5Q7??X.Q!,H;D.
M<A'A^#S-5TOZZ,HO I1&(LL^C$Y]@&]K.%:]ALN2#P!93S<W[7-'0I:7&B%(
M *'5W.B_\92NPA"T\WQ33+1&:%#DTL'HS/M)?3"W3IL4F=]/*M JD9#86C%9
M Q+T<A^"NRH91N<T1_GNR+[EF;Z&+D<D!43G@$D>\ &F&I:L6>H;%U+9A+F7
M"2.EL]7R@!J0.-&:)S(/$_N .#P\Y828'B##]+>4N-4&7P8Z&0E1""(8$M[C
M9=C4'</^W(R4U2EK_\J$6O!ETD3(5223Q?-SNET#_QV>:+WA[IOW/<\!"GX,
M1)\'B]B.2 -! \J>$-_5V,#TX=Q+4X1 ,#8=8D&+WEPC<#=L0')8AI6B&:$>
M8LE8P1+._7PNBG@()K&ETLT)0 A[&*S#9PD(9-\LVRDW6*6^I&Y%(UWAHH=
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M7X6H9YCZ)7>9IJ524L4<4T]0[ J6+%I S2QG"9<#I^R5E=_+'F06IFV9%8
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M[ 3;4EZ*.G;]TVAQT<9Q[J .H6GG^KL-E#2K.6$0_@CH *FWG$L\.W@^)G9
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ME_ Y94DL+'O7"9!#3W(*6S/+:\_QN^#T_!JE2];DWC637[;A?@L^W"FPXN6
MGEWYV;Y;3+Z26U1U\OU5/3?$DYB,X6^I=IG>&FE_H?U>E H9P145L_-"_^RN
M]  $!"BMU@+W+CX$5Q3><OCA=IWP '6[#?N;6LIBV>=Z7A0+.%GFN*,L57:,
MW@KV_X)#N!<[E2T[XW"GVBVPB%+5ZMNNZ %R#!>L'!GT.^/?#!:T=)S+.&\K
MU) M!%6R!?5,1YW<S+DXT$$1[JWSIC2Z@X_8*;I1N/F,")&6'WN%,./$!D#N
M,DZQN3%NTY9C#IR/W'3!<>B<'LS-W7PJZW7I#B2G+]R@/,LE,E5:@[C[)C-,
M/TZ467&:KY9)@H+=QI&?"0T13KT04I9K^IDCV RG$,D&$T//8DN]'>>\I?%(
ML@-Q%/+^BZ=B@N&S1KCH@JAT4&(+N)>C;EQFD98I%;@5F6;O,7SROJ50RO1E
M:B\R,Q9C3YN'7\*!V3;MEN @Q/&*"F_QJR!'"TI& B*RXX R<] ]1G*OB\6.
M6PCYF<VAT9T 'T661W^C]_[,W@UL-:9%T1YK]NI'P#L?,=O7,F9,:Q2!)\:H
MD"\IC"+DR#Q<G;4/+G@X>@/#.?$0?17^6G:7OO,#6B=+>CR_.16J>75[=%^J
M3DK51_>EZIOQ++>Y5'UC?*I:\#&K%3=!H4*[H=B^$T<U& $!W/2/X6C TZ(G
M.Q"@\A$? %EMLJU)VRK_Q9%(Z]<=<HC-?(IF?!<_)L8U#7%?"J"(_N@R-F/I
M77Y@*2 NB 8<F2 $IN=Y290U0]#H@'=GS^/&Q"I2NHP$B[QSJ+_BG1FF*B>G
M:Q35AH3Y:2T)@]YXLZJ\N *"CK,'Y0-3:!8Y"4 .&N!UABQ P98Z"U8^6A&$
M(YI:8T,KM('*82^+3)\Z!SR-^\;$9Q(S@ ;I^.$()P3U"P$([%M@4A*)K+Q]
M_T!XOBM7M (!OXWNZJZ K-]?O!7)*V!2_N["]N-D.]#H-=X% LO[+V'+(=?"
M]XAYM31C7(*S2^57R#</+O]FB^9'6B<][S;&J-%%;GUZR 6\N-O>J/>B"T+"
M5265)(VIJTZ!>++N+AS.9$6)VYNL*AHJ;5^JEZF:E7A4D;E_D"Y(O+V!&F4T
M7E!OZ LH""ZUUQ1&J%-!C&PQHAW,@5D,[PSB ?#*O:2#[W*I1MI7;V:"[@9G
MXU[W"25=QZ_UX0_:Q@LIBJCB)GQ\*F.!98]7EW'7Z3^!QG9G)J?,Z;"#7<!1
MEW&Z6BMW<YD1#EJ$RRVE2HV$K".-4;RR!"B^V%5A3.>]%>510[R2?7^!$C=G
MD],2YTCQ(1P@G@_5!D\1/;BQ&S%6X68$T"G3L8\NEBL1M]T 6_^0.TB#;:/I
MH)[S]O>9-::6YR+ID*27-%3.RJ;&_:2[4R% ;&HRX9Z4CKM,9PRLOHT6I=,M
MP!Z*D"2B L(@,:I 0*7-6("Y( 9F5'P=!E;28>0[N0&*.$JSR'!P8>A'!XU!
M:1W1HU>.3Z,%DC!7^D* X,*_R<E-5C%272Y=1VNQ1ZKL %KC:]<90MX#1;K\
MI<U5B=A[M\"O0/+LGVM(W9SI"Z3HR(N9I#58[TU>-LYNX%XDK L:%FVUI\3Y
MKT72TMJXU@O%W8U4%!.%XHCX8ZE OG[\523S@"ML Q@<QFJ(>'.IUH3$6HFE
MXIJ(&$@_QDE#5%GU[5#D^2<03-A4#0J\--);3I98GQ0Q7FSD.=+IZ?-SL4LF
M+4A*&UZ">W7)%<K3@OWR%:BJB#P@YWUKE8J6]=)[5G;,=KM>(&MP'#101)JQ
MC[6\Y>*__W1Y*/_TR9^NYL!O:&JKDX-5L>S^\N2QNO1BTP_H+[]_)RTR2*_>
MO_QQ<O2=C<_O_PSIX!P=3K^AP?BI8M<Q+--W7=C(U,&]YE3)1\9-7_3@Q!C_
MLQYMJKWB&GMZ-];8PYNSQ+Z9\F)XPS#H8,QNX:+Z'MY!A&='L-[&7HN.CB7G
M(UX11?N14CTJ58*R.88CXDTXB2:OC*LH7#Y\__#@[Y^\<)\=W8V%^^CF+=Q_
M(%?V)L;J=VK]CF0";1G_,SA4__7_''U]^.W1L\EGGI>]0?7X"_W#NG=_G_4R
M_A2)8A@V_=.XN^/V_DT[^^CPV;,G1T=?/SH\>O+P;FSRQS=OD_](Y=AW^;((
M8<L+BYQOXU8/F];U;]Q7<),*[L/]%=R/.&L?_^F^['M?]KUB#>EW6O#CYO;-
M\=OW?(*_>O7)KN4W=^/4>7(#3YU(SO,6ZEM-[BA%GG-VY>6_M^A4?2LT:>]<
MX\V/4N*AC,XK:M<A/KYF?II++Q3_UI7-;^&!]KJ?:"+D'/7=+A30)#IN&)B)
MC&F$%K2[]:Q>:3#VK_=OWTD@-IW<PM$XQKQ^7\R:;=[L>&\_?)B)_!IW>*/*
MF5+9'AT]R@X/OYE$-A>1.;7,^5ZFKH\OGG_Y47K/+(0;@ WSTN0B5CLN/<8B
M8WCI_SB<'AV!WI>SM@:32\F-1-X4&? ][63TT[]1$]'1USHC[XI-Q_S&^C?I
M^IRG?YU.7H??YA7-ZN0Q_O8P&WT.;L,AE)Y5OT4SG90 ]KRHON?#:WE/S1$K
M9%<$U>F*8?N%#^2M'@(3%.LR?MWEULQ"SC9.ZIGCE-05/GDH@\&0&7[3F)XW
MLLBE,OW$J>UJO]S'7C69.WT9%=X*40"1 T>0ZG#@A=V-?L@ZBI/MA@I JJ$1
MP4MC==BQ)QHMHD?5!:6R]!4]1:?JZ%$FBJ/ZM.XGA8VZV3&*N*': AYRL0W_
MHHH;VOH*7R),R@WC@P 4%<ADB[.<RG5^\RW"W@/O7:X@:9V=$">':3W\5&C.
M%W6K?OKGVY<_O'KW_N7;ER\F[X[_\?+=Y/7WDQ<OOWM/6J,_O7WU_M7+=[?0
M;$JA=9.WG?152_%9%1/%-FPK)Q;J\%XC4#&@Y8QMSC7EM7^YP25X'0T8<UJF
MF?+>R@C\QS?3QT^,WSX_.:&,6H>*7T4LO%Y<MRVJ$M@AC!2I\Q U?1RV#,B-
M!L(]U,D<K/23_PP'!WY%.3C6F.(3X6CZ]9/#\4^?!$,Y?72XY]-OZ--O]GSZ
M*+S@H^G3/5=^? B+\'AZN.?G3PXG7X5963%7 &&N:-K%X_K)+Q891= \OPB_
MR.5"XI(]8.MQI9^PFR/S =3:!CTATH8+7?8/H!U@?#SZ]=G)EAQH:D.'^%+0
M(X<#=<40+N469 C6;+L3<%5?Z>GM-AR%1X\?'SLG= RX6@NA2]O']>!57<<%
M!0=:DWZW]Z*H:D=W@]T/=>B6Y0KN03("IJ<9MRI))?>A "2BNI24L%+WA8..
M_ODQV^"*DXH1''R1/Q0$:)L3J&'_S?A0IC>"/(DC="3 !9D5L./0U$'"2YI1
MY96M GZ>.\\J"J#6R2@_5??M/:-8>71XO(H/&Q#3AE^\#D>E_SZ#9XJN6_4^
M?Z;7^[%F7=MJ\NS9]-E_&FW.A6/<?=SFT>==N!!T,.K7K8SYY:V[4O0/K?OW
M(H'SW?1?4\(JGP<'D@BKS@E_'(5F3)4:\%K^;::F*)BR1U\__O;1].O#SW-
M'$Z?'GU]P0%Q^/#1^*>/Z=-'7S_<<T!@31Y-GQT^'3\C'FIG>O4[FM_K-9'W
M(J^_/8?^Z+X+ZF8\RWTZ_&/CMG?O7S__^^3-R[??OW[[X_$_G[^<_/#V^,U?
M;_)1]3 1HG7I"NOL6=&AW<^%7B'].6E+.NK^69]))NJ;C"/RR1O2#6>"L+R3
M)EK)+.9$X*(LAHY;OH\&G(93D9MWVNUZ[;DA4Q$<D5Q)VDH(]XQ&K#2%2=FK
MQX??/+M,6  ,6*SV5A6:ZEKJG=(Q+%:7)J+XX$+*"AHG7T7G, [=(QZZ!U-
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M7=3Y&82(M&!B6N'YZW^]>G%P],RN>3_-USO-@P1>7JZVS;BK1H$54@Q4)N
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M7C;S[9K\V7DQG;Q:PV&6M+G6R@@+&Q:OXLQ.\M)<+/2>M>3[(?:B97@:AN,
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M%G-K$1J/9I5#?K0Y3H+DY?C +98,XJY$P,M,)765 2>A(5#1@D%#QA?!-&^
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M=-O<GVR5?K+K,-E]YHN215KY*]X8OIJEZU]Y\LYU6YJ"O5$I^6;\[ZVNAUZ
ML+\<Q\+[<NG-8+*OO.#>6R;?_5 \,'!:2C0L+W_M(F>SIV,JHO54@++Q:'/
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M3#B5(WD5]W*8@JN$[PS[>:<Q6Z$Z%UID)ZD&!%MI]=%N&8W*B"^]Z9V?H '
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MN=" @8H%;.:=L.YO_<DM?1+)'>.T(EYF!,8%YIW'7N"%$V$EMT)@G0:56U1
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MNOP?AG*<P#K'*)LSJB&S$%>IW7K]BP:QTD!+^?3HQ:O0"Y:)3U-]S\!*8!@
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M4\&$N> JU^Y63O4E2W!Y>V#376&Y-TDBD:$*"+@QG]:-A,0!4+]-X#C:,O=
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M@ILHDNO0HEI)&800HM9#$DL=/[3P0*X%:'LD1]E3XYI/?HA;$RB"&*U\<EW
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M_Q LIOR#VY9_:,L_+&'?DT7ECJY<@:5*.V_8\+S U?8@7L<J>=@"%$LFX7E
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MI/NB3!.?,84H-3D]F4FQ,BTW:Q[&UE;QT$*%V8HMO1,; [&'VZ!=]JV>LW#
MBJ=D#2%]QW<]1OR$^P1@*21<QC9Q0^;3T ULQZ=K;^UNZ/KKWA+I.:W)8DEE
MC9:B'YNB&R((#6U7.D%"O#CDA+DB(I&#1LB8<4F=P+)CB13M6_Y2&2$7:KD(
MEUG^.!B.,4WT_J*&68$;!?T]3]1:F,^DQ:>'P:?C*8D#-"'+B5T0,0++)2P,
M!0F26!+NP$;ZL66%;@CX9'5#BRY,1[HQB:R0[>,%D_W"_"LMV3\8V3=#-A)
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MNU5W6> LE6GR 2IQ+I=@H0,\VL".99$U*N#40M("(6FZ(%IL>X&(+)L(&B4
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M]N1_OEX>?1=G$67>4?\+/<3K882[!SO6[N:'T\/OV^SP=.,"ULF%=;C<@?G
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MFWE:>+LEO!U.Z2X^MT/FAXS8G &\!;"-/' H280 '<8!;3:A:V\=;T;T:VO
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M'#UY=NSR\^_V\RI*H+KW16)7!);%4JEJ+JH*,X:#EE%;)BPHQ4M61XS@&0W
MN11.6>L3#5N[G/&%]5:IGNKV@7CQ9D(%\3)!?#X=2T9O-.&0^56!0$_ "B6
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MDJ?3CDCD4D4$9)2#8,F"$0F!<\_*&(42&UQ8RF %=&L!O<2![Q702P7T=-A
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M-'K'I@T^SQYM\?F>\;S52$;9QH>I4-.\;-L6O4@):T=R-3IV-T6 W4)2.'/
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MJUM?+,:=';)O[.]1:\D) I**2+18\K/8OOH[T-6>?I#]2O FS/A<+2ZQ\MX
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ME"G@.3K!'F4O_</H8Q:6!=OKJ/D&:[-EONC<_L*SO;[RF.?_C\=G(WC/I.1
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ML<JR,O=N(9SB?=RRW9 '93\.<\#9DU1 YLER5[)A=[ IW!ZW?;9A4\# FF"
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M&P-(; ,)':3P2NO*VBA5J+5+BCEI?4RUL*X:0.*N@<23-4G".I *9<+*Z@Y
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M%]N]XO>-F<#.4JMV!X!Q35_^G8&VV1[80LTFI64X;DXW5)[1^>D>ER7_W^D
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MB"%\@#7OCI:^9D$,,D48MC\!20F#6.MW:CUXD&:"AVK[ @W'1,'Z_PZ:F2:
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M0F&5&K\(-5ZNZ5"I\<.K\:P5 0Q*>,<C"AS'7)\E(K ;".*<1>&MHXZ%P@-
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MZDII ;]$XUVDFLE\SD Y2RS=NI#P#*X5-L_8&NJ-,>X5'"H\'@#.UB2-.M)
M\WF"!P"4-B%M0D"1TRBI4Y0X<W4KD@H"*PBL('")$+C3]MUH>W%[$/<[6_Z_
M X#"/*:*[]T-[N9:#R:#%?<:"95;#[*4D-/"(IL\5L%PJ2-;VY1+:#M=85V%
M=2N(=;=)FWEHL!LZ)DN_9+]3>"6'3LF*]"T5!6=('TF*14P]LK"V.760@M4K
M%5+4A^BP5X;X@O2!W3L/A+>N<E%A8(6!J_3@CXR!/7A@^.T:,!P>1732\"!B
M= [QZ255]7DTQ-N;X7U$&^FT-LA&FC.F.07>1S@RQ# FO?)@[ZYMDF5TSZG0
MKD*[57KPV^1):\FM%;FN+>9:6<N ( 2K",=.!AN+(XL;),E51Q;+]-CMCXXM
MZC]VMW?.#Q.WG$;@;-IPEKL8$N2D%TA'BA78M9'EC#=AR()JXBMJQ"ZSAMDS
M.$A^U":'S[>^^BV02Y@@.5"SR!WF'@=C$L.:<^<\CP3SY1RV5C;ILF!M9^XD
M5GNGF: 461$QXH8+9"R-R)H0@V3"D^R9(^M"R?LG-U2M$E97E:7RC)% 2#*1
M)V8-A1U.>1H$)MYK5ITR/@/EGG4X8<<]90$%XW/Y<AF0PPJCA(D1P= D';^Z
M@6FEW*NMW+?QIRQ!NV_F3ZE.TI:KTG.]U+UDE%F'L"4!<:(BV"-4HT1YT!S3
M&&4 *T15K<@J5:Z.AU9;M6=VZ^Q?X%Y9A 6GB#O8MPWS"OGD71!<:ZUDWJVI
M5/<J@EYI]\O6[NK@X_%U>?;@(RKI,8L.42(4;-.6(QVC1<3E EF.>2L5F-5\
M&25B*T5>07,Z"!T8U8P @G.L@PM81"H)B9$$*N5R?/K5=KQ$XWG6X1^M-2II
MG EVKK:$0VX?:I /SAB6"]FZ7.)^G2FV@5?(>GYEZ6'W:3K^?+LAW0**(K8B
M>6,=D ;NO=%44TIB(IP20Q6M,J(>'6WJ<WYX">O"(X -=Q(( V4,.4P(2HQ1
M;IUVT@/Y%VQY==U6*":BTM4Q_:= ]9GT$8P^3DW03$I/I=;<,!PD?B@O?*6]
MM]/>&=-=>8ZMMA0QIVT^15-(RZ@13RH*+8F0.<Z):;ZT4KB5]KY"[:V<Z\M5
MXUGGN@R":$(8J+$1B,,?2'M!P*0R)'KCL/)F;9-*<W^^7ZGQ*COA'EB/?^IB
MKW3X=CH\LQ5[C"U.DB%3-!*-S"-C'$4^&:L]39$EO;;)S2(=KKK_5NI;^="?
M2I-G?>B*NEQ'EB-B*.S&)E%D#4U(.,,8X411C]<VU8)PVTJ/5U:/;],O-B9'
M58XJ]9$K1HW"3JL$-I63WH94A<4_A>4[ZR57QL/^FAPRCB3$@Z%(LX!1U,)1
M^,&C!--7:KF@"^S3<>97%OG^?J)C?:UL63\.?*^BVZ\L)>:$YYA+IP/E0@8'
M ,0UM\(&#Q3#5([S1P>@CW..\^BY2S8G5>/H$=?>(^> ); @B:>6P_;AUC89
M857X^DO6U8A9@KV'DA@LA__G+LM,*%A]['62JG*<KX;VSECKD;NHF.&(&4,0
M5S0@K7% U%!M!#5@PN68-VTV1*6]E?96CO/54.-9QSFFS@5,(L) EQ!/ 39A
M1C3RL'I)<6H%]KE'#J[23)Z=&M_&\_;0>EPYSI>HP[,E*6&I5(X\]]I1Q*ED
M2'M%D,-1)$J]-HZM;2J\J"9O%;-:J6_E.'\J39YUG#,5@3][@[# +K<)Q<A0
M(Q!6Q&#XQ48:US;O=P!6Z?$*LVDFHI96",<DEY89FBB3S)*4-(^J<IP_B>4[
M%UX>2& 48V1U+@$=+$7&6X\PMQH#["8M8+\%N_C^-?!7-+B<T VZ.I[SQ4U9
M]CM]VWK"1KDONLA7U4EX K6=IL8D1[D-BF.@7E[ "QC8&#=@1R_IM*'*&%H6
MI'^>.XH(D0K+L4>Y7"7B@A%D@'(A+",WVH)U)0@@^CHF?-DUPJKN[!6F5I@Z
MAZE4A(0#YH0FS@T)6BG&X4^C@ ";:*JB1L\ 96<#/'.W%*$Q8L"> 64]6+<I
M8A292PKV3F;SD1&AZXJ9I<6<5#!;P6P%LT\%L]7QW7(A=?;XCH;$M$H*$1/R
M*3SAR"5JD1&:,:R(QK%(7UO4EJ#"TPI/*SQ=\D',0P-J5>/KL9!VEKQ2+X*/
M'EDK#9#7J)'&S"(E5+)61Q]<;HC UK&0RTALJ'"VPMD*9Q\29ZL#[\='U=D#
M[Q H=3QQ)#T1B.O(D-$:^*O3FA B@N86^"M=$$1:(6J%J!6B+N\0BR=)@_"2
M$,U3Q)9@SQE-(4DLD_55V;M5P]*YN 0A4V#)*>2<X+EGET=.RH2"-=I%)IF.
MY2F6P"_H%*N(:_BUGR4-_@W-[YO%HV7A;K8'MGBV?\/+HT<YL=VC9GLT8CG"
MMF8[@(2^8;* VD=65IJ5%32G.P"MRDI2ZS=BK\CT&QY0U&PW_PDO@LZ&6K.=
M/Y$UN)A0FU]+S;9M^Z9MP<#AA9PS"%_KU<!B'!1+W,M?"[$?NR?--DQ[K1W[
M\.[WV![$LHL.?-H6L-"UR/9Z\#9\PPXU&CXZ4NGUXJN_-%,-/M-OP<V_-^&+
MA6WZKXE^/+[4^UJK:5VSU<Q6:O&M4]LLGL';7N-?&[4A3.T.3F#F_$PN,4G8
MTY28(HH;+S4&'%+6"?B_\XDN)'K3D/2W;\ 4M.)>&H'3;@?(VU\=6*RM=OBC
MG+?VT25D[</M?V]U_+=G"D5?_]/ _N2?MOUB!GO'W\X/]H\N]M[OGNR>?":[
MVY^:]?VOC;TOG\7!\='YU^.ML]V3C[1^7#_[S\6[\_I%_9!QZIG2N0!'[OYG
M+$$ZR8"8C2D*J26QK-P_0,5BV,J(SFG$BE K&$Z<">4D (0'1LZ3H#C!YR,
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MH^2D(J2TR+?)Z3,+Q".-G]@>@1"4N34Y5VBB\GFSW>LW^X-R^X'K]&*K5?/
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MEVC?]W!%36WZ6Q,#WDMCN?P;1OKYM)+.Q=+Y&>_M>Y(#9O:V/_ZH7QP<ZF"
M<_&$F-$&<149,OG(&98&DQ2-]B9W2-T@5^4"C245Y.LVTD!UPD#[+*<4<R^L
MU59'%SCFB1%J50ET(VGX2=C#3:3AF3MA[P%'N+Z]<Q@];"LY @H;FIM-"8&
M9$N4F(O$6<]@]M<V*5O4!+=V4B[P>K92Q^;4>NVLT01.T^P-B43I./&=7A&?
MUX/I[HWVR2E3:\*,@\]U3H>'F:59N0!QSH UI4$K&W#E$L,U0HE]&20V:CL@
M>F#*#XW=G^_1@%QPPSZ,_K25C=/"M@%D/2V,_2?=M^7#[ML?AD_^(3_W5CN\
M&SWURSZ]N(?BD+W</UH'KS6HBQ0JH&PA(:-C;NP#)BOW*E 1US9AN:],GAYJ
M3R''W?&)4RGMA;LLRW,\A;>:Y=X+&N5B%F\PNF.[!V\#G>]FR0:;J.ECK=5,
MA3!/,6-@NAXU?Z!&,P!Y?O.:%HKN7KP[5$YQ1QQ')D6.N,ZU+01CR IEN/'*
MJ)S[E0"[AK9'X:KM%?Z[$^O!THD .M-XD/]R$=A5'+LUANZ?&2>&M"0Y <2&
M*4X3U]K@:"U8VE)ZP>Q"U9]6]G$X<1.4.?X%PPP[[;YM'S7'1Y)?"@,EABV0
M!GL4/_<BP.)?( M3&ISEX W@8WZZUZ>SK'Z\=<B)<<X(A63 ( J6203('/..
MIQ5VL-E)D0\,9UUZQ7K_;)T5$%8F7!!*,6YXTCY8B96(PF@LI:[6^1'7V1^R
M((17'K#94XRXMQ1I(SE20".-Q #;#%2>SJ_SI>:[0;.572"SSMZ7Y<EH#L,;
M"HHV$K91:L4MDRF<= Q3$WE0C@O%M$P^I& Q%DR9Y(<QRG?Q2MPY'F-6@XK$
MROV&;;_O=,(9[+^5-7B5'NUM'QUBD2C)92 ,]@YQ1PTRAA'DN79)8T\<RP4A
M] :^*D%J; )V,]D_.>TV"]I2\.TP\/U:$?4P/+>!SY3\YI+/#PG.V1#Y:K:$
MOMJ@P+Y+PO,3;'9!>X^M,#AG]B29VX\QYY,53FA%187-CR53//-FQYW+3BX4
MF8B()S#BM10!*>*U"!A;E?)!@UB,S1NUOR=.$&W6\M/2*SWH@^I?E+9F-N^R
M93=V6?T4Y\YB%CQ;"&;A'"_<7]F@S??))PHC>VKD1#\NCAC@IJ6EFP4WGRMV
M7";B&9I&@RC=X6/I[C<&O<+FS9&Z<+N_(AC,-39YKMS+9P$A)H! H)CGM<\;
M?V_4WF]M?2CM@J,A;CT5.%>X>8T7#<:P<X@=]4$Z@H!N6L2E  35S"(''%-Y
M8U-*$OC'!K_*-+R$33#J 1!3MW,R>WY?"E)Q;MVRW:/LE1@Z9\=.C?Q'!'N_
M<QYC$8  B^;C2(HS_A9Q!2[F0+5"<]K +89G.+56++!LY$OVQ:WSH3&H4O]\
MUKT"?[1:'3_E)1Y+:S9Q0=M =?,I>Z=X\])G!/;KT3" 8+?3CG/?OC2.2[T"
M.[B?(]R'8@]_9H/8]\MKP].$F)^MT/',Y9K9ZU%&,YP.NJ>=7GS9K&[!^=2$
ML^LR.N-IW5H/VL+GU=1%O@=4L?KVMT/-8R0T'_0S 5!E,44N,SZE'$G):*4M
M0)42YLH<^)$;:^2R&JIW:ZJ71+E5EV%)I[;;'^GXQ.E5N<%->V7G+K(@CJF,
M;SHKMLW\T='.Z;J=;T >0?]!+%OPVW\'G7[I49YP4?M6QJ6"&>1#^&)#I@M<
MQ(TF8&'7-\[+8?8[.89KL5:-W727-+8,,RA1*<<[=3(- 0K0ZX]\>273+3E#
M#C7HGQ?/-7[@2X<@S$.SW>MW!U?%(F4M;;9+\C,%44.@X'1#Y?"[^=B\LV;H
M-T:1^!-?'(8?XLNO6 <[QJ!_]5<F8A)SY$;L/A$>&CTS01,_&]W+P@9'$;EN
MM-^033#8-[9U9L][:[].!V,VVVAF#F<?_\J'3.GA A:+N0X9[(LU?S. 7:A;
M1E+^VZ[,6&J-;MXW_J<9:0K))18#5SQ1Y2B.B4@BA(,W%#WDL(T5+!ID_VW>
M<D#.__VKO?7>NVC'OM]^/Z-=Y99!/!B5G$G, @<;F5I@130:J017A#B[0#%6
M@R<,C]@ J0")!JW^&&QF8YB*X$V7G=V3)WJ+HC9O=*!7@\OZ>$7TPB6Z=@&,
MVX-XY:A& =;#2-PQ1YZ]9H;;N9#K]=+LNU6U$ YBRSW'FA#NJ70Q,!.L3B00
M188%DB<(SXTSCR:JA/2 ].00<ONI?/B*O"PF+P<7N]N?#T'#HC,FI_W I'-F
M.=).>I1"D#((K%),:YM:RBN+^IU,A"CD C*M3@_8P;"4#!@,ZZ7I<F>2_*@R
MLQO[!1F.?\%35))SE>3L[>\<:FF\!/% 3"6*>*0.Z>R4TL(:#:37"._7-@'3
MKRQT.Y2<$K!&HC.+24.X[)66>,JAJ2,T TO4-XKPU+$E,Q>&/XED(P*8XRB6
M:+X^V.Y37/%-3G5H^JG]2"U,C_K<MH/0S \(TEQDT=C:.)NR]JG<GZX8_366
M^70.C5R)E+#Q'IPZK5;GK/"Q%)3G-"=\Y/4O@HR+W1.>?S">'0"B4K&G_)(C
ML9M.[^C5FJG6S+D7H=;Q18&YPL7YIP7^TCVO%5LA,:4(+[K%B!:,$D]&N2R3
M<CIA]IW:'.(S)A7P2W&9]M#E-"G-BX7^,AIZE TS$P%17&8R''%D/8W=M_.1
M/3.%PLH@QU'N29KR)!6Z51OF,XR?;,)]5*IP[_H9"YW"(SS4_UKVQEAX7-\\
M+9G1>3L'3,>1!_G$GF>_58XVB(4#>3W;K9>TJWPC#[XW<+WXWT&V,X>&M@?@
MR?,X;QEO_/1<Y$[]'J[=C$9[T83'9A]N^7NKX[^]NKWF73Z-/CND8" 8HBVR
M,5C$!>'(Y,(1@07O9/)**E_R!C L8MC*>[:F/%J<&!@0AD=EC;?"YO "D3#W
M)JW5(FSAIQGQNT 3-[=FDYY^)IVC XLVL.)>KTQ7 S@LTKR^QTN70_GI(JTL
M)T#8'&MWUAFT0BF:8TS) #/#O'NEX(Y<<V/=+&R"4/)RZSK?0=+;(.KEZ4A<
M-(PTZ ^Z5Q@KPVS,0F6;!6BZ7C,TX8D*%^],8M;\[K'0GKMVZC?_76+UV#M2
MY'S#KM&RI[WX9O3+;Z/LY6:[P/[B2[]-[T8+TB"+S:E\^]*]L(%+%\,P^7MX
MY^';&\5;,PGLY7N*;A NKGP;;Y KW_O990G9,.3JK_[LLC]_3["K;WJOP?(;
M7?::!/MKB^N:N8\N*$12^L,>I^R&GB$B<^2K$*N#G)O\;BX[8*HTP@VGYDD+
MK^C;D\^R@/B8?>;DIU%8,]"1G-QU6N3ZUGJ-C%% /H"V]/Y5FRT;L:@TSDUK
M0:RV<&2[="E/>Z76O, IRSD1-U>>%]&#<7_*:7?'LBJONK#3JRG=]&"U]%ZM
M)W58B^E'?7_K1WW[\P_X'-@H.[A^?$#VMD/SZ_[G\_KQ'XVO^W\<[^X?B?E:
M3._@>^_.=O?_ %OFXQG8->>[QY_Y+OVSM;L/]_GR1ZO^I0[7^D;_<[$SK,/T
MKE^_> ?WV#E46G+@QP'62W$P<8)&UFJ*B%!6JP1,FK(<*;A.-5]04/E>I9A>
M1+V["OA> _ M+;.Q KZG K[S:> #T78V:(V,]D45T(B,8@Y)21RVCEH6<J@?
M61>:;JAG 7ROH9U>[B !1F\[9WC<MHG'Q.S/EO][R9!]RZ=_,9C]J&3U%1WA
M/BYRU^<HJV<!UE,D1+FGB*=(D(F"(YGS$#Q6EDM?]/_1[/[ ?3OE>>)>814
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M63<4H5XA0GXL0B-_P+A9P:B=RYNY67T G"DZI_[M&S$,6K&3WMI>(__W#@C
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ME1CH\U#8I*H0\00[\'*0E2& P<$IRGL/4H$RB3FQWHC<%%SH&E10ERSII-#
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M&PQ!V&JK, U6T["RKE5]Z;8+% DJ^*S+@"GXK N?8S8+!I>"6,U0)$HCKFQ
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M^$E<EH]6<N"MH>1V)\1T-U)^^.;;%WD97]EIB:>"QN:,H6FH2408C+!5 O'
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MWG3%0Q^53)$B$KQ!G >!#+,8R<!(,,9$6Z?^<*5+PY8">6\=\L" 90!WTLA
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MPW,5ISY:YD3R(4B2X"4Q%%)X1E+8:QXRIC05V"$>'?Q%;$*.TH0"D5I1%7#
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M(J.EGH(E[3$86A)^,LE&,*Q) I7):"HK-]J<3!K IEOO=74PJ-9_IDYZ7+:
M/NRBV>4J4 JRC3&F.!5$,QM8BB9WTQ6D3M'ZCJ0KI+ H*8#=)1G6.B6PM!D-
MH-)(4&FBE\A(QRB-UH%!7JDT<\39"![&X0"@H-T:'0N:B'K<)BUD6B%X0_S'
MS:&76W4[U]RXP97%R(=&'DQT3#'KN4_"$.&(]2H"-7LG1"&?99+/_F5SZ_30
M$!P(=Z#^X(PDBC)DE$V(NT23ELI)5_</FPLEGW->4D4 <^.0ZXW+,:JQG3$R
MR:>>*N-W.@"7/UM0OPY)6YM2H(ER+)6F1O, >HW$V=J+2Q9 ^*U3S=[G0ZT]
M6/A4(F9UKDLJ/=*8><"@1(FCF!FJ\Z&E.3Y]T(47U"^T 175Y69VF"MA+,/&
M8<V<S(4TK"O;N]SM/?EP*$"A$"P2I!4#M91'@0SC8">!>L>==PGTO;5-/7=[
M*S_/AU^W][;>-\[;%_D4_%1$?7$.!^T8!!O1PCC+I0A&""V9)Y03[3E9-@D4
MP7!R>H@-Y<(K@YCR!E@<F-T)$Y%,)%@EHQ%5PZIY=8?_HZJ@9<$NKD_BCB>&
MY!R,X]@.5<6)[*I<K\HDY/H)F0Z&>3@W"FJMFX[K)VY1^R0D(3TWH'X"\4K&
MG$N2:>D<5H!@U-^I5>1,%R"&0D4/I:+K_4.-B0";!,B&^I +K("!*RU!!';%
M"A:2S+55Z%SM-"=>9HKP/5CB[#V94D<7I@0B)-91@GU")'>YJ@+SS JEO?5)
ML3LLU:)?/I0 =K::A\Y@;&4"\(@ZAX4"F"?,410,5SA0C)7650AXWIF/*N]U
M6$.EU9FJG3>LA/)=)]K=F; +)+N_B##4*"121<N?/R"RK!A\"8@\(GONG1[F
ML_Z26HR$-V#^.0=*GA4>U#T:5%0L$"NS]X#.5FI]>$#D8<1!2T#D$6C@Y.B0
M6T>3R15Z"<[G\G0 8TY89!7#RE%#A&5W5:!XG(#('!![@G!(KC6=<,2!1# L
M9 (K(^:3SX$FRZ0IX9#'I,3K[%:02B3+@T9@YH'-X< "=<0XE$!7)Q8T!F7]
MTX=#.O&H/D.R&,IY'"UG8)TFF)/26$OK@X_& N)%&XJVN5P"^M;<^GP8F75*
M.(FPP!IQ$@S*K;(1-1);XD3$TM^A;3YF7 0[+C.::"85M]$ZJ5(RW!F%C9':
M%E)8,BGL;1\2'7!BQ"*AN<RGS3DR1'/D%97:"\Q"/FV.-]22XR(+.C>)M,S)
MJ DW'(C!&"NIR0=X)5 K_U%N2*&,12GCQ!]:S*1G"12<P!5(&>J0PP*0PJD4
M?-9!59SOW5QRO(N!>J%D9 !-D5-&-1,.:^^%M2P$4L*ER][\Z\^'VN06%&#F
MZ*!@\WU(8.N A/#:&N.%"; !:YL,SQ<1#X]W386Y%O>!@Q+J+1?4R:"XP<E)
MK+43R@5G62QAD"73RL[6AT/!.&<I,103S2+$*F0$ED@:$H),2GLBUC;E',/H
M<<(@(0J:M @>S#*>(G::>NU(L !G,F%:PB#+IH'30Y.XPE9PY!BGB-L$/X$Z
MAU+D3C)+0S+T181!;%0X4:.\ TTC&K#W:4PFT@#FOZ?B#J=+"8/\/!7M[1\&
MJD-B42(+=@CBFC-DO?=(VRB(LE)Y$=8V^9Q.<X\0!L&!@IP+EFIA.//16FR8
M-J 4Y3P*?L<9F:)V/)@ 3IJ'(8+4#D2A%'*[02% YS3:H2@T#0143N)QCH/-
M+7VU2!ADCNOL)98#V;J(MT["82'HBXZ/O8%M=097$YU_[NS&XZO^.J.N!745
ME=!*"; X];IG<$=W_(ZJIH,=5I]8ORD!T\K\E,LOU=V8QBL05,=IZK,V=67L
MJZ&'<S3VTW@U ?NC<D'KDTT:QFLJC$I5SZL?/J=8P]3F?L>]^:">T),>]W_Z
M8Q!1[=A-'^\N?/>Q*N4PWF_O0]T8O:I&M0?C^;7=]:=O#A0\V;G^=!AQ=@-2
MC;0RH%,ZG!"LOT$IY1J81">GW1H0EK?G.4K9NXAKWV%9MA(<2P1P[/9TTXKQ
M$A=U58O^+4S=5.;+A#PJS5>[]H?U^2A<U^M>'!WG7V0N<#]F<W<;+H[7@E@$
MX88?Y5: HEJMJFG?;96^JE$@K%K;GO?CN]$/OX#0/6_;JW>M3C7WZJ9?)A^?
M2]E--0FL-J?^>ECESI@-A54N=)<[!M[V-AS6P-NH:N!-]3VLO]-Z0VEZY]=X
M@]SYW?<>:S8PT?=Z:M7C<#CJ.6UDI]HH/D_'5OW#\DAJ;J/2_P+L'W;.Z/_W
M=/O)[TQVHC7N#Q9HMGVE]S&.]=E]";UN,VO>NSWGG/F]MHZ^\Z;X:GKR@I7H
M9!(L>*TYF(G:)Z)-8(8'&9R4\]L%(#FM.'Q'79BC*.S ^_<N(^AW31C,<?]U
M]PT:]NN]/CC;Q\TO?YWL?FE^:])MT"8^B]TO^W3GY(^3 [A^9^_]=?/+SMG^
M/Z?[]>Z<'9Q\^G;PI2GVKS]<[Y_\"1K'J3@X 1WD#.9QLDV:6\UO^_3@&$R3
M07.J7R\C%!1"3Y&!+44<.YL]X1))G*RTE-F@!;#]NE"SH9(%N_7.A[N']]M=
M!&JG6IJ_!! "WF)WBB*ZV%SGPF[!IH6Q:1\4U[W+;H&DY4'2]@PD)6$-Q3F,
M3TQNSHD-<DXH1#S%WDDEL-49DCB9[7_VL ;BSP))+U/[XP^"I/MJ@@62'@9)
MQ[T8"R@M#Y2:,Z"DE1<X)H,P]KETH5/(*AN0E-$Q%B4URF508G36B5OTI$<&
M)5'TI-4#I8_=BU[!I.5ATJ<93%)18V4P(!%V%''IP7;#RB,MLIM&X>"CRIA$
MZ6QDL2A*CXQ)LBA**XA)<&W!I.5ATN<93/+4XZ"D1,1QC7@ 3-)>8Z1<,B1H
MPD4N^DK7B?QIXVW9>M+?JJC.39.;R4,&55BIHH@?MMX!XEV[5S#JT3EU)MA1
M1=?-QM.T?ICW]M%NH0S9[ZC>J(-PCQNXONE8,]:P)K=A;G=SSLJ*Q*2OFEO;
M0XX_/X/WM)M;G\@^W:ZX=^?LX^GNE[^.=[?VQ<[U*;P?GK=W2F=BTG#GP>^?
M+W>V_CK9/\G<6R&%./CR@>^<G++=O9TVC)WL[NWG1)6, NP02V^8I0PQ8GRN
M]P!J1.[1EDP,"5;<:IYJ!&]U+F)XGY'3>H:S;]A&97GTV(%%Y 07S#)C)&73
M0>P%F@9-\=W+RU[)U#Q<K3K\79'5CU=L<H6!CIV-/EHN(N<@*8-BC!)+*)=!
MYX,LXTUS6E4WC6Z_#H\/,V5R8ZOAJO=@E?MU>DJ5+=.MSOQV.T?=JJW(L#'B
MJ(-%MS-L(5*WTKB:>5#=X*/J0Y0W+N0TM+K#>X U^UH?F&J-[W2O/I0%T#ML
MD>ZOJF<-^Z\,8B^W6JE2VO+'&Q4=C*_BW93P-GORR=*3;S7&LDH]^>8BSP^1
M9 IY8)9.&N&"L)Q3)2R)U"3%G>&$N:R^/9=:<_^LCE%5A IP?AL!SAT-ZEZ0
M;-G.!^ZK4RC=(?;>@OT\>.U/GI&N("LG->9.<L/KX[<ZUS%_<&E[H3ZI "IY
M=5#[#(#Q:(3*.;>KFQL9C8Y"CF5)]L^[@]MG#?O=Y0)OK4X^1=OMH'31\75K
MK]LQPGIVJQ9555.OJLE7M]=HW[;;K>70/<9:2:,Z"SGDX^)CN9-9Q-2)DW7K
ML/KM@[$7CCX9>_$H"S^GZ'?;K5 -T=DVR,'8Z!_'F-LRO8<U/8(9UJ/NPO/Z
M-[F;]QMR[Z8!<56PW?8Z($5O7EX?7\[IWWF 8>Z8^@/XIY:RL-YC$OP%DO>X
M2G.<CV*W^]V::.O.G-WY1'H<PU$<+P PPPOC=-:WN=!@E0,\XIU* :D;I0%U
MYCKZK="RO=:H\5BCRKJM>U6-O::ZS8]4L,Y7&&EN %F_8/R5\(I<H6:]\8>%
M:W.F\GZLFUWD:O[Y]S]C!RYVK2I'\N(\SZI:F C7G55Y,*.>:)/T$V).'[8C
MRAX5/JB7I#\&$S-+ @_I](?.FAM-[-FX: Q)9C.?QR8Y,\-Z$5(<\<?[W=\^
MW$P%=JH-XVNEUHA^;CCL\CC6KZJ>DVO@Q+-A^G7_YJI%>&AEQ-Y.S'T>OX(^
M71T1^)]JG5XX&)S9JR&7CV/KE"4Q+9R&S)T;2+9NUV.D[%>T-GK2!,N#,1-;
MU:$MU^WUNI>57=,"6AK4;36F7C]"B1&55@<%\KFOWB1PS!UYB*YJ8FJ'TQM>
M5YTW]Y6R>,?P\^,K9*S[#8X)])MG]R_M^9BM-@D50_:!]TV^X%7(C7' &%)!
MQM]JFS+RWNQK?VKMLU4\MMAPW_C]XRK,\%%SM9H):FK-JFSSL;AM;[!XH_'K
M[0@G]VV*',90L#ID'-"@BX;'C6N+O(+?(3+/*FG#!KK5J7:8T?#'4=F4BH]J
M!2?/=ZCA3'=7_>YTJFHKG6'OY J<+\#8:%<W9D&9Z7BL<0T(C_^[R')BC&G&
M#N!,T^KDH9W!!&+DI>X/3\W4Y3MF=+(*-X9ON8M <L_0^VS!Z,#"7((;5P9N
MG2FCMK:=<*O73##OO7LBR=7BQ?ID1D5]]?&*B[/<DO5ZN!_G %J^=9Y7H*K(
MU;^K!VCW8I )HSHG<B<##XLRP#X-.7/RF7?==X\]_8F3);_,\Q0]^5D3(<E#
MSII(NJ&4?-!9D^]_)QA?^@D6@C<H+H-]I,&2N[]^P.&@B?,R*W6IN<]!IIJ1
MG_@HTW</+NV,0*\N;=C8F@ UVYAG"TP$6%_UJ:[6$DYU+;PNJT<D_WLC;FLJ
M6>Y2#.58EGLY_%Z9^8T\I^]E[*S>(HV.H3886:_\ZSF:?(^5^O'TW_8:XD7@
MYLXDCSL7Z =K]!R987>BU/S$J:R?WH?.?I3_<A\R6WAYE_+T,L)EG!;^R=3L
M[P5QGR<Q<&YY&F--L!XSQIWG2D6++1?2N<BE9T2Q^;F!8CKE9RNZP6VFR?8P
MO^!/4(S^F<,EX;9@],I4JGEP M PY8_N;&U3>+[8_?T#/]C[C)O7.^W=+_MX
M=VO[NDD_?#LXVSG=W?MXW&Q-I_SMX^;) <SEE._O';=W]C[!]9_%P<DGWCQI
M7N_O?3S;IY]$\\N'J^IHQ&^CE+]]LK.W_S7\_A</__-'^X"VO[J3+HRY>=7<
M.R([6^_)SN^?X?T?3_?W/C!X'MFYAO7:^G1]L'5\LM/6^%#;R +3%B6E#.(*
M"Z29XHAC38F1D5LN<VD<*N85QZEL^W_&3JO;:X JG*,N%[$Q<4RICHXOPL]3
MC#:-"3]]GF#ELI7_\]\TD_RGDL%?ZJ'W>#$-0)(*XQ6F(=+$+1,NUP'4).E
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MC*L[LPV!WMOPV\94Y3RX-F]SJW-AJXO'.6U(W)QNJ.P//._V6_F:=[W8KH3
M+Y>M,#@>B:.Q&X>\B6]OL0XPXF)P]RUC")$K-\;>,_$PP=,U[,?^/KY)CSRW
M1Q&Y7K2GR"88[3O;OK17_;6_34(5X-34(D[/_\Y9IO1HLZSQ$MBLVZLV_1W
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M",87O9>?QLZ]N<?&BNS;B: X\7I=<H=-1$>9S/"@/^;41]_.E_VAYS;X9*;
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M_.-!$HG"D$"F@CC+ J&904Z)@?4:-3.MU\VEK(0&MVJW$+Y52@O,]"<*](T
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MO!(M X12_X='UAYTN"*=[E*(948X6&1ELR?.U3,PM53)B&2IA%!Z6%"3I9)
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M X6W<&S5 X4/#NM?+UEC7EM/18Y$>P$$F _$)4D),R"IAVA51%A7:M[=MN?
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MY=,]/256U,J(D>!,("Y9J.(P8,#1('*[O!1,3F8!+6QM)MPZ1.=YI+H4X"S
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M#\"MBPNV -R# =S'FP 7@P^4)8:LD1[QG.K@I,-(6BLCP!T/F3B<;E,AGP_
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M*F*N4XX6WL?=7A#AV2#"$H"00DR">D*)Y3Q89R4-1"9E*1718E,4A$W&@:G
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M;<U^^7D6>M3MC?=A?-//%U^H'-(&KHS?;W+Y[/QNTLD9G@8M39\\O;PYOM2
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ME]IO>^/$L6>=;B_L'Y5B>]W>.)M^B&+*U;4_%A ^'Z!\N81X26VFG H:K;7
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M!P?[V@T)5V X&EY05__\[;_=P>'/SSLU=[N.\:#'>)RVXF7B6)U7BFH'3-H
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M6XB*KL\;V[95QJ@UI;ZTVD/P8M*C;ISADE$2&I6D>22'CHO]PUD2?0^?Y4+
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M5T#P-.(D_QRY4:I1D@]TDC5*\K'WB%F"E0KF0E!)VN HZ. ]MXH9[@"24MK
M3<,*QQ#QO!?_V0_5F;XJTPSSBK1+#)Q@A :.3!/E'N)2=D1&$Y7*3DOK-K;U
M)4ZL!Q];^,AI=ZG*D1F5X:!"=D(#<.:5U3$)RY*.C@J]<C!>I>+U4G%#"8Z2
MRAB1=K/P$I7@5*@X)N*5YDJ)H&)*I1#O&HQAE8!;R'R#=RJ$4L= !A!".9XD
M*K,2E*$JL7#3&+9*MFLEVZ;&ZJ,(E&=.=,JJ1-)&@@<X$98YT)Q4$HYM;'-6
M ]EJ(%M;18<UR/T_<*!? *'J1E\'%'V:TP-LEIKK!,0+01&*F"1&1TJ<4I['
M -;8N+'-Z*9IAQ>]1L*L6818@PI0R??NR'?."Z8E"OR). ^" !696&<CL9Y3
MES,PD?E:U/A*PBWFQ6M0 RHOOGMBGE,+%*,B.DFB3<6EK2-QV@<24I1141.8
M+,$MJ[5JKA%M#]Y[?7NB]R)D7GW8*Y/^ESDQ7!N;@7M%>%:! * $[D7I/9N]
M2B)G:K@M3=IK5-N30(/[E-\K!MP5!C2-^=E9)2CR>VI1E@>%JKCW0(1,'+<V
M,R=]D>775>ZC L&C H*U^P(J$-P1$#3U ),\ RX,"8H# 90!B,_:D4PY_L&R
MT%P4()A/;&DI$#SZH+;=?H^4P+8:TO9 )UE#VAZ[5WT9!=M'17,RT;O,0"GJ
M%#4E381!X(J%<',%>U8C9M+#KYK05F.=I^U1SUI32^M#POTB&;(AD#009W-
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MMCSAU@AL/[#$5EA[&K"VC$D:- L^!2>"X1 <]5JR("$8EBP#0V]>%*T"W+H
M;J?I#-;%FAB(5J:D3^H2B<)*'6!CHA<^2Z\WMN5J49\5VBJTM1#:ED"VG'P$
M?/D(P$%'U*SQ;QT<_@$I1+>TWET!;5V UE2N142&XRC)*NL2W<*)B<!)3C(;
MA#;O&2M.M35D@]X5K*TIQ:;5K95?N4$/YSKL^)3[@]3IGNK8:7BSW+!YTX?
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M): :8QU)(@J!',,H4_JO,;:Z^%!-$^TEW]L1'RKYKIU\FW$3.5&CDR5&>DM
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MTAE;V%:5-ZHVC0<E5512O1FI-D0"*X*0VBLBG421(%E'?#:44.V"8_B?+3H
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M8&!(2^61T9XZA6W2(N72!S<)QVR0I$&2.^RTTB#)PR#)G ''B)$Z&3#;9&#
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MSZ'535&L!E'NJ(A-BI;27!I+>! UKB6AA@<OI<0)_GQ'O0,;'+DICLP9:@*
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MGHQQZZI1 9"R%=6+YR*\8Y[T?#N(GMYLG1VW_7$M'[&2#IC<.0EI_4+^T?(
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M5B[*#/^I8B-+U/5B"-W"NRT)JLOE[$_[[<XXF6;BV,]WV%0%*,V%0$W,L_R
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M>.181:2\2;GH(T7:&(UL]#(8@V%);"X81I:D'EX4&:H=Q*51Z$]6_[QCS3^
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M7<?]\4N<VJ.('*S:%V03O.,+VSFSYX.-7V=!&A!Z;NKG9VWEW*1T9W-3[10
M)[TJY/T%;(>QGZ^",=FU&4OKN)^A^+]^O$8<=IW2PQFT\/>,XB5AV,ZU/I^7
MT:LU3+]*1^EZ^T?95GA!]-Q>C/)?[EP)%EI>5DK )C!Q_U\_.R]BJ^JV?;<=
MZ%^V![[3&XSZ\77*^!N[@R)7[S+2Q?![;S <O#^V_?@O -SPQIX74%^;QO*?
M=^HM]?3+_L%?7_9./@AXYO<]H-YP#?[X^5-[G^Z=PQ;+@4A_V7OYD>S_/K>E
MGKR%9[X]_W3PY=O^ 5S[^1V,YUU[_P2^]_LN;+%'W_?HV[/]SQ_P_W[_<+;_
M_<,ATR:&%"WR*7'$*05P<S8B'AC-P9XQ!%,1)-A>8MC)S,1)S13P(L-"X"1Z
M(Q,+5(.28\&$HO-]Z,NLHS+M+6!%,.VP\;3>=&QW@>?.*.#<OE8MT(^_?':P
MUCJ7B)=,ZNQKT59BSXE60.J""YYO/!)R74I_C&D"R/JPWW:C82$T?[4M_ ;\
M)/1.0=(+3WF3X-G]S3%)AN6POCT$7CP87UX.^-1OV9X!4C($%3CN=0"!6T#(
M!R-_W!K"\#<K(OTU,_'C:LU:O^1_W3&VE"<NZZ6]?'+&,P#2M=7*_L[6^_Q"
M<]+VC[L>]:5C/#MNPZ3FX*63V(HI15\&9@N#G%_4+1AZ%N1NK.R5S ?+18!L
MKEU1ULWZWGU8GM) G<C-\O*;XRL+![6# 6A7M7X48];Z]\'NF]8OZ[6 >^=9
MLO:W_MIJ[0 NAUJ*W\5"R$,]\![L* >Q?S*_K@^YK)NM:F&/;6B=]N/7=F\T
MZ&3[-W8O= <,TNH-!QD**SVK386B4OE=+]8&K(+.*,36+VV0V%6&:WG28,YV
M]8E[&Q(WC$0NL8;]4XE\#!"5!#KKZ\, 0N2T[;J[_\?\9GJQ44YOI3O]ONT>
M%6OH7^<+>^G.F>T'0'(0Q=>I?#JHDXG![KV:88N?W2[\5KQ^>TB"HBD*A230
M)MB$$QBX7B7DHTC8>LR#2AO;BFX*C#=!G!>-VTH:*A9\ E9BC7]V,O^E.N=1
M/QN=IZ/^8)3_46\F60+'4GQBSR?B!]MB.^3PC].:*^5_%+(-F\K,UQ2Y_ JZ
M"M]3CZ1\%?Q:2'W+9M$8;()$7UND0Q2<"AFXYY&G0%QT+@9+!4^*:>*JB,\L
MTNBJLIW'O NH&,/+4;;EJX):E<26#U^?%EO^U;?8]^U!([RKA/<CV]\YE!X3
M+A5!"HL$O%$'9+EQ2(IH ^<AD"@WMN6F$FI3\JO++DBG U$KZ[0@L[%>FGQ7
M;S2$7:(;*J],D<=J_29""#>=VG[E@<ER7 GE[(:8(7B\50)<CQE%^X?;<+D3
M!/O:DBVT8=([QY,TN:BQ$4FH:+1@8/@8I:\,UM6TE5G[W9[F/;>2Y7>5,RG\
MT>O_,1J"892%WL+6V<CS<GD^8@#&T7L?HM.(ZURT(6"*C,K)!C0:$3QU..1"
MTVP3S(U-21<KPJT2Z,'(?08YRM(X+;+Q/R,@YL@5\V@,E#T0LBRAA<],B?3F
MS\DH/+!?N=K+@\^RYO3CB84[[5?;[A14SSM$NY:092JRM=*ILKY6TX?):RSR
MK,WQ0L&/L>,US,X"+-67>-Z*)Z>=WGF,,/TPT3E^.,-(-JY"/(WE)8MJ9PGH
M]2M',4@$&M\'6VD_5A_57'],SH?'_=[HZ+AE6U]MOQW!0(,+VA-V.Q:':DO.
MYTSSXO!^YQW\A-&#)/BR_U8;?S<4]('/WKS_,!&H\N&,J%5.;B )0S3,S-K;
MP7']T=9X=S^M8*Z^'B9KC*M%U&!:)VA\"H.(6:)M9XS4R;;[0"OZ7^(0WK$S
MBN,IJ">_\OJ=9TTH?YT!\/IL*-CAY+;RW9NMH]B-?=LI3-OW3B8[0N4,_ KO
M>EIV]4$K4];\]-3OG;1FA!"$RJ/V-W3<#K"$+YX1T,&8/_M#K#/2"8*821YQ
M27UUFD*$HK!;@Z(DNK$-(AICK?IY42]SXZ5$M2*"FN"! PBI@\58*J!NPHJ(
MTQ7<>#]M>90??X$B3!@=F=GG\FJ_"*/^60_$.':?W>8&8_Z^=XB9=Y9E X-1
MG/<TV-V\#+GD6#!$$@,+MK&=>J.JBO]@WD.W60#C0OO*>5BQ""Z3"QHC-Q@#
M3<2&:V.M2)Q*8X-. MNHKRH7[L=RX>;EXM6DP$\E%8U0S @%C.'02Q>92 DI
MKGBF/!9IC34RA%D;?931*@""V%TN$UL+;ML[=/._]\<QC#JQ=C$L(,6T ;>3
M76Q KLH1T?/V]/M#SK$!L)<(2PJ\5NJROA+I".S6<D^8P_.>^]4DCZT/Q\M>
MM-3K='IGA404!@ <&<8+#QF,"5'%7GZ9XQ> 99E!_:-E:U&9(KZ+C/'%=1AP
M_:<<-E0=?]4C&Q^OEZ BF*-.KFKQ8OR/WT)[<-JQYR_:W?*FY:;?9A^?3Y/G
MLXCR4E0?UP?-QFPIK/)9<YW#5']Q?0R]58ZAYV*DJL\4V2):K?P8;Y&5GUWV
M6$*WF#8_]=C+/Q.,W<E@S=4&](,\L1^F@"Y>NB06M8JGF%_U:L%O6^WTCPYX
M2PA#Y>BM0NYZJ?IOY78H1^F5X549$&4;7EU#[^G/U=_EEQC*S.S P.Q1+/\>
M>QBKZ7N3K:?R]],\=WDR9R;MGBJ=W,U,73&2]_649P2LOY? /LK9%B/Y;(OH
MFU0YN5DX^".*>E[J;DPZ>D.=I3QHKH,TREG%E(TQ$.:Q*('/>CZN\3;/AFI6
M-K7$%8@\;7=D'5#]_?7?^Y_W*-Q_<'3^^@#N^?O=R>N#O;/7?WZ"$>]_>?WG
M![SW\M/)Z]_G ZKWQ$>PW3Z>_-%Y_7)7 -?KP/>)O>\[_-/))WCF6_[I +C>
MR4<.A'XA84\0'E7N@BE]3D )6B%'L$"&!T9\D-(JE?WSFHA-JA8+I_Q<!O;:
MY)C\H!+#W6+&VL'KU5-(KOW^/UR_!WWQRP+ W\1^ :Q; 4QZAW YYA$UA1BS
MA\(;&IR\+D[.)>IIK[BRQB!8<P+VL<KGF-PC;KRG6@5/K=_89G)+WCCSY.XP
M<J)CMUG"HD(VND7%FJ/;G]6YQ#.KUGU-&GBS@CMWP ?+J@UVE[EG&S)X(Y#;
M722#@CG).4%2$9R/?!QR/@#<"2*-9TIJ;#>V-36;C"[V,&QJ^3X]DG,S.+@^
MVQE<"PT:QG.;8##'>&2@FK%L#VIO$?>*(B>C!_.0<^9!&(2+N03?%KFQ57@C
M*+@AJ;FD)MAC(#63*,2FP.\]\YHF3O0!X6IO@;M(FG)<NT*"VH!XX@99%PP2
M,1&PT%T.<=_8%AIO&G&31B3/L5QH0UMN2%O&&- PESN!@OFB2BPFZ:-%3 $>
M<",8TB+F1@7$! U X0W?V"9\:TF\^7U6%'W>[I@_>OT4V\_/(?/PS.6&'IEZ
MX4;]V+AE[@#/WBY0&R(=2TQ&6&"POSCU 2PQ!^88X)Q35C/IS,:V(F+3\$7O
M<]-CK:$V=TAMEJ!!0VYN$PSF^ZT1QV"M PH"& ZWVB'K&9 ;3(@42O/2%9J9
M6R W]^>6&8<UPF!_ "'W=643347,G413/4;*=CW&]G,U))M0JL>%S!\7:)K"
MWHD8)? RSZN>-5H3C22.6K@0HJ8AAU(!?&\J?./ZY]=2M#6/HWH&H5)/.QKJ
MYS"OB89Z+% W1T*)%CY0AQ%.C.6RY0)IFAPRWGL+*!@TKZ*AS&("?.-A:P*>
MUH>LW;!E8!/P](APS"\>&GJ5# X)19ISW"WP-I.76E,I/+$>XUQ:21.^R<1M
M511OW&L/C@2K><P-X: )>'I,8#!':FP23 IC$ U<(^ZD008,.F2-2%0S2C''
M&]M$;;$;DYHFX*D)>+K;8\,[X#5-P-,#PM5BL_-D-"?.>$1LD(A'&I&A,2*A
M0LJECUF0?&.;JDU)1!/OU+"6^V0M3;S3G2+!?+-T[YV0@2&I'2"!EQAISQ/2
MT1'FP:!11@,2D"W"&F],$^_TI(D+;J*='A6:+;80-E2;)"-&D5.#.&,&.2,D
M<ACL,T>T3#YL;'-*-Q7A3;130VSND]@TT4YW# 9SU,9Y(#$F:.2CY(@+GY#C
MUL*/%)@SUD2F@-J(+;4(!8_>)[/6=.;RX"&*F^"AGSJ/^KF&W4WPT.,"NE=G
M!>0*\]G[MO]R]_S0I$@<2!"2T>?.MEPA8SE'.F$:<,26T*I1 B&;BMUYD9%U
M<O@TT4-//'KHYT"OB1YZ-%BW-XMUV#%AK67(.A\0CU8C(XA"0M$HE,52^QP^
M)+:8?#P.JT<7P_[H!MRX!)^G2_"GZL(W*9"/>,OXOD"/$TM*"A]1(I; EB$T
M<@93I#WP@ERHE/#<=VF3,+%)FRS()^X7O"$B-'[!QX<'<Q0R)<RXQ!8)1K.Y
MG..TM##(2,8=DYY17U6G8C=.M&D<@[?I&"2-8_"G'(,&D$TFP8+7FCM/M4]$
MF\ ,#S(X6=G(]\%]&L?@72(=7F ^+A#O@T@(*VT0Y\XA[3A#BE*M$DX&R[2Q
M+3:%DIO<W%9%F\8QV#@&'Y[G_1SH-8[!1X-U<ZPN>%A8&3ER @P\SJ-$AB>-
M1)# ]$/P,:F-;::VR&VE3Z]1)-M: ]-?5?_VW/ L?CN-OFZ<G=NZWQ[+J^=E
M:N]AL"2A-\JMT1J:=Z\TKUKPG6[ND%F6^Z"7_]2PO[M$1++ _JCQW!/JD"="
M(6Y50DXS@YB(Q(G$',8QLS^NU:;2MU6)^8H:^,!^L1O[PM8.9:]._Y:]8D/_
M[H;^_1@*&U9XJQ@XQPJI(LXJ0A!G0B(N;$0@%BX7/Z,\<*&)<X45\L5$I\;7
M=P_)F*5U[6W[^AJJ=U]4;VH5&TYWZWA&%SUZ1AHGG461 IWC*L<SZT0120&;
M9*351&]L\TVX;%/B&S?:6;\,SL9OUQ"W^R!N4\#6,+1;1;0YAN:E]"&X@((6
M@&@!&)KVTB-L<4J&<"M85926WE;@\JTQM%^'63S@OZ']=7L\.-@&05?\]C_A
MC^.AG-C^4;N+JD>\('2,2.UN +%[P62!N'M64)H5=&?0ZJ4)^:KF<\S -F$P
MN<NZ+5W66[T+FV7NDZ^7.?BZ8?;B.,7[CBW<56E5JQ]/;+N;3WXS'.05'ME.
M:QC[)V6(_YR9W5G(H#%R@S&7"ANNC;4B<2J-#3H);*->&M*Q!"[<C^'"7=O-
M_V[\7K]?O-8!O!6=84JP?OY%&/7/H^T_4B3Y]+_'V)_\U;5_F]'KD[?PS+?G
MGPZ^?-L_@&L_OX/QO&OOG\#W?M^EGUX>?0=D.-O__ $#*@!:O#V,U!#"&0-!
MQV"@)8E183J<8.VL2RYI"]1F2\YK6BM/VF!SW47DVJZ 59)#&LF9EIRCP\1$
M((Y0Q'PR0(JI1!9'@H@UE"=84UCI2R2G8-2:"\]J.M)(R16D9/_EAT-)HB(:
M*V2U5X@S#/CB+$;4)"4MUY;G T*^15?A"YCA67';7V/G?*NUTQGT-J<]%P^Q
M>79[+7MTU(]'=AA;;5C_=G< TOO5=D9Q:\*+"CVY1+Y_*B1R3K[]<0RC3GR=
MEDOZ.W@=^%YXN5+N"5!P[B\?P#(8[.39;0_/#_(+'L#X_M6!CYZ=O'XXV_^^
M=ZBDI]0!';9!E3!%@AQS!$5AK8R)<Y7"1BN"_7$*"S'LC[*IO9)TLC7BG*W!
MZ 1&=YYYW? XPO?;X6@P_BV+C>V>_W__I2E1OPU QKNUCO0G(C.K%;\L?M!=
M<G4V/NM;-D%9?&=4 @W?O/\P^ =H\FHFC,OS\MC\<<;K02N4*F;E3QD<6A$F
M-:Q @A;H0^L41A-S1=V6BYW>V8M9W;S<5*C_E$_41%FT8G9,S)SJO T6KV-/
M!_'%^!^_C;-DVMVR!.6FWV8?GY-<YLR<(B/5Q[^=M</P^(4Q6PJK;,S7'NGZ
MBZM/R5:Q\^=LK^HS*;8P-2L_QEMDY6>7/9:(+2[U3SWV\L\$8W<R6+7ZX^G'
M_L#K_\,0_\5+E[B_?);"_OTXB?0<'*BE/J+*;USI3"]5_[W8'/[I^K]NEQVB
M5?C08.6YP-.?J3'S:]74K\Q-J?**7@(!*+_^8=OU7/Z524#USS?C^2V;\\P,
M/H>CIOW)#G)OU29^/N!H/?VU2T^AP#!/1'OB20(["S-#N-.16H,),$G-[K[@
MQ*O_C( N[G8!+48EU^8U;,G] ]BE:[MILO3/YW3JM/WISSU@DCO (M]]V?O[
M WY]\-?QZ[]?\;V_/WV![_S^\2#[:N'S]IPO]^1_OGS\OD/W7NZP_3_??OMT
M\%;L__U*?#PX^@;O"^^W?PS/X_ Y!:MJH?R634IQRS22+"3$N2'(!$60!S'0
MP7EAH]_8)G03*[:I[C[>_.=CCF:=O?=T='4S,%D[U+WVN=;5W_^1@NCJ0Z^?
M0]+;._2Z.H[.>9\*^\CD(_..PC@:%+TNBL[5+4N*<,]L0D*6:CZ*(R.D0][X
MY)*-&.?T1**WV(WKEMT7@#ZWX@P/UCUG/7%O*7F4F.&D"59):IZBMLDR8XUW
MPG$?*;O'R@P_1+_GUU?GON!O=X%$QB0H !]%GN=X )(X<LH$9+5C/#" 0,\V
MMLVF%GB3\QM7I;[%J,VF9,,=L:,;0L4]TJ1+6^XT7.GF8#'?T3J2F(,>D=,>
M(TZ51#9RBEA*N>>.X(D*X$I\B]^X&MCZA7<_&CKT+G:B?9"V.P_ZVM<L5?68
M"%$5R](0HMO'N+T%0N2M"=9J@R(%9./.&J1= OW@S&1IX%3:C6VV2:3>)&(Q
MY/N>^O7<B<OLB2/$D^9"LQC1<*%;QXEY+B15"-1H9)2(B"NI<]\+A5@0)!+O
MF8BYE0_?DC=.=5N_ @B/A@L]8-W.A@S=#=!-EK3A0[>/<V\7^!#FFI*8&R\G
MK<'F"Q8Y3RPBBE%%>%0QV5S.4QNU:<2B@^B>RGDVOJ&&#RV#B5SGLR%#MPX2
M\V1(<VYR3W;N&1A-7F"DP51""8OH* .(R"TQB-ABZ^1!?O;!6+=1X?,BX'FZ
M^$Q^J><=K25,TB8XY8E//#GX/VEP$D):1X50Z>YK!C316@\'D1\6>!3(D#':
M842]D8@[EDOG :T"V'36TJ"#S[YSN:F%WB3TQO6A;EU+USR<ZQE$;#WMH*R?
M \PF*.M)@.4<G[0V9YABBGP@$7%,)+(!S$^15.0BD1""+GR2/&S-E6M7*<B_
M9ZEO=T=%+F>2D6H-XG1+9;_::6_0SM>\Z,>.S7F0=890K6%3-];HCB]NL0Z
M?#1<?<M"YL4#9:<1JF:3LZ9_'O<O$D>.(G+]:+\@FV"T+VSGS)X/-GZ=S>9J
M=]'<),Z__\JW3.G.WK(2(\"L7K\L^@L0O]C/5\&8[-J,I77<ST#\7^U(4T@N
ML1BXXHDJ1W%,1!(A''R@Z"'?V"XYHSF%+^=!9[3\YZ]V>V6:W8I4R.V20[-L
M_>?4I$)1:YU+Q$LFM>,R:2NQYT2K1'1PP?/+$C+7J0K(ZRKS\NFZ:)]3 -_/
MYQWO?M___N'& 7@KTW2/JJC8:R7/;EY3*!WQ- C!@B6<&^D=9DXZK:)C/F"/
M?R"4N!')-1-)O/?]XV%TG$AO(PJ:",03R1U[HD.42AY *IG6I<$M%FIIU;NJ
MF@+L+[!'G+?:W4NK??R4"-V2U)0?^> <%*02C.5E/,[ 1A[$[C,4A_V##X>$
M*>()T4@Q;(",YUYN43O$(I<B4*VM5AO;0V /%<(,%BIZ]/JM3AQ4E5]R>GZW
M-VP-1NYS],-<? -VZB]QF*\ZC?TR_5T?LY2$0F8'6ZUZQ[PH6O4#T+LNCC%#
MK*=62$$--T'H:(CVSA&0-TR(:G#LD0DNR24]=%+ 7JE".8\'< QK9+TV"%LJ
M6/8J>((WMH56FY@N!FE<(JD7HEE$^JS=Z;1\IYU2A7QG[>$QH)YMS;#+#":H
M_0T=MP,0T!?/:37H_LO=P\2<DLH31*3-K81Y0BZ76B$Z&>>UC\;*&D9JBP 5
MOG):)'USNFS4%;4Z1(,5\](J+S@G3B=O$_R_-$)[IG_4>[#1ZO63H\^[AY+#
MFJ6DD)",(.ZU1+E(&,).D! ( 6LHY0!-BL6F)HN!Z$6OK['[+%7Q3&H:Y2[5
MON#SMT ;C\":V65[W]^*G]#TNC)<S1.VKE.N9TUL^LLK>TX56BJ%Q/[[,O_X
M'(I%X9G#E"FK&2?".TZE)!:P3?I<;7^Y7QR)>?1Z=7+:Z9W'^#[VO[9]7 YF
M$Q]W5?WEH#>TG>G/?^\-AON]X<<(@_.]HR[,T!7A2CX_N&+[W]\><L^9TS0B
MZ4$/./9@3&'/4=(L$+!\<,KQY(2SK<6"NRT0U$X6CURK*R\%R$E_,N\@)A<+
M4ZK9=0=QL]7-8)9:V:J!18'+TD4D3*ZJU[%US3L+D 87MH>#BD.C4D9N4K+K
M[+CMCUMGL:Z3E^^8?'>K]S7VYRCYV;A<SKC$[-?*L*HW\!]5E354JI HQTD#
M!>="2\6(UA%[SY70_ IVX)U)>+4M_]'KUW_*US4%'R\$7>Q__WA(HB61!H<T
M,V F:D.0XPX#[^8$,ZN4C00$?4LM+_BXU3H <:JD?*ZT8A:=9749ZSJ.2RO/
M#;*DES2H>0?8X ?EX^")I0C=F1U<"Z=_2H"7 ?;787]P6P75+YI<%T'?'4]L
M.:;,Q7&OEU8P>W\#_,OU8>_;WLL/AUP(P6&;1BPD#UH P*\IH0@;XHVG7$D+
MP*_T9;B?A?$Z,DBXD8+ CL*#Y<IH:Y15TBAFB"!.5A8/'LO@0H631@:?D@P>
M[!ZZ9&6P!".?/,@@E119:CER1@&M!$EQ&)@XQ5N+33K',CA7B/<14O._V\/C
M\4MD%M.KI&IR0%).0,OV\*9CN_4&@%GKWP>[;RKJGFR[?[$510N\J'I(]8RR
M55SP+3LL-X5<)!@NKRX9#<9[T+\Z%KC6>W_< UMG_)Q3V,#R!2>]$#M;<]>,
MANT.O"]8HH/!Z*0>_121^]K+\0$=4*)JN/WVX M*V1W;SB?[M3,^5A_"DK5A
M14+KO!T[=2'DFC=-]M66B\?V:[O7WVJ-JZ=??$G[8D0AV\'YH678Q;"N.&3F
MA)WS5J_ZM W/;T\_XGQ5\=EJ_\Z3$<O(>AD)8/K]L#=F""M>KM4> )#U04B!
M\/9[)^7Q'[;>;U7;^T$?N #0L_JM_:C_-3^@%5/*4E$O&:S@Q9)57U>]6;OK
M>_W3?&0>+]A'&>$IT$4T9KH73'MFJ:HY*7 ._[.=\T&[6(O';7C??@XGR<)B
MJR^<5*7NP+M,JO26$0W*#,^\Y=0C%N?KRA6I;X%[SU6D7M@22DW1,9Z#)E5;
MR<4D-36H7WX\=-(9KYU 1JA,&8('"BTU2H%GVY]H;^FCK$$-@@V2>Q:+1WT!
M@"\_H9X$JU?Z,:U8HT%EWEX+TG]D#[1FRE #23*S6^!FT4) _-3K='IG@\=4
M7)I@O(6K6*CK5I<&HBK4E<M +XGX';\#@- /NI2MN/+*0]5;TH@[*5A]M<K2
MUQVKNN=ZU3=>B<F5YG%6=OZ84>;5@M9?IU+S@TSW5/C\-:+VUWLM+JT)?<T7
MOL)B/*6)(^8A:HO#U#U04L%?$_OA"@)S)UIW&R4]'TJJ;IJYT:V3Q.8JZ5I)
M-:4^.L^%T(XRIJ4F22BFE8@_<#BQ6SMBG^1>3-D48]OU0F[>@0$W<0HA^DC-
MC+J))/]T\/%\[V6 :S[B??HJWT-?_[T+)L='ND_?BOV7?W0^YJR-A2:2QYU]
M&-,^W66?/K]E'P^R:?)1?/S\/_#WC^S3RR]X[^^_CC\=O.7+RL!Q3*TA-").
M:4!<PP^GO$4F188)X=P3L;'-Y86K?^)5^C]7@?J?+EO4:.IJ397!2JMMHI1A
M'K'1*7*O/$VPD*"^,FLJ,;6F$M-HZF/4U/VYI%.5N&=",X0MEX@')G*1(HO4
M_V/OW9O:RI6U\:_BXCV_^LVIBMBZM&Z9MZC*3"[%K@-,9C-[-OEG2M?@!&R.
M;2:!3_^VELUMV82;,<;HG-D$[.5E+4G/H^Y6Z^GDF;,YR.CBVH:8M0?Q_SW,
MMIA]3']Y;8O?9X<5E\;0N+D_GSU#+;4M4>;'>YP>FY/94?GI[OPT+:(&97]*
M1TF2MJP$/!5Q.G(2-:/&)@D9H.0,3-<NN9\A<5N]GQ>.Q*6V%2H2YX'$MJ60
M#$T6G$6;GA8D2DZ,QM\B-UH)L,&+O+;!UZ?SY!]H*#RW(,3YAFBIE=[YJ=E!
MF-(X>^IXQ+,DIYE;D_<R"N94#/I'GLI*UGQ>+ E-RXAE$44$!455'MT5DQ(Q
MU&CT7DRDH'/B"LT!=4%"%[H*3QM56!V\W6OIKWA['GAK+_J<,^X==80'XXKY
MS8D5#(C5!DSPT8MR]OPFO*U\;.!"2G*<:K0TJ_T+<$7F%11X6$+K+&:ZF!75
M [D[&4UK/C&I F,Z$\6A:#YI28S,DI22"T$GKW)$@,@;/9 :"UC*6$ %X+(!
ML&T-4.Y-4CH1&3DC:&X+XAD(HB.+T1NOK<RW >#*AP#."\.?G70;IW@W"=^7
M4L6/TEEBXM(8#,_27?GA 9AK*_P^R&R8GZKDBZY4MR@NVYLR)KP0W$>;B>?1
M$##HU!A ]R9GQ[-B/#BEUS;,.IU.4:BQA,<&YP--B@K.9P;.MJ$A?>+,,T8"
M<$]*"1$T- (E1DGK=<K!2KJVP=@ZG9:[F[8T[B.XV@S;C3*7O!0MN%5:_P2S
MI-@IKYEI';P@Y95'Q^=4ENA87Q7.CP$M_NNO]@M:CDTW_"#Z*%BFR -9:*;!
M!F5P;>;:>8G_^9!G*_9<)8/?$/\%_;W8'"/]K3\<#=*H.Q@30>JEW!T-WW:'
MX: _1-=A>8X<[4VPW&=;B*.MM[_O?_J W[G[F>Y\V/RV]V4/]O[\]Y?MTS^^
M;YUN<<3ER=21HR]_G" '?-O^\/[KI]U_'NR\_0A[7W[I;G_9W__TYY;8WGUW
MNG7Z"7&Y681;ON^\W91_)1:\$EJ4TAT1?R LG4V.2 TB*RJY"'K,WP@A9,42
M?+5@HA%H6F6I *RQ.H++4B;AHP$NVF>4SH09.I/^;T[E3,G$31U7FU: O?F+
MKS8TX+NXS#!GL@*9M$,O1CM<9YTUVE-QHV+L%+ ?#\;-'5]W1[BHAUL<J7J+
M'=E#'Z35I<_N=.[N)6F<X1&NQOW!$!TH7(F/RXG.\4/ZR4,>C<'=.2H/6\YO
M#E-9I0]PV(_+L? T7#_KD&'G:- O1UUCYS.^@A<=G.#]CLK15[S#0>I]'NTW
MRA)CM9!7G2-W4CRYF":J$H?'Y6/-Y#O KSG >Y]-Y.'9P==RPO15Y[=CM,CZ
MG=^[H=]\-N"?#J]H4LEZS2VPC<@R;J(H50Z0'0S[%TV\H*BS9QWB_=$\_+Q_
MW@EE:@^Z_GATW@//\33VY?%N^N!\T,>'5X^N$/;%R$]&/!P<QT94IOE[M.]&
M9YW8' 1L?7IX?'1TT/R*_7^88G-0-O3'EMVEJ7)V8GB8)C<N(W0^.#BTZ7S@
MR_CBE>CE8\./AY-7QA.KB!=TONWW\:O2Z'P2'W9[W</CPTZ)%)1K)Q,.Q_Q_
MCR<-Q:FUV>L4KADU1^Y'LT QZ9_9#W[0S25U$9>T1K[L?!*=G5&^U"GM?F@^
M?S9E^SECVP;C#^)@N[$%?=$!U\^Y)9E@V)&(E%X:NR-%B_&L.WUWC,6K_=L<
M*$T7H"V]=1F//^:@R>B4]T\Z?QQ]Z>_WS@Z.XVV&Z)]UL4-+>.CR#$[8@OZP
M.8%^B3M>=3;+J?[>^%3^/QTV;WURSW*\O4%+:?GD.PMY]7OINN$MW]?Z@O7.
M&Z1%-QB='2MW :?@N&0 _MZ0*(*KK5<V;(2?!@T4IM00+J&F-+;?:V2I#M+H
M3+=J5M^G[Z'HP>+;.(>_C/-ISOJW[]&K'=/NN<I4\RPX4*G@:]*>B0@6_N5P
M]CL_%A88]]X)?D-W?";_BF(6.A''B$KLG<\XU&/!N?[P#,17+CU#:<#>;2X\
MAU1SC#D== _+(XTU$(Z.!P'[*5WJQ#OC9)88_G,U3MZ<=T-#+E.VR@1"I=,;
M*[USU4Q?"6/F?"X-B[U1)HYW!PTY#_?+\G VHYM)>#Y_<4W V3D: [W,?U+>
M;\ZSDWS<'%F=!92)*LEU7'6A#=$BBP(L9(4?PN((E['!-!X"DM[83,&E"#^-
ML__2R?J)Z-N9ANY5P!:&0.8JJR6VO C6C2]'=_"LY>5K7G70V&EN<?'Q<WV[
MD?O^:@S^\[LUA-@\97EID/;+T_^=.C^5A_EO[*%!$:IKKV"U),M421932[(L
M1UN6OB3+C0YVRR$WQHNL'2AO#"@I#!(:]4(;;Q58IQ\]/'2A4[.=1K]-6&>R
M+LV2?EPR79JG"!*]@;^L$M3@S",A6E>*0%OBC+1$B(R=#);Q&)^E,,WFV!QO
MC#BTW8X/C\>J6K.6D;**E!7G6IW?"^U(7+.>DRR,M>O Y'U48:1 3N=S5T6Q
MZTH\CH++_>Y:V_HT;;V=WM!#I5HN5&RN5DM=V@/BMQ,(.?.RSJ)<M]C8?JE=
M-=,)G=EO<Y]K2ZU$<+O>NU9#J?;1S7UTRPGUI 6-S8UAH-D/_=-F[TQ&]E9G
MY%9GN(LY6%6M'D\.[*7V39U4<YE4"TI1?M+,O#]F;WS\5$*\_]TXLW>MD7WK
M"4$[SZ&#_NOQGO_VA<.?XL%_ND-% 6<C<'":!Y7 4N9T=-F#3CZ+P!C<MOK0
M9 MH8E.7_9TW%^&6QOS^]7*P9;,7^H=I.XT^E V)_VDV(WY)N3](N^[[$LGZ
MWR\>-T[ /#K$^]%/A^_D]FY)SMRB)1ES9_>KW/[PCFX??I2?WNZ5ZEK?IQ(P
M#_>P[?A<NU]9T9#>.OU8DC$E?I;N[7[DG]X>?-W^4LKNO1O+KK1/>N!LQ@$%
MDEQ@!)P5Q&2;2*+2,T%U3#JL;4@[HRS E!DW3\&USAW!,\\4[4I^+X/\[L!]
MD *C1C%PPH!0W"OG@C:EJ 8+H$+#?3.+J)2\#_RMDN RD6#KB$B,T4?F ]'*
M: *" [$Q<R*5MH89*WV"M0TA9I#@..Q?F; RX0MA0B1"24%;Z6R H)05(" A
M3*Q.-%EYO158F7#YF+!]'L<:)8).D>0L*(% @?BD I%>9N=Y%%Q%=*+9##W?
MRH25"5\4$XKH6:0T19T5\!A<MDSJR$!Q+0UGU29\5DS8UB.U,:%M'TET@$SH
MF2<FH7?L=*20I?/1-!HDSX8(%Z3-M#R!SNEDU<Y/XTS5ZS>@^-WZ8R:9/VM2
M>^H@WV]ET"95FTL2WJ_-@%5:NQ^M?9R*]Z$)QTSTF7C+'(&4+/'ER&<&*KT.
M*5@OB\Z;>BBMS6:/1S7A;BOCM)H@OTLH?VG"617N<X9[RXJAB/)D&,(=C18"
M:+,0"\(3:;U#RS6H3$-158<'1/<KTI<8Z4L3KJE(GR_2VY$;H3P#+BU11<45
M1.3$V"+9YB3^BZ2.?+^V(6;X*Q7I2XOTA40C*KZ7$M]3>U0J\6 D83'[<3S"
MJ:*)RK5GG(.'0-<VZ%(9[G/*K6J^6X]/#"YS]&&W/W(']XS[7)R'ZL3^<3GQ
M<];>&EF>6P<M-]DO)A=KGF9=9??[L?L?4V&90)T$:H"DI#@!M,Z)M>BVH3&G
M?/)"!BO6-J18GY;!NV\:UAP ]3SVY"JUOGAJ74AHK!+J4Q)JRUQ.FF63=-F^
MLX: ,X%X08%092AE3#AF'+K#LZJ8/6C_KK)J9=7*JG,,0U96?4)6;0<9(3H%
MN P218N6NI":N"0" <Z,1U-5Z"#7-IB94:6ULFIEU<JJ*Q3SK:QZ;U9MV:HR
MZT I)")=I 2T3,BJRA+&O8]2: VFJ74Y[?L_5U*]A5K_LQ%YO"(56A0)+P[8
M3I03B\1IBBE.1NM.-;>LEUYE*6(P!GS@)F1F;!06HHI>J=F&$[]2:NL2F+%]
MY\T;MV[<N'U\J#3H9^SJKVG4*+KV<U&$'"NM]@>__;*S3&6U%BU^MGF*P/]+
MBVB=R(*$$!G!$1#$ .-$%.'Y*)RBWJ+Y,Z-$_7CH)QJXX\X^4\0==_F%BNYE
M@=O^1//V1\JX;M1<XQ-BI(A:GMVW%$-MZ3F?"^@.&^W=0</@KSKNL(]8/3W7
M#QT>A_TS7=XB^>M3ZIVI%3?R:-?*= ['RMLW28V>Z^?BO1JQTDG3#MRP/,P@
MC5L_',LG7VG>1$RT.QR+%D]DJ_&^^(3EX<_2/2?7C15)0]'GO"S<751[SXMW
M]XNF:"I7G+7K%8+RH#R]FT@G#QL-YX,3;/#D9MCR;_M=;'HH6K^CNS:ST>@>
M-\'UPLGEL6E4F;NA>^0:,?";4EJ+&O3XFXM6W9E*<CYN:I1>[8WA^&N*VO1%
M7Q2-\D:$?OQ<D]E4"I@-K[0*Z:07&X'R9ES//O:C;ESO;.8.\DR9QNZ@4<%N
M_LJ3?OW_AU>>M;G?60>_NLJKMW[P&[JX//O5_EV8R.2;PZ*#/+S0D]SL76=:
ME5S^JC;Y]MWWOV1BUD2'OJ9UGD &0XQAFH!QGC'!9.2N+2P*@BOO,P/P$H1/
MQGN@*E@OT$PN^R@M=<K",<AN@^3&,NRW$G_$ZQJ=Q['Z;U$Z[I_SWA7%_1\3
M(+9\V&U4E//K'Q=!N:-JY$R)UAM[Y@G4)C75]U&;U'+=:#MWI4%&URF(1Y%%
MO-]=;VSL[=06J[38K1YV^?2*'D.Y\9EVQ=R4&:NF4SW"NL)'6.^21^2YT<H%
MJ65)(:0:O5LKF;=>NVBR-C,MW%LE%/W(MKU-8;ZF[L=V&OW1.[?RRSG7\O$W
M@^X0Q^)M4V)B+-R^:L'(/MTZW9-[A^^[GP[_^+[SX1W=^?,C[/SYSR][NWML
M^^V>W/GP\=OVGY_V]T[:%3D_GFY_.>CNE;;LOH.]W1*X_(SWVM[?_O('W?[R
M%3Z]?<,^';[_@F;V5":2T"%(Q1D15DJTLY4AS@4@.FJ-,+%1<2@Q#K[.JR)4
MI<[5HLX[,*?D*5 =G+4)0 GELE(AZP *':PLW2V8LQ+FLR3,UNZ-U3)QS0)A
MD0H"T@=B2GA8:N$SU\JR9D]<S>#+JA3P9$A_TXIY7RT']X]QG:@J$_"(=N.-
M6]"71F@G7](XJ8QU)\;:G#+QLO(LZ:R(R%$32,P2#YP2Z71@Y9P1,&0LO51'
MB>IYP7F[?G,P8&Y_EJ1B>5Y8;N<Y.[">,T5 >T8 P!$C:2:)L\!HI-1258X%
M/L196[X3@4MM6OQHQ[8Y%-OYJ6Q@WL^ZF-$?SX2;EB(J-9.:;KLM^V)..2^*
MSJ;ER!.WG%-E2*(,Z4Q126R.'&<DA20"KDXYKFW,+[]XB6),*P[_!9LF%?9+
M#?N6%:/!.J>M)CI)-&5,M,1J"@3YGPH9)>,,UC9@'J=?:X#D?@&2&:6_7UAX
M9/GWU2Z/V9OXY7@X*O'A]X/^X9N=7S=O'41^WQ]<RWGXQDZNE'=7RIL68E0&
MYT8P CTUGXM>4T3*$X8H'RVC)H=<DO[IC/.I5:]I:2EB6?>/%DH,:!0=NI*(
M^7WT.G>_ITA.TZ!?">.NA-&RD;)),@:M2&Y283D:2IX%3IB*1D7' X]V#=T@
MPQG_>8DBMR\AY+-Y>(3]7,RDXA%@<SKA>#!()>U\-,#['C3(JP&?Q9E+S<&G
MZRAQVAU\/QZV7R>CMGLQ:-7)NQ^!36L<J>"D-CJ3E$*Q>)PCSE)*E+*.*PTI
M.E&T:.=US+'&=I80Z7,S>QX#X-5RF0_P6Y9+2,"40^ K[BT!*A@Q,I4XCW8^
M:1&Y=W.S7)8OS/-<Y"O1@N^$?=?[G.YJ)E;QBL5UT'*O! N.D3U"!N6%>UPM
MO_LM 'O3188U3SB,FFC)T/)S*N "H(!$+USD6DDO^-J&D>OFX<&NIQ>WF%.H
MK))N)=UE-+\?\[Q/)=\YD.])N^)39)YK1P(-%,E7)N*M$<2X9+D5$83QZ';/
MH:3GTC#P57FAUE'XVQVH7Q*!H0*H?J]1W>CGZW577DT,]R)+\".QF"O77>C,
MO.ID',94AM:-CLN?KCN8J4CSJOQ[?'A4;C;L' _'PA\QC=+@$!O_HQ:6KRA"
M"4<XW.&DT49(PQ$22VGJ1*_D[!-'[F0B-5)$3(X/<8":;#J?#OK?&HV9HO51
M.L?U3AK'4?\\/-=?:!1NKA=?:-Y>OXNZPF1.DK(FOF;F,6?#M6??9\^/XK/]
M=M;?$R;ME$V9JX^W*(T3;,ZD$:4-5<-DY^TF_RLYXZPVBL18JLL[J8F-S)"4
MB[8)B(2+<EN39*78Z1RPC:A3)S54\S:%5/3.QFN,8*\:/97F)VVPRRFSG6^I
M2!,56:D#1/[P]8,T41:N;<*5O8^VB:#K1IJYRX78=27O*U_R8VD3]0AME?1Q
M9%@>HZW/J5]K6Q^KK7-5XKEV!XG)BY#"%4/[1E-ZN=5='D/H9E7[:FY*./?H
MP5MY;<O=?6>F1P>MCL>99JO<255*3*S@<!?C>UX/? OAL97J.%H[[EX=Q^Q\
MU>Q6J6\J&BL:GQ2-+R%M]U^73C-5M<0J^?7THC>7CE6LRL:GW/KS_>'6Z3^[
M.Q_P<[M;=/O+[]V]W>V#G;<!=CZ4DBJ;='OWEZ^?VF55OGS]OO?GWNG6X29\
M^O#^8.OT(]_^\,_]+?X';)]^!FPSW_KRD6U]^/WKK+/D/' C:9(D!I8(.$V)
MX5F2))U7E"8/.#X;PCQ<YZ:J&59J>][4EBAXS3,SD!4@HWDP2O$@1.1!.0X-
MM=$S:KM72:E*;0^@ME9.!U-!98B91 Z<@+6&&.8E<4$%F4+0U$FTZ<2\JYM6
M:ELNA%=JNYG:..?6,1<BDPX,2YZ*R'0RSO!$I0B%VIB=4!NSE=H62VWM$J,N
M9<>X%R18I9#:%"=.6DM"$CJ(B*^*4-S5AZ>K56JKU/:\J4W(I ($SY-'AU10
M(XS@WF;0'C("I3JD3TMM[7-PP45OK2.X%D4"W&OB/6/$&DMU69BX4>B0KD-E
MMLIL+YO9@K,*J!# N ,KHE$,($3(H(QTUE9_]$F9;:=EM&DF9=:%V82A!!C:
M:XZ[$G13RAFKN>&L'.U_-A+XE=DJLST.L^7D(^##1P ..J+#B7_KX/ /2"&Z
MZHX^;:1M]ZPDTM;W[;>;)W_9J*/W(9(<)"> !$<\FFK$>)R>,D5<DW31:7LV
MFP@O0;QRLVROI^%HYLYNU:!;X(;FV4A4,KHS&4UK1O)@(&139'(-<I'CBGA@
M0&)(43D1(_5E1Y/5RAVKC-H%[-55U#X$M6UQ:V5HX,$2G[TGX-&"<-ER@IA5
M20CO'44+@LUALZZB=GE1NX!MJ(K:!Z"VO0]E7%()E"$Q*XIVO_2(W\2(9#KG
M "%8[1O4UK5VA5&[@!V6BMJ'H+:UU@JCO)=1DLP@$6#!$2\M+KC66&= 4.WM
MV@:OH%UET"Y@\Z""]@&@;>\>T.B\UR80&V(J)<<EXI5SPI!FJ=/>Q4:AZ.'[
MHA6TRPO:!<3%*V@?XM6V ^,ZZQ2"5R2#=P0DI<25''N1@Z%1ZN1U+*A=)J_V
M)1QJ>O?]:"S_-4BCXT&OT[\B]?7":A \J1[M- .=C<WOS=#L])I*=,VX5#ZZ
M$Q]-5Q?03F8?61$9!X-&!%!BG6?$<J!1L,1YL?R56F?+44.N5A:8-WX7$!>O
M^)T??EN>N]1H2R@N"949G8  @K@,%@T+!L5U=\P6<\*NVXK?U<3O B+D%;]S
MPV\[7J[0XH=(33FWX8L[D-&==YG$8+3T%JR)&?'+Z_K[G/"[7*'R'\%WM6OW
M+ [6K649UV3) C/$\%)U4.=,7,B*^)!  (2,_M(RUNZI\'Y^0?4*[T>'=SOT
M[A*U$G0@*BF!5G>2Q$?@)%H0UJ))3JVI\'X!\%Y ^+W"^_&=ZG:07F43A1"4
M^*9HL%"Z_!:(HT$#U5P*MI3X?@E)ZF7^ESK!(]<]* J^KSJ(A='!6,VW*."/
MBVK<OW3P\]TW7'#8_IJ21M,4]NO%:-6(P=W(:;HJ'-J1TB -$:=+5;B /[R)
MNB0 ^ !9 J-N;8.I&3N(=ZX*5[?\E]#F6$# O@+V(8!MQ0*L9]2;3''B>$G
M@B:6,R"@K7*.1R-CL^,_'>&K>3K+#=H%A^GK>KL(^+8C],ES::Q!-X!&1L!Y
M02QSB= 8)3,.N*103K**NMP^'^0N5X#^*EZK4S\?'$^%Y+-Q%*WE2+,A ,P2
MSYPN.VU6Q4!=CF)N/GT%]/(">@$A^0KH1P!T.PBO3*# #2.(ZD# ETQX)26Q
M.>7LJ:(,4@7T"P#T H+PU:)^B$/<#J\##5:CXTL,"[@4HP6-'K&-)*DD-$T<
MHA1%T>_!NE<U!_Y.F'MSV,?&G#:A\Z:"]:#;'W2&E\I]O+1$^*4(J#=U"TO1
MX$':+^4>_TZ;O= _3/_3'PXO#]F;^.5X."H<]7[0/WRS\^OFI#KDFUYL[G&U
M].$E>AN^[P^VT^BW,MZ79+!^':38Q>O0@$F[[GLEOCL17Y@*W4>FI+;H@D@=
M>$FVU\0Z%HGC)@CE$HLVE%#"=*YN31E8&9Z8>_A^>>BA.CKSH8U6Y"*!3"RK
M3*SA%&E#<V*BS\18852D2MKDES$;H5+'\HGA5!-CM;BBO5LA T4D6$.2*,>+
M&ZX L$199C.U5JJ<JHFQXCPQ]RV+Y:&':F+,AS;:.0I2<$Z30L_$" ))26)T
M<L0[KUD(*B8WOUAJI8[EI8ZY;XY4ZE@QZFAOPPB@WI?2!3(K2X#C#YN4)LPI
M&7.*U,10J>,%4,?<MV$J=:P8=4QM!&7-:0:GB98N$\@&B$.Z(#@Y(J4)'%-Y
M&;GC)9RS^#V%_N<>?B!V>FG4P3X_=H.N.^@<(/SP:W[Z[+J]X7]W7M@9BZ78
M$9K>H+X8+>2S#S@RA23?'J?=_K_.3\<,666L.S'6Y^G#%\QKD)$C0S%)0&6*
M?A):/$SH3+U0R%--+O=T,FC--UD97,]A!Z?B^HEQW4X.S=K:K"4QUIA2/M<2
M'%5'$B1%C=,VA*9<4=52?6ZX7C(II8KG1\'S5#ELH[+6NNBOB%(S%M=I1Z4F
MV0MM.;44$BMX-O70QO.!\F)W0.H2_<20;BW1'-=AZR(0&TN<,3$@AN%B[10"
M6^+?C>E-ERIIM.)Z^;8G*JZ?%M=319 E9P+_CTB=<MD_H.A<RT!P;).7/BEE
M\NSSE177*X/K.>P=5%P_L4L]5>G NA 8<T2[Q!#83I7Z)($(EC*/UN/H\F5;
ML%_"*0^<]9TC_&@_=D/'CW$QL^+O+6LNCQ_FM< NC_UC?Y#.ZR[7.NUSZZ#E
M9OIE%9XJ>[N3F3YYM1:QN3.U?YW:!0F:!1RZ4FK* @%G$W$A*A*D\EQF+D"G
MM0TVB]KO+%H]/PP]<:)(9=/*ILNX%54Y=#$<>M(6_G?:>!&)RL(2$%Z4'2<@
M 5_4/G!EJ$0.-0^ON5F)M!)I)=*GW_JK1#H7(IVJH)*\8%I(DE/B!%BBQ"86
MB-!2"YVMH#2L;7"^3BN15B*M1+K\.Z^52!=#I"V+U,ALK-:,4+1-"7H3E)A@
M);$Q4X'+H02FUC;4P^.UE4<KCU8>?7J5PLJC<^'1]H:V5%QDA>Q)N4\$G.+$
M>AN(TDF:1!D(P]$@G=L1_,JCE4<KCSZA.&3ET?E$2-L)!%%:Z4) 6S3+4M&X
M%%&4S!.C<?USUK-FFTG.*'3R7(FT23_XQ\CAE^*_L?OWQO_%'V<-/W2#S]W>
M6?L81ZA,7BHMDF=LUNW%U!N]%JHAUP7#DQ=XOCT>8$]T1ONI<Y+<H).P1;'S
M-H5TZ-.@(]BK3O']7C57E .^KG?2&5R<-W272SJ58X8=-\07!VEX?# JPI3!
M#?<[1^ZD2=7IY$'_L'-P?'C4&1X?=M)!:B;!$*\_<".\W:C??-$?Z_]:;PI$
M_7:,8]#O_-X-_<[1^*1PYZB<!EX_GS%-UT]FU?;Q(79#&/]=N*7;.V[.'5\9
MG$D' %_7922.^L-NN>9UTXCNW^GG;]TXVC_CKTL?G PGO?B(\SBSCD?7?^32
MI K8 VGP1./,N&WUV*6?^X.SYARYSXGX07)?B<O8VM?NX)L[&:[]X^KLQGG<
MZL3V\U_[E#D_VE..,84+0G_0#/IKY(TT*%=AF]S2M*6S/RC+W?_I)IYC]EDD
M7.4@<^TY39DI)J7'-S3_"]8V=@O!%!S]6E;*7E%U=1M71[(]VZ9)9>/_^L$_
M-F:-?PLFX]7/&"^R=J"\,:"D,$@)U MM//HYUNGQLHV?2?%-.6F?T7 6 $XS
M7+=3 AM<<-DXEZ,*5-"UFZAQPL>DF'6OF7E,,FSN^+H[0DB&6\#FUWW7^YPZ
M2&N_#?I?FN*.G8GAT-GQ".NFVUYU+EU7:MZ-BSXV#/;^N&'4?XW<Z'AX=0BN
M<%8K-,<R#3QGH9G&_E0&_4:NG9?XGP^9SPS-735^QDT:;O;.6SYI^$6[A^]=
M=_!O=W"<=O)%K<HWO3AN]+C-X[>:>;B+[?OEH!^^/E,SZ=-_]FDX_'?/_6F/
M=[[\<;)U^,>W[0_OOW[:_2>:2!]A[\LOW>TO^_N?_MP2V[OO3K=./Z$9M4G_
M<_KN^\[;=_0O"9"-B(*H%(" !T<\]YQH"8%''S0(6.LDM":/"AH'Q^E'<U\L
MCQFPBXMN8\MT?#KH?^L<X0+>+-@!E_Q^K_D52:BLS>%\JA^=0^(L-;%_"1*7
MKBN0<!>0R&-(#)OIU7&C<W-C; N>V1S-M25@LGXMW]UH9F%WCA_K? 5OS$+L
MU@-W-$ROSW[Y.7:'V,R3U]U>TSG-AWZ^>ONRS+5,PF;TQF]/5D!KUX')L@A.
M4E,G7SQ9']>;];%EY8[?DP)74G[MVW2=7?O>CVYKUY60][KKC]^3][QK;>O3
MM-7<ZJXW)%7?>#K"3ETZ(WHS-H07$Z4P+?K3LPO53ER+R0IYO73^ZG=%H\+4
MN2K#-+M?;CE7GC1\9VZT^V;WPD^;O0Y^ST$QDJ;R8&<%4.\0;ECN\2\K[[P>
M^%ILK&C'T7GPQHKV39U4<YE4JW7J:?9#W\[IOLU\NB%\_/")=F\)RMK(I6[D
M2U -_.V'[KM/Z/KVRMX ^OUE:^ A9SQ7;1-WUB.NS#8LI,!HR6%QPH!0W"OG
M@C8^.\4"J/#7YGVS6*8"D%?E6GO'AR3VFZAYN>F*[,H>[6_S+?KIPSNZM_M&
M?MK]@V[_N<5WWAX<[KS]O;OWY<WISH?MKUN'?WS?/FGMRAZ^$WNGOW_=V_U]
M?^OMP<'V[D>V=[H'.W_NP?:'?W:WWF[!'O^([7@G_G.Z-:V "(9;I$#B&%,$
MA'#$<NY(I-;S<O:(4H8FQBL&<H:ZTK.7;*@$M:($Q8)4V=)$>4*28L9RYKAG
M.3B60#%:".I^Z2$S"*IRT-TXJ%T0RV9<12 0&4J&G6:96*4D48+KF&WD*<:U
M#:5A75<&J@ST3!A(1,^*ZGG460&/P67+I(X,%-?2<#97$ZDRT)T8J'WHS.O$
M<^"*Z&0U 98CL9Y2PKA-@M+HN-;E]*ZI-E!EH.?#0%(BZ:BHC4F0DG-HS\>D
MDO,)J<CP:@,](0.U;"!<&2!*9*"(KC6!R!@QS@:"@Z?1M18V1;>V(<12$=!J
M!9IGX^U?E\JEUVKICZ@"=1/G7"KH4]GF3FSS<2KJP[*P0>M$DN1 0-%,O,N>
M, C<6LNR![1WQ/S42I;H6%(%[0+5ABIH'P#:MHG +1,F.G1-(B=@ (A55!+A
M4PR(81XLF@A<S.T 307M$H)6\A2H#L[:!*"$<EFID#5. )]9EJZNM$\*VG9D
M@;,DP$N/*ZWPN-)*M.L-**(BYQX$,Y$K7&D?7HFF8G9Y,<NU-=3([()V0+WS
MJB#8",>SBTK'NM ^+69;"VU,,GIE+>& RRM(V2A="Q( & M*&I9YJ0K'E@BS
M+R$99;-DWJ7A;'7K6['-BQ#?7X O?C82E6[N3#=_3#GC$@QG(7!B(3L"B>-O
M-&BBM6,YV<A"2<$0[.'.^/+M/534+M 9KZA]"&K;@K\Z!&:%*>4P- &-]H'G
MTA"99*""6Q=U,1+FX(U7U"XO:A?@C5?4/@"U;7=<!/3# E@B>'''N4K$1ZV)
MY%EZ1TT.#HJ85UUJ5QBT"W#'*V@? MIVX%L*S9A#T%*+!G*,EOB !K(P A=:
MSX*4MOCCRU3-^25LC?_F2ENZ^,VC!F"#KC]N)$/J/OFC^^9_CP;#&;SSZ^5A
M^.6DO'1IE(8U;^=AW+0WY;QKYYD1UA#A0!&@41 72R(A&H'99*FR;M1!YZ56
M7^/[2XCJN?GN%=5/A.J6Q1$<0AJD(S90( !H>WB0EBBO>-3!FUS<!/;P9+R*
MZN5%]=Q\^XKJIT%UV_EW5B*4T?FGPA@"6AMB39(D!>=R9HXR+<I:7??B5QC5
M<W/^*ZJ?"-6MM9I;E81+GD2M$-4^,F*$3,1JBGRM3<EN+76IZV[]8C'Y)OSO
M<7<L@7R_@,"+B$4^=D!@BF\V>V&0W#"]3>-_<W\PEG3='> 3YS08I#CJ%PWN
M\O'*3G=BIS 5'T@X5CQR2F*6#&V.4.J">D7 0J0N>JE*ICT\/#Y0-QR6%^2/
M'1]X,,BKPLH<&:!EGSCO:.9<DQ@M1?M$ ''"&Y)ED#0:P9#ZUS;8*V'L4NU@
M5!9X9O&$N;) [GY/D9RF0;\2P!T)8"KG(&65:<XD\(0$8&,B+J"K$FBT5@A(
M(L@U!+KAC/]<"6!U">"Q0P_5UE\PT-N1B,"81\.>6 ^"0(B<>*$$X<CP( )5
M/!M<Z:5X>"QB<9D*9T4/L+'IQ\Q0K[QZY8M( 2EE.RZJ>XUK=XS2X+#;<R\Q
M%>2GY3JG\:^+D:F!YX?1_=>IT(XQ04?0GGAK&0%A!7&@,O'4:LF *UD*;#,^
M2T5AJEY W4MZCA!>B()"A?#\(-Q6G@0'6D(B00M. -!B<THXPF2BWFN6?/:-
MI,*TP581O!((7HB<0D7PW!#<#JX$EY3$I98D)&)2)-2(+4F8U%(ADJ(1DBW[
M*Z(">#4!O!!MA0K@^0&XM00S(R3-D1%7!(W  QK0P!S1,5'J$YK6"DKZ!E\.
M +^,S(W1L1MTW4'GIU*M>_C?G8/^<(CW?V%I' MVYH?XP/C;S7QT/CX?<'3^
M!X>FDM"=2.C=MX: &DMBZ_OVV\V3OY3FS##J2%9&$TC*$X>C1C@.($4.,BIE
M= 34@QR!NC>SO'LS"_#D*VP?#MNMJ[ U+K,HF24I<$: )T4,2_@;#3IQE]&U
M+SJF>H;U4/=55P:["_#A*W8?CMT_KF*746V2-^6\I(N(74&+ !(C7F>P$AAH
M$&L;3%7LKC)V%^"^5^P^'+NAA5VOE,B1D@2*$D!GAY@0!5$ 6G,3<Q9Z+@J)
M59'A3L [J\'>.7+=6+?>GW+K?2I2>#8VO^'05 :Z&P-]GW+8D[$X#;(E7$-
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M$D<FX,HKN$5G7BJ"7A%/Q8825A7A]&5*BWP)F_J_N=*6+G[S: [._(L(-B[
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MN6"EN$!$SR*E*6HT-'D,Z!<SJ2,#Q;7$>?.HQD'E@@=P02O>$5F,*7)/M.%
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ML=SCG2>]D>56^C39XMAONVWD29ETX(DX[4MV+*7(@]X3" E2#@!!S[WN6"7
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M4FE*>+*" ).<.*HXR>7D,RV%"51<VV"OI&4S-A?O*-:X?$(KE?-6E/,>KWI
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M^A=$WR477-GJ83E?@.R8]([+E<TOJ$*P]J0'3_(+@HTD[&E*3!$%6J8$7,0
M@D[ O\XG^FDGMY_"\ ^ZZ$,U+]/>>6"K21<$V,P$WH]BV,]8LP^/^K4[\)\?
MJ;#Z^.\.]KV_^_:#F>P=O3_=[;T_:?_Q^V<04-V]G3?\X.C7HGW4Z8! 8NW]
M5V>[9Q\['_=?XW^?O?K:/ON,/_&$-=9)(25QCMY;BK3,.3=>2L,")I*I2ML
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M#4^44F.)]8$(RW-"$F:! #E;32,6S&=X(J:&)V(:>%IW>%K,/</",N(9@%(
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M:XWIW'I(,Y];%"OD9,(Z8D&#=DW!U:;LV#,+(#:PLV+867"*)1:]LI8@Z37
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M[;T_:?_Q^^>/^W]V]W;>\(.RBU^G WH!:^]G6?^Q\W'_-?[WF<>[9Z\_26E
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M>2-*QMX'(*"O3F'>_..'UU_W=M[3?Y^].=G;]Y^$=LX$0W*## JZB<7(*LU
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MZG752AP4Z\DTNE5=M.FY.GVH5+A^N4CJKDD_I]>6SJIL XQC[R*]:UCF=(U
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MNZ..2WD^U5T3>7[]__X?/[\O8JO,+_YMT.L5XUYU?^)&YUEN\9IP6V[F BN
M)Y^V.C9W6!G'(5!RT1\/6K%WW!V<YJ65754J-K&'PQC+Y;9.0+=N>5"S;-%O
MQ:_13_(5I]',AZL18N[VTK'CUO%P\*4(N7U,9K?><>R/2E;8!!8;%\-X_JCI
MH-4H+O9C*L:CK19,=Q1GIS [X@BT_Z'M^]@ZMJ?5V^7-F//1?#'TD]YHG#\#
M@[V$P\Q/M]WNZ6:9ACZ[$R ?BC$*.3]\V.H6*<*>C";5^%?M0;6*,+,76[>]
M3W/?!/"ZGR'L:-*OK+5R.?56N*)?GT[=IV>>.FQK_]W+Z@M_)7CBL'4\&8XF
M%HX0WCWI%+[3BA9^'-OA^!0^V.V>']=TP[I%KTQA U.M7UU[@U,<?BE\U1\H
M3Z0B@6J,0R"$83ZN\KQALPHP+@O;S0V'BD'(>/RMRS+&*IQ 6G@0)IPF:[4$
ML[.R,2D+^AN79;Z,AZ,7OTY&L'^CT<S>_*M:P/[Y_-_5T_^K(L&_RHG-^8;A
MI/R+,!GV8&J=AS8ZSU[71N=QIWWVANSNO*(?_WCU]>/.(89QC\"(%+MGG^GN
M'Q^+@P]OV,?]EY>OR/1>@2'X_F1W_^/G@_W?/^_MO"T^]G;!B/Q\MK=_< )S
MZ7S<"=W=\HH,&)8O/V%)K2#>(&6B0EP:A0Q1$GG'M1::>JE *Z-\4:5IE7M6
M-ZSWW<$HMX?*HG>K!71L:WZ>4D[Y8:"5FJ):*>-0A0CY;:#>"\K.'%]R=<C?
M'L:BYX"8XY2R,[FE(@$)UJVM,JGE0?Q@-!YMMB;'TX>F8C@:M_[K-HVSG=?!
M)IDDYEQJ4&D"CT1*S\%\MEA^>KTT9B&O(\VI!V1BNV^GZ\DD^;*7%9U,L;X3
M]_*EP4<1N+AW2O5D]\TGJJ1346DD/-&(@]:)C$\2!1))E#A@+7/^B+ZJC%V=
M_P] Y2=#@,[-3"=QE(V,8M0I9=T)"(%6&)STIU1Y#H%;Y^19@J?+?=;^,RDE
M#(R2)AD(EY+J># &4"QILU6*9ABLO%YU#W0I&KJ\6[H\Y'M ETQIHAE!*DB#
MN# >:2(YR*W(20A@]C!] [K<:NU\N\=>:]I>K^ZKESOLS6I*4[J^%67!%*W
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MW)08YQ2/7O;0@JUYG"5&:91D/$]PI%N7+PLT70SFNAB(IHO!>LQE[;L87.N
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MQ,//P:L/YB^\[+=*,N_[TZI^7O?[387'ZXY8&U.A#B_N7YP$@%)YU>YER)=
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M8-8+PV27[>V\_B0$V"4J>&1S;4(>"$5:"8X4329YKPU3?&-;&[I%UXA9GT.
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M6<G6XQ#3LM?WUR5$!7-C^_=<ZG%5TY"-\[_CY70,_]TY*;4>V3RDVZO:-[#
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M-=K'TQC+4T+[>*X:$K"&DEN[\)>\L%'R[T!="CRC+X77Z4M+PLKSTJ+/YHW
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MC.5Y%EX^C=)VDUX(XG_<A7IQ;*3.<5DL!#0!"],DB5<5Z%K(/[G(ARYPN>E
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M*;.EF[6554Q @MNCV^.U;5$G%OR[)L==W\S@T]@XJ:<U&@ZP'YV;-YM9Y)^
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MY@HOWUT95LA"[(OFRY@S7\J4LC",M)"I'X4)DVLGWZ-SJ</=G6/@2TR$04:
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M,&9)"H:+%Q+FZ9@D?IR0**8\I#SUJ9]N;$\OBM549Y-WT6V*Z9*-H]EH,W,
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MP20OGA3XF8-V,1H,>@+D_(R!T1Y0PF$_&]74X#@8]^"B*4#K=W:7.Q6,"<=
M(OJ(^GPFDS2&9W/+@)^4EFY&D<QL>L59QP*!!*](BEK%2?"4P:#8P0'P$R+8
M03XTD4"5!P;#5^ &2_\Q3+-;'L[F#'$['DFP6D416SFX,&O&PR',PDT?#(2
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MFA%T:9T]I$C@99$ J4B@765/VR"!0@%S_4PPGIG;1 5D:U2@F$ Q 1?4+YF
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M=38,4!W&VF%44]@*+$;TF?/@.Q!P-9D2)N33A)3@-J*NDJ9ITCHL&]#7&5M
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MT3/-DOCAXR3Y3L-G"F9 ,C9?92V!T=6TKD%__Z#36\R-K5T0:HP-9M )2&)
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M]A"JX;DW>W&@F@ J^C4+/_TX1@]K.3P$\O.758S\S]DL?1Y/)B-4U9"I\1@
M"[3#$9"LE&EB-;4B*('Q:IN(<!-TP_.#]J)(=8%4H\KEVP5+S(L@"3,F$VF+
MG171XML]5Q!UE+:-][.-R _KXNPE\ITFMII87T &M$EIN1GUP7^YY-W(6G39
ME$N$*EL<*HZ1%D/7BE$5J,G&@%--!'T_IDU$K[X?T5>:_&IDN.)5E\W0M;.B
MC%2>&Q(30\ND**!EL@&]=X0ELH$81!,>W EG$PKH[X<"^T]Y->F_'OLPGHP7
M8YB/A,XA.H4V)5J#W@A/Q)H()-FD,@Y+<A^:R/P*B(KC6?O=ECO-!#I9W/?.
MMZ'$&6L)SUDG'6SVN<TQRFTL0XIO=I7\33+O.>/UF#R;?OP W=D+"(LKJ\H;
M"YQF2Y@M)SD>& G>,<)YT#D+_"W-;:1_)YXA13?5&+#_S->U9E<&=@6/C1A]
MVZ0)E<FAJ^4S<4KA.%WP(66KE6SCP]Z/:4B!3"TV5)) .V?W*C9TNA*G3$FM
MB9!>$)FH)C[23(1S7B5C'&=MK-XCP(84\=3B1DU9M'"!3J;I=@+!"'A2T01%
M,D2,T4I&@#69$VMC9-SSG%P;7_@Q9#6=/Z8\2$,M250P(DMZ=? :H]$H@@LT
M:YG;; #?Z_P-QCW:GQ4/^$Q;37PUSE=*D['@LI'.DZP,Z@(5,%K!V(?0Z)*G
MWF>0;7(I6B0J#\89J\^W(XB[A7I>QQ?9@G8J8WPA+)H)91CQ.9=$$<TLS1@L
MJS;G%H]%=+NGG[SU7_NI[WR"R\/3F P'+@GHX%'B6:.[A.:6(PVL"M[FD)IF
MG]P!:J J>A=FW)>!LJ\HZBGI4UR;);!Z-NNZV>>2RCK2G&N!3C3&4Q%=:$DE
M<<Q[PHQ3,0MMO6VS/WL'F(&JSQI<V'?J:Z:G=>=7'.9OPP,3J0SH+4 V.+R
M897-'HC5+KGLT33(-AL;]T(::#1;23=4$$.3O:[+5)B2[,(QKE91H7_ T$P[
M0$A6&VUBN0)I&^W>W@8ST-BU!A/VG?IF.UV7:2:0RD%1+&F2&$\(9]%4E: B
M*C TQ1SI8;:YMN#"H8[O*G.AA@AN\.'?G]Z<IM?X<X5KNN\7^+7DG<QG^<TG
MZ/IG[WU?]YZG5KZXNPGV2C=XO]W/>(GL01"+\?0<S?^WUSZ#/.O@BB7X^<NB
M\TCD\=1W7U\AT/D]X9-P3J=D@>BL>,EM]<0G!82;S%@2/#C3YB"JX:#VUF)+
M".6!:XPC9F2*44HBJ) EU242'V(@8&TP+"F;8B,-=AO,D.*=H7#SEAK<4X8U
M,]OZT:Q2AD<B>(U #$$W+)>;591XX11)V7,>LD@,6B7M7P.R9:!$_I0LVD=X
M=9TJ'-SL.J77F*+/2G+T\;1@O.3Q(JMI=H2QD&/,(:L([7RK>W$-*? :*KTJ
M2K9F<G8>+WI]&2 %&AUZH,8'@B&#)X&&2 S(4"K91!"R52KV"L/^VK>=Y*7*
M04._XR)"R2A1Q%'TJ%$V',4#(:0VTW,PU^FXKL6.3+RMPX=!@8H>Q0KH2D\\
M@RG@1(UD3HY2DT@&7@ZJC2%.),3F<?8I]4[+-ILM]P :E(=1E4S[S7V]3/@.
MA[,<V$A!V2M V0!'!U=RT,2*% D5/CENG/6R33[ %1#[%SRY@.EY2>>04CC)
M!'$ZE&5%T:9*[0G+P0G%E,ZFS1'N&L&0U."N4KY=@62'V:U8^VB^>)/+%8/^
M*!FZBW&$^?O9)(VRY2*R@&LGES., (C'I'*<[*2CSKJHVSBP]V,:E.JJ18!*
M(J@7UZR]WI4NQ0#= ;724A+!H</KI"46(D/7FL=DP/#$=-M-EC64_579''"*
M2H&)%[CN)K/^>MW:L5>*ENN5@@"S.,X<2\Z"\(1B]  91:A2&\8_"&M(2F\_
M;MQ6?;6D4>\<'7I/\I_H/W1^@L!.TMEX.IXORK O+D- P:PH.8P$U3(N3* 1
ML:5$O%+:.*ZBX['-T?I&^(9TVEZ7,@WD4\_O\^-I\63?05_0Z</L]7@Q_MC/
MT7M8+";]L<1(TV1EI)3HP$OE65<JSR8@W&7M4:\G+=LD3VX$;\OMH;86MBYU
MZHNG8DG!E0\8&0U!:$D8ET"DM(R@"V")3]HYE@0UK@TY[O:P=Q[)K[/%.JKO
M?%S\/EZ</C^?+S!&ZT9*AR@Y"^CG"G1E3 G. 7T<D;U*(E&G;!MOXG%L0S*U
M.W'BGN"BECAJ$_X^4)=7VLO%1_Q?*K7O E5"V6"(,(8AT"AQ9?J^(J,%I6W,
MN551S:W!#LD UR12,X'5CUZN'# FZU4,H@BVE,[0I:"P,9$D)XMK@'ZD.](A
M\7Z;2UZGG" )]'*<)^C?X-*56A :4F02 %RC])U[-Y<&$IWL*/M;'L..<]TP
M%.?."RYH)AYP^<K$)>IM[T@2N("EP^]SF\.-1T+Q(^_%U);\?A-_C#RM:Y5C
MU]6,:Z9LW?V"AME;&XRH4B+7'55WUQ5W=[K[HIFD.*&<@&.H*VATQ):[CYJ7
M?#[4%D$WJQ]?<R 5SZPC"QELV<G4H23$<T]LB(9$[@SZ'3381IO)]YU9']=2
M'9-Q=U0=VT5*=?-H'BM\K1SWO.A;432Z9,Z5XHV*!(VVURA&6VW-UBIJ?BAO
M?TC,JB[9@W!NF790H(%*,0$/)%&+'D3F0+Q1. '&BJ@\1LZJS06JC>"UFH.7
M^/CQQ^DR03U^_=#YZ1S#O4*8:>I_6I)[O9]V@M8<&?/BO"O4@FX\2Y?"Y2:;
MC(,DX!W.H,VF*!2)JL5KS5U,2K>YEGB P0W)GM3G\Z9K^5AL.8@J>%L^Z$?2
M_]7;V7S1P6+<]2[J*L>D%.N<GZ3_.9\OEI^N9]L:P:&H,^-*(7*K4[E_;8CQ
MVBCA<O:VS:6[5B,:5L1W-,8?E!@'H?G)A1]/BA> B_F]G\![B+@\^_("=\#G
M#"A+-)"LE" 2.*Y2KAC10'6VSIG VIQ15!O"D'*@C\OC=I(_"'%+DY"7D]GG
M_X3T$=869HGW'<2)G\_'>;SLBUFL41E"2+;4E"-12EJ\S8@F!L,<Q:0506IE
MZ.%=NJV',:0[L\<E<%L&'#;&=:7#@8BXO*+31(9B%[S*Q!BK0V0^6]XFO7+[
M&+=5Q,6S@9Q=QH&;B'X?AIS!QD0,RUJBPM%<'=ZV;&4WAN#Q[\2H;5;=;@([
MR&KJMQ2D54D+2IAPK&32,A)4RB08%C,U&$NT.B1Y&-AWXT W)]"V4CK*B<K*
MM-0]1;E\:,N3D[N15SHM*;VV\ 5ON]G%&)_V[.MO\U+MY.5XZJ>QI !@]'^Q
MK%?'K:+&>$=XHJ4A%RCBHG1$V2RS*3U^69OMG\TQ5CCCB "IO\3T:CX_+UW#
MW^2KE3]&%)=GH@)GP4I+)+>:>,YBWZ%><A?PXS;)HH]C&Y)%:\2K.XX[:@JL
M8DK4)_^U7\ WT.0818KE;D'I_B+Q)^*9CWU#.ZV8,D:TRI>[&]&@S-B!6%-%
M.O4N U]BN1QGN452AN@Q-)>!>*E,V3=5)#!OB$?F<C R"MM&X=Z':%#YQ(?2
M,#6D4_/B^*6^N\KBR[)U/8U3X%(S98DV)3[G1A&,ABFQ5G,ADI="M-D7V0C>
MD/8[CF"FZHBM":/Z:K%O/O7WM7_^ ET<XVR,LI0F9,D)Z+Y.,6+#: %-*>48
M+3(GLVV6[?$PM"%5&#L"D_875W4;=GD= V/"DE)<2@_CX,N&]*GOX)E'A"6*
MQ!"RG]210'6I/ N$<EJ2B3DG(6A*C.=6 &.>FK8V;EO$6W8D^J%L8%/I-O"G
M?H'N(W0KU+W5OFMF G6,4F#$^I))KTT@CH$@P@4/*LND4Z-FF-L!W81YY@=E
M7@M95B?<A]DOX^FL&R^^]LMA579]I)T!13T0+2*./YB$0065))MH8W2*^U85
M?A[$M0F=[ ]*IPJ2:N* K?&A1NTW7.\<?Q)24J.)"M:6NPM G.4(,EHF"_ <
MVF2B; ET$WZY']<YJRW*O?E6MK5'5U#].ILNZS1]Q _*YC/.S+)6$_X21Y+.
MX^)=D<W=BC8EKH55Q:@'_*)=J7QLB+"EH;47#-2-.DBWM]6K(MIH\Y/^(/KL
M>+*LIO;NF:'+NSI7\!G.<W:!X;P8G"&>(@E:(5*G:589XYS41N-MCK'BY0H4
M.<<50DG.!ET8XX!8ERG1D@7IP5$9&T5$@[Q<T8@G#]R;V$8 %9O5?>H@COL9
MP>\GL$IR.3DKZ?W_;QE.!:EEV5DD($K*EM(X5"\"26ATLJ=6>]_F\& 3=$.Z
M-W$@TE076KO>AS=*Z?$0561*$A$20Z/C,&("2XD2R4H#1AG;)B9Y!-B0DCD/
M1J)ZHJKC)#X_]>A(C*?3V33B!$PN*ZO,+RNKS*>P&!G)# VH'C50AXJ2^1(N
ME3ZOI6M2$MQ'MI$/N.$+MSPX.(J'5XL=S011N4+JNN3KLKG<+[ XG>$L7, R
MVW@^<IP:D70H;<UE:7+HB.<N$>&M\-$'0:'-X<%&\+8\0/BN&=5.;A7[GMVY
MB\R59RHX4RHE\E)+UA(?2KHOCX!DUY'E-C5WJYP _ B<J2"8:B3YO<,I>9/S
MF[RVG.7P=)W\4W:&1]2)!"(+DJ3$ 89("7IAG(2DJ$8&:_R\"6$>Q[;E)OZ/
M0)[* JO>\J&8UNL] :0%IC/-^'X:2@\3''=I[28H#E^FK)-N4YSJ7DC?PV9]
M;=[4D4]-?Z<#5($O8/G?5]-UW]!W$&%\42Y>C9A&QS9S3[0V)=F0&>*3S20[
MB]XZE&;WS3H]/8INRQWY'X)$U:76D$_%_YKB/^KW9+7/23!)DLH(B05+;(PX
M<.Z8Y"JY;-H<2C\(Z[O89&]/H5T%=0!==+6'\4B!5"X+1X"6!""@BOBH+'%4
MNV0H1,?:]"O8#-]&;/K!]ID;2*XMJVYTOUVA'&56#JEX(*!EZ<4A)'$BE".D
ME**3WD;6YAK$%B WXM</MB7=2H8-2=;[>9?S\-Q_&B_\!*=K) (8Z2@GSEI)
MI,^2>!L<23$DDY),DK9QPS?'N!'%CIT2WYYC5418KPT*SD'Y?]G;NO"39>;B
M?-&-8TD=PU^<3-/U#Z[\Y;**S>TAKJIM_?PE]INR[_P"?LX9XF(D&<\X#"!4
M&D^DT:6#G.3$H@Q#$C'+T.; ]K#C;'3@?U="@N)&*IH%#C@Y(I74)'@I2YFR
MY)-*5$7:9$9WO6EXY/J#P^7[3=71B 355,=RB&_RU6&_F:[F\,;,C8R19?22
M9)G02=,!=2A:49(8XRQYSJUL$Z-M@W)(Q_+?$5&;$:%U M7R$.?Z4LK*^^RE
M)9E+1F14B3B=%<(U&&6$G"RTJ46R.<8A'?Q_1S1M1()C9/G94GZBI.Y34WJU
M<*$QV@T4(V"A2N<H)WR;4[Y=L_R.>W/Q^R?IOB0XAB;EUG$I@B8V RV7ZW 1
M.<&)5IHSZ5S"SP>E2?>YS7(2D3$=/#N?CZ>E#\BRDDS/K>5OTD@C+3(M30Q+
M2IMTB>',T%#23VCV!I+B;1;M-BBW]-6/$J/O2[;[;[I4EF*#6U,K'#@EJ!$6
M7TNIS05JKZ*O^AZ"(\\C6.X$484,/4C'?2 8 5CK59"N4=&,S3%^#V4TFG.L
MC@2K,VQY!^+R9DZ_67777 BA G4E29=G0) 1YR(BR(3.D2P7P(1H>Q%T0Z#?
M0QF.5EQK(<LF5_E>C'M0B_,.WN1ORK?T[:(!I"#<ENU6*BEQN30ABID;8#;'
MW*;-TP;@AN3?'HI7E476SCS^XKL_H&_O\*VN[\CRDAWE$I'"Y647N,#QNPS9
M,V6IL;G-">]&\+Z']-KF1G%ON;4I]8*!(%KH7_RB0/KZ)M\)DQOALU,E,<87
MYC-.4*LF$A-SCG*1,C1RO+:%^ATDY;947?7%V8QU;_+];B+J5J4C+@;%+.I7
M%T.QVA97B1;1A6!%;%]<\1&0WT$&;VNFU1)ART*P[\L4=E]G^?WXX[0O&XY
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M.:\A8DS)&Y4ZVQ#A$%)?#L6G)E*K>[!\?;",@Q$N 4FI9&8I&DD0.%CM<N9
M(076IA_'8][?HU>2OVN>["F)8\1O5VX5^BNW"AO$;H^\J6'<MLT8J\5L]US7
M+'L&.F8IH]<$$J.D-'PEGD5&-/,"U42FJE'*TT.H*MPZOOO9?3KB" ?,&$VE
MD$.YI>I9(J@I<5G03'GDW/G8YECM85S#BMLJ<>:.V\2U1%,O<HOQ_*S,=6E.
M]'A3SP<*'0EG-4/=:L&6;HTJH[ZVBL1$(],Y)^K;7%*K-8)!%;)JQL&CR/OP
M!O6*!U#=A-[Q[&9&\[%Q5#*35UYSQ8OV"HSFGA*E!(K8@B>6V4B2<$9EQE,4
MS;W7^P*=74.^VPT?:0J2T5Q.#;E:$CE8KDDT@G+J/6379K=@C]:<AS*%^_/B
M[A!N/RG4N</2CVTRFWY<0'>V/#T8V91*=V%;KLY8(JDWQ%,54=$F%K6((@OW
MF-*X[^%#VDNL)]<J4WEX^] W&[K1@*BZH7CH)<TLQL8CJWRIY&H7IW70K93U
M,E%!RE9Q*8GC2T99R3MT65%%=1!M^M@\ *J"PWS?HZ_O04G-I 'AB HF$)P&
MU&C"XPQ$R05-7-O4IJ33I@B'9&AJL>@.=[>^M&H&7U?1]6KT3G1>H_;U+A*5
M,WK\ :-"ZZ@D6J=@!5,1^$&X="_"(1FW W&ICK1:FK[7I;;]O/^ZJH^W7T+K
M@\^K8- VQUO)=KTN94[ALAQ__^;78Q_&$_11U_4L7YS#B--DC7>.) _HS*BD
M"0HY$BZTS(9YQ7F;S8U-$>ZKB39]SZ\X\Q\^P^0"?IE-%Z?SD8XR&"D=L=:5
MO@6!$\]3(L$;QM#]TR&WB9YV13PDJ]>$?S?5UD%$6\TD;HKVO\%W'S[/1B8:
MEGU6Q"7&B02<(]2\G("RJ23H0:!M^C!L"71(!G)0M-M%D,=A&]('1E$:+K5Q
MA&%$7 IA2^*9]B1I[J)B00!K<WZR-=0A)9H,CW%;"_,HG'LY.^]&!GU2FB"0
M' *BE @P,*N(4"# Z"@DM$E!V1;ID%)1!L>XK45Y',*-+V"DK0:=E2@1L":2
M.H6JF):&5"Z $H)*UR:E=UND0\II&1[AMA7EP0EWDA?074+UB4FF$R.1:EW:
M,0?BT-4DTH;D4%%;YX_+NFMPAU1V?U#4VUVHQ]H*&=U(4]Y_,P2?V'@[Y";F
M0V^(V&"9XZA((HW%D($D%F@@0CL98@J:A39'PX?:$+GG#2.A@06%=CN&TO$V
M.EQ"'*,6KJWU$9=79FWBS7L ?9?;&=NPYU9N9P7!',;2_39-XWF_90SIYR_E
M NK)6?EII!SE45A*@F<E.UEZXE7$L,.R;)P*4HDV9:9V@OM=[ESLP[#V0FUI
MZ<K=U<_CR<2OLJI?E63;C^-2;W"9$'UY4CS+-W^WQ]E C==6L)G51U^M1,;U
M=_49G\B?9=OA->H1Q]@P41,(2X5$VBABN<J$IN!MXIDFV>9>W&;X]E67Y7[U
M M?21>G5<\<+1\H'&T $4KH>H[O(,3[FV1$.B:.WF%"CMQG_8\B&9&8;<.FF
M"JPJJ(K%$Q+D^Y'=GH*4#61I,]'9%)T<4#N7SMH!L@M2YAQ2&V=M6Z1#LK$'
MH%=305:CVP.+H&1ALT2=E\X0_$^9@,2)]1;7@3/*)J4DA38Y&0_C:JZCK4'W
MR7I). L.'6U 1]MX160.$4-Z6782_O0ZNB)WMM;-VPCH$(OERI6#JU<+1HXZ
M\#$&A(B.NK0V$FLA$RZ%S]R#"ZK-]:OML0[J;LAQN%5#BA4]@5OCOFTTA/%!
M&G D&N.+T2BE@TM;!% B9*^]9:TJM#V.KO8,W&.E T\9$M/$2);13U,*;288
MDH&A"X=1*6]4CV:7@&)8;O7>G+KM]507V3'5=^+&:N&!*,M3Z:F;B 54.PS-
M#C4Q1<;:)'=_Y^J[.<\:R[+EYA5"]],X]I-7T_FB.^^W\_PTO1O/__C%3_VR
M-=[[> KI? *S?%FR)L^Z^;62-:7W!CYHLK[=N/.^5F-$%;:\#CEGM>Z,W"@U
M=+W T(J9D)[/YHO2N7..3H;A/#I.C AE.6A#?$Z*:!I%=H9B>-CH(LF62&L7
MTKKQOF_+MS<>OTT[\),"X)]^/'U61 H?_)>1$<9DX)P(6W+IO. $G;]2"#7S
M8)A57#:ZBUT#_I9.05MMW92JCY7@:B_]9A7@-H7^&G_Z!ITE S9CP,J HAU"
M*TBLBHDHX7W,(C%IVQPK5X$_I%V\[X*WNPO_X)4+1RXP+6C2I;BT6%7'5ZI\
M 4.E$=+3P^C4^Q .*=_WJ.RK(L*C>[G?4GYN^VS7Q^47E]7U6CNZ>X$ZE*];
M;^8:N;OW$A1\8!AK19(U1X+&D(D'RTF6RD-6E(6;+52/JF.V++CP\$N^2:W/
M("S9@R6+<'XR3:]+N?]+28W "07<>4*E+'62N"'!2$<,TSE@8"QS#(^QO2:@
M(6UB-:':];;$1Y#B@:S]#?!OIO#AM)N=?SR]',85^,EP)2 1VY<G!"J)E\$2
M$RDDK;WUJLW1<K4A#-E;K4K;XPK_X-S]?;PX'4\1?Y^$?8F96PP'-3I7T2E
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M2,QK,(W5\\[0AW@0=2!=U4K C7FYW,'VC*,3BW&;$46)E@C.E;I?B@FI08B
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M^D?U7K=NO>#2>@V65T)Q(FD,N@!SWFL>C$/3V$%[TU?=^K4+0L]J0P:9@9M
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M1/,AKGTWG2*9,JX@1D$B19$@Q.QKITWM#(;$&R5 ]K:$;U3>C_9;% MV$>0
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M&6ZUP1H9;AJL4D$R)B3>SMUY@F_$^K5]>PWV18PUW']2]Y)KW_0!YT+3^::
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M22H'VD@+*M"1&=$7*#$SYKE'SMLTA^US%4=MI1Q<[0TZOU\#6"'=!+E\7[M
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MG8+1P:YJWT:FC7"T6MFI@?5 (=I1,E+'<Q*/E_E+R#W]$*8?;[*/DI,D$*?
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MD!=C(1<O;^X#7(GTJAD71$'T!MOTQ6F?QK7_AI7V9UNT%3$"1VE 6<O .Z^
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M3I:?)M/?_L#+W_'GV73Y:5$;[VJ"IB&8$$ E3KM?804P6>%(\RV]$,U#=CT
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M8MTPL .,/D9]=SJ'?W6?-]F/H&"3Q"/D-^!6O G',"&$JRU]<B&]U#J!"VA
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MZ%A*_I,$WKB@<L:<3#T%U/0I\>H#FC$VZ0"6;52^F_/;9B5KB!620 LFL3>
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M-(G&I$@@,.>$)2='?=I>]5K1J\3Z(N9?F#\_H2H@Z^!TX??4YMC\YA0@5B/
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M]>OR_$I0X;77$"'46DWD4$#5WH/OKR5YS2":9)7'*#&3C\6-%%N]P^B5+)E
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MB1?E^PT7CR[4-^[FHN-&5(Q5A*@45-'J3J*7$*TCJ.SZDBXB!3WL!1_WW%-
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M1 79OK6Y)OTP+-YMS"V??R+&G*JYN6>@;'RR'?-ZHLV15P<^N-CZ5?K6C\6
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MG[&^"8:T^L=T]?$EG<RT@L4O?UT_)+Y8+I'^E]=VATA&>.>@2$>R2J@@>J$
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MP$*RSF#_$>C/\\^8+],Z>^X&=V A<VXD6!.1Q!0D^) M")%-0550N#P85;:
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M)H++C:I"GPY['WG0/G+R]E%P ])^JT[]WK7XQO!@2L?:)%:GVK$XD]47HXS
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MEA8RL05YJ2$Q8:-V6H5'\TWO?.;Y^1S["'7PS@!K&->D[0*D7U. 6Y]^B'X
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MI11*8'!V8^S@X:\;VFGZ;@1]M]!C4*S8;( \O **9PN>2P^%6316:17"6*&
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M5"2B06K'V_,+/YH6"=S%]G:R(@#&H^^0KO>Z7[LN_3X:C\]T+CJ>-!$NHEA
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MS!\BW08N]G7VS=JC7.=L*V4S1$:T+;,L4M(DX)*)YX;ZI)+DH4UZP@Y PUD
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M"A;_O@$I7;WO[=6S^-X.E-K.Z\*:P=Q7W?GY:+ZX*#TB$+OE*<<'4>^#MA$
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MZNU694_:"_6Y:U5UNAK<==^6R#<__0HH@6"U5!J=#0.H\S+C_FFB)TES2$I
MMK1-^&T;FN>N)0\1^EU%D"TVFC/G;=!),^)T0N4T0A-ODR%4&A8-59"8&VPO
M>>Z*\!"AWU4$=:PBO,D9XOSCY)=+A 6O_.S;+^/N]]DR1>?,) $^&T,2X$(E
MI9:$P"QA(DBKD@>CVJ0H[(7U#%6C'@UW=437[!>PTXQ:75B4XPVTY40Y44;[
MR41<4HR@(R>L%=K'U,8>.0#D<)T &FM-*V(>2[K5=:'J.L5PW0)P$0C/UJI
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MA^)X\JHR-!<5BZ]V:/EO>%R5FYGQ&+Y"&E^MH:;E*L^2S-E#-L0DC8Y(1 _
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MCE.GWAW!PV9LL8(0:U_$(IH2XWPW\F$T'LVO5I 8.C$"32NBRFQ3F37Z+P:
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M)Z_9<-/2V;71-2#)<'(2]!IS\S?BD5^49^YG[<2T2GAN_MZ8E# Q8<J#<3#
M'Y0!8T+*PV$LWBK?RVOCGC$S:>7F[:/K:)RT*7/E<,FK5<//.4L7DF^@: T(
MUH6=H.,3P%M%,9?BE\L)!B7+VFR3EO<N2DX5G-<2B 4>:\!;S+39FTQ]ZB8>
M'*N;6@3UX'*QM1"G<E3TS.61+%/>I90K\K%RJ<4(=SPRELVFV*R&[FL\AO<E
MXDY@[@D@_W.1$MFZ8?B2_><J''P.@F.?;\BA_3P*9)M#_?ATA G?1,92C*G5
MY='G^^"!2FR>8MQFUQ +!^@@FBCB!5;CQOI0?X"OT"1GCX<JN:)9O-N]R<1<
MZ]:;7I\9.A($3=I[$C,QT>=X3X9O,7P+/?"JF*]+Y45J89%W??(^MV450Z+V
M%[?IM/XP]9O^N$!#)K"*M=-U]]QG?7*OL6L[FTGX2Y P:X&JV@;-@&4>*:U+
M%PIWQCN(VG_JZ9S.T0K<^"<2!VLU.PQ@AO<8)]OS@ABS % <Q;.]I.?/KV>P
M[=$=#(5N0;YG[05F?!7B6["MSO+US%!B!)A A_M_3O33%T;#FVM]&I@ZO-WX
MWX9>>L([EED,O/'8<L#'3NNQU.K11YS(IM&\&Z?>C:[;&[)]2FF,!"M/XOEX
M5=:QS*, NX)]SA0;HY$[%/"VC"4\;>[%-][>G"GBZLK3"<8N7^T52<PF5W[Y
M&YTK6R> UW4[C,A?YOK)_"E1^@FJ1Q8G #3,Y4B'VD;);[J[SUT\I0UR\%[H
M^K%[S&?<3Z@ UA3Z9[2< -[0!/ WRCTF)O+!T\/LUA]9ZGT(P=%W\S;/BS\$
MSY6HU))^UR8L+\YZ-N>;>V<H:O]EHJ^XDR<J@QP*+>JA,M<C6D!R03!YA#,U
MV@O&)7%8BSCGQLU_YA?Z1SYCZ%Q4!+%T:H'OTXB)>P6_V61HNVFS;LJG0J0B
MX@DU@Z*-'\49^;\T!UZ/E=19J/#/]K1\VGE![N["^G>,*\4$?P)X0/ N:PN
MLV]S_XYBA_%3O*GA0QM]F(',>)WS3Z]%,=+>S^^PX<=&^#5L:^QFOQT+PUJ]
M"LS31;2GCM#SK%LB.%"8\F!PC;3K@^GZ1%PM:\QL!6<NX>ZP^7N,5U&:-'"!
MID3R+?3C//HZ7%3_CH_NH^6O;AD!/60<<Y)XVPN;9*/O:;4*@?SN3\TK.(5E
M]0XEURKEX;S!3[0*=X3>_NHW@F5#2D4V-]SFH^587AS/4D6N)KEO^J,9J-&-
M="> 9K/">X76=]MG>4X;/W9-*RE7,^<TM684%__'4K3C3@0EH/6QF =J_*D.
MZCTMK(/ Z>1&--<?+N.'7Z$W"*$#,'IS0/?RC\;^1?H3$)ZDR5R*&)ZR6_X+
M]G*:NU-QBM322FQD'UC!U'WL?G_FJ($ ^YA1'M8.[W\O*%4#4Z&F,#@.@]TU
MD=%-:?(2)P">7A/D.M_1$4CSHUVL3)$_ NS)A-MI=_G7!+4ZEOFYPXV[)73
M)B<UR>4:?V!#N9SN]2B.YSI%K.=)=\GMYCV<2AX\YMH3'K#LC++8S;)<DK9.
M9<.(9)55PI*MWA@D&J7M8+8-:U9Y\"<"6AFGO4J:\@&)968F-K#M09HSQC+,
M"=?:/ KNGJL[YN<]]FW"_#P!!%,T\G;O">D.+RY"AX@I@0U18'[9:Z*T=5PA
M=B_4J<.LT4:YVRC^5MQ1.UB]_05?>6%]K% 8T0U?;T#/F07:CEA2-R'SD[1;
MG]16U(D)15<#]V\!]XS+*'U11_/6.L?I+SU(GS4<>S/20>R09^/E8W8?;T=>
M?87T07]4M\,?/L5KY-Q(_^;:?4W0S!B'<<L.$384 +X] "ZBN!O/K,Y>+D^-
MW;?5C2^\=]WF^D($53^,\J#M25[>LO4^S#KO. WS7OQ/?*B(R13E,SXV6I'U
MPKJ!Y7@?X=,_"QX"&_L%1 MJKB3RJM. DWG: OGV"Q7R)17T&Z0\@G>8QKWQ
M45.!N?)(@J=LH\T3Q8KP#9R#7+985XJ7*]>^Z7L9?-!#%OI%L(=M.8YW8:/B
M#JHI+,R3K/TLQ_+$HZ<RG:J"F8GU:"**5  G@)N(\=JB\<O<86D,-BD'#VGJ
M[<^=Y^#]K&;F!CX04-%#8_NU7N=W$:+%\I?1_-1O&LQCB ?XWM^.'%,=/!=N
M"\#'UDJU2L5,>8S&L#X,/- SX3'7(LLS>U='TP4S\QGL8UMAX3/G:O'2X<6%
M]M%Q-H%9UVI!01#N U H;]?49(^I^KE_XC4#<\AV"+JJT?+*48EOK?FUVA/5
MZ#Z+5-_RY*P/+G:WP&3I:SWX>I,$V@%,5P=4^LS#N,Q2&H/V7(-%@2HYZQ9T
M83\G^BNG\NB+[_2!5R3OF=:-Y#J)).I8Q?B_<#J6"O/',;56EL7V)L0 T 6-
M#+0V\T3,=:[:@_I*PI4+D_$7%(L>)BM??%Y[QV>]^]-/,SV-\*.J)@CS 48
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MD5P_X-5B,XYSC7R![ T#6]-L'3H5 33PX<@BB@/CE$6!.%JM$O24%!24T$/
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MK^(NV"QG>D^$^WE58RO<50MC,'QQTTIS$?.0V"[V/)"7M&/6[?%@N=*)[M>
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M%\/@@K#HJ1+^/&64'51[>8:H=P)@@385[A._"Z9+*)K1W@9J9[=82OWX?&;
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MZVJ\&S1,SB,S Q_@"T0LO4PKRJ*X<)KMY^0/L4?2U#O(1OX+Q5^TBLW#-$\
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MO%EDL[E'2#WS^[[+'ST$0-K1&^%S8"?$>/]3BGEFL^IO1/8L\(M304#E&4U
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M4LTM>YG[-1>[=60'WQ!+<P+0[DI& P2;^.XNSE=C+KPQKCU.<<OVRV%D#4B
M=LK3W1VW?#_,9KD1:R:4;U<E'=6J+E/JR3KWWAEJFF#EU?6]Z%F*]H8KH@5I
MKS53P&L^T3!UU;/_XKN$R%V2 AXG;G.ZLETBL+W6L* [Z E]L=7GV.>@<3\J
M5,T%,L_\ @AKL/ES^S61EX=,_D+^F!C-]UQI[-*O8P(;6:;7:;+WR8E-6(7;
M?=^'(NO8SHY;5$28 S;K1A*)>&ZX \%W9$GX?#"3(KU%"SE%%;X<5Y^U]]4A
M[N&UNN-/%I<)7_&KRECQ,.F,Z*QDW9.9[8!2;%2JF/F>'I.2XCE$!*\;4<Y$
M>0QJL<S1[CC,-]9SRWJ7NK8U4I5MG2K*_DB?4@L'[QGJPW0H1J4G.K=E303E
M=!O&UV(2!1R7RE]9/GG_5HI^,_V,GV+^FCHK)(H;OO],LI0/!R ]LAQ*E9Y/
MEE79BE0OY_@Z!<M<(WF2PT.=_W&9Q]6LT?^E.1\R+BI[9D;93)Y:37=WM-P'
M7X+TQZ3_W<KWCRD*1!I?];*@!_?$3ZI>TS^O-I;_8+[0'^:[=WL8J_@.!Y#M
M2<+W;5;\":6UKZ\J!JCX/?^MWO]3\RSXTW($\0A^U'-,!05AN:^@_[+2:#1"
M0>0XHQMSAW# (H,3=JX$#4<_%P*C8^WPK(7+W/D[U14!2["\&JH_K/'RJ,.F
M1KT0CW/<C;FY\'VU!1E_)&/E,7CQUO&N?0*Y=/)W43]%9L;L=5!6.>G=<X6O
M!W=XXF2VS[O61+FQ,Z.B-AO<BIA%KTA^,@,5H:I:ZKKK1J6S!5@57D<BJAXD
MG\J-LBN[P?R:PC*_US_--GVH57E\8 SZY.M\&2JWQG:M#]8"I?I:(4F=%V;T
M2,K<-#-?CUR:X(FZ8H#WLS:]-JVTK#HYGQQ5W23QE_@ VV?]M\IU$:0RY[O%
MZ!>'ES/G_EYI_TMYW^ZGC,@<PLCS)9)HW=XQ=?_2,C'>+<9*;))\4#4O'S9I
M.)9J[C^PP&8_\Q%%Q1"F@1&YAA)G,VI468#S'FDLEL/\R\U24=83T(W1%//Q
MJE))N-CPAM%W+,B-253BE+\0ZJA5/?.!-AGMPU8X_7>_&^$A'*=7W1-#RU_J
M14G+-/2UX=DY<-Y&_E@O!WP@/1S4)3FA;;3UX3<K0HG##P/JN^?SGH;DW!=\
M<_OE$VM.R  **\CXT#2OHD*6HO%='L0L+^0!WGF/3\1I(8@A(XWTH_='=HU=
M:0GU15ZS)VP;%T3?I")FWM,*9A>4@%SJFM?:*ZF\ =ZK5WCLE<P^QM*V5TXA
M7Y'74Z7<,*B2?;*XVJ/UZN\:A!+!BZ"/XA5WB&AX(LU)KNS^NY8N]2AM=&)4
MARUK7[TM&"L4<8V+]+10K;)\E$Y7;U!KG28PYU?QN @_2_TN'X?5>CIYDF>W
MHNL$RTHTU1TCY;MUW2@O:5CHJC](XD&L2YF=90J@V9[U\+<^C\_C1KXUTJ%5
M9J<KIUONW6I.>K1N=OB,^F;^!_H(I.EY 6[E)]2/O@!V4_"^\H=N92^3Y"(L
MEIW=I^VB=D\VT<4__VVQ@*]AK]#,L)OHL4*I5!&=CD;[-.6U:^FB?DJH[@>U
M4R$\QXA\5LB5W)F&8 SDM,KE\?G&.'08\L58A91,=L^T#Z07,M9KX\]_5MCB
M(62M1E!:<DJ(9]](;.V1WJB/OF_6:A/@%05N(#GO26(Q0MOK/KJCU0JEDX@J
M+KR-#@7(#V\.N==41EM)G7V#:+7Q(@UJJ_,3LFCM0!Y':4A8CF@K>BF?_K<L
M0?X#&-FL6S9WMG(!RB!C7!7PZN'!V9J/X%5V 037H-LK=J56Z7/U^_ D]P9-
M4\C=.-L4YZGKA]:-=2';WQP@D[T/8J "K3O]$[*QUTD2K\OMB&#6)P-HO+0L
MM=<@9"&DC%SUB&8?XMJQLO/M74IS56Q%JQN\FA&WWZIPFA8]:??!J+X\XH-!
M@D8WW9<,HE6.)/>$ +I[C_ "PJP<_+JB%)L*^28,+<CUWH+UZ^* QN!KPCR9
ML0;"7<^5RW*R3XR-R%(Q3K18]#0\'<N'UJA8'ZUY?[OX:?DY:<B 7M!\+XV
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M2-(^5*'W/R47OE.H7Z WDYTB]45*8^8V7D$_/OYWI>+_823"C?\O4$L#!!0
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M'ORR"_2GSISJ\8(4RR(V]1?4"<8OO,ZIL)\"#M!14$7R6Q&#&S8XTLM^*MY
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MI;[:$O&N +O)42W20V[XN?:<S.E_[+YLUT8]7N](JB<GGP(<U>/"I IRUU,
M#L.U#+L/G\<YH]=H@Z%!WPE[&K%[ZK7$9ZX-%1WP^QY@!JMRAA>?L@-<_IP
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MFN>/OYF$:OB)E!@%+R "^#_#^NBWCAR))I$GOZ785HV,=MNN@/PKQO/2%AU
M0M&$O+]IEJ _S:^(+S1KY%.;0*W@,JEW) 4=Q?.A2JLK,LAL@;P(+&F#E<<8
M>\?MKNR7YH>%%?G]OFTPZF$Y$=<?DU.=K %7WTL.%H:P ZBVU)6@2<\K2OAE
M8S=W[PAJS+W$*+$8//L7<1CCG\67QW]4ED'VHJ:],!XX>)15<Z1(D=\6[V6%
MJI,8B#1E$L)DV &C:1@U$-F=;'V.AV2Z/W3>+9YCTIS-B-LG:6;^PL/U.SJ)
M\LR]IX +&\R9A+27C88"M[Z8+9P8;@)_ GGXXTA4#OD1U&6M!_OG4+=)CW#3
M[3QW&J^?!"5J",C3P.(H73SG\)KOH(_<'$I,NMTNG\=$["/1)(WL]^T+V893
M8DZT6<W5"@T1F<HYK**VO^/R3M",^$<8A1@\2#5YG#*KSB*4HT=M/L9*Z@MK
MUV\=U7_=FZQ>"'Z0IZ/W/8_6+J[';8K^4'L,QFFAX6_I:JHN\J%3#9D.#[27
MPJO<1K@['4FU6]SX@7^(D,S9:O3BBS04_;8HO[&W<?B-'+<M![[37_9-\4Z[
M^?-W[S8@(US KL$NSX4**8?]%)5U6$KBZA#2D3W%P7?;$U@!WM+,)]#JU8Q4
M@8*]N]P0?(F19-"9<7:6L\TV7;^N*QS_NR'L]R5D6S<F3;/>#W&_C]/%S1JB
M".L'5A[FX>8-0ONW=44^%%])-?RE=%@:*[$0X/^5YY&804$#I.\4<'Y$YM=B
MQ,MF[L#Y+R=U2EX*U/B5M,4M)D;UE^GVH=IM8L/UCA2SHN?>=]=&#9R\81"!
MGJL>"15/_@XYS7\9\G\_=&WBK77Z6PQ'OVJ=ET(/KHTGS+S$2F=S?DG[QGI\
M"B"^@HWJS%F8$7P5T[-5TQ@]Z-W7-36'&^#3U(=9YA>&]KFO8A*,J944.G_)
M:[JUHN3<=K8EG3HSWHB_6$W<@ R2J%MJJAWBX@BZI,D3GB>)%A/%3_<5[Z::
M;H3ZWEEZ,S":"%&C_(:4DT\![2(FC.JZ(0ME,9W627X>&WHHV_G)YCVL79U;
M$-SM%'#UI[\Q&]?['4C>'!,N)N6]MY^P<]9NP@.ZQX?(S$78@UA#VI0%X [/
M3@WIVF#_7DZ()O,3XGP\,)AT+<^/7RVTIW5.^IE3Y2=NIZRL2(I9@8%/[KJ>
MKS.I7N?3]*?T"6TEUGA>\_.1^J%/2A4[@'1RDM@.L-OPM_3N_E76B2'3(:0A
MLVB C@?L94?K]X*&EHE5*-M"NM3/0W$3AVK\]-.MVF+KR#_Y6;DYQN-I!=JS
MS5F?<J3Z^-^P:"O9J/X-C?]7T!>Q5JM!/U@K+LTV?O7),KZ>HT%)SP8[FEW/
MX?(H.WJ0<L7/L&W7OSI5OE'\%.#_I._-E6<?O^F9%S[2_5-29"6$!4H:UX&E
M/%=U?+A7ML\>Z_4E1'?L09&+5=]6:99QUJLG!FN& H717R$/++(U\KQA0;!Q
M1+E'V=[!%IWP[7,[#*"C"&1XJ<CJR':J8'QFJD1PR2@'&3WVH"'(KE-=_?O>
MS<10$](AN11L^W!(E _M_<A']?M=M:>E+\%TE+@%BX>'A3*NUB*PWXBE@:%=
MN9W4"6=%=+8T<%+W,*:)$(ALLX0_ZLN[9S3^T%DHL1.>!$/X^;9?A_$-8QK+
MT_ECAM1LY,XI>T!"V9/[,6H&L7HR5*$7;S=WDN-. 8[TZ?0ZU;C#,N\^QZT,
M-7ITW*KY3&!++S?MEP7K'62$:%%==5 BT0;_X'J1U_Z;R()<1ZWU<:W9Q^M#
MOQI"F1QGX?=Z1$4'O/;NIKZQ5&+1N?SO&8]_0=+>SI8V?GT:@P@5+1')TRY4
M3<N"M#9!L)JQPB1:3%JZ\JY^Q+D?-$T>'3 5J >A(!#/VY$BT0=BMXZ/O[ 9
M7(=%Z2Y8L/N/BVVPHK<S46F;02^5DH/>U%2F'MWVL!# LZ(C?8I*E+>5_?F#
MEJ[S,><$^&[NX:2T" 78U_JO[*JCBZ-G8B42S<3:X.<M_#;:#V6#*C5NJPFH
MV&YUP*I(- 056UQ7R^&;K%D:K"CZ4RD[3A:]S67?/DKPO?"#X(95,Q;MK3L\
M[K?EJH_,T\0&^G.KM*'"3GS;R.?HZ=F3'NL+OXE>Y4(;*K&20DRJ7BBI&!0U
M9FR2(KV2U&349O\FJZ[^4Q)3%55;3.AV6?..F%%'_(LT)KVK(.7(_!ZMA$_F
MJ1RNHG](=6>Z97^# G0RY&A&N,Y/>BJTN_UC=5?<9%8];Z:X[)'*;9Y"54FB
M/1[TTT!!'K?<%S,C>&MW)G=YX+<*Z[$@?AK#N-,Z?UW32?CE;<_A"VY//<'I
M<"-W(*OP(O,!EREYTW N;FR7:\Q:D$B'G(-$''9MVA,5D9$/,K,=*_)KXYRU
MHG=A58< F24O2#B0B>01N*!YU<31H+P\'.+QV)T15@VE(I0XX4$MU;K%/>@,
MBS4M']9C1+B<&/E+^ F% ]R007EQG'&SAU*BN\&"KC\%4(\)9$62; B#_UZO
M,]]U6Z=_2FWIEHZDL-I^05$KV!$9?04JB3,+3]A*W3(1%EQ-W2_?9#3K9640
M8?57FUAK&TR^6^R@^ 9:072!0EV\]&IQ*PAWBS&8RR_/.F3LEHO]:.D'K6P-
MB0Q69;4BV16D0DV!AM>C%%]/+P)Z"%6&;+DAYX4M,K=:YQZ_ONOR\5[+QBE@
M'+E9_P#W%9AHOD6#3#OS5F#=%X>[<191._9GMZ1L'C"'[,=M-;VD20C\9&PU
M<T\+3[G0W%R8:I'&%&_)F%._&7EG*JL$C3_T23/H]TCL& _<6HK[=?]SP2)(
MMF+]S#KYV5_\WYF%_RL8#IPYX/8_B? (BZOUM37OX)4_6[NCOU)!'NO:/+DM
M_N,7+^N:[<3)I)T0>R'3<)2L.R$"4UCX8Q88,G<71QX(/8@JXOP\R7&##MIV
MHR,0M9F(;UW$[$0F]&,-G)SRC-[R4RD%&&YUX60>Q#R5MW]1,\TIF&!'+;<'
M83>>[<Z;5?*X,LWG4J?9!+?%.%GZ-=QM3!H=;WY!3OBT9D<0"4"VDT>'#E0E
MH]A+7;X;6[]B6I;A%MJ"%A"O0BU. 1^*6J_7RR\1=SY>EY$O^_OM"S<(>]*]
MCK;L4Y^?(VS)&W4$B@2C\!U_[93'9].Q0SKXWS'?Z.J3,Z^G6(N,;E4+=!H7
M[;8==A(JYQ[@JU;2SD]O;BWWO"*B9X!5B(Z+).8%]>G[-]6C:B]&K]*"EPR7
MY@H*-(H@:EZ/*A-^^=N=\?@<NXU9OW&);77\*4!B7Y3]YVRC'CK3MQ7&78]_
M6.5B[P#\PJM:QS.)1$,F>S%0("/IVGG096/1*W><8[WB*$U0'R(=B9LRB<[$
M,\XHV.8.9[O_ZH/%FK96X[ZKWLM_^!;TOKW_YDF'3](0;-,G!>D6'W9UA6<X
MJ[7E3PW?F<BX]YC_C&0Y$]LB[5M+PKN%)D4-O_>]#P+U%E-)[PDE"VHDJD5Z
MLN@S@8_-0_4HEP!TZWQ-6$OFG6*.L0^/<GS%!)_TRVQ *@AN[<S4,2<AAMMZ
MT]T(^[8O[S--U_=@FRB)%>!D'K88Q=#H2S.4XJRS%>7$(R.]1D!O($)]\GVV
MK@]O7Y_ABV GJ_;!V%M )K,J-S'9[O/QR!'XA"]V$&\?/-6YZSPKG/7 0$;Z
M!NL!A=_F>0G[RJ?DLF&+=&9(Q ^Y0:-\$8/5L4_:2O 'B-20_Y6C)VY\G;WW
M/AVMER92FG"\^&0!$L81FPNT5J)<J/]1ZX_=: V17QHF]CGH^MAS>,PB$(AJ
M9$<8/B_*4#-21Z=3.3J:#.]LAN)<P_C#H2J6MAQL5W_GNTN,#BV:6U;ML*P;
M_NYH/(Y:0@^!?YP"6D\!!'62K61?NVEV#;W057D049O(P_;+M5(K#GL*6$!4
M$K]84),$B".'000WYC8$U=2$$ V4=G'&,%_O#3[<,O;>/=;'I! U2$?M;_T7
MMOY8H8:>EZO8@\+G52HZIC_^20N]_SU L80"C("<^0+Y^;A1>P([.W]9:6?J
M.I_.=QN.N1 'R_7.8IZ"F7HO[Z4\[B%"(EZWQ<OO6@?:Q*9'\19_[J/4?;=)
M?NR+C$N$E-SOY9_*A8W1TMQ* 6%;.[@C(KC]2';?PT6-_>[CHU/ !OI7@&NF
M:(I?RN7J2;9,Y!:4Q@2J$2_F@)1S)CO#T&&?O.3.K1#5\6#O!^9JDBY"4[L2
MG[Y(T359:!"E"!URVKC5YT_N'M^LT9HYZ@OH@[,M_AANP19JI4RZ *,-<_^,
M)4D-G2F%V=W_:>D1Y 9E/@/,X1NV#97CFT)?H:66V__[;A/H1/_K7KWD=CM2
MJ--NWN$XOL$/B7WJ[[D=*S E3K48S;P&R2,$)I/A,A^6FB:<]OX$@9DMFYKO
MJVUQ:Z9GQVSS741)5,&R*>UP9C@&B...+<5O)J\+\\@7[:5@1(/G^/"'\5;7
M GKOZ4+*YAF@LLW7<2ZA7XLJG]9VP!#89/M-]T^X>P%]LR= S0[VTN?:W^K3
M]5FT(;_Y5V[])Y9BT;Z%38"9KW6BF,RMH[R'ZCXF<>&H*$G'\OG3Y#BMNK<'
ML<J:O[ HST;MW*["/U*#JN]:@E]0;U2B%^T[!RZA/D ] JD+-!\:\P%BIU$G
M!V1!C(7=NG;1VS2"#T1^8-C/E+7ODI:;B_;! .G:#E;Q@6Q&F@\__GST-<1S
M8BOJ)MP6<@,<2KGC8$#LZ?)PE_+J>D[VK:A7G_9)%;]AFLF*R^"S+:))([XN
M$HH\!61B/.YR3F"/AX>?[6LKP5Y /_]/^)'J-_096O<QKH2T/>UU_BV0< G9
M"0SG&*U?C3P07'*9J/W(G+L(*8!42T6@,)P$*UO#*?,>GX.?R.Z2IY!*R(P:
M&AH]_P6YAJ3#";$_GZANYG>K)4N$O/8<3G=='0:7206KA#<Z7/]F/7LHT](O
MZXT<7=;*ILZ!ZI[%L_NXUV7#DDYUNA>>%G^/RPE"0K[XA<2>K/A*\W]_ /FR
M)Z<(F;:VJ5?Y2VU[O"O_>851 M\N_,JP<0W+/@?:4S^DX%2'28%NON<#K8@*
M*S^WGZ+7@J#OB5 _S:UFQL:Q5MO,:-$= O,IP 2EO,#EU6+_J6K8)&AUR$:2
M'"NK$ #,@%&/,<5@^V3WN7-O2-FAK!4N;,SCXDE2P\BH'0<V&1(-#-2Y(DC-
M=!$Y!I\H:C\%3"$8O!ON!@VP&//B6$]6(_W$G-[F1*H;-4"K%!HB7^]IQ>@/
M(53^EH74PRS^9_6K4.U3  T=_@;/57-Y"(T]+8 82<(]MGC\*!%B#9N?6DW#
M]A8QSH! UGAD8J-@7KJN2? ,PS9X'%7AQQ'9LL2R=#('\2>*JM"HB$4=(XI.
M >7PL L1N,.>5VD:[72=33VUJ/?U 6OS3 _8?[80A=X?IVY^C[=2]GVDKZPF
M24I*0_L5!SDBBQ$K,(VH_'4LO]C]47U3>9WA4P!%?E4--2OIV!C&QF87JRY9
M>Z9['_YSRGBU-;Q8F^6Z+F5\R4T,I!+Q&]BRS2RMPCD91;FN2G?Q]%G\*BT7
MU5LR!.*]-"CC./F#LANSE M-9H45;8M_QBC&_(1T/V.B+ YA%]=A;C6]&9#S
M6[JSJR-HZZ_*XJGJ$U8Z$+<%I($A4##^ZO0F[.'XK<Z'9E=.Z$ZL*9?V2B41
M,57L498F-T$GB]'Y9*\PQUZD$#S^9,Z+V25%[=B,+)J5QND:HYG?)XN*UNS\
MM[2:SJ2TS"%[2MW#1\Z#S]%HQ[WI0B"Z?P\VF<$!O,([.-B]?/F)R[SH$^I2
MT =RO22";>U-#=CJ:>HCU6 97BMVRI:4-T\=<D!LBS-_IWG0+K'?L']K53[(
MZ0AV><%,U.6=WV^]G=^5ZGG(+T?^RDKJ;$_&BT#S3MY@;^_TE]P0S>#M"XQ<
MA>RO5B/+)([=&P(8T!VH<MJM)SQ5;K1A56DAZO'AW[BN/CY EOM<>C>\&O]2
MN=4+DF1O+,I[I[-1Q >M,@L$1;>,MAAX%_+NCAPNC3'.=XHHBTP"J$]2=P?>
M'8*GP%<>$"[V[YQ%N!0T^N[JXL/O[:O+P-_CD,TF9U'*?8?[\1^]2..HTGN@
M]4:)"_4Z9.;Q/[ -80MM,C,:3*UX"+^XI@U_<QG4<PIP. 7$7":)XJ(^I;&Q
MT0V5CB0PUR)?!EG-MU+H33=")QD;'WU&+^=MZ>.3(>%SXHW5P2XG4!W7\/<[
MD'XSX$<YHJ17/LKGPC3Q$"S=C6/FCEQ).-(=11,@1&L_1&O]B@_G2O+/NN,K
M+_TE3X X^T71=+S7$[;J^STY]Y KU.A=9!>2EF"WTQ&PW)3TU4[M!OIF@!W*
M]!1@=PH(T89*X/3NQ1"W66U?46H'#I"->%Z1GGO>O#I?_9WD$T8T'P3.J(6V
M# 5_TL\E\C0IL1CNE1TO_#.CGW^Q\FU0+0(R%RHVO-0PJOA#?_;#!H2&I$>N
MDTRWM@C_(Z7SQ)JK3FC=JV8?^0/E,! "QOT@L?KAOC#.:%L]T'DL>2R!13+/
M$"!F=2.E'[_CJMDY*.]Q&W>Z]^C$2TSD#@S6MHZ WW#;]+3A[[^.K=0#2^ 5
M4AWM!,2"J7I![IX8Y\XY_[4UBR+D%+E"/?FV1"JIBAP/DT:U(=@Z7'P?]K*=
MDSR_9(,?1ND4([/''_BY6KOT"CL>\RQ*XKBL/_;>ZN,,KI)YU$5J5GGW]14/
M+>LVTF<]KI,YQ@!N34C#TG2"A]..Z0Z $S5:1-JXI57.PT@,_'6X'")B:K5I
M!'[+%%+>,52%)[%+S]YF'D?EEO5N<,F.;&C 5,FBJ!WQ50H+K,DD?1P//*3=
MS5,3>IJSY*/$;1Q+HV37XOS*>J17]\3P-Z2J9NN6TX(&TZ+*CUK@E,1=;3BS
M"46V9[=1V2TJ]AI3Z32Q<:#K1ZW)Y_J>),DB^8?@*<768;]"#=K?T]X)QTK1
M[UV=QF[51F*H.V[WA&7SG@,_)TDC.@.^4FZYO)KIJ1'A_^QQJ]-IW_20D]""
M90:V>.4XAN<.C_?VQ[Y8CG)36EH<3"5+1!(8;3[?B6GK7Q?TXI\]5$B3_ 7+
M?F*8NV^*,#FC!\(0/O-?>RWW%W?.3_@M/JDK;WQW9R:FQKW_$GL?3)LR!*9V
MH[ 2LC &;('71?A3E0'=_6 3\GND.&$6Y_N2D(-)2W/(5/1NB^"<,/Q#XNR0
ME(:S9&K/?:HQ;QS([MY3LSUP$7NW#9/WLV]/@;&-?4-5)F4G\\978E$O_J'Y
M4U>GL?SOOH^XYFH'N;GM7?5L1Z_:=T#"?.>921J^]A[47>Q)P5=KSP?JP\,@
MEP^8PT[RZ\J_9*E8K@B= B[O(__,W?[U8T;[78R)P:I)!R7L3UWLA62')\\Y
MM[],PL:,SZ964_[V1B5<P@!L(ZTPA&]3AEB3QFOAD1:29U$SL4/7<?KY%Q8&
M22 =R7.>B63N5*+,WBC3.=>D0C LQ.EG/,,Y!%(&4E:=N&&=<.W#AT=U+@2@
M%VP2SI78!N.L'O1>:VOZ?5?FS5=6.?2JEUQ-XG)$@H%T][I3-OX4$+O3Z%NB
MX>\/4BU>_BCEN FV1WTX@EPE6;IQ*+^XIUIZ"A!]<F.ED90BTH;+U9DUM$M:
M(IT"2IB@UWDR]#\T-AGO(S;/%+M/F(=_].;,!]:+BW$E00<,Z@QJ' Q"T51&
M/#2XF+Q@$M@MS_C9C_;"2_H''=[Z)$3[E[$71_<R[KK-_FG@W8WNY11^<UO?
M8O:,+Y#)<C_^2?7'_TTM<D)K8J>.$E-8ON3Q--$=>BF(5XLR/_)-5/2[R,TG
MK9%DUE(5K%NPBYP')G :%&Z@\OJ+-7\9LA0#W<U5^JQXA6V[B6-7'EK!+<QT
M2\_4!WQ->/O[C\98FSL64HQ=97VPSY0.%->U3A@;ASYI<:NEW2.;*R&;EP1:
M0,;,,[K". C#.QI)3!TRC+$R=[,(4GB%'4Q<5(FDM(TEB]DG"U(D)1<KEQO'
MLBPWZI-4EW4*T/QR$FO[(=3A0Z/4+">BLMR%D%9\"D"/P(4@D\7Q^',#P+U)
M<+HGZIJ<6;,XVF[47?'%<K_C?"ODNN("V4Y]S=#K)@-"VZ+R1Y6!^H%3X$SR
M\:8/43!(?7+:U(@L3SC&#[=A(,$MQM9!C]O9NOEIDS8@2:C+<FY!BS&PE9-=
MWQ3O:*W[_53RH&^$+CQ<BY!9DO8EU^O"8";G5!V*BG";V)5QLV9$>"CJMT>=
ML@=$OO6KE&*HNVOS[;FA#?[I7WN[Q=49IDJC!7CYR0:<+\8U$R_1/EY=_4,N
M&:M5H9J]'4FV(8CA$)H$0TQ@(.?KCS-"SOZMF,\>+:2BC^0T"M7:*8 !*G.^
MSQ7ADGK/YM4]+XI28#J,K8O+6'CO,F["U_$^/' ;^M W3<Y'TU:#&(6G$\A"
M"2GH_>LX5Y!93F?H,? A; Q5,89L=V,>R)^:+A@5650P[@H@H?!BH3MR(D6:
MEH&<?(/5P\\_@HZ>J@[;"*QS:^I;QI\%C1.("F'9<81H4_9/$YO?%>?- & Z
M\LA;O[9U76.[AQ:+!(C]!/'K>^E#<2/'@=E X-=1O1J#'2>)]D6&/%96N":_
MCS<LPV3$>ZW*=*+DE<[P+W? #>2HYL3(0@\!V&HPU8C[T% ?Q1P_\/S8_E""
M<$TLIO%I?=\,7XNM@&7G$RX?TL8^MK53Y.&8R(*2*CHK_R=R5?-J;;PZY:K[
M#@FR!/-I_Y)T"I@41.G\W=,S0+OZ[C\S:NQ"U="V7,-J7##W;&5$YU#LJ G*
MC# W<].F]/:/O^@:G?56)]#;&77?6TH<4JY7=)8+QY>_;9-7!NVF')810%)M
MFAR/IMOG;3X_^-TWD<!\@%S39/2+U\\C)X8'E%BO39#Y0_=$7Y-ULL><_1AO
MW(Y,&)]3[PW'A+LF*$]ECZ)W^B;-$3"CX?VZ Z=?)5N+#MP3#$*)H^@UJ<T0
MXH..A;Z'C&X&;SEWGY4!'_NOU((G%@]?T253>,=+PKU^QG0N'W [;?>J&VV6
M#+-_NGV3[ERTX9X;$!]7[=F#$S\R;"<> ]/LC[L>^9DPORS^!,@&O-(94H*#
M$?_VSCI-@Y%;XP^.M_@?XWMR5%V3/"/SNSL*1 9''&:!J<!JVLT1#XR+U:K%
ML,AD"7?9\C.4P&KB";H?P@2E]E\<8#7]<_B'XAQ&^WKIU3M(I8(H+B<N^H'#
MIACFFO*OEB>;JAL6;#CXH785P6WQ6DEY^_"E],%2<2IG],XQ?SC"L,=>\?HI
M()#F=3.Y>7$'9Z:TB4L(@<2(R VH$WAQ*VC,SGMG%TR(=7KF.9T+EQ0._GR*
M/!?-]*F*H RZHLMFHK_^=Y6I5;] :,0K>?-LGBR+_S<;0/[9P$.F?#$LX*LD
MVB NK2)'FL=J@%ZJ]W_7?QUSR\-TF)_O_%QT7"9\MGK=\%QT91^DR:RM'_J'
M=!^O$N8J)X6E[WNH]PJGJIN1VQQ#3@3;$0>X-CZNIT:+T7P*M%7VV&U^9#@(
M9$%9C^(UVZ.X#6@B7/B^=GM^8$[[QR/R2/0+:<SG_AB<N$3?%LADIW(ZH0Z'
M/LV3*V7!B1U574?-;L/>??8X;QL2_1H<H [A-54>%JG44 "9&AFPQS^>:I)F
M#8@$'??H>+KJ^#J3EJMG_Z90;_\/A7T1LH37]Q'1F5>K"HQ*V<5JJ;GE0 OP
M\X=C(W)WN XS@*F<&R'L+9V>LNB:I*6)&6QY]H?W;BBEO4?NM;(3W;O:,0,%
M/B*PKN<AWVOK(LY%?ZWM\T>&@QV0%PBNRNI%6:J4M0NH^Z1 XC,_1"=:1Q6=
M. 7BVHI]2N,_UA4N"6I]@1[I@4]Y.AV2&EJK>G)B2Y"V%/MI#,%0'8V8@15I
M$)VA"C%EAQ%PH2IKHJW?N9/'$5YW-4M!NWIS_;-V7H21[-'2;!G3"!:B9!!#
MHTA/B:T,9'0?2&\IDFV_I1D*N^?GVV$*ZWKSWE=CF^:-QXR2U/U?L>#)5TZX
M#77\7,-W,Y4[S07>:4QOBK\;#L%I3P$N)5ZM7HI.L"(Y:KKA%Y/2!\B(/I)8
MAR5V_960U['\ !M;ZX%#J>-55/Q)D)*_;ZM;G 4/(=.>;6+'.F$K['Y)P%N9
M%11KAR5HH;!>.KRVV]N^8RQ'5MP]O[@C*Q+T\9^T/EHWST[84,,I9*!-<GJF
M<V=_5CF]_+2AH9M;.O],SUJPV:BH(M..OEN:Y^#EAE%%171CS;U\GE(:J"8^
M\7 WMB.G"O<G]%!N0?7BA68M?-@6*Q9Q_<6VFZN((IS!\R/HP#FO+7KD7F2!
M.5&ZF4CN&L-(>[&&/]>7'X4A'2%LC8]RRHQ=1WB)I4+18&ZHF#O18,N+@D-V
M&3<ZE<[<=Y!TJN8?U]5&1DDFR7"D_P(?#*)GNEHCY9H/>2&*,V:"]$Y:Y,IA
MJ,OWC9OLHMC5\2<4R2KN=MV@[BNG@-E73GA>94(.5H/#)T'> K=(@(Y$'FF&
M(JJ/PDF"7@R&VB*_>8N>'R.__H:*= Y&93!E(9*[TL,Q ?MC?WH_DY6GF/D8
MR().[; KL%$+#D+\>8^J?37H3^JKBSL!AM4JMWLR/RUQD (YW[8O'YASZ7'9
M-"" )B%F<G5"G;]]6+0M_/O_A]N34[!BETT(;L]KF^KCK54_HGX'8"LG@T6-
M0GARFR^3J\&OP\)\PRK3WG,6L>>U_+K=G!*V:S*Y+<MNHOX262XOC**1\_%Y
M#I;X0,X#.S7L7(.8.7"PE)O\S"-[:[3P).WJ+R]WYK@/]V\)%WNJ;6@#1OK>
MTDM(N>E"M"F]\^4Y ^WJOR3-+6:X12!.'4);=JOY \.HTFP&Y/OR;1=>=O(6
MHE0 XPF5/U3?L8\A,"^D1,CY>'!,.Z#/79#>TW_"?H#,@;*= LX?-(WRJNU(
MPOE][TII4JJ"AA;@80'@M_L36]Z]EN<*0^1!!<A6"?@U"2X-%2ZZ0P_B).YS
M_YUVO40]^5&HK_U9#Z21A6CAU _B0',4V?$7GI9TK9D^W[BDR@\K7XT\!9@T
M3V<U/^=RRV@U6T<MQ-V5F9,5I0R2?A BB-><*$RA:B5\*3IT$N$C9VXY1,[)
M@GL4"G8?=+R>8/*KD?7C*_3VI\&<=A?.Z"(&CN.]Q=7-HF^D9R.N8L*;0Y)R
M$I71*O)=CF10&$DC?UWH1K$WW &6-[Q,TA"U9= 9J3M.Q^UA[9 XHG[H2NNZ
M:KRF4-@<2@-N#YS2?4G(_-[FY+GF$L1N=-@ [0]RV@-A#=O,=3'-39(A)(W=
M!,4/MSPR!!5ND)XV$7RQ3AHOQPWBNEWF16!Q[5^E@K'1P)ILUT +<7/-[-_E
M4S(Y/'Y0\QM$=Z8 '70JE)Z0X_8W_RQEI7UG*,H;)25S8IB#QA^"Z'5I38P"
M>H:C*L# HI=Z=FM]CL&1 J6*_X'ZQ[]8;K[MM]+[TX*[=M2-2TCHHX(S%[8Z
M6]EG73E)TE_^BON'0C5ED($7A$-!T@%.M\\9]64Y5CW'O)O*6<)P!=SI-L5O
M04@JTHRJRRP7?M.6 =@OG <VBSN"6>3TW?=F'B3C&OC\!V:W++PP\TQS?FEZ
MP9T]; EJIJ^$OK\[0&ZX7L4PB*J$&A6;O"PR=-D'F_1X!AAQP,8+&U&W/UW?
M@[RXRN=@XWI/%IWCQW\8B(=$\[UP\-5Z.K\[\KHC"$Z4IG2\>?/PS10R8BN[
MSE.<Y=7E-I0,LLQ;C'&"X-GG4FRYFZ4%8,5X,$?HN?O<">NU[D=;('C?W\,:
M:2?FA1H&#?2[7*-<(A:M:Q7U%CXX'YUD<PK8,,CI(EU#:JONUL]I$A'D&%BT
M#GI%!P^4_U2:F[ /68+V8N6\?'7  B07X@V_Q%9\@TGQ2>C\-O^9QC9*F./>
M5&#JS"6Y%9PTOI\"BMF1,^-:ZWJQ%UN0 H0\HBP!@E5&2->5&39:OMU4!B<%
MN6IB8U[WZ?XNF),?/P6\"4.^QT84"&"M?69(8;CYR"HQNKF<_G3OP_Z2!D&(
M#^PWHEIZE&->"?WY^!L-VS6I.7X\\DNS/*S_!-4:8Z5\WS]9Y_[]8U55_:/;
MC7#-QA2-YN 5WFHC,UG$4]#!3!NHA]! W5\"*N&K41G'WJLUFPL3'R=*'%EU
MGG _G>0/5DIX" BNLFI6)$>? E[#"2\>] 91Z]7.YPOT'TJS4\\U-Q@P?'O_
MT8EP"I#I<5JJ[<: 2@SFG.J.F20NR7';/P^B.2.G-NE_:SF469JPL]B.XV\C
MZQ"D3<,79Y+..EF<9]5<%&.Q6$]4-2\%^EJ =I@) FPQT^I5U<.+B?1>EQCJ
M3M"K)3%%$ O%<]&5,96&!_:A7\SN?7'J4@L<V5B"%;49&0VUR6XYB?TZG)_T
M78 B6.6LK\X\Z^R_=X>A;IT)G@,K)FBV'L)8AK8V2ZR,QJ[H;6G)4+-BP&7V
M;9^A$KCQSF,LO=\D3?@J.^M^# S<Y4\VFQ9/O]A[Y#V;L+<^\'' 8[<#:W;M
MR/K;F0-T_&7O'QDJ567EB[_^UI+[D(L4J(U(CW$E8P>5U$0E%4XV+BI(,L=V
M\LG#,E^;A:(GMQ01CN2AYFKU!C6K>,4B07;P<U(Z&=G,'4=-^%-_=ZSA34HN
MZ 34QG7R?5FXM+*T)FX=%M$FO?805P$+<R$RDTP0;19\*1H9;K,SY>V170KI
MH/UN4\_WZR \/T:TZF[$XM9U;\]"4;U4<C*.J5Y."5/D-";#=/^$#B^GU;,8
MVJ7;J6NBX;0>R\/?6NBS: +"R@J=A8R7%?C^(ZZ#<\+%17M75F4-6!!L#LAA
MDZ:5UCJ>:'4ULW_D/<274(\S\K/7_5H]G+S=AF,ES.,;V@>P2"[S6;G0I\7=
M7T\XR(EM+W+99SJ-"@O7,^::F,LQQ7Q.5MS&(KS'7R5+BNMCACO8Q4"I9*Z_
M!6)VIAJTJN\AHPN_:R[R:;3QR@6@NU 5M._2.H'7*C\EB!S.V0%Y8[-0YE#Y
M[UV9?P['[PL88<R_44&<L)#+8ZU/95PY##S'+=+C[".\+NFH,VI,$5.O=)8)
MZ.DK<7]ZI9N?A?H2U_=?BP;$L&YM08^P;&&EQ:[?#!RNO7Z5S8M'=L_'(2ZZ
MPJX3FG='G_5:(:L?.J^@;(N6(=.!&#,+ 5RT;S7NG9SP\*/\I<4,IX,,*JQL
MG9V"]/-R\IB&/-!K0YRAT\AD/1K1P+LW@('$B<E18XM,B6ITU0>Z ^QW4:\H
M+(0>9@X_Y<YM_CDLR_Q!!XR_/BTPE[K8+>X7^L\\Z=HIH&N@T._E=N?*T^%+
MP;F+TZEDB?:9#/:OY[TNB@5PGDBL^:5=*-0R^E"E,GGF9L!%@"G_79F )$%9
M873=&;$^_<?AW7$*$;9>;D%H>_ET\N)%9!J%>SH*R?7Z1_S'(R'&H$M$OZDJ
M5(QP%,.%&24_VK8;YQ44!C_OLSUW(D)"A^.8=)<H*B>(*MMZV[+ES8%)S9 3
MD]>4*Y4U,6_R 8LXUG&T_()Z4CUNMCC<\V'<$B@3N2ALEB/\;*:F <Q1/%UP
MM_6_(2_D!_A"YM1Y7?.)V0^<V1_V"(:S8W@@B>7N\:W8\:LPN[>+N\A!OZLZ
ML4$JB;]/&"*JXD+BWE9>BFFNLK^Y4/P6O7&T60,]"6ME%+67L=+<9260LP6#
M="95=+ H"[C-A GS>PZ=>RW=E*<H"-X 1%2(VNBCV*/Q.A##]WORL9$"R.6]
MO?_(*AMU7[.\X]9W K.6K;38^:@3PT6[,@G-PKE'7(D2IX _RJC_JYPOC8?Z
M??^=TB)$BR7"E"R%*$+9IE+D*P;%E&TJ),:2I*@Q(VN$24*VF>Q9Q[Z;L0PB
M2]9A"&/?S5@_S.+H?U[G_^2<\_N_SNO\SJ/SX'[P>7+?#S[O^[JOZWJ_WQ<<
M[?B- @W>UGBONP=J(X)+^78XK?9 9'/V<V)FC6R .5?)P#*^CZ41^"Q:F*B\
MC 9DB$'/" S=E/FX\[@@)F)#FB"R!_+S&-'; W%NI1&;9O??&T8,469R(2H+
M9VXZ7[CFS4PL7"?^!\\:-?N?(;@2'!K_T"+SPV9 Y%N7TL^8MJJ%>OKD89IK
M$11:1%S+KY%,=.>?%ELA*EM<SHY$5 ))$XLG,Q?)[@<^S)2OJVRL+IW-K\6'
M77;6.5'4\04BLM,RH2,'9-/PT*O$C0LV\PQ>W0ZZ\OTGVB:*FP(L'"G$G+J;
MC_Z%KF,E*%GM("NKP5E_52RG<*'_$QS/3YTTN M"H?\:]YD2'=F.L87G92._
MM*SC0Y@0'U9"WN,_#N(//^1L!F\5 UZ:3VFKIA41$*69,R]]>1%K#@][G_<H
M3I<F_6,@7/^@#[9)#O8.N#HDVZB6>PT- 3PV.\5(LH"BW79$\.+84ODD)].2
M5@ZM/.7Z.1'E5QM*5-L#/5V-, '>/_ITJ\_AQ%#V4^&NPQ&Z<ANN U2%O,EX
MY4I)XSK,;;F=]3"E=W&Z"/-3-DM)Y%2(=@?M5<.SM/CNA9 7*:& /^E_%,'"
M<M[NU>*AQ_#M^.%?+3D3D#./AV])3W^X[Q+*&)Z$D#XI!J-.5M5BS6!<, 38
M!/X9?++&1#&T!O9C5/]\I/ASN]8E0]0B-0BJ/ECY7-EFR2PV1WLVZ(JK)U;"
MX&XAO$Y5QI0>$^5\!-G:C]C2&Q_P0]X8US@K4?W/.J8.-J.V%$?;<COCM4:9
M?JHDE=BVW+*SB1_X]<A\]- =Z^RCMZS%99]?S;*)X.*CPM#)>(%G_-FW0^?^
MFGO']>K^2X'1OUBBD&8Q(0:B;C?%9<1\5&<?^T(ASG#HP*K$YR<[77N@9!%6
M,SE/>RQE='A2^M%CR%7XYSU0R>J'&9H#R2#AS<<45?CU31764:K1#=UTI"@V
MOP.)^>UE7F6:)-2WN0<:E&EV3/?Z<"T(J=(^Q V0Y[50LD@!>JK7V99=UPR[
M(?[+45UB.5M'J?L8K;&G:G #4H]%'FU?$<OY2=>0Q8+!HJ]AU2KXK!;2( QZ
M(B<]+2)__[Z3ND+_LW>QWA5A(_VI$<O11X$=FQFNPI,%YN3K^8OW'W)N]I^Q
ML^<1UW[+2X-?!)D6'=*<'"7@@UY5Q94Y_!,@&%N]=F_S5;M\H=>/6Q>H8JA-
M_"8BRS*Q;:R=3"86\ 51MLVM[RF8"Q= )^&B.F>MK5,B+/0XUE5V,8R33#7T
M$4#$T55B6*I1/ON1AW\'^CY]2UT8I2>KOR@GM8O+<-@< !^<[)_S4=O_2?0A
M@/:_X@1AIKW4?OFILJ2W3>?J'\!C(65"]7*XPT#1+*S<MS1]I-+XT_9=U _8
M ;H_U0=#ZN(9&1JY(^XN?/*E]J8/F9/.4X$6SS8 7O7<VU8*JY_>[,,U;$/.
M;/A8^ @9!RW\:=,_FV/W7I0\M[V$8YA9 )G0\F[/G/!R;\ZH^X,@7D@#01KH
MI4$> 8_SK6YYN"*C787Y(P=JUG4'\C?.3E651J9&JS^)A/?N-$-])Y9JKY>L
MYMI5@3,GKW@AQWCC46&LWO*JH+6KDDKR/W1U+OW,REFW'!];;LGV<CV3I[(8
M/E!(U>V."MTMKA\K4_2K,3GT5#K23NOM$]BZH$N]-P&FFB1S?=L"%_=LS<I&
MT(A>M8+Q2:FPA(=A1:O"U$=UC];X%6WB*:<;XD6=U_\<X6#D'T>6O&IWGFX5
M,23J_'IDT?/&V"$3=FD2_]$"]F&C<L7--47W[K.3N*/G8)V0$T0W19[YSX:"
M4?(X)U"@I-US@@Q0S[CE%3R1SLQ8F6(EEHV?B(2G3(F#G]\(-].T\TG2+O^S
M"];QI3)U)?0'K K5QR@>6V'50'H>%(&0:\G@P7^%'O(/(_O/JULWE_J(Y55=
MB[KW4D!7_\>R_&R?J^#%R+3(3FUC0Y]6AA2[=;W%$S$A]F;$5??4W0WM[^0-
M:67AV)>HQ[_.2@FD+ SM"C@-(G''[=/+UK52M[2 2V!?I)Q@IN9Y!3>)PT%7
M;FWCTV6Y-:XON?1PQCJ_N (2T$*+SL2%6Y&%-*T=<N. %;F3FF:.9MB_K= U
MHYO_-QR3W!1\&#V.8TJ.@BO(2]1U12'NM; RN<6JU%S'*PC54Y21<Z\]+QQR
M^('WD.J0G0(6O-K@]HLS$4N"LH_4Z7GBP53KZ=P8-=/Z<[+T0E-.?![:#DYQ
M@AX=DP[/:>^Q:+MC8C=^;B*+W3]6Q)KU]]1(0AB4[X%N/^OY]2&JJX=@%J'O
M/,M3G1II]-Y/CG$LMSJL* <>KP2_UD7> PVMARF^W@,=0<W-Q6_&$)_'"KX]
MV77V]=4RQ#]$6?8!-EF]I;'R?$&? K?CQROJ47.(%4@PL30X .G"8R#0*)D+
MTG[*$<^V[:J04VI=^!7#^WI791<7-UED9<1KU#V#\1AYD5L+(5%<4SF_R U>
MT44/X('^F/[<:'VUF/T")S^'K4)32)Q8FN@ZT&R@^^EU6+VN?EV^3!-<J$:+
M>M'&H+IB4'%;\@CAZ3ZRO!QCWO0.>[DZ".D$*ESO\!%\W!@7XZ(BJB+C0$Z>
MH[Y:,E(PS^0@0UZL4H3N R[4X4^(]X$Q[!<_=<Y.)>-_\8EZ-:PWL\]5]BM*
M.4I]FXI9--?TIG,\I,_@59:92TLKEL+7,Y$0&F_R9.VKT;:>(R\[DR-ZPT38
M653LV09:_O&^;-86_A(J>,'[N:6!7,JT#-[\+:X8VJ"!";%1+0OY+MW_DC&$
MLCF.*O."W_UT\_?2TH1QRL5H7JU ;_C2)$VVEPH-7.ZY=WO,UMV5S\2F']XE
MZD;"#0^N6$"WC;N]=W#86>]8<@X%S#7X5S8_LO._(SPY@H D&DX/B$XU<'Q_
MR&GJE!0GMX-XZ<X?>O66&EE3R-/];2K%P-/V2].PYNE.N4W9[ 41Z_P<U]_6
M#<6D/V95L)&7VX*3 .I-VD[6YB>M=J(J/K;Z[J@6IJ'#P*"RQU6$^^O:U ._
M2V6[27\R=Q/B)/9 [A_Q9#<PZA>*GQYZ(QA:6AQ=]9-_5H4J+KF?=7G6O^Z0
M*JLH=$C)W@-MJ3!6CI(2<4*'"M7\UV%,3&TRZ9MZSC9A4?LX7 AQ[TI5WJ!X
M3WR$VRFG<HY3"VI*?%MITH2:JOU]WHRUG.?.*^;;AC!$>KN)XXGD4_=X*'03
M=@]Z2V7Y5QCPBAM'P3,/[X$B1]83*^76\16 GS[V^<A2IX]^AR>;$W@P 1;_
M<U<\VH[,1;(+VV#F;'#7[X$*C"*_=XC&EA>,_;@AV^;-DIN#<C(OT<;\EU,-
MCBN,"@L!OT5VY,DDYG'.Z],TCU@4+GGJ604V\/HP;WY7'-H!/4@8;C1TRT$4
M7JD6W5%2@)%K??PS'0L<WQ0.#S<7IBC\YG^6Z\L/NGXPAH@M1JX*)\$\Z1Y$
M^VXP[AF]M+!X-GL_G<<?&O_O@[24+HYHO3CP(F/GTZ+^3.9VU@+'7-HA\:\E
MOO]U85F$-)S@K%'+:/5653TG@WL*X_PG[:M$_I#)IZ@BE1_X [UHQ!BW]1_]
MXTW]I85Z%]]>77*W;HZB;]=;I(0AMIR@+BU,N:&\+\^OHR>,8T<Z6\<+K[$O
M0BHVG.022X$0:O62MTA3225['D*U&-AMBA[;30B(8E'6,F_G02*.O\MX==U(
M(V69WS=HRG3@T-_<Y@Q;AE:+"=VHS,4_U;_P^4F,,6*=L17,^N164CV<9-E8
MMF;5/%6=S\DEM_$\N:HT=$TPU.Z4;N-AZ+O=]N"0JS402\K3Z95:LNZ["IXV
M ES;R<VHA>I:^GT40-&7\<_6GAOEF PMJE%0QTM'?J/):A)$:Y04NUU<B+ZD
M./UH^+&5VF._1'([2G4?/%X=KFN&]KFK8K<E]M'"$HX&/GVU'4\-98U4J[Q&
MA0=.R$M+7#+;?KP6%$5_3ZKZ9]G0=+FEIL-"#2*.?. NK//#"M]C:Q.8BVK&
MRO3:V0>=_>2KD<W54<Z*9%I?^V#1,'\TOQMNP$IM[$>_[^*KVR 4QD)':Z"2
M?35N^4Y%RE9.;XWX:"5IH4U?8''E&D)NIHB%52YV?55GR?Q63JMSBT_K7^+I
MN[8XN_X=-&@FR$5W3>R.HI08%)+N7=&I]O/58.FQ#/(]/'!4Q7G]0)!Y6#X3
M$X+B9W>A+@#1Z*-#2]9+<4$[0II\;<1[J /L#@JDH59!V$(JGI9QMN-^I$TR
M%7WP!>%D\;UKBYPN96&GSVB2=>"^=#516^7A[LP5T^6Q/D"T2S,O8OO""NGF
M05]0'7^)"3P.K/1_*CY$>C >(KWHZ :?VQ?LO27->V]P"4"-?!9G\8 K1A3]
MVQS^<P\4[N/(<&)J89JPQRT+!6>*P]-^@N%T?-N.D'.8^A/RI@S'=*6N>[2N
MYXN[G>I:0C]9>A<:GU[]]G#6\,;EK@SH<L<D@5*"B]P#B8037>'BL^$VT+^[
M(GNA0=+Q-S_UD>=P"V7WB3,BD%?:P0S%0\1I"@.3.K8U06>\'I!D8H ^%X8;
M\J:62ASD EME6MVM?O6D4YFCAYNKN)KPF=8< YIBDV%/.UNW0OQ!X\LWK^=9
M/QL7XIQ?NV/&WT&8JF029/>X_@Z8GM'"0"#O..IZQEW%Z;!59G_1A)J<7\KO
M@71,]6A'FPA/FG 0'0.&1E#L8.;VN5W"8V8ADZ\/,U3=3 G&:)^9M\A/OXI=
ML/M5N5J'-\<+LKXB(3Y48D"55M*N]]N3&6=0!VLSB)^+*WJ"[&VNN;2E+;OD
M>:R).H6Y*QM3_F8>=-Y_V<'&7V!EJ"@NC047$[?]\?,VE58M)+X#@\S;W49)
MZ.K65HBBQ<8:I8\&M)GE(*^^=3 2<<^T4,:VXD+4ZR_GV!2>^:.!8WKU#"V0
MS7E$A%7C66)TH;^]E(98T];+/RH42%C+2B:BLW05D/G3ML+N#$SH]1!A%S>Z
M;^E\# W+MNP'Y_9VT01.&9EO:AOU:BMZX?1:AMS:O>;WHZ[(X@::4CTA_65Q
M>O'^B?=@>OZZ-2L Z>E0,4S1??BN$"]!WZ[; YU"7@]/ZY^(N,*K;=[Q_IJ[
ME4:"_FW>Q.'Y5 <[V>G!\E_BYF/)2Q;@Y?Y).>N4;=,88_5Q,!U_]S=Z/%G?
MK<2)VU,M7YDM0*N<#)73U#L\Y84+];.)/_U JJYO%.R^:TM=!2[*!"KZY0[
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MDF[T(PL,B1*IPOH4V9GEYPC4A5ZFAFOO6&?!G52I>,(SH)+Q\L6H0!#"15V
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MDU.;GEIH8D;E5C4^K4'<Y?)9J(YDA&I!3UORDU.6<M*(OW:*6>MRP&6-_00
M(HLUU4$E*(GD%G0Z^)B)U")-L;UDL%B;>([D\RAFN45MO:6;*O-C]7I$SG?
MLF]ECN^#HNM/GAVW,,FCGF1,%T(( <20Q6%Q:2A9$;,\4;DI;5.\#_(JUI)4
M+O1.M^R02+S^;B6J,RQ/AXT0[OQ15H$%('7(NW!5DO- C#(NDCP?SY)-4I5/
MPC-L&,(@>2I$\]:7>5E[MX.GP:FJ=[]MAI%K0S[?8VDRH"P%RP2804CL#&H/
M$[ 6#(AA DS%2,X$2U8ACY"&M^97T2(!6.)$L1P)%*\#:6("!H/((X3P7UT_
M2Z%[)=ZP>>&Q'TQ K8'O, <+K5G47T-58"S(GJ>7=SF0'V$_E@C"#8C?"\_-
M;L&MJVR,YB(7<H1.A%[ 7,WH5M1257U9ZQ-K+C_:JD%161M.-W)\]PTN3A%9
M!:9ASA:TGMT+.JDC^3#'U$S(-/B"VHW&;;."L;!==ND\ P"5D7J 7 $15G%_
M,%8LW(1[K*#Y?DMXJA$1ST/^P$&G<G4'>]MR7-Z@"G5#5<84[ ;2!2V?C:1$
MGH8"NE@;]AYN.@WWO8,[CEZP'Q3O44,_^;[P4SO0^4Q,F."QZ]D?P^G;KTV5
M/[.!.J';A0 ZJ+0'0D(1RF*(\V2#M%5(6H_L+9CS@/9U]3*B+*JJ]=7B*-2-
M33+'0FQ,TG;[X8'!M\KW&AY<6Y%49V2_ \5YT+F (<[2LB(#Q<?GWD[I OF_
M;X("NMH6I844/GFEX+\SPN^XFOP5YL_A_J<Q(&#&(+@UDJ8GT=?M/ 0AIB'[
M%,DR@1[R6Q ,*!C;Q*VXJW]@NVJ"T". (PTVV'_R DXW? %R_,]FI5V;*I^A
MR5-58&6#;O=8#:ZA8WUM?4?TF4IC>M>C:$"OQ['O&_S 4,]9($U4NQ^#W7*O
MHR&(K$G?UI7XNHYZ/T/3#@L/QBSO;:!2+1*&G_7..JTIN(J9^*IPFWVO8MNK
M$SOX_9;U+&L3S=\8Q^+*"L0PXOQ,^.(WN_6YG2G\CHM?RHR6169' '_M6\&/
M*W'<#1<IOZ@/X:84_7*8NSV*7D2SQ:OKVQ+S&E(BTCYM?$B4X745-RO^@AO,
M3? 7-^HTN,SNPY)V"P[.@Y F+$V4;QC44IE)TZY$]IO XON+^>=Z9EDRN&%1
MN6/ZS8Y7'GHN)D/^WIA$+N/]G:(3V?&;Z$:;_P+G!&*#(ZF =@I+3(E)<BNP
MH$J0DQ8CM^)XX.,,!]A$24:GS=*7J(__"(12X_ _?<==6"0Y<Q:)\S@H(5:V
MUEC+CS 6A\GH5U5CONM^6TQ ^^(:=#%%NS/$3 O. %-4L)DZW9S]@P@%>@'\
M3BF%$]IL T[)WXY$6;F^.#)^O/M9J&6[X1:GH[-:V?TE5B^)E?9<HU>#_^E5
M>E%XPQ.$'.H?Y].45RD^Z"R[E@Z]9O<%%4Q[GER.VJ=QF3G<\99;51SI.=U<
M!$=J4 "R&?51@YOF-*D#I-SX"Q'Q7.CU!BV";BP=':^=/S=1D/#-UPLD+P<&
MGV<Q\"^WTZ6QO/_=B[9)C_6>^@M<["2W3.[5 -]3OOQV*[HY[;0S.+=*U<%^
M-ZK/$3OPRB5(1Z_*?^948HO[@4B='X>T5-)$L#@N@FD#4)"2:S.C8R.*>I;[
MNT?V@WMT6M6JDV.F8WB.,NX9],RZU^EYQ.SB13$3==@N+G( RH.88O!0HDRR
M:FGN$![(8M"<M&)^A.HOIR&7V^D=%2$8I=!C,V>]_(3:AFY7IK(*9DZI[)-N
MV$HH^]DA,%<,MWR[O%0BY.8^)-]NN?8A[W7^G5A(1,= C;)<<AOGY^LU!$@S
M:"N)N$NV^AIQ',B^& B,?!>%Q+A55,/\VKMW"IW28&Q>'G&1MFM#+R27VG<]
M54G:#)[C1!&\<FKE'.$DB2NN9_+#^G27=C2_4["\Q?:46M@5C8+]N"?IM8%5
M;VRC/G%]%MQ$R)*P!%LJ%(;ZR .MHBCVB =IZC6\713RVF\("%HO.><@K]-\
MZ2%N^' IQZ)\R*UK&O?/]]N3_2A^5##<:8KF2$]23D: *-/]1\!;:^T+QJT$
M^GCVF.I&#&&VA CHL?D\*/.1?HT2116GG:78$R&#)0)PU?); 8;0U+\C.N-!
M3JZT\6M_C9O=7[@Y\[,?C?0UM15N_N RM,[UC*1/$YG&S:>B[V;QT("=<UVV
MH"<TW>J>&K\H@=GW/3E.0?FJ\D4/$L(BE8]H(APWXI\"D\%WD4?^,3J]">DM
MH_I/X?A3_/0:-J(\G;!M%1^BUU9#OTRTW%LJ*;J[=?:^ 1- 4:Z,109FB<$E
MYNH97+1K1'1\EU*Q7*%JC4P(QD IYZ^[N\13\::7A',MJAFK>>#3FT@;FC55
M@X65D!;T$\9Y#^QO(4ISOYOW+Z>']\<%&W.4W//43TFFY0]^?YD".'#./&:S
M@"1#B U;12LR5_I,A-!SNC)Z^_:YCCD>(?[ESZ^13(5N>J>>0]T[,Z2=$_43
MP+4!(4"(ZZ!O5@R>/^4TR9@'6 ^2WP!84,#*19TC4<Q%G$>9*@]XXV0@]SY+
M:^VML$6OQ 6O48H$]2;\; >KU=)ING,]$@&'PX^[1&HIB,5>P_)Z%/"5[DPU
MG_N"V3GU7L<ESCQ9XFB8D$:_Q?BA_>K$ K(/+=QC#)/'UZ.1M9! SV,)95-_
MI>ZF6I]4A&K2WWXDG1-)A'VSJ*^,Z.)BN*:"_?_\6](REX?KC$$P 2Y?=36.
M!0:]^_5H/W$]==&NY=F9X]ZO\ ]2W<<>2'"TG#M!BXL%:QK)  E2?J1I<@^)
MBX5/=8L+/1GXQ1=[W2?OK73TS#S#8@].S1F\?GKA5%KB:2FIIB,IDN_FWR-&
M&#)?][*^F9-+* U0/.'*($*#]"6CUA(?T34MW*O6@'_?7FB1+=C4X[;W8_=F
M@D_.R;6!T=\0*$V47D!3)8*&L2)='J\AOR4*"P9DK@=VO'5[-FFD.:K87G"/
M[=3EFH[-&Y(?/GK"%$B>1^F/&2":/DL>HZ$X F1 ^F$:R61T<]AY\F200G.+
M9==*Q;C3-QT3N^_7LZOO7FS85<VS YC($;,23(0H_60^>J%:5Q1):Q4'RIRV
MGUTG0E/O).)-V_(B$JGFS[U5LNM9MKY!P4S/\3[.R11Z$23.. N7HE<Q!. 7
MZ.5U)L=I+C%A]JXM2"&77P_WI7NRU';4!*, =>B%F5N#'(GV;&JEUID$\6^,
M=T5D 8I'-6)<6ODCW<W8VY58G*8[N/PJ*BQF#>ON<6V>7QDH7*I]LK,@L.M>
M2>2#-M5G%"!+C/=2%(G (:=EE::6.2/7^F_C,E]>A>*#VC?<>6Z:*&2>+TN1
M:NJ-MZBW+3.S3M>Z:.1,/C9#,UYA A87R>4LWDT1QIJ3EEOQ?"E_)755O<66
MQ@LPV]O*@A=.*WKJMQ3=!G>9N@)\TYM*4)F5N#^2B&5LTWP232__<#CS+T30
M?:+A4L6B5 BAMF<^(!3P:M:2-[O\^R(/':-M<;GV<='/!HP]J^.)\>32^:1D
MN"5+4"JGNH]:[F&!M^JZ!V=":U2&53HL18BC^L]VSXD&H0,)9>0@5K]'T^3H
M!1&K>)# K\-$%#YOUTX@<D!?-30TZ$3JN\F!JNR!EZH".*//5J?^8!;]V5>
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MU[\OCO29J^^R#JC9K%%/^K9M,AOF&Z-M;@AZ/L;;Y)Z/?)XLD0!0H5\B[N/
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MD\+1IT6)9CM>:GV"JY^?J<$O790Y"J^I9,P@M&=K:2+5$)C$@+3*$OSB+,U
MKR0(ZOO@L$OS2KV"^"3W]MUS8R?F].("WOK?.5:/MVG^$_K7^3'-,@9?)[Z^
M?W,R1(<ON=78;# X)#(D1S5ZH0[??CSOQD)9BI+GN3;'WCN))N 5EA#N.3^]
M]T=@\-T5'$4'<HQV<8[F'!SE5SVA.[A6_[IC@9O8VJ1F-X1YU?XQQ_1VTZN/
M[VIB(Y#$KX5(L@D2)T'BHBE"%B'$+&0?* U, *'H602&31$YJPDY7'!XXT]+
M\.*.WSA]-@("1)QTIUULGN6>VA/@<IS20#;O&8,<=JP'GZU+5CH\C+.\$_/U
M^R6Y<Y]6>"XJG/>%R%'2J'I8V+ =2;P\\BT,,DC>H:R#Q%TIT('KV#OH%+CQ
ML9P['\(X^I0L.0IXK]K%KUTUL5LK^]L0U\/&PJYHG'L-F'(5#EJ!MGIV8\G*
M<77DA?[GJUD:&GE C")4(S1W)(W7SKAN[2"3;1TMA#AS'7$*EG:-))$)MR4&
M]6-.?%UT"WI8R.%]?4;<RO]N4-$KI\.AZ/,%GPNV)@=D]79/Q8R?+#R-;V59
MD[V-)PPQFLGL'A8$0_:Y.2?K5NG0S8<P,N.=%]5]XW"$D-H$S!CHSUKFQ*.F
M[VJ:$P;+(T(=GO.WLO!?XO'!7K\O0O@H$Y=GE#+=C?7=NXM,B\P<XQ1@ \1%
M#[[6'-.<6TU7)_-5.QQ5Y->"&?R4&MSR&YP'LB^XC%+C,?UF'C^CKELT$IX6
ML#:[QZU[O"C9)_-X189=](/LCZ,;8\]#GK=$/657'08)P=UQ)0N/%@<,-Y+K
MC8Y7ZR?K_.8B*1):6UL_&U[%T/0:E[^;A@HE\OR8_N'JXWKRTHD<$Z\T:'Z>
M$9!D,KJ*]XMO07/!'[(V=UJV,MJXK;F<7FG:Q?C<Z*[Z(F&?9E7W)L?H5G\0
MYX%4&1-P;1$5/30V00&3(90TW&S[M$8$D _K;Z.?<'=:VJ#>^\/7K? ,KPN?
M_CJ:V+I_.AG[Y5374U.CG',B9YSL)>9:V'"0EJR!M#\"E"+<?D++4O2@K%2,
M6Q#!QG8&?@8W-U?_I20(D%%JD?_EC[?N."$-ZG]Y*]-V75745>4*7@ R>#C<
MC^6"1>,CDTUZW_ECEILC\.7OIW-=\H-4QXZ'!NC8+40);NE/*V07^;R071!+
M;1H%3=%B0%G!$1[*]D2WGX>M79K?W3U_2B_]_D7\,J6C+O:I(Q.#Z[]Z*L_H
MC:2SA&(:NW#BKC77RI],(W:)."/SLG]P,$C6<_OQ:.Y%3/7$G=OS;H-[/651
MZJU]B];*>6*?@2=LC=S3'\1-<:8?Q$IY2I"&TQD*@<7"Q%!2YAO< H@AS 2T
MPN(M6IKT]Y'?,#/2OCTDXZZVW^O#%ZPT"GCOFD(T1J\/Q3BO0%(C;"3@X* ,
MK]^$>;+T7&-IZZI9U?X9[^HE5W.=U%BYO*DE&;)*!3FX*BU!%EE*DR$-QVX0
MAU/"+>#@>DK.-$/8!N5_F%AIG%&(# [,#GP0Y1P0K#U"CHR]W/G:1O?6)WAI
MC_LC2.\?#BR,Z^/JC9DU5*Y=Q\R>\=U?ZE+%DHH]Z/9NF-""PZ?&UMYT"T>^
M)_RV^O< L@$X$$9E9VANS&(F'"P(FQ]TZVG%KTT'AZM:A19Y:-R*-LVT5,B1
MO+/ __[.FJ_SSG,)K:X@#2=LBU))5,5/\\M$=+*1=4,@&@,BW?B%_Z(Z!GE_
M2YV%UX7[$D+N#/RZ!2XXUX1\?S(J.S$TEXA=J?_ PB_9GX5+:W,EZN59-"6$
MUR6%A ER3R>TRFU%E'TM4=Q5R^Q$;.?P9ZV6$A;0$8]5EU&R+B7U'Y);O:/Q
MWQ:OST08;*ECYEWF<FTS;>_G3^L7"?>*!DODM;RXE0)(CXKEZD=B5'8=B9ZO
MSOVC.:APD/1\2F&_Q31!?4M#Y'KCW-U65T6K$74[L*)"4TKVM^MN%Z^=<W6-
M]CA.?DRL?P,-CJC6'4[8NIM(I'?>.G<I6&;V6>YPE:M1GYEI,>OQ$[OW8%.6
M)Z/*4IVR/IT%^\8\"%;N0Q4K$+$L49):.)<;C7^A/$F[G.,6\  9%/@;@0J5
M0'7YEV=XN=!*,Y@ D##P?/*N!C*(:.XPVR5?"C/;U@!21/H*'R[9ZF"/8&I/
MJ5N&8-87O(0'UVJ=FFJUHXHAA[<VI?!Q)Q6[5F1K<%!!9)_M:\QFF?6,3M5V
MI(X3YJVLZ7!!^Y-LO')X](SJDZ=JJ2?44HXGFL[5EO A0P0X9^&6]&+,5$AF
M5#A:TWV\-=G5%K2>]2@A3,AO9TQT5Y%O7:\5(&IK^O_K)38*^XU_^)CX>^M,
MS4B5=61TU^(W_T/KY>JH4TI8+5MHD&C.@86G;H#>EE.^KAI_,M#9TY$T-3%P
MF$16['E51HGW)-8<L&S4(3*^U:5EW,LU*3_XX?>1L."U1?X;4U'V"I]_WRL+
M-XNXS>>&(L@0J>:HKPHE;NV%JY#$S6!MF^:I/V<;ZC-JLX<C>#&#(M8;?3N/
M%8X:?2-?=P4DVN7O@3(9_-,M,O*.$AV)9;(U&S'Y8Q:3#1%\NS_>6V60[U_>
M%XK2$DN%:.GNO/7-M*[OM<E#3*"Y:) 5I"!,>M5C$MV\.JW6!178H-TX5OFC
MYPV>SZI3EWKUK77H^B71K/6.I O(1T*+P;+21' Z0QH6?YD$H9W$)*4@AJ-7
MHUW#8V2W/WE&/6I(ED>W?.#$XR6O>UJC/AMAS[GY#_53^V)E:X@:>#^:^I\D
M CZ\Q*:SI<AM3JUVNP6%A88&!5<ON2V.9GR(AR9R?W]_P:51!2 '5&FEM^AD
MV$WT=3R?CA#@NMY%*GZ#>V5.];XZXQ69*1D!;8[)_1RGK?MY.N"KQL*JJX]Y
MR:<SZWD-U^C%<'V\!B]-/W]ZT"VX)[O^.RS><Z:RN:53XOX0RJU[[7.T(J9\
M9EA+4RWYF_P#>5_S0HKR1X:V1W0O66+YV(S.F(T S9HDD7QW]NS9K<+E[;X#
M^,6OUMR9N+45K)NJ6G89NSX@X<%KV1HF@ _;6T),90*@,:B;.XA%>A'KS(BF
MUY$;-,:I8')D+AFM/T)G3*A&YE*WHB#&X;(\I/4,$M^U?"; M!B7PY/1.MBZ
M]XSL_+ IP6EGH^V5L(M+V;"<JY"50G;[:$<NRS8/0.)Z3LUU6>+5 SV +C-_
MOR'DK^#]:^$7ZC+T[=%-+#?M)J.A-UW^6=9>?>R<;U3IT@DM.F$TYU'#1R37
M%1P8&*0UB//P[H/6! 8CU5')75>46JN_]"US&RV^*(Z.K6L[:IJAG'<U=.!!
M[;@T((R\+$>I7,U*!@G=,]+'0[@H2%/BEU;.; [#RH3MUN,IJ(!\_0SYT<)T
MOOT&J<O)%&X#A;FV#-+0M/GDWC>X#[PNNA\S17E("+_ EX8F6%4T)^[)CDZ=
M5._?;FNW]!2L_[KU4B+G_'7"Q"]#5+J)-,V"4JF Y/OWLSW] 5DYU.P]777A
M?0L7SY-O ^9JRT.@N&P7JZ#3O=>].40*1[LH$?A%]6O]>#DB89!<KIQIDWZV
M2]XO[![T-0H*-$F3Z1A3J [9S?H^(;?KI/MYY$1NE/\TX%'#$X86S&H(4U=<
M4+XI <+L:RY]T5DD&*Z/;HNU!=W1+)9:-7\<V]UR.^==\UM21^*5C@SPJGE<
M*Y0_2_ ;)6YYU]SP57WFV;K)'Z# #\62P05L86U.'U"P'T/#J; *IW.&'TC6
M83B; 9 (YK>LQF3=62,9?#03<&*XX5>^!-;[0^>T5\&EM(O1*7V?R5MS5)8R
M5,OAL>/&*WK:R?_4F5B88 BBTY;__632#K0UD=1A4U#36O%'?VN?7'B]0^?<
MGYPKJE'D2"<F0%\51 ;+=4^?!QP>Z;+_B&UIRXXB-N"647B+/1Z:)5Z#_Q=F
M;_T5#@+<-$0M(*:/]&QDSIU9YGY!FTT?-6,"5"Z6IT,S&X9,M$@E3^ .3( 7
M4>G-*D3@N^L5,I1B7MF4NH/YY5-  /E3?9<Z)%](+X[NH/1^E" FUS9&>Z0I
MH"%D\P1-OK-+I@I&A;+X1(!BM\H0<N]4I!K/O2!C#;"$>?&%5)LVY7S[,-!9
MZ]^@L2[VJ58TY@*.G/)N,2"M[E:06][<B^"Z19;FMNJ:4VJ?WI9V3-W6:4ZU
M(XHG/,Z[Y*@NZ-5S+YI B5]%Q^L MY90'8EH^AM?V7(H$\!=GQ%=SP24CI4H
MX1C]_,NW[ A(=2R?<H%2W^+Q$\Y;!&+2 (0WPOV"]=T+4<%;)B<H-OU*AU.W
MB1/1MS%//W ? _E+"+Z_:_KIJ??3CU'.B28<L+1>C'/L]AX3<)2R"FF/QTTD
M&6D;9\72;NNDU&K<$__Y/:VT(Z_P>FW(JLN"YSW)"NKC9Y_8_CHGFUR@:%]D
MC"]&5P6Q0%W<=I-5'F+JS_F./X=J'W9"0%N:XVN#9^=WEHA-40_NJ3<V8GX9
MMF9VE[MN/O)=ZRFK6.XKT$/EY]2^GQ"I\LF6L?S?7YP'D,S[E\Q94<43NG17
M0*(!*(QSTM;?(@\;'"IYZVUA[VV[Q"_KQHXKB63NR>0XR]57C_-Q P^GQ**,
MI_N0BRPX^HDEYC(!?DQ GR7Y-+(5W 2?:*37C$$N?-HU0:HB")T]P>T3.FR/
MB4E#\\LFQ')&994I5( U??,ZY>Z^OO9BQ341?B*"GV^LRG2(&_1Z#0 TN5+]
MP:V*^QGA#8EN"@@U(C@6'HR'\OCW*!;;B)A-7XD^^[H^>^$7&1D49^D^GNKQ
MV5?IW(_3KM<'2PEP0[@?,4[=N>\0$AL!E#*/K@LL["EI< O4<VKC(5-__3'J
M[%7KPX-4K)+,_$^V?_;/.>WW,,ZP YH(=R=F?321(7(4\Z$HC42J#3$O*4DQ
MS3K(/T(U+;D4=E8ZVGVAK"W(\J1+(L>ZJ=>HG6G,9.RCACBHD6E8N157JIHZ
M(2+:(*-YZ=M[JM+K-PYUG[D]BA5O?SMG867V^Q1GGIA2P;AZUR62S3!(T.34
M-QATH =(9*3A7@4*G.*.L.%;"M07"9E6@TJ;Y^E*2OSQU$H0(@H^L*R/7P''
M*A&!2:UYC!$4L;Z(A:S5 <M"S4+).GQA4([+LU?-1YTB$ZU>B&LLI=17\$ZM
M?LG-FT+>17)2:O#F@V A&!6'3J"9AM:PP&75:D:W6V7J,$ MUV+Z]4<_)Q];
M(WWY.\-R;9H?G_+7*9,K@O5O$6.R4KU1*;J2<'N_^SH9AIO;VTS S<F]H"#
M/<+)75]5%=W9_LLUJF8IN2==7BU.M?ZG<L#:THA-KX!4]E$Z,>/MXC>8S65B
M?G,91XM0OT"95=A;W18>0;F$'8+2T"RF5/.8UNN#&HKJ, )$]&C+U4_JNE1-
M0:P.+)^>T376Z,5\ED8TGO\P%Q+2LN%>T8$26I3TC5(0NI'[AZHEZ*W/?=%8
MU8E>U@/R)Q]RY/YV%KD51%RRK@@@/_)@><W)UISSVV_<74H#NBB>-Q5B*XMD
M1]+D!$?M:DM:E?NYH1KXH@'LW99I:$CXDI5S^_N.-*OID-<O</G+V_12\;FI
M@Y0$2Q\GI);PFR>3$BSV7-AGZ?DT&A /9+\5U*%/AC_R+<C =3$!*;TSM((9
MHTL!D7?1_L]2ZHT^G<JFS=_<@/ZY?"&X#D)Q[%%FF5(->@+]!1,@ J&XHHE/
MZ24$(>1P$DT)@O%\2%A$KD[O=X9U4D+1:Z^!%Z=[6(A@^S4BQF%Y4SK\D7,N
MN48=8M8]_6?XY: ZV76"]Y;5AH7TZ:[VQ?%LM_/[AGF<KTC8WL+,^)K-BOV;
MTV53726MKH&'NMLE"*/U,]"F+S [/,3PXJ3IVM#RO=3)X0\S56M&H3BHS +M
M,B4-;\/KMI5[DSB1U$)5?9;#;I2XS 38YQRHS]FOI>6U==CSO.3FGY!X?HWG
MW)H;M!<L,?$.]MNUF8A,UDGCRZ)<B1#0OT$"I]UH?>?Q2MGM0T]G[(CNS"^.
MVJ*KMBF?N<8S"BT6UEUB36+_\ZP*_F557Q0:15ZZ8DTU)F0\:2L<RHBN]%0H
M0/$%^P]A\*)%H_E^.W/!Q:X^3T/HWXM@#:G2T#2$ 5QE3F>!QE,+<U7?,SY^
M,\FF:R[X]2PT?]HV;F=-+OI"4B:G_VL>_L0UR='QSD\.KI!G62OTO?T$HRO5
M_CT DEE\S2N;_L@AD!2LNS7#V3[MVJSSS2!8>@'J9E^GT6R2/K>LZ]M=CM,U
MJK&/($,0C/Q%R@610>/Z-[6;[Y=_/KWUZ_!A2>1]8F\UQ/BM?2Z_EI^LZ:0#
M^UF2PA6@CGO=%=)$OU,' E7MN3DO(4X,?'@8T_,B&/=[;V8UW\-DF11L73%4
MC$>J>-_O._]L6.KV3W[A[BBN#)H&Z?@00XY4D(;&N6^*"XVS2$S[5Z'J9F'T
MIKYE.25NG;QWBX<Q(5IJH*]RL)5>)[7+7I"J[MH%7#W?Y1JU.DA\^$8_FW0$
M*#:,^]'9Q)AL;\WMLPVXD6S]$24\'":_#=2J=E'P\?OL=1'HR&K8/RL3%%,D
MJF>Q*@H<S!AGG4/=C#FJ<\$ZO81Z880**?K!8'%#7N<(G6S44-Q4CSB/"9)&
M]5?1=."_K:,'IG\:OI4N3QA\1<@?/W5(45W\+)_/8XE"W5:T*3P3#[B:O&<_
MA!D> (G#.%73()R_I4]H!WH9FU]IG*V='M .0-AS"EYO3@N*6EZ]K?@_V'OO
MJ*:Z=6\TZHL(@D@7$"*"@D9 I"E@HB(B\B("(IVH" @1(M);8J%(%Q!0$"(=
M:1&D2(T0BH"(U-!#@O264,*"M"_ON7?<<>_>]W[GC'OV.=\YX]M_/&-DP(0U
M,]?S_,J:97D8*=6\HW9+=UZ/[T&),22HJ&ARCYIY'64J*]>UFZH)%SKD@Q3,
M>+@AK<&0I_'([PAUR\>KC%D_?(SO+*\0S T3NP>B80\'^U%<8JJ6[2%&C8.2
M1I/$T9V:0(W5TO"\*B,V*&O*B'=\<BW6P6)#/H2:\[T^P3H,!_8?H[<T00!$
MOHT^\A0N,OBJ9K+_ $0L[E1_U>%O?6^^'=Q4DI,X$5N"ES@1KP[8?@1Z\0XZ
M ^?4,3S JV:44'2//=QHJ"I:R>"*A:#VI[ZNKITW9-,GY=>HXV.E%4:L>+XV
M_4#N5MQAM\P3U(*6(/IA>*7-8]1IS)U!^4W1X-=2-P977TV_L=TAG"\35YC_
M>9X')*J[CVX0# 6R/',[2*5N,W=JADC"KG6O%OW>6!$QY[[_:O8Y9\3WI>A<
MV+3!A8*DBX_,^5Y<HF/&$%>&H2>"M2G$<&46@0WB.5UU.3>1N)CJVQG@*/,^
MQ(=6JNUJ*E?_V@CYA(\BX3BJ_4QW9&367YR$C-Q"AQ,KYI(#\@.T6(?I8-H6
M['%D4\<L\&RO<Y?O^KNOF?+,461C_=I+ QAEIQE]](D2V@5[: J0G#$90$D9
MBS:5DP]GW/Z!]WWP"UDBA%#,2?Z=R)UBT?E.[VRD+'/ V?P0=]$BKM+RQ79T
M1-3/9:OWDA(%7^HX(M;/5&PLNT/JU@W,I9J-]=%L@V2AH3Q7QQO^^*)$[:\-
M:-)R<3Q_LVNQ[9( ^:+#\BW-/R9*A^K:Y1%AC_'[0)8Q :VO=XQY/2;/N1$U
M@OD!M1#*@ GE5&869:!#,K-^VEC-=<A'0%KC9[*7SQ',J1QHJM/I[ 5)1SEY
M(UVQUPE__J[\,UHX$(N'@?RC2<28*GZS=<.^M:1V-8VI(N\[<BS\U_V&8L?&
MKN63^][G.M__I#"NK*RL6UI3H53(_=E47P3TS_AG_/>)NU^&2CAZF!YDU!U4
M',T35O7[3E?9</^[?M/CSX_G')N-I7V0KCBS\.T75]V_9V?H?Z5@+#%?KP;#
M2=A(C"1*Q#_G.@=TM&8$*S)O0D\N'O+86MZ)ZS9^/O%GXGG;^F374I7.=*^4
MP3*_PUYJ);CLJCD,']HEGBM8EJKU>IMXQ&I"+Z#DA[S@Q*3NK\6^ #%*.D)Q
M) &YS_:FFN3]AXKF3+NC!D>YOTDJO-;5IXC3CC++"BC8*(W7VY/BY,R\O&8R
MI/Z%<M[)JN$,A'ROYCZU!H_?71_/.ROG6>U78MP;U%5%D)=-PN[!!=39H B"
M9[ SQ;@@FG&)Q+QG2^1WH]7X)O8<LO6+.A1.VA^9(_:][%?+C_ZCO"&+;! ?
MD3+:(#6#X>DF(8(P OY$\[IA'[K4^_SW2!4/7@D7KHEWZ=Z>%;M.OA<@I_OW
ME>0S$U&BW7EN*7XRQ[\V8<P'5S72,Q[2K9J^#O6L%A6-_4R+2=(8=.<M&QQ5
M',.>."9T\;Z !AOT,H0-^K@ .UYIA-X*$=<#OI"EM6X-9.^Z;]$M'MN[3\<$
MEU^7-+C_>O_+%<]$Q&(LXFYM/SEVM3)H\L&[Z;RD;WF7>]-/\H7PE"##V:##
MP:J4^*M?^W4A^6@7&WN'WD_VG4JM-5KBJ>::BQX*F<X!SLEQ%S;4-$5O//UX
MI.RYXD(@QWCV>3/-!B]6-]7$S<F>P#_QX:N5CCM4/-3-4&*#$IU(8/J!439H
MX6W9?X'<^P?%)708;N//!CDVZ'X0C"F4/&BI0JEA&::&HE<$.,X]VZPN"J28
M_5\M/BW5_<1DV50-YX6X%XRK6)?E6[U!?WOWPK"RZJ'[*5^[[ 9$&Z9:O$6
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M1A!N-W]2D1)[K/YE:_:'W[Q= S@77%@:]%7Q0@J87Q?LE+TL8T)+R4!^'.M
M!LVJ^C<LM 8]&FFM6.-VO71,?1_Y[_R[27&SB(MA>47C&TP&$BDSHKC-]3!)
M87Q_#J4F= MV8$&S3B%\RQV&WU,J6Y>[W;]J-C8E_<.^^L;SL[/OWTT_L\K,
M_X>"_EE(\==S]P/6G..F1"1<3]TOPID]WF\#^<$PH1L'RU,\2*7!1I2\T.AA
M[N$3%]@@XN>V^%D'0W(\<*9FA4HJ7<C43+7."&S+6TR]@+K=5P2F+S7R6J,N
MX"B%G7OZ;^9%ZZ$%V4W"7]F@E]7^"M89TQ07//(X4.&D@_9S$7$SJ>Y(P&F
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M[]#,=IL_K9$#0\\ 0W["2(,&B0T2]Z_>CCMIJW.(S+E8TV_B7\,3DL7JA57
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M9@55M5,JNL@&N9//HANNB<+:1-&-UBSY((T!O6:T$R86)\125HDLA9YB0!H
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ML[ZB[5/^)NALJU1R*DI7L+?S$9PA+B*0"8&< 5BD+_N$("L(YP5DC+Z,)0(
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MWWE"ZEC?'F?9W0MDA&6\R.[KT<RT_;A^;$OEPHW3K\I:7D6-BZZ3 CN"HPI
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M1LN8:(],-5>?7K]?@!T%@!85_*"%_>,"O!&TVD%;7?F59"L]!U MC; D*[$
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MSQ6K'C7SK3K+>LF\&$LBE6W+F <1]A-(N""0)"+$41CZJ?1L.,A@S+DQT$9
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MG2#^EA3K;'U;?A9%1[@96S)?[Y@]"KE(0HA"*=7&&0M(4.A[F <),LM9&BK
MW$BO%@K\H$RCQY+K>A.-B7O:V^1F&LPX;DQP1R:Y3G2P(_L"*.E!+3[HY->'
M+HW5N0"U#NX8;RAZ3BG/6HA).6\H1(>D-_@Y@S/9ZVR=CWDER@\Y6>L ^7?9
MFJR9&FJ;P_/J:?OSC1JJ]G/%+ P3%C'HB81 A' "24@E##$."4FD]/S0,JM]
ML#!S8\.MA$"+."C,Z:+),;3])H)\9(ZT1'M(IOK%,+G.6A\NT-09[!=#=R2;
M_?)G7F8FJOTV50/69\Y;JO[2^/E>YV55+A&5+(HH@T@F0FV* PPI]WV($IQ2
M%J?29X,,Q/-#SXT,-R;,CNB+77L&M-*#6OQA%J/!C-C9BFYQGLI*O!#BP;:A
M.5JC6(4&P[^(/6@.RRE+T.() ]*$OJ@W*BOT'#]QL<J^BN+I03U9%T9KDS2P
M0'&,_1"&21! 1$@ 4\9B&".<2B1H(I!1;(K9<'.CKAV!02<QZ$0>D@YS'O!^
MEG(/X^BVV>0(6N05.45RHO2B"Q&URS(R!J@WV>C\4Z;+.3+6:"_UR/RN@6'S
M[$[PQY7X)-5^_T$4U=/U(_V;8-5-_JG8=85^>JA+:*QO/^AP[&WM!1;X81HG
M/N0>54:F3U.(/8_!F'K,)QYB?F*U&[]4H+DQ>:>//FCO- *M2OJ,-R^VQP>Z
M3B[8Z 5JQ2SCWB^=3C-;=<I)&GF=Z!18U&GMU:*.8M3!N@^:4A=J$LI2SU%9
MB@H\KM67=3A#X+>;Q@4P1CD.5TB[#2V_5*AI0\8=0?@L%-S5<P>6_LB^9ERL
MN;;4[_/UM<Z:T6E5RR!@L1=+!D-%P<IRYCZD011#GH@TP8A)3J+ELRK\YVM6
MG!C/Z%LV:S'@O!PY[V16!@M;D4+P!?B_O1_#L#XH8K4BS7F192604]B;T>=%
M4$YTQMV)N "-D*"6<E&G<CJLZ'$&";=E/$X--FWMCC,J/RO8<>YZ._K@(ENV
MA]A/;[^S.YVWH@L6+_TPBM( ^U 2H3;<3 I(XY!"0F1(!1$1#XR*!9\:8':&
M62LCZ(0$6DHS'C@)8O_W[P*:D;][2U2,/_ASJA_YT$O!?KS-O_ZD;JV_\;\C
M_2-L?JP_[),/G>2#/J=2]R&?O6YN"<_*9)$BJQ[5>_57H=MY"7ZE-I[D5ORL
M'EZ]44OX.Y(5?R&K1[&D6$8D5#S!4QQ#)+F &$D$A8@2Q BG-(XM.Z#,0C&;
M;W*:!BN=R( T,H-;+334D?M *K'!5RWW-@1FH;>36M_Y)$];O5F&6]%9"#LG
M!I\L\7H'H 78O)TM1J &"6B4@(8)U#C](^1F#YGW?Y#,;2O5_H?D=0^9SNFR
MO@=)-\Q@:.52(VY*D59[Q9$_9(1F*R7O)J;ABE5J]Z&C79<D#9!(0PR].*80
M)22&J0X^)3&B,O0])NWJ35TDS=SV$AU_:O_M5IV#DN$;A11S=BJ!K4YV:_1E
MDVFVM$XV16.[>,><'>N%RPFJ3M>;RR2:=)EP MXAN[MYZ( HB/]Z?!"K(FN/
MC[THX1%2.RDJ%,TB$@F=XLK53HHC+Q$LIF:!6\\?/3>Z;(4#__+/?H+^U>(,
M?A\P@XB%P3",3$G[" P)1]B'PB+T8# D$X49&+X<=N$$1Y7N#1W8OV.Z,(&C
MDNZ%!!R_8F(GTG/S=5,2+49IX&$601KIK$PF"$QQ', TCM.8>RCRO62B GFG
MI1QP:C4R*6YKX=7>F[(];-ZOAC>U1Z=GFD=VSUPX=?\POI9CWI19U;([/Q'S
M<'[TR/F/X<DX#[0SMX3!4,/6D_U0AP./QA>AFZ!NXR"*>W_)0Y%$'F/0YYQ
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MH[Z,% ,RR?Y"BDQ[-O;2UEZK1]_FQ=.;7(>Y+:7/0P_%5+U/?JH+_'"8<A;
M!-$04XH#BLSSRPP&G)M9WHE\D/C9"0U^:\2V2<(R@;U_51D#S)'7@1?"T2+%
MS3&>$R6^=;C5><IG07;DNK'%JS=GSN0YTV7266BUEU]G<]_$67>;4A!79?EX
MWR1QZ%[=>OGY2ZY#\/09NEY2EE2F.$D8@Q[!@>Z:&T,<1AY,. GBA,>21['5
MF>/X,L]NP=A(-U&VG<7T&IXMSFO2QCYUO#P;;UNI".QHO@"=[F"K?+TOF4%^
MGOU4S2-?ST+N?XS\/?N)<);/-V#H04T[^&,=])VM:S'HH:1ZR'4IEA[W(Q$3
M#BF/$XAX$$(21:GZ-<!1$J4BBHUR6:Q&G=OJL9%;>\A.4E,KO%4?"L-9,-AX
MC('MR"3_XK!:=?EP#^]DS3Y<P&S;\\,.KC.M/PP?-F4'$#O]#AJ!6-X\Q(LD
M2AW8WGBNVFUW@+D71U1 Y-5-Y$(/IAX/()9"$(S]***^N=?H^0!SH^U6Q,Y)
M/<29<01%$R?09=B,[?09!18;G\YE\+R(#^< ,Z<NF]-P]+MHCMPWH4OFM-3[
M+IB>ZP;PVOLUR^_%#?G^]CNY;YO:?29%E9%5:T5_DCO7-.M\K%,)1>#!, I2
MB )ESJ:(,RC"F'I>BCF31O$K@R68&S.V\H*'=LN<2T#65<:RA[K!8T6^ V%M
M=@V:&@,V'1OPD>FV$0THV<". CJAL)F#SFWQ28*]2R>!WX*UQYZ&B6A]G.FP
M8_Q+H.Q=$@8]>+HUXQ*]]Q:5BQXT8-7Y]<?K'Z_5FZD?=_58W>5%'879U/KT
M=.!WB"&G.(((10*FW!?0\V+*PU#B*#;O;MHST-S6$"TJJ&6MOY"-M!:4U0>K
MP<+@"*R1^?\43D,JA?8!9D'ECH";B+&' VC'R@:H]))OW_W3<:R!%GM4:G+]
MT(H?ZUM=B.F-H-4OI-)-<S)1?A&MT5GJ9GO96MN<J_?K_Q*DN/F6+Y&,9"PB
M"0E/ H@PHC!-=$M2WZ,XB#T?>ZE=#YHA8MA\!=-TC%&O6V!;T&, _&9GD6-#
M.C(C:_&AEA]H!1:@5>%I ;2L0 GKLI+'<*@<U_,8(,C$53V&0_6\ML<%SQJ:
M/R-%40BN>'0G<?WG/.??LM7J:LW?JY5R?9O1E:@[T):'OR_3P.=<R!@&7,=Y
MA&$*:1CZ,.&<!Y)2YE&CMGW.))J;R;F5#Y!:P#I ^;95R#8SY]+I,N/*22=A
M9.+L=*GML!UM=*SW9F8:J5WF^C@"T'%*T*5239PYY C$YPE&KAX\C'6?!V5?
M,58\"K[9_HOR,WFJBSC$@40L\'1)3D)U')TN4"Q2R(B(4TQ2&DMBPZ\68\^/
M26O75J5%M.--&\#-&'(D&,=WZQZFO.CS]:W/4&>,-E*[X\(!4#EE/9OQ)^6W
M < <,MF01SBI+*QKT!6$5>6V-U$7 _8F*]DJ+Q\+L40\(4&8,AU^Y4&$2 I3
M)#CT!<&I[T6$<'Q!46$C(>;&8EV16]'EE_%-NNOPJF^#9L>,Z<;&?&3*>U93
M>*/ 8J_GVC;P=JO&:&6$K4 <LX*PF2 O63S8"JHS=8/MGC7@R.4J\,+@[6.1
M7XMUEA<?\TJ4K:?;EQX)DI!!&0L!$6:>LN/4/CFE./7\V ^C@!F?N)P>9VYL
MIP4%6E+0B IJ62U.#WH@-3AM<0/4R!1U'*,A1RT]8%F<M+@!;:*#%LL7S.YT
MY3P2O8<K/;=/=[9R7H>]HQ6#RR]S-;[*UX_=2\FBR*<TP5!*S'2-'@ZQ$#$,
MPC#%<1P2&5K9AT?&F!LA;MQ1M8S#W'^[$-HY] 8",Y6+KA;/X1&I@?JC.-AV
MQWD1E]D114\YP8Y=.L#TV:&+FV_YS5W^6)(U5P98]72C,!;MZQK[B1>B-("<
M^APBWY<P)5S]&C 1"H'"6!H=%UB,.3<&"#P4[J_T/T0_(L_[7W^T6.D-X38P
MD=R#.#);G!-XB.%D"*>%$>4>UHD,JO;-7-=O9O4M!U4KNXXIKY[4KTIZ1_:5
M'4B]MI;AHZ:SN^QTV[/!+&\=P-9U27.=O4/6V6:+0&,N$(\$# F6$%$60T()
MA5BJ[6K*L$P2HY3]DR/,C8EK&0'KA+3@BZ/X&9#MI:B,3*T-(!OYAC#I460L
M>/-2A"9B2=-7QXX/^Y3O9;^C-T['=7UR[S%;[X4##R8Z%]Z?!;_-UK?M*Z<V
MD'Y D(3,1Q0BCRL>(X3 -!$$>R'&#(5V,7G'![)Y-Z>)NJM=V5]K5_9=(RDH
M1-L>[2Y[L#U9. ZOX=G!Q9"-?3JP=?NW(HZP^^Q'P:U[__A0TSKP>]5]YJ+O
MOWH8)^@'-K4K5JO\&U%BETVI/%%\%>7K.U+<"GZ3O\[+2OV]RRLBJ>=3A@7T
M2!I#)#S= C5(81KAA! <IP*'-MZH05+,S4:ZXCQKVFVV H,J!UKD)HZME=J2
M5(;-CQGGC([ZV-O;MZ]!5U%] ?P >ND";)0"6ZVZ0J>U7@NPF:A%.U/=1.W.
MDSM2NPAFIYPW3)))*?$BL X9\[*'#2/4C=U6B#O=%^NK: ),ZK]_%-4G>4.^
M+SV?<#]%!!+&&40R"F"*&88<$S^A08@8L>I_:C3JW ASNX?:2-T&6"U _6\+
MH$M9YU+'6]G1IMDLF-&D<VPGVYI> JLUS5G!Y)36S$:>E,:LP#BD+;N;!V9O
MB;(4XD,3$5>R(JM+D7W(UN)])>[+I4@898DDBIMB!!%!OB*H $$OXD(D&/N>
MM&IR?V:\N5%3(^X"U +K3I<;D<%O6FA02VW9K^X<YF9TY!#)D8GH4A#ML[',
MH'&;>'5FS&ESK,P >)9.97C;P!JZC[04?W_4[8V^JO^[44]IBPJAU$LCE":*
M9%(,$>,QI&DJ((X]0<.$4,^LR]K9D>9&+UM!02TIT*):EFHZ#Z\9GS@!;>R=
MWC"\[$N[GL/";4'6DZ--6T;UG-+/BI^>O6$84;QZ+!7EZ*[M][2M^O%%L/QV
MG?VWX.^Y&BJ3=;WO)K7HBOW],2L$5UNWG=RDNJZJX,<3EY9)B$*?!3%,!?4A
MBA*IS)H$0XR83^. LC! -HPSOLASHZY-!)*N(C4X"G^"J39COWE-X,@TVBD+
M=K3578$Z?<&NPFVF)^A4KIUC.WJ!5NNZ#_S1O%%WO#S=+#DE^ G$GG2EF&X:
M#I><"4<>MG9=W>=%E?UW+9DN3G603![[81PS9>1&,5&6+F(AQ%Z4PH0D/)'(
M0T18]7CH'VYN:\9A8C\@.^+;E2(TQ#O /!&)#IEDZK-$04IA*@F!,?6Y^DW$
M(L7+M;C5]1!O)H4];6!_-O;_)/3-EEYW[_#(R^:NH-IM.F(U!#-,G"Y29X:<
M=($Q4_]P<3"\Z^4W)8>BU0[=FSNR[@HJ++':A$@?,\B\*(9(E\:BB:A+#A+D
MBR3 B5&UP1>1?G;+3JN?LDRSP](R+[==.?\23+]S<3JU_YB;F&>DWAZ6@4K!
M 'X^5X3H1;<TQM,WV]W->0W^83<ZQI,SYI['7(B!VY]V\'?9.JO$A^SK\R'_
M*K+;.V7R7GT5!;D5OY9"/JX^9%(LU>L521J'D*)8'P,@!+'/?(@%#FB4D#06
M5F>-EP@SMS5L0US/5K %^-8J 4BC!7BLU0 KI<="5ZMY$J2P7.DNFDA#NW^B
MZ1E[5]#-3*,'7&E%CBTCG3*@U08TZ@"MC\.=@P-4W>XK+A%HVEV' ^B>[4E<
M/',8%_^Z+C;+Q WY_DJLA<QT9;:F\)%NC/VXTDT[WBDD/A=97C3=.]2UG_.R
MB8Q<IA[VTB#F,&0!U4>S@:;C& I,1)!&0>0SJP U%T+-CILW ;^ZA\R#%KJF
MW/IHY*&3VHY_G4R>&0]//24C\_&N.O5)1*>0MNW;8FX;E8!F 5 KU37]T;=\
M/CMIUKSL$F6G_.Q$L$EYVB64AWSM]-D#TDP_%_EM0>X_JA=<-Y]:8H9#'R4<
M8F7_0B1I G&*$11Q2KQ 47,0F&?_'SQ\;CS:B@>T?.=Z;YU'KI_\+L5C9!)S
M"X5%,ND%D$R41[H+C:,DTA-*]^:/'MXS7>KH"6GWLD9/73,PE^%!6:::].K0
MP -[5=>!RQ_7E>Y5K+B0J3=@21D)%61<APD'$$6^!TDH!<0A2WSI2TY2J[PP
M6P'FQFR=Q+#;H?-69E#TM21W,QEF5N"8$(],EAO1NPCC9SOM3OZZ _P"M"HX
MS'D8")[;] =;(:;-A!@(T;.DB*'/&1BTW.85ZO-$'>28%T]-;<SJ1KM<;\3W
MZI52\_=EF"11C","$\H]17G"AR3"/J08)R%*,4:!%>69#CPWJNNDM0X%-$;:
MC,_&P&]D'NM$;F(+6J$7;1W>"OQ6"PZTY* 6W67 LR5:;N.?30>?-AS:$I)G
MT=&V]P\\<5E7&<]6C[H:]K5@;0N<M]_9ZI$+KG>I.H/LL6JC(MZ28JW(LU3L
M6#<EO[K7?+G$OE3\Y:<PXI$/4:KCI%*N9HH0RH,DC8($V]7^<"*7S<<Y3:D0
MK1;L] +E1C%=G+S6K/$HL:UN^FL6K79 +5Z@U/I9GL8XF63#8YFI)V[L\YD=
M?<!6(?!V;\)>[T]8IY4V%4&MUP(TFCD\J7$)M-LC&R>237MVXQ+,9X<X3A\^
MQ"O8]C.[R=OSI-?Y2OUC7M1-$*YN"R'TOR\CCGR<4%T_( PA2L($8IEZT$L$
M9;'/@M0L;,QFT+D9H+\^J+=#F4M=#S@;OYDAS":N1??@C>UR;"4&-WD7)@7V
MA 8;J4> U,9%Z1[:J5R7#B"V]&S:8=7O\31\UH2>4#OM]CVDEO<ZBQK^7.1?
MLU+]H'M2RKRXK__Z?IWIMN97K/9?J-6C+O7PL!*5N.)_>RPK+8RZ51F0U=-G
M]5;5E6J4X _UYT,\C"@*?4@CW9V<H "F,N0P33A)A4P%2HUZ94PL]]S6CD[0
M!7C0HM91HJ(3]N)0X5%FWLRHG^%\CKR<'0\/WE$:[&BM0P-JO<%6<;#57)<*
MZW2OG]&^)+7^BZ9:V-FWQ$5D\)AS-G9,\"BROW0T\)@38A '/.KP%_=';L+;
M/HIJZ<E ^$B]*0Q%25,GFZ+8@TGH48)P%/)8+4]Y159FR].Q0:S6DLU0XQ'0
MC1X#\-TT^2$I)T?Q-"/]2U$:F:'WTL6[(-FV(MF1ZHVCM!I^ALM8W8.W [U4
M0^!GJO;T^'U^[67F;VUB-]%1=4 *XDE"X@#I6%+%![X^)XNC% I,0Y(@%D2A
M/\1</1AG;N;EQB;9D=,JNN<<KG;&X 5H366\60 UV+XZ <,H]M#A6"]BOYQ0
M^)2]<>KRH04';\GJK3)+JB==,.B3?*V-%%$\$&6,M 6K/$+#* B)/HB*E;D0
M,)CZ)(8A#OTTH($78ZMZ8 9CSHTJ:I%!(W-3Y4JMBKMB#ZP29@*_&8LX!G5D
M1G& YX RA,8(.2Y%>'[<B<L1&@/QO"2A^:W#".DU*>_>*1MSOUL#Q6F4TAA#
M1KT0(BPDI)$70QY2D0A/)I3'=@?B1\>9WP&W%A-():>+5AC'L?6EST*) ABF
M<0"1P%SM!A,)$RS#Q)>$>)%5J-3%R$Y!Z#6N6LJ]MADNX#2CZXM!&IF@C^/C
MMJU(+P9.*?CX2).2;J^RAS3;?_& $^N/>5'=7=V+(F/D6MQJQU+[NGI"8C](
M0]W6.]9'%0R2V \A#8BO=H(A":11Z<7^8>;V^=>"@E92T(IJ<8YZ&L_^S]\=
M2B-__T<!&M).[312%F?,3A";Z%39[M6R.S\^BT/OB?'INZ<[(SZKP=ZI\/FK
M!W!AW8'R]6-9Y>K!78._B# _Y%X$4>*IC6Z@6R=I/QA#7(8>#K'$YC1X;(2Y
M,6#3:78CI,47?10_ ]J[%)61&>\ D"%<=Q09"YJ[%*&)&,[TU;'CMC[E>VGM
MZ(W3,5J?W'MDUGOAL,URTX!$GQ \5G=YH7;EVR33.*#"]QF,L? 4J_$8XE@R
MQ6IIJ+UW@=KUV>SJ3@\U-V9K)&V.L3I9%_:INP88FVWUW" W,OL-!\UZVW<>
M#Z=[OY[A)MT GE?[<!=H<,? +#H=!OV*E(+K0&FQ+IMN;$6AWH@ZS*Y\];2]
MI@W-N_I&"E[_G_;\7:VY#E70 K5N:BE"[/F^@)&4""(:Z^;;"8&"D\1G(<$\
M(E89=R,(.3>JJB6]J,O(&#-I1FLO/3\C$Z+-U-CG]XV(G=M<P#$$G39O<$2H
MG^48CCF6'=5SD2T_J/=P]?DN7XN/C_56!'DD$5Z (0E$ I'G48B3)(21VND&
ML>"!)XPVN<<>/C=JK>4#M8"@D=",68\"U\^(E\(Q]EFK.1+&1-:G\A$"*@7[
M\3;_^I.ZK>:>OR/](VQ^K GGZ ,G(8H^5;H/O/>:2RL97'TEV4KG(+_+BVNR
MVDEITW5EURQ;936/'.3=TU@PM<F+(:,BA(BD&%(D*0P$$]3G//!#.:S"P3"!
MYD8 N^G[&XV@S NH==I-/=W7:FB9A('3:&AL33@Y(]/1Z7DI>^=EHH(+E^$[
M4B&&@4*]4(&&RR \7;CAPN<.#J#/UH*WE0>U;;;?U^)G9:.5'_*RU&WL8HYY
M+-3;S"F&*(P8I"'R8,R]@&(N(S\RJ@XX8.RYL>]A<Q;"JD=2Z)2>6R7T3S^L
ME-1_M Z]-YX),U8="=^1";25&K1BUVE/=3F$/<"U[."'#[TP#PG5MP7,=02_
M\?A3!_;; G,DWM_Z$2.Y_T[M4C_5#8C+M]]%P;)2LVR[/Z*IY%X:IS!!L83(
M]WV($>(PB%/?9]*/14J7#W5EUK=K[LC_9RNES2>\+^N(P0*U9/I[K<O0E.!Q
MS75-FDHM7(!H;<H%$%M- *E (QL0:^[85V@][8X<A6-.Y-C&K!8<4BTYV-4.
M[*@'Z!/8O:Y5$=0Z+D"KY0+LZ+EPME$??1*F=3=:2SDO7^-0D*T=C8,'&K:B
M=.UJKM;/VBE\SE<9>]HIS,BX[X<^A2BE"*(DIA!'(8(L8E[$A<^EF0_2?NBY
MF<C/>I+4F>N=/J"1WH[B+>;!C+O'07=D4MY J/$\TOFED1S\UOYW%(>"/7!.
MB=1B^$D9TAZ60^H;\(2AL35?19.;7[Y>D;*L.Q:^>GJ=KZNBWLVN?B&5]C\\
MO2&5.'3.$@\'GDAABC75\00UY6>3R$MX$"-/V)6?O428N?%>*ZGV\'TZZII]
M(VBUZP>\JL [DA5U%KIEI<:+)M&,(J>:FI%)<T<-L-5#VZX[FH!.%:!U&=4C
MZP)6QW%$%P@T<:31Y= ]CT5R\$Q7'MBZ3>+KO*S*98B]5,:^A BE#"*/"4BX
MH##R/(%CWPM8:E6ZH&^PN1%I+=FE/M0=+(<Z38<A]")>TJ9WK)85_/"Z$#RK
M1O6./D=F9'?HSH O[/]\KOIYA^>1>X;V/:UK+94?\TJ4'W*R+I6Y^"Y;DS7+
MUK=?!!/95TU1Y:NGG8SF_6SF.AI'1_D&D0AD*&*8D*!N_DU@2I(8^DCW3D%1
M&D16%.-2N+E1TEY>_T%*_Z*-IAL0@^UT/LUH[J5F:61:O'R"!K1 =8^DXY:H
M#@6<N$6J>VB?MTP=88R!Q6IR76ZOKJ$GUDQ9FO?D5I2U8U/P>G>X]&GL(T_-
ML4?35-F#!$.B<U_\B 5$X# 0GM41_/DAYT;!K8C-Z9&P/",R0-B,/MWB-C8I
MYG5ATHVT"]"!V J\..-[L*]%8PR/VU(TYX>=MA*-,0S/"M&8WSD@1;BKO:?/
M3Z[)BA1/71T:0:(T]F.81ES3"_5AFA *@R1.1)0*0N+8.$WXU"BS8Y2N,J06
M%#226F3%G@2SGTF<033^1O,9.D.2AT_"9)% [ *NB9*(A\%FEU)\#H[>M.*3
M-T^76GQ._KWTXK,7#[.YOHB*Z&UZUT6E?2D95;3'60C5_WA3,I1$00*CD/ (
M(>*GGF]7D.OX0#9O[C05N3HY-TV)["RL$WB:65678S0R&3X#9X2R4?T@.+67
M3@PUJ8W4K^ZA773FZJ$>>%J]7Y=542\,^BRNV0HD$OL^"QE,==$XQ!(!L<<9
M3"1G%(6AAU!JYWP_.L[<[*'Z,/*KEDQ[4%;Y^A:J8>\!5^+;NN./ VOJB;\8
MKM%M(UJ!K8B+G7/<N@GP*B\?>YKO#?# ]R+BV/E^?*R)_>Z]"C]WN?=?;D</
MM5^H>%J^_KC$.)#"8P'T0ZSV12RDD/A<PE!2EL1!0 /LF3#!]I%S^^A?__G]
MQRNSKWL'E_X/>9BV(W^S_8H:?Y+/=>O)"VTO;CZ^]I?ZNZN_N)U'3?)Q/1>]
M^XZ._,L [\*5TLQ[^UCDUV*=Y47M6&W-P( BFF*$89K&L3*K@PAB05/HIX'
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M(.AY,8<H2!)(! NA1 E*:!!1$E@5EK08>VY,]U%-J(ZXSU>KIB5NH\$";'0
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MVM]^UNU1\_555149?:SJGB/Y?MA?%RFU# -*TYCKQB!(&8E$A#!-9:Q^2L-
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M:L-KU42P9["Y?=#ULJ>7PKH-CMB*:]E4L ]?LVVN*]1&_MPW@#TS*$;H-6@
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M0D(1I10BIBB6Z'*E 2>!0('N?,7L;&G3H>=G7']X?_7J_8?W-^_?7H.KCV_
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M5V1EQA3'A[$BZ,U@X[WE-WH,P%M9:YH@;4/46RVO=;3H,6C-*.%RP$9FA$[
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M7]IQ1]\#)*&*;_9P^XMY0%MR*)4XDS@WW!!AB",:08X2"7F"TYA1%>4H]CM
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M,4H-^7/S4YXKBC.>Q5)X%3'R'']J7X%&+% T8E9'?(^M_#W3[QRGPFW/:4"
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MMNMB4_QW_66)*8W-JA9F6=L$%$P(I#;D.Z$RXR*-22*ISP)W&71JBWXGG9*
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MSVG@41G-!XJG;.5U;S\F>K=:WIN%_-5:IP>M[HP!2+!Q!&&NF>$>@7/(99+
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M'[P5]][9A.[0N686.CSQ6;(,W36]E''H\81^%EX5OEKG,3:N A)(R#PU3J5
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MVWB=:&-#BDQ#'A$.8Z69%)+K+)/>Y_WAY9P:=36J -'H C9[\0';R=_CS'^
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ML-*#1GQ0R>]3-]YG*KIY<E" !R9'=VS[Y*UZ@>Q3@7\@L,<JLQ\0=,\J^CV
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MOU)JONGTO0= LR>XUA"<%*+7]V_+T(]89;[_R1NWP'R/\D^KMGS_$^-<5GX
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M8?UC]>V?>]XHGW6'(NT7VW6)APGXQ[=WYLO^N*++7RFOHJY:+Q&GL0C#!,J
M"(B(_CBI9D<89S0)2)@J1KBUH7=QF*E]HEI04*U11E30RNI@,%P&U,(@ZP6F
M@3_?\PCY1$I=ALK!@NH%LI'L),>7R\T&N@I$IZ5S^>[Q[)FK&AQ8+=>O]MLY
M>R>+_#LU):I^H_G2[.U]7NY^]TFNYUDF91(F,912^\$((P4U5P:0)0H303EA
ML=.AR]41IT:2=6J4"9E:F#22O8XQVO[?'IQI=T!LM7 \,[L^"3*6*8DB!!EC
M"J(P#" 5@D*2QD2%'"=9J-S*4?<Z#>,4I]Z)-P-&Z/909&5*]>W^],DUH?,Z
M_';[GKU".O"ZU@.6SGN@UOCTNA-Z?=11]T.M03C>%;6_T<,PKI)"W__@52U"
M\:YJ,?=%/WPEJHW8>4Q((,.004(HA2A-F#:/)88AHHS0@ =QG#GDE]N,:?6Q
MC)]7W@I\E%7>GG&!\I'JX8#2+M\_<KHN\M(<R?X"^.KI27]<5=*Y@]5X;6(L
MS.P^<!ZI$+:1%&Q%!;6LH!9V5A_6](B=@]W=(X8C6=\W8>EFBUN"TVF17WO&
M>':YI38'UKGM/9X50/1MG]5!^\^F]HWD8:#2-(%)*@1$U%3E3HF 6$9!1H.4
M1PERL<TOCC0UF[SJNJ,9^+"UK5N9H>OPVIE]O8 V,+-ZXN5>J^,:%OT6Z+@X
MVKA5.:XI?5**X^H-GFU.Y(-96;;=U+:=>(*41A@1"4.J;3C$N78D-3M FO&0
M!%P%$2).#4TN##0UFFCD!+N^@Q8]?-R@M>.(/@ ;VOCRP<J]T\@5(/KM*7)I
ML'&[AUQ1^:1/R+7K/?R[STMYGS_);\^2YW2A39.JP*L6_PTMI?A5.Y FY?RK
MI(O\7R8+J@F_,5T-]-^^%*N'@CXUV]6(9TS&(84RRCA$B<*0A4D" XJ0)(2$
M*+/J.]NW8%,C'ZT:-+J!1CFPIQVLU -&/UB5=-AIV'1 W>H(&B4=')\^9]O"
MP7RE.1R8#WN>/I\CHS[GT<'9?:7Y',DQ'NNS=/.A!\"\T]_N<[SQ?/,!4#KP
MXX=XOL]N[(;]E^3K^U6=EOQVM115K_FVNH;$$<DX$S"F&$$4Z/_H%9A!27'$
MPS1,,V6_ E\9;&JK:B.N2;NO!08[B5WV!J] ;+.OVA]P0YOV'9CYK$O7P'/9
M6.T/Q+$V5GU>0,<-53M0NC=4KSQCQ U5.VT.-U0M[_';)[G[3O.%X>]?5\4W
MNI"FE_2N[L/=D_&[_E571]7$GY=S&:9,">/M*(XADHI!2BB#VO=!01BK%">I
M2X*QJP!.)#Q"UO!6PJKRK]M.BC/X=CLL0T(Z^%D\6^\5C)F!K2Y0VQ^PU-I4
M595M('?>D/'%K=>-&F<A1MW \87H>&/'^SF>29'Y,E_+C]HP%4?U5/\HI=HL
M/N9*SDF 11R:Q,@,A9K9: "9L2=3K)(4"2+"*' +++(9=GJQ1;74<&'$!OE1
M:>89D.4Z?S(A!F!3*0$66HN9"0![T0Z!8[B7U<38L5[?8 _,= W*E;S@N%#S
M#-0R R-TCYF7#A#UFX)I,_"XN9@.4)PD9;K<ZT=8^D&?U?OF2ROG:90&"!FC
M*\@B<[BMO=R,$4C36+*,2"1BY7)H=?CXJ?FU?]15^;;R&6Y9/YIM)OE,Z_1Z
M\W<]#719;5M]TXZ.K$O0?5DM<FX9MG\!;#NZ\8=P8&(Y1F_68 +^;/[7]%4'
M56/U'@^SSL/1*XD<#3$J79Q7[Y@8+ESE>8+-'Z78+,P3F\#J+[+X9D+JC$7$
M[Y;B7;[8F% _8T>92:WF=,Z0X'$DL7;+D+9E$%60AIHP" U#A0.9X,BI$:"G
M'%,CE59XL\===;#3)%)I >[6ZR)GF[I8Y?VJ#F5T/!+WG"O+$_/A9V#H7;=&
M@XJ8]B>BTF(&*CVJ<DR-)N#/^WHZAN"J&_'L]US>4Y9QC^UO ^SD5/_&Q_GQ
M:=LJX[Z@RW)1=Y-?BK8,\*ZKZZZ7:SG7CB!B281@$IN:%UE*(8L3!4G&%1(L
M2#+L%%3H(</4>%0[[#)_6 +MJQ=RJ<V)]4X7-]+TF1 [PAP8YH')LI5^!O;D
MK\AQ6[-ZKPWVG@[],>0- /;*CCYRC,J,-P!US(JW/,JG)X9^V+K03_I2K+B4
MIIE0>V9%$BYB1C,H!9<0)=IXQ$%$82 146&:XLBN3-B5<:;&;%M)P9ZH+OT?
M+B-J<83:#TX#4]-9B+QZ95S&RJ5?1B^8C718NL/NV>+U<NR;<16([MX9EV\?
ML7_&51T.>VA<O]R]1$US!/$21NP^7R_D/ Q9ADU_#!Y+!A%A(60L2:!*@SB(
M I)DF=7&V[F'3XW_*J&,AQ9&/[&?VU,XR[VTL^AUT]ZMF S,=:YP.!6MN:2W
M=]6:DP>.5K;FDBK[=6LN7N-;J4%)[7UH__!'W111__!6_SM?OZ5%\:)6Q=^T
M$&7CJLS#."5A*B.8! '1]@R)(4FS#(8RDP$B(I$!=BO;X#+\U#[S]S^>)3=;
M+*KQY-;T!^"5^,ZU&IRFP<YW&P[<@?FB%=S4F]ZV6S4_U]*# _%GH%&@SY("
M/L#U7%_ 2821BPWXP'-:><#K*6XT5Q;K^6D]/BD_Z;>O2<<,<4R(3"FD.$T@
MBC#5+AI-8<2HB.. <)599;%='VIJ]+4K3C@#1DK'3%<+;+MYJE_$!N8D=["L
M:<<>ARZ*T4_9HQ?]KV-JL1AF%!JQ5[>E#(<[/+9OWMY]??_MCJ^W!>;?UYTK
MWLBE5/EZ+E BN4A"XZE0B*3 D BN8"!BPF*FW1J[!LTV@TV-(BIQ@99WMM<"
M C0R@Y\:J2\W/'='VV)_IT<,!R:-\>%SV/+I$<:1]GUNA=-M)\@2G\[MH&O/
M&&]/R%*;@XTAVWMN[;+Z>[Y<&9^V.KA\7"WT,\HY3E3 DX1#QJNV3$1"++F$
M890%"699(I!R* YE-ZK52S]^>:BWM'P$(O^>"[D4)7BFN?#MJ7H6:SM_L@?H
MQN^B>J%7T2 -5+M@&:ASZMDA7ZEE:I?ZEWNE=M[EQRQU3%)5/JEZ:GFWT69C
M8<+@YS))HRRF&.*JN)&VW2#F"86AP+$)#8U(2MQ"TSM&<_DFQHE(_WQ846X&
MEANST6\V9YL:<W0KO1O%=(%NQR\] 3FT3=<$O!DQ9W7450GNKH/FS"L6</1*
M*EWCC<HH%HH?TXG-+7Y<\EXIR4T>]M8(,LU+OTJC2[[(*XM7__*;7*\7L@EU
MXA'+TH# D)M0)R%#B$,<:_,E#11)%<JXE</H+\+4W$ACII<[\:H('//\Q::-
M0.>R6)N"L68'_7E5NF1>WS!3=KPT+/X#T]56^'V7J>JQ?*A O<&^TV%F@DI-
M"8+^",T?QUYYSD.,4>G/'Z9C5KSA26YD6054%2_S;[_-::3)+Y8Q#!DW=9RB
M%!(62"BS3 G!E6E48T-^NT=.C<R^??CTV]V7SU_?V]'3'C;==..G\<#T<5U9
M:QHXU:_CB+ZYN/ZJFW]4'W3U*>\]:I1/\U3T]E,[\Q?W6)EWS?:9J> XY_J[
MP9E2D$0JA8@K#AG+,LA5RA&/$H&X5<C@\8.G]AFUL@$CG'UDS %6W1_4+0@,
M_%G9*>\4!W-.4^\8F(.'C1;_<DZ%_=B7LW_W+-91!P&77^B+R8S0_RPV4GS,
M*3-=4$SB_%)\7C_*8N]7[_*2+U;EII!OJXC]]2[[**0QEG$:0$%#"9&4#%)$
MM0= !%)!P).,Q"XF?[_B3>W3OR^HD( V.H+G6DG'@A_]3J"=)_!ZTS(P'[6*
M@4:S&6AT WN:S"J_K=)O_]=@I^$,-#J"/P=)-QL&_WZ+CO0KXK@E20:!]Z1@
MR3"CN <&?2E6IFFG&>^;++[G7(]3QZU@H7D<QS%DJ0P@TE\/)'$4P8CB-,ZP
M9BYLU9VJ<Y2IL7(C:/61-Y)Z1 1=!K6;8GN#:NBS)1^4G$*!KJ)P<Q30Y1%&
M"P"ZJN1^[,_UBSW"?MYLRGPIR_+MZHGERVHOY.VJ2@O3]*)_*G/]H.K7+0^]
M;%O(M[V2YE30@(@@@E()#A$VU>_31-M]-.9$)&%"F!51]";1U$C%" B^5T5N
MJSYW/SUH05T"7GJ9IF[J>17P!Z:I5AVPI\\,[#0"!RK-MO;<RPQ44U;7)=[K
MX3;VE#D$,HT]=2-%.XTWA6YQ47W"W1D\U<M XT58]8G+01A6KP_VK*"S>7ZN
MCPCHX@U=F.+5WQZE7._L\G+G2T<!8B*E O) 9A E"8)8T4Q;SQPK_;LD#A*W
M$ N7X:<7<]%(#"J1S=?\O%IV%AFX?0KLMC.&@G7H,XD]L<$AN'N2#[0%X8-9
MOV5N7 08M[:-!S0G!6U\GN&=^JAI533!K%_T6'5/YO+KMA?SAV6U$6$^V4(^
M2LVT[5GJ)[G^4N2KHO%'3'75.GGIC33)@/?TQSS$64B#*( 10RE$2 E-@W$"
M&8M9%BL5"9XYYDH.*>_4/(<_EGL]L9^-[*!L_.TZQ1+\Q+46EH;I6)-N1[P3
MFLJ!N;K>+3[0 OQ4Z_$S,(;)##1@@ 8-8."8@4K%[0Z+41+\5*OY\PQ0I=]
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M";9TOD>=MJ&]\7%FS-T#[PWD?EWRV\4:UT?O#<83I[V_)_N4+GPTPV@[6<-
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M42(2&%*DG6R199!*D\D5\"B+8VT2*ZLJ#U?&F1J)56+.JMP;-Y*ZA*,=(?6
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MIXIG$ 4FJY"E%&*""$TH5K&PRBJ\\/RIL<5.O"9VS[LK;@V?'2O< ,K 5."
MQPWM:P^T'J@O;3W&*S6</5#P<B?9P\O\/N#[0M)R4[Q4,7]U[9ZO50ET,>=I
M%"=!&$.%4V1:>F7:L<@DC'BL?8Y,!"SUR9:[/*+5BSQ^BMQ;$YB]6&Q[>12[
M*-[2Z.#VR7< ;O?UWXC?.$30"EG'.<^:.F F+'K=V?[6F16NH]$K070,-RI7
M7%?[F#8L[KC-C:CZE)9Y=>14)72UO0H_E.5&BL^%^5_#6%5[I;NRS!^6^J5/
M4$A0%"M(DD"S3)J$D%358!G/>"@P9Y%5\>]^Q)F:@;&UK??4F;5)I=M.G+5*
M>M9 J]2L;DP'6KW\_!;/*77S;8:?J+'\GZ'FR-LON@W:07PG3Y%>Q;^Z#;Y+
M/MB-3_4-C_XNEQM9;O<R)<4)"B(,489-!41&(<D"LXD<88EE+$-)W,Z<CX>8
MWGES*Z%CP=<3[.SX[18\!F:L5K1!-GHOZ=US@//1(",'-Y]7\32P^<)UOILM
M2IJH_7OZ8Z\3_">Y.Z'@E,0BBB@,8T)-PH. 5"495%2&-!(R3"5SVWZY,N+4
M[*568+"F/\!B)[+C)W\=:=N=FA[Q&WSOIH'.1)SL23L#IA?4$$QAC4[/>SS7
M1AUYU\<2A--](-L;W=A&R'S^KDF*J].SWB^%21*:AQP'I*JNF4K]GSA&D*41
M@:F028JQ?L.053K5Q1$FQR:-D$T]7*#%=$B7N@QD-WGT L_09.&*C#4Y7-7^
M#!F4DO_RL/K^/_6]%0_\$YD?8?UC]?%??NHH'_M5I=J/^_J%?J;#'\N-=BH6
MVKE8JD+^<Z,?_V$MG]ZMGFB^G(LD2AG. AA1%4 49B8 E6$HB4@"EJ09(JF+
MV= YVM0^\D;8RC/?B@N,O#/SNS>K]2/XLQ;=\72G&W0["Z(W* <FA%Y0=+8@
MK-#IU7KH'G%4R\%*^6.KP>ZFOI(NY9(_/M'BK^:5CT+%XHAI]X1EH38@< P)
M#AA,68A(QL,DE$ZGP]<&G!K5G$DEW$KLR3%7,;>CF3Z1')AI;@.QA[3,\\@,
MG)MY-.@K)VB>A^!ZEN:%^[RW0_*E%'M]NIM^WE7+[O_(UX]W7%M2FZKZ07/5
M9[9HXG3+#\OW/[@LR\_*7-_D33T\%-7!\I=B]5]5'MW)?7,9A4F4\00RA3%$
M1%"()8HA#;2A%+$T#I!3T.WKJ#$U:MQ*"E@M*EAM977>NWF-U\)Z0VCBDSW\
M+I,! #0R J/'##0@5/\"?VL4P!X,VVMW"IF.0S42)B"CNJL&8P9V+]+I;;UN
M7;WB//:]'_8:JHR]R?:*TW5FY^XUI?%;;?6#N92BJHS\C2[DW5*\72T6>BS]
M[,_JJ^0R_VZ.+<NY$"16F 60AT2;^5% (*,Q@:%,HR!.) LRIWPV^Z$GN*I5
MDM>UP(WL546FG?2&OO;D=UOI'*;$;G4:!NB!5Y3>,'9>!-SAZI6X'88?E6S=
M83DF2(\G^%9[^6&*)YBJ[]^VU<>;+'+,$A5B(2&.E=(L%FL['P<1# 3' AGC
MG\=N%5TNCC4UVJI$U396U<U@5Y;=M9#+96SMZ*@GQ ;FGQJLIO7#3LXA4O6O
MX]%S497+XXU<..6JXJ?%4:[?,G(CVL]5"]7]UKA?-:G]NBK,'^>(B80KD<!(
M) PB$J60!)F""B41204GB#O%P0XCYM28JH?.IXV^L_TFU>!/HS-HE';<DAWH
M!;'CS->?]H'I]I5G?+S6MU83,HTFN-VB_O=HAVL%=V^-<>U&<UN@RF)MMMS+
MU2(79N?@_7)=K7K-05 :8BZXB"$3-(7(E.=BB@90I6FLJ,)9F$B;!:9[F*DM
M$/N2@E94Q[.V*\!V$W-_< U_KN:#E#4AV@'116CZ"7MDIO]U3&17AAB%B.S4
M;(G$\FJ/1@L?EN5&_^UN21>K!^U0BPU?EW,1,IXE&C$>R00BAA"D#"F8*"I%
MP#D3L965>7F(J1% (R2HI02MF [=",XCV?W5]X//P%_\4- X]&RX&:*1VC>X
M0N76R*$3A<Z>#N?O'*^]0Z?D!YT>NJ_T(+BVTNVOF_5&6UC-84IM8Y7S),@"
M3H,$AC3A$ 4X@B2-*)0BI3A0F8B%MG96:[JP(+K.H9P(;SO@<*_JO1G#X1ON
MQM&"YGI#9V"ZVY9&K@7='4$WHO:&F0/_]8;=2#SHC:$;(5K!TDF,W4\8CR"M
M-#D@2KL[/ C3N*@+^>.W_W.W%&_R59D_Y0M:;(\[$L1DHB3,")':,@PII AK
MPJ1"1"I":9I9=9^]/M34+,1&6/#;C^K@<$]>!T;H!M>"17N#;' WL4'K_QRC
M=?W$PQ4V!R+M#;Z1B/0RC#U1J!4@G13:_83Q*-1*DP,*M;OCMB3<;_H-,0?3
M'_4T+.J#IGOZHRFVW[#V7.*(QUB;G2A((H@D9Y!$BL%0T"2C-%*(.T7"N P^
M-9K]XY=OOX!*<-"JX9>4:X6\W6G)4'@.S,';5-T:3D,@E>3M*;3)X&V$!S\U
MXO_<?]ZN"VJ#I/!:"? JV;PNT%Q*['5ZAH\#_22+AWSY\#LM_I+K\IM\,.M>
ML_2JE(HT3AD4*M;,E3 &69CJGW"LW>@P")+0ZK3@ZDA3HZE65M (Z^(5=@%J
MXTCW!-/0?O010J 1U,?^ZX3,Q8_N";JQW.@+$/;E/EN@T>T]=SU@1.?90H]#
MW]GF!N_XYV=9K%],S/5:L[*IW?1LGKYMBST7-$L#(D.H7>8 (J5_(B1!4"I$
M612B&&/D&/=\9<BID6<K\0P\&YDKRT2V4CL'-U_#V\[&ZQ?%@;EU!^"7+8!;
M@9N:NL/4TK:'J>\@YFO#CAV\; G#F:!EVSL]C+7?"JFMP>+M8[ZDAZMD1L(
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M+B",M#F+:1!#3)#VVT5$M<M.&(RXMF\901RSP,T5[0WC<?S3%F6^*0JYY"^
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MQ9XGI)LO$B)Y-A$PHSZ"<8JQ[Z5($JU1/.S%D9;&HHU'*;E1_C*O=R)5JVF
M>R(#WM0!4%X_W>Q93:8/CSC?UF?>M,G3-%P(7#:%'DTZ 7AB$NR+Y3#PZS7-
MW49X71QMWE"NUY1^$;/UZ@TCDV]40:A-J6I$'??DTM +Y7)50$98"A'C#*9)
M&D"?<=4H R4H,-H8'1IL:432G\$MLV_.06KB-(T':AZO2#4_/PH*_I@V V<
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MI5 YP78POVK<"/,E7SE!XB0SR\T3+;UE5<>9/*_CW#NL>/-TO*2M$%[7:?^
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M_S6O_@5^Q06V*7"L:P4])VP";"=FD?.P'F66WM(4?I(A4*Y[B&F-/7?O,!-
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MGBN.HMG$@;\ PR"X>PPH,T5L:[P@9G'7EW0>#*9^<=-\$=*7Y#T)>[YXD66
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MS*]],'LR.^R#9862X[I].B//7,'/ (R7M?Q,;K9-'?Z0;_CG?9.MEQ(>>HC
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MUT(8IECUT48Q05P2>(*UBF^^/M32R+<6%O!:6I 7/WB;P6NP:S\,K<:1AC/
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M;,O]HUQVT,U>!<>J:\IBEQ=[SFX?>=,NH$FNB-, "Q1R2&@H((J1![,P$3#
M6<8Y3Q//URJ_/Z_82YM!.P5 K0'X+"^U2H29R>AZJX_EF7+JN=C<BL:+D'E!
M=;J F4GT61<_\YKC^<)IYM$MJP8U%=>E0/7FUI>RVJECLFTM\LLILNIRJ')>
M?99&J*?*W3KS64;B@$+&(I4Y(==@F4 9]%$4!"2E"<OBKL30G?YTXT0X+0HZ
M+4IT-\.D<A00;(YB&U8E<F(\O?EB/EO,G*FY N?]_J/4#NL?N031;;$D)Y+-
M6UG))9@ORC Y?;CMAO\V_R&9_@?OG4%\+N7PE5RF***ZJ?Z3LWLY/_0N^ ?.
M"[6W^IGOUCQ&8:P._1,OS2#R@ACB#!%I_UCX64@1(:'9.<!(B1;GVA\4ZO4A
MZ!^D2N7 43N *]#JU[_J?YF>)(RUJ^X!PXS6FGPG[6 H8_.L@-*I/7&0Q,X=
M,KHSC!V?1HR5:N9#"D<@OCR[</7@L179W^PK.654U0W]]SZO:L]?>ON]?[VM
MW?M[.;[J>)&SUL>_XS]W;R16_UH+C_HD2##T$Z&Z!B$!,<=$_H?R+ A3%,=:
MV<D3R+8T5N^7_>Z4 WWM5$!-[]]UFYI60W"B8EL#'"A50:VK=>7V\6^ 9I#5
M=>PZ=9C454PZHL*[,_ GJO0^7KXK57QW!NSERN_NAK";-MIV=ET?L1 G?A(@
M#)D(&$21M&R:)1Y$* A#E A"/&H6NGLZP/+B9TU./2^ ID>6]D!,S'=M]\TI
M^J"=U]DIS3P;8E:F.*_>\X_]PE46D2L=6;PM'XA<0G;TH!Y;1\GD#V0O79XZ
MJO"AW!<[=:XHJ>:VX.LHQH)Y(8%9I+)U>9)"'(7RIPRGOA]%F1?I)Z&-$&1I
M#MR)L #7TJ[J<!4I+RB+RS');NVC$:LR$^H3T\W!I>JIT;A0K2+@U"0WK4E:
M951%EIE,8A"@,I-I9HI.F=)$9H$I#G =C$H9\_SY0E(<H' 2C^+B>6ZFKR_;
M\D=>U6>3'PM1;A_:CLO2]<6;&TK5X/6."2T?'C=\QV_8/_=-EO<_RI+]F6\V
MZT!:-$[]&!(41Q")!$$2^0R&8>1G<HY+DU!KYWE"&9<VZ75RC2-2%\:SF_9F
M-LE59L2>CJ"GI IZK]4$1SW!4=$5.*JZ LNQ\[BY=&9[7W6:G<7NHV=AAQ8Q
MG:!=#'W5N=LA=J]-ZRZ'LMM@^E06]W=\^_".D]VO>+??U@?77_GCH?G0EVU>
MT/Q12?C?'&_OY/O UP3Q@(9I*F=Q598O( E,&8XA92%+0U4\-8W,-J+L!%G>
MAI7\1D*S[2I+$^AM:TT/Z]31.5(!J#0 2H45:)5X6@$E+:C%=;<C-@XNISMG
MEJ+,NL,V#J[G.W$CGV9'@!V/-C6H.).LNW_8;]2)\+$LE3H#7F=9P*,ZE3;-
M$$19D,(L1"F,:41HF*#,CYG)L:OVR$M=GJQ )_H*](3OU6X#2GPS-M2W1\PB
MA% FY*1#$XA8QB!)_!12/Q-QB!$32="%FC9YV=]V>+N[AG%.@TJ?"S/AV4'/
M*OG1*ALI-U?-KOE]7A3*4R5-2/)DID)9&A%.8)BA"**$99!D:0P3$7/F)<07
M+#XUU?M"LP/I](;J1+F:F7C!9K"1GC\Q"6E-[$*XXBMC;\(8+*<.A/[HL_H,
MQJ \=Q/,'S!SQ:ZV)LCOO%)A947= 5"53KPKU:]N][MJA^M/^EF=D/<_^9;F
M%9=>#N5K&L4\C%,*HY!+=X.A&!*1<A@%E/L1S=(@"-:/9F1Y795,*.%Q)NI]
M49^+MQ*#1R5ROS#7CUKYNAOHH1CFKJQ_#? .-!(KLIZI=)>;UTR/]O\Z+\[$
M<XF#(EV',ER_'U^H][T72OU:7G6$YDQYK@X>4..S@+I<3NV\C&)<;E3Z:U3@
M<FH^9V6WW$IEFWI#=L>(\+?E#UZH:EZ\HMN\%F\=X92EB$?0SPB%"$4>3'%$
MH? R'H11$B2^5L49[1&7MA^@!.YE6:A0A$9FT!/:-#'F-=3UYBVG6$X\M8R#
MT2)?11,:Q_DHKXTZ<[Z))@@O\TET;[2CG5_E<F:;JV@/I4F^4:= ._[0-:1!
MQ*,\00AB/^,0$4PA\?P8!EE(TC#-,I1JA0OJ#;<TPOG&[VN'JB>M&;V\@JX>
MM[C#;&J?]25<H)9T@F:5>J XI917AIR53_34?TXFFG<MN_#XVJ<BH]P/((T"
M#R+!$X@1351=\22($H8#EBZSKOCR3I$_[Y7E58J3?.I.NK%J\5?M2OHO@)6"
MU<+KA"^L#/B2R/AJ5;X7L$M@:;9E[ >8"O_76/E;FN1:I;7'!#C_BG_F#_N'
M3[S9)?BJ1&R>JM():.C3F/E,-</ $,6!_"D@&20<Q]B+?9$R_3CEP:&6YDZW
MPH).6E"+NVIIPS"C8QCDX6G!+703$_F,J!E$YSI#;Z8@VQ$HF@7):@$S&.LZ
M_(3Y0E:U-#F)/-6[PZ;E7K'+56@JW^6JM,;;LF![NE,ME+Y*BW.ZNRN/U>W^
MP0LY)GVWW=\?NCNSR OE(@&*%!.(/"X@B3($O33U.4NBB(2I?NN]<<(LC96?
MJ0-HHT_=;$RM"I1&ZK@('W0"]XU2@"FM3/K!C32C!JO/:)R)>7^L76PZ4X\U
MD$GCOOD,-5<#OZD^),,&?FZ '6[D-W*,&1OZN4'CM+&?HV>."R2^*=A'^4X7
M]SG9\*:XP+&NZ[&$#^9!["4TA7X2JE(>F,+4QR$D29R2((J3*&9FNV5F BQO
MSZN3OPZ(:#8TCGH8M3^P-(G>GM5T,$\\<9W@^P)9<!0>_#%)120[X"8)B=04
MX2IQD6;P7 J.-'R*'>6]59JIQ'1%J5_SZE]R4:%^(=<8_EHD3'C,IRKO.X0(
MD4#^%"*8IHQ'V,ODS.69'%$.#;8TW_U$5K"5PJY4?& KKAF)#8*L1UFNH)N8
MH$Y1^UJC]N5UU(R)2 <.I[0S.."L)*.C^G-*T;K'LN;\MI2?Q>Y)%4Y6I?#5
M9O"C6A)\*3<Y?3I.S2'ED: L@V&L2EYF00PSCW*(19HBY(5<4*.2E[H#+XU8
M.KF;1GN[)G:TDQTTPAM6CM<U@1[53 'LQ+0SB.FJ!17\T?[O)*Z1*6IN"[[K
M#CYO37=#2%Z4;3>]WX[!SM2$;XO!5Q\+EO_(V1YONNH]U9T<Y%:\XX)OMZ<G
M9>_*!YP7ZR"B09H1 47DJ3+MU(-8A7F%:43B)/!0Y!GEF+H5;VELV"P23]4#
MG7ZJ(D>GX:$XEORM4E(%5G1JGI["_]%H:EC;U_%;H$>UU[/MQ(1\#;,:4_8T
MZ#LE=L<BSDK_T\#[?)*8:!2+D[1CYF(IFI"(7_GN>RD7\2J_K Z,6(>9ER08
MAS"-J5Q1>](3SG J_Q-DA#":HLB@DIK&@$NC^UZ>KOS0VRBH1FK0$]O@7$4'
M=8W#+<=83DROUX'1X C*,9PS'3.-A=7L-,D H\$3(YWGS'<J9*#5R<F/R7W7
M20;O):LUL;WK-*&"13R!L8A3B*),0.GY(XCC,&6AA^* (*,N'JXE7!K]NTR]
M/<FN;=2=-VO[Y?L0,L%CBCP898& *$#R?6!!"N,0LS@,5>]ZTN;[&]2QN>I;
M\5S:Z=Z-8[Q\G:Q?@7W!5.;^2<1\>=1%)>P?J]_(VQZ'0Z1G>@=BN?1/HH!*
MHO:0]/ 220=ID,#4"T.">)@(C.>N^>#@#9B^C(.-_7G!EF-YO27_56TYL5MZ
M+7J?O4;"12,L(\WAHI1_C7R&UT!V79S@\D"V]0:>=Q2]J:K]0S/8;TI,O*&J
MVI$<L+WHEFSR^V8?0C6'WA>[KWC'U\@+51@1ARF1KP?BB0<S+V/0\UCDQT2D
M 39L^>E(LJ4YEIUL8"N%,ZU3X,I:>A/ 56PP,?&?;[K<TPO\5L\)1\T.EQYU
M6X&#%;\.6=&B3()CQ!V74W EW<QE%QR#^K(\@^L!7%2/N?F95VLO9BB1_P^#
MFI9]+X.81 GT&,VHX&D<AT;K_I=#+(Y?3PN;@#^4D(8G;&> U&7,,?!,3GU&
MR(RL\=)7?L*B+O4P5ZSBTE=SN&S+R966]?-Y57%^^UCW?2SN/W'I)M;_^5SN
M_IOOI$\I!Z*<J;K6MZ([2O+7/O,13F(,A4\"B%@4R45^&D!*,,5A*)(L-BH:
M92G'TJBB+O0N%^5EIPC8*"4J4)0[\,1W@':*&-;8MS23'L?, /[$1-1HH%;0
M'>ZU_*OF?^KFZ@K]@R8KT%FJT\9A#?YQ:+HMPF\IR[Q5^,<!]J(,_\C'N5KW
MOA>"T]VMN"WX,>+T2YD7DL'I5@ET6_1J_YX]QC\Z=6ODAR@6J8!9D";2[_()
MS!"A,,4B4S_X@AJ6Z9M6X*51<Z>#*BBR^\X!:==@Y4'BL4MGQP:W75%?SXQ7
M66@WZBHJEPKWXNU!K3(XF%WMQ/:*II\/S^JMR*=<@D]CHHE7YHZ%OO*"?1H3
MO+Z.GVA<BY"ME[+5<V%.]O4NPYLZ]/@+WNYRU;*FV%4O*8HCPACW0Q@PSB#B
M6.5(H0R&(:*>QT*:\$0[HFN\/$N;<GK"JJSMHRX&L4D.K*01 38O]O/,$R.4
MF=<^!J%E\]IIILBS<_,Z.-$+O'EJ?MM7;9(YVS'*@[%K#H:9+[3-'28GD6\.
M'VL9&,>W.:]NQ3%>>O/T\>&AK6C:];R\H?_>YU5=>J&K22(\C$(>9# AH2J;
M3C.(4<8@18D02$0IBF*C^#=+098VZ35Z*'^\KPDXJ@(.C6G[RA@&L-A:33-.
M909;3!V.8F>&"4HJCP73;5B)K3#S1H^,A.Q%D,C8Y]G45FO:_U9?.>7Y#TPV
M_ -6M:%W3VTYMS?E=EO^F1?W;[%\A^7OURG-J"]B#\H?(HC\B,,LC1#,H@0G
M ?-1B+6R!RW'7QJ3=AJ [4$%4'%:]Q7]GR:V3+0J@8>V#B'IE *TU<JD3)>Y
MR336%M,:8F(:/=C@*#WHQ ==\<># N#M+*";E$.;%/RY*J"=^1 TWOR_NZI\
M9HWA<+$S\\?.6-_,6N?3DF;VC[%)0FQWT%@_ J;-2:8I"[S(3V&01!E$48IA
MFD8)I&D<8,]#,1&!?O+AY8&6-HD<1#T-,#-,%'\57HUYP!%H$Q/^3'B9I!.Z
MP6VN-$);_ SS!U\'93AO<.#^&?,%7]?B-$]0XWJ[;9!N#?"V?"!Y4;\C:B-&
M$C-7[:&**F>\J:#T*<>D87 IR;XYE_A8/.YWZR!*PBC&!(9(901FTI'/0M5(
MCM(P)@D1(=(Z#7 HT]+8N/X4]E73*)-U'TBA H-P]1WDA=B4?U;JCX]R6'4P
M^0-O]MQP=\2%,?4V2F8VT<3<?]@1Z:FS D>%P(E&*W#0:05Z6H%:+7?[)PXQ
M=KJ5XD*N67=5' +Y?(/%Y:/M"/Q#7N0[_BG_P5\4SFRW/K,@S#*?IY"@%$&4
M9@1FV,L@(5'&B1 >\;4\8.T1ET:^C<"PEGAL:=[7X=8C4*<@3DR/P_A-L'.L
M#8Y37GM]U%E92QN$YYRD?Z,SE_'+MOR15[FJ3_ZQ$.7VH?[M1RE'CC?M7H!J
M#EBH,N<;ON,W[)_[IL#%"4G>;7%1-66*UHB0)$$TA6%,5;Y)C&"6Q($J*9>A
M,(R]C&CUV)A7[*5QWV?I8N+F.\5JFU]5&/M%^9VE /\G\J._I^JGV@GM_OZW
MT4[G%*^#M5]Z92-?Q77MZ0QZ2JL:=+7:X*@W."J^ D?55Z<^+^AI/ZF'.Z&U
MIG:"IQ#]VG[RA.;0<*6G'-TN<+)^QAW^V5:F;W^QPS_Y3Y6#S_-"DCJO=NT_
MUX3X,2."P#1+!42(AS C201Y0CE.8TR"5"MITG+\I<U&'UOQ0"N?6;R=*?@:
M>]/30CHQ]Q]*ADKI6V=\=:PC*C7H8%Z!?%;@S0(;)S3 7.>4#_5V'N&2HSC
MFWKF4[.F=*W4/E[S#_7[/[%DXCHZA_7M5'MH .^: +CZG%/M$W+5!ZA>:NWX
MPV.YQ=LGP'(A;^3U8Q2%OS"MJ]-/>\N\%OQH^MA9@QTM=7X>W&C[&&=+,M63
M_;[(_T<N IG\ G*1X\,R\*;U]&\*UFU+Y;RJ*PWPNO9@(=^+IW7L!9B1-("1
M"#!$B< 0)RF#7B"2$*=,Q-PHXW\2*9<WQ36"Y0XV[QW8T'K9-*]EKK)*.JH(
M^CIV^UJ=EG5CA9Z>H%5T!0ZJ3KHD<F>)J5= #B2]]H+''=@:ZQN'@XV;-WH1
MH'+-]4&MM'H+KE[SOY2$PA<>C#PD5#!-!G&:17*"($@@&GA13&QF!,WQE\;U
MYR*IZ\T74*O0WWJQFPMT[6+&\A.@/1=_OPXT^..N)O%)^MU8(C@)[^K*<!5&
M-03H$E>:/L8R%8A^ERNM3:]'PL%Q/V7?^LTZ?G7$$P)[<0RI%TLV#&D(TXB'
M,.28LS @V"-&<2^6<BR-%3LU3KJ:'+<HGKM3A@E EK;28\@9+# Q4QJ"/RE;
MCD33;?Z/I2SSIO^, ^Q%]L_(Q]DV5WUXR)O>!7*40S0,E>,<.[G>D*JNOK,F
M211X-)-^9$(\B%B,(:91 F-?9-BC/$X2WZS;JL'H2V/.GO#UAWHB_DFCXTX#
MPVJ$9K;1X\S)$)^8*5V";='*U0(TQ[U=3228N=FK!3@ON[_:/&1$,T55AGO+
MO_.BRG_P^DB2?RJKZHOZ15E(&2XW[5*Y[M5GOOM-OJ_E=J<V!/Z!\T+=?K.5
M_F]Q_VZ_E?_]4I?\?U,?,T@J7P<\D MN$D,O"!A$1"[,TX F, B3E),4B\2L
M5?65]%@:#?]6;(\[@_+MV.,Z;_J7>ZG+WX!\<PQ]UFN]'GK\_1<P^L0S0=.W
M\02")BJ&@U^4&G^K3U7/E"!3>K:7@%97T"@+&FU7W9F@5-AQ"\?K6<Q]K\<K
MZ#)_4\CK&>QL]\@KBC-VE^8;OU?2?.6/:G05_W/8$GKSU/ZQ7M*L68@2WTL%
MI#X/(!*<PS3T(LA01L. $Y2$1J'O%C(L;7+K;Q"T<H*#%J?!@JII37M%LTU@
MN-JPL9CI/LTD=IAQC\:="49LSQB#.-'6C+X<5]J6,0;J\I:,^:-&K$T^2T7W
MVZU\Y.4=TE!2HA]E!!*&?(@H9Y D@0>Q+^(D89E'HLAX,:$Q\-((LO$&BX/@
M8&.[5ZT-O8&C[AC063SKH\RS;3V;8N7>I]49?'XGU "2LUZCR?V6V\??50.S
MZJ,Z\/LGI[M#C<!CY;_J \ZWOZO\Z%O1MLAIMK0_J.Z)JF_G;E\U?WI^8I=X
M3* @@C0))<>AB$MZBRF,&0]I('S)=5J%IN80=FF\V.JJRJ@?M#VLAWOZKH#2
M&-0J*P^GKM_912>KC=9&<=!HWEUAN(\]Y4NBN>V]$--/O4L^J=4GG0/FL)#;
M+?DI!9YW!W\&Z%]L^,\QIMV<UK1V_]:6\./5AQ^?\[?--"H'/\ZI:^%%01#'
M&0Q1YD$4A@+B*. 0>0%+(A&FG!JUOM0=>&ES32/WH>BAJ>.MC;<>U4^!XL2T
MW0)XE%GR\^_P\T=W[&H*BE.FU!Y\5M8SA>0Y@QG?;Y'#V+2A.&SYWN&?JC21
M"D0N5'V^-L&2Y?CF =_7C2;+8AU&.$(L]2&AB5#MW0.8>4) R9DB"Q(14J9%
M2]82+(V?5$"5G#IV&WZ,'U#/W^R[M"_*MSMU.J2RNQY+HUK7]G8:IK-9T)^:
MUSKQNP,Z98FZN-:I"JNZ^C4&/2VF!M\@Z7%J(\R4]CB%,<QR%,< .9BE:/7@
M^?(4Q^A]DJDXZD'N@V6.L0LL$U$<^0G$,4]4$_@(IIGP( ]B$H=!G*:IM]Z5
M.[P9']IB%XAR&'OJ[5-Z$ICPRZ8.-^!X6^3%?76(,-@-1!B,L0-!$8M##_I!
MI*9^S& 6^ '$"4JRF(6^S:F 4SO,=B1P53N,C^7YBT;>S!U <[UPEP4&IXP*
M)1D;^-%6OF4J]"K?\;:\7H Y\QA.8!"$*42A'THN"BF,,T[\C 4L3K3:H9Y]
M^M*(YRB?4?GI9Y!I+ O& #$Q1QQ%>[W2H 881@6X[4&9K>KV 1S<%"&1:\]=
M_G#Y?3$MMWT>@E=J;#^[:<["VN?E?59-^\)%=@[M\7'G:R[B?Y;;MQM<59^E
M(=LR\"FG@2 )@RQ4P1;$CV#&,P)]+$B6)'Y,F5$3,0L9ELMU<'.^TN@*U'J
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ML93 YK68IY[)L'M%%[PP5*'IBCI)H/AN47!(49Z%.912<F6%466%I9A#&:&
M2X[R/'=MS.)[2>;9S-XO2+LM<J! 7R'W!ZW#C[LN26.!X%Y6*6%A@/(D@;%$
MB7IU,(,T5J^.>G.(Q!RG81Q.EKZS[-0<DU?H93)R=JLG2:0X+E<O5193B!*)
M(4&"0)$S3H(H0RRE$V7;+#F3QG[EID^@F28Y9HF)+]Z);JJ,ER5DLRPZ4\53
M%LJ5&29<%*LWF[JHG][<BZUBV+M?MN5?]5<]&]D\K1)!,T6#F;+^4 R1P"&D
M>41A'LDHPIQE+#4R-"[,LS2#HA45]+*"5EC026O&89>@'><JCX!-S$F.6!D3
MCR$2)PBF$NRGN_+;?Z@1&F[Y)](_PO;'AE NC3T+<1@JV!.$Z>6.J6:/#P_K
M)S76?=%DL U*I_9;1FG(TXQC&(:Z*62DBUDRFD')"4NC.(AP:+5E=''&I9%#
M*S#82WQ87_;G\IX4&\MPNLNPFYDV7L&<F#BNQ-$^:\P4&[\)8Q=GG3=7S!2$
MHS0QXQO=B.<WP8O'^R]B>W]0+S= ,8L0A6F0ZY16GD*<)HILLH E*<&Y#*R.
MFT[.LC2":86$:JI[EZ*YIY$TXX^K\9F8,XZ@F6!?>A0#K]QP>J99^6!4V><<
M,'ZQ:Q_78?B*CFCI&@+W_8#??&=?-=-\4J[0Z^:GJKOX UT7;;K *L H"6/.
M899F@8[#BR 63$"4\)A*F@0X#ZW2A7Q(M31>>:<,1-;L",BNYS+K>R[7^SZ]
MMAUD?2R?&3G-OB@3DUFG3Q^TU\3LW>S^MA?YYKA']K %^2^ZH%6[Y>.SIZU'
MK#UWP/4AV<S]<CV">=Q=U^?@;B3>=/(L6"UX4TV@,SDD4YXBSA(H$Z;;[P8Q
MI(%@D+.<"A9@%J96QMO)699&LGLAV[(C=G1Z&D@S>KP:GHGI;H!,6SC$O^DV
M"H%7%CH]TZRL,JKL<Y88O]BAJ$=?#%=YA+38-"2RZP!+UN\V33"B_NV[35$7
M9'W+6/FXJ8O-7;-Y_; 6M=@72OJUW-QINU+7]%KA@&,<Y@P&*4T@BK%R^K)8
M0H;#,.,$,\2,\K(FEG-IS--K"@:JWH"!LF"@K6Y%T.@+]@J#O<:'A=.TUE"K
MW=1<LRB%,>%#,LZ)"UKZB5GU_ZY5MRB8LHS5GZG RHL_!7:E6*9?F]'2+1-.
M/U^IE^DQ/"@-,\-T]D?7MX^\4(_9>_5FK##! L5$PD F07LN19(\ADD2\X3'
M/%+_;GI4/1AW:5_Y3C2@93,_B!X"=?G@V5']B;]T1II;'2N?T-/Y&'DXUFS'
MQB<4&!X3G_IG^Y?L=?E-;'<U/M0[EK $Q5"Y]@*B,,@A9GJG%3&&\AB'+#)*
M=CX:>6DO6B.<=7V48\ NOV[.,$S\PADC8/72G=36^;4['&VV%^^D$L-7[_0%
MCNFXV_*M_KK^E]!I (+?JJ')79?F]^&QKFJRX>I#^W.Q?E3_O))A$ 8X)C!F
M7$+$,@Y)GH60$TE2*E,6)%;U""SG7]J+W(GE7N37%G^S[;H)49V8%Y3DH!$=
M]+*#3O@^_7<@_@WH%/"8"NR&G-\484L9YDT==@/H**78<1C7,X2FX%OU5JGS
MYKLB!N56O%;N0GFO..)VP[7+\&OQ38G1I$;^NB\5R66:1@F'893E$.4T@3@1
M"<PDR0@2*2:153*,JR!+X[U>#Z ?$-!K G:J +5ZK7O?: -:=:ZH+^F\@J;G
M&].OR^1'(-,MB<-AR75X>CY/<11FYB.7ZR [/I6Y<KPKBER=22AX)71PR"?!
MUJ2J"EFP9E-GGV)#A:0X(QD,)$40<1HH_R_/(.&1\O\H#VA,K(M=N<FR-,+]
M66R+;TK$;P*\+39DPXIFWU7Y ,T6< 64 :I3<G2=PW8;#/POP9N@^4^B#>:H
MOA;J;7(HD.6XFF;,.],:34R^!@E3M%$&'&DS32J5!UC]%]5RE&?^XEK7 7>R
MR-:50SJ6YB#55T7U^H\W_WQ4!++67/&Q7!?LZ8OX7K]2FO^YHD$0$)E', NP
M\ND1Q[KT5@QQG).(1$DL<ZM8&J-9ET:P35MD;2(U/PSD!JW@ED4\C( W8TCO
M<$Z]M7<.R9L.2O!']Z>6'C3B^RS]80.7WT(@1C//6Q;$!HRC(B%6-[LQU*]"
M69_BPT/3Y5H9I(*H-[WK"?'T^X8757/4)_B;[TQ=>GNO_[;",A=IFL<PIT$*
M$54F(TGB&*9$8)0+P3&W*J[N),72&$PK 8K[AV9#LE#2JL$-0RNN6PTS&IL<
MXXEIK97_!NPT (T*-V"GQ T8J@%:/4"KB#]^NPI'KWSG)LFL_'<56,_Y\+K!
M?*6P*'?]\?ZAL1)_KX1BYS73J?Q*H*/(:QV5_4%JRU.9G5T !=MJL5<Q(IG
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M8BX"*]8PGGEI1**K?I/-$V!#<:\^C3B#NO/!Q/58OL@917,"U':U56;(4 E
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M9Y]W2\L6E*/-*^L!W CK%5&/$1.?OPI1_UJV<>'-EDI.4Q$FF,,D9+IL3Q)
MS%D&690+F1!$4F'%3^<F6AH==7*"1E#02^JT67466S,:\H'8Q*SC!I8UQ5Q"
MPBNCG)UL5@*YI/)SOKAXO1L]G-@I?U_6@R.H@*6I0)) $:$0(LHIQ&&60V7>
M9(PSQDE$;&CBTH1+HXO#0Z<W9+M1GKCE,>!%D,WXPB=T$_/&V%&=EAG\,<E)
MG2E"7OGDXJ2S\HHI!,_YQ?@^A_VFVRA(@L]B4Y1;/69OK),@R@*<(A@)&4&$
MN80DY@D,>131E"FSA!CU'!Z98VELHH4$K93->V!()&,H&NPH78_-Q'1Q!(O+
M-M(9?"QVD*['::;-(_/'R&ZW:!R T8VB,[?.MT<T+OO!]M"%2Z\-SOK\M=S6
M?>!7$W.PHC@-I9H59@@GRHH*!*0!QC!)))(\#'% K8HGCTVV-,X;!O4TTK:1
MKVWH9B.QI=LUBK3A#I G_*;>]+D"NBO"G,YC,E$,TXD)7RA Z;SJYZ./1NYQ
MHY)W&[7,HJJ[IL.K-&%24I'!."4,(A)&D+*<PI2+ ''$.);2KC?ALQEL'OEY
M.@KV @+12FC'$,\!%'DH6(@SF(2)@"@5L<ZZ0C#+,-:5;5DB=L6'I@/PL-+'
M?RL S5CUBJ=J8B+=H?'F AK6K'E&9Z]$^7R.6;GQC(+/Z?#<96X,^&O!M">Z
MN;N]VXJV!6UGSHM0RCRC 8QBIBRI1#F---=%8BFF),5YR'.K^,JS,RW-C/JX
M+?DCJ\%6-]=MJWVM&]E-G<C+V)J]Y5X0F_A]W\D(]D).<#1V$0JO-'!^MED)
MX:+2SZGA\@W>BL(>%G%X3=9,1X6KJ=^+NFU.7;#N>GW$UF=']IDZGT3]N-U\
MT..(NEHEE"2IH!P&S1%^C$*(,T&AI 1E'.=,!%8UZ:86>&F4M4LRWC9B@G+3
ME!P$I)'VZHJS?A?;C/R6M(03<^CE2C>_-\VB]PH#75FN5WEWGU;Z9I]P_NLN
M]_63;ABN/-M/NZ>C"8J_'7\Z?!2YG63)IBZ#ZU?HERZ4.\D2&)32G69>MP_8
M[X,:KE_(]V[:JF\V6GT2U>-:R_96(7K+_OE85$6SBYT2$:,,QS"E*((HRS-(
M@I#",.8T0BA#86:51N JR-(^.#]\$MI&5I+]" CGC8R /PI=_);LQ;;[\CBO
MDMD790[L)_Y2#%70!29[ZJ_VS8W!3@V@Z0'<&JR&-=-?"Z57!G<69E9FOA:R
MYXQ[]7BNK@"MWVVJ>OO8-KQK]R*T@?%&2J&[9PI%[DR?S-V)5:ZX,TH4:<8B
M2R#*$PDQ0SF,49+R($41D:&=76\Q^](XLSE,*';2WZB?N[VRK;;/2 T>FL\B
M$!O+4I%VBV)J?T\$]>3&--4=,?<H[W8DM>S*/.ZE!WOQ?9K #JAYMF=M))C9
M.'4 Y]C2=!G$(9;FU6.E3-JJ>EW>TV+3Q!E\W);?"EV(EZS?;62YO6\; FX4
ML9+U+6/E8],SN GJ>5B+6NS+\3;9\CKGK"U=TKG"81813$0 (QH3B*B,(<T$
M@V&$F/H_QD5FM.\QE\!+H]2V7(7-+L=L2SO.LDM<L(F)N=<6#-2] 0.%P4!C
M3=N-SF"O--AK?7-0<+U]"O:J7]K8>)D'PB(\:F$/QDRQ5LMY0.QBN69<K='
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M0H$Y)ZD("4V-_-JQ29;&>7LY@184_-&*:7@>,PKG.'OY FGJ,Q9;?(R)QP2
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MB&Z6C</_KBBK?*;UNLS9\]ID--P7INUKL5QK/!95=]@Z66FN4,I(P!!,1!A
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MBF<0!3&&+,,2!EQO!3., LR(8U&$LX6:&BT9+6H#P.@BJTJDNS*$*V,R&#6
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MSI(8A13!6&0(HDPB2%-&8:1B&BJN4"R<.LSVE&-Z1"BAL0&7<@T66@.Y,FG
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MT)+5G.NNJYHHK1^"/S8J."[23E-C1Q%# 3XPAWC%VIEH^H#FE8F<!!B5JOI
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M&;%BUQ/C3(TXC:# 2 IJ44$EJT/0?@>DW93G$:B!V>PP1GU:9W2]?_9Y!7Y
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M^])3W,8Y"[U!=I[#[MSTM_CJ>\LG]VKL+O*-*-EZ>YKUDWY*VJT'DC-60*Q
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MG&W7V'.,H8 \,I48[-9^]%PW^X;R/Z7X*OE#55=M;*4#$BDR6L@"4)0@@*A
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MUP]T;G:"-8';+C#;(FS')0/B%IA*-I9&6U.[S?/AF<42EX'/^O>W.?(1?RL
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MO5M/;0QIC7.(;O>1LI@&>/L?F$M;NWQ.[>YCX!#/>V,Q4O1NC8E;J'[4[=[
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M33?7LT,#** )++U?S$_+>G@#X;H$)4L7DD$OD;'2(R.95*XC<Z(P4!48[NK
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MX<WB'&/V"<\<MR$C2,IEH(KUD02(BD3ALU32<ENI<>M><AI!SO'J7@PM^P8
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M=5$2[M^WWE%G"$UR-.<4RIP[P)@-&+$9-,D9'.5<.%'+O]Q/T+C=TX8\SQI
MX&WB9NM5:\ZI$U(0%\L<E^0S"4PXPL!&JS-E0M:YY_(@26//?AM X3\'T0'2
M;P]&6QLJ07I31M>%5"RQIJ[<956$)^.4EX$Y7ZGR;!\YS<'G$%4_#J #Y-X
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MUDIB#.PERH0D78;.E6F;5IER@3^*K&@L]\&JN#NWR!@=(\>J]?[=X0-EW !
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M(H\Z,]+-I](L-U2]L&F!(Q]AAPFG3Z"MKYVE]_@5%Q<XLUQH+WD&D7%38E7
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MX?2%@4]&@8_,6,U<+&Q8#.H8*OK5-?O(__[@RE,)I0-[^L,JY%I*MTG)>&S
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MR1+(X[C? 8A^^X*U)??BXQL,:WP___CI_+?RM_55&7%,T4OZ1X"<CFR57(3
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M^R[K"%PHQS4GLX*IJ^E0&3T8Q8S,DADQXE#![[*L8R\L#"_KV$<P4V<B/E.
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M0J[I+IY;<O9X 2Q>2)0>@VT3P1M.8Q<U)Z<Z:$<660=@?)AF=V<E*NG$60I
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M*#J%U-6=H4]<>A8]L, 2J$2,"JP(2*K6 !F'*-L,AWQQ%_-[R7SXQ?P^ N@
M2H_OB3V:2-M*0:Q#I96GOUQ"#HD[JZQ!K1]&,?[E+N;WDO&S%_/[,'S2B_FC
M,SF3%3(H:4$X51VDR"&080":JYIJIXLJ@^9[]I&8/76*VB$GX4E%V'=B-O?2
M2Q8\2(&TB85&"$9$R,@S)T;:$@;UQ?G73<S>"PO#$[/W$<S40=W=*<1*T]E@
MM8:8(JW$B0S.)P9&QZ"M22:I[SDQ>R]!#D_,WH>K'5A8>P00>1(F.&LA%R\O
M@\NNT*Z2Q@51$+U!UL3T^L[2V([Q$1N)JP,@;@LJ2UNT%3$"1VE 6<O .Z^
M)Q8STQS]L'*YL<*!G8<A#I3_L KUO831 :8VWLQU.Z@YKF>&!8V19;!."U#*
M(CBG#&!6Q"43$E.-QH<\H*1S$WX<%!W%_@[A\_IRTOJ,%:\#6D&F0B&>.$='
M?%0*R(2PF^F8V3>,03PFJ/-3KPV8#A%&%X4##Q?R=KE(5VOQS!4I0@!AZUP\
MGK%.;ZI-ZV@=3G C>)OFY-MI>C'986-BZT"1O+!6+'A^&>AKT(KEX:-;MF+9
MN8R)[K!%]!'I- -OA (5$R>E) F,Y/S]/_;>K,FM(TD3_2MC\^[=L2]F\T*R
MI!J.:;L4J^?V?4GSV$AT)0$6D"F)_>NO!W+/1";/ 4[@!"B954FD1.7QY0L/
M]_"M<(%989NNUCYSV(8+CYDC^!CJ&[+W$+RDRY]"XB ,L]FV\>&_Q1SV&&SM
MF<,>HZ^9GU'?K):;U?DBU9J@[Y876_.]??[3UA;I=8'B%"=?4UKPFJ)LIPOS
MH:A8)MS4_1P5G0>+>VA[-;'H.X3/31JM!%F*8F C*5L5BE@H=*F-69:)2.<N
M#EM7M#> YGY]GT:_7P','L+N(#)\PLF7[_Z(YY=IL?SP'XO;9>G:<!9).*P@
MN8ZE<,!: QZ$\R5I'TUL4T$SA+J^8+4/"E:-5=(!S$:$/]G5%S@ZA,+& (K5
M0;M&>BBEEMV*S%**\[A8XQ[GYTY;[W,9-E97!T"\BK!NGER$5MS4%SQ;>*93
MA RPU/19,,4;I0,VFHW]@(S.?:L]=;V:2O#=H.;>8TH(DLZ7<N!<T&3521+.
ME422T*$4@5$WB@,?4]*Y*9H2.WN*OQOXG"6N.4_10U8F@7(YD$56&E"D:"PO
M,9E!95E[@N9D'M</A\HH47< D!W9 )ZR*IE%,"F2WRB$!]3)@XZZ>+21!]<&
M+'MF97IX.3\$. >JH"\0W3.5R+*/(DB"?GUD\ZR XPRA3FOT=,T6[QOMK]\[
M"=-#._5$4-I3$7VAZ4Q(QA1%$X1\RT#QJ,'78#/*I(6P*&VCL5]CZPQZ:).>
M"#FCA#YW>>9NH?QZ^>D3KA?_G=/WBR4NXP+/WR[+:OUIJ[;;=->9P!!9\ 5B
MYJ4.4;$4I!8+5N9@/09G[;#RS8/(.)GVYWT =F0MG5;^^*HG_%?Z\;G^?OHL
M\C,?:)A+'L+23!EE1K&;U2I 04FAOR'7W&6KP(0<)./)9=GF,NDSHTQAJT5>
M/##-=1W.0Y%*(@<A&:43"<-@H['1WV)&>0RV]LPHC]%7ARG!;=H+G9=8 ^/L
ML&ZPH\#&:<P@%==1DC=JW* C^.UGE$=I>TA&>8SH.X3/3<<)>1Y.L01)^UI+
M5AR@8^2"D".0'%:'8-"[^;>741ZEWV$9Y3'"[B!P')2^9%9KC5:"#$[7'<D.
M GE1%.OP9(3,TDG=Y-8[V8SR*!3LDU$>HY(.8#8B8)))EIHP(($)I#/)!'BI
M)'D%UI9$;#$WJ /USYY1WN<R;*RN#H#X+O^6EY=Y<Y:2U10$1]")CJFJM=7!
MY5J2D3B+SB?KVE3)W%#0N4>UIX97$XB[BW:)OZ]7F\TOZU597)P5)CP+HD"1
MU4U01H&S#B')VIC&DV:A39'+/2(ZMSG3P&5?H7=@6!Z.*J0[_&*QO*0K^^?/
M>7TU?OIU+JMUOOIS[_&/O/GN#XJ#27.+99T 7(57$Q#T7Q)I])D/;Y=$'@GX
M+#EMC!;D0R@7*5"FP^-<L,"-#D*H4')HXW\U9.ID\MN'X+D74'1P/JY.=17%
M&7KKZD@"P.V3N"-A!B9)HB9C-EG;DMLDR^]H.)DD^2'HVU/D$UZ_TR8$_KY:
MI=\7Y^>X3-O.N;=UUO^'!3F[USFA/7( 7_V94SS[CR-\HI?^FX^^6J;'W_O;
M8A//5YO+=;Y]BU6J1"MB 2Y<W>M(]RX2)D"H7!2/:-&TZ2T>1>;!3MV0C[TG
M!;RF_^J?9Z(D)FJW.%=:7PT6#I;B**2 /G$,(><VK_WCZ)PWDFB'LR?>83OM
MG:S-V\;Z32S?]4\^AOW;Q<0L5M!BD$Y0E)I%5J *_<H56PN=4:0DA$?7IA'^
MJ%;PSOVX^>S=H7$.M>96@\F%SJ?B%KPC>@T/-G+D1=G6PY:>$'5*]FT,@IY_
M=3M,+UV\G]PQ\_UBN;C(/RQ^RT\$N#WX=TQ24*\PI@@&C0'%2(+>25\':X0B
M;9#X>#+<Y. ;3.R\[S%S@+*-'F<%Z[;0BL*DNO'DW>+#QVVQP@^+F)>;O'G]
MY3W=5?@Y7UXLXAN\R!]6ZR^/.+69<XLB@*_M@RJ$ D$J\C$TR9="*Y1LV"J:
M XB8]R6E/1*/JJ0.7DI>.&>O/JW6%XO_WBKWNS\^5PD\XC7(%+SU#"*K[P4<
M&82@MQOO4O:N\,C;F-!#J)[W->9XMO1HFNT Q3?WQNJE>^/[RUH1]G7>4W;6
M)*,I@,L)*)P3@-Y*R"&0_\.X3XWF]T_)Q;S=%,?W&(ZN^4[KF+\6_?Z$ZYH,
M^"T?4,H\^AO'".M?9FR6 #\APQ"1SKG*F> 4!+A8!XEF-%*+.N/H&WCFO//9
M7U]N%LN\V;R*_[I<;!97*:<O]WYW52N2M(PVY *1UP$81M=AACQ2G*FC<^2Z
M"]VZYF88I:?T%# &:\]'70TTV(%W\/S^&;+WSF0!ANG:=V<1 M8I8RR8C,YG
MQ]H\N?>^_JD%#@8O@AJAE$[!=5V7&<AC$'3ZB'X?0 E9P&LD\5A>' L:96DS
M">+T%D&-T?GP15!C%- !E+9^S76'^;UVS^LB7,=#](5+\#X0,Z'*2-H !J7R
M*OL8&B5-7R2K/T#MH_M=HW(G440'J-IAR[=GCB6*;Z*4$.MKJ4)?!90<:"-+
M"CI&[AJMJ=M-4"\UA\>X^R902:?(JK]<YYOU,^@I9BQ"T5%)&E0,#KST=:"K
MRR8X(W0C5_^KI,ULMZ8 P !0[:^-N<<&O,N;SXMU_1-?4CZGL'[]Y?,Y7M3F
M\YNF%,%<1++ 5B?BH:X!=$I1V)-\]BX8C?I1\OB9;,A7/]4?5@[0ZZJ9D&?N
M2;SM:/\UYB6N%ZOMB0K&"E/W((NH*2Y.)):0,@<M<TF69:&E'6*!ANT[W$5"
M+[7'#>^U:<0_-WZNZ?['<O,YQT59Y'1]OK2U5@1;ZH917K>=90A:E6JDZR#7
ME**;;LKVLV3,N*'P<-6NII;SW/?3VV5<9]P0[8M-7%TN+]Z1C*[Y2#(RYHVD
M\)5B R5R ,S*0>84YYI4A$UZT,WTPD?FW%<YB?Y6#80Y-RC>Y5HV0#I8+-_G
M]:?%$L__ \\O\]_7J]\O/MYC*F=RYKC2(%-ME\2,X+#0!6N9#58Y5]0PA S]
MXCS!52.X-!%S!_'4CW0&+M=;2_MV^?GRXCW]=U=A =V\42&O*Q15W?)*=W+=
MBV%5?>%(TK+8ID[R.8IZZ6@Y0JP^B5(Z!=?-4YES@MNLZRM9W2I%XD$;6)WA
M94I),A.#1X-7#^'Y-#H? *0]%- AE.[?VC=QHY-)8$D0BZ%SEDHF044'@E@*
MB8R[2X/"KH,A]92V_J"U#PJ^ JX#5=(AR'Y8+3_4V_ZZR?_NKK]F+WCFC(D&
MBMK6[L@$'D,!SXTAG\EZG=K,CAM)Z+S/W$>"WY3*FMNI?\S;=YN+Q:<Z+N<]
M_G&?)6T2+XY8BI)\C&RP5J ;,-DSD9P2ZO&(CV=<^F'?F_=5:6(8M9)SAV;L
MN["X2/CCY?G%XO/Y#4^.^+&^.+ \UUREIIB(B &&*'Q2P:LC^?>[J)O7US^2
MP3I8+1U"[<W5'(=?Z!\M+F\>](UW*B91=TYQ"Y4'"HE1D!=@HI))9Y_;K+49
M0MV\1<M'@MK!:NGM0KQY@_G/C.OG+OPBB\A<<_">4^"DR?GT@N(H14&38U[)
MLN?M..#C\XZ'/\95.;4&>D/8[8/?V^405GD(21HD:8I:H&,KJ]H$2$6C4T;D
MS(=EA@^C8]ZI\<? 74.]] ;!FQ3%V^6.T%IKATX6"1@$"=118..Y5,!C-L%+
MI]GC)1@# ??25P?!RYTRO":3>0?.V6T.]>;)^M?\X6I@>7U7M'3[NUP7-2AM
MZJ"23-<_JVL<.,M,"HPY-/'*7B2KEXT\1WCEGTX]/6#MBO;KXZBX1*LCN98H
M:G^\I>-H0@&MDQ'6119%H[WT]\F8N;-A.O4^!L[>LI[[AOMIM;[X^.I37B\B
M_CTOZ]]O*IPM'20G%<4@60L@X=C:PTZN8T&356$B1SGH/GO^&S/C87^MK:87
M84](^+4FZ?&\C@F\"DP9"T6&#)RBA[JCFEB(O- UJYV+FNLG+?X#H/#H(S-7
M?D^/A4.$.#<8OKM<KS[G:Z'<I(ZRXR*B@B1<'3!/WCO&Y" I3[^Q1J =YM_N
M^.$SET=.H_Q#A3:WTM_ES<6J_-_5^CP]9$+(;$PAMUH(<J=4;='"8@W$*$KM
MU>+"?;5=_,4OS%Q),HWZ)Q'?W!AX8, ><E&"5S5;EU.]RY*7X&SR@"XFKY)*
M])OQ=\!H%+2+-!K< 'L+<&X8_!_\C,M7E[6M_'R!KY;II_S[_Y=KG]TC;'OA
MDF!DT#@/A&U?-(7BB8P<TSE2 &Z*LH-0,?2+,Z_YG 8D3<3;0<SYPO25UU]^
MQ/]:K=^<X^8JWDJ*)[**"2BZ"G0<@B0Q6@9(G GNI"6WJ$E$.H+(7G;*'N'M
MHY7J^D;E'6,_X:>;ITM5IP+7UEYGS+9,F!QU9ND,!ELD2RA=:O,.-Y+0>:/G
M9H 9#LR#M=<!.*^F"BZ6'UY]6.?MZ]3MXT%0)17GP8=ZNTC4X'-"4#%[;J2/
MTK>!X;,D=0NXPX'P9,_V%%KI %YOERF7$2?5:>5=,09,5*YFYR*XG ,8)5RT
M.F=6!G6YC0;=2$)[6<9]A)NYI0K[1^C.HVT8#Z8V),=2/"A.$;5C)-/BDO1.
M.RYCFY%->Q [K]%L"IYQ0#U8DUV ]9?U*M)Y?T=J)$H^4NSVM_Q;/E]]OA>U
M69$#TQ2P65GHCBC20KUMR/%QWDMAD.=61G0 >5T#\G"0/ 'EU!KK8M;]S5S
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M9Q! _$F[#A,JI$M87;O>0DL?C&60%2.!:/J+=V0G=;+&"U-D%&V:T)ZC:-[
M> IM?Q5 >XB^3PA=MP+D] 8W'[\_7_U^TUT2,25+\9=TJGIMRH'/NFZPT;(D
MEQ'=H'AF"E ]0V-O,-L'$U\'VA0*Z@!Z+R2=?KC=F,U-1B&\@QAX7;O@$X2B
M,S L4@M,3#>:<S*$NF%P8]_$C3FYMOI&X$_YXDQ;SIDC5]7Y2-P$Y0%CB9"4
M424%F9AM<XN^3%>WJ>(]<3 <:&.5T@'$;D[FF]6GL%ANM?0NQ]6'Y>*_B;]$
M E^4!=XMCKL:/)RV.Q%OY^+3O[O\=%\<FS.!WGN6#/C@ZDAB0U=*5 (2A;^L
M)*NL:?,JW8BA>9^WFX.Z!QATD5QY^^DS+M8U/?1S>2SJNR1#'96=OOLCGE^F
MQ?+#33+@3,I$UQ4=]F#KNZ&M:0!7Y],8XXQSEOSY-M/N#Z%ZWOZ+YL@^FD([
M,.8O\?K]'9]G(GCRQ1TA:3O4/4@&*(V"D+T.PN;,?9O%\P,)G+<G9%9([JNF
M#M"WXPZIHV[H/!&G]*O-@O1VO??QZL[X<B9$B3DQ T'4F81&T=ERQ&<,DOZ%
M=SKZ1@O8QA,[;X_*'"[ I.J;NZ]E#_Y^P2_;^L\S'J31-B!DI8A/D1SXNJ V
M*&%"*=KQ-&QZT0%$S-N0T Q^1]5-AQ@<XF;C;C?[Y9*71[-4SH*/*14ZH=)J
M#XH)2UY-E)!E$3+Y&!.6?3%\+";F+?T]^AGH$AL=>!I?8>^I'U\<.>H::QM=
M8* 2)R?*LP*EMF*F2!=7G*6T?;]@K%EU5'O/MZ7B.@#F#=U7'GY.KV*\_'1Y
M7H?8WCG]/ZPVFS,LQ0ME+2#6B1"1!6(LZ'IUA:Q2E,&UZ? 93.*\V?;F4&RC
MJ@XP^"Y_7JVKZ_0/DN"K3S43]W/YGAC:KDAYNZ1#1K?,S^4-KM=?:IO3]H^<
M&<-+\"(!%['.YG,4;")= 3&SI!CCW.HVV=/]Z)TYM=4<GD?08F]8_26O8U7B
MASR$4Y'K- T30 MCZ].<!)]M 8M>*>:D4*7-R.S]:1Z&V=/-C!U)FW,'<8]O
MCC<?:_G@8GDSKYXX7ZS2F1'>UJ90.HI*@>)(KDO=OE%B8<DK79(:]F8P['O#
MP'5Z&:I6(N\+1=79>)\W%T\B,\/(Z3616#+&@3(H261%0+;):%8<DV[8Y*UA
MWQN&HM/+!K42^=PHNF=9B?1-7;MRL6OMROWIS&?6"QF]-[6]T]>\0@1DP8$.
M2>>BB,4L!F%JGZ\/0]CI)7>.HXZY\3;L"-V.!3^3)47MK(2ZUASH$@^ =)E#
MM#)B,C84@Q.:K]L/#T/9Z25KFBOA- !V,QC\S&J6BP@%<G+U\3_3V1'%@PE"
MVL@D9W;8'M5QWQT&KQ--QC1400<AY]W38O 8;8@@3"TQ15?'<R*"IO"Y2.MX
M'K88?N\7N&$@.KULQD&2[L_^//$/DV&,(9E39NO#M/0>G$L:3.*,.9.Y#L,2
M:5__UC"(G%X^H(6H^T=.]?K.;'26((^ /M4-&46#X]9#"NBB-8Z<OF&[:89]
M;QB"3N\9OY7()T/1__KW)Q(GCO^Y_5?;?U/_JW>Y_(_Z]W^\>_O@Y_^VP(OU
M8O-O<?7IZJ??<(K+]//%Q[Q^+,RK!Y'-8OGP7>WG<O,?_BU?X.)\\Y#-S>+3
MY_.OCF^>[-O_?L?\8[%<D_ $>T<21/[C(B]33O]S&M_BU?()VFM3U/FJ8O-5
MJ+-?X\59MIG9% (85M?D,,O .Q4@E^BQ>&^-;3NX91"9!^\BN6T"NOGL5:\/
M+P*-]+7%6K/:ZQ,@(//TEQ18B!%+;+-S_!F"YNU::8><)_M*)M!'!V[\RPM=
M4'J3BRG@!+&@7-X6S9+;&8KSQ@DI'R^ ZV:=4KN5)U,H?M36I#%:Z %2#P9\
M1\=2E-J"U99<3R8S8,$(7D>AB]?./RZ7^[-M31JEWA>W)HV1]=QN_O4 N9Q^
MQ/4_R3P_'-HNDPH"G852ZHC86B:"C 2CDRK:.!.*'_:T_N)G>MJ=-$IWJR:"
MG!L2?U]G.B?K-Q\7RT=['Y)"BE)+@>AK^ULN"9PN :2(3%HO;#8#GPJ>^T1/
MJY/VAL(T IP;!H,W.QCC?8J.N/"&F"I*@%=D0M%D2W>PK),$!Z%BTL491UJQ
MM#=(FHAW;LQ\]RFO/U"4NM,&"FV,LBI"9D&0#51TU28FP663$A;MLQFV>^FE
MK_2T?VEO;$PFQ@[<T!OO_.Y]+#F-Y(A+B"65NDA,@W.ZSI)C402RB<*U:2M^
M0LK,MTV#".8P:7<$E[^O:ZTRG1'!+%-7[KC*OC8L%P:V*)6D"M*Q-J\J#\CH
MXRUE3Y4^ Y#Q\MT;')^WU6P4?*TOCMR54 +97!\RV"0"79V.0Z@)W:S)#RO6
MDA5M4P0^;5=",PO4!EK3ZF4\[/P5[);Y0_WT+XW0=V;K2@&C'>1D.=!YL76R
M9H2$PMI4QRE@!PGW9FYP&^R,DFI'U]5-^^+?+M?DMUW7[TH7"Q?9D'\6R+I*
M72"4I*!([72RGD779B[%2U3-ZR"W0<W!TN\(2>_7N-R<7REDF7ZY7,>/N,ED
M2VO>KR8 TW]1T'C5*XY*N!1#W?"0,BBDOZ *'#A7U7<4.O$VC[I[$#OON(DV
MN&NEJX[@>.4GNK2M.$@0%8E(9>X@4& ")GH42-&M3K(3/[Q9E6)+/WR,? _T
MP[];INGM%5&QH:N;N82>0>$HZ.H.A8()#, UQY@STLW>9KSV$U+FG:O0T-:,
MEG-'EN3K88'UP145$8*/KG8F"_":6 R:)S1*([JV%233A&O-ZA?G"M?&Z&6:
M<&UJ(W7&=(FE[C$261M0-B<(R0EP6?NZ'(5KT19:\XX?:!2LC9'JS-?6<S-I
M?EFO?EMLZ!=X_G995NM/VW_Z=KFX6.#YG2?W=AE7M;CP(M_Y=+=BR"):5Y@E
M7PX]*.,">#+&$&TD7T\EH?#1,]/P4403T#?S;(%IL->+_DZUH):X7RUK(+)Z
M,J.Q92WM@,\>I8QV+/LS5="RZ$NFP-#7]@ C(@3#$4R0:+DKR=FVV8ZC5- ^
M7T/_CTTNEV0G2CXST90:$E&,+%G-3@02"D_ ?>0&A:$+ILW+_1#J^L@'38^I
MX:/A]]14%R.Q7^CAN K&+=G[5*R&%!/%5]K%FG\EUX;\FZ2]-_SX>PB&OW\T
M3Q;-B;L]--0[YNZ%7:\^U7DS_[W5Z)G2RA?G"C"9ZPY6B>"]38 EIE!*P%;I
MI?&T]I&(FA674VBQ=Z36=2"B\.RKE\RE5* 4B<_%+, Z#$8S:SVVB:,GV-'2
M/*DU*P+':F?_0&9U@>?SS#VEF)$';Q*(;"TH40<BE<0I6LO.^* T,VUNYB9S
M3YLGN]KCL:D&.WB[WNE^/.4*M2]6!0-6L5K6'0V$N@XNRE"(,RU:-?\-HZ^/
MO-DQT#BYMKJPDD\,_5.>#$97F/+ $&L"T5D(HD@(SB7).7D;C2K=AE#71SKN
M^/@[6%.3H>^XCXV_K%=U5M.[Q8>/%YOM0/>8EYL<OKRG/XR?\^7%(KXA5_G#
M:OVEX>/C/F0<XS'R8/',\CCI,RIE4X;$=:RY'D>0+0@H8K9*Z<Q/N;U_FUZX
M*\A_H*)7MRK:O'Z@HW/<;*Y*]GW4QI4L 6VLJXV0T:&.%E)DVF!QG*=A?9)[
MDW!*;Y)CH/0@_W,<!77@=[X0Y[W^\B/^UVJ]Y6W;MRR+L<0+!\&CI* O*Z K
MQ@)RZ5BQ)2=Q](>BQT3.@\YC8F9XH'Z0 OO&YAUC/^&GFVW<=8*'C+7G=5LD
MH!V)$64"FS,=]51B%&U60XPDM-L]OX<!9C@P#]9>!^"\.M.U]/;#.F]G/6QN
MVFA]3O2_ CDG!\H%<KF##""9S19908UM9J@\2U*W@#L<"*L66ID17IOUQ=GU
M]?'S^M>\_HT8VAY%%7U*P8DZ):3>$8&.(C,,<FUPRCHXSP:U>- '[B&*?O<8
M3<]1,$].<(:;=1(5] &A*J)K#C;7ITN)[')Q"3+69I7,,M3^<(@IV6AD1.<'
MO6R/P=%3,N:Q2--H]BE,#A3SW+,47J]QF6[L)/>ZU.5,H&/=:.=\!,=9W4,N
M4O',:*8>-6 \5V)X[Z?.KNY#-;2:0EQSZ_G-MC#QC[__OR2,UXO59O%I<8[K
M&TY*<))A<,#$=EN7"> 364XKE4-T@?[IL*$9+WYFGEND$1*F$^C<T/A[7N;U
M(MZ2;E-="9/ %8MU'XP$AT63"Z:"('Q+I_T@+#S\N?.4;S12_@$BZR!\^<J$
M.J,EWX9\3I.SK&O60!@.W%IM5;$^^U['0$X.GQG?=J934@^(>S"QR#*Z.;UW
M8(VL \J-!%]8/85,9V6"]C*W0=C)3(D<H]X7IT2.D?7<%]'+PPUUXER37P5!
MUBNUIC0QR@A%9L5=0/*_OK$ID:-T-WQ*Y!A!S@V)YX<<"KI4K:?K5N.VQB>3
M;64<(2<IE!-"<SUPQ]LI3(G<&PK3"'!N& P>8R@YRUY%!T)$0TQI#9B$ RX#
MV<Q8YU -6VUTBE,B]P9)$_'.C9F7QQN6I#B+K+X(^SHBE6R@(L],IA $DN^>
M6!B$DU.9$KDW-B83X]QXV,>-_^&VFY1)RX4G\TA_(_DYQ0"S%V!82 %%##P,
MV\EW$!GS(&J&*.C(&NL@1/I*T7UANF@1"]A0QW5R#'32G *GN$8Z93[E1Z\R
M_;1$]%-RL2<ZQO5'C%'5B39ZW^\^^NZ/SU7:#4LL7_C:,2HIAS([2\$DXUF4
MP ID9<FXZBS $?J@,"LR7?"(C8>S'7D?T@MG[^JV"<(H+XV&HL@O4470O<,*
M73G:%IN0+ARMFPAD.(VG5$4Y!E_/;TV:5&L=7-9?Z4AZ4DME770L!P56*7XU
MP@8]!=SHM$HE)/2QS8OG2$)[6;8T+5[&M9,=I+S^L;FS[*IP*XT*DKA#8E$3
MLR%EA&Q,ECX%[Q[/%CH./ONKH&P*GG% /5B378"5G/>8-YMWI$:BY"/=2M>O
MU_>>&:)1$AF%C(JQFDWW!;S3$AR//%@,6C=*20XBKVM '@Z2)Z"<6F.]3R2X
M"QIETIYG9B$)ZT"AL!3490LYHN N"E%DFP[<(=3ULF:DZ=T]N9HZL('WX\N?
MGPP..TN1I!*3@FA37:%1$W=6&' FJ%Q4YB6VZ6QXF:YNZ\KWQ,&JF5(Z@-C=
MJ-6GO-Q=(.=5G$][B;GVQFB&8$PRH*3(X'TM<U0R&ZZ1Y]RF)_,0JN>UALWA
M>32%=@[>[^_X/,M>H*1S21P%3_>*%> P23 BD%<CK2W^^#B]1^"\J>)9(;FO
MFCI W]TDU^]7ZP=3MS)YM(4%#5ICK=1R#)PV=9R#4=&0+XVF3=#\+$GS)IS;
MW\F3J.)$4RY?^_??7UY<KC/>DTINGI@YF*9CI&^F%=PL21[NF"&'4H!V9"A5
MW<K@4\K /4-KLY6RD:7I9&3OKA3<3Z2)][_G\]_RCZOEQ<?-F4DHC:S)W%S#
M2E;JL%B-$!0:G9B5QH@F0CJ,[E-*!HW!X9BQEA-KMP.O81RW_YEQ_?[WU9GC
M(B3A.11K2+Z^9+H<)=8%/47[D!S=G1U ^)K<4QH4?#SD[J/+TP0L(3#77?,F
M1YOI(,8,2BD*([GWX *Y$<(I%UV;^H,]"3ZE*<)'!NUH?9XD;+]?7:[/HB[1
M:F? ,EWJ;4*'DY.@BS?!1^NYT\<?>_T\O:<T>/BXH!VMS=/$+/W9,XL"2_02
MA*Y<>I7!.R2$*8XJ%,.U[ :S]&=/:3CQD3$[5IN=OE@0Y[B,B[H2B>1XN>U>
MI"#[W6+SSQ]QB1^V[8W[/#L,^\%3O!WLP<)$#P!_R^O%;T3P;_G>IPFM_SNG
MVFWQ*M*_6EPL\DZX6KJ@):?@1Y>ZO3I:"%)3:*0M\\X4Q66;<H@#B)[ :#[1
MU-U7WI-67M,?_^=9*IB+X SH_ I0)I.4BE"@8S:)1:V8;?8*,(3 ></]8Z%N
MAY&<7'NG;!6WA1![/<F.^?%'LY"[V.G 3AIF)%WLFHZJJMUI=<HV4FB3<C%)
M>A4,MJFZG=-.XF+]'WA^23_[EHC-Z]K*&?.O'W.^^*'^"$+!ZR]W?^#-:KG]
M^'OZR.LOUU3^+6\6'Z[6'U[5[7!;>[5< N:Q3M&+$D+=C"230V$+>=J\D6EM
MQM/I6N,QV'YBC?O 2 >AV%,VMD6[163'M79@=23AHHK@63102K$JL6*<PB9(
MWTW/S*56G:!E-;GJN@3@=8EN,C$$)$\H6TX^%JLU.DI*T%B\YEF@9&VB_><H
MFA>$4VC[JP#:0_0=0.B&@9Q>;:YYNKM.KLNQ691>2&D@F%ISHX(&S-: X*XH
M:SR=P4$#9/?PA+Y*7&_ V@<%J[8JZ0!E/ZW(F;_AZIJ%8)DR)G+@SF<@HAT$
M7F<WB^*9*BDZV:;@;@<Q\R8CFZ#H4)%W@)J='N[?23 _K#:;6[_@73[?RFSS
M<?%Y:]:9T=Q&<@E0! '*9TEFW9&53R)XEGTIL0VP]J-WYEKC/OVS(ZB^ X#O
M8./ZY&NQ':PC094J.XX&4$<-B<L<?&8H;9N!'<^2U&&P.S$>=GMX!RJG Y3=
M'O%KCF[6&MA<!.,>>%W3H9Q*X&LQ?^;T#Y$I&5*CVHN=]'3AR!VJ[.>>2O:7
M?!?MC3_EB[=+NA>VU=,/>;$F\9A8A"A=H!,F+812! 3A7!3:"*/;-#4^3U,7
MSMS$2)I( QU8HS>X^?C]^>KWATP$\CQE% R$JCM68BT<LJ)0>).=Y(%I:=N\
MF>TD9]XRKS8(.ESN79BB.T?@A]NND!!RH'BX@+5UKJ072."W#$+0P4OGN/5M
M>EQW$#-SFU;OWOQ^2NO ;-UUJ-^,W'X5_W6YV"RV1_3UEWN_J_(D"9*ZZ%>;
M!6G\2HRW>6I7/!>U9]U*1F&X$!*<RXF\4EY,)EN>=)L =4(F>@D']@34L[.F
MCJO=KH"],\9ZN[R=-;\=SG"5SO]E=26,6WMSQW[V.<4Z%=S;NIQ:: %HL@<;
M+/<Q<B9BFSSOQ(S,ZT6V _CQM=R%W_ 5 =P\)3PCB+PNJ_6G>HO>B8!9CSJ%
M"#S6Q]E2 F")%B+F4"1G4=E!Z]"F!OIX5N;U68X,]<::[@SLMT?WNJ:XCK?%
ML#C?%H;\F+%6A:2?E^]RO%ROZ5I[C9O%U:"=>Q<:!J==LB S_449;<!%NM^\
MY%9SBD1T:;1P94HVYNV": ?R8VNX,X"_^@T7YY6;[U?K7_$\_UKYW/).'*_H
M3)\O[H*8.XZC=SY8E4"S2-&,"0C.> 59Y1(T9]HT&HA]*.7S-D:T@_$1]-B!
MLWWWAK?93M5;E$5.K[_<1."7>/XC7E2^O_R-[J;'IU05Z2R/0/$VIVO(>_",
M&>#""F:L5$&UP>PA5 _"JSD5O!Y-?Z=<GOX3KM=;F1\P.V2_#QVM9/UE%CLH
M7B^!,QE,J#LEZTNQ5!!X7;7CDTX.*6@3;6S%C,7K=Y^^>K$L"5'EZ$%[)*_&
MR@"A8 1CBT\H?,A"-I;!B9>)CT'1\V^^X[71P4U][3E7:;U=?K[</HY?%8TR
M4^B&B$!_%: TLX I%7([1/9:BE)$FX3G<Q3U J\]U+QJ(/-.L7.=P7,6F?>%
MD[>!6)=^"T"OL*Y 8RP(XWBC@1?/TS0O?J;1^0 @[:& #J%4C?3J<GGQCMS+
MFX6<VO-85R^6^AZKHJDS\3 !'3TRW^A+<,<Q2$]IZP]:^Z#@*^ Z4"4=@&Q7
M@OAJ_8#A.6#*$'6HK_P^T_&S!7),)BHAE;)MK-5S%/62E#G\KIM$YIUBYZ9Z
MO4CDG"RX\SK7VA(.&!."D2PFF:,VLLT\LN=IFM<@3:/S 4#:0P%S[]=\)JU^
M;5!+U"G:HFKG Z= A"=PP22(00HF72SQ\7/M,_LS7_Q,?^C81Y&K)E+MP-1L
MYZ_^M%K61 9Q]"#-L>5'N>QM2@S(;0QU2ZT&-,J"SM+0/T[H&DWO^!IE\UY;
M$P.KB3IZ@=>;YYAA/'@7BH3,0IVX)!%0. TI9R^"SRZ7-C6&+Y(U;^:^); F
M440'J'J[C*M/^;;4X,&USQ-2K)$LA;B.0EQ99]D'%LD!*%H$9#F4-EW:+Q#5
M2RW(X1[V5)+O%T0WP:SF1"Z96"UK,*M*!"S5V-KD6'2*!=?FG?M%LN;>:S:1
M\H>!:@]-= "KK:&]'BUXTTSBF.>E&%#9U4A$>K+;(0-+.@11T-,UWNZ:>T!+
MEP#:1]&[KK?]I=Y%_<VNI%+-D&[/EPN8C78*0I:,A",M.*<-".]3#%PA*VWB
M_I>HZJ7\Z_![;3+9=V"!=C>A7!\R@3D6'@R4;54:YP5<3AJ\T:SH:#,W;=RC
MEZCJ)=MVJ.Z?!=6!BN@ 5"_T2E+@0-$#S[5LG8*'6M/KZ^1>H0QG3JHL7)M2
MU@.[58\ J$/U/KQA=8P2.H#3VR7]+&*DYG=^_1T_W\2A&JU/5D%D=MMV6P!5
MR8 A6<>-*:DTVA>WDYY>,B,3PV@"X7< H1]6RP_TTS[]+8=["6[DNB8*04A)
MP8>,$EP2"HI2/*C(&?V<)@#:14TO9<6'NT<'R[I#O%P?)"LHOO!U<C)CCL12
M*U<+"Q3'BBB#"$ZI-@[1;GKFO;D.U_-7@+.'T#N SJ]YN5BM?UI=W#Z81BGK
MH,,$'ID'%31=O)P'TK62+ GT*-J,5GA"2E^ V4>_C]L7#A)V)Y%\N+B+);:'
M2&IRSA0Y9,;4O$W2%I!)!XXK%HTK#%VK!0&/:>FE>V"*J/T@.7=@61YR\!-^
MNCE!%'.:&+4&4V0F/K(!%S('A4[Z)#V7LM5XT-T4S1U2':;I%X&SI]CGKNYX
M11IDWUVN5T\MIF?9>5>7[\;Z!L\,V4[%&&2,SA5O9,J/:LR>*>UX_AL]X6%?
M!:ZFEV8/H!"[V7 Z,QF] 5%$?2*@^]B[G(%GJQ7*5)3]:@O15[XQ=\#< A03
M2+,'4*C=;!AEA'9(43X&1M<O227D(,''Q"6BM,K&P:#8_8VYL]\M0#&!-'L$
M!6="WK 2LF$Y.G+A0VT")@_-F92!*2]X\B+ZQXMO1P#C[CMSIY". 8X]I=H#
M0/1NG&>?-+.BCJ9!33A/#KQ7$K@H,69; O+A_L7N;\S]>-8"&!-(LP=0N*<L
MD&'S(C,*S(N5H)0FA,LZ1+$$%@.Y2"')P8!X^O/G#EE;@.% *?8 !+L;S\+X
M@)8'D+'.L4)IP&<"-1<A^"(2IWA_,!AV?V,0(.QI 6(":78 "OF,OVQL%,$J
MK!L7R#62 :'&52"D2L8J[TQP0T'QS#<&@<*=%"BFD&8'H!#NF2 J:$T*UG5F
M!QD\9PLXSQ!*\39RNA7SF&MC?U#XDP+%%-+L 13L^_,5UE::FHBN+-UG1BJ-
M65(495T=[()1$5NF3G8GH^>3$_;QL(V7GK!>^-*PARQV6@B93+1SX^0>RM__
MOGK_<759!\>\_YUD]>4]Z3W+?^-"_Y+7,=_N<8K!DJ18A,12!)41(1!;8&+Q
MR$(JVNM!T-GCX\/0=$+OHJT5,&O";LOA?W[WT_N\_O3#"F]Z^+*021J7H:1,
M+I?T#ERD4#T8(]#:I%"G00!Z\J.'P>.$7D@/$UX'&;AGUA@*A^1@17*SZWAV
M%2@><R@5I,AC\DX7YMM4HAVP;[1AO#-=SG8">7>)FNN#A,&Q) J)AOY6^1#@
M,4:0(CK).3<EMFEI/*DEH:.T/71)Z!C1=P"A(1LILR-I\$""\:(N*&%TT&0A
M!S\)([@H1?DV94:GNR1T% KV6!(Z1B4=H&S'ZH7M"8S"1V5XAFQ<340HXL!K
M! Q::1]*YKH-LIXA:.ZWFPF'T$P@\4Z!4W])'O_U2<L"HXXI %.)C+@6Y.C9
MQ*H1#TE*5K(['H0>D#;SS)$I #  5/MK8^Z@_M6'Q3G^^CG7B;!U"L$OV].7
M?UA\6MSMU8W&83!U1&9081N(@.=:0JE94VLU1_YH!-MS#T #OM8?8@[0[JJE
MJ.?&SO_!Q2\?<?T)'[(@573*BPPRFUBW,$= C &*<,ZIP(-08A!:=O_\F8?-
MM,/'!.*<&Q'O\N;S8EW_Q)>4S^D.7W_Y?(X7=>7(-3<I16M404B*[G3E*>;
M$#3PG+4O@ALWL,CIJY^:>79,.YQ,*^09(;-97YR]P^6'J]X6%7(4+'@HN38J
M>$..GE$4ERIGN%%UU%(<XL/03[WGO]#O'OLN#SX[=T[J<&=W?RGVH/J;)"H3
M0K@Z9B(58ESK" ZS 9%1LQCH="0]K?+G=#8.4-ECI>\AOYG5_N-BN?AT>6.J
M"-,ZEJPA,&)9,<7!QZ) 2/+%2[(H]:!!_H,4_^#3,ZM^'\6MII#BW.K'/^X1
M'IT-4CL#NK9-*^8+N$(A63:2*QZ"M'%0R^<P]=__]#QNY&3JWUN*';QG[-I:
MXY2(Q=<%##J2((+,$+@-X"29PEP4-ZE5D]5^.XY;EB&T&*:SGZB[0LMV ]Q/
MJZH(/'_UJ0XE/[.9^20H5!:%:U#)EEKP[P!YX8X;H:-K,Q/U1;+F[L@Z4.G/
M@NA0#70 I]HF_?ZZ3?J,S*R,WAI 60(H8RA08MR!-E'5!0P)&XT6O$_%W)U:
MTX)E;_EV@(V'-1D/9K/407GINK0&/^0S7:RN[R]@LR/4ZR0@N%H/[+6(%@7!
MOE4Z<"B-<S=[36V$FNBF"]3=2.IF=^_/R[M_]E.^.-/*![KF/; 2.?EW:, E
M*<$XD64T*&2C#;5?)6WNGK%6%]T4FN@ 6G=LW*[1K<GTJZ6C'Y:+_\[I[?([
M7"\7RP^;,\8P69,0=,9<2U 1G*58(FEKO2I"1M&F8&84F7-WHTT+N78:Z@!^
M#VWV]QCSM<^HN>3>F0B9F5R77VEPVR1LL<$J5AS3K;SVW13-W=76\J[<4^X=
MCN^Y?^M_5TJNNQWSO8O?BV 34P(XJCKY6B9P#LDZRY"+82;%W,: C2*SEP+2
MUG[9H1KJP("]P<W'[\]7OV]-\HVI?K]ZG<DZW^Y'_K^+BX^+Y?O?\_EO^<?5
M\N+CYLPRKHF5NA"DSL^.G.QT877AD16.SIFEX]<$B'L2W$O)US20/(;6.@#G
M38KYS>I36%P57CZS#^EFR\B7Q[O]SHI6+ 0*T%FH)90Z%PK5,YU,5$%%FV-A
M;9Y=)R"^E]3M-* ]MC9/$\!GTD3R84*A&\,;8M%'8I$<XIR"QU!"U*R-Y[@'
ML=WD$69#Z"AUS=]^-IS#5^MUS>)MEXW?W2I7.S3J18*9\V3!:U0D9:PE6RR#
M11D+5SSS.*QA=B*"9N^$G :(L^FH UOY*L9UKI1?;U8YBS:A3S&"874'+_H
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MN8FAT '@GR\*33Y'STL&(^JT,T/<T#\)8)5Q(D:,096_BK.GQ</@XNPQRND
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M+GMK?U2[RQA5=("K9SHN;"Z:)Y/!F;I-B8E89Y-)<-XA9Q@UNE9M"J?6[G(
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MA6TO>)#198A2TJ%UOI!G1#Z9LQ@89\Z;U*;\.B87$U>RQH#5HA,==X#OS8L
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M^:UDD#R3@6?K4+>IQ.]"Y2#<Z5/"73,==8"_1S$0^:!GF16CM)1@3<WF<A?
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M1Q!C#TC8XAD+KPOGB0&7%D%I]. S&N VN*)%$B$.KJ5M^8YAB#BMM.48XNP
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MB)SK$Z8E]R(&"R0!7V?@D']FC (G!2]9!"M]FRA\,ST3Y_X/UO-W@+.'T'N
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MP A?Q4(NO=<Q@[,YQ1@5.C/0*FS]CDY;0_<'Q#C2[,[+N,M?!T;T4 @'46(
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MHL,ZP!>3"'6X]_#%PT\_OZ<H9RP@'"C%'H!@G[* .@FCM03C:\=\K/OBK(S
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M70W'&0,+APMQ<AC,E_GC;%5'U*4K;OYX_\OB_!P?ADV2%>4(TTG7DEXLBNY
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MX&D'[[4':COM=072J[;+V[B#N*WKA][EN)A'8G6MT$>\^A(<"Y@!2Q%U"9L
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M3--6S8X'P^.$T"*</MZ[TV>FF-,R8X&LML$)78=&H03!Z1^9(C-'C6?+WG/
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M'F-"XMQ2Q6_"JG:__X$G-(,?^M$#IH\?)Z.-1#)RC]*0XD>?R9W-M=HA"4\
MU](1UE4NS[$RIS\/RC.;O#<2G*DCL ,OX+@*P)P1BGZ+;* 5/G\EDKOB=[A$
M<A<03!W5^W 9_XEILUG^/:S^A9N7RT7>]=-M0YTV<L5**I"40U BUKV$3D )
M//G I#5</77U/OTUSR7)W$GNRT&$T"R<]O'2R%S.+"DR3!36<=D:HC0.O'/&
M%)V8-O$T0$V>CNY1F =AY C.3HV2-\O-@^3LX]\J.L>T8V",+[7V48"/F($9
M+EGTUGO/#P+*T]_5(E:.$>IR. Y/#9@]+1\?HD7P3/<K8\083>^^H\??%2]
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M,1N"X>(@0_MPV$QI3YT@LMM"/X)_$XO][_/%_,OEU6.J9?92> 2;F0 E789
M1A[H'#E+@><H#QIY=Y#@?_CJB45_C."6?7!Q:O&'/V\<G#EI49"17P0]IO2L
M9;+T-0(YDKX6M?'L#IIV<YCX;W[U-'9M;^(_FHL-!%EV#Q[]Y>WUAS$F1=8,
M)%[;4;2FP_,@P*-@NBCCA!]FZ.4/QYAV&G$;@;OCY=( J(YGW#79BWS+ZA>R
M>*R[MHMFFDQPI2%8XD%$+(R)X'(>9N3.$-1,&SLZ 5Q=>]"&EG0#:/_ER]>+
MY3?$&P7D5R\*4SK:B*"3JL619 K$*"-PG] F),<U#%/<^^"1&N\A&QPMM]?
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M\5':-RN-.ZZNUY=?=LSIOR_SL6\9L.'R8.+:Z*0,19(7YQ(H'A0H\MO 1>'
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MVC$@=J:ZNXT3'[.&B(7+&%1( W6X/M]!>YV <=B@O2Y2:A)K^U%+S'ID)3M
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M"";(HJ3 O";[>IC\P)FF3SO)OVOZM(LP&@!7KPZ>M%9H;SE$58BQ/G$(] 1
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MQ/9=!4/L#RBW!M0,+LI$^5['IVT4M>:\^#B+<_ +^ 76_Y][XY,))A,+7.(
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MW\[5JT,"H<,UW (L-FCFQE(G"L4NRZ5.&]=IA'4@1EC,,ABHY,VPP!B[[OA
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M>UO6(>U1)Z:4F7!!B0P2E22=(#BEN/+>XH<38&T?VJ=Q.6/WLGD?VJ=]#-
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MAR' KW]<0<3//U^7O9DO^6NWOBZQ^'4ZN9S,RJ^=>VUD9C&01!.&I\R9TI$
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M"#EN0<+I$?FT[JJ./=^NY_SLYVMM'-%IZ)#7G,BSOCR\(SWM:E5^(,0=2G.
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M-U@#J'NJ//^\OC:3"FBT7"A%N *!?ID*8G%*%O)VB)HJ2UF=IEQ["CKN%LD
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M$3 #(PEC9%8WE):]U"8-R&HU:S\0@'Z6W!D<N<KB.N;BZ GDHKUUN7C!+68
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M[Q$LO98U)PI?=YKS*3Q"MBC<^BGK7@=:^XY7^1G>.//OOIW^!5!+ P04
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M&%,&2L*Y-E]/6:(Q0F(2:%0&ENL)24;"NQ6WM6-R6&B8?4H3OBJ;Y:9K"*G
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MR>\DQ6_^U<9\/SKY%U!+ 0(4 Q0    ( $6!7%0!>B=9/!,  #Y< @ <
M          "  0    !E>%\R,7AV=')S>#(P,C$Q,C,Q>#$P+6LN:'1M4$L!
M A0#%     @ 18%<5/3"PR(P P  @0L  !P              ( !=A,  &5X
M7S(R>'9T<G-X,C R,3$R,S%X,3 M:RYH=&U02P$"% ,4    " !%@5Q4/&#&
M)R<#  "G"   '               @ '@%@  97A?,C,M=G1R<W@R,#(Q,3(S
M,7@Q,'AK+FAT;5!+ 0(4 Q0    ( $6!7%3OHR>5G;4& $[+2  1
M      "  4$:  !V=')S+3(P,C$Q,C,Q+FAT;5!+ 0(4 Q0    ( $6!7%3"
MJ3-EDRT  !$9 @ 1              "  0W0!@!V=')S+3(P,C$Q,C,Q+GAS
M9%!+ 0(4 Q0    ( $6!7%2]%!+4,S$  -?X 0 5              "  <_]
M!@!V=')S+3(P,C$Q,C,Q7V-A;"YX;6Q02P$"% ,4    " !%@5Q4\D\2P))Q
M 0!KVA  %0              @ $U+P< =G1R<RTR,#(Q,3(S,5]D968N>&UL
M4$L! A0#%     @ 18%<5$N>$\$X?P  .XH  !0              ( !^J (
M '9T<G,M,C R,3$R,S%?9S$N:G!G4$L! A0#%     @ 18%<5)HFR[/1.P
MB6D  !0              ( !9" ) '9T<G,M,C R,3$R,S%?9S(N:G!G4$L!
M A0#%     @ 18%<5$1#HB- 7@  8&L  !0              ( !9UP) '9T
M<G,M,C R,3$R,S%?9S,N:G!G4$L! A0#%     @ 18%<5)"7A;QGG0  *K\
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M>#,Q,7@R,#(Q,3(S,2TQ,&LN:'1M4$L! A0#%     @ 18%<5 VH6WL&"
M5B<  !L              ( !QG(. '9T<G-?97@S,3)X,C R,3$R,S$M,3!K
M+FAT;5!+ 0(4 Q0    ( $6!7%0F]/^[! 8  )H:   :              "
M 05[#@!V=')S7V5X,S)X,C R,3$R,S$M,3!K+FAT;5!+!08     $  0 $H$
(  !!@0X    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
